<SEC-DOCUMENT>0000064803-22-000008.txt : 20220209
<SEC-HEADER>0000064803-22-000008.hdr.sgml : 20220209
<ACCEPTANCE-DATETIME>20220209063735
ACCESSION NUMBER:		0000064803-22-000008
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		143
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220209
DATE AS OF CHANGE:		20220209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		22603738

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>cvs-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:101452a2-2146-4b57-8461-1c52c7d6326c,g:5f4a3ace-4815-405a-b6fd-039bed36fdc5,d:bab9fb71d67648f0b758869f160b7f4b--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:cvs="http://www.cvshealth.com/20211231" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cvs-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl80L2ZyYWc6YmU5N2FkM2ZkMGQ1NDFlZGE0NmFlYjhmYzZhYjQ3NmYvdGFibGU6NzM3NmVkZGJiYTNiNDkyZTg2ZjE3OWQyMjAwYjkxNGMvdGFibGVyYW5nZTo3Mzc2ZWRkYmJhM2I0OTJlODZmMTc5ZDIyMDBiOTE0Y18zLTEtMS0xLTE5NjM1_db0717f7-5eb5-4e22-8c88-67bfd90db4c8">0000064803</ix:nonNumeric><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl80L2ZyYWc6YmU5N2FkM2ZkMGQ1NDFlZGE0NmFlYjhmYzZhYjQ3NmYvdGFibGU6NzM3NmVkZGJiYTNiNDkyZTg2ZjE3OWQyMjAwYjkxNGMvdGFibGVyYW5nZTo3Mzc2ZWRkYmJhM2I0OTJlODZmMTc5ZDIyMDBiOTE0Y180LTEtMS0xLTE5NjM1_4eafeac5-d1e8-444d-bfae-f78ee492a39d">2021</ix:nonNumeric><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl80L2ZyYWc6YmU5N2FkM2ZkMGQ1NDFlZGE0NmFlYjhmYzZhYjQ3NmYvdGFibGU6NzM3NmVkZGJiYTNiNDkyZTg2ZjE3OWQyMjAwYjkxNGMvdGFibGVyYW5nZTo3Mzc2ZWRkYmJhM2I0OTJlODZmMTc5ZDIyMDBiOTE0Y181LTEtMS0xLTE5NjM1_378eb569-d6a6-4c02-890f-62d897e9f4f6">FY</ix:nonNumeric><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl80L2ZyYWc6YmU5N2FkM2ZkMGQ1NDFlZGE0NmFlYjhmYzZhYjQ3NmYvdGFibGU6NzM3NmVkZGJiYTNiNDkyZTg2ZjE3OWQyMjAwYjkxNGMvdGFibGVyYW5nZTo3Mzc2ZWRkYmJhM2I0OTJlODZmMTc5ZDIyMDBiOTE0Y182LTEtMS0xLTE5NjM1_4b40bafc-33ba-438e-958d-652094879b2e">false</ix:nonNumeric><ix:nonNumeric contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzktMC0xLTEtMTk2MzU_413fad1d-00be-4acc-8403-96459210c49d">http://fasb.org/us-gaap/2021-01-31#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzktMC0xLTEtMTk2MzU_ce575564-f9c1-4e8e-b797-b6c51cf6b1e3">http://fasb.org/us-gaap/2021-01-31#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:TypeOfCostGoodOrServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzktMC0xLTEtMTk2MzU_d0d59c58-0b62-4ce9-a194-f6d689cd4c1e">http://fasb.org/us-gaap/2021-01-31#ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i59754cbac5c049eeafbc35f207330f42_D20180101-20181231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NjM_bdbd7ade-1f47-46a7-92fa-bfb084c43320">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201602Member</ix:nonNumeric><ix:nonNumeric contextRef="i4b779e18acc147f29614409a3ae3a1e2_D20190101-20191231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NjQ_6d63f6c0-91a9-453b-838f-78265109358a">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</ix:nonNumeric><ix:nonNumeric contextRef="ic8b00a5656814734a6bb268b8e3ca5ce_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcyMzEz_ea62d84c-7b65-4b23-9d75-3a8341c56a52">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" name="us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTAtMS0xLTE5NjM1_55ac48cb-f36e-4b9d-8b69-3e86d1c383ef">http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonNumeric contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" name="us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTAtMS0xLTE5NjM1_fc260d98-5cca-40f0-8e2a-2fb2b3ac6249">http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations</ix:nonNumeric><ix:nonNumeric contextRef="ic8b00a5656814734a6bb268b8e3ca5ce_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzE3MDk_ea62d84c-7b65-4b23-9d75-3a8341c56a52">P3Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cvs-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5e000b7c7ed4445a36ad3eb67d14356_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ic767c69faf834e03aae3c9e3cc80734e_I20220202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i5b1c494708b64508a432d97a589ec1b1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad0aae9c9f234ff9a73812a8299c6fe2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04aed4c0666b4206a0f62a98a13ff94d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb864d41b1c444a2a00ada6c841fd965_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e3c699aa82e4cebaf12b6a7d6a6a99f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbd44c67114d44b491ec9aec28225e15_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9bbc3798d714a95928e301134f0a8b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23e34e947aac44fc9f5cf5448f94f452_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13739c11655d4b66b619ac881014f765_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33c39d0d9ba54e4b907a2d6936ea45ca_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec75ad30e89c49a4bfce46bec785eb96_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f466365cbeb46d881db045c29a1ef18_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia28cc8e6f81b4b99804fb1a37a6048e6_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2ef6efbc0d84de58ef5fd7542800f18_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0431fdd1f66940e9b1962a8525277501_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i922cc6127555413782578a7efd08aea4_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8eb6b30d69b40b48d66138c22c9b950_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5b7f3560a474273bad7b3d0ff254e29_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4a48ec7199f497a8e3d91de1ccd3577_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie160f6b16d2b416d8f1acb180ba3d07c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20b0b671c0474c61b1511d61c0def2a5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaae61e2a7f494d8ea336357a3fa3676f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i025b485e66244023b72a2a031c0188ef_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i216fe0b6c7d94b40ad7a901f182062ef_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9ef2fb7202d49dbab738960740d4b6c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1f119b7cdb141be93131047a1d79f5b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieefff43749444070a945dbf9c2df4d4e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i198e53fbfa9d4d0aa17e97121db6bb9b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3debde841b1842a2a969406ff590b5d4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10cfae3f6a64475c8d6390a56c1755b4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f936984dd7642f09c851e2ced784e3a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3d706b6763848048a19f678eed0d6c4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e7cde5c47fe423a9685bba813200907_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5e60c7959e643d6be2a8ad6547a16ce_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3054d32553d24d498f6e64626c62c7e4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9b253e4431e4506b41e93b4e3ffbff3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i521bf812b8ca4f2f8127d65ed79ea126_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb94485c24fb48c8b7669be4b0fc8159_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b3e30b3db154240b2043b0ca843e316_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3850625417ca4ca39a069dd8c4de7097_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7cf273211e3434f968bd606d4a81280_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41a840db4ee84036b3bbb93303320613_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd578f81db5a45f1bc8d5b32e6e26a16_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6be5d7176aa0457288fec9de68e4d419_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i929ccc146bfa424592ecfc18373af370_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb577f06e3b04c518c1c4543d6ddf983_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79a394a32aeb4c939df5cb7fd7e0d46f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if386c5ae7c994951b21ec945131fa3c6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e4d5f3f2aa745b6b9ea7a35265f341e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85992156090b4f72a932455b1978952b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7770de66bbf94051817d87cf6240655a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a4a4ed30a054247bfaad062f649f9ee_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id62e90e3302f484ca4017d1a85b7a1ff_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eb317bccff647f6823df9e9b149c181_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45641c304daa44c9bd1f3c9070317105_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1c4532731df4ec9acf2bba885ccbc0b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie84ce40f593a4f1b8e95de37fcec950f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71a1c12ec5c146a387fb13e1ae8a699c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66a5573b2fbd4cec83bc9c6bed71ef29_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic88e5b2354294af7a046754ddfa0a46d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61119d4aa25b44fb9ab0ce32bfac9893_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9bf280de01e423da0805c5548da8598_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f46c0fc299d40469a5d7302133c63f1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59754cbac5c049eeafbc35f207330f42_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b779e18acc147f29614409a3ae3a1e2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia694d76108a14467a887dab2055e6ad0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7310250aa7db49e5bb0700f9d3b0c92b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="store"><xbrli:measure>cvs:store</xbrli:measure></xbrli:unit><xbrli:unit id="member"><xbrli:measure>cvs:member</xbrli:measure></xbrli:unit><xbrli:unit id="people"><xbrli:measure>cvs:people</xbrli:measure></xbrli:unit><xbrli:unit id="patient"><xbrli:measure>cvs:patient</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>cvs:Segment</xbrli:measure></xbrli:unit><xbrli:context id="idf62411f04644ec5a62a251e4c8f705a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>cvs:state</xbrli:measure></xbrli:unit><xbrli:unit id="clinic"><xbrli:measure>cvs:clinic</xbrli:measure></xbrli:unit><xbrli:context id="iaa2dfaae047842b6941420922ac5d9c3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d5000b271614c1d855c110b625f929b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib812c723ed9c436d8f87f4410c352090_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cvs:FixturesEquipmentAndInternallyDevelopedSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i485bcdbe665a4e4cbd15d510c347723d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cvs:FixturesEquipmentAndInternallyDevelopedSoftwareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11f43eb2bc384595bbbc2dc60fb0e429_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab960c5fc78c435185612e456997735f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb17dc7419794c27a906e798d28163ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d5a1e36661d4e01b93add403e998d55_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie95f04d20e7d4540beba10c465fb945c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i220afc16aa4243638833bb1917d74494_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06c0e02c68194f43b7f9e96b2667ef52_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i334820a07cbd4de3a8b8dc2ef2625448_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01b95bc53d324e16ab4248f13d4f4b5d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b10e7dd209b41c8afef5d331b8732be_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73df28e0580843f0af8aec248d34934d_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f08d731825c4986934a5374bd021d17_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b5082eb85c041ac945f01d6bc51973d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66d7d53744704d0d935a2fefbe9f6853_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2350df645dc04e808a96e20dad3a3fba_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f4611487c414f69acafa1f966054637_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8b00a5656814734a6bb268b8e3ca5ce_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia549907bd80b4d05927cab95ed27791d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherInsuranceLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if864780575b94e94ab5aaeb609bdc2fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherLongTermInsuranceLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7923496932ec4872a3aac9f738db85f9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherInsuranceLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b4429ac745c44638a7414f5ff8d6894_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherLongTermInsuranceLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="if6a4e820cff84a708a34d9940c913923_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45c5b8fb4d364022b20880618cc963ec_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e7c0dce760d47df841954664e69c360_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92c848c1cac74063a225275fcd16ac3e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:BrazilSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4498de5248d54d40afb291f1fc098731_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1002f99fed94f288ca5f74eedbdeab1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebcc3ed38ad2471582d090e796d7ce3b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fef8cff035c4c69a8c38c9106be1c8d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c932f46423b4eb0b5ffe12d1cb5e4f7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58bb9dd9de57438c8823cb7f0f5b7456_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ddd2583249240ab9fd8716ea50815be_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62292b173722422f93bc0d15e20388ff_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if247a044060a414a9731ef3f633443ec_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ed9316414794c62b549ee70109c3a1c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia48e9a22e1fd4d718486619d4e3719f1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie803710aa3d14d08b76f31d1d981933a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d061d240a9e43d88eb56b03b4b1c305_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5762aa2abba7409a8044131daa10dbbe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f9354e553ba4e88889df599c49592a9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42258aba1f3844c79f036592fd2314f6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief81cfdad9484af6b31eff5e1128145b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e052765fbe5467a80a1782764372f99_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d8f78677d6943988b31d555638bbaf9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2301583729e7424597c39ac7978d0401_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f0540b87ed34aee812a4602f32b0fb6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4344db6c31344de2b14b66847d6c28a3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77576c1c65984cc3b50354c3450129d5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc537d99f46e4ee089fc01dc7844328e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i071a8d3987fb4484affa36468d188f51_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f2f0ce0e931416b9534dcfd36624ed0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b8deab908c04d898d7365d0a57ffc0b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45a45ada9f7246c3b344e458342767f2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61039a6c4f3941c78fea069998c3b394_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ffa587016394b5784b3a8591967b741_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7055234871404d9bafa8741c06125a63_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cdd84a2122f4e48bd7e94aa5a543fc7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i248dfcc1ff5a4287a22a16423cabbfd0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21ddaf2aa6974aadb1b64f7b7a5257ea_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab97b765af4e49ffad5046609f678a8f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fe7b82658e94a3fb768194bb39484ab_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic786c87383ae4399b318ad961ecca522_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide7ebc79d9a54efb884b6972df58c788_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dffb1a91abc47afa1350fc6dd222a18_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a337ef5a1564ee49dd9f743f426f9c9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic10b456383584d7aaf8f683720fcb914_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id140f9f8dcd14083b50ec69d7cbc65da_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c6cb5365a9c4dfe9062cee2d3a679f4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia41f6d7659764a9394360d2e7ea49f1d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib84692036a6a43eea3efda3fce3a9e9d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id67aa7e2958543c5b2a212d2e9f5ce6f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f1ba091cd86434eb258ca50211e3939_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic31dfa14042e414482c4216963d92547_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76be16bc9f6249b9b235ac3756529601_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53db5e5b0b444479a8a8759dbf521388_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia854c1c4120946f68b69cb19bc260e4b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e61340f47284992812b376b1458946d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccc3d52c70ae4beeabf495e0d535c807_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie27ebf5be86d42d08d5b00b28a499bb0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52561c6040014302a3dbd0c238d7e542_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1e0f32f6d3d4988bc853318d22b23fd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic465100ccba348a3afd34c383000632c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0249f41894f841a6b7dafe5cbba83478_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14fe0625f7df490f81964160bf26ed60_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaaa14ca219c45319101f3294251d63b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i447cc1b65f104221ab26818c3ed22faf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic21b7b1b632e49739aa4555420878cbf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8af99e3f8f9947f49861abe488bdd637_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i012def96350649cfbe7d7eb9602d64e1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9001e42259074da8941f556efd30f660_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i966eb89f8da54934ba00320af7713451_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i157fcde113c546639a94d73e35c8837f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib92544612b6649778126fe8e9ab6e9b6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa6bf06bf5cd4d70ac02de5a1d25d970_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fa3db576bc34c4b81beaf1e716f51d7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib11ea18304ed4f7cab2400be338b0bf5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75513592809349c7a84c02e527ec7282_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56591423c17340e982228082d680b5f2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fb12e17ce2a48c9b260a608e997c399_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib775f94073ab4897a08bc1477642f227_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87a4d0a1226941d4b0d276cb76e9483e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe2fbb48419543c3b63c3ed144b5a10f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26af9cce866f4682bb01349800a2150e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifba04a8e07ae4647988ad6d2b6bf1364_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfe3ddb6c3a34749a2820654200c6a8c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7683c6a5bd9a46859b7c36e87aefa23f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7a9899058b146b98d338385726b8c33_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0059ff87fc364aec80f3c7eef6a97f6a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa96e65bf6294c0ca787cbef203ccb23_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic17eebf2b4964519a5671bddafa2ecae_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4d27cdb62c44a25a61a4be0d895fc4c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3037e334694c4257a0adcaa55fac67f7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie27c33f5643f48a6ab725eac74707192_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a078bd350664f23bfb042a07d7c28aa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id33fc8f7a4874100ab8c405e4632eb30_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i054efc215dfa4b1fa92da514a6fad49b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55c01612bdda4f1bb914815afe3bbf95_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72491a4fae084225942f973da304ba25_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76238069608f4813b8d2ac5bfe67dae8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d8804cf6abb4698a6a8f6b7fc6e7b28_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78a023c8e08447dd9462aefe43f9ffb4_D20201022-20201022"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-22</xbrli:startDate><xbrli:endDate>2020-10-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55877e993992468ea1377ad4577db051_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifed7853cc1c344298bd8003d3174178b_D20140101-20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cvs:RedOakMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-01-01</xbrli:startDate><xbrli:endDate>2014-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5565b4e7fc4f4e8aa341da7b6e4e4d86_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cvs:RedOakMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50b4460d87d840bbaafccbc86903992c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1711347a62744966b4e74fee52b0bae9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i064ed72a7c7d4834b6d490201f178cc6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i440e6a46ec8f4ce48ae8a4a7e478b725_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d327db9f7284c37b77bcfaebbe9509a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f571724a5864c5596b142666580c1a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbf81618e0074484b1b2cd8ceee6f5d3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2865e7a41644a8186918f7b00a1a60d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bc52b3acf264acbbaa97645df36b813_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:HeartlandHealthcareServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3bfdde04dbf4f498310d896a5a94507_D20200731-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-31</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i707e6377bc8f46819c6e330be95da61e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic78da50417e849b5a59cd5089920fa13_I20190701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:BrazilSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fd8613bfc0d4364b6e49aa6a8b2d288_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:DrogariaOnofreLtdaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if05932426083419b815e008b577a2a15_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idce08b4519f44779aca159357248a636_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05f36709bd8949388b2c0bffca648d32_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa3a2978a5aa4a7f8e4552df2eb04ad5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22a8dacd69894d99a9e39bcc2ceaa8c3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43542666d6064074a52d8421444a3563_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id321828fa20f46e2b90c44c7dba1e761_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73c392053811482a985a060e47a06d01_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf0593d9cf6f4d2d998803704f53be46_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6d4dcde819446d8a73300389b73166e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i914670b585864902b9f69fc74ba23aec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia121561a4c96461ebf10b737edd09fd8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea2a9101cbed443999a6811800e4ec0b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i747eaf1c298249988bd0ca02e9600501_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice38ed4258344c1a88da2935b0835f1e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51538ba2863d4a39bc671cc6ee1872c4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46e1d222a5ef406c92305c7baf40a7d4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3554a3796746414fb74d5c4eff0aa6b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77885636f2644bf19423ab2c4b27960a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4de919088b4a4df583b8260319c32ee6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a167c8b5fbe46be92df6070dc1ae32b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i353376cd927a4bd89775bb7b09c7be82_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d5babc8be6a447486746fada4d351b2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13b5f509cde24908a226440920b1a447_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>cvs:security</xbrli:measure></xbrli:unit><xbrli:context id="id9b4c5764cb743b6955c25b489dc04b1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ba594078fe94f1fb02a07e79c808914_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7cf85e44bf749c6855a45cc29a5d06c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4529e06963a470caeb617df5697e606_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33ae4ceb49244377b0e406cc7280c9f4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6aa7bf1b9da4fc39d8638e04992a04e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5690dfe9c84946ccbe72c9f299796db2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i094255554a304e7eb4a00d380e2496bd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81f297d193504b64a77dc2ee3da88ccb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62d2db3895b440f7a78f511f11dee508_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i236369a8589648caae4e40a4994ea5c7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if75d546f79f443b2b493051643070b9d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d3bdf971c2e453aaac23e35b5bfcece_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f9e513cbe72495ebcf4e63dba757063_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9e730fea2f548c28423a0d3c0b5d6d4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b3b6d3e1f854783ab31e0f74ac19914_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16a55dfb514944cebf081afcdb79c176_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43d06180041f4758a6cd666c4e52ac41_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd01e0aad9534804950ee3b5c49b699a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide4fcc1c4d10426e82ac1562b152a03f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a11e2f0c8864c3a835f65250185e431_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86f7b3a22ee74b3b99c1724212e5f620_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f64507e6bfd4e3c94c4e571436f0709_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4d761a33dad484ab0489a71620aac4c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec0a30bbded74a4a87b264a68da01b48_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bf8902ea23448c6aa2a6cdd04056a11_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5bd4e5698b542e1afdf687466e73faf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i656346f8e3fc48149bc198665aa2ba23_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i214cd12a886b42369217bf01fba03479_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8250607938c048e5bfa38afa06687ac7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53a9e1cc311f4d7389a00b2614f65e4a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5eb557f297b45a983e00f3a6ebabbc0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id98e3f5681054b74aee1fe95b47cec5d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac455272570c46e5ba3c2c051f9dd18b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4798911f466146f6a09993eaa2849e0e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cac87f1a93a493b810d93704fdee5ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i954fdd1992694dc7a1ffada1f90479f7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb149f2594e24e5e9608148da07fdd9e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9366cbf54d89424ea99dd1bf935c263f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee791b6d216a4e52ba8577e512aefe77_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie04adbbb84d840c68db8746ae5c2ec4e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4c1fa1e1f5b4cfab3344b2360bda448_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic220147cd8734098b32bf1e587f1066f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b1552ff84a14d329639fbcf910ccda7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if07ab5ed5fe44735bee0f7db6106013d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cfce5629c994ec789d3036601d70793_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72e8544f389d4c46a1811d3a41ccd343_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c04a5353793424ea6dd4c537d171bfd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9debbd88735e4e51b8568db394038442_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bb90e71f4ce4742b80486f33e02cf5e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i366b9b5ee8aa4b6f97820e04b932038c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccf3cac287074066895d1a02163e6ea5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96d87ac36ba5416ebb4aef216fdd2adb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97c3ee33af8444709579e3a43a1b8ab6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0377da301945465092de5eaea76ac47d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62b02d0505564979b7eca3037be36f23_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7997178cc177444ea3249f37548ee4e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70079745684b497bb807ab287dd604b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e1919b277f44b2fb842c59d94d1425f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6701a00e113f4e5498744bb48caecc5f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fad7dcab3954d96965b1614328749b8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic031473f406049eeab488d7910cbe99c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a49286ac2764f6c960b95c3ff551ef9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92c71ec3b83541a1aff2732364f1942b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief0401c6d4364a2d91dc94d588b6675b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d7e2c257e7e410baa65d8db69f23863_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6c586309d7344cca6910ecd0006b772_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19b89cce7eda4f3faf261107006bca5d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60dd9ff415cf4307be34d85ab7b5fd40_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8aa576e20ec407ba27840a430d3d8d0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia63d6c6f272f4145a25f9f7581ceda3e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e137b6416194b0c80702e6ccaf7cd12_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i450ae32012bd4a4da4f68d20e1c51dc6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i028a59a7a3bf4c1285313639042fd9a5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f32471feded4c178b2f2c05cebf159d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05fb3cf4bea94dcd9507a7f609bba804_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8da629000164e189d42edeb512f786e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibce5743406e44d979a44db538128707d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41b25c02378c46c99b73c18360004c60_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c71ab108d124b2fb04b4be93eea1a95_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9edfca3af9614ff38ae3dda45b1fe0d3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24d0c995b652444da95a99ac0befe361_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieebeaa16b5e7407db27c743c37fe3062_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia48569365a5049b89c3839c388ba8841_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieed51d61b0d54c6086fdef46e9dc9295_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1746900c4bb4eee8150b6ee721d8c44_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c8f49c4abf245e0ac15d06a1fd72813_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11640c062e35437a84e8bdd5240da928_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91e5f841bc1148249e50546c6b0c4b62_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id661ddecbffb4d32b875d7dde00d256b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id38966f39d564693bc52e2003aea2649_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i324d950c15024b0bb7034483bcf91fcc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i451babf334c54e97bb6b9b0f190306a4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7dc90b07e3e44409f77d5cb120f1791_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3de66b1934ef4735bf9ab13a87c166e6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i866ae3e88ea547cf994e2b7dc57084e0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36ebd6ac03f94f7b9b09d2e42eb22df2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ef2601295cf468496155923c2d3720c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb049bcdaf39409381032754ef26a6e4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3543b9dfd21451eb0a643264ccb77b8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i683159f0075e4dc4bd3680b9a30ee79b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc3513b74a1349019be42383809506e3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib52cf4a485134e87be898eb27b20e43c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5285fd9babe408da40e34a5f27ecdbe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e189ef58904439b8c798dfe80e60a25_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20f2f71ab9e345a3960755605a1726ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71543114cab743abbb973d2eb97c593b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a2c8eac231a44ccb5e9b62290d31c14_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdfdcb99b98d46498997a64233fe6284_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0776297f1b3c4b35a1681eb98f0e6ddc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecac0db5b3bc4f71a118bac63aeab3eb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6693eb63ed74a828d0366b9db5e4445_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied406e9d2fff4ac3ac935e90506bb4cf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i767a0ee4a63e4ed4aa122d6036cf7f2e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c7677c6fdc940cca39670933eff94b7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c74cc1d42334984a93d5efc6aa1eb3a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c0b5fa5eb4a425db34364e49d4cbdfc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i655ea2abe74d44e981581e84041b0fdb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94ed5a8a301045ac95dc4f35d8a94a70_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5a62cd495034feaa642a45f38861a84_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02d753bb590a4315b54f9533067bd31c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fca60115c0f4442898a26ce68ec0a7e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia57d02a5ebe347a2b9e0de4938be4404_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94d0b79c49904cfb8e3bb6884eba4148_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cc1a0e274864af480f200c3ae61c8a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c68ea82b6954ea6b55c0177a55e7799_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia658e0719f064994a3725fa8e7cd5a8f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46044f2e055c425fa8412971d2e99d30_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i300ca3e38be14ff1a4fd2b2fd45caf61_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75a98c27eb9942459eccbefdfca783c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8819a5b1bd5746e9a7bbc6f8ba9cad82_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9de95e7ef9124c3eab5c6cc2fef4f3f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86b4035143a84effa56728c42ea05b4f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6476b9e6b9444e0970ef1e348c4b56b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i002609847daf4257836b24066c83c6cc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8de359f7ead4526b1face6a322f74ad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if02a53ac99ee4a1ea26c7d5e3f59cdc6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb0ed2c7f70d4aa5b6f870dab5201af9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i831eb2d9681540c1865ef9261f998f72_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i802ceb0372954e3b98eecca23defdd06_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87d19268d0744fb497410eaae66e13b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5c0b1f4b23f45dfacb98c427e6d4b31_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e84fb13164240338a6262a473ae3ecc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i306cad7c3b5a47c1a8e32bae3a96c55e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic52bb1dcf3f9437ebd76d07e0d8d07ca_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if97e7b2c34d34d7e990cfbbf44d5d6ed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife5fc6b885a64f58ad6f866ffc705455_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaf20faa368b44408a78e930b5996ccf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i994073ade33544f0933c360c139ab39f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28d3d92a5cf94a3f868e18fd184f97f3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae8be572405d45c991240d652b7efbee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4297a85b816143cebb737cc1343a70fe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49f8a85ce40f4cdfb469db46fc0a3149_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3e2dfc3a14448e4949b0e6ca2e96253_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5019bc214954769b41323ef11d4d630_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0f58cb3118b4270929fe6a3d48f0daf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i956d74f44abd4029b6c77cb197d9452d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3363136ad6a64578bfae7d6bb46bc920_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ebbb82192964b068ed1295f2d2d0aff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51e8f4940ba94ec990e364c713cce559_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentShorttermDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8fe6509813f4691be74589fc2c7309c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0665950998f344f1870f81fb5b6506c5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if31d2cf121644c3fa2ca449a00878b1c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if094b6a90e654e42969ee969a10fb465_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentShorttermDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79c72a2ed64a45778e58402ff15ba10d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e8169d5bee54b719cf109e92dfaf014_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i946cf0e9eaeb44bd9b10d99d0d2271ff_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f78308e3c32426bb0c2ca2138e491d2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1462db60599849f7840faeff7ff4b4f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentShorttermDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i561ca763e6b04428a37bd3c7b792dcce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9f150f106cf4152b9dec763e74aa596_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i565ff383eb0845fbb762f16160ecd982_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie843e7d6706242f988cc00f4c975f5ba_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9109f42655d2473a86af8d939c6306d2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica9f4747830d4246a5c48c387611d7ed_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96db7954709446f6a42325acd7ec241d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8da99b3fc771435a97faa9c280e0aebf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i444b6c2c628f473895e24001c99313a1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb26232bc7ae41f5a142a468a1d38e94_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1e88e7393e140ac8689b32b97e80fb3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i870c8f372f074816aa15ac75a237b726_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f1063eb8760432499ef1d5ac46274bb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5ff79f6ea7640da8266c10697cb62dc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62b52466f3974cad83656f04e7bc004c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63642ca94ea246beba927f59e1a13b04_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib09205453efc4716a5382309d32f4410_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cd5d43d704d45d99a5b19bab4753e1e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39d069b7167947778afa7bcbccb0af02_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc64edc684564c32a2cb0d0d05d56c6b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8f3733991824a44905aef5259a7f9df_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9da88bdaea8642ffbc4835811efe1f4a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb08a50cbb6149819b84374b7f1bb9fa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f215dc5a0264a64b253b72d4f6fcd37_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95b551d0a20b448ab0a332b566d52832_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd1e6f617ae2403f8ab8866007e71088_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0eb0df1025b44c38bf26427309bbed0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd10d01df7834214b6c5d531c819e017_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9f3a4b21109462a92ecc4a3617a03a4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23df6084b54047e19d2389b69af21997_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7c3cc36bebc406d91f45d441bd00dda_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae825b6c46034c2f9017cf824110744e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77d5d134cdca428089c8e81e51a6eb39_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25759438875e48d88a44ca557ed1c835_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if536320d76ef47fb99ae9bca2ae44681_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e2ef37787f44952bf1c36f39df42b89_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1671fc71896b4cbfb0aa01fae5b55103_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadfb5cadc1144fe58f4ba77d2fde510b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb6c57c636ec4b3284104f81a13fd09a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb1458668b5e49a588377fbba57db275_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5a2a1f6fc504570bf00460f0dd185f4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia00a40ff338a463a87188f3855a06aa6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib12b30c60e774f8aafb2ac1b598f1c70_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96dabaf8b16941228a15177e351ad141_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6e912b4083b44c5a957335b177c7c50_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99fe407ef24f415ea6a7582d16faf5db_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61412be3a3f547039aecad27f0ec3dad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0cf3ff73fbc48efb1b7df6e63ad2a1c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d3c804bcc694053a4a943ffedb0ed74_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25f0d513b0894261bdb02c2d00130e8e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82e9727495714f18b22c4dbf7b2c2ab3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b2dcf414fa5408591f2c20e94023b4f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e2f30ce8c9747828f395554d282e011_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94dd966fcddd49c79185fb0a8b2d0815_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4f6242a6485437e8da177a1f5b0f951_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0519e37b33f47f38604624a1c7d2928_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fead32c72504f0d91f1a4db5eaceb10_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e9ffd0e0d5f4defad6c6e47302cd444_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfcc06f892d44fcead268e6e21698a4a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountFinancialAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i594e36f005d3463fa1392c6b6973335e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54659b176aca43799d4dfafb1ae013bf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4560a747fb0428cbb2dfab79c812259_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbcca6fad4064d56beecf38dab7c745c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcf5b0d060a34d59946618c193cd6961_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia42958bc5a30456892df849915469aa3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i974da252533f4b86b21d77a4afd36380_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i225edcbeb1284c59bae6307ce64ff3e7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99c9da9fc50c410b8c73ff24aedfb629_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0701631a0de043b89fd026737221cc81_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6355e336e53c4e8f9fad360d96598544_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i361a96861ee14db9bb7f3e35b6cfabd4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaeb126eb30f245fabd59c464ac7e4e32_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i887e2e3179ff4e359cd08c7e8f1fe438_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37da7fe8ff6e4ca79c5d414c9bdf0e79_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73c432f6e33b44139455c132f65ef574_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8fdc1e0fae4b4a2698619c6886a71a11_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4bb0f2698a942c58b64c02bb8890e28_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i103983e6616d4a4990a7c5de9eaf95be_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00d050761ad14c2da89fffbb93d65282_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d83e40a2262423baedabda99555727d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79e27bc569ff49dbade03b69248d8b84_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb54e269a38e408f8d2a458b20a0a2f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a4de046b34c4136a97065ee6419a19d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if06fa0eea15746e6a253c5997edbd86d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77da570f38b34e80824f67bbd3e96001_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbce2e04d85b437ab5c70fe68d26c55a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3fcb171d2594f08acb2adf5555f935c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3dd11c0ec7649d2b02e6e800b19ee58_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e56982d83d84bda83b00a3ffffe885e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefcbd5f8eaa54f5f81cbe1bbdb76713e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20ffed25fb4d4e59851adea90169ac61_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b7b56c81acb43f6a6abd4fa631a8739_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a39a03b1bea4d85859fc29eb70c86d2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i447bb7cdaf5843b5906448ab4622616a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i254473f0a9d24243b38c3ad981a7cf96_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd712a6b3d0143dca70cd166d1917ef8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88e46bad2a4a460281a974cda1807f05_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f21266668244130a2a3ae68e0af51a2_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id393d68c87a14ecfa59ccd66f88d6986_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertySubjectToOperatingLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if36ce4c23dc24bb698d0b377df751c48_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertySubjectToOperatingLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ec38326eb9b46b19c242875eaaa6067_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i662bccf7d999425aaee1852c1b46776a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4963e68529a4b8092a5dbb197266a3c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72c01c7edc6746428feb2cca829e603b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if19bfb96ace84f7ba6e1dda34847936f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fa3d998066f4ae1b676b83334f1c904_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76012d8261584b91889a99647c4b75ab_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96bd81c6654246d5be1e598d6b692530_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadbcbd4d470f4615bf38443ed006d736_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i158b727557ce414a986ec4f36279d415_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59f215ec163143bab8341e2e7c77c7f5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91523901360c46a3b3e64cd533486ad3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2efd3deebdcf481d98efcf7a26363660_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4c47a098f1b415db3606ac2bcdcf33b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id230e348ab594d0499b52ae6f1d6b47d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e3b186508ca40dd93af39cb786b7ba9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i529804562b5e4b20964ec542de3a4305_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if03bd9fe13614b36a4342b0424978822_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.125June2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f67a675f3fa45c69b8fee2598feedaf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.125June2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d3ecc7d88d84421b8594f43a72e7bb9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie046158c6aa149abae5894fdb3e124c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa15869b2ddd4074bd9606c1b61a3b53_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4892cc30de7a4f45a88addf5dc0f50f4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1545ac7575274fbab03041015d476d86_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i566f70fe4fc44db799a8e103eafc538a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia06ed28b864c45d09aa4e68d0dcd0b8e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83c484e09e5c48ef8e40ce7a9666c2e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38871ce4eafc42498a31f0b4aa3e0fd6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b47680e6fa347cebcc6cb6ba06e1468_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i528008a52e3c42f88ac57efdeb1d1e22_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78c173076a904738ac9a7ceaa5fad016_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia90eaa0d021a4defb944082e8dfa339c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4acc5bb45f824af59b9b441ae8323056_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia75e4b48aa6d46ac8cebd9bd97a2168b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6391c2fe51344c3b0267bc8490521b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f81ece57db84513aa5335f4b3d6ac08_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icea1808ecadc40d6ae18942dd91a82b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90b9d6ed5b7745dba7e056a1af581ada_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc98b0c5fe2c4b849511375a8a2ddc06_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaeff74e546b24362a8ad306bbfe3bac2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia937c17cc45547f2b5ebc4e8a8bc29ad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3df15a807dfe4bc393599d84bb5ae0b8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideb967d8ef3440d2aad2a3470fb2b109_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5a6bf862703486796be7735801625f7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02180112f1f84663b7aaefed8c65784d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida41dacc05104cc79603a44d10527e6f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad98b34b91f2400e8d921831383f78ff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5f70911c7434c7c9d30f3e9f6370e8f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib58d5abd3f97466997c356cc6d003abb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59b67f5f8f844ccc9ef30578495be520_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1b1585ec2b24b72b0323f62ac998309_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bd90d57c71c40889aa14f074e72525d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i196c3c3a85b54d0c823aea5345bb1b47_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia31f8a1af0f74612b2137086a863b2f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point625PercentApril2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e16f05ccac849f6b7239ceda71c5435_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point625PercentApril2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib01ceb33ad054c6a90191f9d95d44d72_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e79f25e44ce4192aef42fac92e6ebba_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dfa4017c31e4a769e1726240bec574a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point3PercentAugust2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46f1a5a00e9349149a87d2a1ca48676d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point3PercentAugust2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e941767d34940eb84521c5bead4b66d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifeff226b8f72491b84a7b76931939c6c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i829935f435f8417e9ebe4db76abf40d6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9a0fde9614c415093ac05b5ccf09851_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2383f6f259884a2ca2d37bfea6f7f9b1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point75PercentApril2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i963597ecd59945d0b5207daf0eb2b186_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point75PercentApril2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib90e1ba9c1fb44d496c2f63b444e51ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point75PercentAugust2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17a365c216d54612a53d69c5c0e80a5f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point75PercentAugust2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c47829d25484ecdabdc89287f759465_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point875PercentFebruary2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fc01427e2da4fb88ab22fdc0b7e32fc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point875PercentFebruary2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6286228091e44d0a7a084cebf96e83d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point125PercentDueSeptember2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7974392fedf4d69b48cf73026d43053_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point125PercentDueSeptember2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66d6bb918a1841c7b29b4e54eaff9002_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22855f4f70944d80a431f1009d80d2d6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6deef011e2dd4c96bd53333619f01231_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie75ef397faf445d3a901e0af5e125899_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d9e820cbb5640bcaab284f7fdabd210_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic356af28bfd045ffa9174ee4741a3d1e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if36b1314b05240d98146140634ecdbbc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica522c18f13c411eae44d16f4d18ce20_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibedc3ae92ee24ab597438f089a05003c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7ccf63bdf184cf98f51d95c1720b750_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66980e2699e94ff68df99ccb53d43a5d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point125PercentApril2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59a1bba78be542ef8a8f0f0622414168_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point125PercentApril2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b5f82fd2e9948249d51305151c10a0a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point7PercentAugust2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a3a26ae8b3f4d658d7d84e925e6932c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point7PercentAugust2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba9e24130d424bf7933c036abe3fcacf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i731815b798d2445687a0b94d8984740b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id78a04082f9f4d9abbc5e0508e3f4590_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcbe63373aad4f449cf221d8fb8bed34_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08f395fb692848039e5b5e89cf899bd7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5872f67f264f4286ab44e43e24612b0d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie72908e23c3040c0a69888583cbcc793_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifed64cc823de43c7bf2f78098c4438cb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ba90e1b15f247189f65ef311ff3a5d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i369332f01d914260ad39bb9f3745585c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i189a6cf6ec97415ea1727e01c3f51404_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4a2069eda0d49ae856f3a624d3da473_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e79648650b54806a91c3d411f2ea35c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e6ba14d8ad442b0b834bdfbf7a454bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c6e0f8b2d6a4e219ead75b3e364997a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67abdddccc3d4638bf07489a3670086b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i301c0abd44f8465691076dc9cc3fae50_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point25PercentApril2050Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73fa3cf6a6e94e878b2a4e89d3fa5283_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point25PercentApril2050Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i014942cdefe642299553301bde433b97_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46529d5778ae40bb990d932509dbac03_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96887b3ac58640beb52a82bd21eb813a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9cad6a94a214f4bbea75d3fac5eaaa9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay172023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0889c6d0f22449efaf79e5043bc52d47_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay172023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i006c485c30a0471dac8a843ae0803178_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay162024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54d42741e9a84f52af2882db08c58b47_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay162024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib44b6fdea84a4c50aac9b470b1ca8124_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay112026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d78ef11f57e4edfa8419e4be3cfac0b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay112026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4daa4bf26a7e4ba985ffd4fefd569f08_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b91388b635e423cafe7fb2c8c8f40f5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c07b91fc15c48388a8d68005ad93a4b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d1e81300be74367a642cc8e00fcf76c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03fc12d9dcc14bec980f92dcfea940fd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib06d0888e42f4a7f9d3dd17b79f3d08d_I20210818"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point125PercentDueSeptember2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a2c1f6bdf614434afbf804874bfc4c5_D20210818-20210818"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-18</xbrli:startDate><xbrli:endDate>2021-08-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4ec5d2a13b34d5b970af83c0b03a435_I20201216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94cc0d983ab94bde8b7090b07fa45718_I20201216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd90a04249054ea4ad16eada8a0b09f2_D20201216-20201216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-16</xbrli:startDate><xbrli:endDate>2020-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id52f5d9f143f42e29ddaadb1b8837a16_I20200821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idce8059065244c0699beb758c0989a41_I20200821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i529043993c644dd8aac8807ee5d2c7c0_I20200821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8afcc1e6458e4e11b0ded455489215ee_D20200821-20200821"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-21</xbrli:startDate><xbrli:endDate>2020-08-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if63aa33153fe4482bfd5fceb634e5359_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3625DueApril2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86d4fa4ab95046118e795a12d33f7b88_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes375DueApril2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie826ee2c5ef840c18914ca3433d41756_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4125DueApril2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4fae0970ac644b7a0ad3a6efb7c6d19_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes425DueApril2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacc2ab2c48914d7f9b06a37e300d7eb8_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes425DueApril2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18bedffd3ee14bd4b98e02cbf1196a0c_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i149ae25cc3b64a2f92739b6ff6dac510_D20211201-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point70PercentDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd0ee6924ea342c4a56038c2e5e18a64_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point70PercentDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f0b12ab5b464e1496ae54d1e5e61e87_D20211201-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53460cbad4244ab5955cd283bcde34d7_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4PointThreePercentDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i276b01d57f2045d0a76f58a233e35d9f_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4PointThreePercentDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39b25004923a449c988737a1efdfe4c5_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82ee6a03a2f04ee8b61b452feff3664b_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a7bb6963c09454281cf0360dcec5944_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4644ff08f014f1b9eb1fa8df30f2d1d_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72ca6906eceb40d5b6a9866cb6f06416_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ac0d8f26f1643619504cfda7d91bffd_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes43Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b86af123f0342d4a6104d4be9148913_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes43Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia73567778f2f4e638670d5dc29eefd86_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b3cb303f4194f528bfb52cc092455a7_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67806e913a8940939ff3cb535bf4e3a6_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e64a0aea79e4b548c70ee282eaf1af6_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie519cc2420df4c91a4824dffc41155eb_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb5f940a259047c798edf06df3e9a282_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c074aa9c6834d2497da9aa3b1bf52d1_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib61285362251444c8c2bfd25138ec3a5_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4d09fbb1bb54cb382bf1b47e6f77cce_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i362f2c27267d4320a08ef6b47fda9bc1_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5d47a67418245f7b61330d02abc51c3_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b1b35e1f5e04251b8abbf5474581c4c_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9179b36d9334dc682bda5ab696933e3_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cvs:FloatingRateNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32d5285ef7b24b989560ef483b6354fe_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08a8d0eb8ca548e48203788144525a13_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc7d49779e63442cafbb5b988ec993dd_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib08d4d156b344abfbbdb0a987bffa850_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia80bef5306614fe7bc79d4a80fdd7a83_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie617a7b5c5cd46409dcd4dd2149324f8_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad60f7a1628244d2a8b435b05fc44593_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1e7d725090f4e1cbead4dffeddf31c7_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03679feac9004c3babd99a1e76970bde_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d6e9082a5464b3c81907ef022a3e221_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f04ec02cc3f4ecd8284b436de929707_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i155bec7d75a941458fedd191eb885b03_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42e14e6ecf0d4519bad91c300172ce00_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf1063688e1c402b918f2251c5ebcda8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3134e38a37b94c8182ff22d5897d2115_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie905fb72796946948258390b761711b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia00abbc1dfc2420285ca81d07349c1ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i875e79c2473a452583e29e73a01bfa80_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b5c96f524674979ae3cadfd2532827d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59c39c821a3d4218a3cb728d2a385e90_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5e7e03431254181936fa5c2d257ec24_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bc62d9f7c66433aa13e9e6998d9d964_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56a20a0bce804c38b73ff7f520b87651_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia01c644b76e14ee0b5670b383fc44619_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i720c85d38c4b4a209ace565912f63128_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i299dbb93baaa4adf91b29303de9f256c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba101ed2ac8446029ae5d685f8acc341_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e7a8e35e6064852930a027b3b59f8bf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbde729393d64e52859d704b20cee518_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i412f89f8ca8d4dbfb8137a440ded6b98_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae01dbcfa8ad41769f633687cc03a2f7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8e7a22df5454c2ea08ecd37884fc4ca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fe528bb55e54ddf9c9174d483315925_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03065bcf27f649d5aea3ecbbae57c360_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03983d809b5d48ac822709e714733860_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7896784f71444553a77160a44c511d51_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f997b24060b4e2e831b7dd663bd1b51_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica9d19a21f7b4daa8e6810612ddacae0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b76b6127e2345bdbe4b25521e947671_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id17472de8a564798bb9bbabef75337c9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76f91d5a4d3f4fde8c530ad87b420488_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie018639f7a93495f8a043153b2b66e54_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i790751c0557c4bcd879d0876e81497d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1878272b63d84cb3ad191576cc40347f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i236be83c9a654e4bb93dd0760efff694_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0da2d0c3648145a5b8e2644ab1e5983d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a93d02e74b1445c87a77245502f00bd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46e716287be2403d9f9833d066720161_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0685d6246774c2192e1c757f435ee9f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6907babce69b467f895e80b4a8a98771_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i752af8c51ae54195805ebd256b2b704b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f35241461c340e69d4ae399ca59d584_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59783636e8a14fa99c118f4ba1fe28ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie59012b0b1f342f68b2de7d2cf4ab087_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5cc0c0211dd4cb0b9436d1dcc14e45f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia291c95e9323450a8b9d5c75e58e6dde_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13f56229e6a44220ac924ebb86adafa3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22bbe4588fd541d6a564c67c1022e726_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if240d2be64a04252b3b1f214f2c30cce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e572606f72547578135489453dbfd32_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c636fbb95ec447f84da5fad0bd31870_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ca55a5008304969aa971098edc7db65_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5750f985ec4049d5a4ce86e6955f062c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8275b2c1a4584bab8295523437070a66_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i353fe81c894e473d8489f94900073b72_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0142cf66eb9e474ba86ff2ef25aa7bb2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09446e526f7f40f1b8b3303c458d33ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id83eb75fcc284b5f8068a783a9650faf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i347ffec6d213490c86926a3020149905_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68728028bd74499a908379ef355b4da0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16f188fd81734863b4051130ab9f098b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97f4fe722e6e43d6bf5d820d11cc2e2c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3aab0ea7df2549f09b6ae42102668e65_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22a8679306fb4d1ba271a7b5a547276e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e5acd236a544fff8d2d17bd87ad5a43_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87a55c8247be45b09ee66e3eeef70a7c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb6a1ac4f81447019bc03b2d0cdb655e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c06aac8a3d747f9985177c9ed3a77fd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ee6597ca53e484eada5596583046f3e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37d7609b746045a585af149f288da888_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib44b71f83a2d49289abcbf4aac524e75_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i248a5597803e4cdf9daeedf87c82dc5e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1308d93a146c4c8488b59a3c5a030c08_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63f7417ba6374a9bb024726d61971b6c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fc62e7b55b64c639f28ec82a4ab6bd1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbd48617b54d4e418e1d710b3ae6d615_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20fea02b40f94c0ba48b95b826283484_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if275586315f94ce8aa9f0a9ac4422fce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdfdfa352a47493f87219a5298ddedc0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3a9437b6cce406685b52a5c81de0dc3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31173b20feb34137842581c3c8ce276b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd69bf1ffd684edcb0e0780c09b5e3ff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e1d94487b2b4e17bcc6022785274fa4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5790b806681342228c412540032c2845_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2bca73c906b44578c01f6b232e46777_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b1bf3752dcf4f309d29e28b80c56ffe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a371f76601c443b8b6c9bcd816f3a93_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b9cd1a5ea464c6daf3d809cfa440c90_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ab5d14a774c4e00912a293ffe6f87bb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib65d80ddf5114b28a867a900c7850eac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id189ff74332342fa9efe4364610c858b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6b00b26ffba4cad87f82b5285574b87_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9149c44a31594b36a308ac1f8c72e95b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03315b2d0c214dc9ae1f36aa4a7b1182_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieabcbb36fc544fe1a63bec192e6a5369_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbab6554354142219fbf65a19f9f7258_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d537c7cac0d4b2bb971a7f1b19afd54_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee91350be21e4df98a159fbf2f617178_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b09818a0a4a496a9fa00fed53ac3bc0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7c8684e46134d5d94ecbacac811adbf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if725d6e275a94ba883eb02d3137c3b23_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dacb79ba9f7420094ee7ba16c6f78c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e824e97dad749fa8146593c0a7fa864_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f2924405ec24521a9aa09e98be58eec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36dd5abbbdcc4f9a9f25788b549f76f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd4080c110824cc891e5f7c1bfadc274_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45c05f5dd5d3432185804a21006dd535_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdc0d801d333478e818a374400b463a0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69656313398948a58d187e87db585202_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dd797aa72de45759796b65f361f095d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f11128fcfa749d782d3026befe4c0b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d2c9c46d28343c39add06320df583f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i504c90860189474a9e7671e231444fcb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98e2d75cd63240afb79819d5aa10ec90_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1f96d3ab2794a19976e875f2624ea6e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41b1ed139bba42e9bb825bb820df17c3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabdd8d0f4b884bafb6a33a56b77ba2d2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9978503911fa41aa862248d7a8b2f088_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9890742ae5e746e59b2065d06764be7a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18e230719b394883bd34f909e74c7ec7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbb9853b8df849048580a1fd16e6682d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5917c3c349de4954858ab57a50dd8cb9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cabad59a0dc44a6ac1fd35c4b99265b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6aedf877fb364df6a2c31ee163a6cfe2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28dff85338264876bb38fd87ca595a93_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ae7533aef2d4ae58181147c89948033_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i980a0570d54d438e9ca44fce0d36118f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f5b472d5fd248fc9d8e4d0ca5faba33_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5541dbb601c340fc980f125354496618_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9db72d0c676148af9dada1f290d09a49_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c114d81513142deb782de5f4fb900d7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia89b4748c514428786ab4dbcbb1f9083_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fbed6015e9f445a8b1b5c27ee92141a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibadbdf8585c74e21a8128d74084c1630_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7afb56947f304bfc81fc6a4e5e0609a2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40b0233400e741c69f64993477c55a4b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ac32e06a1214b17a9a0b84d07f40f6a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1503d3a6c2e498cb8692a32b8d66212_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92012f7aded14a9d87023bc2cc81aca5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9cf82de093b4218a4e15181bf7ad103_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73089e6a3a2241938de74ace9cba6d4d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e982f6ad3ab46928953aac66f4ed7cd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd833f359c8e4d79b0a869ad0038a7ea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id11c855da6024638a23cf8dee7acc5da_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dc8d2b37fd24bc5ba0361ec6cb6d65b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bb5df4dc2c74cb6a22410f86a771e30_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d85bdcd4cfc46a8af15a02b4c576aef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50b42474671845488782a3036f501d1b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28df8a8c64394346a9c15d1cc0276d57_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibafcbe43a8324a158a723bf16031e45e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94adba46e20a49038784a49900c2c598_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73a6d94969d34f66be2e45328cb8f039_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25eb35fe769e4798b61a524290097389_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i263c92882506448d9de97c225b5380ac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic142f878870649039fd16edd170bbf6d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i615e9d3a8c03432b9318ebab3d589854_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica25f49a766947a2adc2da48b7b82874_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i629a1b7b7b2446cc8b1de566b5f3c0de_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05c170e5b7b94386b7fcd1a8079be955_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60dddc7de4d647b3b43c5f0623bcf0f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a78c5e8b0784b46b5d4bb5a8fc3a21d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i243c32908d3d4416bc7ff18ee7ffd240_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab646cf33e884b1698a49fc5490b1a94_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7de4764ce7104e8cb8330af8da0f29b3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib96bf7bb8a4e46c2bb1e0d91aacf9454_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fe8d48e437a42c8ac2e33f34b85a197_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie319f6a95cc24bbdb8d73ca1db401d8f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68c26fea49fd41b19bc33b4ee7857fdf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a9138b4f181419d87234459e11ed427_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf6ce37a6c304453aa21c72054c6c418_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i025b8e46060344f99b00103d8305d8f2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e4ad64d899d4ef984f319b18bd41d23_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76b12c0d6c6040539968eac6791ef12d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5b88ad8263249b9a5226487582fc404_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fe3ea32ebf64cf49fb9d49975086ee9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85cd553b0d4e4d00807d021b0529afcb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70428484fd564ff2a11599326e08e7f3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2809337bb72a4fa6997eeb7883adae59_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94a38e87618941bb9c641ca41807e1e2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife890af6894342c6ab78227d1ee5350c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e00ca9657da47ec87effc5e2a1aeac7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvs:CVSHealth2017IncentiveCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac75a9034e7c40fb82a43cf2c75280b0_I20181128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvs:AetnaInc2010StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85d379918d1544988d301637f8418348_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie67cd2601892401dbc7e134d3a278afc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02c8540613844c24bb3232a954d598c7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43347484543148728067fc355f1bc0cb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ee318d09ac047368832cb3dc191916e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93c58d30105d4b0c9c482412ced85d79_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie549abdb9cf943f6acd4a4f0dc937118_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie333142c626e457f8b7400acc37b2e0e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a27cad79fee4e3fb41f31a513d985a2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39274e5a60794450836f17e832f652ef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7c3db8973f246b592a6bdc7ae66c5d4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied331db8439f40e395a4f8943266cba6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69a67aadd34647f781446b1f63119ac5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if24ed4bf2c534b4b938b4ca3b222bbd1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0b126cbb01d4598a07ab0c18962d7ac_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4ebc26cbc0c4a72b41fad331a976a13_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i047eb0ccbb624e599edde0bdc4b342b3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if345988696b749e88cd89e722c59ebd7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i432b0c5043074ae0812170d09abfa592_I20211209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03653ea4eb4a467299768217a91a7509_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d02c104c6dc4d8080674b3a902331b0_I20161102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f4bc0f557304063afaa3e85428dd4f9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i910e0cab88ca49569118b221e7416e1d_I20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021AcceleratedRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25393db4ea824bb8a945d34240542336_D20220104-20220104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021AcceleratedRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-04</xbrli:startDate><xbrli:endDate>2022-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7be16ef324b484ba18d3c2c816b7220_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i341bdbaf02b943349d5742511da4e641_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8220880f08f4b52bfb75c957326a67e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fc99c6f6f5e4521b483fbb38f266a09_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib746ed191a50496e8dcb173944e10da4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if41fb896ff264b3ead6f51a18d2a3f8e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2d7b1824eba4f87a7eafd51d7fd5787_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i067da125651c46ffad3ae31756f6ebce_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf290335ae9a4ad68f960df21ff9fc4e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f97c5d3b527409f84299ce04961b6b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba1b0c6fc0e8431cb642d84f64a10a03_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75b1f170bf184fb4b59ba89128a6bf98_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11c81300ece14b5cb35d720e3d27f084_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fc98fb6952142bebe0c28e8a1b5c4a8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84a0c7a5f87a43ea863b4f7e44c6d8c2_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4cc032a34c645ef8cc2877c8cab5ad0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i930652f9892c44cc8ed5915dcd507083_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbaffe77aefc4d6d9017917c96a5f507_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64c2bd153480429785df4f0aa2b99af8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife5fc67699f945fa837f90b613f6c602_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c93d0cc21864237a54084f2b97bd15f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91b3a6b550364049b4a377a44fda6b09_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied0d6e0ce99e4b72a1d89046d51bad0d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20b34efac8084fcf97e669d6e307466a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i303cec39156742cabcd569434ed22a00_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1adb1295de224123a78020e0f95fb49f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c37ca64bf504cc4beccb76f7eae0e86_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8b8354161494117b37c8c706d4ff661_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec37d7e54e8e4663af7b1e9dd4764b6d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17206db04de740ee9100c779b2d2d0c6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccee865f86ef46af8613bee2f36c8b98_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94e5299b9a1643d5a0693be093306c61_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i348fed93b022492e8b3985b2e2ba1a8f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac8f4cd98d954c89b07ab4b4c2f7eefc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fb139f86fed450cbb2024fcc197f70c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ac9beb213414c5a99e0c44cdb3d790d_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e511f7eb0324f2f878592c7974ed086_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if460e957577f480e84fb0142bcff8589_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i725fef702fc24e31915c10eeb3b3c3cc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i314a931ba51c4432ab932591b600df30_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8be428b3931542c4965732a9b0d77591_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0df7f1ff461e44849cb29208fac61c4d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id530b2ec12d240fe97ae812c8d6c1fed_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6049578cfc4647f693b348ad92ec2d2b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia08c0a1adcca414ca646fb74221de9ab_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2efea1496c248cdb677d680fb00e679_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7992428725ee4b7598c31808d507c883_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b7aa9f9810b45008c9d9fed20ef83c3_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reinsurance_agreement"><xbrli:measure>cvs:reinsurance_agreement</xbrli:measure></xbrli:unit><xbrli:context id="i9301095d345049e394b9ba1daee2e4e9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:HartfordLifeAndAccidentInsuranceCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i301adeecaf97464ca03a693c09b0877a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:HartfordLifeAndAccidentInsuranceCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2d969162ec640c4bc7ab0e676c9f6e9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:LincolnLifeAnnuityCompanyOfNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46f805b90593415b99804a3433aa2813_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:LincolnLifeAnnuityCompanyOfNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c99d471482b411db975233daa1b1c2d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:VOYARetirementInsuranceAndAnnuityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60a27aec77334f2c9335b816c8cba90b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:VOYARetirementInsuranceAndAnnuityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3af40793c6c847eea71843a3d54a8e74_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:AllOtherReinsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7a078c31fd54364814330592da72814_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:AllOtherReinsurersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lease"><xbrli:measure>cvs:lease</xbrli:measure></xbrli:unit><xbrli:context id="i63b662edcef14a498dbf400ce0e7d2f8_D20120101-20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2012-01-01</xbrli:startDate><xbrli:endDate>2012-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4e995a2f68a477fbac8891b9ff45d93_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:RadcliffAndFlaimVAetnaIncEtAlMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>cvs:claim</xbrli:measure></xbrli:unit><xbrli:context id="i7c55eec168db4721bd5fa5e6c7afd8f1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8549b1a793e64b2bb212ac0ced243d88_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4020d7e493d642d5966e8ca82cc66798_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i528bf90615b04a4388c9e042e7d52e2d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b5addf84c5d4652a8c88278ee498b80_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8ae9e7058b940a287f7a508f1290213_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5eab19a267b14681b658f1fd1f748401_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03972e1ca7ae40f3b269cf247834e557_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i326e08f13dd84d729af0ed31957c20b2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48f87e61e37e492f9c3f8051c3c9e4f5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icae6f1ee606a4353bd0cf7e6f048d3cc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53edb1dedd7242ae84fe83beefc1c6ca_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i869e87b37b534c77b68def0dd025f28b_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTQtMS0xLTE5NjM1_bbdfedd3-ce88-4726-99fa-8969a6b266a6 id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtNC0xLTEtMTk2MzU_03d25cee-62ac-4b19-83d5-83527c502af5 id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTQtMS0xLTE5NjM1_c22f687b-bcc8-4d02-b351-d409fc63a5da id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI3LTQtMS0xLTE5NjM1_2ac0022b-9661-459b-8995-856a8677ed8a id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTQtMS0xLTE5NjM1_97c21c66-2d45-4ea3-968e-8464fda4be09 id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE4LTQtMS0xLTE5NjM1_894b75b1-c20f-4e61-b105-8dbd70b2299b id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtNC0xLTEtMTk2MzU_056fb5fc-124d-4929-b5de-d982249e8938" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjQ_cc82e256-da53-42d6-8a53-0ccced714fe0" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTgtMS0xLTE5NjM1_3e80ea5b-0225-4195-b65a-cd326b24be66 id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTEwLTEtMS0xOTYzNQ_012f1e61-d950-4e7d-9219-63301f2cfd55 id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTYtMS0xLTE5NjM1_0d72284e-6ae8-4fab-975d-68db230b7230" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NDM_62e832f8-7207-4461-9589-4a17539d4b88" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTItMS0xLTE5NjM1_97bbe756-c530-44c3-bf07-3dcd93863f56 id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTItMS0xLTE5NjM1_1c356d2b-3495-4a7b-9749-f110807b49c6 id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzktMi0xLTEtMTk2MzU_8d9b2c4a-a066-410c-b98f-35ad52f2251c id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzktNS0xLTEtMTk2MzU_726be931-cfc8-48b9-9d92-a974cab2539e id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtMi0xLTEtMTk2MzU_38a4f088-ebc0-42d5-9452-dcc4dc666000 id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE5LTUtMS0xLTE5NjM1_b10aa279-9966-4bd0-bcf8-71cf5a78c8cc id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTUtMS0xLTE5NjM1_6e5e1472-d133-4873-995b-e0e350248ee0 id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtNS0xLTEtMTk2MzU_f8dcefcc-b66e-42ce-a3d6-883dd1c703f9 id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTUtMS0xLTE5NjM1_b17f1bab-ba67-4dd0-965f-3feec675cba8 id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtMi0xLTEtMTk2MzU_5a2af167-1a8c-4cd3-92d3-86f595f11839 id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE5LTItMS0xLTE5NjM1_d4eb5856-eaa6-4799-9256-144e4a9519d9 id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI4LTItMS0xLTE5NjM1_c99be6d6-9e00-435a-b19e-b4a88922d547 id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTItMS0xLTE5NjM1_64feac16-0132-4d16-bed6-5f25ece31268 id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI4LTUtMS0xLTE5NjM1_f55a21f2-2a69-40c6-a897-99c2f68660c1 id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTUtMS0xLTE5NjM1_513ca101-da7d-4884-9350-f18e2e7d65ed" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEwOTk1MTE2Mjk5MDk_1e2731a0-00e0-482d-b011-76cfe76e7e7c id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtOC0xLTEtMTk2MzU_27e8ee4a-bc07-4563-9ed8-b0e3e9b0302d id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtNi0xLTEtMTk2MzU_1e2731a0-00e0-482d-b011-76cfe76e7e7c id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtMTAtMS0xLTE5NjM1_4cea8a88-2053-457a-81cf-9f156ab4de60" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU0Njg_97cc772a-a9cc-45ab-acfe-b04e7678cb48" order="1"></ix:relationship></ix:resources></ix:header></div><div id="ibab9fb71d67648f0b758869f160b7f4b_1"></div><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.468%"><tr><td style="width:1.0%"></td><td style="width:21.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.376%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml8zMjk4NTM0ODg0ODIx_9a61366b-94ff-4452-b8dc-41e9be6b2c2f">10-K</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Mark One)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml8xMzgw_89587572-70c7-475f-8c4d-ab54a2b5e220">&#9745;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml8yMTc_e33825d8-c436-4ae0-9adc-c3c652deda17"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml8yMTc_e79527f4-c5ec-4acc-bd09-87c8f29b20e5">December 31</ix:nonNumeric>, 2021</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">or</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml8xMzc0_1af5d221-9ff5-4d1f-9d23-5cc85b04bb3c">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from _________ to_________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml8xMzc1_29fb0952-a872-49b5-b836-1fb5f491166e">001-01011</ix:nonNumeric> </span></div><div style="text-align:center"><img src="cvs-20211231_g1.jpg" alt="cvs-20211231_g1.jpg" style="height:14px;margin-bottom:5pt;vertical-align:text-bottom;width:82px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml8xMzc2_fddfbdc8-ba26-4ee6-95be-b8bcb8dd2b9c">CVS HEALTH CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6ZmQ2YjZmNGMxMzI2NDJiOTlhYTVlZWM3MGU4NTVhMTUvdGFibGVyYW5nZTpmZDZiNmY0YzEzMjY0MmI5OWFhNWVlYzcwZTg1NWExNV8wLTAtMS0xLTE5NjM1_8d43be26-be53-424c-88b1-19b5437f2a3d">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6ZmQ2YjZmNGMxMzI2NDJiOTlhYTVlZWM3MGU4NTVhMTUvdGFibGVyYW5nZTpmZDZiNmY0YzEzMjY0MmI5OWFhNWVlYzcwZTg1NWExNV8wLTEtMS0xLTE5NjM1_6989d31e-719b-4fca-880b-4643b2d2c6a1">05-0494040</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.858%"><tr><td style="width:1.0%"></td><td style="width:17.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.133%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6Y2YxMmMyYWY3NGJhNDg4NjhjMDViYTE2YWNkODMxZjcvdGFibGVyYW5nZTpjZjEyYzJhZjc0YmE0ODg2OGMwNWJhMTZhY2Q4MzFmN18wLTAtMS0xLTE5NjM1_f6007b63-123c-4b81-a62a-e44d1b7e119b">One CVS Drive,</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6Y2YxMmMyYWY3NGJhNDg4NjhjMDViYTE2YWNkODMxZjcvdGFibGVyYW5nZTpjZjEyYzJhZjc0YmE0ODg2OGMwNWJhMTZhY2Q4MzFmN18wLTEtMS0xLTE5NjM1_5ae9ba60-14d6-482f-b557-59539ed38a77">Woonsocket,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6Y2YxMmMyYWY3NGJhNDg4NjhjMDViYTE2YWNkODMxZjcvdGFibGVyYW5nZTpjZjEyYzJhZjc0YmE0ODg2OGMwNWJhMTZhY2Q4MzFmN18wLTItMS0xLTE5NjM1_92314b32-584c-4bf2-a09e-133f0effebb4">Rhode Island</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6Y2YxMmMyYWY3NGJhNDg4NjhjMDViYTE2YWNkODMxZjcvdGFibGVyYW5nZTpjZjEyYzJhZjc0YmE0ODg2OGMwNWJhMTZhY2Q4MzFmN18wLTMtMS0xLTE5NjM1_b6c4b28e-3a6e-4a9d-b6d3-7b22294baa26">02895</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.194%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Registrant&#8217;s telephone number, including area code:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NzVkMjU0YWQwYjJiNDc1MzhjMWZkNTVlNDg1Njc1MTgvdGFibGVyYW5nZTo3NWQyNTRhZDBiMmI0NzUzOGMxZmQ1NWU0ODU2NzUxOF8wLTEtMS0xLTE5NjM1_e6f499b0-80d9-4767-91fd-4dc4ba265273">(401)</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NzVkMjU0YWQwYjJiNDc1MzhjMWZkNTVlNDg1Njc1MTgvdGFibGVyYW5nZTo3NWQyNTRhZDBiMmI0NzUzOGMxZmQ1NWU0ODU2NzUxOF8wLTItMS0xLTE5NjM1_05658338-d5f5-4a0f-8398-542f83d059f3">765-1500</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6ZTRjOTZhNWMzY2IzNDg5OGJiYzdmNTM5MDVlNzhlOWQvdGFibGVyYW5nZTplNGM5NmE1YzNjYjM0ODk4YmJjN2Y1MzkwNWU3OGU5ZF8yLTAtMS0xLTE5NjM1_ba5a9e0e-42bc-4bec-8eac-654a27e18ab0">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6ZTRjOTZhNWMzY2IzNDg5OGJiYzdmNTM5MDVlNzhlOWQvdGFibGVyYW5nZTplNGM5NmE1YzNjYjM0ODk4YmJjN2Y1MzkwNWU3OGU5ZF8yLTEtMS0xLTE5NjM1_94d4f69f-2d77-40e8-acc5-3e9be0b54447">CVS</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6ZTRjOTZhNWMzY2IzNDg5OGJiYzdmNTM5MDVlNzhlOWQvdGFibGVyYW5nZTplNGM5NmE1YzNjYjM0ODk4YmJjN2Y1MzkwNWU3OGU5ZF8yLTItMS0xLTE5NjM1_1b2b949a-240f-4791-8e36-859b06ad46fd">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(g) of the Act:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">None</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.197%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.849%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.197%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml8wLTUtMS0xLTE5NjM1_a3f4e616-17d2-4adc-b6b9-63f2b9aae54b">Yes</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">No</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml8xLTctMS0xLTE5NjM1_c9e444c7-12ca-4cd3-a43a-080c8aed9c09">No</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml8yLTUtMS0xLTE5NjM1_9b96ccfa-ea5c-4651-a3f8-1defbc67ec51">Yes</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">No</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml8zLTUtMS0xLTE5NjM1_c572d72b-9cee-4209-8471-9c6889ff5fc3">Yes</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">No</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml81LTAtMS0xLTE5NjM1_763d32bd-a787-4b3b-913c-fd9e1b2864cc">Large accelerated filer</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml82LTctMS0xLTE5NjM1_d9c6d818-465c-42a1-b97c-8cd2d6849b92">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml83LTctMS0xLTE5NjM1_da7baf97-2ec8-46cf-8337-379f286eef21">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C 7262(b)) by the registered public accounting firm that prepared or issued its audit report.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml85LTctMS0xLTE5NjM1_bb9e9be4-134f-42dc-8c21-bc78b9d39705">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml8xMC00LTEtMS0xOTYzNQ_0c9f5503-a2cf-4670-a83b-44fc669fb3da">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">No</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of the registrant&#8217;s common stock held by non-affiliates was approximately $<ix:nonFraction unitRef="usd" contextRef="ie5e000b7c7ed4445a36ad3eb67d14356_I20210630" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml81OTk_1375ec42-c5bf-4dc7-af7b-91b917ca7ac6">109,651,334,285</ix:nonFraction> as of June&#160;30, 2021, based on the closing price of the common stock on the New York Stock Exchange. For purposes of this calculation, only executive officers and directors are deemed to be affiliates of the registrant.</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of February&#160;2, 2022, the registrant had <ix:nonFraction unitRef="shares" contextRef="ic767c69faf834e03aae3c9e3cc80734e_I20220202" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml84NjQ_7864866c-48f2-4f84-8346-9dd0bb3eaf90">1,312,510,426</ix:nonFraction> shares of common stock outstanding.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml8xMzc4_563896f9-6cc8-41d1-b0d1-fa50af286a12" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following materials are incorporated by reference into this Form 10-K:</span></div><div style="margin-bottom:0.8pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information contained in the definitive proxy statement for CVS Health Corporation&#8217;s 2022 Annual Meeting of Stockholders, to be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year ended December 31, 2021 (the &#8220;Proxy Statement&#8221;), is incorporated by reference in Parts III and IV to the extent described therein.</span></div></ix:nonNumeric><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.903%"><tr><td style="width:1.0%"></td><td style="width:20.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.489%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span><br/></span></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.649%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part&#160;I</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_13">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_34">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_34">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1B:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_37">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_37">63</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_40">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_40">63</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_43">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_43">63</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_46">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_46">63</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_49">Information about our Executive Officers</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_49">64</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part&#160;II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;5:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_55">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_55">65</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_58">Reserved</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_58">66</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_61">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_61">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7A:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_97">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_97">99</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;8:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_100">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_100">102</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_190">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_190">176</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9A:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_193">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_193">176</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9B:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_196">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_196">177</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part&#160;III</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;10:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_202">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_202">177</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;11:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_205">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_205">177</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;12:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_208">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_208">177</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;13:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_211">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_211">178</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;14:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_214">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_214">178</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part&#160;IV</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;15:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_220">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_220">179</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_223">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_223">183</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_226">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_226">184</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise requires, references to the terms &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221; used throughout this Annual Report on Form 10-K (this &#8220;10-K&#8221;) refer to CVS Health Corporation (a Delaware corporation), together with its subsidiaries (collectively, &#8220;CVS Health&#8221; or the &#8220;Company&#8221;). References to competitors and other companies throughout this 10-K, including the information incorporated herein by reference, are for illustrative or comparison purposes only and are not identifying that these companies are the only competitors or closest competitors of the Company or any of the Company&#8217;s businesses, products, or services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Private Securities Litigation Reform Act of 1995 (the &#8220;Reform Act&#8221;) provides a &#8220;safe harbor&#8221; for forward-looking statements, so long as (1) those statements are identified as forward-looking, and (2) the statements are accompanied by meaningful cautionary statements that identify important factors that could cause actual results to differ materially from those discussed in the statement. We are taking advantage of these safe harbor provisions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain information contained in this 10-K is forward-looking within the meaning of the Reform Act or SEC rules. This information includes, but is not limited to: &#8220;Outlook for 2022&#8221; of Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;) included in Item 7, &#8220;Quantitative and Qualitative Disclosures About Market Risk&#8221; included in Item 7A, &#8220;Government Regulation&#8221; included in Item 1, and &#8220;Risk Factors&#8221; included in Item 1A. In addition, throughout this 10-K and our other reports and communications, we use the following words or variations or negatives of these words and similar expressions when we intend to identify forward-looking statements:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.559%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.354%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Anticipates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Believes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Can</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Continue</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Could</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Estimates</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Evaluate</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Expects</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Explore</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Forecast</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Guidance</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Intends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Likely</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">May</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Might</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Outlook</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Potential</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Predict</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Probable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Projects</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Seeks</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Should</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">View</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#183;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Will</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">All statements addressing the future operating performance of CVS Health or any segment or any subsidiary and/or future events or developments, including statements relating to the projected impact of coronavirus disease 2019 (&#8220;COVID-19&#8221;) and its emerging new variants on the Company&#8217;s businesses, investment portfolio, operating results, cash flows and/or financial condition, statements relating to corporate strategy, statements relating to future revenue, operating income or adjusted operating income, earnings per share or adjusted earnings per share, Health Care Benefits segment business, sales results and/or trends, medical cost trends, medical membership, Medicare Part D membership, medical benefit ratios and/or operations, Pharmacy Services segment business, sales results and/or trends and/or operations, Retail/LTC segment business, sales results and/or trends and/or operations, incremental investment spending, interest expense, effective tax rate, weighted-average share count, cash flow from operations, net capital expenditures, cash available for debt repayment, integration synergies, net synergies, integration costs, enterprise modernization, transformation, leverage ratio, cash available for enhancing shareholder value, inventory reduction, turn rate and/or loss rate, debt ratings, the Company&#8217;s ability to attract or retain customers and clients, store development and/or relocations, new product development, and the impact of industry and regulatory developments, as well as statements expressing optimism or pessimism about future operating results or events, are forward-looking statements within the meaning of the Reform Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-looking statements rely on a number of estimates, assumptions and projections concerning future events, and are subject to a number of significant risks and uncertainties and other factors that could cause actual results to differ materially from those statements. Many of these risks and uncertainties and other factors are outside our control. Certain of these risks and uncertainties and other factors are described under &#8220;Risk Factors&#8221; included in Item 1A of this 10-K; these are not the only risks and uncertainties we face. There can be no assurance that the Company has identified all the risks that may affect it. Additional risks and uncertainties not presently known to the Company or that the Company currently believes to be immaterial also may adversely affect the Company&#8217;s businesses. If any of those risks or uncertainties develops into actual events, those events or circumstances could have a material adverse effect on the Company&#8217;s businesses, operating results, cash flows, financial condition and/or stock price, among other effects. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should not put undue reliance on forward-looking statements. Any forward-looking statement speaks only as of the date of this 10-K, and we disclaim any intention or obligation to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.  Business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation, together with its subsidiaries (collectively, &#8220;CVS Health,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;), is a leading diversified health solutions company, making healthier happen now. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. The Company has more than 9,900 retail locations, nearly 1,200 walk-in medical clinics, a leading pharmacy benefits manager with approximately 110 million plan members with expanding specialty pharmacy solutions and a dedicated senior pharmacy care business serving more than one million patients per year. The Company also serves an estimated 35 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Strategy</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company seeks to improve access, lower costs and enhance health outcomes by engaging with consumers when, where and how they desire. This means delivering solutions that are personalized, seamless, connected and increasingly digital. CVS Health is also shifting from transaction-based primary care to addressing holistic health &#8211; physical, emotional, social, economic &#8211; which will lead to higher quality of care and lower medical costs. The Company is a leader in key segments of health care today through foundational businesses and is seeking to create new sources of value by expanding into next generation primary care delivery and health services, with a goal of improving satisfaction levels for both providers and consumers. The Company believes its consumer-centric strategy will drive sustainable long-term growth and deliver value for all stakeholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and its emerging new variants continue to impact the U.S. and other countries around the world. Our strong local presence and scale in communities across the country has enabled us to play an indispensable role in the national response to COVID-19, as well as provide seamless support for our customers wherever they need us: in our CVS locations, in their homes, and virtually. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offered COVID-19 diagnostic testing at more than 4,800 CVS Pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> locations, at community-based testing sites in underserved areas and through its Return Ready</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">solution as of December&#160;31, 2021. During 2021, the Company also began selling over-the-counter (&#8220;OTC&#8221;) test kits in its retail locations and online. The Company began administering COVID-19 vaccinations in long-term care facilities and in certain of its retail pharmacies during December 2020 and February 2021, respectively, and began the administration of COVID-19 boosters and pediatric vaccines during the fourth quarter of 2021. The Company offered COVID-19 vaccinations at more than 9,800 CVS Pharmacy locations as of December&#160;31, 2021. During the year ended December&#160;31, 2021, the Company administered more than 32&#160;million COVID-19 tests and more than 59&#160;million COVID-19 vaccines. The Company expects to continue to play a significant role in COVID-19 testing and vaccine administration in the future, while maintaining a strong commitment to testing and vaccine equity by optimizing site locations and targeting outreach initiatives to reach vulnerable populations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of COVID-19 on the Company&#8217;s businesses, operating results, cash flows and financial condition in the years ended December 31, 2021 and 2020, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this 10-K.</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_22"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers, serving an estimated 35 million people as of December&#160;31, 2021. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">technology (&#8220;HIT&#8221;) products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Products and Services </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk of medical and dental care costs) as &#8220;ASC.&#8221; Health Care Benefits products and services consist of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Commercial Medical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Health Care Benefits segment offers point-of-service (&#8220;POS&#8221;), preferred provider organization (&#8220;PPO&#8221;), health maintenance organization (&#8220;HMO&#8221;) and indemnity benefit (&#8220;Indemnity&#8221;) plans. Commercial medical products also include health savings accounts (&#8220;HSAs&#8221;) and consumer-directed health plans that combine traditional POS or PPO and/or dental coverage, subject to a deductible, with an accumulating benefit account (which may be funded by the plan sponsor and/or the member in the case of HSAs). With the launch of Aetna Virtual Primary Care</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in 2021, eligible members now have access to health services remotely, paired with access to in-person visits with providers in the Company&#8217;s network, including at MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and CVS HealthHUB</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> locations. Principal products and services are targeted specifically to large multi-site national, mid-sized and small employers, individual insureds and expatriates. The Company offers medical stop loss insurance coverage for certain employers who elect to self-insure their health benefits. Under medical stop loss insurance products, the Company assumes risk for costs associated with large individual claims and/or aggregate loss experience within an employer&#8217;s plan above a pre-set annual threshold. The segment also has a portfolio of additional health products and services that complement its medical products such as dental plans, behavioral health and employee assistance products, provider network access and vision products. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Government Medical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In select geographies, the Health Care Benefits segment offers Medicare Advantage plans, Medicare Supplement plans and prescription drug coverage for Medicare beneficiaries; participates in Medicaid and subsidized Children&#8217;s Health Insurance Programs (&#8220;CHIP&#8221;); and participates in demonstration projects for members who are eligible for both Medicare and Medicaid (&#8220;Duals&#8221;). These Government Medical products are further described below:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare Advantage: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through annual contracts with the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;), the Company offers HMO and PPO products for eligible individuals in certain geographic areas through the Medicare Advantage program. Members typically receive enhanced benefits over traditional fee-for-service Medicare coverage (&#8220;Original Medicare&#8221;), including reduced cost-sharing for preventive care, vision and other services. The Company offered network-based HMO and/or PPO plans in 46 states and Washington, D.C. in 2021. For certain qualifying employer groups, the Company&#160;offers Medicare PPO products nationally. When combined with the Company&#8217;s PDP product,&#160;these national PPO plans&#160;form an integrated national Insured Medicare product for employers that provides medical and pharmacy benefits.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare PDP: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a national provider of drug benefits under the Medicare Part D prescription drug program. All Medicare eligible individuals are eligible to participate in this voluntary prescription drug plan. Members typically receive coverage for certain prescription drugs, usually subject to a deductible, co-insurance and/or co-payment. The Company offered PDP plans in all 50 states and Washington, D.C. in 2021. On November 30, 2018, the Company completed the sale of the standalone PDPs of Aetna, Inc. (&#8220;Aetna&#8221;) to WellCare Health Plans, Inc. effective December 31, 2018. The Company provided administrative services to, and retained the financial results of, the divested plans through 2019. Subsequent to 2019, the Company no longer retains the financial results of the divested plans.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare Supplement: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For certain Medicare eligible members, the Company offers&#160;supplemental&#160;coverage for certain health care costs not covered by&#160;Original Medicare. The products included in the Medicare Supplement portfolio help to cover&#160;some of the&#160;gaps in Original Medicare, and include coverage for Medicare&#160;deductibles and coinsurance&#160;amounts. The Company offered a&#160;wide selection of Medicare Supplement products in 49 states and Washington, D.C. in 2021.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Medicaid and CHIP:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company offers health care management services to individuals eligible for Medicaid and CHIP under multi-year contracts with government agencies in various states that are subject to annual appropriations. CHIP are state-subsidized insurance programs that provide benefits for families with uninsured children. The Company offered these services on an Insured or ASC basis in 16 states in 2021.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Duals: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides health coverage to beneficiaries who are dually eligible for both Medicare and Medicaid coverage. These members must meet certain income and resource requirements in order to qualify for </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">this coverage. The Company coordinates 100% of the care for these members and may provide them with additional services in order to manage their health care costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has a portfolio of transformative products and services aimed at creating a holistic and integrated approach to individual health and wellness. These products and services complement the Commercial Medical and Government Medical products and aim to provide innovative solutions, create integrated experience offerings and enable enhanced care delivery to customers. </span></div><div style="margin-bottom:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Provider Networks </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contracts with physicians, hospitals and other providers for services they provide to the Company&#8217;s members. The Company uses a variety of techniques designed to help encourage appropriate utilization of medical services (&#8220;utilization&#8221;) and maintain affordability of quality coverage. In addition to contracts with providers for negotiated rates of reimbursement, these techniques include creating risk sharing arrangements that align economic incentives with providers, the development and implementation of guidelines for the appropriate utilization and the provision of data to providers to enable them to improve health care quality. At December&#160;31, 2021, the Company&#8217;s underlying nationwide provider network had approximately 1.5 million participating providers. Other providers in the Company&#8217;s provider networks also include laboratory, imaging, urgent care and other freestanding health facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Quality Assessment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS uses a 5-star rating system to monitor Medicare health care and drug plans and ensure that they meet CMS&#8217;s quality standards. CMS uses this rating system to provide Medicare beneficiaries with a tool that they can use to compare the overall quality of care and level of customer service of companies that provide Medicare health care and drug plans. The rating system considers a variety of measures adopted by CMS, including quality of preventative services, chronic illness management and overall customer satisfaction. See &#8220;Health Care Benefits Pricing&#8221; below in this Item 1 for further discussion of star ratings. The Company seeks Health Plan accreditation for Aetna HMO plans from the National Committee for Quality Assurance (&#8220;NCQA&#8221;), a private, not-for-profit organization that evaluates, accredits and certifies a wide range of health care organizations. Health care plans seeking accreditation must pass a rigorous, comprehensive review and must annually report on their performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aetna Life Insurance Company (&#8220;ALIC&#8221;), a wholly-owned subsidiary of the Company, has received nationwide NCQA PPO Health Plan accreditation. As of December&#160;31, 2021, all of the Company&#8217;s Commercial HMO and all of ALIC&#8217;s PPO members who were eligible participated in HMOs or PPOs that are accredited by the NCQA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s provider selection and credentialing/re-credentialing policies and procedures are consistent with NCQA and URAC, a health care accrediting organization that establishes quality standards for the health care industry, as well as state and federal, requirements. In addition, the Company is certified under the NCQA Credentials Verification Organization (&#8220;CVO&#8221;) certification program for all certification options and has URAC CVO accreditation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quality assessment programs for contracted providers who participate in the Company&#8217;s networks begin with the initial review of health care practitioners. Practitioners&#8217; licenses and education are verified, and their work history is collected by the Company or in some cases by the practitioner&#8217;s affiliated group or organization. The Company generally requires participating hospitals to be certified by CMS or accredited by The Joint Commission, the American Osteopathic Association, or Det Norske Veritas Healthcare.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers quality and outcome measurement programs, quality improvement programs, and health care data analysis systems to providers and purchasers of health care services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Information Systems</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment currently operates and supports an end-to-end suite of information technology platforms to support member engagement, enrollment, health benefit administration, care management, service operations, financial reporting and analytics.&#160;The multiple platforms are supported by an integration layer to facilitate the transfer of real-time data.&#160;There is continued focus and investment in enterprise data platforms, cloud capabilities, digital products to offer innovative solutions and a seamless experience to the Company&#8217;s members through mobile and web channels.&#160;The Company is making concerted investments in emerging technology capabilities such as voice, artificial intelligence and robotics to further automate, reduce cost and improve the experience for all of its constituents. The Health Care Benefits segment is utilizing the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">full breadth of the Company&#8217;s assets to build enterprise technology that will help guide our members through their health care journey, provide them a high level of service, enable healthier outcomes and encourage them to take next best actions to lead healthier lives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Customers</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical membership is dispersed throughout the United States, and the Company also serves medical members in certain countries outside the United States. The Company offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, many of which are available nationwide. Depending on the product, the Company markets to a range of customers including employer groups, individuals, college students, part-time and hourly workers, health plans, providers, governmental units, government-sponsored plans, labor groups and expatriates. For additional information on medical membership, see &#8220;Health Care Benefits Segment&#8221; in the Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (the &#8220;MD&amp;A&#8221;) included in Item 7 of this 10-K. </span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company markets both Commercial Insured and ASC products and services primarily to employers that sponsor the Company&#8217;s products for the benefit of their employees and their employees&#8217; dependents. Frequently, larger employers offer employees a choice among coverage options, from which the employee makes his or her selection during a designated annual open enrollment period. Typically, employers pay all of the monthly premiums to the Company and, through payroll deductions, obtain reimbursement from employees for a percentage of the premiums that is determined by each employer. Some Health Care Benefits products are sold directly to employees of employer groups on a fully employee-funded basis. In some cases, the Company bills the covered individual directly. In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in eight states through which it sells Insured plans directly to individual consumers.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers Insured Medicare coverage on an individual basis as well as through employer groups to their retirees. Medicaid and CHIP members are enrolled on an individual basis. The Company also offers Insured health care coverage to members who are dually-eligible for both Medicare and Medicaid. </span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Care Benefits products are sold through: the Company&#8217;s sales personnel; independent brokers, agents and consultants who assist in the production and servicing of business; as well as private health insurance exchanges (&#8220;Private Exchanges&#8221;) and Public Exchanges (together with Private Exchanges, &#8220;Insurance Exchanges&#8221;). For large employers or other entities that sponsor the Company&#8217;s products (&#8220;plan sponsors&#8221;), independent consultants and brokers are frequently involved in employer health plan selection decisions and sales. In some instances, the Company may pay commissions, fees and other amounts to brokers, agents, consultants and sales representatives who place business with the Company. In certain cases, the customer pays the broker for services rendered, and the Company may facilitate that arrangement by collecting the funds from the customer and transmitting them to the broker. The Company supports marketing and sales efforts with an advertising program that may include television, radio, billboards, print media and social media, supplemented by market research and direct marketing efforts.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. federal government is a significant customer of the Health Care Benefits segment through contracts with CMS for coverage of Medicare-eligible individuals and federal employee-related benefit programs. Other than the contracts with CMS, the Health Care Benefits segment is not dependent upon a single customer or a few customers the loss of which would have a significant effect on the earnings of the segment. The loss of business from any one, or a few, independent brokers or agents would not have a material adverse effect on the earnings of the Health Care Benefits segment. In 2021, 2020 and 2019, Health Care Benefits segment revenues from the federal government accounted for 14%, 13% and 13%, respectively, of the Company&#8217;s consolidated total revenues. Contracts with CMS for coverage of Medicare-eligible individuals in the Health Care Benefits segment accounted for approximately 79%, 78% and 76%, respectively, of the Company&#8217;s consolidated revenues from the federal government in 2021, 2020 and 2019.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Pricing</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For Commercial Insured plans, contracts containing the pricing and other terms of the relationship are generally established in advance of the policy period and typically have a duration of one year. Fees under ASC plans are generally fixed for a period of one year.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, a fixed premium rate is determined at the beginning of the policy period for Commercial Insured plans. The Company typically cannot recover unanticipated increases in health care and other benefit costs in the current policy period; however, it may consider prior experience for a product in the aggregate or for a specific customer, among other factors, in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determining premium rates for future policy periods. Where required by state laws, premium rates are filed and approved by state regulators prior to contract inception. Future operating results could be adversely affected if the premium rates requested are not approved or are adjusted downward or their approval is delayed by state or federal regulators. </span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has Medicare Advantage and PDP contracts with CMS to provide HMO, PPO and prescription drug coverage to Medicare beneficiaries in certain geographic areas. Under these annual contracts, CMS pays the Company a fixed per member (or &#8220;capitation&#8221;) payment and/or a portion of the premium, both of which are based on membership and adjusted for demographic and health risk factors. CMS also considers inflation, changes in utilization patterns and average per capita fee-for-service Medicare costs in the calculation of the fixed capitation payment or premium. PDP contracts also provide a risk-sharing arrangement with CMS to limit the Company&#8217;s exposure to unfavorable expenses or benefit from favorable expenses. Amounts payable to the Company under the Medicare arrangements are subject to annual revision by CMS, and the Company elects to participate in each Medicare service area or region on an annual basis. Premiums paid to the Company for Medicare products are subject to federal government reviews and audits, which can result, and have resulted, in retroactive and prospective premium adjustments and refunds to the government and/or members. In addition to payments received from CMS, some Medicare Advantage products and all PDP products require a supplemental premium to be paid by the member or sponsoring employer. In some cases these supplemental premiums are adjusted based on the member&#8217;s income and asset levels. Compared to Commercial Medical products, Medicare contracts generate higher per member per month revenues and higher health care and other benefit costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;ACA&#8221;) ties a portion of each Medicare Advantage plan&#8217;s reimbursement to the plan&#8217;s &#8220;star ratings.&#8221; Plans must have a star rating of four or higher (out of five) to qualify for bonus payments. CMS released the Company&#8217;s 2022 star ratings in October 2021. The Company&#8217;s 2022 star ratings will be used to determine which of the Company&#8217;s Medicare Advantage plans have ratings of four stars or higher and qualify for bonus payments in 2023. Based on the Company&#8217;s membership at December&#160;31, 2021, 87% of the Company&#8217;s Medicare Advantage members were in plans with 2022 star ratings of at least 4.0 stars, compared to 83% of the Company&#8217;s Medicare Advantage members being in plans with 2021 star ratings of at least 4.0 stars based on the Company&#8217;s membership at December 31, 2020.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rates for Medicare Supplement products are regulated at the state level and vary by state and plan.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Insured Medicaid contracts, state government agencies pay the Company fixed monthly rates per member that vary by state, line of business and demographics; and the Company arranges, pays for and manages the health care services provided to Medicaid beneficiaries. These rates are subject to change by each state, and, in some instances, provide for adjustment for health risk factors. CMS requires these rates to be actuarially sound. The Company also receives fees from customers where it provides services under ASC Medicaid contracts. ASC Medicaid contracts generally are for periods of more than one year, and certain of them contain performance incentives and limited financial risk sharing with respect to certain medical, financial and operational metrics. Under these arrangements, performance is evaluated annually, with associated financial incentive opportunities, and financial risk share obligations are typically limited to a percentage of the fees otherwise payable to the Company. Payments to the Company under Medicaid contracts are subject to the annual appropriation process in the applicable state.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Duals contracts, the rate setting process is generally established by CMS in partnership with the state government agency participating in the demonstration project. Both CMS and the state government agency may seek premium and other refunds under certain circumstances, including if the Company fails to comply with CMS regulations or other contractual requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers HMO and consumer-directed medical and dental plans to federal employees under the Federal Employees Health Benefits (&#8220;FEHB&#8221;) Program and the Federal Employees Dental and Vision Insurance Program. Premium rates and fees for those plans are subject to federal government review and audit, which can result, and have resulted, in retroactive and prospective premium and fee adjustments and refunds to the government and/or members. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2014, the ACA imposed significant new industry-wide fees, assessments and taxes, including an annual levy known as the health insurer fee (the &#8220;HIF&#8221;). The HIF applied for 2020 and was temporarily suspended for 2019. In December 2019, the HIF was repealed for calendar years after 2020. For additional information on the ACA fees, assessments and taxes, see Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; included in Item 8 of this 10-K. The Company&#8217;s goal is to collect premiums and fees where possible, or solve for, all of the ACA-related fees, assessments and taxes.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Seasonality</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment&#8217;s quarterly operating income progression is also impacted by (i) the seasonality of benefit costs which generally increase during the year as Insured members progress through their annual deductibles and out-of-pocket expense limits and (ii) the seasonality of operating expenses, which are generally the highest during the fourth quarter due primarily to spending to support readiness for the start of the upcoming plan year and marketing associated with Medicare annual enrollment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, the customary quarterly operating income progression was impacted by COVID-19. While overall medical costs in the first quarter were generally consistent with historical baseline levels in the aggregate, the segment experienced increased COVID-19 testing and treatment costs and lower Medicare risk-adjusted revenue. During the second quarter, COVID-19 testing and treatment costs persisted, however at levels significantly lower than those observed during the first quarter. Beginning in the third quarter, medical costs once again increased primarily driven by the spread of the emerging new variants of COVID-19, which resulted in increased testing and treatment costs that continued throughout the fourth quarter.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, the customary quarterly operating income progression was also impacted by COVID-19. Beginning in mid-March, the health care system experienced a significant reduction in utilization that is discretionary and the cancellation of elective medical procedures. Utilization remained below historical levels through April, began to recover in May and June and reached more normal levels in the third and fourth quarters, with select geographies impacted by COVID-19 waves. The impact of the deferral of non-essential care was partially offset by COVID-19 testing and treatment costs, as well as planned COVID-19 related investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Competition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The health care benefits industry is highly competitive, primarily due to a large number of for-profit and not-for-profit competitors, competitors&#8217; marketing and pricing and a proliferation of competing products, including new products that are continually being introduced into the marketplace. New entrants into the marketplace, as well as consolidation within the industry, have contributed to and are expected to intensify the competitive environment. In addition, the rapid pace of change as the industry evolves towards a consumer-focused retail marketplace, including Insurance Exchanges, and the increased use of technology to interact with members, providers and customers, increase the risks the Company currently faces from new entrants and disruptive actions by existing competitors compared to prior periods.</span></div><div><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that the significant factors that distinguish competing health plans include the perceived overall quality (including accreditation status), quality of service, comprehensiveness of coverage, cost (including premium rates, provider discounts and member out-of-pocket costs), product design, financial stability and ratings, breadth and quality of provider networks, ability to offer different provider network options, providers available in such networks, and quality of member support and care management programs. The Company believes that it is competitive on each of these factors. The Company&#8217;s ability to increase the number of persons covered by its health plans or to increase Health Care Benefits segment revenues is affected by its ability to differentiate itself from its competitors on these factors. Competition may also affect the availability of services from providers, including primary care physicians, specialists and hospitals.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insured products compete with local and regional health care benefits plans, health care benefits and other plans sponsored by other large commercial health care benefit insurance companies, health system owned health plans, new entrants into the marketplace and numerous for-profit and not-for-profit organizations operating under licenses from the Blue Cross and Blue Shield Association. The largest competitor in Medicare products is Original Medicare. Additional Health Care Benefits segment competitors include other types of medical and dental provider organizations, various specialty service providers (including pharmacy benefit management (&#8220;PBM&#8221;) services providers), health care consultants, financial services companies, integrated health care delivery organizations (networks of providers who also coordinate administrative services for and assume insurance risk of their members), third party administrators (&#8220;TPAs&#8221;), HIT companies and, for certain plans, programs sponsored by the federal or state governments. Emerging competitors include start up health care benefits plans, technology companies, provider-owned health plans, new joint ventures (including not-for-profit joint ventures among firms from multiple industries), technology firms, financial services firms that are distributing competing products on their proprietary Private Exchanges, and consulting firms that are distributing competing products on their proprietary Private Exchanges, as well as non-traditional distributors such as retail companies. The Company&#8217;s ability to increase the number of persons enrolled in Insured Commercial Medical products also is affected by the desire and ability of employers to self-fund their health coverage.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment&#8217;s ASC plans compete primarily with other large commercial health care benefit companies, numerous for-profit and not-for-profit organizations operating under licenses from the Blue Cross and Blue Shield Association and TPAs.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment&#8217;s international products compete with local, global and U.S.-based health plans and commercial health care benefit insurance companies, many of whom are licensed in more geographies and have a longer operating history, better brand recognition and greater marketplace presence in one or more geographies.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provider solutions and HIT marketplaces and products are evolving rapidly. The Company competes for provider solutions and HIT business with other large health plans and commercial health care benefit insurance companies as well as information technology companies and companies that specialize in provider solutions and HIT. Many information technology product competitors have longer operating histories, better brand recognition, greater marketplace presence and more experience in developing innovative products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to competitive pressures affecting the Company&#8217;s ability to obtain new customers or retain existing customers, the Health Care Benefits segment&#8217;s medical membership has been and may continue to be adversely affected by adverse and/or uncertain economic conditions and reductions in workforce by existing customers due to adverse and/or uncertain general economic conditions, especially in the United States and industries where such membership is concentrated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Reinsurance</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">currently has</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">several reinsurance agreements with non-affiliated insurers that relate to Health Care Benefits insurance policies. The Company entered into these contracts to reduce the risk of catastrophic losses which in turn reduces capital and surplus requirements. The Company frequently evaluates reinsurance opportunities and refines its reinsurance and risk management strategies on a regular basis.</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_16"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of PBM solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services and mail order pharmacy. In addition, through the Pharmacy Services segment, the Company provides specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care (&#8220;Managed Medicaid&#8221;) plans, plans offered on Insurance Exchanges and other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment includes retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. During the year ended December&#160;31, 2021, the Company&#8217;s PBM filled or managed 2.2 billion prescriptions on a 30-day equivalent basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PBM Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company dispenses prescription drugs directly through its mail order dispensing and specialty mail order pharmacies and through pharmacies in its retail network. All prescriptions processed by the Company are analyzed, processed and documented by the Company&#8217;s proprietary prescription management systems. These systems provide essential features and functionality to allow plan members to utilize their prescription drug benefits. These systems also streamline the process by which prescriptions are processed by staff and network pharmacists by enhancing review of various items through automation, including plan eligibility, early refills, duplicate dispensing, appropriateness of dosage, drug interactions or allergies, over-utilization and potential fraud.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plan Design Offerings and Administration</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assists its PBM clients in designing pharmacy benefit plans that help improve health outcomes while minimizing the costs to the client. The Company also assists PBM clients in monitoring the effectiveness of their plans through frequent, informal communications, the use of proprietary software, as well as through formal annual, quarterly and sometimes monthly performance reviews. The Company administers pharmacy benefit plans for clients who contract with it to facilitate prescription drug coverage and claims processing for their eligible plan members. The Company also provides administrative services for Covered Entities.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes recommendations to help PBM clients design benefit plans that promote the use of lower cost, clinically appropriate drugs and helps its PBM clients control costs by recommending plan designs that encourage the use of generic equivalents of brand name drugs when such equivalents are available. Clients also have the option, through plan design, to further lower their pharmacy benefit plan costs by setting different member payment levels for different products on their drug lists or &#8220;formularies,&#8221; which helps guide members to choose lower cost alternatives through appropriate financial incentives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Formulary Management</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes an independent panel of doctors, pharmacists and other medical experts, referred to as the CVS Caremark National Pharmacy and Therapeutics Committee, to review and approve the selection of drugs that meet the Company&#8217;s standards of safety and efficacy for inclusion on one of the Company&#8217;s template formularies. The Company&#8217;s formularies provide recommended products in numerous drug classes to help ensure member access to clinically appropriate drugs with alternatives within a class under the client&#8217;s pharmacy benefit plan, while helping to drive the lowest net cost for clients that select one of the Company&#8217;s formularies. To help improve clinical outcomes for members and clients, the Company conducts ongoing, independent reviews of all drugs, including those appearing on the formularies and generic equivalent products. Many of the Company&#8217;s clients choose to adopt a template formulary offering as part of their plan design. PBM clients are given capabilities to offer real time benefits information for a member&#8217;s specific plan design, provided digitally at the point of prescribing, at the CVS pharmacy and directly to members.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail Pharmacy Network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a national network of approximately 66,000 retail pharmacies, consisting of approximately 40,000 chain pharmacies (which includes CVS Pharmacy locations) and approximately 26,000 independent pharmacies, in the United States, including Puerto Rico, the District of Columbia, Guam and the U.S. Virgin Islands. When a customer fills a prescription in a retail pharmacy, the pharmacy sends prescription data electronically to the Company from the point-of-sale. This data interfaces with the Company&#8217;s proprietary prescription management systems, which verify relevant plan member data and eligibility, while also performing a drug utilization review to help evaluate clinical appropriateness and safety and confirming that the pharmacy will receive payment for the prescription. The Company also offers a performance program for non-Medicare customers, which can be implemented with either the Company&#8217;s broad, national network or with any managed network (as allowed by applicable laws and regulations). Under the program, high performing pharmacies are eligible to receive an incremental positive performance payment. The program aligns with key Healthcare Effectiveness Data Information Set measures utilized by CMS and is funded by client fees.&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mail Order Pharmacy Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment operates mail order dispensing pharmacies in the United States. Plan members or their prescribers submit prescriptions or refill requests, primarily for maintenance medications, to these pharmacies, and staff pharmacists review these prescriptions and refill requests with the assistance of the Company&#8217;s prescription management systems. This review may involve communications with the prescriber and, with the prescriber&#8217;s approval when required, can result in generic substitution, therapeutic interchange or other actions designed to help reduce cost and/or improve quality of treatment. The Company&#8217;s mail order dispensing pharmacies have been awarded Mail Service Pharmacy accreditation from URAC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Specialty Pharmacy and Infusion Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment operates specialty mail order pharmacies, retail specialty pharmacy stores and branches for infusion and enteral nutrition services in the United States. The specialty mail order pharmacies are used for delivery of advanced medications to individuals with chronic or genetic diseases and disorders. The Company&#8217;s specialty mail order pharmacies have been awarded Specialty Pharmacy accreditation from URAC. Substantially all of the Company&#8217;s specialty mail order pharmacies also have been accredited by The Joint Commission and the Accreditation Commission for Health Care (&#8220;ACHC&#8221;), which are independent, not-for-profit organizations that accredit and certify health care programs and organizations in the United States. The ACHC accreditation includes an additional accreditation by the Pharmacy Compounding Accreditation Board, which certifies compliance with the highest level of pharmacy compounding standards. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clinical Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers multiple clinical programs and services to help clients manage overall pharmacy and health care costs in a clinically appropriate manner. These programs are primarily designed to promote better health outcomes and to help target inappropriate medication utilization and non-adherence to medication, each of which may result in adverse medical events that negatively affect member health and client pharmacy and medical spend. These programs include utilization management (&#8220;UM&#8221;), medication management, quality assurance, adherence and counseling programs to complement the client&#8217;s plan design and clinical strategies. To help address prescription opioid abuse and misuse, the Company introduced an industry-leading UM approach that limits to seven days the supply of opioids dispensed for certain acute prescriptions for patients who </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are new to therapy, limits the daily dosage of opioids dispensed based on the strength of the opioid and requires the use of immediate-release formulations of opioids before extended-release opioids are dispensed. The Company&#8217;s Pharmacy Advisor</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> program facilitates pharmacist counseling, both face-to-face and over the telephone, to help participating plan members with certain chronic diseases, such as diabetes and cardiovascular conditions, to identify gaps in care, adhere to their prescribed medications and manage their health conditions. The Company also has digital connectivity that helps to lower drug costs for patients by providing expanded visibility to lower cost alternatives through enhanced analytics and data sharing. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disease Management Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s clinical programs and services utilize advanced protocols and offer clients convenience in working with providers and other third parties. The Company&#8217;s care management program covers diseases such as rheumatoid arthritis, Parkinson&#8217;s disease, epilepsy and multiple sclerosis and is accredited by the NCQA. The Company&#8217;s UM program covers similar diseases and is accredited by the NCQA and URAC. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Benefit Management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s NovoLogix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">online preauthorization tool helps identify and capture cost savings opportunities for specialty drugs billed under the medical benefit by identifying outliers to appropriate dosages and costs, and helps to ensure clinically appropriate use of specialty drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Group Purchasing Organization Services</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates a group purchasing organization that negotiates pricing for the purchase of pharmaceuticals and rebates with pharmaceutical manufacturers on behalf of its participants. The Company also provides various administrative, management and reporting services to pharmaceutical manufacturers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy Services Information Systems</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment&#8217;s claim adjudication platform incorporates architecture that centralizes the data generated from filling mail order prescriptions, adjudicating retail pharmacy claims and delivering other solutions to PBM clients. The Health Engagement Engine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology and proprietary clinical algorithms help connect the various parts of the enterprise and serve an essential role in cost management and health improvement, leveraging cloud-native technologies and practices. This capability transforms pharmacy data into actionable interventions at key points of care, including in retail, mail and specialty pharmacies as well as in customer care call center operations, leveraging our enterprise data platform to improve the quality of care. The technology leverages assisted artificial intelligence to deliver insights to the business and bring automation to otherwise manual tasks. Specialty services also connects with our claim adjudication platform and various health plan adjudication platforms with a centralized architecture servicing many clients and members. Operating services, such as Specialty Expedite</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, provide an interconnected onboarding solution for specialty medications and branding solutions ranging from fulfillment to total patient management. These services are managed through our new innovative specialty workflow and web platform.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy Services Clients</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Pharmacy Services clients are primarily employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, Managed Medicaid plans and plans offered on Insurance Exchanges and other sponsors of health benefit plans throughout the United States and Covered Entities. Pharmaceuticals are provided to eligible members in benefit plans maintained by clients and utilize the Company&#8217;s information systems, among other things, to help perform safety checks, drug interaction screening and identify opportunities for generic substitution. Substantially all of the Pharmacy Services segment&#8217;s revenues are generated from dispensing and managing prescription drugs to eligible members in benefit plans maintained by clients. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy Services Seasonality</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of Pharmacy Services segment revenues are not seasonal in nature. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy Services Competition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes the primary competitive factors in the pharmacy services industry include: (i)&#160;the ability to negotiate favorable discounts from drug manufacturers as well as to negotiate favorable discounts from, and access to, retail pharmacy networks; (ii)&#160;the ability to identify and apply effective cost management programs utilizing clinical strategies, including&#160;the development and utilization of preferred formularies; (iii)&#160;the ability to market PBM products and services; (iv)&#160;the commitment </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to provide flexible, clinically-oriented services to clients and be responsive to clients&#8217; needs; (v)&#160;the quality, scope and costs of products and services offered to clients and their members; and (vi) operational excellence in delivering services. The Pharmacy Services segment has a significant number of competitors offering PBM services, including large, national PBM companies (e.g., Prime Therapeutics and MedImpact), PBMs owned by large national health plans (e.g., the Express Scripts business of Cigna Corporation and the OptumRx business of UnitedHealth) and smaller standalone PBMs. </span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_19"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of December&#160;31, 2021, the Retail/LTC segment operated more than 9,900 retail locations, nearly 1,200 MinuteClinic locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. During the year ended December&#160;31, 2021, the Retail/LTC segment filled 1.6 billion prescriptions on a 30-day equivalent basis. For the year ended December&#160;31, 2021, the Company dispensed approximately 26.4% of the total retail pharmacy prescriptions in the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retail/LTC Products and Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A typical retail store sells prescription drugs and a wide assortment of high-quality, nationally advertised brand name and proprietary brand merchandise. Pharmacy locations may also contract with Covered Entities under the federal 340B drug pricing program. Front store categories include over-the-counter drugs, consumer health products, beauty products and personal care products. LTC operations include distribution of prescription drugs and related consulting and ancillary services. The Company purchases merchandise from numerous manufacturers and distributors. The Company believes that competitive sources are readily available for substantially all of the products carried in its retail stores and the loss of any one supplier would not likely have a material effect on the Retail/LTC segment. The Company&#8217;s MinuteClinic locations offer a variety of health care services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retail/LTC revenues by major product group are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Percentage&#160;of&#160;Revenues</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front store and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy includes LTC sales and sales in pharmacies within Target Corporation (&#8220;Target&#8221;) and other retail stores.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">&#8220;Other&#8221; represents less than 12% of the &#8220;Front store and other&#8221; revenue category in all periods presented.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharmacy revenues represented approximately three-fourths of Retail/LTC segment revenues in each of 2021, 2020 and 2019. The Company believes that retail pharmacy operations will continue to represent a critical part of the Company&#8217;s business due to industry demographics, e.g., an aging American population consuming a greater number of prescription drugs, prescription drugs being used more often as the first line of defense for managing illness, the introduction of new pharmaceutical products, the need for vaccinations, including the COVID-19 vaccination, and Medicare Part&#160;D growth. The Company believes the retail pharmacy business benefits from investment in both people and technology, as well as innovative collaborations with health plans, PBMs and providers. Given the nature of prescriptions, consumers want their prescriptions filled accurately by professional pharmacists using the latest tools and technology, and ready when promised. Consumers also need medication management programs and better information to help them get the most out of their health care dollars. To assist consumers with these needs, the Company has introduced integrated pharmacy health care services that provide an earlier, easier and more effective approach to engaging consumers in behaviors that can help lower costs, improve health and save lives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Front Store</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Front store revenues reflect the Company&#8217;s strategy of innovating with new and unique products and services, using innovative personalized marketing and adjusting the mix of merchandise to match customers&#8217; needs and preferences. A key component of the front store strategy is the ExtraCare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;card program, which is one of the largest and most successful retail loyalty programs in the United States. The ExtraCare program allows the Company to balance marketing efforts so it can reward its best </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">customers by providing them with automatic sale prices, customized coupons, ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;rewards and other benefits. The Company also offers a subscription-based membership program, CarePass</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. The Company continues to launch and enhance new and exclusive brands to create unmatched offerings in beauty products and deliver other unique product offerings, including a full range of high-quality CVS Health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and other proprietary brand products that are only available through CVS stores. The Company currently carries approximately 6,000 CVS Health and proprietary items, which accounted for approximately 22% of front store revenues during 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">MinuteClinic</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company operated nearly 1,200 MinuteClinic&#160;locations in the United States. The clinics are staffed by nurse practitioners and physician assistants who utilize nationally established guidelines to deliver a variety of health care services. Payors value these clinics because they provide convenient, high-quality, cost-effective care, in many cases offering an attractive alternative to more expensive sites of care.&#160;MinuteClinic is collaborating with the Health Care Benefits and Pharmacy Services segments to help meet the needs of the Company&#8217;s health plan members and CVS Caremark&#8217;s client plan members by offering programs that can improve member health and lower costs. MinuteClinic also maintains relationships with leading hospitals, clinics and physicians in the communities we serve to support and enhance quality, access and continuity of care. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">On-site Pharmacies</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also operates a limited number of pharmacies located at client sites, which provide certain health plan members and customers with a convenient alternative for filling their prescriptions and receiving vaccinations, including the COVID-19 vaccination.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Diagnostic Testing</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers medical diagnostic testing primarily through its COVID-19 testing sites located at CVS Pharmacy locations, in its MinuteClinic locations, at community-based testing sites in underserved areas and through its Return Ready</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">solution.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-term Care Pharmacy Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment provides LTC pharmacy services through the Omnicare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> business. Omnicare&#8217;s customers consist of skilled nursing facilities, assisted living facilities, independent living communities, hospitals, correctional facilities, and other health care service providers. The Company provides pharmacy consulting, including monthly patient drug therapy evaluations, to assist in compliance with state and federal regulations and provide proprietary clinical and health management programs. It also provides pharmaceutical case management services for retirees, employees and dependents who have drug benefits under corporate-sponsored health care programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Community Location Development</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health&#8217;s community health destinations are an integral part of its ability to meet the needs of consumers and maintain its leadership position in the changing health care landscape. When paired with its rapidly expanding digital presence, the Company&#8217;s physical presence in thousands of communities across the country represents a competitive advantage by allowing it to develop deep and trusted relationships through everyday engagement in consumer health. The Company&#8217;s community health destinations have played, and will continue to play, a key role in the Company&#8217;s continued growth and success. During 2021, the Company opened approximately 55 new community locations, relocated approximately 15 locations, converted approximately 300 locations into CVS HealthHUB locations and closed approximately 80 locations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s continuous assessment of its national footprint is an essential component of competing effectively in the current health care environment. On an ongoing basis, the Company evaluates changes in population, consumer buying patterns and future health needs to assess the ability of its existing stores and locations to meet the needs of its consumers and the business. During the fourth quarter of 2021, the Company completed a strategic review of its retail business and announced its plans to reduce store density in certain locations through the closure of approximately 900 stores between 2022 and 2024. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Company&#8217;s strategic review of its retail business, CVS Health will also create new store formats to drive higher engagement with consumers. Three distinct models will serve as community health destinations: (a) sites dedicated to offering primary care services; (b) an enhanced version of CVS HealthHUB locations with products and services designed for everyday health and wellness needs; and (c) traditional CVS Pharmacy stores that provide prescription services and health, wellness, personal care and other convenient retail offerings.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retail/LTC Information Systems</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has continued to invest in information systems to enable it to deliver exceptional customer service, enhance safety and quality, and expand patient care services while lowering operating costs. The proprietary WeCARE Workflow tool supports pharmacy teams by prioritizing work to meet customer expectations, facilitating prescriber outreach, and seamlessly integrating clinical programs. This solution delivers improved efficiency and enhances customer experience, as well as provides a framework to accommodate the evolution of pharmacy practice and the expansion of clinical programs. Our Health Engagement Engine technology and data science clinical algorithms enable the Company to help identify opportunities for pharmacists to deliver face-to-face counseling regarding patient health and safety matters, including medication adherence issues, gaps in care and management of certain chronic health conditions. The Company&#8217;s digital strategy is to empower the consumer to navigate their pharmacy experience and manage their condition through integrated online and mobile solutions that offer utility and convenience. The Company&#8217;s LTC digital technology suite, Omniview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, improves the efficiency of customers&#8217; operations with tools that include executive dashboards, pre-admission pricing, electronic ordering of prescription refills, proof-of-delivery tracking, access to patient profiles, receipt and management of facility bills, and real-time validation of Medicare Part D coverage, among other capabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the collaboration of its digital and technical teams, the Company has established critical tools which enable patients to schedule COVID-19 diagnostic testing and vaccination appointments through CVS.com and MinuteClinic.com. Key elements of the offerings include landing pages which highlight services and answer common questions, screening capabilities to determine patient eligibility, service location locator and appointment selection tools to efficiently identify the requested service on a specified date, time, and location and registration pages to collect required patient information, accelerating the administration of the test or vaccine once at the store. Once scheduled, the tools provide the user with instructions and notifications including SMS text message and email reminders, and, following administration, also provide digital results for tests and records for vaccinations, enabling patients to view and save their medical records for convenient access at a later point.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retail/LTC Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of the Retail/LTC segment&#8217;s businesses is dependent upon the Company&#8217;s ability to establish and maintain contractual relationships with pharmacy benefit managers and other payors on acceptable terms. Substantially all of the Retail/LTC segment&#8217;s pharmacy revenues are derived from pharmacy benefit managers, managed care organizations (&#8220;MCOs&#8221;), government funded health care programs, commercial employers and other third-party payors. No single Retail/LTC payor accounted for 10% or more of the Company&#8217;s consolidated total revenues in 2021, 2020 or 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retail/LTC Seasonality</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of Retail/LTC segment revenues, particularly pharmacy revenues, generally are not seasonal in nature. However, front store revenues tend to be higher during the December holiday season. In addition, both pharmacy and front store revenues are affected by the timing and severity of the cough, cold and flu season. Uncharacteristic or extreme weather conditions also can adversely affect consumer shopping patterns and Retail/LTC revenues, expenses and operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, the customary quarterly operating income progression continued to be impacted by COVID-19. During the first quarter, the Company experienced reduced customer traffic in its retail pharmacies, which reflected the impact of a weak cough, cold and flu season, while it administered the highest quarterly volume of COVID-19 diagnostic tests. During the second quarter, the segment generated earnings from COVID-19 vaccinations and saw improved customer traffic as vaccinated customers began more actively shopping in CVS locations. During the third and fourth quarters, emerging new variants drove the continued administration of COVID-19 vaccinations (including booster shots), which reached their highest levels of the year during the fourth quarter, and diagnostic testing. During the third and fourth quarters, the segment also generated earnings from the sale of OTC test kits in the front store. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, the customary quarterly operating income progression was also impacted by COVID-19. During March 2020, the Company experienced greater use of 90-day prescriptions, early refills of maintenance medications and increased front store volume as consumers prepared for the COVID-19 pandemic. Subsequent to March 2020, the Company experienced reduced customer traffic in its retail pharmacies and MinuteClinic locations due to shelter-in-place orders as well as reduced new therapy prescriptions as a result of the COVID-19 pandemic. Beginning in the third quarter, the Company saw an increase in diagnostic testing related to the COVID-19 pandemic and in December 2020, the Company began administering COVID-19 vaccinations in long-term care facilities.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retail/LTC Competition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The retail pharmacy business is highly competitive. The Company believes that it competes principally on the basis of: (i)&#160;store location and convenience, (ii)&#160;customer service and satisfaction, (iii)&#160;product selection and variety, and (iv)&#160;price. In the areas it serves, the Company competes with other drugstore chains (e.g., Walgreens and Rite Aid), supermarkets, discount retailers (e.g., Walmart), independent pharmacies, restrictive pharmacy networks, internet companies (e.g., Amazon), membership clubs,&#160;retail health clinics, urgent care and primary care offices, as well as mail order dispensing pharmacies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LTC pharmacy services are highly regional or local in nature, and within a given geographic area of operation, highly competitive. The Company&#8217;s largest LTC pharmacy competitor nationally is PharMerica. The Company also competes with numerous local and regional institutional pharmacies, pharmacies owned by long-term care facilities and local retail pharmacies. Some states have enacted &#8220;freedom of choice&#8221; or &#8220;any willing provider&#8221; requirements as part of their state Medicaid programs or in separate legislation, which may increase the competition that the Company faces in providing services to long-term care facility residents in these states.</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_25"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as large case pensions and long-term care insurance products.</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_28"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Generic Sourcing Venture</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and Cardinal Health, Inc. (&#8220;Cardinal&#8221;) each have a 50% ownership in Red Oak Sourcing, LLC (&#8220;Red Oak&#8221;), a generic pharmaceutical sourcing entity. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak. Red Oak does not own or hold inventory on behalf of either company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Working Capital Practices</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company funds the growth of its businesses through a combination of cash flow from operations, commercial paper and other short-term borrowings, proceeds from sale-leaseback transactions and long-term borrowings. For additional information on the Company&#8217;s working capital practices, see &#8220;Liquidity and Capital Resources&#8221; in the MD&amp;A included in Item 7 of this 10-K. Employer groups, individuals, college students, part-time and hourly workers, health plans, providers, governmental units, government-sponsored plans (with the exception of Medicare Part D services, which are described below), labor groups and expatriates, which represent the vast majority of Health Care Benefits segment revenues, typically settle in less than 30 days. As a provider of Medicare Part D services, the Company contracts annually with CMS.&#160;Utilization of services each plan year results in the accumulation of either a receivable from or a payable to CMS. The timing of settlement of the receivable or payable with CMS takes several quarters, which impacts working capital from year to year. The majority of the Retail/LTC segment non-pharmacy revenues are paid in cash, or with debit or credit cards. Managed care organizations, pharmacy benefit managers, government funded health care programs, commercial employers and other third party insurance programs, which represent the vast majority of the Company&#8217;s consolidated pharmacy revenues, typically settle in less than 30 days. The remainder of the Company&#8217;s consolidated pharmacy revenues are paid in cash, or with debit or credit cards. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At CVS Health, we share a single, clear purpose: bringing our heart to every moment of your health. We devote significant time and attention to the attraction, development and retention of talent to deliver high levels of service to our customers. Our commitment to them includes a competitive rewards package and programs that support our diverse range of colleagues in rewarding and fulfilling careers. As of December 31, 2021, we employed approximately 300,000 colleagues primarily in the United States including in all 50 states, the District of Columbia and Puerto Rico, approximately 72% of whom were full-time. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe engaged colleagues produce stronger business results and are more likely to build a career with the Company. Each year we conduct an internal engagement survey that provides colleagues with an opportunity to share their opinions and experiences with respect to their role, their team and the enterprise to help our Board and our management identify areas where we can improve colleague experience. The survey covers a broad range of topics including development and opportunities, diversity management, recognition, performance, well-being, compliance and continuous improvement. In 2021, greater than 80% of our colleagues participated in the engagement survey, of which greater than 75% responded that they were actively engaged.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board and our chief executive officer (&#8220;CEO&#8221;) provide oversight of our human capital strategy, which consists of the following categories: total rewards; diversity, equity and inclusion; colleague development; and health and safety.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Rewards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize how vital our colleagues are to our success and strive to offer comprehensive and competitive wages and benefits to meet the varying needs of our colleagues and their families. The benefits and programs include annual bonuses, 401(k) plans, stock awards, an employee stock purchase plan, health care and insurance benefits, paid time off, flexible work schedules, family leave, dependent care resources, colleague assistance programs and tuition assistance, among many others, depending on eligibility. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recognition of the critical role that the attraction and retention of talent plays in the success of our business, during 2021, we also announced a significant investment in our employees through an increase in the Company&#8217;s minimum hourly wage to $15.00 an hour effective July 2022, with incremental increases to the Company&#8217;s competitive hourly rates beginning in August 2021. The new wage structure also incorporates additional increases beyond the $15.00 minimum, with higher starting hourly rates for roles such as pharmacy technicians and call center representatives. In addition, during 2021 we awarded incremental </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">bonuses to select colleague groups in recognition of their ongoing contributions throughout the COVID-19 pandemic, the most significant of which included bonuses to our pharmacist and distribution center colleagues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversity, Equity &amp; Inclusion</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that a diverse workforce creates a healthier, stronger and more sustainable company. We aim to attract, develop, retain and support a diverse workforce that reflects the many customers, patients, members and communities we serve. Our Diversity Management Leadership Council, a cross-functional group of senior leaders appointed by our CEO, works with our Strategic Diversity Management leadership team to intentionally embed diversity across all facets of our business. For our efforts, we have been recognized as a DiversityInc Top 50 Company, a LatinaStyle Top 50 Company for Latinas and earned a 100 percent score on both the Human Rights Campaign Corporate Equality Index as well as the Disability Equality Index, meaning the company is recognized as a &#8220;Best Place to Work for Disability Inclusion.&#8221; The Company discloses information on our diversity, equity and inclusion strategy and programs in our annual Corporate Social Responsibility (&#8220;CSR&#8221;) Report.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a foundation of diversity and inclusion, we continuously focus on increasing underrepresented populations across our business. In 2021, 71% of our total colleague population and 55% of our colleagues at the manager level and above self-reported as female. In addition, in 2021 our colleagues reported their race/ethnicity as: White (49%), Black/African American (17%), Hispanic/Latino (15%), Asian (11%) and Other (8%). The appendix to our CSR Report, our Strategic Diversity Management Report and our EEO-1 Employer Information Report include additional information on the diversity of our workforce.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our diversity management strategy emphasizes workplace representation, inclusion and belonging, talent acquisition and management and a diverse marketplace. We incorporated a diversity metric into our 2021 annual cash incentive program for our most senior leaders who have the greatest ability to influence the overall hiring, development and promotion of our colleagues. We also continued the deployment of conscious inclusion training for colleagues designed to enhance awareness of biases and support inclusive behaviors. Our CSR Report includes additional information with respect to our conscious inclusion training. We support 16 Colleague Resource Groups (&#8220;CRGs&#8221;) that include more than 26,000 colleagues across the enterprise. These groups represent a wide range of professional, cultural, ethical and personal affinities and interests, as well as formal mentoring programs. Our CRGs provide our colleagues with an opportunity to connect and network with one another through a particular affinity, culture or interest. Each of our CRGs is sponsored by a senior leader. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Colleague Development</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers a number of resources and programs that attract, engage, develop, advance and retain colleagues. Training and development provides colleagues the support they need to perform well in their current role while planning and preparing for future roles. We offer an online orientation program that pairs new hires with seasoned colleagues and the training continues throughout a colleague&#8217;s career through in-person, virtual and self-paced learning at all levels. We also provide mentoring, tools and workshops for colleagues to manage their career development. We offer a variety of management and leadership programs that develop incumbent diverse and other high potential colleagues. Our broad training practices include updated, tech-enabled tools and keep our colleagues informed of new developments in our industry that are relevant to their roles. During the year ended December 31, 2021, our colleagues invested more than 13&#160;million hours in learning and development courses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our colleague development program also promotes the importance of compliance across our business. Our colleagues demonstrate this commitment through our annual Code of Conduct training, which 100% of active colleagues completed in 2021. In 2021, we launched more than 70 different training courses as part of our annual Enterprise Compliance Training Program.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health &amp; Safety</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a strong commitment to providing a safe working environment. We have implemented an environmental health and safety management system to support adherence and monitoring of programs designed to make our various business operations compliant with applicable occupational safety and health regulations and requirements. Our Environmental Health and Safety Department oversees the implementation and adherence to programs like Powered Industrial Truck training, materials handling and storage, selection of personal protective equipment and workplace violence prevention. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize Safety Service Plans to analyze data and concentrate on key areas of risk to reduce the chance of workplace incidents. We focus on identifying causes and improving performance when workplace incidents occur. We also engage leaders </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in promoting a culture of safety. With safety task forces in place at each distribution center, we empower leaders and safety business partners to identify policies, procedures and processes that could improve their own operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From the outset of the COVID-19 pandemic, we took a comprehensive approach to managing occupational health and safety challenges presented by the pandemic, including implementing facial covering requirements for our workplaces and providing face masks to colleagues, providing sick leave, implementing symptom screening measures and implementing additional protocols in accordance with applicable Occupational Safety and Health Administration (&#8220;OSHA&#8221;) requirements and guidance and Centers for Disease Control and Prevention (&#8220;CDC&#8221;) guidelines for workplaces. We have emphasized the importance of taking immediate steps toward full vaccination.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental, Social and Governance (&#8220;ESG&#8221;) Strategy</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health believes the health of our people, communities and planet are linked to the health of our business. Our ESG strategy is designed to use our assets to transform the health care experience and invest in community health at the local level, while working to reduce the environmental impact of our operations. Our ESG strategy includes a set of goals we hope to achieve in 2030 or earlier. We believe these goals are achievable without materially adversely affecting our businesses, operating results, cash flows and/or prospects. Our ESG strategy consists of four pillars: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthy People</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthy Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthy Community</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthy Planet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthy People</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through physical and virtual interactions, we provide convenient, personalized and integrated access to health care support and services.  We continue to implement and expand initiatives that build on our innovative health care model, with the ultimate aim to transform the health care experience for every person we reach to improve health outcomes. These include helping to improve chronic disease prevention and management, helping to reduce and prevent prescription drug misuse, and improving the social determinants of health, which include education, transportation and behavioral health. Through our ESG strategy we are focused on our interaction with individuals across all our touchpoints to increase the likelihood that these initiatives will succeed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthy Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we work to transform health care, we are committed to operating a healthy business for all our stakeholders, including our patients, customers, stockholders, clients, partners, communities and colleagues. Throughout our large operational footprint and including our supply chain, we are committed to acting responsibly with respect for human rights, privacy, information security, public policy, marketing and advertising. We focus on diversity, equity and inclusion as well as colleague development, health and safety. Through our ESG strategy we will be investing in colleague mentoring, sponsorship, development and advancement; workforce initiatives that provide employment services and training to the underserved; and providing access to health care while addressing health disparities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthy Community</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By working with community-focused organizations and through innovative programs that can be tailored to and executed across different communities, we are driving positive health outcomes and reducing overall health care costs. Through our recently announced Health Zones initiative, CVS Health and our nonprofit partners are working together to create a model that reduces health disparities, promotes and enhances equity and ensures at-risk communities can thrive. Through our ESG strategy we are building healthier communities through social impact investments, such as supporting health care professionals, reducing food insecurity, engaging our customers in community health, and coordinating care for the underserved.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthy Planet</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our work to improve the planet is aligned with our commitment to the communities we serve and to help protect our businesses from the negative impacts of climate change. All of our businesses, including our community locations, corporate offices and operation centers, distribution centers, and specialty pharmacy and PBM mail pharmacy locations, can be impacted by climate change-related extreme weather events and we are doing our part to reduce our environmental impacts. We are focused on identifying resource efficiencies across our operations and supply chain. We are proud to be recognized as a leader in addressing climate-related issues and are working closely with key stakeholders to make and deliver meaningful progress. Key </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">priorities include the advancement of our greenhouse gas (&#8220;GHG&#8221;) emissions-reduction targets, reduction in our energy consumption, the advancement of sustainability in transportation, logistics and our physical locations, which includes retrofitting community and corporate locations with LED lighting, exploring investments in renewable energy, reducing water use, focusing on smarter consumption through a &#8220;digital first&#8221; approach and the reduction of our use of paper and plastic. In October 2021, CVS Health&#8217;s science-based net zero GHG emissions targets were validated by the Science Based Targets initiatives (&#8220;SBTi&#8221;). We continue to make meaningful progress to reduce our environmental impact.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has registered and/or applied to register a variety of trademarks and service marks used throughout its businesses, as well as domain names, and relies on a combination of copyright, patent, trademark and trade secret laws, in addition to contractual restrictions, to establish and protect the Company&#8217;s proprietary rights. The Company regards its intellectual property as having significant value in the Health Care Benefits, Pharmacy Services and Retail/LTC segments. The Company is not aware of any facts that could materially impact the continuing use of any of its intellectual property.</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operations are subject to comprehensive federal, state and local laws and regulations and comparable multiple levels of international regulation in the jurisdictions in which it does business. There also continues to be a heightened level of review and/or audit by federal, state and international regulators of the health&#160;and related benefits industry&#8217;s business and reporting practices. In addition, many of the Company&#8217;s PBM clients and the Company&#8217;s payors in the Retail/LTC segment, including insurers, Medicare plans, Managed Medicaid plans and MCOs, are themselves subject to extensive regulations that affect the design and implementation of prescription drug benefit plans that they sponsor. Similarly, the Company&#8217;s LTC clients, such as skilled nursing facilities, are subject to government regulations, including many of the same government regulations to which the Company is subject. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws and rules governing the Company&#8217;s businesses and interpretations of those laws and rules continue to expand and become more restrictive each year and are subject to frequent change. The application of these complex legal and regulatory requirements to the detailed operation of the Company&#8217;s businesses creates areas of uncertainty. Further, there are numerous proposed health care, financial services and other laws and regulations at the federal, state and international levels, some of which could adversely affect the Company&#8217;s businesses if they are enacted. The Company cannot predict whether pending or future federal or state legislation or court proceedings will change aspects of how it operates in the specific markets in which it competes or the health care industry generally, but if changes occur, the impact of any such changes could have a material adverse impact on the Company&#8217;s businesses, operating results, cash flows and/or stock price. Possible regulatory or legislative changes include the federal or one or more state governments fundamentally restructuring the Commercial, Medicare or Medicaid marketplace; reducing payments to the Company in connection with Medicare, Medicaid, dual eligible or special needs programs; increasing its involvement in drug reimbursement, pricing, purchasing, and/or importation; or changing the laws governing PBMs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has internal control policies and procedures and conducts training and compliance programs for its employees to help prevent, detect and correct prohibited practices. However, if the Company&#8217;s employees or agents fail to comply with applicable laws governing its international or other operations, it may face investigations, prosecutions and other legal proceedings and actions which could result in civil penalties, administrative remedies and criminal sanctions. Any failure or alleged failure to comply with applicable laws and regulations summarized below, or any adverse applications or interpretations of, or changes in, the laws and regulations affecting the Company and/or its businesses, could have a material adverse effect on the Company&#8217;s operating results, financial condition, cash flows and/or stock price. See Item 3 of this 10-K, &#8220;Legal Proceedings,&#8221; for further information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i) future enactment of new health care or other laws or regulations; (ii) the interpretation or application of existing laws or regulations, including the laws and regulations described in this Government Regulation section, as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii) pending or future federal or state governmental investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv) pending or future government audits, investigations or enforcement actions against the Company; or (v) adverse developments </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in pending or future legal proceedings against or affecting the Company, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuits, or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations Related to COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Families First Coronavirus Response Act (the &#8220;Families First Act&#8221;) and the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) were enacted in March 2020. Each of the Families First Act and the CARES Act requires the Company to provide coverage for COVID-19 related medical services, in many cases without member cost-sharing, in its Insured Health Care Benefits products. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CARES Act also provides relief funding to providers to reimburse them for health care related expenses incurred in preventing, preparing for and/or responding to COVID-19 (provided no other source is obligated to reimburse those expenses) or lost health care related revenues that are attributable to COVID-19. Under the CARES Act, the Company receives reimbursement for uninsured patients in connection with COVID-19 testing and vaccination as well as monoclonal antibody treatment. Aside from such reimbursement, the Company has not requested any funding under the CARES Act. However, in the second quarter of 2020, the Company received $43 million from the CARES Act provider relief fund, all of which was returned to the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) during the second quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CARES Act also allows for the deferral of the payment of the employer share of Social Security taxes effective March 27, 2020 by permitting them to remit the associated payments in two equal installments on or about December 31, 2021 and December 31, 2022. The Company elected to defer approximately $670&#160;million of its Social Security tax payments during the year ended December 31, 2020. The Company paid the first of two equal installments in December 2021 and will remit the second installment on or about December 31, 2022, as required under the CARES Act.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Congress enacted the American Rescue Plan Act in March 2021. Among other changes, as a result of this legislation, Public Exchange plan premium subsidies increased for low-income individuals and became available to people with incomes higher than 400% of the federal poverty limit. These changes are currently in effect through the remainder of 2022, and Congress may extend, or potentially make permanent, these policies in subsequent legislation, which could cause continued shifts in enrollment into Public Exchange plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the Families First Act, the CARES Act, and the American Rescue Plan Act, the Company continues to experience new legislation, regulation, directives, orders and other requirements from federal, state, county and municipal authorities related to the COVID-19 pandemic. These governmental actions have included, but are not limited to, requirements to waive member cost-sharing associated with COVID-19 testing and treatment, provide coverage for additional COVID-19-related services, expand the use of telemedicine, extend grace periods for payments of premiums or limit coverage termination based on non-payment of premiums or fees, modify health benefits coverage eligibility rules to help maintain employee eligibility, and facilitate, accelerate or advance payments to providers, and other requirements related to the public health emergency. These requirements may impact different areas of our business differently and for different lengths of time, and present financial implications with respect to implementing and unwinding our compliance with these new requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operations that fall within the scope of COVID-19 vaccine requirements for federal contractors, certain health care workers, and the requirements of certain jurisdictions such as New York City. Several of these are subject to judicial challenges. We are continuing to closely monitor and update our practices in response to developments or changes in the COVID-19 vaccination policies established by various federal agencies as well as the several state- and municipal-specific COVID-19 vaccine mandates that provide expanded exemptions, modifications, requirements or restrictions regarding employee vaccinations. We have a process for employees to request a reasonable accommodation if they are unable to get vaccinated due to a medical condition, sincerely held religious belief, or any other legally recognized exemption. Employees must apply and be approved for a reasonable accommodation in order to be exempt from the vaccination requirement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in December 2021, the Biden administration reiterated CARES Act guidance noting commercial health insurers are not required to cover workplace or surveillance testing and announced several new directives and actions to combat COVID-19, including the expansion of free at-home testing to be covered by commercial health insurers for the remainder of the public health emergency. On January 10, 2022, the HHS announced that commercial health insurers must cover the costs of up to eight rapid OTC COVID-19 test kits per individual per 30-day period. This requirement will likely impact multiple business operations, including increasing benefit costs in our commercial health insurance business and increasing revenues in our retail business. The requirement may also result in a decrease in more expensive tests and treatments, which could partially mitigate the increase in benefit costs in our commercial health insurance business. These impacts will be highly dependent on the overall supply of testing products. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of this governmental activity on the U.S. economy, consumer, customer and health care provider behavior and health care utilization patterns is beyond our knowledge and control. As a result, the financial and/or operational impact these COVID-19 related governmental actions and inactions will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the collective impact could be material and adverse. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations Related to Multiple Segments of the Company&#8217;s Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Laws Related to Reimbursement by Government Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company is subject to various federal and state laws concerning its submission of claims and other information to Medicare, Medicaid and other federal and state government-sponsored health care programs. Potential sanctions for violating these laws include recoupment or reduction of government reimbursement amounts, civil penalties, treble damages, and exclusion from participation in government health care programs. Such laws include the federal False Claims Act (the &#8220;False Claims Act&#8221;), the federal anti-kickback statute (the &#8220;AKS&#8221;), state false claims acts and anti-kickback statutes in most states, the federal &#8220;Stark Law&#8221; and related state laws. In particular, the False Claims Act prohibits intentionally submitting, conspiring to submit, or causing to be submitted, false claims, records, or statements to the federal government, or intentionally failing to return overpayments, in connection with reimbursement by federal government programs. In addition, any claim for government reimbursement also violates the False Claims Act where it results from a violation of the AKS. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both federal and state false claims laws permit private individuals to file </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or &#8220;whistleblower&#8221; lawsuits on behalf of the federal or state government. Participants in the health and related benefits industry, including the Company, frequently are subject to actions under the False Claims Act or similar state laws. The federal Stark Law generally prohibits physicians from referring Medicare or Medicaid beneficiaries for certain services, including outpatient prescription drugs, to any entity with which the physician, or an immediate family member of the physician, has a financial relationship. The Stark Law further prohibits the entity receiving a prohibited referral from presenting a claim for reimbursement by Medicare or Medicaid for services furnished pursuant to the prohibited referral. Various states have enacted similar laws.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The ACA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The ACA significantly increased federal and state oversight of health plans. Among other requirements, it specifies minimum medical loss ratios (&#8220;MLRs&#8221;) for Commercial and Medicare Insured products, specifies features required to be included in commercial benefit designs, limits commercial individual and small group rating and pricing practices, encourages additional competition (including potential incentives for new participants to enter the marketplace), and includes regulations and processes that could delay or limit the Company&#8217;s ability to appropriately increase its health plan premium rates. This in turn could adversely affect the Company&#8217;s ability to continue to participate in certain product lines and/or geographies that it serves today.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the United States Supreme Court dismissed a challenge on procedural grounds that argued the ACA is unconstitutional in its entirety and issued an opinion preserving the ACA and its consumer protections in its current form. Even though the ACA was deemed constitutional, there may nevertheless be continued efforts to invalidate, modify, repeal or replace portions of it. In addition to litigation, parts of the ACA continue to evolve through the promulgation of executive orders, legislation, regulations and guidance at the federal or state level. The Company expects the ACA, including potential changes thereto, to continue to significantly impact its business operations and operating results, including pricing, medical benefit ratios (&#8220;MBRs&#8221;) and the geographies in which the Company&#8217;s products are available.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicare Regulation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Medicare Advantage products compete directly with Original Medicare and Medicare Advantage products offered by other Medicare Advantage organizations and Medicare Supplement products offered by other insurers. The Company&#8217;s Medicare PDP and Medicare Supplement products are products that Medicare beneficiaries who are enrolled in Original Medicare purchase to enhance their Original Medicare coverage.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company continues to expand the number of counties in which it offers Medicare products. The Company has expanded its Medicare service area and products in 2022 and is seeking to substantially grow its Medicare membership, revenue and operating results over the next several years, including through growth in Medicare Supplement products. The anticipated organic expansion of the Medicare service area and Medicare products offered and the Medicare-related provisions of the ACA significantly increase the Company&#8217;s exposure to funding and regulation of, and changes in government policy with respect to and/or funding or regulation of, the various Medicare programs in which the Company participates, including changes in the amounts payable to us under those programs and/or new reforms or surcharges on existing programs. For example, the ACA requires minimum MLRs for Medicare Advantage and Medicare Part D plans of 85%. If a Medicare Advantage or Medicare Part D contract pays minimum MLR rebates for three consecutive years, it will become ineligible to enroll new members. If a Medicare Advantage or Medicare Part D contract pays such rebates for five consecutive years, it will be terminated by CMS. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to potential lower utilization of medical services by Medicare beneficiaries during the COVID-19 pandemic, it is possible certain Medicare Advantage contracts may not meet the 85% MLR for consecutive years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Medicare Advantage and PDP products are heavily regulated by CMS. The regulations and contractual requirements applicable to the Company and other private participants in Medicare programs are complex, expensive to comply with and subject to change. For example, the Medicare Advantage Overpayment Rule, issued in 2014, implemented the ACA requirements that Medicare Advantage and PDP plans report and refund to CMS overpayments that those plans receive from CMS. Failure to notify overpayments to CMS could result in liability under the False Claims Act. The precise interpretation, impact and legality of this rule are subject to pending litigation. Payments the Company receives from CMS for its Medicare Advantage and Part D businesses also are subject to risk adjustment based on the health status of the individuals enrolled. Elements of that risk adjustment mechanism continue to be challenged by the U.S. Department of Justice (the &#8220;DOJ&#8221;), the Office of the Inspector General of the HHS (the &#8220;OIG&#8221;) and CMS itself. Substantial changes in the risk adjustment mechanism, including changes that result from enforcement or audit actions, could materially affect the amount of the Company&#8217;s Medicare reimbursement, require the Company to raise prices or reduce the benefits offered to Medicare beneficiaries, and potentially limit the Company&#8217;s (and the industry&#8217;s) participation in the Medicare program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has invested significant resources to comply with Medicare standards, and its Medicare compliance efforts will continue to require significant resources. CMS may seek premium and other refunds, prohibit the Company from continuing to market and/or enroll members in or refuse to passively enroll members in one or more of the Company&#8217;s Medicare or Medicare-Medicaid demonstration (historically known as &#8220;dual eligible&#8221;) plans, exclude us from participating in one or more Medicare, dual eligible or dual eligible special needs plan programs and/or institute other sanctions and/or civil monetary penalties against the Company if it fails to comply with CMS regulations or its Medicare contractual requirements. The Company&#8217;s Medicare Supplement products are regulated at the state level and subject to similar significant compliance requirements and risks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in November 2020, the HHS released the final Rebate Rule (the &#8220;Rebate Rule&#8221;), which eliminates the regulatory safe harbor from prosecution under the AKS for rebates from pharmaceutical companies to PBMs in Medicare Part D, replacing it with two far narrower safe harbors designed to directly benefit patients with high out-of-pocket costs and to change the way PBMs are compensated. The new safe harbors are (i) for rebates which are passed on to the patient at the point of sale and (ii) for flat service fee payments made to PBMs which cannot be tied to the list prices of drugs. It is unclear whether the Rebate Rule will be enforceable, whether pharmaceutical companies will respond by reducing list prices, whether list prices in the private market may also be reduced, and what the resulting impact will be to PBMs or the Company. The Pharmaceutical Care Management Association (the &#8220;PCMA&#8221;), which represents PBMs, has filed a suit in an effort to block the Rebate Rule, claiming that the Rebate Rule would lead to higher premiums in Medicare Part D and was adopted in an unlawful manner. The Bipartisan Infrastructure Act of 2021 delays the effective date of the rebate rule to January 2026, and pending Reconciliation legislation would fully repeal the Rebate Rule.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, President Biden signed the Protecting Medicare and American Farmers from Sequester Cuts Act. The legislation extends the suspension of the 2% Medicare sequester cuts until March 2022. Starting in April 2022, the Medicare sequester cuts will be phased back in with a 1% cut that will continue through June. Absent any further changes by Congress, the 2% Medicare sequester would be fully implemented again effective July 1, 2022. Congress suspended the Medicare sequester cuts due to the COVID-19 pandemic, providing a continued increase in Medicare Advantage and Part D plan payments, as well as Medicare fee-for-service provider payments. The legislation also includes a 3% increase in the Medicare Physician Fee Schedule payments for 2022. Congress enacted a similar increase of 3.75% for 2021 which was set to expire. As a result of this increase, Medicare Advantage plans who have contracts with providers based on the Medicare Physician Fee Schedule will need to increase their payment rates by 3%. This increase became effective in January 2022 and does not include any allowance for the increased Medicare Advantage costs that result from the provision.  Taken together, the two provisions represent a modest increase in Medicare Advantage costs relative to our expectations for 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, Congress is considering legislation to add additional benefits to Medicare Part B, such as dental, hearing and vision benefits. The Congressional Budget Office has not yet scored any of the proposals.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Going forward, the Company expects CMS, the OIG, the DOJ, other federal agencies and the U.S. Congress to continue to scrutinize closely each component of the Medicare program (including Medicare Advantage, PDPs, demonstration projects such as Medicare-Medicaid plans and provider network access and adequacy), modify the terms and requirements of the program and possibly seek to recast or limit private insurers&#8217; roles. It is also possible that Congress may reform the structure of the Medicare Part D program and may consider changes to Medicare Advantage payment policies due to recent recommendations by the Medicare Payment Advisory Commission and to reduce the potential added cost burden of costly new </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">benefits, or policies that impact drug pricing such as price controls and inflationary rebates applied to pharmaceutical manufacturers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is not possible to predict the outcome of such regulatory or Congressional activity, any of which could materially and adversely affect the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicare Audits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- CMS regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare Advantage and PDP beneficiaries. For example, CMS conducts risk adjustment data validation (&#8220;RADV&#8221;) audits of a subset of Medicare Advantage contracts for each contract year. Since 2011, CMS has selected certain of the Company&#8217;s Medicare Advantage contracts for various years for RADV audit, and the number of RADV audits continues to increase. The OIG also is auditing the Company&#8217;s risk adjustment data and that of other companies, and the Company expects CMS and the OIG to continue auditing risk adjustment data. The Company also has received Civil Investigative Demands (&#8220;CIDs&#8221;) from, and provided documents and information to, the Civil Division of the DOJ in connection with a current investigation of its patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, CMS issued proposed rules related to, among other things, changes to the RADV audit methodology established by CMS in 2012. CMS projects that the changes to the RADV audit methodology would increase its recoveries from Medicare Advantage plans as a result of RADV audits. CMS has requested comments on the proposed rules, including whether the proposed RADV rule change should apply retroactively to audits of Medicare Advantage plans for contract year 2011 and forward, and gave notice that it has extended the timeline for publication of the final rules until November 2022.  While the Company submitted timely comments to the proposed rules, if they are adopted as proposed there may be potential adverse effects, which could be material, on the Company&#8217;s operating results, financial condition, and cash flows. CMS also has announced that its goal is to subject all Medicare Advantage contracts to either a comprehensive or a targeted RADV audit for each contract year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicare Star Ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - A portion of each Medicare Advantage plan&#8217;s reimbursement is tied to the plan&#8217;s &#8220;star ratings.&#8221; The star rating system considers a variety of measures adopted by CMS, including quality of preventative services, chronic illness management, compliance and overall customer satisfaction. Only Medicare Advantage plans with an overall star rating of four or more stars (out of five stars) are eligible for a quality bonus in their basic premium rates. As a result, the Company&#8217;s Medicare Advantage plans&#8217; operating results in 2022 and going forward will be significantly affected by their star ratings. The Company&#8217;s star ratings and past performance scores are adversely affected by the compliance issues that arise each year in its Medicare operations. CMS released the Company&#8217;s 2022 star ratings in October 2021. The Company&#8217;s 2022 star ratings will be used to determine which of its Medicare Advantage plans have ratings of four stars or higher and qualify for bonus payments in 2023. Based on the Company&#8217;s membership at December 31, 2021, 87% of the Company&#8217;s Medicare Advantage members were in plans with 2022 star ratings of at least 4.0 stars. CMS also gives PDPs star ratings which affect each PDP&#8217;s enrollment. Medicare Advantage and PDP plans that are rated less than three stars for three consecutive years are subject to contract termination by CMS. CMS continues to revise its star ratings system to make it harder to achieve four stars or more. Despite the Company&#8217;s success in achieving high 2022 star ratings and other quality measures and the continuation of its improvement efforts, there can be no assurances that it will be successful in maintaining or improving its star ratings in future years. Accordingly, the Company&#8217;s Medicare Advantage plans may not be eligible for full level quality bonuses, which could adversely affect the benefits such plans can offer, reduce membership and/or reduce profit margins.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicare Benchmark Rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In January 2021, CMS issued its final notice detailing final 2022 Medicare Advantage benchmark payment rates. Final 2022 Medicare Advantage rates resulted in an increase in industry benchmark rates of approximately 4.1%. This rate increase only partially offsets the challenge the Company faces from the impact of the increasing cost of medical care (including prescription medications) and CMS local and national coverage decisions that require the Company to pay for services and supplies that are not factored into the Company&#8217;s bids. The federal government may seek to impose restrictions on the configuration of pharmacy or other provider networks for Medicare Advantage and/or PDP plans, or otherwise restrict the ability of these plans to alter benefits, negotiate prices or establish other terms to improve affordability or maintain viability of products. The Company currently believes that the payments it has received and will receive in the near term are adequate to justify the Company&#8217;s continued participation in the Medicare Advantage and PDP programs, although there are economic and political pressures to continue to reduce spending on the program, and this outlook could change.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">340B Drug Pricing Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The 340B Drug Pricing Program allows eligible Covered Entities to purchase prescription drugs from manufacturers at a steep discount, and is overseen by the HHS and the Health Resources and Services Administration (&#8220;HRSA&#8221;). In 2020, a number of pharmaceutical manufacturers began programs that limited Covered Entities&#8217; participation in the program through contract pharmacies arrangements. In May 2021, HRSA sent enforcement letters to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">multiple manufacturers to curb these practices. In September 2021, HRSA forwarded the enforcement actions to the OIG for potential imposition of civil monetary penalties. Those enforcement actions are currently subject to ongoing litigation. A reduction in Covered Entities&#8217; participation in contract pharmacy arrangements, as a result of the pending enforcement actions or otherwise, a reduction in the use of the Company&#8217;s administrative services by Covered Entities, or a reduction in drug manufacturers&#8217; participation in the program could materially and adversely affect the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Remuneration Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Federal law prohibits, among other things, an entity from knowingly and willfully offering, paying, soliciting or receiving, subject to certain exceptions and &#8220;safe harbors,&#8221; any remuneration to induce the referral of individuals or the purchase, lease or order of items or services for which payment may be made under Medicare, Medicaid or certain other federal and state health care programs. A number of states have similar laws, some of which are not limited to services paid for with government funds. Sanctions for violating these federal and state anti-remuneration laws may include imprisonment, criminal and civil fines, and exclusion from participation in Medicare, Medicaid and other federal and state government-sponsored health care programs. Companies involved in public health care programs such as Medicare and/or Medicaid are required to maintain compliance programs to detect and deter fraud, waste and abuse, and are often the subject of fraud, waste and abuse investigations and audits. The Company has invested significant resources to comply with Medicare and Medicaid program standards. Ongoing vigorous law enforcement and the highly technical regulatory scheme mean that the Company&#8217;s compliance efforts in this area will continue to require significant resources.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antitrust and Unfair Competition </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The U.S. Federal Trade Commission (&#8220;FTC&#8221;) investigates and prosecutes practices that are &#8220;unfair trade practices&#8221; or &#8220;unfair methods of competition.&#8221; Numerous lawsuits have been filed throughout the United States against pharmaceutical manufacturers, retail pharmacies and/or PBMs under various federal and state antitrust and unfair competition laws challenging, among other things: (i) brand name drug pricing and rebate practices of pharmaceutical manufacturers, (ii) the maintenance of retail or specialty pharmacy networks by PBMs, and (iii) various other business practices of PBMs and retail pharmacies. In July 2021, the FTC approved several resolutions that direct agency staff to use compulsory process, such as subpoenas, to investigate seven specific enforcement priorities. Priority targets include, among other businesses, health care businesses, such as pharmaceutical companies, pharmacy benefits managers and hospitals. To the extent that the Company appears to have actual or potential market power in a relevant market or CVS Pharmacy, CVS Specialty or MinuteClinic plays a unique or expanded role in a Health Care Benefits or Pharmacy Services segment product offering, the Company&#8217;s business arrangements and uses of confidential information may be subject to heightened scrutiny from an anti-competitive perspective and possible challenge by state and/or federal regulators and/or private parties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Privacy and Confidentiality Requirements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Many of the Company&#8217;s activities involve the receipt, use and disclosure by the Company of personally identifiable information (&#8220;PII&#8221;) as permitted in accordance with applicable federal and state privacy and data security laws, which require organizations to provide appropriate privacy and security safeguards for such information. In addition to PII, the Company uses and discloses de-identified data for analytical and other purposes when permitted. Additionally, there are industry standards for handling credit card data known as the Payment Card Industry Data Security Standard, which are a set of requirements designed to help ensure that entities that process, store or transmit credit card information maintain a secure environment. Certain states have incorporated these requirements into state laws or enacted other requirements relating to the use and/or disclosure of PII.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal Health Insurance Portability and Accountability Act of 1996 and the regulations issued thereunder (collectively, &#8220;HIPAA&#8221;), as further modified by the American Recovery and Reinvestment Act of 2009 (&#8220;ARRA&#8221;) impose extensive requirements on the way in which health plans, providers, health care clearinghouses (known as &#8220;covered entities&#8221;) and their business associates use, disclose and safeguard protected health information (&#8220;PHI&#8221;). Further, ARRA requires the Company and other covered entities to report any breaches of PHI to impacted individuals and to the HHS and to notify the media in any states where 500 or more people are impacted by the unauthorized release or use of or access to PHI. Criminal penalties and civil sanctions may be imposed for failing to comply with HIPAA standards. The Health Information Technology for Economic and Clinical Health Act (the &#8220;HITECH Act&#8221;), enacted as part of ARRA, amended HIPAA to impose additional restrictions on third-party funded communications using PHI and the receipt of remuneration in exchange for PHI. The HITECH Act also extended HIPAA privacy and security requirements and penalties directly to business associates. HHS has begun to audit health plans, providers and other parties to enforce HIPAA compliance, including with respect to data security. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to HIPAA, state health privacy laws apply to the extent they are more protective of individual privacy than is HIPAA, including laws that place stricter controls on the release of information relating to specific diseases or conditions and requirements to notify members of unauthorized release or use of or access to PHI. States also have adopted regulations to implement provisions of the Financial Modernization Act of 1999 (also known as the Gramm-Leach-Bliley Act (&#8220;GLBA&#8221;)) which generally require insurers, including health insurers, to provide customers with notice regarding how their non-public personal health and financial information is used and the opportunity to &#8220;opt out&#8221; of certain disclosures before the insurer </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares such information with a non-affiliated third party. Like HIPAA, GLBA sets a &#8220;floor&#8221; standard, allowing states to adopt more stringent requirements governing privacy protection. Complying with additional state requirements requires us to make additional investments beyond those the Company has made to comply with HIPAA and GLBA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybersecurity Information Sharing Act of 2015 encourages organizations to share cyber threat indicators with the federal government and, among other things, directs HHS to develop a set of voluntary cybersecurity best practices for organizations in the health care industry. In addition, states have begun to enact more comprehensive privacy laws and regulations addressing consumer rights to data access, deletion, protection or transparency, such as the California Consumer Privacy Act (&#8220;CCPA&#8221;). States also are starting to issue regulations and proposed regulations specifically related to cybersecurity, such as the regulations issued by the New York Department of Financial Services. Complying with conflicting cybersecurity regulations, which may differ from state to state, requires significant resources. In addition, differing approaches to state privacy and/or cyber-security regulation and varying enforcement philosophies may materially and adversely affect the Company&#8217;s ability to standardize its products and services across state lines. Widely-reported large scale commercial data breaches in the United States and abroad increase the likelihood that additional data security legislation will be considered by additional states. These legislative and regulatory developments will impact the design and operation of the Company&#8217;s businesses, its privacy and security strategy and its web-based and mobile assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, each Public Exchange is required to adhere to privacy and security standards with respect to PII, and to impose privacy and security standards that are at least as protective of PII as those the Public Exchange has implemented for itself or non-Public Exchange entities, which include insurers offering plans through the Public Exchange and their designated downstream entities, including PBMs and other business associates. These standards may differ from, and be more stringent than, HIPAA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consumer Protection Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The federal government has many consumer protection laws, such as the Federal Trade Commission Act, the Federal Postal Service Act and the Consumer Product Safety Act. Most states also have similar consumer protection laws and a growing number of states regulate subscription programs. In addition, the federal government and most states have adopted laws and/or regulations requiring places of public accommodation, health care services and other goods and services to be accessible to people with disabilities. These consumer protection and accessibility laws and regulations have been the basis for investigations, lawsuits and multistate settlements relating to, among other matters, the marketing of loyalty programs, and health care products and services, pricing accuracy, expired front store products, financial incentives provided by drug manufacturers to pharmacies in connection with therapeutic interchange programs, disclosures related to how personal data is used and protected and the accessibility of goods and services to people with disabilities. As a result of the Company&#8217;s direct-to-consumer activities, including mobile and web-based solutions offered to members and to other consumers, the Company also is subject to federal and state regulations applicable to electronic communications and to other general consumer protection laws and regulations. For example, the CCPA became effective in 2020, and additional federal and state regulation of consumer privacy protection may be proposed or enacted in 2020. The Company expects these new laws and regulations to impact the design of its products and services and the management and operation of its businesses and to increase its compliance costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transparency in Coverage Rule</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In October 2020, the HHS, the U.S. Department of Labor (&#8220;DOL&#8221;) and the U.S. Internal Revenue Service (&#8220;IRS,&#8221; and together with the HHS and DOL, the &#8220;Tri-Departments&#8221;) released a final rule requiring health insurers to disclose negotiated prices of drugs, medical services, supplies and other covered items. The rule requires group health plans and health insurance issuers in the individual and group markets to disclose cost-sharing information upon request, to a participant, beneficiary, or enrollee and require plans and issuers to publicly disclose in-network provider rates, historical out-of-network allowed amounts and the associated billed charges, and negotiated rates and historical net prices for prescription drugs. Disclosure of data in a machine readable file is required beginning in January 2022, and insurers are required to have a consumer tool in place by January 2023. In August 2021, the federal government delayed enforcement of the requirement to publish machine-readable files for in-network rates, out-of-network allowed amounts and billed charges until July 2022. It also delayed enforcement of machine-readable files related to prescription drug pricing until further rulemaking occurs. The public disclosure of insurer- or PBM-negotiated price concessions may result in drug manufacturers lowering discounts or rebates, resulting in higher drug costs for patients and impacting the ability of the Company to negotiate drug prices and provide competitive products and services to consumers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Consolidated Appropriations Act of 2021 was signed into law in December 2020 and contains further transparency provisions requiring group health plans and health insurance issuers to report certain prescription drug costs, overall spending on health services and prescription drugs, and information about premiums and the impact of rebates and other remuneration on premiums and out-of-pocket costs to the Tri-Departments. No later than 18 months after the first submission and bi-annually thereafter, the Tri-Departments will release a public report on drug pricing trends, drug reimbursement, and the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impact of drug prices on premiums. In August, the Tri-Departments deferred enforcement of both the December 2021 deadline for reporting 2020 plan year data and the June 2022 deadline for reporting 2021 plan year data to December 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Telemarketing and Other Outbound Contacts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Certain federal and state laws, such as the Telephone Consumer Protection Act and the Telemarketing Sales Rule, give the FTC, the Federal Communications Commission and state attorneys general the ability to regulate, and bring enforcement actions relating to, telemarketing practices and certain automated outbound contacts such as phone calls, texts or emails. Under certain circumstances, these laws provide consumers with a private right of action. Violations of these laws could result in substantial statutory penalties and other sanctions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy and Professional Licensure and Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company is subject to a variety of intersecting federal and state statutes and regulations that govern the wholesale distribution of drugs; operation of retail, specialty, infusion, LTC and mail order pharmacies; licensure of facilities and professionals, including pharmacists, technicians, nurses and other health care professionals; registration of facilities with the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;) and analogous state agencies that regulate controlled substances; packaging, storing, shipping and tracking of pharmaceuticals; repackaging of drug products; labeling, medication guides and other consumer disclosures; interactions with prescribers and health care professionals; compounding of prescription medications; dispensing of controlled and non-controlled substances; counseling of patients; transfers of prescriptions; advertisement of prescription products and pharmacy services; security; inventory control; recordkeeping; reporting to Boards of Pharmacy, the U.S. Food and Drug Administration (the &#8220;FDA&#8221;), the U.S. Consumer Product Safety Commission, the DEA and related state agencies; and other elements of pharmacy practice. Pharmacies are highly regulated and have contact with a wide variety of federal, state and local agencies with various powers to investigate, inspect, audit or solicit information, including Boards of Pharmacy and Nursing, the DEA, the FDA, the DOJ, HHS and others. Many of these agencies have broad enforcement powers, conduct audits on a regular basis, can impose substantial fines and penalties, and may revoke the license, registration or program enrollment of a facility or professional. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">State Insurance, HMO and Insurance Holding Company Regulation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of states regulate affiliated groups of insurers and HMOs such as the Company under holding company statutes. These laws may, among other things, require prior regulatory approval of dividends and material intercompany transfers of assets and transactions between the regulated companies and their affiliates, including their parent holding companies. The Company expects the states in which its insurance and HMO subsidiaries are licensed to continue to expand their regulation of the corporate governance and internal control activities of its insurance companies and HMOs. Changes to state insurance, HMO and/or insurance holding company laws or regulations or changes to the interpretation of those laws or regulations, including due to regulators&#8217; increasing concerns regarding insurance company and/or HMO solvency due, among other things, to past and expected payor insolvencies, could negatively affect the Company&#8217;s businesses in various ways, including through increases in solvency fund assessments, requirements that the Company hold greater levels of capital and/or delays in approving dividends from regulated subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PBM offerings of prescription drug coverage under certain risk arrangements may be subject to laws and regulations in various states. Such laws may require that the party at risk become licensed as an insurer, establish reserves or otherwise demonstrate financial viability. Laws that may apply in such cases include insurance laws and laws governing MCOs and limited prepaid health service plans. In addition, several states require that PBMs become directly registered or licensed with the department of insurance or similar government oversight agency regardless of any arrangements they have with clients. PBM licensure laws may include oversight of certain PBM activities and operations and may include auditing of those activities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The states of domicile of the Company&#8217;s regulated subsidiaries have statutory risk-based capital (&#8220;RBC&#8221;) requirements for health and other insurance companies and HMOs based on the National Association of Insurance Commissioners&#8217; (the &#8220;NAIC&#8221;) Risk-Based Capital for Insurers Model Act (the &#8220;RBC Model Act&#8221;). These RBC requirements are intended to assess the capital adequacy of life and health insurers and HMOs, taking into account the risk characteristics of a company&#8217;s investments and products. The RBC Model Act sets forth the formula for calculating RBC requirements, which are designed to take into account asset risks, insurance risks, interest rate risks and other relevant risks with respect to an individual company&#8217;s business. In general, under these laws, an insurance company or HMO must submit a report of its RBC level to the insurance department or insurance commissioner of its state of domicile for each calendar year. At December&#160;31, 2021, the RBC level of each of the Company&#8217;s insurance and HMO subsidiaries was above the level that would require regulatory action.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding restrictions on certain payments of dividends or other distributions by the Company&#8217;s HMO and insurance company subsidiaries, see Note 12 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; included in Item 8 of this 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holding company laws for the states of domicile of certain of the Company&#8217;s subsidiaries also restrict the ability of any person to obtain control of an insurance company or HMO without prior regulatory approval. Under those statutes, without such approval (or an exemption), no person may acquire any voting security of an insurance holding company (such as the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company&#8217;s ultimate parent company, CVS Health Corporation) that controls an insurance company or HMO, or merge with such a holding company, if as a result of such transaction such person would control the insurance holding company. Control is generally defined as the direct or indirect power to direct or cause the direction of the management and policies of a person and is presumed to exist if a person directly or indirectly owns or controls 10% or more of the voting securities of another person.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain states have laws that prohibit submitting a false claim or making a false record or statement in order to secure reimbursement from an insurance company. These state laws vary, and violation of them may lead to the imposition of civil or criminal penalties.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Agreements and Mandates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - From time to time, the Company and/or its various affiliates are subject to certain consent decrees, settlement and other agreements, corrective action plans and corporate integrity agreements with various federal, state and local authorities relating to such matters as privacy practices, controlled substances, PDPs, expired products, environmental and safety matters, marketing and advertising practices, PBM, LTC and other pharmacy operations and various other business practices. Certain of these agreements contain ongoing reporting, monitoring and/or other compliance requirements for the Company. Failure to meet the Company&#8217;s obligations under these agreements could result in civil or criminal remedies, financial penalties, administrative remedies, and/or exclusion from participation in federal health care programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental and Safety Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company&#8217;s businesses are subject to various federal, state and local laws, regulations and other requirements pertaining to protection of the environment, public health and employee safety, including, for example, regulations governing the management of hazardous substances, the cleaning up of contaminated sites, and the maintenance of safe working conditions in the Company&#8217;s retail locations, distribution centers and other facilities. Governmental agencies at the federal, state and local levels continue to focus on the retail and health care sectors&#8217; compliance with such laws and regulations, and have at times pursued enforcement activities. Any failure to comply with these regulations could result in fines or other sanctions by government authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ERISA Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The Employee Retirement Income Security Act of 1974 (&#8220;ERISA&#8221;), provides for comprehensive federal regulation of certain employee pension and benefit plans, including private employer and union sponsored health plans and certain other plans that contract with us to provide PBM services. In general, the Company assists plan sponsors in the administration of their health benefit plans, including the prescription drug benefit portion of those plans, in accordance with the plan designs adopted by the plan sponsors. In addition, the Company may have fiduciary duties where it has specifically contracted with a plan sponsor to accept limited fiduciary responsibility, such as for the adjudication of initial prescription drug benefit claims and/or the appeals of denied claims under a plan. In addition to its fiduciary provisions, ERISA imposes civil and criminal liability on service providers to health plans and certain other persons if certain forms of illegal remuneration are made or received. These provisions of ERISA are broadly written and their application to specific business practices is often uncertain.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s health and related benefits and large case pensions products and services and related fees also are subject to potential issues raised by judicial interpretations relating to ERISA. Under those interpretations, together with DOL regulations, the Company may have ERISA fiduciary duties with respect to PBM members and/or certain general account assets held under contracts that are not guaranteed benefit policies. As a result, certain transactions related to those general account assets are subject to conflict of interest and other restrictions, and the Company must provide certain disclosures to policyholders annually. The Company must comply with these restrictions or face substantial penalties. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, ERISA generally preempts all state and local laws that relate to employee benefit plans, but the extent of the pre-emption continues to be reviewed by courts, including the U.S. Supreme Court. For example, in December 2020, the U.S. Supreme Court upheld an Arkansas law that, among other things, mandates a particular pricing methodology, establishes an appeals process for a pharmacy when the reimbursement is below the pharmacy&#8217;s acquisition cost, permits a pharmacy to reverse and rebill if they cannot procure the drug from its wholesaler at a price equal to or less than the reimbursement rate, prohibits a PBM from reimbursing a pharmacy less than the amount it reimburses an affiliate on a per unit basis, and permits a pharmacy to decline to dispense if the reimbursement is lower than the pharmacy&#8217;s acquisition cost. Also, in November 2021, the U.S. Court of Appeals for the Eighth Circuit upheld a North Dakota law that regulates employer-sponsored ERISA health plans and certain PBM practices within Medicare.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Legislative Initiatives and Regulatory Initiatives </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The U.S. federal and state governments, as well as governments in other countries where the Company does business, continue to enact and seriously consider many broad-based legislative and regulatory proposals that have had a material impact on or could materially impact various aspects of the health care and related benefits system and the Company&#8217;s businesses, operating results and/or cash flows. For example:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Under the Budget Control Act of 2011 and the American Taxpayer Relief Act of 2012 significant, automatic across-the-board budget cuts (known as sequestration) began in March 2013, including Medicare spending cuts of not more than 2% of total program costs per year through 2024. Since then, Congress has extended and modified sequestration a number of times. The CARES Act temporarily suspended Medicare sequestration from May 2020 to the end of December 2020 and extended mandatory sequestration to 2030. Several subsequent acts have extended the temporary suspension of Medicare sequestration through the end of March 2022, at which point a 1% sequestration will take effect April 2022 through June 2022, with the full 2% sequestration due to resume in July 2022. Significant uncertainty remains as to whether and how the U.S. Congress will proceed with actions that create additional federal revenue and/or with entitlement reform. The Company cannot predict future federal Medicare or federal or state Medicaid funding levels or the impact that future federal or state budget actions or entitlement program reform, if it occurs, will have on the Company&#8217;s businesses, operations or operating results, but the effects could be materially adverse, particularly on the Company&#8217;s Medicare and/or Medicaid revenues, MBRs and operating results.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The European Union&#8217;s (&#8220;EU&#8217;s&#8221;) General Data Protection Regulation (&#8220;GDPR&#8221;) began to apply across the EU during 2018.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other significant legislative and/or regulatory measures which are or recently have been under consideration include the following:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increasing the corporate tax rate.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Eliminating payment of manufacturer&#8217;s rebates on prescription drugs to PBMs, PDPs and Managed Medicaid organizations in connection with federally funded health care programs. </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Imposing requirements and restrictions on the design and/or administration of pharmacy benefit plans offered by the Company&#8217;s and its clients&#8217; health plans and/or its PBM clients and/or the services the Company provides to those clients, including prohibiting &#8220;differential&#8221; or &#8220;spread&#8221; pricing in PBM contracts; restricting or eliminating the use of formularies for prescription drugs; restricting the Company&#8217;s ability to require members to obtain drugs through a home delivery or specialty pharmacy; restricting the Company&#8217;s ability to place certain specialty or other drugs in the higher cost tiers of its pharmacy formularies; restricting the Company&#8217;s ability to make changes to drug formularies and/or clinical programs; limiting or eliminating rebates on pharmaceuticals; requiring the use of up front purchase price discounts on pharmaceuticals in lieu of rebates; restricting the Company&#8217;s ability to configure and reimburse its health plan and retail pharmacy provider networks, including use of CVS Pharmacy locations; and restricting or eliminating the use of certain drug pricing methodologies.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increasing federal or state government regulation of, or involvement in, the pricing and/or purchasing of drugs.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restricting the Company&#8217;s ability to limit providers&#8217; participation in its networks and/or remove providers from its networks by imposing network adequacy requirements or otherwise (including in its Medicare and Commercial Health Care Benefits products).</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Imposing assessments on (or to be collected by) health plans or health carriers that may or may not be passed through to their customers. These assessments may include assessments for insolvency, the uninsured, uncompensated care, Medicaid funding or defraying health care provider medical malpractice insurance costs.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mandating coverage by the Company&#8217;s and its clients&#8217; health plans for additional conditions and/or specified procedures, drugs or devices (e.g., high cost pharmaceuticals, experimental pharmaceuticals and oral chemotherapy regimens).</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulating electronic connectivity.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mandating or regulating the disclosure of provider fee schedules, manufacturer&#8217;s rebates and other data about the Company&#8217;s payments to providers and/or payments the Company receives from pharmaceutical manufacturers.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mandating or regulating disclosure of provider outcome and/or efficiency information.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescribing or limiting members&#8217; financial responsibility for health care or other covered services they utilize, including restricting &#8220;surprise&#8221; bills by providers and by specifying procedures for resolving &#8220;surprise&#8221; bills.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescribing payment levels for health care and other covered services rendered to the Company&#8217;s members by providers who do not have contracts with the Company.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assessing the medical device status of home infusion therapy products and/or solutions, mobile consumer wellness tools and clinical decision support tools, which may require compliance with FDA requirements in relation to some of these products, solutions and/or tools.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restricting the ability of employers and/or health plans to establish or impose member financial responsibility.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Proposals to expand benefits under Original Medicare.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Amending or supplementing ERISA to impose greater requirements on PBMs or the administration of employer-funded benefit plans or limit the scope of current ERISA pre-emption, which would among other things expose </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div style="padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company and other health plans to expanded liability for punitive and other extra-contractual damages and additional state regulation.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is uncertain whether the Company can counter the potential adverse effects of such potential legislation or regulation on its operating results or cash flows, including whether it can recoup, through higher premium rates, expanded membership or other measures, the increased costs of mandated coverage or benefits, assessments, fees, taxes or other increased costs, including the cost of modifying its systems to implement any enacted legislation or regulations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s businesses also may be affected by other legislation and regulations. The Dodd-Frank Wall Street Reform and Consumer Protection Act creates incentives for whistleblowers to speak directly to the government rather than utilizing internal compliance programs and reduces the burden of proof under the Foreign Corrupt Practices Act of 1977 (the &#8220;FCPA&#8221;). There also are laws and regulations that set standards for the escheatment of funds to states.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health savings accounts, health reimbursement arrangements and flexible spending accounts and certain of the tax, fee and subsidy provisions of the ACA also are regulated by the U.S. Department of the Treasury and the Internal Revenue Service.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also may be adversely affected by court and regulatory decisions that expand or revise the interpretations of existing statutes and regulations or impose medical malpractice or bad faith liability. Federal and state courts, including the U.S. Supreme Court, continue to consider cases, and federal and state regulators continue to issue regulations and interpretations, addressing bad faith liability for denial of medical claims, the scope of ERISA&#8217;s fiduciary duty requirements, the scope of the False Claims Act and the pre-emptive effect of ERISA and Medicare Part D on state laws.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Audits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The Company is subject to audits of many of its contracts, including its PBM client contracts, its PBM rebate contracts, its PBM network contracts, its contracts relating to Medicare Advantage and/or Medicare Part D, the agreements the Company&#8217;s pharmacies enter into with other payors, its Medicaid contracts and its customer contracts. Because some of the Company&#8217;s contracts are with state or federal governments or with entities contracted with state or federal agencies, audits of these contracts are often regulated by the federal or state agencies responsible for administering federal or state benefits programs, including those which operate Medicaid fee for service plans, Managed Medicaid plans, Medicare Part D plans or Medicare Advantage organizations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal Employee Health Benefits Program </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The Company&#8217;s subsidiaries contract with the Office of Personnel Management (the &#8220;OPM&#8221;) to provide managed health care services under the FEHB program in their service areas. These contracts with the OPM and applicable government regulations establish premium rating arrangements for this program. In addition to other requirements, such as the Transparency in Coverage Rule note above, OPM regulations require that community-rated FEHB plans meet a FEHB program-specific minimum MLR by plan code and market. Managing to these rules is complicated by the simultaneous application of the minimum MLR standards and associated premium rebate requirements of the ACA. The Company also has a contractual arrangement with carriers for the FEHB program, such as the BlueCross BlueShield Association, to provide pharmacy services to federal employees, postal workers, annuitants, and their dependents under the Government-wide Service Benefit Plan, as authorized by the FEHB Act and as part of the FEHB program. Additionally, the Company manages certain FEHB plans on a &#8220;cost-plus&#8221; basis. These arrangements subject the Company to certain aspects of the FEHB Act, and other federal regulations, such as the FEHB Acquisition Regulation, that otherwise would not be applicable to the Company. The OPM also is auditing the Company and its other contractors to, among other things, verify that plans meet their applicable FEHB program-specific MLR and the premiums established under the OPM&#8217;s Insured contracts and costs allocated pursuant to the OPM&#8217;s cost-based contracts are in compliance with the requirements of the applicable FEHB program. The OPM may seek premium refunds or institute other sanctions against the Company if it fails to comply with the FEHB program requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clinical Services Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The Company provides clinical services to health plans, PBMs and providers for a variety of complex and common medical conditions, including arranging for certain members to participate in disease management programs. State laws regulate the practice of medicine, the practice of pharmacy, the practice of nursing and certain other clinical activities. Clinicians engaged in a professional practice in connection with the provision of clinical services must satisfy applicable state licensing requirements and must act within their scope of practice.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Third Party Administration and Other State Licensure Laws </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Many states have licensure or registration laws governing certain types of administrative organizations, such as PPOs, TPAs and companies that provide utilization review services. Several states also have licensure or registration laws governing the organizations that provide or administer consumer card programs (also known as cash card or discount card programs).</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International Regulation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has insurance licenses in several foreign jurisdictions and does business directly or through local affiliations in numerous countries around the world. The Company has taken steps to be able to continue to serve customers in the European Economic Area following the United Kingdom&#8217;s exit from the EU (&#8220;Brexit&#8221;).  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s international operations are subject to different, and sometimes more stringent, legal and regulatory requirements, which vary widely by jurisdiction, including anti-corruption laws; economic sanctions laws; various privacy, insurance, tax, tariff and trade laws and regulations; corporate governance, privacy, data protection (including the EU&#8217;s General Data Protection Regulation which began to apply across the EU during 2018), data mining, data transfer, labor and employment, intellectual property, consumer protection and investment laws and regulations; discriminatory licensing procedures; compulsory cessions of reinsurance; required localization of records and funds; higher premium and income taxes; limitations on dividends and repatriation of capital; and requirements for local participation in an insurer&#8217;s ownership. In addition, the expansion of the Company&#8217;s operations into foreign countries increases the Company&#8217;s exposure to the anti-bribery, anti-corruption and anti-money laundering provisions of U.S. law, including the FCPA, and corresponding foreign laws, including the U.K. Bribery Act 2010 (the &#8220;UK Bribery Act&#8221;). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Corruption Laws</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The FCPA prohibits offering, promising or authorizing others to give anything of value to a foreign government official to obtain or retain business or otherwise secure a business advantage. The Company also is subject to applicable anti-corruption laws of the jurisdictions in which it operates. In many countries outside the United States, health care professionals are employed by the government. Therefore, the Company&#8217;s dealings with them are subject to regulation under the FCPA. Violations of the FCPA and other anti-corruption laws may result in severe criminal and civil sanctions as well as other penalties, and there continues to be a heightened level of FCPA enforcement activity by the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) and the DOJ. The UK Bribery Act is an anti-corruption law that is broader in scope than the FCPA and applies to all companies with a nexus to the United Kingdom. Disclosures of FCPA violations may be shared with the UK authorities, thus potentially exposing companies to liability and potential penalties in multiple jurisdictions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Money Laundering Regulations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Certain lines of the Company&#8217;s businesses are subject to Treasury anti-money laundering regulations. Those lines of business have implemented anti-money laundering policies designed to ensure their compliance with the regulations. The Company also is subject to anti-money laundering laws in non-U.S. jurisdictions where it operates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Office of Foreign Assets Control</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company also is subject to regulation by the Office of Foreign Assets Control of the U.S. Department of Treasury (&#8220;OFAC&#8221;). OFAC administers and enforces economic and trade sanctions based on U.S. foreign policy and national security goals against targeted foreign countries and regimes, terrorists, international narcotics traffickers, those engaged in activities related to the proliferation of weapons of mass destruction, and other threats to the national security, foreign policy or economy of the United States. In addition, the Company is subject to similar regulations in the non-U.S. jurisdictions in which it operates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FDA Regulation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA regulates the Company&#8217;s compounding pharmacy and clinical research operations. The FDA also generally has authority to, among other things, regulate the manufacture, distribution, sale and labeling of medical devices (including hemodialysis devices such as the device the Company is developing and mobile medical devices) and many products sold through retail pharmacies, including prescription drugs, over-the-counter medications, cosmetics, dietary supplements and certain food items. In addition, the FDA regulates the Company&#8217;s activities as a distributor of store brand products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations Related to the Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the laws and regulations discussed above that may affect multiple segments of the Company&#8217;s business, the Company is subject to federal, state, local and international statutes and regulations governing its Health Care Benefits segment specifically. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Differing approaches to state insurance regulation and varying enforcement philosophies may materially and adversely affect the Company&#8217;s ability to standardize its Health Care Benefits products and services across state lines. These laws and regulations, including the ACA, restrict how the Company conducts its business and result in additional burdens and costs to the Company. Significant areas of governmental regulation include premium rates and rating methodologies, underwriting rules and procedures, required benefits, sales and marketing activities, provider rates of payment, restrictions on health plans&#8217; ability to limit providers&#8217; participation in their networks and/or remove providers from their networks and financial condition (including reserves and minimum capital or risk based capital requirements). These laws and regulations are different in each jurisdiction and vary from product to product.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each health insurer and HMO must file periodic financial and operating reports with the states in which it does business. In addition, health insurers and HMOs are subject to state examination and periodic license renewal. Applicable laws also restrict the ability of the Company&#8217;s regulated subsidiaries to pay dividends, and certain dividends require prior regulatory approval. In addition, some of the Company&#8217;s businesses and related activities may be subject to PPO, MCO, utilization review or TPA-related licensure requirements and regulations. These licensure requirements and regulations differ from state to state, but may contain provider network, contracting, product and rate, financial and reporting requirements. There also are laws and regulations that set specific standards for the Company&#8217;s delivery of services, payment of claims, fraud prevention, protection of consumer health information, and payment for covered benefits and services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Required Regulatory Approvals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company must obtain and maintain regulatory approvals to price, market and administer many of its Health Care Benefits products. Supervisory agencies, including CMS, the Center for Consumer Information and Insurance Oversight and the DOL, as well as state health, insurance, managed care and Medicaid agencies, have broad authority to take one or more of the following actions:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Grant, suspend and revoke the Company&#8217;s licenses to transact business;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Suspend or exclude the Company from participation in government programs;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Suspend or limit the Company&#8217;s authority to market products;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulate many aspects of the products and services the Company offers, including the pricing and underwriting of many of its products and services;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assess damages, fines and/or penalties;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Terminate the Company&#8217;s contract with the government agency and/or withhold payments from the government agency to the Company;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Impose retroactive adjustments to premiums and require the Company to pay refunds to the government, customers and/or members;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Restrict the Company&#8217;s ability to conduct acquisitions or dispositions;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Require the Company to maintain minimum capital levels in its subsidiaries and monitor its solvency and reserve adequacy;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulate the Company&#8217;s investment activities on the basis of quality, diversification and other quantitative criteria; and/or</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Exclude the Company&#8217;s plans from participating in Public Exchanges if they are deemed to have a history of &#8220;unreasonable&#8221; premium rate increases or fail to meet other criteria set by HHS or the applicable state.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operations, current and past business practices, current and past contracts, and accounts and other books and records are subject to routine, regular and special investigations, audits, examinations and reviews by, and from time to time the Company receives subpoenas and other requests for information from, federal, state and international supervisory and enforcement agencies, attorneys general and other state, federal and international governmental authorities and legislators. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial Product Pricing and Underwriting Restrictions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Pricing and underwriting regulation by states limits the Company&#8217;s underwriting and rating practices and those of other health insurers, particularly for small employer groups, and varies by state. In general, these limitations apply to certain customer segments and limit the Company&#8217;s ability to set prices for new or renewing groups, or both, based on specific characteristics of the group or the group&#8217;s prior claim experience. In some states, these laws and regulations restrict the Company&#8217;s ability to price for the risk it assumes and/or reflect reasonable costs in the Company&#8217;s pricing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA expanded the premium rate review process by, among other things, requiring the Company&#8217;s Commercial Insured rates to be reviewed for &#8220;reasonableness&#8221; at either the state or the federal level. HHS established a federal premium rate review process that generally applies to proposed premium rate increases equal to or exceeding a federally (or lower state) specified threshold. HHS&#8217;s rate review process imposes additional public disclosure requirements as well as additional review on filings requesting premium rate increases equal to or exceeding this &#8220;reasonableness&#8221; threshold. These combined state and federal review requirements may prevent, further delay or otherwise affect the Company&#8217;s ability to price for the risk it assumes, which could adversely affect its MBRs and operating results, particularly during periods of increased utilization of medical services and/or medical cost trend or when such utilization and/or trend exceeds the Company&#8217;s projections.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA also specifies minimum MLRs of 85% for large group Commercial products and 80% for individual and small group Commercial products. Because the ACA minimum MLRs are structured as &#8220;floors&#8221; for many of their requirements, states have the latitude to enact more stringent rules governing these restrictions. For Commercial products, states have and may adopt higher minimum MLR requirements, use more stringent definitions of &#8220;medical loss ratio,&#8221; incorporate minimum MLR </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requirements into prospective premium rate filings, require prior approval of premium rates or impose other requirements related to minimum MLR. Minimum MLR requirements and similar actions further limit the level of margin the Company can earn in its Insured Commercial products while leaving the Company exposed to medical costs that are higher than those reflected in its pricing. The Company also may be subject to significant fines, penalties, premium refunds and litigation if it fails to comply with minimum MLR laws and regulations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company requested increases in its premium rates in its Commercial Health Care Benefits business for 2022 and expects to continue to request increases in those rates for 2023 and beyond in order to adequately price for projected medical cost trends, required expansions of coverage and rating limits, and significant assessments, fees and taxes imposed by the federal and state governments, including as a result of the ACA. The Company&#8217;s rates also must be adequate to reflect adverse selection in its products, particularly in small group Commercial products. These rate increases may be significant and thus heighten the risks of adverse publicity, adverse regulatory action and adverse selection and the likelihood that the Company&#8217;s requested premium rate increases will be denied, reduced or delayed, which could lead to operating margin compression.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the laws and regulations governing the Company&#8217;s pricing and underwriting practices also limit the differentials in premium rates insurers and other carriers may charge between new and renewal business, and/or between groups based on differing characteristics. They may also require that carriers disclose to customers the basis on which the carrier establishes new business and renewal premium rates and limit the ability of a carrier to terminate customers&#8217; coverage. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recently, with respect to quality improvement activities (&#8220;QIAs&#8221;) that health plans report to HHS, revised regulations no longer provide insurers the option of reporting a flat amount equal to 0.8 percent of earned premium in lieu of reporting the insurers' actual itemized QIA expenditures. This change will impact the Company&#8217;s future MLR calculations and reporting since we have utilized the 0.8 percent premium election.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicaid Regulation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is seeking to substantially grow its Medicaid, dual eligible and dual eligible special needs plan businesses over the next several years. As a result, the Company also is increasing its exposure to changes in government policy with respect to and/or regulation of the various Medicaid, dual eligible and dual eligible special needs plan programs in which the Company participates, including changes in the amounts payable to the Company under those programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 2017, Managed Medicaid products, including those the Company offers, are subject to a minimum federal MLR of 85%. A Medicaid managed care quality rating system and provider network adequacy requirements also apply to Medicaid products. Because the federal minimum MLR is structured as a &#8220;floor,&#8221; states have the latitude to enact more stringent rules governing these restrictions. For Managed Medicaid products, states may adopt higher minimum MLR requirements, use more stringent definitions of &#8220;medical loss ratio&#8221; or impose other requirements related to minimum MLR. Minimum MLR requirements and similar actions further limit the level of margin the Company can earn in its Insured Medicaid products while leaving the Company exposed to medical costs that are higher than those reflected in its pricing. The Company also may be subject to significant fines, penalties, premium refunds and litigation if it fails to comply with minimum MLR laws and regulations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States continue to consider Medicaid expansion; however, 12 states have still not decided to expand as of 2022. States may opt out of the elements of the ACA requiring expansion of Medicaid coverage without losing their current federal Medicaid funding. In addition, the election of new governors and/or state legislatures may impact states&#8217; previous decisions regarding Medicaid expansion. Although Congress enacted incentives for states that had not yet done so to expand Medicaid, this incentive alone may not persuade holdout states to expand.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, Medicaid MCOs faced new requirements and state flexibility that were finalized in the 2020 Medicaid managed care final rule. States now have flexibility related to rate setting and provider network adequacy that could adversely or positively impact our Medicaid plans. Other changes related to managed care operations include beneficiary communications, appeals and grievances, and provider directories.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The economic aspects of the Medicaid, dual eligible and dual eligible special needs plan business vary from state to state and are subject to frequent change. Medicaid premiums are paid by each state and differ from state to state. The federal government and certain states also are considering proposals and legislation for Medicaid and dual eligible program reforms or redesigns, including restrictions on the collection of manufacturer&#8217;s rebates on pharmaceuticals by Medicaid MCOs and their contracted PBMs, further program, population and/or geographic expansions of risk-based managed care, increasing beneficiary cost-sharing or payment levels, and changes to benefits, reimbursement, eligibility criteria, provider network adequacy requirements (including requiring the inclusion of specified high cost providers in the Company&#8217;s networks) and program structure. In some states, current Medicaid and dual eligible funding and premium revenue may not be adequate for the Company to continue </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">program participation. The Company&#8217;s Medicaid and dual eligible contracts with states (or sponsors of Medicaid managed care plans) are subject to cancellation by the state (or the sponsors of the managed care plans) after a short notice period without cause (e.g., when a state discontinues a managed care program) or in the event of insufficient state funding.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Medicaid, dual eligible and dual eligible special needs plan products also are heavily regulated by CMS and state Medicaid agencies, which have the right to audit the Company&#8217;s performance to determine compliance with CMS contracts and regulations. The Company&#8217;s Medicaid products, dual eligible products and CHIP contracts also are subject to complex federal and state regulations and oversight by state Medicaid agencies regarding the services provided to Medicaid enrollees, payment for those services, network requirements (including mandatory inclusion of specified high-cost providers), and other aspects of these programs, and by external review organizations which audit Medicaid plans on behalf of state Medicaid agencies. The laws, regulations and contractual requirements applicable to the Company and other participants in Medicaid and dual eligible programs, including requirements that the Company submit encounter data to the applicable state agency, are extensive, complex and subject to change. The Company has invested significant resources to comply with these standards, and its Medicaid and dual eligible program compliance efforts will continue to require significant resources. CMS and/or state Medicaid agencies may fine the Company, withhold payments to the Company, seek premium and other refunds, terminate the Company&#8217;s existing contracts, elect not to award the Company new contracts or not to renew the Company&#8217;s existing contracts, prohibit the Company from continuing to market and/or enroll members in or refuse to automatically assign members to one or more of the Company&#8217;s Medicaid or dual eligible products, exclude the Company from participating in one or more Medicaid or dual eligible programs and/or institute other sanctions and/or civil monetary penalties against the Company if it fails to comply with CMS or state regulations or contractual requirements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict whether pending or future federal or state legislation or court proceedings will change various aspects of the Medicaid program, nor can it predict the impact those changes will have on its business operations or operating results, but the effects could be materially adverse.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal and State Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The Company is subject to extensive financial and business reporting requirements, including penalties for inaccuracies and/or omissions, at both the federal and state level. The Company&#8217;s ability to comply with certain of these requirements depends on receipt of information from third parties that may not be readily available or reliably provided in all instances. The Company is and will continue to be required to modify its information systems, dedicate significant resources and incur significant expenses to comply with these requirements. However, the Company cannot eliminate the risks of unavailability of or errors in its reports.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Design and Administration and Sales Practices</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - State and/or federal regulatory scrutiny of health care benefit product design and administration and marketing and advertising practices, including the filing of insurance policy forms, the adequacy of provider networks, the accuracy of provider directories, and the adequacy of disclosure regarding products and their administration, is increasing as are the penalties being imposed for inappropriate practices. Medicare, Medicaid and dual eligible products and products offering more limited benefits in particular continue to attract increased regulatory scrutiny.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guaranty Fund Assessments/Solvency Protection</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer governed health plans established under the ACA. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations Related to the Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the laws and regulations discussed above that may affect multiple segments of the Company&#8217;s business, the Company is subject to federal, state and local statutes and regulations governing the operation of its Pharmacy Services segment specifically. Among these are the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PBM Laws and Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Legislation and/or regulations seeking to regulate PBM activities in a comprehensive manner have been proposed or enacted in a number of states. This legislation could adversely affect the Company&#8217;s ability to conduct business on commercially reasonable terms in states where the legislation is in effect and the Company&#8217;s ability to standardize </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">its PBM products and services across state lines. In addition, certain quasi-regulatory organizations, including the National Association of Boards of Pharmacy and the NAIC and the National Council of Insurance Legislators, have issued model regulations or may propose future regulations concerning PBMs and/or PBM activities. Similarly, credentialing organizations such as URAC have established voluntary standards regarding PBM, mail order pharmacy and/or specialty pharmacy activities. While the actions of these quasi-regulatory or standard-setting organizations do not have the force of law, they may influence states to adopt their requirements or recommendations and influence client requirements for PBM, mail order pharmacy and/or specialty pharmacy services. Moreover, any standards established by these organizations could also impact the Company&#8217;s health plan clients and/or the services provided to those clients and/or the Company&#8217;s health plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s PBM activities also are regulated directly and indirectly at the federal and state levels, including being subject to the False Claims Act and state false claims acts and the AKS and state anti-kickback laws. These laws and regulations govern, and proposed legislation and regulations may govern and/or further restrict, critical PBM practices, including disclosure, receipt and retention of rebates and other payments received from pharmaceutical manufacturers; use of, administration of and/or changes to drug formularies, maximum allowable cost (&#8220;MAC&#8221;) list pricing, average wholesale prices (&#8220;AWP&#8221;) and/or clinical programs; the offering to plan sponsors of pricing that includes retail network &#8220;differential&#8221; or &#8220;spread&#8221; (i.e., a difference between the drug price charged to the plan sponsor by a PBM and the price paid by the PBM to the dispensing provider); reconciliation to pricing guarantees; disclosure of data to third parties; drug UM practices; the level of duty a PBM owes its customers; configuration of pharmacy networks; the operations of the Company&#8217;s pharmacies (including audits of its pharmacies); disclosure of negotiated provider reimbursement rates; disclosure of fees associated with administrative service agreements and patient care programs that are attributable to members&#8217; drug utilization; and registration or licensing of PBMs. Failure by the Company or one of its PBM services suppliers to comply with these laws or regulations could result in material fines and/or sanctions and could have a material adverse effect on the Company&#8217;s operating results and/or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s PBM service contracts, including those in which the Company assumes certain risks under performance guarantees or similar arrangements, are generally not subject to insurance regulation by the states. However, state departments of insurance are increasing their oversight of PBM activities due to legislation passing in a number of states requiring PBMs to register or obtain a license with the department, including through market conduct examinations and other audits our licensed entities. In addition, rulemaking is either underway or has already taken place in a number of states with the areas of focus on licensure requirements, pharmacy reimbursement for generics (MAC reimbursement) and pharmacy audits - most of which fall under the state insurance code.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Most-Favored-Nation Rule</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In November 2020, HHS released the Most-Favored-Nation Rule (the &#8220;MFN Rule&#8221;), which requires CMS to take a most-favored-nation approach in calculating payment for Medicare Part B drugs. The MFN Rule will test paying Part B drugs at comparable amounts to the lowest adjusted price paid by any country in the Organization for Economic Co-operation and Development that has a Gross Domestic Product (&#8220;GDP&#8221;) per capita that is at least 60% of the U.S. GDP per capita. The MFN Rule will also test a redesign of the percentage add-on payment structure under Medicare Part B to remove incentives for use of higher-cost drugs through a flat per-dose add-on payment, and will include a financial hardship exemption for participants. The mandatory MFN Rule will operate for seven years, from January 1, 2021 to December 31, 2027. Over the course of the model, CMS will monitor and evaluate the impact of the MFN Rule on beneficiary access to drugs, program costs, and the quality of care for beneficiaries. Further, CMS commits to assess initial impacts of the MFN Rule on quality of care, including access to drugs, prior to beginning performance year 5. Multiple pharmaceutical manufacturers have sued HHS over the rule, and it is currently delayed due to a temporary restraining order prohibiting CMS from implementing it. If implemented, the MFN Rule may impact the ability of the Company to negotiate drug prices and provide competitive products and services to consumers. In August 2021, CMS published a proposed rule to rescind the MFN Rule.  It is unclear whether this rescission may be followed by regulatory or legislative alternatives that present similar, or even more substantial, patient access, provider reimbursement, and other concerns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy Network Access Legislation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Medicare Part D and a majority of states now have some form of legislation affecting the Company&#8217;s (and its health plans&#8217; and its health plan clients&#8217;) ability to limit access to a pharmacy provider network or remove pharmacy network providers. For example, certain &#8220;any willing provider&#8221; legislation may require the Company or its clients to admit a nonparticipating pharmacy if such pharmacy is willing and able to meet the plan&#8217;s price and other applicable terms and conditions for network participation. These laws could negatively affect the services and economic benefits achievable through a limited pharmacy provider network. Also, a majority of states now have some form of legislation affecting the Company&#8217;s ability (and the Company&#8217;s and its client health plans&#8217; ability) to conduct audits of network pharmacies regarding claims submitted to the Company for payment. These laws could negatively affect the Company&#8217;s ability to recover overpayments of claims submitted by network pharmacies that the Company identifies through pharmacy audits. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, several states have passed legislation that limits the ability of PBMs and health insurers to provide special benefit structures for use with affiliated pharmacies, which could result in reduced savings to clients and consumers.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy Pricing Legislation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - A number of states have passed legislation regulating the Company&#8217;s ability to manage and establish MACs for generic prescription drugs. MAC methodology is a common cost management practice used by private and public payors (including CMS) to pay pharmacies for dispensing generic prescription drugs. MAC prices specify the allowable reimbursement by a PBM for a particular strength and dosage of a generic drug that is available from multiple manufacturers but sold at different prices. State legislation can regulate the disclosure of MAC prices and MAC price methodologies, the kinds of drugs that a PBM can pay for at a MAC price, and the rights of pharmacies to appeal a MAC price established by a PBM. These laws could negatively affect the Company&#8217;s ability to establish MAC prices for generic drugs. Additionally, some states have passed legislation that would create a reimbursement benchmark mandate, such as the national average drug acquisition cost and/or the wholesale acquisition cost (&#8220;WAC&#8221;), plus a set dispensing fee, for pharmacies in the network. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Formulary and Plan Design Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- A number of government entities regulate the administration of prescription drug benefits. HHS regulates how Medicare Part D formularies are developed and administered, including requiring the inclusion of all drugs in certain classes and categories, subject to limited exceptions. Under the ACA, CMS imposes drug coverage requirements for health plans required to cover essential health benefits, including plans offered through federal or state Public Exchanges. Additionally, the NAIC and health care accreditation agencies like NCQA and URAC have developed model acts and standards for formulary development that are often incorporated into government requirements. Many states regulate the scope of prescription drug coverage, as well as the delivery channels to receive prescriptions, for insurers, MCOs and Medicaid managed care plans. The increasing government regulation of formularies could significantly affect the Company&#8217;s ability to develop and administer formularies, pharmacy networks and other plan design features. Similarly, some states prohibit health plan sponsors from implementing certain restrictive pharmacy benefit plan design features. This regulation could limit or preclude (i) limited networks, (ii) a requirement to use particular providers, (iii) copayment differentials among providers and (iv) formulary tiering practices. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and Regulations Related to the Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the laws and regulations discussed above that may affect multiple segments of the Company&#8217;s business, the Company is subject to federal, state and local statutes and regulations governing the operation of its Retail/LTC segment specifically. Among these are the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retail Medical Clinics </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- States regulate retail medical clinics operated by nurse practitioners or physician assistants through physician oversight, clinic and lab licensure requirements and the prohibition of the corporate practice of medicine. A number of states have implemented or proposed laws or regulations that impact certain components of retail medical clinic operations such as physician oversight, signage, third party contracting requirements, bathroom facilities, and scope of services. These laws and regulations may affect the operation and expansion of the Company&#8217;s owned and managed retail medical clinics.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Laws - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other federal, state and local laws and regulations also impact the Company&#8217;s retail operations, including laws and regulations governing the practice of optometry, the practice of audiology, the provision of dietician services and the sale of durable medical equipment, contact lenses, eyeglasses, hearing aids and alcohol.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation was incorporated in Delaware in 1996. The corporate office is located at One CVS Drive, Woonsocket, Rhode Island 02895, telephone (401)&#160;765-1500. CVS Health Corporation&#8217;s common stock is listed on the New York Stock Exchange under the trading symbol &#8220;CVS.&#8221; General information about the Company is available through the Company&#8217;s website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http://www.cvshealth.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company&#8217;s financial press releases and filings with the SEC are available free of charge within the Investors section of the Company&#8217;s website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http://investors.cvshealth.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition, the SEC maintains an internet site that contains reports, proxy and information statements and other information regarding issuers, such as the Company, that file electronically with the SEC. The address of that website is </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http://www.sec.gov. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information on or linked to the Company&#8217;s website is neither a part of nor incorporated by reference in this 10-K or any of the Company&#8217;s other SEC filings. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with guidance provided by the SEC regarding use by a company of its websites and social media channels as a means to disclose material information to investors and to comply with its disclosure obligations under SEC Regulation FD, CVS Health Corporation (the &#8220;Registrant&#8221;) hereby notifies investors, the media and other interested parties that it intends to continue to use its media and investor relations website (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http://investors.cvshealth.com/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and its Twitter feed (@CVSHealthIR) </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to publish important information about the Registrant, including information that may be deemed material to investors. The list of social media channels that the Registrant uses may be updated on its media and investor relations website from time to time. The Registrant encourages investors, the media, and other interested parties to review the information the Registrant posts on its website and social media channels as described above, in addition to information announced by the Registrant through its SEC filings, press releases and public conference calls and webcasts.</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.  Risk Factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully consider each of the following risks and uncertainties and all of the other information set forth in this 10-K. These risks and uncertainties and other factors may affect forward-looking statements, including those we make in this 10-K or elsewhere, such as in news releases or investor or analyst calls, meetings or presentations, on our websites or through our social media channels. The risks and uncertainties described below are not the only ones we face. There can be no assurance that we have identified all the risks that affect us. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial also may adversely affect our businesses. Any of these risks or uncertainties could cause our actual results to differ materially from our expectations and the expected results discussed in our forward-looking statements. You should not consider past results to be an indication of future performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the following risks or uncertainties develops into actual events or if the circumstances described in the risks or uncertainties occur or continue to occur, those events or circumstances could have a material adverse effect on our businesses, operating results, cash flows, financial condition and/or stock price, among other effects on us. You should read the following section in conjunction with the MD&amp;A, included in Item 7 of this 10-K, our consolidated financial statements and the related notes, included in Item 8 of this 10-K, and our &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; in this 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the principal risks we face that could negatively impact our businesses, operating results, cash flows and/or financial condition: </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Businesses</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be material and adverse.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to accurately forecast health care and other benefit costs.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adverse economic conditions in the U.S. and abroad can materially and adversely impact our businesses, operating results, cash flows and financial condition.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Each of our segments operates in a highly competitive and evolving business environment.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A change in our Health Care Benefits product mix may adversely affect our profit margins.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We can provide no assurance that we will be able to compete successfully and profitably on Public Exchanges.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Negative public perception of the industries in which we operate can adversely affect our businesses, operating results, cash flows and prospects.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We must maintain and improve our relationships with our customers and increase the demand for our products and services.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We face risks relating to the availability, pricing and safety profiles of prescription drugs that we purchase and sell.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The reserves we hold for expected claims in our Insured Health Care Benefits products are based on estimates that involve an extensive degree of judgment and are inherently variable, and any reserve, including a premium deficiency reserve, may be insufficient.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are exposed to risks relating to the solvency of other insurers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks From Changes in Public Policy and Other Legal and Regulatory Risks</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to potential changes in public policy, laws and regulations, including reform of the U.S. health care system and entitlement programs.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to comply with applicable laws and regulations we could be subject to significant adverse regulatory actions.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If our compliance or other systems and processes fail or are deemed inadequate, we may suffer brand and reputational harm and become subject to regulatory actions and/or litigation.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We routinely are subject to litigation and other adverse legal proceedings, including class actions and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions. Many of these proceedings seek substantial damages which may not be covered by insurance.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We frequently are subject to regular and special governmental audits, investigations and reviews that could result in changes to our business practices and also could result in material refunds, fines, penalties, civil liabilities, criminal liabilities and other sanctions.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our litigation and regulatory risk profiles are changing as we offer new products and services and expand in business areas beyond our historical core businesses.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We face unique regulatory and other challenges in our Medicare and Medicaid businesses.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Programs funded in whole or in part by the U.S. federal government account for a significant portion of our revenues.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to obtain adequate premium rate increases in our Insured Health Care Benefits products, MBRs and operating results and could magnify the adverse impact of increases in health care and other benefit costs and of ACA assessments, fees and taxes.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Minimum MLR rebate requirements limit the level of margin we can earn in our Insured Health Care Benefits products while leaving us exposed to higher than expected medical costs. Challenges to our minimum MLR rebate methodology and/or reports could adversely affect our operating results.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our operating results may be adversely affected by changes in laws and policies governing employers and by union organizing activity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Associated with Mergers, Acquisitions, and Divestitures </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be unable to successfully integrate companies we acquire.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We expect to continue to pursue acquisitions, joint ventures, strategic alliances and other inorganic growth opportunities, which may be unsuccessful, cause us to assume unanticipated liabilities, disrupt our existing businesses, be dilutive or lead us to assume significant debt, among other things.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Operations</span></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failure to meet customer and investor expectations, including with respect to environmental, social and governance goals, may harm our brand and reputation, our ability to retain and grow our customer base and membership.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We and our vendors have experienced and continue to experience information security incidents. We can provide no assurance that we or our vendors will be able to contain detect or prevent incident.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Data governance failures or the failure or disruption of our information technology or infrastructure can adversely affect our reputation, businesses and prospects. Our use and disclosure of members&#8217;, customers&#8217; and other constituents&#8217; sensitive information is subject to complex regulations at multiple levels.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Product liability, product recall or personal injury issues could damage our reputation.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We face significant competition in attracting and retaining talented employees. Further, managing succession for, and retention of, key executives is critical to our success.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Sales of our products and services are dependent on our ability to attract and motivate internal sales personnel and independent third-party brokers, consultants and agents. We may be subject to penalties or other regulatory actions as a result of the marketing practices of brokers and agents selling our products.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failure of our businesses to effectively collaborate could prevent us from maximizing our operating results.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pursuing multiple information technology improvement initiatives simultaneously could make continued development and implementation significantly more challenging. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to payment-related risks that could increase our operating costs, expose us to fraud or theft, subject us to potential liability and disrupt our business operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Both our and our vendors&#8217; operations are subject to a variety of business continuity hazards and risks that could interrupt our operations or otherwise adversely affect our performance and operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Risks</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We would be adversely affected by downgrades or potential downgrades in our credit ratings, should they occur, or if we do not effectively deploy our capital.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Goodwill and other intangible assets could, in the future, become impaired.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adverse conditions in the U.S. and global capital markets can significantly and adversely affect the value of our investments in debt and equity securities, mortgage loans, alternative instruments and other investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Relationships with Manufacturers, Providers, Suppliers and Vendors</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We face risks relating to the market availability, pricing, suppliers and safety profiles of prescription drugs and other products that we purchase and sell.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We need to be able to maintain our ability to contract with providers on competitive terms and develop and maintain attractive networks with high quality providers.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If our suppliers or service providers fail to meet their contractual obligations to us or to comply with applicable laws or regulations, we may be exposed to brand and reputational harm, litigation and/or regulatory action.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may experience increased medical and other benefit costs, litigation risk and customer and member dissatisfaction when providers that do not have contracts with us render services to our Health Care Benefits members.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Continuing consolidation and integration among providers and other suppliers may increase our costs and increase competition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The spread of, impact of and response to COVID-19 underscores and amplifies certain risks we face. The impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be material and adverse.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 has spread to every state in the U.S., has been declared a pandemic by the World Health Organization and has severely impacted, and is expected to continue to severely impact, the economies of the U.S. and other countries around the world.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The legislative and regulatory environment governing our businesses is dynamic and changing frequently, including the Families First Act, the CARES Act, the American Rescue Plan Act and mandated increases to the medical services we must pay for without a corresponding increase in the premiums we receive in our Health Care Benefits Insured products. As a result of COVID-19, including legislative and/or regulatory responses to COVID-19, the premiums we charge in our Insured Health Care Benefits products may prove to be insufficient to cover the cost of medical services delivered to our Insured medical members, which may increase significantly as a result of higher utilization rates of medical facilities and services and other increases in associated hospital and pharmaceutical costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal, state and local governmental policies and initiatives to reduce the transmission of COVID-19, including existing and new variants, such as mask and vaccination mandates, restrictions on large gatherings and social distancing directives, may not effectively combat the severity and/or duration of the COVID-19 pandemic and have resulted in, among other things, a reduction in utilization that is discretionary, the cancellation of elective medical procedures, reduced customer traffic and front store sales in our retail pharmacies, our customers being ordered to close or severely curtail their operations, the adoption of work-from-home policies and a reduction in diagnostic reporting due to reductions in health care provider visits and restrictions on our access to providers&#8217; medical records, all of which impact our businesses. Among other impacts of these policies and initiatives on our businesses, there may be changes in medical claims submission patterns and an adverse impact on (i) drug utilization due to the reduction in discretionary visits with providers; (ii) front store sales as a result of reduced customer traffic in our retail pharmacies; (iii) medical membership in our Health Care Benefits segment and covered lives in our PBM clients due to reductions in workforce at our existing customers (including due to business failures) as well as reduced willingness to change benefits providers by prospective customers; (iv) benefit costs due to COVID-19 related support programs we have put in place for our medical members and mandated increases to the medical services we must pay for without a corresponding increase in the premiums we receive in our Insured Health Care Benefits products; and (v) the amount, timing and collectability of payments to the Company from customers, clients, government payers and members as a result of the impact of COVID-19 on them. Over time, these policies and initiatives also may cause us to experience increased benefit costs and/or decreased revenues in our Health Care Benefits segment if, as a result of our medical members not seeing their providers as a result of COVID-19, we are unable to implement clinical initiatives to manage benefit costs and chronic conditions of our medical members and appropriately document their risk profiles.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in response to COVID-19, during the first half of 2020, we began to offer our medical members expanded benefit coverage and became obligated by governmental action to provide other additional coverage. This expanded benefit coverage continued to be provided without a corresponding increase in the premiums we receive in our Insured Health Care Benefits </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products. We also are taking actions designed to help provide financial and administrative relief for the health care provider community. Such measures and any further steps we take or are required to take to expand or otherwise modify the services delivered to our Health Care Benefits members, provide relief for the health care provider community, or in connection with the relaxation of social distancing directives and other restrictions on movement and economic activity intended to reduce the spread of COVID-19, including the potential for widespread testing and vaccination, including boosters, as a component of lifting those measures, could adversely impact our benefit costs, MBR and operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The various initiatives we have implemented to slow and/or reduce the impact of COVID-19 and the COVID-19-related support programs we have put in place for our customers, medical members and colleagues have increased our operating expenses and reduced the efficiency of our operations. Our operating results will continue to be adversely affected so long as these initiatives continue or if they are expanded. In addition, any adverse economic conditions that could be caused by COVID-19 may have an adverse impact on our net investment income and the value of our investment portfolio.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread of COVID-19, or actions taken to mitigate its spread, could have material and adverse effects on our ability to operate our businesses effectively, including as a result of the complete or partial closure of facilities, labor shortages and/or financial difficulties experienced by third-party service providers. Disruptions in our supply chains, our distribution chains and/or public and private infrastructure, including those caused by industry capacity constraints, material availability, global logistics delays and constraints arising from, among other things, the transportation capacity of ocean shipping containers, and labor availability constraints, could materially and adversely impact our business operations. We have transitioned a significant subset of our colleagues to a remote work environment in an effort to mitigate the spread of COVID-19, as have a significant number of our third-party service providers, which may amplify certain risks to our businesses, including an increased demand for information technology resources, increased risk of phishing and other cybersecurity attacks, increased risk of unauthorized dissemination of sensitive personal information or proprietary or confidential information about us or our medical members or other third-parties and increased risk of business interruptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve and the severity and duration of the pandemic and scope and intensity of the governmental response to it are unknown at this time. We believe COVID-19&#8217;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; vaccination rates; the severity of any new COVID-19 variants and whether vaccines are effective in combating them; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of any additional stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Businesses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to accurately forecast health care and other benefit costs, which could adversely affect our Health Care Benefits segment&#8217;s operating results. There can be no assurance that future health care and other benefits costs will not exceed our projections.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of COVID-19, the current economic environment is adverse and less predictable than recently experienced, which has caused and may continue to cause unanticipated and significant volatility in our health care and other benefits costs, including COVID-19 related testing and vaccination and post-acute care skilled nursing facility and behavioral health costs. In January 2021, the President of the United States issued an executive order to support government efforts to expand access, availability and use of COVID-19 diagnostic, screening and surveillance and addressed the cost of COVID-19 testing by facilitating COVID-19 testing free of charge to those who lack comprehensive health insurance and clarifying group health plans&#8217; and health insurance issuers&#8217; obligations to provide coverage for COVID-19 testing.  In January 2022, the HHS announced that commercial health insurers must cover the cost of up to eight rapid COVID-19 OTC test kits per individual per 30-day period. In addition, the timing of vaccine administration to the general public and related costs as well as the identification of new, more infectious strains of the COVID-19 virus and whether the vaccines will be effective against such new strains are uncertain and may impact our MBR. Premiums for our Insured Health Care Benefits products, which comprised 93% of our Health Care Benefits revenues for 2021, are priced in advance based on our forecasts of health care and other benefit costs during a fixed premium period, which is generally twelve months. These forecasts are typically developed several months before the fixed premium period begins, are influenced by historical data (and recent historical data in particular), are dependent on our ability to anticipate and detect medical cost trends and changes in our members&#8217; behavior and health care utilization patterns and medical claim submission patterns and require a significant degree of judgment. For example, our revenue on Medicare policies is based on bids submitted in June of the year before the contract year. Cost increases in excess of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our projections cannot be recovered in the fixed premium period through higher premiums. As a result, our profits are particularly sensitive to the accuracy of our forecasts of the increases in health care and other benefit costs that we expect to occur and our ability to anticipate and detect medical cost trends. For 2022, those forecasts include adjustments made to pricing based on prospective expectations for liabilities due to testing, vaccines, direct COVID-19 treatment and deferred care. Risk-adjusted revenue has been adjusted for deferred care, and forecasted enrollment considers assumptions about the economic environment, though COVID-19 related impacts remain uncertain. During periods when health care and other benefit costs, utilization and/or medical costs trends experience significant volatility and medical claim submission patterns are changing rapidly as a result of COVID-19, accurately detecting, forecasting, managing, reserving and pricing for our (and our self-insured customers&#8217;) medical cost trends and incurred and future health care and other benefits costs is more challenging. There can be no assurance regarding the accuracy of the health care or other benefit cost projections reflected in our pricing, and our health care and other benefit costs (including COVID-19 related testing and vaccination and post-acute care skilled nursing facility and behavioral health costs) are affected by COVID-19 and other external events over which we have no control. Even relatively small differences between predicted and actual health care and other benefit costs as a percentage of premium revenues can result in significant adverse changes in our Health Care Benefits segment&#8217;s operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of factors contribute to rising health care and other benefit costs, including COVID-19, previously uninsured members entering the health care system, changes in members&#8217; behavior and health care utilization patterns, turnover in our membership, additional government mandated benefits or other regulatory changes (including under the Families First Act, the CARES Act, and the American Rescue Plan Act), changes in the health status of our members, the aging of the population and other changing demographic characteristics, advances in medical technology, increases in the number and cost of prescription drugs (including specialty pharmacy drugs and ultra-high cost drugs and therapies), direct-to-consumer marketing by drug manufacturers, the increasing influence of social media on our members&#8217; health care utilization and other behaviors, changes in health care practices and general economic conditions (such as inflation and employment levels). In addition, government-imposed limitations on Medicare and Medicaid reimbursements to health plans and providers have caused the private sector to bear a greater share of increasing health care and other benefits costs over time, and future amendments to the ACA that increase the uninsured population may amplify this problem. Other factors that affect our health care and other benefit costs include epidemics or other pandemics, changes as a result of the ACA, changes to the ACA and other changes in the regulatory environment, the evolution toward a consumer driven business model, new technologies, influenza-related health care costs (which may be substantial and higher than we expected), clusters of high-cost cases, health care provider and member fraud, and numerous other factors that are or may be beyond our control. For example, the 2020-2021 influenza season was impacted by efforts taken to reduce the spread of COVID-19; and the 2019-2020 influenza season had an earlier than average start and had a higher incidence of influenza than the 2018-2019 influenza season.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Health Care Benefits segment&#8217;s operating results and competitiveness depend in large part on our ability to appropriately manage future health care and other benefit costs through underwriting criteria, product design, provider network configuration, negotiation of favorable provider contracts and medical management programs. Our medical cost management programs may not be successful and may have a smaller impact on health care and benefit costs than we expect. The factors described above may adversely affect our ability to predict and manage health care and other benefit costs, which can adversely affect our competitiveness and operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, if we are not able to accurately and promptly anticipate and detect medical cost trends or accurately estimate the cost of incurred but not yet reported claims or reported claims that have not been paid, our ability to take timely corrective actions to limit future health care costs and reflect our current benefit cost experience in our pricing process may be limited, which would further amplify the extent of any adverse impact on our operating results. These risks are particularly acute during periods when health care and other benefit costs, utilization and/or medical cost trends experience significant volatility and medical claim submission patterns are changing rapidly as a result of COVID-19. Such risks are further magnified by the ACA and other existing and future legislation and regulations that limit our ability to price for our projected and/or experienced increases in utilization and/or medical cost trends.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that future health care and other benefits costs will not exceed our projections.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse economic conditions in the U.S. and abroad can materially and adversely impact our businesses, operating results, cash flows and financial condition, and we do not expect these conditions to improve in the near future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverse economic conditions in the U.S. and abroad, including those caused by COVID-19, can materially and adversely impact our businesses, operating results, cash flows and financial condition, including:</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In our Pharmacy Services segment, by causing drug utilization to decline, reducing demand for PBM services and adversely affecting the financial health of our PBM clients.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In our Retail/LTC segment, by causing drug utilization to decline, changing consumer purchasing power, preferences and/or spending patterns leading to reduced consumer demand for products sold in our stores and adversely affecting the financial health of our LTC pharmacy customers.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By causing our existing customers to reduce workforces (including due to business failures), which would reduce our revenues, the number of covered lives in our PBM clients and/or the number of members our Health Care Benefits segment serves.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By causing our clients and customers and potential clients and customers, particularly those with the most employees or members, and state and local governments, to force us to compete more vigorously on factors such as price and service, including service, discount and other performance guarantees, to retain or obtain their business.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By causing customers and potential customers of our Health Care Benefits and Retail/LTC segments to purchase fewer products and/or products that generate less profit for us than the ones they currently purchase or otherwise would have purchased.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By causing customers and potential customers of our Health Care Benefits segment, particularly smaller employers and individuals, to forego obtaining or renewing their health and other coverage with us.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In our Health Care Benefits segment, by causing unanticipated increases and volatility in utilization of medical and other covered services, including COVID-19 related testing, vaccination and behavioral health services, by our medical members, changes in medical claim submission patterns and/or increases in medical unit costs and/or provider behavior, each of which would increase our costs and limit our ability to accurately detect, forecast, manage, reserve and price for our (and our self-insured customers&#8217;) medical cost trends and incurred and future health care and other benefits costs.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By increasing medical unit costs and causing changes in provider behavior in our Health Care Benefits segment as hospitals and other providers attempt to maintain revenue levels in their efforts to adjust to their own COVID-19-related and other economic challenges.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By weakening the ability or perceived ability of the issuers and/or guarantors of the debt or other securities we hold in our investment portfolio to perform on their obligations to us, which could result in defaults in those securities and has reduced, and may further reduce, the value of those securities and has created, and may continue to create, net realized capital losses for us that reduce our operating results.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By weakening the ability of our customers, including self-insured customers in our Health Care Benefits segment, medical providers and the other companies with which we do business as well as our medical members to perform their obligations to us or causing them not to perform those obligations, either of which could reduce our operating results.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By weakening the ability of our former subsidiaries and/or their purchasers to satisfy their lease obligations that we have guaranteed and causing the Company to be required to satisfy those obligations.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By weakening the financial condition of other insurers, including long-term care insurers and life insurers, which increases the risk that we will receive significant assessments for obligations of insolvent insurers to policyholders and claimants.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">By causing, over time, inflation that could cause interest rates to increase and thereby increase our interest expense and reduce our operating results, as well as decrease the value of the debt securities we hold in our investment portfolio, which would reduce our operating results and/or adversely affect our financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, reductions in workforce by our customers can cause unanticipated increases in the health care and other benefits costs of our Health Care Benefits segment. For example, our business associated with members who have elected to receive benefits under Consolidated Omnibus Budget Reconciliation Act (known as &#8220;COBRA&#8221;) typically has an MBR that is significantly higher than our overall Commercial MBR.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Each of our segments operates in a highly competitive and evolving business environment; and operating income in the industries in which we compete may decline.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of our segments, Health Care Benefits, Pharmacy Services, which includes our PBM business, and Retail/LTC, operates in a highly competitive and evolving business environment. Specifically:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As competition increases in the geographies in which we operate, including competition from new entrants, a significant increase in price compression and/or reimbursement pressures could occur, and this could require us to reevaluate our pricing structures to remain competitive.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In our Health Care Benefits segment we are seeking to substantially grow our Medicaid, dual eligible and dual eligible special needs plan membership over the next several years. In many instances, to acquire and retain our government </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">customers&#8217; business, we must bid against our competitors in a highly competitive environment. Winning bids often are challenged successfully by unsuccessful bidders, and may also be withdrawn or cancelled by the issuing agency.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Customer contracts in our Health Care Benefits segment are generally for a period of one year, and our customers have considerable flexibility in moving between us and our competitors. One of the key factors on which we compete for customers, especially in uncertain economic environments, is overall cost. We are therefore under pressure to contain premium price increases despite being faced with increasing health care and other benefit costs and increasing operating costs. If we are unable to increase our prices to reflect, or otherwise mitigate the impact of, increasing costs, our profitability will be adversely affected. If we are unable to limit our price increases, we may lose members to competitors with more favorable pricing, adversely affecting our revenues and operating results. In response to rising prices, our customers may elect to self-insure or to reduce benefits in order to limit increases in their benefit costs. Alternatively, our customers may purchase different types of products from us that are less profitable. Such elections may result in reduced membership in our more profitable Insured products and/or lower premiums for our Insured products, which may adversely affect our revenues and operating results, although such elections also may reduce our health care and other benefit costs. In addition, our Medicare, Medicaid and CHIP products are subject to termination without cause, periodic re-bid, rate adjustment and program redesign, as customers seek to contain their benefit costs, particularly in an uncertain economy, and our exposure to this risk is increasing as we grow our Government products membership. These actions may adversely affect our membership, revenues and operating results. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We requested increases in our premium rates in our Commercial Health Care Benefits business for 2021 and expect to request increases in those rates for 2022 and beyond in order to adequately price for projected medical cost trends, required expansions of coverage and rating limits, and significant assessments, fees and taxes imposed by federal and state governments, including as a result of the ACA. Our rates also must be adequate to reflect the risk that our products will be selected by people with a higher risk profile or utilization rate than the pool of participants we anticipated when we established pricing for the applicable products (also known as &#8220;adverse selection&#8221;), particularly in small group Commercial products. These rate increases may be significant and thus heighten the risks of adverse publicity, adverse regulatory action and adverse selection and the likelihood that our requested premium rate increases will be denied, reduced or delayed, which could lead to operating margin compression.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The competitive success of our Pharmacy Services segment is dependent on our ability to establish and maintain contractual relationships with network pharmacies as PBM clients evaluate adopting narrow or restricted retail pharmacy networks. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The competitive success of our Retail/LTC segment and our specialty pharmacy operations is dependent on our ability to establish and maintain contractual relationships with PBMs and other payors on acceptable terms as the payors&#8217; clients evaluate adopting narrow or restricted retail pharmacy networks. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In our PBM business, we maintain contractual relationships with brand name drug manufacturers that provide for purchase discounts and/or rebates on drugs dispensed by pharmacies in our retail network and by our specialty and mail order pharmacies (all or a portion of which may be passed on to clients). Manufacturer&#8217;s rebates often depend on a PBM&#8217;s ability to meet contractual requirements, including the placement of a manufacturer&#8217;s products on the PBM&#8217;s formularies. If we lose our relationship with one or more drug manufacturers, or if the discounts or rebates provided by drug manufacturers decline, our operating results, cash flows and/or prospects could be adversely affected. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The PBM industry has been experiencing price compression as a result of competitive pressures and increased client demands for lower prices, increased revenue sharing, including sharing in a larger portion of rebates received from drug manufacturers, enhanced service offerings and/or higher service levels. Marketplace dynamics and regulatory changes also have adversely affected our ability to offer plan sponsors pricing that includes the use of retail &#8220;differential&#8221; or &#8220;spread,&#8221; which could adversely affect our future profitability, and we expect these trends to continue.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our retail pharmacy, specialty pharmacy and LTC pharmacy operations have been affected by reimbursement pressure caused by competition, including client demands for lower prices, generic drug pricing, earlier than expected generic drug introductions and network reimbursement pressure. If we are unable to increase our prices to reflect, or otherwise mitigate the impact of, increasing costs, our profitability will be adversely affected. If we are unable to limit our price increases, we may lose customers to competitors with more favorable pricing, adversely affecting our revenues and operating results.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A shift in the mix of our pharmacy prescription volume towards programs offering lower reimbursement rates as a result of competition or otherwise could adversely affect our margins, including the ongoing shift in pharmacy mix towards 90-day prescriptions at retail and the ongoing shift in pharmacy mix towards Medicare Part D prescriptions.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">PBM client contracts often are for a period of approximately three years. However, PBM clients may require early or periodic re-negotiation of pricing prior to contract expiration. PBM clients are generally well informed, can move between us and our competitors and often seek competing bids prior to expiration of their contracts. We are therefore under pressure to contain price increases despite being faced with increasing drug costs and increasing operating costs. If we are unable to increase our prices to reflect, or otherwise mitigate the impact of, increasing costs, our profitability will be adversely </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">affected. If we are unable to limit our price increases, we may lose customers to competitors with more favorable pricing, adversely affecting our revenues and operating results.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The operating results and margins of our LTC business are further affected by the increased efforts of health care payors to negotiate reduced or capitated pricing arrangements and by the financial health of, and purchases and sales of, our LTC customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, competitors in each of our businesses may offer services and pricing terms that we may not be willing or able to offer. Competition also may come from new entrants and other sources in the future. Unless we can demonstrate enhanced value to our clients through innovative product and service offerings in the rapidly changing health care industry, we may be unable to remain competitive.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disruptive innovation by existing or new competitors could alter the competitive landscape in the future and require us to accurately identify and assess such alterations and make timely and effective changes to our strategies and business model to compete effectively. For example, decisions to buy our Health Care Benefits and Pharmacy Services products and services increasingly are made or influenced by consumers, either through direct purchasing (e.g., Medicare Advantage plans and PDPs) or through Public Exchanges and private health insurance exchanges that allow individual choice. Consumers also are increasingly seeking to access consumer goods and health care products and services locally and through other direct channels such as mobile devices and websites. To compete effectively in the consumer-driven marketplace, we will be required to develop or acquire new capabilities, attract new talent and develop new service and distribution relationships that respond to consumer needs and preferences.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in marketplace dynamics or the actions of competitors or manufacturers, including industry consolidation, the emergence of new competitors and strategic alliances, and decisions to exclude us from new narrow or restricted retail pharmacy networks could materially and adversely affect our businesses, operating results, cash flows and/or prospects. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We can provide no assurance that we will be able to compete successfully on Public Exchanges or that our pricing or other actions will result in the profitability of our Public Exchange products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we entered into the Public Exchanges in eight states. To compete effectively on Public Exchanges, we have developed or acquired the technology, systems, tools and talent necessary to interact with Public Exchanges and engage Public Exchange consumers through enhanced consumer-focused sales, marketing channels and customer interfaces. We have also created new customer service programs and product offerings. While participating on the Public Exchanges, we will have to respond to pricing and other actions taken by existing competitors and regulators as well as potentially disruptive new entrants, which could reduce our profit margins. Due to the price transparency provided by Public Exchanges, when we market products we face competitive pressures from existing and new competitors who may have lower cost structures. Our competitors may bring their Public Exchange and other consumer products to market more quickly, have greater experience marketing to consumers and/or may be targeting the higher margin portions of our business. We can provide no assurance that we will be able to compete successfully or profitably on Public Exchanges or that we will be able to benefit from any opportunities presented by Public Exchanges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there can be no assurance that our pricing or other actions will result in the profitability of our Public Exchange products in 2022 or any future year. We have set 2022 premium rates for our Public Exchange products based on our projections, including as to the health status and quantity of membership and utilization of medical and/or other covered services by members. The accuracy of the projections reflected in our pricing may be impacted by (i) adverse selection among individuals who require or utilize more expensive medical and/or other covered services, (ii) other plans&#8217; withdrawals from participation in the Public Exchanges we serve and (iii) legislation, regulations, enforcement activity and/or judicial decisions that cause Public Exchanges to operate in a manner different than what we projected in setting our premium rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A change in our Health Care Benefits product mix may adversely affect our profit margins.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Insured Health Care Benefits products that involve greater potential risk generally tend to be more profitable than our ASC products. Historically, smaller employer groups have been more likely to purchase Insured Health Care Benefits products because such purchasers are generally unable or unwilling to bear greater liability for health care expenditures, although over the last several years even relatively small employers have moved to ASC products. We also serve, and expect to grow our business with, government-sponsored programs, including Medicare and Medicaid, that are subject to competitive bids and have lower profit margins than our Commercial Insured Health Care Benefits products. A shift of enrollees from more profitable products to less profitable products could have a material adverse effect on the Health Care Benefits segment&#8217;s operating results.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Negative public perception of the industries in which we operate, or of our industries&#8217; or our practices, can adversely affect our businesses, operating results, cash flows and prospects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our brand and reputation are two of our most important assets, and the industries in which we operate have been and are negatively perceived by the public from time to time. Negative publicity may come as a result of adverse media coverage, litigation against us and other industry participants, the ongoing public debates over drug pricing, PBMs, government involvement in drug pricing and purchasing, changes to the ACA, &#8220;surprise&#8221; medical bills, governmental hearings and/or investigations, actual or perceived shortfalls regarding our industries&#8217; or our own products and/or business practices (including PBM operations, drug pricing and insurance coverage determinations) and social media and other media relations activities.  Negative publicity also may come from a failure to meet customer expectations for consistent, high quality and accessible care. This risk may increase as we continue to offer products and services that make greater use of data and as our business model becomes more focused on delivering health care to consumers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, by working with the U.S. government in the distribution and administration of the COVID-19 vaccine, the Company may be subject to negative publicity related to the government&#8217;s actions in response to COVID-19 that are outside of the ability of the Company to control.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Negative public perception and/or publicity of our industries in general, or of us or our key vendors, brokers or product distribution networks in particular, can further increase our costs of doing business and adversely affect our operating results and our stock price by:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adversely affecting our brand and reputation;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adversely affecting our ability to market and sell our products and/or services and/or retain our existing customers and members;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requiring us to change our products and/or services; </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reducing or restricting the revenue we can receive for our products and/or services; and/or</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing or significantly changing the regulatory and legislative requirements with which we must comply.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We must maintain and improve our relationships with our retail and specialty pharmacy customers and increase the demand for our products and services, including proprietary brands.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our businesses depends in part on customer loyalty, superior customer service and our ability to persuade customers to frequent our retail stores and online sites and to purchase products in additional categories and our proprietary brands. Failure to timely identify or effectively respond to changing consumer preferences and spending patterns, and evolving demographic mixes in the communities we serve, an inability to expand the products being purchased by our clients and customers, or the failure or inability to obtain or offer particular categories of products could adversely affect our relationship with our customers and clients and the demand for our products and services and could result in excess inventories of products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer our retail customers proprietary brand products that are available exclusively at our retail stores and through our online retail sites. The sale of proprietary products subjects us to unique risks including potential product liability risks, mandatory or voluntary product recalls, potential supply chain and distribution chain disruptions for raw materials and finished products, our ability to successfully protect our intellectual property rights and the rights of applicable third parties, and other risks generally encountered by entities that source, market and sell private-label products. We also face similar risks for the other products we sell in our retail operations, including supply chain and distribution chain disruption risk. Any failure to adequately address some or all of these risks could have an adverse effect on our retail business, operating results, cash flows and/or financial condition. Additionally, an increase in the sales of our proprietary brands may adversely affect our sales of products owned by our suppliers and adversely impact certain of our supplier relationships. Our ability to locate qualified, economically stable suppliers who satisfy our requirements, and to acquire sufficient products in a timely and effective manner, is critical to ensuring, among other things, that customer confidence is not diminished. Any failure to develop sourcing relationships with a broad and deep supplier base could adversely affect our operating results and erode customer loyalty.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also could be adversely affected if we fail to identify or effectively respond to changes in marketplace dynamics. For example, specialty pharmacy represents a significant and growing proportion of prescription drug spending in the U.S., a significant portion of which is dispensed outside of traditional retail pharmacies. Because our specialty pharmacy business focuses on complex and high-cost medications, many of which are made available by manufacturers to a limited number of pharmacies (so-called limited distribution drugs) that serve a relatively limited universe of patients, the future growth of our </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">specialty pharmacy business depends largely upon expanding our access to key drugs and penetration in certain treatment categories. Any contraction of our base of patients or reduction in demand for the prescriptions we currently dispense could have an adverse effect on our specialty pharmacy business, operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face risks relating to the availability, pricing and safety profiles of prescription drugs that we purchase and sell.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The profitability of our Retail/LTC and Pharmacy Services segments is dependent upon the utilization of prescription drug products. We dispense significant volumes of brand name and generic drugs from our retail, LTC, specialty and mail order pharmacies, and the retail pharmacies in our PBM&#8217;s network also dispense significant volumes of brand name and generic drugs. Our revenues, operating results and cash flows may decline if physicians cease writing prescriptions for drugs or the utilization of drugs is reduced, including due to:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased safety risk profiles or regulatory restrictions;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacturing or other supply issues;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a reduction in drug manufacturers&#8217; participation in federal programs;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain products being withdrawn by their manufacturers or transitioned to over-the-counter products; </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future FDA rulings restricting the supply or increasing the cost of products;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the introduction of new and successful prescription drugs or lower-priced generic alternatives to existing brand name products; or </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inflation in the price of drugs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, increased utilization of generic drugs (which normally yield a higher gross profit rate than equivalent brand name drugs) has resulted in pressure to decrease reimbursement payments to retail, mail order, specialty and LTC pharmacies for generic drugs, causing a reduction in our margins on sales of generic drugs. Consolidation within the generic drug manufacturing industry and other external factors may enhance the ability of manufacturers to sustain or increase pricing of generic drugs and diminish our ability to negotiate reduced generic drug acquisition costs. Any inability to offset increased brand name or generic prescription drug acquisition costs or to modify our activities to lessen the financial impact of such increased costs could have a significant adverse effect on our operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The reserves we hold for expected claims in our Insured Health Care Benefits products are based on estimates that involve an extensive degree of judgment and are inherently variable. Any reserve, including a premium deficiency reserve, may be insufficient. If actual claims exceed our estimates, our operating results could be materially adversely affected, and our ability to take timely corrective actions to limit future costs may be limited.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A large portion of health care claims are not submitted to us until after the end of the quarter in which services are rendered by providers to our members. Our reported health care costs payable for any particular period reflect our estimates of the ultimate cost of such claims as well as claims that have been reported to us but not yet paid. We also must estimate the amount of rebates payable under the MLR rules of the ACA, CMS and the OPM and the amounts payable by us to, and receivable by us from, the United States federal government under the ACA&#8217;s remaining premium stabilization program.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimates of health care costs payable are based on a number of factors, including those derived from historical claim experience, but this estimation process also makes use of extensive judgment. Considerable variability is inherent in such estimates, and the accuracy of the estimates is highly sensitive to changes in medical claims submission and processing patterns and/or procedures, turnover and other changes in membership, changes in product mix, changes in the utilization of medical and/or other covered services, including prescription drugs, changes in medical cost trends, changes in our medical management practices and the introduction of new benefits and products. We estimate health care costs payable periodically, and any resulting adjustments, including premium deficiency reserves, are reflected in current-period operating results within benefit costs. For example, as of December 31, 2021 and 2020, we established a premium deficiency reserve of $16 million and $11 million, respectively, related to Medicaid products in the Health Care Benefits segment. A worsening (or improvement) of health care cost trend rates or changes in claim payment patterns from those that we assumed in estimating health care costs payable as of December 31, 2021 would cause these estimates to change in the near term, and such a change could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, if we are not able to accurately and promptly anticipate and detect medical cost trends or accurately estimate the cost of incurred but not yet reported claims or reported claims that have not been paid, our ability to take timely corrective actions to limit future health care costs and reflect our current benefit cost experience in our pricing process may be limited, which would further exacerbate the extent of any adverse impact on our operating results. These risks are particularly acute during and following periods when utilization of medical and/or other covered services and/or medical cost trends are below </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recent historical levels and in products where there is significant turnover in our membership each year, and such risks are further magnified by the ACA and other legislation and regulations that limit our ability to price for our projected and/or experienced increases in utilization and/or medical cost trends.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results are affected by the health of the economy in general and in the geographies we serve.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses are affected by the U.S. economy and consumer confidence in general and in the geographies we serve, including various economic factors, including inflation and changes in consumer purchasing power, preferences and/or spending patterns. An unfavorable, uncertain or volatile economic environment could cause a decline in drug utilization, an increase in health care utilization and dampen demand for PBM services as well as consumer demand for products sold in our retail stores. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our customers&#8217; operating and financial performance deteriorates, or they are unable to make scheduled payments or obtain adequate financing, our customers may not be able to pay timely, or may delay payment of, amounts owed to us. Any inability of our customers to pay us for our products and services may adversely affect our businesses, operating results and cash flows. In addition, both state and federal government sponsored payers, as a result of budget deficits or spending reductions, may suspend payments or seek to reduce their health care expenditures resulting in our customers delaying payments to us or renegotiating their contracts with us. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, economic conditions including interest rate fluctuations, changes in capital market conditions and regulatory changes may affect our ability to obtain necessary financing on acceptable terms, our ability to secure suitable store locations under acceptable terms, our ability to execute sale-leaseback transactions under acceptable terms and the value of our investment portfolio. Adverse changes in the U.S. economy, consumer confidence and economic conditions could have an adverse effect on our businesses and financial results. This adverse effect could be further exacerbated by the increasing prevalence of high deductible health plans and health plan designs favoring co-insurance over co-payments as members and other consumers may decide to postpone, or not to seek, medical treatment which may lead them to incur more expensive medical treatment in the future and/or decrease our prescription volumes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our Health Care Benefits membership remains concentrated in certain U.S. geographies and in certain industries. Unfavorable changes in health care or other benefit costs or reimbursement rates or increased competition in those geographic areas where our membership is concentrated could therefore have a disproportionately adverse effect on our Health Care Benefits segment&#8217;s operating results. Our Health Care Benefits membership has been and may continue to be affected by workforce reductions by our customers due to adverse and/or uncertain general economic conditions, especially in the U.S. geographies and industries where our membership is concentrated. As a result, we may not be able to profitably grow and diversify our Health Care Benefits membership geographically, by product type or by customer industry, and our revenues and operating results may be disproportionately affected by adverse changes affecting our customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are exposed to risks relating to the solvency of other insurers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to assessments under guaranty fund laws existing in all states for obligations of insolvent insurance companies (including long-term care insurers), HMOs, ACA co-ops and other payors to policyholders and claimants. For example, in the first quarter of 2017, Aetna recorded a discounted estimated liability expense of $231 million pretax for our estimated share of future assessments for long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries. Guaranty funds are maintained by state insurance commissioners to protect policyholders and claimants in the event that an insurer, HMO, ACA co-op and/or other payor becomes insolvent or is unable to meet its financial obligations. These funds are usually financed by assessments against insurers regulated by a state. Future assessments may have an adverse effect on our operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Extreme events, or the threat of extreme events, could materially impact our businesses and health care (including behavioral health) costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nuclear, biological or other attacks, or other acts of violence, including active shooter situations, whether as a result of war or terrorism or otherwise; other man-made disasters; natural disasters, such as hurricanes, tropical storms, floods, fires, earthquakes, tsunamis, cyclones, typhoons or extreme weather conditions such as major or extended winter storms, droughts and tornados, whether as a result of climate change or otherwise; epidemics; pandemics and other extreme events can affect the U.S. economy in general, our industries and us specifically. In particular, such extreme events or the threat of such extreme events could result in significant health care (including behavioral health) costs, which also would be affected by the government&#8217;s actions and the responsiveness of public health agencies and other insurers. Such extreme events or the threat of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such extreme events also could disrupt our supply chains and/or our distribution chains for the products we sell. In addition, our employees and those of our vendors are concentrated in certain large, metropolitan areas which may be particularly exposed to these events. Such events could adversely affect our businesses, operating results and cash flows, and, in the event of extreme circumstances, our financial condition or viability, particularly if our responses to such events are less adequate than those of our competitors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to achieve our environmental, social and governance goals.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dedicated to corporate social responsibility and sustainability and face pressures from our colleagues, customers, and stockholders to make significant advancements in environmental, social and governance matters. In part to address these concerns, we established certain goals as part of our ESG strategy. Achievement of our goals is subject to risks and uncertainties, many of which are outside of our control, and it is possible that we may fail to achieve these goals or that our colleagues, customers, or stockholders might not be satisfied with our efforts. These risks and uncertainties include, but are not limited to: our ability to execute our operational strategies and achieve our goals within the currently projected costs and the expected timeframes; the availability and cost of renewable energy and other materials; compliance with, and changes or additions to, global and regional regulations, taxes, charges, mandates or requirements relating to climate-related goals; labor-related regulations and requirements that restrict or prohibit our ability to impose requirements on third party contractors; the actions of competitors and competitive pressures; an acquisition of or merger with another company that has not adopted similar goals or whose progress towards reaching its goals is not as advanced as ours; and the pace of regional and global recovery from the COVID-19 pandemic. A failure to meet our goals could adversely affect public perception of our business, employee morale or customer or stockholder support. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, an increasing percentage of colleagues, customers, and stockholders considers sustainability factors in making employment, consumer health care and investment decisions. If we are unable to meet our goals, we may lose colleagues, and have difficulty recruiting new colleagues, investors, customers, or partners, our stock price may be negatively impacted, our reputation may be negatively affected, and it may be more difficult for us to compete effectively, all of which would have an adverse effect on our business, operating results, and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks From Changes in Public Policy and Other Legal and Regulatory Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to potential changes in public policy, laws and regulations, including reform of the U.S. health care system, which can adversely affect our businesses. Entitlement program reform, if it occurs, could have a material adverse effect on our businesses, operations and/or operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The political environment in which we operate remains uncertain. It is reasonably possible that our business operations and operating results could be materially adversely affected by legislative, regulatory and public policy changes at the federal or state level, increased government involvement in drug reimbursement, pricing, purchasing and/or importation and/or increased regulation of PBMs, including: changes to the regulatory environment for health care and related benefits, including Medicare, the ACA, and related Public Exchange regulations; changes to laws or regulations governing drug reimbursement and/or pricing; changes to the laws and regulations governing PBMs&#8217;, PDPs&#8217; and/or Managed Medicaid organizations&#8217; interactions with government funded health care programs; changes to laws and/or regulations governing drug manufacturers&#8217; rebates; changes to laws and/or regulations governing reimbursements paid to pharmacists by and/or reporting required by PBMs; changes to immigration policies and/or other public policy initiatives. It is not possible to predict whether or when any such changes will occur or what form any such changes may take (including through the use of U.S. Presidential Executive Orders). Other significant changes to health care and related benefits system legislation or regulation as well as changes with respect to tax and trade policies, tariffs and other government regulations affecting trade between the United States and other countries also are possible and could adversely affect our businesses. If we fail to respond adequately to such changes, including by implementing strategic and operational initiatives, or do not respond as effectively as our competitors, our businesses, operations and operating results may be materially adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Efforts to amend the ACA and related regulations are possible. It is also possible that federal and state governments will continue to enact and seriously consider many broad-based legislative and regulatory proposals that will or could materially impact various aspects of the health care and related benefits system and our businesses. Further changes to federal health care and related benefits laws, including the ACA, drug reimbursement and pricing laws, laws governing PBMs and/or laws governing PBMs&#8217;, PDPs&#8217; and/or Managed Medicaid organizations&#8217; interactions with government funded health care programs, are probable. We cannot predict the effect, if any, that new health care and related benefits legislation, future changes to the ACA or the implementation of or failure to implement the outstanding provisions of ACA, may have on our Health Care Benefits, Pharmacy Services and/or retail pharmacy, LTC pharmacy operations and/or operating results. The federal and many </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">state governments also are considering changes in the interpretation, enforcement and/or application of existing programs, laws and regulations, including changes to payments under and funding of Medicare and Medicaid programs and increased regulation of PBMs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, changes in existing federal or state laws or regulations or the adoption of new laws or regulations relating to additional regulation of PBMs (including network restrictions, formulary management affiliate reimbursement, contractual guarantees and reconciliations, or other PBM services), drug pricing or purchasing, patent term extensions and/or purchase discount and/or rebate arrangements with drug manufacturers also could reduce the discounts or rebates we receive. Changes in existing federal or state laws or regulations or the adoption of new laws or regulations relating to claims processing and billing, including our ability to use MAC lists and collect transmission fees, also could adversely affect our profitability. For example, on October 29, 2020, the HHS released a final rule requiring health insurers to disclose drug pricing and cost-sharing information. The final rule requires group health plans and health insurance issuers in the individual and group markets to disclose cost-sharing information upon request, to a participant, beneficiary, or enrollee, which, unless otherwise indicated, for the purpose of the final rules includes an authorized representative, and requires plans and issuers to disclose in-network provider rates, historical out-of-network allowed amounts and the associated billed charges, and negotiated rates for prescription drugs. While the specific regulation requiring PBMs to disclose negotiated price concessions was paused under federal guidance released in August 2021, if it resurfaces, the regulation may result in drug manufacturers lowering discounts or rebates, resulting in higher drug costs for patients and impacting the ability of the Company to negotiate drug prices and provide competitive products and services to consumers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in November 2020, the HHS released the Rebate Rule, which eliminates the regulatory safe harbor from prosecution under the AKS for rebates from pharmaceutical companies to PBMs in Medicare Part D and in Medicaid MCOs, replacing it with two far narrower safe harbors designed to directly benefit patients with high out-of-pocket costs and to change the way PBMs are compensated. The new safe harbors are (i) for rebates which are passed on to the patient at the point of sale and (ii) for flat service fee payments made to PBMs which cannot be tied to the list prices of drugs. The PCMA, which represents PBMs, has filed a suit in an effort to block the Rebate Rule, claiming that the Rebate Rule would lead to higher premiums in Medicare Part D and was adopted in an unlawful manner. It is unclear whether the Rebate Rule will be enforceable, whether pharmaceutical companies will respond by reducing list prices, whether list prices in the private market may also be reduced, and what the resulting impact will be to PBMs or the Company. The Bipartisan Infrastructure Act of 2021 delays the effective date of the rebate rule to January 2026, and pending Reconciliation legislation would fully repeal the Rebate Rule.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Consolidated Appropriations Act of 2021 was signed into law in December 2020 and contains transparency provisions requiring group health plans and health insurance issuers to report certain prescription drug costs, overall spending on health services and prescription drugs, and information about premiums and the impact of rebates and other remuneration on premiums and out-of-pocket costs to the Tri-Departments. No later than 18 months after the first submission and bi-annually thereafter, the Tri-Departments will release a public report on drug pricing trends, drug reimbursement, and the impact of drug prices on premiums. In August, the Tri-Departments deferred enforcement of both the December 2021 deadline for reporting 2020 plan year data and the June 2022 deadline for reporting 2021 plan year data to December 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the enactment or content of new legislation or regulations or changes to existing laws or regulations or their enforcement, interpretation or application, or the effect they will have on our business operations or operating results, which could be materially adverse. Even if we could predict such matters, it is not possible to eliminate the adverse impact of public policy changes that would fundamentally change the dynamics of one or more of the industries in which we compete. Examples of such changes include: the federal or one or more state governments fundamentally restructuring or reducing the funding available for Medicare, Medicaid, dual eligible or dual eligible special needs plan programs, increasing its involvement in drug reimbursement, pricing, purchasing and/or importation, changing the laws and regulations governing PBMs&#8217;, PDPs&#8217; and/or Managed Medicaid organizations&#8217; interactions with government funded health care programs, changing the tax treatment of health or related benefits, or significantly altering the ACA. The likelihood of adverse changes remains high due to state and federal budgetary pressures, and our businesses and operating results could be materially and adversely affected by such changes, even if we correctly predict their occurrence. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on these matters, see &#8220;Government Regulation&#8221; included in Item 1 of this 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with applicable laws and regulations, many of which are highly complex, we could be subject to significant adverse regulatory actions, including monetary penalties, or suffer brand and reputational harm.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses are subject to extensive regulation and oversight by state, federal and international governmental authorities. The laws and regulations governing our operations and interpretations of those laws and regulations, including those related to human capital and climate change, are increasing in number and complexity, change frequently and can be inconsistent or conflict with one another. In general, these laws and regulations are designed to benefit and protect customers, members and providers rather than us or our investors. In addition, the governmental authorities that regulate our businesses have broad latitude to make, interpret and enforce the laws and regulations that govern us and continue to interpret and enforce those laws and regulations more strictly and more aggressively each year. We also must follow various restrictions on certain of our businesses and the payment of dividends by certain of our subsidiaries put in place by certain state regulators.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our Pharmacy Services and Retail/LTC operations, products and services are subject to:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the clinical quality, patient safety and other risks inherent in the dispensing, packaging and distribution of drugs and other health care products and services, including claims related to purported dispensing and other operational errors (any failure by our Pharmacy Services and/or Retail/LTC operations to adhere to the laws and regulations applicable to the dispensing of drugs could subject us to civil and criminal penalties);</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal and state anti-kickback and other laws that govern our relationship with drug manufacturers, customers and consumers;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compliance requirements under ERISA, including fiduciary obligations in connection with the development and implementation of items such as drug formularies and preferred drug listings; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal and state legislative proposals and/or regulatory activity that could adversely affect pharmacy benefit industry practices.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Health Care Benefits products are highly regulated, particularly those that serve Medicare, Medicaid, dual eligible, dual eligible special needs and small group Commercial customers and members. The laws and regulations governing participation in Medicare Advantage (including dual eligible special needs plans), Medicare Part D, Medicaid, and managed Medicaid plans are complex, are subject to interpretation and can expose us to penalties for non-compliance. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scope of the practices and activities that are prohibited by federal and state false claims acts is the subject of pending litigation. Claims under federal and state false claims acts can be brought by the government or by private individuals on behalf of the government through a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or &#8220;whistleblower&#8221; suit, and we are a defendant in a number of such proceedings. If we are convicted of fraud or other criminal conduct in the performance of a government program or if there is an adverse decision against us under the False Claims Act, we may be temporarily or permanently suspended from participating in government health care programs, including Medicare Advantage, Medicare Part D, Medicaid, dual eligible and dual eligible special needs plan programs, and we also may be required to pay significant fines and/or other monetary penalties. Whistleblower suits have resulted in significant settlements between governmental agencies and health care companies. The significant incentives and protections provided to whistleblowers under applicable law increase the risk of whistleblower suits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to comply with laws and regulations that apply to government programs, we could be subject to criminal fines, civil penalties, premium refunds, prohibitions on marketing or active or passive enrollment of members, corrective actions, termination of our contracts or other sanctions which could have a material adverse effect on our ability to participate in Medicare Advantage, Medicare Part D, Medicaid, dual eligible, dual eligible special needs plan and other programs and on our operating results, cash flows and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses, profitability and growth also may be adversely affected by (i) judicial and regulatory decisions that change and/or expand the interpretations of existing statutes and regulations, impose medical or bad faith liability, increase our responsibilities under ERISA or the remedies available under ERISA, or reduce the scope of ERISA pre-emption of state law claims or (ii) other legislation and regulations. For example, in December 2020, the U.S. Supreme Court upheld an Arkansas law that, among other things, mandates a particular pricing methodology, establishes an appeals process for a pharmacy when the reimbursement is below the pharmacy&#8217;s acquisition cost, permits a pharmacy to reverse and rebill if they cannot procure the drug from its wholesaler at a price equal to or less than the reimbursement rate, prohibits a PBM from reimbursing a pharmacy less than the amount it reimburses an affiliate on a per unit basis, and permits a pharmacy to decline to dispense if the reimbursement is lower than the pharmacy&#8217;s acquisition cost. Also, in November 2021, the U.S. Court of Appeals for the Eighth Circuit upheld a North Dakota law that regulates employer-sponsored ERISA health plans and certain PBM practices within Medicare.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our compliance or other systems and processes fail or are deemed inadequate, we may suffer brand and reputational harm and become subject to regulatory actions and/or litigation.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to being subject to extensive and complex regulations, many of our contracts with customers include detailed requirements. In order to be eligible to offer certain products or bid on certain contracts, we must demonstrate that we have robust systems and processes in place that are designed to maintain compliance with all applicable legal, regulatory and contractual requirements. These systems and processes frequently are reviewed and audited by our customers and regulators. If our systems and processes designed to maintain compliance with applicable legal and contractual requirements, and to prevent and detect instances of, or the potential for, non-compliance fail or are deemed inadequate, we may suffer brand and reputational harm and be subject to regulatory actions, litigation and other proceedings which may result in damages, fines, suspension or loss of licensure, suspension or exclusion from participation in government programs and/or other penalties, any of which could adversely affect our businesses, operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We routinely are subject to litigation and other adverse legal proceedings, including class actions and qui tam actions. Many of these proceedings seek substantial damages which may not be covered by insurance. These proceedings are costly to defend, may result in changes in our business practices, harm our brand and reputation and adversely affect our businesses and operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PBM, retail pharmacy, mail order pharmacy, specialty pharmacy, LTC pharmacy and health care and related benefits are highly regulated industries whose participants frequently are subject to litigation and other adverse legal proceedings. We are currently subject to various litigation and arbitration matters, investigations, regulatory audits, inspections, government inquiries, and regulatory and other legal proceedings, both inside and outside the U.S. Outside the U.S., contractual rights, tax positions and applicable regulations may be subject to interpretation or uncertainty to a greater degree than in the U.S. Litigation related to our provision of professional services in our medical clinics, pharmacies and LTC operations is increasing as we expand our services along the continuum of health care.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation, and particularly securities, derivative, collective or class action and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> litigation, is often expensive and disruptive. Many of the legal proceedings against us seek substantial damages (including non-economic or punitive damages and treble damages), and certain of these proceedings also seek changes in our business practices. While we currently have insurance coverage for some potential liabilities, other potential liabilities may not be covered by insurance, insurers may dispute coverage and/or the amount of our insurance may not be enough to cover the damages awarded or costs incurred. In addition, some types of damages, like punitive damages, may not be covered by insurance, and in some jurisdictions the coverage of punitive damages is prohibited. Insurance coverage for all or some forms of liability also may become unavailable or prohibitively expensive in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outcome of litigation and other adverse legal proceedings is always uncertain, and outcomes that are not justifiable by the evidence or existing law or regulation can and do occur, and the costs incurred frequently are substantial regardless of the outcome. Litigation and other adverse legal proceedings could materially adversely affect our businesses, operating results and/or cash flows because of brand and reputational harm to us caused by such proceedings, the cost of defending such proceedings, the cost of settlement or judgments against us, or the changes in our operations that could result from such proceedings. See Item 3 of this 10-K for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We frequently are subject to regular and special governmental audits, investigations and reviews that could result in changes to our business practices and also could result in material refunds, fines, penalties, civil liabilities, criminal liabilities and other sanctions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As one of the largest national retail, mail order, specialty and LTC pharmacy, PBM and health care and related benefits providers, we frequently are subject to regular and special governmental market conduct and other audits, investigations and reviews by, and we receive subpoenas and other requests for information from, various federal and state agencies, regulatory authorities, attorneys general, committees, subcommittees and members of the U.S. Congress and other state, federal and international governmental authorities. For example, we have received CIDs from, and provided documents and information to, the Civil Division of the DOJ in connection with a current investigation of our patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. CMS and the OIG also are auditing the risk adjustment-related data of certain of our Medicare Advantage plans, and the number of such audits continues to increase. Several such audits, investigations and reviews by governmental authorities currently are pending, some of which may be resolved in 2022, the results of which may be adverse to us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and state governments have made investigating and prosecuting health care and other insurance fraud, waste and abuse a priority. Fraud, waste and abuse prohibitions encompass a wide range of activities, including kickbacks for referral of members, billing for unnecessary medical and/or other covered services, improper marketing and violations of patient privacy </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rights. The regulations and contractual requirements applicable to us and other industry participants are complex and subject to change, making it necessary for us to invest significant resources in complying with our regulatory and contractual requirements. Ongoing vigorous law enforcement and the highly technical regulatory scheme mean that our compliance efforts in this area will continue to require significant resources. In addition, our medical costs and the medical expenses of our Health Care Benefits ASC customers may be adversely affected if we do not prevent or detect fraudulent activity by providers and/or members.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regular and special governmental audits, investigations and reviews by federal, state and international regulators could result in changes to our business practices, and also could result in significant or material premium refunds, fines, penalties, civil liabilities, criminal liabilities or other sanctions, including suspension or exclusion from participation in government programs and suspension or loss of licensure. Any of these audits, investigations or reviews could have a material adverse effect on our businesses, operating results, cash flows and/or financial condition or result in significant liabilities and negative publicity for us. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Legal and Regulatory Proceedings&#8221; in Note 16 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; included in Item 8 of this 10-K for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our litigation and regulatory risk profile are changing as we offer new products and services and expand in business areas beyond our historical core businesses of Health Care Benefits, Pharmacy Services and Retail/LTC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we focused primarily on providing Health Care Benefits, Pharmacy Services and Retail/LTC products and services. As a result of our transformation program and other innovation initiatives, we are expanding our presence in the health care space and plan to offer new products and services (such as the home hemodialysis device we are developing) which present a different litigation and regulatory risk profile than the products and services that we historically have offered. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increased volume of business in areas beyond our historical core businesses and new products and services subject us to litigation and regulatory risks that are different from the risks of providing Health Care Benefits, Pharmacy Services and Retail/LTC products and services and increase significantly our exposure to other risks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face unique regulatory and other challenges in our Medicare and Medicaid businesses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are seeking to substantially grow the Medicare and Medicaid membership in our Health Care Benefits segment in 2022 and over the next several years. We face unique regulatory and other challenges that may inhibit the growth and profitability of those businesses.</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In January 2021, CMS issued its final notice detailing final 2022 Medicare Advantage benchmark payment rates. Final 2022 Medicare Advantage rates resulted in an increase in industry benchmark rates of approximately 4.1%. We cannot predict future Medicare funding levels, the impact of future federal budget actions or ensure that such changes or actions will not have an adverse effect on our Medicare operating results.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The organic expansion of our Medicare Advantage and Medicare Part D service area is subject to the ability of CMS to process our requests for service area expansions and our ability to build cost competitive provider networks in the expanded service areas that meet applicable network adequacy requirements. CMS&#8217; decisions on our requests for service area expansions also may be affected adversely by compliance issues that arise each year in our Medicare operations. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">CMS regularly audits our performance to determine our compliance with CMS&#8217;s regulations and our contracts with CMS and to assess the quality of the services we provide to our Medicare members. As a result of these audits, we may be subject to significant or material retroactive adjustments to and/or withholding of certain premiums and fees, fines, criminal liability, civil monetary penalties, CMS imposed sanctions (including suspension or exclusion from participation in government programs) or other restrictions on our Medicare, Medicaid and other businesses, including suspension or loss of licensure. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Star ratings&#8221; from CMS for our Medicare Advantage plans will continue to have a significant effect on our plans&#8217; operating results. Only Medicare Advantage plans with a star rating of four or higher (out of five) are eligible for a quality bonus in their basic premium rates. CMS continues to change its rating system to make achieving and maintaining a four or higher star rating more difficult. Our star ratings and past performance scores are adversely affected by the compliance issues that arise each year in our Medicare operations. If our star ratings fall below four for a significant portion of our Medicare Advantage membership or do not match the performance of our competitors or the star rating quality bonuses are reduced or eliminated, our revenues, operating results and cash flows may be significantly adversely affected.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Payments we receive from CMS for our Medicare Advantage and Medicare Part D businesses also are subject to risk adjustment based on the health status of the individuals we enroll. Elements of that risk adjustment mechanism continue to be challenged by the DOJ, the OIG and CMS itself. Substantial changes in the risk adjustment mechanism, including changes that result from enforcement or audit actions, could materially affect the amount of our Medicare reimbursement, require us to raise prices or reduce the benefits we offer to Medicare beneficiaries, and potentially limit our (and the industry&#8217;s) participation in the Medicare program.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes to the ability of PBMs to have pharmacy performance programs in place for clients and report payments via direct and indirect reporting mechanisms could impact the Pharmacy Services business.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medicare Part D has resulted in increased utilization of prescription medications and puts pressure on our pharmacy gross margin rates due to regulatory and competitive pressures. Further, as a result of the ACA and changes to the retiree drug subsidy rules, clients of our PBM business could decide to discontinue providing prescription drug benefits to their Medicare-eligible members. To the extent this phenomenon occurs, the adverse effects of increasing customer migration into Medicare Part D may outweigh the benefits we realize from growth of our Medicare Part D products. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our Medicare Part D operating results and our ability to expand our Medicare Part D business could be adversely affected if: the cost and complexity of Medicare Part D exceed management&#8217;s expectations or prevent effective program implementation or administration; changes to the regulations regarding how drug costs are reported for Medicare Part D are implemented in a manner that adversely affects the profitability of our Medicare Part D business; changes to the applicable regulations impact our ability to retain fees from third parties including network pharmacies; the government alters Medicare Part D program requirements or reduces funding because of the higher-than-anticipated cost to taxpayers of Medicare Part D or for other reasons; the government mandated use of point-of-sale manufacturer&#8217;s rebates effective in 2022 continues; the government enacts price controls on certain pharmaceutical products in Medicare Part D; the government makes changes to how pharmacy pay-for-performance is calculated; or reinsurance thresholds are reduced below their current levels.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have experienced challenges in obtaining complete and accurate encounter data for our Medicaid products due to difficulties with providers and third-party vendors submitting claims in a timely fashion in the proper format, and with state agencies in coordinating such submissions. As states increase their reliance on encounter data, these difficulties could affect the Medicaid premium rates we receive and how Medicaid membership is assigned to us, which could have a material adverse effect on our Medicaid operating results and cash flows and/or our ability to bid for, and continue to participate in, certain Medicaid programs.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to report and correct errors discovered through our own auditing procedures or during a CMS audit or otherwise fail to comply with the applicable laws and regulations, we could be subject to fines, civil monetary penalties or other sanctions, including fines and penalties under the False Claims Act, which could have a material adverse effect on our ability to participate in Medicare Advantage, Medicare Part D or other government programs, and on our operating results, cash flows and financial condition. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain of our Medicaid contracts require the submission of complete and correct encounter data. The accurate and timely reporting of encounter data is increasingly important to the success of our Medicaid programs because more states are using encounter data to determine compliance with performance standards and, in part, to set premium rates. We have expended and may continue to expend additional effort and incur significant additional costs to collect accurate, or to correct inaccurate or incomplete, encounter data and have been and could be exposed to premium withholding, operating sanctions and financial fines and penalties for noncompliance. We have experienced challenges in obtaining complete and accurate encounter data due to difficulties with providers and third-party vendors submitting claims in a timely fashion in the proper format, and with state agencies in coordinating such submissions. As states increase their reliance on encounter data, these difficulties could affect the Medicaid premium rates we receive and how Medicaid membership is assigned to us, which could have a material adverse effect on our Medicaid operating results and cash flows and/or our ability to successfully bid for, and continue to participate in, certain Medicaid programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Programs funded in whole or in part by the U.S. federal government account for a significant portion of our revenues, and we expect that percentage to increase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Programs funded in whole or in part by the U.S. federal government account for a significant portion of our revenues, and we expect that percentage to increase. As our government funded businesses grow, our exposure to changes in federal and state government policy with respect to and/or regulation of the various government funded programs in which we participate also increases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws and regulations governing participation in Medicare Advantage (including dual eligible special needs plans), Medicare Part D, Medicaid, and managed Medicaid plans are complex, are subject to interpretation and can expose us to penalties for non-compliance. Federal, state and local governments have the right to cancel or not to renew their contracts with </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">us on short notice without cause or if funds are not available. Funding for these programs is dependent on many factors outside our control, including general economic conditions, continuing government efforts to contain health care costs and budgetary constraints at the federal or applicable state or local level and general political issues and priorities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. federal government and our other government customers also may reduce funding for health care or other programs, cancel or decline to renew contracts with us, or make changes that adversely affect the number of persons eligible for certain programs, the services provided to enrollees in such programs, our premiums and our administrative and health care and other benefit costs, any of which could have a material adverse effect on our businesses, operating results and cash flows. When federal funding is delayed, suspended or curtailed, we continue to receive, and we remain liable for and are required to fund, claims from providers for providing services to beneficiaries of federally funded health benefits programs in which we participate. An extended federal government shutdown or a delay by Congress in raising the federal government&#8217;s debt ceiling also could lead to a delay, reduction, suspension or cancellation of federal government spending and a significant increase in interest rates that could, in turn, have a material adverse effect on the value of our investment portfolio, our ability to access the capital markets and our businesses, operating results, cash flows and liquidity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Possible changes in industry pricing benchmarks and drug pricing generally can adversely affect our PBM and Retail/LTC businesses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that the pharmaceutical industry, regulators, or federal policymakers may evaluate and/or develop an alternative pricing reference to replace AWP or WAC, which are the pricing references used for many of our PBM and LTC client contracts, drug purchase agreements, retail network contracts, specialty payor agreements and other contracts with third party payors in connection with the reimbursement of drug payments. In addition, many state Medicaid fee-for-service programs have established pharmacy network payments on the basis of Actual Acquisition Cost (&#8220;AAC&#8221;). The use of an AAC basis in fee for service Medicaid could have an impact on reimbursement practices in Health Care Benefits&#8217; Commercial and other Government products. It is also possible that Congress may enact some limited form of price negotiation for Medicare. In addition, CMS also publishes the National Average Drug Acquisition Cost (&#8220;NADAC&#8221;) for certain drugs; NADAC pricing is being adopted in an increasing number of states.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future changes to the use of AWP, WAC or to other published pricing benchmarks used to establish drug pricing, including changes in the basis for calculating reimbursement by federal and state health care programs and/or other payors, could impact the reimbursement we receive from Medicare and Medicaid programs, the reimbursement we receive from our PBM clients and other payors and/or our ability to negotiate rebates and/or discounts with drug manufacturers, wholesalers, PBMs and retail pharmacies. A failure or inability to fully offset any increased prices or costs or to modify our operations to mitigate the impact of such increases could have a material adverse effect on our operating results. Additionally, any future changes in drug prices could be significantly different than our projections. We cannot predict the effect of these possible changes on our businesses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to obtain adequate premium rate increases in our Insured Health Care Benefits products, which would have an adverse effect on our revenues, MBRs and operating results and could magnify the adverse impact of increases in health care and other benefit costs and of ACA assessments, fees and taxes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium rates for our Insured Health Care Benefits products generally must be filed with state insurance regulators and are subject to their approval, which creates risk for us in the current political and regulatory environment. The ACA generally requires a review by HHS in conjunction with state regulators of premium rate increases that exceed a federally specified threshold (or lower state-specific thresholds set by states determined by HHS to have adequate processes). Rate reviews can magnify the adverse impact on our operating margins, MBRs and operating results of increases in health care and other benefit costs, increased utilization of covered services, and ACA assessments, fees and taxes, by restricting our ability to reflect these increases and/or these assessments, fees and taxes in our pricing. Further, our ability to reflect ACA assessments, fees and taxes in our Medicare, Medicaid and CHIP premium rates is limited.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 2013, HHS has issued determinations to health plans that their premium rate increases were &#8220;unreasonable,&#8221; and we continue to experience challenges to appropriate premium rate increases in certain states. Regulators or legislatures in several states have implemented or are considering limits on premium rate increases, either by enforcing existing legal requirements more stringently or proposing different regulatory standards. Regulators or legislatures in several states also have conducted hearings on proposed premium rate increases, which can result, and in some instances have resulted, in substantial delays in implementing proposed rate increases even if they ultimately are approved. Our plans can be excluded from participating in small group Public Exchanges if they are deemed to have a history of &#8220;unreasonable&#8221; rate increases. Any significant rate increases we may request heighten the risks of adverse publicity, adverse regulatory action and adverse selection and the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">likelihood that our requested premium rate increases will be denied, reduced or delayed, which could adversely affect our MBRs and lead to operating margin compression.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate continued regulatory and legislative action to increase regulation of premium rates in our Insured Health Care Benefits products. We may not be able to obtain rates that are actuarially justified or that are sufficient to make our policies profitable in one or more product lines or geographies. If we are unable to obtain adequate premium rates and/or premium rate increases, it could materially and adversely affect our operating margins and MBRs and our ability to earn adequate returns on Insured Health Care Benefits products in one or more states or cause us to withdraw from certain geographies and/or products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Minimum MLR rebate requirements limit the level of margin we can earn in our Insured Health Care Benefits products while leaving us exposed to higher than expected medical costs. Challenges to our minimum MLR rebate methodology and/or reports could adversely affect our operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA&#8217;s minimum MLR rebate requirements limit the level of margin we can earn in Health Care Benefits&#8217; Commercial Insured and Medicare Insured businesses. CMS minimum MLR rebate regulations limit the level of margin we can earn in our Medicaid Insured business. Certain portions of our Health Care Benefits Medicaid and FEHB program business also are subject to minimum MLR rebate requirements in addition to but separate from those imposed by the ACA. Minimum MLR rebate requirements leave us exposed to medical costs that are higher than those reflected in our pricing. The process supporting the management and determination of the amount of MLR rebates payable is complex and requires judgment, and the minimum MLR reporting requirements are detailed. CMS has also proposed, but not yet finalized, a definition of &#8220;prescription drug price concessions&#8221; for commercial MLR calculation purposes, which would make additional PBM information available to plans and the HHS, potentially further complicating the MLR calculation process. Federal and state auditors are challenging our Commercial Health Care Benefits business&#8217; compliance with the ACA&#8217;s minimum MLR requirements as well as our FEHB plans&#8217; compliance with OPM&#8217;s FEHB program-specific minimum MLR requirements. Our Medicare and Medicaid contracts also are subject to minimum MLR audits. If a Medicare Advantage or Medicare Part D contract pays minimum MLR rebates for three consecutive years, it will become ineligible to enroll new members. If a Medicare Advantage or Medicare Part D contract pays such rebates for five consecutive years, it will be terminated by CMS. Additional challenges to our methodology and/or reports relating to minimum MLR and related rebates by federal and state regulators and private litigants are reasonably possible. The outcome of these audits and additional challenges could adversely affect our operating results. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results may be adversely affected by changes in laws and policies governing employers and by union organizing activity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Congress and certain state legislatures continue to consider and pass legislation that increases our costs of doing business, including increased minimum wages and requiring employers to provide paid sick leave or paid family leave. In addition, our employee-related operating costs may be increased by union organizing activity and it is possible that the National Labor Relations Board may adopt regulatory changes through re-making or case law that could facilitate union organizing. If we are unable to reflect these increased expenses in our pricing or otherwise modify our operations to mitigate the effects of such increases, our operating results will be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face international political, legal and compliance, operational, regulatory, economic and other risks that may be more significant than in our domestic operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international operations present political, legal, compliance, operational, regulatory, economic and other risks that we do not face or that are more significant than in our domestic operations. These risks vary widely by country and include varying regional and geopolitical business conditions and demands, government intervention and censorship, discriminatory regulation, climate change regulation, nationalization or expropriation of assets and pricing constraints. Our international products need to meet country-specific customer and member preferences as well as country-specific legal requirements, including those related to licensing, data privacy, data storage and data protection.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international operations increase our exposure to, and require us to devote significant management resources to implement controls and systems to comply with, the privacy and data protection laws of non-U.S. jurisdictions, such as the EU&#8217;s GDPR, and the anti-bribery, anti-corruption and anti-money laundering laws of the United States (including the FCPA) and the United Kingdom (including the UK Bribery Act) and similar laws in other jurisdictions. Implementing our compliance policies, internal controls and other systems upon our expansion into new countries and geographies may require the investment of considerable management time and financial and other resources over several years before any significant revenues or profits are generated. Violations of these laws and regulations could result in fines, criminal sanctions against us, our officers or employees, restrictions or outright prohibitions on the conduct of our business, and significant brand and reputational harm. We </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">must regularly reassess the size, capability and location of our global infrastructure and make appropriate changes, and must have effective change management processes and internal controls in place to address changes in our businesses and operations. Our success depends, in part, on our ability to anticipate these risks and manage these difficulties, and the failure to do so could have a material adverse effect on our brand, reputation, businesses, operating results and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international operations require us to overcome logistical and other challenges based on differing languages, cultures, legal and regulatory schemes and time zones. Our international operations encounter labor laws, standards and customs that can be difficult and make employee relationships less flexible than in our domestic operations and expensive to modify or terminate. In some countries we are required to, or choose to, operate with local business associates, which requires us to manage our relationships with these third parties and may reduce our operational flexibility and ability to quickly respond to business challenges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some countries we may be exposed to currency exchange controls or other restrictions that prevent us from transferring funds internationally or converting local currencies into U.S. dollars or other currencies. Fluctuations in foreign currency exchange rates may adversely affect our revenues, operating results and cash flows from our international operations. Some of our operations are, and are increasingly likely to be, in emerging markets where these risks are heightened. Any measures we may implement to reduce the effect of volatile currencies and other risks on our international operations may not be effective.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Associated with Mergers, Acquisitions, and Divestitures </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to successfully integrate companies we acquire.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of any acquisition we complete, we will need to successfully integrate the products, services and related assets, as well as internal controls into our business operations. If an acquisition is consummated, the integration of the acquired business, its products, services and related assets into our company also may be complex and time-consuming and, if the integration is not fully successful, we may not achieve the anticipated benefits, operating and cost synergies and/or growth opportunities of an acquisition. Potential difficulties that may be encountered in the integration process include the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Integrating personnel, operations and systems (including internal control environments and compliance policies), while maintaining focus on producing and delivering consistent, high quality products and services;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Coordinating geographically dispersed organizations;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disrupting management&#8217;s attention from our ongoing business operations;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Retaining existing customers and attracting new customers; </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Managing inefficiencies associated with integrating our operations; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reconciling post-acquisition costs and liabilities between buyer and seller.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An inability to realize the full extent of the anticipated benefits, operating and cost synergies, innovations and operations efficiencies or growth opportunities of an acquisition, as well as any delays or additional expenses encountered in the integration process, could have a material adverse effect on our businesses and operating results. Furthermore, acquisitions, even if successfully integrated, may fail to further our business strategy as anticipated, expose us to increased competition or challenges with respect to our products, services or service areas, and expose us to additional liabilities associated with an acquired business including risks and liabilities associated with litigation involving the acquired business. Any one of these challenges or risks could impair our ability to realize any benefit from our acquisitions after we have expended resources on them.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We expect to continue to pursue acquisitions, joint ventures, strategic alliances and other inorganic growth opportunities, which may be unsuccessful, cause us to assume unanticipated liabilities, disrupt our existing businesses, be dilutive or lead us to assume significant debt, among other things.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to pursue acquisitions, joint ventures, strategic alliances and other inorganic growth opportunities as part of our growth strategy. In addition to the integration risks noted above, some other risks we face with respect to acquisitions and other inorganic growth strategies include:</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we frequently compete with other firms, some of which may have greater financial and other resources and a greater tolerance for risk, to acquire attractive companies;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the acquired, alliance and/or joint venture businesses may not perform as projected;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the goodwill or other intangible assets established as a result of our acquisitions may be incorrectly valued or may become impaired;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may assume unanticipated liabilities, including those that were not disclosed to us or which we underestimated;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the acquired businesses, or the pursuit of other inorganic growth strategies, could disrupt or compete with our existing businesses, distract management, result in the loss of key employees, divert resources, result in tax costs or inefficiencies and make it difficult to maintain our current business standards, controls, information technology systems, policies, procedures and performance;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may finance future acquisitions and other inorganic growth strategies by issuing common stock for some or all of the purchase price, which would dilute the ownership interests of our stockholders;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may incur significant debt in connection with acquisitions (whether to finance acquisitions or by assuming debt from the businesses we acquire);</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not have the expertise to manage and profitably grow the businesses we acquire, and we may need to rely on the retention of key personnel and other suppliers of businesses we acquire, which may be difficult or impossible to accomplish;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may enter into merger or purchase agreements but, due to reasons within or outside our control, fail to complete the related transactions, which could result in termination fees or other penalties that could be material, cause material disruptions to our businesses and operations and adversely affect our brand and reputation;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in order to complete a proposed acquisition, we may be required to divest certain portions of our business, for which we may not be able to obtain favorable pricing;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be involved in litigation related to mergers or acquisitions, including for matters that occurred prior to the applicable closing, which may be costly to defend and may result in adverse rulings against us that could be material; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the integration into our businesses of the businesses and entities we acquire may affect the way in which existing laws and regulations apply to us, including subjecting us to laws and regulations that did not previously apply to us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, joint ventures present risks that are different from acquisitions, including selection of appropriate joint venture parties, initial and ongoing governance of the joint venture, joint venture compliance activities (including compliance with applicable CMS requirements), growing the joint venture&#8217;s business in a manner acceptable to all the parties, including other providers in the networks that include joint ventures, maintaining positive relationships among the joint venture parties and the joint venture&#8217;s customers, and member and business disruption that may occur upon joint venture termination.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to meet customer expectations may harm our brand and reputation, our ability to retain and grow our customer base and membership and our operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to attract and retain customers and members is dependent upon providing cost effective, quality customer service operations (such as call center operations, PBM functions, retail pharmacy and LTC services, retail, mail order and specialty pharmacy prescription delivery, claims processing, customer case installation and online access and tools) that meet or exceed our customers&#8217; and members&#8217; expectations, either directly or through vendors. As we seek to reduce general and administrative expenses, we must balance the potential impact of cost-saving measures on our customers and other services and performances. If we misjudge the effects of such measures, customers and other services may be adversely affected. We depend on third parties for certain of our customer service, PBM and prescription delivery operations. If we or our vendors fail to provide service that meets our customers&#8217; and members&#8217; expectations, we may have difficulty retaining or profitably growing our customer base and/or membership, which could adversely affect our operating results. For example, noncompliance with any privacy or security laws or regulations or any security breach involving us or one of our third-party vendors could have a material adverse effect on our businesses, operating results, brand and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We and our vendors have experienced and continue to experience cyber attacks. We can provide no assurance that we or our vendors will be able to detect, prevent or contain the effects of such attacks or other information security (including cybersecurity) risks or threats in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our vendors have experienced diverse cyber attacks and expect to continue to experience cyber attacks going forward. As examples, the Company and its vendors have experienced attempts to gain access to systems, denial of service attacks, attempted malware infections, account takeovers, scanning activity, and phishing emails. Attacks can originate from external criminals, terrorists, nation states, or internal actors. The Company is dedicating and will continue to dedicate significant resources and incur significant expenses to maintain and update on an ongoing basis the systems and processes that are </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">designed to mitigate the information security risks it faces and protect the security of its computer systems, software, networks and other technology assets against attempts by unauthorized parties to obtain access to confidential information, disrupt or degrade service, or cause other damage. The impact of cyber attacks has not been material to the Company&#8217;s operations or operating results through December 31, 2021. The Board and its Audit Committee and Nominating and Corporate Governance Committee are regularly informed regarding the Company&#8217;s information security policies, practices and status. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A compromise of our information security controls or of those businesses with whom we interact, which results in confidential information being accessed, obtained, damaged, or used by unauthorized or improper persons, could harm our reputation and expose us to regulatory actions and claims from customers and clients, financial institutions, payment card associations and other persons, any of which could adversely affect our businesses, operating results and financial condition. Because the techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently and may not immediately produce signs of intrusion, we may be unable to anticipate these techniques or to implement adequate preventative measures. Moreover, a data security breach could require that we expend significant resources related to our information systems and infrastructure, and could distract management and other key personnel from performing their primary operational duties. We also could be adversely affected by any significant disruption in the systems of third parties we interact with, including key payors and vendors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs of attempting to protect against the foregoing risks and the costs of responding to an information security incident are significant. Large scale data breaches at other entities increase the challenge we and our vendors face in maintaining the security of our information technology systems and proprietary information and of our customers&#8217;, members&#8217; and other constituents&#8217; sensitive information. Following an information security incident, our and/or our vendors&#8217; remediation efforts may not be successful, and could result in interruptions, delays or cessation of service, and loss of existing or potential customers and members. In addition, breaches of our and/or our vendors&#8217; security measures and the unauthorized access to or dissemination of sensitive personal information or proprietary information or confidential information about us, our customers, our members or other third-parties, could expose our customers&#8217;, members&#8217; and other constituents&#8217; private information and our customers, members and other constituents to the risk of financial or medical identity theft, or expose us or other third parties to a risk of loss or misuse of this information, and result in investigations, regulatory enforcement actions, material fines and penalties, loss of customers, litigation or other actions which could have a material adverse effect on our brand, reputation, businesses, operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data governance failures can adversely affect our reputation, businesses and prospects. Our use and disclosure of members&#8217;, customers&#8217; and other constituents&#8217; sensitive information is subject to complex regulations at multiple levels. We would be adversely affected if we or our business associates or other vendors fail to adequately protect members&#8217;, customers&#8217; or other constituents&#8217; sensitive information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our information systems are critical to the operation of our businesses. We collect, process, maintain, retain, evaluate, utilize and distribute large amounts of personal health and financial information and other confidential and sensitive data about our customers, members and other constituents in the ordinary course of our businesses. Some of our information systems rely upon third party systems, including cloud service providers, to accomplish these tasks. The use and disclosure of such information is regulated at the federal, state and international levels, and these laws, rules and regulations are subject to change and increased enforcement activity, such as the California Consumer Privacy Act which went into effect January 1, 2020, the EU&#8217;s GDPR which began to apply across the EU during 2018 and the audit program implemented by HHS under HIPAA. In some cases, such laws, rules and regulations also apply to our vendors and/or may hold us liable for any violations by our vendors. International laws, rules and regulations governing the use and disclosure of such information are generally more stringent than U.S. laws and regulations, and they vary from jurisdiction to jurisdiction. Noncompliance with any privacy or security laws or regulations, or any security breach, information security incident, and any other incident involving the theft, misappropriation, loss or other unauthorized disclosure of, or access to, sensitive or confidential customer, member or other constituent information, whether by us, by one of our business associates or vendors or by another third party, could require us to expend significant resources to remediate any damage, could interrupt our operations and could adversely affect our brand and reputation, membership and operating results and also could expose and/or has exposed us to mandatory disclosure to the media, litigation (including class action litigation), governmental investigations and enforcement proceedings, material fines, penalties and/or remediation costs, and compensatory, special, punitive and statutory damages, consent orders, adverse actions against our licenses to do business and/or injunctive relief, any of which could adversely affect our businesses, operating results, cash flows or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses depend on our customers&#8217;, members&#8217; and other constituents&#8217; willingness to entrust us with their health related and other sensitive personal information. Events that adversely affect that trust, including inadequate disclosure to our members or customers of our uses of their information, failing to keep our information technology systems and our customers&#8217;, members&#8217; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and other constituents&#8217; sensitive information secure from significant attack, theft, damage, loss or unauthorized disclosure or access, whether as a result of our action or inaction (including human error) or that of our business associates, vendors or other third parties, could adversely affect our brand and reputation, membership and operating results and also could expose and/or has exposed us to mandatory disclosure to the media, litigation (including class action litigation), governmental investigations and enforcement proceedings, material fines, penalties and/or remediation costs, and compensatory, special, punitive and statutory damages, consent orders, adverse actions against our licenses to do business and/or injunctive relief, any of which could adversely affect our businesses, operating results, cash flows or financial condition. Large scale data breaches at other entities increase the challenge we and our vendors face in maintaining the security of our information technology systems and proprietary information and of our customers&#8217;, members&#8217; and other constituents&#8217; sensitive information. There can be no assurance that additional such failures will not occur, or if any do occur, that we will detect them or that they can be sufficiently remediated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product liability, product recall or personal injury issues could damage our reputation and have a significant adverse effect on our businesses, operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The products that we sell could become subject to contamination, product tampering, mislabeling, recall or other damage. In addition, errors in the dispensing, packaging or administration of drugs or other products and consuming drugs in a manner that is not prescribed could lead to serious injury or death. Product liability or personal injury claims may be asserted against us with respect to any of the drugs or other products we sell or services we provide. For example, we are a defendant in hundreds of litigation proceedings relating to opioids and the sale of products containing talc. Our businesses involve the provision of professional services, including by pharmacists, physician assistants, nurses and nurse practitioners, which exposes us to professional liability claims. Should a product or other liability issue arise, the coverage available under our insurance programs and the indemnification amounts available to us from third parties may not be adequate to protect us against the financial impact of the related claims. We also may not be able to maintain our existing levels of insurance on acceptable terms in the future. A product liability or personal injury issue or judgment against us or a product recall, tampering, or mislabeling could damage our reputation and have a significant adverse effect on our businesses, operating results and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face significant competition in attracting and retaining talented employees. Further, managing succession for, and retention of, key executives is critical to our success, and our failure to do so could adversely affect our businesses, operating results and/or future performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to attract and retain qualified and experienced employees is essential to meet our current and future goals and objectives. There is no guarantee we will be able to attract and retain such employees or that competition among potential employers will not result in increased compensation and/or benefits costs. If we are unable to retain existing employees or attract additional employees, or we experience an unexpected loss of leadership, we could experience a material adverse effect on our businesses, operating results and/or future performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our failure to adequately plan for succession of senior management and other key management roles or the failure of key employees to successfully transition into new roles could have a material adverse effect on our businesses, operating results and/or future performance. The succession plans we have in place and our employment arrangements with certain key executives do not guarantee the services of these executives will continue to be available to us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales of our products and services are dependent on our ability to attract and motivate internal sales personnel and independent third-party brokers, consultants and agents. New distribution channels create new disintermediation risk. We may be subject to penalties or other regulatory actions as a result of the marketing practices of brokers and agents selling our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are sold primarily through our sales personnel, who frequently work with independent brokers, consultants and agents who assist in the production and servicing of business. The independent brokers, consultants and agents generally are not dedicated to us exclusively and may frequently recommend and/or market health care benefits products of our competitors. Accordingly, we must compete intensely for their services and allegiance. Our sales could be adversely affected if we are unable to attract, retain or motivate sales personnel and third-party brokers, consultants and agents, or if we do not adequately provide support, training and education to this sales network regarding our complex product portfolio, or if our sales strategy is not appropriately aligned across distribution channels. This risk is heightened as we develop, operate and expand our consumer-oriented products and services and we expand in the health care space and our business model evolves to include a greater focus on consumers and direct-to-consumer sales, such as competing for sales on Insurance Exchanges.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New distribution channels for our products and services continue to emerge, including Private Exchanges operated by health care consultants and technology companies. These channels may make it more difficult for us to directly engage consumers and other customers in the selection and management of their health care benefits, in health care utilization and in the effective navigation of the health care system. We also may be challenged by new technologies and marketplace entrants that could interfere with our existing relationships with customers and health plan members in these areas.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there have been several investigations regarding the marketing practices of brokers and agents selling health care and other insurance products and the payments they receive. These investigations have resulted in enforcement actions against companies in our industry and brokers and agents marketing and selling those companies&#8217; products. For example, CMS and state departments of insurance have increased their scrutiny of the marketing practices of brokers and agents who market Medicare products. These investigations and enforcement actions could result in penalties and the imposition of corrective action plans and/or changes to industry practices, which could adversely affect our ability to market our products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure of our businesses to effectively collaborate could prevent us from maximizing our operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To maximize our overall enterprise value, our various businesses need to collaborate effectively. Our businesses need to be aligned in order to prioritize goals and coordinate the design of new products intended to utilize the offerings of multiple businesses, including our transformation and enterprise modernization programs. In addition, misaligned incentives, information siloes, ineffective product development and failure of our corporate governance policies or procedures, for example significant financial decisions being made at an inappropriate level in our organization, also could prevent us from maximizing our operating results and/or achieving our financial and other projections. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The failure or disruption of our information technology systems or the failure of our information technology infrastructure to support our businesses could adversely affect our reputation, businesses, operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our information systems are subject to damage or interruption from power outages, facility damage, computer and telecommunications failures, computer viruses, security breaches (including credit card or personally identifiable information breaches), cyber attacks, vandalism, catastrophic events and human error. If our information systems are damaged, fail to work properly or otherwise become unavailable, we may incur substantial costs to repair or replace them, and may experience reputational damage, loss of critical information, customer disruption and interruptions or delays in our ability to perform essential functions and implement new and innovative services. In addition, compliance with changes in U.S. and foreign laws and regulations, including privacy and information security laws and standards, may cause us to incur significant expense due to increased investment in technology and the development of new operational processes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business success and operating results depend in part on effective information technology systems and on continuing to develop and implement improvements in technology. Pursuing multiple initiatives simultaneously could make this continued development and implementation significantly more challenging.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many aspects of our operations are dependent on our information systems and the information collected, processed, stored, and handled by these systems. We rely heavily on our computer systems to manage our ordering, pricing, point-of-sale, pharmacy fulfillment, inventory replenishment, claims processing, customer loyalty and subscription programs, finance and other processes. Throughout our operations, we collect, process, maintain, retain, evaluate, utilize and distribute large amounts of confidential and sensitive data and information, including personally identifiable information and protected health information, that our customers, members and other constituents provide to purchase products or services, enroll in programs or services, register on our websites, interact with our personnel, or otherwise communicate with us. In addition, for these operations, we depend in part on the secure transmission of confidential information over public networks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have many different information and other technology systems supporting our businesses (including as a result of our acquisitions). Our businesses depend in large part on these systems to adequately price our products and services; accurately establish reserves, process claims and report operating results; and interact with providers, employer plan sponsors, customers, members, consumers and vendors in an efficient and uninterrupted fashion. In addition, recent trends toward greater consumer engagement in health care require new and enhanced technologies, including more sophisticated applications for mobile devices. Certain of our technology systems (including software) are older, legacy systems that are less flexible, less efficient and require a significant ongoing commitment of capital and human resources to maintain, protect and enhance them and to integrate them with our other systems. We must re-engineer and reduce the number of these systems to meet changing consumer and vendor preferences and needs, improve our productivity and reduce our operating expenses. We also need to develop or acquire new technology systems, contract with new vendors or modify certain of our existing systems to support the consumer-oriented and transformation products and services we are developing, operating and expanding and/or to meet current </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and developing industry and regulatory standards, including to keep pace with continuing changes in information processing technology and emerging cybersecurity risks and threats. If we fail to achieve these objectives, our ability to profitably grow our business and/or our operating results may be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, information technology and other technology and process improvement projects, including our transformation and enterprise modernization programs, frequently are long-term in nature and may take longer to complete and cost more than we expect and may not deliver the benefits we project once they are complete. If we do not effectively and efficiently secure, manage, integrate and enhance our technology portfolio (including vendor sourced systems), we could, among other things, have problems determining health care and other benefit cost estimates and/or establishing appropriate pricing, meeting the needs of customers, consumers, providers, members and vendors, developing and expanding our consumer-oriented products and services or keeping pace with industry and regulatory standards, and our operating results may be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to payment-related risks that could increase our operating costs, expose us to fraud or theft, subject us to potential liability and disrupt our business operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accept payments using a variety of methods, including cash, checks, credit cards, debit cards, gift cards, mobile payments and potentially other technologies in the future. Acceptance of these payment methods subjects us to rules, regulations, contractual obligations and compliance requirements, including payment network rules and operating guidelines, data security standards and certification requirements, and rules governing electronic funds transfers. These requirements may change in the future, which could make compliance more difficult or costly. For certain payment options, including credit and debit cards, we pay interchange and other fees, which could increase periodically thereby raising our operating costs. We rely on third parties to provide payment processing services, including the processing of credit cards, debit cards, and various other forms of electronic payment. If these vendors are unable to provide these services to us, or if their systems are compromised, our operations could be disrupted. The payment methods that we offer also expose us to potential fraud and theft by persons seeking to obtain unauthorized access to, or exploit any weaknesses in, the payment systems we use. If we fail to abide by applicable rules or requirements, or if data relating to our payment systems is compromised due to a breach or misuse, we may be responsible for any costs incurred by payment card issuing banks and other third parties or subject to fines and higher transaction fees. In addition, our reputation and ability to accept certain types of payments could each be harmed resulting in reduced sales and adverse effects on our operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Both our and our vendors&#8217; operations are subject to a variety of business continuity hazards and risks, any of which could interrupt our operations or otherwise adversely affect our performance and operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our vendors are subject to business continuity hazards and other risks, including natural disasters, utility and other mechanical failures, acts of war or terrorism, acts of civil unrest, disruption of communications, data security and preservation, disruption of supply or distribution, safety regulation and labor difficulties. The occurrence of any of these or other events to us or our vendors might disrupt or shut down our operations or otherwise adversely affect our operations. We also may be subject to certain liability claims in the event of an injury or loss of life, or damage to property, resulting from such events. Although we have developed procedures for crisis management and disaster recovery and business continuity plans and maintain insurance policies that we believe are customary and adequate for our size and industry, our insurance policies include limits and exclusions and, as a result, our coverage may be insufficient to protect against all potential hazards and risks incident to our businesses. In addition, our crisis management and disaster recovery procedures and business continuity plans may not be effective. Should any such hazards or risks occur, or should our insurance coverage be inadequate or unavailable, our businesses, operating results, cash flows and financial condition could be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We would be adversely affected if we do not effectively deploy our capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Downgrades or potential downgrades in our credit ratings, should they occur, could adversely affect our brand and reputation, businesses, operating results, cash flows and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations generate significant capital, and we have the ability to raise additional capital. The manner in which we deploy our capital, including investments in our businesses, our operations (such as information technology and other strategic and capital projects), dividends, acquisitions, share and/or debt repurchases, repayment of debt, reinsurance or other capital uses, impacts our financial strength, claims paying ability and credit ratings issued by nationally-recognized statistical rating organizations. Credit ratings issued by nationally-recognized statistical rating organizations are broadly distributed and generally used throughout our industries. Our ratings reflect each rating organization&#8217;s opinion of our financial strength, operating performance and ability to meet our debt obligations or obligations to our insureds. We believe our credit ratings and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the financial strength and claims paying ability of our principal insurance and HMO subsidiaries are important factors in marketing our Health Care Benefits products to certain of our customers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the ratings organizations reviews our ratings periodically, and there can be no assurance that our current ratings will be maintained in the future. Downgrades in our ratings could adversely affect our businesses, operating results, cash flows and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and other intangible assets could, in the future, become impaired.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021 and December 31, 2020, we had $108.1 billion and $110.7 billion, respectively, of goodwill and other intangible assets. Goodwill and indefinite-lived intangible assets are subject to annual impairment reviews, or more frequent reviews if events or circumstances indicate that the carrying value may not be recoverable. When evaluating goodwill for potential impairment, we compare the fair value of our reporting units to their respective carrying amounts. We estimate the fair value of our reporting units using a combination of a discounted cash flow method and a market multiple method. If the carrying amount of a reporting unit exceeds its estimated fair value, a goodwill impairment loss is recognized in an amount equal to the excess to the extent of the goodwill balance. Indefinite-lived intangible assets are tested for impairment by comparing the estimated fair value of the asset to its carrying value. The Company estimates the fair value of its indefinite-lived trademarks using the relief from royalty method under the income approach. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value. Definite-lived intangible assets are tested for impairment whenever events or changes in circumstances indicate that the carrying value of such an asset may not be recoverable. If indicators of impairment are present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#8217;s estimated future cash flows (discounted). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated fair values could change if, for example, there are changes in the business climate, industry-wide changes, changes in the competitive environment, adverse legal or regulatory actions or developments, changes in capital structure, cost of debt, interest rates, capital expenditure levels, operating cash flows or market capitalization. Because of the significance of our goodwill and intangible assets, any future impairment of these assets could require material noncash charges to our operating results, which also could have a material adverse effect on our financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse conditions in the U.S. and global capital markets can significantly and adversely affect the value of our investments in debt and equity securities, mortgage loans, alternative investments and other investments, and our operating results and/or our financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global capital markets, including credit markets, continue to experience volatility and uncertainty. As an insurer, we have a substantial investment portfolio that supports our policy liabilities and surplus and is comprised largely of debt securities of issuers located in the U.S. As a result, the income we earn from our investment portfolio is largely driven by the level of interest rates in the U.S., and to a lesser extent the international financial markets; and volatility, uncertainty and/or disruptions in the global capital markets, particularly the U.S. credit markets, and governments&#8217; monetary policy, particularly U.S. monetary policy, can significantly and adversely affect the value of our investment portfolio, our operating results and/or our financial condition by:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significantly reducing the value and/or liquidity of the debt securities we hold in our investment portfolio and creating realized capital losses that reduce our operating results and/or unrealized capital losses that reduce our shareholders&#8217; equity;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">keeping interest rates low on high-quality short-term or medium-term debt securities (such as we have experienced during recent years) and thereby materially reducing our net investment income and operating results as the proceeds from securities in our investment portfolio that mature or are otherwise disposed of continue to be reinvested in lower yielding securities;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reducing the fair values of our investments if interest rates rise;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">causing non-performance of or defaults on their obligations to us by third parties, including customers, issuers of securities in our investment portfolio, mortgage borrowers and/or reinsurance and/or derivatives counterparties;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">making it more difficult to value certain of our investment securities, for example if trading becomes less frequent, which could lead to significant period-to-period changes in our estimates of the fair values of those securities and cause period-to-period volatility in our net income and shareholders&#8217; equity;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reducing our ability to issue short-term debt securities at attractive interest rates, thereby increasing our interest expense and decreasing our operating results; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reducing our ability to issue other securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we seek, within guidelines we deem appropriate, to match the duration of our assets and liabilities and to manage our credit and counterparty exposures, a failure adequately to do so could adversely affect our net income and our financial condition and, in extreme circumstances, our cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Relationships with Manufacturers, Providers, Suppliers and Vendors</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face risks relating to the market availability, pricing, suppliers and safety profiles of prescription drugs and other products that we purchase and sell.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Retail/LTC segment and our mail order and specialty pharmacy operations generate revenues in significant part by dispensing prescription drugs. Our PBM business generates revenues primarily by contracting with clients to provide prescription drugs and related health care services to plan members. As a result, we are dependent on our relationships with prescription drug manufacturers and suppliers. We acquire a substantial amount of our mail order and specialty pharmacies&#8217; prescription drug supply from a limited number of suppliers. Certain of our agreements with such suppliers are short-term and cancelable by either party without cause. In addition, these agreements may allow the supplier to distribute through channels other than us. Certain of these agreements also allow pricing and other terms to be adjusted periodically for changing market conditions or required service levels. A termination or modification to any of these relationships could adversely affect our prescription drug supply and have a material adverse effect on our businesses, operating results and financial condition. Moreover, many products distributed by our pharmacies are manufactured with ingredients that are susceptible to supply shortages. In some cases, we depend upon a single source of supply. Any such supply shortages or loss of any such single source of supply could adversely affect our operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Much of the branded and generic drug product that we sell in our pharmacies, and much of the other merchandise we sell, is manufactured in whole or in substantial part outside of the United States. In most cases, the products or merchandise are imported by others and sold to us. As a result, significant changes in tax or trade policies, tariffs or trade relations between the United States and other countries, such as the imposition of unilateral tariffs on imported products, could result in significant increases in our costs, restrict our access to suppliers, depress economic activity, and have a material adverse effect on our businesses, operating results and cash flows. In addition, other countries may change their business and trade policies and such changes, as well as any negative sentiments towards the United States in response to increased import tariffs and other changes in U.S. trade regulations, could adversely affect our businesses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our suppliers are independent entities subject to their own operational and financial risks that are outside our control. If our current suppliers were to stop selling prescription drugs to us or delay delivery, including as a result of supply shortages, supplier production disruptions, supplier quality issues, closing or bankruptcies of our suppliers, or for other reasons, we may be unable to procure alternatives from other suppliers in a timely and efficient manner and on acceptable terms, or at all. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results may be adversely affected if we are unable to contract with providers on competitive terms and develop and maintain attractive networks with high quality providers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are seeking to enhance our health care provider networks by entering into joint ventures and other collaborative risk-sharing arrangements with providers. Providers&#8217; willingness to enter these arrangements with us depends upon, among other things, our ability to provide them with up to date quality of care data to support these value-based contracts. These arrangements are designed to give providers incentives to engage in population health management and optimize delivery of health care to our members. These arrangements also may allow us to expand into new geographies, target new customer groups, increase membership and reduce medical costs and, if we provide technology or other services to the relevant health system or provider organization, may contribute to our revenue and earnings from alternative sources. If such arrangements do not result in the lower medical costs that we project or if we fail to attract providers to such arrangements, or are less successful at implementing such arrangements than our competitors, our medical costs may not be competitive and may be higher than we project, our attractiveness to customers may be reduced, we may lose or be unable to grow medical membership, and our ability to profitably grow our business and/or our operating results may be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe joint ventures, accountable care organizations (&#8220;ACOs&#8221;) and other non-traditional health care provider organizational structures present opportunities for us, the implementation of our joint ventures and other non-traditional structure strategies may not achieve the intended results, which could adversely affect our operating results and cash flows. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, joint ventures require us to maintain collaborative relationships with our counterparties, continue to gain access to provider rates that make the joint ventures economically sustainable and devote significant management time to the operation and management of the joint ventures. We may not be able to achieve these objectives in one or more of our joint ventures, which could adversely affect our operating results and cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our suppliers or service providers fail to meet their contractual obligations to us or to comply with applicable laws or regulations, we may be exposed to brand and reputational harm, litigation and/or regulatory action. This risk is particularly high in our Medicare, Medicaid, dual eligible and dual eligible special needs plan programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our suppliers, we contract with various third parties to perform certain functions and services and provide us with certain information technology systems. Our arrangements with suppliers and these third parties may expose us to public scrutiny, adversely affect our brand and reputation, expose us to litigation or regulatory action, and otherwise make our operations vulnerable if we fail to adequately oversee, monitor and regulate their performance or if they fail to meet their contractual obligations to us or to comply with applicable laws or regulations, including those related to human capital and climate change. For example, certain of our vendors have been responsible for releases of sensitive information of our members and employees, which has caused us to incur additional expenses and given rise to regulatory actions and litigation against us.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks are particularly high in our in Medicare Advantage (including dual eligible special needs plans), Medicare Part D, Medicaid, and managed Medicaid plans, where third parties may perform medical management and other member related services for us. Any failure of our or these third parties&#8217; prevention, detection or control systems related to regulatory compliance, compliance with our internal policies, data security and/or cybersecurity or any incident involving the theft, misappropriation, loss or other unauthorized disclosure of, or access to, members&#8217;, customers&#8217; or other constituents&#8217; sensitive information could require us to expend significant resources to remediate any damage, interrupt our operations and adversely affect our brand and reputation and also expose us to whistleblower, class action and other litigation, other proceedings, prohibitions on marketing or active or passive enrollment of members, corrective actions, fines, sanctions and/or penalties, any of which could adversely affect our businesses, operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may experience increased medical and other benefit costs, litigation risk and customer and member dissatisfaction when providers that do not have contracts with us render services to our Health Care Benefits members.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some providers that render services to our Health Care Benefits members do not have contracts with us. In those cases, we do not have a pre-established understanding with these providers as to the amount of compensation that is due to them for services rendered to our members. In some states, the amount of compensation due to these nonparticipating providers is defined by law or regulation, but in most instances it is either not defined or it is established by a standard that is not clearly translatable into dollar terms. In such instances providers may believe that they are underpaid for their services and may either litigate or arbitrate their dispute with us or try to recover the difference between what we have paid them and the amount they charged us from our members, which may result in customer and member dissatisfaction. For example, in October 2018, an arbitrator awarded certain claimant hospitals approximately $150 million in a proceeding relating to Aetna&#8217;s out-of-network benefit payment and administration practices, and in March 2019 that award was reduced to approximately $86 million. Such disputes may cause us to pay higher medical or other benefit costs than we projected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Continuing consolidation and integration among providers and other suppliers may increase our medical and other covered benefits costs, make it difficult for us to compete in certain geographies and create new competitors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hospitals and other providers and health systems continue to consolidate across the health care industry. While this consolidation could increase efficiency and has the potential to improve the delivery of health care services, it also reduces competition and the number of potential contracting parties in certain geographies. These health systems also are increasingly forming and considering forming health plans to directly offer health insurance in competition with us, a process that has been accelerated by the ACA. In addition, ACOs (including Commercial and Medicaid-only ACOs developed as a result of state Medicaid laws), practice management companies, consolidation among and by integrated health systems and other changes in the organizational structures that physicians, hospitals and other providers adopt continues to change the way these providers interact with us and the competitive landscape in which we operate. These changes may increase our medical and other covered benefits costs, may affect the way we price our products and services and estimate our medical and other covered benefits costs and may require us to change our operations, including by withdrawing from certain geographies where we do not have a significant presence across our businesses or are unable to collaborate or contract with providers on acceptable terms. Each of these changes may adversely affect our businesses and operating results.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_37"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B.  Unresolved Staff Comments.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no unresolved SEC Staff Comments.</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_40"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.  Properties.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s principal office is an owned building complex located in Woonsocket, Rhode Island, which totals approximately one million square feet. The Company also leases office space in other locations in the United States. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment&#8217;s principal office is an owned building complex located in Hartford, Connecticut, which totals approximately 1.7 million square feet. The Health Care Benefits segment also owns or leases office space in other locations in the United States and several other countries. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment includes owned or leased mail service dispensing pharmacies, call centers, on-site pharmacy stores, retail specialty pharmacy stores, specialty mail service pharmacies and branches for infusion and enteral services throughout the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Retail/LTC segment operated the following properties:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Approximately 8,075 retail stores, of which approximately 5% were owned. Net selling space for retail stores was approximately 79.8 million square feet as of December&#160;31, 2021. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Approximately 1,865 retail pharmacies within retail chains, as well as approximately 80 clinics in Target Corporation (&#8220;Target&#8221;) stores;</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Owned distribution centers and leased distribution facilities throughout the United States totaling approximately 10.7 million square feet; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Owned and leased LTC pharmacies throughout the United States and an owned LTC repackaging facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with certain business dispositions completed between 1995 and 1997, the Company continues to guarantee lease obligations for 72 former stores. The Company is indemnified for these guarantee obligations by the respective initial purchasers. These guarantees generally remain in effect for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. For additional information on these guarantees, see &#8220;Lease Guarantees&#8221; in Note 16 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; included in Item 8 of this 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that the Company&#8217;s owned and leased facilities are suitable and adequate to meet the Company&#8217;s anticipated needs. At the end of the existing lease terms, management believes the leases can be renewed or replaced by alternative space. For additional information on the right-of-use assets and lease liabilities associated with the Company&#8217;s leases, see Note 6 &#8216;&#8216;Leases&#8217;&#8217; included in Item 8 of this 10-K.</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_43"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.  Legal Proceedings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in Note 16 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; included in Item 8 of this 10-K is incorporated herein by reference.</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_46"></div><div style="padding-right:72pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.  Mine Safety Disclosures.</span></div><div style="padding-right:72pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_49"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information about our Executive Officers </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the name, age and biographical information for each of the Registrant&#8217;s executive officers as of February&#160;9, 2022. In each case the officer&#8217;s term of office extends to the date of the meeting of the Board following the next annual meeting of stockholders of CVS Health Corporation. Previous positions and responsibilities held by each of the executive officers over the past five years or more are indicated below:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Troyen A. Brennan, M.D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., age 67, Executive Vice President and Chief Medical Officer of CVS Health Corporation since November&#160;2008; Executive Vice President and Chief Medical Officer of Aetna Inc. from February&#160;2006 through November&#160;2008.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;James D. Clark</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 57, Senior Vice President - Controller and Chief Accounting Officer of CVS Health Corporation since November 2018; Vice President - Finance and Accounting of CVS Pharmacy, Inc. from September 2009 through October 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Daniel P. Finke</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 51, Executive Vice President of CVS Health Corporation and President of Health Care Benefits since February 2021; Executive Vice President, Commercial Business and Markets of Aetna Inc. from February 2020 through January 2021; Executive Vice President, Consumer Health and Service of Aetna Inc. from June 2018 through January 2020; Senior Vice President, Network and Clinical Services of Aetna Inc. from January 2016 through May 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Shawn M. Guertin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 58, Executive Vice President and Chief Financial Officer of CVS Health Corporation since May 2021; Executive Vice President, Chief Financial Officer and Chief Enterprise Risk Officer of Aetna Inc. from February 2013 through May 2019; Senior Vice President, Finance of Aetna Inc. from April 2011 through January 2013.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Laurie P. Havanec</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 61, Executive Vice President and Chief People Officer of CVS Health Corporation since February 2021; Executive Vice President and Chief People Officer, Otis Worldwide Corporation, an elevator, escalator and moving walkway manufacturer, from October 2019 through January 2021; Corporate Vice President, Talent of United Technologies Corporation, a multinational manufacturing conglomerate, from April 2017 through October 2019; Vice President - Human Resources, Institution Businesses of Aetna Inc. from 2013 through March 2017.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Alan M. Lotvin, M.D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., age 60, Executive Vice President of CVS Health Corporation and President of CVS Caremark since March 2020; Executive Vice President - Transformation of CVS Health Corporation from June 2018 through February 2020; Executive Vice President - Specialty Pharmacy, CVS Caremark from November 2012 through May 2018.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Karen S. Lynch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 59, President and Chief Executive Officer of CVS Health Corporation since February 2021; Executive Vice President of CVS Health Corporation from November 2018 through January 2021; President of Aetna Inc. from January 2015 through January 2021; and a director of CVS Health Corporation since February 2021. Ms. Lynch is also a member of the board of directors of U.S. Bancorp, a banking and financial services company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Thomas M. Moriarty</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 58, Executive Vice President and General Counsel of CVS Health Corporation since October&#160;2012; Chief Policy and External Affairs Officer since March 2017; Chief Strategy Officer from March 2014 through February 2017.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Michelle A. Peluso</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 49, Executive Vice President and Chief Customer Officer of CVS Health Corporation since January 2021 and Co-President of  Retail since January 2022; Senior Vice President, Digital Sales and Chief Marketing Officer, IBM, a multinational technology corporation, from February 2016 through January 2021; Chief Executive Officer, Gilt Groupe, Inc., an online shopping destination, from 2013 through February 2016. Ms. Peluso is also a member of the board of directors of Nike, Inc., an athletic footwear and clothing manufacturer.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Jonathan C. Roberts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 66, Executive Vice President and Chief Operating Officer of CVS Health Corporation since March 2017; Executive Vice President of CVS Health Corporation and President of CVS Caremark from September&#160;2012 through February 2017.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Prem Shah</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, age 42, Executive Vice President and Chief Pharmacy Officer of CVS Health Corporation since November&#160;2021 and Co-President of Retail since January 2022; Executive Vice President, Specialty and Product Innovation , CVS Caremark from August 2018 through November 2021; Vice President - Specialty Pharmacy, CVS Caremark from February 2013 through July 2018.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_52"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_55"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.  Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation&#8217;s common stock is listed on the New York Stock Exchange under the symbol &#8220;CVS.&#8221; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, 2020 and 2019, the quarterly cash dividend was $0.50 per share. In December 2021, the Board authorized a 10% increase in the quarterly cash dividend to $0.55 per share effective in 2022. CVS Health Corporation has paid cash dividends every quarter since becoming a public company. Future dividends will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; included in Item 8 of this 10-K for information regarding CVS Health Corporation&#8217;s dividends.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders of Common Stock</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;2, 2022, there were 24,946 registered holders of the registrant&#8217;s common stock according to the records maintained by the registrant&#8217;s transfer agent.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase programs have been authorized by the Board:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.588%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2021 (&#8220;2021 Repurchase Program&#8221;)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2016 (&#8220;2016 Repurchase Program&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the share Repurchase Programs was effective immediately. The 2016 Repurchase program was terminated effective December 9, 2021. The 2021 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) transactions, and/or other derivative transactions. The 2021 Repurchase Program can be modified or terminated by the Board at any time. During the three months ended December&#160;31, 2021, the Company did not repurchase any shares of common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $1.5&#160;billion fixed dollar ASR with Barclays Bank PLC (&#8220;Barclays&#8221;). Upon payment of the $1.5&#160;billion purchase price on January 4, 2022, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to 80% of the $1.5&#160;billion notional amount of the ASR or approximately 11.6&#160;million shares at a price of $103.34 per share, which were placed into treasury stock in January 2022. At the conclusion of the ASR, the Company may receive additional shares equal to the remaining 20% of the $1.5&#160;billion notional amount. The ultimate number of shares the Company may receive will depend on the daily volume-weighted average price of the Company&#8217;s stock over an averaging period, less a discount. It is also possible, depending on such weighted average price, that the Company will have an obligation to Barclays which, at the Company&#8217;s option, could be settled in additional cash or by issuing shares. Under the terms of the ASR, the maximum number of shares that could be delivered to the Company is 29.0&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; included in Item 8 of this 10-K for additional information regarding the Company&#8217;s share repurchases.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph compares the cumulative total shareholder return on CVS Health Corporation&#8217;s common stock (assuming reinvestment of dividends) with the cumulative total return on the S&amp;P 500 Index, the S&amp;P 500 Food and Staples Retailing Industry Group Index and the S&amp;P 500 Healthcare Sector Group Index from December 31, 2016 through December 31, 2021. The graph assumes a $100 investment in shares of CVS Health Corporation&#8217;s common stock on December 31, 2016.</span></div><div style="text-align:center"><img src="cvs-20211231_g2.jpg" alt="cvs-20211231_g2.jpg" style="height:333px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.265%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CVS Health Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500 Food &amp; Staples Retailing Group Index </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500 Health Care Group Index </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes CVS Health Corporation.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes five companies (COST, KR, SYY, WBA, WMT).</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes 64 companies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The year-ended values of each investment shown in the preceding graph are based on share price appreciation plus dividends, with the dividends reinvested as of the last business day of the month during which such dividends were ex-dividend. The calculations exclude trading commissions and taxes. Total shareholder returns from each investment can be calculated from the year-end investment values shown beneath the graph. </span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_58"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.  Reserved</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_61"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.  Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations. (&#8220;MD&amp;A&#8221;) </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis should be read in conjunction with the audited consolidated financial statements and related notes included in Item 8 of this Annual Report on Form 10-K (this &#8220;10-K&#8221;), &#8220;Risk Factors&#8221; included in Item 1A of this 10-K and the &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; in this 10-K.</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation, together with its subsidiaries (collectively, &#8220;CVS Health,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; or &#8220;us&#8221;), is a diversified health solutions company united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. The Company has more than 9,900 retail locations, nearly 1,200 walk-in medical clinics, a leading pharmacy benefits manager with approximately 110 million plan members with expanding specialty pharmacy solutions and a dedicated senior pharmacy care business serving more than one million patients per year. The Company also serves an estimated 35 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services, and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in eight states through which it sells Insured plans directly to individual consumers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services and mail order pharmacy. In addition, through the Pharmacy Services segment, the Company provides specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, coronavirus disease 2019 (&#8220;COVID-19&#8221;) and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consulting and other ancillary services to long-term care facilities and other care settings. As of December&#160;31, 2021, the Retail/LTC segment operated more than 9,900 retail locations, nearly 1,200 MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">locations as well as online retail pharmacy websites, LTC pharmacies and onsite pharmacies. For the year ended December&#160;31, 2021, the Company dispensed approximately 26.4% of the total retail pharmacy prescriptions in the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of the Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related integration costs; and</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as large case pensions and long-term care insurance products.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and its emerging new variants continue to impact the U.S. and other countries around the world. Our strong local presence and scale in communities across the country has enabled us to continue to play an indispensable role in the national response to COVID-19, as well as provide seamless support for our customers wherever they need us: in our CVS locations, in their homes, and virtually. The COVID-19 pandemic had a significant impact on the Company&#8217;s operating results for the years ended December 31, 2021 and 2020, primarily in the Company&#8217;s Health Care Benefits and Retail/LTC segments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Benefits Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in mid-March 2020, the health system experienced a significant reduction in utilization of medical services (&#8220;utilization&#8221;) that is discretionary and the cancellation of elective medical procedures. Utilization remained below historical levels through April 2020, began to recover in May and June 2020 and reached more normal levels in the third and fourth quarters of 2020, with select geographies impacted by COVID-19 waves. In response to COVID-19, the Company provided expanded benefit coverage to its members, including cost-sharing waivers for COVID-19 related treatments, as well as assistance to members through premium credits, telehealth cost-sharing waivers and other investments. During 2020, COVID-19 also resulted in a shift in the Company&#8217;s medical membership. The Company experienced declines in Commercial membership due to reductions in workforce at our existing customers, substantially offset by increases in Medicaid membership primarily as a result of the suspension of eligibility redeterminations and increased unemployment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, overall medical costs in the first quarter were generally consistent with historical baseline levels in the aggregate, however the segment experienced increased COVID-19 testing and treatment costs and lower Medicare risk-adjusted revenue. During the second quarter, COVID-19 testing and treatment costs persisted, however at levels significantly lower than those observed during the first quarter. Beginning in the third quarter of 2021, medical costs once again increased primarily driven by the spread of emerging new variants of COVID-19, which resulted in increased testing and treatment costs throughout the remainder of the year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2020, the Company experienced increased prescription volume due to the greater use of 90-day prescriptions and early refills of maintenance medications, as well as increased front store volume as consumers prepared for the COVID-19 pandemic. Beginning in the second quarter and continuing throughout the remainder of the year, the Company experienced reduced customer traffic in its retail pharmacies and MinuteClinic locations due to shelter-in-place orders as well as reduced new therapy prescriptions and decreased long-term care prescription volume as a result of the COVID-19 pandemic. In addition, the Company incurred incremental operating expenses associated with the Company&#8217;s COVID-19 pandemic response efforts and waived fees associated with prescription home delivery and associated front store products. During 2020, the Company also played a key role in supporting the local communities in which it operates through the administration of diagnostic testing at its CVS Pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> locations, as well as in long-term care facilities, at community-based testing sites in underserved areas and through its Return Ready</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">solution. The Company also began administering COVID-19 vaccinations in long-term care facilities during December 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, the Company experienced reduced customer traffic in its retail pharmacies, which reflected the impact of a weak cough, cold and flu season, while it administered the highest quarterly volume of COVID-19 diagnostic tests. The Company began administering COVID-19 vaccines in its retail pharmacies during February 2021. During the second quarter, the segment generated earnings from COVID-19 vaccines and saw improved customer traffic as vaccinated customers began more actively shopping in CVS locations. During the third and fourth quarters, emerging new variants drove the continued administration of COVID-19 vaccinations (including boosters) and diagnostic testing, while the segment also generated earnings from the sale of over-the-counter (&#8220;OTC&#8221;) test kits in the front store. During the year ended December&#160;31, 2021, the Company administered more than 32&#160;million COVID-19 tests and more than 59&#160;million COVID-19 vaccines and sold more than 22 million OTC test kits. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. We believe COVID-19&#8217;s impact on our businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond our knowledge and control. As a result, the impact COVID-19 will have on our businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_70"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information summarizes the Company&#8217;s results of operations for 2021 compared to 2020. For discussion of the Company&#8217;s results of operations for 2020&#160;compared to&#160;2019,&#160;see &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on February 16, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Consolidated Financial Results</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.266%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December&#160;31,&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 vs. 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,776&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,405&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,930&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store impairments </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254,795&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,789&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,193&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,911&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,987&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(718)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,924&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,035&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(404)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(128)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(988)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,722.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,420&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,770&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,997&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,898&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,201&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,631&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,898&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,192&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,631&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(533.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,910&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,179&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,634&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2021 compared to 2020</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $23.4 billion or 8.7% in 2021 compared to 2020. The increase in total revenues was primarily driven by growth across all segments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this MD&amp;A for additional information about the revenues of the Company&#8217;s segments.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $1.9 billion or 5.5% in 2021 compared to 2020. The increase in operating expenses was primarily due to incremental costs associated with growth in the business, including costs associated with the administration of COVID-19 vaccinations and diagnostic testing in the Retail/LTC segment. The increase in operating expenses was partially offset by the repeal of the non-deductible health insurer fee (&#8220;HIF&#8221;) for 2021 and gains from anti-trust legal settlements of $263 million recorded in 2021. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a&#160;percentage of total revenues decreased to 12.7% in 2021 compared to 13.1% in 2020. The decrease in operating expenses as a percentage of total revenues was primarily due to the increases in total revenues referred to above.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this MD&amp;A for additional information about the operating expenses of the Company&#8217;s segments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating income decreased $718 million or 5.2% in 2021 compared to 2020. The decrease in operating income was primarily due to:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A store impairment charge of approximately $1.4 billion recorded in the fourth quarter of 2021 related to planned retail store closures over the next three years; </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Decreased operating income in the Health Care Benefits segment, driven by higher COVID-19 related costs in 2021 compared to the prior year, including the impact of the deferral of elective procedures and other discretionary utilization in response to the COVID-19 pandemic during 2020, as well as the absence of pre-tax income of $307 million associated with the receipt of amounts owed to the Company under the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the &#8220;ACA&#8221;) risk corridor program (&#8220;ACA risk corridor receipt&#8221;); and</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $431 million goodwill impairment charge associated with the LTC business in the Retail/LTC segment recorded during the third quarter of 2021, partially offset by:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased prescription and front store volume and the administration of COVID-19 vaccinations and diagnostic testing in the Retail/LTC segment;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Improved purchasing economics and growth in specialty pharmacy in the Pharmacy Services segment; </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gains from anti-trust legal settlements of $263 million recorded in 2021; and</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Lower acquisition-related integration costs  in 2021 compared to the prior year.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Please see &#8220;Segment Analysis&#8221; later in this MD&amp;A for additional information about the operating income of the Company&#8217;s segments.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interest expense decreased $404 million in 2021 compared to 2020, due to lower debt in the year ended December&#160;31, 2021. See &#8220;Liquidity and Capital Resources&#8221; later in this report for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss on early extinguishment of debt</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During 2021, the loss on early extinguishment of debt relates to the Company&#8217;s repayment of approximately </span><span style="background-color:#ffffff;color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2.3&#160;billion of its outstanding senior notes in December </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 pursuant to its early redemption make-whole provision for such senior notes, which resulted in a loss on early extinguishment of debt of $89&#160;million</span><span style="background-color:#ffffff;color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and the repayment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of approximately $2.0&#160;billion of its outstanding senior notes pursuant to its tender offer for such notes in August 2021, which resulted in a loss on early extinguishment of debt of $363&#160;million. During 2020, the loss on early extinguishment of debt relates to the Company&#8217;s repayment of $6.0 billion of its outstanding senior notes pursuant to its tender offers for such senior notes in August 2020, which resulted in a loss on early extinguishment of debt of $766&#160;million, and the repayment of $4.5&#160;billion of its outstanding senior notes pursuant to its tender offers for such senior notes in December 2020, which resulted in a loss on early extinguishment of debt of $674&#160;million. See Note 8 &#8216;&#8216;Borrowings and Credit Agreements&#8217;&#8217; included in Item 8 of this 10-K for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income tax provision</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s effective income tax rate decreased to 24.2% in 2021 compared to 26.3% in the prior year primarily due to the repeal of the non-deductible HIF for 2021 and the favorable impact of a prior year refund claim approved by the Internal Revenue Service during the fourth quarter of 2021. The decrease was partially offset by the absence of the favorable resolution of certain tax matters in the fourth quarter of 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loss from discontinued operations</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In connection with certain business dispositions completed between 1995 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens &#8216;n Things and Bob&#8217;s Stores, each of which subsequently filed for bankruptcy. The Company&#8217;s loss from discontinued operations in 2020 primarily included lease-related costs required to satisfy these lease guarantees.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">See &#8220;Discontinued Operations&#8221; in Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; and &#8220;Lease Guarantees&#8221; in Note 16 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; included in Item 8 of this 10-K for additional information about the Company&#8217;s discontinued operations and the Company&#8217;s lease guarantees, respectively.</span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_73"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outlook for 2022</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to 2022, the Company believes you should consider the following important information:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Health Care Benefits segment is expected to benefit from Medicare and Commercial membership growth, partially offset by membership declines in its Medicaid products. The projected MBR is expected to decrease compared to 2021, reflecting a combination of expected improved pricing and a reduction in COVID-19 related medical costs. While the Company still expects a net negative impact from COVID-19 in 2022 within the Health Care Benefits segment, the expectation is the impact will be less adverse than what was experienced in 2021. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Pharmacy Services segment is expected to benefit from the Company&#8217;s ability to drive further improvements in purchasing economics and continued growth in specialty pharmacy, partially offset by continued price compression and state regulation of pharmacy pricing.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Retail/LTC segment is expected to continue to benefit from increased prescription volume and improved generic drug purchasing, partially offset by continued pharmacy reimbursement pressure and incremental operating expenses associated with the Company&#8217;s minimum wage investment. The Company expects that COVID-19 vaccinations and diagnostic testing will continue in 2022, albeit at lower levels than those experienced during 2021. The Company expects to see continued strength in Front Store sales, including sales of OTC test kits, in 2022. The extent of COVID-19 vaccinations, diagnostic testing and OTC test kit sales will be dependent upon various factors including vaccine hesitancy, the emergence of new variants, government testing initiatives and the availability and administration of pediatric and booster vaccinations.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company is expected to benefit from the continuation of its enterprise-wide cost savings initiatives, which aim to reduce the Company&#8217;s operating cost structure in a way that improves the consumer experience and is sustainable. Key drivers include:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investments in digital, technology and analytics capabilities that will streamline processes and improve outcomes,  </span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Implementing workforce and workplace strategies, and</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Deploying vendor and procurement strategies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">            </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company expects changes to its business environment to continue as elected and other government officials at the national and state levels continue to propose and enact significant modifications to public policy and existing laws and regulations that govern or impact the Company&#8217;s businesses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The COVID-19 pandemic continues to impact the economies of the U.S. and other countries around the world. The Company believes COVID-19&#8217;s impact on its businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic, as well as the pandemic&#8217;s impact on the U.S. and global economies, global supply chain, consumer behavior, and health care utilization patterns. In addition, as described in the &#8220;Government Regulation&#8221; section of this Form 10-K, federal, state and local governmental policies and initiatives designed to reduce the transmission of COVID-19 and emerging new variants may not effectively combat the severity and/or duration of the COVID-19 pandemic, and have resulted in a myriad of impacts on the Company&#8217;s businesses. Those primary drivers are beyond the Company&#8217;s knowledge and control. As a result, the impact COVID-19 will have on the Company&#8217;s businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s current expectations described above are forward-looking statements. Please see &#8220;Risk Factors&#8221; included in Item 1A of this 10-K and the &#8220;Cautionary Statement Concerning Forward-Looking Statements&#8221; in this 10-K for information regarding important factors that may cause the Company&#8217;s actual results to differ from those currently projected and/or otherwise materially affect the Company.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Analysis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion of segment operating results is presented based on the Company&#8217;s reportable segments in accordance with the accounting guidance for segment reporting and is consistent with the segment disclosure in Note 17 &#8216;&#8216;Segment Reporting&#8217;&#8217; included in Item 8 of this 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three operating segments, Health Care Benefits, Pharmacy Services and Retail/LTC, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the Company&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliations of operating income (GAAP measure) to adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:29.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.619%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,923)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,471)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(711)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,198&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,604&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,439)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(697)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Total revenues of the Pharmacy Services segment include approximately $11.6 billion, $10.9 billion and $11.5 billion of retail co-payments for 2021, 2020 and 2019, respectively. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; included in Item 8 of this 10-K for additional information about retail co-payments.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#8220;PSS members&#8221;) enrolled in Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> elect to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.</span></div><div style="padding-left:13.5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following are reconciliations of consolidated operating income (GAAP measure) to consolidated adjusted operating income, as well as reconciliations of segment GAAP operating income to segment adjusted operating income:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.017%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,606)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(711)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,552&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store impairments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,859&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,623&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,471)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(711)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,312&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.017%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,640&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,641)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receipt of fully reserved ACA risk corridor receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (7)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,188&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,688&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,146&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,306)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.017%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;<br/>Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss) (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,639&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,735&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,483)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(697)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,987&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store impairments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,202&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,129&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,705&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(697)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,339&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2021, 2020 and 2019, acquisition-related integration costs relate to the Company&#8217;s acquisition (&#8220;Aetna Acquisition&#8221;) of Aetna Inc. (&#8220;Aetna&#8221;). The acquisition-related integration costs are reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within the Corporate/Other segment.  </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">During the year ended December 31, 2021, the store impairment charge relates to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. During the year ended December 31, 2019, the store impairment charges related to the write down of operating lease right-of-use assets in connection with the planned closure of 68 underperforming retail pharmacy stores in 2019 and 2020. The store impairment charges are reflected in the Company&#8217;s GAAP consolidated statements of operations within the Retail/LTC segment. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">During the year ended December 31, 2021, the goodwill impairment charge relates to the LTC reporting unit within the Retail/LTC segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In June 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s GAAP consolidated statement of operations for the year ended December 31, 2021 as a reduction of operating expenses within the Health Care Benefits segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction of operating expenses in the Company&#8217;s GAAP consolidated statement of operations within the Health Care Benefits segment. In 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in the Company&#8217;s GAAP consolidated statement of operations in operating expenses within the Retail/LTC segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, the Company received $313&#160;million owed to it under the ACA&#8217;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#8217;s minimum medical loss ratio (&#8220;MLR&#8221;) rebate requirements and premium taxes, the Company recognized pre-tax income of $307&#160;million in the Company&#8217;s GAAP consolidated statement of operations within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div style="text-indent:6.75pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Benefits Segment </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The following table summarizes the Health Care Benefits segment&#8217;s performance for the respective periods:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.555%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 vs. 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages and basis points (&#8220;bps&#8221;)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,064</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,301</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,763</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,536</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,683</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,974</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(291)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,186</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,467</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,604</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,719</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,662</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,083</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,092</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,579</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MBR (Benefit costs as a % of premium revenues)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">410</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">bps</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">bps</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,003</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,218</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,873</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,521</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,166</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,639</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,645)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,012</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,188</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,202</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,176)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium revenues (by business):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,739</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,928</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,818</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,811</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,110</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,325</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,373</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,213</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(840)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:22.5pt;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.93pt">See &#8220;Segment Analysis&#8221; above in this MD&amp;A for a reconciliation of operating income (GAAP measure) to adjusted operating income for the Health Care Benefits segment, which represents the Company&#8217;s principal measure of segment performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2021 compared to 2020</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $6.7 billion, or 8.9%, to $82.2 billion in 2021 compared to 2020 primarily driven by growth in the Government Services business, partially offset by the unfavorable impact of the repeal of the HIF for 2021 and the absence of the ACA risk corridor receipt.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Benefit Ratio (&#8220;MBR&#8221;)</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical benefit ratio is calculated as benefit costs divided by premium revenues and represents the percentage of premium revenues spent on medical benefits for the Company&#8217;s Insured members. Management uses MBR to assess the underlying business performance and underwriting of its insurance products, understand variances between actual results and expected results and identify trends in period-over-period results. MBR provides management and investors with information useful in assessing the operating results of the Company&#8217;s Insured Health Care Benefits products.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The MBR increased from 80.9% to 85.0% in 2021 compared to the prior year. The increase was primarily driven by higher COVID-19 related costs in 2021 compared to the prior year, including the impact of the deferral of elective procedures and other discretionary utilization in response to the COVID-19 pandemic during 2020 and the repeal of the HIF for 2021, partially offset by improved underlying performance in the current year.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Health Care Benefits segment include selling, general and administrative expenses and depreciation and amortization expenses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses decreased $215 million, or 1.5%, in 2021 compared to 2020. The decrease in operating expenses was primarily due to the repeal of the HIF for 2021, partially offset by incremental operating expenses to support the growth in the Government Services business described above and the net impact of the sale of the Workers&#8217; Compensation business sold on July 31, 2020. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income decreased $1.2 billion, or 19.0%, in 2021 compared to 2020. The decrease in adjusted operating income was primarily driven by higher COVID-19 related costs in 2021 compared to the prior year, including the impact of the deferral of elective procedures and other discretionary utilization in response to the COVID-19 pandemic during 2020. The decrease was partially offset by improved performance in the underlying Government Services business and higher favorable development of prior-years&#8217; health care cost estimates in 2021 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Health Care Benefits segment&#8217;s medical membership as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.849%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In thousands</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Insured</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical membership:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total medical membership</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,847&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,001&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,848&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,145&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,267&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,412&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental membership information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Prescription Drug Plan (standalone)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medical Membership</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership represents the number of members covered by the Company&#8217;s Insured and ASC medical products and related services at a specified point in time. Management uses this metric to understand variances between actual medical membership and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of medical membership on segment total revenues and operating results.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Medical membership as of December&#160;31, 2021 of 23.8 million increased 436,000 compared with December&#160;31, 2020, primarily reflecting increases in Medicare and Medicaid products, partially offset by declines in Commercial self-insured membership.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Update</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 15, 2021, the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) issued its final notice detailing final 2022 Medicare Advantage benchmark payment rates. Final 2022 Medicare Advantage rates resulted in an increase in industry benchmark rates of approximately 4.1%. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA ties a portion of each Medicare Advantage plan&#8217;s reimbursement to the plan&#8217;s &#8220;star ratings.&#8221; Plans must have a star rating of four or higher (out of five) to qualify for bonus payments. CMS released the Company&#8217;s 2022 star ratings in October 2021. The Company&#8217;s 2022 star ratings will be used to determine which of the Company&#8217;s Medicare Advantage plans have ratings of four stars or higher and qualify for bonus payments in 2023. Based on the Company&#8217;s membership at December 31, 2021, 87% of the Company&#8217;s Medicare Advantage members were in plans with 2022 star ratings of at least 4.0 stars, compared to 83% of the Company&#8217;s Medicare Advantage members being in plans with 2021 star ratings of at least 4.0 stars based on the Company&#8217;s membership at December 31, 2020.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pharmacy Services Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Pharmacy Services segment&#8217;s performance for the respective periods:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.118%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 vs. 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,851</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,950</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,946</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,938</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,491</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,084&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,894</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,045</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,245</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,849&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,461</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,511</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,667</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,454</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,735</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,859</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,688</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,129</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (by distribution channel):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,715</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,045</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,755</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,710)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,547</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,071</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,141</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">760</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy claims processed:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,244.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,112.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,014.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,914.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,790.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic dispensing rate: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy network </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">See &#8220;Segment Analysis&#8221; above in this MD&amp;A for a reconciliation of operating income (GAAP measure) to adjusted operating income for the Pharmacy Services segment, which represents the Company&#8217;s principal measure of segment performance.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice program.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Includes an adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal prescription.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2021 compared to 2020</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $11.1 billion, or 7.8%, to $153.0 billion in 2021 compared to 2020. The increase was primarily driven by increased pharmacy claims volume, growth in specialty pharmacy and brand inflation, partially offset by continued price compression.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Pharmacy Services segment include selling, general and administrative expenses; depreciation and amortization expense; and expenses related to specialty retail pharmacies, which include store and administrative payroll, employee benefits and occupancy costs.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues remained consistent at 1.0% in both 2021 and 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $1.2 billion, or 20.6%, in 2021 compared to 2020. The increase in adjusted operating income was primarily driven by improved purchasing economics which reflected increased contributions from the products and services of the Company&#8217;s group purchasing organization and specialty pharmacy (including pharmacy and/or administrative services for providers and Covered Entities). These increases were partially offset by continued price compression. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As you review the Pharmacy Services segment&#8217;s performance in this area, you should consider the following important information about the business:</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s efforts to (i)&#160;retain existing clients, (ii)&#160;obtain new business and (iii)&#160;maintain or improve the rebates, fees and/or discounts the Company receives from manufacturers, wholesalers and retail pharmacies continue to have an impact on adjusted operating income. In particular, competitive pressures in the PBM industry have caused the Company and other PBMs to continue to share with clients a larger portion of rebates, fees and/or discounts received from pharmaceutical manufacturers. In addition, marketplace dynamics and regulatory changes have limited the Company&#8217;s ability to offer plan sponsors pricing that includes retail network &#8220;differential&#8221; or &#8220;spread,&#8221; and the Company expects these trends to continue. The &#8220;differential&#8221; or &#8220;spread&#8221; is any difference between the drug price charged to plan sponsors, including Medicare Part&#160;D plan sponsors, by a PBM and the price paid for the drug by the PBM to the dispensing provider.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy claims processed</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total pharmacy claims processed represents the number of prescription claims processed through our pharmacy benefits manager and dispensed by either our retail network pharmacies or our own mail and specialty pharmacies. Management uses this metric to understand variances between actual claims processed and expected amounts as well as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of pharmacy claim volume on segment total revenues and operating results.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s pharmacy network claims processed on a 30-day equivalent basis increased 6.9% to 1.9 billion claims in 2021 compared to 1.8 billion claims in 2020. The increase in pharmacy network claims processed was primarily driven by net new business and COVID-19 vaccinations, as well as increased new therapy prescriptions, which were adversely impacted by the COVID-19 pandemic during 2020. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s mail choice claims processed on a 30-day equivalent basis increased 2.4% to 330.7 million claims in 2021 compared to 322.8 million claims in 2020. The increase in mail choice claims was primarily driven by net new business and the continued adoption of Maintenance Choice offerings.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Excluding the impact of COVID-19 vaccinations, total pharmacy claims processed increased 4.2%, on a 30-day equivalent basis, in 2021 compared to the prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Generic dispensing rate is calculated by dividing the Pharmacy Services segment&#8217;s generic drug prescriptions processed or filled by its total prescriptions processed or filled. Management uses this metric to evaluate the effectiveness of the business at encouraging the use of generic drugs when they are available and clinically appropriate, which aids in decreasing costs for client members and retail customers. This metric provides management and investors with information useful in understanding trends in segment total revenues and operating results. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Pharmacy Services segment&#8217;s total generic dispensing rate decreased to 86.8% in 2021 compared to 88.2% in the prior year. The decrease in the segment&#8217;s generic dispensing rate was primarily driven by an increase in brand prescriptions, largely attributable to COVID-19 vaccinations in 2021. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s total generic dispensing rate increased to 88.5% in 2021.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retail/LTC Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Retail/LTC segment&#8217;s performance for the respective periods:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 vs. 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,652</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,944</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,729</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,436</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">879</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,105</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,198</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,608</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,907&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,590&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,832</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,284</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,688</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store impairments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,162</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,274</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,896</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,322</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,640</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,793</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(318)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,623</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,146</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,705</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(559)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income as a % of total revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues (by major goods/service lines):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,121</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,176</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,442</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,945&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,315</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,655</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,422</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,652</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescriptions filled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,587.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,417.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same store sales increase: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription volume </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generic dispensing rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:22.5pt;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.93pt">See &#8220;Segment Analysis&#8221; above in this MD&amp;A for a reconciliation of operating income (GAAP measure) to adjusted operating income for the Retail/LTC segment, which represents the Company&#8217;s principal measure of segment performance.</span></div><div style="padding-left:22.5pt;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.93pt">Includes an adjustment to convert 90&#8209;day prescriptions to the equivalent of three 30&#8209;day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product&#160;days supplied compared to a normal prescription.</span></div><div style="padding-left:22.5pt;text-indent:-20.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:10.93pt">Same store sales and prescription volume represent the change in revenues and prescriptions filled in the Company&#8217;s retail pharmacy stores that have been operating for greater than one year, expressed as a percentage that indicates the increase or decrease relative to the comparable prior period. Same store metrics exclude revenues from MinuteClinic, revenues and prescriptions from LTC operations and, in 2019, revenues and prescriptions from stores in Brazil. Management uses these metrics to evaluate the performance of existing stores on a comparable basis and to inform future decisions regarding existing stores and new locations. Same-store metrics provide management and investors with information useful in understanding the portion of current revenues and prescriptions resulting from organic growth in existing locations versus the portion resulting from opening new stores.</span></div><div style="padding-left:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2021 compared to 2020</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $8.9 billion, or 9.8%, to $100.1 billion in 2021 compared to 2020. The increase was primarily driven by increased prescription and front store volume, the administration of COVID-19 vaccinations and diagnostic testing, as well as brand inflation. These increases were partially offset by continued pharmacy reimbursement pressure and the impact of recent generic introductions. COVID-19 vaccinations, diagnostic testing and OTC test kit sales contributed approximately 45% of the increase in the segment&#8217;s revenues in 2021 compared to the prior year. The prior year reflected </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the ongoing expansion of the Company&#8217;s diagnostic testing program which began in April 2020, an immaterial impact from COVID-19 vaccinations which began in December 2020 and no OTC test kit sales.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pharmacy same store sales increased 9.3% in 2021 compared to 2020. The increase was driven by the 9.3% increase in pharmacy same store prescription volume on a 30-day equivalent basis and brand inflation. These increases were partially offset by continued pharmacy reimbursement pressure and the impact of recent generic introductions.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Front store same store sales increased 7.6% in 2021 compared to 2020. The increase was primarily due to strength in consumer health, including the sale of OTC test kits, as well as increased beauty and personal care sales in 2021.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other revenues increased 94.0% in 2021 compared to 2020. The increase was primarily due to increased COVID-19 diagnostic testing in 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Store impairments</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During 2021, the Company recorded a store impairment charge of approximately $1.4 billion related to the write-down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. See Note 6 &#8216;&#8216;Leases&#8217;&#8217; included in Item 8 of this 10-K for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill impairment</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During 2021, the Company recorded a $431 million goodwill impairment charge related to the LTC reporting unit within the Retail/LTC segment. See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; included in Item 8 of this 10-K for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses in the Retail/LTC segment include store payroll, store employee benefits, store occupancy costs, selling expenses, advertising expenses, depreciation and amortization expense and certain administrative expenses.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses increased $1.9 billion, or 10.3%, in 2021 compared to 2020. The increase was primarily due to incremental costs associated with increased volume including COVID-19 vaccinations and diagnostic testing, as well as increased investments in the segment&#8217;s capabilities and colleague compensation and benefits. These increases were partially offset by gains from anti-trust legal settlements of $231 million recorded in 2021, the absence of incremental expenses associated with the Company&#8217;s initial COVID-19 pandemic mitigation efforts incurred in 2020 and the impact of cost savings initiatives in 2021.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating expenses as a percentage of total revenues remained relatively consistent at 20.1% and 20.0% in 2021 and 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating income</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating income increased $1.5 billion, or 24.0%, in 2021 compared to 2020. The increase in adjusted operating income was primarily driven by the administration of COVID-19 vaccinations and diagnostic testing, the increased prescription and front store volume described above, improved generic drug purchasing and gains from anti-trust legal settlements of $231 million recorded in 2021. These increases were partially offset by continued pharmacy reimbursement pressure and increased investments in the segment&#8217;s capabilities and colleague compensation and benefits. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As you review the Retail/LTC segment&#8217;s performance in this area, you should consider the following important information about the business:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The segment&#8217;s adjusted operating income benefited from the administration of COVID-19 vaccinations, diagnostic testing and OTC test kit sales which contributed approximately 30% of the segment&#8217;s adjusted operating income in 2021.</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The segment&#8217;s adjusted operating income has been adversely affected by the efforts of managed care organizations, PBMs and governmental and other third-party payors to reduce their prescription drug costs, including the use of restrictive networks, as well as changes in the mix of business within the pharmacy portion of the Retail/LTC segment. If the pharmacy reimbursement pressure accelerates, the segment may not be able to grow revenues, and its adjusted operating income could be adversely affected.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The increased use of generic drugs has positively impacted the segment&#8217;s adjusted operating income but has resulted in third-party payors augmenting their efforts to reduce reimbursement payments to retail pharmacies for prescriptions. This trend, which the Company expects to continue, reduces the benefit the segment realizes from brand-to-generic drug conversions.</span></div><div style="padding-left:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prescriptions filled</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescriptions filled represents the number of prescriptions dispensed through the Retail/LTC segment&#8217;s pharmacies. Management uses this metric to understand variances between actual prescriptions dispensed and expected amounts as well </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as trends in period-over-period results. This metric provides management and investors with information useful in understanding the impact of prescription volume on segment total revenues and operating results.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prescriptions filled increased 8.4%, on a 30-day equivalent basis, in 2021 compared to 2020 primarily driven by COVID-19 vaccinations and the continued adoption of patient care programs, as well as increased new therapy prescriptions, which were adversely impacted by the COVID-19 pandemic in 2020. Excluding the impact of COVID-19 vaccinations, prescriptions filled increased 4.3%, on a 30-day equivalent basis, in 2021 compared to the prior year.</span></div><div style="padding-left:54pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Generic dispensing rate</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Generic dispensing rate is calculated by dividing the Retail/LTC segment&#8217;s generic drug prescriptions filled by its total prescriptions filled. Management uses this metric to evaluate the effectiveness of the business at encouraging the use of generic drugs when they are available and clinically appropriate, which aids in decreasing costs for client members and retail customers. This metric provides management and investors with information useful in understanding trends in segment total revenues and operating results. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Retail/LTC segment&#8217;s generic dispensing rate decreased to 85.7% in 2021 compared to 88.3% in the prior year. The decrease in the segment&#8217;s generic dispensing rate was primarily driven by an increase in brand prescriptions, largely attributable to COVID-19 vaccinations in 2021. Excluding the impact of COVID-19 vaccinations, the segment&#8217;s total generic dispensing rate increased to 89.0% in 2021.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_88"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate/Other Segment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Corporate/Other segment&#8217;s performance for the respective periods:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.703%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 vs. 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except percentages</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,846</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,710</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,606)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,641)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,483)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating loss</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,471)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,306)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See &#8220;Segment Analysis&#8221; above in this MD&amp;A for a reconciliation of Corporate/Other segment operating loss (GAAP measure) to adjusted operating loss, which represents the Company&#8217;s principal measure of segment performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2021 compared to 2020</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues primarily relate to products for which the Company no longer solicits or accepts new customers, such as large case pensions and long-term care insurance products.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total revenues increased $295 million in 2021 compared to 2020. The increase was primarily driven by higher net investment income, primarily driven by private equity investments and increased net realized capital gains in 2021 compared to 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjusted operating loss</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted operating loss increased $165 million in 2021 compared to 2020. The increase was primarily driven by higher employee benefit costs and incremental operating expenses associated with the Company&#8217;s investments in transformation, partially offset by the increase in net investment income in 2021 described above.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_91"></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a level of liquidity sufficient to allow it to meet its cash needs in the short-term. Over the long term, the Company manages its cash and capital structure to maximize shareholder return, maintain its financial condition and maintain flexibility for future strategic initiatives. The Company continuously assesses its regulatory capital requirements, working capital needs, debt and leverage levels, debt maturity schedule, capital expenditure requirements, dividend payouts, potential share repurchases and future investments or acquisitions. The Company believes its operating cash flows, commercial paper program, credit facilities, as well as any potential future borrowings, will be sufficient to fund these future payments and long-term initiatives. As of&#160;December&#160;31, 2021, the Company had approximately&#160;$9.4 billion&#160;in cash and cash equivalents, approximately&#160;$3.8 billion&#160;of which was held by the parent company or nonrestricted subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net change in cash, cash equivalents and restricted cash for the years ended December&#160;31, 2021, 2020 and 2019 was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:36.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020 vs. 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,865&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,261)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,534)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,339)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,195)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,696)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,660)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,635&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,855&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(987)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.5)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commentary - 2021 compared to 2020</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash provided by operating activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased by $2.4 billion in 2021 compared to 2020 due primarily to the timing of payments and higher operating income in the Retail/LTC segment. The increase was partially offset by reduced benefit costs due to the deferral of elective procedures and other discretionary utilization in the Health Care Benefits segment as a result of the COVID-19 pandemic, which favorably impacted operating cash flows in 2020 and did not recur during the current year.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash used in investing activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decreased by $273 million in 2021 compared to 2020 primarily due to increased proceeds from the sale and maturity of investments and a decrease in cash used for acquisitions, partially offset by the absence of $840 million in proceeds from the sale of the Workers&#8217; Compensation business in 2020 and increased purchases of investments during 2021 compared to the prior year. In addition, cash used in investing activities reflected the following activity:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gross capital expenditures remained relatively consistent at approximately $2.5 billion and $2.4 billion in 2021 and 2020, respectively. During 2021, approximately 64% of the Company&#8217;s total capital expenditures were for technology, digital and other strategic initiatives and 36% were for store, fulfillment and support facilities expansion and improvements. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Net cash used in financing activities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased to $11.4 billion in 2021 compared to $7.7 billion in 2020. The increase in cash used in finance activities primarily related to lower proceeds from the issuance of long-term debt, partially offset by lower repayments of long-term debt during 2021 compared to the prior year. </span></div><div style="margin-bottom:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in net cash used in investing activities for the years ended December&#160;31, 2021, 2020 and 2019 was the following store development activity: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stores (beginning of year)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,962&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,896&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,921&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New and acquired stores </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closed stores </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stores (end of year)</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,939&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,962&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,896&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Relocated stores </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes retail drugstores and pharmacies within retail chains, primarily in Target Corporation (&#8220;Target&#8221;) stores.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Relocated stores are not included in new and acquired stores or closed stores totals.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper and Back-up Credit Facilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any commercial paper outstanding as of December 31, 2021 or 2020. In connection with its commercial paper program, the Company maintains a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 17, 2023, a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 16, 2024, and a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 11, 2026. The credit facilities allow for borrowings at various rates that are dependent, in part, on the Company&#8217;s public debt ratings and require the Company to pay a weighted average quarterly facility fee of approximately 0.03%, regardless of usage. As of December&#160;31, 2021 and 2020, there were no borrowings outstanding under any of the Company&#8217;s back-up credit facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A subsidiary of the Company is a member of the FHLBB. As a member, the subsidiary has the ability to obtain cash advances, subject to certain minimum collateral requirements. The maximum borrowing capacity available from the FHLBB as of December&#160;31, 2021 was approximately $995 million. At both December&#160;31, 2021 and 2020, there were no outstanding advances from the FHLBB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 18, 2021, the Company issued $1.0&#160;billion aggregate principal amount of 2.125% unsecured senior notes due September 15, 2031 for total proceeds of $987&#160;million, net of discounts, underwriting fees and offering expenses. The net proceeds of this offering were used for the purchase of senior notes in connection with the Company&#8217;s cash tender offer in August 2021 as described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2020, the Company issued $750&#160;million aggregate principal amount of 1.3% unsecured senior notes due August 21, 2027 and $1.25&#160;billion aggregate principal amount of 1.875% unsecured senior notes due February 28, 2031 for total proceeds of approximately $1.99&#160;billion, net of discounts and underwriting fees. The $750&#160;million aggregate principal amount of 1.3% unsecured senior notes represent a further issuance of the Company&#8217;s 1.3% unsecured senior notes due August 21, 2027 initially issued in an aggregate principal amount of $1.5&#160;billion on August 21, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 21, 2020, the Company issued $1.5&#160;billion aggregate principal amount of 1.3% unsecured senior notes due August 21, 2027, $1.25&#160;billion aggregate principal amount of 1.75% unsecured senior notes due August 21, 2030 and $1.25&#160;billion aggregate principal amount of 2.7% unsecured senior notes due August 21, 2040 (collectively, the &#8220;August 2020 Notes&#8221;) for total proceeds of approximately $3.97&#160;billion, net of discounts and underwriting fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2020, the Company issued $750&#160;million aggregate principal amount of 3.625% unsecured senior notes due April 1, 2027, $1.5&#160;billion aggregate principal amount of 3.75% unsecured senior notes due April 1, 2030, $1.0&#160;billion aggregate principal amount of 4.125% unsecured senior notes due April 1, 2040 and $750&#160;million aggregate principal amount of 4.25% unsecured senior notes due April 1, 2050 (collectively, the &#8220;March 2020 Notes&#8221;) for total proceeds of approximately $3.95&#160;billion, net of discounts and underwriting fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds of these offerings were used for general corporate purposes, which may include working capital, capital expenditures, as well as the repurchase and/or repayment of indebtedness.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2020, the Company entered into several interest rate swap transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of the March 2020 Notes. In connection with the issuance of the March 2020 Notes, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $7&#160;million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $5&#160;million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the March 2020 Notes.  See Note 13 &#8216;&#8216;Other Comprehensive Income&#8217;&#8217; included in Item 8 of this 10-K for additional information.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Early Extinguishments of Debt</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company redeemed for cash the remaining $2.3&#160;billion of its outstanding 3.7% senior notes due 2023. In connection with the early redemption of such senior notes, the Company paid a make-whole premium of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$80 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in excess of the aggregate principal amount of the senior notes that were redeemed, wrote-off </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$8 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of unamortized deferred financing costs and incurred</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $1 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in fees, for a total loss on early extinguishment of debt of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$89&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company purchased approximately $2.0&#160;billion of its outstanding 4.3% senior notes due 2028 through a cash tender offer. In connection with the purchase of such senior notes, the Company paid a premium of $332 million&#160;in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $26&#160;million of unamortized deferred financing costs and incurred $5&#160;million in fees, for a total loss on early extinguishment of debt of $363&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company purchased $4.5&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $113&#160;million of its 4.0% senior notes due 2023, $1.4&#160;billion of its 3.7% senior notes due 2023, $1.0&#160;billion of its 4.1% senior notes due 2025 and $2.0&#160;billion of its 4.3% senior notes due 2028. In connection with the purchase of such senior notes, the Company paid a premium of $619&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $45&#160;million of unamortized deferred financing costs and incurred $10&#160;million in fees, for a total loss on early extinguishment of debt of $674&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company purchased $6.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $723&#160;million of its 4.0% senior notes due 2023, $2.3&#160;billion of its 3.7% senior notes due 2023 and $3.0&#160;billion of its 4.1% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $706&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $47&#160;million of unamortized deferred financing costs and incurred $13&#160;million in fees, for a total loss on early extinguishment of debt of $766&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, the Company purchased $4.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $1.3&#160;billion of its 3.125% senior notes due 2020, $723&#160;million of its floating rate notes due 2020, $328&#160;million of its 4.125% senior notes due 2021, $297&#160;million of 4.125% senior notes due 2021 issued by Aetna, $413&#160;million of 5.45% senior notes due 2021 issued by Coventry Health Care, Inc., a wholly-owned subsidiary of Aetna, and $962&#160;million of its 3.35% senior notes due 2021. In connection with the purchase of such senior notes, the Company paid a premium of $76&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, incurred $8&#160;million in fees and recognized a net gain of $5&#160;million on the write-off of net unamortized deferred financing premiums, for a net loss on early extinguishment of debt of $79&#160;million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 8 &#8216;&#8216;Borrowings and Credit Agreements&#8217;&#8217; and Note 12 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; included in Item 8 of this 10-K for additional information about debt issuances, debt repayments, share repurchases and dividend payments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#8217;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s back-up revolving credit facilities, unsecured senior notes and unsecured floating rate notes (see Note 8 &#8216;&#8216;Borrowings and Credit Agreements&#8217;&#8217; included in Item 8 of this 10-K) contain customary restrictive financial and operating covenants. These covenants do not include an acceleration of the Company&#8217;s debt maturities in the event of a downgrade in the Company&#8217;s credit ratings. The Company does not believe the restrictions contained in these covenants materially affect its financial or operating flexibility. As of December&#160;31, 2021, the Company was in compliance with all of its debt covenants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company&#8217;s long-term debt was rated &#8220;Baa2&#8221; by Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;) and &#8220;BBB&#8221; by Standard&#160;&amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;), and its commercial paper program was rated &#8220;P-2&#8221; by Moody&#8217;s and &#8220;A-2&#8221; by S&amp;P. The outlook on the Company&#8217;s long-term debt is &#8220;Stable&#8221; by Moody&#8217;s and &#8220;Positive&#8221; by S&amp;P. In assessing the Company&#8217;s credit strength, the Company believes that both Moody&#8217;s and S&amp;P considered, among other things, the Company&#8217;s capital structure and financial policies as well as its consolidated balance sheet, its historical acquisition activity </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and other financial information. Although the Company currently believes its long-term debt ratings will remain investment grade, it cannot guarantee the future actions of Moody&#8217;s and/or S&amp;P. The Company&#8217;s debt ratings have a direct impact on its future borrowing costs, access to capital markets and new store operating lease costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Programs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021, 2020 and 2019, the Company did not repurchase any shares of common stock. See Note 12 &#8216;&#8216;Shareholders&#8217; Equity&#8217;&#8217; included in Item 8 of this 10-K for additional information on the Company&#8217;s share repurchase program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quarterly Cash Dividend</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, 2020 and 2019, the quarterly cash dividend was $0.50 per share. In December 2021, CVS Health Corporation&#8217;s Board of Directors (the &#8220;Board&#8221;) authorized a 10% increase in the quarterly cash dividend to $0.55 per share effective in 2022. CVS Health Corporation has paid cash dividends every quarter since becoming a public company. Future dividends will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Cash Requirements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes certain estimated future cash requirements under the Company&#8217;s various contractual obligations at December&#160;31, 2021, in total and disaggregated into current and long-term obligations. The table below does not include future payments of claims to health care providers or pharmacies because certain terms of these payments are not determinable at December&#160;31, 2021 (for example, the timing and volume of future services provided under fee-for-service arrangements and future membership levels for capitated arrangements). </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-Term</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,385&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual lease obligations with Target </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,419&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payments on long-term debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities on the consolidated balance sheets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Future policy benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (5) </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unpaid claims</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (5) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) (6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,571&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,163&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Refer to Note 6 &#8216;&#8216;Leases&#8217;&#8217; included in Item 8 of this 10-K for additional information regarding the maturity of lease liabilities under operating and finance leases. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target. See Note 6 &#8216;&#8216;Leases&#8217;&#8217; included in Item 8 of this 10-K for additional information regarding the lease arrangements with Target. Amounts related to such operating and finance leases are reflected within the operating lease liabilities and finance lease liabilities in the table above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings are reflected in the table above assuming equivalent stores continue to operate through the term of the arrangements. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Refer to Note 8 &#8216;&#8216;Borrowings and Credit Agreements&#8217;&#8217; included in Item 8 of this 10-K for additional information regarding the maturities of debt principal. Interest payments on long-term debt are calculated using outstanding balances and interest rates in effect on December&#160;31, 2021.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Payments of other long-term liabilities exclude Separate Accounts liabilities of approximately $5.1 billion because these liabilities are supported by assets that are legally segregated and are not subject to claims that arise out of the Company&#8217;s business.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total payments of future policy benefits, unpaid claims and policyholders&#8217; funds include $728 million, $1.6 billion and $186 million, respectively, of reserves for contracts subject to reinsurance. The Company expects the assuming reinsurance carrier to fund these obligations and has reflected these amounts as reinsurance recoverable assets on the consolidated balance sheets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Customer funds associated with group life and health contracts of approximately $3.0 billion have been excluded from the table above because such funds may be used primarily at the customer&#8217;s discretion to offset future premiums and/or for refunds, and the timing of the related cash flows cannot be determined. Additionally, net unrealized capital gains on debt securities supporting experience-rated products of $92 million, before tax, have been excluded from the table above.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restrictions on Certain Payments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to general state law restrictions on payments of dividends and other distributions to stockholders applicable to all corporations, health maintenance organizations (&#8220;HMOs&#8221;) and insurance companies are subject to further regulations that, among other things, may require those companies to maintain certain levels of equity (referred to as surplus) and restrict the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amount of dividends and other distributions that may be paid to their equity holders. These regulations are not directly applicable to CVS Health Corporation as a holding company, since CVS Health Corporation is not an HMO or an insurance company. In addition, in connection with the Aetna Acquisition, the Company made certain undertakings that require prior regulatory approval of dividends by certain of its HMOs and insurance companies. The additional regulations and undertakings applicable to the Company&#8217;s HMO and insurance company subsidiaries are not expected to affect the Company&#8217;s ability to service the Company&#8217;s debt, meet other financing obligations or pay dividends, or the ability of any of the Company&#8217;s subsidiaries to service their debt or other financing obligations. Under applicable regulatory requirements and undertakings, at December&#160;31, 2021, the maximum amount of dividends that may be paid by the Company&#8217;s insurance and HMO subsidiaries without prior approval by regulatory authorities was $2.9 billion in the aggregate. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains capital levels in its operating subsidiaries at or above targeted and/or required capital levels and dividends amounts in excess of these levels to meet liquidity requirements, including the payment of interest on debt and stockholder dividends. In addition, at the Company&#8217;s discretion, it uses these funds for other purposes such as funding share and debt repurchase programs, investments in new businesses and other purposes considered advisable. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, the Company held investments of $450 million and $524 million, respectively, that are not accounted for as Separate Accounts assets but are legally segregated and are not subject to claims that arise out of the Company&#8217;s business. See Note 3 &#8216;&#8216;Investments&#8217;&#8217; included in Item 8 of this 10-K for additional information on investments related to the 2012 conversion of an existing group annuity contract from a participating to a non-participating contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Solvency Regulation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The National Association of Insurance Commissioners (the &#8220;NAIC&#8221;) utilizes risk-based capital (&#8220;RBC&#8221;) standards for insurance companies that are designed to identify weakly-capitalized companies by comparing each company&#8217;s adjusted surplus to its required surplus (the &#8220;RBC Ratio&#8221;). The RBC Ratio is designed to reflect the risk profile of insurance companies. Within certain ratio ranges, regulators have increasing authority to take action as the RBC Ratio decreases. There are four levels of regulatory action, ranging from requiring an insurer to submit a comprehensive financial plan for increasing its RBC to the state insurance commissioner to requiring the state insurance commissioner to place the insurer under regulatory control. At December&#160;31, 2021, the RBC Ratio of each of the Company&#8217;s primary insurance subsidiaries was above the level that would require regulatory action. The RBC framework described above for insurers has been extended by the NAIC to health organizations, including HMOs. Although not all states had adopted these rules at December&#160;31, 2021, at that date, each of the Company&#8217;s active HMOs had a surplus that exceeded either the applicable state net worth requirements or, where adopted, the levels that would require regulatory action under the NAIC&#8217;s RBC rules. External rating agencies use their own capital models and/or RBC standards when they determine a company&#8217;s rating.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares the consolidated financial statements in conformity with generally accepted accounting principles, which require management to make certain estimates and apply judgment. Estimates and judgments are based on historical experience, current trends and other factors that management believes to be important at the time the consolidated financial statements are prepared. On a regular basis, the Company reviews its accounting policies and how they are applied and disclosed in the consolidated financial statements. While the Company believes the historical experience, current trends and other factors considered by management support the preparation of the consolidated financial statements in conformity with generally accepted accounting principles, actual results could differ from estimates, and such differences could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant accounting policies are discussed in Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; included in Item 8 of this 10-K. Management believes the following accounting policies include a higher degree of judgment and/or complexity and, thus, are considered to be critical accounting policies. The Company has discussed the development and selection of these critical accounting policies with the Audit Committee of the Board (the &#8220;Audit Committee&#8221;), and the Audit Committee has reviewed the disclosures relating to them.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which, in the Company&#8217;s Commercial business, reflect contracted rates per member and the number of covered members recorded in the Company&#8217;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. Revenue related to the Company&#8217;s Government business is collected monthly from the U.S. federal government and various government agencies based on fixed payment rates and member eligibility. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise. A significant difference in the actual level of retroactivity compared to estimated levels would have a significant effect on the Company&#8217;s operating results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Premium Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the MLR rebate requirements of the ACA is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Services Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#8217;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#8217;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#8217;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting for Medicare Part D </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include insurance premiums earned by the Company&#8217;s PDPs, which are determined based on the PDP&#8217;s annual bid and related contractual arrangements with CMS. The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment sells prescription drugs directly through its mail service dispensing pharmacies and indirectly through the Company&#8217;s retail pharmacy network. The Company&#8217;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the dispensing of prescription drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions dispensed indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#8220;Drug Discounts&#8221; and &#8220;Guarantees&#8221; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#8220;retail co-payments&#8221;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Pharmacy Services segment:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by mail service dispensing pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by third party pharmacies in the Company&#8217;s retail pharmacy network and associated administrative fees are recognized at the Company&#8217;s point-of-sale, which is when the claim is adjudicated by the Company&#8217;s online claims processing system and the Company has transferred control of the prescription drug and completed all of its performance obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Drug Discounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records revenue net of manufacturers&#8217; rebates earned by its clients based on their plan members&#8217; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#8217; rebates earned by its clients. The estimates are based on the best available data at period-end and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#8217; rebate amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantees</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Retail Pharmacy</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer returns are not material to the Company&#8217;s operating results or financial condition. Sales taxes are not included in revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loyalty and Other Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customer loyalty program, ExtraCare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, consists of two components, ExtraSavings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers a subscription-based membership program, CarePass</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-term Care</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of long-term care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#8217;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Walk-In Medical Clinics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For services provided by the Company&#8217;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairments of Debt Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly reviews its debt securities to determine whether a decline in fair value below the cost basis or carrying value has occurred. If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. The Company analyzes all facts and circumstances believed to be relevant for each investment when performing this analysis, in accordance with applicable accounting guidance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principle payments; and any changes to the rating of the security by a rating agency. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021 and 2020, the Company recorded yield-related impairment losses on debt securities of $42 million and $49 million, respectively. During the years ended December&#160;31, 2021 and 2020, the Company did not record credit-related impairment losses on debt securities. During the year ended December 31, 2019, the Company recorded other-than-temporary impairment (&#8220;OTTI&#8221;) losses on debt securities of $24 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks inherent in assessing the impairment of a debt security include the risk that market factors may differ from projections and the risk that facts and circumstances factored into the Company&#8217;s assessment may change with the passage of time. Unexpected changes to market factors and circumstances that were not present in past reporting periods are among the factors that may result in a current period decision to sell debt securities that were not impaired in prior reporting periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vendor Allowances and Purchase Discounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vendor and manufacturer receivables were $10.6 billion and $9.8 billion as of December&#160;31, 2021 and 2020, respectively, the majority of which relate to purchase discounts and vendor allowances as described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Pharmacy Services segment to receive purchase discounts from established list prices in one, or a combination, of the following forms: (i)&#160;a direct discount at the time of purchase, (ii)&#160;a discount for the prompt payment of invoices or (iii)&#160;when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within 30&#160;days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#8217;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Pharmacy Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Pharmacy Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vendor allowances received by the Retail/LTC segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any such allowances received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon sales volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company establishes a receivable for vendor income that is earned but not yet received based on historical trends and data. The majority of vendor receivables are collected within the following fiscal quarter. Historically, adjustments to the Company&#8217;s vendor receivables resulting from the reconciliation of receivables recognized to the amounts collected have not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have not been any material changes in the way the Company accounts for vendor allowances or purchase discounts during the past three&#160;years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost or net realizable value using the weighted average cost method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of ending inventory is reduced for estimated inventory losses that have occurred during the interim period between physical inventory counts. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. The Company&#8217;s accounting for inventory contains uncertainty since management must use judgment to estimate the inventory losses that have occurred during the interim period between physical inventory counts. When estimating these losses, a number of factors are considered which include historical physical inventory results on a location-by-location basis and current physical inventory loss trends.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total reserve for estimated inventory losses covered by this critical accounting policy was $522 million and $369 million as of December&#160;31, 2021 and 2020, respectively. Although management believes there is sufficient current and historical information available to record reasonable estimates for estimated inventory losses, it is possible that actual results could differ. In order to help investors assess the aggregate risk, if any, associated with the inventory-related uncertainties discussed above, a ten&#160;percent (10%)&#160;pre-tax change in estimated inventory losses, which is a reasonably likely change, would increase or decrease the total reserve for estimated inventory losses by approximately $52 million as of December&#160;31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although management believes that the estimates discussed above are reasonable and the related calculations conform to generally accepted accounting principles, actual results could differ from such estimates, and such differences could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Right-of-Use Assets and Lease Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#8217;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. The Company evaluates the recoverability of its right-of-use assets as described in &#8220;Long-Lived Asset Impairment&#8221; below.  </span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s real estate leases typically contain options that permit renewals for additional periods of up to five years each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For real estate leases, the Company accounts for lease components and nonlease components as a single lease component.  Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Asset Impairment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recoverability of Definite-Lived Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such an asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#8217;s estimated future cash flows (discounted). If required, an impairment loss is recorded for the portion of the asset group&#8217;s carrying value that exceeds the asset group&#8217;s estimated future cash flows (discounted).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The long-lived asset impairment loss calculation contains uncertainty since management must use judgment to estimate each asset group&#8217;s future sales, profitability and cash flows. When preparing these estimates, the Company considers historical results and current operating trends and consolidated sales, profitability and cash flow results and forecasts. These estimates can be affected by a number of factors including general economic and regulatory conditions, efforts of third party organizations to reduce their prescription drug costs and/or increased member co-payments, the continued efforts of competitors to gain market share and consumer spending patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company completed a strategic review of its retail business and announced the creation of new formats for its stores to continue to drive higher engagement with customers. As part of this review, the Company evaluated changes in population, consumer buying patterns and future health needs to ensure it has the right kinds of stores in the right locations for consumers and for the business. In connection with this initiative, on November 17, 2021, the Board of Directors of CVS Health Corporation (the &#8220;Board&#8221;) authorized the closing of approximately 900 stores over the next three years. The Company expects to close approximately 300 stores each year between 2022 and 2024. As a result, management determined that there were indicators of impairment with respect to the impacted stores&#8217; asset groups, including the associated operating lease right-of-use assets and property and equipment. A long-lived asset impairment test was performed during the fourth quarter of 2021 and the results of the impairment test indicated that the fair value of certain retail store asset groups were lower than their respective carrying values. Accordingly, in the three months ended December 31, 2021, the Company recorded a store impairment charge of approximately $1.4 billion, consisting of a write down of approximately $1.1&#160;billion related to operating lease right-of-use assets and $261&#160;million related to property and equipment, within the Retail/LTC segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material impairment charges recognized on long-lived assets in the year ended December 31, 2020. During the year ended December 31, 2019, the Company recorded store impairment charges of $231 million, primarily related to operating lease right-of-use asset impairment charges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recoverability of Goodwill</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of amounts paid for acquisitions over the fair value of the net identifiable assets acquired. Goodwill is subject to annual impairment reviews, or more frequent reviews if events or circumstances indicate that the carrying value may not be recoverable. Goodwill is tested for impairment on a reporting unit basis. The impairment test is performed by comparing the reporting unit&#8217;s fair value with its net book value (or carrying amount), including goodwill. The fair value of the reporting units is estimated using a combination of a discounted cash flow method and a market multiple method. If the net book value (carrying amount) of the reporting unit exceeds its fair value, the reporting unit&#8217;s goodwill is considered to be impaired, and an impairment is recognized in an amount equal to the excess.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of the fair value of the reporting units requires the Company to make significant assumptions and estimates. These assumptions and estimates primarily include the selection of appropriate peer group companies; control premiums and valuation multiples appropriate for acquisitions in the industries in which the Company competes; discount rates; terminal growth rates; and forecasts of revenue, operating income, depreciation and amortization, income taxes, capital expenditures and future working capital requirements. When determining these assumptions and preparing these estimates, the Company considers each reporting unit&#8217;s historical results and current operating trends; consolidated revenues, profitability and cash flow results and forecasts; and industry trends. The Company&#8217;s estimates can be affected by a number of factors, including general economic and regulatory conditions; the risk-free interest rate environment; the Company&#8217;s market capitalization; efforts of customers and payers to reduce costs, including their prescription drug costs, and/or increase member co-payments; the continued efforts of competitors to gain market share, consumer spending patterns and the Company&#8217;s ability to achieve its revenue growth projections and execute on its cost reduction initiatives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Goodwill Impairment Test</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill. The results of the impairment tests indicated an impairment of the goodwill associated with the LTC reporting unit, as the reporting unit&#8217;s carrying value exceeded its fair value as of the testing date. The results of the impairment tests of the remaining reporting units indicated that there was no impairment of goodwill as of the testing date. The fair values of the reporting units with goodwill exceeded their carrying values by significant margins, with the exception of the Commercial Business reporting unit, which exceeded its carrying value by approximately 3%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; included in Item 8 of this 10-K, during 2021, the LTC reporting unit has continued to face challenges that have impacted the Company&#8217;s ability to grow the LTC reporting unit&#8217;s business at the rate estimated when its 2020 goodwill impairment test was performed. These challenges include lower net facility admissions, net long-term care facility customer losses and the prolonged adverse impact of the COVID-19 pandemic and the emerging new variants, which resulted in more significant declines in occupancy rates experienced by the Company&#8217;s long-term care facility customers than previously anticipated. During the third quarter of 2021, LTC management updated their 2021 annual forecast and submitted their long-term plan which showed deterioration in the financial results for the remainder of 2021 and beyond. The Company utilized these updated projections in performing its annual impairment test, which indicated that the fair value of the LTC reporting unit was lower than its carrying value, resulting in a $431 million goodwill impairment charge in the third quarter of 2021. The fair value of the LTC reporting unit was determined using a combination of a discounted cash flow method and a market multiple method. Subsequent to the impairment charge recorded in the third quarter of 2021, there is no remaining goodwill balance in the LTC reporting unit. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has experienced declines in its Commercial Insured medical membership subsequent to the closing date of the Aetna Acquisition and may continue to do so for a number of reasons, including as a result of the competitive Commercial business environment. In addition, COVID-19 and the emerging new variants have had and may continue to have an adverse impact on medical membership in the Commercial business due to reductions in workforce at existing customers (including due to business failures) as well as reduced willingness to change benefit providers by prospective customers. The Company&#8217;s fair value estimate is sensitive to significant assumptions including changes in medical membership, revenue growth rate, operating income and the discount rate. Although the Company believes the financial projections used to determine the fair value of the Commercial Business reporting unit in the third quarter of 2021 were reasonable and achievable, the challenges described above may affect the Company&#8217;s ability to increase medical membership or operating income in the Commercial Business reporting unit at the rate estimated when such goodwill impairment test was performed and may continue to do so. As of December 31, 2021, the goodwill balance in the Commercial Business reporting unit was $26.5 billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 Goodwill Impairment Test</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2020, the Company performed its required annual impairment test of goodwill. The results of this impairment test indicated that there was no impairment of goodwill as of the testing date. The goodwill impairment test resulted in the fair values of all of the Company&#8217;s reporting units exceeding their carrying values by significant margins, with the exception of the Commercial Business and LTC reporting units, which exceeded their carrying values by approximately 6% and 12%, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 Goodwill Impairment Test</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2019, the Company performed its required annual impairment test of goodwill. The results of this impairment test indicated that there was no impairment of goodwill as of the testing date. The goodwill impairment test resulted in the fair values of all of the Company&#8217;s reporting units exceeding their carrying values by significant margins, with the exception of the Commercial Business and LTC reporting units, which exceeded their carrying values by approximately 4% and 9%, respectively.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recoverability of Indefinite-Lived Intangible Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are subject to annual impairment reviews, or more frequent reviews if events or circumstances indicate that their carrying value may not be recoverable. Indefinite-lived intangible assets are tested by comparing the estimated fair value of the asset to its carrying value. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indefinite-lived intangible asset impairment loss calculation contains uncertainty since management must use judgment to estimate fair value based on the assumption that, in lieu of ownership of an intangible asset, the Company would be willing to pay a royalty in order to utilize the benefits of the asset. Fair value is estimated by discounting the hypothetical royalty payments to their present value over the estimated economic life of the asset. These estimates can be affected by a number of factors including general economic conditions, availability of market information and the profitability of the Company. There were no impairment losses recognized on indefinite-lived intangible assets in any of the years ended December&#160;31, 2021, 2020 or 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Costs Payable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At&#160;December&#160;31, 2021 and 2020, 75% and 77% respectively, of health care costs payable are estimates of the ultimate cost of (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid (collectively, &#8220;IBNR&#8221;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. The remainder of health care costs payable is primarily comprised of pharmacy and capitation payables, other amounts due to providers pursuant to risk sharing agreements and accruals for state assessments. The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; included in Item 8 of this 10-K for additional information on the Company&#8217;s reserving methodology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021 and 2020, the Company observed an increase in completion factors relative to those assumed at the prior year end. After considering the claims paid in 2021 and 2020 with dates of service prior to the fourth quarter of the previous year, the Company observed assumed incurred claim weighted average completion factors that were 21 and 4 basis points higher, respectively, than previously estimated, resulting in a decrease of $207 million and $35 million in 2021 and 2020, respectively, in health care costs payable that related to the prior year. The Company has considered the pattern of changes in its completion factors when determining the completion factors used in its estimates of IBNR as of December&#160;31, 2021. However, based on historical claim experience, it is reasonably possible that the Company&#8217;s estimated weighted average completion factors may vary by plus or minus 13 basis points from the Company&#8217;s assumed rates, which could impact health care costs payable by approximately plus or minus $186 million pretax.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also during 2021 and 2020, the Company observed that health care costs for claims with claim incurred dates of three months or less before the financial statement date were lower than previously estimated. Specifically, after considering the claims paid in 2021 and 2020 with claim incurred dates for the fourth quarter of the previous year, the Company observed health care costs that were 5.0% and 4.0% lower, respectively, for each fourth quarter than previously estimated, resulting in a reduction of $581 million and $394 million in 2021 and 2020, respectively, in health care costs payable that related to prior year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management considers historical health care cost trend rates together with its knowledge of recent events that may impact current trends when developing estimates of current health care cost trend rates. When establishing reserves as of December&#160;31, 2021, the Company increased its assumed health care cost trend rates for the most recent three months by 1.8% from health care cost trend rates recently observed. Health care cost trend rates during the past two years have been impacted by utilization changes driven by the COVID-19 pandemic. The impact has not been uniform, with products and select geographies experiencing utilization impacts due to COVID-19 waves. Based on historical claim experience, it is reasonably possible that the Company&#8217;s estimated health care cost trend rates may vary by plus or minus 3.5% from the assumed rates, which could impact health care costs payable by plus or minus $450 million pretax.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes using the asset and liability method. Deferred tax assets and liabilities are established for any temporary differences between financial and tax reporting bases and are adjusted as needed to reflect changes in the enacted tax rates expected to be in effect when the temporary differences reverse. Such adjustments are recorded in the period </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in which changes in tax laws are enacted, regardless of when they are effective. Deferred tax assets are reduced, if necessary, by a valuation allowance to the extent future realization of those losses, deductions or other tax benefits is sufficiently uncertain.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgment is required in determining the provision for income taxes and the related taxes payable and deferred tax assets and liabilities since, in the ordinary course of business, there are transactions and calculations where the ultimate tax outcome is uncertain. Additionally, the Company&#8217;s tax returns are subject to audit by various domestic and foreign tax authorities that could result in material adjustments based on differing interpretations of the tax laws. Although management believes that its estimates are reasonable and are based on the best available information at the time the provision is prepared, actual results could differ from these estimates resulting in a final tax outcome that may be materially different from that which is reflected in the consolidated financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax benefit from an uncertain tax position is recognized only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement with the related tax authority. Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision. Significant judgment is required in determining uncertain tax positions. The Company has established accruals for uncertain tax positions using its judgment and adjusts these accruals, as warranted, due to changing facts and circumstances.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; included in Item 8 of this 10-K for a description of new accounting pronouncements applicable to the Company.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A.  Quantitative and Qualitative Disclosures About Market Risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s earnings and financial condition are exposed to interest rate risk, credit quality risk, market valuation risk, foreign currency risk, commodity risk and operational risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Interest Rate and Credit Quality Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages interest rate risk by seeking to maintain a tight match between the durations of assets and liabilities when appropriate.&#160;The Company manages credit quality risk by seeking to maintain high average credit quality ratings and diversified sector exposure within its debt securities portfolio.&#160;In connection with its investment and risk management objectives, the Company also uses derivative financial instruments whose market value is at least partially determined by, among other things, levels of or changes in interest rates (short-term or long-term), duration, prepayment rates, equity markets or credit ratings/spreads.&#160;The Company&#8217;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.&#160;These instruments, viewed separately, subject the Company to varying degrees of interest rate, equity price and credit risk.&#160;However, when used for hedging, the Company expects these instruments to reduce overall risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s investment portfolio supported the following products at December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.428%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience-rated products </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,142&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,812&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment risks associated with experience-rated products generally do not impact the Company&#8217;s operating results. The risks associated with investments supporting experience-rated pension and annuity products in the large case pensions business in the Company&#8217;s Corporate/Other segment are assumed by the contract holders and not by the Company (subject to, among other things, certain minimum guarantees).&#160;Assets supporting experience-rated products may be subject to contract holder or participant withdrawals.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The debt securities in the Company&#8217;s investment portfolio had an average credit quality rating of A at both December&#160;31, 2021 and 2020, with a fair value of approximately $6.7 billion and $6.3 billion rated AAA at December&#160;31, 2021 and 2020, respectively.&#160;The fair value of debt securities that were rated below investment grade (that is, having a credit quality rating below BBB-/Baa3) was $2.3 billion and $1.9 billion at December&#160;31, 2021 and 2020, respectively (of which 2% at both December&#160;31, 2021 and 2020 supported experience-rated products).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, the Company held $305 million and $321 million, respectively, of municipal debt securities that were guaranteed by third parties, representing 1% of total investments at both December&#160;31, 2021 and 2020.&#160;These securities had an average credit quality rating of AA at both December&#160;31, 2021 and 2020 with the guarantee. These securities had an average credit quality rating of A at both December&#160;31, 2021 and 2020, respectively, without the guarantee.&#160;The Company does not have any significant concentration of investments with third party guarantors (either direct or indirect).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally classifies debt securities as available for sale, and carries them at fair value on the consolidated balance sheets.&#160;At both December&#160;31, 2021 and 2020, less than 1% of debt securities were valued using inputs that reflect the Company&#8217;s assumptions (categorized as Level 3 inputs in accordance with accounting principles generally accepted in the United States of America).&#160;See Note 4 &#8216;&#8216;Fair Value&#8217;&#8217; included in Item 8 of this 10-K for additional information on the methodologies and key assumptions used to determine the fair value of investments. For additional information related to investments, see Note 3 &#8216;&#8216;Investments&#8217;&#8217; included in Item 8 of this 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly reviews debt securities in its portfolio to determine whether a decline in fair value below the cost basis or carrying value has occurred.&#160;If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. The amount of the credit-related component is recorded as an allowance </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. The impairment of debt securities is considered a critical accounting policy.&#160;See &#8216;&#8216;Critical Accounting Policies - Impairments of Debt Securities&#8221; in the MD&amp;A included in Item 7 of this 10-K for additional information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Market Valuation Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly evaluates its risk from market-sensitive instruments by examining, among other things, levels of or changes in interest rates (short-term or long-term), duration, prepayment rates, equity markets and/or credit ratings/spreads. The Company also regularly evaluates the appropriateness of investments relative to management-approved investment guidelines (and operates within those guidelines) and the business objectives of its portfolios.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a quarterly basis, the Company reviews the impact of hypothetical net losses in its investment portfolio on the Company&#8217;s consolidated near-term financial condition, operating results and cash flows assuming the occurrence of certain reasonably possible changes in near-term market rates and prices. Interest rate changes (whether resulting from changes in treasury yields or credit spreads or other factors) represent the most material risk exposure category for the Company.&#160;The Company has estimated the impact on the fair value of market sensitive instruments based on the net present value of cash flows using a representative set of likely future interest rate scenarios. The assumptions used were as follows: an immediate increase of 100 basis points in interest rates (which the Company believes represents a moderately adverse scenario) for long-term debt issued by the Company, as well as its interest rate sensitive investments and an immediate decrease of 15% in prices for publicly traded domestic equity securities in the Company&#8217;s investment portfolio.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming an immediate increase of 100 basis points in interest rates, the theoretical decline in the fair values of market sensitive instruments at December&#160;31, 2021 is as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The fair value of long-term debt issued by the Company would decline by approximately $4.6 billion ($5.8 billion pretax). Changes in the fair value of long-term debt do not impact the Company&#8217;s operating results or financial condition.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The theoretical reduction in the fair value of interest rate sensitive investments partially offset by the theoretical reduction in the fair value of interest rate sensitive liabilities would result in a net decline in fair value of approximately $680 million ($860 million pretax) related to continuing non-experience-rated products. Reductions in the fair value of investment securities would be reflected as an unrealized loss in equity, as the Company classifies these debt securities as available for sale. The Company does not record liabilities at fair value.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the value of the Company&#8217;s publicly traded domestic equity securities held within its investment portfolio were to decline by 15%, this would result in a net decline in fair value of $14&#160;million ($18&#160;million pretax).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on overall exposure to interest rate risk and equity price risk, the Company believes that these changes in market rates and prices would not materially affect consolidated near-term financial condition, operating results or cash flows as of December&#160;31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Foreign Currency and Commodity Risk</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, the Company did not have any material foreign currency exchange rate or commodity derivative instruments in place and believes its exposure to foreign currency exchange rate risk is not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Operational Risks</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also faces certain operational risks. Those risks include risks related to the COVID-19 pandemic and risks related to information security, including cybersecurity. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread of COVID-19, or actions taken to mitigate its spread, could have material and adverse effects on our ability to operate our businesses effectively, including as a result of the complete or partial closure of facilities or labor shortages. Disruptions in our supply chains, our distribution chains and/or public and private infrastructure, including communications, financial services and supply chains, could materially and adversely impact our business operations. We have transitioned a significant subset of our colleagues to a remote work environment in an effort to mitigate the spread of COVID-19, as have a significant number of our third-party service providers, which may amplify certain risks to our businesses, including an increased demand for information technology resources, increased risk of phishing and other cyber attacks, increased risk of unauthorized dissemination of sensitive personal information or proprietary or confidential information about us or our medical members or other third-parties and increased risk of business interruptions.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its vendors have experienced diverse cyber attacks and expect to continue to experience cyber attacks going forward. As examples, the Company and its vendors have experienced attempts to gain access to systems, denial of service attacks, attempted malware infections, account takeovers, scanning activity and phishing emails. Attacks can originate from external criminals, terrorists, nation states or internal actors. The Company is dedicating and will continue to dedicate significant resources and incur significant expenses to maintain and update on an ongoing basis the systems and processes that are designed to mitigate the information security risks it faces and protect the security of its computer systems, software, networks and other technology assets against attempts by unauthorized parties to obtain access to confidential information, disrupt or degrade service or cause other damage. The impact of cyber attacks has not been material to the Company&#8217;s operations or operating results through December&#160;31, 2021. The Board and its Audit Committee and Nominating and Corporate Governance Committee are regularly informed regarding the Company&#8217;s information security policies, practices and status.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_100"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.  Financial Statements and Supplementary Data.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Consolidated Financial Statements</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.310%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_103">Consolidated Statements of Operations for the years ended December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_103">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_103">, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_103">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_103"> and 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_103">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_103">103</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_109">Consolidated Statements of Comprehensive Income</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_109"> for the years ended December 31, 2021, 2020 and 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_109">104</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_112">Consolidated Balance Sheets as of December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_112">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_112"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_112">20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_112">105</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_118">Consolidated Statements of Cash Flows for the years ended December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_118">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_118">, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_118">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_118"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_118">19</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_118">106</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_121">Consolidated Statements of Shareholders&#8217; Equity for the years ended December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_121">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_121">, 2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_121">020</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_121"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_121">19</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_121">108</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_127">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_127">109</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_184">Reports of Independent Registered Public Accounting Firm</a></span><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"> </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">(Public Company Accounting Oversight Board ID: <ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDAvZnJhZzoxNjIwZTUwZjA3YTA0Y2UzOWY5NmU2NTY0YWI3MTJhYS90YWJsZTo4NWRhNjc1ODIzNTc0MDZmOGQ0ZGI3OTRlNjEwNjBiMC90YWJsZXJhbmdlOjg1ZGE2NzU4MjM1NzQwNmY4ZDRkYjc5NGU2MTA2MGIwXzEzLTAtMS0xLTc1MDIyL3RleHRyZWdpb246YWM0N2Q1ZmQ3MjIxNGNkNTk2OWIxZjcyODE3MTZiNWJfMzg0ODI5MDY5NzgzNQ_2f47f977-9617-4162-9a2d-228c7072b94b">42</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_184">172</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_100">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Operations</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b1c494708b64508a432d97a589ec1b1_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMtMS0xLTEtMTk2MzU_ed51a452-6f16-426d-bf53-e4e3043527c5">203,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad0aae9c9f234ff9a73812a8299c6fe2_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMtMy0xLTEtMTk2MzU_881d1485-6bde-436e-8d59-a28cd23db5ea">190,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04aed4c0666b4206a0f62a98a13ff94d_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMtNS0xLTEtMTk2MzU_71837681-4daa-49fd-af13-56302f2aae91">185,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzQtMS0xLTEtMTk2MzU_074b0727-d607-46a3-9b60-b477b575b0a3">76,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzQtMy0xLTEtMTk2MzU_d6774641-d58d-4905-86ad-1bcf09921f5f">69,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzQtNS0xLTEtMTk2MzU_2ebd117b-7d40-410b-a48f-9d0df5dba93d">63,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb864d41b1c444a2a00ada6c841fd965_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzUtMS0xLTEtMTk2MzU_d35c6e2c-a483-4125-bd76-f05d0a16e914">11,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3c699aa82e4cebaf12b6a7d6a6a99f_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzUtMy0xLTEtMTk2MzU_4ee329f3-4fbf-423d-8a29-55a08bb9934d">7,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbd44c67114d44b491ec9aec28225e15_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzUtNS0xLTEtMTk2MzU_14a81d71-dd8d-4b84-952a-ecfcace68cf8">7,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzYtMS0xLTEtMTk2MzU_f6d45f2a-0d0d-4bc7-b1f9-bb669ec86531">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzYtMy0xLTEtMTk2MzU_bfa27cf6-60b5-41df-a2a0-7d99bd28e604">798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzYtNS0xLTEtMTk2MzU_65396eb3-2832-4901-91ac-fd8b0d970ead">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzctMS0xLTEtMTk2MzU_e5d761f8-bff1-4c3f-a857-c2bffc4051f6">292,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzctMy0xLTEtMTk2MzU_60f10293-3c3a-4600-86a1-3ac92b4ff375">268,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzctNS0xLTEtMTk2MzU_5a5df62b-1e6d-446c-bd36-7c80cda95ff6">256,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzktMC0xLTEtMTk2MzU_413fad1d-00be-4acc-8403-96459210c49d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzktMC0xLTEtMTk2MzU_ce575564-f9c1-4e8e-b797-b6c51cf6b1e3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzktMC0xLTEtMTk2MzU_d0d59c58-0b62-4ce9-a194-f6d689cd4c1e">Cost of products sold</span></span></span></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzktMS0xLTEtMTk2MzU_63e9684d-5745-4a6d-8ec7-56a79265dd1e">175,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzktMy0xLTEtMTk2MzU_6ac33646-ca7f-4846-a599-a26dddf92798">163,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzktNS0xLTEtMTk2MzU_e589789a-2451-4ad1-9b2f-fee1a64f26f4">158,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEwLTEtMS0xLTE5NjM1_ba6b4f0b-acd0-448e-83b2-883075f7fb49">64,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEwLTMtMS0xLTE5NjM1_7c5bbfcc-9dbf-4a0f-b079-d5c17b20ad67">55,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEwLTUtMS0xLTE5NjM1_51f28795-e924-4a69-8e19-9c65bfbd9803">52,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzExLTEtMS0xLTU0ODg2_df1d90a4-edac-4032-8ffe-227c29ccc723">1,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzExLTMtMS0xLTU0ODg2_f8a050f6-53b8-4080-a469-3e0d1da3e7a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="cvs:StoreImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzExLTUtMS0xLTU0ODg2_68493c06-ca2c-4079-95f4-53e8c87cfc52">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzExLTEtMS0xLTE5NjM1_83459672-f771-42c4-ac9f-0ffc116c8589">431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzExLTMtMS0xLTE5NjM1_f7674ffd-e1d0-4844-8954-6d6b91c8bfda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzExLTUtMS0xLTE5NjM1_7e068847-a110-4725-88e0-3ebfbb631661">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="cvs:OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEyLTEtMS0xLTE5NjM1_2fc77dd3-3eab-4616-bbd2-57db14428d50">37,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEyLTMtMS0xLTE5NjM1_82cb6b1f-ca45-457f-acc4-e5776c23802c">35,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="cvs:OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEyLTUtMS0xLTE5NjM1_446d0769-d4b8-4c2a-964a-9c20e6973827">33,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEzLTEtMS0xLTE5NjM1_fda79f6c-6adf-4fff-80eb-5fc7654ade11">278,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEzLTMtMS0xLTE5NjM1_ed956971-838b-4262-b03e-e779f709d9f5">254,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEzLTUtMS0xLTE5NjM1_05726286-8ffd-4536-9530-166e6759bbed">244,789</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE0LTEtMS0xLTE5NjM1_c6595525-3d9d-4c9e-a78f-efc92e11fb3b">13,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE0LTMtMS0xLTE5NjM1_375d4b99-295e-4687-944f-030b3e481a2b">13,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE0LTUtMS0xLTE5NjM1_2a893dd5-cf34-49c5-8464-db376bf35c70">11,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE1LTEtMS0xLTE5NjM1_2bf50131-c9a9-4f5b-bf0e-d4bab9a7603e">2,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE1LTMtMS0xLTE5NjM1_8e3b63b0-2e0f-4f70-a245-682744bae3c2">2,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE1LTUtMS0xLTE5NjM1_6563c308-0d93-454d-aeba-6bcbfc892760">3,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE2LTEtMS0xLTE5NjM1_ffb2ed5a-1d2c-416a-8a64-b80882cdb46d">452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE2LTMtMS0xLTE5NjM1_e9324632-90fe-4cb7-896e-11c71d6d0125">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE2LTUtMS0xLTE5NjM1_5d802bdc-5168-4d43-b38e-b4d946f27d9e">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE3LTEtMS0xLTE5NjM1_c69b7d8e-13f6-4c8e-b6c2-76f5dc19199b">182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE3LTMtMS0xLTE5NjM1_c5500b23-d855-470b-a816-fac895878716">206</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE3LTUtMS0xLTE5NjM1_3c03baa8-6c25-434b-aea7-1daf6006a6a9">124</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income tax provision</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE4LTEtMS0xLTE5NjM1_779464b8-d867-418e-b8af-304953a0f737">10,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE4LTMtMS0xLTE5NjM1_23a3338e-9cc8-4572-abac-2fe34430282e">9,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE4LTUtMS0xLTE5NjM1_1deb739e-2bd9-466c-8809-3b0d69f7215f">8,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE5LTEtMS0xLTE5NjM1_ebb769ab-ddc2-4766-8b44-45b2b7070222">2,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE5LTMtMS0xLTE5NjM1_efd04343-fc63-47f9-b621-a8c2684e200f">2,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE5LTUtMS0xLTE5NjM1_07b42c61-3cbf-4665-bcf7-0f985334efcd">2,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIwLTEtMS0xLTE5NjM1_979db47b-6805-46e0-991c-091818447fa6">7,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIwLTMtMS0xLTE5NjM1_49192a1b-5222-4d12-897f-3d379539d6cf">7,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIwLTUtMS0xLTE5NjM1_98947f14-987f-487d-8ea6-92df1e7ecf39">6,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIxLTEtMS0xLTE5NjM1_0adf693b-4c38-4b09-8e19-17ed9fcba78f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIxLTMtMS0xLTE5NjM1_294fa4a2-8cb5-45c2-845f-814e97c1f38c">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIxLTUtMS0xLTE5NjM1_dc527405-6318-4016-850c-1cf3360f5c86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIyLTEtMS0xLTE5NjM1_cd518ef2-bc6f-4084-8121-4b45dc784472">7,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIyLTMtMS0xLTE5NjM1_d6a4c39c-3eac-4889-b0fc-544909292a0c">7,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIyLTUtMS0xLTE5NjM1_d850f32a-305a-4df6-8713-897ce454f3a4">6,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIzLTEtMS0xLTE5NjM1_8f5d1968-a24d-49a6-8c7d-ae2fb465e84f">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIzLTMtMS0xLTE5NjM1_a02b958f-9cca-4456-ac1f-08eea9680618">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIzLTUtMS0xLTE5NjM1_fcd784b8-8e3c-47db-a33c-86ad5b597df1">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI0LTEtMS0xLTE5NjM1_12c9104b-559b-4023-bca3-b23b18f058aa">7,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI0LTMtMS0xLTE5NjM1_d04d02a4-36e0-49fe-aa7d-ecb3e82fa34b">7,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI0LTUtMS0xLTE5NjM1_a1361448-3827-40a3-980d-7d7992b6ef00">6,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per share:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI3LTEtMS0xLTE5NjM1_7d590c1d-937a-4216-886e-9e867dea1dcd">6.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI3LTMtMS0xLTE5NjM1_dfcd2dc0-2917-43e4-b23a-1c9d63953925">5.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI3LTUtMS0xLTE5NjM1_ad3d93ec-2f3c-41bb-bade-bf2d6c170e3c">5.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI4LTEtMS0xLTE5NjM1_38cc0b00-fec1-4958-8a37-79f7998a0e30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI4LTMtMS0xLTE5NjM1_c247b389-d762-4e2d-8048-47f1aa054dd1">0.01</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI4LTUtMS0xLTE5NjM1_c972c391-8262-4fdf-b620-12580083f3d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI5LTEtMS0xLTE5NjM1_77a84742-44e5-4d7f-be91-60b16f0ff867">6.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI5LTMtMS0xLTE5NjM1_2b827271-c2e3-454e-a6cf-c78e081006b4">5.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI5LTUtMS0xLTE5NjM1_3e48898d-85f0-4db4-a9f1-22f97f93b63f">5.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average basic shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMwLTEtMS0xLTE5NjM1_9d73d772-18c8-44c6-a51b-4c367ff0db9a">1,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMwLTMtMS0xLTE5NjM1_e7e99a03-5c36-418d-bb90-3c1efb830e93">1,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMwLTUtMS0xLTE5NjM1_31bc37c9-bb3d-4361-885b-2058b465c90c">1,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMyLTEtMS0xLTE5NjM1_f5b8a036-3154-4150-97f1-1f24dfe1d4dd">5.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMyLTMtMS0xLTE5NjM1_86a5bce7-344a-4b70-b4fd-7c51ee0d9d77">5.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMyLTUtMS0xLTE5NjM1_b1dd4782-e759-435c-8d9e-5d1c31f9c3f0">5.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to CVS Health</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMzLTEtMS0xLTE5NjM1_d72ce382-079a-4a68-bd23-0067fe9a8101">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="2" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMzLTMtMS0xLTE5NjM1_3879fe24-9a06-4035-9052-a7ba2aa99ce9">0.01</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="2" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMzLTUtMS0xLTE5NjM1_70743065-6850-44bc-ace7-dcb771696f17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to CVS Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM0LTEtMS0xLTE5NjM1_8a3ccd57-60df-4b94-a9b4-fc6dd8514b26">5.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM0LTMtMS0xLTE5NjM1_21a38801-e480-4ff0-a886-48024362c759">5.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM0LTUtMS0xLTE5NjM1_ff7f1b08-821f-4468-9011-fe5e507af0e5">5.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average diluted shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM1LTEtMS0xLTE5NjM1_66a56f2b-73ac-4a85-9138-95370707e2bd">1,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM1LTMtMS0xLTE5NjM1_d5d38fc0-1664-46e4-ba3d-1aaebf55d20b">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM1LTUtMS0xLTE5NjM1_163ba47e-a7e7-44ba-bbb9-32a35d2d5dc3">1,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends declared per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM2LTEtMS0xLTE5NjM1_b05a0ecd-9a8b-49d9-8d76-e4cb66b12a8c">2.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM2LTMtMS0xLTE5NjM1_218605cc-e317-47ed-aeb9-174e104e3d7d">2.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM2LTUtMS0xLTE5NjM1_7b323639-128c-45a7-a674-d1b58bd6a17e">2.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_109"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_100">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzItMS0xLTEtMTk2MzU_cd518ef2-bc6f-4084-8121-4b45dc784472">7,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzItMy0xLTEtMTk2MzU_d6a4c39c-3eac-4889-b0fc-544909292a0c">7,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzItNS0xLTEtMTk2MzU_d850f32a-305a-4df6-8713-897ce454f3a4">6,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized investment gains (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzQtMS0xLTEtMTk2MzU_3b51d37a-d548-4ee2-b8d4-76a8d340e709">436</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzQtMy0xLTEtMTk2MzU_535a7282-0003-41fb-9f74-22ca7e553e85">440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzQtNS0xLTEtMTk2MzU_b4a99237-af0e-44c4-8a77-73fe5a32f3fa">677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzUtMS0xLTEtMTk2MzU_70caa640-c522-4509-84a3-ea3c94a32cc5">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzUtMy0xLTEtMTk2MzU_6ca51956-afca-4b99-ab97-8e05af303ea2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzUtNS0xLTEtMTk2MzU_5e2c1d8f-f8e3-4a07-9a8b-9dd32b31927b">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzYtMS0xLTEtMTk2MzU_81fe1ca5-118c-4875-9a46-66c340fb1ae0">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzYtMy0xLTEtMTk2MzU_027b6a20-f477-4f7c-85af-e8a864e123c7">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzYtNS0xLTEtMTk2MzU_263a6183-8e43-4eee-b7b7-3c487c083862">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and other postretirement benefits </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzctMS0xLTEtMTk2MzU_eefd6293-22ad-42b7-a91b-6da7c3968a13">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzctMy0xLTEtMTk2MzU_6cf57425-7849-434a-8bb2-8facedbdcc9c">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzctNS0xLTEtMTk2MzU_655105fd-42b2-4f1b-a4c3-6a031901c1f8">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzgtMS0xLTEtMTk2MzU_eef6559a-abe3-4299-bea8-9f97e5554331">449</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzgtMy0xLTEtMTk2MzU_a1b78711-2601-4d16-a3dc-5deea61fda9f">395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzgtNS0xLTEtMTk2MzU_4216b621-dbd2-43dd-8d74-b1317fe37c3b">917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzktMS0xLTEtMTk2MzU_d08298f6-85de-4c96-85a1-a03bc183b625">7,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzktMy0xLTEtMTk2MzU_ecc6ef40-fbab-4718-bf4c-b36afadf16f7">7,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzktNS0xLTEtMTk2MzU_05a4668a-6fdd-4295-9289-042a54270eff">7,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzEwLTEtMS0xLTE5NjM1_23fef9b6-2371-4666-af49-098efc0f0dc0">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzEwLTMtMS0xLTE5NjM1_33677bce-f715-44e2-bc0c-cbd287807575">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzEwLTUtMS0xLTE5NjM1_4741bb78-7eea-4ce3-a235-5e9ecb0717a4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to CVS Health</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzExLTEtMS0xLTE5NjM1_6a31bb2c-d0c2-4dd8-8864-a5978bb74cc2">7,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzExLTMtMS0xLTE5NjM1_774820c3-bc4e-4588-86ec-078f297807a1">7,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzExLTUtMS0xLTE5NjM1_7c3801cb-cbf4-45a2-81cd-e5c4dfe4052a">7,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_112"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_100">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except per share amounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMtMS0xLTEtMTk2MzU_f5cc04aa-c641-4c96-9046-12137ac56422">9,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMtMy0xLTEtMTk2MzU_c6dae105-688e-42f8-af5e-b8f75a2bf934">7,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQtMS0xLTEtMTk2MzU_b8fa5cac-6d13-41a5-9c68-afbf5523e9a7">3,117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQtMy0xLTEtMTk2MzU_6addb5c5-2255-472e-a193-082fe5acc2eb">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzUtMS0xLTEtMTk2MzU_eb05dacb-b665-4232-a320-649507536e23">24,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzUtMy0xLTEtMTk2MzU_3f1b6810-f5f3-4800-9cc5-070968a25318">21,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzYtMS0xLTEtMTk2MzU_de2345e3-55ee-49f8-81db-a5d7abecef53">17,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzYtMy0xLTEtMTk2MzU_d70ec9cc-dad0-4ead-8624-dd2a92069a21">18,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzctMS0xLTEtMTk2MzU_c0a73019-2c65-494c-9196-b1b224d7c48d">5,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzctMy0xLTEtMTk2MzU_c490108b-336b-441f-a48a-73c47a76b771">5,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzgtMS0xLTEtMTk2MzU_8e872c6c-d0be-4cd5-82bd-fe00465c9402">60,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzgtMy0xLTEtMTk2MzU_04d9aa8b-ef68-489b-abf9-ba8dbb6e2159">56,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzktMS0xLTEtMTk2MzU_716e172c-63bb-410b-a0e2-e34e228c2528">23,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzktMy0xLTEtMTk2MzU_a89b5022-023d-4370-94ab-4a82ae8a61bc">20,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzEwLTEtMS0xLTE5NjM1_c5f7d540-6891-4e77-9b73-6181f290d67f">12,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzEwLTMtMS0xLTE5NjM1_6a20807a-07b6-428c-bc7a-73f7b2d1e067">12,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzExLTEtMS0xLTE5NjM1_02b35e5a-fac2-4724-a69f-fcd315a0e2f4">19,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzExLTMtMS0xLTE5NjM1_13015cc3-7480-4fb0-8a70-15ec21001989">20,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzEyLTEtMS0xLTE5NjM1_68789c5d-b3fe-4be8-92b9-c58c5b531753">79,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzEyLTMtMS0xLTE5NjM1_352fb464-05c1-4f24-ba2a-bbbd87c13525">79,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzEzLTEtMS0xLTE5NjM1_4e45f40f-7d49-4de4-ae6c-bc1e5b572c62">29,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzEzLTMtMS0xLTE5NjM1_276b742f-d931-4e54-8256-dfcc51aa3673">31,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate accounts assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzE0LTEtMS0xLTE5NjM1_95b6dad9-7280-4b7b-b3e7-8f6f40ba1358">5,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzE0LTMtMS0xLTE5NjM1_d9eccfbc-5e92-4c45-a6a2-814f34566431">4,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzE1LTEtMS0xLTE5NjM1_56410a04-78da-4791-8ef5-ccc24b1ff346">4,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzE1LTMtMS0xLTE5NjM1_ef235398-0cb2-441c-b40a-0899ae95c1f2">4,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzE2LTEtMS0xLTE5NjM1_64d6d074-ffe3-4ee6-bf6a-c2b5bf0b390c">232,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzE2LTMtMS0xLTE5NjM1_1e7721d1-193b-44a4-b835-b6439ca62bcf">230,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzE5LTEtMS0xLTE5NjM1_fe7121ec-6d43-4188-8dce-338138b6c7ea">12,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzE5LTMtMS0xLTE5NjM1_a9a32aa7-0594-4cd9-a3f7-949ecb84aa75">11,138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy claims and discounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:PharmacyClaimsandDiscountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzIwLTEtMS0xLTE5NjM1_fff96ae4-071c-40be-b453-65a3957beae6">17,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:PharmacyClaimsandDiscountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzIwLTMtMS0xLTE5NjM1_80f8054c-bd3d-47f3-b857-3162edb03b2e">15,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzIxLTEtMS0xLTE5NjM1_72da33e9-3511-4dae-b7be-dafd25882a9c">8,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzIxLTMtMS0xLTE5NjM1_187dd936-f5e5-43a2-9458-db516d8792ef">7,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policyholders&#8217; funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:OtherPolicyholderFunds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzIyLTEtMS0xLTE5NjM1_cf850842-5b0b-4f26-aba5-eaba9fdc4a5e">4,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:OtherPolicyholderFunds" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzIyLTMtMS0xLTE5NjM1_94110204-3032-42f4-a1bb-0642d7387939">4,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzIzLTEtMS0xLTE5NjM1_ab396c2c-1683-4a63-ab6a-e6031b572185">17,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzIzLTMtMS0xLTE5NjM1_7a2d25bd-9784-4806-a729-e601726f3b7f">14,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other insurance liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI0LTEtMS0xLTE5NjM1_7fcd3e35-30af-485b-8be9-6003a27b6445">1,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI0LTMtMS0xLTE5NjM1_a1479ea4-07a3-46d6-aa22-e60efc294d97">1,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI1LTEtMS0xLTE5NjM1_552d66b1-7423-4b6c-8d6f-231b2ee66573">1,646</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI1LTMtMS0xLTE5NjM1_a1f6f1b2-6d18-4db6-bd09-dd30549f7310">1,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI3LTEtMS0xLTE5NjM1_63434eca-8303-44bd-90a5-335dd6128d71">4,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI3LTMtMS0xLTE5NjM1_55ae75b5-9911-473e-a2ff-dfbac61b3d73">5,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI4LTEtMS0xLTE5NjM1_00cd14b1-167e-49c9-9546-52117af98c7a">67,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI4LTMtMS0xLTE5NjM1_06cf8e13-3a04-4070-a3e3-0b559db13250">62,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI5LTEtMS0xLTE5NjM1_2d18264a-fab4-4f9e-bee1-41bd32c8bb6f">18,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI5LTMtMS0xLTE5NjM1_89e4d666-5188-4987-a638-2a2591b87695">18,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMwLTEtMS0xLTE5NjM1_ba3fcc44-0d5f-442d-b93c-2b1510045a05">51,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMwLTMtMS0xLTE5NjM1_57922b55-6db6-48f0-9391-f1e2e85dbb9a">59,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMxLTEtMS0xLTE5NjM1_7e839379-6753-4fbb-8754-2c65e4b982e9">6,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMxLTMtMS0xLTE5NjM1_1bb5b9f0-b97f-4166-833b-d97b0b990bef">6,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separate accounts liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMyLTEtMS0xLTE5NjM1_b455440d-ecdf-4bc2-b307-d8a24b691c37">5,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:SeparateAccountsLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMyLTMtMS0xLTE5NjM1_5d4dbda2-c1af-441d-bc4a-6328c43182b7">4,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term insurance liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMzLTEtMS0xLTE5NjM1_f5305791-f970-4e7b-9105-cec3bf5b74bd">6,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:OtherInsuranceLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMzLTMtMS0xLTE5NjM1_ba2d47a2-4f8c-4d05-8aab-bdddf3a66a12">7,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM0LTEtMS0xLTE5NjM1_342ad8d2-f622-45d8-a61f-ec68d879efe3">1,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM0LTMtMS0xLTE5NjM1_baa6fbe1-dc52-4561-9f71-f03628270525">2,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM1LTEtMS0xLTE5NjM1_9dab007d-7c03-4e19-a62b-96f74b197610">157,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM1LTMtMS0xLTE5NjM1_7b2d29a0-90be-4a68-980d-febe22d54925">161,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 16)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM2LTEtMS0xLTE5NjM1_ab5d2f59-d087-4a9b-a266-b45cf90289be"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM2LTMtMS0xLTE5NjM1_30353ecb-62bf-430c-911f-2deabed6a21d"></ix:nonFraction></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDlkZGNlNmIzMmMyNGQzZmFhYWRlOWFiMmMyNDQ3M2NfMzE_a7387f64-998e-46c9-b0bb-097cc667ca67"><ix:nonFraction unitRef="usdPerShare" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDlkZGNlNmIzMmMyNGQzZmFhYWRlOWFiMmMyNDQ3M2NfMzE_c5b8a22f-7ec0-48d0-bf65-e1228ccceef0">0.01</ix:nonFraction></ix:nonFraction>: <ix:nonFraction unitRef="shares" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDlkZGNlNmIzMmMyNGQzZmFhYWRlOWFiMmMyNDQ3M2NfMzU_7ed259e0-78b6-4f2d-8b9b-94be56ade6b1"><ix:nonFraction unitRef="shares" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDlkZGNlNmIzMmMyNGQzZmFhYWRlOWFiMmMyNDQ3M2NfMzU_ba8c5ab2-6288-4c34-b7ee-54cef96bd12e">0.1</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDlkZGNlNmIzMmMyNGQzZmFhYWRlOWFiMmMyNDQ3M2NfNTc_6bc7ac6d-f80a-4d55-b445-46a89b834dfd"><ix:nonFraction unitRef="shares" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDlkZGNlNmIzMmMyNGQzZmFhYWRlOWFiMmMyNDQ3M2NfNTc_787cb0d6-1584-462d-b714-75359fbcc15a"><ix:nonFraction unitRef="shares" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDlkZGNlNmIzMmMyNGQzZmFhYWRlOWFiMmMyNDQ3M2NfNTc_bd54e186-d082-4d4b-9f55-806cd054204e"><ix:nonFraction unitRef="shares" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDlkZGNlNmIzMmMyNGQzZmFhYWRlOWFiMmMyNDQ3M2NfNTc_fe4a3d5c-78be-4829-8703-5b5fef00d001">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued or outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTEtMS0xLTE5NjM1_a9ad9f3d-9c89-435b-a04d-154dc8341cae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTMtMS0xLTE5NjM1_9cd3489d-7e21-476b-91e4-023c0876033c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjRlYWFjNDY5MjBkNDQ5ZGFiYzE5NDViM2I0OWYyZGNfMjg_92d6359e-bd24-4319-b64f-7d0c56cf1860"><ix:nonFraction unitRef="usdPerShare" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjRlYWFjNDY5MjBkNDQ5ZGFiYzE5NDViM2I0OWYyZGNfMjg_9ea13e7a-6527-4241-9fb7-3acb8894f67e">0.01</ix:nonFraction></ix:nonFraction>: <ix:nonFraction unitRef="shares" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjRlYWFjNDY5MjBkNDQ5ZGFiYzE5NDViM2I0OWYyZGNfMzI_6216534b-da1f-45ff-b50e-a6620df1c65d"><ix:nonFraction unitRef="shares" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjRlYWFjNDY5MjBkNDQ5ZGFiYzE5NDViM2I0OWYyZGNfMzI_da1cdb4e-deb6-4abd-9256-419bea07e9bd">3,200</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjRlYWFjNDY5MjBkNDQ5ZGFiYzE5NDViM2I0OWYyZGNfNTQ_f0dcce00-f7f4-4cba-957a-944d1d38de66">1,744</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjRlYWFjNDY5MjBkNDQ5ZGFiYzE5NDViM2I0OWYyZGNfNzU_7b271a29-b54d-48f0-9a5c-43d1e267a350">1,322</ix:nonFraction> shares outstanding at December&#160;31, 2021 and <ix:nonFraction unitRef="shares" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjRlYWFjNDY5MjBkNDQ5ZGFiYzE5NDViM2I0OWYyZGNfMTIy_bce23ca8-05cd-42d9-ad39-a42392a722b3">1,733</ix:nonFraction> shares issued and <ix:nonFraction unitRef="shares" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjRlYWFjNDY5MjBkNDQ5ZGFiYzE5NDViM2I0OWYyZGNfMTQz_20a7b114-dad5-48e8-8cae-73d3819df739">1,310</ix:nonFraction> shares outstanding at December&#160;31, 2020 and capital surplus</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTEtMS0xLTE5NjM1_300206ce-27f5-4246-bca6-aecfdfcc3456">47,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTMtMS0xLTE5NjM1_7ef2884c-9a0c-4fa0-9407-700ae3974995">46,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost: <ix:nonFraction unitRef="shares" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQxLTAtMS0xLTE5NjM1L3RleHRyZWdpb246YzRjYWY3NjgyZTM4NDg2M2I0ZjYwM2MzZTAwYWE1YTZfMjk_2a71a285-487e-41d9-9193-46ac28410af4">422</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQxLTAtMS0xLTE5NjM1L3RleHRyZWdpb246YzRjYWY3NjgyZTM4NDg2M2I0ZjYwM2MzZTAwYWE1YTZfMzY_7e644d59-ba32-4562-8ef4-c2632c0b4bb7">423</ix:nonFraction> shares at December&#160;31, 2021 and 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQxLTEtMS0xLTE5NjM1_7ca11a1d-a16b-48e4-a4a1-d24cb100a237">28,173</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQxLTMtMS0xLTE5NjM1_c8738445-f38a-4138-be92-621a4c1d877c">28,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQyLTEtMS0xLTE5NjM1_f7b4c311-f011-4b1e-a750-a4a9943270f7">54,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQyLTMtMS0xLTE5NjM1_54d11563-29f7-4162-b44e-9b713850692c">49,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQzLTEtMS0xLTE5NjM1_62be6c45-2938-4111-bf41-e4690391d04c">965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQzLTMtMS0xLTE5NjM1_1bf38c9c-f017-4951-8bcd-f34665700743">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total CVS Health shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQ0LTEtMS0xLTE5NjM1_3aa2c329-f69c-4e8e-909f-7394d3fe17ba">75,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQ0LTMtMS0xLTE5NjM1_f015a635-1d8e-4245-a8ba-62ca0d228f81">69,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQ1LTEtMS0xLTE5NjM1_37a31958-e90e-4fb1-9466-e0d1bcadaa66">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQ1LTMtMS0xLTE5NjM1_81a668fa-01f8-477b-a3a8-2520723fcd8a">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQ2LTEtMS0xLTE5NjM1_4bf45e92-0096-4768-a785-6a67cfc3744d">75,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQ2LTMtMS0xLTE5NjM1_b59f40bc-a570-45fa-b2cb-50455f4a96b3">69,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQ3LTEtMS0xLTE5NjM1_241d1398-a2b0-454a-873e-7bdfa341a4c6">232,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQ3LTMtMS0xLTE5NjM1_ffa7ee7d-e80e-426d-add1-3d3f4b84bbda">230,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_100">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts from customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromCustomers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMtMS0xLTEtMTk2MzU_7437e87f-7278-4559-afb0-f3cfd72eb652">284,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromCustomers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMtMy0xLTEtMTk2MzU_f5dcf690-57a6-4d83-8d9f-d643c2901294">264,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromCustomers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMtNS0xLTEtMTk2MzU_4c396255-d647-41a5-8b03-0887b73b033f">248,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzQtMS0xLTEtMTk2MzU_2fd2727e-eae1-4cee-bb40-c346c75ee06a">165,783</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzQtMy0xLTEtMTk2MzU_9c2809ba-8939-448e-bc89-9fba1e9d5c3d">158,636</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzQtNS0xLTEtMTk2MzU_f07218d2-afa6-4902-b58e-8b35c63fb7b6">149,655</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance benefits paid </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="cvs:PaymentsforInsuranceBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzUtMS0xLTEtMTk2MzU_7a370814-fdeb-4057-b2cf-72315e355bd6">63,598</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:PaymentsforInsuranceBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzUtMy0xLTEtMTk2MzU_b2d22d86-c691-4a61-947c-75261a354685">55,124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="cvs:PaymentsforInsuranceBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzUtNS0xLTEtMTk2MzU_6c558b49-8539-450e-a3f2-ef0656b71da2">52,242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid to other suppliers and employees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToSuppliersAndEmployees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzYtMS0xLTEtMTk2MzU_cd55727c-f2d0-4699-9947-d9e1c927e87c">31,652</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToSuppliersAndEmployees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzYtMy0xLTEtMTk2MzU_7e9e8376-f822-41cf-b46b-09f96a220a46">29,763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToSuppliersAndEmployees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzYtNS0xLTEtMTk2MzU_aeb8c8c3-efda-4f18-a772-9c527f8e00e3">28,932</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and investment income received</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzctMS0xLTEtMTk2MzU_9f487421-7eeb-4406-9c30-157097865377">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzctMy0xLTEtMTk2MzU_9bfa18aa-f3bd-40bf-a5de-5675be48a045">894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromInterestAndDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzctNS0xLTEtMTk2MzU_9f5b88ff-7c69-461b-abcb-941846be116d">955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzgtMS0xLTEtMTk2MzU_a681766b-8caf-49c4-a345-1f0917878a79">2,469</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzgtMy0xLTEtMTk2MzU_2c30ab10-3e8c-477b-bbce-44b52656c13a">2,904</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzgtNS0xLTEtMTk2MzU_d9ca7a3d-e6b2-4b87-a473-6ba374309123">2,954</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzktMS0xLTEtMTk2MzU_e58fa5f5-c653-4de7-b8f8-b0857518aba9">3,195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzktMy0xLTEtMTk2MzU_e113b417-8fab-4c68-b05f-b6eb0c451260">2,929</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzktNS0xLTEtMTk2MzU_1f32d040-07f0-4266-91ba-bf4f52cefa0b">2,717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzEwLTEtMS0xLTE5NjM1_284c04fb-383e-411a-ac18-d01b6efab3ce">18,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzEwLTMtMS0xLTE5NjM1_9896e395-1b4a-4152-9f5a-207addca8dd0">15,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzEwLTUtMS0xLTE5NjM1_f747a230-74c0-4c11-81c6-5195569f6053">12,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales and maturities of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzEzLTEtMS0xLTE5NjM1_30f976fa-c958-44a0-b83d-257012d00294">7,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzEzLTMtMS0xLTE5NjM1_617a0b63-2ffe-4a76-bbbb-db91a14266de">6,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzEzLTUtMS0xLTE5NjM1_3cdee541-ce91-449c-82b1-46369e7659b5">7,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE0LTEtMS0xLTE5NjM1_e2c3c14b-1603-4ce4-83b6-d72715fafc40">9,963</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE0LTMtMS0xLTE5NjM1_4396ddc4-2d0a-4270-ae62-6d6e68d4e8c4">9,639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE0LTUtMS0xLTE5NjM1_ce6e49cf-d4eb-4856-8c1d-7d9943a3368d">7,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE1LTEtMS0xLTE5NjM1_2dd2018c-a637-431b-8bab-efb2f5f1ab9b">2,520</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE1LTMtMS0xLTE5NjM1_333c896f-1b57-4793-81b6-65ae0f46c937">2,437</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE1LTUtMS0xLTE5NjM1_39a48adb-2173-4668-82d2-d9b708bc01b5">2,457</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale-leaseback transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE2LTEtMS0xLTE5NjM1_36ac42e0-6626-439f-8517-aa9e2a780d0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE2LTMtMS0xLTE5NjM1_f75f7d52-4971-4ce3-9595-d603b1857654">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE2LTUtMS0xLTE5NjM1_df0818cf-a0d8-4b04-88a3-4fd392aafd37">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (net of cash acquired)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE3LTEtMS0xLTE5NjM1_59593d3e-9b31-4a44-a13e-21e8fe8549c8">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE3LTMtMS0xLTE5NjM1_80cbf144-4404-4950-b7d7-a9a8b66db3ac">866</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE3LTUtMS0xLTE5NjM1_ebae0bbc-ca5a-4dfc-93ce-2e05fef48c9a">444</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of subsidiary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE4LTEtMS0xLTE5NjM1_ca301417-1606-4b5b-a2c8-4ea0b052116c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE4LTMtMS0xLTE5NjM1_2f1b622b-73d7-4eba-8028-bb301ef2d921">840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE4LTUtMS0xLTE5NjM1_5b50b977-a6b1-4614-8df4-59067bc20306">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE5LTEtMS0xLTE5NjM1_33f1b9a2-fcb1-43ce-9a8f-04541d1c927e">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE5LTMtMS0xLTE5NjM1_5abdfd51-0a82-4520-b199-b44f7c404a06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE5LTUtMS0xLTE5NjM1_ebdbe7d7-8c9b-4582-81f0-dbd609f87599">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzIwLTEtMS0xLTE5NjM1_d1b9c8f6-c0e0-40ba-bbc2-f3df78491dbf">5,261</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzIwLTMtMS0xLTE5NjM1_f87fb9dc-4d7d-4ebd-85f4-8d137af5f5c8">5,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzIwLTUtMS0xLTE5NjM1_874dacd8-f4b4-4ad7-8d0a-e3834e8d05c4">3,339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net repayments of short-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzIzLTEtMS0xLTE5NjM1_6c4f4146-87f1-45db-903f-b87a54659051">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzIzLTMtMS0xLTE5NjM1_3b7a3f06-446d-4ea4-8966-fa1c4ee01da3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzIzLTUtMS0xLTE5NjM1_32b07263-16f6-40f1-82d2-f7cae0df6c97">720</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI0LTEtMS0xLTE5NjM1_2b5908ec-aa22-4f6f-af0e-dfa0aefc391a">987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI0LTMtMS0xLTE5NjM1_5d07fcde-cef4-4873-a4d0-8cbcb436fbae">9,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI0LTUtMS0xLTE5NjM1_8bc37e76-ade6-4aac-8300-7996ee319030">3,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI1LTEtMS0xLTE5NjM1_b774b2a1-da08-4d1b-9d6d-4c4d905837b8">10,254</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI1LTMtMS0xLTE5NjM1_74d0cd9b-8ea5-4455-bdc0-b6365118be36">15,631</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI1LTUtMS0xLTE5NjM1_f774d4b2-5a5c-4760-a476-a187c417abb9">8,336</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI2LTEtMS0xLTE5NjM1_f658968a-5435-4cb2-862b-dba2bf414125">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI2LTMtMS0xLTE5NjM1_2775d5a5-c13a-4d90-b96d-b1568f35be1b">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI2LTUtMS0xLTE5NjM1_7fce72f9-dd63-4b31-9895-b63f0c38bb56">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI4LTEtMS0xLTE5NjM1_f0feb582-c055-4bb3-887d-a1cd90bbc01c">2,625</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI4LTMtMS0xLTE5NjM1_81947dfc-2068-4a6a-85b4-a69752bd78c3">2,624</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI4LTUtMS0xLTE5NjM1_8df9d6b3-d5ee-4718-87a9-4ff5012f4dd0">2,603</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI5LTEtMS0xLTE5NjM1_476ea744-ed25-490c-a6b0-81cce40c28d9">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI5LTMtMS0xLTE5NjM1_1abf4e42-89ff-4d17-bec5-d2ba80f18a0c">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI5LTUtMS0xLTE5NjM1_532e8ad6-4e34-4bd9-b554-b01534bf950d">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMwLTEtMS0xLTE5NjM1_d587d60a-9990-4601-bc08-196506e5d20a">168</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMwLTMtMS0xLTE5NjM1_3e9c9913-5fa8-4b0b-8847-98b58dac8e90">88</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMwLTUtMS0xLTE5NjM1_855dccc9-80ac-4c8d-922a-31bd4c6c90fe">112</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMxLTEtMS0xLTE5NjM1_c433d303-0f12-4ada-b8cf-986f97b526f5">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMxLTMtMS0xLTE5NjM1_09bed019-66a8-4db5-b9b2-1085b3cffe7b">432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMxLTUtMS0xLTE5NjM1_e417f9d3-6900-4e65-9f25-5968036a9636">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMyLTEtMS0xLTE5NjM1_38249492-fbe5-4d75-b1d5-45b1204e88f0">11,356</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMyLTMtMS0xLTE5NjM1_58932c13-266e-4cca-9631-db91192f88e5">7,696</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMyLTUtMS0xLTE5NjM1_a37f9cb2-6b8e-47c5-8d20-7ddbba898a70">7,654</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM0LTEtMS0xLTE5NjM1_079eaa38-3b68-485f-b1e1-904420e5a1bf">1,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM0LTMtMS0xLTE5NjM1_2f7e5272-0473-4bd7-9285-5af5c793b74e">2,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM0LTUtMS0xLTE5NjM1_5aa33cc4-eb04-4409-943a-e67358e4e321">1,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at the beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM1LTEtMS0xLTE5NjM1_221fb4ec-e7dc-4848-a5bc-aba38210777f">11,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM1LTMtMS0xLTE5NjM1_5da5d97d-2a54-4ffa-9cf1-1a6096fdcd12">8,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23e34e947aac44fc9f5cf5448f94f452_I20181231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM1LTUtMS0xLTE5NjM1_cc38810b-b16d-4323-ae2c-99f0e9b93345">6,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM2LTEtMS0xLTE5NjM1_e6cf54b8-a7ea-4187-a1a7-1d9497f211fe">12,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM2LTMtMS0xLTE5NjM1_6412e66a-6a3a-47f7-97b7-3bbc25e6ed8a">11,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM2LTUtMS0xLTE5NjM1_6e870ba4-be71-4cdd-85a5-963d5f7e5fcb">8,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_100">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzMtMS0xLTEtMTk2MzU_cd518ef2-bc6f-4084-8121-4b45dc784472">7,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzMtMy0xLTEtMTk2MzU_d6a4c39c-3eac-4889-b0fc-544909292a0c">7,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzMtNS0xLTEtMTk2MzU_b49b8778-b077-44db-819b-fd6ceb65c5c3">6,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments required to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzUtMS0xLTEtMTk2MzU_222556ae-bb7e-4979-8aa7-eec691fb9355">4,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzUtMy0xLTEtMTk2MzU_7587b4a3-8ed8-4883-b2e9-d9733f85a409">4,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzUtNS0xLTEtMTk2MzU_14530ac2-9398-46ed-9aa4-fff534e3031a">4,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzYtMS0xLTEtNTQ0ODI_efc86a60-f2ac-4bf7-8f9b-cb1c539255c8">1,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzYtMy0xLTEtNTQ0ODI_fe5ba633-453d-425b-b369-b3a35c716977">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="cvs:StoreImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzYtNS0xLTEtNTQ1MDg_a0494c9e-601d-44c9-b5df-3625b77be2b3">231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzYtMS0xLTEtMTk2MzU_3930af18-b01f-4588-a6f6-7c90bb586ab6">431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzYtMy0xLTEtMTk2MzU_9d9f2379-97f1-4fb5-8c0b-575a308fa0d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzYtNS0xLTEtMTk2MzU_05b23d22-ad14-4800-839d-ec181c23f560">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzgtMS0xLTEtMTk2MzU_fd557d9a-5982-4067-8a6a-e86aaaedbf88">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzgtMy0xLTEtMTk2MzU_b4954f0e-39c4-47f3-8192-008a6c5dd204">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzgtNS0xLTEtMTk2MzU_fb40e202-51bf-4b72-8626-f27d251e9dd2">453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on sale of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzktMS0xLTEtMTk2MzU_284628b4-26d4-4f8c-a399-c1a53458a598">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzktMy0xLTEtMTk2MzU_859f85f7-1aba-41d0-94ce-3b9b5b105f63">269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzktNS0xLTEtMTk2MzU_b85a1ff5-e3f1-4030-932b-044f745c0750">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzEwLTEtMS0xLTE5NjM1_0c7a8cc5-99de-4b2f-83b5-982b9bcf19ba">452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzEwLTMtMS0xLTE5NjM1_3a2f87f9-af97-4c9c-a121-0e9e11d66b40">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzEwLTUtMS0xLTE5NjM1_caf5521d-bd37-4fa6-9466-9570f3f8f092">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzExLTEtMS0xLTE5NjM1_7f7e9907-d6e9-4be2-8729-69a9d397de0b">428</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzExLTMtMS0xLTE5NjM1_32feff35-8861-4c6c-8913-77017d07cb5b">570</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzExLTUtMS0xLTE5NjM1_fda11be1-51ff-4395-a636-893c70c78ace">654</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other noncash items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzEyLTEtMS0xLTE5NjM1_4c097983-5558-4adb-8726-9328a8339922">390</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzEyLTMtMS0xLTE5NjM1_4724d269-cc7f-4fe2-9b9f-bdf2fa6a2183">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzEyLTUtMS0xLTE5NjM1_b427bf57-e610-4f59-a100-19da312f69fc">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in operating assets and liabilities, net of effects from acquisitions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE0LTEtMS0xLTE5NjM1_c3fc4fc7-faba-47ec-b2a0-320c236c44e8">2,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE0LTMtMS0xLTE5NjM1_35387dd4-4df6-44d9-a264-eb98e738d67a">1,510</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE0LTUtMS0xLTE5NjM1_a8343880-e0e6-4b11-9fdd-44c73f751a20">2,158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE1LTEtMS0xLTE5NjM1_f0475519-87cf-4cd1-a857-d754222b762b">735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE1LTMtMS0xLTE5NjM1_02f6f2e9-e345-4d76-927f-3d39bd05e381">973</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE1LTUtMS0xLTE5NjM1_7b2aaa5a-c506-472e-8b5c-ddb3db3675a0">1,075</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE2LTEtMS0xLTE5NjM1_45aa25f5-b348-48e3-bb9c-aed653c0700c">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE2LTMtMS0xLTE5NjM1_61e79f53-2999-41c6-9d79-8806a7376fa0">364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE2LTUtMS0xLTE5NjM1_39a550eb-fd68-41c1-a5f6-c76d3dd1fca6">614</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and pharmacy claims and discounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE3LTEtMS0xLTE5NjM1_8b28ff8d-4a0e-49db-b02a-1a116fdbbabf">2,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE3LTMtMS0xLTE5NjM1_aed9c43f-2305-4984-8841-336f2eedf67e">2,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE3LTUtMS0xLTE5NjM1_579744f8-ba20-40ea-b21a-fab4238a1491">3,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable and other insurance liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE4LTEtMS0xLTE5NjM1_25549046-987d-4367-8663-4e132f7e5660">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE4LTMtMS0xLTE5NjM1_8ae07492-5dbe-46f2-9c2e-7998e3053da5">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE4LTUtMS0xLTE5NjM1_7ae816af-571b-458f-abd3-0ed64a7d57e3">320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE5LTEtMS0xLTE5NjM1_12f7e839-9993-4878-a408-d6614f836542">2,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE5LTMtMS0xLTE5NjM1_595a555f-1594-4665-a4c7-de0aeea40f12">2,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE5LTUtMS0xLTE5NjM1_53b194a3-9760-4d18-b3c8-b78e7e7c4d55">1,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzIwLTEtMS0xLTE5NjM1_99413bca-bd66-4704-93cc-d3c06bff7683">18,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzIwLTMtMS0xLTE5NjM1_2775b30f-d8ce-40b3-a7c8-aa330db3fa93">15,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzIwLTUtMS0xLTE5NjM1_a736baa5-6155-4a17-8343-f0dbe54f99f7">12,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_121"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_100">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Shareholders&#8217; Equity</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to CVS Health</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares<br/>outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock and</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Surplus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>CVS Health<br/>Shareholders&#8217; <br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders&#8217;<br/>Equity</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling <br/>Interests </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i13739c11655d4b66b619ac881014f765_I20181231" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtMS0xLTEtMTk2MzU_d0d3eddd-0fb5-45ce-adf1-aa149ea511ce">1,720</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i33c39d0d9ba54e4b907a2d6936ea45ca_I20181231" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtMi0xLTEtMTk2MzU_5a2af167-1a8c-4cd3-92d3-86f595f11839">425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec75ad30e89c49a4bfce46bec785eb96_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtNC0xLTEtMTk2MzU_03d25cee-62ac-4b19-83d5-83527c502af5">45,440</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33c39d0d9ba54e4b907a2d6936ea45ca_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtNS0xLTEtMTk2MzU_f8dcefcc-b66e-42ce-a3d6-883dd1c703f9">28,228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f466365cbeb46d881db045c29a1ef18_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtNi0xLTEtMTk2MzU_ac1599e0-4622-4c55-9bb2-50a39e13248c">40,911</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia28cc8e6f81b4b99804fb1a37a6048e6_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtNy0xLTEtMTk2MzU_0b7fa53f-306a-4542-9bbe-14a7f09f01e1">102</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2ef6efbc0d84de58ef5fd7542800f18_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtOC0xLTEtMTk2MzU_8eca5d64-24dc-4e9c-ab5e-d8109099292a">58,225</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0431fdd1f66940e9b1962a8525277501_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtOS0xLTEtMTk2MzU_75b2d78d-8f34-48c9-8977-1fbbb42b120a">318</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23e34e947aac44fc9f5cf5448f94f452_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtMTAtMS0xLTE5NjM1_104646ff-e05b-4610-a1f0-b49d66602f7b">58,543</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adoption of new accounting standards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> (3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i922cc6127555413782578a7efd08aea4_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtNi0xLTEtMTk2MzU_1e2731a0-00e0-482d-b011-76cfe76e7e7c">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8eb6b30d69b40b48d66138c22c9b950_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtOC0xLTEtMTk2MzU_27e8ee4a-bc07-4563-9ed8-b0e3e9b0302d">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5b7f3560a474273bad7b3d0ff254e29_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtMTAtMS0xLTE5NjM1_4cea8a88-2053-457a-81cf-9f156ab4de60">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4a48ec7199f497a8e3d91de1ccd3577_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzUtNi0xLTEtMTk2MzU_85bb7190-a730-4662-bc40-87fc8f53469b">6,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie160f6b16d2b416d8f1acb180ba3d07c_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzUtOC0xLTEtMTk2MzU_0fd5d3b9-3af8-4d46-abf4-fd6637fc594d">6,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20b0b671c0474c61b1511d61c0def2a5_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzUtOS0xLTEtMTk2MzU_64dc48c6-6fb7-4743-b106-7d1c00f225e8">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzUtMTAtMS0xLTE5NjM1_0eeab21f-2e05-40c8-9063-27dbebfd9ffe">6,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive income (Note 13)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaae61e2a7f494d8ea336357a3fa3676f_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzYtNy0xLTEtMTk2MzU_200dd5d6-714b-4b78-b2a5-510728386489">917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie160f6b16d2b416d8f1acb180ba3d07c_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzYtOC0xLTEtMTk2MzU_54e55ad2-bff0-47dc-98cd-705dbe797316">917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzYtMTAtMS0xLTE5NjM1_d017fb79-3383-4a24-adb5-140befd39782">917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i025b485e66244023b72a2a031c0188ef_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtMS0xLTEtMTk2MzU_aae2c572-3595-4ef7-9c8d-59cee4b86a9a">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i216fe0b6c7d94b40ad7a901f182062ef_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtMi0xLTEtMTk2MzU_38a4f088-ebc0-42d5-9452-dcc4dc666000">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ef2fb7202d49dbab738960740d4b6c_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtNC0xLTEtMTk2MzU_056fb5fc-124d-4929-b5de-d982249e8938">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie160f6b16d2b416d8f1acb180ba3d07c_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtOC0xLTEtMTk2MzU_d556ba44-99f1-4538-a8b3-1303305b44cc">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtMTAtMS0xLTE5NjM1_9c089ea0-cc84-4a9d-af8f-1d5a23dc2e17">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Purchase of treasury shares, net of ESPP issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i216fe0b6c7d94b40ad7a901f182062ef_D20190101-20191231" decimals="-6" name="cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzktMi0xLTEtMTk2MzU_8d9b2c4a-a066-410c-b98f-35ad52f2251c">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i216fe0b6c7d94b40ad7a901f182062ef_D20190101-20191231" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzktNS0xLTEtMTk2MzU_726be931-cfc8-48b9-9d92-a974cab2539e">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie160f6b16d2b416d8f1acb180ba3d07c_D20190101-20191231" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzktOC0xLTEtMTk2MzU_e479bc45-863f-4178-90dd-191a473e7f52">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzktMTAtMS0xLTE5NjM1_5175c4ff-06b2-44ce-af7d-7701189ef3c9">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4a48ec7199f497a8e3d91de1ccd3577_D20190101-20191231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEwLTYtMS0xLTE5NjM1_8dae2041-c593-4b3f-9892-c4d82dce8882">2,615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie160f6b16d2b416d8f1acb180ba3d07c_D20190101-20191231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEwLTgtMS0xLTE5NjM1_27e98431-66cf-47f0-b90a-e7d29553e0a9">2,615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEwLTEwLTEtMS0xOTYzNQ_c593c071-c1fa-414a-a22c-11cdfdf57be4">2,615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other decreases in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20b0b671c0474c61b1511d61c0def2a5_D20190101-20191231" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEyLTktMS0xLTE5NjM1_503e9a44-f43a-4bc4-bb09-3d7d54b7f468">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEyLTEwLTEtMS0xOTYzNQ_76cd478a-d3f0-4db5-afed-57478752f609">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id1f119b7cdb141be93131047a1d79f5b_I20191231" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTEtMS0xLTE5NjM1_94b0df74-c020-4413-ae6f-de38bf846895">1,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ieefff43749444070a945dbf9c2df4d4e_I20191231" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTItMS0xLTE5NjM1_97bbe756-c530-44c3-bf07-3dcd93863f56">425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i198e53fbfa9d4d0aa17e97121db6bb9b_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTQtMS0xLTE5NjM1_c22f687b-bcc8-4d02-b351-d409fc63a5da">45,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieefff43749444070a945dbf9c2df4d4e_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTUtMS0xLTE5NjM1_513ca101-da7d-4884-9350-f18e2e7d65ed">28,235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3debde841b1842a2a969406ff590b5d4_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTYtMS0xLTE5NjM1_43881444-954f-4c69-b89b-999615befb04">45,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10cfae3f6a64475c8d6390a56c1755b4_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTctMS0xLTE5NjM1_da29e6e9-e8a3-4503-9fa7-5d1185cba2e4">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f936984dd7642f09c851e2ced784e3a_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTgtMS0xLTE5NjM1_4c98b564-63dd-4536-a06a-34ee7b961a02">63,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3d706b6763848048a19f678eed0d6c4_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTktMS0xLTE5NjM1_322bcf38-2c5a-448b-ad0f-136fff2db827">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTEwLTEtMS0xOTYzNQ_c3b0ca65-cb12-4059-8912-d32a89761840">64,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adoption of new accounting standard </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e7cde5c47fe423a9685bba813200907_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTYtMS0xLTE5NjM1_0d72284e-6ae8-4fab-975d-68db230b7230">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id5e60c7959e643d6be2a8ad6547a16ce_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTgtMS0xLTE5NjM1_3e80ea5b-0225-4195-b65a-cd326b24be66">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3054d32553d24d498f6e64626c62c7e4_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTEwLTEtMS0xOTYzNQ_012f1e61-d950-4e7d-9219-63301f2cfd55">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9b253e4431e4506b41e93b4e3ffbff3_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE1LTYtMS0xLTE5NjM1_10e9ca46-bd60-4518-8922-941a5729f7cf">7,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521bf812b8ca4f2f8127d65ed79ea126_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE1LTgtMS0xLTE5NjM1_7608056a-7691-4ba2-afbe-d6b4eceb1104">7,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb94485c24fb48c8b7669be4b0fc8159_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE1LTktMS0xLTE5NjM1_fa6bab22-9058-4028-b15d-6b11aa87f8fd">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE1LTEwLTEtMS0xOTYzNQ_74b5fa81-2547-4fac-a687-4658fa0a47de">7,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive income (Note 13)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b3e30b3db154240b2043b0ca843e316_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE2LTctMS0xLTE5NjM1_ac4ec36d-37d3-44ad-9d04-afa78313c66d">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521bf812b8ca4f2f8127d65ed79ea126_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE2LTgtMS0xLTE5NjM1_f404f976-c603-4e16-b051-0aa55c31f593">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE2LTEwLTEtMS0xOTYzNQ_652d6cf0-cf10-4a95-8935-a10c732379fc">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3850625417ca4ca39a069dd8c4de7097_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE4LTEtMS0xLTE5NjM1_dcbd26d8-8889-4733-8703-2dce84bd5c51">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7cf273211e3434f968bd606d4a81280_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE4LTQtMS0xLTE5NjM1_894b75b1-c20f-4e61-b105-8dbd70b2299b">541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521bf812b8ca4f2f8127d65ed79ea126_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE4LTgtMS0xLTE5NjM1_ef3d6562-7668-44bd-869a-4585a0eba71c">541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE4LTEwLTEtMS0xOTYzNQ_32c877c4-6c7d-41ac-90af-86d3aa06242f">541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">ESPP issuances, net of purchase of treasury shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i41a840db4ee84036b3bbb93303320613_D20200101-20201231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE5LTItMS0xLTE5NjM1_d4eb5856-eaa6-4799-9256-144e4a9519d9">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41a840db4ee84036b3bbb93303320613_D20200101-20201231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE5LTUtMS0xLTE5NjM1_b10aa279-9966-4bd0-bcf8-71cf5a78c8cc">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i521bf812b8ca4f2f8127d65ed79ea126_D20200101-20201231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE5LTgtMS0xLTE5NjM1_e2eabb19-efb9-4767-8dff-35773f72ead4">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE5LTEwLTEtMS0xOTYzNQ_de2adec5-83f2-4741-9cc9-e44819a647f0">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9b253e4431e4506b41e93b4e3ffbff3_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIwLTYtMS0xLTE5NjM1_208861ca-730f-45be-963b-9a061651a275">2,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i521bf812b8ca4f2f8127d65ed79ea126_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIwLTgtMS0xLTE5NjM1_91dc6697-9e08-4567-9836-dd9fb9c5c796">2,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIwLTEwLTEtMS0xOTYzNQ_e14e59e1-da97-4956-9f82-c690848774c7">2,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other decreases in noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb94485c24fb48c8b7669be4b0fc8159_D20200101-20201231" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIyLTktMS0xLTE5NjM1_f4f94624-d2f3-43e6-96ee-1d3e1a0ec25d">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIyLTEwLTEtMS0xOTYzNQ_e55d63dd-594a-4a9d-b207-74a1c114f5e2">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibd578f81db5a45f1bc8d5b32e6e26a16_I20201231" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTEtMS0xLTE5NjM1_50c55617-ad70-485d-be3b-cab34ce8f246">1,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6be5d7176aa0457288fec9de68e4d419_I20201231" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTItMS0xLTE5NjM1_64feac16-0132-4d16-bed6-5f25ece31268">423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i929ccc146bfa424592ecfc18373af370_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTQtMS0xLTE5NjM1_bbdfedd3-ce88-4726-99fa-8969a6b266a6">46,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6be5d7176aa0457288fec9de68e4d419_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTUtMS0xLTE5NjM1_6e5e1472-d133-4873-995b-e0e350248ee0">28,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb577f06e3b04c518c1c4543d6ddf983_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTYtMS0xLTE5NjM1_3bf21ebb-c3b6-4f8f-a4a1-5269d4923fac">49,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79a394a32aeb4c939df5cb7fd7e0d46f_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTctMS0xLTE5NjM1_e999f2a7-4913-4dfc-8771-54a5c0676c86">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if386c5ae7c994951b21ec945131fa3c6_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTgtMS0xLTE5NjM1_4e1e7631-0ccc-4b3d-aeb6-ff40d09aa775">69,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e4d5f3f2aa745b6b9ea7a35265f341e_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTktMS0xLTE5NjM1_995710dd-a536-45a4-aa0f-e9b0fb6f064c">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTEwLTEtMS0xOTYzNQ_86233165-c748-4f1b-9d5d-a5745f848460">69,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85992156090b4f72a932455b1978952b_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI1LTYtMS0xLTE5NjM1_8891224b-4445-405f-82f8-e47681c86998">7,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7770de66bbf94051817d87cf6240655a_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI1LTgtMS0xLTE5NjM1_12e91338-a119-474b-8b86-7cd6d401309e">7,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a4a4ed30a054247bfaad062f649f9ee_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI1LTktMS0xLTE5NjM1_cc32bf8a-d92b-4a46-abb6-8ad3371253a0">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI1LTEwLTEtMS0xOTYzNQ_3ebcfa62-21ca-468f-8755-a1b4dbd67024">7,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive loss (Note 13)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id62e90e3302f484ca4017d1a85b7a1ff_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI2LTctMS0xLTE5NjM1_cd5abcec-58e2-4c11-b6b4-61752bd647cb">449</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7770de66bbf94051817d87cf6240655a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI2LTgtMS0xLTE5NjM1_c9e1a140-6be8-41b1-b6dd-f17db8739e25">449</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI2LTEwLTEtMS0xOTYzNQ_a0348da8-14a1-40db-8087-ae8679b86e07">449</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock option activity, stock awards and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4eb317bccff647f6823df9e9b149c181_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI3LTEtMS0xLTE5NjM1_d2ebba53-346a-4a0d-8493-d5299f05ac9a">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45641c304daa44c9bd1f3c9070317105_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI3LTQtMS0xLTE5NjM1_2ac0022b-9661-459b-8995-856a8677ed8a">864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7770de66bbf94051817d87cf6240655a_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI3LTgtMS0xLTE5NjM1_11b13436-b3e2-4326-8ac7-0e9222dc46ba">864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI3LTEwLTEtMS0xOTYzNQ_7e1e23ea-4e69-4acc-87ed-dd2a9e4cef49">864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">ESPP issuances, net of purchase of treasury shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic1c4532731df4ec9acf2bba885ccbc0b_D20210101-20211231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI4LTItMS0xLTE5NjM1_c99be6d6-9e00-435a-b19e-b4a88922d547">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1c4532731df4ec9acf2bba885ccbc0b_D20210101-20211231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI4LTUtMS0xLTE5NjM1_f55a21f2-2a69-40c6-a897-99c2f68660c1">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7770de66bbf94051817d87cf6240655a_D20210101-20211231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI4LTgtMS0xLTE5NjM1_2bf73e51-b429-45e1-8768-59548fb2da7b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI4LTEwLTEtMS0xOTYzNQ_04ce3220-b53b-44e5-b604-44ed6fb669ed">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85992156090b4f72a932455b1978952b_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI5LTYtMS0xLTE5NjM1_5d145465-f479-437b-8075-93fafac50de5">2,644</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7770de66bbf94051817d87cf6240655a_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI5LTgtMS0xLTE5NjM1_84585cc3-8a43-4f0e-acd1-ccc86132d720">2,644</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI5LTEwLTEtMS0xOTYzNQ_2af4ca73-7402-42e0-a5bf-06a85a7686fd">2,644</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other increases in noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a4a4ed30a054247bfaad062f649f9ee_D20210101-20211231" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMwLTktMS0xLTE5NjM1_fe161968-610a-4ca7-9697-138c4e12f8fe">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMwLTEwLTEtMS0xOTYzNQ_03302628-ee4e-43cf-9f1b-5cec40f314aa">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie84ce40f593a4f1b8e95de37fcec950f_I20211231" decimals="-6" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTEtMS0xLTE5NjM1_e52f52b5-9ef3-4f6f-9997-7ac02f8b1909">1,744</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i71a1c12ec5c146a387fb13e1ae8a699c_I20211231" decimals="-6" sign="-" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTItMS0xLTE5NjM1_1c356d2b-3495-4a7b-9749-f110807b49c6">422</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66a5573b2fbd4cec83bc9c6bed71ef29_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTQtMS0xLTE5NjM1_97c21c66-2d45-4ea3-968e-8464fda4be09">47,377</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71a1c12ec5c146a387fb13e1ae8a699c_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTUtMS0xLTE5NjM1_b17f1bab-ba67-4dd0-965f-3feec675cba8">28,173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic88e5b2354294af7a046754ddfa0a46d_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTYtMS0xLTE5NjM1_86eb78f2-04af-48e9-838e-ffc92feeab4c">54,906</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61119d4aa25b44fb9ab0ce32bfac9893_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTctMS0xLTE5NjM1_e5842af6-afd4-4a4e-b3a5-c55accd9e1b0">965</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9bf280de01e423da0805c5548da8598_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTgtMS0xLTE5NjM1_6de59978-0501-41ba-9246-81623245d535">75,075</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f46c0fc299d40469a5d7302133c63f1_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTktMS0xLTE5NjM1_7c03f277-0226-49a3-b87b-9d6fe7f91e8d">306</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTEwLTEtMS0xOTYzNQ_fd4e15cb-8af8-4d51-8a22-b14d9654a28f">75,381</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7" footnoteRole="http://www.xbrl.org/2003/role/footnote">Treasury shares include <ix:nonFraction unitRef="shares" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:TreasuryStockSharesHeldinTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyNg_2742f4c1-ccab-4fa2-bafe-ea5d173eb180"><ix:nonFraction unitRef="shares" contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231" decimals="-6" name="cvs:TreasuryStockSharesHeldinTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyNg_6419c046-b48f-4618-a968-99bc4d3645ed"><ix:nonFraction unitRef="shares" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:TreasuryStockSharesHeldinTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyNg_e3309405-dac6-4007-ad93-3e3b3eae9f42">1</ix:nonFraction></ix:nonFraction></ix:nonFraction> million shares held in trust for each of the years ended December 31, 2021, 2020 and 2019. Treasury stock includes $<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:TreasuryStockValueSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzIzNg_27d37e70-1658-4c4c-9586-0927176f1e3b"><ix:nonFraction unitRef="usd" contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231" decimals="-6" name="cvs:TreasuryStockValueSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzIzNg_2be11832-e74f-41f4-80f8-2c6c8574e523"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:TreasuryStockValueSharesHeldInTrust" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzIzNg_dda28916-8460-4dbb-9c04-c367d9f849ae">29</ix:nonFraction></ix:nonFraction></ix:nonFraction> million related to shares held in trust for each of the years ended December 31, 2021, 2020 and 2019. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information.</ix:footnote></span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjQ_cc82e256-da53-42d6-8a53-0ccced714fe0" footnoteRole="http://www.xbrl.org/2003/role/footnote">Common stock and capital surplus includes the par value of common stock of $<ix:nonFraction unitRef="usd" contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzQ0NA_56345325-2c2c-460c-a3dc-9492ee914d3b"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzQ0NA_85768385-ff6b-4e82-9d2d-cb40ec9ab58f"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzQ0NA_f6c55ca3-0a33-461c-a79c-c71fc19c1f56">17</ix:nonFraction></ix:nonFraction></ix:nonFraction> million as of December 31, 2021, 2020 and 2019.</ix:footnote></span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU0Njg_97cc772a-a9cc-45ab-acfe-b04e7678cb48" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NjM_bdbd7ade-1f47-46a7-92fa-bfb084c43320">Accounting Standards Update (&#8220;ASU&#8221;) 2016-02</span>, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 842), which resulted in an increase to retained earnings of $<ix:nonFraction unitRef="usd" contextRef="i922cc6127555413782578a7efd08aea4_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEwOTk1MTE2Mjk5MDk_1e2731a0-00e0-482d-b011-76cfe76e7e7c">178</ix:nonFraction> million during the year ended December 31, 2019.</span></ix:footnote></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NDM_62e832f8-7207-4461-9589-4a17539d4b88" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NjQ_6d63f6c0-91a9-453b-838f-78265109358a">ASU 2016-13</span>, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 326), which resulted in a reduction to retained earnings of $<ix:nonFraction unitRef="usd" contextRef="ia694d76108a14467a887dab2055e6ad0_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NDY_9af37667-cc3f-4e43-8268-dda837632fca">3</ix:nonFraction>&#160;million during the year ended December 31, 2020.</span></ix:footnote></div><div style="margin-bottom:3pt;text-indent:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_127"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_100">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_130"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDIy_bca58685-3d1b-427f-8507-2cee9fde4a0b" continuedAt="i6f3c126eaf1f42f4a80e215a66452333" escape="true">Significant Accounting Policies </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i6f3c126eaf1f42f4a80e215a66452333" continuedAt="i5c9ec03615c94322b9dd6b9c33471580"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation, together with its subsidiaries (collectively, &#8220;CVS Health&#8221; or the &#8220;Company&#8221;), has more than <ix:nonFraction unitRef="store" contextRef="i7310250aa7db49e5bb0700f9d3b0c92b_I20211231" decimals="INF" name="us-gaap:NumberOfStores" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzE4Mg_70a0cc07-ad41-4499-a7b3-c923041a2ba4">9,900</ix:nonFraction> retail locations, nearly <ix:nonFraction unitRef="member" contextRef="i7310250aa7db49e5bb0700f9d3b0c92b_I20211231" decimals="-2" name="cvs:NumberofWalkInMedicalClinics" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIxNw_a65730ac-5bd4-4e33-bd78-d2a948100c4d">1,200</ix:nonFraction> walk-in medical clinics, a leading pharmacy benefits manager with approximately <ix:nonFraction unitRef="people" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:NumberOfPlanMembers" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMwMA_3ea1504a-5527-4a2f-a0f9-d1b3a21fd218">110</ix:nonFraction> million plan members with expanding specialty pharmacy solutions and a dedicated senior pharmacy care business serving more than <ix:nonFraction unitRef="patient" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="INF" name="cvs:NumberofPatientsServedperYear" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzM3Nw_31ec9d15-40f8-4717-9583-660e8af2b6f4">one million</ix:nonFraction> patients per year. The Company also serves an estimated <ix:nonFraction unitRef="people" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:NumberOfPeopleServed" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ3OA_5b92280b-68f8-4f95-8bfb-a8567ee9a731">35</ix:nonFraction> million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The coronavirus disease 2019 (&#8220;COVID-19&#8221;) and its emerging new variants continue to impact the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#8217;s businesses, operating results, cash flows and financial condition in the years ended December 31, 2021 and 2020, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDAy_69497644-3d0d-45d5-ae72-3d14f6a41f4e" continuedAt="i3b3f53246e554001815aaad5ed69c676" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="segment" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzE4Nzg_b07a84ab-91f6-49c5-84e5-b7d1dd84638e">four</ix:nonFraction> reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in <ix:nonFraction unitRef="state" contextRef="idf62411f04644ec5a62a251e4c8f705a_D20210101-20211231" decimals="INF" name="cvs:IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzEwOTk1MTE3NDE2MTQ_4fa57cca-000e-4968-89b3-00c3a130252a">eight</ix:nonFraction> states through which it sells Insured plans directly to individual consumers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services and mail order pharmacy. In addition, through the Pharmacy Services segment, the Company provides specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of December&#160;31, 2021, the Retail/LTC segment operated more than <ix:nonFraction unitRef="store" contextRef="i7310250aa7db49e5bb0700f9d3b0c92b_I20211231" decimals="0" name="us-gaap:NumberOfStores" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzM1ODA_98772ac3-184b-436a-abc8-e47603e7e8cc">9,900</ix:nonFraction> retail locations, nearly <ix:nonFraction unitRef="clinic" contextRef="i7310250aa7db49e5bb0700f9d3b0c92b_I20211231" decimals="0" name="cvs:NumberofWalkInMedicalClinics" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzM2MTU_ae986bd4-cc63-4d95-867a-5c34a8cbef09">1,200</ix:nonFraction> MinuteClinic locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i5c9ec03615c94322b9dd6b9c33471580" continuedAt="idc2013590956400d93e44f226cd1c696"><ix:continuation id="i3b3f53246e554001815aaad5ed69c676"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NTM2_07b6c8ba-a753-4ecc-a2e6-adaae48ff289" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NTA0_839b7957-50eb-4f78-8585-00729c89120b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform with the current year presentation.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDIz_ffb93942-02aa-4bca-a57c-a7b9005fe80b" continuedAt="ied91a109e5ad49b180e5831c8fd340cd" escape="true">Use of Estimates</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ied91a109e5ad49b180e5831c8fd340cd">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDM1_dff7f813-ceab-4fa9-985a-bae807fdac81" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when purchased. The Company invests in short-term money market funds, commercial paper and time deposits, as well as other debt securities that are classified as cash equivalents within the accompanying consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash (included in other current assets) represents funds held on behalf of members, including health savings account (&#8220;HSA&#8221;) funds associated with high deductible health plans. Beginning in 2021, the Company began presenting these funds held on behalf of members in restricted cash and, for statement of cash flow purposes, retrospectively adjusted the 2020 and 2019 balances by the amounts shown in the table below in the line item &#8220;restricted cash (included in other current assets)&#8221; to conform with the current year presentation. Restricted cash (included in other assets) represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDgz_57c314b7-aff9-462c-9b7a-9e02ebfe3589" escape="true"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the consolidated balance sheets to total cash, cash equivalents and restricted cash on the consolidated statements of cash flows as of December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzEtMS0xLTEtMTk2MzU_f5cc04aa-c641-4c96-9046-12137ac56422">9,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzEtMy0xLTEtMTk2MzU_c6dae105-688e-42f8-af5e-b8f75a2bf934">7,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzEtNS0xLTEtMTk2MzU_4e612a02-07eb-437a-9e24-917513ab4745">5,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:RestrictedCashCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzItMS0xLTEtNjQyOTQ_6264c47b-6a64-44ca-a242-fbb133a86d44">3,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:RestrictedCashCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzItMy0xLTEtNjQyOTQ_14856876-cc2d-4546-a297-fe25a0c3f6a4">2,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231" decimals="-6" name="us-gaap:RestrictedCashCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzItNS0xLTEtNjQyOTQ_c7be8a26-26c0-4955-8d63-db8d56fec7b7">2,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzMtMS0xLTEtMTk2MzU_bbd330e8-3987-437e-9cf5-76b3adab4213">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzMtMy0xLTEtMTk2MzU_6bf5e6a0-7be6-4994-9635-bf6d733cf93e">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzMtNS0xLTEtMTk2MzU_c1808d78-6bad-4095-8298-2559fa40bd47">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzQtMS0xLTEtMTk2MzU_90ffd139-0d59-4cbb-bc97-4dbe106f4110">12,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzQtMy0xLTEtMTk2MzU_d6a874e4-f062-40eb-9be7-d5ef2cb3b139">11,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzQtNS0xLTEtMTk2MzU_7ca78e29-f74f-40a8-a220-67dd631124e4">8,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idc2013590956400d93e44f226cd1c696" continuedAt="id5c6e93149c843c1a193ecdf8b3cf2a5"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDg0_bc3e775d-b4f2-480e-adb8-4d10d9fa8ed3" continuedAt="idc21dc592f9a47a6ad091bddeedb4576" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist primarily of U.S. Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next twelve months, in which case it is classified as current on the consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. See Note 4 &#8216;&#8216;Fair Value&#8217;&#8217; for additional information on how the Company estimates the fair value of these investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principal payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. Interest is not accrued on debt securities when management believes the collection of interest is unlikely.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#8217;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities with readily available fair values are measured at fair value with changes in fair value recognized in net income (loss).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage Loans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mortgage loan investments on the consolidated balance sheets are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id5c6e93149c843c1a193ecdf8b3cf2a5" continuedAt="i1cda75da3b99419695177906d0f471cb"><ix:continuation id="idc21dc592f9a47a6ad091bddeedb4576"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Investments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments consist primarily of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Private equity and hedge fund limited partnerships, which are accounted for using the equity method of accounting. Under this method, the carrying value of the investment is based on the value of the Company&#8217;s equity ownership of the underlying investment funds provided by the general partner or manager of the investments, the financial statements of which generally are audited. As a result of the timing of the receipt of the valuation information provided by the fund managers, these investments are generally reported on up to a three month lag. The Company reviews investments for impairment at least quarterly and monitors their performance throughout the year through discussions with the administrators, managers and/or general partners. If the Company becomes aware of an impairment of a limited partnership&#8217;s investments through its review or prior to receiving the limited partnership&#8217;s financial statements at the financial statement date, an impairment will be recognized by recording a reduction in the carrying value of the limited partnership with a corresponding charge to net investment income. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investment real estate, which is carried on the consolidated balance sheets at depreciated cost, including capital additions, net of write-downs for other-than-temporary declines in fair value. Depreciation is calculated using the straight-line method based on the estimated useful life of each asset. If any real estate investment is considered held-for-sale, it is carried at the lower of its carrying value or fair value less estimated selling costs. The Company generally estimates fair value using net operating income and applying a capitalization rate in conjunction with comparable sales information. At the time of the sale, the difference between the sales price and the carrying value is recorded as a realized capital gain or loss. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Privately-placed equity securities, which are carried on the consolidated balance sheets at cost less impairments, plus or minus subsequent adjustments for observable price changes. Additionally, as a member of the Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;), a subsidiary of the Company is required to purchase and hold shares of the FHLBB. These shares are restricted and carried at cost. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Income</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment income on the Company&#8217;s investments is recorded when earned and is reflected in the Company&#8217;s net income (other than net investment income on assets supporting experience-rated products). Experience-rated products are products in the large case pensions business where the contract holder, not the Company, assumes investment and other risks, subject to, among other things, minimum guarantees provided by the Company. The effect of investment performance on experience-rated products is allocated to contract holders&#8217; accounts daily, based on the underlying investment experience and, therefore, does not impact the Company&#8217;s net income (as long as the contract&#8217;s minimum guarantees are not triggered). Net investment income on assets supporting large case pensions&#8217; experience-rated products is included in net investment income in the consolidated statements of operations and is credited to contract holders&#8217; accounts through a charge to benefit costs. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments (other than realized capital gains and losses on investments supporting experience-rated products) are included as a component of net investment income in the consolidated statements of operations. Realized capital gains and losses are determined on a specific identification basis. Purchases and sales of debt and equity securities and alternative investments are reflected on the trade date. Purchases and sales of mortgage loans and investment real estate are reflected on the closing date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are not included in realized capital gains and losses in the consolidated statements of operations and instead are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized capital gains and losses on investments (other than unrealized capital gains and losses on investments supporting experience-rated products) are reflected in shareholders&#8217; equity, net of tax, as a component of accumulated other comprehensive income. Unrealized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NTA2_6dd78741-02ef-4243-b004-931169250bf7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#8217;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1cda75da3b99419695177906d0f471cb" continuedAt="i382685f0adce42889c732ea29a682f8f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDEz_f0f1fcd8-0245-431c-87df-3d4692a30524" continuedAt="ic7d1f827d56b40eb8bb723cca71cf6ea" escape="true">Accounts Receivable</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic7d1f827d56b40eb8bb723cca71cf6ea" continuedAt="i43ef2bf6666042778c8d362fc7725b3a">Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations.</ix:continuation> <ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3Mzkx_c93a3843-cb8f-4eb7-a199-4a5e7950df32" continuedAt="i32282a11d60748d390e836be44f98c7c" escape="true">Accounts receivable, net is composed of the following at December&#160;31, 2021 and 2020:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i32282a11d60748d390e836be44f98c7c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzEtMS0xLTEtMTk2MzU_bb28417b-43ee-4bbc-b77c-a2aad7c11130">7,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzEtMy0xLTEtMTk2MzU_2e5d788f-bf36-4ff1-b0bf-b252ef9a6f2b">7,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:VendorandManufacturerReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzItMS0xLTEtMTk2MzU_152dd4eb-37a9-4d43-9d23-b2363acfbf7a">10,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:VendorandManufacturerReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzItMy0xLTEtMTk2MzU_3f0f8d51-655d-46b8-988b-a3eef4a4d9bc">9,815</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzMtMS0xLTEtMTk2MzU_de478219-38e8-4a1f-a496-d478765eeeef">2,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:PremiumsReceivableAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzMtMy0xLTEtMTk2MzU_c7cb5c1c-2bb4-4bda-a5ba-c42d236dadd9">2,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzQtMS0xLTEtMTk2MzU_3fc64a66-d74e-4297-8cbd-c7f3407d8f0a">3,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzQtMy0xLTEtMTk2MzU_b2946550-ef66-496d-bc84-710cfe0414a9">2,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzUtMS0xLTEtMTk2MzU_d110776d-5772-4c4f-996b-7eb67644a4c9">24,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzUtMy0xLTEtMTk2MzU_a4219712-5840-4327-8201-704060ced36b">21,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for credit losses was $<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzEwOTk1MTE3MjAxNDQ_09c63d05-9504-40bb-a6a6-f27be387100c">339</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzE5MDI5_592e6fdf-ea72-4028-820d-17b511ed8991">358</ix:nonFraction>&#160;million as of December&#160;31, 2021 and 2020, respectively. <ix:continuation id="i43ef2bf6666042778c8d362fc7725b3a">When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDU0_3efb3cab-d66a-4008-b23d-36e8432f18f9" continuedAt="i94f8ae4fab164ebc81f04ee5a6612134" escape="true">Inventories </ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i94f8ae4fab164ebc81f04ee5a6612134">Inventories are valued at the lower of cost or net realizable value using the weighted average cost method. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. During the interim period between physical inventory counts, the Company accrues for anticipated physical inventory losses on a location-by-location basis based on historical results and current physical inventory trends.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ReinsuranceAccountingPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3Mzky_959029d9-d82f-46d0-a56a-f16958f9197e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance Recoverables </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#8217;s primary liability as the direct insurer of the risks reinsured. Failure of reinsurers to indemnify the Company could result in losses; however, the Company does not expect charges for unrecoverable reinsurance to have a material effect on its consolidated operating results or financial condition. The Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities or economic characteristics of its reinsurers. At December&#160;31, 2021, the Company&#8217;s reinsurance recoverables consisted primarily of amounts due from third parties that are rated consistent with companies that are considered to have the ability to meet their obligations. Reinsurance recoverables are recorded as other current assets or other assets on the consolidated balance sheets.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDU1_accffcfc-7426-4b78-b9d3-4cdcafc58d89" continuedAt="i2be2615a54bd49f3aac5e4922e34103c" escape="true">Health Care Contract Acquisition Costs</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2be2615a54bd49f3aac5e4922e34103c">Insurance products included in the Health Care Benefits segment are cancellable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. Acquisition costs for certain long-duration insurance contracts are deferred and are recorded as other current assets or other assets on the consolidated balance sheets and are amortized over the estimated life of the contracts. The amortization of deferred acquisition costs is recorded in operating expenses in the consolidated statements of operations.</ix:continuation> At December&#160;31, 2021 and 2020, the balance of deferred acquisition costs was $<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIyMTQ1_2fb2da89-8834-4020-915a-0fbfbf65e3ba">895</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DeferredPolicyAcquisitionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIyMTUy_9d335161-0a79-484a-bf5a-bd09293301d3">546</ix:nonFraction> million, respectively, comprised primarily of commissions paid on Medicare Supplement products within the Health Care Benefits segment. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDY2_e059627e-e05f-4963-b8ad-e5e029f315e0" continuedAt="ic3868fcecac7489785bba4226f472173" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is reported at historical cost, net of accumulated depreciation. Property, equipment and improvements to leased premises are depreciated using the straight-line method over the estimated useful lives of the assets, or when applicable, the term of the lease, whichever is shorter. Estimated useful lives generally range from <ix:nonNumeric contextRef="iaa2dfaae047842b6941420922ac5d9c3_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIyNjU2_e02e900e-89bb-4398-9d64-e8c46aedfc8a">1</ix:nonNumeric> to <ix:nonNumeric contextRef="i9d5000b271614c1d855c110b625f929b_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIyNjYy_040c87af-eacc-4395-b6c4-f25e639d38cb">40</ix:nonNumeric> years for buildings, building improvements and leasehold improvements and <ix:nonNumeric contextRef="ib812c723ed9c436d8f87f4410c352090_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIyNzM5_3b30d882-c3fb-4583-b015-3d4067a39741">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i485bcdbe665a4e4cbd15d510c347723d_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIyNzQ1_2da148ac-acca-4d60-a5d1-f8838c2535ad">10</ix:nonNumeric> years for fixtures, equipment and internally developed software. Repair and maintenance costs are charged directly to expense as incurred. Major renewals or replacements that </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i382685f0adce42889c732ea29a682f8f" continuedAt="i5ae2ff2c3d744c379d599e534e1a20ea"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic3868fcecac7489785bba4226f472173">substantially extend the useful life of an asset are capitalized and depreciated. Application development stage costs for significant internally developed software projects are capitalized and depreciated.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDAw_39fe2768-e442-420f-a888-a000b3bd0f1d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consists of the following at December&#160;31, 2021 and 2020: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11f43eb2bc384595bbbc2dc60fb0e429_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzEtMS0xLTEtMTk2MzU_f02c77c3-af22-44fd-9a00-83600f210d07">2,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab960c5fc78c435185612e456997735f_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzEtMy0xLTEtMTk2MzU_f76cf44b-4cc4-4770-8caa-a52547824d3c">2,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb17dc7419794c27a906e798d28163ce_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzItMS0xLTEtMTk2MzU_d86775da-5e48-4b4c-8cc6-2be73a0186f6">4,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d5a1e36661d4e01b93add403e998d55_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzItMy0xLTEtMTk2MzU_1b9bddf3-0b7a-43d7-97b5-e7fff2464cd2">3,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixtures and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie95f04d20e7d4540beba10c465fb945c_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzMtMS0xLTEtMTk2MzU_c76b78b4-8251-49a4-b7b4-46215e3eee0a">13,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220afc16aa4243638833bb1917d74494_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzMtMy0xLTEtMTk2MzU_24232579-d343-4ee4-ac70-09bc183ffaf2">13,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c0e02c68194f43b7f9e96b2667ef52_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzQtMS0xLTEtMTk2MzU_c48fde66-b130-4963-be76-867ad818e5b0">6,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i334820a07cbd4de3a8b8dc2ef2625448_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzQtMy0xLTEtMTk2MzU_7654bc1f-7bf4-4556-953c-d880676ac079">6,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01b95bc53d324e16ab4248f13d4f4b5d_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzUtMS0xLTEtMTk2MzU_347a140c-4239-4ed8-97be-249cb2c6b068">7,426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b10e7dd209b41c8afef5d331b8732be_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzUtMy0xLTEtMTk2MzU_6766b410-3434-4283-b6c4-d564e27ce67e">6,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzYtMS0xLTEtMTk2MzU_b01d17ac-fde2-4ca2-b848-cef2631efde0">33,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzYtMy0xLTEtMTk2MzU_42ca96fb-b6ce-4edd-aa5e-fef4367fd821">31,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzctMS0xLTEtMTk2MzU_3fd9b6e4-ab2d-4225-a257-41f3b0171b7d">20,654</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzctMy0xLTEtMTk2MzU_203c6677-a832-45cc-a725-189d28d656b5">18,700</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzgtMS0xLTEtMTk2MzU_a0335999-6488-4fa4-8095-5e857271a3c6">12,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzgtMy0xLTEtMTk2MzU_a0829871-dd4a-45fd-911f-49599343d7cc">12,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense (which includes the amortization of property and equipment under finance or capital leases) totaled $<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-8" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIzMzIw_9ad8ac32-2b0e-44e4-8014-87099347455b">2.3</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-8" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIzMzI0_fac1e01c-169a-4ed2-959b-0d54243d2f78">2.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-8" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIzMzMx_c6307603-475e-4a10-8431-7747e09ef388">1.9</ix:nonFraction> billion for the years ended December&#160;31, 2021, 2020 and 2019, respectively. During the year ended December&#160;31, 2021, the Company recorded an impairment on property and equipment of $<ix:nonFraction unitRef="usd" contextRef="i73df28e0580843f0af8aec248d34934d_D20211001-20211231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzM4NDgyOTA4MzkzOTk_d99fc181-eba5-4789-af84-a684f768a25f">261</ix:nonFraction>&#160;million in connection with the planned closure of certain retail stores. See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about this impairment charge as well as the Company&#8217;s finance leases. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDA1_3c31acbe-07a6-4969-bdda-c98a49e668c0" continuedAt="ia85bf99332e944d1abece549669185de" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Right-of-Use Assets and Lease Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#8217;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s real estate leases typically contain options that permit renewals for additional periods of up to <ix:nonNumeric contextRef="i2f08d731825c4986934a5374bd021d17_D20210101-20211231" name="cvs:LesseeOperatingAndFinanceLeasesRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzI0NDY5_2d866c1d-af3e-4e32-8063-97b506c29a2e">five years</ix:nonNumeric> each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For real estate leases, the Company accounts for lease components and nonlease components as a single lease component.  Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia85bf99332e944d1abece549669185de">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about right-of-use assets and lease liabilities.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDQw_936818a0-7491-469b-850b-9fd7424bf9fe" continuedAt="ib6b281a483b34d71857cbae505705044" escape="true">Goodwill </ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib6b281a483b34d71857cbae505705044">The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently if necessary, as further described in &#8220;Long-Lived Asset Impairment&#8221; below.</ix:continuation> See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about goodwill. </span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5ae2ff2c3d744c379d599e534e1a20ea" continuedAt="i455ba1f3a97d4e9abfe631c46b7b4393"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDQx_9fda69f5-47cc-4c80-aa63-39d30576889a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#8220;VOBA&#8221;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Other than VOBA, definite-lived intangible assets are amortized using the straight-line method. VOBA is amortized over the expected life of the acquired contracts in proportion to estimated premiums. Indefinite-lived intangible assets are not amortized but are tested for impairment annually, or more frequently if necessary, as further described in &#8220;Long-Lived Asset Impairment&#8221; below.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about intangible assets. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDY0_7f59e140-b252-4f29-9c5d-f53adc39c674" continuedAt="i5f92968b5fe24562b7b66e233653cd65" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Asset Impairment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#8217;s estimated future cash flows (discounted). If required, an impairment loss is recorded for the portion of the asset group&#8217;s carrying value that exceeds the asset group&#8217;s estimated future cash flows (discounted). During the year ended December&#160;31, 2021, the Company recorded a store impairment charge of approximately $<ix:nonFraction unitRef="usd" contextRef="i0b5082eb85c041ac945f01d6bc51973d_D20210101-20211231" decimals="-8" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzEwOTk1MTE3NDc1NTQ_86ad6253-a937-489a-98d3-272c929c5407">1.4</ix:nonFraction> billion primarily related to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately <ix:nonFraction unitRef="store" contextRef="i0b5082eb85c041ac945f01d6bc51973d_D20210101-20211231" decimals="-2" name="cvs:NumberOfStoresPlannedClosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMyOTg1MzUwMzA1Mjg_faf16a90-e7e8-448b-b01d-9455286893a3">900</ix:nonFraction> retail stores between 2022 and 2024. There were <ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzEwOTk1MTE3NDgyOTk_790d8935-3f83-44c3-8ea2-ae35cd9802d1">no</ix:nonFraction> material impairment charges recognized on long-lived assets in the year ended 2020. During the year ended December&#160;31, 2019 the Company recorded a store impairment charge of $<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzI5MDQy_9b4539d8-ff1d-41b9-b8ca-aef4a7ad6ca1">231</ix:nonFraction> million primarily related to operating lease right-of-use assets. See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about the right-of-use asset impairment charges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When evaluating goodwill for potential impairment, the Company compares the fair value of its reporting units to their respective carrying amounts. The Company estimates the fair value of its reporting units using a combination of a discounted cash flow method and a market multiple method. If the carrying amount of a reporting unit exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill, the results of which indicated an impairment of the goodwill associated with the LTC reporting unit. Accordingly, during the third quarter of 2021, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="i66d7d53744704d0d935a2fefbe9f6853_D20210701-20210930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzOTgwNDY2MzcyNDE_b6a3f7a7-b9d0-4db1-9ee1-d123799f81cc">431</ix:nonFraction>&#160;million goodwill impairment charge. The results of the impairment tests indicated that there was no impairment of goodwill of the remaining reporting units as of the testing date or during the year ended December&#160;31, 2021. During the third quarter of both 2020 and 2019, the Company performed its required annual goodwill impairment tests and concluded there were <ix:nonFraction unitRef="usd" contextRef="i2350df645dc04e808a96e20dad3a3fba_D20200701-20200930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzI5OTUx_22f8906a-c9c3-446d-b283-1a3b007c91d1"><ix:nonFraction unitRef="usd" contextRef="i7f4611487c414f69acafa1f966054637_D20190701-20190930" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzI5OTUx_291e250c-a71f-4226-95a9-89bd84bdad76">no</ix:nonFraction></ix:nonFraction> goodwill impairments as of the testing dates or during the years ended December&#160;31, 2020 and 2019. See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about the goodwill impairment charge recorded during the year ended December&#160;31, 2021. </span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5f92968b5fe24562b7b66e233653cd65">Indefinite-lived intangible assets are tested for impairment by comparing the estimated fair value of the asset to its carrying value. The Company estimates the fair value of its indefinite-lived trademarks using the relief from royalty method under the income approach. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value.</ix:continuation> There were <ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMwNTk3_21d2f110-c6c8-47f4-8332-dcc02788c8e4"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMwNTk3_23d3f0e4-c465-45e5-a264-415ebaebfa2a"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMwNTk3_6c9cbe79-1b3d-4a25-bd91-766f6be850d3">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment losses recognized on indefinite-lived intangible assets in any of the years ended December&#160;31, 2021, 2020 or 2019.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:PolicyholderAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDcy_b91c3987-7fbb-4beb-ac3c-03792b5875a6" continuedAt="i8147ec52efdc4df98fb27f1ba37d23b7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses. Deposits, withdrawals and net </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i455ba1f3a97d4e9abfe631c46b7b4393" continuedAt="i6aad6712dee842d1a2e851acedc85c4f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8147ec52efdc4df98fb27f1ba37d23b7">investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.</ix:continuation></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:HealthCareCostsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDQ4_a80e0dbb-74b7-43be-becf-dcd365ee4f2b" continuedAt="i36bdc760f17b47149c097161ed3d18ee" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Costs Payable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care costs payable consist principally of unpaid fee-for-service medical, dental and pharmacy claims, capitation costs, other amounts due to providers pursuant to risk-sharing arrangements related to the Health Care Benefits segment&#8217;s Insured Commercial, Medicare and Medicaid products and accruals for state assessments. Unpaid health care claims include an estimate of payments the Company will make for (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid, each as of the financial statement date (collectively, &#8220;IBNR&#8221;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. Such estimates are developed using actuarial principles and assumptions which consider, among other things, historical and projected claim submission and processing patterns, assumed and historical medical cost trends, historical utilization of medical services, claim inventory levels, changes in Insured membership and product mix, seasonality and other relevant factors. The Company reflects changes in these estimates in benefit costs in the Company&#8217;s consolidated operating results in the period they are determined. Capitation costs represent contractual monthly fees paid to participating physicians and other medical providers for providing medical care, regardless of the volume of medical services provided to the Insured member. Amounts due under risk-sharing arrangements are based on the terms of the underlying contracts with the providers and consider claims experience under the contracts through the financial statement date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. Of those factors, the Company considers the analysis of historical and projected claim payment patterns (including claims submission and processing patterns) and the assumed health care cost trend rate (the year-over-year change in per member per month health care costs) to be the most critical assumptions. In developing its IBNR estimate, the Company consistently applies these actuarial principles and assumptions each period, with consideration to the variability of related factors. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of IBNR in 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company analyzes historical claim payment patterns by comparing claim incurred dates (i.e., the date services were provided) to claim payment dates to estimate &#8220;completion factors.&#8221; The Company uses completion factors predominantly to estimate the ultimate cost of claims incurred more than three months before the financial statement date. The Company estimates completion factors by aggregating claim data based on the month of service and month of claim payment and estimating the percentage of claims incurred for a given month that are complete by each month thereafter. For any given month, substantially all claims are paid within <ix:nonNumeric contextRef="ic8b00a5656814734a6bb268b8e3ca5ce_D20210101-20211231" name="cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzM0Nzk1_c5bd2584-1589-4595-9200-ae57af096ce3">six months</ix:nonNumeric> of the date of service, but it can take up to <ix:nonNumeric contextRef="i2f08d731825c4986934a5374bd021d17_D20210101-20211231" name="cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzM0ODQ0_62f87a9f-0b6c-4e57-8211-0d01f395b15d">48</ix:nonNumeric> months or longer after the date of service before all of the claims are completely resolved and paid. These historically-derived completion factors are then applied to claims paid through the financial statement date to estimate the ultimate claim cost for a given month&#8217;s incurred claim activity. The difference between the estimated ultimate claim cost and the claims paid through the financial statement date represents the Company&#8217;s estimate of claims remaining to be paid as of the financial statement date and is included in the Company&#8217;s health care costs payable. The completion factors the Company uses reflect judgments and possible adjustments based on data such as claim inventory levels, claim submission and processing patterns and, to a lesser extent, other factors such as changes in health care cost trend rates, changes in Insured membership and changes in product mix. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claims may be more (less) complete than originally estimated using the Company&#8217;s completion factors, which may result in reserves that are higher (lower) than the ultimate cost of claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because claims incurred within three months before the financial statement date are less mature, the Company uses a combination of historically-derived completion factors and the assumed health care cost trend rate to estimate the ultimate cost of claims incurred for these months. The Company applies its actuarial judgment and places a greater emphasis on the assumed health care cost trend rate for the most recent claim incurred dates as these months may be influenced by seasonal patterns and changes in membership and product mix.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s health care cost trend rate is affected by changes in per member utilization of medical services as well as changes in the unit cost of such services. Many factors influence the health care cost trend rate, including the Company&#8217;s ability to manage benefit costs through product design, negotiation of favorable provider contracts and medical management programs, as well as the mix of the Company&#8217;s business. The health status of the Company&#8217;s Insured members, aging of the population and other demographic characteristics, advances in medical technology and other factors continue to contribute to rising per member utilization and unit costs. Changes in health care practices, inflation, new technologies, increases in the cost of </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6aad6712dee842d1a2e851acedc85c4f" continuedAt="ic0e4a2133f984cc785b19c30f97d8317"><ix:continuation id="i36bdc760f17b47149c097161ed3d18ee"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prescription drugs (including specialty pharmacy drugs), direct-to-consumer marketing by pharmaceutical companies, clusters of high-cost cases, claim intensity, changes in the regulatory environment, health care provider or member fraud and numerous other factors also contribute to the cost of health care and the Company&#8217;s health care cost trend rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each reporting period, the Company uses an extensive degree of judgment in the process of estimating its health care costs payable. As a result, considerable variability and uncertainty is inherent in such estimates, particularly with respect to claims with claim incurred dates of three months or less before the financial statement date; and the adequacy of such estimates is highly sensitive to changes in assumed completion factors and the assumed health care cost trend rates. For each reporting period the Company recognizes the actuarial best estimate of health care costs payable considering the potential volatility in assumed completion factors and health care cost trend rates, as well as other factors. The Company believes its estimate of health care costs payable is reasonable and adequate to cover its obligations at December&#160;31, 2021; however, actual claim payments may differ from the Company&#8217;s estimates. A worsening (or improvement) of the Company&#8217;s health care cost trend rates or changes in completion factors from those that the Company assumed in estimating health care costs payable at December&#160;31, 2021 would cause these estimates to change in the near term, and such a change could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each quarter, the Company re-examines previously established health care costs payable estimates based on actual claim payments for prior periods and other changes in facts and circumstances. Given the extensive degree of judgment in this estimate, it is possible that the Company&#8217;s estimates of health care costs payable could develop either favorably (that is, its actual benefit costs for the period were less than estimated) or unfavorably. The changes in the Company&#8217;s estimate of health care costs payable may relate to a prior quarter, prior year or earlier periods. For a roll forward of the Company&#8217;s health care costs payable, see Note 7 &#8216;&#8216;Health Care Costs Payable.&#8217;&#8217; The Company&#8217;s reserving practice is to consistently recognize the actuarial best estimate of its ultimate liability for health care costs payable.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NTI1_c6bf175e-bd20-4a2f-bd59-a98b9bff0698" continuedAt="ifd994e417bf14820abcfd78cfea9a276" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Insurance Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unpaid Claims</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unpaid claims consist primarily of reserves associated with certain short-duration group disability and term life insurance contracts, including an estimate for IBNR as of the financial statement date. Reserves associated with certain short-duration group disability and term life insurance contracts are based upon the Company&#8217;s estimate of the present value of future benefits, which is based on assumed investment yields and assumptions regarding mortality, morbidity and recoveries from the U.S. Social Security Administration. The Company develops its estimate of IBNR using actuarial principles and assumptions which consider, among other things, contractual requirements, claim incidence rates, claim recovery rates, seasonality and other relevant factors. The Company discounts certain claim liabilities related to group long-term disability and life insurance waiver of premium contracts. The discount rates generally reflect the Company&#8217;s expected investment returns for the investments supporting all incurral years of these liabilities. The discount rates for retrospectively-rated contracts are set at contractually specified levels. The Company&#8217;s estimates of unpaid claims are subject to change due to changes in the underlying experience of the insurance contracts, changes in investment yields or other factors, and these changes are recorded in current and future benefits in the consolidated statements of operations in the period they are determined. The Company estimates its reserve for claims IBNR for life products largely based on completion factors. The completion factors used are based on the Company&#8217;s historical experience and reflect judgments and possible adjustments based on data such as claim inventory levels, claim payment patterns, changes in business volume and other factors. If claims are submitted or processed on a faster (slower) pace than historical periods, the actual claims may be more (less) complete than originally estimated using completion factors, which may result in reserves that are higher (lower) than required to cover future life benefit payments. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of unpaid claims IBNR in 2021. As of December&#160;31, 2021, unpaid claims balances of $<ix:nonFraction unitRef="usd" contextRef="ia549907bd80b4d05927cab95ed27791d_I20211231" decimals="-6" name="cvs:LiabilityforUnpaidClaims" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQxOTc4_3c73685a-c06c-4592-b15d-3c604da34c24">324</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if864780575b94e94ab5aaeb609bdc2fc_I20211231" decimals="-8" name="cvs:LiabilityforUnpaidClaims" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQxOTg1_ff104f70-01e9-4e29-8fb8-9420bcf55153">1.3</ix:nonFraction> billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2020, unpaid claims balances of $<ix:nonFraction unitRef="usd" contextRef="i7923496932ec4872a3aac9f738db85f9_I20201231" decimals="-6" name="cvs:LiabilityforUnpaidClaims" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQyMTI2_e05b7b19-da05-4df6-bb52-3b66b4bb5d51">532</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6b4429ac745c44638a7414f5ff8d6894_I20201231" decimals="-8" name="cvs:LiabilityforUnpaidClaims" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQyMTMz_2238f18a-3709-4ab4-9d5b-81f34ef7f86b">1.5</ix:nonFraction> billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all life and disability insurance liabilities have been fully ceded to unrelated third parties through indemnity reinsurance agreements; however, the Company remains directly obligated to the policyholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Future Policy Benefits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future policy benefits consist primarily of reserves for limited payment pension and annuity contracts and long-term care insurance contracts. Reserves for limited payment pension and annuity contracts are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality, retirement, expense and interest rate experience. Such assumptions generally vary by plan, year of issue and policy duration. Assumed interest rates on such contracts ranged from <ix:nonFraction unitRef="number" contextRef="ic8b00a5656814734a6bb268b8e3ca5ce_D20210101-20211231" decimals="3" name="cvs:LimitedPaymentsContracts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQyOTg2_3c8ce723-962f-459d-a522-3cd82093eddb">3.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i2f08d731825c4986934a5374bd021d17_D20210101-20211231" decimals="3" name="cvs:LimitedPaymentsContracts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQyOTky_23a3e361-0a9b-405f-8d14-955a57f3e5f6">11.3</ix:nonFraction>% in the year ended December&#160;31, 2021 and from <ix:nonFraction unitRef="number" contextRef="if6a4e820cff84a708a34d9940c913923_D20200101-20201231" decimals="3" name="cvs:LimitedPaymentsContracts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzMDM4_dd8e1ba8-0ecf-4ee3-bc37-45dd76951265">3.3</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i45c5b8fb4d364022b20880618cc963ec_D20200101-20201231" decimals="3" name="cvs:LimitedPaymentsContracts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzMDQ0_a2d09667-3c67-4ed2-859e-17440149d9f5">11.3</ix:nonFraction>% in the year ended December&#160;31, 2020. The Company periodically reviews mortality assumptions against both industry standards and its experience. Reserves for long-</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic0e4a2133f984cc785b19c30f97d8317" continuedAt="i6cf33b4faaf34430943a527db26ac469"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifd994e417bf14820abcfd78cfea9a276">duration long-term care contracts represent the Company&#8217;s estimate of the present value of future benefits and essential maintenance expenses to be paid to or on behalf of policyholders less the present value of future gross premiums. The assumed interest rate on such contracts was <ix:nonFraction unitRef="number" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="3" name="cvs:AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzNDU1_58a797ac-8f44-417d-b90a-57bcaabaae6f"><ix:nonFraction unitRef="number" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="3" name="cvs:AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzNDU1_d1b5f252-4427-4ded-84c1-261333705446">5.1</ix:nonFraction></ix:nonFraction>% in both the years ended December 31, 2021 and 2020. The Company&#8217;s estimate of the present value of future benefits under such contracts is based upon mortality, morbidity and interest rate assumptions.</ix:continuation> As of December&#160;31, 2021, future policy benefits balances of $<ix:nonFraction unitRef="usd" contextRef="ia549907bd80b4d05927cab95ed27791d_I20211231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzNzAz_c1c1f288-72f1-4532-a1ea-e3c0b05e582b">416</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if864780575b94e94ab5aaeb609bdc2fc_I20211231" decimals="-8" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzNzEw_af57df69-63fa-409d-992a-542d5bd50e0e">5.1</ix:nonFraction> billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2020, future policy benefits balances of $<ix:nonFraction unitRef="usd" contextRef="i7923496932ec4872a3aac9f738db85f9_I20201231" decimals="-6" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzODYw_af90dfd5-a99f-4bf8-a43a-5b1714e19d96">462</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6b4429ac745c44638a7414f5ff8d6894_I20201231" decimals="-8" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzODY3_c4da48d4-a080-4bc2-b089-c21efc0ec6fe">5.5</ix:nonFraction> billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="cvs:InsurancePremiumDeficiencyReservePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDkw_6f7b838b-5204-4b11-8d67-f5d7b9390648" continuedAt="i5ccfdf80fc9f4c8189cdefce4ac5e709" escape="true">Premium Deficiency Reserves</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5ccfdf80fc9f4c8189cdefce4ac5e709">The Company evaluates its insurance contracts to determine if it is probable that a loss will be incurred. A premium deficiency loss is recognized when it is probable that expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), will exceed existing reserves plus anticipated future premiums and reinsurance recoveries. Anticipated investment income is not considered in the calculation of premium deficiency losses for short-duration contracts. For purposes of determining premium deficiency losses, contracts are grouped consistent with the Company&#8217;s method of acquiring, servicing and measuring the profitability of such contracts.</ix:continuation> As of December&#160;31, 2021 and 2020, the Company established a premium deficiency reserve of $<ix:nonFraction unitRef="usd" contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ0NzYy_a0918f1b-b36d-4143-90d0-ee5479de8fba">16</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7e7c0dce760d47df841954664e69c360_I20201231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ0NzY5_c0e64093-26e8-4fb7-b52c-4eebe190937f">11</ix:nonFraction> million, respectively, related to Medicaid products in the Health Care Benefits segment. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:AllocationsToPolicyholdersPolicies" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDg2_5d0b0780-01f1-488c-b53e-8c4261d956d2" continuedAt="iccf671f01df2486592592cfcffedb364" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policyholders&#8217; Funds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Policyholders&#8217; funds consist primarily of reserves for pension and annuity investment contracts and customer funds associated with certain health contracts. Reserves for such contracts are equal to cumulative deposits less withdrawals and charges plus  interest credited thereon, net of experience-rated adjustments. In 2021, interest rates for pension and annuity investment contracts ranged from <ix:nonFraction unitRef="number" contextRef="ic8b00a5656814734a6bb268b8e3ca5ce_D20210101-20211231" decimals="3" name="cvs:PensionAndAnnuityInvestmentContractsInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ1Mjcz_d3b511fe-c1b5-4eba-856d-fa98a4d681ba">3.5</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i2f08d731825c4986934a5374bd021d17_D20210101-20211231" decimals="3" name="cvs:PensionAndAnnuityInvestmentContractsInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ1Mjc5_ff73afce-8538-43c3-8081-1d3011830820">4.8</ix:nonFraction>%. In 2020, interest rates for pension and annuity investment contracts ranged from <ix:nonFraction unitRef="number" contextRef="if6a4e820cff84a708a34d9940c913923_D20200101-20201231" decimals="3" name="cvs:PensionAndAnnuityInvestmentContractsInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ1MzY0_ff663d7d-53a6-4497-9832-a2d139e5a315">4.1</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i45c5b8fb4d364022b20880618cc963ec_D20200101-20201231" decimals="3" name="cvs:PensionAndAnnuityInvestmentContractsInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ1Mzcw_fb6d40f3-3a1c-40a6-a5bc-eaab594d4ea5">5.1</ix:nonFraction>%. Reserves for contracts subject to experience rating reflect the Company&#8217;s rights as well as the rights of policyholders and plan participants. The Company also holds funds for HSAs on behalf of members associated with high deductible health plans. These amounts are held to pay for qualified health care expenses incurred by these members. The HSA balances were approximately $<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-8" name="cvs:HeathSavingsAccountBalance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ1Nzc4_4bc67c31-a9b3-41cd-bebf-4ac3d48587eb">2.9</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-8" name="cvs:HeathSavingsAccountBalance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ1Nzg1_91f9ccb1-de78-40d1-82f6-9f2bab9d1b4f">2.7</ix:nonFraction> billion at December&#160;31, 2021 and 2020, respectively, and are reflected in other current assets with a corresponding liability in policyholders&#8217; funds. These assets are considered restricted cash for cash flow statement purposes.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iccf671f01df2486592592cfcffedb364">Policyholders&#8217; funds liabilities that are expected to be paid within twelve months from the balance sheet date are classified as current on the consolidated balance sheets. Policyholders&#8217; funds liabilities that are expected to be paid greater than twelve months from the balance sheet date are included in other long-term liabilities on the consolidated balance sheets.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:SelfInsuranceReservePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3Mzk0_d453d2c3-f7d9-4afc-b7f6-da0415e08320" continuedAt="ieda59269d83044cdab7a3ae658f193a5" escape="true">Self-Insurance Liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ieda59269d83044cdab7a3ae658f193a5">The Company is self-insured for certain losses related to general liability, workers&#8217; compensation and auto liability. The Company obtains third party insurance coverage to limit exposure from these claims. The Company is also self-insured for certain losses related to health and medical liabilities. The Company&#8217;s self-insurance accruals, which include reported claims and claims incurred but not reported, are calculated using standard insurance industry actuarial assumptions and the Company&#8217;s historical claims experience.</ix:continuation> At December&#160;31, 2021 and 2020, self-insurance liabilities totaled $<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ2ODkz_f96163ed-6eb8-41d0-b6b3-811b0f20a8b5">1.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ2OTAw_da560efc-d03c-49d1-a426-357a471607a9">927</ix:nonFraction> million, respectively, and were recorded as accrued expenses on the consolidated balance sheets.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDMw_be736bae-1229-4f8b-af71-28017e30af85" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation and Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For non-U.S. dollar functional currency locations, (i) assets and liabilities are translated at end-of-period exchange rates, (ii) revenues and expenses are translated at average exchange rates in effect during the period and (iii) equity is translated at historical exchange rates. The resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For U.S. dollar functional currency locations, foreign currency assets and liabilities are remeasured into U.S. dollars at end-of-period exchange rates, except for nonmonetary balance sheet accounts which are remeasured at historical exchange rates. Revenues and expenses are remeasured at average exchange rates in effect during each period, except for those expenses related to the nonmonetary balance sheet amounts which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in net income.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6cf33b4faaf34430943a527db26ac469" continuedAt="i6aab1fa4d0874e65aacf380475dca0bf"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses from foreign currency transactions and the effects of foreign currency remeasurements were not material in the years ended December&#160;31, 2021 or 2020. On July 1, 2019, the Company sold its Brazilian subsidiary, Drogaria Onofre Ltda. (&#8220;Onofre&#8221;) for an immaterial amount. The Company recorded a loss on the divestiture, which included the elimination of the subsidiary&#8217;s $<ix:nonFraction unitRef="usd" contextRef="i92c848c1cac74063a225275fcd16ac3e_D20190101-20191231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ4Mzc4_642a042b-9e6f-4e20-8a96-b7a25b6721c5">154</ix:nonFraction> million cumulative translation adjustment from accumulated other comprehensive income during the year ended December 31, 2019.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDc2_4cc14bb5-2d28-4047-9860-509a99459a3b" continuedAt="ie381b052a4c440b88f5cb8a86bcb5dbd" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which, in the Company&#8217;s Commercial business, reflect contracted rates per member and the number of covered members recorded in the Company&#8217;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. Revenue related to the Company&#8217;s Government business is collected monthly from the U.S. federal government and various government agencies based on fixed payment rates and member eligibility. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Premium Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the minimum medical loss ratio (&#8220;MLR&#8221;) rebate requirements of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (as amended, collectively, the &#8220;ACA&#8221;) is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Services Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#8217;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#8217;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#8217;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting for Medicare Part D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include insurance premiums earned by the Company&#8217;s PDPs, which are determined based on the PDP&#8217;s annual bid and related contractual arrangements with the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;). The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6aab1fa4d0874e65aacf380475dca0bf" continuedAt="ifbecf862bc5246088ef74f612b8e9985"><ix:continuation id="ie381b052a4c440b88f5cb8a86bcb5dbd" continuedAt="ia41b1f54ae114399b344decfe1977e7a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment sells prescription drugs directly through its mail service dispensing pharmacies and indirectly through the Company&#8217;s retail pharmacy network. The Company&#8217;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the dispensing of prescription drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions dispensed indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#8220;Drug Discounts&#8221; and &#8220;Guarantees&#8221; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#8220;retail co-payments&#8221;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Pharmacy Services segment:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by mail service dispensing pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by third party pharmacies in the Company&#8217;s retail pharmacy network and associated administrative fees are recognized at the Company&#8217;s point-of-sale, which is when the claim is adjudicated by the Company&#8217;s online claims processing system and the Company has transferred control of the prescription drug and completed all of its performance obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Drug Discounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records revenue net of manufacturers&#8217; rebates earned by its clients based on their plan members&#8217; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#8217; rebates earned by its clients. The estimates are based on the best available data at period-end and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#8217; rebate amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantees</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="ifbecf862bc5246088ef74f612b8e9985" continuedAt="id463a80e7ccc4e28b820b79f7b97d329"><ix:continuation id="ia41b1f54ae114399b344decfe1977e7a" continuedAt="if730ccb8061e45a9b5ab50dd4e4975ed"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Retail Pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer returns are not material to the Company&#8217;s operating results or financial condition. Sales taxes are not included in revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loyalty and Other Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customer loyalty program, ExtraCare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, consists of two components, ExtraSavings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers a subscription-based membership program, CarePass</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-term Care</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of long-term care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#8217;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Walk-In Medical Clinics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For services provided by the Company&#8217;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id463a80e7ccc4e28b820b79f7b97d329" continuedAt="i04d69815ba32437887fba7b54fa5d0d4"><ix:continuation id="if730ccb8061e45a9b5ab50dd4e4975ed" continuedAt="i0fa1f25321f240e4aef2393161a94f89"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDc0_363406e4-ec87-4478-96ff-1a3a2ddff602" continuedAt="i51b8fab779244b838cb557ca09bb807d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by major source in each segment for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:28.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.535%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.944%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.159%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.462%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4498de5248d54d40afb291f1fc098731_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMtMS0xLTEtMjU2NDE_c6668d41-a73b-410c-9710-4ccc9b3383e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1002f99fed94f288ca5f74eedbdeab1_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMtMS0xLTEtMTk2MzU_958dcec6-c468-4b26-9861-543e1efc9f21">152,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebcc3ed38ad2471582d090e796d7ce3b_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMtMy0xLTEtMTk2MzU_ea1c5b63-ff58-4a4e-927f-160e60c08523">76,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fef8cff035c4c69a8c38c9106be1c8d_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMtNy0xLTEtMTk2MzU_e62686b6-cef8-4f43-8386-654dc1968d43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c932f46423b4eb0b5ffe12d1cb5e4f7_D20210101-20211231" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMtOS0xLTEtMTk2MzU_59517358-0d86-42e9-9251-5d0850fd7a10">43,765</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58bb9dd9de57438c8823cb7f0f5b7456_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMtMTEtMS0xLTE5NjM1_1c69da4f-0999-4289-b900-1f4738160cb7">184,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ddd2583249240ab9fd8716ea50815be_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQtMS0xLTEtMjU2NDE_e0e87fbe-8fc8-4446-8ab7-4b48ebc2fe48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62292b173722422f93bc0d15e20388ff_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQtMS0xLTEtMTk2MzU_2e35b7da-ad79-4531-a54e-0ddaf71a87f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if247a044060a414a9731ef3f633443ec_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQtMy0xLTEtMTk2MzU_f083234e-ca61-4587-ad30-a9f9e73201c2">21,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed9316414794c62b549ee70109c3a1c_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQtNy0xLTEtMTk2MzU_e317f2b6-8d31-4204-998e-534286252f6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48e9a22e1fd4d718486619d4e3719f1_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQtOS0xLTEtMTk2MzU_655456d5-62e9-48b6-b0bc-5fb5dfcc6ffc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie803710aa3d14d08b76f31d1d981933a_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQtMTEtMS0xLTE5NjM1_1a771d79-e8eb-4aec-be01-893bed2b8261">21,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d061d240a9e43d88eb56b03b4b1c305_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzUtMS0xLTEtMjU2NDE_aff90937-9685-4e90-8e64-75ae44822bba">76,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5762aa2abba7409a8044131daa10dbbe_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzUtMS0xLTEtMTk2MzU_dc8f25fd-c436-4171-87af-e2b644e1b8f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f9354e553ba4e88889df599c49592a9_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzUtMy0xLTEtMTk2MzU_78939051-f88a-47a7-93d5-f7465d771eb9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42258aba1f3844c79f036592fd2314f6_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzUtNy0xLTEtMTk2MzU_a8b6935d-c6c5-420f-b0c5-b748c5e1f8e6">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief81cfdad9484af6b31eff5e1128145b_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzUtOS0xLTEtMTk2MzU_5046e6c2-ea4b-41cb-8b28-1860d68bb967">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e052765fbe5467a80a1782764372f99_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzUtMTEtMS0xLTE5NjM1_44e410d6-4d4e-4bf7-8817-0f649567ef3a">76,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8f78677d6943988b31d555638bbaf9_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzYtMS0xLTEtMjU2NDE_87203dc5-275f-4c9c-af26-9d298658f2cf">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzYtMS0xLTEtMTk2MzU_4f0b9e61-a8bc-4ba3-87ea-5484b815ff7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2301583729e7424597c39ac7978d0401_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzYtMy0xLTEtMTk2MzU_75c5b9b9-5e70-4f4f-8f3a-13e1ff733cf9">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f0540b87ed34aee812a4602f32b0fb6_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzYtNy0xLTEtMTk2MzU_ca0e21d1-eb80-4330-9646-12bc22b6f83c">596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4344db6c31344de2b14b66847d6c28a3_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzYtOS0xLTEtMTk2MzU_1056160d-b4a9-4190-a225-acafe4b9ba25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzYtMTEtMS0xLTE5NjM1_df8d0650-4ac8-497f-bd9a-b2cb8fac22df">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77576c1c65984cc3b50354c3450129d5_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzctMS0xLTEtMjU2NDE_8cf7d1f5-2e64-4321-aa3d-5101952f75b2">5,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc537d99f46e4ee089fc01dc7844328e_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzctMS0xLTEtMTk2MzU_66d62d76-848f-40b2-9676-303c4148ed4d">760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i071a8d3987fb4484affa36468d188f51_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzctMy0xLTEtMTk2MzU_eb1b9846-0c04-4ba5-9a3b-95340f84f989">2,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2f0ce0e931416b9534dcfd36624ed0_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzctNy0xLTEtMTk2MzU_a92d8ac1-835e-4763-8684-0d916e3a780d">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b8deab908c04d898d7365d0a57ffc0b_D20210101-20211231" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzctOS0xLTEtMTk2MzU_b7ff53ac-3f6f-4001-9d51-d5776c023880">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45a45ada9f7246c3b344e458342767f2_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzctMTEtMS0xLTE5NjM1_cd02065f-012f-4b24-b90f-4f5515b78442">8,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8f78677d6943988b31d555638bbaf9_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzgtMS0xLTEtMjU2NDE_0002a2f1-e946-4539-970a-ede506440c3a">82,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzgtMS0xLTEtMTk2MzU_3a7f4585-06a0-4959-b23b-4d41406372b0">153,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2301583729e7424597c39ac7978d0401_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzgtMy0xLTEtMTk2MzU_4fa2e3b3-8a6c-4d1a-874a-b9fbd0fad65e">100,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f0540b87ed34aee812a4602f32b0fb6_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzgtNy0xLTEtMTk2MzU_8c9433c4-80b4-456d-806f-0500e4e4dc56">721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4344db6c31344de2b14b66847d6c28a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzgtOS0xLTEtMTk2MzU_8834d9b7-6a4e-4b8d-9b9b-475e25fbff52">43,923</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzgtMTEtMS0xLTE5NjM1_1e46d657-98ef-4088-ba5d-a11688b20e7d">292,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61039a6c4f3941c78fea069998c3b394_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzExLTEtMS0xLTE5NjM1_eef48ca0-91b2-4a7e-83ac-526d70921b00">91,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ffa587016394b5784b3a8591967b741_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzEyLTEtMS0xLTE5NjM1_5e21e99f-f357-4317-ac89-83471c3140f2">60,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7055234871404d9bafa8741c06125a63_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzEzLTEtMS0xLTE5NjM1_95da85c6-7a3f-46a1-ab53-5f7bc31a3501">760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE0LTEtMS0xLTE5NjM1_25c5df10-98c7-4b1f-97fc-95134a35ac41">153,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cdd84a2122f4e48bd7e94aa5a543fc7_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE4LTEtMS0xLTI1NjQ0_3d5b2c2a-9a43-4b93-9feb-ecb31e2ee5da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i248dfcc1ff5a4287a22a16423cabbfd0_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE4LTEtMS0xLTE5NjM1_d11a0f36-4810-4f32-803b-00dc28fb2602">141,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21ddaf2aa6974aadb1b64f7b7a5257ea_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE4LTMtMS0xLTE5NjM1_14a2104c-2831-4bae-ae51-1c85e9e448d1">70,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab97b765af4e49ffad5046609f678a8f_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE4LTctMS0xLTE5NjM1_f08442f0-2ae6-4d86-854e-4cc0ed0d9280">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fe7b82658e94a3fb768194bb39484ab_D20200101-20201231" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE4LTktMS0xLTE5NjM1_ed91e107-281e-44d2-8949-642c94f768b1">40,003</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic786c87383ae4399b318ad961ecca522_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE4LTExLTEtMS0xOTYzNQ_9c74a3a1-49c3-4481-811b-d017829b1e95">171,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide7ebc79d9a54efb884b6972df58c788_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE5LTEtMS0xLTI1NjQ0_7f7cf61b-ad04-4fe5-8dd9-273f23911741">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dffb1a91abc47afa1350fc6dd222a18_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE5LTEtMS0xLTE5NjM1_1529eaa4-8a78-44cb-bde8-fa3c2334e829">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a337ef5a1564ee49dd9f743f426f9c9_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE5LTMtMS0xLTE5NjM1_1b5554f9-6cae-4c50-af86-a41ef5336f0b">19,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic10b456383584d7aaf8f683720fcb914_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE5LTctMS0xLTE5NjM1_1019c2e8-54fb-47d9-801f-8af69c207354">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id140f9f8dcd14083b50ec69d7cbc65da_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE5LTktMS0xLTE5NjM1_cd18ba18-56a9-4b81-85e7-7fe564025182">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c6cb5365a9c4dfe9062cee2d3a679f4_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE5LTExLTEtMS0xOTYzNQ_9eb444f2-8d57-4d48-9d5a-ae82d80b2656">19,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia41f6d7659764a9394360d2e7ea49f1d_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIwLTEtMS0xLTI1NjQ0_a871bbe2-d45a-43fb-9f1e-c47c6d7bec87">69,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib84692036a6a43eea3efda3fce3a9e9d_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIwLTEtMS0xLTE5NjM1_22e2add3-9aff-407f-bffc-0a2f97058502">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id67aa7e2958543c5b2a212d2e9f5ce6f_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIwLTMtMS0xLTE5NjM1_bd539977-136c-499f-bf58-4fb09d788fad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f1ba091cd86434eb258ca50211e3939_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIwLTctMS0xLTE5NjM1_02d104f3-b34a-438f-a358-005365328166">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic31dfa14042e414482c4216963d92547_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIwLTktMS0xLTE5NjM1_92a3a80c-fe62-4b8c-a302-5183cb514fba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76be16bc9f6249b9b235ac3756529601_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIwLTExLTEtMS0xOTYzNQ_13303828-0239-48cf-a780-00f1a4bbb56f">69,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53db5e5b0b444479a8a8759dbf521388_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIxLTEtMS0xLTI1NjQ0_7b942c53-3aad-4f5a-8c38-e5ecefe7049e">483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIxLTEtMS0xLTE5NjM1_8b2dec84-88a2-4ed1-bb22-e68e12520e19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia854c1c4120946f68b69cb19bc260e4b_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIxLTMtMS0xLTE5NjM1_0827eba8-38ea-4ace-a87d-2309f6ab7049">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e61340f47284992812b376b1458946d_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIxLTctMS0xLTE5NjM1_b6cb1e51-ae88-45a1-90f0-774778836e86">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccc3d52c70ae4beeabf495e0d535c807_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIxLTktMS0xLTE5NjM1_5b126704-8639-4736-b25f-3d62547b8ef0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIxLTExLTEtMS0xOTYzNQ_11c3f093-98d8-4ae1-839e-48bdc2d1b70b">798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie27ebf5be86d42d08d5b00b28a499bb0_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIyLTEtMS0xLTI1NjQ0_0984b82d-c7e9-4ee8-92c8-0e0afb123d89">5,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52561c6040014302a3dbd0c238d7e542_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIyLTEtMS0xLTE5NjM1_781caed2-8ada-4339-9ce0-065e8f5f9d38">822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e0f32f6d3d4988bc853318d22b23fd_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIyLTMtMS0xLTE5NjM1_5e88c8b3-7b75-4485-8a1b-15aad5a0434b">1,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic465100ccba348a3afd34c383000632c_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIyLTctMS0xLTE5NjM1_ff9cdef4-74e1-4608-9be1-36c2974f5191">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0249f41894f841a6b7dafe5cbba83478_D20200101-20201231" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIyLTktMS0xLTE5NjM1_dc32c2d5-a39b-4b39-ac4c-42b7351bebcd">320</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14fe0625f7df490f81964160bf26ed60_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIyLTExLTEtMS0xOTYzNQ_df364998-dbfe-4f74-b066-12b509f6eda8">7,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53db5e5b0b444479a8a8759dbf521388_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIzLTEtMS0xLTI1NjQ0_9eb1b82b-2c57-4542-a21d-67735f48bb86">75,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIzLTEtMS0xLTE5NjM1_7d86cce2-2c7e-4173-8b11-f829ac76aaab">141,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia854c1c4120946f68b69cb19bc260e4b_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIzLTMtMS0xLTE5NjM1_f79b069f-4b6a-4dfe-ab83-a8078865a3bc">91,198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e61340f47284992812b376b1458946d_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIzLTctMS0xLTE5NjM1_07015ac0-4d46-49b0-92ec-d36585cc9c24">426</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccc3d52c70ae4beeabf495e0d535c807_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIzLTktMS0xLTE5NjM1_7e4edfdf-7918-4ec5-b1fa-35d89bb72683">40,323</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIzLTExLTEtMS0xOTYzNQ_353346d5-c79c-4c99-881e-b2ec3e07e83f">268,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaaa14ca219c45319101f3294251d63b_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzI2LTEtMS0xLTE5NjM1_8a2108d5-62b2-4f38-87c8-ff6f219f9d49">85,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i447cc1b65f104221ab26818c3ed22faf_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzI3LTEtMS0xLTE5NjM1_23e4ce6f-e789-4f28-bc46-51c410a985ec">56,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic21b7b1b632e49739aa4555420878cbf_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzI4LTEtMS0xLTE5NjM1_d82b1e25-2a73-4329-b34e-aa90c26721ca">822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzI5LTEtMS0xLTE5NjM1_34ef07a2-d8c0-46a8-ace2-797c7653cac7">141,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8af99e3f8f9947f49861abe488bdd637_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMzLTEtMS0xLTI1NjQ3_e7f212f9-c1d0-4e06-ba6e-adb378952e61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i012def96350649cfbe7d7eb9602d64e1_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMzLTEtMS0xLTE5NjM1_8d5ea816-edc7-416b-9984-7b6f84d6cb07">140,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9001e42259074da8941f556efd30f660_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMzLTMtMS0xLTE5NjM1_cb6e3b3e-fa50-4f4e-a3d1-fdf0aeecce99">66,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i966eb89f8da54934ba00320af7713451_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMzLTctMS0xLTE5NjM1_bcecaf08-3a7a-4200-8e37-ec458b5eb9e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i157fcde113c546639a94d73e35c8837f_D20190101-20191231" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMzLTktMS0xLTE5NjM1_5efc8185-29cc-4631-8292-9dc271d3fb4d">41,413</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib92544612b6649778126fe8e9ab6e9b6_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMzLTExLTEtMS0xOTYzNQ_74731546-cba2-4ac1-922a-d94a6df2cc34">165,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa6bf06bf5cd4d70ac02de5a1d25d970_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM0LTEtMS0xLTI1NjQ3_7c65cb37-5b81-45ba-aecd-fe5c458a3a27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa3db576bc34c4b81beaf1e716f51d7_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM0LTEtMS0xLTE5NjM1_702d3642-8244-49cc-89ea-0adbe2de556d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib11ea18304ed4f7cab2400be338b0bf5_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM0LTMtMS0xLTE5NjM1_4d2c1607-9bc3-44ef-b332-c1c78c2bb4a3">19,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75513592809349c7a84c02e527ec7282_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM0LTctMS0xLTE5NjM1_821c4ad1-4c6a-49f4-be18-0a41a3f8195f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56591423c17340e982228082d680b5f2_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM0LTktMS0xLTE5NjM1_e2e1dbb9-d415-4eb4-8706-0c35f15195ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fb12e17ce2a48c9b260a608e997c399_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM0LTExLTEtMS0xOTYzNQ_4a78fbb3-1ab5-4aca-bd9e-e90a908d7007">19,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib775f94073ab4897a08bc1477642f227_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM1LTEtMS0xLTI1NjQ3_099f928f-acee-43f2-92fb-2d678f4dae74">63,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87a4d0a1226941d4b0d276cb76e9483e_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM1LTEtMS0xLTE5NjM1_434a7561-0286-4263-aef0-78b76abc8a11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe2fbb48419543c3b63c3ed144b5a10f_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM1LTMtMS0xLTE5NjM1_2aee2116-ffa2-4c50-8628-3b25a5e70ea5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26af9cce866f4682bb01349800a2150e_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM1LTctMS0xLTE5NjM1_8410c6f2-1b9a-4ea9-8729-8e9a81124cad">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifba04a8e07ae4647988ad6d2b6bf1364_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM1LTktMS0xLTE5NjM1_da114265-a1ac-48bf-bd64-f11eed9ea830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfe3ddb6c3a34749a2820654200c6a8c_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM1LTExLTEtMS0xOTYzNQ_20f65f25-9fb6-4986-bed4-4a5449bdae99">63,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7683c6a5bd9a46859b7c36e87aefa23f_D20190101-20191231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM2LTEtMS0xLTI1NjQ3_b5c2faf5-1723-4fb0-8341-d961ddefc548">599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM2LTEtMS0xLTE5NjM1_3422700f-c34e-42f7-9432-7f9b867805a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0059ff87fc364aec80f3c7eef6a97f6a_D20190101-20191231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM2LTMtMS0xLTE5NjM1_39544555-7a52-4339-89ff-4f4ced2f9a1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa96e65bf6294c0ca787cbef203ccb23_D20190101-20191231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM2LTctMS0xLTE5NjM1_3788f6ed-90ef-4a4a-8968-6c5e2d52da9e">412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic17eebf2b4964519a5671bddafa2ecae_D20190101-20191231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM2LTktMS0xLTE5NjM1_4a29f702-b4ab-4e92-8a14-9776484b9182">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM2LTExLTEtMS0xOTYzNQ_9e85dbd2-25ef-44cd-a83c-84a273256515">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4d27cdb62c44a25a61a4be0d895fc4c_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM3LTEtMS0xLTI1NjQ3_4ceb7f96-279f-4593-841b-89ee1ee68663">5,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3037e334694c4257a0adcaa55fac67f7_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM3LTEtMS0xLTE5NjM1_0130747e-bfc2-41a3-a1b3-2618476f284a">595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie27c33f5643f48a6ab725eac74707192_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM3LTMtMS0xLTE5NjM1_6d5052e8-86d4-463b-a34e-78df0c7c353f">744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a078bd350664f23bfb042a07d7c28aa_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM3LTctMS0xLTE5NjM1_d897c2f7-362f-47c1-8148-c2593d505aa8">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id33fc8f7a4874100ab8c405e4632eb30_D20190101-20191231" decimals="-6" sign="-" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM3LTktMS0xLTE5NjM1_aa8c3199-1cad-4c73-89d3-3a388563e86e">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i054efc215dfa4b1fa92da514a6fad49b_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM3LTExLTEtMS0xOTYzNQ_8267c123-92ef-45b3-af15-6a330c65b986">7,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7683c6a5bd9a46859b7c36e87aefa23f_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM4LTEtMS0xLTI1NjQ3_ac3810ad-7a40-4bbe-b041-748b4905223a">69,604</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM4LTEtMS0xLTE5NjM1_8d0a3c76-046b-47b2-91fa-8996b55743a9">141,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0059ff87fc364aec80f3c7eef6a97f6a_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM4LTMtMS0xLTE5NjM1_1fbdbb59-e903-4a00-9d7a-e9d032d19dfa">86,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa96e65bf6294c0ca787cbef203ccb23_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM4LTctMS0xLTE5NjM1_83a6c50f-2a63-41ee-b002-456544fac06c">512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic17eebf2b4964519a5671bddafa2ecae_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM4LTktMS0xLTE5NjM1_033f757a-e7d4-45f1-a00c-58cd996bb014">41,439</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM4LTExLTEtMS0xOTYzNQ_5f249e96-2546-4a6c-b469-d251b5637267">256,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55c01612bdda4f1bb914815afe3bbf95_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQxLTEtMS0xLTE5NjM1_c3912754-b7f6-431b-a377-d07c242987f8">88,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72491a4fae084225942f973da304ba25_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQyLTEtMS0xLTE5NjM1_e3c5eeb3-2f01-47d0-8b17-07af8325aa46">52,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76238069608f4813b8d2ac5bfe67dae8_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQzLTEtMS0xLTE5NjM1_dc2a4afa-a32e-4473-8a94-b58d23015101">595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQ0LTEtMS0xLTE5NjM1_e561c2f9-9c5e-463c-a91f-2e9eb3aea6d4">141,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i04d69815ba32437887fba7b54fa5d0d4" continuedAt="iab931fc0f3584dbeadc08dd2c056c1e2"><ix:continuation id="i0fa1f25321f240e4aef2393161a94f89"><div style="padding-left:18pt;text-indent:-18pt"><ix:continuation id="i51b8fab779244b838cb557ca09bb807d" continuedAt="ib0934727859941bcad38aafdd7bb0496"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.</span></ix:continuation></div><div style="padding-left:18pt;text-indent:-18pt"><ix:continuation id="ib0934727859941bcad38aafdd7bb0496" continuedAt="i531a1dbaa9a048ebab359ddb73cd0f2f"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i531a1dbaa9a048ebab359ddb73cd0f2f">program.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDAx_e6c5c13d-7ced-4b5e-bfcc-2283c43deda9" continuedAt="i5515ef53bf38457fb21ec5a03dcb5003" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTo5ZGZlNzA5ODQyMDA0ZTRiYjhmNjZlYWQ1ZWY3NmU4NS90YWJsZXJhbmdlOjlkZmU3MDk4NDIwMDRlNGJiOGY2NmVhZDVlZjc2ZTg1XzEtMS0xLTEtMTk2MzU_bb28417b-43ee-4bbc-b77c-a2aad7c11130">7,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTo5ZGZlNzA5ODQyMDA0ZTRiYjhmNjZlYWQ1ZWY3NmU4NS90YWJsZXJhbmdlOjlkZmU3MDk4NDIwMDRlNGJiOGY2NmVhZDVlZjc2ZTg1XzEtMy0xLTEtMTk2MzU_2e5d788f-bf36-4ff1-b0bf-b252ef9a6f2b">7,101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTo5ZGZlNzA5ODQyMDA0ZTRiYjhmNjZlYWQ1ZWY3NmU4NS90YWJsZXJhbmdlOjlkZmU3MDk4NDIwMDRlNGJiOGY2NmVhZDVlZjc2ZTg1XzItMS0xLTEtMTk2MzU_491655a3-e1e4-4837-bae2-0354cafd40d0">87</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTo5ZGZlNzA5ODQyMDA0ZTRiYjhmNjZlYWQ1ZWY3NmU4NS90YWJsZXJhbmdlOjlkZmU3MDk4NDIwMDRlNGJiOGY2NmVhZDVlZjc2ZTg1XzItMy0xLTEtMTk2MzU_8996082b-281d-4a99-b34e-3b3bd2502f37">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021 and 2020, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><ix:continuation id="i5515ef53bf38457fb21ec5a03dcb5003"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTphNTk1NjEwOTE2MjA0MzE2OGFmZDhlMmY1OGUwYmNiZi90YWJsZXJhbmdlOmE1OTU2MTA5MTYyMDQzMTY4YWZkOGUyZjU4ZTBiY2JmXzEtMS0xLTEtMTk2MzU_4be091b9-7ec2-4445-aa7f-1a073fc65be4">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTphNTk1NjEwOTE2MjA0MzE2OGFmZDhlMmY1OGUwYmNiZi90YWJsZXJhbmdlOmE1OTU2MTA5MTYyMDQzMTY4YWZkOGUyZjU4ZTBiY2JmXzEtMy0xLTEtMTk2MzU_cad4c496-8ff8-4f05-a0b8-c4c512c84aff">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTphNTk1NjEwOTE2MjA0MzE2OGFmZDhlMmY1OGUwYmNiZi90YWJsZXJhbmdlOmE1OTU2MTA5MTYyMDQzMTY4YWZkOGUyZjU4ZTBiY2JmXzMtMS0xLTEtMTk2MzU_9a0725fd-fb17-414d-ba0c-ac66338e7db3">387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTphNTk1NjEwOTE2MjA0MzE2OGFmZDhlMmY1OGUwYmNiZi90YWJsZXJhbmdlOmE1OTU2MTA5MTYyMDQzMTY4YWZkOGUyZjU4ZTBiY2JmXzMtMy0xLTEtMTk2MzU_71b3fd07-4d05-46bd-b7bf-bc50a3155cdb">357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="cvs:ContractWithCustomerLiabilityRedemptionAndBreakage" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTphNTk1NjEwOTE2MjA0MzE2OGFmZDhlMmY1OGUwYmNiZi90YWJsZXJhbmdlOmE1OTU2MTA5MTYyMDQzMTY4YWZkOGUyZjU4ZTBiY2JmXzQtMS0xLTEtMTk2MzU_e7edb254-e9b0-49f2-93a4-2332c1e549f0">371</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:ContractWithCustomerLiabilityRedemptionAndBreakage" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTphNTk1NjEwOTE2MjA0MzE2OGFmZDhlMmY1OGUwYmNiZi90YWJsZXJhbmdlOmE1OTU2MTA5MTYyMDQzMTY4YWZkOGUyZjU4ZTBiY2JmXzQtMy0xLTEtMTk2MzU_9a55f171-469a-42ff-b939-e20974a7dfde">359</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTphNTk1NjEwOTE2MjA0MzE2OGFmZDhlMmY1OGUwYmNiZi90YWJsZXJhbmdlOmE1OTU2MTA5MTYyMDQzMTY4YWZkOGUyZjU4ZTBiY2JmXzUtMS0xLTEtMTk2MzU_870dbdac-f2cf-47cd-9cc7-49db8b03d133">87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTphNTk1NjEwOTE2MjA0MzE2OGFmZDhlMmY1OGUwYmNiZi90YWJsZXJhbmdlOmE1OTU2MTA5MTYyMDQzMTY4YWZkOGUyZjU4ZTBiY2JmXzUtMy0xLTEtMTk2MzU_c492300a-fdf1-4941-9b92-7ed349961511">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="padding-right:4.5pt"><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDY4_f1800253-0b55-4edb-9e81-0b94a5aaa68b" continuedAt="i60a093d3472e4abaa3fa7b5b1974300e" escape="true"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for cost of products sold as follows:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold includes: (i) the cost of prescription drugs sold during the reporting period directly through the Company&#8217;s mail service dispensing pharmacies and indirectly through the Company&#8217;s retail pharmacy network, (ii) shipping and handling costs, and (iii) the operating costs of the Company&#8217;s mail service dispensing pharmacies and client service operations and related information technology support costs including depreciation and amortization. The cost of prescription drugs sold component of cost of products sold includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients&#8217; benefit plans from the Company&#8217;s mail service dispensing pharmacies, net of any volume-related or other discounts (see &#8220;Vendor Allowances and Purchase Discounts&#8221; below) and (ii) the cost of prescription drugs sold (including retail co-payments) through the Company&#8217;s retail pharmacy network under contracts where the Company is the principal, net of any volume-related or other discounts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i60a093d3472e4abaa3fa7b5b1974300e">Cost of products sold includes: the cost of merchandise sold during the reporting period, including prescription drug costs, and the related purchasing costs, warehousing and delivery costs (including depreciation and amortization) and actual and estimated inventory losses.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="cvs:VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDg3_af328b2e-3edc-4c3a-8e54-9279b618c390" continuedAt="i8d1d80d1b9c24c39ab81d35a99de068c" escape="true"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vendor Allowances and Purchase Discounts </span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for vendor allowances and purchase discounts as follows: </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Pharmacy Services segment to receive </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iab931fc0f3584dbeadc08dd2c056c1e2" continuedAt="i2440888b323d42759b88c2c858b86702"><ix:continuation id="i8d1d80d1b9c24c39ab81d35a99de068c" continuedAt="i9f41ab19700b454c82ad018f713dcafd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, (ii) a discount for the prompt payment of invoices or (iii) when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within <ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="cvs:PharmacyRebatePeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzY2OTMz_0e4b163c-fe6e-4b65-9150-c8f9ee166988">30</ix:nonNumeric> days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#8217;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Pharmacy Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Pharmacy Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9f41ab19700b454c82ad018f713dcafd">Vendor allowances received by the Retail/LTC segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any amounts received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon sales volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract. The total amortization of these upfront payments was not material to the Company&#8217;s consolidated financial statements in any of the periods presented.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:HealthCareEntitiesPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NTIz_0771b3cb-4da9-4bf7-9175-c31f8a2fde6c" continuedAt="i9fc361c3265e46f4a6c36deba9e55694" escape="true"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Reform</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Insurer Fee</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1, 2014, the ACA has imposed an annual premium-based health insurer fee (&#8220;HIF&#8221;) for each calendar year, payable in September, which was not deductible for tax purposes. The Company has been required to estimate a liability for the HIF at the beginning of the calendar year in which the fee was payable with a corresponding deferred asset that was amortized ratably to operating expenses over the calendar year. The Company recorded the liability for the HIF in accrued expenses and recorded the deferred asset in other current assets. In December 2019, the HIF was repealed for calendar years after 2020, therefore there was <ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="INF" name="cvs:HealthInsurerFee" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzYwNDczMTQwNzA1MjY_3c823ba7-b625-4296-8723-ae3f56bce692">no</ix:nonFraction> expense related to the HIF in the year ended December&#160;31, 2021. In the year ended December 31, 2020, operating expenses included $<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-8" name="cvs:HealthInsurerFee" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzEwOTk1MTE3MTk2MTY_14d0909a-d923-4b8f-b365-b23d6b6d78da">1.0</ix:nonFraction>&#160;billion related to the Company&#8217;s share of the HIF. There was <ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="INF" name="cvs:HealthInsurerFee" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzY5NzQ0_97359291-bacc-4f86-be71-89c060a69148">no</ix:nonFraction> expense related to the HIF in 2019, since there was a one-year suspension of the HIF for 2019. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a permanent risk adjustment program to transfer funds from qualified individual and small group insurance plans with below average risk scores to plans with above average risk scores. Based on the risk of the Company&#8217;s qualified plan members relative to the average risk of members of other qualified plans in comparable markets, as defined by the ACA, the Company estimates its ultimate risk adjustment receivable (recorded in accounts receivable) or payable (recorded in accrued expenses) for the current calendar year and reflects the pro-rata year-to-date impact as an adjustment to premium revenue. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Corridor</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) based on their ratio of allowable costs to target costs (as defined by the ACA). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company filed a lawsuit in August 2019 to recover the $<ix:nonFraction unitRef="usd" contextRef="i5d8804cf6abb4698a6a8f6b7fc6e7b28_I20190831" decimals="-6" name="us-gaap:GainContingencyUnrecordedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcxMDIy_017a8888-4980-41c4-8848-914dab223551">313</ix:nonFraction>&#160;million it was owed under the ACA&#8217;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#8217;s temporary risk corridor program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company received the $<ix:nonFraction unitRef="usd" contextRef="i78a023c8e08447dd9462aefe43f9ffb4_D20201022-20201022" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcxMzY1_5ae05736-2dda-4dda-9ce0-207d05f0b4fc">313</ix:nonFraction>&#160;million it was owed under the ACA&#8217;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the year ended December 31, 2020. After considering </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2440888b323d42759b88c2c858b86702" continuedAt="i9df3e62854cd48e0b8149333e91760b3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9fc361c3265e46f4a6c36deba9e55694">offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recorded pre-tax income of $<ix:nonFraction unitRef="usd" contextRef="i55877e993992468ea1377ad4577db051_I20201231" decimals="-6" name="cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcxNjY1_a2e59d72-d9a0-4cc6-8743-3d59b837e681">307</ix:nonFraction> million and after-tax income of $<ix:nonFraction unitRef="usd" contextRef="i55877e993992468ea1377ad4577db051_I20201231" decimals="-6" name="cvs:FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcxNjky_e787c239-8536-4e38-9624-20bd97d0d921">223</ix:nonFraction>&#160;million during the year ended December&#160;31, 2020.</ix:continuation> </span></div><div><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDc1_fe1f5231-0826-486c-90be-98a01edfbe89" continuedAt="i305b7f535c8f4596ae8c794a83a173be" escape="true">Advertising Costs </ix:nonNumeric></span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i305b7f535c8f4596ae8c794a83a173be">Advertising costs, which are reduced by the portion funded by vendors, are expensed when the related advertising takes place. Net advertising costs, which are included in operating expenses, were $<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcyMDU0_2c68f05b-d8d4-40aa-9b5b-d880e75b358d">523</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcyMDU4_3b5015f9-393f-408b-9b16-01a23ba567e1">461</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcyMDY1_35e019d0-6bf7-4c67-8b3e-0e6bac06fe47">396</ix:nonFraction> million in 2021, 2020 and 2019, respectively.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NTAy_afb3cc99-b625-4874-adb9-49efad49a6e1" continuedAt="ibdff94ebb31f4cb1aabdc96e49d66ddf" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibdff94ebb31f4cb1aabdc96e49d66ddf">Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcyMzEz_ea62d84c-7b65-4b23-9d75-3a8341c56a52">three</span> to <ix:nonNumeric contextRef="i2f08d731825c4986934a5374bd021d17_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMyOTg1MzUwMjc2NDA_4666c407-4d00-4ae1-9777-71426957336f">five years</ix:nonNumeric>) using the straight-line method.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDQ0_9baa14f3-7478-46ba-8438-62ee7b132eaa" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year or years in which the differences are expected to reverse. The effect of a change in the tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date of such change.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and the Company&#8217;s recent operating results. The Company establishes a valuation allowance when it does not consider it more likely than not that a deferred tax asset will be recovered.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process whereby (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:PensionAndOtherPostretirementPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDAz_8c6f8126-4aa3-4761-bbe3-dc647f2d495f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors defined benefit pension plans (&#8220;pension plans&#8221;) and other postretirement employee benefit plans (&#8220;OPEB plans&#8221;) for its employees and retirees. The Company recognizes the funded status of its pension and OPEB plans on the consolidated balance sheets based on the year-end measurements of plan assets and benefit obligations. When the fair value of plan assets are in excess of the plan benefit obligations, the amounts are reported in other current assets and other assets. When the fair value of plan benefit obligations are in excess of plan assets, the amounts are reported in accrued expenses and other long-term liabilities based on the amount by which the actuarial present value of benefits payable in the next twelve months included in the benefit obligation exceeds the fair value of plan assets. The net periodic benefit cost (income) for the Company&#8217;s pension and OPEB plans do not contain a service cost component as these plans have been frozen for an extended period of time.&#160;Non-service cost components of pension and postretirement net periodic benefit cost (income) are included in other income in the consolidated statements of operations.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDc3_4cd9f64f-1c66-47a2-83ee-ac9ae91b91cd" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the two-class method. The Company calculates basic earnings per share based on the weighted average number of common shares outstanding for the period. See Note 14 &#8216;&#8216;Earnings Per Share&#8217;&#8217; for additional information.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9df3e62854cd48e0b8149333e91760b3" continuedAt="iee19a325a29f42a0bf17944b5e2a952f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="cvs:SharesHeldInTrustPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDM0_648b2174-889f-4129-a697-cef74cae9982" continuedAt="ib0719bd72ae34f059da7c2484b30b9c1" escape="true">Shares Held in Trust</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib0719bd72ae34f059da7c2484b30b9c1">The Company maintains grantor trusts, which held approximately <ix:nonFraction unitRef="shares" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:TreasuryStockSharesHeldinTrust" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMyOTg1MzUwMjc2MjQ_075b8416-9926-4969-b17a-000d0d88693c"><ix:nonFraction unitRef="shares" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:TreasuryStockSharesHeldinTrust" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMyOTg1MzUwMjc2MjQ_ba365d0d-aeae-4693-af71-a08519b594c9">one million</ix:nonFraction></ix:nonFraction> shares of its common stock at both December&#160;31, 2021 and 2020. These shares are designated for use under various employee compensation plans. Since the Company holds these shares, they are excluded from the computation of basic and diluted shares outstanding.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDcw_a757b7c8-4c01-4f15-b4f6-c43e29c863b2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in (i) a generic pharmaceutical sourcing entity, (ii) certain hedge fund and private equity investments and (iii) certain real estate partnerships that are considered VIEs. The Company does not have a future obligation to fund losses or debts on behalf of these investments; however, it may voluntarily contribute funds. In evaluating whether the Company is the primary beneficiary of a VIE, the Company considers several factors, including whether the Company has (a) the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and (b) the obligation to absorb losses and the right to receive benefits that could potentially be significant to the VIE. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Primary Beneficiary</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, the Company and Cardinal Health, Inc. (&#8220;Cardinal&#8221;) established Red Oak Sourcing, LLC (&#8220;Red Oak&#8221;), a generic pharmaceutical sourcing entity in which the Company and Cardinal each own <ix:nonFraction unitRef="number" contextRef="ifed7853cc1c344298bd8003d3174178b_D20140101-20141231" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzc3OTA2_9d811b47-00dc-43ab-b99b-c8fbdc68f861">50</ix:nonFraction>%. The Red Oak arrangement had an initial term of <ix:nonNumeric contextRef="ifed7853cc1c344298bd8003d3174178b_D20140101-20141231" name="cvs:Initialcontractualterm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzc3OTU3_927ba7f6-b68d-454d-98c5-49d716be06ab">ten years</ix:nonNumeric>. In 2021, the Red Oak arrangement was amended to extend the initial term an additional <ix:nonNumeric contextRef="i5565b4e7fc4f4e8aa341da7b6e4e4d86_D20210101-20211231" name="cvs:VariableInterestEntityAmendedContractExtensionTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzM4NDgyOTA4Mzk5NTk_7c8e0ef9-cb17-4a51-8136-0d27ff243193">five years</ix:nonNumeric>, for a total term of <ix:nonNumeric contextRef="i5565b4e7fc4f4e8aa341da7b6e4e4d86_D20210101-20211231" name="cvs:VariableInterestEntityAmendedContractTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMyOTg1MzUwMDc3NDY_6d2bd8e8-43e0-4325-8f33-9e5d7d867039">15</ix:nonNumeric> years. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak; however, Red Oak does not own or hold inventory on behalf of either company. No physical assets (e.g., property and equipment) were contributed to Red Oak by either company, and minimal funding was provided to capitalize Red Oak. The Company has determined that it is the primary beneficiary of this VIE because it has the ability to direct the activities of Red Oak. Consequently, the Company consolidates Red Oak in its consolidated financial statements within the Retail/LTC segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal is required to pay the Company quarterly payments, which began in October 2014 and will extend through June 2029. As milestones are met, the quarterly payments increase. The Company received $<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:ProceedsFromVariableInterestEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzk4OTU2MDQ3OTQyNjE_06b41edc-0213-430a-9247-29526ddeac4d"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="cvs:ProceedsFromVariableInterestEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzk4OTU2MDQ3OTQyNjE_20065b4c-c358-4f1d-be7b-21fe53a37ab5"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="cvs:ProceedsFromVariableInterestEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzk4OTU2MDQ3OTQyNjE_28c94540-7318-4017-aaa9-f01b382ed73e">183</ix:nonFraction></ix:nonFraction></ix:nonFraction> million from Cardinal during each of the years ended December&#160;31, 2021, 2020 and 2019. The payments reduce the Company&#8217;s carrying value of inventory and are recognized in cost of products sold when the related inventory is sold. Amounts reimbursed by Cardinal for the years ended December&#160;31, 2021, 2020 and 2019, and amounts due to or due from Cardinal at December&#160;31, 2021 and 2020 were immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Other Variable Interest Holder</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has invested in certain VIEs for which it has determined that it is not the primary beneficiary, consisting of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Hedge fund and private equity investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in hedge fund and private equity investments in order to generate investment returns for its investment portfolio supporting its insurance businesses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Real estate partnerships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in various real estate partnerships, including those that construct, own and manage low-income housing developments. For the low income housing development investments, substantially all of the projected benefits to the Company are from tax credits and other tax benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not the primary beneficiary of these VIEs because the nature of the Company&#8217;s involvement with the activities of these VIEs does not give the Company the power to direct the activities that most significantly impact their economic performance. The Company records the amount of its investment in these VIEs as long-term investments on the consolidated balance sheets and recognizes its share of each VIE&#8217;s income or losses in net income (loss).&#160;The Company&#8217;s maximum exposure to loss from these VIEs is limited to its investment balances as disclosed below and the risk of recapture of previously recognized tax credits related to the real estate partnerships, which the Company does not consider significant.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NTA5_1221fb11-be38-4d18-a07b-813668cc564c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total amount of other variable interest holder VIE assets included in long-term investments on the consolidated balance sheets at December&#160;31, 2021 and 2020 was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.990%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedge fund investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50b4460d87d840bbaafccbc86903992c_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmQxM2ZkMmYzMmE0NmUzOWYxYzRjYmY5OTk3OWFkMi90YWJsZXJhbmdlOmRiZDEzZmQyZjMyYTQ2ZTM5ZjFjNGNiZjk5OTc5YWQyXzEtMS0xLTEtMTk2MzU_f907d989-a977-4ad1-8a2e-0be1925ccef9">463</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1711347a62744966b4e74fee52b0bae9_I20201231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmQxM2ZkMmYzMmE0NmUzOWYxYzRjYmY5OTk3OWFkMi90YWJsZXJhbmdlOmRiZDEzZmQyZjMyYTQ2ZTM5ZjFjNGNiZjk5OTc5YWQyXzEtMy0xLTEtMTk2MzU_d2e01e3a-b3ea-4f5c-9923-e506f8d3a9eb">342</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i064ed72a7c7d4834b6d490201f178cc6_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmQxM2ZkMmYzMmE0NmUzOWYxYzRjYmY5OTk3OWFkMi90YWJsZXJhbmdlOmRiZDEzZmQyZjMyYTQ2ZTM5ZjFjNGNiZjk5OTc5YWQyXzItMS0xLTEtMTk2MzU_7fa34b33-ccb4-4c6f-81fa-458fef554cf2">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i440e6a46ec8f4ce48ae8a4a7e478b725_I20201231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmQxM2ZkMmYzMmE0NmUzOWYxYzRjYmY5OTk3OWFkMi90YWJsZXJhbmdlOmRiZDEzZmQyZjMyYTQ2ZTM5ZjFjNGNiZjk5OTc5YWQyXzItMy0xLTEtMTk2MzU_757bde2f-5f7f-4428-a04c-c31b49bd28bf">547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate partnerships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d327db9f7284c37b77bcfaebbe9509a_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmQxM2ZkMmYzMmE0NmUzOWYxYzRjYmY5OTk3OWFkMi90YWJsZXJhbmdlOmRiZDEzZmQyZjMyYTQ2ZTM5ZjFjNGNiZjk5OTc5YWQyXzMtMS0xLTEtMTk2MzU_e4ee08df-f21e-4b40-ae88-7d0291f572bc">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f571724a5864c5596b142666580c1a9_I20201231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmQxM2ZkMmYzMmE0NmUzOWYxYzRjYmY5OTk3OWFkMi90YWJsZXJhbmdlOmRiZDEzZmQyZjMyYTQ2ZTM5ZjFjNGNiZjk5OTc5YWQyXzMtMy0xLTEtMTk2MzU_d0c0b72b-0081-4ecd-9a48-65880c5076ea">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbf81618e0074484b1b2cd8ceee6f5d3_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmQxM2ZkMmYzMmE0NmUzOWYxYzRjYmY5OTk3OWFkMi90YWJsZXJhbmdlOmRiZDEzZmQyZjMyYTQ2ZTM5ZjFjNGNiZjk5OTc5YWQyXzQtMS0xLTEtMTk2MzU_72df66ae-e590-4122-9e51-9721f23279af">1,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2865e7a41644a8186918f7b00a1a60d_I20201231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmQxM2ZkMmYzMmE0NmUzOWYxYzRjYmY5OTk3OWFkMi90YWJsZXJhbmdlOmRiZDEzZmQyZjMyYTQ2ZTM5ZjFjNGNiZjk5OTc5YWQyXzQtMy0xLTEtMTk2MzU_a147e5b5-9b71-4d03-a926-91e3e69f25e3">1,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iee19a325a29f42a0bf17944b5e2a952f" continuedAt="id2f5ba450a8747629ab4d19e7dd512b8"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDc4_4a319ba8-52fc-4011-930c-4e61f85739cd" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzgxMTk4_1ec7e2cf-2787-4bf1-803e-954e54f8a891">52</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzgxMjAy_2f4a7648-1557-43c3-81b3-79f1e8a2e49e">56</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzgxMjA5_9bf5aeb0-4ed0-456b-b5ff-dc8fd154024e">32</ix:nonFraction> million in the years ended December&#160;31, 2021, 2020 and 2019, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in <ix:nonFraction unitRef="state" contextRef="i9bc52b3acf264acbbaa97645df36b813_I20211231" decimals="INF" name="us-gaap:NumberOfStatesInWhichEntityOperates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzgxNTE0_e1ca778f-2263-4862-8ebf-348630d0a583">four</ix:nonFraction> states. Heartland paid the Company $<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzgxNTUy_0aa0a6bb-1a12-4568-a641-fbcb861e9603">79</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzgxNTU2_a6edfddf-67e1-4ae2-a636-a853571319b5">77</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzgxNTYz_854c6d15-0c06-4dee-bbad-e381e1d5407d">96</ix:nonFraction> million for pharmaceutical inventory purchases during the years ended December&#160;31, 2021, 2020 and 2019, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021, 2020 and 2019, the Company made charitable contributions of&#160;$<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzgxOTg5_6f60aaf7-7b0e-4de9-a465-ca852cc3f652">50</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzE2NDkyNjc1NTkyNTE_6b37f4b5-dd30-40f5-bb9c-b4fdb4225f2d">50</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzE2NDkyNjc1NTkyODM_4e593b77-b387-4403-abc5-78d2a01d6fcc">30</ix:nonFraction>&#160;million, respectively,&#160;to the CVS Health Foundation, a non-profit entity that focuses on health, education and community involvement programs. The charitable contributions were recorded as operating expenses in the consolidated statements of operations within the Corporate/Other segment for the years ended December&#160;31, 2021, 2020 and 2019.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:DiscontinuedOperationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDgw_722405c9-37f2-4824-85a7-887a9e5f4004" continuedAt="ie107e5c609724b42980813327e529fb6" escape="true">Discontinued Operations</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie107e5c609724b42980813327e529fb6">In connection with certain business dispositions completed between 1995 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens &#8216;n Things and Bob&#8217;s Stores, each of which subsequently filed for bankruptcy. The Company&#8217;s loss from discontinued operations includes lease-related costs that the Company believes it will likely be required to satisfy pursuant to these lease guarantees.</ix:continuation> See &#8220;Lease Guarantees&#8221; in Note 16 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; for additional information. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMyOTg1MzUwMzA1MzI_2c57979d-998e-423d-910e-eeab8da73ab7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the results of discontinued operations for the year ended December 31, 2020. </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZToxZDc0N2U4YzA5ZDI0ODQ3YWQyM2ExMmI1YjAyYTY1ZS90YWJsZXJhbmdlOjFkNzQ3ZThjMDlkMjQ4NDdhZDIzYTEyYjViMDJhNjVlXzEtMS0xLTEtMTk2MzU_78643e69-8f05-4546-81fa-f4fa01239e3a">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZToxZDc0N2U4YzA5ZDI0ODQ3YWQyM2ExMmI1YjAyYTY1ZS90YWJsZXJhbmdlOjFkNzQ3ZThjMDlkMjQ4NDdhZDIzYTEyYjViMDJhNjVlXzItMS0xLTEtMTk2MzU_f68246aa-87a4-46b7-bb03-555cffa7629a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZToxZDc0N2U4YzA5ZDI0ODQ3YWQyM2ExMmI1YjAyYTY1ZS90YWJsZXJhbmdlOjFkNzQ3ZThjMDlkMjQ4NDdhZDIzYTEyYjViMDJhNjVlXzMtMS0xLTEtMTk2MzU_630ef0f1-2d73-4b5f-bd83-e9d8201a021b">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results from discontinued operations were immaterial for the years ended December 31, 2021 and 2019.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NTAw_bec131f0-f357-4a85-a0a8-6c9408fa5afd" continuedAt="ie5b0fafab99340439b20965a3c8ee32c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id2f5ba450a8747629ab4d19e7dd512b8"><ix:continuation id="ie5b0fafab99340439b20965a3c8ee32c">liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#8217;s expected investment yield under the existing guidance.</ix:continuation></ix:continuation></span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_133"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzMvZnJhZzpjM2Y0NTYzMWI3Y2Y0ODRlOGQ5NWQ4NDlkMDRlMjVkZS90ZXh0cmVnaW9uOmMzZjQ1NjMxYjdjZjQ4NGU4ZDk1ZDg0OWQwNGUyNWRlXzU5Nzg_73e62459-44ee-4e40-8dc8-18ad12f8d116" continuedAt="i633b37f88669429185f729fa992f77a0" escape="true">Divestitures</ix:nonNumeric></span></div><div style="text-indent:-9pt"><span><br/></span></div><ix:continuation id="i633b37f88669429185f729fa992f77a0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Workers&#8217; Compensation Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2020, the Company sold its Workers&#8217; Compensation business for approximately $<ix:nonFraction unitRef="usd" contextRef="ic3bfdde04dbf4f498310d896a5a94507_D20200731-20200731" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzMvZnJhZzpjM2Y0NTYzMWI3Y2Y0ODRlOGQ5NWQ4NDlkMDRlMjVkZS90ZXh0cmVnaW9uOmMzZjQ1NjMxYjdjZjQ4NGU4ZDk1ZDg0OWQwNGUyNWRlXzQ1Nzc_12c6b2b3-4334-4049-8382-d2e29c70f483">850</ix:nonFraction>&#160;million. The results of this business were reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $<ix:nonFraction unitRef="usd" contextRef="i707e6377bc8f46819c6e330be95da61e_D20200101-20201231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzMvZnJhZzpjM2Y0NTYzMWI3Y2Y0ODRlOGQ5NWQ4NDlkMDRlMjVkZS90ZXh0cmVnaW9uOmMzZjQ1NjMxYjdjZjQ4NGU4ZDk1ZDg0OWQwNGUyNWRlXzEwOTk1MTE2MzM3NzQ_5e1dc08e-85f1-4e1a-9c4a-f0ba4c0c9bd9">269</ix:nonFraction> million in the year ended December&#160;31, 2020, which is reflected as a reduction in operating expenses in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Brazilian Subsidiary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2019, the Company sold its Brazilian subsidiary, Onofre, for an immaterial amount. Onofre operated <ix:nonFraction unitRef="store" contextRef="ic78da50417e849b5a59cd5089920fa13_I20190701" decimals="INF" name="us-gaap:NumberOfStores" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzMvZnJhZzpjM2Y0NTYzMWI3Y2Y0ODRlOGQ5NWQ4NDlkMDRlMjVkZS90ZXh0cmVnaW9uOmMzZjQ1NjMxYjdjZjQ4NGU4ZDk1ZDg0OWQwNGUyNWRlXzUwNjY_179c3886-34a0-4d6d-9146-67f7a938f5e8">50</ix:nonFraction> retail pharmacy stores, the results of which historically had been reported within the Retail/LTC segment. The Company recorded a pre-tax loss on the divestiture of $<ix:nonFraction unitRef="usd" contextRef="i7fd8613bfc0d4364b6e49aa6a8b2d288_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzMvZnJhZzpjM2Y0NTYzMWI3Y2Y0ODRlOGQ5NWQ4NDlkMDRlMjVkZS90ZXh0cmVnaW9uOmMzZjQ1NjMxYjdjZjQ4NGU4ZDk1ZDg0OWQwNGUyNWRlXzUyMzQ_dfeacd8c-f173-42c3-b4bc-f6ce38383ffc">205</ix:nonFraction> million in the year ended December 31, 2019, which primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in operating expenses in the Company&#8217;s consolidated statement of operations within the Retail/LTC segment.</span></div></ix:continuation><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_136"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzczNzg_5cdcccba-1559-4c5a-b7bf-bc5bff6ee94b" continuedAt="ibc98352c7a7c4f3d97071cae78865e26" escape="true">Investments</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ibc98352c7a7c4f3d97071cae78865e26" continuedAt="i9684e47511ab4288b4c2e1023fb87252"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="cvs:TotalInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzczNzQ_82b3e5d6-8859-468e-a437-846f98c7edd1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.016%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if05932426083419b815e008b577a2a15_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzItMS0xLTEtMTk2MzU_7ad5e762-d95c-48ae-b8bd-d643a7793ece">3,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if05932426083419b815e008b577a2a15_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzItMy0xLTEtMTk2MzU_913ddb1e-aff3-4227-8b47-99e468cd6364">20,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if05932426083419b815e008b577a2a15_I20211231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzItNS0xLTEtMTk2MzU_0b699cb7-4848-4351-9412-1e84c5500c23">23,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idce08b4519f44779aca159357248a636_I20201231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzItNy0xLTEtMTk2MzU_5e50620b-69b9-4ffa-9d0a-65d4961607ba">2,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idce08b4519f44779aca159357248a636_I20201231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzItOS0xLTEtMTk2MzU_460b8bc1-8018-401a-bd04-0e821a2418c1">18,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idce08b4519f44779aca159357248a636_I20201231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzItMTEtMS0xLTE5NjM1_f04bac4e-750c-41fb-b72a-408ef8a157b8">21,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f36709bd8949388b2c0bffca648d32_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzMtMS0xLTEtMTk2MzU_b7dd802c-79b8-4f6e-b694-a3b4c7c1c737">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f36709bd8949388b2c0bffca648d32_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzMtMy0xLTEtMTk2MzU_57197ce8-a3d3-4faa-8c90-db1b81cca651">844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05f36709bd8949388b2c0bffca648d32_I20211231" decimals="-6" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzMtNS0xLTEtMTk2MzU_674443f5-c452-4137-9313-6001fe17c2b1">902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3a2978a5aa4a7f8e4552df2eb04ad5_I20201231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzMtNy0xLTEtMTk2MzU_5bb2911e-8329-46e4-a48f-3c6285f803e9">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3a2978a5aa4a7f8e4552df2eb04ad5_I20201231" decimals="-6" name="us-gaap:LongTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzMtOS0xLTEtMTk2MzU_0424cc44-5c87-49a5-9aae-cd269660dfc3">821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3a2978a5aa4a7f8e4552df2eb04ad5_I20201231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzMtMTEtMS0xLTE5NjM1_ef6c4de3-3cc8-45bc-9111-f1121cba8ac0">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22a8dacd69894d99a9e39bcc2ceaa8c3_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzQtMS0xLTEtMTk2MzU_fca6c35f-fe2b-480d-a599-9b607e91ba9b">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22a8dacd69894d99a9e39bcc2ceaa8c3_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzQtMy0xLTEtMTk2MzU_3652fbbf-8f61-45f6-82d7-66a6d79ed658">1,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22a8dacd69894d99a9e39bcc2ceaa8c3_I20211231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzQtNS0xLTEtMTk2MzU_ebbc31aa-6e70-48c8-b491-778290f4d910">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43542666d6064074a52d8421444a3563_I20201231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzQtNy0xLTEtMTk2MzU_fc4697f4-e8b2-4ec0-9e16-86a2eeb1314c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43542666d6064074a52d8421444a3563_I20201231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzQtOS0xLTEtMTk2MzU_d5a9ef4a-1bd5-4af9-b6af-c1c4bdaa6fc5">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43542666d6064074a52d8421444a3563_I20201231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzQtMTEtMS0xLTE5NjM1_80f5752e-b0f9-4fb0-a9d3-c13fd7a2b0e0">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzUtMS0xLTEtMTk2MzU_5656d119-6e8d-4a81-a1e0-f424d02f775d">3,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzUtMy0xLTEtMTk2MzU_0bdf8d13-1309-40bb-8926-84b5da1151cf">23,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzUtNS0xLTEtMTk2MzU_483a21ea-7410-4217-b6de-03e96fb96414">26,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzUtNy0xLTEtMTk2MzU_5d61fc62-7b2c-426c-ad77-36adc7eb49a5">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzUtOS0xLTEtMTk2MzU_6a98e062-9b27-4a1f-a493-2cb69ff3eef1">20,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzUtMTEtMS0xLTE5NjM1_9d97edae-a1fc-4ab0-bba4-f950581426a2">23,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, the Company held investments of $<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:RestrictedInvestmentsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzEzNA_f78a7108-d9dd-433b-869a-a36aba6083b6">450</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:RestrictedInvestmentsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzE0MQ_fc30eda0-e123-41b2-816b-5e5802086277">524</ix:nonFraction> million, respectively, related to the 2012 conversion of an existing group annuity contract from a participating to a non-participating contract. These investments are included in the total investments of large case pensions supporting non-experience-rated products. Although these investments are not accounted for as Separate Accounts assets, they are legally segregated and are not subject to claims that arise out of the Company&#8217;s business and only support future policy benefits obligations under that group annuity contract. </span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9684e47511ab4288b4c2e1023fb87252" continuedAt="i24f37f5cd2b649478d21a61cb54286d7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzczOTc_a93d9f36-0aeb-43a5-9b03-fa594973d984" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at December&#160;31, 2021 and 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.701%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.014%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzMtNS0xLTEtMTk2MzU_4dbd2232-e718-4b32-987d-718361766f79">2,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzMtNy0xLTEtMTk2MzU_60c5e3dc-f501-4d0a-bfa1-bd552d11c374">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzMtOS0xLTEtMTk2MzU_34425626-3500-4630-a631-4b1d4b6a73bb">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzMtMTEtMS0xLTE5NjM1_11e701d1-37da-4abb-9376-d4fbf32521a1">2,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzQtNS0xLTEtMTk2MzU_82b8addd-059a-416f-bbe3-309eafed1c9a">2,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzQtNy0xLTEtMTk2MzU_da8f5f54-7d88-40b8-83f5-4f3f90a415a7">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzQtOS0xLTEtMTk2MzU_c6e018a3-f64f-4f0d-a455-ab2e57228a7a">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzQtMTEtMS0xLTE5NjM1_646b1d2f-3e80-4379-990b-9da972797e7a">3,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzUtNS0xLTEtMTk2MzU_3cb344e9-e395-41d3-99dc-7479468d2798">9,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzUtNy0xLTEtMTk2MzU_6e5f82c4-1997-43c7-9802-78a469860021">682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzUtOS0xLTEtMTk2MzU_beb35a03-8caf-423e-81ac-c95d6380846c">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzUtMTEtMS0xLTE5NjM1_42a4ceb8-7e4e-430d-922f-b99a9ebb66ae">9,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73c392053811482a985a060e47a06d01_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzYtNS0xLTEtMTk2MzU_740cce5f-1d5b-4161-9e16-3d9925027548">2,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73c392053811482a985a060e47a06d01_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzYtNy0xLTEtMTk2MzU_d5d80475-34e7-4e56-9690-4e6e84213201">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73c392053811482a985a060e47a06d01_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzYtOS0xLTEtMTk2MzU_8fb29c3a-8733-45a6-8c02-4c5558bdb047">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73c392053811482a985a060e47a06d01_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzYtMTEtMS0xLTE5NjM1_e31e4db8-e820-4372-a9ee-53d5985c5d80">2,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzctNS0xLTEtMTk2MzU_97a21407-b09c-4213-b5b5-b9f585d75138">870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzctNy0xLTEtMTk2MzU_9652d178-67e4-4d1d-bb16-7622c54e3982">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzctOS0xLTEtMTk2MzU_615e316d-1233-4a97-82cf-7530c720ab51">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzctMTEtMS0xLTE5NjM1_8bca9613-d0b6-4f07-9f1f-ff3c6c157949">875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzgtNS0xLTEtMTk2MzU_8fd009b3-edbd-44b5-b488-5e165351d785">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzgtNy0xLTEtMTk2MzU_24e46491-90c3-4305-bd64-1d9df1ce16ae">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzgtOS0xLTEtMTk2MzU_a7b44de5-3cd4-461a-8d17-e24d3adb24e1">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzgtMTEtMS0xLTE5NjM1_44cd7055-e434-422d-a86c-7d567e0490c2">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914670b585864902b9f69fc74ba23aec_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzktNS0xLTEtMTk2MzU_6551a2cb-9896-468f-90fb-212a1598ef2b">2,791</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914670b585864902b9f69fc74ba23aec_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzktNy0xLTEtMTk2MzU_e4b6ae8d-b793-4892-b726-3475585aea97">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i914670b585864902b9f69fc74ba23aec_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzktOS0xLTEtMTk2MzU_7975359a-64d9-40f9-b1a3-6432d9ab5ef6">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914670b585864902b9f69fc74ba23aec_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzktMTEtMS0xLTE5NjM1_1a95d8a4-eaed-4e99-b898-df530894eb7b">2,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia121561a4c96461ebf10b737edd09fd8_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzEwLTUtMS0xLTE5NjM1_324d57b9-f790-48b9-883b-b880bb66f6e9">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia121561a4c96461ebf10b737edd09fd8_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzEwLTctMS0xLTE5NjM1_9f581f9d-9796-4725-ae98-136a20b782f9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia121561a4c96461ebf10b737edd09fd8_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzEwLTktMS0xLTE5NjM1_9325bb11-f068-4a48-b12a-99ae762c5bd0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia121561a4c96461ebf10b737edd09fd8_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzEwLTExLTEtMS0xOTYzNQ_1773e46a-0051-4463-b07b-3d97bc41f3e8">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzExLTUtMS0xLTE5NjM1_18abacbb-5cd6-43eb-a0df-fbcf102102cc">22,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzExLTctMS0xLTE5NjM1_4b608a7c-7546-47ca-b3a0-4c8daa3b5704">1,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzExLTktMS0xLTE5NjM1_5a3b3bee-67f0-42e9-9272-f6400994da70">106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzExLTExLTEtMS0xOTYzNQ_d57bcb83-bac6-4e9c-9054-51608d5d7935">23,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE1LTUtMS0xLTE5NjM1_a3c6445f-88bd-4780-b16b-324193c5b8e5">2,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE1LTctMS0xLTE5NjM1_3d9fc609-1946-4e46-9811-e0061f88939a">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE1LTktMS0xLTE5NjM1_238e7520-6419-49ff-bcf0-d65d03fe4f93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE1LTExLTEtMS0xOTYzNQ_8be5ba68-bd6c-4995-a895-08719713fa3f">2,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE2LTUtMS0xLTE5NjM1_f37c2fa1-5154-4f16-b989-20312e48609f">2,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE2LTctMS0xLTE5NjM1_4625e90c-5ccb-4e19-95ce-86d5f314921c">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE2LTktMS0xLTE5NjM1_89ae21ee-074f-4376-9264-1017f0f5aceb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE2LTExLTEtMS0xOTYzNQ_fc4ecbf5-1541-4c40-9746-c22a6545f8e4">2,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE3LTUtMS0xLTE5NjM1_bfe03327-8545-4567-9b6a-df0d3f90bfb7">7,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE3LTctMS0xLTE5NjM1_c3ddc394-72d2-4240-a176-b6f614494bfd">1,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE3LTktMS0xLTE5NjM1_6c69c120-1829-4b8e-8828-20ecfdaf4919">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE3LTExLTEtMS0xOTYzNQ_e91d47a7-deb9-4630-b2e1-f494f9341b17">8,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE4LTUtMS0xLTE5NjM1_4e93e990-363e-4985-b10d-7804a0c0c1f1">2,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE4LTctMS0xLTE5NjM1_29257d45-e6ba-4cec-8805-6c1a642df0c8">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE4LTktMS0xLTE5NjM1_fe942981-d255-4437-85bc-25d47de4290b">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE4LTExLTEtMS0xOTYzNQ_dc84fa1f-8b55-4dbd-acc2-056af490280c">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE5LTUtMS0xLTE5NjM1_92434672-d338-44f6-baf9-8979565b0d00">673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE5LTctMS0xLTE5NjM1_871d552a-068c-4679-87d5-af068be425ef">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE5LTktMS0xLTE5NjM1_966b1c6f-a5eb-4977-a104-1e739a1c8245">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE5LTExLTEtMS0xOTYzNQ_26c8c714-2726-436e-9c00-e330c3f3e1ab">705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIwLTUtMS0xLTE5NjM1_1d9fc348-6281-4ce4-a923-aafb1c2b3bb7">962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIwLTctMS0xLTE5NjM1_9fea54c7-7894-42ac-b0b1-99de8849bf28">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIwLTktMS0xLTE5NjM1_8b6e18e1-d92a-4f0c-8bce-c55b636c3f5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIwLTExLTEtMS0xOTYzNQ_796f8998-7f50-4ee2-a478-62643252ce01">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIxLTUtMS0xLTE5NjM1_6183bff6-c7f8-43f4-b7ea-639728d4c969">2,369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIxLTctMS0xLTE5NjM1_7e61bfe8-05da-4c94-9855-fb308f200d4e">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIxLTktMS0xLTE5NjM1_2e572e0f-ee45-47a6-acd6-cc2b484983c0">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIxLTExLTEtMS0xOTYzNQ_74a5be17-5443-446f-9285-d19c44576f29">2,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77885636f2644bf19423ab2c4b27960a_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIyLTUtMS0xLTE5NjM1_45d10d64-84d2-4db0-a38a-21b256f16792">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77885636f2644bf19423ab2c4b27960a_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIyLTctMS0xLTE5NjM1_53825b3c-ddc6-456d-ad11-6098d2a289db">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77885636f2644bf19423ab2c4b27960a_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIyLTktMS0xLTE5NjM1_21fe3187-5129-469c-b624-d81804aeb5bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77885636f2644bf19423ab2c4b27960a_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIyLTExLTEtMS0xOTYzNQ_413ae11a-ba2f-41c1-aeb1-7e97689b5ade">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIzLTUtMS0xLTE5NjM1_fe4c37f3-2749-4189-bab2-f32dcb425658">19,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIzLTctMS0xLTE5NjM1_503a00ab-61c8-4bac-b46d-20bf56f2c9b7">1,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIzLTktMS0xLTE5NjM1_0c2291e2-60ab-4db4-afd7-23ab371ae636">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIzLTExLTEtMS0xOTYzNQ_d1354d3f-d889-4b83-ae0b-a62cecf80345">21,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">There was <ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzM4NDgyOTA3MDY5NTM_0e764b78-4fa5-481c-8480-0a5db3d2caac"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzM4NDgyOTA3MDY5NTM_878a8a9f-8072-4467-8825-231fc3a18d87">no</ix:nonFraction></ix:nonFraction> allowance for expected credit losses recorded on available-for-sale debt securities at December&#160;31, 2021 or 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results.&#160;At December&#160;31, 2021, debt securities with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzE3MzI_4c7fda01-3d6b-4ad9-8b65-a997202b47bb">864</ix:nonFraction> million, gross unrealized capital gains of $<ix:nonFraction unitRef="usd" contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzE3NzA_f18a9437-57c0-4513-ad88-4843518e2ed3">94</ix:nonFraction> million and gross unrealized capital losses of $<ix:nonFraction unitRef="usd" contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzE3Nzc_ed565204-493c-4035-9d81-7269d624d2a4">2</ix:nonFraction> million and at December&#160;31, 2020, debt securities with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i4a167c8b5fbe46be92df6070dc1ae32b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzE4NjA_369fd297-6001-46ce-bcc0-ea45b89a4f70">919</ix:nonFraction> million, gross unrealized capital gains of $<ix:nonFraction unitRef="usd" contextRef="i4a167c8b5fbe46be92df6070dc1ae32b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzE4OTg_15ff4fd9-ef0f-45ae-b1f5-0247deb4a2e0">135</ix:nonFraction> million and <ix:nonFraction unitRef="usd" contextRef="i4a167c8b5fbe46be92df6070dc1ae32b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzE5MDU_13194ecb-271e-4b2b-8202-948bc44ec435">no</ix:nonFraction> gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i24f37f5cd2b649478d21a61cb54286d7" continuedAt="i29757a49e95d44dfac25154c5734d29a"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzczNzU_064af826-27a8-4bf0-8556-483e5296a6e2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities at December&#160;31, 2021 are shown below by contractual maturity.&#160;&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzItMS0xLTEtMTk2MzU_572a8185-f63b-449a-8706-5a7ecdae15f5">1,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzItMy0xLTEtMTk2MzU_d757b36c-b658-49b2-a696-f0c5ab9dd517">1,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzMtMS0xLTEtMTk2MzU_d54ff84e-493b-4908-8818-64674e34077a">6,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzMtMy0xLTEtMTk2MzU_f310d1bb-56f7-40e7-8bc6-d0dbd9ee2478">7,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzQtMS0xLTEtMTk2MzU_cda72a1d-a821-4a67-b579-adb65e1e3b3f">4,733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzQtMy0xLTEtMTk2MzU_ac9aa7f5-1dc5-4846-bc35-7378df2223a7">4,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzUtMS0xLTEtMTk2MzU_101e60aa-d565-4952-aaee-d0a6420f0900">4,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzUtMy0xLTEtMTk2MzU_ac03ca26-7bd9-4b2e-ae06-69cbc9dd4b69">4,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzYtMS0xLTEtMTk2MzU_b0f5a7ae-d194-4188-811f-760225a79fe1">870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzYtMy0xLTEtMTk2MzU_205eeff8-290a-4291-966b-959275a1a11a">875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzctMS0xLTEtMTk2MzU_b8ea90af-03f8-4f38-a5fe-ccd114542326">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzctMy0xLTEtMTk2MzU_6a6ed9e5-b530-4963-903b-418722fa0460">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914670b585864902b9f69fc74ba23aec_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzgtMS0xLTEtMTk2MzU_9b3b21d5-90f1-4f84-b933-9d51308dc4b6">2,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914670b585864902b9f69fc74ba23aec_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzgtMy0xLTEtMTk2MzU_77920ef6-f7e3-4fc3-807e-2da72db1a89b">2,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzktMS0xLTEtMTk2MzU_5ba374dc-6507-4386-9e22-a892017eaad8">22,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzktMy0xLTEtMTk2MzU_014da023-74d1-482b-8e03-2565f383b672">23,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage-Backed and Other Asset-Backed Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s residential mortgage-backed securities at December&#160;31, 2021 were issued by the Government National Mortgage Association, the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation and carry agency guarantees and explicit or implicit guarantees by the U.S. Government.&#160;At December&#160;31, 2021, the Company&#8217;s residential mortgage-backed securities had an average credit quality rating of AAA and a weighted average duration of <ix:nonNumeric contextRef="i353376cd927a4bd89775bb7b09c7be82_D20210101-20211231" name="cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzI5MjM_330afaf3-61be-4c3d-9b78-7f68285c9645">4.7</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s commercial mortgage-backed securities have underlying loans that are dispersed throughout the United States. Significant market observable inputs used to value these securities include loss severity and probability of default.&#160;At December&#160;31, 2021, these securities had an average credit quality rating of AAA and a weighted average duration of <ix:nonNumeric contextRef="i6d5babc8be6a447486746fada4d351b2_D20210101-20211231" name="cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzMyNzE_8f6e6341-e8a8-47b1-ad3f-ef2d5bbf4ea0">6.1</ix:nonNumeric> years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s other asset-backed securities have a variety of underlying collateral (e.g., automobile loans, credit card receivables, home equity loans and commercial loans). Significant market observable inputs used to value these securities include the unemployment rate, loss severity and probability of default.&#160;At December&#160;31, 2021, these securities had an average credit quality rating of AA and a weighted average duration of <ix:nonNumeric contextRef="i13b5f509cde24908a226440920b1a447_D20210101-20211231" name="cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzM2OTQ_9cb6e6ca-8f85-4085-ad62-56e046548203">1.0</ix:nonNumeric> year.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i29757a49e95d44dfac25154c5734d29a" continuedAt="i1f6f68a9fa2649d69b4073ecd79c679d"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzczODg_615f5c6f-a40f-4bb5-a0a9-9b3f54ffdbff" continuedAt="i73d874c5f4b643ecbbd7f28ded804c93" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at December&#160;31, 2021 and 2020 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtMS0xLTEtMTk2MzU_909747fb-c166-4593-bbf6-58a93deb0806">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtMy0xLTEtMTk2MzU_5aac47a8-9450-42bc-a840-fb05c25ab014">242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtNS0xLTEtMTk2MzU_c047f086-d5c5-4781-929d-f418414a59d5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtNy0xLTEtMTk2MzU_01338be3-a43a-436a-8735-a9c84b2a8ec1">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtOS0xLTEtMTk2MzU_0c8c434f-f072-4ec0-9a77-b3ff6ceb52c1">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtMTEtMS0xLTE5NjM1_d3536376-5836-41c5-8c97-b8fbf01745b5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtMTMtMS0xLTE5NjM1_4dd27c03-19f4-43f2-b728-457e3c24052f">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtMTUtMS0xLTE5NjM1_27a912c0-6d47-442d-83b1-8c5de96bef25">282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtMTctMS0xLTE5NjM1_ae012a04-2666-4e93-8cea-28fa39c6a6f7">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtMS0xLTEtMTk2MzU_97de3a8f-4d32-4ff6-ab36-d0cdd30166c4">233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtMy0xLTEtMTk2MzU_a1a1d9ec-4507-4b34-a68e-f2674a6f2667">428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtNS0xLTEtMTk2MzU_a4e9d598-83eb-4aec-b75d-ec866dc77c67">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtNy0xLTEtMTk2MzU_87aad035-1805-4505-8e66-5bce47e032ba">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtOS0xLTEtMTk2MzU_00ce669b-595e-4d20-813e-c27625f40bfc">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtMTEtMS0xLTE5NjM1_919117f4-9b5d-4de1-898b-1768cb580be3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtMTMtMS0xLTE5NjM1_b40d6dd4-c1f4-4096-b5c8-db80cba98d31">246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtMTUtMS0xLTE5NjM1_db14c7d0-67ab-434c-82a7-49ede4e6fb27">461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtMTctMS0xLTE5NjM1_8dee5533-5075-4723-baa6-c61fca34ba4b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtMS0xLTEtMTk2MzU_d0bcf906-8d8c-4b05-9dbd-84fc8f6cac57">1,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtMy0xLTEtMTk2MzU_7c961f12-1646-4c22-a8c5-5dc63dfc22a2">2,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtNS0xLTEtMTk2MzU_0c7235ac-2929-44c1-83cf-fccf0382e65f">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtNy0xLTEtMTk2MzU_9aa9134b-0a67-460e-8209-78f293527ccf">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtOS0xLTEtMTk2MzU_c76f6b76-7156-453c-bce8-60aa186154e1">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtMTEtMS0xLTE5NjM1_4e83a0e9-cecb-4c4d-8556-d33d92eeaa8f">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtMTMtMS0xLTE5NjM1_d077acb4-ad94-4dbc-9e5a-8f669dfd52b8">1,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtMTUtMS0xLTE5NjM1_73e0676b-4c41-4b78-9e26-2517787d5647">2,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtMTctMS0xLTE5NjM1_b5dd81bd-0bd9-4cc4-9352-c19aea17c1ae">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i73c392053811482a985a060e47a06d01_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctMS0xLTEtMTk2MzU_72867dfb-4cc7-4a12-8abd-36d9bf44d275">449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73c392053811482a985a060e47a06d01_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctMy0xLTEtMTk2MzU_a45f42f0-fb86-4fdd-9dc0-6133bb90f2d0">747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73c392053811482a985a060e47a06d01_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctNS0xLTEtMTk2MzU_7d9950d8-ea55-4299-b582-a1601d79e31d">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i73c392053811482a985a060e47a06d01_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctNy0xLTEtMTk2MzU_bfe182a2-1b61-4182-b095-70445d1256d8">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73c392053811482a985a060e47a06d01_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctOS0xLTEtMTk2MzU_a56259e1-e3b4-4052-85b7-6617047ced44">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73c392053811482a985a060e47a06d01_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctMTEtMS0xLTE5NjM1_3e09e342-54fa-47ac-a29d-835d971dca36">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i73c392053811482a985a060e47a06d01_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctMTMtMS0xLTE5NjM1_640e62fc-d879-4af8-91ff-82c20b5041c2">506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73c392053811482a985a060e47a06d01_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctMTUtMS0xLTE5NjM1_534e49cc-e883-456c-b5f0-24aa84a03896">838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73c392053811482a985a060e47a06d01_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctMTctMS0xLTE5NjM1_ca370e16-ae80-4271-85f9-53495d8c0d11">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtMS0xLTEtMTk2MzU_4be77c42-c79c-4aaf-9838-44045f12e60e">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtMy0xLTEtMTk2MzU_c263f3c5-314c-4229-b005-f5b8176e727c">593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtNS0xLTEtMTk2MzU_14ed8039-1747-4e78-8d49-c84adeb707a7">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtNy0xLTEtMTk2MzU_9e910cea-99d2-4463-9736-500fc799dcd8">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtOS0xLTEtMTk2MzU_dfb8cdde-bd38-4231-8361-a8b5655fb858">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtMTEtMS0xLTE5NjM1_38680f4d-865e-4217-b74d-898f6ee3b385">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtMTMtMS0xLTE5NjM1_10697314-f298-477b-a04f-1d3cb3a7eae1">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtMTUtMS0xLTE5NjM1_11d8a23c-57be-4c8b-ade1-0257648e88e9">629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtMTctMS0xLTE5NjM1_685ac922-f082-47d2-866d-6fb9cd9caaa3">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktMS0xLTEtMTk2MzU_e62dcee0-cbbb-494e-946a-0937f8d6b75b">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktMy0xLTEtMTk2MzU_b0f3ee66-f5f4-4594-9dac-e5b5fa92a220">462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktNS0xLTEtMTk2MzU_dc9e4195-b026-4e86-8a55-d6258e6f9589">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktNy0xLTEtMTk2MzU_aac69b25-2c89-4fdc-97e0-f64724acefe5">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktOS0xLTEtMTk2MzU_35306e69-6d69-4daf-8917-5c5c094ce782">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktMTEtMS0xLTE5NjM1_4ddafb69-74bb-450d-963a-95967b7b1ed2">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktMTMtMS0xLTE5NjM1_2c82817b-d590-4a75-aad2-85241741d878">223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktMTUtMS0xLTE5NjM1_685a2c99-bb6e-4fc9-8092-6c68064b4f5a">574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktMTctMS0xLTE5NjM1_1e33bfc7-60db-4904-b714-4753a6a49a98">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i914670b585864902b9f69fc74ba23aec_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTEtMS0xLTE5NjM1_1987e043-fabb-431a-92f3-f83def640644">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914670b585864902b9f69fc74ba23aec_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTMtMS0xLTE5NjM1_9c9e4d49-0ffc-48e3-bf0d-05cd05318483">2,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914670b585864902b9f69fc74ba23aec_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTUtMS0xLTE5NjM1_7bd0deef-7d31-4031-904c-ed9b203406ed">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i914670b585864902b9f69fc74ba23aec_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTctMS0xLTE5NjM1_3b1c2f65-4b6b-47a4-bec9-001af4ac41e4">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914670b585864902b9f69fc74ba23aec_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTktMS0xLTE5NjM1_173fb7fd-c2aa-4587-b80d-8a05843c820a">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914670b585864902b9f69fc74ba23aec_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTExLTEtMS0xOTYzNQ_801ca60f-bca3-4e54-9f4e-5701e0aa2349">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i914670b585864902b9f69fc74ba23aec_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTEzLTEtMS0xOTYzNQ_ec10e9db-06ab-487f-801c-58e597b7f7b1">1,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914670b585864902b9f69fc74ba23aec_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTE1LTEtMS0xOTYzNQ_f882bd5a-b503-4799-a7fc-e4c38c1508a3">2,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914670b585864902b9f69fc74ba23aec_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTE3LTEtMS0xOTYzNQ_bbef891f-1f63-4656-8f80-5504448d87e2">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTEtMS0xLTYzNTEy_00e4f358-f90a-4806-a2fd-3f9cf08430e2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTMtMS0xLTYzNTEy_f123ff6b-062b-4063-9518-875ac351e956">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTUtMS0xLTYzNTEy_9ecbb866-174d-495e-a847-257cd7fdc90e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTctMS0xLTYzNTEy_f39eff5b-2e5b-4aee-a3ae-8e78bf5232f8">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTktMS0xLTYzNTEy_0a021167-aae8-49e0-b11d-67cb4f39a6cf">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTExLTEtMS02MzUxMg_81ac6e64-7dae-425f-89f8-5586ef3bd439">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTEzLTEtMS02MzUxMg_a0f04f9e-34e8-493e-9415-81c6a00c720c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTE1LTEtMS02MzUxMg_dcf33b63-8307-4520-a5bf-9b0b02cd628b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTE3LTEtMS02MzUxMg_96e83855-ced9-43bb-8ce3-5138a2f6c3f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTEtMS0xLTE5NjM1_eea68539-b5ff-4997-8d78-c9cba1643c71">3,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTMtMS0xLTE5NjM1_85b25866-8872-4a25-95c1-13e3c9932ed7">6,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTUtMS0xLTE5NjM1_dcdb78bd-9fda-47a5-99ec-d789a64c41f0">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTctMS0xLTE5NjM1_65a2421e-a0c5-4b57-a99b-cd4f417a0c16">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTktMS0xLTE5NjM1_80da21dd-2635-46d3-91c7-5b76a650b4cb">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTExLTEtMS0xOTYzNQ_527ae343-367e-45c7-b77d-81a3fca3fd72">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTEzLTEtMS0xOTYzNQ_30ef4b48-53fa-4762-90c4-95e5196b2c45">4,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTE1LTEtMS0xOTYzNQ_20f53a83-e859-4bd9-b406-1b2efe96656c">7,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTE3LTEtMS0xOTYzNQ_db7ef677-233a-4ee9-8372-85abfc8af7da">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTEtMS0xLTE5NjM1_5324c51d-04c0-4f7a-b59b-1d7df337769a">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTMtMS0xLTE5NjM1_882375f9-7248-4481-bad7-9bb39ccd3fa6">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTUtMS0xLTE5NjM1_a13c8509-7822-408a-9c8e-d737c7302a8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTctMS0xLTE5NjM1_12fb62a6-9e75-4fbb-b050-305e4c1df52f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTktMS0xLTE5NjM1_10f2864b-33d1-4df3-95ac-98bc4c3872c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTExLTEtMS0xOTYzNQ_48f7e33f-deee-4847-9370-8aa0a2226575">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTEzLTEtMS0xOTYzNQ_46fd63aa-40ff-46cc-9186-878e540db68f">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTE1LTEtMS0xOTYzNQ_f4602399-19fc-41ec-9b59-60bfcb44745b">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTE3LTEtMS0xOTYzNQ_d2d1c5b8-7e75-4043-a92a-839e499c0c0e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTEtMS0xLTE5NjM1_1e04a0ff-5972-4915-b593-d4dc4ec1754f">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTMtMS0xLTE5NjM1_4b993329-fe74-4845-97c0-0cfc7cc63b65">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTUtMS0xLTE5NjM1_e6a59517-34f4-498b-bbd1-7262e75a3b2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTctMS0xLTE5NjM1_7b186206-d33d-4472-9ceb-0cabe612c1f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTktMS0xLTE5NjM1_ebffe669-0886-4e02-846e-6d0b0464206c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTExLTEtMS0xOTYzNQ_3985e684-1f30-4dc4-91d2-d67c9d3962c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTEzLTEtMS0xOTYzNQ_b1e62d6d-66c2-477b-a75e-fb251d14b49b">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTE1LTEtMS0xOTYzNQ_c64030e9-6d73-455c-935f-f346605553a8">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTE3LTEtMS0xOTYzNQ_4267382f-8bd6-42b5-af0c-0c93c6dcdfa8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTEtMS0xLTE5NjM1_f5bb909a-7bd7-45e3-8bfa-8119d6731b6a">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTMtMS0xLTE5NjM1_8f942d19-1b93-439d-8a9c-76e3f4b91e6f">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTUtMS0xLTE5NjM1_edeb8e47-d410-4095-8b1f-1fccb2a8b14e">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTctMS0xLTE5NjM1_76d22ee8-68a8-49c5-bdd9-ece303ca50ad">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTktMS0xLTE5NjM1_99ff63c2-2a80-49a6-9527-35d45a0d0f6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTExLTEtMS0xOTYzNQ_23055e83-20fc-480f-9305-f5901f5e2e91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTEzLTEtMS0xOTYzNQ_33e54939-ca6f-4ac4-a4dd-4a931e474975">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTE1LTEtMS0xOTYzNQ_860e20f4-451e-4a40-bc88-bac407c7f7c6">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTE3LTEtMS0xOTYzNQ_80c21284-51f5-4610-a3ed-e0fa3e1ad6f0">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTEtMS0xLTE5NjM1_cbd00b73-b7a3-43ec-858d-91b4828eeff2">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTMtMS0xLTE5NjM1_4e98c8ef-4a25-45e9-bca8-9ee2867703b3">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTUtMS0xLTE5NjM1_62cb4bee-6b1d-42c9-bd80-dd381d4b718b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTctMS0xLTE5NjM1_b9c5637d-4c36-4705-ac05-e98af2d550dd">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTktMS0xLTE5NjM1_327519a9-2ef5-49d9-a119-4141e5288b5f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTExLTEtMS0xOTYzNQ_50adc07a-e33b-4f4b-a598-7a68c32de5d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTEzLTEtMS0xOTYzNQ_739685a1-9d1d-4841-86cd-e0a5a247a142">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTE1LTEtMS0xOTYzNQ_c39c5aaa-e0ad-4806-82e4-6289b70c22a1">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTE3LTEtMS0xOTYzNQ_df506dd4-0c4d-41de-83e0-d970204bad7e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTEtMS0xLTE5NjM1_f102ae38-01a1-4c92-b2f2-08bcd5aaccef">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTMtMS0xLTE5NjM1_e3945631-8318-4101-ae0a-099da3829560">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTUtMS0xLTE5NjM1_5715feeb-27c6-4326-bf83-1d816d59895e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTctMS0xLTE5NjM1_b7645a3b-bad4-434a-8275-39d109f8106b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTktMS0xLTE5NjM1_691e18e4-4bbc-4309-9fe5-b3dfe1631571">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTExLTEtMS0xOTYzNQ_13660649-bc1a-4ae5-bf7f-4e7bfe266cb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTEzLTEtMS0xOTYzNQ_2e41295f-e5db-4328-b880-478073bba5d7">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTE1LTEtMS0xOTYzNQ_16170205-25d4-49b1-8a9d-6eb5b9d8fdd7">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTE3LTEtMS0xOTYzNQ_d4ae9363-e213-4aa3-b63b-414170351855">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTEtMS0xLTE5NjM1_c3153f9a-f52f-454c-9e0b-e268d8bc5710">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTMtMS0xLTE5NjM1_93ced934-8add-4888-83d9-0abe1838b45f">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTUtMS0xLTE5NjM1_317a46c2-bf84-4379-bb7f-869f5da8a27b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTctMS0xLTE5NjM1_42a31a8e-d61e-4619-aab5-02d4391961d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTktMS0xLTE5NjM1_1e471acb-8f09-4b4b-8648-0db3368da4fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTExLTEtMS0xOTYzNQ_1911db05-a343-4010-9683-46bd7bd60d77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTEzLTEtMS0xOTYzNQ_e6febbd1-cb20-4060-9063-c69a5e834a71">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTE1LTEtMS0xOTYzNQ_94e82adc-f35e-4e1b-8d12-92570f73c6d4">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTE3LTEtMS0xOTYzNQ_844b7de1-7354-4061-97c3-dcb34cdac8bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTEtMS0xLTE5NjM1_b0ee50e9-8c18-4863-a5bd-cb29d404d5a5">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTMtMS0xLTE5NjM1_87e7b1ff-7a0e-49c8-b125-4799b8ed8562">256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTUtMS0xLTE5NjM1_b5ebd76f-1163-4da2-a6dd-d566635fbc54">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTctMS0xLTE5NjM1_7805375e-9e51-4ffb-a300-9db5eb2c47f6">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTktMS0xLTE5NjM1_e8847200-a9f0-4769-9951-cc4eb1b63e22">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTExLTEtMS0xOTYzNQ_160a23a2-b516-4e79-b6eb-1bbbb60d7656">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTEzLTEtMS0xOTYzNQ_cae74488-3076-4189-b0e2-aa44715a2cad">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTE1LTEtMS0xOTYzNQ_1cbeddcf-018b-412b-9dba-447e0e9cd00e">297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTE3LTEtMS0xOTYzNQ_341f602a-5f1c-4a87-8b97-c1e3f7c2e254">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTEtMS0xLTE5NjM1_ed75f261-782e-4351-aeeb-9b0b9aaee98f">468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTMtMS0xLTE5NjM1_17ba183a-4bd4-4f03-9262-a13eb0c13687">869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTUtMS0xLTE5NjM1_4b1668e5-cc87-4bbd-a602-360977fa2536">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTctMS0xLTE5NjM1_b6592e90-1a76-4fb2-9591-98cea5f920fd">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTktMS0xLTE5NjM1_f0715e06-2ce8-48c4-9d94-21be63be6360">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTExLTEtMS0xOTYzNQ_aa33ce36-c64f-4fdc-b415-32a54f435a78">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="security" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTEzLTEtMS0xOTYzNQ_cd7e15b2-a4e9-4222-ad6a-12dca9ce2c80">527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTE1LTEtMS0xOTYzNQ_75934444-3618-4b24-908c-d3274d6dacd7">915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTE3LTEtMS0xOTYzNQ_1a901b12-44eb-4d30-bd93-39dac870b052">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#8217;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#8217;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery. Unrealized capital losses at December&#160;31, 2021 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of December&#160;31, 2021, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1f6f68a9fa2649d69b4073ecd79c679d" continuedAt="i667a1d42face4b36b35fb709f99dc07b"><ix:continuation id="i73d874c5f4b643ecbbd7f28ded804c93"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.432%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting experience-<br/>rated products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting remaining<br/>products</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzMtMS0xLTEtMTk2MzU_ad765219-a5b0-4bec-8709-4076f59088e0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzMtMy0xLTEtMTk2MzU_104dc908-e0eb-4b64-87ae-fbc464dd1221">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzMtNS0xLTEtMTk2MzU_f654a26c-76b7-4b27-b335-02d279430a9b">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzMtNy0xLTEtMTk2MzU_47e5bcc0-5900-4fde-8430-a78b459674fe">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzMtOS0xLTEtMTk2MzU_e3aa7230-b264-44ff-98b3-ae6426a64dbd">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzMtMTEtMS0xLTE5NjM1_b45bc3d4-6e6f-4c3e-a4a5-179f7a2a278b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzQtMS0xLTEtMTk2MzU_7d4ad260-e7a2-4acb-94d9-c85256daee5c">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzQtMy0xLTEtMTk2MzU_fdfd1054-da65-468a-9c02-d85f2a723199">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzQtNS0xLTEtMTk2MzU_5c6b57dd-19cd-4733-bd8d-0ad84edc0331">2,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzQtNy0xLTEtMTk2MzU_e8811b2f-0c8c-41a1-9fad-a5691c75b077">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzQtOS0xLTEtMTk2MzU_54504037-89d4-459b-8196-c5f51d0a175c">2,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzQtMTEtMS0xLTE5NjM1_08a52a3e-d6b0-4241-8f6d-3fe1a41df47e">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzUtMS0xLTEtMTk2MzU_5a5083b2-d20b-49e7-9c98-7d0827f9c7a7">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzUtMy0xLTEtMTk2MzU_4e70df7f-22c7-4142-8ca4-b5c6e284160e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzUtNS0xLTEtMTk2MzU_021738df-7f7c-4ff6-93d0-d4936959446f">1,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzUtNy0xLTEtMTk2MzU_7b1c024b-49eb-4ff1-a628-fdd24c46b95d">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzUtOS0xLTEtMTk2MzU_f6ce1cbc-2170-4fd9-8361-4dc101aa4c7d">1,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzUtMTEtMS0xLTE5NjM1_a4eee589-1c20-4b0c-b47a-98c9ca6fb74c">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzYtMS0xLTEtMTk2MzU_c4266e55-89a2-455a-b4e1-599b5cfe23ed">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzYtMy0xLTEtMTk2MzU_816ffb61-5254-4aa0-9bb9-e2e6b7a910ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzYtNS0xLTEtMTk2MzU_feaa73df-8344-448f-b1d4-9aba0cc32f64">445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzYtNy0xLTEtMTk2MzU_493e0b84-37d9-4aad-82b5-b213ecf4b1ad">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzYtOS0xLTEtMTk2MzU_2f9f6a6f-1c97-41ca-b0b5-d3f685cf1a30">462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzYtMTEtMS0xLTE5NjM1_eb7747ac-9b2d-4a3a-86fa-910d65dbdffb">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7cf85e44bf749c6855a45cc29a5d06c_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzctMS0xLTEtMTk2MzU_27e57e0f-19ba-4021-b15d-d63e3fd56852">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7cf85e44bf749c6855a45cc29a5d06c_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzctMy0xLTEtMTk2MzU_8757c92f-1af4-470f-920f-791bf8b7c12d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4529e06963a470caeb617df5697e606_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzctNS0xLTEtMTk2MzU_a1a09706-2d5f-4cd1-bc49-ef00ca56a0d4">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4529e06963a470caeb617df5697e606_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzctNy0xLTEtMTk2MzU_1748da3d-29a5-4240-a11b-5fc71ad2e524">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzctOS0xLTEtMTk2MzU_d60c14d0-bd14-456d-8b48-bac7d08418da">629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzctMTEtMS0xLTE5NjM1_3199f0f1-c64f-469b-b836-7805be242d44">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33ae4ceb49244377b0e406cc7280c9f4_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzgtMS0xLTEtMTk2MzU_218eb37d-ee40-4b78-946a-c93da820d142">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33ae4ceb49244377b0e406cc7280c9f4_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzgtMy0xLTEtMTk2MzU_79324475-c34b-4e33-b3a9-b26de9b14138">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6aa7bf1b9da4fc39d8638e04992a04e_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzgtNS0xLTEtMTk2MzU_4e71e6b8-e97c-412c-be11-0100f36a4b89">568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6aa7bf1b9da4fc39d8638e04992a04e_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzgtNy0xLTEtMTk2MzU_b26cc690-4245-44f3-ba17-a9d2a5c157e0">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzgtOS0xLTEtMTk2MzU_aea531fd-3a21-4c44-be03-1e194e4b10a2">574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzgtMTEtMS0xLTE5NjM1_fb04bbd3-36ee-4fae-b64f-33000253eae6">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5690dfe9c84946ccbe72c9f299796db2_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzktMS0xLTEtMTk2MzU_df411115-91b3-4a57-ae2c-12c62f0b48ec">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5690dfe9c84946ccbe72c9f299796db2_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzktMy0xLTEtMTk2MzU_b8da32f2-c921-4bd6-a77b-8b1a03012f6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094255554a304e7eb4a00d380e2496bd_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzktNS0xLTEtMTk2MzU_6b8f5c4e-08f7-41c9-ae49-56586529be24">2,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i094255554a304e7eb4a00d380e2496bd_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzktNy0xLTEtMTk2MzU_d6b66de2-f778-4692-b067-0515a4cc9ccc">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914670b585864902b9f69fc74ba23aec_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzktOS0xLTEtMTk2MzU_18a92837-c4a5-4dce-ab53-a072a65b99cc">2,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i914670b585864902b9f69fc74ba23aec_I20211231" decimals="-6" name="cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzktMTEtMS0xLTE5NjM1_ef28a158-392b-4f26-814e-3370b1249d20">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzEwLTEtMS0xLTE5NjM1_5f21ae59-1ed7-4b73-961d-05d5e56a2fae">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzEwLTMtMS0xLTE5NjM1_3a1f961c-afec-4900-b7ea-985201953dac">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzEwLTUtMS0xLTE5NjM1_1f34b9ef-d1be-4480-bdc5-69e89d3ce35d">7,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzEwLTctMS0xLTE5NjM1_d5b30692-b8b2-4622-b4d8-d9f3629b0c22">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzEwLTktMS0xLTE5NjM1_f7a52476-49af-440f-a5c0-fbbbf7662222">7,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzEwLTExLTEtMS0xOTYzNQ_219a5b6a-b00f-4434-8b4d-403efcf01af1">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="cvs:ActivityInMortgageLoanPortfolioTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzczOTA_a978b356-5665-4f30-a988-7b4bcea04aa7" continuedAt="i1c63a71eb1b7403a9a674d5a67a47dea" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;During the years ended December 31, 2021 and 2020, the Company had the following activity in its mortgage loan portfolio:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f297d193504b64a77dc2ee3da88ccb_D20210101-20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyN2M4ZWJlY2VkNGE0NWQ0OTI2YzY4MmI1MGM1MTU5My90YWJsZXJhbmdlOjI3YzhlYmVjZWQ0YTQ1ZDQ5MjZjNjgyYjUwYzUxNTkzXzEtMS0xLTEtMTk2MzU_e40f7733-2b60-4c4d-bb37-4fa457fd7109">262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62d2db3895b440f7a78f511f11dee508_D20200101-20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateNewMortgageLoans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyN2M4ZWJlY2VkNGE0NWQ0OTI2YzY4MmI1MGM1MTU5My90YWJsZXJhbmdlOjI3YzhlYmVjZWQ0YTQ1ZDQ5MjZjNjgyYjUwYzUxNTkzXzEtMy0xLTEtMTk2MzU_0446ec3b-9bdf-4c26-871d-033bd17c2dc1">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f297d193504b64a77dc2ee3da88ccb_D20210101-20211231" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyN2M4ZWJlY2VkNGE0NWQ0OTI2YzY4MmI1MGM1MTU5My90YWJsZXJhbmdlOjI3YzhlYmVjZWQ0YTQ1ZDQ5MjZjNjgyYjUwYzUxNTkzXzItMS0xLTEtMTk2MzU_5c7beebd-193c-4d5a-b684-918bfec6969d">373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62d2db3895b440f7a78f511f11dee508_D20200101-20201231" decimals="-6" name="cvs:MortgageLoansOnRealEstateLoansFullyRepaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyN2M4ZWJlY2VkNGE0NWQ0OTI2YzY4MmI1MGM1MTU5My90YWJsZXJhbmdlOjI3YzhlYmVjZWQ0YTQ1ZDQ5MjZjNjgyYjUwYzUxNTkzXzItMy0xLTEtMTk2MzU_6928f44c-c409-4596-a51d-edae8282f0b8">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81f297d193504b64a77dc2ee3da88ccb_D20210101-20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateForeclosures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyN2M4ZWJlY2VkNGE0NWQ0OTI2YzY4MmI1MGM1MTU5My90YWJsZXJhbmdlOjI3YzhlYmVjZWQ0YTQ1ZDQ5MjZjNjgyYjUwYzUxNTkzXzMtMS0xLTEtMTk2MzU_7cc7c293-bede-445e-9558-0743e603fc7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62d2db3895b440f7a78f511f11dee508_D20200101-20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateForeclosures" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyN2M4ZWJlY2VkNGE0NWQ0OTI2YzY4MmI1MGM1MTU5My90YWJsZXJhbmdlOjI3YzhlYmVjZWQ0YTQ1ZDQ5MjZjNjgyYjUwYzUxNTkzXzMtMy0xLTEtMTk2MzU_d86fd2b5-cacb-4d6e-832e-14a3cb2889f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#8217;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents loans of superior quality.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 2 to 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 5 and 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represent loans where credit risk is not substantial, but these loans warrant management&#8217;s close attention.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i667a1d42face4b36b35fb709f99dc07b" continuedAt="i4d9c81c918054e3aab805d158362f066"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzc0MDA_32f62cde-104f-4c2f-ad23-df69df733046" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon the Company&#8217;s assessments at December&#160;31, 2021 and 2020, the amortized cost basis of the Company&#8217;s mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.943%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.950%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236369a8589648caae4e40a4994ea5c7_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzMtMS0xLTEtMTk2MzU_93b6c834-d6ce-4b2e-b5f9-b0b367cd6c15">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if75d546f79f443b2b493051643070b9d_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzMtMy0xLTEtMTk2MzU_6a68f1be-5006-4b4c-bafc-d02747d10335">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d3bdf971c2e453aaac23e35b5bfcece_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzMtNS0xLTEtMTk2MzU_46fcd4c9-91be-4cf5-b5e3-1b89a753de3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f9e513cbe72495ebcf4e63dba757063_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzMtNy0xLTEtMTk2MzU_284b38dc-9df4-4908-8fc6-8975ccac40a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e730fea2f548c28423a0d3c0b5d6d4_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzMtOS0xLTEtMTk2MzU_eb8d0ccc-c945-470a-b21b-c19d29171801">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b3b6d3e1f854783ab31e0f74ac19914_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzMtMTEtMS0xLTE5NjM1_788f115f-691f-4c2b-bb45-3b7670abbb28">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16a55dfb514944cebf081afcdb79c176_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzMtMTMtMS0xLTE5NjM1_1a7d96f1-5e64-4ae6-96d2-64cf631c3d68">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43d06180041f4758a6cd666c4e52ac41_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzQtMS0xLTEtMTk2MzU_62b2e678-06a9-43c0-a8b7-368d6af49eed">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd01e0aad9534804950ee3b5c49b699a_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzQtMy0xLTEtMTk2MzU_dcd520a6-dca4-4ddd-8b4c-bc6b545b3676">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide4fcc1c4d10426e82ac1562b152a03f_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzQtNS0xLTEtMTk2MzU_db94cd70-4c42-4578-91dc-422e2253c62a">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a11e2f0c8864c3a835f65250185e431_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzQtNy0xLTEtMTk2MzU_37ee8427-caf6-4ca3-a064-2fb22dea5455">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86f7b3a22ee74b3b99c1724212e5f620_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzQtOS0xLTEtMTk2MzU_278446a0-ceed-4cde-93df-566e2d8ace89">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f64507e6bfd4e3c94c4e571436f0709_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzQtMTEtMS0xLTE5NjM1_8f02c82a-3410-4521-bd99-3730ba4f0e49">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4d761a33dad484ab0489a71620aac4c_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzQtMTMtMS0xLTE5NjM1_2c6ab70d-4aa5-43a1-90be-03a4412d9b01">861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec0a30bbded74a4a87b264a68da01b48_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzUtMS0xLTEtMTk2MzU_e07e0d0e-f32b-4cd5-b155-7add03d26e0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bf8902ea23448c6aa2a6cdd04056a11_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzUtMy0xLTEtMTk2MzU_10528dd1-7a2a-4a4d-bfc7-1505e9e56d19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5bd4e5698b542e1afdf687466e73faf_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzUtNS0xLTEtMTk2MzU_7bcfccd2-09c3-412d-b93a-71cec349337e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i656346f8e3fc48149bc198665aa2ba23_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzUtNy0xLTEtMTk2MzU_5f774121-0854-4666-986a-352774fcc955">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i214cd12a886b42369217bf01fba03479_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzUtOS0xLTEtMTk2MzU_76b3fd3b-108f-4c9d-81f6-8946f8283d5c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8250607938c048e5bfa38afa06687ac7_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzUtMTEtMS0xLTE5NjM1_86bc41dc-aaf5-4265-95b7-6abe45055354">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53a9e1cc311f4d7389a00b2614f65e4a_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzUtMTMtMS0xLTE5NjM1_79805612-5d38-446f-ab84-8ed7d8cec2a3">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5eb557f297b45a983e00f3a6ebabbc0_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzYtMS0xLTEtMTk2MzU_c02d8baf-5e57-48cd-8d7b-36e39b842526">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id98e3f5681054b74aee1fe95b47cec5d_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzYtMy0xLTEtMTk2MzU_a0cf105c-c659-4105-b399-5f22787e8c63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac455272570c46e5ba3c2c051f9dd18b_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzYtNS0xLTEtMTk2MzU_59073d05-51e9-4b53-b3de-f33929be7d77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4798911f466146f6a09993eaa2849e0e_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzYtNy0xLTEtMTk2MzU_24ff6119-ea28-4589-9026-732549101279">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cac87f1a93a493b810d93704fdee5ab_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzYtOS0xLTEtMTk2MzU_1219e669-4b04-41c1-8555-0bc3acf13f11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i954fdd1992694dc7a1ffada1f90479f7_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzYtMTEtMS0xLTE5NjM1_4750e1cd-8f74-4312-bafa-543f6c9c97bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb149f2594e24e5e9608148da07fdd9e_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzYtMTMtMS0xLTE5NjM1_8ad24737-0f89-494d-b360-34cb81a72ec7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9366cbf54d89424ea99dd1bf935c263f_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzctMS0xLTEtMTk2MzU_4ad8a11e-0796-4dbd-851c-7ef9c627b7a3">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee791b6d216a4e52ba8577e512aefe77_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzctMy0xLTEtMTk2MzU_254aa705-f304-423d-b860-7cf6036ca58b">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie04adbbb84d840c68db8746ae5c2ec4e_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzctNS0xLTEtMTk2MzU_4f656ee1-7368-47f1-b28f-219247b5c3e7">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4c1fa1e1f5b4cfab3344b2360bda448_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzctNy0xLTEtMTk2MzU_4b2cebf7-eaf4-4f40-8451-c42550e30019">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic220147cd8734098b32bf1e587f1066f_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzctOS0xLTEtMTk2MzU_5563d6a1-39eb-4078-b446-057bea565063">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b1552ff84a14d329639fbcf910ccda7_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzctMTEtMS0xLTE5NjM1_3d1a5ae5-0a3e-4346-bf70-130d7e73a7f5">383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if07ab5ed5fe44735bee0f7db6106013d_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzctMTMtMS0xLTE5NjM1_756fdbb5-8ca5-4050-80b1-78255a66ab02">902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cfce5629c994ec789d3036601d70793_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEwLTMtMS0xLTE5NjM1_5df10d21-2e0c-4139-9304-e3f895513093">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72e8544f389d4c46a1811d3a41ccd343_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEwLTUtMS0xLTE5NjM1_34aab280-7452-4cdc-80bf-984885f31812">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c04a5353793424ea6dd4c537d171bfd_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEwLTctMS0xLTE5NjM1_1766a6e1-b12e-4f29-8577-3944b079811d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9debbd88735e4e51b8568db394038442_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEwLTktMS0xLTE5NjM1_90966b81-508c-47cd-b732-09691e681d98">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bb90e71f4ce4742b80486f33e02cf5e_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEwLTExLTEtMS0xOTYzNQ_9478242f-19ba-456d-982f-7e120be2067c">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i366b9b5ee8aa4b6f97820e04b932038c_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEwLTEzLTEtMS0xOTYzNQ_9c6548ac-fddf-4e5f-8927-df45770f77b3">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccf3cac287074066895d1a02163e6ea5_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzExLTMtMS0xLTE5NjM1_cb1e42f8-5edc-4e7e-ac0b-09190f65d493">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d87ac36ba5416ebb4aef216fdd2adb_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzExLTUtMS0xLTE5NjM1_8cf4969a-6a68-4d7e-b905-cb8784a6def4">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97c3ee33af8444709579e3a43a1b8ab6_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzExLTctMS0xLTE5NjM1_b5ddc38a-ffcf-41a5-953c-764d7ac68b7d">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0377da301945465092de5eaea76ac47d_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzExLTktMS0xLTE5NjM1_e976d7ca-08ea-49b8-8f68-ef68fbf83aeb">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b02d0505564979b7eca3037be36f23_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzExLTExLTEtMS0xOTYzNQ_1a3f628c-a3cc-451e-8ca1-ad578c60f720">595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7997178cc177444ea3249f37548ee4e3_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzExLTEzLTEtMS0xOTYzNQ_4bb68260-8e8d-4e98-a069-a04fec098417">952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70079745684b497bb807ab287dd604b9_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEyLTMtMS0xLTE5NjM1_914b822f-9aa4-4a55-ba4c-7e00383e7274">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e1919b277f44b2fb842c59d94d1425f_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEyLTUtMS0xLTE5NjM1_6f68da66-0eae-4df3-8bbd-9d5ec86845e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6701a00e113f4e5498744bb48caecc5f_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEyLTctMS0xLTE5NjM1_d9f21653-3c63-489c-831d-62a0498838eb">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fad7dcab3954d96965b1614328749b8_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEyLTktMS0xLTE5NjM1_76224a9b-2d37-49d0-859d-d113bb23c31f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic031473f406049eeab488d7910cbe99c_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEyLTExLTEtMS0xOTYzNQ_7f4394d1-6bc0-4459-ba5f-98590bdfdd78">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a49286ac2764f6c960b95c3ff551ef9_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEyLTEzLTEtMS0xOTYzNQ_773a86d9-c8a9-4a6c-a17d-da246afde386">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c71ec3b83541a1aff2732364f1942b_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEzLTMtMS0xLTE5NjM1_ddd4f59a-4298-40b5-a62f-2a715c737922">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief0401c6d4364a2d91dc94d588b6675b_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEzLTUtMS0xLTE5NjM1_de592ec5-3d8e-491f-b801-79bb3e871eec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d7e2c257e7e410baa65d8db69f23863_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEzLTctMS0xLTE5NjM1_3cfb4ea8-306c-413f-b38b-06c421ceaa07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6c586309d7344cca6910ecd0006b772_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEzLTktMS0xLTE5NjM1_71f96318-24f7-49a7-b2e6-526a360d4e63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19b89cce7eda4f3faf261107006bca5d_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEzLTExLTEtMS0xOTYzNQ_328fa938-243a-4251-8c9a-52b87ed26925">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60dd9ff415cf4307be34d85ab7b5fd40_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEzLTEzLTEtMS0xOTYzNQ_ec7b8b27-c1d9-40a9-9a9c-574e940f6555">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8aa576e20ec407ba27840a430d3d8d0_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzE0LTMtMS0xLTE5NjM1_e387e5e4-753f-413e-9934-96ab4d9ffd7c">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia63d6c6f272f4145a25f9f7581ceda3e_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzE0LTUtMS0xLTE5NjM1_6a4d7471-c7bf-402d-aa4c-9a601b85a9a6">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e137b6416194b0c80702e6ccaf7cd12_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzE0LTctMS0xLTE5NjM1_5b3c8288-f76c-4cfe-bbb3-a70a0c8aec09">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i450ae32012bd4a4da4f68d20e1c51dc6_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzE0LTktMS0xLTE5NjM1_36b139da-5125-49dc-b5df-05c55791e332">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i028a59a7a3bf4c1285313639042fd9a5_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzE0LTExLTEtMS0xOTYzNQ_978b8a8e-ffae-40d7-a3d6-18fc87b7ae16">661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f32471feded4c178b2f2c05cebf159d_I20201231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzE0LTEzLTEtMS0xOTYzNQ_a5f76123-4860-4265-9bbd-75235b81245f">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:continuation id="i1c63a71eb1b7403a9a674d5a67a47dea"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 scheduled mortgage loan principal repayments were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if07ab5ed5fe44735bee0f7db6106013d_I20211231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYWM2ZDU4M2E1MmE0MjBjYTQ2ZjIyNmExM2VjOTM5Mi90YWJsZXJhbmdlOmRhYzZkNTgzYTUyYTQyMGNhNDZmMjI2YTEzZWM5MzkyXzEtMS0xLTEtMTk2MzU_a2a33053-e781-49de-8b05-c21bcdd352f0">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if07ab5ed5fe44735bee0f7db6106013d_I20211231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYWM2ZDU4M2E1MmE0MjBjYTQ2ZjIyNmExM2VjOTM5Mi90YWJsZXJhbmdlOmRhYzZkNTgzYTUyYTQyMGNhNDZmMjI2YTEzZWM5MzkyXzItMS0xLTEtMTk2MzU_a1604387-3de6-4b1f-a03c-42c6987d627c">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if07ab5ed5fe44735bee0f7db6106013d_I20211231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYWM2ZDU4M2E1MmE0MjBjYTQ2ZjIyNmExM2VjOTM5Mi90YWJsZXJhbmdlOmRhYzZkNTgzYTUyYTQyMGNhNDZmMjI2YTEzZWM5MzkyXzMtMS0xLTEtMTk2MzU_83f817a5-8754-428b-ae38-a1e0f196d1f4">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if07ab5ed5fe44735bee0f7db6106013d_I20211231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYWM2ZDU4M2E1MmE0MjBjYTQ2ZjIyNmExM2VjOTM5Mi90YWJsZXJhbmdlOmRhYzZkNTgzYTUyYTQyMGNhNDZmMjI2YTEzZWM5MzkyXzQtMS0xLTEtMTk2MzU_8e35eaf3-7c57-4d98-b4b7-f1133d7da945">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if07ab5ed5fe44735bee0f7db6106013d_I20211231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYWM2ZDU4M2E1MmE0MjBjYTQ2ZjIyNmExM2VjOTM5Mi90YWJsZXJhbmdlOmRhYzZkNTgzYTUyYTQyMGNhNDZmMjI2YTEzZWM5MzkyXzUtMS0xLTEtMTk2MzU_44d67ce2-5a11-4494-a9fd-9b7aba93c31e">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if07ab5ed5fe44735bee0f7db6106013d_I20211231" decimals="-6" name="cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYWM2ZDU4M2E1MmE0MjBjYTQ2ZjIyNmExM2VjOTM5Mi90YWJsZXJhbmdlOmRhYzZkNTgzYTUyYTQyMGNhNDZmMjI2YTEzZWM5MzkyXzYtMS0xLTEtMTk2MzU_a3861b97-c905-4e87-8c9f-b333868f4fb6">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if07ab5ed5fe44735bee0f7db6106013d_I20211231" decimals="-6" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYWM2ZDU4M2E1MmE0MjBjYTQ2ZjIyNmExM2VjOTM5Mi90YWJsZXJhbmdlOmRhYzZkNTgzYTUyYTQyMGNhNDZmMjI2YTEzZWM5MzkyXzctMS0xLTEtMTk2MzU_2de30d9a-0976-4009-a42f-5f5d1e8dc17b">902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Income</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:InvestmentIncomeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzczODA_4d03d083-f8a1-44f4-8b0b-243ae89cce12" continuedAt="i89341746c65748aea9afc7583c223990" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the years ended December 31, 2021, 2020 and 2019 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05fb3cf4bea94dcd9507a7f609bba804_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzEtMS0xLTEtMTk2MzU_66c0e673-46d1-43c0-b1a9-8fa5178bfcf0">634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8da629000164e189d42edeb512f786e_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzEtMy0xLTEtMTk2MzU_206cae12-8071-4a63-8cd5-0c6cb71abb74">598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce5743406e44d979a44db538128707d_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzEtNS0xLTEtMTk2MzU_2401840f-5c10-4939-9d23-3899e5f996d6">589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41b25c02378c46c99b73c18360004c60_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzItMS0xLTEtMTk2MzU_fcbe29ec-e162-4f55-b4ff-608c445c78db">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c71ab108d124b2fb04b4be93eea1a95_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzItMy0xLTEtMTk2MzU_fa36c9b8-4d44-48fe-8beb-2498bc81d982">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9edfca3af9614ff38ae3dda45b1fe0d3_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzItNS0xLTEtMTk2MzU_8f531f03-ffd8-4997-b6b6-42c807de326e">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24d0c995b652444da95a99ac0befe361_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzMtMS0xLTEtMTk2MzU_404d04d2-56fb-4629-9dc9-fe89f83d3119">381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieebeaa16b5e7407db27c743c37fe3062_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzMtMy0xLTEtMTk2MzU_c43f0c8c-72b4-4fd9-af99-6784823b1efd">123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48569365a5049b89c3839c388ba8841_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzMtNS0xLTEtMTk2MzU_59090781-2392-4276-8cf7-387ed2ba3a63">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzQtMS0xLTEtMTk2MzU_3b295aba-b594-450a-b8c4-1bc482cf93c0">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzQtMy0xLTEtMTk2MzU_2e2783bd-8160-4e47-96cb-a9cb5b94a04b">781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzQtNS0xLTEtMTk2MzU_f521926b-3c2a-4e64-99db-41ad76d2cf38">854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzUtMS0xLTEtMTk2MzU_c68e8356-4b9a-448b-a2b6-2ae6239a8dda">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzUtMy0xLTEtMTk2MzU_59ce104b-f44f-475a-b077-28b6e5fdc3d3">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeInvestmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzUtNS0xLTEtMTk2MzU_6b837156-e030-457c-afee-9dc934022db5">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzYtMS0xLTEtMTk2MzU_ea584060-1d8a-4b52-b695-4ffcc0093262">1,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzYtMy0xLTEtMTk2MzU_00c42c76-1085-43ee-85b0-07612d991fcc">746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="cvs:InvestmentIncomeExcludingCapitalGainsorLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzYtNS0xLTEtMTk2MzU_8322900a-08ae-473a-8983-88424be07afc">812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzctMS0xLTEtMTk2MzU_617ef422-9e1a-4fda-8fcd-656d42d073ec">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzctMy0xLTEtMTk2MzU_acdba65c-f5a8-418e-b203-dd6a3e3ca9a7">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:RealizedInvestmentGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzctNS0xLTEtMTk2MzU_ba3b2b7f-0144-4b48-ae80-c243635b72c3">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzgtMS0xLTEtMTk2MzU_d3ba924f-538f-4ac8-af20-ad20203c1a4c">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzgtMy0xLTEtMTk2MzU_526d7a09-73a2-4d4e-a490-240e73f29806">798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzgtNS0xLTEtMTk2MzU_3f17974d-ebb6-4c52-9795-5b49f1b77288">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital gains are net of yield-related impairment losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" sign="-" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzY0MTE_e665b9d1-35d2-4438-a719-28cf3d9dd8fe">42</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" sign="-" name="cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzEwOTk1MTE2MzY5NDI_7e34111c-e32d-4e70-a3da-5fcee792ee13">49</ix:nonFraction> million for the years ended December&#160;31, 2021 and 2020, respectively. There were <ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzY0NDg_408c5854-cd6e-483c-b8b0-6bdb632c5e15"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzY0NDg_a4b0dd46-0f1b-4277-87a1-6c2eee6fd16f">no</ix:nonFraction></ix:nonFraction> credit-related losses on debt securities in the years ended December&#160;31, 2021 and 2020. Net realized capital gains are net of other-than-temporary impairment (&#8220;OTTI&#8221;) losses on debt securities of $<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzEwOTk1MTE2MzY3MjE_dca84a66-fb5a-4fba-9218-ce9fa48fd5f1">24</ix:nonFraction> million for the year ended December 31, 2019.</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i89341746c65748aea9afc7583c223990" continuedAt="i3343285f276f40508061c6370fbff167">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="i3343285f276f40508061c6370fbff167">Net investment income includes $<ix:nonFraction unitRef="usd" contextRef="ieed51d61b0d54c6086fdef46e9dc9295_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzY3ODM_749e4b6e-1dbd-4b68-b7cb-5aff5f30c7cf">38</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="id1746900c4bb4eee8150b6ee721d8c44_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzY3ODc_b006f672-52b8-4b80-953b-12a564f6a157">42</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0c8f49c4abf245e0ac15d06a1fd72813_D20190101-20191231" decimals="-6" name="us-gaap:InvestmentIncomeNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzY3OTQ_67cca0fc-d718-4dc4-bdc0-34556c9e9ebd">44</ix:nonFraction> million for the years ended December 31, 2021, 2020 and 2019, respectively, related to investments supporting experience-rated products.</ix:continuation> </span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4d9c81c918054e3aab805d158362f066"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital gains and losses recognized during the year ended December 31, 2021 related to investments in equity securities held as of December 31, 2021 were not material.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzczODE_d7c33fd2-ffb0-4715-b689-3221641e9a7a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses in the years ended December 31, 2021, 2020 and 2019 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzEtMS0xLTEtMTk2MzU_5eda9453-f58b-47e4-84cf-1db9d3beade4">3,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzEtMy0xLTEtMTk2MzU_6d4c71a8-73d3-4042-86e2-ae6f0976a1d3">3,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzEtNS0xLTEtMTk2MzU_3cb3f641-4aa5-4307-95bc-464086e01565">4,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzItMS0xLTEtMTk2MzU_cb4fdd63-e380-49f0-9536-a4fb2e386833">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzItMy0xLTEtMTk2MzU_d843ade3-3e35-4e59-b79a-52fecbea267c">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzItNS0xLTEtMTk2MzU_51f10caf-8571-4c7f-bce2-86d681b02d44">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzMtMS0xLTEtMTk2MzU_9abe0ec6-ebcc-4285-97ab-4d9caa4a55f0">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzMtMy0xLTEtMTk2MzU_c9de41df-5ed3-43dc-8f14-d7f75c3d6679">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzMtNS0xLTEtMTk2MzU_db98fa8c-6608-4979-8665-950682686667">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_139"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzEwNTM3_dae7fc92-21a0-40cb-8e02-177ec2b38277" continuedAt="i3f445a7743b944fa82ea4f408b06c4d9" escape="true">Fair Value</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3f445a7743b944fa82ea4f408b06c4d9" continuedAt="i99e7c4349bc04f4695310d4383c7c9cb"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;In this note, the Company provides details on the fair value of financial assets and liabilities and how it determines those fair values.&#160;The Company presents this information for those financial instruments that are measured at fair value for which the change in fair value impacts net income attributable to CVS Health or other comprehensive income separately from other financial assets and liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s financial instruments are measured at fair value on the consolidated balance sheets.&#160;The fair values of these instruments are based on valuations that include inputs that can be classified within one of three levels of a hierarchy established by GAAP.&#160;&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;valuation inputs&#8221;) that qualifies a financial asset or liability for each level:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Valuation inputs other than Level 1 that are based on observable market data.&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Developed from unobservable data, reflecting the Company&#8217;s assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities are classified based upon the lowest level of input that is significant to the valuation.&#160;When quoted prices in active markets for identical assets and liabilities are available, the Company uses these quoted market prices to determine the fair value of financial assets and liabilities and classifies these assets and liabilities in Level 1.&#160;In other cases where a quoted market price for identical assets and liabilities in an active market is either not available or not observable, the Company estimates fair value using valuation methodologies based on available and observable market information or by using a matrix pricing model.&#160;These financial assets and liabilities are classified in Level 2.&#160;If quoted market prices are not available, the Company determines fair value using broker quotes or an internal analysis of each investment&#8217;s financial performance and cash flow projections.&#160;Thus, financial assets and liabilities may be classified in Level 3 even though there may be some significant inputs that may be observable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of the valuation methodologies used for the Company&#8217;s financial assets and liabilities that are measured at fair value, including the general classification of such assets and liabilities pursuant to the valuation hierarchy.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. When quoted prices are available in an active market, cash equivalents are classified in Level 1 of the fair value hierarchy. Fair values of cash equivalent instruments that do not trade on a regular basis in active markets are classified as Level 2.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Where quoted prices are available in an active market, debt securities are classified in Level 1 of the fair value hierarchy.&#160;The Company&#8217;s&#160;Level 1 debt securities consist primarily of U.S. Treasury securities.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s Level 2 debt securities are obtained using models, such as matrix pricing, which use quoted market prices of debt securities with similar characteristics or discounted cash flows to estimate fair value. The </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i99e7c4349bc04f4695310d4383c7c9cb" continuedAt="i34222dbbf82446279c4471d1beda6852"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company reviews these prices to ensure they are based on observable market inputs that include quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets and inputs that are observable that are not prices (such as interest rates and credit risks). The Company also reviews the methodologies and the assumptions used to calculate prices from these observable inputs. On a quarterly basis, the Company selects a sample of its Level 2 debt securities&#8217; prices and compares them to prices provided by a secondary source. Variances over a specified threshold are identified and reviewed to confirm the price provided by the primary source represents an appropriate estimate of fair value. In addition, the Company&#8217;s internal investment team consistently compares the prices obtained for select Level 2 debt securities to the team&#8217;s own independent estimates of fair value for those securities.&#160;The Company obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December&#160;31, 2021 or 2020. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also values certain debt securities using Level 3 inputs.&#160;For Level 3 debt securities, fair values are determined by outside brokers or, in the case of certain private placement securities, are priced internally.&#160;Outside brokers determine the value of these debt securities through a combination of their knowledge of the current pricing environment and market flows.&#160;The Company did not have any broker quoted debt securities for the years ended December&#160;31, 2021 and 2020. For some private placement securities, the Company&#8217;s internal staff determines the value of these debt securities by analyzing spreads of corporate and sector indices as well as interest spreads of comparable public bonds.&#160;Examples of these private placement Level 3 debt securities include certain U.S. and foreign securities and certain tax-exempt municipal securities.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company currently has two classifications of equity securities:&#160;those that are publicly traded and those that are privately placed.&#160;Publicly-traded equity securities are classified in Level 1 because quoted prices are available for these securities in an active market.&#160;For privately placed equity securities, there is no active market; therefore, these securities are classified in Level 3 because the Company prices these securities through an internal analysis of each investment&#8217;s financial statements and cash flow projections. Significant unobservable inputs consist of earnings and revenue multiples, discount for lack of marketability and comparability adjustments. An increase or decrease in any of these unobservable inputs would have resulted in a change in the fair value measurement. </span></div></ix:continuation><div style="padding-left:36pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i34222dbbf82446279c4471d1beda6852" continuedAt="i12173b418b5e45bebd9decbe566092ec"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="i11640c062e35437a84e8bdd5240da928_I20201231" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzMyOTg1MzQ4OTQ5Nzc_3c16b411-d347-4500-9147-cd4bf404e6c8"><ix:nonFraction unitRef="usd" contextRef="i91e5f841bc1148249e50546c6b0c4b62_I20211231" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzMyOTg1MzQ4OTQ5Nzc_4850a2fe-c335-411c-8af3-a5de271a1d8b">no</ix:nonFraction></ix:nonFraction> financial liabilities measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2021 or 2020. <ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzEwNTQy_87d4faa8-f647-405a-a317-ef19ecbb1f5b" continuedAt="ib591138f1c6e4b7581d9b5362731ad10" escape="true">Financial assets measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2021 and 2020 were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ib591138f1c6e4b7581d9b5362731ad10"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id661ddecbffb4d32b875d7dde00d256b_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzItMS0xLTEtMTk2MzU_db62e9ac-8bd1-432d-a6d4-0b13de837aa9">4,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38966f39d564693bc52e2003aea2649_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzItMy0xLTEtMTk2MzU_d0d5f3de-7a93-4bad-8af0-b6f521fff828">4,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i324d950c15024b0bb7034483bcf91fcc_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzItNS0xLTEtMTk2MzU_02324820-ed68-4f71-a59a-854d620825a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e5f841bc1148249e50546c6b0c4b62_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzItNy0xLTEtMTk2MzU_1ead85df-300a-431d-9d6d-e460370e54e0">9,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i451babf334c54e97bb6b9b0f190306a4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzQtMS0xLTEtMTk2MzU_9e48daa6-d215-4330-a1c0-43e93a82cd84">2,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7dc90b07e3e44409f77d5cb120f1791_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzQtMy0xLTEtMTk2MzU_f80f41d0-ec34-46a7-a097-7d91688ff446">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de66b1934ef4735bf9ab13a87c166e6_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzQtNS0xLTEtMTk2MzU_c1dc05e1-1d5f-40cb-9ae2-4ae41ad45a12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866ae3e88ea547cf994e2b7dc57084e0_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzQtNy0xLTEtMTk2MzU_8bcebada-6bd4-494c-85ac-c670853df2bd">2,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36ebd6ac03f94f7b9b09d2e42eb22df2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzUtMS0xLTEtMTk2MzU_3e4b1634-2b14-43d1-abe3-85b7df675711">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ef2601295cf468496155923c2d3720c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzUtMy0xLTEtMTk2MzU_3a227fb5-4c15-4fba-928c-0f37234bbbc0">3,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb049bcdaf39409381032754ef26a6e4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzUtNS0xLTEtMTk2MzU_ffabe6d4-2978-4b4f-8233-0c3cab2a3dca">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3543b9dfd21451eb0a643264ccb77b8_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzUtNy0xLTEtMTk2MzU_5582b093-074c-4a39-b578-5749187a4b60">3,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i683159f0075e4dc4bd3680b9a30ee79b_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzYtMS0xLTEtMTk2MzU_1eb2b1a2-7d2c-4ef8-beb6-bc69dff5fc07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc3513b74a1349019be42383809506e3_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzYtMy0xLTEtMTk2MzU_9229edee-d1dd-4add-9626-aab93ca78a67">9,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib52cf4a485134e87be898eb27b20e43c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzYtNS0xLTEtMTk2MzU_b9304929-5b7b-4f71-a478-3a61e6f43f39">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5285fd9babe408da40e34a5f27ecdbe_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzYtNy0xLTEtMTk2MzU_e5853983-c6c3-4da4-bd71-57e1a29d53a6">9,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e189ef58904439b8c798dfe80e60a25_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzctMS0xLTEtMTk2MzU_71b4ecaf-d6d8-41f7-bece-58a3f3c20fc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f2f71ab9e345a3960755605a1726ab_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzctMy0xLTEtMTk2MzU_47760a92-1a63-4adf-97b5-dce73989673a">2,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71543114cab743abbb973d2eb97c593b_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzctNS0xLTEtMTk2MzU_8908cf00-8299-4140-af68-b5d1a9a6a855">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a2c8eac231a44ccb5e9b62290d31c14_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzctNy0xLTEtMTk2MzU_3fb0a85e-eaad-45d2-947f-fb240ded9ee2">2,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdfdcb99b98d46498997a64233fe6284_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzgtMS0xLTEtMTk2MzU_96a43783-9bb5-420b-86af-233452ed797f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0776297f1b3c4b35a1681eb98f0e6ddc_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzgtMy0xLTEtMTk2MzU_e18b8c8e-b82d-40b3-a899-79b5fe1b6ad9">875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecac0db5b3bc4f71a118bac63aeab3eb_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzgtNS0xLTEtMTk2MzU_94ac00ca-6181-422f-acea-ff5021bd1e0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6693eb63ed74a828d0366b9db5e4445_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzgtNy0xLTEtMTk2MzU_87d83000-bd66-41a5-926d-8a36d18729cf">875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied406e9d2fff4ac3ac935e90506bb4cf_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzktMS0xLTEtMTk2MzU_fa06ad9a-cd8a-429a-b8f0-1189b30906e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i767a0ee4a63e4ed4aa122d6036cf7f2e_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzktMy0xLTEtMTk2MzU_09210249-2a58-4b9c-a9a1-1d7802f06cf1">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7677c6fdc940cca39670933eff94b7_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzktNS0xLTEtMTk2MzU_e40ea364-b1bc-4fec-a327-86b4a8518e55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c74cc1d42334984a93d5efc6aa1eb3a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzktNy0xLTEtMTk2MzU_4a4dd173-15bb-47dc-a2f4-42a48f87ddf8">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0b5fa5eb4a425db34364e49d4cbdfc_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEwLTEtMS0xLTE5NjM1_1aafa62d-a277-4cea-af7b-d8ee2823a546">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i655ea2abe74d44e981581e84041b0fdb_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEwLTMtMS0xLTE5NjM1_85f2abfe-09c4-47cb-9799-4fdf6641fe1a">2,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94ed5a8a301045ac95dc4f35d8a94a70_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEwLTUtMS0xLTE5NjM1_ea65eb08-58ca-43d2-8062-87f985df7852">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5a62cd495034feaa642a45f38861a84_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEwLTctMS0xLTE5NjM1_7e440a99-a361-4b2f-80b7-feb3e160c198">2,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02d753bb590a4315b54f9533067bd31c_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzExLTEtMS0xLTE5NjM1_d22fb185-d2e2-437d-8e6f-731d5b4689ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fca60115c0f4442898a26ce68ec0a7e_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzExLTMtMS0xLTE5NjM1_294d52f1-5d51-42f0-8f32-a6b23f10ad4a">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57d02a5ebe347a2b9e0de4938be4404_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzExLTUtMS0xLTE5NjM1_a4eb8f36-eb71-4ff0-8ea6-2473b5041e9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d0b79c49904cfb8e3bb6884eba4148_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzExLTctMS0xLTE5NjM1_02328b43-7c81-430d-98b7-de0daac7ab71">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id661ddecbffb4d32b875d7dde00d256b_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEyLTEtMS0xLTE5NjM1_8a2daec4-767a-450a-a68b-572468373214">2,372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38966f39d564693bc52e2003aea2649_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEyLTMtMS0xLTE5NjM1_acdcf2eb-484d-4bd8-9d15-a8781811cc54">20,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i324d950c15024b0bb7034483bcf91fcc_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEyLTUtMS0xLTE5NjM1_0996909e-5138-4d7f-8ebe-1f436c011722">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e5f841bc1148249e50546c6b0c4b62_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEyLTctMS0xLTE5NjM1_3187dd14-e58e-4621-bda0-feecf2fd94b2">23,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id661ddecbffb4d32b875d7dde00d256b_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEzLTEtMS0xLTE5NjM1_455cf5e6-1d2a-491d-9982-b15a533e1b51">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38966f39d564693bc52e2003aea2649_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEzLTMtMS0xLTE5NjM1_d56a73c5-dde3-4776-b252-56ad94ae954f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i324d950c15024b0bb7034483bcf91fcc_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEzLTUtMS0xLTE5NjM1_d17038f9-34aa-4fd4-842a-a63e33a25d82">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e5f841bc1148249e50546c6b0c4b62_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEzLTctMS0xLTE5NjM1_76584318-bc25-4737-af1f-033b90b29ab1">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id661ddecbffb4d32b875d7dde00d256b_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE0LTEtMS0xLTE5NjM1_88732148-344d-4cf3-95f3-f91f3f3eccdd">7,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38966f39d564693bc52e2003aea2649_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE0LTMtMS0xLTE5NjM1_2a9cefa1-9056-40b2-b2fe-2cccb6179e65">25,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i324d950c15024b0bb7034483bcf91fcc_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE0LTUtMS0xLTE5NjM1_fe563017-34d1-469b-b37d-3acc7d1f5e43">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e5f841bc1148249e50546c6b0c4b62_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE0LTctMS0xLTE5NjM1_c209bf84-c72e-4d23-8ab0-31b740237aa4">32,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cc1a0e274864af480f200c3ae61c8a9_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE3LTEtMS0xLTE5NjM1_a01272fa-2bae-4454-866b-b476c8b8f29c">3,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c68ea82b6954ea6b55c0177a55e7799_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE3LTMtMS0xLTE5NjM1_7cd1f333-8c00-4b71-9346-3a6e1fa2befa">3,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia658e0719f064994a3725fa8e7cd5a8f_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE3LTUtMS0xLTE5NjM1_717586c6-f7bf-4466-8148-864693f1e0c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11640c062e35437a84e8bdd5240da928_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE3LTctMS0xLTE5NjM1_ba5b1571-3c0a-47eb-be3b-4b1998a80421">7,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46044f2e055c425fa8412971d2e99d30_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE5LTEtMS0xLTE5NjM1_2cd8387f-86c7-48b0-8496-9e95546dabad">2,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i300ca3e38be14ff1a4fd2b2fd45caf61_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE5LTMtMS0xLTE5NjM1_c06e6087-87b7-4a02-99ab-430444f0b527">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a98c27eb9942459eccbefdfca783c9_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE5LTUtMS0xLTE5NjM1_1cb0e2c6-9d18-4120-b719-c18100456f0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8819a5b1bd5746e9a7bbc6f8ba9cad82_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE5LTctMS0xLTE5NjM1_849fb874-caca-4efe-ae05-95f3662bbf3e">2,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9de95e7ef9124c3eab5c6cc2fef4f3f0_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIwLTEtMS0xLTE5NjM1_72244562-f7fd-4343-88be-fc2cca1c2d81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86b4035143a84effa56728c42ea05b4f_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIwLTMtMS0xLTE5NjM1_1776cb3f-aa51-4c3e-9af4-261347c263fe">2,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6476b9e6b9444e0970ef1e348c4b56b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIwLTUtMS0xLTE5NjM1_5143aee6-7819-48e7-a31f-f0fb51b8c3bb">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i002609847daf4257836b24066c83c6cc_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIwLTctMS0xLTE5NjM1_3b15ddca-03e8-4275-8c72-39cb010d6e5d">2,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8de359f7ead4526b1face6a322f74ad_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIxLTEtMS0xLTE5NjM1_c3e9a53e-6cca-4e29-afd1-c3f6fc909785">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if02a53ac99ee4a1ea26c7d5e3f59cdc6_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIxLTMtMS0xLTE5NjM1_eb6264aa-f556-4ebd-8b61-dcf56cb3aaea">8,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb0ed2c7f70d4aa5b6f870dab5201af9_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIxLTUtMS0xLTE5NjM1_0d9e4f40-c0c8-42fc-9f79-0c34892abe8a">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i831eb2d9681540c1865ef9261f998f72_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIxLTctMS0xLTE5NjM1_ef8212ff-081c-449d-add5-aff3ebc69d80">8,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i802ceb0372954e3b98eecca23defdd06_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIyLTEtMS0xLTE5NjM1_f9290e9c-f76e-4317-a3e7-bf2e9ade8ba0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87d19268d0744fb497410eaae66e13b4_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIyLTMtMS0xLTE5NjM1_bdd10e32-aba2-4b7c-9e83-f8190a6528d0">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5c0b1f4b23f45dfacb98c427e6d4b31_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIyLTUtMS0xLTE5NjM1_66d4e55d-7dd2-449a-b2ea-eb715d3254fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e84fb13164240338a6262a473ae3ecc_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIyLTctMS0xLTE5NjM1_a74d7b0f-6567-41af-a268-0e83d0624abd">2,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i306cad7c3b5a47c1a8e32bae3a96c55e_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIzLTEtMS0xLTE5NjM1_089362e4-163f-4adc-ba9f-b6394c45bcdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic52bb1dcf3f9437ebd76d07e0d8d07ca_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIzLTMtMS0xLTE5NjM1_e8504914-0e1a-4526-86d7-8ed0efb8d9a2">705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if97e7b2c34d34d7e990cfbbf44d5d6ed_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIzLTUtMS0xLTE5NjM1_64a15a37-5c1e-407c-92ca-d3c1353a892c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife5fc6b885a64f58ad6f866ffc705455_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIzLTctMS0xLTE5NjM1_505d7564-398e-4757-ab15-8b97851b6ba2">705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaf20faa368b44408a78e930b5996ccf_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI0LTEtMS0xLTE5NjM1_fe1aec9c-32d3-42d0-ac45-6ee8400446e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i994073ade33544f0933c360c139ab39f_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI0LTMtMS0xLTE5NjM1_f6787c3b-5eb2-4e58-b69b-0de7785fb02e">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28d3d92a5cf94a3f868e18fd184f97f3_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI0LTUtMS0xLTE5NjM1_195145ca-8c73-4615-b64f-5e1d22d334c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae8be572405d45c991240d652b7efbee_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI0LTctMS0xLTE5NjM1_631c1321-8e30-4662-8af7-00f737fd34ca">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4297a85b816143cebb737cc1343a70fe_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI1LTEtMS0xLTE5NjM1_949d7017-be06-455d-aa43-891deb91a529">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49f8a85ce40f4cdfb469db46fc0a3149_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI1LTMtMS0xLTE5NjM1_545d7275-cae6-4567-93c6-665c6e9b5a28">2,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3e2dfc3a14448e4949b0e6ca2e96253_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI1LTUtMS0xLTE5NjM1_dfc0d49f-b425-4718-9898-b9ea7363af94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5019bc214954769b41323ef11d4d630_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI1LTctMS0xLTE5NjM1_d1eb0cbb-9b5f-45be-83ac-ae2933c620cf">2,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0f58cb3118b4270929fe6a3d48f0daf_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI2LTEtMS0xLTE5NjM1_21d954fb-582e-47b1-8f82-6a6621f96a62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i956d74f44abd4029b6c77cb197d9452d_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI2LTMtMS0xLTE5NjM1_2920a0a5-70e4-42b6-bfa0-17c173abcb79">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3363136ad6a64578bfae7d6bb46bc920_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI2LTUtMS0xLTE5NjM1_89424af6-03b9-4992-82ae-97c2f81e17ee">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ebbb82192964b068ed1295f2d2d0aff_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI2LTctMS0xLTE5NjM1_48e97154-b12a-4ef3-9af6-576723f36ba3">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cc1a0e274864af480f200c3ae61c8a9_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI3LTEtMS0xLTE5NjM1_08a6d599-e9fd-4119-b14f-de50b9c3eeca">2,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c68ea82b6954ea6b55c0177a55e7799_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI3LTMtMS0xLTE5NjM1_0ecdae13-e763-4850-b02d-6d7136b9f737">18,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia658e0719f064994a3725fa8e7cd5a8f_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI3LTUtMS0xLTE5NjM1_625a5da5-8b01-4052-8ab9-82c17d67cb74">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11640c062e35437a84e8bdd5240da928_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI3LTctMS0xLTE5NjM1_9cf64201-9188-4e34-a294-9ccbb7cfe200">21,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cc1a0e274864af480f200c3ae61c8a9_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI4LTEtMS0xLTE5NjM1_6e911efc-2093-40ac-a6c9-f9031c3bca3c">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c68ea82b6954ea6b55c0177a55e7799_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI4LTMtMS0xLTE5NjM1_2df8b09f-482a-4abd-9b28-18896ecb1e96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia658e0719f064994a3725fa8e7cd5a8f_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI4LTUtMS0xLTE5NjM1_98c3e500-ff30-4c97-9a66-94dc356c1da7">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11640c062e35437a84e8bdd5240da928_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI4LTctMS0xLTE5NjM1_05f83af2-b8fb-46e4-90ff-f6e606e02eaf">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cc1a0e274864af480f200c3ae61c8a9_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI5LTEtMS0xLTE5NjM1_10d37f15-cf68-41dc-8244-1c2f7ebfe52c">6,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c68ea82b6954ea6b55c0177a55e7799_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI5LTMtMS0xLTE5NjM1_b32befd9-0d01-4a0a-b1cd-950bed7dc526">22,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia658e0719f064994a3725fa8e7cd5a8f_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI5LTUtMS0xLTE5NjM1_00ab9972-781a-44c3-9149-90eaaa43874b">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11640c062e35437a84e8bdd5240da928_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI5LTctMS0xLTE5NjM1_04d28fe6-80d6-41a4-9c37-33fec6d6612f">29,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i12173b418b5e45bebd9decbe566092ec" continuedAt="ife40e2336aab43728384e2c7ffde78a9"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzEwNTM4_c0fc7a2c-13ab-4d98-836b-c9f548f8ce28" continuedAt="i45113ad95c9a4e5b8595d59cda4da2ea" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">States, <br/>municipalities<br/>&#160;and political <br/>subdivisions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other asset-<br/>backed<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable<br/>preferred<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i002609847daf4257836b24066c83c6cc_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzEtMS0xLTEtMTk2MzU_e2568add-0f00-4e15-99f5-6e950c562086">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i831eb2d9681540c1865ef9261f998f72_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzEtMy0xLTEtMTk2MzU_7716959b-cb17-440d-a6bb-4d530a3ffb2f">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51e8f4940ba94ec990e364c713cce559_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzEtNS0xLTEtNjEyMDI_3ff94bc1-3bfc-4853-b8c9-27942b3dcfa7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5019bc214954769b41323ef11d4d630_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzEtMTEtMS0xLTYxMTYw_35272a5a-401f-4645-ba3e-7767408ded16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ebbb82192964b068ed1295f2d2d0aff_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzEtMTMtMS0xLTYxMjE3_24fe1a34-5cfa-4e41-a270-5016577fc38c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8fe6509813f4691be74589fc2c7309c_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzEtMTQtMS0xLTYxMjM4_73245753-e2a1-4473-a211-3bfd5cd2c96f">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11640c062e35437a84e8bdd5240da928_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzEtOS0xLTEtMTk2MzU_93d278cf-2153-4934-911d-5dc90cda3415">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital gains (losses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0665950998f344f1870f81fb5b6506c5_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzMtMS0xLTEtMTk2MzU_c7aa3401-b655-4d4c-bd47-e995574e5359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if31d2cf121644c3fa2ca449a00878b1c_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzMtMy0xLTEtMTk2MzU_fbb5ada7-af3f-40e6-ae5e-34ea7fa7de8c">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if094b6a90e654e42969ee969a10fb465_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzMtNS0xLTEtNjEyMDI_1c3923b2-abf4-4dc3-a98d-4a0f83c294ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c72a2ed64a45778e58402ff15ba10d_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzMtMTEtMS0xLTYxMTY5_7ff02735-c413-4d26-a6b3-60b39fa4759b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e8169d5bee54b719cf109e92dfaf014_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzMtMTMtMS0xLTYxMjE3_ed2d207e-1e72-419e-99a3-1c04df097a05">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946cf0e9eaeb44bd9b10d99d0d2271ff_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzMtMTQtMS0xLTYxMjM4_a531a252-8c43-49d6-8925-4c5b9b72a5ae">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f78308e3c32426bb0c2ca2138e491d2_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzMtOS0xLTEtMTk2MzU_0d684171-acb6-49b5-813d-3d6bf662d961">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0665950998f344f1870f81fb5b6506c5_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzQtMS0xLTEtMTk2MzU_0f0722a3-505a-492f-84fb-da6ee284a5fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if31d2cf121644c3fa2ca449a00878b1c_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzQtMy0xLTEtMTk2MzU_eecc2652-c973-4b32-8995-20cbffadbeba">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if094b6a90e654e42969ee969a10fb465_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzQtNS0xLTEtNjEyMDI_397df3e1-06c2-482d-9ade-409a3c850131">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c72a2ed64a45778e58402ff15ba10d_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzQtMTEtMS0xLTYxMTY5_c6c54bfc-4a4f-455e-ba52-a6ab20bc41aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e8169d5bee54b719cf109e92dfaf014_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzQtMTMtMS0xLTYxMjE3_e75f95bc-ef37-4d28-8119-44be84848de6">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946cf0e9eaeb44bd9b10d99d0d2271ff_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzQtMTQtMS0xLTYxMjM4_b610d731-c7bb-4daa-998e-39c9ccae0333">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f78308e3c32426bb0c2ca2138e491d2_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzQtOS0xLTEtMTk2MzU_cc149a5f-9eb2-4814-b0c8-2240d1504e8b">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0665950998f344f1870f81fb5b6506c5_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzUtMS0xLTEtMTk2MzU_36f11c46-9886-4538-a132-5b05cee91694">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if31d2cf121644c3fa2ca449a00878b1c_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzUtMy0xLTEtMTk2MzU_7a6db92a-1658-48e1-90cc-0f1dd8ab44ff">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if094b6a90e654e42969ee969a10fb465_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzUtNS0xLTEtNjEyMDI_a3d2ae7e-07ff-4118-9f55-41912a146271">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c72a2ed64a45778e58402ff15ba10d_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzUtMTEtMS0xLTYxMTc2_8e000e27-2ada-44e6-a6c9-ac11f76ef5f6">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e8169d5bee54b719cf109e92dfaf014_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzUtMTMtMS0xLTYxMjE3_81b09c93-7a35-45bc-987c-0b703f0179ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946cf0e9eaeb44bd9b10d99d0d2271ff_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzUtMTQtMS0xLTYxMjM4_5c3ffb6a-c756-46ee-83cd-d5f233c81602">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f78308e3c32426bb0c2ca2138e491d2_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzUtOS0xLTEtMTk2MzU_3ebf5617-9c26-422f-a334-f860573adca4">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0665950998f344f1870f81fb5b6506c5_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzYtMS0xLTEtMTk2MzU_33d772e1-e631-42d1-b40c-03ee212cc54f">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if31d2cf121644c3fa2ca449a00878b1c_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzYtMy0xLTEtMTk2MzU_7f7e8229-0f9f-4724-b9d1-9c1bfa39120a">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if094b6a90e654e42969ee969a10fb465_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzYtNS0xLTEtNjEyMDI_1bfc8383-e6e1-4674-8f4c-502b500895ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c72a2ed64a45778e58402ff15ba10d_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzYtMTEtMS0xLTYxMTc2_05efbdfb-be6f-4fe5-8009-13cd77197df8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e8169d5bee54b719cf109e92dfaf014_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzYtMTMtMS0xLTYxMjE3_4fcba971-b04b-4853-a386-2424327b1160">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i946cf0e9eaeb44bd9b10d99d0d2271ff_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzYtMTQtMS0xLTYxMjM4_c3992b1e-3ad0-4b52-b5b7-a5b7c533ea3c">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f78308e3c32426bb0c2ca2138e491d2_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzYtOS0xLTEtMTk2MzU_93fa06ec-91ff-44a2-85fa-82cec241da92">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0665950998f344f1870f81fb5b6506c5_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzctMS0xLTEtMTk2MzU_1286444a-85b0-46ef-ad04-08b3ce418f6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if31d2cf121644c3fa2ca449a00878b1c_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzctMy0xLTEtMTk2MzU_3e1783f5-6a4e-4344-bba1-cd78613c3c52">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if094b6a90e654e42969ee969a10fb465_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzctNS0xLTEtNjEyMDI_06bfabb3-3c7d-4f6e-ba55-0e993e635beb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c72a2ed64a45778e58402ff15ba10d_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzctMTEtMS0xLTYxMTc2_c9523e19-82d9-4c47-8982-ac1c45006d7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e8169d5bee54b719cf109e92dfaf014_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzctMTMtMS0xLTYxMjE3_aca98ba6-a12b-468d-83aa-6c2a4ab4f719">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946cf0e9eaeb44bd9b10d99d0d2271ff_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzctMTQtMS0xLTYxMjM4_3dfdef08-7548-4737-b9e8-5e48a49b0746">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f78308e3c32426bb0c2ca2138e491d2_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzctOS0xLTEtMTk2MzU_c192cc18-82c3-444f-93d4-ca0901b082c7">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0665950998f344f1870f81fb5b6506c5_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzgtMS0xLTEtMTk2MzU_6653efec-4345-488a-b4c1-0e25f8856fdc">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if31d2cf121644c3fa2ca449a00878b1c_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzgtMy0xLTEtMTk2MzU_51611d54-e7c0-43db-bbba-01b5c245d731">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if094b6a90e654e42969ee969a10fb465_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzgtNS0xLTEtNjEyMDI_103f50f3-8bbc-40ca-b87f-2b0a544c040a">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c72a2ed64a45778e58402ff15ba10d_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzgtMTEtMS0xLTYxMTc2_d70b1767-54ca-4afa-96cf-b2a2abea84f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e8169d5bee54b719cf109e92dfaf014_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzgtMTMtMS0xLTYxMjE3_c9c96225-45fc-4377-9ff8-5a15dc3ffaf5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946cf0e9eaeb44bd9b10d99d0d2271ff_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzgtMTQtMS0xLTYxMjM4_1ae8a352-444f-4408-a0f4-1f9f1762a93f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f78308e3c32426bb0c2ca2138e491d2_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzgtOS0xLTEtMTk2MzU_ebeb2aa8-d9f7-4a51-aa58-1b371726ccd6">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3543b9dfd21451eb0a643264ccb77b8_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzktMS0xLTEtMTk2MzU_102fdb19-d937-487c-b4e7-ddf238112298">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5285fd9babe408da40e34a5f27ecdbe_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzktMy0xLTEtMTk2MzU_c1d971ef-c063-4079-bbc0-a2e0791fb8e6">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1462db60599849f7840faeff7ff4b4f8_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzktNS0xLTEtNjEyMDI_49baf63f-6c5d-4328-a2da-8536c2b19121">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5a62cd495034feaa642a45f38861a84_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzktMTEtMS0xLTYxMTc2_7ab991eb-c37c-45a1-8541-107293326658">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d0b79c49904cfb8e3bb6884eba4148_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzktMTMtMS0xLTYxMjE3_df764627-91a4-4530-92f9-f28cf65351b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561ca763e6b04428a37bd3c7b792dcce_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzktMTQtMS0xLTYxMjM4_7b80bb46-1e43-4600-8210-cdbb0ce1c550">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e5f841bc1148249e50546c6b0c4b62_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzktOS0xLTEtMTk2MzU_c116bbf7-7150-416a-8ccc-9f0d703e3fa6">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in unrealized capital losses included in other comprehensive income associated with Level 3 financial assets which were held as of December&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzcyMzA_d2f52fd8-30c5-4e63-a779-dfc8240792db">4</ix:nonFraction> million during the year ended December&#160;31, 2021. </span></div><div><span><br/></span></div><ix:continuation id="i45113ad95c9a4e5b8595d59cda4da2ea"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.859%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">States, <br/>municipalities<br/>&#160;and political <br/>subdivisions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable<br/>preferred<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9f150f106cf4152b9dec763e74aa596_I20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzEtMS0xLTEtMTk2MzU_952fece9-3f4f-4c61-b352-fc01ca6838b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565ff383eb0845fbb762f16160ecd982_I20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzEtMy0xLTEtMTk2MzU_db38f959-dd86-4f2c-9c31-f296b6be7aaf">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie843e7d6706242f988cc00f4c975f5ba_I20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzEtNy0xLTEtMTk2MzU_97a70c9e-b11b-4942-abf9-43c32aec2c39">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9109f42655d2473a86af8d939c6306d2_I20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzEtOS0xLTEtNjEyNTk_b6dc766b-f6bf-4510-a89d-77825f3b8571">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica9f4747830d4246a5c48c387611d7ed_I20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzEtOS0xLTEtMTk2MzU_e767aa5e-d330-4025-a5d2-3ff743716efc">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital gains (losses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96db7954709446f6a42325acd7ec241d_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzMtMS0xLTEtMTk2MzU_e3e985fe-4c28-4783-9328-6c96146f89e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8da99b3fc771435a97faa9c280e0aebf_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzMtMy0xLTEtMTk2MzU_cb608e0d-c5bc-4f98-8501-6dde44844fe8">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i444b6c2c628f473895e24001c99313a1_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzMtNy0xLTEtMTk2MzU_dbd44ff8-21a1-4f3d-a40c-3ecc9b5b1169">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb26232bc7ae41f5a142a468a1d38e94_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzMtOS0xLTEtNjEyNTk_c0bbffe7-db9b-45a4-a89a-13c8a072d5ee">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1e88e7393e140ac8689b32b97e80fb3_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzMtOS0xLTEtMTk2MzU_fec554f9-7cbf-4ede-aff9-76f5dc5804e8">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96db7954709446f6a42325acd7ec241d_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzQtMS0xLTEtMTk2MzU_efdc1e15-404d-4126-9405-fc606c27e36b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8da99b3fc771435a97faa9c280e0aebf_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzQtMy0xLTEtMTk2MzU_dd057fd9-409c-4c9f-ab9f-89c41652a256">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i444b6c2c628f473895e24001c99313a1_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzQtNy0xLTEtMTk2MzU_23dbda95-3f8f-4f24-9a38-61c43fb6f982">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb26232bc7ae41f5a142a468a1d38e94_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzQtOS0xLTEtNjEyNTk_ca8f400e-fce2-4bc2-80c7-57a245e9adc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1e88e7393e140ac8689b32b97e80fb3_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzQtOS0xLTEtMTk2MzU_67ed2ef5-b822-4799-b12d-8cf74620782f">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96db7954709446f6a42325acd7ec241d_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzUtMS0xLTEtMTk2MzU_95e9c909-06be-461f-854d-417e360f21fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8da99b3fc771435a97faa9c280e0aebf_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzUtMy0xLTEtMTk2MzU_8cc0a8a0-a0f8-4590-826e-36eb82ace6ed">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i444b6c2c628f473895e24001c99313a1_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzUtNy0xLTEtMTk2MzU_06115f6f-e664-457a-9125-192b2bd596b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb26232bc7ae41f5a142a468a1d38e94_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzUtOS0xLTEtNjEyNTk_9ab268dc-00a7-4a59-9106-0c5d24f71a61">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1e88e7393e140ac8689b32b97e80fb3_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzUtOS0xLTEtMTk2MzU_b3371598-d8b6-4517-bdd5-e3e129caa923">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96db7954709446f6a42325acd7ec241d_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzYtMS0xLTEtMTk2MzU_ac3b23ff-6ee9-4359-b24f-b5297e988d6a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8da99b3fc771435a97faa9c280e0aebf_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzYtMy0xLTEtMTk2MzU_1ad12012-7ef2-4d27-b64f-6283b00a2f36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i444b6c2c628f473895e24001c99313a1_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzYtNy0xLTEtMTk2MzU_55893f83-f5d6-41dd-858d-3c4498dc23f4">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb26232bc7ae41f5a142a468a1d38e94_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzYtOS0xLTEtNjEyNTk_2de83249-3997-4c77-8417-50837e73f91e">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1e88e7393e140ac8689b32b97e80fb3_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzYtOS0xLTEtMTk2MzU_654fd91e-f439-4b6c-b1a2-e0e08af2e1c5">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96db7954709446f6a42325acd7ec241d_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzctMS0xLTEtMTk2MzU_c85282b2-a508-4cd7-b42e-33ca99fef6cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8da99b3fc771435a97faa9c280e0aebf_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzctMy0xLTEtMTk2MzU_58aad34e-8dcc-4a05-abe9-4f91ecda3ac7">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i444b6c2c628f473895e24001c99313a1_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzctNy0xLTEtMTk2MzU_e70a8435-4027-4a10-9b1d-a21b5c3877ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb26232bc7ae41f5a142a468a1d38e94_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzctOS0xLTEtNjEyNTk_2e5537d8-8f5f-4d44-b6fe-85e4ea95bc06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1e88e7393e140ac8689b32b97e80fb3_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzctOS0xLTEtMTk2MzU_c70a46c2-ff33-4d21-a6dc-f6a009fabe9a">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96db7954709446f6a42325acd7ec241d_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzgtMS0xLTEtMTk2MzU_b4d0a3d8-adf1-4f06-b318-ffa883e42b1b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8da99b3fc771435a97faa9c280e0aebf_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzgtMy0xLTEtMTk2MzU_656348ce-3a57-4ee2-872f-f1cb78a32bc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i444b6c2c628f473895e24001c99313a1_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzgtNy0xLTEtMTk2MzU_8e717dd6-5bb3-4aad-91f1-a36e56e270f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb26232bc7ae41f5a142a468a1d38e94_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzgtOS0xLTEtNjEyNTk_9b22a7ef-41d0-4ccd-850d-c17826e42850">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1e88e7393e140ac8689b32b97e80fb3_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzgtOS0xLTEtMTk2MzU_324cf59c-37e6-4272-8eff-45de7b1e6d3a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i002609847daf4257836b24066c83c6cc_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzktMS0xLTEtMTk2MzU_d6099dd4-396b-4b17-8ad4-8ac3fb5ab243">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i831eb2d9681540c1865ef9261f998f72_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzktMy0xLTEtMTk2MzU_1a073e41-0e09-4e5b-b802-dff1bacf1938">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ebbb82192964b068ed1295f2d2d0aff_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzktNy0xLTEtMTk2MzU_06da7cea-522b-450a-8433-506ecd447d81">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8fe6509813f4691be74589fc2c7309c_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzktOS0xLTEtNjEyNTk_d4441c70-6926-479a-978b-13c0752b8ee4">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11640c062e35437a84e8bdd5240da928_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzktOS0xLTEtMTk2MzU_bc9f046d-118b-4ea6-9d59-80b41f60eab6">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in unrealized capital losses included in other comprehensive income associated with Level 3 financial assets which were held as of December&#160;31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzEwOTk1MTE2Mzg3NTM_d8807777-5dc0-4400-b8de-f7cc9883a238">4</ix:nonFraction>&#160;million during the year ended December&#160;31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total gross transfers into (out of) Level 3 during the years ended December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers into Level 3</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i870c8f372f074816aa15ac75a237b726_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkM2I1ZDA0NjNjNjE0MTc4YWJiOGQ5MTk4NTIyZjQ4ZS90YWJsZXJhbmdlOmQzYjVkMDQ2M2M2MTQxNzhhYmI4ZDkxOTg1MjJmNDhlXzEtMS0xLTEtMTk2MzU_4fa08dbd-f859-46f7-8aac-58e10696bea4">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f1063eb8760432499ef1d5ac46274bb_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkM2I1ZDA0NjNjNjE0MTc4YWJiOGQ5MTk4NTIyZjQ4ZS90YWJsZXJhbmdlOmQzYjVkMDQ2M2M2MTQxNzhhYmI4ZDkxOTg1MjJmNDhlXzEtMy0xLTEtMTk2MzU_4ddaa93c-ff60-456c-891b-b9b7049d68e1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i870c8f372f074816aa15ac75a237b726_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkM2I1ZDA0NjNjNjE0MTc4YWJiOGQ5MTk4NTIyZjQ4ZS90YWJsZXJhbmdlOmQzYjVkMDQ2M2M2MTQxNzhhYmI4ZDkxOTg1MjJmNDhlXzItMS0xLTEtMTk2MzU_4cf1bdf9-f08e-4600-847c-fc190b939f7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f1063eb8760432499ef1d5ac46274bb_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkM2I1ZDA0NjNjNjE0MTc4YWJiOGQ5MTk4NTIyZjQ4ZS90YWJsZXJhbmdlOmQzYjVkMDQ2M2M2MTQxNzhhYmI4ZDkxOTg1MjJmNDhlXzItMy0xLTEtMTk2MzU_6d9ab05e-1b07-4d6a-979f-224aa22e9165">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers into Level 3</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i870c8f372f074816aa15ac75a237b726_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkM2I1ZDA0NjNjNjE0MTc4YWJiOGQ5MTk4NTIyZjQ4ZS90YWJsZXJhbmdlOmQzYjVkMDQ2M2M2MTQxNzhhYmI4ZDkxOTg1MjJmNDhlXzMtMS0xLTEtMTk2MzU_812c1e3f-b6c5-41a5-bdd2-88204e3c7a0a">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f1063eb8760432499ef1d5ac46274bb_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkM2I1ZDA0NjNjNjE0MTc4YWJiOGQ5MTk4NTIyZjQ4ZS90YWJsZXJhbmdlOmQzYjVkMDQ2M2M2MTQxNzhhYmI4ZDkxOTg1MjJmNDhlXzMtMy0xLTEtMTk2MzU_ea552476-1b04-482b-85d1-d31e74fa793a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ife40e2336aab43728384e2c7ffde78a9" continuedAt="i37ef21e096414fd5a4c7eaf0dc70f3c6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments Not Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzEwNTI5_ca4652bb-56de-4730-8e02-7f1858a29323" continuedAt="i3067e5a0b56b42958425f728caf39b3e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the consolidated balance sheets at adjusted cost or contract value at December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.700%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5ff79f6ea7640da8266c10697cb62dc_I20211231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzQtMS0xLTEtMTk2MzU_6784e2ad-f15e-44b7-acdb-de35059ada91">902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b52466f3974cad83656f04e7bc004c_I20211231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzQtMy0xLTEtMTk2MzU_8ad41c73-10d1-4bba-b8d6-b27dce0e1524">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63642ca94ea246beba927f59e1a13b04_I20211231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzQtNS0xLTEtMTk2MzU_d96f972a-f06b-4289-bba3-4c85be9783ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib09205453efc4716a5382309d32f4410_I20211231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzQtNy0xLTEtMTk2MzU_b8e7fd9a-d417-4529-9cde-5599b748c15b">907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cd5d43d704d45d99a5b19bab4753e1e_I20211231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzQtOS0xLTEtMTk2MzU_7a41b9f8-ea31-40c7-a962-cc24d648d92b">907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5ff79f6ea7640da8266c10697cb62dc_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzUtMS0xLTEtMTk2MzU_db613405-dbd6-4422-985f-b82db4c7b423">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5ff79f6ea7640da8266c10697cb62dc_I20211231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzgtMS0xLTEtMTk2MzU_774b12ad-23be-498f-9e27-a53415fd7761">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b52466f3974cad83656f04e7bc004c_I20211231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzgtMy0xLTEtMTk2MzU_e49a44a6-26a9-4fa4-a8f8-927c33bad12c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63642ca94ea246beba927f59e1a13b04_I20211231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzgtNS0xLTEtMTk2MzU_52f6087e-eb3b-4b45-9542-8fa6d0c46db8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib09205453efc4716a5382309d32f4410_I20211231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzgtNy0xLTEtMTk2MzU_6b789418-4d79-4f7c-9b3c-c760f9ea1426">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cd5d43d704d45d99a5b19bab4753e1e_I20211231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzgtOS0xLTEtMTk2MzU_e61fca18-3380-4ffe-beba-ae9d1dd9a78a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5ff79f6ea7640da8266c10697cb62dc_I20211231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzktMS0xLTEtMTk2MzU_0d1cc272-609f-41f1-b65e-874a7bb02527">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b52466f3974cad83656f04e7bc004c_I20211231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzktMy0xLTEtMTk2MzU_e45b7da9-065a-4674-9096-d79da2d2e69f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63642ca94ea246beba927f59e1a13b04_I20211231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzktNS0xLTEtMTk2MzU_9e5e8aa3-aae9-4f93-8a79-1763d98532e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib09205453efc4716a5382309d32f4410_I20211231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzktNy0xLTEtMTk2MzU_49363323-a45b-49c0-8c6c-1b11e04500d5">373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cd5d43d704d45d99a5b19bab4753e1e_I20211231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzktOS0xLTEtMTk2MzU_a2bed119-ed2f-429f-a3dc-261049990a09">373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5ff79f6ea7640da8266c10697cb62dc_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzEwLTEtMS0xLTE5NjM1_97835fb6-6430-4310-8c98-35096598481f">56,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62b52466f3974cad83656f04e7bc004c_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzEwLTMtMS0xLTE5NjM1_a31aa1cf-ec7e-4eb1-ac24-93c68f79ca8f">64,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63642ca94ea246beba927f59e1a13b04_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzEwLTUtMS0xLTE5NjM1_160d635d-ee11-4364-83b7-d878f65b2ce8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib09205453efc4716a5382309d32f4410_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzEwLTctMS0xLTE5NjM1_0aa00725-f842-4846-9ecb-153b7e22f3d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cd5d43d704d45d99a5b19bab4753e1e_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzEwLTktMS0xLTE5NjM1_6c5ab8c0-6fde-4d9a-9ccf-5a77544538aa">64,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39d069b7167947778afa7bcbccb0af02_I20201231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE0LTEtMS0xLTE5NjM1_22493822-f29a-4b1a-bb69-16056088495e">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc64edc684564c32a2cb0d0d05d56c6b_I20201231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE0LTMtMS0xLTE5NjM1_166dfa25-77c6-4c44-be6a-83de892aeb4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f3733991824a44905aef5259a7f9df_I20201231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE0LTUtMS0xLTE5NjM1_f095241e-e89a-4237-a9b6-a9c467ebfa03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da88bdaea8642ffbc4835811efe1f4a_I20201231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE0LTctMS0xLTE5NjM1_8f136d5c-f154-42d6-bdba-64d1641815cd">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb08a50cbb6149819b84374b7f1bb9fa_I20201231" decimals="-6" name="us-gaap:MortgagesHeldForSaleFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE0LTktMS0xLTE5NjM1_7dba34c7-99b0-4a83-995c-e4827f111ea6">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39d069b7167947778afa7bcbccb0af02_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE1LTEtMS0xLTE5NjM1_87eebda8-64f6-4b40-a2ac-9073f3fd88d6">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39d069b7167947778afa7bcbccb0af02_I20201231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE4LTEtMS0xLTE5NjM1_8b9b18fe-b8bf-4c32-8fc3-bc0fccb4b232">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc64edc684564c32a2cb0d0d05d56c6b_I20201231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE4LTMtMS0xLTE5NjM1_5bba2df2-33f3-48c4-9882-f2e0fb14c5cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f3733991824a44905aef5259a7f9df_I20201231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE4LTUtMS0xLTE5NjM1_a417f633-5916-49b9-bbf2-e4ce1de6a390">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da88bdaea8642ffbc4835811efe1f4a_I20201231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE4LTctMS0xLTE5NjM1_87878509-5498-47c4-ab5b-25e7d50a8c48">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb08a50cbb6149819b84374b7f1bb9fa_I20201231" decimals="-6" name="cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE4LTktMS0xLTE5NjM1_c58e59b5-a975-42a6-8fa6-7446d971fd2a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39d069b7167947778afa7bcbccb0af02_I20201231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE5LTEtMS0xLTE5NjM1_cc0fb63e-8a66-4d2c-b41e-ccbbbe933ed3">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc64edc684564c32a2cb0d0d05d56c6b_I20201231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE5LTMtMS0xLTE5NjM1_84fd0a33-b157-4454-a9aa-c5f88e13546b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f3733991824a44905aef5259a7f9df_I20201231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE5LTUtMS0xLTE5NjM1_c1ab4ea4-28fa-4408-b8f2-b60bc8dd0f53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da88bdaea8642ffbc4835811efe1f4a_I20201231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE5LTctMS0xLTE5NjM1_3c0b9704-71eb-4b2d-b5d3-14c8a4b54acc">371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb08a50cbb6149819b84374b7f1bb9fa_I20201231" decimals="-6" name="cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE5LTktMS0xLTE5NjM1_c378de15-1322-4914-9969-ef7e6e849abe">371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39d069b7167947778afa7bcbccb0af02_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzIwLTEtMS0xLTE5NjM1_2164657c-7222-4534-b534-a59871fe266b">64,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc64edc684564c32a2cb0d0d05d56c6b_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzIwLTMtMS0xLTE5NjM1_8ba60e71-ccd8-43b7-947f-f1020e727baa">75,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f3733991824a44905aef5259a7f9df_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzIwLTUtMS0xLTE5NjM1_214dc609-574c-4dad-9c71-2615bb1904d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9da88bdaea8642ffbc4835811efe1f4a_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzIwLTctMS0xLTE5NjM1_a3e9e815-4dbd-401c-840d-d15f9689b523">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb08a50cbb6149819b84374b7f1bb9fa_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzIwLTktMS0xLTE5NjM1_e1507715-2bb5-4c22-b870-374c159b9347">75,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i3067e5a0b56b42958425f728caf39b3e" continuedAt="if09dae6c5ce84fd59c09ca3f4300cca3">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="if09dae6c5ce84fd59c09ca3f4300cca3">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information regarding the valuation of cost method investments.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets relate to the Company&#8217;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Net investment income and capital gains and losses on Separate Accounts assets accrue directly to such contract holders.&#160;The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses.&#160;Deposits, withdrawals, net investment income and realized and unrealized capital gains and losses on Separate Accounts assets are not reflected in the consolidated statements of operations, shareholders&#8217; equity or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets include debt and equity securities.&#160;The valuation methodologies used for these assets are similar to the methodologies described above in this Note 4 &#8216;&#8216;Fair Value.&#8217;&#8217;&#160;Separate Accounts assets also include investments in common/collective trusts that are carried at fair value. Common/collective trusts invest in other investment funds otherwise known as the underlying funds. The Separate Accounts&#8217; interests in the common/collective trust funds are based on the fair values of the investments of the underlying funds and therefore are classified in Level 2. The assets in the underlying funds primarily consist of equity securities. Investments in common/collective trust funds are valued at their respective net asset value (&#8220;NAV&#8221;) per share/unit on the valuation date.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i37ef21e096414fd5a4c7eaf0dc70f3c6"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzEwNTM0_dfb9fc95-3ad8-4b95-8a65-a68f7ef10b11" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts financial assets at December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.953%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f215dc5a0264a64b253b72d4f6fcd37_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzItMS0xLTEtMTk2MzU_a14278f4-1023-446d-aa81-07ddc625241a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95b551d0a20b448ab0a332b566d52832_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzItMy0xLTEtMTk2MzU_acc25ff8-c2cf-4b17-8b63-a925f8e9e1e8">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd1e6f617ae2403f8ab8866007e71088_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzItNS0xLTEtMTk2MzU_c1417beb-638c-4378-8fe5-826c6c3336d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0eb0df1025b44c38bf26427309bbed0_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzItNy0xLTEtMTk2MzU_b24bb46a-1951-4efb-b36d-51ba5a8b38af">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd10d01df7834214b6c5d531c819e017_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzItOS0xLTEtMTk2MzU_9886422c-aa16-45e4-a87b-126cb80e1216">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9f3a4b21109462a92ecc4a3617a03a4_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzItMTEtMS0xLTE5NjM1_9c12eae2-2d8d-41bf-9dd6-c3d79c585b1b">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23df6084b54047e19d2389b69af21997_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzItMTMtMS0xLTE5NjM1_06746873-ebe5-4b6b-8152-189fe3c6baf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7c3cc36bebc406d91f45d441bd00dda_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzItMTUtMS0xLTE5NjM1_80f67f33-4258-4143-bccb-0ee04ee1633c">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae825b6c46034c2f9017cf824110744e_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzMtMS0xLTEtMTk2MzU_d0f93502-c029-407d-957a-80dd35aa3566">1,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77d5d134cdca428089c8e81e51a6eb39_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzMtMy0xLTEtMTk2MzU_24ed5866-cca8-44e4-839c-2ae4fe5f241f">3,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25759438875e48d88a44ca557ed1c835_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzMtNS0xLTEtMTk2MzU_8414c3c3-8ae4-43ef-869a-51a4e0c3c0eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if536320d76ef47fb99ae9bca2ae44681_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzMtNy0xLTEtMTk2MzU_0439efb1-95a4-40a7-ba67-6594b7341ab3">4,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e2ef37787f44952bf1c36f39df42b89_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzMtOS0xLTEtMTk2MzU_8d8c67fb-a034-416c-95a7-b0a5ecd1f02d">1,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1671fc71896b4cbfb0aa01fae5b55103_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzMtMTEtMS0xLTE5NjM1_21be7a37-03fd-47ad-a97f-922b3cbf5e0f">2,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadfb5cadc1144fe58f4ba77d2fde510b_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzMtMTMtMS0xLTE5NjM1_10f4500a-30a2-4bf8-a651-a8c54dd41351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6c57c636ec4b3284104f81a13fd09a_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzMtMTUtMS0xLTE5NjM1_a7431921-5c46-4e55-91e5-f779e7ea6773">4,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb1458668b5e49a588377fbba57db275_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzQtMS0xLTEtMTk2MzU_8f1f0691-207d-4588-8fed-b8b97366ef79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5a2a1f6fc504570bf00460f0dd185f4_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzQtMy0xLTEtMTk2MzU_46c4c659-bb73-47a0-a40a-66f89bd2fd86">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00a40ff338a463a87188f3855a06aa6_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzQtNS0xLTEtMTk2MzU_b351541f-0ce4-4695-abfa-9b0cdc7e230d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib12b30c60e774f8aafb2ac1b598f1c70_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzQtNy0xLTEtMTk2MzU_ab9968f2-3813-471c-9bd7-f795b3dd5fda">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96dabaf8b16941228a15177e351ad141_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzQtOS0xLTEtMTk2MzU_6603786c-3999-495a-9dc0-1ebfbd367473">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6e912b4083b44c5a957335b177c7c50_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzQtMTEtMS0xLTE5NjM1_03dc8f74-67e6-4bb3-bbc8-d520d16f318e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99fe407ef24f415ea6a7582d16faf5db_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzQtMTMtMS0xLTE5NjM1_195647b3-897d-447d-ab89-52e7a33f049c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61412be3a3f547039aecad27f0ec3dad_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzQtMTUtMS0xLTE5NjM1_e04375f6-44ff-4e67-8fef-83598a28d38d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0cf3ff73fbc48efb1b7df6e63ad2a1c_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzUtMS0xLTEtMTk2MzU_715c7049-98b3-4979-a484-e4bed968ab57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d3c804bcc694053a4a943ffedb0ed74_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzUtMy0xLTEtMTk2MzU_dbdd7ab6-89da-4286-9588-c1102b72bfd8">547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25f0d513b0894261bdb02c2d00130e8e_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzUtNS0xLTEtMTk2MzU_17438ad3-24cf-48da-ad27-6bc7dab58fda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82e9727495714f18b22c4dbf7b2c2ab3_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzUtNy0xLTEtMTk2MzU_6cff5218-96fb-4b75-a55f-cede6bdc34e1">547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b2dcf414fa5408591f2c20e94023b4f_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzUtOS0xLTEtMTk2MzU_1e704cb3-9885-4d27-a252-8e25fc47a627">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e2f30ce8c9747828f395554d282e011_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzUtMTEtMS0xLTE5NjM1_feab2031-cf91-4087-b605-9bf3db75e0f8">563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94dd966fcddd49c79185fb0a8b2d0815_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzUtMTMtMS0xLTE5NjM1_d4e42d1a-16e0-4fbb-887c-ca40e4a8d462">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f6242a6485437e8da177a1f5b0f951_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzUtMTUtMS0xLTE5NjM1_c8b5ffb8-9db0-4b4f-9ca0-31e93a9a3d19">563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id661ddecbffb4d32b875d7dde00d256b_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzYtMS0xLTEtMTk2MzU_b6da7363-3e80-4641-8c4b-5a9294800ed6">1,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38966f39d564693bc52e2003aea2649_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzYtMy0xLTEtMTk2MzU_06f4d325-c9e8-42d2-9581-eb25fefa87ff">3,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i324d950c15024b0bb7034483bcf91fcc_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzYtNS0xLTEtMTk2MzU_ea00d81b-0eb3-4ba0-81e1-fb956007fba0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e5f841bc1148249e50546c6b0c4b62_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzYtNy0xLTEtMTk2MzU_c6403eef-44e4-4674-bf13-1cdb92e8e5aa">5,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cc1a0e274864af480f200c3ae61c8a9_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzYtOS0xLTEtMTk2MzU_59d5bdae-a6e1-452c-9976-7f38c22205e6">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c68ea82b6954ea6b55c0177a55e7799_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzYtMTEtMS0xLTE5NjM1_79514d9f-ea86-4ec4-9065-de6f15788b73">3,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia658e0719f064994a3725fa8e7cd5a8f_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzYtMTMtMS0xLTE5NjM1_cb4ea781-9aed-4add-ab6a-5b9acd531d6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11640c062e35437a84e8bdd5240da928_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzYtMTUtMS0xLTE5NjM1_c0fd025d-e949-4699-94dd-2fe76b7649e4">4,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $<ix:nonFraction unitRef="usd" contextRef="ic0519e37b33f47f38604624a1c7d2928_I20211231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzE2NDkyNjc0NTIzODM_bbd4bd0b-9708-43a9-a655-c673d321719f">70</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6fead32c72504f0d91f1a4db5eaceb10_I20201231" decimals="-6" name="us-gaap:SeparateAccountAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzYwNDczMTM5NjM1MDQ_49b1e105-cc6f-4e29-baea-af9f1167107c">29</ix:nonFraction>&#160;million of other receivables at December&#160;31, 2021 and 2020, respectively.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2021 and 2020, the Company had <ix:nonFraction unitRef="usd" contextRef="i6e9ffd0e0d5f4defad6c6e47302cd444_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzk5NzA_e286aa51-bce0-45dd-ae13-2a215ac711a3"><ix:nonFraction unitRef="usd" contextRef="icfcc06f892d44fcead268e6e21698a4a_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzk5NzA_fd4e3214-d755-4d39-ad09-9923aa9a1c27">no</ix:nonFraction></ix:nonFraction> gross transfers of Separate Accounts financial assets into or out of Level 3.</span></div></ix:continuation><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_142"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzQxMDA_57c7d9c4-2ca7-47d6-b38f-76adac0e9750" continuedAt="i396dab38a9f1462a9166ad76f71355f9" escape="true">Goodwill and Other Intangibles</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i396dab38a9f1462a9166ad76f71355f9" continuedAt="i3f3aea14bfd946f3a6bd1c47d3460eee"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzQxMDI_63d7eb18-0013-45fd-8643-eebbb4273d8d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the changes in the carrying amount of goodwill by segment for the&#160;years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.455%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i594e36f005d3463fa1392c6b6973335e_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzEtMS0xLTEtMjU2NjI_c49fb271-d8af-4c34-b9e7-cc98312b5767">45,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54659b176aca43799d4dfafb1ae013bf_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzEtMS0xLTEtMTk2MzU_e410d2e5-8b81-4c29-a08d-14e1436ed5db">23,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4560a747fb0428cbb2dfab79c812259_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzEtMy0xLTEtMTk2MzU_d66c50fc-2da9-40be-ba59-262b25d93cd6">10,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzEtNy0xLTEtMTk2MzU_6cf093e3-14d1-4d28-ae0d-981120c5a54a">79,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbcca6fad4064d56beecf38dab7c745c_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzItMS0xLTEtMjU2NjI_e53043f5-70d2-4d79-bd90-8e260615c8a8">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcf5b0d060a34d59946618c193cd6961_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzItMS0xLTEtMTk2MzU_4c23c45f-64c6-4dc6-97ce-db534f167b1a">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia42958bc5a30456892df849915469aa3_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzItMy0xLTEtMTk2MzU_d7577df6-716d-47ae-afde-181d587cc111">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzItNy0xLTEtMTk2MzU_b1417023-300f-4838-925c-99aa080092a2">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture of Workers&#8217; Compensation business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbcca6fad4064d56beecf38dab7c745c_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzMtMS0xLTEtMjU2NjI_e1492e09-6c21-4caf-bfd3-9b322961d065">505</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcf5b0d060a34d59946618c193cd6961_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzMtMS0xLTEtMTk2MzU_7ee11f96-abdf-46fc-8c7c-ee2aef19d3fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia42958bc5a30456892df849915469aa3_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzMtMy0xLTEtMTk2MzU_c85e75bc-0642-4ca7-8ce6-eaeb5a39adca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzMtNy0xLTEtMTk2MzU_dee0fe1e-24d3-4b0e-9350-0409116bc15c">505</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i974da252533f4b86b21d77a4afd36380_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzYtMS0xLTEtMjU2NjI_63a403ab-75fc-4eda-a65f-595c85eeb04d">45,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225edcbeb1284c59bae6307ce64ff3e7_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzYtMS0xLTEtMTk2MzU_5bbc7abc-e883-473f-9f67-ec8cb44ab036">23,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99c9da9fc50c410b8c73ff24aedfb629_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzYtMy0xLTEtMTk2MzU_edae0a91-0849-4c56-b7b2-fdeb69390d0a">10,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzYtNy0xLTEtMTk2MzU_ed164b88-26a3-4684-b1e8-cfc3a00d587c">79,552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf62411f04644ec5a62a251e4c8f705a_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzgtMS0xLTEtMjU2NjI_e3ff06ed-a5cd-4a0e-b429-f58fc0bab1b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0701631a0de043b89fd026737221cc81_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzgtMS0xLTEtMTk2MzU_024ff943-f55e-424d-8712-766169c7c946">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b5082eb85c041ac945f01d6bc51973d_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzgtMy0xLTEtMTk2MzU_fa736855-69e1-4a34-bb04-3ed94cbac49e">431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzgtNy0xLTEtMTk2MzU_3e3bb22a-25b1-493f-82e7-9252a1634b6f">431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6355e336e53c4e8f9fad360d96598544_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzEwLTEtMS0xLTI1NjYy_443e0eb4-0fda-4221-9ab7-0e5f0e5196f1">45,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i361a96861ee14db9bb7f3e35b6cfabd4_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzEwLTEtMS0xLTE5NjM1_90fbf0e5-f974-46eb-9963-51859729bf51">23,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7310250aa7db49e5bb0700f9d3b0c92b_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzEwLTMtMS0xLTE5NjM1_0f65fb02-28f6-4805-8c26-ad3e5332c718">10,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzEwLTctMS0xLTE5NjM1_6ab851d3-3370-41cb-bb3d-148194fc9eb6">79,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the decrease in the carrying amount of goodwill was primarily driven by a goodwill impairment charge related to the LTC reporting unit within the Retail/LTC segment. During the year ended December&#160;31, 2020, the decrease in the carrying amount of goodwill was primarily driven by the divestiture of the Workers&#8217; Compensation business, partially offset by goodwill associated with immaterial acquisitions. See Note 2 &#8216;&#8216;Divestitures&#8217;&#8217; for further discussion regarding the Workers&#8217; Compensation business divestiture.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill. The results of the impairment tests indicated an impairment of the goodwill associated with the LTC reporting unit, as the reporting unit&#8217;s carrying value exceeded its fair value as of the testing date. The results of the impairment tests of the remaining reporting units indicated that there was no impairment of goodwill as of the testing date. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the LTC reporting unit has continued to face challenges that have impacted the Company&#8217;s ability to grow the LTC reporting unit&#8217;s business at the rate estimated when its 2020 goodwill impairment test was performed. These challenges include lower net facility admissions, net long-term care facility customer losses and the prolonged adverse impact of the COVID-19 pandemic and the emerging new variants, which resulted in more significant declines in occupancy rates experienced by the Company&#8217;s long-term care facility customers than previously anticipated. During the third quarter of 2021, LTC management updated their 2021 annual forecast and submitted their long-term plan which showed deterioration in the financial results for the remainder of 2021 and beyond. The Company utilized these updated projections in performing its annual impairment test, which indicated that the fair value of the LTC reporting unit was lower than its carrying value, resulting in a $<ix:nonFraction unitRef="usd" contextRef="i66d7d53744704d0d935a2fefbe9f6853_D20210701-20210930" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzE2NDkyNjc0NTExNzI_b6a3f7a7-b9d0-4db1-9ee1-d123799f81cc">431</ix:nonFraction>&#160;million goodwill impairment charge in the third quarter of 2021. The fair value of the LTC reporting unit was determined using a combination of a discounted cash flow method and a market multiple method. As of December&#160;31, 2021, there was <ix:nonFraction unitRef="usd" contextRef="iaeb126eb30f245fabd59c464ac7e4e32_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzE2NDkyNjc0NTExNTc_c8d60bcf-4668-4c90-af09-1d9b1c58015a">no</ix:nonFraction> remaining goodwill balance in the LTC reporting unit. During the third quarter of 2021, the Company also performed an impairment test of the intangible assets of the LTC reporting unit and concluded these assets were not impaired. As of December&#160;31, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i887e2e3179ff4e359cd08c7e8f1fe438_I20211231" decimals="-8" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3Xzk4OTU2MDQ2NjQwNjU_4ba82a07-c3f3-49f3-a59b-2f5ec64c3883">2.7</ix:nonFraction> billion of intangible assets related to customer lists in the LTC reporting unit. </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3f3aea14bfd946f3a6bd1c47d3460eee"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2020, the Company performed its required annual impairment tests of goodwill. The results of the impairment tests indicated that there was no impairment of goodwill. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, cumulative goodwill impairments were $<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-8" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3Xzk4OTU2MDQ2NjM4MDA_d0515d83-1b3e-4b73-bc3a-b7954ac2131b">6.6</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-8" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3Xzk4OTU2MDQ2NjM4MDg_58c32051-c5a0-46e8-90d7-96569b6e2049">6.1</ix:nonFraction> billion, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="cvs:FinitelivedandindefinitelivedintangibleassetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzQwOTc_d55fcf32-8a02-4918-9c5b-3713ad2e5637" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s intangible assets as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except weighted average life</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzItMS0xLTEtMTk2MzU_415a4881-3546-4095-abce-365d9ac68564">10,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzItNS0xLTEtMTk2MzU_957b7872-2929-4d9f-9d53-b05b33b49ab2">10,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37da7fe8ff6e4ca79c5d414c9bdf0e79_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzMtMS0xLTEtMTk2MzU_22c024c5-6126-44b1-9f2c-cd3cae199849">25,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37da7fe8ff6e4ca79c5d414c9bdf0e79_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzMtMy0xLTEtMTk2MzU_6b92ce60-0975-47cc-970a-7ec1d3780f93">10,564</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37da7fe8ff6e4ca79c5d414c9bdf0e79_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzMtNS0xLTEtMTk2MzU_8c8d501b-7214-47b5-9d49-19320e954677">14,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i73c432f6e33b44139455c132f65ef574_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzMtNy0xLTEtMTk2MzU_413860c6-79cd-4fce-8069-4366c1620929">15.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fdc1e0fae4b4a2698619c6886a71a11_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzQtMS0xLTEtMTk2MzU_433e73ef-7a4e-40f1-a48d-0e8589253b30">1,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fdc1e0fae4b4a2698619c6886a71a11_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzQtMy0xLTEtMTk2MzU_fa664650-147b-4672-8ff1-6cbab2c48b53">1,060</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fdc1e0fae4b4a2698619c6886a71a11_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzQtNS0xLTEtMTk2MzU_9de25386-e686-47c3-8765-bc38330cc2e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib4bb0f2698a942c58b64c02bb8890e28_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzQtNy0xLTEtMTk2MzU_4c6749fd-4721-4c69-8309-04fa59bed357">3.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i103983e6616d4a4990a7c5de9eaf95be_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzUtMS0xLTEtMTk2MzU_b2f9ba98-e203-47f4-a286-bc61a00684e4">4,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i103983e6616d4a4990a7c5de9eaf95be_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzUtMy0xLTEtMTk2MzU_9f43637d-1f8d-4845-b207-43a8978cc72c">651</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i103983e6616d4a4990a7c5de9eaf95be_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzUtNS0xLTEtMTk2MzU_f2e5440f-f0e8-4758-9aad-38dc4e31146e">3,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i00d050761ad14c2da89fffbb93d65282_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzUtNy0xLTEtMTk2MzU_848d4b6b-d7f0-4f24-9a97-6f8e3e956a00">20.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d83e40a2262423baedabda99555727d_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzYtMS0xLTEtMTk2MzU_c6d0bce6-e091-4baa-97ea-b7341b542591">590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d83e40a2262423baedabda99555727d_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzYtMy0xLTEtMTk2MzU_bf621161-7698-49db-a5f0-26a9d6bb0035">173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d83e40a2262423baedabda99555727d_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzYtNS0xLTEtMTk2MzU_204b3bac-188f-4feb-95ab-9de9401f8b16">417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i79e27bc569ff49dbade03b69248d8b84_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzYtNy0xLTEtMTk2MzU_92fc8009-5eb4-4d82-ac61-32bcd819e63b">20.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb54e269a38e408f8d2a458b20a0a2f8_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzctMS0xLTEtMTk2MzU_3e7597cd-6ba0-4d16-b4a5-f823e1f22cec">318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb54e269a38e408f8d2a458b20a0a2f8_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzctMy0xLTEtMTk2MzU_546578e4-235f-44af-acbf-22940006dba2">279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb54e269a38e408f8d2a458b20a0a2f8_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzctNS0xLTEtMTk2MzU_f39accb8-aae1-4688-badf-98e377342419">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3a4de046b34c4136a97065ee6419a19d_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzctNy0xLTEtMTk2MzU_df15fa61-b66a-47c2-bf78-6ed59d434eb2">8.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzgtMS0xLTEtMTk2MzU_11c48f62-6611-4fc2-bb04-9ad9d692a116">41,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzgtMy0xLTEtMTk2MzU_e02d53f7-0921-4168-a89f-12433223b4a1">12,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzgtNS0xLTEtMTk2MzU_07b783d0-257c-444d-aded-dbc6d35d63c1">29,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzgtNy0xLTEtMTk2MzU_aaeb80a7-a309-421c-b05d-708f9014e759">15.3</ix:nonNumeric></span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzExLTEtMS0xLTE5NjM1_99b76b4c-e7dc-497a-ac5e-9d119d997c1c">10,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzExLTUtMS0xLTE5NjM1_f7fa3d4d-ab64-4593-bbfc-4bb71ba096a1">10,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06fa0eea15746e6a253c5997edbd86d_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzEyLTEtMS0xLTE5NjM1_718ed45a-efec-4850-8e5f-c73215a9a76e">24,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if06fa0eea15746e6a253c5997edbd86d_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzEyLTMtMS0xLTE5NjM1_9f45ab58-62e9-4a7e-8ae1-0278db85794e">8,923</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06fa0eea15746e6a253c5997edbd86d_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzEyLTUtMS0xLTE5NjM1_43ab3be2-7d4a-45ab-8e2c-ecad94581486">16,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i77da570f38b34e80824f67bbd3e96001_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzEyLTctMS0xLTE5NjM1_15a339da-121c-4ef8-89e1-fdebf46d8494">14.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbce2e04d85b437ab5c70fe68d26c55a_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzEzLTEtMS0xLTE5NjM1_36a3f064-444f-4d7b-9416-b710262d4c43">1,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idbce2e04d85b437ab5c70fe68d26c55a_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzEzLTMtMS0xLTE5NjM1_5808fd68-c3f3-412e-ada7-6723da00c20d">739</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbce2e04d85b437ab5c70fe68d26c55a_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzEzLTUtMS0xLTE5NjM1_7a27276f-3588-4dd6-a07c-74e62fb9b1ba">321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id3fcb171d2594f08acb2adf5555f935c_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzEzLTctMS0xLTE5NjM1_609de0f2-c3be-45e3-a4b6-abc831f72861">3.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3dd11c0ec7649d2b02e6e800b19ee58_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE0LTEtMS0xLTE5NjM1_152f01ad-5bff-4628-8c91-19be4b7fc3ff">4,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3dd11c0ec7649d2b02e6e800b19ee58_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE0LTMtMS0xLTE5NjM1_8c567514-2bac-484c-8b36-4c309693359e">440</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3dd11c0ec7649d2b02e6e800b19ee58_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE0LTUtMS0xLTE5NjM1_d03d2a3d-82e8-4ab1-b1e0-bdec6e4fed30">3,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5e56982d83d84bda83b00a3ffffe885e_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE0LTctMS0xLTE5NjM1_0fb85706-298c-47a8-b2de-09759991689e">20.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefcbd5f8eaa54f5f81cbe1bbdb76713e_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE1LTEtMS0xLTE5NjM1_dc7e20ec-2eba-4671-b18e-2922813edaee">590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefcbd5f8eaa54f5f81cbe1bbdb76713e_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE1LTMtMS0xLTE5NjM1_785aa2f5-73cb-4003-b0c9-bf561d942077">119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefcbd5f8eaa54f5f81cbe1bbdb76713e_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE1LTUtMS0xLTE5NjM1_3c6a668f-b787-4643-af73-736704121bb1">471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i20ffed25fb4d4e59851adea90169ac61_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE1LTctMS0xLTE5NjM1_93e033c5-c53e-4212-83cc-c05f5bbf84fd">20.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b7b56c81acb43f6a6abd4fa631a8739_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE2LTEtMS0xLTE5NjM1_bcc0f1c3-1f80-4b37-bab7-5478f86b54b7">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b7b56c81acb43f6a6abd4fa631a8739_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE2LTMtMS0xLTE5NjM1_bfc91a95-ebad-417d-b2c5-16bff5f39383">260</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b7b56c81acb43f6a6abd4fa631a8739_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE2LTUtMS0xLTE5NjM1_1f741fba-aea7-4955-8141-098bea2447d5">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2a39a03b1bea4d85859fc29eb70c86d2_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE2LTctMS0xLTE5NjM1_51d460e4-6012-4d16-aca8-c19e9d1e8b03">7.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE3LTEtMS0xLTE5NjM1_0068ead0-0a6e-4c5c-b8e6-05cb331077f5">41,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE3LTMtMS0xLTE5NjM1_1561110d-9803-41d2-abff-5ec8d4dbaeb9">10,481</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE3LTUtMS0xLTE5NjM1_77752c56-4adb-4151-b6b1-3dd11e70a3f4">31,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" name="us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE3LTctMS0xLTE5NjM1_3d1e7791-3635-4ceb-aba8-85361520b459">15.2</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for intangible assets totaled $<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzM4OTY_2322f286-38d8-494a-8e5b-76d575fa7232">2.3</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzM5MDA_b0be262d-b34e-407f-acea-b46e595b4d45">2.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzM5MDc_0212d21f-7cc6-4384-a5f2-d7a7e8492540">2.4</ix:nonFraction> billion for the years ended December 31, 2021, 2020 and 2019, respectively. <ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzQwOTM_6fae97e7-01d0-4f36-bf91-affd994058a9" continuedAt="i8187ec481af14e4ea64edddf7d43d4a2" escape="true">The projected annual amortization expense for the Company&#8217;s intangible assets for the next five&#160;years is as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="i8187ec481af14e4ea64edddf7d43d4a2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZTpjNzYzYTBiMGJlNmY0MmVjOGIzMWQ0OGMwMTEyNmU5NS90YWJsZXJhbmdlOmM3NjNhMGIwYmU2ZjQyZWM4YjMxZDQ4YzAxMTI2ZTk1XzEtMS0xLTEtMTk2MzU_f3e112ed-93f6-4595-b30f-e35864c00789">1,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZTpjNzYzYTBiMGJlNmY0MmVjOGIzMWQ0OGMwMTEyNmU5NS90YWJsZXJhbmdlOmM3NjNhMGIwYmU2ZjQyZWM4YjMxZDQ4YzAxMTI2ZTk1XzItMS0xLTEtMTk2MzU_cd32200c-9d7e-42d5-b134-3ecc1f7f41ae">1,826</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZTpjNzYzYTBiMGJlNmY0MmVjOGIzMWQ0OGMwMTEyNmU5NS90YWJsZXJhbmdlOmM3NjNhMGIwYmU2ZjQyZWM4YjMxZDQ4YzAxMTI2ZTk1XzMtMS0xLTEtMTk2MzU_36eae7c2-cd73-4f2a-b6a0-6bd2e1f6213f">1,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZTpjNzYzYTBiMGJlNmY0MmVjOGIzMWQ0OGMwMTEyNmU5NS90YWJsZXJhbmdlOmM3NjNhMGIwYmU2ZjQyZWM4YjMxZDQ4YzAxMTI2ZTk1XzQtMS0xLTEtMTk2MzU_1ce399e8-ba41-46e9-954b-7c5b1e9f49d0">1,734</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZTpjNzYzYTBiMGJlNmY0MmVjOGIzMWQ0OGMwMTEyNmU5NS90YWJsZXJhbmdlOmM3NjNhMGIwYmU2ZjQyZWM4YjMxZDQ4YzAxMTI2ZTk1XzUtMS0xLTEtMTk2MzU_28f2b847-a5a6-4073-b86b-2f2ec4e68eae">1,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_145"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzU0NjA_0ee4fecf-f4c9-416a-9b54-7d6f5401fb8a" continuedAt="i8b7498d822b5496d8717b888c64449d6" escape="true"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzU0NjU_b4e5dfb9-b8a8-4854-b03c-5608a7fc0bbe" continuedAt="i5f97d1af092b4480b486cf26aa16af26" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8b7498d822b5496d8717b888c64449d6" continuedAt="i4cfb659741fe438abedbda2db428e892"><ix:continuation id="i5f97d1af092b4480b486cf26aa16af26" continuedAt="ibb6c01f03a394320ba2107adfd73efa1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases most of its retail stores and mail order facilities and certain distribution centers and corporate offices under operating or finance leases, typically with initial terms of <ix:nonNumeric contextRef="i447bb7cdaf5843b5906448ab4622616a_I20211231" name="us-gaap:LesseeFinanceLeaseTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzEwOTk1MTE2MzYwNzk_95d502f9-db4f-4f75-848b-1383495064f5"><ix:nonNumeric contextRef="i447bb7cdaf5843b5906448ab4622616a_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzEwOTk1MTE2MzYwNzk_979bd2b7-56f8-407f-b348-6c20a0444ee1">15</ix:nonNumeric></ix:nonNumeric> to <ix:nonNumeric contextRef="i254473f0a9d24243b38c3ad981a7cf96_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzMyOTg1MzQ5MTUyNzk_3b95cd4a-57c3-4474-887f-acbab295749c"><ix:nonNumeric contextRef="i254473f0a9d24243b38c3ad981a7cf96_I20211231" name="us-gaap:LesseeFinanceLeaseTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzMyOTg1MzQ5MTUyNzk_ce1fb6ea-8a36-42a4-9462-203141b420e7">25</ix:nonNumeric></ix:nonNumeric> years. The Company also leases certain equipment and other assets under operating or finance leases, typically with initial terms of <ix:nonNumeric contextRef="icd712a6b3d0143dca70cd166d1917ef8_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzEwOTk1MTE2MzYwOTM_9132547a-a369-4220-b0c5-5e74c97f4dbe"><ix:nonNumeric contextRef="icd712a6b3d0143dca70cd166d1917ef8_I20211231" name="us-gaap:LesseeFinanceLeaseTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzMyOTg1MzQ5MTUyODI_d2b8aeb8-7bcc-47ca-afda-689c9e99be08">3</ix:nonNumeric></ix:nonNumeric> to <ix:nonNumeric contextRef="i88e46bad2a4a460281a974cda1807f05_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzMyOTg1MzQ5MTUyODA_864aa545-cb93-4f0c-bf3f-258d9aa95cb0"><ix:nonNumeric contextRef="i88e46bad2a4a460281a974cda1807f05_I20211231" name="us-gaap:LesseeFinanceLeaseTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzMyOTg1MzQ5MTUyODA_e7b024f9-e60f-4c4e-a332-b5233e0fdeab">10</ix:nonNumeric></ix:nonNumeric> years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company leases pharmacy space at the stores of another retail chain for which the noncancelable contractual term of the pharmacy lease arrangement exceeds the remaining estimated economic life of the buildings. For these pharmacy lease arrangements, the Company concluded that for accounting purposes the lease term was the remaining estimated economic life of the buildings. Consequently, most of these individual pharmacy leases are finance leases.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4cfb659741fe438abedbda2db428e892" continuedAt="if2fd9cd5129942dc9e373927a8110512"><ix:continuation id="ibb6c01f03a394320ba2107adfd73efa1" continuedAt="i4fd38cc829534dd597ae97b62a032a3f"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzU0NzA_fb6dc1a6-79c2-4a90-a726-33caa31acabe" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.160%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzEtMS0xLTEtMTk2MzU_474fba18-50ad-4308-9071-92e158ea35b2">2,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzEtMy0xLTEtMTk2MzU_374407af-73cd-424d-9902-edd399456563">2,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzEtNS0xLTEtNDQxMjY_70b51ecf-e899-4529-906c-a4f7f30f1ce5">2,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzMtMS0xLTEtMTk2MzU_99a78375-d9c3-4340-994a-46dc10be7234">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzMtMy0xLTEtMTk2MzU_bb80bdea-de4d-4810-8350-d350853b5690">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzMtNS0xLTEtNDQxMzU_b01aafdf-b089-4030-a57f-b5037cd87a20">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzQtMS0xLTEtMTk2MzU_0aa0a16e-8139-4e87-9cf4-43ff2d1fafd0">62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzQtMy0xLTEtMTk2MzU_3959d376-2868-415a-a635-a41345e53354">58</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzQtNS0xLTEtNDQxMzg_e463bc39-0107-4c34-88bc-986773f370c0">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="cvs:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzUtMS0xLTEtMTk2MzU_4c2c8f23-2b75-4a4d-90af-bf9d3052b588">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzUtMy0xLTEtMTk2MzU_4fc31568-94c6-4b23-81c8-1af2ec2b682a">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="cvs:FinanceLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzUtNS0xLTEtNDQxNDE_f491e808-be4a-4b83-893d-1afaf84fe00c">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzYtMS0xLTEtMTk2MzU_625c46d1-769b-4d36-a533-bbf1e86d8e61">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzYtMy0xLTEtMTk2MzU_9335dd3a-b391-4249-b35f-253f335ed544">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ShortTermLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzYtNS0xLTEtNDQxNDQ_5180e24d-42e9-4e16-9122-22ccab9ea210">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzctMS0xLTEtMTk2MzU_aca01ef2-423b-4c44-b7e3-3cc38676d819">604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzctMy0xLTEtMTk2MzU_ba07f03d-47d0-419d-ba22-ab31d3f4d247">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:VariableLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzctNS0xLTEtNDQxNDc_37d516c8-a176-466e-a45c-9911a0c11dcf">581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzgtMS0xLTEtMTk2MzU_d9443d9b-e79e-429e-b8d8-7abcafe59c87">59</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzgtMy0xLTEtMTk2MzU_10bc744f-d44f-4ca6-9605-c6d280c080f2">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:SubleaseIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzgtNS0xLTEtNDQxNTA_e46a4280-407d-452f-9b7a-5646ed574804">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzktMS0xLTEtMTk2MzU_3d94eb94-8f88-4618-8dfc-44b19efbcb07">3,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzktMy0xLTEtMTk2MzU_2d9de24d-1701-4186-838c-7fdb0933d218">3,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzktNS0xLTEtNDQxNTM_02713661-8159-4a25-b9f5-64184ae6ae3c">3,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the years ended December&#160;31, 2021, 2020 and 2019 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.160%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzItMS0xLTEtMTk2MzU_6bb1b6e7-9585-4c40-9ed4-2ba2b81ec052">2,714</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzItMy0xLTEtMTk2MzU_82c4b54a-d5e7-41f1-93b1-62c99ca9a459">2,724</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzItNS0xLTEtNDQxNjQ_eec5c524-c8db-4f83-baaf-1ac740fce685">2,701</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for interest portion of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzMtMS0xLTEtMTk2MzU_1b4e739c-67ab-48cb-bede-a1c44759582f">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzMtMy0xLTEtMTk2MzU_701268a2-7b8f-4ffa-845d-d077b35c0e49">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzMtNS0xLTEtNDQxNjQ_2d9d0cbf-ab6e-4bbb-ac30-788ddca20f7f">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows paid for principal portion of finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzQtMS0xLTEtMTk2MzU_176981bf-ecba-4554-a44c-cb85e6accb47">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzQtMy0xLTEtMTk2MzU_13691bad-7503-4978-9b05-64cd3dbba3de">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzQtNS0xLTEtNDQxNjQ_61239d26-4890-40e6-8018-4c631bb4a3da">26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzYtMS0xLTEtMTk2MzU_6d01827b-1e61-4c5e-bc8f-b1ff066881cc">1,254</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzYtMy0xLTEtMTk2MzU_ea0b4ee0-3022-4e54-8844-a28e5b6d02c1">1,679</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzYtNS0xLTEtNDQxNjc_a8f2a7d7-9af0-4a5f-86a1-cfe5c6849495">1,824</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzctMS0xLTEtMTk2MzU_67d68bfe-348d-4e4c-9267-80c7780a1284">278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzctMy0xLTEtMTk2MzU_27e173d2-c3a3-42df-adb1-8a4bdf5ea7d2">313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzctNS0xLTEtNDQxNjc_c26aff2a-eaa3-45a2-a630-95f900313675">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if2fd9cd5129942dc9e373927a8110512" continuedAt="ia6c0eb66e8ae4dda8ba52d210ef1fca8"><ix:continuation id="i4fd38cc829534dd597ae97b62a032a3f" continuedAt="if2a1440efdf343bda9315617583fd6c7"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="cvs:LesseeLeaseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzU0NjM_2b8236eb-76e5-4220-8693-0b9a6deaf3d7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases as of December&#160;31, 2021 and 2020 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except remaining lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzItMS0xLTEtMTk2MzU_699bac86-5aa1-4edf-ade5-77d85b2c42bf">19,122</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzItMy0xLTEtMTk2MzU_0d824f40-7e24-42b1-b0bc-551d87d40d05">20,729</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzQtMS0xLTEtMTk2MzU_82131072-2aa5-4443-a82a-87bb46cccdd6">1,646</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzQtMy0xLTEtMTk2MzU_89fbdd0d-388e-4309-b6ef-9df6d3da0853">1,638</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzUtMS0xLTEtMTk2MzU_a95e0048-5f3f-4750-8392-b36a207612b5">18,177</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzUtMy0xLTEtMTk2MzU_24f8173f-eb08-42f2-8cd5-443c1a1becd0">18,757</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzYtMS0xLTEtMTk2MzU_c8384606-8e0e-4370-91f0-a9328663328a">19,823</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzYtMy0xLTEtMTk2MzU_f487ab0c-f0ba-4dcd-b52a-700b824c9d7a">20,395</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:FinanceLeaseRightOfUseAssetGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzktMS0xLTEtMTk2MzU_9df79f05-dbc6-4fe3-b4f9-cf2a641991d9">1,375</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:FinanceLeaseRightOfUseAssetGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzktMy0xLTEtMTk2MzU_de8aa7ce-a5e3-43f5-8d7c-7ae790b06a99">1,107</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzEwLTEtMS0xLTE5NjM1_3b290fa9-7eec-4ac6-ba03-623d335ffae1">188</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzEwLTMtMS0xLTE5NjM1_ba25c300-3f2b-42c0-8c3d-009ed7f50003">106</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:FinanceLeaseRightOfUseAssetNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzExLTEtMS0xLTE5NjM1_2c301296-4c09-4215-9511-32bcd5109318">1,187</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:FinanceLeaseRightOfUseAssetNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzExLTMtMS0xLTE5NjM1_d6581ed2-c556-4d2d-a5cf-92b286950bc9">1,001</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzEzLTEtMS0xLTE5NjM1_85635bb8-6639-4e9b-a2b5-b47894034308">50</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzEzLTMtMS0xLTE5NjM1_55629b72-4d74-4c56-864b-3b7e3f0e344a">33</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzE0LTEtMS0xLTE5NjM1_32c73653-e4c6-4a50-b907-d7253a194a52">1,250</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzE0LTMtMS0xLTE5NjM1_8557d32e-70a5-40a5-86f3-6931e2b46c3a">1,050</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzE1LTEtMS0xLTE5NjM1_936b9c0a-cd53-4811-b0d7-2c387d51c358">1,300</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzE1LTMtMS0xLTE5NjM1_aab0d997-cc3f-4ff0-a552-ea14f48286f3">1,083</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzE4LTEtMS0xLTE5NjM1_7f3c88f0-5968-4936-aa4c-6b4e6ce2b77a">12.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzE4LTMtMS0xLTE5NjM1_99b0406b-155e-4ebf-a9c7-cd3fc730a0cc">13.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzE5LTEtMS0xLTE5NjM1_7c1d4f5d-68e4-4931-b56b-9db2002a76ed">20.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzE5LTMtMS0xLTE5NjM1_112c8660-51d2-4ba9-bc4c-844237c87720">20.3</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzIyLTEtMS0xLTE5NjM1_149c3b0a-8efb-4870-b7a2-807ca2ca941e">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzIyLTMtMS0xLTE5NjM1_461ac1eb-0686-47e1-a0ae-b9bc1c6a076a">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzIzLTEtMS0xLTE5NjM1_bddbd346-c032-49f2-b374-fd1c91b56d34">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzIzLTMtMS0xLTE5NjM1_f8edce3a-7c34-4c3a-a057-1230732fcc9d">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzU0NjQ_55128836-f272-4a75-b72f-5cabf8aa8675" escape="true"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzU0Njc_05144a34-42e1-4fcf-9709-14fd3ca3816b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.453%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance<br/>Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating<br/>Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzEtMS0xLTEtMTk2MzU_0efbebb4-246e-47eb-ae26-6169b87af65d">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzEtMy0xLTEtMTk2MzU_43d5919e-4074-4340-a918-004e1d0e6546">2,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:LesseeLiabilityPaymentsYearOne" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzEtNS0xLTEtMTk2MzU_95e8c041-9477-4011-9f15-64be9eb4a1e6">2,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzItMS0xLTEtMTk2MzU_85fb9f8b-c291-4ccc-a2f5-c27f747b3d81">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzItMy0xLTEtMTk2MzU_374bf0aa-bf99-46d6-acc0-1929f0a66919">2,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:LesseeLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzItNS0xLTEtMTk2MzU_df5d2265-9242-41a8-af19-d227d0b9c054">2,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzMtMS0xLTEtMTk2MzU_3121c2db-6fb2-4af5-bc80-eaeb5cc750b1">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzMtMy0xLTEtMTk2MzU_1dee61a1-7fb2-40a9-867d-a43b4e413ef4">2,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:LesseeLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzMtNS0xLTEtMTk2MzU_57ca02fe-034d-4d88-9d0b-11caea8e6bc2">2,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzQtMS0xLTEtMTk2MzU_f5c01d6d-e2a0-4981-8c2a-12b84bcc91af">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzQtMy0xLTEtMTk2MzU_2f3d2039-d8d9-4e20-b203-6cdacb6bfb3e">2,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:LesseeLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzQtNS0xLTEtMTk2MzU_6cb3d0fc-be22-4624-abdd-a75fa3aab764">2,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzUtMS0xLTEtMTk2MzU_97f03861-15f6-48e8-97d8-efe8a6f1293e">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzUtMy0xLTEtMTk2MzU_23af2f05-0d7b-4fb5-9c74-5c65d47a683a">2,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:LesseeLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzUtNS0xLTEtMTk2MzU_18bbbcd4-5105-4edb-aefe-997716250fa6">2,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzYtMS0xLTEtMTk2MzU_aec96d25-ba77-4231-8250-c3c278abdaa1">1,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzYtMy0xLTEtMTk2MzU_f67448fe-1158-4a04-96fe-19fc439fcf38">14,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:LesseeLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzYtNS0xLTEtMTk2MzU_e02cb550-6a9e-4634-82ab-4bc0a88f56d7">15,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzctMS0xLTEtMTk2MzU_0116ce97-38d5-43c5-9d69-cb23a9bbc06b">2,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzctMy0xLTEtMTk2MzU_aab3122a-0a32-4e3a-8091-18a8314aee93">26,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:LesseeLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzctNS0xLTEtMTk2MzU_c6edd9b0-1bae-41e5-9523-66bea50a7fec">28,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzgtMS0xLTEtMTk2MzU_d0c8967b-66b2-4ed2-bc63-41d74e8bca63">768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzgtMy0xLTEtMTk2MzU_fd806136-d7c2-44e7-ac1d-0f9186b8dbbc">6,247</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:LesseeLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzgtNS0xLTEtMTk2MzU_6bbf95a0-eb60-4b7b-b241-5ce834d85a58">7,015</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzktMS0xLTEtMTk2MzU_c481cedb-ef63-45fe-87d1-f4b177fa3794">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzktMy0xLTEtMTk2MzU_f96c1c1d-b482-4591-91c6-8f848c78b772">19,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:LeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzktNS0xLTEtMTk2MzU_6da34e48-df1b-4769-b3a5-88087f1208a8">21,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Future operating lease payments have not been reduced by minimum sublease rentals of $<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzE5MDE_749f7d30-5f85-4edb-80bb-470315434372">311</ix:nonFraction> million due in the future under noncancelable subleases.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-8" name="cvs:OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzIyMTA_8fa393cc-be95-4c2d-a7a8-dcb9c728b028">2.4</ix:nonFraction> billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.</span></div></ix:nonNumeric></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Transactions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company finances a portion of its store development program through sale-leaseback transactions. The properties are generally sold at net book value, which generally approximates fair value, and the resulting leases generally qualify and are accounted for as operating leases. The operating leases that resulted from these transactions are included in the tables above. The Company does not have any retained or contingent interests in the stores and does not provide any guarantees, other than a </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia6c0eb66e8ae4dda8ba52d210ef1fca8"><ix:continuation id="if2a1440efdf343bda9315617583fd6c7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">guarantee of lease payments, in connection with the sale-leaseback transactions. There were no sale-leaseback transactions in 2021. Proceeds from sale-leaseback transactions totaled $<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzEwOTk1MTE2MzQzMjI_5d07c110-bd6b-42ab-bc1a-4d1df836b9d2">101</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzE2NDkyNjc0NDg2NjQ_f38c4076-04ef-414e-8094-704d4105ddea">5</ix:nonFraction> million in the years ended December 31, 2020 and 2019, respectively. Gains from sale-leaseback transactions totaled $<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzEwOTk1MTE2MzQzMzQ_00d40f3c-cc23-482d-9360-0988806a994a">3</ix:nonFraction> million in the year ended December 31, 2020. There were <ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:SaleAndLeasebackTransactionGainLossNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzE2NDkyNjc0NDg3OTI_eeba95b8-9ef4-4f5c-a8f0-52d8b763ebf7">no</ix:nonFraction> material gains from sale-leaseback transactions in the year ended December 31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Store Impairment Charges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its retail store right-of-use and property and equipment assets for impairment at the retail store level, which is the lowest level at which cash flows can be identified. For retail stores where there is an indicator of impairment present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated undiscounted future cash flows used in the analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to its estimated fair value which is the greater of the asset group&#8217;s estimated future cash flows (discounted), or the consideration of what a market participant would pay to lease the assets, net of leasing costs. The Company&#8217;s estimate of fair value considers historical results, current operating trends, consolidated sales, profitability and cash flow results and forecasts. For assets which the Company has determined it will be able to sublease, the estimated future cash flows include the estimated sublease income, net of estimated leasing costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the carrying value of an asset group exceeds its estimated fair value, an impairment loss is recorded to reduce the value of the asset group to its estimated fair value. As the impaired assets are measured at fair value on a nonrecurring basis primarily using unobservable inputs as of the measurement date, the assets are classified in Level 3 of the fair value hierarchy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company completed a strategic review of its retail business and announced the creation of new formats for its stores to continue to drive higher engagement with customers. As part of this review, the Company evaluated changes in population, consumer buying patterns and future health needs to ensure it has the right kinds of stores in the right locations for consumers and for the business. In connection with this initiative, on November 17, 2021, the Board of Directors of CVS Health Corporation (the &#8220;Board&#8221;) authorized the closing of approximately <ix:nonFraction unitRef="store" contextRef="i5f21266668244130a2a3ae68e0af51a2_D20211001-20211231" decimals="-2" name="cvs:NumberOfStoresPlannedClosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3MjQ2NjA_e66c9210-df27-4321-98e2-e77e051ca067">900</ix:nonFraction> retail stores over the next <ix:nonNumeric contextRef="i5f21266668244130a2a3ae68e0af51a2_D20211001-20211231" name="cvs:NumberOfStoresPlannedClosurePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzMyOTg1MzQ5MTM2ODk_0dce3385-efaf-46d1-96ca-319587e449d5">three years</ix:nonNumeric>. The Company expects to close approximately <ix:nonFraction unitRef="store" contextRef="i5f21266668244130a2a3ae68e0af51a2_D20211001-20211231" decimals="INF" name="cvs:NumberOfStoresAnnualPlannedClosuresForClosurePeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3MjQ2NjU_2cf24495-e6c1-4ff4-8ea3-df3f243fac78">300</ix:nonFraction> stores each year between 2022 and 2024. As a result, management determined that there were indicators of impairment with respect to the impacted stores&#8217; asset groups, including the associated operating lease right-of-use assets and property and equipment. A long-lived asset impairment test was performed during the fourth quarter of 2021 and the results of the impairment test indicated that the fair value of certain retail store asset groups was lower than their respective carrying values. Accordingly, in the three months ended December 31, 2021, the Company recorded a store impairment charge of approximately $<ix:nonFraction unitRef="usd" contextRef="i5f21266668244130a2a3ae68e0af51a2_D20211001-20211231" decimals="-8" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3MzkwMTE_faf1f322-030b-46b5-bd4e-f252a5586314">1.4</ix:nonFraction>&#160;billion, consisting of a write down of approximately $<ix:nonFraction unitRef="usd" contextRef="id393d68c87a14ecfa59ccd66f88d6986_D20211001-20211231" decimals="-8" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3MjQ2ODY_23f86224-e59a-4512-9314-ff4e9bc572b1">1.1</ix:nonFraction>&#160;billion related to operating lease right-of-use assets and $<ix:nonFraction unitRef="usd" contextRef="i73df28e0580843f0af8aec248d34934d_D20211001-20211231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3MjQ3MDA_d99fc181-eba5-4789-af84-a684f768a25f">261</ix:nonFraction>&#160;million related to property and equipment, within the Retail/LTC segment. Subsequent to the impairment loss, the fair value of the associated operating lease right-of use assets and property and equipment were $<ix:nonFraction unitRef="usd" contextRef="if36ce4c23dc24bb698d0b377df751c48_I20211231" decimals="-6" name="cvs:OperatingLeaseRightOfUseAssetFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3MjgzNjc_44ee4395-6917-4abd-ae32-34decc28e121">356</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i2ec38326eb9b46b19c242875eaaa6067_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3MjgzODE_4c091dad-102d-429b-9b95-8c191d903c95">185</ix:nonFraction>&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, the Company performed reviews of its retail stores and determined it would close <ix:nonFraction unitRef="store" contextRef="i662bccf7d999425aaee1852c1b46776a_D20190101-20191231" decimals="INF" name="cvs:NumberOfStoresPlannedClosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3Mjg3NjA_76bf9c92-c385-4e68-8e5a-d121f67896eb">68</ix:nonFraction> underperforming retail pharmacy stores. As a result, management determined that there were indicators of impairment with respect to the impacted stores, including the associated operating lease right-of-use assets. Long-lived asset impairment tests were performed and the results indicated that the fair value of those underperforming retail stores were lower than their respective carrying values. Accordingly, the Company recorded store impairment charges of $<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3Mjg5NTA_9b4539d8-ff1d-41b9-b8ca-aef4a7ad6ca1">231</ix:nonFraction> million during the year ended December 31, 2019, primarily related to these operating lease right-of-use asset impairment charges, within the Retail/LTC segment.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_148"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzM4MTM_c17e1be7-c740-4a4b-93a1-08e738617759" continuedAt="i08b0af0840c84c2c83c070afb375eacb" escape="true">Health Care Costs Payable</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i08b0af0840c84c2c83c070afb375eacb" continuedAt="ia6fc89100fa64273abcfc2d3cd893ce2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is information about incurred and cumulative paid health care claims development as of December&#160;31, 2021, net of reinsurance, and the total IBNR liabilities plus expected development on reported claims included within the net incurred claims amounts. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for information on how the Company estimates IBNR reserves and health care costs payable as well as changes to those methodologies, if any. The Company&#8217;s estimate of IBNR liabilities is primarily based on trend and completion factors. Claim frequency is not used in the calculation of the Company&#8217;s liability. In addition, it is impracticable to disclose claim frequency information for health care claims due to the Company&#8217;s inability to gather consistent claim frequency information across its multiple claims processing systems. Any claim frequency count disclosure would not be comparable across the Company&#8217;s different claim processing systems and would not be consistent from period to period based on the volume of claims processed through each system. As a result, health care claim count frequency is not included in the disclosures below.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzM4MTQ_1d0450c6-4f8b-4e88-b6de-fea80d52c529" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information about incurred and paid health care claims development for the year ended December&#160;31, 2020 is presented as required unaudited supplemental information.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Incurred Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4963e68529a4b8092a5dbb197266a3c_I20201231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzMtMS0xLTEtMTk2MzU_1c57de17-04cb-4f2b-994c-1613daa5e0ae">54,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c01c7edc6746428feb2cca829e603b_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzMtMy0xLTEtMTk2MzU_7d3c346a-5b6c-4904-bc56-9fd9d55980db">53,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if19bfb96ace84f7ba6e1dda34847936f_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzQtMy0xLTEtMTk2MzU_73e37307-e50a-4a81-9c95-d3dd1868cec5">62,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzUtMy0xLTEtMTk2MzU_bab644ac-2523-44a7-80f9-92bae16cbe79">116,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cumulative Paid Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4963e68529a4b8092a5dbb197266a3c_I20201231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzEwLTEtMS0xLTE5NjM1_60dbb0be-78b4-469f-9dbe-e1212e1e5f5a">47,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72c01c7edc6746428feb2cca829e603b_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzEwLTMtMS0xLTE5NjM1_5f9b7ca9-df03-45fc-a5c2-70cc4d7d8fbf">53,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if19bfb96ace84f7ba6e1dda34847936f_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzExLTMtMS0xLTE5NjM1_78c90f5b-a65e-468e-975a-04ae150cd5d5">54,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzEyLTMtMS0xLTE5NjM1_e18e95b6-3f8f-4afd-8e2b-ea0c3604a47c">108,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All outstanding liabilities for health care costs payable prior to 2020, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzEzLTMtMS0xLTE5NjM1_f545a6b5-1a4d-4a7e-9eba-540b84fd5d94">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total outstanding liabilities for health care costs payable, net of reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzE0LTMtMS0xLTE5NjM1_54fa32cf-800c-4399-be0c-b123eb6c74a2">8,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, the Company&#8217;s liabilities for IBNR plus expected development on reported claims totaled approximately $<ix:nonFraction unitRef="usd" contextRef="i6355e336e53c4e8f9fad360d96598544_I20211231" decimals="-8" name="us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzE0MjQ_e90537ee-ed96-4dad-9524-f75063a6671e">6.6</ix:nonFraction> billion. Substantially all of the Company&#8217;s liabilities for IBNR plus expected development on reported claims at December&#160;31, 2021 related to the current calendar year.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzM4MTU_1d30dd13-4658-4441-8810-bae9be604669" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the December&#160;31, 2021 health care net incurred and paid claims development tables to the health care costs payable liability on the consolidated balance sheet is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-duration health care costs payable, net of reinsurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTozNjA1YzA3YzNiZmM0NWJlYWZhYWM5OTQ3OWFhYWVmYS90YWJsZXJhbmdlOjM2MDVjMDdjM2JmYzQ1YmVhZmFhYzk5NDc5YWFhZWZhXzEtMS0xLTEtMTk2MzU_54fa32cf-800c-4399-be0c-b123eb6c74a2">8,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTozNjA1YzA3YzNiZmM0NWJlYWZhYWM5OTQ3OWFhYWVmYS90YWJsZXJhbmdlOjM2MDVjMDdjM2JmYzQ1YmVhZmFhYzk5NDc5YWFhZWZhXzItMS0xLTEtMTk2MzU_f66f534e-644e-47c0-be85-09370d32bc25">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTozNjA1YzA3YzNiZmM0NWJlYWZhYWM5OTQ3OWFhYWVmYS90YWJsZXJhbmdlOjM2MDVjMDdjM2JmYzQ1YmVhZmFhYzk5NDc5YWFhZWZhXzMtMS0xLTEtMTk2MzU_37bc4395-e4a5-4a23-acf5-b5e8c2d80836">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance lines other than short duration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTozNjA1YzA3YzNiZmM0NWJlYWZhYWM5OTQ3OWFhYWVmYS90YWJsZXJhbmdlOjM2MDVjMDdjM2JmYzQ1YmVhZmFhYzk5NDc5YWFhZWZhXzQtMS0xLTEtMTk2MzU_15c58acd-af85-49bc-b4fa-95f60e183074">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total health care costs payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTozNjA1YzA3YzNiZmM0NWJlYWZhYWM5OTQ3OWFhYWVmYS90YWJsZXJhbmdlOjM2MDVjMDdjM2JmYzQ1YmVhZmFhYzk5NDc5YWFhZWZhXzUtMS0xLTEtMTk2MzU_e47fc71e-f3b5-4587-ac09-3df9434b8569">8,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia6fc89100fa64273abcfc2d3cd893ce2"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzM4MTg_a6366dd5-bcf2-44b8-b6cf-7bcd76703403" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the years ended December 31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.160%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e7c0dce760d47df841954664e69c360_I20201231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEtMS0xLTEtMTk2MzU_f633aba6-79e0-4026-8150-3cc7a44d7104">7,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEtMy0xLTEtMTk2MzU_28ed5aef-cca8-4f39-a3e7-b3266d7e54e2">6,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fa3d998066f4ae1b676b83334f1c904_I20181231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEtNS0xLTEtMTk2MzU_4c29b99b-1457-493e-ad40-6a986301392f">6,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e7c0dce760d47df841954664e69c360_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzItMS0xLTEtMTk2MzU_c7a7ab4d-ed36-4346-9e3c-0e0c8a80ccdc">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzItMy0xLTEtMTk2MzU_008ad40d-8522-4c04-abb4-1abe70aab888">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fa3d998066f4ae1b676b83334f1c904_I20181231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzItNS0xLTEtMTk2MzU_a97273e2-bab8-4a62-bbf4-c0ef42fe49b8">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e7c0dce760d47df841954664e69c360_I20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzMtMS0xLTEtMTk2MzU_22ceaebc-e941-408c-a31e-b9d08851cfdd">7,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzMtMy0xLTEtMTk2MzU_fae10964-8f3a-4846-9671-2818e808641e">6,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fa3d998066f4ae1b676b83334f1c904_I20181231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzMtNS0xLTEtMTk2MzU_c914bba4-42aa-4008-a206-1acf5a66e84c">6,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzQtMS0xLTEtMTk2MzU_4d470c83-0975-40e9-8f96-cfe7881bb3a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76012d8261584b91889a99647c4b75ab_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzQtMy0xLTEtMTk2MzU_0cd5dc36-1e8a-4fb0-8e77-adf2f66c3253">414</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzQtNS0xLTEtMTk2MzU_37f52d98-fde4-4a46-ac9e-d1e6723651ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzctMS0xLTEtMTk2MzU_1c66d126-229d-4457-aba3-291eac190e4d">64,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76012d8261584b91889a99647c4b75ab_D20200101-20201231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzctMy0xLTEtMTk2MzU_5608ce8c-5cdf-47a8-8d41-33ca75bfb023">55,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzctNS0xLTEtMTk2MzU_c43c8828-ae99-4bd1-9e71-4913cd26152e">52,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzgtMS0xLTEtMTk2MzU_e9bc5fc5-6339-4902-9d6f-cf6fbfcd9ccf">788</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76012d8261584b91889a99647c4b75ab_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzgtMy0xLTEtMTk2MzU_c88168d3-f2bb-4a2b-9948-2703f83e3fc8">429</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzgtNS0xLTEtMTk2MzU_7ecb3779-d4fd-4141-a4ee-29f5a1f6200d">524</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzktMS0xLTEtMTk2MzU_136f707f-b6d6-4b20-b3ac-027b10ccbc99">63,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76012d8261584b91889a99647c4b75ab_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzktMy0xLTEtMTk2MzU_3e0ec571-9a89-42cc-92b0-f469a4dde290">55,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzktNS0xLTEtMTk2MzU_dafafddd-84ee-49e1-b055-df46a5794411">52,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzExLTEtMS0xLTE5NjM1_8bed8f72-acb4-4a5d-81c1-d788881069f7">56,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76012d8261584b91889a99647c4b75ab_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzExLTMtMS0xLTE5NjM1_38a3a44c-68a8-4e3d-b46e-16764049715e">48,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzExLTUtMS0xLTE5NjM1_ad7ff34f-0c70-46da-a8d9-2455ac816227">46,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEyLTEtMS0xLTE5NjM1_fde5dc0e-45b0-4dbc-9705-46f4cbe29ddb">6,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76012d8261584b91889a99647c4b75ab_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEyLTMtMS0xLTE5NjM1_14a3aeb3-0efe-45ab-a6b8-0fd121bfe007">6,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEyLTUtMS0xLTE5NjM1_96228bcd-78d5-4d5e-ab81-0bf03fe46724">5,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEzLTEtMS0xLTE5NjM1_8b448c83-dea1-40ac-b688-741932c903d1">63,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76012d8261584b91889a99647c4b75ab_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEzLTMtMS0xLTE5NjM1_397a7b34-add4-4059-972e-f9e3f81c4a78">54,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEzLTUtMS0xLTE5NjM1_b6a7ca41-9404-4f47-b0bc-cac0187841df">51,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE0LTEtMS0xLTE5NjM1_a0918f1b-b36d-4143-90d0-ee5479de8fba">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e7c0dce760d47df841954664e69c360_I20201231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE0LTMtMS0xLTE5NjM1_c0e64093-26e8-4fb7-b52c-4eebe190937f">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE0LTUtMS0xLTE5NjM1_b0792ca7-ca45-4b2c-9f34-a79c4c822bd3">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE1LTEtMS0xLTE5NjM1_8c2909f6-c06b-42a8-a1b3-b9fd6defd246">8,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e7c0dce760d47df841954664e69c360_I20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE1LTMtMS0xLTE5NjM1_6aebc9fa-29e4-4aa1-b5eb-09893dcccf3a">7,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE1LTUtMS0xLTE5NjM1_48aa1849-4de4-4bed-b6f0-2753ed314d2e">6,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE2LTEtMS0xLTE5NjM1_5e0826de-cfd7-4684-bb41-75e2ae6e44d6">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e7c0dce760d47df841954664e69c360_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE2LTMtMS0xLTE5NjM1_2924a524-3445-4d31-a78d-f6b6903ba7de">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE2LTUtMS0xLTE5NjM1_9ef49f65-aa23-4db9-a1cc-2c590d4cff19">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE3LTEtMS0xLTE5NjM1_70a776a9-006d-43e0-9072-c6bb906d769a">8,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e7c0dce760d47df841954664e69c360_I20201231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE3LTMtMS0xLTE5NjM1_7a20f91d-9c81-465d-a375-8c244504ef49">7,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE3LTUtMS0xLTE5NjM1_6d7e7158-67e5-4876-afab-880af2fb1e90">6,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the years ended December&#160;31, 2021, 2020 and 2019 in the table above exclude (i) $<ix:nonFraction unitRef="usd" contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI1NDQ_a0918f1b-b36d-4143-90d0-ee5479de8fba">16</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i7e7c0dce760d47df841954664e69c360_I20201231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI1NDg_c0e64093-26e8-4fb7-b52c-4eebe190937f">11</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231" decimals="-6" name="cvs:PremiumDeficiencyReserveLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI1NTU_b0792ca7-ca45-4b2c-9f34-a79c4c822bd3">4</ix:nonFraction> million, respectively, for a premium deficiency reserve related to the Company&#8217;s Medicaid products, (ii) $<ix:nonFraction unitRef="usd" contextRef="idf62411f04644ec5a62a251e4c8f705a_D20210101-20211231" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI2NTU_b11f2e5e-4b4e-408b-b3dc-01d36c739c14">59</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ibbcca6fad4064d56beecf38dab7c745c_D20200101-20201231" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI2NTk_dd924c04-a816-4e41-97a2-00ac4b0eb6c5">41</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i96bd81c6654246d5be1e598d6b692530_D20190101-20191231" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI2NjY_464216aa-3118-43dd-9c12-dc2725e0435f">41</ix:nonFraction> million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the consolidated balance sheets and (iii) $<ix:nonFraction unitRef="usd" contextRef="iadbcbd4d470f4615bf38443ed006d736_D20210101-20211231" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI4NDA_cbf363f2-f842-4c5b-8394-81c35cdf1f71">212</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i158b727557ce414a986ec4f36279d415_D20200101-20201231" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI4NDQ_3f66eb40-9b8f-4319-96a0-2f5685eea198">221</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i59f215ec163143bab8341e2e7c77c7f5_D20190101-20191231" decimals="-6" name="cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI4NTE_64b04354-37c3-4837-a08b-fc4d86967fdd">285</ix:nonFraction> million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the consolidated balance sheets.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of prior years&#8217; health care costs payable decreased by $<ix:nonFraction unitRef="usd" contextRef="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzMwOTE_e9bc5fc5-6339-4902-9d6f-cf6fbfcd9ccf">788</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i76012d8261584b91889a99647c4b75ab_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzMwOTg_c88168d3-f2bb-4a2b-9948-2703f83e3fc8">429</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzEwOTk1MTE2MzIxOTE_7ecb3779-d4fd-4141-a4ee-29f5a1f6200d">524</ix:nonFraction> million in 2021, 2020 and 2019, respectively, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#8217;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year. This development does not directly correspond to an increase in the Company&#8217;s operating results as these reductions were offset by estimated current period health care costs when the Company established the estimate of the current year health care costs payable.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_151"></div><div style="margin-bottom:3pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzgwMzM_d14d1173-46ca-45b3-9900-2ddaf5bc273b" continuedAt="ibf0903b485ac4e1b961d69a8c2ffb454" escape="true">Borrowings and Credit Agreements</ix:nonNumeric></span></div><ix:continuation id="ibf0903b485ac4e1b961d69a8c2ffb454" continuedAt="i7ca9c37b8cbd4aaabd23c585c7599757"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzc5NDQ_23154819-34d5-4e47-bfba-79cd011fea90" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.452%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i91523901360c46a3b3e64cd533486ad3_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246N2I4YTU4ZTMwMmMxNGM0NDliZWVlMGIyMGJjMjZkOTFfNA_1698ffe3-14f0-47a4-9701-af754fc624a5">3.35</ix:nonFraction>% senior notes due March 2021</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91523901360c46a3b3e64cd533486ad3_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEwLTEtMS0xLTE5NjM1_0ef3c07f-c980-4d77-98b8-e336c3cf936e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2efd3deebdcf481d98efcf7a26363660_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEwLTMtMS0xLTE5NjM1_abf1b70f-c58e-496e-b2b6-9cc0143b9b9c">2,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Floating rate notes due March 2021 (<ix:nonFraction unitRef="number" contextRef="id4c47a098f1b415db3606ac2bcdcf33b_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzExLTAtMS0xLTE5NjM1L3RleHRyZWdpb246NGIwNjk1MWVkNTk2NDQwNTlkNTQ0ODQ0OGJhYWFiZDJfNDA_451e3526-7a0f-41fa-a987-b57715383705">0.950</ix:nonFraction>% at December 31, 2020)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id230e348ab594d0499b52ae6f1d6b47d_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzExLTEtMS0xLTE5NjM1_a7cff589-01a5-44ff-9506-602fe42f4372">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c47a098f1b415db3606ac2bcdcf33b_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzExLTMtMS0xLTE5NjM1_3ce76cba-9006-4172-876f-b6f77d69ceee">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e3b186508ca40dd93af39cb786b7ba9_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEyLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDNmZjNjNmZjYmJhNGNhODhlZTg0Y2M1YTg5OGU5NzJfNA_940844c2-9192-488e-8560-c67170fa4ad5">4.125</ix:nonFraction>% senior notes due May 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e3b186508ca40dd93af39cb786b7ba9_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEyLTEtMS0xLTE5NjM1_3c3eeb7d-8900-4e06-ae73-e02141c67476">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i529804562b5e4b20964ec542de3a4305_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEyLTMtMS0xLTE5NjM1_b8ad611e-3ed6-4762-80e2-bb5bc153c6de">222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if03bd9fe13614b36a4342b0424978822_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEzLTAtMS0xLTE5NjM1L3RleHRyZWdpb246YTM5YzY2YmQ4MTQ1NGY1MzkzMDI4N2QwMjBmNzllNWRfNA_ec450893-8bc8-420e-b308-7f14c337d036">2.125</ix:nonFraction>% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if03bd9fe13614b36a4342b0424978822_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEzLTEtMS0xLTE5NjM1_30d99a92-3c76-47c8-8f1b-cb4d733b1b93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f67a675f3fa45c69b8fee2598feedaf_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEzLTMtMS0xLTE5NjM1_f52bac95-c503-4a84-9c6c-ff5313133ac9">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8d3ecc7d88d84421b8594f43a72e7bb9_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE0LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZWQyMmRjMmMyZDU2NDk1YjhlOTk2YTg1NTY4NmM3MzlfNA_6c23d856-5aab-472a-ab10-881d726364e8">4.125</ix:nonFraction>% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d3ecc7d88d84421b8594f43a72e7bb9_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE0LTEtMS0xLTE5NjM1_67f0b305-7adf-49ec-a6f0-7de4a9804a66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie046158c6aa149abae5894fdb3e124c7_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE0LTMtMS0xLTE5NjM1_8bfdf6fc-0504-4621-a9de-b5785c4007a6">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifa15869b2ddd4074bd9606c1b61a3b53_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE1LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YmQwOWU5N2M5MWFiNDgwN2JkMmI3NjNiODlmYTAxY2VfNA_5a4a7364-b983-4a4c-b11b-69b7e67a0b7c">5.45</ix:nonFraction>% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa15869b2ddd4074bd9606c1b61a3b53_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE1LTEtMS0xLTE5NjM1_1cbd2773-67de-4265-a18d-98618789a436">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4892cc30de7a4f45a88addf5dc0f50f4_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE1LTMtMS0xLTE5NjM1_37264f05-374e-4a7f-aa8f-4cba30a881a9">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1545ac7575274fbab03041015d476d86_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE3LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MmM4NTM3YzE1ZjA1NDBiMmE5OTc4YzYxYThhOTZhNzFfNA_fba90f29-3e68-4c02-9fb6-aba202b38fca">3.5</ix:nonFraction>% senior notes due July 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1545ac7575274fbab03041015d476d86_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE3LTEtMS0xLTE5NjM1_2f157950-fc14-45a8-84c7-4a0ee0c07bcd">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i566f70fe4fc44db799a8e103eafc538a_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE3LTMtMS0xLTE5NjM1_c511be90-73e5-44a0-9d06-dd4fab69e7c2">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia06ed28b864c45d09aa4e68d0dcd0b8e_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE4LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ODUyYzI3OWQzZTc4NGU0M2IwYzhmM2IyNjAxMDRlYzFfNA_b5e6152f-caf3-4f03-be71-375c0902434e">2.75</ix:nonFraction>% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia06ed28b864c45d09aa4e68d0dcd0b8e_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE4LTEtMS0xLTE5NjM1_74076771-499d-4a9d-90f1-96bd79dcdfa6">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83c484e09e5c48ef8e40ce7a9666c2e3_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE4LTMtMS0xLTE5NjM1_c1aeaf23-fadf-4ebc-8caf-e65a5af385eb">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i38871ce4eafc42498a31f0b4aa3e0fd6_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZmQ3NjRhZWRkYTNlNDhkY2IzOGNiNmEzODQxNjA5OTBfNA_e103bed6-1f6a-4bd0-8409-18e0fedc3224">2.75</ix:nonFraction>% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38871ce4eafc42498a31f0b4aa3e0fd6_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE5LTEtMS0xLTE5NjM1_1a5333b7-9a24-4675-b35b-84392cca9648">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b47680e6fa347cebcc6cb6ba06e1468_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE5LTMtMS0xLTE5NjM1_526bf786-0ee7-4354-bf55-eea3dcfb1981">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i528008a52e3c42f88ac57efdeb1d1e22_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246Y2M3MjMzYzA3MWNhNDJjNDlkYWQ4NGEwZjQ3ZDQwZTJfNA_2101d99b-5df6-4d35-a6fc-01e4e7b8bd10">4.75</ix:nonFraction>% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i528008a52e3c42f88ac57efdeb1d1e22_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIwLTEtMS0xLTE5NjM1_d9d74cb1-2bab-47b2-b021-d941f6becb74">399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78c173076a904738ac9a7ceaa5fad016_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIwLTMtMS0xLTE5NjM1_a48f16ff-841e-4fc5-bb54-3b9930da141f">399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia90eaa0d021a4defb944082e8dfa339c_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIxLTAtMS0xLTE5NjM1L3RleHRyZWdpb246M2EwMmNmMmIxZjFmNDdjOWFjOTk5MzEzMjg2MjgyNWNfNA_167a2201-002c-4271-9950-fd8493951b46">3.7</ix:nonFraction>% senior notes due March 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia90eaa0d021a4defb944082e8dfa339c_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIxLTEtMS0xLTE5NjM1_e213909b-9534-493c-9414-3d6c35d7edd6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4acc5bb45f824af59b9b441ae8323056_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIxLTMtMS0xLTE5NjM1_12c9d0e8-1f45-4dc8-b056-bbf10673b11d">2,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia75e4b48aa6d46ac8cebd9bd97a2168b_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIyLTAtMS0xLTE5NjM1L3RleHRyZWdpb246YjljNjAwZjdiNTE3NGM2ZThmNTc2YjI5MzQyOTk1MDRfNA_1245a264-87fb-48e1-bed1-6d1103ccf548">2.8</ix:nonFraction>% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia75e4b48aa6d46ac8cebd9bd97a2168b_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIyLTEtMS0xLTE5NjM1_4d0d0d7c-b7f2-4aca-8053-371b1caf86b9">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6391c2fe51344c3b0267bc8490521b4_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIyLTMtMS0xLTE5NjM1_55318ba1-9885-4f8a-9e63-b59900c25521">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3f81ece57db84513aa5335f4b3d6ac08_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIzLTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZmM5Y2UzZGVkYTYxNGEzMmI3NmUzMWJhMTk1MzhiNzZfNA_cbf73771-81e3-4cf0-8779-2e2ea9dc6547">4</ix:nonFraction>% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f81ece57db84513aa5335f4b3d6ac08_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIzLTEtMS0xLTE5NjM1_4bdff1d0-f531-43e0-b0dd-ad2dfe6dedb4">414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea1808ecadc40d6ae18942dd91a82b4_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIzLTMtMS0xLTE5NjM1_c546d0e4-7c42-4710-9d54-4feb3f8e5652">414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i90b9d6ed5b7745dba7e056a1af581ada_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI0LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YWM1OWNlYTIwYjAyNGY1MjlhMjQxMDllYTU4ODQxY2FfNA_f5de9bf9-f35d-4352-9e86-06d667cbc1be">3.375</ix:nonFraction>% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90b9d6ed5b7745dba7e056a1af581ada_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI0LTEtMS0xLTE5NjM1_37fb7488-2508-4382-8d93-e29a148382d7">650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc98b0c5fe2c4b849511375a8a2ddc06_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI0LTMtMS0xLTE5NjM1_5c9d912f-e8eb-4198-99c1-918d76236c23">650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaeff74e546b24362a8ad306bbfe3bac2_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI1LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjZmOWQ1OTVlY2ZkNDY0YTliN2FmMWQ1MzI0NTgyYzVfNA_7777defe-1678-4824-8a93-3847aad4264f">2.625</ix:nonFraction>% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeff74e546b24362a8ad306bbfe3bac2_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI1LTEtMS0xLTE5NjM1_2fa6da57-be16-4d95-b00b-5217754cd61a">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia937c17cc45547f2b5ebc4e8a8bc29ad_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI1LTMtMS0xLTE5NjM1_9e4a42a0-0ffb-476b-850e-b1026356f140">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3df15a807dfe4bc393599d84bb5ae0b8_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI2LTAtMS0xLTE5NjM1L3RleHRyZWdpb246N2Q1Nzc0ZjVkMWE0NGNhN2I4NzU0OTY3ZTIxYmE1YmNfNA_f39fdf6c-9ef9-4c71-910e-02b280b5ee84">3.5</ix:nonFraction>% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3df15a807dfe4bc393599d84bb5ae0b8_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI2LTEtMS0xLTE5NjM1_7455ca00-a3f7-4c9c-9593-c114768b3017">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideb967d8ef3440d2aad2a3470fb2b109_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI2LTMtMS0xLTE5NjM1_a5245e5b-1848-48a9-abd3-c5ba4c5d625c">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5a6bf862703486796be7735801625f7_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI3LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YTJkNjc4OTI1MjJjNGVjMGIzYjE1MzU3YmZjY2QzZjNfNA_3ac8b6c8-d1af-47ac-9c09-edf3c94e4ce2">5</ix:nonFraction>% senior notes due December 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5a6bf862703486796be7735801625f7_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI3LTEtMS0xLTE5NjM1_b6c262e1-1fd8-419c-b334-d529622acb2b">299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02180112f1f84663b7aaefed8c65784d_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI3LTMtMS0xLTE5NjM1_9bfcb7f3-255c-4eca-970b-3751c5f387b0">299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida41dacc05104cc79603a44d10527e6f_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI4LTAtMS0xLTE5NjM1L3RleHRyZWdpb246NmU2ZGMyMjFiOGI4NDk4OGFiN2UwMjcyMTlhMTUwMDFfNA_e98cdaff-40f5-4c16-a0a4-edff8cc31f65">4.1</ix:nonFraction>% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida41dacc05104cc79603a44d10527e6f_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI4LTEtMS0xLTE5NjM1_5914551e-06da-43ac-8a37-e346a081c2ab">950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad98b34b91f2400e8d921831383f78ff_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI4LTMtMS0xLTE5NjM1_dcbf0aca-2e30-4cc4-8a32-2a2cd60104dd">950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5f70911c7434c7c9d30f3e9f6370e8f_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZWU4ODJjNDhjMGZhNGJkZjhhNGU4Y2U1MTEzZGI3NTNfNA_091ffb00-f31a-4e11-84af-61d8316c17ae">3.875</ix:nonFraction>% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f70911c7434c7c9d30f3e9f6370e8f_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI5LTEtMS0xLTE5NjM1_1523b6e9-194e-40b0-b17f-652cfe75bcf0">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib58d5abd3f97466997c356cc6d003abb_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI5LTMtMS0xLTE5NjM1_03636a60-9489-47bb-b92b-74577b942069">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i59b67f5f8f844ccc9ef30578495be520_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246N2Y1ZjdhZGNiYjFmNGQ0ZTgzZDkxYjM1OTFhMGYxMzJfNA_36bf964c-e647-412f-89b4-4acfa4c50a06">2.875</ix:nonFraction>% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59b67f5f8f844ccc9ef30578495be520_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMwLTEtMS0xLTE5NjM1_2581b30e-61df-45a5-82b0-9b886284ecd8">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1b1585ec2b24b72b0323f62ac998309_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMwLTMtMS0xLTE5NjM1_258e5a04-9e86-40b3-865e-66f3e6264dcc">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3bd90d57c71c40889aa14f074e72525d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMxLTAtMS0xLTE5NjM1L3RleHRyZWdpb246NTU1NDE0NzdkMzc2NDgzNTg0OTY3M2MzZDFlNTY0YTVfNA_c7f11fd6-766d-4289-ac34-db14b25df22d">3</ix:nonFraction>% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bd90d57c71c40889aa14f074e72525d_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMxLTEtMS0xLTE5NjM1_e242ce25-1542-4237-80e2-b7fdde66df91">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i196c3c3a85b54d0c823aea5345bb1b47_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMxLTMtMS0xLTE5NjM1_034a9993-fd0c-4167-b35c-0825f22391fd">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia31f8a1af0f74612b2137086a863b2f5_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMyLTAtMS0xLTE5NjM1L3RleHRyZWdpb246YTg1NTkwMTM0Mjk2NGNhODk2ZjMzZGM3YjRhOGVmNWRfNA_6360918f-27ce-4108-8bba-96bce1728b94">3.625</ix:nonFraction>% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia31f8a1af0f74612b2137086a863b2f5_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMyLTEtMS0xLTE5NjM1_eaeef7db-50e4-45c8-8204-d00d45c9c8a0">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e16f05ccac849f6b7239ceda71c5435_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMyLTMtMS0xLTE5NjM1_1a2ec139-bca9-407f-bba3-7c26cb73a0ae">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib01ceb33ad054c6a90191f9d95d44d72_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMzLTAtMS0xLTE5NjM1L3RleHRyZWdpb246M2FlOGYzNTQ4MTUyNDk0ZDkwYmFmY2QwNGM4ODhkMmFfNA_2184ec94-acb9-498f-a553-04cc9ec92696">6.25</ix:nonFraction>% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib01ceb33ad054c6a90191f9d95d44d72_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMzLTEtMS0xLTE5NjM1_5babb4fe-aa4c-4b0b-9931-019b45d6f301">372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e79f25e44ce4192aef42fac92e6ebba_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMzLTMtMS0xLTE5NjM1_2415e6dd-1e0d-4dbf-bbf4-418f50faad28">372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7dfa4017c31e4a769e1726240bec574a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM0LTAtMS0xLTE5NjM1L3RleHRyZWdpb246NTEwOTdjZmI2Yjg5NGFiYmExMmQzMDdmYjBmYWIyMDlfNA_d77e4b6c-0c04-47e4-9274-6c6e82ac0592">1.3</ix:nonFraction>% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfa4017c31e4a769e1726240bec574a_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM0LTEtMS0xLTE5NjM1_8d1a6b03-47bc-48f9-b97c-48557f79e232">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46f1a5a00e9349149a87d2a1ca48676d_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM0LTMtMS0xLTE5NjM1_16668e27-cc86-41bd-a5b4-4c3272ec688e">2,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9e941767d34940eb84521c5bead4b66d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM1LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YTNhMzY2N2YxYjM1NDllMmE5ZTcxOGYzZjNmYjIyOTRfNA_1ba3fc35-62fa-45f9-a9e6-d0f44528ac9f">4.3</ix:nonFraction>% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e941767d34940eb84521c5bead4b66d_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM1LTEtMS0xLTE5NjM1_4e0f8ad4-e16c-4ba6-b47c-5f699411dc72">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeff226b8f72491b84a7b76931939c6c_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM1LTMtMS0xLTE5NjM1_96d88726-d64e-4f75-a8ea-b2d5493ec9b1">7,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i829935f435f8417e9ebe4db76abf40d6_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM2LTAtMS0xLTE5NjM1L3RleHRyZWdpb246OWU5NThlNDllZTQ2NDcxMjg0MjRjZTQ1NzNlOTZlN2JfNA_9b1a9289-8916-40c5-b63c-58b8af166ac1">3.25</ix:nonFraction>% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i829935f435f8417e9ebe4db76abf40d6_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM2LTEtMS0xLTE5NjM1_d5c63735-488b-433d-ab1d-23e7394435bd">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9a0fde9614c415093ac05b5ccf09851_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM2LTMtMS0xLTE5NjM1_352a5526-6bb1-48a8-8114-5b8604bf66a9">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2383f6f259884a2ca2d37bfea6f7f9b1_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM3LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YzQyMDBjMjBlNTI1NGUzYjkyZWFmZDcyZjA0ODg3NTZfNA_af8a0964-978f-404b-95ea-92d6cbf09c06">3.75</ix:nonFraction>% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2383f6f259884a2ca2d37bfea6f7f9b1_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM3LTEtMS0xLTE5NjM1_8ebf3807-942e-4ea2-910f-26b9384158f5">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i963597ecd59945d0b5207daf0eb2b186_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM3LTMtMS0xLTE5NjM1_ee5332ac-b5a6-4076-b9c3-5e9eb744a073">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib90e1ba9c1fb44d496c2f63b444e51ab_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM4LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YmMyZGFmYzhhMDJlNDM0Njk0OTUxNTc5ODllNzYxOTFfNA_6c8ceca7-b7de-4b1b-bd6b-505c9dce38a1">1.75</ix:nonFraction>% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib90e1ba9c1fb44d496c2f63b444e51ab_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM4LTEtMS0xLTE5NjM1_218789ce-3882-487e-8e29-852ed74b156b">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a365c216d54612a53d69c5c0e80a5f_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM4LTMtMS0xLTE5NjM1_ef334dd4-3284-4472-b683-32dd56b7e917">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8c47829d25484ecdabdc89287f759465_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YjU3Zjc5MmIxYjBkNGUzZDhjZTFhYmI5NzU1YTU0OTZfNA_dd587e93-e607-46f0-8044-27df90434d7f">1.875</ix:nonFraction>% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c47829d25484ecdabdc89287f759465_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM5LTEtMS0xLTE5NjM1_5cf56346-9cfc-4420-b04d-6053f2424156">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fc01427e2da4fb88ab22fdc0b7e32fc_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM5LTMtMS0xLTE5NjM1_8ece5eb7-679f-469b-9f13-5f891b4a791f">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie6286228091e44d0a7a084cebf96e83d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQwLTAtMS0xLTIwNzM3L3RleHRyZWdpb246OTY4ZWNjM2FlYmYzNDQ2M2EyNmZhNjFkNjRkN2NjNGVfMTA5OTUxMTYyNzgyNg_35f6416d-2261-4508-8962-61fb6484e24a">2.125</ix:nonFraction>% senior notes due September 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6286228091e44d0a7a084cebf96e83d_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQwLTEtMS0xLTIwODAx_9d095400-4218-4a50-8013-521e846254af">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7974392fedf4d69b48cf73026d43053_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQwLTMtMS0xLTIwODI4_c6e99cfd-a2c6-46a2-89bf-cf0ab2407955">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i66d6bb918a1841c7b29b4e54eaff9002_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246YTlmYTk2ZDk0ZGYxNGYxN2FlY2FmYmI5OWM3OWY2ZjNfNA_d4a49f4d-d1bd-43f0-bf5d-cdb51513e247">4.875</ix:nonFraction>% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66d6bb918a1841c7b29b4e54eaff9002_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQwLTEtMS0xLTE5NjM1_3b1fe4db-4242-4112-ba37-11214bccaad8">652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22855f4f70944d80a431f1009d80d2d6_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQwLTMtMS0xLTE5NjM1_df0e546b-293b-40b5-ba6c-7e996895e932">652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6deef011e2dd4c96bd53333619f01231_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQxLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MWRjMzBkMTA0YTBmNDljOGE1ODNkMzA3Y2ZiZTI1YjFfNA_a2df4f2f-2ada-4a00-bcbd-55e0504448ae">6.625</ix:nonFraction>% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6deef011e2dd4c96bd53333619f01231_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQxLTEtMS0xLTE5NjM1_3051ec61-ef62-4b61-aa7f-ef54d4a46e87">771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie75ef397faf445d3a901e0af5e125899_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQxLTMtMS0xLTE5NjM1_a7856a97-b600-404d-94eb-138eb57c05a8">771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d9e820cbb5640bcaab284f7fdabd210_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQyLTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZDU3NmMzZjMzODIxNDJmNjkzYWEzNGRmM2I4MWQzN2ZfNA_14460d2e-c386-4c86-9ab7-25612f58b725">6.75</ix:nonFraction>% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d9e820cbb5640bcaab284f7fdabd210_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQyLTEtMS0xLTE5NjM1_2140a8d6-a126-4142-a103-01e06dcf7ea5">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic356af28bfd045ffa9174ee4741a3d1e_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQyLTMtMS0xLTE5NjM1_a816bb15-de65-40a3-9de8-07bbec900086">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if36b1314b05240d98146140634ecdbbc_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQzLTAtMS0xLTE5NjM1L3RleHRyZWdpb246NWUyOWExM2FlNmMyNDMzODgyNzExYmM0OTI4OTUwODZfNA_022eb6e5-6b4f-4089-a684-2c9920f1481b">4.78</ix:nonFraction>% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if36b1314b05240d98146140634ecdbbc_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQzLTEtMS0xLTE5NjM1_a6e9db67-7851-4dd6-95cb-11dedb161aab">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica522c18f13c411eae44d16f4d18ce20_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQzLTMtMS0xLTE5NjM1_d973db6b-8bee-4935-a238-da8f75282cde">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibedc3ae92ee24ab597438f089a05003c_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ0LTAtMS0xLTE5NjM1L3RleHRyZWdpb246M2JhNzcyNjYxOWQ1NDNmM2I3MzU5ZmQ3YmRhZjRkMjNfNA_ba59d202-b2d7-4ae0-86b1-538fe03f3ae4">6.125</ix:nonFraction>% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibedc3ae92ee24ab597438f089a05003c_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ0LTEtMS0xLTE5NjM1_4c55c3a7-dcd6-4e53-a5b8-8b5bd3dab63a">447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7ccf63bdf184cf98f51d95c1720b750_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ0LTMtMS0xLTE5NjM1_30cc8302-ad06-43dd-9384-e013c4e832d9">447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i66980e2699e94ff68df99ccb53d43a5d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ1LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YzYxZjc5YzhjZDU5NDg2NzkzY2UyODRlZTM4YzhmZTNfNA_5e024777-14d6-4231-9abc-15fef3c274b2">4.125</ix:nonFraction>% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66980e2699e94ff68df99ccb53d43a5d_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ1LTEtMS0xLTE5NjM1_a53876fa-eb8b-475b-b9f5-b466917d3bff">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59a1bba78be542ef8a8f0f0622414168_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ1LTMtMS0xLTE5NjM1_e837bcab-b0a3-424c-af48-c6be21c80794">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6b5f82fd2e9948249d51305151c10a0a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ2LTAtMS0xLTE5NjM1L3RleHRyZWdpb246Zjg4YjBlNTA0YTZkNDFkNWIwZjljMjAzYjg4ZmQwMThfNA_544fcdca-0db6-4af9-84b9-66b50357af6e">2.7</ix:nonFraction>% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b5f82fd2e9948249d51305151c10a0a_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ2LTEtMS0xLTE5NjM1_81510492-b238-48da-8996-57e99c8ef01f">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a3a26ae8b3f4d658d7d84e925e6932c_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ2LTMtMS0xLTE5NjM1_be8e5d35-e1e3-4de7-8aa3-44bccfffa04e">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iba9e24130d424bf7933c036abe3fcacf_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ3LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZWFkYTY0ZjYwMmQyNDc4OGIxNzRjMWE1NTBjYWEzNGFfNA_e94d5fac-5c49-444f-b96e-c21c2f80667f">5.75</ix:nonFraction>% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba9e24130d424bf7933c036abe3fcacf_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ3LTEtMS0xLTE5NjM1_134f19b9-d8f7-4574-b7f3-d53d90fbd265">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i731815b798d2445687a0b94d8984740b_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ3LTMtMS0xLTE5NjM1_52de2486-b8db-49e2-b247-1ed3ee44f0b1">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id78a04082f9f4d9abbc5e0508e3f4590_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ4LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZTQwN2Q0NmIyN2MwNDZmNWExMmQ3OTM1YWRkNTQxODFfNA_4375a82c-b40f-4bb5-8c71-b834c92fd429">4.5</ix:nonFraction>% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id78a04082f9f4d9abbc5e0508e3f4590_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ4LTEtMS0xLTE5NjM1_a75b66ca-0511-443a-8294-2c544236d2ea">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcbe63373aad4f449cf221d8fb8bed34_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ4LTMtMS0xLTE5NjM1_8d82d0ac-9ec7-46a9-a1d0-3d5cc0d68f22">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i08f395fb692848039e5b5e89cf899bd7_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YTQwMWZkNDkwMzgzNDkxNTkzY2Q1NzllMjYzZjBjMjBfNA_a33226d6-8325-4c39-86ee-f9cf6e7a42f4">4.125</ix:nonFraction>% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08f395fb692848039e5b5e89cf899bd7_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ5LTEtMS0xLTE5NjM1_fa2cf9e3-c5ca-4d7d-8d43-9bbd998ed765">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5872f67f264f4286ab44e43e24612b0d_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ5LTMtMS0xLTE5NjM1_10a227c9-4c26-4456-b507-3451fd3e9643">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie72908e23c3040c0a69888583cbcc793_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246NTgxMzMzNDYxYmFhNDM0NmIwYjI2MTRhYjU2MDllM2NfNA_85a7313b-ce74-41d6-8ea5-a6c6445a3838">5.3</ix:nonFraction>% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie72908e23c3040c0a69888583cbcc793_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUwLTEtMS0xLTE5NjM1_e292dfda-7190-48d0-8ce2-f258f710e948">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifed64cc823de43c7bf2f78098c4438cb_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUwLTMtMS0xLTE5NjM1_8e69bfcf-534e-41c1-bbd5-9d38c99b77db">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ba90e1b15f247189f65ef311ff3a5d8_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUxLTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZjQzNzhiZDFjZmM1NDFjNWE2NmY2NWY4YWNmY2RjZGRfNA_49493277-4ad0-4a5a-ba99-22b72fa3f94d">4.75</ix:nonFraction>% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ba90e1b15f247189f65ef311ff3a5d8_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUxLTEtMS0xLTE5NjM1_4ed75ca3-b348-40f1-a278-ba125f4b56e9">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i369332f01d914260ad39bb9f3745585c_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUxLTMtMS0xLTE5NjM1_8aa58304-7cca-46d4-88cd-e20367548fcd">375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i189a6cf6ec97415ea1727e01c3f51404_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUyLTAtMS0xLTE5NjM1L3RleHRyZWdpb246Yjk2MzdmMTQ5NTBhNDU5ZmJiMTIxNmZjMTUwNzYwNDBfNA_d39ea20a-d565-432d-bd3b-f6e5d9614f13">5.125</ix:nonFraction>% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i189a6cf6ec97415ea1727e01c3f51404_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUyLTEtMS0xLTE5NjM1_57374eba-bfd7-4198-89ab-d8ed610afbf5">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4a2069eda0d49ae856f3a624d3da473_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUyLTMtMS0xLTE5NjM1_f0e13dd2-234b-45a5-a662-51c610ee8bc8">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2e79648650b54806a91c3d411f2ea35c_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUzLTAtMS0xLTE5NjM1L3RleHRyZWdpb246YjdkZTI4MTA3MWIyNGVlZjgzNDY1MWQ2NTYwMGUxMGZfNA_a45c63f8-e62b-4ad9-834a-d3789e01e547">3.875</ix:nonFraction>% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e79648650b54806a91c3d411f2ea35c_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUzLTEtMS0xLTE5NjM1_a0e9acc5-9eca-4d62-903b-6784fc1f452b">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e6ba14d8ad442b0b834bdfbf7a454bf_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUzLTMtMS0xLTE5NjM1_e0a58aed-35c2-4430-92be-2a0af76af304">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8c6e0f8b2d6a4e219ead75b3e364997a_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU0LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjY1YTExZGUzYTcwNDllM2JiMzY5ZWFmMTNiYjdkOTlfNA_6d39105d-186f-45a1-939b-ca387f8c2bb2">5.05</ix:nonFraction>% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c6e0f8b2d6a4e219ead75b3e364997a_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU0LTEtMS0xLTE5NjM1_cd3e04fc-5b49-40ff-a76b-65307e3e2d29">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67abdddccc3d4638bf07489a3670086b_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU0LTMtMS0xLTE5NjM1_8240c4a8-02de-4789-bc9e-3fa530448f22">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i301c0abd44f8465691076dc9cc3fae50_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU1LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YzQ5OGIyM2ZlZmQyNDA3Njg2MWE4MTc4ZDEyYWVjMWVfNA_0e3942fd-867e-4957-834a-f42975f08bac">4.25</ix:nonFraction>% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i301c0abd44f8465691076dc9cc3fae50_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU1LTEtMS0xLTE5NjM1_f5bab5d7-ae48-4af4-a37f-42f70b984884">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73fa3cf6a6e94e878b2a4e89d3fa5283_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU1LTMtMS0xLTE5NjM1_71ebd14e-325e-41df-a1d0-56f9ace57a94">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTAtMS0xLTE5NjM1_55ac48cb-f36e-4b9d-8b69-3e86d1c383ef"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTAtMS0xLTE5NjM1_fc260d98-5cca-40f0-8e2a-2fb2b3ac6249">Finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTEtMS0xLTE5NjM1_eaa71fe3-07b4-4caf-ac18-da82465a2248">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTMtMS0xLTE5NjM1_915f2e11-66eb-4d4a-a54f-372f0f52b93d">1,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i014942cdefe642299553301bde433b97_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU3LTEtMS0xLTE5NjM1_15ad3ad6-5bfc-4277-bbff-d3c02e74bd5e">320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46529d5778ae40bb990d932509dbac03_I20201231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU3LTMtMS0xLTE5NjM1_8497a552-3805-42fd-83fc-a5ade171ef7f">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:LongtermDebtGrossAndLeaseObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU4LTEtMS0xLTE5NjM1_6e096837-3e0c-4d0c-9ae9-e3bc07368c16">56,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:LongtermDebtGrossAndLeaseObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU4LTMtMS0xLTE5NjM1_4ca00125-0075-4946-b496-4a3d58c622df">65,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU5LTEtMS0xLTE5NjM1_9740e1f0-337a-4b50-974a-7ae084dd56e2">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU5LTMtMS0xLTE5NjM1_9b9e63d4-e356-4aee-9b93-9e682f248b30">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzYwLTEtMS0xLTE5NjM1_236eb5e5-f6b3-4663-af96-0f516769cadd">786</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzYwLTMtMS0xLTE5NjM1_840e7aad-736d-4a88-9631-88ddc201987c">909</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzYxLTEtMS0xLTE5NjM1_bc3800e2-2322-409a-b57f-f322c100a67e">56,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzYxLTMtMS0xLTE5NjM1_cac595ea-3a8d-4a8d-a1a5-9d924fa43c75">64,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzY0LTEtMS0xLTE5NjM1_6bf808ad-6e9e-4f47-b520-5d516c4e1165">4,205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzY0LTMtMS0xLTE5NjM1_0971eb8c-fa05-43ec-92a4-8f86c8a8860d">5,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzY1LTEtMS0xLTE5NjM1_ca4e1c17-8921-44b9-9412-80e8ff5d92ed">51,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzY1LTMtMS0xLTE5NjM1_9eaf23e6-0277-40fb-b0f9-ee587333aacd">59,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7ca9c37b8cbd4aaabd23c585c7599757" continuedAt="i1294b4e9a7c940d1ae3351ea8ed5fef9"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzgwMTc_8dbe4983-9f76-4d19-9405-7b62838b5e25" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s required repayments of debt principal due during each of the next five&#160;years and thereafter, as of December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzEtMS0xLTEtMTk2MzU_d4f9958a-8e72-4bed-a56c-37a66d10f840">4,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzItMS0xLTEtMTk2MzU_bcb58a17-e61a-4b6d-949f-badf0cc06101">1,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzMtMS0xLTEtMTk2MzU_54b86650-0c95-4a58-b083-7eeab7be56ee">2,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzQtMS0xLTEtMTk2MzU_4b6e7951-ca2b-4639-87d7-d39ad26d6430">3,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzUtMS0xLTEtMTk2MzU_9128ae42-d234-4ec3-824d-70f1e70c03a0">2,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzYtMS0xLTEtMTk2MzU_4a504396-ec0e-4ed7-befd-5308d0b870ea">40,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzctMS0xLTEtMTk2MzU_f70eae16-c586-4c4f-b122-aa06b5fa8374">55,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzgtMS0xLTEtMTk2MzU_eaa71fe3-07b4-4caf-ac18-da82465a2248">1,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:LongtermDebtGrossAndLeaseObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzktMS0xLTEtMTk2MzU_9713317c-7ff2-43da-b3a4-fbe7dd421547">56,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for a summary of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">maturities of the Company&#8217;s finance lease liabilities.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper and Back-up Credit Facilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did <ix:nonFraction unitRef="usd" contextRef="i96887b3ac58640beb52a82bd21eb813a_I20211231" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzQ4Mg_f8481535-772b-418a-8c0f-2ec2c8821cca">no</ix:nonFraction>t have any commercial paper outstanding as of December 31, 2021 or 2020. In connection with its commercial paper program, the Company maintains a $<ix:nonFraction unitRef="usd" contextRef="ie9cad6a94a214f4bbea75d3fac5eaaa9_I20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzgwOA_b3b8c069-e154-4350-8740-e046f6b854d8">2.0</ix:nonFraction> billion, <ix:nonNumeric contextRef="i0889c6d0f22449efaf79e5043bc52d47_D20210101-20211231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzgwMjg_58aee847-e40c-4027-b9d1-884aba8994d9">five-year</ix:nonNumeric> unsecured back-up revolving credit facility, which expires on May 17, 2023, a $<ix:nonFraction unitRef="usd" contextRef="i006c485c30a0471dac8a843ae0803178_I20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzkwMQ_5cdf4c45-bf3c-4a2d-b15d-c37b0e012be9">2.0</ix:nonFraction> billion, <ix:nonNumeric contextRef="i54d42741e9a84f52af2882db08c58b47_D20210101-20211231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzc5ODk_a6ea6a7d-5e24-490c-b165-51f6b5629239">five-year</ix:nonNumeric> unsecured back-up revolving credit facility, which expires on May 16, 2024, and a $<ix:nonFraction unitRef="usd" contextRef="ib44b6fdea84a4c50aac9b470b1ca8124_I20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2MzgzMjU_9dab7c39-56ad-4f3b-9c10-35290dd7e13c">2.0</ix:nonFraction> billion, <ix:nonNumeric contextRef="i6d78ef11f57e4edfa8419e4be3cfac0b_D20210101-20211231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzMyOTg1MzQ5MDM5ODQ_ea307430-b01b-4808-84d6-5928f71c38c1">five-year</ix:nonNumeric> unsecured back-up revolving credit facility, which expires on May 11, 2026. The credit facilities allow for borrowings at various rates that are dependent, in part, on the Company&#8217;s public debt ratings and require the Company to pay a weighted average quarterly facility fee of approximately <ix:nonFraction unitRef="number" contextRef="i4daa4bf26a7e4ba985ffd4fefd569f08_D20210101-20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEyMDU_7fb68130-b4eb-4f0b-b65c-1b73c12fbfb9">0.03</ix:nonFraction>%, regardless of usage. As of December&#160;31, 2021 and 2020, there were <ix:nonFraction unitRef="usd" contextRef="i5b91388b635e423cafe7fb2c8c8f40f5_I20201231" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEyNTg_8ba6fddb-b7dc-4782-8bfc-fcaec8904f85"><ix:nonFraction unitRef="usd" contextRef="i6c07b91fc15c48388a8d68005ad93a4b_I20211231" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEyNTg_98167d72-b9b9-4762-9e4c-ed2a0594bac4">no</ix:nonFraction></ix:nonFraction> borrowings outstanding under any of the Company&#8217;s back-up credit facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A subsidiary of the Company is a member of the FHLBB. As a member, the subsidiary has the ability to obtain cash advances, subject to certain minimum collateral requirements. The maximum borrowing capacity available from the FHLBB as of December&#160;31, 2021 was approximately $<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE2NzQ_19044dfe-add9-469a-be5c-e0520a67050b">995</ix:nonFraction> million. At both December&#160;31, 2021 and 2020, there were <ix:nonFraction unitRef="usd" contextRef="i3d1e81300be74367a642cc8e00fcf76c_I20211231" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE3MDg_b7ba726c-5288-4c87-93ec-167869f494be"><ix:nonFraction unitRef="usd" contextRef="i03fc12d9dcc14bec980f92dcfea940fd_I20201231" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE3MDg_c958c82b-091b-4c7e-99ac-f0ab013a1f89">no</ix:nonFraction></ix:nonFraction> outstanding advances from the FHLBB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 18, 2021, the Company issued $<ix:nonFraction unitRef="usd" contextRef="ib06d0888e42f4a7f9d3dd17b79f3d08d_I20210818" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDIyNTg_3d732491-594c-4398-9eb7-7b932a315047">1.0</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ib06d0888e42f4a7f9d3dd17b79f3d08d_I20210818" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDIyNzM_9b82a038-21e2-4d9e-92ce-a9d25f2cbda5">2.125</ix:nonFraction>% unsecured senior notes due September 15, 2031 for total proceeds of $<ix:nonFraction unitRef="usd" contextRef="i2a2c1f6bdf614434afbf804874bfc4c5_D20210818-20210818" decimals="-6" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDIyODI_006a7ece-f39b-4ede-98d5-f26d509b41c4">987</ix:nonFraction>&#160;million, net of discounts, underwriting fees and offering expenses. The net proceeds of this offering were used for the purchase of senior notes in connection with the Company&#8217;s cash tender offer in August 2021 as described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="if4ec5d2a13b34d5b970af83c0b03a435_I20201216" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE4MjM_07ef0088-d57d-420f-9635-0987522d53ed">750</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="if4ec5d2a13b34d5b970af83c0b03a435_I20201216" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE4NTY_b556cdd0-4497-4d3e-ad5f-7c7c7310d225">1.3</ix:nonFraction>% unsecured senior notes due August 21, 2027 and $<ix:nonFraction unitRef="usd" contextRef="i94cc0d983ab94bde8b7090b07fa45718_I20201216" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE5MDY_81a52418-e2e8-4645-bbd3-3bac0f23879e">1.25</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i94cc0d983ab94bde8b7090b07fa45718_I20201216" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE5Mzk_11415f82-74e5-40da-8a1d-70918b4c35d3">1.875</ix:nonFraction>% unsecured senior notes due February 28, 2031 for total proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="ibd90a04249054ea4ad16eada8a0b09f2_D20201216-20201216" decimals="-7" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzIwMjM_00476b1b-5f18-48ce-9b4d-0ab7838efc2a">1.99</ix:nonFraction>&#160;billion, net of discounts and underwriting fees. The $<ix:nonFraction unitRef="usd" contextRef="if4ec5d2a13b34d5b970af83c0b03a435_I20201216" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzIwNzE_6e9ee254-ee2e-40c9-b3cc-c21f55e4af98">750</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="if4ec5d2a13b34d5b970af83c0b03a435_I20201216" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzIxMDQ_b556cdd0-4497-4d3e-ad5f-7c7c7310d225">1.3</ix:nonFraction>% unsecured senior notes represent a further issuance of the Company&#8217;s <ix:nonFraction unitRef="number" contextRef="if4ec5d2a13b34d5b970af83c0b03a435_I20201216" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzM4NDgyOTA3MTc4OTM_56176a31-18df-42b3-ab5c-7ec80151ebc7">1.3</ix:nonFraction>% unsecured senior notes due August 21, 2027 initially issued in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="id52f5d9f143f42e29ddaadb1b8837a16_I20200821" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzIyNzU_183d7b18-e5d6-4543-af9f-b019e54cd666">1.5</ix:nonFraction>&#160;billion on August 21, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 21, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="id52f5d9f143f42e29ddaadb1b8837a16_I20200821" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzIzMzg_183d7b18-e5d6-4543-af9f-b019e54cd666">1.5</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="id52f5d9f143f42e29ddaadb1b8837a16_I20200821" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzIzNzE_2f3ec7be-45ca-40e3-9987-1fb24c019415">1.3</ix:nonFraction>% unsecured senior notes due August 21, 2027, $<ix:nonFraction unitRef="usd" contextRef="idce8059065244c0699beb758c0989a41_I20200821" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI0MTg_1fbbba77-12a2-48ef-bca2-902c7a7201df">1.25</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="idce8059065244c0699beb758c0989a41_I20200821" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI0NTE_88ec4589-6038-4d15-b63a-c003f950a280">1.75</ix:nonFraction>% unsecured senior notes due August 21, 2030 and $<ix:nonFraction unitRef="usd" contextRef="i529043993c644dd8aac8807ee5d2c7c0_I20200821" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI1MDE_8b288d33-e67a-4efa-8555-4506e3482740">1.25</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i529043993c644dd8aac8807ee5d2c7c0_I20200821" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI1MzQ_9a0f3d12-d456-492d-b447-a2ebbc178c9e">2.7</ix:nonFraction>% unsecured senior notes due August 21, 2040 (collectively, the &#8220;August 2020 Notes&#8221;) for total proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i8afcc1e6458e4e11b0ded455489215ee_D20200821-20200821" decimals="-7" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI2NTY_7ed1fe2e-3046-4ea2-ad37-719ecbe888fc">3.97</ix:nonFraction>&#160;billion, net of discounts and underwriting fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2020, the Company issued $<ix:nonFraction unitRef="usd" contextRef="if63aa33153fe4482bfd5fceb634e5359_I20200331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI3Mzk_bb6b234d-77cc-48c2-bb14-4aa09e869158">750</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="if63aa33153fe4482bfd5fceb634e5359_I20200331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI3NzI_a0b13ac9-88e7-486c-bfb5-3d254bbf4169">3.625</ix:nonFraction>% unsecured senior notes due April 1, 2027, $<ix:nonFraction unitRef="usd" contextRef="i86d4fa4ab95046118e795a12d33f7b88_I20200331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI4MTc_a92c8442-7e0a-46cd-af50-77187f8d9126">1.5</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="i86d4fa4ab95046118e795a12d33f7b88_I20200331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI4NTA_91fc7dc3-4ebf-417d-bc5b-310381858a14">3.75</ix:nonFraction>% unsecured senior notes due April 1, 2030, $<ix:nonFraction unitRef="usd" contextRef="ie826ee2c5ef840c18914ca3433d41756_I20200331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI4OTU_3875a13d-a3cb-4c81-866e-27d7dfe06f32">1.0</ix:nonFraction>&#160;billion aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ie826ee2c5ef840c18914ca3433d41756_I20200331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI5Mjg_fb74747c-9aff-40b4-87f3-a0e58e7dc0b8">4.125</ix:nonFraction>% unsecured senior notes due April 1, 2040 and $<ix:nonFraction unitRef="usd" contextRef="ib4fae0970ac644b7a0ad3a6efb7c6d19_I20200331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI5NzY_bd2a18d5-1c37-453f-a13a-060217b05d3c">750</ix:nonFraction>&#160;million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ib4fae0970ac644b7a0ad3a6efb7c6d19_I20200331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzMwMDk_98263f88-301a-4426-9265-26277284913e">4.25</ix:nonFraction>% </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1294b4e9a7c940d1ae3351ea8ed5fef9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unsecured senior notes due April 1, 2050 (collectively, the &#8220;March 2020 Notes&#8221;) for total proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="iacc2ab2c48914d7f9b06a37e300d7eb8_D20200101-20200331" decimals="-7" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzMxMjg_a37c1e51-324c-429d-a914-93fdd2d2f38d">3.95</ix:nonFraction>&#160;billion, net of discounts and underwriting fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds of these offerings were used for general corporate purposes, which may include working capital, capital expenditures, as well as the repurchase and/or repayment of indebtedness.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2020, the Company entered into several interest rate swap transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of the March 2020 Notes. In connection with the issuance of the March 2020 Notes, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $<ix:nonFraction unitRef="usd" contextRef="i18bedffd3ee14bd4b98e02cbf1196a0c_D20200101-20200331" decimals="-6" name="us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzM4NTY_a8724d46-5e91-4ed0-b425-59dd1bce7388">7</ix:nonFraction>&#160;million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $<ix:nonFraction unitRef="usd" contextRef="i18bedffd3ee14bd4b98e02cbf1196a0c_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzM5NTA_14a53352-e71c-4ebb-986d-c9b06689f5e8">5</ix:nonFraction>&#160;million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the March 2020 Notes. See Note 13 &#8216;&#8216;Other Comprehensive Income&#8217;&#8217; for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Early Extinguishments of Debt</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company redeemed for cash the remaining $<ix:nonFraction unitRef="usd" contextRef="i149ae25cc3b64a2f92739b6ff6dac510_D20211201-20211231" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE2NDkyNjc0NjAxNDA_6945710b-6751-4693-b09c-14f72a798284">2.3</ix:nonFraction>&#160;billion of its outstanding <ix:nonFraction unitRef="number" contextRef="icd0ee6924ea342c4a56038c2e5e18a64_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE2NDkyNjc0NjAxNTU_03a15c60-d9c8-41f8-8068-543dec6519d8">3.7</ix:nonFraction>% senior notes due 2023. In connection with the early redemption of such senior notes, the Company paid a make-whole premium of $<ix:nonFraction unitRef="usd" contextRef="i5f0b12ab5b464e1496ae54d1e5e61e87_D20211201-20211231" decimals="INF" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE2NDkyNjc0NjAxNjM_1946ec4b-d16a-46c0-91ce-79c5f7df0284">80</ix:nonFraction> million in excess of the aggregate principal amount of the senior notes that were redeemed, wrote-off $<ix:nonFraction unitRef="usd" contextRef="i5f0b12ab5b464e1496ae54d1e5e61e87_D20211201-20211231" decimals="-6" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE2NDkyNjc0NjAxNjU_fb98f9d3-36a0-47ad-82b2-14247cf09713">8</ix:nonFraction> million of unamortized deferred financing costs and incurred $<ix:nonFraction unitRef="usd" contextRef="i5f0b12ab5b464e1496ae54d1e5e61e87_D20211201-20211231" decimals="-6" name="cvs:DebtExtinguishmentFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE2NDkyNjc0NjAxNjc_a0e09f65-4af4-446e-bc9a-3292ffaa7f6b">1</ix:nonFraction> million in fees, for a total loss on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="i5f0b12ab5b464e1496ae54d1e5e61e87_D20211201-20211231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE2NDkyNjc0NjAxNjk_f35e99f5-ee0a-4055-9e98-fcf2dc047952">89</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company purchased approximately $<ix:nonFraction unitRef="usd" contextRef="i53460cbad4244ab5955cd283bcde34d7_D20210801-20210831" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDIxOTk_69caecda-b76c-4a44-b421-ed5a931ffb22">2.0</ix:nonFraction>&#160;billion of its outstanding <ix:nonFraction unitRef="number" contextRef="i276b01d57f2045d0a76f58a233e35d9f_I20210831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDIyMTQ_fce7349e-bb5f-440f-a2d1-291ec2f9285c">4.3</ix:nonFraction>% senior notes due 2028 through a cash tender offer. In connection with the purchase of such senior notes, the Company paid a premium of $<ix:nonFraction unitRef="usd" contextRef="i39b25004923a449c988737a1efdfe4c5_D20210801-20210831" decimals="INF" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDIyMjE_fba7d30e-4b09-4590-94dd-de710d534571">332</ix:nonFraction> million&#160;in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $<ix:nonFraction unitRef="usd" contextRef="i39b25004923a449c988737a1efdfe4c5_D20210801-20210831" decimals="-6" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDIyMjg_d14f983d-ee27-49c3-9533-3869c40fb82e">26</ix:nonFraction>&#160;million of unamortized deferred financing costs and incurred $<ix:nonFraction unitRef="usd" contextRef="i39b25004923a449c988737a1efdfe4c5_D20210801-20210831" decimals="-6" name="cvs:DebtExtinguishmentFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYwNDczMTM5NjcyOTE_11641377-ef9f-4f2f-b321-2d947e598a2d">5</ix:nonFraction>&#160;million in fees, for a total loss on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="i39b25004923a449c988737a1efdfe4c5_D20210801-20210831" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDIyNDM_c7659ea5-cec2-4111-b7d2-18c0d5077d8a">363</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company purchased $<ix:nonFraction unitRef="usd" contextRef="i82ee6a03a2f04ee8b61b452feff3664b_D20201201-20201231" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU0NDI_ab8b5208-773f-4e78-b95d-79aee0342b5e">4.5</ix:nonFraction>&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $<ix:nonFraction unitRef="usd" contextRef="i2a7bb6963c09454281cf0360dcec5944_D20201201-20201231" decimals="-6" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU1NTY_6fa42455-d316-4cc9-8a7b-1bb31a2dab3e">113</ix:nonFraction>&#160;million of its <ix:nonFraction unitRef="number" contextRef="icea1808ecadc40d6ae18942dd91a82b4_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU1NjY_70f034c9-9ca1-4c82-aaf7-ea3e96319273">4.0</ix:nonFraction>% senior notes due 2023, $<ix:nonFraction unitRef="usd" contextRef="ie4644ff08f014f1b9eb1fa8df30f2d1d_D20201201-20201231" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU1OTI_b7323a00-2ed4-4ed1-b7df-e75234c5e0ab">1.4</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="i4acc5bb45f824af59b9b441ae8323056_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU2MDI_4c88a56c-1d61-4889-8c6d-703b0ed3067f">3.7</ix:nonFraction>% senior notes due 2023, $<ix:nonFraction unitRef="usd" contextRef="i72ca6906eceb40d5b6a9866cb6f06416_D20201201-20201231" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU2Mjg_54f15ca4-e1d0-4b07-b4e1-86d201a2e6f3">1.0</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="iad98b34b91f2400e8d921831383f78ff_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU2Mzg_864b32ee-8915-41fb-8c0e-efc0ad1ceab4">4.1</ix:nonFraction>% senior notes due 2025 and $<ix:nonFraction unitRef="usd" contextRef="i7ac0d8f26f1643619504cfda7d91bffd_D20201201-20201231" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU2Njc_fd52d78e-0f98-4015-9f63-a6ca34868670">2.0</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="i4b86af123f0342d4a6104d4be9148913_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU2Nzc_cffebc7d-1f24-49d2-94cb-fa5da1a31e47">4.3</ix:nonFraction>% senior notes due 2028. In connection with the purchase of such senior notes, the Company paid a premium of $<ix:nonFraction unitRef="usd" contextRef="ia73567778f2f4e638670d5dc29eefd86_D20201201-20201231" decimals="INF" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU3ODc_c716fec7-5949-45aa-a459-f1c1cc5afea2">619</ix:nonFraction>&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $<ix:nonFraction unitRef="usd" contextRef="ia73567778f2f4e638670d5dc29eefd86_D20201201-20201231" decimals="-6" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU4ODU_b1949adb-f4f0-46b6-80da-885755e2aaaf">45</ix:nonFraction>&#160;million of unamortized deferred financing costs and incurred $<ix:nonFraction unitRef="usd" contextRef="ia73567778f2f4e638670d5dc29eefd86_D20201201-20201231" decimals="-6" name="cvs:DebtExtinguishmentFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU5NDE_638694bd-a40a-4bc1-a7fd-f2757124d28f">10</ix:nonFraction>&#160;million in fees, for a total loss on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="ia73567778f2f4e638670d5dc29eefd86_D20201201-20201231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYwMDU_f41cebca-e001-4d6c-bc28-8c5a23344c15">674</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company purchased $<ix:nonFraction unitRef="usd" contextRef="i2b3cb303f4194f528bfb52cc092455a7_D20200801-20200831" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYwNDg_f8dab376-660a-4e14-8fd8-c32ea7da1a3e">6.0</ix:nonFraction>&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $<ix:nonFraction unitRef="usd" contextRef="i67806e913a8940939ff3cb535bf4e3a6_D20200801-20200831" decimals="-6" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYxNjI_04bd086b-5cbc-48bf-a612-87c3af211b56">723</ix:nonFraction>&#160;million of its <ix:nonFraction unitRef="number" contextRef="i2e64a0aea79e4b548c70ee282eaf1af6_I20200831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYxNzI_d6ab33ac-7ac7-4400-8208-cf24a2ff86b9">4.0</ix:nonFraction>% senior notes due 2023, $<ix:nonFraction unitRef="usd" contextRef="ie519cc2420df4c91a4824dffc41155eb_D20200801-20200831" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYxOTg_32d52c2e-f4d6-49dc-8125-601ebbc7636d">2.3</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="ifb5f940a259047c798edf06df3e9a282_I20200831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYyMDg_7d52b654-039c-4bdd-82c0-86bc9d0df1d2">3.7</ix:nonFraction>% senior notes due 2023 and $<ix:nonFraction unitRef="usd" contextRef="i0c074aa9c6834d2497da9aa3b1bf52d1_D20200801-20200831" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYyMzc_a1890b72-83e0-4003-b39b-ba8fed92db68">3.0</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="ib61285362251444c8c2bfd25138ec3a5_I20200831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYyNDc_b7ca28e9-0a11-4f39-9fe1-71c9e2df9671">4.1</ix:nonFraction>% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $<ix:nonFraction unitRef="usd" contextRef="id4d09fbb1bb54cb382bf1b47e6f77cce_D20200801-20200831" decimals="INF" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYzNTc_0191a5fb-5a75-4fcf-8124-c8dc3b88d1a3">706</ix:nonFraction>&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $<ix:nonFraction unitRef="usd" contextRef="id4d09fbb1bb54cb382bf1b47e6f77cce_D20200801-20200831" decimals="-6" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzY0NTU_25686a15-fae2-47ce-9cdc-e33e1db5775e">47</ix:nonFraction>&#160;million of unamortized deferred financing costs and incurred $<ix:nonFraction unitRef="usd" contextRef="id4d09fbb1bb54cb382bf1b47e6f77cce_D20200801-20200831" decimals="-6" name="cvs:DebtExtinguishmentFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzY1MTE_5ea9b2dd-c9fb-491d-bd63-c85e35f0829a">13</ix:nonFraction>&#160;million in fees, for a total loss on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="id4d09fbb1bb54cb382bf1b47e6f77cce_D20200801-20200831" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzY1NzU_3c8bc8b7-683e-4003-ac13-f3b4779caf2f">766</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, the Company purchased $<ix:nonFraction unitRef="usd" contextRef="i362f2c27267d4320a08ef6b47fda9bc1_D20190801-20190831" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQxOTY_2b2bda18-0d58-4c9d-b1bc-f1c5f0af78b3">4.0</ix:nonFraction>&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $<ix:nonFraction unitRef="usd" contextRef="if5d47a67418245f7b61330d02abc51c3_D20190801-20190831" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQyMTE_7aa8f484-f403-4a94-8ca9-f660e95232a2">1.3</ix:nonFraction>&#160;billion of its <ix:nonFraction unitRef="number" contextRef="i4b1b35e1f5e04251b8abbf5474581c4c_I20190831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQyMjY_28a4c85a-efa5-4bae-b981-da35b0df0405">3.125</ix:nonFraction>% senior notes due 2020, $<ix:nonFraction unitRef="usd" contextRef="ia9179b36d9334dc682bda5ab696933e3_D20190801-20190831" decimals="-6" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzMyOTg1MzQ5MDIwMTE_cb84381b-6ae1-4e52-86bf-94338bf65c79">723</ix:nonFraction>&#160;million of its floating rate notes due 2020, $<ix:nonFraction unitRef="usd" contextRef="i32d5285ef7b24b989560ef483b6354fe_D20190801-20190831" decimals="-6" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQyMzc_c5c9907c-1450-4939-9c8a-569731493711">328</ix:nonFraction>&#160;million of its <ix:nonFraction unitRef="number" contextRef="i08a8d0eb8ca548e48203788144525a13_I20190831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQyNTI_9934796f-6f20-4d65-ba73-efde477107df">4.125</ix:nonFraction>% senior notes due 2021, $<ix:nonFraction unitRef="usd" contextRef="icc7d49779e63442cafbb5b988ec993dd_D20190801-20190831" decimals="-6" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQyNjE_4cf09c10-918e-4920-8f34-ed82b8f9ddd8">297</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="ib08d4d156b344abfbbdb0a987bffa850_I20190831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQyNzY_2249407d-d0e8-410e-9381-b45f524eb243">4.125</ix:nonFraction>% senior notes due 2021 issued by Aetna Inc. (&#8220;Aetna&#8221;), $<ix:nonFraction unitRef="usd" contextRef="ia80bef5306614fe7bc79d4a80fdd7a83_D20190801-20190831" decimals="-6" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQyODY_44f6be25-ad94-46e1-813e-70cf49891d90">413</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="ie617a7b5c5cd46409dcd4dd2149324f8_I20190831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQzMDE_f905f65d-c064-432b-b368-e6760d6a3fbd">5.45</ix:nonFraction>% senior notes due 2021 issued by Coventry Health Care, Inc., a wholly-owned subsidiary of Aetna, and $<ix:nonFraction unitRef="usd" contextRef="iad60f7a1628244d2a8b435b05fc44593_D20190801-20190831" decimals="-6" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQzMDk_d9e532b5-ef3d-4b4a-91c3-854dc8efb7bf">962</ix:nonFraction>&#160;million of its <ix:nonFraction unitRef="number" contextRef="if1e7d725090f4e1cbead4dffeddf31c7_I20190831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQzMjQ_9962cc29-2720-4b66-89a4-0eaa379120b8">3.35</ix:nonFraction>% senior notes due 2021. In connection with the purchase of such senior notes, the Company paid a premium of $<ix:nonFraction unitRef="usd" contextRef="i03679feac9004c3babd99a1e76970bde_D20190801-20190831" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQzMzI_e2bc098e-5882-47d6-9b0c-bcb965b0ecf2">76</ix:nonFraction>&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, incurred $<ix:nonFraction unitRef="usd" contextRef="i03679feac9004c3babd99a1e76970bde_D20190801-20190831" decimals="-6" name="cvs:DebtExtinguishmentFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzMyOTg1MzQ5MDE5OTg_bd682bb1-44bd-42bb-97fc-4e3add32d6c2">8</ix:nonFraction>&#160;million in fees and recognized a net gain of $<ix:nonFraction unitRef="usd" contextRef="i03679feac9004c3babd99a1e76970bde_D20190801-20190831" decimals="-6" name="cvs:NetGainFromWriteOffOfDeferredDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQzNTA_1e234789-40c2-4ab3-96cc-ad9472dabce8">5</ix:nonFraction>&#160;million on the write-off of net unamortized deferred financing premiums, for a net loss on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="i03679feac9004c3babd99a1e76970bde_D20190801-20190831" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQzNjM_10d2d067-81e6-4331-a8fa-deebf966d4d1">79</ix:nonFraction>&#160;million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s back-up revolving credit facilities, unsecured senior notes and unsecured floating rate notes contain customary restrictive financial and operating covenants. These covenants do not include an acceleration of the Company&#8217;s debt maturities in the event of a downgrade in the Company&#8217;s credit ratings. The Company does not believe the restrictions contained in these covenants materially affect its financial or operating flexibility. As of December&#160;31, 2021, the Company was in compliance with all of its debt covenants.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_154"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19.5pt"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODU3_2dc42c37-ae54-4d5c-a330-ed230c114f59" continuedAt="i744f6850e33347ebbbecfc03efe4b178" escape="true">Pension Plans and Other Postretirement Benefits</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i744f6850e33347ebbbecfc03efe4b178" continuedAt="ia433f64921354e16bc9eb238f3506470"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company sponsors several active 401(k) savings plans that cover all employees who meet plan eligibility requirements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes matching contributions consistent with the provisions of the respective plans. At the participant&#8217;s option, account balances, including the Company&#8217;s matching contribution, can be invested among various investment options under each plan. The CVS Health Future Fund 401(k) Plan offers CVS Health Corporation&#8217;s common stock fund as an investment option. The Company also maintains nonqualified, unfunded deferred compensation plans for certain key employees. The plans provide participants the opportunity to defer portions of their eligible compensation and for certain nonqualified plans, participants receive matching contributions equivalent to what they could have received under the CVS Health Future Fund 401(k) Plan absent certain restrictions and limitations under the Internal Revenue Code. The Company&#8217;s contributions under its defined contribution plans were $<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwOTQ_9031425c-af99-4273-89ce-905e0b80ea10">552</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwOTg_7562583a-d3d3-4fc4-af1c-2e97e2036be7">520</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExMDU_972384aa-7026-4317-b14f-1e08e7875569">550</ix:nonFraction> million in the years ended December&#160;31, 2021, 2020 and 2019, respectively. The Company&#8217;s contributions for the year ended December 31, 2019 include contributions to the Aetna 401(k) Plan, which was merged into the CVS Health Future Fund 401(k) Plan on January 1, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Benefit Pension Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors a tax-qualified defined benefit pension plan that was frozen in 2010 and a nonqualified supplemental pension plan that was frozen in 2007. The Company also sponsors several other defined benefit pension plans that are unfunded nonqualified supplemental retirement plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Benefit Obligation and Plan Assets</span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODYz_e1cde68d-737b-4853-b882-d03f29d10855" escape="true"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODY0_a3ff7557-1892-4e3f-8d34-fd0fd431e31a" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables outline the change in pension benefit obligation and plan assets over the specified periods:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzItMS0xLTEtMTk2MzU_f546d37a-77b5-4cfe-881b-bd42136996f5">6,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f04ec02cc3f4ecd8284b436de929707_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzItMy0xLTEtMTk2MzU_516fcb95-b1ec-4584-aabd-763037da88e9">6,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzQtMS0xLTEtMTk2MzU_54b45615-59b8-4708-887f-d892033efb34">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzQtMy0xLTEtMTk2MzU_e2f76b95-f0aa-4dbf-a540-c63cd7df3f5c">168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzUtMS0xLTEtMTk2MzU_cef6e18e-dea1-4942-8026-bf3eeac6053e">102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzUtMy0xLTEtMTk2MzU_7612b68b-980d-4a53-a721-b039279ce272">413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzYtMS0xLTEtMTk2MzU_e4eed65e-6eb0-4e74-aa04-1c6460a7b142">408</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzYtMy0xLTEtMTk2MzU_57de96f1-6450-4a00-8739-07179c07ec5a">358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzctMS0xLTEtNjgyODk_b848b85a-650e-48ed-801f-40207159c709">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzctMy0xLTEtNzA0MTE_30c9f2eb-9857-41f2-aed0-9650b2e88c04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzctMS0xLTEtMTk2MzU_215d2502-5f2a-48e6-88e3-d81f1590864d">6,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzctMy0xLTEtMTk2MzU_f43a0b4a-5552-4d40-a9a2-33dafb465df2">6,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzEwLTEtMS0xLTE5NjM1_e904f2d7-6fce-40fd-b847-bcdb44e3b544">6,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f04ec02cc3f4ecd8284b436de929707_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzEwLTMtMS0xLTE5NjM1_fb1ee381-3934-46e0-a9ca-0bcf25337af4">6,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzEyLTEtMS0xLTE5NjM1_1805ec5e-42d4-441d-9d71-9407f00e6681">215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzEyLTMtMS0xLTE5NjM1_d150bed0-269d-4041-9431-0fd1f2734b53">783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzEzLTEtMS0xLTE5NjM1_223ecddc-4afe-4057-97f0-47870bc46730">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzEzLTMtMS0xLTE5NjM1_4a519dc0-7ad9-496f-aca1-078b7bcd5b3f">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzE0LTEtMS0xLTE5NjM1_f66fc7aa-5284-41c9-879d-b7853c23086d">408</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzE0LTMtMS0xLTE5NjM1_d2a0b73a-2d59-489c-975a-35af7deba7bc">358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzE2LTEtMS0xLTY4MzAw_95f15130-3c11-4645-8edb-976ce53af01e">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanSettlementsPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzE2LTMtMS0xLTcwNDE1_668fa81b-134e-41c6-80cb-10fd6c23dccc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzE1LTEtMS0xLTE5NjM1_dc07a06d-413e-4efd-a10c-94a446c73027">6,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzE1LTMtMS0xLTE5NjM1_5a114c62-fc40-4724-ad06-9313f1c69527">6,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzE3LTEtMS0xLTE5NjM1_15bd0465-8489-4e3c-b35c-c6928276479f">668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzE3LTMtMS0xLTE5NjM1_b7a7bd04-9f55-499b-8196-4a857f7792ee">383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the pension benefit obligation during the years ended December&#160;31, 2021 and 2020 was primarily driven by the change in the discount rate during each respective period.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia433f64921354e16bc9eb238f3506470" continuedAt="i88ce48eb8b484fbfacaa9dbf14c85c40"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODY1_5d443bc0-726e-4787-83c0-03d45e0feef3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets (liabilities) recognized on the consolidated balance sheets at December&#160;31, 2021 and 2020 for the defined benefit pension plans consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets reflected in other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZToxMzJkNDQ5Y2JkNmU0ZmY1ODZmNzkyMzMyMGY3YjlmZS90YWJsZXJhbmdlOjEzMmQ0NDljYmQ2ZTRmZjU4NmY3OTIzMzIwZjdiOWZlXzEtMS0xLTEtMTk2MzU_933df598-666b-4d40-9be1-b5597b3d31c9">946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZToxMzJkNDQ5Y2JkNmU0ZmY1ODZmNzkyMzMyMGY3YjlmZS90YWJsZXJhbmdlOjEzMmQ0NDljYmQ2ZTRmZjU4NmY3OTIzMzIwZjdiOWZlXzEtMy0xLTEtMTk2MzU_8f6f1fe9-63d7-4b23-906f-3bb6f0285aaf">744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities reflected in accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZToxMzJkNDQ5Y2JkNmU0ZmY1ODZmNzkyMzMyMGY3YjlmZS90YWJsZXJhbmdlOjEzMmQ0NDljYmQ2ZTRmZjU4NmY3OTIzMzIwZjdiOWZlXzItMS0xLTEtMTk2MzU_37b191c9-c08b-45ce-9892-75a7966e4a8d">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZToxMzJkNDQ5Y2JkNmU0ZmY1ODZmNzkyMzMyMGY3YjlmZS90YWJsZXJhbmdlOjEzMmQ0NDljYmQ2ZTRmZjU4NmY3OTIzMzIwZjdiOWZlXzItMy0xLTEtMTk2MzU_75742209-7bc6-4e30-874e-8a02070c3b76">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities reflected in other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZToxMzJkNDQ5Y2JkNmU0ZmY1ODZmNzkyMzMyMGY3YjlmZS90YWJsZXJhbmdlOjEzMmQ0NDljYmQ2ZTRmZjU4NmY3OTIzMzIwZjdiOWZlXzMtMS0xLTEtMTk2MzU_c4d8272c-9c55-42b7-adea-38076ce0a4e6">250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZToxMzJkNDQ5Y2JkNmU0ZmY1ODZmNzkyMzMyMGY3YjlmZS90YWJsZXJhbmdlOjEzMmQ0NDljYmQ2ZTRmZjU4NmY3OTIzMzIwZjdiOWZlXzMtMy0xLTEtMTk2MzU_7724ab46-fa83-4695-95dd-87f54605e3c6">285</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZToxMzJkNDQ5Y2JkNmU0ZmY1ODZmNzkyMzMyMGY3YjlmZS90YWJsZXJhbmdlOjEzMmQ0NDljYmQ2ZTRmZjU4NmY3OTIzMzIwZjdiOWZlXzQtMS0xLTEtMTk2MzU_d02fb97c-8c35-486c-a41a-c9d3abd5f1c7">668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZToxMzJkNDQ5Y2JkNmU0ZmY1ODZmNzkyMzMyMGY3YjlmZS90YWJsZXJhbmdlOjEzMmQ0NDljYmQ2ZTRmZjU4NmY3OTIzMzIwZjdiOWZlXzQtMy0xLTEtMTk2MzU_56e8e9f1-4d9c-453a-ae36-5389b5ca8984">383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Periodic Benefit Cost (Income)</span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODUx_c593a6bd-da6d-4aed-9012-8a1577876252" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost (income) for the years ended December&#160;31, 2021, 2020 and 2019 are shown below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of net periodic benefit cost (income):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzItMS0xLTEtMTk2MzU_05931d8a-b941-40ba-9172-d83260b4bf02">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzItMy0xLTEtMTk2MzU_9cc17b29-6030-499e-9aaa-2b6313cfbc9e">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf1063688e1c402b918f2251c5ebcda8_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzItNS0xLTEtMTk2MzU_9485760e-9351-4532-86bc-4a0f22b32938">225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzMtMS0xLTEtMTk2MzU_56ed9d4b-15ce-48c3-9790-b1ffed2470b5">317</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzMtMy0xLTEtMTk2MzU_7f537545-d465-4074-b927-0ce23ee07395">388</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf1063688e1c402b918f2251c5ebcda8_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzMtNS0xLTEtMTk2MzU_ed168074-113a-4429-8b71-c50a03a042e4">357</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzQtMS0xLTEtMTk2MzU_8bc1a84b-b6ed-4e4f-87c5-e9a9808aa601">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzQtMy0xLTEtMTk2MzU_42e37742-d1cc-4d55-950f-e2dcb8a073eb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf1063688e1c402b918f2251c5ebcda8_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzQtNS0xLTEtMTk2MzU_58d235d8-f400-4113-917c-db834e4b248c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzUtMS0xLTEtNjgzMzQ_a4405cc8-ca4a-4027-bb1f-19278fd5c8a6">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzUtMy0xLTEtNzA0MTg_89508622-6f4e-4339-981a-f92eac2c4fd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf1063688e1c402b918f2251c5ebcda8_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzUtNS0xLTEtNzA0MTg_e89b15f6-7572-455d-bb7f-7c2d9eabfa59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzUtMS0xLTEtMTk2MzU_c7dbe635-d310-400b-8a12-1f865c3f5c9e">186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzUtMy0xLTEtMTk2MzU_3df0b8fd-3be4-4d86-8166-c644a8198806">218</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf1063688e1c402b918f2251c5ebcda8_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzUtNS0xLTEtMTk2MzU_a578cb62-b4e7-4e9a-8ce9-3aac682a7223">131</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Plan Assumptions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a series of actuarial assumptions to determine its benefit obligation and net periodic benefit cost (income), the most significant of which include discount rates and expected return on plan assets assumptions. </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discount Rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate is determined using a yield curve as of the annual measurement date. The yield curve consists of a series of individual discount rates, with each discount rate corresponding to a single point in time, based on high-quality bonds. Projected benefit payments are discounted to the measurement date using the corresponding rate from the yield curve that is consistent with the maturity profile of the expected liability cash flows.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Return on Plan Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected long-term rate of return on plan assets is determined by using the plan&#8217;s target allocation and return expectations based on many factors including forecasted long-term capital market real returns and the inflationary outlook on a plan by plan basis. See &#8220;Pension Plan Assets&#8221; below for additional details regarding the pension plan assets as of December 31, 2021 and 2020.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also considers other assumptions including mortality, interest crediting rate, termination and retirement rates and cost of living adjustments. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODU5_7ddebfb0-e483-4d09-8e88-74f14617026c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its benefit obligation based on the following weighted average assumptions as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo2ODRmZWJmM2Q3YmI0N2JjYWZiYzc4MDg3NDRlZjlkZC90YWJsZXJhbmdlOjY4NGZlYmYzZDdiYjQ3YmNhZmJjNzgwODc0NGVmOWRkXzEtMS0xLTEtMTk2MzU_dfe75005-8501-4a5d-8213-f090fba85d96">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo2ODRmZWJmM2Q3YmI0N2JjYWZiYzc4MDg3NDRlZjlkZC90YWJsZXJhbmdlOjY4NGZlYmYzZDdiYjQ3YmNhZmJjNzgwODc0NGVmOWRkXzEtMy0xLTEtMTk2MzU_be79df72-27ea-44a1-95f2-c4d1d4b4c7b7">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its net periodic benefit cost (income) based on the following weighted average assumptions for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpjYWQ2MjEwNWZjNjk0ODdiYThjZmJkMDAzMjJkODE3MS90YWJsZXJhbmdlOmNhZDYyMTA1ZmM2OTQ4N2JhOGNmYmQwMDMyMmQ4MTcxXzEtMS0xLTEtMTk2MzU_6eda6782-6c67-4a76-b4aa-dfac5f6fabf9">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpjYWQ2MjEwNWZjNjk0ODdiYThjZmJkMDAzMjJkODE3MS90YWJsZXJhbmdlOmNhZDYyMTA1ZmM2OTQ4N2JhOGNmYmQwMDMyMmQ4MTcxXzEtMy0xLTEtMTk2MzU_dc2d1abc-7a28-4911-81ea-a3bc46f13cd4">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpjYWQ2MjEwNWZjNjk0ODdiYThjZmJkMDAzMjJkODE3MS90YWJsZXJhbmdlOmNhZDYyMTA1ZmM2OTQ4N2JhOGNmYmQwMDMyMmQ4MTcxXzEtNS0xLTEtMTk2MzU_4fee6ec7-3bce-47b1-9386-8ce5c7d53451">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpjYWQ2MjEwNWZjNjk0ODdiYThjZmJkMDAzMjJkODE3MS90YWJsZXJhbmdlOmNhZDYyMTA1ZmM2OTQ4N2JhOGNmYmQwMDMyMmQ4MTcxXzItMS0xLTEtMTk2MzU_3c201a26-c0b4-44dd-8ce8-7f6ff598bf15">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpjYWQ2MjEwNWZjNjk0ODdiYThjZmJkMDAzMjJkODE3MS90YWJsZXJhbmdlOmNhZDYyMTA1ZmM2OTQ4N2JhOGNmYmQwMDMyMmQ4MTcxXzItMy0xLTEtMTk2MzU_15c83b70-0bfd-4131-a96e-1f93d80b72a6">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpjYWQ2MjEwNWZjNjk0ODdiYThjZmJkMDAzMjJkODE3MS90YWJsZXJhbmdlOmNhZDYyMTA1ZmM2OTQ4N2JhOGNmYmQwMDMyMmQ4MTcxXzItNS0xLTEtMTk2MzU_0fa58b55-9631-4afb-995b-75e5804472ec">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i88ce48eb8b484fbfacaa9dbf14c85c40" continuedAt="if64f7e0a35e542feb9f5928c851c4177"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Plan Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pension plan assets primarily include debt and equity securities held in separate accounts, common/collective trusts and real estate investments. The valuation methodologies used to value these debt and equity securities and common/collective trusts are similar to the methodologies described in Note 4 &#8220;Fair Value.&#8221; Pension plan assets also include investments in other assets that are carried at fair value. The following is a description of the valuation methodologies used to value real estate investments and these additional investments, including the general classification pursuant to the fair value hierarchy.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Real estate investments are valued by independent third party appraisers. The appraisals comply with the Uniform Standards of Professional Appraisal Practice, which include, among other things, the income, cost, and sales comparison approaches to estimating property value. Therefore, these investments are classified in Level 3.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Private equity and hedge fund limited partnerships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Private equity and hedge fund limited partnerships are carried at fair value which is estimated using the NAV per unit as reported by the administrator of the underlying investment fund as a practical expedient to fair value. Therefore, these investments have been excluded from the fair value table below.</span></div><div style="padding-left:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODcw_60e380c6-6c76-44b1-bec9-13b816f078f2" continuedAt="ia6a08a427e6d4464aa27fcfd1ec0fc0b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2021 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3134e38a37b94c8182ff22d5897d2115_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEtMS0xLTEtMTk2MzU_7080cb57-971b-4317-9a4a-56417cd579a2">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie905fb72796946948258390b761711b2_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEtMy0xLTEtMTk2MzU_020b885f-9811-492e-b1f0-7e05aefe1b35">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00abbc1dfc2420285ca81d07349c1ce_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEtNS0xLTEtMTk2MzU_9f6c1f1e-ad18-4159-a240-82b4af54abc3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i875e79c2473a452583e29e73a01bfa80_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEtNy0xLTEtMTk2MzU_9f57220c-e3f1-4a0d-994b-4ff15c4e3787">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5c96f524674979ae3cadfd2532827d_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzMtMS0xLTEtMTk2MzU_dd02092d-e9f5-4c18-b519-980216e9a779">1,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59c39c821a3d4218a3cb728d2a385e90_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzMtMy0xLTEtMTk2MzU_0b3cbea1-6c97-41d3-8728-ed5d9d7437ac">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5e7e03431254181936fa5c2d257ec24_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzMtNS0xLTEtMTk2MzU_f4392c6d-a3d6-4dc5-b065-18722b9926f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bc62d9f7c66433aa13e9e6998d9d964_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzMtNy0xLTEtMTk2MzU_90467741-2ee9-4e8e-acbe-ba046fbc2e9a">1,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a20a0bce804c38b73ff7f520b87651_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzQtMS0xLTEtMTk2MzU_0051f958-6635-4d8f-b343-0fb1ec3325bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia01c644b76e14ee0b5670b383fc44619_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzQtMy0xLTEtMTk2MzU_4ed44182-aeb3-4879-a6c3-1f245c049c49">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i720c85d38c4b4a209ace565912f63128_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzQtNS0xLTEtMTk2MzU_26d90b77-3731-4654-b0f7-f00280c9d8f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299dbb93baaa4adf91b29303de9f256c_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzQtNy0xLTEtMTk2MzU_833d6eda-1cec-4bba-84ce-0879a429681d">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba101ed2ac8446029ae5d685f8acc341_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzUtMS0xLTEtMTk2MzU_4359b308-5d83-4755-9d30-d60992791886">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e7a8e35e6064852930a027b3b59f8bf_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzUtMy0xLTEtMTk2MzU_07a4a457-f9a2-43f0-a4a0-198e3f7122a4">2,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbde729393d64e52859d704b20cee518_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzUtNS0xLTEtMTk2MzU_29ecbd6c-0a7c-4e14-a539-b007ea49405f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i412f89f8ca8d4dbfb8137a440ded6b98_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzUtNy0xLTEtMTk2MzU_9d7ce209-652d-45aa-a7f6-2cd98a03ffd3">2,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae01dbcfa8ad41769f633687cc03a2f7_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzYtMS0xLTEtMTk2MzU_6404837a-981f-47a2-aa89-3175fa9e0708">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8e7a22df5454c2ea08ecd37884fc4ca_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzYtMy0xLTEtMTk2MzU_e52456fe-e3bd-4b50-acd3-bec69d23757f">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fe528bb55e54ddf9c9174d483315925_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzYtNS0xLTEtMTk2MzU_7e3570f1-4d78-453e-8781-c3a33a30e111">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03065bcf27f649d5aea3ecbbae57c360_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzYtNy0xLTEtMTk2MzU_11575abc-b332-425a-b66a-adf5f0cf7e09">202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03983d809b5d48ac822709e714733860_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzctMS0xLTEtMTk2MzU_085a55e4-8566-4699-9a03-a10d5579b6bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7896784f71444553a77160a44c511d51_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzctMy0xLTEtMTk2MzU_73f477b2-6fc7-489b-8767-fbedbd20f311">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f997b24060b4e2e831b7dd663bd1b51_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzctNS0xLTEtMTk2MzU_973a625c-18df-48bc-ac29-2b120c07643d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica9d19a21f7b4daa8e6810612ddacae0_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzctNy0xLTEtMTk2MzU_8b470dc7-1ea9-45cb-9540-809922597c89">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b76b6127e2345bdbe4b25521e947671_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzgtMS0xLTEtMTk2MzU_b84162f3-637b-4881-b2ce-2b7b7e26d265">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id17472de8a564798bb9bbabef75337c9_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzgtMy0xLTEtMTk2MzU_eedf27e5-f31b-41fd-a10b-f15936ce2d51">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76f91d5a4d3f4fde8c530ad87b420488_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzgtNS0xLTEtMTk2MzU_660040d4-f60e-4394-8dc7-c001175ff315">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie018639f7a93495f8a043153b2b66e54_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzgtNy0xLTEtMTk2MzU_3b7b5862-ad5f-4404-a763-a3ca34cb642c">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i790751c0557c4bcd879d0876e81497d8_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzktMS0xLTEtMTk2MzU_13e836ce-fb88-4900-b1ec-c5681133d70b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1878272b63d84cb3ad191576cc40347f_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzktMy0xLTEtMTk2MzU_a9cffd52-b48a-4700-b00b-b92e98204a5a">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i236be83c9a654e4bb93dd0760efff694_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzktNS0xLTEtMTk2MzU_0c9c85c8-55e8-402e-9cc8-915af4795b2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0da2d0c3648145a5b8e2644ab1e5983d_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzktNy0xLTEtMTk2MzU_a09fec6c-656e-4e96-b4b2-908f4ee92b97">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a93d02e74b1445c87a77245502f00bd_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEwLTEtMS0xLTE5NjM1_e07340a7-8c25-4291-b05d-94404fd5333d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e716287be2403d9f9833d066720161_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEwLTMtMS0xLTE5NjM1_2047a40f-ca29-4ae4-9df9-51dad694f631">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0685d6246774c2192e1c757f435ee9f_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEwLTUtMS0xLTE5NjM1_520a60ed-dd16-4a27-bc1e-776505f81e7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6907babce69b467f895e80b4a8a98771_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEwLTctMS0xLTE5NjM1_2483a545-19f2-4e16-b3f3-44b35f4fdacc">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i752af8c51ae54195805ebd256b2b704b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzExLTEtMS0xLTE5NjM1_778ccdff-e6b3-48d6-ac57-e1d07f18e2f7">1,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f35241461c340e69d4ae399ca59d584_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzExLTMtMS0xLTE5NjM1_ac4feb09-b78f-4164-881e-b7d290b3d898">3,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59783636e8a14fa99c118f4ba1fe28ce_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzExLTUtMS0xLTE5NjM1_9045c6ab-ad01-46aa-ba7b-43875338006c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie59012b0b1f342f68b2de7d2cf4ab087_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzExLTctMS0xLTE5NjM1_955b56b4-e3e6-4821-be95-dde68a983230">4,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5cc0c0211dd4cb0b9436d1dcc14e45f_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEzLTEtMS0xLTE5NjM1_04ea240f-f464-4c2e-b2fe-f80ae17e8902">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia291c95e9323450a8b9d5c75e58e6dde_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEzLTMtMS0xLTE5NjM1_a8ef7d91-6623-4a4a-b5a2-63759aee8f2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13f56229e6a44220ac924ebb86adafa3_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEzLTUtMS0xLTE5NjM1_812eafee-0054-4a4e-a2e9-98e45edd5edb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22bbe4588fd541d6a564c67c1022e726_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEzLTctMS0xLTE5NjM1_e80c579b-234c-4f42-aae6-64b79921022e">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if240d2be64a04252b3b1f214f2c30cce_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE0LTEtMS0xLTE5NjM1_f46c00ce-9e8e-46bd-8876-fe0396754148">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e572606f72547578135489453dbfd32_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE0LTMtMS0xLTE5NjM1_bdb4abaf-2a6e-4e5a-9d11-22d5c7964bb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c636fbb95ec447f84da5fad0bd31870_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE0LTUtMS0xLTE5NjM1_7ebaf61d-a642-4e95-b1dd-f952d90beb12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca55a5008304969aa971098edc7db65_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE0LTctMS0xLTE5NjM1_fff7bfe9-117f-48f6-afd9-31c7b608d562">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5750f985ec4049d5a4ce86e6955f062c_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE1LTEtMS0xLTE5NjM1_f27f486b-46c7-44d9-8c69-3aaf76cfd4a5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8275b2c1a4584bab8295523437070a66_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE1LTMtMS0xLTE5NjM1_8d14157b-99d2-4aaf-8fee-f5715c1852d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i353fe81c894e473d8489f94900073b72_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE1LTUtMS0xLTE5NjM1_24ca399e-e184-4304-a4d3-58db8798945d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0142cf66eb9e474ba86ff2ef25aa7bb2_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE1LTctMS0xLTE5NjM1_a5bf7545-6e0f-4886-a0e9-4eab04c1b673">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09446e526f7f40f1b8b3303c458d33ce_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE2LTEtMS0xLTE5NjM1_5cce19d0-b858-4f3d-8c6a-636740a8a474">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id83eb75fcc284b5f8068a783a9650faf_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE2LTMtMS0xLTE5NjM1_a6cfba02-7e34-4536-9b52-b5f914f5ff33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i347ffec6d213490c86926a3020149905_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE2LTUtMS0xLTE5NjM1_80fcc0f4-763d-4315-a634-245953931857">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68728028bd74499a908379ef355b4da0_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE2LTctMS0xLTE5NjM1_57ddbb63-5fbd-4ddc-b7b2-1b5c9835f5d5">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16f188fd81734863b4051130ab9f098b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE4LTEtMS0xLTE5NjM1_c03ec167-3535-41a7-9718-96f2e43db121">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97f4fe722e6e43d6bf5d820d11cc2e2c_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE4LTMtMS0xLTE5NjM1_5aa565d5-28d7-4a2a-9f87-66446b33b03c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aab0ea7df2549f09b6ae42102668e65_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE4LTUtMS0xLTE5NjM1_358dc9ef-2dd5-414f-b39d-138e1ccf012f">378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22a8679306fb4d1ba271a7b5a547276e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE4LTctMS0xLTE5NjM1_6e4a29cf-c080-41e8-a5c7-3c106ce97b42">378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e5acd236a544fff8d2d17bd87ad5a43_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE5LTEtMS0xLTE5NjM1_2a075803-703c-4b7b-8117-07ff0c6b7871">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87a55c8247be45b09ee66e3eeef70a7c_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE5LTMtMS0xLTE5NjM1_7a68e742-b720-492a-9918-4fad92f503fc">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb6a1ac4f81447019bc03b2d0cdb655e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE5LTUtMS0xLTE5NjM1_3d855267-8f51-42d2-9e4d-dd8f7e43f2de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c06aac8a3d747f9985177c9ed3a77fd_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE5LTctMS0xLTE5NjM1_1abb2e38-a70f-4026-86ee-80ffd643e007">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ee6597ca53e484eada5596583046f3e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzIxLTEtMS0xLTE5NjM1_e91a7315-406b-461a-8f87-36557823a41e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37d7609b746045a585af149f288da888_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzIxLTMtMS0xLTE5NjM1_f99be0fa-8a67-4f19-98ed-42a998a70d31">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44b71f83a2d49289abcbf4aac524e75_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzIxLTUtMS0xLTE5NjM1_25fd7a0e-d659-4a48-942b-c7a8e2275d18">378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i248a5597803e4cdf9daeedf87c82dc5e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzIxLTctMS0xLTE5NjM1_9454341d-a18d-4b36-aa33-41000ee3d767">788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1308d93a146c4c8488b59a3c5a030c08_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzIyLTEtMS0xLTE5NjM1_be04e760-2f80-4736-bde0-8434e5771b99">1,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f7417ba6374a9bb024726d61971b6c_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzIyLTMtMS0xLTE5NjM1_46209144-0df5-46cf-86ac-713933dbaaba">3,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fc62e7b55b64c639f28ec82a4ab6bd1_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzIyLTUtMS0xLTE5NjM1_9611715f-f99f-44bb-a5e8-9c08127789ae">378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbd48617b54d4e418e1d710b3ae6d615_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzIyLTctMS0xLTE5NjM1_daf7c794-4585-49f8-a99c-cbc3a86bc730">5,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $<ix:nonFraction unitRef="usd" contextRef="i20fea02b40f94c0ba48b95b826283484_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzU3NTM_579875e5-92b3-4c63-90bc-bae1593fd6d3">261</ix:nonFraction> million of equity securities and $<ix:nonFraction unitRef="usd" contextRef="if275586315f94ce8aa9f0a9ac4422fce_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzU3ODE_f21385ea-c62d-43ad-a84b-f6f4f77ca284">149</ix:nonFraction> million of debt securities. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $<ix:nonFraction unitRef="usd" contextRef="icdfdfa352a47493f87219a5298ddedc0_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzM4NDgyOTA3MTA5MTI_100873c8-9565-447f-bf0d-6478ef70c7b7">76</ix:nonFraction> million of other receivables as well as $<ix:nonFraction unitRef="usd" contextRef="ib3a9437b6cce406685b52a5c81de0dc3_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzU4NTA_5cce71b5-5ece-4b04-bcf4-4d8940a73073">583</ix:nonFraction> million of private equity limited partnership investments and $<ix:nonFraction unitRef="usd" contextRef="i31173b20feb34137842581c3c8ce276b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzU5MDc_09cf3937-588f-4700-86a0-2dbadb5806f5">237</ix:nonFraction> million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if64f7e0a35e542feb9f5928c851c4177" continuedAt="i4ae6fdc1bf844704a2ea2197baaa99eb"><ix:continuation id="ia6a08a427e6d4464aa27fcfd1ec0fc0b" continuedAt="i1c5a58d860544b6d934f685505ef51e0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2020 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd69bf1ffd684edcb0e0780c09b5e3ff_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEtMS0xLTEtMTk2MzU_69d35d7c-d05e-47fe-bf3b-34d64b69c9d9">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e1d94487b2b4e17bcc6022785274fa4_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEtMy0xLTEtMTk2MzU_efca0dd8-04cc-4d84-b939-5b99dd686c0f">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5790b806681342228c412540032c2845_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEtNS0xLTEtMTk2MzU_a4cdaa08-a681-4c97-aaf3-a87e1e3ef172">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2bca73c906b44578c01f6b232e46777_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEtNy0xLTEtMTk2MzU_6df0df2f-0548-4292-9906-3e019b6295f9">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b1bf3752dcf4f309d29e28b80c56ffe_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzMtMS0xLTEtMTk2MzU_11d92d77-0e00-4fdd-8521-e4cf55752fbf">575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a371f76601c443b8b6c9bcd816f3a93_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzMtMy0xLTEtMTk2MzU_eec61db6-73cd-4d2f-87b2-30ada18dc49b">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b9cd1a5ea464c6daf3d809cfa440c90_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzMtNS0xLTEtMTk2MzU_73f15893-1fd8-458b-aa11-2cfa3897707a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ab5d14a774c4e00912a293ffe6f87bb_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzMtNy0xLTEtMTk2MzU_a3e37c9f-f9da-45e4-9d34-b43b9fa3f6b2">611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib65d80ddf5114b28a867a900c7850eac_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzQtMS0xLTEtMTk2MzU_16b5191b-d792-4436-a42c-c37cfbd943d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id189ff74332342fa9efe4364610c858b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzQtMy0xLTEtMTk2MzU_35eb92bc-776d-4e75-9eaf-6ce93e8ca294">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6b00b26ffba4cad87f82b5285574b87_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzQtNS0xLTEtMTk2MzU_9bb63697-7b52-4fd0-a7d2-a5f44474d342">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9149c44a31594b36a308ac1f8c72e95b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzQtNy0xLTEtMTk2MzU_296eefdb-46d4-4446-b99f-91bb404d6de9">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03315b2d0c214dc9ae1f36aa4a7b1182_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzUtMS0xLTEtMTk2MzU_1b43c22f-57fd-402e-83cd-8f4f78bb2d24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieabcbb36fc544fe1a63bec192e6a5369_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzUtMy0xLTEtMTk2MzU_2c1ea008-5260-4cd0-9790-791dc581385a">2,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbab6554354142219fbf65a19f9f7258_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzUtNS0xLTEtMTk2MzU_3b8b741a-2f3d-466f-a3d1-01df22f858e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d537c7cac0d4b2bb971a7f1b19afd54_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzUtNy0xLTEtMTk2MzU_ca1ae84e-d852-4da4-9db4-e4d31ef163bc">2,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee91350be21e4df98a159fbf2f617178_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzYtMS0xLTEtMTk2MzU_7b1c1dec-7fae-4306-a08a-50b2996636e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b09818a0a4a496a9fa00fed53ac3bc0_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzYtMy0xLTEtMTk2MzU_5fcea0b0-cc00-4a51-8937-7a28b9a3beda">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7c8684e46134d5d94ecbacac811adbf_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzYtNS0xLTEtMTk2MzU_a732a0c8-3971-45f5-9c8c-9da9c83d13ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if725d6e275a94ba883eb02d3137c3b23_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzYtNy0xLTEtMTk2MzU_f1317ada-95f2-490c-b356-fdb38d68a75a">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dacb79ba9f7420094ee7ba16c6f78c7_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzctMS0xLTEtMTk2MzU_6606e61a-c3b2-4603-ac9c-b78955df0d4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e824e97dad749fa8146593c0a7fa864_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzctMy0xLTEtMTk2MzU_69385c02-ac30-415c-a504-ad4fa66db8e4">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f2924405ec24521a9aa09e98be58eec_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzctNS0xLTEtMTk2MzU_481ba285-b528-4991-95c5-89e07a5a9f8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36dd5abbbdcc4f9a9f25788b549f76f2_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzctNy0xLTEtMTk2MzU_8b2bf15f-82f9-4e9c-a057-315b0b35ddc8">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd4080c110824cc891e5f7c1bfadc274_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzgtMS0xLTEtMTk2MzU_6570148f-463d-493c-a275-d11f18996ab7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45c05f5dd5d3432185804a21006dd535_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzgtMy0xLTEtMTk2MzU_090e9a3e-8713-4a7b-885a-ad77b9bce950">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdc0d801d333478e818a374400b463a0_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzgtNS0xLTEtMTk2MzU_497d9ddd-a6d2-43c0-a85f-3c620fbb6e55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69656313398948a58d187e87db585202_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzgtNy0xLTEtMTk2MzU_9f49b518-291d-4252-b29e-0737dcf3093c">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dd797aa72de45759796b65f361f095d_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzktMS0xLTEtMTk2MzU_d58ee0e4-e1b8-4df9-97d9-6511bad36e30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f11128fcfa749d782d3026befe4c0b4_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzktMy0xLTEtMTk2MzU_dac6177b-1eac-4d3e-8e49-117cce931aa4">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d2c9c46d28343c39add06320df583f6_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzktNS0xLTEtMTk2MzU_ff6d9db7-646b-4e23-abeb-69a4d9fbab04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i504c90860189474a9e7671e231444fcb_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzktNy0xLTEtMTk2MzU_c5e7aca8-f158-4bfa-b622-20f7341219d9">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e2d75cd63240afb79819d5aa10ec90_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEwLTEtMS0xLTE5NjM1_8b091776-f14b-4275-9d72-985bb938ff70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f96d3ab2794a19976e875f2624ea6e_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEwLTMtMS0xLTE5NjM1_5b208c28-b0b4-45bd-96e2-abd0b2f0fa8d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41b1ed139bba42e9bb825bb820df17c3_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEwLTUtMS0xLTE5NjM1_5436ea5c-2ff3-4dc0-bb37-a229bba9feba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabdd8d0f4b884bafb6a33a56b77ba2d2_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEwLTctMS0xLTE5NjM1_39ee6108-8742-4c79-8d7b-0a1b0856031a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9978503911fa41aa862248d7a8b2f088_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzExLTEtMS0xLTE5NjM1_777ec4fd-ccea-436a-b423-8249b44166e7">575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9890742ae5e746e59b2065d06764be7a_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzExLTMtMS0xLTE5NjM1_7debb720-2547-4858-b9d3-dfa7d85019ba">2,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18e230719b394883bd34f909e74c7ec7_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzExLTUtMS0xLTE5NjM1_24cc1999-9d35-4540-b181-11b8de372c31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbb9853b8df849048580a1fd16e6682d_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzExLTctMS0xLTE5NjM1_091ecd19-126b-4ec7-b888-a8eb5e041627">3,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5917c3c349de4954858ab57a50dd8cb9_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEzLTEtMS0xLTE5NjM1_9fe14bcf-1dd7-4757-8981-2f3da5c92f8e">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cabad59a0dc44a6ac1fd35c4b99265b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEzLTMtMS0xLTE5NjM1_970e926e-2e22-4dfb-b78e-25634598d0c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6aedf877fb364df6a2c31ee163a6cfe2_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEzLTUtMS0xLTE5NjM1_09c5a25c-2ad0-4147-9894-b029296c1eb8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28dff85338264876bb38fd87ca595a93_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEzLTctMS0xLTE5NjM1_351e0952-6d83-41b2-86c0-f6b4802804ad">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ae7533aef2d4ae58181147c89948033_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE0LTEtMS0xLTE5NjM1_feeaf988-9146-4a57-a1d7-29a43debb799">537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i980a0570d54d438e9ca44fce0d36118f_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE0LTMtMS0xLTE5NjM1_cd1411a0-33b1-4174-92e8-c0fc541c0ffd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f5b472d5fd248fc9d8e4d0ca5faba33_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE0LTUtMS0xLTE5NjM1_2552ec11-31c2-4415-b1b6-16d3268e0f88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5541dbb601c340fc980f125354496618_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE0LTctMS0xLTE5NjM1_d039f8eb-8bea-447a-bf08-52cf8941ecf3">537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9db72d0c676148af9dada1f290d09a49_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE1LTEtMS0xLTE5NjM1_b98f1b3f-219c-4579-8461-4cfa9a5f6a6d">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c114d81513142deb782de5f4fb900d7_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE1LTMtMS0xLTE5NjM1_6fc51609-f000-4be0-8047-d7d9d6a4aaee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89b4748c514428786ab4dbcbb1f9083_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE1LTUtMS0xLTE5NjM1_2e5ae276-44e1-4591-b23a-1866adf115a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fbed6015e9f445a8b1b5c27ee92141a_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE1LTctMS0xLTE5NjM1_a3256ffa-bbd3-4a19-8291-35c1ecfbe0a4">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibadbdf8585c74e21a8128d74084c1630_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE2LTEtMS0xLTE5NjM1_0e18b0fd-5db6-444d-ab50-4a3c59543495">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7afb56947f304bfc81fc6a4e5e0609a2_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE2LTMtMS0xLTE5NjM1_3d25291e-ca4c-47de-817e-45be53957cb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40b0233400e741c69f64993477c55a4b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE2LTUtMS0xLTE5NjM1_37586b95-73da-4902-acde-a365acad3bce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ac32e06a1214b17a9a0b84d07f40f6a_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE2LTctMS0xLTE5NjM1_80d1c1d3-6c54-4b49-93c6-b649d2f37385">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1503d3a6c2e498cb8692a32b8d66212_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE4LTEtMS0xLTE5NjM1_9c74936e-74cf-4d5a-a89e-51aebaeb26c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92012f7aded14a9d87023bc2cc81aca5_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE4LTMtMS0xLTE5NjM1_e05d2e02-1420-4346-a3f1-be25bfae1521">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9cf82de093b4218a4e15181bf7ad103_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE4LTUtMS0xLTE5NjM1_096c9ad0-64a5-4c91-86b8-25166a81e0ed">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73089e6a3a2241938de74ace9cba6d4d_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE4LTctMS0xLTE5NjM1_f25d8b56-8f20-4203-950c-5533116bf25c">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e982f6ad3ab46928953aac66f4ed7cd_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE5LTEtMS0xLTE5NjM1_a07d2ea0-7f63-45a6-aa4f-573eb0d245c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd833f359c8e4d79b0a869ad0038a7ea_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE5LTMtMS0xLTE5NjM1_6aec7a59-79cb-4b41-bbda-d3784875c0cf">266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id11c855da6024638a23cf8dee7acc5da_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE5LTUtMS0xLTE5NjM1_ca2d3f8c-bb7d-4914-8e7b-6c959292391c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc8d2b37fd24bc5ba0361ec6cb6d65b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE5LTctMS0xLTE5NjM1_13d48e2c-6398-49e9-b6fa-23163e367027">266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb5df4dc2c74cb6a22410f86a771e30_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIwLTEtMS0xLTE5NjM1_b8e20ec5-cc47-4218-a0f9-a37ea7efc1ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d85bdcd4cfc46a8af15a02b4c576aef_I20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIwLTMtMS0xLTE5NjM1_34f9b3d3-79e8-4326-8d75-5ccf4f34fd03">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50b42474671845488782a3036f501d1b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIwLTUtMS0xLTE5NjM1_72d7f060-7475-4eb4-8514-8d679414a5d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28df8a8c64394346a9c15d1cc0276d57_I20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIwLTctMS0xLTE5NjM1_43877f6b-458d-470e-86bd-6911c76f9701">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibafcbe43a8324a158a723bf16031e45e_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIxLTEtMS0xLTE5NjM1_823915e2-76c7-462b-8558-b38bf39a034b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94adba46e20a49038784a49900c2c598_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIxLTMtMS0xLTE5NjM1_d0452839-0016-4473-94d4-93272077241a">263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73a6d94969d34f66be2e45328cb8f039_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIxLTUtMS0xLTE5NjM1_90d61417-57a0-4d56-9024-f087fd738f60">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25eb35fe769e4798b61a524290097389_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIxLTctMS0xLTE5NjM1_d0cd67bc-973a-4b4e-a259-bc4923287e6a">606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i263c92882506448d9de97c225b5380ac_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIyLTEtMS0xLTE5NjM1_981a7952-6706-4353-bbc9-4df59bb8c340">2,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic142f878870649039fd16edd170bbf6d_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIyLTMtMS0xLTE5NjM1_f66629a3-2240-4781-92d4-19576505c283">3,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i615e9d3a8c03432b9318ebab3d589854_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIyLTUtMS0xLTE5NjM1_0bb72a49-9e60-4f39-93b2-fca2311a8222">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica25f49a766947a2adc2da48b7b82874_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIyLTctMS0xLTE5NjM1_5e1a313f-ec41-4087-9e74-afd0f1e5a599">5,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $<ix:nonFraction unitRef="usd" contextRef="i629a1b7b7b2446cc8b1de566b5f3c0de_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwOTk1MTE2NDAzNDE_eba42899-f85b-4bfa-a5a2-bfa7ba62103f">84</ix:nonFraction> million of equity securities and $<ix:nonFraction unitRef="usd" contextRef="i05c170e5b7b94386b7fcd1a8079be955_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwOTk1MTE2NDAzNDc_1598093b-b481-4402-a837-7f9082fdc280">182</ix:nonFraction> million of debt securities. </span></div></ix:continuation><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i1c5a58d860544b6d934f685505ef51e0" continuedAt="ia27f2eafdc7a49ae89b4cb7dc0a5d19d">(2)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"><ix:continuation id="ia27f2eafdc7a49ae89b4cb7dc0a5d19d">Excludes $<ix:nonFraction unitRef="usd" contextRef="i60dddc7de4d647b3b43c5f0623bcf0f0_I20201231" decimals="-5" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwOTk1MTE2NDAzNTM_b7baf838-d2c3-4fcb-81fa-6547c3985e20">142</ix:nonFraction> million of other receivables as well as $<ix:nonFraction unitRef="usd" contextRef="i9a78c5e8b0784b46b5d4bb5a8fc3a21d_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwOTk1MTE2NDAzNTk_92f5355b-33ad-477f-8c2d-b95cd5896a4c">624</ix:nonFraction> million of private equity limited partnership investments and $<ix:nonFraction unitRef="usd" contextRef="i243c32908d3d4416bc7ff18ee7ffd240_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwOTk1MTE2NDAzNjU_94dadf15-9d5c-4ddb-b6e0-561ebe43ddcb">214</ix:nonFraction> million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODQ5_4d970e31-a30c-4488-9f96-4d89c358a9f3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:74.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.759%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.761%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9cf82de093b4218a4e15181bf7ad103_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzItMS0xLTEtMTk2MzU_af6193bb-b50a-4d4c-bf44-1f51e0d1c406">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i615e9d3a8c03432b9318ebab3d589854_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzItNS0xLTEtMTk2MzU_f5b267ac-1e77-4828-9b83-695617d57b64">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab646cf33e884b1698a49fc5490b1a94_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzMtMS0xLTEtMTk2MzU_daea7945-721f-4c9e-b34b-4447e5ca9eb5">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de4764ce7104e8cb8330af8da0f29b3_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzMtNS0xLTEtMTk2MzU_03cee1ee-1543-4f2a-91bb-1e474009ac0f">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab646cf33e884b1698a49fc5490b1a94_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzQtMS0xLTEtMTk2MzU_b34f1c92-17cc-4d63-95c0-c6f8f10dac64">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7de4764ce7104e8cb8330af8da0f29b3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzQtNS0xLTEtMTk2MzU_1d63aff9-c0de-46f2-8634-10a3a61d36e8">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab646cf33e884b1698a49fc5490b1a94_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzUtMS0xLTEtMTk2MzU_e5ad0722-d0dd-43f9-b97d-1a6fab1ea47c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de4764ce7104e8cb8330af8da0f29b3_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzUtNS0xLTEtMTk2MzU_0a71b6da-b480-43b6-94cb-d7a11965a664">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aab0ea7df2549f09b6ae42102668e65_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzYtMS0xLTEtMTk2MzU_d448a432-6d30-4643-b02b-0b7b854d3684">378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fc62e7b55b64c639f28ec82a4ab6bd1_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzYtNS0xLTEtMTk2MzU_1c61f1f7-4a3b-4fc5-89ba-4d00e0a34233">378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2020 were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib96bf7bb8a4e46c2bb1e0d91aacf9454_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzItMS0xLTEtMTk2MzU_317b3964-682e-4abb-ac73-1bac6943a6eb">353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fe8d48e437a42c8ac2e33f34b85a197_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzItMy0xLTEtMTk2MzU_4613433a-c739-436d-9dea-7adbb23980ba">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie319f6a95cc24bbdb8d73ca1db401d8f_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzItNS0xLTEtMTk2MzU_56c33031-9a18-46cf-9a02-d66d12cb7d13">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68c26fea49fd41b19bc33b4ee7857fdf_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzMtMS0xLTEtMTk2MzU_4ec189e6-5c3d-4aa6-8f17-4db72923b61b">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a9138b4f181419d87234459e11ed427_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzMtMy0xLTEtMTk2MzU_8bf6892a-a5e3-4375-8f76-7f3ef8394f2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf6ce37a6c304453aa21c72054c6c418_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzMtNS0xLTEtMTk2MzU_5f1b8708-1b34-4b86-bed8-ad85c3f6fd05">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68c26fea49fd41b19bc33b4ee7857fdf_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzQtMS0xLTEtMTk2MzU_f6fa2f4d-ef79-43a2-9465-115570b4eed5">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a9138b4f181419d87234459e11ed427_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzQtMy0xLTEtMTk2MzU_6fa4e0fc-ca31-4a06-927e-ff2ee24df40e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf6ce37a6c304453aa21c72054c6c418_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzQtNS0xLTEtMTk2MzU_591e38d8-6264-4a55-86a9-abb844ff6e7c">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68c26fea49fd41b19bc33b4ee7857fdf_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzUtMS0xLTEtMTk2MzU_60139571-67b3-45e8-b0c5-76fe386c1cd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a9138b4f181419d87234459e11ed427_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzUtMy0xLTEtMTk2MzU_38faf527-786f-4af1-ae5a-15aae815cae7">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf6ce37a6c304453aa21c72054c6c418_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzUtNS0xLTEtMTk2MzU_133fb37b-ff7c-47a5-8d20-b304fc852e6c">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9cf82de093b4218a4e15181bf7ad103_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzYtMS0xLTEtMTk2MzU_835521e6-56eb-4f33-9d48-d5a53f99115e">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbab6554354142219fbf65a19f9f7258_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzYtMy0xLTEtMTk2MzU_a0845ad9-29de-49bc-b5d4-e87f4284a966">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i615e9d3a8c03432b9318ebab3d589854_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzYtNS0xLTEtMTk2MzU_7a1bb3bf-f82f-486d-b0fc-cc69257437a2">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4ae6fdc1bf844704a2ea2197baaa99eb" continuedAt="ia24f93f97744489093d1f6f2f213c48f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pension plan invests in a diversified mix of assets designed to generate returns that will enable the plan to meet its future benefit obligations. The risk of unexpected investment and actuarial outcomes is regularly evaluated. This evaluation is performed through forecasting and assessing ranges of investment outcomes over short- and long-term horizons and by assessing the pension plan&#8217;s liability characteristics. Complementary investment styles and strategies are utilized by professional investment management firms to further improve portfolio and operational risk characteristics. Public and private equity investments are used primarily to increase overall plan returns. Real estate investments are viewed favorably for their diversification benefits and above-average dividend generation. Fixed income investments provide diversification benefits and liability hedging attributes that are desirable, especially in falling interest rate environments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, target investment allocations for the Company&#8217;s pension plan were: <ix:nonFraction unitRef="number" contextRef="i025b8e46060344f99b00103d8305d8f2_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5Xzc4Mzg_61a8e1bb-15f7-4662-9f0b-478043a72dc6">12</ix:nonFraction>% in equity securities, <ix:nonFraction unitRef="number" contextRef="i9e4ad64d899d4ef984f319b18bd41d23_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5Xzc4NjM_e42ca180-cc20-4c62-88b2-9b985447e18b">77</ix:nonFraction>% in fixed income and debt securities, <ix:nonFraction unitRef="number" contextRef="i76b12c0d6c6040539968eac6791ef12d_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5Xzc5MDM_2e3bbfb5-4a26-4e3e-adda-9f09c707e920">5</ix:nonFraction>% in real estate, <ix:nonFraction unitRef="number" contextRef="id5b88ad8263249b9a5226487582fc404_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5Xzc5MjI_216c1e30-5fe3-4484-9b82-6a815f82bc2f">3</ix:nonFraction>% in private equity limited partnerships and <ix:nonFraction unitRef="number" contextRef="i7fe3ea32ebf64cf49fb9d49975086ee9_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5Xzc5Njg_49a640d5-fb4e-4a50-af33-0183dc6d5699">3</ix:nonFraction>% in hedge funds. Actual asset allocations may differ from target allocations due to tactical decisions to overweight or underweight certain assets or as a result of normal fluctuations in asset values. Asset allocations are consistent with stated investment policies and, as a general rule, periodically rebalanced back to target asset allocations. Asset allocations and investment performance are formally reviewed periodically throughout the year by the pension plan&#8217;s Investment Subcommittee. Forecasting of asset and liability growth is performed at least annually.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally contributes to its tax-qualified pension plan based on minimum funding requirements determined under applicable federal laws and regulations. Employer contributions related to the nonqualified supplemental pension plans generally represent payments to retirees for current benefits. The Company contributed $<ix:nonFraction unitRef="usd" contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5Xzg4ODE_5dc6f303-8fbc-482d-92d2-8db7de7db745">78</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5Xzg4ODU_6aa6229e-14e7-48d4-868c-88cbe1a07da5">25</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iaf1063688e1c402b918f2251c5ebcda8_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5Xzg4OTI_1a9ece45-4468-4c40-8161-fed349a01250">25</ix:nonFraction> million to its pension plans during 2021, 2020 and 2019, respectively. No contributions are required for the tax-qualified pension plan in 2022. The Company expects to make an immaterial amount of contributions for all other pension plans in 2022. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODcz_054b1266-7148-412e-a6f7-85fe1d281daf" continuedAt="ibdce44f41c27423097aaf760cebcf0b0" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the pension benefit obligation as of December&#160;31, 2021: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo0YWM1NDc5M2E0NTA0MGU2OGU3NWI2MWQ1YjY1ZjZlMS90YWJsZXJhbmdlOjRhYzU0NzkzYTQ1MDQwZTY4ZTc1YjYxZDViNjVmNmUxXzEtMS0xLTEtMTk2MzU_e9614773-bb05-4532-ba58-70ed4b83aad2">371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo0YWM1NDc5M2E0NTA0MGU2OGU3NWI2MWQ1YjY1ZjZlMS90YWJsZXJhbmdlOjRhYzU0NzkzYTQ1MDQwZTY4ZTc1YjYxZDViNjVmNmUxXzItMS0xLTEtMTk2MzU_cd00236d-cdd9-4cf3-88a5-feedaca3b0be">371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo0YWM1NDc5M2E0NTA0MGU2OGU3NWI2MWQ1YjY1ZjZlMS90YWJsZXJhbmdlOjRhYzU0NzkzYTQ1MDQwZTY4ZTc1YjYxZDViNjVmNmUxXzMtMS0xLTEtMTk2MzU_ab898eb8-8c57-4304-a1b2-da49f30a958f">371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo0YWM1NDc5M2E0NTA0MGU2OGU3NWI2MWQ1YjY1ZjZlMS90YWJsZXJhbmdlOjRhYzU0NzkzYTQ1MDQwZTY4ZTc1YjYxZDViNjVmNmUxXzQtMS0xLTEtMTk2MzU_05fb1b13-9514-403e-a306-04b5bc251557">371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo0YWM1NDc5M2E0NTA0MGU2OGU3NWI2MWQ1YjY1ZjZlMS90YWJsZXJhbmdlOjRhYzU0NzkzYTQ1MDQwZTY4ZTc1YjYxZDViNjVmNmUxXzUtMS0xLTEtMTk2MzU_dbd9d005-c349-47eb-a20d-9ae3429042db">368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027-2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo0YWM1NDc5M2E0NTA0MGU2OGU3NWI2MWQ1YjY1ZjZlMS90YWJsZXJhbmdlOjRhYzU0NzkzYTQ1MDQwZTY4ZTc1YjYxZDViNjVmNmUxXzYtMS0xLTEtMTk2MzU_fec0ef43-41e5-4df0-bbc2-fcbeb4195923">1,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Multiemployer Pension Plans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover its union-represented employees. The risks of participating in these multiemployer plans are different from single-employer pension plans in the following respects: (i) assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers, (ii) if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers, and (iii) if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the applicable plan, which is referred to as a withdrawal liability. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the multiemployer pension plans in which the Company participates are individually significant to the Company. The Company&#8217;s contributions to multiemployer pension plans were $<ix:nonFraction unitRef="usd" contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231" decimals="-6" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwMzc2_c18594d6-6b8c-4d6d-b97c-9b57b76a6343">19</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231" decimals="-6" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwMzgw_33decb15-5611-49b6-882c-f1d7158293fa">19</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iaf1063688e1c402b918f2251c5ebcda8_D20190101-20191231" decimals="-6" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwMzg3_bbff391b-2918-4b5f-a9bb-88d9a8b147a2">18</ix:nonFraction> million in 2021, 2020 and 2019, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Postretirement Benefits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides postretirement health care and life insurance benefits to certain retirees who meet eligibility requirements. The Company&#8217;s funding policy is generally to pay covered expenses as they are incurred. For retiree medical plan accounting, the Company reviews external data and its own historical trends for health care costs to determine the health care cost trend rates. As of December&#160;31, 2021 and 2020, the Company&#8217;s other postretirement benefits had an accumulated postretirement benefit obligation of $<ix:nonFraction unitRef="usd" contextRef="i85cd553b0d4e4d00807d021b0529afcb_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExMDU5_e093eb3a-ad7b-4851-a80a-05ec7253a284">207</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i70428484fd564ff2a11599326e08e7f3_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExMDY2_5eb1dc3f-50c6-48c5-9a40-fbf84043b8fe">226</ix:nonFraction> million, respectively. Net periodic benefit costs related to these other postretirement benefits were $<ix:nonFraction unitRef="usd" contextRef="i2809337bb72a4fa6997eeb7883adae59_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExMTYz_a6359bee-660e-4930-ac1a-657beeb52f13">4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i94a38e87618941bb9c641ca41807e1e2_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExMTY3_0c1a19ae-4f76-470d-a2e6-84eb026eff5b">12</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife890af6894342c6ab78227d1ee5350c_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExMTc0_fcc5a02d-9ad7-469e-aeb9-4c22d7591bf9">7</ix:nonFraction> million in 2021, 2020 and 2019, respectively. </span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia24f93f97744489093d1f6f2f213c48f" continuedAt="i18d766d7e40a422c9af13225b3259fb6"><ix:continuation id="ibdce44f41c27423097aaf760cebcf0b0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the accumulated other postretirement benefit obligation as of December&#160;31, 2021: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:86.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd553b0d4e4d00807d021b0529afcb_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo3M2Q0OTZmMzU5Zjk0MDFmODA1MTk3NzE1OTg2MmFjNC90YWJsZXJhbmdlOjczZDQ5NmYzNTlmOTQwMWY4MDUxOTc3MTU5ODYyYWM0XzEtMS0xLTEtMTk2MzU_f6651ff3-2162-4155-8d39-5c0b9f3b5b8e">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd553b0d4e4d00807d021b0529afcb_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo3M2Q0OTZmMzU5Zjk0MDFmODA1MTk3NzE1OTg2MmFjNC90YWJsZXJhbmdlOjczZDQ5NmYzNTlmOTQwMWY4MDUxOTc3MTU5ODYyYWM0XzItMS0xLTEtMTk2MzU_d18b5ff9-f4f9-48c4-8905-369d4650ff2e">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd553b0d4e4d00807d021b0529afcb_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo3M2Q0OTZmMzU5Zjk0MDFmODA1MTk3NzE1OTg2MmFjNC90YWJsZXJhbmdlOjczZDQ5NmYzNTlmOTQwMWY4MDUxOTc3MTU5ODYyYWM0XzMtMS0xLTEtMTk2MzU_efd45581-e013-4f81-99ef-84e4dd7b46ae">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd553b0d4e4d00807d021b0529afcb_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo3M2Q0OTZmMzU5Zjk0MDFmODA1MTk3NzE1OTg2MmFjNC90YWJsZXJhbmdlOjczZDQ5NmYzNTlmOTQwMWY4MDUxOTc3MTU5ODYyYWM0XzQtMS0xLTEtMTk2MzU_4b689038-d53d-4bcb-ac92-2eb907daca7a">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd553b0d4e4d00807d021b0529afcb_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo3M2Q0OTZmMzU5Zjk0MDFmODA1MTk3NzE1OTg2MmFjNC90YWJsZXJhbmdlOjczZDQ5NmYzNTlmOTQwMWY4MDUxOTc3MTU5ODYyYWM0XzUtMS0xLTEtMTk2MzU_5bdc423d-2460-4e2e-aa96-a053865f2c2f">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027-2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85cd553b0d4e4d00807d021b0529afcb_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo3M2Q0OTZmMzU5Zjk0MDFmODA1MTk3NzE1OTg2MmFjNC90YWJsZXJhbmdlOjczZDQ5NmYzNTlmOTQwMWY4MDUxOTc3MTU5ODYyYWM0XzYtMS0xLTEtMTk2MzU_ee85f9d0-fc0e-4aa7-84c0-7b6ca3c1d1bc">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i18d766d7e40a422c9af13225b3259fb6">Pursuant to various collective bargaining agreements, the Company also contributes to multiemployer health and welfare plans that cover certain union-represented employees. The plans provide postretirement health care and life insurance benefits to certain employees who meet eligibility requirements. The Company&#8217;s contributions to multiemployer health and welfare plans totaled $<ix:nonFraction unitRef="usd" contextRef="i2809337bb72a4fa6997eeb7883adae59_D20210101-20211231" decimals="-6" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODAx_79c6573f-2994-4c0d-8249-e2af2bbca7be">60</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i94a38e87618941bb9c641ca41807e1e2_D20200101-20201231" decimals="-6" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODA1_cd204597-344c-4c0b-b2e5-c6fad1888577">54</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ife890af6894342c6ab78227d1ee5350c_D20190101-20191231" decimals="-6" name="us-gaap:MultiemployerPlanPensionInsignificantPlanContribution" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODEy_545d9bbd-f1d2-4a81-9f2e-5b7b81f4d316">57</ix:nonFraction> million in 2021, 2020 and 2019, respectively.</ix:continuation> </span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_160"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzQyODY_b8282ef2-874e-4055-bdb2-891481b541cd" continuedAt="i3c444f5701ce4700900b35a2481da492" escape="true">Income Taxes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3c444f5701ce4700900b35a2481da492" continuedAt="i0f5e71e5ad4a40a4aa95519fbf4cbde2"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzQyODg_ffbf19fd-dbf7-4592-8010-1c54721ad091" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision for continuing operations consisted of the following for the&#160;years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzItMS0xLTEtMTk2MzU_7ef96f07-d71c-4b84-b5f1-6e1abbfbcc4a">2,285</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzItMy0xLTEtMTk2MzU_a8b790fe-f7bc-4f6b-8303-7fc4897c0480">2,615</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzItNS0xLTEtMTk2MzU_cc0c784d-06d3-4af2-b41a-d69f803c1220">2,450</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzMtMS0xLTEtMTk2MzU_793bed85-4249-4132-a9f1-7ef4d7dc78a7">665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzMtMy0xLTEtMTk2MzU_58b23dd4-de79-4a3b-b5bf-72e17a695946">518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzMtNS0xLTEtMTk2MzU_66ea4942-bdf6-4c91-a63d-2ea335156cb3">565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzQtMS0xLTEtMTk2MzU_42897588-7534-42cf-8df1-a3aa97c3b65a">2,950</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzQtMy0xLTEtMTk2MzU_bf096000-4ba4-4f71-af53-57789ae14f63">3,133</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzQtNS0xLTEtMTk2MzU_806fb6c4-3794-411e-ac7b-1a63670d341a">3,015</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzYtMS0xLTEtMTk2MzU_54486388-d9c9-4af7-ba2e-a6d505e8196d">306</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzYtMy0xLTEtMTk2MzU_752ec94f-0a4d-42cd-9d3f-a5b50ae4f36a">450</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzYtNS0xLTEtMTk2MzU_1ccb064d-8016-49be-864b-a098bcd3eab9">535</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzctMS0xLTEtMTk2MzU_89276498-f747-4845-8e6e-08f1bc67f154">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzctMy0xLTEtMTk2MzU_4f395ad3-b0ba-4b2c-88f3-3e93a3ae6068">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzctNS0xLTEtMTk2MzU_e1c6ffab-5943-4e5b-8ce1-10076450dbea">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzgtMS0xLTEtMTk2MzU_ad7e4e3b-a0a6-4969-8364-a9d28ba32000">428</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzgtMy0xLTEtMTk2MzU_01be94ba-70e5-4bf4-a8af-cda3eaf90d9b">564</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzgtNS0xLTEtMTk2MzU_ded3090b-8fe9-4e72-bd2c-dbda8b9f6cf3">649</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzktMS0xLTEtMTk2MzU_6076048e-065c-4ad9-b18f-debc6e6bcc9e">2,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzktMy0xLTEtMTk2MzU_cf627594-97c2-4057-a3b6-838625db083a">2,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzktNS0xLTEtMTk2MzU_65ec79e7-01e4-4aa5-aeef-765e37840151">2,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzQyODk_85963f0a-cfd3-4eff-973e-75d0a83efce6" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of the statutory income tax rate to the Company&#8217;s effective income tax rate for continuing operations for the&#160;years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzEtMS0xLTEtMTk2MzU_690b91b1-04a9-4b6f-b91c-59635c2e62b4">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzEtMy0xLTEtMTk2MzU_764188b8-71b3-4f94-b281-4012963eec6c">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzEtNS0xLTEtMTk2MzU_f7966e61-da66-4b99-84b5-e77397206774">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzItMS0xLTEtMTk2MzU_2e72dc8f-d942-4190-bf50-3556bc8b0a1a">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzItMy0xLTEtMTk2MzU_384451f6-3b77-444b-8036-dbc0ee247d4d">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzItNS0xLTEtMTk2MzU_716bec7e-c481-4dc5-92a6-bc1cf2ed8241">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurer fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="3" name="cvs:HealthInsurerFeeTaxEffectPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzQtMS0xLTEtMTk2MzU_9f908fc5-4c53-402c-bca4-8116bf597d0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="3" name="cvs:HealthInsurerFeeTaxEffectPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzQtMy0xLTEtMTk2MzU_b049a64d-ef88-4895-8746-60d652765f64">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="3" name="cvs:HealthInsurerFeeTaxEffectPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzQtNS0xLTEtMTk2MzU_621e0fc3-4eef-480c-97d3-155811e84d94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis difference upon disposition of subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzYtMS0xLTEtMTk2MzU_60d38d37-9f18-414d-a1ed-487b3398c16e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzYtMy0xLTEtMTk2MzU_651f8635-017f-48af-ba73-4ced03e17415">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzYtNS0xLTEtMTk2MzU_e4966db4-b182-45c3-9f5f-f11bfe6bb543">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year refund claim </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzUtMS0xLTEtNjc1NTk_3e564ec3-1ff7-4817-9f25-0703beab4df5">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzUtMy0xLTEtNjc1NTk_3252c4a5-99ae-4bea-a123-9ee4894bc183">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzUtNS0xLTEtNjc1NTk_fc392397-5c14-4118-95cb-9ca1292b9a26">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzctMS0xLTEtMTk2MzU_10a8819f-3745-459d-a0cf-81c5923fc07d">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzctMy0xLTEtMTk2MzU_00ede423-e95d-41f9-a0b7-f15e96699534">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzctNS0xLTEtMTk2MzU_0b61f719-8d00-4c96-b187-6d0e4efc3982">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzgtMS0xLTEtMTk2MzU_62910e5c-d1f0-4315-8dec-558d378d378e">24.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzgtMy0xLTEtMTk2MzU_d2c4a1f1-565f-418d-9de5-f2cd4443caba">26.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzgtNS0xLTEtMTk2MzU_4c46f1be-6e02-486c-97ee-62d4d7c5975c">26.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0f5e71e5ad4a40a4aa95519fbf4cbde2" continuedAt="i09f9e49769c34d939f16b0b3513d71e8"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzQyNzY_9deb747b-c8a2-4e76-9416-1a220a1d672b" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of the Company&#8217;s deferred income tax assets and liabilities as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:78.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzItMS0xLTEtMTk2MzU_a8933681-62d5-4c74-8f80-3d2bbe19eab7">5,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzItMy0xLTEtMTk2MzU_26df5aa1-f651-4334-bed6-373dda65d727">5,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzMtMS0xLTEtMTk2MzU_c6bb36b4-5178-41a0-a09f-51df0baf5817">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzMtMy0xLTEtMTk2MzU_0430780d-7586-494c-861f-616ce4fc170b">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzQtMS0xLTEtMTk2MzU_ef56f27e-9c18-4de0-bba1-61ff1181226f">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzQtMy0xLTEtMTk2MzU_84a026d7-0d66-42e3-867c-308231fe2714">238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debts and other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzUtMS0xLTEtMTk2MzU_e7a770e4-f3f4-47c2-a421-c6ffb10bee73">489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzUtMy0xLTEtMTk2MzU_43958928-b56b-4296-bcff-172248aeae01">395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and capital loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzctMS0xLTEtMTk2MzU_f8128262-f0a9-4e25-8c8d-411b0a3e5f8a">416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzctMy0xLTEtMTk2MzU_963ddbce-60e1-4491-98bd-fe65f320db03">568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzgtMS0xLTEtMTk2MzU_e0314f80-d986-4f0f-87fd-6952726323fb">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzgtMy0xLTEtMTk2MzU_133213e3-4dee-4420-a785-0cc1a98243f2">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzktMS0xLTEtMTk2MzU_fdc59ee5-45ba-4f03-bd84-9c8672cf1f30">501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzktMy0xLTEtMTk2MzU_125a4d23-26d3-4b59-baba-894600a22a29">489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll tax deferral</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DeferredTaxAssetsPayrollTaxDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzEwLTEtMS0xLTE5NjM1_3d1f54a3-660c-4ef3-992c-176dc2b88cb9">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:DeferredTaxAssetsPayrollTaxDeferral" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzEwLTMtMS0xLTE5NjM1_79e3be5c-58ba-429d-ab86-0f99e915043b">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzExLTEtMS0xLTE5NjM1_12128ac1-600a-47c3-8b1d-b32c2426fb2a">396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzExLTMtMS0xLTE5NjM1_e946ed14-74fa-40a3-88c2-67410addd203">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzEyLTEtMS0xLTE5NjM1_868810f9-2a73-4dae-b2e8-13dee4ef487d">325</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzEyLTMtMS0xLTE5NjM1_3ca1baa2-8524-4399-99d2-43f86cac974d">454</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzEzLTEtMS0xLTE5NjM1_5c0a4a99-ac24-4282-9323-0aee17fa9b58">7,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzEzLTMtMS0xLTE5NjM1_89af1c84-3dbd-44c5-ab76-f3119949c1f5">7,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DeferredTaxLiabilitiesRetirementBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE1LTEtMS0xLTE5NjM1_fc23fb4b-435d-4fa4-8624-c2211a6a9604">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:DeferredTaxLiabilitiesRetirementBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE1LTMtMS0xLTE5NjM1_d2e9e3ce-8a7a-4b19-b45b-8eac6ce7614a">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE2LTEtMS0xLTE5NjM1_ad6c31f8-2353-4749-ba24-fb90284e0ea3">334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE2LTMtMS0xLTE5NjM1_62fa2e9e-18e0-4c45-95fc-61b35e79a808">421</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE3LTEtMS0xLTE5NjM1_1d5493a2-1b79-4941-a446-ba5525e1fa77">4,947</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE3LTMtMS0xLTE5NjM1_bf65d831-706e-4f8a-88f2-00e957fb670e">5,368</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="cvs:DeferredTaxLiabilitiesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE4LTEtMS0xLTE5NjM1_cca5a37c-6bbd-4b29-8153-2b5f61c6adce">8,381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="cvs:DeferredTaxLiabilitiesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE4LTMtMS0xLTE5NjM1_38fb2ef4-6b3b-4dc4-a492-24e9e4ccbbd1">8,750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE5LTEtMS0xLTE5NjM1_8ef6f913-55c1-4bea-b1c5-d530a042f456">13,767</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE5LTMtMS0xLTE5NjM1_21ecc55e-045f-42ef-b043-9b179728607f">14,568</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzIwLTEtMS0xLTE5NjM1_5ae6499a-542b-415a-9108-5a074178d044">6,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzIwLTMtMS0xLTE5NjM1_eebcb7a7-2f80-4f5f-9c72-843b15ddba08">6,794</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had net operating and capital loss carryovers of $<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzEzMDI_f8128262-f0a9-4e25-8c8d-411b0a3e5f8a">416</ix:nonFraction> million, which expire between 2022 and 2041. The Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and the Company&#8217;s recent operating results. The Company established a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzE2MzA_868810f9-2a73-4dae-b2e8-13dee4ef487d">325</ix:nonFraction> million as of December&#160;31, 2021 because it does not consider it more likely than not that these deferred tax assets will be recovered.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzQyNzc_83ff644f-80aa-408a-a486-de257d7360f9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balance of unrecognized tax benefits in 2021, 2020 and 2019 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzEtMS0xLTEtMTk2MzU_14fb7866-659b-42ac-bfee-c29816ff8302">768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzEtMy0xLTEtMTk2MzU_2e326ba8-4ea8-4150-ad14-f7fb2751c5b5">655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23e34e947aac44fc9f5cf5448f94f452_I20181231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzEtNS0xLTEtMTk2MzU_881a6e9e-7a55-4677-95b1-aa13deddbd1d">661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzItMS0xLTEtMTk2MzU_328ff217-08d0-4956-b214-16fe4aae7101">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzItMy0xLTEtMTk2MzU_ccbbaf28-1784-4795-8ebf-b9f5980653d0">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzItNS0xLTEtMTk2MzU_51fe54a0-d59c-45ef-a387-f4111ee72639">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzMtMS0xLTEtMTk2MzU_777f1d36-51b5-43d4-9414-5060381fe99b">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzMtMy0xLTEtMTk2MzU_3a604df1-f216-406b-8550-901006300793">182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzMtNS0xLTEtMTk2MzU_babd2a68-9344-4e17-9934-fe5f45a551f1">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzQtMS0xLTEtMTk2MzU_d6f82796-bd84-4ab8-9f38-5cf7b1bb7bde">33</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzQtMy0xLTEtMTk2MzU_9220d01a-c5db-406b-9a9c-4bbcf7c9c0a4">56</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzQtNS0xLTEtMTk2MzU_0c3896fe-7e6e-400f-b42c-6688a60f4825">111</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of statutes of limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzUtMS0xLTEtMTk2MzU_21ec9212-5f36-4494-831a-d5445947599b">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzUtMy0xLTEtMTk2MzU_2c161acc-6f3f-4efa-813a-66de9461d3eb">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzUtNS0xLTEtMTk2MzU_3608831d-f7db-4678-ac1b-6edc8742e11b">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzYtMS0xLTEtMTk2MzU_723110cb-c316-4178-8de8-2859be48c23d">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzYtMy0xLTEtMTk2MzU_8fadc74f-4192-436a-bf7f-08819c06f586">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzYtNS0xLTEtMTk2MzU_c62e69e5-fd26-46bd-8971-e968cbaae626">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzctMS0xLTEtMTk2MzU_bfb2a475-d3f6-46e7-8f13-e00a48120016">782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzctMy0xLTEtMTk2MzU_d46f984f-2199-47db-ac7a-3f09296ba59e">768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzctNS0xLTEtMTk2MzU_2b84a8a1-fbe5-4246-9d6a-cf5e8b27367c">655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation and most of its subsidiaries are subject to U.S. federal income tax as well as income tax of numerous state and local jurisdictions. CVS Health Corporation participated in the Compliance Assurance Process through 2019, which is a program made available by the U.S. Internal Revenue Service (&#8220;IRS&#8221;) to certain qualifying large taxpayers, under which participants work collaboratively with the IRS to identify and resolve potential tax issues through open, cooperative and transparent interaction prior to the annual filing of their federal income tax returns. The IRS has completed its examinations of the Company&#8217;s consolidated U.S. federal income tax returns for tax years through and including 2013 and 2018. The IRS has substantially completed its examinations of the Company&#8217;s consolidated U.S. federal income tax returns for tax years 2014 through 2017 and 2019.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i09f9e49769c34d939f16b0b3513d71e8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation and its subsidiaries are also currently under income tax examinations by a number of state and local tax authorities. As of December&#160;31, 2021, no examination has resulted in any proposed adjustments that would result in a material change to the Company&#8217;s operating results, financial condition or liquidity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all material state and local income tax matters have been concluded for fiscal years through 2014. Certain state exams are likely to be concluded and certain state statutes of limitations will lapse in 2022, but the change in the balance of the Company&#8217;s uncertain tax positions is projected to be immaterial. In addition, it is reasonably possible that the Company&#8217;s unrecognized tax benefits could change within the next twelve months due to the anticipated conclusion of various examinations with the IRS for various years. An estimate of the range of the possible change cannot be made at this time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records interest expense related to unrecognized tax benefits and penalties in the income tax provision. The Company accrued interest expense of approximately $<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzM5MTA_8fda36d5-f051-4e0e-952a-7efff3395dc2">40</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzM5MTQ_cbadba4f-4665-4133-9e73-1f69679854f9">34</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzM5MjE_9734ed2a-6c12-4c29-b4bd-0ba36708d80a">49</ix:nonFraction> million in 2021, 2020 and 2019, respectively. The Company had approximately $<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzM5ODY_b06fb92a-63b6-4044-8210-72ec672c234b">151</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzM5OTM_53257055-119a-47c7-aff5-8e1b84f64df6">121</ix:nonFraction> million accrued for interest and penalties as of December&#160;31, 2021 and 2020, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the total amount of unrecognized tax benefits that, if recognized, would affect the Company&#8217;s effective income tax rate is approximately $<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzQyMTE_d6b6135f-fb69-4197-80f4-fbc0dbd326cb">669</ix:nonFraction> million, after considering the federal benefit of state income taxes.</span></div></ix:continuation><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_163"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NTU_b690a805-f63d-4ecc-bf73-fffc67da84ec" continuedAt="i2cebb5698a14471297d62ec7c6824a58" escape="true">Stock Incentive Plans</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2cebb5698a14471297d62ec7c6824a58" continuedAt="i08ae390ba6e44d64b528023560bb7e33"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the CVS Health 2017 Incentive Compensation Plan (&#8220;ICP&#8221;) provide for grants of annual incentive and long-term performance awards to executive officers and other officers and employees of the Company or any subsidiary of the Company, as well as equity compensation to outside directors of CVS Health Corporation. Payment of such annual incentive and long-term performance awards will be in cash, stock, other awards or other property, at the discretion of the Management Planning and Development Committee (the &#8220;MP&amp;D Committee&#8221;) of the Board. The ICP allows for a maximum of <ix:nonFraction unitRef="shares" contextRef="i1e00ca9657da47ec87effc5e2a1aeac7_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzYzOQ_d693c3e1-3eec-4378-a99c-aca530e4c2ce">58</ix:nonFraction> million shares of CVS Health Corporation common stock to be reserved and available for grants. As of December&#160;31, 2021, there were approximately <ix:nonFraction unitRef="shares" contextRef="i1e00ca9657da47ec87effc5e2a1aeac7_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzc1Mg_1e61ff49-7303-43b7-b3fe-fa9445bbad45">30</ix:nonFraction> million shares of CVS Health Corporation common stock available for future grants under the ICP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the acquisition of Aetna (the &#8220;Aetna Acquisition&#8221;) on November 28, 2018, approximately <ix:nonFraction unitRef="shares" contextRef="iac75a9034e7c40fb82a43cf2c75280b0_I20181128" decimals="-6" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg4MQ_d48f7141-f2bc-4efd-aa01-1a6c4dc1b212">22</ix:nonFraction> million shares of Aetna common stock subject to awards outstanding under the Amended Aetna Inc. 2010 Stock Incentive Plan (&#8220;SIP&#8221;) were assumed by CVS Health Corporation. In addition, in accordance with the merger agreement, shares which were available for future issuance under the SIP were converted into approximately <ix:nonFraction unitRef="shares" contextRef="iac75a9034e7c40fb82a43cf2c75280b0_I20181128" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzExODQ_a76d3f0c-4bf4-4a9c-bb21-ebde2eed5bf7">32</ix:nonFraction> million shares of CVS Health Corporation common stock reserved and available for issuance pursuant to future awards. Subsequent to the expiration of the SIP on May 21, 2020, the ICP is the only compensation plan under which the Company grants stock options, restricted stock and other stock-based awards to its employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzE3MDk_ea62d84c-7b65-4b23-9d75-3a8341c56a52">three</span> to <ix:nonNumeric contextRef="i2f08d731825c4986934a5374bd021d17_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzMyOTg1MzQ4OTM5NzY_b5633e98-197b-4cd4-88cd-ffd41e6077cb">five years</ix:nonNumeric>) using the straight-line method. <ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NTY_a6dd0f24-32b9-4cca-b42b-61ec98152950" continuedAt="i37bb615c0e55455f9baa4451134de4fa" escape="true">The following table is a summary of stock-based compensation for the&#160;years ended December&#160;31, 2021, 2020 and 2019:</ix:nonNumeric></span></div><ix:continuation id="i37bb615c0e55455f9baa4451134de4fa"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and stock appreciation rights (&#8220;SARs&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzEtMS0xLTEtMTk2MzU_faee2223-30c5-4de6-b2cb-674e3f7ced70">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d379918d1544988d301637f8418348_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzEtMy0xLTEtMTk2MzU_bb60bf11-99fe-4595-b85c-bf3b71c881fa">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie67cd2601892401dbc7e134d3a278afc_D20190101-20191231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzEtNS0xLTEtMTk2MzU_e4ae17ee-3637-4646-87ce-5d86c8fe2d81">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzItMS0xLTEtMTk2MzU_72add207-0944-40a2-b2b0-5d5f243c9f23">404</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43347484543148728067fc355f1bc0cb_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzItMy0xLTEtMTk2MzU_ba2ebc70-30e0-49bd-975f-ef3a55f86ce6">329</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee318d09ac047368832cb3dc191916e_D20190101-20191231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzItNS0xLTEtMTk2MzU_912042cb-9cdb-4d3b-a926-5bc3677dd6d9">377</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzMtMS0xLTEtMTk2MzU_044e5f0f-7ba6-495f-acd4-ce140640f497">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzMtMy0xLTEtMTk2MzU_bf8cc9be-2df4-45df-9f36-9fca66c5c984">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzMtNS0xLTEtMTk2MzU_af20f758-5ee2-4db5-ba8e-41a15c5036be">453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes the ESPP.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Employee Stock Purchase Plan (&#8220;ESPP&#8221;) provides for the purchase of up to <ix:nonFraction unitRef="shares" contextRef="i93c58d30105d4b0c9c482412ced85d79_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzIyNzQ_b55debeb-c595-45c5-9a8f-571a4798e1d6">60</ix:nonFraction> million shares of CVS Health Corporation common stock. Under the ESPP, eligible employees may purchase common stock at the end of each six&#160;month offering period at a purchase price equal to <ix:nonFraction unitRef="number" contextRef="ie549abdb9cf943f6acd4a4f0dc937118_D20210101-20211231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzI0NDY_ccc59db3-810e-4c53-9148-823fa34ea065">90</ix:nonFraction>% of the lower of the fair market value on the first day or the last day of the offering period. During 2021, approximately <ix:nonFraction unitRef="shares" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzI1Njk_22341548-c6ea-4f02-b7ae-745ca21957a3">3</ix:nonFraction> million shares of common stock were purchased under the provisions of the ESPP at an average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="2" name="cvs:StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzI2NjY_2234520c-0d3a-469f-b6c2-2b242f8ae605">60.51</ix:nonFraction> per share. As of December&#160;31, 2021, approximately <ix:nonFraction unitRef="shares" contextRef="i93c58d30105d4b0c9c482412ced85d79_I20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzI3MDQ_895a2bfc-cfc4-4286-89a2-8edaaf9b8d97">31</ix:nonFraction> million shares of common stock were available for issuance under the ESPP.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i08ae390ba6e44d64b528023560bb7e33" continuedAt="ib4a04dd7f2f94170af62991f3d47fe9b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock-based compensation associated with the ESPP is estimated on the date of grant (the first day of the six&#160;month offering period) using the Black-Scholes option pricing model.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NjM_bed2892f-de1f-4b4b-b26f-0b233c350352" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the assumptions used to value the ESPP awards for the&#160;years ended December&#160;31, 2021, 2020 and 2019:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie549abdb9cf943f6acd4a4f0dc937118_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzEtMS0xLTEtMTk2MzU_81317cb9-8a1c-4bac-b551-fe6de7e427f7">1.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie333142c626e457f8b7400acc37b2e0e_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzEtMy0xLTEtMTk2MzU_60674811-85ef-41b5-80f4-2a9ae77cfc91">1.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2a27cad79fee4e3fb41f31a513d985a2_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzEtNS0xLTEtMTk2MzU_24c13af7-180a-42e6-ae75-f65aac367d93">1.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie549abdb9cf943f6acd4a4f0dc937118_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzItMS0xLTEtMTk2MzU_d0e67670-9dda-4534-b163-0484977b2873">25.27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie333142c626e457f8b7400acc37b2e0e_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzItMy0xLTEtMTk2MzU_131f94fe-fafd-480d-9480-3ac2f22acbf8">37.21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2a27cad79fee4e3fb41f31a513d985a2_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzItNS0xLTEtMTk2MzU_ae3a0959-293d-4cdd-9bde-827db7e3cbd3">27.96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie549abdb9cf943f6acd4a4f0dc937118_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzMtMS0xLTEtMTk2MzU_9d8b1789-83e8-499b-b59a-fa5e50ff865f">0.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie333142c626e457f8b7400acc37b2e0e_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzMtMy0xLTEtMTk2MzU_c023f15b-bb0f-4783-87e7-7819623247ed">0.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2a27cad79fee4e3fb41f31a513d985a2_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzMtNS0xLTEtMTk2MzU_2c66aa63-18ec-4101-afb7-476052d4e455">2.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie549abdb9cf943f6acd4a4f0dc937118_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzQtMS0xLTEtMTk2MzU_22fa1c0c-3ee8-4716-9c09-b596566c363f">0.5</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie333142c626e457f8b7400acc37b2e0e_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzQtMy0xLTEtMTk2MzU_c9356cca-7d64-43c6-96f6-72056a09942a">0.5</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2a27cad79fee4e3fb41f31a513d985a2_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzQtNS0xLTEtMTk2MzU_f33cb9e1-72df-45a1-ae40-4ed4dd1157d5">0.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie549abdb9cf943f6acd4a4f0dc937118_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzUtMS0xLTEtMTk2MzU_6ad54796-93e7-4277-a08f-e3aec84a8320">12.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie333142c626e457f8b7400acc37b2e0e_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzUtMy0xLTEtMTk2MzU_ab3746cb-8cb5-4631-aed0-f21c9f93026f">13.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2a27cad79fee4e3fb41f31a513d985a2_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzUtNS0xLTEtMTk2MzU_4aa65ea9-8d04-425f-9035-a2ac0ad83417">10.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is calculated based on semi-annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#8217;s daily stock price over the previous six&#160;month period.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on the Treasury constant maturity interest rate whose term is consistent with the expected term of ESPP purchases (i.e., six&#160;months).</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected life is based on the semi-annual purchase period.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units and Performance Stock Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s restricted stock units and performance stock units are considered nonvested share awards and require no payment from the employee. The fair value of the restricted stock units is based on the market price of CVS Health Corporation common stock on the grant date and is recognized on a straight-line basis over the vesting period. For each restricted stock unit granted, employees receive one share of common stock, net of taxes, at the end of the vesting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s performance stock units contain performance vesting conditions in addition to a service vesting condition. Vesting of the Company&#8217;s performance stock units is dependent upon the degree to which the Company achieves its performance goals, which are generally set for a three-year performance period and are approved at the time of grant by the MP&amp;D Committee. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of performance stock units granted with service and performance vesting conditions is based on the market price of CVS Health Corporation common stock on the grant date and is recognized over the vesting period. Certain of the performance stock units also contain a market vesting condition based on the performance of CVS Health Corporation common stock relative to a comparator group. The fair value of these performance stock units is determined using a Monte Carlo simulation as of the grant date and is recognized over the vesting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i39274e5a60794450836f17e832f652ef_I20211231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzUzNTk_33d36230-e001-4ca3-9940-6564ef0add4b">529</ix:nonFraction> million of total unrecognized compensation cost related to the Company&#8217;s restricted stock units and performance stock units that are expected to vest. These costs are expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzU1ODE_e384cdd2-1e3d-4fea-bdc9-329a03019e03">2.1</ix:nonNumeric> years. The total fair value of restricted stock units vested during 2021, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzU2NjQ_220ef69e-9fa3-45c7-bfaf-1e2dc8d0dbf6">406</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i43347484543148728067fc355f1bc0cb_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzU2Njg_5aa87985-ee75-4920-81ed-71f6b8490938">229</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4ee318d09ac047368832cb3dc191916e_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzU2NzU_87db9e91-09f4-4e5d-b255-2f06a9a93908">265</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NDk_2513ed8f-a007-4b9b-ae49-c0578cc62f7d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the restricted stock unit and performance stock unit activity for the&#160;year ended December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.422%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In thousands, except weighted average grant date fair value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7c3db8973f246b592a6bdc7ae66c5d4_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzEtMS0xLTEtMTk2MzU_535188c2-a77c-43d6-8fc7-07a99eba88fd">14,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if7c3db8973f246b592a6bdc7ae66c5d4_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzEtMy0xLTEtMTk2MzU_135d162f-cda7-40b4-92de-e39f3e61046f">58.12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzItMS0xLTEtMTk2MzU_96ff9d53-04fd-4fa8-92c7-e9e87c61989f">6,190</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzItMy0xLTEtMTk2MzU_be28c381-88e4-495f-bf27-1ca70b9904ac">74.39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzMtMS0xLTEtMTk2MzU_b51d9f52-3bf2-4645-86c9-573282951089">5,448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzMtMy0xLTEtMTk2MzU_26008efb-f0eb-4172-95c2-471689e18795">74.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzQtMS0xLTEtMTk2MzU_8b424cf6-eef0-4cc2-9e15-868fbbc2dbe9">1,236</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzQtMy0xLTEtMTk2MzU_4e5802f8-5f88-4da3-9eab-e56bb4fef751">63.40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39274e5a60794450836f17e832f652ef_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzUtMS0xLTEtMTk2MzU_c41c8af2-e633-415d-ab13-3172276cc87b">14,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i39274e5a60794450836f17e832f652ef_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzUtMy0xLTEtMTk2MzU_6f3acca2-1ea4-48a0-b1c9-f509117adb14">63.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options and SARs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All stock option grants are awarded at fair value on the date of grant. The fair value of stock options is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">157</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib4a04dd7f2f94170af62991f3d47fe9b" continuedAt="idabea09ea7af4f4b80868c721b3f48f4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">service period. Stock options granted generally become exercisable over a <ix:nonNumeric contextRef="ied331db8439f40e395a4f8943266cba6_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NTI_0a28066e-868e-4721-9d9a-98028250aad9">four-year</ix:nonNumeric> period from the grant date. Stock options granted through 2018 generally expire <ix:nonNumeric contextRef="i69a67aadd34647f781446b1f63119ac5_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzYyNTU_36f0f9bb-9dca-4d5b-ba09-3e9e0c8566f1">seven years</ix:nonNumeric> after the grant date. Stock options granted subsequent to 2018 generally expire <ix:nonNumeric contextRef="if24ed4bf2c534b4b938b4ca3b222bbd1_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzYzMzg_ceef3672-cac8-452b-bab5-636125253a93">ten years</ix:nonNumeric> after the grant date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All unvested Aetna SARs outstanding upon the acquisition of Aetna were converted into replacement CVS Health Corporation SARs. The replacement SARs granted are settled in CVS Health Corporation common stock, net of taxes, based on the appreciation of the stock price on the exercise date over the market price on the date of grant. The fair value of SARs is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite service period. SARs generally become exercisable over a <ix:nonNumeric contextRef="id0b126cbb01d4598a07ab0c18962d7ac_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NDI_e1e5de9e-dcc4-4ff0-8182-c14d96ffa296">three-year</ix:nonNumeric> period from the grant date. SARs generally expire <ix:nonNumeric contextRef="id0b126cbb01d4598a07ab0c18962d7ac_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzcwMzA_f831be10-82e0-4494-8c72-75848ff54195">ten years</ix:nonNumeric> after the grant date. No SARs have been granted subsequent to the Aetna Acquisition.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NjA_4e8cf7ce-61c1-495f-8401-5efa3a89d732" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of stock option and SAR activity that occurred for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from stock options exercised (including ESPP)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzEtMS0xLTEtMTk2MzU_79d5f3a8-64df-41d5-945a-d4c69a89de69">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d379918d1544988d301637f8418348_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzEtMy0xLTEtMTk2MzU_38fbe0fa-c7e1-4d5f-b3e2-18df83b3f2b1">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie67cd2601892401dbc7e134d3a278afc_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzEtNS0xLTEtMTk2MzU_302941cd-2913-446f-9cc9-cb66237a6cb8">210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes for net share settlement of equity awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzItMS0xLTEtMTk2MzU_3a217fff-04b4-4164-a753-24d76975f7bd">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d379918d1544988d301637f8418348_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzItMy0xLTEtMTk2MzU_86fd83b7-0fed-4430-9666-39cc8df5d742">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie67cd2601892401dbc7e134d3a278afc_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzItNS0xLTEtMTk2MzU_bc6515c5-1d78-4fcd-9c89-e6f057fb392b">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value of stock options and SARs exercised </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzMtMS0xLTEtMTk2MzU_06cb35ca-6a95-42d1-9291-731cf65a911d">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d379918d1544988d301637f8418348_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzMtMy0xLTEtMTk2MzU_792ec368-c1f9-4a15-9979-d7307d31a9d9">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie67cd2601892401dbc7e134d3a278afc_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzMtNS0xLTEtMTk2MzU_e5e928b3-ec96-45ee-9fc9-50faeee40234">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of stock options and SARs vested </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231" decimals="-6" name="cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzQtMS0xLTEtMTk2MzU_396209e9-f3cb-41b8-8132-9f4b60d86f80">224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85d379918d1544988d301637f8418348_D20200101-20201231" decimals="-6" name="cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzQtMy0xLTEtMTk2MzU_14e1a4e9-7840-4fd4-9ee7-0aeb9854842b">252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie67cd2601892401dbc7e134d3a278afc_D20190101-20191231" decimals="-6" name="cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzQtNS0xLTEtMTk2MzU_349f55c7-49f1-45ce-b0b4-90cf2d3da26e">467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NjE_ae33d7bc-3797-4f4b-8561-828ce7904f11" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option is estimated using the Black-Scholes option pricing model based on the following assumptions at the time of grant:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ied331db8439f40e395a4f8943266cba6_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzEtMS0xLTEtMTk2MzU_630f4c6c-120a-4ecc-9740-cda06f3ba46b">2.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie4ebc26cbc0c4a72b41fad331a976a13_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzEtMy0xLTEtMTk2MzU_47500623-6a43-4d20-a7b3-008ff79c26cf">3.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i047eb0ccbb624e599edde0bdc4b342b3_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzEtNS0xLTEtMTk2MzU_730831b7-3329-42d3-ab5f-3f4848462b94">3.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ied331db8439f40e395a4f8943266cba6_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzItMS0xLTEtMTk2MzU_c4e09ef0-aeeb-47b7-9784-3892726cd865">27.10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie4ebc26cbc0c4a72b41fad331a976a13_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzItMy0xLTEtMTk2MzU_927b0ab9-39dc-464f-abca-6975a6a69c13">25.22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i047eb0ccbb624e599edde0bdc4b342b3_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzItNS0xLTEtMTk2MzU_53ff54f5-d6ab-4e81-8a9e-78f667191d1c">21.76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ied331db8439f40e395a4f8943266cba6_D20210101-20211231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzMtMS0xLTEtMTk2MzU_912f3cf1-64ba-4178-91ba-40737077fe26">1.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie4ebc26cbc0c4a72b41fad331a976a13_D20200101-20201231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzMtMy0xLTEtMTk2MzU_f9935a48-7884-4ef6-845f-c1141dca0509">0.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i047eb0ccbb624e599edde0bdc4b342b3_D20190101-20191231" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzMtNS0xLTEtMTk2MzU_489e1292-9ba4-479d-8006-c4ef3a1ca92e">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ied331db8439f40e395a4f8943266cba6_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzQtMS0xLTEtMTk2MzU_b04bedb8-b97f-4ca4-b4f8-4c2d29e1f9fa">6.3</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie4ebc26cbc0c4a72b41fad331a976a13_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzQtMy0xLTEtMTk2MzU_9145058b-a42d-4ae8-972e-37b656c83eda">6.3</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i047eb0ccbb624e599edde0bdc4b342b3_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzQtNS0xLTEtMTk2MzU_2faf8602-4831-41e7-ae25-b84cdb40eead">6.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ied331db8439f40e395a4f8943266cba6_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzUtMS0xLTEtMTk2MzU_99eda277-ef61-4f62-9867-0f8513b5f6eb">14.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie4ebc26cbc0c4a72b41fad331a976a13_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzUtMy0xLTEtMTk2MzU_b6eaea6c-0e46-456e-baba-258455807663">8.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i047eb0ccbb624e599edde0bdc4b342b3_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzUtNS0xLTEtMTk2MzU_6bcd6e86-0242-49e0-b913-f78ad226a9a7">6.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is based on annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#8217;s daily stock price over a period equal to the expected life of each option grant after adjustments for infrequent events such as stock splits.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on yields from U.S. Treasury zero-coupon issues with a remaining term equal to the expected term of the options being valued.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected life represents the number of&#160;years the options are expected to be outstanding from grant date based on historical option or SAR holder exercise experience.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, unrecognized compensation expense related to unvested stock options totaled $<ix:nonFraction unitRef="usd" contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzgzODk_ec8fa21c-9c61-4ce4-8ef8-d3be1990bf3d">38</ix:nonFraction> million, which the Company expects to be recognized over a weighted-average period of <ix:nonNumeric contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg0NzA_0f4e6e96-7ab7-4692-bcf7-91621b36a2f4">2.0</ix:nonNumeric> years. After considering anticipated forfeitures, the Company expects approximately <ix:nonFraction unitRef="shares" contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231" decimals="-6" name="cvs:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg1NTE_e12d8f03-f884-4a66-bf7b-fd378931982c">9</ix:nonFraction> million of the unvested stock options to vest over the requisite service period.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idabea09ea7af4f4b80868c721b3f48f4"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NTQ_06988345-18a0-4a8d-8025-63dffdcf026c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s stock option and SAR activity for the&#160;year ended December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.747%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;thousands, except weighted average exercise price and remaining contractual term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if345988696b749e88cd89e722c59ebd7_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzEtMS0xLTEtMTk2MzU_744ebb94-125e-4594-9ffa-c988e1503ca8">23,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if345988696b749e88cd89e722c59ebd7_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzEtMy0xLTEtMTk2MzU_ceb8c6e8-e96c-4bfb-8e30-0e5eb6804f6a">69.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzItMS0xLTEtMTk2MzU_48f8f30b-ce46-48b6-86c1-0abd3e9e000d">3,322</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzItMy0xLTEtMTk2MzU_a406db26-5200-43db-9c04-b222109901c4">74.66</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzMtMS0xLTEtMTk2MzU_0ddcb770-a146-484b-ab70-ffc8068b79da">6,366</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzMtMy0xLTEtMTk2MzU_d6195562-942d-4341-8f00-24191c72df95">63.41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzQtMS0xLTEtMTk2MzU_96196d90-3a00-4394-856b-82476d146361">694</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzQtMy0xLTEtMTk2MzU_de84493e-934f-42fa-bf12-6917afe8a359">62.66</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzUtMS0xLTEtMTk2MzU_23aa87fa-3cd6-4840-8131-8d15abd639fa">1,156</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzUtMy0xLTEtMTk2MzU_64844068-f4f8-4b3d-9652-23b1519eee4e">87.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzYtMS0xLTEtMTk2MzU_1e8fe726-c831-41fb-8954-dcacbf844c27">19,061</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzYtMy0xLTEtMTk2MzU_258a5423-a78f-4595-aa2c-a50ddc61a069">71.74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzYtNS0xLTEtMTk2MzU_7c46d0a6-5124-42b0-8d3d-2362ebd7a613">4.75</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzYtNy0xLTEtMTk2MzU_d32dbdbb-95ae-42d7-b95d-48ecbd6d4f4c">603,137</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzctMS0xLTEtMTk2MzU_45f968a1-b9bd-4325-b981-a1f4a2a1efc9">9,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzctMy0xLTEtMTk2MzU_b092dd8d-3cc6-40ed-a12d-490646d1b3a7">79.99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzctNS0xLTEtMTk2MzU_7eae689b-f871-43e3-8264-623bdd88b239">2.61</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzctNy0xLTEtMTk2MzU_ad970ed0-9487-4101-860d-83b1ba5b25ef">229,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at end of year and expected to vest in the future</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzgtMS0xLTEtMTk2MzU_7b362d2d-8ff2-4b7b-ba43-c79e583e75e4">18,709</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzgtMy0xLTEtMTk2MzU_2d5261d9-fc0b-46c3-adb4-f162872b7399">71.82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzgtNS0xLTEtMTk2MzU_732decf9-8bab-42e2-95fb-661784493a40">4.69</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzgtNy0xLTEtMTk2MzU_a2ad0d28-c18b-4fae-9caf-38cd9060c065">590,514</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_166"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzI4NTI_a37e823a-3fae-42d2-8f50-5ba1ab42cc2d" continuedAt="i64b5fa22127942938c5fdd1ffa8e13f5" escape="true">Shareholders&#8217; Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i64b5fa22127942938c5fdd1ffa8e13f5" continuedAt="i40826959bbd141d7b36a8fe61618324f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzI4NDU_ef0f2302-d0bf-4045-9a92-2a89e171d596" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase programs have been authorized by the Board:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2021 (&#8220;2021 Repurchase Program&#8221;)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i432b0c5043074ae0812170d09abfa592_I20211209" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZToyMzg0MzVhMWFlZWQ0NDRmYjQyM2FiYWNhMDhjNzFlNi90YWJsZXJhbmdlOjIzODQzNWExYWVlZDQ0NGZiNDIzYWJhY2EwOGM3MWU2XzEtMS0xLTEtNTQ1MzI_26645ded-3513-4f08-8fa6-a4964509cca9">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03653ea4eb4a467299768217a91a7509_I20211231" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZToyMzg0MzVhMWFlZWQ0NDRmYjQyM2FiYWNhMDhjNzFlNi90YWJsZXJhbmdlOjIzODQzNWExYWVlZDQ0NGZiNDIzYWJhY2EwOGM3MWU2XzEtMy0xLTEtNTQ1Mzk_21109f0a-654a-4309-84ba-377088ccb034">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2016 (&#8220;2016 Repurchase Program&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d02c104c6dc4d8080674b3a902331b0_I20161102" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZToyMzg0MzVhMWFlZWQ0NDRmYjQyM2FiYWNhMDhjNzFlNi90YWJsZXJhbmdlOjIzODQzNWExYWVlZDQ0NGZiNDIzYWJhY2EwOGM3MWU2XzEtMS0xLTEtMTk2MzU_28a81533-9ea3-4610-a48b-7ca868c32437">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f4bc0f557304063afaa3e85428dd4f9_I20211231" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:fixed-zero" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZToyMzg0MzVhMWFlZWQ0NDRmYjQyM2FiYWNhMDhjNzFlNi90YWJsZXJhbmdlOjIzODQzNWExYWVlZDQ0NGZiNDIzYWJhY2EwOGM3MWU2XzEtMy0xLTEtMTk2MzU_3e4a6cbc-c9ef-4b60-8103-25b04a38e750">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the share Repurchase Programs was effective immediately. The 2016 Repurchase program was terminated effective December 9, 2021. The 2021 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) transactions, and/or other derivative transactions. The 2021 Repurchase Program can be modified or terminated by the Board at any time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021, 2020 and 2019, the Company did not repurchase any shares of common stock pursuant to the 2016 or 2021 Repurchase Programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $<ix:nonFraction unitRef="usd" contextRef="i910e0cab88ca49569118b221e7416e1d_I20220104" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzEwOTk1MTE2MzMzMzc_630c9d78-e4ba-43d5-a8ac-baa9fffb207b">1.5</ix:nonFraction>&#160;billion fixed dollar ASR with Barclays Bank PLC (&#8220;Barclays&#8221;). Upon payment of the $<ix:nonFraction unitRef="usd" contextRef="i25393db4ea824bb8a945d34240542336_D20220104-20220104" decimals="-8" name="cvs:PaymentsForAcceleratedShareRepurchasesAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzEwOTk1MTE2MzMzNTU_a8877e9d-ed48-4689-b625-2ac77f59dd6a">1.5</ix:nonFraction>&#160;billion purchase price on January 4, 2022, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to <ix:nonFraction unitRef="number" contextRef="i910e0cab88ca49569118b221e7416e1d_I20220104" decimals="2" name="cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzMyOTg1MzQ4OTIyNjA_b38940f0-9b2c-4941-9b97-3b489397ef07">80</ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="i910e0cab88ca49569118b221e7416e1d_I20220104" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzEwOTk1MTE2MzMzNzI_c1c5e7f0-f3e9-41d8-a12a-c2d4862d78aa">1.5</ix:nonFraction> billion notional amount of the ASR or approximately <ix:nonFraction unitRef="shares" contextRef="i910e0cab88ca49569118b221e7416e1d_I20220104" decimals="-5" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzEwOTk1MTE2MzMzNzk_9f97580a-f803-42bd-a9de-31a6430cdc5d">11.6</ix:nonFraction>&#160;million shares at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i910e0cab88ca49569118b221e7416e1d_I20220104" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzEwOTk1MTE2MzM0NzQ_8b0d73dd-fdf0-448f-bb53-49bbdf7b5239">103.34</ix:nonFraction> per share, which were placed into treasury stock in January 2022. At the conclusion of the ASR, the Company may receive additional shares equal to the remaining <ix:nonFraction unitRef="number" contextRef="i910e0cab88ca49569118b221e7416e1d_I20220104" decimals="2" name="cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzMyOTg1MzQ4OTIyNjY_fcafce7a-be35-4b06-88c5-2d807576a71c">20</ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="i910e0cab88ca49569118b221e7416e1d_I20220104" decimals="-8" name="cvs:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzEwOTk1MTE2MzMzOTg_60b28f48-81f0-42d0-b710-572d1edf282a">1.5</ix:nonFraction>&#160;billion notional amount. The ultimate number of shares the Company may receive will depend on the daily volume-weighted average price of the Company&#8217;s stock over an averaging period, less a discount. It is also possible, depending on such weighted average price, that the Company will have an obligation to Barclays which, at the Company&#8217;s option, could be settled in additional cash or by issuing shares. Under the terms of the ASR, the maximum number of shares that could be delivered to the Company is <ix:nonFraction unitRef="shares" contextRef="i910e0cab88ca49569118b221e7416e1d_I20220104" decimals="-5" name="cvs:AcceleratedShareRepurchaseProgramMaximumNumberOfShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzEwOTk1MTE2MzM0Mjc_eb1c2f09-ec9a-4ea9-8de0-2ae4117c1cc6">29.0</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quarterly cash dividend declared by the Board was $<ix:nonFraction unitRef="usdPerShare" contextRef="ia7be16ef324b484ba18d3c2c816b7220_I20200930" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzY2OA_8b31424c-8820-44e9-8183-9e7966c9eea7"><ix:nonFraction unitRef="usdPerShare" contextRef="i341bdbaf02b943349d5742511da4e641_I20200331" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzY2OA_9337e0db-dfae-4b64-bc0d-c995016e97ac"><ix:nonFraction unitRef="usdPerShare" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzY2OA_b4917a0e-2e5b-4edf-bb26-e1b6bd3b2278"><ix:nonFraction unitRef="usdPerShare" contextRef="ib8220880f08f4b52bfb75c957326a67e_I20200630" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzY2OA_ccab11ff-1256-4117-ac23-ee97aed62a7e"><ix:nonFraction unitRef="usdPerShare" contextRef="i7fc99c6f6f5e4521b483fbb38f266a09_I20210930" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzY2OA_d41d0c33-6ab4-466a-9d6d-97f3f5881a99"><ix:nonFraction unitRef="usdPerShare" contextRef="ib746ed191a50496e8dcb173944e10da4_I20210331" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzY2OA_d682fb99-6820-4ed2-ac53-cc0c052d180e"><ix:nonFraction unitRef="usdPerShare" contextRef="ie5e000b7c7ed4445a36ad3eb67d14356_I20210630" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzY2OA_f74b980b-88c4-4e8c-a7d1-874cb8e3e8b4"><ix:nonFraction unitRef="usdPerShare" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzY2OA_fb854b76-19db-48a2-befd-81d4f62047d2">0.50</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> per share in 2021 and 2020. In December 2021, the Board authorized a <ix:nonFraction unitRef="number" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="INF" name="cvs:DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzk4OTU2MDQ2NTYzMjM_1c677507-6846-4227-ba69-f149d95893dc">10</ix:nonFraction>% increase in the quarterly cash dividend to $<ix:nonFraction unitRef="usdPerShare" contextRef="if41fb896ff264b3ead6f51a18d2a3f8e_I20221231" decimals="INF" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzk4OTU2MDQ2NTY0NTM_2177a185-7eb6-4e52-a588-160e73bebb72">0.55</ix:nonFraction> per share effective in 2022. CVS Health Corporation has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Requirements</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s insurance business operations are conducted through subsidiaries that principally consist of health maintenance organizations (&#8220;HMOs&#8221;) and insurance companies. The Company&#8217;s HMO and insurance subsidiaries report their financial </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">159</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i40826959bbd141d7b36a8fe61618324f"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">statements in accordance with accounting practices prescribed by state regulatory authorities which may differ from GAAP. <ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfRegulatoryAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzYwNDczMTM5NTU5NjA_f5f1e7ce-ed03-4ad2-bb01-240971ee34fa" continuedAt="i36b45a15e62a44b6a6ddd5d6a2f5c0a0" escape="true">The combined statutory net income for the years ended and estimated combined statutory and capital surplus at December&#160;31, 2021, 2020 and 2019 for the Company&#8217;s insurance and HMO subsidiaries were as follows:</ix:nonNumeric></span></div><div><ix:continuation id="i36b45a15e62a44b6a6ddd5d6a2f5c0a0"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory net income </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2d7b1824eba4f87a7eafd51d7fd5787_D20210101-20211231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTpmYzA3ODM2MDM1NTM0ZDA4OTI1YTgzNzU5ODI1YzQwNi90YWJsZXJhbmdlOmZjMDc4MzYwMzU1MzRkMDg5MjVhODM3NTk4MjVjNDA2XzEtMS0xLTEtMTk2MzU_04b5da87-5575-4957-947b-36a63dc541c9">3,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i067da125651c46ffad3ae31756f6ebce_D20200101-20201231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTpmYzA3ODM2MDM1NTM0ZDA4OTI1YTgzNzU5ODI1YzQwNi90YWJsZXJhbmdlOmZjMDc4MzYwMzU1MzRkMDg5MjVhODM3NTk4MjVjNDA2XzEtMy0xLTEtMTk2MzU_c8753965-bdeb-4b23-bd60-610024a2e2b0">3,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf290335ae9a4ad68f960df21ff9fc4e_D20190101-20191231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTpmYzA3ODM2MDM1NTM0ZDA4OTI1YTgzNzU5ODI1YzQwNi90YWJsZXJhbmdlOmZjMDc4MzYwMzU1MzRkMDg5MjVhODM3NTk4MjVjNDA2XzEtNS0xLTEtMjQyNDU_48c6417a-25a8-4f6c-9f9c-63943ea09076">2,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated statutory capital and surplus</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f97c5d3b527409f84299ce04961b6b5_I20211231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTpmYzA3ODM2MDM1NTM0ZDA4OTI1YTgzNzU5ODI1YzQwNi90YWJsZXJhbmdlOmZjMDc4MzYwMzU1MzRkMDg5MjVhODM3NTk4MjVjNDA2XzItMS0xLTEtMTk2MzU_9de88895-fec0-47cb-9827-e0f9927b26bf">14,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba1b0c6fc0e8431cb642d84f64a10a03_I20201231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTpmYzA3ODM2MDM1NTM0ZDA4OTI1YTgzNzU5ODI1YzQwNi90YWJsZXJhbmdlOmZjMDc4MzYwMzU1MzRkMDg5MjVhODM3NTk4MjVjNDA2XzItMy0xLTEtMTk2MzU_4eb73acb-bf17-4d37-94cf-7f2a34ce561e">13,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75b1f170bf184fb4b59ba89128a6bf98_I20191231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTpmYzA3ODM2MDM1NTM0ZDA4OTI1YTgzNzU5ODI1YzQwNi90YWJsZXJhbmdlOmZjMDc4MzYwMzU1MzRkMDg5MjVhODM3NTk4MjVjNDA2XzItNS0xLTEtMTk2MzU_44e21580-cf5a-4f38-8c45-b49e99190dce">10,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s insurance and HMO subsidiaries paid $<ix:nonFraction unitRef="usd" contextRef="ia2d7b1824eba4f87a7eafd51d7fd5787_D20210101-20211231" decimals="-6" name="us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzE4NjE_c79ea909-ad3b-4c69-9f1a-4fad340c3c88">1.6</ix:nonFraction> billion of gross dividends to the Company for the year ended December&#160;31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to general state law restrictions on payments of dividends and other distributions to stockholders applicable to all corporations, HMOs and insurance companies are subject to further regulations that, among other things, may require those companies to maintain certain levels of equity and restrict the amount of dividends and other distributions that may be paid to their equity holders. In addition, in connection with the Aetna Acquisition, the Company made certain undertakings that require prior regulatory approval of dividends by certain of its HMOs and insurance companies. <ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:StatutoryAccountingPracticesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzI4NTE_3fd3b7da-76dc-4cba-a03b-6ac204837e1f" continuedAt="ibf093ae4afcb4cf2841fae1615fd856a" escape="true">At December&#160;31, 2021, these amounts were as follows:</ix:nonNumeric></span></div><div style="margin-top:5pt"><ix:continuation id="ibf093ae4afcb4cf2841fae1615fd856a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:88.196%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.604%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated minimum statutory surplus required by regulators</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTo3NTk5MDcwMmI2NjY0OThkOGE4ZjU2YTY0ZTVhZDAzZS90YWJsZXJhbmdlOjc1OTkwNzAyYjY2NjQ5OGQ4YThmNTZhNjRlNWFkMDNlXzEtMS0xLTEtMTk2MzU_9f8fc2f4-f1b6-4732-8cf3-cb4327ddb316">7,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments on deposit with regulatory bodies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:AssetsHeldByInsuranceRegulators" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTo3NTk5MDcwMmI2NjY0OThkOGE4ZjU2YTY0ZTVhZDAzZS90YWJsZXJhbmdlOjc1OTkwNzAyYjY2NjQ5OGQ4YThmNTZhNjRlNWFkMDNlXzItMS0xLTEtMTk2MzU_d6bc5c94-9512-40bd-b665-e3c9360e930e">794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated maximum dividend distributions permitted in 2022 without prior regulatory approval</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTo3NTk5MDcwMmI2NjY0OThkOGE4ZjU2YTY0ZTVhZDAzZS90YWJsZXJhbmdlOjc1OTkwNzAyYjY2NjQ5OGQ4YThmNTZhNjRlNWFkMDNlXzMtMS0xLTEtMTk2MzU_f3ee22f3-e05e-49cc-b997-465d839c7607">2,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, noncontrolling interests were $<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzI2Mjg_37a31958-e90e-4fb1-9466-e0d1bcadaa66">306</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzI2MzU_81a668fa-01f8-477b-a3a8-2520723fcd8a">312</ix:nonFraction> million, respectively, primarily related to third party interests in the Company&#8217;s operating entities.&#160;The noncontrolling entities&#8217; share is included in total shareholders</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> equity on the consolidated balance sheets.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">160</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_169"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90ZXh0cmVnaW9uOjVmNjIzZDYyYWY0NDQxNmRiNDRhMmMzZDQ0YmM4NmU0XzE1MDA_86b6e1f9-38c6-45f1-b11a-cb6c44b80b55" continuedAt="i0fdb367cee8443f3be1793b6ca616abc" escape="true">Other Comprehensive Income</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0fdb367cee8443f3be1793b6ca616abc"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90ZXh0cmVnaW9uOjVmNjIzZDYyYWY0NDQxNmRiNDRhMmMzZDQ0YmM4NmU0XzE1MDE_5dd94f07-155b-4502-9c77-b1354d542a43" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income in 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c81300ece14b5cb35d720e3d27f084_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMtMS0xLTEtMTk2MzU_54792f24-1103-4c8e-97fa-c9ddd131a142">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fc98fb6952142bebe0c28e8a1b5c4a8_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMtMy0xLTEtMTk2MzU_e2449b41-8d96-4cd5-bf44-d1f979703680">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84a0c7a5f87a43ea863b4f7e44c6d8c2_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMtNS0xLTEtMTk2MzU_5b5eb474-d515-4413-935d-bf1f71be7837">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="id4cc032a34c645ef8cc2877c8cab5ad0_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzQtMC0xLTEtMTk2MzUvdGV4dHJlZ2lvbjphNDQxMmE3ZjEyN2E0ZmE1OGNiYjkwNGZiMTc0N2RhNl81Nw_477b0ba3-83a5-4309-8096-a7f891d3bf4e">489</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="i930652f9892c44cc8ed5915dcd507083_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzQtMC0xLTEtMTk2MzUvdGV4dHJlZ2lvbjphNDQxMmE3ZjEyN2E0ZmE1OGNiYjkwNGZiMTc0N2RhNl82MQ_04a00d59-4102-4162-b5c6-512c0fbc81a3">497</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="icbaffe77aefc4d6d9017917c96a5f507_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzQtMC0xLTEtMTk2MzUvdGV4dHJlZ2lvbjphNDQxMmE3ZjEyN2E0ZmE1OGNiYjkwNGZiMTc0N2RhNl82OA_c5e28289-12f2-4d3d-9408-97ec940bb524">927</ix:nonFraction> pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4cc032a34c645ef8cc2877c8cab5ad0_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzQtMS0xLTEtMTk2MzU_220a346e-c720-4ddd-a5ca-8ff938d6b6af">410</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i930652f9892c44cc8ed5915dcd507083_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzQtMy0xLTEtMTk2MzU_dbb9d825-1a41-4a7a-8b94-2ca21f85e14f">415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbaffe77aefc4d6d9017917c96a5f507_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzQtNS0xLTEtMTk2MzU_7f8a39b9-75ce-4930-8d2e-b47303a25b3c">763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="id4cc032a34c645ef8cc2877c8cab5ad0_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzUtMC0xLTEtMTk2MzUvdGV4dHJlZ2lvbjpiNDlmN2IyMDM5ZWM0MGI1OWY5NTRlZGMzMjgwMmRiMV83MA_c652741c-5012-45df-a92e-cea8c30f5f02">32</ix:nonFraction>), $<ix:nonFraction unitRef="usd" contextRef="i930652f9892c44cc8ed5915dcd507083_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzUtMC0xLTEtMTk2MzUvdGV4dHJlZ2lvbjpiNDlmN2IyMDM5ZWM0MGI1OWY5NTRlZGMzMjgwMmRiMV83NA_b0d4932c-434d-433d-8da1-bb7a73ee146a">31</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="icbaffe77aefc4d6d9017917c96a5f507_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzUtMC0xLTEtMTk2MzUvdGV4dHJlZ2lvbjpiNDlmN2IyMDM5ZWM0MGI1OWY5NTRlZGMzMjgwMmRiMV84MQ_245164a8-364f-4fe9-91ec-15a92fb7df75">105</ix:nonFraction>) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4cc032a34c645ef8cc2877c8cab5ad0_D20210101-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzUtMS0xLTEtMTk2MzU_851f2ae0-d334-4f10-bfa2-68c659161afe">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i930652f9892c44cc8ed5915dcd507083_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzUtMy0xLTEtMTk2MzU_1fd3a042-12a4-43a7-b2d2-54f8c5177370">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbaffe77aefc4d6d9017917c96a5f507_D20190101-20191231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzUtNS0xLTEtMTk2MzU_20ff54b2-135e-4b97-a24d-079d5ee43bd0">86</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4cc032a34c645ef8cc2877c8cab5ad0_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzYtMS0xLTEtMTk2MzU_38331e2d-1c9c-43f5-84d8-56e053f3debf">436</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i930652f9892c44cc8ed5915dcd507083_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzYtMy0xLTEtMTk2MzU_d3138014-d0c0-493a-bb0c-49b011f09b83">440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbaffe77aefc4d6d9017917c96a5f507_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzYtNS0xLTEtMTk2MzU_44d32e24-a7d0-4eaf-9aed-5d37a9815bf4">677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64c2bd153480429785df4f0aa2b99af8_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzctMS0xLTEtMTk2MzU_90527a60-e672-487c-a594-2a8eeb68cdfc">778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11c81300ece14b5cb35d720e3d27f084_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzctMy0xLTEtMTk2MzU_3a7daf08-037b-4c3d-bccf-854846bcaaa8">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fc98fb6952142bebe0c28e8a1b5c4a8_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzctNS0xLTEtMTk2MzU_23ad0e63-9470-4d57-9999-1bc58bdfc853">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife5fc67699f945fa837f90b613f6c602_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEwLTEtMS0xLTE5NjM1_72d76b10-c551-4378-93ff-1241cb25c12e">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93d0cc21864237a54084f2b97bd15f_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEwLTMtMS0xLTE5NjM1_fea9a5ab-996b-477e-9af9-c9cbedb57cf3">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91b3a6b550364049b4a377a44fda6b09_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEwLTUtMS0xLTE5NjM1_1df7acdf-6949-4225-83a4-7bb54b64057e">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied0d6e0ce99e4b72a1d89046d51bad0d_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzExLTEtMS0xLTE5NjM1_b3aa1326-c656-42c5-841a-2e7bc75a75ef">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20b34efac8084fcf97e669d6e307466a_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzExLTMtMS0xLTE5NjM1_d5ba679c-7c51-4c91-b634-27e557785024">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i303cec39156742cabcd569434ed22a00_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzExLTUtMS0xLTE5NjM1_6ad40516-15f9-4080-805e-2513339a6250">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied0d6e0ce99e4b72a1d89046d51bad0d_D20210101-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEyLTEtMS0xLTE5NjM1_bf77ce45-03c5-41bb-b59e-1aee4add2b80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20b34efac8084fcf97e669d6e307466a_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEyLTMtMS0xLTE5NjM1_70bae644-8da8-4b3b-923c-0be720b68284">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i303cec39156742cabcd569434ed22a00_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEyLTUtMS0xLTE5NjM1_51ee5aa3-9b4c-4e41-b196-b67958168f16">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied0d6e0ce99e4b72a1d89046d51bad0d_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEzLTEtMS0xLTE5NjM1_c256a8f2-7f94-4c73-ae31-35ef3c65a2a5">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20b34efac8084fcf97e669d6e307466a_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEzLTMtMS0xLTE5NjM1_c7b7fcbc-5b37-4a26-9359-a35933ae211e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i303cec39156742cabcd569434ed22a00_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEzLTUtMS0xLTE5NjM1_5626f11e-1442-4008-ac4e-7497eec1f090">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1adb1295de224123a78020e0f95fb49f_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE0LTEtMS0xLTE5NjM1_5920311a-c59d-41d7-9673-05f9a649cd52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife5fc67699f945fa837f90b613f6c602_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE0LTMtMS0xLTE5NjM1_c04dadef-72a4-4778-900a-ab4713361f9a">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c93d0cc21864237a54084f2b97bd15f_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE0LTUtMS0xLTE5NjM1_a28a8a2d-d358-4d01-8515-789f9fc0973d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c37ca64bf504cc4beccb76f7eae0e86_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE3LTEtMS0xLTE5NjM1_315531fc-a94c-411e-8e3c-dc8588da2c1f">248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b8354161494117b37c8c706d4ff661_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE3LTMtMS0xLTE5NjM1_c70d238f-2880-4a28-88c6-9081cc811c19">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec37d7e54e8e4663af7b1e9dd4764b6d_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE3LTUtMS0xLTE5NjM1_9684fba3-195b-407b-a572-a883e6817e1f">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="i17206db04de740ee9100c779b2d2d0c6_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MzRmNDQzMDE1MDk2NDAyYzljYmYzYmU4NmUxZjc4OTZfNjQ_eb488d12-283c-4a19-af07-2d6562e93527">0</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="iccee865f86ef46af8613bee2f36c8b98_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MzRmNDQzMDE1MDk2NDAyYzljYmYzYmU4NmUxZjc4OTZfNjg_2563fc9f-5b45-4552-8d07-ad32a048c007">7</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="i94e5299b9a1643d5a0693be093306c61_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MzRmNDQzMDE1MDk2NDAyYzljYmYzYmU4NmUxZjc4OTZfNzU_0b1aa829-3449-4c5d-ab6b-ada04baf4852">25</ix:nonFraction>) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17206db04de740ee9100c779b2d2d0c6_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE5LTEtMS0xLTE5NjM1_d610cde5-ae1f-431c-b8b4-ca068bdab632">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccee865f86ef46af8613bee2f36c8b98_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE5LTMtMS0xLTE5NjM1_ebadf186-1b32-49e6-b2eb-e528d09fe766">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e5299b9a1643d5a0693be093306c61_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE5LTUtMS0xLTE5NjM1_7695b353-d10d-4624-9eb8-67837fa21bba">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(<ix:nonFraction unitRef="usd" contextRef="i17206db04de740ee9100c779b2d2d0c6_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZDkzMDVjNDJjZTU5NGNkMzhkMWIxNDFjZDhlOTIxNDdfNzc_6f0de9a0-2a59-4424-a50e-bdd3c750dbb7">34</ix:nonFraction>), $(<ix:nonFraction unitRef="usd" contextRef="iccee865f86ef46af8613bee2f36c8b98_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZDkzMDVjNDJjZTU5NGNkMzhkMWIxNDFjZDhlOTIxNDdfODE_6cc767b9-e794-4473-9a97-ad084d96b109">35</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="i94e5299b9a1643d5a0693be093306c61_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZDkzMDVjNDJjZTU5NGNkMzhkMWIxNDFjZDhlOTIxNDdfODg_cad1abcc-3228-4143-a4a4-1c305271a3ab">20</ix:nonFraction>) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17206db04de740ee9100c779b2d2d0c6_D20210101-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIwLTEtMS0xLTE5NjM1_fe3f266d-f185-43cc-8c48-d4cad93e2fa0">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccee865f86ef46af8613bee2f36c8b98_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIwLTMtMS0xLTE5NjM1_980025b5-a6bd-4748-8360-cbc09e4889e1">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e5299b9a1643d5a0693be093306c61_D20190101-20191231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIwLTUtMS0xLTE5NjM1_4e82fae8-d865-43d3-ab00-c3065d683392">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17206db04de740ee9100c779b2d2d0c6_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIxLTEtMS0xLTE5NjM1_db1e6669-27ea-4ea5-9bb0-dc38d0ba891f">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccee865f86ef46af8613bee2f36c8b98_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIxLTMtMS0xLTE5NjM1_da71aca6-ad82-4925-9530-19aebbeb3f37">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e5299b9a1643d5a0693be093306c61_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIxLTUtMS0xLTE5NjM1_aa6c871c-e7f9-4f75-a967-bdc3ed9da69e">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i348fed93b022492e8b3985b2e2ba1a8f_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIyLTEtMS0xLTE5NjM1_5545cd55-aa3e-45cf-89ba-47943f589024">222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c37ca64bf504cc4beccb76f7eae0e86_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIyLTMtMS0xLTE5NjM1_424f23a1-6124-4473-92c1-e32eb6709e82">248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b8354161494117b37c8c706d4ff661_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIyLTUtMS0xLTE5NjM1_5e50b812-e639-48b7-8ae7-0bc4e9598ed8">279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac8f4cd98d954c89b07ab4b4c2f7eefc_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI1LTEtMS0xLTE5NjM1_eec9e83f-9a8f-4784-915d-9795ed323707">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fb139f86fed450cbb2024fcc197f70c_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI1LTMtMS0xLTE5NjM1_b583e681-d897-4d54-ad06-c97d0dd9de72">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ac9beb213414c5a99e0c44cdb3d790d_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI1LTUtMS0xLTE5NjM1_0861a15a-4472-4394-859c-f258d51e1830">149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="i5e511f7eb0324f2f878592c7974ed086_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI3LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZDYxMzE1NTBjZDU0NGY4NDgxN2JlNzllZTlkY2Q3YjBfNjQ_47f4d7b2-3cb4-4ff1-b8b4-a0328ad8e6a6">20</ix:nonFraction>, $(<ix:nonFraction unitRef="usd" contextRef="if460e957577f480e84fb0142bcff8589_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI3LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZDYxMzE1NTBjZDU0NGY4NDgxN2JlNzllZTlkY2Q3YjBfNjg_c1322a33-a63c-4679-b593-7209d9ddd41c">30</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="i725fef702fc24e31915c10eeb3b3c3cc_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI3LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZDYxMzE1NTBjZDU0NGY4NDgxN2JlNzllZTlkY2Q3YjBfNzU_aa7b0d1d-6a9a-4a02-8b97-5bddaaf4d6c9">162</ix:nonFraction> pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e511f7eb0324f2f878592c7974ed086_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI3LTEtMS0xLTE5NjM1_41b0f714-5b0a-4000-a59b-644eb57f010d">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if460e957577f480e84fb0142bcff8589_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI3LTMtMS0xLTE5NjM1_a12b80a0-93f8-4801-b3cc-bd1333b30f5f">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i725fef702fc24e31915c10eeb3b3c3cc_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI3LTUtMS0xLTE5NjM1_1e710af0-9fd1-4f02-b001-298911e9ba32">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usd" contextRef="i5e511f7eb0324f2f878592c7974ed086_D20210101-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI4LTAtMS0xLTE5NjM1L3RleHRyZWdpb246Njk0YmU4ZDRmYmY0NGY0NGEyZTI0NjUyYTFhNmNhNzJfNjg_3bb7f437-d265-4601-9309-0730afa5c32e">6</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="if460e957577f480e84fb0142bcff8589_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI4LTAtMS0xLTE5NjM1L3RleHRyZWdpb246Njk0YmU4ZDRmYmY0NGY0NGEyZTI0NjUyYTFhNmNhNzJfNzI_22a6016e-16d7-4eb2-8576-6c7604acdf56">7</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="i725fef702fc24e31915c10eeb3b3c3cc_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI4LTAtMS0xLTE5NjM1L3RleHRyZWdpb246Njk0YmU4ZDRmYmY0NGY0NGEyZTI0NjUyYTFhNmNhNzJfNzk_1edbe4ce-3ed5-4201-a93d-49b7a3e268be">12</ix:nonFraction>) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e511f7eb0324f2f878592c7974ed086_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI4LTEtMS0xLTE5NjM1_2ccb7395-fdd4-4e2f-bec0-d0caf5b702e7">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if460e957577f480e84fb0142bcff8589_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI4LTMtMS0xLTE5NjM1_073e956d-333b-4fad-bfb7-e715eed995ff">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i725fef702fc24e31915c10eeb3b3c3cc_D20190101-20191231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI4LTUtMS0xLTE5NjM1_fee1df0f-0228-499d-9338-3cb1e4d347d5">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e511f7eb0324f2f878592c7974ed086_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI5LTEtMS0xLTE5NjM1_52a00d76-883a-4fd1-9501-5703c457dea7">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if460e957577f480e84fb0142bcff8589_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI5LTMtMS0xLTE5NjM1_6c3e9227-4607-470b-a8f0-3cb6eecaea9e">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i725fef702fc24e31915c10eeb3b3c3cc_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI5LTUtMS0xLTE5NjM1_e50dd45a-9b36-4ed1-b997-d0caddfd552a">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i314a931ba51c4432ab932591b600df30_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMwLTEtMS0xLTE5NjM1_df182b08-e9eb-4126-bc1d-1a4f99e9fcd9">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac8f4cd98d954c89b07ab4b4c2f7eefc_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMwLTMtMS0xLTE5NjM1_11734762-6aa1-4353-a800-92b5db2ee712">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fb139f86fed450cbb2024fcc197f70c_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMwLTUtMS0xLTE5NjM1_89a125e5-b586-41e6-8e3b-732fab06a83f">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of year accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8be428b3931542c4965732a9b0d77591_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMyLTEtMS0xLTE5NjM1_2fbace21-15dd-4fa6-8b67-1ac145fd6e0b">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0df7f1ff461e44849cb29208fac61c4d_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMyLTMtMS0xLTE5NjM1_dc8cf481-f3ac-4adc-a96d-a235959af47e">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id530b2ec12d240fe97ae812c8d6c1fed_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMyLTUtMS0xLTE5NjM1_61332c54-5ed1-4257-8f3f-167b24fd55a0">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzM0LTEtMS0xLTE5NjM1_eef6559a-abe3-4299-bea8-9f97e5554331">449</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzM0LTMtMS0xLTE5NjM1_a1b78711-2601-4d16-a3dc-5deea61fda9f">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzM0LTUtMS0xLTE5NjM1_4216b621-dbd2-43dd-8d74-b1317fe37c3b">917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of year accumulated other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6049578cfc4647f693b348ad92ec2d2b_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzM1LTEtMS0xLTE5NjM1_42ba789d-5a43-4a7c-95ac-f11c13509c3b">965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8be428b3931542c4965732a9b0d77591_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzM1LTMtMS0xLTE5NjM1_50d98a2f-9c0d-4dde-954c-720335185838">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0df7f1ff461e44849cb29208fac61c4d_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzM1LTUtMS0xLTE5NjM1_23beb49c-01a7-43bd-8b08-0662037f2b06">1,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the consolidated statements of operations. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income (loss) represent the elimination of the cumulative translation adjustment associated with the sale of Onofre, which was sold on July 1, 2019. The loss on the divestiture of Onofre is reflected in operating expenses in the consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included within interest expense in the consolidated statements of operations. The Company expects to reclassify approximately $<ix:nonFraction unitRef="usd" contextRef="i348fed93b022492e8b3985b2e2ba1a8f_I20211231" decimals="-6" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90ZXh0cmVnaW9uOjVmNjIzZDYyYWY0NDQxNmRiNDRhMmMzZDQ0YmM4NmU0XzEwOTk1MTE2Mjk3Njg_eb2c2da2-02dc-4bee-9959-2824ee5ba872">11</ix:nonFraction> million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the consolidated statements of operations.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">161</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_172"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90ZXh0cmVnaW9uOmU2MjIxNDE3YmVlMDQ0MGNiNzllMDlhZmQ0NWNiOWM1XzEzMDY_11e1eedc-168a-47aa-9e9c-b78d9540608d" continuedAt="i41e33dc357454b47bda212515a068b9b" escape="true">Earnings Per Share</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i41e33dc357454b47bda212515a068b9b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the two-class method. SARs and options to purchase <ix:nonFraction unitRef="shares" contextRef="ia08c0a1adcca414ca646fb74221de9ab_D20210101-20211231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90ZXh0cmVnaW9uOmU2MjIxNDE3YmVlMDQ0MGNiNzllMDlhZmQ0NWNiOWM1XzM3Mw_e4d14f81-8fcf-44c8-9311-90e123b8a283">7</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="if2efea1496c248cdb677d680fb00e679_D20200101-20201231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90ZXh0cmVnaW9uOmU2MjIxNDE3YmVlMDQ0MGNiNzllMDlhZmQ0NWNiOWM1XzM4MA_d9598794-786c-4e44-8b7c-1fae7e93325c">15</ix:nonFraction>&#160;million, and <ix:nonFraction unitRef="shares" contextRef="i7992428725ee4b7598c31808d507c883_D20190101-20191231" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90ZXh0cmVnaW9uOmU2MjIxNDE3YmVlMDQ0MGNiNzllMDlhZmQ0NWNiOWM1XzE2NDkyNjc0NDMwNDA_488be5fa-7582-440d-a5d7-2c1e51fa1cf0">17</ix:nonFraction>&#160;million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the years ended December&#160;31, 2021, 2020 and 2019, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90ZXh0cmVnaW9uOmU2MjIxNDE3YmVlMDQ0MGNiNzllMDlhZmQ0NWNiOWM1XzEzMDk_cd3ecc0c-7d7a-4def-829f-1e973e2935e1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share from continuing operations for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzItMS0xLTEtMTk2MzU_979db47b-6805-46e0-991c-091818447fa6">7,898</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzItMy0xLTEtMTk2MzU_49192a1b-5222-4d12-897f-3d379539d6cf">7,201</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzItNS0xLTEtMTk2MzU_8f99dab8-2d30-4c98-ba49-6f62b13cffb2">6,631</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income allocated to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzMtMS0xLTEtMTk2MzU_dd5586ca-ea10-4b17-ad73-e8920ec76790">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzMtMy0xLTEtMTk2MzU_1a0204d6-0f0b-4c0e-9b2b-b644b41ac61e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzMtNS0xLTEtMTk2MzU_2c2156f8-3f24-4ff2-9198-7b7acf27e8b9">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzQtMS0xLTEtMTk2MzU_91b5c468-d298-45f0-9caa-04997601865f">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzQtMy0xLTEtMTk2MzU_82ab9e40-9569-491d-a2d3-012f0373553b">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzQtNS0xLTEtMTk2MzU_4e7d05c6-e010-4bcd-a70a-3eb6e633b024">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzUtMS0xLTEtMTk2MzU_a7ef9ad9-a049-4f7b-aa75-d7d6ce7f80f9">7,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzUtMy0xLTEtMTk2MzU_fe30c3ba-da01-4668-8070-abe2c39a3331">7,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzUtNS0xLTEtMTk2MzU_9e7e1b4e-0a44-4b93-8b66-5484c85528bb">6,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzgtMS0xLTEtMTk2MzU_9d73d772-18c8-44c6-a51b-4c367ff0db9a">1,319</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzgtMy0xLTEtMTk2MzU_e7e99a03-5c36-418d-bb90-3c1efb830e93">1,309</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzgtNS0xLTEtMTk2MzU_31bc37c9-bb3d-4361-885b-2058b465c90c">1,301</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzktMS0xLTEtMTk2MzU_77d40692-96f7-4e22-9779-48c5604da026">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzktMy0xLTEtMTk2MzU_db9423e0-09d7-4d6f-90be-f39de783c8c7">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzktNS0xLTEtMTk2MzU_86dada29-760d-4e2a-8875-7592c1df8663">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzEwLTEtMS0xLTE5NjM1_66a56f2b-73ac-4a85-9138-95370707e2bd">1,329</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzEwLTMtMS0xLTE5NjM1_d5d38fc0-1664-46e4-ba3d-1aaebf55d20b">1,314</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzEwLTUtMS0xLTE5NjM1_163ba47e-a7e7-44ba-bbb9-32a35d2d5dc3">1,305</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share from continuing operations:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzEzLTEtMS0xLTE5NjM1_7d590c1d-937a-4216-886e-9e867dea1dcd">6.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzEzLTMtMS0xLTE5NjM1_dfcd2dc0-2917-43e4-b23a-1c9d63953925">5.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzEzLTUtMS0xLTE5NjM1_ad3d93ec-2f3c-41bb-bade-bf2d6c170e3c">5.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzE0LTEtMS0xLTE5NjM1_f5b8a036-3154-4150-97f1-1f24dfe1d4dd">5.95</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzE0LTMtMS0xLTE5NjM1_86a5bce7-344a-4b70-b4fd-7c51ee0d9d77">5.47</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzE0LTUtMS0xLTE5NjM1_b1dd4782-e759-435c-8d9e-5d1c31f9c3f0">5.08</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_175"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ReinsuranceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90ZXh0cmVnaW9uOmNiMzdlNWRmMjk2YTQ5ZDE5YWUyNDFjOTA5ZWRiYWE0XzIxMDc_2ec6393c-2e7c-4363-91e3-6eeb931dc7ee" continuedAt="id7bfc8f23a804449b2a29f5302d60eff" escape="true">Reinsurance</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="id7bfc8f23a804449b2a29f5302d60eff" continuedAt="i9d1965f8b2b04227b94a3a5ed6e93082"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#8217;s primary liability as the direct insurer of the risks reinsured.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 30, 2018, the Company completed the sale of Aetna&#8217;s standalone Medicare Part D prescription drug plans to a subsidiary of WellCare Health Plans, Inc. (&#8220;WellCare&#8221;), effective December 31, 2018. In connection with that sale, subsidiaries of WellCare and Aetna entered into reinsurance agreements under which WellCare ceded to Aetna 100% of the insurance risk related to the divested standalone Medicare Part D prescription drug plans for the 2019 PDP plan year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the Company entered into <ix:nonFraction unitRef="reinsurance_agreement" contextRef="i9b7aa9f9810b45008c9d9fed20ef83c3_D20220101-20220131" decimals="INF" name="cvs:NumberofReinsuranceContractsEnteredInto" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90ZXh0cmVnaW9uOmNiMzdlNWRmMjk2YTQ5ZDE5YWUyNDFjOTA5ZWRiYWE0XzkxMw_8a1a21fd-d603-4619-b920-b0da4db8e028">two</ix:nonFraction> <ix:nonNumeric contextRef="i9b7aa9f9810b45008c9d9fed20ef83c3_D20220101-20220131" name="cvs:FourYearsReinsuranceAgreementWithUnrelatedInsurer" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90ZXh0cmVnaW9uOmNiMzdlNWRmMjk2YTQ5ZDE5YWUyNDFjOTA5ZWRiYWE0XzIxMDg_37fe2f59-7376-4210-9e64-68627dd04171">four-year</ix:nonNumeric> reinsurance agreements with an unrelated reinsurer that allow it to reduce required capital and provide collateralized excess of loss reinsurance coverage on a portion of the Health Care Benefits segment&#8217;s group Commercial Insured business.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90ZXh0cmVnaW9uOmNiMzdlNWRmMjk2YTQ5ZDE5YWUyNDFjOTA5ZWRiYWE0XzIxMDM_eac10661-fa3a-498a-9e0a-2e1e3dd7e698" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance recoverables (recorded as other current assets or other assets on the consolidated balance sheets) at December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reinsurer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hartford Life and Accident Insurance Company</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9301095d345049e394b9ba1daee2e4e9_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzItMS0xLTEtMTk2MzU_41c77f71-d644-4c84-80c4-430b2dca5350">1,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i301adeecaf97464ca03a693c09b0877a_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzItMy0xLTEtMTk2MzU_244dd01e-77ab-4e05-975f-b3ca1c4b4f51">2,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lincoln Life &amp; Annuity Company of New York</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2d969162ec640c4bc7ab0e676c9f6e9_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzMtMS0xLTEtMTk2MzU_800d15f2-abf7-4183-9584-f9a43b0c9c11">395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46f805b90593415b99804a3433aa2813_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzMtMy0xLTEtMTk2MzU_288baeb6-c6a6-4f50-b36f-1c246c55f1ff">406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VOYA Retirement Insurance and Annuity Company </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c99d471482b411db975233daa1b1c2d_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzUtMS0xLTEtMTk2MzU_d343b795-5cb4-4fe4-900e-336bad22851e">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60a27aec77334f2c9335b816c8cba90b_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzUtMy0xLTEtMTk2MzU_5ecc870b-62aa-42c0-8f73-d05690cdc4af">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3af40793c6c847eea71843a3d54a8e74_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzYtMS0xLTEtMTk2MzU_2fe55a10-cf65-4213-b7f5-ad369012373e">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a078c31fd54364814330592da72814_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzYtMy0xLTEtMTk2MzU_244de8dd-39d7-4473-abe7-4ee3d59332b6">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzctMS0xLTEtMTk2MzU_4cbe883f-abd9-4d9a-a6ce-a86476a4f5a7">2,549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzctMy0xLTEtMTk2MzU_0c9f07fa-2321-4ec9-8222-785315eb61fd">3,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">162</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9d1965f8b2b04227b94a3a5ed6e93082"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90ZXh0cmVnaW9uOmNiMzdlNWRmMjk2YTQ5ZDE5YWUyNDFjOTA5ZWRiYWE0XzIxMTE_3d4ccefd-2476-4093-8c95-1246e2e0bda1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct, assumed and ceded premiums earned for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.236%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:DirectPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzEtMS0xLTEtMTk2MzU_d35e981f-c0ce-45a2-8bb3-f6f5445c5133">76,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:DirectPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzEtMy0xLTEtMTk2MzU_4cf99bc0-371f-4a83-9ecd-c32d82b8a4df">69,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:DirectPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzEtNS0xLTEtMTk2MzU_b08498ff-eb8f-428a-aa7b-1b3689e5c366">62,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:AssumedPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzItMS0xLTEtMTk2MzU_25648372-4ced-4990-8841-1bfca736e836">492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:AssumedPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzItMy0xLTEtMTk2MzU_75afd8b8-794b-4cd8-a61d-1a6acbc6c4da">478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:AssumedPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzItNS0xLTEtMTk2MzU_5d3b8ca2-4334-4859-967e-9d8744ec0cea">2,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:CededPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzMtMS0xLTEtMTk2MzU_a9df8b9b-2e36-49db-9a6b-1335faf6e181">680</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:CededPremiumsEarned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzMtMy0xLTEtMTk2MzU_302d65a1-7908-4c8a-ad5d-522f20c81f44">825</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:CededPremiumsEarned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzMtNS0xLTEtMTk2MzU_b8f9fee7-ea01-4f75-907e-3e01c0f0d973">1,954</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzQtMS0xLTEtMTk2MzU_1ccc9180-af15-4a6b-8946-47094df8e317">76,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzQtMy0xLTEtMTk2MzU_546d1500-cc3b-46c5-acb2-b9258b4f7408">69,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzQtNS0xLTEtMTk2MzU_66bb51bf-fbe8-4eb1-9cc2-67cdd9703584">63,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:EffectsOfReinsuranceTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90ZXh0cmVnaW9uOmNiMzdlNWRmMjk2YTQ5ZDE5YWUyNDFjOTA5ZWRiYWE0XzIxMTM_0aaf2029-cc42-4780-9580-d6984f6589a5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of reinsurance on benefit costs for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.236%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzEtMS0xLTEtMTk2MzU_a40021bd-8bbd-460e-9e28-6d73c3cfa51e">64,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzEtMy0xLTEtMTk2MzU_a5ee0e35-5996-4a45-bd66-a0d723f1a912">56,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzEtNS0xLTEtMTk2MzU_b8cf1574-bda4-4859-becd-c4d6cc55a3cb">52,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzItMS0xLTEtMTk2MzU_6fb63cef-17eb-4243-bcb0-d8f26f4dd202">398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzItMy0xLTEtMTk2MzU_d7bf5f48-6d8f-4040-8915-e4a2b0a56cd9">329</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzItNS0xLTEtMTk2MzU_5e4ee7d4-081d-41fb-923c-5a13555c91f5">1,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzMtMS0xLTEtMTk2MzU_c0976ff2-50af-4f14-83a5-7d572efa98cb">552</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzMtMy0xLTEtMTk2MzU_9d241656-a058-4b87-85f6-913bc901af3a">727</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzMtNS0xLTEtMTk2MzU_8a561673-f4d8-4388-9cea-c8bfe1f1ecbc">1,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net benefit costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzQtMS0xLTEtMTk2MzU_14e7a61d-5de0-4167-99d8-9b52fb593e31">64,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzQtMy0xLTEtMTk2MzU_17d5f655-01ea-4f59-aa9c-6843e0ad50dc">55,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzQtNS0xLTEtMTk2MzU_86526826-eb60-40f9-a3c9-87b36354734a">52,529</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is not a material difference between premiums on a written basis versus an earned basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has various agreements with unrelated reinsurers that do not qualify for reinsurance accounting under GAAP, and consequently are accounted for using deposit accounting. The Company entered into these contracts to reduce the risk of catastrophic loss which in turn reduces the Company&#8217;s capital and surplus requirements. Total deposit assets and liabilities related to reinsurance agreements that do not qualify for reinsurance accounting under GAAP were not material as of December&#160;31, 2021 or 2020.</span></div></ix:continuation><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_178"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzgvZnJhZzo2MTM1NGM4M2Q3YTU0YjdlYTIwOTlkOWIzZWQyNWY1OC90ZXh0cmVnaW9uOjYxMzU0YzgzZDdhNTRiN2VhMjA5OWQ5YjNlZDI1ZjU4XzI5ODA1_6a7ced0b-a87c-4f2f-9a58-3f7049fa626f" continuedAt="i608ce4d5916440b18853406b34f23862" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i608ce4d5916440b18853406b34f23862" continuedAt="idc26814d2a504312917753aa9bc2c987"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. The Company believes COVID-19&#8217;s impact on its businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond the Company&#8217;s knowledge and control. As a result, the impact COVID-19 will have on the Company&#8217;s businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has the following significant guarantee arrangements at December&#160;31, 2021:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ASC Claim Funding Accounts - The Company has arrangements with certain banks for the processing of claim payments for its ASC customers. The banks maintain accounts to fund claims of the Company&#8217;s ASC customers. The customer is responsible for funding the amount paid by the bank each day. In these arrangements, the Company guarantees that the banks will not sustain losses if the responsible ASC customer does not properly fund its account. The aggregate maximum exposure under these arrangements is generally limited to $<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-6" name="us-gaap:GuaranteeObligationsMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzgvZnJhZzo2MTM1NGM4M2Q3YTU0YjdlYTIwOTlkOWIzZWQyNWY1OC90ZXh0cmVnaW9uOjYxMzU0YzgzZDdhNTRiN2VhMjA5OWQ5YjNlZDI1ZjU4XzE0OTg_dd63254a-b781-4396-b23e-b1c6edf1f100">250</ix:nonFraction> million. The Company can limit its exposure to these guarantees by suspending the payment of claims for ASC customers that have not adequately funded the amount paid by the bank. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Separate Accounts Assets - Certain Separate Accounts assets associated with the large case pensions business in the Corporate/Other segment represent funds maintained as a contractual requirement to fund specific pension annuities that the Company has guaranteed. Minimum contractual obligations underlying the guaranteed benefits in these Separate Accounts were approximately $<ix:nonFraction unitRef="usd" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="-8" name="cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzgvZnJhZzo2MTM1NGM4M2Q3YTU0YjdlYTIwOTlkOWIzZWQyNWY1OC90ZXh0cmVnaW9uOjYxMzU0YzgzZDdhNTRiN2VhMjA5OWQ5YjNlZDI1ZjU4XzEzNzQzODk1NDI3MDgx_ce781649-8c37-444f-a5f2-bfaa3d58f423">1.3</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231" decimals="-8" name="cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzgvZnJhZzo2MTM1NGM4M2Q3YTU0YjdlYTIwOTlkOWIzZWQyNWY1OC90ZXh0cmVnaW9uOjYxMzU0YzgzZDdhNTRiN2VhMjA5OWQ5YjNlZDI1ZjU4XzIwNTE_fd3e7de7-c4b2-4f2b-952c-720382ecc8ab">1.4</ix:nonFraction> billion at December&#160;31, 2021 and 2020, respectively. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information on Separate Accounts. Contract holders assume all investment and mortality risk and are required to maintain Separate Accounts balances at or above a specified level. The level of required funds is a function of the risk underlying the Separate Account&#8217;s investment strategy. If contract holders do not maintain the required level of Separate Accounts assets to meet the annuity guarantees, the Company would </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">163</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idc26814d2a504312917753aa9bc2c987" continuedAt="iac3fa37d0cce41839921212a1b8a1de3"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">establish an additional liability. Contract holders&#8217; balances in the Separate Accounts at December&#160;31, 2021 exceeded the value of the guaranteed benefit obligation. As a result, the Company was not required to maintain any additional liability for its related guarantees at December&#160;31, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#8217;s Stores and Linens &#8216;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#8217;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#8217;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of December&#160;31, 2021, the Company guaranteed <ix:nonFraction unitRef="lease" contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231" decimals="INF" name="cvs:GuarantorObligationsNumberofLeases" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzgvZnJhZzo2MTM1NGM4M2Q3YTU0YjdlYTIwOTlkOWIzZWQyNWY1OC90ZXh0cmVnaW9uOjYxMzU0YzgzZDdhNTRiN2VhMjA5OWQ5YjNlZDI1ZjU4XzM5MDY_9b861239-698a-4b2f-876c-5e29c4a66260">72</ix:nonFraction> such store leases (excluding the lease guarantees related to Linens &#8216;n Things, which have been recorded as a liability on the consolidated balance sheets), with the maximum remaining lease term extending through 2030.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#8220;Penn Treaty&#8221;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#8217;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#8217;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s total guaranty fund assessments liability was immaterial at both December&#160;31, 2021 and 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CMS, state insurance and health and welfare departments, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the U.S. Department of Justice (the &#8220;DOJ&#8221;), </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">state attorneys general, the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;) and other governmental authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">164</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iac3fa37d0cce41839921212a1b8a1de3" continuedAt="i85544769cf2a4045b2cb9b1b7923e878"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#8217;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#8217;s financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#8217;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations.  In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Usual and Customary Pricing Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#8217;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PBM Litigation and Investigations</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is facing multiple lawsuits, including by a State Attorney General, governmental subdivisions and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers.  These complaints, brought by a number of different types of plaintiffs under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims.  The Company has also received subpoenas, civil investigative demands (&#8220;CIDs&#8221;) and other requests for documents and information from, and is being investigated by, Attorneys General of multiple states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Behnke v. CVS Caremark Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#8217;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#8217;s PBM. The Company is defending itself against these claims.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">165</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i85544769cf2a4045b2cb9b1b7923e878" continuedAt="i5d228f2d18f645bcb39dd1bbca1ab453"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled Substances Litigation, Audits and Subpoenas</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information. In November 2021, the Company was among the chain pharmacies found liable by a jury in a trial in federal court in Ohio; the remedy pursuant to that verdict has not been determined and the Company plans to appeal.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS Pharmacy locations concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. In January 2022, the DOJ served the Company with a CID regarding similar subjects. The Company is providing documents and information in response to these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prescription Processing Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#8217;s Office for the Southern District of New York (the &#8220;SDNY&#8221;) filed a complaint-in-intervention in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2016, the Company received a CID from the U.S. Attorney&#8217;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#8217;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Provider Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#8220;out-of-network providers&#8221;).&#160;Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services and/or otherwise allege that the Company failed to timely or appropriately pay or administer out-of-network claims and benefits (including the Company&#8217;s post payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">166</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i5d228f2d18f645bcb39dd1bbca1ab453" continuedAt="i3651988308644b548c7debdd33c062ff"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CMS Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#8217;s and other companies&#8217; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#8217; medical records to determine whether those records support the related diagnosis codes that determine the members&#8217; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#8220;RADV&#8221;) audits of various Medicare Advantage plans, including certain of the Company&#8217;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#8217;s risk adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the HHS (the &#8220;OIG&#8221;) also is auditing the Company&#8217;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately <ix:nonFraction unitRef="member" contextRef="i63b662edcef14a498dbf400ce0e7d2f8_D20120101-20121231" decimals="-2" name="cvs:LossContingencyAuditMethodologySampleSize" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzgvZnJhZzo2MTM1NGM4M2Q3YTU0YjdlYTIwOTlkOWIzZWQyNWY1OC90ZXh0cmVnaW9uOjYxMzU0YzgzZDdhNTRiN2VhMjA5OWQ5YjNlZDI1ZjU4XzEwOTk1MTE3MDQyMzU_174a2e50-225f-4471-b762-630459d21b1d">200</ix:nonFraction> members to all risk adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#8217;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#8217;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#8217;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#8217;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, the OIG or otherwise, including audits of the Company&#8217;s MLR rebates, methodology and/or reports, could be material and could adversely affect the Company&#8217;s operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare and Medicaid CIDs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#8217;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#8217;s LTC business unit. The Company and its current and former officers and directors are defending themselves against these claims. Since filing, several of the cases have been consolidated, and the first-filed federal case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Miami Fire Fighters&#8217; and Police Officers&#8217; Retirement Trust, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anarkat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), was dismissed with prejudice in February 2021. Plaintiffs have appealed that decision to the First Circuit after their motion for reconsideration was denied. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Act Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Waterford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">167</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3651988308644b548c7debdd33c062ff" continuedAt="i56d2bf31bedc417c8ae5e595c842681c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">re CVS Health Corp. Securities Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Warren</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freundlich</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) have been stayed pending the outcome of the First Circuit appeal. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August and September 2020, <ix:nonFraction unitRef="claim" contextRef="ia4e995a2f68a477fbac8891b9ff45d93_I20201231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzgvZnJhZzo2MTM1NGM4M2Q3YTU0YjdlYTIwOTlkOWIzZWQyNWY1OC90ZXh0cmVnaW9uOjYxMzU0YzgzZDdhNTRiN2VhMjA5OWQ5YjNlZDI1ZjU4XzM4NDgyOTA3ODEyMjc_d6f90f92-5393-4a72-a34a-57f25548100f">two</ix:nonFraction> class actions under the Employee Retirement Income Security Act of 1974 (&#8220;ERISA&#8221;) were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna, and several current and former executives, directors and/or members of Aetna&#8217;s Compensation and Talent Management Committee: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Radcliffe v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flaim v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#8217;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#8217;s LTC business unit. The district court consolidated the actions and the Company is defending itself against these claims. In October 2021, the consolidated case was dismissed without prejudice. Plaintiffs may seek leave to file an amended complaint. The Company also received a related document request pursuant to ERISA &#167; 104(b), to which the Company has responded.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company received a demand for inspection of books and records pursuant to Delaware Corporation Law Section 220 (the &#8220;Demand&#8221;). The Demand purports to be related to potential breaches of fiduciary duties by the Board in relation to certain matters concerning opioids.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Legal and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, breach of fiduciary duty, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, denial of or failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#8217;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#8217;s operating results. The Company will continue to defend contract awards it receives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#8217;s and the rest of the health care and related benefits industry&#8217;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#8217; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading national health solutions company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#8217;s businesses, changes to or clarifications of the Company&#8217;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">168</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><ix:continuation id="i56d2bf31bedc417c8ae5e595c842681c"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulations as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit against the Company, whether sealed or unsealed, or in any future </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span></ix:continuation></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_181"></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzc2MzE_74e27502-f3b5-487b-ba07-7f0ab6445a58" continuedAt="if699aabe6601467d821821b71c676e5f" escape="true">Segment Reporting</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if699aabe6601467d821821b71c676e5f" continuedAt="i8307d26b1f4a4e0788a0b84f6a9af41b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="segment" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzQx_dc76b93e-26a9-440b-806e-4846b1e4521f">three</ix:nonFraction> operating segments, Health Care Benefits, Pharmacy Services and Retail/LTC, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the Company&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliation of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.</span></div><div><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, 2020 and 2019, revenues from the federal government accounted for <ix:nonFraction unitRef="number" contextRef="i7c55eec168db4721bd5fa5e6c7afd8f1_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzE1MDk_cff551ef-4838-42c4-85fb-d0c3c3b0c20f">17</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i8549b1a793e64b2bb212ac0ced243d88_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzE1MTY_6a04b784-4151-4f9d-b5c9-910ddb74afff">16</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i4020d7e493d642d5966e8ca82cc66798_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzEwOTk1MTE2Mzk0MTU_1f79d34e-32a3-49cd-af3d-c3ccdd66d06d">16</ix:nonFraction>%, respectively, of the Company&#8217;s consolidated total revenues, primarily related to contracts with CMS for coverage of Medicare-eligible individuals within the Health Care Benefits segment.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">169</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8307d26b1f4a4e0788a0b84f6a9af41b" continuedAt="i81dca6b7757e4b0eb15eeaab62dc7c4e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzc2Mjg_47e74491-3db2-45a0-a2e7-12e7780d944c" escape="true"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.827%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.746%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;<br/>Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8f78677d6943988b31d555638bbaf9_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzItMS0xLTEtMjU2ODI_f922d649-1bf1-4a83-a26d-33679e96f1ca">81,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzItMS0xLTEtMTk2MzU_91fc60f2-0375-47df-a937-1696da49fdbf">143,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2301583729e7424597c39ac7978d0401_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzItMy0xLTEtMTk2MzU_a4e188d4-ca60-4187-8f8d-68849b7f0e9e">66,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f0540b87ed34aee812a4602f32b0fb6_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzItNy0xLTEtMTk2MzU_8d1b99b3-f1a7-4ebc-9b5d-3ecd8d3fbcbc">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzItMTEtMS0xLTE5NjM1_855fc45f-8ba5-40db-b13e-68fe63fa5f6e">290,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i528bf90615b04a4388c9e042e7d52e2d_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzMtMS0xLTEtMjU2ODI_894cbd53-4c1d-4883-98fd-2654fadd7788">85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b5addf84c5d4652a8c88278ee498b80_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzMtMS0xLTEtMTk2MzU_39271600-3e8a-4f20-b960-c4f5d0efeea8">9,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8ae9e7058b940a287f7a508f1290213_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzMtMy0xLTEtMTk2MzU_c8300a79-0ed1-453f-b9c2-f47a921f7419">34,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4344db6c31344de2b14b66847d6c28a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzMtOS0xLTEtMTk2MzU_b6909b73-3c35-4c03-877c-4477f2690975">43,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8f78677d6943988b31d555638bbaf9_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzQtMS0xLTEtMjU2ODI_87203dc5-275f-4c9c-af26-9d298658f2cf">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzQtMS0xLTEtMTk2MzU_4f0b9e61-a8bc-4ba3-87ea-5484b815ff7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2301583729e7424597c39ac7978d0401_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzQtMy0xLTEtMTk2MzU_75c5b9b9-5e70-4f4f-8f3a-13e1ff733cf9">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f0540b87ed34aee812a4602f32b0fb6_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzQtNy0xLTEtMTk2MzU_ca0e21d1-eb80-4330-9646-12bc22b6f83c">596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4344db6c31344de2b14b66847d6c28a3_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzQtOS0xLTEtMTk2MzU_1056160d-b4a9-4190-a225-acafe4b9ba25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzQtMTEtMS0xLTE5NjM1_e0facd50-fc02-40c5-a6fe-1669168efe3b">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8f78677d6943988b31d555638bbaf9_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzUtMS0xLTEtMjU2ODI_5b0f0779-3a95-4a5c-aa7f-18465cb8dc33">82,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzUtMS0xLTEtMTk2MzU_87d774f8-5f03-441f-a34a-8f98a7c6e65b">153,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2301583729e7424597c39ac7978d0401_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzUtMy0xLTEtMTk2MzU_fa37708b-0fde-4536-8271-b0693872355e">100,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f0540b87ed34aee812a4602f32b0fb6_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzUtNy0xLTEtMTk2MzU_55058538-8582-4b5e-9bba-dc76ea4483fe">721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4344db6c31344de2b14b66847d6c28a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzUtOS0xLTEtMTk2MzU_6a1b84d2-521c-48e3-9c51-28a1ed13c4fc">43,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzUtMTEtMS0xLTE5NjM1_0ed770e6-258e-4be6-bba0-8ee5df73f1ee">292,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8f78677d6943988b31d555638bbaf9_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzYtMS0xLTEtMjU2ODI_27822a4f-f934-4e43-b7f8-cadb15565b59">5,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzYtMS0xLTEtMTk2MzU_e349eddb-f385-4880-9f22-5a7f36e6b60a">6,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2301583729e7424597c39ac7978d0401_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzYtMy0xLTEtMTk2MzU_42d3ec3a-3ffa-451d-aa04-ab9342d66191">7,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f0540b87ed34aee812a4602f32b0fb6_D20210101-20211231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzYtNy0xLTEtMTk2MzU_62958ad2-8063-4eb4-bf72-b8b827ad5252">1,471</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4344db6c31344de2b14b66847d6c28a3_D20210101-20211231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzYtOS0xLTEtMTk2MzU_aa15573f-4d99-4435-a01f-3f87a86805c0">711</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzYtMTEtMS0xLTE5NjM1_4bd521cf-737b-4d7e-aaa8-dc79672ce2b8">17,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8f78677d6943988b31d555638bbaf9_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzctMS0xLTEtMjU2ODI_fa42cbf7-e13d-4a17-a15c-525057a5542f">1,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzctMS0xLTEtMTk2MzU_d56c11d3-0a21-44b4-af77-652b2343061d">576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2301583729e7424597c39ac7978d0401_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzctMy0xLTEtMTk2MzU_916de669-6c8c-4027-8e59-518a673b17b8">1,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f0540b87ed34aee812a4602f32b0fb6_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzctNy0xLTEtMTk2MzU_aac5ac6c-f117-4b7a-aa06-e2e713f7d00a">215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4344db6c31344de2b14b66847d6c28a3_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzctOS0xLTEtMTk2MzU_4cd11d06-af4c-4010-99f1-caec8ad01087">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzctMTEtMS0xLTE5NjM1_b64bfcbe-7153-4703-ac81-053e19ff2847">4,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53db5e5b0b444479a8a8759dbf521388_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzktMS0xLTEtMjU2ODI_c156ee7e-e4bb-47d3-8ad7-21f677338804">74,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzktMS0xLTEtMTk2MzU_11fd5dea-5944-48bb-97bd-ed68d25511a7">132,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia854c1c4120946f68b69cb19bc260e4b_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzktMy0xLTEtMTk2MzU_7b767408-39da-4590-be3c-7d77b17d2f27">60,208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e61340f47284992812b376b1458946d_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzktNy0xLTEtMTk2MzU_3f2b3dc5-4245-481b-bfa0-eb8774af8dc3">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzktMTEtMS0xLTE5NjM1_56e040ce-44a8-4ad0-93af-6430253422eb">267,908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eab19a267b14681b658f1fd1f748401_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEwLTEtMS0xLTI1Njgy_5a963705-3bba-46f9-b0b8-010874f9f88a">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03972e1ca7ae40f3b269cf247834e557_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEwLTEtMS0xLTE5NjM1_4fde681e-d252-402c-8459-3600a8e71bb7">9,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i326e08f13dd84d729af0ed31957c20b2_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEwLTMtMS0xLTE5NjM1_94b493d9-015a-4c0f-b9f4-d257dd638843">30,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccc3d52c70ae4beeabf495e0d535c807_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEwLTktMS0xLTE5NjM1_c03c34d6-9ad8-4140-a24b-c7d7c6ea2cd1">40,323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53db5e5b0b444479a8a8759dbf521388_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzExLTEtMS0xLTI1Njgy_c54d4114-4d67-4e41-99cf-be3ff7805eef">483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzExLTEtMS0xLTE5NjM1_d7648abe-98a0-4bee-941c-c0aae62c7f29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia854c1c4120946f68b69cb19bc260e4b_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzExLTMtMS0xLTE5NjM1_18ac0791-adbf-4112-9d5b-14d15fee55c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e61340f47284992812b376b1458946d_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzExLTctMS0xLTE5NjM1_a25aa740-51da-4271-8e0d-4af42f2b0348">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccc3d52c70ae4beeabf495e0d535c807_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzExLTktMS0xLTE5NjM1_c16d4e37-b78a-499c-ad94-bfe77bb9c2a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzExLTExLTEtMS0xOTYzNQ_5c4d47e5-2781-4b50-81f4-cc59d2cbe833">798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53db5e5b0b444479a8a8759dbf521388_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEyLTEtMS0xLTI1Njgy_dd00c25c-f239-4e06-bd4d-c04ba93dbbf5">75,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEyLTEtMS0xLTE5NjM1_1c3be91e-718b-4adb-a921-0e01e610afda">141,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia854c1c4120946f68b69cb19bc260e4b_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEyLTMtMS0xLTE5NjM1_cd45eb3c-2e1c-48ad-942c-2eaba156a8db">91,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e61340f47284992812b376b1458946d_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEyLTctMS0xLTE5NjM1_d4610d07-8bcc-4d9e-8930-a8bf3d6d8155">426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccc3d52c70ae4beeabf495e0d535c807_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEyLTktMS0xLTE5NjM1_c14fdba1-9910-4c6b-bc9c-2f29da2fdb80">40,323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEyLTExLTEtMS0xOTYzNQ_3ee84e57-1aa6-4a5e-91fa-93a3c200b5a9">268,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53db5e5b0b444479a8a8759dbf521388_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEzLTEtMS0xLTI1Njgy_7d31b04d-35fd-449c-a6b4-90659364eeb4">6,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEzLTEtMS0xLTE5NjM1_4b35f394-7d77-4034-b2cf-c7d4d113ffe9">5,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia854c1c4120946f68b69cb19bc260e4b_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEzLTMtMS0xLTE5NjM1_59acbeaf-dd9f-4f7b-b2fd-f0a4c21f3fc9">6,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e61340f47284992812b376b1458946d_D20200101-20201231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEzLTctMS0xLTE5NjM1_f4e67923-0212-49e9-870c-1f160473ed19">1,306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccc3d52c70ae4beeabf495e0d535c807_D20200101-20201231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEzLTktMS0xLTE5NjM1_711846b8-23ce-4fc3-a3ca-f46bbe7a33ba">708</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEzLTExLTEtMS0xOTYzNQ_739c5c76-ab06-4017-87bd-bd269d8aedab">16,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53db5e5b0b444479a8a8759dbf521388_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE0LTEtMS0xLTI1Njgy_94f6adb5-b22d-4ea2-8bd9-24d533c068e5">1,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE0LTEtMS0xLTE5NjM1_a01c222c-660a-4291-a2c1-df6f98f0178a">612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia854c1c4120946f68b69cb19bc260e4b_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE0LTMtMS0xLTE5NjM1_61365730-fbbb-42d1-b23a-e24e62a79755">1,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e61340f47284992812b376b1458946d_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE0LTctMS0xLTE5NjM1_7c86ee01-acaa-49eb-83b5-73aaba9ef456">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccc3d52c70ae4beeabf495e0d535c807_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE0LTktMS0xLTE5NjM1_6e8b2bc4-81c2-44fe-9f9c-bdfdf924fcde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE0LTExLTEtMS0xOTYzNQ_8b77882b-b357-46a3-8d1c-4a8b59880704">4,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7683c6a5bd9a46859b7c36e87aefa23f_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE2LTEtMS0xLTI1Njgy_dcb46a5f-e066-4863-8ba3-393f4ec2fa1b">68,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE2LTEtMS0xLTE5NjM1_1f043516-e066-4fbe-9bac-e49e06d383eb">130,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0059ff87fc364aec80f3c7eef6a97f6a_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE2LTMtMS0xLTE5NjM1_0b658d39-b927-4420-95d3-1472de6df251">56,258</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa96e65bf6294c0ca787cbef203ccb23_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE2LTctMS0xLTE5NjM1_78750d91-3054-4e31-baa6-b526f3abb462">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE2LTExLTEtMS0xOTYzNQ_26ef95e2-2d55-4db8-8abc-cfc84e254cef">255,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f87e61e37e492f9c3f8051c3c9e4f5_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE3LTEtMS0xLTI1Njgy_12464791-d241-439b-ac32-d04899615908">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae6f1ee606a4353bd0cf7e6f048d3cc_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE3LTEtMS0xLTE5NjM1_14a6257a-e976-415f-9289-87da86451aea">11,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53edb1dedd7242ae84fe83beefc1c6ca_D20190101-20191231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE3LTMtMS0xLTE5NjM1_fe76b8ae-83b3-4e26-a830-2e61c525db2c">30,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic17eebf2b4964519a5671bddafa2ecae_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE3LTktMS0xLTE5NjM1_46e37e39-931d-43aa-a89a-75a20113bc4e">41,439</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7683c6a5bd9a46859b7c36e87aefa23f_D20190101-20191231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE4LTEtMS0xLTI1Njgy_916b1714-8bd9-4c2e-b262-76aa5dd58cd4">599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE4LTEtMS0xLTE5NjM1_197a7ddc-4171-426a-bda0-39823db00557">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0059ff87fc364aec80f3c7eef6a97f6a_D20190101-20191231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE4LTMtMS0xLTE5NjM1_f5636e0f-1d7a-4ffa-a1bd-f38386d06e35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa96e65bf6294c0ca787cbef203ccb23_D20190101-20191231" decimals="-6" name="us-gaap:NetInvestmentIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE4LTctMS0xLTE5NjM1_1691061e-97bf-4bd6-9d69-a47454c2dd6f">412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic17eebf2b4964519a5671bddafa2ecae_D20190101-20191231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE4LTktMS0xLTE5NjM1_ed65de10-a8fb-44ce-b1aa-87c416fdbabf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:NetInvestmentIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE4LTExLTEtMS0xOTYzNQ_7862a8b1-67a0-4ad3-8928-63ead322c698">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7683c6a5bd9a46859b7c36e87aefa23f_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE5LTEtMS0xLTI1Njgy_bcc889b7-3a2c-474b-ab7a-f9785a5c8cf8">69,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE5LTEtMS0xLTE5NjM1_d6fc221a-79b3-48df-8e2a-780d65e0e2f7">141,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0059ff87fc364aec80f3c7eef6a97f6a_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE5LTMtMS0xLTE5NjM1_ebcc83a7-f33c-48ce-93bb-56547cf84b7e">86,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa96e65bf6294c0ca787cbef203ccb23_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE5LTctMS0xLTE5NjM1_3f12e3a8-3736-4bda-9c3b-0f5c50b3927f">512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic17eebf2b4964519a5671bddafa2ecae_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE5LTktMS0xLTE5NjM1_f1ca6677-0126-475a-91ce-6f2c8c581dd1">41,439</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE5LTExLTEtMS0xOTYzNQ_722ff73d-1d89-46cf-a891-b4572c7b9c00">256,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7683c6a5bd9a46859b7c36e87aefa23f_D20190101-20191231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIwLTEtMS0xLTI1Njgy_a225af20-f680-420a-9170-3dc104a63bc7">5,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIwLTEtMS0xLTE5NjM1_eed9e406-cf5d-44dd-9d21-ebcec4371c6d">5,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0059ff87fc364aec80f3c7eef6a97f6a_D20190101-20191231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIwLTMtMS0xLTE5NjM1_17e0e39d-a01a-42dc-b093-74c738006e67">6,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa96e65bf6294c0ca787cbef203ccb23_D20190101-20191231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIwLTctMS0xLTE5NjM1_b37c5497-f889-453b-b813-245fb1ccb494">1,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic17eebf2b4964519a5671bddafa2ecae_D20190101-20191231" decimals="-6" sign="-" name="cvs:AdjustedOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIwLTktMS0xLTE5NjM1_cb795cb0-36b1-48a6-a4ab-03cc7f923043">697</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIwLTExLTEtMS0xOTYzNQ_91fc1491-ea3c-4502-b851-01b6a706171e">15,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7683c6a5bd9a46859b7c36e87aefa23f_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIxLTEtMS0xLTI1Njgy_5a45b603-7a81-4ee2-9c52-00cf9e63b29f">1,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIxLTEtMS0xLTE5NjM1_a6bf0f00-f31e-4b98-b6d8-8c4a0d433ef3">766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0059ff87fc364aec80f3c7eef6a97f6a_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIxLTMtMS0xLTE5NjM1_01fb6e36-b03f-49d7-81b6-5951b1738847">1,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa96e65bf6294c0ca787cbef203ccb23_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIxLTctMS0xLTE5NjM1_2ee0a1ab-8e1e-457e-b0e8-d429b38cc6a3">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic17eebf2b4964519a5671bddafa2ecae_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIxLTktMS0xLTE5NjM1_61fae447-1b4d-4c9d-ad7c-a4a41bf43284">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIxLTExLTEtMS0xOTYzNQ_61a26b9b-4b15-4296-a75d-ac12a19a3883">4,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Total revenues of the Pharmacy Services segment include approximately $<ix:nonFraction unitRef="usd" contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231" decimals="-8" name="cvs:NetRevenuesRetailCoPayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzI0NTg_69d68eac-8733-41a7-a926-bf84aedf6574">11.6</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231" decimals="-8" name="cvs:NetRevenuesRetailCoPayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzI0NjI_2c349245-b8e0-4b25-a0bc-6756c23694cf">10.9</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231" decimals="-8" name="cvs:NetRevenuesRetailCoPayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzI0Njk_fde9a5f6-105e-449c-9279-b618c3b5b280">11.5</ix:nonFraction> billion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">of retail co-payments for 2021, 2020 and 2019, respectively. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information about retail co-payments.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#8220;PSS members&#8221;) enrolled in Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> elect to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i81dca6b7757e4b0eb15eeaab62dc7c4e"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzc2Mjk_e87ae3c3-2838-421d-815e-0ac88aa9db0e" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of consolidated operating income to adjusted operating income for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzEtMS0xLTEtMTk2MzU_91e0a4cd-4a0c-476c-8fe7-d24684e548fc">13,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzEtMy0xLTEtMTk2MzU_d4d2ae5d-7345-4393-88f4-e660572caa9d">13,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzEtNS0xLTEtMTk2MzU_1cec23cf-0dcd-44a6-862c-259b9ef0f3b0">11,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzItMS0xLTEtMTk2MzU_0cdc7da2-0199-41bd-bf7a-bdcad10e4140">2,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzItMy0xLTEtMTk2MzU_fcc74278-d4c0-49e0-a000-78d55e30b5d4">2,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzItNS0xLTEtMTk2MzU_7bd76e82-2b63-49e4-bd24-20c4dd72b561">2,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzMtMS0xLTEtMTk2MzU_ff000350-b9c0-4432-9226-e8b6f9afcb94">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzMtMy0xLTEtMTk2MzU_85089311-2125-402a-9405-84be4411dfcc">332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzMtNS0xLTEtMTk2MzU_5cda08f6-f0f8-49d4-b991-a065210d1312">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store impairments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtMS0xLTEtNDM0Njk_8bff20cc-6cd6-4b10-b128-40a616ad4ae2">1,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:StoreImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtMy0xLTEtNDM0Njk_70115544-d440-4ea9-8313-f97bd5a5a432">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="cvs:StoreImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtNS0xLTEtNDM0Njk_011b5419-8d51-4394-b864-064aa740ff77">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtMS0xLTEtMzAxNTA_42406a52-dc1a-4408-b15c-b9be2db21719">431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtMy0xLTEtMzAxNTM_b6e65f0f-3b2d-48b7-b7d8-056e7b9067b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtNS0xLTEtMzAxNTY_efbbbf8b-3ec4-4dc9-87bb-d577672f3e2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" sign="-" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzUtMS0xLTEtMzE2MTE_40c00cce-eafa-4dda-9377-4a55e77e712a">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzUtMy0xLTEtMzE2Mzk_244b30d8-19e8-46a8-9885-7583f93e51b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzUtNS0xLTEtMzE2NTc_c07d1af3-d3c2-4c37-96f7-91601d80a19e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtMS0xLTEtMTk2MzU_84a5d76c-daeb-4994-9c8b-390fec963b1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtMy0xLTEtMTk2MzU_516ee691-0304-40a1-a5f7-b4b3f39515e3">269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtNS0xLTEtMTk2MzU_da76e5a4-735b-4c24-8378-9173e6004e76">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receipt of fully reserved ACA risk corridor receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzUtMS0xLTEtMTk2MzU_ad2f8415-2590-460f-a5bf-1d68b9c7e1c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzUtMy0xLTEtMTk2MzU_3e065e01-1c41-4fc8-8340-700a357af023">307</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzUtNS0xLTEtMTk2MzU_65d335d2-19ac-49da-8aec-e2684695750d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzEwLTEtMS0xLTE5NjM1_d760a1bd-890f-4ebd-9c20-d833251e6118">17,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzEwLTMtMS0xLTE5NjM1_739c5c76-ab06-4017-87bd-bd269d8aedab">16,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="-6" name="cvs:AdjustedOperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzEwLTUtMS0xLTE5NjM1_91fc1491-ea3c-4502-b851-01b6a706171e">15,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2021, 2020 and 2019, acquisition-related integration costs relate to the Aetna Acquisition. The acquisition-related integration costs are reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within the Corporate/Other segment.  </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">During the year ended December 31, 2021, the store impairment charge relates to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately <ix:nonFraction unitRef="store" contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" decimals="INF" name="cvs:NumberOfStoresPlannedClosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzE2NDkyNjc0NjgyMjE_e365fcb5-15b2-49f6-89b5-ca9c36ebf6b3">900</ix:nonFraction> retail stores between 2022 and 2024. During the year ended December 31, 2019, the store impairment charges related to the write down of operating lease right-of-use assets in connection with the planned closure of <ix:nonFraction unitRef="store" contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231" decimals="INF" name="cvs:NumberOfStoresPlannedClosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzE2NDkyNjc0NjgyMjc_05bb6628-18cf-47ba-8e9c-2fbfc8639069">68</ix:nonFraction> underperforming retail pharmacy stores in 2019 and 2020. The store impairment charges are reflected in the Company&#8217;s GAAP consolidated statements of operations within the Retail/LTC segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">During the year ended December 31, 2021, the goodwill impairment charge relates to the LTC reporting unit within the Retail/LTC segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In June 2021, the Company received $<ix:nonFraction unitRef="usd" contextRef="i869e87b37b534c77b68def0dd025f28b_D20210601-20210630" decimals="-6" name="cvs:ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzEwOTk1MTE2NTQzNTE_398b6915-efff-4d7a-9073-cbb0346b0b80">61</ix:nonFraction>&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s GAAP consolidated statement of operations for the year ended December 31, 2021 as a reduction of operating expenses within the Health Care Benefits segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold on July 31, 2020 for approximately $<ix:nonFraction unitRef="usd" contextRef="i707e6377bc8f46819c6e330be95da61e_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzEwOTk1MTE2NTQzNjY_477cdf0a-10c5-4a66-9325-bdc551ce9049">850</ix:nonFraction>&#160;million. The gain on divestiture is reflected as a reduction of operating expenses in the Company&#8217;s GAAP consolidated statement of operations within the Health Care Benefits segment. In 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in the Company&#8217;s GAAP consolidated statement of operations in operating expenses within the Retail/LTC segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, the Company received $<ix:nonFraction unitRef="usd" contextRef="i55877e993992468ea1377ad4577db051_I20201231" decimals="-6" name="us-gaap:GainContingencyUnrecordedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzEwOTk1MTE2NTQzODI_fd128ea6-178a-4e5a-8a0c-830a9fcdcd82">313</ix:nonFraction>&#160;million owed to it under the ACA&#8217;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recognized pre-tax income of $<ix:nonFraction unitRef="usd" contextRef="i55877e993992468ea1377ad4577db051_I20201231" decimals="-6" name="cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzEwOTk1MTE2NTQzOTc_4258e0ce-c133-4615-b3db-bd26f58e6102">307</ix:nonFraction>&#160;million in the Company&#8217;s GAAP consolidated statement of operations within the Health Care Benefits segment.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="text-indent:6.75pt"><span><br/></span></div><div style="text-indent:6.75pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">171</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_184"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-right:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_100">Index to Consolidated Financial Statements</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of CVS Health Corporation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited CVS Health Corporation&#8217;s internal control over financial reporting as of December&#160;31, 2021, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, CVS Health Corporation (the Company) maintained, in all material respects, effective internal control over financial reporting as of December&#160;31, 2021, based on the COSO criteria.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the 2021 consolidated financial statements of the Company and our report dated February&#160;9, 2022, expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODQvZnJhZzo2ZDRmNDUxOTQ3NTc0ZmViYTVhMTlhNzU4YTAwOTIyNy90ZXh0cmVnaW9uOjZkNGY0NTE5NDc1NzRmZWJhNWExOWE3NThhMDA5MjI3XzMyOTg1MzQ4ODcyMDc_ec8b0da6-7ee7-4cf1-ab65-3934ee7e9166">Ernst &amp; Young LLP</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODQvZnJhZzo2ZDRmNDUxOTQ3NTc0ZmViYTVhMTlhNzU4YTAwOTIyNy90ZXh0cmVnaW9uOjZkNGY0NTE5NDc1NzRmZWJhNWExOWE3NThhMDA5MjI3XzMyOTg1MzQ4ODcyMDk_933f6590-458b-4891-afe4-32f90de8dbf2">Boston, Massachusetts</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;9, 2022 </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">172</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_187"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of CVS Health Corporation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of CVS Health Corporation (the Company) as of December&#160;31, 2021 and 2020, the related consolidated statements of operations, comprehensive income, shareholders&#8217; equity and cash flows for each of the three years in the period ended December&#160;31, 2021, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December&#160;31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December&#160;31, 2021, in conformity with U.S. generally accepted accounting principles. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December&#160;31, 2021, based on criteria established in Internal Control-Integrated</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February&#160;9, 2022, expressed an unqualified opinion thereon.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.305%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">Annual goodwill impairment test of the Commercial Business reporting unit</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the Company&#8217;s goodwill related to the Commercial Business reporting unit was $26.5 billion. As discussed in Note 1 to the consolidated financial statements, goodwill is not amortized, but rather is subject to an annual impairment review, or more frequent reviews, if events and circumstances indicate an impairment exists. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Auditing management's annual goodwill impairment test related to the Commercial Business reporting unit was complex and highly judgmental due to the significant estimation required to determine the fair value of the reporting unit. In particular, the fair value estimate was sensitive to changes in significant assumptions, such as the discount rate, projected revenue and projected operating income that are forward-looking and affected by future economic and market conditions.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s annual goodwill impairment review process, including controls over management&#8217;s review of the significant assumptions described above.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To test the estimated fair value of the Commercial Business reporting unit, we performed audit procedures that included, among others, assessing methodologies and testing the significant assumptions discussed above and the underlying data used by the Company in its analysis. We compared the significant assumptions to the reporting unit&#8217;s historical results and third-party industry data. We performed sensitivity analyses of significant assumptions to evaluate the changes in the fair value of the reporting unit that would result from changes in the key assumptions. We involved valuation specialists to assist in our assessment of the methodology and significant assumptions (such as the discount rate) used by the Company. In addition, we tested management&#8217;s reconciliation of the fair value of all reporting units to the market capitalization of the Company.  </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">Valuation of health care costs payable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the incurred but not reported (&#8220;IBNR&#8221;) liabilities represented $6.6 billion of $8.8 billion of health care costs payable. As discussed in Note 1 to the consolidated financial statements, the Company&#8217;s liability for health care costs payable includes estimated payments for (1) services rendered to members but not yet reported and (2) claims that have been reported but not yet paid, each as of the financial statement date (collectively, &#8220;IBNR&#8221;). The estimated IBNR liability is developed utilizing actuarial principles and assumptions that include historical and projected claim submission and processing patterns, historical and assumed medical cost trends, historical utilization of medical services, claim inventory levels, changes in membership and product mix, seasonality and other relevant factors to record the actuarial best estimate of health care costs payable. There is significant uncertainty inherent in determining management&#8217;s actuarial best estimate of health care costs payable. In particular, the estimate is sensitive to the assumed completion factors and the assumed health care cost trend rates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Auditing management&#8217;s actuarial best estimate of IBNR reserves for health care costs payable for its products and services involved a high degree of subjectivity in evaluating management&#8217;s assumptions used in the valuation process.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the process for estimating IBNR reserves. This included, among others, controls over the completeness and accuracy of data used in the actuarial projections, the transfer of data between underlying source systems, and the review and approval processes that management has in place for the actuarial principles and assumptions used in estimating the health care costs payable.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To test IBNR reserves, our audit procedures included, among others, testing the completeness and accuracy of the underlying claim and membership data used in the calculation of IBNR reserves. We involved actuarial specialists to assist with our audit procedures, which included, among others, evaluating the methodologies applied by the Company in determining the actuarially determined liability, evaluating management&#8217;s actuarial principles and assumptions used in their analysis based on historical claim experience, and independently calculating a range of reserve estimates for comparison to management&#8217;s actuarial best estimate of the liability for health care costs payable. Additionally, we performed a review of the prior period liabilities for incurred but not paid claims to subsequent claims development.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">174</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2007.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boston, Massachusetts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;9, 2022</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">175</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_190"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.  Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.</span></div><div><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_193"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A.  Controls and Procedures.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of disclosure controls and procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of the design and operation of the Company&#8217;s disclosure controls and procedures (as defined in Rules&#160;13a-15 (f)&#160;and 15d-15(f) under the Securities Exchange Act of 1934) as of December&#160;31, 2021, have concluded that as of such date the Company&#8217;s disclosure controls and procedures were adequate and effective at a reasonable assurance level and designed to ensure that material information relating to the Company and its consolidated subsidiaries would be made known to such officers on a timely basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s report on internal control over financial reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management is responsible for establishing and maintaining adequate internal control over financial r</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eporting. The Company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the assets of the Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of the Company&#8217;s consolidated financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company&#8217;s assets that could have a material effect on the Company&#8217;s consolidated financial statements. In order to ensure the Company&#8217;s internal control over financial reporting is effective, management regularly assesses such control and did so most recently for its financial reporting as of December&#160;31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management conducted an assessment of the effectiveness of the Company&#8217;s internal control over financial reporting based on the criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control-Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 Framework). This evaluation included review of the documentation, evaluation of the design effectiveness and testing of the operating effectiveness of controls. The Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s system of internal control over financial reporting is enhanced by periodic reviews by the Company&#8217;s internal auditors, written policies and procedures and a written Code of Conduct adopted by CVS Health Corporation&#8217;s Board of Directors, applicable to all employees of the Company. In addition, the Company has an internal Disclosure Committee, comprised of management from each functional area within the Company, which performs a separate review of disclosure controls and procedures. There are inherent limitations in the effectiveness of any system of internal control over financial reporting.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on management&#8217;s assessment, management concluded that the Company&#8217;s internal control over financial reporting is effective and provides reasonable assurance that assets are safeguarded and that the financial records are reliable for preparing financial statements as of December&#160;31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ernst&#160;&amp; Young LLP, the Company&#8217;s independent registered public accounting firm, is appointed by CVS Health Corporation&#8217;s Board of Directors and ratified by CVS Health Corporation&#8217;s stockholders. They were engaged to render an opinion regarding the fair presentation of the Company</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s consolidated financial statements as well as conducting an audit of internal control over financial reporting. Their reports included in Item 8 of this Form 10-K are based upon audits conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in internal control over financial reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been no change in the Company&#8217;s internal control over financial reporting identified in connection with the evaluation required by paragraph (d)&#160;of Rule&#160;13a-15 or Rule&#160;15d-15 that occurred during the fourth quarter ended December&#160;31, 2021 that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">176</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_196"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B.  Other Information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No events have occurred during the fourth quarter ended December&#160;31, 2021 that would require disclosure under this item.</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_199"></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_202"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10.  Directors, Executive Officers and Corporate Governance.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning the Executive Officers of CVS Health Corporation is included in Part I of this 10-K pursuant to General Instruction G to Form 10-K. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sections of the Proxy Statement under the captions &#8220;Committees of the Board as of the Annual Meeting,&#8221; &#8220;Code of Conduct,&#8221; &#8220;Audit Committee Report,&#8221; and &#8220;Biographies of our Incumbent Board Nominees&#8221; are incorporated herein by reference. </span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_205"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11.  Executive Compensation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sections of the Proxy Statement under the captions &#8220;Non-Employee Director Compensation&#8221; and &#8220;Executive Compensation and Related Matters,&#8221; including &#8220;Letter from the Management Planning and Development Committee,&#8221; &#8220;Compensation Committee Report,&#8221; &#8220;Compensation Discussion and Analysis&#8221; and &#8220;Compensation of Named Executive Officers&#8221; are incorporated herein by reference.</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_208"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12.  Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sections of the Proxy Statement under the captions &#8220;Share Ownership of Directors and Certain Executive Officers&#8221; and &#8220;Share Ownership of Principal Stockholders&#8221; are incorporated herein by reference. Those sections contain information concerning security ownership of certain beneficial owners and management and related stockholder matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the registrant&#8217;s common stock that may be issued upon the exercise of options, warrants and rights under all of the Company&#8217;s equity compensation plans as of December&#160;31, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">securities&#160;to&#160;be</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">issued&#160;upon</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">exercise&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">outstanding</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">options,&#160;warrants</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">and&#160;rights </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) (2)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>average&#160;exercise<br/>price&#160;of<br/>outstanding<br/>options,&#160;warrants<br/>and&#160;rights<br/>(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number&#160;of&#160;securities</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">remaining&#160;available&#160;for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">future&#160;issuance&#160;under</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">equity&#160;compensation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">plans&#160;(excluding</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">securities&#160;reflected&#160;in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">first&#160;column)&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(c)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans approved by stockholders </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,075&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.09&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,585&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans not approved by stockholders </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,139&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.68&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,585&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Shares in thousands.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Consists of: (i) 17,575 shares of common stock underlying outstanding options, (ii) 854 shares of common stock issuable upon the exercise of outstanding stock appreciation rights (&#8220;SARs&#8221;) and (iii) 15,710 shares of common stock issuable on the vesting of outstanding restricted stock units, deferred stock units and performance stock units, assuming target level performance in the case of performance stock units. The number of shares included with respect to outstanding SARs is the number of shares of CVS Health Corporation common stock that would have been issued had the SARs been exercised based on the closing price per share of CVS Health Corporation common stock on December 31, 2021, as reported on the NYSE, which was $103.16.  </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Consists of the CVS Health 2017 Incentive Compensation Plan.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Consists of the Amended Aetna Inc. 2010 Stock Incentive Plan (the &#8220;Aetna Stock Plan&#8221;). The Aetna Stock Plan expired on May 21, 2020, therefore there are no securities available for future issuance under this plan.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Aetna Stock Plan was last approved by Aetna&#8217;s shareholders at Aetna&#8217;s 2017 Annual Meeting on May 19, 2017. The Company elected to continue to grant awards under the Aetna Stock Plan to employees of Aetna and its subsidiaries following the completion of the Company&#8217;s acquisition of Aetna. The Aetna Stock Plan was designed to promote the Company&#8217;s interests and those of its stockholders and to further align the interests of stockholders and employees by tying awards to total return to stockholders, enabling plan participants to acquire additional equity interests in the Company and providing compensation opportunities dependent upon the Company&#8217;s performance. The Aetna Stock Plan was not submitted to the Company&#8217;s stockholders and expired on May 21, 2020. Under the Aetna Stock Plan, eligible participants could be granted stock options to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">177</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">purchase shares of CVS Health Corporation common stock, SARs, time-vesting and/or performance-vesting incentive stock or incentive units and other stock-based awards.</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_211"></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13.  Certain Relationships and Related Transactions, and Director Independence.</span></div><div style="padding-right:6.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sections of the Proxy Statement under the captions &#8220;Independence Determinations for Directors&#8221; and &#8220;Related Person Transaction Policy&#8221; are incorporated herein by reference.</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_214"></div><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14.  Principal Accountant Fees and Services.</span></div><div style="padding-right:2.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The section of the Proxy Statement under the caption &#8220;Item 2: Ratification of Appointment of Independent Registered Public Accounting Firm for 2021&#8221; is incorporated herein by reference.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">178</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_217"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div style="padding-left:3.37pt;padding-right:3.37pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_220"></div><div style="-sec-extract:summary;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15.  Exhibits, Financial Statement Schedules.</span></div><div style="padding-right:2.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are filed as part of this 10-K:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Financial Statements. See &#8220;Index to Consolidated Financial Statements&#8221; in Item 8 of this 10-K.</span></div><div style="text-align:center"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Financial Statement Schedules. All financial statement schedules are omitted because they are not applicable, not required under the instructions, or the information is included in the consolidated financial statements or related notes.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Exhibits. The exhibits listed in the &#8220;Index to Exhibits&#8221; in this Item 15 are filed or incorporated by reference as part of this 10-K. Exhibits marked with an asterisk (*)&#160;are management contracts or compensatory plans or arrangements. Exhibits other than those listed are omitted because they are not required to be listed or are not applicable. Pursuant to Item 601(b)(4)(iii) of Regulation S-K, the Registrant hereby agrees to furnish to the Securities and Exchange Commission a copy of any omitted instrument that is not required to be listed.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO EXHIBITS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Articles of Incorporation and Bylaws</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312518184593/d456958dex31c.htm">Restated Certificate of Incorporation of the Registrant dated June 4, 2018 (incorporated by reference to Exhibit&#160;3.1C of Registrant&#8217;s Current Report on Form&#160;8-K filed June 5, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000094787120000619/ss177554_ex0301.htm">By-Laws of the Registrant, as amended and restated July 8, 2020 (incorporated by reference to Exhibit&#160;3.1 to the Registrant&#8217;s Current Report on Form&#160;8-K filed July 10, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Instruments defining the rights of security holders, including indentures</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/0000950103-96-001174.txt">Specimen common stock certificate (incorporated by reference to Exhibit 4.1 to the Registration Statement of the Registrant ((then known as CVS Corporation) as successor to Melville Corporation) on Form 8-B filed November 4, 1996).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000095010306001962/ex0401.htm">Senior Indenture dated August 15, 2006, between the Registrant and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed August 15, 2006).</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312518079390/d547656dex42.htm">Form of the Registrant&#8217;s 2021 Floating Rate Note (incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed March 12, 2018).</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312518079390/d547656dex44.htm">Form of the Registrant&#8217;s 2021 Note (incorporated by reference to Exhibit 4.4 to the Registrant&#8217;s Current Report on Form 8-K filed March 12, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312518079390/d547656dex45.htm">Form of the Registrant&#8217;s 2023 Note (incorporated by reference to Exhibit 4.5 to the Registrant&#8217;s Current Report on Form 8-K filed March 12, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312518079390/d547656dex46.htm">Form of the Registrant&#8217;s 2025 Note (incorporated by reference to Exhibit 4.6 to the Registrant&#8217;s Current Report on Form 8-K filed March 12, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312518079390/d547656dex47.htm">Form of the Registrant&#8217;s 2028 Note (incorporated by reference to Exhibit 4.7 to the Registrant&#8217;s Current Report on Form 8-K filed March 12, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312518079390/d547656dex48.htm">Form of the Registrant&#8217;s 2038 Note (incorporated by reference to Exhibit 4.8 to the Registrant&#8217;s Current Report on Form 8-K filed March 12, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312518079390/d547656dex49.htm">Form of the Registrant&#8217;s 2048 Note (incorporated by reference to Exhibit 4.9 to the Registrant&#8217;s Current Report on Form 8-K filed March 12, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312519222479/d791446dex41.htm">Form of the Registrant&#8217;s 2024 Note (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed August 15, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312519222479/d791446dex42.htm">Form of the Registrant&#8217;s 2026 Note (incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed August 15, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312519222479/d791446dex43.htm">Form of the Registrant&#8217;s 2029 Note (incorporated by reference to Exhibit 4.3 to the Registrant&#8217;s Current Report on Form 8-K filed August 15, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520092890/d876921dex41.htm">Form of the Registrant&#8217;s 2027 Note (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed on March 31, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520092890/d876921dex42.htm">Form of the Registrant&#8217;s 2030 Note (incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed on March 31, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.15</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520092890/d876921dex43.htm">Form of the Registrant&#8217;s 2040 Note (incorporated by reference to Exhibit 4.3 to the Registrant&#8217;s Current Report on Form 8-K filed on March 31, 2020).</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">179</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520092890/d876921dex44.htm">Form of the Registrant&#8217;s 2050 Note (incorporated by reference to Exhibit 4.4 to the Registrant&#8217;s Current Report on Form 8-K filed on March 31, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520227082/d54415dex41.htm">Form of the Registrant&#8217;s 2027 Note (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed on August 21, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520227082/d54415dex42.htm">Form of the Registrant&#8217;s 2030 Note (incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed on August 21, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520227082/d54415dex43.htm">Form of the Registrant&#8217;s 2040 Note (incorporated by reference to Exhibit 4.3 to the Registrant&#8217;s Current Report on Form 8-K filed on August 21, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520319098/d57932dex41.htm">Form of the Registrant&#8217;s 2027 Note (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed on December 16, 2020). </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000119312520319098/d57932dex42.htm">Form of the Registrant&#8217;s 2031 Note (incorporated by reference to Exhibit 4.2 to the Registrant&#8217;s Current Report on Form 8-K filed on December 16, 2020). </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000064803/000119312521250356/d209728dex41.htm">Form of the</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000064803/000119312521250356/d209728dex41.htm"> 2031 Note (incorporated by reference to Exhibit 4.1 to the Registrant&#8217;s Current Report on Form 8-K filed on August 18, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit423-2021.htm">Material terms of outstanding securities that are registered under Section 12 of the 1934 Act as required by Item 202(a)-(d) and (f) of Regulation S-K.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Material Contracts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/a06302021ex102.htm">Five Year Credit Agreement dated as of May 11, 2021, by and among the Registrant, the lenders party thereto, and Bank of America, N.A., as Administrative Agent (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/ex102-06302019.htm">Five Year Credit Agreement, dated as of May 16, 2019, by and among the Registrant, the lenders party thereto and Bank of America N.A., as Administrative Agent (incorporated by reference to Exhibit&#160;10.2 of the Registrant&#8217;s Quarterly Report on Form&#160;10-Q for the fiscal quarter ended June 30, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/ex103-06302019.htm">Amendment No. 1 to Five Year Credit Agreement dated as of May 16, 2019, to the Five Year Credit Agreement dated as of May 17, 2018, by and among the Registrant, the lenders party thereto and The Bank of New York Mellon, as Administrative Agent (incorporated by reference to Exhibit 10.3 of the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000155837018006683/cvs-20180630ex102e86994.htm">Five Year Credit Agreement dated as of May 17, 2018, by and among the Registrant, the lenders party thereto and The Bank of New York Mellon, as Administrative Agent (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312509163865/dex106.htm">The Registrant&#8217;s Supplemental Retirement Plan I for Select Senior Management, as amended and restated as of December 31, 2008 (incorporated by reference to Exhibit 10.6 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2009).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480314000008/ex1025restrictivecovenanta.htm">Form of Enterprise Non-Competition, Non-Disclosure and Developments Agreement between the Registrant and certain of the Registrant&#8217;s executive officers (incorporated by reference to Exhibit 10.25 of the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2013).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/exhibit1011-2019.htm">The Registrant&#8217;s Deferred Stock Compensation Plan, as amended and restated (incorporated by reference to Exhibit 10.11 to the Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000094787120000499/ss173456-ex9902.htm">The Registrant&#8217;s 2007 Employee Stock Purchase Plan, as amended (incorporated by reference to Exhibit&#160;99.2 to the Registrant&#8217;s Registration Statement on Form&#160;S-8 filed May 19, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480316000074/a1028universal409adefiniti.htm">Universal 409A Definition Document, as amended (incorporated by reference to Exhibit&#160;10.28 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December 31, 2015).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1010-2021.htm">The Registrant&#8217;s Amended and Restated Deferred Compensation Plan.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480317000006/ex1025partnershipequitypro.htm">The Registrant&#8217;s Partnership Equity Program, as amended (incorporated by reference to Exhibit&#160;10.25 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December 31, 2016).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480317000006/ex1027performance-basedres.htm">The Registrant&#8217;s Performance-Based Restricted Stock Unit Plan, as amended (incorporated by reference to Exhibit&#160;10.27 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December 31, 2016).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000094787120000499/ss173456-ex9901.htm">The Registrant&#8217;s 2017 Incentive Compensation Plan, as amended (incorporated by reference to Exhibit 99.1 to the Registrant&#8217;s Registration Statement on Form S-8 filed May 19, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000155837017006198/cvs-20170630ex1043fff6d.htm">The Registrant&#8217;s Executive Incentive Plan, as amended (incorporated by reference to Exhibit&#160;10.4 to the Registrant&#8217;s Quarterly Report on Form&#160;10-Q for the fiscal quarter ended June 30, 2017).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000155837017006198/cvs-20170630ex105a3120c.htm">The Registrant&#8217;s Long-Term Incentive Plan, as amended (incorporated by reference to Exhibit 10.5 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2017).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480315000008/ex1029formofnon-qualifieds.htm">Form&#160;of Non-Qualified Stock Option Agreement between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit&#160;10.29 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2014).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480315000008/ex1030formofrestrictedstoc.htm">Form&#160;of Restricted Stock Unit Agreement - Annual Grant - between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit&#160;10.30 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2014).</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">180</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480315000008/ex1031formofpbrsagreement.htm">Form&#160;of Performance-Based Restricted Stock Unit Agreement between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit&#160;10.31 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2014).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480315000008/ex1032pepcompanymatchingpr.htm">Form&#160;of Partnership Equity Program Participant Purchased RSUs, Company Matching RSUs and Company Matching Options Agreement (Pre-Tax) (incorporated by reference to Exhibit&#160;10.32 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2014).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480315000008/ex1033pepcompanymatchingpo.htm">Form&#160;of Partnership Equity Program Participant Purchased RSUs, Company Matching RSUs and Company Matching Options Agreement (Post-Tax) (incorporated by reference to Exhibit&#160;10.33 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2014).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000155837018003777/cvs-20180331ex10150a8df.htm">Form of Performance Stock Unit Agreement - Annual Grant between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000155837018003777/cvs-20180331ex102304379.htm">Form of Performance Stock Unit Agreement (LTIP) - Annual Grant between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/a09302020ex101.htm">Form of Performance Stock Unit Agreement - Annual Grant between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/exhibit1027-2019.htm">The Registrant&#8217;s Management Incentive Plan (incorporated by reference to Exhibit 10.27 to the Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1025-2021.htm">The Registrant&#8217;s Amended and Restated Severance Plan for Non-Store Employees dated October 11, 2021.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000013/ex1038.htm">The Registrant&#8217;s Performance-Based Restricted Stock Unit Program, as amended (incorporated by reference to Exhibit 10.38 to the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000013/ex1039.htm">Form&#160;of Non-Qualified Stock Option Agreement between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit 10.39 to the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000013/ex1040.htm">Form&#160;of Restricted Stock Unit Agreement - Annual Grant - between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit 10.40 to the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000013/ex1041.htm">Form&#160;of Performance-Based Restricted Stock Unit Agreement between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit 10.41 to the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000013/ex1042.htm">Form&#160;of Partnership Equity Program Participant Purchased RSUs, Company Matching RSUs and Company Matching Options Agreement (Pre-Tax) (incorporated by reference to Exhibit 10.42 to the Registrant&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2018).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480314000008/ex1031peppost-taxagreement.htm">Form&#160;of Partnership Equity Program Participant Purchased RSUs, Company Matching RSUs and Company Matching Options Agreement (Post-Tax) (incorporated by reference to Exhibit&#160;10.31 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2013).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000039/ex105-06302019.htm">Form of Performance Stock Unit Agreement - Annual Grant between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit 10.5 of the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2019).</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000119312509041089/dex1038.htm">Amended and Restated Employment Agreement between the Registrant and Larry Merlo (incorporated by reference to Exhibit&#160;10.38 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2008).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000110465913011354/a12-28799_1ex10d31.htm">Amendment dated as of December&#160;21, 2012 to the Amended and Restated Employment Agreement between the Registrant and Larry Merlo (incorporated by reference to Exhibit&#160;10.31 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2012).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480317000006/ex1037ceooptionagreement16.htm">Form&#160;of Non-Qualified Stock Option Agreement - Annual Grant between the Registrant and Larry Merlo (incorporated by reference to Exhibit&#160;10.37 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December 31, 2016).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480317000006/ex1038ceorsuagreement16.htm">Form&#160;of Restricted Stock Unit Agreement - Annual Grant between the Registrant and Larry Merlo (incorporated by reference to Exhibit&#160;10.38 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December 31, 2016).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480315000002/exhibit101amendmentdatedja.htm">Amendment dated January 22, 2015 to Nonqualified Stock Option Agreements between the Registrant and Larry Merlo (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Current Report on Form 8-K filed January 23, 2015).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000039/ex105-06302019.htm">Form of Performance Stock Unit Agreement - Annual Grant between the Registrant and selected employees of the Registrant (incorporated by reference to Exhibit 10.5 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480319000021/ex101.htm">Change in Control Agreement effective as of July 19, 2010 between the Registrant and Eva Boratto (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2019).</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">181</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.40*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/exhibit1048-2019.htm">Restrictive Covenant Agreement dated June 21, 2019 between the Registrant and Eva Boratto (incorporated by reference to Exhibit 10.48 to the registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.41*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/a06302021ex103.htm">Separation Agreement dated June 9, 2021 between CVS Pharmacy, Inc. and Eva C. Boratto (incorporated by reference to Exhibit 10.3 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.42*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000110465913011354/a12-28799_1ex10d33.htm">Change in Control Agreement dated December&#160;22, 2008 between the Registrant and Jonathan Roberts (incorporated by reference to Exhibit&#160;10.33 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2012).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.43*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000110465913011354/a12-28799_1ex10d34.htm">Amendment dated as of December&#160;31, 2012 to the Change in Control Agreement dated December&#160;22, 2008 between the Registrant and Jonathan Roberts (incorporated by reference to Exhibit&#160;10.34 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2012).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.44*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480317000006/ex1044robertsrsuagreement16.htm">Restricted Stock Unit Agreement - Annual Grant dated April 1, 2016 between the Registrant and Jonathan Roberts (incorporated by reference to Exhibit&#160;10.44 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December 31, 2016).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.45*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480317000006/ex1045robertsrestrictiveco.htm">Restrictive Covenant Agreement dated May 20, 2016 between the Registrant and Jonathan Roberts (incorporated by reference to Exhibit&#160;10.45 to the Registrant&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December 31, 2016).</a></span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.46*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/64803/000006480315000023/ex101changeincontrolagreem.htm">Change in Control Agreement dated October 1, 2012 between the Registrant and Thomas Moriarty (incorporated by reference to Exhibit 10.1 of the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2015).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.47*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/exhibit1056-2019.htm">Restrictive Covenant Agreement dated July 8, 2019 between the Registrant and Thomas Moriarty (incorporated by reference to Exhibit 10.56 of the Registrant's Annual Report on form 10-K for the fiscal year ended December 31, 2019).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.48*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/exhibit1051-2020.htm">Amended and Restated Employment Agreement dated November 5, 2020 between the Registrant and Karen S. Lynch (incorporated by reference to Exhibit 10.51 to the Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.49*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/exhibit1052-2020.htm">Restrictive Covenant Agreement dated November 6, 2020 between the Registrant and Karen S. Lynch (incorporated by reference to Exhibit 10.52 to the Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/a03312021ex101.htm">Restrictive Covenant Agreement dated September 29, 2020 between the Registrant and Alan Lotvin (incorporated by reference to Exhibit 10.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2021)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/a03312021ex102.htm">Change in Control Agreement dated October 15, 2012 between the Registrant and Alan Lotvin (incorporated by reference to Exhibit 10.2 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2021)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.52*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/a06302021ex104.htm">Letter Agreement dated May 16, 2021 between the Registrant and Shawn Guertin (incorporated by reference to Exhibit 10.4 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2021).</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.53*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/a06302021ex105.htm">Restrictive Covenant Agreement dated May 16, 2021 between CVS Pharmacy, Inc. and Shawn Guertin </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/a06302021ex105.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/a06302021ex105.htm">(incorporated by reference to Exhibit 10.5 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.54*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/a06302021ex106.htm">Change in Control Agreement dated May 16, 2021 between the Registrant and Shawn Guertin (incorporated by reference to Exhibit 10.6 to the Registrant&#8217;s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2021). </a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.55*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1055-2021.htm">Form of Nonqualified Stock Option Agreement between the Registrant and selected employees of the Registrant.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.56*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Descriptions of certain arrangements not embodied in formal documents as described under the heading &#8220;Non-Employee Director Compensation&#8221; are incorporated herein by reference to the Proxy Statement (when filed). </span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subsidiaries of the registrant</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit211-2021.htm">Subsidiaries of CVS Health Corporation.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consents of experts and counsel</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit231-2021.htm">Consent of Ernst&#160;&amp; Young LLP.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Rule 13a-14(a)/15d-14(a) Certifications</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-2021.htm">Certification by the Chief Executive Officer.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-2021.htm">Certification by the Chief Financial Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Section 1350 Certifications</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-2021.htm">Certification by the Chief Executive Officer.</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">182</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-2021.htm">Certification by the Chief Financial Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interactive Data File</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the CVS Health Corporation Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2021 formatted in Inline XBRL: (i)&#160;the Consolidated Statements of Operations, (ii) the Consolidated Statements of Comprehensive Income, (iii)&#160;the Consolidated Balance Sheets, (iv)&#160;the Consolidated Statements of Cash Flows, (v) the Consolidated Statements of Shareholders&#8217; Equity and (vi)&#160;the related Notes to Consolidated Financial Statements. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File - The cover page from the Company's Annual Report on Form 10-K for the year ended December 31, 2021, formatted in Inline XBRL (included as Exhibit 101).</span></td></tr></table></div><div><span><br/></span></div><div id="ibab9fb71d67648f0b758869f160b7f4b_223"></div><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16.  Form 10-K Summary.</span></div><div style="padding-right:2.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">183</span></div></div></div><div id="ibab9fb71d67648f0b758869f160b7f4b_226"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ibab9fb71d67648f0b758869f160b7f4b_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.738%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.582%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CVS HEALTH CORPORATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 9, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ SHAWN M. GUERTIN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shawn M. Guertin</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:37.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.337%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ FERNANDO AGUIRRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fernando Aguirre</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ C. DAVID BROWN II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">C. David Brown II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ JAMES D. CLARK</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President - Controller and Chief</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">James D. Clark</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounting Officer (Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ ALECIA A. DECOUDREAUX</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Alecia A. DeCoudreaux</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ NANCY-ANN M. DEPARLE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nancy-Ann M. DeParle</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;DAVID W. DORMAN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chair of the Board and Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">David W. Dorman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ ROGER N. FARAH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Roger N. Farah</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ ANNE M. FINUCANE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Anne M. Finucane</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ SHAWN M. GUERTIN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shawn M. Guertin</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Officer (Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ EDWARD J. LUDWIG</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Edward J. Ludwig</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ KAREN S. LYNCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Karen S. Lynch</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Principal Executive Officer) and Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ JEAN-PIERRE MILLON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Jean-Pierre Millon</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ MARY L. SCHAPIRO</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Mary L. Schapiro</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ WILLIAM C. WELDON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">William C. Weldon</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ TONY L. WHITE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 9, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Tony L. White</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.23
<SEQUENCE>2
<FILENAME>exhibit423-2021.htm
<DESCRIPTION>EX-4.23
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i89b23c625dd84656b5c8153042299b1d_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 4.23</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF COMMON STOCK REGISTERED UNDER SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:center"><font><br></font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following description (this &#8220;Description&#8221;) of the terms of the common stock of CVS Health Corporation (&#8220;CVS Health&#8221;) is a summary only and is qualified by reference to the relevant provisions of Delaware law and the Restated Certificate of Incorporation (the &#8220;Charter&#8221;) and the By-Laws (the &#8220;By-Laws&#8221;) of CVS Health.&#160;Copies of the Charter and the By-Laws&#160;are incorporated by reference as exhibits to the Annual Report on Form 10-K to which this Description is an exhibit.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Authorized Capital Stock</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Charter as of February 9, 2022, the authorized capital stock of CVS Health consisted of (i)&#160;3,200,000,000 shares of common stock, par value of $0.01 per share (&#8220;common stock&#8221;), (ii)&#160;120,619 shares of cumulative preferred stock, par value $0.01 per share (&#8220;preferred stock&#8221;), and (iii)&#160;50,000,000 shares of preference stock, par value $1.00 per share (&#8220;preference stock&#8221;).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of shares of common stock are entitled to one vote per share on all matters voted on by CVS Health stockholders, including elections of directors. Except as otherwise required by law, or by the provisions of the preferred stock or the preference stock, or provided in any resolution adopted by the CVS Health board of directors (the &#8220;board&#8221;) with respect to any subsequently created class or series of shares of CVS Health, the holders of the shares of common stock exclusively possess all voting power. The Charter precludes cumulative voting in the election of directors. The Charter provides for a majority vote standard for uncontested elections of directors, and a plurality of votes standard for contested elections of directors. Subject to any rights of any outstanding series of preferred stock or preference stock, (i) the holders of shares of common stock are entitled to such dividends as may be declared from time to time by the board from funds available therefor, (ii)&#160;no dividends may be declared, paid, or set aside for payment on shares of common stock unless full cumulative dividends are paid on any outstanding preference stock and any other preferred stock issued and outstanding at such time that is designated to have such dividend preference and (iii)&#160;upon dissolution the holders of shares of common stock are entitled to receive pro rata all assets of CVS Health available for distribution to such holders, subject to any liquidation preferences designated to any preferred stock or preference stock that may be issued and outstanding at such time of liquidation.</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">No Preemptive Rights</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Charter provides that no holder of any shares of CVS Health of any class or series may have any preemptive right to purchase or subscribe to any shares of CVS Health or any security convertible into shares of CVS Health of any class or series.</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Provisions Relating to Amendments to CVS Health&#8217;s Charter and&#160;By-Laws</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Delaware law, stockholders have the right to adopt, amend or repeal the certificate of incorporation and&#160;by-laws&#160;of a corporation. However, Delaware law requires that any amendment to the Charter also be approved by the board. Under Delaware law, unless a higher vote is required in a corporation&#8217;s certificate of incorporation, amendments to the corporation&#8217;s certificate of incorporation will be adopted upon receiving at a properly convened meeting the affirmative vote of a majority of the votes cast by all stockholders entitled to vote thereon, and if any class or series is entitled to vote thereon as a class, the affirmative vote of a majority of the votes cast in each class vote.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the&#160;By-Laws&#160;may be amended by the board with respect to all matters not exclusively reserved by law to the stockholders. Amendments to the&#160;By-Laws&#160;may be adopted and approved by the affirmative vote of the holders of record of a majority of the outstanding shares of stock of CVS Health entitled to vote at any annual or special meeting, or by the affirmative vote of a majority of the directors cast at any regular or special meeting, at which a quorum is present.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Statutory and Charter Provisions</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain provisions of the Charter and By-Laws summarized in the following paragraphs may be deemed to have an antitakeover effect and may delay, defer or prevent a tender offer or takeover attempt.  </font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Potential Issuances of Preferred Stock and Preference Stock</font></div><div style="margin-bottom:3pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February 9, 2022, the Charter authorized 120,619 shares of preferred stock, par value $0.01 per share and 50,000,000 shares of preference stock, par value $1.00 per share. The Charter also authorizes the board to issue shares of preferred stock or preference stock, from time to time, in such class or classes, and such series within any class, and with such designations, preferences and relative, participating, optional or other special rights, and qualifications, limitations or restrictions thereof as the board may determine, including, for example, (i)&#160;the designation of the class or series&#59; (ii)&#160;the number of shares of the class or series, which number the board may thereafter (except where otherwise provided in the designation of any subsequently authorized class or series) increase or decrease (but not below the number of shares thereof then outstanding)&#59; (iii)&#160;whether dividends, if any, will be cumulative or noncumulative and the dividend rate of the class or series&#59; (iv)&#160;the dates on which dividends, if any, will be payable&#59; (v)&#160;the redemption rights and price or prices, if any, for shares of the class or series&#59; (vi)&#160;the terms and amounts of any sinking fund provided for the purchase or redemption of shares of the class or series&#59; (vii)&#160;the amounts payable on shares of the class or series in the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of CVS Health&#59; (viii)&#160;whether the shares of the class or series will be convertible into shares of any other class or series, or any other security, of CVS Health or any other corporation, and, if so, the specification of such other class or series or such other security, the conversion price or prices or rate or rates, any adjustments thereof, the date or dates as of which such shares will be convertible and all other terms and conditions upon which such conversion may be made&#59; (ix)&#160;restrictions on the issuance of shares of the same class or series or of any other class or series&#59; and (x)&#160;the voting rights, if any, of the holders of such class or series. The authorized capital stock of CVS Health, including preferred stock, preference stock and common stock, will be available for issuance without further action by CVS Health stockholders, unless such action is required by applicable law or the rules of any stock exchange or automated quotation system on which CVS Health&#8217;s securities may be listed or traded. If the approval of CVS Health stockholders is not so required, the board does not intend to seek stockholder approval.</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the board has no intention at the present time of doing so, it could issue a class or series of preferred stock or preference stock that could, depending on the terms of such class or series, impede completion of a merger, tender offer or other takeover attempt that the holders of some, or a majority, of CVS Health shares might believe to be in their best interests or in which CVS Health stockholders might receive a premium for their shares over the then-current market price of such shares.</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Potential Issuances of Rights to Purchase Securities</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health does not currently have a stockholder rights plan, although the board retains the right to adopt a new plan at a future date. The Charter grants the board exclusive authority to create and issue rights entitling the holders thereof to purchase from CVS Health shares of capital stock or other securities and to elect to repurchase, redeem, terminate or amend any such rights. The times at which and terms upon which such rights are to be issued, repurchased, redeemed, terminated or amended are to be determined exclusively by the board and set forth in the contracts or instruments that evidence any such rights. The authority of the board with respect to such rights includes determining, for example, (i)&#160;the purchase price of the capital stock or other securities or property to be purchased upon exercise of such rights&#59; (ii)&#160;provisions relating to the times at which and the circumstances under which such rights may be exercised or sold or otherwise transferred, either together with or separately from any other shares or other securities of CVS Health&#59; (iii)&#160;provisions which adjust the number or exercise price of such rights or the amount or nature of the shares, other securities or other property receivable upon exercise of such rights in the event of a combination, split or recapitalization of any shares of CVS Health, a change in ownership of CVS Health&#8217;s shares or other securities or a reorganization, merger, consolidation, sale of assets or other occurrence relating to CVS Health or any shares of CVS Health, and provisions restricting the ability of CVS Health to enter into any such transaction absent an assumption by the other party or parties thereto of the obligations of CVS Health under such rights&#59; (iv)&#160;provisions which deny the holder of a specified percentage of the outstanding securities of CVS Health the right to exercise such rights and&#47;or cause such rights held by such holder to become void&#59; (v)&#160;provisions which</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">permit CVS Health to redeem or exchange such rights&#59; and (vi)&#160;the appointment of the rights agent with respect to such rights. This provision is intended to confirm the board&#8217;s exclusive authority to issue, repurchase, redeem, terminate or amend share purchase rights or other rights to purchase shares or securities of CVS Health or any other corporation.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stockholder Action by Written Consent</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Charter provides that stockholder action may be taken at an annual or special meeting of stockholders or by written consent in lieu of a meeting, but only if such action is taken in accordance with the provisions of the Charter and&#160;By-Laws.&#160;Any person other than CVS Health seeking to have the CVS Health stockholders authorize or take corporate action by written consent without a meeting is required to deliver a written notice signed by holders of record of at least twenty-five percent (25%) of the voting power of the outstanding capital stock of CVS Health entitled to express consent on the relevant action and request that a record date be fixed for such purpose.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stockholder Vote on Fundamental or Extraordinary Corporate Transactions</font></div><div style="margin-bottom:3pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Delaware law, a sale, lease or exchange of all or substantially all of CVS Health&#8217;s assets, an amendment to the Charter, a merger or consolidation of CVS Health with another corporation or a dissolution of CVS Health generally requires the affirmative vote of the board and, with limited exceptions, the affirmative vote of a majority of the aggregate voting power of the outstanding stock entitled to vote on the transaction.</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to transactions with related persons (persons who own at least 10% of the outstanding capital stock of CVS Health), the Charter provides that a majority of outstanding shares (excluding those owned by the related person) voting as a single class is required to approve a business combination transaction with a related person, unless (i) such transaction is approved by a majority of continuing directors (directors who are not the related person, or an affiliate or associate thereof (or a representative or nominee of the related person or such affiliate or associate), that is involved in the relevant business combination and (a) who were members of the board immediately prior to the time that such related person became a related person or (b) whose initial election as a director was recommended by the affirmative vote of a least a majority of the continuing directors then in office, provided that, in either such case, such continuing director has continued in office after becoming a continuing director) or (ii) certain fair price requirements are met.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Anti-Takeover Provisions</font></div><div style="text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health has not opted out of Section 203 of the Delaware General Corporation Law, which provides that, if a person acquires 15% or more of the outstanding voting stock of a Delaware corporation, thereby becoming an &#8220;interested stockholder,&#8221; that person may not engage in certain &#8220;business combinations&#8221; with the corporation, including mergers, purchases and sales of 10% or more of its assets, stock purchases and other transactions pursuant to which the percentage of the corporation&#8217;s stock owned by the interested stockholder increases (other than on a pro rata basis) or pursuant to which the interested stockholder receives a financial benefit from the corporation, for a period of three years after becoming an interested stockholder unless one of the following exceptions applies&#58; (i) the board approved the acquisition of stock pursuant to which the person became an interested stockholder or the transaction that resulted in the person becoming an interested stockholder prior to the time that the person became an interested stockholder&#59; (ii) upon consummation of the transaction that resulted in the person becoming an interested stockholder such person owned at least 85% of the outstanding voting stock of CVS Health, excluding, for purposes of determining the voting stock outstanding, voting stock owned by directors who are also officers and certain employee stock plans&#59; or (iii) the transaction is approved by the board and by the affirmative vote of two-thirds of the outstanding voting stock which is not owned by the interested stockholder. An &#8220;interested stockholder&#8221; also includes the affiliates and associates of a 15% or more owner and any affiliate or associate of CVS Health who was the owner of 15% or more of the outstanding voting stock within the three-year period prior to determine whether a person is an interested stockholder.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>3
<FILENAME>exhibit1010-2021.htm
<DESCRIPTION>EX-10.10
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i009a378e00aa4e49a12f0bcc9e797e84_1"></div><div style="min-height:72pt;width:100%"><div style="padding-left:360pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.10</font></div></div><div><img alt="cvshealthlogob.jpg" src="cvshealthlogob.jpg" style="height:23px;margin-bottom:5pt;vertical-align:text-bottom;width:151px"></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:22.5pt;padding-right:22.5pt;text-align:center;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:26pt;font-weight:700;line-height:100%">CVS HEALTH CORPORATION</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.352%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="padding-left:22.5pt;padding-right:22.5pt;text-align:center;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DEFERRED COMPENSATION PLAN</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.352%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:90pt;padding-right:90pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Amended and Restated Effective January 1, 2022</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></div></div><div id="i009a378e00aa4e49a12f0bcc9e797e84_4"></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:466.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:25.25pt;padding-right:25.25pt;text-align:center;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CVS HEALTH CORPORATION</font></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:25.25pt;padding-right:25.25pt;text-align:center;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Deferred Compensation Plan</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td></tr></table></div><div style="padding-left:22.5pt;padding-right:22.5pt;text-align:center;text-indent:-27pt"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:34.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:406.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PAGE</font></td><td colspan="3" style="padding:0 1pt 0 3.77pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ARTICLE I &#8211;INTRODUCTION............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none">5</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of Plan.........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">5</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purpose of Plan.....................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8220;Top Hat&#8221; Pension Benefit Plan..............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funding..................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Date.........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administration........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number and Gender..............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Headings................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ARTICLE II &#8211; DEFINITIONS..............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Account..................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aetna Plans...........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Affiliate...................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual Cash Incentive...........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual Cash Incentive Deferral.............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base Salary............................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base Salary Deferral..............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">6</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beneficiary.............................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">7</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Board.....................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">7</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in Control..................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">7</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Code......................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commissions.........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commissions Deferral...........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.14</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Committee.............................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.15</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company Account..................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.16</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company Contribution...........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.17</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CVS Caremark Retention Payment.......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.18</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferrals................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.19</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferral Account....................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></td></tr></table></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; i</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:34.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:406.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.20</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Compensation Election...........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.21</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disability.................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.22</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution Date....................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.23</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Date.........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.24</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elective Deferrals...................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eligible Executive...................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.26</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee...............................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ERISA....................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.28</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive...............................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.29</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Future Fund...........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grandfathered Company Account.........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.31</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grandfathered Deferral Account............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.32</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lost Matching Contributions..................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.33</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Participant..............................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.34</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan Administrator..................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.35</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plan Year................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.36</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Qualified Future Fund Matching Contribution........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.37</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement.............................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.38</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specified Employee...............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.39</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specific Future Year...............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination of Employment...................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">10</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Pay................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">10</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.42</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Universal 409A Definition Document.....................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">10</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.43</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation Date........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">10</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.44</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year of Service.......................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">10</a></font></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ARTICLE III &#8211; ELIGIBILITY AND PARTICIPATION..........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eligibility.................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">11</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commencement of Participation............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">11</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination of Participation...................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">11</a></font></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ARTICLE IV &#8211; DEFERRALS &#38; COMPANY CONTRIBUTIONS........................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none">12</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferrals................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">12</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filing Requirements of Deferred Compensation Elections....................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">12</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Modification or Revocation of Election by Participant............................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">13</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company Contributions and Other Deferrals.........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">14</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferral and Contribution Timing...........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">15</a></font></div></td></tr></table></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; ii</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:34.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:406.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:18pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ARTICLE V &#8211; ACCOUNTS................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Establishment of Bookkeeping Accounts...............................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subaccounts..........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hypothetical Nature of Accounts............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting...................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferral Crediting Options.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">17</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hypothetical Gains or Losses................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">18</a></font></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ARTICLE VI &#8211; DISTRIBUTION OF ACCOUNT.................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none">19</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution Elections &#8211; Timing of Payment...........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">19</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disability Distributions............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">19</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Distributions in the Event of Death.</a>.......................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">19</a></font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions Upon Termination of Employment Other Than Retirement, Death or Disability</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">20</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Change in Control.</a>.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">20</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Form of Payment.</a>..................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">20</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Change of Distribution Election.</a>............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">21</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Account Valuation upon a Distribution.</a>..................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">22</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Designation of Beneficiary.</a>....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">22</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Unclaimed Account.</a>...............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">22</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Hardship Withdrawals.</a>...........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">22</a></font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Distribution of Grandfathered Deferral Account and the Grandfathered Company Account</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">23</a></font></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none">ARTICLE VII &#8211; ADMINISTRATION</a>....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none">24</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Plan Administrator.</a>.................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">24</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">General Powers of Administration.</a>........................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">24</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Costs of Administration.</a>.........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">24</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Indemnification.</a>......................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">24</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">409A Compliance.</a>..................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">25</a></font></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none">ARTICLE VIII &#8211; CLAIMS PROCEDURE</a>............................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none">26</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Claims.</a>...................................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">26</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Claim Decision.</a>......................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">26</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Request for Review&#47;Appeal</a><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">..................................................................................................</a><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">26</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Review of Decision.</a>..............................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">26</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Time Limit for Bringing Legal Action.</a>.....................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_4" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">26</a></font></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none">ARTICLE IX &#8211; MISCELLANEOUS</a>.....................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none">27</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Not Contract of Employment.</a>.................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">27</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Non-Assignability of Benefits.</a>................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">27</a></font></div></td></tr></table></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; iii</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:34.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:406.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Withholding and Deduction and Taxes.</a>.................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">27</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Amendment and Termination.</a>................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">27</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Compliance with Securities and Other Laws.</a>........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">28</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">No Trust Created.</a>..................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">28</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.7</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Unsecured General Creditor Status of Employee.</a>.................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">28</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Limitation.</a>..............................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">28</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Payment to Minors and Incompetents.</a>..................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">28</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.10</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Acceleration of or Delay in Payments</a><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">...................................................................................</a><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">.</a></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">29</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.11</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Severability.</a>............................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">29</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.12</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Governing Laws.</a>....................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">29</a></font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.13</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Binding Effect.</a>........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">29</a></font></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none">APPENDIX A &#8211; PROVISIONS APPLICABLE TO A PARTICIPANT&#8217;S GRANDFATHERED DEFERRAL ACCOUNT AND GRANDFATHERED COMPANY ACCOUNT</a>....................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none">30</a></font></div></td></tr><tr style="height:14pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Article I &#8211; Definitions</a>.........................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">30</a></font></div></td></tr><tr style="height:14pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Article IV &#8211; Deferrals and Company Contributions</a>...........................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">30</a></font></div></td></tr><tr style="height:18pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Article V &#8211; Maintenance of Accounts</a>................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">30</a></font></div></td></tr><tr style="height:18pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Article VI &#8211; Payment of Benefit</a>.........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">30</a></font></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none">APPENDIX B &#8211; PROVISIONS APPLICABLE TO A PARTICIPANT&#8217;S ACCOUNT UNDER THE OMNICARE, INC. DEFERRED COMPENSATION PLAN</a>.................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none">32</a></font></div></td></tr><tr style="height:18pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Article 2&#58; Participation</a>.......................................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">32</a></font></div></td></tr><tr style="height:18pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:8.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">Article 3&#58; Contributions &#38; Deferral Elections</a>.....................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none">32</a></font></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:33pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none">APPENDIX C APPENDIX C &#8211; PROVISIONS APPLICABLE TO A PARTICIPANT&#8217;S ACCOUNT UNDER THE AETNA SUPPLEMENTAL 401(K) PLAN AND AETNA DEFERRED COMPENSATION PROGRAM</a>...........................................................................................................</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a href="#i009a378e00aa4e49a12f0bcc9e797e84_7" style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none">33</a></font></div></td></tr></table></div><div style="padding-left:4.5pt;padding-right:-9pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:4.5pt;padding-right:-9pt"><font><br></font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:center"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; iv</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><div id="i009a378e00aa4e49a12f0bcc9e797e84_106"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:2pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE I &#8211; INTRODUCTION</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Name of Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation (the &#8220;Company&#8221;) hereby adopts the CVS Health Deferred Compensation Plan as amended and restated as of January 1, 2022 (the &#8220;Plan&#8221;).</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Purpose of Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The purpose of the Plan is to provide certain eligible employees of the Company or an Affiliate authorized by the Committee to participate in the Plan the opportunity to defer elements of his or her compensation which might not otherwise be deferrable under other plans maintained by the Company or an Affiliate and to make deferrals and receive contributions that would be obtainable under the CVS Health Future Fund 401(k) Plan (&#8220;Future Fund&#8221;) in the absence of certain restrictions and limitations in the Internal Revenue Code.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">&#8220;Top Hat&#8221; Pension Benefit Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan is an &#8220;employee pension benefit plan&#8221; within the meaning of ERISA. However, the Plan    is unfunded and maintained for a select group of management or highly compensated employees and, therefore, it is intended that the Plan will be exempt from Parts 2, 3 and 4 of Title I of ERISA. The Plan is not intended to qualify under Section 401(a) of the Code.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Funding.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan is unfunded. All benefits will be paid from the general assets of the Company. Participants in the Plan shall have the status of general unsecured creditors of the Company.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Effective Date.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan was originally effective as of January 1, 1997, and amended and restated in its entirety effective as of December 31, 2008, to comply with the provisions of Section 409A of the Internal Revenue Code and regulations promulgated thereunder and as of December 17, 2014, October 1, 2015, November 1, 2016, and January 1, 2020 to reflect certain design and administrative changes desired by the Company.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Administration.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan shall be administered by the Deferred Compensation Plans Committee, as defined in Article VII.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Number and Gender.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Wherever appropriate herein, words used in the singular shall be considered to include the plural and words used in the plural shall be considered to include the singular. The masculine gender, where appearing in the Plan, shall be deemed to include the feminine gender. The feminine gender, where appearing in the Plan, shall be deemed to include the masculine gender.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Headings.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The headings of Articles and Sections herein are included solely for convenience, and if there is  any conflict between such headings and the text of the Plan, the text shall control.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="margin-bottom:10pt;margin-top:2pt"><font><br></font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 1</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE II &#8211; DEFINITIONS</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of the Plan, the following words and phrases shall have the meanings set forth below, unless their context clearly requires a different meaning&#58;</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Account.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company Account, Deferral Account, Grandfathered Company Account, and the  Grandfathered Deferral Account maintained by the Company on behalf of each Participant pursuant to the Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Aetna Plans.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Aetna Deferred Compensation Program (&#8220;Aetna Program&#8221;) and the Aetna Supplemental 401K Plan (&#8220;Aetna Supplemental Plan&#8221;).</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Affiliate.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A subsidiary of the Company, as defined in the Company&#8217;s Universal 409A Definition Document.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Annual Cash Incentive. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount awarded to a Participant in cash for a Plan Year under a regular (annual) incentive  plan (other than an exceptional performance award program or a one-time incentive plan or program) maintained by the Company or an Affiliate, and any other amount otherwise included in Annual Cash Incentive for purposes of the Plan under rules as are adopted by the Committee.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2015, Operation Production Incentives shall be excluded from the definition of Annual Cash Incentive.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Annual Cash Incentive Deferral. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of a Participant&#8217;s Annual Cash Incentive which a Participant elects to have withheld    on a pre-tax basis from his or her Annual Cash Incentive and credited to his or her Deferral Account pursuant to the Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Base Salary. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The base rate of cash compensation paid by the Company or an Affiliate to or for the benefit of a Participant for services rendered or labor performed while a Participant, including deferrals  pursuant to the Plan and any pre-tax contribution to be made on the Participant&#8217;s behalf to any qualified plan maintained by the Company or an Affiliate pursuant to a cash or deferred arrangement maintained by the Company or an Affiliate (as defined under Section 401(k) of the Code) or under any cafeteria plan (as defined under Section 125 of the Code) or under a qualified transportation fringe (as defined under Section 132(f) of the Code). Base Salary shall exclude any overtime, premium pay, shift differentials, bonuses, commissions or any other form of supplemental cash compensation, except to the extent otherwise deemed &#8220;Base Salary&#8221; for purposes of the Plan under rules as are adopted by the Committee.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Base Salary Deferral. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of a Participant&#8217;s Base Salary which the Participant elects to have withheld on a pre- tax basis from his or her Base Salary and credited to his or her Deferral Account pursuant to the Plan.</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 2</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Beneficiary. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The person or persons (which may include trusts) designated in writing (either by hand or electronic submission) by the Participant on the beneficiary designation form prescribed by the Plan Administrator to receive the amounts, if any, payable under the Plan upon the death of the Participant. In the absence of such written designation by the Participant, the Beneficiary shall mean, in the following order, the Participant&#8217;s spouse, if any&#59; the person named as the Participant&#8217;s beneficiary under the Company&#8217;s life insurance program&#59; or the Participant&#8217;s estate. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Board. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors of the Company.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Change in Control. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Change in Control&#8221; as such term is defined in the Universal 409A Definition Document.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Code. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Internal Revenue Code of 1986, as amended. References to any provision of the Code or regulation (including a proposed regulation) thereunder shall include any successor provisions or regulations.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Commissions. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of a Participant&#8217;s sales commissions or other commissions payable under a sales commissions or other commissions plan maintained by the Company or an Affiliate. (Sales commissions for purposes of the Plan shall mean sales commissions as defined in Treas. Reg. Section 1.409A-2(a)(12)(i) and any subsequent guidance and such sales commissions are considered to be earned in the taxable year of the Participant in which the sale is completed so that the amount of the Commissions are reasonably determinable.)</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Commissions Deferral. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of a Participant&#8217;s Commissions that a Participant elects to have withheld on a pre-tax basis from his or her Commissions and credited to his or her Deferral Account pursuant to the Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Committee. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Management Planning and Development Committee of the Board of Directors of the Company or any other directors of the Company designated as the Committee.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Company Account. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The bookkeeping account (or subaccount(s) thereof) maintained for each Participant to record the amount of Company Contributions that are either (i) credited on his or her behalf under Section 4.4 on or after January 1, 2005 or (ii) were credited on his or her behalf under Section 4.4 prior to January 1, 2005, but became vested on or after January 1, 2005, as adjusted pursuant to Section 5.6.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.16</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Company Contribution. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount, as determined by the Company on an annual basis based on the provisions of the Plan, which is credited on the Participant&#8217;s behalf by the Company to his or her Company Account pursuant to the provisions of Section 4.4(a) of the Plan.</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 3</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">CVS Caremark Retention Payment. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount granted to an Eligible Executive, as defined in and provided for under the provisions   of the employment term sheet agreement entered into between the Company or an Affiliate and  said Eligible Executive, as a former employee of Caremark Rx, Inc., in connection with the merger involving Caremark, Rx, Inc. and the Company.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.18</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Deferrals. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of deferrals credited to a Participant pursuant to Section 4.1.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.19</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Deferral Account. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The bookkeeping account (or subaccount(s) thereof) maintained for each Participant to record any and all deferrals made under the Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.20</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Deferred Compensation Election. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The written election (either by hand or electronic submission) including any amendments, attachments and appendices thereto as prescribed by the Plan Administrator, regardless of how it may be titled, under which the Participant agrees to defer a portion of his or her Base Salary and&#47;or Annual Cash Incentive or Commissions under the Plan (or any other cash remuneration payable    to a Participant that he or she may elect to defer under the provisions of the Plan, including but not limited to awards under the Company&#8217;s Long Term Incentive Plan (LTIP). This election as to  deferral and the related form and timing of distribution is made by the Participant and constitutes  the agreement entered into between the Company and a Participant for participation in the Plan. The Participant elects the terms of his or her deferral pursuant to the provisions of this Plan and   the administrative procedures established by the Plan Administrator.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.21</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Disability.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Disability&#8221; as defined in the Company&#8217;s Long-Term Disability Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.22</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Distribution Date. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The date on which a Participant&#8217;s distribution is scheduled to be paid with respect to his or her Account under the Plan pursuant to his or her Deferred Compensation Election, which date shall take into account any processing period.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.23</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Effective Date. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 1, 1997.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.24</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Elective Deferrals. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Elective Deferrals as defined in the Future Fund.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.25</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Eligible Executive. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An Executive who is eligible to participate in the Plan as provided in Section 3.1(a).</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.26</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Employee. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any common-law full-time salaried exempt employee of the Company or an Affiliate, other than a store manager, pharmacist or MinuteClinic practitioner, who has been authorized by the Committee to participate in the Plan.</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 4</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.27</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">ERISA. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Employee Retirement Income Security Act of 1974, as amended.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.28</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Executive. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An Employee whose Base Salary (determined on the basis of a maximum forty (40) hour work week) equals or exceeds $175,000 (as adjusted from time to time by the Committee).</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.29</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Future Fund. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CVS Health Future Fund 401(k) Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.30</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Grandfathered Company Account. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The bookkeeping account (or subaccount(s)) maintained for each Participant to record the amount of Company Contributions credited on a Participant&#8217;s behalf under Section 4.4, which were vested as of December 31, 2004, adjusted as provided in Section 5.6.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.31</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Grandfathered Deferral Account. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The bookkeeping account (or subaccount(s)) maintained for each Participant to record (i) the amount of Base Salary and&#47;or Annual Cash Incentive or Commissions deferred in accordance with Section 4.1, (ii) the amount of LTIP deferrals deferred in accordance with Section 4.4, and&#47;or (iii)  the amount of cash retention award deferrals deferred in accordance with Section 4.4, as of December 31, 2004, adjusted pursuant to Section 5.6.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.32</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Lost Matching Contributions. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts credited on a Participant&#8217;s behalf to his or her Company Account pursuant to the provisions of Section 4.4(a).</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.33</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Participant. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Eligible Executive participating in the Plan as set forth in Section 3.2.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.34</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Plan Administrator. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Deferred Compensation Plans Committee appointed pursuant to Section 7.1 to administer the Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.35</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Plan Year. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A calendar year ending on December 31.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.36</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Qualified Future Fund Matching Contribution. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total of all matching contributions that could have been made by the Company or an Affiliate with respect to a Plan Year for the benefit of a Participant under and in accordance with the terms  of Future Fund.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.37</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Retirement. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Termination of Employment with the Company and all Affiliates on or after (i) age fifty-five (55) and the completion of ten (10) or more Years of Service or, if earlier, (ii) age sixty (60) and the completion of five (5) or more Years of Service.</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 5</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.38</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Specified Employee. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Specified Employee&#8221; as such term is defined in the Universal 409A Definition Document.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.39</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Specific Future Year. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A calendar year in the future elected by a Participant with respect to the distribution of his or her Account(s) (or subaccount(s) thereof) pursuant to the Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.40</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Termination of Employment. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Termination of employment&#8221; as such term is defined in the Universal 409A Definition Document.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.41</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Total Pay</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total of Base Salary, Annual Cash Incentive and Commissions. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.42</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Universal 409A Definition Document. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The document developed by the Company for the purpose of defining terms relating to benefits or amounts in all plans covered by Section 409A of the Code and sponsored by the Company or any Affiliate.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.43</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Valuation Date. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The date on which an Account is valued under the Plan, as determined by the Committee, by reference to the New York Stock Exchange.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.44</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Year of Service. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Year of Participation Service as defined in Future Fund.</font></div><div style="margin-top:3.6pt;padding-left:41pt"><font><br></font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 6</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE III &#8211; ELIGIBILITY AND PARTICIPATION</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Eligibility.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">An Employee who is an Executive on October 1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of a calendar year (or such other date in the calendar year as designated by the Committee) shall be eligible to participate in the Plan. The Committee may, in its sole discretion, designate other key employees of the Company or an Affiliate who are members of a select group of management or highly compensated employees as eligible to participate in the Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Notwithstanding any Plan provision to the contrary, Employees must also be subject to the income tax laws of the United States in order to be eligible for participation in the Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Subject to the provisions of Sections 3.3 and Section 4.1, an Eligible Executive shall remain eligible to continue participation in the Plan for each Plan Year following his or her initial year of participation in the Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">A Participant who ceases to be an Executive can continue to be eligible to participate unless and until such Participant fails to make an annual deferral election under the Plan   or under the CVS Health Corporation Deferred Stock Compensation Plan, at which point the Employee must meet the threshold compensation level in order to be eligible to participate for a future Plan Year.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Deferred Compensation Plan Participants who made a deferral under the Deferred Compensation Plan with respect to the two most recent enrollment periods shall,  regardless of compensation threshold, be eligible to participate in the Deferred Compensation Plan for the 2020 Plan Year.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Active Aetna employees who elected to defer in either of the Aetna Plans in the two most recent enrollment periods shall, regardless of compensation threshold, be eligible to participate in the Deferred Compensation Plan for the 2020 Plan Year.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Commencement of Participation.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An Eligible Executive shall become a Participant effective as of the date that the Eligible Executive&#8217;s first Deferred Compensation Election becomes effective, provided that the Eligible Executive has provided such information as the Plan Administrator deems necessary to properly administer the Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Termination of Participation.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.78pt">Participation shall cease when the benefits that have been credited to a Participant&#8217;s Deferral Account have been distributed to him or her.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.78pt">Subject to the provisions of Section 4.3(c), a Participant shall only be eligible to make Deferrals under the Plan for as long as he or she remains an Eligible Executive.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.34pt">If a former Participant who has incurred a Termination of Employment with the Company and all Affiliates and whose participation in the Plan ceased under Section 3.3(a) is reemployed as an Executive, the former Participant may again become eligible to participate in accordance with the provisions of Section 3.1(a).</font></div><div style="height:84.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 7</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><div id="i009a378e00aa4e49a12f0bcc9e797e84_668"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:2pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE IV &#8211; DEFERRALS &#38; COMPANY CONTRIBUTIONS</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Deferrals.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Subject to the following provisions of this Article IV, an Eligible Executive may defer for any Plan Year&#58; (i) up to fifty percent (50%) of Base Salary otherwise earned and payable in that Plan Year, and&#47;or (ii) up to eighty percent (80%) of Annual Cash Incentive otherwise earned in that Plan Year and payable in that Plan Year or in the first calendar quarter of the following Plan Year, and&#47;or (iii) with respect to Deferred Compensation Elections made  prior to November 1, 2021, up to eighty percent (80%) of Commissions otherwise earned   in that Plan Year and payable in that Plan Year or in the first calendar quarter of the following Plan Year, and with respect to Deferred Compensation Elections made on or after November 1, 2021, up to eighty percent (80%) of Commissions otherwise payable in the applicable Plan Year in accordance with Section 4.2. The Plan Administrator may, as it deems appropriate, establish maximum or minimum limits on the amounts which may be deferred for a Plan Year and&#47;or the times of such Deferred Compensation Elections. An Eligible Executive shall be given advance notice of any such limits. Notwithstanding anything in the Plan to the contrary, a previously submitted Participant&#8217;s Deferred Compensation Election (with respect to Base Salary, Annual Cash Incentive and&#47;or Commissions) shall be disregarded following the Participant&#8217;s Termination of Employment.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Deferrals under the Plan shall be calculated with respect to the gross cash compensation payable to the Participant prior to any deductions (e.g., 401(k) deferrals) or withholdings. However, the Deferrals shall be reduced by the Plan Administrator as necessary if it is later determined, after Deferrals are made under the Plan and after additional deduction of all required income and employment taxes, 401(k) and other employee benefit deductions, and other deductions required by law, that all such total deferrals will exceed one hundred percent (100%) of the cash compensation of the Participant available under Section 4.1(a). Changes to payroll withholdings that affect the amount of compensation being deferred to the Plan shall be allowed only to the extent permissible under Section 409A of the Code.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Filing Requirements of Deferred Compensation Elections.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the following provisions of this Section, during an annual enrollment period established by the Plan Administrator in any Plan Year, an Eligible Executive described in Section 3.1 may  elect, subject to Section 4.1 above, to defer&#58; (a) a portion of his or her Base Salary that is otherwise earned and payable in the next Plan Year, and&#47;or (b) a portion of his or her Annual Cash Incentive otherwise earned in the next Plan Year and payable in that Plan Year or in the first calendar quarter of the subsequent Plan Year, and&#47;or (c) with respect to Deferred Compensation Elections made prior to November 1, 2021, a portion of his or her Commissions otherwise earned in the next Plan Year and payable in that Plan Year or in the first calendar quarter of the subsequent Plan Year,    and with respect to Deferred Compensation Elections made on or after November 1, 2021, a portion of his or her Commissions payable in the second succeeding Plan Year following the calendar year in which such Deferred Compensation Election is made. The aforementioned Deferred Compensation Elections are to be made by submitting a Deferred Compensation Election during such annual enrollment period. If an Executive becomes an Eligible Executive after October 1 (or such later date as prescribed by the Plan Administrator) in any calendar year, he or she may not make a Deferred Compensation Election for Base Salary, Annual Cash Incentive or Commissions earned in the next Plan Year (and on or after November 1, 2021, for Commissions payable in the second succeeding Plan Year).</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant shall submit a Deferred Compensation Election in the manner specified by the Plan Administrator and a Deferred Compensation Election that is not timely filed shall be considered  void and have no effect. If a Participant does not file a Deferred Compensation Election applicable to his or her Base Salary, Annual Cash Incentive or Commissions earned in a Plan Year on or before  the close of the  applicable annual enrollment  period (or such  later date  prescribed  by the</font></div><div style="height:62.46pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 8</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><div id="i009a378e00aa4e49a12f0bcc9e797e84_693"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan Administrator), the Participant shall be deemed to have elected not to make a Deferred Compensation Election for such Plan Year. The Plan Administrator shall establish procedures that govern deferral elections under the Plan, including the ability to make separate elections for Base Salary, Annual Cash Incentive or Commissions, and any other cash remuneration payable to the Participant that the Committee or Plan Administrator permits a Participant to defer under the Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the provisions of this Article, an Eligible Executive must file a new Deferred Compensation Election for each Plan Year that the Eligible Executive is eligible to participate in the Plan if the Eligible Executive intends to make a deferral under the Plan for such Plan Year.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Modification or Revocation of Election by Participant.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">A Participant&#8217;s Deferred Compensation Election for a Plan Year shall become irrevocable  as of the close of business on the date established by the Plan Administrator, but not later than the applicable date described below.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.01pt">In the case of a deferral of Base Salary and&#47;or Annual Cash Incentives and with respect to Commissions, Deferred Compensation Elections made before  November 1, 2021, on the last day of the calendar year preceding the Plan Year    in which such Base Salary or Annual Cash Incentive or Commissions applicable    to that Deferred Compensation Election is earned. Such Deferred Compensation Elections shall become effective as of the first day of the Plan Year in which such Base Salary and&#47;or Annual Cash Incentive and&#47;or Commission is earned.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.79pt">In the case of a deferral of Commissions, for Deferred Compensation Elections made on or after November 1, 2021, on the last day of the second calendar year preceding the Plan Year in which such Commissions applicable to that Deferred Compensation Election are paid. Such Deferred Compensation Elections shall become effective as of the first day of the Plan Year that precedes the Plan Year    in which such Commission is paid.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the Plan Administrator may cancel a Participant&#8217;s Deferred Compensation Elections for the balance of a Plan Year if the Participant submits evidence of an unforeseeable emergency (as defined in the Universal 409A Definition Document) to the Plan Administrator. Any Base Salary, Annual Cash Incentive, Commissions or other cash remuneration which would have been deferred pursuant to that cancelled Deferred Compensation Election shall be paid to the Eligible Executive as if he or she had not made that election.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant may revoke or change a Deferred Compensation Election any time prior to  the date such election becomes irrevocable. Any such change or revocation shall be made in a form and manner determined by the Plan Administrator. Under no circumstances may  a Participant&#8217;s Deferred Compensation Election be made, modified or revoked  retroactively.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">If a Participant&#8217;s Deferred Compensation Election applicable to his or her Base Salary    and&#47;or Annual Cash Incentive or Commissions is cancelled for a Plan Year, he or she will not be permitted to elect to make Deferrals again until the next Plan Year.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">If a Participant ceases to be an Executive after the date a Deferred Compensation Election becomes effective but continues to be employed by the Company or an Affiliate, his or her Deferred Compensation Election currently in effect shall remain in force.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Notwithstanding anything in the Plan to the contrary, if an Eligible Executive&#58;</font></div><div style="height:93.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 9</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><div id="i009a378e00aa4e49a12f0bcc9e797e84_716"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:2pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.01pt">receives a withdrawal of deferred cash contributions on account of hardship from any plan which is maintained by the Company or an Affiliate and which meets the requirements of Section 401(k) of the Code (or any successor thereto)&#59; and</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.79pt">is precluded from making contributions to such 401(k) plan for at least six (6) months after receipt of the hardship withdrawal,</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Eligible Executive&#8217;s Deferred Compensation Election with respect to Base Salary, Annual Cash Incentive or Commissions in effect at that time shall be cancelled. Any Base Salary, Annual Cash Incentive or Commissions payment which would have been deferred pursuant to that Deferred Compensation Election but for the application of this Section 4.3(d) shall be paid to the Eligible Executive as if he or she had not made that election.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Company Contributions and Other Deferrals.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.78pt">Company Contributions &#8211; Restoration of Lost Matching Contribution</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of Lost Matching Contributions credited under the Plan on a Participant&#8217;s behalf each calendar year shall be equal to (i) minus (ii) where&#58;</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.01pt">is the lesser of (a) total Qualified Future Fund Matching Contribution that would have been allocated on the Participant&#8217;s behalf under Future Fund for the Plan Year, without giving effect to any reductions or limitations required by Sections 401(a)(17), 401(k), 402(g) and&#47;or 415 of the Code (i.e., 5% of Total Pay), and (b) the Future Fund matching contribution that would have been allocated on the participants behalf, had the participant contributed the maximum amount permissible by law for that plan year, plus his or her Deferral under Section 4.1 for the Plan Year&#59; and</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.79pt">If the Participant is eligible to contribute to Future Fund (whether pre-tax or after-tax) during the Plan Year, (ii) is the maximum amount of matching contributions  that could have been made on the participants behalf to Future Fund had the participant contributed the maximum amount permissible by law for that Plan Year.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:108pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if the Participant is not eligible to contribute to Future Fund during the Plan Year but is eligible to contribute to another qualified defined contribution plan (whether pre-tax or after-tax) maintained by the Company or an Affiliate during that Plan Year, the amount under this clause (ii) shall equal, unless otherwise provided by the Committee, the maximum amount of matching contributions the Participant would have received under the provisions of Future Fund for that Plan Year had   he or she been eligible to contribute to Future Fund during that Plan Year, based  on his or her Base Salary and&#47;or Annual Cash Incentive or Commissions otherwise earned and payable in that Plan Year.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this subsection (a), for the Plan Year in which the requirement to complete one (1) Year of Service is met, Total Compensation for the entire Plan Year shall be taken into account.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, for purposes of determining the Lost Matching   Contributions to be credited under this Section 4.4(a), Years of Service with respect to a Participant employed by Red Oak Sourcing, LLC, the limited liability corporation formed pursuant to the Framework Agreement between CVS Pharmacy, Inc. and Cardinal Health 110 Inc., dated December 10, 2013 (&#8220;Cardinal&#8221;), who immediately prior to becoming employed by Red Oak Sourcing, LLC was employed by Cardinal, shall include the period  of such Participant&#8217;s employment rendered with Cardinal.</font></div><div style="height:89.46pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 10</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><div id="i009a378e00aa4e49a12f0bcc9e797e84_736"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lost Matching Contributions shall be credited under this Section 4.4(a) with respect to a Participant who made a Bonus Deferral Contribution election under the Omnicare, Inc. Deferred Compensation Plan with respect to the 2016 Plan Year but such Lost Matching Contributions shall be subject to the Participant&#8217;s distribution election and the distribution provisions of the Omnicare, Inc. Deferred Compensation Plan in effect on the date of such Participant&#8217;s election.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding anything in the Plan to the contrary, a Participant shall not be eligible to receive a Lost Matching Contribution following the Participant&#8217;s Termination of  Employment, unless the Participant terminates due to Retirement.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of clarification, in no event shall a Participant be eligible to receive a Lost Matching Contribution if the Participant does not make an actual deferral into the Plan for the Plan Year.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.78pt">LTIP Deferrals.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the sole discretion of the Committee, all or a portion of a Participant&#8217;s cash award under the LTIP may be deferred under the Plan. Such election shall be made in accordance with the procedures established by the Plan Administrator. The deferral election applicable to   an LTIP cash award shall be made prior to the close of the calendar year preceding the   first day of the performance period applicable to that award. Notwithstanding the foregoing, such election shall become irrevocable as of the close of business of the last day of the calendar year preceding the first day of the performance period applicable to that award. However, if such award meets the definition of performance-based compensation (as defined under Treas. Reg. Section 1.409A-1(e) and any subsequent guidance), the Plan Administrator may permit such election to be made in accordance with the provisions under Treas. Reg. Section 1.409A-2(a)(8) and subsequent guidance. Notwithstanding anything   in the Plan to the contrary, a previously submitted deferral election of a Participant&#8217;s cash award under the LTIP shall be disregarded following the Participant&#8217;s Termination of Employment.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.34pt">Cash Retention Award Deferrals.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the sole discretion of the Committee and subject to the procedures established by the Plan Administrator, an Eligible Executive may elect to defer all or a portion of a cash retention award that may be otherwise paid under a cash retention program maintained by the Company or an Affiliate. The deferral election applicable to such cash retention award shall be made in accordance with the provisions of Treasury Regulations Section 1.409A- 2(a)(5). Notwithstanding anything in the Plan to the contrary, a previously submitted  deferral election of a Participant&#8217;s cash retention award shall be disregarded following the Participant&#8217;s Termination of Employment.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Deferral and Contribution Timing.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Base Salary Deferrals will be credited to the Account of each Participant as of the date of the paycheck from which the deferral was withheld. A Participant whose employment terminates during a payroll period will cease deferral withholding effective as of the first day of the following payroll period.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual Cash Incentive Deferrals and Commission Deferrals will be credited to the Account of each Participant as of the day on which such Annual Cash Incentive or Commissions, whichever is applicable, otherwise would have been paid to the Participant in cash.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company Contributions for the Restoration of Lost Matching Contribution pursuant to Section 4.4(a)</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 11</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><div id="i009a378e00aa4e49a12f0bcc9e797e84_770"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">above will generally be credited to the Participant&#8217;s Company Account as of the last day of each Plan Year following the Participant&#8217;s completion of one (1) Year of Participation Service (as defined in Future Fund).</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LTIP deferrals shall be credited to the Account of the Participant at the time designated by the Plan Administrator.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash retention awards Deferrals will be credited to the Account of the Participant as of the day on which such cash retention award otherwise would have been paid to the Participant in cash.</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 12</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE V&#8211; ACCOUNTS</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Establishment of Bookkeeping Accounts.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate bookkeeping accounts shall be maintained for each Participant. Said accounts (or subaccount(s) thereof) shall be credited with the deferrals and contributions made by or on behalf  of the Participant pursuant to the Plan and credited (or charged, as the case may be) with the hypothetical investment results determined pursuant to this Article of the Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Subaccounts.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within each Participant&#8217;s bookkeeping account, separate subaccount(s) shall be maintained to the extent necessary for the administration of the Plan. Generally, subaccount(s) will be set up for each year, for each Deferred Compensation Election the Participant makes, and for the Company Contribution credited each year on behalf of a Participant.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Hypothetical Nature of Accounts.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounts established under this Article shall be hypothetical in nature and shall be maintained for bookkeeping purposes only so that hypothetical gains or losses on the deferrals or contributions made to the Plan can be credited (or charged, as the case may be).</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither the Plan nor any of the accounts, or subaccount(s), established hereunder shall hold any actual funds or assets. The right of any person to receive one or more payments under the Plan shall be an unsecured claim against the general assets of the Company. Any liability of the Company to any Participant, former Participant, or Beneficiary with respect to a right to payment shall be based solely upon contractual obligations created by the Plan. The Company, an Affiliate, the Board, the Committee, or any other person shall not be deemed to be a trustee of any amounts to be paid under the Plan. Nothing contained in the Plan, and no action taken pursuant to its provisions, shall create or be construed to create a trust of any kind, or a fiduciary relationship, between the Company, an Affiliate, the Board, the Committee, the Plan Administrator, or any other person and a Participant or any other person.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Vesting.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deferral Account</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Participant shall be one hundred percent (100%) vested in his or her Deferral Account and Grandfathered Deferral Account at all times. A Participant shall be one hundred percent (100%) vested in the LTIP deferrals credited on his or her behalf pursuant to Section 4.4(b) and any cash retention award deferrals credited on his or her behalf pursuant to Section 4.4(c).</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company Account</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Participant shall be one hundred percent (100%) vested in his or her Company Account and Grandfathered Company Account at all times.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Deferral Crediting Options.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferral Crediting Options are similar to investment choices in a qualified defined contribution plan, except that they are hypothetical in nature and no funds are actually held in the Plan. Deferral Crediting Options determine the hypothetical gain or loss to be reflected in the Participant Accounts and shall be elected by Participants in the manner determined by the Plan Administrator.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Deferral Crediting Options offered to Participants are determined by the Plan Administrator at its sole discretion. The Plan Administrator specifically retains the right to change the Deferral Crediting Options at any time, in its sole discretion.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event the Plan Administrator designates more than one Deferral Crediting Option, each Participant shall electronically submit a Deferral Crediting Option election during each annual </font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 13</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enrollment period, which shall be used to measure the hypothetical investment performance of his or her Accounts, within such time period and on such form as the Plan Administrator may prescribe. The designation of a Deferral Crediting Option shall not require the Company to invest or earmark their general assets in any manner. If a Participant fails to make a Deferral Crediting Option, his or her Accounts shall be deemed invested in a Deferral Crediting Option as determined by the Plan Administrator.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant may change his or her election of a Deferral Crediting Option used to measure the hypothetical investment performance of his or her Account balance within such time periods and in such manner prescribed by the Plan Administrator. The election shall be effective as soon as administratively practicable after the date on which the election is submitted in the manner specified by the Plan Administrator.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any amounts added to or subtracted from a Participant&#8217;s Account on any given Valuation Date will be converted to hypothetical unit equivalents (&#8220;Hypothetical Units&#8221;) with a value per Hypothetical Unit (&#8220;Unit Price&#8221;) based on the daily closing price on said date (&#8220;Unit Price&#8221;) for any given Deferral Crediting Option.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Hypothetical Gains or Losses.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any hypothetical dividends, capital gains and any other income or unit activity will be reflected in  the Deferral Crediting Options. The timing of these will be the same as for the funds on which each Deferral Crediting Option is based.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gain or loss on Participant Accounts will be calculated each Valuation Date. The Unit Price  shall determine each Deferral Crediting Option&#8217;s hypothetical value, based on the number of units within the Account for any given Deferral Crediting Option. Account balances on a given day will    be based on the previous day&#8217;s New York Stock Exchange closing price.</font></div><div style="height:78.48pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 14</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><div id="i009a378e00aa4e49a12f0bcc9e797e84_877"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:2pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE VI &#8211; DISTRIBUTION OF ACCOUNT</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Distribution Elections &#8211; Timing of Payment.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Subject to the limitations set forth in this Article VI, each time a Participant makes a Deferred Compensation Election with respect to a Plan Year beginning on or after January 1, 2016, the Participant shall designate on that applicable Deferred Compensation Election, separately for Participant deferrals and Company Contributions, as adjusted pursuant to Article V, that the distribution of such deferrals shall be made or commence, as the case may be, pursuant to Section 6.6, as of (i) the Participant&#8217;s Retirement&#59; or (ii) a Specific Future Year not later than the Plan Year in which the Participant attains age seventy-one (71).</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant may choose different options with respect to each Deferred Compensation Election. A Participant may not change the election made pursuant to the provisions of this Section 6.1, except as otherwise provided in Section 6.7 below.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.01pt;text-decoration:underline">Retirement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The distribution of the portion of a Participant&#8217;s Deferral or Company Account (or subaccount(s)) that is deferred to Retirement under this Section shall commence on the first business day in the January next following his or her Retirement, pursuant to the provisions of Section 6.6, provided, however, that with respect to a Participant who is a Specified Employee as of the date of his or her Retirement, payment of any portion of his or her Deferral or Company Account (or any subaccount(s) thereof) that is subject to Section 409A of the Code will be delayed until the first business day of the seventh (7th) month following the date such Retirement occurs.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.79pt;text-decoration:underline">Specific Future Year</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event a Participant elects to have the distribution of such deferrals made or commence as of a Specific Future Year, subject to rules established by the Plan Administrator, the deferral period must be at least five (5) Plan Years. The distribution of the portion of a Participant&#8217;s Deferral or Company Account (or subaccount(s)) that is deferred to a Specific Future Year shall commence on the first business day of January in that specific year pursuant to   the provisions of Section 6.6.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Company Contributions shall be distributed pursuant to the Participant&#8217;s distribution election. In the event a Participant has not made a distribution election for the Company Contributions for that Plan Year, such distribution shall mirror his or her distribution election made with respect to his or her Base Salary Deferral or Annual Cash Incentive or Commissions Deferral for that Plan Year, if any, in such order&#59; otherwise, such distribution shall be made at the Participant&#8217;s Retirement.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Disability Distributions.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if a Participant has a Termination of Employment because he or she has become Disabled, as determined by the Plan Administrator, such Participant will receive the balance of his or her Deferral Account and Company Account paid out in five (5) annual substantially equal installments with the first payment to be made within seventy-five (75) days from the date of the Participant&#8217;s Termination of Employment. Subsequent annual payments will be paid as of the first business day in January of each subsequent year of the installment period.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Distributions in the Event of Death.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, in the event of a Participant&#8217;s death, the Participant&#8217;s Beneficiary   will receive the remaining balance of the Participant&#8217;s Deferral Account and Company Account paid</font></div><div style="height:85.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 15</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><div id="i009a378e00aa4e49a12f0bcc9e797e84_923"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in two (2) annual installments with the first payment to be made within seventy-five (75) days of the Participant&#8217;s date of death. The second annual payment will be paid as of the first business day in January of the subsequent calendar year.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Distributions Upon Termination of Employment Other Than Retirement, Death or Disability. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, in the event a Participant incurs a Termination of Employment from the Company and all Affiliates for any reason other than Retirement, death or Disability, said Participant will receive his or her entire Deferral Account and Company Account balance in a single lump sum payment. Such payment shall be made within seventy-five (75) days of the date the Participant&#8217;s Termination of Employment occurs&#59; provided, however, that with respect to a Participant who is a Specified Employee as of the date of his or her Termination of Employment for reasons other than death, payment of any portion of his or her Deferral or Company Account (or  any subaccount(s) thereof) pursuant to the provisions of this Section 6.4 will be delayed until the first business day of the seventh (7th) month following the date such Termination of Employment occurs.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Change in Control.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing provisions of this Article VI, upon the occurrence of a Change in Control, a Participant who has a valid change in control election(s) in effect shall automatically receive the balance of his or her Deferral Account and Company Account related to that election,   in cash, in a single lump sum payment. Such lump sum payment shall be paid within forty-five (45) business days after the Change in Control occurs. If such Participant dies after such Change in Control event occurs, but before receiving such payment, it shall be made to his or her Beneficiary.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Form of Payment.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.78pt">Installments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the limitations set forth in Article VI, distributions will be made in annual (or quarterly, if the election was made prior to October 1, 2008) installments, as elected by the Participant, for up to, and including, ten (10) years (fifteen (15) years for an election made prior to October 1, 2008). The initial installment of an annual or quarterly payment stream will begin as of the first business day of the January (a) next following the Participant&#8217;s date of Retirement or (b) of the Specific Future Year, as the case may be, in accordance with the provisions of set forth in Section 6.1. Subsequent annual or quarterly payments will be as of the first business day of each subsequent calendar year or quarter  of the installment period. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each installment will be equal to a fraction of the Account balance (or subaccount(s) thereof) as of the date the installment is paid, with the numerator of the fraction being &#8220;1&#8221; and the denominator being the number of payments remaining in the payment schedule.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing provisions of this paragraph (a), if a Participant dies before receiving payment of the entire balance of his or her Deferral and Company Accounts  under the provisions of this Section, the remaining value of such Accounts shall be payable to his or her Beneficiary in accordance with the provisions of Section 6.9.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:23.78pt">Lump sum</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Participant may elect distribution in the form of a single lump sum payment. Except for Specified Employees, distribution shall be made as of the first business day of the January (a) next following the Participant&#8217;s date of Retirement or (b) of the Specific Future Year, as the case may be, in accordance with the provisions of set forth in Section 6.1.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:41pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:68.58pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 16</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Distributions to a Participant made pursuant to Section 6.1 will occur pursuant to the Participant&#8217;s payment elections at the time he or she submits the applicable Deferred Compensation Election. A Participant may choose different forms of payment with respect to each Deferred Compensation Election. Company Contributions, adjusted pursuant to Article V, shall be distributed pursuant to the Participant&#8217;s form of payment election made with respect to his or her Company Contributions for that year. If the Participant has not made an election with respect to his or her Company Contributions, the portion of his or   her Company Account attributable to such Company contributions will be distributed in accordance with his or her form of payment election with respect to his or her Base Salary Deferral, Annual Cash Incentive or Commissions Deferrals for that year, if any, in that  order&#59; otherwise payment will be made in a lump sum payment. In the absence of an election of the form of payment by a Participant on a Deferred Compensation Election, the portion of the Participant&#8217;s Account deferred pursuant to that Deferred Compensation Election, adjusted pursuant to the provisions of Article V, shall be paid in a single lump  sum.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">A Participant shall not change his or her form of payment election, except as otherwise provided in Section 6.7 below.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Change of Distribution Election.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">In accordance with such procedures as the Plan Administrator may prescribe, a Participant may elect to change his or her Specific Future Year election under Section 6.1(a)(ii) with respect to a portion of his or her Deferral Account (or an Interim Distribution date election applicable to a portion of his or her Deferral Account or Company Account made pursuant  to the provisions of the Plan as in effect prior to December 31, 2008) to a later Specific Future Year (or, if applicable, a later Interim Distribution date) by duly completing,   executing and filing with the Plan Administrator a new Specific Future Year election (or Interim Distribution date election) applicable to such Deferrals, subject to the following limitations&#58;</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.01pt">such election must be made at least twelve (12) months prior to the Specific Future Year (or Interim Distribution date) then in effect with respect to that portion of his   or her Deferral or Company Account (or subaccount(s) thereof), and such election will not become effective until at least twelve (12) months after the date on which the election is made&#59; and</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.79pt">the new Specific Future Year (or Interim Distribution date) shall be a calendar year that is not less than five (5) years from the Specific Future Year (or Interim Distribution date) then in effect.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, effective for election changes made on or after January 1, 2021, a Participant may elect to delay his or her distribution from an elected Specific Future Year to a new Specific Future Year that is at least five (5) years from the Specific Future Year then in effect, provided the election is made in accordance with the foregoing provisions of this Section 6.7(a). A Participant may elect to delay his or her distribution from an elected Specific Future Year (or Interim Distribution date) pursuant to this Section 6.7(a) more than once, provided that all such elections comply with the provisions of this Section 6.7(a).</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">In accordance with such procedures as the Plan Administrator may prescribe, a Participant may elect to delay the payment of a portion of his or her Deferral or Company Account (or any subaccount(s) thereof) scheduled to be paid at his or her Retirement to his or her Retirement plus five (5) calendar years by duly completing, executing and filing with the Plan Administrator a new Retirement election applicable to such deferrals&#59; provided, </font></div><div style="height:68.58pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 17</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">however such election must be made at least twelve (12) months prior to Retirement and shall not become effective until at least twelve (12) months after the date on which the election is made.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">In accordance with such procedures as the Plan Administrator may prescribe, a Participant may elect to change the form of payment election under Section 6.6 applicable to his or   her distribution under Section 6.1(a)(i) or (ii) by duly completing, executing and filing with the Plan Administrator a new form of payment election applicable to such deferrals, subject to the following limitations&#58;</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:31.01pt">such election must be made at least twelve (12) months prior to the Specific Future Year then in effect with respect to that portion of his or her Deferral or Company Account (or subaccount(s) thereof), and such election will not become effective  until at least twelve (12) months after the date on which the election is made&#59; and</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.79pt">the distribution of that portion of his or her Deferral or Company Account (or subaccount(s) thereof) shall be deferred for five (5) years from the date such amount would otherwise have been paid absent this election.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing or any provision of any Appendix to this Plan, effective for election changes made on or after January 1, 2021, in no case may a Participant elect to change the form of payment election to an installment form that includes payments for a period in excess of ten (10) years.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">It is the Company&#8217;s intent that the provisions of Sections 6.7(a), (b) and (c) comply with the subsequent election provisions in Section 409A(a)(4)(C) of the Code, related regulations and other applicable guidance, and this Section 6.7 shall be interpreted accordingly. The Plan Administrator may impose additional restrictions or conditions on a Participant&#8217;s ability to make an election pursuant to this Section 6.7. For avoidance of doubt, a Participant may not elect to alter the distribution of any portion of his or her Deferral or Company Accounts (or any subaccount(s) thereof) from Retirement to a Specific Future Year or, except as provided in paragraph (a) above, from a Specific Future Year to Retirement.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Account Valuation upon a Distribution.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to a distribution made pursuant to this Article, the Valuation Date of a Participant&#8217;s Account shall be the day immediately preceding the Distribution Date.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Designation of Beneficiary.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Participant shall have the right to designate a Beneficiary to receive payment of his or her Account in the event of death. Any such designation may be changed at any time by executing and submitting (either by hand or electronic submission) a new designation on a form prescribed by the Plan Administrator.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Unclaimed Account. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Plan Administrator is unable to locate a Participant or Beneficiary to whom an Account is payable, such Account may be forfeited to the Company upon the Plan Administrator&#8217;s determination. Notwithstanding the foregoing, if subsequent to any such forfeiture, the Participant  or Beneficiary to whom such Account is payable makes a valid claim, such forfeited Account shall be restored to the Plan and paid by the Company.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Hardship Withdrawals.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A  Participant may apply  in writing to  the  Plan  Administrator for,  and the Plan  Administrator may </font></div><div style="height:68.58pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 18</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.06pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">grant, a hardship withdrawal of all or any part of a Participant&#8217;s Deferral or Company Account if the Plan Administrator, in its sole discretion, determines that the Participant has incurred an Unforeseeable Emergency, as defined in the Universal 409A Definition Document.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Administrator shall determine whether an event qualifies as a hardship within this Section, in its sole and absolute discretion. Such request shall be made in a time and manner determined  by the Plan Administrator. The payment made from a Participant&#8217;s Deferral or Company Account   (or any subaccount(s) thereof) pursuant to the provisions of this Section 6.11 shall not be in excess of the amount necessary to meet such financial hardship of the Participant, including amounts necessary to pay any federal, state or local income taxes with respect to the payment and shall not be available unless all other financial resources of the Participant have been exhausted. Payment shall be made in the month following the date the Plan Administrator determines that the Participant has incurred an unforeseeable severe financial hardship and grants the right to a withdrawal pursuant to this Section 6.11.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Distribution of Grandfathered Deferral Account and the Grandfathered Company Account.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing provisions of this Article VI, the distribution from a Participant&#8217;s Grandfathered Deferral Account and Grandfathered Company Account (or subaccount(s)) shall be made pursuant to the provisions of the Plan as set forth on October 3, 2004, without regard to any amendments after October 3, 2004 which would constitute a material modification for Section 409A of the Code, as modified in Appendix A attached hereto.</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:center"><font><br></font></div><div style="height:68.58pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 19</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE VI &#8212;            ADMINISTRATION</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Plan Administrator.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan shall be administered by the Deferred Compensation Plans Committee, appointed by the Committee as Plan Administrator. The Plan Administrator shall be responsible for the general operation and administration of the Plan and for carrying out the provisions thereof. The Plan Administrator may delegate to others certain aspects of the management and operations of the  Plan including the employment of advisors and the delegation of ministerial duties to qualified individuals, provided that such delegation is in writing.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">General Powers of Administration.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Administrator shall have the exclusive responsibility and complete discretionary authority to control the operation, management and administration of the Plan, with all powers necessary to enable it properly to carry out such responsibilities, including, but not limited to, the power to interpret the Plan and any related documents, to establish procedures for making any elections called for under the Plan, to make factual determinations regarding any and all matters arising hereunder, including, but not limited to, the right to determine eligibility for benefits, the right to construe the terms of the Plan, the right to remedy possible ambiguities, inequities, inconsistencies or omissions, and the right to resolve all interpretive, equitable or other questions arising under the Plan. The decisions of the Plan Administrator or such other party as is authorized under the terms  of any grantor trust on all matters shall be final, binding and conclusive on all persons to the extent permitted by law. The Plan Administrator shall have all powers necessary or appropriate to enable   it to carry out its administrative duties. Not in limitation, but in application of the foregoing, the Plan Administrator shall have the duty and power to interpret the Plan and determine all questions that may raise hereunder as to the status and rights of Employees, Participants, Beneficiaries, and any other person. The Plan Administrator may exercise the powers hereby granted in its sole and absolute discretion. No member of the Deferred Compensation Plans Committee shall be personally liable for any actions taken by the Plan Administrator unless the member&#8217;s action involves gross negligence or willful misconduct.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Costs of Administration.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs of administering the Plan shall be borne by the Company unless and until the Participant receives written notice of the imposition of such administrative costs&#59; with such costs to begin with the next Plan Year and none may be assessed retroactively for prior Plan Years.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such costs shall be charged against the Participant&#8217;s Account and shall be uniform or proportional for all Participants. Such costs shall not exceed the standard rates for similarly designed nonqualified plans under administration by high quality third party administrators at the time such costs are initially imposed and thereafter.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Indemnification.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall indemnify each director, officer or employee of the Company or any Affiliate  and each member of the Committee and Deferred Compensation Plans Committee, including any subcommittee or delegates thereof, against any and all claims, losses, damages, expenses, including attorney&#8217;s fees, incurred by them, and any liability, including any amounts paid in settlement with their approval, arising from their action or failure to act, except when the same is judicially determined to be attributable to their gross negligence or willful misconduct, as a result of the fact that he or she is or was serving the Plan in any capacity at the request of the Company.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="height:68.58pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 20</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">409A Compliance.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the accounts subject to Section 409A of the Code, the Plan is intended to comply with the requirements of Section 409A of the Code and the provisions hereof shall be interpreted    in a manner that satisfies the requirements of Section 409A of the Code and the regulations thereunder, and the Plan shall be operated accordingly. Regardless of, and superseding any other provision of the Plan to the contrary, if any provision of the Plan would otherwise frustrate or conflict with this intent, the provision will be interpreted and deemed amended so as to avoid this conflict.</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:68.58pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 21</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-right:-18pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE VIII &#8211; CLAIMS PROCEDURE</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Claims.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A person who believes that he or she is being denied a benefit to which he or she is entitled under the Plan (hereinafter referred to as a &#8220;Claimant&#8221;) may file a written request for such benefit with the Plan Administrator, setting forth his or her claim. The request must be addressed to the Senior Vice President, Compensation and Benefits, at the Company&#8217;s then principal place of business.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Claim Decision.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon receipt of a claim, the Plan Administrator or its delegate shall review and determine the claim within ninety (90) days. If the Plan Administrator determines that additional time is needed to review the claim, the Plan Administrator will provide the Claimant with a notice of the extension before the end of the initial ninety (90)-day period. The notice of extension will provide the date by which the Plan Administrator expects to make a decision.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the claim is denied in whole or in part, the Plan Administrator shall notify the Claimant in writing   of the following&#58;</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The reason or reasons for such denial&#59;</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The pertinent provisions of the Plan&#59;</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Appropriate information as to the steps to be taken if the Claimant wishes to submit the claim for review&#59; and</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The time limits for requesting a review under this Section.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Request for Review&#47;Appeal.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within sixty (60) days after the receipt by the Claimant of the initial written notice of a denial, the Claimant may request in writing that the initial determination be reviewed. Such request must be addressed to the Senior Vice President, Compensation and Benefits, at the Company&#8217;s then principal place of business. The Claimant or his or her duly authorized representative may, but  need not, submit issues and comments in writing for consideration by the Appeals Committee, a subcommittee of the Deferred Compensation Plans Committee. If the Claimant does not request a review of the initial determination within such sixty (60)-day period, he or she shall be barred and stopped from challenging the Plan Administrator&#8217;s initial determination.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Review of Decision.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within sixty (60) days after the Plan Administrator&#8217;s receipt of a request for review, the Appeals Committee of the Plan Administrator will review the Plan Administrator&#8217;s initial determination. After considering all materials presented by the Claimant, the Appeals Committee will render a written decision, setting forth the reasons for the decision and containing references to the pertinent provisions of the Plan. If the Appeals Committee requires an extension of the sixty (60)-day time period, the Appeals Committee will so notify the Claimant and will render the decision as soon as possible, but no later than one hundred twenty (120) days after receipt of the request for review.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Time Limit for Bringing Legal Action.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any legal action by the Claimant must be brought within ninety (90) days following the date of the decision on the final review under Section 8.4 above. </font></div><div style="height:68.58pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.891%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 22</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><div id="i009a378e00aa4e49a12f0bcc9e797e84_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARTICLE IX &#8211; MISCELLANEOUS</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Not Contract of Employment.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption and maintenance of the Plan shall not be deemed to be a contract between the Company or an Affiliate and any person and shall not be consideration for the employment of any person. Nothing herein contained shall be deemed to give any person the right to be retained in    the employ of the Company or an Affiliate or to restrict the right of the Company or an Affiliate to discharge any person at any time nor shall the Plan be deemed to give the Company or an Affiliate the right to require any person to remain in the employ of the Company or an Affiliate or to restrict any person&#8217;s right to terminate his or her employment at any time.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Non-Assignability of Benefits.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No Participant, Beneficiary or distributees of benefits under the Plan shall have any power or right   to transfer, assign, anticipate, hypothecate or otherwise encumber any part or all of the amounts payable hereunder, which are expressly declared to be unassignable and nontransferable. Any   such attempted assignment or transfer shall be void. No amount payable hereunder shall, prior to actual payment thereof, be subject to seizure by any creditor of any such Participant, Beneficiary    or other distributees for the payment of any debt judgment or other obligation, by a proceeding at  law or in equity, nor transferable by operation of law in the event of the bankruptcy, insolvency or death of such Participant, Beneficiary or other distributee hereunder.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Withholding and Deduction and Taxes. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All deferrals and payments provided for hereunder shall be subject to applicable withholding and other deductions as shall be required of the Company under any applicable local, state or federal law. The Company may require that the Participant or Beneficiary making a deferral or receiving payments pay to the Company the amount of any federal, state or local taxes, if any, that the Company or any Affiliate is required to withhold with respect to such deferrals or payments or the Company or any Affiliate may deduct from other wages paid by the Company or any Affiliate the amount of any withholding taxes due with respect to such deferrals or payments. A Participant or Beneficiary shall be solely responsible for any tax consequences related to deferrals or payments made under the Plan. The Company shall have no obligation to make any payment under the Plan until the Company&#8217;s or any Affiliate&#8217;s tax withholding obligations have been satisfied by the Participant or Beneficiary. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Amendment and Termination.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee or its delegate may from time to time, in its discretion, amend, in whole or in part, any or all of the provisions of the Plan&#59; provided, however, that no amendment may be made that would impair the rights of a Participant with respect to amounts already allocated to his or her Account without the Participant&#8217;s consent. To the extent consistent with the rules relating to plan terminations and liquidations in Treas. Reg. Section 1.409A-3(j)(4)(ix) or otherwise consistent with Section 409A of the Code, the Committee, in its sole discretion, may terminate the Plan and any related Deferred Compensation Election at any time and in that event the Committee may provide that, without the prior written consent of Participants, the Participants&#8217; Accounts shall be distributed in a single cash lump sum upon termination of the Plan. Unless so distributed in accordance with  the preceding sentence, in the event of a Plan termination, the Plan Administrator shall continue to maintain the Participants&#8217; Accounts until distributed pursuant to the terms of the Plan and Participants shall remain one hundred percent (100%) vested in all amounts credited to their Accounts. In the event of a Plan termination, the distribution of a Participant&#8217;s Grandfathered Deferral Account and Grandfathered Company Account shall be made pursuant to the provisions    of the Plan as set forth on October 3, 2004, without regard to any amendments after October 3, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.196%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 23</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2004 which would constitute a material modification for Section 409A of the Code, as modified in Appendix A attached hereto.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Compliance with Securities and Other Laws.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any Plan provision to the contrary, the Committee may at any time impose such restrictions on the Plan and participation therein, including limiting the amount of any deferral or    the timing thereof, as the Committee may deem advisable from time to time in order to comply or preserve compliance with any applicable laws, including any applicable state and federal securities laws and exemptions from registration available thereunder.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">No Trust Created.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nothing contained in the Plan and no action taken pursuant to its provisions by the Company or   any person, shall create, nor be construed to create, a trust of any kind or a fiduciary relationship between the Company or an Affiliate and the Participant, Beneficiary, or any other person.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Unsecured General Creditor Status of Employee.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The payments to the Participant, Beneficiary or any other distributees hereunder shall be made   from assets which shall continue, for all purposes, to be a part of the general, unrestricted assets    of the Company. No person shall have or acquire any interest in any such assets by virtue of the provisions of the Plan. The Company&#8217;s obligation hereunder shall be an unfunded and unsecured promise to pay money in the future. To the extent that the Participant, Beneficiary or other distributees acquire a right to receive payments from the Company under the provisions hereof,  such right shall be no greater than the right of any unsecured general creditor of the Company. No such person shall have or acquire any legal or equitable right, interest or claim in or to any property or assets of the Company.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that, in its discretion, the Company purchases an insurance policy, or policies, insuring the life of the Employee, or any other property, to allow the Company to recover the cost of providing the benefits, in whole, or in part, hereunder, neither the Participant, Beneficiary or other distributee shall have or acquire any rights whatsoever therein or in the proceeds therefrom. The Company  shall be the sole owner and beneficiary of any such policy or policies and, as such, shall possess and, may exercise all incidents of ownership therein. No such policy, policies or other property shall be held in any trust for a Participant, Beneficiary or other distributee or held as collateral security    for any obligation of the Company hereunder. An Employee&#8217;s participation in the underwriting or other steps necessary to acquire such policy or policies may be required by the Company and, if required, shall not be a suggestion of any beneficial interest in such policy or policies to a Participant.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Limitation.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant and his or her Beneficiary shall assume all risk in connection with any decrease in value of his or her Account, and neither the Company nor the Committee or the Plan Administrator shall be liable or responsible therefor.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt">Payment to Minors and Incompetents.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any Participant, spouse, or Beneficiary entitled to receive any benefits hereunder is a minor or is deemed by the Plan Administrator or is adjudicated to be legally incapable of giving a valid receipt and discharge for such benefits, the benefits will be paid to the person or entity as the Plan Administrator determines has been appointed or established to receive such payment on behalf of such person. Such payment shall, to the extent made, be deemed a complete discharge of any payment obligation under the Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.196%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 24</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Acceleration of or Delay in Payments.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Plan Administrator, in its sole and absolute discretion, may elect to accelerate the time or form  of payment of a benefit owed to the Participant hereunder, provided such acceleration is permitted under Treas. Reg. Section 1.409A-3(j)(4) and any subsequent guidance. The Plan Administrator  may also, in its sole and absolute discretion, delay the time for payment of a benefit owed to the Participant hereunder, to the extent permitted under Treas. Reg. Section 1.409A- 2(b)(7) and any subsequent guidance.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Severability.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any provision of the Plan shall be held illegal or invalid for any reason, said illegality or invalidity shall not affect the remaining provisions hereof&#59; instead, each provision shall be fully severable and the Plan shall be construed and enforced as if said illegal or invalid provision had never been included herein.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Governing Laws.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All provisions of the Plan shall be construed in accordance with the laws of Rhode Island, except     to the extent preempted by federal law.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.55pt">Binding Effect.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the Plan shall be binding on each Participant and his or her heirs and legal representatives and on the Company and its successors and assigns.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.196%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 25</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><div id="i009a378e00aa4e49a12f0bcc9e797e84_998"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center;text-indent:40.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">APPENDIX A &#8211; PROVISIONS APPLICABLE TO A PARTICIPANT&#8217;S GRANDFATHERED DEFERRAL ACCOUNT AND GRANDFATHERED COMPANY ACCOUNT</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Appendix A constitutes an integral part of the Plan and is applicable with respect to the Grandfathered Deferral Account and the Grandfathered Company Account of those individuals who were Participants in   the Plan on December 31, 2004. The Grandfathered Deferral Account and Grandfathered Company   Account are subject to all the terms and conditions of the Plan as set forth on October 3, 2004, without regard to any Plan amendments after October 3, 2004 which would constitute a material modification for Section 409A of the Code, as modified below. Section references in this Appendix A correspond to appropriate Sections of the Plan as set forth on October 3, 2004.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article I &#8211; Definitions</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Section 2.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Company Account means the Participant&#8217;s Grandfathered Company Account as set forth in Section 2.28.</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Section 2.19</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Deferral Account means the Participant&#8217;s Grandfathered Deferral Account as set forth in Section 2.29 of the foregoing provisions of the Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of a Participant&#8217;s Grandfathered Deferral Account and Grandfathered Company Account, the term Change in Control shall have the meaning set forth in the 1997 Incentive Compensation Plan as in effect on October 3, 2004.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article IV &#8211; Deferrals and Company Contributions</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provisions of Section 4.03 shall continue to apply to a Participant&#8217;s Grandfathered Deferral Account, Grandfathered Company Account and amounts transferred from the Melville Deferred Compensation Plan that were vested on or earlier than December 31, 2004.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article V &#8211; Maintenance of Accounts</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provisions of Section V as set forth in the foregoing provisions of the Plan as amended and restated effective as of December 31, 2008 shall be applicable to a Participant&#8217;s Grandfathered Deferral Account   and Grandfathered Company Account on and after January 1, 2009.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article VI &#8211; Payment of Benefit</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this Article VI &#8211; Payment of Benefit, the term &#8220;termination of employment&#8221; or any other similar language means with respect to a Participant the complete cessation of providing service to the Company and any Affiliate as an employee.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:19.34pt">Form of Payment</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective on or after October 1, 2008, a Participant shall not elect installments in excess of ten (10) years or quarterly installments.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:19.34pt">Disability Distributions</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Participant shall be entitled to distribution under this Section if such Participant becomes &#8220;Disabled&#8221; as such term is defined under Section 6.03 of the Plan.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:19.34pt">Change of Distribution Election</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On and after January 1, 2009, a change in a Specific Future Year distribution date or an Interim distribution date shall be effective only if the new Specific Future Year distribution date or an Interim </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.196%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 26</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">distribution date is not less than five (5) years later then the date in effect prior to the change election.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the forms of distribution election available to Participants covered    by this Appendix A shall be limited to the forms of distribution described in Section 6.6 of the Plan, but in no case may a Participant elect to change the form of payment election to an installment    form that includes payments for a period of in excess of ten (10) years</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.196%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 27</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><div id="i009a378e00aa4e49a12f0bcc9e797e84_1015"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;margin-top:2pt;padding-left:18pt;padding-right:18pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">APPENDIX B &#8211; PROVISIONS APPLICABLE TO A PARTICIPANT&#8217;S ACCOUNT   UNDER THE OMNICARE, INC. DEFERRED COMPENSATION PLAN</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Appendix B constitutes an integral part of the Plan and is applicable with respect to a Participant&#8217;s Account (&#8220;Omnicare Account&#8221;) under the Omnicare, Inc. Deferred Compensation Plan, effective January 1, 2017. The Participants&#8217; Omnicare Accounts are subject to all the terms and conditions of the Omnicare    Plan as set forth on January 1, 2013. Section references in this Appendix B correspond to appropriate Sections of the Omnicare Plan as set forth on January 1, 2013.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 2&#58; Participation</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective December 31, 2016, there shall be no new Participants in the Plan. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 3&#58; Contributions &#38; Deferral Elections</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.11pt">Elections to Defer Compensation.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective December 31, 2016 there shall be no new Elections to defer Compensation. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.11pt">Company Contributions.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective December 31, 2016 there shall be no Discretionary Company Contributions or Company Matching Contributions.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:22.11pt">Investment Elections.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2017, a Participant shall be eligible to designate the investment of his or her Omnicare Account solely in accordance with the Deferral Crediting Options of the CVS Health Corporation Deferred Compensation Plan.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.196%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 28</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><div id="i009a378e00aa4e49a12f0bcc9e797e84_1030"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:0.8pt;padding-right:0.8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">APPENDIX C APPENDIX C &#8211; PROVISIONS APPLICABLE TO A PARTICIPANT&#8217;S ACCOUNT UNDER THE AETNA SUPPLEMENTAL 401(K) PLAN AND AETNA DEFERRED COMPENSATION PROGRAM</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Appendix C constitutes an integral part of the Plan and is applicable with respect to a Participant&#8217;s accounts under the Aetna Supplemental 401(k) Plan and Aetna Deferred Compensation Program (collectively, the &#8220;Aetna Accounts&#8221;), effective January 1, 2020, which have been merged into the Plan. The Participants&#8217; Aetna Accounts are subject to all the terms and conditions of the Plan except that the Aetna Accounts shall remain subject to the distribution provisions of the Supplemental 401(k) Plan as set forth on January 1, 2009, as amended, and the Deferred Compensation Program as set forth on January 1, 2008,   as applicable, and as set forth below&#58;</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AETNA SUPPLEMENTAL 401(K) PLAN</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payment of Deferred Amounts</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt">Timing of </font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pay</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">m</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">nt f</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">o</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">r Participants wh</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ose Ter</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">mina</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">t</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ion from Servi</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ce O</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">u</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">rs </font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">on or after January 1</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, 2</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">005. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The </font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vested Ac</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cou</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t ba</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ance of a</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y </font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant </font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">w</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">h</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">os</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e </font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Term</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ination </font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from Se</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ce (&#8220;separation from service&#8221; as defined Code Section 409A) occurs o</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n or after J</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">anuary 1</font><font style="color:#2f2f2f;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2005 shall b</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e paid in a </font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lump s</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">um n</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o </font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ate</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r than thirty &#91;30&#93;</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ays after </font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">er of (a</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) the da</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e th</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t </font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is six (6) mo</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ths fo</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">owing the P</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">articipa</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;s Terminati</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n </font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">om Se</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vic</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e D</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e&#59; or (b) th</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e </font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">J</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">anuary 1 nex</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t </font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fo</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">owing the P</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">articipa</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;s Terminatio</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n f</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">m </font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Se</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">v</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ce </font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D</font><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">te.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt">Election as to Time of Payment &#8211; Prior Participants.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Participant who incurred a Termination from Service prior to January 1, 2005 shall have had  an opportunity to make an election, on a form and in the manner prescribed by the Company for   this purpose, specifying the time at which his or her vested Account balance is to be paid.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise provided in paragraph 3 and 4 below, payment of any such Participant&#8217;s vested Account balance shall be made to the Participant in a lump sum as soon as practicable after the Valuation Date on or next following the time specified for payment in the election made by the Participant under this paragraph 2.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the absence of an election which complies with either paragraph 2 or 3, any such Participant&#8217;s vested Account balance shall be paid in a lump sum as soon as practicable after the Valuation Date on or next following the Participant&#8217;s Termination from Service.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt">Time of Payment-Certain Prior Participants.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This paragraph 3 applies to Participants who ceased to be Employees prior to October 1, 1996 without having made an election pursuant to paragraph 2 hereof. Payment of the Account balance  of any such Participant shall be made in a lump sum at the earlier of the commencement of the Participant&#8217;s (i) final distribution from the Aetna 401(k) Plan&#59; or (ii) required minimum distributions following attainment of age 70&#189;, unless the Participant has otherwise elected, prior to termination   of employment, to receive payment at a later date.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt">Payment in the Event of Participant&#8217;s Death.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any election that may have been made by a Participant pursuant to paragraph 2    or 3, and notwithstanding the provisions of paragraph 1, any vested Account balance that has not been paid to the Participant as of the date of the Participant&#8217;s death shall be paid to the Participant&#8217;s Beneficiary in a lump sum on the Valuation Date on or next following the Participant&#8217;s death.</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acceleration of Payment.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.634%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 29</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a Participant experiences an &#8220;unforeseeable emergency&#8221; as defined in Section 409A, the Participant may submit to the Administrator a written request for a distribution, including such documentation as the Administrator may require. The Administrator shall review the request and make a determination approving or denying the requested distribution. If approved, distribution   shall be made on the first business day of the month following the approval and shall be limited to such amount as is reasonably necessary to alleviate the Participant&#8217;s emergency need, taking into account other assets available to the Participant to the extent required by Section 409A. In addition, and notwithstanding any other provision of this Plan to the contrary, the Company, in its sole discretion, may accelerate the payment of vested Account balances in any other circumstances permitted under Section 409A.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#040404;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt">Change of Distribution Election.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify"><font style="color:#131313;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provisions of Section 6.7(c) shall apply to Aetna Accounts.</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AETNA DEFERRED COMPENSATION PROGRAM</font></div><div style="margin-bottom:10pt;margin-top:2pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payment</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Payment will begin on the specified date or event elected by the Participant for each year&#8217;s  deferrals. The form of payment(s) will be made according to the option(s) elected by the Participant for each year&#8217;s deferred funds. If the Participant failed to specify the time and form of payment on  an election form, payment shall be made in accordance with&#58; (a) if applicable, the time and form specified by the Company in the separate written arrangement providing for the compensation or   (b) if not so specified, the time of payment shall be the Participant&#8217;s separation from service and    the form of payment shall be a single lump sum. Payments are subject to such deductions as may be required in accordance with federal and state tax regulations. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Notwithstanding the preceding paragraph, if a Participant is a &#8220;Specified Employee&#8221; within the meaning of Section 409A at the time of termination of employment, any payment of &#8220;deferred compensation&#8221; hereunder to which the participant would otherwise be entitled, due to such termination of employment, during the first six months following termination of employment, shall remain in the Participant&#8217;s bookkeeping account and be paid in a lump sum on the six-month anniversary of the Specified Employee&#8217;s termination of employment date (or, if earlier, death). This requirement shall only apply to the extent required by Section 409A. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The payment of &#8220;deferred compensation&#8221; (within the meaning of Section 409A) under this program may not be accelerated in violation of Section 409A.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Unless otherwise noted in the deferral election form, in the event of the Participant&#8217;s &#8220;disability&#8221; </font><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(within the meaning of Section 409A) or death during the deferral period, payment shall be made   to the Participant or the Participant&#8217;s beneficiary upon such event. </font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">In case of an &#8220;unforeseeable emergency,&#8221; within the meaning of Section 409A, a Participant may submit a request for payment of amounts already deferred to be advanced and&#47;or a deferral election to be canceled, to the extent permitted under Section 409A. The Company shall make the determination of unforeseeable emergency in its sole discretion consistent with the requirements     of Section 409A. If approved, payment shall be made on the first day of the month following  approval and shall be limited to such amount as is reasonably necessary to alleviate the  Participant&#8217;s emergency need, taking into account other assets available to the Participant to the extent required by Section 409A.</font></div><div style="margin-bottom:10pt;margin-top:2pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The provisions of Section 6.7(c) shall apply to Aetna Accounts.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.634%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proprietary</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page &#124; 30</font></div></td></tr></table></div><div style="text-align:right"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.25
<SEQUENCE>4
<FILENAME>exhibit1025-2021.htm
<DESCRIPTION>EX-10.25
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id7218dcf41fd488fb9dcd458b05c383e_193"></div><div style="min-height:72pt;width:100%"><div style="padding-right:36pt;text-align:right"><font><br></font></div><div style="padding-left:0.62pt;padding-right:36pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:119%">Exhibit 10.25</font></div></div><div style="margin-top:100pt;padding-left:73.7pt;padding-right:73.7pt;text-align:center;text-indent:-0.5pt"><font><br></font></div><div style="margin-top:120pt;padding-left:72.06pt;padding-right:72.06pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:14pt;font-weight:700;line-height:120%">CVS HEALTH SEVERANCE PLAN FOR</font></div><div style="padding-left:72.06pt;padding-right:72.06pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:14pt;font-weight:700;line-height:120%">NON-STORE EMPLOYEES</font></div><div style="padding-left:70.87pt;padding-right:70.87pt;text-align:center;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:14pt;font-weight:700;line-height:120%">       (Amended and Restated as of October 11, 2021)</font></div><div style="padding-left:69.23pt;padding-right:69.23pt;text-align:center"><font><br></font></div><div style="padding-left:69.23pt;padding-right:69.23pt;text-align:center"><font><br></font></div><div style="padding-left:69.23pt;padding-right:69.23pt;text-align:center"><font><br></font></div><div style="padding-left:69.23pt;padding-right:69.23pt;text-align:center"><font><br></font></div><div style="padding-left:69.23pt;padding-right:69.23pt;text-align:center"><font><br></font></div><div style="padding-left:69.23pt;padding-right:69.23pt;text-align:center"><font><br></font></div><div style="padding-left:69.23pt;padding-right:69.23pt;text-align:center"><font><br></font></div><div style="padding-left:69.23pt;padding-right:69.23pt;text-align:center"><font><br></font></div><div style="padding-left:69.23pt;padding-right:69.23pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#414141;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Proprietary</font></div></div></div><div id="id7218dcf41fd488fb9dcd458b05c383e_1"></div><hr style="page-break-after:always"><div style="min-height:22.5pt;width:100%"><div style="padding-left:0.62pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:1.85pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.5pt;font-weight:400;line-height:125%"> </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="margin-bottom:3pt;padding-left:161.65pt;padding-right:161.65pt;text-align:center;text-indent:4.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:700;line-height:122%">      CVS HEALTH SEVERANCE PLAN </font></div><div style="margin-bottom:0.15pt;padding-left:157.02pt;padding-right:157.02pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:700;line-height:122%">      FOR NON-STORE EMPLOYEES</font></div><div style="padding-left:161.55pt;padding-right:161.55pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:700;line-height:119%">(Amended and Restated as of October 11, 2021)</font></div><div><font><br></font></div><div style="padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, CVS Health Corporation (the  &#8220;Company&#8221;)  has  established  the  CVS  Health Severance Plan for Non-Store Employees (the &#8220;Plan&#8221;) to provide financial assistance to employees in non-store positions who are involuntarily terminated and are eligible within the terms and conditions of the Plan&#59;</font></div><div><font><br></font></div><div style="padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, it is intended that the Plan constitute an employee welfare benefit plan within the scope of Section 3(1) of the Employee Retirement Income Security Act of 1974, as amended (&#8220;ERISA&#8221;), that the Plan constitute a separation pay plan within the scope of Department of Labor (&#8220;DOL&#8221;) Regulation Section 2510.3- 2(b), and that all payments made under the Plan be deductible by the Company under Section 162(a) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;)&#59;</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:58.5pt;padding-right:22.95pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the benefits provided under the Plan are intended to constitute separation pay within        the meaning of Treasury Regulation Section 1.409A-1(b)(9)(iii)&#59;</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:98.55pt;padding-right:22.95pt;text-align:justify;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, this document is the official plan document&#59; and</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:57pt;padding-right:44.05pt;text-align:justify;text-indent:41.05pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Company wishes to make certain amendments to the Plan, effective as of October 11, 2021 (the &#8220;Effective Date&#8221;)&#59;</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:58.5pt;padding-right:22.95pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">NOW, THEREFORE, as of the Effective Date, the Company does hereby amend the Plan to           provide as follows&#58;</font></div><div style="padding-left:42.32pt;padding-right:42.32pt;text-align:center;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:128%">ARTICLE 1</font></div><div style="padding-left:18.6pt;padding-right:18.6pt;text-align:center;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">DEFINITIONS</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div><div style="margin-bottom:4.4pt"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:58.5pt;padding-right:22.95pt;text-align:justify;text-indent:40.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">For purposes of the Plan, the following terms, when used with an initial capital letter, shall have the meaning set forth below unless a different meaning is plainly required by the context.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:120%">1.1 &#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean (a) any corporation which is required to be aggregated with the     Company under Code Section 414(b), (c), (m), or (o) and (b) any other entity in which the Company has an ownership interest and which the Company designates as an Affiliate for purposes of the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:61.3pt;padding-right:22.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">1.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">&#8221; shall refer to a termination of an Eligible Employee&#8217;s employment because of the </font></div><div style="margin-bottom:0.25pt;padding-left:61.8pt;padding-right:22.95pt;text-align:justify;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">Eligible Employee&#8217;s (a) failure to satisfactorily perform under a performance improvement plan of the Employer&#59; (b) acts of unethical business activity, including but not limited to fraud, misappropriation, embezzlement, dishonesty, harassment, discrimination in violation of Employer policies, or willful or negligent destruction of property of an Employer or an Affiliate&#59; (c) misconduct that could cause damage (monetary, reputational or otherwise) to the Employer, an Affiliate, or any personnel thereof&#59; (d) conviction of or a plea of guilty or nolo contendere to any felony, whether or not any right to appeal has been or may be exercised&#59; (e) negligence of duty&#59; (f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">insubordination&#59; or (g) a violation of the Employer&#8217;s policy, procedure, or practice.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;    </font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean the Internal Revenue Code of 1986, as amended.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;  </font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Eligible Employee</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean an individual who is employed by the Employer on a regular basis in a non-store position and has been employed by the Employer in any position for a minimum of ninety (90) days prior to the individual&#8217;s separation of employment. For purposes of the Plan, distribution warehouse employees, field managers and employees employed by CVS ProCare, Inc. working at Company headquarters, shall be treated as working in a non-store location and therefore not subject to exclusion from eligibility. For purposes of the Plan, individuals in the following categories will not be considered Eligible Employees&#58;</font></div><div><font><br></font></div><div style="height:31.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6.55pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="padding-left:0.31pt;padding-right:0.31pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:119%">2 </font></div><div style="padding-left:5.3pt"><font style="color:#414141;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Proprietary</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:22.5pt;width:100%"><div style="padding-left:0.62pt;text-align:justify"><font><br></font></div></div><div style="padding-left:98.55pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">(a)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:34.59pt">individuals who are covered by a collective bargaining agreement, provided welfare benefits were the subject of bargaining, unless the terms of the collective bargaining agreement provide for participation in the Plan&#59;</font></div><div style="padding-left:134.55pt;padding-right:22.95pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:98.55pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:33.44pt">individuals who are seasonal employees, leased employees, independent contractors, temporary employees, or consultants&#59;</font></div><div style="margin-bottom:0.25pt;padding-left:36pt;padding-right:23.3pt;text-align:justify;text-indent:-0.5pt"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:134.55pt;padding-right:22.95pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:98.55pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:34.47pt">individuals who work for the Employer or an Affiliate in a store location of the Company or an Affiliate, or whose compensation is paid through or according to a store payroll, including but not limited to&#58; pharmacists, store managers, assistant store managers, crew, and pharmacy staff&#59;</font></div><div style="margin-bottom:0.25pt;padding-left:134.55pt;padding-right:22.95pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:98.55pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:33.55pt">individuals employed by MinuteClinic, L.L.C. or by any practitioner-owned entity managed by MinuteClinic, L.L.C.&#59;</font></div><div style="margin-bottom:0.25pt;padding-left:36pt;padding-right:23.3pt;text-align:justify;text-indent:-0.5pt"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:134.55pt;padding-right:22.95pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:98.55pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:34.47pt">the President and CEO of CVS Health Corporation&#59;</font></div><div style="margin-bottom:0.25pt;padding-left:134.55pt;padding-right:22.95pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:98.55pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:35.5pt">individuals employed in Puerto Rico&#59; and</font></div><div style="margin-bottom:0.25pt;padding-left:134.55pt;padding-right:22.95pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:98.55pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:34.13pt">individuals employed outside the United States of America.</font></div><div style="margin-bottom:0.25pt;padding-left:61.8pt;padding-right:26.3pt;text-align:justify;text-indent:-0.5pt"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.8pt;padding-right:26.3pt;text-align:justify;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">The decision of whether an individual falls into one of these categories and whether an individual is employed    by an Employer on a regular basis in a non-store position for a minimum of ninety (90) days shall be made by   the Employer in its sole discretion. Any individual who is excluded from being considered an Eligible Employee under the Plan shall be excluded from the Plan regardless of the individual&#8217;s reclassification by a government agency, including a reclassification by the Internal Revenue Service for tax withholding purposes.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.5</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:34pt">&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Employer</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean CVS Pharmacy, Inc., Caremark Rx, L.L.C. and Aetna Inc. and any current or future Affiliate thereof that does not maintain its own severance plan for employees of that Affiliate.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.6</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:34pt">&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">ERISA</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean the Employee Retirement Income Security Act of 1974, as amended.</font></div><div style="margin-bottom:7.15pt"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.7</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:34pt">&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exempt Employee</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean an Eligible Employee who is paid on a salaried basis for payroll purposes and classified in the sole discretion of the Employer under its normal classification procedures   as an exempt employee under the Fair Labor Standards Act.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.8pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.8</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:33.5pt">&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Involuntary Termination</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean an Eligible Employee&#8217;s termination of employment  with the Employer due to the unilateral action of the Employer, including but not limited to a termination as a result of the elimination of an Eligible Employee&#8217;s position due to a reorganization or changes in responsibilities,  a reduction in force, or a closing of the business unit in which the Eligible Employee works&#59; provided, however, that such Involuntary Termination constitutes a separation from service under Treasury Regulation Section 1.409A-1(h).  Notwithstanding the foregoing, an Eligible Employee will not have an Involuntary  Termination if the Eligible Employee&#58; (a) is terminated for Cause, as determined by the Employer  in  its  sole discretion&#59;  (b)  voluntarily  terminates  his or her  employment  at any time  or  resigns  prior  to  an Involuntary Termination&#59;    (c) takes a leave of absence&#59; (d) is administratively terminated for failure to return from a leave of absence upon expiration of his or her leave&#59; (e) terminates employment due to his or her death or disability&#59; (f) transfers to an Affiliate&#59; (g) transfers to a new employer in connection with the sale of an Employer facility&#59; or (h) fails to accept an offer for a job with the Employer that is comparable to the job that he or she is performing for the Employer at the time of the offer. For purposes of Subsection (h) of this Section 1.8, whether a job is considered &#8220;comparable&#8221; shall be determined in the sole discretion of the Employer, taking into account whether the new  job is located 50 or fewer miles from the Eligible Employee&#8217;s job at the time of the offer, whether the compensation offered is materially less than the Eligible Employee&#8217;s compensation at the time of the offer, and </font></div><div style="height:31.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6.55pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="padding-left:0.31pt;padding-right:0.31pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:119%">3 </font></div><div style="padding-left:5.3pt"><font style="color:#414141;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Proprietary</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:22.5pt;width:100%"><div style="padding-left:0.62pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:0.25pt;padding-left:61.8pt;padding-right:22.95pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">whether the new job will result in a substantial change of duties from the Eligible Employee&#8217;s job at the time of the offer. The determination of whether an Eligible Employee&#8217;s termination of employment is an Involuntary Termination shall be made in the sole discretion of the Employer. If an Employer deems an Eligible Employee&#8217;s termination of employment to be an Involuntary Termination and, Employer later learns of facts and circumstances that, had the Employer known such facts and circumstances at the time of termination, would   have resulted in a termination of employment for Cause, the Eligible Employee&#8217;s termination shall be deemed as of the date of termination to not have been an Involuntary Termination.</font></div><div style="margin-bottom:0.25pt;padding-left:97.8pt;padding-right:22.95pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.9</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:34pt">&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Non-exempt Employee</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean an Eligible Employee who is paid on an hourly basis    for time worked and classified in the sole discretion of the Employer under its normal classification procedures    as a non-exempt employee under the Fair Labor Standards Act.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.10</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:28.85pt">&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Administrator</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean the Senior Vice President of Human Resources of CVS Pharmacy, Inc., or such other person, designated by the Chief People Officer of the Company to act as the Plan Administrator.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.11</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:28.85pt">&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Rehire Date</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean the date an Eligible Employee accepts reemployment with any Employer.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.12</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:28.85pt">&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Severance Pay</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean the pay an Eligible Employee is eligible to receive under Subsection (b) of Section 2.1 of the Plan upon his or her Involuntary Termination.</font></div><div><font><br></font></div><div style="padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">1.13</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:28.85pt">&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Severance Period</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">&#8221; shall mean the period of time during which an Eligible Employee is  eligible to receive Severance Pay</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.14</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:28.85pt">&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Weekly Rate</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean, (a) with respect to an Eligible Employee paid on a salaried basis,   an Eligible Employee&#8217;s annual base salary (as determined by the Employer), as of the date of the Eligible Employee&#8217;s Involuntary Termination, expressed on a weekly basis (as determined in the sole discretion of the Employer), and (b) with respect to an Eligible Employee paid on an hourly basis, the hourly wage rate of the Eligible Employee as of the date of the Eligible Employee&#8217;s Involuntary Termination multiplied by the Eligible Employee&#8217;s regularly scheduled number of hours of service per week (as determined by the Employer), not in excess of 40 hours. Weekly Rate shall exclude any overtime, incentive, and bonus payments, unless otherwise required by law.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">1.15</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:28.85pt">&#8220;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Year of Service</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall mean each full year of service performed by the Eligible Employee    for an Employer as reflected in the records of the Employer and as determined as of the Eligible Employee&#8217;s   date of termination of employment, based on the Employer&#8217;s policies and procedures for determining periods of service, and the applicable law.</font></div><div style="margin-bottom:0.05pt"><font><br></font></div><div><font><br></font></div><div style="padding-left:151.85pt;padding-right:151.85pt;text-align:center;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:128%">ARTICLE 2</font></div><div style="padding-left:76.5pt;padding-right:76.5pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">SEVERANCE PAY AND ELIGIBLE EMPLOYEE BENEFITS</font></div><div style="margin-bottom:7.15pt"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:72.5pt;padding-right:22.95pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">2.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Eligibility</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. Upon his or her Involuntary Termination, an Eligible Employee may, in the discretion of the Plan Administrator, be granted Severance Pay and benefits provided under Subsections (b),  (c), and (d) of this Section 2.1, provided the conditions of Section 2.2 are satisfied. The determination of whether Severance Pay is payable under the Plan, and the form and amount of such pay, shall be made in the sole discretion of the Plan Administrator.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:72.5pt;padding-right:22.95pt;text-align:justify;text-indent:35.9pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.59pt;text-decoration:underline">Severance Pay</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. The Severance Pay payable to an Eligible Employee in the event of   Involuntary Termination shall be determined by the Plan Administrator in its, his or her sole discretion, using the guidelines set forth in Appendix A for the applicable Eligible Employee&#8217;s grade, as determined by the Employer. Notwithstanding such referenced guidelines, the Plan Administrator may increase or decrease (including, to zero) the amount of Severance Pay with respect to any Eligible Employee for reasons it, he or   </font></div><div style="height:31.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6.55pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="padding-left:0.31pt;padding-right:0.31pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:119%">4 </font></div><div style="padding-left:5.3pt"><font style="color:#414141;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Proprietary</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:22.5pt;width:100%"><div style="padding-left:0.62pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:0.25pt;padding-left:72.5pt;padding-right:22.95pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">she deems appropriate in its sole discretion at any time, whether before or after payments of Severance Pay have commenced (including, but not limited to, a decrease to take into account any debts owed to an Employer or a decrease if an Eligible Employee fails to satisfactorily perform his or her duties and is not on or has not completed a performance improvement plan at the time of termination of employment), at any time, whether before or after payments of Severance Pay have commenced. A special one-time lump sum payment shall be made with respect to each Eligible Employee who experienced an Involuntary Termination on or after January 1, 2021 and prior to October 11, 2021 equal to the difference, if any, between the Severance Pay payable to  such Eligible Employee under Appendix A as in effect upon his or her Involuntary Termination and the Severance Pay that would have been paid to him or her under Appendix A as in effect as of October 11, 2021.</font></div><div style="margin-bottom:0.25pt;padding-left:107.9pt;padding-right:23.1pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;padding-right:23.1pt;text-align:justify;text-indent:35.9pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">(c)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:25.12pt;text-decoration:underline">COBRA Assistance</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">.  In the event an Eligible Employee who has an Involuntary Termination</font></div><div style="margin-bottom:0.25pt;padding-left:79.5pt;padding-right:22.95pt;text-align:justify;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(i) is eligible to elect continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 as amended (&#8220;COBRA&#8221;) in accordance with the terms of the medical and prescription drug plan and&#47;or dental plan of the Employer and (ii) properly and timely elects such continuation coverage, the Employer   may pay for a portion of the cost of COBRA coverage equivalent to the contribution which the Employer makes on behalf of similarly situated active employees under such plan for the appropriate tier of coverage selected and in place immediately prior to the date of the Eligible Employee&#8217;s Involuntary Termination (</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">, employee-only, family coverage), for a period determined in the sole discretion of the Plan Administrator, which generally shall be the Severance Period but in any event no longer than eighteen (18) months from the date of the Involuntary Termination. Any COBRA assistance provided under this Subsection (c) shall be   paid by the Employer directly to the insurance carrier, if applicable. The portion of the COBRA premium   not covered by the COBRA assistance specified in this Subsection (c) must be paid by the Eligible Employee directly to the insurance carrier or service provider that administers COBRA, as applicable, based on the standard rules under the respective plan for payment of COBRA premiums. This Subsection (c) does not provide COBRA assistance in the event the Eligible Employee fails to properly and timely elect COBRA continuation coverage, regardless of whether his or her covered dependents elect COBRA continuation coverage.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:79pt;padding-right:22.95pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Outplacement Services</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. Upon an Involuntary Termination, the outplacement services   provided to an Eligible Employee shall be provided in the sole discretion of the Plan Administrator based    on the guidelines contained in this Subsection (d).</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:115pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.09pt">If an Eligible Employee so desires, he or she may be eligible for outplacement   services for assistance in obtaining new employment, provided through a vendor selected by the Employer, with the Employer directly providing payment to such vendor. The provision of outplacement services is contingent upon the Eligible Employee&#8217;s cooperation with the   outplacement service vendor, upon the active efforts of the Eligible Employee to locate a new position, and upon the Eligible Employee initiating outplacement services during the Severance Period.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:115pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.58pt">Subject to the requirements of Paragraph (i) of this Subsection (d), outplacement services shall be offered for a period of time determined in the sole discretion of the Plan Administrator, based on the guidelines set forth in Appendix A for the applicable Eligible  Employee&#8217;s grade, as determined by the Employer, provided that in no event shall such services extend beyond twelve (12) months following the Involuntary Termination of the Eligible Employee.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:76.5pt;padding-right:23.2pt;text-align:justify;text-indent:35.9pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.62pt;text-decoration:underline">Form and Timing of Payment</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. In the event an Eligible Employee is awarded Severance Pay under the terms of Subsection (a) of this Section 2.1, such Severance Pay shall be paid following an Eligible Employee&#8217;s Involuntary Termination (except as provided in Section 2.3, below), as follows&#58; No Severance    Pay shall commence (with respect to salary continuation payments) or be paid (with respect to a lump sum)    (i) prior to the expiration of the later of a period that is identified in a severance agreement with the Eligible Employee during which he or she may consider the execution of the release of claims form (the &#8220;Consideration Period&#8221;) or a period ending at least seven (7) days following the execution of the release of claims form (the &#8220;Revocation Period&#8221;), or (ii) later than sixty (60) days following the date of  Eligible  Employee&#8217;s  Involuntary  Termination.    Severance Pay that is paid in the form of salary continuation shall </font></div><div style="height:31.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6.55pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="padding-left:0.31pt;padding-right:0.31pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:119%">5 </font></div><div style="padding-left:5.3pt"><font style="color:#414141;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Proprietary</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:22.5pt;width:100%"><div style="padding-left:0.62pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:0.25pt;padding-left:76.5pt;padding-right:23.2pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">commence as soon as feasible following expiration of the later of the Consideration Period or the Revocation Period, which generally shall be the first regularly scheduled payroll date following the expiration of the Consideration Period or the Revocation Period, as the case may be, and shall thereafter be paid in substantially equal installments in accordance with the Employer&#8217;s regular payroll practice, except as provided in Section  2.3 of the Plan, except that the first installment paid after the expiration of the later of the Consideration Period or the Revocation Period shall include, on a retroactive basis, all installments that would have been  paid had they started as soon as administratively feasible after the date of the Eligible Employee&#8217;s Involuntary Termination. It is the intent of the Plan that the Severance Period in all cases be measured from the date of  the Eligible Employee&#8217;s Involuntary Termination. Further, in the Plan Administrator&#8217;s sole discretion, Severance Pay may be paid to any Eligible Employees in a single lump sum, in which event Severance Pay  shall be paid within the period that satisfies the 409A requirements for short-term deferrals under Section 409A of the Code.</font></div><div style="margin-bottom:0.25pt;padding-left:112.4pt;padding-right:23.2pt;text-align:justify"><font><br></font></div><div style="padding-left:76.5pt;padding-right:23.2pt;text-align:justify;text-indent:35.9pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">(f)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:21.65pt;text-decoration:underline">Withholding</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">. Any payment of Severance Pay to an Eligible Employee shall be subject              to normal withholding for state and federal income taxes and Social Security taxes.</font></div><div style="margin-bottom:0.25pt;padding-left:79.85pt;padding-right:22.95pt;text-align:justify;text-indent:-0.5pt"><font><br></font></div><div style="padding-left:79.85pt;padding-right:22.95pt;text-align:justify;text-indent:35.9pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">(g)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:16.93pt;text-decoration:underline">Death</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">.&#160;&#160;&#160;&#160;Upon the death of the Eligible Employee who had an Involuntary Termination and who has not received all Severance Pay payable under the Plan, the Severance Pay otherwise payable under Section 2.1(b) of the Plan shall be paid in the form of a lump sum to the Eligible Employee&#8217;s surviving legal spouse or, if there is no surviving legal spouse, to the Eligible Employee&#8217;s estate as soon as practicable, but    in no event later than 60 days following death. Any other severance benefits provided under this Section 2.1 (COBRA assistance and outplacement services) shall cease upon the Eligible Employee&#8217;s death.</font></div><div><font><br></font></div><div style="padding-left:90pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">2.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Conditions on Payment of Severance Pay and Benefits</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">. Payment of the Severance Pay and   benefits provided in Section 2.1 of the Plan shall be subject to and conditioned upon the following&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:112.5pt;padding-right:23.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.64pt">to the extent an Eligible Employee receives notice of a date selected by the Employer (in its sole discretion) on which the Eligible Employee&#8217;s Involuntary Termination shall occur (a &#8220;Designated Termination Date&#8221;), the Eligible Employee must continue to work in a satisfactory manner until his or her Designated Termination Date&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:112.5pt;padding-right:23.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">(b)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:19.49pt">the Eligible Employee must cooperate in transitioning all of the Eligible Employee&#8217;s work in consultation with the Eligible Employee&#8217;s supervisor or other designated employee&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:112.5pt;padding-right:23.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.52pt">the Eligible Employee must execute and deliver a severance agreement that includes    a release of claims, which agreement shall be in a form specified by the Employer from time to time, which may include restrictive covenants and a waiver as described in Subsection (d) of this Section  2.2) within the  time period specified under the terms of the applicable severance offer.  Further, in  no event will Severance Pay be paid with respect to an Eligible Employee in the event the release of claims form is revoked during the Revocation Period (described in Section 2.1(e) of the Plan)&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:112.5pt;padding-right:23.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.6pt">the Eligible Employee must waive the right to receive any other severance payment relating to salary continuation or salary replacement the Eligible Employee may otherwise be eligible to receive upon termination of employment under any employment agreement, severance plan, practice, policy or program of the Employer or an Affiliate.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:90pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">2.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Maximum Severance Pay</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding any other provisions to the contrary, benefits</font></div><div style="margin-bottom:0.25pt;padding-left:61.8pt;padding-right:22.95pt;text-align:justify;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">paid hereunder (a) shall not exceed two times the lesser of (i) the Eligible Employee&#8217;s Compensation (as defined  in this Section 2.3) during the calendar year immediately preceding the Eligible Employee&#8217;s Involuntary Termination or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code for the calendar year in which the Eligible Employee&#8217;s Involuntary Termination occurs and (b) shall be paid in full within twenty-four (24) months after the date the Eligible Employee&#8217;s Involuntary Termination occurs. In the event that any Severance Pay payable to an Eligible Employee would exceed the twenty-four (24) month period provided in the foregoing sentence if the Severance Pay continued to  </font></div><div style="height:31.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6.55pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="padding-left:0.31pt;padding-right:0.31pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:119%">6 </font></div><div style="padding-left:5.3pt"><font style="color:#414141;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Proprietary</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:22.5pt;width:100%"><div style="padding-left:0.62pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:0.25pt;padding-left:61.8pt;padding-right:22.95pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">be paid in accordance with the Employer&#8217;s regular payroll practice, any Severance Pay that would otherwise  exceed the twenty-four (24) month time period will be paid to the Eligible Employee in a lump sum on the last regular payroll date within the twenty-four (24) month period. For purposes of this Section 2.3, &#8220;Compensation&#8221; shall mean the Eligible Employee&#8217;s total annualized compensation, based upon the annual rate of pay for services provided to the Employer for the calendar year preceding the calendar year in which the Eligible Employee&#8217;s Involuntary Termination occurs, adjusted for any increase in such preceding calendar year that was expected to continue indefinitely if the Eligible Employee had not had an Involuntary Termination.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">2.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Cessation of Severance Pay Upon Reemployment</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. If an Eligible Employee who had an Involuntary Termination and who is receiving Severance Pay thereafter accepts reemployment with any Employer during the Severance Period, such Employee&#8217;s Severance Pay shall cease on the Rehire Date and any remaining Severance Pay shall be forfeited.</font></div><div style="margin-bottom:0.3pt"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">2.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Cessation of Severance Pay After Commencement of Payments</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. If an Eligible Employee is deemed to have an Involuntary Termination and begins to receive Severance Pay under the Plan and the  Employer or the Plan Administrator becomes aware of facts and circumstances that, had the Employer known same at the time of the Eligible Employee&#8217;s termination of employment, would have affected the Employer&#8217;s determination as to whether such Employee&#8217;s termination was an Involuntary Termination, the Plan  Administrator may suspend any future Severance Pay payments to the Eligible Employee while the Employer investigates the facts and circumstances and finalizes such investigation, and, if the Employer determines that the Eligible Employee should have been terminated for Cause, such Eligible Employee&#8217;s Severance Pay shall cease    as of the suspension date, any remaining Severance Pay shall be forfeited and any Severance Pay that has been  paid shall be subject to repayment by the Eligible Employee.</font></div><div style="margin-bottom:0.3pt"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">2.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Impact of Debt on Severance Pay</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. In the event an Eligible Employee is indebted to the  Company or Employer (determined in the sole discretion of the Company or Employer, as applicable), the Plan Administrator reserves the right to reduce, offset, withhold, and&#47;or forfeit the Severance Pay otherwise payable under the Plan.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">2.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Employee Benefits</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. As of the date of an Eligible Employee&#8217;s Involuntary Termination, the Eligible Employee&#8217;s active participation in any benefit plan, program, or policy sponsored or subsidized by the Employer shall cease, unless otherwise continued pursuant to the terms of such plan, program or policy.</font></div><div style="margin-bottom:0.45pt"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">2.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Awards</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. Any award or grant made to the Eligible Employee under any stock option, stock purchase, or stock appreciation rights plan of the Company or Employer shall be administered and interpreted     in accordance with the terms of the applicable plan documents.</font></div><div style="margin-bottom:0.3pt"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">2.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Paid Time Off</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. Any pay for accrued paid time off shall be determined under the terms of         the Employer's applicable policies</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">2.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Bonuses</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. Whether any bonuses or other incentive payments are payable to an Eligible    Employee shall be determined based on the terms of any applicable bonus or incentive program, plan, or policy.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">2.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Benefits Not Vested</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. No one under any circumstance is automatically entitled to Severance      Pay or benefits described in Section 2.1 of the Plan. Notwithstanding anything in the Plan to the contrary, the  Plan Administrator reserves the right, at its, his or her sole discretion, to increase, decrease, or eliminate Severance Pay and benefits under the Plan.</font></div><div><font><br></font></div><div style="padding-left:46.17pt;padding-right:46.17pt;text-align:center;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:128%">ARTICLE 3 </font></div><div style="padding-left:22.87pt;padding-right:22.87pt;text-align:center;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">ADMINISTRATION OF THE PLAN</font></div><div style="margin-bottom:8.95pt"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">3.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Control and Administration</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding any other provision in the Plan, and to the full extent permitted under ERISA and the Internal Revenue Code, the Plan Administrator shall  have  the exclusive right, power and final authority, in its, his or her sole and absolute discretion, to administer, apply, construe and </font></div><div style="height:31.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6.55pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="padding-left:0.31pt;padding-right:0.31pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:119%">7 </font></div><div style="padding-left:5.3pt"><font style="color:#414141;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Proprietary</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:22.5pt;width:100%"><div style="padding-left:0.62pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">interpret the terms of the Plan and all  related  plan  documents  and  all  facts  surrounding claims for benefits under the Plan and shall determine all questions arising in the administration, interpretation and application of   the Plan, including, but not limited to, those concerning eligibility for benefits. Accordingly, benefits under the Plan shall be paid only if the Plan Administrator decides in its, his or her sole discretion that an Eligible Employee is entitled to benefits, and the Plan Administrator shall decide all questions regarding the form, amount and duration of benefits. The Plan Administrator may consult with attorneys, consultants and other persons for  advice, counsel and reports to make determinations under the Plan, and the Plan Administrator may delegate its administrative duties and responsibilities to persons or entities of its choice, in all cases who may be employees    of the Company. All determinations of the Plan Administrator shall be conclusive and binding on all parties. The Plan Administrator shall be the named fiduciary of the Plan for purposes of ERISA.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:97.8pt;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">3.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">Claim Procedures</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">.</font></div><div style="margin-bottom:7.25pt"><font><br></font></div><div style="margin-bottom:1.35pt;padding-left:57.5pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">(a)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:3.64pt;text-decoration:underline">Procedure for Granting or Denying Claims</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">.  An Eligible Employee, or his or her duly authorized representative, may file a claim for payment of benefits under the Plan within 30 days after termination of employment. Such a claim must be made in writing and be delivered to the Plan Administrator, in person or by mail, postage paid. Within 90 days after receipt of such claim, the Plan Administrator shall notify the claimant of the granting or denying, in whole or in part, of such claim, unless special circumstances require an extension of  time for processing the claim. In no event may the extension exceed 90 days from the end of the initial 90-day period. If such extension is necessary, the claimant will be given a written notice to this effect prior to the expiration of the initial 90-day period. The Plan Administrator shall have full discretion to deny or grant a claim    in whole or in part.</font></div><div><font><br></font></div><div style="padding-left:50.5pt;padding-right:23.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">(b)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:9.49pt;text-decoration:underline">Requirement for Notice of Claim Denial</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">. The Plan Administrator shall provide to every             claimant who is denied a claim for benefits a written or electronic notice setting forth in a manner calculated to       be understood by the claimant&#58;</font></div><div><font><br></font></div><div style="padding-left:151.3pt;padding-right:33.75pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:128%">(i)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:128%;padding-left:27.14pt">The specific reason or reasons for the denial&#59;</font></div><div><font><br></font></div><div style="padding-left:151.3pt;padding-right:33.75pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">(ii)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:24.63pt">Specific reference to pertinent Plan provisions on which the denial is based&#59;</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:151.3pt;padding-right:33.75pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.12pt">A description of any additional material or information necessary for the claimant to perfect the claim and an explanation of why such material is necessary&#59; and </font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:151.3pt;padding-right:33.75pt;text-align:justify;text-indent:-36.05pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.99pt">An explanation of the Plan&#8217;s claim review procedures and the time limits applicable to such procedures, including a statement of the claimant&#8217;s right to bring a civil action under Section 502(a) of ERISA following an adverse determination on review. </font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:50.5pt;padding-right:23.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.52pt;text-decoration:underline">Right to Appeal on Claim Denial</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. Within 60 days after receipt by the claimant of written or electronic notification of the denial (in whole or in part) of his or her claim, the claimant or his or her duly authorized representative may make a written application to the Plan Administrator, in person or by certified mail, postage prepaid, to be afforded a full and fair review of such denial. The claimant or his or her duly authorized representative may submit written comments, documents, records, and other information relating to the claim for benefits. Moreover, the claimant or his or her duly authorized representative shall be provided, upon request and free of charge, reasonable access to, and copies of, all documents, records, and other information relevant to the claimant&#8217;s claim for benefits.</font></div><div><font><br></font></div><div style="margin-bottom:1.75pt;padding-left:50.5pt;padding-right:23.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.6pt;text-decoration:underline">Disposition of Disputed Claims</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. Upon receipt of a request for review, the Plan Administrator shall make a decision on the claim. The review shall take into account all comments, documents, records, and other information submitted by the claimant relating to the claim, without regard to whether such information was submitted or considered in the initial benefit determination. The decision on review shall be made not later than 60 days after the Plan Administrator's receipt of a request for a review, unless special circumstances require an  extension of time for processing, in which case a decision shall be rendered not later than 120 days after receipt of </font></div><div style="height:31.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6.55pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="padding-left:0.31pt;padding-right:0.31pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:119%">8 </font></div><div style="padding-left:5.3pt"><font style="color:#414141;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Proprietary</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:22.5pt;width:100%"><div style="padding-left:0.62pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:1.75pt;padding-left:50.5pt;padding-right:23.1pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">the request for review. If an extension is necessary, the claimant shall be given written notice of the extension prior to the expiration of the initial 60-day period.</font></div><div style="padding-left:14.5pt;padding-right:23.1pt;text-align:justify;text-indent:54pt"><font><br></font></div><div style="padding-left:49.5pt;text-indent:63pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%">The Plan Administrator shall provide the claimant or his or her duly authorized representative with    written or electronic notification of the Plan Administrator&#8217;s determination on review. In the case of an adverse determination, the notification shall set forth, in a manner calculated to be understood by the claimant, the specific   reason or reasons for the decision as well as specific references to the Plan provisions on which the decision was       based. The decision shall also include a statement that the claimant is entitled to receive, upon request and free of     charge, reasonable access to, and copies of, all documents, records, and other information relevant to the             claimant&#8217;s claim for benefits. Moreover, the decision shall contain a statement of the claimant&#8217;s right to bring an         action under Section 502(a) of ERISA.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.3</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:34pt;text-decoration:underline">Conditions to Legal Action. </font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">No legal action may be commenced or maintained against the Plan, the Company or any Employer prior to the claimant&#8217;s exhaustion of the claims procedures set forth in Section 3.2 of the Plan. In addition, no legal action may be commenced against the Plan more than ninety (90) days after the Plan Administrator&#8217;s final claim determination on review pursuant to Section 3.2(d) of the Plan.  Any legal action must be conducted in the United States District Court for Rhode Island.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">3.4</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:34pt;text-decoration:underline">Named Fiduciary</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. The Plan Administrator of the Plan shall be the Named Fiduciary of the Plan for purposes of ERISA Section 402(a)(1).</font></div><div style="padding-left:42.45pt;padding-right:42.45pt;text-align:center;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:128%">ARTICLE 4 </font></div><div style="padding-left:18.6pt;padding-right:18.6pt;text-align:center;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%;text-decoration:underline">MISCELLANEOUS</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div><div style="margin-bottom:7.25pt"><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">4.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;  </font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Amendment or Termination</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. The Plan may be amended, terminated, withdrawn or suspended   at any time in writing by the Management Planning and Development Committee of the Company or any individual designated by such Committee to take such actions.</font></div><div style="margin-bottom:0.45pt"><font><br></font></div><div style="padding-left:61.3pt;padding-right:22.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">4.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Choice of Law</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. The validity, interpretation, construction and performance of the obligations created under the Plan shall be governed by ERISA, and to the extent not preempted by federal law, the laws of  the State of Rhode Island without regard to its conflicts of law principles.</font></div><div><font><br></font></div><div style="padding-left:61.3pt;padding-right:22.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">4.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Validity</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. The invalidity or unenforceability of any provision of the Plan shall not affect the  validity or enforceability of any other provision of the Plan, which shall remain in full force and effect.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">4.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Exclusive Source of Rights</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. The Plan contains all of the terms and conditions with      respect to the benefits provided hereunder, and no employee or former employee of the Company or any Employer may rely on any  other  communication  or  representation,  whether  oral  or  written,  of  the Company or any Employer or  any  of  its subsidiaries, or any officer or employee thereof, as creating any right or obligation not expressly provided by the Plan.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">4.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Non-assignability</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. No benefit which shall be payable under the Plan to any Eligible Employee shall be subject in any manner to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, or charge (except as required by law), and any attempt to anticipate, alienate, sell, transfer, assign, pledge, encumber, or charge a benefit shall be null and void. No benefit shall in any manner be liable for, or subject to, the debts, contracts, liabilities, engagements, or torts of any Eligible Employee. No benefit shall be subject to legal attachment or legal process for, or against, the Eligible Employee and the same shall not be recognized under the Plan. Notwithstanding the preceding sentence, the Employer retains the discretion, in accordance with federal and&#47;or state laws, to reduce the amount of benefits payable under the Plan to any Eligible Employee to recover any amounts that the Eligible Employee owes to the Employer.</font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">4.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">No Employment Rights</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. The Plan shall not give any Eligible Employee any right or claim    except to the extent that the right is specifically provided under the terms of the Plan. The establishment of the Plan shall not be construed (a) to give any Eligible Employee a right to continue in the employ of the Employer  </font></div><div style="height:31.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6.55pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="padding-left:0.31pt;padding-right:0.31pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:119%">9 </font></div><div style="padding-left:5.3pt"><font style="color:#414141;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Proprietary</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:22.5pt;width:100%"><div style="padding-left:0.62pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:0.25pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">or (b) to interfere with the right of the Employer to terminate the employment of any Eligible Employee at any time.</font></div><div style="margin-bottom:0.45pt"><font><br></font></div><div style="padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">4.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Headings</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. Article and section headings are for convenience only and the language of the         Plan itself will be controlling.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:35.99pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">4.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Gender and Numbers</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  Masculine pronouns include the feminine as well as the neuter       genders, and the singular shall include the plural, unless indicated otherwise by the context.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:61.3pt;padding-right:22.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">4.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Code Section 409A</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">. The benefits provided under the terms of the Plan are intended to fall</font></div><div style="margin-bottom:13.6pt;padding-left:61.8pt;padding-right:22.95pt;text-align:justify;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">within the short-term deferral exception, the separation pay exception or another exception to the application of Section 409A of the Code and the applicable guidance issued thereunder. In furtherance of this intent, the Plan shall be interpreted, operated and administered in a manner consistent with this intention. To the extent the benefits provided under the Plan become subject to Code Section 409A and applicable guidance issued thereunder, the Plan shall be construed, and benefits paid hereunder, as necessary to comply with Section 409A   of the Code and such guidance. Further, to the extent that an Eligible Employee becomes entitled to receive Severance Pay under the terms of the Plan, and, at the time of the Eligible Employee&#8217;s Involuntary Termination, he or she is a &#8220;specified employee&#8221; within the meaning of Treasury Regulation Section 1.409A- 1(i), any portion  of Severance Pay payable to such Eligible Employee that is subject to Code Section 409A and applicable guidance thereunder shall be delayed until the date that is the earlier of (i) the Eligible Employee&#8217;s death or (ii) six months following the date of the Eligible Employee&#8217;s Involuntary Termination, at which time the payments that were delayed for such six month period shall be paid in a lump sum on the date of the next occurring regular payroll date of the Employer, and any remaining payments shall  be  paid according to the original schedule provided herein. In addition, each payment of a salary continuation stream of installment payments hereunder shall be a separate payment for purposes of Section 409A of the Code.</font></div><div style="margin-bottom:14.6pt;padding-left:61.3pt;padding-right:22.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">4.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Funding</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">.  The Plan is not funded, and Severance Pay and benefits under the Plan are paid      from the general assets of the Employer.</font></div><div style="margin-bottom:14.6pt;padding-left:61.3pt;padding-right:22.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">4.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Plan Year. </font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">The Plan&#8217;s records shall be maintained on the basis of the calendar year.</font></div><div style="margin-bottom:15.6pt;padding-left:57.5pt;padding-right:22.95pt;text-align:justify;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Management Planning and Development Committee of the Company, or its duly authorized delegate, has amended the Plan as of the Effective Date pursuant to the execution hereof on its behalf by a duly authorized officer on October 11</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">,</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:120%"> 2021.</font></div><div style="margin-bottom:4.85pt;padding-left:117.45pt;padding-right:117.45pt;text-align:center;text-indent:-0.5pt"><font><br></font></div><div style="padding-left:67.97pt;padding-right:67.97pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.594%"><tr><td style="width:1.0%"></td><td style="width:3.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.796%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.660%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.447%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:0 1pt 0 3.77pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:700;line-height:125%">CVS HEALTH CORPORATION</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:125%">By&#58; </font></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:125%">&#47;s&#47; Laurie P. Havanec</font></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:125%">Date&#58; </font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:125%">October, 26, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:125%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Garamond',serif;font-size:12pt;font-weight:400;line-height:125%">EVP and Chief People Officer</font></td></tr></table></div><div style="padding-left:30.03pt;padding-right:30.03pt;text-align:center"><font><br></font></div><div style="padding-left:30.03pt;padding-right:30.03pt;text-align:center"><font><br></font></div><div style="padding-left:30.03pt;padding-right:30.03pt;text-align:center"><font><br></font></div><div style="padding-left:30.03pt;padding-right:30.03pt;text-align:center"><font><br></font></div><div style="padding-left:30.03pt;padding-right:30.03pt;text-align:center"><font><br></font></div><div style="padding-left:30.03pt;padding-right:30.03pt;text-align:center"><font><br></font></div><div style="padding-left:30.03pt;padding-right:30.03pt;text-align:center"><font><br></font></div><div style="padding-left:30.03pt;padding-right:30.03pt;text-align:center"><font><br></font></div><div style="padding-left:30.03pt;padding-right:30.03pt;text-align:center"><font><br></font></div><div style="padding-left:30.03pt;padding-right:30.03pt;text-align:center"><font><br></font></div><div style="padding-left:30.03pt;padding-right:30.03pt;text-align:center"><font><br></font></div><div style="padding-left:30.03pt;padding-right:30.03pt;text-align:center"><font><br></font></div><div style="padding-left:30.03pt;padding-right:30.03pt;text-align:center"><font><br></font></div><div style="height:31.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6.55pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="padding-left:0.31pt;padding-right:0.31pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:119%">10 </font></div><div style="padding-left:5.3pt"><font style="color:#414141;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Proprietary</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:22.5pt;width:100%"><div style="padding-left:0.62pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:0.15pt;padding-left:155.87pt;padding-right:155.87pt;text-align:center;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:700;line-height:122%">Appendix A</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:122%"> </font></div><div style="margin-bottom:0.15pt;padding-left:155.87pt;padding-right:155.87pt;text-align:center;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:700;line-height:122%">Amount of Severance Pay and Outplacement </font></div><div style="padding-left:68.46pt;padding-right:68.46pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:700;line-height:119%">Services, effective as of October 11, 2021</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:119%"> </font></div><div><font><br></font></div><div style="margin-bottom:0.25pt;padding-left:39.25pt;text-align:justify;text-indent:-0.5pt"><font style="color:#000000;font-family:'Garamond',serif;font-size:10pt;font-weight:400;line-height:120%">Severance Pay is the Weekly Rate payable for the number of weeks listed below, determined by Grade and Years of Service (YOS) </font></div><div style="padding-left:19.15pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:5.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.925%"></td><td style="width:0.1%"></td></tr><tr style="height:36pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.95pt;padding-left:0.3pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.5pt;font-weight:400;line-height:125%">&#160;</font></div><div style="padding-left:0.3pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></div><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Tier 1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.95pt;padding-left:0.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.5pt;font-weight:400;line-height:125%">&#160;</font></div><div style="padding-left:0.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></div><div style="padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Tier 2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.95pt;padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.5pt;font-weight:400;line-height:125%">&#160;</font></div><div style="padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></div><div style="padding-left:1.15pt;padding-right:1.15pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Tier 3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.95pt;padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.5pt;font-weight:400;line-height:119%">&#160;</font></div><div style="padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:119%">&#160;</font></div><div style="padding-left:1.22pt;padding-right:1.22pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:119%">Tier 4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> </font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.95pt;padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.5pt;font-weight:400;line-height:119%">&#160;</font></div><div style="padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:119%">&#160;</font></div><div style="padding-left:1.22pt;padding-right:1.22pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:119%">Executive Tier 1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> </font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.95pt;padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.5pt;font-weight:400;line-height:119%">&#160;</font></div><div style="padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:119%">&#160;</font></div><div style="padding-left:1.22pt;padding-right:1.22pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:119%">Executive Tier 2 </font></div></td></tr><tr style="height:70pt"><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.55pt;padding-right:2.55pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Grades 101, 102, 103, 104, 105, 106, 550, 551, 552, 652, 752</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.55pt;padding-right:3.55pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Grades 107, 108,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">201, 202, 203, 301, 302, 405, 406, 407, 408, 553, 554, 653, 753, 654, 754</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.62pt;padding-right:0.62pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Grades 109, 110, 111, 204, 205, 303, 304, 409, 410, 411, 555, 556, 557, 558, 655, 656, 657, 658, 755, 756, 757, 758</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.97pt;padding-right:0.97pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Grades 112, 206, 305, 412, 559, 560, 659, 759</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.6pt;padding-right:2.6pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Grades 36 A-Z, 70G</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.5pt;padding-right:3.5pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Grades 38 A-Z, 39 A-Z, 71G, 72G</font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.22pt;padding-right:1.22pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Full</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">YOS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Number of</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Weeks</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Number of</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Weeks</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13pt;font-weight:400;line-height:125%">&#160;</font></div><div style="padding-left:1.05pt;padding-right:1.05pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Number of Weeks</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Number of</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Weeks</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Number of</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Weeks</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.22pt;padding-right:0.22pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Number of</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Weeks</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">0 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">4 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">13 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">1 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">4 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">6 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">13 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.9pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">*52 or 78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">6 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">8 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">13 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">3 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">8 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">10 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">13 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">4 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">10 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">12 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">13 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">5 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">12 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">14 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">14 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">6 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">13 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">16 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">16 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">7 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">13 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">18 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">18 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">8 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">13 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">20 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">20 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">9 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">13 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">20 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">20 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">10 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">13 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">20 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">20 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">11 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">13 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">20 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">21 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">12 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">13 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">20 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">22 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">13 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">13 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">20 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">23 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">14 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">14</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">20 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">24 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">15 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">15</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">20 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">25 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">28 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">16 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">16</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">21</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">29 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">17 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">17</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">22</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">30 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">18 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">18</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">23</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">31 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">19 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">19</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">24</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">32 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">20 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">20</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">25</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">33 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">21 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">21</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">34 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">22 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">22</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">35 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">23 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">23</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">36 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">24 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">24</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">37 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">25 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">25</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">38 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">27</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">39 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">27 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">28</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">39 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52 </font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78 </font></div></td></tr><tr><td colspan="3" style="border-bottom:0.75pt solid #000;border-left:0.9pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">28</font></div></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">29</font></div></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">39</font></div></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52</font></div></td><td colspan="3" style="border-bottom:0.75pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78</font></div></td></tr></table></div><div style="height:31.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6.55pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="padding-left:0.31pt;padding-right:0.31pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:119%">11 </font></div><div style="padding-left:5.3pt"><font style="color:#414141;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Proprietary</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%"> </font></div></div></div><hr style="page-break-after:always"><div style="min-height:22.5pt;width:100%"><div style="padding-left:0.62pt;text-align:justify"><font><br></font></div></div><div style="padding-left:19.15pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:5.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.875%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:0.75pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">29</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">30</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">39</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font><br></font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.95pt;padding-left:0.3pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.5pt;font-weight:400;line-height:125%">&#160;</font></div><div style="padding-left:0.3pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></div><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Tier 1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.95pt;padding-left:0.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.5pt;font-weight:400;line-height:125%">&#160;</font></div><div style="padding-left:0.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></div><div style="padding-left:1.2pt;padding-right:1.2pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Tier 2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.95pt;padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.5pt;font-weight:400;line-height:125%">&#160;</font></div><div style="padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></div><div style="padding-left:1.32pt;padding-right:1.32pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Tier 3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.95pt;padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.5pt;font-weight:400;line-height:125%">&#160;</font></div><div style="padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></div><div style="padding-left:1.27pt;padding-right:1.27pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Tier 4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.95pt;padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.5pt;font-weight:400;line-height:119%">&#160;</font></div><div style="padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:119%">&#160;</font></div><div style="padding-left:1.27pt;padding-right:1.27pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:119%">Executive Tier 1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:119%"> </font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.95pt;padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.5pt;font-weight:400;line-height:119%">&#160;</font></div><div style="padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:119%">&#160;</font></div><div style="padding-left:1.27pt;padding-right:1.27pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:119%">Executive Tier 2</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font><br></font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Grades 101, 102, 103, 104, 105, 106, 550, 551, 552, 652, 752</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.2pt;padding-right:1.2pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Grades 107, 108,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">201, 202, 203, 301, 302, 405, 406, 407, 408, 553, 554, 653, 753, 654, 754</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.32pt;padding-right:1.32pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Grades 109, 110, 111, 204, 205, 303, 304, 409, 410, 411, 555, 556, 557, 558, 655, 656, 657, 658, 755, 756, 757, 758</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.27pt;padding-right:1.27pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Grades 112, 206, 305, 412, 559, 560, 659, 759</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.27pt;padding-right:1.27pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Grades 36 A-Z, 70G</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.2pt;padding-right:1.2pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Grades 38 A-Z, 39 A-Z, 71G, 72G</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:0.75pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Full YOS</font></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:0.75pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Number of Weeks</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.2pt;padding-right:1.2pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Number of Weeks</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.32pt;padding-right:1.32pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Number of Weeks</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.27pt;padding-right:1.27pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Number of Weeks</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.27pt;padding-right:1.27pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Number of Weeks</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.2pt;padding-right:1.2pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Number of Weeks</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">30</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">31</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">39</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">31</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">32</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">39</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">32</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">33</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">39</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">33</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">34</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">39</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">34</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">35</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">39</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">35</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">36</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">39</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">36+</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.65pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">39</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">39</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.55pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">52</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.4pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">78</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.3pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:119%">&#160;</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:119%">&#160;&#160;6-Week Virtual </font></div><div style="padding-left:1.3pt;padding-right:1.3pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Outplacement</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:119%"> </font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:119%">&#160;</font></div><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:119%">3-Month Virtual </font></div><div style="padding-left:1.35pt;padding-right:1.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:119%">Outplacement</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:119%"> </font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.4pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:125%">3-Month Professional Outplacement</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.2pt;padding-right:1.2pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:125%">3-Month</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="padding-left:1.2pt;padding-right:1.2pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Professional </font></div><div style="padding-left:1.2pt;padding-right:1.2pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Outplacement</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.2pt;padding-right:1.2pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:125%">6-Month</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="padding-left:1.25pt;padding-right:1.25pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Executive </font></div><div style="padding-left:0.35pt;padding-right:0.35pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Outplacement</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.12pt;padding-right:1.12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:125%">6-Month</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="padding-left:1.15pt;padding-right:1.15pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Executive </font></div><div style="padding-left:0.3pt;padding-right:0.3pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Outplacement</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div></td></tr></table></div><div style="margin-bottom:0.55pt"><font><br></font></div><div style="margin-bottom:18.35pt;padding-left:139.45pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">* </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Under 18 months of service receives 52 weeks</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:125%"> </font></div><div style="height:31.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6.55pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> </font></div><div style="padding-left:0.31pt;padding-right:0.31pt;text-align:center"><font style="color:#000000;font-family:'Garamond',serif;font-size:11pt;font-weight:400;line-height:119%">12 </font></div><div style="padding-left:5.3pt"><font style="color:#414141;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Proprietary</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%"> </font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.55
<SEQUENCE>5
<FILENAME>exhibit1055-2021.htm
<DESCRIPTION>EX-10.55
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ie0dda61d5c98404287d139e92560e95f_1"></div><div style="min-height:58.32pt;width:100%"><div style="margin-top:0.06pt;padding-left:360pt;text-align:right"><font><br></font></div><div style="margin-top:0.06pt;padding-left:360pt;text-align:right"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.55</font></div></div><div style="margin-top:6pt"><img alt="cvshealthlogo1.jpg" src="cvshealthlogo1.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:221px"></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CVS HEALTH CORPORATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NONQUALIFIED STOCK OPTION AGREEMENT </font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GRANT DATE&#58;  &#91;MERGED FIELD&#93;</font></div><div style="margin-top:6pt;text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">GRANT OF AWARD</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.   Pursuant and subject to the provisions of the </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;MERGED FIELD&#93;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of CVS Health Corporation (the &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), on the date set forth above (the &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Grant Date</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), CVS Health Corporation (the &#8221;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company&#8221;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) has granted and hereby evidences the Grant to the person named below (the &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), subject to the terms and conditions set forth or incorporated in this Nonqualified Stock Option Agreement (&#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the right, and option, to purchase from the Company the aggregate number of shares of Common Stock ($.01 par value) of the Company (&#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shares</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) set forth below, at the purchase price indicated below (the &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Option</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), such Option to be exercised as hereinafter provided.  The Plan is hereby made a part hereof and Participant agrees to be bound by all the provisions of the Plan.  Capitalized terms not otherwise defined herein shall have the meaning assigned to such term(s) in the Plan.  The Option is a nonqualified option as defined in the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:0.06pt;padding-left:63.46pt;padding-right:63.46pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:213.00pt"><tr><td style="width:1.0pt"></td><td style="width:124.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:85.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Participant&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;MERGED FIELD&#93;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee ID&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;MERGED FIELD&#93;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;MERGED FIELD&#93;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Option Price&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#91;MERGED FIELD&#93;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">TERM OF OPTION</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.  </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term of this Option shall be for a period of ten (10) years from the Grant Date, subject to the earlier termination of the Option, as set forth in the Plan and in this Agreement.  No portion of the Option shall be exercisable after the term of the Option.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXERCISE OF OPTION</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   (a)&#160;&#160;&#160;&#160;The Option, subject to the provisions of the Plan, shall be exercised by submitting a request to exercise to the Company&#8217;s stock option administrator, in accordance with the Company&#8217;s current exercise policies and procedures, specifying the number    of Shares to be purchased, which number may not be less than one hundred (100) Shares (unless the number of Shares purchased is the total balance which is then exercisable).  An exercise by Participant of all or part of this Option shall be effected through the Company&#8217;s &#8220;cashless exercise&#8221; procedures.  Otherwise, at the time of exercise, Participant shall tender to the Company cash or cash equivalent for the aggregate option price of the Shares Participant has elected to purchase or certificates for Shares of Common Stock of the Company owned by Participant for at least six (6) months with a fair market value at least equal to the aggregate option price of the Shares Participant has elected to purchase, or a combination of the foregoing. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Prior to its expiration or termination and except as otherwise provided herein, the Option will become vested in accordance with the vesting schedule set forth below, each date on which vesting occurs a &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting Date</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, and any vested Option will be exercisable by Participant prior to the expiration of its term so long as Participant has maintained continuous employment with the Company or a subsidiary of the Company from the Grant Date through the exercise date&#58; </font></div><div style="padding-left:108pt;padding-right:36pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;padding-right:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;25% of the Option shall vest on the 1st anniversary of the Grant Date.</font></div><div style="padding-left:72pt;padding-right:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;25% of the Option shall vest on the 2nd anniversary of the Grant Date.</font></div><div style="padding-left:72pt;padding-right:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;25% of the Option shall vest on the 3rd anniversary of the Grant Date.</font></div><div style="padding-left:72pt;padding-right:36pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;25% of the Option shall vest on the 4th anniversary of the Grant Date.</font></div><div style="padding-left:72pt;padding-right:36pt;text-align:justify;text-indent:-22.5pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:58.86pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td></tr></table><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</font></div><div style="margin-top:6pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.32pt;width:100%"><div style="margin-top:6pt;padding-left:360pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;padding-left:360pt;text-align:right"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">TAXES</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.  </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon a cashless exercise of the Option the Company shall withhold from the proceeds of the exercise of the Option any required taxes. If the Option is exercised other than through a cashless exercise Company shall have the right to require Participant to pay the amount of any withholding taxes immediately, upon notification from the Company, before the proceeds  from the exercise of the Option are delivered to Participant. Furthermore, the Company may elect to deduct such taxes from any other amounts then payable to Participant in cash or in Shares or from any other amounts payable any time thereafter to Participant to the extent allowed under applicable law. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">NON-TRANSFERABILITY</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.  </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Option shall not be transferable by Participant other than by will   or by the laws of descent and distribution, and during Participant&#8217;s lifetime shall be exercised only by the Participant during the continuance of Participant&#8217;s employment with the Company and any of    its subsidiaries. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">FORFEITURE OF OPTION UPON TERMINATION OF EMPLOYMENT</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless otherwise provided for in the Plan or in this Agreement, as of the date on which Participant&#8217;s employment with the Company and its subsidiaries terminates, the Option, to the extent unexercised as of the employment  termination date, shall be forfeited immediately in its entirety, provided that, if the Participant&#8217;s employment with the Company and its subsidiaries terminates without Cause, the Option, to the extent vested and unexercised, shall be exercisable at any time on or before the ninetieth (90</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) day immediately following the employment termination date and, to the extent unvested, shall be forfeited immediately.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">TERMINATION OF PARTICIPANT&#8217;S EMPLOYMENT WITHOUT CAUSE.  </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that Participant&#8217;s employment with the Company and its subsidiaries is terminated without Cause and Participant receives severance pay following Participant&#8217;s employment pursuant to a written agreement,    vesting of the Option shall continue through the end of the severance period set forth in the agreement providing for such severance pay.  To the extent vested, the Option shall be exercisable  at any time during the severance period and on or before the ninetieth (90th) day following the last day of the severance period, as long as no government regulations or rules are violated by such continued vesting or exercise period&#59; provided, however, that in no event will the Option be exercisable beyond its original term.  Any portion of the Option not vested as of the last day of the severance period shall be forfeited as of the last day of the severance period.  In the event that Participant returns to employment with the Company or any subsidiary prior to the expiration of the severance period, Participant shall be treated as if his or her employment with the Company or any subsidiary of the Company had continued through the severance period for purposes of determining eligibility for continued vesting.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">RETIREMENT OF PARTICIPANT</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.   </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event Participant&#8217;s employment with the Company and any subsidiary of the Company terminates by reason of a Qualified Retirement, Participant (a) shall continue to vest in the Option, to the extent unvested as of the retirement date,  for a period of three (3) years following Participant&#8217;s retirement date and (b) may exercise the Option, to the extent  vested, at any time within the period of three (3) years following Participant&#8217;s retirement date, but    not beyond the original term of the Option, in both cases as long as no government regulations or rules are violated by such continued vesting or exercise period.  To the extent unvested or  unexercised at the end of the three (3) year period following Participant&#8217;s retirement date, the Option shall be forfeited.  In the event Participant&#8217;s termination of employment qualifies as a Qualified Retirement and Participant also enters into a severance agreement with the Company, the terms of this Section 8 shall apply with respect to the vesting and exercise of the Option as of the Participant&#8217;s employment termination date.  &#8220;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Qualified Retirement</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean termination of employment on or after attainment of age fifty-five (55) with at least ten (10) years of continuous service, or attainment  of age sixty (60) with at least five (5) years of continuous service, provided that&#58;&#160; (i) if Participant elects to terminate his or her employment voluntarily, Participant has provided the Company with at least twelve (12) months advance notice, in accordance with the provisions of Section 13 below, of his or her retirement date or such other term of advance notice as is determined by the Chief Human Resources Officer of the Company&#59; or (ii) if the Company elects to terminate Participant&#8217;s employment, such termination is without cause. &#160;A Participant shall also be deemed to have </font></div><div style="height:58.86pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td></tr></table><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2</font></div><div style="margin-top:6pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.32pt;width:100%"><div style="margin-top:6pt;padding-left:360pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;padding-left:360pt;text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">experienced a Qualified Retirement if the Company elects to terminate Participant&#8217;s employment without Cause and Participant shall meet the age and service requirement set forth above during   the severance period set forth in a severance agreement with the Company. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">DISABILITY OF PARTICIPANT</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.  </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event Participant&#8217;s employment with the Company and  any subsidiary of the Company terminates by reason of total and permanent disability (as defined in the Company&#8217;s Long-Term Disability Plan, or, if not defined in such Plan, as defined by the Social Security Administration), the Option shall vest as of the employment termination date on a pro-rata basis as follows&#58; the Option shall vest with respect to a total number of Shares as of the employment termination date (which is the last day that Participant is employed by the Company and any subsidiary of the Company) equal to (i) the number of Shares subject to the Option on the Grant   Date </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">multiplied</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by the following fraction&#58;  (A) the numerator shall be the whole number of months elapsed as of the employment termination date since the Grant Date and (B) the denominator shall be forty-eight (48), </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">minus</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ii) the number of Shares with respect to which the Option vested prior to   the employment termination date (whether or not the Option was previously exercised).  For purposes of this calculation, the number of months in the numerator in sub-section (A) above shall include any partial month in which Participant has worked.  For example, if the time elapsed between the Grant Date and the employment termination date is eight months and five days, the numerator in sub-section (A) above shall be nine</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.  </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Option may be exercised to the extent vested at any time within one (1) year of Participant&#8217;s employment termination date but not beyond the original term of the Option.  The prorated Option shall vest on the Participant&#8217;s employment termination date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">DEATH OF PARTICIPANT</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.   </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of Participant&#8217;s death while Participant is employed    with the Company and any subsidiary of the Company, the Option shall immediately vest in full, and the Option shall remain exercisable for a period of one (1) year after Participant&#8217;s death, or until the Option expiration date, whichever occurs first, by Participant&#8217;s Beneficiary.  At the end of said one   (1)-year time period, all rights with respect to any Option that is unexercised shall terminate and the Option shall be cancelled.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">TRANSFER OF EMPLOYMENT</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. &#160;&#160;&#160;&#160;Transfer of Participant&#8217;s employment from the Company to a subsidiary of the Company, among or between subsidiaries of the Company, or from a subsidiary of the Company to the Company shall not be treated as termination of employment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">REQUIRED ACCEPTANCE OF AWARD.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">   </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Option may not be exercised unless and until the Company has received the Participant&#8217;s acceptance of the terms and conditions set forth herein.  Acceptance shall be submitted electronically as required by the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">NOTICE</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.   </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any notice required to be given hereunder to the Company shall be in writing.  If     by regular mail, any required notice shall be addressed to&#58; CVS Health Corporation, Attention&#58; Senior Director, Executive Compensation, One CVS Drive, Woonsocket, RI  02895.  If by electronic mail, any notice required shall be sent to&#58;  </font><font style="color:#0000ff;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">equityadministration&#64;cvshealth.com</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, with &#8220;Retirement Notice&#8221; in   the subject line. Any notice required to be given hereunder to Participant shall be addressed to Participant at his or her address as shown on the records of the Company, subject to the right of  either party hereafter to designate in writing to the other some other address.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">RECOUPMENT OF OPTION AWARD</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.  </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Option subject to this Agreement under the Plan shall be subject to the terms of the Company&#8217;s Recoupment Policy as it exists from time to time, which   may require the Participant to immediately repay to the Company the value of any pre-tax  economic benefit that he or she may derive from the Award.  By accepting this Award, Participant acknowledges that a copy of the Company&#8217;s Recoupment Policy has been made available for the Participant&#8217;s reference.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">COMMITTEE AUTHORITY</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.  </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee shall have the authority, in its sole discretion, to make any interpretations, determinations, and&#47;or take any administrative actions with respect to the Plan and this Agreement, including whether any post-termination payments to Participant shall be  deemed severance pay, the duration of any severance period, and&#47;or whether a termination was without cause.</font></div><div style="height:58.86pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td></tr></table><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</font></div><div style="margin-top:6pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.32pt;width:100%"><div style="margin-top:6pt;padding-left:360pt;text-align:right"><font><br></font></div><div style="margin-top:6pt;padding-left:360pt;text-align:right"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">GOVERNING LAW</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   This Nonqualified Stock Option Agreement and the Option evidenced hereby shall be governed by the laws of Delaware, without giving effect to principles of conflict of laws.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ACKNOWLEDGEMENT.</font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;  </font><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Agreement shall be fully effective only upon the Participant&#8217;s formal acceptance of the terms and conditions set forth above as required by the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.848%"><tr><td style="width:1.0%"></td><td style="width:5.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BY&#58;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.06pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, Chief Human Resources Officer</font></div><div><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr></table></div><div style="margin-top:0.06pt"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="margin-top:0.06pt;text-align:right"><font><br></font></div><div style="margin-top:0.06pt;text-align:right"><font><br></font></div><div style="margin-top:0.06pt;text-align:right"><font><br></font></div><div style="margin-top:0.06pt;text-align:right"><font><br></font></div><div style="margin-top:0.06pt;text-align:right"><font><br></font></div><div style="margin-top:0.06pt;text-align:right"><font><br></font></div><div style="margin-top:0.06pt;text-align:right"><font><br></font></div><div style="margin-top:0.06pt;text-align:right"><font><br></font></div><div style="margin-top:0.06pt;text-align:right"><font><br></font></div><div style="margin-top:0.06pt;text-align:right"><font><br></font></div><div style="margin-top:0.06pt;text-align:right"><font><br></font></div><div style="margin-top:0.06pt;text-align:right"><font><br></font></div><div style="margin-top:0.06pt;text-align:right"><font><br></font></div><div style="margin-top:0.06pt;text-align:right"><font style="color:#000000;font-family:'Century Gothic',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock Option Agreement </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:58.86pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td></tr></table><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</font></div><div style="margin-top:6pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>6
<FILENAME>exhibit211-2021.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i253852a585774353a6d4b18da12255fb_1"></div><div style="min-height:79.2pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit 21.1</font></div><div style="text-align:right"><font><br></font></div><div><font><br></font></div></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">Subsidiaries of CVS Health Corporation</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Listed below are subsidiaries under CVS Health Corporation at December 31, 2021 with their jurisdictions of  organization shown in parentheses. Subsidiaries excluded from the list below are not insurance companies and would not, in the aggregate, constitute a &#8220;significant subsidiary&#8221; of CVS Health Corporation, as that term is defined in Rule 1-02(w) of Regulation S-X.</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">CVS Foreign, Inc. (New York)</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Caremark Indemnity Ltd. (Bermuda)</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS International, L.L.C. (Delaware)</font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:14.5pt">CVS Pharmacy, Inc. (Rhode Island)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Aetna Inc. (Pennsylvania)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Aetna Health Holdings, LLC (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Health of California Inc. (California)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Health Inc. (Connecticut) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Health Inc. (Florida) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Health Inc. (Georgia) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Health Inc. (Maine) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Health of Michigan Inc. (Michigan) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Health Inc. (New Jersey) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Health Inc. (New York)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health Inc. (New York)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Health Inc. (Pennsylvania)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Health Inc. (Texas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health of California Inc. (California)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Health of Ohio Inc. (Ohio)Aetna Better Health of Texas Inc. (Texas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health of Washington, Inc. (Washington)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health Inc. (Georgia) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna HealthAssurance Pennsylvania, Inc. (Pennsylvania)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Dental of California Inc. (California)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Dental Inc. (New Jersey) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Dental Inc. (Texas) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Rx Home Delivery, LLC (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Health Management, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Ireland Inc. (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Specialty Pharmacy, LLC (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Cofinity, Inc. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">&#64;Credentials Inc. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health Inc. (Pennsylvania)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health Inc. (Connecticut)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health of Illinois Inc. (Illinois) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health Premier Plan MMAI Inc. (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health of Kansas Inc. (Kansas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health, Inc. (Louisiana)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Florida Inc. (Florida)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health of Indiana Inc. (Indiana)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.2pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health Inc. (Ohio)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health of Oklahoma Inc. (Oklahoma)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health of Nevada Inc. (Nevada)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health Inc. (New Jersey)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health of North Carolina Inc. (North Carolina)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Network Services LLC (Connecticut)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Risk Assurance Company of Connecticut Inc. (Connecticut)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Student Health Agency Inc. (Massachusetts)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Delaware Physicians Care, Incorporated (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Schaller Anderson Medical Administrators, Incorporated (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Medicaid Administrators LLC (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">iTriage, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Medical Examinations of New York, P.C. (New York)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">bswift LLC (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Prodigy Health Group, Inc. (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Niagara Re, Inc. (New York)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Performax, Inc. (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Scrip World, LLC (Utah)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Precision Benefit Services, Inc. (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">American Health Holding, Inc. (Ohio)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Meritain Health, Inc. (New York)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Administrative Enterprises, Inc. (Arizona)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">U.S Healthcare Holdings, LLC (Ohio)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Prime Net, Inc. (Ohio)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Professional Risk Management, Inc. (Ohio)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">ADMINCO, Inc. (Arizona) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna ACO Holdings Inc. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Pharmacy Management Services LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coventry Transplant Network, Inc. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Health of Iowa Inc. (Iowa)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coventry Health Care of Nebraska, Inc. (Nebraska)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Health Inc. (Louisiana)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">HealthAssurance Pennsylvania, Inc. (Pennsylvania)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coventry Prescription Management Services Inc. (Nevada)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coventry Health and Life Insurance Company (Missouri)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health of Kentucky Insurance Company (Kentucky)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coventry Health Care of Virginia, Inc. (Virginia)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coventry Health Care of Missouri, Inc. (Missouri)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health of Missouri LLC (Missouri)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coventry Health Care of Illinois, Inc. (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coventry Health Care of West Virginia, Inc. (West Virginia)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coventry HealthCare Management Corporation (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coventry Health Care of Kansas, Inc. (Kansas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coventry Health Care National Accounts, Inc. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health of Michigan Inc. (Michigan)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Health of Utah Inc. (Utah)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health of Tennessee Inc. (Tennessee)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.2pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coventry Health Care National Network, Inc. (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coventry Consumer Advantage, Inc. (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">MHNet Specialty Services, LLC (Maryland)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Mental Health Network of New York IPA, Inc. (New York)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Mental Health Associates, Inc. (Louisiana)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">MHNet of Florida, Inc. (Florida)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Group Dental Service, Inc. (Maryland)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Group Dental Service of Maryland, Inc. (Maryland)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Florida Health Plan Administrators, LLC (Florida)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Better Health of Florida Inc. (Florida)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Carefree Insurance Services, Inc. (Florida)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coventry Health Plan of Florida, Inc. (Florida)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">First Health Group Corp. (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">First Health Life &#38; Health Insurance Company (Texas)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Claims Administration Corp. (Maryland)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">First Choice of the Midwest LLC (South Dakota)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Continental Life Insurance Company of Brentwood, Tennessee (Tennessee)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">American Continental Insurance Company (Tennessee)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Aetna Life Insurance Company (Connecticut)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">AHP Holdings, Inc. (Connecticut) </font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Insurance Company of Connecticut (Connecticut)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">AE Fourteen, Incorporated (Connecticut) </font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Life Assignment Company (Connecticut) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna ACO Holdings Inc. (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Innovation Health Holdings, LLC (Delaware)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Innovation Health Insurance Company (Virginia)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.59pt">Innovation Health Plan, Inc. (Virginia)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Texas Health + Aetna Health Insurance Holding Company LLC (Texas)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Texas Health + Aetna Health Insurance Company (Texas)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.59pt">Texas Health + Aetna Health Plan Inc. (Texas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Banner Health and Aetna Health Insurance Holding Company LLC (Delaware) </font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Banner Health and Aetna Health Insurance Company (Arizona)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.59pt">Banner Health and Aetna Health Plan Inc. (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Sutter Health and Aetna Insurance Holding Company LLC (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Sutter Health and Aetna Administrative Services LLC (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Sutter Health and Aetna Insurance Company (California)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Allina Health and Aetna Insurance Holding Company LLC (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Allina Health and Aetna Insurance Company (Minnesota) </font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Allina Health and Aetna Health Plan Inc. (Minnesota)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Aetna International LLC (Connecticut)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Life &#38; Casualty (Bermuda) Ltd. (Bermuda)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna International Ex Pat LLC (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Global Holdings Limited (England &#38; Wales)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Insurance (Hong Kong) Limited (Hong Kong)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Virtual Home Healthcare LLC (Dubai)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Minor Health Enterprise Co, Ltd. (Thailand)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Health Care Management Co. Ltd. (Thailand)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.2pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Aetna Services (Thailand) Limited (Thailand)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Aetna Health Insurance (Thailand) Public Company Limited (Thailand)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Health Insurance (Thailand) Public Company Limited (Thailand)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Holdings (Thailand) Limited (Thailand)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Health Care Management Co. Ltd. (Thailand)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Minor Health Enterprise Co, Ltd. (Thailand)</font></div><div style="padding-left:180pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.59pt">Aetna Health Insurance (Thailand) Public Company Limited (Thailand)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Global Benefits (Bermuda) Limited (Bermuda)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Goodhealth Worldwide (Global) Limited (Bermuda)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Global Benefits (Europe) Limited (England &#38; Wales)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Global Benefits (Asia Pacific) Limited (Hong Kong) </font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">PT Aetna Management Consulting (Indonesia)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Goodhealth Worldwide (Asia) Limited (Hong Kong)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Global Benefits Limited (DIFC, UAE)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Global Benefits (Middle East) LLC (UAE) </font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Pt. Aetna Global Benefits Indonesia (Indonesia)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Spinnaker Topco Limited (Bermuda)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Spinnaker Bidco Limited (England and Wales)</font></div><div style="padding-left:180pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.59pt">Aetna Holdco (UK) Limited (England and Wales)</font></div><div style="padding-left:198pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Aetna Global Benefits (UK) Limited (England and Wales)</font></div><div style="padding-left:198pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Aetna Insurance Company Limited (England and Wales)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Insurance (Singapore) Pte. Ltd. (Singapore)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Health Insurance Company of Europe DAC (Ireland)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna (Shanghai) Enterprise Services Co. Ltd. (China)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna (Beijing) Enterprise Management Services Co., Ltd. (China)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Global Benefits (Singapore) PTE. LTD. (Singapore)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Indian Health Organisation Private Limited (India)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">PT Aetna Management Consulting (Indonesia)</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">PE Holdings, LLC (Connecticut) </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Resources LLC (Delaware) </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Canal Place, LLC (Delaware) </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Ventures, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Phoenix Data Solutions LLC (Delaware) </font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Aetna Financial Holdings, LLC (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Asset Advisors, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">U.S. Healthcare Properties, Inc. (Pennsylvania) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Capital Management, LLC (Delaware) </font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Partners Diversified Fund, LLC (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Workers&#8217; Comp Access, LLC (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Behavioral Health, LLC (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Managed Care Coordinators, Inc. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Horizon Behavioral Services, LLC (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Employee Assistance Services, LLC (Kentucky)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Health and Human Resource Center, Inc. (California)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Resources for Living, LLC (Texas)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">The Vasquez Group Inc. (Illinois)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Work and Family Benefits, Inc. (New Jersey)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.2pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Card Solutions, LLC (Connecticut)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">PayFlex Holdings, Inc. (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">PayFlex Systems USA, Inc. (Nebraska)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Aetna Health and Life Insurance Company (Connecticut) </font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Aetna Health Insurance Company (Pennsylvania) </font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Aetna Health Insurance Company of New York (New York)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">AUSHC Holdings, Inc. (Connecticut) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">PHPSNE Parent Corporation (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Active Health Management, Inc. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Health Data &#38; Management Solutions, Inc. (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Aetna Integrated Informatics, Inc. (Pennsylvania)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Health Re, Inc. (Vermont)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">ASI Wings, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Aetna Corporate Services LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Echo Merger Sub, Inc. (Delaware)</font></div><div><font><br></font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">CVS Pharmacy, Inc. (continued)</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Alabama CVS Pharmacy, L.L.C. (Alabama)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Alaska CVS Pharmacy, L.L.C. (Alaska)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">American Drug Stores Delaware, L.L.C. (Delaware)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Arkansas CVS Pharmacy, L.L.C. (Arkansas)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">CareCenter Pharmacy, L.L.C. (Delaware)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Caremark Rx, L.L.C. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">ACS ACQCO CORP. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Advanced Care Scripts, Inc. (Florida)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CaremarkPCS, L.L.C. (Delaware) </font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">CaremarkPCS Health, L.L.C. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark IPA, L.L.C. (New York)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Accordant Health Services, L.L.C. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">AdvancePCS SpecialtyRx, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">AdvanceRx.com, L.L.C. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Caremark PhC, L.L.C. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Caremark Ulysses Holding Corp. (New York)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">MemberHealth LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">UAC Holding, Inc. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Caremark, L.L.C. (California)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Arizona Mail Pharmacy, LLC (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Arizona Specialty Pharmacy, L.L.C. (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark California Specialty Pharmacy, L.L.C. (California)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Florida Mail Pharmacy, LLC (Florida)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Florida Specialty Pharmacy, LLC (Florida)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Hawaii Mail Pharmacy, L.L.C. (Hawaii)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Hawaii Specialty Pharmacy, LLC (Hawaii)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Illinois Mail Pharmacy, LLC (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">CVS Caremark Advanced Technology Pharmacy, L.L.C. (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Illinois Specialty Pharmacy, LLC (Illinois)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.2pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Irving Resource Center, LLC (Texas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Kansas Specialty Pharmacy, LLC (Kansas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Logistics, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Louisiana Specialty Pharmacy, LLC (Louisiana)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Maryland Specialty Pharmacy, LLC (Maryland)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Massachusetts Specialty Pharmacy, L.L.C. (Massachusetts)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Michigan Specialty Pharmacy, LLC (Michigan)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Minnesota Specialty Pharmacy, LLC (Minnesota)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark New Jersey Specialty Pharmacy, LLC (New Jersey)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark North Carolina Specialty Pharmacy, LLC (North Carolina)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Ohio Specialty Pharmacy, L.L.C. (Ohio)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Pennsylvania Specialty Pharmacy, LLC (Pennsylvania)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Redlands Pharmacy, L.L.C. (California)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Repack, LLC (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Tennessee Specialty Pharmacy, LLC (Tennessee)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Texas Mail Pharmacy, LLC (Texas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Texas Specialty Pharmacy, LLC (Texas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Caremark Washington Specialty Pharmacy, LLC (Washington)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Central Rx Services, LLC (Nevada)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">CVS Caremark TN SUTA, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Generation Health, L.L.C. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">NovoLogix, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CaremarkPCS Alabama Mail Pharmacy, LLC (Alabama)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Caremark Part D Services, L.L.C. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Eckerd Corporation of Florida, Inc. (Florida)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Express Pharmacy Services of PA, L.L.C. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Ocean Acquisition Sub, L.L.C. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coram LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">T2 Medical, Inc. (Delaware)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Coram Healthcare Corporation of Alabama (Delaware)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Coram Healthcare Corporation of Florida (Delaware)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Coram Healthcare Corporation of Greater D.C. (Delaware)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Coram Healthcare Corporation of Greater New York (New York)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Coram Healthcare Corporation of Indiana (Delaware)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Coram Healthcare Corporation of Mississippi (Delaware)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Coram Healthcare Corporation of Nevada (Delaware)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Coram Healthcare Corporation of Northern California (Delaware)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Coram Healthcare Corporation of Southern California (Delaware)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Coram Healthcare Corporation of Southern Florida (Delaware)</font></div><div style="padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Coram Specialty Infusion Services, L.L.C. (Delaware)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coram Rx, LLC (Delaware)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coram Healthcare Corporation of North Texas (Delaware)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coram Healthcare Corporation of Utah (Delaware)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Coram Healthcare Corporation of Massachusetts (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Coram Alternate Site Services, Inc. (Delaware)</font></div><div style="padding-left:144pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Geneva Woods Management, LLC (Delaware)</font></div><div style="padding-left:108pt"><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.2pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Part D Holding Company, L.L.C. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Accendo Insurance Company (Utah)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Silverscript Insurance Company (Tennessee)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Connecticut CVS Pharmacy, L.L.C. (Connecticut)</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Coram Clinical Trials, Inc. (Delaware)*</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Cabot Holdings Inc. (Delaware)*</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Shaw Holdings Inc. (Delaware)*</font></div><div style="padding-left:94.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Omnicare, LLC (Delaware)*</font></div><div style="padding-left:117pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Evergreen Pharmaceutical of California, LLC (California)</font></div><div style="padding-left:117pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">JHC Acquisition, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Geneva Woods Pharmacy, LLC (Alaska)</font></div><div style="padding-left:180pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Geneva Woods Health Services, LLC (Delaware)</font></div><div style="padding-left:216pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.08pt">Geneva Woods Retail Pharmacy LLC (Delaware)</font></div><div style="padding-left:216pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.08pt">Geneva Woods LTC Pharmacy, LLC</font></div><div style="padding-left:229.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Geneva Woods Pharmacy Wyoming, LLC (Delaware)</font></div><div style="padding-left:229.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Geneva Woods Pharmacy Washington, LLC (Delaware)</font></div><div style="padding-left:229.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Geneva Woods Pharmacy Alaska, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">AMC - Tennessee, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">CHP Acquisition, LLC (Delaware)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.59pt">Home Pharmacy Services, LLC (Missouri)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">CP Acquisition, LLC (Oklahoma)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Managed Healthcare, LLC (Delaware) </font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Medical Arts Health Care, LLC (Georgia)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">NIV Acquisition, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">OCR Services, LLC (Delaware)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.08pt">Shore Pharmaceutical Providers, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Omnicare of Nevada, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Omnicare Pharmacies of the Great Plains Holding, LLC (Delaware)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.08pt">Omnicare of Nebraska LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Pharmacy Associates of Glenn Falls, LLC (New York)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Sterling Healthcare Services, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Superior Care Pharmacy, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">TCPI Acquisition, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">UC Acquisition, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Weber Medical Systems LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Williamson Drug Company, LLC (Virginia)</font></div><div style="padding-left:117pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Med World Acquisition Corp. (Delaware)</font></div><div style="padding-left:117pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">MHHP Acquisition Company, LLC (Delaware)</font></div><div style="padding-left:81pt"><font><br></font></div><div style="padding-left:135pt"><font><br></font></div><div style="margin-bottom:8pt;padding-left:135pt;text-indent:-135pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">______________________</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:161%"> *Coram Clinical Trials, Inc. &#8211; CVS Pharmacy, Inc. 75%&#47;Aetna Life Insurance Company 25%</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:161%"> *</font><font style="color:#ff0000;font-family:'Arial Narrow',sans-serif;font-size:5.2pt;font-weight:400;line-height:161%;position:relative;top:-2.8pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:161%">CVS Cabot Holdings, Inc. &#8211; Coram Clinical Trials, Inc. 99.72%&#47;Aetna Inc. .28% </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:161%"> *CVS Shaw Holdings, Inc. &#8211; Coram Clinical Trials, Inc. 99.72%&#47;Aetna Inc. .28% </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:161%"> *Omnicare, LLC &#8211; Aetna Inc 0.28%&#47;CVS Cabot Holdings, Inc. 49.86%&#47;CVS Shaw Holdings, Inc. 49.86%</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.2pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Omnicare, LLC (continued)</font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:117pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">NeighborCare Pharmacy Services, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">APS Acquisition LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">ASCO HealthCare, LLC (Maryland)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Badger Acquisition LLC (Delaware)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.59pt">Badger Acquisition of Minnesota LLC (Delaware)</font></div><div style="padding-left:180pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Merwin Long Term Care, LLC (Minnesota)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.59pt">Badger Acquisition of Ohio LLC (Delaware) </font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.59pt">Badger Acquisition of Kentucky LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Best Care LTC Acquisition Company, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Care Pharmaceutical Services, LP (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">CCRx Holdings, LLC (Delaware)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.59pt">Continuing Care Rx, LLC (Pennsylvania)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.59pt">CCRx of North Carolina LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Compscript, LLC (Florida)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.59pt">Campo&#8217;s Medical Pharmacy, LLC (Louisiana)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:15.08pt">D &#38; R Pharmaceutical Services LLC (Kentucky)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Enloe Drugs, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Evergreen Pharmaceutical, LLC (Washington)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Home Care Pharmacy, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Interlock Pharmacy Systems, LLC (Missouri)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Langsam Health Services, LLC (Delaware)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.59pt">LCPS Acquisition, LLC (Delaware)</font></div><div style="padding-left:180pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Omnicare Pharmacy of Tennessee LLC (Delaware)</font></div><div style="padding-left:144pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:23.46pt">Lobos Acquisition, LLC (Delaware)</font></div><div style="padding-left:144pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:23.46pt">Lo-Med Prescription Services, LLC (Ohio) </font></div><div style="padding-left:157.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.09pt">ZS Acquisition Company, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Main Street Pharmacy, L.L.C. (Maryland)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">NCS Healthcare of Illinois, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">NCS Healthcare of Iowa, LLC (Ohio)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.59pt">Martin Health Services, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">NCS Healthcare of Kansas, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">NCS Healthcare of Kentucky, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">NCS Healthcare of Montana, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">NCS Healthcare of New Mexico, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">NCS Healthcare of South Carolina, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">NCS Healthcare of Tennessee, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">NCS Healthcare of Ohio, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">NCS Healthcare of Wisconsin, LLC (Ohio)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">North Shore Pharmacy Services LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Omnicare Indiana Partnership Holding Company LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Omnicare of New York, LLC (Delaware)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.59pt">NeighborCare of Indiana, LLC (Indiana)</font></div><div style="padding-left:180pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Grandview Pharmacy, LLC (Indiana)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.59pt">NeighborCare of Virginia, LLC (Virginia)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Omnicare Pharmacies of Pennsylvania West LLC (Pennsylvania)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.2pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Omnicare Pharmacy and Supply Services LLC (South Dakota)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Omnicare Pharmacy of the Midwest, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Omnicare Property Management, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Pharmacy Consultants, LLC (South Carolina)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">PRN Pharmaceutical Services, LP (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Roeschen&#8217;s Healthcare LLC (Wisconsin)</font></div><div style="padding-left:162pt;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.59pt">PP Acquisition Company LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Specialized Pharmacy Services, LLC (Michigan)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Value Health Care Services LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">VAPS Acquisition Company, LLC (Delaware)</font></div><div style="padding-left:135pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Westhaven Services Co, LLC (Ohio)</font></div><div style="padding-left:117pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Three Forks Apothecary, LLC (Kentucky)</font></div><div style="margin-bottom:8pt;padding-left:117pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">UNI-Care Health Services of Maine, LLC (New Hampshire)</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">CVS Pharmacy, Inc. (continued)</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS 2948 Henderson, L.L.C. (Nevada)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS AL Distribution, L.L.C. (Alabama)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Albany, L.L.C. (New York)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS AOC Services, L.L.C. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS AOC Corporation (California)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Care Concierge, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Health Applications, LLC (Rhode Island)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Health Clinical Trial Services LLC (Connecticut)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Health Solutions LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Health Ventures Management, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Health Ventures Fund GP, LLC (Delaware)</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Health Ventures Fund, LP (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Indiana, L.L.C. (Indiana)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS International, L.L.C. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">CCI Foreign, S.&#224; R.L. (R.C.S. Luxembourg)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">Beauty Holdings, L.L.C. (Delaware)</font></div><div style="padding-left:108pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.5pt">Pamplona Sa&#250;de e Beleza LTDA (Brazil)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Kidney Care, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">CVS Kidney Care Health Services LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">CVS Kidney Care Advanced Technologies LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:14.46pt">CVS Kidney Care Home Dialysis LLC (Delaware)</font></div><div style="padding-left:103.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:9.96pt">CVS-SHC Kidney Care Home Dialysis of Austin LLC (Delaware)</font></div><div style="padding-left:103.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:9.96pt">CVS-SHC Kidney Care Home Dialysis of Los Angeles LLC (Delaware)</font></div><div style="padding-left:103.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:9.96pt">CVS-SHC Kidney Care Home Dialysis of Philadelphia LLC (Delaware)</font></div><div style="padding-left:103.5pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:9.96pt">CVS-SHC Renal Holdings LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Management Support, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Manchester NH, L.L.C. (New Hampshire)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Media Exchange LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Michigan, L.L.C. (Michigan)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Orlando FL Distribution, L.L.C. (Florida)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.2pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS PA Distribution, L.L.C. (Pennsylvania)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Pharmacy Overseas Online, LLC</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS PR Center, Inc. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Puerto Rico CVS Pharmacy, L.L.C. (Puerto Rico)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Caremark Puerto Rico, L.L.C. (Puerto Rico)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Caremark Puerto Rico Specialty Pharmacy, L.L.C. (Puerto Rico)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS RS Arizona, L.L.C. (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Arizona CVS Stores, L.L.C. (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS 3268 Gilbert, L.L.C. (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS 3745 Peoria, L.L.C. (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Gilbert 3272, L.L.C. (Arizona)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Rx Services, Inc. (New York)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Busse CVS, L.L.C. (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Goodyear CVS, L.L.C. (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Sheffield Avenue CVS, L.L.C. (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">South Wabash CVS, L.L.C. (Illinois)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Thomas Phoenix CVS, L.L.C. (Arizona)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Washington Lamb CVS, L.L.C. (Nevada)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS SC Distribution, L.L.C. (South Carolina)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS State Capital, L.L.C. (Maine)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS TN Distribution, L.L.C. (Tennessee)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Transportation, L.L.C. (Indiana)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Vero FL Distribution, L.L.C. (Florida)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">D.A.W., LLC (Massachusetts)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Delaware CVS Pharmacy, L.L.C. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">District of Columbia CVS Pharmacy, L.L.C. (District of Columbia)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Enterprise Patient Safety Organization, LLC (Rhode Island)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">E.T.B., Inc. (Texas)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Garfield Beach CVS, L.L.C. (California)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Georgia CVS Pharmacy, L.L.C. (Georgia)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">German Dobson CVS, L.L.C. (Arizona)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Grand St. Paul CVS, L.L.C. (Minnesota)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Highland Park CVS, L.L.C. (Illinois)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Holiday CVS, L.L.C. (Florida)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Hook-SupeRx, L.L.C. (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Idaho CVS Pharmacy, L.L.C. (Idaho)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Iowa CVS Pharmacy, L.L.C. (Iowa)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Kansas CVS Pharmacy, L.L.C. (Kansas)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Kentucky CVS Pharmacy, L.L.C. (Kentucky)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Longs Drug Stores California, L.L.C. (California)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Louisiana CVS Pharmacy, L.L.C. (Louisiana)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Maryland CVS Pharmacy, L.L.C. (Maryland)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Melville Realty Company, Inc. (New York)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">CVS Bellmore Avenue, L.L.C. (New York)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic, L.L.C. (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Alabama, L.L.C. (Alabama)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Arkansas, LLC (Arkansas)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.2pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Arizona, LLC (Minnesota)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Colorado LLC (Colorado)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Florida, LLC (Minnesota)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Georgia, LLC (Minnesota)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Hawaii, L.L.C. (Hawaii)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Illinois, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Kentucky, L.L.C. (Kentucky)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Louisiana, L.L.C. (Louisiana)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Maine, L.L.C. (Maine)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Maryland, LLC (Minnesota)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Massachusetts, LLC (Massachusetts)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Nebraska, L.L.C. (Nebraska)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of New Hampshire, L.L.C. (New Hampshire)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of New Mexico, L.L.C. (New Mexico)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Ohio, LLC (Ohio)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Oklahoma, LLC (Oklahoma)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Oregon, LLC (Oregon)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Pennsylvania, LLC (Minnesota)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Rhode Island, LLC (Minnesota)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of South Carolina, L.L.C. (South Carolina)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Texas, LLC (Minnesota)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Utah, L.L.C. (Utah)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Virginia, LLC (Virginia)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Washington, LLC (Oregon)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Diagnostic of Wisconsin, L.L.C. (Wisconsin)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Online Diagnostic Services, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Physician Practice of Texas (Texas)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Telehealth Services, LLC (Delaware)</font></div><div style="padding-left:90pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">MinuteClinic Telehealth Services of Texas Association (Texas)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Mississippi CVS Pharmacy, L.L.C. (Mississippi)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Missouri CVS Pharmacy, L.L.C. (Missouri)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Montana CVS Pharmacy, L.L.C. (Montana)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Nebraska CVS Pharmacy, L.L.C. (Nebraska)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">New Jersey CVS Pharmacy, L.L.C. (New Jersey)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">North Carolina CVS Pharmacy, L.L.C. (North Carolina)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Ohio CVS Stores, L.L.C. (Ohio)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Oklahoma CVS Pharmacy, L.L.C. (Oklahoma)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Oregon CVS Pharmacy, L.L.C. (Oregon)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Pennsylvania CVS Pharmacy, L.L.C. (Pennsylvania)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">ProCare Pharmacy Direct, L.L.C. (Ohio)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">ProCare Pharmacy, L.L.C. (Rhode Island)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Red Oak Sourcing, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Rhode Island CVS Pharmacy, L.L.C. (Rhode Island)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">South Carolina CVS Pharmacy, L.L.C. (South Carolina)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Tennessee CVS Pharmacy, L.L.C. (Tennessee)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Utah CVS Pharmacy, L.L.C. (Utah)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Vermont CVS Pharmacy, L.L.C. (Vermont)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.2pt;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Virginia CVS Pharmacy, L.L.C. (Virginia)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Warm Springs Road CVS, L.L.C. (Nevada)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Washington CVS Pharmacy, L.L.C. (Washington)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Wellpartner, LLC (Delaware)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">West Virginia CVS Pharmacy, L.L.C. (West Virginia)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Wisconsin CVS Pharmacy, L.L.C. (Wisconsin)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Woodward Detroit CVS, L.L.C. (Michigan)</font></div><div style="padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Zinc Health Ventures, LLC (Delaware)</font></div><div style="margin-bottom:8pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Courier New',monospace;font-size:10pt;font-weight:400;line-height:139%">&#9702;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:12pt">Zinc Health Services, LLC (Delaware)</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">12</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>exhibit231-2021.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i2a9ae71db4a142318870eabd99c99766_1"></div><div style="min-height:72pt;width:100%"><div style="padding-left:18pt;text-align:right"><font><br></font></div><div style="padding-left:18pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consent of Independent Registered Public Accounting Firm</font></div><div style="padding-left:18pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div style="margin-top:12pt;padding-left:27.35pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Registration Statement (Form S-3ASR No. 333-238506) of CVS Health Corporation, and</font></div><div style="margin-bottom:12pt;padding-left:27.35pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Registration Statements (Form S-8 Nos. 333-238507, 333-230035, 333-228622, 333-167746, 333-217853, 333-208805, 333-141481, 333-139470, 333-63664, 333-91253, 333-49407, 333-34927, and 333-28043) of CVS Health Corporation&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of our reports dated February&#160;9, 2022, with respect to the consolidated financial statements of CVS Health Corporation and the effectiveness of internal control over financial reporting of CVS Health Corporation included in this Annual Report (Form 10-K) of CVS Health Corporation for the year ended December&#160;31, 2021.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Boston, Massachusetts</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;9, 2022</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:18pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>8
<FILENAME>exhibit311-2021.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i446b66398a634c4784a89aca00a84380_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:5pt;text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karen S. Lynch, President and Chief Executive Officer of CVS Health Corporation, certify that&#58; </font></div><div><font><br></font></div><div style="margin-bottom:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this annual report on Form 10-K of CVS Health Corporation&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:45pt;text-indent:-18pt"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 9, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;&#160;KAREN S. LYNCH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karen S. Lynch</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>9
<FILENAME>exhibit312-2021.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ice2a19df37c14a8a858406724ab9b471_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="margin-bottom:5pt;text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Shawn M. Guertin, Executive Vice President and Chief Financial Officer of CVS Health Corporation, certify that&#58; </font></div><div><font><br></font></div><div style="margin-bottom:6pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this annual report on Form 10-K of CVS Health Corporation&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. &#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. &#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:27pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:6pt;margin-top:5pt;padding-left:45pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:10pt;margin-top:10pt;padding-left:45pt;text-indent:-18pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.121%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 9, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160; SHAWN M. GUERTIN</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shawn M. Guertin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>10
<FILENAME>exhibit321-2021.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i475fe29769e443e59600955cf863c089_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-bottom:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Annual Report of CVS Health Corporation (the &#34;Company&#34;) on Form 10-K for the period ended December&#160;31, 2021 (the &#8220;Report&#8221;) solely for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code. </font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karen S. Lynch, President and Chief Executive Officer of the Company, certify that, to the best of my knowledge&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font><br></font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 9, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;KAREN S. LYNCH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karen S. Lynch</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>11
<FILENAME>exhibit322-2021.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="if1bbb6c55a954e69b54b4d9b318ba9cf_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2 </font></div><div style="margin-bottom:5pt;text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with the Annual Report of CVS Health Corporation (the &#34;Company&#34;) on Form 10-K for the period ended December&#160;31, 2021 (the &#8220;Report&#8221;) solely for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code. </font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Shawn M. Guertin, Executive Vice President and Chief Financial Officer of the Company, certify that, to the best of my knowledge&#58; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;text-indent:-13.5pt"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.049%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 9, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;&#160;&#160;&#160;&#160;SHAWN M. GUERTIN</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shawn M. Guertin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President and Chief Financial&#160;Officer</font></td></tr></table></div><div style="margin-bottom:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>cvs-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:101452a2-2146-4b57-8461-1c52c7d6326c,g:5f4a3ace-4815-405a-b6fd-039bed36fdc5-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cvshealth.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.cvshealth.com/role/CoverPage">
        <link:definition>000010001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.cvshealth.com/role/AuditInformation">
        <link:definition>000020002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations">
        <link:definition>100010003 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>100020004 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheets">
        <link:definition>100030005 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>100040006 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>100050007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows_1" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1">
        <link:definition>100050007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofShareholdersEquity" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity">
        <link:definition>100060008 - Statement - Consolidated Statements of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofShareholdersEquityParentheticals" roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals">
        <link:definition>100070009 - Statement - Consolidated Statements of Shareholders' Equity (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies">
        <link:definition>210011001 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>220022001 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesTables" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables">
        <link:definition>230033001 - Disclosure - Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>240044001 - Disclosure - Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesRestrictedCashDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails">
        <link:definition>240054002 - Disclosure - Significant Accounting Policies - Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesAccountsReceivableDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails">
        <link:definition>240064003 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPropertyPlantandEquipmentDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails">
        <link:definition>240074004 - Disclosure - Significant Accounting Policies - Property Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDisaggregationofRevenueDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails">
        <link:definition>240084005 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails">
        <link:definition>240094006 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesContractBalancesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails">
        <link:definition>240104007 - Disclosure - Significant Accounting Policies - Contract Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesVariableInterestEntitiesDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails">
        <link:definition>240114008 - Disclosure - Significant Accounting Policies - Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDiscontinuedOperationsDetails" roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails">
        <link:definition>240124009 - Disclosure - Significant Accounting Policies - Discontinued Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Divestitures" roleURI="http://www.cvshealth.com/role/Divestitures">
        <link:definition>210131002 - Disclosure - Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DivestituresNarrativeDetails" roleURI="http://www.cvshealth.com/role/DivestituresNarrativeDetails">
        <link:definition>240144010 - Disclosure - Divestitures - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.cvshealth.com/role/Investments">
        <link:definition>210151003 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.cvshealth.com/role/InvestmentsTables">
        <link:definition>230163002 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsScheduleofTotalInvestmentsDetails" roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails">
        <link:definition>240174011 - Disclosure - Investments - Schedule of Total Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://www.cvshealth.com/role/InvestmentsNarrativeDetails">
        <link:definition>240184012 - Disclosure - Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesDetails" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails">
        <link:definition>240194013 - Disclosure - Investments - Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsDebtSecuritiesbyMaturityDetails" roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails">
        <link:definition>240204014 - Disclosure - Investments - Debt Securities by Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsUnrealizedLossPositionDetails" roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails">
        <link:definition>240214015 - Disclosure - Investments - Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsUnrealizedLossPositionMaturitiesDetails" roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails">
        <link:definition>240224016 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMortgageLoansDetails" roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails">
        <link:definition>240234017 - Disclosure - Investments - Mortgage Loans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsMortgageLoansCreditRatingsIndicatorDetails" roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails">
        <link:definition>240244018 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails" roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails">
        <link:definition>240254019 - Disclosure - Investments - Schedule of Mortgage Loan Principal Repayments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNetInvestmentIncomeDetails" roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails">
        <link:definition>240264020 - Disclosure - Investments - Net Investment Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsRealizedGainsDetails" roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails">
        <link:definition>240274021 - Disclosure - Investments - Realized Gains (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValue" roleURI="http://www.cvshealth.com/role/FairValue">
        <link:definition>210281004 - Disclosure - Fair Value</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueTables" roleURI="http://www.cvshealth.com/role/FairValueTables">
        <link:definition>230293003 - Disclosure - Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueFairValueMeasurementsDetails" roleURI="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails">
        <link:definition>240304022 - Disclosure - Fair Value - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueChangesinLevel3FinancialAssetsDetails" roleURI="http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails">
        <link:definition>240314023 - Disclosure - Fair Value - Changes in Level 3 Financial Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueGrossTransfersIntoOutOfLevel3Details" roleURI="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details">
        <link:definition>240324024 - Disclosure - Fair Value - Gross Transfers Into (Out Of) Level 3 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueCarryingValueandFairValueClassifiedbyLevelDetails" roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails">
        <link:definition>240334025 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueSeparateAccountsFairValueDetails" roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails">
        <link:definition>240344026 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueNarrativeDetails" roleURI="http://www.cvshealth.com/role/FairValueNarrativeDetails">
        <link:definition>240354027 - Disclosure - Fair Value - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibles" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangibles">
        <link:definition>210361005 - Disclosure - Goodwill and Other Intangibles</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangiblesTables" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables">
        <link:definition>230373004 - Disclosure - Goodwill and Other Intangibles (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangiblesGoodwillDetails" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails">
        <link:definition>240384028 - Disclosure - Goodwill and Other Intangibles - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangiblesNarrativeDetails" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails">
        <link:definition>240394029 - Disclosure - Goodwill and Other Intangibles - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangiblesIntangibleAssetsDetails" roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails">
        <link:definition>240404030 - Disclosure - Goodwill and Other Intangibles - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails" roleURI="http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails">
        <link:definition>240414031 - Disclosure - Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.cvshealth.com/role/Leases">
        <link:definition>210421006 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.cvshealth.com/role/LeasesTables">
        <link:definition>230433005 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.cvshealth.com/role/LeasesNarrativeDetails">
        <link:definition>240444032 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSummaryoftheComponentsofNetLeaseCostDetails" roleURI="http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails">
        <link:definition>240454033 - Disclosure - Leases - Summary of the Components of Net Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowInformationDetails" roleURI="http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails">
        <link:definition>240464034 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>240474035 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails">
        <link:definition>240484036 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1">
        <link:definition>240484036 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayable" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable">
        <link:definition>210491007 - Disclosure - Health Care Costs Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableTables" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables">
        <link:definition>230503006 - Disclosure - Health Care Costs Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails">
        <link:definition>240514037 - Disclosure - Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableNarrativeDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails">
        <link:definition>240524038 - Disclosure - Health Care Costs Payable - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails">
        <link:definition>240534039 - Disclosure - Health Care Costs Payable - Reconciliation of Health Care Net Incurred and Paid Claims Development to Health Care Costs Payable Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails" roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails">
        <link:definition>240544040 - Disclosure - Health Care Costs Payable - Reconciliation of Health Care Costs Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangements" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangements">
        <link:definition>210551008 - Disclosure - Borrowings and Credit Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsTables" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables">
        <link:definition>230563007 - Disclosure - Borrowings and Credit Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsScheduleofDebtDetails" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails">
        <link:definition>240574041 - Disclosure - Borrowings and Credit Arrangements - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsDebtMaturitiesDetails" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails">
        <link:definition>240584042 - Disclosure - Borrowings and Credit Arrangements - Debt Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsShorttermBorrowingsDetails" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails">
        <link:definition>240594043 - Disclosure - Borrowings and Credit Arrangements - Short-term Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsLongTermBorrowingsDetails" roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails">
        <link:definition>240604044 - Disclosure - Borrowings and Credit Arrangements - Long-Term Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefits" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits">
        <link:definition>210611009 - Disclosure - Pension Plans and Other Postretirement Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsTables" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables">
        <link:definition>230623008 - Disclosure - Pension Plans and Other Postretirement Benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsNarrativeDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails">
        <link:definition>240634045 - Disclosure - Pension Plans and Other Postretirement Benefits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails">
        <link:definition>240644046 - Disclosure - Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails">
        <link:definition>240654047 - Disclosure - Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails">
        <link:definition>240664048 - Disclosure - Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails">
        <link:definition>240674049 - Disclosure - Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails">
        <link:definition>240684050 - Disclosure - Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails" roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails">
        <link:definition>240694051 - Disclosure - Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.cvshealth.com/role/IncomeTaxes">
        <link:definition>210701010 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.cvshealth.com/role/IncomeTaxesTables">
        <link:definition>230713009 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesIncomeTaxProvisionDetails" roleURI="http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails">
        <link:definition>240724052 - Disclosure - Income Taxes - Income Tax Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>240734053 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectiveTaxRateReconciliationDetails" roleURI="http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails">
        <link:definition>240744054 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>240754055 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesUnrecognizedTaxBenefitsDetails" roleURI="http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails">
        <link:definition>240764056 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlans" roleURI="http://www.cvshealth.com/role/StockIncentivePlans">
        <link:definition>210771011 - Disclosure - Stock Incentive Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansTables" roleURI="http://www.cvshealth.com/role/StockIncentivePlansTables">
        <link:definition>230783010 - Disclosure - Stock Incentive Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansStockBasedCompensationExpenseandESPPDetails" roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails">
        <link:definition>240794057 - Disclosure - Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansValuationandAssumptionsDetails" roleURI="http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails">
        <link:definition>240804058 - Disclosure - Stock Incentive Plans - Valuation and Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansRestrictedStockActivityDetails" roleURI="http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails">
        <link:definition>240814059 - Disclosure - Stock Incentive Plans - Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockIncentivePlansStockOptionandSARActivityDetails" roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails">
        <link:definition>240824060 - Disclosure - Stock Incentive Plans - Stock Option and SAR Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://www.cvshealth.com/role/ShareholdersEquity">
        <link:definition>210831012 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://www.cvshealth.com/role/ShareholdersEquityTables">
        <link:definition>230843011 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityShareRepurchasesDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails">
        <link:definition>240854061 - Disclosure - Shareholders' Equity - Share Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityAcceleratedShareRepurchasesDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails">
        <link:definition>240864062 - Disclosure - Shareholders' Equity - Accelerated Share Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityDividendsDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails">
        <link:definition>240874063 - Disclosure - Shareholders' Equity - Dividends (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityRegulatoryRequirementsDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails">
        <link:definition>240884064 - Disclosure - Shareholders' Equity - Regulatory Requirements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNoncontrollingInterestsDetails" roleURI="http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails">
        <link:definition>240894065 - Disclosure - Shareholders' Equity - Noncontrolling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncome" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncome">
        <link:definition>210901013 - Disclosure - Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeTables" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables">
        <link:definition>230913012 - Disclosure - Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveIncomeDetails" roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails">
        <link:definition>240924066 - Disclosure - Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.cvshealth.com/role/EarningsPerShare">
        <link:definition>210931014 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.cvshealth.com/role/EarningsPerShareTables">
        <link:definition>230943013 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDetails" roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails">
        <link:definition>240954067 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Reinsurance" roleURI="http://www.cvshealth.com/role/Reinsurance">
        <link:definition>210961015 - Disclosure - Reinsurance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceTables" roleURI="http://www.cvshealth.com/role/ReinsuranceTables">
        <link:definition>230973014 - Disclosure - Reinsurance (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceNarrativeDetails" roleURI="http://www.cvshealth.com/role/ReinsuranceNarrativeDetails">
        <link:definition>240984068 - Disclosure - Reinsurance - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceReinsuranceRecoverablesDetails" roleURI="http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails">
        <link:definition>240994069 - Disclosure - Reinsurance - Reinsurance Recoverables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReinsuranceEffectsofReinsuranceDetails" roleURI="http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails">
        <link:definition>241004070 - Disclosure - Reinsurance - Effects of Reinsurance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies">
        <link:definition>211011016 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails">
        <link:definition>241024071 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.cvshealth.com/role/SegmentReporting">
        <link:definition>211031017 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.cvshealth.com/role/SegmentReportingTables">
        <link:definition>231043015 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNarrativeDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails">
        <link:definition>241054072 - Disclosure - Segment Reporting - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails">
        <link:definition>241064073 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails">
        <link:definition>241074074 - Disclosure - Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cvs_Category2To4Member" abstract="true" name="Category2To4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HealthInsurerFee" abstract="false" name="HealthInsurerFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes5.3DueDecember2043Member" abstract="true" name="SeniorNotes5.3DueDecember2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HeartlandHealthcareServicesMember" abstract="true" name="HeartlandHealthcareServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" abstract="false" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.75DueMarch2044Member" abstract="true" name="SeniorNotes4.75DueMarch2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" abstract="false" name="AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" abstract="false" name="DeferredTaxLiabilitiesDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OtherLongTermInsuranceLiabilitiesMember" abstract="true" name="OtherLongTermInsuranceLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OtherAcquiredIntangibleAssetsTable" abstract="true" name="OtherAcquiredIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_NumberOfStoresPlannedClosurePeriod" abstract="false" name="NumberOfStoresPlannedClosurePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TreasuryStockSharesHeldinTrust" abstract="false" name="TreasuryStockSharesHeldinTrust" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member" abstract="true" name="ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SalesChannelOtherMember" abstract="true" name="SalesChannelOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes1Point875PercentFebruary2031Member" abstract="true" name="SeniorNotes1Point875PercentFebruary2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ProviderNetworksMember" abstract="true" name="ProviderNetworksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4Point125PercentApril2040Member" abstract="true" name="SeniorNotes4Point125PercentApril2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.375DueAugust2024Member" abstract="true" name="SeniorNotes3.375DueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" abstract="false" name="IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SeniorNotes13DueAugust2027Member" abstract="true" name="SeniorNotes13DueAugust2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NumberofPatientsServedperYear" abstract="false" name="NumberofPatientsServedperYear" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SeniorNotes3Point75PercentApril2030Member" abstract="true" name="SeniorNotes3Point75PercentApril2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" abstract="false" name="AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cvs_ValueOfBusinessAcquiredMember" abstract="true" name="ValueOfBusinessAcquiredMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes175DueAugust2030Member" abstract="true" name="SeniorNotes175DueAugust2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SupportingRemainingProductsMember" abstract="true" name="SupportingRemainingProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" abstract="false" name="FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_FloatingRateNotesMember" abstract="true" name="FloatingRateNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_RedOakMember" abstract="true" name="RedOakMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" abstract="true" name="VOYARetirementInsuranceAndAnnuityCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" abstract="false" name="DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cvs_SeniorNotes1875DueFebruary2031Member" abstract="true" name="SeniorNotes1875DueFebruary2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PharmacyClaimsandDiscountsPayableCurrent" abstract="false" name="PharmacyClaimsandDiscountsPayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SupportingExperienceRatedProductsMember" abstract="true" name="SupportingExperienceRatedProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" abstract="true" name="DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_PremiumDeficiencyReserveLiability" abstract="false" name="PremiumDeficiencyReserveLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes425DueApril2050Member" abstract="true" name="SeniorNotes425DueApril2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TreasuryStockValueSharesHeldInTrust" abstract="false" name="TreasuryStockValueSharesHeldInTrust" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PaymentsForAcceleratedShareRepurchasesAmount" abstract="false" name="PaymentsForAcceleratedShareRepurchasesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" abstract="false" name="FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_EquitySecuritiesDomesticRealEstateMember" abstract="true" name="EquitySecuritiesDomesticRealEstateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LongtermDebtGrossAndLeaseObligation" abstract="false" name="LongtermDebtGrossAndLeaseObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_RevolvingCreditFacilityExpiringMay162024Member" abstract="true" name="RevolvingCreditFacilityExpiringMay162024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" abstract="false" name="DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes43Due2028Member" abstract="true" name="SeniorNotes43Due2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_USFederalGovernmentMember" abstract="true" name="USFederalGovernmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" abstract="false" name="DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DeferredTaxLiabilitiesRetirementBenefits" abstract="false" name="DeferredTaxLiabilitiesRetirementBenefits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" abstract="true" name="DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_CoventryHealthCareWorkersCompensationBusinessMember" abstract="true" name="CoventryHealthCareWorkersCompensationBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LimitedPaymentsContracts" abstract="false" name="LimitedPaymentsContracts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cvs_SeniorNotes3.125DueMarch2020Member" abstract="true" name="SeniorNotes3.125DueMarch2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OtherAcquiredIntangibleAssetsLineItems" abstract="true" name="OtherAcquiredIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" abstract="true" name="FixturesEquipmentAndInternallyDevelopedSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HealthCareBenefitsSegmentMember" abstract="true" name="HealthCareBenefitsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueMay2021Member" abstract="true" name="SeniorNotes4.125DueMay2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDueYearFive" abstract="false" name="LesseeLiabilityPaymentsDueYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" abstract="false" name="LesseeOperatingAndFinanceLeasesRenewalTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_SeniorNotes3.7DueMarch2023Member" abstract="true" name="SeniorNotes3.7DueMarch2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_FinanceLeaseRightOfUseAssetNet" abstract="false" name="FinanceLeaseRightOfUseAssetNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes2.75DueDecember2022Member" abstract="true" name="SeniorNotes2.75DueDecember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsLineItems" abstract="true" name="TotalInvestmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" abstract="false" name="ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueNovember2042Member" abstract="true" name="SeniorNotes4.125DueNovember2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes27DueAugust2040Member" abstract="true" name="SeniorNotes27DueAugust2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" abstract="true" name="MortgageLoansOnRealEstateYearOfOriginationDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" abstract="true" name="LincolnLifeAnnuityCompanyOfNewYorkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HartfordLifeAndAccidentInsuranceCompanyMember" abstract="true" name="HartfordLifeAndAccidentInsuranceCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDueYearFour" abstract="false" name="LesseeLiabilityPaymentsDueYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes2.75DueNovember2022Member" abstract="true" name="SeniorNotes2.75DueNovember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.125June2021Member" abstract="true" name="SeniorNotes2.125June2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_VendorandManufacturerReceivables" abstract="false" name="VendorandManufacturerReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" abstract="false" name="NoncontrollinginterestOtherPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ProceedsFromVariableInterestEntity" abstract="false" name="ProceedsFromVariableInterestEntity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4PointThreePercentDue2028Member" abstract="true" name="SeniorNotes4PointThreePercentDue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_FinanceLeaseRightOfUseAssetGross" abstract="false" name="FinanceLeaseRightOfUseAssetGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3Point70PercentDue2023Member" abstract="true" name="SeniorNotes3Point70PercentDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4DueDecember2023Member" abstract="true" name="SeniorNotes4DueDecember2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" abstract="false" name="DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ChangeInContractWithCustomerLiabilityRollForward" abstract="true" name="ChangeInContractWithCustomerLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_CVSHealth2017IncentiveCompensationPlanMember" abstract="true" name="CVSHealth2017IncentiveCompensationPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_CashFlowLesseeAbstract" abstract="true" name="CashFlowLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_BackUpCreditFacilitiesMember" abstract="true" name="BackUpCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodThreeMember" abstract="true" name="YearOfOriginationPeriodThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" abstract="false" name="RelatedPartyTransactionCharitableContributionToNonProfitEntity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_Category7Member" abstract="true" name="Category7Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3DueAugust2026Member" abstract="true" name="SeniorNotes3DueAugust2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PensionAndAnnuityInvestmentContractsInterest" abstract="false" name="PensionAndAnnuityInvestmentContractsInterest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cvs_RevolvingCreditFacilityExpiringMay172023Member" abstract="true" name="RevolvingCreditFacilityExpiringMay172023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesNoncurrent" abstract="false" name="OtherInsuranceLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDueYearTwo" abstract="false" name="LesseeLiabilityPaymentsDueYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4Point25PercentApril2050Member" abstract="true" name="SeniorNotes4Point25PercentApril2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.3DueMarch2028Member" abstract="true" name="SeniorNotes4.3DueMarch2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" abstract="false" name="HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" abstract="false" name="InvestmentContractsWithoutFixedMaturityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes3Point625PercentApril2027Member" abstract="true" name="SeniorNotes3Point625PercentApril2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" abstract="true" name="RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes3625DueApril2027Member" abstract="true" name="SeniorNotes3625DueApril2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" abstract="true" name="DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" abstract="false" name="ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesMember" abstract="true" name="OtherInsuranceLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PremiumsMember" abstract="true" name="PremiumsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" abstract="false" name="ContractualObligationsToMaintainLevelsOfSeparateAccounts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumberOfPlanMembers" abstract="false" name="NumberOfPlanMembers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_CommonAndCollectiveTrustsMember" abstract="true" name="CommonAndCollectiveTrustsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ActivityInMortgageLoanPortfolioTableTextBlock" abstract="false" name="ActivityInMortgageLoanPortfolioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" abstract="false" name="VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_BrazilSubsidiaryMember" abstract="true" name="BrazilSubsidiaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" abstract="false" name="CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_TotalInvestmentsTable" abstract="true" name="TotalInvestmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes2.875DueJune2026Member" abstract="true" name="SeniorNotes2.875DueJune2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" abstract="false" name="AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodTwoMember" abstract="true" name="YearOfOriginationPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_A2016RepurchaseProgramMember" abstract="true" name="A2016RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DenominatorForEarningsPerShareCalculationAbstract" abstract="true" name="DenominatorForEarningsPerShareCalculationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes375DueApril2030Member" abstract="true" name="SeniorNotes375DueApril2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PaymentsforInsuranceBenefits" abstract="false" name="PaymentsforInsuranceBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_WeightedAverageRemainingLeaseTermAbstract" abstract="true" name="WeightedAverageRemainingLeaseTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_FrontStoreRevenueMember" abstract="true" name="FrontStoreRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" abstract="true" name="MortgageLoansOnRealEstateYearOfOriginationAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_YearOfOriginationPriorToPeriodFiveMember" abstract="true" name="YearOfOriginationPriorToPeriodFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.5DueMay2042Member" abstract="true" name="SeniorNotes4.5DueMay2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PharmacyServicesSegmentMember" abstract="true" name="PharmacyServicesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_A2021AcceleratedRepurchaseProgramMember" abstract="true" name="A2021AcceleratedRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" abstract="true" name="FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_VariableInterestEntityAmendedContractTerm" abstract="false" name="VariableInterestEntityAmendedContractTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_SeparateAccountFinancialAssetsMember" abstract="true" name="SeparateAccountFinancialAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" abstract="false" name="ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes5.75DueMay2041Member" abstract="true" name="SeniorNotes5.75DueMay2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" abstract="false" name="BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" abstract="false" name="PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" abstract="false" name="FourYearsReinsuranceAgreementWithUnrelatedInsurer" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_PharmacyRevenueMember" abstract="true" name="PharmacyRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes5.125DueJuly2045Member" abstract="true" name="SeniorNotes5.125DueJuly2045Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_TotalInvestmentsDomain" abstract="true" name="TotalInvestmentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LongTermCareReportingUnitMember" abstract="true" name="LongTermCareReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NumeratorForEarningsPerShareCalculationAbstract" abstract="true" name="NumeratorForEarningsPerShareCalculationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_PharmacyRebatePeriod" abstract="false" name="PharmacyRebatePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_Initialcontractualterm" abstract="false" name="Initialcontractualterm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_NetRevenuesRetailCoPayments" abstract="false" name="NetRevenuesRetailCoPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock" abstract="false" name="FinitelivedandindefinitelivedintangibleassetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" abstract="false" name="StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="cvs_RetailLongTermCareSegmentMember" abstract="true" name="RetailLongTermCareSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LeasesWeightedAverageDiscountRateAbstract" abstract="true" name="LeasesWeightedAverageDiscountRateAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SharesHeldInTrustPolicyTextBlock" abstract="false" name="SharesHeldInTrustPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDue" abstract="false" name="LesseeLiabilityPaymentsDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_OtherInsuranceLiabilitiesCurrent" abstract="false" name="OtherInsuranceLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" abstract="false" name="ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure" abstract="false" name="OperatingLeaseRightOfUseAssetFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" abstract="false" name="TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes5DueDecember2024Member" abstract="true" name="SeniorNotes5DueDecember2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OtherAssetBackedSecuritiesMember" abstract="true" name="OtherAssetBackedSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.875DueJuly2025Member" abstract="true" name="SeniorNotes3.875DueJuly2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_AetnaInc2010StockIncentivePlanMember" abstract="true" name="AetnaInc2010StockIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.5DueJuly2022Member" abstract="true" name="SeniorNotes3.5DueJuly2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HealthInsurerFeeTaxEffectPercent" abstract="false" name="HealthInsurerFeeTaxEffectPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cvs_SeniorNotes4.875DueJuly2035Member" abstract="true" name="SeniorNotes4.875DueJuly2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.35DueMarch2021Member" abstract="true" name="SeniorNotes3.35DueMarch2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NumberOfPeopleServed" abstract="false" name="NumberOfPeopleServed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments" abstract="false" name="OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares" abstract="false" name="AcceleratedShareRepurchaseProgramMaximumNumberOfShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_SeniorNotes4.75DueDecember2022Member" abstract="true" name="SeniorNotes4.75DueDecember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_FloatingRateNotesDueMarch2021Member" abstract="true" name="FloatingRateNotesDueMarch2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" abstract="false" name="DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_InsuranceAndHmoMember" abstract="true" name="InsuranceAndHmoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_HeathSavingsAccountBalance" abstract="false" name="HeathSavingsAccountBalance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_EmployeeStockOptionsandStockAppreciationRightsMember" abstract="true" name="EmployeeStockOptionsandStockAppreciationRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_FloatingRateNotesDueMarch2020Member" abstract="true" name="FloatingRateNotesDueMarch2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.625DueAugust2024Member" abstract="true" name="SeniorNotes2.625DueAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NumberofWalkInMedicalClinics" abstract="false" name="NumberofWalkInMedicalClinics" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" abstract="false" name="DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" abstract="false" name="ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_RevolvingCreditFacilityExpiringMay112026Member" abstract="true" name="RevolvingCreditFacilityExpiringMay112026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LiabilityforUnpaidClaims" abstract="false" name="LiabilityforUnpaidClaims" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodFiveMember" abstract="true" name="YearOfOriginationPeriodFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OutstandingSeniorNotesMember" abstract="true" name="OutstandingSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_RestrictedStockUnitsandPerformanceShareUnitsMember" abstract="true" name="RestrictedStockUnitsandPerformanceShareUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes6.125DueSeptember2039Member" abstract="true" name="SeniorNotes6.125DueSeptember2039Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod" abstract="false" name="NumberOfStoresAnnualPlannedClosuresForClosurePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member" abstract="true" name="ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NumberOfStoresPlannedClosure" abstract="false" name="NumberOfStoresPlannedClosure" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SeniorNotes6.25DueJune2027Member" abstract="true" name="SeniorNotes6.25DueJune2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes4.1DueMarch2025Member" abstract="true" name="SeniorNotes4.1DueMarch2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_NumberofReinsuranceContractsEnteredInto" abstract="false" name="NumberofReinsuranceContractsEnteredInto" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" abstract="false" name="YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" abstract="true" name="LesseeLeasesLiabilitiesPaymentsDueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_SeniorNotes3.25DueAugust2029Member" abstract="true" name="SeniorNotes3.25DueAugust2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes1Point3PercentAugust2027Member" abstract="true" name="SeniorNotes1Point3PercentAugust2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_RadcliffAndFlaimVAetnaIncEtAlMember" abstract="true" name="RadcliffAndFlaimVAetnaIncEtAlMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_A2021RepurchaseProgramMember" abstract="true" name="A2021RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DrogariaOnofreLtdaMember" abstract="true" name="DrogariaOnofreLtdaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_GuarantorObligationsNumberofLeases" abstract="false" name="GuarantorObligationsNumberofLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_RedeemablePreferredSecuritiesMember" abstract="true" name="RedeemablePreferredSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateLoansFullyRepaid" abstract="false" name="MortgageLoansOnRealEstateLoansFullyRepaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TotalInvestmentsAxis" abstract="true" name="TotalInvestmentsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="cvs_LossContingencyAuditMethodologySampleSize" abstract="false" name="LossContingencyAuditMethodologySampleSize" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvs_SeniorNotes3.5DueNovember2024Member" abstract="true" name="SeniorNotes3.5DueNovember2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansMember" abstract="true" name="MortgageLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtAndEquitySecuritiesAvailableForSaleMember" abstract="true" name="DebtAndEquitySecuritiesAvailableForSaleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2Point7PercentAugust2040Member" abstract="true" name="SeniorNotes2Point7PercentAugust2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DebtExtinguishmentFees" abstract="false" name="DebtExtinguishmentFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" abstract="false" name="TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" abstract="false" name="InsurancePremiumDeficiencyReservePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_SeniorNotes1Point75PercentAugust2030Member" abstract="true" name="SeniorNotes1Point75PercentAugust2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDueAfterYearFive" abstract="false" name="LesseeLiabilityPaymentsDueAfterYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" abstract="false" name="ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" abstract="false" name="DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.78DueMarch2038Member" abstract="true" name="SeniorNotes4.78DueMarch2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodOneMember" abstract="true" name="YearOfOriginationPeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_DeferredTaxAssetsPayrollTaxDeferral" abstract="false" name="DeferredTaxAssetsPayrollTaxDeferral" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4.125DueJune2021Member" abstract="true" name="SeniorNotes4.125DueJune2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_VariableInterestEntityAmendedContractExtensionTerm" abstract="false" name="VariableInterestEntityAmendedContractExtensionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvs_BarclaysBankMember" abstract="true" name="BarclaysBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" abstract="false" name="InvestmentContractsWithFixedMaturityFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_Category1Member" abstract="true" name="Category1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" abstract="false" name="ContractWithCustomerLiabilityRedemptionAndBreakage" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_Categories5and6Member" abstract="true" name="Categories5and6Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LeaseLiability" abstract="false" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes6.625DueJune2036Member" abstract="true" name="SeniorNotes6.625DueJune2036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2.8DueJune2023Member" abstract="true" name="SeniorNotes2.8DueJune2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" abstract="false" name="MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes5.05DueMarch2048Member" abstract="true" name="SeniorNotes5.05DueMarch2048Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_AcceleratedShareRepurchasesAgreementAmount" abstract="false" name="AcceleratedShareRepurchasesAgreementAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_TotalInvestmentsTableTextBlock" abstract="false" name="TotalInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsDueYearThree" abstract="false" name="LesseeLiabilityPaymentsDueYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_InvestmentIncomeExcludingCapitalGainsorLosses" abstract="false" name="InvestmentIncomeExcludingCapitalGainsorLosses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts" abstract="false" name="NetGainFromWriteOffOfDeferredDebtIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes4125DueApril2040Member" abstract="true" name="SeniorNotes4125DueApril2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes2Point125PercentDueSeptember2031Member" abstract="true" name="SeniorNotes2Point125PercentDueSeptember2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_LesseeLiabilityUndiscountedExcessAmount" abstract="false" name="LesseeLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_SeniorNotes5.45DueJune2021Member" abstract="true" name="SeniorNotes5.45DueJune2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes6.75DueDecember2037Member" abstract="true" name="SeniorNotes6.75DueDecember2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_AdjustedOperatingIncomeLoss" abstract="false" name="AdjustedOperatingIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_LesseeLeaseTableTextBlock" abstract="false" name="LesseeLeaseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cvs_LesseeLiabilityPaymentsYearOne" abstract="false" name="LesseeLiabilityPaymentsYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_StoreImpairmentCharges" abstract="false" name="StoreImpairmentCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_AllOtherReinsurersMember" abstract="true" name="AllOtherReinsurersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_SeniorNotes3.875DueAugust2047Member" abstract="true" name="SeniorNotes3.875DueAugust2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" abstract="true" name="USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" abstract="false" name="OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_YearOfOriginationPeriodFourMember" abstract="true" name="YearOfOriginationPeriodFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" abstract="false" name="PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" abstract="false" name="FinanceLeaseRightOfUseAssetAccumulatedDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>cvs-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:101452a2-2146-4b57-8461-1c52c7d6326c,g:5f4a3ace-4815-405a-b6fd-039bed36fdc5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cvs-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_5aadde15-c034-48bb-be58-39f31e194ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_517f14b3-eb20-4a21-8b05-c555fc90ea4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_5aadde15-c034-48bb-be58-39f31e194ccd" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_517f14b3-eb20-4a21-8b05-c555fc90ea4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_ed915c8a-bcb7-45eb-974a-ba9c0d3f5a07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_5aadde15-c034-48bb-be58-39f31e194ccd" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_ed915c8a-bcb7-45eb-974a-ba9c0d3f5a07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_b87ef406-a047-48a3-9272-c3ad28ba17d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_5aadde15-c034-48bb-be58-39f31e194ccd" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_b87ef406-a047-48a3-9272-c3ad28ba17d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments_0b4ff355-9dcb-43c3-953b-29d5bb09e702" xlink:href="cvs-20211231.xsd#cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_5aadde15-c034-48bb-be58-39f31e194ccd" xlink:to="loc_cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments_0b4ff355-9dcb-43c3-953b-29d5bb09e702" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_128f4803-946d-4d18-a2fe-8f82bed33e81" xlink:href="cvs-20211231.xsd#cvs_StoreImpairmentCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_5aadde15-c034-48bb-be58-39f31e194ccd" xlink:to="loc_cvs_StoreImpairmentCharges_128f4803-946d-4d18-a2fe-8f82bed33e81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_83314e93-f9dd-4bed-8f9a-67c051c61e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_ea08ffca-d71f-4f5a-a9b8-a0438d05a0df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_83314e93-f9dd-4bed-8f9a-67c051c61e74" xlink:to="loc_us-gaap_CostsAndExpenses_ea08ffca-d71f-4f5a-a9b8-a0438d05a0df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_022756b3-ac5b-4f76-95ad-afa004eddd21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_83314e93-f9dd-4bed-8f9a-67c051c61e74" xlink:to="loc_us-gaap_Revenues_022756b3-ac5b-4f76-95ad-afa004eddd21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_13d988ce-134d-4e0b-8c1c-d651aa5dc9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c68c2325-a6cb-4e42-966a-7877b77437a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_13d988ce-134d-4e0b-8c1c-d651aa5dc9b6" xlink:to="loc_us-gaap_ProfitLoss_c68c2325-a6cb-4e42-966a-7877b77437a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6d6013f4-f07e-4c70-8211-3f0efd058e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_13d988ce-134d-4e0b-8c1c-d651aa5dc9b6" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6d6013f4-f07e-4c70-8211-3f0efd058e6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_9936f65e-dfa5-4f40-94c9-37d1d7fc6839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0f0497ce-90e8-403b-8440-413bac4d2800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_9936f65e-dfa5-4f40-94c9-37d1d7fc6839" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0f0497ce-90e8-403b-8440-413bac4d2800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7a116932-a2a8-4da6-b4f3-b8e81a0a2ead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_9936f65e-dfa5-4f40-94c9-37d1d7fc6839" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7a116932-a2a8-4da6-b4f3-b8e81a0a2ead" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5739f3d4-e82a-4133-9c63-de8dc1d9ec87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_344e01f8-21bd-438e-be21-d0e7344ecffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_5739f3d4-e82a-4133-9c63-de8dc1d9ec87" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_344e01f8-21bd-438e-be21-d0e7344ecffb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_0ca765b2-a6b3-4de2-b544-f993eb408f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_5739f3d4-e82a-4133-9c63-de8dc1d9ec87" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_0ca765b2-a6b3-4de2-b544-f993eb408f0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_62acdf0f-d669-4dd5-9d52-925ae62e7579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_e8f56bf7-cf60-4082-8006-2176e2df0a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_62acdf0f-d669-4dd5-9d52-925ae62e7579" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_e8f56bf7-cf60-4082-8006-2176e2df0a74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_87909b41-d9b6-48e5-bb14-563a1b74355f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_62acdf0f-d669-4dd5-9d52-925ae62e7579" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_87909b41-d9b6-48e5-bb14-563a1b74355f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c0c64571-6ebf-48c9-9daa-4072cab2ee51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_a0eec6a8-e51e-44bd-aa47-614ea27e239d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_c0c64571-6ebf-48c9-9daa-4072cab2ee51" xlink:to="loc_us-gaap_NetInvestmentIncome_a0eec6a8-e51e-44bd-aa47-614ea27e239d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_1126d92e-e4ef-4f6d-82a7-ebfda11ba40a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_c0c64571-6ebf-48c9-9daa-4072cab2ee51" xlink:to="loc_us-gaap_PremiumsEarnedNet_1126d92e-e4ef-4f6d-82a7-ebfda11ba40a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_47ab6c26-7e5e-40d3-9532-b0f1b66b2047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_c0c64571-6ebf-48c9-9daa-4072cab2ee51" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_47ab6c26-7e5e-40d3-9532-b0f1b66b2047" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c7e43b3f-8faf-4882-92ec-63837d4499e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_02ee7dc3-ca1c-43cc-898e-b4a581fa2c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c7e43b3f-8faf-4882-92ec-63837d4499e2" xlink:to="loc_us-gaap_OperatingIncomeLoss_02ee7dc3-ca1c-43cc-898e-b4a581fa2c3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_496b9736-560b-4fc6-8994-5723c0a92912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c7e43b3f-8faf-4882-92ec-63837d4499e2" xlink:to="loc_us-gaap_InterestExpense_496b9736-560b-4fc6-8994-5723c0a92912" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0cae4de9-e8ef-4ac3-b10b-19b115ff6689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c7e43b3f-8faf-4882-92ec-63837d4499e2" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_0cae4de9-e8ef-4ac3-b10b-19b115ff6689" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c6105e3d-d65d-44cb-84ad-32bef37ef258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c7e43b3f-8faf-4882-92ec-63837d4499e2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_c6105e3d-d65d-44cb-84ad-32bef37ef258" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c3b29c8a-e7a6-4709-bdbf-8a74598bec50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d39207f6-cca8-4775-b8c2-e693cb442f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_c3b29c8a-e7a6-4709-bdbf-8a74598bec50" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d39207f6-cca8-4775-b8c2-e693cb442f27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_bdf6165f-6863-407b-b3ad-b61ca596b21a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_c3b29c8a-e7a6-4709-bdbf-8a74598bec50" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_bdf6165f-6863-407b-b3ad-b61ca596b21a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="cvs-20211231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_384ddc01-8623-4a19-91dc-b8f16777e236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_98b1f394-45fd-4306-9362-c9f175752f88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_384ddc01-8623-4a19-91dc-b8f16777e236" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_98b1f394-45fd-4306-9362-c9f175752f88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_0a6cdb8c-4b80-4fcd-a01d-f74ec6085f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_384ddc01-8623-4a19-91dc-b8f16777e236" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_0a6cdb8c-4b80-4fcd-a01d-f74ec6085f4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_53bd0e69-a41e-4c97-bbeb-a84a85a72e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_384ddc01-8623-4a19-91dc-b8f16777e236" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_53bd0e69-a41e-4c97-bbeb-a84a85a72e2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e94b477d-a0b1-4753-a22c-4fb8ba749609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_384ddc01-8623-4a19-91dc-b8f16777e236" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e94b477d-a0b1-4753-a22c-4fb8ba749609" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d6416149-42ef-4235-9a36-7433e108d230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6e4d3d46-8e7e-4659-aec6-da0e32d52dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d6416149-42ef-4235-9a36-7433e108d230" xlink:to="loc_us-gaap_ProfitLoss_6e4d3d46-8e7e-4659-aec6-da0e32d52dbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d47f5360-7567-4b19-a44a-b64f15ba487c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d6416149-42ef-4235-9a36-7433e108d230" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d47f5360-7567-4b19-a44a-b64f15ba487c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7bb7c21e-7f08-4dc5-a0e0-248c928c039a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_21cd52a6-7d22-4f6e-86a8-17d660aa3a26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_7bb7c21e-7f08-4dc5-a0e0-248c928c039a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_21cd52a6-7d22-4f6e-86a8-17d660aa3a26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0502a393-7b4b-41a7-98f5-fe7ca2c6f080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_7bb7c21e-7f08-4dc5-a0e0-248c928c039a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0502a393-7b4b-41a7-98f5-fe7ca2c6f080" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cvs-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_06c9eb81-99e9-4050-9e33-80eedc2a1480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_ca82313f-dbb2-485b-b8b0-e0cf6375ae56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_06c9eb81-99e9-4050-9e33-80eedc2a1480" xlink:to="loc_us-gaap_PreferredStockValue_ca82313f-dbb2-485b-b8b0-e0cf6375ae56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_804aebcf-f293-4c55-9fb5-40f8b0dbd908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_06c9eb81-99e9-4050-9e33-80eedc2a1480" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_804aebcf-f293-4c55-9fb5-40f8b0dbd908" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_94789d28-66b7-46cf-9233-fdd4b47fc45c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_06c9eb81-99e9-4050-9e33-80eedc2a1480" xlink:to="loc_us-gaap_TreasuryStockValue_94789d28-66b7-46cf-9233-fdd4b47fc45c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_976a9cad-5e6b-40f2-817d-bbd84838b209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_06c9eb81-99e9-4050-9e33-80eedc2a1480" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_976a9cad-5e6b-40f2-817d-bbd84838b209" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0917b1b0-3131-4852-9839-2aaf27448393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_06c9eb81-99e9-4050-9e33-80eedc2a1480" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0917b1b0-3131-4852-9839-2aaf27448393" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_fc995ae8-4995-4928-8d16-b91b7df9e5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_97cafbab-61d5-44c9-86f3-6a43b5cc7f21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fc995ae8-4995-4928-8d16-b91b7df9e5d8" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_97cafbab-61d5-44c9-86f3-6a43b5cc7f21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_74bcef52-f0b0-40d2-aaf3-4fd35fe9fae4" xlink:href="cvs-20211231.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fc995ae8-4995-4928-8d16-b91b7df9e5d8" xlink:to="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_74bcef52-f0b0-40d2-aaf3-4fd35fe9fae4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_0e81e48f-a96a-492a-987c-b5b72b20c54c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fc995ae8-4995-4928-8d16-b91b7df9e5d8" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_0e81e48f-a96a-492a-987c-b5b72b20c54c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_16e58aab-6184-41c5-a218-b8f28992669f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fc995ae8-4995-4928-8d16-b91b7df9e5d8" xlink:to="loc_us-gaap_OtherPolicyholderFunds_16e58aab-6184-41c5-a218-b8f28992669f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_99b1b08e-0047-415d-9862-50efccb7df84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fc995ae8-4995-4928-8d16-b91b7df9e5d8" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_99b1b08e-0047-415d-9862-50efccb7df84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_5ff3af78-a353-411a-afeb-3cfc0eb34b64" xlink:href="cvs-20211231.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fc995ae8-4995-4928-8d16-b91b7df9e5d8" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_5ff3af78-a353-411a-afeb-3cfc0eb34b64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_59fc1a64-966a-49c7-8a10-bb6e23685ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fc995ae8-4995-4928-8d16-b91b7df9e5d8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_59fc1a64-966a-49c7-8a10-bb6e23685ac3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a90965e3-d7c2-4c49-ae3f-a210a82aa5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_fc995ae8-4995-4928-8d16-b91b7df9e5d8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a90965e3-d7c2-4c49-ae3f-a210a82aa5f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c90cc0f5-18e3-4bcd-b85a-8e8012dabdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_325efbba-edc6-4e55-9601-977f6c32c8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c90cc0f5-18e3-4bcd-b85a-8e8012dabdcd" xlink:to="loc_us-gaap_Liabilities_325efbba-edc6-4e55-9601-977f6c32c8cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_46c7d1f1-2a67-44b5-a7a9-c331dd1f1166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c90cc0f5-18e3-4bcd-b85a-8e8012dabdcd" xlink:to="loc_us-gaap_CommitmentsAndContingencies_46c7d1f1-2a67-44b5-a7a9-c331dd1f1166" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f48fdd1a-9fff-4ee1-85a2-b1fd5b3353fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c90cc0f5-18e3-4bcd-b85a-8e8012dabdcd" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f48fdd1a-9fff-4ee1-85a2-b1fd5b3353fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_49d38b03-8ef1-4f75-9a58-fc9318499bae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_afda52aa-7120-4ed2-99db-04cbc2cd6c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_49d38b03-8ef1-4f75-9a58-fc9318499bae" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_afda52aa-7120-4ed2-99db-04cbc2cd6c3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0d2150c2-0be9-4c96-a8d6-0c96b2829a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_49d38b03-8ef1-4f75-9a58-fc9318499bae" xlink:to="loc_us-gaap_AssetsCurrent_0d2150c2-0be9-4c96-a8d6-0c96b2829a7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7c792835-be5a-409b-a248-b572bcd825d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_49d38b03-8ef1-4f75-9a58-fc9318499bae" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7c792835-be5a-409b-a248-b572bcd825d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_2fbf84d0-097c-4042-b9c2-6c333c723d69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_49d38b03-8ef1-4f75-9a58-fc9318499bae" xlink:to="loc_us-gaap_SeparateAccountAssets_2fbf84d0-097c-4042-b9c2-6c333c723d69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_06bb347a-be43-49e8-91a9-77f0341e492f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_49d38b03-8ef1-4f75-9a58-fc9318499bae" xlink:to="loc_us-gaap_Goodwill_06bb347a-be43-49e8-91a9-77f0341e492f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cbc56b3d-d3ac-4b4b-95ce-559b37c5b800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_49d38b03-8ef1-4f75-9a58-fc9318499bae" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cbc56b3d-d3ac-4b4b-95ce-559b37c5b800" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_0fae71e8-0323-454c-8133-13e8311fb7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_49d38b03-8ef1-4f75-9a58-fc9318499bae" xlink:to="loc_us-gaap_LongTermInvestments_0fae71e8-0323-454c-8133-13e8311fb7e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_b04ac747-9362-434e-b1d7-5c4b69d9b0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_49d38b03-8ef1-4f75-9a58-fc9318499bae" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_b04ac747-9362-434e-b1d7-5c4b69d9b0bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_4824561e-fc6d-4cf9-95a3-47688e59bf8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_86b07895-a33e-467a-b940-1f56857427f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4824561e-fc6d-4cf9-95a3-47688e59bf8d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_86b07895-a33e-467a-b940-1f56857427f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_653e5746-2160-4699-84e7-e0e1bbe13065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4824561e-fc6d-4cf9-95a3-47688e59bf8d" xlink:to="loc_us-gaap_ShortTermInvestments_653e5746-2160-4699-84e7-e0e1bbe13065" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_353c05fd-caef-444e-b6cd-87d3e228df33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4824561e-fc6d-4cf9-95a3-47688e59bf8d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_353c05fd-caef-444e-b6cd-87d3e228df33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_cf962b47-4b6b-43f0-9774-24ffe4a0582f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4824561e-fc6d-4cf9-95a3-47688e59bf8d" xlink:to="loc_us-gaap_InventoryNet_cf962b47-4b6b-43f0-9774-24ffe4a0582f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_c512a270-fea4-4d95-ad6a-95777a22b42a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4824561e-fc6d-4cf9-95a3-47688e59bf8d" xlink:to="loc_us-gaap_OtherAssetsCurrent_c512a270-fea4-4d95-ad6a-95777a22b42a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_becea9a9-df5f-4e44-88f2-a82bb8b0a9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_68c64eb5-e5f0-4306-8032-2a1a780c2696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_becea9a9-df5f-4e44-88f2-a82bb8b0a9ca" xlink:to="loc_us-gaap_StockholdersEquity_68c64eb5-e5f0-4306-8032-2a1a780c2696" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_9980b822-d165-4127-95c0-2cc3e3ada796" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_becea9a9-df5f-4e44-88f2-a82bb8b0a9ca" xlink:to="loc_us-gaap_MinorityInterest_9980b822-d165-4127-95c0-2cc3e3ada796" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f06a9ddd-f080-4343-a8df-026ffc7e4837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7c4e1464-ed06-4fb2-aab2-12a1b446384b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f06a9ddd-f080-4343-a8df-026ffc7e4837" xlink:to="loc_us-gaap_LiabilitiesCurrent_7c4e1464-ed06-4fb2-aab2-12a1b446384b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_90603995-64c0-4764-ab5b-588dbb708cac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f06a9ddd-f080-4343-a8df-026ffc7e4837" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_90603995-64c0-4764-ab5b-588dbb708cac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f74c4af8-197a-4445-b363-4412d13309ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f06a9ddd-f080-4343-a8df-026ffc7e4837" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f74c4af8-197a-4445-b363-4412d13309ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_d08bf10d-8068-4b3e-a04b-2fc7a1312628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f06a9ddd-f080-4343-a8df-026ffc7e4837" xlink:to="loc_us-gaap_SeparateAccountsLiability_d08bf10d-8068-4b3e-a04b-2fc7a1312628" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_81edce54-bcb4-4f5d-a1bb-2bc66d8b9e98" xlink:href="cvs-20211231.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f06a9ddd-f080-4343-a8df-026ffc7e4837" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_81edce54-bcb4-4f5d-a1bb-2bc66d8b9e98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_58a4d180-ca5c-4868-a4f8-cf6435cd8949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f06a9ddd-f080-4343-a8df-026ffc7e4837" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_58a4d180-ca5c-4868-a4f8-cf6435cd8949" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1f1bee0b-7ec5-4867-9bb1-9f58ee7f04f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f06a9ddd-f080-4343-a8df-026ffc7e4837" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1f1bee0b-7ec5-4867-9bb1-9f58ee7f04f1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cvs-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7d20cd26-b6a0-4898-8d55-34edc5f1812d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c1350e5d-938c-4c3e-9661-3f781f15a275" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7d20cd26-b6a0-4898-8d55-34edc5f1812d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c1350e5d-938c-4c3e-9661-3f781f15a275" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3f015e9a-be40-4def-aaec-f00b9a88caed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7d20cd26-b6a0-4898-8d55-34edc5f1812d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3f015e9a-be40-4def-aaec-f00b9a88caed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e49421bf-a03d-4347-ab3a-6bbb375d332d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7d20cd26-b6a0-4898-8d55-34edc5f1812d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e49421bf-a03d-4347-ab3a-6bbb375d332d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_228ae819-ef3c-4b47-97e7-59c1fb9bb79b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0ed240f1-c027-45fd-8dcb-8d245588652d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_228ae819-ef3c-4b47-97e7-59c1fb9bb79b" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_0ed240f1-c027-45fd-8dcb-8d245588652d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a55a5a1f-01c5-4ce0-8549-c6eebf1e6464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_228ae819-ef3c-4b47-97e7-59c1fb9bb79b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a55a5a1f-01c5-4ce0-8549-c6eebf1e6464" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_62854eaf-6b43-48a0-83f6-c0e67a293733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_228ae819-ef3c-4b47-97e7-59c1fb9bb79b" xlink:to="loc_us-gaap_PaymentsOfDividends_62854eaf-6b43-48a0-83f6-c0e67a293733" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_47795b85-68bb-4e4c-9fe8-0ec45c4edc27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_228ae819-ef3c-4b47-97e7-59c1fb9bb79b" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_47795b85-68bb-4e4c-9fe8-0ec45c4edc27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_94155347-d793-431d-afc5-5968ad8167b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_228ae819-ef3c-4b47-97e7-59c1fb9bb79b" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_94155347-d793-431d-afc5-5968ad8167b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7e1a958c-e977-4912-8b49-79258b1c6318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_228ae819-ef3c-4b47-97e7-59c1fb9bb79b" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7e1a958c-e977-4912-8b49-79258b1c6318" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_514c3b06-9717-45c7-801f-b849494f3816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_228ae819-ef3c-4b47-97e7-59c1fb9bb79b" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_514c3b06-9717-45c7-801f-b849494f3816" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_82455b48-c024-49f9-8f19-59a213075ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_228ae819-ef3c-4b47-97e7-59c1fb9bb79b" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_82455b48-c024-49f9-8f19-59a213075ce0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc5efadf-1635-4a3b-8e0c-656b867b43dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_4757c906-3e92-4e5b-93b2-dcd931977f46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc5efadf-1635-4a3b-8e0c-656b867b43dc" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_4757c906-3e92-4e5b-93b2-dcd931977f46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_8e27ecb0-cd9c-469e-8ae9-80abe97f195d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc5efadf-1635-4a3b-8e0c-656b867b43dc" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_8e27ecb0-cd9c-469e-8ae9-80abe97f195d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_0c4a0048-73d6-4bee-b6df-485968116b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc5efadf-1635-4a3b-8e0c-656b867b43dc" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_0c4a0048-73d6-4bee-b6df-485968116b7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_acb4397a-0003-4d8f-acda-7f7b9c3d43ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc5efadf-1635-4a3b-8e0c-656b867b43dc" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_acb4397a-0003-4d8f-acda-7f7b9c3d43ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_862b6161-1c45-47de-a19f-e4784677a11c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc5efadf-1635-4a3b-8e0c-656b867b43dc" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_862b6161-1c45-47de-a19f-e4784677a11c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6d689fb3-77ee-491e-b028-f77159834f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc5efadf-1635-4a3b-8e0c-656b867b43dc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6d689fb3-77ee-491e-b028-f77159834f8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_be31cf1e-c32e-425c-b5dc-d16639c0129f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc5efadf-1635-4a3b-8e0c-656b867b43dc" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_be31cf1e-c32e-425c-b5dc-d16639c0129f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_f5793f6c-c668-495c-9a56-5d4bc7787598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc5efadf-1635-4a3b-8e0c-656b867b43dc" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_f5793f6c-c668-495c-9a56-5d4bc7787598" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8112cf23-7996-4a07-9712-ce61e3856aff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc5efadf-1635-4a3b-8e0c-656b867b43dc" xlink:to="loc_us-gaap_ProfitLoss_8112cf23-7996-4a07-9712-ce61e3856aff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_f8d07447-6379-4a31-8f1f-9c895a1d06e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc5efadf-1635-4a3b-8e0c-656b867b43dc" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_f8d07447-6379-4a31-8f1f-9c895a1d06e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_e3f07043-33b7-4526-b3f0-48638bc21860" xlink:href="cvs-20211231.xsd#cvs_StoreImpairmentCharges"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc5efadf-1635-4a3b-8e0c-656b867b43dc" xlink:to="loc_cvs_StoreImpairmentCharges_e3f07043-33b7-4526-b3f0-48638bc21860" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_6628783f-922d-4b6b-820e-962611417df2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc5efadf-1635-4a3b-8e0c-656b867b43dc" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_6628783f-922d-4b6b-820e-962611417df2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_ec901c6a-cef1-405f-b4ad-08fa186245a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc5efadf-1635-4a3b-8e0c-656b867b43dc" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_ec901c6a-cef1-405f-b4ad-08fa186245a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_82255f27-760f-4dc7-8054-29e5d651c146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc5efadf-1635-4a3b-8e0c-656b867b43dc" xlink:to="loc_us-gaap_ShareBasedCompensation_82255f27-760f-4dc7-8054-29e5d651c146" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_86efd1bd-b212-4fa0-add6-c01b9942a6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fc5efadf-1635-4a3b-8e0c-656b867b43dc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_86efd1bd-b212-4fa0-add6-c01b9942a6f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aeb5194e-933b-473a-b34c-f627051a7120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_300fdda6-02df-4b36-9284-999fd7d9644a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aeb5194e-933b-473a-b34c-f627051a7120" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_300fdda6-02df-4b36-9284-999fd7d9644a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_eeaa8087-0f48-49c9-815e-6f9d27a1192a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aeb5194e-933b-473a-b34c-f627051a7120" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_eeaa8087-0f48-49c9-815e-6f9d27a1192a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_ffb2d8f1-e43b-480c-8b93-0c076a6c9818" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aeb5194e-933b-473a-b34c-f627051a7120" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_ffb2d8f1-e43b-480c-8b93-0c076a6c9818" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_fe939d74-3a94-4b85-abfe-f7e140d50ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aeb5194e-933b-473a-b34c-f627051a7120" xlink:to="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_fe939d74-3a94-4b85-abfe-f7e140d50ff7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_36b2aa38-f6ba-4beb-8602-e22774449184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aeb5194e-933b-473a-b34c-f627051a7120" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_36b2aa38-f6ba-4beb-8602-e22774449184" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2d0ea2de-2cb1-4971-9e17-baaf7bf0c0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aeb5194e-933b-473a-b34c-f627051a7120" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_2d0ea2de-2cb1-4971-9e17-baaf7bf0c0b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_23735cf3-90dd-4196-bab3-044c0a956ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aeb5194e-933b-473a-b34c-f627051a7120" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_23735cf3-90dd-4196-bab3-044c0a956ed7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1" xlink:type="simple" xlink:href="cvs-20211231.xsd#ConsolidatedStatementsofCashFlows_1"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_314bb498-59c2-42e6-8a25-312368cd624e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_b8658689-8106-48b8-996f-9885a0ebef9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_314bb498-59c2-42e6-8a25-312368cd624e" xlink:to="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_b8658689-8106-48b8-996f-9885a0ebef9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_c402c057-1c5f-4069-a9c9-8f8e8387b45f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_314bb498-59c2-42e6-8a25-312368cd624e" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_c402c057-1c5f-4069-a9c9-8f8e8387b45f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_fbaec53c-0c43-4a78-bab7-afb8f07064cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_314bb498-59c2-42e6-8a25-312368cd624e" xlink:to="loc_us-gaap_ProceedsFromCustomers_fbaec53c-0c43-4a78-bab7-afb8f07064cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits_5e18b813-6ded-45a5-b5a9-25c4b2d0df87" xlink:href="cvs-20211231.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_314bb498-59c2-42e6-8a25-312368cd624e" xlink:to="loc_cvs_PaymentsforInsuranceBenefits_5e18b813-6ded-45a5-b5a9-25c4b2d0df87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees_712d4a50-ab44-45f1-956a-28415d07da0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_314bb498-59c2-42e6-8a25-312368cd624e" xlink:to="loc_us-gaap_PaymentsToSuppliersAndEmployees_712d4a50-ab44-45f1-956a-28415d07da0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_e1f9aba4-f420-4eb4-a43b-fab935d998ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_314bb498-59c2-42e6-8a25-312368cd624e" xlink:to="loc_us-gaap_InterestPaidNet_e1f9aba4-f420-4eb4-a43b-fab935d998ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_c1b795c0-a6a5-4ea5-a342-2d63c9ec2948" xlink:href="cvs-20211231.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_314bb498-59c2-42e6-8a25-312368cd624e" xlink:to="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_c1b795c0-a6a5-4ea5-a342-2d63c9ec2948" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cd1bcf8b-d2e3-48a4-8064-654b60976d12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_7429657a-9356-4fc3-9eac-23666586fe24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cd1bcf8b-d2e3-48a4-8064-654b60976d12" xlink:to="loc_us-gaap_RestrictedCashCurrent_7429657a-9356-4fc3-9eac-23666586fe24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_8088f324-5c4c-4ddc-aded-11e7cc7ba008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cd1bcf8b-d2e3-48a4-8064-654b60976d12" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_8088f324-5c4c-4ddc-aded-11e7cc7ba008" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f783b69b-9964-427b-8f3c-e7d0c972a50b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cd1bcf8b-d2e3-48a4-8064-654b60976d12" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f783b69b-9964-427b-8f3c-e7d0c972a50b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_90a2e296-9ce4-48de-a7a6-39ed3e24ff0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_eb9e2acc-1539-49fd-8f31-b0e9f4d37f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_90a2e296-9ce4-48de-a7a6-39ed3e24ff0d" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_eb9e2acc-1539-49fd-8f31-b0e9f4d37f4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_0197c58f-a8d8-45ca-b713-8bbeaedcdf5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_90a2e296-9ce4-48de-a7a6-39ed3e24ff0d" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_0197c58f-a8d8-45ca-b713-8bbeaedcdf5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_dfa31bdb-df37-4098-8739-621317f7f378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_90a2e296-9ce4-48de-a7a6-39ed3e24ff0d" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_dfa31bdb-df37-4098-8739-621317f7f378" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables_3c55a205-947d-4fbf-aab5-a005be36d859" xlink:href="cvs-20211231.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_90a2e296-9ce4-48de-a7a6-39ed3e24ff0d" xlink:to="loc_cvs_VendorandManufacturerReceivables_3c55a205-947d-4fbf-aab5-a005be36d859" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d3cdb3d2-f382-4677-9a18-2d41f24c1855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_3b3b0265-149b-45e2-b1e9-acd971b00fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d3cdb3d2-f382-4677-9a18-2d41f24c1855" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_3b3b0265-149b-45e2-b1e9-acd971b00fb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2e5645cb-73e1-47c0-8ee6-459888ecce27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d3cdb3d2-f382-4677-9a18-2d41f24c1855" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2e5645cb-73e1-47c0-8ee6-459888ecce27" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesDiscontinuedOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_a70d433c-ef78-483c-98f4-e89dd0cb6a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_16c531c3-20a6-4b53-9082-c1325ce89cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_a70d433c-ef78-483c-98f4-e89dd0cb6a86" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_16c531c3-20a6-4b53-9082-c1325ce89cb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_ce15c89a-adce-4e87-95cb-fd3bb1c690f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_a70d433c-ef78-483c-98f4-e89dd0cb6a86" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_ce15c89a-adce-4e87-95cb-fd3bb1c690f3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsScheduleofTotalInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_d2998bf0-769f-48b8-b9ac-2e9db4af2456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_19d9d987-2e11-4a61-97ea-15b5679dcdcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_d2998bf0-769f-48b8-b9ac-2e9db4af2456" xlink:to="loc_us-gaap_ShortTermInvestments_19d9d987-2e11-4a61-97ea-15b5679dcdcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_927f2a9a-c5c4-45a5-a652-80ff1b2764f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_d2998bf0-769f-48b8-b9ac-2e9db4af2456" xlink:to="loc_us-gaap_LongTermInvestments_927f2a9a-c5c4-45a5-a652-80ff1b2764f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_6edf301f-cd68-49d8-8885-52051688f89e" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3163b7ef-7563-4b98-92a2-544f16ade402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_6edf301f-cd68-49d8-8885-52051688f89e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3163b7ef-7563-4b98-92a2-544f16ade402" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_eb746a76-c1e4-417e-a2ea-5f79faaef283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_6edf301f-cd68-49d8-8885-52051688f89e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_eb746a76-c1e4-417e-a2ea-5f79faaef283" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_069b5857-f887-439e-ad28-770449176f82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_6edf301f-cd68-49d8-8885-52051688f89e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_069b5857-f887-439e-ad28-770449176f82" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ca3a21ed-f506-4e99-8b8b-d9c3929ad939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_2fb427a0-e6ad-4aa5-b84b-ea220cb45cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ca3a21ed-f506-4e99-8b8b-d9c3929ad939" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_2fb427a0-e6ad-4aa5-b84b-ea220cb45cbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_c84c86ba-1840-41b6-bc34-a536154cd324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ca3a21ed-f506-4e99-8b8b-d9c3929ad939" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_c84c86ba-1840-41b6-bc34-a536154cd324" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_5f1e3b7a-31bd-44e8-a6e0-fb8c85ad6919" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ca3a21ed-f506-4e99-8b8b-d9c3929ad939" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_5f1e3b7a-31bd-44e8-a6e0-fb8c85ad6919" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_65a1b936-7866-4002-9ee7-a4cc326218e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ca3a21ed-f506-4e99-8b8b-d9c3929ad939" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_65a1b936-7866-4002-9ee7-a4cc326218e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_c8b4faa2-70e3-482d-b0bd-2e228aab114f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ca3a21ed-f506-4e99-8b8b-d9c3929ad939" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_c8b4faa2-70e3-482d-b0bd-2e228aab114f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_3f8d0e64-660f-43ad-82c9-94da49755d10" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_83f95e97-961b-418c-b004-7e7c986339f7" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_3f8d0e64-660f-43ad-82c9-94da49755d10" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_83f95e97-961b-418c-b004-7e7c986339f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_087dd66c-81f8-4512-8975-f47a1958c0f6" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_3f8d0e64-660f-43ad-82c9-94da49755d10" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_087dd66c-81f8-4512-8975-f47a1958c0f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_f4d8da75-f1a0-4722-a65b-5912f0e27122" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_3f8d0e64-660f-43ad-82c9-94da49755d10" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_f4d8da75-f1a0-4722-a65b-5912f0e27122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_54308e7f-7afb-4cab-b505-fc92ccdd8094" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_3f8d0e64-660f-43ad-82c9-94da49755d10" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_54308e7f-7afb-4cab-b505-fc92ccdd8094" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_4505786f-c0ff-43a1-9cde-8261d1dae690" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_3f8d0e64-660f-43ad-82c9-94da49755d10" xlink:to="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_4505786f-c0ff-43a1-9cde-8261d1dae690" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_b3f4c95d-0477-4643-b97c-4ed90531e026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_bfad03f0-666e-4d2f-8c95-264b1c6c49b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_b3f4c95d-0477-4643-b97c-4ed90531e026" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_bfad03f0-666e-4d2f-8c95-264b1c6c49b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_d0fdf6e2-cf4d-44ee-b98e-2008f517ca3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_b3f4c95d-0477-4643-b97c-4ed90531e026" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_d0fdf6e2-cf4d-44ee-b98e-2008f517ca3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_6c7216a3-6914-48ec-bb41-b7746e83e99e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_779f49df-be59-469d-9c83-a7cc9b9a4b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_6c7216a3-6914-48ec-bb41-b7746e83e99e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_779f49df-be59-469d-9c83-a7cc9b9a4b09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_71c07028-173d-4b0c-8b55-40d489f05659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_6c7216a3-6914-48ec-bb41-b7746e83e99e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_71c07028-173d-4b0c-8b55-40d489f05659" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_36653202-eaec-48e6-9500-2691dfd29faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_7bf20ae4-08bf-41fe-8f3f-62ebdecc7c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_36653202-eaec-48e6-9500-2691dfd29faf" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_7bf20ae4-08bf-41fe-8f3f-62ebdecc7c43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_e52d3309-b005-471e-a063-265e39503ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_36653202-eaec-48e6-9500-2691dfd29faf" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_e52d3309-b005-471e-a063-265e39503ec2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_9d220ca7-a9ed-41ff-a551-086d3bebbd9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_28dd9308-a6a8-4b4b-96c8-240754f1189e" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_9d220ca7-a9ed-41ff-a551-086d3bebbd9d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_28dd9308-a6a8-4b4b-96c8-240754f1189e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_a0a6f875-bfd2-43f1-b7d7-b01072a957b4" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_9d220ca7-a9ed-41ff-a551-086d3bebbd9d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_a0a6f875-bfd2-43f1-b7d7-b01072a957b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_38667fee-f070-4c04-ac1d-3734d839d3b3" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_9d220ca7-a9ed-41ff-a551-086d3bebbd9d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_38667fee-f070-4c04-ac1d-3734d839d3b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_43396c62-0f16-4104-bc2c-ac8c0103770e" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_9d220ca7-a9ed-41ff-a551-086d3bebbd9d" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_43396c62-0f16-4104-bc2c-ac8c0103770e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_498fdb0c-db07-49d6-928d-624c56be7d40" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_9d220ca7-a9ed-41ff-a551-086d3bebbd9d" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_498fdb0c-db07-49d6-928d-624c56be7d40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_871f5dc4-0f35-413c-923a-5daadec99640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_20cd8afc-19e5-4a8b-ab96-d58d58bb3344" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_871f5dc4-0f35-413c-923a-5daadec99640" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_20cd8afc-19e5-4a8b-ab96-d58d58bb3344" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_82f5cdfc-eb35-46c6-9947-2b8f426f323f" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_871f5dc4-0f35-413c-923a-5daadec99640" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_82f5cdfc-eb35-46c6-9947-2b8f426f323f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_c5cd53df-fe61-4a79-b837-66438031a24d" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_871f5dc4-0f35-413c-923a-5daadec99640" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_c5cd53df-fe61-4a79-b837-66438031a24d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_44e2c261-6700-4d0b-8f50-594e13fb31db" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_871f5dc4-0f35-413c-923a-5daadec99640" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_44e2c261-6700-4d0b-8f50-594e13fb31db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_1ee8bcbc-0123-4ede-926a-b7ada12c7b95" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_871f5dc4-0f35-413c-923a-5daadec99640" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_1ee8bcbc-0123-4ede-926a-b7ada12c7b95" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_244eaf47-98e4-4ff9-9ef5-d61ca3b6d629" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_1e1d85cc-3775-4c6c-a1dc-1cf649cf2b15" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_244eaf47-98e4-4ff9-9ef5-d61ca3b6d629" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_1e1d85cc-3775-4c6c-a1dc-1cf649cf2b15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_db645656-2167-4d69-b366-c9f63f5e4773" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_244eaf47-98e4-4ff9-9ef5-d61ca3b6d629" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_db645656-2167-4d69-b366-c9f63f5e4773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_412416b3-35e5-40f9-8f5b-5011fb606758" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_244eaf47-98e4-4ff9-9ef5-d61ca3b6d629" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_412416b3-35e5-40f9-8f5b-5011fb606758" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_dfa00701-e680-4cb0-8802-e88a080a5dbf" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_244eaf47-98e4-4ff9-9ef5-d61ca3b6d629" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_dfa00701-e680-4cb0-8802-e88a080a5dbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_802b82df-e517-4bf7-9024-903167b8e728" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_244eaf47-98e4-4ff9-9ef5-d61ca3b6d629" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_802b82df-e517-4bf7-9024-903167b8e728" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_8738a8aa-c20e-48c4-97b2-f6d5e7ffe763" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_244eaf47-98e4-4ff9-9ef5-d61ca3b6d629" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_8738a8aa-c20e-48c4-97b2-f6d5e7ffe763" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_584476b5-a7e3-47bb-9025-efb3ea238bad" xlink:href="cvs-20211231.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_db71b9f3-e442-4cbc-8af6-e2b876d0f439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_584476b5-a7e3-47bb-9025-efb3ea238bad" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_db71b9f3-e442-4cbc-8af6-e2b876d0f439" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_29799ca0-b6cb-496c-a5cf-d00b0d866f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_584476b5-a7e3-47bb-9025-efb3ea238bad" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_29799ca0-b6cb-496c-a5cf-d00b0d866f7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_6bb84b9f-a7f0-4b4b-b048-8e4c63ad56dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_c6d64639-da5d-463d-a3b9-41e126eb9a0f" xlink:href="cvs-20211231.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeNet_6bb84b9f-a7f0-4b4b-b048-8e4c63ad56dc" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_c6d64639-da5d-463d-a3b9-41e126eb9a0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_924b8256-b2a9-4bc2-9723-da25c7dfe53a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InvestmentIncomeNet_6bb84b9f-a7f0-4b4b-b048-8e4c63ad56dc" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_924b8256-b2a9-4bc2-9723-da25c7dfe53a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#FairValueFairValueMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_780bb323-5d23-4ac8-a742-94ff3e2de9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_018b3a04-f96c-4a92-b8e3-5b3107656242" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_780bb323-5d23-4ac8-a742-94ff3e2de9a1" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_018b3a04-f96c-4a92-b8e3-5b3107656242" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_935d323f-8d98-4729-8662-b5f29fa9504f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_780bb323-5d23-4ac8-a742-94ff3e2de9a1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_935d323f-8d98-4729-8662-b5f29fa9504f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_9e097c4d-3c17-4ae4-b463-12c4240ca178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_780bb323-5d23-4ac8-a742-94ff3e2de9a1" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_9e097c4d-3c17-4ae4-b463-12c4240ca178" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="simple" xlink:href="cvs-20211231.xsd#FairValueGrossTransfersIntoOutOfLevel3Details"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_24e33dc8-bd19-41f5-9cda-33e497fa6528" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_dfc0d282-c41c-42ca-bdde-265098b91bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_24e33dc8-bd19-41f5-9cda-33e497fa6528" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_dfc0d282-c41c-42ca-bdde-265098b91bb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_8341242c-237c-4bbe-ba17-8b8f4a50b481" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_24e33dc8-bd19-41f5-9cda-33e497fa6528" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_8341242c-237c-4bbe-ba17-8b8f4a50b481" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#GoodwillandOtherIntangiblesIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6072ea28-c46c-41be-b4dc-ea39cfc6ae01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_63fb9929-4a1a-4d04-aa85-d3413ecb309f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6072ea28-c46c-41be-b4dc-ea39cfc6ae01" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_63fb9929-4a1a-4d04-aa85-d3413ecb309f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e060c83a-fe6c-4ce2-b6ea-e95fbdbcea90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_6072ea28-c46c-41be-b4dc-ea39cfc6ae01" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e060c83a-fe6c-4ce2-b6ea-e95fbdbcea90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d6462adc-b630-419e-9d87-fd7a436adcd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1bbf2dad-99d1-400f-bf17-a39088d5b844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d6462adc-b630-419e-9d87-fd7a436adcd2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1bbf2dad-99d1-400f-bf17-a39088d5b844" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_f6aa19ce-95a0-4672-9444-23fddbe06aec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d6462adc-b630-419e-9d87-fd7a436adcd2" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_f6aa19ce-95a0-4672-9444-23fddbe06aec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_cfacaaaa-139f-4894-92dc-ca77d53bafcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_00259fea-ff89-46ea-9170-d6144a825c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_cfacaaaa-139f-4894-92dc-ca77d53bafcc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_00259fea-ff89-46ea-9170-d6144a825c7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a8a5b762-18c6-46d2-970e-acfb7d324f39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_cfacaaaa-139f-4894-92dc-ca77d53bafcc" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a8a5b762-18c6-46d2-970e-acfb7d324f39" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#LeasesSummaryoftheComponentsofNetLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseCost_28d2841d-0828-401c-970d-d191b93c7ede" xlink:href="cvs-20211231.xsd#cvs_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_6e9b1292-2943-4973-8d96-03d4ae217ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_FinanceLeaseCost_28d2841d-0828-401c-970d-d191b93c7ede" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_6e9b1292-2943-4973-8d96-03d4ae217ba0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_f7c06425-6252-4696-8404-c6122bd33a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_FinanceLeaseCost_28d2841d-0828-401c-970d-d191b93c7ede" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_f7c06425-6252-4696-8404-c6122bd33a4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_00dee1ab-aa97-4191-9a59-2ff03de1c581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_6e015f2b-221b-4f07-952e-3f8f2ff9e8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_00dee1ab-aa97-4191-9a59-2ff03de1c581" xlink:to="loc_us-gaap_SubleaseIncome_6e015f2b-221b-4f07-952e-3f8f2ff9e8b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_3e002655-ef15-44f3-9e8b-f3a2cbe11ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_00dee1ab-aa97-4191-9a59-2ff03de1c581" xlink:to="loc_us-gaap_VariableLeaseCost_3e002655-ef15-44f3-9e8b-f3a2cbe11ad9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_32e8ab32-9f04-4770-9824-11cab69b4b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_00dee1ab-aa97-4191-9a59-2ff03de1c581" xlink:to="loc_us-gaap_OperatingLeaseCost_32e8ab32-9f04-4770-9824-11cab69b4b5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseCost_7a846373-71e5-4ed0-93dd-474472e53e0a" xlink:href="cvs-20211231.xsd#cvs_FinanceLeaseCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_00dee1ab-aa97-4191-9a59-2ff03de1c581" xlink:to="loc_cvs_FinanceLeaseCost_7a846373-71e5-4ed0-93dd-474472e53e0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_4e3cd4aa-688c-4368-b1cc-f77ce815edee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_00dee1ab-aa97-4191-9a59-2ff03de1c581" xlink:to="loc_us-gaap_ShortTermLeaseCost_4e3cd4aa-688c-4368-b1cc-f77ce815edee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d4a0b670-2cf1-440c-a372-7dd9327eeaf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_54e6de7a-cb06-462c-a753-70f14525f2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_d4a0b670-2cf1-440c-a372-7dd9327eeaf6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_54e6de7a-cb06-462c-a753-70f14525f2ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_902d22c8-819d-4336-a53a-9530cb7d6257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_d4a0b670-2cf1-440c-a372-7dd9327eeaf6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_902d22c8-819d-4336-a53a-9530cb7d6257" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetNet_461d354a-bd51-4159-9509-10e3e5ceb838" xlink:href="cvs-20211231.xsd#cvs_FinanceLeaseRightOfUseAssetNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetGross_8c00543e-f58c-4e8b-85c4-a94f2539fa9d" xlink:href="cvs-20211231.xsd#cvs_FinanceLeaseRightOfUseAssetGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_FinanceLeaseRightOfUseAssetNet_461d354a-bd51-4159-9509-10e3e5ceb838" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetGross_8c00543e-f58c-4e8b-85c4-a94f2539fa9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_8baec516-ee42-4401-8e10-060fe99d8746" xlink:href="cvs-20211231.xsd#cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_FinanceLeaseRightOfUseAssetNet_461d354a-bd51-4159-9509-10e3e5ceb838" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_8baec516-ee42-4401-8e10-060fe99d8746" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d0c0d7f1-ff6a-4eb7-b16f-bdf66b485305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cfbba7cc-8653-4cd9-a40e-f77eb287ac05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_d0c0d7f1-ff6a-4eb7-b16f-bdf66b485305" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_cfbba7cc-8653-4cd9-a40e-f77eb287ac05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_178c0272-0c1a-44ff-93f8-7f60bbe8ba9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_d0c0d7f1-ff6a-4eb7-b16f-bdf66b485305" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_178c0272-0c1a-44ff-93f8-7f60bbe8ba9e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_54b67727-4503-4e75-a82e-06de2505692f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_24ea5b2f-0cff-49f3-953e-7dba946047e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_54b67727-4503-4e75-a82e-06de2505692f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_24ea5b2f-0cff-49f3-953e-7dba946047e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_f957ae23-b12c-4efb-bf54-d359ae0836e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_54b67727-4503-4e75-a82e-06de2505692f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_f957ae23-b12c-4efb-bf54-d359ae0836e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_552323e4-f0b7-42d8-aef3-f5a32f942442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_54b67727-4503-4e75-a82e-06de2505692f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_552323e4-f0b7-42d8-aef3-f5a32f942442" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_fb07e679-0d5b-4131-b7c4-82d609b4e949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_54b67727-4503-4e75-a82e-06de2505692f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_fb07e679-0d5b-4131-b7c4-82d609b4e949" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_9765961a-4cc1-441e-86ee-df2a9463c36e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_54b67727-4503-4e75-a82e-06de2505692f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_9765961a-4cc1-441e-86ee-df2a9463c36e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_a8d300c8-149f-4195-bb9f-a9e276eff788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_54b67727-4503-4e75-a82e-06de2505692f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_a8d300c8-149f-4195-bb9f-a9e276eff788" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_ba756c0d-107e-4b3b-b88c-680bbd67541b" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_9987bee7-5183-4461-97af-e38ae4f9dc22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_ba756c0d-107e-4b3b-b88c-680bbd67541b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_9987bee7-5183-4461-97af-e38ae4f9dc22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0a5c3dbf-006c-4011-9c62-6469cb13eca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_ba756c0d-107e-4b3b-b88c-680bbd67541b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0a5c3dbf-006c-4011-9c62-6469cb13eca7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDue_b0de7a8c-d143-477a-ad7c-1ad78e47e4b9" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsYearOne_fb12f732-485d-416c-87ad-8997aede8037" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsYearOne"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_b0de7a8c-d143-477a-ad7c-1ad78e47e4b9" xlink:to="loc_cvs_LesseeLiabilityPaymentsYearOne_fb12f732-485d-416c-87ad-8997aede8037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_a0e2b776-c9e9-4c70-b049-e5e3d25ee00d" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_b0de7a8c-d143-477a-ad7c-1ad78e47e4b9" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_a0e2b776-c9e9-4c70-b049-e5e3d25ee00d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearThree_e36e58f4-75f7-487b-a2f9-c42eef34a560" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_b0de7a8c-d143-477a-ad7c-1ad78e47e4b9" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearThree_e36e58f4-75f7-487b-a2f9-c42eef34a560" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFour_51782caa-d05d-40e5-9994-b54d6fcc0148" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_b0de7a8c-d143-477a-ad7c-1ad78e47e4b9" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearFour_51782caa-d05d-40e5-9994-b54d6fcc0148" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFive_a01ba5de-7af9-474b-87f5-02d8cb93f695" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_b0de7a8c-d143-477a-ad7c-1ad78e47e4b9" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearFive_a01ba5de-7af9-474b-87f5-02d8cb93f695" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_0ced3a3b-05c2-455e-aafc-babe018b8462" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_b0de7a8c-d143-477a-ad7c-1ad78e47e4b9" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_0ced3a3b-05c2-455e-aafc-babe018b8462" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFour_5a1e1dcc-1902-4d15-8e55-f4fd55c9d105" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_1a679711-bcf6-4943-98ab-f5d281d57453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFour_5a1e1dcc-1902-4d15-8e55-f4fd55c9d105" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_1a679711-bcf6-4943-98ab-f5d281d57453" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d55a0290-c742-4c48-864c-677ae53cd696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFour_5a1e1dcc-1902-4d15-8e55-f4fd55c9d105" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d55a0290-c742-4c48-864c-677ae53cd696" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeaseLiability_c0f91438-d0a7-4166-9886-bc97590e4cbc" xlink:href="cvs-20211231.xsd#cvs_LeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_fb69e532-1ba4-4510-bab7-f731f1d4701c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LeaseLiability_c0f91438-d0a7-4166-9886-bc97590e4cbc" xlink:to="loc_us-gaap_FinanceLeaseLiability_fb69e532-1ba4-4510-bab7-f731f1d4701c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_44b372ea-554d-489c-ba0b-b290d7e39e93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LeaseLiability_c0f91438-d0a7-4166-9886-bc97590e4cbc" xlink:to="loc_us-gaap_OperatingLeaseLiability_44b372ea-554d-489c-ba0b-b290d7e39e93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_71efda1f-9e07-49a3-b74f-e8f8f95a9350" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_e881b06e-83d6-43c7-8b43-dd176857df79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_71efda1f-9e07-49a3-b74f-e8f8f95a9350" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_e881b06e-83d6-43c7-8b43-dd176857df79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_025098eb-3dc9-4337-b138-754b632ec6bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_71efda1f-9e07-49a3-b74f-e8f8f95a9350" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_025098eb-3dc9-4337-b138-754b632ec6bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ded2f3f8-ac61-4cc8-865e-868fe5e0113a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1c05f045-d9e6-41b5-89cc-1e0b16d810b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ded2f3f8-ac61-4cc8-865e-868fe5e0113a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1c05f045-d9e6-41b5-89cc-1e0b16d810b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_5eb3f754-0451-4a4b-ab8f-beb8bf73d4db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ded2f3f8-ac61-4cc8-865e-868fe5e0113a" xlink:to="loc_us-gaap_OperatingLeaseLiability_5eb3f754-0451-4a4b-ab8f-beb8bf73d4db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearThree_b71d1f83-1218-47f5-9d77-87fb3fbfb818" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4a4f99cc-7e76-49d5-9dc8-fa6e7a21ca5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearThree_b71d1f83-1218-47f5-9d77-87fb3fbfb818" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4a4f99cc-7e76-49d5-9dc8-fa6e7a21ca5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4aacf6c1-53ee-4d19-93fb-0f9514a42a40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearThree_b71d1f83-1218-47f5-9d77-87fb3fbfb818" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4aacf6c1-53ee-4d19-93fb-0f9514a42a40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_13a16aa0-7351-4123-beaf-d98526e70d69" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_e28d9b33-666c-48b4-b4a2-e5b4655a0a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_13a16aa0-7351-4123-beaf-d98526e70d69" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_e28d9b33-666c-48b4-b4a2-e5b4655a0a9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c60ae6af-dafc-449a-88c7-6ba4e0618cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_13a16aa0-7351-4123-beaf-d98526e70d69" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c60ae6af-dafc-449a-88c7-6ba4e0618cef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsYearOne_2c3b2719-c08d-4958-a036-c152eb74f387" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsYearOne"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bf8bf155-0690-416a-9d40-9302bcd4620b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsYearOne_2c3b2719-c08d-4958-a036-c152eb74f387" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bf8bf155-0690-416a-9d40-9302bcd4620b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_7e2e1385-e1c7-4227-9e09-88a290bbc159" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsYearOne_2c3b2719-c08d-4958-a036-c152eb74f387" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_7e2e1385-e1c7-4227-9e09-88a290bbc159" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFive_5b8fe9ab-c81c-49a2-9240-cacc9d8004ac" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_e6fa832e-e1d9-4461-b383-d79f2f39ecb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFive_5b8fe9ab-c81c-49a2-9240-cacc9d8004ac" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_e6fa832e-e1d9-4461-b383-d79f2f39ecb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4009beaa-ccab-48ea-848b-6f2f06fb9113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFive_5b8fe9ab-c81c-49a2-9240-cacc9d8004ac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_4009beaa-ccab-48ea-848b-6f2f06fb9113" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="cvs-20211231.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_94ad5cd3-e30a-4375-a1f8-ecf9fed69148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_e7a09014-466d-4490-8d5b-06354a0f15c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_94ad5cd3-e30a-4375-a1f8-ecf9fed69148" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_e7a09014-466d-4490-8d5b-06354a0f15c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_b6a44631-65be-428a-8e1a-c4056e9d1002" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_94ad5cd3-e30a-4375-a1f8-ecf9fed69148" xlink:to="loc_us-gaap_FinanceLeaseLiability_b6a44631-65be-428a-8e1a-c4056e9d1002" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDue_ea1c24a4-7f62-4f8c-9463-d23ed2d2d8e1" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_71026821-dad1-4c78-8928-e05cfe9993d6" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_ea1c24a4-7f62-4f8c-9463-d23ed2d2d8e1" xlink:to="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_71026821-dad1-4c78-8928-e05cfe9993d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeaseLiability_ddbcf858-22d5-4b73-9e75-19c25bc534e2" xlink:href="cvs-20211231.xsd#cvs_LeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue_ea1c24a4-7f62-4f8c-9463-d23ed2d2d8e1" xlink:to="loc_cvs_LeaseLiability_ddbcf858-22d5-4b73-9e75-19c25bc534e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_78391297-76f9-470e-86c1-3cb5f9754066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_adb6743f-f89e-4351-b866-f2a38385da56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_78391297-76f9-470e-86c1-3cb5f9754066" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_adb6743f-f89e-4351-b866-f2a38385da56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b50e37e0-33d1-4448-b7e9-bafc28082b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_78391297-76f9-470e-86c1-3cb5f9754066" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b50e37e0-33d1-4448-b7e9-bafc28082b60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c68f7cbf-b690-4ccf-8546-52d20a5d37f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_78391297-76f9-470e-86c1-3cb5f9754066" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c68f7cbf-b690-4ccf-8546-52d20a5d37f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6a46812f-1883-475b-9b6d-15bd96f5049d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_78391297-76f9-470e-86c1-3cb5f9754066" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6a46812f-1883-475b-9b6d-15bd96f5049d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_542289b9-b0e1-489a-82e4-cf8359df372d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_78391297-76f9-470e-86c1-3cb5f9754066" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_542289b9-b0e1-489a-82e4-cf8359df372d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9a6f52a6-d3e2-4afb-a4f7-2d902874fc81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_78391297-76f9-470e-86c1-3cb5f9754066" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_9a6f52a6-d3e2-4afb-a4f7-2d902874fc81" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_ce2e5033-f146-48ec-88e9-9ceccaf2fc40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_ae98bf00-4a81-4b47-a7ee-7e19a55589f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_ce2e5033-f146-48ec-88e9-9ceccaf2fc40" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_ae98bf00-4a81-4b47-a7ee-7e19a55589f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_e2e475c2-6156-47c7-9b23-bb06466834e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_ce2e5033-f146-48ec-88e9-9ceccaf2fc40" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_e2e475c2-6156-47c7-9b23-bb06466834e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_391eba2d-9f28-4c4a-824e-fe8380e9e749" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_ce2e5033-f146-48ec-88e9-9ceccaf2fc40" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_391eba2d-9f28-4c4a-824e-fe8380e9e749" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b5f43f94-7dfb-4e58-bb3d-d1b187b9b05b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_ab63beb2-30d2-4a15-a50b-7a3732d8d568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b5f43f94-7dfb-4e58-bb3d-d1b187b9b05b" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_ab63beb2-30d2-4a15-a50b-7a3732d8d568" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ed2016b8-eeb3-44ea-88cc-becaf14a32d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b5f43f94-7dfb-4e58-bb3d-d1b187b9b05b" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ed2016b8-eeb3-44ea-88cc-becaf14a32d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_de15e115-bbac-4a10-8ba1-6a31be0c5354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b5f43f94-7dfb-4e58-bb3d-d1b187b9b05b" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_de15e115-bbac-4a10-8ba1-6a31be0c5354" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_fa712f4c-0983-42bc-b794-b6c2a4d24256" xlink:href="cvs-20211231.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_b5f43f94-7dfb-4e58-bb3d-d1b187b9b05b" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_fa712f4c-0983-42bc-b794-b6c2a4d24256" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_c5d6a3fa-67f9-4ad6-93c0-02db882e7ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_46fee4f6-6eb8-492b-807c-d2769e3b0d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_c5d6a3fa-67f9-4ad6-93c0-02db882e7ecd" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_46fee4f6-6eb8-492b-807c-d2769e3b0d87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_ebb7ffaa-2ddb-4d74-aa19-31546d0ab615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_c5d6a3fa-67f9-4ad6-93c0-02db882e7ecd" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_ebb7ffaa-2ddb-4d74-aa19-31546d0ab615" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_f2b74472-59b7-4b6c-8410-fab9158407db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_878608b1-e6de-400e-88e3-0719aec6431b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_f2b74472-59b7-4b6c-8410-fab9158407db" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_878608b1-e6de-400e-88e3-0719aec6431b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_6f0ce814-5931-4e36-bcab-15519103233d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_f2b74472-59b7-4b6c-8410-fab9158407db" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_6f0ce814-5931-4e36-bcab-15519103233d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#BorrowingsandCreditArrangementsScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_8f5c7326-07e8-4024-a6bb-b128e51cb1ec" xlink:href="cvs-20211231.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c0a85a6f-f187-475b-8933-5ac7bb02d956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation_8f5c7326-07e8-4024-a6bb-b128e51cb1ec" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_c0a85a6f-f187-475b-8933-5ac7bb02d956" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_c32a606e-e14a-4151-8dae-a1122d544aef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation_8f5c7326-07e8-4024-a6bb-b128e51cb1ec" xlink:to="loc_us-gaap_FinanceLeaseLiability_c32a606e-e14a-4151-8dae-a1122d544aef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#BorrowingsandCreditArrangementsDebtMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a4306541-c070-42c4-9447-760fd55b06ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b53dbfa9-63b5-4220-8fec-f9c910af4b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a4306541-c070-42c4-9447-760fd55b06ed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b53dbfa9-63b5-4220-8fec-f9c910af4b2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_fe1674bd-194f-4e29-991e-1002667241e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a4306541-c070-42c4-9447-760fd55b06ed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_fe1674bd-194f-4e29-991e-1002667241e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_c07779ed-8933-4f36-a24b-b74c1892deca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a4306541-c070-42c4-9447-760fd55b06ed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_c07779ed-8933-4f36-a24b-b74c1892deca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8a7ef4f2-f06d-4243-8c99-255f8e789c95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a4306541-c070-42c4-9447-760fd55b06ed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_8a7ef4f2-f06d-4243-8c99-255f8e789c95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0f87a733-4db2-4626-a605-3b6ca2631b95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a4306541-c070-42c4-9447-760fd55b06ed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0f87a733-4db2-4626-a605-3b6ca2631b95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_6aaa98c5-66e9-4a91-aacd-3dcc64314cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a4306541-c070-42c4-9447-760fd55b06ed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_6aaa98c5-66e9-4a91-aacd-3dcc64314cd1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_04b10602-4374-4510-a637-5fb3e155ca02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_307a1949-e12b-4318-909f-f0653a347b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_04b10602-4374-4510-a637-5fb3e155ca02" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_307a1949-e12b-4318-909f-f0653a347b11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_d9904e14-2850-441d-9550-d8a0c822f952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_04b10602-4374-4510-a637-5fb3e155ca02" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_d9904e14-2850-441d-9550-d8a0c822f952" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_3856b593-020d-4e05-b615-f92f5346f4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_6983c20c-ff24-4312-a7d1-4679dd12f19f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_3856b593-020d-4e05-b615-f92f5346f4c5" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_6983c20c-ff24-4312-a7d1-4679dd12f19f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_0e897977-485a-497c-93bf-6e8f4599b592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_3856b593-020d-4e05-b615-f92f5346f4c5" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_0e897977-485a-497c-93bf-6e8f4599b592" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_f914130f-6338-44f2-9e64-e8ab51540f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_3856b593-020d-4e05-b615-f92f5346f4c5" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_f914130f-6338-44f2-9e64-e8ab51540f03" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_48a58ec8-d23d-4b8c-9967-611d47865cea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_cf42b47b-97b9-4fdd-a021-33339942240b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_48a58ec8-d23d-4b8c-9967-611d47865cea" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_cf42b47b-97b9-4fdd-a021-33339942240b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_ff25cb22-3616-4795-9f07-dec87cf81d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_48a58ec8-d23d-4b8c-9967-611d47865cea" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_ff25cb22-3616-4795-9f07-dec87cf81d4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_02ed8dce-70f5-462d-b4b2-cbfd6010640b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_48a58ec8-d23d-4b8c-9967-611d47865cea" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_02ed8dce-70f5-462d-b4b2-cbfd6010640b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_c0142d9e-f16f-4b83-94dd-bbff098f8b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_48a58ec8-d23d-4b8c-9967-611d47865cea" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_c0142d9e-f16f-4b83-94dd-bbff098f8b6e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#IncomeTaxesIncomeTaxProvisionDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6a6c42be-95a2-4c36-aa7a-8012a32422ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_fc538433-f66e-452f-ba5a-5e8c6b6443cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6a6c42be-95a2-4c36-aa7a-8012a32422ea" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_fc538433-f66e-452f-ba5a-5e8c6b6443cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_10c4a69d-fe72-4b28-82be-85d4eaf56411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6a6c42be-95a2-4c36-aa7a-8012a32422ea" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_10c4a69d-fe72-4b28-82be-85d4eaf56411" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_bab62a53-7019-48d9-9aca-f4931ec7ca6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_a68dffcb-8996-49e4-878d-5c785d4d5def" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_bab62a53-7019-48d9-9aca-f4931ec7ca6b" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_a68dffcb-8996-49e4-878d-5c785d4d5def" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_8fffba16-ee59-48d0-8247-583224f055fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_bab62a53-7019-48d9-9aca-f4931ec7ca6b" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_8fffba16-ee59-48d0-8247-583224f055fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_31833d43-708b-4bea-aee9-c19c5cfe3bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_9798856d-cc7a-4466-ab83-490c78b06211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_31833d43-708b-4bea-aee9-c19c5cfe3bbf" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_9798856d-cc7a-4466-ab83-490c78b06211" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_569b6927-332d-434e-99a3-88f62f33044f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_31833d43-708b-4bea-aee9-c19c5cfe3bbf" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_569b6927-332d-434e-99a3-88f62f33044f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#IncomeTaxesEffectiveTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bf55c501-7311-4ea9-be69-532609eb95bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_8465e2d6-80e1-4387-b980-b00af2640723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bf55c501-7311-4ea9-be69-532609eb95bb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_8465e2d6-80e1-4387-b980-b00af2640723" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_e001c40b-1149-483b-b71a-97d7dd553a25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bf55c501-7311-4ea9-be69-532609eb95bb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_e001c40b-1149-483b-b71a-97d7dd553a25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_fe0bec9d-847f-42bf-91c4-48dff5a6f9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bf55c501-7311-4ea9-be69-532609eb95bb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_fe0bec9d-847f-42bf-91c4-48dff5a6f9c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFeeTaxEffectPercent_94923278-60eb-46e9-b2b8-f17455f15f26" xlink:href="cvs-20211231.xsd#cvs_HealthInsurerFeeTaxEffectPercent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bf55c501-7311-4ea9-be69-532609eb95bb" xlink:to="loc_cvs_HealthInsurerFeeTaxEffectPercent_94923278-60eb-46e9-b2b8-f17455f15f26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_069ac5ea-06bd-4b32-8210-1c9634349ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bf55c501-7311-4ea9-be69-532609eb95bb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_069ac5ea-06bd-4b32-8210-1c9634349ba3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_7b0fbf6a-8c44-4690-aed1-d73e7c0afb6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bf55c501-7311-4ea9-be69-532609eb95bb" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_7b0fbf6a-8c44-4690-aed1-d73e7c0afb6a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_c20ae73f-11c6-432a-a807-b32281b2e94c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_aae89d38-d063-43cb-b371-6af20346017e" xlink:href="cvs-20211231.xsd#cvs_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_c20ae73f-11c6-432a-a807-b32281b2e94c" xlink:to="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_aae89d38-d063-43cb-b371-6af20346017e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_058bd240-c53e-4bf7-91e5-a19ab180d7f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_c20ae73f-11c6-432a-a807-b32281b2e94c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_058bd240-c53e-4bf7-91e5-a19ab180d7f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_77163863-7109-472a-a075-2417ea647413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_c20ae73f-11c6-432a-a807-b32281b2e94c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_77163863-7109-472a-a075-2417ea647413" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits_ba2b7b31-d08e-452b-8178-7774ed17a24b" xlink:href="cvs-20211231.xsd#cvs_DeferredTaxLiabilitiesRetirementBenefits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_c20ae73f-11c6-432a-a807-b32281b2e94c" xlink:to="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits_ba2b7b31-d08e-452b-8178-7774ed17a24b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_3218c2ee-1663-48e6-90a2-81d99cabdb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_d8888bb8-ccae-41b3-a1dc-05d39b7a2b8f" xlink:href="cvs-20211231.xsd#cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_3218c2ee-1663-48e6-90a2-81d99cabdb2c" xlink:to="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_d8888bb8-ccae-41b3-a1dc-05d39b7a2b8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3f2edeb6-729f-4a0a-8577-a6207fc0b906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_3218c2ee-1663-48e6-90a2-81d99cabdb2c" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_3f2edeb6-729f-4a0a-8577-a6207fc0b906" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_b2ba81e6-e6e9-4426-837d-295c7f30e8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_3218c2ee-1663-48e6-90a2-81d99cabdb2c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_b2ba81e6-e6e9-4426-837d-295c7f30e8ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral_eff40fbc-e337-4d57-98dc-d0bf40a14024" xlink:href="cvs-20211231.xsd#cvs_DeferredTaxAssetsPayrollTaxDeferral"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_3218c2ee-1663-48e6-90a2-81d99cabdb2c" xlink:to="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral_eff40fbc-e337-4d57-98dc-d0bf40a14024" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_94d8a874-96cd-42a7-8ae0-3fcd5ac4b51e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_3218c2ee-1663-48e6-90a2-81d99cabdb2c" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_94d8a874-96cd-42a7-8ae0-3fcd5ac4b51e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_3cf7109a-9e05-4354-ac75-0b92042fbf92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_3218c2ee-1663-48e6-90a2-81d99cabdb2c" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_3cf7109a-9e05-4354-ac75-0b92042fbf92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_a003f9b2-7bbb-4ae3-97b1-75b24d7a6428" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_3218c2ee-1663-48e6-90a2-81d99cabdb2c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_a003f9b2-7bbb-4ae3-97b1-75b24d7a6428" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_fb83056d-48c8-4e0e-ad79-ea57162507dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_3218c2ee-1663-48e6-90a2-81d99cabdb2c" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_fb83056d-48c8-4e0e-ad79-ea57162507dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2b82b9d7-7a3a-4b76-88ad-37f8804fda27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_3218c2ee-1663-48e6-90a2-81d99cabdb2c" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_2b82b9d7-7a3a-4b76-88ad-37f8804fda27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_051cc6a5-ca8d-498a-82b7-850038e9c104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_3218c2ee-1663-48e6-90a2-81d99cabdb2c" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_051cc6a5-ca8d-498a-82b7-850038e9c104" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_fdcb2811-9a74-4f9e-b819-338552eb2a43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_18eaaa65-e43a-4aca-b8dc-4067a4a643da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_fdcb2811-9a74-4f9e-b819-338552eb2a43" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_18eaaa65-e43a-4aca-b8dc-4067a4a643da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_dc5886fc-b917-41b7-a73e-66175ee746d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_fdcb2811-9a74-4f9e-b819-338552eb2a43" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_dc5886fc-b917-41b7-a73e-66175ee746d0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#OtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1a63db8d-c14c-455b-bd82-9a5cc6da3ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f9c553a1-6ba4-468a-9b82-0e757c706018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1a63db8d-c14c-455b-bd82-9a5cc6da3ab9" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f9c553a1-6ba4-468a-9b82-0e757c706018" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_91634d9c-c552-4bf3-a527-e9aab6200e15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1a63db8d-c14c-455b-bd82-9a5cc6da3ab9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_91634d9c-c552-4bf3-a527-e9aab6200e15" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#EarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1d935d6f-b398-4a1e-844e-758eea1c51db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3a78d96f-a4e9-4c72-9a9f-8a57291b7cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1d935d6f-b398-4a1e-844e-758eea1c51db" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3a78d96f-a4e9-4c72-9a9f-8a57291b7cfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_9e39cef6-a579-44ce-ac3c-93efa4f1275d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1d935d6f-b398-4a1e-844e-758eea1c51db" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_9e39cef6-a579-44ce-ac3c-93efa4f1275d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_d50caa80-93de-46eb-adb9-0f12d9d82b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2cf7062a-fad1-4576-b625-79837a5b052b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_d50caa80-93de-46eb-adb9-0f12d9d82b9a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2cf7062a-fad1-4576-b625-79837a5b052b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_05a55773-61d2-4b47-a32f-4558a4920218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_d50caa80-93de-46eb-adb9-0f12d9d82b9a" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_05a55773-61d2-4b47-a32f-4558a4920218" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_20e1c257-4ab4-404c-b96a-1f969ea0ade2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_d50caa80-93de-46eb-adb9-0f12d9d82b9a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_20e1c257-4ab4-404c-b96a-1f969ea0ade2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#ReinsuranceEffectsofReinsuranceDetails"/>
  <link:calculationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_e91d111d-0192-456b-9064-1364b99a8c50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_1fcdfe25-d8ae-4fec-9928-86af824d3b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_e91d111d-0192-456b-9064-1364b99a8c50" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_1fcdfe25-d8ae-4fec-9928-86af824d3b9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_6374393d-86e3-449b-a8b9-7e83a09f140f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_e91d111d-0192-456b-9064-1364b99a8c50" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_6374393d-86e3-449b-a8b9-7e83a09f140f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_1e930461-bb82-47bb-bf84-b923e5933953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_e91d111d-0192-456b-9064-1364b99a8c50" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_1e930461-bb82-47bb-bf84-b923e5933953" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_6bebc25a-5693-4d0f-959e-39e20d77f059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsEarned_87dacfd7-01d4-440b-b719-747a34cb6f06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectPremiumsEarned"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PremiumsEarnedNet_6bebc25a-5693-4d0f-959e-39e20d77f059" xlink:to="loc_us-gaap_DirectPremiumsEarned_87dacfd7-01d4-440b-b719-747a34cb6f06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsEarned_703ae9bf-0433-4346-855e-16950d2b927c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssumedPremiumsEarned"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PremiumsEarnedNet_6bebc25a-5693-4d0f-959e-39e20d77f059" xlink:to="loc_us-gaap_AssumedPremiumsEarned_703ae9bf-0433-4346-855e-16950d2b927c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsEarned_c54ad348-8f97-4b2b-b2b1-b077ef76bf80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CededPremiumsEarned"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PremiumsEarnedNet_6bebc25a-5693-4d0f-959e-39e20d77f059" xlink:to="loc_us-gaap_CededPremiumsEarned_c54ad348-8f97-4b2b-b2b1-b077ef76bf80" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>cvs-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:101452a2-2146-4b57-8461-1c52c7d6326c,g:5f4a3ace-4815-405a-b6fd-039bed36fdc5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cvs-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="extended" id="i0f9ed06e84ff4c418a95ef06421bdfa6_ConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_60f77678-d7ef-4ef4-ae5e-b4d022a88c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_RevenuesAbstract_60f77678-d7ef-4ef4-ae5e-b4d022a88c9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_187e05f4-d829-4488-b300-63e208250c22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_60f77678-d7ef-4ef4-ae5e-b4d022a88c9c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_187e05f4-d829-4488-b300-63e208250c22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_76f1da2e-de1c-473b-b2f3-809d0e2a7fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_60f77678-d7ef-4ef4-ae5e-b4d022a88c9c" xlink:to="loc_us-gaap_PremiumsEarnedNet_76f1da2e-de1c-473b-b2f3-809d0e2a7fdf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_8b89749a-dc81-4919-a1a1-170fde65e3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_60f77678-d7ef-4ef4-ae5e-b4d022a88c9c" xlink:to="loc_us-gaap_NetInvestmentIncome_8b89749a-dc81-4919-a1a1-170fde65e3a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2a67266a-8394-45ed-ad38-ff6f5f56f9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_60f77678-d7ef-4ef4-ae5e-b4d022a88c9c" xlink:to="loc_us-gaap_Revenues_2a67266a-8394-45ed-ad38-ff6f5f56f9f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_439f2156-e7f2-4d21-9e32-5181cc4337f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_OperatingExpensesAbstract_439f2156-e7f2-4d21-9e32-5181cc4337f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_cdc89f4c-8cfa-4ad5-9359-02ba49d911dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_439f2156-e7f2-4d21-9e32-5181cc4337f2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_cdc89f4c-8cfa-4ad5-9359-02ba49d911dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_d1927887-e644-4652-a99c-c1b1f20b864e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_439f2156-e7f2-4d21-9e32-5181cc4337f2" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_d1927887-e644-4652-a99c-c1b1f20b864e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_1d219bc4-4e68-4d95-98b4-d8ee3e4f836e" xlink:href="cvs-20211231.xsd#cvs_StoreImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_439f2156-e7f2-4d21-9e32-5181cc4337f2" xlink:to="loc_cvs_StoreImpairmentCharges_1d219bc4-4e68-4d95-98b4-d8ee3e4f836e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_85f2f463-5d18-4650-b5f6-43eb061ab55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_439f2156-e7f2-4d21-9e32-5181cc4337f2" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_85f2f463-5d18-4650-b5f6-43eb061ab55a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments_46d37cde-18af-40fd-b47e-0c2d4b5ffcc7" xlink:href="cvs-20211231.xsd#cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_439f2156-e7f2-4d21-9e32-5181cc4337f2" xlink:to="loc_cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments_46d37cde-18af-40fd-b47e-0c2d4b5ffcc7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_45591aad-4b0b-4352-a5f4-d5a4c7b93d03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_439f2156-e7f2-4d21-9e32-5181cc4337f2" xlink:to="loc_us-gaap_CostsAndExpenses_45591aad-4b0b-4352-a5f4-d5a4c7b93d03" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_69d6753d-d1a1-48f7-90de-d4d1f7bea141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_OperatingIncomeLoss_69d6753d-d1a1-48f7-90de-d4d1f7bea141" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d8be281e-da74-40fc-b98f-abe804d831cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_InterestExpense_d8be281e-da74-40fc-b98f-abe804d831cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2dc0e3a0-f872-4892-a0df-c8db97756189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2dc0e3a0-f872-4892-a0df-c8db97756189" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6c78bbda-5c39-4224-aec8-a7c31ef5915e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6c78bbda-5c39-4224-aec8-a7c31ef5915e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_92855ee9-286d-412b-8999-67c6340a643b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_92855ee9-286d-412b-8999-67c6340a643b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7de43476-690f-4343-b514-fd38aefa8ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7de43476-690f-4343-b514-fd38aefa8ef1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_5565d655-a81a-4f22-9bd0-f7b353200634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_5565d655-a81a-4f22-9bd0-f7b353200634" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_81a29a55-8de8-4bb2-8caf-354b845b9eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_81a29a55-8de8-4bb2-8caf-354b845b9eb3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_20b987c5-fca7-47f5-9529-ea82249d940e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_ProfitLoss_20b987c5-fca7-47f5-9529-ea82249d940e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_307d979b-4742-4329-b2d5-627abcf09186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_307d979b-4742-4329-b2d5-627abcf09186" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_92fcb5d0-b0c9-46c2-8c9f-7954287460f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_NetIncomeLoss_92fcb5d0-b0c9-46c2-8c9f-7954287460f0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_b1fea05e-05f2-4726-a5e2-1a4f78a63ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_b1fea05e-05f2-4726-a5e2-1a4f78a63ba5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_914c69f8-5b94-41df-840f-c3b6112064dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b1fea05e-05f2-4726-a5e2-1a4f78a63ba5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_914c69f8-5b94-41df-840f-c3b6112064dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_830c20d4-1fe7-4356-a14e-a8e6a9bbab84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b1fea05e-05f2-4726-a5e2-1a4f78a63ba5" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_830c20d4-1fe7-4356-a14e-a8e6a9bbab84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0ce49382-a5d7-4f6d-9a2a-7445652e0d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b1fea05e-05f2-4726-a5e2-1a4f78a63ba5" xlink:to="loc_us-gaap_EarningsPerShareBasic_0ce49382-a5d7-4f6d-9a2a-7445652e0d73" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9e74dfa3-5a1c-46c8-8a92-4b1f7f8ff016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b1fea05e-05f2-4726-a5e2-1a4f78a63ba5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9e74dfa3-5a1c-46c8-8a92-4b1f7f8ff016" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_5722dcf0-5fed-4c7d-817a-6e2066457793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_5722dcf0-5fed-4c7d-817a-6e2066457793" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_850ad440-6f88-4034-b6ff-886a0851419f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5722dcf0-5fed-4c7d-817a-6e2066457793" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_850ad440-6f88-4034-b6ff-886a0851419f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_76aec40b-21c7-4624-a329-2b5f97617a97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5722dcf0-5fed-4c7d-817a-6e2066457793" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_76aec40b-21c7-4624-a329-2b5f97617a97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_70c56660-2dd4-4220-aaed-86c3c27a5cce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5722dcf0-5fed-4c7d-817a-6e2066457793" xlink:to="loc_us-gaap_EarningsPerShareDiluted_70c56660-2dd4-4220-aaed-86c3c27a5cce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_490409ba-3e15-4470-b654-b21f4da58675" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5722dcf0-5fed-4c7d-817a-6e2066457793" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_490409ba-3e15-4470-b654-b21f4da58675" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_9b5dced3-e3c0-43a8-b70d-4d9b40d93365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_9b5dced3-e3c0-43a8-b70d-4d9b40d93365" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_47716780-9f4e-486c-b262-9d50b0e2a605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_47716780-9f4e-486c-b262-9d50b0e2a605" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0319c316-63ee-44e9-9ff7-3f4e334bf347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_StatementTable_0319c316-63ee-44e9-9ff7-3f4e334bf347" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_da8ac55e-3444-4195-bf97-9866c77b087e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0319c316-63ee-44e9-9ff7-3f4e334bf347" xlink:to="loc_srt_ProductOrServiceAxis_da8ac55e-3444-4195-bf97-9866c77b087e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_da8ac55e-3444-4195-bf97-9866c77b087e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_da8ac55e-3444-4195-bf97-9866c77b087e" xlink:to="loc_srt_ProductsAndServicesDomain_da8ac55e-3444-4195-bf97-9866c77b087e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_524cf7f4-5f92-46ee-9467-57b7d0c39b38" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_da8ac55e-3444-4195-bf97-9866c77b087e" xlink:to="loc_srt_ProductsAndServicesDomain_524cf7f4-5f92-46ee-9467-57b7d0c39b38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_25b20d33-0f34-49cc-87dd-74539b21a924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_524cf7f4-5f92-46ee-9467-57b7d0c39b38" xlink:to="loc_us-gaap_ProductMember_25b20d33-0f34-49cc-87dd-74539b21a924" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_0e57c84a-7487-45fc-88b8-162735fa0c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_524cf7f4-5f92-46ee-9467-57b7d0c39b38" xlink:to="loc_us-gaap_ServiceMember_0e57c84a-7487-45fc-88b8-162735fa0c88" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="cvs-20211231.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended" id="i1f48fbc9aaa24c7fbfe9e43e7edf591e_ConsolidatedStatementsofShareholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_945bbd6d-0d42-4b78-809c-87e4d26a091c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_945bbd6d-0d42-4b78-809c-87e4d26a091c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_cbe9335a-fdcf-406d-a360-f64b3306e89e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_us-gaap_SharesOutstanding_cbe9335a-fdcf-406d-a360-f64b3306e89e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eb87c89f-76fc-432e-852e-702ac36e6acf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eb87c89f-76fc-432e-852e-702ac36e6acf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_36bc9004-ab0a-40a5-8918-532124b4b0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_us-gaap_ProfitLoss_36bc9004-ab0a-40a5-8918-532124b4b0ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_91e4aa07-c67a-4f5c-a193-f807fc427515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_91e4aa07-c67a-4f5c-a193-f807fc427515" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_469fed92-35ea-4ed5-8e3c-a50906a50110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_469fed92-35ea-4ed5-8e3c-a50906a50110" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e3327c9c-ba56-488f-9991-99ef5886a837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e3327c9c-ba56-488f-9991-99ef5886a837" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_678f51ce-b3e5-4cf6-8039-70838b33631e" xlink:href="cvs-20211231.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_678f51ce-b3e5-4cf6-8039-70838b33631e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_6c080d42-35d3-4e04-beaf-4e88b7c1de9a" xlink:href="cvs-20211231.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_6c080d42-35d3-4e04-beaf-4e88b7c1de9a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_29a167ca-88aa-421d-909f-1e78eb0780c2" xlink:href="cvs-20211231.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_29a167ca-88aa-421d-909f-1e78eb0780c2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_cdf73609-78da-4755-987d-526724ca2d2f" xlink:href="cvs-20211231.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_cdf73609-78da-4755-987d-526724ca2d2f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_cd8cb9f6-998b-4135-af3d-4c06c313de6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_us-gaap_DividendsCommonStock_cd8cb9f6-998b-4135-af3d-4c06c313de6d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_5f1c78ac-7c77-49ac-9918-8fc26730db79" xlink:href="cvs-20211231.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_5f1c78ac-7c77-49ac-9918-8fc26730db79" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_00c89eea-ba20-4b73-b86a-8e0d707221b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_53ffc9f6-d9e1-4349-9e51-aa84a1c785ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1e58ff3c-e7b0-4c0d-95d3-2c9b3fc2cee3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_945bbd6d-0d42-4b78-809c-87e4d26a091c" xlink:to="loc_us-gaap_StatementTable_1e58ff3c-e7b0-4c0d-95d3-2c9b3fc2cee3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d138ae5f-7661-4e84-9b68-745a77c1f008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1e58ff3c-e7b0-4c0d-95d3-2c9b3fc2cee3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d138ae5f-7661-4e84-9b68-745a77c1f008" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d138ae5f-7661-4e84-9b68-745a77c1f008_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d138ae5f-7661-4e84-9b68-745a77c1f008" xlink:to="loc_us-gaap_EquityComponentDomain_d138ae5f-7661-4e84-9b68-745a77c1f008_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d138ae5f-7661-4e84-9b68-745a77c1f008" xlink:to="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_982d2ba3-44b3-4bc7-bcda-2c88374c49ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:to="loc_us-gaap_CommonStockMember_982d2ba3-44b3-4bc7-bcda-2c88374c49ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_53d499bd-8579-483f-9c5d-a65e4beec8e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:to="loc_us-gaap_TreasuryStockMember_53d499bd-8579-483f-9c5d-a65e4beec8e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_110accbb-9408-4cb9-9c69-42e16430e531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_110accbb-9408-4cb9-9c69-42e16430e531" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b7fcae1f-0548-489a-b2af-2a7e7ce64fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:to="loc_us-gaap_RetainedEarningsMember_b7fcae1f-0548-489a-b2af-2a7e7ce64fc7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1ba6e5ea-6f03-4603-bb52-d75cd6222148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1ba6e5ea-6f03-4603-bb52-d75cd6222148" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_6c2aebd0-3dfd-4c17-8119-e778df36d650" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:to="loc_us-gaap_ParentMember_6c2aebd0-3dfd-4c17-8119-e778df36d650" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_2011ecfd-1975-4e67-a9a1-13095340ce2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:to="loc_us-gaap_NoncontrollingInterestMember_2011ecfd-1975-4e67-a9a1-13095340ce2b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f5735df7-bc1e-4bb9-a72f-cb8b743746c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1e58ff3c-e7b0-4c0d-95d3-2c9b3fc2cee3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f5735df7-bc1e-4bb9-a72f-cb8b743746c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f5735df7-bc1e-4bb9-a72f-cb8b743746c2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f5735df7-bc1e-4bb9-a72f-cb8b743746c2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f5735df7-bc1e-4bb9-a72f-cb8b743746c2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_29b2135e-d249-4d42-a08c-70e13c2d84e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f5735df7-bc1e-4bb9-a72f-cb8b743746c2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_29b2135e-d249-4d42-a08c-70e13c2d84e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_68625a5b-07ff-4c47-8545-189eadef1aa1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_29b2135e-d249-4d42-a08c-70e13c2d84e5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_68625a5b-07ff-4c47-8545-189eadef1aa1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="simple" xlink:href="cvs-20211231.xsd#ConsolidatedStatementsofShareholdersEquityParentheticals"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="extended" id="ie97cf568a69b4245a6ae5bbba7c73325_ConsolidatedStatementsofShareholdersEquityParentheticals">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_25b899c0-beab-4f41-a806-b17506f97792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust_dd175127-c697-45f8-9e32-9bf249572aea" xlink:href="cvs-20211231.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_25b899c0-beab-4f41-a806-b17506f97792" xlink:to="loc_cvs_TreasuryStockSharesHeldinTrust_dd175127-c697-45f8-9e32-9bf249572aea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust_43a19b97-26fc-413c-946b-ca79c093e3d1" xlink:href="cvs-20211231.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_25b899c0-beab-4f41-a806-b17506f97792" xlink:to="loc_cvs_TreasuryStockValueSharesHeldInTrust_43a19b97-26fc-413c-946b-ca79c093e3d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c4f7c802-d12b-4ade-b032-2599c9f9a7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_25b899c0-beab-4f41-a806-b17506f97792" xlink:to="loc_us-gaap_CommonStockValue_c4f7c802-d12b-4ade-b032-2599c9f9a7f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_69d4ed07-f6c5-434a-b6c7-7df00e1cbbe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_25b899c0-beab-4f41-a806-b17506f97792" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_69d4ed07-f6c5-434a-b6c7-7df00e1cbbe4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_971daef9-9c2d-4389-9062-c0d22f11bb63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_25b899c0-beab-4f41-a806-b17506f97792" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_971daef9-9c2d-4389-9062-c0d22f11bb63" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7cf1896a-2384-4877-b942-0692895b676e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_25b899c0-beab-4f41-a806-b17506f97792" xlink:to="loc_us-gaap_StatementTable_7cf1896a-2384-4877-b942-0692895b676e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9a511e8c-5857-4812-88d5-068e83e5f124" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7cf1896a-2384-4877-b942-0692895b676e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9a511e8c-5857-4812-88d5-068e83e5f124" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9a511e8c-5857-4812-88d5-068e83e5f124_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9a511e8c-5857-4812-88d5-068e83e5f124" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_9a511e8c-5857-4812-88d5-068e83e5f124_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_adff72e3-e5a3-4c75-bb7a-5b233eecbd85" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9a511e8c-5857-4812-88d5-068e83e5f124" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_adff72e3-e5a3-4c75-bb7a-5b233eecbd85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e1f26780-f635-4ad2-bdfe-46f586c744e1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_adff72e3-e5a3-4c75-bb7a-5b233eecbd85" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e1f26780-f635-4ad2-bdfe-46f586c744e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1f6c58f2-181e-4531-b651-3906050770d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7cf1896a-2384-4877-b942-0692895b676e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1f6c58f2-181e-4531-b651-3906050770d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1f6c58f2-181e-4531-b651-3906050770d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1f6c58f2-181e-4531-b651-3906050770d2" xlink:to="loc_us-gaap_EquityComponentDomain_1f6c58f2-181e-4531-b651-3906050770d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bea25e54-2409-481f-9a72-108866505cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1f6c58f2-181e-4531-b651-3906050770d2" xlink:to="loc_us-gaap_EquityComponentDomain_bea25e54-2409-481f-9a72-108866505cef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8a280d27-70c7-4d18-bcc9-cb1df62ede66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bea25e54-2409-481f-9a72-108866505cef" xlink:to="loc_us-gaap_RetainedEarningsMember_8a280d27-70c7-4d18-bcc9-cb1df62ede66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b3be7bb3-6aac-450d-83c9-0b2cf97fbbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7cf1896a-2384-4877-b942-0692895b676e" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b3be7bb3-6aac-450d-83c9-0b2cf97fbbc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_b3be7bb3-6aac-450d-83c9-0b2cf97fbbc0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b3be7bb3-6aac-450d-83c9-0b2cf97fbbc0" xlink:to="loc_us-gaap_TypeOfAdoptionMember_b3be7bb3-6aac-450d-83c9-0b2cf97fbbc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_b032fd27-409b-4dbf-a8cb-be8dbb36b459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b3be7bb3-6aac-450d-83c9-0b2cf97fbbc0" xlink:to="loc_us-gaap_TypeOfAdoptionMember_b032fd27-409b-4dbf-a8cb-be8dbb36b459" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_0e69671f-d6d2-4df6-adb2-d0c3a23e8682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_b032fd27-409b-4dbf-a8cb-be8dbb36b459" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_0e69671f-d6d2-4df6-adb2-d0c3a23e8682" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_2c796f5f-585d-45d5-84b3-2c14fdfdb4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_b032fd27-409b-4dbf-a8cb-be8dbb36b459" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_2c796f5f-585d-45d5-84b3-2c14fdfdb4a3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="if7c82c2293f042a7ae0d98d10f1707a7_SignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_4233f27f-74c7-4ed2-9110-5d52ed8da68d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_NumberOfStores_4233f27f-74c7-4ed2-9110-5d52ed8da68d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics_a0d15310-2f8f-4675-b3c6-a47173985d45" xlink:href="cvs-20211231.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_NumberofWalkInMedicalClinics_a0d15310-2f8f-4675-b3c6-a47173985d45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPlanMembers_a3dc930c-59ff-47a1-bcce-37be4e5f9a6e" xlink:href="cvs-20211231.xsd#cvs_NumberOfPlanMembers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_NumberOfPlanMembers_a3dc930c-59ff-47a1-bcce-37be4e5f9a6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear_1b32c1b8-6cf4-4dcb-85b9-2cd9f4819355" xlink:href="cvs-20211231.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_NumberofPatientsServedperYear_1b32c1b8-6cf4-4dcb-85b9-2cd9f4819355" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed_40deadc1-d82a-48a7-8c7f-6048ed38a3eb" xlink:href="cvs-20211231.xsd#cvs_NumberOfPeopleServed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_NumberOfPeopleServed_40deadc1-d82a-48a7-8c7f-6048ed38a3eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_640f50cf-4f87-441f-84b8-ae359558dff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_NumberOfReportableSegments_640f50cf-4f87-441f-84b8-ae359558dff9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_42911db3-699f-430f-a625-39c0f962acb3" xlink:href="cvs-20211231.xsd#cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_42911db3-699f-430f-a625-39c0f962acb3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_7e5f53e8-2739-40f5-aaca-d2f01eea66d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_7e5f53e8-2739-40f5-aaca-d2f01eea66d3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b92b505b-7945-46e6-b2a8-f385e6a08583" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b92b505b-7945-46e6-b2a8-f385e6a08583" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_6ebc5475-37c2-42bc-b6a8-acc3e9367b50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_Depreciation_6ebc5475-37c2-42bc-b6a8-acc3e9367b50" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_ad5acd89-8d49-4489-a196-334b35880199" xlink:href="cvs-20211231.xsd#cvs_StoreImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_StoreImpairmentCharges_ad5acd89-8d49-4489-a196-334b35880199" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_c0c48dac-2230-4448-8399-8debef4b7ade" xlink:href="cvs-20211231.xsd#cvs_LesseeOperatingAndFinanceLeasesRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_c0c48dac-2230-4448-8399-8debef4b7ade" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_514a1838-54a8-43ef-bac1-809ee9cf72fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_514a1838-54a8-43ef-bac1-809ee9cf72fe" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b2870201-8c8e-4113-be7b-8fd7c2428963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b2870201-8c8e-4113-be7b-8fd7c2428963" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_e39ad544-8961-4512-93d6-95dd157bc776" xlink:href="cvs-20211231.xsd#cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_e39ad544-8961-4512-93d6-95dd157bc776" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityforUnpaidClaims_d2e26943-0e5b-4052-967e-35666dbd0338" xlink:href="cvs-20211231.xsd#cvs_LiabilityforUnpaidClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_LiabilityforUnpaidClaims_d2e26943-0e5b-4052-967e-35666dbd0338" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LimitedPaymentsContracts_e3b93108-a17f-4e47-aad6-c180dcf53766" xlink:href="cvs-20211231.xsd#cvs_LimitedPaymentsContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_LimitedPaymentsContracts_e3b93108-a17f-4e47-aad6-c180dcf53766" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts_b875f19c-ca5d-43b8-9a89-85547dd8ddb6" xlink:href="cvs-20211231.xsd#cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts_b875f19c-ca5d-43b8-9a89-85547dd8ddb6" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_d256c0c7-574f-414a-bd61-3ab891ec9091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_d256c0c7-574f-414a-bd61-3ab891ec9091" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_212a2d76-535a-45ec-b2e6-4f1a549d98bb" xlink:href="cvs-20211231.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_212a2d76-535a-45ec-b2e6-4f1a549d98bb" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PensionAndAnnuityInvestmentContractsInterest_ae2b78ff-6092-46f8-aa3a-1724b07dfbd0" xlink:href="cvs-20211231.xsd#cvs_PensionAndAnnuityInvestmentContractsInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_PensionAndAnnuityInvestmentContractsInterest_ae2b78ff-6092-46f8-aa3a-1724b07dfbd0" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeathSavingsAccountBalance_bae2c8b3-c7f1-4857-b2c1-c527baa0bdd8" xlink:href="cvs-20211231.xsd#cvs_HeathSavingsAccountBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_HeathSavingsAccountBalance_bae2c8b3-c7f1-4857-b2c1-c527baa0bdd8" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_1ef592c7-80f1-45ff-8866-a37460f67342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_SelfInsuranceReserve_1ef592c7-80f1-45ff-8866-a37460f67342" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_985aabf9-cddd-4c91-87fd-8f8f3320e277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_985aabf9-cddd-4c91-87fd-8f8f3320e277" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRebatePeriod_a79a8963-90cc-4b62-9090-8f26c9ea93ca" xlink:href="cvs-20211231.xsd#cvs_PharmacyRebatePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_PharmacyRebatePeriod_a79a8963-90cc-4b62-9090-8f26c9ea93ca" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee_5f3778ac-dfc2-4d0d-ad7c-cd487b3caecb" xlink:href="cvs-20211231.xsd#cvs_HealthInsurerFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_HealthInsurerFee_5f3778ac-dfc2-4d0d-ad7c-cd487b3caecb" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount_a8f78887-3bde-48e3-a801-a191b6ffb0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_GainContingencyUnrecordedAmount_a8f78887-3bde-48e3-a801-a191b6ffb0cb" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_f692eedb-d9bd-49fc-859d-6d6507251de7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_f692eedb-d9bd-49fc-859d-6d6507251de7" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_ea5a8256-2e0e-4a03-92fe-5087b121ee92" xlink:href="cvs-20211231.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_ea5a8256-2e0e-4a03-92fe-5087b121ee92" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_85e26cb4-2d1a-4916-9ac2-90760387ff5b" xlink:href="cvs-20211231.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_85e26cb4-2d1a-4916-9ac2-90760387ff5b" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_cf275d3f-f5e9-4985-b788-da6501d43dae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_AdvertisingExpense_cf275d3f-f5e9-4985-b788-da6501d43dae" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a9dee145-30b8-4e94-a596-23446c9768c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a9dee145-30b8-4e94-a596-23446c9768c9" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust_5579361c-0596-48ad-8ef6-a403db90cc35" xlink:href="cvs-20211231.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_TreasuryStockSharesHeldinTrust_5579361c-0596-48ad-8ef6-a403db90cc35" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_31681cbe-51bc-4e31-8dd4-d333f31043b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_31681cbe-51bc-4e31-8dd4-d333f31043b0" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Initialcontractualterm_c95d5adc-0c80-408f-9754-368f3d022395" xlink:href="cvs-20211231.xsd#cvs_Initialcontractualterm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_Initialcontractualterm_c95d5adc-0c80-408f-9754-368f3d022395" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VariableInterestEntityAmendedContractExtensionTerm_09a524fb-3282-403a-a048-32ace7325f45" xlink:href="cvs-20211231.xsd#cvs_VariableInterestEntityAmendedContractExtensionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_VariableInterestEntityAmendedContractExtensionTerm_09a524fb-3282-403a-a048-32ace7325f45" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VariableInterestEntityAmendedContractTerm_74437563-15bf-4e61-be87-4bfbc9238fdc" xlink:href="cvs-20211231.xsd#cvs_VariableInterestEntityAmendedContractTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_VariableInterestEntityAmendedContractTerm_74437563-15bf-4e61-be87-4bfbc9238fdc" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_e28d023c-5845-4a93-a59e-a003120d9a33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_e28d023c-5845-4a93-a59e-a003120d9a33" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_a6ae5394-2173-4822-963f-a8222d8317b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_a6ae5394-2173-4822-963f-a8222d8317b6" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_6e4792f5-3b34-475f-91e2-e62bb0ef8503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_6e4792f5-3b34-475f-91e2-e62bb0ef8503" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_d2b0a7d6-bf99-4909-b4de-cd287e7616fa" xlink:href="cvs-20211231.xsd#cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_d2b0a7d6-bf99-4909-b4de-cd287e7616fa" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresPlannedClosure_470bf4e0-0555-45fc-a62b-26b9cd1aaba1" xlink:href="cvs-20211231.xsd#cvs_NumberOfStoresPlannedClosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_NumberOfStoresPlannedClosure_470bf4e0-0555-45fc-a62b-26b9cd1aaba1" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ae8a05ad-222f-4113-b30e-88896379471b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_srt_ProductOrServiceAxis_ae8a05ad-222f-4113-b30e-88896379471b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ae8a05ad-222f-4113-b30e-88896379471b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_ae8a05ad-222f-4113-b30e-88896379471b" xlink:to="loc_srt_ProductsAndServicesDomain_ae8a05ad-222f-4113-b30e-88896379471b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6b5d6de7-4939-42c8-b223-98b85af59c16" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_ae8a05ad-222f-4113-b30e-88896379471b" xlink:to="loc_srt_ProductsAndServicesDomain_6b5d6de7-4939-42c8-b223-98b85af59c16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_cf88db63-f3a0-4df6-b26d-c8a47ee0adc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6b5d6de7-4939-42c8-b223-98b85af59c16" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_cf88db63-f3a0-4df6-b26d-c8a47ee0adc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fb534fcb-0c30-419f-873d-a4cd34fbed60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fb534fcb-0c30-419f-873d-a4cd34fbed60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fb534fcb-0c30-419f-873d-a4cd34fbed60_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fb534fcb-0c30-419f-873d-a4cd34fbed60" xlink:to="loc_us-gaap_SegmentDomain_fb534fcb-0c30-419f-873d-a4cd34fbed60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_50c4658d-096f-448f-b7c0-8b409936c23a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fb534fcb-0c30-419f-873d-a4cd34fbed60" xlink:to="loc_us-gaap_SegmentDomain_50c4658d-096f-448f-b7c0-8b409936c23a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_485175fe-a9c9-49dc-8cb6-0ee999b00420" xlink:href="cvs-20211231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_50c4658d-096f-448f-b7c0-8b409936c23a" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_485175fe-a9c9-49dc-8cb6-0ee999b00420" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_1b0d4795-0560-40eb-9e66-4059ca87e7fe" xlink:href="cvs-20211231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_50c4658d-096f-448f-b7c0-8b409936c23a" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_1b0d4795-0560-40eb-9e66-4059ca87e7fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f4f0eb0c-46f1-4369-abd8-40c91faf5da1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f4f0eb0c-46f1-4369-abd8-40c91faf5da1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f4f0eb0c-46f1-4369-abd8-40c91faf5da1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f4f0eb0c-46f1-4369-abd8-40c91faf5da1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f4f0eb0c-46f1-4369-abd8-40c91faf5da1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e46132d0-6fa9-4513-ad12-e125b0c0d7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f4f0eb0c-46f1-4369-abd8-40c91faf5da1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e46132d0-6fa9-4513-ad12-e125b0c0d7cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BrazilSubsidiaryMember_e169b5c3-3564-4df5-b3b9-91189413f6ed" xlink:href="cvs-20211231.xsd#cvs_BrazilSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e46132d0-6fa9-4513-ad12-e125b0c0d7cc" xlink:to="loc_cvs_BrazilSubsidiaryMember_e169b5c3-3564-4df5-b3b9-91189413f6ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_51a2ab68-d928-40a3-8c50-e48b6b0ee77e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_51a2ab68-d928-40a3-8c50-e48b6b0ee77e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_51a2ab68-d928-40a3-8c50-e48b6b0ee77e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_51a2ab68-d928-40a3-8c50-e48b6b0ee77e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_51a2ab68-d928-40a3-8c50-e48b6b0ee77e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_282210d1-c22c-43a8-8355-0af43b03df48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_51a2ab68-d928-40a3-8c50-e48b6b0ee77e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_282210d1-c22c-43a8-8355-0af43b03df48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_edc1f5b4-920e-49e9-9628-ba9197f93b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_282210d1-c22c-43a8-8355-0af43b03df48" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_edc1f5b4-920e-49e9-9628-ba9197f93b49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9df0871d-65aa-4375-8e72-1ec83bc6a417" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_srt_RangeAxis_9df0871d-65aa-4375-8e72-1ec83bc6a417" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9df0871d-65aa-4375-8e72-1ec83bc6a417_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9df0871d-65aa-4375-8e72-1ec83bc6a417" xlink:to="loc_srt_RangeMember_9df0871d-65aa-4375-8e72-1ec83bc6a417_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3146c42b-b7cd-46d5-ab22-1ff5f3e461a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9df0871d-65aa-4375-8e72-1ec83bc6a417" xlink:to="loc_srt_RangeMember_3146c42b-b7cd-46d5-ab22-1ff5f3e461a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ae0f5750-5197-46da-9e3e-384d742022f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3146c42b-b7cd-46d5-ab22-1ff5f3e461a1" xlink:to="loc_srt_MinimumMember_ae0f5750-5197-46da-9e3e-384d742022f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f2efac50-9f25-4ef2-86d9-c410c643d3ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3146c42b-b7cd-46d5-ab22-1ff5f3e461a1" xlink:to="loc_srt_MaximumMember_f2efac50-9f25-4ef2-86d9-c410c643d3ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1bda6c3a-afee-41c7-830e-53ef4b688b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1bda6c3a-afee-41c7-830e-53ef4b688b4c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1bda6c3a-afee-41c7-830e-53ef4b688b4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1bda6c3a-afee-41c7-830e-53ef4b688b4c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1bda6c3a-afee-41c7-830e-53ef4b688b4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e4c338bc-2de7-429b-85e7-781c2d204a70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1bda6c3a-afee-41c7-830e-53ef4b688b4c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e4c338bc-2de7-429b-85e7-781c2d204a70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_39e403ec-02e2-48cc-8b7b-431351251692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e4c338bc-2de7-429b-85e7-781c2d204a70" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_39e403ec-02e2-48cc-8b7b-431351251692" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_ae05a733-2d61-4d2f-a4e7-2ce578952544" xlink:href="cvs-20211231.xsd#cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e4c338bc-2de7-429b-85e7-781c2d204a70" xlink:to="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_ae05a733-2d61-4d2f-a4e7-2ce578952544" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_10c98886-496c-4839-b674-0d3096b9710e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e4c338bc-2de7-429b-85e7-781c2d204a70" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_10c98886-496c-4839-b674-0d3096b9710e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_0070c948-82eb-458f-89e0-d4bd170cc200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_0070c948-82eb-458f-89e0-d4bd170cc200" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0070c948-82eb-458f-89e0-d4bd170cc200_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0070c948-82eb-458f-89e0-d4bd170cc200" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0070c948-82eb-458f-89e0-d4bd170cc200_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_694ac8b9-1b55-4421-b392-f7a8d5317a95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0070c948-82eb-458f-89e0-d4bd170cc200" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_694ac8b9-1b55-4421-b392-f7a8d5317a95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesMember_e4fa4127-8f24-469e-824f-f643841687be" xlink:href="cvs-20211231.xsd#cvs_OtherInsuranceLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_694ac8b9-1b55-4421-b392-f7a8d5317a95" xlink:to="loc_cvs_OtherInsuranceLiabilitiesMember_e4fa4127-8f24-469e-824f-f643841687be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherLongTermInsuranceLiabilitiesMember_39681c7c-7dc3-4585-b2bc-0c732833d33d" xlink:href="cvs-20211231.xsd#cvs_OtherLongTermInsuranceLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_694ac8b9-1b55-4421-b392-f7a8d5317a95" xlink:to="loc_cvs_OtherLongTermInsuranceLiabilitiesMember_39681c7c-7dc3-4585-b2bc-0c732833d33d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ca201eb5-eb29-4b8a-9377-8f1f19db1054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ca201eb5-eb29-4b8a-9377-8f1f19db1054" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ca201eb5-eb29-4b8a-9377-8f1f19db1054_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ca201eb5-eb29-4b8a-9377-8f1f19db1054" xlink:to="loc_us-gaap_EquityComponentDomain_ca201eb5-eb29-4b8a-9377-8f1f19db1054_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_db97a2b3-a3af-4ec6-a8cf-c8f459ff7121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ca201eb5-eb29-4b8a-9377-8f1f19db1054" xlink:to="loc_us-gaap_EquityComponentDomain_db97a2b3-a3af-4ec6-a8cf-c8f459ff7121" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_eb614f69-450d-40f2-97c9-557f53bcab7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_db97a2b3-a3af-4ec6-a8cf-c8f459ff7121" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_eb614f69-450d-40f2-97c9-557f53bcab7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_4f989122-f210-4285-a3ca-5331e7d7893e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_dei_LegalEntityAxis_4f989122-f210-4285-a3ca-5331e7d7893e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4f989122-f210-4285-a3ca-5331e7d7893e_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_4f989122-f210-4285-a3ca-5331e7d7893e" xlink:to="loc_dei_EntityDomain_4f989122-f210-4285-a3ca-5331e7d7893e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_01f0e17c-0a97-412e-8b6f-bb274b441b41" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_4f989122-f210-4285-a3ca-5331e7d7893e" xlink:to="loc_dei_EntityDomain_01f0e17c-0a97-412e-8b6f-bb274b441b41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember_b1a667d0-c67c-4cde-b0e2-26bd81681d21" xlink:href="cvs-20211231.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_01f0e17c-0a97-412e-8b6f-bb274b441b41" xlink:to="loc_cvs_HeartlandHealthcareServicesMember_b1a667d0-c67c-4cde-b0e2-26bd81681d21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8a8575ec-ee45-4e1a-bced-5e3eddec68a9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_srt_LitigationCaseAxis_8a8575ec-ee45-4e1a-bced-5e3eddec68a9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8a8575ec-ee45-4e1a-bced-5e3eddec68a9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_8a8575ec-ee45-4e1a-bced-5e3eddec68a9" xlink:to="loc_srt_LitigationCaseTypeDomain_8a8575ec-ee45-4e1a-bced-5e3eddec68a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_623c7d4b-5847-4acc-a381-0b00b2d50c5f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_8a8575ec-ee45-4e1a-bced-5e3eddec68a9" xlink:to="loc_srt_LitigationCaseTypeDomain_623c7d4b-5847-4acc-a381-0b00b2d50c5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_0b679c8b-eec2-48e6-ad1c-82aa28f5d7da" xlink:href="cvs-20211231.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_623c7d4b-5847-4acc-a381-0b00b2d50c5f" xlink:to="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_0b679c8b-eec2-48e6-ad1c-82aa28f5d7da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_ec930d68-5b30-495d-8b32-671bd21de3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_us-gaap_LitigationStatusAxis_ec930d68-5b30-495d-8b32-671bd21de3ff" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_ec930d68-5b30-495d-8b32-671bd21de3ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_ec930d68-5b30-495d-8b32-671bd21de3ff" xlink:to="loc_us-gaap_LitigationStatusDomain_ec930d68-5b30-495d-8b32-671bd21de3ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_6a1eac5f-fd05-41b4-83dd-e8d5252d31bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_ec930d68-5b30-495d-8b32-671bd21de3ff" xlink:to="loc_us-gaap_LitigationStatusDomain_6a1eac5f-fd05-41b4-83dd-e8d5252d31bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_76d05413-df14-40b0-9398-6f53335af41f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_6a1eac5f-fd05-41b4-83dd-e8d5252d31bb" xlink:to="loc_us-gaap_SettledLitigationMember_76d05413-df14-40b0-9398-6f53335af41f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="extended" id="iea6608a4907d409097c6d99f89dc9cf6_SignificantAccountingPoliciesPropertyPlantandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_68bf2946-68b0-4ae2-86af-1ca4ec96b624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e2ef37eb-a9ac-43c9-bb68-fe2c29bfec61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_68bf2946-68b0-4ae2-86af-1ca4ec96b624" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e2ef37eb-a9ac-43c9-bb68-fe2c29bfec61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6158f1f0-1a94-4f78-b18b-99b06e14448a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_68bf2946-68b0-4ae2-86af-1ca4ec96b624" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6158f1f0-1a94-4f78-b18b-99b06e14448a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_483d996b-4402-4cfc-9cff-e6c346dae628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_68bf2946-68b0-4ae2-86af-1ca4ec96b624" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_483d996b-4402-4cfc-9cff-e6c346dae628" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_554500a3-095f-4654-a9cc-31f63d5a7b25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_68bf2946-68b0-4ae2-86af-1ca4ec96b624" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_554500a3-095f-4654-a9cc-31f63d5a7b25" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e99176e-5abd-46ac-8235-fb7b94f3d047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_554500a3-095f-4654-a9cc-31f63d5a7b25" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e99176e-5abd-46ac-8235-fb7b94f3d047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9e99176e-5abd-46ac-8235-fb7b94f3d047_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e99176e-5abd-46ac-8235-fb7b94f3d047" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9e99176e-5abd-46ac-8235-fb7b94f3d047_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7791b588-84e2-4fb1-8d62-9e2ad87b2199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e99176e-5abd-46ac-8235-fb7b94f3d047" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7791b588-84e2-4fb1-8d62-9e2ad87b2199" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_68956f1c-91d1-444d-b3cd-03939eccf6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7791b588-84e2-4fb1-8d62-9e2ad87b2199" xlink:to="loc_us-gaap_LandMember_68956f1c-91d1-444d-b3cd-03939eccf6d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_afe08987-8f85-408d-8c03-df57c98c7973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7791b588-84e2-4fb1-8d62-9e2ad87b2199" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_afe08987-8f85-408d-8c03-df57c98c7973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_59f1191d-9b38-4ffe-8e60-273326239ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7791b588-84e2-4fb1-8d62-9e2ad87b2199" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_59f1191d-9b38-4ffe-8e60-273326239ac7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_5e5d92d2-0241-4cde-b672-e462dfa8d9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7791b588-84e2-4fb1-8d62-9e2ad87b2199" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_5e5d92d2-0241-4cde-b672-e462dfa8d9c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_5a34275e-9e6d-4244-ace1-977853b2658c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7791b588-84e2-4fb1-8d62-9e2ad87b2199" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_5a34275e-9e6d-4244-ace1-977853b2658c" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended" id="i98867dec02614d7f9a7c4e55680d1208_SignificantAccountingPoliciesDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_bea8288a-6511-4922-9ca4-87b11a3ba14d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_5dd6a0be-de2f-4852-8bba-ac576a0eae02" xlink:href="cvs-20211231.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bea8288a-6511-4922-9ca4-87b11a3ba14d" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_5dd6a0be-de2f-4852-8bba-ac576a0eae02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_3e958a02-c696-408a-96b8-aed8f7c75396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bea8288a-6511-4922-9ca4-87b11a3ba14d" xlink:to="loc_us-gaap_NetInvestmentIncome_3e958a02-c696-408a-96b8-aed8f7c75396" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fa0c0c59-9eb9-4ff2-83ef-729efb8a5e75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bea8288a-6511-4922-9ca4-87b11a3ba14d" xlink:to="loc_us-gaap_Revenues_fa0c0c59-9eb9-4ff2-83ef-729efb8a5e75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b0e5071e-6976-49c0-ab9e-73ad7a1d9ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bea8288a-6511-4922-9ca4-87b11a3ba14d" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b0e5071e-6976-49c0-ab9e-73ad7a1d9ffc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3257b2bb-a15c-486d-a5bc-ff187e9368ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b0e5071e-6976-49c0-ab9e-73ad7a1d9ffc" xlink:to="loc_srt_ConsolidationItemsAxis_3257b2bb-a15c-486d-a5bc-ff187e9368ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3257b2bb-a15c-486d-a5bc-ff187e9368ab_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_3257b2bb-a15c-486d-a5bc-ff187e9368ab" xlink:to="loc_srt_ConsolidationItemsDomain_3257b2bb-a15c-486d-a5bc-ff187e9368ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_88cd23b8-62a6-49c6-a057-53ef5653ac08" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_3257b2bb-a15c-486d-a5bc-ff187e9368ab" xlink:to="loc_srt_ConsolidationItemsDomain_88cd23b8-62a6-49c6-a057-53ef5653ac08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_a7ce5ddc-4633-4bce-92e8-6acc35ba3b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_88cd23b8-62a6-49c6-a057-53ef5653ac08" xlink:to="loc_us-gaap_OperatingSegmentsMember_a7ce5ddc-4633-4bce-92e8-6acc35ba3b07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b3fc0b75-72ec-42f4-b6da-ba15abc2ebab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_88cd23b8-62a6-49c6-a057-53ef5653ac08" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b3fc0b75-72ec-42f4-b6da-ba15abc2ebab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_713c4bf7-5500-4033-bc60-94c38d7c7f12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_88cd23b8-62a6-49c6-a057-53ef5653ac08" xlink:to="loc_us-gaap_IntersegmentEliminationMember_713c4bf7-5500-4033-bc60-94c38d7c7f12" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_29fce7da-2d88-4396-b2ef-5e43aacbb6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b0e5071e-6976-49c0-ab9e-73ad7a1d9ffc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_29fce7da-2d88-4396-b2ef-5e43aacbb6ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_29fce7da-2d88-4396-b2ef-5e43aacbb6ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_29fce7da-2d88-4396-b2ef-5e43aacbb6ec" xlink:to="loc_us-gaap_SegmentDomain_29fce7da-2d88-4396-b2ef-5e43aacbb6ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_145e4bc4-7f4f-4b85-a304-13d9ca41699d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_29fce7da-2d88-4396-b2ef-5e43aacbb6ec" xlink:to="loc_us-gaap_SegmentDomain_145e4bc4-7f4f-4b85-a304-13d9ca41699d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_d46e3754-8157-4391-8ea8-885a54f42cb6" xlink:href="cvs-20211231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_145e4bc4-7f4f-4b85-a304-13d9ca41699d" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_d46e3754-8157-4391-8ea8-885a54f42cb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_fb76d548-dcdf-4c0b-8999-08be7571d9e8" xlink:href="cvs-20211231.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_145e4bc4-7f4f-4b85-a304-13d9ca41699d" xlink:to="loc_cvs_PharmacyServicesSegmentMember_fb76d548-dcdf-4c0b-8999-08be7571d9e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_604c8bb8-bb4b-4019-be80-85eb933d4858" xlink:href="cvs-20211231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_145e4bc4-7f4f-4b85-a304-13d9ca41699d" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_604c8bb8-bb4b-4019-be80-85eb933d4858" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4ee8bd82-d418-4e8e-aeaf-f779d6e885ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b0e5071e-6976-49c0-ab9e-73ad7a1d9ffc" xlink:to="loc_srt_ProductOrServiceAxis_4ee8bd82-d418-4e8e-aeaf-f779d6e885ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4ee8bd82-d418-4e8e-aeaf-f779d6e885ed_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4ee8bd82-d418-4e8e-aeaf-f779d6e885ed" xlink:to="loc_srt_ProductsAndServicesDomain_4ee8bd82-d418-4e8e-aeaf-f779d6e885ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_574faef5-663c-48ee-ba49-bcf9dd5d49ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4ee8bd82-d418-4e8e-aeaf-f779d6e885ed" xlink:to="loc_srt_ProductsAndServicesDomain_574faef5-663c-48ee-ba49-bcf9dd5d49ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember_f01f6426-e7ac-4260-9261-fd241c8a213d" xlink:href="cvs-20211231.xsd#cvs_PharmacyRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_574faef5-663c-48ee-ba49-bcf9dd5d49ed" xlink:to="loc_cvs_PharmacyRevenueMember_f01f6426-e7ac-4260-9261-fd241c8a213d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember_79541de3-3e07-4c9f-9f31-e65f8a8c01f6" xlink:href="cvs-20211231.xsd#cvs_FrontStoreRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_574faef5-663c-48ee-ba49-bcf9dd5d49ed" xlink:to="loc_cvs_FrontStoreRevenueMember_79541de3-3e07-4c9f-9f31-e65f8a8c01f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember_3517701e-cf49-4a53-b5b3-354ccda9e732" xlink:href="cvs-20211231.xsd#cvs_PremiumsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_574faef5-663c-48ee-ba49-bcf9dd5d49ed" xlink:to="loc_cvs_PremiumsMember_3517701e-cf49-4a53-b5b3-354ccda9e732" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_f22c7fd2-0ebf-409c-b4cc-6d5816312e43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_574faef5-663c-48ee-ba49-bcf9dd5d49ed" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_f22c7fd2-0ebf-409c-b4cc-6d5816312e43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_a4a8770b-f82e-47cd-96ba-35958507b438" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b0e5071e-6976-49c0-ab9e-73ad7a1d9ffc" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_a4a8770b-f82e-47cd-96ba-35958507b438" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_a4a8770b-f82e-47cd-96ba-35958507b438_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_a4a8770b-f82e-47cd-96ba-35958507b438" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_a4a8770b-f82e-47cd-96ba-35958507b438_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9c4b3104-bdf1-47e9-8cf1-913fbe4eba87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_a4a8770b-f82e-47cd-96ba-35958507b438" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9c4b3104-bdf1-47e9-8cf1-913fbe4eba87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_5ecf04be-fdf1-48a0-adaa-371074b27e44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9c4b3104-bdf1-47e9-8cf1-913fbe4eba87" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_5ecf04be-fdf1-48a0-adaa-371074b27e44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_14f7bc1f-3210-4f5d-beda-5ee71ec02ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9c4b3104-bdf1-47e9-8cf1-913fbe4eba87" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_14f7bc1f-3210-4f5d-beda-5ee71ec02ce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember_28b2d56d-01a9-454f-a217-c9edf2a3eb60" xlink:href="cvs-20211231.xsd#cvs_SalesChannelOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9c4b3104-bdf1-47e9-8cf1-913fbe4eba87" xlink:to="loc_cvs_SalesChannelOtherMember_28b2d56d-01a9-454f-a217-c9edf2a3eb60" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesVariableInterestEntitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="extended" id="i1e0eb672f4af4ec7800f2adf35381e61_SignificantAccountingPoliciesVariableInterestEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_17b76385-33ed-4682-a6a0-98a08c54ed9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_587974ad-319d-4383-8134-91476fc85ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_17b76385-33ed-4682-a6a0-98a08c54ed9d" xlink:to="loc_us-gaap_LongTermInvestments_587974ad-319d-4383-8134-91476fc85ccb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_45af2523-2e7a-4191-bfac-07e70070bb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_17b76385-33ed-4682-a6a0-98a08c54ed9d" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_45af2523-2e7a-4191-bfac-07e70070bb4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Initialcontractualterm_22d338bc-be35-4549-a418-0036c59ac649" xlink:href="cvs-20211231.xsd#cvs_Initialcontractualterm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_17b76385-33ed-4682-a6a0-98a08c54ed9d" xlink:to="loc_cvs_Initialcontractualterm_22d338bc-be35-4549-a418-0036c59ac649" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VariableInterestEntityAmendedContractExtensionTerm_345e289d-41ce-4512-904e-776fb8da21bc" xlink:href="cvs-20211231.xsd#cvs_VariableInterestEntityAmendedContractExtensionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_17b76385-33ed-4682-a6a0-98a08c54ed9d" xlink:to="loc_cvs_VariableInterestEntityAmendedContractExtensionTerm_345e289d-41ce-4512-904e-776fb8da21bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VariableInterestEntityAmendedContractTerm_224885ea-a443-480d-800e-b28cebde987f" xlink:href="cvs-20211231.xsd#cvs_VariableInterestEntityAmendedContractTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_17b76385-33ed-4682-a6a0-98a08c54ed9d" xlink:to="loc_cvs_VariableInterestEntityAmendedContractTerm_224885ea-a443-480d-800e-b28cebde987f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsFromVariableInterestEntity_94d19db9-9faa-490e-b7eb-20b999f3709a" xlink:href="cvs-20211231.xsd#cvs_ProceedsFromVariableInterestEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_17b76385-33ed-4682-a6a0-98a08c54ed9d" xlink:to="loc_cvs_ProceedsFromVariableInterestEntity_94d19db9-9faa-490e-b7eb-20b999f3709a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4c117566-85bc-4807-89c8-d0e9f406d5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_17b76385-33ed-4682-a6a0-98a08c54ed9d" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4c117566-85bc-4807-89c8-d0e9f406d5cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_645f75d4-dce0-484b-a438-a771fb2cec7d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4c117566-85bc-4807-89c8-d0e9f406d5cc" xlink:to="loc_srt_ConsolidatedEntitiesAxis_645f75d4-dce0-484b-a438-a771fb2cec7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_645f75d4-dce0-484b-a438-a771fb2cec7d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_645f75d4-dce0-484b-a438-a771fb2cec7d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_645f75d4-dce0-484b-a438-a771fb2cec7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_cd20e004-e092-4aa6-9cc5-6423a2bb34b9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_645f75d4-dce0-484b-a438-a771fb2cec7d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_cd20e004-e092-4aa6-9cc5-6423a2bb34b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_7a259195-d558-4c44-87bf-c9688b22ca06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_cd20e004-e092-4aa6-9cc5-6423a2bb34b9" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_7a259195-d558-4c44-87bf-c9688b22ca06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_31308654-f577-4090-8bef-a580ce67c720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4c117566-85bc-4807-89c8-d0e9f406d5cc" xlink:to="loc_us-gaap_InvestmentTypeAxis_31308654-f577-4090-8bef-a580ce67c720" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_31308654-f577-4090-8bef-a580ce67c720_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_31308654-f577-4090-8bef-a580ce67c720" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_31308654-f577-4090-8bef-a580ce67c720_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_37a326eb-ab8b-466d-8d6f-5ada4a00a3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_31308654-f577-4090-8bef-a580ce67c720" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_37a326eb-ab8b-466d-8d6f-5ada4a00a3a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_1548fbd5-d631-4dbb-bddb-0c8c87eb698e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_37a326eb-ab8b-466d-8d6f-5ada4a00a3a5" xlink:to="loc_us-gaap_HedgeFundsMember_1548fbd5-d631-4dbb-bddb-0c8c87eb698e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_c5d2bda0-6714-4fae-9c3a-3b891b70fe85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_37a326eb-ab8b-466d-8d6f-5ada4a00a3a5" xlink:to="loc_us-gaap_PrivateEquityFundsMember_c5d2bda0-6714-4fae-9c3a-3b891b70fe85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_40dcdda5-ee7f-4b26-9678-876d4869f4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_37a326eb-ab8b-466d-8d6f-5ada4a00a3a5" xlink:to="loc_us-gaap_RealEstateFundsMember_40dcdda5-ee7f-4b26-9678-876d4869f4a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_72e976ca-1385-486d-8e2a-ce28c0faf69c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4c117566-85bc-4807-89c8-d0e9f406d5cc" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_72e976ca-1385-486d-8e2a-ce28c0faf69c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_72e976ca-1385-486d-8e2a-ce28c0faf69c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_72e976ca-1385-486d-8e2a-ce28c0faf69c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_72e976ca-1385-486d-8e2a-ce28c0faf69c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1bff7c03-0fa8-4a31-b2fa-70eae4ec2ff0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_72e976ca-1385-486d-8e2a-ce28c0faf69c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1bff7c03-0fa8-4a31-b2fa-70eae4ec2ff0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RedOakMember_dd240101-7ef5-4fa3-a3d3-3b57299cc8e4" xlink:href="cvs-20211231.xsd#cvs_RedOakMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1bff7c03-0fa8-4a31-b2fa-70eae4ec2ff0" xlink:to="loc_cvs_RedOakMember_dd240101-7ef5-4fa3-a3d3-3b57299cc8e4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/DivestituresNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#DivestituresNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/DivestituresNarrativeDetails" xlink:type="extended" id="i937208af065d42aba29d055179e233c6_DivestituresNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d72346d1-104e-495d-a256-203414aa3d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_aa8497b2-7c72-40c6-8dc7-b9d50f472001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d72346d1-104e-495d-a256-203414aa3d50" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_aa8497b2-7c72-40c6-8dc7-b9d50f472001" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_b3a83997-b217-49aa-8f7e-22c670f2f5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d72346d1-104e-495d-a256-203414aa3d50" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_b3a83997-b217-49aa-8f7e-22c670f2f5ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_1f9be073-c968-487a-ab94-1b96584046b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d72346d1-104e-495d-a256-203414aa3d50" xlink:to="loc_us-gaap_NumberOfStores_1f9be073-c968-487a-ab94-1b96584046b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_859030ed-8f97-4f2b-8f70-aedc990f2180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d72346d1-104e-495d-a256-203414aa3d50" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_859030ed-8f97-4f2b-8f70-aedc990f2180" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8c5cd3c0-0e9a-456f-a845-5085765093d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_859030ed-8f97-4f2b-8f70-aedc990f2180" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8c5cd3c0-0e9a-456f-a845-5085765093d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_8c5cd3c0-0e9a-456f-a845-5085765093d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8c5cd3c0-0e9a-456f-a845-5085765093d7" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_8c5cd3c0-0e9a-456f-a845-5085765093d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3e933b17-00e7-4bcc-9b9c-990d53d41b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8c5cd3c0-0e9a-456f-a845-5085765093d7" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3e933b17-00e7-4bcc-9b9c-990d53d41b42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_efc0edfe-3a47-4d9f-8f02-b16531724b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3e933b17-00e7-4bcc-9b9c-990d53d41b42" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_efc0edfe-3a47-4d9f-8f02-b16531724b7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2314828e-e3ed-45b0-9705-802e72cb6ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_859030ed-8f97-4f2b-8f70-aedc990f2180" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2314828e-e3ed-45b0-9705-802e72cb6ed0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2314828e-e3ed-45b0-9705-802e72cb6ed0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2314828e-e3ed-45b0-9705-802e72cb6ed0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2314828e-e3ed-45b0-9705-802e72cb6ed0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_428fd27f-4681-43a9-bc3b-674419ca4d83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2314828e-e3ed-45b0-9705-802e72cb6ed0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_428fd27f-4681-43a9-bc3b-674419ca4d83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_d9c4eb44-caa8-4603-9876-7780a2fae113" xlink:href="cvs-20211231.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_428fd27f-4681-43a9-bc3b-674419ca4d83" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_d9c4eb44-caa8-4603-9876-7780a2fae113" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BrazilSubsidiaryMember_c198d801-7291-4bee-a665-3cf35d89bb35" xlink:href="cvs-20211231.xsd#cvs_BrazilSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_428fd27f-4681-43a9-bc3b-674419ca4d83" xlink:to="loc_cvs_BrazilSubsidiaryMember_c198d801-7291-4bee-a665-3cf35d89bb35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DrogariaOnofreLtdaMember_94c1379b-732f-47e4-b842-a74bcb36e4e7" xlink:href="cvs-20211231.xsd#cvs_DrogariaOnofreLtdaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_428fd27f-4681-43a9-bc3b-674419ca4d83" xlink:to="loc_cvs_DrogariaOnofreLtdaMember_94c1379b-732f-47e4-b842-a74bcb36e4e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ba045c17-5736-4280-9eff-b69e39700479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_859030ed-8f97-4f2b-8f70-aedc990f2180" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ba045c17-5736-4280-9eff-b69e39700479" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ba045c17-5736-4280-9eff-b69e39700479_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ba045c17-5736-4280-9eff-b69e39700479" xlink:to="loc_us-gaap_SegmentDomain_ba045c17-5736-4280-9eff-b69e39700479_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_381456c9-bbc3-4a99-87ec-5eb23beaaeeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ba045c17-5736-4280-9eff-b69e39700479" xlink:to="loc_us-gaap_SegmentDomain_381456c9-bbc3-4a99-87ec-5eb23beaaeeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_6ba4500e-adf5-4a3c-aa65-3885a6e8b818" xlink:href="cvs-20211231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_381456c9-bbc3-4a99-87ec-5eb23beaaeeb" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_6ba4500e-adf5-4a3c-aa65-3885a6e8b818" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_58a623c7-c0bc-4f58-8666-9332730b64b6" xlink:href="cvs-20211231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_381456c9-bbc3-4a99-87ec-5eb23beaaeeb" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_58a623c7-c0bc-4f58-8666-9332730b64b6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsScheduleofTotalInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="extended" id="iecf025e8b8ea414883b9027b986e88c8_InvestmentsScheduleofTotalInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems_a78a13fe-f0ca-430d-ab7e-60f2fec6c0e1" xlink:href="cvs-20211231.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_1d8c99a8-b9e1-4180-8914-98c151548337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_a78a13fe-f0ca-430d-ab7e-60f2fec6c0e1" xlink:to="loc_us-gaap_ShortTermInvestments_1d8c99a8-b9e1-4180-8914-98c151548337" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_9b327e5c-ef7b-4774-a3cc-2e69a9feec4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_a78a13fe-f0ca-430d-ab7e-60f2fec6c0e1" xlink:to="loc_us-gaap_LongTermInvestments_9b327e5c-ef7b-4774-a3cc-2e69a9feec4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_2006b01a-a6a5-49a9-8a93-7f25f6dc8e62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsLineItems_a78a13fe-f0ca-430d-ab7e-60f2fec6c0e1" xlink:to="loc_us-gaap_Investments_2006b01a-a6a5-49a9-8a93-7f25f6dc8e62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable_266ede71-c091-43ad-84ca-15c032469ea0" xlink:href="cvs-20211231.xsd#cvs_TotalInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cvs_TotalInvestmentsLineItems_a78a13fe-f0ca-430d-ab7e-60f2fec6c0e1" xlink:to="loc_cvs_TotalInvestmentsTable_266ede71-c091-43ad-84ca-15c032469ea0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis_aaacab26-d8c4-4f1e-b765-913f2c2e134a" xlink:href="cvs-20211231.xsd#cvs_TotalInvestmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cvs_TotalInvestmentsTable_266ede71-c091-43ad-84ca-15c032469ea0" xlink:to="loc_cvs_TotalInvestmentsAxis_aaacab26-d8c4-4f1e-b765-913f2c2e134a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_aaacab26-d8c4-4f1e-b765-913f2c2e134a_default" xlink:href="cvs-20211231.xsd#cvs_TotalInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_TotalInvestmentsAxis_aaacab26-d8c4-4f1e-b765-913f2c2e134a" xlink:to="loc_cvs_TotalInvestmentsDomain_aaacab26-d8c4-4f1e-b765-913f2c2e134a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_10474012-268e-4bb4-8a83-d9e589f130ec" xlink:href="cvs-20211231.xsd#cvs_TotalInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_TotalInvestmentsAxis_aaacab26-d8c4-4f1e-b765-913f2c2e134a" xlink:to="loc_cvs_TotalInvestmentsDomain_10474012-268e-4bb4-8a83-d9e589f130ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_ab763960-19ca-4548-93d8-635c6f7b1ff5" xlink:href="cvs-20211231.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_10474012-268e-4bb4-8a83-d9e589f130ec" xlink:to="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_ab763960-19ca-4548-93d8-635c6f7b1ff5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_da6f024e-142d-4362-bb3e-fc324408b41e" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_10474012-268e-4bb4-8a83-d9e589f130ec" xlink:to="loc_cvs_MortgageLoansMember_da6f024e-142d-4362-bb3e-fc324408b41e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_d973ea86-3d63-4506-8183-3da576f72c25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_TotalInvestmentsDomain_10474012-268e-4bb4-8a83-d9e589f130ec" xlink:to="loc_us-gaap_OtherInvestmentsMember_d973ea86-3d63-4506-8183-3da576f72c25" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsNarrativeDetails" xlink:type="extended" id="ibd210ab218184139a1198b6eed3abf40_InvestmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75671b1a-e52e-437b-bb46-2467eabe312b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedInvestmentsAtFairValue_6a9794dc-17ba-4280-be1a-db883660cddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedInvestmentsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75671b1a-e52e-437b-bb46-2467eabe312b" xlink:to="loc_us-gaap_RestrictedInvestmentsAtFairValue_6a9794dc-17ba-4280-be1a-db883660cddb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_feb2b788-0b3a-4abd-a3f8-26c9e40852b0" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75671b1a-e52e-437b-bb46-2467eabe312b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_feb2b788-0b3a-4abd-a3f8-26c9e40852b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0587f3b0-d0b9-4215-8353-51ca60bc2556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75671b1a-e52e-437b-bb46-2467eabe312b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0587f3b0-d0b9-4215-8353-51ca60bc2556" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6b7cc181-4460-469a-9b0a-2cd8fdedfab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0587f3b0-d0b9-4215-8353-51ca60bc2556" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6b7cc181-4460-469a-9b0a-2cd8fdedfab7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6b7cc181-4460-469a-9b0a-2cd8fdedfab7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6b7cc181-4460-469a-9b0a-2cd8fdedfab7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6b7cc181-4460-469a-9b0a-2cd8fdedfab7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d318edf2-288a-40a8-ab9d-58a20c1820c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6b7cc181-4460-469a-9b0a-2cd8fdedfab7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d318edf2-288a-40a8-ab9d-58a20c1820c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_a3150a03-4535-43b3-9fef-4b4f9e3fef73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d318edf2-288a-40a8-ab9d-58a20c1820c7" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_a3150a03-4535-43b3-9fef-4b4f9e3fef73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d2f4491b-0fcc-4153-ac12-6ddab9fd768b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d318edf2-288a-40a8-ab9d-58a20c1820c7" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d2f4491b-0fcc-4153-ac12-6ddab9fd768b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_7ec63237-70f1-4a26-97b9-56db2c88c08c" xlink:href="cvs-20211231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d318edf2-288a-40a8-ab9d-58a20c1820c7" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_7ec63237-70f1-4a26-97b9-56db2c88c08c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended" id="i81bb4e350c4a4c4ba15bfb228d7a09b3_InvestmentsDebtSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_48de20b6-d2da-4f33-a238-c352026772e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_0bff4759-010d-4fb5-a15f-09f92331acbb" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_48de20b6-d2da-4f33-a238-c352026772e5" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_0bff4759-010d-4fb5-a15f-09f92331acbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_eaecae1c-ee31-460f-b7a1-17e46dd9f46f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_48de20b6-d2da-4f33-a238-c352026772e5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_eaecae1c-ee31-460f-b7a1-17e46dd9f46f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_fdb73760-9723-4a16-8e30-27df386f7318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_48de20b6-d2da-4f33-a238-c352026772e5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_fdb73760-9723-4a16-8e30-27df386f7318" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b1c9a04a-db8c-41a3-9f35-16088e9b405b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_48de20b6-d2da-4f33-a238-c352026772e5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b1c9a04a-db8c-41a3-9f35-16088e9b405b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_7ade3560-3dc8-41b0-adb2-f36c2eaeed7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_48de20b6-d2da-4f33-a238-c352026772e5" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_7ade3560-3dc8-41b0-adb2-f36c2eaeed7e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_766e3604-b008-418c-a140-bfee8becd876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_48de20b6-d2da-4f33-a238-c352026772e5" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_766e3604-b008-418c-a140-bfee8becd876" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a853c1a1-9ca0-4bc7-b394-2c457bcf477e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_766e3604-b008-418c-a140-bfee8becd876" xlink:to="loc_srt_ProductOrServiceAxis_a853c1a1-9ca0-4bc7-b394-2c457bcf477e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a853c1a1-9ca0-4bc7-b394-2c457bcf477e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a853c1a1-9ca0-4bc7-b394-2c457bcf477e" xlink:to="loc_srt_ProductsAndServicesDomain_a853c1a1-9ca0-4bc7-b394-2c457bcf477e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_023c1abb-1e31-4c62-b985-b190b9aee9ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a853c1a1-9ca0-4bc7-b394-2c457bcf477e" xlink:to="loc_srt_ProductsAndServicesDomain_023c1abb-1e31-4c62-b985-b190b9aee9ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_75963f81-c178-4329-8915-3d56217763b5" xlink:href="cvs-20211231.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_023c1abb-1e31-4c62-b985-b190b9aee9ed" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_75963f81-c178-4329-8915-3d56217763b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b334fb45-86d5-457c-83af-2d5d5fdc73f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_766e3604-b008-418c-a140-bfee8becd876" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b334fb45-86d5-457c-83af-2d5d5fdc73f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b334fb45-86d5-457c-83af-2d5d5fdc73f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b334fb45-86d5-457c-83af-2d5d5fdc73f1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b334fb45-86d5-457c-83af-2d5d5fdc73f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b334fb45-86d5-457c-83af-2d5d5fdc73f1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_74df9a2c-946b-4679-93e3-309618d25cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_74df9a2c-946b-4679-93e3-309618d25cc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_024a363c-fb69-4b27-a94d-c889b104c05d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_024a363c-fb69-4b27-a94d-c889b104c05d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_853b1c86-5103-4cc8-86ad-76f683313517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_853b1c86-5103-4cc8-86ad-76f683313517" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_53010547-dd47-4e53-ba02-539fcae901ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_53010547-dd47-4e53-ba02-539fcae901ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6debf397-88b3-40f2-b525-d0ab51f8a8c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6debf397-88b3-40f2-b525-d0ab51f8a8c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_66113f64-2c7f-4f1b-9aaf-72bdb9e8eb16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_66113f64-2c7f-4f1b-9aaf-72bdb9e8eb16" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_c6ecf15a-d35a-4ede-ada3-26e3edbcfd9f" xlink:href="cvs-20211231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_c6ecf15a-d35a-4ede-ada3-26e3edbcfd9f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_9b98d22b-eca1-47b7-83e3-c58c88266891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_9b98d22b-eca1-47b7-83e3-c58c88266891" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended" id="i658be4efab7043658af93a5de73ef18c_InvestmentsDebtSecuritiesbyMaturityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2c79130b-9f26-4b68-b3c9-5c9f7696839c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_271b83ec-85b7-4137-815e-44907585160b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2c79130b-9f26-4b68-b3c9-5c9f7696839c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_271b83ec-85b7-4137-815e-44907585160b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_aa977aae-928d-4754-b9fd-ad0cd3555e3f" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_271b83ec-85b7-4137-815e-44907585160b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_aa977aae-928d-4754-b9fd-ad0cd3555e3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_ad14c0ba-aecc-4501-a24e-350fc5d08064" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_271b83ec-85b7-4137-815e-44907585160b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_ad14c0ba-aecc-4501-a24e-350fc5d08064" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_dfadad27-153b-494f-ad71-6569dd50462f" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_271b83ec-85b7-4137-815e-44907585160b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_dfadad27-153b-494f-ad71-6569dd50462f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_03b1bd5a-a934-420e-8d5c-340a2282da69" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_271b83ec-85b7-4137-815e-44907585160b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_03b1bd5a-a934-420e-8d5c-340a2282da69" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_155c1534-2466-491c-b3b2-48541351461f" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_271b83ec-85b7-4137-815e-44907585160b" xlink:to="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_155c1534-2466-491c-b3b2-48541351461f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_2730e616-ff57-4785-ab4b-55212730a163" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_271b83ec-85b7-4137-815e-44907585160b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_2730e616-ff57-4785-ab4b-55212730a163" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_b5ec82f9-eb7b-4376-a050-ee2acfeadca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2c79130b-9f26-4b68-b3c9-5c9f7696839c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_b5ec82f9-eb7b-4376-a050-ee2acfeadca7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_c201986f-d860-4383-8b2d-ac266b049ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_b5ec82f9-eb7b-4376-a050-ee2acfeadca7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_c201986f-d860-4383-8b2d-ac266b049ff8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2361e0d1-ff48-4e19-b298-87ab2ae99042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_b5ec82f9-eb7b-4376-a050-ee2acfeadca7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2361e0d1-ff48-4e19-b298-87ab2ae99042" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_907594cc-a8bd-4046-90e4-89aecb4e72ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_b5ec82f9-eb7b-4376-a050-ee2acfeadca7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_907594cc-a8bd-4046-90e4-89aecb4e72ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_386b1a5b-0ca8-498f-9543-eee93afc46c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_b5ec82f9-eb7b-4376-a050-ee2acfeadca7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_386b1a5b-0ca8-498f-9543-eee93afc46c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_2392c468-848a-4d33-bf14-c42008d5d0af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_b5ec82f9-eb7b-4376-a050-ee2acfeadca7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_2392c468-848a-4d33-bf14-c42008d5d0af" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_35584601-1506-4057-bd02-f8e0be4a8609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_b5ec82f9-eb7b-4376-a050-ee2acfeadca7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_35584601-1506-4057-bd02-f8e0be4a8609" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_929b133b-8f22-487d-b502-a9232c0e9bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2c79130b-9f26-4b68-b3c9-5c9f7696839c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_929b133b-8f22-487d-b502-a9232c0e9bfb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d5c9288e-b50d-4ce2-8f38-a668ac66e656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_929b133b-8f22-487d-b502-a9232c0e9bfb" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d5c9288e-b50d-4ce2-8f38-a668ac66e656" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d5c9288e-b50d-4ce2-8f38-a668ac66e656_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d5c9288e-b50d-4ce2-8f38-a668ac66e656" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d5c9288e-b50d-4ce2-8f38-a668ac66e656_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_94853a2e-7200-4bfe-abce-9bd88fac0abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d5c9288e-b50d-4ce2-8f38-a668ac66e656" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_94853a2e-7200-4bfe-abce-9bd88fac0abd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c7ddfa43-0a81-4bc8-b1a3-2fc230ed4bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_94853a2e-7200-4bfe-abce-9bd88fac0abd" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c7ddfa43-0a81-4bc8-b1a3-2fc230ed4bf9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_9a96369b-9d86-43ad-955a-2d6c13769ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_94853a2e-7200-4bfe-abce-9bd88fac0abd" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_9a96369b-9d86-43ad-955a-2d6c13769ffe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_75a10c9b-bb28-4e2b-896a-104f16216280" xlink:href="cvs-20211231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_94853a2e-7200-4bfe-abce-9bd88fac0abd" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_75a10c9b-bb28-4e2b-896a-104f16216280" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended" id="ie7ce94959b244bc5845b110143900553_InvestmentsUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_55e49cf0-f144-4fb6-9090-2336ca455e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_ea1fcc33-e1f0-4c02-81a6-ebded4835922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_55e49cf0-f144-4fb6-9090-2336ca455e5c" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_ea1fcc33-e1f0-4c02-81a6-ebded4835922" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_ab51f1e5-caad-401e-ab2d-84831c7f34b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_ea1fcc33-e1f0-4c02-81a6-ebded4835922" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_ab51f1e5-caad-401e-ab2d-84831c7f34b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_d707a149-ca2b-4bc4-89af-1e25c246d0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_ea1fcc33-e1f0-4c02-81a6-ebded4835922" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_d707a149-ca2b-4bc4-89af-1e25c246d0e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_cecfae33-a3ea-48a6-ac2f-a6a4d60c666b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_ea1fcc33-e1f0-4c02-81a6-ebded4835922" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_cecfae33-a3ea-48a6-ac2f-a6a4d60c666b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_280ff8a7-d9ec-4df5-b15b-7a289c480288" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_55e49cf0-f144-4fb6-9090-2336ca455e5c" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_280ff8a7-d9ec-4df5-b15b-7a289c480288" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_4ecf4fa6-1be1-4347-97b5-a871634bac4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_280ff8a7-d9ec-4df5-b15b-7a289c480288" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_4ecf4fa6-1be1-4347-97b5-a871634bac4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_54f95456-5c91-4727-81d0-f14d7e84f686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_280ff8a7-d9ec-4df5-b15b-7a289c480288" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_54f95456-5c91-4727-81d0-f14d7e84f686" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5a8b1c95-f7e0-46d5-ba00-e003a726980b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_280ff8a7-d9ec-4df5-b15b-7a289c480288" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5a8b1c95-f7e0-46d5-ba00-e003a726980b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_9ed94919-32c5-4bce-b013-f4c83d71fc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_55e49cf0-f144-4fb6-9090-2336ca455e5c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_9ed94919-32c5-4bce-b013-f4c83d71fc6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_449dd197-9588-4db4-bc43-17fad2db05bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_9ed94919-32c5-4bce-b013-f4c83d71fc6f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_449dd197-9588-4db4-bc43-17fad2db05bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_c84c1838-070b-42cf-b3d8-088a6ff8fa39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_9ed94919-32c5-4bce-b013-f4c83d71fc6f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_c84c1838-070b-42cf-b3d8-088a6ff8fa39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_4c5451b4-d58f-408b-acb3-926ecd50eafc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_9ed94919-32c5-4bce-b013-f4c83d71fc6f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_4c5451b4-d58f-408b-acb3-926ecd50eafc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_00ce8f8c-eead-4b86-bc3c-01f486b38b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_55e49cf0-f144-4fb6-9090-2336ca455e5c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_00ce8f8c-eead-4b86-bc3c-01f486b38b8f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_75de39ca-10c3-495c-9d47-d6cb79b5c34c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_00ce8f8c-eead-4b86-bc3c-01f486b38b8f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_75de39ca-10c3-495c-9d47-d6cb79b5c34c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_75de39ca-10c3-495c-9d47-d6cb79b5c34c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_75de39ca-10c3-495c-9d47-d6cb79b5c34c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_75de39ca-10c3-495c-9d47-d6cb79b5c34c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_75de39ca-10c3-495c-9d47-d6cb79b5c34c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f56a012a-e8c2-4a88-b088-3d05b3c0ed6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f56a012a-e8c2-4a88-b088-3d05b3c0ed6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_da07fd03-42f6-408c-b462-a051101a8aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_da07fd03-42f6-408c-b462-a051101a8aaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_86648057-8629-4cec-b6bc-0f1012eb0bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_86648057-8629-4cec-b6bc-0f1012eb0bb2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_d3edf21a-74db-4094-9c82-c207ed2473bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_d3edf21a-74db-4094-9c82-c207ed2473bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_0352620d-9dbd-4135-be8c-5ed802a4b070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_0352620d-9dbd-4135-be8c-5ed802a4b070" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c3d65c49-e110-48d2-8f82-d51bff4af3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c3d65c49-e110-48d2-8f82-d51bff4af3ca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_60c366e8-2083-4e54-be09-cc21374531d9" xlink:href="cvs-20211231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_60c366e8-2083-4e54-be09-cc21374531d9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RedeemablePreferredSecuritiesMember_74b96b95-1085-4dd7-9e3c-ccae21f0798f" xlink:href="cvs-20211231.xsd#cvs_RedeemablePreferredSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:to="loc_cvs_RedeemablePreferredSecuritiesMember_74b96b95-1085-4dd7-9e3c-ccae21f0798f" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended" id="ic993119e43724cb48157565a58cf9aee_InvestmentsUnrealizedLossPositionMaturitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5e4893dc-f67e-4dcf-ae25-dfb9cb5ad311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_fb8ade5d-1d0d-4e7f-a26e-4ce6a3400a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5e4893dc-f67e-4dcf-ae25-dfb9cb5ad311" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_fb8ade5d-1d0d-4e7f-a26e-4ce6a3400a83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_e44f98fb-fdce-421f-85c2-e3fdc8952138" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_fb8ade5d-1d0d-4e7f-a26e-4ce6a3400a83" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_e44f98fb-fdce-421f-85c2-e3fdc8952138" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_0b037852-164a-427f-ad14-4f4b12bc517a" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_fb8ade5d-1d0d-4e7f-a26e-4ce6a3400a83" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_0b037852-164a-427f-ad14-4f4b12bc517a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_11e31841-81af-4c3c-bceb-88930f798f46" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_fb8ade5d-1d0d-4e7f-a26e-4ce6a3400a83" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_11e31841-81af-4c3c-bceb-88930f798f46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_42779de2-c7b4-4bae-8121-f1386e049898" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_fb8ade5d-1d0d-4e7f-a26e-4ce6a3400a83" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_42779de2-c7b4-4bae-8121-f1386e049898" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_b6df4f24-b50a-4268-afb9-5cf3614fc6b5" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_fb8ade5d-1d0d-4e7f-a26e-4ce6a3400a83" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_b6df4f24-b50a-4268-afb9-5cf3614fc6b5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_8cff124a-fa89-46d1-a954-7d2ec4002c02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_fb8ade5d-1d0d-4e7f-a26e-4ce6a3400a83" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_8cff124a-fa89-46d1-a954-7d2ec4002c02" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_619e7e94-1093-47ac-a59c-ed382e5d07c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5e4893dc-f67e-4dcf-ae25-dfb9cb5ad311" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_619e7e94-1093-47ac-a59c-ed382e5d07c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_baa8229b-bb16-4545-9a35-8387b97fd21e" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_619e7e94-1093-47ac-a59c-ed382e5d07c8" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_baa8229b-bb16-4545-9a35-8387b97fd21e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_d70ed7a7-2202-4e69-baa8-4bff2017e306" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_619e7e94-1093-47ac-a59c-ed382e5d07c8" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_d70ed7a7-2202-4e69-baa8-4bff2017e306" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_79ec3c04-ae36-4fc1-b551-a928d9f9919a" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_619e7e94-1093-47ac-a59c-ed382e5d07c8" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_79ec3c04-ae36-4fc1-b551-a928d9f9919a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_f7b97615-3c14-424c-89bf-bf9f92cafaea" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_619e7e94-1093-47ac-a59c-ed382e5d07c8" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_f7b97615-3c14-424c-89bf-bf9f92cafaea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_5314199a-0b59-4a82-be53-6562afe05223" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_619e7e94-1093-47ac-a59c-ed382e5d07c8" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_5314199a-0b59-4a82-be53-6562afe05223" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_3b5e800b-d612-4629-aa01-101a1f57c442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_619e7e94-1093-47ac-a59c-ed382e5d07c8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_3b5e800b-d612-4629-aa01-101a1f57c442" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8cb7ab6d-0c05-4c88-be79-63a78cb65427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5e4893dc-f67e-4dcf-ae25-dfb9cb5ad311" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8cb7ab6d-0c05-4c88-be79-63a78cb65427" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0f3ba5c3-797a-4b20-bfac-4d63c4854ad5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8cb7ab6d-0c05-4c88-be79-63a78cb65427" xlink:to="loc_srt_ProductOrServiceAxis_0f3ba5c3-797a-4b20-bfac-4d63c4854ad5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0f3ba5c3-797a-4b20-bfac-4d63c4854ad5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_0f3ba5c3-797a-4b20-bfac-4d63c4854ad5" xlink:to="loc_srt_ProductsAndServicesDomain_0f3ba5c3-797a-4b20-bfac-4d63c4854ad5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e62e47cd-6004-4f53-8adc-91a6848437ae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_0f3ba5c3-797a-4b20-bfac-4d63c4854ad5" xlink:to="loc_srt_ProductsAndServicesDomain_e62e47cd-6004-4f53-8adc-91a6848437ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_746f8ba8-f850-48f7-8901-6a371080cb29" xlink:href="cvs-20211231.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e62e47cd-6004-4f53-8adc-91a6848437ae" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_746f8ba8-f850-48f7-8901-6a371080cb29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember_a20a40c1-bc69-4234-a442-8f9a999cb195" xlink:href="cvs-20211231.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e62e47cd-6004-4f53-8adc-91a6848437ae" xlink:to="loc_cvs_SupportingRemainingProductsMember_a20a40c1-bc69-4234-a442-8f9a999cb195" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_467af509-9c37-454b-a3ef-a823f0107d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8cb7ab6d-0c05-4c88-be79-63a78cb65427" xlink:to="loc_us-gaap_FinancialInstrumentAxis_467af509-9c37-454b-a3ef-a823f0107d19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_467af509-9c37-454b-a3ef-a823f0107d19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_467af509-9c37-454b-a3ef-a823f0107d19" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_467af509-9c37-454b-a3ef-a823f0107d19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca6e9832-04ee-42f4-babd-1a3d8a597907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_467af509-9c37-454b-a3ef-a823f0107d19" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca6e9832-04ee-42f4-babd-1a3d8a597907" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_2f78216a-c055-4895-b65d-a800508011f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca6e9832-04ee-42f4-babd-1a3d8a597907" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_2f78216a-c055-4895-b65d-a800508011f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ff7f5bf6-6bc6-408d-b473-3fb69a647fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca6e9832-04ee-42f4-babd-1a3d8a597907" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ff7f5bf6-6bc6-408d-b473-3fb69a647fd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_896f2f06-c55b-47a3-a6f5-a4a9471d4708" xlink:href="cvs-20211231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca6e9832-04ee-42f4-babd-1a3d8a597907" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_896f2f06-c55b-47a3-a6f5-a4a9471d4708" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsMortgageLoansDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended" id="i21943e3b92eb40bab0341c17651761d2_InvestmentsMortgageLoansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_f895cad1-bddd-423f-ba50-80fe0df354f2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_82c9ea1c-f9a3-4123-8997-5c8913b5f764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_f895cad1-bddd-423f-ba50-80fe0df354f2" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_82c9ea1c-f9a3-4123-8997-5c8913b5f764" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_99d04866-872a-41df-a205-2a1c8767489c" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_f895cad1-bddd-423f-ba50-80fe0df354f2" xlink:to="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_99d04866-872a-41df-a205-2a1c8767489c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_611bad80-ae19-4ac7-bc18-d8d447542953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_f895cad1-bddd-423f-ba50-80fe0df354f2" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_611bad80-ae19-4ac7-bc18-d8d447542953" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_d5bd44c5-4445-4f84-bc20-1d086f515f97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_f895cad1-bddd-423f-ba50-80fe0df354f2" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_d5bd44c5-4445-4f84-bc20-1d086f515f97" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_986aefdd-0790-446a-91f1-88c993dafcdb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_d5bd44c5-4445-4f84-bc20-1d086f515f97" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_986aefdd-0790-446a-91f1-88c993dafcdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_986aefdd-0790-446a-91f1-88c993dafcdb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_986aefdd-0790-446a-91f1-88c993dafcdb" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_986aefdd-0790-446a-91f1-88c993dafcdb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_042fe98a-47e0-46f2-afef-de14c35925bb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_986aefdd-0790-446a-91f1-88c993dafcdb" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_042fe98a-47e0-46f2-afef-de14c35925bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_00de3c2c-3979-42ea-9eee-28fd263d6e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_042fe98a-47e0-46f2-afef-de14c35925bb" xlink:to="loc_us-gaap_CommercialRealEstateMember_00de3c2c-3979-42ea-9eee-28fd263d6e22" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended" id="i5cc4e7e4662f44dab5b0ff04480040c1_InvestmentsMortgageLoansCreditRatingsIndicatorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_1f01586a-67e0-42b6-80b6-15c8a0353e69" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate_4ace6042-8d78-461c-a8a9-e1b324e11de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_1f01586a-67e0-42b6-80b6-15c8a0353e69" xlink:to="loc_us-gaap_MortgageLoansOnRealEstate_4ace6042-8d78-461c-a8a9-e1b324e11de1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_99d5f1f2-6e7d-46d8-b4f1-738bbd51877d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_1f01586a-67e0-42b6-80b6-15c8a0353e69" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_99d5f1f2-6e7d-46d8-b4f1-738bbd51877d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c5aa6b2a-870d-424e-9d9e-629d346fe25b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_99d5f1f2-6e7d-46d8-b4f1-738bbd51877d" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c5aa6b2a-870d-424e-9d9e-629d346fe25b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_c5aa6b2a-870d-424e-9d9e-629d346fe25b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c5aa6b2a-870d-424e-9d9e-629d346fe25b" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_c5aa6b2a-870d-424e-9d9e-629d346fe25b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_91c288d4-ad1c-477b-86c9-23f77f80d98e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c5aa6b2a-870d-424e-9d9e-629d346fe25b" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_91c288d4-ad1c-477b-86c9-23f77f80d98e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_8861a318-96f2-41ea-aad3-230af93d4b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_91c288d4-ad1c-477b-86c9-23f77f80d98e" xlink:to="loc_us-gaap_CommercialRealEstateMember_8861a318-96f2-41ea-aad3-230af93d4b61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentAxis_3ff9047a-ecd3-445e-ad32-df31f57e6576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalCreditAssessmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_99d5f1f2-6e7d-46d8-b4f1-738bbd51877d" xlink:to="loc_us-gaap_InternalCreditAssessmentAxis_3ff9047a-ecd3-445e-ad32-df31f57e6576" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain_3ff9047a-ecd3-445e-ad32-df31f57e6576_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis_3ff9047a-ecd3-445e-ad32-df31f57e6576" xlink:to="loc_us-gaap_InternalCreditAssessmentDomain_3ff9047a-ecd3-445e-ad32-df31f57e6576_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain_18451b24-c399-439e-9d1e-2c712a89adf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis_3ff9047a-ecd3-445e-ad32-df31f57e6576" xlink:to="loc_us-gaap_InternalCreditAssessmentDomain_18451b24-c399-439e-9d1e-2c712a89adf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member_62c02aaf-0587-4cfe-9c47-c56587c5e1f9" xlink:href="cvs-20211231.xsd#cvs_Category1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_18451b24-c399-439e-9d1e-2c712a89adf1" xlink:to="loc_cvs_Category1Member_62c02aaf-0587-4cfe-9c47-c56587c5e1f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member_e69c7758-7a2e-4ebf-859a-a0a538a664c1" xlink:href="cvs-20211231.xsd#cvs_Category2To4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_18451b24-c399-439e-9d1e-2c712a89adf1" xlink:to="loc_cvs_Category2To4Member_e69c7758-7a2e-4ebf-859a-a0a538a664c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member_b006da70-7fb0-493f-a9a4-43fde0f2ef3e" xlink:href="cvs-20211231.xsd#cvs_Categories5and6Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_18451b24-c399-439e-9d1e-2c712a89adf1" xlink:to="loc_cvs_Categories5and6Member_b006da70-7fb0-493f-a9a4-43fde0f2ef3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member_26aff81b-fdde-436c-a317-85d645a1fa74" xlink:href="cvs-20211231.xsd#cvs_Category7Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_18451b24-c399-439e-9d1e-2c712a89adf1" xlink:to="loc_cvs_Category7Member_26aff81b-fdde-436c-a317-85d645a1fa74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_633164cc-ba33-42ab-8cb8-f58d2f43e55b" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_99d5f1f2-6e7d-46d8-b4f1-738bbd51877d" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_633164cc-ba33-42ab-8cb8-f58d2f43e55b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_633164cc-ba33-42ab-8cb8-f58d2f43e55b_default" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_633164cc-ba33-42ab-8cb8-f58d2f43e55b" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_633164cc-ba33-42ab-8cb8-f58d2f43e55b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_99b77fe0-612b-41f9-9bb5-2b802e44290a" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_633164cc-ba33-42ab-8cb8-f58d2f43e55b" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_99b77fe0-612b-41f9-9bb5-2b802e44290a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember_1bc65727-a476-44dc-8cfd-d2013114aae8" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_99b77fe0-612b-41f9-9bb5-2b802e44290a" xlink:to="loc_cvs_YearOfOriginationPeriodOneMember_1bc65727-a476-44dc-8cfd-d2013114aae8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember_bec03062-3732-4e45-8cea-42d3e11c684f" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_99b77fe0-612b-41f9-9bb5-2b802e44290a" xlink:to="loc_cvs_YearOfOriginationPeriodTwoMember_bec03062-3732-4e45-8cea-42d3e11c684f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember_b9efcb8e-c67d-4f48-a63b-3b00fbbfbbc1" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_99b77fe0-612b-41f9-9bb5-2b802e44290a" xlink:to="loc_cvs_YearOfOriginationPeriodThreeMember_b9efcb8e-c67d-4f48-a63b-3b00fbbfbbc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember_3517743c-fd63-4a0a-a46f-c44158816295" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_99b77fe0-612b-41f9-9bb5-2b802e44290a" xlink:to="loc_cvs_YearOfOriginationPeriodFourMember_3517743c-fd63-4a0a-a46f-c44158816295" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember_1ea813ae-892d-46d3-9806-6cd2aa60c429" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_99b77fe0-612b-41f9-9bb5-2b802e44290a" xlink:to="loc_cvs_YearOfOriginationPeriodFiveMember_1ea813ae-892d-46d3-9806-6cd2aa60c429" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_e77e53ea-1df7-426e-830b-425c5e0c9ab7" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_99b77fe0-612b-41f9-9bb5-2b802e44290a" xlink:to="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_e77e53ea-1df7-426e-830b-425c5e0c9ab7" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails" xlink:type="extended" id="i59249d49995d4256a05578d6956b6c84_InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_fb0002b9-2e73-43f1-adf3-75c2d99b3010" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_fb0002b9-2e73-43f1-adf3-75c2d99b3010" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_ab0a1ca1-7910-40c7-829d-cd07d4e4fda2" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_ab0a1ca1-7910-40c7-829d-cd07d4e4fda2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_4752dce5-7473-4785-83da-d943921ba1ea" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_4752dce5-7473-4785-83da-d943921ba1ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_82e68b65-1aa0-4fa2-93e1-2f5ecf7c9604" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_82e68b65-1aa0-4fa2-93e1-2f5ecf7c9604" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_aedbb485-da19-4b0d-a033-29e99fd67b35" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_aedbb485-da19-4b0d-a033-29e99fd67b35" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_8b9075da-f363-45a4-9fca-66e1ce22f262" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_8b9075da-f363-45a4-9fca-66e1ce22f262" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_e1d50dfc-5908-4807-a3c3-63c8272579ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_e1d50dfc-5908-4807-a3c3-63c8272579ac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_0e1ca1e7-d86e-4b35-a447-800043bd8a98" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_0e1ca1e7-d86e-4b35-a447-800043bd8a98" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_2f1fe8a9-b297-4ccf-a673-720ebaafa4cb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_0e1ca1e7-d86e-4b35-a447-800043bd8a98" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_2f1fe8a9-b297-4ccf-a673-720ebaafa4cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_2f1fe8a9-b297-4ccf-a673-720ebaafa4cb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_2f1fe8a9-b297-4ccf-a673-720ebaafa4cb" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_2f1fe8a9-b297-4ccf-a673-720ebaafa4cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_9da10927-ee36-43e1-9f85-4ca4ee434b63" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_2f1fe8a9-b297-4ccf-a673-720ebaafa4cb" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_9da10927-ee36-43e1-9f85-4ca4ee434b63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_8686febe-e107-4cce-9c85-01a8dd96c41d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_9da10927-ee36-43e1-9f85-4ca4ee434b63" xlink:to="loc_us-gaap_CommercialRealEstateMember_8686febe-e107-4cce-9c85-01a8dd96c41d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended" id="i09103f0bb41e472f95eeb2bb1ff8fbf1_InvestmentsNetInvestmentIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_8b291016-e07f-4a14-b2f6-df10b17e3fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_8b291016-e07f-4a14-b2f6-df10b17e3fdd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_3b325d12-a5b9-43fc-8298-b7b361bdc425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_3b325d12-a5b9-43fc-8298-b7b361bdc425" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_efbdf9ef-fb2e-4a81-864c-8bf2471335f5" xlink:href="cvs-20211231.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_efbdf9ef-fb2e-4a81-864c-8bf2471335f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_5cb2ca01-2b46-4594-9ff5-ffb013f92bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_5cb2ca01-2b46-4594-9ff5-ffb013f92bf0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_a34f93f7-cf8b-4ac8-b90b-d30661b10670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:to="loc_us-gaap_InvestmentIncomeNet_a34f93f7-cf8b-4ac8-b90b-d30661b10670" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_4509c93f-94da-4c9a-89af-19c1aa5c815d" xlink:href="cvs-20211231.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:to="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_4509c93f-94da-4c9a-89af-19c1aa5c815d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_e74fb9fc-eb34-4664-b874-9bd9e82af9cd" xlink:href="cvs-20211231.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:to="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_e74fb9fc-eb34-4664-b874-9bd9e82af9cd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_3c1dac58-043c-4684-99b1-b7aed34888a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_3c1dac58-043c-4684-99b1-b7aed34888a0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6462f089-2c72-4926-9616-2867fcd733b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6462f089-2c72-4926-9616-2867fcd733b9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ec89b056-ff23-4473-898a-56873886bb45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6462f089-2c72-4926-9616-2867fcd733b9" xlink:to="loc_us-gaap_InvestmentTypeAxis_ec89b056-ff23-4473-898a-56873886bb45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ec89b056-ff23-4473-898a-56873886bb45_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_ec89b056-ff23-4473-898a-56873886bb45" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ec89b056-ff23-4473-898a-56873886bb45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_85921385-6f06-48e9-a5a0-8bff3c337b97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_ec89b056-ff23-4473-898a-56873886bb45" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_85921385-6f06-48e9-a5a0-8bff3c337b97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_84e0dafa-c7e1-4bf5-9d21-c28f9e72e6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_85921385-6f06-48e9-a5a0-8bff3c337b97" xlink:to="loc_us-gaap_DebtSecuritiesMember_84e0dafa-c7e1-4bf5-9d21-c28f9e72e6c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_5d035b36-ee81-4674-b6a5-c61c311642a9" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_85921385-6f06-48e9-a5a0-8bff3c337b97" xlink:to="loc_cvs_MortgageLoansMember_5d035b36-ee81-4674-b6a5-c61c311642a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_b842e145-e3ea-4ee5-8bcd-937c991a1120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_85921385-6f06-48e9-a5a0-8bff3c337b97" xlink:to="loc_us-gaap_OtherInvestmentsMember_b842e145-e3ea-4ee5-8bcd-937c991a1120" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4efc3993-9975-417f-a174-ddb5be4178eb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6462f089-2c72-4926-9616-2867fcd733b9" xlink:to="loc_srt_ProductOrServiceAxis_4efc3993-9975-417f-a174-ddb5be4178eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4efc3993-9975-417f-a174-ddb5be4178eb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4efc3993-9975-417f-a174-ddb5be4178eb" xlink:to="loc_srt_ProductsAndServicesDomain_4efc3993-9975-417f-a174-ddb5be4178eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_894079a6-29e8-4f88-a796-167d506c3060" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4efc3993-9975-417f-a174-ddb5be4178eb" xlink:to="loc_srt_ProductsAndServicesDomain_894079a6-29e8-4f88-a796-167d506c3060" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_a35828f3-0ecc-4aa5-937d-2715c7330d0e" xlink:href="cvs-20211231.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_894079a6-29e8-4f88-a796-167d506c3060" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_a35828f3-0ecc-4aa5-937d-2715c7330d0e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#FairValueFairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="extended" id="ia75c356a897a49499ceba4c6c04fc997_FairValueFairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ecc76c5a-e1b2-425f-831c-aa4907ac26d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_7cc78049-0dbb-4441-930c-0d893f94c1be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ecc76c5a-e1b2-425f-831c-aa4907ac26d3" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_7cc78049-0dbb-4441-930c-0d893f94c1be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b1731ab3-c500-40e2-b8c2-f4448ad29494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ecc76c5a-e1b2-425f-831c-aa4907ac26d3" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b1731ab3-c500-40e2-b8c2-f4448ad29494" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_28324c9f-9433-4763-8826-48e121542b08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ecc76c5a-e1b2-425f-831c-aa4907ac26d3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_28324c9f-9433-4763-8826-48e121542b08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_21dc247d-431d-40fe-8c97-529dea7dbdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ecc76c5a-e1b2-425f-831c-aa4907ac26d3" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_21dc247d-431d-40fe-8c97-529dea7dbdfe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_cfd4f196-cfab-48da-a77d-0ef8f65613ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ecc76c5a-e1b2-425f-831c-aa4907ac26d3" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_cfd4f196-cfab-48da-a77d-0ef8f65613ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_85ed06d4-ae36-428a-823e-22570385fc50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ecc76c5a-e1b2-425f-831c-aa4907ac26d3" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_85ed06d4-ae36-428a-823e-22570385fc50" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ebdcb19b-a790-4abf-9f74-494dad9ed01b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_85ed06d4-ae36-428a-823e-22570385fc50" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ebdcb19b-a790-4abf-9f74-494dad9ed01b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ebdcb19b-a790-4abf-9f74-494dad9ed01b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ebdcb19b-a790-4abf-9f74-494dad9ed01b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ebdcb19b-a790-4abf-9f74-494dad9ed01b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_96b7459e-28c8-4003-b8e1-17e5d8611319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ebdcb19b-a790-4abf-9f74-494dad9ed01b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_96b7459e-28c8-4003-b8e1-17e5d8611319" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_f7b2bfdf-f447-4478-bccd-37c074e4c9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_96b7459e-28c8-4003-b8e1-17e5d8611319" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_f7b2bfdf-f447-4478-bccd-37c074e4c9d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_365c2b20-19ea-45e7-be1c-83e8410633ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_85ed06d4-ae36-428a-823e-22570385fc50" xlink:to="loc_us-gaap_FinancialInstrumentAxis_365c2b20-19ea-45e7-be1c-83e8410633ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_365c2b20-19ea-45e7-be1c-83e8410633ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_365c2b20-19ea-45e7-be1c-83e8410633ed" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_365c2b20-19ea-45e7-be1c-83e8410633ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_365c2b20-19ea-45e7-be1c-83e8410633ed" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_b76841bd-ffb9-4e69-ab76-ec14c34a10fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_b76841bd-ffb9-4e69-ab76-ec14c34a10fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_091e2b14-ae32-4ad9-8dec-12e7b294db83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_091e2b14-ae32-4ad9-8dec-12e7b294db83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_4c8d7fb5-d61a-4133-b084-73c16e7bc9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_4c8d7fb5-d61a-4133-b084-73c16e7bc9b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_c1ac463e-7055-453f-ac42-d11d4ead1e42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_c1ac463e-7055-453f-ac42-d11d4ead1e42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d0643808-78e4-4ef2-b7c7-2940feb1ffce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d0643808-78e4-4ef2-b7c7-2940feb1ffce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_0c4dfdf0-feb3-4100-b06a-f0144de45765" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_0c4dfdf0-feb3-4100-b06a-f0144de45765" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_bf5107dc-079c-429c-aaa6-c6a11e04dee8" xlink:href="cvs-20211231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_bf5107dc-079c-429c-aaa6-c6a11e04dee8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_eb85af22-a20d-4a86-abbe-0dba31e28b64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_eb85af22-a20d-4a86-abbe-0dba31e28b64" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fc0cf90c-3dd0-4c84-8215-8fead48c47f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_85ed06d4-ae36-428a-823e-22570385fc50" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fc0cf90c-3dd0-4c84-8215-8fead48c47f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc0cf90c-3dd0-4c84-8215-8fead48c47f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fc0cf90c-3dd0-4c84-8215-8fead48c47f2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fc0cf90c-3dd0-4c84-8215-8fead48c47f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f588a1cf-25bb-401b-a5c5-da9b1d6f9012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fc0cf90c-3dd0-4c84-8215-8fead48c47f2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f588a1cf-25bb-401b-a5c5-da9b1d6f9012" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_36501d14-74c8-41d4-982f-cb64429aee21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f588a1cf-25bb-401b-a5c5-da9b1d6f9012" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_36501d14-74c8-41d4-982f-cb64429aee21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_551b7d93-535e-4ec9-a9d0-40a5db1f3736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f588a1cf-25bb-401b-a5c5-da9b1d6f9012" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_551b7d93-535e-4ec9-a9d0-40a5db1f3736" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4e28794f-dc3b-40e2-bd3c-2b9083b83a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f588a1cf-25bb-401b-a5c5-da9b1d6f9012" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4e28794f-dc3b-40e2-bd3c-2b9083b83a1a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#FairValueChangesinLevel3FinancialAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails" xlink:type="extended" id="i519409a7b426450ba7074739542290d3_FairValueChangesinLevel3FinancialAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_13d4255c-224f-4fc9-95bb-a46bbb032f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_378a232c-f190-4f36-a2f6-82f5e06fa13d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_13d4255c-224f-4fc9-95bb-a46bbb032f9c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_378a232c-f190-4f36-a2f6-82f5e06fa13d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_b9caaa87-e96f-46d8-b2e0-efe986a8616b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_378a232c-f190-4f36-a2f6-82f5e06fa13d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_b9caaa87-e96f-46d8-b2e0-efe986a8616b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_9e1d08dc-4423-4e64-94f3-f2443404231f" xlink:href="cvs-20211231.xsd#cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_378a232c-f190-4f36-a2f6-82f5e06fa13d" xlink:to="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_9e1d08dc-4423-4e64-94f3-f2443404231f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_64d1ec45-1e38-4edc-820e-783220155707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_9e1d08dc-4423-4e64-94f3-f2443404231f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_64d1ec45-1e38-4edc-820e-783220155707" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_85d5a873-22a4-4748-bf58-96e9df7f24ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_9e1d08dc-4423-4e64-94f3-f2443404231f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_85d5a873-22a4-4748-bf58-96e9df7f24ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_718ab892-d53b-4328-828a-efed9c56c6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_378a232c-f190-4f36-a2f6-82f5e06fa13d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_718ab892-d53b-4328-828a-efed9c56c6eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_20833112-71f5-4f88-9227-01cae46dd7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_378a232c-f190-4f36-a2f6-82f5e06fa13d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_20833112-71f5-4f88-9227-01cae46dd7aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_909fcb64-e95d-48e0-9e00-13f681e41911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_378a232c-f190-4f36-a2f6-82f5e06fa13d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_909fcb64-e95d-48e0-9e00-13f681e41911" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_cea29adb-049b-45ed-8b2c-c6ae5458ac9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_378a232c-f190-4f36-a2f6-82f5e06fa13d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_cea29adb-049b-45ed-8b2c-c6ae5458ac9b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_2a12bf0b-2c6b-4cac-aade-0c3f4d39b4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_c65dfdff-606d-46e2-985a-bba2b139f69e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_13d4255c-224f-4fc9-95bb-a46bbb032f9c" xlink:to="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_c65dfdff-606d-46e2-985a-bba2b139f69e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9898adbc-b360-4cc4-9fac-6b5d85c8d651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_13d4255c-224f-4fc9-95bb-a46bbb032f9c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9898adbc-b360-4cc4-9fac-6b5d85c8d651" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_74c127c6-a62a-4e48-880e-d418b649319c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9898adbc-b360-4cc4-9fac-6b5d85c8d651" xlink:to="loc_us-gaap_FinancialInstrumentAxis_74c127c6-a62a-4e48-880e-d418b649319c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_74c127c6-a62a-4e48-880e-d418b649319c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_74c127c6-a62a-4e48-880e-d418b649319c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_74c127c6-a62a-4e48-880e-d418b649319c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8a7ece9-07c8-462a-900e-a73ad4855b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_74c127c6-a62a-4e48-880e-d418b649319c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8a7ece9-07c8-462a-900e-a73ad4855b62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_d46c53b8-6fc9-4148-8a88-99670b2e41ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8a7ece9-07c8-462a-900e-a73ad4855b62" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_d46c53b8-6fc9-4148-8a88-99670b2e41ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_befb60bd-183b-42c1-ab75-8a1511424bda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8a7ece9-07c8-462a-900e-a73ad4855b62" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_befb60bd-183b-42c1-ab75-8a1511424bda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember_cecf642e-a5f2-4fe4-90ec-30b316210057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8a7ece9-07c8-462a-900e-a73ad4855b62" xlink:to="loc_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember_cecf642e-a5f2-4fe4-90ec-30b316210057" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_0a0c5235-246e-4b04-a927-010057c93dc1" xlink:href="cvs-20211231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8a7ece9-07c8-462a-900e-a73ad4855b62" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_0a0c5235-246e-4b04-a927-010057c93dc1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_bf46add9-a4c0-4211-a55b-86b408b9d3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8a7ece9-07c8-462a-900e-a73ad4855b62" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_bf46add9-a4c0-4211-a55b-86b408b9d3c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_0838a1ab-73c3-49b3-b829-0f51f31fda00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8a7ece9-07c8-462a-900e-a73ad4855b62" xlink:to="loc_us-gaap_EquitySecuritiesMember_0838a1ab-73c3-49b3-b829-0f51f31fda00" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bcfd319b-a61f-48a1-89ea-40dfeca91dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9898adbc-b360-4cc4-9fac-6b5d85c8d651" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bcfd319b-a61f-48a1-89ea-40dfeca91dcc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_bcfd319b-a61f-48a1-89ea-40dfeca91dcc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bcfd319b-a61f-48a1-89ea-40dfeca91dcc" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_bcfd319b-a61f-48a1-89ea-40dfeca91dcc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f5c81019-b44b-4505-8ec2-db32a5524f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bcfd319b-a61f-48a1-89ea-40dfeca91dcc" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f5c81019-b44b-4505-8ec2-db32a5524f5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_21d58205-0ef7-4388-aef7-1eacbc1df5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f5c81019-b44b-4505-8ec2-db32a5524f5d" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_21d58205-0ef7-4388-aef7-1eacbc1df5e4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="simple" xlink:href="cvs-20211231.xsd#FairValueGrossTransfersIntoOutOfLevel3Details"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="extended" id="i3ef58e73aa85403296b5b448bb14729a_FairValueGrossTransfersIntoOutOfLevel3Details">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4bcc1308-263c-4175-882b-73851fc21fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_410b89af-a476-4bec-9d1b-ed84204157a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4bcc1308-263c-4175-882b-73851fc21fb6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_410b89af-a476-4bec-9d1b-ed84204157a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_f310e4fc-16ce-40c3-ae66-b7a06577463a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4bcc1308-263c-4175-882b-73851fc21fb6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_f310e4fc-16ce-40c3-ae66-b7a06577463a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_2d721781-66b3-4acb-b0f5-6f99f566d1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4bcc1308-263c-4175-882b-73851fc21fb6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_2d721781-66b3-4acb-b0f5-6f99f566d1ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3703ac3d-5a84-4bed-af3e-717d9e838549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4bcc1308-263c-4175-882b-73851fc21fb6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3703ac3d-5a84-4bed-af3e-717d9e838549" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_35c4ce8f-dbed-4246-ba09-cf88c5e68e92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3703ac3d-5a84-4bed-af3e-717d9e838549" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_35c4ce8f-dbed-4246-ba09-cf88c5e68e92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_35c4ce8f-dbed-4246-ba09-cf88c5e68e92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_35c4ce8f-dbed-4246-ba09-cf88c5e68e92" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_35c4ce8f-dbed-4246-ba09-cf88c5e68e92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_90bd5d79-f047-4258-83ce-4fa1ab300c66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_35c4ce8f-dbed-4246-ba09-cf88c5e68e92" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_90bd5d79-f047-4258-83ce-4fa1ab300c66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_41c44b4e-14df-4c63-aa2a-22ca117c92e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_90bd5d79-f047-4258-83ce-4fa1ab300c66" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_41c44b4e-14df-4c63-aa2a-22ca117c92e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f5aa868a-2d41-4bd1-94b4-6979c16a2f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3703ac3d-5a84-4bed-af3e-717d9e838549" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f5aa868a-2d41-4bd1-94b4-6979c16a2f1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5aa868a-2d41-4bd1-94b4-6979c16a2f1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f5aa868a-2d41-4bd1-94b4-6979c16a2f1d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5aa868a-2d41-4bd1-94b4-6979c16a2f1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d1d5d219-31b5-4f75-955f-7136eebaf83b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f5aa868a-2d41-4bd1-94b4-6979c16a2f1d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d1d5d219-31b5-4f75-955f-7136eebaf83b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a0919d2f-a8fa-4b39-912e-9f3e0afe3613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d1d5d219-31b5-4f75-955f-7136eebaf83b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a0919d2f-a8fa-4b39-912e-9f3e0afe3613" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended" id="i6b2bb168aa38496798410d62d2099778_FairValueCarryingValueandFairValueClassifiedbyLevelDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f3038b02-2328-42c0-873c-ef2be9f42601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5994f7d7-06a8-4474-ba14-97fef457ff12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f3038b02-2328-42c0-873c-ef2be9f42601" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5994f7d7-06a8-4474-ba14-97fef457ff12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_e783a50c-1798-46c4-928a-edef978feaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5994f7d7-06a8-4474-ba14-97fef457ff12" xlink:to="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_e783a50c-1798-46c4-928a-edef978feaaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_97284a5f-1fd8-48e1-8829-330b498782bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5994f7d7-06a8-4474-ba14-97fef457ff12" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_97284a5f-1fd8-48e1-8829-330b498782bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_38886806-2fd5-4e31-9905-f0dfdb62a433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f3038b02-2328-42c0-873c-ef2be9f42601" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_38886806-2fd5-4e31-9905-f0dfdb62a433" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_25513aac-11fd-450f-8ce3-a3c8ad4ff9d9" xlink:href="cvs-20211231.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_38886806-2fd5-4e31-9905-f0dfdb62a433" xlink:to="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_25513aac-11fd-450f-8ce3-a3c8ad4ff9d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_1726b3c9-fa53-481c-b449-82ab51447269" xlink:href="cvs-20211231.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_38886806-2fd5-4e31-9905-f0dfdb62a433" xlink:to="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_1726b3c9-fa53-481c-b449-82ab51447269" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_a110fc07-3043-4e87-9d49-81d2d00548b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_38886806-2fd5-4e31-9905-f0dfdb62a433" xlink:to="loc_us-gaap_DebtInstrumentFairValue_a110fc07-3043-4e87-9d49-81d2d00548b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_181cc323-7880-4be6-90be-2c4ef96d91c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f3038b02-2328-42c0-873c-ef2be9f42601" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_181cc323-7880-4be6-90be-2c4ef96d91c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f501303a-d7d6-44da-aeed-97d659498bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_181cc323-7880-4be6-90be-2c4ef96d91c1" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f501303a-d7d6-44da-aeed-97d659498bf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f501303a-d7d6-44da-aeed-97d659498bf5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f501303a-d7d6-44da-aeed-97d659498bf5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f501303a-d7d6-44da-aeed-97d659498bf5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c07934cd-8765-4955-b6d2-d603b01f0439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f501303a-d7d6-44da-aeed-97d659498bf5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c07934cd-8765-4955-b6d2-d603b01f0439" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_3b5a1afe-0204-4462-9f4d-c5a52cd60f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c07934cd-8765-4955-b6d2-d603b01f0439" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_3b5a1afe-0204-4462-9f4d-c5a52cd60f0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_61a0aa82-1611-458d-b052-0b48b3810c40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_181cc323-7880-4be6-90be-2c4ef96d91c1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_61a0aa82-1611-458d-b052-0b48b3810c40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61a0aa82-1611-458d-b052-0b48b3810c40_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_61a0aa82-1611-458d-b052-0b48b3810c40" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61a0aa82-1611-458d-b052-0b48b3810c40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ac64c27-3308-47d7-bb10-1b53e0f0e7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_61a0aa82-1611-458d-b052-0b48b3810c40" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ac64c27-3308-47d7-bb10-1b53e0f0e7e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_73084201-8537-42a1-a7e8-8363eef42d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ac64c27-3308-47d7-bb10-1b53e0f0e7e6" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_73084201-8537-42a1-a7e8-8363eef42d87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5dbc41e7-c188-4e0f-8239-31d49d46dba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ac64c27-3308-47d7-bb10-1b53e0f0e7e6" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5dbc41e7-c188-4e0f-8239-31d49d46dba4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_791b4726-77a1-4f89-ae42-ccf0142bf87c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ac64c27-3308-47d7-bb10-1b53e0f0e7e6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_791b4726-77a1-4f89-ae42-ccf0142bf87c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_d139ef85-5843-421c-9814-80167eb05379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_181cc323-7880-4be6-90be-2c4ef96d91c1" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_d139ef85-5843-421c-9814-80167eb05379" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d139ef85-5843-421c-9814-80167eb05379_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d139ef85-5843-421c-9814-80167eb05379" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d139ef85-5843-421c-9814-80167eb05379_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5f41c4af-f417-4ce3-a8f7-3c274dbb30cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d139ef85-5843-421c-9814-80167eb05379" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5f41c4af-f417-4ce3-a8f7-3c274dbb30cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_06ca8ece-937b-4007-bf80-43138801efc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5f41c4af-f417-4ce3-a8f7-3c274dbb30cc" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_06ca8ece-937b-4007-bf80-43138801efc5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_be1cfae7-38fd-4cc8-96cc-f4ef0a78c163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_06ca8ece-937b-4007-bf80-43138801efc5" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_be1cfae7-38fd-4cc8-96cc-f4ef0a78c163" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_aedcda99-02f2-47a7-b664-f4b79eebfb42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_06ca8ece-937b-4007-bf80-43138801efc5" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_aedcda99-02f2-47a7-b664-f4b79eebfb42" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended" id="i3d5d4901cb8540d0bd4862ffb7fcd399_FairValueSeparateAccountsFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_0c60bd34-9fa8-4ec6-9fab-2136471dbe36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_5f460877-107d-43a4-8308-8f00b6da2c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_0c60bd34-9fa8-4ec6-9fab-2136471dbe36" xlink:to="loc_us-gaap_SeparateAccountAssets_5f460877-107d-43a4-8308-8f00b6da2c47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_9edb180f-17c2-47e8-add8-e1b60d26ae0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_0c60bd34-9fa8-4ec6-9fab-2136471dbe36" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_9edb180f-17c2-47e8-add8-e1b60d26ae0d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d423fc4e-7b07-4334-ae3b-d34805bfac58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_9edb180f-17c2-47e8-add8-e1b60d26ae0d" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d423fc4e-7b07-4334-ae3b-d34805bfac58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d423fc4e-7b07-4334-ae3b-d34805bfac58_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d423fc4e-7b07-4334-ae3b-d34805bfac58" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d423fc4e-7b07-4334-ae3b-d34805bfac58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_79250e2a-4474-489a-a905-26da30d869f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d423fc4e-7b07-4334-ae3b-d34805bfac58" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_79250e2a-4474-489a-a905-26da30d869f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_59a9a11e-1f0e-4dbd-ac38-6618127da789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_79250e2a-4474-489a-a905-26da30d869f2" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_59a9a11e-1f0e-4dbd-ac38-6618127da789" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37e99e2c-13ed-4703-ab5d-db337c0a051c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_9edb180f-17c2-47e8-add8-e1b60d26ae0d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37e99e2c-13ed-4703-ab5d-db337c0a051c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_37e99e2c-13ed-4703-ab5d-db337c0a051c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37e99e2c-13ed-4703-ab5d-db337c0a051c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_37e99e2c-13ed-4703-ab5d-db337c0a051c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_655f2d9f-5438-43dd-a918-0739553eb373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37e99e2c-13ed-4703-ab5d-db337c0a051c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_655f2d9f-5438-43dd-a918-0739553eb373" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4c85a250-497d-4083-91b5-512e9a78530c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_655f2d9f-5438-43dd-a918-0739553eb373" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4c85a250-497d-4083-91b5-512e9a78530c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7a4853f2-a3ad-45ea-aa18-b13654f2ec8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_655f2d9f-5438-43dd-a918-0739553eb373" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7a4853f2-a3ad-45ea-aa18-b13654f2ec8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_85d4d87e-ab1f-40f4-a165-b817daf50248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_655f2d9f-5438-43dd-a918-0739553eb373" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_85d4d87e-ab1f-40f4-a165-b817daf50248" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis_820479b4-9b62-4322-9c50-64eafe74cf89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_9edb180f-17c2-47e8-add8-e1b60d26ae0d" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryAxis_820479b4-9b62-4322-9c50-64eafe74cf89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_820479b4-9b62-4322-9c50-64eafe74cf89_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_820479b4-9b62-4322-9c50-64eafe74cf89" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_820479b4-9b62-4322-9c50-64eafe74cf89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_02e38347-1684-45ff-99bb-96b85c054dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_820479b4-9b62-4322-9c50-64eafe74cf89" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_02e38347-1684-45ff-99bb-96b85c054dc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_13a48b57-e7c4-402a-b206-24407461b5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_02e38347-1684-45ff-99bb-96b85c054dc3" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_13a48b57-e7c4-402a-b206-24407461b5b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_8528027f-d8b3-4e48-9951-2ccdb16cf795" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_02e38347-1684-45ff-99bb-96b85c054dc3" xlink:to="loc_us-gaap_DebtSecuritiesMember_8528027f-d8b3-4e48-9951-2ccdb16cf795" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_75380002-8031-4738-8548-95864c549b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_02e38347-1684-45ff-99bb-96b85c054dc3" xlink:to="loc_us-gaap_EquitySecuritiesMember_75380002-8031-4738-8548-95864c549b61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_9056731c-f7f7-41f6-bc83-3ee0584ab805" xlink:href="cvs-20211231.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_02e38347-1684-45ff-99bb-96b85c054dc3" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_9056731c-f7f7-41f6-bc83-3ee0584ab805" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeparateAccountFinancialAssetsMember_6b1523ad-fe0b-41ff-8df4-45136fb4edbb" xlink:href="cvs-20211231.xsd#cvs_SeparateAccountFinancialAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_02e38347-1684-45ff-99bb-96b85c054dc3" xlink:to="loc_cvs_SeparateAccountFinancialAssetsMember_6b1523ad-fe0b-41ff-8df4-45136fb4edbb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1b70b9b5-30ce-4c1e-bceb-b5c38db14b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_9edb180f-17c2-47e8-add8-e1b60d26ae0d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1b70b9b5-30ce-4c1e-bceb-b5c38db14b26" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1b70b9b5-30ce-4c1e-bceb-b5c38db14b26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1b70b9b5-30ce-4c1e-bceb-b5c38db14b26" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1b70b9b5-30ce-4c1e-bceb-b5c38db14b26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ca4e5bb1-bf68-4926-bfaa-09ed3d5b8abf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1b70b9b5-30ce-4c1e-bceb-b5c38db14b26" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ca4e5bb1-bf68-4926-bfaa-09ed3d5b8abf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_1c9c43e0-0a3f-4026-9140-3fa7fa0e3134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ca4e5bb1-bf68-4926-bfaa-09ed3d5b8abf" xlink:to="loc_us-gaap_AccountsReceivableMember_1c9c43e0-0a3f-4026-9140-3fa7fa0e3134" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#FairValueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/FairValueNarrativeDetails" xlink:type="extended" id="i1a2f0f1d7809440fb078cfbe8c66ec7d_FairValueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b002e6c1-5e05-41b0-9bf0-309c02cfbbd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_7e6e9ad0-fcd2-42d6-ba02-b7a1aa0feb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b002e6c1-5e05-41b0-9bf0-309c02cfbbd9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_7e6e9ad0-fcd2-42d6-ba02-b7a1aa0feb5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_73010ee9-3b6f-47b2-b478-cefb7511b6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b002e6c1-5e05-41b0-9bf0-309c02cfbbd9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_73010ee9-3b6f-47b2-b478-cefb7511b6c5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_308f411a-b553-4842-85da-17cdcea713c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_73010ee9-3b6f-47b2-b478-cefb7511b6c5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_308f411a-b553-4842-85da-17cdcea713c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_308f411a-b553-4842-85da-17cdcea713c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_308f411a-b553-4842-85da-17cdcea713c6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_308f411a-b553-4842-85da-17cdcea713c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_97264735-e961-47a2-a16c-e7b6da0757c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_308f411a-b553-4842-85da-17cdcea713c6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_97264735-e961-47a2-a16c-e7b6da0757c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6d74d9cb-a630-420f-8de2-5e20a5128184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_97264735-e961-47a2-a16c-e7b6da0757c8" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6d74d9cb-a630-420f-8de2-5e20a5128184" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0902638a-159f-4403-adba-f1160c001ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_73010ee9-3b6f-47b2-b478-cefb7511b6c5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0902638a-159f-4403-adba-f1160c001ed0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0902638a-159f-4403-adba-f1160c001ed0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0902638a-159f-4403-adba-f1160c001ed0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0902638a-159f-4403-adba-f1160c001ed0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_da91774b-65c7-42b8-b7d5-76adbb530422" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0902638a-159f-4403-adba-f1160c001ed0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_da91774b-65c7-42b8-b7d5-76adbb530422" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_53952d9b-3b9a-497f-a1f5-c643f2a452a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_da91774b-65c7-42b8-b7d5-76adbb530422" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_53952d9b-3b9a-497f-a1f5-c643f2a452a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis_9501bd23-c615-45c3-bda6-1c9fd350466c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_73010ee9-3b6f-47b2-b478-cefb7511b6c5" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryAxis_9501bd23-c615-45c3-bda6-1c9fd350466c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_9501bd23-c615-45c3-bda6-1c9fd350466c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_9501bd23-c615-45c3-bda6-1c9fd350466c" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_9501bd23-c615-45c3-bda6-1c9fd350466c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_d372f6d3-bb1a-4396-b2ed-609190ef72c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_9501bd23-c615-45c3-bda6-1c9fd350466c" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_d372f6d3-bb1a-4396-b2ed-609190ef72c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeparateAccountFinancialAssetsMember_92ebcd06-4256-48a3-a786-3cd487ca02c1" xlink:href="cvs-20211231.xsd#cvs_SeparateAccountFinancialAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_d372f6d3-bb1a-4396-b2ed-609190ef72c4" xlink:to="loc_cvs_SeparateAccountFinancialAssetsMember_92ebcd06-4256-48a3-a786-3cd487ca02c1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#GoodwillandOtherIntangiblesGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="extended" id="ie3e24473b6364cc4a800b4ef992b1d89_GoodwillandOtherIntangiblesGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_741cafa4-3be0-4397-9173-a6942bc421da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_134ac382-a551-47e7-9b87-d00f5d61e07d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_741cafa4-3be0-4397-9173-a6942bc421da" xlink:to="loc_us-gaap_GoodwillRollForward_134ac382-a551-47e7-9b87-d00f5d61e07d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7af16205-946e-43ed-b07e-1f5ceb3e53db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_134ac382-a551-47e7-9b87-d00f5d61e07d" xlink:to="loc_us-gaap_Goodwill_7af16205-946e-43ed-b07e-1f5ceb3e53db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_0728955c-6792-4784-bb46-cbdf9efa43a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_134ac382-a551-47e7-9b87-d00f5d61e07d" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_0728955c-6792-4784-bb46-cbdf9efa43a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_a1699da2-eb18-4cce-9bce-d7b5cd8d2648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_134ac382-a551-47e7-9b87-d00f5d61e07d" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_a1699da2-eb18-4cce-9bce-d7b5cd8d2648" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_736a4ada-3a86-464c-8aa3-7eac13d92b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_134ac382-a551-47e7-9b87-d00f5d61e07d" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_736a4ada-3a86-464c-8aa3-7eac13d92b8e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9af159ed-2123-4c8e-9290-1c0d2c4cef4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_c6d4c423-a97b-4201-a43d-6c3dd393f46f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_741cafa4-3be0-4397-9173-a6942bc421da" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_c6d4c423-a97b-4201-a43d-6c3dd393f46f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6b5cdc60-7161-4cea-a1d7-92fd323f5111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c6d4c423-a97b-4201-a43d-6c3dd393f46f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6b5cdc60-7161-4cea-a1d7-92fd323f5111" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6b5cdc60-7161-4cea-a1d7-92fd323f5111_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6b5cdc60-7161-4cea-a1d7-92fd323f5111" xlink:to="loc_us-gaap_SegmentDomain_6b5cdc60-7161-4cea-a1d7-92fd323f5111_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0d0d1c56-d3d2-46a1-abf5-0f4f29d72252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6b5cdc60-7161-4cea-a1d7-92fd323f5111" xlink:to="loc_us-gaap_SegmentDomain_0d0d1c56-d3d2-46a1-abf5-0f4f29d72252" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_c17a6a0a-1ed0-43a4-8061-f15616fd4712" xlink:href="cvs-20211231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0d0d1c56-d3d2-46a1-abf5-0f4f29d72252" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_c17a6a0a-1ed0-43a4-8061-f15616fd4712" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_02e9cdaf-fe42-4325-b0eb-f1b58981f95d" xlink:href="cvs-20211231.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0d0d1c56-d3d2-46a1-abf5-0f4f29d72252" xlink:to="loc_cvs_PharmacyServicesSegmentMember_02e9cdaf-fe42-4325-b0eb-f1b58981f95d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_4c25ab2c-f03a-452b-aa42-9bc980533b38" xlink:href="cvs-20211231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0d0d1c56-d3d2-46a1-abf5-0f4f29d72252" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_4c25ab2c-f03a-452b-aa42-9bc980533b38" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#GoodwillandOtherIntangiblesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="extended" id="ic03ee7fb9a29468284bfa68b2eac1325_GoodwillandOtherIntangiblesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_d8355d52-fb57-4b97-9489-e704aa9a9821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_66cbc3fc-b95b-4251-b4fa-8730268ac333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d8355d52-fb57-4b97-9489-e704aa9a9821" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_66cbc3fc-b95b-4251-b4fa-8730268ac333" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2944de8c-2f02-4136-876e-d37083fe000d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d8355d52-fb57-4b97-9489-e704aa9a9821" xlink:to="loc_us-gaap_Goodwill_2944de8c-2f02-4136-876e-d37083fe000d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_54cd1680-923d-45e5-9ff9-bac22e8b98e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d8355d52-fb57-4b97-9489-e704aa9a9821" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_54cd1680-923d-45e5-9ff9-bac22e8b98e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c8f687ce-e544-485d-8d5b-a362615c4124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_d8355d52-fb57-4b97-9489-e704aa9a9821" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c8f687ce-e544-485d-8d5b-a362615c4124" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_f31604e6-3e5f-41d4-a64a-927cce5573e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_d8355d52-fb57-4b97-9489-e704aa9a9821" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_f31604e6-3e5f-41d4-a64a-927cce5573e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_f08e0712-5ce4-40be-a027-5a5152c90a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f31604e6-3e5f-41d4-a64a-927cce5573e9" xlink:to="loc_us-gaap_ReportingUnitAxis_f08e0712-5ce4-40be-a027-5a5152c90a94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_f08e0712-5ce4-40be-a027-5a5152c90a94_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_f08e0712-5ce4-40be-a027-5a5152c90a94" xlink:to="loc_us-gaap_ReportingUnitDomain_f08e0712-5ce4-40be-a027-5a5152c90a94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_f84cd41d-4101-4790-bf48-90ec429bda0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_f08e0712-5ce4-40be-a027-5a5152c90a94" xlink:to="loc_us-gaap_ReportingUnitDomain_f84cd41d-4101-4790-bf48-90ec429bda0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareReportingUnitMember_9bfc0723-1e89-4bcc-9b49-eaeeb3fac2a0" xlink:href="cvs-20211231.xsd#cvs_LongTermCareReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_f84cd41d-4101-4790-bf48-90ec429bda0b" xlink:to="loc_cvs_LongTermCareReportingUnitMember_9bfc0723-1e89-4bcc-9b49-eaeeb3fac2a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2fb09592-9b0e-4146-bc8c-869a1ec133c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f31604e6-3e5f-41d4-a64a-927cce5573e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2fb09592-9b0e-4146-bc8c-869a1ec133c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2fb09592-9b0e-4146-bc8c-869a1ec133c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2fb09592-9b0e-4146-bc8c-869a1ec133c9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2fb09592-9b0e-4146-bc8c-869a1ec133c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b23ef1aa-28b8-46ef-83ca-f827a293918e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2fb09592-9b0e-4146-bc8c-869a1ec133c9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b23ef1aa-28b8-46ef-83ca-f827a293918e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerListsMember_35dc9aee-8ea6-4aa4-ba8e-de3d6343fa8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerListsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b23ef1aa-28b8-46ef-83ca-f827a293918e" xlink:to="loc_us-gaap_CustomerListsMember_35dc9aee-8ea6-4aa4-ba8e-de3d6343fa8a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#GoodwillandOtherIntangiblesIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="extended" id="i8564b0f474174ccea787d676b870f254_GoodwillandOtherIntangiblesIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:href="cvs-20211231.xsd#cvs_OtherAcquiredIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_79ec5c0a-4a9e-46fa-91b9-4deaaa795d05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_79ec5c0a-4a9e-46fa-91b9-4deaaa795d05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6155d101-8d70-47ad-b014-25147a283cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6155d101-8d70-47ad-b014-25147a283cd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e738b600-2981-4b98-bed7-46eb44d7f943" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e738b600-2981-4b98-bed7-46eb44d7f943" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c493f989-7884-48b6-b149-5c54c02df0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c493f989-7884-48b6-b149-5c54c02df0f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_24be0721-acf1-4c6b-bd8a-3244bf96f883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_24be0721-acf1-4c6b-bd8a-3244bf96f883" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_73b287e8-6a4b-4233-9a59-a381ae8260c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_73b287e8-6a4b-4233-9a59-a381ae8260c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_a0fbb459-ea71-49bd-bc7e-f323ffd974c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_a0fbb459-ea71-49bd-bc7e-f323ffd974c9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7130f8bd-7087-4b32-ba12-15d3fe78b2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7130f8bd-7087-4b32-ba12-15d3fe78b2c0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsTable_63158502-8acd-42b8-9941-2349c4270975" xlink:href="cvs-20211231.xsd#cvs_OtherAcquiredIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:to="loc_cvs_OtherAcquiredIntangibleAssetsTable_63158502-8acd-42b8-9941-2349c4270975" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd79aa3c-fcda-4133-8df6-5a999247646d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable_63158502-8acd-42b8-9941-2349c4270975" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd79aa3c-fcda-4133-8df6-5a999247646d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd79aa3c-fcda-4133-8df6-5a999247646d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd79aa3c-fcda-4133-8df6-5a999247646d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd79aa3c-fcda-4133-8df6-5a999247646d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb4667dd-e990-4c77-b89c-2fd04d71adf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd79aa3c-fcda-4133-8df6-5a999247646d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb4667dd-e990-4c77-b89c-2fd04d71adf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_015d1609-c49c-47a7-bfd7-b7fb2d600379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb4667dd-e990-4c77-b89c-2fd04d71adf7" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_015d1609-c49c-47a7-bfd7-b7fb2d600379" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_00e63fb2-38fc-47ac-b3a2-6e9c5780c1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb4667dd-e990-4c77-b89c-2fd04d71adf7" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_00e63fb2-38fc-47ac-b3a2-6e9c5780c1d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProviderNetworksMember_7d9d3ba9-1af8-4154-9340-072146468a68" xlink:href="cvs-20211231.xsd#cvs_ProviderNetworksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb4667dd-e990-4c77-b89c-2fd04d71adf7" xlink:to="loc_cvs_ProviderNetworksMember_7d9d3ba9-1af8-4154-9340-072146468a68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ValueOfBusinessAcquiredMember_e9179423-4edc-44f8-8783-e9932b63b866" xlink:href="cvs-20211231.xsd#cvs_ValueOfBusinessAcquiredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb4667dd-e990-4c77-b89c-2fd04d71adf7" xlink:to="loc_cvs_ValueOfBusinessAcquiredMember_e9179423-4edc-44f8-8783-e9932b63b866" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_29533541-d01d-4e32-9562-6b60c028c342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb4667dd-e990-4c77-b89c-2fd04d71adf7" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_29533541-d01d-4e32-9562-6b60c028c342" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i199214181b01478d94e98ff9f77f10e4_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1fd09813-07b6-41a0-9493-02a638bb08a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1fd09813-07b6-41a0-9493-02a638bb08a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_5e0918e8-43c5-4892-a854-7ddd99ba4840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_5e0918e8-43c5-4892-a854-7ddd99ba4840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_7ebe2f0c-a6de-4d43-9b08-81076a0f3cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_7ebe2f0c-a6de-4d43-9b08-81076a0f3cb7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_d8a1899e-b0f2-40f7-8742-fc4996b14b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_d8a1899e-b0f2-40f7-8742-fc4996b14b0c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresPlannedClosure_69fc8a66-2d21-4c27-ac6d-b0bf48d0d9ac" xlink:href="cvs-20211231.xsd#cvs_NumberOfStoresPlannedClosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_cvs_NumberOfStoresPlannedClosure_69fc8a66-2d21-4c27-ac6d-b0bf48d0d9ac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresPlannedClosurePeriod_ad23f045-b42e-4b29-99ae-6a5bf6ac8afe" xlink:href="cvs-20211231.xsd#cvs_NumberOfStoresPlannedClosurePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_cvs_NumberOfStoresPlannedClosurePeriod_ad23f045-b42e-4b29-99ae-6a5bf6ac8afe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod_14ff11d7-7fe7-45c1-b5b0-2300c36acdf5" xlink:href="cvs-20211231.xsd#cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod_14ff11d7-7fe7-45c1-b5b0-2300c36acdf5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_860d9c14-0ae9-46bc-af57-edfb7c9f6446" xlink:href="cvs-20211231.xsd#cvs_StoreImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_cvs_StoreImpairmentCharges_860d9c14-0ae9-46bc-af57-edfb7c9f6446" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure_fb67592b-2415-4daa-8b4a-452d535ea173" xlink:href="cvs-20211231.xsd#cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure_fb67592b-2415-4daa-8b4a-452d535ea173" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure_60170872-7e84-45c1-8bc7-df8d58d6b227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure_60170872-7e84-45c1-8bc7-df8d58d6b227" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4a155689-8288-4fbd-8a3d-0bde4e58a32a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4a155689-8288-4fbd-8a3d-0bde4e58a32a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0f1267ba-bb83-488c-a740-18175c3d85b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4a155689-8288-4fbd-8a3d-0bde4e58a32a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0f1267ba-bb83-488c-a740-18175c3d85b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f1267ba-bb83-488c-a740-18175c3d85b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0f1267ba-bb83-488c-a740-18175c3d85b4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0f1267ba-bb83-488c-a740-18175c3d85b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6b04eb68-41ae-4954-b7a5-1320f5ff7467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0f1267ba-bb83-488c-a740-18175c3d85b4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6b04eb68-41ae-4954-b7a5-1320f5ff7467" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_4db3a43e-46fb-4b09-8597-c7f0936f0b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6b04eb68-41ae-4954-b7a5-1320f5ff7467" xlink:to="loc_us-gaap_BuildingMember_4db3a43e-46fb-4b09-8597-c7f0936f0b1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_d9cce78a-493c-472e-a25d-cdee3b30eff8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6b04eb68-41ae-4954-b7a5-1320f5ff7467" xlink:to="loc_us-gaap_EquipmentMember_d9cce78a-493c-472e-a25d-cdee3b30eff8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOperatingLeaseMember_8d56f1ab-1452-475a-98db-1f5415b8e374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOperatingLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6b04eb68-41ae-4954-b7a5-1320f5ff7467" xlink:to="loc_us-gaap_PropertySubjectToOperatingLeaseMember_8d56f1ab-1452-475a-98db-1f5415b8e374" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_eb42cff2-4921-4e48-96a5-da804781e677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6b04eb68-41ae-4954-b7a5-1320f5ff7467" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_eb42cff2-4921-4e48-96a5-da804781e677" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_64250b11-94a5-451e-9c9b-67f6b1f10728" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4a155689-8288-4fbd-8a3d-0bde4e58a32a" xlink:to="loc_srt_RangeAxis_64250b11-94a5-451e-9c9b-67f6b1f10728" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_64250b11-94a5-451e-9c9b-67f6b1f10728_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_64250b11-94a5-451e-9c9b-67f6b1f10728" xlink:to="loc_srt_RangeMember_64250b11-94a5-451e-9c9b-67f6b1f10728_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2b830772-0f80-48fe-9d2d-41ad77d633c1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_64250b11-94a5-451e-9c9b-67f6b1f10728" xlink:to="loc_srt_RangeMember_2b830772-0f80-48fe-9d2d-41ad77d633c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a64a94f0-e4d2-4df0-a247-02c2e0620684" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2b830772-0f80-48fe-9d2d-41ad77d633c1" xlink:to="loc_srt_MinimumMember_a64a94f0-e4d2-4df0-a247-02c2e0620684" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0c06728d-fab1-492e-860f-8e857ff126fe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2b830772-0f80-48fe-9d2d-41ad77d633c1" xlink:to="loc_srt_MaximumMember_0c06728d-fab1-492e-860f-8e857ff126fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_03ea5c75-f957-4ea9-8cc3-aecf61ef8e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4a155689-8288-4fbd-8a3d-0bde4e58a32a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_03ea5c75-f957-4ea9-8cc3-aecf61ef8e1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_03ea5c75-f957-4ea9-8cc3-aecf61ef8e1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_03ea5c75-f957-4ea9-8cc3-aecf61ef8e1f" xlink:to="loc_us-gaap_SegmentDomain_03ea5c75-f957-4ea9-8cc3-aecf61ef8e1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_99b625f6-b875-4883-92c6-0fcb3e4ce89c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_03ea5c75-f957-4ea9-8cc3-aecf61ef8e1f" xlink:to="loc_us-gaap_SegmentDomain_99b625f6-b875-4883-92c6-0fcb3e4ce89c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_435dee77-1a27-4712-a65f-46f52b4032b0" xlink:href="cvs-20211231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_99b625f6-b875-4883-92c6-0fcb3e4ce89c" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_435dee77-1a27-4712-a65f-46f52b4032b0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="extended" id="i27b96e8b4e8c4b10a36804407f644f2d_HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_89dbb8db-7cae-4603-bafa-08db016d7eda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_52b0192e-9e20-48e3-a85e-24e506ce519a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_89dbb8db-7cae-4603-bafa-08db016d7eda" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_52b0192e-9e20-48e3-a85e-24e506ce519a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_6d44901e-d884-43e0-8791-c1d44fba1b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_89dbb8db-7cae-4603-bafa-08db016d7eda" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_6d44901e-d884-43e0-8791-c1d44fba1b9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_cbf16221-3f5e-4ce4-b9be-9ec919a2ff1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_89dbb8db-7cae-4603-bafa-08db016d7eda" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_cbf16221-3f5e-4ce4-b9be-9ec919a2ff1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_9f24926f-a8b2-4d5f-be56-bed0fa7f263d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_89dbb8db-7cae-4603-bafa-08db016d7eda" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_9f24926f-a8b2-4d5f-be56-bed0fa7f263d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_bbed4b7c-896e-4ea6-8fb1-396232c36aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_89dbb8db-7cae-4603-bafa-08db016d7eda" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_bbed4b7c-896e-4ea6-8fb1-396232c36aca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d0087ba9-677a-4571-9757-a299a5d57715" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_bbed4b7c-896e-4ea6-8fb1-396232c36aca" xlink:to="loc_srt_ProductOrServiceAxis_d0087ba9-677a-4571-9757-a299a5d57715" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d0087ba9-677a-4571-9757-a299a5d57715_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d0087ba9-677a-4571-9757-a299a5d57715" xlink:to="loc_srt_ProductsAndServicesDomain_d0087ba9-677a-4571-9757-a299a5d57715_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bd4d2c2b-b3a3-473f-a13a-1b43c5f97751" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d0087ba9-677a-4571-9757-a299a5d57715" xlink:to="loc_srt_ProductsAndServicesDomain_bd4d2c2b-b3a3-473f-a13a-1b43c5f97751" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_0780ed34-333a-469f-a54e-dc224db6b799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bd4d2c2b-b3a3-473f-a13a-1b43c5f97751" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_0780ed34-333a-469f-a54e-dc224db6b799" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_7ba3bd60-7e54-46b8-8127-d25ebac82f53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_bbed4b7c-896e-4ea6-8fb1-396232c36aca" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_7ba3bd60-7e54-46b8-8127-d25ebac82f53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_7ba3bd60-7e54-46b8-8127-d25ebac82f53_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_7ba3bd60-7e54-46b8-8127-d25ebac82f53" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_7ba3bd60-7e54-46b8-8127-d25ebac82f53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_515f380f-e45c-47fb-b8f4-f61e97767588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_7ba3bd60-7e54-46b8-8127-d25ebac82f53" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_515f380f-e45c-47fb-b8f4-f61e97767588" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_a8388b91-08f1-48e4-a0d7-4c1bb96dd329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_515f380f-e45c-47fb-b8f4-f61e97767588" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_a8388b91-08f1-48e4-a0d7-4c1bb96dd329" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_13eb18d3-25aa-4d85-a702-1005f9e9fb18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_515f380f-e45c-47fb-b8f4-f61e97767588" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_13eb18d3-25aa-4d85-a702-1005f9e9fb18" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended" id="i6247e0d544d447fda9d7b140f3670cdc_HealthCareCostsPayableNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_41eb6263-0bd6-4e97-b9bd-d3150576b5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_0e3bb67e-ac0f-412a-b54c-f8f2fead3647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_41eb6263-0bd6-4e97-b9bd-d3150576b5a5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_0e3bb67e-ac0f-412a-b54c-f8f2fead3647" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_0feabd72-b732-4de8-aa96-240f842c84ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_41eb6263-0bd6-4e97-b9bd-d3150576b5a5" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_0feabd72-b732-4de8-aa96-240f842c84ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_5c92dd41-8cbb-4bf5-a225-750a237d1f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_41eb6263-0bd6-4e97-b9bd-d3150576b5a5" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_5c92dd41-8cbb-4bf5-a225-750a237d1f4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b15962f8-c7be-468c-a379-d63d363d44ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_5c92dd41-8cbb-4bf5-a225-750a237d1f4f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b15962f8-c7be-468c-a379-d63d363d44ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b15962f8-c7be-468c-a379-d63d363d44ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b15962f8-c7be-468c-a379-d63d363d44ec" xlink:to="loc_us-gaap_SegmentDomain_b15962f8-c7be-468c-a379-d63d363d44ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_71d8e8ff-93d3-4975-9620-9e7bc51fe0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b15962f8-c7be-468c-a379-d63d363d44ec" xlink:to="loc_us-gaap_SegmentDomain_71d8e8ff-93d3-4975-9620-9e7bc51fe0d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_805f814c-5721-4e89-87e4-8826809e4ca3" xlink:href="cvs-20211231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_71d8e8ff-93d3-4975-9620-9e7bc51fe0d8" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_805f814c-5721-4e89-87e4-8826809e4ca3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails" xlink:type="extended" id="ie4aa244edf5447249df81f9529428583_HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_c86550c5-e32d-4db2-8cd5-ed7188a25192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_353d38fa-dc79-4b6d-bfc3-a5a9852a3da6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_c86550c5-e32d-4db2-8cd5-ed7188a25192" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_353d38fa-dc79-4b6d-bfc3-a5a9852a3da6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ac3016b1-95e5-4b46-9921-64bf6a062dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_c86550c5-e32d-4db2-8cd5-ed7188a25192" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ac3016b1-95e5-4b46-9921-64bf6a062dcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_6c36b90c-c08f-4263-b026-61571a31c894" xlink:href="cvs-20211231.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_c86550c5-e32d-4db2-8cd5-ed7188a25192" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_6c36b90c-c08f-4263-b026-61571a31c894" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_f45cb315-85db-4a7d-b370-3b1bc74061fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_c86550c5-e32d-4db2-8cd5-ed7188a25192" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_f45cb315-85db-4a7d-b370-3b1bc74061fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_276c9b95-2c88-46df-b652-4cd0d9cd8823" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_c86550c5-e32d-4db2-8cd5-ed7188a25192" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_276c9b95-2c88-46df-b652-4cd0d9cd8823" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_b201094e-47be-41d5-836b-ca3b634a3746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_c86550c5-e32d-4db2-8cd5-ed7188a25192" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_b201094e-47be-41d5-836b-ca3b634a3746" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8fe3ca88-dc08-4ce9-ab47-d2a43fde8de2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_b201094e-47be-41d5-836b-ca3b634a3746" xlink:to="loc_srt_ProductOrServiceAxis_8fe3ca88-dc08-4ce9-ab47-d2a43fde8de2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8fe3ca88-dc08-4ce9-ab47-d2a43fde8de2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8fe3ca88-dc08-4ce9-ab47-d2a43fde8de2" xlink:to="loc_srt_ProductsAndServicesDomain_8fe3ca88-dc08-4ce9-ab47-d2a43fde8de2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_55d2a9f6-dec6-42b5-bca5-a16b10e652a3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8fe3ca88-dc08-4ce9-ab47-d2a43fde8de2" xlink:to="loc_srt_ProductsAndServicesDomain_55d2a9f6-dec6-42b5-bca5-a16b10e652a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_80491801-3278-4eb9-8abb-a1a48f0b819e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_55d2a9f6-dec6-42b5-bca5-a16b10e652a3" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_80491801-3278-4eb9-8abb-a1a48f0b819e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails" xlink:type="extended" id="idc23b098ccc34ff6abcbbf00ce83f6a1_HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_18b97879-5841-4884-bb81-4d5de5b4b0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_18b97879-5841-4884-bb81-4d5de5b4b0e0" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_ec98d90d-e092-4ec6-865a-7b18526e6009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_ec98d90d-e092-4ec6-865a-7b18526e6009" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_2f4dd6b1-854e-4f81-9800-d9a4bfd9e43d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_2f4dd6b1-854e-4f81-9800-d9a4bfd9e43d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_ac603fa1-3018-4397-b9c3-f8dc93711001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_ac603fa1-3018-4397-b9c3-f8dc93711001" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_fcd43a38-1a1f-4a77-b144-6939448d94bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_fcd43a38-1a1f-4a77-b144-6939448d94bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_378904aa-4bed-41ba-b950-4f8c32a325d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_378904aa-4bed-41ba-b950-4f8c32a325d8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_25b5dcc4-fce6-4d53-945a-56d5f9d3d4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_378904aa-4bed-41ba-b950-4f8c32a325d8" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_25b5dcc4-fce6-4d53-945a-56d5f9d3d4c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_32549546-870a-42c5-a922-c1d891eeb95f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_378904aa-4bed-41ba-b950-4f8c32a325d8" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_32549546-870a-42c5-a922-c1d891eeb95f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_3b645998-7bd0-4068-98b3-f1a24dc0f9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_378904aa-4bed-41ba-b950-4f8c32a325d8" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_3b645998-7bd0-4068-98b3-f1a24dc0f9e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_f39c6883-9202-4407-b553-f3f72013a551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_f39c6883-9202-4407-b553-f3f72013a551" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_2bce708f-0507-43f3-8470-199e6071ae30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_f39c6883-9202-4407-b553-f3f72013a551" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_2bce708f-0507-43f3-8470-199e6071ae30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_2e14df6a-ee41-42af-8089-3814ce46fff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_f39c6883-9202-4407-b553-f3f72013a551" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_2e14df6a-ee41-42af-8089-3814ce46fff4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_84444b5c-7b3e-4229-9d7c-556e432c0bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_f39c6883-9202-4407-b553-f3f72013a551" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_84444b5c-7b3e-4229-9d7c-556e432c0bc6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_1c622a88-1bfe-4a71-81f7-edc63950becd" xlink:href="cvs-20211231.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_1c622a88-1bfe-4a71-81f7-edc63950becd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_f65595fe-d452-4061-8fd5-f5eb8c314941" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_dbadc6fd-928d-48cf-9c10-d1e6720a9d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_515872fb-248a-43b6-a6f6-8b04585d0e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_bb49ada5-4200-4194-860f-12e38ce02714" xlink:href="cvs-20211231.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_18b97879-5841-4884-bb81-4d5de5b4b0e0" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_bb49ada5-4200-4194-860f-12e38ce02714" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_4b18390f-6ced-413f-b4ca-40a68bf35a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_18b97879-5841-4884-bb81-4d5de5b4b0e0" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_4b18390f-6ced-413f-b4ca-40a68bf35a0b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_aa2861a4-e601-43c2-822e-4b1564527085" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_4b18390f-6ced-413f-b4ca-40a68bf35a0b" xlink:to="loc_srt_ProductOrServiceAxis_aa2861a4-e601-43c2-822e-4b1564527085" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_aa2861a4-e601-43c2-822e-4b1564527085_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_aa2861a4-e601-43c2-822e-4b1564527085" xlink:to="loc_srt_ProductsAndServicesDomain_aa2861a4-e601-43c2-822e-4b1564527085_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_29eed1f4-f214-4591-bd45-b9a82a9179e6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_aa2861a4-e601-43c2-822e-4b1564527085" xlink:to="loc_srt_ProductsAndServicesDomain_29eed1f4-f214-4591-bd45-b9a82a9179e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_7830448c-f351-46fd-b8a4-95c6e20843c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_29eed1f4-f214-4591-bd45-b9a82a9179e6" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_7830448c-f351-46fd-b8a4-95c6e20843c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9a868829-0f2d-4775-bb5a-9752a077ffed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_4b18390f-6ced-413f-b4ca-40a68bf35a0b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9a868829-0f2d-4775-bb5a-9752a077ffed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9a868829-0f2d-4775-bb5a-9752a077ffed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9a868829-0f2d-4775-bb5a-9752a077ffed" xlink:to="loc_us-gaap_SegmentDomain_9a868829-0f2d-4775-bb5a-9752a077ffed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7babd931-5240-4da4-97dc-7f13d0b3e53f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9a868829-0f2d-4775-bb5a-9752a077ffed" xlink:to="loc_us-gaap_SegmentDomain_7babd931-5240-4da4-97dc-7f13d0b3e53f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_fd578c1b-1156-43d1-a32d-7106e6bbb117" xlink:href="cvs-20211231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7babd931-5240-4da4-97dc-7f13d0b3e53f" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_fd578c1b-1156-43d1-a32d-7106e6bbb117" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_dbb4f7e8-7439-412f-b163-061a3080862b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7babd931-5240-4da4-97dc-7f13d0b3e53f" xlink:to="loc_us-gaap_CorporateAndOtherMember_dbb4f7e8-7439-412f-b163-061a3080862b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#BorrowingsandCreditArrangementsScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails" xlink:type="extended" id="if8013dacbb01454ba07997cf7c46795d_BorrowingsandCreditArrangementsScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ffb4a442-fe96-48cb-8610-24e705e88408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ffb4a442-fe96-48cb-8610-24e705e88408" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_04c3d3ce-03f5-47f6-b703-870fd4368632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_04c3d3ce-03f5-47f6-b703-870fd4368632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_7d382e04-6633-4687-900d-c1655bab72d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_us-gaap_FinanceLeaseLiability_7d382e04-6633-4687-900d-c1655bab72d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_35015e2c-8a12-4f9b-a98f-b36bf5f1b94e" xlink:href="cvs-20211231.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_35015e2c-8a12-4f9b-a98f-b36bf5f1b94e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_072921e9-5711-4716-bb08-753e3b4b6e06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_072921e9-5711-4716-bb08-753e3b4b6e06" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_9c502b24-d4a8-4046-8852-1ca585438945" xlink:href="cvs-20211231.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_9c502b24-d4a8-4046-8852-1ca585438945" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_22a5d74e-6ecc-4400-af50-63350cc5dd77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_22a5d74e-6ecc-4400-af50-63350cc5dd77" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_ab500047-cf08-41dd-ac1e-79fa28fe8447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_ab500047-cf08-41dd-ac1e-79fa28fe8447" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_2ef5a866-3979-4f29-8605-abc4d2ca5fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_2ef5a866-3979-4f29-8605-abc4d2ca5fa9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_3397760f-4cd8-491f-9b3f-2ae6de7d4cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_3397760f-4cd8-491f-9b3f-2ae6de7d4cd6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2a0136a6-697e-43e8-a134-c2e560b93de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_us-gaap_DebtInstrumentTable_2a0136a6-697e-43e8-a134-c2e560b93de0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8fd9be31-86bd-4bf6-826e-debbc9beff0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2a0136a6-697e-43e8-a134-c2e560b93de0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8fd9be31-86bd-4bf6-826e-debbc9beff0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8fd9be31-86bd-4bf6-826e-debbc9beff0d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8fd9be31-86bd-4bf6-826e-debbc9beff0d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8fd9be31-86bd-4bf6-826e-debbc9beff0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_db588793-3a02-410a-ae49-09121393602d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8fd9be31-86bd-4bf6-826e-debbc9beff0d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_db588793-3a02-410a-ae49-09121393602d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_19aef551-3c49-457f-8b61-e3e01b09051d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_db588793-3a02-410a-ae49-09121393602d" xlink:to="loc_us-gaap_SeniorNotesMember_19aef551-3c49-457f-8b61-e3e01b09051d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_fef5d017-c656-4cac-bff3-21a2eb282bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_db588793-3a02-410a-ae49-09121393602d" xlink:to="loc_us-gaap_NotesPayableToBanksMember_fef5d017-c656-4cac-bff3-21a2eb282bd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_aa0ab4cc-6cca-4426-bd38-2f77f2f96cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_db588793-3a02-410a-ae49-09121393602d" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_aa0ab4cc-6cca-4426-bd38-2f77f2f96cd8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ad4aa71e-9f60-45d3-a96e-54d070ae03e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2a0136a6-697e-43e8-a134-c2e560b93de0" xlink:to="loc_us-gaap_DebtInstrumentAxis_ad4aa71e-9f60-45d3-a96e-54d070ae03e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ad4aa71e-9f60-45d3-a96e-54d070ae03e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ad4aa71e-9f60-45d3-a96e-54d070ae03e4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ad4aa71e-9f60-45d3-a96e-54d070ae03e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ad4aa71e-9f60-45d3-a96e-54d070ae03e4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member_a5f91bfa-a638-4f69-aa57-de33a9cb74db" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3.35DueMarch2021Member_a5f91bfa-a638-4f69-aa57-de33a9cb74db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2021Member_48a7cfd8-9dad-4f94-a366-b8811389cef3" xlink:href="cvs-20211231.xsd#cvs_FloatingRateNotesDueMarch2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_FloatingRateNotesDueMarch2021Member_48a7cfd8-9dad-4f94-a366-b8811389cef3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member_bbc4094d-30eb-4531-96e2-348c719e2e6d" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.125DueMay2021Member_bbc4094d-30eb-4531-96e2-348c719e2e6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.125June2021Member_baff6f09-8989-476f-bb7a-8dfe69d6fb8f" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.125June2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes2.125June2021Member_baff6f09-8989-476f-bb7a-8dfe69d6fb8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member_c1a957c8-acf4-42af-a696-3ceea20ce68f" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.125DueJune2021Member_c1a957c8-acf4-42af-a696-3ceea20ce68f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member_72872f52-a791-44d5-a987-a0588e217629" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes5.45DueJune2021Member_72872f52-a791-44d5-a987-a0588e217629" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member_231d41e5-90b8-4f70-b69e-8e435df2aad8" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3.5DueJuly2022Member_231d41e5-90b8-4f70-b69e-8e435df2aad8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member_9984af4c-f3ab-4ac1-8d8b-de58b103ce6d" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes2.75DueNovember2022Member_9984af4c-f3ab-4ac1-8d8b-de58b103ce6d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member_2102dcdb-6b42-4c18-b840-6c36158af490" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes2.75DueDecember2022Member_2102dcdb-6b42-4c18-b840-6c36158af490" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member_537efd91-beb9-4ae1-a996-cc39f2111d7e" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.75DueDecember2022Member_537efd91-beb9-4ae1-a996-cc39f2111d7e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_c0263e3a-debc-49be-b104-cda9c3d0a290" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_c0263e3a-debc-49be-b104-cda9c3d0a290" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member_43eb4f9f-0779-4143-b3f7-e8e8b983f992" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes2.8DueJune2023Member_43eb4f9f-0779-4143-b3f7-e8e8b983f992" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_af9e34e8-5a54-4a73-886d-1dd1e9fb0a53" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_af9e34e8-5a54-4a73-886d-1dd1e9fb0a53" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member_499b78c7-7386-4f58-a495-813890e2e71e" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3.375DueAugust2024Member_499b78c7-7386-4f58-a495-813890e2e71e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_ec6fe8da-87ec-4816-9259-08b0cbdce94b" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_ec6fe8da-87ec-4816-9259-08b0cbdce94b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member_b4ed4d72-b168-4bb5-bec1-5c776182d001" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3.5DueNovember2024Member_b4ed4d72-b168-4bb5-bec1-5c776182d001" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member_7fc49230-f2b8-4363-9333-5b186c39761f" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes5DueDecember2024Member_7fc49230-f2b8-4363-9333-5b186c39761f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_6396af8f-0849-4d6f-8bb5-183fc7d32e82" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_6396af8f-0849-4d6f-8bb5-183fc7d32e82" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member_d8d135b1-87c8-4574-bf9f-a5d99275552c" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3.875DueJuly2025Member_d8d135b1-87c8-4574-bf9f-a5d99275552c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member_4e2b0a00-639e-4809-b40e-3e00d9360cf3" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes2.875DueJune2026Member_4e2b0a00-639e-4809-b40e-3e00d9360cf3" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_0d7ffd14-2959-43af-8c26-5d5aa44d68c7" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_0d7ffd14-2959-43af-8c26-5d5aa44d68c7" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point625PercentApril2027Member_532ecee3-f988-45e1-af9e-b69f75aafe68" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3Point625PercentApril2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3Point625PercentApril2027Member_532ecee3-f988-45e1-af9e-b69f75aafe68" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member_b404ef8f-572a-45eb-b083-d252fcfbd349" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes6.25DueJune2027Member_b404ef8f-572a-45eb-b083-d252fcfbd349" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point3PercentAugust2027Member_22e2672c-9645-4115-8a6f-7864aa4261b6" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes1Point3PercentAugust2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes1Point3PercentAugust2027Member_22e2672c-9645-4115-8a6f-7864aa4261b6" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member_54d60a46-0662-4cdb-8aa3-e18597790098" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.3DueMarch2028Member_54d60a46-0662-4cdb-8aa3-e18597790098" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_93702bb8-35a5-4135-ba25-556262bafc5c" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_93702bb8-35a5-4135-ba25-556262bafc5c" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point75PercentApril2030Member_eb6d5399-6cf7-4bad-97c5-d115b8c2e8a5" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3Point75PercentApril2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3Point75PercentApril2030Member_eb6d5399-6cf7-4bad-97c5-d115b8c2e8a5" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point75PercentAugust2030Member_e1375d75-d031-47b5-b2d6-e4125ac9ceba" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes1Point75PercentAugust2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes1Point75PercentAugust2030Member_e1375d75-d031-47b5-b2d6-e4125ac9ceba" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member_634a8b23-3896-4d8e-b365-3de61885b396" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes1Point875PercentFebruary2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member_634a8b23-3896-4d8e-b365-3de61885b396" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_2a7caf33-f0ba-4488-9921-9fd429885998" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2Point125PercentDueSeptember2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_2a7caf33-f0ba-4488-9921-9fd429885998" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member_5b1ed552-6f47-430e-a2e0-a510c6fbdca3" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.875DueJuly2035Member_5b1ed552-6f47-430e-a2e0-a510c6fbdca3" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member_8dbfb394-5ac8-4a17-8e2a-e1fdc9530526" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes6.625DueJune2036Member_8dbfb394-5ac8-4a17-8e2a-e1fdc9530526" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member_6b6e1453-402c-43f5-89a5-634ff0d5f35f" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes6.75DueDecember2037Member_6b6e1453-402c-43f5-89a5-634ff0d5f35f" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member_dbc75e1f-6f40-4736-a555-7790cde378bd" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.78DueMarch2038Member_dbc75e1f-6f40-4736-a555-7790cde378bd" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member_3ae4df58-7d78-4489-9c05-c90742530e46" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes6.125DueSeptember2039Member_3ae4df58-7d78-4489-9c05-c90742530e46" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point125PercentApril2040Member_76d28a99-c38a-4c4e-a59e-f85999d3a11b" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4Point125PercentApril2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4Point125PercentApril2040Member_76d28a99-c38a-4c4e-a59e-f85999d3a11b" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point7PercentAugust2040Member_2b341973-cf18-4fb1-a512-8e5c288e8ab9" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2Point7PercentAugust2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes2Point7PercentAugust2040Member_2b341973-cf18-4fb1-a512-8e5c288e8ab9" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member_7fea112c-1c79-46c0-8a10-3ae0ed79f21c" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes5.75DueMay2041Member_7fea112c-1c79-46c0-8a10-3ae0ed79f21c" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member_318c8f93-6cc3-46cf-869b-c656792b7e5d" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.5DueMay2042Member_318c8f93-6cc3-46cf-869b-c656792b7e5d" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member_52c375c4-1f7e-451b-9da6-79fb4c85029b" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.125DueNovember2042Member_52c375c4-1f7e-451b-9da6-79fb4c85029b" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member_35bcfb2e-fd4e-4dc0-8048-5cbef8cd2dc2" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes5.3DueDecember2043Member_35bcfb2e-fd4e-4dc0-8048-5cbef8cd2dc2" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member_00ee11c1-f0c2-414e-87de-ace05d38c198" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.75DueMarch2044Member_00ee11c1-f0c2-414e-87de-ace05d38c198" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member_0525c717-cebe-4e99-879b-a9ace67727b6" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes5.125DueJuly2045Member_0525c717-cebe-4e99-879b-a9ace67727b6" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member_efea38d7-e65a-4c49-8a26-5a7746b87a89" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3.875DueAugust2047Member_efea38d7-e65a-4c49-8a26-5a7746b87a89" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member_832ea44f-d9eb-4bfc-9d98-920a5d65846f" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes5.05DueMarch2048Member_832ea44f-d9eb-4bfc-9d98-920a5d65846f" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point25PercentApril2050Member_38cfa8ae-8253-4100-ace4-1fefc1bbd6ce" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4Point25PercentApril2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4Point25PercentApril2050Member_38cfa8ae-8253-4100-ace4-1fefc1bbd6ce" xlink:type="arc" order="45"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#BorrowingsandCreditArrangementsShorttermBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails" xlink:type="extended" id="i43d8e04cb1a845899636449d2e2b84f9_BorrowingsandCreditArrangementsShorttermBorrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_7e299986-1eec-4a50-b3b7-d5b2e74c5481" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_ba8fa0e8-e28e-46e3-9b2e-bc9737c66879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7e299986-1eec-4a50-b3b7-d5b2e74c5481" xlink:to="loc_us-gaap_ShortTermBorrowings_ba8fa0e8-e28e-46e3-9b2e-bc9737c66879" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8a3d6c69-9c23-4f1c-bb2c-9eb10143d203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7e299986-1eec-4a50-b3b7-d5b2e74c5481" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8a3d6c69-9c23-4f1c-bb2c-9eb10143d203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_181ec629-f2a5-4a7d-9450-aa8a5bba5359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7e299986-1eec-4a50-b3b7-d5b2e74c5481" xlink:to="loc_us-gaap_DebtInstrumentTerm_181ec629-f2a5-4a7d-9450-aa8a5bba5359" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_b7c1f8f1-3b57-4a21-add4-211fbc25a62d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7e299986-1eec-4a50-b3b7-d5b2e74c5481" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_b7c1f8f1-3b57-4a21-add4-211fbc25a62d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_bae967dc-5888-44cf-a87d-c53bd9f7cb59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7e299986-1eec-4a50-b3b7-d5b2e74c5481" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_bae967dc-5888-44cf-a87d-c53bd9f7cb59" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_b4d42d20-cb16-4e75-b4ed-0ba7c1d35247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7e299986-1eec-4a50-b3b7-d5b2e74c5481" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_b4d42d20-cb16-4e75-b4ed-0ba7c1d35247" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_5b3b62fb-140b-4031-93e5-e1d8f74949e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b4d42d20-cb16-4e75-b4ed-0ba7c1d35247" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_5b3b62fb-140b-4031-93e5-e1d8f74949e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_5b3b62fb-140b-4031-93e5-e1d8f74949e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_5b3b62fb-140b-4031-93e5-e1d8f74949e8" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_5b3b62fb-140b-4031-93e5-e1d8f74949e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_d2d0d449-4e9e-4f60-b596-435e88ee0fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_5b3b62fb-140b-4031-93e5-e1d8f74949e8" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_d2d0d449-4e9e-4f60-b596-435e88ee0fb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_efb024e7-3d67-4d45-a6c8-12936aa7539f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_d2d0d449-4e9e-4f60-b596-435e88ee0fb7" xlink:to="loc_us-gaap_CommercialPaperMember_efb024e7-3d67-4d45-a6c8-12936aa7539f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_a17ad4d0-94c9-43e4-bbc9-a492ad40a52e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_d2d0d449-4e9e-4f60-b596-435e88ee0fb7" xlink:to="loc_us-gaap_LineOfCreditMember_a17ad4d0-94c9-43e4-bbc9-a492ad40a52e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember_6ed183ba-dd69-4264-9bee-f83c1ca03509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_d2d0d449-4e9e-4f60-b596-435e88ee0fb7" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesMember_6ed183ba-dd69-4264-9bee-f83c1ca03509" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8e28ed5e-a495-4592-9a1a-5eb0892ba987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b4d42d20-cb16-4e75-b4ed-0ba7c1d35247" xlink:to="loc_us-gaap_DebtInstrumentAxis_8e28ed5e-a495-4592-9a1a-5eb0892ba987" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8e28ed5e-a495-4592-9a1a-5eb0892ba987_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8e28ed5e-a495-4592-9a1a-5eb0892ba987" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8e28ed5e-a495-4592-9a1a-5eb0892ba987_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5a3e8e06-def9-467d-9f63-a08b0a3fa344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8e28ed5e-a495-4592-9a1a-5eb0892ba987" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5a3e8e06-def9-467d-9f63-a08b0a3fa344" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BackUpCreditFacilitiesMember_70f51a16-ea38-4b7f-b6bf-4001315cf8ef" xlink:href="cvs-20211231.xsd#cvs_BackUpCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5a3e8e06-def9-467d-9f63-a08b0a3fa344" xlink:to="loc_cvs_BackUpCreditFacilitiesMember_70f51a16-ea38-4b7f-b6bf-4001315cf8ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay172023Member_516d6f37-aaa3-4b31-ba6e-23700224f920" xlink:href="cvs-20211231.xsd#cvs_RevolvingCreditFacilityExpiringMay172023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_70f51a16-ea38-4b7f-b6bf-4001315cf8ef" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay172023Member_516d6f37-aaa3-4b31-ba6e-23700224f920" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay162024Member_42bf6459-202c-416c-8ccf-de0ed01032b2" xlink:href="cvs-20211231.xsd#cvs_RevolvingCreditFacilityExpiringMay162024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_70f51a16-ea38-4b7f-b6bf-4001315cf8ef" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay162024Member_42bf6459-202c-416c-8ccf-de0ed01032b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay112026Member_68fcdd92-a7c4-4bae-9319-2a82997b139a" xlink:href="cvs-20211231.xsd#cvs_RevolvingCreditFacilityExpiringMay112026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_70f51a16-ea38-4b7f-b6bf-4001315cf8ef" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay112026Member_68fcdd92-a7c4-4bae-9319-2a82997b139a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#BorrowingsandCreditArrangementsLongTermBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails" xlink:type="extended" id="i8be6687ce98f46279e23457adcfeff93_BorrowingsandCreditArrangementsLongTermBorrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ffc59021-fd3c-4489-bbb5-97a99a0ceb44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ffc59021-fd3c-4489-bbb5-97a99a0ceb44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b3e0a5ba-efdb-40dc-b141-efa36cbf0872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b3e0a5ba-efdb-40dc-b141-efa36cbf0872" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_dd2b4270-1895-4720-89b0-5a44e150562d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_dd2b4270-1895-4720-89b0-5a44e150562d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_a2565a65-121d-457d-9fb7-e012d857fbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_a2565a65-121d-457d-9fb7-e012d857fbd6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_891faf49-3726-4879-8fcc-90ac79795517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_891faf49-3726-4879-8fcc-90ac79795517" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_23b5d34b-7d98-4b3e-a4f0-8840afe0dca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_23b5d34b-7d98-4b3e-a4f0-8840afe0dca4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_d45ce7e6-475a-4987-bd39-57fea9d1697b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_d45ce7e6-475a-4987-bd39-57fea9d1697b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_e9412638-2af9-42c4-9a3d-95a991e51b46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_e9412638-2af9-42c4-9a3d-95a991e51b46" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtExtinguishmentFees_951f6e81-7e50-4218-af7a-f8083e3dcae4" xlink:href="cvs-20211231.xsd#cvs_DebtExtinguishmentFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_cvs_DebtExtinguishmentFees_951f6e81-7e50-4218-af7a-f8083e3dcae4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b9159e4c-53df-4813-a98d-ace659c18ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b9159e4c-53df-4813-a98d-ace659c18ba8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_605d9f0e-aa10-44c5-975d-eee30fe9e646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_605d9f0e-aa10-44c5-975d-eee30fe9e646" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts_18818d1b-d5a0-4fef-8c92-3686b5d3588d" xlink:href="cvs-20211231.xsd#cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts_18818d1b-d5a0-4fef-8c92-3686b5d3588d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_80e538bd-fd6b-4321-a095-0e7d8a74d61e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_DebtInstrumentTable_80e538bd-fd6b-4321-a095-0e7d8a74d61e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e652ca84-38bf-490d-8cd6-7fe8f4ad605a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_80e538bd-fd6b-4321-a095-0e7d8a74d61e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e652ca84-38bf-490d-8cd6-7fe8f4ad605a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e652ca84-38bf-490d-8cd6-7fe8f4ad605a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e652ca84-38bf-490d-8cd6-7fe8f4ad605a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e652ca84-38bf-490d-8cd6-7fe8f4ad605a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_34fb88e8-3910-476e-abdd-64010ae988a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e652ca84-38bf-490d-8cd6-7fe8f4ad605a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_34fb88e8-3910-476e-abdd-64010ae988a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_021a2f8a-9aaf-4ffc-8296-c16bd715c3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_34fb88e8-3910-476e-abdd-64010ae988a8" xlink:to="loc_us-gaap_SeniorNotesMember_021a2f8a-9aaf-4ffc-8296-c16bd715c3f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_a80ea49d-e1e8-4b36-a7d9-002ede18ed40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_34fb88e8-3910-476e-abdd-64010ae988a8" xlink:to="loc_us-gaap_NotesPayableToBanksMember_a80ea49d-e1e8-4b36-a7d9-002ede18ed40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesMember_fc325b7b-62a3-42c7-ab0d-b045e7d4da2e" xlink:href="cvs-20211231.xsd#cvs_FloatingRateNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_34fb88e8-3910-476e-abdd-64010ae988a8" xlink:to="loc_cvs_FloatingRateNotesMember_fc325b7b-62a3-42c7-ab0d-b045e7d4da2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_05a03c7c-912d-40a8-97ee-b062ea6ae9af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_80e538bd-fd6b-4321-a095-0e7d8a74d61e" xlink:to="loc_us-gaap_DebtInstrumentAxis_05a03c7c-912d-40a8-97ee-b062ea6ae9af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_05a03c7c-912d-40a8-97ee-b062ea6ae9af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_05a03c7c-912d-40a8-97ee-b062ea6ae9af" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_05a03c7c-912d-40a8-97ee-b062ea6ae9af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_05a03c7c-912d-40a8-97ee-b062ea6ae9af" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_27c84ba0-f12d-471e-9075-afe10b8654ca" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2Point125PercentDueSeptember2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_27c84ba0-f12d-471e-9075-afe10b8654ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member_7625f25c-956a-4622-ba3a-a05b0bf0b3c6" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes13DueAugust2027Member_7625f25c-956a-4622-ba3a-a05b0bf0b3c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1875DueFebruary2031Member_bf7871f3-bf65-49fc-9581-6134df762553" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes1875DueFebruary2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes1875DueFebruary2031Member_bf7871f3-bf65-49fc-9581-6134df762553" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member_8d7288ff-65fb-456e-a54f-b0daf926ed34" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes175DueAugust2030Member_8d7288ff-65fb-456e-a54f-b0daf926ed34" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member_01e84d9c-fe2f-4276-b013-695887f01c4e" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes27DueAugust2040Member_01e84d9c-fe2f-4276-b013-695887f01c4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3625DueApril2027Member_08a1e925-5f28-40f1-86d8-a133544d318f" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3625DueApril2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes3625DueApril2027Member_08a1e925-5f28-40f1-86d8-a133544d318f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes375DueApril2030Member_03a931b5-bdb5-4cf0-b186-97854d4a2fc1" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes375DueApril2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes375DueApril2030Member_03a931b5-bdb5-4cf0-b186-97854d4a2fc1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4125DueApril2040Member_5a81b8b0-5c23-4ec5-ace9-473ee8c0cdda" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4125DueApril2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes4125DueApril2040Member_5a81b8b0-5c23-4ec5-ace9-473ee8c0cdda" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes425DueApril2050Member_913190e8-2c9a-4a9f-a43c-53c4fc62674a" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes425DueApril2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes425DueApril2050Member_913190e8-2c9a-4a9f-a43c-53c4fc62674a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_049cd54b-212d-4cc0-9722-cff1aa470889" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_049cd54b-212d-4cc0-9722-cff1aa470889" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_8aea9846-ae60-477a-b8e1-901f219acf64" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_8aea9846-ae60-477a-b8e1-901f219acf64" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_3cbb5e0e-d31c-4822-9f1b-e03a05ec66df" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_3cbb5e0e-d31c-4822-9f1b-e03a05ec66df" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4PointThreePercentDue2028Member_e09bdb81-98f5-40e3-84fb-d438f7270115" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4PointThreePercentDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes4PointThreePercentDue2028Member_e09bdb81-98f5-40e3-84fb-d438f7270115" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OutstandingSeniorNotesMember_e7a946f0-916f-4b2d-9539-6024e93a8fbf" xlink:href="cvs-20211231.xsd#cvs_OutstandingSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_OutstandingSeniorNotesMember_e7a946f0-916f-4b2d-9539-6024e93a8fbf" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_8922f006-f7a6-4c20-b8f5-466a5ce956fc" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_8922f006-f7a6-4c20-b8f5-466a5ce956fc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_5c40f76c-91a5-4b46-b6f8-a23dd98dd336" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_5c40f76c-91a5-4b46-b6f8-a23dd98dd336" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_79f4994f-a889-4ce9-995f-30c6e4255f91" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_79f4994f-a889-4ce9-995f-30c6e4255f91" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes43Due2028Member_71d6f10e-5dd6-49bb-bdf0-00bcd49be658" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes43Due2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes43Due2028Member_71d6f10e-5dd6-49bb-bdf0-00bcd49be658" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member_25c22686-9224-4e8b-831d-85fe2e54c301" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes4.125DueMay2021Member_25c22686-9224-4e8b-831d-85fe2e54c301" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member_c153d454-f12c-42c5-b6d6-d148998ecdda" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes4.125DueJune2021Member_c153d454-f12c-42c5-b6d6-d148998ecdda" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member_0b5b604d-2359-463d-9949-239c9036615a" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes5.45DueJune2021Member_0b5b604d-2359-463d-9949-239c9036615a" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member_601b4c55-d4d2-4b1e-a02f-22381ed055bb" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes3.35DueMarch2021Member_601b4c55-d4d2-4b1e-a02f-22381ed055bb" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point70PercentDue2023Member_2b3312ce-9095-4481-a1e4-0ef776093a8b" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3Point70PercentDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes3Point70PercentDue2023Member_2b3312ce-9095-4481-a1e4-0ef776093a8b" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.125DueMarch2020Member_591df0e9-d0f8-4516-bccb-a51fb7a8a90d" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.125DueMarch2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes3.125DueMarch2020Member_591df0e9-d0f8-4516-bccb-a51fb7a8a90d" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2020Member_0cd8e368-24ff-4345-bc59-4f1db181594b" xlink:href="cvs-20211231.xsd#cvs_FloatingRateNotesDueMarch2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_FloatingRateNotesDueMarch2020Member_0cd8e368-24ff-4345-bc59-4f1db181594b" xlink:type="arc" order="24"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#PensionPlansandOtherPostretirementBenefitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails" xlink:type="extended" id="i3f38e829303f42738cb48466b2d72b57_PensionPlansandOtherPostretirementBenefitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4198394a-29bc-42ef-afac-a87f86a99605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_7220e771-3e28-4cd2-bcdf-bc48b78e1ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4198394a-29bc-42ef-afac-a87f86a99605" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_7220e771-3e28-4cd2-bcdf-bc48b78e1ef8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_526b2aad-a585-4b1a-98f0-d1c6e2cbdb24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4198394a-29bc-42ef-afac-a87f86a99605" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_526b2aad-a585-4b1a-98f0-d1c6e2cbdb24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_0c1c13a4-99aa-48bc-a536-e8b5da8b1233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4198394a-29bc-42ef-afac-a87f86a99605" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_0c1c13a4-99aa-48bc-a536-e8b5da8b1233" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_69bb23af-6b62-447c-bc23-a4fedba2c22c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MultiemployerPlanPensionInsignificantPlanContribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4198394a-29bc-42ef-afac-a87f86a99605" xlink:to="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_69bb23af-6b62-447c-bc23-a4fedba2c22c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_efc453c9-f68c-43a9-83d3-6b4c549e12ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4198394a-29bc-42ef-afac-a87f86a99605" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_efc453c9-f68c-43a9-83d3-6b4c549e12ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_05734367-9e87-4631-ab2d-1e2061641067" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4198394a-29bc-42ef-afac-a87f86a99605" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_05734367-9e87-4631-ab2d-1e2061641067" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_37beb9b5-4dc5-471a-8032-668f1e7261fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4198394a-29bc-42ef-afac-a87f86a99605" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_37beb9b5-4dc5-471a-8032-668f1e7261fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_0acdc8e1-9f70-4adf-b30a-20d0b6f73674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_37beb9b5-4dc5-471a-8032-668f1e7261fb" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_0acdc8e1-9f70-4adf-b30a-20d0b6f73674" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0acdc8e1-9f70-4adf-b30a-20d0b6f73674_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0acdc8e1-9f70-4adf-b30a-20d0b6f73674" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0acdc8e1-9f70-4adf-b30a-20d0b6f73674_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_1c98c97c-94c4-444e-a252-7938181de1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0acdc8e1-9f70-4adf-b30a-20d0b6f73674" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_1c98c97c-94c4-444e-a252-7938181de1ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_7f8f19c9-29b6-41f3-bc62-e1302f0d81bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1c98c97c-94c4-444e-a252-7938181de1ae" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_7f8f19c9-29b6-41f3-bc62-e1302f0d81bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e016841d-515b-4f35-af0f-56966a86f277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1c98c97c-94c4-444e-a252-7938181de1ae" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e016841d-515b-4f35-af0f-56966a86f277" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_bb89d0c6-3fe2-446f-b10a-7ac08d8cb350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_37beb9b5-4dc5-471a-8032-668f1e7261fb" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_bb89d0c6-3fe2-446f-b10a-7ac08d8cb350" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_bb89d0c6-3fe2-446f-b10a-7ac08d8cb350_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_bb89d0c6-3fe2-446f-b10a-7ac08d8cb350" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_bb89d0c6-3fe2-446f-b10a-7ac08d8cb350_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_d70364e0-7168-4900-ba28-04b7e7f1ef5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_bb89d0c6-3fe2-446f-b10a-7ac08d8cb350" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_d70364e0-7168-4900-ba28-04b7e7f1ef5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_85c86028-8a0d-4906-befa-924d36994652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d70364e0-7168-4900-ba28-04b7e7f1ef5b" xlink:to="loc_us-gaap_EquitySecuritiesMember_85c86028-8a0d-4906-befa-924d36994652" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_0016d978-9dd7-468f-815a-fc6ef56f1ada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d70364e0-7168-4900-ba28-04b7e7f1ef5b" xlink:to="loc_us-gaap_DebtSecuritiesMember_0016d978-9dd7-468f-815a-fc6ef56f1ada" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentMember_48de8a73-272b-47d4-99d0-55a389e642c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d70364e0-7168-4900-ba28-04b7e7f1ef5b" xlink:to="loc_us-gaap_RealEstateInvestmentMember_48de8a73-272b-47d4-99d0-55a389e642c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_ce247c52-700f-4dd1-9a14-e07390fd60cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d70364e0-7168-4900-ba28-04b7e7f1ef5b" xlink:to="loc_us-gaap_PrivateEquityFundsMember_ce247c52-700f-4dd1-9a14-e07390fd60cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_cbca853f-1dd0-45eb-b1e4-dc8255b819c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d70364e0-7168-4900-ba28-04b7e7f1ef5b" xlink:to="loc_us-gaap_HedgeFundsMember_cbca853f-1dd0-45eb-b1e4-dc8255b819c6" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="extended" id="i334a4a9f2f30428a97ece5b20f94335c_PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_365fc468-a1a1-409a-8125-357130cff67e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_692c0caa-eb69-48f8-9c7e-5a4c282c9364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_365fc468-a1a1-409a-8125-357130cff67e" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_692c0caa-eb69-48f8-9c7e-5a4c282c9364" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_c852f86b-62c2-40b9-9d0f-bb44fd492dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_692c0caa-eb69-48f8-9c7e-5a4c282c9364" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_c852f86b-62c2-40b9-9d0f-bb44fd492dc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_8948fcce-1d42-4615-81c7-6dd8d4bc2a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_692c0caa-eb69-48f8-9c7e-5a4c282c9364" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_8948fcce-1d42-4615-81c7-6dd8d4bc2a5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_d57e587b-d037-4c70-9f31-f062daafed67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_692c0caa-eb69-48f8-9c7e-5a4c282c9364" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_d57e587b-d037-4c70-9f31-f062daafed67" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_6fce5a06-574d-4b05-8d6a-2e9c17791036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_692c0caa-eb69-48f8-9c7e-5a4c282c9364" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_6fce5a06-574d-4b05-8d6a-2e9c17791036" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_9a56d630-0ecd-438d-b6d2-6295d128e37f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_692c0caa-eb69-48f8-9c7e-5a4c282c9364" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_9a56d630-0ecd-438d-b6d2-6295d128e37f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_d04d840b-1197-45a7-b32a-f93be1c08c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a0a9ebfc-e12a-4f95-9e9c-6c0c5fa24d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_365fc468-a1a1-409a-8125-357130cff67e" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a0a9ebfc-e12a-4f95-9e9c-6c0c5fa24d3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_02871789-c1b5-43b4-a84f-91da59f4e5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a0a9ebfc-e12a-4f95-9e9c-6c0c5fa24d3b" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_02871789-c1b5-43b4-a84f-91da59f4e5eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_fd42bfd5-1a92-4668-a28e-f70dc39285fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a0a9ebfc-e12a-4f95-9e9c-6c0c5fa24d3b" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_fd42bfd5-1a92-4668-a28e-f70dc39285fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_4aaec5b3-2145-4494-ba6c-ace251c98195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a0a9ebfc-e12a-4f95-9e9c-6c0c5fa24d3b" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_4aaec5b3-2145-4494-ba6c-ace251c98195" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_67a4dc6c-db64-41a4-8e47-8bc681658ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a0a9ebfc-e12a-4f95-9e9c-6c0c5fa24d3b" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_67a4dc6c-db64-41a4-8e47-8bc681658ab8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_8fc0f667-5f68-4ba8-bf4f-da478d00d8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a0a9ebfc-e12a-4f95-9e9c-6c0c5fa24d3b" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_8fc0f667-5f68-4ba8-bf4f-da478d00d8a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c72896a2-a12b-41db-a692-b41f22b356e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_e7bc97e3-29f0-4b60-b0db-c3545d56d45f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_365fc468-a1a1-409a-8125-357130cff67e" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_e7bc97e3-29f0-4b60-b0db-c3545d56d45f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_835162c2-8c64-462a-b898-fb25d3e5b161" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_365fc468-a1a1-409a-8125-357130cff67e" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_835162c2-8c64-462a-b898-fb25d3e5b161" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_9f42b758-1d05-4259-8f57-2658e5ea8a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_835162c2-8c64-462a-b898-fb25d3e5b161" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_9f42b758-1d05-4259-8f57-2658e5ea8a99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_68a60b1c-8cc6-454c-9fed-b8cb7aa2326c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_835162c2-8c64-462a-b898-fb25d3e5b161" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_68a60b1c-8cc6-454c-9fed-b8cb7aa2326c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_e2547da9-564a-4c0f-98d0-e3ae5b2fffda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_835162c2-8c64-462a-b898-fb25d3e5b161" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_e2547da9-564a-4c0f-98d0-e3ae5b2fffda" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_98468a98-bbc7-4a48-9be2-e8b2a4311d51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_835162c2-8c64-462a-b898-fb25d3e5b161" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_98468a98-bbc7-4a48-9be2-e8b2a4311d51" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ef7996f0-9266-444e-bd3f-15802e073556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_365fc468-a1a1-409a-8125-357130cff67e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ef7996f0-9266-444e-bd3f-15802e073556" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_657ad008-feaa-48f6-8207-05b08df8e3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ef7996f0-9266-444e-bd3f-15802e073556" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_657ad008-feaa-48f6-8207-05b08df8e3dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_657ad008-feaa-48f6-8207-05b08df8e3dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_657ad008-feaa-48f6-8207-05b08df8e3dd" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_657ad008-feaa-48f6-8207-05b08df8e3dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_316e50ec-033f-41d6-a5ed-8cde993bde14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_657ad008-feaa-48f6-8207-05b08df8e3dd" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_316e50ec-033f-41d6-a5ed-8cde993bde14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_422a54f4-0acd-4b91-9af0-b6d7829542a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_316e50ec-033f-41d6-a5ed-8cde993bde14" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_422a54f4-0acd-4b91-9af0-b6d7829542a0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="extended" id="i75e73972ad444666a79bc2819bfdc154_PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7e68f60a-2147-411e-a09a-3adb27c478b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_99b53265-3874-422f-ba00-1b3f4c38f545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7e68f60a-2147-411e-a09a-3adb27c478b7" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_99b53265-3874-422f-ba00-1b3f4c38f545" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_1a651002-cd16-46b4-b67f-362399c19a76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_99b53265-3874-422f-ba00-1b3f4c38f545" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_1a651002-cd16-46b4-b67f-362399c19a76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_d8e39575-6734-4459-8461-c09f1524464e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_99b53265-3874-422f-ba00-1b3f4c38f545" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_d8e39575-6734-4459-8461-c09f1524464e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_a3a8aa92-6c88-45d6-9ffe-7ffb1d93a461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_99b53265-3874-422f-ba00-1b3f4c38f545" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_a3a8aa92-6c88-45d6-9ffe-7ffb1d93a461" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_fb5a7757-e1f7-4740-9def-3a415a20a62e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_99b53265-3874-422f-ba00-1b3f4c38f545" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_fb5a7757-e1f7-4740-9def-3a415a20a62e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1970ce87-7d1b-4f80-b1ff-6336b8819160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_99b53265-3874-422f-ba00-1b3f4c38f545" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1970ce87-7d1b-4f80-b1ff-6336b8819160" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4ffae4f9-f216-407a-87a4-7ff68b559cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7e68f60a-2147-411e-a09a-3adb27c478b7" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4ffae4f9-f216-407a-87a4-7ff68b559cbe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_50c5f1c4-b226-4d4b-8b53-67250cb282a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4ffae4f9-f216-407a-87a4-7ff68b559cbe" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_50c5f1c4-b226-4d4b-8b53-67250cb282a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_50c5f1c4-b226-4d4b-8b53-67250cb282a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_50c5f1c4-b226-4d4b-8b53-67250cb282a1" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_50c5f1c4-b226-4d4b-8b53-67250cb282a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_ace0212e-8a7a-4745-a28f-6330504906a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_50c5f1c4-b226-4d4b-8b53-67250cb282a1" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_ace0212e-8a7a-4745-a28f-6330504906a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_2a372908-72cc-4999-af5e-c1262e606697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_ace0212e-8a7a-4745-a28f-6330504906a2" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_2a372908-72cc-4999-af5e-c1262e606697" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails" xlink:type="extended" id="ief24c3aa1eed4f5aad7d48adf5dcb047_PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdf02ca6-5306-4387-a25c-97fbfa67ec74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5b9cc3a1-dcd5-41ed-87ef-ebff09542f09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdf02ca6-5306-4387-a25c-97fbfa67ec74" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5b9cc3a1-dcd5-41ed-87ef-ebff09542f09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_a5b3653d-258e-44d2-8be2-5466dacfc73a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdf02ca6-5306-4387-a25c-97fbfa67ec74" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_a5b3653d-258e-44d2-8be2-5466dacfc73a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce7f508c-b692-4fde-98d3-efd92152d927" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdf02ca6-5306-4387-a25c-97fbfa67ec74" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce7f508c-b692-4fde-98d3-efd92152d927" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d8d97187-a356-4e9e-854d-73a878bdf18d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce7f508c-b692-4fde-98d3-efd92152d927" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d8d97187-a356-4e9e-854d-73a878bdf18d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d8d97187-a356-4e9e-854d-73a878bdf18d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d8d97187-a356-4e9e-854d-73a878bdf18d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d8d97187-a356-4e9e-854d-73a878bdf18d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0a6ed53d-76b7-49d8-bc81-8c7834ea1bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d8d97187-a356-4e9e-854d-73a878bdf18d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0a6ed53d-76b7-49d8-bc81-8c7834ea1bb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_ff9edbc5-7533-43a2-be78-11a84c430d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0a6ed53d-76b7-49d8-bc81-8c7834ea1bb5" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_ff9edbc5-7533-43a2-be78-11a84c430d50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c24ae6a4-28d8-4032-8419-f13aa8abe47b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce7f508c-b692-4fde-98d3-efd92152d927" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c24ae6a4-28d8-4032-8419-f13aa8abe47b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_c24ae6a4-28d8-4032-8419-f13aa8abe47b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c24ae6a4-28d8-4032-8419-f13aa8abe47b" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_c24ae6a4-28d8-4032-8419-f13aa8abe47b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c24ae6a4-28d8-4032-8419-f13aa8abe47b" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_78aa509f-7825-40b3-9b77-17e549f52450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_78aa509f-7825-40b3-9b77-17e549f52450" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_d2045212-e2d4-4823-8fdc-313e3fed0c10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_d2045212-e2d4-4823-8fdc-313e3fed0c10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_5b9ed084-9c2d-464a-9d5e-ddce55914266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_5b9ed084-9c2d-464a-9d5e-ddce55914266" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_d119fdcf-cdaf-48ec-a3c3-b4e28af69f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_d119fdcf-cdaf-48ec-a3c3-b4e28af69f3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_c3f3f893-19ba-4a59-a5e2-85ccd8d82b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_c3f3f893-19ba-4a59-a5e2-85ccd8d82b40" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_f2f255af-42a5-48d1-8094-239c2a7ae149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_f2f255af-42a5-48d1-8094-239c2a7ae149" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6912bd31-fd8e-4176-bca7-1eaf386e208c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6912bd31-fd8e-4176-bca7-1eaf386e208c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_43005806-a35d-4144-874a-ff859345eab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_43005806-a35d-4144-874a-ff859345eab7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RedeemablePreferredSecuritiesMember_d7da209d-7390-4bb8-a2e6-7890dc1a7c67" xlink:href="cvs-20211231.xsd#cvs_RedeemablePreferredSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:to="loc_cvs_RedeemablePreferredSecuritiesMember_d7da209d-7390-4bb8-a2e6-7890dc1a7c67" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_04fd3925-f76e-42de-93e2-4d38ee69616b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_us-gaap_EquitySecuritiesMember_04fd3925-f76e-42de-93e2-4d38ee69616b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_20759707-2a3e-4d40-b6f8-b34868cbe068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesMember_04fd3925-f76e-42de-93e2-4d38ee69616b" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_20759707-2a3e-4d40-b6f8-b34868cbe068" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_3f0f193e-bda5-4ecb-b542-afe1f83cc103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesMember_04fd3925-f76e-42de-93e2-4d38ee69616b" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_3f0f193e-bda5-4ecb-b542-afe1f83cc103" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EquitySecuritiesDomesticRealEstateMember_56cf62e2-e799-4e7a-a3b2-54d162f7595a" xlink:href="cvs-20211231.xsd#cvs_EquitySecuritiesDomesticRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquitySecuritiesMember_04fd3925-f76e-42de-93e2-4d38ee69616b" xlink:to="loc_cvs_EquitySecuritiesDomesticRealEstateMember_56cf62e2-e799-4e7a-a3b2-54d162f7595a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_b4d3a47c-352a-4ac8-a270-fbd98796ab09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_us-gaap_OtherInvestmentsMember_b4d3a47c-352a-4ac8-a270-fbd98796ab09" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember_fd3d2ed0-e61e-4c37-a8a5-1751297a08d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentsMember_b4d3a47c-352a-4ac8-a270-fbd98796ab09" xlink:to="loc_us-gaap_DefinedBenefitPlanRealEstateMember_fd3d2ed0-e61e-4c37-a8a5-1751297a08d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_74ae36fa-a746-4be2-8aef-80a9b9d6a600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentsMember_b4d3a47c-352a-4ac8-a270-fbd98796ab09" xlink:to="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_74ae36fa-a746-4be2-8aef-80a9b9d6a600" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDerivativeMember_0a56baf8-6f49-41da-9bcb-01dcbc04d2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDerivativeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentsMember_b4d3a47c-352a-4ac8-a270-fbd98796ab09" xlink:to="loc_us-gaap_DefinedBenefitPlanDerivativeMember_0a56baf8-6f49-41da-9bcb-01dcbc04d2d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_80c34b0f-6237-4c1d-b9aa-275276ec98f1" xlink:href="cvs-20211231.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_80c34b0f-6237-4c1d-b9aa-275276ec98f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_4f6e4f3a-8f02-451a-943d-e32cf2c7d4a4" xlink:href="cvs-20211231.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_4f6e4f3a-8f02-451a-943d-e32cf2c7d4a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_e4227faf-5b79-48f0-909c-f527aa37ad3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_us-gaap_PrivateEquityFundsMember_e4227faf-5b79-48f0-909c-f527aa37ad3c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_60a7c10d-cd15-4ddd-855a-f19e62f3d039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_us-gaap_HedgeFundsMember_60a7c10d-cd15-4ddd-855a-f19e62f3d039" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_8eff31ad-b489-4ed6-9304-f2769e448831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_us-gaap_AccountsReceivableMember_8eff31ad-b489-4ed6-9304-f2769e448831" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f4d2ad0f-711d-466a-b3d7-6ba6978f9cab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce7f508c-b692-4fde-98d3-efd92152d927" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f4d2ad0f-711d-466a-b3d7-6ba6978f9cab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f4d2ad0f-711d-466a-b3d7-6ba6978f9cab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f4d2ad0f-711d-466a-b3d7-6ba6978f9cab" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f4d2ad0f-711d-466a-b3d7-6ba6978f9cab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d00ca0d-e1b1-4c70-aa5a-1014dcfae844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f4d2ad0f-711d-466a-b3d7-6ba6978f9cab" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d00ca0d-e1b1-4c70-aa5a-1014dcfae844" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_05285b04-fe8f-4a39-adcf-92c36a964b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d00ca0d-e1b1-4c70-aa5a-1014dcfae844" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_05285b04-fe8f-4a39-adcf-92c36a964b8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_866b6653-e034-45a8-9ddc-9737698ec83c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d00ca0d-e1b1-4c70-aa5a-1014dcfae844" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_866b6653-e034-45a8-9ddc-9737698ec83c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b849082f-6ce8-48b6-9068-0361013e4a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d00ca0d-e1b1-4c70-aa5a-1014dcfae844" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b849082f-6ce8-48b6-9068-0361013e4a2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_dab3cb66-f101-4558-8f82-b6a0d115a3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d00ca0d-e1b1-4c70-aa5a-1014dcfae844" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_dab3cb66-f101-4558-8f82-b6a0d115a3b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_400483f9-6d1b-4c1e-b74d-510661f8c165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d00ca0d-e1b1-4c70-aa5a-1014dcfae844" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_400483f9-6d1b-4c1e-b74d-510661f8c165" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails" xlink:type="extended" id="i06e79fdc0d634a11b6446bdd58068d83_PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7f572a8c-9093-440d-8a64-2f7cdab8ff8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7e38c20d-babc-4663-a685-d2baeb07626d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7f572a8c-9093-440d-8a64-2f7cdab8ff8d" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7e38c20d-babc-4663-a685-d2baeb07626d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_167a6be2-cc70-439b-93ba-45a96b650d25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7e38c20d-babc-4663-a685-d2baeb07626d" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_167a6be2-cc70-439b-93ba-45a96b650d25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_7aa4bc95-2d7d-447d-8f5d-3aa79e6e31c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7e38c20d-babc-4663-a685-d2baeb07626d" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_7aa4bc95-2d7d-447d-8f5d-3aa79e6e31c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_f9d06efb-3e75-4043-97ee-dd73777cd66d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7e38c20d-babc-4663-a685-d2baeb07626d" xlink:to="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_f9d06efb-3e75-4043-97ee-dd73777cd66d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_b070766e-6981-43c7-8f93-7990fec6f4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7e38c20d-babc-4663-a685-d2baeb07626d" xlink:to="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_b070766e-6981-43c7-8f93-7990fec6f4e9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_258c2d6e-91cc-4b74-8d93-93fa3bbbb6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8b814554-3f53-4279-9a16-5d52f105986b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7f572a8c-9093-440d-8a64-2f7cdab8ff8d" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8b814554-3f53-4279-9a16-5d52f105986b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d4e41bbc-4cc6-4a8d-8dc5-dc1096958dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8b814554-3f53-4279-9a16-5d52f105986b" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d4e41bbc-4cc6-4a8d-8dc5-dc1096958dd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_d4e41bbc-4cc6-4a8d-8dc5-dc1096958dd6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d4e41bbc-4cc6-4a8d-8dc5-dc1096958dd6" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_d4e41bbc-4cc6-4a8d-8dc5-dc1096958dd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_0425e3f7-c51f-49d8-ac58-56493a941edc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d4e41bbc-4cc6-4a8d-8dc5-dc1096958dd6" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_0425e3f7-c51f-49d8-ac58-56493a941edc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember_af59a298-7b06-4e0e-b180-ce3eae15d47d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0425e3f7-c51f-49d8-ac58-56493a941edc" xlink:to="loc_us-gaap_DefinedBenefitPlanRealEstateMember_af59a298-7b06-4e0e-b180-ce3eae15d47d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_24e34895-d91d-4f41-b718-b6c3988c6c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0425e3f7-c51f-49d8-ac58-56493a941edc" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_24e34895-d91d-4f41-b718-b6c3988c6c6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37fb479a-2e20-4f75-bed4-645ca5648227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8b814554-3f53-4279-9a16-5d52f105986b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37fb479a-2e20-4f75-bed4-645ca5648227" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_37fb479a-2e20-4f75-bed4-645ca5648227_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37fb479a-2e20-4f75-bed4-645ca5648227" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_37fb479a-2e20-4f75-bed4-645ca5648227_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88cfce68-5f80-4979-b9b5-f07b2da092e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37fb479a-2e20-4f75-bed4-645ca5648227" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88cfce68-5f80-4979-b9b5-f07b2da092e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_665dcd00-2239-4b25-918b-957d29923238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88cfce68-5f80-4979-b9b5-f07b2da092e1" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_665dcd00-2239-4b25-918b-957d29923238" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_7d6692b7-eebd-48e1-821c-096f47c3989f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8b814554-3f53-4279-9a16-5d52f105986b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_7d6692b7-eebd-48e1-821c-096f47c3989f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_7d6692b7-eebd-48e1-821c-096f47c3989f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_7d6692b7-eebd-48e1-821c-096f47c3989f" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_7d6692b7-eebd-48e1-821c-096f47c3989f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_29ea8122-441e-4d67-ad77-1ab92a9a3ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_7d6692b7-eebd-48e1-821c-096f47c3989f" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_29ea8122-441e-4d67-ad77-1ab92a9a3ff9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_2405e2aa-c171-4302-8953-fac7f1cb9042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_29ea8122-441e-4d67-ad77-1ab92a9a3ff9" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_2405e2aa-c171-4302-8953-fac7f1cb9042" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails" xlink:type="extended" id="ifb41fde51c1540e394feed02d77eb6f0_PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1826cfa2-3ada-4ca6-8296-2d4ff1d406f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_a2c61293-0779-49c6-8075-1815d44a542a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1826cfa2-3ada-4ca6-8296-2d4ff1d406f3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_a2c61293-0779-49c6-8075-1815d44a542a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_0c997312-0ddc-4533-abbe-14a8c25b8476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1826cfa2-3ada-4ca6-8296-2d4ff1d406f3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_0c997312-0ddc-4533-abbe-14a8c25b8476" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_d04ed668-4a7d-4e7d-9f7b-1356dcc64808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1826cfa2-3ada-4ca6-8296-2d4ff1d406f3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_d04ed668-4a7d-4e7d-9f7b-1356dcc64808" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_6e320e80-6c34-4f5c-a610-54f79919485a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1826cfa2-3ada-4ca6-8296-2d4ff1d406f3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_6e320e80-6c34-4f5c-a610-54f79919485a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_e6b45e25-26ce-47e7-8a33-e48f519f6ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1826cfa2-3ada-4ca6-8296-2d4ff1d406f3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_e6b45e25-26ce-47e7-8a33-e48f519f6ba9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_2c90c0ac-6588-490c-a53f-a43bc6dab713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1826cfa2-3ada-4ca6-8296-2d4ff1d406f3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_2c90c0ac-6588-490c-a53f-a43bc6dab713" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f7fef02c-8be1-4332-a0c6-b6f1bef6fc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1826cfa2-3ada-4ca6-8296-2d4ff1d406f3" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f7fef02c-8be1-4332-a0c6-b6f1bef6fc6a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a1653802-2a80-45f6-9480-2d1468ac7108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f7fef02c-8be1-4332-a0c6-b6f1bef6fc6a" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a1653802-2a80-45f6-9480-2d1468ac7108" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_a1653802-2a80-45f6-9480-2d1468ac7108_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a1653802-2a80-45f6-9480-2d1468ac7108" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_a1653802-2a80-45f6-9480-2d1468ac7108_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d2e17f24-64b2-4f28-ac10-1ecfb88c90d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a1653802-2a80-45f6-9480-2d1468ac7108" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d2e17f24-64b2-4f28-ac10-1ecfb88c90d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_1b774f61-94f8-49cb-9b66-22f9126c316e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_d2e17f24-64b2-4f28-ac10-1ecfb88c90d3" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_1b774f61-94f8-49cb-9b66-22f9126c316e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_be68e1a6-0c52-4765-9366-714c97fa5d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_d2e17f24-64b2-4f28-ac10-1ecfb88c90d3" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_be68e1a6-0c52-4765-9366-714c97fa5d72" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails" xlink:type="extended" id="if6b95b6f2c6447c49849a2d372931c09_StockIncentivePlansStockBasedCompensationExpenseandESPPDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ae4fc267-b0ad-4ae5-a95b-689729860690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ae4fc267-b0ad-4ae5-a95b-689729860690" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_34165bc1-1a72-43f8-b848-18e44b242dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_34165bc1-1a72-43f8-b848-18e44b242dc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f15c47d8-0694-4d07-8513-912e8682208c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f15c47d8-0694-4d07-8513-912e8682208c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_61f6c05e-0044-4e51-8fe3-accb5f22fccb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_61f6c05e-0044-4e51-8fe3-accb5f22fccb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_105c1b7f-b264-45d9-b06d-36d58a5d48a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_105c1b7f-b264-45d9-b06d-36d58a5d48a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_3057929b-82ea-44e6-9a96-480cd7e9426e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_3057929b-82ea-44e6-9a96-480cd7e9426e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7d1797ea-4a16-4224-9de7-7ab40db2a93f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7d1797ea-4a16-4224-9de7-7ab40db2a93f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_102fe7c8-f749-4725-b84f-2505ba004080" xlink:href="cvs-20211231.xsd#cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_102fe7c8-f749-4725-b84f-2505ba004080" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_b8c16b65-d158-49a1-aa06-40c55bdd7816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_b8c16b65-d158-49a1-aa06-40c55bdd7816" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8ccfb6f7-4d54-4c98-bfd7-9616a7f6f520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8ccfb6f7-4d54-4c98-bfd7-9616a7f6f520" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0cb077c9-a128-42e3-a8e0-ffaf285585e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0cb077c9-a128-42e3-a8e0-ffaf285585e9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_590c8316-c49a-4ac7-b72b-12a7b6ede87e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_590c8316-c49a-4ac7-b72b-12a7b6ede87e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_4e26101f-6b60-45fd-98c1-09faab64c1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_4e26101f-6b60-45fd-98c1-09faab64c1ef" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber_9aa5ca6a-b96b-49c1-a0bb-fca8678834c7" xlink:href="cvs-20211231.xsd#cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber_9aa5ca6a-b96b-49c1-a0bb-fca8678834c7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f16b594a-7033-4436-a87f-dc6d5bb40140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f16b594a-7033-4436-a87f-dc6d5bb40140" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1a2b006e-1df7-4387-b332-825b4599b88c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f16b594a-7033-4436-a87f-dc6d5bb40140" xlink:to="loc_us-gaap_PlanNameAxis_1a2b006e-1df7-4387-b332-825b4599b88c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1a2b006e-1df7-4387-b332-825b4599b88c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_1a2b006e-1df7-4387-b332-825b4599b88c" xlink:to="loc_us-gaap_PlanNameDomain_1a2b006e-1df7-4387-b332-825b4599b88c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5ec5f3b8-aab5-46ce-a2c1-e9d404cee02c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_1a2b006e-1df7-4387-b332-825b4599b88c" xlink:to="loc_us-gaap_PlanNameDomain_5ec5f3b8-aab5-46ce-a2c1-e9d404cee02c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember_c5a2869f-c4db-4ef4-aaaa-e97e971672a8" xlink:href="cvs-20211231.xsd#cvs_CVSHealth2017IncentiveCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_5ec5f3b8-aab5-46ce-a2c1-e9d404cee02c" xlink:to="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember_c5a2869f-c4db-4ef4-aaaa-e97e971672a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc2010StockIncentivePlanMember_e7ebe55b-10a3-463f-b8b9-83a79301246a" xlink:href="cvs-20211231.xsd#cvs_AetnaInc2010StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_5ec5f3b8-aab5-46ce-a2c1-e9d404cee02c" xlink:to="loc_cvs_AetnaInc2010StockIncentivePlanMember_e7ebe55b-10a3-463f-b8b9-83a79301246a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e63fef4b-92be-4c52-b387-e55e40f9894a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f16b594a-7033-4436-a87f-dc6d5bb40140" xlink:to="loc_srt_RangeAxis_e63fef4b-92be-4c52-b387-e55e40f9894a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e63fef4b-92be-4c52-b387-e55e40f9894a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e63fef4b-92be-4c52-b387-e55e40f9894a" xlink:to="loc_srt_RangeMember_e63fef4b-92be-4c52-b387-e55e40f9894a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8c375166-3a2c-40e2-9a99-c4041f2724f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e63fef4b-92be-4c52-b387-e55e40f9894a" xlink:to="loc_srt_RangeMember_8c375166-3a2c-40e2-9a99-c4041f2724f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6cc38335-29ee-4e84-aab8-42695a72333a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8c375166-3a2c-40e2-9a99-c4041f2724f1" xlink:to="loc_srt_MinimumMember_6cc38335-29ee-4e84-aab8-42695a72333a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8af31fe0-1ac5-47f4-99b4-bcc8afa33220" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8c375166-3a2c-40e2-9a99-c4041f2724f1" xlink:to="loc_srt_MaximumMember_8af31fe0-1ac5-47f4-99b4-bcc8afa33220" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f196500a-28e2-4eb0-932e-8e93fd54b7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f16b594a-7033-4436-a87f-dc6d5bb40140" xlink:to="loc_us-gaap_AwardTypeAxis_f196500a-28e2-4eb0-932e-8e93fd54b7b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f196500a-28e2-4eb0-932e-8e93fd54b7b0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f196500a-28e2-4eb0-932e-8e93fd54b7b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f196500a-28e2-4eb0-932e-8e93fd54b7b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7010c31-6095-4d90-889e-2ca4d56b051d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f196500a-28e2-4eb0-932e-8e93fd54b7b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7010c31-6095-4d90-889e-2ca4d56b051d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_12aa7bc4-c878-464b-a7ab-6c4d65190efe" xlink:href="cvs-20211231.xsd#cvs_EmployeeStockOptionsandStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7010c31-6095-4d90-889e-2ca4d56b051d" xlink:to="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_12aa7bc4-c878-464b-a7ab-6c4d65190efe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_2219bce7-21e2-478e-a44a-dca83d3383f2" xlink:href="cvs-20211231.xsd#cvs_RestrictedStockUnitsandPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7010c31-6095-4d90-889e-2ca4d56b051d" xlink:to="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_2219bce7-21e2-478e-a44a-dca83d3383f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_8c73edb9-d458-4025-98fc-d2e113db94d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7010c31-6095-4d90-889e-2ca4d56b051d" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_8c73edb9-d458-4025-98fc-d2e113db94d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e5ec4dec-698e-48e7-99ae-f9dbe9ac5fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7010c31-6095-4d90-889e-2ca4d56b051d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e5ec4dec-698e-48e7-99ae-f9dbe9ac5fe3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_c02cdb48-d161-458c-a09b-f98d58bae602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7010c31-6095-4d90-889e-2ca4d56b051d" xlink:to="loc_us-gaap_EmployeeStockMember_c02cdb48-d161-458c-a09b-f98d58bae602" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#StockIncentivePlansValuationandAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails" xlink:type="extended" id="i3f8985fccf974b2a9e40668795c418ba_StockIncentivePlansValuationandAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db3b9772-46e7-48da-9c47-511adea2aeed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c3cf9aa6-4f1d-481a-bc94-481e3a2f7afb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db3b9772-46e7-48da-9c47-511adea2aeed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c3cf9aa6-4f1d-481a-bc94-481e3a2f7afb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_837a4384-cf5d-4fec-b10f-c3645ef769dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db3b9772-46e7-48da-9c47-511adea2aeed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_837a4384-cf5d-4fec-b10f-c3645ef769dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d4b5b42c-4dca-418c-b44b-3611e924ece6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db3b9772-46e7-48da-9c47-511adea2aeed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d4b5b42c-4dca-418c-b44b-3611e924ece6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_777ed994-d3a3-4a44-9295-0cd904587d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db3b9772-46e7-48da-9c47-511adea2aeed" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_777ed994-d3a3-4a44-9295-0cd904587d2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dc7ad3f3-d803-44a2-97f1-a9ad3b39d371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db3b9772-46e7-48da-9c47-511adea2aeed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dc7ad3f3-d803-44a2-97f1-a9ad3b39d371" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3f8a05a8-fc8f-4ebc-a34b-3c564663c031" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db3b9772-46e7-48da-9c47-511adea2aeed" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3f8a05a8-fc8f-4ebc-a34b-3c564663c031" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9d106914-8a1b-4f9b-b356-36b57a466614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3f8a05a8-fc8f-4ebc-a34b-3c564663c031" xlink:to="loc_us-gaap_AwardTypeAxis_9d106914-8a1b-4f9b-b356-36b57a466614" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d106914-8a1b-4f9b-b356-36b57a466614_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9d106914-8a1b-4f9b-b356-36b57a466614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d106914-8a1b-4f9b-b356-36b57a466614_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_255bf4c1-1536-4966-af86-4104ccde321a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9d106914-8a1b-4f9b-b356-36b57a466614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_255bf4c1-1536-4966-af86-4104ccde321a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_33d48d97-8d30-4583-ba53-62f4231e50e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_255bf4c1-1536-4966-af86-4104ccde321a" xlink:to="loc_us-gaap_EmployeeStockMember_33d48d97-8d30-4583-ba53-62f4231e50e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_a9a21f6a-1351-47d5-85ae-6d848290ea87" xlink:href="cvs-20211231.xsd#cvs_EmployeeStockOptionsandStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_255bf4c1-1536-4966-af86-4104ccde321a" xlink:to="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_a9a21f6a-1351-47d5-85ae-6d848290ea87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2d187daf-8980-428f-b6e9-ce98ee14eb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_255bf4c1-1536-4966-af86-4104ccde321a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2d187daf-8980-428f-b6e9-ce98ee14eb5e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#StockIncentivePlansRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails" xlink:type="extended" id="ibe3500805a814b5eb86ba272db7b636a_StockIncentivePlansRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80e450d9-b636-4c60-9f3e-000c011252ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26352bf8-60a7-4889-a698-5a95f8c22b58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80e450d9-b636-4c60-9f3e-000c011252ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26352bf8-60a7-4889-a698-5a95f8c22b58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_39e80692-4ce0-47bf-93af-56632fa35055" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26352bf8-60a7-4889-a698-5a95f8c22b58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_39e80692-4ce0-47bf-93af-56632fa35055" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ce46c891-6882-4709-bb4d-2011b5678f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26352bf8-60a7-4889-a698-5a95f8c22b58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ce46c891-6882-4709-bb4d-2011b5678f87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_87c89057-1fa4-46af-bc68-537296c9d26c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26352bf8-60a7-4889-a698-5a95f8c22b58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_87c89057-1fa4-46af-bc68-537296c9d26c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d58c7f3d-9f49-46e5-b4fc-25ed0aea3507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26352bf8-60a7-4889-a698-5a95f8c22b58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d58c7f3d-9f49-46e5-b4fc-25ed0aea3507" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_fb2f698f-164b-4467-8099-bf895fb15865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91e0d106-eae8-4dcb-ae60-b82707dcb607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80e450d9-b636-4c60-9f3e-000c011252ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91e0d106-eae8-4dcb-ae60-b82707dcb607" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_afaf1db5-3881-4ace-af6d-52965391d7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91e0d106-eae8-4dcb-ae60-b82707dcb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_afaf1db5-3881-4ace-af6d-52965391d7c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_719fa737-7690-478a-bf32-8b1a09960ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91e0d106-eae8-4dcb-ae60-b82707dcb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_719fa737-7690-478a-bf32-8b1a09960ad0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e2515894-b969-49a3-a6f0-a15aec8776bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91e0d106-eae8-4dcb-ae60-b82707dcb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e2515894-b969-49a3-a6f0-a15aec8776bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_59e2be26-0c4c-4527-b403-ec764994026d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91e0d106-eae8-4dcb-ae60-b82707dcb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_59e2be26-0c4c-4527-b403-ec764994026d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_329bb4fd-01f3-4b42-aa53-68005c235b27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d9e4d0de-307c-485c-8513-2cd8aaee5090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80e450d9-b636-4c60-9f3e-000c011252ad" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d9e4d0de-307c-485c-8513-2cd8aaee5090" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9d541f69-ee0e-4630-b2f6-58e5f4330e94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d9e4d0de-307c-485c-8513-2cd8aaee5090" xlink:to="loc_us-gaap_AwardTypeAxis_9d541f69-ee0e-4630-b2f6-58e5f4330e94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d541f69-ee0e-4630-b2f6-58e5f4330e94_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9d541f69-ee0e-4630-b2f6-58e5f4330e94" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d541f69-ee0e-4630-b2f6-58e5f4330e94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ba8bd0e3-d076-4702-8ea6-0ce36ef839fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9d541f69-ee0e-4630-b2f6-58e5f4330e94" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ba8bd0e3-d076-4702-8ea6-0ce36ef839fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_67d4985e-1114-482c-809d-9881ec939e7d" xlink:href="cvs-20211231.xsd#cvs_RestrictedStockUnitsandPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ba8bd0e3-d076-4702-8ea6-0ce36ef839fd" xlink:to="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_67d4985e-1114-482c-809d-9881ec939e7d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#StockIncentivePlansStockOptionandSARActivityDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails" xlink:type="extended" id="i89b67e15851b4742b778bbe4c6317e9d_StockIncentivePlansStockOptionandSARActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_996c4389-702b-4ef6-bca4-aa21ad6a46b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_996c4389-702b-4ef6-bca4-aa21ad6a46b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_aa222027-8df7-4c0c-8a38-53091b4dd119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_aa222027-8df7-4c0c-8a38-53091b4dd119" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9b47b1d3-ef2a-46a4-b47c-8826c857e8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9b47b1d3-ef2a-46a4-b47c-8826c857e8f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_87c5fec2-b502-47d0-8160-c7818c772ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_87c5fec2-b502-47d0-8160-c7818c772ee0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_dc2b98c0-9569-42eb-9dec-f4c9ceb34dfa" xlink:href="cvs-20211231.xsd#cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:to="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_dc2b98c0-9569-42eb-9dec-f4c9ceb34dfa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a954362e-10d4-4f7a-b15b-3f55eb518a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a954362e-10d4-4f7a-b15b-3f55eb518a4c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c2eaf947-b251-414e-8eed-e5bbd50a2040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a954362e-10d4-4f7a-b15b-3f55eb518a4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c2eaf947-b251-414e-8eed-e5bbd50a2040" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e4202ba9-e4a0-4ee6-92e2-64fa493968b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a954362e-10d4-4f7a-b15b-3f55eb518a4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e4202ba9-e4a0-4ee6-92e2-64fa493968b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6fffe567-b5a4-40e0-b72a-b93cbb1b676c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a954362e-10d4-4f7a-b15b-3f55eb518a4c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6fffe567-b5a4-40e0-b72a-b93cbb1b676c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_cbe7a7a7-f221-46ef-9ca2-16ee029332ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a954362e-10d4-4f7a-b15b-3f55eb518a4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_cbe7a7a7-f221-46ef-9ca2-16ee029332ac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_86e8e5c5-896e-4eb9-b64f-dbb3e16a40f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a954362e-10d4-4f7a-b15b-3f55eb518a4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_86e8e5c5-896e-4eb9-b64f-dbb3e16a40f8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f6266cfb-f47b-45a6-83c4-71888ade20e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_70b9f78f-2326-4dc1-8236-dc0102ad78de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_70b9f78f-2326-4dc1-8236-dc0102ad78de" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_03187ead-9c96-4cbc-be0c-1673ff405b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_70b9f78f-2326-4dc1-8236-dc0102ad78de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_03187ead-9c96-4cbc-be0c-1673ff405b4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_79267af5-82e6-4510-9287-a7d1444e5651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_70b9f78f-2326-4dc1-8236-dc0102ad78de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_79267af5-82e6-4510-9287-a7d1444e5651" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_674f7670-fac9-41be-83d9-1d9ec3cf66d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_70b9f78f-2326-4dc1-8236-dc0102ad78de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_674f7670-fac9-41be-83d9-1d9ec3cf66d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_fa83be31-c8d7-48d9-97fd-61a32d2a6760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_70b9f78f-2326-4dc1-8236-dc0102ad78de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_fa83be31-c8d7-48d9-97fd-61a32d2a6760" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_e67ae4e4-2741-495b-8beb-b566ba6e9f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_70b9f78f-2326-4dc1-8236-dc0102ad78de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_e67ae4e4-2741-495b-8beb-b566ba6e9f29" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_afca2c97-e0e3-4e0d-b4be-1873080e313c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5deb2272-73b4-4cad-90ec-4ddca9052a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5deb2272-73b4-4cad-90ec-4ddca9052a9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_17416df6-b36d-4f9c-b957-161331a795e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_17416df6-b36d-4f9c-b957-161331a795e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1d87a590-d33b-4810-ae19-e48021980cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1d87a590-d33b-4810-ae19-e48021980cc2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_bba9ac79-7492-4fdd-81ba-8dd0a2d9631e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_bba9ac79-7492-4fdd-81ba-8dd0a2d9631e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_18f3a077-7f72-4ddf-8d79-44ac0916ad73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_18f3a077-7f72-4ddf-8d79-44ac0916ad73" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9585eb28-80f9-4784-9889-19b82d77ad83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9585eb28-80f9-4784-9889-19b82d77ad83" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_bf231ca1-9ff2-4148-9ce9-2ec9e87a5bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_bf231ca1-9ff2-4148-9ce9-2ec9e87a5bc1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_17a0036d-9ea3-48da-ba42-5ef5dcf95bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_17a0036d-9ea3-48da-ba42-5ef5dcf95bb9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_b7a3f967-a816-4a97-9152-cdf4ebd2c739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_b7a3f967-a816-4a97-9152-cdf4ebd2c739" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_66ec4d77-f505-4ed6-bea5-f694b7c7daae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_66ec4d77-f505-4ed6-bea5-f694b7c7daae" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98d517d2-3de0-4e5f-8dfc-cbb089d74049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98d517d2-3de0-4e5f-8dfc-cbb089d74049" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1d5137cf-5e8c-4007-ae49-219fe85ed9c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98d517d2-3de0-4e5f-8dfc-cbb089d74049" xlink:to="loc_us-gaap_AwardTypeAxis_1d5137cf-5e8c-4007-ae49-219fe85ed9c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1d5137cf-5e8c-4007-ae49-219fe85ed9c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1d5137cf-5e8c-4007-ae49-219fe85ed9c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1d5137cf-5e8c-4007-ae49-219fe85ed9c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c1e7075f-613e-4d31-8096-6b951b55fbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1d5137cf-5e8c-4007-ae49-219fe85ed9c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c1e7075f-613e-4d31-8096-6b951b55fbb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member_ca03ac8e-d2c2-4272-8bba-b8ef3613b8ef" xlink:href="cvs-20211231.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c1e7075f-613e-4d31-8096-6b951b55fbb5" xlink:to="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member_ca03ac8e-d2c2-4272-8bba-b8ef3613b8ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member_c0ff7d16-06c9-4c07-844e-7a16471d557d" xlink:href="cvs-20211231.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c1e7075f-613e-4d31-8096-6b951b55fbb5" xlink:to="loc_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member_c0ff7d16-06c9-4c07-844e-7a16471d557d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_c2dfdf35-f08d-4e35-92f6-a24983f59561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c1e7075f-613e-4d31-8096-6b951b55fbb5" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_c2dfdf35-f08d-4e35-92f6-a24983f59561" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_5f26ef89-6b67-48a0-80b2-f30c0bd259d3" xlink:href="cvs-20211231.xsd#cvs_EmployeeStockOptionsandStockAppreciationRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c1e7075f-613e-4d31-8096-6b951b55fbb5" xlink:to="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_5f26ef89-6b67-48a0-80b2-f30c0bd259d3" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#ShareholdersEquityShareRepurchasesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="extended" id="ieb3d324523fd4838957df51284fcd047_ShareholdersEquityShareRepurchasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_a5bd4e9f-841a-41f5-ba60-7cf0eb7317de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ff8db252-ffaf-4442-bc77-4568372f34b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_a5bd4e9f-841a-41f5-ba60-7cf0eb7317de" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ff8db252-ffaf-4442-bc77-4568372f34b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_eca9b03b-16a8-4024-8a59-7ecaf728fff3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_a5bd4e9f-841a-41f5-ba60-7cf0eb7317de" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_eca9b03b-16a8-4024-8a59-7ecaf728fff3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_05b7a797-dff5-4bfa-96a7-79ebbf58f1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_a5bd4e9f-841a-41f5-ba60-7cf0eb7317de" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_05b7a797-dff5-4bfa-96a7-79ebbf58f1f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_01a521c4-bb0a-4ad6-8e96-202c523a2216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_05b7a797-dff5-4bfa-96a7-79ebbf58f1f1" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_01a521c4-bb0a-4ad6-8e96-202c523a2216" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_01a521c4-bb0a-4ad6-8e96-202c523a2216_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_01a521c4-bb0a-4ad6-8e96-202c523a2216" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_01a521c4-bb0a-4ad6-8e96-202c523a2216_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_5a45a8e0-7b1d-4323-a153-abcc1171b46f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_01a521c4-bb0a-4ad6-8e96-202c523a2216" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_5a45a8e0-7b1d-4323-a153-abcc1171b46f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021RepurchaseProgramMember_99b74b06-fafb-4cf7-882a-1fbbe832c041" xlink:href="cvs-20211231.xsd#cvs_A2021RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_5a45a8e0-7b1d-4323-a153-abcc1171b46f" xlink:to="loc_cvs_A2021RepurchaseProgramMember_99b74b06-fafb-4cf7-882a-1fbbe832c041" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2016RepurchaseProgramMember_d65cf251-e3da-4a0f-a59e-a881aeab2c8a" xlink:href="cvs-20211231.xsd#cvs_A2016RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_5a45a8e0-7b1d-4323-a153-abcc1171b46f" xlink:to="loc_cvs_A2016RepurchaseProgramMember_d65cf251-e3da-4a0f-a59e-a881aeab2c8a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#ShareholdersEquityAcceleratedShareRepurchasesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails" xlink:type="extended" id="ifae36b708aaf4c3498cfe159495173fc_ShareholdersEquityAcceleratedShareRepurchasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesAgreementAmount_0e68373a-69d5-4a92-9485-fdcf9d55597b" xlink:href="cvs-20211231.xsd#cvs_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:to="loc_cvs_AcceleratedShareRepurchasesAgreementAmount_0e68373a-69d5-4a92-9485-fdcf9d55597b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount_3ae692b2-e777-4c42-806e-910f948a0f9a" xlink:href="cvs-20211231.xsd#cvs_PaymentsForAcceleratedShareRepurchasesAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:to="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount_3ae692b2-e777-4c42-806e-910f948a0f9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_78622b6e-4bf1-47a2-ac50-f51c05b593c7" xlink:href="cvs-20211231.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:to="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_78622b6e-4bf1-47a2-ac50-f51c05b593c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares_055774c9-7378-4b1b-9c39-b45101515904" xlink:href="cvs-20211231.xsd#cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:to="loc_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares_055774c9-7378-4b1b-9c39-b45101515904" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_78786947-e86f-4e58-b406-44649553da1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:to="loc_us-gaap_TreasuryStockCommonShares_78786947-e86f-4e58-b406-44649553da1d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_900a0199-85dc-468f-88a6-7918a3450a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:to="loc_us-gaap_SharePrice_900a0199-85dc-468f-88a6-7918a3450a1f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_33729cfc-fa5a-4f7e-a805-ff1eefd61cff" xlink:href="cvs-20211231.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:to="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_33729cfc-fa5a-4f7e-a805-ff1eefd61cff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_de5e2dd4-d13c-41f1-a8b5-3e76e28dad6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_de5e2dd4-d13c-41f1-a8b5-3e76e28dad6f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_e465f404-b373-4e39-baa8-cc7a3ab6d979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_de5e2dd4-d13c-41f1-a8b5-3e76e28dad6f" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_e465f404-b373-4e39-baa8-cc7a3ab6d979" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_e465f404-b373-4e39-baa8-cc7a3ab6d979_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_e465f404-b373-4e39-baa8-cc7a3ab6d979" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_e465f404-b373-4e39-baa8-cc7a3ab6d979_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_483873ee-676c-493d-a8f2-27c3b86225cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_e465f404-b373-4e39-baa8-cc7a3ab6d979" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_483873ee-676c-493d-a8f2-27c3b86225cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021AcceleratedRepurchaseProgramMember_f0be2bab-0e43-4ee5-8db9-8daea51a71ea" xlink:href="cvs-20211231.xsd#cvs_A2021AcceleratedRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_483873ee-676c-493d-a8f2-27c3b86225cc" xlink:to="loc_cvs_A2021AcceleratedRepurchaseProgramMember_f0be2bab-0e43-4ee5-8db9-8daea51a71ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5f629828-ad98-4e55-9492-fbea25ded2bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_de5e2dd4-d13c-41f1-a8b5-3e76e28dad6f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5f629828-ad98-4e55-9492-fbea25ded2bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5f629828-ad98-4e55-9492-fbea25ded2bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5f629828-ad98-4e55-9492-fbea25ded2bc" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5f629828-ad98-4e55-9492-fbea25ded2bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c6ba16e4-5936-4128-a068-9423dd7721de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5f629828-ad98-4e55-9492-fbea25ded2bc" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c6ba16e4-5936-4128-a068-9423dd7721de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a9c81c06-424e-44c5-ba7a-8fbfa274ef94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c6ba16e4-5936-4128-a068-9423dd7721de" xlink:to="loc_us-gaap_SubsequentEventMember_a9c81c06-424e-44c5-ba7a-8fbfa274ef94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f2c42b37-a3a4-4188-b7b7-0b4da7cae35a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_de5e2dd4-d13c-41f1-a8b5-3e76e28dad6f" xlink:to="loc_srt_CounterpartyNameAxis_f2c42b37-a3a4-4188-b7b7-0b4da7cae35a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f2c42b37-a3a4-4188-b7b7-0b4da7cae35a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_f2c42b37-a3a4-4188-b7b7-0b4da7cae35a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f2c42b37-a3a4-4188-b7b7-0b4da7cae35a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9d7d2dd2-1616-411a-bb57-ed0a38a96dd8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_f2c42b37-a3a4-4188-b7b7-0b4da7cae35a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9d7d2dd2-1616-411a-bb57-ed0a38a96dd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BarclaysBankMember_d1acfbbd-c056-4461-97a9-ef23c14f87c3" xlink:href="cvs-20211231.xsd#cvs_BarclaysBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9d7d2dd2-1616-411a-bb57-ed0a38a96dd8" xlink:to="loc_cvs_BarclaysBankMember_d1acfbbd-c056-4461-97a9-ef23c14f87c3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#ShareholdersEquityDividendsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="extended" id="i58830ba4ddf043a1884db65ac4d61ca7_ShareholdersEquityDividendsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_c302a8e4-f6b2-45d6-bea1-39a04e572909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_c2f7ff45-4865-46cd-936e-5e0b02b48557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_c302a8e4-f6b2-45d6-bea1-39a04e572909" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_c2f7ff45-4865-46cd-936e-5e0b02b48557" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent_7132a327-fa8b-4625-b517-2fec3f7a7c0f" xlink:href="cvs-20211231.xsd#cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DividendsPayableLineItems_c302a8e4-f6b2-45d6-bea1-39a04e572909" xlink:to="loc_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent_7132a327-fa8b-4625-b517-2fec3f7a7c0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_a7588dc0-da3a-4bb1-8262-8aca8c38ead4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DividendsPayableLineItems_c302a8e4-f6b2-45d6-bea1-39a04e572909" xlink:to="loc_us-gaap_DividendsPayableTable_a7588dc0-da3a-4bb1-8262-8aca8c38ead4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_5f724429-d73b-492f-94c0-499b9c62d1bb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DividendsPayableTable_a7588dc0-da3a-4bb1-8262-8aca8c38ead4" xlink:to="loc_srt_StatementScenarioAxis_5f724429-d73b-492f-94c0-499b9c62d1bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_5f724429-d73b-492f-94c0-499b9c62d1bb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_5f724429-d73b-492f-94c0-499b9c62d1bb" xlink:to="loc_srt_ScenarioUnspecifiedDomain_5f724429-d73b-492f-94c0-499b9c62d1bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e948896d-58b9-4ced-9d06-d0d5ca43adec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_5f724429-d73b-492f-94c0-499b9c62d1bb" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e948896d-58b9-4ced-9d06-d0d5ca43adec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_a86fda48-1edf-4c6d-8a79-bdda560014e3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_e948896d-58b9-4ced-9d06-d0d5ca43adec" xlink:to="loc_srt_ScenarioForecastMember_a86fda48-1edf-4c6d-8a79-bdda560014e3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#ShareholdersEquityRegulatoryRequirementsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails" xlink:type="extended" id="i7e1781fe52b74b07a2afe8eaa6394f88_ShareholdersEquityRegulatoryRequirementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesLineItems_ef84e64a-c21a-4797-b4dd-e83065d60267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_b19e98c9-6614-4c8e-a75c-04ce26583eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_ef84e64a-c21a-4797-b4dd-e83065d60267" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_b19e98c9-6614-4c8e-a75c-04ce26583eb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_b5d54e77-4815-4ad3-a006-0b94c6b78884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_ef84e64a-c21a-4797-b4dd-e83065d60267" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_b5d54e77-4815-4ad3-a006-0b94c6b78884" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_79f23de6-bd98-4f3d-8ec1-5494ac059dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_ef84e64a-c21a-4797-b4dd-e83065d60267" xlink:to="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_79f23de6-bd98-4f3d-8ec1-5494ac059dc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_83c0b368-b549-4513-b244-5f552e81c604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_ef84e64a-c21a-4797-b4dd-e83065d60267" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_83c0b368-b549-4513-b244-5f552e81c604" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldByInsuranceRegulators_0c3bc703-6b5b-4ab5-9587-7a0fd34f0b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldByInsuranceRegulators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_ef84e64a-c21a-4797-b4dd-e83065d60267" xlink:to="loc_us-gaap_AssetsHeldByInsuranceRegulators_0c3bc703-6b5b-4ab5-9587-7a0fd34f0b51" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_4b26c981-7487-4dbb-bb0d-cb1ba013850e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_ef84e64a-c21a-4797-b4dd-e83065d60267" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_4b26c981-7487-4dbb-bb0d-cb1ba013850e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesTable_bb66b11e-3470-46f0-8599-3ead88df2e34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_ef84e64a-c21a-4797-b4dd-e83065d60267" xlink:to="loc_us-gaap_StatutoryAccountingPracticesTable_bb66b11e-3470-46f0-8599-3ead88df2e34" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f6ee346f-f7f3-45e0-9a7c-dd187de97bde" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable_bb66b11e-3470-46f0-8599-3ead88df2e34" xlink:to="loc_dei_LegalEntityAxis_f6ee346f-f7f3-45e0-9a7c-dd187de97bde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_f6ee346f-f7f3-45e0-9a7c-dd187de97bde_default" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_f6ee346f-f7f3-45e0-9a7c-dd187de97bde" xlink:to="loc_dei_EntityDomain_f6ee346f-f7f3-45e0-9a7c-dd187de97bde_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8ad4ca52-807e-430b-9616-1cb83ef0130f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_f6ee346f-f7f3-45e0-9a7c-dd187de97bde" xlink:to="loc_dei_EntityDomain_8ad4ca52-807e-430b-9616-1cb83ef0130f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InsuranceAndHmoMember_6adc8496-a040-414b-aa3f-bb68823fde8c" xlink:href="cvs-20211231.xsd#cvs_InsuranceAndHmoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_8ad4ca52-807e-430b-9616-1cb83ef0130f" xlink:to="loc_cvs_InsuranceAndHmoMember_6adc8496-a040-414b-aa3f-bb68823fde8c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#OtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended" id="ic99fc8a7db01428a9b019e3b36ffa3d6_OtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_5d577c64-fe16-4177-807c-f4453b15d8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_896d9d53-e484-452d-95be-5c0809aa4231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_5d577c64-fe16-4177-807c-f4453b15d8b8" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_896d9d53-e484-452d-95be-5c0809aa4231" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_295ea1dc-81d6-48f2-9a16-9258a19b5f13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_896d9d53-e484-452d-95be-5c0809aa4231" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_295ea1dc-81d6-48f2-9a16-9258a19b5f13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_79d27241-fb63-45c1-b53a-60190316a424" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_896d9d53-e484-452d-95be-5c0809aa4231" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_79d27241-fb63-45c1-b53a-60190316a424" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e1e9b6e8-8a0c-4aeb-9395-9d4a60ce4fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_896d9d53-e484-452d-95be-5c0809aa4231" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e1e9b6e8-8a0c-4aeb-9395-9d4a60ce4fc3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f676abc7-9b91-4b53-b480-143c4877573a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_896d9d53-e484-452d-95be-5c0809aa4231" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f676abc7-9b91-4b53-b480-143c4877573a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c5c801e5-6bfc-4886-9d28-aa54d2eaf885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_4a2b5e1a-f2c1-4fb1-b243-d4e81e407935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_5d577c64-fe16-4177-807c-f4453b15d8b8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_4a2b5e1a-f2c1-4fb1-b243-d4e81e407935" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_b4eb43a0-a1b0-492c-8a40-6c7a096db1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_5d577c64-fe16-4177-807c-f4453b15d8b8" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_b4eb43a0-a1b0-492c-8a40-6c7a096db1e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_a95f59a0-2364-431c-9ea6-097eb967e98f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_5d577c64-fe16-4177-807c-f4453b15d8b8" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_a95f59a0-2364-431c-9ea6-097eb967e98f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_473a893f-659b-4a47-a806-c7de8811ca35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_5d577c64-fe16-4177-807c-f4453b15d8b8" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_473a893f-659b-4a47-a806-c7de8811ca35" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f7273e16-c5bd-481a-9363-e6b1cc7878f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_473a893f-659b-4a47-a806-c7de8811ca35" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f7273e16-c5bd-481a-9363-e6b1cc7878f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f7273e16-c5bd-481a-9363-e6b1cc7878f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f7273e16-c5bd-481a-9363-e6b1cc7878f1" xlink:to="loc_us-gaap_EquityComponentDomain_f7273e16-c5bd-481a-9363-e6b1cc7878f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a7803d8d-13c8-477f-a358-92533d41962c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f7273e16-c5bd-481a-9363-e6b1cc7878f1" xlink:to="loc_us-gaap_EquityComponentDomain_a7803d8d-13c8-477f-a358-92533d41962c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_5d1272fa-5953-4526-97ab-e358516748b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a7803d8d-13c8-477f-a358-92533d41962c" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_5d1272fa-5953-4526-97ab-e358516748b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_9c7dd438-fb18-418b-9516-db121162d8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a7803d8d-13c8-477f-a358-92533d41962c" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_9c7dd438-fb18-418b-9516-db121162d8b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_9e249cf5-3c96-4ba2-9ea6-0a9ba8ab155a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a7803d8d-13c8-477f-a358-92533d41962c" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_9e249cf5-3c96-4ba2-9ea6-0a9ba8ab155a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_73d141f5-211b-4b7e-b394-b596bdba33dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a7803d8d-13c8-477f-a358-92533d41962c" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_73d141f5-211b-4b7e-b394-b596bdba33dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_c1b1f732-f25d-4a5f-a0ba-e654711da393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a7803d8d-13c8-477f-a358-92533d41962c" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_c1b1f732-f25d-4a5f-a0ba-e654711da393" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#EarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended" id="i10f5232975884b758e5222d951c6ee84_EarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_71fc4730-40b1-4d38-b718-8ec6551fed4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c3185a60-dd02-4745-9f67-b60fce065078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_71fc4730-40b1-4d38-b718-8ec6551fed4c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c3185a60-dd02-4745-9f67-b60fce065078" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c24419ad-8d05-4adf-9e52-18bab894219c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_71fc4730-40b1-4d38-b718-8ec6551fed4c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c24419ad-8d05-4adf-9e52-18bab894219c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_caf70f96-c0a3-48d3-a45e-a79107dac804" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c24419ad-8d05-4adf-9e52-18bab894219c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_caf70f96-c0a3-48d3-a45e-a79107dac804" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_caf70f96-c0a3-48d3-a45e-a79107dac804_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_caf70f96-c0a3-48d3-a45e-a79107dac804" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_caf70f96-c0a3-48d3-a45e-a79107dac804_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c1f5d3ea-829b-4c76-8722-1f6a582ccd28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_caf70f96-c0a3-48d3-a45e-a79107dac804" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c1f5d3ea-829b-4c76-8722-1f6a582ccd28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_7b75cfb3-6ce2-481e-b4d8-c1139738554f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c1f5d3ea-829b-4c76-8722-1f6a582ccd28" xlink:to="loc_us-gaap_EmployeeStockOptionMember_7b75cfb3-6ce2-481e-b4d8-c1139738554f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#ReinsuranceNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ReinsuranceNarrativeDetails" xlink:type="extended" id="if57773b3a1454b788ecc96b5672d8879_ReinsuranceNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_02ee26b7-c4f4-49c7-833d-c5198600680b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofReinsuranceContractsEnteredInto_dc9e04a8-71ae-4200-b14e-a24d677f1012" xlink:href="cvs-20211231.xsd#cvs_NumberofReinsuranceContractsEnteredInto"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_02ee26b7-c4f4-49c7-833d-c5198600680b" xlink:to="loc_cvs_NumberofReinsuranceContractsEnteredInto_dc9e04a8-71ae-4200-b14e-a24d677f1012" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_18055598-951f-466d-8132-fedabf77c1e3" xlink:href="cvs-20211231.xsd#cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_02ee26b7-c4f4-49c7-833d-c5198600680b" xlink:to="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_18055598-951f-466d-8132-fedabf77c1e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_e9eb6bf2-31f9-40f1-9088-287c0dc7730d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_02ee26b7-c4f4-49c7-833d-c5198600680b" xlink:to="loc_us-gaap_SubsequentEventTable_e9eb6bf2-31f9-40f1-9088-287c0dc7730d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_affae135-64e9-464a-a0c2-128bdae827aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_e9eb6bf2-31f9-40f1-9088-287c0dc7730d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_affae135-64e9-464a-a0c2-128bdae827aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_affae135-64e9-464a-a0c2-128bdae827aa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_affae135-64e9-464a-a0c2-128bdae827aa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_affae135-64e9-464a-a0c2-128bdae827aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_76166eb0-878e-4ab2-9314-9b8f41d6b58d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_affae135-64e9-464a-a0c2-128bdae827aa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_76166eb0-878e-4ab2-9314-9b8f41d6b58d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_362124c5-f451-45d6-a8ba-73c58eaf3787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_76166eb0-878e-4ab2-9314-9b8f41d6b58d" xlink:to="loc_us-gaap_SubsequentEventMember_362124c5-f451-45d6-a8ba-73c58eaf3787" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#ReinsuranceReinsuranceRecoverablesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="extended" id="i0440da7e3a8449839eee5871fed61afb_ReinsuranceReinsuranceRecoverablesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskLineItems_6cde22d1-df37-454d-93e4-5a4db110672c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CededCreditRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_2820e874-3871-483b-a426-ebc295483bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskLineItems_6cde22d1-df37-454d-93e4-5a4db110672c" xlink:to="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_2820e874-3871-483b-a426-ebc295483bf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskTable_dd9f8759-2082-4450-8358-f6baa845f702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CededCreditRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CededCreditRiskLineItems_6cde22d1-df37-454d-93e4-5a4db110672c" xlink:to="loc_us-gaap_CededCreditRiskTable_dd9f8759-2082-4450-8358-f6baa845f702" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskAxis_49c94a91-b3f2-43c1-805d-5711454bb7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CededCreditRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_CededCreditRiskTable_dd9f8759-2082-4450-8358-f6baa845f702" xlink:to="loc_us-gaap_CededCreditRiskAxis_49c94a91-b3f2-43c1-805d-5711454bb7ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain_49c94a91-b3f2-43c1-805d-5711454bb7ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CededCreditRiskAxis_49c94a91-b3f2-43c1-805d-5711454bb7ec" xlink:to="loc_us-gaap_CededCreditRiskReinsurerDomain_49c94a91-b3f2-43c1-805d-5711454bb7ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain_16070a71-525d-4298-82b3-dd490f883c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CededCreditRiskAxis_49c94a91-b3f2-43c1-805d-5711454bb7ec" xlink:to="loc_us-gaap_CededCreditRiskReinsurerDomain_16070a71-525d-4298-82b3-dd490f883c31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_885ddf7d-12eb-4a2d-8546-fa5b0f33b1a3" xlink:href="cvs-20211231.xsd#cvs_HartfordLifeAndAccidentInsuranceCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_16070a71-525d-4298-82b3-dd490f883c31" xlink:to="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_885ddf7d-12eb-4a2d-8546-fa5b0f33b1a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_76329f72-f90a-4c5d-bdf6-8a24f35cfddc" xlink:href="cvs-20211231.xsd#cvs_LincolnLifeAnnuityCompanyOfNewYorkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_16070a71-525d-4298-82b3-dd490f883c31" xlink:to="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_76329f72-f90a-4c5d-bdf6-8a24f35cfddc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_652f366c-4959-4e86-a050-c26d571eb753" xlink:href="cvs-20211231.xsd#cvs_VOYARetirementInsuranceAndAnnuityCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_16070a71-525d-4298-82b3-dd490f883c31" xlink:to="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_652f366c-4959-4e86-a050-c26d571eb753" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AllOtherReinsurersMember_fbbfb5b1-143e-4fcc-b6a5-d20d5bb04205" xlink:href="cvs-20211231.xsd#cvs_AllOtherReinsurersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_16070a71-525d-4298-82b3-dd490f883c31" xlink:to="loc_cvs_AllOtherReinsurersMember_fbbfb5b1-143e-4fcc-b6a5-d20d5bb04205" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="ie1ee6cae7dbf4cb096f99b3118bd54e9_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8caf528e-5443-4ddf-943a-65e77ef4b53e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_4b602b86-6127-4a9b-bbfd-890ffa6bdfeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8caf528e-5443-4ddf-943a-65e77ef4b53e" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_4b602b86-6127-4a9b-bbfd-890ffa6bdfeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyAuditMethodologySampleSize_66e5bc74-e130-4a09-a61f-b51fb2806169" xlink:href="cvs-20211231.xsd#cvs_LossContingencyAuditMethodologySampleSize"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8caf528e-5443-4ddf-943a-65e77ef4b53e" xlink:to="loc_cvs_LossContingencyAuditMethodologySampleSize_66e5bc74-e130-4a09-a61f-b51fb2806169" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_78aacebc-25f4-4f17-a850-64e80f6d74e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_8caf528e-5443-4ddf-943a-65e77ef4b53e" xlink:to="loc_us-gaap_LossContingenciesTable_78aacebc-25f4-4f17-a850-64e80f6d74e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_3cdf8078-9acc-4c1e-89a4-b3a9079dfcc0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_78aacebc-25f4-4f17-a850-64e80f6d74e4" xlink:to="loc_srt_LitigationCaseAxis_3cdf8078-9acc-4c1e-89a4-b3a9079dfcc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_3cdf8078-9acc-4c1e-89a4-b3a9079dfcc0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_3cdf8078-9acc-4c1e-89a4-b3a9079dfcc0" xlink:to="loc_srt_LitigationCaseTypeDomain_3cdf8078-9acc-4c1e-89a4-b3a9079dfcc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_86db4413-dacc-4cd2-a7b2-8fe7dfff7141" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_3cdf8078-9acc-4c1e-89a4-b3a9079dfcc0" xlink:to="loc_srt_LitigationCaseTypeDomain_86db4413-dacc-4cd2-a7b2-8fe7dfff7141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffAndFlaimVAetnaIncEtAlMember_d1a0700f-b51a-4431-ad3a-aa93e2c39dd8" xlink:href="cvs-20211231.xsd#cvs_RadcliffAndFlaimVAetnaIncEtAlMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_86db4413-dacc-4cd2-a7b2-8fe7dfff7141" xlink:to="loc_cvs_RadcliffAndFlaimVAetnaIncEtAlMember_d1a0700f-b51a-4431-ad3a-aa93e2c39dd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_4cec483b-ca15-4b7f-b2f0-f5f1d4d64c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_78aacebc-25f4-4f17-a850-64e80f6d74e4" xlink:to="loc_us-gaap_LitigationStatusAxis_4cec483b-ca15-4b7f-b2f0-f5f1d4d64c37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_4cec483b-ca15-4b7f-b2f0-f5f1d4d64c37_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_4cec483b-ca15-4b7f-b2f0-f5f1d4d64c37" xlink:to="loc_us-gaap_LitigationStatusDomain_4cec483b-ca15-4b7f-b2f0-f5f1d4d64c37_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_fdb7e227-63cf-4b65-bd4f-eaf150555a42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_4cec483b-ca15-4b7f-b2f0-f5f1d4d64c37" xlink:to="loc_us-gaap_LitigationStatusDomain_fdb7e227-63cf-4b65-bd4f-eaf150555a42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_5d625683-be38-4558-abcb-11636da23e12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_fdb7e227-63cf-4b65-bd4f-eaf150555a42" xlink:to="loc_us-gaap_PendingLitigationMember_5d625683-be38-4558-abcb-11636da23e12" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SegmentReportingNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="extended" id="ica4a916796994573ae3256113444cba8_SegmentReportingNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_f4d9abd7-bbac-4b30-a971-4c9fc0adc37e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_e6fa0664-62bc-40c0-b07b-80b54e80c0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f4d9abd7-bbac-4b30-a971-4c9fc0adc37e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_e6fa0664-62bc-40c0-b07b-80b54e80c0d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_9192de00-32cd-4c03-ad27-826c00c0252d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f4d9abd7-bbac-4b30-a971-4c9fc0adc37e" xlink:to="loc_us-gaap_ConcentrationRiskTable_9192de00-32cd-4c03-ad27-826c00c0252d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_858285c7-8804-4852-965e-630367ae0d9d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_9192de00-32cd-4c03-ad27-826c00c0252d" xlink:to="loc_srt_MajorCustomersAxis_858285c7-8804-4852-965e-630367ae0d9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_858285c7-8804-4852-965e-630367ae0d9d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_858285c7-8804-4852-965e-630367ae0d9d" xlink:to="loc_srt_NameOfMajorCustomerDomain_858285c7-8804-4852-965e-630367ae0d9d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_4f9db009-9db9-4caa-8413-b09ce28cd0a6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_858285c7-8804-4852-965e-630367ae0d9d" xlink:to="loc_srt_NameOfMajorCustomerDomain_4f9db009-9db9-4caa-8413-b09ce28cd0a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USFederalGovernmentMember_a039ee18-abaa-43e6-a2f1-4c32eac0551f" xlink:href="cvs-20211231.xsd#cvs_USFederalGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_4f9db009-9db9-4caa-8413-b09ce28cd0a6" xlink:to="loc_cvs_USFederalGovernmentMember_a039ee18-abaa-43e6-a2f1-4c32eac0551f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_083fcaef-1d49-40c0-92fd-d77540c0b789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_9192de00-32cd-4c03-ad27-826c00c0252d" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_083fcaef-1d49-40c0-92fd-d77540c0b789" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_083fcaef-1d49-40c0-92fd-d77540c0b789_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_083fcaef-1d49-40c0-92fd-d77540c0b789" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_083fcaef-1d49-40c0-92fd-d77540c0b789_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e740cbe8-c52e-45b6-b572-22c6d774d32e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_083fcaef-1d49-40c0-92fd-d77540c0b789" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e740cbe8-c52e-45b6-b572-22c6d774d32e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_1c16f912-b58d-4a3f-8686-d5e7de99b214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_e740cbe8-c52e-45b6-b572-22c6d774d32e" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_1c16f912-b58d-4a3f-8686-d5e7de99b214" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7faaf79d-6cf3-4a88-ac5d-3d5f7f75f37c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_9192de00-32cd-4c03-ad27-826c00c0252d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7faaf79d-6cf3-4a88-ac5d-3d5f7f75f37c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7faaf79d-6cf3-4a88-ac5d-3d5f7f75f37c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7faaf79d-6cf3-4a88-ac5d-3d5f7f75f37c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7faaf79d-6cf3-4a88-ac5d-3d5f7f75f37c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_91773996-3884-48bc-9f46-033a9a38ded9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7faaf79d-6cf3-4a88-ac5d-3d5f7f75f37c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_91773996-3884-48bc-9f46-033a9a38ded9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_afe5036d-94a8-431d-afe6-6fca8cecaf62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_91773996-3884-48bc-9f46-033a9a38ded9" xlink:to="loc_us-gaap_SalesRevenueNetMember_afe5036d-94a8-431d-afe6-6fca8cecaf62" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended" id="i5346365e7cb945e2aba3a0efedc6c41a_SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_f51a1a70-3bb1-40dc-9a39-ecded6a02024" xlink:href="cvs-20211231.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_f51a1a70-3bb1-40dc-9a39-ecded6a02024" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_11ddef64-4c12-4458-86b9-4da987104635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_11ddef64-4c12-4458-86b9-4da987104635" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_35b79dcc-4812-419d-85bc-890ab129125f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:to="loc_us-gaap_NetInvestmentIncome_35b79dcc-4812-419d-85bc-890ab129125f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a9f92a4f-6855-4dea-ac4b-47bab3a76ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:to="loc_us-gaap_Revenues_a9f92a4f-6855-4dea-ac4b-47bab3a76ae4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_9a1ce214-1171-4da5-9e4e-407e3be80c72" xlink:href="cvs-20211231.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_9a1ce214-1171-4da5-9e4e-407e3be80c72" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_cd931bf6-fe96-4894-a840-2663260ea7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_cd931bf6-fe96-4894-a840-2663260ea7bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments_ee97f975-a13b-43ef-ba02-20b916b9a5c4" xlink:href="cvs-20211231.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:to="loc_cvs_NetRevenuesRetailCoPayments_ee97f975-a13b-43ef-ba02-20b916b9a5c4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d26d4e7-9906-494c-92e6-19ca3eb5f1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d26d4e7-9906-494c-92e6-19ca3eb5f1ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3a404f0c-0da7-4c9a-85b6-de55ab027637" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d26d4e7-9906-494c-92e6-19ca3eb5f1ad" xlink:to="loc_srt_ConsolidationItemsAxis_3a404f0c-0da7-4c9a-85b6-de55ab027637" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3a404f0c-0da7-4c9a-85b6-de55ab027637_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_3a404f0c-0da7-4c9a-85b6-de55ab027637" xlink:to="loc_srt_ConsolidationItemsDomain_3a404f0c-0da7-4c9a-85b6-de55ab027637_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_49a84f5d-13ce-4e9a-9e5b-4b821a1e40f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_3a404f0c-0da7-4c9a-85b6-de55ab027637" xlink:to="loc_srt_ConsolidationItemsDomain_49a84f5d-13ce-4e9a-9e5b-4b821a1e40f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9a667c0a-3d19-458c-8391-73e35a0af5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_49a84f5d-13ce-4e9a-9e5b-4b821a1e40f6" xlink:to="loc_us-gaap_OperatingSegmentsMember_9a667c0a-3d19-458c-8391-73e35a0af5b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_ccc467d4-2d41-4894-9bc1-8297542cf184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_49a84f5d-13ce-4e9a-9e5b-4b821a1e40f6" xlink:to="loc_us-gaap_IntersegmentEliminationMember_ccc467d4-2d41-4894-9bc1-8297542cf184" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_c82e1ee4-b5ae-413e-befb-12a82c10f2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_49a84f5d-13ce-4e9a-9e5b-4b821a1e40f6" xlink:to="loc_us-gaap_CorporateNonSegmentMember_c82e1ee4-b5ae-413e-befb-12a82c10f2d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0b226584-c94f-4da3-81b7-d8ce07dc2c57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d26d4e7-9906-494c-92e6-19ca3eb5f1ad" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0b226584-c94f-4da3-81b7-d8ce07dc2c57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0b226584-c94f-4da3-81b7-d8ce07dc2c57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0b226584-c94f-4da3-81b7-d8ce07dc2c57" xlink:to="loc_us-gaap_SegmentDomain_0b226584-c94f-4da3-81b7-d8ce07dc2c57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_810a57f9-1678-4b75-82f7-201fd6a92285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0b226584-c94f-4da3-81b7-d8ce07dc2c57" xlink:to="loc_us-gaap_SegmentDomain_810a57f9-1678-4b75-82f7-201fd6a92285" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_b4ba4c88-0b04-4b5e-ab1f-7e0b95aeacf4" xlink:href="cvs-20211231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_810a57f9-1678-4b75-82f7-201fd6a92285" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_b4ba4c88-0b04-4b5e-ab1f-7e0b95aeacf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_4903fbe7-dd74-4a63-91fa-d0aa555df342" xlink:href="cvs-20211231.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_810a57f9-1678-4b75-82f7-201fd6a92285" xlink:to="loc_cvs_PharmacyServicesSegmentMember_4903fbe7-dd74-4a63-91fa-d0aa555df342" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_119b3ea7-a009-4521-9f6a-5b2c22dd9203" xlink:href="cvs-20211231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_810a57f9-1678-4b75-82f7-201fd6a92285" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_119b3ea7-a009-4521-9f6a-5b2c22dd9203" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="extended" id="ib6fc3612b8d546a3ace16dc9623dd240_SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0e7f0f6b-044c-46dd-9311-0e275821d4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresPlannedClosure_9caa2c1d-aaf7-4174-ba4b-1a2e346292f5" xlink:href="cvs-20211231.xsd#cvs_NumberOfStoresPlannedClosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e7f0f6b-044c-46dd-9311-0e275821d4f0" xlink:to="loc_cvs_NumberOfStoresPlannedClosure_9caa2c1d-aaf7-4174-ba4b-1a2e346292f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_7b9b6183-e33a-4e69-866c-ffe3debacd02" xlink:href="cvs-20211231.xsd#cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e7f0f6b-044c-46dd-9311-0e275821d4f0" xlink:to="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_7b9b6183-e33a-4e69-866c-ffe3debacd02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_5020e348-c46a-44ad-a6fe-1f22fe364bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e7f0f6b-044c-46dd-9311-0e275821d4f0" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_5020e348-c46a-44ad-a6fe-1f22fe364bfd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount_c8bc876b-8c77-4139-a23f-20d8ededef9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e7f0f6b-044c-46dd-9311-0e275821d4f0" xlink:to="loc_us-gaap_GainContingencyUnrecordedAmount_c8bc876b-8c77-4139-a23f-20d8ededef9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_96e5c926-0e1d-4813-af6d-862f042f0287" xlink:href="cvs-20211231.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e7f0f6b-044c-46dd-9311-0e275821d4f0" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_96e5c926-0e1d-4813-af6d-862f042f0287" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4aeb6d95-c003-4a95-ae2a-4e0c14f9bbda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e7f0f6b-044c-46dd-9311-0e275821d4f0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4aeb6d95-c003-4a95-ae2a-4e0c14f9bbda" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b1cada54-4253-4303-a747-056db3183419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4aeb6d95-c003-4a95-ae2a-4e0c14f9bbda" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b1cada54-4253-4303-a747-056db3183419" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b1cada54-4253-4303-a747-056db3183419_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b1cada54-4253-4303-a747-056db3183419" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b1cada54-4253-4303-a747-056db3183419_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_406a0fa9-9b0a-4ec1-86e6-a9039673c60c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b1cada54-4253-4303-a747-056db3183419" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_406a0fa9-9b0a-4ec1-86e6-a9039673c60c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_0e0e6e80-4fe5-43f8-8fe6-2aa038454f6c" xlink:href="cvs-20211231.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_406a0fa9-9b0a-4ec1-86e6-a9039673c60c" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_0e0e6e80-4fe5-43f8-8fe6-2aa038454f6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_de839a3b-b0e1-4075-a18b-bd995b9e12fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4aeb6d95-c003-4a95-ae2a-4e0c14f9bbda" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_de839a3b-b0e1-4075-a18b-bd995b9e12fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_de839a3b-b0e1-4075-a18b-bd995b9e12fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_de839a3b-b0e1-4075-a18b-bd995b9e12fa" xlink:to="loc_us-gaap_SegmentDomain_de839a3b-b0e1-4075-a18b-bd995b9e12fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7901e75d-8400-49a4-a717-1bf604827c40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_de839a3b-b0e1-4075-a18b-bd995b9e12fa" xlink:to="loc_us-gaap_SegmentDomain_7901e75d-8400-49a4-a717-1bf604827c40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_3c36d06c-1269-4d8c-b53a-b14e71b88ebb" xlink:href="cvs-20211231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7901e75d-8400-49a4-a717-1bf604827c40" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_3c36d06c-1269-4d8c-b53a-b14e71b88ebb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_ac44cfad-a6f7-453b-a18f-3115b4f9d19d" xlink:href="cvs-20211231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7901e75d-8400-49a4-a717-1bf604827c40" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_ac44cfad-a6f7-453b-a18f-3115b4f9d19d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_99c29bfb-0b86-468d-be08-d6b181287c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4aeb6d95-c003-4a95-ae2a-4e0c14f9bbda" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_99c29bfb-0b86-468d-be08-d6b181287c24" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_99c29bfb-0b86-468d-be08-d6b181287c24_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_99c29bfb-0b86-468d-be08-d6b181287c24" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_99c29bfb-0b86-468d-be08-d6b181287c24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_41498631-c9b5-4956-9c49-639d1202a7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_99c29bfb-0b86-468d-be08-d6b181287c24" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_41498631-c9b5-4956-9c49-639d1202a7ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_06faddcc-bffd-4b99-93ca-91663b2ffb85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_41498631-c9b5-4956-9c49-639d1202a7ec" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_06faddcc-bffd-4b99-93ca-91663b2ffb85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_e3c358c5-4005-4c4f-a706-213beb0d58b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4aeb6d95-c003-4a95-ae2a-4e0c14f9bbda" xlink:to="loc_srt_LitigationCaseAxis_e3c358c5-4005-4c4f-a706-213beb0d58b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e3c358c5-4005-4c4f-a706-213beb0d58b2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_e3c358c5-4005-4c4f-a706-213beb0d58b2" xlink:to="loc_srt_LitigationCaseTypeDomain_e3c358c5-4005-4c4f-a706-213beb0d58b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_0e74d6df-06cb-45c8-aa61-a82221859d94" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_e3c358c5-4005-4c4f-a706-213beb0d58b2" xlink:to="loc_srt_LitigationCaseTypeDomain_0e74d6df-06cb-45c8-aa61-a82221859d94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_22acbd2c-78f5-48ee-9176-a523f77cb5d1" xlink:href="cvs-20211231.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_0e74d6df-06cb-45c8-aa61-a82221859d94" xlink:to="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_22acbd2c-78f5-48ee-9176-a523f77cb5d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_9978f7c0-d422-4369-b80d-cd8436a01f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4aeb6d95-c003-4a95-ae2a-4e0c14f9bbda" xlink:to="loc_us-gaap_LitigationStatusAxis_9978f7c0-d422-4369-b80d-cd8436a01f1b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_9978f7c0-d422-4369-b80d-cd8436a01f1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_9978f7c0-d422-4369-b80d-cd8436a01f1b" xlink:to="loc_us-gaap_LitigationStatusDomain_9978f7c0-d422-4369-b80d-cd8436a01f1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_f99018c8-30a8-4669-93b5-05c3ea14ab37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_9978f7c0-d422-4369-b80d-cd8436a01f1b" xlink:to="loc_us-gaap_LitigationStatusDomain_f99018c8-30a8-4669-93b5-05c3ea14ab37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_e55ab1be-c05e-42c4-9a2b-1d523a6c8a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_f99018c8-30a8-4669-93b5-05c3ea14ab37" xlink:to="loc_us-gaap_SettledLitigationMember_e55ab1be-c05e-42c4-9a2b-1d523a6c8a7f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>cvs-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:101452a2-2146-4b57-8461-1c52c7d6326c,g:5f4a3ace-4815-405a-b6fd-039bed36fdc5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_srt_NameOfMajorCustomerDomain_91038d51-75bb-44ed-bda8-0f93942895ca_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_81c31f93-9edb-4f7b-98a5-ea8395a1eb16_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified, pre-tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_0269e906-6b8c-46fc-995f-23dcbb6fca51_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (gain) loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_eab3fee5-5584-4ebd-8bc6-8f57ed193f5f_terseLabel_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other asset-backed securities</link:label>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_label_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Asset-Backed Securities [Member]</link:label>
    <link:label id="lab_cvs_OtherAssetBackedSecuritiesMember_documentation_en-US" xlink:label="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities collateralized by a variety of assets such as automobile loans, credit card receivables, home equity loans, etc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember" xlink:href="cvs-20211231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherAssetBackedSecuritiesMember" xlink:to="lab_cvs_OtherAssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0fc22b86-9d33-478a-a31c-b46e8a2bb92e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_fd23d6c2-ead3-44f0-b8e2-8b40cb01678e_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_750d96ed-834e-4d7b-a3b5-b846e570880f_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_0bcace5a-7123-44c6-acff-eb1fd36d262d_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_51ac5ca7-d78b-42d8-b780-b4cb6f480514_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueMay2021Member_1646f2a5-6748-4f4e-aa9a-e89c7c0a6692_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueMay2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due May 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueMay2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueMay2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due May 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueMay2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueMay2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due May 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueMay2021Member" xlink:to="lab_cvs_SeniorNotes4.125DueMay2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FinanceLeaseCost_2df2a313-41b4-4291-a49c-1b72a0a2a141_totalLabel_en-US" xlink:label="lab_cvs_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease costs</link:label>
    <link:label id="lab_cvs_FinanceLeaseCost_label_en-US" xlink:label="lab_cvs_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Cost</link:label>
    <link:label id="lab_cvs_FinanceLeaseCost_documentation_en-US" xlink:label="lab_cvs_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseCost" xlink:href="cvs-20211231.xsd#cvs_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FinanceLeaseCost" xlink:to="lab_cvs_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_7a9d93e8-12a2-4929-80db-dc9a4da2dabf_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_185d3f31-f37f-4ca0-8f6e-a9464b02a400_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueJune2021Member_05226921-79e6-4443-8494-b10098f36691_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due June 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueJune2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due June 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueJune2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due June 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueJune2021Member" xlink:to="lab_cvs_SeniorNotes4.125DueJune2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_cc404a71-683a-4433-a2b7-64b0269d0f00_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectPremiumsEarned_046829c7-2bc8-4e06-b206-af2968151143_terseLabel_en-US" xlink:label="lab_us-gaap_DirectPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct</link:label>
    <link:label id="lab_us-gaap_DirectPremiumsEarned_label_en-US" xlink:label="lab_us-gaap_DirectPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Premiums Earned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsEarned" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectPremiumsEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectPremiumsEarned" xlink:to="lab_us-gaap_DirectPremiumsEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_685a8a1f-326e-43e6-96e1-18844473effc_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_c706354b-4ba0-4b85-a62a-3abbc01d9f16_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTTI losses, investments, portion recognized in earnings, net</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage_8f2e6b46-e055-4f3c-86a2-4a50fa78632d_negatedTerseLabel_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption and breakage</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage_label_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Redemption And Breakage</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage_documentation_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Redemption And Breakage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:href="cvs-20211231.xsd#cvs_ContractWithCustomerLiabilityRedemptionAndBreakage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:to="lab_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_5eb245ae-1d5c-4391-aa12-f1d1c7710195_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_c98dd486-c70f-4818-a32b-5b998be2a1e8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of contract with customer assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_b6cefffc-c3cb-46c9-ac94-ab38f4d436f1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01: 3,200 shares authorized; 1,744 shares issued and 1,322 shares outstanding at December&#160;31, 2021 and 1,733 shares issued and 1,310 shares outstanding at December&#160;31, 2020 and capital surplus</link:label>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stocks, Including Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:to="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_9c3f2908-ca86-4e4d-8d9b-2850a63fe07f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_99262e57-faa9-4733-84be-2ed236695882_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_14ddd111-ed48-4c2b-af8f-0e5d6fef6040_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation and Transactions</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_028bae7e-ac21-4704-8330-311b84b7ff42_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities reflected in accrued expenses</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_b5e055a1-0a0e-421c-9158-22472d73375e_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.05% senior notes due March 2048</link:label>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.05%, Due March 2048 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.05DueMarch2048Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.05%, Due March 2048 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.05DueMarch2048Member" xlink:to="lab_cvs_SeniorNotes5.05DueMarch2048Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_86eea126-ffa6-4919-97d4-185bfddc1d06_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_d1512710-563e-4815-b314-4abd58da28be_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c89ee5ff-36dd-44f0-90cd-dc061d920326_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_445b83e8-4245-4ef0-b190-5c719ade0ece_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% senior notes due July 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due July 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueJuly2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due July 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.5DueJuly2022Member" xlink:to="lab_cvs_SeniorNotes3.5DueJuly2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5211735c-97de-4775-bc04-7e2f1137a41b_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_08b1ca3f-2530-44b8-bd7c-9f1dcea9c699_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_2691f838-9519-42c9-9865-191967bf0f25_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for grant</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_44d53b80-961e-4712-bec4-cfdd339067bd_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_26f2ff94-e1a1-460a-92a6-1723c48bcc82_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred Health Care Claims, Net of Reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category7Member_a823bccf-9d52-49b0-90e7-6083c21b899a_terseLabel_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7</link:label>
    <link:label id="lab_cvs_Category7Member_label_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 7 [Member]</link:label>
    <link:label id="lab_cvs_Category7Member_documentation_en-US" xlink:label="lab_cvs_Category7Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan credit quality indicator - Category 7</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member" xlink:href="cvs-20211231.xsd#cvs_Category7Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category7Member" xlink:to="lab_cvs_Category7Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7a9beaa5-9377-4d57-bdf9-f42515bc7d1b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_a85d6c17-c066-46a0-8395-0fab479dcf2e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_72d08c49-7de1-43e6-bb0c-4672b2f13d26_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of stock options and SARs exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2Point7PercentAugust2040Member_26e96a8c-bbdc-4f17-a6d7-18a4c82b5520_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.7% senior notes due August 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes2Point7PercentAugust2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2 Point 7 Percent, August 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2Point7PercentAugust2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2 Point 7 Percent, August 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2Point7PercentAugust2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:to="lab_cvs_SeniorNotes2Point7PercentAugust2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_209867a2-a321-4e65-b79c-9103b6da58a1_terseLabel_en-US" xlink:label="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized and unrealized capital gains (losses):</link:label>
    <link:label id="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_label_en-US" xlink:label="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured On Recurring Basis, Unobservable Unput Reconciliation, Net Realized And Unrealized Capital Gaines (Losses) [Abstract]</link:label>
    <link:label id="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_documentation_en-US" xlink:label="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured On Recurring Basis, Unobservable Unput Reconciliation, Net Realized And Unrealized Capital Gaines (Losses) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:href="cvs-20211231.xsd#cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:to="lab_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_0a87c0e9-06e2-4bf7-b662-e71d5de56695_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_ca5274b3-0c22-473f-aeb5-aeb08d53ed3f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_fb6ebb0c-337e-4b45-bf42-6bc1b912bf03_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsYearOne_ad00659e-48cd-45ba-81d5-9373f5f1d21d_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsYearOne_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Year One</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsYearOne_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsYearOne" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsYearOne" xlink:to="lab_cvs_LesseeLiabilityPaymentsYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0462c5bf-d493-46f9-a4b9-764a764f2585_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining as of December 31, 2021</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_0246040f-c7a3-4378-875a-0d7a6837a166_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_9be5d4a7-e908-4f62-8474-23d3e8cc5f0a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_550b8a89-c0fc-4d75-b643-a2a1d8531ce3_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_a78f7fbf-61fe-4bb7-8937-fb669c0ef6fa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_74afe93d-0b5c-46dc-ba7a-2d327e9c1cb8_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of change in health care costs payable</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_ccd4e217-9876-4261-bbaa-6cbf60558c15_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_820efb02-695d-4181-9ceb-6ef39d66708d_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which entity operates</link:label>
    <link:label id="lab_us-gaap_NumberOfStatesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of States in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfStatesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_b9de93fa-8341-43bb-b31c-489880e30ccc_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay112026Member_ae7f08ba-8ddd-4555-83a1-b921adb39ee3_terseLabel_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay112026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 11, 2026</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay112026Member_label_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay112026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 11, 2026 [Member]</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay112026Member_documentation_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay112026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 11, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay112026Member" xlink:href="cvs-20211231.xsd#cvs_RevolvingCreditFacilityExpiringMay112026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RevolvingCreditFacilityExpiringMay112026Member" xlink:to="lab_cvs_RevolvingCreditFacilityExpiringMay112026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_b577c8b0-a38d-4b84-8f02-ee3c809e53d0_terseLabel_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator for earnings per share calculation:</link:label>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_label_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:label id="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract_documentation_en-US" xlink:label="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:href="cvs-20211231.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:to="lab_cvs_NumeratorForEarningsPerShareCalculationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_f5ef9297-8411-49be-8a42-a42c5ba97f05_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Included in earnings&#160;</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02b942a0-af69-49b2-a7d7-3a5dce9be4f6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_f9b1d82c-de9c-4294-94fd-eb196724aa6a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b1366ef9-b269-49b1-a33a-3328f0cb7e0f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_9cef335e-72c3-4998-985b-fe8227106648_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_70005421-9991-4344-8365-9e9243e957e9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_be8be98b-26b4-4f9d-893c-0531bd244745_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares exercisable at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_c18644fd-f309-4bed-a15c-0c67407dbfed_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of net actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderAccountsPolicy_9c5555dc-310b-488e-9a86-f685abe7ba55_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Accounts</link:label>
    <link:label id="lab_us-gaap_PolicyholderAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_PolicyholderAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderAccountsPolicy" xlink:to="lab_us-gaap_PolicyholderAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_015c9d40-cde4-4271-81ba-59de66476442_terseLabel_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment contracts without a fixed maturity</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_label_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts Without A Fixed Maturity, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:href="cvs-20211231.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:to="lab_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_9b8dfa1b-3e29-4941-b1ed-45ed67885205_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt securities by contractual maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesMember_42e06619-e228-4a3e-81b4-a4aee84052c0_terseLabel_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank Advances</link:label>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesMember_label_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank Advances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:to="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1ef05771-1b18-4026-a708-e3c002efac7c_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_89d96789-aad1-4e7d-b17b-421d36edd6d9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_cd4f7c33-16a1-4642-8307-9d8954a7e6d1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_bc755c8a-17fa-4bff-90c3-f20755ca696e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_77c1d41b-e640-4ae7-8821-701e82e42bac_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_8c12777b-63c6-404b-9999-0a7fa3b18f37_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumptions used to determine net benefit costs</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_051e75e5-2780-47ac-8557-92091747660c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountAssetCategoryDomain_46a935c8-5c4f-495b-b919-752e56ceddd5_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssetCategoryDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset Category [Domain]</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssetCategoryDomain_label_en-US" xlink:label="lab_us-gaap_SeparateAccountAssetCategoryDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain" xlink:to="lab_us-gaap_SeparateAccountAssetCategoryDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_57a1985d-1c35-4490-9095-7e91fffe744c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and rents</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_ca78ff9b-e7fd-4ffa-829b-189e0732b247_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesMember" xlink:to="lab_us-gaap_DebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_2cbd96aa-2eaa-4923-b059-f1962b82622f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_ffa12747-6570-43ab-a823-ff7a4643bfe3_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VIE, ownership percentage</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstate_cb9a736e-5c62-4489-b035-7c16d134d604_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstate_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstate" xlink:to="lab_us-gaap_MortgageLoansOnRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateFundsMember_ae00c9bf-afa0-4991-844a-a1fe8311f47b_verboseLabel_en-US" xlink:label="lab_us-gaap_RealEstateFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate partnerships</link:label>
    <link:label id="lab_us-gaap_RealEstateFundsMember_label_en-US" xlink:label="lab_us-gaap_RealEstateFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateFundsMember" xlink:to="lab_us-gaap_RealEstateFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_4f51dfb5-1697-4b35-9c12-9754783f87f0_terseLabel_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit-related impairment loss</link:label>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings</link:label>
    <link:label id="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_documentation_en-US" xlink:label="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="cvs-20211231.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_54f847ed-aabb-43bb-872d-de3c786eec95_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_9185c4dc-3d24-46ed-9d40-8600f36c1786_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts liabilities</link:label>
    <link:label id="lab_us-gaap_SeparateAccountsLiability_label_en-US" xlink:label="lab_us-gaap_SeparateAccountsLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountsLiability" xlink:to="lab_us-gaap_SeparateAccountsLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category2To4Member_9f98a59c-4c07-47a8-ae27-98ca4086ead3_terseLabel_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2 to 4</link:label>
    <link:label id="lab_cvs_Category2To4Member_label_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 2 to 4 [Member]</link:label>
    <link:label id="lab_cvs_Category2To4Member_documentation_en-US" xlink:label="lab_cvs_Category2To4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Credit Quality Indicator - Category 2 to 4 [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member" xlink:href="cvs-20211231.xsd#cvs_Category2To4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category2To4Member" xlink:to="lab_cvs_Category2To4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_b1587a61-b77e-4678-9eed-b9638dd316ab_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.3% senior notes due December 2043</link:label>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.3%, Due December 2043 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.3DueDecember2043Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.3%, Due December 2043 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.3DueDecember2043Member" xlink:to="lab_cvs_SeniorNotes5.3DueDecember2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_ca3021f2-a07f-428b-bef2-c42d983c399f_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Three</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_3aa72e33-bb85-49b4-b369-a740a51ff6a6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_20cba387-0a95-4c9a-9126-62c160a301aa_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_687ddf2a-64ec-457b-a611-ed07f5b56af9_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_adfc1020-f701-42b3-b49a-e7c1df9f4ea1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows paid for principal portion of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_A2021RepurchaseProgramMember_7a4877d8-276a-47de-a30e-6249fe14a547_terseLabel_en-US" xlink:label="lab_cvs_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program</link:label>
    <link:label id="lab_cvs_A2021RepurchaseProgramMember_label_en-US" xlink:label="lab_cvs_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program [Member]</link:label>
    <link:label id="lab_cvs_A2021RepurchaseProgramMember_documentation_en-US" xlink:label="lab_cvs_A2021RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021RepurchaseProgramMember" xlink:href="cvs-20211231.xsd#cvs_A2021RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_A2021RepurchaseProgramMember" xlink:to="lab_cvs_A2021RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_aaeb91f8-7fed-496e-8898-8f60a157c544_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_9f4ce964-57f8-4011-95bc-4b38acfebadd_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in prior years' healthcare costs payable</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_995e933f-918a-406a-81e7-1f5d87be24dd_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_2c3c8318-ed2f-4faa-b50f-7f66459d1565_terseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_19a71bc9-8389-4613-9ee1-a02fda310694_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination [Domain]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:to="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ebefa18c-8847-4e14-ba45-d79c9dbb3b27_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_37545776-3ab1-49f7-ab15-6bcbf52d632b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountAssetCategoryAxis_bbc06392-4b47-47fe-9f8b-820421ec691e_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssetCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset Category [Axis]</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssetCategoryAxis_label_en-US" xlink:label="lab_us-gaap_SeparateAccountAssetCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis" xlink:to="lab_us-gaap_SeparateAccountAssetCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_72c841b0-b89c-463a-8047-e41f2dc830ef_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_372fbe49-0c66-43dd-9135-f3216bc5a699_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_bec03a08-085c-41ca-ac38-ad0aeab05374_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsDomain_c18f1705-ba9f-438d-ad05-ecb147f91d32_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Domain]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsDomain_label_en-US" xlink:label="lab_cvs_TotalInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain" xlink:href="cvs-20211231.xsd#cvs_TotalInvestmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsDomain" xlink:to="lab_cvs_TotalInvestmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_b941983c-3cc1-432f-8ed9-d6a7df536bfb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_aa947d96-5d11-4af8-b2fb-76f820b26ac3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_f5582526-e0de-44d2-b8c4-fab40edcfd16_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior</link:label>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Prior To Period Five [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPriorToPeriodFiveMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Prior To Period Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:to="lab_cvs_YearOfOriginationPriorToPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_cba55c9b-537e-41ef-9bb4-0c36e67e2f59_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_2b38ebb0-0d85-4e33-9042-9b60325e8357_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent assets reflected in other assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_c94a531f-ad76-40e5-8bba-ee682129148f_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_cfe5355d-5436-4d55-b04d-f6396a584ac2_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_70b163ba-00d2-49d0-b122-fdd1d2225017_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskAxis_fadbd523-af29-4817-89f2-9e3b2542fdf7_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Reinsurer [Axis]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskAxis_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Reinsurer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CededCreditRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskAxis" xlink:to="lab_us-gaap_CededCreditRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfStores_7a15b453-d3b5-4611-8d46-1dd7ef9fdde9_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of retail locations (more than)</link:label>
    <link:label id="lab_us-gaap_NumberOfStores_03544bc5-7252-4ca9-a957-5c8f61a7b05d_verboseLabel_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of stores</link:label>
    <link:label id="lab_us-gaap_NumberOfStores_label_en-US" xlink:label="lab_us-gaap_NumberOfStores" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Stores</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfStores" xlink:to="lab_us-gaap_NumberOfStores" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_321f5350-7e5e-419a-bdb8-54ab6e9036af_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3% senior notes due August 2026</link:label>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3%, Due August 2026 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3DueAugust2026Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3%, Due August 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3DueAugust2026Member" xlink:to="lab_cvs_SeniorNotes3DueAugust2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityUndiscountedExcessAmount_3e51cdb5-fc28-4f24-9c5c-4d02282af2c2_negatedTotalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_cvs_LesseeLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_cvs_LesseeLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:to="lab_cvs_LesseeLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_72a6e807-b50d-49b4-afdf-d6e38e507356_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_f334b7f6-2fa4-43e9-8d50-ebe18cc45255_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_24623425-de21-4523-8d15-da08749062ae_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_fec03f7f-5430-496f-8d01-5077b4b65126_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_ed45f001-d4c2-4112-8a0f-9617f655372f_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_73fe1dde-7ed7-4f0d-b916-7fc2bc57fc6b_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined statutory net income</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Net Income Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_b2628c3d-7399-462a-aefa-0eeed45c3b97_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:to="lab_us-gaap_DiscontinuedOperationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskLineItems_ec8c6d4e-66f8-4c11-acae-0e41f1956942_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskLineItems_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CededCreditRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskLineItems" xlink:to="lab_us-gaap_CededCreditRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_7665182f-f6c2-47ec-9694-3223ca4ad777_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e4decc0d-5aa6-477f-9173-2d69a0af5270_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_bed4a1e7-c65c-4feb-85a9-94368a26b94e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_3fefe2af-2ce2-4892-8784-5efe9c0d943a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_USFederalGovernmentMember_d43878a4-24ef-467d-8c75-b6d7e7c1266e_terseLabel_en-US" xlink:label="lab_cvs_USFederalGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Federal Government</link:label>
    <link:label id="lab_cvs_USFederalGovernmentMember_label_en-US" xlink:label="lab_cvs_USFederalGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Federal Government [Member]</link:label>
    <link:label id="lab_cvs_USFederalGovernmentMember_documentation_en-US" xlink:label="lab_cvs_USFederalGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Federal Government</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USFederalGovernmentMember" xlink:href="cvs-20211231.xsd#cvs_USFederalGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_USFederalGovernmentMember" xlink:to="lab_cvs_USFederalGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_bdd38749-4758-4f67-a3c3-38285830a4f0_terseLabel_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of leases guaranteed</link:label>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_label_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Number of Leases</link:label>
    <link:label id="lab_cvs_GuarantorObligationsNumberofLeases_documentation_en-US" xlink:label="lab_cvs_GuarantorObligationsNumberofLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Number of Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_GuarantorObligationsNumberofLeases" xlink:href="cvs-20211231.xsd#cvs_GuarantorObligationsNumberofLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_GuarantorObligationsNumberofLeases" xlink:to="lab_cvs_GuarantorObligationsNumberofLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_89e3dd8e-03ac-4dae-9f44-5a519db764c7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_f4bfca32-2a26-4680-840f-212d3ce46bf0_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_3a70676a-0bbd-4740-91cb-89534fa1ab7c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_31d466e4-8fbc-4253-90cd-05b6e70cb4e2_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_89437b9e-54ba-4a5e-a11f-9607459b56c1_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on tax positions related to the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_fef485be-e8ed-4685-bb23-8eb34d2ac366_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee benefits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_c8071761-190d-4b44-ac20-0bb3d5ee6df0_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_cb42126b-6c78-4a90-90c6-23a114803705_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay172023Member_1c88ab7b-5cbc-4425-a0f9-f6928490d673_terseLabel_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay172023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 17, 2023</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay172023Member_label_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay172023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 17, 2023 [Member]</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay172023Member_documentation_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay172023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 17, 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay172023Member" xlink:href="cvs-20211231.xsd#cvs_RevolvingCreditFacilityExpiringMay172023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RevolvingCreditFacilityExpiringMay172023Member" xlink:to="lab_cvs_RevolvingCreditFacilityExpiringMay172023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_7e311947-856d-4a9e-82e5-4e4a993a08c4_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_225196e8-94b8-4151-a69e-aa73660f339b_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_3600b468-f6d7-48ca-bc87-8fa92dfc0a4e_terseLabel_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services</link:label>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_label_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services Segment [Member]</link:label>
    <link:label id="lab_cvs_PharmacyServicesSegmentMember_documentation_en-US" xlink:label="lab_cvs_PharmacyServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Services Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember" xlink:href="cvs-20211231.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyServicesSegmentMember" xlink:to="lab_cvs_PharmacyServicesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FrontStoreRevenueMember_5db9e45d-0995-4ad4-983a-32781e3d5f9c_terseLabel_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store</link:label>
    <link:label id="lab_cvs_FrontStoreRevenueMember_label_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store Revenue [Member]</link:label>
    <link:label id="lab_cvs_FrontStoreRevenueMember_documentation_en-US" xlink:label="lab_cvs_FrontStoreRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Front Store Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember" xlink:href="cvs-20211231.xsd#cvs_FrontStoreRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FrontStoreRevenueMember" xlink:to="lab_cvs_FrontStoreRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_c4d032d2-a9a8-40ce-ad22-b434cf29bc16_terseLabel_en-US" xlink:label="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four years reinsurance agreement with unrelated insurer</link:label>
    <link:label id="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_label_en-US" xlink:label="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Years Reinsurance Agreement With Unrelated Insurer</link:label>
    <link:label id="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_documentation_en-US" xlink:label="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This line item represents the four years of a reinsurance agreement with an unrelated insurer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:href="cvs-20211231.xsd#cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:to="lab_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_8a42f94b-03ff-4769-a073-dca876de7640_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets, indefinite-lived</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_1027f97b-e297-47cf-9377-dda7325506c1_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_0ebc5aff-e756-4ab2-867e-38d7ab7b126e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_a599d3d3-fb01-4ccd-84a2-96042e63e431_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and pharmacy claims and discounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_39790a21-de3c-42c8-89c9-b184b0a0ca0e_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_7c58da64-f2dc-49d0-b20d-ea31db6bac7e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_de36547b-2b0a-437c-b71d-a00e7be22e9e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_d3e1fc91-7155-4acb-b8ca-b43a6b5e073d_negatedTerseLabel_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance benefits paid</link:label>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_label_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Insurance Benefits</link:label>
    <link:label id="lab_cvs_PaymentsforInsuranceBenefits_documentation_en-US" xlink:label="lab_cvs_PaymentsforInsuranceBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Insurance Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits" xlink:href="cvs-20211231.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsforInsuranceBenefits" xlink:to="lab_cvs_PaymentsforInsuranceBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_df65118c-e677-4221-8362-1b1373cebfe2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_5b1ccd4a-337e-4aae-8c30-6ce2e5d67427_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option activity, stock awards and other</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_92c63041-54ea-4142-810d-e12c85a0e43a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement losses</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_149c78f3-1ed9-4081-a98d-7da06a6471e2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized capital gains</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthInsurerFee_6d239ef5-3ad8-4e6f-bb39-92937d2d66c7_terseLabel_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurer fee</link:label>
    <link:label id="lab_cvs_HealthInsurerFee_label_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurer Fee</link:label>
    <link:label id="lab_cvs_HealthInsurerFee_documentation_en-US" xlink:label="lab_cvs_HealthInsurerFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee" xlink:href="cvs-20211231.xsd#cvs_HealthInsurerFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthInsurerFee" xlink:to="lab_cvs_HealthInsurerFee" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfStoresPlannedClosurePeriod_a39491fc-6f17-4e65-b311-7133edf74784_terseLabel_en-US" xlink:label="lab_cvs_NumberOfStoresPlannedClosurePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of stores, planned closure period (in years)</link:label>
    <link:label id="lab_cvs_NumberOfStoresPlannedClosurePeriod_label_en-US" xlink:label="lab_cvs_NumberOfStoresPlannedClosurePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Stores, Planned Closure Period</link:label>
    <link:label id="lab_cvs_NumberOfStoresPlannedClosurePeriod_documentation_en-US" xlink:label="lab_cvs_NumberOfStoresPlannedClosurePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Stores, Planned Closure Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresPlannedClosurePeriod" xlink:href="cvs-20211231.xsd#cvs_NumberOfStoresPlannedClosurePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfStoresPlannedClosurePeriod" xlink:to="lab_cvs_NumberOfStoresPlannedClosurePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_19be972a-36e0-4b69-aa56-5afa68e32148_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_43d05ef9-d35b-4c79-b611-2b8275844d04_negatedTerseLabel_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</link:label>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_label_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</link:label>
    <link:label id="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_documentation_en-US" xlink:label="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:href="cvs-20211231.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:to="lab_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_814f25d3-1319-40a4-9d8a-0604798f6a8f_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_62f24bd8-087a-4a81-a12b-572194561425_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_141c94c9-6ea5-4e6b-8d82-01648ab8511b_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_aefa4e17-b6d5-4aff-a138-49ea962a034b_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date, unrealized losses</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:to="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_3b046e1a-141b-43be-adaa-2d2c86eba556_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_18c87620-3c92-46f9-888f-e6d3a7a66053_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_17225c3a-6e57-4f11-b708-1310f679bb14_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_251b188e-a714-4098-868a-032b374c8c0c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DrogariaOnofreLtdaMember_5f12dcbb-ac22-4381-b338-755ca17888f9_terseLabel_en-US" xlink:label="lab_cvs_DrogariaOnofreLtdaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drogaria onofre Ltda.</link:label>
    <link:label id="lab_cvs_DrogariaOnofreLtdaMember_label_en-US" xlink:label="lab_cvs_DrogariaOnofreLtdaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drogaria onofre Ltda. [Member]</link:label>
    <link:label id="lab_cvs_DrogariaOnofreLtdaMember_documentation_en-US" xlink:label="lab_cvs_DrogariaOnofreLtdaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drogaria onofre Ltda.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DrogariaOnofreLtdaMember" xlink:href="cvs-20211231.xsd#cvs_DrogariaOnofreLtdaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DrogariaOnofreLtdaMember" xlink:to="lab_cvs_DrogariaOnofreLtdaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_88399f53-28f8-41b0-86a2-0be806fd9043_terseLabel_en-US" xlink:label="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lincoln Life &amp; Annuity Company of New York</link:label>
    <link:label id="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_label_en-US" xlink:label="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lincoln Life &amp; Annuity Company Of New York [Member]</link:label>
    <link:label id="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_documentation_en-US" xlink:label="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lincoln Life &amp; Annuity Company Of New York [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:href="cvs-20211231.xsd#cvs_LincolnLifeAnnuityCompanyOfNewYorkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:to="lab_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_14ddec0d-e33d-4f6b-9911-cdf8404a69bd_terseLabel_en-US" xlink:label="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease obligations:</link:label>
    <link:label id="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_label_en-US" xlink:label="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:label id="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_documentation_en-US" xlink:label="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:href="cvs-20211231.xsd#cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:to="lab_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_b8aa624b-b445-4ec6-a7d1-42f8ac040ccb_terseLabel_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield-related impairment loss</link:label>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings</link:label>
    <link:label id="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_documentation_en-US" xlink:label="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yield Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="cvs-20211231.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_d8207944-4321-4392-952b-793403dac83d_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Two</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_3c34d88f-c9d0-4876-8523-a06f16b68248_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_bd812bd9-f5d2-41a1-bd08-df226d5065e6_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a70c1295-1dab-4d55-a103-11a1c43aa430_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price exercisable at end of year ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_185fc3ab-dd5b-4173-abdc-b12b00164af1_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax penalties and interest accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4PointThreePercentDue2028Member_01ee7ed8-691e-4f0d-9817-1620922aa24f_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4PointThreePercentDue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due 2028</link:label>
    <link:label id="lab_cvs_SeniorNotes4PointThreePercentDue2028Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4PointThreePercentDue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4 Point Three Percent, Due 2028 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4PointThreePercentDue2028Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4PointThreePercentDue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4 Point Three Percent, Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4PointThreePercentDue2028Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4PointThreePercentDue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4PointThreePercentDue2028Member" xlink:to="lab_cvs_SeniorNotes4PointThreePercentDue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_eb7866d3-a546-42f6-a954-26534358109d_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_9ae4b724-91d4-454a-8aad-212fefa68d4c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_f4119d29-61cf-4118-b85c-166c863c903e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_e8954feb-f36f-496a-be2e-a1c5e63d3e48_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average contractual term, outstanding at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_c1680db2-85f4-45ef-9eb7-e3db3c08cd50_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% senior notes due August 2047</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due August 2047 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueAugust2047Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due August 2047 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.875DueAugust2047Member" xlink:to="lab_cvs_SeniorNotes3.875DueAugust2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_81138d44-237f-4085-b7cf-55981d4149cf_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_c3c3e6eb-06d8-4783-b84a-3831377c8ef2_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_bbefc6b5-85ca-46b4-b1c7-045c68f3e31c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_314a3972-991b-4ff5-862d-b668cbc09ac9_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.125% senior notes due July 2045</link:label>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.125%, Due July 2045 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.125DueJuly2045Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.125%, Due July 2045 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.125DueJuly2045Member" xlink:to="lab_cvs_SeniorNotes5.125DueJuly2045Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_0ececed2-7cb5-4a8c-93a8-9d7eccc5e779_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_5b156e8d-efd2-4113-a185-e1f7764872a4_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_477819e0-704c-48d7-b843-d86ab5db64c8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_05c087b3-9d45-40b3-aa62-1f7f38b2355a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_4bbaca3e-d23a-4237-9f00-6fa474e9c014_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7988ad07-099b-4fc9-9366-0b23cee951cd_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation not yet recognized, period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_125530bd-ff17-45d3-a5f1-7481c7393b93_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4507b7b1-3412-4ef9-8c51-5fb9186decd8_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at beginning of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_83a4ef36-abe3-4c7f-a443-f58a78c125d5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested at end of year (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_a21010bc-f2df-4c80-8e75-18dfef01a320_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_c0068c1c-d0c0-44e8-95b0-3866aadc7e9c_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividend declared (USD per share)</link:label>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_label_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableAmountPerShare" xlink:to="lab_us-gaap_DividendsPayableAmountPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentMember_b962b93a-52c2-4514-bb14-43dc60480caa_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentMember_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateInvestmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentMember" xlink:to="lab_us-gaap_RealEstateInvestmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_23653577-cf88-4df0-ac9d-c8253f60d446_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value and estimated fair value of certain financial instruments</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_ba1393a6-5d03-4127-abdb-399e23ce2bc8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_47d3f9d8-f8ff-4c1a-a08a-68b3b863d76f_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Mortgage Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_ee535725-6228-4f8c-b8e2-9e85251f9a0a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_57d771b1-12a1-44ca-b5c1-2d7a49ab06cf_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock_14aec55e-16a5-463a-b7c5-08e2585622ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:to="lab_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_e3a50284-ddb9-42c6-8ec2-fb1a3517c464_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_90da0641-c281-4574-9a38-133ae30e27bc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of valuation assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_08b2b0d7-1e0d-4ebb-b429-8aad6cd18e79_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_a3401172-4019-465f-af72-26e82217bb78_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3Point625PercentApril2027Member_f8e7daab-eade-4e9e-8e6a-49194a56bffa_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% senior notes due April 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes3Point625PercentApril2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3 Point 625 Percent, April 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3Point625PercentApril2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3 Point 625 Percent, April 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3Point625PercentApril2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:to="lab_cvs_SeniorNotes3Point625PercentApril2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_4abb3e86-9f67-4b3e-b236-a46466fc80d2_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_7f14a163-5937-4287-a82f-41fe8ee25b9a_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.625% senior notes due June 2036</link:label>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.625%, Due June 2036 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.625DueJune2036Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.625%, Due June 2036 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.625DueJune2036Member" xlink:to="lab_cvs_SeniorNotes6.625DueJune2036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_b8c4f0f0-787a-4950-95a0-64292521097c_terseLabel_en-US" xlink:label="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Department of Health and Human Services, ACA Risk Corridor Receivables</link:label>
    <link:label id="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_label_en-US" xlink:label="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Department of Health and Human Services, ACA Risk Corridor Receivables [Member]</link:label>
    <link:label id="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_documentation_en-US" xlink:label="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Department of Health and Human Services, ACA Risk Corridor Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:href="cvs-20211231.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:to="lab_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_56c78beb-25e9-4ade-a290-860f35be1d90_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_b627e892-14dd-4603-88c7-b9375159b937_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Next Twelve Months</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherLongTermInsuranceLiabilitiesMember_556b677c-f66e-4845-9d86-4a9d7527c85a_terseLabel_en-US" xlink:label="lab_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Insurance Liabilities</link:label>
    <link:label id="lab_cvs_OtherLongTermInsuranceLiabilitiesMember_label_en-US" xlink:label="lab_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Insurance Liabilities [Member]</link:label>
    <link:label id="lab_cvs_OtherLongTermInsuranceLiabilitiesMember_documentation_en-US" xlink:label="lab_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Insurance Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:href="cvs-20211231.xsd#cvs_OtherLongTermInsuranceLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:to="lab_cvs_OtherLongTermInsuranceLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_006646a6-1c57-4de7-93b0-63d362c11e80_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits_41ab13b7-e435-4109-9959-2ddb5628f43c_negatedTerseLabel_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement benefits</link:label>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits_label_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Retirement Benefits</link:label>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits_documentation_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Retirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:href="cvs-20211231.xsd#cvs_DeferredTaxLiabilitiesRetirementBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:to="lab_cvs_DeferredTaxLiabilitiesRetirementBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_9523a267-4b8d-4b4f-986d-e620f99d7176_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:to="lab_us-gaap_TypeOfCostGoodOrServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_24430e6d-103b-4d5b-97b5-f6d54a5e5fc4_terseLabel_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares held in trust (in shares)</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_label_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Held in Trust</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesHeldinTrust_documentation_en-US" xlink:label="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Held in Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust" xlink:href="cvs-20211231.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockSharesHeldinTrust" xlink:to="lab_cvs_TreasuryStockSharesHeldinTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_db98dd7a-291d-4215-9d3d-3f376d3a495a_terseLabel_en-US" xlink:label="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VOYA Retirement Insurance and Annuity Company</link:label>
    <link:label id="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_label_en-US" xlink:label="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VOYA Retirement Insurance And Annuity Company [Member]</link:label>
    <link:label id="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_documentation_en-US" xlink:label="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VOYA Retirement Insurance And Annuity Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:href="cvs-20211231.xsd#cvs_VOYARetirementInsuranceAndAnnuityCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:to="lab_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_97deea6e-d26b-4f88-8293-5e6607ad9767_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_e25ab772-60eb-47ce-9c81-5e0bc5c5d5e3_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, beginning of period, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_a6c60342-3e6c-41bd-ba9c-b569b6387d4e_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, end of period, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_fdc457e5-2dae-4d96-9c61-9e0589299d4d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_74eccd2b-eb16-43be-a2c1-c11cfcb3de8e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in level 3 financial assets</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.125DueMarch2020Member_db283e07-36e6-4c56-ad3e-855cf0e760fb_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.125DueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% senior notes due March 2020</link:label>
    <link:label id="lab_cvs_SeniorNotes3.125DueMarch2020Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.125DueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.125%, Due March 2020 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.125DueMarch2020Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.125DueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.125%, Due March 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.125DueMarch2020Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.125DueMarch2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.125DueMarch2020Member" xlink:to="lab_cvs_SeniorNotes3.125DueMarch2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_a4ea5cd8-50da-4af7-9c93-88a99c4eeba2_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_281a71ac-d943-4922-b5f7-861fac6fedab_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_a922c0ab-92d0-449a-9ed0-bf399ebeaa76_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3d728941-9db3-4d06-b1d2-ca2116f895a2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fe2f8edd-8b26-4217-9f75-b106f6009cd6_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_f66f0287-23bf-4e81-8421-feabe15c5b3d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash receipts from customers</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCustomers_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCustomers" xlink:to="lab_us-gaap_ProceedsFromCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CashFlowLesseeAbstract_3ef73488-7cb9-4f37-a5f8-af56acdde9b8_terseLabel_en-US" xlink:label="lab_cvs_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_cvs_CashFlowLesseeAbstract_label_en-US" xlink:label="lab_cvs_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:label id="lab_cvs_CashFlowLesseeAbstract_documentation_en-US" xlink:label="lab_cvs_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CashFlowLesseeAbstract" xlink:href="cvs-20211231.xsd#cvs_CashFlowLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CashFlowLesseeAbstract" xlink:to="lab_cvs_CashFlowLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_de1d799d-54dd-4623-be16-13484a3e47e9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_c57a6579-beed-4c13-9ef2-15093441f891_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_97e98496-7b72-4ae4-91f5-57a7e1cd01f6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_486bfc2b-dbaa-427c-b76f-4e0c30f8f847_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_cb4959dc-1c00-47e1-934e-db652a74c453_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_d9335866-bb60-4d42-b52a-a31714ce7daf_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_18513972-af60-466e-b769-8f7bf6a6bfbe_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_9b2205c4-0587-41b3-adb6-20089b6f08a6_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_6a2ea577-bb7a-44ab-af9b-f842969ebaed_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount_18540f07-9d75-4fde-aef8-fc1e45e4e582_terseLabel_en-US" xlink:label="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for ASR, amount</link:label>
    <link:label id="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount_label_en-US" xlink:label="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Accelerated Share Repurchases, Amount</link:label>
    <link:label id="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount_documentation_en-US" xlink:label="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Accelerated Share Repurchases, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:href="cvs-20211231.xsd#cvs_PaymentsForAcceleratedShareRepurchasesAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:to="lab_cvs_PaymentsForAcceleratedShareRepurchasesAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_507124ce-0809-449a-981d-bdf0b45bff6c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_36691e98-f0a3-41fe-82b8-8a18dbeb7238_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt and lease obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_dd6ab4a5-d70c-4a5d-af4a-86725d8985b0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_ea928dbb-b72c-441d-ab8c-17f919304917_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2beab1f8-2a77-467f-a602-2a89bf4128c7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_ce490eb1-bc62-492b-8dae-5350b78a2467_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_18ee12ec-4b2f-41c3-a727-429a19edd58e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_985500cb-559e-4aa6-95d1-05b5b83305f0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_fc403794-6c59-409c-84f3-f94dd9760f1b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027-2031</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_a75a3124-1cd8-4440-bada-88643d10dfc8_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount awarded from other party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded from Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_4b4cbe74-a7e5-49c0-8d95-16c8140e3abc_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BackUpCreditFacilitiesMember_d752e45a-4dde-45c2-90b6-baf9fcc306db_terseLabel_en-US" xlink:label="lab_cvs_BackUpCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Back-Up Credit Facilities</link:label>
    <link:label id="lab_cvs_BackUpCreditFacilitiesMember_label_en-US" xlink:label="lab_cvs_BackUpCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Back-Up Credit Facilities [Member]</link:label>
    <link:label id="lab_cvs_BackUpCreditFacilitiesMember_documentation_en-US" xlink:label="lab_cvs_BackUpCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Back-Up Credit Facilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BackUpCreditFacilitiesMember" xlink:href="cvs-20211231.xsd#cvs_BackUpCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BackUpCreditFacilitiesMember" xlink:to="lab_cvs_BackUpCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_e7203f77-2d57-4ecc-b57f-a309b3f5863b_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. corporate securities</link:label>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_27056093-62d0-487c-b05c-1825cf931b0f_verboseLabel_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. corporate securities</link:label>
    <link:label id="lab_us-gaap_DomesticCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Corporate, US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_DomesticCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_3565784f-de0a-429b-bd3e-fccf218377f5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LongTermCareReportingUnitMember_fa9e79bc-63af-4432-aa48-565d9787f239_terseLabel_en-US" xlink:label="lab_cvs_LongTermCareReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Care Reporting Unit</link:label>
    <link:label id="lab_cvs_LongTermCareReportingUnitMember_label_en-US" xlink:label="lab_cvs_LongTermCareReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Care Reporting Unit [Member]</link:label>
    <link:label id="lab_cvs_LongTermCareReportingUnitMember_documentation_en-US" xlink:label="lab_cvs_LongTermCareReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Care Reporting Unit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareReportingUnitMember" xlink:href="cvs-20211231.xsd#cvs_LongTermCareReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LongTermCareReportingUnitMember" xlink:to="lab_cvs_LongTermCareReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_ccedbac9-890b-4eff-a169-6294ce3623aa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_c6d777bc-6ce2-494c-a29e-d2b12e0c3737_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber_bc204d53-b8e3-4ee8-9b8c-30fac4f36fb5_terseLabel_en-US" xlink:label="lab_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected to vest (in shares)</link:label>
    <link:label id="lab_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber_label_en-US" xlink:label="lab_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Number</link:label>
    <link:label id="lab_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber_documentation_en-US" xlink:label="lab_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" xlink:href="cvs-20211231.xsd#cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" xlink:to="lab_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_022e8edb-70cf-4054-b20f-a263098eacef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_201c17a1-d96d-4c28-827c-df9a8c12c0f5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_194ee683-87bb-44a8-8b73-2887b1119604_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsDeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="lab_us-gaap_DeferredTaxAssetsDeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_38ab9a04-4a12-4b57-bbef-08ec44406e44_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fc992d7c-7abe-4ad0-8aee-3858a69280cf_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_645cf73b-c1a5-439d-9649-ef3eab5307ef_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_46d6bd9a-d723-4ec2-b7d1-5e5521bcf15a_terseLabel_en-US" xlink:label="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charitable contribution to CVS Health Foundation</link:label>
    <link:label id="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_label_en-US" xlink:label="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Charitable Contribution To Non-Profit Entity</link:label>
    <link:label id="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_documentation_en-US" xlink:label="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Charitable Contribution To Non-Profit Entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:href="cvs-20211231.xsd#cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:to="lab_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_45e1f3d0-b673-4283-9e53-ac2dba409e13_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3041abd1-a05b-46f0-b55d-f873c3a2af3f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_898999ae-f07a-4ff8-a43c-ac15b82b86a2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_03f24f64-1427-4179-913a-164dd1d00287_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_23b9138a-b36a-41dd-8932-e7fa1a842022_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_19430ea6-2a0a-4d0a-9a7a-86569a671696_terseLabel_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common/collective trusts, Equity Securities</link:label>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_label_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Common Collective Trust, Equity Securities [Member]</link:label>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_documentation_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Common Collective Trust, Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:href="cvs-20211231.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:to="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearTwo_3e752b09-7f65-4665-b8dc-d0473f5d4987_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Two</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearTwo_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:to="lab_cvs_LesseeLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_21f2510c-6d51-4ff0-a36b-68f43ffde6f8_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_ae6a1390-b718-4741-b6ac-2ce2976d904b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededPremiumsEarned_c03b3852-5ad8-4c02-a116-e3477402c8e0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CededPremiumsEarned" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded</link:label>
    <link:label id="lab_us-gaap_CededPremiumsEarned_label_en-US" xlink:label="lab_us-gaap_CededPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Premiums Earned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsEarned" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CededPremiumsEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededPremiumsEarned" xlink:to="lab_us-gaap_CededPremiumsEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HeathSavingsAccountBalance_6d8ad622-37e4-46af-8183-2f46ef2e31ea_terseLabel_en-US" xlink:label="lab_cvs_HeathSavingsAccountBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HSA balances</link:label>
    <link:label id="lab_cvs_HeathSavingsAccountBalance_label_en-US" xlink:label="lab_cvs_HeathSavingsAccountBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heath Savings Account Balance</link:label>
    <link:label id="lab_cvs_HeathSavingsAccountBalance_documentation_en-US" xlink:label="lab_cvs_HeathSavingsAccountBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heath Savings Account Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeathSavingsAccountBalance" xlink:href="cvs-20211231.xsd#cvs_HeathSavingsAccountBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HeathSavingsAccountBalance" xlink:to="lab_cvs_HeathSavingsAccountBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_67407585-0df4-4a6c-96c5-9f13eed5a120_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value exercisable at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_9a0fc172-ba1a-44b1-86fe-802226707dce_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.75% senior notes due November 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due November 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueNovember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due November 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.75DueNovember2022Member" xlink:to="lab_cvs_SeniorNotes2.75DueNovember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_e6906734-6cea-4de3-b268-46819cea5dc5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reconciliation of cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_84f28a28-6dd7-4dc8-8b8b-a32e557a4229_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred securities</link:label>
    <link:label id="lab_us-gaap_RedeemablePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemablePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemablePreferredStockMember" xlink:to="lab_us-gaap_RedeemablePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2da636b1-d014-47ca-9fb0-7c4c053185a0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RedeemablePreferredSecuritiesMember_5d836761-88a2-42aa-a58f-aca1e89bab41_terseLabel_en-US" xlink:label="lab_cvs_RedeemablePreferredSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable preferred securities</link:label>
    <link:label id="lab_cvs_RedeemablePreferredSecuritiesMember_label_en-US" xlink:label="lab_cvs_RedeemablePreferredSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Securities [Member]</link:label>
    <link:label id="lab_cvs_RedeemablePreferredSecuritiesMember_documentation_en-US" xlink:label="lab_cvs_RedeemablePreferredSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Preferred Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RedeemablePreferredSecuritiesMember" xlink:href="cvs-20211231.xsd#cvs_RedeemablePreferredSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RedeemablePreferredSecuritiesMember" xlink:to="lab_cvs_RedeemablePreferredSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_c01afcef-02aa-4e89-8825-bb11ce4aae82_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life of property plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_aae7b081-b8b3-44f8-84c7-209839d2c232_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_d893f988-3fb4-42fe-b793-38df17642606_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Accumulated Other Comprehensive Income (Loss) by Component</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_bca50835-2e7a-4a1b-b54b-5520f79f7cc1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_4f0721c0-aaf1-4197-be1f-dfa2b50ca0b5_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated maximum dividend distributions permitted in 2022 without prior regulatory approval</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_4c5a9100-ac1c-4259-9b45-05358655740b_totalLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_fce7de18-be35-43a0-a749-cf3fc9439291_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_c439f98c-71f0-47d9-843d-02bdaa18fde6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_63f6ad4c-088b-4b2c-82ad-6d22635d5dfe_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1b85644a-2d94-47d5-a0c5-bf2e3d16322e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_086a2f1a-499c-42dc-b386-9624d14495a8_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current taxes</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_c365a496-381a-4886-8cfd-29d6dad5e679_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_8510a76d-8c2b-406f-91ec-b0d76ccd05a2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_8ab3a513-e8f9-407b-aece-1ac38e716b04_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost (income)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_f707c411-624d-48ec-91b0-b1d99f7d6e54_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_c465fc4f-dffb-430c-87ce-d8ec85930517_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6a4a2f5e-c038-4f1a-aaeb-cba092920d1e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_39434677-b6bd-4a4a-9c16-4df3b5aeda40_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_8b3d7a88-634c-49ba-9e66-8d95188b58cf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease term (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_58832d76-84ca-4952-a493-3202deb0473f_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_3e122d12-831d-4897-82fc-7d800dab1aa4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_3845766c-f39b-43ab-aecc-27077e6a3c88_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_8fc23697-c151-4509-917f-fff7ddb1c1aa_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_5eb58138-c14f-44dd-a404-53dc673ffa0a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_b419b354-e82a-4452-8697-601813a52781_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_de380a74-7aa4-4218-b0b9-527687b5f247_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_7d2b9f4f-51bd-41b1-a948-14de94f5641e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfPlanMembers_8c01d60d-59f2-4fc2-9c4f-63740a4bc687_terseLabel_en-US" xlink:label="lab_cvs_NumberOfPlanMembers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plan members</link:label>
    <link:label id="lab_cvs_NumberOfPlanMembers_label_en-US" xlink:label="lab_cvs_NumberOfPlanMembers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Plan Members</link:label>
    <link:label id="lab_cvs_NumberOfPlanMembers_documentation_en-US" xlink:label="lab_cvs_NumberOfPlanMembers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Plan Members</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPlanMembers" xlink:href="cvs-20211231.xsd#cvs_NumberOfPlanMembers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfPlanMembers" xlink:to="lab_cvs_NumberOfPlanMembers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_31c91016-2823-48d7-8c73-919239cb8f53_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets and Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_d72b8d8b-3a9f-45fd-8fc5-f0225b226da2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_36a21116-9070-4b6f-8e8f-ec20ca38e8a6_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectsOfReinsuranceTableTextBlock_82293032-7417-497c-abc2-b4f3daa3ac2a_terseLabel_en-US" xlink:label="lab_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of impact of reinsurance on benefit costs</link:label>
    <link:label id="lab_us-gaap_EffectsOfReinsuranceTableTextBlock_label_en-US" xlink:label="lab_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Reinsurance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectsOfReinsuranceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:to="lab_us-gaap_EffectsOfReinsuranceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes1875DueFebruary2031Member_f8c0cec4-d576-4785-a3fc-8e385d5fe709_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.875%, senior notes due February 2031</link:label>
    <link:label id="lab_cvs_SeniorNotes1875DueFebruary2031Member_label_en-US" xlink:label="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.875%, Due February 2031 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes1875DueFebruary2031Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.875%, Due February 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1875DueFebruary2031Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes1875DueFebruary2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes1875DueFebruary2031Member" xlink:to="lab_cvs_SeniorNotes1875DueFebruary2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_ba800423-954b-4ed7-b7ec-e001fa025cd4_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4% senior notes due December 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4%, Due December 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4DueDecember2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4%, Due December 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4DueDecember2023Member" xlink:to="lab_cvs_SeniorNotes4DueDecember2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_c01feeff-9ffb-4464-b2a9-99fb3ae34560_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3d61a28f-bc91-40e1-bfb0-27b3de4e985d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, forfeited ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_9432fc39-4187-463d-a4af-aa63b3bc62e3_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_eda524f4-9974-4e8f-925f-8352229296bb_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_f847be4f-910b-46ff-bb7e-135b929239c6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_e908ce86-bb4a-48d4-a9b9-7d03bfd80a5e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_84d5cfd5-5e5b-49b1-8a27-f8be64668574_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_2419b95b-ce03-4ac5-adba-9d389ca7dcf0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FloatingRateNotesMember_e10eb4f4-e3a6-4f7e-9d8e-cc3643d934d5_terseLabel_en-US" xlink:label="lab_cvs_FloatingRateNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes</link:label>
    <link:label id="lab_cvs_FloatingRateNotesMember_label_en-US" xlink:label="lab_cvs_FloatingRateNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes [Member]</link:label>
    <link:label id="lab_cvs_FloatingRateNotesMember_documentation_en-US" xlink:label="lab_cvs_FloatingRateNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesMember" xlink:href="cvs-20211231.xsd#cvs_FloatingRateNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FloatingRateNotesMember" xlink:to="lab_cvs_FloatingRateNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAbstract_b8bcd218-0f60-4431-9ad5-dd653b643114_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:label id="lab_us-gaap_InsuranceAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableTable_8d439458-21e4-49c4-a124-d69165e19117_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableTable_label_en-US" xlink:label="lab_us-gaap_DividendsPayableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableTable" xlink:to="lab_us-gaap_DividendsPayableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ad08be22-30ce-4b10-bbf3-308ad4c6c5d1_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgeFundsMember_ffb4c01c-a919-4c88-b4a6-2160a8fa614b_verboseLabel_en-US" xlink:label="lab_us-gaap_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge fund investments</link:label>
    <link:label id="lab_us-gaap_HedgeFundsMember_e2f2f72d-80dc-41f9-aab2-21751e4e29c9_terseLabel_en-US" xlink:label="lab_us-gaap_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Funds</link:label>
    <link:label id="lab_us-gaap_HedgeFundsMember_label_en-US" xlink:label="lab_us-gaap_HedgeFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgeFundsMember" xlink:to="lab_us-gaap_HedgeFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_16fc987c-e3bc-46d7-b6c1-8d399184caad_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in plan assets:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_b0c2fc4d-50c4-4968-bb4a-473f379cf52a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_aee6bae2-2158-47a7-ad10-5a7d5541768d_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_6e711f70-4ad6-4a19-8cfc-538c9f36299f_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_c5f6dcbd-0ec1-47bf-9ae0-d998cd2959a6_terseLabel_en-US" xlink:label="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_label_en-US" xlink:label="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:to="lab_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_8f638fd6-ead6-4ecf-9b07-ee4f72b77bac_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e4779a33-8065-426b-b1c2-f8678e4550fa_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_381bb52d-b8df-4e2a-bb66-40847f61ddad_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e1b76d9e-5327-4e28-b78a-31bb13818b4a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_901612c1-ef09-472b-9f03-f4d60dc276b5_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% senior notes due August 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.375%, Due August 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.375DueAugust2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.375%, Due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.375DueAugust2024Member" xlink:to="lab_cvs_SeniorNotes3.375DueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d0b3007b-b65f-4e34-882b-ba8f6d879ee2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_de970951-d366-4e2d-bebc-f4ba1bac1db4_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_917400bc-d443-4f41-b55f-dfa56e18f1a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_3765bba8-f8b1-487f-bc31-0d33a925e2a5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_e6334e99-0f6b-4648-8a99-e884dcae1910_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% senior notes due August 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.3%, Due August 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes13DueAugust2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.3%, Due August 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes13DueAugust2027Member" xlink:to="lab_cvs_SeniorNotes13DueAugust2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ChangeInContractWithCustomerLiabilityRollForward_3366a5b4-d868-4c00-ab4e-b67eefca0175_terseLabel_en-US" xlink:label="lab_cvs_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cvs_ChangeInContractWithCustomerLiabilityRollForward_label_en-US" xlink:label="lab_cvs_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Roll Forward]</link:label>
    <link:label id="lab_cvs_ChangeInContractWithCustomerLiabilityRollForward_documentation_en-US" xlink:label="lab_cvs_ChangeInContractWithCustomerLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeInContractWithCustomerLiabilityRollForward" xlink:href="cvs-20211231.xsd#cvs_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ChangeInContractWithCustomerLiabilityRollForward" xlink:to="lab_cvs_ChangeInContractWithCustomerLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_113eaef3-3549-4258-a9c9-0edee28fd0a6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation not yet recognized, options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_ba3268b3-cc34-4361-a2ae-ccf8e1e8d0c4_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% senior notes due March 2044</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due March 2044 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueMarch2044Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due March 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.75DueMarch2044Member" xlink:to="lab_cvs_SeniorNotes4.75DueMarch2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_3afa7628-bcdd-4479-b70a-22e5643fd9cc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_53360dc7-dd62-4360-b35b-9ff5e424750f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_04661c3e-b139-467d-b388-de44202f61a0_terseLabel_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP issuances, net of purchase of treasury shares</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_documentation_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:href="cvs-20211231.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:to="lab_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_30f52d24-ef54-43cf-a1ba-b31c8f9d62b9_negatedTerseLabel_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discounts and deferred financing costs</link:label>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_label_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</link:label>
    <link:label id="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_documentation_en-US" xlink:label="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:href="cvs-20211231.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:to="lab_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ab90a4f6-183e-4e28-86c3-12f88a608357_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation not yet recognized, other than options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_169b8db1-d88a-478c-9779-d4131111f603_terseLabel_en-US" xlink:label="lab_cvs_EmployeeStockOptionsandStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Options and Stock Appreciation Rights</link:label>
    <link:label id="lab_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_label_en-US" xlink:label="lab_cvs_EmployeeStockOptionsandStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Options and Stock Appreciation Rights [Member]</link:label>
    <link:label id="lab_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_documentation_en-US" xlink:label="lab_cvs_EmployeeStockOptionsandStockAppreciationRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Options and Stock Appreciation Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember" xlink:href="cvs-20211231.xsd#cvs_EmployeeStockOptionsandStockAppreciationRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember" xlink:to="lab_cvs_EmployeeStockOptionsandStockAppreciationRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_7d0e3e63-d2d8-4eae-839e-1cd62ac05581_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_fbcadf7e-a9c4-41c1-864f-b0315bc940dd_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_28612a1a-0096-405e-968d-e332b0108c6e_terseLabel_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains from sale-leaseback transactions</link:label>
    <link:label id="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet_label_en-US" xlink:label="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and Leaseback Transaction, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:to="lab_us-gaap_SaleAndLeasebackTransactionGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDue_50d71664-647e-4235-b893-4dd8338bb478_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDue_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDue_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDue" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDue" xlink:to="lab_cvs_LesseeLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansMember_26dc8786-c940-40d5-a3dd-23cad38d82e8_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_cvs_MortgageLoansMember_label_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans [Member]</link:label>
    <link:label id="lab_cvs_MortgageLoansMember_documentation_en-US" xlink:label="lab_cvs_MortgageLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents mortgage loans for the reporting period measured at carrying value. We carry the value of our mortgage loan investments on our balance sheet at the unpaid principal balance, net of impairment reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansMember" xlink:to="lab_cvs_MortgageLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearThree_04346e1d-396a-4aac-b97c-ad23195eece4_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Three</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearThree_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:to="lab_cvs_LesseeLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_766410a3-6ce0-4df8-8f63-8cbd644dc63b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f396b435-6ab6-4ef9-b45b-8b8f8f6e258f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_2b8f8274-884b-4ec1-8095-eada8f42fa80_totalLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Commercial and Consumer, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_8dc901c1-6021-4952-850a-77dd16f4f22b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_b74ed5dd-664b-4a1c-9668-3c5fa4b74996_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_a9b5755a-bd5b-46c6-a094-6f8be6427767_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_d95b0df8-c3cc-427a-b156-6ef2a3e8f76b_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ProceedsFromVariableInterestEntity_5c2e917a-9d3b-4e02-a15b-91d90177e4cb_terseLabel_en-US" xlink:label="lab_cvs_ProceedsFromVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from VIE</link:label>
    <link:label id="lab_cvs_ProceedsFromVariableInterestEntity_label_en-US" xlink:label="lab_cvs_ProceedsFromVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Variable Interest Entity</link:label>
    <link:label id="lab_cvs_ProceedsFromVariableInterestEntity_documentation_en-US" xlink:label="lab_cvs_ProceedsFromVariableInterestEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Variable Interest Entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsFromVariableInterestEntity" xlink:href="cvs-20211231.xsd#cvs_ProceedsFromVariableInterestEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ProceedsFromVariableInterestEntity" xlink:to="lab_cvs_ProceedsFromVariableInterestEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes43Due2028Member_df113003-28e1-4e74-89db-c17722c8749c_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes43Due2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.3% senior notes due 2028</link:label>
    <link:label id="lab_cvs_SeniorNotes43Due2028Member_label_en-US" xlink:label="lab_cvs_SeniorNotes43Due2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due 2028 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes43Due2028Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes43Due2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes43Due2028Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes43Due2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes43Due2028Member" xlink:to="lab_cvs_SeniorNotes43Due2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2021Member_354534ba-77b1-4165-b5b0-20fd61577c70_terseLabel_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating rate notes due March 2021</link:label>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2021Member_label_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due March 2021 [Member]</link:label>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2021Member_documentation_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due March 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2021Member" xlink:href="cvs-20211231.xsd#cvs_FloatingRateNotesDueMarch2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FloatingRateNotesDueMarch2021Member" xlink:to="lab_cvs_FloatingRateNotesDueMarch2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_7ad80453-5db3-4362-9405-b80d0507a9eb_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash (included in other assets)</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsLineItems_7ce64e8b-c611-4905-9e20-a059c74dc225_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Line Items]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsLineItems_label_en-US" xlink:label="lab_cvs_TotalInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems" xlink:href="cvs-20211231.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsLineItems" xlink:to="lab_cvs_TotalInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_4094291c-84c0-4c36-97a8-791ea615d1cb_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesMember_3f59311b-4bce-4f38-9b84-c6ef92e08289_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesMember_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities [Member]</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesMember_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesMember" xlink:href="cvs-20211231.xsd#cvs_OtherInsuranceLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesMember" xlink:to="lab_cvs_OtherInsuranceLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_59f3919e-b155-4def-bb5f-eea5329c0dea_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_2ee6b1f5-d4d3-4342-8960-977cdbab848c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_6abff85c-897a-42e8-b4f7-ec6024d1599c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Assets Transferred into (out of) Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels" xlink:to="lab_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_fdad47d1-e68f-44c5-b722-4af2e25ccbe5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.35DueMarch2021Member_e9d154ab-11a1-4c45-91ed-e3e62d1606f0_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.35DueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.35% senior notes due March 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes3.35DueMarch2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.35DueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.35%, Due March 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.35DueMarch2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.35DueMarch2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.35%, Due March 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.35DueMarch2021Member" xlink:to="lab_cvs_SeniorNotes3.35DueMarch2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_f00ed8ed-94eb-4034-b7be-7578abc2fbef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in benefit obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Projected Benefit Obligations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_0cb9810a-a74a-4a63-b6f3-e294690df560_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_756d6812-d485-4a4a-9eb7-13121597a37e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_4e7cdc0f-93f6-4dba-885d-0fba9d386756_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember_f2a585d5-75b8-437a-85d4-d5cd9f0c179f_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign securities</link:label>
    <link:label id="lab_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Government Short-term Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BarclaysBankMember_9adaceea-b63f-4110-9f29-ef378fc534e0_terseLabel_en-US" xlink:label="lab_cvs_BarclaysBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays Bank</link:label>
    <link:label id="lab_cvs_BarclaysBankMember_label_en-US" xlink:label="lab_cvs_BarclaysBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays Bank [Member]</link:label>
    <link:label id="lab_cvs_BarclaysBankMember_documentation_en-US" xlink:label="lab_cvs_BarclaysBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays Bank</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BarclaysBankMember" xlink:href="cvs-20211231.xsd#cvs_BarclaysBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BarclaysBankMember" xlink:to="lab_cvs_BarclaysBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_c206f128-73a7-4db0-b1bd-9724792e3c34_terseLabel_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other increases (decreases) in noncontrolling interest</link:label>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_label_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, Other Period Increase (Decrease)</link:label>
    <link:label id="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, Other Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:href="cvs-20211231.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:to="lab_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_9b12d396-bc36-457f-bcfc-0e777e6b0df1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4125DueApril2040Member_dcd57aad-0058-462a-a994-33c30b61ccc4_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due April 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes4125DueApril2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due April 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4125DueApril2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4125DueApril2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due April 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4125DueApril2040Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4125DueApril2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4125DueApril2040Member" xlink:to="lab_cvs_SeniorNotes4125DueApril2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_448cc472-42b1-4b86-8ca2-37df1f0e9332_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income tax provision</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_d7bcc5b8-c20d-4360-b0dc-0f1c0d5e1596_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_5aba0664-add9-4ad5-a914-4d1977187697_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LimitedPaymentsContracts_0b9ec310-3615-44ba-9615-7d90f8b2cfe7_terseLabel_en-US" xlink:label="lab_cvs_LimitedPaymentsContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed interest rates on limited payment pension contracts on large case pension business (in hundredths)</link:label>
    <link:label id="lab_cvs_LimitedPaymentsContracts_label_en-US" xlink:label="lab_cvs_LimitedPaymentsContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Payments Contracts</link:label>
    <link:label id="lab_cvs_LimitedPaymentsContracts_documentation_en-US" xlink:label="lab_cvs_LimitedPaymentsContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum assumed interest rates on limited payment contracts on large case pensions business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LimitedPaymentsContracts" xlink:href="cvs-20211231.xsd#cvs_LimitedPaymentsContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LimitedPaymentsContracts" xlink:to="lab_cvs_LimitedPaymentsContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_748865a3-3f3d-49b4-8275-d3618cd4e065_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_f6b66ee4-99c1-4fcc-ac30-4322d413acc1_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_826ef42c-bff7-43ef-baf8-6c14163c42bd_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseTermOfContract1_e4168605-8986-4eb8-a4ab-39e7909f8858_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease term (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:to="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_8b6d3766-9537-4510-a5f1-5f279532fd2c_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_3d392502-2c28-4c42-972c-9ea6ed45bc0e_terseLabel_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities available for sale</link:label>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_label_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Securities Available For Sale [Member]</link:label>
    <link:label id="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_documentation_en-US" xlink:label="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities. Such securities are reported at fair value; unrealized gains and losses related to Available-for-sale securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:href="cvs-20211231.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:to="lab_cvs_DebtAndEquitySecuritiesAvailableForSaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_ab90eff9-789c-4274-bc6b-284f53829ada_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_6892ab7f-96f9-4047-988e-70db8585ea1d_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_4c7559c1-6e21-4cb8-9924-3c85f2fd6ad6_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of basic and diluted earnings (loss) per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_a61f58e0-9405-452d-8f4d-60eb4ed46e27_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_438319a1-3e80-40fe-8788-056189e7aed5_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_label_en-US" xlink:label="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:to="lab_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_3e87e1ea-0cf6-467c-b7ea-48b4809552e6_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_5d570ad5-0b7d-4fb1-ab58-358b70b40a26_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net realized capital gains</link:label>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_label_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:to="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_4a752c83-a1c5-4437-bd76-9cb7a9581e86_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_db506b6f-7e6f-44e4-87d0-e130b0fbc91d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_99e18721-b0da-4241-9353-0c4ed19e81e7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_d4eece29-a771-41d8-ba79-cdf4325869ac_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_979f18d2-4bf6-4a5f-a52c-6200c01fc0be_negatedTerseLabel_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_label_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Accumulated Depreciation</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_documentation_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Accumulated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:href="cvs-20211231.xsd#cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:to="lab_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_bf312a35-ac9b-4986-8701-5830c636bc3b_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_b3c18f3a-3851-4cb3-91aa-dd319d856f30_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_8f0101db-5103-4dd2-80e1-d421ae50653a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of liability for unpaid claims and claims adjustment expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_cd9977cb-0c07-4d42-ac76-c3d6c07540a8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_f8711ea7-1d30-4249-b015-38bb3fc19923_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.75% senior notes due December 2037</link:label>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.75%, Due December 2037 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.75DueDecember2037Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.75%, Due December 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.75DueDecember2037Member" xlink:to="lab_cvs_SeniorNotes6.75DueDecember2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b7bed5d2-b36b-49a2-aa08-99e95ffac67d_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (income) loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_995e24d7-4fd9-4b28-96f8-e87b956fff3e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive (income) loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_242ed558-86d8-4e87-8a2b-6cd60ff54c18_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Life (years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Weighted Average Period before Next Renewal or Extension</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d4acd49-ada7-45ed-ac20-1527267dad1b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LossContingencyAuditMethodologySampleSize_c7201291-a1ae-4069-8203-1d34bfaef76f_terseLabel_en-US" xlink:label="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit methodology sample size</link:label>
    <link:label id="lab_cvs_LossContingencyAuditMethodologySampleSize_label_en-US" xlink:label="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Audit Methodology Sample Size</link:label>
    <link:label id="lab_cvs_LossContingencyAuditMethodologySampleSize_documentation_en-US" xlink:label="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Audit Methodology Sample Size</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyAuditMethodologySampleSize" xlink:href="cvs-20211231.xsd#cvs_LossContingencyAuditMethodologySampleSize"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LossContingencyAuditMethodologySampleSize" xlink:to="lab_cvs_LossContingencyAuditMethodologySampleSize" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_c6cb01c3-a46d-4b0e-8292-db1b2bd345b2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_5db259d0-5d37-4292-aa01-d6c286655da5_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ValueOfBusinessAcquiredMember_938f99b0-732f-4d51-ad06-d5a81fb929c0_terseLabel_en-US" xlink:label="lab_cvs_ValueOfBusinessAcquiredMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of Business Acquired</link:label>
    <link:label id="lab_cvs_ValueOfBusinessAcquiredMember_label_en-US" xlink:label="lab_cvs_ValueOfBusinessAcquiredMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Of Business Acquired [Member]</link:label>
    <link:label id="lab_cvs_ValueOfBusinessAcquiredMember_documentation_en-US" xlink:label="lab_cvs_ValueOfBusinessAcquiredMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Of Business Acquired [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ValueOfBusinessAcquiredMember" xlink:href="cvs-20211231.xsd#cvs_ValueOfBusinessAcquiredMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ValueOfBusinessAcquiredMember" xlink:to="lab_cvs_ValueOfBusinessAcquiredMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_09e5aa32-5af6-474d-a081-9a1a3115fa8c_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.875% senior notes due July 2025</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due July 2025 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.875DueJuly2025Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.875%, Due July 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.875DueJuly2025Member" xlink:to="lab_cvs_SeniorNotes3.875DueJuly2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_6e7fc5d3-1c21-4d9b-9a38-b3cb5f21345a_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease costs and supplemental cash flow information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_24d13669-7ca2-473b-83d7-82e1cb5906c8_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed</link:label>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_label_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:to="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive_bae4b0fc-394d-4ea7-80db-74db7feedde4_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due After Year Five</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:to="lab_cvs_LesseeLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LeasesWeightedAverageDiscountRateAbstract_3bc5ce95-8a72-46d1-92c5-f81ccb70f3fd_terseLabel_en-US" xlink:label="lab_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_cvs_LeasesWeightedAverageDiscountRateAbstract_label_en-US" xlink:label="lab_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Weighted Average Discount Rate [Abstract]</link:label>
    <link:label id="lab_cvs_LeasesWeightedAverageDiscountRateAbstract_documentation_en-US" xlink:label="lab_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Weighted Average Discount Rate [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:href="cvs-20211231.xsd#cvs_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:to="lab_cvs_LeasesWeightedAverageDiscountRateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_9d9981b0-2fb8-4e0b-937f-cd21e4a21baa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentsMember" xlink:to="lab_us-gaap_OtherInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.45DueJune2021Member_fdffb85c-bb44-47fa-acba-6d8d40e24cd8_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.45DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.45% senior notes due June 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes5.45DueJune2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.45DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.45%, Due June 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.45DueJune2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.45DueJune2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item represents senior notes due 2021 with a coupon rate of 5.45%.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.45DueJune2021Member" xlink:to="lab_cvs_SeniorNotes5.45DueJune2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BrazilSubsidiaryMember_92fb8179-ed67-41f7-87ca-b95afd1a2835_terseLabel_en-US" xlink:label="lab_cvs_BrazilSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil Subsidiary</link:label>
    <link:label id="lab_cvs_BrazilSubsidiaryMember_label_en-US" xlink:label="lab_cvs_BrazilSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil Subsidiary [Member]</link:label>
    <link:label id="lab_cvs_BrazilSubsidiaryMember_documentation_en-US" xlink:label="lab_cvs_BrazilSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil Subsidiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BrazilSubsidiaryMember" xlink:href="cvs-20211231.xsd#cvs_BrazilSubsidiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BrazilSubsidiaryMember" xlink:to="lab_cvs_BrazilSubsidiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_172c6b32-f021-4f62-89b3-4374019a1169_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_2f296caf-3c39-4d77-9e44-db662edda994_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2Point125PercentDueSeptember2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% senior notes due September 2031</link:label>
    <link:label id="lab_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2Point125PercentDueSeptember2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2 Point 125 Percent, Due September 2031 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2Point125PercentDueSeptember2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2 Point 125 Percent, Due September 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2Point125PercentDueSeptember2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member" xlink:to="lab_cvs_SeniorNotes2Point125PercentDueSeptember2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_5ed67f8c-0c11-4b33-8c88-b9baa60c7f0e_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial liabilities fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_78244c0a-d589-4b7f-820b-c1443cf00bd6_verboseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfPeopleServed_69434d4f-bf0f-440a-b9f8-364e543b0b7b_terseLabel_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of people served</link:label>
    <link:label id="lab_cvs_NumberOfPeopleServed_label_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Served</link:label>
    <link:label id="lab_cvs_NumberOfPeopleServed_documentation_en-US" xlink:label="lab_cvs_NumberOfPeopleServed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of People Served</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed" xlink:href="cvs-20211231.xsd#cvs_NumberOfPeopleServed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfPeopleServed" xlink:to="lab_cvs_NumberOfPeopleServed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_0ac5e434-e681-4199-8c75-bac7786bd0be_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_28cca065-23ac-4aed-9bc2-80f2634fb20f_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average duration of securities</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Weighted Average Duration Of Securities</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Weighted Average Duration Of Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_be6217bc-a9fe-4822-a074-33a612823133_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_9dd831f0-c2fe-491d-9592-9fb000af4170_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost: 422 and 423 shares at December&#160;31, 2021 and 2020</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeparateAccountFinancialAssetsMember_d8ea11cf-1029-46d7-8106-655f9bc217b7_terseLabel_en-US" xlink:label="lab_cvs_SeparateAccountFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Accounts, financial assets</link:label>
    <link:label id="lab_cvs_SeparateAccountFinancialAssetsMember_label_en-US" xlink:label="lab_cvs_SeparateAccountFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Financial Assets [Member]</link:label>
    <link:label id="lab_cvs_SeparateAccountFinancialAssetsMember_documentation_en-US" xlink:label="lab_cvs_SeparateAccountFinancialAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account, Financial Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeparateAccountFinancialAssetsMember" xlink:href="cvs-20211231.xsd#cvs_SeparateAccountFinancialAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeparateAccountFinancialAssetsMember" xlink:to="lab_cvs_SeparateAccountFinancialAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_02fba7c7-bfa5-439f-a8ab-ad37f0b6724c_terseLabel_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment contracts with a fixed maturity</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_label_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts With Fixed Maturity, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Contracts With Fixed Maturity, Fair Value Disclosure.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:href="cvs-20211231.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:to="lab_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0175e6fe-f614-4153-93a8-e9d2ed02c511_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_a32daf14-4498-42fb-8a0a-2b4757c6c4a0_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax penalties and interest expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_41e67389-411e-4b62-8d48-53b075703749_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.5% senior notes due November 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due November 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.5DueNovember2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.5%, Due November 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.5DueNovember2024Member" xlink:to="lab_cvs_SeniorNotes3.5DueNovember2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_990edffd-1556-4f01-83a2-253003e4edef_terseLabel_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former gain contingency, recognized in current period, net of tax</link:label>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Gain Contingency, Recognized in Current Period, Net of Tax</link:label>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_documentation_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Gain Contingency, Recognized in Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:href="cvs-20211231.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:to="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_41c079fa-5b22-4b42-a81f-556cf20d94c1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_151534c9-8c98-4df0-aa46-c9dce7784c38_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_A2021AcceleratedRepurchaseProgramMember_ea1c7eb9-5928-4c82-a800-d3cc135820d0_terseLabel_en-US" xlink:label="lab_cvs_A2021AcceleratedRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 ASR</link:label>
    <link:label id="lab_cvs_A2021AcceleratedRepurchaseProgramMember_label_en-US" xlink:label="lab_cvs_A2021AcceleratedRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Accelerated Repurchase Program [Member]</link:label>
    <link:label id="lab_cvs_A2021AcceleratedRepurchaseProgramMember_documentation_en-US" xlink:label="lab_cvs_A2021AcceleratedRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Accelerated Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021AcceleratedRepurchaseProgramMember" xlink:href="cvs-20211231.xsd#cvs_A2021AcceleratedRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_A2021AcceleratedRepurchaseProgramMember" xlink:to="lab_cvs_A2021AcceleratedRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_6c7d3237-451b-47f0-96c6-ed5c8abbc7a9_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_c3384d79-9362-4d85-b4aa-832b44be68f6_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other insurance liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Current</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesCurrent_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent" xlink:href="cvs-20211231.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesCurrent" xlink:to="lab_cvs_OtherInsuranceLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_1e84c793-ebf3-4f45-881b-8e0ae5065c4a_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.75% senior notes due December 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due December 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.75DueDecember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.75%, Due December 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.75DueDecember2022Member" xlink:to="lab_cvs_SeniorNotes2.75DueDecember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_f4c82d94-659a-4dd9-98bd-a4abdcae04fa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_4f64ce10-57c4-4238-8727-986dba06af32_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_fe6cda71-113f-465e-8fd1-db571ea8f1d2_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from derivative instruments</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Derivative Instrument, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_9c4f4c01-a261-4cce-ad00-e77fc7af2b1f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_b2c95449-7698-438f-bd79-269f01bd74f8_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AuditorInformationAbstract_label_en-US" xlink:label="lab_cvs_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_cvs_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_cvs_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AuditorInformationAbstract" xlink:href="cvs-20211231.xsd#cvs_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AuditorInformationAbstract" xlink:to="lab_cvs_AuditorInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_98d20aeb-58c7-492d-9fac-c3fda7f20c9d_verboseLabel_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium deficiency reserve</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_c8fc1f22-189f-408d-bc86-13192e5e6991_terseLabel_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Premium deficiency reserve</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_label_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Deficiency Reserve Liability</link:label>
    <link:label id="lab_cvs_PremiumDeficiencyReserveLiability_documentation_en-US" xlink:label="lab_cvs_PremiumDeficiencyReserveLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability" xlink:href="cvs-20211231.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumDeficiencyReserveLiability" xlink:to="lab_cvs_PremiumDeficiencyReserveLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_97fc6787-527b-4308-8617-9e2977164652_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Other Revenues from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member_ad8ad1db-2349-478d-ac7a-b073d575ad55_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.875% senior notes due February 2031</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member_label_en-US" xlink:label="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 875 Percent, February 2031 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 875 Percent, February 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes1Point875PercentFebruary2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:to="lab_cvs_SeniorNotes1Point875PercentFebruary2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LeaseLiability_999f9a6b-7308-4954-92e9-2ab819c856d3_totalLabel_en-US" xlink:label="lab_cvs_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_cvs_LeaseLiability_label_en-US" xlink:label="lab_cvs_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:label id="lab_cvs_LeaseLiability_documentation_en-US" xlink:label="lab_cvs_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeaseLiability" xlink:href="cvs-20211231.xsd#cvs_LeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LeaseLiability" xlink:to="lab_cvs_LeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_b6cfd7ac-2954-4079-837d-0065c91fec59_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_706d8534-0e92-4cdd-bbad-dffc62de29c2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e803cd23-72e4-48f2-882f-a50254f18eef_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFour_6434e037-d63e-48b4-913d-041012a14e7b_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Four</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFour_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:to="lab_cvs_LesseeLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_4b3eca4a-b703-4544-872d-73436fdec148_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AetnaInc2010StockIncentivePlanMember_d4240dea-3993-4fce-998b-2c15c42a514d_terseLabel_en-US" xlink:label="lab_cvs_AetnaInc2010StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna Inc 2010 Stock Incentive Plan</link:label>
    <link:label id="lab_cvs_AetnaInc2010StockIncentivePlanMember_label_en-US" xlink:label="lab_cvs_AetnaInc2010StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna Inc 2010 Stock Incentive Plan [Member]</link:label>
    <link:label id="lab_cvs_AetnaInc2010StockIncentivePlanMember_documentation_en-US" xlink:label="lab_cvs_AetnaInc2010StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aetna Inc 2010 Stock Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc2010StockIncentivePlanMember" xlink:href="cvs-20211231.xsd#cvs_AetnaInc2010StockIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AetnaInc2010StockIncentivePlanMember" xlink:to="lab_cvs_AetnaInc2010StockIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_289ed7e4-3388-45c1-95ca-b00b85045a75_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due November 2042</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.125%, Due November 2042 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.125DueNovember2042Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item represents senior notes due 2042 with a coupon rate of 4.125%.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.125DueNovember2042Member" xlink:to="lab_cvs_SeniorNotes4.125DueNovember2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_64546442-19a9-483d-b350-a2642c44ef4d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Fair Value, Inputs, Level 1, 2 and 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1, 2 and 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:to="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_120acb9b-c29c-43a3-b687-c136312865d9_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Direct</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_979a97ea-4c1d-4965-960a-dc9399dff49a_terseLabel_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Co-payments</link:label>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_label_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Retail CoPayments</link:label>
    <link:label id="lab_cvs_NetRevenuesRetailCoPayments_documentation_en-US" xlink:label="lab_cvs_NetRevenuesRetailCoPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Revenues, Retail CoPayments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments" xlink:href="cvs-20211231.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NetRevenuesRetailCoPayments" xlink:to="lab_cvs_NetRevenuesRetailCoPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_98cdc54c-7a76-4f5c-8f32-75047b0ab8b3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_2fdb8473-6717-448f-8c5a-a401e2005bdd_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2b23923b-33a4-4666-91a5-644990e2f054_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_7f438418-b64f-46e8-b3cc-bf1a182b34c7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_33fa1109-8357-4817-a946-b8ac9b50fa15_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_606a5c15-74f1-438e-8689-4fe67fd11894_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_93a7d471-b974-4c8a-b5cf-6e7ee94a6e37_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_b5ed03d5-9bce-4838-b751-11dded7474e1_terseLabel_en-US" xlink:label="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixtures, equipment and internally developed software</link:label>
    <link:label id="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_label_en-US" xlink:label="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixtures, Equipment And Internally Developed Software [Member]</link:label>
    <link:label id="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_documentation_en-US" xlink:label="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixtures, Equipment And Internally Developed Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:href="cvs-20211231.xsd#cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:to="lab_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentIncome_e3d187f3-332d-40b7-9183-7c11c2c99742_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_NetInvestmentIncome_label_en-US" xlink:label="lab_us-gaap_NetInvestmentIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentIncome" xlink:to="lab_us-gaap_NetInvestmentIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_031822ee-2ac6-4124-96d5-dc30c12f6e35_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e8d6ea39-8c8b-4a1d-ab24-a82272ff7e15_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_2aabc174-28a5-4602-ac59-3a2c5f948175_terseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure_8a08f83b-e384-4bfe-87c1-101b263f3a82_terseLabel_en-US" xlink:label="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgages Held-for-sale, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:to="lab_us-gaap_MortgagesHeldForSaleFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_dd784128-2787-438e-9087-5763795a3361_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_d7533144-a5fa-4cd0-822d-35bd6d9d685a_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual pretax amortization for other acquired intangible assets over the next five years</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_180d8466-c976-4dab-a6fa-e257e4d66c70_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Included in other comprehensive income</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_f2842a44-0cb1-472f-9efa-f2ca9ab8c111_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_390794f7-09d1-4b2d-9583-ce520962b061_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_34491d27-d9ad-4c2a-b6f0-db3899d07029_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_d76e1af9-03a9-4136-af78-2e8509662d26_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_e7d96d82-544b-4abb-865b-db54211f7d13_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_c1caa5cc-21fb-4e4b-92ec-af3a3f592a1d_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_a9498853-b552-4ff8-8c63-28dbbaae2d70_verboseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative translation adjustment from AOCI eliminated upon divestiture</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_fca2f8b1-eb9b-4492-89f9-a6e69e4bfaf4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified from accumulated other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LiabilityforUnpaidClaims_8655be7f-aff6-4e58-a486-4d5416bec031_terseLabel_en-US" xlink:label="lab_cvs_LiabilityforUnpaidClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for unpaid claims</link:label>
    <link:label id="lab_cvs_LiabilityforUnpaidClaims_label_en-US" xlink:label="lab_cvs_LiabilityforUnpaidClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims</link:label>
    <link:label id="lab_cvs_LiabilityforUnpaidClaims_documentation_en-US" xlink:label="lab_cvs_LiabilityforUnpaidClaims" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the total liability on the balance sheet for unpaid claims for both short-duration and long-duration insurance contracts after reinsurance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityforUnpaidClaims" xlink:href="cvs-20211231.xsd#cvs_LiabilityforUnpaidClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LiabilityforUnpaidClaims" xlink:to="lab_cvs_LiabilityforUnpaidClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_e74140af-1100-4995-889c-ed4cef4172e1_negatedTerseLabel_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares, net of ESPP issuances</link:label>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_label_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:label id="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_documentation_en-US" xlink:label="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:href="cvs-20211231.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:to="lab_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_d6c6d6c7-b5f7-42d3-93ac-a9629a9e8ce9_terseLabel_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal home loan bank advances maximum amount available</link:label>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_label_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank, Advances, General Debt Obligations, Maximum Amount Available</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" xlink:to="lab_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_8163e236-4bd7-498a-b1d6-d36446ae135f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of stock options and stock appreciation rights award activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_e8ed5dd0-cab8-408d-a238-748e02336d8e_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated minimum statutory surplus required by regulators</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus Required</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d01bee8b-dfaa-439c-ac36-03dd02c27e08_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, outstanding at beginning of year ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7b490fd6-8642-4860-a13f-5614aef77263_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, outstanding at end of year ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_54351aa2-9840-417f-a15a-b72dd497e9be_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_5e182d2c-f26b-44ce-ad16-749f7a13db7a_terseLabel_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting remaining products</link:label>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_label_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting Remaining Products [Member]</link:label>
    <link:label id="lab_cvs_SupportingRemainingProductsMember_documentation_en-US" xlink:label="lab_cvs_SupportingRemainingProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities in an unrealized capital loss position supporting remaining products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember" xlink:href="cvs-20211231.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SupportingRemainingProductsMember" xlink:to="lab_cvs_SupportingRemainingProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_a48ea242-1827-492f-b3eb-ddd400c530a5_terseLabel_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states the Company has submitted regulatory filings for a January 2022 entrance into the individual public health insurance exchange</link:label>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_label_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States</link:label>
    <link:label id="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_documentation_en-US" xlink:label="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:href="cvs-20211231.xsd#cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:to="lab_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_80a599e2-bc48-4678-a0ff-68abb204b8b0_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_df9433bb-435d-4bc2-b469-40df23a60911_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_4ee9a8b4-2590-43cd-9a6a-b42b228c7a50_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_31f4d75c-d514-440b-904c-fe4b8f5cebf4_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_a336f859-b482-419b-8e13-3189faf817b9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumsMember_df28e328-060e-4bd7-85f9-f603882ca854_terseLabel_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_cvs_PremiumsMember_label_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums [Member]</link:label>
    <link:label id="lab_cvs_PremiumsMember_documentation_en-US" xlink:label="lab_cvs_PremiumsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember" xlink:href="cvs-20211231.xsd#cvs_PremiumsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumsMember" xlink:to="lab_cvs_PremiumsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8d89b698-6ddd-4aa4-bdf8-5cb8332bc83d_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_3ffa6f21-302a-4e94-98f5-e4068ea4826e_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.75% senior notes due May 2041</link:label>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.75%, Due May 2041 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5.75DueMay2041Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5.75%, Due May 2041 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5.75DueMay2041Member" xlink:to="lab_cvs_SeniorNotes5.75DueMay2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_4fc94336-ab1d-4d78-b2bc-8efdf02fd8ed_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife_5c70167d-d32b-4d85-9d59-6ce186aa35e6_terseLabel_en-US" xlink:label="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, amount due in excess of remaining estimated economic life</link:label>
    <link:label id="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife_label_en-US" xlink:label="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Capital Leases, Amount Due In Excess Of Remaining Estimated Economic Life</link:label>
    <link:label id="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife_documentation_en-US" xlink:label="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating And Capital Leases, Amount Due In Excess Of Remaining Estimated Economic Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:href="cvs-20211231.xsd#cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:to="lab_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_210046e0-dfde-4b53-bcab-f7f47dc6eb6f_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_136790b2-2e24-4251-a092-99f9acab05fb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales and maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_2c44c96d-bb99-4916-9e6b-f61196572642_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_b519f0b7-566c-4998-aae1-87a2ba6a1caf_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_8df3101b-d0b3-4b12-907f-232e80c7bdf0_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_a971fc92-7205-4ec7-b76b-3a0363e90064_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_9e8cd5b7-18ba-4a21-907d-7d527002afc3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_fcea9f8e-b538-45d0-96e0-acfb51498712_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total health care costs payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_8fa6bc8c-3b71-4b9f-9f0d-c9f5b0ca3e04_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, beginning of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_139fb943-c664-4cb3-a6d9-4f1e9a1ad9b8_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable, end of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_53bec3ae-9031-412c-b6aa-03e04cc967a8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_86f41285-22ba-47ca-8182-a7466d6deab8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_94010cd9-4e46-435d-9a5c-9b226f7fe3dd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4f3a49f7-be7a-4456-b43a-55e579e7d845_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average diluted shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fd9991b4-cedb-47ba-ae17-ad0b5003c414_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_019ad32a-b204-44d0-adab-72a2b56a0eeb_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_8a725753-1f48-466b-974b-0ce38635b60b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_c147f362-5cd5-4e37-99b8-91534e19d661_terseLabel_en-US" xlink:label="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease renewal term</link:label>
    <link:label id="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_label_en-US" xlink:label="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Leases, Renewal Term</link:label>
    <link:label id="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_documentation_en-US" xlink:label="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating And Finance Leases, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:href="cvs-20211231.xsd#cvs_LesseeOperatingAndFinanceLeasesRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:to="lab_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RadcliffAndFlaimVAetnaIncEtAlMember_f93a8175-44b9-4199-990a-8b8fd6cc2980_terseLabel_en-US" xlink:label="lab_cvs_RadcliffAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliff and Flaim v Aetna Inc., et al</link:label>
    <link:label id="lab_cvs_RadcliffAndFlaimVAetnaIncEtAlMember_label_en-US" xlink:label="lab_cvs_RadcliffAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliff and Flaim v Aetna Inc., et al [Member]</link:label>
    <link:label id="lab_cvs_RadcliffAndFlaimVAetnaIncEtAlMember_documentation_en-US" xlink:label="lab_cvs_RadcliffAndFlaimVAetnaIncEtAlMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radcliff and Flaim v Aetna Inc., et al</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffAndFlaimVAetnaIncEtAlMember" xlink:href="cvs-20211231.xsd#cvs_RadcliffAndFlaimVAetnaIncEtAlMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RadcliffAndFlaimVAetnaIncEtAlMember" xlink:to="lab_cvs_RadcliffAndFlaimVAetnaIncEtAlMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3Point75PercentApril2030Member_69006986-10f8-4025-9fb3-c3e02ca815d6_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% senior notes due April 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes3Point75PercentApril2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3 Point 75 Percent, April 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3Point75PercentApril2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3 Point 75 Percent, April 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3Point75PercentApril2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:to="lab_cvs_SeniorNotes3Point75PercentApril2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_101ea2aa-8ca4-4248-bc44-d38ee24a1c55_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_9b813748-d704-458a-b346-7e4b7f211b93_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_145f4f9a-5af8-45fe-97d1-5d49d6b23fb7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_957f6bf1-8113-4f99-b728-acdbca4fa52b_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_628d7e2d-f5a0-4097-a6ec-348f6d0aab5a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total incurred health care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskTable_ba5f9f33-c5e0-4548-bdb1-4bcf9daf6b92_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Table]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskTable_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CededCreditRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskTable" xlink:to="lab_us-gaap_CededCreditRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_cb2f2c9f-746d-4c71-b78c-035b38e4f23b_negatedLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment expenses</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInvestmentExpense_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Investment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInvestmentExpense" xlink:to="lab_us-gaap_InvestmentIncomeInvestmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_ce0bbf80-7432-42cb-a1fb-623bf5b2a4cd_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsAxis_06d49be5-e2b1-4b6c-9648-2f7bed4bcc8c_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Axis]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsAxis_label_en-US" xlink:label="lab_cvs_TotalInvestmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis" xlink:href="cvs-20211231.xsd#cvs_TotalInvestmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsAxis" xlink:to="lab_cvs_TotalInvestmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_e2f4446f-9ec7-42dc-9875-2ea4322030d7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_cffd09d1-3972-46ab-abbf-62dca2537416_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0660db1b-6c75-4909-ae0d-18a4219e2163_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_VariableInterestEntityAmendedContractTerm_92a806d1-5362-4694-a939-0c05bcd3d12d_terseLabel_en-US" xlink:label="lab_cvs_VariableInterestEntityAmendedContractTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended contract term (in years)</link:label>
    <link:label id="lab_cvs_VariableInterestEntityAmendedContractTerm_label_en-US" xlink:label="lab_cvs_VariableInterestEntityAmendedContractTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Amended Contract Term</link:label>
    <link:label id="lab_cvs_VariableInterestEntityAmendedContractTerm_documentation_en-US" xlink:label="lab_cvs_VariableInterestEntityAmendedContractTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Amended Contract Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VariableInterestEntityAmendedContractTerm" xlink:href="cvs-20211231.xsd#cvs_VariableInterestEntityAmendedContractTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_VariableInterestEntityAmendedContractTerm" xlink:to="lab_cvs_VariableInterestEntityAmendedContractTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_468b38cc-0c1a-4ad9-a94d-60e1c3828dd9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a1519ab6-f5bb-4b2c-9de8-165da23eea18_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_7d0c681b-d3af-443e-8dcb-b3a2f10f0a14_terseLabel_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term insurance liabilities</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_label_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Noncurrent</link:label>
    <link:label id="lab_cvs_OtherInsuranceLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:href="cvs-20211231.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:to="lab_cvs_OtherInsuranceLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_90ef7a56-bc49-4831-a868-ec0c930c6fe3_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCosts_ba70c05c-3062-4108-a14a-1803a78c4341_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred acquisition costs</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCosts_label_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredPolicyAcquisitionCosts" xlink:to="lab_us-gaap_DeferredPolicyAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e534c3a6-a24b-4253-b453-34f694c89422_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_3bd82604-11a7-43e1-a17b-172406e7fdcc_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_6087bd70-911b-44cc-a728-e945faf4198b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_d268a6e8-db61-4dbe-812c-e16f02fcec18_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for taxes related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_faff0e0a-586d-432a-a795-8f17a0a75b04_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for taxes for net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_405eedb1-372a-42a9-82b5-d1cefcb478f4_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts_0daf9357-453b-4b87-809b-7ad350355360_terseLabel_en-US" xlink:label="lab_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed interest rates on long-duration group life and long-term care contracts</link:label>
    <link:label id="lab_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts_label_en-US" xlink:label="lab_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Interest Rates On Long Duration Group Life And Long Term Care Contracts</link:label>
    <link:label id="lab_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts_documentation_en-US" xlink:label="lab_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Interest Rates On Long Duration Group Life And Long Term Care Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" xlink:href="cvs-20211231.xsd#cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" xlink:to="lab_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_31b50341-7811-4b83-a599-be2191293cbc_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_c44a49c0-445a-41ac-b31c-3d0fce90aebc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded</link:label>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_label_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Ceded</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:to="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure_c4872a43-1b96-4ec4-960d-205a8253559f_terseLabel_en-US" xlink:label="lab_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, right-of-use asset, fair value</link:label>
    <link:label id="lab_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure_label_en-US" xlink:label="lab_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, Right-of-Use Asset, Fair Value Disclosure</link:label>
    <link:label id="lab_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure_documentation_en-US" xlink:label="lab_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, Right-of-Use Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure" xlink:href="cvs-20211231.xsd#cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure" xlink:to="lab_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_VariableInterestEntityAmendedContractExtensionTerm_c1b8b3bb-b461-4925-bbc4-d5857f35a017_terseLabel_en-US" xlink:label="lab_cvs_VariableInterestEntityAmendedContractExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended contract extension term</link:label>
    <link:label id="lab_cvs_VariableInterestEntityAmendedContractExtensionTerm_label_en-US" xlink:label="lab_cvs_VariableInterestEntityAmendedContractExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Amended Contract Extension Term</link:label>
    <link:label id="lab_cvs_VariableInterestEntityAmendedContractExtensionTerm_documentation_en-US" xlink:label="lab_cvs_VariableInterestEntityAmendedContractExtensionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Amended Contract Extension Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VariableInterestEntityAmendedContractExtensionTerm" xlink:href="cvs-20211231.xsd#cvs_VariableInterestEntityAmendedContractExtensionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_VariableInterestEntityAmendedContractExtensionTerm" xlink:to="lab_cvs_VariableInterestEntityAmendedContractExtensionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock_32d631a4-bb11-40aa-bfb1-56986e1d3a16_terseLabel_en-US" xlink:label="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Deficiency Reserves</link:label>
    <link:label id="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock_label_en-US" xlink:label="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Premium Deficiency Reserve [Policy Text Block]</link:label>
    <link:label id="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock_documentation_en-US" xlink:label="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Premium Deficiency Reserve [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:href="cvs-20211231.xsd#cvs_InsurancePremiumDeficiencyReservePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:to="lab_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_8a83803f-8494-4bd5-b0d3-5dbf68e67dea_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_0c5db133-4dc3-45f7-8c48-fda2479d436d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_b3f1ec7f-2f0b-4f5e-91bf-818e62deb323_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value vested at end of year and expected to vest in the future</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_bb1bce30-de10-40c3-bb99-a48c6a5b20f3_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_27ffa4a7-986a-4b18-b225-d2d3c3009034_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Two [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodTwoMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodTwoMember" xlink:to="lab_cvs_YearOfOriginationPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_603833db-f13d-4ebf-8b42-12be9acad01b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_e21b644a-801c-411c-84d8-ffd882035efe_totalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total claims paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_6a074eda-3449-43d0-a8de-892287d31822_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeTextBlock" xlink:to="lab_us-gaap_InvestmentIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_02ac40df-ba51-4fe7-aa25-fb55e054acb5_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements Recently Adopted and Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_4c53e346-4744-4e1c-b60a-8051e8ec5c3b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_bb53dc67-41e1-4add-ab3f-2671c0c648b6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_f0584464-03db-4ea9-bca8-6a6876c14019_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateForeclosures_e4a5e864-ebbb-49a3-ba34-3c8905744f54_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans foreclosed</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateForeclosures_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Foreclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateForeclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_214389ed-9129-493e-984d-7737febd47e2_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_ee80d0fe-0128-46c2-a9a1-756c38fef0eb_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_7ea8f586-e06d-4bb9-9a5a-425cced5ffa0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_18e39ccf-c95c-417b-b345-fb8001d94f70_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_c3dc34fc-9e7e-4c76-a01c-e1103ba842b5_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_f749a193-7def-4a62-8111-af7d2e3aa771_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.5% senior notes due May 2042</link:label>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.5%, Due May 2042 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.5DueMay2042Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.5%, Due May 2042 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.5DueMay2042Member" xlink:to="lab_cvs_SeniorNotes4.5DueMay2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_aa774af4-5994-4e97-b0c4-2d7d00a79676_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, net carrying amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_952c1da5-13df-4f27-bf4d-745316d57a6e_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_df83b725-a224-4696-9315-d30e09de739e_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of the period</link:label>
    <link:label id="lab_us-gaap_Goodwill_81fa3a9f-288a-4b4a-abc7-3deccf48f4b7_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of the period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_2f0bb964-6520-4317-b2e2-9c19b5f9bc99_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_37e300ae-ea77-45be-8f1e-324c2a57e3cf_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f8b4a20b-8675-4037-9ffa-a1dae1a63125_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_297a6ce2-697c-4d6e-9889-875727347212_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_d72deae6-fc51-4373-8bf6-57ff2ca7855b_terseLabel_en-US" xlink:label="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hartford Life and Accident Insurance Company</link:label>
    <link:label id="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_label_en-US" xlink:label="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hartford Life And Accident Insurance Company [Member]</link:label>
    <link:label id="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_documentation_en-US" xlink:label="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hartford Life And Accident Insurance Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:href="cvs-20211231.xsd#cvs_HartfordLifeAndAccidentInsuranceCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:to="lab_cvs_HartfordLifeAndAccidentInsuranceCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_73b8b90b-13c0-4fe8-925e-f7617c18ec89_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share</link:label>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:to="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsLineItems_e96308e2-8b87-416f-bb1a-03bbd23a54c1_terseLabel_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets[Line Items]</link:label>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsLineItems_label_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Acquired Intangible Assets [Line Items]</link:label>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:href="cvs-20211231.xsd#cvs_OtherAcquiredIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:to="lab_cvs_OtherAcquiredIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_012d4256-551a-42f8-9f5d-7e9bda8f71a4_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_2f081a9e-619e-4958-b9e6-ae6432ee9892_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1c3728b4-c66c-4426-ae8b-851189088507_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments required to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_5e971872-bb44-4b35-b9fb-3440c8ff303b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceAccountingPolicy_447add59-73d0-45d6-8e46-967c50916853_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceAccountingPolicy_label_en-US" xlink:label="lab_us-gaap_ReinsuranceAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Accounting Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceAccountingPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceAccountingPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceAccountingPolicy" xlink:to="lab_us-gaap_ReinsuranceAccountingPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_6473d5cd-84c7-4e0c-97a5-1008ac3c0364_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDerivativeMember_73e5b606-7de3-485a-b693-8357bfc19fd9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDerivativeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDerivativeMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDerivativeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Derivative [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDerivativeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDerivativeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDerivativeMember" xlink:to="lab_us-gaap_DefinedBenefitPlanDerivativeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_e3c9533d-4b2d-4299-91a3-abc07f10a3eb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Income, Reported Amounts, by Category [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:to="lab_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_d3830314-650c-4530-84f0-9f7fb4c836a3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToSuppliersAndEmployees_2b25d036-639d-41d8-9b81-0f2b0e2300d0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid to other suppliers and employees</link:label>
    <link:label id="lab_us-gaap_PaymentsToSuppliersAndEmployees_label_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Suppliers and Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToSuppliersAndEmployees" xlink:to="lab_us-gaap_PaymentsToSuppliersAndEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_ba38dfca-0467-4799-aa82-647abebba595_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_22df39c1-500e-48dc-a4fd-9bd1dabce42e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock and Capital Surplus</link:label>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Including Additional Paid in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_7fb407cb-dc69-421e-b358-5c81e9c9c5aa_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term vested at end of year and expected to vest in the future</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_6abf61ca-e51d-4a00-95d3-6258acb2322e_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_03ef84e3-e8e0-4c6f-b3c3-9eb6ff33e28a_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_b0632926-15da-4a5f-9b06-f163368ecd41_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase programs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d433951a-d1e7-487d-a566-41307a11e4c7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_236ededb-2404-47db-bfd0-308a86a34732_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate account financial assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_711267c7-b431-4854-8e86-69963435dc6f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_32c97b71-0560-495c-899c-403a1abf85cd_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-related integration costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b7562fa0-8d7b-4a6e-8bd0-267e0513fa8a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_2f9c31d9-e540-4339-a697-082520b39fd3_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_6ac7589e-805f-4484-8646-cf8626171923_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_78de9772-d3f4-416e-8b34-95c15542e54e_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New mortgage loans</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_91d45d44-bb67-4b9f-9519-bfac89b90284_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_dd8f7d45-3cb5-435d-b925-c29ebd66c86e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_e5dd50f3-e58e-4aa6-8347-babf1b59c1af_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit (OPEB) Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:to="lab_us-gaap_PensionAndOtherPostretirementPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b2ca7d88-0da9-4e02-8a34-3d0aeed78ff4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss and capital loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_dd61eb6a-ab4f-4368-a076-539a22671597_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6a41ece0-71d3-4dfb-899d-7d0fafcce7e6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d460975e-c57a-4f9d-b66a-b7f992f65d45_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_0f684a26-44f4-40ab-a0f2-b66f472e8eb0_terseLabel_en-US" xlink:label="lab_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash proceeds received and tax benefit from share-based payment awards</link:label>
    <link:label id="lab_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Proceeds Received and Tax Benefit from Share-based Payment Awards [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:to="lab_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_e1c23ca1-65dd-4bb0-bdd4-29a974f613cf_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_b7d609c6-b99e-430f-b98c-609beea25c3b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of maturities of long-term debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral_327126ea-9554-4da8-bb7d-5a55975ef536_terseLabel_en-US" xlink:label="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll tax deferral</link:label>
    <link:label id="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral_label_en-US" xlink:label="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Payroll Tax Deferral</link:label>
    <link:label id="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral_documentation_en-US" xlink:label="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Payroll Tax Deferral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:href="cvs-20211231.xsd#cvs_DeferredTaxAssetsPayrollTaxDeferral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:to="lab_cvs_DeferredTaxAssetsPayrollTaxDeferral" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ProviderNetworksMember_f13f82d5-a1ec-4aec-afa5-5583dec6ea24_terseLabel_en-US" xlink:label="lab_cvs_ProviderNetworksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider networks</link:label>
    <link:label id="lab_cvs_ProviderNetworksMember_label_en-US" xlink:label="lab_cvs_ProviderNetworksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider networks [Member]</link:label>
    <link:label id="lab_cvs_ProviderNetworksMember_documentation_en-US" xlink:label="lab_cvs_ProviderNetworksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired in a business combination or other transaction. This item represents the value ascribed to the relationships with the acquiree's physicians, hospitals and other health care providers network.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProviderNetworksMember" xlink:href="cvs-20211231.xsd#cvs_ProviderNetworksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ProviderNetworksMember" xlink:to="lab_cvs_ProviderNetworksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_1d9e1f01-a7c6-4de0-8e46-c1c3c302ce08_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Policy</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_25061ea7-0de5-4930-b5e7-79c8279a980d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_e1569bb2-660f-43a7-bd4d-8a7ad77eac9c_terseLabel_en-US" xlink:label="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average purchase price of shares purchased (in dollars per share)</link:label>
    <link:label id="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_label_en-US" xlink:label="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Employee Stock Purchase Plan, Average Purchase Price of Shares Purchased</link:label>
    <link:label id="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_documentation_en-US" xlink:label="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Employee Stock Purchase Plan, Average Purchase Price of Shares Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:href="cvs-20211231.xsd#cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:to="lab_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SharesHeldInTrustPolicyTextBlock_50283105-0fea-4270-93e7-c350801fa57a_terseLabel_en-US" xlink:label="lab_cvs_SharesHeldInTrustPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Held in Trust</link:label>
    <link:label id="lab_cvs_SharesHeldInTrustPolicyTextBlock_label_en-US" xlink:label="lab_cvs_SharesHeldInTrustPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Held In Trust [Policy Text Block]</link:label>
    <link:label id="lab_cvs_SharesHeldInTrustPolicyTextBlock_documentation_en-US" xlink:label="lab_cvs_SharesHeldInTrustPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Held In Trust [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SharesHeldInTrustPolicyTextBlock" xlink:href="cvs-20211231.xsd#cvs_SharesHeldInTrustPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SharesHeldInTrustPolicyTextBlock" xlink:to="lab_cvs_SharesHeldInTrustPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_afbbb2c2-eac9-451b-9304-414431891b53_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares_b72e189b-8081-43f2-9c54-6ddfcda0d4fa_terseLabel_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR, maximum amount of shares received or delivered</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares_label_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Program, Maximum Number of Shares</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares_documentation_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Program, Maximum Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares" xlink:href="cvs-20211231.xsd#cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares" xlink:to="lab_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_7372e47b-77d4-4381-b53d-e5721cdb8b22_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_170f2452-2bc6-4f21-9968-b33af63d30c0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_c158e71c-7f0a-4f3d-8680-d97ac8fac909_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Contract Acquisition Costs</link:label>
    <link:label id="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_label_en-US" xlink:label="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Policy Acquisition Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:to="lab_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_fd50b554-3217-4bc0-a3db-9a9687d3908a_terseLabel_en-US" xlink:label="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipt related purchase price adjustment from acquisition</link:label>
    <link:label id="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_label_en-US" xlink:label="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipt from Business Combination, Purchase Price Adjustment, Outside of Measurement Period</link:label>
    <link:label id="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_documentation_en-US" xlink:label="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipt from Business Combination, Purchase Price Adjustment, Outside of Measurement Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:href="cvs-20211231.xsd#cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:to="lab_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_bb801a6d-349f-41dd-852e-c91a4dd73801_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_e940d915-d036-4983-a9cd-94a26d4128ee_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_9d815b87-4ab4-453c-b33a-74013c2cc59c_totalLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available For Sale, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available For Sale, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_7b435fee-2a24-4c9e-b222-934738ad9894_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Four</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_7b31059d-6b95-4d77-b929-c3b6b17752f3_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3Point70PercentDue2023Member_d265c32f-7938-4565-b663-70f7774e24e6_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3Point70PercentDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3 Point 70 Percent, Due 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes3Point70PercentDue2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3Point70PercentDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3 Point 70 Percent, Due 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3Point70PercentDue2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3Point70PercentDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3 Point 70 Percent, Due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point70PercentDue2023Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3Point70PercentDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3Point70PercentDue2023Member" xlink:to="lab_cvs_SeniorNotes3Point70PercentDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_8d661927-f8f8-4be7-b4eb-1ad59bc3a28e_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_0a5cd4f5-71ad-49ad-9c2f-058cff10e444_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities available for sale</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_d2d464dd-2eab-4cc0-b7d8-b9501fc81fdf_terseLabel_en-US" xlink:label="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases Liabilities Payments Due [Abstract]</link:label>
    <link:label id="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_documentation_en-US" xlink:label="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases Liabilities Payments Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:href="cvs-20211231.xsd#cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:to="lab_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_415c788d-186b-4a2d-916e-540841ee0355_terseLabel_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP issuances, net of purchase of treasury shares (in shares)</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_label_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</link:label>
    <link:label id="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_documentation_en-US" xlink:label="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:href="cvs-20211231.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:to="lab_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2020Member_2230303a-3a72-4e33-a40f-12fdd79f4150_terseLabel_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating rate notes due March 2020</link:label>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2020Member_label_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due March 2020 [Member]</link:label>
    <link:label id="lab_cvs_FloatingRateNotesDueMarch2020Member_documentation_en-US" xlink:label="lab_cvs_FloatingRateNotesDueMarch2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Floating Rate Notes Due March 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2020Member" xlink:href="cvs-20211231.xsd#cvs_FloatingRateNotesDueMarch2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FloatingRateNotesDueMarch2020Member" xlink:to="lab_cvs_FloatingRateNotesDueMarch2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_ea6f98e3-2be7-43fb-974d-efde78661388_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease costs</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_9f161b8b-96fb-4aaa-a028-461145e2466b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InsuranceAndHmoMember_cf8cc887-c237-4587-8996-55aa881cbd48_terseLabel_en-US" xlink:label="lab_cvs_InsuranceAndHmoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and HMO</link:label>
    <link:label id="lab_cvs_InsuranceAndHmoMember_label_en-US" xlink:label="lab_cvs_InsuranceAndHmoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and HMO [Member]</link:label>
    <link:label id="lab_cvs_InsuranceAndHmoMember_documentation_en-US" xlink:label="lab_cvs_InsuranceAndHmoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance and HMO subsidiaries [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InsuranceAndHmoMember" xlink:href="cvs-20211231.xsd#cvs_InsuranceAndHmoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InsuranceAndHmoMember" xlink:to="lab_cvs_InsuranceAndHmoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_dc5c3458-3ab3-4bbf-9ffa-1fb9ac5c621d_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution centers and Corporate offices</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_4990d526-cd0b-4655-97a6-3cc5ed026c84_terseLabel_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail/ LTC</link:label>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_label_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Long-Term Care Segment [Member]</link:label>
    <link:label id="lab_cvs_RetailLongTermCareSegmentMember_documentation_en-US" xlink:label="lab_cvs_RetailLongTermCareSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Long-Term Care Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember" xlink:href="cvs-20211231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RetailLongTermCareSegmentMember" xlink:to="lab_cvs_RetailLongTermCareSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_dc8116e7-8dfc-4217-9b2e-cf5595b9116b_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_68b6c41f-2f59-49e8-9423-1c91a81c4e41_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_52507ea9-2226-49cd-9ee6-b8b9f5511d8f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4e83fdfa-3780-475b-92f3-504ff7705746_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested in period, fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_fb8d789b-4f44-493b-8349-393ec0fe59b7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_23e9f82a-8dda-4c54-9d9d-20672fad2c8e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_47521acd-6fe1-4cb8-b260-41baf74e95b4_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Reform</link:label>
    <link:label id="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareEntitiesPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:to="lab_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_07916b0d-3d9d-4761-b55a-0ee9bcae7fa5_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy network</link:label>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:to="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_c6ba27f3-54c3-4056-827a-779f797b22ce_terseLabel_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR percent of notional amount received in shares</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_label_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percent of Notional Amount Received in Shares</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_documentation_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percent of Notional Amount Received in Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:href="cvs-20211231.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:to="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_f22212c7-bdee-409a-8653-8a0d52f7d0f0_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% senior notes due December 2022</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due December 2022 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.75DueDecember2022Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.75%, Due December 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.75DueDecember2022Member" xlink:to="lab_cvs_SeniorNotes4.75DueDecember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4164403e-3978-41e5-9c5d-e273dabd75b7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8b621c4d-1327-41c8-913a-4f9b68d3e25d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_92e4bb4a-90ec-4023-a551-58da970ea4cc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities reflected in other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_5716e73f-076e-4341-ae3a-db0b54639b98_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_1794b84b-5cd1-461c-a0e3-af1f7e824f89_terseLabel_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator for earnings per share calculation:</link:label>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_label_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:label id="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract_documentation_en-US" xlink:label="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator For Earnings Per Share Calculation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:href="cvs-20211231.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:to="lab_cvs_DenominatorForEarningsPerShareCalculationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_ee22d98a-7183-48d5-a4d6-4e51d2714fa8_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Paid Health Care Claims, Net of Reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_40557e44-25a7-4766-b8cb-27d27f8de317_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_ac8a2d57-5ed9-4106-bb80-ae1757513366_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.125% senior notes due September 2039</link:label>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.125%, Due September 2039 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.125DueSeptember2039Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.125%, Due September 2039 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:to="lab_cvs_SeniorNotes6.125DueSeptember2039Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_1dbca499-b7de-4959-be9f-f8421e30ce29_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_3688b6b5-266c-4959-b67c-f649f508b62c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_81ded18a-db05-4d86-b350-5d5eb442b5c6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative goodwill impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_f8515479-c6df-4859-97d2-eb741624a93e_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_dff5d52a-00a3-4e13-9e25-f1ff9bdf5a3f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price vested at end of year and expected to vest in the future ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededCreditRiskReinsurerDomain_3c9d26f3-d7c1-40a2-9e63-97e34ab0d623_terseLabel_en-US" xlink:label="lab_us-gaap_CededCreditRiskReinsurerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Reinsurer [Domain]</link:label>
    <link:label id="lab_us-gaap_CededCreditRiskReinsurerDomain_label_en-US" xlink:label="lab_us-gaap_CededCreditRiskReinsurerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Credit Risk, Reinsurer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain" xlink:to="lab_us-gaap_CededCreditRiskReinsurerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_accf2c54-174a-4ef6-b806-6f4d9cbc5593_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_e4bcc796-c975-49ff-bc6a-4f8f9de1bcbd_terseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">States, municipalities and political subdivisions</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_c912d86d-df10-48c8-822e-63c37a9349a8_verboseLabel_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">States, municipalities and political subdivisions</link:label>
    <link:label id="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember_label_en-US" xlink:label="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US States and Political Subdivisions Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:to="lab_us-gaap_USStatesAndPoliticalSubdivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c56df144-72c4-4834-9f16-eb2ad40c5bf0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_9f28e0e1-b5a3-4827-85c6-d9ad3ca456ff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Separate Account Investment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:to="lab_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_61cc944e-50ea-4a6a-b7d0-9cec1cff80d1_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percent</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesAgreementAmount_1031b147-0be9-47a2-bc70-70386d8af6e2_terseLabel_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR agreement, amount</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesAgreementAmount_label_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases Agreement, Amount</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesAgreementAmount_documentation_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases Agreement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:href="cvs-20211231.xsd#cvs_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:to="lab_cvs_AcceleratedShareRepurchasesAgreementAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_a1ca71fe-dbbf-4ea6-8904-9c36b84c4cae_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangibles</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f00c1b0c-e236-4ef8-a6d7-3562f94e5540_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_eb3c80dd-0dfa-41e2-814a-3e372478edb8_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_adb2d1bf-ec7e-430c-a68e-ea96746d9f88_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ff21c68a-56df-4ea5-bb8b-79bc128e5ed8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding at end of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes375DueApril2030Member_077c46d0-59ef-429e-9e4e-c527db824de8_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes375DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% senior notes due April 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes375DueApril2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes375DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.75%, Due April 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes375DueApril2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes375DueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.75%, Due April 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes375DueApril2030Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes375DueApril2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes375DueApril2030Member" xlink:to="lab_cvs_SeniorNotes375DueApril2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_83bbf903-94a6-4782-822f-f7d9918aa337_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_e328d3ab-1fdb-421c-bee8-34d1998c827c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialRealEstateMember_b8d061ea-ff4e-4482-a41f-4b70860e7304_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Real Estate</link:label>
    <link:label id="lab_us-gaap_CommercialRealEstateMember_label_en-US" xlink:label="lab_us-gaap_CommercialRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Real Estate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialRealEstateMember" xlink:to="lab_us-gaap_CommercialRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceDisclosuresAbstract_b715300e-6ab0-4be8-9c84-f31656796a25_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReinsuranceDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ReinsuranceDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract" xlink:to="lab_us-gaap_ReinsuranceDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_4b9887e0-2ec2-4222-b40c-11a2c0180603_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7152ab00-c87c-4f27-938d-01c4328397a1_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_45df89ab-6f2b-46a2-a7f6-2d821d0df4b2_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:to="lab_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_e20913f2-22e6-4b04-a446-89a4716b4a6e_terseLabel_en-US" xlink:label="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debts and other allowances</link:label>
    <link:label id="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_label_en-US" xlink:label="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Bad Debts And Other Allowances</link:label>
    <link:label id="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_documentation_en-US" xlink:label="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Bad Debts And Other Allowances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:href="cvs-20211231.xsd#cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:to="lab_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_813cf7c1-82f4-4232-8c8b-dc77abdf1cc2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Tax Effect of Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:to="lab_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_c39a6508-5b49-4745-bac0-bc8224e7df34_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_bef9fedd-81eb-4c5d-ab44-71829b34c731_terseLabel_en-US" xlink:label="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases:</link:label>
    <link:label id="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="cvs-20211231.xsd#cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_d177f808-b4b4-44c1-addb-e8cfe30bf6ef_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_01f3782b-fac2-40f7-997c-aab36dfe5ad2_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.25% senior notes due August 2029</link:label>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.25%, Due August 2029 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.25DueAugust2029Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.25%, Due August 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.25DueAugust2029Member" xlink:to="lab_cvs_SeniorNotes3.25DueAugust2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_8ba761b8-8494-4297-804f-b7f6faf46473_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of deferred tax assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_616c11fb-dc5e-4e60-8ee7-3357f98dda48_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_71c13c17-bf6d-40bd-aa6c-b07574c0a3c2_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5% senior notes due December 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5%, Due December 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes5DueDecember2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 5%, Due December 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes5DueDecember2024Member" xlink:to="lab_cvs_SeniorNotes5DueDecember2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_883333f6-084b-4b61-940f-0368b714a987_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalCreditAssessmentDomain_ce1d7b80-cfc2-49fa-ac01-5396f6dfa5e8_terseLabel_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Domain]</link:label>
    <link:label id="lab_us-gaap_InternalCreditAssessmentDomain_label_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain" xlink:to="lab_us-gaap_InternalCreditAssessmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_abd8334d-fed5-4922-b750-2f2595861baf_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target investment allocations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f2a5e395-49f5-44c8-957d-b5c02ef1cf5e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_be4cbe39-cd09-49af-82cd-b386efa4b146_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount expected to be reclassified</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_ba5db871-30b7-4dec-abcf-c1442d5e694d_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_7cffd7e6-e772-44bb-8f4d-a6234fab7c70_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss on sale of subsidiaries</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_5cefaf77-ea6e-4e1f-91db-26e28765a20f_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on sale of subsidiaries</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_e2df4966-1a83-4bdb-9e24-5237c28c6433_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofReinsuranceContractsEnteredInto_ac1aad2f-497f-42af-af79-cf44bc28812b_terseLabel_en-US" xlink:label="lab_cvs_NumberofReinsuranceContractsEnteredInto" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reinsurance contracts entered into</link:label>
    <link:label id="lab_cvs_NumberofReinsuranceContractsEnteredInto_label_en-US" xlink:label="lab_cvs_NumberofReinsuranceContractsEnteredInto" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reinsurance Contracts Entered Into</link:label>
    <link:label id="lab_cvs_NumberofReinsuranceContractsEnteredInto_documentation_en-US" xlink:label="lab_cvs_NumberofReinsuranceContractsEnteredInto" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reinsurance contracts entered into with an unrelated insurer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofReinsuranceContractsEnteredInto" xlink:href="cvs-20211231.xsd#cvs_NumberofReinsuranceContractsEnteredInto"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofReinsuranceContractsEnteredInto" xlink:to="lab_cvs_NumberofReinsuranceContractsEnteredInto" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a62939e5-f244-4342-b29a-a437f7aa9b22_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and other postretirement benefits</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_41ef990d-3724-4b64-a6e0-dd84eee87bcb_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government securities</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f914efc5-d236-4856-9c93-12753b3612cd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_2c96a211-bef1-41e7-a62a-6cc80467a437_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_e53a855a-4a11-45dc-b080-505211c7c81e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior year refund claim</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Settlement, Domestic, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Initialcontractualterm_1faf0de6-7bc6-40fe-bf36-6ff6fd61ba33_terseLabel_en-US" xlink:label="lab_cvs_Initialcontractualterm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial contractual term (in years)</link:label>
    <link:label id="lab_cvs_Initialcontractualterm_label_en-US" xlink:label="lab_cvs_Initialcontractualterm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial contractual term</link:label>
    <link:label id="lab_cvs_Initialcontractualterm_documentation_en-US" xlink:label="lab_cvs_Initialcontractualterm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Initial Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Initialcontractualterm" xlink:href="cvs-20211231.xsd#cvs_Initialcontractualterm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Initialcontractualterm" xlink:to="lab_cvs_Initialcontractualterm" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_6bc16ae0-9b76-4276-bd99-c368cfcb9b76_terseLabel_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former gain contingency, recognized in current period, before tax</link:label>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Gain Contingency, Recognized in Current Period, Before Tax</link:label>
    <link:label id="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_documentation_en-US" xlink:label="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Gain Contingency, Recognized in Current Period, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:href="cvs-20211231.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:to="lab_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_6cf9030f-ae1a-40c3-93fb-8f9a9bbf0170_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of disaggregation of revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_7def043c-3504-4973-8a39-9ab1298a9d1f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c7ff96c5-e04a-4864-b014-ae5f2a3815e5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_469b12be-0cfc-48f5-accc-0166c8c8d854_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, maturity, without single maturity date, fair value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:to="lab_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_87a566e1-12b9-4654-9ad3-3e5dc7c17c85_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU and performance share unit activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_ff1c163b-b5e3-48b7-b02f-b84bdb52d865_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Categories5and6Member_ac1643eb-20a8-4485-bd62-43dd630753ad_terseLabel_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5 and 6</link:label>
    <link:label id="lab_cvs_Categories5and6Member_label_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Categories 5 and 6 [Member]</link:label>
    <link:label id="lab_cvs_Categories5and6Member_documentation_en-US" xlink:label="lab_cvs_Categories5and6Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan credit quality indicator - Categories 5 and 6</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member" xlink:href="cvs-20211231.xsd#cvs_Categories5and6Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Categories5and6Member" xlink:to="lab_cvs_Categories5and6Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_3425a00d-510b-44c3-9a3c-ac2e97220f1b_terseLabel_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury shares, net of ESPP issuances (in shares)</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_label_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:label id="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_documentation_en-US" xlink:label="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:href="cvs-20211231.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:to="lab_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_d239f4d6-c49b-4564-96fb-6fe3d7b00280_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_9e380990-3404-48fc-b99d-293c8b061f3f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows paid for operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_7d907bd1-91ab-4a8c-b9e8-fc2ba5c9fbe0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net repayments of short-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_227fd3c1-59f1-4634-b0ee-ea3ac3124f4a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All outstanding liabilities for health care costs payable prior to 2020, net of reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Not Separately Presented</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_ad74a66d-22ce-4925-adb6-84029e788316_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipt of fully reserved ACA risk corridor receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Recovery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes1Point75PercentAugust2030Member_c230a55f-46ad-4240-877c-a75a157a19e1_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.75% senior notes due August 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point75PercentAugust2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 75 Percent, August 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point75PercentAugust2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 75 Percent, August 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes1Point75PercentAugust2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:to="lab_cvs_SeniorNotes1Point75PercentAugust2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_f083b90c-3f80-4845-adf1-533f8ce50290_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_6ab2d22d-3d15-4a04-9953-e0c23aff357f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_773b3a88-6b26-46ee-a7b6-6bc3bb7ea0f7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:to="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetNet_f239d496-3c4a-4278-813e-e261827202bf_totalLabel_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetNet_label_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Net</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetNet_documentation_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetNet" xlink:href="cvs-20211231.xsd#cvs_FinanceLeaseRightOfUseAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FinanceLeaseRightOfUseAssetNet" xlink:to="lab_cvs_FinanceLeaseRightOfUseAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesLineItems_1f91a3ef-b8d7-4235-860f-767c45da42d5_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesLineItems_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems" xlink:to="lab_us-gaap_StatutoryAccountingPracticesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_9616df08-71aa-4897-941c-643b4f826d06_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.875% senior notes due July 2035</link:label>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.875%, Due July 2035 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.875DueJuly2035Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.875%, Due July 2035 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.875DueJuly2035Member" xlink:to="lab_cvs_SeniorNotes4.875DueJuly2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_674ec342-ae06-4299-9112-ce8610c231d4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_5c919cac-9740-4359-9728-ba39597384e2_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subtotal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_59ff2aa0-08b6-4268-82e6-c13e7f4d5199_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_884ec983-66b5-4744-9cb7-d812287d7fae_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_1deecf64-c8da-4c75-aaa3-13c2aa28fd80_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClaimsDevelopmentLineItems_7f2865f2-254c-4ce2-b995-9e13afdae453_terseLabel_en-US" xlink:label="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims Development [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClaimsDevelopmentLineItems_label_en-US" xlink:label="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims Development [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems" xlink:to="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_6ad6a9b4-e51d-4b6b-96d9-c38906e5b385_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_8181c0ab-42aa-4519-b0c1-45646a99bdbb_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share from continuing operations, diluted (USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_0139eb3f-c60d-445a-9aab-c8a84681bfaf_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.25% senior notes due June 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.25%, Due June 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes6.25DueJune2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 6.25%, Due June 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes6.25DueJune2027Member" xlink:to="lab_cvs_SeniorNotes6.25DueJune2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_009c0e70-a6ac-412c-beb8-16648ae38507_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_03e87096-ecc4-4e41-a2b5-0fc68ff22c5e_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RedOakMember_85e8c497-44a4-4368-91e2-6ef90c287c38_terseLabel_en-US" xlink:label="lab_cvs_RedOakMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Red Oak</link:label>
    <link:label id="lab_cvs_RedOakMember_label_en-US" xlink:label="lab_cvs_RedOakMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Red Oak [Member]</link:label>
    <link:label id="lab_cvs_RedOakMember_documentation_en-US" xlink:label="lab_cvs_RedOakMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Red Oak</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RedOakMember" xlink:href="cvs-20211231.xsd#cvs_RedOakMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RedOakMember" xlink:to="lab_cvs_RedOakMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyRevenueMember_e566b514-fb19-4dd1-9ae4-1ccac4d9a379_terseLabel_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy</link:label>
    <link:label id="lab_cvs_PharmacyRevenueMember_label_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Revenue [Member]</link:label>
    <link:label id="lab_cvs_PharmacyRevenueMember_documentation_en-US" xlink:label="lab_cvs_PharmacyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember" xlink:href="cvs-20211231.xsd#cvs_PharmacyRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyRevenueMember" xlink:to="lab_cvs_PharmacyRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_427078c0-72fb-478b-a4c1-127583d357d4_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_62411893-1251-45a8-97a9-2c6345377689_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_8790ac31-2796-4563-827f-c23a5f4582fc_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_01eabeec-4226-4ee0-b2cf-1b69c50b4662_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_bbbde3f3-44b5-4cc0-ac8d-a9f3c08e066d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes1Point3PercentAugust2027Member_6fed062d-4fbb-4128-8b22-f01dd2f62917_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.3% senior notes due August 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point3PercentAugust2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 3 Percent, August 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes1Point3PercentAugust2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1 Point 3 Percent, August 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes1Point3PercentAugust2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:to="lab_cvs_SeniorNotes1Point3PercentAugust2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_3a99bfa7-b309-49b7-a574-6c788ba3eca9_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future noncancelable subleases, future minimum payments</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payments to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_1bcfe894-4468-46e8-b57f-0794395355a8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities (included in accrued expenses)</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_bf7b7eaf-21f4-4032-bb01-be36d4912742_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities, beginning of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_0f94190c-5527-42a1-b194-1aa560d10ef4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities, end of period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3.7DueMarch2023Member_fbcf1d86-2eb4-4589-ac20-ee34746e84ca_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.7% senior notes due March 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes3.7DueMarch2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.7%, Due March 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3.7DueMarch2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.7%, Due March 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3.7DueMarch2023Member" xlink:to="lab_cvs_SeniorNotes3.7DueMarch2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_aee19d5e-167f-4b66-9ef1-da290788e0f3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_WeightedAverageRemainingLeaseTermAbstract_033f7556-8b79-4dc3-b849-2743e7fc3e21_terseLabel_en-US" xlink:label="lab_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_cvs_WeightedAverageRemainingLeaseTermAbstract_label_en-US" xlink:label="lab_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:label id="lab_cvs_WeightedAverageRemainingLeaseTermAbstract_documentation_en-US" xlink:label="lab_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:href="cvs-20211231.xsd#cvs_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:to="lab_cvs_WeightedAverageRemainingLeaseTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_83a4dac0-6c62-4af9-b054-bed4633ba69d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, exercised ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_5bfec913-4d0d-42a5-a3fc-25049f5e9d36_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_d9f5bb92-49db-4375-b971-b7227a71287b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit payments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4Point25PercentApril2050Member_558337b7-3a18-4716-adc2-b02095dd0166_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.25% senior notes due April 2050</link:label>
    <link:label id="lab_cvs_SeniorNotes4Point25PercentApril2050Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4 Point 25 Percent, April 2050 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4Point25PercentApril2050Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4 Point 25 Percent, April 2050</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4Point25PercentApril2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:to="lab_cvs_SeniorNotes4Point25PercentApril2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_a65638e3-326c-4a44-9d66-c2c38f7efcd3_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_f5441425-8740-449a-807f-a2d98e14b64d_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.7% senior notes due August 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.7%, Due August 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes27DueAugust2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.7%, Due August 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes27DueAugust2040Member" xlink:to="lab_cvs_SeniorNotes27DueAugust2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_7125ec14-b673-49ad-a5d3-f77b19e27a0e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_42d1c927-7d0b-4df4-9485-ee09213620a8_terseLabel_en-US" xlink:label="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases:</link:label>
    <link:label id="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="cvs-20211231.xsd#cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_b1994101-2982-47fe-8de5-ed28518be910_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases, sales and settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:to="lab_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod_7c344570-642d-4b39-ba3f-993006f0bfdc_terseLabel_en-US" xlink:label="lab_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of stores, annual planned closures for closure period</link:label>
    <link:label id="lab_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod_label_en-US" xlink:label="lab_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Stores, Annual Planned Closures For Closure Period</link:label>
    <link:label id="lab_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod_documentation_en-US" xlink:label="lab_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Stores, Annual Planned Closures For Closure Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod" xlink:href="cvs-20211231.xsd#cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod" xlink:to="lab_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_d72808c3-215a-43d2-b4b1-f71ff28fa4e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_9f6da7e8-f424-42cd-91cd-a39478972025_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts_27dc167b-78b9-424f-901f-10e36c6e8c36_terseLabel_en-US" xlink:label="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual obligations underlying the guaranteed benefits</link:label>
    <link:label id="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts_label_en-US" xlink:label="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligations To Maintain Levels Of Separate Accounts</link:label>
    <link:label id="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts_documentation_en-US" xlink:label="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the contractual obligation to maintain the required level of funding in Separate Accounts necessary to fund specific guaranteed pensions annuities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:href="cvs-20211231.xsd#cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:to="lab_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_28fb2a28-14ee-4921-9f09-233e69df938a_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_9b28e9b4-b8d9-4bb5-8495-85f561f32958_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_26f7a542-850d-46da-b6f7-93b2a4b1d32c_terseLabel_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting experience- rated products</link:label>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_label_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting Experience Rated Products [Member]</link:label>
    <link:label id="lab_cvs_SupportingExperienceRatedProductsMember_documentation_en-US" xlink:label="lab_cvs_SupportingExperienceRatedProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supporting discontinued and experience-rated products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember" xlink:href="cvs-20211231.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SupportingExperienceRatedProductsMember" xlink:to="lab_cvs_SupportingExperienceRatedProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_0649d6c8-1ed7-4145-93f5-14eff3daf002_totalLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total outstanding liabilities for health care costs payable, net of reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_3b3d3373-c6ec-46f0-a91f-21d049ce809b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration health care costs payable, net of reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock_92cf684b-5dc4-4fec-b3da-576805785cba_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory accounting practices disclosure</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock" xlink:to="lab_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_90d9fa40-fd64-4022-9c98-dd3b9ae28c7e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_1a7e51e2-fb4e-4c1c-b5db-fda800a2c500_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_77d94d17-b839-4547-bf02-249406563a3b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets, investment within plan asset category, amount</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_afd5e3dc-1fda-4c10-b01d-8fe683ffe587_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_64232fa8-194b-4a99-9067-3088e527140a_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_1fd13f92-292a-46bc-a60b-d29985c08faf_negatedTerseLabel_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_label_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Depreciation and Amortization</link:label>
    <link:label id="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_documentation_en-US" xlink:label="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Depreciation and Amortization - Amount of deferred tax liability attributable to taxable temporary differences from depreciation and amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:href="cvs-20211231.xsd#cvs_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:to="lab_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_ef00cf0f-12d9-45ff-abe7-c5eda878d826_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_241e53da-3aa4-474c-acae-0e42963ceecf_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_f1e3a6fd-d443-40e7-aed5-8c2f5cbb5345_verboseLabel_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds and related gross realized capital gains and losses from the sale of debt securities</link:label>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_label_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds And Related Gross Realized Capital Gains Losses From Sale Of Debt Securities [Table Text Block]</link:label>
    <link:label id="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:href="cvs-20211231.xsd#cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:to="lab_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainContingencyUnrecordedAmount_0332a09c-b1f6-4e13-a5fd-ffd9a81a6d44_terseLabel_en-US" xlink:label="lab_us-gaap_GainContingencyUnrecordedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain contingency, unrecorded amount</link:label>
    <link:label id="lab_us-gaap_GainContingencyUnrecordedAmount_label_en-US" xlink:label="lab_us-gaap_GainContingencyUnrecordedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Unrecorded Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainContingencyUnrecordedAmount" xlink:to="lab_us-gaap_GainContingencyUnrecordedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_7690a7a9-ecc4-4264-ae34-76c69d7540de_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% senior notes due June 2026</link:label>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.875%, Due June 2026 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.875DueJune2026Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.875%, Due June 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.875DueJune2026Member" xlink:to="lab_cvs_SeniorNotes2.875DueJune2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_d08bc57b-ee05-4b4f-a9a1-c77ed9c006c9_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_4c2b7a4a-7bd1-4247-8046-a27711d0b37a_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_5fd47170-a89c-4ce3-8d99-e97b635d0160_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI before Reclass, pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_7d959062-33c9-4699-96dc-ab3245401411_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Greater than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_18dad71f-54d2-4d7c-8196-3d13d8c44df9_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal After Year Five</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal After Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock_47c9aa54-1fcd-48f4-96fe-04324e481e89_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of change in level 3 plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_02c90f3a-54fe-4bd8-892a-c76ce6335757_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a66048b2-2704-4a5f-b4f9-e7d667471478_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions (net of cash acquired)</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_3d762caf-4340-4301-90fe-cf132b0a1628_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings and Credit Arrangements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_6362f770-e363-4bf1-8bf7-da2e189f88a6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets (liabilities) recognized on the consolidated balance sheet</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AllOtherReinsurersMember_82f33e60-7f49-476d-a274-6bd99ba8699d_terseLabel_en-US" xlink:label="lab_cvs_AllOtherReinsurersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other</link:label>
    <link:label id="lab_cvs_AllOtherReinsurersMember_label_en-US" xlink:label="lab_cvs_AllOtherReinsurersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other Reinsurers [Member]</link:label>
    <link:label id="lab_cvs_AllOtherReinsurersMember_documentation_en-US" xlink:label="lab_cvs_AllOtherReinsurersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other Reinsurers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AllOtherReinsurersMember" xlink:href="cvs-20211231.xsd#cvs_AllOtherReinsurersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AllOtherReinsurersMember" xlink:to="lab_cvs_AllOtherReinsurersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0c10595e-c9b2-4da1-b259-5aab18658737_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of components of income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_ffbbe3e1-30f9-48e1-a515-6004298771c1_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.3% senior notes due March 2028</link:label>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due March 2028 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.3DueMarch2028Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.3%, Due March 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.3DueMarch2028Member" xlink:to="lab_cvs_SeniorNotes4.3DueMarch2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_77d50d3d-6134-4daa-a37e-d9a1411ee125_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_d838cfe8-0908-4e72-a7ef-ee307fbe38e3_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_336b84ac-a689-4a19-8489-0356f5fd7376_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_e18e0032-08e3-4c60-a9d0-aadd4dc19054_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common/collective trusts</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Common Collective Trust [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_9a901d7f-f360-4bf1-9aac-db65de545fdf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_c8b8dcf4-ad7a-47a8-9d9f-9fc65d8a548f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Assets and Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_1b787a1e-51c1-402b-87ba-e11d4e1e9e00_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium receivables</link:label>
    <link:label id="lab_us-gaap_PremiumsReceivableAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsReceivableAtCarryingValue" xlink:to="lab_us-gaap_PremiumsReceivableAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_a17f236c-a1c2-4b74-85df-73d5048c8239_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_ebe7139a-0a79-4fcf-9653-3234ae6a9b63_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_a40df8a9-228a-4f41-8428-5399eb62329b_terseLabel_en-US" xlink:label="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of stock options and SARs vested</link:label>
    <link:label id="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_label_en-US" xlink:label="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Equity Instruments Other Than Options, Vested In Period, Fair Value</link:label>
    <link:label id="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_documentation_en-US" xlink:label="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Equity Instruments Other Than Options, Vested In Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:href="cvs-20211231.xsd#cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:to="lab_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_eaaff25f-8364-4397-91ba-9b79a884b410_totalLabel_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt principal</link:label>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_f5d18730-99b4-44dd-bcc2-cdbba5b6ac8c_terseLabel_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt principal</link:label>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_label_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross And Lease Obligation</link:label>
    <link:label id="lab_cvs_LongtermDebtGrossAndLeaseObligation_documentation_en-US" xlink:label="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross And Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation" xlink:href="cvs-20211231.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LongtermDebtGrossAndLeaseObligation" xlink:to="lab_cvs_LongtermDebtGrossAndLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLeaseTableTextBlock_8548447e-64ff-4a89-8c4e-a78b8a213dac_terseLabel_en-US" xlink:label="lab_cvs_LesseeLeaseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental balance sheet information</link:label>
    <link:label id="lab_cvs_LesseeLeaseTableTextBlock_label_en-US" xlink:label="lab_cvs_LesseeLeaseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease [Table Text Block]</link:label>
    <link:label id="lab_cvs_LesseeLeaseTableTextBlock_documentation_en-US" xlink:label="lab_cvs_LesseeLeaseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLeaseTableTextBlock" xlink:href="cvs-20211231.xsd#cvs_LesseeLeaseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLeaseTableTextBlock" xlink:to="lab_cvs_LesseeLeaseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_4d9c3a66-debe-4096-bf51-7aa0638d35d2_terseLabel_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits</link:label>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_label_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits Segment [Member]</link:label>
    <link:label id="lab_cvs_HealthCareBenefitsSegmentMember_documentation_en-US" xlink:label="lab_cvs_HealthCareBenefitsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Benefits Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember" xlink:href="cvs-20211231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthCareBenefitsSegmentMember" xlink:to="lab_cvs_HealthCareBenefitsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_08cbbdf7-92dd-4fac-b067-10c756d87a9b_totalLabel_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment income (excluding net realized capital gains or losses)</link:label>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_label_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Excluding Capital Gains or Losses</link:label>
    <link:label id="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_documentation_en-US" xlink:label="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Excluding Capital Gains or Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:href="cvs-20211231.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:to="lab_cvs_InvestmentIncomeExcludingCapitalGainsorLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_6b01d376-59c2-4bf9-acfa-b16950c08ea7_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceTextBlock_c95bc776-2ba3-4601-97e7-118d3bd1e742_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance</link:label>
    <link:label id="lab_us-gaap_ReinsuranceTextBlock_label_en-US" xlink:label="lab_us-gaap_ReinsuranceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceTextBlock" xlink:to="lab_us-gaap_ReinsuranceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_9326a6b9-e819-4626-a136-75ca9e0bd3a0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1f00df1a-a87c-46d0-8d4a-5f3e4897b54b_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_85fc11cd-cd59-4e53-a31f-c262552d4062_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_8b77da26-35ea-41f0-bd0a-60439298c494_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 16)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_f2dd01e4-f795-4dbc-8088-5651712b0955_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_53b89891-d2ec-46e4-be97-150507f68e3c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care costs payable and other insurance liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_7d855622-f70b-47a7-bcf0-7921cd67dbe8_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_a322253b-291c-468d-b5b1-7c4ef049bb64_terseLabel_en-US" xlink:label="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Insurance Liabilities</link:label>
    <link:label id="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid Policy Claims and Claims Adjustment Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:to="lab_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1790985d-4662-41fe-b1ea-065e2c3ea498_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_34359792-7c31-4bbf-9f8b-3e39b64d5683_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_bc854844-0b63-4854-916c-3b5ae1554964_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_b9c41053-2787-4f86-8478-935a9b06583d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefits_b2b6bf2f-af69-4fa0-9e8e-c419192d4b0f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future policy benefits</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefits_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Future Policy Benefit, before Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefits" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_1729d8d9-3e7f-46f1-9879-fbf3fce909aa_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_49892d0a-9ba0-44ee-b841-bb87874eeb34_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_c01114e7-feaf-4aeb-86b9-231c4a44740a_terseLabel_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common/collective trusts</link:label>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_label_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common and Collective Trusts [Member]</link:label>
    <link:label id="lab_cvs_CommonAndCollectiveTrustsMember_documentation_en-US" xlink:label="lab_cvs_CommonAndCollectiveTrustsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The total amount of Common/Collective Trusts held by the company, primarily related to investment funds otherwise known as underlying funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember" xlink:href="cvs-20211231.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CommonAndCollectiveTrustsMember" xlink:to="lab_cvs_CommonAndCollectiveTrustsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_75a945a8-7bca-4a3b-a4fb-9c2c7bea05e8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASU 2016-13</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201613Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201613Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201613Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_5c15ea4a-39e7-4316-be73-e219373d8560_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_27eb3a0c-db33-4aff-b899-5ee94eba9fca_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertySubjectToOperatingLeaseMember_d948bdcc-2943-4fd9-a471-5967098e7e76_terseLabel_en-US" xlink:label="lab_us-gaap_PropertySubjectToOperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_PropertySubjectToOperatingLeaseMember_label_en-US" xlink:label="lab_us-gaap_PropertySubjectToOperatingLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Subject to Operating Lease [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOperatingLeaseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOperatingLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertySubjectToOperatingLeaseMember" xlink:to="lab_us-gaap_PropertySubjectToOperatingLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_14c1dc43-2d45-4374-8c9d-6bcc56119251_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) claims liability, net</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetGross_091cfb34-abb1-405f-8e72-e8a2b0870340_terseLabel_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetGross_label_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Gross</link:label>
    <link:label id="lab_cvs_FinanceLeaseRightOfUseAssetGross_documentation_en-US" xlink:label="lab_cvs_FinanceLeaseRightOfUseAssetGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-Of-Use Asset, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetGross" xlink:href="cvs-20211231.xsd#cvs_FinanceLeaseRightOfUseAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FinanceLeaseRightOfUseAssetGross" xlink:to="lab_cvs_FinanceLeaseRightOfUseAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_b3c2405d-9f4d-4b29-b5f0-85e6d4f6797f_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_f918a034-169e-4d5d-9736-95306e0e1025_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_d85762bb-5b0c-497a-b384-c5d01d3ba98f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_db5eb489-b45c-4a7d-b3db-274b26631386_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_7dc1a70f-261a-4e9c-af32-52302a9b7d1a_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities in an unrealized capital loss position</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ee76b1c8-3bfd-4f86-bcc2-47e4c3276c7f_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_959f5d91-cba1-4f79-9391-dd5c62cca983_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Paid and Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:to="lab_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember_e8f8178d-98d4-4cd8-90b6-374e59f0ef7e_terseLabel_en-US" xlink:label="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS Health 2017 Incentive Compensation Plan</link:label>
    <link:label id="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember_label_en-US" xlink:label="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS Health 2017 Incentive Compensation Plan [Member]</link:label>
    <link:label id="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember_documentation_en-US" xlink:label="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CVS Health 2017 Incentive Compensation Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:href="cvs-20211231.xsd#cvs_CVSHealth2017IncentiveCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:to="lab_cvs_CVSHealth2017IncentiveCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_3e2a06d2-d14d-4a32-951d-fce393480376_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_e9577d0e-5c6c-4957-a0c8-8163a1953c6d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_4ae51d37-29ab-459a-923b-da2c912a65cd_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_1dd0c7e9-a3f8-45d9-ad53-e4a78601d454_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ab17ed86-8950-40c8-abe9-574c0044752b_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OutstandingSeniorNotesMember_0f55a5fd-3ca8-4fc0-8f4e-216199427ace_terseLabel_en-US" xlink:label="lab_cvs_OutstandingSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Senior Notes</link:label>
    <link:label id="lab_cvs_OutstandingSeniorNotesMember_label_en-US" xlink:label="lab_cvs_OutstandingSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Senior Notes [Member]</link:label>
    <link:label id="lab_cvs_OutstandingSeniorNotesMember_documentation_en-US" xlink:label="lab_cvs_OutstandingSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OutstandingSeniorNotesMember" xlink:href="cvs-20211231.xsd#cvs_OutstandingSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OutstandingSeniorNotesMember" xlink:to="lab_cvs_OutstandingSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_72caa4e8-8b0a-4b57-bf53-47867954480d_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFive_0a003070-22f0-4626-8729-a73ce3459a09_totalLabel_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Five</link:label>
    <link:label id="lab_cvs_LesseeLiabilityPaymentsDueYearFive_documentation_en-US" xlink:label="lab_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Liability, Payments, Due Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:to="lab_cvs_LesseeLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_bdc065ce-5a8a-4d45-ba76-143fc5d0c5a7_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_97067d2c-e8b7-49fc-8f02-3dd2d4f4d744_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_21b4f097-aa74-4eb6-baf3-f4fbb8a0cf20_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Claims paid</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_19c0099b-d247-406c-b6ee-776ed044579c_verboseLabel_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_1ddb830b-5c9d-4541-8a5b-8845c7de7690_terseLabel_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from external customers</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_documentation_en-US" xlink:label="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="cvs-20211231.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_6b5c99c4-086a-491e-b918-a62c4d10cde8_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_f2ee40c8-fa26-4cb7-a3b6-89aa2aaa78cc_netLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (GAAP measure)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_864e9405-07ca-4823-96ec-1571e6d9e5af_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes3625DueApril2027Member_c036adad-8c46-41a7-bb83-abbb63aff016_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes3625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% senior notes due April 2027</link:label>
    <link:label id="lab_cvs_SeniorNotes3625DueApril2027Member_label_en-US" xlink:label="lab_cvs_SeniorNotes3625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.625%, Due April 2027 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes3625DueApril2027Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes3625DueApril2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 3.625%, Due April 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3625DueApril2027Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3625DueApril2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes3625DueApril2027Member" xlink:to="lab_cvs_SeniorNotes3625DueApril2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_018a958e-dc44-48f8-9a5e-dd93b596b073_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_b3a9e529-541b-4235-8406-69afe9ee28c1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c2bc6d03-51f0-4a1f-9a8c-f33e7672fd88_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_a114a344-2d09-45ee-9b3c-171bc23ab810_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_47b36c09-a36c-4846-b755-8d3cec926a9a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_3438403c-59c7-4156-8b5e-01606e47109d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocationsToPolicyholdersPolicies_48d4576b-ee68-43c3-8357-d3568c724b9e_terseLabel_en-US" xlink:label="lab_us-gaap_AllocationsToPolicyholdersPolicies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholders' Funds</link:label>
    <link:label id="lab_us-gaap_AllocationsToPolicyholdersPolicies_label_en-US" xlink:label="lab_us-gaap_AllocationsToPolicyholdersPolicies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocations to Policyholders, Policies [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocationsToPolicyholdersPolicies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocationsToPolicyholdersPolicies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocationsToPolicyholdersPolicies" xlink:to="lab_us-gaap_AllocationsToPolicyholdersPolicies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_a8ac71b4-ff90-4af8-bb12-5467663073cd_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_121ee132-e226-4b0f-8452-5e4f3bca037a_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldByInsuranceRegulators_5ed9b450-b032-47aa-8abf-c836501ed44e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldByInsuranceRegulators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments on deposit with regulatory bodies</link:label>
    <link:label id="lab_us-gaap_AssetsHeldByInsuranceRegulators_label_en-US" xlink:label="lab_us-gaap_AssetsHeldByInsuranceRegulators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held by Insurance Regulators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldByInsuranceRegulators" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldByInsuranceRegulators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldByInsuranceRegulators" xlink:to="lab_us-gaap_AssetsHeldByInsuranceRegulators" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_055ad83a-2a51-4620-95c4-8dbd1170cb8c_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mail choice</link:label>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:to="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_ea6c1b63-40af-46ee-9250-13c3622c7036_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_8f2e58d7-b295-42d2-869c-c1878888a908_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRealEstateMember_b18479ee-4368-4983-ab38-dc46b5d5e28c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRealEstateMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Real Estate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:to="lab_us-gaap_DefinedBenefitPlanRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_a4d3ddf6-63e5-42fb-b0ae-08d96f780237_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit payments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes425DueApril2050Member_feec5047-be4f-4aba-a7dc-7e4cdde1bfbe_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes425DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.25% senior notes due April 2050</link:label>
    <link:label id="lab_cvs_SeniorNotes425DueApril2050Member_label_en-US" xlink:label="lab_cvs_SeniorNotes425DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.25%, Due April 2050 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes425DueApril2050Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes425DueApril2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.25%, Due April 2050</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes425DueApril2050Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes425DueApril2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes425DueApril2050Member" xlink:to="lab_cvs_SeniorNotes425DueApril2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_bf45722c-f195-4701-aca2-349a0ac53861_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_430e4199-b2d8-489d-b24f-ff2f7b803e44_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentMember" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_32689b6b-6868-4996-900b-25c7f13241d4_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_b0fb44d5-0155-42fa-93aa-e8e817796693_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_04cd7236-d601-4082-ac3d-bab1cff2f4be_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_917e9b47-c1e2-4f54-a36f-5f1ee40432fa_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_b2e69da5-9fb3-4cce-bc48-3c4421c90752_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalCreditAssessmentAxis_af54d8ea-0c82-4bbc-9990-9154f69043a0_terseLabel_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Axis]</link:label>
    <link:label id="lab_us-gaap_InternalCreditAssessmentAxis_label_en-US" xlink:label="lab_us-gaap_InternalCreditAssessmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Credit Assessment [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalCreditAssessmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis" xlink:to="lab_us-gaap_InternalCreditAssessmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_851c6664-c8ed-4b3f-8be7-0c1209699c13_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_9dbe7c2c-cf76-4f8c-8ace-8471d6dcca61_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, granted ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_25d65b43-68d3-42e1-81d0-0e54e14e7ce5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic value outstanding at end of year</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_3cde75b7-e6bc-4bb1-98f2-87569704ab08_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination [Axis]</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Year Of Origination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:to="lab_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_f2090f85-76b1-4191-9f26-87138c5853ff_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4Point125PercentApril2040Member_84b17ccd-9d9c-4e1f-bcf1-07c744354937_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.125% senior notes due April 2040</link:label>
    <link:label id="lab_cvs_SeniorNotes4Point125PercentApril2040Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4 Point 125 Percent, April 2040 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4Point125PercentApril2040Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4 Point 125 Percent, April 2040</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4Point125PercentApril2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:to="lab_cvs_SeniorNotes4Point125PercentApril2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_f4ed22a7-41b7-4b72-bfcb-d2a6f3d2f8ef_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Three [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodThreeMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodThreeMember" xlink:to="lab_cvs_YearOfOriginationPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_d0443f23-6154-47e7-a7da-e21139d92806_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_1d8846e6-e80b-455d-8c5f-3348b66c69a4_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_76acc9e4-ab83-4ea6-8e21-1f930bbda848_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_ef7136cc-4184-47d6-93c9-085d686d1c1d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in plan assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_91123a7a-cb7f-4dcb-a00e-2d0fc560a3cf_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_09196720-d94a-49d1-9bd5-0435d7034930_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average assumptions used in determining benefit obligations and net benefit costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_deb61f32-f3a1-46c3-ab33-db280328f10f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_c1a3f8a2-636c-4d3b-b472-566a546fedab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_c40b1466-78f6-424a-bdf3-94194f5bcfb9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross realized capital losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_5165e8b3-9108-4935-879d-9bd890ac3a93_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_cf38eece-bebc-43a5-9218-2205ae6eb9e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of expected future benefits payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_83e671ef-1d76-410f-928f-9072c6ab276c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_e42be68e-981c-4e0b-bcb0-055291ecfd95_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_5e3e240a-dc26-4456-8d8c-32211ad4ab82_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of unrecognized tax benefits roll forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_72cfd3b0-d35e-4f14-8128-4ea9e31a1fcd_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_3201bc0d-e20a-4f92-8fae-26f1fb799bc3_terseLabel_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rewards earnings and gift card issuances</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_label_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance</link:label>
    <link:label id="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_documentation_en-US" xlink:label="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:href="cvs-20211231.xsd#cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:to="lab_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_f826a23f-74d5-4e2f-8ca7-cc8417d52c84_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_dd656839-238e-44d1-aca4-7c6cf96ede1e_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_449e4fd5-a0b8-42b3-ba5c-f04f6d343322_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_54eb89fb-6f58-44d4-a93c-7ef84286feb1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_23b9d350-9413-487d-9fe6-7a046567b7c6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASU 2016-02</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_b0064991-c463-43ef-8d96-be9fcd800943_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_76188210-cca7-4373-a195-c3e164f2be18_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_a790fcd3-0d20-4a05-a104-2c6c27c00597_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_e7fbb704-857f-4a94-8c61-611d6f2b660b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected long-term rate of return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_c9940579-d959-44a7-8dd7-16e739c659f5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_98584c05-c105-4903-b973-ce6f86c91ea8_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_3cd0c5c0-f865-438f-bc21-12a5e862be80_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_be8d46fc-fd41-485d-af3b-afff6195374e_terseLabel_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patients served per year (more than)</link:label>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_label_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Patients Served per Year</link:label>
    <link:label id="lab_cvs_NumberofPatientsServedperYear_documentation_en-US" xlink:label="lab_cvs_NumberofPatientsServedperYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Patients Served per Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear" xlink:href="cvs-20211231.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofPatientsServedperYear" xlink:to="lab_cvs_NumberofPatientsServedperYear" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_3d2f12be-856f-414e-9c96-c6293791b07b_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_008ae8f9-9573-474b-8168-2f90b15d283b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_94863682-7e52-4f43-9c17-e92730c3ed86_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_ae1d471e-fdb8-491d-a23a-d6eecbca52c9_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1aa16009-41cf-499c-aac7-8d19211b72ce_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_7fc76cd7-b73a-48f1-9f25-ccd62c4c708f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock_98397d4e-bb39-4bdd-96ea-21f07a0c5972_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs Payable</link:label>
    <link:label id="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareCostsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_HealthCareCostsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_accc599b-0738-4147-9bc1-93138446c17d_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_71ae66d6-9d28-4605-bd37-e6d0c7de3b6a_terseLabel_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common/collective trusts, Debt Securities</link:label>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_label_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Common Collective Trust, Debt Securities [Member]</link:label>
    <link:label id="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_documentation_en-US" xlink:label="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Common Collective Trust, Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:href="cvs-20211231.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:to="lab_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_ec12c92f-c5be-456a-91d7-676243313298_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers into Level 3, net</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_1af4bf03-0a8f-4b17-b951-273bb2743c3f_totalLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net transfers into Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_a57533ac-658a-4464-b924-4a0314442def_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combined statutory capital and surplus</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus, Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member_95b7b172-bf99-4042-b979-2fcfede1c13c_terseLabel_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options granted subsequent to 2018</link:label>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member_label_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Granted Subsequent to 2018 [Member]</link:label>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member_documentation_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Granted Subsequent to 2018</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member" xlink:href="cvs-20211231.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member" xlink:to="lab_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateLineItems_237977ce-5747-4c9c-90d8-e2fa505b9fa0_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate [Line Items]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateLineItems_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems" xlink:to="lab_srt_MortgageLoansOnRealEstateLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_8af3fc61-ed4f-4b58-a30c-6a9ccad3cca0_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets, Trademarks</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_Category1Member_4be0d0eb-1db8-4a57-9f29-9d3b9df63a9f_terseLabel_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1</link:label>
    <link:label id="lab_cvs_Category1Member_label_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Category 1 [Member]</link:label>
    <link:label id="lab_cvs_Category1Member_documentation_en-US" xlink:label="lab_cvs_Category1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Credit Quality Indicator - Category 1 [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member" xlink:href="cvs-20211231.xsd#cvs_Category1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_Category1Member" xlink:to="lab_cvs_Category1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_cd590fb9-b66f-4c19-8aea-b251784e2944_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_cb2a5e91-3c4a-41cb-a9d3-8d77a64883ee_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received from stock options exercised (including ESPP)</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_944f91c5-ed6c-4165-98c7-cbd7f9fa1f17_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_94ab1318-dfad-4745-b18d-91860c3dd437_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_a480d866-2426-4dac-85a8-010d9fb4a0dc_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_f397b515-60d0-4fc5-87bf-0d6cbbc8fbd5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale-leaseback transactions</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lease Payment, Sales-Type and Direct Financing Leases, Investing Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" xlink:to="lab_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a4f0c203-1de9-4bee-af69-8870ae9e3b6f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_44a93f5d-bd3c-4975-953c-b06e8ece0120_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a6e84d4f-c81e-4e12-b2ed-b1487cc64f3a_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of year balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4f112866-6402-46e3-9185-3dc28a66aca8_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of year balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cfa02245-dc54-438d-be71-e1aaf7e9aaf8_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_64d5239c-d608-4959-98d4-00537eea1db1_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_dd6017c8-dac6-4cf5-aa83-2ce9a74c3dfe_terseLabel_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit costs recorded in other insurance liabilities</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_label_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</link:label>
    <link:label id="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_documentation_en-US" xlink:label="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:href="cvs-20211231.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:to="lab_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_6ae38073-385e-49be-aaa2-554aaefff9d9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock_ccc32c8f-806a-4804-b234-2612d086b2f6_terseLabel_en-US" xlink:label="lab_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock_label_en-US" xlink:label="lab_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite lived and indefinite lived intangible assets [Table Text Block]</link:label>
    <link:label id="lab_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the cost, accumulated amortization and net balance of intangibles assets and amortization period, in total and by major class. Finite-lived intangible assets have a stated useful life over which their gross carrying value is amortized. Indefinite intangible assets have a projected indefinite period of benefit (hence are not amortized).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock" xlink:href="cvs-20211231.xsd#cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock" xlink:to="lab_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PensionAndAnnuityInvestmentContractsInterest_78541c40-4184-4724-9ec7-4274869f2f4e_terseLabel_en-US" xlink:label="lab_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate for pension and annuity investment contracts</link:label>
    <link:label id="lab_cvs_PensionAndAnnuityInvestmentContractsInterest_label_en-US" xlink:label="lab_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension And Annuity Investment Contracts Interest</link:label>
    <link:label id="lab_cvs_PensionAndAnnuityInvestmentContractsInterest_documentation_en-US" xlink:label="lab_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension And Annuity Investment Contracts Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:href="cvs-20211231.xsd#cvs_PensionAndAnnuityInvestmentContractsInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:to="lab_cvs_PensionAndAnnuityInvestmentContractsInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_46d86755-c128-449e-bac1-8bab06b55614_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_8392109e-abaa-46dc-8f98-09dcd5a85f84_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5149f40d-c2f6-4706-9eb4-57719417b7f6_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_6a06d31c-4c9b-4cb4-8d6a-b8630a108e94_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium paid in excess of debt principal</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_122ccf21-482b-4bd5-9034-c353f8680d7e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_dc269399-dd9b-4006-882d-de25574cde91_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_bc43505a-685c-47e6-899e-1b02ad454e4d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_bcf7052a-adc6-4c17-8fa4-7f04b0676f1f_terseLabel_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR, shares to be received at the end of program as a percent of notional amount</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_label_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percent of Notional Amount in Shares to be Received at End of Program</link:label>
    <link:label id="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_documentation_en-US" xlink:label="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Percent of Notional Amount in Shares to be Received at End of Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:href="cvs-20211231.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:to="lab_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_229dc8cc-9842-469a-ae22-e56daca36aaa_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_40de79b1-0de0-4c20-b788-6fe4d46c9a45_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Components of incurred health care costs</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_95efbc77-2628-4945-84b1-0267a833a2a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summarized financial information of segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_23089efa-8e3b-4f7c-accc-4214d455389d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6f4f30cb-48cb-4999-835f-47b730eeedaf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_63ac5479-55e2-414b-afeb-3b9da47c13bf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, expired ($ per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_5e438800-e259-4a8c-b625-bd52a3d8779b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedInvestmentsAtFairValue_1591335b-dc3d-4f80-ab4a-050229392d35_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedInvestmentsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments related to 2012 contract conversion</link:label>
    <link:label id="lab_us-gaap_RestrictedInvestmentsAtFairValue_label_en-US" xlink:label="lab_us-gaap_RestrictedInvestmentsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Investments, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedInvestmentsAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedInvestmentsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedInvestmentsAtFairValue" xlink:to="lab_us-gaap_RestrictedInvestmentsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_5ea02d8f-8ca9-4757-b2b8-0d197cee76cd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_7737a0eb-7c74-4c61-acb4-66f59bd81ee4_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_0f841e3b-e558-4893-87a9-3d8f8a8c025c_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One year through five years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_fc0c6b41-3657-49b7-8382-82d476bf94b1_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_7f4ac0f2-8935-45d6-9fa8-87c944973308_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_09b9602f-2eb9-4f8f-a05d-5464abd2e42b_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_2c46ad98-a776-4796-b13c-81540fa3576b_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_7c5d57b7-d4de-4670-9338-e23ba1a9cb4d_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease costs</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_a38be05c-bb9d-452f-a359-9fbe41bd3e82_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_20b40e7a-9120-492e-890c-2eb0ea793ad8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_96471cfd-e85f-4f8f-8e9c-c4fb8638ee66_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableToBanksMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableToBanksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable to Banks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableToBanksMember" xlink:to="lab_us-gaap_NotesPayableToBanksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_98dc6c01-a0b4-4e70-a9c9-4f7816fd797c_verboseLabel_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted operating income (loss)</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_6b491d45-befb-4378-b21f-5473cf484d4b_terseLabel_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted operating income</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_label_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Operating Income (Loss)</link:label>
    <link:label id="lab_cvs_AdjustedOperatingIncomeLoss_documentation_en-US" xlink:label="lab_cvs_AdjustedOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss" xlink:href="cvs-20211231.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_AdjustedOperatingIncomeLoss" xlink:to="lab_cvs_AdjustedOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_8b72b45f-e1ba-40a7-b8be-8121b94823f1_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.75% senior notes due August 2030</link:label>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_label_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.75%, Due August 2030 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes175DueAugust2030Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 1.75%, Due August 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes175DueAugust2030Member" xlink:to="lab_cvs_SeniorNotes175DueAugust2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAbstract_cb110541-47bd-4360-b284-933b766e78e0_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_a87cc3a7-3b64-4164-92cd-188830339ae2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4a7cea37-3346-4f0d-b734-b5bc595889e0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_16abac47-a013-4f03-b2f6-5ba31d5461ca_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:label id="lab_us-gaap_DividendsPayableLineItems_label_en-US" xlink:label="lab_us-gaap_DividendsPayableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableLineItems" xlink:to="lab_us-gaap_DividendsPayableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_44f6e451-7729-4d2c-9014-3efc4f0442c3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_cc8dd80f-1022-43ed-8b3d-0d0111c9ffe2_totalLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_ffe8ad7d-4d04-47c0-aa90-6a318a57ffdf_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_82494d83-cc15-4224-a408-3118bba53207_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1db06057-ea9b-4330-8c4d-40f1444b7c8d_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_637692aa-fe59-4b0a-9b79-43ba82f36de2_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_88bc14bf-831d-4c91-9faf-2ac1f42192dd_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information about incurred and paid health care claims development</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Claims Development [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_275fc158-ee5c-436b-8f7d-b87c74a7cd49_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_f817e71a-15ed-4a2e-b5c4-fce7ee1ad0e7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock percent</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_f882ce7d-7b5e-4f09-8db9-6a29dfc07b58_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Five</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans On Real Estate Collections Of Principal In Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:to="lab_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4204936c-bccd-4fc5-9b6e-b8a677b4f353_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_5a58ca17-450d-4323-810b-8fcebcf04ad5_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_91f3fdbd-26b0-4e91-a3a6-d44c4d4c7596_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_811a7882-2187-4a12-a7aa-cdc17ca42075_terseLabel_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and manufacturer receivables</link:label>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_label_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and Manufacturer Receivables</link:label>
    <link:label id="lab_cvs_VendorandManufacturerReceivables_documentation_en-US" xlink:label="lab_cvs_VendorandManufacturerReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor and Manufacturer Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables" xlink:href="cvs-20211231.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_VendorandManufacturerReceivables" xlink:to="lab_cvs_VendorandManufacturerReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_e66e4c06-2cdc-40ab-b99d-e207bad88580_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate/ Other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts_b97434c3-92c8-4941-b464-ee226f86d8fb_terseLabel_en-US" xlink:label="lab_cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain on write-off of net unamortized deferred financing premiums on early extinguishment of debt</link:label>
    <link:label id="lab_cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts_label_en-US" xlink:label="lab_cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Gain from Write Off of Deferred Debt Issuance Costs</link:label>
    <link:label id="lab_cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts_documentation_en-US" xlink:label="lab_cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Gain from Write Off of Deferred Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts" xlink:href="cvs-20211231.xsd#cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts" xlink:to="lab_cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_9651aa93-0297-425b-90d6-863e681ee396_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_49f8f600-ac76-4724-afdf-e839dc60890f_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans and Other Postretirement Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8ba07336-c923-4d3f-aafd-4a4a05a22d7b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_38fa8581-756b-4504-bf02-debd7b45a67d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_5286ba25-06be-460c-b531-e651716249c9_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_ce97ec76-2bd9-4322-bb95-01cbea9d5ff6_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_ee5c4483-baa9-45fb-8bde-8c61a8fbb46f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_392871d5-4430-48ec-97e2-3614fe15d116_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unrealized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_97f0db17-ee13-4385-9203-d72bc9792209_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture of Workers&#8217; Compensation business</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_ff9a1426-6b85-47de-b384-6eba15f0a62a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and rents</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_577b776c-e7e5-45fd-88fd-d2216040f9d2_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_470ab828-b153-4f94-a4b2-6adb2a038e03_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625% senior notes due August 2024</link:label>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.625%, Due August 2024 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.625DueAugust2024Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.625%, Due August 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.625DueAugust2024Member" xlink:to="lab_cvs_SeniorNotes2.625DueAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_029001b5-0e96-4ed7-83aa-6d4e5b26680f_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_14c6ce4b-47a9-4f03-8a16-1b834fbe197e_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_d0b33d32-738d-435d-bac6-026b2de8f502_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. domestic</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_589544da-3b1f-4fc0-891c-e5729f8c4d27_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_84b9c86b-96c0-4af3-a584-292d16439847_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis difference upon disposition of subsidiary</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Business, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_bbfa1456-b712-48a1-9cfd-73d5b3d6c8e9_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesTable_7cc382e1-d0dc-4249-a59d-3df3c231d521_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Table]</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesTable_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable" xlink:to="lab_us-gaap_StatutoryAccountingPracticesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_e51aebaf-fb6d-44f1-9a9c-84e1c5f4cd39_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_9ad34eff-91f6-4bce-aca8-47ac5f13e17f_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_425f0af9-a84a-4264-8b2a-d85427a496ab_totalLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_label_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsEarnedNet" xlink:to="lab_us-gaap_PremiumsEarnedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_7ccca283-0b06-468a-9d2b-937f853e1e37_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.8% senior notes due June 2023</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due June 2023 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.8DueJune2023Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.8%, Due June 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.8DueJune2023Member" xlink:to="lab_cvs_SeniorNotes2.8DueJune2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_d8e49afc-8e77-4051-9295-7b3cc939f67e_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_e0cfc54c-cf49-439f-8538-c5bc13d1d95a_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_8450747d-97e7-4ca4-a7b3-1cb074783831_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure_6f4357a4-98f1-4993-ad52-638e30360546_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, fair value</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ca45843-2c01-4e75-a711-a6587d011321_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_1b3767ad-a7a8-4da9-90ed-9d1a8d42e0df_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_a296bd31-4150-4806-8684-c937f9dcfc69_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs Payable</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance and Deposit Contracts [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:to="lab_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsTable_410e0719-5fa6-4e21-8955-f63870833d98_terseLabel_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Table]</link:label>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsTable_label_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Acquired Intangible Assets [Table]</link:label>
    <link:label id="lab_cvs_OtherAcquiredIntangibleAssetsTable_documentation_en-US" xlink:label="lab_cvs_OtherAcquiredIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsTable" xlink:href="cvs-20211231.xsd#cvs_OtherAcquiredIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable" xlink:to="lab_cvs_OtherAcquiredIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6fb1cba5-15a7-48d3-a3ed-77d0280024b2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_bc434355-6580-41ab-99f5-eb5f9d8d1f68_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixtures and equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_669b4090-0d37-4d69-9dc6-253e20d28756_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_3161987e-718b-4569-874c-a5c1ff66c45e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_10554a93-a849-4444-8c47-e17e5bc70a94_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_fe05d050-e60d-4e5e-9aa1-af102ded7bc2_totalLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net benefit costs</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_36b15c7a-e146-48c3-a104-eb718f8f0879_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign securities</link:label>
    <link:label id="lab_us-gaap_ForeignCorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Corporate, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignCorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_8f3e1217-8f4d-467d-8f37-a2e400e1a581_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_d1e28f6b-1d72-4c5e-8640-ef136587cb56_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate/ Other</link:label>
    <link:label id="lab_us-gaap_CorporateAndOtherMember_label_en-US" xlink:label="lab_us-gaap_CorporateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateAndOtherMember" xlink:to="lab_us-gaap_CorporateAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_ee919576-8e95-42c8-a615-8391ae2d3263_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bfd65d04-06e8-48f5-a318-8505e16725eb_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average basic shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5d25c0c5-104f-4a97-a0e3-105d01448fe9_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_31b21a69-4c41-4c2c-98a7-9cd5e7c227a6_terseLabel_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans fully repaid</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_label_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Loans Fully Repaid</link:label>
    <link:label id="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_documentation_en-US" xlink:label="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pertains to amount of mortgage loans fully repaid.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:to="lab_cvs_MortgageLoansOnRealEstateLoansFullyRepaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_aa3a8be7-d761-469a-b0cc-d673021f8a23_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_d27a7289-0045-4734-931f-51bf7d44fbe6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_f0b54480-980e-4e93-a8b7-ccd9a748f208_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Four [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFourMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodFourMember" xlink:to="lab_cvs_YearOfOriginationPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_2e28c3df-49bb-4034-b90e-68689fc8d524_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_a75dd431-1538-4ae5-aaf9-077ef71a6cdd_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_1e97dad0-ed93-4b2f-84bd-b1417eb8057e_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_d4bf050d-29aa-44fe-a165-9ae040e4a3ee_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_36f5625d-d0e6-4b18-9ec9-8cd5cebb8a1d_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_d4248125-f127-4d90-8f54-08372ab2ddc3_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to CVS Health</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_58b2a86f-5d8e-44be-9e1c-67570f9f88ae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_label_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:to="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a84675a0-0e19-4503-8114-f5f7eaecf568_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_e90bbafd-199e-467d-a08c-8ffe1434a647_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and OPEB plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_a59ca9c9-17ab-437b-a587-a240cc932dda_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of assets (liabilities) recognized in Balance Sheet</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_fcf9e682-a581-48b7-b6ae-26bc95fbdd6e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_05c5f768-6e43-4488-8d46-e5d4d63d0d8f_terseLabel_en-US" xlink:label="lab_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer plans, plan contributions</link:label>
    <link:label id="lab_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_label_en-US" xlink:label="lab_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Multiemployer Plan, Pension, Insignificant, Plan Contribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MultiemployerPlanPensionInsignificantPlanContribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution" xlink:to="lab_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberOfStoresPlannedClosure_11280eb3-6cc8-456e-928e-569a39f67be3_terseLabel_en-US" xlink:label="lab_cvs_NumberOfStoresPlannedClosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of stores, planned closure</link:label>
    <link:label id="lab_cvs_NumberOfStoresPlannedClosure_label_en-US" xlink:label="lab_cvs_NumberOfStoresPlannedClosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Stores, Planned Closure</link:label>
    <link:label id="lab_cvs_NumberOfStoresPlannedClosure_documentation_en-US" xlink:label="lab_cvs_NumberOfStoresPlannedClosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Stores, Planned Closure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresPlannedClosure" xlink:href="cvs-20211231.xsd#cvs_NumberOfStoresPlannedClosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberOfStoresPlannedClosure" xlink:to="lab_cvs_NumberOfStoresPlannedClosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_7fab27ee-80b7-4e03-98f4-f180f59a73cf_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_aa18e7cf-ebba-43de-ac08-319964af9436_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations attributable to CVS Health (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_e3e64650-6324-44a0-af65-53a113538675_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per share from continuing operations, basic (USD per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_0d3053be-fee4-4bc9-9af6-5fcd9c0fa285_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.1% senior notes due March 2025</link:label>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.1%, Due March 2025 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.1DueMarch2025Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.1%, Due March 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.1DueMarch2025Member" xlink:to="lab_cvs_SeniorNotes4.1DueMarch2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_8d939b72-1936-47e7-b0f5-0b52e2f4d497_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_0d33d956-7d49-4703-ab06-30316fd96f38_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_9954d443-257a-4a5e-9aba-2f21fbe37706_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of effective income tax rate reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_d79a8614-9bd5-46f1-93b3-c5493a113a1d_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total CVS Health Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_bc68414e-634b-4a97-bf68-849c691ed4db_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_b1d74692-c8b4-43d7-b587-8afb1a961835_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_38086b09-131f-4712-adc9-64817847aa54_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock dividends</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_ff75a536-da97-4c6a-9a97-70d513385244_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_5e44128c-a7ca-4ace-aa3d-47bfcdf6a066_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of variable interest entities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7bd2b9c9-9e67-4475-a8bc-d8a6f6293e60_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_b868fd86-83fd-4fe6-9c34-65bb53a8680a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9564d930-9880-495b-b89c-ab3de69f9307_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_6182f812-3a16-4139-8491-06e4f73c1137_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross transfers into Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_cf249a92-abc8-48f0-9810-081bdea2c80c_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_212c4ef9-f9f8-44bd-b1e6-4cca8f513b6b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_dda080a5-7037-45cf-b8e0-6acea833865f_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_704bc6e1-3af4-4b1b-a43e-83e89e2142a2_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyRebatePeriod_64916e8b-f7c0-4e6a-bf68-ff5b372fe824_terseLabel_en-US" xlink:label="lab_cvs_PharmacyRebatePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy rebate period</link:label>
    <link:label id="lab_cvs_PharmacyRebatePeriod_label_en-US" xlink:label="lab_cvs_PharmacyRebatePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Rebate Period</link:label>
    <link:label id="lab_cvs_PharmacyRebatePeriod_documentation_en-US" xlink:label="lab_cvs_PharmacyRebatePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Rebate Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRebatePeriod" xlink:href="cvs-20211231.xsd#cvs_PharmacyRebatePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyRebatePeriod" xlink:to="lab_cvs_PharmacyRebatePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_801999ea-8bcb-401e-8814-382d5793a5a9_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_dacbcc62-27a0-4604-8d5c-e84175fb0c6e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Securities, Less than 12 months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_a75bf058-18b7-4f5c-9ba4-03925d2b7034_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of subsidiary</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_aef47f83-457c-4b3d-9ffb-716053432bfa_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5f97a6cc-27c6-4bc5-a700-931e6d29778f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_c7afb096-8fce-463f-a517-e6c1e33a2542_terseLabel_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares held in trust</link:label>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_label_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Shares Held In Trust</link:label>
    <link:label id="lab_cvs_TreasuryStockValueSharesHeldInTrust_documentation_en-US" xlink:label="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Shares Held In Trust</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust" xlink:href="cvs-20211231.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TreasuryStockValueSharesHeldInTrust" xlink:to="lab_cvs_TreasuryStockValueSharesHeldInTrust" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_58557bd4-acbe-4290-8c79-92ff4b6671ae_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_9197881d-565d-488f-b24d-9a92770210b5_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_acc5bb5b-4da5-43c8-9431-9dfa2a6c568a_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost, Total</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent_c0ed182c-5894-434c-bb16-34405a56898c_terseLabel_en-US" xlink:label="lab_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly dividends declared, percent increase</link:label>
    <link:label id="lab_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent_label_en-US" xlink:label="lab_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Quarterly Dividends Declared, Increase Amount, Percent</link:label>
    <link:label id="lab_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent_documentation_en-US" xlink:label="lab_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Quarterly Dividends Declared, Increase Amount, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" xlink:href="cvs-20211231.xsd#cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" xlink:to="lab_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_913ca179-338d-4dda-b5bd-fc6d11f86898_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_b3af0958-f90b-4c8c-8f43-b6a0df33b11a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SalesChannelOtherMember_5abbea6d-280f-48ba-a522-79366ac6f3bb_terseLabel_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_cvs_SalesChannelOtherMember_label_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Other [Member]</link:label>
    <link:label id="lab_cvs_SalesChannelOtherMember_documentation_en-US" xlink:label="lab_cvs_SalesChannelOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember" xlink:href="cvs-20211231.xsd#cvs_SalesChannelOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SalesChannelOtherMember" xlink:to="lab_cvs_SalesChannelOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments_ca9fefc1-5226-4043-ab6d-7884e0af5e0a_terseLabel_en-US" xlink:label="lab_cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments_label_en-US" xlink:label="lab_cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Excluding Store Impairments and Goodwill Impairments</link:label>
    <link:label id="lab_cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments_documentation_en-US" xlink:label="lab_cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses, Excluding Store Impairments and Goodwill Impairments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments" xlink:href="cvs-20211231.xsd#cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments" xlink:to="lab_cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_aa6438b1-39e6-4906-a17b-8a45b4876882_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_8c8d3a62-8e2d-4293-ae9f-1e3a59691db2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_65d4094c-7cac-4978-a14b-7eb2caa99331_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Greater than ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_04fef00d-9157-4778-bd5b-e6db39156f89_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_26a05244-a873-4795-8aa2-55456aad27d7_terseLabel_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential Mortgage Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes2.125June2021Member_2e7ab840-b19d-46ff-b145-fe1b69bf1b59_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes2.125June2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% senior notes due June 2021</link:label>
    <link:label id="lab_cvs_SeniorNotes2.125June2021Member_label_en-US" xlink:label="lab_cvs_SeniorNotes2.125June2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.125%, June 2021 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes2.125June2021Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes2.125June2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 2.125%, June 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.125June2021Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.125June2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes2.125June2021Member" xlink:to="lab_cvs_SeniorNotes2.125June2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_a5ab66e9-8a70-4897-81a9-0d8131a50780_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_054b9f07-e1b8-4f1c-855f-11d9425c5125_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation, beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_98b7cd53-e917-4512-b0a2-14f712d5b78c_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation, end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_16692856-44dc-44c1-9c9c-794c9079b6b5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of long-term debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_60f69ad4-906c-4df6-8117-6dbb4b2eb558_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_f10ba08e-0cdf-452c-8812-26d351f0b6f3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6168c96d-c19d-4e37-95a1-0513b832e8be_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_842688b8-1783-45a7-a353-e8569a9ebcb3_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer contracts/relationships and covenants not to compete</link:label>
    <link:label id="lab_us-gaap_CustomerRelatedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-Related Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:to="lab_us-gaap_CustomerRelatedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_25aecfd2-e5c0-452b-9956-d5dee71da4cf_terseLabel_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line</link:label>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_label_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthInsuranceProductLineMember" xlink:to="lab_us-gaap_HealthInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_f2aac46b-114b-4cce-abb3-fbde05c3df7f_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit costs</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net, Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_93106113-9f09-40fc-a755-530e0341c664_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_4dde3d8b-83a4-4ca4-92ea-c65e7672e28d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_d2457bb3-76f4-42b3-839d-2e518b990b95_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_89d9370b-4257-4abf-b60c-baf8192334be_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_d17204d8-03ba-433e-a5a0-d8128e9eede3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt premiums</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_ab479ab5-136d-468a-944e-f65848402060_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested at end of year and expected to vest in the future (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member_b4dfff60-0fe4-40e2-ab9e-6f85028dfc2c_terseLabel_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options granted through 2018</link:label>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member_label_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Granted Prior Through 2018 [Member]</link:label>
    <link:label id="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member_documentation_en-US" xlink:label="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Granted Prior Through 2018</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member" xlink:href="cvs-20211231.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member" xlink:to="lab_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_a978a86d-6f96-43ce-b07c-3955f162b6d0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_e9de3921-3294-4e3b-90b4-7178c827d264_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumptions used to determine benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_a3ebdec9-b8d8-427e-a0cd-d5caa3173170_terseLabel_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy claims and discounts payable</link:label>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_label_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims and Discounts Payable, Current</link:label>
    <link:label id="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent_documentation_en-US" xlink:label="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Claims and Discounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:href="cvs-20211231.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:to="lab_cvs_PharmacyClaimsandDiscountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_c4809360-fa7b-40e0-ab06-55cb8456c0a9_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_251ddd2c-0e55-45f7-ac7c-4dc52c8b161f_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Asset Impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_EquitySecuritiesDomesticRealEstateMember_8d804e6c-3f9b-42a6-9b3a-f7505d3c297c_terseLabel_en-US" xlink:label="lab_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic real estate</link:label>
    <link:label id="lab_cvs_EquitySecuritiesDomesticRealEstateMember_label_en-US" xlink:label="lab_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Domestic Real Estate [Member]</link:label>
    <link:label id="lab_cvs_EquitySecuritiesDomesticRealEstateMember_documentation_en-US" xlink:label="lab_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This category includes information about ownership interests or the right to acquire ownership interests in domestic real estate whose ownership interest is represented by shares of common or preferred stock (which is neither mandatorily redeemable no redeemable at the option of the holder), convertible securities, stock rights, or stock warrants categorized by other type.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:href="cvs-20211231.xsd#cvs_EquitySecuritiesDomesticRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:to="lab_cvs_EquitySecuritiesDomesticRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_526c2b28-5f4d-4f9d-9f6c-62535a2b5017_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtExtinguishmentFees_3b79c268-4227-4a3d-bc9a-2729ede3593e_terseLabel_en-US" xlink:label="lab_cvs_DebtExtinguishmentFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment fees</link:label>
    <link:label id="lab_cvs_DebtExtinguishmentFees_label_en-US" xlink:label="lab_cvs_DebtExtinguishmentFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Extinguishment Fees</link:label>
    <link:label id="lab_cvs_DebtExtinguishmentFees_documentation_en-US" xlink:label="lab_cvs_DebtExtinguishmentFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Extinguishment Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtExtinguishmentFees" xlink:href="cvs-20211231.xsd#cvs_DebtExtinguishmentFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtExtinguishmentFees" xlink:to="lab_cvs_DebtExtinguishmentFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRegulatoryAssetsTextBlock_edd6e8a8-ded0-4b70-ba0e-d0cf92255bfd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRegulatoryAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of regulatory Requirements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRegulatoryAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRegulatoryAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Regulatory Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRegulatoryAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRegulatoryAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRegulatoryAssetsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRegulatoryAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_49118ad2-a6b3-4ef8-9944-8c239c59c350_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_b7e01786-bf9c-4ac7-b178-5e52b06c3a78_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Products Sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3d56f645-5d38-4e97-8d45-9cdc2bc3c0d4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term exercisable at end of year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_c3d93101-0514-47db-aa95-6dbba7b9b09f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share from continuing operations:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_dc1a2873-693f-4643-8794-330f0ca7ed69_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Payment for Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanSettlementsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_8bc50c66-6098-40ad-9ce7-b1649ad65770_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period One [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodOneMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodOneMember" xlink:to="lab_cvs_YearOfOriginationPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_bc3044f8-d4c2-4333-886c-dbffe284a584_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_f615031b-b92e-460a-8ca4-10af2983c1d9_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_d1a9d8cf-8e00-45a6-b657-cc2e5ab2b0ad_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_7d5bfa76-d5ea-48a8-8f66-d7f5e0e1c446_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash (included in other current assets)</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_3f843527-ae00-4c97-85d6-d9bd416c712d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d549f46c-3589-418c-a7b4-0b204e6f8dc3_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0b42cf0a-6994-4e13-bf54-157191d9ac1d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at the end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e4ade18c-b5d3-490d-ab64-4219650cb55c_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthInsurerFeeTaxEffectPercent_d8bd0852-7e7e-4cd5-820b-932c15f32c17_terseLabel_en-US" xlink:label="lab_cvs_HealthInsurerFeeTaxEffectPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurer fee</link:label>
    <link:label id="lab_cvs_HealthInsurerFeeTaxEffectPercent_label_en-US" xlink:label="lab_cvs_HealthInsurerFeeTaxEffectPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurer Fee Tax Effect, Percent</link:label>
    <link:label id="lab_cvs_HealthInsurerFeeTaxEffectPercent_documentation_en-US" xlink:label="lab_cvs_HealthInsurerFeeTaxEffectPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the tax effect of the health care reform's non-tax deductible health insurer fee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFeeTaxEffectPercent" xlink:href="cvs-20211231.xsd#cvs_HealthInsurerFeeTaxEffectPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthInsurerFeeTaxEffectPercent" xlink:to="lab_cvs_HealthInsurerFeeTaxEffectPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay162024Member_48618d1e-98d0-4def-aa42-24014cee316b_terseLabel_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay162024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 16, 2024</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay162024Member_label_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay162024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 16, 2024 [Member]</link:label>
    <link:label id="lab_cvs_RevolvingCreditFacilityExpiringMay162024Member_documentation_en-US" xlink:label="lab_cvs_RevolvingCreditFacilityExpiringMay162024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Expiring May 16, 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay162024Member" xlink:href="cvs-20211231.xsd#cvs_RevolvingCreditFacilityExpiringMay162024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RevolvingCreditFacilityExpiringMay162024Member" xlink:to="lab_cvs_RevolvingCreditFacilityExpiringMay162024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_d3e7b9f3-42cd-4840-b852-930085aa158c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_c8c53250-e47a-4081-8393-ec89ecd63533_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_bc8bd257-f791-4b17-9eae-7ef9304ec5e7_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor obligations, maximum exposure</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Maximum Exposure, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:to="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_77e9ca99-bb89-4e00-89a3-73b98d88bb63_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5fc08d6b-7885-44d2-8882-cdbcce7053fb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_de3e4879-7650-4874-8552-527fe2e3995a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_faa28c24-d1ef-452a-b0c0-6f9a4983be4d_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets related to customer lists</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_6721c166-3238-4143-ae9b-2f6973946ca2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets, gross carrying amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_d04cdac3-3702-4a4c-a24b-a1e566073a65_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock_8d5974d3-6c34-4608-9304-23724f1fae7f_terseLabel_en-US" xlink:label="lab_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor Allowances And Purchase Discounts</link:label>
    <link:label id="lab_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock_label_en-US" xlink:label="lab_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor Allowances And Purchase Discounts [Policy Text Block]</link:label>
    <link:label id="lab_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock_documentation_en-US" xlink:label="lab_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor Allowances And Purchase Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" xlink:href="cvs-20211231.xsd#cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" xlink:to="lab_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6e2a9e01-ff81-4fdc-8f63-7b571835a94f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_26e9f9ff-c852-4f29-87d4-af3091922e63_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Claims Development [Table]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Claims Development [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_120fc09f-dc25-4bfd-b935-75910b636d72_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2e279de0-2c18-4f69-a606-2944afbe7bfd_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option activity, stock awards and other (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9862f7f3-d7a4-49f1-8b49-f87616550460_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_01756bb0-0d65-40a9-9036-213c9142ba6d_terseLabel_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.78% senior notes due March 2038</link:label>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_label_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.78%, Due March 2038 [Member]</link:label>
    <link:label id="lab_cvs_SeniorNotes4.78DueMarch2038Member_documentation_en-US" xlink:label="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes, 4.78%, Due March 2038 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_SeniorNotes4.78DueMarch2038Member" xlink:to="lab_cvs_SeniorNotes4.78DueMarch2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_3357b1de-f46e-4280-8639-bc06b40c34a1_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_c41bb77a-27ba-489d-a8ae-2f45ef8a0f47_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_550e6b1c-4a6f-4571-b244-774d404ba8a6_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_01a43b0b-95b0-41a3-873f-623a599be41c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_ed358ae5-da3c-475c-9426-05869ceeef49_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReservePolicyTextBlock_010281b9-9136-4593-a4ff-54d623510d57_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-Insurance Liabilities</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReservePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReservePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:to="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_52269127-0612-4526-8a49-495671f1c380_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivateEquityFundsMember_fc93e9ab-e813-416e-a151-d6495c528612_verboseLabel_en-US" xlink:label="lab_us-gaap_PrivateEquityFundsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private equity investments</link:label>
    <link:label id="lab_us-gaap_PrivateEquityFundsMember_label_en-US" xlink:label="lab_us-gaap_PrivateEquityFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Equity Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivateEquityFundsMember" xlink:to="lab_us-gaap_PrivateEquityFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_d4e81d14-5d8a-45ef-90be-0a899edea0f2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of discontinued operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_fc2bf720-50ce-46de-99fa-7df58835aeb6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration of statutes of limitation</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_5038fc69-9b6f-44f4-b4c1-f7dbbc38a52b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_37e2f115-a330-4280-b645-e39bc13c0cf0_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_bab890f8-d1f3-4ada-9846-389931116cf5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_e62b3a34-e16d-45d5-b45b-82a87506ea75_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of operating earnings to net income</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2f90c3d6-b7f9-416b-995d-22f201eb0f4d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in benefit obligation:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_352e8724-9a54-401f-b38d-32deb5b60a28_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_c92d4d06-9f48-4dd5-8628-6f86d92ee8ab_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building, building improvements and leasehold improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_72cbad13-bc2a-4e31-85e4-717e95d46869_verboseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bdf29843-fea4-467d-b49d-aecb0c2be061_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities, net of effects from acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_fbb6cede-e861-471b-a07e-25fa78b8e802_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssumedPremiumsEarned_073317c0-51fd-42fd-8085-d927ee644191_terseLabel_en-US" xlink:label="lab_us-gaap_AssumedPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed</link:label>
    <link:label id="lab_us-gaap_AssumedPremiumsEarned_label_en-US" xlink:label="lab_us-gaap_AssumedPremiumsEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed Premiums Earned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsEarned" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssumedPremiumsEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssumedPremiumsEarned" xlink:to="lab_us-gaap_AssumedPremiumsEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_da03a9ea-bc66-4960-bf64-2fac9b246fd9_verboseLabel_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity in mortgage loan portfolio</link:label>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_label_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity in mortgage loan portfolio [Table Text Block]</link:label>
    <link:label id="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Table representing activities in mortgage loan portfolio during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:href="cvs-20211231.xsd#cvs_ActivityInMortgageLoanPortfolioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:to="lab_cvs_ActivityInMortgageLoanPortfolioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_b3350240-166d-442f-842e-7575cfbac148_terseLabel_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After five years through ten years</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_label_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</link:label>
    <link:label id="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_documentation_en-US" xlink:label="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:to="lab_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeparateAccountAssets_f93d744c-4881-48cd-8b0c-51beaef79698_terseLabel_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate accounts assets</link:label>
    <link:label id="lab_us-gaap_SeparateAccountAssets_label_en-US" xlink:label="lab_us-gaap_SeparateAccountAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Account Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeparateAccountAssets" xlink:to="lab_us-gaap_SeparateAccountAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_22da105c-5a4c-4b0e-be23-4175f66d04b5_terseLabel_en-US" xlink:label="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period after date of service a claim is paid</link:label>
    <link:label id="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_label_en-US" xlink:label="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs Payable, Period After Date Of Services Claims Are Paid</link:label>
    <link:label id="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_documentation_en-US" xlink:label="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Costs Payable, Period After Date Of Services Claims Are Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:href="cvs-20211231.xsd#cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:to="lab_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_19796a86-5cd4-43f1-a0d1-3974d2a4b2db_terseLabel_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of walk-in medical clinics</link:label>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_label_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Walk In Medical Clinics</link:label>
    <link:label id="lab_cvs_NumberofWalkInMedicalClinics_documentation_en-US" xlink:label="lab_cvs_NumberofWalkInMedicalClinics" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Walk In Medical Clinics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics" xlink:href="cvs-20211231.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_NumberofWalkInMedicalClinics" xlink:to="lab_cvs_NumberofWalkInMedicalClinics" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_ab0cebd1-d6c9-4055-90a5-54abafc28c84_terseLabel_en-US" xlink:label="lab_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance Share Units</link:label>
    <link:label id="lab_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_label_en-US" xlink:label="lab_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance Share Units [Member]</link:label>
    <link:label id="lab_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_documentation_en-US" xlink:label="lab_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Performance Share Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember" xlink:href="cvs-20211231.xsd#cvs_RestrictedStockUnitsandPerformanceShareUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember" xlink:to="lab_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1a9fc85b-d9c7-449e-96d9-6e706147c4eb_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_da366ec7-d1d8-48a5-a767-7f19bd66e53e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows paid for interest portion of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateScheduleTable_4f611970-1ab5-49ed-b0d3-44a4e3780c78_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate [Table]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateScheduleTable_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable" xlink:to="lab_srt_MortgageLoansOnRealEstateScheduleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_f177539d-60a6-4946-9354-65dc23c10cb3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_b8bda302-e91b-42c3-a26e-0f101e74cb97_verboseLabel_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loan internal credit rating</link:label>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_label_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Mortgage Loan Internal Credit Ratings [Table Text Block]</link:label>
    <link:label id="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:href="cvs-20211231.xsd#cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:to="lab_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsTable_632545e9-ff18-4123-bf4d-9d2e623ab772_terseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTable_label_en-US" xlink:label="lab_cvs_TotalInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable" xlink:href="cvs-20211231.xsd#cvs_TotalInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsTable" xlink:to="lab_cvs_TotalInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_195aebd0-91a1-4241-ba6d-1aa128fb88f8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_3ae21adf-fcc4-4022-b8a6-6b2df3a723ca_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized capital losses included in OCI associated with Level 3 financial assets</link:label>
    <link:label id="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_label_en-US" xlink:label="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" xlink:to="lab_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_19e39a31-90ec-4ddd-aba9-90a93590e614_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_a44d9dd4-8ce8-48da-a87c-bbcc784d268b_verboseLabel_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total investments</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_label_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Investments [Table Text Block]</link:label>
    <link:label id="lab_cvs_TotalInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_cvs_TotalInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item includes total investments, both current and long-term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTableTextBlock" xlink:href="cvs-20211231.xsd#cvs_TotalInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_TotalInvestmentsTableTextBlock" xlink:to="lab_cvs_TotalInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_a0d80dbc-5358-421e-9205-b43c496287cd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_a3f444ba-5401-4e7d-b881-5815c870cae6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerListsMember_2974e6a3-def4-4533-b35a-0bd8c8d39801_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerListsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Lists</link:label>
    <link:label id="lab_us-gaap_CustomerListsMember_label_en-US" xlink:label="lab_us-gaap_CustomerListsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Lists [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerListsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerListsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerListsMember" xlink:to="lab_us-gaap_CustomerListsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_cd2d56da-e567-4a4d-91ab-a4287f4f9c24_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_bb4bf28b-9502-4ed3-a405-788529db425b_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_d3ff1e83-f843-4d0a-ab71-bb98665a62c9_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember_d20cf77e-ec3c-4ad4-be0a-61286193113d_terseLabel_en-US" xlink:label="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coventry Health Care Workers Compensation Business</link:label>
    <link:label id="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember_label_en-US" xlink:label="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coventry Health Care Workers Compensation Business [Member]</link:label>
    <link:label id="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember_documentation_en-US" xlink:label="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coventry Health Care Workers Compensation Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:href="cvs-20211231.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:to="lab_cvs_CoventryHealthCareWorkersCompensationBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock_e16c9cb7-decf-4a48-8fff-2fad8b07301c_terseLabel_en-US" xlink:label="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of direct, assumed and ceded premiums earned</link:label>
    <link:label id="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock_label_en-US" xlink:label="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-17, Insurance Companies, Reinsurance [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:to="lab_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_8b596545-f8a5-4794-99ec-764ac4578109_terseLabel_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services</link:label>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_label_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services [Member]</link:label>
    <link:label id="lab_cvs_HeartlandHealthcareServicesMember_documentation_en-US" xlink:label="lab_cvs_HeartlandHealthcareServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heartland Healthcare Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember" xlink:href="cvs-20211231.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_HeartlandHealthcareServicesMember" xlink:to="lab_cvs_HeartlandHealthcareServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_4c0b59d4-e9af-47b2-8de2-dc3b922be2a8_verboseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal of debt extinguished</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromInterestAndDividendsReceived_fa3b968e-270e-4bc9-b383-92d7fdd8946c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and investment income received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromInterestAndDividendsReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Interest and Dividends Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:to="lab_us-gaap_ProceedsFromInterestAndDividendsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_A2016RepurchaseProgramMember_7b976a7c-1774-4693-893f-0b9a467cf3dc_terseLabel_en-US" xlink:label="lab_cvs_A2016RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Repurchase Program</link:label>
    <link:label id="lab_cvs_A2016RepurchaseProgramMember_label_en-US" xlink:label="lab_cvs_A2016RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Repurchase Program [Member]</link:label>
    <link:label id="lab_cvs_A2016RepurchaseProgramMember_documentation_en-US" xlink:label="lab_cvs_A2016RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2016RepurchaseProgramMember" xlink:href="cvs-20211231.xsd#cvs_A2016RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_A2016RepurchaseProgramMember" xlink:to="lab_cvs_A2016RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAbstract_55a0d60c-7e12-4124-8283-162190837360_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting [Abstract]</link:label>
    <link:label id="lab_us-gaap_OffsettingAbstract_label_en-US" xlink:label="lab_us-gaap_OffsettingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAbstract" xlink:to="lab_us-gaap_OffsettingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_7f3cce29-453a-44ce-a60f-3ede68609ae9_terseLabel_en-US" xlink:label="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition purchase price adjustments outside of measurement period</link:label>
    <link:label id="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_label_en-US" xlink:label="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Purchase Price Adjustment, Outside of Measurement Period</link:label>
    <link:label id="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_documentation_en-US" xlink:label="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Purchase Price Adjustment, Outside of Measurement Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:href="cvs-20211231.xsd#cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:to="lab_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_19510fa1-4579-40da-b237-6288e866a65f_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1217476c-6cd2-4f9d-98a3-ea6cd5e6b81a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_535a598a-10a1-41a7-98e9-4146831c8bfb_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of deferred debt issuance cost</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_823a189e-7a55-49f2-9c41-b6cdd3ad70f8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholders&#8217; funds</link:label>
    <link:label id="lab_us-gaap_OtherPolicyholderFunds_label_en-US" xlink:label="lab_us-gaap_OtherPolicyholderFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Policyholder Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPolicyholderFunds" xlink:to="lab_us-gaap_OtherPolicyholderFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_b8eb9984-a81c-4bea-a6b4-71f4424d1b3c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_693d799f-2b04-44f9-a435-58868b727a2d_terseLabel_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_label_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Five [Member]</link:label>
    <link:label id="lab_cvs_YearOfOriginationPeriodFiveMember_documentation_en-US" xlink:label="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year Of Origination Period Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_YearOfOriginationPeriodFiveMember" xlink:to="lab_cvs_YearOfOriginationPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_3bbee08a-5420-48d3-ae84-bcb884f369bd_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self insurance liabilities</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReserve" xlink:to="lab_us-gaap_SelfInsuranceReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_daea227c-d4cb-4c56-a4c0-9b8e27486e23_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvs_StoreImpairmentCharges_53f95e98-9f95-47e8-9236-b769bc09975f_terseLabel_en-US" xlink:label="lab_cvs_StoreImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Store impairments</link:label>
    <link:label id="lab_cvs_StoreImpairmentCharges_546a2db3-cc11-4bc3-96ae-066262b4f271_verboseLabel_en-US" xlink:label="lab_cvs_StoreImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Store impairment charges</link:label>
    <link:label id="lab_cvs_StoreImpairmentCharges_label_en-US" xlink:label="lab_cvs_StoreImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Store Impairment Charges</link:label>
    <link:label id="lab_cvs_StoreImpairmentCharges_documentation_en-US" xlink:label="lab_cvs_StoreImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Store Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges" xlink:href="cvs-20211231.xsd#cvs_StoreImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvs_StoreImpairmentCharges" xlink:to="lab_cvs_StoreImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_5683439f-5cc7-4a3d-b472-6b8f840cd122_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less than one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_6ab39dec-9ed8-4e4c-b562-c3e3c4d43f36_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_68f75467-d467-4222-840d-4f6671bd97bc_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance lines other than short duration</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Other Reconciling Item</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_f0fb7cff-5b15-44b3-8e88-b3e419f14b7c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_7a212791-c199-44cf-b361-c8b9ce6c7414_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule ESPP valuation assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_236e9c5f-5262-4bea-8fb5-6ddf445d20d0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>cvs-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:101452a2-2146-4b57-8461-1c52c7d6326c,g:5f4a3ace-4815-405a-b6fd-039bed36fdc5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com/role/CoverPage" xlink:type="simple" xlink:href="cvs-20211231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e26970f9-dbb3-489e-a2c0-8f1e54e38213" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_DocumentType_e26970f9-dbb3-489e-a2c0-8f1e54e38213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_e27a94f5-5870-45b5-94f4-5f8137c1920e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_DocumentAnnualReport_e27a94f5-5870-45b5-94f4-5f8137c1920e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4a5da5a1-ed06-47d4-ae37-ca0739cf4741" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_DocumentPeriodEndDate_4a5da5a1-ed06-47d4-ae37-ca0739cf4741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_40b790f2-1dee-4123-af73-b78245679a85" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_CurrentFiscalYearEndDate_40b790f2-1dee-4123-af73-b78245679a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_480ef718-f1da-4b0c-a7c4-064234f823cf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_DocumentTransitionReport_480ef718-f1da-4b0c-a7c4-064234f823cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_bd54e7b1-4144-4239-a3fa-5eaef1de8881" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityFileNumber_bd54e7b1-4144-4239-a3fa-5eaef1de8881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_78d8b7e8-0d5e-47ef-9714-fd210c4a2247" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityRegistrantName_78d8b7e8-0d5e-47ef-9714-fd210c4a2247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_9ffcae4e-61f6-4f4d-b921-b15f12ddb798" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityIncorporationStateCountryCode_9ffcae4e-61f6-4f4d-b921-b15f12ddb798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_a99fe3ed-5dfd-4053-acd0-145306f2d0e2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityTaxIdentificationNumber_a99fe3ed-5dfd-4053-acd0-145306f2d0e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_4109e7c2-bb85-4ca4-a127-02cef0b98e66" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityAddressAddressLine1_4109e7c2-bb85-4ca4-a127-02cef0b98e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_576170a8-5a2c-41dd-a5da-a9d110790ed3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityAddressCityOrTown_576170a8-5a2c-41dd-a5da-a9d110790ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b9d79d24-1d08-42df-97d4-339044095a57" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityAddressStateOrProvince_b9d79d24-1d08-42df-97d4-339044095a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9361ccd1-65cd-434f-8aa5-f512570917e8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityAddressPostalZipCode_9361ccd1-65cd-434f-8aa5-f512570917e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f683586d-2553-489e-ba64-72059fd72569" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_CityAreaCode_f683586d-2553-489e-ba64-72059fd72569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_c227518c-8db7-4058-804d-c53911fd22a9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_LocalPhoneNumber_c227518c-8db7-4058-804d-c53911fd22a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8d86dd44-e4de-4a5a-8a43-9b4c8b67ff86" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_Security12bTitle_8d86dd44-e4de-4a5a-8a43-9b4c8b67ff86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_944993f2-75bf-45ac-b6cc-7854fd42bf34" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_TradingSymbol_944993f2-75bf-45ac-b6cc-7854fd42bf34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a2d62ed4-6aaa-40b7-a9b0-48fb7aa57e22" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_SecurityExchangeName_a2d62ed4-6aaa-40b7-a9b0-48fb7aa57e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_1ff726cd-67f3-4f10-89cb-dee46c2f6bcf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_1ff726cd-67f3-4f10-89cb-dee46c2f6bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_3aaac814-1e18-43ba-bd6f-2bc78ac63f22" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityVoluntaryFilers_3aaac814-1e18-43ba-bd6f-2bc78ac63f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_7c2273e7-1598-4db3-903f-bbdd347d2c44" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityCurrentReportingStatus_7c2273e7-1598-4db3-903f-bbdd347d2c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_1415f4d2-aec8-4b2a-bae2-193a7e1b8fa2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityInteractiveDataCurrent_1415f4d2-aec8-4b2a-bae2-193a7e1b8fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_d75ccb74-a1a7-45fc-a392-f735d09385a9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityFilerCategory_d75ccb74-a1a7-45fc-a392-f735d09385a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_645d6868-761a-46c9-8d23-3859d1a7bb31" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntitySmallBusiness_645d6868-761a-46c9-8d23-3859d1a7bb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_18abfe50-f73c-4170-8cf5-180191737e09" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityEmergingGrowthCompany_18abfe50-f73c-4170-8cf5-180191737e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_6a3128ec-2ba4-4fd5-9501-8f8c6f47cf1c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_IcfrAuditorAttestationFlag_6a3128ec-2ba4-4fd5-9501-8f8c6f47cf1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_b594a3b7-93d5-40ff-b917-9bd0d4fb60cd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityShellCompany_b594a3b7-93d5-40ff-b917-9bd0d4fb60cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_15b8e042-655a-4369-84a5-ef56504226ae" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityPublicFloat_15b8e042-655a-4369-84a5-ef56504226ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_b2fbc199-7670-4bae-a6ff-41155071211b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_b2fbc199-7670-4bae-a6ff-41155071211b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_0f1ef716-2eba-47eb-a897-d6f0cf19f3b1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_0f1ef716-2eba-47eb-a897-d6f0cf19f3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_31c525a9-a04b-41c2-b93b-811775d4dc28" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_EntityCentralIndexKey_31c525a9-a04b-41c2-b93b-811775d4dc28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d77efaea-8f63-4bb2-8104-19738a1750ca" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_DocumentFiscalYearFocus_d77efaea-8f63-4bb2-8104-19738a1750ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4548f2dc-a630-4bce-8c45-063acf9b75df" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_DocumentFiscalPeriodFocus_4548f2dc-a630-4bce-8c45-063acf9b75df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_dee40d95-351b-48b6-a4af-41a8eefbc6f0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bac52896-e233-44f4-8024-a33ef835bcb7" xlink:to="loc_dei_AmendmentFlag_dee40d95-351b-48b6-a4af-41a8eefbc6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/AuditInformation" xlink:type="simple" xlink:href="cvs-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AuditorInformationAbstract_8c7f95b6-2fb5-4087-bd0f-899ff192d75f" xlink:href="cvs-20211231.xsd#cvs_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_d49ee011-a002-40d5-9cbd-812a0cbd4f7d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AuditorInformationAbstract_8c7f95b6-2fb5-4087-bd0f-899ff192d75f" xlink:to="loc_dei_AuditorName_d49ee011-a002-40d5-9cbd-812a0cbd4f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_973444ef-3cd8-403c-a06d-ff36c2f4f6c2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AuditorInformationAbstract_8c7f95b6-2fb5-4087-bd0f-899ff192d75f" xlink:to="loc_dei_AuditorLocation_973444ef-3cd8-403c-a06d-ff36c2f4f6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_b66d1e94-bb3c-41de-bf1e-990f035141e0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_AuditorInformationAbstract_8c7f95b6-2fb5-4087-bd0f-899ff192d75f" xlink:to="loc_dei_AuditorFirmId_b66d1e94-bb3c-41de-bf1e-990f035141e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="cvs-20211231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_32ed4418-16ba-4abe-8916-8d5cdd535587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0319c316-63ee-44e9-9ff7-3f4e334bf347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_32ed4418-16ba-4abe-8916-8d5cdd535587" xlink:to="loc_us-gaap_StatementTable_0319c316-63ee-44e9-9ff7-3f4e334bf347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_da8ac55e-3444-4195-bf97-9866c77b087e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0319c316-63ee-44e9-9ff7-3f4e334bf347" xlink:to="loc_srt_ProductOrServiceAxis_da8ac55e-3444-4195-bf97-9866c77b087e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_524cf7f4-5f92-46ee-9467-57b7d0c39b38" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_da8ac55e-3444-4195-bf97-9866c77b087e" xlink:to="loc_srt_ProductsAndServicesDomain_524cf7f4-5f92-46ee-9467-57b7d0c39b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_25b20d33-0f34-49cc-87dd-74539b21a924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_524cf7f4-5f92-46ee-9467-57b7d0c39b38" xlink:to="loc_us-gaap_ProductMember_25b20d33-0f34-49cc-87dd-74539b21a924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_0e57c84a-7487-45fc-88b8-162735fa0c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_524cf7f4-5f92-46ee-9467-57b7d0c39b38" xlink:to="loc_us-gaap_ServiceMember_0e57c84a-7487-45fc-88b8-162735fa0c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0319c316-63ee-44e9-9ff7-3f4e334bf347" xlink:to="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_60f77678-d7ef-4ef4-ae5e-b4d022a88c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_RevenuesAbstract_60f77678-d7ef-4ef4-ae5e-b4d022a88c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_187e05f4-d829-4488-b300-63e208250c22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_60f77678-d7ef-4ef4-ae5e-b4d022a88c9c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_187e05f4-d829-4488-b300-63e208250c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_76f1da2e-de1c-473b-b2f3-809d0e2a7fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_60f77678-d7ef-4ef4-ae5e-b4d022a88c9c" xlink:to="loc_us-gaap_PremiumsEarnedNet_76f1da2e-de1c-473b-b2f3-809d0e2a7fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_8b89749a-dc81-4919-a1a1-170fde65e3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_60f77678-d7ef-4ef4-ae5e-b4d022a88c9c" xlink:to="loc_us-gaap_NetInvestmentIncome_8b89749a-dc81-4919-a1a1-170fde65e3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2a67266a-8394-45ed-ad38-ff6f5f56f9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_60f77678-d7ef-4ef4-ae5e-b4d022a88c9c" xlink:to="loc_us-gaap_Revenues_2a67266a-8394-45ed-ad38-ff6f5f56f9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_439f2156-e7f2-4d21-9e32-5181cc4337f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_OperatingExpensesAbstract_439f2156-e7f2-4d21-9e32-5181cc4337f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_cdc89f4c-8cfa-4ad5-9359-02ba49d911dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_439f2156-e7f2-4d21-9e32-5181cc4337f2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_cdc89f4c-8cfa-4ad5-9359-02ba49d911dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_d1927887-e644-4652-a99c-c1b1f20b864e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_439f2156-e7f2-4d21-9e32-5181cc4337f2" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_d1927887-e644-4652-a99c-c1b1f20b864e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_1d219bc4-4e68-4d95-98b4-d8ee3e4f836e" xlink:href="cvs-20211231.xsd#cvs_StoreImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_439f2156-e7f2-4d21-9e32-5181cc4337f2" xlink:to="loc_cvs_StoreImpairmentCharges_1d219bc4-4e68-4d95-98b4-d8ee3e4f836e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_85f2f463-5d18-4650-b5f6-43eb061ab55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_439f2156-e7f2-4d21-9e32-5181cc4337f2" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_85f2f463-5d18-4650-b5f6-43eb061ab55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments_46d37cde-18af-40fd-b47e-0c2d4b5ffcc7" xlink:href="cvs-20211231.xsd#cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_439f2156-e7f2-4d21-9e32-5181cc4337f2" xlink:to="loc_cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments_46d37cde-18af-40fd-b47e-0c2d4b5ffcc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_45591aad-4b0b-4352-a5f4-d5a4c7b93d03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_439f2156-e7f2-4d21-9e32-5181cc4337f2" xlink:to="loc_us-gaap_CostsAndExpenses_45591aad-4b0b-4352-a5f4-d5a4c7b93d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_69d6753d-d1a1-48f7-90de-d4d1f7bea141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_OperatingIncomeLoss_69d6753d-d1a1-48f7-90de-d4d1f7bea141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d8be281e-da74-40fc-b98f-abe804d831cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_InterestExpense_d8be281e-da74-40fc-b98f-abe804d831cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2dc0e3a0-f872-4892-a0df-c8db97756189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2dc0e3a0-f872-4892-a0df-c8db97756189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6c78bbda-5c39-4224-aec8-a7c31ef5915e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6c78bbda-5c39-4224-aec8-a7c31ef5915e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_92855ee9-286d-412b-8999-67c6340a643b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_92855ee9-286d-412b-8999-67c6340a643b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7de43476-690f-4343-b514-fd38aefa8ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7de43476-690f-4343-b514-fd38aefa8ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_5565d655-a81a-4f22-9bd0-f7b353200634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_5565d655-a81a-4f22-9bd0-f7b353200634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_81a29a55-8de8-4bb2-8caf-354b845b9eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_81a29a55-8de8-4bb2-8caf-354b845b9eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_20b987c5-fca7-47f5-9529-ea82249d940e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_ProfitLoss_20b987c5-fca7-47f5-9529-ea82249d940e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_307d979b-4742-4329-b2d5-627abcf09186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_307d979b-4742-4329-b2d5-627abcf09186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_92fcb5d0-b0c9-46c2-8c9f-7954287460f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_NetIncomeLoss_92fcb5d0-b0c9-46c2-8c9f-7954287460f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_b1fea05e-05f2-4726-a5e2-1a4f78a63ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_b1fea05e-05f2-4726-a5e2-1a4f78a63ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_914c69f8-5b94-41df-840f-c3b6112064dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b1fea05e-05f2-4726-a5e2-1a4f78a63ba5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_914c69f8-5b94-41df-840f-c3b6112064dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_830c20d4-1fe7-4356-a14e-a8e6a9bbab84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b1fea05e-05f2-4726-a5e2-1a4f78a63ba5" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare_830c20d4-1fe7-4356-a14e-a8e6a9bbab84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0ce49382-a5d7-4f6d-9a2a-7445652e0d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b1fea05e-05f2-4726-a5e2-1a4f78a63ba5" xlink:to="loc_us-gaap_EarningsPerShareBasic_0ce49382-a5d7-4f6d-9a2a-7445652e0d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9e74dfa3-5a1c-46c8-8a92-4b1f7f8ff016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b1fea05e-05f2-4726-a5e2-1a4f78a63ba5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9e74dfa3-5a1c-46c8-8a92-4b1f7f8ff016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_5722dcf0-5fed-4c7d-817a-6e2066457793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_5722dcf0-5fed-4c7d-817a-6e2066457793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_850ad440-6f88-4034-b6ff-886a0851419f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5722dcf0-5fed-4c7d-817a-6e2066457793" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_850ad440-6f88-4034-b6ff-886a0851419f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_76aec40b-21c7-4624-a329-2b5f97617a97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5722dcf0-5fed-4c7d-817a-6e2066457793" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare_76aec40b-21c7-4624-a329-2b5f97617a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_70c56660-2dd4-4220-aaed-86c3c27a5cce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5722dcf0-5fed-4c7d-817a-6e2066457793" xlink:to="loc_us-gaap_EarningsPerShareDiluted_70c56660-2dd4-4220-aaed-86c3c27a5cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_490409ba-3e15-4470-b654-b21f4da58675" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_5722dcf0-5fed-4c7d-817a-6e2066457793" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_490409ba-3e15-4470-b654-b21f4da58675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_9b5dced3-e3c0-43a8-b70d-4d9b40d93365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_9b5dced3-e3c0-43a8-b70d-4d9b40d93365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_47716780-9f4e-486c-b262-9d50b0e2a605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfCostGoodOrServiceExtensibleList"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e22ecd37-f0ba-4180-b2bc-31b4d85b8727" xlink:to="loc_us-gaap_TypeOfCostGoodOrServiceExtensibleList_47716780-9f4e-486c-b262-9d50b0e2a605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="cvs-20211231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_42574886-363f-4070-bf7f-6b4a3f74bcc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c57696a1-2746-4e8d-8043-4822fb2c073d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_42574886-363f-4070-bf7f-6b4a3f74bcc7" xlink:to="loc_us-gaap_ProfitLoss_c57696a1-2746-4e8d-8043-4822fb2c073d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_cd7b40e1-5c10-4233-bd31-6ee482347811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_42574886-363f-4070-bf7f-6b4a3f74bcc7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_cd7b40e1-5c10-4233-bd31-6ee482347811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1132be07-97c3-4100-acee-578df5944333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_cd7b40e1-5c10-4233-bd31-6ee482347811" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1132be07-97c3-4100-acee-578df5944333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_28320da7-f06f-4846-a7a1-4b1927abb1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_cd7b40e1-5c10-4233-bd31-6ee482347811" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_28320da7-f06f-4846-a7a1-4b1927abb1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ad9f100a-893f-47cb-9c6d-8a50def9a0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_cd7b40e1-5c10-4233-bd31-6ee482347811" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_ad9f100a-893f-47cb-9c6d-8a50def9a0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4619aa6e-7b6a-4f27-aac2-29a9ff6c1605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_cd7b40e1-5c10-4233-bd31-6ee482347811" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4619aa6e-7b6a-4f27-aac2-29a9ff6c1605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f2587289-7f49-485a-847e-7b7bcb615fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_cd7b40e1-5c10-4233-bd31-6ee482347811" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f2587289-7f49-485a-847e-7b7bcb615fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_69d6d166-b0c8-4481-8631-e5eba59424e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_42574886-363f-4070-bf7f-6b4a3f74bcc7" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_69d6d166-b0c8-4481-8631-e5eba59424e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_44962527-ff1c-4a29-b6c4-c3ef2b2439c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_42574886-363f-4070-bf7f-6b4a3f74bcc7" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_44962527-ff1c-4a29-b6c4-c3ef2b2439c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b98994df-8166-4996-817f-7d26a41300e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_42574886-363f-4070-bf7f-6b4a3f74bcc7" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b98994df-8166-4996-817f-7d26a41300e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cvs-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0cea7ff4-ee2f-4b24-960f-ff7f0beb046d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_90ee93ff-52b3-4144-98f2-3b6f623ac067" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0cea7ff4-ee2f-4b24-960f-ff7f0beb046d" xlink:to="loc_us-gaap_AssetsAbstract_90ee93ff-52b3-4144-98f2-3b6f623ac067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cf2073b8-4d16-415d-9e34-b6a148a2a98d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90ee93ff-52b3-4144-98f2-3b6f623ac067" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cf2073b8-4d16-415d-9e34-b6a148a2a98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_b1951247-7e9c-4039-8141-8fdf365718f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90ee93ff-52b3-4144-98f2-3b6f623ac067" xlink:to="loc_us-gaap_ShortTermInvestments_b1951247-7e9c-4039-8141-8fdf365718f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d634ee19-daff-4268-8615-ae99e729c9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90ee93ff-52b3-4144-98f2-3b6f623ac067" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d634ee19-daff-4268-8615-ae99e729c9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a88e1a79-01fe-4072-b71a-ea1ff7a41981" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90ee93ff-52b3-4144-98f2-3b6f623ac067" xlink:to="loc_us-gaap_InventoryNet_a88e1a79-01fe-4072-b71a-ea1ff7a41981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_2aec2f28-40d1-49e6-b353-74dd98e110c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90ee93ff-52b3-4144-98f2-3b6f623ac067" xlink:to="loc_us-gaap_OtherAssetsCurrent_2aec2f28-40d1-49e6-b353-74dd98e110c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_abf4117a-cbe6-4fe6-96f4-bcf755219e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90ee93ff-52b3-4144-98f2-3b6f623ac067" xlink:to="loc_us-gaap_AssetsCurrent_abf4117a-cbe6-4fe6-96f4-bcf755219e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_7bae4428-7ec8-4459-8416-66dac8f65b77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90ee93ff-52b3-4144-98f2-3b6f623ac067" xlink:to="loc_us-gaap_LongTermInvestments_7bae4428-7ec8-4459-8416-66dac8f65b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1f1219b1-caf5-4503-bec4-1385eca65bda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90ee93ff-52b3-4144-98f2-3b6f623ac067" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1f1219b1-caf5-4503-bec4-1385eca65bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_8b74713a-1320-4416-8048-4a6732ccd5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90ee93ff-52b3-4144-98f2-3b6f623ac067" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_8b74713a-1320-4416-8048-4a6732ccd5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_000447c6-1e29-4525-82a0-b60940c6331b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90ee93ff-52b3-4144-98f2-3b6f623ac067" xlink:to="loc_us-gaap_Goodwill_000447c6-1e29-4525-82a0-b60940c6331b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_69c97452-5867-4082-ae27-fb435c274112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90ee93ff-52b3-4144-98f2-3b6f623ac067" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_69c97452-5867-4082-ae27-fb435c274112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_582274ae-9e51-42cc-ab07-b9413277c7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90ee93ff-52b3-4144-98f2-3b6f623ac067" xlink:to="loc_us-gaap_SeparateAccountAssets_582274ae-9e51-42cc-ab07-b9413277c7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8403722d-5936-47b6-8c8a-97afbc9f9c76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90ee93ff-52b3-4144-98f2-3b6f623ac067" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8403722d-5936-47b6-8c8a-97afbc9f9c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b4a0b637-1844-4d5c-add6-466bcf808139" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_90ee93ff-52b3-4144-98f2-3b6f623ac067" xlink:to="loc_us-gaap_Assets_b4a0b637-1844-4d5c-add6-466bcf808139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0cea7ff4-ee2f-4b24-960f-ff7f0beb046d" xlink:to="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_ebaf48dd-bb2a-4c94-b10a-1ada1fdb26b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_ebaf48dd-bb2a-4c94-b10a-1ada1fdb26b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_b88e7f18-9257-4305-81f8-fea460fe0fb5" xlink:href="cvs-20211231.xsd#cvs_PharmacyClaimsandDiscountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:to="loc_cvs_PharmacyClaimsandDiscountsPayableCurrent_b88e7f18-9257-4305-81f8-fea460fe0fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_20205923-75ae-4392-a2a0-27cb2640ca92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_20205923-75ae-4392-a2a0-27cb2640ca92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPolicyholderFunds_32365677-7f2e-4b1b-8a05-104504240bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPolicyholderFunds"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:to="loc_us-gaap_OtherPolicyholderFunds_32365677-7f2e-4b1b-8a05-104504240bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ffb8a907-eff6-4ef7-bbfe-d874ab6b571d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_ffb8a907-eff6-4ef7-bbfe-d874ab6b571d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesCurrent_c9f9cc48-88d8-4fd5-849a-45325ce60335" xlink:href="cvs-20211231.xsd#cvs_OtherInsuranceLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:to="loc_cvs_OtherInsuranceLiabilitiesCurrent_c9f9cc48-88d8-4fd5-849a-45325ce60335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f8e4d03c-e556-40e1-98d9-d54f12b82a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f8e4d03c-e556-40e1-98d9-d54f12b82a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_4c8b2b45-4f33-4ca7-be85-ff5b15e47c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_4c8b2b45-4f33-4ca7-be85-ff5b15e47c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3286a6ce-1c04-4327-a270-9040e25494a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:to="loc_us-gaap_LiabilitiesCurrent_3286a6ce-1c04-4327-a270-9040e25494a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6e8bbe2f-702a-4134-8046-eff647a08603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6e8bbe2f-702a-4134-8046-eff647a08603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_68899445-a833-4843-9f4a-f6b8a8e5c233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_68899445-a833-4843-9f4a-f6b8a8e5c233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_94ebe50d-0b80-445e-9461-6653e4d4dd49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_94ebe50d-0b80-445e-9461-6653e4d4dd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountsLiability_7641308c-1f8d-40f4-a962-d61975f72b7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountsLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:to="loc_us-gaap_SeparateAccountsLiability_7641308c-1f8d-40f4-a962-d61975f72b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_cc1e0135-9896-4f6d-99dd-6f5525292d55" xlink:href="cvs-20211231.xsd#cvs_OtherInsuranceLiabilitiesNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:to="loc_cvs_OtherInsuranceLiabilitiesNoncurrent_cc1e0135-9896-4f6d-99dd-6f5525292d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_46a5fb65-9ff3-405d-91fe-d0252fe73eef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_46a5fb65-9ff3-405d-91fe-d0252fe73eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_931794ea-0ce2-4db0-b4fc-b0fe84ed5022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_579cdc30-1f75-46d5-9bdf-3d4875d2e25a" xlink:to="loc_us-gaap_Liabilities_931794ea-0ce2-4db0-b4fc-b0fe84ed5022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_1fefded2-15aa-4c80-8d58-25e9c9aa259f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0cea7ff4-ee2f-4b24-960f-ff7f0beb046d" xlink:to="loc_us-gaap_CommitmentsAndContingencies_1fefded2-15aa-4c80-8d58-25e9c9aa259f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f75b16a1-c1a2-4077-b1b4-c04e3ee2590e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0cea7ff4-ee2f-4b24-960f-ff7f0beb046d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f75b16a1-c1a2-4077-b1b4-c04e3ee2590e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_a5eec224-dcca-4371-922d-287bcc685dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f75b16a1-c1a2-4077-b1b4-c04e3ee2590e" xlink:to="loc_us-gaap_PreferredStockValue_a5eec224-dcca-4371-922d-287bcc685dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_8cf1f485-dec3-4dea-b1d2-5caba2217e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f75b16a1-c1a2-4077-b1b4-c04e3ee2590e" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_8cf1f485-dec3-4dea-b1d2-5caba2217e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_39e255b4-b425-4128-806f-04e5fca4970c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f75b16a1-c1a2-4077-b1b4-c04e3ee2590e" xlink:to="loc_us-gaap_TreasuryStockValue_39e255b4-b425-4128-806f-04e5fca4970c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_544ac865-7c32-4ab0-af93-058a149c8a49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f75b16a1-c1a2-4077-b1b4-c04e3ee2590e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_544ac865-7c32-4ab0-af93-058a149c8a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_71046726-b833-4aa1-a8b4-814e6056a123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f75b16a1-c1a2-4077-b1b4-c04e3ee2590e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_71046726-b833-4aa1-a8b4-814e6056a123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_51ae8fca-e5d1-46dc-ba53-e986ba8130a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f75b16a1-c1a2-4077-b1b4-c04e3ee2590e" xlink:to="loc_us-gaap_StockholdersEquity_51ae8fca-e5d1-46dc-ba53-e986ba8130a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_a7c4b55a-7b8d-4277-84ed-f8c0b2a8109b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f75b16a1-c1a2-4077-b1b4-c04e3ee2590e" xlink:to="loc_us-gaap_MinorityInterest_a7c4b55a-7b8d-4277-84ed-f8c0b2a8109b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_854bbab9-0d25-435c-8a7e-28532ece1c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_f75b16a1-c1a2-4077-b1b4-c04e3ee2590e" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_854bbab9-0d25-435c-8a7e-28532ece1c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9fcc691e-5b7a-41be-8ffb-b927808985b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0cea7ff4-ee2f-4b24-960f-ff7f0beb046d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_9fcc691e-5b7a-41be-8ffb-b927808985b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="cvs-20211231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_7202eaa6-127a-4671-80eb-f0d4aa235976" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0541fe65-0409-49e9-8e15-5296e7426e15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7202eaa6-127a-4671-80eb-f0d4aa235976" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_0541fe65-0409-49e9-8e15-5296e7426e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_0342c975-6e26-4b96-b9c3-10f9d7ccfb87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7202eaa6-127a-4671-80eb-f0d4aa235976" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_0342c975-6e26-4b96-b9c3-10f9d7ccfb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_b8ba7289-9fc0-456b-b66c-c2f9c78360d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7202eaa6-127a-4671-80eb-f0d4aa235976" xlink:to="loc_us-gaap_PreferredStockSharesIssued_b8ba7289-9fc0-456b-b66c-c2f9c78360d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_5a3aec32-5fa4-4341-8f2a-bcbea7d20056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7202eaa6-127a-4671-80eb-f0d4aa235976" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_5a3aec32-5fa4-4341-8f2a-bcbea7d20056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0dae8c86-ae19-411c-88f6-0823d6177d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7202eaa6-127a-4671-80eb-f0d4aa235976" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0dae8c86-ae19-411c-88f6-0823d6177d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_029cce07-4049-4748-bdc4-b947d566c7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7202eaa6-127a-4671-80eb-f0d4aa235976" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_029cce07-4049-4748-bdc4-b947d566c7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d7bade01-da3e-426f-ac7b-788efac5fcc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7202eaa6-127a-4671-80eb-f0d4aa235976" xlink:to="loc_us-gaap_CommonStockSharesIssued_d7bade01-da3e-426f-ac7b-788efac5fcc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_60fc8e78-9d0f-4c64-868d-8ca39552a66f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7202eaa6-127a-4671-80eb-f0d4aa235976" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_60fc8e78-9d0f-4c64-868d-8ca39552a66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_33911c3f-2a99-4e2b-b2e5-07746e101b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7202eaa6-127a-4671-80eb-f0d4aa235976" xlink:to="loc_us-gaap_TreasuryStockShares_33911c3f-2a99-4e2b-b2e5-07746e101b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cvs-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_f90d09e9-ec32-4dec-a72a-0a32ba23566d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_beb888a2-5ed1-4195-99be-f0abfbd1f5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f90d09e9-ec32-4dec-a72a-0a32ba23566d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_beb888a2-5ed1-4195-99be-f0abfbd1f5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCustomers_b7f31143-afd0-418e-9380-57913cac82a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_beb888a2-5ed1-4195-99be-f0abfbd1f5b7" xlink:to="loc_us-gaap_ProceedsFromCustomers_b7f31143-afd0-418e-9380-57913cac82a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_88b5ad58-3117-4090-8929-eb948123b45a" xlink:href="cvs-20211231.xsd#cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_beb888a2-5ed1-4195-99be-f0abfbd1f5b7" xlink:to="loc_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies_88b5ad58-3117-4090-8929-eb948123b45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsforInsuranceBenefits_efedaa43-ceae-433b-b149-82a1fc22e8f1" xlink:href="cvs-20211231.xsd#cvs_PaymentsforInsuranceBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_beb888a2-5ed1-4195-99be-f0abfbd1f5b7" xlink:to="loc_cvs_PaymentsforInsuranceBenefits_efedaa43-ceae-433b-b149-82a1fc22e8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliersAndEmployees_418844c4-96f0-4a28-8601-107cf0a9ed02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToSuppliersAndEmployees"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_beb888a2-5ed1-4195-99be-f0abfbd1f5b7" xlink:to="loc_us-gaap_PaymentsToSuppliersAndEmployees_418844c4-96f0-4a28-8601-107cf0a9ed02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_604ea93b-eea1-442f-898b-818e41f8efe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromInterestAndDividendsReceived"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_beb888a2-5ed1-4195-99be-f0abfbd1f5b7" xlink:to="loc_us-gaap_ProceedsFromInterestAndDividendsReceived_604ea93b-eea1-442f-898b-818e41f8efe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_5d4510e2-6193-4828-9909-d185e89cb66e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_beb888a2-5ed1-4195-99be-f0abfbd1f5b7" xlink:to="loc_us-gaap_InterestPaidNet_5d4510e2-6193-4828-9909-d185e89cb66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_6f47689c-84eb-422c-88e3-0fb953c81753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_beb888a2-5ed1-4195-99be-f0abfbd1f5b7" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_6f47689c-84eb-422c-88e3-0fb953c81753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f53522f8-fba0-4e91-815d-6679fa1f0761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_beb888a2-5ed1-4195-99be-f0abfbd1f5b7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f53522f8-fba0-4e91-815d-6679fa1f0761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac071b49-5a37-4540-a378-7ebe9efce178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f90d09e9-ec32-4dec-a72a-0a32ba23566d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac071b49-5a37-4540-a378-7ebe9efce178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_f8abd32c-98c7-4026-af3d-9678baa06599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac071b49-5a37-4540-a378-7ebe9efce178" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_f8abd32c-98c7-4026-af3d-9678baa06599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_01279eb2-1694-4b7e-97f0-6f2be347c70c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac071b49-5a37-4540-a378-7ebe9efce178" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_01279eb2-1694-4b7e-97f0-6f2be347c70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b83c62f1-435b-4129-a843-dc00b2cf5ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac071b49-5a37-4540-a378-7ebe9efce178" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b83c62f1-435b-4129-a843-dc00b2cf5ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_7919030a-6d78-4413-a458-aa212316baad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac071b49-5a37-4540-a378-7ebe9efce178" xlink:to="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_7919030a-6d78-4413-a458-aa212316baad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f3428833-787a-4e6d-89e0-19f565930f37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac071b49-5a37-4540-a378-7ebe9efce178" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_f3428833-787a-4e6d-89e0-19f565930f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_105b991e-70ae-4fdb-861d-c8fb8ab54a15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac071b49-5a37-4540-a378-7ebe9efce178" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_105b991e-70ae-4fdb-861d-c8fb8ab54a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_55716eab-63ce-48a2-b0ae-1a427d4ca17f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac071b49-5a37-4540-a378-7ebe9efce178" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_55716eab-63ce-48a2-b0ae-1a427d4ca17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e0400e5d-9bdb-4972-8649-cca6014841f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac071b49-5a37-4540-a378-7ebe9efce178" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e0400e5d-9bdb-4972-8649-cca6014841f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2bb23ef0-a35a-4bac-aba3-522194be7249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f90d09e9-ec32-4dec-a72a-0a32ba23566d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2bb23ef0-a35a-4bac-aba3-522194be7249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_9c4a6946-40aa-45f2-bc86-995a313c729b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2bb23ef0-a35a-4bac-aba3-522194be7249" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_9c4a6946-40aa-45f2-bc86-995a313c729b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7d32e089-ea7b-42a7-aff1-a97c7b56a8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2bb23ef0-a35a-4bac-aba3-522194be7249" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_7d32e089-ea7b-42a7-aff1-a97c7b56a8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_617d93d7-b651-4c6a-b77c-7345d468a475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2bb23ef0-a35a-4bac-aba3-522194be7249" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_617d93d7-b651-4c6a-b77c-7345d468a475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_acbe60d2-c741-492f-a037-d27102c5b006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2bb23ef0-a35a-4bac-aba3-522194be7249" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_acbe60d2-c741-492f-a037-d27102c5b006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_1a66abb5-fbd6-4cc1-9b46-29e0e21830d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2bb23ef0-a35a-4bac-aba3-522194be7249" xlink:to="loc_us-gaap_PaymentsOfDividends_1a66abb5-fbd6-4cc1-9b46-29e0e21830d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_60d89613-953e-4ac5-b758-3ae3c0d46711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2bb23ef0-a35a-4bac-aba3-522194be7249" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_60d89613-953e-4ac5-b758-3ae3c0d46711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_21ee3748-d510-49c3-a237-b7182b7a801a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2bb23ef0-a35a-4bac-aba3-522194be7249" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_21ee3748-d510-49c3-a237-b7182b7a801a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_42d0ba44-7a3c-4e17-b39a-eedfa32dcc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2bb23ef0-a35a-4bac-aba3-522194be7249" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_42d0ba44-7a3c-4e17-b39a-eedfa32dcc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47231779-60dd-461b-9b67-0249ec657d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2bb23ef0-a35a-4bac-aba3-522194be7249" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47231779-60dd-461b-9b67-0249ec657d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5575a4d9-875d-4f36-bae3-82e23f5753e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f90d09e9-ec32-4dec-a72a-0a32ba23566d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5575a4d9-875d-4f36-bae3-82e23f5753e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9bcb0159-deec-4c5d-be66-3aa7401810ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f90d09e9-ec32-4dec-a72a-0a32ba23566d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9bcb0159-deec-4c5d-be66-3aa7401810ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0812db51-dbf5-487b-b4b0-1b650e2a1430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f90d09e9-ec32-4dec-a72a-0a32ba23566d" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0812db51-dbf5-487b-b4b0-1b650e2a1430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1f712faf-011e-41b4-bdb9-35b01c48a22f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f90d09e9-ec32-4dec-a72a-0a32ba23566d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1f712faf-011e-41b4-bdb9-35b01c48a22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5aa66dae-ad2c-4eb9-8246-0ddcd9e84aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1f712faf-011e-41b4-bdb9-35b01c48a22f" xlink:to="loc_us-gaap_ProfitLoss_5aa66dae-ad2c-4eb9-8246-0ddcd9e84aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_35824ad6-0bde-4598-b8f5-b95e7e907597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1f712faf-011e-41b4-bdb9-35b01c48a22f" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_35824ad6-0bde-4598-b8f5-b95e7e907597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4dfe978a-b866-489c-8c77-4c77bb51b243" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_35824ad6-0bde-4598-b8f5-b95e7e907597" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4dfe978a-b866-489c-8c77-4c77bb51b243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_b768479f-4d9b-446c-b059-910e8103171d" xlink:href="cvs-20211231.xsd#cvs_StoreImpairmentCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_35824ad6-0bde-4598-b8f5-b95e7e907597" xlink:to="loc_cvs_StoreImpairmentCharges_b768479f-4d9b-446c-b059-910e8103171d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_a4d59141-4dea-47ea-9274-a6e45a077523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_35824ad6-0bde-4598-b8f5-b95e7e907597" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_a4d59141-4dea-47ea-9274-a6e45a077523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8af51d47-550a-41ed-a898-d35619e7dc10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_35824ad6-0bde-4598-b8f5-b95e7e907597" xlink:to="loc_us-gaap_ShareBasedCompensation_8af51d47-550a-41ed-a898-d35619e7dc10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_5eca7cd3-40c2-49d5-a573-0ee40178d1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_35824ad6-0bde-4598-b8f5-b95e7e907597" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_5eca7cd3-40c2-49d5-a573-0ee40178d1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fe8ce16e-e655-43e5-aa1b-a26456b37008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_35824ad6-0bde-4598-b8f5-b95e7e907597" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fe8ce16e-e655-43e5-aa1b-a26456b37008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_d298abbb-ed68-46bd-bf1d-7fe9d8dec270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_35824ad6-0bde-4598-b8f5-b95e7e907597" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_d298abbb-ed68-46bd-bf1d-7fe9d8dec270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_c816ee8e-389a-4344-8bfc-3c0de6fe2bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_35824ad6-0bde-4598-b8f5-b95e7e907597" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_c816ee8e-389a-4344-8bfc-3c0de6fe2bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94c71e54-5d29-4cb0-b17c-80efdece2ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1f712faf-011e-41b4-bdb9-35b01c48a22f" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94c71e54-5d29-4cb0-b17c-80efdece2ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2ed0758b-50e5-47d3-a523-aa57772e8248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94c71e54-5d29-4cb0-b17c-80efdece2ddd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2ed0758b-50e5-47d3-a523-aa57772e8248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_a5aefc40-d584-4293-a293-0d686a6438f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94c71e54-5d29-4cb0-b17c-80efdece2ddd" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_a5aefc40-d584-4293-a293-0d686a6438f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9af1e85c-c620-45bf-af0b-6fd501b9b7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94c71e54-5d29-4cb0-b17c-80efdece2ddd" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9af1e85c-c620-45bf-af0b-6fd501b9b7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d44705d9-690f-4100-8f24-6c87b707e892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94c71e54-5d29-4cb0-b17c-80efdece2ddd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d44705d9-690f-4100-8f24-6c87b707e892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_e6aa0d38-c189-4048-ad3c-207ef59cadbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInsuranceLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94c71e54-5d29-4cb0-b17c-80efdece2ddd" xlink:to="loc_us-gaap_IncreaseDecreaseInInsuranceLiabilities_e6aa0d38-c189-4048-ad3c-207ef59cadbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_d43f949b-0d24-423a-b241-60027a504fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94c71e54-5d29-4cb0-b17c-80efdece2ddd" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_d43f949b-0d24-423a-b241-60027a504fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4ff7047c-b23d-4476-94f1-6301139d9de2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_94c71e54-5d29-4cb0-b17c-80efdece2ddd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4ff7047c-b23d-4476-94f1-6301139d9de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1" xlink:type="simple" xlink:href="cvs-20211231.xsd#ConsolidatedStatementsofCashFlows_1"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="cvs-20211231.xsd#ConsolidatedStatementsofShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_8239a401-6f93-4566-a233-a86e5a7575cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1e58ff3c-e7b0-4c0d-95d3-2c9b3fc2cee3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_8239a401-6f93-4566-a233-a86e5a7575cc" xlink:to="loc_us-gaap_StatementTable_1e58ff3c-e7b0-4c0d-95d3-2c9b3fc2cee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d138ae5f-7661-4e84-9b68-745a77c1f008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1e58ff3c-e7b0-4c0d-95d3-2c9b3fc2cee3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d138ae5f-7661-4e84-9b68-745a77c1f008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d138ae5f-7661-4e84-9b68-745a77c1f008" xlink:to="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_982d2ba3-44b3-4bc7-bcda-2c88374c49ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:to="loc_us-gaap_CommonStockMember_982d2ba3-44b3-4bc7-bcda-2c88374c49ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_53d499bd-8579-483f-9c5d-a65e4beec8e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:to="loc_us-gaap_TreasuryStockMember_53d499bd-8579-483f-9c5d-a65e4beec8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_110accbb-9408-4cb9-9c69-42e16430e531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_110accbb-9408-4cb9-9c69-42e16430e531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b7fcae1f-0548-489a-b2af-2a7e7ce64fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:to="loc_us-gaap_RetainedEarningsMember_b7fcae1f-0548-489a-b2af-2a7e7ce64fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1ba6e5ea-6f03-4603-bb52-d75cd6222148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1ba6e5ea-6f03-4603-bb52-d75cd6222148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_6c2aebd0-3dfd-4c17-8119-e778df36d650" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:to="loc_us-gaap_ParentMember_6c2aebd0-3dfd-4c17-8119-e778df36d650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_2011ecfd-1975-4e67-a9a1-13095340ce2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_76840aea-1da7-4cb6-a850-870153dc26f5" xlink:to="loc_us-gaap_NoncontrollingInterestMember_2011ecfd-1975-4e67-a9a1-13095340ce2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f5735df7-bc1e-4bb9-a72f-cb8b743746c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1e58ff3c-e7b0-4c0d-95d3-2c9b3fc2cee3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f5735df7-bc1e-4bb9-a72f-cb8b743746c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_29b2135e-d249-4d42-a08c-70e13c2d84e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_f5735df7-bc1e-4bb9-a72f-cb8b743746c2" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_29b2135e-d249-4d42-a08c-70e13c2d84e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_68625a5b-07ff-4c47-8545-189eadef1aa1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_29b2135e-d249-4d42-a08c-70e13c2d84e5" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_68625a5b-07ff-4c47-8545-189eadef1aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_945bbd6d-0d42-4b78-809c-87e4d26a091c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1e58ff3c-e7b0-4c0d-95d3-2c9b3fc2cee3" xlink:to="loc_us-gaap_StatementLineItems_945bbd6d-0d42-4b78-809c-87e4d26a091c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_945bbd6d-0d42-4b78-809c-87e4d26a091c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_cbe9335a-fdcf-406d-a360-f64b3306e89e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_us-gaap_SharesOutstanding_cbe9335a-fdcf-406d-a360-f64b3306e89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eb87c89f-76fc-432e-852e-702ac36e6acf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_eb87c89f-76fc-432e-852e-702ac36e6acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_36bc9004-ab0a-40a5-8918-532124b4b0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_us-gaap_ProfitLoss_36bc9004-ab0a-40a5-8918-532124b4b0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_91e4aa07-c67a-4f5c-a193-f807fc427515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_91e4aa07-c67a-4f5c-a193-f807fc427515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_469fed92-35ea-4ed5-8e3c-a50906a50110" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_469fed92-35ea-4ed5-8e3c-a50906a50110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e3327c9c-ba56-488f-9991-99ef5886a837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e3327c9c-ba56-488f-9991-99ef5886a837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_678f51ce-b3e5-4cf6-8039-70838b33631e" xlink:href="cvs-20211231.xsd#cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance_678f51ce-b3e5-4cf6-8039-70838b33631e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_6c080d42-35d3-4e04-beaf-4e88b7c1de9a" xlink:href="cvs-20211231.xsd#cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance_6c080d42-35d3-4e04-beaf-4e88b7c1de9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_29a167ca-88aa-421d-909f-1e78eb0780c2" xlink:href="cvs-20211231.xsd#cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod_29a167ca-88aa-421d-909f-1e78eb0780c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_cdf73609-78da-4755-987d-526724ca2d2f" xlink:href="cvs-20211231.xsd#cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod_cdf73609-78da-4755-987d-526724ca2d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_cd8cb9f6-998b-4135-af3d-4c06c313de6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_us-gaap_DividendsCommonStock_cd8cb9f6-998b-4135-af3d-4c06c313de6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_5f1c78ac-7c77-49ac-9918-8fc26730db79" xlink:href="cvs-20211231.xsd#cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease_5f1c78ac-7c77-49ac-9918-8fc26730db79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_00c89eea-ba20-4b73-b86a-8e0d707221b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_us-gaap_SharesOutstanding_00c89eea-ba20-4b73-b86a-8e0d707221b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_53ffc9f6-d9e1-4349-9e51-aa84a1c785ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_710699ed-bb39-47ee-a692-81c9f08c29c4" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_53ffc9f6-d9e1-4349-9e51-aa84a1c785ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="simple" xlink:href="cvs-20211231.xsd#ConsolidatedStatementsofShareholdersEquityParentheticals"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_cc4a77db-40d8-4adc-81f0-5a5bd196c3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7cf1896a-2384-4877-b942-0692895b676e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_cc4a77db-40d8-4adc-81f0-5a5bd196c3e0" xlink:to="loc_us-gaap_StatementTable_7cf1896a-2384-4877-b942-0692895b676e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9a511e8c-5857-4812-88d5-068e83e5f124" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7cf1896a-2384-4877-b942-0692895b676e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9a511e8c-5857-4812-88d5-068e83e5f124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_adff72e3-e5a3-4c75-bb7a-5b233eecbd85" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_9a511e8c-5857-4812-88d5-068e83e5f124" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_adff72e3-e5a3-4c75-bb7a-5b233eecbd85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e1f26780-f635-4ad2-bdfe-46f586c744e1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_adff72e3-e5a3-4c75-bb7a-5b233eecbd85" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e1f26780-f635-4ad2-bdfe-46f586c744e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1f6c58f2-181e-4531-b651-3906050770d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7cf1896a-2384-4877-b942-0692895b676e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1f6c58f2-181e-4531-b651-3906050770d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bea25e54-2409-481f-9a72-108866505cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1f6c58f2-181e-4531-b651-3906050770d2" xlink:to="loc_us-gaap_EquityComponentDomain_bea25e54-2409-481f-9a72-108866505cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_8a280d27-70c7-4d18-bcc9-cb1df62ede66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bea25e54-2409-481f-9a72-108866505cef" xlink:to="loc_us-gaap_RetainedEarningsMember_8a280d27-70c7-4d18-bcc9-cb1df62ede66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b3be7bb3-6aac-450d-83c9-0b2cf97fbbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7cf1896a-2384-4877-b942-0692895b676e" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b3be7bb3-6aac-450d-83c9-0b2cf97fbbc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_b032fd27-409b-4dbf-a8cb-be8dbb36b459" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_b3be7bb3-6aac-450d-83c9-0b2cf97fbbc0" xlink:to="loc_us-gaap_TypeOfAdoptionMember_b032fd27-409b-4dbf-a8cb-be8dbb36b459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_0e69671f-d6d2-4df6-adb2-d0c3a23e8682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_b032fd27-409b-4dbf-a8cb-be8dbb36b459" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_0e69671f-d6d2-4df6-adb2-d0c3a23e8682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201613Member_2c796f5f-585d-45d5-84b3-2c14fdfdb4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_b032fd27-409b-4dbf-a8cb-be8dbb36b459" xlink:to="loc_us-gaap_AccountingStandardsUpdate201613Member_2c796f5f-585d-45d5-84b3-2c14fdfdb4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_25b899c0-beab-4f41-a806-b17506f97792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7cf1896a-2384-4877-b942-0692895b676e" xlink:to="loc_us-gaap_StatementLineItems_25b899c0-beab-4f41-a806-b17506f97792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust_dd175127-c697-45f8-9e32-9bf249572aea" xlink:href="cvs-20211231.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_25b899c0-beab-4f41-a806-b17506f97792" xlink:to="loc_cvs_TreasuryStockSharesHeldinTrust_dd175127-c697-45f8-9e32-9bf249572aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockValueSharesHeldInTrust_43a19b97-26fc-413c-946b-ca79c093e3d1" xlink:href="cvs-20211231.xsd#cvs_TreasuryStockValueSharesHeldInTrust"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_25b899c0-beab-4f41-a806-b17506f97792" xlink:to="loc_cvs_TreasuryStockValueSharesHeldInTrust_43a19b97-26fc-413c-946b-ca79c093e3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c4f7c802-d12b-4ade-b032-2599c9f9a7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_25b899c0-beab-4f41-a806-b17506f97792" xlink:to="loc_us-gaap_CommonStockValue_c4f7c802-d12b-4ade-b032-2599c9f9a7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_69d4ed07-f6c5-434a-b6c7-7df00e1cbbe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_25b899c0-beab-4f41-a806-b17506f97792" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_69d4ed07-f6c5-434a-b6c7-7df00e1cbbe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_971daef9-9c2d-4389-9062-c0d22f11bb63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_25b899c0-beab-4f41-a806-b17506f97792" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_971daef9-9c2d-4389-9062-c0d22f11bb63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1e79d829-ca48-4ed9-90e8-e030ba38aee4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_5db717ab-6b33-4f0a-8e8a-1bb9600aafb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1e79d829-ca48-4ed9-90e8-e030ba38aee4" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_5db717ab-6b33-4f0a-8e8a-1bb9600aafb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_57ec0cb1-c469-44cb-9da2-f66b0f63d091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_57ec0cb1-c469-44cb-9da2-f66b0f63d091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ecc08e90-b495-470b-a7fd-cea6f7e2f149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ecc08e90-b495-470b-a7fd-cea6f7e2f149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_08e33d9a-1f25-44d9-b09c-286af3f36f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_08e33d9a-1f25-44d9-b09c-286af3f36f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_388695bc-7d50-44ed-96a2-081990be5e78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_UseOfEstimates_388695bc-7d50-44ed-96a2-081990be5e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_11529338-f6d9-4994-a2b1-b2f0753c0eba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_11529338-f6d9-4994-a2b1-b2f0753c0eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_f60398d6-5b34-4ac0-9477-a90dd0050079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_f60398d6-5b34-4ac0-9477-a90dd0050079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_61277210-76da-4835-aa5c-a2ff5e45118e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_61277210-76da-4835-aa5c-a2ff5e45118e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_86a84f53-660c-4099-bdf5-8e9fb77f169d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_86a84f53-660c-4099-bdf5-8e9fb77f169d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_2d5f6b51-f7d7-4914-9dee-e2e8e6ba0e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_2d5f6b51-f7d7-4914-9dee-e2e8e6ba0e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceAccountingPolicy_ad51e29e-948e-4db9-9676-11ae307ba44b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceAccountingPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_ReinsuranceAccountingPolicy_ad51e29e-948e-4db9-9676-11ae307ba44b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_a5001dce-22bc-4299-baf2-3ae8671e5e07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy_a5001dce-22bc-4299-baf2-3ae8671e5e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_138c5fcf-2dcd-4cea-aaf3-b9e113741e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_138c5fcf-2dcd-4cea-aaf3-b9e113741e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_055e5573-9e38-4082-928b-0d41a18b0f63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_055e5573-9e38-4082-928b-0d41a18b0f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_b604e848-a8bc-42bc-ad53-1d418a9bdae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_b604e848-a8bc-42bc-ad53-1d418a9bdae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_908cc862-e2ac-416b-8418-9a8c656d99d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_908cc862-e2ac-416b-8418-9a8c656d99d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_ea0d846f-f7c7-4002-90f2-6333fc61fe4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_ea0d846f-f7c7-4002-90f2-6333fc61fe4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderAccountsPolicy_3fbd5c9b-532f-4deb-a3fd-b2afc2bbbc69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderAccountsPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_PolicyholderAccountsPolicy_3fbd5c9b-532f-4deb-a3fd-b2afc2bbbc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareCostsPolicyPolicyTextBlock_78bcb88f-4d30-4193-b1f5-7e3843aa332b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareCostsPolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_HealthCareCostsPolicyPolicyTextBlock_78bcb88f-4d30-4193-b1f5-7e3843aa332b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_eb2358ee-fc99-4577-bd2f-41e200478e6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy_eb2358ee-fc99-4577-bd2f-41e200478e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock_51a67567-0a24-4e57-80bd-779acf53129e" xlink:href="cvs-20211231.xsd#cvs_InsurancePremiumDeficiencyReservePolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock_51a67567-0a24-4e57-80bd-779acf53129e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocationsToPolicyholdersPolicies_4c4ab13b-0bb4-4e64-a47f-fa2559b95850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocationsToPolicyholdersPolicies"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_AllocationsToPolicyholdersPolicies_4c4ab13b-0bb4-4e64-a47f-fa2559b95850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReservePolicyTextBlock_24e720c1-857e-454a-aadb-ac99bab272b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReservePolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_SelfInsuranceReservePolicyTextBlock_24e720c1-857e-454a-aadb-ac99bab272b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_ebb991a1-a874-45d4-aa94-4bad694fbcce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_ebb991a1-a874-45d4-aa94-4bad694fbcce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_69707816-2da5-4d95-be20-b07290fc69b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_69707816-2da5-4d95-be20-b07290fc69b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_127922dc-d5d0-47cd-b678-527870b48af1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_127922dc-d5d0-47cd-b678-527870b48af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock_0abb7d0a-b959-4ab9-9098-fee264deea78" xlink:href="cvs-20211231.xsd#cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock_0abb7d0a-b959-4ab9-9098-fee264deea78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_3cfcf33a-9ae9-47b4-9c31-f12cffa9df65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthCareEntitiesPolicyPolicyTextBlock"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock_3cfcf33a-9ae9-47b4-9c31-f12cffa9df65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_d901164a-f2d2-4822-a9ff-3300b8aa7ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_d901164a-f2d2-4822-a9ff-3300b8aa7ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_73443182-185d-451c-a16e-7d5651fa1f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_73443182-185d-451c-a16e-7d5651fa1f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_95507f79-d4f3-4968-9b27-7b12a1094bea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_95507f79-d4f3-4968-9b27-7b12a1094bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_9e3eedd3-7b2f-43a6-8de9-74bd50b38dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementPlansPolicy"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_PensionAndOtherPostretirementPlansPolicy_9e3eedd3-7b2f-43a6-8de9-74bd50b38dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_581d5b89-0ff1-4a23-a4d2-0eaf725ed7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_581d5b89-0ff1-4a23-a4d2-0eaf725ed7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SharesHeldInTrustPolicyTextBlock_df6f418a-d39c-4503-ab57-a63de6e8eb91" xlink:href="cvs-20211231.xsd#cvs_SharesHeldInTrustPolicyTextBlock"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_cvs_SharesHeldInTrustPolicyTextBlock_df6f418a-d39c-4503-ab57-a63de6e8eb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_f99afe78-6624-4d10-952b-881405443bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_f99afe78-6624-4d10-952b-881405443bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_55bb8403-c5ed-4045-ab2e-931729c2b47f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_55bb8403-c5ed-4045-ab2e-931729c2b47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_7d3f7e03-701f-426f-acad-0a6975243fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsPolicyTextBlock"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_DiscontinuedOperationsPolicyTextBlock_7d3f7e03-701f-426f-acad-0a6975243fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2a7628f6-b3a3-43d2-ac51-3171869786ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d30d0c7d-04e7-432f-8a8d-4600bcb9c0af" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2a7628f6-b3a3-43d2-ac51-3171869786ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e9ad28ce-3c50-4b32-a1b2-64299ddf8410" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_bd37e30b-7079-41d2-87f2-141bcce17b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e9ad28ce-3c50-4b32-a1b2-64299ddf8410" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_bd37e30b-7079-41d2-87f2-141bcce17b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_b573b4c4-3ebd-4bd0-9649-0c420aecd2a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e9ad28ce-3c50-4b32-a1b2-64299ddf8410" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_b573b4c4-3ebd-4bd0-9649-0c420aecd2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ffb391b0-bc12-49eb-b1d4-4558a2e07bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e9ad28ce-3c50-4b32-a1b2-64299ddf8410" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ffb391b0-bc12-49eb-b1d4-4558a2e07bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_7e8814e2-eaf2-46eb-bdb8-182cfff260ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e9ad28ce-3c50-4b32-a1b2-64299ddf8410" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_7e8814e2-eaf2-46eb-bdb8-182cfff260ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d6f723bb-ee1d-476b-9e0c-b5ee69afa612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e9ad28ce-3c50-4b32-a1b2-64299ddf8410" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_d6f723bb-ee1d-476b-9e0c-b5ee69afa612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_0c8e46f7-9155-4427-b86a-307233b5d9df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e9ad28ce-3c50-4b32-a1b2-64299ddf8410" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_0c8e46f7-9155-4427-b86a-307233b5d9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_19db3a79-9d8e-42f9-822e-2a837fa63f78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e9ad28ce-3c50-4b32-a1b2-64299ddf8410" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_19db3a79-9d8e-42f9-822e-2a837fa63f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7e6beb6a-1800-416c-90c8-d58dc29f0534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7e6beb6a-1800-416c-90c8-d58dc29f0534" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_ae8a05ad-222f-4113-b30e-88896379471b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_srt_ProductOrServiceAxis_ae8a05ad-222f-4113-b30e-88896379471b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6b5d6de7-4939-42c8-b223-98b85af59c16" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_ae8a05ad-222f-4113-b30e-88896379471b" xlink:to="loc_srt_ProductsAndServicesDomain_6b5d6de7-4939-42c8-b223-98b85af59c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_cf88db63-f3a0-4df6-b26d-c8a47ee0adc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6b5d6de7-4939-42c8-b223-98b85af59c16" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_cf88db63-f3a0-4df6-b26d-c8a47ee0adc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fb534fcb-0c30-419f-873d-a4cd34fbed60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fb534fcb-0c30-419f-873d-a4cd34fbed60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_50c4658d-096f-448f-b7c0-8b409936c23a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fb534fcb-0c30-419f-873d-a4cd34fbed60" xlink:to="loc_us-gaap_SegmentDomain_50c4658d-096f-448f-b7c0-8b409936c23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_485175fe-a9c9-49dc-8cb6-0ee999b00420" xlink:href="cvs-20211231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_50c4658d-096f-448f-b7c0-8b409936c23a" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_485175fe-a9c9-49dc-8cb6-0ee999b00420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_1b0d4795-0560-40eb-9e66-4059ca87e7fe" xlink:href="cvs-20211231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_50c4658d-096f-448f-b7c0-8b409936c23a" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_1b0d4795-0560-40eb-9e66-4059ca87e7fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f4f0eb0c-46f1-4369-abd8-40c91faf5da1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f4f0eb0c-46f1-4369-abd8-40c91faf5da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e46132d0-6fa9-4513-ad12-e125b0c0d7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f4f0eb0c-46f1-4369-abd8-40c91faf5da1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e46132d0-6fa9-4513-ad12-e125b0c0d7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BrazilSubsidiaryMember_e169b5c3-3564-4df5-b3b9-91189413f6ed" xlink:href="cvs-20211231.xsd#cvs_BrazilSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e46132d0-6fa9-4513-ad12-e125b0c0d7cc" xlink:to="loc_cvs_BrazilSubsidiaryMember_e169b5c3-3564-4df5-b3b9-91189413f6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_51a2ab68-d928-40a3-8c50-e48b6b0ee77e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_51a2ab68-d928-40a3-8c50-e48b6b0ee77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_282210d1-c22c-43a8-8355-0af43b03df48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_51a2ab68-d928-40a3-8c50-e48b6b0ee77e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_282210d1-c22c-43a8-8355-0af43b03df48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_edc1f5b4-920e-49e9-9628-ba9197f93b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_282210d1-c22c-43a8-8355-0af43b03df48" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_edc1f5b4-920e-49e9-9628-ba9197f93b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9df0871d-65aa-4375-8e72-1ec83bc6a417" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_srt_RangeAxis_9df0871d-65aa-4375-8e72-1ec83bc6a417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3146c42b-b7cd-46d5-ab22-1ff5f3e461a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9df0871d-65aa-4375-8e72-1ec83bc6a417" xlink:to="loc_srt_RangeMember_3146c42b-b7cd-46d5-ab22-1ff5f3e461a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ae0f5750-5197-46da-9e3e-384d742022f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3146c42b-b7cd-46d5-ab22-1ff5f3e461a1" xlink:to="loc_srt_MinimumMember_ae0f5750-5197-46da-9e3e-384d742022f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f2efac50-9f25-4ef2-86d9-c410c643d3ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3146c42b-b7cd-46d5-ab22-1ff5f3e461a1" xlink:to="loc_srt_MaximumMember_f2efac50-9f25-4ef2-86d9-c410c643d3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1bda6c3a-afee-41c7-830e-53ef4b688b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1bda6c3a-afee-41c7-830e-53ef4b688b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e4c338bc-2de7-429b-85e7-781c2d204a70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1bda6c3a-afee-41c7-830e-53ef4b688b4c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e4c338bc-2de7-429b-85e7-781c2d204a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_39e403ec-02e2-48cc-8b7b-431351251692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e4c338bc-2de7-429b-85e7-781c2d204a70" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_39e403ec-02e2-48cc-8b7b-431351251692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_ae05a733-2d61-4d2f-a4e7-2ce578952544" xlink:href="cvs-20211231.xsd#cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e4c338bc-2de7-429b-85e7-781c2d204a70" xlink:to="loc_cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember_ae05a733-2d61-4d2f-a4e7-2ce578952544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_10c98886-496c-4839-b674-0d3096b9710e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e4c338bc-2de7-429b-85e7-781c2d204a70" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_10c98886-496c-4839-b674-0d3096b9710e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_0070c948-82eb-458f-89e0-d4bd170cc200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_0070c948-82eb-458f-89e0-d4bd170cc200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_694ac8b9-1b55-4421-b392-f7a8d5317a95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_0070c948-82eb-458f-89e0-d4bd170cc200" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_694ac8b9-1b55-4421-b392-f7a8d5317a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherInsuranceLiabilitiesMember_e4fa4127-8f24-469e-824f-f643841687be" xlink:href="cvs-20211231.xsd#cvs_OtherInsuranceLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_694ac8b9-1b55-4421-b392-f7a8d5317a95" xlink:to="loc_cvs_OtherInsuranceLiabilitiesMember_e4fa4127-8f24-469e-824f-f643841687be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherLongTermInsuranceLiabilitiesMember_39681c7c-7dc3-4585-b2bc-0c732833d33d" xlink:href="cvs-20211231.xsd#cvs_OtherLongTermInsuranceLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_694ac8b9-1b55-4421-b392-f7a8d5317a95" xlink:to="loc_cvs_OtherLongTermInsuranceLiabilitiesMember_39681c7c-7dc3-4585-b2bc-0c732833d33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ca201eb5-eb29-4b8a-9377-8f1f19db1054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ca201eb5-eb29-4b8a-9377-8f1f19db1054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_db97a2b3-a3af-4ec6-a8cf-c8f459ff7121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ca201eb5-eb29-4b8a-9377-8f1f19db1054" xlink:to="loc_us-gaap_EquityComponentDomain_db97a2b3-a3af-4ec6-a8cf-c8f459ff7121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_eb614f69-450d-40f2-97c9-557f53bcab7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_db97a2b3-a3af-4ec6-a8cf-c8f459ff7121" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_eb614f69-450d-40f2-97c9-557f53bcab7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_4f989122-f210-4285-a3ca-5331e7d7893e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_dei_LegalEntityAxis_4f989122-f210-4285-a3ca-5331e7d7893e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_01f0e17c-0a97-412e-8b6f-bb274b441b41" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_4f989122-f210-4285-a3ca-5331e7d7893e" xlink:to="loc_dei_EntityDomain_01f0e17c-0a97-412e-8b6f-bb274b441b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeartlandHealthcareServicesMember_b1a667d0-c67c-4cde-b0e2-26bd81681d21" xlink:href="cvs-20211231.xsd#cvs_HeartlandHealthcareServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_01f0e17c-0a97-412e-8b6f-bb274b441b41" xlink:to="loc_cvs_HeartlandHealthcareServicesMember_b1a667d0-c67c-4cde-b0e2-26bd81681d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8a8575ec-ee45-4e1a-bced-5e3eddec68a9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_srt_LitigationCaseAxis_8a8575ec-ee45-4e1a-bced-5e3eddec68a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_623c7d4b-5847-4acc-a381-0b00b2d50c5f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_8a8575ec-ee45-4e1a-bced-5e3eddec68a9" xlink:to="loc_srt_LitigationCaseTypeDomain_623c7d4b-5847-4acc-a381-0b00b2d50c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_0b679c8b-eec2-48e6-ad1c-82aa28f5d7da" xlink:href="cvs-20211231.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_623c7d4b-5847-4acc-a381-0b00b2d50c5f" xlink:to="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_0b679c8b-eec2-48e6-ad1c-82aa28f5d7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_ec930d68-5b30-495d-8b32-671bd21de3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_us-gaap_LitigationStatusAxis_ec930d68-5b30-495d-8b32-671bd21de3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_6a1eac5f-fd05-41b4-83dd-e8d5252d31bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_ec930d68-5b30-495d-8b32-671bd21de3ff" xlink:to="loc_us-gaap_LitigationStatusDomain_6a1eac5f-fd05-41b4-83dd-e8d5252d31bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_76d05413-df14-40b0-9398-6f53335af41f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_6a1eac5f-fd05-41b4-83dd-e8d5252d31bb" xlink:to="loc_us-gaap_SettledLitigationMember_76d05413-df14-40b0-9398-6f53335af41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_196d82fb-1bd8-4d4d-a1a9-2d63202004ba" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_4233f27f-74c7-4ed2-9110-5d52ed8da68d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_NumberOfStores_4233f27f-74c7-4ed2-9110-5d52ed8da68d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofWalkInMedicalClinics_a0d15310-2f8f-4675-b3c6-a47173985d45" xlink:href="cvs-20211231.xsd#cvs_NumberofWalkInMedicalClinics"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_NumberofWalkInMedicalClinics_a0d15310-2f8f-4675-b3c6-a47173985d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPlanMembers_a3dc930c-59ff-47a1-bcce-37be4e5f9a6e" xlink:href="cvs-20211231.xsd#cvs_NumberOfPlanMembers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_NumberOfPlanMembers_a3dc930c-59ff-47a1-bcce-37be4e5f9a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofPatientsServedperYear_1b32c1b8-6cf4-4dcb-85b9-2cd9f4819355" xlink:href="cvs-20211231.xsd#cvs_NumberofPatientsServedperYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_NumberofPatientsServedperYear_1b32c1b8-6cf4-4dcb-85b9-2cd9f4819355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfPeopleServed_40deadc1-d82a-48a7-8c7f-6048ed38a3eb" xlink:href="cvs-20211231.xsd#cvs_NumberOfPeopleServed"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_NumberOfPeopleServed_40deadc1-d82a-48a7-8c7f-6048ed38a3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_640f50cf-4f87-441f-84b8-ae359558dff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_NumberOfReportableSegments_640f50cf-4f87-441f-84b8-ae359558dff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_42911db3-699f-430f-a625-39c0f962acb3" xlink:href="cvs-20211231.xsd#cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates_42911db3-699f-430f-a625-39c0f962acb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCosts_7e5f53e8-2739-40f5-aaca-d2f01eea66d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredPolicyAcquisitionCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCosts_7e5f53e8-2739-40f5-aaca-d2f01eea66d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b92b505b-7945-46e6-b2a8-f385e6a08583" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_b92b505b-7945-46e6-b2a8-f385e6a08583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_6ebc5475-37c2-42bc-b6a8-acc3e9367b50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_Depreciation_6ebc5475-37c2-42bc-b6a8-acc3e9367b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_ad5acd89-8d49-4489-a196-334b35880199" xlink:href="cvs-20211231.xsd#cvs_StoreImpairmentCharges"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_StoreImpairmentCharges_ad5acd89-8d49-4489-a196-334b35880199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_c0c48dac-2230-4448-8399-8debef4b7ade" xlink:href="cvs-20211231.xsd#cvs_LesseeOperatingAndFinanceLeasesRenewalTerm"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm_c0c48dac-2230-4448-8399-8debef4b7ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_514a1838-54a8-43ef-bac1-809ee9cf72fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_514a1838-54a8-43ef-bac1-809ee9cf72fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b2870201-8c8e-4113-be7b-8fd7c2428963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b2870201-8c8e-4113-be7b-8fd7c2428963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_e39ad544-8961-4512-93d6-95dd157bc776" xlink:href="cvs-20211231.xsd#cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid_e39ad544-8961-4512-93d6-95dd157bc776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityforUnpaidClaims_d2e26943-0e5b-4052-967e-35666dbd0338" xlink:href="cvs-20211231.xsd#cvs_LiabilityforUnpaidClaims"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_LiabilityforUnpaidClaims_d2e26943-0e5b-4052-967e-35666dbd0338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LimitedPaymentsContracts_e3b93108-a17f-4e47-aad6-c180dcf53766" xlink:href="cvs-20211231.xsd#cvs_LimitedPaymentsContracts"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_LimitedPaymentsContracts_e3b93108-a17f-4e47-aad6-c180dcf53766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts_b875f19c-ca5d-43b8-9a89-85547dd8ddb6" xlink:href="cvs-20211231.xsd#cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts_b875f19c-ca5d-43b8-9a89-85547dd8ddb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_d256c0c7-574f-414a-bd61-3ab891ec9091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_d256c0c7-574f-414a-bd61-3ab891ec9091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_212a2d76-535a-45ec-b2e6-4f1a549d98bb" xlink:href="cvs-20211231.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_212a2d76-535a-45ec-b2e6-4f1a549d98bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PensionAndAnnuityInvestmentContractsInterest_ae2b78ff-6092-46f8-aa3a-1724b07dfbd0" xlink:href="cvs-20211231.xsd#cvs_PensionAndAnnuityInvestmentContractsInterest"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_PensionAndAnnuityInvestmentContractsInterest_ae2b78ff-6092-46f8-aa3a-1724b07dfbd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HeathSavingsAccountBalance_bae2c8b3-c7f1-4857-b2c1-c527baa0bdd8" xlink:href="cvs-20211231.xsd#cvs_HeathSavingsAccountBalance"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_HeathSavingsAccountBalance_bae2c8b3-c7f1-4857-b2c1-c527baa0bdd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_1ef592c7-80f1-45ff-8866-a37460f67342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_SelfInsuranceReserve_1ef592c7-80f1-45ff-8866-a37460f67342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_985aabf9-cddd-4c91-87fd-8f8f3320e277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_985aabf9-cddd-4c91-87fd-8f8f3320e277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRebatePeriod_a79a8963-90cc-4b62-9090-8f26c9ea93ca" xlink:href="cvs-20211231.xsd#cvs_PharmacyRebatePeriod"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_PharmacyRebatePeriod_a79a8963-90cc-4b62-9090-8f26c9ea93ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFee_5f3778ac-dfc2-4d0d-ad7c-cd487b3caecb" xlink:href="cvs-20211231.xsd#cvs_HealthInsurerFee"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_HealthInsurerFee_5f3778ac-dfc2-4d0d-ad7c-cd487b3caecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount_a8f78887-3bde-48e3-a801-a191b6ffb0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_GainContingencyUnrecordedAmount_a8f78887-3bde-48e3-a801-a191b6ffb0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_f692eedb-d9bd-49fc-859d-6d6507251de7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_f692eedb-d9bd-49fc-859d-6d6507251de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_ea5a8256-2e0e-4a03-92fe-5087b121ee92" xlink:href="cvs-20211231.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_ea5a8256-2e0e-4a03-92fe-5087b121ee92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_85e26cb4-2d1a-4916-9ac2-90760387ff5b" xlink:href="cvs-20211231.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax_85e26cb4-2d1a-4916-9ac2-90760387ff5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_cf275d3f-f5e9-4985-b788-da6501d43dae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_AdvertisingExpense_cf275d3f-f5e9-4985-b788-da6501d43dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a9dee145-30b8-4e94-a596-23446c9768c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a9dee145-30b8-4e94-a596-23446c9768c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TreasuryStockSharesHeldinTrust_5579361c-0596-48ad-8ef6-a403db90cc35" xlink:href="cvs-20211231.xsd#cvs_TreasuryStockSharesHeldinTrust"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_TreasuryStockSharesHeldinTrust_5579361c-0596-48ad-8ef6-a403db90cc35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_31681cbe-51bc-4e31-8dd4-d333f31043b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_31681cbe-51bc-4e31-8dd4-d333f31043b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Initialcontractualterm_c95d5adc-0c80-408f-9754-368f3d022395" xlink:href="cvs-20211231.xsd#cvs_Initialcontractualterm"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_Initialcontractualterm_c95d5adc-0c80-408f-9754-368f3d022395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VariableInterestEntityAmendedContractExtensionTerm_09a524fb-3282-403a-a048-32ace7325f45" xlink:href="cvs-20211231.xsd#cvs_VariableInterestEntityAmendedContractExtensionTerm"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_VariableInterestEntityAmendedContractExtensionTerm_09a524fb-3282-403a-a048-32ace7325f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VariableInterestEntityAmendedContractTerm_74437563-15bf-4e61-be87-4bfbc9238fdc" xlink:href="cvs-20211231.xsd#cvs_VariableInterestEntityAmendedContractTerm"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_VariableInterestEntityAmendedContractTerm_74437563-15bf-4e61-be87-4bfbc9238fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_e28d023c-5845-4a93-a59e-a003120d9a33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_e28d023c-5845-4a93-a59e-a003120d9a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStatesInWhichEntityOperates_a6ae5394-2173-4822-963f-a8222d8317b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_NumberOfStatesInWhichEntityOperates_a6ae5394-2173-4822-963f-a8222d8317b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_6e4792f5-3b34-475f-91e2-e62bb0ef8503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_6e4792f5-3b34-475f-91e2-e62bb0ef8503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_d2b0a7d6-bf99-4909-b4de-cd287e7616fa" xlink:href="cvs-20211231.xsd#cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity_d2b0a7d6-bf99-4909-b4de-cd287e7616fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresPlannedClosure_470bf4e0-0555-45fc-a62b-26b9cd1aaba1" xlink:href="cvs-20211231.xsd#cvs_NumberOfStoresPlannedClosure"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_b60d8370-7a37-465c-8d1f-90e201a0753a" xlink:to="loc_cvs_NumberOfStoresPlannedClosure_470bf4e0-0555-45fc-a62b-26b9cd1aaba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8fbffec3-80e7-440c-ba8d-e6a5b434aa50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_54c2d10a-618c-469d-bd70-5d3b2af93992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8fbffec3-80e7-440c-ba8d-e6a5b434aa50" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_54c2d10a-618c-469d-bd70-5d3b2af93992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_94687184-6c41-414f-9349-4968b4f34cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8fbffec3-80e7-440c-ba8d-e6a5b434aa50" xlink:to="loc_us-gaap_RestrictedCashCurrent_94687184-6c41-414f-9349-4968b4f34cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_aec17ee0-4147-45e6-ade1-94f2427fcfbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8fbffec3-80e7-440c-ba8d-e6a5b434aa50" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_aec17ee0-4147-45e6-ade1-94f2427fcfbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8e4bf37c-d738-45d0-a61b-2ccfe6467a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8fbffec3-80e7-440c-ba8d-e6a5b434aa50" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8e4bf37c-d738-45d0-a61b-2ccfe6467a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c3f21eb0-8421-4424-97dd-7dd06ea1d509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_c6bb7baf-2aa1-4f13-aee6-856e4d101814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c3f21eb0-8421-4424-97dd-7dd06ea1d509" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_c6bb7baf-2aa1-4f13-aee6-856e4d101814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VendorandManufacturerReceivables_7fa8bc1c-77b4-4cbc-bddc-ece5d7826b79" xlink:href="cvs-20211231.xsd#cvs_VendorandManufacturerReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c3f21eb0-8421-4424-97dd-7dd06ea1d509" xlink:to="loc_cvs_VendorandManufacturerReceivables_7fa8bc1c-77b4-4cbc-bddc-ece5d7826b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsReceivableAtCarryingValue_e0e8eb23-6d8c-4171-802b-b1c796b5b22f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsReceivableAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c3f21eb0-8421-4424-97dd-7dd06ea1d509" xlink:to="loc_us-gaap_PremiumsReceivableAtCarryingValue_e0e8eb23-6d8c-4171-802b-b1c796b5b22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_89d431a8-8b5b-4670-af76-80a36f859090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c3f21eb0-8421-4424-97dd-7dd06ea1d509" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_89d431a8-8b5b-4670-af76-80a36f859090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_88497104-7f3d-4b74-a5b4-d50d0f316757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c3f21eb0-8421-4424-97dd-7dd06ea1d509" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_88497104-7f3d-4b74-a5b4-d50d0f316757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_17e521ea-68fb-43c5-bfe1-becedaedf0d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c3f21eb0-8421-4424-97dd-7dd06ea1d509" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_17e521ea-68fb-43c5-bfe1-becedaedf0d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_faa23bb1-a09a-4bd4-96f1-4a86ce4b8f99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_554500a3-095f-4654-a9cc-31f63d5a7b25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_faa23bb1-a09a-4bd4-96f1-4a86ce4b8f99" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_554500a3-095f-4654-a9cc-31f63d5a7b25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e99176e-5abd-46ac-8235-fb7b94f3d047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_554500a3-095f-4654-a9cc-31f63d5a7b25" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e99176e-5abd-46ac-8235-fb7b94f3d047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7791b588-84e2-4fb1-8d62-9e2ad87b2199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9e99176e-5abd-46ac-8235-fb7b94f3d047" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7791b588-84e2-4fb1-8d62-9e2ad87b2199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_68956f1c-91d1-444d-b3cd-03939eccf6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7791b588-84e2-4fb1-8d62-9e2ad87b2199" xlink:to="loc_us-gaap_LandMember_68956f1c-91d1-444d-b3cd-03939eccf6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_afe08987-8f85-408d-8c03-df57c98c7973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7791b588-84e2-4fb1-8d62-9e2ad87b2199" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_afe08987-8f85-408d-8c03-df57c98c7973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_59f1191d-9b38-4ffe-8e60-273326239ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7791b588-84e2-4fb1-8d62-9e2ad87b2199" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_59f1191d-9b38-4ffe-8e60-273326239ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_5e5d92d2-0241-4cde-b672-e462dfa8d9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7791b588-84e2-4fb1-8d62-9e2ad87b2199" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_5e5d92d2-0241-4cde-b672-e462dfa8d9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_5a34275e-9e6d-4244-ace1-977853b2658c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7791b588-84e2-4fb1-8d62-9e2ad87b2199" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_5a34275e-9e6d-4244-ace1-977853b2658c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_68bf2946-68b0-4ae2-86af-1ca4ec96b624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_554500a3-095f-4654-a9cc-31f63d5a7b25" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_68bf2946-68b0-4ae2-86af-1ca4ec96b624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e2ef37eb-a9ac-43c9-bb68-fe2c29bfec61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_68bf2946-68b0-4ae2-86af-1ca4ec96b624" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e2ef37eb-a9ac-43c9-bb68-fe2c29bfec61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6158f1f0-1a94-4f78-b18b-99b06e14448a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_68bf2946-68b0-4ae2-86af-1ca4ec96b624" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_6158f1f0-1a94-4f78-b18b-99b06e14448a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_483d996b-4402-4cfc-9cff-e6c346dae628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_68bf2946-68b0-4ae2-86af-1ca4ec96b624" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_483d996b-4402-4cfc-9cff-e6c346dae628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_24cc40b0-cbbc-4b06-b3d4-5766588961ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_b0e5071e-6976-49c0-ab9e-73ad7a1d9ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_24cc40b0-cbbc-4b06-b3d4-5766588961ba" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_b0e5071e-6976-49c0-ab9e-73ad7a1d9ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3257b2bb-a15c-486d-a5bc-ff187e9368ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b0e5071e-6976-49c0-ab9e-73ad7a1d9ffc" xlink:to="loc_srt_ConsolidationItemsAxis_3257b2bb-a15c-486d-a5bc-ff187e9368ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_88cd23b8-62a6-49c6-a057-53ef5653ac08" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_3257b2bb-a15c-486d-a5bc-ff187e9368ab" xlink:to="loc_srt_ConsolidationItemsDomain_88cd23b8-62a6-49c6-a057-53ef5653ac08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_a7ce5ddc-4633-4bce-92e8-6acc35ba3b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_88cd23b8-62a6-49c6-a057-53ef5653ac08" xlink:to="loc_us-gaap_OperatingSegmentsMember_a7ce5ddc-4633-4bce-92e8-6acc35ba3b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_b3fc0b75-72ec-42f4-b6da-ba15abc2ebab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_88cd23b8-62a6-49c6-a057-53ef5653ac08" xlink:to="loc_us-gaap_CorporateNonSegmentMember_b3fc0b75-72ec-42f4-b6da-ba15abc2ebab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_713c4bf7-5500-4033-bc60-94c38d7c7f12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_88cd23b8-62a6-49c6-a057-53ef5653ac08" xlink:to="loc_us-gaap_IntersegmentEliminationMember_713c4bf7-5500-4033-bc60-94c38d7c7f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_29fce7da-2d88-4396-b2ef-5e43aacbb6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b0e5071e-6976-49c0-ab9e-73ad7a1d9ffc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_29fce7da-2d88-4396-b2ef-5e43aacbb6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_145e4bc4-7f4f-4b85-a304-13d9ca41699d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_29fce7da-2d88-4396-b2ef-5e43aacbb6ec" xlink:to="loc_us-gaap_SegmentDomain_145e4bc4-7f4f-4b85-a304-13d9ca41699d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_d46e3754-8157-4391-8ea8-885a54f42cb6" xlink:href="cvs-20211231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_145e4bc4-7f4f-4b85-a304-13d9ca41699d" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_d46e3754-8157-4391-8ea8-885a54f42cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_fb76d548-dcdf-4c0b-8999-08be7571d9e8" xlink:href="cvs-20211231.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_145e4bc4-7f4f-4b85-a304-13d9ca41699d" xlink:to="loc_cvs_PharmacyServicesSegmentMember_fb76d548-dcdf-4c0b-8999-08be7571d9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_604c8bb8-bb4b-4019-be80-85eb933d4858" xlink:href="cvs-20211231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_145e4bc4-7f4f-4b85-a304-13d9ca41699d" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_604c8bb8-bb4b-4019-be80-85eb933d4858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4ee8bd82-d418-4e8e-aeaf-f779d6e885ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b0e5071e-6976-49c0-ab9e-73ad7a1d9ffc" xlink:to="loc_srt_ProductOrServiceAxis_4ee8bd82-d418-4e8e-aeaf-f779d6e885ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_574faef5-663c-48ee-ba49-bcf9dd5d49ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4ee8bd82-d418-4e8e-aeaf-f779d6e885ed" xlink:to="loc_srt_ProductsAndServicesDomain_574faef5-663c-48ee-ba49-bcf9dd5d49ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyRevenueMember_f01f6426-e7ac-4260-9261-fd241c8a213d" xlink:href="cvs-20211231.xsd#cvs_PharmacyRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_574faef5-663c-48ee-ba49-bcf9dd5d49ed" xlink:to="loc_cvs_PharmacyRevenueMember_f01f6426-e7ac-4260-9261-fd241c8a213d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FrontStoreRevenueMember_79541de3-3e07-4c9f-9f31-e65f8a8c01f6" xlink:href="cvs-20211231.xsd#cvs_FrontStoreRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_574faef5-663c-48ee-ba49-bcf9dd5d49ed" xlink:to="loc_cvs_FrontStoreRevenueMember_79541de3-3e07-4c9f-9f31-e65f8a8c01f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsMember_3517701e-cf49-4a53-b5b3-354ccda9e732" xlink:href="cvs-20211231.xsd#cvs_PremiumsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_574faef5-663c-48ee-ba49-bcf9dd5d49ed" xlink:to="loc_cvs_PremiumsMember_3517701e-cf49-4a53-b5b3-354ccda9e732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_f22c7fd2-0ebf-409c-b4cc-6d5816312e43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_574faef5-663c-48ee-ba49-bcf9dd5d49ed" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_f22c7fd2-0ebf-409c-b4cc-6d5816312e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_a4a8770b-f82e-47cd-96ba-35958507b438" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b0e5071e-6976-49c0-ab9e-73ad7a1d9ffc" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_a4a8770b-f82e-47cd-96ba-35958507b438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9c4b3104-bdf1-47e9-8cf1-913fbe4eba87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_a4a8770b-f82e-47cd-96ba-35958507b438" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9c4b3104-bdf1-47e9-8cf1-913fbe4eba87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_5ecf04be-fdf1-48a0-adaa-371074b27e44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9c4b3104-bdf1-47e9-8cf1-913fbe4eba87" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_5ecf04be-fdf1-48a0-adaa-371074b27e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_14f7bc1f-3210-4f5d-beda-5ee71ec02ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9c4b3104-bdf1-47e9-8cf1-913fbe4eba87" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_14f7bc1f-3210-4f5d-beda-5ee71ec02ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SalesChannelOtherMember_28b2d56d-01a9-454f-a217-c9edf2a3eb60" xlink:href="cvs-20211231.xsd#cvs_SalesChannelOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_9c4b3104-bdf1-47e9-8cf1-913fbe4eba87" xlink:to="loc_cvs_SalesChannelOtherMember_28b2d56d-01a9-454f-a217-c9edf2a3eb60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_bea8288a-6511-4922-9ca4-87b11a3ba14d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_b0e5071e-6976-49c0-ab9e-73ad7a1d9ffc" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_bea8288a-6511-4922-9ca4-87b11a3ba14d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_5dd6a0be-de2f-4852-8bba-ac576a0eae02" xlink:href="cvs-20211231.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bea8288a-6511-4922-9ca4-87b11a3ba14d" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_5dd6a0be-de2f-4852-8bba-ac576a0eae02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_3e958a02-c696-408a-96b8-aed8f7c75396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bea8288a-6511-4922-9ca4-87b11a3ba14d" xlink:to="loc_us-gaap_NetInvestmentIncome_3e958a02-c696-408a-96b8-aed8f7c75396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fa0c0c59-9eb9-4ff2-83ef-729efb8a5e75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bea8288a-6511-4922-9ca4-87b11a3ba14d" xlink:to="loc_us-gaap_Revenues_fa0c0c59-9eb9-4ff2-83ef-729efb8a5e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3cc93064-1ce8-480f-a10c-589afd13d5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_066e3f9c-fc07-494d-9188-e69b04ac641e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3cc93064-1ce8-480f-a10c-589afd13d5f4" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_066e3f9c-fc07-494d-9188-e69b04ac641e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_4c97cc0d-f091-41fe-a57f-a51eeb9b46ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3cc93064-1ce8-480f-a10c-589afd13d5f4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_4c97cc0d-f091-41fe-a57f-a51eeb9b46ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesContractBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ae93a362-c12b-497a-8d48-67176dc8b69a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_fc32fc04-dd67-433d-9e11-acb2ebfb9def" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ae93a362-c12b-497a-8d48-67176dc8b69a" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_fc32fc04-dd67-433d-9e11-acb2ebfb9def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ChangeInContractWithCustomerLiabilityRollForward_8b60669c-ae20-47f3-9b1a-cb0fc8d3e42d" xlink:href="cvs-20211231.xsd#cvs_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_fc32fc04-dd67-433d-9e11-acb2ebfb9def" xlink:to="loc_cvs_ChangeInContractWithCustomerLiabilityRollForward_8b60669c-ae20-47f3-9b1a-cb0fc8d3e42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a04d8e63-7c9c-45e7-b079-956404a7193a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeInContractWithCustomerLiabilityRollForward_8b60669c-ae20-47f3-9b1a-cb0fc8d3e42d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a04d8e63-7c9c-45e7-b079-956404a7193a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_b5444b1e-97c6-4190-87fa-ea4bff68f5cd" xlink:href="cvs-20211231.xsd#cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeInContractWithCustomerLiabilityRollForward_8b60669c-ae20-47f3-9b1a-cb0fc8d3e42d" xlink:to="loc_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance_b5444b1e-97c6-4190-87fa-ea4bff68f5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage_4c72a79c-cfca-4bf3-8020-642e2af50e37" xlink:href="cvs-20211231.xsd#cvs_ContractWithCustomerLiabilityRedemptionAndBreakage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeInContractWithCustomerLiabilityRollForward_8b60669c-ae20-47f3-9b1a-cb0fc8d3e42d" xlink:to="loc_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage_4c72a79c-cfca-4bf3-8020-642e2af50e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a21f2b1d-f4a2-4f17-a42a-9dd18efc9b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_ChangeInContractWithCustomerLiabilityRollForward_8b60669c-ae20-47f3-9b1a-cb0fc8d3e42d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a21f2b1d-f4a2-4f17-a42a-9dd18efc9b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesVariableInterestEntitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5dc43125-5439-4c5d-8d83-8455d9f60244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4c117566-85bc-4807-89c8-d0e9f406d5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5dc43125-5439-4c5d-8d83-8455d9f60244" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4c117566-85bc-4807-89c8-d0e9f406d5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_645f75d4-dce0-484b-a438-a771fb2cec7d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4c117566-85bc-4807-89c8-d0e9f406d5cc" xlink:to="loc_srt_ConsolidatedEntitiesAxis_645f75d4-dce0-484b-a438-a771fb2cec7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_cd20e004-e092-4aa6-9cc5-6423a2bb34b9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_645f75d4-dce0-484b-a438-a771fb2cec7d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_cd20e004-e092-4aa6-9cc5-6423a2bb34b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_7a259195-d558-4c44-87bf-c9688b22ca06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_cd20e004-e092-4aa6-9cc5-6423a2bb34b9" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_7a259195-d558-4c44-87bf-c9688b22ca06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_31308654-f577-4090-8bef-a580ce67c720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4c117566-85bc-4807-89c8-d0e9f406d5cc" xlink:to="loc_us-gaap_InvestmentTypeAxis_31308654-f577-4090-8bef-a580ce67c720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_37a326eb-ab8b-466d-8d6f-5ada4a00a3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_31308654-f577-4090-8bef-a580ce67c720" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_37a326eb-ab8b-466d-8d6f-5ada4a00a3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_1548fbd5-d631-4dbb-bddb-0c8c87eb698e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_37a326eb-ab8b-466d-8d6f-5ada4a00a3a5" xlink:to="loc_us-gaap_HedgeFundsMember_1548fbd5-d631-4dbb-bddb-0c8c87eb698e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_c5d2bda0-6714-4fae-9c3a-3b891b70fe85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_37a326eb-ab8b-466d-8d6f-5ada4a00a3a5" xlink:to="loc_us-gaap_PrivateEquityFundsMember_c5d2bda0-6714-4fae-9c3a-3b891b70fe85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateFundsMember_40dcdda5-ee7f-4b26-9678-876d4869f4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateFundsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_37a326eb-ab8b-466d-8d6f-5ada4a00a3a5" xlink:to="loc_us-gaap_RealEstateFundsMember_40dcdda5-ee7f-4b26-9678-876d4869f4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_72e976ca-1385-486d-8e2a-ce28c0faf69c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4c117566-85bc-4807-89c8-d0e9f406d5cc" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_72e976ca-1385-486d-8e2a-ce28c0faf69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1bff7c03-0fa8-4a31-b2fa-70eae4ec2ff0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_72e976ca-1385-486d-8e2a-ce28c0faf69c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1bff7c03-0fa8-4a31-b2fa-70eae4ec2ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RedOakMember_dd240101-7ef5-4fa3-a3d3-3b57299cc8e4" xlink:href="cvs-20211231.xsd#cvs_RedOakMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1bff7c03-0fa8-4a31-b2fa-70eae4ec2ff0" xlink:to="loc_cvs_RedOakMember_dd240101-7ef5-4fa3-a3d3-3b57299cc8e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_17b76385-33ed-4682-a6a0-98a08c54ed9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4c117566-85bc-4807-89c8-d0e9f406d5cc" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_17b76385-33ed-4682-a6a0-98a08c54ed9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_587974ad-319d-4383-8134-91476fc85ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_17b76385-33ed-4682-a6a0-98a08c54ed9d" xlink:to="loc_us-gaap_LongTermInvestments_587974ad-319d-4383-8134-91476fc85ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_45af2523-2e7a-4191-bfac-07e70070bb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_17b76385-33ed-4682-a6a0-98a08c54ed9d" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_45af2523-2e7a-4191-bfac-07e70070bb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Initialcontractualterm_22d338bc-be35-4549-a418-0036c59ac649" xlink:href="cvs-20211231.xsd#cvs_Initialcontractualterm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_17b76385-33ed-4682-a6a0-98a08c54ed9d" xlink:to="loc_cvs_Initialcontractualterm_22d338bc-be35-4549-a418-0036c59ac649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VariableInterestEntityAmendedContractExtensionTerm_345e289d-41ce-4512-904e-776fb8da21bc" xlink:href="cvs-20211231.xsd#cvs_VariableInterestEntityAmendedContractExtensionTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_17b76385-33ed-4682-a6a0-98a08c54ed9d" xlink:to="loc_cvs_VariableInterestEntityAmendedContractExtensionTerm_345e289d-41ce-4512-904e-776fb8da21bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VariableInterestEntityAmendedContractTerm_224885ea-a443-480d-800e-b28cebde987f" xlink:href="cvs-20211231.xsd#cvs_VariableInterestEntityAmendedContractTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_17b76385-33ed-4682-a6a0-98a08c54ed9d" xlink:to="loc_cvs_VariableInterestEntityAmendedContractTerm_224885ea-a443-480d-800e-b28cebde987f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsFromVariableInterestEntity_94d19db9-9faa-490e-b7eb-20b999f3709a" xlink:href="cvs-20211231.xsd#cvs_ProceedsFromVariableInterestEntity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_17b76385-33ed-4682-a6a0-98a08c54ed9d" xlink:to="loc_cvs_ProceedsFromVariableInterestEntity_94d19db9-9faa-490e-b7eb-20b999f3709a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SignificantAccountingPoliciesDiscontinuedOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6c1886f5-0431-430f-a906-1ad1eab119d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_b334e9ac-ee09-445d-9cd5-aadcfdf5219c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6c1886f5-0431-430f-a906-1ad1eab119d2" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax_b334e9ac-ee09-445d-9cd5-aadcfdf5219c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_066b0a63-ecd8-49d4-a388-d9c3afe74b88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6c1886f5-0431-430f-a906-1ad1eab119d2" xlink:to="loc_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation_066b0a63-ecd8-49d4-a388-d9c3afe74b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_9efe1a27-e734-464a-b2fb-68e43ecaacf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6c1886f5-0431-430f-a906-1ad1eab119d2" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_9efe1a27-e734-464a-b2fb-68e43ecaacf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Divestitures" xlink:type="simple" xlink:href="cvs-20211231.xsd#Divestitures"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Divestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5e0292ce-ec5f-497a-9dbf-591d7bca97a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_8a81e876-0a58-4c8a-a8fc-6ec13290af0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5e0292ce-ec5f-497a-9dbf-591d7bca97a0" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_8a81e876-0a58-4c8a-a8fc-6ec13290af0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/DivestituresNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#DivestituresNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/DivestituresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_47e5877c-b15f-4361-8446-dd1d87c4144e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_859030ed-8f97-4f2b-8f70-aedc990f2180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_47e5877c-b15f-4361-8446-dd1d87c4144e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_859030ed-8f97-4f2b-8f70-aedc990f2180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_8c5cd3c0-0e9a-456f-a845-5085765093d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_859030ed-8f97-4f2b-8f70-aedc990f2180" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_8c5cd3c0-0e9a-456f-a845-5085765093d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3e933b17-00e7-4bcc-9b9c-990d53d41b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_8c5cd3c0-0e9a-456f-a845-5085765093d7" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3e933b17-00e7-4bcc-9b9c-990d53d41b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_efc0edfe-3a47-4d9f-8f02-b16531724b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_3e933b17-00e7-4bcc-9b9c-990d53d41b42" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_efc0edfe-3a47-4d9f-8f02-b16531724b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2314828e-e3ed-45b0-9705-802e72cb6ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_859030ed-8f97-4f2b-8f70-aedc990f2180" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2314828e-e3ed-45b0-9705-802e72cb6ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_428fd27f-4681-43a9-bc3b-674419ca4d83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2314828e-e3ed-45b0-9705-802e72cb6ed0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_428fd27f-4681-43a9-bc3b-674419ca4d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_d9c4eb44-caa8-4603-9876-7780a2fae113" xlink:href="cvs-20211231.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_428fd27f-4681-43a9-bc3b-674419ca4d83" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_d9c4eb44-caa8-4603-9876-7780a2fae113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BrazilSubsidiaryMember_c198d801-7291-4bee-a665-3cf35d89bb35" xlink:href="cvs-20211231.xsd#cvs_BrazilSubsidiaryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_428fd27f-4681-43a9-bc3b-674419ca4d83" xlink:to="loc_cvs_BrazilSubsidiaryMember_c198d801-7291-4bee-a665-3cf35d89bb35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DrogariaOnofreLtdaMember_94c1379b-732f-47e4-b842-a74bcb36e4e7" xlink:href="cvs-20211231.xsd#cvs_DrogariaOnofreLtdaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_428fd27f-4681-43a9-bc3b-674419ca4d83" xlink:to="loc_cvs_DrogariaOnofreLtdaMember_94c1379b-732f-47e4-b842-a74bcb36e4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ba045c17-5736-4280-9eff-b69e39700479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_859030ed-8f97-4f2b-8f70-aedc990f2180" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ba045c17-5736-4280-9eff-b69e39700479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_381456c9-bbc3-4a99-87ec-5eb23beaaeeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ba045c17-5736-4280-9eff-b69e39700479" xlink:to="loc_us-gaap_SegmentDomain_381456c9-bbc3-4a99-87ec-5eb23beaaeeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_6ba4500e-adf5-4a3c-aa65-3885a6e8b818" xlink:href="cvs-20211231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_381456c9-bbc3-4a99-87ec-5eb23beaaeeb" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_6ba4500e-adf5-4a3c-aa65-3885a6e8b818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_58a623c7-c0bc-4f58-8666-9332730b64b6" xlink:href="cvs-20211231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_381456c9-bbc3-4a99-87ec-5eb23beaaeeb" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_58a623c7-c0bc-4f58-8666-9332730b64b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d72346d1-104e-495d-a256-203414aa3d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_859030ed-8f97-4f2b-8f70-aedc990f2180" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_d72346d1-104e-495d-a256-203414aa3d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_aa8497b2-7c72-40c6-8dc7-b9d50f472001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d72346d1-104e-495d-a256-203414aa3d50" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_aa8497b2-7c72-40c6-8dc7-b9d50f472001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_b3a83997-b217-49aa-8f7e-22c670f2f5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d72346d1-104e-495d-a256-203414aa3d50" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_b3a83997-b217-49aa-8f7e-22c670f2f5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfStores_1f9be073-c968-487a-ab94-1b96584046b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfStores"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d72346d1-104e-495d-a256-203414aa3d50" xlink:to="loc_us-gaap_NumberOfStores_1f9be073-c968-487a-ab94-1b96584046b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Investments" xlink:type="simple" xlink:href="cvs-20211231.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_b0fe5bae-5ea4-49ea-be3d-7a69710be3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_8bb45ef5-23ba-4adf-8f3e-5a33c94f5f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_b0fe5bae-5ea4-49ea-be3d-7a69710be3b8" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_8bb45ef5-23ba-4adf-8f3e-5a33c94f5f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_59857816-06c0-4925-b933-7ace3a18704c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTableTextBlock_3a21445c-07ea-4c02-b29a-f2334cc36858" xlink:href="cvs-20211231.xsd#cvs_TotalInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_59857816-06c0-4925-b933-7ace3a18704c" xlink:to="loc_cvs_TotalInvestmentsTableTextBlock_3a21445c-07ea-4c02-b29a-f2334cc36858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_926496cd-fa60-497c-85d4-08d78c419ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_59857816-06c0-4925-b933-7ace3a18704c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_926496cd-fa60-497c-85d4-08d78c419ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_94d2d670-4555-4f71-bdfb-6a0591d36990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_59857816-06c0-4925-b933-7ace3a18704c" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_94d2d670-4555-4f71-bdfb-6a0591d36990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_43741bd6-7cce-4436-98c4-cef83af68e71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_59857816-06c0-4925-b933-7ace3a18704c" xlink:to="loc_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock_43741bd6-7cce-4436-98c4-cef83af68e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_b8da2cb8-151c-4dbf-834f-0dec77706075" xlink:href="cvs-20211231.xsd#cvs_ActivityInMortgageLoanPortfolioTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_59857816-06c0-4925-b933-7ace3a18704c" xlink:to="loc_cvs_ActivityInMortgageLoanPortfolioTableTextBlock_b8da2cb8-151c-4dbf-834f-0dec77706075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_af4cf4ea-0cb0-4e20-9b5b-23b1f783c4f4" xlink:href="cvs-20211231.xsd#cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_59857816-06c0-4925-b933-7ace3a18704c" xlink:to="loc_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock_af4cf4ea-0cb0-4e20-9b5b-23b1f783c4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeTextBlock_8c7b4c11-d987-4529-8f0a-4a39a40a5779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_59857816-06c0-4925-b933-7ace3a18704c" xlink:to="loc_us-gaap_InvestmentIncomeTextBlock_8c7b4c11-d987-4529-8f0a-4a39a40a5779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_0c1d1852-2be6-4655-a4f9-a9567efdba12" xlink:href="cvs-20211231.xsd#cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_59857816-06c0-4925-b933-7ace3a18704c" xlink:to="loc_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock_0c1d1852-2be6-4655-a4f9-a9567efdba12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsScheduleofTotalInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_88fad003-3852-43ee-9c0e-f85fad08c670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsTable_266ede71-c091-43ad-84ca-15c032469ea0" xlink:href="cvs-20211231.xsd#cvs_TotalInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_88fad003-3852-43ee-9c0e-f85fad08c670" xlink:to="loc_cvs_TotalInvestmentsTable_266ede71-c091-43ad-84ca-15c032469ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsAxis_aaacab26-d8c4-4f1e-b765-913f2c2e134a" xlink:href="cvs-20211231.xsd#cvs_TotalInvestmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_266ede71-c091-43ad-84ca-15c032469ea0" xlink:to="loc_cvs_TotalInvestmentsAxis_aaacab26-d8c4-4f1e-b765-913f2c2e134a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsDomain_10474012-268e-4bb4-8a83-d9e589f130ec" xlink:href="cvs-20211231.xsd#cvs_TotalInvestmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsAxis_aaacab26-d8c4-4f1e-b765-913f2c2e134a" xlink:to="loc_cvs_TotalInvestmentsDomain_10474012-268e-4bb4-8a83-d9e589f130ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_ab763960-19ca-4548-93d8-635c6f7b1ff5" xlink:href="cvs-20211231.xsd#cvs_DebtAndEquitySecuritiesAvailableForSaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_10474012-268e-4bb4-8a83-d9e589f130ec" xlink:to="loc_cvs_DebtAndEquitySecuritiesAvailableForSaleMember_ab763960-19ca-4548-93d8-635c6f7b1ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_da6f024e-142d-4362-bb3e-fc324408b41e" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_10474012-268e-4bb4-8a83-d9e589f130ec" xlink:to="loc_cvs_MortgageLoansMember_da6f024e-142d-4362-bb3e-fc324408b41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_d973ea86-3d63-4506-8183-3da576f72c25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsDomain_10474012-268e-4bb4-8a83-d9e589f130ec" xlink:to="loc_us-gaap_OtherInvestmentsMember_d973ea86-3d63-4506-8183-3da576f72c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_TotalInvestmentsLineItems_a78a13fe-f0ca-430d-ab7e-60f2fec6c0e1" xlink:href="cvs-20211231.xsd#cvs_TotalInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsTable_266ede71-c091-43ad-84ca-15c032469ea0" xlink:to="loc_cvs_TotalInvestmentsLineItems_a78a13fe-f0ca-430d-ab7e-60f2fec6c0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_1d8c99a8-b9e1-4180-8914-98c151548337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_a78a13fe-f0ca-430d-ab7e-60f2fec6c0e1" xlink:to="loc_us-gaap_ShortTermInvestments_1d8c99a8-b9e1-4180-8914-98c151548337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_9b327e5c-ef7b-4774-a3cc-2e69a9feec4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_a78a13fe-f0ca-430d-ab7e-60f2fec6c0e1" xlink:to="loc_us-gaap_LongTermInvestments_9b327e5c-ef7b-4774-a3cc-2e69a9feec4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_2006b01a-a6a5-49a9-8a93-7f25f6dc8e62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_TotalInvestmentsLineItems_a78a13fe-f0ca-430d-ab7e-60f2fec6c0e1" xlink:to="loc_us-gaap_Investments_2006b01a-a6a5-49a9-8a93-7f25f6dc8e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a26be548-0bb2-49e4-bd8e-31c371024baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0587f3b0-d0b9-4215-8353-51ca60bc2556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a26be548-0bb2-49e4-bd8e-31c371024baa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0587f3b0-d0b9-4215-8353-51ca60bc2556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6b7cc181-4460-469a-9b0a-2cd8fdedfab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0587f3b0-d0b9-4215-8353-51ca60bc2556" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6b7cc181-4460-469a-9b0a-2cd8fdedfab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d318edf2-288a-40a8-ab9d-58a20c1820c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6b7cc181-4460-469a-9b0a-2cd8fdedfab7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d318edf2-288a-40a8-ab9d-58a20c1820c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_a3150a03-4535-43b3-9fef-4b4f9e3fef73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d318edf2-288a-40a8-ab9d-58a20c1820c7" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_a3150a03-4535-43b3-9fef-4b4f9e3fef73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d2f4491b-0fcc-4153-ac12-6ddab9fd768b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d318edf2-288a-40a8-ab9d-58a20c1820c7" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d2f4491b-0fcc-4153-ac12-6ddab9fd768b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_7ec63237-70f1-4a26-97b9-56db2c88c08c" xlink:href="cvs-20211231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d318edf2-288a-40a8-ab9d-58a20c1820c7" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_7ec63237-70f1-4a26-97b9-56db2c88c08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75671b1a-e52e-437b-bb46-2467eabe312b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0587f3b0-d0b9-4215-8353-51ca60bc2556" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75671b1a-e52e-437b-bb46-2467eabe312b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedInvestmentsAtFairValue_6a9794dc-17ba-4280-be1a-db883660cddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedInvestmentsAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75671b1a-e52e-437b-bb46-2467eabe312b" xlink:to="loc_us-gaap_RestrictedInvestmentsAtFairValue_6a9794dc-17ba-4280-be1a-db883660cddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_feb2b788-0b3a-4abd-a3f8-26c9e40852b0" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_75671b1a-e52e-437b-bb46-2467eabe312b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities_feb2b788-0b3a-4abd-a3f8-26c9e40852b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_0b716a26-1589-44fe-8c1c-7b9f4c4411e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_766e3604-b008-418c-a140-bfee8becd876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_0b716a26-1589-44fe-8c1c-7b9f4c4411e7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_766e3604-b008-418c-a140-bfee8becd876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a853c1a1-9ca0-4bc7-b394-2c457bcf477e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_766e3604-b008-418c-a140-bfee8becd876" xlink:to="loc_srt_ProductOrServiceAxis_a853c1a1-9ca0-4bc7-b394-2c457bcf477e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_023c1abb-1e31-4c62-b985-b190b9aee9ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a853c1a1-9ca0-4bc7-b394-2c457bcf477e" xlink:to="loc_srt_ProductsAndServicesDomain_023c1abb-1e31-4c62-b985-b190b9aee9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_75963f81-c178-4329-8915-3d56217763b5" xlink:href="cvs-20211231.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_023c1abb-1e31-4c62-b985-b190b9aee9ed" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_75963f81-c178-4329-8915-3d56217763b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b334fb45-86d5-457c-83af-2d5d5fdc73f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_766e3604-b008-418c-a140-bfee8becd876" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b334fb45-86d5-457c-83af-2d5d5fdc73f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b334fb45-86d5-457c-83af-2d5d5fdc73f1" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_74df9a2c-946b-4679-93e3-309618d25cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_74df9a2c-946b-4679-93e3-309618d25cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_024a363c-fb69-4b27-a94d-c889b104c05d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_024a363c-fb69-4b27-a94d-c889b104c05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_853b1c86-5103-4cc8-86ad-76f683313517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_853b1c86-5103-4cc8-86ad-76f683313517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_53010547-dd47-4e53-ba02-539fcae901ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_53010547-dd47-4e53-ba02-539fcae901ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6debf397-88b3-40f2-b525-d0ab51f8a8c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6debf397-88b3-40f2-b525-d0ab51f8a8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_66113f64-2c7f-4f1b-9aaf-72bdb9e8eb16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_66113f64-2c7f-4f1b-9aaf-72bdb9e8eb16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_c6ecf15a-d35a-4ede-ada3-26e3edbcfd9f" xlink:href="cvs-20211231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_c6ecf15a-d35a-4ede-ada3-26e3edbcfd9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_9b98d22b-eca1-47b7-83e3-c58c88266891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_63f477e1-ae08-4f2c-acbc-fb0123e49ebc" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_9b98d22b-eca1-47b7-83e3-c58c88266891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_48de20b6-d2da-4f33-a238-c352026772e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_766e3604-b008-418c-a140-bfee8becd876" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_48de20b6-d2da-4f33-a238-c352026772e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_0bff4759-010d-4fb5-a15f-09f92331acbb" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_48de20b6-d2da-4f33-a238-c352026772e5" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_0bff4759-010d-4fb5-a15f-09f92331acbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_eaecae1c-ee31-460f-b7a1-17e46dd9f46f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_48de20b6-d2da-4f33-a238-c352026772e5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_eaecae1c-ee31-460f-b7a1-17e46dd9f46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_fdb73760-9723-4a16-8e30-27df386f7318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_48de20b6-d2da-4f33-a238-c352026772e5" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_fdb73760-9723-4a16-8e30-27df386f7318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b1c9a04a-db8c-41a3-9f35-16088e9b405b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_48de20b6-d2da-4f33-a238-c352026772e5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b1c9a04a-db8c-41a3-9f35-16088e9b405b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_7ade3560-3dc8-41b0-adb2-f36c2eaeed7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_48de20b6-d2da-4f33-a238-c352026772e5" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_7ade3560-3dc8-41b0-adb2-f36c2eaeed7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsDebtSecuritiesbyMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_d3242a02-da73-4f0f-b67b-0c538a284878" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_929b133b-8f22-487d-b502-a9232c0e9bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_d3242a02-da73-4f0f-b67b-0c538a284878" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_929b133b-8f22-487d-b502-a9232c0e9bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d5c9288e-b50d-4ce2-8f38-a668ac66e656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_929b133b-8f22-487d-b502-a9232c0e9bfb" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d5c9288e-b50d-4ce2-8f38-a668ac66e656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_94853a2e-7200-4bfe-abce-9bd88fac0abd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d5c9288e-b50d-4ce2-8f38-a668ac66e656" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_94853a2e-7200-4bfe-abce-9bd88fac0abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c7ddfa43-0a81-4bc8-b1a3-2fc230ed4bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_94853a2e-7200-4bfe-abce-9bd88fac0abd" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_c7ddfa43-0a81-4bc8-b1a3-2fc230ed4bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_9a96369b-9d86-43ad-955a-2d6c13769ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_94853a2e-7200-4bfe-abce-9bd88fac0abd" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_9a96369b-9d86-43ad-955a-2d6c13769ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_75a10c9b-bb28-4e2b-896a-104f16216280" xlink:href="cvs-20211231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_94853a2e-7200-4bfe-abce-9bd88fac0abd" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_75a10c9b-bb28-4e2b-896a-104f16216280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2c79130b-9f26-4b68-b3c9-5c9f7696839c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_929b133b-8f22-487d-b502-a9232c0e9bfb" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2c79130b-9f26-4b68-b3c9-5c9f7696839c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_271b83ec-85b7-4137-815e-44907585160b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2c79130b-9f26-4b68-b3c9-5c9f7696839c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_271b83ec-85b7-4137-815e-44907585160b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_aa977aae-928d-4754-b9fd-ad0cd3555e3f" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_271b83ec-85b7-4137-815e-44907585160b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet_aa977aae-928d-4754-b9fd-ad0cd3555e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_ad14c0ba-aecc-4501-a24e-350fc5d08064" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_271b83ec-85b7-4137-815e-44907585160b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet_ad14c0ba-aecc-4501-a24e-350fc5d08064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_dfadad27-153b-494f-ad71-6569dd50462f" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_271b83ec-85b7-4137-815e-44907585160b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet_dfadad27-153b-494f-ad71-6569dd50462f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_03b1bd5a-a934-420e-8d5c-340a2282da69" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_271b83ec-85b7-4137-815e-44907585160b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet_03b1bd5a-a934-420e-8d5c-340a2282da69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_155c1534-2466-491c-b3b2-48541351461f" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_271b83ec-85b7-4137-815e-44907585160b" xlink:to="loc_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet_155c1534-2466-491c-b3b2-48541351461f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_2730e616-ff57-4785-ab4b-55212730a163" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract_271b83ec-85b7-4137-815e-44907585160b" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet_2730e616-ff57-4785-ab4b-55212730a163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_b5ec82f9-eb7b-4376-a050-ee2acfeadca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2c79130b-9f26-4b68-b3c9-5c9f7696839c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_b5ec82f9-eb7b-4376-a050-ee2acfeadca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_c201986f-d860-4383-8b2d-ac266b049ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_b5ec82f9-eb7b-4376-a050-ee2acfeadca7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_c201986f-d860-4383-8b2d-ac266b049ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2361e0d1-ff48-4e19-b298-87ab2ae99042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_b5ec82f9-eb7b-4376-a050-ee2acfeadca7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2361e0d1-ff48-4e19-b298-87ab2ae99042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_907594cc-a8bd-4046-90e4-89aecb4e72ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_b5ec82f9-eb7b-4376-a050-ee2acfeadca7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_907594cc-a8bd-4046-90e4-89aecb4e72ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_386b1a5b-0ca8-498f-9543-eee93afc46c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_b5ec82f9-eb7b-4376-a050-ee2acfeadca7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_386b1a5b-0ca8-498f-9543-eee93afc46c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_2392c468-848a-4d33-bf14-c42008d5d0af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_b5ec82f9-eb7b-4376-a050-ee2acfeadca7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_2392c468-848a-4d33-bf14-c42008d5d0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_35584601-1506-4057-bd02-f8e0be4a8609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_b5ec82f9-eb7b-4376-a050-ee2acfeadca7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_35584601-1506-4057-bd02-f8e0be4a8609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_a3036735-24e2-4bea-b82f-c86189e782f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_00ce8f8c-eead-4b86-bc3c-01f486b38b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_a3036735-24e2-4bea-b82f-c86189e782f9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_00ce8f8c-eead-4b86-bc3c-01f486b38b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_75de39ca-10c3-495c-9d47-d6cb79b5c34c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_00ce8f8c-eead-4b86-bc3c-01f486b38b8f" xlink:to="loc_us-gaap_FinancialInstrumentAxis_75de39ca-10c3-495c-9d47-d6cb79b5c34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_75de39ca-10c3-495c-9d47-d6cb79b5c34c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f56a012a-e8c2-4a88-b088-3d05b3c0ed6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f56a012a-e8c2-4a88-b088-3d05b3c0ed6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_da07fd03-42f6-408c-b462-a051101a8aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_da07fd03-42f6-408c-b462-a051101a8aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_86648057-8629-4cec-b6bc-0f1012eb0bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_86648057-8629-4cec-b6bc-0f1012eb0bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_d3edf21a-74db-4094-9c82-c207ed2473bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_d3edf21a-74db-4094-9c82-c207ed2473bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_0352620d-9dbd-4135-be8c-5ed802a4b070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_0352620d-9dbd-4135-be8c-5ed802a4b070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c3d65c49-e110-48d2-8f82-d51bff4af3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_c3d65c49-e110-48d2-8f82-d51bff4af3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_60c366e8-2083-4e54-be09-cc21374531d9" xlink:href="cvs-20211231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_60c366e8-2083-4e54-be09-cc21374531d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RedeemablePreferredSecuritiesMember_74b96b95-1085-4dd7-9e3c-ccae21f0798f" xlink:href="cvs-20211231.xsd#cvs_RedeemablePreferredSecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9f2225c2-e12c-4ca4-8519-2b4168ac763b" xlink:to="loc_cvs_RedeemablePreferredSecuritiesMember_74b96b95-1085-4dd7-9e3c-ccae21f0798f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_55e49cf0-f144-4fb6-9090-2336ca455e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_00ce8f8c-eead-4b86-bc3c-01f486b38b8f" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_55e49cf0-f144-4fb6-9090-2336ca455e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_ea1fcc33-e1f0-4c02-81a6-ebded4835922" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_55e49cf0-f144-4fb6-9090-2336ca455e5c" xlink:to="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_ea1fcc33-e1f0-4c02-81a6-ebded4835922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_ab51f1e5-caad-401e-ab2d-84831c7f34b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_ea1fcc33-e1f0-4c02-81a6-ebded4835922" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_ab51f1e5-caad-401e-ab2d-84831c7f34b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_d707a149-ca2b-4bc4-89af-1e25c246d0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_ea1fcc33-e1f0-4c02-81a6-ebded4835922" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_d707a149-ca2b-4bc4-89af-1e25c246d0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_cecfae33-a3ea-48a6-ac2f-a6a4d60c666b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract_ea1fcc33-e1f0-4c02-81a6-ebded4835922" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_cecfae33-a3ea-48a6-ac2f-a6a4d60c666b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_280ff8a7-d9ec-4df5-b15b-7a289c480288" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_55e49cf0-f144-4fb6-9090-2336ca455e5c" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_280ff8a7-d9ec-4df5-b15b-7a289c480288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_4ecf4fa6-1be1-4347-97b5-a871634bac4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_280ff8a7-d9ec-4df5-b15b-7a289c480288" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_4ecf4fa6-1be1-4347-97b5-a871634bac4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_54f95456-5c91-4727-81d0-f14d7e84f686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_280ff8a7-d9ec-4df5-b15b-7a289c480288" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_54f95456-5c91-4727-81d0-f14d7e84f686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5a8b1c95-f7e0-46d5-ba00-e003a726980b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract_280ff8a7-d9ec-4df5-b15b-7a289c480288" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_5a8b1c95-f7e0-46d5-ba00-e003a726980b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_9ed94919-32c5-4bce-b013-f4c83d71fc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_55e49cf0-f144-4fb6-9090-2336ca455e5c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_9ed94919-32c5-4bce-b013-f4c83d71fc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_449dd197-9588-4db4-bc43-17fad2db05bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_9ed94919-32c5-4bce-b013-f4c83d71fc6f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_449dd197-9588-4db4-bc43-17fad2db05bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_c84c1838-070b-42cf-b3d8-088a6ff8fa39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_9ed94919-32c5-4bce-b013-f4c83d71fc6f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_c84c1838-070b-42cf-b3d8-088a6ff8fa39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_4c5451b4-d58f-408b-acb3-926ecd50eafc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_9ed94919-32c5-4bce-b013-f4c83d71fc6f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_4c5451b4-d58f-408b-acb3-926ecd50eafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsUnrealizedLossPositionMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_eb95e687-443a-4406-a80d-79bde5b5dc55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8cb7ab6d-0c05-4c88-be79-63a78cb65427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_eb95e687-443a-4406-a80d-79bde5b5dc55" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8cb7ab6d-0c05-4c88-be79-63a78cb65427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0f3ba5c3-797a-4b20-bfac-4d63c4854ad5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8cb7ab6d-0c05-4c88-be79-63a78cb65427" xlink:to="loc_srt_ProductOrServiceAxis_0f3ba5c3-797a-4b20-bfac-4d63c4854ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e62e47cd-6004-4f53-8adc-91a6848437ae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_0f3ba5c3-797a-4b20-bfac-4d63c4854ad5" xlink:to="loc_srt_ProductsAndServicesDomain_e62e47cd-6004-4f53-8adc-91a6848437ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_746f8ba8-f850-48f7-8901-6a371080cb29" xlink:href="cvs-20211231.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e62e47cd-6004-4f53-8adc-91a6848437ae" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_746f8ba8-f850-48f7-8901-6a371080cb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingRemainingProductsMember_a20a40c1-bc69-4234-a442-8f9a999cb195" xlink:href="cvs-20211231.xsd#cvs_SupportingRemainingProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e62e47cd-6004-4f53-8adc-91a6848437ae" xlink:to="loc_cvs_SupportingRemainingProductsMember_a20a40c1-bc69-4234-a442-8f9a999cb195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_467af509-9c37-454b-a3ef-a823f0107d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8cb7ab6d-0c05-4c88-be79-63a78cb65427" xlink:to="loc_us-gaap_FinancialInstrumentAxis_467af509-9c37-454b-a3ef-a823f0107d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca6e9832-04ee-42f4-babd-1a3d8a597907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_467af509-9c37-454b-a3ef-a823f0107d19" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca6e9832-04ee-42f4-babd-1a3d8a597907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_2f78216a-c055-4895-b65d-a800508011f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca6e9832-04ee-42f4-babd-1a3d8a597907" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_2f78216a-c055-4895-b65d-a800508011f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ff7f5bf6-6bc6-408d-b473-3fb69a647fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca6e9832-04ee-42f4-babd-1a3d8a597907" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_ff7f5bf6-6bc6-408d-b473-3fb69a647fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_896f2f06-c55b-47a3-a6f5-a4a9471d4708" xlink:href="cvs-20211231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ca6e9832-04ee-42f4-babd-1a3d8a597907" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_896f2f06-c55b-47a3-a6f5-a4a9471d4708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5e4893dc-f67e-4dcf-ae25-dfb9cb5ad311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8cb7ab6d-0c05-4c88-be79-63a78cb65427" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5e4893dc-f67e-4dcf-ae25-dfb9cb5ad311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_fb8ade5d-1d0d-4e7f-a26e-4ce6a3400a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5e4893dc-f67e-4dcf-ae25-dfb9cb5ad311" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_fb8ade5d-1d0d-4e7f-a26e-4ce6a3400a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_e44f98fb-fdce-421f-85c2-e3fdc8952138" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_fb8ade5d-1d0d-4e7f-a26e-4ce6a3400a83" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear_e44f98fb-fdce-421f-85c2-e3fdc8952138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_0b037852-164a-427f-ad14-4f4b12bc517a" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_fb8ade5d-1d0d-4e7f-a26e-4ce6a3400a83" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears_0b037852-164a-427f-ad14-4f4b12bc517a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_11e31841-81af-4c3c-bceb-88930f798f46" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_fb8ade5d-1d0d-4e7f-a26e-4ce6a3400a83" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears_11e31841-81af-4c3c-bceb-88930f798f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_42779de2-c7b4-4bae-8121-f1386e049898" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_fb8ade5d-1d0d-4e7f-a26e-4ce6a3400a83" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears_42779de2-c7b4-4bae-8121-f1386e049898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_b6df4f24-b50a-4268-afb9-5cf3614fc6b5" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_fb8ade5d-1d0d-4e7f-a26e-4ce6a3400a83" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue_b6df4f24-b50a-4268-afb9-5cf3614fc6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_8cff124a-fa89-46d1-a954-7d2ec4002c02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_fb8ade5d-1d0d-4e7f-a26e-4ce6a3400a83" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_8cff124a-fa89-46d1-a954-7d2ec4002c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_619e7e94-1093-47ac-a59c-ed382e5d07c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5e4893dc-f67e-4dcf-ae25-dfb9cb5ad311" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_619e7e94-1093-47ac-a59c-ed382e5d07c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_baa8229b-bb16-4545-9a35-8387b97fd21e" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_619e7e94-1093-47ac-a59c-ed382e5d07c8" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss_baa8229b-bb16-4545-9a35-8387b97fd21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_d70ed7a7-2202-4e69-baa8-4bff2017e306" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_619e7e94-1093-47ac-a59c-ed382e5d07c8" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss_d70ed7a7-2202-4e69-baa8-4bff2017e306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_79ec3c04-ae36-4fc1-b551-a928d9f9919a" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_619e7e94-1093-47ac-a59c-ed382e5d07c8" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss_79ec3c04-ae36-4fc1-b551-a928d9f9919a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_f7b97615-3c14-424c-89bf-bf9f92cafaea" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_619e7e94-1093-47ac-a59c-ed382e5d07c8" xlink:to="loc_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss_f7b97615-3c14-424c-89bf-bf9f92cafaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_5314199a-0b59-4a82-be53-6562afe05223" xlink:href="cvs-20211231.xsd#cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_619e7e94-1093-47ac-a59c-ed382e5d07c8" xlink:to="loc_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost_5314199a-0b59-4a82-be53-6562afe05223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_3b5e800b-d612-4629-aa01-101a1f57c442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_619e7e94-1093-47ac-a59c-ed382e5d07c8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_3b5e800b-d612-4629-aa01-101a1f57c442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsMortgageLoansDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_517dc08c-f1ce-4a85-bbe4-c5b1252fc75c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_d5bd44c5-4445-4f84-bc20-1d086f515f97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_517dc08c-f1ce-4a85-bbe4-c5b1252fc75c" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_d5bd44c5-4445-4f84-bc20-1d086f515f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_986aefdd-0790-446a-91f1-88c993dafcdb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_d5bd44c5-4445-4f84-bc20-1d086f515f97" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_986aefdd-0790-446a-91f1-88c993dafcdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_042fe98a-47e0-46f2-afef-de14c35925bb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_986aefdd-0790-446a-91f1-88c993dafcdb" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_042fe98a-47e0-46f2-afef-de14c35925bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_00de3c2c-3979-42ea-9eee-28fd263d6e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_042fe98a-47e0-46f2-afef-de14c35925bb" xlink:to="loc_us-gaap_CommercialRealEstateMember_00de3c2c-3979-42ea-9eee-28fd263d6e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_f895cad1-bddd-423f-ba50-80fe0df354f2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_d5bd44c5-4445-4f84-bc20-1d086f515f97" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_f895cad1-bddd-423f-ba50-80fe0df354f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_82c9ea1c-f9a3-4123-8997-5c8913b5f764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateNewMortgageLoans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_f895cad1-bddd-423f-ba50-80fe0df354f2" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans_82c9ea1c-f9a3-4123-8997-5c8913b5f764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_99d04866-872a-41df-a205-2a1c8767489c" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateLoansFullyRepaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_f895cad1-bddd-423f-ba50-80fe0df354f2" xlink:to="loc_cvs_MortgageLoansOnRealEstateLoansFullyRepaid_99d04866-872a-41df-a205-2a1c8767489c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_611bad80-ae19-4ac7-bc18-d8d447542953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateForeclosures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_f895cad1-bddd-423f-ba50-80fe0df354f2" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateForeclosures_611bad80-ae19-4ac7-bc18-d8d447542953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsMortgageLoansCreditRatingsIndicatorDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_8bb0030f-ff1e-44d3-a7a2-ddd0a52d108a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_99d5f1f2-6e7d-46d8-b4f1-738bbd51877d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_8bb0030f-ff1e-44d3-a7a2-ddd0a52d108a" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_99d5f1f2-6e7d-46d8-b4f1-738bbd51877d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c5aa6b2a-870d-424e-9d9e-629d346fe25b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_99d5f1f2-6e7d-46d8-b4f1-738bbd51877d" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c5aa6b2a-870d-424e-9d9e-629d346fe25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_91c288d4-ad1c-477b-86c9-23f77f80d98e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_c5aa6b2a-870d-424e-9d9e-629d346fe25b" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_91c288d4-ad1c-477b-86c9-23f77f80d98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_8861a318-96f2-41ea-aad3-230af93d4b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_91c288d4-ad1c-477b-86c9-23f77f80d98e" xlink:to="loc_us-gaap_CommercialRealEstateMember_8861a318-96f2-41ea-aad3-230af93d4b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentAxis_3ff9047a-ecd3-445e-ad32-df31f57e6576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalCreditAssessmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_99d5f1f2-6e7d-46d8-b4f1-738bbd51877d" xlink:to="loc_us-gaap_InternalCreditAssessmentAxis_3ff9047a-ecd3-445e-ad32-df31f57e6576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalCreditAssessmentDomain_18451b24-c399-439e-9d1e-2c712a89adf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalCreditAssessmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentAxis_3ff9047a-ecd3-445e-ad32-df31f57e6576" xlink:to="loc_us-gaap_InternalCreditAssessmentDomain_18451b24-c399-439e-9d1e-2c712a89adf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category1Member_62c02aaf-0587-4cfe-9c47-c56587c5e1f9" xlink:href="cvs-20211231.xsd#cvs_Category1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_18451b24-c399-439e-9d1e-2c712a89adf1" xlink:to="loc_cvs_Category1Member_62c02aaf-0587-4cfe-9c47-c56587c5e1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category2To4Member_e69c7758-7a2e-4ebf-859a-a0a538a664c1" xlink:href="cvs-20211231.xsd#cvs_Category2To4Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_18451b24-c399-439e-9d1e-2c712a89adf1" xlink:to="loc_cvs_Category2To4Member_e69c7758-7a2e-4ebf-859a-a0a538a664c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Categories5and6Member_b006da70-7fb0-493f-a9a4-43fde0f2ef3e" xlink:href="cvs-20211231.xsd#cvs_Categories5and6Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_18451b24-c399-439e-9d1e-2c712a89adf1" xlink:to="loc_cvs_Categories5and6Member_b006da70-7fb0-493f-a9a4-43fde0f2ef3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_Category7Member_26aff81b-fdde-436c-a317-85d645a1fa74" xlink:href="cvs-20211231.xsd#cvs_Category7Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InternalCreditAssessmentDomain_18451b24-c399-439e-9d1e-2c712a89adf1" xlink:to="loc_cvs_Category7Member_26aff81b-fdde-436c-a317-85d645a1fa74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_633164cc-ba33-42ab-8cb8-f58d2f43e55b" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_99d5f1f2-6e7d-46d8-b4f1-738bbd51877d" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_633164cc-ba33-42ab-8cb8-f58d2f43e55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_99b77fe0-612b-41f9-9bb5-2b802e44290a" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateYearOfOriginationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis_633164cc-ba33-42ab-8cb8-f58d2f43e55b" xlink:to="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_99b77fe0-612b-41f9-9bb5-2b802e44290a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodOneMember_1bc65727-a476-44dc-8cfd-d2013114aae8" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_99b77fe0-612b-41f9-9bb5-2b802e44290a" xlink:to="loc_cvs_YearOfOriginationPeriodOneMember_1bc65727-a476-44dc-8cfd-d2013114aae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodTwoMember_bec03062-3732-4e45-8cea-42d3e11c684f" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_99b77fe0-612b-41f9-9bb5-2b802e44290a" xlink:to="loc_cvs_YearOfOriginationPeriodTwoMember_bec03062-3732-4e45-8cea-42d3e11c684f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodThreeMember_b9efcb8e-c67d-4f48-a63b-3b00fbbfbbc1" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_99b77fe0-612b-41f9-9bb5-2b802e44290a" xlink:to="loc_cvs_YearOfOriginationPeriodThreeMember_b9efcb8e-c67d-4f48-a63b-3b00fbbfbbc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFourMember_3517743c-fd63-4a0a-a46f-c44158816295" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPeriodFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_99b77fe0-612b-41f9-9bb5-2b802e44290a" xlink:to="loc_cvs_YearOfOriginationPeriodFourMember_3517743c-fd63-4a0a-a46f-c44158816295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPeriodFiveMember_1ea813ae-892d-46d3-9806-6cd2aa60c429" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPeriodFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_99b77fe0-612b-41f9-9bb5-2b802e44290a" xlink:to="loc_cvs_YearOfOriginationPeriodFiveMember_1ea813ae-892d-46d3-9806-6cd2aa60c429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_e77e53ea-1df7-426e-830b-425c5e0c9ab7" xlink:href="cvs-20211231.xsd#cvs_YearOfOriginationPriorToPeriodFiveMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_MortgageLoansOnRealEstateYearOfOriginationDomain_99b77fe0-612b-41f9-9bb5-2b802e44290a" xlink:to="loc_cvs_YearOfOriginationPriorToPeriodFiveMember_e77e53ea-1df7-426e-830b-425c5e0c9ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_1f01586a-67e0-42b6-80b6-15c8a0353e69" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_99d5f1f2-6e7d-46d8-b4f1-738bbd51877d" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_1f01586a-67e0-42b6-80b6-15c8a0353e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstate_4ace6042-8d78-461c-a8a9-e1b324e11de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_1f01586a-67e0-42b6-80b6-15c8a0353e69" xlink:to="loc_us-gaap_MortgageLoansOnRealEstate_4ace6042-8d78-461c-a8a9-e1b324e11de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_cf5d9cfe-ae18-422f-a9a9-b76edabc3525" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateScheduleTable_0e1ca1e7-d86e-4b35-a447-800043bd8a98" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateScheduleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_cf5d9cfe-ae18-422f-a9a9-b76edabc3525" xlink:to="loc_srt_MortgageLoansOnRealEstateScheduleTable_0e1ca1e7-d86e-4b35-a447-800043bd8a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_2f1fe8a9-b297-4ccf-a673-720ebaafa4cb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_0e1ca1e7-d86e-4b35-a447-800043bd8a98" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_2f1fe8a9-b297-4ccf-a673-720ebaafa4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_9da10927-ee36-43e1-9f85-4ca4ee434b63" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_2f1fe8a9-b297-4ccf-a673-720ebaafa4cb" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_9da10927-ee36-43e1-9f85-4ca4ee434b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialRealEstateMember_8686febe-e107-4cce-9c85-01a8dd96c41d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_9da10927-ee36-43e1-9f85-4ca4ee434b63" xlink:to="loc_us-gaap_CommercialRealEstateMember_8686febe-e107-4cce-9c85-01a8dd96c41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateScheduleTable_0e1ca1e7-d86e-4b35-a447-800043bd8a98" xlink:to="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_fb0002b9-2e73-43f1-adf3-75c2d99b3010" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths_fb0002b9-2e73-43f1-adf3-75c2d99b3010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_ab0a1ca1-7910-40c7-829d-cd07d4e4fda2" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo_ab0a1ca1-7910-40c7-829d-cd07d4e4fda2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_4752dce5-7473-4785-83da-d943921ba1ea" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree_4752dce5-7473-4785-83da-d943921ba1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_82e68b65-1aa0-4fa2-93e1-2f5ecf7c9604" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour_82e68b65-1aa0-4fa2-93e1-2f5ecf7c9604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_aedbb485-da19-4b0d-a033-29e99fd67b35" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive_aedbb485-da19-4b0d-a033-29e99fd67b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_8b9075da-f363-45a4-9fca-66e1ce22f262" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:to="loc_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive_8b9075da-f363-45a4-9fca-66e1ce22f262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_e1d50dfc-5908-4807-a3c3-63c8272579ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateLineItems_201b9298-11a8-473a-b161-fb8f6c293593" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_e1d50dfc-5908-4807-a3c3-63c8272579ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsNetInvestmentIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_d18ec89e-665a-43d5-bda8-e70f4195d400" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6462f089-2c72-4926-9616-2867fcd733b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_d18ec89e-665a-43d5-bda8-e70f4195d400" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6462f089-2c72-4926-9616-2867fcd733b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ec89b056-ff23-4473-898a-56873886bb45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6462f089-2c72-4926-9616-2867fcd733b9" xlink:to="loc_us-gaap_InvestmentTypeAxis_ec89b056-ff23-4473-898a-56873886bb45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_85921385-6f06-48e9-a5a0-8bff3c337b97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_ec89b056-ff23-4473-898a-56873886bb45" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_85921385-6f06-48e9-a5a0-8bff3c337b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_84e0dafa-c7e1-4bf5-9d21-c28f9e72e6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_85921385-6f06-48e9-a5a0-8bff3c337b97" xlink:to="loc_us-gaap_DebtSecuritiesMember_84e0dafa-c7e1-4bf5-9d21-c28f9e72e6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_MortgageLoansMember_5d035b36-ee81-4674-b6a5-c61c311642a9" xlink:href="cvs-20211231.xsd#cvs_MortgageLoansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_85921385-6f06-48e9-a5a0-8bff3c337b97" xlink:to="loc_cvs_MortgageLoansMember_5d035b36-ee81-4674-b6a5-c61c311642a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_b842e145-e3ea-4ee5-8bcd-937c991a1120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_85921385-6f06-48e9-a5a0-8bff3c337b97" xlink:to="loc_us-gaap_OtherInvestmentsMember_b842e145-e3ea-4ee5-8bcd-937c991a1120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4efc3993-9975-417f-a174-ddb5be4178eb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6462f089-2c72-4926-9616-2867fcd733b9" xlink:to="loc_srt_ProductOrServiceAxis_4efc3993-9975-417f-a174-ddb5be4178eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_894079a6-29e8-4f88-a796-167d506c3060" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4efc3993-9975-417f-a174-ddb5be4178eb" xlink:to="loc_srt_ProductsAndServicesDomain_894079a6-29e8-4f88-a796-167d506c3060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SupportingExperienceRatedProductsMember_a35828f3-0ecc-4aa5-937d-2715c7330d0e" xlink:href="cvs-20211231.xsd#cvs_SupportingExperienceRatedProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_894079a6-29e8-4f88-a796-167d506c3060" xlink:to="loc_cvs_SupportingExperienceRatedProductsMember_a35828f3-0ecc-4aa5-937d-2715c7330d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable_6462f089-2c72-4926-9616-2867fcd733b9" xlink:to="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_8b291016-e07f-4a14-b2f6-df10b17e3fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_8b291016-e07f-4a14-b2f6-df10b17e3fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInvestmentExpense_3b325d12-a5b9-43fc-8298-b7b361bdc425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInvestmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:to="loc_us-gaap_InvestmentIncomeInvestmentExpense_3b325d12-a5b9-43fc-8298-b7b361bdc425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_efbdf9ef-fb2e-4a81-864c-8bf2471335f5" xlink:href="cvs-20211231.xsd#cvs_InvestmentIncomeExcludingCapitalGainsorLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:to="loc_cvs_InvestmentIncomeExcludingCapitalGainsorLosses_efbdf9ef-fb2e-4a81-864c-8bf2471335f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_5cb2ca01-2b46-4594-9ff5-ffb013f92bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_5cb2ca01-2b46-4594-9ff5-ffb013f92bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_a34f93f7-cf8b-4ac8-b90b-d30661b10670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:to="loc_us-gaap_InvestmentIncomeNet_a34f93f7-cf8b-4ac8-b90b-d30661b10670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_4509c93f-94da-4c9a-89af-19c1aa5c815d" xlink:href="cvs-20211231.xsd#cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:to="loc_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_4509c93f-94da-4c9a-89af-19c1aa5c815d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_e74fb9fc-eb34-4664-b874-9bd9e82af9cd" xlink:href="cvs-20211231.xsd#cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:to="loc_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_e74fb9fc-eb34-4664-b874-9bd9e82af9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_3c1dac58-043c-4684-99b1-b7aed34888a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems_305f477c-30ff-4fcf-b28d-0343f8364477" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_3c1dac58-043c-4684-99b1-b7aed34888a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#InvestmentsRealizedGainsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAbstract_5b9f374b-7a7f-47d0-a097-dad81bc9c505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_068eeb98-2968-4bea-af68-d1cea6367b71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_5b9f374b-7a7f-47d0-a097-dad81bc9c505" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_068eeb98-2968-4bea-af68-d1cea6367b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_f9be1392-4429-4f6e-8e2b-dbe342028ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_5b9f374b-7a7f-47d0-a097-dad81bc9c505" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_f9be1392-4429-4f6e-8e2b-dbe342028ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_9024ee93-7994-4df5-b7f3-073ad3e49e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAbstract_5b9f374b-7a7f-47d0-a097-dad81bc9c505" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_9024ee93-7994-4df5-b7f3-073ad3e49e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValue" xlink:type="simple" xlink:href="cvs-20211231.xsd#FairValue"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c07b568b-1562-4eb5-9a77-20d99957d19a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_9e00b8f2-2645-4372-a8db-2d1d93a5da8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c07b568b-1562-4eb5-9a77-20d99957d19a" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_9e00b8f2-2645-4372-a8db-2d1d93a5da8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueTables" xlink:type="simple" xlink:href="cvs-20211231.xsd#FairValueTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4e7932ca-362e-47d6-b6f8-47532e62f465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_0893e69a-520e-4685-aa29-a2d57e63f0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4e7932ca-362e-47d6-b6f8-47532e62f465" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_0893e69a-520e-4685-aa29-a2d57e63f0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_c3797a86-dd96-4729-8b7f-8e88dc79c150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4e7932ca-362e-47d6-b6f8-47532e62f465" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_c3797a86-dd96-4729-8b7f-8e88dc79c150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_0d8026b5-d850-4a77-b022-465322a400ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4e7932ca-362e-47d6-b6f8-47532e62f465" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_0d8026b5-d850-4a77-b022-465322a400ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_e9d81c85-6187-4bbc-962f-aecf7937bf63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4e7932ca-362e-47d6-b6f8-47532e62f465" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock_e9d81c85-6187-4bbc-962f-aecf7937bf63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#FairValueFairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2a34a9f8-7ce2-42a5-a4d3-b2261ac96eff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_85ed06d4-ae36-428a-823e-22570385fc50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2a34a9f8-7ce2-42a5-a4d3-b2261ac96eff" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_85ed06d4-ae36-428a-823e-22570385fc50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ebdcb19b-a790-4abf-9f74-494dad9ed01b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_85ed06d4-ae36-428a-823e-22570385fc50" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ebdcb19b-a790-4abf-9f74-494dad9ed01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_96b7459e-28c8-4003-b8e1-17e5d8611319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ebdcb19b-a790-4abf-9f74-494dad9ed01b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_96b7459e-28c8-4003-b8e1-17e5d8611319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_f7b2bfdf-f447-4478-bccd-37c074e4c9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_96b7459e-28c8-4003-b8e1-17e5d8611319" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_f7b2bfdf-f447-4478-bccd-37c074e4c9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_365c2b20-19ea-45e7-be1c-83e8410633ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_85ed06d4-ae36-428a-823e-22570385fc50" xlink:to="loc_us-gaap_FinancialInstrumentAxis_365c2b20-19ea-45e7-be1c-83e8410633ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_365c2b20-19ea-45e7-be1c-83e8410633ed" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_b76841bd-ffb9-4e69-ab76-ec14c34a10fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_b76841bd-ffb9-4e69-ab76-ec14c34a10fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_091e2b14-ae32-4ad9-8dec-12e7b294db83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_091e2b14-ae32-4ad9-8dec-12e7b294db83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_4c8d7fb5-d61a-4133-b084-73c16e7bc9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_4c8d7fb5-d61a-4133-b084-73c16e7bc9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_c1ac463e-7055-453f-ac42-d11d4ead1e42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_c1ac463e-7055-453f-ac42-d11d4ead1e42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d0643808-78e4-4ef2-b7c7-2940feb1ffce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_d0643808-78e4-4ef2-b7c7-2940feb1ffce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_0c4dfdf0-feb3-4100-b06a-f0144de45765" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_0c4dfdf0-feb3-4100-b06a-f0144de45765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_bf5107dc-079c-429c-aaa6-c6a11e04dee8" xlink:href="cvs-20211231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_bf5107dc-079c-429c-aaa6-c6a11e04dee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_eb85af22-a20d-4a86-abbe-0dba31e28b64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9459d8fb-c2d7-4617-a5cf-e7f73299e768" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_eb85af22-a20d-4a86-abbe-0dba31e28b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fc0cf90c-3dd0-4c84-8215-8fead48c47f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_85ed06d4-ae36-428a-823e-22570385fc50" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fc0cf90c-3dd0-4c84-8215-8fead48c47f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f588a1cf-25bb-401b-a5c5-da9b1d6f9012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_fc0cf90c-3dd0-4c84-8215-8fead48c47f2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f588a1cf-25bb-401b-a5c5-da9b1d6f9012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_36501d14-74c8-41d4-982f-cb64429aee21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f588a1cf-25bb-401b-a5c5-da9b1d6f9012" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_36501d14-74c8-41d4-982f-cb64429aee21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_551b7d93-535e-4ec9-a9d0-40a5db1f3736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f588a1cf-25bb-401b-a5c5-da9b1d6f9012" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_551b7d93-535e-4ec9-a9d0-40a5db1f3736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4e28794f-dc3b-40e2-bd3c-2b9083b83a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f588a1cf-25bb-401b-a5c5-da9b1d6f9012" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4e28794f-dc3b-40e2-bd3c-2b9083b83a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ecc76c5a-e1b2-425f-831c-aa4907ac26d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_85ed06d4-ae36-428a-823e-22570385fc50" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ecc76c5a-e1b2-425f-831c-aa4907ac26d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_7cc78049-0dbb-4441-930c-0d893f94c1be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ecc76c5a-e1b2-425f-831c-aa4907ac26d3" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_7cc78049-0dbb-4441-930c-0d893f94c1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b1731ab3-c500-40e2-b8c2-f4448ad29494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ecc76c5a-e1b2-425f-831c-aa4907ac26d3" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b1731ab3-c500-40e2-b8c2-f4448ad29494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_28324c9f-9433-4763-8826-48e121542b08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ecc76c5a-e1b2-425f-831c-aa4907ac26d3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_28324c9f-9433-4763-8826-48e121542b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_21dc247d-431d-40fe-8c97-529dea7dbdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ecc76c5a-e1b2-425f-831c-aa4907ac26d3" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_21dc247d-431d-40fe-8c97-529dea7dbdfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_cfd4f196-cfab-48da-a77d-0ef8f65613ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ecc76c5a-e1b2-425f-831c-aa4907ac26d3" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_cfd4f196-cfab-48da-a77d-0ef8f65613ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#FairValueChangesinLevel3FinancialAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_66ab76e5-19c8-4728-b491-015c182ca30c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9898adbc-b360-4cc4-9fac-6b5d85c8d651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_66ab76e5-19c8-4728-b491-015c182ca30c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9898adbc-b360-4cc4-9fac-6b5d85c8d651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_74c127c6-a62a-4e48-880e-d418b649319c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9898adbc-b360-4cc4-9fac-6b5d85c8d651" xlink:to="loc_us-gaap_FinancialInstrumentAxis_74c127c6-a62a-4e48-880e-d418b649319c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8a7ece9-07c8-462a-900e-a73ad4855b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_74c127c6-a62a-4e48-880e-d418b649319c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8a7ece9-07c8-462a-900e-a73ad4855b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_d46c53b8-6fc9-4148-8a88-99670b2e41ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8a7ece9-07c8-462a-900e-a73ad4855b62" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_d46c53b8-6fc9-4148-8a88-99670b2e41ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_befb60bd-183b-42c1-ab75-8a1511424bda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8a7ece9-07c8-462a-900e-a73ad4855b62" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_befb60bd-183b-42c1-ab75-8a1511424bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember_cecf642e-a5f2-4fe4-90ec-30b316210057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8a7ece9-07c8-462a-900e-a73ad4855b62" xlink:to="loc_us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember_cecf642e-a5f2-4fe4-90ec-30b316210057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAssetBackedSecuritiesMember_0a0c5235-246e-4b04-a927-010057c93dc1" xlink:href="cvs-20211231.xsd#cvs_OtherAssetBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8a7ece9-07c8-462a-900e-a73ad4855b62" xlink:to="loc_cvs_OtherAssetBackedSecuritiesMember_0a0c5235-246e-4b04-a927-010057c93dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemablePreferredStockMember_bf46add9-a4c0-4211-a55b-86b408b9d3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8a7ece9-07c8-462a-900e-a73ad4855b62" xlink:to="loc_us-gaap_RedeemablePreferredStockMember_bf46add9-a4c0-4211-a55b-86b408b9d3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_0838a1ab-73c3-49b3-b829-0f51f31fda00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d8a7ece9-07c8-462a-900e-a73ad4855b62" xlink:to="loc_us-gaap_EquitySecuritiesMember_0838a1ab-73c3-49b3-b829-0f51f31fda00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bcfd319b-a61f-48a1-89ea-40dfeca91dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9898adbc-b360-4cc4-9fac-6b5d85c8d651" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bcfd319b-a61f-48a1-89ea-40dfeca91dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f5c81019-b44b-4505-8ec2-db32a5524f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_bcfd319b-a61f-48a1-89ea-40dfeca91dcc" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f5c81019-b44b-4505-8ec2-db32a5524f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_21d58205-0ef7-4388-aef7-1eacbc1df5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f5c81019-b44b-4505-8ec2-db32a5524f5d" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_21d58205-0ef7-4388-aef7-1eacbc1df5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_13d4255c-224f-4fc9-95bb-a46bbb032f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9898adbc-b360-4cc4-9fac-6b5d85c8d651" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_13d4255c-224f-4fc9-95bb-a46bbb032f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_378a232c-f190-4f36-a2f6-82f5e06fa13d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_13d4255c-224f-4fc9-95bb-a46bbb032f9c" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_378a232c-f190-4f36-a2f6-82f5e06fa13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_b9caaa87-e96f-46d8-b2e0-efe986a8616b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_378a232c-f190-4f36-a2f6-82f5e06fa13d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_b9caaa87-e96f-46d8-b2e0-efe986a8616b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_9e1d08dc-4423-4e64-94f3-f2443404231f" xlink:href="cvs-20211231.xsd#cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_378a232c-f190-4f36-a2f6-82f5e06fa13d" xlink:to="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_9e1d08dc-4423-4e64-94f3-f2443404231f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_64d1ec45-1e38-4edc-820e-783220155707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_9e1d08dc-4423-4e64-94f3-f2443404231f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_64d1ec45-1e38-4edc-820e-783220155707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_85d5a873-22a4-4748-bf58-96e9df7f24ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract_9e1d08dc-4423-4e64-94f3-f2443404231f" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_85d5a873-22a4-4748-bf58-96e9df7f24ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_718ab892-d53b-4328-828a-efed9c56c6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_378a232c-f190-4f36-a2f6-82f5e06fa13d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_718ab892-d53b-4328-828a-efed9c56c6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_20833112-71f5-4f88-9227-01cae46dd7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_378a232c-f190-4f36-a2f6-82f5e06fa13d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_20833112-71f5-4f88-9227-01cae46dd7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_909fcb64-e95d-48e0-9e00-13f681e41911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_378a232c-f190-4f36-a2f6-82f5e06fa13d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_909fcb64-e95d-48e0-9e00-13f681e41911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_cea29adb-049b-45ed-8b2c-c6ae5458ac9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_378a232c-f190-4f36-a2f6-82f5e06fa13d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_cea29adb-049b-45ed-8b2c-c6ae5458ac9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_2a12bf0b-2c6b-4cac-aade-0c3f4d39b4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_378a232c-f190-4f36-a2f6-82f5e06fa13d" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_2a12bf0b-2c6b-4cac-aade-0c3f4d39b4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_c65dfdff-606d-46e2-985a-bba2b139f69e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_13d4255c-224f-4fc9-95bb-a46bbb032f9c" xlink:to="loc_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci_c65dfdff-606d-46e2-985a-bba2b139f69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="simple" xlink:href="cvs-20211231.xsd#FairValueGrossTransfersIntoOutOfLevel3Details"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_56efd2c9-cf0b-4442-860b-392bbd827e7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3703ac3d-5a84-4bed-af3e-717d9e838549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_56efd2c9-cf0b-4442-860b-392bbd827e7d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3703ac3d-5a84-4bed-af3e-717d9e838549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_35c4ce8f-dbed-4246-ba09-cf88c5e68e92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3703ac3d-5a84-4bed-af3e-717d9e838549" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_35c4ce8f-dbed-4246-ba09-cf88c5e68e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_90bd5d79-f047-4258-83ce-4fa1ab300c66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_35c4ce8f-dbed-4246-ba09-cf88c5e68e92" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_90bd5d79-f047-4258-83ce-4fa1ab300c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_41c44b4e-14df-4c63-aa2a-22ca117c92e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_90bd5d79-f047-4258-83ce-4fa1ab300c66" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_41c44b4e-14df-4c63-aa2a-22ca117c92e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f5aa868a-2d41-4bd1-94b4-6979c16a2f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3703ac3d-5a84-4bed-af3e-717d9e838549" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f5aa868a-2d41-4bd1-94b4-6979c16a2f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d1d5d219-31b5-4f75-955f-7136eebaf83b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f5aa868a-2d41-4bd1-94b4-6979c16a2f1d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d1d5d219-31b5-4f75-955f-7136eebaf83b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_a0919d2f-a8fa-4b39-912e-9f3e0afe3613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d1d5d219-31b5-4f75-955f-7136eebaf83b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_a0919d2f-a8fa-4b39-912e-9f3e0afe3613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4bcc1308-263c-4175-882b-73851fc21fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_3703ac3d-5a84-4bed-af3e-717d9e838549" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4bcc1308-263c-4175-882b-73851fc21fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_410b89af-a476-4bec-9d1b-ed84204157a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4bcc1308-263c-4175-882b-73851fc21fb6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_410b89af-a476-4bec-9d1b-ed84204157a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_f310e4fc-16ce-40c3-ae66-b7a06577463a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4bcc1308-263c-4175-882b-73851fc21fb6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_f310e4fc-16ce-40c3-ae66-b7a06577463a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_2d721781-66b3-4acb-b0f5-6f99f566d1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4bcc1308-263c-4175-882b-73851fc21fb6" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_2d721781-66b3-4acb-b0f5-6f99f566d1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#FairValueCarryingValueandFairValueClassifiedbyLevelDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9d952b4a-b229-4db5-aae1-1a6815384b13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_181cc323-7880-4be6-90be-2c4ef96d91c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9d952b4a-b229-4db5-aae1-1a6815384b13" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_181cc323-7880-4be6-90be-2c4ef96d91c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f501303a-d7d6-44da-aeed-97d659498bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_181cc323-7880-4be6-90be-2c4ef96d91c1" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f501303a-d7d6-44da-aeed-97d659498bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c07934cd-8765-4955-b6d2-d603b01f0439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f501303a-d7d6-44da-aeed-97d659498bf5" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c07934cd-8765-4955-b6d2-d603b01f0439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_3b5a1afe-0204-4462-9f4d-c5a52cd60f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c07934cd-8765-4955-b6d2-d603b01f0439" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_3b5a1afe-0204-4462-9f4d-c5a52cd60f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_61a0aa82-1611-458d-b052-0b48b3810c40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_181cc323-7880-4be6-90be-2c4ef96d91c1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_61a0aa82-1611-458d-b052-0b48b3810c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ac64c27-3308-47d7-bb10-1b53e0f0e7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_61a0aa82-1611-458d-b052-0b48b3810c40" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ac64c27-3308-47d7-bb10-1b53e0f0e7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_73084201-8537-42a1-a7e8-8363eef42d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ac64c27-3308-47d7-bb10-1b53e0f0e7e6" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_73084201-8537-42a1-a7e8-8363eef42d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_5dbc41e7-c188-4e0f-8239-31d49d46dba4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ac64c27-3308-47d7-bb10-1b53e0f0e7e6" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_5dbc41e7-c188-4e0f-8239-31d49d46dba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_791b4726-77a1-4f89-ae42-ccf0142bf87c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ac64c27-3308-47d7-bb10-1b53e0f0e7e6" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_791b4726-77a1-4f89-ae42-ccf0142bf87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_d139ef85-5843-421c-9814-80167eb05379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_181cc323-7880-4be6-90be-2c4ef96d91c1" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_d139ef85-5843-421c-9814-80167eb05379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5f41c4af-f417-4ce3-a8f7-3c274dbb30cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_d139ef85-5843-421c-9814-80167eb05379" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5f41c4af-f417-4ce3-a8f7-3c274dbb30cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_06ca8ece-937b-4007-bf80-43138801efc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_5f41c4af-f417-4ce3-a8f7-3c274dbb30cc" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_06ca8ece-937b-4007-bf80-43138801efc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_be1cfae7-38fd-4cc8-96cc-f4ef0a78c163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_06ca8ece-937b-4007-bf80-43138801efc5" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_be1cfae7-38fd-4cc8-96cc-f4ef0a78c163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_aedcda99-02f2-47a7-b664-f4b79eebfb42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_06ca8ece-937b-4007-bf80-43138801efc5" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_aedcda99-02f2-47a7-b664-f4b79eebfb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f3038b02-2328-42c0-873c-ef2be9f42601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_181cc323-7880-4be6-90be-2c4ef96d91c1" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f3038b02-2328-42c0-873c-ef2be9f42601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5994f7d7-06a8-4474-ba14-97fef457ff12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f3038b02-2328-42c0-873c-ef2be9f42601" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5994f7d7-06a8-4474-ba14-97fef457ff12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_e783a50c-1798-46c4-928a-edef978feaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MortgagesHeldForSaleFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5994f7d7-06a8-4474-ba14-97fef457ff12" xlink:to="loc_us-gaap_MortgagesHeldForSaleFairValueDisclosure_e783a50c-1798-46c4-928a-edef978feaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_97284a5f-1fd8-48e1-8829-330b498782bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_5994f7d7-06a8-4474-ba14-97fef457ff12" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_97284a5f-1fd8-48e1-8829-330b498782bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_38886806-2fd5-4e31-9905-f0dfdb62a433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_f3038b02-2328-42c0-873c-ef2be9f42601" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_38886806-2fd5-4e31-9905-f0dfdb62a433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_25513aac-11fd-450f-8ce3-a3c8ad4ff9d9" xlink:href="cvs-20211231.xsd#cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_38886806-2fd5-4e31-9905-f0dfdb62a433" xlink:to="loc_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure_25513aac-11fd-450f-8ce3-a3c8ad4ff9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_1726b3c9-fa53-481c-b449-82ab51447269" xlink:href="cvs-20211231.xsd#cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_38886806-2fd5-4e31-9905-f0dfdb62a433" xlink:to="loc_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure_1726b3c9-fa53-481c-b449-82ab51447269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_a110fc07-3043-4e87-9d49-81d2d00548b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_38886806-2fd5-4e31-9905-f0dfdb62a433" xlink:to="loc_us-gaap_DebtInstrumentFairValue_a110fc07-3043-4e87-9d49-81d2d00548b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#FairValueSeparateAccountsFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4c81354f-4987-4ed6-ad74-2cb50bb1c7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_9edb180f-17c2-47e8-add8-e1b60d26ae0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4c81354f-4987-4ed6-ad74-2cb50bb1c7b3" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_9edb180f-17c2-47e8-add8-e1b60d26ae0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d423fc4e-7b07-4334-ae3b-d34805bfac58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_9edb180f-17c2-47e8-add8-e1b60d26ae0d" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d423fc4e-7b07-4334-ae3b-d34805bfac58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_79250e2a-4474-489a-a905-26da30d869f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d423fc4e-7b07-4334-ae3b-d34805bfac58" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_79250e2a-4474-489a-a905-26da30d869f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_59a9a11e-1f0e-4dbd-ac38-6618127da789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_79250e2a-4474-489a-a905-26da30d869f2" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_59a9a11e-1f0e-4dbd-ac38-6618127da789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37e99e2c-13ed-4703-ab5d-db337c0a051c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_9edb180f-17c2-47e8-add8-e1b60d26ae0d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37e99e2c-13ed-4703-ab5d-db337c0a051c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_655f2d9f-5438-43dd-a918-0739553eb373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37e99e2c-13ed-4703-ab5d-db337c0a051c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_655f2d9f-5438-43dd-a918-0739553eb373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4c85a250-497d-4083-91b5-512e9a78530c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_655f2d9f-5438-43dd-a918-0739553eb373" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4c85a250-497d-4083-91b5-512e9a78530c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_7a4853f2-a3ad-45ea-aa18-b13654f2ec8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_655f2d9f-5438-43dd-a918-0739553eb373" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_7a4853f2-a3ad-45ea-aa18-b13654f2ec8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_85d4d87e-ab1f-40f4-a165-b817daf50248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_655f2d9f-5438-43dd-a918-0739553eb373" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_85d4d87e-ab1f-40f4-a165-b817daf50248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis_820479b4-9b62-4322-9c50-64eafe74cf89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_9edb180f-17c2-47e8-add8-e1b60d26ae0d" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryAxis_820479b4-9b62-4322-9c50-64eafe74cf89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_02e38347-1684-45ff-99bb-96b85c054dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_820479b4-9b62-4322-9c50-64eafe74cf89" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_02e38347-1684-45ff-99bb-96b85c054dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_13a48b57-e7c4-402a-b206-24407461b5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_02e38347-1684-45ff-99bb-96b85c054dc3" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_13a48b57-e7c4-402a-b206-24407461b5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_8528027f-d8b3-4e48-9951-2ccdb16cf795" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_02e38347-1684-45ff-99bb-96b85c054dc3" xlink:to="loc_us-gaap_DebtSecuritiesMember_8528027f-d8b3-4e48-9951-2ccdb16cf795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_75380002-8031-4738-8548-95864c549b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_02e38347-1684-45ff-99bb-96b85c054dc3" xlink:to="loc_us-gaap_EquitySecuritiesMember_75380002-8031-4738-8548-95864c549b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CommonAndCollectiveTrustsMember_9056731c-f7f7-41f6-bc83-3ee0584ab805" xlink:href="cvs-20211231.xsd#cvs_CommonAndCollectiveTrustsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_02e38347-1684-45ff-99bb-96b85c054dc3" xlink:to="loc_cvs_CommonAndCollectiveTrustsMember_9056731c-f7f7-41f6-bc83-3ee0584ab805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeparateAccountFinancialAssetsMember_6b1523ad-fe0b-41ff-8df4-45136fb4edbb" xlink:href="cvs-20211231.xsd#cvs_SeparateAccountFinancialAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_02e38347-1684-45ff-99bb-96b85c054dc3" xlink:to="loc_cvs_SeparateAccountFinancialAssetsMember_6b1523ad-fe0b-41ff-8df4-45136fb4edbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_1b70b9b5-30ce-4c1e-bceb-b5c38db14b26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_9edb180f-17c2-47e8-add8-e1b60d26ae0d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_1b70b9b5-30ce-4c1e-bceb-b5c38db14b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_ca4e5bb1-bf68-4926-bfaa-09ed3d5b8abf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_1b70b9b5-30ce-4c1e-bceb-b5c38db14b26" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_ca4e5bb1-bf68-4926-bfaa-09ed3d5b8abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_1c9c43e0-0a3f-4026-9140-3fa7fa0e3134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_ca4e5bb1-bf68-4926-bfaa-09ed3d5b8abf" xlink:to="loc_us-gaap_AccountsReceivableMember_1c9c43e0-0a3f-4026-9140-3fa7fa0e3134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_0c60bd34-9fa8-4ec6-9fab-2136471dbe36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable_9edb180f-17c2-47e8-add8-e1b60d26ae0d" xlink:to="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_0c60bd34-9fa8-4ec6-9fab-2136471dbe36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssets_5f460877-107d-43a4-8308-8f00b6da2c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems_0c60bd34-9fa8-4ec6-9fab-2136471dbe36" xlink:to="loc_us-gaap_SeparateAccountAssets_5f460877-107d-43a4-8308-8f00b6da2c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/FairValueNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#FairValueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/FairValueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAbstract_b21965c8-196b-4297-9aa0-16a33e62f478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_73010ee9-3b6f-47b2-b478-cefb7511b6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAbstract_b21965c8-196b-4297-9aa0-16a33e62f478" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_73010ee9-3b6f-47b2-b478-cefb7511b6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_308f411a-b553-4842-85da-17cdcea713c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_73010ee9-3b6f-47b2-b478-cefb7511b6c5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_308f411a-b553-4842-85da-17cdcea713c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_97264735-e961-47a2-a16c-e7b6da0757c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_308f411a-b553-4842-85da-17cdcea713c6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_97264735-e961-47a2-a16c-e7b6da0757c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_6d74d9cb-a630-420f-8de2-5e20a5128184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_97264735-e961-47a2-a16c-e7b6da0757c8" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_6d74d9cb-a630-420f-8de2-5e20a5128184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0902638a-159f-4403-adba-f1160c001ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_73010ee9-3b6f-47b2-b478-cefb7511b6c5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0902638a-159f-4403-adba-f1160c001ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_da91774b-65c7-42b8-b7d5-76adbb530422" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0902638a-159f-4403-adba-f1160c001ed0" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_da91774b-65c7-42b8-b7d5-76adbb530422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_53952d9b-3b9a-497f-a1f5-c643f2a452a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_da91774b-65c7-42b8-b7d5-76adbb530422" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_53952d9b-3b9a-497f-a1f5-c643f2a452a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryAxis_9501bd23-c615-45c3-bda6-1c9fd350466c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssetCategoryAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_73010ee9-3b6f-47b2-b478-cefb7511b6c5" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryAxis_9501bd23-c615-45c3-bda6-1c9fd350466c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeparateAccountAssetCategoryDomain_d372f6d3-bb1a-4396-b2ed-609190ef72c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeparateAccountAssetCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryAxis_9501bd23-c615-45c3-bda6-1c9fd350466c" xlink:to="loc_us-gaap_SeparateAccountAssetCategoryDomain_d372f6d3-bb1a-4396-b2ed-609190ef72c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeparateAccountFinancialAssetsMember_92ebcd06-4256-48a3-a786-3cd487ca02c1" xlink:href="cvs-20211231.xsd#cvs_SeparateAccountFinancialAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeparateAccountAssetCategoryDomain_d372f6d3-bb1a-4396-b2ed-609190ef72c4" xlink:to="loc_cvs_SeparateAccountFinancialAssetsMember_92ebcd06-4256-48a3-a786-3cd487ca02c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b002e6c1-5e05-41b0-9bf0-309c02cfbbd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_73010ee9-3b6f-47b2-b478-cefb7511b6c5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b002e6c1-5e05-41b0-9bf0-309c02cfbbd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_7e6e9ad0-fcd2-42d6-ba02-b7a1aa0feb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b002e6c1-5e05-41b0-9bf0-309c02cfbbd9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_7e6e9ad0-fcd2-42d6-ba02-b7a1aa0feb5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangibles" xlink:type="simple" xlink:href="cvs-20211231.xsd#GoodwillandOtherIntangibles"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangibles" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e0e49936-affc-4e8c-9665-a32ad3c3b467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_33b099d2-29a6-49ac-b4f0-87d5d1e58360" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e0e49936-affc-4e8c-9665-a32ad3c3b467" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_33b099d2-29a6-49ac-b4f0-87d5d1e58360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables" xlink:type="simple" xlink:href="cvs-20211231.xsd#GoodwillandOtherIntangiblesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_94f73895-25e0-44de-9e30-8ceccae5bb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_7044e149-277c-48c5-8a8c-6d27f4c6d0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_94f73895-25e0-44de-9e30-8ceccae5bb6e" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_7044e149-277c-48c5-8a8c-6d27f4c6d0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock_bfaf096d-2e34-459e-9209-75305f9c6e30" xlink:href="cvs-20211231.xsd#cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_94f73895-25e0-44de-9e30-8ceccae5bb6e" xlink:to="loc_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock_bfaf096d-2e34-459e-9209-75305f9c6e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_dfeaaaa7-bbfd-405a-ab28-8a4e2f467be1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_94f73895-25e0-44de-9e30-8ceccae5bb6e" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_dfeaaaa7-bbfd-405a-ab28-8a4e2f467be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#GoodwillandOtherIntangiblesGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_735be54d-f360-4d93-8e41-238a360de4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_c6d4c423-a97b-4201-a43d-6c3dd393f46f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_735be54d-f360-4d93-8e41-238a360de4c2" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_c6d4c423-a97b-4201-a43d-6c3dd393f46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6b5cdc60-7161-4cea-a1d7-92fd323f5111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c6d4c423-a97b-4201-a43d-6c3dd393f46f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6b5cdc60-7161-4cea-a1d7-92fd323f5111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0d0d1c56-d3d2-46a1-abf5-0f4f29d72252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6b5cdc60-7161-4cea-a1d7-92fd323f5111" xlink:to="loc_us-gaap_SegmentDomain_0d0d1c56-d3d2-46a1-abf5-0f4f29d72252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_c17a6a0a-1ed0-43a4-8061-f15616fd4712" xlink:href="cvs-20211231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0d0d1c56-d3d2-46a1-abf5-0f4f29d72252" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_c17a6a0a-1ed0-43a4-8061-f15616fd4712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_02e9cdaf-fe42-4325-b0eb-f1b58981f95d" xlink:href="cvs-20211231.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0d0d1c56-d3d2-46a1-abf5-0f4f29d72252" xlink:to="loc_cvs_PharmacyServicesSegmentMember_02e9cdaf-fe42-4325-b0eb-f1b58981f95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_4c25ab2c-f03a-452b-aa42-9bc980533b38" xlink:href="cvs-20211231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0d0d1c56-d3d2-46a1-abf5-0f4f29d72252" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_4c25ab2c-f03a-452b-aa42-9bc980533b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_741cafa4-3be0-4397-9173-a6942bc421da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_c6d4c423-a97b-4201-a43d-6c3dd393f46f" xlink:to="loc_us-gaap_GoodwillLineItems_741cafa4-3be0-4397-9173-a6942bc421da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_134ac382-a551-47e7-9b87-d00f5d61e07d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_741cafa4-3be0-4397-9173-a6942bc421da" xlink:to="loc_us-gaap_GoodwillRollForward_134ac382-a551-47e7-9b87-d00f5d61e07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_7af16205-946e-43ed-b07e-1f5ceb3e53db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_134ac382-a551-47e7-9b87-d00f5d61e07d" xlink:to="loc_us-gaap_Goodwill_7af16205-946e-43ed-b07e-1f5ceb3e53db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_0728955c-6792-4784-bb46-cbdf9efa43a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_134ac382-a551-47e7-9b87-d00f5d61e07d" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_0728955c-6792-4784-bb46-cbdf9efa43a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_a1699da2-eb18-4cce-9bce-d7b5cd8d2648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_134ac382-a551-47e7-9b87-d00f5d61e07d" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_a1699da2-eb18-4cce-9bce-d7b5cd8d2648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_736a4ada-3a86-464c-8aa3-7eac13d92b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_134ac382-a551-47e7-9b87-d00f5d61e07d" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_736a4ada-3a86-464c-8aa3-7eac13d92b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9af159ed-2123-4c8e-9290-1c0d2c4cef4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_134ac382-a551-47e7-9b87-d00f5d61e07d" xlink:to="loc_us-gaap_Goodwill_9af159ed-2123-4c8e-9290-1c0d2c4cef4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#GoodwillandOtherIntangiblesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9b483da6-3518-44bc-9e11-ae334f4d3ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_f31604e6-3e5f-41d4-a64a-927cce5573e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9b483da6-3518-44bc-9e11-ae334f4d3ff2" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_f31604e6-3e5f-41d4-a64a-927cce5573e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_f08e0712-5ce4-40be-a027-5a5152c90a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f31604e6-3e5f-41d4-a64a-927cce5573e9" xlink:to="loc_us-gaap_ReportingUnitAxis_f08e0712-5ce4-40be-a027-5a5152c90a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_f84cd41d-4101-4790-bf48-90ec429bda0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_f08e0712-5ce4-40be-a027-5a5152c90a94" xlink:to="loc_us-gaap_ReportingUnitDomain_f84cd41d-4101-4790-bf48-90ec429bda0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongTermCareReportingUnitMember_9bfc0723-1e89-4bcc-9b49-eaeeb3fac2a0" xlink:href="cvs-20211231.xsd#cvs_LongTermCareReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_f84cd41d-4101-4790-bf48-90ec429bda0b" xlink:to="loc_cvs_LongTermCareReportingUnitMember_9bfc0723-1e89-4bcc-9b49-eaeeb3fac2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2fb09592-9b0e-4146-bc8c-869a1ec133c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f31604e6-3e5f-41d4-a64a-927cce5573e9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2fb09592-9b0e-4146-bc8c-869a1ec133c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b23ef1aa-28b8-46ef-83ca-f827a293918e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2fb09592-9b0e-4146-bc8c-869a1ec133c9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b23ef1aa-28b8-46ef-83ca-f827a293918e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerListsMember_35dc9aee-8ea6-4aa4-ba8e-de3d6343fa8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerListsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b23ef1aa-28b8-46ef-83ca-f827a293918e" xlink:to="loc_us-gaap_CustomerListsMember_35dc9aee-8ea6-4aa4-ba8e-de3d6343fa8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_d8355d52-fb57-4b97-9489-e704aa9a9821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_f31604e6-3e5f-41d4-a64a-927cce5573e9" xlink:to="loc_us-gaap_GoodwillLineItems_d8355d52-fb57-4b97-9489-e704aa9a9821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_66cbc3fc-b95b-4251-b4fa-8730268ac333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d8355d52-fb57-4b97-9489-e704aa9a9821" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_66cbc3fc-b95b-4251-b4fa-8730268ac333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2944de8c-2f02-4136-876e-d37083fe000d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d8355d52-fb57-4b97-9489-e704aa9a9821" xlink:to="loc_us-gaap_Goodwill_2944de8c-2f02-4136-876e-d37083fe000d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_54cd1680-923d-45e5-9ff9-bac22e8b98e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d8355d52-fb57-4b97-9489-e704aa9a9821" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_54cd1680-923d-45e5-9ff9-bac22e8b98e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c8f687ce-e544-485d-8d5b-a362615c4124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_d8355d52-fb57-4b97-9489-e704aa9a9821" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_c8f687ce-e544-485d-8d5b-a362615c4124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#GoodwillandOtherIntangiblesIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1ae24a29-7ed1-4246-b843-0ab18f1adc06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsTable_63158502-8acd-42b8-9941-2349c4270975" xlink:href="cvs-20211231.xsd#cvs_OtherAcquiredIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1ae24a29-7ed1-4246-b843-0ab18f1adc06" xlink:to="loc_cvs_OtherAcquiredIntangibleAssetsTable_63158502-8acd-42b8-9941-2349c4270975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd79aa3c-fcda-4133-8df6-5a999247646d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable_63158502-8acd-42b8-9941-2349c4270975" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd79aa3c-fcda-4133-8df6-5a999247646d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb4667dd-e990-4c77-b89c-2fd04d71adf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd79aa3c-fcda-4133-8df6-5a999247646d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb4667dd-e990-4c77-b89c-2fd04d71adf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_015d1609-c49c-47a7-bfd7-b7fb2d600379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelatedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb4667dd-e990-4c77-b89c-2fd04d71adf7" xlink:to="loc_us-gaap_CustomerRelatedIntangibleAssetsMember_015d1609-c49c-47a7-bfd7-b7fb2d600379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_00e63fb2-38fc-47ac-b3a2-6e9c5780c1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb4667dd-e990-4c77-b89c-2fd04d71adf7" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_00e63fb2-38fc-47ac-b3a2-6e9c5780c1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ProviderNetworksMember_7d9d3ba9-1af8-4154-9340-072146468a68" xlink:href="cvs-20211231.xsd#cvs_ProviderNetworksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb4667dd-e990-4c77-b89c-2fd04d71adf7" xlink:to="loc_cvs_ProviderNetworksMember_7d9d3ba9-1af8-4154-9340-072146468a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ValueOfBusinessAcquiredMember_e9179423-4edc-44f8-8783-e9932b63b866" xlink:href="cvs-20211231.xsd#cvs_ValueOfBusinessAcquiredMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb4667dd-e990-4c77-b89c-2fd04d71adf7" xlink:to="loc_cvs_ValueOfBusinessAcquiredMember_e9179423-4edc-44f8-8783-e9932b63b866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_29533541-d01d-4e32-9562-6b60c028c342" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cb4667dd-e990-4c77-b89c-2fd04d71adf7" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_29533541-d01d-4e32-9562-6b60c028c342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:href="cvs-20211231.xsd#cvs_OtherAcquiredIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsTable_63158502-8acd-42b8-9941-2349c4270975" xlink:to="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_79ec5c0a-4a9e-46fa-91b9-4deaaa795d05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_79ec5c0a-4a9e-46fa-91b9-4deaaa795d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6155d101-8d70-47ad-b014-25147a283cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_6155d101-8d70-47ad-b014-25147a283cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e738b600-2981-4b98-bed7-46eb44d7f943" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e738b600-2981-4b98-bed7-46eb44d7f943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c493f989-7884-48b6-b149-5c54c02df0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c493f989-7884-48b6-b149-5c54c02df0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_24be0721-acf1-4c6b-bd8a-3244bf96f883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_24be0721-acf1-4c6b-bd8a-3244bf96f883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_73b287e8-6a4b-4233-9a59-a381ae8260c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_73b287e8-6a4b-4233-9a59-a381ae8260c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_a0fbb459-ea71-49bd-bc7e-f323ffd974c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension_a0fbb459-ea71-49bd-bc7e-f323ffd974c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7130f8bd-7087-4b32-ba12-15d3fe78b2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OtherAcquiredIntangibleAssetsLineItems_b1636aeb-4500-40ee-b6fd-bd1eb9ed385a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7130f8bd-7087-4b32-ba12-15d3fe78b2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f814f50-c807-4704-8864-d562342d03ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_fed5e89a-3af4-46ed-a1e6-caff2a043b75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9f814f50-c807-4704-8864-d562342d03ee" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_fed5e89a-3af4-46ed-a1e6-caff2a043b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f72c8641-2584-4a95-93b7-a963d3cfd4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_fed5e89a-3af4-46ed-a1e6-caff2a043b75" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f72c8641-2584-4a95-93b7-a963d3cfd4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0e5b82da-73ee-4c51-9d44-330091bf7d80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_fed5e89a-3af4-46ed-a1e6-caff2a043b75" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0e5b82da-73ee-4c51-9d44-330091bf7d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b0746066-fd9c-424b-b62e-74107ac770ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_fed5e89a-3af4-46ed-a1e6-caff2a043b75" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b0746066-fd9c-424b-b62e-74107ac770ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cdf5fe85-41f9-4657-80a0-ecbc74a1a1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_fed5e89a-3af4-46ed-a1e6-caff2a043b75" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_cdf5fe85-41f9-4657-80a0-ecbc74a1a1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_20d45ff4-9635-4c38-b6f6-a9b13b9d690e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_fed5e89a-3af4-46ed-a1e6-caff2a043b75" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_20d45ff4-9635-4c38-b6f6-a9b13b9d690e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Leases" xlink:type="simple" xlink:href="cvs-20211231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ea9de6b9-db69-4f65-b4e4-e97edfa4c77c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_4b6e2668-ab0e-4413-8043-1f8008688727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ea9de6b9-db69-4f65-b4e4-e97edfa4c77c" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_4b6e2668-ab0e-4413-8043-1f8008688727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_fad76930-0d2d-4679-a5fb-74df120a0197" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ea9de6b9-db69-4f65-b4e4-e97edfa4c77c" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_fad76930-0d2d-4679-a5fb-74df120a0197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesTables" xlink:type="simple" xlink:href="cvs-20211231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_94e31aeb-c745-41ec-998f-e88122b4226d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_94e7fd79-1804-4b3c-82e5-2770c743777d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_94e31aeb-c745-41ec-998f-e88122b4226d" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_94e7fd79-1804-4b3c-82e5-2770c743777d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLeaseTableTextBlock_4d48c270-23d0-424d-936a-e072d85723c9" xlink:href="cvs-20211231.xsd#cvs_LesseeLeaseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_94e31aeb-c745-41ec-998f-e88122b4226d" xlink:to="loc_cvs_LesseeLeaseTableTextBlock_4d48c270-23d0-424d-936a-e072d85723c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_aa9aeb2c-c511-4204-8043-991bdbf265f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_94e31aeb-c745-41ec-998f-e88122b4226d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_aa9aeb2c-c511-4204-8043-991bdbf265f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_996014b2-a458-4f3d-bdb3-3b27bd9d5e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_94e31aeb-c745-41ec-998f-e88122b4226d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_996014b2-a458-4f3d-bdb3-3b27bd9d5e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3de5d66c-82a2-410f-b7b4-fb542d66edb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4a155689-8288-4fbd-8a3d-0bde4e58a32a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3de5d66c-82a2-410f-b7b4-fb542d66edb6" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4a155689-8288-4fbd-8a3d-0bde4e58a32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0f1267ba-bb83-488c-a740-18175c3d85b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4a155689-8288-4fbd-8a3d-0bde4e58a32a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0f1267ba-bb83-488c-a740-18175c3d85b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6b04eb68-41ae-4954-b7a5-1320f5ff7467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0f1267ba-bb83-488c-a740-18175c3d85b4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6b04eb68-41ae-4954-b7a5-1320f5ff7467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_4db3a43e-46fb-4b09-8597-c7f0936f0b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6b04eb68-41ae-4954-b7a5-1320f5ff7467" xlink:to="loc_us-gaap_BuildingMember_4db3a43e-46fb-4b09-8597-c7f0936f0b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_d9cce78a-493c-472e-a25d-cdee3b30eff8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6b04eb68-41ae-4954-b7a5-1320f5ff7467" xlink:to="loc_us-gaap_EquipmentMember_d9cce78a-493c-472e-a25d-cdee3b30eff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertySubjectToOperatingLeaseMember_8d56f1ab-1452-475a-98db-1f5415b8e374" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertySubjectToOperatingLeaseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6b04eb68-41ae-4954-b7a5-1320f5ff7467" xlink:to="loc_us-gaap_PropertySubjectToOperatingLeaseMember_8d56f1ab-1452-475a-98db-1f5415b8e374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentMember_eb42cff2-4921-4e48-96a5-da804781e677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6b04eb68-41ae-4954-b7a5-1320f5ff7467" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentMember_eb42cff2-4921-4e48-96a5-da804781e677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_64250b11-94a5-451e-9c9b-67f6b1f10728" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4a155689-8288-4fbd-8a3d-0bde4e58a32a" xlink:to="loc_srt_RangeAxis_64250b11-94a5-451e-9c9b-67f6b1f10728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2b830772-0f80-48fe-9d2d-41ad77d633c1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_64250b11-94a5-451e-9c9b-67f6b1f10728" xlink:to="loc_srt_RangeMember_2b830772-0f80-48fe-9d2d-41ad77d633c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a64a94f0-e4d2-4df0-a247-02c2e0620684" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2b830772-0f80-48fe-9d2d-41ad77d633c1" xlink:to="loc_srt_MinimumMember_a64a94f0-e4d2-4df0-a247-02c2e0620684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_0c06728d-fab1-492e-860f-8e857ff126fe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2b830772-0f80-48fe-9d2d-41ad77d633c1" xlink:to="loc_srt_MaximumMember_0c06728d-fab1-492e-860f-8e857ff126fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_03ea5c75-f957-4ea9-8cc3-aecf61ef8e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4a155689-8288-4fbd-8a3d-0bde4e58a32a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_03ea5c75-f957-4ea9-8cc3-aecf61ef8e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_99b625f6-b875-4883-92c6-0fcb3e4ce89c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_03ea5c75-f957-4ea9-8cc3-aecf61ef8e1f" xlink:to="loc_us-gaap_SegmentDomain_99b625f6-b875-4883-92c6-0fcb3e4ce89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_435dee77-1a27-4712-a65f-46f52b4032b0" xlink:href="cvs-20211231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_99b625f6-b875-4883-92c6-0fcb3e4ce89c" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_435dee77-1a27-4712-a65f-46f52b4032b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4a155689-8288-4fbd-8a3d-0bde4e58a32a" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1fd09813-07b6-41a0-9493-02a638bb08a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_1fd09813-07b6-41a0-9493-02a638bb08a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_5e0918e8-43c5-4892-a854-7ddd99ba4840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_5e0918e8-43c5-4892-a854-7ddd99ba4840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_7ebe2f0c-a6de-4d43-9b08-81076a0f3cb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity_7ebe2f0c-a6de-4d43-9b08-81076a0f3cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_d8a1899e-b0f2-40f7-8742-fc4996b14b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleAndLeasebackTransactionGainLossNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_us-gaap_SaleAndLeasebackTransactionGainLossNet_d8a1899e-b0f2-40f7-8742-fc4996b14b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresPlannedClosure_69fc8a66-2d21-4c27-ac6d-b0bf48d0d9ac" xlink:href="cvs-20211231.xsd#cvs_NumberOfStoresPlannedClosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_cvs_NumberOfStoresPlannedClosure_69fc8a66-2d21-4c27-ac6d-b0bf48d0d9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresPlannedClosurePeriod_ad23f045-b42e-4b29-99ae-6a5bf6ac8afe" xlink:href="cvs-20211231.xsd#cvs_NumberOfStoresPlannedClosurePeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_cvs_NumberOfStoresPlannedClosurePeriod_ad23f045-b42e-4b29-99ae-6a5bf6ac8afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod_14ff11d7-7fe7-45c1-b5b0-2300c36acdf5" xlink:href="cvs-20211231.xsd#cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod_14ff11d7-7fe7-45c1-b5b0-2300c36acdf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_860d9c14-0ae9-46bc-af57-edfb7c9f6446" xlink:href="cvs-20211231.xsd#cvs_StoreImpairmentCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_cvs_StoreImpairmentCharges_860d9c14-0ae9-46bc-af57-edfb7c9f6446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure_fb67592b-2415-4daa-8b4a-452d535ea173" xlink:href="cvs-20211231.xsd#cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure_fb67592b-2415-4daa-8b4a-452d535ea173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure_60170872-7e84-45c1-8bc7-df8d58d6b227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentFairValueDisclosure"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_6d931f61-208a-478d-ad26-8cb81a0f899b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure_60170872-7e84-45c1-8bc7-df8d58d6b227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#LeasesSummaryoftheComponentsofNetLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_642a501d-fc3a-47b4-b724-ab1dd7e588d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_babde6b0-fcad-4e78-b343-58e9371e7e69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_642a501d-fc3a-47b4-b724-ab1dd7e588d6" xlink:to="loc_us-gaap_OperatingLeaseCost_babde6b0-fcad-4e78-b343-58e9371e7e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_49f56090-a15e-4e60-82f0-a27a0d2ab179" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_642a501d-fc3a-47b4-b724-ab1dd7e588d6" xlink:to="loc_us-gaap_LeaseCostAbstract_49f56090-a15e-4e60-82f0-a27a0d2ab179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_b7c3a6ec-3485-4234-8f4a-ab6fadb64f39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_49f56090-a15e-4e60-82f0-a27a0d2ab179" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_b7c3a6ec-3485-4234-8f4a-ab6fadb64f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_66d2753d-c621-4b9e-8150-dcb302aeefd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_49f56090-a15e-4e60-82f0-a27a0d2ab179" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_66d2753d-c621-4b9e-8150-dcb302aeefd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseCost_d1d90e2e-8597-4670-85b8-3af3b7fcc0d0" xlink:href="cvs-20211231.xsd#cvs_FinanceLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_49f56090-a15e-4e60-82f0-a27a0d2ab179" xlink:to="loc_cvs_FinanceLeaseCost_d1d90e2e-8597-4670-85b8-3af3b7fcc0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_09d0a643-c790-4f1e-9b3a-e4d7d49fc7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_49f56090-a15e-4e60-82f0-a27a0d2ab179" xlink:to="loc_us-gaap_ShortTermLeaseCost_09d0a643-c790-4f1e-9b3a-e4d7d49fc7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_0ce08962-06ee-4c44-a4a3-7a86d7550833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_49f56090-a15e-4e60-82f0-a27a0d2ab179" xlink:to="loc_us-gaap_VariableLeaseCost_0ce08962-06ee-4c44-a4a3-7a86d7550833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_a6a418e7-b65b-43f6-a4e6-ca4b6d2484af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_49f56090-a15e-4e60-82f0-a27a0d2ab179" xlink:to="loc_us-gaap_SubleaseIncome_a6a418e7-b65b-43f6-a4e6-ca4b6d2484af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_35d2aadd-3dde-4f26-99af-d25d2c21c21c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_49f56090-a15e-4e60-82f0-a27a0d2ab179" xlink:to="loc_us-gaap_LeaseCost_35d2aadd-3dde-4f26-99af-d25d2c21c21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_eb75f573-1019-423c-9e87-f7d430169f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CashFlowLesseeAbstract_bfc4b2c5-6920-4d03-885e-1b8427ce03c9" xlink:href="cvs-20211231.xsd#cvs_CashFlowLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_eb75f573-1019-423c-9e87-f7d430169f64" xlink:to="loc_cvs_CashFlowLesseeAbstract_bfc4b2c5-6920-4d03-885e-1b8427ce03c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_2dbd1178-816a-4b89-94d2-0ed03c5a4633" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_CashFlowLesseeAbstract_bfc4b2c5-6920-4d03-885e-1b8427ce03c9" xlink:to="loc_us-gaap_OperatingLeasePayments_2dbd1178-816a-4b89-94d2-0ed03c5a4633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_764cdd7a-71fd-4f45-9986-4248ae6489ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_CashFlowLesseeAbstract_bfc4b2c5-6920-4d03-885e-1b8427ce03c9" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_764cdd7a-71fd-4f45-9986-4248ae6489ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_e38c6ce5-2a6b-4fe5-86ba-21f7444df449" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_CashFlowLesseeAbstract_bfc4b2c5-6920-4d03-885e-1b8427ce03c9" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_e38c6ce5-2a6b-4fe5-86ba-21f7444df449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_dc4f0629-08a1-4dab-a1f2-e7aba2420fc6" xlink:href="cvs-20211231.xsd#cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_CashFlowLesseeAbstract_bfc4b2c5-6920-4d03-885e-1b8427ce03c9" xlink:to="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_dc4f0629-08a1-4dab-a1f2-e7aba2420fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_dce490d0-d119-40fc-8850-a140479710c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_dc4f0629-08a1-4dab-a1f2-e7aba2420fc6" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_dce490d0-d119-40fc-8850-a140479710c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_bbf9df8f-8a2b-469d-b831-7346dcf185a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_dc4f0629-08a1-4dab-a1f2-e7aba2420fc6" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_bbf9df8f-8a2b-469d-b831-7346dcf185a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_77ec8a2c-d906-47a2-b51d-abe715300c94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_bf92b0a8-3586-4443-9232-4c2fbebebcbb" xlink:href="cvs-20211231.xsd#cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77ec8a2c-d906-47a2-b51d-abe715300c94" xlink:to="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_bf92b0a8-3586-4443-9232-4c2fbebebcbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_850c8db0-cc7a-4177-b14e-6e470342c893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_bf92b0a8-3586-4443-9232-4c2fbebebcbb" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_850c8db0-cc7a-4177-b14e-6e470342c893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c1f187a6-0d6e-4978-9a27-647db596a668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_bf92b0a8-3586-4443-9232-4c2fbebebcbb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c1f187a6-0d6e-4978-9a27-647db596a668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_91c8b134-672f-4a37-870b-888e6ad9599e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_bf92b0a8-3586-4443-9232-4c2fbebebcbb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_91c8b134-672f-4a37-870b-888e6ad9599e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ca0b1b5b-2bc7-4827-81f0-1f426ca04a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_bf92b0a8-3586-4443-9232-4c2fbebebcbb" xlink:to="loc_us-gaap_OperatingLeaseLiability_ca0b1b5b-2bc7-4827-81f0-1f426ca04a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_ac8cbd25-3d3a-4955-84da-3d3f54e1897a" xlink:href="cvs-20211231.xsd#cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77ec8a2c-d906-47a2-b51d-abe715300c94" xlink:to="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_ac8cbd25-3d3a-4955-84da-3d3f54e1897a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetGross_b99c96a3-4e13-4482-9f00-50215f3361d5" xlink:href="cvs-20211231.xsd#cvs_FinanceLeaseRightOfUseAssetGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_ac8cbd25-3d3a-4955-84da-3d3f54e1897a" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetGross_b99c96a3-4e13-4482-9f00-50215f3361d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_7035c517-b018-4e16-b9d4-7edf655d7378" xlink:href="cvs-20211231.xsd#cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_ac8cbd25-3d3a-4955-84da-3d3f54e1897a" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation_7035c517-b018-4e16-b9d4-7edf655d7378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FinanceLeaseRightOfUseAssetNet_ba225216-2b9e-4e50-9f38-43846bbbc3c2" xlink:href="cvs-20211231.xsd#cvs_FinanceLeaseRightOfUseAssetNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_ac8cbd25-3d3a-4955-84da-3d3f54e1897a" xlink:to="loc_cvs_FinanceLeaseRightOfUseAssetNet_ba225216-2b9e-4e50-9f38-43846bbbc3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_f0d566ca-b8a6-48d9-bfc4-46dfa8839aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_ac8cbd25-3d3a-4955-84da-3d3f54e1897a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_f0d566ca-b8a6-48d9-bfc4-46dfa8839aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_919e9320-fb3e-4be2-89b3-48d2bdbd3cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_ac8cbd25-3d3a-4955-84da-3d3f54e1897a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_919e9320-fb3e-4be2-89b3-48d2bdbd3cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_66f0dc76-b8bb-433e-8b6d-f84e1e6126fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_ac8cbd25-3d3a-4955-84da-3d3f54e1897a" xlink:to="loc_us-gaap_FinanceLeaseLiability_66f0dc76-b8bb-433e-8b6d-f84e1e6126fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_WeightedAverageRemainingLeaseTermAbstract_2352022d-67b0-44d6-b23b-fc319311348a" xlink:href="cvs-20211231.xsd#cvs_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77ec8a2c-d906-47a2-b51d-abe715300c94" xlink:to="loc_cvs_WeightedAverageRemainingLeaseTermAbstract_2352022d-67b0-44d6-b23b-fc319311348a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_6ca32c4a-2bfe-4bfd-a0b9-e1ee201ed580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_WeightedAverageRemainingLeaseTermAbstract_2352022d-67b0-44d6-b23b-fc319311348a" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_6ca32c4a-2bfe-4bfd-a0b9-e1ee201ed580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_ce54375b-f0b4-4565-a28f-1f8647d3edd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_WeightedAverageRemainingLeaseTermAbstract_2352022d-67b0-44d6-b23b-fc319311348a" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_ce54375b-f0b4-4565-a28f-1f8647d3edd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeasesWeightedAverageDiscountRateAbstract_bf590d45-eb12-4625-83a9-b08bdd9a15dc" xlink:href="cvs-20211231.xsd#cvs_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_77ec8a2c-d906-47a2-b51d-abe715300c94" xlink:to="loc_cvs_LeasesWeightedAverageDiscountRateAbstract_bf590d45-eb12-4625-83a9-b08bdd9a15dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_fdf83062-621d-4d12-9b12-32241bdb97f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LeasesWeightedAverageDiscountRateAbstract_bf590d45-eb12-4625-83a9-b08bdd9a15dc" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_fdf83062-621d-4d12-9b12-32241bdb97f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_81c7643c-01b7-44fb-9ceb-61803050e223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LeasesWeightedAverageDiscountRateAbstract_bf590d45-eb12-4625-83a9-b08bdd9a15dc" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_81c7643c-01b7-44fb-9ceb-61803050e223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_76859093-ae19-4115-b764-74ff4ce38d28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1fe7503e-61cd-4212-87a6-a3e20e05dd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_76859093-ae19-4115-b764-74ff4ce38d28" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1fe7503e-61cd-4212-87a6-a3e20e05dd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_26936083-ac30-4338-87a1-fd65be0f5eab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1fe7503e-61cd-4212-87a6-a3e20e05dd8d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_26936083-ac30-4338-87a1-fd65be0f5eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_7b7d5c3d-d247-43c8-891d-6f71aef666a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1fe7503e-61cd-4212-87a6-a3e20e05dd8d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_7b7d5c3d-d247-43c8-891d-6f71aef666a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_81ed72a6-3009-4700-b0fb-e94d753b72cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1fe7503e-61cd-4212-87a6-a3e20e05dd8d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_81ed72a6-3009-4700-b0fb-e94d753b72cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_ae2c7e23-786b-4964-b3d1-b3bce984015e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1fe7503e-61cd-4212-87a6-a3e20e05dd8d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_ae2c7e23-786b-4964-b3d1-b3bce984015e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_c6bce1e6-fb9a-4fe9-a411-a58eba5cfb04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1fe7503e-61cd-4212-87a6-a3e20e05dd8d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_c6bce1e6-fb9a-4fe9-a411-a58eba5cfb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_25c4f780-3ec9-4bf2-a726-6337398d75f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1fe7503e-61cd-4212-87a6-a3e20e05dd8d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_25c4f780-3ec9-4bf2-a726-6337398d75f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_68cf429b-75b6-43f7-a85b-10471ef3b26e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1fe7503e-61cd-4212-87a6-a3e20e05dd8d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_68cf429b-75b6-43f7-a85b-10471ef3b26e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_badf5b47-e85a-4e06-b03f-d1337fdbe4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1fe7503e-61cd-4212-87a6-a3e20e05dd8d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_badf5b47-e85a-4e06-b03f-d1337fdbe4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_597532ae-87e3-44f0-92e2-e5df6cd04eda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_1fe7503e-61cd-4212-87a6-a3e20e05dd8d" xlink:to="loc_us-gaap_FinanceLeaseLiability_597532ae-87e3-44f0-92e2-e5df6cd04eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f164dbe6-3b8a-44f3-8ac2-9c9c503d510d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_76859093-ae19-4115-b764-74ff4ce38d28" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f164dbe6-3b8a-44f3-8ac2-9c9c503d510d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d3882899-681a-4de6-87de-375a51f6b561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f164dbe6-3b8a-44f3-8ac2-9c9c503d510d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_d3882899-681a-4de6-87de-375a51f6b561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_87c5deef-f3b8-4134-a018-f944764aa2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f164dbe6-3b8a-44f3-8ac2-9c9c503d510d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_87c5deef-f3b8-4134-a018-f944764aa2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6d443237-7161-4657-aec7-c27a093b4617" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f164dbe6-3b8a-44f3-8ac2-9c9c503d510d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6d443237-7161-4657-aec7-c27a093b4617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_bccef9e9-79a1-4a38-8f2d-ebadcb67f2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f164dbe6-3b8a-44f3-8ac2-9c9c503d510d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_bccef9e9-79a1-4a38-8f2d-ebadcb67f2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2af8e26a-0638-4ce7-befe-854f033b9903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f164dbe6-3b8a-44f3-8ac2-9c9c503d510d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2af8e26a-0638-4ce7-befe-854f033b9903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9e815a6c-7a18-43ac-8853-3747fc70caef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f164dbe6-3b8a-44f3-8ac2-9c9c503d510d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9e815a6c-7a18-43ac-8853-3747fc70caef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a8801d12-54e9-4224-84d0-99fbfffa13dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f164dbe6-3b8a-44f3-8ac2-9c9c503d510d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a8801d12-54e9-4224-84d0-99fbfffa13dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0bc5fec1-3210-4750-bb5c-60441056eb2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f164dbe6-3b8a-44f3-8ac2-9c9c503d510d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0bc5fec1-3210-4750-bb5c-60441056eb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_154880b8-3701-423c-847c-054d51920599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f164dbe6-3b8a-44f3-8ac2-9c9c503d510d" xlink:to="loc_us-gaap_OperatingLeaseLiability_154880b8-3701-423c-847c-054d51920599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_042a7c64-73ca-4f3f-9619-56775829e727" xlink:href="cvs-20211231.xsd#cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_76859093-ae19-4115-b764-74ff4ce38d28" xlink:to="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_042a7c64-73ca-4f3f-9619-56775829e727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsYearOne_23be6ed6-0fa7-4ad6-b54e-11d826068dde" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsYearOne"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_042a7c64-73ca-4f3f-9619-56775829e727" xlink:to="loc_cvs_LesseeLiabilityPaymentsYearOne_23be6ed6-0fa7-4ad6-b54e-11d826068dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_fe9d88ae-6e45-48c5-adb3-1382571f6375" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_042a7c64-73ca-4f3f-9619-56775829e727" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearTwo_fe9d88ae-6e45-48c5-adb3-1382571f6375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearThree_a85eacb0-d613-49f9-a43c-70108eca68b9" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_042a7c64-73ca-4f3f-9619-56775829e727" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearThree_a85eacb0-d613-49f9-a43c-70108eca68b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFour_2991e8e3-a5d0-4b72-8ec3-97452a4b2062" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_042a7c64-73ca-4f3f-9619-56775829e727" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearFour_2991e8e3-a5d0-4b72-8ec3-97452a4b2062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueYearFive_968bb8e6-3932-4d47-9256-7e7ab65ee279" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_042a7c64-73ca-4f3f-9619-56775829e727" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueYearFive_968bb8e6-3932-4d47-9256-7e7ab65ee279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_8c11ee47-ce60-4b64-b05b-08400670b928" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_042a7c64-73ca-4f3f-9619-56775829e727" xlink:to="loc_cvs_LesseeLiabilityPaymentsDueAfterYearFive_8c11ee47-ce60-4b64-b05b-08400670b928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityPaymentsDue_ea154392-ba95-4bfd-a27e-7af09d1effbf" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_042a7c64-73ca-4f3f-9619-56775829e727" xlink:to="loc_cvs_LesseeLiabilityPaymentsDue_ea154392-ba95-4bfd-a27e-7af09d1effbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_ffc2c2fd-06f2-4730-80d8-09d075683a29" xlink:href="cvs-20211231.xsd#cvs_LesseeLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_042a7c64-73ca-4f3f-9619-56775829e727" xlink:to="loc_cvs_LesseeLiabilityUndiscountedExcessAmount_ffc2c2fd-06f2-4730-80d8-09d075683a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LeaseLiability_84798a06-bcae-46e5-a93e-f2c0963ffda0" xlink:href="cvs-20211231.xsd#cvs_LeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract_042a7c64-73ca-4f3f-9619-56775829e727" xlink:to="loc_cvs_LeaseLiability_84798a06-bcae-46e5-a93e-f2c0963ffda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_e4fb93dc-1655-43ef-89b9-12dea602b3a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_76859093-ae19-4115-b764-74ff4ce38d28" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_e4fb93dc-1655-43ef-89b9-12dea602b3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife_7ff8575c-c224-425c-822e-d7a2f762211d" xlink:href="cvs-20211231.xsd#cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_76859093-ae19-4115-b764-74ff4ce38d28" xlink:to="loc_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife_7ff8575c-c224-425c-822e-d7a2f762211d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="cvs-20211231.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="simple" xlink:href="cvs-20211231.xsd#HealthCareCostsPayable"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_a4707ae3-3d5a-463f-9c3f-4bbb1b4256eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_f8274e23-b46a-49b7-bb33-2c7bc3e8a5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_a4707ae3-3d5a-463f-9c3f-4bbb1b4256eb" xlink:to="loc_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock_f8274e23-b46a-49b7-bb33-2c7bc3e8a5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="simple" xlink:href="cvs-20211231.xsd#HealthCareCostsPayableTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_87db6bb6-2ea2-49c0-9d43-3e462e58a54a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_313a1dad-1693-4ec9-afdc-1b5a387f7145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_87db6bb6-2ea2-49c0-9d43-3e462e58a54a" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_313a1dad-1693-4ec9-afdc-1b5a387f7145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_f146f72d-1afb-45c8-801b-5b5fb43eb20f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_87db6bb6-2ea2-49c0-9d43-3e462e58a54a" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_f146f72d-1afb-45c8-801b-5b5fb43eb20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_3a4942ce-2c36-4f53-8748-63fdbc30cc59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_87db6bb6-2ea2-49c0-9d43-3e462e58a54a" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock_3a4942ce-2c36-4f53-8748-63fdbc30cc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_81abda8e-3c2d-46d8-8c30-707f298f3fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_bbed4b7c-896e-4ea6-8fb1-396232c36aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_81abda8e-3c2d-46d8-8c30-707f298f3fd5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_bbed4b7c-896e-4ea6-8fb1-396232c36aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d0087ba9-677a-4571-9757-a299a5d57715" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_bbed4b7c-896e-4ea6-8fb1-396232c36aca" xlink:to="loc_srt_ProductOrServiceAxis_d0087ba9-677a-4571-9757-a299a5d57715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bd4d2c2b-b3a3-473f-a13a-1b43c5f97751" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d0087ba9-677a-4571-9757-a299a5d57715" xlink:to="loc_srt_ProductsAndServicesDomain_bd4d2c2b-b3a3-473f-a13a-1b43c5f97751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_0780ed34-333a-469f-a54e-dc224db6b799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bd4d2c2b-b3a3-473f-a13a-1b43c5f97751" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_0780ed34-333a-469f-a54e-dc224db6b799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_7ba3bd60-7e54-46b8-8127-d25ebac82f53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_bbed4b7c-896e-4ea6-8fb1-396232c36aca" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_7ba3bd60-7e54-46b8-8127-d25ebac82f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_515f380f-e45c-47fb-b8f4-f61e97767588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_7ba3bd60-7e54-46b8-8127-d25ebac82f53" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_515f380f-e45c-47fb-b8f4-f61e97767588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_a8388b91-08f1-48e4-a0d7-4c1bb96dd329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_515f380f-e45c-47fb-b8f4-f61e97767588" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2019Member_a8388b91-08f1-48e4-a0d7-4c1bb96dd329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_13eb18d3-25aa-4d85-a702-1005f9e9fb18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_515f380f-e45c-47fb-b8f4-f61e97767588" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_13eb18d3-25aa-4d85-a702-1005f9e9fb18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_89dbb8db-7cae-4603-bafa-08db016d7eda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_bbed4b7c-896e-4ea6-8fb1-396232c36aca" xlink:to="loc_us-gaap_ClaimsDevelopmentLineItems_89dbb8db-7cae-4603-bafa-08db016d7eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_52b0192e-9e20-48e3-a85e-24e506ce519a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_89dbb8db-7cae-4603-bafa-08db016d7eda" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_52b0192e-9e20-48e3-a85e-24e506ce519a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_6d44901e-d884-43e0-8791-c1d44fba1b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_89dbb8db-7cae-4603-bafa-08db016d7eda" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_6d44901e-d884-43e0-8791-c1d44fba1b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_cbf16221-3f5e-4ce4-b9be-9ec919a2ff1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_89dbb8db-7cae-4603-bafa-08db016d7eda" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented_cbf16221-3f5e-4ce4-b9be-9ec919a2ff1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_9f24926f-a8b2-4d5f-be56-bed0fa7f263d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_89dbb8db-7cae-4603-bafa-08db016d7eda" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_9f24926f-a8b2-4d5f-be56-bed0fa7f263d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#HealthCareCostsPayableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_c1c8bf98-416a-48e7-8bdb-f66a2aecd88c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_5c92dd41-8cbb-4bf5-a225-750a237d1f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_c1c8bf98-416a-48e7-8bdb-f66a2aecd88c" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_5c92dd41-8cbb-4bf5-a225-750a237d1f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b15962f8-c7be-468c-a379-d63d363d44ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_5c92dd41-8cbb-4bf5-a225-750a237d1f4f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b15962f8-c7be-468c-a379-d63d363d44ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_71d8e8ff-93d3-4975-9620-9e7bc51fe0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b15962f8-c7be-468c-a379-d63d363d44ec" xlink:to="loc_us-gaap_SegmentDomain_71d8e8ff-93d3-4975-9620-9e7bc51fe0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_805f814c-5721-4e89-87e4-8826809e4ca3" xlink:href="cvs-20211231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_71d8e8ff-93d3-4975-9620-9e7bc51fe0d8" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_805f814c-5721-4e89-87e4-8826809e4ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_41eb6263-0bd6-4e97-b9bd-d3150576b5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_5c92dd41-8cbb-4bf5-a225-750a237d1f4f" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_41eb6263-0bd6-4e97-b9bd-d3150576b5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_0e3bb67e-ac0f-412a-b54c-f8f2fead3647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_41eb6263-0bd6-4e97-b9bd-d3150576b5a5" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet_0e3bb67e-ac0f-412a-b54c-f8f2fead3647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_0feabd72-b732-4de8-aa96-240f842c84ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_41eb6263-0bd6-4e97-b9bd-d3150576b5a5" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_0feabd72-b732-4de8-aa96-240f842c84ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_395f0705-6463-487e-8841-46a273edec0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_b201094e-47be-41d5-836b-ca3b634a3746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_395f0705-6463-487e-8841-46a273edec0d" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_b201094e-47be-41d5-836b-ca3b634a3746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8fe3ca88-dc08-4ce9-ab47-d2a43fde8de2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_b201094e-47be-41d5-836b-ca3b634a3746" xlink:to="loc_srt_ProductOrServiceAxis_8fe3ca88-dc08-4ce9-ab47-d2a43fde8de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_55d2a9f6-dec6-42b5-bca5-a16b10e652a3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8fe3ca88-dc08-4ce9-ab47-d2a43fde8de2" xlink:to="loc_srt_ProductsAndServicesDomain_55d2a9f6-dec6-42b5-bca5-a16b10e652a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_80491801-3278-4eb9-8abb-a1a48f0b819e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_55d2a9f6-dec6-42b5-bca5-a16b10e652a3" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_80491801-3278-4eb9-8abb-a1a48f0b819e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_c86550c5-e32d-4db2-8cd5-ed7188a25192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable_b201094e-47be-41d5-836b-ca3b634a3746" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_c86550c5-e32d-4db2-8cd5-ed7188a25192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_353d38fa-dc79-4b6d-bfc3-a5a9852a3da6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_c86550c5-e32d-4db2-8cd5-ed7188a25192" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_353d38fa-dc79-4b6d-bfc3-a5a9852a3da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ac3016b1-95e5-4b46-9921-64bf6a062dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_c86550c5-e32d-4db2-8cd5-ed7188a25192" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_ac3016b1-95e5-4b46-9921-64bf6a062dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_6c36b90c-c08f-4263-b026-61571a31c894" xlink:href="cvs-20211231.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_c86550c5-e32d-4db2-8cd5-ed7188a25192" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_6c36b90c-c08f-4263-b026-61571a31c894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_f45cb315-85db-4a7d-b370-3b1bc74061fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_c86550c5-e32d-4db2-8cd5-ed7188a25192" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem_f45cb315-85db-4a7d-b370-3b1bc74061fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_276c9b95-2c88-46df-b652-4cd0d9cd8823" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems_c86550c5-e32d-4db2-8cd5-ed7188a25192" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_276c9b95-2c88-46df-b652-4cd0d9cd8823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_a81c105e-54c1-4ef8-922b-2f5346ece040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_4b18390f-6ced-413f-b4ca-40a68bf35a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_a81c105e-54c1-4ef8-922b-2f5346ece040" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_4b18390f-6ced-413f-b4ca-40a68bf35a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_aa2861a4-e601-43c2-822e-4b1564527085" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_4b18390f-6ced-413f-b4ca-40a68bf35a0b" xlink:to="loc_srt_ProductOrServiceAxis_aa2861a4-e601-43c2-822e-4b1564527085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_29eed1f4-f214-4591-bd45-b9a82a9179e6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_aa2861a4-e601-43c2-822e-4b1564527085" xlink:to="loc_srt_ProductsAndServicesDomain_29eed1f4-f214-4591-bd45-b9a82a9179e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_7830448c-f351-46fd-b8a4-95c6e20843c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_29eed1f4-f214-4591-bd45-b9a82a9179e6" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_7830448c-f351-46fd-b8a4-95c6e20843c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9a868829-0f2d-4775-bb5a-9752a077ffed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_4b18390f-6ced-413f-b4ca-40a68bf35a0b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9a868829-0f2d-4775-bb5a-9752a077ffed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7babd931-5240-4da4-97dc-7f13d0b3e53f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9a868829-0f2d-4775-bb5a-9752a077ffed" xlink:to="loc_us-gaap_SegmentDomain_7babd931-5240-4da4-97dc-7f13d0b3e53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_fd578c1b-1156-43d1-a32d-7106e6bbb117" xlink:href="cvs-20211231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7babd931-5240-4da4-97dc-7f13d0b3e53f" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_fd578c1b-1156-43d1-a32d-7106e6bbb117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateAndOtherMember_dbb4f7e8-7439-412f-b163-061a3080862b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7babd931-5240-4da4-97dc-7f13d0b3e53f" xlink:to="loc_us-gaap_CorporateAndOtherMember_dbb4f7e8-7439-412f-b163-061a3080862b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_18b97879-5841-4884-bb81-4d5de5b4b0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_4b18390f-6ced-413f-b4ca-40a68bf35a0b" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_18b97879-5841-4884-bb81-4d5de5b4b0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_18b97879-5841-4884-bb81-4d5de5b4b0e0" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_ec98d90d-e092-4ec6-865a-7b18526e6009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_ec98d90d-e092-4ec6-865a-7b18526e6009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_2f4dd6b1-854e-4f81-9800-d9a4bfd9e43d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_2f4dd6b1-854e-4f81-9800-d9a4bfd9e43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_ac603fa1-3018-4397-b9c3-f8dc93711001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_ac603fa1-3018-4397-b9c3-f8dc93711001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_fcd43a38-1a1f-4a77-b144-6939448d94bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_fcd43a38-1a1f-4a77-b144-6939448d94bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_378904aa-4bed-41ba-b950-4f8c32a325d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_378904aa-4bed-41ba-b950-4f8c32a325d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_25b5dcc4-fce6-4d53-945a-56d5f9d3d4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_378904aa-4bed-41ba-b950-4f8c32a325d8" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_25b5dcc4-fce6-4d53-945a-56d5f9d3d4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_32549546-870a-42c5-a922-c1d891eeb95f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_378904aa-4bed-41ba-b950-4f8c32a325d8" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_32549546-870a-42c5-a922-c1d891eeb95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_3b645998-7bd0-4068-98b3-f1a24dc0f9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_378904aa-4bed-41ba-b950-4f8c32a325d8" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_3b645998-7bd0-4068-98b3-f1a24dc0f9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_f39c6883-9202-4407-b553-f3f72013a551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_f39c6883-9202-4407-b553-f3f72013a551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_2bce708f-0507-43f3-8470-199e6071ae30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_f39c6883-9202-4407-b553-f3f72013a551" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_2bce708f-0507-43f3-8470-199e6071ae30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_2e14df6a-ee41-42af-8089-3814ce46fff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_f39c6883-9202-4407-b553-f3f72013a551" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_2e14df6a-ee41-42af-8089-3814ce46fff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_84444b5c-7b3e-4229-9d7c-556e432c0bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_f39c6883-9202-4407-b553-f3f72013a551" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_84444b5c-7b3e-4229-9d7c-556e432c0bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumDeficiencyReserveLiability_1c622a88-1bfe-4a71-81f7-edc63950becd" xlink:href="cvs-20211231.xsd#cvs_PremiumDeficiencyReserveLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:to="loc_cvs_PremiumDeficiencyReserveLiability_1c622a88-1bfe-4a71-81f7-edc63950becd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_f65595fe-d452-4061-8fd5-f5eb8c314941" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_f65595fe-d452-4061-8fd5-f5eb8c314941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_dbadc6fd-928d-48cf-9c10-d1e6720a9d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_dbadc6fd-928d-48cf-9c10-d1e6720a9d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_515872fb-248a-43b6-a6f6-8b04585d0e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_eac6698a-612a-4d62-8ef5-046295bf6377" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_515872fb-248a-43b6-a6f6-8b04585d0e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_bb49ada5-4200-4194-860f-12e38ce02714" xlink:href="cvs-20211231.xsd#cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_18b97879-5841-4884-bb81-4d5de5b4b0e0" xlink:to="loc_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts_bb49ada5-4200-4194-860f-12e38ce02714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangements" xlink:type="simple" xlink:href="cvs-20211231.xsd#BorrowingsandCreditArrangements"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c8395559-0c38-41d4-a4ec-33e6a292a092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_047e6716-56a5-4675-bed6-242bc33143b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c8395559-0c38-41d4-a4ec-33e6a292a092" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_047e6716-56a5-4675-bed6-242bc33143b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables" xlink:type="simple" xlink:href="cvs-20211231.xsd#BorrowingsandCreditArrangementsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9bd579d4-f214-48fb-a6b0-c4568988c655" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_2d0e4d5f-c087-4108-90d6-c34411c2e5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9bd579d4-f214-48fb-a6b0-c4568988c655" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_2d0e4d5f-c087-4108-90d6-c34411c2e5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_ed7d5e99-d0df-4087-aaa0-be93f71308fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9bd579d4-f214-48fb-a6b0-c4568988c655" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_ed7d5e99-d0df-4087-aaa0-be93f71308fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#BorrowingsandCreditArrangementsScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fe4d5684-1ba5-491e-a248-e9b70ca5366f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2a0136a6-697e-43e8-a134-c2e560b93de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fe4d5684-1ba5-491e-a248-e9b70ca5366f" xlink:to="loc_us-gaap_DebtInstrumentTable_2a0136a6-697e-43e8-a134-c2e560b93de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8fd9be31-86bd-4bf6-826e-debbc9beff0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2a0136a6-697e-43e8-a134-c2e560b93de0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8fd9be31-86bd-4bf6-826e-debbc9beff0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_db588793-3a02-410a-ae49-09121393602d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8fd9be31-86bd-4bf6-826e-debbc9beff0d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_db588793-3a02-410a-ae49-09121393602d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_19aef551-3c49-457f-8b61-e3e01b09051d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_db588793-3a02-410a-ae49-09121393602d" xlink:to="loc_us-gaap_SeniorNotesMember_19aef551-3c49-457f-8b61-e3e01b09051d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_fef5d017-c656-4cac-bff3-21a2eb282bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_db588793-3a02-410a-ae49-09121393602d" xlink:to="loc_us-gaap_NotesPayableToBanksMember_fef5d017-c656-4cac-bff3-21a2eb282bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_aa0ab4cc-6cca-4426-bd38-2f77f2f96cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_db588793-3a02-410a-ae49-09121393602d" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_aa0ab4cc-6cca-4426-bd38-2f77f2f96cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ad4aa71e-9f60-45d3-a96e-54d070ae03e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2a0136a6-697e-43e8-a134-c2e560b93de0" xlink:to="loc_us-gaap_DebtInstrumentAxis_ad4aa71e-9f60-45d3-a96e-54d070ae03e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ad4aa71e-9f60-45d3-a96e-54d070ae03e4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member_a5f91bfa-a638-4f69-aa57-de33a9cb74db" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3.35DueMarch2021Member_a5f91bfa-a638-4f69-aa57-de33a9cb74db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2021Member_48a7cfd8-9dad-4f94-a366-b8811389cef3" xlink:href="cvs-20211231.xsd#cvs_FloatingRateNotesDueMarch2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_FloatingRateNotesDueMarch2021Member_48a7cfd8-9dad-4f94-a366-b8811389cef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member_bbc4094d-30eb-4531-96e2-348c719e2e6d" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.125DueMay2021Member_bbc4094d-30eb-4531-96e2-348c719e2e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.125June2021Member_baff6f09-8989-476f-bb7a-8dfe69d6fb8f" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.125June2021Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes2.125June2021Member_baff6f09-8989-476f-bb7a-8dfe69d6fb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member_c1a957c8-acf4-42af-a696-3ceea20ce68f" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.125DueJune2021Member_c1a957c8-acf4-42af-a696-3ceea20ce68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member_72872f52-a791-44d5-a987-a0588e217629" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes5.45DueJune2021Member_72872f52-a791-44d5-a987-a0588e217629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueJuly2022Member_231d41e5-90b8-4f70-b69e-8e435df2aad8" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.5DueJuly2022Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3.5DueJuly2022Member_231d41e5-90b8-4f70-b69e-8e435df2aad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueNovember2022Member_9984af4c-f3ab-4ac1-8d8b-de58b103ce6d" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.75DueNovember2022Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes2.75DueNovember2022Member_9984af4c-f3ab-4ac1-8d8b-de58b103ce6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.75DueDecember2022Member_2102dcdb-6b42-4c18-b840-6c36158af490" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.75DueDecember2022Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes2.75DueDecember2022Member_2102dcdb-6b42-4c18-b840-6c36158af490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueDecember2022Member_537efd91-beb9-4ae1-a996-cc39f2111d7e" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.75DueDecember2022Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.75DueDecember2022Member_537efd91-beb9-4ae1-a996-cc39f2111d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_c0263e3a-debc-49be-b104-cda9c3d0a290" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_c0263e3a-debc-49be-b104-cda9c3d0a290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.8DueJune2023Member_43eb4f9f-0779-4143-b3f7-e8e8b983f992" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.8DueJune2023Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes2.8DueJune2023Member_43eb4f9f-0779-4143-b3f7-e8e8b983f992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_af9e34e8-5a54-4a73-886d-1dd1e9fb0a53" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_af9e34e8-5a54-4a73-886d-1dd1e9fb0a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.375DueAugust2024Member_499b78c7-7386-4f58-a495-813890e2e71e" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.375DueAugust2024Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3.375DueAugust2024Member_499b78c7-7386-4f58-a495-813890e2e71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_ec6fe8da-87ec-4816-9259-08b0cbdce94b" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_ec6fe8da-87ec-4816-9259-08b0cbdce94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.5DueNovember2024Member_b4ed4d72-b168-4bb5-bec1-5c776182d001" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.5DueNovember2024Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3.5DueNovember2024Member_b4ed4d72-b168-4bb5-bec1-5c776182d001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5DueDecember2024Member_7fc49230-f2b8-4363-9333-5b186c39761f" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5DueDecember2024Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes5DueDecember2024Member_7fc49230-f2b8-4363-9333-5b186c39761f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_6396af8f-0849-4d6f-8bb5-183fc7d32e82" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_6396af8f-0849-4d6f-8bb5-183fc7d32e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueJuly2025Member_d8d135b1-87c8-4574-bf9f-a5d99275552c" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.875DueJuly2025Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3.875DueJuly2025Member_d8d135b1-87c8-4574-bf9f-a5d99275552c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.875DueJune2026Member_4e2b0a00-639e-4809-b40e-3e00d9360cf3" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.875DueJune2026Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes2.875DueJune2026Member_4e2b0a00-639e-4809-b40e-3e00d9360cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_0d7ffd14-2959-43af-8c26-5d5aa44d68c7" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_0d7ffd14-2959-43af-8c26-5d5aa44d68c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point625PercentApril2027Member_532ecee3-f988-45e1-af9e-b69f75aafe68" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3Point625PercentApril2027Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3Point625PercentApril2027Member_532ecee3-f988-45e1-af9e-b69f75aafe68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.25DueJune2027Member_b404ef8f-572a-45eb-b083-d252fcfbd349" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes6.25DueJune2027Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes6.25DueJune2027Member_b404ef8f-572a-45eb-b083-d252fcfbd349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point3PercentAugust2027Member_22e2672c-9645-4115-8a6f-7864aa4261b6" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes1Point3PercentAugust2027Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes1Point3PercentAugust2027Member_22e2672c-9645-4115-8a6f-7864aa4261b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.3DueMarch2028Member_54d60a46-0662-4cdb-8aa3-e18597790098" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.3DueMarch2028Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.3DueMarch2028Member_54d60a46-0662-4cdb-8aa3-e18597790098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_93702bb8-35a5-4135-ba25-556262bafc5c" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_93702bb8-35a5-4135-ba25-556262bafc5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point75PercentApril2030Member_eb6d5399-6cf7-4bad-97c5-d115b8c2e8a5" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3Point75PercentApril2030Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3Point75PercentApril2030Member_eb6d5399-6cf7-4bad-97c5-d115b8c2e8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point75PercentAugust2030Member_e1375d75-d031-47b5-b2d6-e4125ac9ceba" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes1Point75PercentAugust2030Member"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes1Point75PercentAugust2030Member_e1375d75-d031-47b5-b2d6-e4125ac9ceba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member_634a8b23-3896-4d8e-b365-3de61885b396" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes1Point875PercentFebruary2031Member"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes1Point875PercentFebruary2031Member_634a8b23-3896-4d8e-b365-3de61885b396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_2a7caf33-f0ba-4488-9921-9fd429885998" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2Point125PercentDueSeptember2031Member"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_2a7caf33-f0ba-4488-9921-9fd429885998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.875DueJuly2035Member_5b1ed552-6f47-430e-a2e0-a510c6fbdca3" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.875DueJuly2035Member"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.875DueJuly2035Member_5b1ed552-6f47-430e-a2e0-a510c6fbdca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.625DueJune2036Member_8dbfb394-5ac8-4a17-8e2a-e1fdc9530526" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes6.625DueJune2036Member"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes6.625DueJune2036Member_8dbfb394-5ac8-4a17-8e2a-e1fdc9530526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.75DueDecember2037Member_6b6e1453-402c-43f5-89a5-634ff0d5f35f" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes6.75DueDecember2037Member"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes6.75DueDecember2037Member_6b6e1453-402c-43f5-89a5-634ff0d5f35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.78DueMarch2038Member_dbc75e1f-6f40-4736-a555-7790cde378bd" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.78DueMarch2038Member"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.78DueMarch2038Member_dbc75e1f-6f40-4736-a555-7790cde378bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes6.125DueSeptember2039Member_3ae4df58-7d78-4489-9c05-c90742530e46" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes6.125DueSeptember2039Member"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes6.125DueSeptember2039Member_3ae4df58-7d78-4489-9c05-c90742530e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point125PercentApril2040Member_76d28a99-c38a-4c4e-a59e-f85999d3a11b" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4Point125PercentApril2040Member"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4Point125PercentApril2040Member_76d28a99-c38a-4c4e-a59e-f85999d3a11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point7PercentAugust2040Member_2b341973-cf18-4fb1-a512-8e5c288e8ab9" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2Point7PercentAugust2040Member"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes2Point7PercentAugust2040Member_2b341973-cf18-4fb1-a512-8e5c288e8ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.75DueMay2041Member_7fea112c-1c79-46c0-8a10-3ae0ed79f21c" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5.75DueMay2041Member"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes5.75DueMay2041Member_7fea112c-1c79-46c0-8a10-3ae0ed79f21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.5DueMay2042Member_318c8f93-6cc3-46cf-869b-c656792b7e5d" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.5DueMay2042Member"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.5DueMay2042Member_318c8f93-6cc3-46cf-869b-c656792b7e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueNovember2042Member_52c375c4-1f7e-451b-9da6-79fb4c85029b" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.125DueNovember2042Member"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.125DueNovember2042Member_52c375c4-1f7e-451b-9da6-79fb4c85029b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.3DueDecember2043Member_35bcfb2e-fd4e-4dc0-8048-5cbef8cd2dc2" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5.3DueDecember2043Member"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes5.3DueDecember2043Member_35bcfb2e-fd4e-4dc0-8048-5cbef8cd2dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.75DueMarch2044Member_00ee11c1-f0c2-414e-87de-ace05d38c198" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.75DueMarch2044Member"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4.75DueMarch2044Member_00ee11c1-f0c2-414e-87de-ace05d38c198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.125DueJuly2045Member_0525c717-cebe-4e99-879b-a9ace67727b6" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5.125DueJuly2045Member"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes5.125DueJuly2045Member_0525c717-cebe-4e99-879b-a9ace67727b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.875DueAugust2047Member_efea38d7-e65a-4c49-8a26-5a7746b87a89" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.875DueAugust2047Member"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes3.875DueAugust2047Member_efea38d7-e65a-4c49-8a26-5a7746b87a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.05DueMarch2048Member_832ea44f-d9eb-4bfc-9d98-920a5d65846f" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5.05DueMarch2048Member"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes5.05DueMarch2048Member_832ea44f-d9eb-4bfc-9d98-920a5d65846f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4Point25PercentApril2050Member_38cfa8ae-8253-4100-ace4-1fefc1bbd6ce" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4Point25PercentApril2050Member"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cf393cc6-4f90-4e40-ac5b-e4bab31a8bef" xlink:to="loc_cvs_SeniorNotes4Point25PercentApril2050Member_38cfa8ae-8253-4100-ace4-1fefc1bbd6ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2a0136a6-697e-43e8-a134-c2e560b93de0" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ffb4a442-fe96-48cb-8610-24e705e88408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ffb4a442-fe96-48cb-8610-24e705e88408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_04c3d3ce-03f5-47f6-b703-870fd4368632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_04c3d3ce-03f5-47f6-b703-870fd4368632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_7d382e04-6633-4687-900d-c1655bab72d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_us-gaap_FinanceLeaseLiability_7d382e04-6633-4687-900d-c1655bab72d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_35015e2c-8a12-4f9b-a98f-b36bf5f1b94e" xlink:href="cvs-20211231.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_35015e2c-8a12-4f9b-a98f-b36bf5f1b94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_072921e9-5711-4716-bb08-753e3b4b6e06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_072921e9-5711-4716-bb08-753e3b4b6e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_9c502b24-d4a8-4046-8852-1ca585438945" xlink:href="cvs-20211231.xsd#cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet_9c502b24-d4a8-4046-8852-1ca585438945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_22a5d74e-6ecc-4400-af50-63350cc5dd77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_22a5d74e-6ecc-4400-af50-63350cc5dd77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_ab500047-cf08-41dd-ac1e-79fa28fe8447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_ab500047-cf08-41dd-ac1e-79fa28fe8447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_2ef5a866-3979-4f29-8605-abc4d2ca5fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_2ef5a866-3979-4f29-8605-abc4d2ca5fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_3397760f-4cd8-491f-9b3f-2ae6de7d4cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f15c444d-bd82-4d91-88e3-266aa28af77a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList_3397760f-4cd8-491f-9b3f-2ae6de7d4cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#BorrowingsandCreditArrangementsDebtMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_24efb167-9d64-4591-bf3a-affb2eee2e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_b3e54cd1-a972-4b2a-94ae-34c3248d253f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_24efb167-9d64-4591-bf3a-affb2eee2e33" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_b3e54cd1-a972-4b2a-94ae-34c3248d253f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_b5ca9d58-56c8-4dbb-ae0c-3c75b093eba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_b3e54cd1-a972-4b2a-94ae-34c3248d253f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_b5ca9d58-56c8-4dbb-ae0c-3c75b093eba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b38a315d-4198-4b11-b57c-8dcedb7f13c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_b3e54cd1-a972-4b2a-94ae-34c3248d253f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_b38a315d-4198-4b11-b57c-8dcedb7f13c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2e11c4a7-0d68-4751-9a48-8c0342165d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_b3e54cd1-a972-4b2a-94ae-34c3248d253f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2e11c4a7-0d68-4751-9a48-8c0342165d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d7068270-a451-4cac-978b-2b9c3bb40a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_b3e54cd1-a972-4b2a-94ae-34c3248d253f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_d7068270-a451-4cac-978b-2b9c3bb40a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_6167cd38-e8f0-4d4f-888b-3a6870d94faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_b3e54cd1-a972-4b2a-94ae-34c3248d253f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_6167cd38-e8f0-4d4f-888b-3a6870d94faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_c2b5dbdc-2dbb-4978-b90a-5fd73486e441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_b3e54cd1-a972-4b2a-94ae-34c3248d253f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_c2b5dbdc-2dbb-4978-b90a-5fd73486e441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_0c76876f-2a6c-4a95-8cbd-21485c334320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_b3e54cd1-a972-4b2a-94ae-34c3248d253f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_0c76876f-2a6c-4a95-8cbd-21485c334320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_afdf89c6-b984-4e1f-9178-a0d346064ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_24efb167-9d64-4591-bf3a-affb2eee2e33" xlink:to="loc_us-gaap_FinanceLeaseLiability_afdf89c6-b984-4e1f-9178-a0d346064ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LongtermDebtGrossAndLeaseObligation_dc0cec22-c721-43ee-8598-4853715d5713" xlink:href="cvs-20211231.xsd#cvs_LongtermDebtGrossAndLeaseObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_24efb167-9d64-4591-bf3a-affb2eee2e33" xlink:to="loc_cvs_LongtermDebtGrossAndLeaseObligation_dc0cec22-c721-43ee-8598-4853715d5713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#BorrowingsandCreditArrangementsShorttermBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1c1a1c1c-eeb8-474b-88e5-4e23b5a12805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_b4d42d20-cb16-4e75-b4ed-0ba7c1d35247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1c1a1c1c-eeb8-474b-88e5-4e23b5a12805" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_b4d42d20-cb16-4e75-b4ed-0ba7c1d35247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_5b3b62fb-140b-4031-93e5-e1d8f74949e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b4d42d20-cb16-4e75-b4ed-0ba7c1d35247" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_5b3b62fb-140b-4031-93e5-e1d8f74949e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_d2d0d449-4e9e-4f60-b596-435e88ee0fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_5b3b62fb-140b-4031-93e5-e1d8f74949e8" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_d2d0d449-4e9e-4f60-b596-435e88ee0fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_efb024e7-3d67-4d45-a6c8-12936aa7539f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_d2d0d449-4e9e-4f60-b596-435e88ee0fb7" xlink:to="loc_us-gaap_CommercialPaperMember_efb024e7-3d67-4d45-a6c8-12936aa7539f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_a17ad4d0-94c9-43e4-bbc9-a492ad40a52e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_d2d0d449-4e9e-4f60-b596-435e88ee0fb7" xlink:to="loc_us-gaap_LineOfCreditMember_a17ad4d0-94c9-43e4-bbc9-a492ad40a52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember_6ed183ba-dd69-4264-9bee-f83c1ca03509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_d2d0d449-4e9e-4f60-b596-435e88ee0fb7" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesMember_6ed183ba-dd69-4264-9bee-f83c1ca03509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8e28ed5e-a495-4592-9a1a-5eb0892ba987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b4d42d20-cb16-4e75-b4ed-0ba7c1d35247" xlink:to="loc_us-gaap_DebtInstrumentAxis_8e28ed5e-a495-4592-9a1a-5eb0892ba987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5a3e8e06-def9-467d-9f63-a08b0a3fa344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8e28ed5e-a495-4592-9a1a-5eb0892ba987" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5a3e8e06-def9-467d-9f63-a08b0a3fa344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BackUpCreditFacilitiesMember_70f51a16-ea38-4b7f-b6bf-4001315cf8ef" xlink:href="cvs-20211231.xsd#cvs_BackUpCreditFacilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5a3e8e06-def9-467d-9f63-a08b0a3fa344" xlink:to="loc_cvs_BackUpCreditFacilitiesMember_70f51a16-ea38-4b7f-b6bf-4001315cf8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay172023Member_516d6f37-aaa3-4b31-ba6e-23700224f920" xlink:href="cvs-20211231.xsd#cvs_RevolvingCreditFacilityExpiringMay172023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_70f51a16-ea38-4b7f-b6bf-4001315cf8ef" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay172023Member_516d6f37-aaa3-4b31-ba6e-23700224f920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay162024Member_42bf6459-202c-416c-8ccf-de0ed01032b2" xlink:href="cvs-20211231.xsd#cvs_RevolvingCreditFacilityExpiringMay162024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_70f51a16-ea38-4b7f-b6bf-4001315cf8ef" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay162024Member_42bf6459-202c-416c-8ccf-de0ed01032b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RevolvingCreditFacilityExpiringMay112026Member_68fcdd92-a7c4-4bae-9319-2a82997b139a" xlink:href="cvs-20211231.xsd#cvs_RevolvingCreditFacilityExpiringMay112026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_BackUpCreditFacilitiesMember_70f51a16-ea38-4b7f-b6bf-4001315cf8ef" xlink:to="loc_cvs_RevolvingCreditFacilityExpiringMay112026Member_68fcdd92-a7c4-4bae-9319-2a82997b139a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_7e299986-1eec-4a50-b3b7-d5b2e74c5481" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_b4d42d20-cb16-4e75-b4ed-0ba7c1d35247" xlink:to="loc_us-gaap_ShortTermDebtLineItems_7e299986-1eec-4a50-b3b7-d5b2e74c5481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_ba8fa0e8-e28e-46e3-9b2e-bc9737c66879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7e299986-1eec-4a50-b3b7-d5b2e74c5481" xlink:to="loc_us-gaap_ShortTermBorrowings_ba8fa0e8-e28e-46e3-9b2e-bc9737c66879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8a3d6c69-9c23-4f1c-bb2c-9eb10143d203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7e299986-1eec-4a50-b3b7-d5b2e74c5481" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8a3d6c69-9c23-4f1c-bb2c-9eb10143d203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_181ec629-f2a5-4a7d-9450-aa8a5bba5359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7e299986-1eec-4a50-b3b7-d5b2e74c5481" xlink:to="loc_us-gaap_DebtInstrumentTerm_181ec629-f2a5-4a7d-9450-aa8a5bba5359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_b7c1f8f1-3b57-4a21-add4-211fbc25a62d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7e299986-1eec-4a50-b3b7-d5b2e74c5481" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_b7c1f8f1-3b57-4a21-add4-211fbc25a62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_bae967dc-5888-44cf-a87d-c53bd9f7cb59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_7e299986-1eec-4a50-b3b7-d5b2e74c5481" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable_bae967dc-5888-44cf-a87d-c53bd9f7cb59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#BorrowingsandCreditArrangementsLongTermBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1ea1740e-3fed-426e-9a33-4182e2be9452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_80e538bd-fd6b-4321-a095-0e7d8a74d61e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1ea1740e-3fed-426e-9a33-4182e2be9452" xlink:to="loc_us-gaap_DebtInstrumentTable_80e538bd-fd6b-4321-a095-0e7d8a74d61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e652ca84-38bf-490d-8cd6-7fe8f4ad605a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_80e538bd-fd6b-4321-a095-0e7d8a74d61e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e652ca84-38bf-490d-8cd6-7fe8f4ad605a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_34fb88e8-3910-476e-abdd-64010ae988a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e652ca84-38bf-490d-8cd6-7fe8f4ad605a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_34fb88e8-3910-476e-abdd-64010ae988a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_021a2f8a-9aaf-4ffc-8296-c16bd715c3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_34fb88e8-3910-476e-abdd-64010ae988a8" xlink:to="loc_us-gaap_SeniorNotesMember_021a2f8a-9aaf-4ffc-8296-c16bd715c3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableToBanksMember_a80ea49d-e1e8-4b36-a7d9-002ede18ed40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableToBanksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_34fb88e8-3910-476e-abdd-64010ae988a8" xlink:to="loc_us-gaap_NotesPayableToBanksMember_a80ea49d-e1e8-4b36-a7d9-002ede18ed40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesMember_fc325b7b-62a3-42c7-ab0d-b045e7d4da2e" xlink:href="cvs-20211231.xsd#cvs_FloatingRateNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_34fb88e8-3910-476e-abdd-64010ae988a8" xlink:to="loc_cvs_FloatingRateNotesMember_fc325b7b-62a3-42c7-ab0d-b045e7d4da2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_05a03c7c-912d-40a8-97ee-b062ea6ae9af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_80e538bd-fd6b-4321-a095-0e7d8a74d61e" xlink:to="loc_us-gaap_DebtInstrumentAxis_05a03c7c-912d-40a8-97ee-b062ea6ae9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_05a03c7c-912d-40a8-97ee-b062ea6ae9af" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_27c84ba0-f12d-471e-9075-afe10b8654ca" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2Point125PercentDueSeptember2031Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes2Point125PercentDueSeptember2031Member_27c84ba0-f12d-471e-9075-afe10b8654ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes13DueAugust2027Member_7625f25c-956a-4622-ba3a-a05b0bf0b3c6" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes13DueAugust2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes13DueAugust2027Member_7625f25c-956a-4622-ba3a-a05b0bf0b3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes1875DueFebruary2031Member_bf7871f3-bf65-49fc-9581-6134df762553" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes1875DueFebruary2031Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes1875DueFebruary2031Member_bf7871f3-bf65-49fc-9581-6134df762553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes175DueAugust2030Member_8d7288ff-65fb-456e-a54f-b0daf926ed34" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes175DueAugust2030Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes175DueAugust2030Member_8d7288ff-65fb-456e-a54f-b0daf926ed34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes27DueAugust2040Member_01e84d9c-fe2f-4276-b013-695887f01c4e" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes27DueAugust2040Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes27DueAugust2040Member_01e84d9c-fe2f-4276-b013-695887f01c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3625DueApril2027Member_08a1e925-5f28-40f1-86d8-a133544d318f" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3625DueApril2027Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes3625DueApril2027Member_08a1e925-5f28-40f1-86d8-a133544d318f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes375DueApril2030Member_03a931b5-bdb5-4cf0-b186-97854d4a2fc1" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes375DueApril2030Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes375DueApril2030Member_03a931b5-bdb5-4cf0-b186-97854d4a2fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4125DueApril2040Member_5a81b8b0-5c23-4ec5-ace9-473ee8c0cdda" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4125DueApril2040Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes4125DueApril2040Member_5a81b8b0-5c23-4ec5-ace9-473ee8c0cdda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes425DueApril2050Member_913190e8-2c9a-4a9f-a43c-53c4fc62674a" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes425DueApril2050Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes425DueApril2050Member_913190e8-2c9a-4a9f-a43c-53c4fc62674a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes2.625DueAugust2024Member_049cd54b-212d-4cc0-9722-cff1aa470889" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes2.625DueAugust2024Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes2.625DueAugust2024Member_049cd54b-212d-4cc0-9722-cff1aa470889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3DueAugust2026Member_8aea9846-ae60-477a-b8e1-901f219acf64" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3DueAugust2026Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes3DueAugust2026Member_8aea9846-ae60-477a-b8e1-901f219acf64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.25DueAugust2029Member_3cbb5e0e-d31c-4822-9f1b-e03a05ec66df" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.25DueAugust2029Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes3.25DueAugust2029Member_3cbb5e0e-d31c-4822-9f1b-e03a05ec66df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4PointThreePercentDue2028Member_e09bdb81-98f5-40e3-84fb-d438f7270115" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4PointThreePercentDue2028Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes4PointThreePercentDue2028Member_e09bdb81-98f5-40e3-84fb-d438f7270115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_OutstandingSeniorNotesMember_e7a946f0-916f-4b2d-9539-6024e93a8fbf" xlink:href="cvs-20211231.xsd#cvs_OutstandingSeniorNotesMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_OutstandingSeniorNotesMember_e7a946f0-916f-4b2d-9539-6024e93a8fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4DueDecember2023Member_8922f006-f7a6-4c20-b8f5-466a5ce956fc" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4DueDecember2023Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes4DueDecember2023Member_8922f006-f7a6-4c20-b8f5-466a5ce956fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.7DueMarch2023Member_5c40f76c-91a5-4b46-b6f8-a23dd98dd336" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.7DueMarch2023Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes3.7DueMarch2023Member_5c40f76c-91a5-4b46-b6f8-a23dd98dd336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.1DueMarch2025Member_79f4994f-a889-4ce9-995f-30c6e4255f91" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.1DueMarch2025Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes4.1DueMarch2025Member_79f4994f-a889-4ce9-995f-30c6e4255f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes43Due2028Member_71d6f10e-5dd6-49bb-bdf0-00bcd49be658" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes43Due2028Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes43Due2028Member_71d6f10e-5dd6-49bb-bdf0-00bcd49be658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueMay2021Member_25c22686-9224-4e8b-831d-85fe2e54c301" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.125DueMay2021Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes4.125DueMay2021Member_25c22686-9224-4e8b-831d-85fe2e54c301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes4.125DueJune2021Member_c153d454-f12c-42c5-b6d6-d148998ecdda" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes4.125DueJune2021Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes4.125DueJune2021Member_c153d454-f12c-42c5-b6d6-d148998ecdda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes5.45DueJune2021Member_0b5b604d-2359-463d-9949-239c9036615a" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes5.45DueJune2021Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes5.45DueJune2021Member_0b5b604d-2359-463d-9949-239c9036615a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.35DueMarch2021Member_601b4c55-d4d2-4b1e-a02f-22381ed055bb" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.35DueMarch2021Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes3.35DueMarch2021Member_601b4c55-d4d2-4b1e-a02f-22381ed055bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3Point70PercentDue2023Member_2b3312ce-9095-4481-a1e4-0ef776093a8b" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3Point70PercentDue2023Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes3Point70PercentDue2023Member_2b3312ce-9095-4481-a1e4-0ef776093a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SeniorNotes3.125DueMarch2020Member_591df0e9-d0f8-4516-bccb-a51fb7a8a90d" xlink:href="cvs-20211231.xsd#cvs_SeniorNotes3.125DueMarch2020Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_SeniorNotes3.125DueMarch2020Member_591df0e9-d0f8-4516-bccb-a51fb7a8a90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FloatingRateNotesDueMarch2020Member_0cd8e368-24ff-4345-bc59-4f1db181594b" xlink:href="cvs-20211231.xsd#cvs_FloatingRateNotesDueMarch2020Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_973dacfb-613b-48b5-a894-2c340cdc65d1" xlink:to="loc_cvs_FloatingRateNotesDueMarch2020Member_0cd8e368-24ff-4345-bc59-4f1db181594b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_80e538bd-fd6b-4321-a095-0e7d8a74d61e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_ffc59021-fd3c-4489-bbb5-97a99a0ceb44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_ffc59021-fd3c-4489-bbb5-97a99a0ceb44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b3e0a5ba-efdb-40dc-b141-efa36cbf0872" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b3e0a5ba-efdb-40dc-b141-efa36cbf0872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_dd2b4270-1895-4720-89b0-5a44e150562d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_dd2b4270-1895-4720-89b0-5a44e150562d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_a2565a65-121d-457d-9fb7-e012d857fbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities_a2565a65-121d-457d-9fb7-e012d857fbd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_891faf49-3726-4879-8fcc-90ac79795517" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_891faf49-3726-4879-8fcc-90ac79795517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_23b5d34b-7d98-4b3e-a4f0-8840afe0dca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_23b5d34b-7d98-4b3e-a4f0-8840afe0dca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_d45ce7e6-475a-4987-bd39-57fea9d1697b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_d45ce7e6-475a-4987-bd39-57fea9d1697b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_e9412638-2af9-42c4-9a3d-95a991e51b46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_e9412638-2af9-42c4-9a3d-95a991e51b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DebtExtinguishmentFees_951f6e81-7e50-4218-af7a-f8083e3dcae4" xlink:href="cvs-20211231.xsd#cvs_DebtExtinguishmentFees"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_cvs_DebtExtinguishmentFees_951f6e81-7e50-4218-af7a-f8083e3dcae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b9159e4c-53df-4813-a98d-ace659c18ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b9159e4c-53df-4813-a98d-ace659c18ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_605d9f0e-aa10-44c5-975d-eee30fe9e646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_605d9f0e-aa10-44c5-975d-eee30fe9e646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts_18818d1b-d5a0-4fef-8c92-3686b5d3588d" xlink:href="cvs-20211231.xsd#cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_46e93b21-63bb-4649-b384-594de0320e70" xlink:to="loc_cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts_18818d1b-d5a0-4fef-8c92-3686b5d3588d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits" xlink:type="simple" xlink:href="cvs-20211231.xsd#PensionPlansandOtherPostretirementBenefits"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b7cee83c-f8c9-4994-838c-0f0c34f6f118" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_6e407901-9a93-465d-83f2-d855a9b8669f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b7cee83c-f8c9-4994-838c-0f0c34f6f118" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_6e407901-9a93-465d-83f2-d855a9b8669f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables" xlink:type="simple" xlink:href="cvs-20211231.xsd#PensionPlansandOtherPostretirementBenefitsTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ea53c5aa-e28a-477c-bee9-2786548c2ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_b90959a4-9ce1-40d0-9932-8820a712cec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ea53c5aa-e28a-477c-bee9-2786548c2ba6" xlink:to="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_b90959a4-9ce1-40d0-9932-8820a712cec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_8f3c9177-8cba-4090-9b91-485980437a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ea53c5aa-e28a-477c-bee9-2786548c2ba6" xlink:to="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_8f3c9177-8cba-4090-9b91-485980437a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_40c2ddc6-3f28-4099-8170-7e5a075054b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ea53c5aa-e28a-477c-bee9-2786548c2ba6" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_40c2ddc6-3f28-4099-8170-7e5a075054b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_3352a394-9f06-416d-b786-9514ff470a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ea53c5aa-e28a-477c-bee9-2786548c2ba6" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_3352a394-9f06-416d-b786-9514ff470a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_6ce814d5-2089-4ed3-b4c9-98b1f4b69f65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ea53c5aa-e28a-477c-bee9-2786548c2ba6" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_6ce814d5-2089-4ed3-b4c9-98b1f4b69f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_8b8d0ab4-63ec-4ec0-bf82-a347de446cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ea53c5aa-e28a-477c-bee9-2786548c2ba6" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_8b8d0ab4-63ec-4ec0-bf82-a347de446cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock_39788f7b-7bbc-47a5-92f2-cd9e9105be28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ea53c5aa-e28a-477c-bee9-2786548c2ba6" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock_39788f7b-7bbc-47a5-92f2-cd9e9105be28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_5d025dd2-0419-4d3a-9298-9e11b51072ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ea53c5aa-e28a-477c-bee9-2786548c2ba6" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_5d025dd2-0419-4d3a-9298-9e11b51072ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#PensionPlansandOtherPostretirementBenefitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_19552678-bbfe-429c-b67c-bcba6a1cb74f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_37beb9b5-4dc5-471a-8032-668f1e7261fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_19552678-bbfe-429c-b67c-bcba6a1cb74f" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_37beb9b5-4dc5-471a-8032-668f1e7261fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_0acdc8e1-9f70-4adf-b30a-20d0b6f73674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_37beb9b5-4dc5-471a-8032-668f1e7261fb" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_0acdc8e1-9f70-4adf-b30a-20d0b6f73674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_1c98c97c-94c4-444e-a252-7938181de1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_0acdc8e1-9f70-4adf-b30a-20d0b6f73674" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_1c98c97c-94c4-444e-a252-7938181de1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_7f8f19c9-29b6-41f3-bc62-e1302f0d81bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1c98c97c-94c4-444e-a252-7938181de1ae" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_7f8f19c9-29b6-41f3-bc62-e1302f0d81bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e016841d-515b-4f35-af0f-56966a86f277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1c98c97c-94c4-444e-a252-7938181de1ae" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_e016841d-515b-4f35-af0f-56966a86f277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_bb89d0c6-3fe2-446f-b10a-7ac08d8cb350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_37beb9b5-4dc5-471a-8032-668f1e7261fb" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_bb89d0c6-3fe2-446f-b10a-7ac08d8cb350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_d70364e0-7168-4900-ba28-04b7e7f1ef5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_bb89d0c6-3fe2-446f-b10a-7ac08d8cb350" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_d70364e0-7168-4900-ba28-04b7e7f1ef5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_85c86028-8a0d-4906-befa-924d36994652" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d70364e0-7168-4900-ba28-04b7e7f1ef5b" xlink:to="loc_us-gaap_EquitySecuritiesMember_85c86028-8a0d-4906-befa-924d36994652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_0016d978-9dd7-468f-815a-fc6ef56f1ada" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d70364e0-7168-4900-ba28-04b7e7f1ef5b" xlink:to="loc_us-gaap_DebtSecuritiesMember_0016d978-9dd7-468f-815a-fc6ef56f1ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentMember_48de8a73-272b-47d4-99d0-55a389e642c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealEstateInvestmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d70364e0-7168-4900-ba28-04b7e7f1ef5b" xlink:to="loc_us-gaap_RealEstateInvestmentMember_48de8a73-272b-47d4-99d0-55a389e642c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_ce247c52-700f-4dd1-9a14-e07390fd60cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d70364e0-7168-4900-ba28-04b7e7f1ef5b" xlink:to="loc_us-gaap_PrivateEquityFundsMember_ce247c52-700f-4dd1-9a14-e07390fd60cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_cbca853f-1dd0-45eb-b1e4-dc8255b819c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_d70364e0-7168-4900-ba28-04b7e7f1ef5b" xlink:to="loc_us-gaap_HedgeFundsMember_cbca853f-1dd0-45eb-b1e4-dc8255b819c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4198394a-29bc-42ef-afac-a87f86a99605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_37beb9b5-4dc5-471a-8032-668f1e7261fb" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4198394a-29bc-42ef-afac-a87f86a99605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_7220e771-3e28-4cd2-bcdf-bc48b78e1ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4198394a-29bc-42ef-afac-a87f86a99605" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_7220e771-3e28-4cd2-bcdf-bc48b78e1ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_526b2aad-a585-4b1a-98f0-d1c6e2cbdb24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4198394a-29bc-42ef-afac-a87f86a99605" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_526b2aad-a585-4b1a-98f0-d1c6e2cbdb24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_0c1c13a4-99aa-48bc-a536-e8b5da8b1233" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4198394a-29bc-42ef-afac-a87f86a99605" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_0c1c13a4-99aa-48bc-a536-e8b5da8b1233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_69bb23af-6b62-447c-bc23-a4fedba2c22c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MultiemployerPlanPensionInsignificantPlanContribution"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4198394a-29bc-42ef-afac-a87f86a99605" xlink:to="loc_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution_69bb23af-6b62-447c-bc23-a4fedba2c22c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_efc453c9-f68c-43a9-83d3-6b4c549e12ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4198394a-29bc-42ef-afac-a87f86a99605" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_efc453c9-f68c-43a9-83d3-6b4c549e12ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_05734367-9e87-4631-ab2d-1e2061641067" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4198394a-29bc-42ef-afac-a87f86a99605" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_05734367-9e87-4631-ab2d-1e2061641067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6689300c-f05f-484b-9b9a-2d7d83fc6eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ef7996f0-9266-444e-bd3f-15802e073556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6689300c-f05f-484b-9b9a-2d7d83fc6eb6" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ef7996f0-9266-444e-bd3f-15802e073556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_657ad008-feaa-48f6-8207-05b08df8e3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ef7996f0-9266-444e-bd3f-15802e073556" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_657ad008-feaa-48f6-8207-05b08df8e3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_316e50ec-033f-41d6-a5ed-8cde993bde14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_657ad008-feaa-48f6-8207-05b08df8e3dd" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_316e50ec-033f-41d6-a5ed-8cde993bde14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_422a54f4-0acd-4b91-9af0-b6d7829542a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_316e50ec-033f-41d6-a5ed-8cde993bde14" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_422a54f4-0acd-4b91-9af0-b6d7829542a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_365fc468-a1a1-409a-8125-357130cff67e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ef7996f0-9266-444e-bd3f-15802e073556" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_365fc468-a1a1-409a-8125-357130cff67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_692c0caa-eb69-48f8-9c7e-5a4c282c9364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_365fc468-a1a1-409a-8125-357130cff67e" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_692c0caa-eb69-48f8-9c7e-5a4c282c9364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_c852f86b-62c2-40b9-9d0f-bb44fd492dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_692c0caa-eb69-48f8-9c7e-5a4c282c9364" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_c852f86b-62c2-40b9-9d0f-bb44fd492dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_8948fcce-1d42-4615-81c7-6dd8d4bc2a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_692c0caa-eb69-48f8-9c7e-5a4c282c9364" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_8948fcce-1d42-4615-81c7-6dd8d4bc2a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_d57e587b-d037-4c70-9f31-f062daafed67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_692c0caa-eb69-48f8-9c7e-5a4c282c9364" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_d57e587b-d037-4c70-9f31-f062daafed67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_6fce5a06-574d-4b05-8d6a-2e9c17791036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_692c0caa-eb69-48f8-9c7e-5a4c282c9364" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_6fce5a06-574d-4b05-8d6a-2e9c17791036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_9a56d630-0ecd-438d-b6d2-6295d128e37f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_692c0caa-eb69-48f8-9c7e-5a4c282c9364" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement_9a56d630-0ecd-438d-b6d2-6295d128e37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_d04d840b-1197-45a7-b32a-f93be1c08c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_692c0caa-eb69-48f8-9c7e-5a4c282c9364" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_d04d840b-1197-45a7-b32a-f93be1c08c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a0a9ebfc-e12a-4f95-9e9c-6c0c5fa24d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_365fc468-a1a1-409a-8125-357130cff67e" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a0a9ebfc-e12a-4f95-9e9c-6c0c5fa24d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_02871789-c1b5-43b4-a84f-91da59f4e5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a0a9ebfc-e12a-4f95-9e9c-6c0c5fa24d3b" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_02871789-c1b5-43b4-a84f-91da59f4e5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_fd42bfd5-1a92-4668-a28e-f70dc39285fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a0a9ebfc-e12a-4f95-9e9c-6c0c5fa24d3b" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_fd42bfd5-1a92-4668-a28e-f70dc39285fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_4aaec5b3-2145-4494-ba6c-ace251c98195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a0a9ebfc-e12a-4f95-9e9c-6c0c5fa24d3b" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_4aaec5b3-2145-4494-ba6c-ace251c98195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_67a4dc6c-db64-41a4-8e47-8bc681658ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a0a9ebfc-e12a-4f95-9e9c-6c0c5fa24d3b" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_67a4dc6c-db64-41a4-8e47-8bc681658ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_8fc0f667-5f68-4ba8-bf4f-da478d00d8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanSettlementsPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a0a9ebfc-e12a-4f95-9e9c-6c0c5fa24d3b" xlink:to="loc_us-gaap_DefinedBenefitPlanSettlementsPlanAssets_8fc0f667-5f68-4ba8-bf4f-da478d00d8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c72896a2-a12b-41db-a692-b41f22b356e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_a0a9ebfc-e12a-4f95-9e9c-6c0c5fa24d3b" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_c72896a2-a12b-41db-a692-b41f22b356e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_e7bc97e3-29f0-4b60-b0db-c3545d56d45f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_365fc468-a1a1-409a-8125-357130cff67e" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_e7bc97e3-29f0-4b60-b0db-c3545d56d45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_835162c2-8c64-462a-b898-fb25d3e5b161" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_365fc468-a1a1-409a-8125-357130cff67e" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_835162c2-8c64-462a-b898-fb25d3e5b161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_9f42b758-1d05-4259-8f57-2658e5ea8a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_835162c2-8c64-462a-b898-fb25d3e5b161" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_9f42b758-1d05-4259-8f57-2658e5ea8a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_68a60b1c-8cc6-454c-9fed-b8cb7aa2326c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_835162c2-8c64-462a-b898-fb25d3e5b161" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_68a60b1c-8cc6-454c-9fed-b8cb7aa2326c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_e2547da9-564a-4c0f-98d0-e3ae5b2fffda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_835162c2-8c64-462a-b898-fb25d3e5b161" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_e2547da9-564a-4c0f-98d0-e3ae5b2fffda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_98468a98-bbc7-4a48-9be2-e8b2a4311d51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract_835162c2-8c64-462a-b898-fb25d3e5b161" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_98468a98-bbc7-4a48-9be2-e8b2a4311d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b37f6c58-b98c-41e9-bfaa-38daddaa28d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4ffae4f9-f216-407a-87a4-7ff68b559cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b37f6c58-b98c-41e9-bfaa-38daddaa28d4" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4ffae4f9-f216-407a-87a4-7ff68b559cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_50c5f1c4-b226-4d4b-8b53-67250cb282a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4ffae4f9-f216-407a-87a4-7ff68b559cbe" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_50c5f1c4-b226-4d4b-8b53-67250cb282a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_ace0212e-8a7a-4745-a28f-6330504906a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_50c5f1c4-b226-4d4b-8b53-67250cb282a1" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_ace0212e-8a7a-4745-a28f-6330504906a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_2a372908-72cc-4999-af5e-c1262e606697" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_ace0212e-8a7a-4745-a28f-6330504906a2" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_2a372908-72cc-4999-af5e-c1262e606697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7e68f60a-2147-411e-a09a-3adb27c478b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4ffae4f9-f216-407a-87a4-7ff68b559cbe" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7e68f60a-2147-411e-a09a-3adb27c478b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_99b53265-3874-422f-ba00-1b3f4c38f545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7e68f60a-2147-411e-a09a-3adb27c478b7" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_99b53265-3874-422f-ba00-1b3f4c38f545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_1a651002-cd16-46b4-b67f-362399c19a76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_99b53265-3874-422f-ba00-1b3f4c38f545" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_1a651002-cd16-46b4-b67f-362399c19a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_d8e39575-6734-4459-8461-c09f1524464e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_99b53265-3874-422f-ba00-1b3f4c38f545" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_d8e39575-6734-4459-8461-c09f1524464e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_a3a8aa92-6c88-45d6-9ffe-7ffb1d93a461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_99b53265-3874-422f-ba00-1b3f4c38f545" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_a3a8aa92-6c88-45d6-9ffe-7ffb1d93a461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_fb5a7757-e1f7-4740-9def-3a415a20a62e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_99b53265-3874-422f-ba00-1b3f4c38f545" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1_fb5a7757-e1f7-4740-9def-3a415a20a62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1970ce87-7d1b-4f80-b1ff-6336b8819160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_99b53265-3874-422f-ba00-1b3f4c38f545" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1970ce87-7d1b-4f80-b1ff-6336b8819160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e2a5e37f-5a52-4d50-9308-38d53544624f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_19508f03-d212-4696-a35e-51c36d5f9058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e2a5e37f-5a52-4d50-9308-38d53544624f" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_19508f03-d212-4696-a35e-51c36d5f9058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_7ae1dfd9-26e0-46ea-98f9-1521d33a60d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract_19508f03-d212-4696-a35e-51c36d5f9058" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_7ae1dfd9-26e0-46ea-98f9-1521d33a60d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_4c3091c6-ad7d-4898-b984-2f1b6a960e25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e2a5e37f-5a52-4d50-9308-38d53544624f" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_4c3091c6-ad7d-4898-b984-2f1b6a960e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_4433e54e-a0b2-43d2-90a7-57348676815a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_4c3091c6-ad7d-4898-b984-2f1b6a960e25" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_4433e54e-a0b2-43d2-90a7-57348676815a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_cb57f2ac-7865-461b-b441-40caa152b031" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract_4c3091c6-ad7d-4898-b984-2f1b6a960e25" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_cb57f2ac-7865-461b-b441-40caa152b031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d8735f94-a592-4bf3-9f0a-a24e9efd8a87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce7f508c-b692-4fde-98d3-efd92152d927" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d8735f94-a592-4bf3-9f0a-a24e9efd8a87" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce7f508c-b692-4fde-98d3-efd92152d927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d8d97187-a356-4e9e-854d-73a878bdf18d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce7f508c-b692-4fde-98d3-efd92152d927" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d8d97187-a356-4e9e-854d-73a878bdf18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_0a6ed53d-76b7-49d8-bc81-8c7834ea1bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d8d97187-a356-4e9e-854d-73a878bdf18d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_0a6ed53d-76b7-49d8-bc81-8c7834ea1bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_ff9edbc5-7533-43a2-be78-11a84c430d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_0a6ed53d-76b7-49d8-bc81-8c7834ea1bb5" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_ff9edbc5-7533-43a2-be78-11a84c430d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c24ae6a4-28d8-4032-8419-f13aa8abe47b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce7f508c-b692-4fde-98d3-efd92152d927" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c24ae6a4-28d8-4032-8419-f13aa8abe47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_c24ae6a4-28d8-4032-8419-f13aa8abe47b" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_78aa509f-7825-40b3-9b77-17e549f52450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_78aa509f-7825-40b3-9b77-17e549f52450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_d2045212-e2d4-4823-8fdc-313e3fed0c10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_d2045212-e2d4-4823-8fdc-313e3fed0c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_5b9ed084-9c2d-464a-9d5e-ddce55914266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USStatesAndPoliticalSubdivisionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:to="loc_us-gaap_USStatesAndPoliticalSubdivisionsMember_5b9ed084-9c2d-464a-9d5e-ddce55914266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_d119fdcf-cdaf-48ec-a3c3-b4e28af69f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_d119fdcf-cdaf-48ec-a3c3-b4e28af69f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_c3f3f893-19ba-4a59-a5e2-85ccd8d82b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:to="loc_us-gaap_ForeignCorporateDebtSecuritiesMember_c3f3f893-19ba-4a59-a5e2-85ccd8d82b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_f2f255af-42a5-48d1-8094-239c2a7ae149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_f2f255af-42a5-48d1-8094-239c2a7ae149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6912bd31-fd8e-4176-bca7-1eaf386e208c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_6912bd31-fd8e-4176-bca7-1eaf386e208c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_43005806-a35d-4144-874a-ff859345eab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_43005806-a35d-4144-874a-ff859345eab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RedeemablePreferredSecuritiesMember_d7da209d-7390-4bb8-a2e6-7890dc1a7c67" xlink:href="cvs-20211231.xsd#cvs_RedeemablePreferredSecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesMember_83ecea58-3c68-4117-ab01-cba55692f62e" xlink:to="loc_cvs_RedeemablePreferredSecuritiesMember_d7da209d-7390-4bb8-a2e6-7890dc1a7c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_04fd3925-f76e-42de-93e2-4d38ee69616b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_us-gaap_EquitySecuritiesMember_04fd3925-f76e-42de-93e2-4d38ee69616b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_20759707-2a3e-4d40-b6f8-b34868cbe068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesMember_04fd3925-f76e-42de-93e2-4d38ee69616b" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_20759707-2a3e-4d40-b6f8-b34868cbe068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_3f0f193e-bda5-4ecb-b542-afe1f83cc103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesMember_04fd3925-f76e-42de-93e2-4d38ee69616b" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_3f0f193e-bda5-4ecb-b542-afe1f83cc103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EquitySecuritiesDomesticRealEstateMember_56cf62e2-e799-4e7a-a3b2-54d162f7595a" xlink:href="cvs-20211231.xsd#cvs_EquitySecuritiesDomesticRealEstateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquitySecuritiesMember_04fd3925-f76e-42de-93e2-4d38ee69616b" xlink:to="loc_cvs_EquitySecuritiesDomesticRealEstateMember_56cf62e2-e799-4e7a-a3b2-54d162f7595a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_b4d3a47c-352a-4ac8-a270-fbd98796ab09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_us-gaap_OtherInvestmentsMember_b4d3a47c-352a-4ac8-a270-fbd98796ab09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember_fd3d2ed0-e61e-4c37-a8a5-1751297a08d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentsMember_b4d3a47c-352a-4ac8-a270-fbd98796ab09" xlink:to="loc_us-gaap_DefinedBenefitPlanRealEstateMember_fd3d2ed0-e61e-4c37-a8a5-1751297a08d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_74ae36fa-a746-4be2-8aef-80a9b9d6a600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentsMember_b4d3a47c-352a-4ac8-a270-fbd98796ab09" xlink:to="loc_us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember_74ae36fa-a746-4be2-8aef-80a9b9d6a600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDerivativeMember_0a56baf8-6f49-41da-9bcb-01dcbc04d2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDerivativeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentsMember_b4d3a47c-352a-4ac8-a270-fbd98796ab09" xlink:to="loc_us-gaap_DefinedBenefitPlanDerivativeMember_0a56baf8-6f49-41da-9bcb-01dcbc04d2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_80c34b0f-6237-4c1d-b9aa-275276ec98f1" xlink:href="cvs-20211231.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember_80c34b0f-6237-4c1d-b9aa-275276ec98f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_4f6e4f3a-8f02-451a-943d-e32cf2c7d4a4" xlink:href="cvs-20211231.xsd#cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember_4f6e4f3a-8f02-451a-943d-e32cf2c7d4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivateEquityFundsMember_e4227faf-5b79-48f0-909c-f527aa37ad3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivateEquityFundsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_us-gaap_PrivateEquityFundsMember_e4227faf-5b79-48f0-909c-f527aa37ad3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgeFundsMember_60a7c10d-cd15-4ddd-855a-f19e62f3d039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgeFundsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_us-gaap_HedgeFundsMember_60a7c10d-cd15-4ddd-855a-f19e62f3d039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_8eff31ad-b489-4ed6-9304-f2769e448831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_2081e368-1f2b-4bb0-b810-9dff38bcaab5" xlink:to="loc_us-gaap_AccountsReceivableMember_8eff31ad-b489-4ed6-9304-f2769e448831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f4d2ad0f-711d-466a-b3d7-6ba6978f9cab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce7f508c-b692-4fde-98d3-efd92152d927" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f4d2ad0f-711d-466a-b3d7-6ba6978f9cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d00ca0d-e1b1-4c70-aa5a-1014dcfae844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f4d2ad0f-711d-466a-b3d7-6ba6978f9cab" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d00ca0d-e1b1-4c70-aa5a-1014dcfae844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_05285b04-fe8f-4a39-adcf-92c36a964b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d00ca0d-e1b1-4c70-aa5a-1014dcfae844" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_05285b04-fe8f-4a39-adcf-92c36a964b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_866b6653-e034-45a8-9ddc-9737698ec83c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d00ca0d-e1b1-4c70-aa5a-1014dcfae844" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_866b6653-e034-45a8-9ddc-9737698ec83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_b849082f-6ce8-48b6-9068-0361013e4a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d00ca0d-e1b1-4c70-aa5a-1014dcfae844" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_b849082f-6ce8-48b6-9068-0361013e4a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_dab3cb66-f101-4558-8f82-b6a0d115a3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d00ca0d-e1b1-4c70-aa5a-1014dcfae844" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_dab3cb66-f101-4558-8f82-b6a0d115a3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_400483f9-6d1b-4c1e-b74d-510661f8c165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5d00ca0d-e1b1-4c70-aa5a-1014dcfae844" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_400483f9-6d1b-4c1e-b74d-510661f8c165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdf02ca6-5306-4387-a25c-97fbfa67ec74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ce7f508c-b692-4fde-98d3-efd92152d927" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdf02ca6-5306-4387-a25c-97fbfa67ec74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5b9cc3a1-dcd5-41ed-87ef-ebff09542f09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdf02ca6-5306-4387-a25c-97fbfa67ec74" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5b9cc3a1-dcd5-41ed-87ef-ebff09542f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_a5b3653d-258e-44d2-8be2-5466dacfc73a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_bdf02ca6-5306-4387-a25c-97fbfa67ec74" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount_a5b3653d-258e-44d2-8be2-5466dacfc73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1b3baf15-d0ae-4596-a9ec-0cbe0766cd85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8b814554-3f53-4279-9a16-5d52f105986b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1b3baf15-d0ae-4596-a9ec-0cbe0766cd85" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8b814554-3f53-4279-9a16-5d52f105986b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d4e41bbc-4cc6-4a8d-8dc5-dc1096958dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8b814554-3f53-4279-9a16-5d52f105986b" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d4e41bbc-4cc6-4a8d-8dc5-dc1096958dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_0425e3f7-c51f-49d8-ac58-56493a941edc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_d4e41bbc-4cc6-4a8d-8dc5-dc1096958dd6" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_0425e3f7-c51f-49d8-ac58-56493a941edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRealEstateMember_af59a298-7b06-4e0e-b180-ce3eae15d47d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0425e3f7-c51f-49d8-ac58-56493a941edc" xlink:to="loc_us-gaap_DefinedBenefitPlanRealEstateMember_af59a298-7b06-4e0e-b180-ce3eae15d47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_24e34895-d91d-4f41-b718-b6c3988c6c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_0425e3f7-c51f-49d8-ac58-56493a941edc" xlink:to="loc_us-gaap_DomesticCorporateDebtSecuritiesMember_24e34895-d91d-4f41-b718-b6c3988c6c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37fb479a-2e20-4f75-bed4-645ca5648227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8b814554-3f53-4279-9a16-5d52f105986b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37fb479a-2e20-4f75-bed4-645ca5648227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88cfce68-5f80-4979-b9b5-f07b2da092e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_37fb479a-2e20-4f75-bed4-645ca5648227" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88cfce68-5f80-4979-b9b5-f07b2da092e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_665dcd00-2239-4b25-918b-957d29923238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_88cfce68-5f80-4979-b9b5-f07b2da092e1" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_665dcd00-2239-4b25-918b-957d29923238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_7d6692b7-eebd-48e1-821c-096f47c3989f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8b814554-3f53-4279-9a16-5d52f105986b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_7d6692b7-eebd-48e1-821c-096f47c3989f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_29ea8122-441e-4d67-ad77-1ab92a9a3ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_7d6692b7-eebd-48e1-821c-096f47c3989f" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_29ea8122-441e-4d67-ad77-1ab92a9a3ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_2405e2aa-c171-4302-8953-fac7f1cb9042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_29ea8122-441e-4d67-ad77-1ab92a9a3ff9" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_2405e2aa-c171-4302-8953-fac7f1cb9042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7f572a8c-9093-440d-8a64-2f7cdab8ff8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_8b814554-3f53-4279-9a16-5d52f105986b" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7f572a8c-9093-440d-8a64-2f7cdab8ff8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7e38c20d-babc-4663-a685-d2baeb07626d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_7f572a8c-9093-440d-8a64-2f7cdab8ff8d" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7e38c20d-babc-4663-a685-d2baeb07626d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_167a6be2-cc70-439b-93ba-45a96b650d25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7e38c20d-babc-4663-a685-d2baeb07626d" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_167a6be2-cc70-439b-93ba-45a96b650d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_7aa4bc95-2d7d-447d-8f5d-3aa79e6e31c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7e38c20d-babc-4663-a685-d2baeb07626d" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld_7aa4bc95-2d7d-447d-8f5d-3aa79e6e31c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_f9d06efb-3e75-4043-97ee-dd73777cd66d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7e38c20d-babc-4663-a685-d2baeb07626d" xlink:to="loc_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements_f9d06efb-3e75-4043-97ee-dd73777cd66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_b070766e-6981-43c7-8f93-7990fec6f4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7e38c20d-babc-4663-a685-d2baeb07626d" xlink:to="loc_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels_b070766e-6981-43c7-8f93-7990fec6f4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_258c2d6e-91cc-4b74-8d93-93fa3bbbb6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_7e38c20d-babc-4663-a685-d2baeb07626d" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_258c2d6e-91cc-4b74-8d93-93fa3bbbb6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_840fb572-442a-48ed-9d49-9f5e7fd30930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f7fef02c-8be1-4332-a0c6-b6f1bef6fc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_840fb572-442a-48ed-9d49-9f5e7fd30930" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f7fef02c-8be1-4332-a0c6-b6f1bef6fc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_a1653802-2a80-45f6-9480-2d1468ac7108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f7fef02c-8be1-4332-a0c6-b6f1bef6fc6a" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_a1653802-2a80-45f6-9480-2d1468ac7108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d2e17f24-64b2-4f28-ac10-1ecfb88c90d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_a1653802-2a80-45f6-9480-2d1468ac7108" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d2e17f24-64b2-4f28-ac10-1ecfb88c90d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_1b774f61-94f8-49cb-9b66-22f9126c316e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_d2e17f24-64b2-4f28-ac10-1ecfb88c90d3" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_1b774f61-94f8-49cb-9b66-22f9126c316e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_be68e1a6-0c52-4765-9366-714c97fa5d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_d2e17f24-64b2-4f28-ac10-1ecfb88c90d3" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_be68e1a6-0c52-4765-9366-714c97fa5d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1826cfa2-3ada-4ca6-8296-2d4ff1d406f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f7fef02c-8be1-4332-a0c6-b6f1bef6fc6a" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1826cfa2-3ada-4ca6-8296-2d4ff1d406f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_a2c61293-0779-49c6-8075-1815d44a542a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1826cfa2-3ada-4ca6-8296-2d4ff1d406f3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_a2c61293-0779-49c6-8075-1815d44a542a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_0c997312-0ddc-4533-abbe-14a8c25b8476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1826cfa2-3ada-4ca6-8296-2d4ff1d406f3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_0c997312-0ddc-4533-abbe-14a8c25b8476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_d04ed668-4a7d-4e7d-9f7b-1356dcc64808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1826cfa2-3ada-4ca6-8296-2d4ff1d406f3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_d04ed668-4a7d-4e7d-9f7b-1356dcc64808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_6e320e80-6c34-4f5c-a610-54f79919485a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1826cfa2-3ada-4ca6-8296-2d4ff1d406f3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_6e320e80-6c34-4f5c-a610-54f79919485a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_e6b45e25-26ce-47e7-8a33-e48f519f6ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1826cfa2-3ada-4ca6-8296-2d4ff1d406f3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_e6b45e25-26ce-47e7-8a33-e48f519f6ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_2c90c0ac-6588-490c-a53f-a43bc6dab713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1826cfa2-3ada-4ca6-8296-2d4ff1d406f3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_2c90c0ac-6588-490c-a53f-a43bc6dab713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cvs-20211231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_bbb0429b-9d66-4565-9709-389fe8a13ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_ebf43b59-7b0f-47ae-9f26-ab680cbca21c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bbb0429b-9d66-4565-9709-389fe8a13ed7" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_ebf43b59-7b0f-47ae-9f26-ab680cbca21c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="cvs-20211231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e157f0f1-0273-4ade-baa7-9ce938b80ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_b36516a5-3cad-4ced-829e-561e228b186b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e157f0f1-0273-4ade-baa7-9ce938b80ff9" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_b36516a5-3cad-4ced-829e-561e228b186b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_621c7480-5aef-4341-a30d-1edda77d1b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e157f0f1-0273-4ade-baa7-9ce938b80ff9" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_621c7480-5aef-4341-a30d-1edda77d1b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_5571be1a-bc17-4513-a644-96c96f8a073f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e157f0f1-0273-4ade-baa7-9ce938b80ff9" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_5571be1a-bc17-4513-a644-96c96f8a073f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_9562a091-26ee-442d-a162-5af7ace2828b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e157f0f1-0273-4ade-baa7-9ce938b80ff9" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_9562a091-26ee-442d-a162-5af7ace2828b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#IncomeTaxesIncomeTaxProvisionDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_050285a0-26ec-4fdf-8c44-a527582c826f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_32062d42-e1a1-4b46-84cb-84a45e80e80b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_050285a0-26ec-4fdf-8c44-a527582c826f" xlink:to="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_32062d42-e1a1-4b46-84cb-84a45e80e80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_02a5aae1-2194-492e-a469-28b4a36b03b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_32062d42-e1a1-4b46-84cb-84a45e80e80b" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_02a5aae1-2194-492e-a469-28b4a36b03b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_09033fcd-a6a7-4e14-bcf1-86205099da0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_02a5aae1-2194-492e-a469-28b4a36b03b1" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_09033fcd-a6a7-4e14-bcf1-86205099da0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_664094c1-a339-4746-b795-a5d5e75aaf25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_02a5aae1-2194-492e-a469-28b4a36b03b1" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_664094c1-a339-4746-b795-a5d5e75aaf25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_a268ba47-8b3c-4de4-9977-50d9da805179" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_02a5aae1-2194-492e-a469-28b4a36b03b1" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_a268ba47-8b3c-4de4-9977-50d9da805179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d3ae95b2-6a9d-429f-8298-36e2fab5bd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_32062d42-e1a1-4b46-84cb-84a45e80e80b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d3ae95b2-6a9d-429f-8298-36e2fab5bd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_e09d965b-ae5a-460f-8804-b8885edfaa8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d3ae95b2-6a9d-429f-8298-36e2fab5bd0c" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_e09d965b-ae5a-460f-8804-b8885edfaa8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_aab07f9d-93f7-4c33-bd2a-5ad549b0d0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d3ae95b2-6a9d-429f-8298-36e2fab5bd0c" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_aab07f9d-93f7-4c33-bd2a-5ad549b0d0b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fb8f6b31-90a9-4d56-9b00-8a519ba0ba98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d3ae95b2-6a9d-429f-8298-36e2fab5bd0c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_fb8f6b31-90a9-4d56-9b00-8a519ba0ba98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_cd73496c-d536-43d5-b302-3c44fff6c9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_32062d42-e1a1-4b46-84cb-84a45e80e80b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_cd73496c-d536-43d5-b302-3c44fff6c9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_98c53a7e-bc80-4434-aeee-b9d443e2217a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_35c09134-1369-4dd3-909a-79ce93a47f55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_98c53a7e-bc80-4434-aeee-b9d443e2217a" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_35c09134-1369-4dd3-909a-79ce93a47f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a5809df3-d232-47dd-94bc-2abd0856bf76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_98c53a7e-bc80-4434-aeee-b9d443e2217a" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_a5809df3-d232-47dd-94bc-2abd0856bf76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_a0fd6f7a-2456-4119-a2c7-43c2fc4fe956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_98c53a7e-bc80-4434-aeee-b9d443e2217a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_a0fd6f7a-2456-4119-a2c7-43c2fc4fe956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_36cb1bf7-0b3e-47b1-a9c1-3d5bde0ee879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_98c53a7e-bc80-4434-aeee-b9d443e2217a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_36cb1bf7-0b3e-47b1-a9c1-3d5bde0ee879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_a9414935-5157-484a-bb7f-e56495a6f09e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_98c53a7e-bc80-4434-aeee-b9d443e2217a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_a9414935-5157-484a-bb7f-e56495a6f09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#IncomeTaxesEffectiveTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f8cee765-9dc9-4695-bf1f-27f74634757f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3a63548-9471-491d-9080-6e01251528f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f8cee765-9dc9-4695-bf1f-27f74634757f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3a63548-9471-491d-9080-6e01251528f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2e03ec61-10dd-42a8-91bb-f68d129660a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3a63548-9471-491d-9080-6e01251528f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2e03ec61-10dd-42a8-91bb-f68d129660a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dea83e35-ecb1-485a-b3cf-2adff66d44a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3a63548-9471-491d-9080-6e01251528f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_dea83e35-ecb1-485a-b3cf-2adff66d44a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthInsurerFeeTaxEffectPercent_7056cd5d-a632-4934-9e6c-08b512935d00" xlink:href="cvs-20211231.xsd#cvs_HealthInsurerFeeTaxEffectPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3a63548-9471-491d-9080-6e01251528f1" xlink:to="loc_cvs_HealthInsurerFeeTaxEffectPercent_7056cd5d-a632-4934-9e6c-08b512935d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_309f8823-98aa-48a8-ac64-f2fb40c88b61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3a63548-9471-491d-9080-6e01251528f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness_309f8823-98aa-48a8-ac64-f2fb40c88b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_901cdb8e-87d5-4bd0-aa81-bdeda7f5b9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3a63548-9471-491d-9080-6e01251528f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic_901cdb8e-87d5-4bd0-aa81-bdeda7f5b9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_93cbe240-c063-41c6-911e-49e5fdf16d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3a63548-9471-491d-9080-6e01251528f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_93cbe240-c063-41c6-911e-49e5fdf16d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9de07a3c-0a9b-40dc-9fb7-a2fd0d6f1488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3a63548-9471-491d-9080-6e01251528f1" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9de07a3c-0a9b-40dc-9fb7-a2fd0d6f1488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_942fa015-3788-489a-9911-5c675e1253e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_72e76df3-98e4-42a0-a275-4c43d856c04d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_942fa015-3788-489a-9911-5c675e1253e1" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_72e76df3-98e4-42a0-a275-4c43d856c04d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_056f2023-c102-45d0-a484-8edcb3dc8bce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_72e76df3-98e4-42a0-a275-4c43d856c04d" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_056f2023-c102-45d0-a484-8edcb3dc8bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_cfa9083b-3b32-4616-9550-cdee0018e15b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_056f2023-c102-45d0-a484-8edcb3dc8bce" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent_cfa9083b-3b32-4616-9550-cdee0018e15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_7c2daa16-cbf8-4353-a9a7-4b05e30543eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_056f2023-c102-45d0-a484-8edcb3dc8bce" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_7c2daa16-cbf8-4353-a9a7-4b05e30543eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_032336ed-75d6-4ae3-a9e2-8166d8c57ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_056f2023-c102-45d0-a484-8edcb3dc8bce" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_032336ed-75d6-4ae3-a9e2-8166d8c57ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_ec59190d-73d5-49c4-be17-186e956be9b0" xlink:href="cvs-20211231.xsd#cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_056f2023-c102-45d0-a484-8edcb3dc8bce" xlink:to="loc_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances_ec59190d-73d5-49c4-be17-186e956be9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_11e0412c-3e74-40d0-9927-4be236c77854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_056f2023-c102-45d0-a484-8edcb3dc8bce" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_11e0412c-3e74-40d0-9927-4be236c77854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsDeferredIncome_f4185c06-523a-412a-9071-e059d2fb9b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_056f2023-c102-45d0-a484-8edcb3dc8bce" xlink:to="loc_us-gaap_DeferredTaxAssetsDeferredIncome_f4185c06-523a-412a-9071-e059d2fb9b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_9fd4f6fc-3c6b-4ed8-bdff-c59e38abc248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_056f2023-c102-45d0-a484-8edcb3dc8bce" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_9fd4f6fc-3c6b-4ed8-bdff-c59e38abc248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral_701d821b-b82d-456b-9dfd-e9547df1a2ff" xlink:href="cvs-20211231.xsd#cvs_DeferredTaxAssetsPayrollTaxDeferral"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_056f2023-c102-45d0-a484-8edcb3dc8bce" xlink:to="loc_cvs_DeferredTaxAssetsPayrollTaxDeferral_701d821b-b82d-456b-9dfd-e9547df1a2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_9bea7589-b65e-46db-b13e-98debe749dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_056f2023-c102-45d0-a484-8edcb3dc8bce" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_9bea7589-b65e-46db-b13e-98debe749dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2c62fbdd-c67e-4893-8e61-e03daf52c2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_056f2023-c102-45d0-a484-8edcb3dc8bce" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2c62fbdd-c67e-4893-8e61-e03daf52c2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_e7dc9f71-40c3-4e80-aee0-2673459347b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_056f2023-c102-45d0-a484-8edcb3dc8bce" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_e7dc9f71-40c3-4e80-aee0-2673459347b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_9e74dbbe-6ca8-4478-a145-170c9637b302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_72e76df3-98e4-42a0-a275-4c43d856c04d" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_9e74dbbe-6ca8-4478-a145-170c9637b302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits_c163153f-e029-40dd-bb53-7fd6702cda46" xlink:href="cvs-20211231.xsd#cvs_DeferredTaxLiabilitiesRetirementBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_9e74dbbe-6ca8-4478-a145-170c9637b302" xlink:to="loc_cvs_DeferredTaxLiabilitiesRetirementBenefits_c163153f-e029-40dd-bb53-7fd6702cda46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_b089f6fa-6f41-40a7-9d60-173079fbeee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_9e74dbbe-6ca8-4478-a145-170c9637b302" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_b089f6fa-6f41-40a7-9d60-173079fbeee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_7fa6e583-e67c-41b0-8502-1783bbbb96f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_9e74dbbe-6ca8-4478-a145-170c9637b302" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_7fa6e583-e67c-41b0-8502-1783bbbb96f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_bf5c0017-8910-4d87-ba6b-747305606699" xlink:href="cvs-20211231.xsd#cvs_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_9e74dbbe-6ca8-4478-a145-170c9637b302" xlink:to="loc_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization_bf5c0017-8910-4d87-ba6b-747305606699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_289b3536-a33b-470e-a7de-92a0c1a9f2da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_72e76df3-98e4-42a0-a275-4c43d856c04d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_289b3536-a33b-470e-a7de-92a0c1a9f2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_595c293a-f6a6-4961-b030-47af0033910a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract_72e76df3-98e4-42a0-a275-4c43d856c04d" xlink:to="loc_us-gaap_DeferredTaxLiabilities_595c293a-f6a6-4961-b030-47af0033910a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#IncomeTaxesUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4f4d2faf-328a-49d9-bb35-afea0f22055d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a57ce70b-a8a8-4801-b1fa-203f39e51d89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4f4d2faf-328a-49d9-bb35-afea0f22055d" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a57ce70b-a8a8-4801-b1fa-203f39e51d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_62264692-fb51-4e60-9989-52d843fbe78d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a57ce70b-a8a8-4801-b1fa-203f39e51d89" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_62264692-fb51-4e60-9989-52d843fbe78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_e47b21a8-d8fd-472d-a233-afffb0f4ab8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a57ce70b-a8a8-4801-b1fa-203f39e51d89" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_e47b21a8-d8fd-472d-a233-afffb0f4ab8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_8ba84712-53f0-4931-9bdd-80979735dfee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a57ce70b-a8a8-4801-b1fa-203f39e51d89" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_8ba84712-53f0-4931-9bdd-80979735dfee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_21f57d5d-2f89-4036-bad1-05ecd07f0969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a57ce70b-a8a8-4801-b1fa-203f39e51d89" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_21f57d5d-2f89-4036-bad1-05ecd07f0969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_c24e4620-eca3-4548-b47a-02df9706c108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a57ce70b-a8a8-4801-b1fa-203f39e51d89" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_c24e4620-eca3-4548-b47a-02df9706c108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_720cb870-66d2-492d-bf0d-a807f31ec99c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a57ce70b-a8a8-4801-b1fa-203f39e51d89" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_720cb870-66d2-492d-bf0d-a807f31ec99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_7b02c05a-740d-435e-95dc-b868b2f8edac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_a57ce70b-a8a8-4801-b1fa-203f39e51d89" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_7b02c05a-740d-435e-95dc-b868b2f8edac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlans" xlink:type="simple" xlink:href="cvs-20211231.xsd#StockIncentivePlans"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fa970427-0ffb-4440-9c37-9f6ddebe552e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_e05074a2-ddc2-46f6-92a8-e1191fd072a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fa970427-0ffb-4440-9c37-9f6ddebe552e" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_e05074a2-ddc2-46f6-92a8-e1191fd072a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansTables" xlink:type="simple" xlink:href="cvs-20211231.xsd#StockIncentivePlansTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c9c9dd30-d20c-4082-97d5-b9ac565c3a48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_f4ddabef-55d3-4076-8f8a-1be82786be58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c9c9dd30-d20c-4082-97d5-b9ac565c3a48" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_f4ddabef-55d3-4076-8f8a-1be82786be58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_0eb09832-dc8b-4c07-a579-28089ba40f14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c9c9dd30-d20c-4082-97d5-b9ac565c3a48" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_0eb09832-dc8b-4c07-a579-28089ba40f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_4b862227-f20e-4bc4-a106-d85be9200292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c9c9dd30-d20c-4082-97d5-b9ac565c3a48" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_4b862227-f20e-4bc4-a106-d85be9200292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_4afbe4f6-ee46-431b-ad33-730da5aa85d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c9c9dd30-d20c-4082-97d5-b9ac565c3a48" xlink:to="loc_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock_4afbe4f6-ee46-431b-ad33-730da5aa85d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_e155ab39-4a5b-4fe7-bc9f-9e0afce3ac7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c9c9dd30-d20c-4082-97d5-b9ac565c3a48" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_e155ab39-4a5b-4fe7-bc9f-9e0afce3ac7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_cf97624e-d1f7-4b35-8531-e5ec1c93f584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c9c9dd30-d20c-4082-97d5-b9ac565c3a48" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_cf97624e-d1f7-4b35-8531-e5ec1c93f584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5221114c-20a3-49e1-8b37-6e7104b3b6e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f16b594a-7033-4436-a87f-dc6d5bb40140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5221114c-20a3-49e1-8b37-6e7104b3b6e2" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f16b594a-7033-4436-a87f-dc6d5bb40140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1a2b006e-1df7-4387-b332-825b4599b88c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f16b594a-7033-4436-a87f-dc6d5bb40140" xlink:to="loc_us-gaap_PlanNameAxis_1a2b006e-1df7-4387-b332-825b4599b88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5ec5f3b8-aab5-46ce-a2c1-e9d404cee02c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_1a2b006e-1df7-4387-b332-825b4599b88c" xlink:to="loc_us-gaap_PlanNameDomain_5ec5f3b8-aab5-46ce-a2c1-e9d404cee02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember_c5a2869f-c4db-4ef4-aaaa-e97e971672a8" xlink:href="cvs-20211231.xsd#cvs_CVSHealth2017IncentiveCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_5ec5f3b8-aab5-46ce-a2c1-e9d404cee02c" xlink:to="loc_cvs_CVSHealth2017IncentiveCompensationPlanMember_c5a2869f-c4db-4ef4-aaaa-e97e971672a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AetnaInc2010StockIncentivePlanMember_e7ebe55b-10a3-463f-b8b9-83a79301246a" xlink:href="cvs-20211231.xsd#cvs_AetnaInc2010StockIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_5ec5f3b8-aab5-46ce-a2c1-e9d404cee02c" xlink:to="loc_cvs_AetnaInc2010StockIncentivePlanMember_e7ebe55b-10a3-463f-b8b9-83a79301246a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e63fef4b-92be-4c52-b387-e55e40f9894a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f16b594a-7033-4436-a87f-dc6d5bb40140" xlink:to="loc_srt_RangeAxis_e63fef4b-92be-4c52-b387-e55e40f9894a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8c375166-3a2c-40e2-9a99-c4041f2724f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e63fef4b-92be-4c52-b387-e55e40f9894a" xlink:to="loc_srt_RangeMember_8c375166-3a2c-40e2-9a99-c4041f2724f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6cc38335-29ee-4e84-aab8-42695a72333a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8c375166-3a2c-40e2-9a99-c4041f2724f1" xlink:to="loc_srt_MinimumMember_6cc38335-29ee-4e84-aab8-42695a72333a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8af31fe0-1ac5-47f4-99b4-bcc8afa33220" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8c375166-3a2c-40e2-9a99-c4041f2724f1" xlink:to="loc_srt_MaximumMember_8af31fe0-1ac5-47f4-99b4-bcc8afa33220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f196500a-28e2-4eb0-932e-8e93fd54b7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f16b594a-7033-4436-a87f-dc6d5bb40140" xlink:to="loc_us-gaap_AwardTypeAxis_f196500a-28e2-4eb0-932e-8e93fd54b7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7010c31-6095-4d90-889e-2ca4d56b051d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f196500a-28e2-4eb0-932e-8e93fd54b7b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7010c31-6095-4d90-889e-2ca4d56b051d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_12aa7bc4-c878-464b-a7ab-6c4d65190efe" xlink:href="cvs-20211231.xsd#cvs_EmployeeStockOptionsandStockAppreciationRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7010c31-6095-4d90-889e-2ca4d56b051d" xlink:to="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_12aa7bc4-c878-464b-a7ab-6c4d65190efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_2219bce7-21e2-478e-a44a-dca83d3383f2" xlink:href="cvs-20211231.xsd#cvs_RestrictedStockUnitsandPerformanceShareUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7010c31-6095-4d90-889e-2ca4d56b051d" xlink:to="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_2219bce7-21e2-478e-a44a-dca83d3383f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_8c73edb9-d458-4025-98fc-d2e113db94d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7010c31-6095-4d90-889e-2ca4d56b051d" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_8c73edb9-d458-4025-98fc-d2e113db94d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e5ec4dec-698e-48e7-99ae-f9dbe9ac5fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7010c31-6095-4d90-889e-2ca4d56b051d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e5ec4dec-698e-48e7-99ae-f9dbe9ac5fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_c02cdb48-d161-458c-a09b-f98d58bae602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a7010c31-6095-4d90-889e-2ca4d56b051d" xlink:to="loc_us-gaap_EmployeeStockMember_c02cdb48-d161-458c-a09b-f98d58bae602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f16b594a-7033-4436-a87f-dc6d5bb40140" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ae4fc267-b0ad-4ae5-a95b-689729860690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ae4fc267-b0ad-4ae5-a95b-689729860690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_34165bc1-1a72-43f8-b848-18e44b242dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_34165bc1-1a72-43f8-b848-18e44b242dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f15c47d8-0694-4d07-8513-912e8682208c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f15c47d8-0694-4d07-8513-912e8682208c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_61f6c05e-0044-4e51-8fe3-accb5f22fccb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_61f6c05e-0044-4e51-8fe3-accb5f22fccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_105c1b7f-b264-45d9-b06d-36d58a5d48a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_105c1b7f-b264-45d9-b06d-36d58a5d48a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_3057929b-82ea-44e6-9a96-480cd7e9426e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_3057929b-82ea-44e6-9a96-480cd7e9426e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7d1797ea-4a16-4224-9de7-7ab40db2a93f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7d1797ea-4a16-4224-9de7-7ab40db2a93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_102fe7c8-f749-4725-b84f-2505ba004080" xlink:href="cvs-20211231.xsd#cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased_102fe7c8-f749-4725-b84f-2505ba004080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_b8c16b65-d158-49a1-aa06-40c55bdd7816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_b8c16b65-d158-49a1-aa06-40c55bdd7816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8ccfb6f7-4d54-4c98-bfd7-9616a7f6f520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8ccfb6f7-4d54-4c98-bfd7-9616a7f6f520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0cb077c9-a128-42e3-a8e0-ffaf285585e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0cb077c9-a128-42e3-a8e0-ffaf285585e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_590c8316-c49a-4ac7-b72b-12a7b6ede87e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_590c8316-c49a-4ac7-b72b-12a7b6ede87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_4e26101f-6b60-45fd-98c1-09faab64c1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_4e26101f-6b60-45fd-98c1-09faab64c1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber_9aa5ca6a-b96b-49c1-a0bb-fca8678834c7" xlink:href="cvs-20211231.xsd#cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0123bdd6-497f-4ed8-9d26-998b2ae0d51a" xlink:to="loc_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber_9aa5ca6a-b96b-49c1-a0bb-fca8678834c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#StockIncentivePlansValuationandAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1075e2d8-6711-41ed-9524-adf75ba03816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3f8a05a8-fc8f-4ebc-a34b-3c564663c031" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1075e2d8-6711-41ed-9524-adf75ba03816" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3f8a05a8-fc8f-4ebc-a34b-3c564663c031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9d106914-8a1b-4f9b-b356-36b57a466614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3f8a05a8-fc8f-4ebc-a34b-3c564663c031" xlink:to="loc_us-gaap_AwardTypeAxis_9d106914-8a1b-4f9b-b356-36b57a466614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_255bf4c1-1536-4966-af86-4104ccde321a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9d106914-8a1b-4f9b-b356-36b57a466614" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_255bf4c1-1536-4966-af86-4104ccde321a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_33d48d97-8d30-4583-ba53-62f4231e50e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_255bf4c1-1536-4966-af86-4104ccde321a" xlink:to="loc_us-gaap_EmployeeStockMember_33d48d97-8d30-4583-ba53-62f4231e50e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_a9a21f6a-1351-47d5-85ae-6d848290ea87" xlink:href="cvs-20211231.xsd#cvs_EmployeeStockOptionsandStockAppreciationRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_255bf4c1-1536-4966-af86-4104ccde321a" xlink:to="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_a9a21f6a-1351-47d5-85ae-6d848290ea87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2d187daf-8980-428f-b6e9-ce98ee14eb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_255bf4c1-1536-4966-af86-4104ccde321a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2d187daf-8980-428f-b6e9-ce98ee14eb5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db3b9772-46e7-48da-9c47-511adea2aeed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3f8a05a8-fc8f-4ebc-a34b-3c564663c031" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db3b9772-46e7-48da-9c47-511adea2aeed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c3cf9aa6-4f1d-481a-bc94-481e3a2f7afb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db3b9772-46e7-48da-9c47-511adea2aeed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c3cf9aa6-4f1d-481a-bc94-481e3a2f7afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_837a4384-cf5d-4fec-b10f-c3645ef769dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db3b9772-46e7-48da-9c47-511adea2aeed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_837a4384-cf5d-4fec-b10f-c3645ef769dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d4b5b42c-4dca-418c-b44b-3611e924ece6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db3b9772-46e7-48da-9c47-511adea2aeed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_d4b5b42c-4dca-418c-b44b-3611e924ece6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_777ed994-d3a3-4a44-9295-0cd904587d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db3b9772-46e7-48da-9c47-511adea2aeed" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_777ed994-d3a3-4a44-9295-0cd904587d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dc7ad3f3-d803-44a2-97f1-a9ad3b39d371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db3b9772-46e7-48da-9c47-511adea2aeed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dc7ad3f3-d803-44a2-97f1-a9ad3b39d371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#StockIncentivePlansRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d16d6aa9-a0b7-4715-be3d-8d46ab8c2519" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d9e4d0de-307c-485c-8513-2cd8aaee5090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d16d6aa9-a0b7-4715-be3d-8d46ab8c2519" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d9e4d0de-307c-485c-8513-2cd8aaee5090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9d541f69-ee0e-4630-b2f6-58e5f4330e94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d9e4d0de-307c-485c-8513-2cd8aaee5090" xlink:to="loc_us-gaap_AwardTypeAxis_9d541f69-ee0e-4630-b2f6-58e5f4330e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ba8bd0e3-d076-4702-8ea6-0ce36ef839fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9d541f69-ee0e-4630-b2f6-58e5f4330e94" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ba8bd0e3-d076-4702-8ea6-0ce36ef839fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_67d4985e-1114-482c-809d-9881ec939e7d" xlink:href="cvs-20211231.xsd#cvs_RestrictedStockUnitsandPerformanceShareUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ba8bd0e3-d076-4702-8ea6-0ce36ef839fd" xlink:to="loc_cvs_RestrictedStockUnitsandPerformanceShareUnitsMember_67d4985e-1114-482c-809d-9881ec939e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80e450d9-b636-4c60-9f3e-000c011252ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d9e4d0de-307c-485c-8513-2cd8aaee5090" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80e450d9-b636-4c60-9f3e-000c011252ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26352bf8-60a7-4889-a698-5a95f8c22b58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80e450d9-b636-4c60-9f3e-000c011252ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26352bf8-60a7-4889-a698-5a95f8c22b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_39e80692-4ce0-47bf-93af-56632fa35055" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26352bf8-60a7-4889-a698-5a95f8c22b58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_39e80692-4ce0-47bf-93af-56632fa35055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ce46c891-6882-4709-bb4d-2011b5678f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26352bf8-60a7-4889-a698-5a95f8c22b58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ce46c891-6882-4709-bb4d-2011b5678f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_87c89057-1fa4-46af-bc68-537296c9d26c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26352bf8-60a7-4889-a698-5a95f8c22b58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_87c89057-1fa4-46af-bc68-537296c9d26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d58c7f3d-9f49-46e5-b4fc-25ed0aea3507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26352bf8-60a7-4889-a698-5a95f8c22b58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d58c7f3d-9f49-46e5-b4fc-25ed0aea3507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_fb2f698f-164b-4467-8099-bf895fb15865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26352bf8-60a7-4889-a698-5a95f8c22b58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_fb2f698f-164b-4467-8099-bf895fb15865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91e0d106-eae8-4dcb-ae60-b82707dcb607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_80e450d9-b636-4c60-9f3e-000c011252ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91e0d106-eae8-4dcb-ae60-b82707dcb607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_afaf1db5-3881-4ace-af6d-52965391d7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91e0d106-eae8-4dcb-ae60-b82707dcb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_afaf1db5-3881-4ace-af6d-52965391d7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_719fa737-7690-478a-bf32-8b1a09960ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91e0d106-eae8-4dcb-ae60-b82707dcb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_719fa737-7690-478a-bf32-8b1a09960ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e2515894-b969-49a3-a6f0-a15aec8776bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91e0d106-eae8-4dcb-ae60-b82707dcb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e2515894-b969-49a3-a6f0-a15aec8776bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_59e2be26-0c4c-4527-b403-ec764994026d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91e0d106-eae8-4dcb-ae60-b82707dcb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_59e2be26-0c4c-4527-b403-ec764994026d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_329bb4fd-01f3-4b42-aa53-68005c235b27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_91e0d106-eae8-4dcb-ae60-b82707dcb607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_329bb4fd-01f3-4b42-aa53-68005c235b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#StockIncentivePlansStockOptionandSARActivityDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_30a29c96-aec9-42db-bd90-c5c44686e56b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98d517d2-3de0-4e5f-8dfc-cbb089d74049" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_30a29c96-aec9-42db-bd90-c5c44686e56b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98d517d2-3de0-4e5f-8dfc-cbb089d74049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1d5137cf-5e8c-4007-ae49-219fe85ed9c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98d517d2-3de0-4e5f-8dfc-cbb089d74049" xlink:to="loc_us-gaap_AwardTypeAxis_1d5137cf-5e8c-4007-ae49-219fe85ed9c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c1e7075f-613e-4d31-8096-6b951b55fbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1d5137cf-5e8c-4007-ae49-219fe85ed9c7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c1e7075f-613e-4d31-8096-6b951b55fbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member_ca03ac8e-d2c2-4272-8bba-b8ef3613b8ef" xlink:href="cvs-20211231.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c1e7075f-613e-4d31-8096-6b951b55fbb5" xlink:to="loc_cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member_ca03ac8e-d2c2-4272-8bba-b8ef3613b8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member_c0ff7d16-06c9-4c07-844e-7a16471d557d" xlink:href="cvs-20211231.xsd#cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c1e7075f-613e-4d31-8096-6b951b55fbb5" xlink:to="loc_cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member_c0ff7d16-06c9-4c07-844e-7a16471d557d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_c2dfdf35-f08d-4e35-92f6-a24983f59561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c1e7075f-613e-4d31-8096-6b951b55fbb5" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_c2dfdf35-f08d-4e35-92f6-a24983f59561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_5f26ef89-6b67-48a0-80b2-f30c0bd259d3" xlink:href="cvs-20211231.xsd#cvs_EmployeeStockOptionsandStockAppreciationRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c1e7075f-613e-4d31-8096-6b951b55fbb5" xlink:to="loc_cvs_EmployeeStockOptionsandStockAppreciationRightsMember_5f26ef89-6b67-48a0-80b2-f30c0bd259d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_98d517d2-3de0-4e5f-8dfc-cbb089d74049" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_996c4389-702b-4ef6-bca4-aa21ad6a46b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_996c4389-702b-4ef6-bca4-aa21ad6a46b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_aa222027-8df7-4c0c-8a38-53091b4dd119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_aa222027-8df7-4c0c-8a38-53091b4dd119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9b47b1d3-ef2a-46a4-b47c-8826c857e8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9b47b1d3-ef2a-46a4-b47c-8826c857e8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_87c5fec2-b502-47d0-8160-c7818c772ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_87c5fec2-b502-47d0-8160-c7818c772ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_dc2b98c0-9569-42eb-9dec-f4c9ceb34dfa" xlink:href="cvs-20211231.xsd#cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:to="loc_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue_dc2b98c0-9569-42eb-9dec-f4c9ceb34dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a954362e-10d4-4f7a-b15b-3f55eb518a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a954362e-10d4-4f7a-b15b-3f55eb518a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c2eaf947-b251-414e-8eed-e5bbd50a2040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a954362e-10d4-4f7a-b15b-3f55eb518a4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c2eaf947-b251-414e-8eed-e5bbd50a2040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e4202ba9-e4a0-4ee6-92e2-64fa493968b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a954362e-10d4-4f7a-b15b-3f55eb518a4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_e4202ba9-e4a0-4ee6-92e2-64fa493968b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6fffe567-b5a4-40e0-b72a-b93cbb1b676c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a954362e-10d4-4f7a-b15b-3f55eb518a4c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6fffe567-b5a4-40e0-b72a-b93cbb1b676c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_cbe7a7a7-f221-46ef-9ca2-16ee029332ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a954362e-10d4-4f7a-b15b-3f55eb518a4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_cbe7a7a7-f221-46ef-9ca2-16ee029332ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_86e8e5c5-896e-4eb9-b64f-dbb3e16a40f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a954362e-10d4-4f7a-b15b-3f55eb518a4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_86e8e5c5-896e-4eb9-b64f-dbb3e16a40f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f6266cfb-f47b-45a6-83c4-71888ade20e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_a954362e-10d4-4f7a-b15b-3f55eb518a4c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_f6266cfb-f47b-45a6-83c4-71888ade20e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_70b9f78f-2326-4dc1-8236-dc0102ad78de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_70b9f78f-2326-4dc1-8236-dc0102ad78de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_03187ead-9c96-4cbc-be0c-1673ff405b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_70b9f78f-2326-4dc1-8236-dc0102ad78de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_03187ead-9c96-4cbc-be0c-1673ff405b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_79267af5-82e6-4510-9287-a7d1444e5651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_70b9f78f-2326-4dc1-8236-dc0102ad78de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_79267af5-82e6-4510-9287-a7d1444e5651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_674f7670-fac9-41be-83d9-1d9ec3cf66d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_70b9f78f-2326-4dc1-8236-dc0102ad78de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_674f7670-fac9-41be-83d9-1d9ec3cf66d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_fa83be31-c8d7-48d9-97fd-61a32d2a6760" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_70b9f78f-2326-4dc1-8236-dc0102ad78de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_fa83be31-c8d7-48d9-97fd-61a32d2a6760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_e67ae4e4-2741-495b-8beb-b566ba6e9f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_70b9f78f-2326-4dc1-8236-dc0102ad78de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_e67ae4e4-2741-495b-8beb-b566ba6e9f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_afca2c97-e0e3-4e0d-b4be-1873080e313c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_70b9f78f-2326-4dc1-8236-dc0102ad78de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_afca2c97-e0e3-4e0d-b4be-1873080e313c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ebaa773e-d41d-47ad-82e7-9ac681985cf0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5deb2272-73b4-4cad-90ec-4ddca9052a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_5deb2272-73b4-4cad-90ec-4ddca9052a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_17416df6-b36d-4f9c-b957-161331a795e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_17416df6-b36d-4f9c-b957-161331a795e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1d87a590-d33b-4810-ae19-e48021980cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1d87a590-d33b-4810-ae19-e48021980cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_bba9ac79-7492-4fdd-81ba-8dd0a2d9631e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_bba9ac79-7492-4fdd-81ba-8dd0a2d9631e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_18f3a077-7f72-4ddf-8d79-44ac0916ad73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_18f3a077-7f72-4ddf-8d79-44ac0916ad73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9585eb28-80f9-4784-9889-19b82d77ad83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_9585eb28-80f9-4784-9889-19b82d77ad83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_bf231ca1-9ff2-4148-9ce9-2ec9e87a5bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_bf231ca1-9ff2-4148-9ce9-2ec9e87a5bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_17a0036d-9ea3-48da-ba42-5ef5dcf95bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_17a0036d-9ea3-48da-ba42-5ef5dcf95bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_b7a3f967-a816-4a97-9152-cdf4ebd2c739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_b7a3f967-a816-4a97-9152-cdf4ebd2c739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_66ec4d77-f505-4ed6-bea5-f694b7c7daae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_fc77979f-10a7-4251-bdc8-f8848c0a7677" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_66ec4d77-f505-4ed6-bea5-f694b7c7daae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="cvs-20211231.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_cb56ccc7-8c69-4d58-b76c-bf856460aaa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_46c880a6-27cf-4cea-9dc4-82591350aed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cb56ccc7-8c69-4d58-b76c-bf856460aaa8" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_46c880a6-27cf-4cea-9dc4-82591350aed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="cvs-20211231.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_90b4cb14-ddee-4356-82b2-ee9e2c59943b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_f2b27709-e216-49a1-83c3-467f64b728a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_90b4cb14-ddee-4356-82b2-ee9e2c59943b" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_f2b27709-e216-49a1-83c3-467f64b728a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRegulatoryAssetsTextBlock_247737cf-5daa-4ae9-bfe7-78bb48470d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRegulatoryAssetsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_90b4cb14-ddee-4356-82b2-ee9e2c59943b" xlink:to="loc_us-gaap_ScheduleOfRegulatoryAssetsTextBlock_247737cf-5daa-4ae9-bfe7-78bb48470d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock_5a34964a-b527-4ab7-bd98-f3add084cede" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesDisclosureTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_90b4cb14-ddee-4356-82b2-ee9e2c59943b" xlink:to="loc_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock_5a34964a-b527-4ab7-bd98-f3add084cede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#ShareholdersEquityShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ffb5310d-f246-49f9-af97-c13e0adac2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_05b7a797-dff5-4bfa-96a7-79ebbf58f1f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ffb5310d-f246-49f9-af97-c13e0adac2f7" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_05b7a797-dff5-4bfa-96a7-79ebbf58f1f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_01a521c4-bb0a-4ad6-8e96-202c523a2216" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_05b7a797-dff5-4bfa-96a7-79ebbf58f1f1" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_01a521c4-bb0a-4ad6-8e96-202c523a2216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_5a45a8e0-7b1d-4323-a153-abcc1171b46f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_01a521c4-bb0a-4ad6-8e96-202c523a2216" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_5a45a8e0-7b1d-4323-a153-abcc1171b46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021RepurchaseProgramMember_99b74b06-fafb-4cf7-882a-1fbbe832c041" xlink:href="cvs-20211231.xsd#cvs_A2021RepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_5a45a8e0-7b1d-4323-a153-abcc1171b46f" xlink:to="loc_cvs_A2021RepurchaseProgramMember_99b74b06-fafb-4cf7-882a-1fbbe832c041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2016RepurchaseProgramMember_d65cf251-e3da-4a0f-a59e-a881aeab2c8a" xlink:href="cvs-20211231.xsd#cvs_A2016RepurchaseProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_5a45a8e0-7b1d-4323-a153-abcc1171b46f" xlink:to="loc_cvs_A2016RepurchaseProgramMember_d65cf251-e3da-4a0f-a59e-a881aeab2c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_a5bd4e9f-841a-41f5-ba60-7cf0eb7317de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_05b7a797-dff5-4bfa-96a7-79ebbf58f1f1" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_a5bd4e9f-841a-41f5-ba60-7cf0eb7317de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ff8db252-ffaf-4442-bc77-4568372f34b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_a5bd4e9f-841a-41f5-ba60-7cf0eb7317de" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ff8db252-ffaf-4442-bc77-4568372f34b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_eca9b03b-16a8-4024-8a59-7ecaf728fff3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_a5bd4e9f-841a-41f5-ba60-7cf0eb7317de" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_eca9b03b-16a8-4024-8a59-7ecaf728fff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#ShareholdersEquityAcceleratedShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_69b72e9d-0413-4960-bf29-075f99f66d09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_de5e2dd4-d13c-41f1-a8b5-3e76e28dad6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_69b72e9d-0413-4960-bf29-075f99f66d09" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_de5e2dd4-d13c-41f1-a8b5-3e76e28dad6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_e465f404-b373-4e39-baa8-cc7a3ab6d979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_de5e2dd4-d13c-41f1-a8b5-3e76e28dad6f" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_e465f404-b373-4e39-baa8-cc7a3ab6d979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_483873ee-676c-493d-a8f2-27c3b86225cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_e465f404-b373-4e39-baa8-cc7a3ab6d979" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_483873ee-676c-493d-a8f2-27c3b86225cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_A2021AcceleratedRepurchaseProgramMember_f0be2bab-0e43-4ee5-8db9-8daea51a71ea" xlink:href="cvs-20211231.xsd#cvs_A2021AcceleratedRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_483873ee-676c-493d-a8f2-27c3b86225cc" xlink:to="loc_cvs_A2021AcceleratedRepurchaseProgramMember_f0be2bab-0e43-4ee5-8db9-8daea51a71ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5f629828-ad98-4e55-9492-fbea25ded2bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_de5e2dd4-d13c-41f1-a8b5-3e76e28dad6f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5f629828-ad98-4e55-9492-fbea25ded2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c6ba16e4-5936-4128-a068-9423dd7721de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5f629828-ad98-4e55-9492-fbea25ded2bc" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c6ba16e4-5936-4128-a068-9423dd7721de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a9c81c06-424e-44c5-ba7a-8fbfa274ef94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c6ba16e4-5936-4128-a068-9423dd7721de" xlink:to="loc_us-gaap_SubsequentEventMember_a9c81c06-424e-44c5-ba7a-8fbfa274ef94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f2c42b37-a3a4-4188-b7b7-0b4da7cae35a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_de5e2dd4-d13c-41f1-a8b5-3e76e28dad6f" xlink:to="loc_srt_CounterpartyNameAxis_f2c42b37-a3a4-4188-b7b7-0b4da7cae35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9d7d2dd2-1616-411a-bb57-ed0a38a96dd8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_f2c42b37-a3a4-4188-b7b7-0b4da7cae35a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9d7d2dd2-1616-411a-bb57-ed0a38a96dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BarclaysBankMember_d1acfbbd-c056-4461-97a9-ef23c14f87c3" xlink:href="cvs-20211231.xsd#cvs_BarclaysBankMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9d7d2dd2-1616-411a-bb57-ed0a38a96dd8" xlink:to="loc_cvs_BarclaysBankMember_d1acfbbd-c056-4461-97a9-ef23c14f87c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_de5e2dd4-d13c-41f1-a8b5-3e76e28dad6f" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesAgreementAmount_0e68373a-69d5-4a92-9485-fdcf9d55597b" xlink:href="cvs-20211231.xsd#cvs_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:to="loc_cvs_AcceleratedShareRepurchasesAgreementAmount_0e68373a-69d5-4a92-9485-fdcf9d55597b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount_3ae692b2-e777-4c42-806e-910f948a0f9a" xlink:href="cvs-20211231.xsd#cvs_PaymentsForAcceleratedShareRepurchasesAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:to="loc_cvs_PaymentsForAcceleratedShareRepurchasesAmount_3ae692b2-e777-4c42-806e-910f948a0f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_78622b6e-4bf1-47a2-ac50-f51c05b593c7" xlink:href="cvs-20211231.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:to="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares_78622b6e-4bf1-47a2-ac50-f51c05b593c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares_055774c9-7378-4b1b-9c39-b45101515904" xlink:href="cvs-20211231.xsd#cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:to="loc_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares_055774c9-7378-4b1b-9c39-b45101515904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_78786947-e86f-4e58-b406-44649553da1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:to="loc_us-gaap_TreasuryStockCommonShares_78786947-e86f-4e58-b406-44649553da1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_900a0199-85dc-468f-88a6-7918a3450a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:to="loc_us-gaap_SharePrice_900a0199-85dc-468f-88a6-7918a3450a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_33729cfc-fa5a-4f7e-a805-ff1eefd61cff" xlink:href="cvs-20211231.xsd#cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_1bb2c5f5-8e56-4cc2-8419-9e2cdebeec46" xlink:to="loc_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram_33729cfc-fa5a-4f7e-a805-ff1eefd61cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#ShareholdersEquityDividendsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b5bd7691-bc41-42f8-8a6f-81b0520ee9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableTable_a7588dc0-da3a-4bb1-8262-8aca8c38ead4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b5bd7691-bc41-42f8-8a6f-81b0520ee9bd" xlink:to="loc_us-gaap_DividendsPayableTable_a7588dc0-da3a-4bb1-8262-8aca8c38ead4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_5f724429-d73b-492f-94c0-499b9c62d1bb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_a7588dc0-da3a-4bb1-8262-8aca8c38ead4" xlink:to="loc_srt_StatementScenarioAxis_5f724429-d73b-492f-94c0-499b9c62d1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e948896d-58b9-4ced-9d06-d0d5ca43adec" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_5f724429-d73b-492f-94c0-499b9c62d1bb" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e948896d-58b9-4ced-9d06-d0d5ca43adec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_a86fda48-1edf-4c6d-8a79-bdda560014e3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_e948896d-58b9-4ced-9d06-d0d5ca43adec" xlink:to="loc_srt_ScenarioForecastMember_a86fda48-1edf-4c6d-8a79-bdda560014e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableLineItems_c302a8e4-f6b2-45d6-bea1-39a04e572909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableTable_a7588dc0-da3a-4bb1-8262-8aca8c38ead4" xlink:to="loc_us-gaap_DividendsPayableLineItems_c302a8e4-f6b2-45d6-bea1-39a04e572909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_c2f7ff45-4865-46cd-936e-5e0b02b48557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_c302a8e4-f6b2-45d6-bea1-39a04e572909" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_c2f7ff45-4865-46cd-936e-5e0b02b48557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent_7132a327-fa8b-4625-b517-2fec3f7a7c0f" xlink:href="cvs-20211231.xsd#cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DividendsPayableLineItems_c302a8e4-f6b2-45d6-bea1-39a04e572909" xlink:to="loc_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent_7132a327-fa8b-4625-b517-2fec3f7a7c0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#ShareholdersEquityRegulatoryRequirementsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0989fe4a-b935-4eb2-9923-a17d84074e03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesTable_bb66b11e-3470-46f0-8599-3ead88df2e34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0989fe4a-b935-4eb2-9923-a17d84074e03" xlink:to="loc_us-gaap_StatutoryAccountingPracticesTable_bb66b11e-3470-46f0-8599-3ead88df2e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_f6ee346f-f7f3-45e0-9a7c-dd187de97bde" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable_bb66b11e-3470-46f0-8599-3ead88df2e34" xlink:to="loc_dei_LegalEntityAxis_f6ee346f-f7f3-45e0-9a7c-dd187de97bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8ad4ca52-807e-430b-9616-1cb83ef0130f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_f6ee346f-f7f3-45e0-9a7c-dd187de97bde" xlink:to="loc_dei_EntityDomain_8ad4ca52-807e-430b-9616-1cb83ef0130f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_InsuranceAndHmoMember_6adc8496-a040-414b-aa3f-bb68823fde8c" xlink:href="cvs-20211231.xsd#cvs_InsuranceAndHmoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_8ad4ca52-807e-430b-9616-1cb83ef0130f" xlink:to="loc_cvs_InsuranceAndHmoMember_6adc8496-a040-414b-aa3f-bb68823fde8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesLineItems_ef84e64a-c21a-4797-b4dd-e83065d60267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesTable_bb66b11e-3470-46f0-8599-3ead88df2e34" xlink:to="loc_us-gaap_StatutoryAccountingPracticesLineItems_ef84e64a-c21a-4797-b4dd-e83065d60267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_b19e98c9-6614-4c8e-a75c-04ce26583eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_ef84e64a-c21a-4797-b4dd-e83065d60267" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount_b19e98c9-6614-4c8e-a75c-04ce26583eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_b5d54e77-4815-4ad3-a006-0b94c6b78884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_ef84e64a-c21a-4797-b4dd-e83065d60267" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_b5d54e77-4815-4ad3-a006-0b94c6b78884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_79f23de6-bd98-4f3d-8ec1-5494ac059dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_ef84e64a-c21a-4797-b4dd-e83065d60267" xlink:to="loc_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries_79f23de6-bd98-4f3d-8ec1-5494ac059dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_83c0b368-b549-4513-b244-5f552e81c604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_ef84e64a-c21a-4797-b4dd-e83065d60267" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_83c0b368-b549-4513-b244-5f552e81c604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldByInsuranceRegulators_0c3bc703-6b5b-4ab5-9587-7a0fd34f0b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldByInsuranceRegulators"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_ef84e64a-c21a-4797-b4dd-e83065d60267" xlink:to="loc_us-gaap_AssetsHeldByInsuranceRegulators_0c3bc703-6b5b-4ab5-9587-7a0fd34f0b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_4b26c981-7487-4dbb-bb0d-cb1ba013850e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatutoryAccountingPracticesLineItems_ef84e64a-c21a-4797-b4dd-e83065d60267" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_4b26c981-7487-4dbb-bb0d-cb1ba013850e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#ShareholdersEquityNoncontrollingInterestsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a6bda068-95fa-43dc-8f75-ef8e04e91ade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_f89c64d8-05a2-4a7e-b01c-7b2a79b5cec8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a6bda068-95fa-43dc-8f75-ef8e04e91ade" xlink:to="loc_us-gaap_MinorityInterest_f89c64d8-05a2-4a7e-b01c-7b2a79b5cec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="simple" xlink:href="cvs-20211231.xsd#OtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41f1f882-8781-4e6f-8d64-f5ab87bf6665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_48357f1a-d94f-4644-aff7-854c7dcac1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41f1f882-8781-4e6f-8d64-f5ab87bf6665" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_48357f1a-d94f-4644-aff7-854c7dcac1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="cvs-20211231.xsd#OtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7f0cac90-57c4-41e1-9f36-c400cb37f728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6d5c4760-ff11-4313-80f6-9c1da384fb02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_7f0cac90-57c4-41e1-9f36-c400cb37f728" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6d5c4760-ff11-4313-80f6-9c1da384fb02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#OtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6102e691-3783-4107-907d-943c84536356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_473a893f-659b-4a47-a806-c7de8811ca35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6102e691-3783-4107-907d-943c84536356" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_473a893f-659b-4a47-a806-c7de8811ca35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f7273e16-c5bd-481a-9363-e6b1cc7878f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_473a893f-659b-4a47-a806-c7de8811ca35" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f7273e16-c5bd-481a-9363-e6b1cc7878f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a7803d8d-13c8-477f-a358-92533d41962c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f7273e16-c5bd-481a-9363-e6b1cc7878f1" xlink:to="loc_us-gaap_EquityComponentDomain_a7803d8d-13c8-477f-a358-92533d41962c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_5d1272fa-5953-4526-97ab-e358516748b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a7803d8d-13c8-477f-a358-92533d41962c" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_5d1272fa-5953-4526-97ab-e358516748b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_9c7dd438-fb18-418b-9516-db121162d8b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a7803d8d-13c8-477f-a358-92533d41962c" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_9c7dd438-fb18-418b-9516-db121162d8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_9e249cf5-3c96-4ba2-9ea6-0a9ba8ab155a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a7803d8d-13c8-477f-a358-92533d41962c" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_9e249cf5-3c96-4ba2-9ea6-0a9ba8ab155a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_73d141f5-211b-4b7e-b394-b596bdba33dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a7803d8d-13c8-477f-a358-92533d41962c" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_73d141f5-211b-4b7e-b394-b596bdba33dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_c1b1f732-f25d-4a5f-a0ba-e654711da393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a7803d8d-13c8-477f-a358-92533d41962c" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_c1b1f732-f25d-4a5f-a0ba-e654711da393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_5d577c64-fe16-4177-807c-f4453b15d8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_473a893f-659b-4a47-a806-c7de8811ca35" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_5d577c64-fe16-4177-807c-f4453b15d8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_896d9d53-e484-452d-95be-5c0809aa4231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_5d577c64-fe16-4177-807c-f4453b15d8b8" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_896d9d53-e484-452d-95be-5c0809aa4231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_295ea1dc-81d6-48f2-9a16-9258a19b5f13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_896d9d53-e484-452d-95be-5c0809aa4231" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_295ea1dc-81d6-48f2-9a16-9258a19b5f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_79d27241-fb63-45c1-b53a-60190316a424" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_896d9d53-e484-452d-95be-5c0809aa4231" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_79d27241-fb63-45c1-b53a-60190316a424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e1e9b6e8-8a0c-4aeb-9395-9d4a60ce4fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_896d9d53-e484-452d-95be-5c0809aa4231" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e1e9b6e8-8a0c-4aeb-9395-9d4a60ce4fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f676abc7-9b91-4b53-b480-143c4877573a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_896d9d53-e484-452d-95be-5c0809aa4231" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f676abc7-9b91-4b53-b480-143c4877573a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c5c801e5-6bfc-4886-9d28-aa54d2eaf885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_896d9d53-e484-452d-95be-5c0809aa4231" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c5c801e5-6bfc-4886-9d28-aa54d2eaf885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_4a2b5e1a-f2c1-4fb1-b243-d4e81e407935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_5d577c64-fe16-4177-807c-f4453b15d8b8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_4a2b5e1a-f2c1-4fb1-b243-d4e81e407935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_b4eb43a0-a1b0-492c-8a40-6c7a096db1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_5d577c64-fe16-4177-807c-f4453b15d8b8" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_b4eb43a0-a1b0-492c-8a40-6c7a096db1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_a95f59a0-2364-431c-9ea6-097eb967e98f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems_5d577c64-fe16-4177-807c-f4453b15d8b8" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_a95f59a0-2364-431c-9ea6-097eb967e98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="simple" xlink:href="cvs-20211231.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b203a2d0-9db7-41c0-bda4-b985fbbeffb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_8ea49d7b-022a-4a98-a5c3-3c7186663e06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b203a2d0-9db7-41c0-bda4-b985fbbeffb1" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_8ea49d7b-022a-4a98-a5c3-3c7186663e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="cvs-20211231.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a591dc3e-a002-46ec-a7f3-e0802ad99521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c4bf7308-e88c-4044-9bbd-4adaac26197b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a591dc3e-a002-46ec-a7f3-e0802ad99521" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c4bf7308-e88c-4044-9bbd-4adaac26197b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#EarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0f153114-ba7b-410a-9e13-b397a075808a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c24419ad-8d05-4adf-9e52-18bab894219c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0f153114-ba7b-410a-9e13-b397a075808a" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c24419ad-8d05-4adf-9e52-18bab894219c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_caf70f96-c0a3-48d3-a45e-a79107dac804" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c24419ad-8d05-4adf-9e52-18bab894219c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_caf70f96-c0a3-48d3-a45e-a79107dac804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c1f5d3ea-829b-4c76-8722-1f6a582ccd28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_caf70f96-c0a3-48d3-a45e-a79107dac804" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c1f5d3ea-829b-4c76-8722-1f6a582ccd28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_7b75cfb3-6ce2-481e-b4d8-c1139738554f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c1f5d3ea-829b-4c76-8722-1f6a582ccd28" xlink:to="loc_us-gaap_EmployeeStockOptionMember_7b75cfb3-6ce2-481e-b4d8-c1139738554f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_71fc4730-40b1-4d38-b718-8ec6551fed4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c24419ad-8d05-4adf-9e52-18bab894219c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_71fc4730-40b1-4d38-b718-8ec6551fed4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c3185a60-dd02-4745-9f67-b60fce065078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_71fc4730-40b1-4d38-b718-8ec6551fed4c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c3185a60-dd02-4745-9f67-b60fce065078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_8ef4a55e-a26b-4f37-b410-ed95b40b15ac" xlink:href="cvs-20211231.xsd#cvs_NumeratorForEarningsPerShareCalculationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0f153114-ba7b-410a-9e13-b397a075808a" xlink:to="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_8ef4a55e-a26b-4f37-b410-ed95b40b15ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_500c3e6f-542f-4a5d-ac3b-a978a6a0fe99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_8ef4a55e-a26b-4f37-b410-ed95b40b15ac" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_500c3e6f-542f-4a5d-ac3b-a978a6a0fe99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_979a2afe-ade7-4952-ba8f-1f112a419cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_8ef4a55e-a26b-4f37-b410-ed95b40b15ac" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_979a2afe-ade7-4952-ba8f-1f112a419cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a8598d1b-840f-434b-99a9-e0f0ce314c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_8ef4a55e-a26b-4f37-b410-ed95b40b15ac" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a8598d1b-840f-434b-99a9-e0f0ce314c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_c4f87f39-cc24-4d8a-9a4b-3ad61384c642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_NumeratorForEarningsPerShareCalculationAbstract_8ef4a55e-a26b-4f37-b410-ed95b40b15ac" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_c4f87f39-cc24-4d8a-9a4b-3ad61384c642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_89f05297-b323-445b-8300-c266ab1cdd44" xlink:href="cvs-20211231.xsd#cvs_DenominatorForEarningsPerShareCalculationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0f153114-ba7b-410a-9e13-b397a075808a" xlink:to="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_89f05297-b323-445b-8300-c266ab1cdd44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_03570a9f-f23b-453a-8349-8cfce761ad78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_89f05297-b323-445b-8300-c266ab1cdd44" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_03570a9f-f23b-453a-8349-8cfce761ad78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_db32bbd9-3037-462b-b2e1-8990a7dbcaf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_89f05297-b323-445b-8300-c266ab1cdd44" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_db32bbd9-3037-462b-b2e1-8990a7dbcaf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b4fd7423-bd2f-4c8c-907f-0ef383fc1eec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cvs_DenominatorForEarningsPerShareCalculationAbstract_89f05297-b323-445b-8300-c266ab1cdd44" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b4fd7423-bd2f-4c8c-907f-0ef383fc1eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_97f5642a-afa9-4a47-aa63-2f7e09d9d47b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0f153114-ba7b-410a-9e13-b397a075808a" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_97f5642a-afa9-4a47-aa63-2f7e09d9d47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d6d703cd-55eb-4097-b864-bf310cee79f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_97f5642a-afa9-4a47-aa63-2f7e09d9d47b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d6d703cd-55eb-4097-b864-bf310cee79f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_0f7ba0a5-66c3-4886-808d-3f948c9e86b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_97f5642a-afa9-4a47-aa63-2f7e09d9d47b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_0f7ba0a5-66c3-4886-808d-3f948c9e86b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/Reinsurance" xlink:type="simple" xlink:href="cvs-20211231.xsd#Reinsurance"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/Reinsurance" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_13f0cf03-11c7-4737-bdd1-2ddfadb8962f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceTextBlock_d9010977-c6c5-4132-b1a5-026a4283bb23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_13f0cf03-11c7-4737-bdd1-2ddfadb8962f" xlink:to="loc_us-gaap_ReinsuranceTextBlock_d9010977-c6c5-4132-b1a5-026a4283bb23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceTables" xlink:type="simple" xlink:href="cvs-20211231.xsd#ReinsuranceTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_4ff0b145-62a9-4b23-92d9-7e97575f5846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock_02da5780-ee7a-41ff-8a54-85e7cded3539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_4ff0b145-62a9-4b23-92d9-7e97575f5846" xlink:to="loc_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock_02da5780-ee7a-41ff-8a54-85e7cded3539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock_4c1d9fad-770e-4d68-8749-9d19a60efbcf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_4ff0b145-62a9-4b23-92d9-7e97575f5846" xlink:to="loc_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock_4c1d9fad-770e-4d68-8749-9d19a60efbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectsOfReinsuranceTableTextBlock_afd836a7-3200-4010-9286-160758aee0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectsOfReinsuranceTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_4ff0b145-62a9-4b23-92d9-7e97575f5846" xlink:to="loc_us-gaap_EffectsOfReinsuranceTableTextBlock_afd836a7-3200-4010-9286-160758aee0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#ReinsuranceNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_5b12864f-28d8-4db7-ab80-4d583910ba9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_e9eb6bf2-31f9-40f1-9088-287c0dc7730d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_5b12864f-28d8-4db7-ab80-4d583910ba9e" xlink:to="loc_us-gaap_SubsequentEventTable_e9eb6bf2-31f9-40f1-9088-287c0dc7730d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_affae135-64e9-464a-a0c2-128bdae827aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e9eb6bf2-31f9-40f1-9088-287c0dc7730d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_affae135-64e9-464a-a0c2-128bdae827aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_76166eb0-878e-4ab2-9314-9b8f41d6b58d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_affae135-64e9-464a-a0c2-128bdae827aa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_76166eb0-878e-4ab2-9314-9b8f41d6b58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_362124c5-f451-45d6-a8ba-73c58eaf3787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_76166eb0-878e-4ab2-9314-9b8f41d6b58d" xlink:to="loc_us-gaap_SubsequentEventMember_362124c5-f451-45d6-a8ba-73c58eaf3787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_02ee26b7-c4f4-49c7-833d-c5198600680b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_e9eb6bf2-31f9-40f1-9088-287c0dc7730d" xlink:to="loc_us-gaap_SubsequentEventLineItems_02ee26b7-c4f4-49c7-833d-c5198600680b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberofReinsuranceContractsEnteredInto_dc9e04a8-71ae-4200-b14e-a24d677f1012" xlink:href="cvs-20211231.xsd#cvs_NumberofReinsuranceContractsEnteredInto"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_02ee26b7-c4f4-49c7-833d-c5198600680b" xlink:to="loc_cvs_NumberofReinsuranceContractsEnteredInto_dc9e04a8-71ae-4200-b14e-a24d677f1012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_18055598-951f-466d-8132-fedabf77c1e3" xlink:href="cvs-20211231.xsd#cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_02ee26b7-c4f4-49c7-833d-c5198600680b" xlink:to="loc_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer_18055598-951f-466d-8132-fedabf77c1e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#ReinsuranceReinsuranceRecoverablesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_aacc4bc7-5d1c-4254-abc7-fb9e994e796c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskTable_dd9f8759-2082-4450-8358-f6baa845f702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CededCreditRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_aacc4bc7-5d1c-4254-abc7-fb9e994e796c" xlink:to="loc_us-gaap_CededCreditRiskTable_dd9f8759-2082-4450-8358-f6baa845f702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskAxis_49c94a91-b3f2-43c1-805d-5711454bb7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CededCreditRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_dd9f8759-2082-4450-8358-f6baa845f702" xlink:to="loc_us-gaap_CededCreditRiskAxis_49c94a91-b3f2-43c1-805d-5711454bb7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskReinsurerDomain_16070a71-525d-4298-82b3-dd490f883c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CededCreditRiskReinsurerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskAxis_49c94a91-b3f2-43c1-805d-5711454bb7ec" xlink:to="loc_us-gaap_CededCreditRiskReinsurerDomain_16070a71-525d-4298-82b3-dd490f883c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_885ddf7d-12eb-4a2d-8546-fa5b0f33b1a3" xlink:href="cvs-20211231.xsd#cvs_HartfordLifeAndAccidentInsuranceCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_16070a71-525d-4298-82b3-dd490f883c31" xlink:to="loc_cvs_HartfordLifeAndAccidentInsuranceCompanyMember_885ddf7d-12eb-4a2d-8546-fa5b0f33b1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_76329f72-f90a-4c5d-bdf6-8a24f35cfddc" xlink:href="cvs-20211231.xsd#cvs_LincolnLifeAnnuityCompanyOfNewYorkMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_16070a71-525d-4298-82b3-dd490f883c31" xlink:to="loc_cvs_LincolnLifeAnnuityCompanyOfNewYorkMember_76329f72-f90a-4c5d-bdf6-8a24f35cfddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_652f366c-4959-4e86-a050-c26d571eb753" xlink:href="cvs-20211231.xsd#cvs_VOYARetirementInsuranceAndAnnuityCompanyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_16070a71-525d-4298-82b3-dd490f883c31" xlink:to="loc_cvs_VOYARetirementInsuranceAndAnnuityCompanyMember_652f366c-4959-4e86-a050-c26d571eb753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AllOtherReinsurersMember_fbbfb5b1-143e-4fcc-b6a5-d20d5bb04205" xlink:href="cvs-20211231.xsd#cvs_AllOtherReinsurersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskReinsurerDomain_16070a71-525d-4298-82b3-dd490f883c31" xlink:to="loc_cvs_AllOtherReinsurersMember_fbbfb5b1-143e-4fcc-b6a5-d20d5bb04205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededCreditRiskLineItems_6cde22d1-df37-454d-93e4-5a4db110672c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CededCreditRiskLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskTable_dd9f8759-2082-4450-8358-f6baa845f702" xlink:to="loc_us-gaap_CededCreditRiskLineItems_6cde22d1-df37-454d-93e4-5a4db110672c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_2820e874-3871-483b-a426-ebc295483bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CededCreditRiskLineItems_6cde22d1-df37-454d-93e4-5a4db110672c" xlink:to="loc_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses_2820e874-3871-483b-a426-ebc295483bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#ReinsuranceEffectsofReinsuranceDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceDisclosuresAbstract_259e8662-286f-4be9-9980-ed2946259840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_9d547622-a2cb-494d-9c24-0efad11d40a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_259e8662-286f-4be9-9980-ed2946259840" xlink:to="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_9d547622-a2cb-494d-9c24-0efad11d40a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectPremiumsEarned_5e5ce026-f3e9-4ad4-83e9-6ed2790be427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DirectPremiumsEarned"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_9d547622-a2cb-494d-9c24-0efad11d40a2" xlink:to="loc_us-gaap_DirectPremiumsEarned_5e5ce026-f3e9-4ad4-83e9-6ed2790be427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssumedPremiumsEarned_e520d44f-ff37-44a6-984f-72593d625e20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssumedPremiumsEarned"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_9d547622-a2cb-494d-9c24-0efad11d40a2" xlink:to="loc_us-gaap_AssumedPremiumsEarned_e520d44f-ff37-44a6-984f-72593d625e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsEarned_9a61e785-8124-462f-9795-3c9356af859b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CededPremiumsEarned"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_9d547622-a2cb-494d-9c24-0efad11d40a2" xlink:to="loc_us-gaap_CededPremiumsEarned_9a61e785-8124-462f-9795-3c9356af859b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_6683bcb9-ee1f-428c-8c74-67afff2432bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract_9d547622-a2cb-494d-9c24-0efad11d40a2" xlink:to="loc_us-gaap_PremiumsEarnedNet_6683bcb9-ee1f-428c-8c74-67afff2432bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_39100118-4000-48fb-b3c8-d44eafb95945" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsuranceDisclosuresAbstract_259e8662-286f-4be9-9980-ed2946259840" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_39100118-4000-48fb-b3c8-d44eafb95945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_23aa8474-bdb0-40b2-a88c-d35cde621231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_39100118-4000-48fb-b3c8-d44eafb95945" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross_23aa8474-bdb0-40b2-a88c-d35cde621231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_bda8800f-31c8-427e-ab65-73baccf83230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_39100118-4000-48fb-b3c8-d44eafb95945" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed_bda8800f-31c8-427e-ab65-73baccf83230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_fc511e79-1699-4300-9bf9-a21c87931a71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_39100118-4000-48fb-b3c8-d44eafb95945" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_fc511e79-1699-4300-9bf9-a21c87931a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_e0c26048-b236-4fe0-9cb8-15a1cef1cb53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract_39100118-4000-48fb-b3c8-d44eafb95945" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet_e0c26048-b236-4fe0-9cb8-15a1cef1cb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cvs-20211231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3088fe7b-fde4-427c-9f73-56ac32275e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_87d5a7ba-5e96-442a-93e6-62aae5472661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3088fe7b-fde4-427c-9f73-56ac32275e3c" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_87d5a7ba-5e96-442a-93e6-62aae5472661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7c32d218-a6bb-44a7-b2e2-4da39b3b745b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_4cb082bb-c3ef-40d0-b7e7-a4852a38c753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7c32d218-a6bb-44a7-b2e2-4da39b3b745b" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_4cb082bb-c3ef-40d0-b7e7-a4852a38c753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts_2b316fd4-3421-434c-b5b1-8a1d7a3b813e" xlink:href="cvs-20211231.xsd#cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7c32d218-a6bb-44a7-b2e2-4da39b3b745b" xlink:to="loc_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts_2b316fd4-3421-434c-b5b1-8a1d7a3b813e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_GuarantorObligationsNumberofLeases_22ffb6c8-15e2-4354-ba22-e1c41d4ae70c" xlink:href="cvs-20211231.xsd#cvs_GuarantorObligationsNumberofLeases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7c32d218-a6bb-44a7-b2e2-4da39b3b745b" xlink:to="loc_cvs_GuarantorObligationsNumberofLeases_22ffb6c8-15e2-4354-ba22-e1c41d4ae70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_78aacebc-25f4-4f17-a850-64e80f6d74e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7c32d218-a6bb-44a7-b2e2-4da39b3b745b" xlink:to="loc_us-gaap_LossContingenciesTable_78aacebc-25f4-4f17-a850-64e80f6d74e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_3cdf8078-9acc-4c1e-89a4-b3a9079dfcc0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_78aacebc-25f4-4f17-a850-64e80f6d74e4" xlink:to="loc_srt_LitigationCaseAxis_3cdf8078-9acc-4c1e-89a4-b3a9079dfcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_86db4413-dacc-4cd2-a7b2-8fe7dfff7141" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_3cdf8078-9acc-4c1e-89a4-b3a9079dfcc0" xlink:to="loc_srt_LitigationCaseTypeDomain_86db4413-dacc-4cd2-a7b2-8fe7dfff7141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RadcliffAndFlaimVAetnaIncEtAlMember_d1a0700f-b51a-4431-ad3a-aa93e2c39dd8" xlink:href="cvs-20211231.xsd#cvs_RadcliffAndFlaimVAetnaIncEtAlMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_86db4413-dacc-4cd2-a7b2-8fe7dfff7141" xlink:to="loc_cvs_RadcliffAndFlaimVAetnaIncEtAlMember_d1a0700f-b51a-4431-ad3a-aa93e2c39dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_4cec483b-ca15-4b7f-b2f0-f5f1d4d64c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_78aacebc-25f4-4f17-a850-64e80f6d74e4" xlink:to="loc_us-gaap_LitigationStatusAxis_4cec483b-ca15-4b7f-b2f0-f5f1d4d64c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_fdb7e227-63cf-4b65-bd4f-eaf150555a42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_4cec483b-ca15-4b7f-b2f0-f5f1d4d64c37" xlink:to="loc_us-gaap_LitigationStatusDomain_fdb7e227-63cf-4b65-bd4f-eaf150555a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_5d625683-be38-4558-abcb-11636da23e12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_fdb7e227-63cf-4b65-bd4f-eaf150555a42" xlink:to="loc_us-gaap_PendingLitigationMember_5d625683-be38-4558-abcb-11636da23e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8caf528e-5443-4ddf-943a-65e77ef4b53e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_78aacebc-25f4-4f17-a850-64e80f6d74e4" xlink:to="loc_us-gaap_LossContingenciesLineItems_8caf528e-5443-4ddf-943a-65e77ef4b53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_4b602b86-6127-4a9b-bbfd-890ffa6bdfeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8caf528e-5443-4ddf-943a-65e77ef4b53e" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_4b602b86-6127-4a9b-bbfd-890ffa6bdfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_LossContingencyAuditMethodologySampleSize_66e5bc74-e130-4a09-a61f-b51fb2806169" xlink:href="cvs-20211231.xsd#cvs_LossContingencyAuditMethodologySampleSize"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8caf528e-5443-4ddf-943a-65e77ef4b53e" xlink:to="loc_cvs_LossContingencyAuditMethodologySampleSize_66e5bc74-e130-4a09-a61f-b51fb2806169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReporting" xlink:type="simple" xlink:href="cvs-20211231.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_11bb384d-2deb-43a7-b524-8ce4839acf0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_1632df4e-fcc4-46b0-86d9-13a1fcf3d637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_11bb384d-2deb-43a7-b524-8ce4839acf0e" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_1632df4e-fcc4-46b0-86d9-13a1fcf3d637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="cvs-20211231.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5835a026-4900-4e37-a415-5128bdd73f39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_53e48c9e-6aad-459d-9c2b-f16af52e73d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5835a026-4900-4e37-a415-5128bdd73f39" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_53e48c9e-6aad-459d-9c2b-f16af52e73d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_2031d08a-4e2e-4bf1-b683-3475e2031863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5835a026-4900-4e37-a415-5128bdd73f39" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_2031d08a-4e2e-4bf1-b683-3475e2031863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SegmentReportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_820993c9-2f72-4469-b3e9-884a2f7594e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_0bf7df09-f147-4c0b-ac80-c2a17b42d27c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_820993c9-2f72-4469-b3e9-884a2f7594e6" xlink:to="loc_us-gaap_NumberOfOperatingSegments_0bf7df09-f147-4c0b-ac80-c2a17b42d27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_9192de00-32cd-4c03-ad27-826c00c0252d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_820993c9-2f72-4469-b3e9-884a2f7594e6" xlink:to="loc_us-gaap_ConcentrationRiskTable_9192de00-32cd-4c03-ad27-826c00c0252d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_858285c7-8804-4852-965e-630367ae0d9d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_9192de00-32cd-4c03-ad27-826c00c0252d" xlink:to="loc_srt_MajorCustomersAxis_858285c7-8804-4852-965e-630367ae0d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_4f9db009-9db9-4caa-8413-b09ce28cd0a6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_858285c7-8804-4852-965e-630367ae0d9d" xlink:to="loc_srt_NameOfMajorCustomerDomain_4f9db009-9db9-4caa-8413-b09ce28cd0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USFederalGovernmentMember_a039ee18-abaa-43e6-a2f1-4c32eac0551f" xlink:href="cvs-20211231.xsd#cvs_USFederalGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4f9db009-9db9-4caa-8413-b09ce28cd0a6" xlink:to="loc_cvs_USFederalGovernmentMember_a039ee18-abaa-43e6-a2f1-4c32eac0551f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_083fcaef-1d49-40c0-92fd-d77540c0b789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_9192de00-32cd-4c03-ad27-826c00c0252d" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_083fcaef-1d49-40c0-92fd-d77540c0b789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e740cbe8-c52e-45b6-b572-22c6d774d32e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_083fcaef-1d49-40c0-92fd-d77540c0b789" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e740cbe8-c52e-45b6-b572-22c6d774d32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_1c16f912-b58d-4a3f-8686-d5e7de99b214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_e740cbe8-c52e-45b6-b572-22c6d774d32e" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_1c16f912-b58d-4a3f-8686-d5e7de99b214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7faaf79d-6cf3-4a88-ac5d-3d5f7f75f37c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_9192de00-32cd-4c03-ad27-826c00c0252d" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7faaf79d-6cf3-4a88-ac5d-3d5f7f75f37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_91773996-3884-48bc-9f46-033a9a38ded9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7faaf79d-6cf3-4a88-ac5d-3d5f7f75f37c" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_91773996-3884-48bc-9f46-033a9a38ded9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_afe5036d-94a8-431d-afe6-6fca8cecaf62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_91773996-3884-48bc-9f46-033a9a38ded9" xlink:to="loc_us-gaap_SalesRevenueNetMember_afe5036d-94a8-431d-afe6-6fca8cecaf62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_f4d9abd7-bbac-4b30-a971-4c9fc0adc37e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_9192de00-32cd-4c03-ad27-826c00c0252d" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_f4d9abd7-bbac-4b30-a971-4c9fc0adc37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_e6fa0664-62bc-40c0-b07b-80b54e80c0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_f4d9abd7-bbac-4b30-a971-4c9fc0adc37e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_e6fa0664-62bc-40c0-b07b-80b54e80c0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_da7fa11b-6b50-428f-a7fe-b3cb352e5aae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d26d4e7-9906-494c-92e6-19ca3eb5f1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_da7fa11b-6b50-428f-a7fe-b3cb352e5aae" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d26d4e7-9906-494c-92e6-19ca3eb5f1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3a404f0c-0da7-4c9a-85b6-de55ab027637" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d26d4e7-9906-494c-92e6-19ca3eb5f1ad" xlink:to="loc_srt_ConsolidationItemsAxis_3a404f0c-0da7-4c9a-85b6-de55ab027637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_49a84f5d-13ce-4e9a-9e5b-4b821a1e40f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_3a404f0c-0da7-4c9a-85b6-de55ab027637" xlink:to="loc_srt_ConsolidationItemsDomain_49a84f5d-13ce-4e9a-9e5b-4b821a1e40f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9a667c0a-3d19-458c-8391-73e35a0af5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_49a84f5d-13ce-4e9a-9e5b-4b821a1e40f6" xlink:to="loc_us-gaap_OperatingSegmentsMember_9a667c0a-3d19-458c-8391-73e35a0af5b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_ccc467d4-2d41-4894-9bc1-8297542cf184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_49a84f5d-13ce-4e9a-9e5b-4b821a1e40f6" xlink:to="loc_us-gaap_IntersegmentEliminationMember_ccc467d4-2d41-4894-9bc1-8297542cf184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_c82e1ee4-b5ae-413e-befb-12a82c10f2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_49a84f5d-13ce-4e9a-9e5b-4b821a1e40f6" xlink:to="loc_us-gaap_CorporateNonSegmentMember_c82e1ee4-b5ae-413e-befb-12a82c10f2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0b226584-c94f-4da3-81b7-d8ce07dc2c57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d26d4e7-9906-494c-92e6-19ca3eb5f1ad" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0b226584-c94f-4da3-81b7-d8ce07dc2c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_810a57f9-1678-4b75-82f7-201fd6a92285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0b226584-c94f-4da3-81b7-d8ce07dc2c57" xlink:to="loc_us-gaap_SegmentDomain_810a57f9-1678-4b75-82f7-201fd6a92285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_b4ba4c88-0b04-4b5e-ab1f-7e0b95aeacf4" xlink:href="cvs-20211231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_810a57f9-1678-4b75-82f7-201fd6a92285" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_b4ba4c88-0b04-4b5e-ab1f-7e0b95aeacf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PharmacyServicesSegmentMember_4903fbe7-dd74-4a63-91fa-d0aa555df342" xlink:href="cvs-20211231.xsd#cvs_PharmacyServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_810a57f9-1678-4b75-82f7-201fd6a92285" xlink:to="loc_cvs_PharmacyServicesSegmentMember_4903fbe7-dd74-4a63-91fa-d0aa555df342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_119b3ea7-a009-4521-9f6a-5b2c22dd9203" xlink:href="cvs-20211231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_810a57f9-1678-4b75-82f7-201fd6a92285" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_119b3ea7-a009-4521-9f6a-5b2c22dd9203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2d26d4e7-9906-494c-92e6-19ca3eb5f1ad" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_f51a1a70-3bb1-40dc-9a39-ecded6a02024" xlink:href="cvs-20211231.xsd#cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:to="loc_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax_f51a1a70-3bb1-40dc-9a39-ecded6a02024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_11ddef64-4c12-4458-86b9-4da987104635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_11ddef64-4c12-4458-86b9-4da987104635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentIncome_35b79dcc-4812-419d-85bc-890ab129125f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:to="loc_us-gaap_NetInvestmentIncome_35b79dcc-4812-419d-85bc-890ab129125f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a9f92a4f-6855-4dea-ac4b-47bab3a76ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:to="loc_us-gaap_Revenues_a9f92a4f-6855-4dea-ac4b-47bab3a76ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_9a1ce214-1171-4da5-9e4e-407e3be80c72" xlink:href="cvs-20211231.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_9a1ce214-1171-4da5-9e4e-407e3be80c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_cd931bf6-fe96-4894-a840-2663260ea7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_cd931bf6-fe96-4894-a840-2663260ea7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NetRevenuesRetailCoPayments_ee97f975-a13b-43ef-ba02-20b916b9a5c4" xlink:href="cvs-20211231.xsd#cvs_NetRevenuesRetailCoPayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2a3dfd66-2383-4002-850b-d9d8ab472ab5" xlink:to="loc_cvs_NetRevenuesRetailCoPayments_ee97f975-a13b-43ef-ba02-20b916b9a5c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="simple" xlink:href="cvs-20211231.xsd#SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7c393277-9820-4fa8-ac49-ddd80cad3063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7d35ab29-6c62-4657-8be8-41d4c62021a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7c393277-9820-4fa8-ac49-ddd80cad3063" xlink:to="loc_us-gaap_OperatingIncomeLoss_7d35ab29-6c62-4657-8be8-41d4c62021a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_57bf5a87-bcfd-4717-9457-b5a9e543b429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7c393277-9820-4fa8-ac49-ddd80cad3063" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_57bf5a87-bcfd-4717-9457-b5a9e543b429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_45eb43e9-adb4-4b63-99fb-0b61715e6f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7c393277-9820-4fa8-ac49-ddd80cad3063" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_45eb43e9-adb4-4b63-99fb-0b61715e6f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_StoreImpairmentCharges_d4985611-21cb-4a4d-9d79-2058f2210f7c" xlink:href="cvs-20211231.xsd#cvs_StoreImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7c393277-9820-4fa8-ac49-ddd80cad3063" xlink:to="loc_cvs_StoreImpairmentCharges_d4985611-21cb-4a4d-9d79-2058f2210f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_d33343d7-e197-45be-b004-70472a459f74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7c393277-9820-4fa8-ac49-ddd80cad3063" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_d33343d7-e197-45be-b004-70472a459f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_d579789f-d93b-40f8-8c05-3855955d8464" xlink:href="cvs-20211231.xsd#cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7c393277-9820-4fa8-ac49-ddd80cad3063" xlink:to="loc_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_d579789f-d93b-40f8-8c05-3855955d8464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_d2958f6e-1988-4485-81a3-dfd9e10ffcd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7c393277-9820-4fa8-ac49-ddd80cad3063" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_d2958f6e-1988-4485-81a3-dfd9e10ffcd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_80c43fc6-29f3-4c99-8a79-e82ba410972f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7c393277-9820-4fa8-ac49-ddd80cad3063" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_80c43fc6-29f3-4c99-8a79-e82ba410972f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_AdjustedOperatingIncomeLoss_fdc87c00-058a-40a0-9cd9-f39f134229ee" xlink:href="cvs-20211231.xsd#cvs_AdjustedOperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7c393277-9820-4fa8-ac49-ddd80cad3063" xlink:to="loc_cvs_AdjustedOperatingIncomeLoss_fdc87c00-058a-40a0-9cd9-f39f134229ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4aeb6d95-c003-4a95-ae2a-4e0c14f9bbda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7c393277-9820-4fa8-ac49-ddd80cad3063" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4aeb6d95-c003-4a95-ae2a-4e0c14f9bbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b1cada54-4253-4303-a747-056db3183419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4aeb6d95-c003-4a95-ae2a-4e0c14f9bbda" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b1cada54-4253-4303-a747-056db3183419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_406a0fa9-9b0a-4ec1-86e6-a9039673c60c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b1cada54-4253-4303-a747-056db3183419" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_406a0fa9-9b0a-4ec1-86e6-a9039673c60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_0e0e6e80-4fe5-43f8-8fe6-2aa038454f6c" xlink:href="cvs-20211231.xsd#cvs_CoventryHealthCareWorkersCompensationBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_406a0fa9-9b0a-4ec1-86e6-a9039673c60c" xlink:to="loc_cvs_CoventryHealthCareWorkersCompensationBusinessMember_0e0e6e80-4fe5-43f8-8fe6-2aa038454f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_de839a3b-b0e1-4075-a18b-bd995b9e12fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4aeb6d95-c003-4a95-ae2a-4e0c14f9bbda" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_de839a3b-b0e1-4075-a18b-bd995b9e12fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7901e75d-8400-49a4-a717-1bf604827c40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_de839a3b-b0e1-4075-a18b-bd995b9e12fa" xlink:to="loc_us-gaap_SegmentDomain_7901e75d-8400-49a4-a717-1bf604827c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_RetailLongTermCareSegmentMember_3c36d06c-1269-4d8c-b53a-b14e71b88ebb" xlink:href="cvs-20211231.xsd#cvs_RetailLongTermCareSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7901e75d-8400-49a4-a717-1bf604827c40" xlink:to="loc_cvs_RetailLongTermCareSegmentMember_3c36d06c-1269-4d8c-b53a-b14e71b88ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_HealthCareBenefitsSegmentMember_ac44cfad-a6f7-453b-a18f-3115b4f9d19d" xlink:href="cvs-20211231.xsd#cvs_HealthCareBenefitsSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7901e75d-8400-49a4-a717-1bf604827c40" xlink:to="loc_cvs_HealthCareBenefitsSegmentMember_ac44cfad-a6f7-453b-a18f-3115b4f9d19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_99c29bfb-0b86-468d-be08-d6b181287c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4aeb6d95-c003-4a95-ae2a-4e0c14f9bbda" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_99c29bfb-0b86-468d-be08-d6b181287c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_41498631-c9b5-4956-9c49-639d1202a7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_99c29bfb-0b86-468d-be08-d6b181287c24" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_41498631-c9b5-4956-9c49-639d1202a7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_06faddcc-bffd-4b99-93ca-91663b2ffb85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_41498631-c9b5-4956-9c49-639d1202a7ec" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_06faddcc-bffd-4b99-93ca-91663b2ffb85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_e3c358c5-4005-4c4f-a706-213beb0d58b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4aeb6d95-c003-4a95-ae2a-4e0c14f9bbda" xlink:to="loc_srt_LitigationCaseAxis_e3c358c5-4005-4c4f-a706-213beb0d58b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_0e74d6df-06cb-45c8-aa61-a82221859d94" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_e3c358c5-4005-4c4f-a706-213beb0d58b2" xlink:to="loc_srt_LitigationCaseTypeDomain_0e74d6df-06cb-45c8-aa61-a82221859d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_22acbd2c-78f5-48ee-9176-a523f77cb5d1" xlink:href="cvs-20211231.xsd#cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_0e74d6df-06cb-45c8-aa61-a82221859d94" xlink:to="loc_cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember_22acbd2c-78f5-48ee-9176-a523f77cb5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_9978f7c0-d422-4369-b80d-cd8436a01f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4aeb6d95-c003-4a95-ae2a-4e0c14f9bbda" xlink:to="loc_us-gaap_LitigationStatusAxis_9978f7c0-d422-4369-b80d-cd8436a01f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_f99018c8-30a8-4669-93b5-05c3ea14ab37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_9978f7c0-d422-4369-b80d-cd8436a01f1b" xlink:to="loc_us-gaap_LitigationStatusDomain_f99018c8-30a8-4669-93b5-05c3ea14ab37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_e55ab1be-c05e-42c4-9a2b-1d523a6c8a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_f99018c8-30a8-4669-93b5-05c3ea14ab37" xlink:to="loc_us-gaap_SettledLitigationMember_e55ab1be-c05e-42c4-9a2b-1d523a6c8a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0e7f0f6b-044c-46dd-9311-0e275821d4f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4aeb6d95-c003-4a95-ae2a-4e0c14f9bbda" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_0e7f0f6b-044c-46dd-9311-0e275821d4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_NumberOfStoresPlannedClosure_9caa2c1d-aaf7-4174-ba4b-1a2e346292f5" xlink:href="cvs-20211231.xsd#cvs_NumberOfStoresPlannedClosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e7f0f6b-044c-46dd-9311-0e275821d4f0" xlink:to="loc_cvs_NumberOfStoresPlannedClosure_9caa2c1d-aaf7-4174-ba4b-1a2e346292f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_7b9b6183-e33a-4e69-866c-ffe3debacd02" xlink:href="cvs-20211231.xsd#cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e7f0f6b-044c-46dd-9311-0e275821d4f0" xlink:to="loc_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod_7b9b6183-e33a-4e69-866c-ffe3debacd02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_5020e348-c46a-44ad-a6fe-1f22fe364bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e7f0f6b-044c-46dd-9311-0e275821d4f0" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_5020e348-c46a-44ad-a6fe-1f22fe364bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainContingencyUnrecordedAmount_c8bc876b-8c77-4139-a23f-20d8ededef9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainContingencyUnrecordedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e7f0f6b-044c-46dd-9311-0e275821d4f0" xlink:to="loc_us-gaap_GainContingencyUnrecordedAmount_c8bc876b-8c77-4139-a23f-20d8ededef9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_96e5c926-0e1d-4813-af6d-862f042f0287" xlink:href="cvs-20211231.xsd#cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0e7f0f6b-044c-46dd-9311-0e275821d4f0" xlink:to="loc_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax_96e5c926-0e1d-4813-af6d-862f042f0287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>cvs-20211231_g1.jpg
<DESCRIPTION>CVS HEALTH LOGO
<TEXT>
begin 644 cvs-20211231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  < )T# 2(  A$! Q$!_\0
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M>(O@BW@63PU_PLX3?\([?_V@?#O]N&P_L[S/M.S[=Y()\[9Y>[G;CY3\[?\
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&-FB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>cvs-20211231_g2.jpg
<DESCRIPTION>STOCK PERFORMANCE GRAPH
<TEXT>
begin 644 cvs-20211231_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXBG5^1__  ;I_MI_MY_&S]A'QS^T%\0/@UH?C1-8\9>*/$5]XXU;XC&QGO\
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MW#5/^%V-JJZ@&(G%W_;<T'G[_O>9L&W=G..]?J?KUUX6_P""C7_!NQ;?&O\
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M0>UC-Q%&\<4Y0;T1BI90W4 E$)'?:OH*=-#%<1-;W$2O&ZE71UR&!X((/44
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MXI^.O!>J_#GQB?$VC37NKZK;-I.J++I0@>W\YV\IP^V1  WS$$#FM3X?:_\
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M0-LC@["P*LWI_P"U-_P4 7XP_P#!=+XF?L.?$WX9>)O!7AK1O =SI]A!\+_
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\
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MFHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\
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M_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\
M\^,/_?H4?V=I_P#SXP_]^A4U% #(K:V@),%NB$]2B 9I]%% !1110 4444 %
M%%% !1110 4444 %%%?!?[2W_!=*Q^ 4VO\ Q#\+?\$]_CCX\^$/A#4)K3Q1
M\8O#6AVZZ6OD2&.YN+..:59+RUB=75KH!(28VVN5 <@'WI17)? ;XY_"[]IG
MX,^&OC_\%/%,6M>%/%ND0ZEH>IPJRB:"09&Y6 9'4Y5D8!E964@$$5XSX_\
M^"G7P4\&_P#!27P!_P $Q])TF\UGQIXRT/4M4U;4+.91:^'X[:S:[BBG)!WS
M31KN$0(9$>)V^65-P!])T5XK^T)^VEX:^#GQG\)?LN^!/ U_XY^*7C:PNM2T
M?P?I5W#;K9Z7;$"?4[ZYF(6TM5=EB5L.\LK!(XW(<K>_97_;!\#?M0W'C'P=
M:^']0\,^./AOKXT7XA>!M;>)KS1KIHA- ^Z)F2:VN(66:"=#MD0]%=710#UR
MBBB@ KPOP#_RD$\?_P#8B:5_Z,:O=*\+\ _\I!/'_P#V(FE?^C&H ]THHHH
M**** "BBB@ HHHH **** "LWQC_R+%[_ -<#6E6;XQ_Y%B]_ZX&@"YIW_(/@
M_P"N*_R%35#IW_(/@_ZXK_(5-0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !6/X'_Y!$O_ %^S?^A5L5C^!_\ D$2_]?LW
M_H5 &Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% &/9?\CO>_\ 7E%_,UL5CV7_ ".][_UY1?S-;% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8]E_R.][_ ->4
M7\S6Q6/9?\CO>_\ 7E%_,T ;%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 8_B7_D+Z/_U^G_T$UL5C^)?^0OH__7Z?
M_036Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^$EU?_H4+W_OI:/^$EU?_H4+W_OI:V** ,?_ (275_\ H4+W_OI:/^$EU?\
MZ%"]_P"^EK8HH Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI:V** ,?_ (275_\
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MX275_P#H4+W_ +Z6MBB@#'_X275_^A0O?^^EH_X275_^A0O?^^EK8HH Q_\
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MB3^R/[,_L[R=-M+;[/YOVOS,^3&F[=Y:?>SC;QC)S^:=??7_  0Z_P":H?\
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M44 %8_@?_D$2_P#7[-_Z%6Q6/X'_ .01+_U^S?\ H5 &Q1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/9?\CO>_P#7
ME%_,UL5CV7_([WO_ %Y1?S-;% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %8]E_R.][_UY1?S-;%8]E_R.][_ ->47\S0
M!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK=^W%=+0!X-\4OA;>>![PZAIZO-IDS_NY#R82?X&_H>_UK[+_P""'7_-4/\
MN"?^W]>47UC9ZG9R:?J%LDT,R%9(W&0P-?1?_!)CX/ZO\-O^%A:^+67^QM9E
MTQ-*N91C>T/VOS4!_BV^;'S_ +7J#0!]C4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7YP_MB?\$=/&/QE^#'C/]J7XE?MX
M_&+0OCK:Z->^(-%U[PQ\0KFQT'PK<PQO/#IMG91;$6QBVK$TAQ/+M:9G#N0/
MT>KYO_:>-]^VQ>Z[^PW\,M:N+;PM(!8_'#QCI\I7[%82(&E\/VD@ZW]W"P24
MK_QZVLS.VV6:W# 'EW[$GBO]L+_@HU_P1X^"_B3QO\6=3\!^+OB'HEN/B#XW
M\/;+76%TE'N%-WIY*&."[O(X;;]Z% B6\EEC 9(Q7SQ\6/V3/B-_P2,_X*.?
MLR>(_P!BW]I#XG:[X1^-GQ#;P=\2OAEX\\9W.N6UY"8#,^JQ>>2T<D,:S2N^
M<@HH!5'D1OTQL/B-^S]\)OA;JD^E>+O#NB>#_AM;?V9JIMKF..ST&.UMXB+9
MMORQ>7"T0\OJ 57&>*\;\$^#['QY\8/^'D_[542^%=,\*^'KK3_A/X>\2XMG
M\,Z5=%/MFK7BR8\G4;X1Q)Y1PUO;I'"0)9;A: /'?'OQAU3]N'_@M;J__!//
M6M;U&#X5?!'X50^)O'&@Z;J,UJOB7Q%J$EO]BM[UH65I;."TG$X@+;'F(,BN
M$3&C^P=\?/%/P?\ ^"HOQX_X)3>(O$NHZOX9\-^'-,\?_".76-0EN[O3-'NU
MABOM,:>9FDDMX+R9/LX8L8XY#'G:B!>'_9K\&:E\%?\ @YN_:,/BR!H(OC+\
M#O#WB;PC<2C"746FK9:9=1(QX9UDCW%!R%(;&,&C]F?P9J_Q,_X.;OVB_CSH
MD+R:!\.O@/H/@C4KU!^Z.IW[V6I+"&Z,R10/N4?=++G!(H _22BBB@#RV_\
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MPAEB4$$]#BI?^$Q\,?\ 0:@_[ZJ;3]/L&L(";*$DPKDF,>@J;^SM/_Y\8?\
MOT* *?\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\
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M_P!^A1_9VG_\^,/_ 'Z% %/_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJKG]G:?\
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M_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\
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M'_OT* *?_"8^&/\ H-0?]]4?\)CX8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\
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MJV*Q_ __ "")?^OV;_T*@#8HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^SQXG^%VF_&2X%I\,]9\2:A9S+=7[0FX@TR_2WD8Z??3PJSQ0L9%8QO&9%E
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M>U'PY_P=4?&WP1H+NFF>)OV7=(UCQ!#&<+)?VE]86UM*_8LL$\BC/.'..,T
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ML45C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^- &Q16/]B\;_ /0;LO\
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M!NR_\!C_ (T ;%%8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"- &Q16/\
M8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C0!L45C_ &+QO_T&[+_P&/\ C1]B
M\;_]!NR_\!C_ (T ;%%8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"- &Q1
M6/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C0!L45C_ &+QO_T&[+_P&/\
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ME966FV<6G:=:16]O;QK'!!!&$2-%& JJ.     .E2UC_ &+QO_T&[+_P&/\
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MI7_HQJ]TKPOP#_RD$\?_ /8B:5_Z,:@#W2BBB@ HHHH **** "BBB@ HHHH
M*S?&/_(L7O\ UP-:59OC'_D6+W_K@: +FG?\@^#_ *XK_(5-4.G?\@^#_KBO
M\A4U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %8_@?_D$2_\ 7[-_Z%6Q6/X'_P"01+_U^S?^A4 ;%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8]E_R.][_P!>
M47\S6Q6/9?\ ([WO_7E%_,UL4 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5CV7_([WO\ UY1?S-;%8]E_R.][_P!>47\S
M0!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !117@7_  ] _88_Z+C_ .6SJ?\ \C4 >R^)?^0OH_\ U^G_ -!-;%?.&N?\
M%,?V([S4=-GMOC7N2WN2\Q_X1O4AM&W&>;;G\*TO^'H'[#'_ $7'_P MG4__
M )&H ]]HK@?@=^U!\"_VD?[4_P"%+>./[:_L7R/[2_XEEU;>3YWF>7_KXDW9
M\I_NYQMYQD9[#Q'XF\.>#]&G\1^+=?LM,T^V3=<7VH720Q1#U9W( _$T 7J9
M<7%O9V[W=W.D442%Y)9&"JB@9))/  '>O -4_;>U3XF:A-X6_8Z^$>I>/KJ.
M0Q3>)+I6L=#M&[EKB0 RD==B ;A]UC61XA_9IUGQA9KXS_;]_:+74; .'7P;
MHETVF:'&PYV'!$MV0>A)#<XYH Z;QK^W=X .OS?#_P#9\\*ZG\4/$\?RO9>%
ME!LK8] 9[TCRHUSQN&X \'%9#?L__M1?M"J;S]I[XQCPKH$G+>!?A],8MZ?W
M+J];+OQPR+E#U!6MSP=\3[*WT./P3^Q_\!%?2X3MBU.6S&FZ4AZ%QP'F/'.
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M $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^J
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M?_D$2_\ 7[-_Z%4W_"8^&/\ H-0?]]5E^$O$N@V.F20W>J11L;J5@K'L6X-
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M4_X3'PQ_T&H/^^J -*BLW_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZH TJ*S?\
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M_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"C^SM/_Y\8?\
MOT*FHH A_L[3_P#GQA_[]"C^SM/_ .?&'_OT*FHH A_L[3_^?&'_ +]"L[Q=
M8V4?AJ\>.SB5A"<%8P"*UZS?&/\ R+%[_P!<#0!-I^GV#6$!-E"285R3&/05
M-_9VG_\ /C#_ -^A1IW_ "#X/^N*_P A4U $/]G:?_SXP_\ ?H4?V=I__/C#
M_P!^A4U% $/]G:?_ ,^,/_?H4?V=I_\ SXP_]^A4U% $/]G:?_SXP_\ ?H4?
MV=I__/C#_P!^A4U% $/]G:?_ ,^,/_?H4?V=I_\ SXP_]^A4U% $/]G:?_SX
MP_\ ?H4?V=I__/C#_P!^A4U% $/]G:?_ ,^,/_?H4?V=I_\ SXP_]^A4U% $
M/]G:?_SXP_\ ?H4?V=I__/C#_P!^A4U% $/]G:?_ ,^,/_?H4?V=I_\ SXP_
M]^A4U% $/]G:?_SXP_\ ?H4?V=I__/C#_P!^A4U% $/]G:?_ ,^,/_?H4?V=
MI_\ SXP_]^A4U% $/]G:?_SXP_\ ?H4?V=I__/C#_P!^A4U% $/]G:?_ ,^,
M/_?H5D>"[*SETJ1I;2)C]LE&6C!XW5NUC^!_^01+_P!?LW_H5 &E_9VG_P#/
MC#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H5-10!#
M_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\
M?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:
M?_SXP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_
M 'Z%']G:?_SXP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9
MVG_\^,/_ 'Z%']G:?_SXP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H
M5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H5-10!A6=E9GQG>Q&TBVBSC(7RQ
M@')K7_L[3_\ GQA_[]"LVR_Y'>]_Z\HOYFMB@"'^SM/_ .?&'_OT*/[.T_\
MY\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT
M*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B@"'^SM/_
M .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA_P"_0J:B
M@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/[.T__GQA
M_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\8?\ OT*/
M[.T__GQA_P"_0J:B@"'^SM/_ .?&'_OT*/[.T_\ Y\8?^_0J:B@"'^SM/_Y\
M8?\ OT*R+.RLSXSO8C:1;19QD+Y8P#DUNUCV7_([WO\ UY1?S- &E_9VG_\
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MVWG6-O,EQ>M'*YC9K?#$&(L-S$T ?J=_P1Q\4WWCK5OBEK&OB-@HT401,,I
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M6\!^!_ _A^T\)^"O!NE:/I5A$(K'3-+TZ*WM[>,=$CCC4*B^P %7_P"SM/\
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MEZG=/<;[;3K><8>*W6":5HV60S)N"T ?55%?)_QO_;+^)GCW_@H9HW_!,O\
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M/T.T*?SKQ+P[^R3^T]XD*L- ^%OPVM&^X;?29/$.HQ?[S7C&$GT*D5VFG?\
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MP1N/"FK_  ^U!K'P5J,OB?3-3&I:(X,D41:QNI]C6[EX@'VCRO("YVMC[OH
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MZ1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\
MP@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\ X%M1_P (/I'_
M #\WO_@6U;%% &/_ ,(/I'_/S>_^!;51\2^$M,L=!NKN&XNBT<1(#W+$?B*Z
M:LWQC_R+%[_UP- %2R\%Z5+9Q2M<WF6B4G%TV.E2_P#"#Z1_S\WO_@6U:6G?
M\@^#_KBO\A4U &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\
M_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_
M (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\ P@^D?\_-
M[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6
MU;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;
M4?\ "#Z1_P _-[_X%M6Q10!C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10
M!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P
M@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\ X%M69X5\*Z=J&G2333W((N9% 2X9
M1@-75UC^!_\ D$2_]?LW_H5 !_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q
M10!C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_
M  @^D?\ /S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8_
M_"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I
M'_/S>_\ @6U;%% &/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M6Q10!C_P#"
M#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\
M/S>_^!;5L44 8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\
MWO\ X%M1_P (/I'_ #\WO_@6U;%% &/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\
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M'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44
M<IKGA73K74=-ACGN2)[DJY:X8D#;V]*T_P#A!](_Y^;W_P "VH\2_P#(7T?_
M *_3_P"@FMB@#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJV** ,?_ (0?2/\
MGYO?_ MJ/^$'TC_GYO?_  +:MBB@#'_X0?2/^?F]_P# MJ/^$'TC_GYO?_ M
MJV** ,?_ (0?2/\ GYO?_ MJ/^$'TC_GYO?_  +:MBB@#'_X0?2/^?F]_P#
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M #\WO_@6U'_"#Z1_S\WO_@6U;%% &/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
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M;/CCQ#KOP?UG0;J;P7IZ2:5J$D9EB"2D*Q*G&&R2/]TU]35X7X!_Y2">/_\
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M7O\ WTM'_"2ZO_T*%[_WTM;%% &/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\
M?2UL44 8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_WTM;%% &/_P )+J__ $*%
M[_WTM'_"2ZO_ -"A>_\ ?2UL44 8_P#PDNK_ /0H7O\ WTM'_"2ZO_T*%[_W
MTM;%% &/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\ ?2UL44 8_P#PDNK_ /0H
M7O\ WTM'_"2ZO_T*%[_WTM;%% &/_P )+J__ $*%[_WTM'_"2ZO_ -"A>_\
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M[K)*3D?@*/[/_:]\8_\ 'WK_ (5\'6[=!96KZA=)]?,Q$?PH [W_ (275_\
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MVC]I_P".OC/Q%!)S)X<\,M'H^FD?\\W6(EYE]R5:O$O^'K__  4;_:7Q;?L
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M_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+6Q10!C_\)+J__0H7O_?2T?\
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M_P#(L7O_ %P- %2R\1ZJEG$B^$KQ@(E 8,N#QUJ7_A)=7_Z%"]_[Z6M+3O\
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M>\D'6.TT:[<_^B@* /4:*\L_X:V\"W'_ "!O WC/4<]/L7AF5L_3<1_DT?\
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MY^[-(.O'KZ3X+^.?_!;?XPZ2/#?[%?\ P2S^%?[-WA>; M_$'QM\4">Z>/\
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MOC#X&_LJ:!<](])LG\:^)K4'J&:4KI[X'0K@YS[5^@\<<<,:Q1(%50 JJ,
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M/^U5$OA73/"OAZZT_P"$_A[Q+BV?PSI5T4^V:M>+)CR=1OA'$GE'#6]ND<)
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MX0?2/^?F]_\  MJH^)?"6F6.@W5W#<71:.(D![EB/Q% '0:=_P @^#_KBO\
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MO-,O)&@\.MJ*Q3:DBP0W4LQM-OEJYW/M\HY! QN7@YX^NM#_ &7?@9X<6/\
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M'PLTRSU=Y[+6-)NOAK=S7FC7\#[)H)-M\$9P-LBG #I+&V%#8'WM_P ,9?\
M!P,_R-_P6D\ H#P73]G/3R5]P#-@GZU^0'_!H1_P4B_X9L_;)U#]B'XC:]Y/
MA'XR[?[!^T2XCL_$D"'R,9X7[3$&@/=I$ME[5_3]0!\ ?\,(_P#!>\\'_@O-
MH ]Q^R[H>1_Y'H_X=X?\%U_^EBK_ ,U&\,?_ "17W_10!\ ?\.U/^"SIY;_@
MX:U_/?'[-WAT?^U:/^'7/_!65_GF_P"#@OQ\7/+%/@KH*C/? W<#VK[_ **
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M/&M?M&_M(ZD!_JUOOCEJ+",]R-N.O]*^_P"B@#X _P"(;?\ X)]W'RZSX_\
MCEJ2#E(K[XU:LRJ?4;9!S1_Q#2_\$P[CY-8L/BIJ,0Y$%[\8M:9 W]X;;@<]
M1^)K[_HH ^ /^(9+_@D7/^[U;X1^-K^'_GWO/BUK[)GL<+> Y'UH_P"(7_\
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M%%% !1110 4444 %%%% !1110 4444 8_B7_ )"^C_\ 7Z?_ $$UL5C^)?\
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MBJ#X4_!_]DC38XO]7_PC_A>_TR4?3R854=/S/H*X/[0DOBH37R3_ ";/K/\
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M359YG_P[&_X*[>/QN^-W_!?CQ>(G^]8_#SX+Z+H7E#NJSH[NW^\PS0/^#?\
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M_P :/L7C?_H-V7_@,?\ &@#8HK'^Q>-_^@W9?^ Q_P :/L7C?_H-V7_@,?\
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MBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\ Z#=E_P"
MQ_QH^Q>-_P#H-V7_ (#'_&@#8HK'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\
M@,?\: -BBL?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QH V**Q_L7C?\
MZ#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&@ LO\ D=[W_KRB_F:V*Y2UM?%)\4W4
M<>J6PN!;1F20P':5R< "M/[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\
M&C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H
MV**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\
M&C[%XW_Z#=E_X#'_ !H V**Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !H
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M >W^34@_9?\ ^"E^G#.F?\%-[:Y4=(=0^$.F'_Q]6S_]8T?7<6M\-/Y.G_\
M)H/]6LAG\&=8?_MZ&+7Y8:2_$^I**^7/^%.?\%8--_X\OVR/AYJ6.G]H^ /)
MW=^?*/'IQVH_X1G_ (+&:;_QY?$SX!ZECI_:.E:K#GZ^4._]!2_M"HMZ%1?*
M+_*3#_5+"R_AYKA9?]O58_\ I=&)]1T5\M/K'_!8_3?^/KP;\!M3QU_L[4]3
MAW=N/-7CUY[5$_Q7_P""MFF\7/[)WP_U+'?3_'2Q9[?\M5_'Z4?VG36].HO^
MW)/\DP_U*Q<OX>,PLO\ N9I1_P#2Y1/JJBOE!OVEO^"H.G'&J?\ !."&=/\
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M<G%WV6E[KU3Q?_P4O_:K\4:S'JMCXFTS2(X)=\%II^C0NB'IUG$C'CWKT[X
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M>R;_ +R/Y+X@P'#? &<5LO5!XO$TVO>K>[1C=*4;4X2<JCY6G><XQOHZ4D>
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M+_P&/^-'V+QO_P!!NR_\!C_C0!L451TJ#7X9'.L7\$RE?D$46T@U>H ****
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MR6[?9/I;RU/W?PJ\(<&L&\QXBPS=1MJ%*::44OM2B]W)WLGI;6SNK>_^%O\
M@I?^U7X?\0MX@U3Q/IFL^8 LMKJ&C0I&R@],P"-A]<_G7VU^R1^VCX$_:FTJ
M:QM[,Z1XDL(A)J&B2S;]R9QYT+X&],D \ J2 1@@G\IJZOX'?%75_@E\6-"^
M)^CF9GTF_22X@@(W7$!.V6'D@'?&67GUKQ\IXFS#!XJ/MZCG!O5-W=NZ;UT^
MYGW7&OA'PQGN45/[/PT*&)BFX.FE!-K:,HJT6I;7M=;I[I_LK17S#_PVY^UO
MXJX^%G_!,KQU<AO]6_B[Q+8Z)CW82[R/I1_PG'_!7'QC_P @'X'?!OP:K_\
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M=&FU_P"!OU/F'_AK+]OOQ;\OP[_X)JWUI"WW;[Q=\1+&RV>FZ *7/X&@7/\
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M.$'_  2'\.3>+I]+_P"%Y7HLX8UDV?V$GFD$]-_G8S[[?PK[?K'LO^1WO?\
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MZ]=%8_6O"+CO"<%9W4CCKK#UTE)I7<7%OEE9:M*\DTM=;J]K/\IJ*^@/%_\
MP3._:J\+ZS'I5CX;TO5XYY=D%WI^LPHC]^DYC8<>U>G? '_@DUXJNM9M]>_:
M%UZTM-.B<.^A:3<&2>XQ_!)* %C7UV%B1D J>:_.:/#^<UJWLU1DO-JR^_;[
MC^J<?XG<"8# O%2Q].:M=1A)2F_+E6J;\[)=6CT+_@DG\,-5\*_!O6_B-JML
MT(\4:G&MBKC'F6]L'42#V,DDJ_\  ,]Z^L*K:-H^E>'M)MM!T+3X;2RLH$@M
M+6W0*D4:@!54#@   8JS7Z[EN"CEV!IX=._*M_/=_B?P[Q7G]7BCB+$YI./+
M[65TNT4E&*\VHI)OJPHHHKN/G@HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ K-\8_\BQ>_]<#6E6;XQ_Y%B]_ZX&@"YIW_ "#X/^N*_P A
M4U0Z=_R#X/\ KBO\A4U !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !17RK_P6R^+_ .T-\!?^"8OQ3^+/[,*:LOB?
M1].M))[O0%!U"QTMKZW34KJVR#LFBLFN9%D_Y9[?,'*"OG?5_BK^SSXQU[]E
M3Q__ ,$>OB#<:OK_ (U^)&GS>*8='\17E[]M\"I'*NNSZ_'/*^9(<Q(LUW_I
M"WAC2-MS." ?IE17P%X]^,.J?MP_\%K=7_X)YZUK>HP?"KX(_"J'Q-XXT'3=
M1FM5\2^(M0DM_L5O>M"RM+9P6DXG$!;8\Q!D5PB8T?V#OCYXI^#_ /P5%^/'
M_!*;Q%XEU'5_#/AOPYIGC_X1RZQJ$MW=Z9H]VL,5]IC3S,TDEO!>3)]G#%C'
M'(8\[40* ?=E%%% !7A?@'_E()X__P"Q$TK_ -&-717_ .VQ^REI=]/IFH?'
M+0XKBVF:*>)Y6RCJ2&4_+U!!%>/^$/VHOV?-,_;%\9_%*]^+.D)H&H>%--LK
M/4A.622X1W+1X + @ GD <4 ?65%>2_\-W?LA_\ 1>-$_P"^I/\ XBC_ (;N
M_9#_ .B\:)_WU)_\10!ZU17DO_#=W[(?_1>-$_[ZD_\ B*/^&[OV0_\ HO&B
M?]]2?_$4 >M45Y+_ ,-W?LA_]%XT3_OJ3_XBC_AN[]D/_HO&B?\ ?4G_ ,10
M!ZU17DO_  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !% 'K5%>2_\
M-W?LA_\ 1>-$_P"^I/\ XBC_ (;N_9#_ .B\:)_WU)_\10!ZU6;XQ_Y%B]_Z
MX&O-_P#AN[]D/_HO&B?]]2?_ !%9WBS]NC]DFX\.7D-O\<M'D=H2%1!*23[
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M_P"^I/\ XB@#UJBO)?\ AN[]D/\ Z+QHG_?4G_Q%'_#=W[(?_1>-$_[ZD_\
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MOV0_^B\:)_WU)_\ $4 >M45Y+_PW=^R'_P!%XT3_ +ZD_P#B*/\ AN[]D/\
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M?"WXB6&M7%E");J*S+9C0G 8Y XSQ79T %%%% !1110 4444 %%%% !1110
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M%% '/_\ "IOA7_T33P__ .":#_XBC_A4WPK_ .B:>'__  30?_$5T%% '/\
M_"IOA7_T33P__P"":#_XBC_A4WPK_P"B:>'_ /P30?\ Q%=!10!S_P#PJ;X5
M_P#1-/#_ /X)H/\ XBC_ (5-\*_^B:>'_P#P30?_ !%=!10!S_\ PJ;X5_\
M1-/#_P#X)H/_ (BC_A4WPK_Z)IX?_P#!-!_\17044 <__P *F^%?_1-/#_\
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M?\*F^%?_ $33P_\ ^":#_P"(KH** .?_ .%3?"O_ *)IX?\ _!-!_P#$4?\
M"IOA7_T33P__ .":#_XBN@HH Y__ (5-\*_^B:>'_P#P30?_ !%'_"IOA7_T
M33P__P"":#_XBN@HH Y__A4WPK_Z)IX?_P#!-!_\11_PJ;X5_P#1-/#_ /X)
MH/\ XBN@HH Y_P#X5-\*_P#HFGA__P $T'_Q%'_"IOA7_P!$T\/_ /@F@_\
MB*Z"B@#G_P#A4WPK_P"B:>'_ /P30?\ Q%'_  J;X5_]$T\/_P#@F@_^(KH*
M* .?_P"%3?"O_HFGA_\ \$T'_P 11_PJ;X5_]$T\/_\ @F@_^(KH** .?_X5
M-\*_^B:>'_\ P30?_$4?\*F^%?\ T33P_P#^":#_ .(KH** .?\ ^%3?"O\
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M^(KH** .?_X5-\*_^B:>'_\ P30?_$4?\*F^%?\ T33P_P#^":#_ .(KH**
M.?\ ^%3?"O\ Z)IX?_\ !-!_\11_PJ;X5_\ 1-/#_P#X)H/_ (BN@HH Y_\
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M"O\ Z)IX?_\ !-!_\11_PJ;X5_\ 1-/#_P#X)H/_ (BN@HH Y_\ X5-\*_\
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M0!S_ /PJ;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,17044 <_\
M\*F^%?\ T33P_P#^":#_ .(H_P"%3?"O_HFGA_\ \$T'_P 17044 <__ ,*F
M^%?_ $33P_\ ^":#_P"(H_X5-\*_^B:>'_\ P30?_$5T%% '/_\ "IOA7_T3
M3P__ .":#_XBC_A4WPK_ .B:>'__  30?_$5T%% '/\ _"IOA7_T33P__P""
M:#_XBC_A4WPK_P"B:>'_ /P30?\ Q%=!10!S_P#PJ;X5_P#1-/#_ /X)H/\
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M  30?_$5T%% '/\ _"IOA7_T33P__P"":#_XBC_A4WPK_P"B:>'_ /P30?\
MQ%=!10!S_P#PJ;X5_P#1-/#_ /X)H/\ XBC_ (5-\*_^B:>'_P#P30?_ !%=
M!10!S_\ PJ;X5_\ 1-/#_P#X)H/_ (BC_A4WPK_Z)IX?_P#!-!_\17044 9N
MA^#?"'AB9[CPWX4TW3Y)5VRO8V,<1<=<$H!D5I444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5X%
M\2?^"I__  3C^#WQN_X9Q^*/[:OPZT+QLMREO/H&I>)88Y;69\;8IV)V02'(
M^21E;YAQR,^]7$<LL#Q0SF)V0A) H)0XX.#P<>]?#/\ P44_X)]_\$^_A5_P
M26^+?@OQM\#_  V^FZ+\.]4U!?$EYI$#ZS=ZZ+>1H-1:[V>;-J,UXR'S"2TL
MLNTY#E2 ?<.HZMI6CZ5/KNK:G;VME:V[3W-Y<S*D4,2J6:1G8@*H4$EB< #-
M>>?!C]L?]EW]H?Q!+X5^"OQPT#Q%J*:<-1BL[&[^>[L2^P7MN& ^U6I<A?M$
M.^+) W9(K\NO^"@+?M"_!#_@B_\ L8?\$\OB]K>H0^*/C'XY\#?#_P")"S7#
M"X33'"O<Z>\@.[<"+:V?GYD213D,<^Y_\'"?C)_V3? ?[,_[9?PRABTO6_AA
M^T1HNG6S6<8C#Z#J%K<P:CIH"XQ#-%#"I4<8C&.0" #[R^-'QT^#/[.7P^O?
MBM\>_BGH/@[PWIZYN];\1ZI%:6Z'!(7?(P#.<85!EF/ !/%='I&K:=KVDVNN
M:1=+/:7MND]K.F<21NH96&>Q!!KX,_X.:?AWX"\5_P#!&7XS^*O$O@O2K_5=
M#T?3I-%U.[T^.2YL&;6+#<8964M%N  ;:1D<'(KZI_X6]X3_ &?OV*1\>/'L
MKIH?@KX7C7=8>( N+6TT[[1+M!ZMLC; ]: .B^+G[0'P4^ UMI]Q\8?B?HWA
M]]8NC:Z)::A>*MSJEP!N,%K ,RW4N.?+B5FQSBND\/:[8^)]#M/$.F17:6][
M LL*7^GS6LP5AD;X9T22-O5756'<5^/G_!/#_@H-X8^'?P9U7_@M/_P4+^!'
MQ8UG7_BEJLT<OQ TOP,]WH?PS\*_:S#8Z9:^9(DZV9PL\MS:PRK,\R>8[2H1
M7Z]>!?''A#XF^"M(^(_P^\1VFL:#K^F0:CHNK6$PD@O;6:-9(IHV'#(R,K ]
MP: -6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /$_VF?\
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M^)?).T:GHVM&VC,$^/\ 6)#,JSH#D)(-PYH _1>BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** $9E52S$  9)/:O _AS_P %4/\ @G%\7?C<
M?V</AE^VK\.M<\;&Z>V@T#3_ !+#)+=3KG=# P.R>08/R1LS?*>.#CU?XR_"
MW1?C=\+=<^$7B?4KZUTKQ'8-8:NVFW)AFELY,+/"LB_-'YD1>,NI#J)"5*L
M1^=?_!P/^P#^SEJ_[ ?ACP)^S7\!/"_A?XMI\2O#&B_ 2Y\(:)!IMW9ZK-J,
M(>**2W162%+)+N=QG8@MA*<&(, #]'?B9\4/AQ\&/ VH?$SXM>.M)\->'M)A
M$NI:UK=^EM;6ZE@HW22$ $L54#JS, ,D@5C_  9_:+^"/[0EIJ5U\&_B/I^N
M/HMTEMK5G S1W6G2N@=$N+>4++ 70AU$BKN4AER#FOA+_@H9XZU[XK_\%O/V
M*/V%/$=\;KPIIL.N?$?Q+9LN(]2U*PL+H:9*Z=/W%Q;R2*.@,N>JKBW^VW\0
MM3_9F_X.!/V3/%_A*X-O;?'+P3XG\#^.K6(X6_M[!([W3Y''1GBN;KY7(+!&
MD4$!C0!]0?'S_@I]_P $]/V6_BA;_!7]H;]L;P!X1\53K&QT/6O$$44]NL@!
MC:<9Q;*P(8-*4!4YSCFO<-+U33-<TRWUK1=1@O+.\@2>TN[699(IXG4,KHRD
MAE((((."""*^:_C!^P#_ ,$^/"?[+'Q*L/VA/@]X8U3P_K&F:OK_ ,3O&'B'
M2;>34;Z1UEN;K49;LIO66/YFB92/(6.-8MBQH!Q?_! 'X.?%[X3?\$;_ (+?
M#/\ :,M[F369/#%S<OIFKJ7DMM-N[RXN+.UD5^1MM)H5,;#Y!^[P N* /ISX
M??M%? CXL_$/Q7\)_A?\7?#_ (A\1^!OL@\8Z1HNJ1W,NC/<F<01W(C)$4C?
M9IOW;$, F2 ",]G7YO\ _!)WP/X-^'/_  6C_P""B7@_P!X5T[1-)MM2^&3V
MVF:59);V\+2Z'?2R%8XP%7=([L<#DL3WK](* "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@"KKFN:+X8T2\\2^)-7M=/T[3K62YO[^]G6*&V@C4N\
MLCL0J(J@L6)  !)K\K/%O_!P%_P1P_:(^-PU?X^?MC:=IOP]^''B(7/A+PDW
MA/6;H^)=7MGS'K5W]GLY$:V@<;K.WR29%%S( Z6ZQ?J[10!^9/\ P5%OA_P4
MZ_X)V_#'_@H?^QAX+U_Q%;_![XSZ7\2/"%BVE20W_BC2-+NY(;M[:UD E&\!
MYXD=5DD2W7"YD53/_P %4-4^&?\ P5QU;]FO]C[]D_X@Z1XWTV_^+VD_$/XA
MZOX;O4NX-"\*Z?;W!=[MHR1;27#W"Q01R[7>1' 7Y'V_I?5>PTC2=*:9M+TR
MWMC<S&:X-O J>;(>KM@?,Q]3S0!\&_\ !S7\0O ?A'_@C%\9/#/BGQII6G:E
MX@TK3[?0M.O=0CBN-1E35[!G2"-B&F95(9@@.T<G YKVCQEX$\)?M\?\$J=?
M^#/PB^(NC:E;_$/X+7/A_2]=TW44N+6*ZN=*,,;,\18821U++UP",5])44 ?
MEK^S3^T7\&;#_@@)J_['OQS2VTKXG>"OA+JOPQ\4?!Z]*MKT^NI:36-M9P60
M)EN7O,P20-$K+()PRMA6(^Q?^"4'[.'Q#_9%_P""<'P;_9R^+4P;Q-X7\$6M
MOKL(F$@M;E]TTEL&!(80F0Q @X(CR.,5[V^AZ*^KKK[Z/:F_2+RDO3;J9E3^
MZ'QN Y/&<5:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M _,?]N#_ (+C?\$M/&'QRU_]AGXS?MBZ9X;\#>'I?LOQ5N['2]2O'\2RAB)/
M#]M+8V\JI;Y4K>S%@64FVC!,DTD/8_'WX@_LZ?\ !?3_ ()6?';]G[]@/4YM
M9\/0Z/;Z1X7\0RZ'/I6G7NNV1AU&"P@CNHXI$2-X;)'D,:Q@7(VEMC8_0>B@
M#\IOVJOVGK+]KC_@A5HG['7P=FAU#X__ !*\):'\/YOA290FLZ1K44MK;ZP+
MZU_UUG!:)#<R23RHJ*@C8D"5,_:GQ!\-_"_]B7_@F+-\(_%?C_2])T'P%\%_
M^$9M=6UB]CM(IA::0;:/YI& W.(LA<Y/;->^Q:1I,&I2ZS#I=NEY/&J37:P*
M)9%'16;&2!V!-6* /A3_ (-M/B#X$\8_\$;/@KH7A/QGI6I7VA>'KBUUNQL;
M^.6;3YCJ%V1'.BDM$Q ) 8 D<CBNT_X*BI_PO#Q7\#_^"?\ :_O8?BS\2X-5
M\:6Y^ZWA;P]LU:_5\<A)KF/3;0]B+P@GFOK>J\FD:3-JL6NRZ7;M>P0O##>-
M IECC<J617QD*2JD@'!*C/04 6**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *^#O\ @IK_ ,%K/V,_V3?BM;?L5>+/VLM-\ >+M6LA/XN\
M51Z9=:A)X0TYU5AY<5M!/G4YT<&W21?+B4_:)0RK%!<_>-% 'Q%^Q!^VW_P2
M_P#VZ_A]KW_!/G_@GSXFO?$?@[1/AW=VGB74-/\ #VH6EII5O=YMUCEFU"&.
M2YN[DS7,V\>87:&=Y7WGY_$/^";W[1FC?\$X?^"27BC]B[]H[7K33/C%\"I?
M$GAZQ\%&3&I^*IKB[N[K1I=+M/\ 6WL=Z+J&.%HE8,R.#@HX7]3*KSZ1I-SJ
M,&KW.EV\EW;*RVUT\"F2(,,,%8C*@CKCK0!\E?\ !%C]DK4_^";7_!*CX;_!
M3XX7UGHVMZ3H]SK7C66]NTCBT^[O;B6\EADD)V#R%E2%FSM)A)!(.:\,_P"#
M<'XR_"3QI:?M;^'/"/Q-T#4M1U']L_QSK^GV%CJ\,LUSI5P-/$%]&BL6>W<H
MP64 H2I -?IA10!^?*W/@35_^"PWQ\\!_P#!12/0O^$5U_X6^']+_9_LO'7E
M#1]2T&6"5O$EO;^?B&2Z:]$'GQ_ZXPQVYP8U!#_^"%/[/]Q^S/KO[1?PI^"7
MBN_UG]G"T^*,$OP&O;N\:Y@"2V22ZM%8S.29K*&\D%NDJED>2"9@S.9&/WSK
M.A:)XBL_[.\0:-:7UOO#>1>6ZRIN'0[6!&:LHB1H(XT"JHPJJ, #TH 6BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /E#_@J%_P5L_9A_X)
MH>&=$T'XI_%/0M*\:^-)3!X6L-7CN9X+.+)634[V.T1YQ9Q$'(1=\S@1)@EW
MC\K_ .">?_!5K_@E5XS^(FC_ +*'[&_[0FJ_%OXG_$'6[G6?&&MQ^$-1M)]3
MNQ 9;S5[ZXNK:&&*-(H%BCA1CY:+;6\2!%7;^@=% 'YL_P#!.F3P!_P2K_:O
M_:N_9P_:;\>Z-X(\->,?B;<_%CX:>(O$^I165CK&E:C$/ML,$TK*KRV4D,<4
ML>=X#QO@JX8]E_P0E_9U\>>#O#?QW_;1^)GA:_T*^_:0^..L^,_#^C:K:/;W
M=KX=:>3^S//B<!XY'2267:P!V21D@$D#[LU'2-)U=8EU;3+>Z$$RS0"X@5_+
MD7HZY!PP[$<BK% 'YB?L-?M!_ ?Q)_P<5_M<6WA[XS^%KYM=\!^![;0_L>OV
M\@U&>WL0)XK<JY$SQEU#JF2I." 17UI_P4-^'O\ P3F\<^ -,U?_ (*#:!X2
MOK3PY>?;O"[ZO,Z:K#=G&%TTV[+>//(R*HBMLO*RJH5B *^AZI/X;\.R:\OB
MF30;)M42W\A-2:U0SK%DGRQ)C<%RS';G&6/K0!\!?\$BO^">.H>"?VE_B?\
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M*PPRL,@CTJ'3-+TS1;&/3-'TZ"TMH@1%;VT*QH@)R<*H '))_&@#\M?VAO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%>9>/_ -LK]F'X8ZK)H7C'XQZ7#>0L5GMK,27;Q,.JN+='V$>AP:QK
M8BAAH\U6:BN[:7YG=@,LS+-:OLL%1G5EVA%R?W139Z;17&_"_P#:$^"GQHWI
M\,?B3IFK31KNDM(9BEPJ_P!XQ.%<#WVXKLJJE5I5H<].2DNZ=T98O!XS 5W1
MQ5.5.:WC).+7JG9A1116AS!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !117F_QL_:X_9[_9TUBRT#XR?$
M'^Q[O4+8W%G%_9-W<>9&&VELP1.!R,8)!H ](HKP+_AZ!^PQ_P!%Q_\ +9U/
M_P"1J/\ AZ!^PQ_T7'_RV=3_ /D:@#WVBO*OA#^VS^S'\>?& \!?"CXF?VKJ
MS6SW M/[&O8/W:8W-NFA1>,CC.:]5H **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **POB;X3UOQUX!U3PAX;\<7_AJ^O[4Q6VO:8BM<639!\Q
M _RD\8Y]:\ _X82_:1_Z26_$_P#\ K/_ .)KEKUZ]*25.DYKNG%?FT>]E65Y
M3CJ,IXK'PP\D[*,H59-JV]Z<)+RU=SZ<HKYC_P"&$OVD?^DEOQ/_ / *S_\
MB:/^&$OVD?\ I);\3_\ P"L__B:P^MXW_H&E_P"!0_\ DCU/]7N&O^AS2_\
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M%%P^J^ M.\"R:JO]CW\JR:E9"W\R&.VEB82&28>6D11M[-(F#DBMK]I'X"^
M/VM_V<?&'[.OQ/TYW\/^._#%UI.I(\6)84GB*B10?NRQL5=3U5T4]17Y1?\
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MX"TB?Q!XG\&Z5=?\4]KUC!^^N(!;/E8LJ&86Y#V[E518HR0X /V#M%=+2))
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M"2WN5GV/;3J2H,,JK("RC;EAGRW7?^"W7_!*[PSX5\)^.-=_;&T"WTCQMAM
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M'=1 ;X692 ZY[@G(^E %BBO _P#AD/XY_P#1]_C_ /\  2U_^)H_X9#^.?\
MT??X_P#_  $M?_B: /?*_.'_ (+8_P#)8/!G_8M2_P#I0U?47_#(?QS_ .C[
M_'__ ("6O_Q-?$__  5%^%_C'X6_$CPSIOC+XS:WXTFNM$DEAN];BC5[=1,1
ML7RP!@GGGO0!\OT444 ?47_!(7_D\"'_ +%J^_\ :=?JE7Y"?\$X_ 7B7XC_
M +2$?AOPG\3=4\)79T2ZE&KZ.B-,%79E,.",'//TK[__ .&0_CG_ -'W^/\
M_P !+7_XF@#WRBO _P#AD/XY_P#1]_C_ /\  2U_^)J?2?V3_C9I^J6U_=?M
MP>.[J*"X222UFM;;9,JL"4;"YP0,'ZT >ZU^9G_!5?\ :[^'/PV_X*K?!#]F
M']NSXA:QX._9Q\4?#[4-12_M]7N=,TK7?%HO!#%::M=6[HQLX+<))Y;.(?-N
MHFF!097],Z^>_P!J/X<?L6_MW>-->_X)T?M6?"_2/%3P^"K#Q;!IFJL%F^SW
M%U>V1NK.1"LT$L#VP5I8V4@7<:YPY! ..^'G[#$/P<_;-^'?QY_9E^*GBYOA
M/=>%M9M]:\!2^-[S4] M[N>.W>RU.RBN)Y%@W(L\;+$?+/F(RJI:1G\__P"#
MC']I'XI_LP?L":1XV\ ^*]=T#0=4^+'A[1_B=X@\,74EOJ.G^&)Y9/MK6\\6
M)()'*0P"1"&'GD @D5\T_L__ +.7[1__  0D_P""K7P2_8Z^!/[0WB'XA?LY
M?M$7.N6VG_#[Q3.+B\\)W5C;"YDG@8 *J+YD3F2-45T,JRH72.4]U\,]0\(?
M\%]_VD?VN?V;_P!I;QCJ=I\.?@]KTW@#P=\--*U%[41W@-U!+XFO41@;RX%Q
M;%K1)LPV_E9\LR_O* /1?V</BS^S9^SM^U3XU_:&^$_Q=L/ W[)47P^T_1[K
MQ3XH\6R1>&=>\:/?R.MUI,]]*4D5;/,,UU"PAN)7C4-))"Y7UK_@I/XT^$O[
M0G_!)SXT_'?X+_%-=6MM#^$'B77O!WC+P/XIEB\F]M-+GN(9X+JSE7=B2-#P
MQ5AD'()%?G)^P)\9/'_Q1%S_ ,&P'_!0#5=&?5?AYXM@M]0\47NKQ^7XL\&:
M=-!J%II%HK,7DNIBEM&%X:/3_.SMF@P?TY_X*A:WX/G_ ."7'[47A+PMJ%@7
M\/? 3Q997VGV+*/[/8^';B6.%D7B,^3)$X7CY'0@8(H _.O3O@QXI\&?\&ZG
MAS_@I-\)/VM_C!X+^,V@?#"W\7S^+9/C!KE]::U=1RY>UO-/OKN:SFCF'R*G
ME !RF.,HWZ8_\$P_VE/B%^V%_P $^_A)^TU\6- BTWQ)XR\%VNH:S;V\)CB>
M<@JT\:'[D<NWS57)PL@&3C-?(7_!*S_@FG^RW^U[_P $?OV>K3]H^#QIXL\/
MR>#=/U*Y\$ZC\2=9_L*XN8W9D,EBET(G17 80D&($<)UK]*="T+1/"VAV?AG
MPSH]KIVFZ=:1VNGZ?8VZQ06T$:A(XHT4!415 4*    !0!^<W_!?3]NSX!_!
MV^^'G['7[0WQY^*OPI\%>.9)M7\?_$KX3V4ZZEIEE;G996D=U'#+]G-Q>8D=
ME21_)LI(]G[\,/2_^">'PD_9%_8C_9$\<_MD_ W]N+XJ_'?P+JWAJ7Q%<>+/
MB+\15\0?9[+3;>XEDBM-L,*VQ_UOFHR"3>@5\>6%'V5K6G^%O%MC?>#/$-CI
M^IVUS:>7J>DWL231RP2!EVRQ-D,C ,,,,'!'/-?F3^S/^P"/!%S_ ,%'OV-?
MV68A9?"?QKH\6E> -"MY?] T?Q-J7AJZ&KVEN<[45&N=.RJ\1@I'QY9% #/V
M4_ OQ=_;F_X)&^(O^"EGQ ^)_B?3?CUXYTCQ#XP\!:]I7B.ZBA\&_9)[H:3I
MEC;JXA%D$MHO.B:,_:1/-YWF%LC+^*W_  5W^)_[5_[ ?[&^D_!WQ'<>#O'/
M[7OCFQ\+^)M?\/2F*YT*QL[H6WB&XL'Y,,WF*4B?[T:3%@P=58=U_P $KOC/
MX:\'_P#!M7I7C[7Y!IX\ ?!_Q39>([6[7RY;&ZTUM0BGAE1L%)-T6=I /SKZ
MBOB;X.?LM_$+]EC]D/\ X)-_'?XG:/<6>F^$_B[J$7B9KA"HTU/%NH+=:?+,
M#_JD")&&9L!6< X+ 4 ?>/[3OBZR_P""57[>W[,R_!N^U2R^&/QT\43_  Z\
M>>$;[7+J]MO[5E6(Z1JL'VF1S%=><TD4\@.9XV'F;G1&'Z%5^;G_  7$\&:O
M\=?VX/V"_P!GCPA$]QJK_M _\)G>Q0C+0:5HB6]S=S-C[BA'VACP6( R>*_2
M.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)X[U'1IEFT6X^)WQ+U;Q#'ITRC"SPP7MP\"3J,XN/+\X;B X!(KVRB@ KA_
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M>'/#NB>+]6T2RL9;="ENZ0Z9=6Z9B4E8R0=@X7%?)G_!S3HNE67_  1Q\3_
MKPG'JNLZSJFLZ!%H>A?:;K5M4OXK?5K6:=_WC2W$X2)&9Y&+8XRV2,_I#10!
MX'\'_P!B[]DR^O\ P;\9_"NK:[XVL?"JM<?#8^(_'6H:UI^@EHVA\VSBN9G0
M3(A>)9I \T2EXU= 64['[1G[!G[-W[3_ ,0O#/QF\?\ AO5--\>>#8Y8O"WC
MWPAXAN]'UG3X9,B2W%U:2(TL#!GS#+OC.]OERQ)]DHH \P^'_P"Q[\"/AAX
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?@2UOF5;.\\4:BMI!,S;\(LLF$+'8YVYSA2<8K*^"?\ P4$_88_:0\4IX%^
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MMJU]#:VMK"TUS<W$H2.*-02SLQP%4 $DG@ 5Y3\%OV\_V//VB?&B_#WX*?M
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ML=P_M^>,_BU%8?".X\.V&NP^+I-(O&5K"]:%;67[,L)N<R-/" GE;P7 *CG
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M0?%OB[PIX!\,:AXV\=>)M/T71M)M)+K5-6U:\2WMK.!%+/+++(0L:* 268@
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M]H+]K7]FG]E'1[?Q'^TI\;/#_@?3;IPD&I>);];6V9R<!/-?"!C@X4G)QP*
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ML?\ X[7S_P#\."/^"-O_ $CV^'__ (!S?_'*/^'!'_!&W_I'M\/_ /P#F_\
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MCP=^PA\-]2TC6=/AOM*U&TMY7BNK:9!)%*C"3YE9&5@>X(H ^D/^&L/V6?\
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M=#37/%%GJFE:T_A&3E?$EG8WL5S/IQ7(\P2+'N\K/[TQB,<N*]3_ &-/V_\
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M6B_M-?#[7I+F/Q!;M''I=O%+'/>LP?"P1N=CR'"HP()!!QV?[=/[0/P)MO\
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MQO34?#OQ$NY5@T35K-)+\O<V]\^()X@94)D1RH\U3GYAG1_X-BO%_@7XN_\
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M_:5TZZUCQ7H6FW$^GVA:V.+<RA/GN K%W@0-)"H!E$>^/?WOAKX\_"#X6?\
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MQJ$.E:592W-S<RK';V\*%GD<G 4 <DDT ?H1\(_VB_AO\6?"47B*UUZTT^Y
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MBWX#^/M:\&78MGU.)TFLX+T.OV@6$5SNNHQY*F>YMH+Q 87D)_2?]O+]O_\
M9?\ V@?^".O[1OQ<\"_$:V@\'ZU\*/%>@>"_$NMYT^#Q5=R:++&O]G+<A)+A
M3<3?9E8+\\L;A-P 8@'P]\2/C9^P]XL_X-0/!GP2^)7C[PCXB\;W?PQL=.\"
M>#[#4+>]UL>)_. M5MK:)FG29'(+[5!$1D#?*Q!_4G_@E-X5_:%\$?\ !.#X
M+^$OVJY+\_$"P\ 6$7B--6<M>0N$_=Q7!;YC.D7EI(6);>K9).37C_\ P;X>
M*?@M\0_^"4/P-O/!>M^&]8UWP]X"MK#6GL)H)KS39E>:,PS;<R0ME' 5L9 .
M.*^X: /S[_X+3^%?VZ_%WCOX<:K\$_\ @G1X0_:0^$G@R&]UOQO\/?%.OV<8
MUC4GC:WM]MI<AEN#;0-<.BF.8-+<QLL9D@0TO[#W[=G[!MW_ ,$T_C3^UU^P
MM^RCX;^#^L?#7PYK=]\2_AC9>";/1+W2M;TO3YY_L][#:Q1B7B,A)2,E=RD(
MZR1I[_\ %G_@JK_P3^^ /[2=W^R;\??VF-!\">-+70[?5EMO&9DTRSNK:8L$
M,%[<*EM,^5(\M)"V<@ E6 \;_9]_8O\ #?[0'Q _;*^.UGH-[X=\$?M2:+IO
MAG2$O--DM)M1M;31;FPN=:^S2!6C2XEOI1'O"M*ELLV-LRL0#S7_ ()C_ 31
M?C)_P;>WFC_%91K.K_&3X?\ B[Q)XXUJ_ >XU35-2FO9?MTKG[TR 6^U^J^1
M&1]T5\IZ3^VS\3OVYOV&O^"8_P"SK\5-;GU*#XR?%EX/B;]JD+GQ#8>$]2C@
M^SW1.?.2X(@FDW<LZ GO7T1^QO\ M-V'['W_  1!\0_L8_&N[@T_X]_"KP[X
MA\!0?"^.8/K&N:O))=KHXT^U'[Z\ANXYK9XIHD9&7S&SB-R.%\>_\$R?B?\
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M(KAKQH+Z\6U^SP2W=GI\4XD$S+Y3R?:%'R12,0#W73/^"FGQ.\#_ +2/P1^
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M97OK,6YB-Q %8^=$'C=2Z94$<GD4 ?5'CK]M/XS^)]5^(.E_L6?LRZ=\3_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
D* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>cvshealthlogo1.jpg
<DESCRIPTION>CVS HEALTH LOGO
<TEXT>
begin 644 cvshealthlogo1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1"N17AI9@  34T *@    @ ! $[  (
M   4   (2H=I  0    !   (7IR=  $    H   0?NH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $1U<F%N9"P@
M4')I<V-I;&QA($,   'J'  '   (#   "'      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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MM^S7X+T^[L[_ ,4:A;1W%Q'<?9K3S%#"+"@LP![G<!GMB@0P_M+:];2+/?\
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MYZ _3MVKD^#Z&E4;F"H,L>BJ,D_A6$JG,K-'OX3+%A*SG"H^7^7H.B5GGC5
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M+AH[AY(V201LNX\JRMTP:!GM?QQ_Y(MXA_ZY1_\ HU*YW]FC_DF%S_V$Y?\
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-:YSM10!^E%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>cvshealthlogob.jpg
<DESCRIPTION>CVS HEALTH LOGO
<TEXT>
begin 644 cvshealthlogob.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1"N17AI9@  34T *@    @ ! $[  (
M   4   (2H=I  0    !   (7IR=  $    H   0?NH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $1U<F%N9"P@
M4')I<V-I;&QA($,   'J'  '   (#   "'      '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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MM^S7X+T^[L[_ ,4:A;1W%Q'<?9K3S%#"+"@LP![G<!GMB@0P_M+:];2+/?\
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MYZ _3MVKD^#Z&E4;F"H,L>BJ,D_A6$JG,K-'OX3+%A*SG"H^7^7H.B5GGC5
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M+AH[AY(V201LNX\JRMTP:!GM?QQ_Y(MXA_ZY1_\ HU*YW]FC_DF%S_V$Y?\
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-:YSM10!^E%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211328116952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 02, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(401)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109,651,334,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,312,510,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following materials are incorporated by reference into this Form 10-K:</span></div><div style="margin-bottom:0.8pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information contained in the definitive proxy statement for CVS Health Corporation&#8217;s 2022 Annual Meeting of Stockholders, to be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year ended December 31, 2021 (the &#8220;Proxy Statement&#8221;), is incorporated by reference in Parts III and IV to the extent described therein.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211335863448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AuditorInformationAbstract', window );"><strong>Auditor Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Boston, Massachusetts<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AuditorInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Auditor Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AuditorInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211325460696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">$ 76,132,000,000<span></span>
</td>
<td class="nump">$ 69,364,000,000<span></span>
</td>
<td class="nump">$ 63,122,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">1,199,000,000<span></span>
</td>
<td class="nump">798,000,000<span></span>
</td>
<td class="nump">1,011,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">292,111,000,000<span></span>
</td>
<td class="nump">268,706,000,000<span></span>
</td>
<td class="nump">256,776,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating costs:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">175,803,000,000<span></span>
</td>
<td class="nump">163,981,000,000<span></span>
</td>
<td class="nump">158,719,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefit costs</a></td>
<td class="nump">64,260,000,000<span></span>
</td>
<td class="nump">55,679,000,000<span></span>
</td>
<td class="nump">52,529,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairments</a></td>
<td class="nump">1,358,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">231,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">431,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments', window );">Operating expenses</a></td>
<td class="nump">37,066,000,000<span></span>
</td>
<td class="nump">35,135,000,000<span></span>
</td>
<td class="nump">33,310,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs</a></td>
<td class="nump">278,918,000,000<span></span>
</td>
<td class="nump">254,795,000,000<span></span>
</td>
<td class="nump">244,789,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">13,193,000,000<span></span>
</td>
<td class="nump">13,911,000,000<span></span>
</td>
<td class="nump">11,987,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">2,503,000,000<span></span>
</td>
<td class="nump">2,907,000,000<span></span>
</td>
<td class="nump">3,035,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">452,000,000<span></span>
</td>
<td class="nump">1,440,000,000<span></span>
</td>
<td class="nump">79,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="num">(182,000,000)<span></span>
</td>
<td class="num">(206,000,000)<span></span>
</td>
<td class="num">(124,000,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income tax provision</a></td>
<td class="nump">10,420,000,000<span></span>
</td>
<td class="nump">9,770,000,000<span></span>
</td>
<td class="nump">8,997,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision</a></td>
<td class="nump">2,522,000,000<span></span>
</td>
<td class="nump">2,569,000,000<span></span>
</td>
<td class="nump">2,366,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">7,898,000,000<span></span>
</td>
<td class="nump">7,201,000,000<span></span>
</td>
<td class="nump">6,631,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">7,898,000,000<span></span>
</td>
<td class="nump">7,192,000,000<span></span>
</td>
<td class="nump">6,631,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to noncontrolling interests</a></td>
<td class="nump">12,000,000<span></span>
</td>
<td class="num">(13,000,000)<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to CVS Health</a></td>
<td class="nump">$ 7,910,000,000<span></span>
</td>
<td class="nump">$ 7,179,000,000<span></span>
</td>
<td class="nump">$ 6,634,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Income from continuing operations attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 6.00<span></span>
</td>
<td class="nump">$ 5.49<span></span>
</td>
<td class="nump">$ 5.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare', window );">Loss from discontinued operations attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 6.00<span></span>
</td>
<td class="nump">$ 5.48<span></span>
</td>
<td class="nump">$ 5.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average basic shares outstanding (in shares)</a></td>
<td class="nump">1,319<span></span>
</td>
<td class="nump">1,309<span></span>
</td>
<td class="nump">1,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Income from continuing operations attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 5.95<span></span>
</td>
<td class="nump">$ 5.47<span></span>
</td>
<td class="nump">$ 5.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare', window );">Loss from discontinued operations attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income attributable to CVS Health (in dollars per share)</a></td>
<td class="nump">$ 5.95<span></span>
</td>
<td class="nump">$ 5.46<span></span>
</td>
<td class="nump">$ 5.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average diluted shares outstanding (in shares)</a></td>
<td class="nump">1,329<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
<td class="nump">1,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share (in dollars per share)</a></td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList', window );">Cost, Product and Service [Extensible List]</a></td>
<td class="text">Products<span></span>
</td>
<td class="text">Products<span></span>
</td>
<td class="text">Products<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 203,738,000,000<span></span>
</td>
<td class="nump">$ 190,688,000,000<span></span>
</td>
<td class="nump">$ 185,236,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 11,042,000,000<span></span>
</td>
<td class="nump">$ 7,856,000,000<span></span>
</td>
<td class="nump">$ 7,407,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses, Excluding Store Impairments and Goodwill Impairments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StoreImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Store Impairment Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StoreImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfCostGoodOrServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates type of cost from product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123410239&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfCostGoodOrServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211328104088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 7,898<span></span>
</td>
<td class="nump">$ 7,192<span></span>
</td>
<td class="nump">$ 6,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Net unrealized investment gains (losses)</a></td>
<td class="num">(436)<span></span>
</td>
<td class="nump">440<span></span>
</td>
<td class="nump">677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net cash flow hedges</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and other postretirement benefits</a></td>
<td class="nump">20<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(449)<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="nump">917<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">7,449<span></span>
</td>
<td class="nump">7,587<span></span>
</td>
<td class="nump">7,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Comprehensive (income) loss attributable to noncontrolling interests</a></td>
<td class="nump">12<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to CVS Health</a></td>
<td class="nump">$ 7,461<span></span>
</td>
<td class="nump">$ 7,574<span></span>
</td>
<td class="nump">$ 7,551<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211328155544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 9,408<span></span>
</td>
<td class="nump">$ 7,854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments</a></td>
<td class="nump">3,117<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">24,431<span></span>
</td>
<td class="nump">21,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">17,760<span></span>
</td>
<td class="nump">18,496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">5,292<span></span>
</td>
<td class="nump">5,277<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">60,008<span></span>
</td>
<td class="nump">56,369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">23,025<span></span>
</td>
<td class="nump">20,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">12,896<span></span>
</td>
<td class="nump">12,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">19,122<span></span>
</td>
<td class="nump">20,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">79,121<span></span>
</td>
<td class="nump">79,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">29,026<span></span>
</td>
<td class="nump">31,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">5,087<span></span>
</td>
<td class="nump">4,881<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">4,714<span></span>
</td>
<td class="nump">4,624<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">232,999<span></span>
</td>
<td class="nump">230,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">12,544<span></span>
</td>
<td class="nump">11,138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PharmacyClaimsandDiscountsPayableCurrent', window );">Pharmacy claims and discounts payable</a></td>
<td class="nump">17,330<span></span>
</td>
<td class="nump">15,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable</a></td>
<td class="nump">8,808<span></span>
</td>
<td class="nump">7,936<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPolicyholderFunds', window );">Policyholders&#8217; funds</a></td>
<td class="nump">4,301<span></span>
</td>
<td class="nump">4,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">17,670<span></span>
</td>
<td class="nump">14,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesCurrent', window );">Other insurance liabilities</a></td>
<td class="nump">1,303<span></span>
</td>
<td class="nump">1,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">1,646<span></span>
</td>
<td class="nump">1,638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">4,205<span></span>
</td>
<td class="nump">5,440<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">67,807<span></span>
</td>
<td class="nump">62,017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">18,177<span></span>
</td>
<td class="nump">18,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">51,971<span></span>
</td>
<td class="nump">59,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">6,270<span></span>
</td>
<td class="nump">6,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountsLiability', window );">Separate accounts liabilities</a></td>
<td class="nump">5,087<span></span>
</td>
<td class="nump">4,881<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherInsuranceLiabilitiesNoncurrent', window );">Other long-term insurance liabilities</a></td>
<td class="nump">6,402<span></span>
</td>
<td class="nump">7,007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">1,904<span></span>
</td>
<td class="nump">2,351<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">157,618<span></span>
</td>
<td class="nump">161,014<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 16)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital', window );">Common stock, par value $0.01: 3,200 shares authorized; 1,744 shares issued and 1,322 shares outstanding at December&#160;31, 2021 and 1,733 shares issued and 1,310 shares outstanding at December&#160;31, 2020 and capital surplus</a></td>
<td class="nump">47,377<span></span>
</td>
<td class="nump">46,513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost: 422 and 423 shares at December&#160;31, 2021 and 2020</a></td>
<td class="num">(28,173)<span></span>
</td>
<td class="num">(28,178)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">54,906<span></span>
</td>
<td class="nump">49,640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">965<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total CVS Health shareholders&#8217; equity</a></td>
<td class="nump">75,075<span></span>
</td>
<td class="nump">69,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">306<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">75,381<span></span>
</td>
<td class="nump">69,701<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 232,999<span></span>
</td>
<td class="nump">$ 230,715<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherInsuranceLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Insurance Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherInsuranceLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PharmacyClaimsandDiscountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pharmacy Claims and Discounts Payable, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PharmacyClaimsandDiscountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of par value plus amounts in excess of par value or issuance value for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStocksIncludingAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPolicyholderFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPolicyholderFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountsLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422401-158474<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=SL117422267-158473<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountsLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211328242040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">3,200,000,000<span></span>
</td>
<td class="nump">3,200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">1,744,000,000<span></span>
</td>
<td class="nump">1,733,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">1,322,000,000<span></span>
</td>
<td class="nump">1,310,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">422,000,000<span></span>
</td>
<td class="nump">423,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211332128968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCustomers', window );">Cash receipts from customers</a></td>
<td class="nump">$ 284,219,000,000<span></span>
</td>
<td class="nump">$ 264,327,000,000<span></span>
</td>
<td class="nump">$ 248,393,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies', window );">Cash paid for inventory and prescriptions dispensed by retail network pharmacies</a></td>
<td class="num">(165,783,000,000)<span></span>
</td>
<td class="num">(158,636,000,000)<span></span>
</td>
<td class="num">(149,655,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PaymentsforInsuranceBenefits', window );">Insurance benefits paid</a></td>
<td class="num">(63,598,000,000)<span></span>
</td>
<td class="num">(55,124,000,000)<span></span>
</td>
<td class="num">(52,242,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToSuppliersAndEmployees', window );">Cash paid to other suppliers and employees</a></td>
<td class="num">(31,652,000,000)<span></span>
</td>
<td class="num">(29,763,000,000)<span></span>
</td>
<td class="num">(28,932,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromInterestAndDividendsReceived', window );">Interest and investment income received</a></td>
<td class="nump">743,000,000<span></span>
</td>
<td class="nump">894,000,000<span></span>
</td>
<td class="nump">955,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="num">(2,469,000,000)<span></span>
</td>
<td class="num">(2,904,000,000)<span></span>
</td>
<td class="num">(2,954,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="num">(3,195,000,000)<span></span>
</td>
<td class="num">(2,929,000,000)<span></span>
</td>
<td class="num">(2,717,000,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">18,265,000,000<span></span>
</td>
<td class="nump">15,865,000,000<span></span>
</td>
<td class="nump">12,848,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales and maturities of investments</a></td>
<td class="nump">7,246,000,000<span></span>
</td>
<td class="nump">6,467,000,000<span></span>
</td>
<td class="nump">7,049,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(9,963,000,000)<span></span>
</td>
<td class="num">(9,639,000,000)<span></span>
</td>
<td class="num">(7,534,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(2,520,000,000)<span></span>
</td>
<td class="num">(2,437,000,000)<span></span>
</td>
<td class="num">(2,457,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity', window );">Proceeds from sale-leaseback transactions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">101,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions (net of cash acquired)</a></td>
<td class="num">(146,000,000)<span></span>
</td>
<td class="num">(866,000,000)<span></span>
</td>
<td class="num">(444,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of subsidiary</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">840,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">122,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">42,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(5,261,000,000)<span></span>
</td>
<td class="num">(5,534,000,000)<span></span>
</td>
<td class="num">(3,339,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Net repayments of short-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(720,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">987,000,000<span></span>
</td>
<td class="nump">9,958,000,000<span></span>
</td>
<td class="nump">3,736,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(10,254,000,000)<span></span>
</td>
<td class="num">(15,631,000,000)<span></span>
</td>
<td class="num">(8,336,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities', window );">Derivative settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7,000,000)<span></span>
</td>
<td class="num">(25,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(2,625,000,000)<span></span>
</td>
<td class="num">(2,624,000,000)<span></span>
</td>
<td class="num">(2,603,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">549,000,000<span></span>
</td>
<td class="nump">264,000,000<span></span>
</td>
<td class="nump">210,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes related to net share settlement of equity awards</a></td>
<td class="num">(168,000,000)<span></span>
</td>
<td class="num">(88,000,000)<span></span>
</td>
<td class="num">(112,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="nump">155,000,000<span></span>
</td>
<td class="nump">432,000,000<span></span>
</td>
<td class="nump">196,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(11,356,000,000)<span></span>
</td>
<td class="num">(7,696,000,000)<span></span>
</td>
<td class="num">(7,654,000,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">1,648,000,000<span></span>
</td>
<td class="nump">2,635,000,000<span></span>
</td>
<td class="nump">1,855,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the beginning of the period</a></td>
<td class="nump">11,043,000,000<span></span>
</td>
<td class="nump">8,408,000,000<span></span>
</td>
<td class="nump">6,553,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the end of the period</a></td>
<td class="nump">12,691,000,000<span></span>
</td>
<td class="nump">11,043,000,000<span></span>
</td>
<td class="nump">8,408,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Reconciliation of net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">7,898,000,000<span></span>
</td>
<td class="nump">7,192,000,000<span></span>
</td>
<td class="nump">6,631,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments required to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,512,000,000<span></span>
</td>
<td class="nump">4,441,000,000<span></span>
</td>
<td class="nump">4,371,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairments</a></td>
<td class="nump">1,358,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">231,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">431,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">484,000,000<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="nump">453,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">(Gain) loss on sale of subsidiaries</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(269,000,000)<span></span>
</td>
<td class="nump">205,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">452,000,000<span></span>
</td>
<td class="nump">1,440,000,000<span></span>
</td>
<td class="nump">79,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="num">(428,000,000)<span></span>
</td>
<td class="num">(570,000,000)<span></span>
</td>
<td class="num">(654,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other noncash items</a></td>
<td class="num">(390,000,000)<span></span>
</td>
<td class="nump">72,000,000<span></span>
</td>
<td class="nump">33,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities, net of effects from acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(2,703,000,000)<span></span>
</td>
<td class="num">(1,510,000,000)<span></span>
</td>
<td class="num">(2,158,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">735,000,000<span></span>
</td>
<td class="num">(973,000,000)<span></span>
</td>
<td class="num">(1,075,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(3,000,000)<span></span>
</td>
<td class="nump">364,000,000<span></span>
</td>
<td class="num">(614,000,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable and pharmacy claims and discounts payable</a></td>
<td class="nump">2,898,000,000<span></span>
</td>
<td class="nump">2,769,000,000<span></span>
</td>
<td class="nump">3,550,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities', window );">Health care costs payable and other insurance liabilities</a></td>
<td class="nump">169,000,000<span></span>
</td>
<td class="num">(231,000,000)<span></span>
</td>
<td class="nump">320,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">2,852,000,000<span></span>
</td>
<td class="nump">2,740,000,000<span></span>
</td>
<td class="nump">1,476,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">$ 18,265,000,000<span></span>
</td>
<td class="nump">$ 15,865,000,000<span></span>
</td>
<td class="nump">$ 12,848,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsforInsuranceBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Insurance Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsforInsuranceBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StoreImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Store Impairment Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StoreImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToSuppliersAndEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to suppliers for goods and services provided and to employees for services provided.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToSuppliersAndEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash receipts from customers during the current period which are usually for sales of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromInterestAndDividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received for dividends and interest on the entity's equity and debt investments during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3337-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromInterestAndDividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from principal payment received from sales-type and direct financing leases classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 230<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123398031&amp;loc=SL120154370-112784<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211323118808">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' Equity - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th" colspan="2"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Shares</div></th>
<th class="th" colspan="2"><div>Treasury Shares</div></th>
<th class="th"><div>Common Stock and Capital Surplus</div></th>
<th class="th"><sup>[3]</sup></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><sup>[4]</sup></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Total CVS Health Shareholders&#8217; Equity</div></th>
<th class="th" colspan="2">
<div>Total CVS Health Shareholders&#8217; Equity </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2018</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,720<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance at Dec. 31, 2018</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 58,543<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,228)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="nump">$ 45,440<span></span>
</td>
<td class="nump">$ 40,911<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 102<span></span>
</td>
<td class="nump">$ 58,225<span></span>
</td>
<td class="nump">$ 178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">6,634<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">917<span></span>
</td>
<td class="nump">917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance', window );">Purchase of treasury shares, net of ESPP issuances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,615)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(2,615)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,615)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,727<span></span>
</td>
<td class="num">(425)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">64,170<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,235)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="nump">45,972<span></span>
</td>
<td class="nump">45,108<span></span>
</td>
<td colspan="2" class="num">$ (3)<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
<td class="nump">63,864<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">7,179<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="nump">541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,644)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(2,644)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,644)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,733<span></span>
</td>
<td class="num">(423)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">69,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,178)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="nump">46,513<span></span>
</td>
<td class="nump">49,640<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">69,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">7,910<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(449)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(449)<span></span>
</td>
<td class="num">(449)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option activity, stock awards and other (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option activity, stock awards and other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="nump">864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod', window );">ESPP issuances, net of purchase of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Common stock dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,644)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(2,644)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,644)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease', window );">Other increases (decreases) in noncontrolling interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,744<span></span>
</td>
<td class="num">(422)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 75,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (28,173)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="nump">$ 47,377<span></span>
</td>
<td class="nump">$ 54,906<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 965<span></span>
</td>
<td class="nump">$ 75,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 306<span></span>
</td>
</tr>
<tr><td colspan="17"></td></tr>
<tr><td colspan="17"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Treasury shares include 1 million shares held in trust for each of the years ended December 31, 2021, 2020 and 2019. Treasury stock includes $29 million related to shares held in trust for each of the years ended December 31, 2021, 2020 and 2019. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NjM_bdbd7ade-1f47-46a7-92fa-bfb084c43320">Accounting Standards Update (&#8220;ASU&#8221;) 2016-02</span>, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 842), which resulted in an increase to retained earnings of $178 million during the year ended December 31, 2019.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Common stock and capital surplus includes the par value of common stock of $17 million as of December 31, 2021, 2020 and 2019.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NjQ_6d63f6c0-91a9-453b-838f-78265109358a">ASU 2016-13</span>, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 326), which resulted in a reduction to retained earnings of $3&#160;million during the year ended December 31, 2020.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling interest, Other Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211325293912">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Shareholders' Equity (Parentheticals) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesHeldinTrust', window );">Treasury shares held in trust (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockValueSharesHeldInTrust', window );">Treasury shares held in trust</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 29<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 64,170<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 58,543<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">75,381<span></span>
</td>
<td class="nump">69,701<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">ASU 2016-02</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">ASU 2016-02<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member', window );">ASU 2016-13</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">ASU 2016-13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 45,108<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 40,911<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 54,906<span></span>
</td>
<td class="nump">$ 49,640<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings | ASU 2016-02</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 178<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings | ASU 2016-13</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Cumulative adjustment to retained earnings as a result of new accounting standard adoption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (3)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NjQ_6d63f6c0-91a9-453b-838f-78265109358a">ASU 2016-13</span>, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 326), which resulted in a reduction to retained earnings of $3&#160;million during the year ended December 31, 2020.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NjM_bdbd7ade-1f47-46a7-92fa-bfb084c43320">Accounting Standards Update (&#8220;ASU&#8221;) 2016-02</span>, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 842), which resulted in an increase to retained earnings of $178 million during the year ended December 31, 2019.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesHeldinTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Held in Trust</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesHeldinTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockValueSharesHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Shares Held In Trust</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockValueSharesHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211336811656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business&#160; </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation, together with its subsidiaries (collectively, &#8220;CVS Health&#8221; or the &#8220;Company&#8221;), has more than 9,900 retail locations, nearly 1,200 walk-in medical clinics, a leading pharmacy benefits manager with approximately 110 million plan members with expanding specialty pharmacy solutions and a dedicated senior pharmacy care business serving more than one million patients per year. The Company also serves an estimated 35 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#8220;PDP&#8221;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The coronavirus disease 2019 (&#8220;COVID-19&#8221;) and its emerging new variants continue to impact the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#8217;s businesses, operating results, cash flows and financial condition in the years ended December 31, 2021 and 2020, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in eight states through which it sells Insured plans directly to individual consumers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services and mail order pharmacy. In addition, through the Pharmacy Services segment, the Company provides specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of December&#160;31, 2021, the Retail/LTC segment operated more than 9,900 retail locations, nearly 1,200 MinuteClinic locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform with the current year presentation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when purchased. The Company invests in short-term money market funds, commercial paper and time deposits, as well as other debt securities that are classified as cash equivalents within the accompanying consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash (included in other current assets) represents funds held on behalf of members, including health savings account (&#8220;HSA&#8221;) funds associated with high deductible health plans. Beginning in 2021, the Company began presenting these funds held on behalf of members in restricted cash and, for statement of cash flow purposes, retrospectively adjusted the 2020 and 2019 balances by the amounts shown in the table below in the line item &#8220;restricted cash (included in other current assets)&#8221; to conform with the current year presentation. Restricted cash (included in other assets) represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.</span></div><div><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the consolidated balance sheets to total cash, cash equivalents and restricted cash on the consolidated statements of cash flows as of December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,691&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,043&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist primarily of U.S. Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next twelve months, in which case it is classified as current on the consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. See Note 4 &#8216;&#8216;Fair Value&#8217;&#8217; for additional information on how the Company estimates the fair value of these investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principal payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. Interest is not accrued on debt securities when management believes the collection of interest is unlikely.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#8217;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities with readily available fair values are measured at fair value with changes in fair value recognized in net income (loss).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage Loans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mortgage loan investments on the consolidated balance sheets are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Investments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments consist primarily of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Private equity and hedge fund limited partnerships, which are accounted for using the equity method of accounting. Under this method, the carrying value of the investment is based on the value of the Company&#8217;s equity ownership of the underlying investment funds provided by the general partner or manager of the investments, the financial statements of which generally are audited. As a result of the timing of the receipt of the valuation information provided by the fund managers, these investments are generally reported on up to a three month lag. The Company reviews investments for impairment at least quarterly and monitors their performance throughout the year through discussions with the administrators, managers and/or general partners. If the Company becomes aware of an impairment of a limited partnership&#8217;s investments through its review or prior to receiving the limited partnership&#8217;s financial statements at the financial statement date, an impairment will be recognized by recording a reduction in the carrying value of the limited partnership with a corresponding charge to net investment income. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investment real estate, which is carried on the consolidated balance sheets at depreciated cost, including capital additions, net of write-downs for other-than-temporary declines in fair value. Depreciation is calculated using the straight-line method based on the estimated useful life of each asset. If any real estate investment is considered held-for-sale, it is carried at the lower of its carrying value or fair value less estimated selling costs. The Company generally estimates fair value using net operating income and applying a capitalization rate in conjunction with comparable sales information. At the time of the sale, the difference between the sales price and the carrying value is recorded as a realized capital gain or loss. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Privately-placed equity securities, which are carried on the consolidated balance sheets at cost less impairments, plus or minus subsequent adjustments for observable price changes. Additionally, as a member of the Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;), a subsidiary of the Company is required to purchase and hold shares of the FHLBB. These shares are restricted and carried at cost. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Income</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment income on the Company&#8217;s investments is recorded when earned and is reflected in the Company&#8217;s net income (other than net investment income on assets supporting experience-rated products). Experience-rated products are products in the large case pensions business where the contract holder, not the Company, assumes investment and other risks, subject to, among other things, minimum guarantees provided by the Company. The effect of investment performance on experience-rated products is allocated to contract holders&#8217; accounts daily, based on the underlying investment experience and, therefore, does not impact the Company&#8217;s net income (as long as the contract&#8217;s minimum guarantees are not triggered). Net investment income on assets supporting large case pensions&#8217; experience-rated products is included in net investment income in the consolidated statements of operations and is credited to contract holders&#8217; accounts through a charge to benefit costs. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments (other than realized capital gains and losses on investments supporting experience-rated products) are included as a component of net investment income in the consolidated statements of operations. Realized capital gains and losses are determined on a specific identification basis. Purchases and sales of debt and equity securities and alternative investments are reflected on the trade date. Purchases and sales of mortgage loans and investment real estate are reflected on the closing date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are not included in realized capital gains and losses in the consolidated statements of operations and instead are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized capital gains and losses on investments (other than unrealized capital gains and losses on investments supporting experience-rated products) are reflected in shareholders&#8217; equity, net of tax, as a component of accumulated other comprehensive income. Unrealized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#8217;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations. Accounts receivable, net is composed of the following at December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,431&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,742&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s allowance for credit losses was $339&#160;million and $358&#160;million as of December&#160;31, 2021 and 2020, respectively. When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventories </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are valued at the lower of cost or net realizable value using the weighted average cost method. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. During the interim period between physical inventory counts, the Company accrues for anticipated physical inventory losses on a location-by-location basis based on historical results and current physical inventory trends. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance Recoverables </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#8217;s primary liability as the direct insurer of the risks reinsured. Failure of reinsurers to indemnify the Company could result in losses; however, the Company does not expect charges for unrecoverable reinsurance to have a material effect on its consolidated operating results or financial condition. The Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities or economic characteristics of its reinsurers. At December&#160;31, 2021, the Company&#8217;s reinsurance recoverables consisted primarily of amounts due from third parties that are rated consistent with companies that are considered to have the ability to meet their obligations. Reinsurance recoverables are recorded as other current assets or other assets on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Contract Acquisition Costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance products included in the Health Care Benefits segment are cancellable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. Acquisition costs for certain long-duration insurance contracts are deferred and are recorded as other current assets or other assets on the consolidated balance sheets and are amortized over the estimated life of the contracts. The amortization of deferred acquisition costs is recorded in operating expenses in the consolidated statements of operations. At December&#160;31, 2021 and 2020, the balance of deferred acquisition costs was $895 million and $546 million, respectively, comprised primarily of commissions paid on Medicare Supplement products within the Health Care Benefits segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is reported at historical cost, net of accumulated depreciation. Property, equipment and improvements to leased premises are depreciated using the straight-line method over the estimated useful lives of the assets, or when applicable, the term of the lease, whichever is shorter. Estimated useful lives generally range from 1 to 40 years for buildings, building improvements and leasehold improvements and 3 to 10 years for fixtures, equipment and internally developed software. Repair and maintenance costs are charged directly to expense as incurred. Major renewals or replacements that </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">substantially extend the useful life of an asset are capitalized and depreciated. Application development stage costs for significant internally developed software projects are capitalized and depreciated. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consists of the following at December&#160;31, 2021 and 2020: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,134&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixtures and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,700)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,896&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,606&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense (which includes the amortization of property and equipment under finance or capital leases) totaled $2.3 billion, $2.1 billion and $1.9 billion for the years ended December&#160;31, 2021, 2020 and 2019, respectively. During the year ended December&#160;31, 2021, the Company recorded an impairment on property and equipment of $261&#160;million in connection with the planned closure of certain retail stores. See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about this impairment charge as well as the Company&#8217;s finance leases. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Right-of-Use Assets and Lease Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#8217;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s real estate leases typically contain options that permit renewals for additional periods of up to five years each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For real estate leases, the Company accounts for lease components and nonlease components as a single lease component.  Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about right-of-use assets and lease liabilities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently if necessary, as further described in &#8220;Long-Lived Asset Impairment&#8221; below. See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about goodwill. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#8220;VOBA&#8221;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Other than VOBA, definite-lived intangible assets are amortized using the straight-line method. VOBA is amortized over the expected life of the acquired contracts in proportion to estimated premiums. Indefinite-lived intangible assets are not amortized but are tested for impairment annually, or more frequently if necessary, as further described in &#8220;Long-Lived Asset Impairment&#8221; below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about intangible assets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Asset Impairment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#8217;s estimated future cash flows (discounted). If required, an impairment loss is recorded for the portion of the asset group&#8217;s carrying value that exceeds the asset group&#8217;s estimated future cash flows (discounted). During the year ended December&#160;31, 2021, the Company recorded a store impairment charge of approximately $1.4 billion primarily related to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. There were no material impairment charges recognized on long-lived assets in the year ended 2020. During the year ended December&#160;31, 2019 the Company recorded a store impairment charge of $231 million primarily related to operating lease right-of-use assets. See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about the right-of-use asset impairment charges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When evaluating goodwill for potential impairment, the Company compares the fair value of its reporting units to their respective carrying amounts. The Company estimates the fair value of its reporting units using a combination of a discounted cash flow method and a market multiple method. If the carrying amount of a reporting unit exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill, the results of which indicated an impairment of the goodwill associated with the LTC reporting unit. Accordingly, during the third quarter of 2021, the Company recorded a $431&#160;million goodwill impairment charge. The results of the impairment tests indicated that there was no impairment of goodwill of the remaining reporting units as of the testing date or during the year ended December&#160;31, 2021. During the third quarter of both 2020 and 2019, the Company performed its required annual goodwill impairment tests and concluded there were no goodwill impairments as of the testing dates or during the years ended December&#160;31, 2020 and 2019. See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about the goodwill impairment charge recorded during the year ended December&#160;31, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets are tested for impairment by comparing the estimated fair value of the asset to its carrying value. The Company estimates the fair value of its indefinite-lived trademarks using the relief from royalty method under the income approach. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value. There were no impairment losses recognized on indefinite-lived intangible assets in any of the years ended December&#160;31, 2021, 2020 or 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses. Deposits, withdrawals and net </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Costs Payable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care costs payable consist principally of unpaid fee-for-service medical, dental and pharmacy claims, capitation costs, other amounts due to providers pursuant to risk-sharing arrangements related to the Health Care Benefits segment&#8217;s Insured Commercial, Medicare and Medicaid products and accruals for state assessments. Unpaid health care claims include an estimate of payments the Company will make for (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid, each as of the financial statement date (collectively, &#8220;IBNR&#8221;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. Such estimates are developed using actuarial principles and assumptions which consider, among other things, historical and projected claim submission and processing patterns, assumed and historical medical cost trends, historical utilization of medical services, claim inventory levels, changes in Insured membership and product mix, seasonality and other relevant factors. The Company reflects changes in these estimates in benefit costs in the Company&#8217;s consolidated operating results in the period they are determined. Capitation costs represent contractual monthly fees paid to participating physicians and other medical providers for providing medical care, regardless of the volume of medical services provided to the Insured member. Amounts due under risk-sharing arrangements are based on the terms of the underlying contracts with the providers and consider claims experience under the contracts through the financial statement date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. Of those factors, the Company considers the analysis of historical and projected claim payment patterns (including claims submission and processing patterns) and the assumed health care cost trend rate (the year-over-year change in per member per month health care costs) to be the most critical assumptions. In developing its IBNR estimate, the Company consistently applies these actuarial principles and assumptions each period, with consideration to the variability of related factors. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of IBNR in 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company analyzes historical claim payment patterns by comparing claim incurred dates (i.e., the date services were provided) to claim payment dates to estimate &#8220;completion factors.&#8221; The Company uses completion factors predominantly to estimate the ultimate cost of claims incurred more than three months before the financial statement date. The Company estimates completion factors by aggregating claim data based on the month of service and month of claim payment and estimating the percentage of claims incurred for a given month that are complete by each month thereafter. For any given month, substantially all claims are paid within six months of the date of service, but it can take up to 48 months or longer after the date of service before all of the claims are completely resolved and paid. These historically-derived completion factors are then applied to claims paid through the financial statement date to estimate the ultimate claim cost for a given month&#8217;s incurred claim activity. The difference between the estimated ultimate claim cost and the claims paid through the financial statement date represents the Company&#8217;s estimate of claims remaining to be paid as of the financial statement date and is included in the Company&#8217;s health care costs payable. The completion factors the Company uses reflect judgments and possible adjustments based on data such as claim inventory levels, claim submission and processing patterns and, to a lesser extent, other factors such as changes in health care cost trend rates, changes in Insured membership and changes in product mix. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claims may be more (less) complete than originally estimated using the Company&#8217;s completion factors, which may result in reserves that are higher (lower) than the ultimate cost of claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because claims incurred within three months before the financial statement date are less mature, the Company uses a combination of historically-derived completion factors and the assumed health care cost trend rate to estimate the ultimate cost of claims incurred for these months. The Company applies its actuarial judgment and places a greater emphasis on the assumed health care cost trend rate for the most recent claim incurred dates as these months may be influenced by seasonal patterns and changes in membership and product mix.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s health care cost trend rate is affected by changes in per member utilization of medical services as well as changes in the unit cost of such services. Many factors influence the health care cost trend rate, including the Company&#8217;s ability to manage benefit costs through product design, negotiation of favorable provider contracts and medical management programs, as well as the mix of the Company&#8217;s business. The health status of the Company&#8217;s Insured members, aging of the population and other demographic characteristics, advances in medical technology and other factors continue to contribute to rising per member utilization and unit costs. Changes in health care practices, inflation, new technologies, increases in the cost of </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prescription drugs (including specialty pharmacy drugs), direct-to-consumer marketing by pharmaceutical companies, clusters of high-cost cases, claim intensity, changes in the regulatory environment, health care provider or member fraud and numerous other factors also contribute to the cost of health care and the Company&#8217;s health care cost trend rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each reporting period, the Company uses an extensive degree of judgment in the process of estimating its health care costs payable. As a result, considerable variability and uncertainty is inherent in such estimates, particularly with respect to claims with claim incurred dates of three months or less before the financial statement date; and the adequacy of such estimates is highly sensitive to changes in assumed completion factors and the assumed health care cost trend rates. For each reporting period the Company recognizes the actuarial best estimate of health care costs payable considering the potential volatility in assumed completion factors and health care cost trend rates, as well as other factors. The Company believes its estimate of health care costs payable is reasonable and adequate to cover its obligations at December&#160;31, 2021; however, actual claim payments may differ from the Company&#8217;s estimates. A worsening (or improvement) of the Company&#8217;s health care cost trend rates or changes in completion factors from those that the Company assumed in estimating health care costs payable at December&#160;31, 2021 would cause these estimates to change in the near term, and such a change could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each quarter, the Company re-examines previously established health care costs payable estimates based on actual claim payments for prior periods and other changes in facts and circumstances. Given the extensive degree of judgment in this estimate, it is possible that the Company&#8217;s estimates of health care costs payable could develop either favorably (that is, its actual benefit costs for the period were less than estimated) or unfavorably. The changes in the Company&#8217;s estimate of health care costs payable may relate to a prior quarter, prior year or earlier periods. For a roll forward of the Company&#8217;s health care costs payable, see Note 7 &#8216;&#8216;Health Care Costs Payable.&#8217;&#8217; The Company&#8217;s reserving practice is to consistently recognize the actuarial best estimate of its ultimate liability for health care costs payable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Insurance Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unpaid Claims</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unpaid claims consist primarily of reserves associated with certain short-duration group disability and term life insurance contracts, including an estimate for IBNR as of the financial statement date. Reserves associated with certain short-duration group disability and term life insurance contracts are based upon the Company&#8217;s estimate of the present value of future benefits, which is based on assumed investment yields and assumptions regarding mortality, morbidity and recoveries from the U.S. Social Security Administration. The Company develops its estimate of IBNR using actuarial principles and assumptions which consider, among other things, contractual requirements, claim incidence rates, claim recovery rates, seasonality and other relevant factors. The Company discounts certain claim liabilities related to group long-term disability and life insurance waiver of premium contracts. The discount rates generally reflect the Company&#8217;s expected investment returns for the investments supporting all incurral years of these liabilities. The discount rates for retrospectively-rated contracts are set at contractually specified levels. The Company&#8217;s estimates of unpaid claims are subject to change due to changes in the underlying experience of the insurance contracts, changes in investment yields or other factors, and these changes are recorded in current and future benefits in the consolidated statements of operations in the period they are determined. The Company estimates its reserve for claims IBNR for life products largely based on completion factors. The completion factors used are based on the Company&#8217;s historical experience and reflect judgments and possible adjustments based on data such as claim inventory levels, claim payment patterns, changes in business volume and other factors. If claims are submitted or processed on a faster (slower) pace than historical periods, the actual claims may be more (less) complete than originally estimated using completion factors, which may result in reserves that are higher (lower) than required to cover future life benefit payments. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of unpaid claims IBNR in 2021. As of December&#160;31, 2021, unpaid claims balances of $324 million and $1.3 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2020, unpaid claims balances of $532 million and $1.5 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all life and disability insurance liabilities have been fully ceded to unrelated third parties through indemnity reinsurance agreements; however, the Company remains directly obligated to the policyholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Future Policy Benefits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future policy benefits consist primarily of reserves for limited payment pension and annuity contracts and long-term care insurance contracts. Reserves for limited payment pension and annuity contracts are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality, retirement, expense and interest rate experience. Such assumptions generally vary by plan, year of issue and policy duration. Assumed interest rates on such contracts ranged from 3.0% to 11.3% in the year ended December&#160;31, 2021 and from 3.3% to 11.3% in the year ended December&#160;31, 2020. The Company periodically reviews mortality assumptions against both industry standards and its experience. Reserves for long-</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">duration long-term care contracts represent the Company&#8217;s estimate of the present value of future benefits and essential maintenance expenses to be paid to or on behalf of policyholders less the present value of future gross premiums. The assumed interest rate on such contracts was 5.1% in both the years ended December 31, 2021 and 2020. The Company&#8217;s estimate of the present value of future benefits under such contracts is based upon mortality, morbidity and interest rate assumptions. As of December&#160;31, 2021, future policy benefits balances of $416 million and $5.1 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2020, future policy benefits balances of $462 million and $5.5 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Premium Deficiency Reserves</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its insurance contracts to determine if it is probable that a loss will be incurred. A premium deficiency loss is recognized when it is probable that expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), will exceed existing reserves plus anticipated future premiums and reinsurance recoveries. Anticipated investment income is not considered in the calculation of premium deficiency losses for short-duration contracts. For purposes of determining premium deficiency losses, contracts are grouped consistent with the Company&#8217;s method of acquiring, servicing and measuring the profitability of such contracts. As of December&#160;31, 2021 and 2020, the Company established a premium deficiency reserve of $16 million and $11 million, respectively, related to Medicaid products in the Health Care Benefits segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policyholders&#8217; Funds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Policyholders&#8217; funds consist primarily of reserves for pension and annuity investment contracts and customer funds associated with certain health contracts. Reserves for such contracts are equal to cumulative deposits less withdrawals and charges plus  interest credited thereon, net of experience-rated adjustments. In 2021, interest rates for pension and annuity investment contracts ranged from 3.5% to 4.8%. In 2020, interest rates for pension and annuity investment contracts ranged from 4.1% to 5.1%. Reserves for contracts subject to experience rating reflect the Company&#8217;s rights as well as the rights of policyholders and plan participants. The Company also holds funds for HSAs on behalf of members associated with high deductible health plans. These amounts are held to pay for qualified health care expenses incurred by these members. The HSA balances were approximately $2.9 billion and $2.7 billion at December&#160;31, 2021 and 2020, respectively, and are reflected in other current assets with a corresponding liability in policyholders&#8217; funds. These assets are considered restricted cash for cash flow statement purposes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Policyholders&#8217; funds liabilities that are expected to be paid within twelve months from the balance sheet date are classified as current on the consolidated balance sheets. Policyholders&#8217; funds liabilities that are expected to be paid greater than twelve months from the balance sheet date are included in other long-term liabilities on the consolidated balance sheets. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Self-Insurance Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is self-insured for certain losses related to general liability, workers&#8217; compensation and auto liability. The Company obtains third party insurance coverage to limit exposure from these claims. The Company is also self-insured for certain losses related to health and medical liabilities. The Company&#8217;s self-insurance accruals, which include reported claims and claims incurred but not reported, are calculated using standard insurance industry actuarial assumptions and the Company&#8217;s historical claims experience. At December&#160;31, 2021 and 2020, self-insurance liabilities totaled $1.1 billion and $927 million, respectively, and were recorded as accrued expenses on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation and Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For non-U.S. dollar functional currency locations, (i) assets and liabilities are translated at end-of-period exchange rates, (ii) revenues and expenses are translated at average exchange rates in effect during the period and (iii) equity is translated at historical exchange rates. The resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For U.S. dollar functional currency locations, foreign currency assets and liabilities are remeasured into U.S. dollars at end-of-period exchange rates, except for nonmonetary balance sheet accounts which are remeasured at historical exchange rates. Revenues and expenses are remeasured at average exchange rates in effect during each period, except for those expenses related to the nonmonetary balance sheet amounts which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in net income.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses from foreign currency transactions and the effects of foreign currency remeasurements were not material in the years ended December&#160;31, 2021 or 2020. On July 1, 2019, the Company sold its Brazilian subsidiary, Drogaria Onofre Ltda. (&#8220;Onofre&#8221;) for an immaterial amount. The Company recorded a loss on the divestiture, which included the elimination of the subsidiary&#8217;s $154 million cumulative translation adjustment from accumulated other comprehensive income during the year ended December 31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which, in the Company&#8217;s Commercial business, reflect contracted rates per member and the number of covered members recorded in the Company&#8217;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. Revenue related to the Company&#8217;s Government business is collected monthly from the U.S. federal government and various government agencies based on fixed payment rates and member eligibility. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Premium Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the minimum medical loss ratio (&#8220;MLR&#8221;) rebate requirements of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (as amended, collectively, the &#8220;ACA&#8221;) is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Services Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#8217;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#8217;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#8217;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting for Medicare Part D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include insurance premiums earned by the Company&#8217;s PDPs, which are determined based on the PDP&#8217;s annual bid and related contractual arrangements with the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;). The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment sells prescription drugs directly through its mail service dispensing pharmacies and indirectly through the Company&#8217;s retail pharmacy network. The Company&#8217;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the dispensing of prescription drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions dispensed indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#8220;Drug Discounts&#8221; and &#8220;Guarantees&#8221; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#8220;retail co-payments&#8221;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Pharmacy Services segment:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by mail service dispensing pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by third party pharmacies in the Company&#8217;s retail pharmacy network and associated administrative fees are recognized at the Company&#8217;s point-of-sale, which is when the claim is adjudicated by the Company&#8217;s online claims processing system and the Company has transferred control of the prescription drug and completed all of its performance obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Drug Discounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records revenue net of manufacturers&#8217; rebates earned by its clients based on their plan members&#8217; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#8217; rebates earned by its clients. The estimates are based on the best available data at period-end and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#8217; rebate amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantees</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Retail Pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer returns are not material to the Company&#8217;s operating results or financial condition. Sales taxes are not included in revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loyalty and Other Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customer loyalty program, ExtraCare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, consists of two components, ExtraSavings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers a subscription-based membership program, CarePass</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-term Care</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of long-term care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#8217;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Walk-In Medical Clinics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For services provided by the Company&#8217;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by major source in each segment for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:28.737%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.944%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.944%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.462%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">152,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">76,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43,765)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">184,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">76,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">76,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82,186&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">153,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100,105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43,923)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91,715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">60,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">153,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">70,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(40,003)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">171,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">75,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91,198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">85,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">140,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(41,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">165,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,604&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">86,608&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(41,439)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">256,776&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">52,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021 and 2020, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for cost of products sold as follows:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold includes: (i) the cost of prescription drugs sold during the reporting period directly through the Company&#8217;s mail service dispensing pharmacies and indirectly through the Company&#8217;s retail pharmacy network, (ii) shipping and handling costs, and (iii) the operating costs of the Company&#8217;s mail service dispensing pharmacies and client service operations and related information technology support costs including depreciation and amortization. The cost of prescription drugs sold component of cost of products sold includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients&#8217; benefit plans from the Company&#8217;s mail service dispensing pharmacies, net of any volume-related or other discounts (see &#8220;Vendor Allowances and Purchase Discounts&#8221; below) and (ii) the cost of prescription drugs sold (including retail co-payments) through the Company&#8217;s retail pharmacy network under contracts where the Company is the principal, net of any volume-related or other discounts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold includes: the cost of merchandise sold during the reporting period, including prescription drug costs, and the related purchasing costs, warehousing and delivery costs (including depreciation and amortization) and actual and estimated inventory losses. </span></div><div><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vendor Allowances and Purchase Discounts </span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for vendor allowances and purchase discounts as follows: </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Pharmacy Services segment to receive </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, (ii) a discount for the prompt payment of invoices or (iii) when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#8217;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Pharmacy Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Pharmacy Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vendor allowances received by the Retail/LTC segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any amounts received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon sales volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract. The total amortization of these upfront payments was not material to the Company&#8217;s consolidated financial statements in any of the periods presented. </span></div><div><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Reform</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Insurer Fee</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1, 2014, the ACA has imposed an annual premium-based health insurer fee (&#8220;HIF&#8221;) for each calendar year, payable in September, which was not deductible for tax purposes. The Company has been required to estimate a liability for the HIF at the beginning of the calendar year in which the fee was payable with a corresponding deferred asset that was amortized ratably to operating expenses over the calendar year. The Company recorded the liability for the HIF in accrued expenses and recorded the deferred asset in other current assets. In December 2019, the HIF was repealed for calendar years after 2020, therefore there was no expense related to the HIF in the year ended December&#160;31, 2021. In the year ended December 31, 2020, operating expenses included $1.0&#160;billion related to the Company&#8217;s share of the HIF. There was no expense related to the HIF in 2019, since there was a one-year suspension of the HIF for 2019. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a permanent risk adjustment program to transfer funds from qualified individual and small group insurance plans with below average risk scores to plans with above average risk scores. Based on the risk of the Company&#8217;s qualified plan members relative to the average risk of members of other qualified plans in comparable markets, as defined by the ACA, the Company estimates its ultimate risk adjustment receivable (recorded in accounts receivable) or payable (recorded in accrued expenses) for the current calendar year and reflects the pro-rata year-to-date impact as an adjustment to premium revenue. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Corridor</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) based on their ratio of allowable costs to target costs (as defined by the ACA). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company filed a lawsuit in August 2019 to recover the $313&#160;million it was owed under the ACA&#8217;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#8217;s temporary risk corridor program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company received the $313&#160;million it was owed under the ACA&#8217;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the year ended December 31, 2020. After considering </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recorded pre-tax income of $307 million and after-tax income of $223&#160;million during the year ended December&#160;31, 2020. </span></div><div><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Costs </span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs, which are reduced by the portion funded by vendors, are expensed when the related advertising takes place. Net advertising costs, which are included in operating expenses, were $523 million, $461 million and $396 million in 2021, 2020 and 2019, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcyMzEz_ea62d84c-7b65-4b23-9d75-3a8341c56a52">three</span> to five years) using the straight-line method. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year or years in which the differences are expected to reverse. The effect of a change in the tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date of such change.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and the Company&#8217;s recent operating results. The Company establishes a valuation allowance when it does not consider it more likely than not that a deferred tax asset will be recovered.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process whereby (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors defined benefit pension plans (&#8220;pension plans&#8221;) and other postretirement employee benefit plans (&#8220;OPEB plans&#8221;) for its employees and retirees. The Company recognizes the funded status of its pension and OPEB plans on the consolidated balance sheets based on the year-end measurements of plan assets and benefit obligations. When the fair value of plan assets are in excess of the plan benefit obligations, the amounts are reported in other current assets and other assets. When the fair value of plan benefit obligations are in excess of plan assets, the amounts are reported in accrued expenses and other long-term liabilities based on the amount by which the actuarial present value of benefits payable in the next twelve months included in the benefit obligation exceeds the fair value of plan assets. The net periodic benefit cost (income) for the Company&#8217;s pension and OPEB plans do not contain a service cost component as these plans have been frozen for an extended period of time.&#160;Non-service cost components of pension and postretirement net periodic benefit cost (income) are included in other income in the consolidated statements of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the two-class method. The Company calculates basic earnings per share based on the weighted average number of common shares outstanding for the period. See Note 14 &#8216;&#8216;Earnings Per Share&#8217;&#8217; for additional information.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shares Held in Trust</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains grantor trusts, which held approximately one million shares of its common stock at both December&#160;31, 2021 and 2020. These shares are designated for use under various employee compensation plans. Since the Company holds these shares, they are excluded from the computation of basic and diluted shares outstanding. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in (i) a generic pharmaceutical sourcing entity, (ii) certain hedge fund and private equity investments and (iii) certain real estate partnerships that are considered VIEs. The Company does not have a future obligation to fund losses or debts on behalf of these investments; however, it may voluntarily contribute funds. In evaluating whether the Company is the primary beneficiary of a VIE, the Company considers several factors, including whether the Company has (a) the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and (b) the obligation to absorb losses and the right to receive benefits that could potentially be significant to the VIE. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Primary Beneficiary</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, the Company and Cardinal Health, Inc. (&#8220;Cardinal&#8221;) established Red Oak Sourcing, LLC (&#8220;Red Oak&#8221;), a generic pharmaceutical sourcing entity in which the Company and Cardinal each own 50%. The Red Oak arrangement had an initial term of ten years. In 2021, the Red Oak arrangement was amended to extend the initial term an additional five years, for a total term of 15 years. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak; however, Red Oak does not own or hold inventory on behalf of either company. No physical assets (e.g., property and equipment) were contributed to Red Oak by either company, and minimal funding was provided to capitalize Red Oak. The Company has determined that it is the primary beneficiary of this VIE because it has the ability to direct the activities of Red Oak. Consequently, the Company consolidates Red Oak in its consolidated financial statements within the Retail/LTC segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal is required to pay the Company quarterly payments, which began in October 2014 and will extend through June 2029. As milestones are met, the quarterly payments increase. The Company received $183 million from Cardinal during each of the years ended December&#160;31, 2021, 2020 and 2019. The payments reduce the Company&#8217;s carrying value of inventory and are recognized in cost of products sold when the related inventory is sold. Amounts reimbursed by Cardinal for the years ended December&#160;31, 2021, 2020 and 2019, and amounts due to or due from Cardinal at December&#160;31, 2021 and 2020 were immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Other Variable Interest Holder</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has invested in certain VIEs for which it has determined that it is not the primary beneficiary, consisting of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Hedge fund and private equity investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in hedge fund and private equity investments in order to generate investment returns for its investment portfolio supporting its insurance businesses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Real estate partnerships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in various real estate partnerships, including those that construct, own and manage low-income housing developments. For the low income housing development investments, substantially all of the projected benefits to the Company are from tax credits and other tax benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not the primary beneficiary of these VIEs because the nature of the Company&#8217;s involvement with the activities of these VIEs does not give the Company the power to direct the activities that most significantly impact their economic performance. The Company records the amount of its investment in these VIEs as long-term investments on the consolidated balance sheets and recognizes its share of each VIE&#8217;s income or losses in net income (loss).&#160;The Company&#8217;s maximum exposure to loss from these VIEs is limited to its investment balances as disclosed below and the risk of recapture of previously recognized tax credits related to the real estate partnerships, which the Company does not consider significant.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total amount of other variable interest holder VIE assets included in long-term investments on the consolidated balance sheets at December&#160;31, 2021 and 2020 was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedge fund investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate partnerships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,289&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $52 million, $56 million and $32 million in the years ended December&#160;31, 2021, 2020 and 2019, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $79 million, $77 million and $96 million for pharmaceutical inventory purchases during the years ended December&#160;31, 2021, 2020 and 2019, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021, 2020 and 2019, the Company made charitable contributions of&#160;$50&#160;million, $50 million and $30&#160;million, respectively,&#160;to the CVS Health Foundation, a non-profit entity that focuses on health, education and community involvement programs. The charitable contributions were recorded as operating expenses in the consolidated statements of operations within the Corporate/Other segment for the years ended December&#160;31, 2021, 2020 and 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discontinued Operations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with certain business dispositions completed between 1995 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens &#8216;n Things and Bob&#8217;s Stores, each of which subsequently filed for bankruptcy. The Company&#8217;s loss from discontinued operations includes lease-related costs that the Company believes it will likely be required to satisfy pursuant to these lease guarantees. See &#8220;Lease Guarantees&#8221; in Note 16 &#8216;&#8216;Commitments and Contingencies&#8217;&#8217; for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the results of discontinued operations for the year ended December 31, 2020. </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Results from discontinued operations were immaterial for the years ended December 31, 2021 and 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s </span></div>liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#8217;s expected investment yield under the existing guidance.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211336824776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Divestitures</a></td>
<td class="text">Divestitures<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Workers&#8217; Compensation Business</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2020, the Company sold its Workers&#8217; Compensation business for approximately $850&#160;million. The results of this business were reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $269 million in the year ended December&#160;31, 2020, which is reflected as a reduction in operating expenses in the Company&#8217;s consolidated statement of operations within the Health Care Benefits segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Brazilian Subsidiary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 1, 2019, the Company sold its Brazilian subsidiary, Onofre, for an immaterial amount. Onofre operated 50 retail pharmacy stores, the results of which historically had been reported within the Retail/LTC segment. The Company recorded a pre-tax loss on the divestiture of $205 million in the year ended December 31, 2019, which primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in operating expenses in the Company&#8217;s consolidated statement of operations within the Retail/LTC segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211336037448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.016%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,117&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,025&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,142&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, the Company held investments of $450 million and $524 million, respectively, related to the 2012 conversion of an existing group annuity contract from a participating to a non-participating contract. These investments are included in the total investments of large case pensions supporting non-experience-rated products. Although these investments are not accounted for as Separate Accounts assets, they are legally segregated and are not subject to claims that arise out of the Company&#8217;s business and only support future policy benefits obligations under that group annuity contract. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at December&#160;31, 2021 and 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.701%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,396&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">There was no allowance for expected credit losses recorded on available-for-sale debt securities at December&#160;31, 2021 or 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results.&#160;At December&#160;31, 2021, debt securities with a fair value of $864 million, gross unrealized capital gains of $94 million and gross unrealized capital losses of $2 million and at December&#160;31, 2020, debt securities with a fair value of $919 million, gross unrealized capital gains of $135 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities at December&#160;31, 2021 are shown below by contractual maturity.&#160;&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,174&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage-Backed and Other Asset-Backed Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s residential mortgage-backed securities at December&#160;31, 2021 were issued by the Government National Mortgage Association, the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation and carry agency guarantees and explicit or implicit guarantees by the U.S. Government.&#160;At December&#160;31, 2021, the Company&#8217;s residential mortgage-backed securities had an average credit quality rating of AAA and a weighted average duration of 4.7 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s commercial mortgage-backed securities have underlying loans that are dispersed throughout the United States. Significant market observable inputs used to value these securities include loss severity and probability of default.&#160;At December&#160;31, 2021, these securities had an average credit quality rating of AAA and a weighted average duration of 6.1 years.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s other asset-backed securities have a variety of underlying collateral (e.g., automobile loans, credit card receivables, home equity loans and commercial loans). Significant market observable inputs used to value these securities include the unemployment rate, loss severity and probability of default.&#160;At December&#160;31, 2021, these securities had an average credit quality rating of AA and a weighted average duration of 1.0 year.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at December&#160;31, 2021 and 2020 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,384&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#8217;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#8217;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#8217;s current prospects for recovery. Unrealized capital losses at December&#160;31, 2021 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of December&#160;31, 2021, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting experience-<br/>rated products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting remaining<br/>products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,305&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;During the years ended December 31, 2021 and 2020, the Company had the following activity in its mortgage loan portfolio:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#8217;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. </span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 1 - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents loans of superior quality.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 2 to 4 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Categories 5 and 6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represent loans where credit risk is not substantial, but these loans warrant management&#8217;s close attention.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Category 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon the Company&#8217;s assessments at December&#160;31, 2021 and 2020, the amortized cost basis of the Company&#8217;s mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.950%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 scheduled mortgage loan principal repayments were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Investment Income</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the years ended December 31, 2021, 2020 and 2019 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital gains are net of yield-related impairment losses on debt securities of $42 million and $49 million for the years ended December&#160;31, 2021 and 2020, respectively. There were no credit-related losses on debt securities in the years ended December&#160;31, 2021 and 2020. Net realized capital gains are net of other-than-temporary impairment (&#8220;OTTI&#8221;) losses on debt securities of $24 million for the year ended December 31, 2019.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net investment income includes $38 million, $42 million and $44 million for the years ended December 31, 2021, 2020 and 2019, respectively, related to investments supporting experience-rated products. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital gains and losses recognized during the year ended December 31, 2021 related to investments in equity securities held as of December 31, 2021 were not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses in the years ended December 31, 2021, 2020 and 2019 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,913&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211324875560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value</a></td>
<td class="text">Fair Value<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;In this note, the Company provides details on the fair value of financial assets and liabilities and how it determines those fair values.&#160;The Company presents this information for those financial instruments that are measured at fair value for which the change in fair value impacts net income attributable to CVS Health or other comprehensive income separately from other financial assets and liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s financial instruments are measured at fair value on the consolidated balance sheets.&#160;The fair values of these instruments are based on valuations that include inputs that can be classified within one of three levels of a hierarchy established by GAAP.&#160;&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#8220;valuation inputs&#8221;) that qualifies a financial asset or liability for each level:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 &#8211; Unadjusted quoted prices for identical assets or liabilities in active markets.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 &#8211; Valuation inputs other than Level 1 that are based on observable market data.&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 &#8211; Developed from unobservable data, reflecting the Company&#8217;s assumptions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities are classified based upon the lowest level of input that is significant to the valuation.&#160;When quoted prices in active markets for identical assets and liabilities are available, the Company uses these quoted market prices to determine the fair value of financial assets and liabilities and classifies these assets and liabilities in Level 1.&#160;In other cases where a quoted market price for identical assets and liabilities in an active market is either not available or not observable, the Company estimates fair value using valuation methodologies based on available and observable market information or by using a matrix pricing model.&#160;These financial assets and liabilities are classified in Level 2.&#160;If quoted market prices are not available, the Company determines fair value using broker quotes or an internal analysis of each investment&#8217;s financial performance and cash flow projections.&#160;Thus, financial assets and liabilities may be classified in Level 3 even though there may be some significant inputs that may be observable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of the valuation methodologies used for the Company&#8217;s financial assets and liabilities that are measured at fair value, including the general classification of such assets and liabilities pursuant to the valuation hierarchy.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash and Cash Equivalents </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. When quoted prices are available in an active market, cash equivalents are classified in Level 1 of the fair value hierarchy. Fair values of cash equivalent instruments that do not trade on a regular basis in active markets are classified as Level 2.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Where quoted prices are available in an active market, debt securities are classified in Level 1 of the fair value hierarchy.&#160;The Company&#8217;s&#160;Level 1 debt securities consist primarily of U.S. Treasury securities.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s Level 2 debt securities are obtained using models, such as matrix pricing, which use quoted market prices of debt securities with similar characteristics or discounted cash flows to estimate fair value. The </span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company reviews these prices to ensure they are based on observable market inputs that include quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets and inputs that are observable that are not prices (such as interest rates and credit risks). The Company also reviews the methodologies and the assumptions used to calculate prices from these observable inputs. On a quarterly basis, the Company selects a sample of its Level 2 debt securities&#8217; prices and compares them to prices provided by a secondary source. Variances over a specified threshold are identified and reviewed to confirm the price provided by the primary source represents an appropriate estimate of fair value. In addition, the Company&#8217;s internal investment team consistently compares the prices obtained for select Level 2 debt securities to the team&#8217;s own independent estimates of fair value for those securities.&#160;The Company obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December&#160;31, 2021 or 2020. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also values certain debt securities using Level 3 inputs.&#160;For Level 3 debt securities, fair values are determined by outside brokers or, in the case of certain private placement securities, are priced internally.&#160;Outside brokers determine the value of these debt securities through a combination of their knowledge of the current pricing environment and market flows.&#160;The Company did not have any broker quoted debt securities for the years ended December&#160;31, 2021 and 2020. For some private placement securities, the Company&#8217;s internal staff determines the value of these debt securities by analyzing spreads of corporate and sector indices as well as interest spreads of comparable public bonds.&#160;Examples of these private placement Level 3 debt securities include certain U.S. and foreign securities and certain tax-exempt municipal securities.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company currently has two classifications of equity securities:&#160;those that are publicly traded and those that are privately placed.&#160;Publicly-traded equity securities are classified in Level 1 because quoted prices are available for these securities in an active market.&#160;For privately placed equity securities, there is no active market; therefore, these securities are classified in Level 3 because the Company prices these securities through an internal analysis of each investment&#8217;s financial statements and cash flow projections. Significant unobservable inputs consist of earnings and revenue multiples, discount for lack of marketability and comparability adjustments. An increase or decrease in any of these unobservable inputs would have resulted in a change in the fair value measurement. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no financial liabilities measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2021 or 2020. Financial assets measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,440&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,266&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,817&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,372&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,633&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,089&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.434%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">States, <br/>municipalities<br/>&#160;and political <br/>subdivisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other asset-<br/>backed<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable<br/>preferred<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital gains (losses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in unrealized capital losses included in other comprehensive income associated with Level 3 financial assets which were held as of December&#160;31, 2021 was $4 million during the year ended December&#160;31, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">States, <br/>municipalities<br/>&#160;and political <br/>subdivisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable<br/>preferred<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital gains (losses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in unrealized capital losses included in other comprehensive income associated with Level 3 financial assets which were held as of December&#160;31, 2020 was $4&#160;million during the year ended December&#160;31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total gross transfers into (out of) Level 3 during the years ended December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers into Level 3</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers into Level 3</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments Not Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the consolidated balance sheets at adjusted cost or contract value at December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information regarding the valuation of cost method investments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts Measured at Fair Value on the Consolidated Balance Sheets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets relate to the Company&#8217;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Net investment income and capital gains and losses on Separate Accounts assets accrue directly to such contract holders.&#160;The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses.&#160;Deposits, withdrawals, net investment income and realized and unrealized capital gains and losses on Separate Accounts assets are not reflected in the consolidated statements of operations, shareholders&#8217; equity or cash flows.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets include debt and equity securities.&#160;The valuation methodologies used for these assets are similar to the methodologies described above in this Note 4 &#8216;&#8216;Fair Value.&#8217;&#8217;&#160;Separate Accounts assets also include investments in common/collective trusts that are carried at fair value. Common/collective trusts invest in other investment funds otherwise known as the underlying funds. The Separate Accounts&#8217; interests in the common/collective trust funds are based on the fair values of the investments of the underlying funds and therefore are classified in Level 2. The assets in the underlying funds primarily consist of equity securities. Investments in common/collective trust funds are valued at their respective net asset value (&#8220;NAV&#8221;) per share/unit on the valuation date.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts financial assets at December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.953%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,782&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,017&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $70 million and $29&#160;million of other receivables at December&#160;31, 2021 and 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2021 and 2020, the Company had no gross transfers of Separate Accounts financial assets into or out of Level 3.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211507273208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangibles<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangibles</a></td>
<td class="text">Goodwill and Other Intangibles<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the changes in the carrying amount of goodwill by segment for the&#160;years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.455%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture of Workers&#8217; Compensation business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(505)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(505)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,130&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,552&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,130&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,376&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,121&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2021, the decrease in the carrying amount of goodwill was primarily driven by a goodwill impairment charge related to the LTC reporting unit within the Retail/LTC segment. During the year ended December&#160;31, 2020, the decrease in the carrying amount of goodwill was primarily driven by the divestiture of the Workers&#8217; Compensation business, partially offset by goodwill associated with immaterial acquisitions. See Note 2 &#8216;&#8216;Divestitures&#8217;&#8217; for further discussion regarding the Workers&#8217; Compensation business divestiture.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill. The results of the impairment tests indicated an impairment of the goodwill associated with the LTC reporting unit, as the reporting unit&#8217;s carrying value exceeded its fair value as of the testing date. The results of the impairment tests of the remaining reporting units indicated that there was no impairment of goodwill as of the testing date. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, the LTC reporting unit has continued to face challenges that have impacted the Company&#8217;s ability to grow the LTC reporting unit&#8217;s business at the rate estimated when its 2020 goodwill impairment test was performed. These challenges include lower net facility admissions, net long-term care facility customer losses and the prolonged adverse impact of the COVID-19 pandemic and the emerging new variants, which resulted in more significant declines in occupancy rates experienced by the Company&#8217;s long-term care facility customers than previously anticipated. During the third quarter of 2021, LTC management updated their 2021 annual forecast and submitted their long-term plan which showed deterioration in the financial results for the remainder of 2021 and beyond. The Company utilized these updated projections in performing its annual impairment test, which indicated that the fair value of the LTC reporting unit was lower than its carrying value, resulting in a $431&#160;million goodwill impairment charge in the third quarter of 2021. The fair value of the LTC reporting unit was determined using a combination of a discounted cash flow method and a market multiple method. As of December&#160;31, 2021, there was no remaining goodwill balance in the LTC reporting unit. During the third quarter of 2021, the Company also performed an impairment test of the intangible assets of the LTC reporting unit and concluded these assets were not impaired. As of December&#160;31, 2021, there was $2.7 billion of intangible assets related to customer lists in the LTC reporting unit. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2020, the Company performed its required annual impairment tests of goodwill. The results of the impairment tests indicated that there was no impairment of goodwill. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, cumulative goodwill impairments were $6.6 billion and $6.1 billion, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s intangible assets as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except weighted average life</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,084&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,564)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,060)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(651)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,753&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,727)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,026&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,923)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(440)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,623&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,481)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,142&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for intangible assets totaled $2.3 billion, $2.3 billion and $2.4 billion for the years ended December 31, 2021, 2020 and 2019, respectively. The projected annual amortization expense for the Company&#8217;s intangible assets for the next five&#160;years is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211329348168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases most of its retail stores and mail order facilities and certain distribution centers and corporate offices under operating or finance leases, typically with initial terms of 15 to 25 years. The Company also leases certain equipment and other assets under operating or finance leases, typically with initial terms of 3 to 10 years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company leases pharmacy space at the stores of another retail chain for which the noncancelable contractual term of the pharmacy lease arrangement exceeds the remaining estimated economic life of the buildings. For these pharmacy lease arrangements, the Company concluded that for accounting purposes the lease term was the remaining estimated economic life of the buildings. Consequently, most of these individual pharmacy leases are finance leases.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,633&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the years ended December&#160;31, 2021, 2020 and 2019 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,714&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,724&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,701&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for interest portion of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows paid for principal portion of finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,824&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases as of December&#160;31, 2021 and 2020 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except remaining lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,122</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,729</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,177</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,757</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,823</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,395</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,375</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance<br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating<br/>Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,068&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,247)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,823&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Future operating lease payments have not been reduced by minimum sublease rentals of $311 million due in the future under noncancelable subleases.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.4 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Transactions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company finances a portion of its store development program through sale-leaseback transactions. The properties are generally sold at net book value, which generally approximates fair value, and the resulting leases generally qualify and are accounted for as operating leases. The operating leases that resulted from these transactions are included in the tables above. The Company does not have any retained or contingent interests in the stores and does not provide any guarantees, other than a </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">guarantee of lease payments, in connection with the sale-leaseback transactions. There were no sale-leaseback transactions in 2021. Proceeds from sale-leaseback transactions totaled $101 million and $5 million in the years ended December 31, 2020 and 2019, respectively. Gains from sale-leaseback transactions totaled $3 million in the year ended December 31, 2020. There were no material gains from sale-leaseback transactions in the year ended December 31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Store Impairment Charges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its retail store right-of-use and property and equipment assets for impairment at the retail store level, which is the lowest level at which cash flows can be identified. For retail stores where there is an indicator of impairment present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated undiscounted future cash flows used in the analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to its estimated fair value which is the greater of the asset group&#8217;s estimated future cash flows (discounted), or the consideration of what a market participant would pay to lease the assets, net of leasing costs. The Company&#8217;s estimate of fair value considers historical results, current operating trends, consolidated sales, profitability and cash flow results and forecasts. For assets which the Company has determined it will be able to sublease, the estimated future cash flows include the estimated sublease income, net of estimated leasing costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the carrying value of an asset group exceeds its estimated fair value, an impairment loss is recorded to reduce the value of the asset group to its estimated fair value. As the impaired assets are measured at fair value on a nonrecurring basis primarily using unobservable inputs as of the measurement date, the assets are classified in Level 3 of the fair value hierarchy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company completed a strategic review of its retail business and announced the creation of new formats for its stores to continue to drive higher engagement with customers. As part of this review, the Company evaluated changes in population, consumer buying patterns and future health needs to ensure it has the right kinds of stores in the right locations for consumers and for the business. In connection with this initiative, on November 17, 2021, the Board of Directors of CVS Health Corporation (the &#8220;Board&#8221;) authorized the closing of approximately 900 retail stores over the next three years. The Company expects to close approximately 300 stores each year between 2022 and 2024. As a result, management determined that there were indicators of impairment with respect to the impacted stores&#8217; asset groups, including the associated operating lease right-of-use assets and property and equipment. A long-lived asset impairment test was performed during the fourth quarter of 2021 and the results of the impairment test indicated that the fair value of certain retail store asset groups was lower than their respective carrying values. Accordingly, in the three months ended December 31, 2021, the Company recorded a store impairment charge of approximately $1.4&#160;billion, consisting of a write down of approximately $1.1&#160;billion related to operating lease right-of-use assets and $261&#160;million related to property and equipment, within the Retail/LTC segment. Subsequent to the impairment loss, the fair value of the associated operating lease right-of use assets and property and equipment were $356&#160;million and $185&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, the Company performed reviews of its retail stores and determined it would close 68 underperforming retail pharmacy stores. As a result, management determined that there were indicators of impairment with respect to the impacted stores, including the associated operating lease right-of-use assets. Long-lived asset impairment tests were performed and the results indicated that the fair value of those underperforming retail stores were lower than their respective carrying values. Accordingly, the Company recorded store impairment charges of $231 million during the year ended December 31, 2019, primarily related to these operating lease right-of-use asset impairment charges, within the Retail/LTC segment.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases most of its retail stores and mail order facilities and certain distribution centers and corporate offices under operating or finance leases, typically with initial terms of 15 to 25 years. The Company also leases certain equipment and other assets under operating or finance leases, typically with initial terms of 3 to 10 years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company leases pharmacy space at the stores of another retail chain for which the noncancelable contractual term of the pharmacy lease arrangement exceeds the remaining estimated economic life of the buildings. For these pharmacy lease arrangements, the Company concluded that for accounting purposes the lease term was the remaining estimated economic life of the buildings. Consequently, most of these individual pharmacy leases are finance leases.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,633&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the years ended December&#160;31, 2021, 2020 and 2019 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,714&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,724&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,701&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for interest portion of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows paid for principal portion of finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,824&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases as of December&#160;31, 2021 and 2020 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except remaining lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,122</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,729</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,177</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,757</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,823</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,395</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,375</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance<br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating<br/>Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,068&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,247)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,823&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Future operating lease payments have not been reduced by minimum sublease rentals of $311 million due in the future under noncancelable subleases.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.4 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Transactions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company finances a portion of its store development program through sale-leaseback transactions. The properties are generally sold at net book value, which generally approximates fair value, and the resulting leases generally qualify and are accounted for as operating leases. The operating leases that resulted from these transactions are included in the tables above. The Company does not have any retained or contingent interests in the stores and does not provide any guarantees, other than a </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">guarantee of lease payments, in connection with the sale-leaseback transactions. There were no sale-leaseback transactions in 2021. Proceeds from sale-leaseback transactions totaled $101 million and $5 million in the years ended December 31, 2020 and 2019, respectively. Gains from sale-leaseback transactions totaled $3 million in the year ended December 31, 2020. There were no material gains from sale-leaseback transactions in the year ended December 31, 2019.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Store Impairment Charges</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its retail store right-of-use and property and equipment assets for impairment at the retail store level, which is the lowest level at which cash flows can be identified. For retail stores where there is an indicator of impairment present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated undiscounted future cash flows used in the analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to its estimated fair value which is the greater of the asset group&#8217;s estimated future cash flows (discounted), or the consideration of what a market participant would pay to lease the assets, net of leasing costs. The Company&#8217;s estimate of fair value considers historical results, current operating trends, consolidated sales, profitability and cash flow results and forecasts. For assets which the Company has determined it will be able to sublease, the estimated future cash flows include the estimated sublease income, net of estimated leasing costs. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the carrying value of an asset group exceeds its estimated fair value, an impairment loss is recorded to reduce the value of the asset group to its estimated fair value. As the impaired assets are measured at fair value on a nonrecurring basis primarily using unobservable inputs as of the measurement date, the assets are classified in Level 3 of the fair value hierarchy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2021, the Company completed a strategic review of its retail business and announced the creation of new formats for its stores to continue to drive higher engagement with customers. As part of this review, the Company evaluated changes in population, consumer buying patterns and future health needs to ensure it has the right kinds of stores in the right locations for consumers and for the business. In connection with this initiative, on November 17, 2021, the Board of Directors of CVS Health Corporation (the &#8220;Board&#8221;) authorized the closing of approximately 900 retail stores over the next three years. The Company expects to close approximately 300 stores each year between 2022 and 2024. As a result, management determined that there were indicators of impairment with respect to the impacted stores&#8217; asset groups, including the associated operating lease right-of-use assets and property and equipment. A long-lived asset impairment test was performed during the fourth quarter of 2021 and the results of the impairment test indicated that the fair value of certain retail store asset groups was lower than their respective carrying values. Accordingly, in the three months ended December 31, 2021, the Company recorded a store impairment charge of approximately $1.4&#160;billion, consisting of a write down of approximately $1.1&#160;billion related to operating lease right-of-use assets and $261&#160;million related to property and equipment, within the Retail/LTC segment. Subsequent to the impairment loss, the fair value of the associated operating lease right-of use assets and property and equipment were $356&#160;million and $185&#160;million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, the Company performed reviews of its retail stores and determined it would close 68 underperforming retail pharmacy stores. As a result, management determined that there were indicators of impairment with respect to the impacted stores, including the associated operating lease right-of-use assets. Long-lived asset impairment tests were performed and the results indicated that the fair value of those underperforming retail stores were lower than their respective carrying values. Accordingly, the Company recorded store impairment charges of $231 million during the year ended December 31, 2019, primarily related to these operating lease right-of-use asset impairment charges, within the Retail/LTC segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211329294568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock', window );">Health Care Costs Payable</a></td>
<td class="text">Health Care Costs Payable<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is information about incurred and cumulative paid health care claims development as of December&#160;31, 2021, net of reinsurance, and the total IBNR liabilities plus expected development on reported claims included within the net incurred claims amounts. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for information on how the Company estimates IBNR reserves and health care costs payable as well as changes to those methodologies, if any. The Company&#8217;s estimate of IBNR liabilities is primarily based on trend and completion factors. Claim frequency is not used in the calculation of the Company&#8217;s liability. In addition, it is impracticable to disclose claim frequency information for health care claims due to the Company&#8217;s inability to gather consistent claim frequency information across its multiple claims processing systems. Any claim frequency count disclosure would not be comparable across the Company&#8217;s different claim processing systems and would not be consistent from period to period based on the volume of claims processed through each system. As a result, health care claim count frequency is not included in the disclosures below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information about incurred and paid health care claims development for the year ended December&#160;31, 2020 is presented as required unaudited supplemental information.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Incurred Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,634&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cumulative Paid Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All outstanding liabilities for health care costs payable prior to 2020, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total outstanding liabilities for health care costs payable, net of reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,574&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, the Company&#8217;s liabilities for IBNR plus expected development on reported claims totaled approximately $6.6 billion. Substantially all of the Company&#8217;s liabilities for IBNR plus expected development on reported claims at December&#160;31, 2021 related to the current calendar year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the December&#160;31, 2021 health care net incurred and paid claims development tables to the health care costs payable liability on the consolidated balance sheet is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.105%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-duration health care costs payable, net of reinsurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance lines other than short duration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total health care costs payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,808&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the years ended December 31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(788)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(524)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,973&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,406&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,199&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,115&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,779&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,472&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,800&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,926&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,808&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the years ended December&#160;31, 2021, 2020 and 2019 in the table above exclude (i) $16 million, $11 million and $4 million, respectively, for a premium deficiency reserve related to the Company&#8217;s Medicaid products, (ii) $59 million, $41 million and $41 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the consolidated balance sheets and (iii) $212 million, $221 million and $285 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s estimates of prior years&#8217; health care costs payable decreased by $788 million, $429 million and $524 million in 2021, 2020 and 2019, respectively, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#8217;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year. This development does not directly correspond to an increase in the Company&#8217;s operating results as these reductions were offset by estimated current period health care costs when the Company established the estimate of the current year health care costs payable.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI http://asc.fasb.org/topic&amp;trid=2303980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211329438312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings and Credit Arrangements</a></td>
<td class="text">Borrowings and Credit Agreements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.452%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.35% senior notes due March 2021</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Floating rate notes due March 2021 (0.950% at December 31, 2020)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.125% senior notes due May 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.125% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.125% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.45% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5% senior notes due July 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.75% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.7% senior notes due March 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.375% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.625% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5% senior notes due December 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.875% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.875% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.625% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.25% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.25% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.75% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.75% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.875% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.125% senior notes due September 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.875% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.625% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.75% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.78% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.125% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.125% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.75% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.125% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.3% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.75% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.125% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.875% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.05% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.25% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTAtMS0xLTE5NjM1_55ac48cb-f36e-4b9d-8b69-3e86d1c383ef"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTAtMS0xLTE5NjM1_fc260d98-5cca-40f0-8e2a-2fb2b3ac6249">Finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,743&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,318&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(786)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,971&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,207&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s required repayments of debt principal due during each of the next five&#160;years and thereafter, as of December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,743&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for a summary of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">maturities of the Company&#8217;s finance lease liabilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper and Back-up Credit Facilities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any commercial paper outstanding as of December 31, 2021 or 2020. In connection with its commercial paper program, the Company maintains a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 17, 2023, a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 16, 2024, and a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 11, 2026. The credit facilities allow for borrowings at various rates that are dependent, in part, on the Company&#8217;s public debt ratings and require the Company to pay a weighted average quarterly facility fee of approximately 0.03%, regardless of usage. As of December&#160;31, 2021 and 2020, there were no borrowings outstanding under any of the Company&#8217;s back-up credit facilities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A subsidiary of the Company is a member of the FHLBB. As a member, the subsidiary has the ability to obtain cash advances, subject to certain minimum collateral requirements. The maximum borrowing capacity available from the FHLBB as of December&#160;31, 2021 was approximately $995 million. At both December&#160;31, 2021 and 2020, there were no outstanding advances from the FHLBB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Borrowings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 18, 2021, the Company issued $1.0&#160;billion aggregate principal amount of 2.125% unsecured senior notes due September 15, 2031 for total proceeds of $987&#160;million, net of discounts, underwriting fees and offering expenses. The net proceeds of this offering were used for the purchase of senior notes in connection with the Company&#8217;s cash tender offer in August 2021 as described below.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2020 Notes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2020, the Company issued $750&#160;million aggregate principal amount of 1.3% unsecured senior notes due August 21, 2027 and $1.25&#160;billion aggregate principal amount of 1.875% unsecured senior notes due February 28, 2031 for total proceeds of approximately $1.99&#160;billion, net of discounts and underwriting fees. The $750&#160;million aggregate principal amount of 1.3% unsecured senior notes represent a further issuance of the Company&#8217;s 1.3% unsecured senior notes due August 21, 2027 initially issued in an aggregate principal amount of $1.5&#160;billion on August 21, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 21, 2020, the Company issued $1.5&#160;billion aggregate principal amount of 1.3% unsecured senior notes due August 21, 2027, $1.25&#160;billion aggregate principal amount of 1.75% unsecured senior notes due August 21, 2030 and $1.25&#160;billion aggregate principal amount of 2.7% unsecured senior notes due August 21, 2040 (collectively, the &#8220;August 2020 Notes&#8221;) for total proceeds of approximately $3.97&#160;billion, net of discounts and underwriting fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2020, the Company issued $750&#160;million aggregate principal amount of 3.625% unsecured senior notes due April 1, 2027, $1.5&#160;billion aggregate principal amount of 3.75% unsecured senior notes due April 1, 2030, $1.0&#160;billion aggregate principal amount of 4.125% unsecured senior notes due April 1, 2040 and $750&#160;million aggregate principal amount of 4.25% </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unsecured senior notes due April 1, 2050 (collectively, the &#8220;March 2020 Notes&#8221;) for total proceeds of approximately $3.95&#160;billion, net of discounts and underwriting fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net proceeds of these offerings were used for general corporate purposes, which may include working capital, capital expenditures, as well as the repurchase and/or repayment of indebtedness.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During March 2020, the Company entered into several interest rate swap transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of the March 2020 Notes. In connection with the issuance of the March 2020 Notes, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $7&#160;million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $5&#160;million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the March 2020 Notes. See Note 13 &#8216;&#8216;Other Comprehensive Income&#8217;&#8217; for additional information. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Early Extinguishments of Debt</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company redeemed for cash the remaining $2.3&#160;billion of its outstanding 3.7% senior notes due 2023. In connection with the early redemption of such senior notes, the Company paid a make-whole premium of $80 million in excess of the aggregate principal amount of the senior notes that were redeemed, wrote-off $8 million of unamortized deferred financing costs and incurred $1 million in fees, for a total loss on early extinguishment of debt of $89&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, the Company purchased approximately $2.0&#160;billion of its outstanding 4.3% senior notes due 2028 through a cash tender offer. In connection with the purchase of such senior notes, the Company paid a premium of $332 million&#160;in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $26&#160;million of unamortized deferred financing costs and incurred $5&#160;million in fees, for a total loss on early extinguishment of debt of $363&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company purchased $4.5&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $113&#160;million of its 4.0% senior notes due 2023, $1.4&#160;billion of its 3.7% senior notes due 2023, $1.0&#160;billion of its 4.1% senior notes due 2025 and $2.0&#160;billion of its 4.3% senior notes due 2028. In connection with the purchase of such senior notes, the Company paid a premium of $619&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $45&#160;million of unamortized deferred financing costs and incurred $10&#160;million in fees, for a total loss on early extinguishment of debt of $674&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company purchased $6.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $723&#160;million of its 4.0% senior notes due 2023, $2.3&#160;billion of its 3.7% senior notes due 2023 and $3.0&#160;billion of its 4.1% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $706&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $47&#160;million of unamortized deferred financing costs and incurred $13&#160;million in fees, for a total loss on early extinguishment of debt of $766&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, the Company purchased $4.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $1.3&#160;billion of its 3.125% senior notes due 2020, $723&#160;million of its floating rate notes due 2020, $328&#160;million of its 4.125% senior notes due 2021, $297&#160;million of 4.125% senior notes due 2021 issued by Aetna Inc. (&#8220;Aetna&#8221;), $413&#160;million of 5.45% senior notes due 2021 issued by Coventry Health Care, Inc., a wholly-owned subsidiary of Aetna, and $962&#160;million of its 3.35% senior notes due 2021. In connection with the purchase of such senior notes, the Company paid a premium of $76&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, incurred $8&#160;million in fees and recognized a net gain of $5&#160;million on the write-off of net unamortized deferred financing premiums, for a net loss on early extinguishment of debt of $79&#160;million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Covenants</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s back-up revolving credit facilities, unsecured senior notes and unsecured floating rate notes contain customary restrictive financial and operating covenants. These covenants do not include an acceleration of the Company&#8217;s debt maturities in the event of a downgrade in the Company&#8217;s credit ratings. The Company does not believe the restrictions contained in these covenants materially affect its financial or operating flexibility. As of December&#160;31, 2021, the Company was in compliance with all of its debt covenants.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211329357768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension Plans and Other Postretirement Benefits</a></td>
<td class="text">Pension Plans and Other Postretirement Benefits<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company sponsors several active 401(k) savings plans that cover all employees who meet plan eligibility requirements. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes matching contributions consistent with the provisions of the respective plans. At the participant&#8217;s option, account balances, including the Company&#8217;s matching contribution, can be invested among various investment options under each plan. The CVS Health Future Fund 401(k) Plan offers CVS Health Corporation&#8217;s common stock fund as an investment option. The Company also maintains nonqualified, unfunded deferred compensation plans for certain key employees. The plans provide participants the opportunity to defer portions of their eligible compensation and for certain nonqualified plans, participants receive matching contributions equivalent to what they could have received under the CVS Health Future Fund 401(k) Plan absent certain restrictions and limitations under the Internal Revenue Code. The Company&#8217;s contributions under its defined contribution plans were $552 million, $520 million and $550 million in the years ended December&#160;31, 2021, 2020 and 2019, respectively. The Company&#8217;s contributions for the year ended December 31, 2019 include contributions to the Aetna 401(k) Plan, which was merged into the CVS Health Future Fund 401(k) Plan on January 1, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Benefit Pension Plans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors a tax-qualified defined benefit pension plan that was frozen in 2010 and a nonqualified supplemental pension plan that was frozen in 2007. The Company also sponsors several other defined benefit pension plans that are unfunded nonqualified supplemental retirement plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Benefit Obligation and Plan Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables outline the change in pension benefit obligation and plan assets over the specified periods:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,845&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the pension benefit obligation during the years ended December&#160;31, 2021 and 2020 was primarily driven by the change in the discount rate during each respective period.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets (liabilities) recognized on the consolidated balance sheets at December&#160;31, 2021 and 2020 for the defined benefit pension plans consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets reflected in other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities reflected in accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities reflected in other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Periodic Benefit Cost (Income)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost (income) for the years ended December&#160;31, 2021, 2020 and 2019 are shown below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of net periodic benefit cost (income):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Plan Assumptions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a series of actuarial assumptions to determine its benefit obligation and net periodic benefit cost (income), the most significant of which include discount rates and expected return on plan assets assumptions. </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Discount Rates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discount rate is determined using a yield curve as of the annual measurement date. The yield curve consists of a series of individual discount rates, with each discount rate corresponding to a single point in time, based on high-quality bonds. Projected benefit payments are discounted to the measurement date using the corresponding rate from the yield curve that is consistent with the maturity profile of the expected liability cash flows.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Return on Plan Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected long-term rate of return on plan assets is determined by using the plan&#8217;s target allocation and return expectations based on many factors including forecasted long-term capital market real returns and the inflationary outlook on a plan by plan basis. See &#8220;Pension Plan Assets&#8221; below for additional details regarding the pension plan assets as of December 31, 2021 and 2020.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also considers other assumptions including mortality, interest crediting rate, termination and retirement rates and cost of living adjustments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its benefit obligation based on the following weighted average assumptions as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its net periodic benefit cost (income) based on the following weighted average assumptions for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension Plan Assets</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pension plan assets primarily include debt and equity securities held in separate accounts, common/collective trusts and real estate investments. The valuation methodologies used to value these debt and equity securities and common/collective trusts are similar to the methodologies described in Note 4 &#8220;Fair Value.&#8221; Pension plan assets also include investments in other assets that are carried at fair value. The following is a description of the valuation methodologies used to value real estate investments and these additional investments, including the general classification pursuant to the fair value hierarchy.</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Real Estate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Real estate investments are valued by independent third party appraisers. The appraisals comply with the Uniform Standards of Professional Appraisal Practice, which include, among other things, the income, cost, and sales comparison approaches to estimating property value. Therefore, these investments are classified in Level 3.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Private equity and hedge fund limited partnerships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Private equity and hedge fund limited partnerships are carried at fair value which is estimated using the NAV per unit as reported by the administrator of the underlying investment fund as a practical expedient to fair value. Therefore, these investments have been excluded from the fair value table below.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2021 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,553&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,837&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $261 million of equity securities and $149 million of debt securities. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $76 million of other receivables as well as $583 million of private equity limited partnership investments and $237 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2020 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,291&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,231&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,865&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $84 million of equity securities and $182 million of debt securities. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $142 million of other receivables as well as $624 million of private equity limited partnership investments and $214 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:74.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.759%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.761%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2020 were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s pension plan invests in a diversified mix of assets designed to generate returns that will enable the plan to meet its future benefit obligations. The risk of unexpected investment and actuarial outcomes is regularly evaluated. This evaluation is performed through forecasting and assessing ranges of investment outcomes over short- and long-term horizons and by assessing the pension plan&#8217;s liability characteristics. Complementary investment styles and strategies are utilized by professional investment management firms to further improve portfolio and operational risk characteristics. Public and private equity investments are used primarily to increase overall plan returns. Real estate investments are viewed favorably for their diversification benefits and above-average dividend generation. Fixed income investments provide diversification benefits and liability hedging attributes that are desirable, especially in falling interest rate environments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, target investment allocations for the Company&#8217;s pension plan were: 12% in equity securities, 77% in fixed income and debt securities, 5% in real estate, 3% in private equity limited partnerships and 3% in hedge funds. Actual asset allocations may differ from target allocations due to tactical decisions to overweight or underweight certain assets or as a result of normal fluctuations in asset values. Asset allocations are consistent with stated investment policies and, as a general rule, periodically rebalanced back to target asset allocations. Asset allocations and investment performance are formally reviewed periodically throughout the year by the pension plan&#8217;s Investment Subcommittee. Forecasting of asset and liability growth is performed at least annually.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flows</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally contributes to its tax-qualified pension plan based on minimum funding requirements determined under applicable federal laws and regulations. Employer contributions related to the nonqualified supplemental pension plans generally represent payments to retirees for current benefits. The Company contributed $78 million, $25 million and $25 million to its pension plans during 2021, 2020 and 2019, respectively. No contributions are required for the tax-qualified pension plan in 2022. The Company expects to make an immaterial amount of contributions for all other pension plans in 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the pension benefit obligation as of December&#160;31, 2021: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027-2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Multiemployer Pension Plans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover its union-represented employees. The risks of participating in these multiemployer plans are different from single-employer pension plans in the following respects: (i) assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers, (ii) if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers, and (iii) if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the applicable plan, which is referred to as a withdrawal liability. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the multiemployer pension plans in which the Company participates are individually significant to the Company. The Company&#8217;s contributions to multiemployer pension plans were $19 million, $19 million and $18 million in 2021, 2020 and 2019, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Postretirement Benefits</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides postretirement health care and life insurance benefits to certain retirees who meet eligibility requirements. The Company&#8217;s funding policy is generally to pay covered expenses as they are incurred. For retiree medical plan accounting, the Company reviews external data and its own historical trends for health care costs to determine the health care cost trend rates. As of December&#160;31, 2021 and 2020, the Company&#8217;s other postretirement benefits had an accumulated postretirement benefit obligation of $207 million and $226 million, respectively. Net periodic benefit costs related to these other postretirement benefits were $4 million, $12 million and $7 million in 2021, 2020 and 2019, respectively. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the accumulated other postretirement benefit obligation as of December&#160;31, 2021: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:86.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027-2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Pursuant to various collective bargaining agreements, the Company also contributes to multiemployer health and welfare plans that cover certain union-represented employees. The plans provide postretirement health care and life insurance benefits to certain employees who meet eligibility requirements. The Company&#8217;s contributions to multiemployer health and welfare plans totaled $60 million, $54 million and $57 million in 2021, 2020 and 2019, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211329294568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision for continuing operations consisted of the following for the&#160;years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,615&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,450&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,950&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,133&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,015&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(535)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(428)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(564)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(649)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,522&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of the statutory income tax rate to the Company&#8217;s effective income tax rate for continuing operations for the&#160;years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurer fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis difference upon disposition of subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year refund claim </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of the Company&#8217;s deferred income tax assets and liabilities as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debts and other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and capital loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll tax deferral</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(454)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,497&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,774&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,947)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,368)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,381)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,750)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,767)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,568)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,270)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,794)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had net operating and capital loss carryovers of $416 million, which expire between 2022 and 2041. The Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and the Company&#8217;s recent operating results. The Company established a valuation allowance of $325 million as of December&#160;31, 2021 because it does not consider it more likely than not that these deferred tax assets will be recovered.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balance of unrecognized tax benefits in 2021, 2020 and 2019 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of statutes of limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation and most of its subsidiaries are subject to U.S. federal income tax as well as income tax of numerous state and local jurisdictions. CVS Health Corporation participated in the Compliance Assurance Process through 2019, which is a program made available by the U.S. Internal Revenue Service (&#8220;IRS&#8221;) to certain qualifying large taxpayers, under which participants work collaboratively with the IRS to identify and resolve potential tax issues through open, cooperative and transparent interaction prior to the annual filing of their federal income tax returns. The IRS has completed its examinations of the Company&#8217;s consolidated U.S. federal income tax returns for tax years through and including 2013 and 2018. The IRS has substantially completed its examinations of the Company&#8217;s consolidated U.S. federal income tax returns for tax years 2014 through 2017 and 2019.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CVS Health Corporation and its subsidiaries are also currently under income tax examinations by a number of state and local tax authorities. As of December&#160;31, 2021, no examination has resulted in any proposed adjustments that would result in a material change to the Company&#8217;s operating results, financial condition or liquidity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all material state and local income tax matters have been concluded for fiscal years through 2014. Certain state exams are likely to be concluded and certain state statutes of limitations will lapse in 2022, but the change in the balance of the Company&#8217;s uncertain tax positions is projected to be immaterial. In addition, it is reasonably possible that the Company&#8217;s unrecognized tax benefits could change within the next twelve months due to the anticipated conclusion of various examinations with the IRS for various years. An estimate of the range of the possible change cannot be made at this time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records interest expense related to unrecognized tax benefits and penalties in the income tax provision. The Company accrued interest expense of approximately $40 million, $34 million and $49 million in 2021, 2020 and 2019, respectively. The Company had approximately $151 million and $121 million accrued for interest and penalties as of December&#160;31, 2021 and 2020, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the total amount of unrecognized tax benefits that, if recognized, would affect the Company&#8217;s effective income tax rate is approximately $669 million, after considering the federal benefit of state income taxes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331337736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Incentive Plans</a></td>
<td class="text">Stock Incentive Plans<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the CVS Health 2017 Incentive Compensation Plan (&#8220;ICP&#8221;) provide for grants of annual incentive and long-term performance awards to executive officers and other officers and employees of the Company or any subsidiary of the Company, as well as equity compensation to outside directors of CVS Health Corporation. Payment of such annual incentive and long-term performance awards will be in cash, stock, other awards or other property, at the discretion of the Management Planning and Development Committee (the &#8220;MP&amp;D Committee&#8221;) of the Board. The ICP allows for a maximum of 58 million shares of CVS Health Corporation common stock to be reserved and available for grants. As of December&#160;31, 2021, there were approximately 30 million shares of CVS Health Corporation common stock available for future grants under the ICP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the acquisition of Aetna (the &#8220;Aetna Acquisition&#8221;) on November 28, 2018, approximately 22 million shares of Aetna common stock subject to awards outstanding under the Amended Aetna Inc. 2010 Stock Incentive Plan (&#8220;SIP&#8221;) were assumed by CVS Health Corporation. In addition, in accordance with the merger agreement, shares which were available for future issuance under the SIP were converted into approximately 32 million shares of CVS Health Corporation common stock reserved and available for issuance pursuant to future awards. Subsequent to the expiration of the SIP on May 21, 2020, the ICP is the only compensation plan under which the Company grants stock options, restricted stock and other stock-based awards to its employees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzE3MDk_ea62d84c-7b65-4b23-9d75-3a8341c56a52">three</span> to five years) using the straight-line method. The following table is a summary of stock-based compensation for the&#160;years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and stock appreciation rights (&#8220;SARs&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Employee Stock Purchase Plan (&#8220;ESPP&#8221;) provides for the purchase of up to 60 million shares of CVS Health Corporation common stock. Under the ESPP, eligible employees may purchase common stock at the end of each six&#160;month offering period at a purchase price equal to 90% of the lower of the fair market value on the first day or the last day of the offering period. During 2021, approximately 3 million shares of common stock were purchased under the provisions of the ESPP at an average price of $60.51 per share. As of December&#160;31, 2021, approximately 31 million shares of common stock were available for issuance under the ESPP.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock-based compensation associated with the ESPP is estimated on the date of grant (the first day of the six&#160;month offering period) using the Black-Scholes option pricing model.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the assumptions used to value the ESPP awards for the&#160;years ended December&#160;31, 2021, 2020 and 2019:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is calculated based on semi-annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#8217;s daily stock price over the previous six&#160;month period.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on the Treasury constant maturity interest rate whose term is consistent with the expected term of ESPP purchases (i.e., six&#160;months).</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected life is based on the semi-annual purchase period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units and Performance Stock Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s restricted stock units and performance stock units are considered nonvested share awards and require no payment from the employee. The fair value of the restricted stock units is based on the market price of CVS Health Corporation common stock on the grant date and is recognized on a straight-line basis over the vesting period. For each restricted stock unit granted, employees receive one share of common stock, net of taxes, at the end of the vesting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s performance stock units contain performance vesting conditions in addition to a service vesting condition. Vesting of the Company&#8217;s performance stock units is dependent upon the degree to which the Company achieves its performance goals, which are generally set for a three-year performance period and are approved at the time of grant by the MP&amp;D Committee. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of performance stock units granted with service and performance vesting conditions is based on the market price of CVS Health Corporation common stock on the grant date and is recognized over the vesting period. Certain of the performance stock units also contain a market vesting condition based on the performance of CVS Health Corporation common stock relative to a comparator group. The fair value of these performance stock units is determined using a Monte Carlo simulation as of the grant date and is recognized over the vesting period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, there was $529 million of total unrecognized compensation cost related to the Company&#8217;s restricted stock units and performance stock units that are expected to vest. These costs are expected to be recognized over a weighted-average period of 2.1 years. The total fair value of restricted stock units vested during 2021, 2020 and 2019 was $406 million, $229 million and $265 million, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the restricted stock unit and performance stock unit activity for the&#160;year ended December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In thousands, except weighted average grant date fair value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,190&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,236)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,330&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options and SARs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All stock option grants are awarded at fair value on the date of grant. The fair value of stock options is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">service period. Stock options granted generally become exercisable over a four-year period from the grant date. Stock options granted through 2018 generally expire seven years after the grant date. Stock options granted subsequent to 2018 generally expire ten years after the grant date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All unvested Aetna SARs outstanding upon the acquisition of Aetna were converted into replacement CVS Health Corporation SARs. The replacement SARs granted are settled in CVS Health Corporation common stock, net of taxes, based on the appreciation of the stock price on the exercise date over the market price on the date of grant. The fair value of SARs is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite service period. SARs generally become exercisable over a three-year period from the grant date. SARs generally expire ten years after the grant date. No SARs have been granted subsequent to the Aetna Acquisition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of stock option and SAR activity that occurred for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from stock options exercised (including ESPP)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes for net share settlement of equity awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value of stock options and SARs exercised </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of stock options and SARs vested </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option is estimated using the Black-Scholes option pricing model based on the following assumptions at the time of grant:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is based on annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#8217;s daily stock price over a period equal to the expected life of each option grant after adjustments for infrequent events such as stock splits.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on yields from U.S. Treasury zero-coupon issues with a remaining term equal to the expected term of the options being valued.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected life represents the number of&#160;years the options are expected to be outstanding from grant date based on historical option or SAR holder exercise experience.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, unrecognized compensation expense related to unvested stock options totaled $38 million, which the Company expects to be recognized over a weighted-average period of 2.0 years. After considering anticipated forfeitures, the Company expects approximately 9 million of the unvested stock options to vest over the requisite service period.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s stock option and SAR activity for the&#160;year ended December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.747%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;thousands, except weighted average exercise price and remaining contractual term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,955&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,366)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(694)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,061&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603,137&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,704&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.61</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at end of year and expected to vest in the future</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.69</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,514&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331334360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">Shareholders&#8217; Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase programs have been authorized by the Board:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2021 (&#8220;2021 Repurchase Program&#8221;)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2016 (&#8220;2016 Repurchase Program&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the share Repurchase Programs was effective immediately. The 2016 Repurchase program was terminated effective December 9, 2021. The 2021 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) transactions, and/or other derivative transactions. The 2021 Repurchase Program can be modified or terminated by the Board at any time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021, 2020 and 2019, the Company did not repurchase any shares of common stock pursuant to the 2016 or 2021 Repurchase Programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $1.5&#160;billion fixed dollar ASR with Barclays Bank PLC (&#8220;Barclays&#8221;). Upon payment of the $1.5&#160;billion purchase price on January 4, 2022, the Company received a number of shares of CVS Health Corporation&#8217;s common stock equal to 80% of the $1.5 billion notional amount of the ASR or approximately 11.6&#160;million shares at a price of $103.34 per share, which were placed into treasury stock in January 2022. At the conclusion of the ASR, the Company may receive additional shares equal to the remaining 20% of the $1.5&#160;billion notional amount. The ultimate number of shares the Company may receive will depend on the daily volume-weighted average price of the Company&#8217;s stock over an averaging period, less a discount. It is also possible, depending on such weighted average price, that the Company will have an obligation to Barclays which, at the Company&#8217;s option, could be settled in additional cash or by issuing shares. Under the terms of the ASR, the maximum number of shares that could be delivered to the Company is 29.0&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quarterly cash dividend declared by the Board was $0.50 per share in 2021 and 2020. In December 2021, the Board authorized a 10% increase in the quarterly cash dividend to $0.55 per share effective in 2022. CVS Health Corporation has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#8217;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Requirements</span></div><div><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s insurance business operations are conducted through subsidiaries that principally consist of health maintenance organizations (&#8220;HMOs&#8221;) and insurance companies. The Company&#8217;s HMO and insurance subsidiaries report their financial </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">statements in accordance with accounting practices prescribed by state regulatory authorities which may differ from GAAP. The combined statutory net income for the years ended and estimated combined statutory and capital surplus at December&#160;31, 2021, 2020 and 2019 for the Company&#8217;s insurance and HMO subsidiaries were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory net income </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated statutory capital and surplus</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s insurance and HMO subsidiaries paid $1.6 billion of gross dividends to the Company for the year ended December&#160;31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to general state law restrictions on payments of dividends and other distributions to stockholders applicable to all corporations, HMOs and insurance companies are subject to further regulations that, among other things, may require those companies to maintain certain levels of equity and restrict the amount of dividends and other distributions that may be paid to their equity holders. In addition, in connection with the Aetna Acquisition, the Company made certain undertakings that require prior regulatory approval of dividends by certain of its HMOs and insurance companies. At December&#160;31, 2021, these amounts were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:88.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated minimum statutory surplus required by regulators</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments on deposit with regulatory bodies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated maximum dividend distributions permitted in 2022 without prior regulatory approval</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 and 2020, noncontrolling interests were $306 million and $312 million, respectively, primarily related to third party interests in the Company&#8217;s operating entities.&#160;The noncontrolling entities&#8217; share is included in total shareholders</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> equity on the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331336344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Other Comprehensive Income</a></td>
<td class="text">Other Comprehensive Income<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income in 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.529%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(489), $497 and $927 pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(32), $31 and $(105) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(436)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($0, $(7) and $(25) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(34), $(35) and $(20) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($20, $(30) and $162 pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($6, $7 and $(12) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of year accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of year accumulated other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the consolidated statements of operations. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income (loss) represent the elimination of the cumulative translation adjustment associated with the sale of Onofre, which was sold on July 1, 2019. The loss on the divestiture of Onofre is reflected in operating expenses in the consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included within interest expense in the consolidated statements of operations. The Company expects to reclassify approximately $11 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the consolidated statements of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331330184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Earnings Per Share<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the two-class method. SARs and options to purchase 7 million, 15&#160;million, and 17&#160;million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the years ended December&#160;31, 2021, 2020 and 2019, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share from continuing operations for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,898&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,201&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income allocated to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,910&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,629&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,301&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share from continuing operations:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331328792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reinsurance<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceDisclosuresAbstract', window );"><strong>Reinsurance Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceTextBlock', window );">Reinsurance</a></td>
<td class="text">Reinsurance<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#8217;s primary liability as the direct insurer of the risks reinsured.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 30, 2018, the Company completed the sale of Aetna&#8217;s standalone Medicare Part D prescription drug plans to a subsidiary of WellCare Health Plans, Inc. (&#8220;WellCare&#8221;), effective December 31, 2018. In connection with that sale, subsidiaries of WellCare and Aetna entered into reinsurance agreements under which WellCare ceded to Aetna 100% of the insurance risk related to the divested standalone Medicare Part D prescription drug plans for the 2019 PDP plan year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, the Company entered into two four-year reinsurance agreements with an unrelated reinsurer that allow it to reduce required capital and provide collateralized excess of loss reinsurance coverage on a portion of the Health Care Benefits segment&#8217;s group Commercial Insured business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance recoverables (recorded as other current assets or other assets on the consolidated balance sheets) at December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reinsurer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hartford Life and Accident Insurance Company</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lincoln Life &amp; Annuity Company of New York</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VOYA Retirement Insurance and Annuity Company </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,549&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct, assumed and ceded premiums earned for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.236%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(680)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,954)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,132&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,364&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of reinsurance on benefit costs for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.236%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net benefit costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,260&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,679&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,529&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is not a material difference between premiums on a written basis versus an earned basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has various agreements with unrelated reinsurers that do not qualify for reinsurance accounting under GAAP, and consequently are accounted for using deposit accounting. The Company entered into these contracts to reduce the risk of catastrophic loss which in turn reduces the Company&#8217;s capital and surplus requirements. Total deposit assets and liabilities related to reinsurance agreements that do not qualify for reinsurance accounting under GAAP were not material as of December&#160;31, 2021 or 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure pertaining to the existence, magnitude and information about insurance that has been ceded to or assumed from another insurance company, including the methodologies and assumptions used in determining recorded amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI http://asc.fasb.org/topic&amp;trid=2303980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331324616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. The Company believes COVID-19&#8217;s impact on its businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#8217;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond the Company&#8217;s knowledge and control. As a result, the impact COVID-19 will have on the Company&#8217;s businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has the following significant guarantee arrangements at December&#160;31, 2021:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ASC Claim Funding Accounts - The Company has arrangements with certain banks for the processing of claim payments for its ASC customers. The banks maintain accounts to fund claims of the Company&#8217;s ASC customers. The customer is responsible for funding the amount paid by the bank each day. In these arrangements, the Company guarantees that the banks will not sustain losses if the responsible ASC customer does not properly fund its account. The aggregate maximum exposure under these arrangements is generally limited to $250 million. The Company can limit its exposure to these guarantees by suspending the payment of claims for ASC customers that have not adequately funded the amount paid by the bank. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Separate Accounts Assets - Certain Separate Accounts assets associated with the large case pensions business in the Corporate/Other segment represent funds maintained as a contractual requirement to fund specific pension annuities that the Company has guaranteed. Minimum contractual obligations underlying the guaranteed benefits in these Separate Accounts were approximately $1.3&#160;billion and $1.4 billion at December&#160;31, 2021 and 2020, respectively. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information on Separate Accounts. Contract holders assume all investment and mortality risk and are required to maintain Separate Accounts balances at or above a specified level. The level of required funds is a function of the risk underlying the Separate Account&#8217;s investment strategy. If contract holders do not maintain the required level of Separate Accounts assets to meet the annuity guarantees, the Company would </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">establish an additional liability. Contract holders&#8217; balances in the Separate Accounts at December&#160;31, 2021 exceeded the value of the guaranteed benefit obligation. As a result, the Company was not required to maintain any additional liability for its related guarantees at December&#160;31, 2021. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Guarantees</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#8217;s Stores and Linens &#8216;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#8217;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#8217;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of December&#160;31, 2021, the Company guaranteed 72 such store leases (excluding the lease guarantees related to Linens &#8216;n Things, which have been recorded as a liability on the consolidated balance sheets), with the maximum remaining lease term extending through 2030.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#8217;s assessments generally are based on a formula relating to the Company&#8217;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#8220;Penn Treaty&#8221;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#8217;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#8217;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s total guaranty fund assessments liability was immaterial at both December&#160;31, 2021 and 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CMS, state insurance and health and welfare departments, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the U.S. Department of Justice (the &#8220;DOJ&#8221;), </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">state attorneys general, the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;) and other governmental authorities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#8217;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#8217;s financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#8217;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations.  In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Usual and Customary Pricing Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#8217;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PBM Litigation and Investigations</span></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is facing multiple lawsuits, including by a State Attorney General, governmental subdivisions and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers.  These complaints, brought by a number of different types of plaintiffs under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims.  The Company has also received subpoenas, civil investigative demands (&#8220;CIDs&#8221;) and other requests for documents and information from, and is being investigated by, Attorneys General of multiple states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Behnke v. CVS Caremark Corporation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#8217;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#8217;s PBM. The Company is defending itself against these claims.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled Substances Litigation, Audits and Subpoenas</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information. In November 2021, the Company was among the chain pharmacies found liable by a jury in a trial in federal court in Ohio; the remedy pursuant to that verdict has not been determined and the Company plans to appeal.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS Pharmacy locations concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. In January 2022, the DOJ served the Company with a CID regarding similar subjects. The Company is providing documents and information in response to these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Prescription Processing Litigation and Investigations</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ex rel.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Bassan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> v. Omnicare, Inc. and CVS Health Corp. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#8217;s Office for the Southern District of New York (the &#8220;SDNY&#8221;) filed a complaint-in-intervention in this previously sealed </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#8217;s Omnicare pharmacies&#8217; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.</span></div><div style="text-indent:18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2016, the Company received a CID from the U.S. Attorney&#8217;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#8217;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Provider Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#8220;out-of-network providers&#8221;).&#160;Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services and/or otherwise allege that the Company failed to timely or appropriately pay or administer out-of-network claims and benefits (including the Company&#8217;s post payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CMS Actions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS regularly audits the Company&#8217;s performance to determine its compliance with CMS&#8217;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#8217;s and other companies&#8217; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#8217; medical records to determine whether those records support the related diagnosis codes that determine the members&#8217; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#8220;RADV&#8221;) audits of various Medicare Advantage plans, including certain of the Company&#8217;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#8217;s risk adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the HHS (the &#8220;OIG&#8221;) also is auditing the Company&#8217;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately 200 members to all risk adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#8217;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#8217;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#8217;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#8217;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, the OIG or otherwise, including audits of the Company&#8217;s MLR rebates, methodology and/or reports, could be material and could adversely affect the Company&#8217;s operating results, cash flows and/or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Medicare and Medicaid CIDs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#8217;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stockholder Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#8217;s LTC business unit. The Company and its current and former officers and directors are defending themselves against these claims. Since filing, several of the cases have been consolidated, and the first-filed federal case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Miami Fire Fighters&#8217; and Police Officers&#8217; Retirement Trust, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anarkat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), was dismissed with prejudice in February 2021. Plaintiffs have appealed that decision to the First Circuit after their motion for reconsideration was denied. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re CVS Health Corp. Securities Act Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Waterford</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">re CVS Health Corp. Securities Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (formerly known as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Warren</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freundlich</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) have been stayed pending the outcome of the First Circuit appeal. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August and September 2020, two class actions under the Employee Retirement Income Security Act of 1974 (&#8220;ERISA&#8221;) were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna, and several current and former executives, directors and/or members of Aetna&#8217;s Compensation and Talent Management Committee: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Radcliffe v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flaim v. Aetna Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#8217;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#8217;s LTC business unit. The district court consolidated the actions and the Company is defending itself against these claims. In October 2021, the consolidated case was dismissed without prejudice. Plaintiffs may seek leave to file an amended complaint. The Company also received a related document request pursuant to ERISA &#167; 104(b), to which the Company has responded.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company received a demand for inspection of books and records pursuant to Delaware Corporation Law Section 220 (the &#8220;Demand&#8221;). The Demand purports to be related to potential breaches of fiduciary duties by the Board in relation to certain matters concerning opioids.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Other Legal and Regulatory Proceedings</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, breach of fiduciary duty, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, denial of or failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#8217;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#8217;s operating results. The Company will continue to defend contract awards it receives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#8217;s and the rest of the health care and related benefits industry&#8217;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#8217; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a leading national health solutions company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#8217;s businesses, changes to or clarifications of the Company&#8217;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulations as they may relate to one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#8217;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit against the Company, whether sealed or unsealed, or in any future </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211429387544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three operating segments, Health Care Benefits, Pharmacy Services and Retail/LTC, as well as a Corporate/Other segment. The Company&#8217;s segments maintain separate financial information, and the Company&#8217;s chief operating decision maker (the &#8220;CODM&#8221;) evaluates the segments&#8217; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#8217;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#8217;s business nor reflect the Company&#8217;s underlying business performance. See the reconciliation of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#8217;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.</span></div><div><span><br/></span></div><div style="padding-right:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, 2020 and 2019, revenues from the federal government accounted for 17%, 16% and 16%, respectively, of the Company&#8217;s consolidated total revenues, primarily related to contracts with CMS for coverage of Medicare-eligible individuals within the Health Care Benefits segment.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of financial measures of the Company&#8217;s segments to the consolidated totals:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.308%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.746%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.003%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;<br/>Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,923)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,923)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,471)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(711)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,467&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,198&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,439)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,439)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(697)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Total revenues of the Pharmacy Services segment include approximately $11.6 billion, $10.9 billion and $11.5 billion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">of retail co-payments for 2021, 2020 and 2019, respectively. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information about retail co-payments.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#8220;PSS members&#8221;) enrolled in Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> elect to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of consolidated operating income to adjusted operating income for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,987&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store impairments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receipt of fully reserved ACA risk corridor receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,312&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,339&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2021, 2020 and 2019, acquisition-related integration costs relate to the Aetna Acquisition. The acquisition-related integration costs are reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within the Corporate/Other segment.  </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">During the year ended December 31, 2021, the store impairment charge relates to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. During the year ended December 31, 2019, the store impairment charges related to the write down of operating lease right-of-use assets in connection with the planned closure of 68 underperforming retail pharmacy stores in 2019 and 2020. The store impairment charges are reflected in the Company&#8217;s GAAP consolidated statements of operations within the Retail/LTC segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">During the year ended December 31, 2021, the goodwill impairment charge relates to the LTC reporting unit within the Retail/LTC segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In June 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s GAAP consolidated statement of operations for the year ended December 31, 2021 as a reduction of operating expenses within the Health Care Benefits segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction of operating expenses in the Company&#8217;s GAAP consolidated statement of operations within the Health Care Benefits segment. In 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in the Company&#8217;s GAAP consolidated statement of operations in operating expenses within the Retail/LTC segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, the Company received $313&#160;million owed to it under the ACA&#8217;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recognized pre-tax income of $307&#160;million in the Company&#8217;s GAAP consolidated statement of operations within the Health Care Benefits segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211323045016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Policy</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Care Benefits segment operates as one of the nation&#8217;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#8217; compensation administrative services through its Coventry Health Care Workers&#8217; Compensation business (&#8220;Workers&#8217; Compensation business&#8221;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#8217;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#8220;providers&#8221;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#8220;Insured&#8221; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#8220;ASC.&#8221; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#8220;Public Exchanges&#8221;) in eight states through which it sells Insured plans directly to individual consumers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment provides a full range of pharmacy benefit management (&#8220;PBM&#8221;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services and mail order pharmacy. In addition, through the Pharmacy Services segment, the Company provides specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#8220;Covered Entities&#8221;). The Pharmacy Services segment&#8217;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#8220;LTC&#8221;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of December&#160;31, 2021, the Retail/LTC segment operated more than 9,900 retail locations, nearly 1,200 MinuteClinic locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate/Other Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Management and administrative expenses to support the Company&#8217;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#8217;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#8220;VIEs&#8221;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform with the current year presentation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents and Restricted Cash</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when purchased. The Company invests in short-term money market funds, commercial paper and time deposits, as well as other debt securities that are classified as cash equivalents within the accompanying consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash (included in other current assets) represents funds held on behalf of members, including health savings account (&#8220;HSA&#8221;) funds associated with high deductible health plans. Beginning in 2021, the Company began presenting these funds held on behalf of members in restricted cash and, for statement of cash flow purposes, retrospectively adjusted the 2020 and 2019 balances by the amounts shown in the table below in the line item &#8220;restricted cash (included in other current assets)&#8221; to conform with the current year presentation. Restricted cash (included in other assets) represents amounts held in a trust in one of the Company&#8217;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt Securities </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist primarily of U.S. Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next twelve months, in which case it is classified as current on the consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. See Note 4 &#8216;&#8216;Fair Value&#8217;&#8217; for additional information on how the Company estimates the fair value of these investments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principal payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. Interest is not accrued on debt securities when management believes the collection of interest is unlikely.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#8217;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Securities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity securities with readily available fair values are measured at fair value with changes in fair value recognized in net income (loss).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mortgage Loans</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mortgage loan investments on the consolidated balance sheets are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Investments</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments consist primarily of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Private equity and hedge fund limited partnerships, which are accounted for using the equity method of accounting. Under this method, the carrying value of the investment is based on the value of the Company&#8217;s equity ownership of the underlying investment funds provided by the general partner or manager of the investments, the financial statements of which generally are audited. As a result of the timing of the receipt of the valuation information provided by the fund managers, these investments are generally reported on up to a three month lag. The Company reviews investments for impairment at least quarterly and monitors their performance throughout the year through discussions with the administrators, managers and/or general partners. If the Company becomes aware of an impairment of a limited partnership&#8217;s investments through its review or prior to receiving the limited partnership&#8217;s financial statements at the financial statement date, an impairment will be recognized by recording a reduction in the carrying value of the limited partnership with a corresponding charge to net investment income. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investment real estate, which is carried on the consolidated balance sheets at depreciated cost, including capital additions, net of write-downs for other-than-temporary declines in fair value. Depreciation is calculated using the straight-line method based on the estimated useful life of each asset. If any real estate investment is considered held-for-sale, it is carried at the lower of its carrying value or fair value less estimated selling costs. The Company generally estimates fair value using net operating income and applying a capitalization rate in conjunction with comparable sales information. At the time of the sale, the difference between the sales price and the carrying value is recorded as a realized capital gain or loss. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Privately-placed equity securities, which are carried on the consolidated balance sheets at cost less impairments, plus or minus subsequent adjustments for observable price changes. Additionally, as a member of the Federal Home Loan Bank of Boston (&#8220;FHLBB&#8221;), a subsidiary of the Company is required to purchase and hold shares of the FHLBB. These shares are restricted and carried at cost. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Income</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net investment income on the Company&#8217;s investments is recorded when earned and is reflected in the Company&#8217;s net income (other than net investment income on assets supporting experience-rated products). Experience-rated products are products in the large case pensions business where the contract holder, not the Company, assumes investment and other risks, subject to, among other things, minimum guarantees provided by the Company. The effect of investment performance on experience-rated products is allocated to contract holders&#8217; accounts daily, based on the underlying investment experience and, therefore, does not impact the Company&#8217;s net income (as long as the contract&#8217;s minimum guarantees are not triggered). Net investment income on assets supporting large case pensions&#8217; experience-rated products is included in net investment income in the consolidated statements of operations and is credited to contract holders&#8217; accounts through a charge to benefit costs. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments (other than realized capital gains and losses on investments supporting experience-rated products) are included as a component of net investment income in the consolidated statements of operations. Realized capital gains and losses are determined on a specific identification basis. Purchases and sales of debt and equity securities and alternative investments are reflected on the trade date. Purchases and sales of mortgage loans and investment real estate are reflected on the closing date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are not included in realized capital gains and losses in the consolidated statements of operations and instead are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized capital gains and losses on investments (other than unrealized capital gains and losses on investments supporting experience-rated products) are reflected in shareholders&#8217; equity, net of tax, as a component of accumulated other comprehensive income. Unrealized capital gains and losses on investments supporting large case pensions&#8217; experience-rated products are credited directly to contract holders&#8217; accounts. The contract holders&#8217; accounts are reflected in policyholders&#8217; funds on the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#8217;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text">Accounts ReceivableAccounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations.When developing an estimate of the Company&#8217;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#8217;s accounts receivable are short duration in nature and typically settle in less than 30 days.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">Inventories Inventories are valued at the lower of cost or net realizable value using the weighted average cost method. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. During the interim period between physical inventory counts, the Company accrues for anticipated physical inventory losses on a location-by-location basis based on historical results and current physical inventory trends.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceAccountingPolicy', window );">Reinsurance Recoverables</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reinsurance Recoverables </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#8217;s primary liability as the direct insurer of the risks reinsured. Failure of reinsurers to indemnify the Company could result in losses; however, the Company does not expect charges for unrecoverable reinsurance to have a material effect on its consolidated operating results or financial condition. The Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities or economic characteristics of its reinsurers. At December&#160;31, 2021, the Company&#8217;s reinsurance recoverables consisted primarily of amounts due from third parties that are rated consistent with companies that are considered to have the ability to meet their obligations. Reinsurance recoverables are recorded as other current assets or other assets on the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy', window );">Health Care Contract Acquisition Costs</a></td>
<td class="text">Health Care Contract Acquisition CostsInsurance products included in the Health Care Benefits segment are cancellable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. Acquisition costs for certain long-duration insurance contracts are deferred and are recorded as other current assets or other assets on the consolidated balance sheets and are amortized over the estimated life of the contracts. The amortization of deferred acquisition costs is recorded in operating expenses in the consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is reported at historical cost, net of accumulated depreciation. Property, equipment and improvements to leased premises are depreciated using the straight-line method over the estimated useful lives of the assets, or when applicable, the term of the lease, whichever is shorter. Estimated useful lives generally range from 1 to 40 years for buildings, building improvements and leasehold improvements and 3 to 10 years for fixtures, equipment and internally developed software. Repair and maintenance costs are charged directly to expense as incurred. Major renewals or replacements that </span></div>substantially extend the useful life of an asset are capitalized and depreciated. Application development stage costs for significant internally developed software projects are capitalized and depreciated.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Right-of-Use Assets and Lease Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Right-of-Use Assets and Lease Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#8217;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s real estate leases typically contain options that permit renewals for additional periods of up to five years each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For real estate leases, the Company accounts for lease components and nonlease components as a single lease component.  Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.</span></div>See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about right-of-use assets and lease liabilities.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text">Goodwill The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently if necessary, as further described in &#8220;Long-Lived Asset Impairment&#8221; below.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#8220;VOBA&#8221;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Other than VOBA, definite-lived intangible assets are amortized using the straight-line method. VOBA is amortized over the expected life of the acquired contracts in proportion to estimated premiums. Indefinite-lived intangible assets are not amortized but are tested for impairment annually, or more frequently if necessary, as further described in &#8220;Long-Lived Asset Impairment&#8221; below.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Long-Lived Asset Impairment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Asset Impairment</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#8217;s estimated future cash flows (discounted). If required, an impairment loss is recorded for the portion of the asset group&#8217;s carrying value that exceeds the asset group&#8217;s estimated future cash flows (discounted). During the year ended December&#160;31, 2021, the Company recorded a store impairment charge of approximately $1.4 billion primarily related to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. There were no material impairment charges recognized on long-lived assets in the year ended 2020. During the year ended December&#160;31, 2019 the Company recorded a store impairment charge of $231 million primarily related to operating lease right-of-use assets. See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for additional information about the right-of-use asset impairment charges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When evaluating goodwill for potential impairment, the Company compares the fair value of its reporting units to their respective carrying amounts. The Company estimates the fair value of its reporting units using a combination of a discounted cash flow method and a market multiple method. If the carrying amount of a reporting unit exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill, the results of which indicated an impairment of the goodwill associated with the LTC reporting unit. Accordingly, during the third quarter of 2021, the Company recorded a $431&#160;million goodwill impairment charge. The results of the impairment tests indicated that there was no impairment of goodwill of the remaining reporting units as of the testing date or during the year ended December&#160;31, 2021. During the third quarter of both 2020 and 2019, the Company performed its required annual goodwill impairment tests and concluded there were no goodwill impairments as of the testing dates or during the years ended December&#160;31, 2020 and 2019. See Note 5 &#8216;&#8216;Goodwill and Other Intangibles&#8217;&#8217; for additional information about the goodwill impairment charge recorded during the year ended December&#160;31, 2021. </span></div>Indefinite-lived intangible assets are tested for impairment by comparing the estimated fair value of the asset to its carrying value. The Company estimates the fair value of its indefinite-lived trademarks using the relief from royalty method under the income approach. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderAccountsPolicy', window );">Separate Accounts</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separate Accounts</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#8217;s other businesses. Deposits, withdrawals and net </span></div>investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareCostsPolicyPolicyTextBlock', window );">Health Care Costs Payable</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Costs Payable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care costs payable consist principally of unpaid fee-for-service medical, dental and pharmacy claims, capitation costs, other amounts due to providers pursuant to risk-sharing arrangements related to the Health Care Benefits segment&#8217;s Insured Commercial, Medicare and Medicaid products and accruals for state assessments. Unpaid health care claims include an estimate of payments the Company will make for (i) services rendered to the Company&#8217;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid, each as of the financial statement date (collectively, &#8220;IBNR&#8221;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. Such estimates are developed using actuarial principles and assumptions which consider, among other things, historical and projected claim submission and processing patterns, assumed and historical medical cost trends, historical utilization of medical services, claim inventory levels, changes in Insured membership and product mix, seasonality and other relevant factors. The Company reflects changes in these estimates in benefit costs in the Company&#8217;s consolidated operating results in the period they are determined. Capitation costs represent contractual monthly fees paid to participating physicians and other medical providers for providing medical care, regardless of the volume of medical services provided to the Insured member. Amounts due under risk-sharing arrangements are based on the terms of the underlying contracts with the providers and consider claims experience under the contracts through the financial statement date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. Of those factors, the Company considers the analysis of historical and projected claim payment patterns (including claims submission and processing patterns) and the assumed health care cost trend rate (the year-over-year change in per member per month health care costs) to be the most critical assumptions. In developing its IBNR estimate, the Company consistently applies these actuarial principles and assumptions each period, with consideration to the variability of related factors. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of IBNR in 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company analyzes historical claim payment patterns by comparing claim incurred dates (i.e., the date services were provided) to claim payment dates to estimate &#8220;completion factors.&#8221; The Company uses completion factors predominantly to estimate the ultimate cost of claims incurred more than three months before the financial statement date. The Company estimates completion factors by aggregating claim data based on the month of service and month of claim payment and estimating the percentage of claims incurred for a given month that are complete by each month thereafter. For any given month, substantially all claims are paid within six months of the date of service, but it can take up to 48 months or longer after the date of service before all of the claims are completely resolved and paid. These historically-derived completion factors are then applied to claims paid through the financial statement date to estimate the ultimate claim cost for a given month&#8217;s incurred claim activity. The difference between the estimated ultimate claim cost and the claims paid through the financial statement date represents the Company&#8217;s estimate of claims remaining to be paid as of the financial statement date and is included in the Company&#8217;s health care costs payable. The completion factors the Company uses reflect judgments and possible adjustments based on data such as claim inventory levels, claim submission and processing patterns and, to a lesser extent, other factors such as changes in health care cost trend rates, changes in Insured membership and changes in product mix. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claims may be more (less) complete than originally estimated using the Company&#8217;s completion factors, which may result in reserves that are higher (lower) than the ultimate cost of claims.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because claims incurred within three months before the financial statement date are less mature, the Company uses a combination of historically-derived completion factors and the assumed health care cost trend rate to estimate the ultimate cost of claims incurred for these months. The Company applies its actuarial judgment and places a greater emphasis on the assumed health care cost trend rate for the most recent claim incurred dates as these months may be influenced by seasonal patterns and changes in membership and product mix.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s health care cost trend rate is affected by changes in per member utilization of medical services as well as changes in the unit cost of such services. Many factors influence the health care cost trend rate, including the Company&#8217;s ability to manage benefit costs through product design, negotiation of favorable provider contracts and medical management programs, as well as the mix of the Company&#8217;s business. The health status of the Company&#8217;s Insured members, aging of the population and other demographic characteristics, advances in medical technology and other factors continue to contribute to rising per member utilization and unit costs. Changes in health care practices, inflation, new technologies, increases in the cost of </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prescription drugs (including specialty pharmacy drugs), direct-to-consumer marketing by pharmaceutical companies, clusters of high-cost cases, claim intensity, changes in the regulatory environment, health care provider or member fraud and numerous other factors also contribute to the cost of health care and the Company&#8217;s health care cost trend rate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each reporting period, the Company uses an extensive degree of judgment in the process of estimating its health care costs payable. As a result, considerable variability and uncertainty is inherent in such estimates, particularly with respect to claims with claim incurred dates of three months or less before the financial statement date; and the adequacy of such estimates is highly sensitive to changes in assumed completion factors and the assumed health care cost trend rates. For each reporting period the Company recognizes the actuarial best estimate of health care costs payable considering the potential volatility in assumed completion factors and health care cost trend rates, as well as other factors. The Company believes its estimate of health care costs payable is reasonable and adequate to cover its obligations at December&#160;31, 2021; however, actual claim payments may differ from the Company&#8217;s estimates. A worsening (or improvement) of the Company&#8217;s health care cost trend rates or changes in completion factors from those that the Company assumed in estimating health care costs payable at December&#160;31, 2021 would cause these estimates to change in the near term, and such a change could be material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each quarter, the Company re-examines previously established health care costs payable estimates based on actual claim payments for prior periods and other changes in facts and circumstances. Given the extensive degree of judgment in this estimate, it is possible that the Company&#8217;s estimates of health care costs payable could develop either favorably (that is, its actual benefit costs for the period were less than estimated) or unfavorably. The changes in the Company&#8217;s estimate of health care costs payable may relate to a prior quarter, prior year or earlier periods. For a roll forward of the Company&#8217;s health care costs payable, see Note 7 &#8216;&#8216;Health Care Costs Payable.&#8217;&#8217; The Company&#8217;s reserving practice is to consistently recognize the actuarial best estimate of its ultimate liability for health care costs payable.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy', window );">Other Insurance Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Insurance Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unpaid Claims</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unpaid claims consist primarily of reserves associated with certain short-duration group disability and term life insurance contracts, including an estimate for IBNR as of the financial statement date. Reserves associated with certain short-duration group disability and term life insurance contracts are based upon the Company&#8217;s estimate of the present value of future benefits, which is based on assumed investment yields and assumptions regarding mortality, morbidity and recoveries from the U.S. Social Security Administration. The Company develops its estimate of IBNR using actuarial principles and assumptions which consider, among other things, contractual requirements, claim incidence rates, claim recovery rates, seasonality and other relevant factors. The Company discounts certain claim liabilities related to group long-term disability and life insurance waiver of premium contracts. The discount rates generally reflect the Company&#8217;s expected investment returns for the investments supporting all incurral years of these liabilities. The discount rates for retrospectively-rated contracts are set at contractually specified levels. The Company&#8217;s estimates of unpaid claims are subject to change due to changes in the underlying experience of the insurance contracts, changes in investment yields or other factors, and these changes are recorded in current and future benefits in the consolidated statements of operations in the period they are determined. The Company estimates its reserve for claims IBNR for life products largely based on completion factors. The completion factors used are based on the Company&#8217;s historical experience and reflect judgments and possible adjustments based on data such as claim inventory levels, claim payment patterns, changes in business volume and other factors. If claims are submitted or processed on a faster (slower) pace than historical periods, the actual claims may be more (less) complete than originally estimated using completion factors, which may result in reserves that are higher (lower) than required to cover future life benefit payments. There have been no significant changes to the methodologies or assumptions used to develop the Company&#8217;s estimate of unpaid claims IBNR in 2021. As of December&#160;31, 2021, unpaid claims balances of $324 million and $1.3 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2020, unpaid claims balances of $532 million and $1.5 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all life and disability insurance liabilities have been fully ceded to unrelated third parties through indemnity reinsurance agreements; however, the Company remains directly obligated to the policyholders.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Future Policy Benefits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future policy benefits consist primarily of reserves for limited payment pension and annuity contracts and long-term care insurance contracts. Reserves for limited payment pension and annuity contracts are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality, retirement, expense and interest rate experience. Such assumptions generally vary by plan, year of issue and policy duration. Assumed interest rates on such contracts ranged from 3.0% to 11.3% in the year ended December&#160;31, 2021 and from 3.3% to 11.3% in the year ended December&#160;31, 2020. The Company periodically reviews mortality assumptions against both industry standards and its experience. Reserves for long-</span></div>duration long-term care contracts represent the Company&#8217;s estimate of the present value of future benefits and essential maintenance expenses to be paid to or on behalf of policyholders less the present value of future gross premiums. The assumed interest rate on such contracts was 5.1% in both the years ended December 31, 2021 and 2020. The Company&#8217;s estimate of the present value of future benefits under such contracts is based upon mortality, morbidity and interest rate assumptions.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock', window );">Premium Deficiency Reserves</a></td>
<td class="text">Premium Deficiency ReservesThe Company evaluates its insurance contracts to determine if it is probable that a loss will be incurred. A premium deficiency loss is recognized when it is probable that expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), will exceed existing reserves plus anticipated future premiums and reinsurance recoveries. Anticipated investment income is not considered in the calculation of premium deficiency losses for short-duration contracts. For purposes of determining premium deficiency losses, contracts are grouped consistent with the Company&#8217;s method of acquiring, servicing and measuring the profitability of such contracts.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocationsToPolicyholdersPolicies', window );">Policyholders' Funds</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policyholders&#8217; Funds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Policyholders&#8217; funds consist primarily of reserves for pension and annuity investment contracts and customer funds associated with certain health contracts. Reserves for such contracts are equal to cumulative deposits less withdrawals and charges plus  interest credited thereon, net of experience-rated adjustments. In 2021, interest rates for pension and annuity investment contracts ranged from 3.5% to 4.8%. In 2020, interest rates for pension and annuity investment contracts ranged from 4.1% to 5.1%. Reserves for contracts subject to experience rating reflect the Company&#8217;s rights as well as the rights of policyholders and plan participants. The Company also holds funds for HSAs on behalf of members associated with high deductible health plans. These amounts are held to pay for qualified health care expenses incurred by these members. The HSA balances were approximately $2.9 billion and $2.7 billion at December&#160;31, 2021 and 2020, respectively, and are reflected in other current assets with a corresponding liability in policyholders&#8217; funds. These assets are considered restricted cash for cash flow statement purposes.</span></div>Policyholders&#8217; funds liabilities that are expected to be paid within twelve months from the balance sheet date are classified as current on the consolidated balance sheets. Policyholders&#8217; funds liabilities that are expected to be paid greater than twelve months from the balance sheet date are included in other long-term liabilities on the consolidated balance sheets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReservePolicyTextBlock', window );">Self-Insurance Liabilities</a></td>
<td class="text">Self-Insurance LiabilitiesThe Company is self-insured for certain losses related to general liability, workers&#8217; compensation and auto liability. The Company obtains third party insurance coverage to limit exposure from these claims. The Company is also self-insured for certain losses related to health and medical liabilities. The Company&#8217;s self-insurance accruals, which include reported claims and claims incurred but not reported, are calculated using standard insurance industry actuarial assumptions and the Company&#8217;s historical claims experience.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation and Transactions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Translation and Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For non-U.S. dollar functional currency locations, (i) assets and liabilities are translated at end-of-period exchange rates, (ii) revenues and expenses are translated at average exchange rates in effect during the period and (iii) equity is translated at historical exchange rates. The resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For U.S. dollar functional currency locations, foreign currency assets and liabilities are remeasured into U.S. dollars at end-of-period exchange rates, except for nonmonetary balance sheet accounts which are remeasured at historical exchange rates. Revenues and expenses are remeasured at average exchange rates in effect during each period, except for those expenses related to the nonmonetary balance sheet amounts which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in net income.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Benefits Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which, in the Company&#8217;s Commercial business, reflect contracted rates per member and the number of covered members recorded in the Company&#8217;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. Revenue related to the Company&#8217;s Government business is collected monthly from the U.S. federal government and various government agencies based on fixed payment rates and member eligibility. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Premium Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the minimum medical loss ratio (&#8220;MLR&#8221;) rebate requirements of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (as amended, collectively, the &#8220;ACA&#8221;) is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Services Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#8217;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#8217;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#8217;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Accounting for Medicare Part D</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include insurance premiums earned by the Company&#8217;s PDPs, which are determined based on the PDP&#8217;s annual bid and related contractual arrangements with the U.S. Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;). The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment sells prescription drugs directly through its mail service dispensing pharmacies and indirectly through the Company&#8217;s retail pharmacy network. The Company&#8217;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the dispensing of prescription drugs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions dispensed indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#8220;Drug Discounts&#8221; and &#8220;Guarantees&#8221; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#8220;retail co-payments&#8221;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Pharmacy Services segment:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by mail service dispensing pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues generated from prescription drugs sold by third party pharmacies in the Company&#8217;s retail pharmacy network and associated administrative fees are recognized at the Company&#8217;s point-of-sale, which is when the claim is adjudicated by the Company&#8217;s online claims processing system and the Company has transferred control of the prescription drug and completed all of its performance obligations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Drug Discounts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records revenue net of manufacturers&#8217; rebates earned by its clients based on their plan members&#8217; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#8217; rebates earned by its clients. The estimates are based on the best available data at period-end and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#8217; rebate amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Guarantees</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Retail Pharmacy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#8217;s operating results or financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer returns are not material to the Company&#8217;s operating results or financial condition. Sales taxes are not included in revenues.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Loyalty and Other Programs</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s customer loyalty program, ExtraCare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, consists of two components, ExtraSavings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers a subscription-based membership program, CarePass</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long-term Care</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of long-term care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#8217;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Walk-In Medical Clinics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For services provided by the Company&#8217;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by major source in each segment for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:28.737%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.944%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.944%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.462%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">152,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">76,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43,765)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">184,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">76,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">76,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82,186&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">153,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100,105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43,923)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91,715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">60,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">153,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">70,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(40,003)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">171,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">75,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91,198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">85,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">140,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(41,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">165,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,604&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">86,608&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(41,439)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">256,776&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">52,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily represent the Company&#8217;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021 and 2020, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Products Sold</a></td>
<td class="text"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for cost of products sold as follows:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold includes: (i) the cost of prescription drugs sold during the reporting period directly through the Company&#8217;s mail service dispensing pharmacies and indirectly through the Company&#8217;s retail pharmacy network, (ii) shipping and handling costs, and (iii) the operating costs of the Company&#8217;s mail service dispensing pharmacies and client service operations and related information technology support costs including depreciation and amortization. The cost of prescription drugs sold component of cost of products sold includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients&#8217; benefit plans from the Company&#8217;s mail service dispensing pharmacies, net of any volume-related or other discounts (see &#8220;Vendor Allowances and Purchase Discounts&#8221; below) and (ii) the cost of prescription drugs sold (including retail co-payments) through the Company&#8217;s retail pharmacy network under contracts where the Company is the principal, net of any volume-related or other discounts. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div>Cost of products sold includes: the cost of merchandise sold during the reporting period, including prescription drug costs, and the related purchasing costs, warehousing and delivery costs (including depreciation and amortization) and actual and estimated inventory losses.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock', window );">Vendor Allowances And Purchase Discounts</a></td>
<td class="text"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Vendor Allowances and Purchase Discounts </span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for vendor allowances and purchase discounts as follows: </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharmacy Services Segment</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pharmacy Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Pharmacy Services segment to receive </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, (ii) a discount for the prompt payment of invoices or (iii) when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#8217;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Pharmacy Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Pharmacy Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Retail/LTC Segment</span></div>Vendor allowances received by the Retail/LTC segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any amounts received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon sales volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract. The total amortization of these upfront payments was not material to the Company&#8217;s consolidated financial statements in any of the periods presented.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock', window );">Health Care Reform</a></td>
<td class="text"><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Reform</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div style="padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Insurer Fee</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1, 2014, the ACA has imposed an annual premium-based health insurer fee (&#8220;HIF&#8221;) for each calendar year, payable in September, which was not deductible for tax purposes. The Company has been required to estimate a liability for the HIF at the beginning of the calendar year in which the fee was payable with a corresponding deferred asset that was amortized ratably to operating expenses over the calendar year. The Company recorded the liability for the HIF in accrued expenses and recorded the deferred asset in other current assets. In December 2019, the HIF was repealed for calendar years after 2020, therefore there was no expense related to the HIF in the year ended December&#160;31, 2021. In the year ended December 31, 2020, operating expenses included $1.0&#160;billion related to the Company&#8217;s share of the HIF. There was no expense related to the HIF in 2019, since there was a one-year suspension of the HIF for 2019. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a permanent risk adjustment program to transfer funds from qualified individual and small group insurance plans with below average risk scores to plans with above average risk scores. Based on the risk of the Company&#8217;s qualified plan members relative to the average risk of members of other qualified plans in comparable markets, as defined by the ACA, the Company estimates its ultimate risk adjustment receivable (recorded in accounts receivable) or payable (recorded in accrued expenses) for the current calendar year and reflects the pro-rata year-to-date impact as an adjustment to premium revenue. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Corridor</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#8220;HHS&#8221;) based on their ratio of allowable costs to target costs (as defined by the ACA). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company filed a lawsuit in August 2019 to recover the $313&#160;million it was owed under the ACA&#8217;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#8217;s temporary risk corridor program. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company received the $313&#160;million it was owed under the ACA&#8217;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the year ended December 31, 2020. After considering </span></div>offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recorded pre-tax income of $307 million and after-tax income of $223&#160;million during the year ended December&#160;31, 2020.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text">Advertising Costs Advertising costs, which are reduced by the portion funded by vendors, are expensed when the related advertising takes place. Net advertising costs, which are included in operating expenses, were $523 million, $461 million and $396 million in 2021, 2020 and 2019, respectively.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text">Stock-Based CompensationStock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcyMzEz_ea62d84c-7b65-4b23-9d75-3a8341c56a52">three</span> to five years) using the straight-line method.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year or years in which the differences are expected to reverse. The effect of a change in the tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date of such change.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and the Company&#8217;s recent operating results. The Company establishes a valuation allowance when it does not consider it more likely than not that a deferred tax asset will be recovered.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions on the basis of a two-step process whereby (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementPlansPolicy', window );">Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit (OPEB) Plans</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans</span></div><div style="padding-right:4.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sponsors defined benefit pension plans (&#8220;pension plans&#8221;) and other postretirement employee benefit plans (&#8220;OPEB plans&#8221;) for its employees and retirees. The Company recognizes the funded status of its pension and OPEB plans on the consolidated balance sheets based on the year-end measurements of plan assets and benefit obligations. When the fair value of plan assets are in excess of the plan benefit obligations, the amounts are reported in other current assets and other assets. When the fair value of plan benefit obligations are in excess of plan assets, the amounts are reported in accrued expenses and other long-term liabilities based on the amount by which the actuarial present value of benefits payable in the next twelve months included in the benefit obligation exceeds the fair value of plan assets. The net periodic benefit cost (income) for the Company&#8217;s pension and OPEB plans do not contain a service cost component as these plans have been frozen for an extended period of time.&#160;Non-service cost components of pension and postretirement net periodic benefit cost (income) are included in other income in the consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings per Common Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share is computed using the two-class method. The Company calculates basic earnings per share based on the weighted average number of common shares outstanding for the period. See Note 14 &#8216;&#8216;Earnings Per Share&#8217;&#8217; for additional information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_SharesHeldInTrustPolicyTextBlock', window );">Shares Held in Trust</a></td>
<td class="text">Shares Held in TrustThe Company maintains grantor trusts, which held approximately one million shares of its common stock at both December&#160;31, 2021 and 2020. These shares are designated for use under various employee compensation plans. Since the Company holds these shares, they are excluded from the computation of basic and diluted shares outstanding.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Interest Entities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in (i) a generic pharmaceutical sourcing entity, (ii) certain hedge fund and private equity investments and (iii) certain real estate partnerships that are considered VIEs. The Company does not have a future obligation to fund losses or debts on behalf of these investments; however, it may voluntarily contribute funds. In evaluating whether the Company is the primary beneficiary of a VIE, the Company considers several factors, including whether the Company has (a) the power to direct the activities that most significantly impact the VIE&#8217;s economic performance and (b) the obligation to absorb losses and the right to receive benefits that could potentially be significant to the VIE. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Primary Beneficiary</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, the Company and Cardinal Health, Inc. (&#8220;Cardinal&#8221;) established Red Oak Sourcing, LLC (&#8220;Red Oak&#8221;), a generic pharmaceutical sourcing entity in which the Company and Cardinal each own 50%. The Red Oak arrangement had an initial term of ten years. In 2021, the Red Oak arrangement was amended to extend the initial term an additional five years, for a total term of 15 years. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak; however, Red Oak does not own or hold inventory on behalf of either company. No physical assets (e.g., property and equipment) were contributed to Red Oak by either company, and minimal funding was provided to capitalize Red Oak. The Company has determined that it is the primary beneficiary of this VIE because it has the ability to direct the activities of Red Oak. Consequently, the Company consolidates Red Oak in its consolidated financial statements within the Retail/LTC segment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cardinal is required to pay the Company quarterly payments, which began in October 2014 and will extend through June 2029. As milestones are met, the quarterly payments increase. The Company received $183 million from Cardinal during each of the years ended December&#160;31, 2021, 2020 and 2019. The payments reduce the Company&#8217;s carrying value of inventory and are recognized in cost of products sold when the related inventory is sold. Amounts reimbursed by Cardinal for the years ended December&#160;31, 2021, 2020 and 2019, and amounts due to or due from Cardinal at December&#160;31, 2021 and 2020 were immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Interest Entities - Other Variable Interest Holder</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has invested in certain VIEs for which it has determined that it is not the primary beneficiary, consisting of the following:</span></div><div><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Hedge fund and private equity investments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in hedge fund and private equity investments in order to generate investment returns for its investment portfolio supporting its insurance businesses.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Real estate partnerships</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Company invests in various real estate partnerships, including those that construct, own and manage low-income housing developments. For the low income housing development investments, substantially all of the projected benefits to the Company are from tax credits and other tax benefits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not the primary beneficiary of these VIEs because the nature of the Company&#8217;s involvement with the activities of these VIEs does not give the Company the power to direct the activities that most significantly impact their economic performance. The Company records the amount of its investment in these VIEs as long-term investments on the consolidated balance sheets and recognizes its share of each VIE&#8217;s income or losses in net income (loss).&#160;The Company&#8217;s maximum exposure to loss from these VIEs is limited to its investment balances as disclosed below and the risk of recapture of previously recognized tax credits related to the real estate partnerships, which the Company does not consider significant.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Related Party Transactions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Related Party Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in SureScripts, LLC (&#8220;SureScripts&#8221;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $52 million, $56 million and $32 million in the years ended December&#160;31, 2021, 2020 and 2019, respectively. The Company&#8217;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an equity method investment in Heartland Healthcare Services, LLC (&#8220;Heartland&#8221;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $79 million, $77 million and $96 million for pharmaceutical inventory purchases during the years ended December&#160;31, 2021, 2020 and 2019, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#8217;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021, 2020 and 2019, the Company made charitable contributions of&#160;$50&#160;million, $50 million and $30&#160;million, respectively,&#160;to the CVS Health Foundation, a non-profit entity that focuses on health, education and community involvement programs. The charitable contributions were recorded as operating expenses in the consolidated statements of operations within the Corporate/Other segment for the years ended December&#160;31, 2021, 2020 and 2019.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsPolicyTextBlock', window );">Discontinued Operations</a></td>
<td class="text">Discontinued OperationsIn connection with certain business dispositions completed between 1995 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens &#8216;n Things and Bob&#8217;s Stores, each of which subsequently filed for bankruptcy. The Company&#8217;s loss from discontinued operations includes lease-related costs that the Company believes it will likely be required to satisfy pursuant to these lease guarantees.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements Recently Adopted and Not Yet Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Recently Adopted </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#8217;s consolidated operating results, cash flows, financial condition or related disclosures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Insurance Contracts</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Targeted Improvements to the Accounting for Long-Duration Contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#8217;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#8217;s </span></div>liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#8217;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#8217;s expected investment yield under the existing guidance.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InsurancePremiumDeficiencyReservePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Insurance Premium Deficiency Reserve [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InsurancePremiumDeficiencyReservePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_SharesHeldInTrustPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Shares Held In Trust [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_SharesHeldInTrustPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Vendor Allowances And Purchase Discounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocationsToPolicyholdersPolicies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining amounts of income and expenses allocated to policyholders and contract holders, excluding the method for determining dividends payable to policyholders and accounting policies pertaining to separate accounts for variable annuity contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6483535&amp;loc=d3e16392-158451<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocationsToPolicyholdersPolicies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferred policy acquisition costs, including the nature, type, and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35755530&amp;loc=d3e11264-158415<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759068-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section S99<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=26872618&amp;loc=d3e7436-122677<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareCostsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for  accruing health care costs for a prepaid health care service provider.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 405<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491204&amp;loc=d3e4879-115612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 720<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49178521&amp;loc=d3e9162-115647<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareCostsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareEntitiesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for all health care policies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareEntitiesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66047640&amp;loc=d3e39622-114963<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=d3e29149-114947<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6412939&amp;loc=d3e15145-114933<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for contracts reported in separate accounts, including the extent and terms of minimum guarantees, basis of presentation for separate account assets and liabilities and related separate account activity, the liability valuation method and assumptions used in valuing each type of policyholder and contract holder account maintained by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceAccountingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reinsurance accounting policy, for example, but not limited to, description of the methodologies and assumptions underlying determination of reinsurance recoverables, reinsurance payables and retention policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27758-158548<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6816-158387<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27830-158548<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceAccountingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReservePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReservePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14754-158437<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14784-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211325430680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Schedule of reconciliation of cash and cash equivalents</a></td>
<td class="text"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of cash and cash equivalents on the consolidated balance sheets to total cash, cash equivalents and restricted cash on the consolidated statements of cash flows as of December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other current assets)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash (included in other assets)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,691&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,043&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,408&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of accounts receivable, net</a></td>
<td class="text">Accounts receivable, net is composed of the following at December&#160;31, 2021 and 2020:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor and manufacturer receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,815&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Total accounts receivable, net </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,431&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,742&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consists of the following at December&#160;31, 2021 and 2020: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,134&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixtures and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,550&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,700)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,896&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,606&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of disaggregation of revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table disaggregates the Company&#8217;s revenue by major source in each segment for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:28.737%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.535%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.944%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.944%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.569%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.462%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment<br/>Eliminations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">152,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">76,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43,765)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">184,618&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21,315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">76,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">76,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">2,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82,186&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">153,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">100,105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(43,923)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91,715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">60,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">153,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">70,176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(40,003)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">171,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,655&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">75,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91,198&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">85,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">56,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Major goods/services lines:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">140,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">66,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(41,413)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">165,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Front Store</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">5,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">7,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">69,604&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">86,608&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(41,439)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">256,776&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy Services distribution channel:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pharmacy network</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">88,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Mail choice </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">52,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#8217;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#8217;s retail pharmacies under the Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"> </span>program.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of contract with customer assets and liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables (included in accounts receivable, net)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (included in accrued expenses)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2021 and 2020, the contract liabilities balance includes increases related to customers&#8217; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rewards earnings and gift card issuances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and breakage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of variable interest entities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total amount of other variable interest holder VIE assets included in long-term investments on the consolidated balance sheets at December&#160;31, 2021 and 2020 was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.990%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedge fund investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate partnerships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,289&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of discontinued operations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the results of discontinued operations for the year ended December 31, 2020. </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6228884-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211323036216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsTableTextBlock', window );">Total investments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total investments at December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.016%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Long-term</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities available for sale</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,231&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,774&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,117&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,025&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,142&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Debt securities available for sale</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities available for sale at December&#160;31, 2021 and 2020 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.701%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cost </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,172&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,396&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">There was no allowance for expected credit losses recorded on available-for-sale debt securities at December&#160;31, 2021 or 2020.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Investment risks associated with the Company&#8217;s experience-rated products generally do not impact the Company&#8217;s consolidated operating results.&#160;At December&#160;31, 2021, debt securities with a fair value of $864 million, gross unrealized capital gains of $94 million and gross unrealized capital losses of $2 million and at December&#160;31, 2020, debt securities with a fair value of $919 million, gross unrealized capital gains of $135 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Fair value of debt securities by contractual maturity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortized cost and fair value of debt securities at December&#160;31, 2021 are shown below by contractual maturity.&#160;&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair <br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,174&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock', window );">Debt securities in an unrealized capital loss position</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the debt securities the Company held at December&#160;31, 2021 and 2020 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Greater than 12 months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except number of securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number<br/>of<br/>&#160;Securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,037&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,800&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,384&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">915&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity dates for debt securities in an unrealized capital loss position at December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting experience-<br/>rated products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supporting remaining<br/>products</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to mature:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than one year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year through five years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After five years through ten years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,365&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,305&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,384&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ActivityInMortgageLoanPortfolioTableTextBlock', window );">Activity in mortgage loan portfolio</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s mortgage loans are collateralized by commercial real estate.&#160;During the years ended December 31, 2021 and 2020, the Company had the following activity in its mortgage loan portfolio:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New mortgage loans</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans fully repaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans foreclosed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021 scheduled mortgage loan principal repayments were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock', window );">Mortgage loan internal credit rating</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon the Company&#8217;s assessments at December&#160;31, 2021 and 2020, the amortized cost basis of the Company&#8217;s mortgage loans within each credit quality indicator by year of origination was as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.950%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost Basis by Year of Origination</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except credit quality indicator</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prior</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 to 4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 and 6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeTextBlock', window );">Net investment income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sources of net investment income for the years ended December 31, 2021, 2020 and 2019 were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income (excluding net realized capital gains or losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized capital gains </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Net realized capital gains are net of yield-related impairment losses on debt securities of $42 million and $49 million for the years ended December&#160;31, 2021 and 2020, respectively. There were no credit-related losses on debt securities in the years ended December&#160;31, 2021 and 2020. Net realized capital gains are net of other-than-temporary impairment (&#8220;OTTI&#8221;) losses on debt securities of $24 million for the year ended December 31, 2019.</span></div>(2)Net investment income includes $38 million, $42 million and $44 million for the years ended December 31, 2021, 2020 and 2019, respectively, related to investments supporting experience-rated products.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock', window );">Proceeds and related gross realized capital gains and losses from the sale of debt securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses in the years ended December 31, 2021, 2020 and 2019 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,572&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,913&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross realized capital losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ActivityInMortgageLoanPortfolioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Table representing activities in mortgage loan portfolio during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ActivityInMortgageLoanPortfolioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item includes total investments, both current and long-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211325216328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair value of financial assets and liabilities</a></td>
<td class="text">Financial assets measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2021 and 2020 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,812&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,240&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,440&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,266&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,817&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,869&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,370&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,372&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,633&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,089&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Changes in level 3 financial assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.434%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">States, <br/>municipalities<br/>&#160;and political <br/>subdivisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Foreign<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other asset-<br/>backed<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable<br/>preferred<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital gains (losses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">States, <br/>municipalities<br/>&#160;and political <br/>subdivisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.<br/>corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Redeemable<br/>preferred<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net realized and unrealized capital gains (losses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in earnings&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Included in other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers into Level 3, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in unrealized capital losses included in other comprehensive income associated with Level 3 financial assets which were held as of December&#160;31, 2020 was $4&#160;million during the year ended December&#160;31, 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total gross transfers into (out of) Level 3 during the years ended December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers into Level 3</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net transfers into Level 3</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Carrying value and estimated fair value of certain financial instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the consolidated balance sheets at adjusted cost or contract value at December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;Estimated Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment contract liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a fixed maturity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Without a fixed maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,940&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div>(1)It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information regarding the valuation of cost method investments.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock', window );">Separate account financial assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separate Accounts financial assets at December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.953%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common/collective trusts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,782&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,017&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,385&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $70 million and $29&#160;million of other receivables at December&#160;31, 2021 and 2020, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of asset supporting separate account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124504833&amp;loc=d3e7104-158389<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211323118888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangibles (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Change in goodwill</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a summary of the changes in the carrying amount of goodwill by segment for the&#160;years ended December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.455%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy<br/>Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture of Workers&#8217; Compensation business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(505)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(505)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,130&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,807&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,552&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,130&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,615&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,376&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,121&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock', window );">Other intangible assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s intangible assets as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions, except weighted average life</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,084&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,564)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,060)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(651)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,753&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,727)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,026&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.3</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks (indefinite-lived)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,498&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships and covenants not to compete</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,923)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,029&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider networks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(440)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Value of Business Acquired </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,623&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,481)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,142&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Estimated annual pretax amortization for other acquired intangible assets over the next five years</a></td>
<td class="text">The projected annual amortization expense for the Company&#8217;s intangible assets for the next five&#160;years is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,826&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,734&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the cost, accumulated amortization and net balance of intangibles assets and amortization period, in total and by major class. Finite-lived intangible assets have a stated useful life over which their gross carrying value is amortized. Indefinite intangible assets have a projected indefinite period of benefit (hence are not amortized).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211332329544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease costs and supplemental cash flow information</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,633&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,670&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sublease income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,327&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,357&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases for the years ended December&#160;31, 2021, 2020 and 2019 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,714&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,724&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,701&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows paid for interest portion of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows paid for principal portion of finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,679&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,824&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLeaseTableTextBlock', window );">Supplemental balance sheet information</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases as of December&#160;31, 2021 and 2020 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.159%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions, except remaining lease term and discount rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,122</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,729</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,177</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,757</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,823</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,395</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance leases:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,375</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,001</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining lease term </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(in years)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of operating lease liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance<br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating<br/>Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,068&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,247)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,823&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Future operating lease payments have not been reduced by minimum sublease rentals of $311 million due in the future under noncancelable subleases.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.4 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Maturities of financing lease liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.453%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Finance<br/>Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating<br/>Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,509&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease payments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,068&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,247)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,015)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,823&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Future operating lease payments have not been reduced by minimum sublease rentals of $311 million due in the future under noncancelable subleases.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.4 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLeaseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Lease [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLeaseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331288984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock', window );">Information about incurred and paid health care claims development</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information about incurred and paid health care claims development for the year ended December&#160;31, 2020 is presented as required unaudited supplemental information.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Incurred Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,529&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,634&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cumulative Paid Health Care Claims,<br/>Net of Reinsurance<br/>For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date of Service</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,190&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All outstanding liabilities for health care costs payable prior to 2020, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total outstanding liabilities for health care costs payable, net of reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,574&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of liability for unpaid claims and claims adjustment expense</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of the December&#160;31, 2021 health care net incurred and paid claims development tables to the health care costs payable liability on the consolidated balance sheet is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.105%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-duration health care costs payable, net of reinsurance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,574&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance lines other than short duration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total health care costs payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,808&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock', window );">Components of change in health care costs payable</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of the change in health care costs payable during the years ended December 31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.160%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, beginning of period, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions, net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Components of incurred health care costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(788)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(524)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred health care costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,973&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,406&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,199&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Claims paid</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,770&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total claims paid</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,115&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,779&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,472&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Premium deficiency reserve</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,800&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,926&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Reinsurance recoverables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care costs payable, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,808&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,936&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,879&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Total incurred health care costs for the years ended December&#160;31, 2021, 2020 and 2019 in the table above exclude (i) $16 million, $11 million and $4 million, respectively, for a premium deficiency reserve related to the Company&#8217;s Medicaid products, (ii) $59 million, $41 million and $41 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the consolidated balance sheets and (iii) $212 million, $221 million and $285 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted information about claims development by accident year for short-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for the reconciliation of claims development to the liability for unpaid claims and claim adjustment expense for short-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211325222984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Carrying value of long-term debt</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s borrowings as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.452%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Long-term debt</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.35% senior notes due March 2021</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Floating rate notes due March 2021 (0.950% at December 31, 2020)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.125% senior notes due May 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.125% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.125% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.45% senior notes due June 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5% senior notes due July 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.75% senior notes due November 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.75% senior notes due December 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.7% senior notes due March 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8% senior notes due June 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4% senior notes due December 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.375% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.625% senior notes due August 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5% senior notes due November 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5% senior notes due December 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1% senior notes due March 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.875% senior notes due July 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.875% senior notes due June 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3% senior notes due August 2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.625% senior notes due April 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.25% senior notes due June 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3% senior notes due August 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3% senior notes due March 2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.25% senior notes due August 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.75% senior notes due April 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.75% senior notes due August 2030</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.875% senior notes due February 2031</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.125% senior notes due September 2031</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.875% senior notes due July 2035</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.625% senior notes due June 2036</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.75% senior notes due December 2037</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.78% senior notes due March 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.125% senior notes due September 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.125% senior notes due April 2040</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7% senior notes due August 2040</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.75% senior notes due May 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5% senior notes due May 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.125% senior notes due November 2042</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.3% senior notes due December 2043</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.75% senior notes due March 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.125% senior notes due July 2045</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.875% senior notes due August 2047</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.05% senior notes due March 2048</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.25% senior notes due April 2050</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTAtMS0xLTE5NjM1_55ac48cb-f36e-4b9d-8b69-3e86d1c383ef"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTAtMS0xLTE5NjM1_fc260d98-5cca-40f0-8e2a-2fb2b3ac6249">Finance lease liabilities</span></span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total debt principal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,743&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">65,318&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt premiums</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt discounts and deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(786)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56,176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,647&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,205)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51,971&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59,207&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of maturities of long-term debt</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the Company&#8217;s required repayments of debt principal due during each of the next five&#160;years and thereafter, as of December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,743&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">See Note 6 &#8216;&#8216;Leases&#8217;&#8217; for a summary of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">maturities of the Company&#8217;s finance lease liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211335288760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock', window );">Schedule of changes in benefit obligations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables outline the change in pension benefit obligation and plan assets over the specified periods:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,845&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock', window );">Schedule of changes in plan assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables outline the change in pension benefit obligation and plan assets over the specified periods:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial (gain) loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets, end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,845&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock', window );">Schedule of assets (liabilities) recognized in Balance Sheet</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets (liabilities) recognized on the consolidated balance sheets at December&#160;31, 2021 and 2020 for the defined benefit pension plans consisted of the following:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets reflected in other assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities reflected in accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities reflected in other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of net periodic benefit cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of net periodic benefit cost (income) for the years ended December&#160;31, 2021, 2020 and 2019 are shown below:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of net periodic benefit cost (income):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost (income)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Weighted average assumptions used in determining benefit obligations and net benefit costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its benefit obligation based on the following weighted average assumptions as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined its net periodic benefit cost (income) based on the following weighted average assumptions for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected long-term rate of return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of changes in fair value of plan assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2021 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,553&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,566&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,837&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,781&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $261 million of equity securities and $149 million of debt securities. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Excludes $76 million of other receivables as well as $583 million of private equity limited partnership investments and $237 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2020 were as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;States, municipalities and political subdivisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. corporate securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Foreign securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Residential mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Commercial mortgage-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Redeemable preferred securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,887&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;U.S. domestic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Domestic real estate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Real estate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Common/collective trusts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Derivatives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other investments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total pension investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,291&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,231&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,865&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The assets in the underlying funds of common/collective trusts consist of $84 million of equity securities and $182 million of debt securities. </span></div>(2)Excludes $142 million of other receivables as well as $624 million of private equity limited partnership investments and $214 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock', window );">Schedule of change in level 3 plan assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:74.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.759%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.761%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2020 were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Real estate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S. corporate<br/>securities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases, sales and settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers out of Level 3</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of expected future benefits payments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the pension benefit obligation as of December&#160;31, 2021: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:86.162%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027-2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the accumulated other postretirement benefit obligation as of December&#160;31, 2021: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:86.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027-2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of defined benefit plan asset investment. Includes, but is not limited to, fair value of category of plan asset and its level within fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211335248856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of components of income tax expense (benefit)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision for continuing operations consisted of the following for the&#160;years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,615&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,450&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,950&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,133&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,015&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(450)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(535)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(428)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(564)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(649)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,522&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,569&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of effective income tax rate reconciliation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a reconciliation of the statutory income tax rate to the Company&#8217;s effective income tax rate for continuing operations for the&#160;years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes, net of federal tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurer fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basis difference upon disposition of subsidiary</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year refund claim </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred tax assets and liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the components of the Company&#8217;s deferred income tax assets and liabilities as of December&#160;31, 2021 and 2020:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.711%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,563&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debts and other allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss and capital loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll tax deferral</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(454)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,497&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,774&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and rents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,947)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,368)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,381)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,750)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,767)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,568)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,270)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,794)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of unrecognized tax benefits roll forward</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balance of unrecognized tax benefits in 2021, 2020 and 2019 is as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of statutes of limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=124434304&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211335889016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Stock-based compensation</a></td>
<td class="text">The following table is a summary of stock-based compensation for the&#160;years ended December&#160;31, 2021, 2020 and 2019:<div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and stock appreciation rights (&#8220;SARs&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units and performance stock units</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Includes the ESPP.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule ESPP valuation assumptions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the assumptions used to value the ESPP awards for the&#160;years ended December&#160;31, 2021, 2020 and 2019:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.70&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is calculated based on semi-annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#8217;s daily stock price over the previous six&#160;month period.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on the Treasury constant maturity interest rate whose term is consistent with the expected term of ESPP purchases (i.e., six&#160;months).</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected life is based on the semi-annual purchase period.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">RSU and performance share unit activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the restricted stock unit and performance stock unit activity for the&#160;year ended December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In thousands, except weighted average grant date fair value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,190&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,236)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year, nonvested</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,330&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock', window );">Cash proceeds received and tax benefit from share-based payment awards</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of stock option and SAR activity that occurred for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash received from stock options exercised (including ESPP)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes for net share settlement of equity awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intrinsic value of stock options and SARs exercised </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of stock options and SARs vested </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of valuation assumptions</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option is estimated using the Black-Scholes option pricing model based on the following assumptions at the time of grant:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The dividend yield is based on annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#8217;s daily stock price over a period equal to the expected life of each option grant after adjustments for infrequent events such as stock splits.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The risk-free interest rate is selected based on yields from U.S. Treasury zero-coupon issues with a remaining term equal to the expected term of the options being valued.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The expected life represents the number of&#160;years the options are expected to be outstanding from grant date based on historical option or SAR holder exercise experience.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock', window );">Schedule of stock options and stock appreciation rights award activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of the Company&#8217;s stock option and SAR activity for the&#160;year ended December&#160;31, 2021:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.747%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;thousands, except weighted average exercise price and remaining contractual term</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,955&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,366)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(694)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at end of year</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,061&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603,137&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,704&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.61</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,034&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at end of year and expected to vest in the future</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,709&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.69</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590,514&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash received from exercise of stock options and similar instruments granted under share-based payment arrangements and tax benefit from exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331384792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Share repurchase programs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following share repurchase programs have been authorized by the Board:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In billions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Authorization&#160;Date</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Remaining as of<br/>December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 9, 2021 (&#8220;2021 Repurchase Program&#8221;)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2016 (&#8220;2016 Repurchase Program&#8221;)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRegulatoryAssetsTextBlock', window );">Schedule of regulatory Requirements</a></td>
<td class="text">The combined statutory net income for the years ended and estimated combined statutory and capital surplus at December&#160;31, 2021, 2020 and 2019 for the Company&#8217;s insurance and HMO subsidiaries were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statutory net income </span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.05pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated statutory capital and surplus</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock', window );">Statutory accounting practices disclosure</a></td>
<td class="text">At December&#160;31, 2021, these amounts were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:88.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.604%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated minimum statutory surplus required by regulators</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments on deposit with regulatory bodies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated maximum dividend distributions permitted in 2022 without prior regulatory approval</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRegulatoryAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets that are created when regulatory agencies permit public utilities to defer certain costs included in rate-setting to the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 980<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6499975&amp;loc=d3e44250-110382<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 980<br> -SubTopic 715<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501251&amp;loc=d3e52485-110419<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 980<br> -SubTopic 340<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6499975&amp;loc=d3e44264-110382<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRegulatoryAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of how the entity's reporting under GAAP as of the balance sheet date differs from the results based on prescribed and permitted accounting practices of the state or country of domicile in which a relevant statutory filing is made, or differences in results based on the National Association of Insurance Commissioners (NAIC) prescribed practices, or a combination thereof. Describes the accounting practices used and the related monetary effect on statutory surplus, net income, and risk-based capital. If an insurance enterprise's risk-based capital would have triggered a regulatory event had it not used a permitted practice, that fact is disclosed in the financial statements. Permitted statutory accounting practices include practices not prescribed but allowed by the domiciliary state insurance department regulatory authority.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.23(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24790-158529<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24746-158529<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 55<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82848697&amp;loc=d3e24959-158530<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82848697&amp;loc=d3e24938-158530<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211329321976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders&#8217; equity included the following activity in accumulated other comprehensive income in 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.529%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">At December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net unrealized investment gains (losses):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(489), $497 and $927 pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(32), $31 and $(105) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(436)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign currency translation adjustments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income (loss) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flow hedges:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($0, $(7) and $(25) pretax)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive income </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($(34), $(35) and $(20) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and other postretirement benefits:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning of year balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(149)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($20, $(30) and $162 pretax)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from accumulated other comprehensive loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">($6, $7 and $(12) pretax)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of year balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total beginning of year accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total end of year accumulated other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the consolidated statements of operations. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income (loss) represent the elimination of the cumulative translation adjustment associated with the sale of Onofre, which was sold on July 1, 2019. The loss on the divestiture of Onofre is reflected in operating expenses in the consolidated statements of operations.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included within interest expense in the consolidated statements of operations. The Company expects to reclassify approximately $11 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the consolidated statements of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211329284424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of basic and diluted earnings (loss) per share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of basic and diluted earnings per share from continuing operations for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,898&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,201&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income allocated to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to CVS Health</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,910&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,629&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator for earnings per share calculation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,301&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares, diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,329&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,305&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share from continuing operations:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211325235352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reinsurance (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceDisclosuresAbstract', window );"><strong>Reinsurance Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock', window );">Schedule of reinsurance recoverables</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance recoverables (recorded as other current assets or other assets on the consolidated balance sheets) at December&#160;31, 2021 and 2020 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reinsurer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hartford Life and Accident Insurance Company</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lincoln Life &amp; Annuity Company of New York</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VOYA Retirement Insurance and Annuity Company </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,549&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock', window );">Schedule of direct, assumed and ceded premiums earned</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct, assumed and ceded premiums earned for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.236%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(680)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,954)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net premiums</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,132&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,364&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,122&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectsOfReinsuranceTableTextBlock', window );">Schedule of impact of reinsurance on benefit costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of reinsurance on benefit costs for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.236%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Direct</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ceded</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net benefit costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,260&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,679&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,529&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the supplemental schedule of reinsurance information. Reinsurance schedule includes, but is not limited to, the type of insurance, gross amount of premiums, premiums ceded to other entities, premiums assumed from other entities, net amount of premium revenue, and the percentage of the premiums assumed to net premium revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectsOfReinsuranceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effects of reinsurance, for example, but not limited to, disclosure of direct, assumed, and ceded insurance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectsOfReinsuranceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of reinsurer or group of reinsurers for whom the entity has a concentration of credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123600520&amp;loc=SL75241803-196195<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211329473224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summarized financial information of segments</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.308%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.827%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.746%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.003%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Health Care<br/>Benefits</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Pharmacy&#160;<br/>Services </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retail/<br/>LTC</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate/<br/>Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Intersegment</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Eliminations </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated<br/>Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">290,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,923)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,923)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,012&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,471)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(711)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,884&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,908&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,467&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,198&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,323)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,706&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues from external customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,439)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,604&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,439)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Adjusted operating income (loss) </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(697)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,723&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Total revenues of the Pharmacy Services segment include approximately $11.6 billion, $10.9 billion and $11.5 billion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">of retail co-payments for 2021, 2020 and 2019, respectively. See Note 1 &#8216;&#8216;Significant Accounting Policies&#8217;&#8217; for additional information about retail co-payments.</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#8220;PSS members&#8221;) enrolled in Maintenance Choice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> elect to pick up maintenance prescriptions at one of the Company&#8217;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of operating earnings to net income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of consolidated operating income to adjusted operating income for the years ended December&#160;31, 2021, 2020 and 2019:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.576%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">In&#160;millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (GAAP measure)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,987&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition-related integration costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Store impairments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill impairment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition purchase price adjustment outside of measurement period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Gain) loss on divestiture of subsidiary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(6)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receipt of fully reserved ACA risk corridor receivable </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(7)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,312&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,008&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,339&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">_____________________________________________</span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">The Company&#8217;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#8217;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#8217;s insurance products, the services performed for the Company&#8217;s customers or the sale of the Company&#8217;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#8217;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#8217;s and investors&#8217; ability to compare the Company&#8217;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#8217;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2021, 2020 and 2019, acquisition-related integration costs relate to the Aetna Acquisition. The acquisition-related integration costs are reflected in the Company&#8217;s GAAP consolidated statements of operations in operating expenses within the Corporate/Other segment.  </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">During the year ended December 31, 2021, the store impairment charge relates to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. During the year ended December 31, 2019, the store impairment charges related to the write down of operating lease right-of-use assets in connection with the planned closure of 68 underperforming retail pharmacy stores in 2019 and 2020. The store impairment charges are reflected in the Company&#8217;s GAAP consolidated statements of operations within the Retail/LTC segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">During the year ended December 31, 2021, the goodwill impairment charge relates to the LTC reporting unit within the Retail/LTC segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In June 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#8217;s GAAP consolidated statement of operations for the year ended December 31, 2021 as a reduction of operating expenses within the Health Care Benefits segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#8217; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction of operating expenses in the Company&#8217;s GAAP consolidated statement of operations within the Health Care Benefits segment. In 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in the Company&#8217;s GAAP consolidated statement of operations in operating expenses within the Retail/LTC segment. </span></div><div style="padding-left:13.5pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">In 2020, the Company received $313&#160;million owed to it under the ACA&#8217;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#8217;s minimum MLR rebate requirements and premium taxes, the Company recognized pre-tax income of $307&#160;million in the Company&#8217;s GAAP consolidated statement of operations within the Health Care Benefits segment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211317562488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Narrative (Details)<br> shares in Millions, people in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="7"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 22, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>store</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>store </div>
<div>state </div>
<div>Segment</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>store </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>store</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>member</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>people</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>patient</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>state</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>clinic</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 01, 2019 </div>
<div>store</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfPlanMembers', window );">Number of plan members | people</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofPatientsServedperYear', window );">Number of patients served per year (more than) | patient</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfPeopleServed', window );">Number of people served | people</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCosts', window );">Deferred acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 895,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 895,000,000<span></span>
</td>
<td class="nump">$ 546,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000,000<span></span>
</td>
<td class="nump">2,100,000,000<span></span>
</td>
<td class="nump">$ 1,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,358,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">231,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">431,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets, indefinite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts', window );">Assumed interest rates on long-duration group life and long-term care contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HeathSavingsAccountBalance', window );">HSA balances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000,000<span></span>
</td>
<td class="nump">$ 2,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="nump">927,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PharmacyRebatePeriod', window );">Pharmacy rebate period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthInsurerFee', window );">Health insurer fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">523,000,000<span></span>
</td>
<td class="nump">$ 461,000,000<span></span>
</td>
<td class="nump">$ 396,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TreasuryStockSharesHeldinTrust', window );">Treasury shares held in trust (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses from transactions with related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,000,000<span></span>
</td>
<td class="nump">$ 56,000,000<span></span>
</td>
<td class="nump">$ 32,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty', window );">Other revenues from transactions with related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,000,000<span></span>
</td>
<td class="nump">77,000,000<span></span>
</td>
<td class="nump">96,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity', window );">Charitable contribution to CVS Health Foundation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfStoresPlannedClosure', window );">Number of stores, planned closure | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember', window );">U.S. Department of Health and Human Services, ACA Risk Corridor Receivables | Settled Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingencyUnrecordedAmount', window );">Gain contingency, unrecorded amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 313,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Amount awarded from other party</a></td>
<td class="nump">$ 313,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax', window );">Former gain contingency, recognized in current period, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax', window );">Former gain contingency, recognized in current period, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">223,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=cvs_HeartlandHealthcareServicesMember', window );">Heartland Healthcare Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states in which entity operates | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Cumulative translation adjustment from AOCI eliminated upon divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">$ (154,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherInsuranceLiabilitiesMember', window );">Other Insurance Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityforUnpaidClaims', window );">Liability for unpaid claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,000,000<span></span>
</td>
<td class="nump">532,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefits', window );">Future policy benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">416,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">416,000,000<span></span>
</td>
<td class="nump">462,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherLongTermInsuranceLiabilitiesMember', window );">Other Long-Term Insurance Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityforUnpaidClaims', window );">Liability for unpaid claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000,000<span></span>
</td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefits', window );">Future policy benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,100,000,000<span></span>
</td>
<td class="nump">$ 5,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid', window );">Period after date of service a claim is paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LimitedPaymentsContracts', window );">Assumed interest rates on limited payment pension contracts on large case pension business (in hundredths)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PensionAndAnnuityInvestmentContractsInterest', window );">Interest rate for pension and annuity investment contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Building, building improvements and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Fixtures, equipment and internally developed software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm', window );">Lease renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid', window );">Period after date of service a claim is paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LimitedPaymentsContracts', window );">Assumed interest rates on limited payment pension contracts on large case pension business (in hundredths)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.30%<span></span>
</td>
<td class="nump">11.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PensionAndAnnuityInvestmentContractsInterest', window );">Interest rate for pension and annuity investment contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.80%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Building, building improvements and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Fixtures, equipment and internally developed software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_BrazilSubsidiaryMember', window );">Brazil Subsidiary | Discontinued Operations, Disposed of by Sale | Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Cumulative translation adjustment from AOCI eliminated upon divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of retail locations (more than) | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofWalkInMedicalClinics', window );">Number of walk-in medical clinics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 431,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfStoresPlannedClosure', window );">Number of stores, planned closure | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC | Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 261,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC | Brazil Subsidiary | Discontinued Operations, Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of retail locations (more than) | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates', window );">Number of states the Company has submitted regulatory filings for a January 2022 entrance into the individual public health insurance exchange | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Premium deficiency reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,000,000<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="nump">$ 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assumed Interest Rates On Long Duration Group Life And Long Term Care Contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Former Gain Contingency, Recognized in Current Period, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Former Gain Contingency, Recognized in Current Period, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Health Care Costs Payable, Period After Date Of Services Claims Are Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthInsurerFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthInsurerFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HeathSavingsAccountBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Heath Savings Account Balance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HeathSavingsAccountBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeOperatingAndFinanceLeasesRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating And Finance Leases, Renewal Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeOperatingAndFinanceLeasesRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LiabilityforUnpaidClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the total liability on the balance sheet for unpaid claims for both short-duration and long-duration insurance contracts after reinsurance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LiabilityforUnpaidClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LimitedPaymentsContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum assumed interest rates on limited payment contracts on large case pensions business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LimitedPaymentsContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfPeopleServed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of People Served</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfPeopleServed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfPlanMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Plan Members</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfPlanMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfStoresPlannedClosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Stores, Planned Closure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfStoresPlannedClosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofPatientsServedperYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Patients Served per Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofPatientsServedperYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofWalkInMedicalClinics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Walk In Medical Clinics</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofWalkInMedicalClinics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PensionAndAnnuityInvestmentContractsInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pension And Annuity Investment Contracts Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PensionAndAnnuityInvestmentContractsInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PharmacyRebatePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pharmacy Rebate Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PharmacyRebatePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumDeficiencyReserveLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumDeficiencyReserveLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Charitable Contribution To Non-Profit Entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StoreImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Store Impairment Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StoreImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TreasuryStockSharesHeldinTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Shares, Held in Trust</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TreasuryStockSharesHeldinTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred policy acquisition cost capitalized on contract remaining in force.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124505477&amp;loc=SL117422543-158416<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124506110&amp;loc=d3e32546-158582<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 30<br> -Section 55<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124504731&amp;loc=d3e11522-158419<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingencyUnrecordedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount or range of possible amounts of gain that could be realized upon the resolution of a contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6397426&amp;loc=d3e17499-108355<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingencyUnrecordedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 55<br> -Paragraph 29E<br> -URI http://asc.fasb.org/extlink&amp;oid=124504033&amp;loc=SL117819541-158441<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124506351&amp;loc=d3e14931-158439<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cvs_HeartlandHealthcareServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cvs_HeartlandHealthcareServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherInsuranceLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=cvs_OtherInsuranceLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=cvs_OtherLongTermInsuranceLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=cvs_OtherLongTermInsuranceLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_BrazilSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_BrazilSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331195112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Restricted Cash (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 9,408<span></span>
</td>
<td class="nump">$ 7,854<span></span>
</td>
<td class="nump">$ 5,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash (included in other current assets)</a></td>
<td class="nump">3,065<span></span>
</td>
<td class="nump">2,913<span></span>
</td>
<td class="nump">2,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash (included in other assets)</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">276<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows</a></td>
<td class="nump">$ 12,691<span></span>
</td>
<td class="nump">$ 11,043<span></span>
</td>
<td class="nump">$ 8,408<span></span>
</td>
<td class="nump">$ 6,553<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211332291432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Accounts Receivable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Trade receivables</a></td>
<td class="nump">$ 7,932<span></span>
</td>
<td class="nump">$ 7,101<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_VendorandManufacturerReceivables', window );">Vendor and manufacturer receivables</a></td>
<td class="nump">10,573<span></span>
</td>
<td class="nump">9,815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsReceivableAtCarryingValue', window );">Premium receivables</a></td>
<td class="nump">2,537<span></span>
</td>
<td class="nump">2,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">3,389<span></span>
</td>
<td class="nump">2,198<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Total accounts receivable, net</a></td>
<td class="nump">24,431<span></span>
</td>
<td class="nump">21,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for credit loss</a></td>
<td class="nump">$ 339<span></span>
</td>
<td class="nump">$ 358<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_VendorandManufacturerReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Vendor and Manufacturer Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_VendorandManufacturerReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsReceivableAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsReceivableAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211325395816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Property Plant and Equipment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 33,550<span></span>
</td>
<td class="nump">$ 31,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation and amortization</a></td>
<td class="num">(20,654)<span></span>
</td>
<td class="num">(18,700)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">12,896<span></span>
</td>
<td class="nump">12,606<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">2,038<span></span>
</td>
<td class="nump">2,134<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">4,225<span></span>
</td>
<td class="nump">3,950<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Fixtures and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">13,619<span></span>
</td>
<td class="nump">13,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">6,242<span></span>
</td>
<td class="nump">6,077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 7,426<span></span>
</td>
<td class="nump">$ 6,020<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211323453256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 290,912<span></span>
</td>
<td class="nump">$ 267,908<span></span>
</td>
<td class="nump">$ 255,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">1,199<span></span>
</td>
<td class="nump">798<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">292,111<span></span>
</td>
<td class="nump">268,706<span></span>
</td>
<td class="nump">256,776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember', window );">Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">184,618<span></span>
</td>
<td class="nump">171,289<span></span>
</td>
<td class="nump">165,925<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember', window );">Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">21,315<span></span>
</td>
<td class="nump">19,655<span></span>
</td>
<td class="nump">19,422<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_PremiumsMember', window );">Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">76,132<span></span>
</td>
<td class="nump">69,364<span></span>
</td>
<td class="nump">63,122<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">8,847<span></span>
</td>
<td class="nump">7,600<span></span>
</td>
<td class="nump">7,296<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">81,515<span></span>
</td>
<td class="nump">74,926<span></span>
</td>
<td class="nump">68,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">586<span></span>
</td>
<td class="nump">483<span></span>
</td>
<td class="nump">599<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">82,186<span></span>
</td>
<td class="nump">75,467<span></span>
</td>
<td class="nump">69,604<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">76,064<span></span>
</td>
<td class="nump">69,301<span></span>
</td>
<td class="nump">63,031<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">5,536<span></span>
</td>
<td class="nump">5,683<span></span>
</td>
<td class="nump">5,974<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">143,194<span></span>
</td>
<td class="nump">132,663<span></span>
</td>
<td class="nump">130,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">153,022<span></span>
</td>
<td class="nump">141,938<span></span>
</td>
<td class="nump">141,491<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Pharmacy network</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">91,715<span></span>
</td>
<td class="nump">85,045<span></span>
</td>
<td class="nump">88,755<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Mail choice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">60,547<span></span>
</td>
<td class="nump">56,071<span></span>
</td>
<td class="nump">52,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">760<span></span>
</td>
<td class="nump">822<span></span>
</td>
<td class="nump">595<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">152,262<span></span>
</td>
<td class="nump">141,116<span></span>
</td>
<td class="nump">140,896<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">760<span></span>
</td>
<td class="nump">822<span></span>
</td>
<td class="nump">595<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">66,078<span></span>
</td>
<td class="nump">60,208<span></span>
</td>
<td class="nump">56,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">100,105<span></span>
</td>
<td class="nump">91,198<span></span>
</td>
<td class="nump">86,608<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">76,121<span></span>
</td>
<td class="nump">70,176<span></span>
</td>
<td class="nump">66,442<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">21,315<span></span>
</td>
<td class="nump">19,655<span></span>
</td>
<td class="nump">19,422<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">2,652<span></span>
</td>
<td class="nump">1,367<span></span>
</td>
<td class="nump">744<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">596<span></span>
</td>
<td class="nump">315<span></span>
</td>
<td class="nump">412<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">721<span></span>
</td>
<td class="nump">426<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(43,923)<span></span>
</td>
<td class="num">(40,323)<span></span>
</td>
<td class="num">(41,439)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">(43,765)<span></span>
</td>
<td class="num">(40,003)<span></span>
</td>
<td class="num">(41,413)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Front Store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">$ (158)<span></span>
</td>
<td class="num">$ (320)<span></span>
</td>
<td class="num">$ (26)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_PharmacyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_FrontStoreRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_PremiumsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_PremiumsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=cvs_SalesChannelOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=cvs_SalesChannelOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331157688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - Receivables and Contracted Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Trade receivables</a></td>
<td class="nump">$ 7,932<span></span>
</td>
<td class="nump">$ 7,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities (included in accrued expenses)</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211329915128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Contract Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ChangeInContractWithCustomerLiabilityRollForward', window );"><strong>Change in Contract with Customer, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities, beginning of period</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance', window );">Rewards earnings and gift card issuances</a></td>
<td class="nump">387<span></span>
</td>
<td class="nump">357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage', window );">Redemption and breakage</a></td>
<td class="num">(371)<span></span>
</td>
<td class="num">(359)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities, end of period</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ChangeInContractWithCustomerLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in Contract with Customer, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ChangeInContractWithCustomerLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractWithCustomerLiabilityRedemptionAndBreakage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer Liability Redemption And Breakage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractWithCustomerLiabilityRedemptionAndBreakage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211328176600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Variable Interest Entities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">$ 23,025<span></span>
</td>
<td class="nump">$ 20,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ProceedsFromVariableInterestEntity', window );">Proceeds from VIE</a></td>
<td class="nump">$ 183<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">$ 183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cvs_RedOakMember', window );">Red Oak</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">VIE, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_Initialcontractualterm', window );">Initial contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_VariableInterestEntityAmendedContractExtensionTerm', window );">Amended contract extension term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_VariableInterestEntityAmendedContractTerm', window );">Amended contract term (in years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">$ 1,289<span></span>
</td>
<td class="nump">1,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary | Hedge fund investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">463<span></span>
</td>
<td class="nump">342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary | Private equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">601<span></span>
</td>
<td class="nump">547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary | Real estate partnerships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">$ 225<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_Initialcontractualterm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entity, Initial Contractual Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_Initialcontractualterm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ProceedsFromVariableInterestEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Variable Interest Entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ProceedsFromVariableInterestEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_VariableInterestEntityAmendedContractExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entity, Amended Contract Extension Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_VariableInterestEntityAmendedContractExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_VariableInterestEntityAmendedContractTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entity, Amended Contract Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_VariableInterestEntityAmendedContractTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cvs_RedOakMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cvs_RedOakMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_HedgeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_HedgeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_PrivateEquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_PrivateEquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_RealEstateFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_RealEstateFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211335895768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Discontinued Operations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax', window );">Loss from discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation', window );">Income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331410968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Divestitures - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>store</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 01, 2019 </div>
<div>store</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 840<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on sale of subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="num">(205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of stores | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | Coventry Health Care Workers Compensation Business | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of subsidiary</a></td>
<td class="nump">$ 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on sale of subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | Brazil Subsidiary | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStores', window );">Number of stores | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | Drogaria onofre Ltda. | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain (loss) on sale of subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStores">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of stores.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStores</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_BrazilSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_BrazilSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_DrogariaOnofreLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_DrogariaOnofreLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211322648472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Schedule of Total Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">$ 3,117<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">23,025<span></span>
</td>
<td class="nump">20,812<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">26,142<span></span>
</td>
<td class="nump">23,812<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember', window );">Debt securities available for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">3,009<span></span>
</td>
<td class="nump">2,774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">20,231<span></span>
</td>
<td class="nump">18,414<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">23,240<span></span>
</td>
<td class="nump">21,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">844<span></span>
</td>
<td class="nump">821<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">902<span></span>
</td>
<td class="nump">1,047<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_TotalInvestmentsLineItems', window );"><strong>Total Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Current</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term</a></td>
<td class="nump">1,950<span></span>
</td>
<td class="nump">1,577<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 1,577<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=cvs_DebtAndEquitySecuritiesAvailableForSaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=cvs_MortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_TotalInvestmentsAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211324466872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedInvestmentsAtFairValue', window );">Investments related to 2012 contract conversion</a></td>
<td class="nump">$ 450<span></span>
</td>
<td class="nump">$ 524<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities', window );">Weighted average duration of securities</a></td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities', window );">Weighted average duration of securities</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities', window );">Weighted average duration of securities</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Weighted Average Duration Of Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedInvestmentsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate value of all restricted investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12.6(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611133-123010<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Footnote 11(c)))<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedInvestmentsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211323273768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Debt Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">$ 22,174<span></span>
</td>
<td class="nump">$ 19,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1,172<span></span>
</td>
<td class="nump">1,803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(106)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">23,240<span></span>
</td>
<td class="nump">21,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for credit loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,349<span></span>
</td>
<td class="nump">2,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,416<span></span>
</td>
<td class="nump">2,469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,947<span></span>
</td>
<td class="nump">2,556<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">3,091<span></span>
</td>
<td class="nump">2,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">9,093<span></span>
</td>
<td class="nump">7,879<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">682<span></span>
</td>
<td class="nump">1,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(40)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">9,735<span></span>
</td>
<td class="nump">8,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,821<span></span>
</td>
<td class="nump">2,595<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">196<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,993<span></span>
</td>
<td class="nump">2,918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">870<span></span>
</td>
<td class="nump">673<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(10)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">875<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">1,278<span></span>
</td>
<td class="nump">962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,310<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,791<span></span>
</td>
<td class="nump">2,369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2,792<span></span>
</td>
<td class="nump">2,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 864<span></span>
</td>
<td class="nump">$ 919<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available For Sale, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211323250856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Debt Securities by Maturity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet', window );">Less than one year</a></td>
<td class="nump">$ 1,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet', window );">One year through five years</a></td>
<td class="nump">6,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet', window );">After five years through ten years</a></td>
<td class="nump">4,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet', window );">Greater than ten years</a></td>
<td class="nump">4,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">22,174<span></span>
</td>
<td class="nump">$ 19,396<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Less than one year</a></td>
<td class="nump">1,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">One year through five years</a></td>
<td class="nump">7,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">After five years through ten years</a></td>
<td class="nump">4,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Greater than ten years</a></td>
<td class="nump">4,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">23,240<span></span>
</td>
<td class="nump">21,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">870<span></span>
</td>
<td class="nump">673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">875<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">1,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">1,278<span></span>
</td>
<td class="nump">962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">1,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">1,310<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">2,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet', window );">Amortized Cost</a></td>
<td class="nump">2,791<span></span>
</td>
<td class="nump">2,369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date</a></td>
<td class="nump">2,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total</a></td>
<td class="nump">$ 2,792<span></span>
</td>
<td class="nump">$ 2,403<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available For Sale, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211323982840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Unrealized Loss Position (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>security</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>security</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">3,700<span></span>
</td>
<td class="nump">468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">317<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">4,017<span></span>
</td>
<td class="nump">527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="nump">$ 869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">584<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">7,384<span></span>
</td>
<td class="nump">915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 106<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">53<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 242<span></span>
</td>
<td class="nump">$ 205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">282<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">233<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 428<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">461<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">1,610<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">1,775<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 2,296<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">238<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">2,534<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 40<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">449<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">57<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">506<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 747<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">838<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 593<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">629<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 462<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">574<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">1,011<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">1,037<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 2,030<span></span>
</td>
<td class="nump">$ 256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">2,061<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_RedeemablePreferredSecuritiesMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract', window );"><strong>Number of Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions', window );">Number of Securities, Less than 12 months | security</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions', window );">Number of Securities, Greater than 12 months | security</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of Securities | security</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value, Less than 12 months</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value, Greater than 12 months</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses, Less than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses, Greater than 12 months</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_RedeemablePreferredSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_RedeemablePreferredSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211324793832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Unrealized Loss Position Maturities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">2,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">1,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">7,384<span></span>
</td>
<td class="nump">$ 915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">629<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">574<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">2,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">2,061<span></span>
</td>
<td class="nump">297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear', window );">Less than one year</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears', window );">One year through five years</a></td>
<td class="nump">2,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears', window );">After five years through ten years</a></td>
<td class="nump">1,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears', window );">Greater than ten years</a></td>
<td class="nump">445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">7,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss', window );">Less than one year</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss', window );">One year through five years</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss', window );">After five years through ten years</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss', window );">Greater than ten years</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember', window );">Supporting remaining products | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue', window );">Debt securities, maturity, without single maturity date, fair value</a></td>
<td class="nump">2,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost', window );">Debt securities, maturity, without single maturity date, unrealized losses</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingRemainingProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211323015944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Mortgage Loans (Details) - Commercial Real Estate - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans', window );">New mortgage loans</a></td>
<td class="nump">$ 262<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateLoansFullyRepaid', window );">Mortgage loans fully repaid</a></td>
<td class="nump">373<span></span>
</td>
<td class="nump">187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateForeclosures', window );">Mortgage loans foreclosed</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateLoansFullyRepaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pertains to amount of mortgage loans fully repaid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateLoansFullyRepaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateForeclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from foreclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Footnote 6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateForeclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateNewMortgageLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Footnote 6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateNewMortgageLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211325057368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Mortgage Loans Credit Ratings Indicator (Details) - Commercial Real Estate - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">$ 902<span></span>
</td>
<td class="nump">$ 1,047<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">661<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">1 | Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">861<span></span>
</td>
<td class="nump">952<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">2 to 4 | Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">595<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">5 and 6 | Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember', window );">7 | Prior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstate', window );">Mortgage loans</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 948<br> -SubTopic 310<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-29(Column G))<br> -URI http://asc.fasb.org/extlink&amp;oid=120402547&amp;loc=d3e617274-123014<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateYearOfOriginationAxis=cvs_YearOfOriginationPriorToPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=cvs_Category1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=cvs_Category1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=cvs_Category2To4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=cvs_Category2To4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=cvs_Categories5and6Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=cvs_Categories5and6Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalCreditAssessmentAxis=cvs_Category7Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalCreditAssessmentAxis=cvs_Category7Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211332356696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Schedule of Mortgage Loan Principal Repayments (Details) - Commercial Real Estate<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateLineItems', window );"><strong>Mortgage Loans on Real Estate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive', window );">2026</a></td>
<td class="nump">177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet', window );">Total</a></td>
<td class="nump">$ 902<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal After Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal In Next Twelve Months</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal In Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal In Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal In Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Mortgage Loans On Real Estate Collections Of Principal In Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=us-gaap_CommercialRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211323209064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Net Investment Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">$ 1,070<span></span>
</td>
<td class="nump">$ 781<span></span>
</td>
<td class="nump">$ 854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInvestmentExpense', window );">Investment expenses</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentIncomeExcludingCapitalGainsorLosses', window );">Net investment income (excluding net realized capital gains or losses)</a></td>
<td class="nump">1,023<span></span>
</td>
<td class="nump">746<span></span>
</td>
<td class="nump">812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Net realized capital gains</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">199<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Net investment income</a></td>
<td class="nump">1,199<span></span>
</td>
<td class="nump">798<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Yield-related impairment loss</a></td>
<td class="num">(42)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Credit-related impairment loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">OTTI losses, investments, portion recognized in earnings, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember', window );">Supporting experience- rated products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Net investment income</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">634<span></span>
</td>
<td class="nump">598<span></span>
</td>
<td class="nump">589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember', window );">Other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems', window );"><strong>Schedule of Investment Income, Reported Amounts, by Category [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Gross investment income</a></td>
<td class="nump">$ 381<span></span>
</td>
<td class="nump">$ 123<span></span>
</td>
<td class="nump">$ 194<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentIncomeExcludingCapitalGainsorLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Income, Excluding Capital Gains or Losses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentIncomeExcludingCapitalGainsorLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Yield Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInvestmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses related to the generation of investment income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInvestmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cvs_SupportingExperienceRatedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=cvs_MortgageLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211335691960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Realized Gains (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAbstract', window );"><strong>Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales</a></td>
<td class="nump">$ 3,572<span></span>
</td>
<td class="nump">$ 3,913<span></span>
</td>
<td class="nump">$ 4,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain', window );">Gross realized capital gains</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss', window );">Gross realized capital losses</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211322299256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Fair Value Measurements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 23,240<span></span>
</td>
<td class="nump">$ 21,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,416<span></span>
</td>
<td class="nump">2,469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">3,091<span></span>
</td>
<td class="nump">2,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">9,735<span></span>
</td>
<td class="nump">8,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember', window );">Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,993<span></span>
</td>
<td class="nump">2,918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">875<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,310<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,792<span></span>
</td>
<td class="nump">2,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Financial liabilities fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">9,408<span></span>
</td>
<td class="nump">7,854<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">23,240<span></span>
</td>
<td class="nump">21,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">169<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">32,817<span></span>
</td>
<td class="nump">29,089<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">4,954<span></span>
</td>
<td class="nump">3,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,372<span></span>
</td>
<td class="nump">2,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">7,440<span></span>
</td>
<td class="nump">6,372<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">4,454<span></span>
</td>
<td class="nump">3,869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">20,812<span></span>
</td>
<td class="nump">18,764<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">25,266<span></span>
</td>
<td class="nump">22,633<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity securities</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,416<span></span>
</td>
<td class="nump">2,469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,372<span></span>
</td>
<td class="nump">2,370<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. government securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">3,091<span></span>
</td>
<td class="nump">2,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">3,086<span></span>
</td>
<td class="nump">2,727<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | States, municipalities and political subdivisions | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">9,735<span></span>
</td>
<td class="nump">8,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">9,697<span></span>
</td>
<td class="nump">8,842<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | U.S. corporate securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,993<span></span>
</td>
<td class="nump">2,918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,983<span></span>
</td>
<td class="nump">2,918<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Foreign securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">875<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">875<span></span>
</td>
<td class="nump">705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Residential mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,310<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,310<span></span>
</td>
<td class="nump">1,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Commercial mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,792<span></span>
</td>
<td class="nump">2,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">2,789<span></span>
</td>
<td class="nump">2,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other asset-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Redeemable preferred securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211324688792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Changes in Level 3 Financial Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci', window );">Change in unrealized capital losses included in OCI associated with Level 3 financial assets</a></td>
<td class="num">$ (4)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings&#160;</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into Level 3, net</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember', window );">States, municipalities and political subdivisions | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings&#160;</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into Level 3, net</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings&#160;</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into Level 3, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember', window );">Foreign securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings&#160;</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into Level 3, net</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember', window );">Other asset-backed securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings&#160;</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into Level 3, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember', window );">Redeemable preferred securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings&#160;</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into Level 3, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Equity securities | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract', window );"><strong>Net realized and unrealized capital gains (losses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Included in earnings&#160;</a></td>
<td class="nump">13<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Included in other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into Level 3, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Ending balance</a></td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Assets Measured On Recurring Basis, Unobservable Unput Reconciliation, Net Realized And Unrealized Capital Gaines (Losses) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3) and still held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=cvs_OtherAssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_RedeemablePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211332106344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Gross Transfers Into (Out Of) Level 3 (Details) - Recurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Net transfers into Level 3</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Gross transfers into Level 3</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Gross transfers out of Level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Net transfers into Level 3</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211324775848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Carrying Value and Fair Value Classified by Level (Details) - Nonrecurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">$ 902<span></span>
</td>
<td class="nump">$ 1,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities</a></td>
<td class="nump">126<span></span>
</td>
<td class="nump">145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts with a fixed maturity</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts without a fixed maturity</a></td>
<td class="nump">336<span></span>
</td>
<td class="nump">322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">56,176<span></span>
</td>
<td class="nump">64,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">907<span></span>
</td>
<td class="nump">1,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts with a fixed maturity</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts without a fixed maturity</a></td>
<td class="nump">373<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">64,157<span></span>
</td>
<td class="nump">75,940<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 1 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts with a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts without a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">64,157<span></span>
</td>
<td class="nump">75,940<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 2 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts with a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts without a fixed maturity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Level 3 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure', window );">Mortgage loans</a></td>
<td class="nump">907<span></span>
</td>
<td class="nump">1,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure', window );">Investment contracts with a fixed maturity</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure', window );">Investment contracts without a fixed maturity</a></td>
<td class="nump">373<span></span>
</td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Contracts With Fixed Maturity, Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgagesHeldForSaleFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of mortgage loans held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgagesHeldForSaleFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211322575464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value - Separate Accounts Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 5,087<span></span>
</td>
<td class="nump">$ 4,881<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">5,017<span></span>
</td>
<td class="nump">4,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">4,281<span></span>
</td>
<td class="nump">4,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">547<span></span>
</td>
<td class="nump">563<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1,235<span></span>
</td>
<td class="nump">1,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1,233<span></span>
</td>
<td class="nump">1,465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">3,782<span></span>
</td>
<td class="nump">3,385<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">3,048<span></span>
</td>
<td class="nump">2,634<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">547<span></span>
</td>
<td class="nump">563<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 3 | Common/collective trusts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems', window );"><strong>Fair Value, Separate Account Investment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeparateAccountAssets', window );">Separate accounts assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset at fair value held for benefit of separate account policyholder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124508989&amp;loc=d3e19393-158473<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6484091&amp;loc=d3e19268-158472<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 80<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=124505678&amp;loc=SL117422397-158474<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=cvs_CommonAndCollectiveTrustsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=cvs_CommonAndCollectiveTrustsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331168024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value - Narrative (Details) - Recurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into Level 3, net</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into Level 3, net</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Separate Accounts, financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet', window );">Transfers into Level 3, net</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeparateAccountAssetCategoryAxis=cvs_SeparateAccountFinancialAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeparateAccountAssetCategoryAxis=cvs_SeparateAccountFinancialAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211324948120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangibles - Goodwill (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,552,000,000<span></span>
</td>
<td class="nump">$ 79,749,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestiture of Workers&#8217; Compensation business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(505,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(431,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, end of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,121,000,000<span></span>
</td>
<td class="nump">79,552,000,000<span></span>
</td>
<td class="nump">79,749,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,130,000,000<span></span>
</td>
<td class="nump">45,361,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestiture of Workers&#8217; Compensation business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(505,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, end of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,130,000,000<span></span>
</td>
<td class="nump">45,130,000,000<span></span>
</td>
<td class="nump">45,361,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember', window );">Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,615,000,000<span></span>
</td>
<td class="nump">23,581,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestiture of Workers&#8217; Compensation business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, end of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,615,000,000<span></span>
</td>
<td class="nump">23,615,000,000<span></span>
</td>
<td class="nump">23,581,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, beginning of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,807,000,000<span></span>
</td>
<td class="nump">10,807,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestiture of Workers&#8217; Compensation business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(431,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, end of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,376,000,000<span></span>
</td>
<td class="nump">$ 10,807,000,000<span></span>
</td>
<td class="nump">$ 10,807,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211322993960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangibles - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 431,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,121,000,000<span></span>
</td>
<td class="nump">79,552,000,000<span></span>
</td>
<td class="nump">$ 79,749,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Cumulative goodwill impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,600,000,000<span></span>
</td>
<td class="nump">$ 6,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cvs_LongTermCareReportingUnitMember', window );">Long-Term Care Reporting Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="nump">$ 431,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cvs_LongTermCareReportingUnitMember', window );">Long-Term Care Reporting Unit | Customer Lists</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets related to customer lists</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=cvs_LongTermCareReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=cvs_LongTermCareReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211317460088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangibles - Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets, Trademarks</a></td>
<td class="nump">$ 10,498<span></span>
</td>
<td class="nump">$ 10,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(12,727)<span></span>
</td>
<td class="num">(10,481)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, gross</a></td>
<td class="nump">41,753<span></span>
</td>
<td class="nump">41,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">$ 29,026<span></span>
</td>
<td class="nump">$ 31,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">15 years 3 months 18 days<span></span>
</td>
<td class="text">15 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 2,259<span></span>
</td>
<td class="nump">$ 2,341<span></span>
</td>
<td class="nump">$ 2,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember', window );">Customer contracts/relationships and covenants not to compete</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">25,084<span></span>
</td>
<td class="nump">24,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(10,564)<span></span>
</td>
<td class="num">(8,923)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">$ 14,520<span></span>
</td>
<td class="nump">$ 16,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">14 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">$ 1,060<span></span>
</td>
<td class="nump">$ 1,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(1,060)<span></span>
</td>
<td class="num">(739)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ProviderNetworksMember', window );">Provider networks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">$ 4,203<span></span>
</td>
<td class="nump">$ 4,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(651)<span></span>
</td>
<td class="num">(440)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">$ 3,552<span></span>
</td>
<td class="nump">$ 3,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ValueOfBusinessAcquiredMember', window );">Value of Business Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">$ 590<span></span>
</td>
<td class="nump">$ 590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(173)<span></span>
</td>
<td class="num">(119)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">$ 417<span></span>
</td>
<td class="nump">$ 471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OtherAcquiredIntangibleAssetsLineItems', window );"><strong>Other Intangible Assets[Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-lived intangible assets, gross carrying amount</a></td>
<td class="nump">$ 318<span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Finite-lived intangible assets, accumulated amortization</a></td>
<td class="num">(279)<span></span>
</td>
<td class="num">(260)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-lived intangible assets, net carrying amount</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension', window );">Weighted Average Life (years)</a></td>
<td class="text">8 years 4 months 24 days<span></span>
</td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OtherAcquiredIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OtherAcquiredIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period before the next renewal or extension (both explicit and implicit) for intangible assets that have been renewed or extended, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ProviderNetworksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ProviderNetworksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ValueOfBusinessAcquiredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cvs_ValueOfBusinessAcquiredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211332224696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 1,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">1,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">1,785<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">1,734<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">2026</a></td>
<td class="nump">$ 1,494<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211323405048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>store</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>store</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>store</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity', window );">Proceeds from sale-leaseback transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 101.0<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleAndLeasebackTransactionGainLossNet', window );">Gains from sale-leaseback transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfStoresPlannedClosure', window );">Number of stores, planned closure | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,358.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 231.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfStoresPlannedClosure', window );">Number of stores, planned closure | store</a></td>
<td class="nump">900<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfStoresPlannedClosurePeriod', window );">Number of stores, planned closure period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod', window );">Number of stores, annual planned closures for closure period | store</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairment charges</a></td>
<td class="nump">$ 1,400.0<span></span>
</td>
<td class="nump">$ 1,400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Distribution centers and Corporate offices | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease term (in years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseTermOfContract1', window );">Finance lease term (in years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Distribution centers and Corporate offices | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease term (in years)</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseTermOfContract1', window );">Finance lease term (in years)</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease term (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseTermOfContract1', window );">Finance lease term (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease term (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseTermOfContract1', window );">Finance lease term (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertySubjectToOperatingLeaseMember', window );">Operating lease assets | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairment charges</a></td>
<td class="nump">$ 1,100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure', window );">Operating lease, right-of-use asset, fair value</a></td>
<td class="nump">356.0<span></span>
</td>
<td class="nump">$ 356.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property and equipment | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairment charges</a></td>
<td class="nump">261.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure', window );">Property and equipment, fair value</a></td>
<td class="nump">$ 185.0<span></span>
</td>
<td class="nump">$ 185.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Stores, Annual Planned Closures For Closure Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfStoresPlannedClosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Stores, Planned Closure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfStoresPlannedClosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfStoresPlannedClosurePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Stores, Planned Closure Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfStoresPlannedClosurePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease, Right-of-Use Asset, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StoreImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Store Impairment Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StoreImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from principal payment received from sales-type and direct financing leases classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 230<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123398031&amp;loc=SL120154370-112784<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleAndLeasebackTransactionGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123417830&amp;loc=SL77919786-209982<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleAndLeasebackTransactionGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertySubjectToOperatingLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertySubjectToOperatingLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211323904200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Summary of the Components of Net Lease Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 2,633<span></span>
</td>
<td class="nump">$ 2,670<span></span>
</td>
<td class="nump">$ 2,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Finance lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FinanceLeaseCost', window );">Total finance lease costs</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease costs</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">604<span></span>
</td>
<td class="nump">599<span></span>
</td>
<td class="nump">581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Less: sublease income</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease, Cost, Total</a></td>
<td class="nump">$ 3,327<span></span>
</td>
<td class="nump">$ 3,350<span></span>
</td>
<td class="nump">$ 3,357<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211332241112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_CashFlowLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows paid for operating leases</a></td>
<td class="nump">$ 2,714<span></span>
</td>
<td class="nump">$ 2,724<span></span>
</td>
<td class="nump">$ 2,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows paid for interest portion of finance leases</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows paid for principal portion of finance leases</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract', window );"><strong>Right-of-use assets obtained in exchange for lease obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">1,254<span></span>
</td>
<td class="nump">1,679<span></span>
</td>
<td class="nump">1,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Finance leases</a></td>
<td class="nump">$ 278<span></span>
</td>
<td class="nump">$ 313<span></span>
</td>
<td class="nump">$ 283<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_CashFlowLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Flow, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_CashFlowLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331159304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Operating leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 19,122<span></span>
</td>
<td class="nump">$ 20,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">1,646<span></span>
</td>
<td class="nump">1,638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">18,177<span></span>
</td>
<td class="nump">18,757<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">19,823<span></span>
</td>
<td class="nump">20,395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Finance leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FinanceLeaseRightOfUseAssetGross', window );">Property and equipment, gross</a></td>
<td class="nump">1,375<span></span>
</td>
<td class="nump">1,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation', window );">Accumulated depreciation</a></td>
<td class="num">(188)<span></span>
</td>
<td class="num">(106)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FinanceLeaseRightOfUseAssetNet', window );">Property and equipment, net</a></td>
<td class="nump">1,187<span></span>
</td>
<td class="nump">1,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term debt</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="nump">$ 1,083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_WeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted average remaining lease term (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases</a></td>
<td class="text">12 years 9 months 18 days<span></span>
</td>
<td class="text">13 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">20 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LeasesWeightedAverageDiscountRateAbstract', window );"><strong>Weighted average discount rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Assets And Liabilities, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Right-Of-Use Asset, Accumulated Depreciation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FinanceLeaseRightOfUseAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Right-Of-Use Asset, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FinanceLeaseRightOfUseAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FinanceLeaseRightOfUseAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Right-Of-Use Asset, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FinanceLeaseRightOfUseAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LeasesWeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases, Weighted Average Discount Rate [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LeasesWeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Assets And Liabilities, Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_WeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Lease Term [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_WeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211324657464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Operating and Finance Lease Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">2,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(768)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">$ 1,083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">2,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">2,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">2,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">2,217<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">2,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">14,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">26,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(6,247)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">19,823<span></span>
</td>
<td class="nump">$ 20,395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsYearOne', window );">2022</a></td>
<td class="nump">2,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">2,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">2,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">2,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">2,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">15,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">28,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LesseeLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(7,015)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">21,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">Future noncancelable subleases, future minimum payments</a></td>
<td class="nump">311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife', window );">Leases, amount due in excess of remaining estimated economic life</a></td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Leases Liabilities Payments Due [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due After Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due Year Five</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due Year Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Due Year Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityPaymentsYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Payments, Year One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityPaymentsYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LesseeLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LesseeLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating And Capital Leases, Amount Due In Excess Of Remaining Estimated Economic Life</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payments to be received by lessor for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124258985&amp;loc=SL77919396-209981<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331082648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details) - Health Insurance Product Line - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Incurred Health Care Claims, Net of Reinsurance</a></td>
<td class="nump">$ 116,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Cumulative Paid Health Care Claims, Net of Reinsurance</a></td>
<td class="nump">108,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented', window );">All outstanding liabilities for health care costs payable prior to 2020, net of reinsurance</a></td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Total outstanding liabilities for health care costs payable, net of reinsurance</a></td>
<td class="nump">8,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Incurred Health Care Claims, Net of Reinsurance</a></td>
<td class="nump">53,804<span></span>
</td>
<td class="nump">$ 54,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Cumulative Paid Health Care Claims, Net of Reinsurance</a></td>
<td class="nump">53,590<span></span>
</td>
<td class="nump">$ 47,567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Incurred Health Care Claims, Net of Reinsurance</a></td>
<td class="nump">62,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Cumulative Paid Health Care Claims, Net of Reinsurance</a></td>
<td class="nump">$ 54,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClaimsDevelopmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClaimsDevelopmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of incurred claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts for accident years not separately presented in claim development information. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211329267656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Health Care Costs Payable - Narrative (Details)<br> $ in Billions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet', window );">Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) claims liability, net</a></td>
<td class="nump">$ 6.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671321-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671317-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211328097400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Health Care Costs Payable - Reconciliation of Health Care Net Incurred and Paid Claims Development to Health Care Costs Payable Liability (Details) - Health Insurance Product Line - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems', window );"><strong>Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Short-duration health care costs payable, net of reinsurance</a></td>
<td class="nump">$ 8,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Reinsurance recoverables</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Premium deficiency reserve</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem', window );">Insurance lines other than short duration</a></td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Total health care costs payable</a></td>
<td class="nump">$ 8,808<span></span>
</td>
<td class="nump">$ 7,936<span></span>
</td>
<td class="nump">$ 6,879<span></span>
</td>
<td class="nump">$ 6,147<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumDeficiencyReserveLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumDeficiencyReserveLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reconciling item for the reconciliation of the liability in the disclosure of claims development (in excess of) less than the liability for unpaid claims and claims adjustment expense for short-duration insurance contracts, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211323229544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Health Care Costs Payable - Reconciliation of Health Care Costs Payable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, beginning of period, net</a></td>
<td class="nump">$ 7,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, end of period, net</a></td>
<td class="nump">8,808<span></span>
</td>
<td class="nump">$ 7,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts', window );">Benefit costs recorded in other insurance liabilities</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts', window );">Benefit costs recorded in other insurance liabilities</a></td>
<td class="nump">212<span></span>
</td>
<td class="nump">221<span></span>
</td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Health Insurance Product Line</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, beginning of period</a></td>
<td class="nump">7,936<span></span>
</td>
<td class="nump">6,879<span></span>
</td>
<td class="nump">6,147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Less: Reinsurance recoverables</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, beginning of period, net</a></td>
<td class="nump">7,926<span></span>
</td>
<td class="nump">6,874<span></span>
</td>
<td class="nump">6,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions', window );">Acquisitions, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Add: Components of incurred health care costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">64,761<span></span>
</td>
<td class="nump">55,835<span></span>
</td>
<td class="nump">52,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Decrease in prior years' healthcare costs payable</a></td>
<td class="num">(788)<span></span>
</td>
<td class="num">(429)<span></span>
</td>
<td class="num">(524)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total incurred health care costs</a></td>
<td class="nump">63,973<span></span>
</td>
<td class="nump">55,406<span></span>
</td>
<td class="nump">52,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Less: Claims paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current year</a></td>
<td class="nump">56,323<span></span>
</td>
<td class="nump">48,770<span></span>
</td>
<td class="nump">46,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior years</a></td>
<td class="nump">6,792<span></span>
</td>
<td class="nump">6,009<span></span>
</td>
<td class="nump">5,314<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total claims paid</a></td>
<td class="nump">63,115<span></span>
</td>
<td class="nump">54,779<span></span>
</td>
<td class="nump">51,472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumDeficiencyReserveLiability', window );">Add: Premium deficiency reserve</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Health care costs payable, end of period, net</a></td>
<td class="nump">8,800<span></span>
</td>
<td class="nump">7,926<span></span>
</td>
<td class="nump">6,874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Add: Reinsurance recoverables</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Health care costs payable, end of period</a></td>
<td class="nump">$ 8,808<span></span>
</td>
<td class="nump">$ 7,936<span></span>
</td>
<td class="nump">$ 6,879<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumDeficiencyReserveLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumDeficiencyReserveLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211318876520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Schedule of Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Aug. 18, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 55,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease liabilities</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LongtermDebtGrossAndLeaseObligation', window );">Total debt principal</a></td>
<td class="nump">56,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt premiums</a></td>
<td class="nump">219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet', window );">Debt discounts and deferred financing costs</a></td>
<td class="num">(786)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(909)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Long-term debt and lease obligations</a></td>
<td class="nump">56,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="num">(4,205)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,440)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">$ 51,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Long-term debt<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Long-term debt<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.35% senior notes due March 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due May 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.125% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.45% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.45%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.5% senior notes due July 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due November 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.75% senior notes due December 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% senior notes due December 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.7% senior notes due March 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.8% senior notes due June 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4% senior notes due December 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.375% senior notes due August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.625% senior notes due August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.5% senior notes due November 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5% senior notes due December 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.1% senior notes due March 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% senior notes due July 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.875% senior notes due June 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3% senior notes due August 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.625% senior notes due April 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.25% senior notes due June 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.3% senior notes due August 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.3% senior notes due March 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.25% senior notes due August 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.75% senior notes due April 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.75% senior notes due August 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.875% senior notes due February 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">1.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.125% senior notes due September 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.875% senior notes due July 2035</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.625% senior notes due June 2036</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.75% senior notes due December 2037</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.78% senior notes due March 2038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 6.125% senior notes due September 2039</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">6.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">447<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due April 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.7% senior notes due August 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.75% senior notes due May 2041</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.5% senior notes due May 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due November 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.3% senior notes due December 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.75% senior notes due March 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.125% senior notes due July 2045</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.875% senior notes due August 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.05% senior notes due March 2048</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">5.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.25% senior notes due April 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember', window );">Notes Payable | Floating rate notes due March 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other Debt Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LongtermDebtGrossAndLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Gross And Lease Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LongtermDebtGrossAndLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.35DueMarch2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.35DueMarch2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueMay2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueMay2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.125June2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.125June2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueJune2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueJune2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.45DueJune2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.45DueJune2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueJuly2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueJuly2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueNovember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueNovember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.75DueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJune2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.8DueJune2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.375DueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.375DueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueNovember2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.5DueNovember2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5DueDecember2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5DueDecember2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueJuly2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueJuly2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.875DueJune2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.875DueJune2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point625PercentApril2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point625PercentApril2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.25DueJune2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.25DueJune2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point3PercentAugust2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point3PercentAugust2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.3DueMarch2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.3DueMarch2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point75PercentApril2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point75PercentApril2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point75PercentAugust2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point75PercentAugust2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point875PercentFebruary2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1Point875PercentFebruary2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2Point125PercentDueSeptember2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2Point125PercentDueSeptember2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.875DueJuly2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.875DueJuly2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.625DueJune2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.625DueJune2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.75DueDecember2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.75DueDecember2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.78DueMarch2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.78DueMarch2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.125DueSeptember2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes6.125DueSeptember2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4Point125PercentApril2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4Point125PercentApril2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2Point7PercentAugust2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2Point7PercentAugust2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.75DueMay2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.75DueMay2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.5DueMay2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.5DueMay2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueNovember2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueNovember2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.3DueDecember2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.3DueDecember2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueMarch2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.75DueMarch2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.125DueJuly2045Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.125DueJuly2045Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueAugust2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.875DueAugust2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.05DueMarch2048Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.05DueMarch2048Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4Point25PercentApril2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4Point25PercentApril2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331114280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Debt Maturities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Long-term Debt, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 4,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">1,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">2,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">3,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2026</a></td>
<td class="nump">2,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">40,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Subtotal</a></td>
<td class="nump">55,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance lease liabilities</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">$ 1,083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LongtermDebtGrossAndLeaseObligation', window );">Total debt principal</a></td>
<td class="nump">$ 56,743<span></span>
</td>
<td class="nump">$ 65,318<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LongtermDebtGrossAndLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Gross And Lease Obligation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LongtermDebtGrossAndLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211328134936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Short-term Borrowings (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable', window );">Federal home loan bank advances maximum amount available</a></td>
<td class="nump">$ 995,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Back-Up Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.03%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility, Expiring May 17, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility, Expiring May 16, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility, Expiring May 11, 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember', window );">Federal Home Loan Bank Advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of maximum advances or credit lines available from the Federal Home Loan Bank (FHLB).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6479118&amp;loc=d3e64650-112822<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22 (b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_BackUpCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_BackUpCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay172023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay172023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay162024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay162024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay112026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_RevolvingCreditFacilityExpiringMay112026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211320473544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Long-Term Borrowings (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 18, 2021</div></th>
<th class="th"><div>Dec. 16, 2020</div></th>
<th class="th"><div>Aug. 21, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt</a></td>
<td class="nump">$ 987,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,970,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities', window );">Proceeds from derivative instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Loss on net cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost', window );">Premium paid in excess of debt principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000,000<span></span>
</td>
<td class="nump">$ 332,000,000<span></span>
</td>
<td class="nump">$ 619,000,000<span></span>
</td>
<td class="nump">$ 706,000,000<span></span>
</td>
<td class="nump">$ 76,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write off of deferred debt issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="nump">26,000,000<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="nump">47,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DebtExtinguishmentFees', window );">Debt extinguishment fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,000,000<span></span>
</td>
<td class="nump">$ 363,000,000<span></span>
</td>
<td class="nump">674,000,000<span></span>
</td>
<td class="nump">766,000,000<span></span>
</td>
<td class="nump">79,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">452,000,000<span></span>
</td>
<td class="nump">1,440,000,000<span></span>
</td>
<td class="nump">$ 79,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,443,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,443,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts', window );">Net gain on write-off of net unamortized deferred financing premiums on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.125% senior notes due September 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.3% senior notes due August 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.875%, senior notes due February 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,990,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 1.75% senior notes due August 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.7% senior notes due August 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.625% senior notes due April 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.75% senior notes due April 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due April 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.25% senior notes due April 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2.625% senior notes due August 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3% senior notes due August 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.25% senior notes due August 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Notes, 4.3%, Due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Outstanding Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000,000<span></span>
</td>
<td class="nump">$ 6,000,000,000<span></span>
</td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4% senior notes due December 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,000,000<span></span>
</td>
<td class="nump">$ 723,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414,000,000<span></span>
</td>
<td class="nump">$ 414,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.7% senior notes due March 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="nump">$ 2,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,336,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,336,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.1% senior notes due March 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.3% senior notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due May 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 328,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 222,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.125% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 297,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">203,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">203,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 5.45% senior notes due June 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 413,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">187,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">187,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.35% senior notes due March 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 962,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,038,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,038,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | Senior Notes, 3 Point 70 Percent, Due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 3.125% senior notes due March 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=cvs_FloatingRateNotesMember', window );">Floating Rate Notes | Floating rate notes due March 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Aggregate principal of debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 723,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DebtExtinguishmentFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Extinguishment Fees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DebtExtinguishmentFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Gain from Write Off of Deferred Debt Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2Point125PercentDueSeptember2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2Point125PercentDueSeptember2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes13DueAugust2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes13DueAugust2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1875DueFebruary2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes1875DueFebruary2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes175DueAugust2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes175DueAugust2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes27DueAugust2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes27DueAugust2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3625DueApril2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3625DueApril2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes375DueApril2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes375DueApril2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4125DueApril2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4125DueApril2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes425DueApril2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes425DueApril2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes2.625DueAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3DueAugust2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.25DueAugust2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4PointThreePercentDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4PointThreePercentDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_OutstandingSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_OutstandingSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4DueDecember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.7DueMarch2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.1DueMarch2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes43Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes43Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueMay2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueMay2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueJune2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes4.125DueJune2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.45DueJune2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes5.45DueJune2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.35DueMarch2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.35DueMarch2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point70PercentDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3Point70PercentDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.125DueMarch2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_SeniorNotes3.125DueMarch2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=cvs_FloatingRateNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=cvs_FloatingRateNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvs_FloatingRateNotesDueMarch2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211322650792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Defined contribution plan, employer contributions</a></td>
<td class="nump">$ 552<span></span>
</td>
<td class="nump">$ 520<span></span>
</td>
<td class="nump">$ 550<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution', window );">Multiemployer plans, plan contributions</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation</a></td>
<td class="nump">6,009<span></span>
</td>
<td class="nump">6,462<span></span>
</td>
<td class="nump">6,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="num">$ (186)<span></span>
</td>
<td class="num">(218)<span></span>
</td>
<td class="num">(131)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target investment allocations</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target investment allocations</a></td>
<td class="nump">77.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Real Estate Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target investment allocations</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Private equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target investment allocations</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan | Hedge Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target investment allocations</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution', window );">Multiemployer plans, plan contributions</a></td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MultiemployerPlanPensionInsignificantPlanContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by multiemployer pension plan from all employers participating in multiemployer pension plan determined to be individually insignificant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 80<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877416&amp;loc=SL14450678-114947<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MultiemployerPlanPensionInsignificantPlanContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_RealEstateInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211324643512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation, beginning of year</a></td>
<td class="nump">$ 6,462<span></span>
</td>
<td class="nump">$ 6,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">168<span></span>
</td>
<td class="nump">$ 225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gain) loss</a></td>
<td class="num">(102)<span></span>
</td>
<td class="nump">413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefit payments</a></td>
<td class="num">(408)<span></span>
</td>
<td class="num">(358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement', window );">Settlements</a></td>
<td class="num">(53)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation, end of year</a></td>
<td class="nump">6,009<span></span>
</td>
<td class="nump">6,462<span></span>
</td>
<td class="nump">6,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Beginning balance</a></td>
<td class="nump">6,845<span></span>
</td>
<td class="nump">6,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="nump">215<span></span>
</td>
<td class="nump">783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefit payments</a></td>
<td class="num">(408)<span></span>
</td>
<td class="num">(358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets', window );">Settlements</a></td>
<td class="num">(53)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Ending balance</a></td>
<td class="nump">6,677<span></span>
</td>
<td class="nump">6,845<span></span>
</td>
<td class="nump">$ 6,395<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="nump">668<span></span>
</td>
<td class="nump">383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract', window );"><strong>Assets (liabilities) recognized on the consolidated balance sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Noncurrent assets reflected in other assets</a></td>
<td class="nump">946<span></span>
</td>
<td class="nump">744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities reflected in accrued expenses</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Noncurrent liabilities reflected in other long-term liabilities</a></td>
<td class="num">(250)<span></span>
</td>
<td class="num">(285)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Net assets</a></td>
<td class="nump">$ 668<span></span>
</td>
<td class="nump">$ 383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases benefit obligation of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract. Excludes decreases to benefit obligation for remeasurement due to settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(10)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanSettlementsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanSettlementsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211429991352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Costs (Details) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">$ 168<span></span>
</td>
<td class="nump">$ 225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(317)<span></span>
</td>
<td class="num">(388)<span></span>
</td>
<td class="num">(357)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Amortization of net actuarial loss</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1', window );">Settlement losses</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost (income)</a></td>
<td class="num">$ (186)<span></span>
</td>
<td class="num">$ (218)<span></span>
</td>
<td class="num">$ (131)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211323015688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract', window );"><strong>Assumptions used to determine benefit obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract', window );"><strong>Assumptions used to determine net benefit costs</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected long-term rate of return on plan assets</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211318312888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 6,677.0<span></span>
</td>
<td class="nump">$ 6,845.0<span></span>
</td>
<td class="nump">$ 6,395.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1,566.0<span></span>
</td>
<td class="nump">2,291.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3,837.0<span></span>
</td>
<td class="nump">3,231.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">378.0<span></span>
</td>
<td class="nump">343.0<span></span>
</td>
<td class="nump">354.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">5,781.0<span></span>
</td>
<td class="nump">5,865.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Cash and cash equivalents | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">60.0<span></span>
</td>
<td class="nump">118.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Cash and cash equivalents | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">97.0<span></span>
</td>
<td class="nump">81.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Cash and cash equivalents | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Cash and cash equivalents | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">157.0<span></span>
</td>
<td class="nump">199.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Debt securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1,223.0<span></span>
</td>
<td class="nump">575.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Debt securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">3,330.0<span></span>
</td>
<td class="nump">2,887.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Debt securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Debt securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">4,553.0<span></span>
</td>
<td class="nump">3,462.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. government securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1,223.0<span></span>
</td>
<td class="nump">575.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. government securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">36.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. government securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. government securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1,224.0<span></span>
</td>
<td class="nump">611.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">States, municipalities and political subdivisions | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">States, municipalities and political subdivisions | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">150.0<span></span>
</td>
<td class="nump">170.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">States, municipalities and political subdivisions | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">States, municipalities and political subdivisions | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">150.0<span></span>
</td>
<td class="nump">170.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. corporate securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. corporate securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2,458.0<span></span>
</td>
<td class="nump">2,006.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. corporate securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. corporate securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2,458.0<span></span>
</td>
<td class="nump">2,006.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">202.0<span></span>
</td>
<td class="nump">167.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Foreign securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">202.0<span></span>
</td>
<td class="nump">167.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Residential mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Residential mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">277.0<span></span>
</td>
<td class="nump">287.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Residential mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Residential mortgage-backed securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">277.0<span></span>
</td>
<td class="nump">287.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Commercial mortgage-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Commercial mortgage-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">76.0<span></span>
</td>
<td class="nump">83.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Commercial mortgage-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Commercial mortgage-backed securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">76.0<span></span>
</td>
<td class="nump">83.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other asset-backed securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other asset-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">162.0<span></span>
</td>
<td class="nump">133.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other asset-backed securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other asset-backed securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">162.0<span></span>
</td>
<td class="nump">133.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Redeemable preferred securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Redeemable preferred securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Redeemable preferred securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Redeemable preferred securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Equity securities | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">283.0<span></span>
</td>
<td class="nump">1,598.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Equity securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Equity securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Equity securities | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">283.0<span></span>
</td>
<td class="nump">1,598.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. domestic | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">201.0<span></span>
</td>
<td class="nump">1,046.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. domestic | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. domestic | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">U.S. domestic | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">201.0<span></span>
</td>
<td class="nump">1,046.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">International | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">81.0<span></span>
</td>
<td class="nump">537.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">International | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">International | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">International | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">81.0<span></span>
</td>
<td class="nump">537.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Domestic real estate | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Domestic real estate | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Domestic real estate | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Domestic real estate | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other investments | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other investments | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">410.0<span></span>
</td>
<td class="nump">263.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other investments | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">378.0<span></span>
</td>
<td class="nump">343.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other investments | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">788.0<span></span>
</td>
<td class="nump">606.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Real estate | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Real estate | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Real estate | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">378.0<span></span>
</td>
<td class="nump">343.0<span></span>
</td>
<td class="nump">$ 353.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Real estate | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">378.0<span></span>
</td>
<td class="nump">343.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">410.0<span></span>
</td>
<td class="nump">266.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">410.0<span></span>
</td>
<td class="nump">266.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Derivatives | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Derivatives | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Derivatives | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Derivatives | Total Fair Value, Inputs, Level 1, 2 and 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts, Equity Securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount', window );">Plan assets, investment within plan asset category, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts, Equity Securities | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount', window );">Plan assets, investment within plan asset category, amount</a></td>
<td class="nump">261.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts, Debt Securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount', window );">Plan assets, investment within plan asset category, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Common/collective trusts, Debt Securities | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount', window );">Plan assets, investment within plan asset category, amount</a></td>
<td class="nump">149.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Private equity investments | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">583.0<span></span>
</td>
<td class="nump">624.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Hedge fund investments | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">237.0<span></span>
</td>
<td class="nump">214.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Other receivables | Fair Value Measured at Net Asset Value Per Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 76.0<span></span>
</td>
<td class="nump">$ 142.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment within defined benefit plan asset category.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USStatesAndPoliticalSubdivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ForeignCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ForeignCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_RedeemablePreferredSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_RedeemablePreferredSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_EquitySecuritiesDomesticRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_EquitySecuritiesDomesticRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDerivativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDerivativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_PrivateEquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_HedgeFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211330285928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Beginning balance</a></td>
<td class="nump">$ 6,845<span></span>
</td>
<td class="nump">$ 6,395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Ending balance</a></td>
<td class="nump">6,677<span></span>
</td>
<td class="nump">6,845<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Beginning balance</a></td>
<td class="nump">343<span></span>
</td>
<td class="nump">354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld', window );">Actual return on plan assets</a></td>
<td class="nump">43<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements', window );">Purchases, sales and settlements</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels', window );">Transfers out of Level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Ending balance</a></td>
<td class="nump">378<span></span>
</td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember', window );">Real estate | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Beginning balance</a></td>
<td class="nump">343<span></span>
</td>
<td class="nump">353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld', window );">Actual return on plan assets</a></td>
<td class="nump">43<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements', window );">Purchases, sales and settlements</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels', window );">Transfers out of Level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Ending balance</a></td>
<td class="nump">378<span></span>
</td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DomesticCorporateDebtSecuritiesMember', window );">U.S. corporate securities | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld', window );">Actual return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements', window );">Purchases, sales and settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels', window );">Transfers out of Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Ending balance</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan from actual return (loss) on assets still held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)(A)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, measured using unobservable input, of increase (decrease) in plan asset of defined benefit plan from purchase, sale and settlement of trade associated with underlying investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)(B)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan, for assets transferred into (out of) Level 3 of fair value hierarchy. Includes, but is not limited to, transfer due to change in observability of significant inputs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)(C)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DomesticCorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DomesticCorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211322633480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2023</a></td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2024</a></td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2025</a></td>
<td class="nump">371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2026</a></td>
<td class="nump">368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2027-2031</a></td>
<td class="nump">1,776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Postretirement Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2022</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2023</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2024</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2025</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2026</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2027-2031</a></td>
<td class="nump">$ 60<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211335207848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Income Tax Provision (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 2,285<span></span>
</td>
<td class="nump">$ 2,615<span></span>
</td>
<td class="nump">$ 2,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">665<span></span>
</td>
<td class="nump">518<span></span>
</td>
<td class="nump">565<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current taxes</a></td>
<td class="nump">2,950<span></span>
</td>
<td class="nump">3,133<span></span>
</td>
<td class="nump">3,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(306)<span></span>
</td>
<td class="num">(450)<span></span>
</td>
<td class="num">(535)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(122)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income taxes</a></td>
<td class="num">(428)<span></span>
</td>
<td class="num">(564)<span></span>
</td>
<td class="num">(649)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">$ 2,522<span></span>
</td>
<td class="nump">$ 2,569<span></span>
</td>
<td class="nump">$ 2,366<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211335898840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss and capital loss carryforwards</a></td>
<td class="nump">$ 416<span></span>
</td>
<td class="nump">$ 568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">325<span></span>
</td>
<td class="nump">454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Income tax penalties and interest expense</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Income tax penalties and interest accrued</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">$ 121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">$ 669<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331194408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Effective Tax Rate Reconciliation (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Amount [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Statutory income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal tax benefit</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_HealthInsurerFeeTaxEffectPercent', window );">Health insurer fee</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness', window );">Basis difference upon disposition of subsidiary</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic', window );">Prior year refund claim</a></td>
<td class="num">(1.20%)<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">24.20%<span></span>
</td>
<td class="nump">26.30%<span></span>
</td>
<td class="nump">26.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_HealthInsurerFeeTaxEffectPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the tax effect of the health care reform's non-tax deductible health insurer fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_HealthInsurerFeeTaxEffectPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to disposition of a business not qualifying as a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to domestic income tax settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331162168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent', window );">Lease and rents</a></td>
<td class="nump">$ 5,563<span></span>
</td>
<td class="nump">$ 5,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventory</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation', window );">Employee benefits</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances', window );">Bad debts and other allowances</a></td>
<td class="nump">489<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss and capital loss carryforwards</a></td>
<td class="nump">416<span></span>
</td>
<td class="nump">568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred income</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves', window );">Insurance reserves</a></td>
<td class="nump">501<span></span>
</td>
<td class="nump">489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DeferredTaxAssetsPayrollTaxDeferral', window );">Payroll tax deferral</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">396<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(325)<span></span>
</td>
<td class="num">(454)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred income tax assets</a></td>
<td class="nump">7,497<span></span>
</td>
<td class="nump">7,774<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred income tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DeferredTaxLiabilitiesRetirementBenefits', window );">Retirement benefits</a></td>
<td class="num">(105)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesInvestments', window );">Investments</a></td>
<td class="num">(334)<span></span>
</td>
<td class="num">(421)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Lease and rents</a></td>
<td class="num">(4,947)<span></span>
</td>
<td class="num">(5,368)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(8,381)<span></span>
</td>
<td class="num">(8,750)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred income tax liabilities</a></td>
<td class="num">(13,767)<span></span>
</td>
<td class="num">(14,568)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred income tax liabilities</a></td>
<td class="num">$ (6,270)<span></span>
</td>
<td class="num">$ (6,794)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DeferredTaxAssetsPayrollTaxDeferral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Payroll Tax Deferral</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DeferredTaxAssetsPayrollTaxDeferral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Bad Debts And Other Allowances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DeferredTaxLiabilitiesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Depreciation and Amortization - Amount of deferred tax liability attributable to taxable temporary differences from depreciation and amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DeferredTaxLiabilitiesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DeferredTaxLiabilitiesRetirementBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Retirement Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DeferredTaxLiabilitiesRetirementBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred rent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211334732984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning balance</a></td>
<td class="nump">$ 768<span></span>
</td>
<td class="nump">$ 655<span></span>
</td>
<td class="nump">$ 661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions based on tax positions related to the current year</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions based on tax positions related to prior years</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions for tax positions of prior years</a></td>
<td class="num">(33)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="num">(111)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Expiration of statutes of limitation</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance</a></td>
<td class="nump">$ 782<span></span>
</td>
<td class="nump">$ 768<span></span>
</td>
<td class="nump">$ 655<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211318278024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Nov. 28, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 484<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued employee stock purchase plan (in shares)</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased', window );">Average purchase price of shares purchased (in dollars per share)</a></td>
<td class="nump">$ 60.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsandStockAppreciationRightsMember', window );">Employee Stock Options and Stock Appreciation Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation not yet recognized, period for recognition</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Compensation not yet recognized, options</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber', window );">Expected to vest (in shares)</a></td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvs_RestrictedStockUnitsandPerformanceShareUnitsMember', window );">Restricted Stock Units and Performance Share Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 404<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Compensation not yet recognized, other than options</a></td>
<td class="nump">$ 529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation not yet recognized, period for recognition</a></td>
<td class="text">2 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Vested in period, fair value</a></td>
<td class="nump">$ 406<span></span>
</td>
<td class="nump">$ 229<span></span>
</td>
<td class="nump">$ 265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights (SARs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized</a></td>
<td class="nump">60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant</a></td>
<td class="nump">31,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock percent</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cvs_CVSHealth2017IncentiveCompensationPlanMember', window );">CVS Health 2017 Incentive Compensation Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized</a></td>
<td class="nump">58,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant</a></td>
<td class="nump">30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cvs_AetnaInc2010StockIncentivePlanMember', window );">Aetna Inc 2010 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Capital shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Employee Stock Purchase Plan, Average Purchase Price of Shares Purchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsandStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsandStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_RestrictedStockUnitsandPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_RestrictedStockUnitsandPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cvs_CVSHealth2017IncentiveCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cvs_CVSHealth2017IncentiveCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cvs_AetnaInc2010StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cvs_AetnaInc2010StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211318241992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Valuation and Assumptions (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">1.34%<span></span>
</td>
<td class="nump">1.46%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">25.27%<span></span>
</td>
<td class="nump">37.21%<span></span>
</td>
<td class="nump">27.96%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.08%<span></span>
</td>
<td class="nump">0.81%<span></span>
</td>
<td class="nump">2.27%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 12.55<span></span>
</td>
<td class="nump">$ 13.85<span></span>
</td>
<td class="nump">$ 10.51<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">2.68%<span></span>
</td>
<td class="nump">3.42%<span></span>
</td>
<td class="nump">3.68%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">27.10%<span></span>
</td>
<td class="nump">25.22%<span></span>
</td>
<td class="nump">21.76%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.13%<span></span>
</td>
<td class="nump">0.61%<span></span>
</td>
<td class="nump">0.56%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 14.57<span></span>
</td>
<td class="nump">$ 8.78<span></span>
</td>
<td class="nump">$ 6.27<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211332240952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Restricted Stock Activity (Details) - Restricted Stock Units and Performance Share Units<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at beginning of period (in shares) | shares</a></td>
<td class="nump">14,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">6,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(5,448)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(1,236)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested at end of period (in shares) | shares</a></td>
<td class="nump">14,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted average grant date fair value (in dollars per share)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at beginning of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 58.12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">74.39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">74.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">63.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested at end of year (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 63.02<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_RestrictedStockUnitsandPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_RestrictedStockUnitsandPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211324807256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Incentive Plans - Stock Option and SAR Activity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received from stock options exercised (including ESPP)</a></td>
<td class="nump">$ 549,000<span></span>
</td>
<td class="nump">$ 264,000<span></span>
</td>
<td class="nump">$ 210,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes for net share settlement of equity awards</a></td>
<td class="nump">$ 168,000<span></span>
</td>
<td class="nump">88,000<span></span>
</td>
<td class="nump">112,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member', window );">Stock options granted through 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member', window );">Stock options granted subsequent to 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights (SARs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsandStockAppreciationRightsMember', window );">Employee Stock Options and Stock Appreciation Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received from stock options exercised (including ESPP)</a></td>
<td class="nump">$ 549,000<span></span>
</td>
<td class="nump">264,000<span></span>
</td>
<td class="nump">210,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes for net share settlement of equity awards</a></td>
<td class="nump">168,000<span></span>
</td>
<td class="nump">88,000<span></span>
</td>
<td class="nump">112,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of stock options and SARs exercised</a></td>
<td class="nump">105,000<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue', window );">Fair value of stock options and SARs vested</a></td>
<td class="nump">$ 224,000<span></span>
</td>
<td class="nump">$ 252,000<span></span>
</td>
<td class="nump">$ 467,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Outstanding at beginning of year (in shares)</a></td>
<td class="nump">23,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares granted (in shares)</a></td>
<td class="nump">3,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares exercised (in shares)</a></td>
<td class="num">(6,366)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Shares forfeited (in shares)</a></td>
<td class="num">(694)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Shares expired (in shares)</a></td>
<td class="num">(1,156)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Outstanding at end of year (in shares)</a></td>
<td class="nump">19,061<span></span>
</td>
<td class="nump">23,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, outstanding at beginning of year ($ per share)</a></td>
<td class="nump">$ 69.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, granted ($ per share)</a></td>
<td class="nump">74.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, exercised ($ per share)</a></td>
<td class="nump">63.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, forfeited ($ per share)</a></td>
<td class="nump">62.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, expired ($ per share)</a></td>
<td class="nump">87.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, outstanding at end of year ($ per share)</a></td>
<td class="nump">$ 71.74<span></span>
</td>
<td class="nump">$ 69.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average contractual term, outstanding at end of year</a></td>
<td class="text">4 years 9 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic value outstanding at end of year</a></td>
<td class="nump">$ 603,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares exercisable at end of year (in shares)</a></td>
<td class="nump">9,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price exercisable at end of year ($ per share)</a></td>
<td class="nump">$ 79.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term exercisable at end of year</a></td>
<td class="text">2 years 7 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value exercisable at end of year</a></td>
<td class="nump">$ 229,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Shares vested at end of year and expected to vest in the future (in shares)</a></td>
<td class="nump">18,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price vested at end of year and expected to vest in the future ($ per share)</a></td>
<td class="nump">$ 71.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term vested at end of year and expected to vest in the future</a></td>
<td class="text">4 years 8 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value vested at end of year and expected to vest in the future</a></td>
<td class="nump">$ 590,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Equity Instruments Other Than Options, Vested In Period, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsandStockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvs_EmployeeStockOptionsandStockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211335582840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Share Repurchases (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 09, 2021</div></th>
<th class="th"><div>Nov. 02, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember', window );">2021 Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining as of December 31, 2021</a></td>
<td class="nump">$ 10,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2016RepurchaseProgramMember', window );">2016 Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining as of December 31, 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=cvs_A2021RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2016RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=cvs_A2016RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211330287656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Accelerated Share Repurchases (Details) - 2021 ASR - Subsequent Event - Barclays Bank<br> $ / shares in Units, shares in Millions, $ in Billions</strong></div></th>
<th class="th">
<div>Jan. 04, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesAgreementAmount', window );">ASR agreement, amount | $</a></td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PaymentsForAcceleratedShareRepurchasesAmount', window );">Payments for ASR, amount | $</a></td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares', window );">ASR percent of notional amount received in shares</a></td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares', window );">ASR, maximum amount of shares received or delivered | shares</a></td>
<td class="nump">29.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Shares repurchased (in shares) | shares</a></td>
<td class="nump">11.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 103.34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram', window );">ASR, shares to be received at the end of program as a percent of notional amount</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchase Program, Maximum Number of Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AcceleratedShareRepurchasesAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases Agreement, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AcceleratedShareRepurchasesAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Percent of Notional Amount in Shares to be Received at End of Program</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Percent of Notional Amount Received in Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PaymentsForAcceleratedShareRepurchasesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Accelerated Share Repurchases, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PaymentsForAcceleratedShareRepurchasesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=cvs_A2021AcceleratedRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=cvs_A2021AcceleratedRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=cvs_BarclaysBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=cvs_BarclaysBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211317468456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Dividends (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Cash dividend declared (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent', window );">Quarterly dividends declared, percent increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableLineItems', window );"><strong>Dividends Payable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Cash dividend declared (USD per share)</a></td>
<td class="nump">$ 0.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividends Payable, Quarterly Dividends Declared, Increase Amount, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211323393768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Regulatory Requirements (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesLineItems', window );"><strong>Statutory Accounting Practices [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired', window );">Estimated minimum statutory surplus required by regulators</a></td>
<td class="nump">$ 7,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldByInsuranceRegulators', window );">Investments on deposit with regulatory bodies</a></td>
<td class="nump">794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval', window );">Estimated maximum dividend distributions permitted in 2022 without prior regulatory approval</a></td>
<td class="nump">2,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=cvs_InsuranceAndHmoMember', window );">Insurance and HMO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesLineItems', window );"><strong>Statutory Accounting Practices [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount', window );">Combined statutory net income</a></td>
<td class="nump">3,302<span></span>
</td>
<td class="nump">$ 3,667<span></span>
</td>
<td class="nump">$ 2,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance', window );">Combined statutory capital and surplus</a></td>
<td class="nump">14,879<span></span>
</td>
<td class="nump">$ 13,238<span></span>
</td>
<td class="nump">$ 10,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries', window );">Dividends paid</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldByInsuranceRegulators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of cash and investment securities on deposit with state regulatory authorities in connection with capital requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123600598&amp;loc=SL75763979-209797<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldByInsuranceRegulators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents disclosure of the aggregate cash dividends paid to the entity by consolidated subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of dividends that can be declared or paid without approval of regulatory agency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net income for the period determined using accounting principles prescribed or permitted by insurance regulators.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cvs_InsuranceAndHmoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cvs_InsuranceAndHmoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211329498536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Noncontrolling Interests (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">$ 306<span></span>
</td>
<td class="nump">$ 312<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211322721944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="nump">$ 64,170<span></span>
</td>
<td class="nump">$ 69,701<span></span>
</td>
<td class="nump">$ 64,170<span></span>
</td>
<td class="nump">$ 58,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(449)<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="nump">917<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,381<span></span>
</td>
<td class="nump">69,701<span></span>
</td>
<td class="nump">64,170<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Net unrealized investment gains (losses)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="nump">774<span></span>
</td>
<td class="nump">1,214<span></span>
</td>
<td class="nump">774<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(410)<span></span>
</td>
<td class="nump">415<span></span>
</td>
<td class="nump">763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="num">(86)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(436)<span></span>
</td>
<td class="nump">440<span></span>
</td>
<td class="nump">677<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">778<span></span>
</td>
<td class="nump">1,214<span></span>
</td>
<td class="nump">774<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before Reclass, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(489)<span></span>
</td>
<td class="nump">497<span></span>
</td>
<td class="nump">927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(158)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">154<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Net cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="nump">279<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before Reclass, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Amount expected to be reclassified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Pension and OPEB plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from accumulated other comprehensive loss, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">OCI before Reclass, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified, pre-tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">AOCI Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Changes in Accumulated Other Comprehensive Income (Loss) by Component</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning of year balance</a></td>
<td class="nump">$ 1,019<span></span>
</td>
<td class="nump">1,414<span></span>
</td>
<td class="nump">1,019<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">End of year balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 965<span></span>
</td>
<td class="nump">$ 1,414<span></span>
</td>
<td class="nump">$ 1,019<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211322888152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumeratorForEarningsPerShareCalculationAbstract', window );"><strong>Numerator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">$ 7,898<span></span>
</td>
<td class="nump">$ 7,201<span></span>
</td>
<td class="nump">$ 6,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted', window );">Income allocated to participating securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to noncontrolling interests</a></td>
<td class="nump">12<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income from continuing operations attributable to CVS Health</a></td>
<td class="nump">$ 7,910<span></span>
</td>
<td class="nump">$ 7,188<span></span>
</td>
<td class="nump">$ 6,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_DenominatorForEarningsPerShareCalculationAbstract', window );"><strong>Denominator for earnings per share calculation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares, basic (in shares)</a></td>
<td class="nump">1,319<span></span>
</td>
<td class="nump">1,309<span></span>
</td>
<td class="nump">1,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares, diluted (in shares)</a></td>
<td class="nump">1,329<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
<td class="nump">1,305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings per share from continuing operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Earnings (loss) per share from continuing operations, basic (USD per share)</a></td>
<td class="nump">$ 6.00<span></span>
</td>
<td class="nump">$ 5.49<span></span>
</td>
<td class="nump">$ 5.10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Earnings (loss) per share from continuing operations, diluted (USD per share)</a></td>
<td class="nump">$ 5.95<span></span>
</td>
<td class="nump">$ 5.47<span></span>
</td>
<td class="nump">$ 5.08<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of EPS (in shares)</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_DenominatorForEarningsPerShareCalculationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Denominator For Earnings Per Share Calculation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_DenominatorForEarningsPerShareCalculationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumeratorForEarningsPerShareCalculationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Numerator For Earnings Per Share Calculation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumeratorForEarningsPerShareCalculationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211329395208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reinsurance - Narrative (Details) - Subsequent Event<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jan. 31, 2022 </div>
<div>reinsurance_agreement</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberofReinsuranceContractsEnteredInto', window );">Number of reinsurance contracts entered into</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer', window );">Four years reinsurance agreement with unrelated insurer</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This line item represents the four years of a reinsurance agreement with an unrelated insurer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberofReinsuranceContractsEnteredInto">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reinsurance contracts entered into with an unrelated insurer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberofReinsuranceContractsEnteredInto</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211330207592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Reinsurance - Reinsurance Recoverables (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Total reinsurance recoverables</a></td>
<td class="nump">$ 2,549<span></span>
</td>
<td class="nump">$ 3,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskAxis=cvs_HartfordLifeAndAccidentInsuranceCompanyMember', window );">Hartford Life and Accident Insurance Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Total reinsurance recoverables</a></td>
<td class="nump">1,887<span></span>
</td>
<td class="nump">2,364<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskAxis=cvs_LincolnLifeAnnuityCompanyOfNewYorkMember', window );">Lincoln Life &amp; Annuity Company of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Total reinsurance recoverables</a></td>
<td class="nump">395<span></span>
</td>
<td class="nump">406<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskAxis=cvs_VOYARetirementInsuranceAndAnnuityCompanyMember', window );">VOYA Retirement Insurance and Annuity Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Total reinsurance recoverables</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskAxis=cvs_AllOtherReinsurersMember', window );">All Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededCreditRiskLineItems', window );"><strong>Ceded Credit Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses', window );">Total reinsurance recoverables</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 115<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, policy benefits and policy reserves. Excludes premiums paid under reinsurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21409-158489<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123600520&amp;loc=SL75241803-196195<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=cvs_HartfordLifeAndAccidentInsuranceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=cvs_HartfordLifeAndAccidentInsuranceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=cvs_LincolnLifeAnnuityCompanyOfNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=cvs_LincolnLifeAnnuityCompanyOfNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=cvs_VOYARetirementInsuranceAndAnnuityCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=cvs_VOYARetirementInsuranceAndAnnuityCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededCreditRiskAxis=cvs_AllOtherReinsurersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededCreditRiskAxis=cvs_AllOtherReinsurersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331288984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reinsurance - Effects of Reinsurance (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract', window );"><strong>Premiums Earned, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DirectPremiumsEarned', window );">Direct</a></td>
<td class="nump">$ 76,320<span></span>
</td>
<td class="nump">$ 69,711<span></span>
</td>
<td class="nump">$ 62,968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssumedPremiumsEarned', window );">Assumed</a></td>
<td class="nump">492<span></span>
</td>
<td class="nump">478<span></span>
</td>
<td class="nump">2,108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CededPremiumsEarned', window );">Ceded</a></td>
<td class="num">(680)<span></span>
</td>
<td class="num">(825)<span></span>
</td>
<td class="num">(1,954)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Net premiums</a></td>
<td class="nump">76,132<span></span>
</td>
<td class="nump">69,364<span></span>
</td>
<td class="nump">63,122<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract', window );"><strong>Policyholder Benefits and Claims Incurred, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross', window );">Direct</a></td>
<td class="nump">64,414<span></span>
</td>
<td class="nump">56,077<span></span>
</td>
<td class="nump">52,592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed', window );">Assumed</a></td>
<td class="nump">398<span></span>
</td>
<td class="nump">329<span></span>
</td>
<td class="nump">1,562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded', window );">Ceded</a></td>
<td class="num">(552)<span></span>
</td>
<td class="num">(727)<span></span>
</td>
<td class="num">(1,625)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet', window );">Net benefit costs</a></td>
<td class="nump">$ 64,260<span></span>
</td>
<td class="nump">$ 55,679<span></span>
</td>
<td class="nump">$ 52,529<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssumedPremiumsEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of earned premiums assumed from other entities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssumedPremiumsEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededPremiumsEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of earned premiums ceded to other entities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column C))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84167274&amp;loc=d3e27175-158546<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededPremiumsEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectPremiumsEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectPremiumsEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of policy benefits and costs incurred for policies assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reduction of provision for policy benefits and costs incurred for policies ceded.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211329997752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2012 </div>
<div>member</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>lease</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Guarantor obligations, maximum exposure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts', window );">Contractual obligations underlying the guaranteed benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_GuarantorObligationsNumberofLeases', window );">Number of leases guaranteed | lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_LossContingencyAuditMethodologySampleSize', window );">Audit methodology sample size | member</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_RadcliffAndFlaimVAetnaIncEtAlMember', window );">Radcliff and Flaim v Aetna Inc., et al | Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of claims | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the contractual obligation to maintain the required level of funding in Separate Accounts necessary to fund specific guaranteed pensions annuities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_GuarantorObligationsNumberofLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Guarantor Obligations, Number of Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_GuarantorObligationsNumberofLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_LossContingencyAuditMethodologySampleSize">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Audit Methodology Sample Size</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_LossContingencyAuditMethodologySampleSize</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_RadcliffAndFlaimVAetnaIncEtAlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_RadcliffAndFlaimVAetnaIncEtAlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211331357608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Narrative (Details) - Segment<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cvs_USFederalGovernmentMember', window );">US Federal Government | Customer Concentration Risk | Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percent</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cvs_USFederalGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cvs_USFederalGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211322801752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">$ 290,912<span></span>
</td>
<td class="nump">$ 267,908<span></span>
</td>
<td class="nump">$ 255,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">1,199<span></span>
</td>
<td class="nump">798<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">292,111<span></span>
</td>
<td class="nump">268,706<span></span>
</td>
<td class="nump">256,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">17,312<span></span>
</td>
<td class="nump">16,008<span></span>
</td>
<td class="nump">15,339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,512<span></span>
</td>
<td class="nump">4,441<span></span>
</td>
<td class="nump">4,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">81,515<span></span>
</td>
<td class="nump">74,926<span></span>
</td>
<td class="nump">68,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">586<span></span>
</td>
<td class="nump">483<span></span>
</td>
<td class="nump">599<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">82,186<span></span>
</td>
<td class="nump">75,467<span></span>
</td>
<td class="nump">69,604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">5,012<span></span>
</td>
<td class="nump">6,188<span></span>
</td>
<td class="nump">5,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,837<span></span>
</td>
<td class="nump">1,832<span></span>
</td>
<td class="nump">1,721<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">143,194<span></span>
</td>
<td class="nump">132,663<span></span>
</td>
<td class="nump">130,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">153,022<span></span>
</td>
<td class="nump">141,938<span></span>
</td>
<td class="nump">141,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">6,859<span></span>
</td>
<td class="nump">5,688<span></span>
</td>
<td class="nump">5,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">576<span></span>
</td>
<td class="nump">612<span></span>
</td>
<td class="nump">766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NetRevenuesRetailCoPayments', window );">Co-payments</a></td>
<td class="nump">11,600<span></span>
</td>
<td class="nump">10,900<span></span>
</td>
<td class="nump">11,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">66,078<span></span>
</td>
<td class="nump">60,208<span></span>
</td>
<td class="nump">56,258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">100,105<span></span>
</td>
<td class="nump">91,198<span></span>
</td>
<td class="nump">86,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="nump">7,623<span></span>
</td>
<td class="nump">6,146<span></span>
</td>
<td class="nump">6,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,884<span></span>
</td>
<td class="nump">1,801<span></span>
</td>
<td class="nump">1,723<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="num">(43,923)<span></span>
</td>
<td class="num">(40,323)<span></span>
</td>
<td class="num">(41,439)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(43,923)<span></span>
</td>
<td class="num">(40,323)<span></span>
</td>
<td class="num">(41,439)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="num">(711)<span></span>
</td>
<td class="num">(708)<span></span>
</td>
<td class="num">(697)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Pharmacy Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">9,828<span></span>
</td>
<td class="nump">9,275<span></span>
</td>
<td class="nump">11,063<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">34,010<span></span>
</td>
<td class="nump">30,990<span></span>
</td>
<td class="nump">30,350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate/ Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues from external customers</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentIncome', window );">Net investment income</a></td>
<td class="nump">596<span></span>
</td>
<td class="nump">315<span></span>
</td>
<td class="nump">412<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">721<span></span>
</td>
<td class="nump">426<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income (loss)</a></td>
<td class="num">(1,471)<span></span>
</td>
<td class="num">(1,306)<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 215<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
<td class="nump">$ 161<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NetRevenuesRetailCoPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Revenues, Retail CoPayments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NetRevenuesRetailCoPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_PharmacyServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140211323539064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>store</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>store</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>store</div>
</th>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (GAAP measure)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,193,000,000<span></span>
</td>
<td class="nump">$ 13,911,000,000<span></span>
</td>
<td class="nump">$ 11,987,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,259,000,000<span></span>
</td>
<td class="nump">2,341,000,000<span></span>
</td>
<td class="nump">2,436,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Acquisition-related integration costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,000,000<span></span>
</td>
<td class="nump">332,000,000<span></span>
</td>
<td class="nump">480,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,358,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">231,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">431,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod', window );">Acquisition purchase price adjustments outside of measurement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(61,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">(Gain) loss on sale of subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(269,000,000)<span></span>
</td>
<td class="nump">205,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries', window );">Receipt of fully reserved ACA risk corridor receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(307,000,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_AdjustedOperatingIncomeLoss', window );">Adjusted operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,312,000,000<span></span>
</td>
<td class="nump">16,008,000,000<span></span>
</td>
<td class="nump">$ 15,339,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfStoresPlannedClosure', window );">Number of stores, planned closure | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">840,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember', window );">U.S. Department of Health and Human Services, ACA Risk Corridor Receivables | Settled Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainContingencyUnrecordedAmount', window );">Gain contingency, unrecorded amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 313,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax', window );">Former gain contingency, recognized in current period, before tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember', window );">Retail/ LTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_StoreImpairmentCharges', window );">Store impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 431,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_NumberOfStoresPlannedClosure', window );">Number of stores, planned closure | store</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember', window );">Health Care Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod', window );">Receipt related purchase price adjustment from acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember', window );">Coventry Health Care Workers Compensation Business | Health Care Benefits | Discontinued Operations, Disposed of by Sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">(Gain) loss on sale of subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(269,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of subsidiary</a></td>
<td class="nump">$ 850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_AdjustedOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted Operating Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_AdjustedOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Purchase Price Adjustment, Outside of Measurement Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Former Gain Contingency, Recognized in Current Period, Before Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_NumberOfStoresPlannedClosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Stores, Planned Closure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_NumberOfStoresPlannedClosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Receipt from Business Combination, Purchase Price Adjustment, Outside of Measurement Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvs_StoreImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Store Impairment Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvs_StoreImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in allowance for credit loss on accounts receivable, from recovery.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainContingencyUnrecordedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount or range of possible amounts of gain that could be realized upon the resolution of a contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6397426&amp;loc=d3e17499-108355<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainContingencyUnrecordedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_RetailLongTermCareSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvs_HealthCareBenefitsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cvs_CoventryHealthCareWorkersCompensationBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>cvs-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cvs="http://www.cvshealth.com/20211231"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cvs-20211231.xsd" xlink:type="simple"/>
    <context id="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie5e000b7c7ed4445a36ad3eb67d14356_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic767c69faf834e03aae3c9e3cc80734e_I20220202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2022-02-02</instant>
        </period>
    </context>
    <context id="i5b1c494708b64508a432d97a589ec1b1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iad0aae9c9f234ff9a73812a8299c6fe2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i04aed4c0666b4206a0f62a98a13ff94d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7c0970400e154d55993f70f521cd55da_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icb864d41b1c444a2a00ada6c841fd965_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0e3c699aa82e4cebaf12b6a7d6a6a99f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibbd44c67114d44b491ec9aec28225e15_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic9bbc3798d714a95928e301134f0a8b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i23e34e947aac44fc9f5cf5448f94f452_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i13739c11655d4b66b619ac881014f765_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i33c39d0d9ba54e4b907a2d6936ea45ca_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iec75ad30e89c49a4bfce46bec785eb96_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i0f466365cbeb46d881db045c29a1ef18_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia28cc8e6f81b4b99804fb1a37a6048e6_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id2ef6efbc0d84de58ef5fd7542800f18_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i0431fdd1f66940e9b1962a8525277501_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i922cc6127555413782578a7efd08aea4_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id8eb6b30d69b40b48d66138c22c9b950_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id5b7f3560a474273bad7b3d0ff254e29_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ia4a48ec7199f497a8e3d91de1ccd3577_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie160f6b16d2b416d8f1acb180ba3d07c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i20b0b671c0474c61b1511d61c0def2a5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaae61e2a7f494d8ea336357a3fa3676f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i025b485e66244023b72a2a031c0188ef_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i216fe0b6c7d94b40ad7a901f182062ef_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if9ef2fb7202d49dbab738960740d4b6c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id1f119b7cdb141be93131047a1d79f5b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieefff43749444070a945dbf9c2df4d4e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i198e53fbfa9d4d0aa17e97121db6bb9b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3debde841b1842a2a969406ff590b5d4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i10cfae3f6a64475c8d6390a56c1755b4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0f936984dd7642f09c851e2ced784e3a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if3d706b6763848048a19f678eed0d6c4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9e7cde5c47fe423a9685bba813200907_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id5e60c7959e643d6be2a8ad6547a16ce_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3054d32553d24d498f6e64626c62c7e4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia9b253e4431e4506b41e93b4e3ffbff3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i521bf812b8ca4f2f8127d65ed79ea126_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieb94485c24fb48c8b7669be4b0fc8159_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0b3e30b3db154240b2043b0ca843e316_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3850625417ca4ca39a069dd8c4de7097_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id7cf273211e3434f968bd606d4a81280_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i41a840db4ee84036b3bbb93303320613_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibd578f81db5a45f1bc8d5b32e6e26a16_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6be5d7176aa0457288fec9de68e4d419_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i929ccc146bfa424592ecfc18373af370_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb577f06e3b04c518c1c4543d6ddf983_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i79a394a32aeb4c939df5cb7fd7e0d46f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if386c5ae7c994951b21ec945131fa3c6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0e4d5f3f2aa745b6b9ea7a35265f341e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i85992156090b4f72a932455b1978952b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7770de66bbf94051817d87cf6240655a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3a4a4ed30a054247bfaad062f649f9ee_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id62e90e3302f484ca4017d1a85b7a1ff_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4eb317bccff647f6823df9e9b149c181_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i45641c304daa44c9bd1f3c9070317105_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic1c4532731df4ec9acf2bba885ccbc0b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie84ce40f593a4f1b8e95de37fcec950f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i71a1c12ec5c146a387fb13e1ae8a699c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i66a5573b2fbd4cec83bc9c6bed71ef29_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic88e5b2354294af7a046754ddfa0a46d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i61119d4aa25b44fb9ab0ce32bfac9893_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if9bf280de01e423da0805c5548da8598_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f46c0fc299d40469a5d7302133c63f1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i59754cbac5c049eeafbc35f207330f42_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i4b779e18acc147f29614409a3ae3a1e2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia694d76108a14467a887dab2055e6ad0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7310250aa7db49e5bb0700f9d3b0c92b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idf62411f04644ec5a62a251e4c8f705a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaa2dfaae047842b6941420922ac5d9c3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9d5000b271614c1d855c110b625f929b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib812c723ed9c436d8f87f4410c352090_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cvs:FixturesEquipmentAndInternallyDevelopedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i485bcdbe665a4e4cbd15d510c347723d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">cvs:FixturesEquipmentAndInternallyDevelopedSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i11f43eb2bc384595bbbc2dc60fb0e429_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iab960c5fc78c435185612e456997735f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb17dc7419794c27a906e798d28163ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3d5a1e36661d4e01b93add403e998d55_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie95f04d20e7d4540beba10c465fb945c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i220afc16aa4243638833bb1917d74494_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i06c0e02c68194f43b7f9e96b2667ef52_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i334820a07cbd4de3a8b8dc2ef2625448_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i01b95bc53d324e16ab4248f13d4f4b5d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7b10e7dd209b41c8afef5d331b8732be_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i73df28e0580843f0af8aec248d34934d_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2f08d731825c4986934a5374bd021d17_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0b5082eb85c041ac945f01d6bc51973d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i66d7d53744704d0d935a2fefbe9f6853_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2350df645dc04e808a96e20dad3a3fba_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7f4611487c414f69acafa1f966054637_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ic8b00a5656814734a6bb268b8e3ca5ce_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia549907bd80b4d05927cab95ed27791d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherInsuranceLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if864780575b94e94ab5aaeb609bdc2fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherLongTermInsuranceLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7923496932ec4872a3aac9f738db85f9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherInsuranceLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6b4429ac745c44638a7414f5ff8d6894_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">cvs:OtherLongTermInsuranceLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if6a4e820cff84a708a34d9940c913923_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i45c5b8fb4d364022b20880618cc963ec_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7e7c0dce760d47df841954664e69c360_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i92c848c1cac74063a225275fcd16ac3e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:BrazilSubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4498de5248d54d40afb291f1fc098731_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic1002f99fed94f288ca5f74eedbdeab1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iebcc3ed38ad2471582d090e796d7ce3b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3fef8cff035c4c69a8c38c9106be1c8d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7c932f46423b4eb0b5ffe12d1cb5e4f7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i58bb9dd9de57438c8823cb7f0f5b7456_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6ddd2583249240ab9fd8716ea50815be_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i62292b173722422f93bc0d15e20388ff_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if247a044060a414a9731ef3f633443ec_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0ed9316414794c62b549ee70109c3a1c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia48e9a22e1fd4d718486619d4e3719f1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie803710aa3d14d08b76f31d1d981933a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8d061d240a9e43d88eb56b03b4b1c305_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5762aa2abba7409a8044131daa10dbbe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8f9354e553ba4e88889df599c49592a9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i42258aba1f3844c79f036592fd2314f6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ief81cfdad9484af6b31eff5e1128145b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6e052765fbe5467a80a1782764372f99_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9d8f78677d6943988b31d555638bbaf9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2301583729e7424597c39ac7978d0401_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7f0540b87ed34aee812a4602f32b0fb6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4344db6c31344de2b14b66847d6c28a3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i77576c1c65984cc3b50354c3450129d5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibc537d99f46e4ee089fc01dc7844328e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i071a8d3987fb4484affa36468d188f51_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6f2f0ce0e931416b9534dcfd36624ed0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3b8deab908c04d898d7365d0a57ffc0b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i45a45ada9f7246c3b344e458342767f2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i61039a6c4f3941c78fea069998c3b394_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1ffa587016394b5784b3a8591967b741_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7055234871404d9bafa8741c06125a63_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1cdd84a2122f4e48bd7e94aa5a543fc7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i248dfcc1ff5a4287a22a16423cabbfd0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i21ddaf2aa6974aadb1b64f7b7a5257ea_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iab97b765af4e49ffad5046609f678a8f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4fe7b82658e94a3fb768194bb39484ab_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic786c87383ae4399b318ad961ecca522_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ide7ebc79d9a54efb884b6972df58c788_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7dffb1a91abc47afa1350fc6dd222a18_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7a337ef5a1564ee49dd9f743f426f9c9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic10b456383584d7aaf8f683720fcb914_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id140f9f8dcd14083b50ec69d7cbc65da_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0c6cb5365a9c4dfe9062cee2d3a679f4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia41f6d7659764a9394360d2e7ea49f1d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib84692036a6a43eea3efda3fce3a9e9d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id67aa7e2958543c5b2a212d2e9f5ce6f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4f1ba091cd86434eb258ca50211e3939_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic31dfa14042e414482c4216963d92547_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i76be16bc9f6249b9b235ac3756529601_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i53db5e5b0b444479a8a8759dbf521388_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia854c1c4120946f68b69cb19bc260e4b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7e61340f47284992812b376b1458946d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iccc3d52c70ae4beeabf495e0d535c807_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie27ebf5be86d42d08d5b00b28a499bb0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i52561c6040014302a3dbd0c238d7e542_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia1e0f32f6d3d4988bc853318d22b23fd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic465100ccba348a3afd34c383000632c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0249f41894f841a6b7dafe5cbba83478_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i14fe0625f7df490f81964160bf26ed60_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icaaa14ca219c45319101f3294251d63b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i447cc1b65f104221ab26818c3ed22faf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic21b7b1b632e49739aa4555420878cbf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8af99e3f8f9947f49861abe488bdd637_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i012def96350649cfbe7d7eb9602d64e1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9001e42259074da8941f556efd30f660_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i966eb89f8da54934ba00320af7713451_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i157fcde113c546639a94d73e35c8837f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib92544612b6649778126fe8e9ab6e9b6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PharmacyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifa6bf06bf5cd4d70ac02de5a1d25d970_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9fa3db576bc34c4b81beaf1e716f51d7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib11ea18304ed4f7cab2400be338b0bf5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i75513592809349c7a84c02e527ec7282_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i56591423c17340e982228082d680b5f2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2fb12e17ce2a48c9b260a608e997c399_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:FrontStoreRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib775f94073ab4897a08bc1477642f227_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i87a4d0a1226941d4b0d276cb76e9483e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibe2fbb48419543c3b63c3ed144b5a10f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i26af9cce866f4682bb01349800a2150e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifba04a8e07ae4647988ad6d2b6bf1364_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icfe3ddb6c3a34749a2820654200c6a8c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:PremiumsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7683c6a5bd9a46859b7c36e87aefa23f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id7a9899058b146b98d338385726b8c33_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0059ff87fc364aec80f3c7eef6a97f6a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaa96e65bf6294c0ca787cbef203ccb23_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic17eebf2b4964519a5671bddafa2ecae_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie4d27cdb62c44a25a61a4be0d895fc4c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3037e334694c4257a0adcaa55fac67f7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie27c33f5643f48a6ab725eac74707192_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1a078bd350664f23bfb042a07d7c28aa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id33fc8f7a4874100ab8c405e4632eb30_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i054efc215dfa4b1fa92da514a6fad49b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i55c01612bdda4f1bb914815afe3bbf95_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i72491a4fae084225942f973da304ba25_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i76238069608f4813b8d2ac5bfe67dae8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvs:SalesChannelOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5d8804cf6abb4698a6a8f6b7fc6e7b28_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="i78a023c8e08447dd9462aefe43f9ffb4_D20201022-20201022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-22</startDate>
            <endDate>2020-10-22</endDate>
        </period>
    </context>
    <context id="i55877e993992468ea1377ad4577db051_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifed7853cc1c344298bd8003d3174178b_D20140101-20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cvs:RedOakMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="i5565b4e7fc4f4e8aa341da7b6e4e4d86_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cvs:RedOakMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i50b4460d87d840bbaafccbc86903992c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1711347a62744966b4e74fee52b0bae9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i064ed72a7c7d4834b6d490201f178cc6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i440e6a46ec8f4ce48ae8a4a7e478b725_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2d327db9f7284c37b77bcfaebbe9509a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f571724a5864c5596b142666580c1a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:RealEstateFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibbf81618e0074484b1b2cd8ceee6f5d3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia2865e7a41644a8186918f7b00a1a60d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9bc52b3acf264acbbaa97645df36b813_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:HeartlandHealthcareServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic3bfdde04dbf4f498310d896a5a94507_D20200731-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-31</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i707e6377bc8f46819c6e330be95da61e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:CoventryHealthCareWorkersCompensationBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic78da50417e849b5a59cd5089920fa13_I20190701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:BrazilSubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-01</instant>
        </period>
    </context>
    <context id="i7fd8613bfc0d4364b6e49aa6a8b2d288_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cvs:DrogariaOnofreLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if05932426083419b815e008b577a2a15_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idce08b4519f44779aca159357248a636_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:DebtAndEquitySecuritiesAvailableForSaleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i05f36709bd8949388b2c0bffca648d32_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifa3a2978a5aa4a7f8e4552df2eb04ad5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i22a8dacd69894d99a9e39bcc2ceaa8c3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i43542666d6064074a52d8421444a3563_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cvs:TotalInvestmentsAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id321828fa20f46e2b90c44c7dba1e761_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i73c392053811482a985a060e47a06d01_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaf0593d9cf6f4d2d998803704f53be46_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib6d4dcde819446d8a73300389b73166e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i914670b585864902b9f69fc74ba23aec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia121561a4c96461ebf10b737edd09fd8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iea2a9101cbed443999a6811800e4ec0b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i747eaf1c298249988bd0ca02e9600501_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ice38ed4258344c1a88da2935b0835f1e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i51538ba2863d4a39bc671cc6ee1872c4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i46e1d222a5ef406c92305c7baf40a7d4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3554a3796746414fb74d5c4eff0aa6b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i77885636f2644bf19423ab2c4b27960a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4de919088b4a4df583b8260319c32ee6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4a167c8b5fbe46be92df6070dc1ae32b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i353376cd927a4bd89775bb7b09c7be82_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6d5babc8be6a447486746fada4d351b2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i13b5f509cde24908a226440920b1a447_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id9b4c5764cb743b6955c25b489dc04b1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1ba594078fe94f1fb02a07e79c808914_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib7cf85e44bf749c6855a45cc29a5d06c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib4529e06963a470caeb617df5697e606_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i33ae4ceb49244377b0e406cc7280c9f4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib6aa7bf1b9da4fc39d8638e04992a04e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5690dfe9c84946ccbe72c9f299796db2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i094255554a304e7eb4a00d380e2496bd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingRemainingProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i81f297d193504b64a77dc2ee3da88ccb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i62d2db3895b440f7a78f511f11dee508_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i236369a8589648caae4e40a4994ea5c7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if75d546f79f443b2b493051643070b9d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d3bdf971c2e453aaac23e35b5bfcece_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3f9e513cbe72495ebcf4e63dba757063_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if9e730fea2f548c28423a0d3c0b5d6d4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2b3b6d3e1f854783ab31e0f74ac19914_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i16a55dfb514944cebf081afcdb79c176_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i43d06180041f4758a6cd666c4e52ac41_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idd01e0aad9534804950ee3b5c49b699a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ide4fcc1c4d10426e82ac1562b152a03f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1a11e2f0c8864c3a835f65250185e431_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i86f7b3a22ee74b3b99c1724212e5f620_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f64507e6bfd4e3c94c4e571436f0709_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if4d761a33dad484ab0489a71620aac4c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iec0a30bbded74a4a87b264a68da01b48_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4bf8902ea23448c6aa2a6cdd04056a11_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia5bd4e5698b542e1afdf687466e73faf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i656346f8e3fc48149bc198665aa2ba23_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i214cd12a886b42369217bf01fba03479_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8250607938c048e5bfa38afa06687ac7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i53a9e1cc311f4d7389a00b2614f65e4a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id5eb557f297b45a983e00f3a6ebabbc0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id98e3f5681054b74aee1fe95b47cec5d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iac455272570c46e5ba3c2c051f9dd18b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4798911f466146f6a09993eaa2849e0e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5cac87f1a93a493b810d93704fdee5ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i954fdd1992694dc7a1ffada1f90479f7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifb149f2594e24e5e9608148da07fdd9e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9366cbf54d89424ea99dd1bf935c263f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iee791b6d216a4e52ba8577e512aefe77_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie04adbbb84d840c68db8746ae5c2ec4e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib4c1fa1e1f5b4cfab3344b2360bda448_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic220147cd8734098b32bf1e587f1066f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2b1552ff84a14d329639fbcf910ccda7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if07ab5ed5fe44735bee0f7db6106013d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7cfce5629c994ec789d3036601d70793_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i72e8544f389d4c46a1811d3a41ccd343_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8c04a5353793424ea6dd4c537d171bfd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9debbd88735e4e51b8568db394038442_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5bb90e71f4ce4742b80486f33e02cf5e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i366b9b5ee8aa4b6f97820e04b932038c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iccf3cac287074066895d1a02163e6ea5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i96d87ac36ba5416ebb4aef216fdd2adb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i97c3ee33af8444709579e3a43a1b8ab6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0377da301945465092de5eaea76ac47d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i62b02d0505564979b7eca3037be36f23_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7997178cc177444ea3249f37548ee4e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category2To4Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i70079745684b497bb807ab287dd604b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8e1919b277f44b2fb842c59d94d1425f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6701a00e113f4e5498744bb48caecc5f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7fad7dcab3954d96965b1614328749b8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic031473f406049eeab488d7910cbe99c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0a49286ac2764f6c960b95c3ff551ef9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Categories5and6Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i92c71ec3b83541a1aff2732364f1942b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ief0401c6d4364a2d91dc94d588b6675b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d7e2c257e7e410baa65d8db69f23863_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia6c586309d7344cca6910ecd0006b772_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i19b89cce7eda4f3faf261107006bca5d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i60dd9ff415cf4307be34d85ab7b5fd40_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InternalCreditAssessmentAxis">cvs:Category7Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic8aa576e20ec407ba27840a430d3d8d0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia63d6c6f272f4145a25f9f7581ceda3e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1e137b6416194b0c80702e6ccaf7cd12_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i450ae32012bd4a4da4f68d20e1c51dc6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i028a59a7a3bf4c1285313639042fd9a5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cvs:MortgageLoansOnRealEstateYearOfOriginationAxis">cvs:YearOfOriginationPriorToPeriodFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0f32471feded4c178b2f2c05cebf159d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">us-gaap:CommercialRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i05fb3cf4bea94dcd9507a7f609bba804_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib8da629000164e189d42edeb512f786e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibce5743406e44d979a44db538128707d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i41b25c02378c46c99b73c18360004c60_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8c71ab108d124b2fb04b4be93eea1a95_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9edfca3af9614ff38ae3dda45b1fe0d3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">cvs:MortgageLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i24d0c995b652444da95a99ac0befe361_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieebeaa16b5e7407db27c743c37fe3062_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia48569365a5049b89c3839c388ba8841_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ieed51d61b0d54c6086fdef46e9dc9295_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id1746900c4bb4eee8150b6ee721d8c44_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0c8f49c4abf245e0ac15d06a1fd72813_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cvs:SupportingExperienceRatedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i11640c062e35437a84e8bdd5240da928_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i91e5f841bc1148249e50546c6b0c4b62_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id661ddecbffb4d32b875d7dde00d256b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id38966f39d564693bc52e2003aea2649_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i324d950c15024b0bb7034483bcf91fcc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i451babf334c54e97bb6b9b0f190306a4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia7dc90b07e3e44409f77d5cb120f1791_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3de66b1934ef4735bf9ab13a87c166e6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i866ae3e88ea547cf994e2b7dc57084e0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i36ebd6ac03f94f7b9b09d2e42eb22df2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ef2601295cf468496155923c2d3720c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieb049bcdaf39409381032754ef26a6e4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id3543b9dfd21451eb0a643264ccb77b8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i683159f0075e4dc4bd3680b9a30ee79b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idc3513b74a1349019be42383809506e3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib52cf4a485134e87be898eb27b20e43c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if5285fd9babe408da40e34a5f27ecdbe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1e189ef58904439b8c798dfe80e60a25_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i20f2f71ab9e345a3960755605a1726ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i71543114cab743abbb973d2eb97c593b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3a2c8eac231a44ccb5e9b62290d31c14_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icdfdcb99b98d46498997a64233fe6284_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0776297f1b3c4b35a1681eb98f0e6ddc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iecac0db5b3bc4f71a118bac63aeab3eb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if6693eb63ed74a828d0366b9db5e4445_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ied406e9d2fff4ac3ac935e90506bb4cf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i767a0ee4a63e4ed4aa122d6036cf7f2e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3c7677c6fdc940cca39670933eff94b7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0c74cc1d42334984a93d5efc6aa1eb3a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3c0b5fa5eb4a425db34364e49d4cbdfc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i655ea2abe74d44e981581e84041b0fdb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i94ed5a8a301045ac95dc4f35d8a94a70_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id5a62cd495034feaa642a45f38861a84_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i02d753bb590a4315b54f9533067bd31c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8fca60115c0f4442898a26ce68ec0a7e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia57d02a5ebe347a2b9e0de4938be4404_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i94d0b79c49904cfb8e3bb6884eba4148_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6cc1a0e274864af480f200c3ae61c8a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c68ea82b6954ea6b55c0177a55e7799_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia658e0719f064994a3725fa8e7cd5a8f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i46044f2e055c425fa8412971d2e99d30_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i300ca3e38be14ff1a4fd2b2fd45caf61_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75a98c27eb9942459eccbefdfca783c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8819a5b1bd5746e9a7bbc6f8ba9cad82_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9de95e7ef9124c3eab5c6cc2fef4f3f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i86b4035143a84effa56728c42ea05b4f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib6476b9e6b9444e0970ef1e348c4b56b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i002609847daf4257836b24066c83c6cc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id8de359f7ead4526b1face6a322f74ad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if02a53ac99ee4a1ea26c7d5e3f59cdc6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idb0ed2c7f70d4aa5b6f870dab5201af9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i831eb2d9681540c1865ef9261f998f72_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i802ceb0372954e3b98eecca23defdd06_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i87d19268d0744fb497410eaae66e13b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia5c0b1f4b23f45dfacb98c427e6d4b31_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4e84fb13164240338a6262a473ae3ecc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i306cad7c3b5a47c1a8e32bae3a96c55e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic52bb1dcf3f9437ebd76d07e0d8d07ca_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if97e7b2c34d34d7e990cfbbf44d5d6ed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife5fc6b885a64f58ad6f866ffc705455_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieaf20faa368b44408a78e930b5996ccf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i994073ade33544f0933c360c139ab39f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i28d3d92a5cf94a3f868e18fd184f97f3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iae8be572405d45c991240d652b7efbee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4297a85b816143cebb737cc1343a70fe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i49f8a85ce40f4cdfb469db46fc0a3149_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if3e2dfc3a14448e4949b0e6ca2e96253_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id5019bc214954769b41323ef11d4d630_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if0f58cb3118b4270929fe6a3d48f0daf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i956d74f44abd4029b6c77cb197d9452d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3363136ad6a64578bfae7d6bb46bc920_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ebbb82192964b068ed1295f2d2d0aff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i51e8f4940ba94ec990e364c713cce559_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia8fe6509813f4691be74589fc2c7309c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0665950998f344f1870f81fb5b6506c5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if31d2cf121644c3fa2ca449a00878b1c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if094b6a90e654e42969ee969a10fb465_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i79c72a2ed64a45778e58402ff15ba10d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">cvs:OtherAssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0e8169d5bee54b719cf109e92dfaf014_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i946cf0e9eaeb44bd9b10d99d0d2271ff_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4f78308e3c32426bb0c2ca2138e491d2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1462db60599849f7840faeff7ff4b4f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i561ca763e6b04428a37bd3c7b792dcce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id9f150f106cf4152b9dec763e74aa596_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i565ff383eb0845fbb762f16160ecd982_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie843e7d6706242f988cc00f4c975f5ba_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9109f42655d2473a86af8d939c6306d2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ica9f4747830d4246a5c48c387611d7ed_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i96db7954709446f6a42325acd7ec241d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8da99b3fc771435a97faa9c280e0aebf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i444b6c2c628f473895e24001c99313a1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:RedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifb26232bc7ae41f5a142a468a1d38e94_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie1e88e7393e140ac8689b32b97e80fb3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i870c8f372f074816aa15ac75a237b726_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3f1063eb8760432499ef1d5ac46274bb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie5ff79f6ea7640da8266c10697cb62dc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i62b52466f3974cad83656f04e7bc004c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i63642ca94ea246beba927f59e1a13b04_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib09205453efc4716a5382309d32f4410_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6cd5d43d704d45d99a5b19bab4753e1e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i39d069b7167947778afa7bcbccb0af02_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icc64edc684564c32a2cb0d0d05d56c6b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia8f3733991824a44905aef5259a7f9df_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9da88bdaea8642ffbc4835811efe1f4a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idb08a50cbb6149819b84374b7f1bb9fa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1f215dc5a0264a64b253b72d4f6fcd37_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i95b551d0a20b448ab0a332b566d52832_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifd1e6f617ae2403f8ab8866007e71088_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic0eb0df1025b44c38bf26427309bbed0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifd10d01df7834214b6c5d531c819e017_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if9f3a4b21109462a92ecc4a3617a03a4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i23df6084b54047e19d2389b69af21997_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic7c3cc36bebc406d91f45d441bd00dda_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iae825b6c46034c2f9017cf824110744e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i77d5d134cdca428089c8e81e51a6eb39_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i25759438875e48d88a44ca557ed1c835_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if536320d76ef47fb99ae9bca2ae44681_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1e2ef37787f44952bf1c36f39df42b89_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1671fc71896b4cbfb0aa01fae5b55103_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iadfb5cadc1144fe58f4ba77d2fde510b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icb6c57c636ec4b3284104f81a13fd09a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icb1458668b5e49a588377fbba57db275_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib5a2a1f6fc504570bf00460f0dd185f4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia00a40ff338a463a87188f3855a06aa6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib12b30c60e774f8aafb2ac1b598f1c70_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i96dabaf8b16941228a15177e351ad141_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie6e912b4083b44c5a957335b177c7c50_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i99fe407ef24f415ea6a7582d16faf5db_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i61412be3a3f547039aecad27f0ec3dad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if0cf3ff73fbc48efb1b7df6e63ad2a1c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d3c804bcc694053a4a943ffedb0ed74_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i25f0d513b0894261bdb02c2d00130e8e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82e9727495714f18b22c4dbf7b2c2ab3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0b2dcf414fa5408591f2c20e94023b4f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8e2f30ce8c9747828f395554d282e011_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i94dd966fcddd49c79185fb0a8b2d0815_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia4f6242a6485437e8da177a1f5b0f951_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:CommonAndCollectiveTrustsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic0519e37b33f47f38604624a1c7d2928_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6fead32c72504f0d91f1a4db5eaceb10_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e9ffd0e0d5f4defad6c6e47302cd444_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icfcc06f892d44fcead268e6e21698a4a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SeparateAccountAssetCategoryAxis">cvs:SeparateAccountFinancialAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i594e36f005d3463fa1392c6b6973335e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i54659b176aca43799d4dfafb1ae013bf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id4560a747fb0428cbb2dfab79c812259_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibbcca6fad4064d56beecf38dab7c745c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idcf5b0d060a34d59946618c193cd6961_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia42958bc5a30456892df849915469aa3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i974da252533f4b86b21d77a4afd36380_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i225edcbeb1284c59bae6307ce64ff3e7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i99c9da9fc50c410b8c73ff24aedfb629_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0701631a0de043b89fd026737221cc81_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6355e336e53c4e8f9fad360d96598544_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i361a96861ee14db9bb7f3e35b6cfabd4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaeb126eb30f245fabd59c464ac7e4e32_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i887e2e3179ff4e359cd08c7e8f1fe438_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cvs:LongTermCareReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i37da7fe8ff6e4ca79c5d414c9bdf0e79_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i73c432f6e33b44139455c132f65ef574_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8fdc1e0fae4b4a2698619c6886a71a11_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib4bb0f2698a942c58b64c02bb8890e28_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i103983e6616d4a4990a7c5de9eaf95be_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i00d050761ad14c2da89fffbb93d65282_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6d83e40a2262423baedabda99555727d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i79e27bc569ff49dbade03b69248d8b84_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibb54e269a38e408f8d2a458b20a0a2f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3a4de046b34c4136a97065ee6419a19d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if06fa0eea15746e6a253c5997edbd86d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i77da570f38b34e80824f67bbd3e96001_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idbce2e04d85b437ab5c70fe68d26c55a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id3fcb171d2594f08acb2adf5555f935c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia3dd11c0ec7649d2b02e6e800b19ee58_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e56982d83d84bda83b00a3ffffe885e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ProviderNetworksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iefcbd5f8eaa54f5f81cbe1bbdb76713e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i20ffed25fb4d4e59851adea90169ac61_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cvs:ValueOfBusinessAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9b7b56c81acb43f6a6abd4fa631a8739_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2a39a03b1bea4d85859fc29eb70c86d2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i447bb7cdaf5843b5906448ab4622616a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i254473f0a9d24243b38c3ad981a7cf96_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icd712a6b3d0143dca70cd166d1917ef8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i88e46bad2a4a460281a974cda1807f05_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f21266668244130a2a3ae68e0af51a2_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id393d68c87a14ecfa59ccd66f88d6986_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertySubjectToOperatingLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if36ce4c23dc24bb698d0b377df751c48_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertySubjectToOperatingLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2ec38326eb9b46b19c242875eaaa6067_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i662bccf7d999425aaee1852c1b46776a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id4963e68529a4b8092a5dbb197266a3c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i72c01c7edc6746428feb2cca829e603b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if19bfb96ace84f7ba6e1dda34847936f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2fa3d998066f4ae1b676b83334f1c904_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i76012d8261584b91889a99647c4b75ab_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i96bd81c6654246d5be1e598d6b692530_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iadbcbd4d470f4615bf38443ed006d736_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i158b727557ce414a986ec4f36279d415_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i59f215ec163143bab8341e2e7c77c7f5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i91523901360c46a3b3e64cd533486ad3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2efd3deebdcf481d98efcf7a26363660_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id4c47a098f1b415db3606ac2bcdcf33b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id230e348ab594d0499b52ae6f1d6b47d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3e3b186508ca40dd93af39cb786b7ba9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i529804562b5e4b20964ec542de3a4305_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if03bd9fe13614b36a4342b0424978822_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.125June2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8f67a675f3fa45c69b8fee2598feedaf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.125June2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d3ecc7d88d84421b8594f43a72e7bb9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie046158c6aa149abae5894fdb3e124c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifa15869b2ddd4074bd9606c1b61a3b53_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4892cc30de7a4f45a88addf5dc0f50f4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1545ac7575274fbab03041015d476d86_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i566f70fe4fc44db799a8e103eafc538a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueJuly2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia06ed28b864c45d09aa4e68d0dcd0b8e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i83c484e09e5c48ef8e40ce7a9666c2e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueNovember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i38871ce4eafc42498a31f0b4aa3e0fd6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b47680e6fa347cebcc6cb6ba06e1468_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i528008a52e3c42f88ac57efdeb1d1e22_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i78c173076a904738ac9a7ceaa5fad016_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia90eaa0d021a4defb944082e8dfa339c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4acc5bb45f824af59b9b441ae8323056_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia75e4b48aa6d46ac8cebd9bd97a2168b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id6391c2fe51344c3b0267bc8490521b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.8DueJune2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f81ece57db84513aa5335f4b3d6ac08_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icea1808ecadc40d6ae18942dd91a82b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i90b9d6ed5b7745dba7e056a1af581ada_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifc98b0c5fe2c4b849511375a8a2ddc06_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.375DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaeff74e546b24362a8ad306bbfe3bac2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia937c17cc45547f2b5ebc4e8a8bc29ad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.625DueAugust2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3df15a807dfe4bc393599d84bb5ae0b8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ideb967d8ef3440d2aad2a3470fb2b109_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.5DueNovember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic5a6bf862703486796be7735801625f7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i02180112f1f84663b7aaefed8c65784d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5DueDecember2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ida41dacc05104cc79603a44d10527e6f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iad98b34b91f2400e8d921831383f78ff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic5f70911c7434c7c9d30f3e9f6370e8f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib58d5abd3f97466997c356cc6d003abb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueJuly2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i59b67f5f8f844ccc9ef30578495be520_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib1b1585ec2b24b72b0323f62ac998309_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2.875DueJune2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3bd90d57c71c40889aa14f074e72525d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i196c3c3a85b54d0c823aea5345bb1b47_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3DueAugust2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia31f8a1af0f74612b2137086a863b2f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point625PercentApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5e16f05ccac849f6b7239ceda71c5435_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point625PercentApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib01ceb33ad054c6a90191f9d95d44d72_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6e79f25e44ce4192aef42fac92e6ebba_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.25DueJune2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7dfa4017c31e4a769e1726240bec574a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point3PercentAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i46f1a5a00e9349149a87d2a1ca48676d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point3PercentAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9e941767d34940eb84521c5bead4b66d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifeff226b8f72491b84a7b76931939c6c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.3DueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i829935f435f8417e9ebe4db76abf40d6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic9a0fde9614c415093ac05b5ccf09851_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.25DueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2383f6f259884a2ca2d37bfea6f7f9b1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point75PercentApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i963597ecd59945d0b5207daf0eb2b186_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point75PercentApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib90e1ba9c1fb44d496c2f63b444e51ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point75PercentAugust2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i17a365c216d54612a53d69c5c0e80a5f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point75PercentAugust2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8c47829d25484ecdabdc89287f759465_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point875PercentFebruary2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8fc01427e2da4fb88ab22fdc0b7e32fc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1Point875PercentFebruary2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie6286228091e44d0a7a084cebf96e83d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point125PercentDueSeptember2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id7974392fedf4d69b48cf73026d43053_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point125PercentDueSeptember2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i66d6bb918a1841c7b29b4e54eaff9002_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i22855f4f70944d80a431f1009d80d2d6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.875DueJuly2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6deef011e2dd4c96bd53333619f01231_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie75ef397faf445d3a901e0af5e125899_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.625DueJune2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6d9e820cbb5640bcaab284f7fdabd210_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic356af28bfd045ffa9174ee4741a3d1e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.75DueDecember2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if36b1314b05240d98146140634ecdbbc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ica522c18f13c411eae44d16f4d18ce20_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.78DueMarch2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibedc3ae92ee24ab597438f089a05003c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if7ccf63bdf184cf98f51d95c1720b750_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes6.125DueSeptember2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i66980e2699e94ff68df99ccb53d43a5d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point125PercentApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i59a1bba78be542ef8a8f0f0622414168_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point125PercentApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6b5f82fd2e9948249d51305151c10a0a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point7PercentAugust2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0a3a26ae8b3f4d658d7d84e925e6932c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point7PercentAugust2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba9e24130d424bf7933c036abe3fcacf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i731815b798d2445687a0b94d8984740b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.75DueMay2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id78a04082f9f4d9abbc5e0508e3f4590_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifcbe63373aad4f449cf221d8fb8bed34_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.5DueMay2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i08f395fb692848039e5b5e89cf899bd7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5872f67f264f4286ab44e43e24612b0d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueNovember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie72908e23c3040c0a69888583cbcc793_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifed64cc823de43c7bf2f78098c4438cb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.3DueDecember2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2ba90e1b15f247189f65ef311ff3a5d8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i369332f01d914260ad39bb9f3745585c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.75DueMarch2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i189a6cf6ec97415ea1727e01c3f51404_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia4a2069eda0d49ae856f3a624d3da473_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.125DueJuly2045Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2e79648650b54806a91c3d411f2ea35c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9e6ba14d8ad442b0b834bdfbf7a454bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.875DueAugust2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8c6e0f8b2d6a4e219ead75b3e364997a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i67abdddccc3d4638bf07489a3670086b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.05DueMarch2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i301c0abd44f8465691076dc9cc3fae50_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point25PercentApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i73fa3cf6a6e94e878b2a4e89d3fa5283_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4Point25PercentApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i014942cdefe642299553301bde433b97_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i46529d5778ae40bb990d932509dbac03_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i96887b3ac58640beb52a82bd21eb813a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie9cad6a94a214f4bbea75d3fac5eaaa9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay172023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0889c6d0f22449efaf79e5043bc52d47_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay172023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i006c485c30a0471dac8a843ae0803178_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay162024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i54d42741e9a84f52af2882db08c58b47_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay162024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib44b6fdea84a4c50aac9b470b1ca8124_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay112026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6d78ef11f57e4edfa8419e4be3cfac0b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:RevolvingCreditFacilityExpiringMay112026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4daa4bf26a7e4ba985ffd4fefd569f08_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5b91388b635e423cafe7fb2c8c8f40f5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6c07b91fc15c48388a8d68005ad93a4b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:BackUpCreditFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3d1e81300be74367a642cc8e00fcf76c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i03fc12d9dcc14bec980f92dcfea940fd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib06d0888e42f4a7f9d3dd17b79f3d08d_I20210818">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes2Point125PercentDueSeptember2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-18</instant>
        </period>
    </context>
    <context id="i2a2c1f6bdf614434afbf804874bfc4c5_D20210818-20210818">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-08-18</startDate>
            <endDate>2021-08-18</endDate>
        </period>
    </context>
    <context id="if4ec5d2a13b34d5b970af83c0b03a435_I20201216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-16</instant>
        </period>
    </context>
    <context id="i94cc0d983ab94bde8b7090b07fa45718_I20201216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-16</instant>
        </period>
    </context>
    <context id="ibd90a04249054ea4ad16eada8a0b09f2_D20201216-20201216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes1875DueFebruary2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-16</startDate>
            <endDate>2020-12-16</endDate>
        </period>
    </context>
    <context id="id52f5d9f143f42e29ddaadb1b8837a16_I20200821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes13DueAugust2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-21</instant>
        </period>
    </context>
    <context id="idce8059065244c0699beb758c0989a41_I20200821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes175DueAugust2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-21</instant>
        </period>
    </context>
    <context id="i529043993c644dd8aac8807ee5d2c7c0_I20200821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes27DueAugust2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-21</instant>
        </period>
    </context>
    <context id="i8afcc1e6458e4e11b0ded455489215ee_D20200821-20200821">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-08-21</startDate>
            <endDate>2020-08-21</endDate>
        </period>
    </context>
    <context id="if63aa33153fe4482bfd5fceb634e5359_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3625DueApril2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i86d4fa4ab95046118e795a12d33f7b88_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes375DueApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie826ee2c5ef840c18914ca3433d41756_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4125DueApril2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib4fae0970ac644b7a0ad3a6efb7c6d19_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes425DueApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iacc2ab2c48914d7f9b06a37e300d7eb8_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes425DueApril2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i18bedffd3ee14bd4b98e02cbf1196a0c_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i149ae25cc3b64a2f92739b6ff6dac510_D20211201-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point70PercentDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icd0ee6924ea342c4a56038c2e5e18a64_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3Point70PercentDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f0b12ab5b464e1496ae54d1e5e61e87_D20211201-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i53460cbad4244ab5955cd283bcde34d7_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4PointThreePercentDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i276b01d57f2045d0a76f58a233e35d9f_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4PointThreePercentDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="i39b25004923a449c988737a1efdfe4c5_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i82ee6a03a2f04ee8b61b452feff3664b_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2a7bb6963c09454281cf0360dcec5944_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie4644ff08f014f1b9eb1fa8df30f2d1d_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i72ca6906eceb40d5b6a9866cb6f06416_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7ac0d8f26f1643619504cfda7d91bffd_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes43Due2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4b86af123f0342d4a6104d4be9148913_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes43Due2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia73567778f2f4e638670d5dc29eefd86_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2b3cb303f4194f528bfb52cc092455a7_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i67806e913a8940939ff3cb535bf4e3a6_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i2e64a0aea79e4b548c70ee282eaf1af6_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4DueDecember2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="ie519cc2420df4c91a4824dffc41155eb_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="ifb5f940a259047c798edf06df3e9a282_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.7DueMarch2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="i0c074aa9c6834d2497da9aa3b1bf52d1_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="ib61285362251444c8c2bfd25138ec3a5_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.1DueMarch2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="id4d09fbb1bb54cb382bf1b47e6f77cce_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i362f2c27267d4320a08ef6b47fda9bc1_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:OutstandingSeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="if5d47a67418245f7b61330d02abc51c3_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i4b1b35e1f5e04251b8abbf5474581c4c_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.125DueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="ia9179b36d9334dc682bda5ab696933e3_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:FloatingRateNotesDueMarch2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">cvs:FloatingRateNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i32d5285ef7b24b989560ef483b6354fe_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i08a8d0eb8ca548e48203788144525a13_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="icc7d49779e63442cafbb5b988ec993dd_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="ib08d4d156b344abfbbdb0a987bffa850_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes4.125DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="ia80bef5306614fe7bc79d4a80fdd7a83_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="ie617a7b5c5cd46409dcd4dd2149324f8_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes5.45DueJune2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="iad60f7a1628244d2a8b435b05fc44593_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="if1e7d725090f4e1cbead4dffeddf31c7_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvs:SeniorNotes3.35DueMarch2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="i03679feac9004c3babd99a1e76970bde_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i4d6e9082a5464b3c81907ef022a3e221_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f04ec02cc3f4ecd8284b436de929707_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i155bec7d75a941458fedd191eb885b03_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i42e14e6ecf0d4519bad91c300172ce00_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaf1063688e1c402b918f2251c5ebcda8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3134e38a37b94c8182ff22d5897d2115_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie905fb72796946948258390b761711b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia00abbc1dfc2420285ca81d07349c1ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i875e79c2473a452583e29e73a01bfa80_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1b5c96f524674979ae3cadfd2532827d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i59c39c821a3d4218a3cb728d2a385e90_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if5e7e03431254181936fa5c2d257ec24_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2bc62d9f7c66433aa13e9e6998d9d964_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i56a20a0bce804c38b73ff7f520b87651_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia01c644b76e14ee0b5670b383fc44619_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i720c85d38c4b4a209ace565912f63128_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i299dbb93baaa4adf91b29303de9f256c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iba101ed2ac8446029ae5d685f8acc341_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6e7a8e35e6064852930a027b3b59f8bf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibbde729393d64e52859d704b20cee518_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i412f89f8ca8d4dbfb8137a440ded6b98_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iae01dbcfa8ad41769f633687cc03a2f7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if8e7a22df5454c2ea08ecd37884fc4ca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1fe528bb55e54ddf9c9174d483315925_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i03065bcf27f649d5aea3ecbbae57c360_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i03983d809b5d48ac822709e714733860_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7896784f71444553a77160a44c511d51_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2f997b24060b4e2e831b7dd663bd1b51_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ica9d19a21f7b4daa8e6810612ddacae0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5b76b6127e2345bdbe4b25521e947671_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id17472de8a564798bb9bbabef75337c9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76f91d5a4d3f4fde8c530ad87b420488_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie018639f7a93495f8a043153b2b66e54_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i790751c0557c4bcd879d0876e81497d8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1878272b63d84cb3ad191576cc40347f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i236be83c9a654e4bb93dd0760efff694_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0da2d0c3648145a5b8e2644ab1e5983d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2a93d02e74b1445c87a77245502f00bd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i46e716287be2403d9f9833d066720161_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if0685d6246774c2192e1c757f435ee9f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6907babce69b467f895e80b4a8a98771_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i752af8c51ae54195805ebd256b2b704b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f35241461c340e69d4ae399ca59d584_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i59783636e8a14fa99c118f4ba1fe28ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie59012b0b1f342f68b2de7d2cf4ab087_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib5cc0c0211dd4cb0b9436d1dcc14e45f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia291c95e9323450a8b9d5c75e58e6dde_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i13f56229e6a44220ac924ebb86adafa3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i22bbe4588fd541d6a564c67c1022e726_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if240d2be64a04252b3b1f214f2c30cce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4e572606f72547578135489453dbfd32_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9c636fbb95ec447f84da5fad0bd31870_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0ca55a5008304969aa971098edc7db65_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5750f985ec4049d5a4ce86e6955f062c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8275b2c1a4584bab8295523437070a66_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i353fe81c894e473d8489f94900073b72_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0142cf66eb9e474ba86ff2ef25aa7bb2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i09446e526f7f40f1b8b3303c458d33ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id83eb75fcc284b5f8068a783a9650faf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i347ffec6d213490c86926a3020149905_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i68728028bd74499a908379ef355b4da0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i16f188fd81734863b4051130ab9f098b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i97f4fe722e6e43d6bf5d820d11cc2e2c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3aab0ea7df2549f09b6ae42102668e65_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i22a8679306fb4d1ba271a7b5a547276e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1e5acd236a544fff8d2d17bd87ad5a43_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87a55c8247be45b09ee66e3eeef70a7c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idb6a1ac4f81447019bc03b2d0cdb655e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7c06aac8a3d747f9985177c9ed3a77fd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7ee6597ca53e484eada5596583046f3e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i37d7609b746045a585af149f288da888_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib44b71f83a2d49289abcbf4aac524e75_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i248a5597803e4cdf9daeedf87c82dc5e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1308d93a146c4c8488b59a3c5a030c08_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i63f7417ba6374a9bb024726d61971b6c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0fc62e7b55b64c639f28ec82a4ab6bd1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifbd48617b54d4e418e1d710b3ae6d615_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i20fea02b40f94c0ba48b95b826283484_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if275586315f94ce8aa9f0a9ac4422fce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icdfdfa352a47493f87219a5298ddedc0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib3a9437b6cce406685b52a5c81de0dc3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i31173b20feb34137842581c3c8ce276b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifd69bf1ffd684edcb0e0780c09b5e3ff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e1d94487b2b4e17bcc6022785274fa4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5790b806681342228c412540032c2845_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic2bca73c906b44578c01f6b232e46777_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7b1bf3752dcf4f309d29e28b80c56ffe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a371f76601c443b8b6c9bcd816f3a93_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5b9cd1a5ea464c6daf3d809cfa440c90_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9ab5d14a774c4e00912a293ffe6f87bb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib65d80ddf5114b28a867a900c7850eac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id189ff74332342fa9efe4364610c858b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id6b00b26ffba4cad87f82b5285574b87_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9149c44a31594b36a308ac1f8c72e95b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USStatesAndPoliticalSubdivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i03315b2d0c214dc9ae1f36aa4a7b1182_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieabcbb36fc544fe1a63bec192e6a5369_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icbab6554354142219fbf65a19f9f7258_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2d537c7cac0d4b2bb971a7f1b19afd54_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee91350be21e4df98a159fbf2f617178_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5b09818a0a4a496a9fa00fed53ac3bc0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie7c8684e46134d5d94ecbacac811adbf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if725d6e275a94ba883eb02d3137c3b23_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0dacb79ba9f7420094ee7ba16c6f78c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4e824e97dad749fa8146593c0a7fa864_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2f2924405ec24521a9aa09e98be58eec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36dd5abbbdcc4f9a9f25788b549f76f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd4080c110824cc891e5f7c1bfadc274_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i45c05f5dd5d3432185804a21006dd535_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifdc0d801d333478e818a374400b463a0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i69656313398948a58d187e87db585202_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5dd797aa72de45759796b65f361f095d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f11128fcfa749d782d3026befe4c0b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6d2c9c46d28343c39add06320df583f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i504c90860189474a9e7671e231444fcb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i98e2d75cd63240afb79819d5aa10ec90_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie1f96d3ab2794a19976e875f2624ea6e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i41b1ed139bba42e9bb825bb820df17c3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iabdd8d0f4b884bafb6a33a56b77ba2d2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:RedeemablePreferredSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9978503911fa41aa862248d7a8b2f088_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9890742ae5e746e59b2065d06764be7a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i18e230719b394883bd34f909e74c7ec7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icbb9853b8df849048580a1fd16e6682d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5917c3c349de4954858ab57a50dd8cb9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7cabad59a0dc44a6ac1fd35c4b99265b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6aedf877fb364df6a2c31ee163a6cfe2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i28dff85338264876bb38fd87ca595a93_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3ae7533aef2d4ae58181147c89948033_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i980a0570d54d438e9ca44fce0d36118f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f5b472d5fd248fc9d8e4d0ca5faba33_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5541dbb601c340fc980f125354496618_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9db72d0c676148af9dada1f290d09a49_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8c114d81513142deb782de5f4fb900d7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia89b4748c514428786ab4dbcbb1f9083_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7fbed6015e9f445a8b1b5c27ee92141a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:EquitySecuritiesDomesticRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibadbdf8585c74e21a8128d74084c1630_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7afb56947f304bfc81fc6a4e5e0609a2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i40b0233400e741c69f64993477c55a4b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ac32e06a1214b17a9a0b84d07f40f6a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id1503d3a6c2e498cb8692a32b8d66212_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i92012f7aded14a9d87023bc2cc81aca5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib9cf82de093b4218a4e15181bf7ad103_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i73089e6a3a2241938de74ace9cba6d4d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e982f6ad3ab46928953aac66f4ed7cd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibd833f359c8e4d79b0a869ad0038a7ea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id11c855da6024638a23cf8dee7acc5da_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5dc8d2b37fd24bc5ba0361ec6cb6d65b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCommonCollectiveTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4bb5df4dc2c74cb6a22410f86a771e30_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d85bdcd4cfc46a8af15a02b4c576aef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i50b42474671845488782a3036f501d1b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i28df8a8c64394346a9c15d1cc0276d57_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibafcbe43a8324a158a723bf16031e45e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i94adba46e20a49038784a49900c2c598_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i73a6d94969d34f66be2e45328cb8f039_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i25eb35fe769e4798b61a524290097389_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i263c92882506448d9de97c225b5380ac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic142f878870649039fd16edd170bbf6d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i615e9d3a8c03432b9318ebab3d589854_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ica25f49a766947a2adc2da48b7b82874_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i629a1b7b7b2446cc8b1de566b5f3c0de_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i05c170e5b7b94386b7fcd1a8079be955_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">cvs:DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i60dddc7de4d647b3b43c5f0623bcf0f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9a78c5e8b0784b46b5d4bb5a8fc3a21d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i243c32908d3d4416bc7ff18ee7ffd240_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iab646cf33e884b1698a49fc5490b1a94_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7de4764ce7104e8cb8330af8da0f29b3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib96bf7bb8a4e46c2bb1e0d91aacf9454_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2fe8d48e437a42c8ac2e33f34b85a197_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie319f6a95cc24bbdb8d73ca1db401d8f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i68c26fea49fd41b19bc33b4ee7857fdf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanRealEstateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8a9138b4f181419d87234459e11ed427_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DomesticCorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icf6ce37a6c304453aa21c72054c6c418_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i025b8e46060344f99b00103d8305d8f2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9e4ad64d899d4ef984f319b18bd41d23_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76b12c0d6c6040539968eac6791ef12d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:RealEstateInvestmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id5b88ad8263249b9a5226487582fc404_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7fe3ea32ebf64cf49fb9d49975086ee9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:HedgeFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i85cd553b0d4e4d00807d021b0529afcb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i70428484fd564ff2a11599326e08e7f3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2809337bb72a4fa6997eeb7883adae59_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i94a38e87618941bb9c641ca41807e1e2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ife890af6894342c6ab78227d1ee5350c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1e00ca9657da47ec87effc5e2a1aeac7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvs:CVSHealth2017IncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iac75a9034e7c40fb82a43cf2c75280b0_I20181128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvs:AetnaInc2010StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-28</instant>
        </period>
    </context>
    <context id="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i85d379918d1544988d301637f8418348_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie67cd2601892401dbc7e134d3a278afc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i02c8540613844c24bb3232a954d598c7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i43347484543148728067fc355f1bc0cb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4ee318d09ac047368832cb3dc191916e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i93c58d30105d4b0c9c482412ced85d79_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie549abdb9cf943f6acd4a4f0dc937118_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie333142c626e457f8b7400acc37b2e0e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2a27cad79fee4e3fb41f31a513d985a2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i39274e5a60794450836f17e832f652ef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if7c3db8973f246b592a6bdc7ae66c5d4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:RestrictedStockUnitsandPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ied331db8439f40e395a4f8943266cba6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i69a67aadd34647f781446b1f63119ac5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if24ed4bf2c534b4b938b4ca3b222bbd1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id0b126cbb01d4598a07ab0c18962d7ac_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie4ebc26cbc0c4a72b41fad331a976a13_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i047eb0ccbb624e599edde0bdc4b342b3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if345988696b749e88cd89e722c59ebd7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvs:EmployeeStockOptionsandStockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i432b0c5043074ae0812170d09abfa592_I20211209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-09</instant>
        </period>
    </context>
    <context id="i03653ea4eb4a467299768217a91a7509_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5d02c104c6dc4d8080674b3a902331b0_I20161102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-11-02</instant>
        </period>
    </context>
    <context id="i9f4bc0f557304063afaa3e85428dd4f9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2016RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i910e0cab88ca49569118b221e7416e1d_I20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021AcceleratedRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-04</instant>
        </period>
    </context>
    <context id="i25393db4ea824bb8a945d34240542336_D20220104-20220104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">cvs:BarclaysBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">cvs:A2021AcceleratedRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-04</startDate>
            <endDate>2022-01-04</endDate>
        </period>
    </context>
    <context id="ia7be16ef324b484ba18d3c2c816b7220_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i341bdbaf02b943349d5742511da4e641_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ib8220880f08f4b52bfb75c957326a67e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7fc99c6f6f5e4521b483fbb38f266a09_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib746ed191a50496e8dcb173944e10da4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if41fb896ff264b3ead6f51a18d2a3f8e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia2d7b1824eba4f87a7eafd51d7fd5787_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i067da125651c46ffad3ae31756f6ebce_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaf290335ae9a4ad68f960df21ff9fc4e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3f97c5d3b527409f84299ce04961b6b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iba1b0c6fc0e8431cb642d84f64a10a03_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75b1f170bf184fb4b59ba89128a6bf98_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cvs:InsuranceAndHmoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i11c81300ece14b5cb35d720e3d27f084_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3fc98fb6952142bebe0c28e8a1b5c4a8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i84a0c7a5f87a43ea863b4f7e44c6d8c2_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id4cc032a34c645ef8cc2877c8cab5ad0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i930652f9892c44cc8ed5915dcd507083_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icbaffe77aefc4d6d9017917c96a5f507_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i64c2bd153480429785df4f0aa2b99af8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ife5fc67699f945fa837f90b613f6c602_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c93d0cc21864237a54084f2b97bd15f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i91b3a6b550364049b4a377a44fda6b09_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ied0d6e0ce99e4b72a1d89046d51bad0d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i20b34efac8084fcf97e669d6e307466a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i303cec39156742cabcd569434ed22a00_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1adb1295de224123a78020e0f95fb49f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3c37ca64bf504cc4beccb76f7eae0e86_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8b8354161494117b37c8c706d4ff661_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iec37d7e54e8e4663af7b1e9dd4764b6d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i17206db04de740ee9100c779b2d2d0c6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iccee865f86ef46af8613bee2f36c8b98_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i94e5299b9a1643d5a0693be093306c61_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i348fed93b022492e8b3985b2e2ba1a8f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iac8f4cd98d954c89b07ab4b4c2f7eefc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9fb139f86fed450cbb2024fcc197f70c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5ac9beb213414c5a99e0c44cdb3d790d_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i5e511f7eb0324f2f878592c7974ed086_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if460e957577f480e84fb0142bcff8589_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i725fef702fc24e31915c10eeb3b3c3cc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i314a931ba51c4432ab932591b600df30_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8be428b3931542c4965732a9b0d77591_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0df7f1ff461e44849cb29208fac61c4d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id530b2ec12d240fe97ae812c8d6c1fed_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6049578cfc4647f693b348ad92ec2d2b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia08c0a1adcca414ca646fb74221de9ab_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if2efea1496c248cdb677d680fb00e679_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7992428725ee4b7598c31808d507c883_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9b7aa9f9810b45008c9d9fed20ef83c3_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i9301095d345049e394b9ba1daee2e4e9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:HartfordLifeAndAccidentInsuranceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i301adeecaf97464ca03a693c09b0877a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:HartfordLifeAndAccidentInsuranceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib2d969162ec640c4bc7ab0e676c9f6e9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:LincolnLifeAnnuityCompanyOfNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i46f805b90593415b99804a3433aa2813_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:LincolnLifeAnnuityCompanyOfNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c99d471482b411db975233daa1b1c2d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:VOYARetirementInsuranceAndAnnuityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i60a27aec77334f2c9335b816c8cba90b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:VOYARetirementInsuranceAndAnnuityCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3af40793c6c847eea71843a3d54a8e74_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:AllOtherReinsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id7a078c31fd54364814330592da72814_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CededCreditRiskAxis">cvs:AllOtherReinsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i63b662edcef14a498dbf400ce0e7d2f8_D20120101-20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2012-01-01</startDate>
            <endDate>2012-12-31</endDate>
        </period>
    </context>
    <context id="ia4e995a2f68a477fbac8891b9ff45d93_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvs:RadcliffAndFlaimVAetnaIncEtAlMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7c55eec168db4721bd5fa5e6c7afd8f1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8549b1a793e64b2bb212ac0ced243d88_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4020d7e493d642d5966e8ca82cc66798_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cvs:USFederalGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i528bf90615b04a4388c9e042e7d52e2d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3b5addf84c5d4652a8c88278ee498b80_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia8ae9e7058b940a287f7a508f1290213_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5eab19a267b14681b658f1fd1f748401_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i03972e1ca7ae40f3b269cf247834e557_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i326e08f13dd84d729af0ed31957c20b2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i48f87e61e37e492f9c3f8051c3c9e4f5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icae6f1ee606a4353bd0cf7e6f048d3cc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:PharmacyServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i53edb1dedd7242ae84fe83beefc1c6ca_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:RetailLongTermCareSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i869e87b37b534c77b68def0dd025f28b_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvs:HealthCareBenefitsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="store">
        <measure>cvs:store</measure>
    </unit>
    <unit id="member">
        <measure>cvs:member</measure>
    </unit>
    <unit id="people">
        <measure>cvs:people</measure>
    </unit>
    <unit id="patient">
        <measure>cvs:patient</measure>
    </unit>
    <unit id="segment">
        <measure>cvs:Segment</measure>
    </unit>
    <unit id="state">
        <measure>cvs:state</measure>
    </unit>
    <unit id="clinic">
        <measure>cvs:clinic</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="security">
        <measure>cvs:security</measure>
    </unit>
    <unit id="reinsurance_agreement">
        <measure>cvs:reinsurance_agreement</measure>
    </unit>
    <unit id="lease">
        <measure>cvs:lease</measure>
    </unit>
    <unit id="claim">
        <measure>cvs:claim</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl80L2ZyYWc6YmU5N2FkM2ZkMGQ1NDFlZGE0NmFlYjhmYzZhYjQ3NmYvdGFibGU6NzM3NmVkZGJiYTNiNDkyZTg2ZjE3OWQyMjAwYjkxNGMvdGFibGVyYW5nZTo3Mzc2ZWRkYmJhM2I0OTJlODZmMTc5ZDIyMDBiOTE0Y18zLTEtMS0xLTE5NjM1_db0717f7-5eb5-4e22-8c88-67bfd90db4c8">0000064803</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl80L2ZyYWc6YmU5N2FkM2ZkMGQ1NDFlZGE0NmFlYjhmYzZhYjQ3NmYvdGFibGU6NzM3NmVkZGJiYTNiNDkyZTg2ZjE3OWQyMjAwYjkxNGMvdGFibGVyYW5nZTo3Mzc2ZWRkYmJhM2I0OTJlODZmMTc5ZDIyMDBiOTE0Y180LTEtMS0xLTE5NjM1_4eafeac5-d1e8-444d-bfae-f78ee492a39d">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl80L2ZyYWc6YmU5N2FkM2ZkMGQ1NDFlZGE0NmFlYjhmYzZhYjQ3NmYvdGFibGU6NzM3NmVkZGJiYTNiNDkyZTg2ZjE3OWQyMjAwYjkxNGMvdGFibGVyYW5nZTo3Mzc2ZWRkYmJhM2I0OTJlODZmMTc5ZDIyMDBiOTE0Y181LTEtMS0xLTE5NjM1_378eb569-d6a6-4c02-890f-62d897e9f4f6">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl80L2ZyYWc6YmU5N2FkM2ZkMGQ1NDFlZGE0NmFlYjhmYzZhYjQ3NmYvdGFibGU6NzM3NmVkZGJiYTNiNDkyZTg2ZjE3OWQyMjAwYjkxNGMvdGFibGVyYW5nZTo3Mzc2ZWRkYmJhM2I0OTJlODZmMTc5ZDIyMDBiOTE0Y182LTEtMS0xLTE5NjM1_4b40bafc-33ba-438e-958d-652094879b2e">false</dei:AmendmentFlag>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzktMC0xLTEtMTk2MzU_413fad1d-00be-4acc-8403-96459210c49d">http://fasb.org/us-gaap/2021-01-31#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzktMC0xLTEtMTk2MzU_ce575564-f9c1-4e8e-b797-b6c51cf6b1e3">http://fasb.org/us-gaap/2021-01-31#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:TypeOfCostGoodOrServiceExtensibleList
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzktMC0xLTEtMTk2MzU_d0d59c58-0b62-4ce9-a194-f6d689cd4c1e">http://fasb.org/us-gaap/2021-01-31#ProductMember</us-gaap:TypeOfCostGoodOrServiceExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i59754cbac5c049eeafbc35f207330f42_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NjM_bdbd7ade-1f47-46a7-92fa-bfb084c43320">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201602Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i4b779e18acc147f29614409a3ae3a1e2_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NjQ_6d63f6c0-91a9-453b-838f-78265109358a">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ic8b00a5656814734a6bb268b8e3ca5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcyMzEz_ea62d84c-7b65-4b23-9d75-3a8341c56a52">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTAtMS0xLTE5NjM1_55ac48cb-f36e-4b9d-8b69-3e86d1c383ef">http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTAtMS0xLTE5NjM1_fc260d98-5cca-40f0-8e2a-2fb2b3ac6249">http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations</us-gaap:FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ic8b00a5656814734a6bb268b8e3ca5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzE3MDk_ea62d84c-7b65-4b23-9d75-3a8341c56a52">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml8zMjk4NTM0ODg0ODIx_9a61366b-94ff-4452-b8dc-41e9be6b2c2f">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml8xMzgw_89587572-70c7-475f-8c4d-ab54a2b5e220">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml8yMTc_e33825d8-c436-4ae0-9adc-c3c652deda17">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml8yMTc_e79527f4-c5ec-4acc-bd09-87c8f29b20e5">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml8xMzc0_1af5d221-9ff5-4d1f-9d23-5cc85b04bb3c">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml8xMzc1_29fb0952-a872-49b5-b836-1fb5f491166e">001-01011</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml8xMzc2_fddfbdc8-ba26-4ee6-95be-b8bcb8dd2b9c">CVS HEALTH CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6ZmQ2YjZmNGMxMzI2NDJiOTlhYTVlZWM3MGU4NTVhMTUvdGFibGVyYW5nZTpmZDZiNmY0YzEzMjY0MmI5OWFhNWVlYzcwZTg1NWExNV8wLTAtMS0xLTE5NjM1_8d43be26-be53-424c-88b1-19b5437f2a3d">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6ZmQ2YjZmNGMxMzI2NDJiOTlhYTVlZWM3MGU4NTVhMTUvdGFibGVyYW5nZTpmZDZiNmY0YzEzMjY0MmI5OWFhNWVlYzcwZTg1NWExNV8wLTEtMS0xLTE5NjM1_6989d31e-719b-4fca-880b-4643b2d2c6a1">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6Y2YxMmMyYWY3NGJhNDg4NjhjMDViYTE2YWNkODMxZjcvdGFibGVyYW5nZTpjZjEyYzJhZjc0YmE0ODg2OGMwNWJhMTZhY2Q4MzFmN18wLTAtMS0xLTE5NjM1_f6007b63-123c-4b81-a62a-e44d1b7e119b">One CVS Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6Y2YxMmMyYWY3NGJhNDg4NjhjMDViYTE2YWNkODMxZjcvdGFibGVyYW5nZTpjZjEyYzJhZjc0YmE0ODg2OGMwNWJhMTZhY2Q4MzFmN18wLTEtMS0xLTE5NjM1_5ae9ba60-14d6-482f-b557-59539ed38a77">Woonsocket,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6Y2YxMmMyYWY3NGJhNDg4NjhjMDViYTE2YWNkODMxZjcvdGFibGVyYW5nZTpjZjEyYzJhZjc0YmE0ODg2OGMwNWJhMTZhY2Q4MzFmN18wLTItMS0xLTE5NjM1_92314b32-584c-4bf2-a09e-133f0effebb4">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6Y2YxMmMyYWY3NGJhNDg4NjhjMDViYTE2YWNkODMxZjcvdGFibGVyYW5nZTpjZjEyYzJhZjc0YmE0ODg2OGMwNWJhMTZhY2Q4MzFmN18wLTMtMS0xLTE5NjM1_b6c4b28e-3a6e-4a9d-b6d3-7b22294baa26">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NzVkMjU0YWQwYjJiNDc1MzhjMWZkNTVlNDg1Njc1MTgvdGFibGVyYW5nZTo3NWQyNTRhZDBiMmI0NzUzOGMxZmQ1NWU0ODU2NzUxOF8wLTEtMS0xLTE5NjM1_e6f499b0-80d9-4767-91fd-4dc4ba265273">(401)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NzVkMjU0YWQwYjJiNDc1MzhjMWZkNTVlNDg1Njc1MTgvdGFibGVyYW5nZTo3NWQyNTRhZDBiMmI0NzUzOGMxZmQ1NWU0ODU2NzUxOF8wLTItMS0xLTE5NjM1_05658338-d5f5-4a0f-8398-542f83d059f3">765-1500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6ZTRjOTZhNWMzY2IzNDg5OGJiYzdmNTM5MDVlNzhlOWQvdGFibGVyYW5nZTplNGM5NmE1YzNjYjM0ODk4YmJjN2Y1MzkwNWU3OGU5ZF8yLTAtMS0xLTE5NjM1_ba5a9e0e-42bc-4bec-8eac-654a27e18ab0">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6ZTRjOTZhNWMzY2IzNDg5OGJiYzdmNTM5MDVlNzhlOWQvdGFibGVyYW5nZTplNGM5NmE1YzNjYjM0ODk4YmJjN2Y1MzkwNWU3OGU5ZF8yLTEtMS0xLTE5NjM1_94d4f69f-2d77-40e8-acc5-3e9be0b54447">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6ZTRjOTZhNWMzY2IzNDg5OGJiYzdmNTM5MDVlNzhlOWQvdGFibGVyYW5nZTplNGM5NmE1YzNjYjM0ODk4YmJjN2Y1MzkwNWU3OGU5ZF8yLTItMS0xLTE5NjM1_1b2b949a-240f-4791-8e36-859b06ad46fd">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml8wLTUtMS0xLTE5NjM1_a3f4e616-17d2-4adc-b6b9-63f2b9aae54b">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml8xLTctMS0xLTE5NjM1_c9e444c7-12ca-4cd3-a43a-080c8aed9c09">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml8yLTUtMS0xLTE5NjM1_9b96ccfa-ea5c-4651-a3f8-1defbc67ec51">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml8zLTUtMS0xLTE5NjM1_c572d72b-9cee-4209-8471-9c6889ff5fc3">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml81LTAtMS0xLTE5NjM1_763d32bd-a787-4b3b-913c-fd9e1b2864cc">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml82LTctMS0xLTE5NjM1_d9c6d818-465c-42a1-b97c-8cd2d6849b92">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml83LTctMS0xLTE5NjM1_da7baf97-2ec8-46cf-8337-379f286eef21">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml85LTctMS0xLTE5NjM1_bb9e9be4-134f-42dc-8c21-bc78b9d39705">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGFibGU6NGU0OGExNTA0MjhkNGY1YmI3NTE1MDM4Y2Y0NzZhOTIvdGFibGVyYW5nZTo0ZTQ4YTE1MDQyOGQ0ZjViYjc1MTUwMzhjZjQ3NmE5Ml8xMC00LTEtMS0xOTYzNQ_0c9f5503-a2cf-4670-a83b-44fc669fb3da">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="ie5e000b7c7ed4445a36ad3eb67d14356_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml81OTk_1375ec42-c5bf-4dc7-af7b-91b917ca7ac6"
      unitRef="usd">109651334285</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ic767c69faf834e03aae3c9e3cc80734e_I20220202"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml84NjQ_7864866c-48f2-4f84-8346-9dd0bb3eaf90"
      unitRef="shares">1312510426</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xL2ZyYWc6NDExN2FmYTYyODE1NGNiNDk5NTc1ZjI1YmY0YWVkNTIvdGV4dHJlZ2lvbjo0MTE3YWZhNjI4MTU0Y2I0OTk1NzVmMjViZjRhZWQ1Ml8xMzc4_563896f9-6cc8-41d1-b0d1-fa50af286a12">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The following materials are incorporated by reference into this Form 10-K:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:0.8pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Information contained in the definitive proxy statement for CVS Health Corporation&#x2019;s 2022 Annual Meeting of Stockholders, to be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year ended December 31, 2021 (the &#x201c;Proxy Statement&#x201d;), is incorporated by reference in Parts III and IV to the extent described therein.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDAvZnJhZzoxNjIwZTUwZjA3YTA0Y2UzOWY5NmU2NTY0YWI3MTJhYS90YWJsZTo4NWRhNjc1ODIzNTc0MDZmOGQ0ZGI3OTRlNjEwNjBiMC90YWJsZXJhbmdlOjg1ZGE2NzU4MjM1NzQwNmY4ZDRkYjc5NGU2MTA2MGIwXzEzLTAtMS0xLTc1MDIyL3RleHRyZWdpb246YWM0N2Q1ZmQ3MjIxNGNkNTk2OWIxZjcyODE3MTZiNWJfMzg0ODI5MDY5NzgzNQ_2f47f977-9617-4162-9a2d-228c7072b94b">42</dei:AuditorFirmId>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b1c494708b64508a432d97a589ec1b1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMtMS0xLTEtMTk2MzU_ed51a452-6f16-426d-bf53-e4e3043527c5"
      unitRef="usd">203738000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad0aae9c9f234ff9a73812a8299c6fe2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMtMy0xLTEtMTk2MzU_881d1485-6bde-436e-8d59-a28cd23db5ea"
      unitRef="usd">190688000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04aed4c0666b4206a0f62a98a13ff94d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMtNS0xLTEtMTk2MzU_71837681-4daa-49fd-af13-56302f2aae91"
      unitRef="usd">185236000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:PremiumsEarnedNet
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzQtMS0xLTEtMTk2MzU_074b0727-d607-46a3-9b60-b477b575b0a3"
      unitRef="usd">76132000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzQtMy0xLTEtMTk2MzU_d6774641-d58d-4905-86ad-1bcf09921f5f"
      unitRef="usd">69364000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzQtNS0xLTEtMTk2MzU_2ebd117b-7d40-410b-a48f-9d0df5dba93d"
      unitRef="usd">63122000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb864d41b1c444a2a00ada6c841fd965_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzUtMS0xLTEtMTk2MzU_d35c6e2c-a483-4125-bd76-f05d0a16e914"
      unitRef="usd">11042000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e3c699aa82e4cebaf12b6a7d6a6a99f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzUtMy0xLTEtMTk2MzU_4ee329f3-4fbf-423d-8a29-55a08bb9934d"
      unitRef="usd">7856000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbd44c67114d44b491ec9aec28225e15_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzUtNS0xLTEtMTk2MzU_14a81d71-dd8d-4b84-952a-ecfcace68cf8"
      unitRef="usd">7407000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzYtMS0xLTEtMTk2MzU_f6d45f2a-0d0d-4bc7-b1f9-bb669ec86531"
      unitRef="usd">1199000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzYtMy0xLTEtMTk2MzU_bfa27cf6-60b5-41df-a2a0-7d99bd28e604"
      unitRef="usd">798000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzYtNS0xLTEtMTk2MzU_65396eb3-2832-4901-91ac-fd8b0d970ead"
      unitRef="usd">1011000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzctMS0xLTEtMTk2MzU_e5d761f8-bff1-4c3f-a857-c2bffc4051f6"
      unitRef="usd">292111000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzctMy0xLTEtMTk2MzU_60f10293-3c3a-4600-86a1-3ac92b4ff375"
      unitRef="usd">268706000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzctNS0xLTEtMTk2MzU_5a5df62b-1e6d-446c-bd36-7c80cda95ff6"
      unitRef="usd">256776000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzktMS0xLTEtMTk2MzU_63e9684d-5745-4a6d-8ec7-56a79265dd1e"
      unitRef="usd">175803000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzktMy0xLTEtMTk2MzU_6ac33646-ca7f-4846-a599-a26dddf92798"
      unitRef="usd">163981000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzktNS0xLTEtMTk2MzU_e589789a-2451-4ad1-9b2f-fee1a64f26f4"
      unitRef="usd">158719000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEwLTEtMS0xLTE5NjM1_ba6b4f0b-acd0-448e-83b2-883075f7fb49"
      unitRef="usd">64260000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEwLTMtMS0xLTE5NjM1_7c5bbfcc-9dbf-4a0f-b079-d5c17b20ad67"
      unitRef="usd">55679000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEwLTUtMS0xLTE5NjM1_51f28795-e924-4a69-8e19-9c65bfbd9803"
      unitRef="usd">52529000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <cvs:StoreImpairmentCharges
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzExLTEtMS0xLTU0ODg2_df1d90a4-edac-4032-8ffe-227c29ccc723"
      unitRef="usd">1358000000</cvs:StoreImpairmentCharges>
    <cvs:StoreImpairmentCharges
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzExLTMtMS0xLTU0ODg2_f8a050f6-53b8-4080-a469-3e0d1da3e7a4"
      unitRef="usd">0</cvs:StoreImpairmentCharges>
    <cvs:StoreImpairmentCharges
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzExLTUtMS0xLTU0ODg2_68493c06-ca2c-4079-95f4-53e8c87cfc52"
      unitRef="usd">231000000</cvs:StoreImpairmentCharges>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzExLTEtMS0xLTE5NjM1_83459672-f771-42c4-ac9f-0ffc116c8589"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzExLTMtMS0xLTE5NjM1_f7674ffd-e1d0-4844-8954-6d6b91c8bfda"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzExLTUtMS0xLTE5NjM1_7e068847-a110-4725-88e0-3ebfbb631661"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <cvs:OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEyLTEtMS0xLTE5NjM1_2fc77dd3-3eab-4616-bbd2-57db14428d50"
      unitRef="usd">37066000000</cvs:OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments>
    <cvs:OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEyLTMtMS0xLTE5NjM1_82cb6b1f-ca45-457f-acc4-e5776c23802c"
      unitRef="usd">35135000000</cvs:OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments>
    <cvs:OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEyLTUtMS0xLTE5NjM1_446d0769-d4b8-4c2a-964a-9c20e6973827"
      unitRef="usd">33310000000</cvs:OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments>
    <us-gaap:CostsAndExpenses
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEzLTEtMS0xLTE5NjM1_fda79f6c-6adf-4fff-80eb-5fc7654ade11"
      unitRef="usd">278918000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEzLTMtMS0xLTE5NjM1_ed956971-838b-4262-b03e-e779f709d9f5"
      unitRef="usd">254795000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzEzLTUtMS0xLTE5NjM1_05726286-8ffd-4536-9530-166e6759bbed"
      unitRef="usd">244789000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE0LTEtMS0xLTE5NjM1_c6595525-3d9d-4c9e-a78f-efc92e11fb3b"
      unitRef="usd">13193000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE0LTMtMS0xLTE5NjM1_375d4b99-295e-4687-944f-030b3e481a2b"
      unitRef="usd">13911000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE0LTUtMS0xLTE5NjM1_2a893dd5-cf34-49c5-8464-db376bf35c70"
      unitRef="usd">11987000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE1LTEtMS0xLTE5NjM1_2bf50131-c9a9-4f5b-bf0e-d4bab9a7603e"
      unitRef="usd">2503000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE1LTMtMS0xLTE5NjM1_8e3b63b0-2e0f-4f70-a245-682744bae3c2"
      unitRef="usd">2907000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE1LTUtMS0xLTE5NjM1_6563c308-0d93-454d-aeba-6bcbfc892760"
      unitRef="usd">3035000000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE2LTEtMS0xLTE5NjM1_ffb2ed5a-1d2c-416a-8a64-b80882cdb46d"
      unitRef="usd">-452000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE2LTMtMS0xLTE5NjM1_e9324632-90fe-4cb7-896e-11c71d6d0125"
      unitRef="usd">-1440000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE2LTUtMS0xLTE5NjM1_5d802bdc-5168-4d43-b38e-b4d946f27d9e"
      unitRef="usd">-79000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE3LTEtMS0xLTE5NjM1_c69b7d8e-13f6-4c8e-b6c2-76f5dc19199b"
      unitRef="usd">182000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE3LTMtMS0xLTE5NjM1_c5500b23-d855-470b-a816-fac895878716"
      unitRef="usd">206000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE3LTUtMS0xLTE5NjM1_3c03baa8-6c25-434b-aea7-1daf6006a6a9"
      unitRef="usd">124000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE4LTEtMS0xLTE5NjM1_779464b8-d867-418e-b8af-304953a0f737"
      unitRef="usd">10420000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE4LTMtMS0xLTE5NjM1_23a3338e-9cc8-4572-abac-2fe34430282e"
      unitRef="usd">9770000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE4LTUtMS0xLTE5NjM1_1deb739e-2bd9-466c-8809-3b0d69f7215f"
      unitRef="usd">8997000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE5LTEtMS0xLTE5NjM1_ebb769ab-ddc2-4766-8b44-45b2b7070222"
      unitRef="usd">2522000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE5LTMtMS0xLTE5NjM1_efd04343-fc63-47f9-b621-a8c2684e200f"
      unitRef="usd">2569000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzE5LTUtMS0xLTE5NjM1_07b42c61-3cbf-4665-bcf7-0f985334efcd"
      unitRef="usd">2366000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIwLTEtMS0xLTE5NjM1_979db47b-6805-46e0-991c-091818447fa6"
      unitRef="usd">7898000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIwLTMtMS0xLTE5NjM1_49192a1b-5222-4d12-897f-3d379539d6cf"
      unitRef="usd">7201000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIwLTUtMS0xLTE5NjM1_98947f14-987f-487d-8ea6-92df1e7ecf39"
      unitRef="usd">6631000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIxLTEtMS0xLTE5NjM1_0adf693b-4c38-4b09-8e19-17ed9fcba78f"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIxLTMtMS0xLTE5NjM1_294fa4a2-8cb5-45c2-845f-814e97c1f38c"
      unitRef="usd">-9000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIxLTUtMS0xLTE5NjM1_dc527405-6318-4016-850c-1cf3360f5c86"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIyLTEtMS0xLTE5NjM1_cd518ef2-bc6f-4084-8121-4b45dc784472"
      unitRef="usd">7898000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIyLTMtMS0xLTE5NjM1_d6a4c39c-3eac-4889-b0fc-544909292a0c"
      unitRef="usd">7192000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIyLTUtMS0xLTE5NjM1_d850f32a-305a-4df6-8713-897ce454f3a4"
      unitRef="usd">6631000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIzLTEtMS0xLTE5NjM1_8f5d1968-a24d-49a6-8c7d-ae2fb465e84f"
      unitRef="usd">-12000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIzLTMtMS0xLTE5NjM1_a02b958f-9cca-4456-ac1f-08eea9680618"
      unitRef="usd">13000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzIzLTUtMS0xLTE5NjM1_fcd784b8-8e3c-47db-a33c-86ad5b597df1"
      unitRef="usd">-3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI0LTEtMS0xLTE5NjM1_12c9104b-559b-4023-bca3-b23b18f058aa"
      unitRef="usd">7910000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI0LTMtMS0xLTE5NjM1_d04d02a4-36e0-49fe-aa7d-ecb3e82fa34b"
      unitRef="usd">7179000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI0LTUtMS0xLTE5NjM1_a1361448-3827-40a3-980d-7d7992b6ef00"
      unitRef="usd">6634000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI3LTEtMS0xLTE5NjM1_7d590c1d-937a-4216-886e-9e867dea1dcd"
      unitRef="usdPerShare">6.00</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI3LTMtMS0xLTE5NjM1_dfcd2dc0-2917-43e4-b23a-1c9d63953925"
      unitRef="usdPerShare">5.49</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI3LTUtMS0xLTE5NjM1_ad3d93ec-2f3c-41bb-bade-bf2d6c170e3c"
      unitRef="usdPerShare">5.10</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI4LTEtMS0xLTE5NjM1_38cc0b00-fec1-4958-8a37-79f7998a0e30"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI4LTMtMS0xLTE5NjM1_c247b389-d762-4e2d-8048-47f1aa054dd1"
      unitRef="usdPerShare">-0.01</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI4LTUtMS0xLTE5NjM1_c972c391-8262-4fdf-b620-12580083f3d1"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI5LTEtMS0xLTE5NjM1_77a84742-44e5-4d7f-be91-60b16f0ff867"
      unitRef="usdPerShare">6.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI5LTMtMS0xLTE5NjM1_2b827271-c2e3-454e-a6cf-c78e081006b4"
      unitRef="usdPerShare">5.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzI5LTUtMS0xLTE5NjM1_3e48898d-85f0-4db4-a9f1-22f97f93b63f"
      unitRef="usdPerShare">5.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMwLTEtMS0xLTE5NjM1_9d73d772-18c8-44c6-a51b-4c367ff0db9a"
      unitRef="shares">1319000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMwLTMtMS0xLTE5NjM1_e7e99a03-5c36-418d-bb90-3c1efb830e93"
      unitRef="shares">1309000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMwLTUtMS0xLTE5NjM1_31bc37c9-bb3d-4361-885b-2058b465c90c"
      unitRef="shares">1301000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMyLTEtMS0xLTE5NjM1_f5b8a036-3154-4150-97f1-1f24dfe1d4dd"
      unitRef="usdPerShare">5.95</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMyLTMtMS0xLTE5NjM1_86a5bce7-344a-4b70-b4fd-7c51ee0d9d77"
      unitRef="usdPerShare">5.47</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMyLTUtMS0xLTE5NjM1_b1dd4782-e759-435c-8d9e-5d1c31f9c3f0"
      unitRef="usdPerShare">5.08</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMzLTEtMS0xLTE5NjM1_d72ce382-079a-4a68-bd23-0067fe9a8101"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMzLTMtMS0xLTE5NjM1_3879fe24-9a06-4035-9052-a7ba2aa99ce9"
      unitRef="usdPerShare">-0.01</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzMzLTUtMS0xLTE5NjM1_70743065-6850-44bc-ace7-dcb771696f17"
      unitRef="usdPerShare">0</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM0LTEtMS0xLTE5NjM1_8a3ccd57-60df-4b94-a9b4-fc6dd8514b26"
      unitRef="usdPerShare">5.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM0LTMtMS0xLTE5NjM1_21a38801-e480-4ff0-a886-48024362c759"
      unitRef="usdPerShare">5.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM0LTUtMS0xLTE5NjM1_ff7f1b08-821f-4468-9011-fe5e507af0e5"
      unitRef="usdPerShare">5.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM1LTEtMS0xLTE5NjM1_66a56f2b-73ac-4a85-9138-95370707e2bd"
      unitRef="shares">1329000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM1LTMtMS0xLTE5NjM1_d5d38fc0-1664-46e4-ba3d-1aaebf55d20b"
      unitRef="shares">1314000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM1LTUtMS0xLTE5NjM1_163ba47e-a7e7-44ba-bbb9-32a35d2d5dc3"
      unitRef="shares">1305000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM2LTEtMS0xLTE5NjM1_b05a0ecd-9a8b-49d9-8d76-e4cb66b12a8c"
      unitRef="usdPerShare">2.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM2LTMtMS0xLTE5NjM1_218605cc-e317-47ed-aeb9-174e104e3d7d"
      unitRef="usdPerShare">2.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDMvZnJhZzpjY2NhN2Y0ZTc4NWU0NzNiODA2ZDAwNzQ3OGE0ZjkyOC90YWJsZTpiNmRlZjE4M2YzNDY0YzIyOGI1MjMwNWI2OGE0ZmZjYS90YWJsZXJhbmdlOmI2ZGVmMTgzZjM0NjRjMjI4YjUyMzA1YjY4YTRmZmNhXzM2LTUtMS0xLTE5NjM1_7b323639-128c-45a7-a674-d1b58bd6a17e"
      unitRef="usdPerShare">2.00</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ProfitLoss
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzItMS0xLTEtMTk2MzU_cd518ef2-bc6f-4084-8121-4b45dc784472"
      unitRef="usd">7898000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzItMy0xLTEtMTk2MzU_d6a4c39c-3eac-4889-b0fc-544909292a0c"
      unitRef="usd">7192000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzItNS0xLTEtMTk2MzU_d850f32a-305a-4df6-8713-897ce454f3a4"
      unitRef="usd">6631000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzQtMS0xLTEtMTk2MzU_3b51d37a-d548-4ee2-b8d4-76a8d340e709"
      unitRef="usd">-436000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzQtMy0xLTEtMTk2MzU_535a7282-0003-41fb-9f74-22ca7e553e85"
      unitRef="usd">440000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzQtNS0xLTEtMTk2MzU_b4a99237-af0e-44c4-8a77-73fe5a32f3fa"
      unitRef="usd">677000000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzUtMS0xLTEtMTk2MzU_70caa640-c522-4509-84a3-ea3c94a32cc5"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzUtMy0xLTEtMTk2MzU_6ca51956-afca-4b99-ab97-8e05af303ea2"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzUtNS0xLTEtMTk2MzU_5e2c1d8f-f8e3-4a07-9a8b-9dd32b31927b"
      unitRef="usd">162000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzYtMS0xLTEtMTk2MzU_81fe1ca5-118c-4875-9a46-66c340fb1ae0"
      unitRef="usd">-26000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzYtMy0xLTEtMTk2MzU_027b6a20-f477-4f7c-85af-e8a864e123c7"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzYtNS0xLTEtMTk2MzU_263a6183-8e43-4eee-b7b7-3c487c083862"
      unitRef="usd">-33000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzctMS0xLTEtMTk2MzU_eefd6293-22ad-42b7-a91b-6da7c3968a13"
      unitRef="usd">-20000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzctMy0xLTEtMTk2MzU_6cf57425-7849-434a-8bb2-8facedbdcc9c"
      unitRef="usd">17000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzctNS0xLTEtMTk2MzU_655105fd-42b2-4f1b-a4c3-6a031901c1f8"
      unitRef="usd">-111000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzgtMS0xLTEtMTk2MzU_eef6559a-abe3-4299-bea8-9f97e5554331"
      unitRef="usd">-449000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzgtMy0xLTEtMTk2MzU_a1b78711-2601-4d16-a3dc-5deea61fda9f"
      unitRef="usd">395000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzgtNS0xLTEtMTk2MzU_4216b621-dbd2-43dd-8d74-b1317fe37c3b"
      unitRef="usd">917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzktMS0xLTEtMTk2MzU_d08298f6-85de-4c96-85a1-a03bc183b625"
      unitRef="usd">7449000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzktMy0xLTEtMTk2MzU_ecc6ef40-fbab-4718-bf4c-b36afadf16f7"
      unitRef="usd">7587000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzktNS0xLTEtMTk2MzU_05a4668a-6fdd-4295-9289-042a54270eff"
      unitRef="usd">7548000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzEwLTEtMS0xLTE5NjM1_23fef9b6-2371-4666-af49-098efc0f0dc0"
      unitRef="usd">-12000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzEwLTMtMS0xLTE5NjM1_33677bce-f715-44e2-bc0c-cbd287807575"
      unitRef="usd">13000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzEwLTUtMS0xLTE5NjM1_4741bb78-7eea-4ce3-a235-5e9ecb0717a4"
      unitRef="usd">-3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzExLTEtMS0xLTE5NjM1_6a31bb2c-d0c2-4dd8-8864-a5978bb74cc2"
      unitRef="usd">7461000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzExLTMtMS0xLTE5NjM1_774820c3-bc4e-4588-86ec-078f297807a1"
      unitRef="usd">7574000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMDkvZnJhZzozNDQxM2Y3NTUyZWU0NzEwOTI4M2Q2MDcwOGVkYzA3OC90YWJsZTo0N2I3MzlmODAyYmY0YjBjYjdiMWJhYTliN2JmNjZkNC90YWJsZXJhbmdlOjQ3YjczOWY4MDJiZjRiMGNiN2IxYmFhOWI3YmY2NmQ0XzExLTUtMS0xLTE5NjM1_7c3801cb-cbf4-45a2-81cd-e5c4dfe4052a"
      unitRef="usd">7551000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMtMS0xLTEtMTk2MzU_f5cc04aa-c641-4c96-9046-12137ac56422"
      unitRef="usd">9408000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMtMy0xLTEtMTk2MzU_c6dae105-688e-42f8-af5e-b8f75a2bf934"
      unitRef="usd">7854000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQtMS0xLTEtMTk2MzU_b8fa5cac-6d13-41a5-9c68-afbf5523e9a7"
      unitRef="usd">3117000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQtMy0xLTEtMTk2MzU_6addb5c5-2255-472e-a193-082fe5acc2eb"
      unitRef="usd">3000000000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzUtMS0xLTEtMTk2MzU_eb05dacb-b665-4232-a320-649507536e23"
      unitRef="usd">24431000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzUtMy0xLTEtMTk2MzU_3f1b6810-f5f3-4800-9cc5-070968a25318"
      unitRef="usd">21742000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzYtMS0xLTEtMTk2MzU_de2345e3-55ee-49f8-81db-a5d7abecef53"
      unitRef="usd">17760000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzYtMy0xLTEtMTk2MzU_d70ec9cc-dad0-4ead-8624-dd2a92069a21"
      unitRef="usd">18496000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzctMS0xLTEtMTk2MzU_c0a73019-2c65-494c-9196-b1b224d7c48d"
      unitRef="usd">5292000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzctMy0xLTEtMTk2MzU_c490108b-336b-441f-a48a-73c47a76b771"
      unitRef="usd">5277000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzgtMS0xLTEtMTk2MzU_8e872c6c-d0be-4cd5-82bd-fe00465c9402"
      unitRef="usd">60008000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzgtMy0xLTEtMTk2MzU_04d9aa8b-ef68-489b-abf9-ba8dbb6e2159"
      unitRef="usd">56369000000</us-gaap:AssetsCurrent>
    <us-gaap:LongTermInvestments
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzktMS0xLTEtMTk2MzU_716e172c-63bb-410b-a0e2-e34e228c2528"
      unitRef="usd">23025000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzktMy0xLTEtMTk2MzU_a89b5022-023d-4370-94ab-4a82ae8a61bc"
      unitRef="usd">20812000000</us-gaap:LongTermInvestments>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzEwLTEtMS0xLTE5NjM1_c5f7d540-6891-4e77-9b73-6181f290d67f"
      unitRef="usd">12896000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzEwLTMtMS0xLTE5NjM1_6a20807a-07b6-428c-bc7a-73f7b2d1e067"
      unitRef="usd">12606000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzExLTEtMS0xLTE5NjM1_02b35e5a-fac2-4724-a69f-fcd315a0e2f4"
      unitRef="usd">19122000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzExLTMtMS0xLTE5NjM1_13015cc3-7480-4fb0-8a70-15ec21001989"
      unitRef="usd">20729000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzEyLTEtMS0xLTE5NjM1_68789c5d-b3fe-4be8-92b9-c58c5b531753"
      unitRef="usd">79121000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzEyLTMtMS0xLTE5NjM1_352fb464-05c1-4f24-ba2a-bbbd87c13525"
      unitRef="usd">79552000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzEzLTEtMS0xLTE5NjM1_4e45f40f-7d49-4de4-ae6c-bc1e5b572c62"
      unitRef="usd">29026000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzEzLTMtMS0xLTE5NjM1_276b742f-d931-4e54-8256-dfcc51aa3673"
      unitRef="usd">31142000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:SeparateAccountAssets
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzE0LTEtMS0xLTE5NjM1_95b6dad9-7280-4b7b-b3e7-8f6f40ba1358"
      unitRef="usd">5087000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzE0LTMtMS0xLTE5NjM1_d9eccfbc-5e92-4c45-a6a2-814f34566431"
      unitRef="usd">4881000000</us-gaap:SeparateAccountAssets>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzE1LTEtMS0xLTE5NjM1_56410a04-78da-4791-8ef5-ccc24b1ff346"
      unitRef="usd">4714000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzE1LTMtMS0xLTE5NjM1_ef235398-0cb2-441c-b40a-0899ae95c1f2"
      unitRef="usd">4624000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzE2LTEtMS0xLTE5NjM1_64d6d074-ffe3-4ee6-bf6a-c2b5bf0b390c"
      unitRef="usd">232999000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzE2LTMtMS0xLTE5NjM1_1e7721d1-193b-44a4-b835-b6439ca62bcf"
      unitRef="usd">230715000000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzE5LTEtMS0xLTE5NjM1_fe7121ec-6d43-4188-8dce-338138b6c7ea"
      unitRef="usd">12544000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzE5LTMtMS0xLTE5NjM1_a9a32aa7-0594-4cd9-a3f7-949ecb84aa75"
      unitRef="usd">11138000000</us-gaap:AccountsPayableTradeCurrent>
    <cvs:PharmacyClaimsandDiscountsPayableCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzIwLTEtMS0xLTE5NjM1_fff96ae4-071c-40be-b453-65a3957beae6"
      unitRef="usd">17330000000</cvs:PharmacyClaimsandDiscountsPayableCurrent>
    <cvs:PharmacyClaimsandDiscountsPayableCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzIwLTMtMS0xLTE5NjM1_80f8054c-bd3d-47f3-b857-3162edb03b2e"
      unitRef="usd">15795000000</cvs:PharmacyClaimsandDiscountsPayableCurrent>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzIxLTEtMS0xLTE5NjM1_72da33e9-3511-4dae-b7be-dafd25882a9c"
      unitRef="usd">8808000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzIxLTMtMS0xLTE5NjM1_187dd936-f5e5-43a2-9458-db516d8792ef"
      unitRef="usd">7936000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:OtherPolicyholderFunds
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzIyLTEtMS0xLTE5NjM1_cf850842-5b0b-4f26-aba5-eaba9fdc4a5e"
      unitRef="usd">4301000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:OtherPolicyholderFunds
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzIyLTMtMS0xLTE5NjM1_94110204-3032-42f4-a1bb-0642d7387939"
      unitRef="usd">4270000000</us-gaap:OtherPolicyholderFunds>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzIzLTEtMS0xLTE5NjM1_ab396c2c-1683-4a63-ab6a-e6031b572185"
      unitRef="usd">17670000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzIzLTMtMS0xLTE5NjM1_7a2d25bd-9784-4806-a729-e601726f3b7f"
      unitRef="usd">14243000000</us-gaap:AccruedLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI0LTEtMS0xLTE5NjM1_7fcd3e35-30af-485b-8be9-6003a27b6445"
      unitRef="usd">1303000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <cvs:OtherInsuranceLiabilitiesCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI0LTMtMS0xLTE5NjM1_a1479ea4-07a3-46d6-aa22-e60efc294d97"
      unitRef="usd">1557000000</cvs:OtherInsuranceLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI1LTEtMS0xLTE5NjM1_552d66b1-7423-4b6c-8d6f-231b2ee66573"
      unitRef="usd">1646000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI1LTMtMS0xLTE5NjM1_a1f6f1b2-6d18-4db6-bd09-dd30549f7310"
      unitRef="usd">1638000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI3LTEtMS0xLTE5NjM1_63434eca-8303-44bd-90a5-335dd6128d71"
      unitRef="usd">4205000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI3LTMtMS0xLTE5NjM1_55ae75b5-9911-473e-a2ff-dfbac61b3d73"
      unitRef="usd">5440000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI4LTEtMS0xLTE5NjM1_00cd14b1-167e-49c9-9546-52117af98c7a"
      unitRef="usd">67807000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI4LTMtMS0xLTE5NjM1_06cf8e13-3a04-4070-a3e3-0b559db13250"
      unitRef="usd">62017000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI5LTEtMS0xLTE5NjM1_2d18264a-fab4-4f9e-bee1-41bd32c8bb6f"
      unitRef="usd">18177000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzI5LTMtMS0xLTE5NjM1_89e4d666-5188-4987-a638-2a2591b87695"
      unitRef="usd">18757000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMwLTEtMS0xLTE5NjM1_ba3fcc44-0d5f-442d-b93c-2b1510045a05"
      unitRef="usd">51971000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMwLTMtMS0xLTE5NjM1_57922b55-6db6-48f0-9391-f1e2e85dbb9a"
      unitRef="usd">59207000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMxLTEtMS0xLTE5NjM1_7e839379-6753-4fbb-8754-2c65e4b982e9"
      unitRef="usd">6270000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMxLTMtMS0xLTE5NjM1_1bb5b9f0-b97f-4166-833b-d97b0b990bef"
      unitRef="usd">6794000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:SeparateAccountsLiability
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMyLTEtMS0xLTE5NjM1_b455440d-ecdf-4bc2-b307-d8a24b691c37"
      unitRef="usd">5087000000</us-gaap:SeparateAccountsLiability>
    <us-gaap:SeparateAccountsLiability
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMyLTMtMS0xLTE5NjM1_5d4dbda2-c1af-441d-bc4a-6328c43182b7"
      unitRef="usd">4881000000</us-gaap:SeparateAccountsLiability>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMzLTEtMS0xLTE5NjM1_f5305791-f970-4e7b-9105-cec3bf5b74bd"
      unitRef="usd">6402000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <cvs:OtherInsuranceLiabilitiesNoncurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzMzLTMtMS0xLTE5NjM1_ba2d47a2-4f8c-4d05-8aab-bdddf3a66a12"
      unitRef="usd">7007000000</cvs:OtherInsuranceLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM0LTEtMS0xLTE5NjM1_342ad8d2-f622-45d8-a61f-ec68d879efe3"
      unitRef="usd">1904000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM0LTMtMS0xLTE5NjM1_baa6fbe1-dc52-4561-9f71-f03628270525"
      unitRef="usd">2351000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM1LTEtMS0xLTE5NjM1_9dab007d-7c03-4e19-a62b-96f74b197610"
      unitRef="usd">157618000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM1LTMtMS0xLTE5NjM1_7b2d29a0-90be-4a68-980d-febe22d54925"
      unitRef="usd">161014000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM2LTEtMS0xLTE5NjM1_ab5d2f59-d087-4a9b-a266-b45cf90289be"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM2LTMtMS0xLTE5NjM1_30353ecb-62bf-430c-911f-2deabed6a21d"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDlkZGNlNmIzMmMyNGQzZmFhYWRlOWFiMmMyNDQ3M2NfMzE_a7387f64-998e-46c9-b0bb-097cc667ca67"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDlkZGNlNmIzMmMyNGQzZmFhYWRlOWFiMmMyNDQ3M2NfMzE_c5b8a22f-7ec0-48d0-bf65-e1228ccceef0"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDlkZGNlNmIzMmMyNGQzZmFhYWRlOWFiMmMyNDQ3M2NfMzU_7ed259e0-78b6-4f2d-8b9b-94be56ade6b1"
      unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDlkZGNlNmIzMmMyNGQzZmFhYWRlOWFiMmMyNDQ3M2NfMzU_ba8c5ab2-6288-4c34-b7ee-54cef96bd12e"
      unitRef="shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDlkZGNlNmIzMmMyNGQzZmFhYWRlOWFiMmMyNDQ3M2NfNTc_6bc7ac6d-f80a-4d55-b445-46a89b834dfd"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDlkZGNlNmIzMmMyNGQzZmFhYWRlOWFiMmMyNDQ3M2NfNTc_787cb0d6-1584-462d-b714-75359fbcc15a"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDlkZGNlNmIzMmMyNGQzZmFhYWRlOWFiMmMyNDQ3M2NfNTc_bd54e186-d082-4d4b-9f55-806cd054204e"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDlkZGNlNmIzMmMyNGQzZmFhYWRlOWFiMmMyNDQ3M2NfNTc_fe4a3d5c-78be-4829-8703-5b5fef00d001"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTEtMS0xLTE5NjM1_a9ad9f3d-9c89-435b-a04d-154dc8341cae"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzM5LTMtMS0xLTE5NjM1_9cd3489d-7e21-476b-91e4-023c0876033c"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjRlYWFjNDY5MjBkNDQ5ZGFiYzE5NDViM2I0OWYyZGNfMjg_92d6359e-bd24-4319-b64f-7d0c56cf1860"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjRlYWFjNDY5MjBkNDQ5ZGFiYzE5NDViM2I0OWYyZGNfMjg_9ea13e7a-6527-4241-9fb7-3acb8894f67e"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjRlYWFjNDY5MjBkNDQ5ZGFiYzE5NDViM2I0OWYyZGNfMzI_6216534b-da1f-45ff-b50e-a6620df1c65d"
      unitRef="shares">3200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjRlYWFjNDY5MjBkNDQ5ZGFiYzE5NDViM2I0OWYyZGNfMzI_da1cdb4e-deb6-4abd-9256-419bea07e9bd"
      unitRef="shares">3200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjRlYWFjNDY5MjBkNDQ5ZGFiYzE5NDViM2I0OWYyZGNfNTQ_f0dcce00-f7f4-4cba-957a-944d1d38de66"
      unitRef="shares">1744000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjRlYWFjNDY5MjBkNDQ5ZGFiYzE5NDViM2I0OWYyZGNfNzU_7b271a29-b54d-48f0-9a5c-43d1e267a350"
      unitRef="shares">1322000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjRlYWFjNDY5MjBkNDQ5ZGFiYzE5NDViM2I0OWYyZGNfMTIy_bce23ca8-05cd-42d9-ad39-a42392a722b3"
      unitRef="shares">1733000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjRlYWFjNDY5MjBkNDQ5ZGFiYzE5NDViM2I0OWYyZGNfMTQz_20a7b114-dad5-48e8-8cae-73d3819df739"
      unitRef="shares">1310000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTEtMS0xLTE5NjM1_300206ce-27f5-4246-bca6-aecfdfcc3456"
      unitRef="usd">47377000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQwLTMtMS0xLTE5NjM1_7ef2884c-9a0c-4fa0-9407-700ae3974995"
      unitRef="usd">46513000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQxLTAtMS0xLTE5NjM1L3RleHRyZWdpb246YzRjYWY3NjgyZTM4NDg2M2I0ZjYwM2MzZTAwYWE1YTZfMjk_2a71a285-487e-41d9-9193-46ac28410af4"
      unitRef="shares">422000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQxLTAtMS0xLTE5NjM1L3RleHRyZWdpb246YzRjYWY3NjgyZTM4NDg2M2I0ZjYwM2MzZTAwYWE1YTZfMzY_7e644d59-ba32-4562-8ef4-c2632c0b4bb7"
      unitRef="shares">423000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQxLTEtMS0xLTE5NjM1_7ca11a1d-a16b-48e4-a4a1-d24cb100a237"
      unitRef="usd">28173000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQxLTMtMS0xLTE5NjM1_c8738445-f38a-4138-be92-621a4c1d877c"
      unitRef="usd">28178000000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQyLTEtMS0xLTE5NjM1_f7b4c311-f011-4b1e-a750-a4a9943270f7"
      unitRef="usd">54906000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQyLTMtMS0xLTE5NjM1_54d11563-29f7-4162-b44e-9b713850692c"
      unitRef="usd">49640000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQzLTEtMS0xLTE5NjM1_62be6c45-2938-4111-bf41-e4690391d04c"
      unitRef="usd">965000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQzLTMtMS0xLTE5NjM1_1bf38c9c-f017-4951-8bcd-f34665700743"
      unitRef="usd">1414000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQ0LTEtMS0xLTE5NjM1_3aa2c329-f69c-4e8e-909f-7394d3fe17ba"
      unitRef="usd">75075000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQ0LTMtMS0xLTE5NjM1_f015a635-1d8e-4245-a8ba-62ca0d228f81"
      unitRef="usd">69389000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQ1LTEtMS0xLTE5NjM1_37a31958-e90e-4fb1-9466-e0d1bcadaa66"
      unitRef="usd">306000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQ1LTMtMS0xLTE5NjM1_81a668fa-01f8-477b-a3a8-2520723fcd8a"
      unitRef="usd">312000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQ2LTEtMS0xLTE5NjM1_4bf45e92-0096-4768-a785-6a67cfc3744d"
      unitRef="usd">75381000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQ2LTMtMS0xLTE5NjM1_b59f40bc-a570-45fa-b2cb-50455f4a96b3"
      unitRef="usd">69701000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQ3LTEtMS0xLTE5NjM1_241d1398-a2b0-454a-873e-7bdfa341a4c6"
      unitRef="usd">232999000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTIvZnJhZzowMmUzZDYyNjZlMWM0MDVhYmUyMTQ3ODM3NjQyMTczYS90YWJsZTpiMTcxOGFhM2M2ZDM0ZWIxOTczY2JiNzMyYTI5ZDQ4OC90YWJsZXJhbmdlOmIxNzE4YWEzYzZkMzRlYjE5NzNjYmI3MzJhMjlkNDg4XzQ3LTMtMS0xLTE5NjM1_ffa7ee7d-e80e-426d-add1-3d3f4b84bbda"
      unitRef="usd">230715000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProceedsFromCustomers
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMtMS0xLTEtMTk2MzU_7437e87f-7278-4559-afb0-f3cfd72eb652"
      unitRef="usd">284219000000</us-gaap:ProceedsFromCustomers>
    <us-gaap:ProceedsFromCustomers
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMtMy0xLTEtMTk2MzU_f5dcf690-57a6-4d83-8d9f-d643c2901294"
      unitRef="usd">264327000000</us-gaap:ProceedsFromCustomers>
    <us-gaap:ProceedsFromCustomers
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMtNS0xLTEtMTk2MzU_4c396255-d647-41a5-8b03-0887b73b033f"
      unitRef="usd">248393000000</us-gaap:ProceedsFromCustomers>
    <cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzQtMS0xLTEtMTk2MzU_2fd2727e-eae1-4cee-bb40-c346c75ee06a"
      unitRef="usd">165783000000</cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies>
    <cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzQtMy0xLTEtMTk2MzU_9c2809ba-8939-448e-bc89-9fba1e9d5c3d"
      unitRef="usd">158636000000</cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies>
    <cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzQtNS0xLTEtMTk2MzU_f07218d2-afa6-4902-b58e-8b35c63fb7b6"
      unitRef="usd">149655000000</cvs:PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies>
    <cvs:PaymentsforInsuranceBenefits
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzUtMS0xLTEtMTk2MzU_7a370814-fdeb-4057-b2cf-72315e355bd6"
      unitRef="usd">63598000000</cvs:PaymentsforInsuranceBenefits>
    <cvs:PaymentsforInsuranceBenefits
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzUtMy0xLTEtMTk2MzU_b2d22d86-c691-4a61-947c-75261a354685"
      unitRef="usd">55124000000</cvs:PaymentsforInsuranceBenefits>
    <cvs:PaymentsforInsuranceBenefits
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzUtNS0xLTEtMTk2MzU_6c558b49-8539-450e-a3f2-ef0656b71da2"
      unitRef="usd">52242000000</cvs:PaymentsforInsuranceBenefits>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzYtMS0xLTEtMTk2MzU_cd55727c-f2d0-4699-9947-d9e1c927e87c"
      unitRef="usd">31652000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzYtMy0xLTEtMTk2MzU_7e9e8376-f822-41cf-b46b-09f96a220a46"
      unitRef="usd">29763000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:PaymentsToSuppliersAndEmployees
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzYtNS0xLTEtMTk2MzU_aeb8c8c3-efda-4f18-a772-9c527f8e00e3"
      unitRef="usd">28932000000</us-gaap:PaymentsToSuppliersAndEmployees>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzctMS0xLTEtMTk2MzU_9f487421-7eeb-4406-9c30-157097865377"
      unitRef="usd">743000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzctMy0xLTEtMTk2MzU_9bfa18aa-f3bd-40bf-a5de-5675be48a045"
      unitRef="usd">894000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:ProceedsFromInterestAndDividendsReceived
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzctNS0xLTEtMTk2MzU_9f5b88ff-7c69-461b-abcb-941846be116d"
      unitRef="usd">955000000</us-gaap:ProceedsFromInterestAndDividendsReceived>
    <us-gaap:InterestPaidNet
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzgtMS0xLTEtMTk2MzU_a681766b-8caf-49c4-a345-1f0917878a79"
      unitRef="usd">2469000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzgtMy0xLTEtMTk2MzU_2c30ab10-3e8c-477b-bbce-44b52656c13a"
      unitRef="usd">2904000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzgtNS0xLTEtMTk2MzU_d9ca7a3d-e6b2-4b87-a473-6ba374309123"
      unitRef="usd">2954000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzktMS0xLTEtMTk2MzU_e58fa5f5-c653-4de7-b8f8-b0857518aba9"
      unitRef="usd">3195000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzktMy0xLTEtMTk2MzU_e113b417-8fab-4c68-b05f-b6eb0c451260"
      unitRef="usd">2929000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzktNS0xLTEtMTk2MzU_1f32d040-07f0-4266-91ba-bf4f52cefa0b"
      unitRef="usd">2717000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzEwLTEtMS0xLTE5NjM1_284c04fb-383e-411a-ac18-d01b6efab3ce"
      unitRef="usd">18265000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzEwLTMtMS0xLTE5NjM1_9896e395-1b4a-4152-9f5a-207addca8dd0"
      unitRef="usd">15865000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzEwLTUtMS0xLTE5NjM1_f747a230-74c0-4c11-81c6-5195569f6053"
      unitRef="usd">12848000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzEzLTEtMS0xLTE5NjM1_30f976fa-c958-44a0-b83d-257012d00294"
      unitRef="usd">7246000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzEzLTMtMS0xLTE5NjM1_617a0b63-2ffe-4a76-bbbb-db91a14266de"
      unitRef="usd">6467000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzEzLTUtMS0xLTE5NjM1_3cdee541-ce91-449c-82b1-46369e7659b5"
      unitRef="usd">7049000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE0LTEtMS0xLTE5NjM1_e2c3c14b-1603-4ce4-83b6-d72715fafc40"
      unitRef="usd">9963000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE0LTMtMS0xLTE5NjM1_4396ddc4-2d0a-4270-ae62-6d6e68d4e8c4"
      unitRef="usd">9639000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE0LTUtMS0xLTE5NjM1_ce6e49cf-d4eb-4856-8c1d-7d9943a3368d"
      unitRef="usd">7534000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE1LTEtMS0xLTE5NjM1_2dd2018c-a637-431b-8bab-efb2f5f1ab9b"
      unitRef="usd">2520000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE1LTMtMS0xLTE5NjM1_333c896f-1b57-4793-81b6-65ae0f46c937"
      unitRef="usd">2437000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE1LTUtMS0xLTE5NjM1_39a48adb-2173-4668-82d2-d9b708bc01b5"
      unitRef="usd">2457000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE2LTEtMS0xLTE5NjM1_36ac42e0-6626-439f-8517-aa9e2a780d0c"
      unitRef="usd">0</us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity>
    <us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE2LTMtMS0xLTE5NjM1_f75f7d52-4971-4ce3-9595-d603b1857654"
      unitRef="usd">101000000</us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity>
    <us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE2LTUtMS0xLTE5NjM1_df0818cf-a0d8-4b04-88a3-4fd392aafd37"
      unitRef="usd">5000000</us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE3LTEtMS0xLTE5NjM1_59593d3e-9b31-4a44-a13e-21e8fe8549c8"
      unitRef="usd">146000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE3LTMtMS0xLTE5NjM1_80cbf144-4404-4950-b7d7-a9a8b66db3ac"
      unitRef="usd">866000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE3LTUtMS0xLTE5NjM1_ebae0bbc-ca5a-4dfc-93ce-2e05fef48c9a"
      unitRef="usd">444000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE4LTEtMS0xLTE5NjM1_ca301417-1606-4b5b-a2c8-4ea0b052116c"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE4LTMtMS0xLTE5NjM1_2f1b622b-73d7-4eba-8028-bb301ef2d921"
      unitRef="usd">840000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE4LTUtMS0xLTE5NjM1_5b50b977-a6b1-4614-8df4-59067bc20306"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE5LTEtMS0xLTE5NjM1_33f1b9a2-fcb1-43ce-9a8f-04541d1c927e"
      unitRef="usd">-122000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE5LTMtMS0xLTE5NjM1_5abdfd51-0a82-4520-b199-b44f7c404a06"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzE5LTUtMS0xLTE5NjM1_ebdbe7d7-8c9b-4582-81f0-dbd609f87599"
      unitRef="usd">-42000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzIwLTEtMS0xLTE5NjM1_d1b9c8f6-c0e0-40ba-bbc2-f3df78491dbf"
      unitRef="usd">-5261000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzIwLTMtMS0xLTE5NjM1_f87fb9dc-4d7d-4ebd-85f4-8d137af5f5c8"
      unitRef="usd">-5534000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzIwLTUtMS0xLTE5NjM1_874dacd8-f4b4-4ad7-8d0a-e3834e8d05c4"
      unitRef="usd">-3339000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzIzLTEtMS0xLTE5NjM1_6c4f4146-87f1-45db-903f-b87a54659051"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzIzLTMtMS0xLTE5NjM1_3b7a3f06-446d-4ea4-8966-fa1c4ee01da3"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzIzLTUtMS0xLTE5NjM1_32b07263-16f6-40f1-82d2-f7cae0df6c97"
      unitRef="usd">-720000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI0LTEtMS0xLTE5NjM1_2b5908ec-aa22-4f6f-af0e-dfa0aefc391a"
      unitRef="usd">987000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI0LTMtMS0xLTE5NjM1_5d07fcde-cef4-4873-a4d0-8cbcb436fbae"
      unitRef="usd">9958000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI0LTUtMS0xLTE5NjM1_8bc37e76-ade6-4aac-8300-7996ee319030"
      unitRef="usd">3736000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI1LTEtMS0xLTE5NjM1_b774b2a1-da08-4d1b-9d6d-4c4d905837b8"
      unitRef="usd">10254000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI1LTMtMS0xLTE5NjM1_74d0cd9b-8ea5-4455-bdc0-b6365118be36"
      unitRef="usd">15631000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI1LTUtMS0xLTE5NjM1_f774d4b2-5a5c-4760-a476-a187c417abb9"
      unitRef="usd">8336000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI2LTEtMS0xLTE5NjM1_f658968a-5435-4cb2-862b-dba2bf414125"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI2LTMtMS0xLTE5NjM1_2775d5a5-c13a-4d90-b96d-b1568f35be1b"
      unitRef="usd">7000000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI2LTUtMS0xLTE5NjM1_7fce72f9-dd63-4b31-9895-b63f0c38bb56"
      unitRef="usd">25000000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:PaymentsOfDividends
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI4LTEtMS0xLTE5NjM1_f0feb582-c055-4bb3-887d-a1cd90bbc01c"
      unitRef="usd">2625000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI4LTMtMS0xLTE5NjM1_81947dfc-2068-4a6a-85b4-a69752bd78c3"
      unitRef="usd">2624000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI4LTUtMS0xLTE5NjM1_8df9d6b3-d5ee-4718-87a9-4ff5012f4dd0"
      unitRef="usd">2603000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI5LTEtMS0xLTE5NjM1_476ea744-ed25-490c-a6b0-81cce40c28d9"
      unitRef="usd">549000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI5LTMtMS0xLTE5NjM1_1abf4e42-89ff-4d17-bec5-d2ba80f18a0c"
      unitRef="usd">264000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzI5LTUtMS0xLTE5NjM1_532e8ad6-4e34-4bd9-b554-b01534bf950d"
      unitRef="usd">210000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMwLTEtMS0xLTE5NjM1_d587d60a-9990-4601-bc08-196506e5d20a"
      unitRef="usd">168000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMwLTMtMS0xLTE5NjM1_3e9c9913-5fa8-4b0b-8847-98b58dac8e90"
      unitRef="usd">88000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMwLTUtMS0xLTE5NjM1_855dccc9-80ac-4c8d-922a-31bd4c6c90fe"
      unitRef="usd">112000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMxLTEtMS0xLTE5NjM1_c433d303-0f12-4ada-b8cf-986f97b526f5"
      unitRef="usd">155000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMxLTMtMS0xLTE5NjM1_09bed019-66a8-4db5-b9b2-1085b3cffe7b"
      unitRef="usd">432000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMxLTUtMS0xLTE5NjM1_e417f9d3-6900-4e65-9f25-5968036a9636"
      unitRef="usd">196000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMyLTEtMS0xLTE5NjM1_38249492-fbe5-4d75-b1d5-45b1204e88f0"
      unitRef="usd">-11356000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMyLTMtMS0xLTE5NjM1_58932c13-266e-4cca-9631-db91192f88e5"
      unitRef="usd">-7696000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzMyLTUtMS0xLTE5NjM1_a37f9cb2-6b8e-47c5-8d20-7ddbba898a70"
      unitRef="usd">-7654000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM0LTEtMS0xLTE5NjM1_079eaa38-3b68-485f-b1e1-904420e5a1bf"
      unitRef="usd">1648000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM0LTMtMS0xLTE5NjM1_2f7e5272-0473-4bd7-9285-5af5c793b74e"
      unitRef="usd">2635000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM0LTUtMS0xLTE5NjM1_5aa33cc4-eb04-4409-943a-e67358e4e321"
      unitRef="usd">1855000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM1LTEtMS0xLTE5NjM1_221fb4ec-e7dc-4848-a5bc-aba38210777f"
      unitRef="usd">11043000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM1LTMtMS0xLTE5NjM1_5da5d97d-2a54-4ffa-9cf1-1a6096fdcd12"
      unitRef="usd">8408000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i23e34e947aac44fc9f5cf5448f94f452_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM1LTUtMS0xLTE5NjM1_cc38810b-b16d-4323-ae2c-99f0e9b93345"
      unitRef="usd">6553000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM2LTEtMS0xLTE5NjM1_e6cf54b8-a7ea-4187-a1a7-1d9497f211fe"
      unitRef="usd">12691000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM2LTMtMS0xLTE5NjM1_6412e66a-6a3a-47f7-97b7-3bbc25e6ed8a"
      unitRef="usd">11043000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpmMjI2ZGI3YWE4NDQ0MjI4ODRhOTc1NjRmNmFlZTA2Mi90YWJsZXJhbmdlOmYyMjZkYjdhYTg0NDQyMjg4NGE5NzU2NGY2YWVlMDYyXzM2LTUtMS0xLTE5NjM1_6e870ba4-be71-4cdd-85a5-963d5f7e5fcb"
      unitRef="usd">8408000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ProfitLoss
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzMtMS0xLTEtMTk2MzU_cd518ef2-bc6f-4084-8121-4b45dc784472"
      unitRef="usd">7898000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzMtMy0xLTEtMTk2MzU_d6a4c39c-3eac-4889-b0fc-544909292a0c"
      unitRef="usd">7192000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzMtNS0xLTEtMTk2MzU_b49b8778-b077-44db-819b-fd6ceb65c5c3"
      unitRef="usd">6631000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzUtMS0xLTEtMTk2MzU_222556ae-bb7e-4979-8aa7-eec691fb9355"
      unitRef="usd">4512000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzUtMy0xLTEtMTk2MzU_7587b4a3-8ed8-4883-b2e9-d9733f85a409"
      unitRef="usd">4441000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzUtNS0xLTEtMTk2MzU_14530ac2-9398-46ed-9aa4-fff534e3031a"
      unitRef="usd">4371000000</us-gaap:DepreciationDepletionAndAmortization>
    <cvs:StoreImpairmentCharges
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzYtMS0xLTEtNTQ0ODI_efc86a60-f2ac-4bf7-8f9b-cb1c539255c8"
      unitRef="usd">1358000000</cvs:StoreImpairmentCharges>
    <cvs:StoreImpairmentCharges
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzYtMy0xLTEtNTQ0ODI_fe5ba633-453d-425b-b369-b3a35c716977"
      unitRef="usd">0</cvs:StoreImpairmentCharges>
    <cvs:StoreImpairmentCharges
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzYtNS0xLTEtNTQ1MDg_a0494c9e-601d-44c9-b5df-3625b77be2b3"
      unitRef="usd">231000000</cvs:StoreImpairmentCharges>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzYtMS0xLTEtMTk2MzU_3930af18-b01f-4588-a6f6-7c90bb586ab6"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzYtMy0xLTEtMTk2MzU_9d9f2379-97f1-4fb5-8c0b-575a308fa0d6"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzYtNS0xLTEtMTk2MzU_05b23d22-ad14-4800-839d-ec181c23f560"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzgtMS0xLTEtMTk2MzU_fd557d9a-5982-4067-8a6a-e86aaaedbf88"
      unitRef="usd">484000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzgtMy0xLTEtMTk2MzU_b4954f0e-39c4-47f3-8192-008a6c5dd204"
      unitRef="usd">400000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzgtNS0xLTEtMTk2MzU_fb40e202-51bf-4b72-8626-f27d251e9dd2"
      unitRef="usd">453000000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzktMS0xLTEtMTk2MzU_284628b4-26d4-4f8c-a399-c1a53458a598"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzktMy0xLTEtMTk2MzU_859f85f7-1aba-41d0-94ce-3b9b5b105f63"
      unitRef="usd">269000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzktNS0xLTEtMTk2MzU_b85a1ff5-e3f1-4030-932b-044f745c0750"
      unitRef="usd">-205000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzEwLTEtMS0xLTE5NjM1_0c7a8cc5-99de-4b2f-83b5-982b9bcf19ba"
      unitRef="usd">-452000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzEwLTMtMS0xLTE5NjM1_3a2f87f9-af97-4c9c-a121-0e9e11d66b40"
      unitRef="usd">-1440000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzEwLTUtMS0xLTE5NjM1_caf5521d-bd37-4fa6-9466-9570f3f8f092"
      unitRef="usd">-79000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzExLTEtMS0xLTE5NjM1_7f7e9907-d6e9-4be2-8729-69a9d397de0b"
      unitRef="usd">-428000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzExLTMtMS0xLTE5NjM1_32feff35-8861-4c6c-8913-77017d07cb5b"
      unitRef="usd">-570000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzExLTUtMS0xLTE5NjM1_fda11be1-51ff-4395-a636-893c70c78ace"
      unitRef="usd">-654000000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzEyLTEtMS0xLTE5NjM1_4c097983-5558-4adb-8726-9328a8339922"
      unitRef="usd">390000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzEyLTMtMS0xLTE5NjM1_4724d269-cc7f-4fe2-9b9f-bdf2fa6a2183"
      unitRef="usd">-72000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzEyLTUtMS0xLTE5NjM1_b427bf57-e610-4f59-a100-19da312f69fc"
      unitRef="usd">-33000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE0LTEtMS0xLTE5NjM1_c3fc4fc7-faba-47ec-b2a0-320c236c44e8"
      unitRef="usd">2703000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE0LTMtMS0xLTE5NjM1_35387dd4-4df6-44d9-a264-eb98e738d67a"
      unitRef="usd">1510000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE0LTUtMS0xLTE5NjM1_a8343880-e0e6-4b11-9fdd-44c73f751a20"
      unitRef="usd">2158000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE1LTEtMS0xLTE5NjM1_f0475519-87cf-4cd1-a857-d754222b762b"
      unitRef="usd">-735000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE1LTMtMS0xLTE5NjM1_02f6f2e9-e345-4d76-927f-3d39bd05e381"
      unitRef="usd">973000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE1LTUtMS0xLTE5NjM1_7b2aaa5a-c506-472e-8b5c-ddb3db3675a0"
      unitRef="usd">1075000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE2LTEtMS0xLTE5NjM1_45aa25f5-b348-48e3-bb9c-aed653c0700c"
      unitRef="usd">3000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE2LTMtMS0xLTE5NjM1_61e79f53-2999-41c6-9d79-8806a7376fa0"
      unitRef="usd">-364000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE2LTUtMS0xLTE5NjM1_39a550eb-fd68-41c1-a5f6-c76d3dd1fca6"
      unitRef="usd">614000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE3LTEtMS0xLTE5NjM1_8b28ff8d-4a0e-49db-b02a-1a116fdbbabf"
      unitRef="usd">2898000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE3LTMtMS0xLTE5NjM1_aed9c43f-2305-4984-8841-336f2eedf67e"
      unitRef="usd">2769000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE3LTUtMS0xLTE5NjM1_579744f8-ba20-40ea-b21a-fab4238a1491"
      unitRef="usd">3550000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE4LTEtMS0xLTE5NjM1_25549046-987d-4367-8663-4e132f7e5660"
      unitRef="usd">169000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE4LTMtMS0xLTE5NjM1_8ae07492-5dbe-46f2-9c2e-7998e3053da5"
      unitRef="usd">-231000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInInsuranceLiabilities
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE4LTUtMS0xLTE5NjM1_7ae816af-571b-458f-abd3-0ed64a7d57e3"
      unitRef="usd">320000000</us-gaap:IncreaseDecreaseInInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE5LTEtMS0xLTE5NjM1_12f7e839-9993-4878-a408-d6614f836542"
      unitRef="usd">2852000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE5LTMtMS0xLTE5NjM1_595a555f-1594-4665-a4c7-de0aeea40f12"
      unitRef="usd">2740000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzE5LTUtMS0xLTE5NjM1_53b194a3-9760-4d18-b3c8-b78e7e7c4d55"
      unitRef="usd">1476000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzIwLTEtMS0xLTE5NjM1_99413bca-bd66-4704-93cc-d3c06bff7683"
      unitRef="usd">18265000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzIwLTMtMS0xLTE5NjM1_2775b30f-d8ce-40b3-a7c8-aa330db3fa93"
      unitRef="usd">15865000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMTgvZnJhZzo2MWRlZjdjN2I2YjQ0ZDdhOTY1YTcxNDg5NGJjNzJkMS90YWJsZTpiZDAwYjQ4NzM3ZTU0MjJiOTdjNTMwZWE0ZGE2MzY0NC90YWJsZXJhbmdlOmJkMDBiNDg3MzdlNTQyMmI5N2M1MzBlYTRkYTYzNjQ0XzIwLTUtMS0xLTE5NjM1_a736baa5-6155-4a17-8343-f0dbe54f99f7"
      unitRef="usd">12848000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:SharesOutstanding
      contextRef="i13739c11655d4b66b619ac881014f765_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtMS0xLTEtMTk2MzU_d0d3eddd-0fb5-45ce-adf1-aa149ea511ce"
      unitRef="shares">1720000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i33c39d0d9ba54e4b907a2d6936ea45ca_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtMi0xLTEtMTk2MzU_5a2af167-1a8c-4cd3-92d3-86f595f11839"
      unitRef="shares">-425000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec75ad30e89c49a4bfce46bec785eb96_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtNC0xLTEtMTk2MzU_03d25cee-62ac-4b19-83d5-83527c502af5"
      unitRef="usd">45440000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i33c39d0d9ba54e4b907a2d6936ea45ca_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtNS0xLTEtMTk2MzU_f8dcefcc-b66e-42ce-a3d6-883dd1c703f9"
      unitRef="usd">-28228000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0f466365cbeb46d881db045c29a1ef18_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtNi0xLTEtMTk2MzU_ac1599e0-4622-4c55-9bb2-50a39e13248c"
      unitRef="usd">40911000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia28cc8e6f81b4b99804fb1a37a6048e6_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtNy0xLTEtMTk2MzU_0b7fa53f-306a-4542-9bbe-14a7f09f01e1"
      unitRef="usd">102000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id2ef6efbc0d84de58ef5fd7542800f18_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtOC0xLTEtMTk2MzU_8eca5d64-24dc-4e9c-ab5e-d8109099292a"
      unitRef="usd">58225000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0431fdd1f66940e9b1962a8525277501_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtOS0xLTEtMTk2MzU_75b2d78d-8f34-48c9-8977-1fbbb42b120a"
      unitRef="usd">318000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i23e34e947aac44fc9f5cf5448f94f452_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtMTAtMS0xLTE5NjM1_104646ff-e05b-4610-a1f0-b49d66602f7b"
      unitRef="usd">58543000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i922cc6127555413782578a7efd08aea4_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtNi0xLTEtMTk2MzU_1e2731a0-00e0-482d-b011-76cfe76e7e7c"
      unitRef="usd">178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id8eb6b30d69b40b48d66138c22c9b950_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtOC0xLTEtMTk2MzU_27e8ee4a-bc07-4563-9ed8-b0e3e9b0302d"
      unitRef="usd">178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id5b7f3560a474273bad7b3d0ff254e29_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtMTAtMS0xLTE5NjM1_4cea8a88-2053-457a-81cf-9f156ab4de60"
      unitRef="usd">178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ia4a48ec7199f497a8e3d91de1ccd3577_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzUtNi0xLTEtMTk2MzU_85bb7190-a730-4662-bc40-87fc8f53469b"
      unitRef="usd">6634000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie160f6b16d2b416d8f1acb180ba3d07c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzUtOC0xLTEtMTk2MzU_0fd5d3b9-3af8-4d46-abf4-fd6637fc594d"
      unitRef="usd">6634000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i20b0b671c0474c61b1511d61c0def2a5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzUtOS0xLTEtMTk2MzU_64dc48c6-6fb7-4743-b106-7d1c00f225e8"
      unitRef="usd">-3000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzUtMTAtMS0xLTE5NjM1_0eeab21f-2e05-40c8-9063-27dbebfd9ffe"
      unitRef="usd">6631000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iaae61e2a7f494d8ea336357a3fa3676f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzYtNy0xLTEtMTk2MzU_200dd5d6-714b-4b78-b2a5-510728386489"
      unitRef="usd">917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie160f6b16d2b416d8f1acb180ba3d07c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzYtOC0xLTEtMTk2MzU_54e55ad2-bff0-47dc-98cd-705dbe797316"
      unitRef="usd">917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzYtMTAtMS0xLTE5NjM1_d017fb79-3383-4a24-adb5-140befd39782"
      unitRef="usd">917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i025b485e66244023b72a2a031c0188ef_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtMS0xLTEtMTk2MzU_aae2c572-3595-4ef7-9c8d-59cee4b86a9a"
      unitRef="shares">7000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i216fe0b6c7d94b40ad7a901f182062ef_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtMi0xLTEtMTk2MzU_38a4f088-ebc0-42d5-9452-dcc4dc666000"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if9ef2fb7202d49dbab738960740d4b6c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtNC0xLTEtMTk2MzU_056fb5fc-124d-4929-b5de-d982249e8938"
      unitRef="usd">532000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie160f6b16d2b416d8f1acb180ba3d07c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtOC0xLTEtMTk2MzU_d556ba44-99f1-4538-a8b3-1303305b44cc"
      unitRef="usd">532000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtMTAtMS0xLTE5NjM1_9c089ea0-cc84-4a9d-af8f-1d5a23dc2e17"
      unitRef="usd">532000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance
      contextRef="i216fe0b6c7d94b40ad7a901f182062ef_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzktMi0xLTEtMTk2MzU_8d9b2c4a-a066-410c-b98f-35ad52f2251c"
      unitRef="shares">2000000</cvs:TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="i216fe0b6c7d94b40ad7a901f182062ef_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzktNS0xLTEtMTk2MzU_726be931-cfc8-48b9-9d92-a974cab2539e"
      unitRef="usd">7000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="ie160f6b16d2b416d8f1acb180ba3d07c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzktOC0xLTEtMTk2MzU_e479bc45-863f-4178-90dd-191a473e7f52"
      unitRef="usd">7000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzktMTAtMS0xLTE5NjM1_5175c4ff-06b2-44ce-af7d-7701189ef3c9"
      unitRef="usd">7000000</cvs:TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance>
    <us-gaap:DividendsCommonStock
      contextRef="ia4a48ec7199f497a8e3d91de1ccd3577_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEwLTYtMS0xLTE5NjM1_8dae2041-c593-4b3f-9892-c4d82dce8882"
      unitRef="usd">2615000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ie160f6b16d2b416d8f1acb180ba3d07c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEwLTgtMS0xLTE5NjM1_27e98431-66cf-47f0-b90a-e7d29553e0a9"
      unitRef="usd">2615000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEwLTEwLTEtMS0xOTYzNQ_c593c071-c1fa-414a-a22c-11cdfdf57be4"
      unitRef="usd">2615000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i20b0b671c0474c61b1511d61c0def2a5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEyLTktMS0xLTE5NjM1_503e9a44-f43a-4bc4-bb09-3d7d54b7f468"
      unitRef="usd">-9000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEyLTEwLTEtMS0xOTYzNQ_76cd478a-d3f0-4db5-afed-57478752f609"
      unitRef="usd">-9000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="id1f119b7cdb141be93131047a1d79f5b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTEtMS0xLTE5NjM1_94b0df74-c020-4413-ae6f-de38bf846895"
      unitRef="shares">1727000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="ieefff43749444070a945dbf9c2df4d4e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTItMS0xLTE5NjM1_97bbe756-c530-44c3-bf07-3dcd93863f56"
      unitRef="shares">-425000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i198e53fbfa9d4d0aa17e97121db6bb9b_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTQtMS0xLTE5NjM1_c22f687b-bcc8-4d02-b351-d409fc63a5da"
      unitRef="usd">45972000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieefff43749444070a945dbf9c2df4d4e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTUtMS0xLTE5NjM1_513ca101-da7d-4884-9350-f18e2e7d65ed"
      unitRef="usd">-28235000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3debde841b1842a2a969406ff590b5d4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTYtMS0xLTE5NjM1_43881444-954f-4c69-b89b-999615befb04"
      unitRef="usd">45108000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i10cfae3f6a64475c8d6390a56c1755b4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTctMS0xLTE5NjM1_da29e6e9-e8a3-4503-9fa7-5d1185cba2e4"
      unitRef="usd">1019000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0f936984dd7642f09c851e2ced784e3a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTgtMS0xLTE5NjM1_4c98b564-63dd-4536-a06a-34ee7b961a02"
      unitRef="usd">63864000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if3d706b6763848048a19f678eed0d6c4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTktMS0xLTE5NjM1_322bcf38-2c5a-448b-ad0f-136fff2db827"
      unitRef="usd">306000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTEwLTEtMS0xOTYzNQ_c3b0ca65-cb12-4059-8912-d32a89761840"
      unitRef="usd">64170000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e7cde5c47fe423a9685bba813200907_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTYtMS0xLTE5NjM1_0d72284e-6ae8-4fab-975d-68db230b7230"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id5e60c7959e643d6be2a8ad6547a16ce_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTgtMS0xLTE5NjM1_3e80ea5b-0225-4195-b65a-cd326b24be66"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3054d32553d24d498f6e64626c62c7e4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTEwLTEtMS0xOTYzNQ_012f1e61-d950-4e7d-9219-63301f2cfd55"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="ia9b253e4431e4506b41e93b4e3ffbff3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE1LTYtMS0xLTE5NjM1_10e9ca46-bd60-4518-8922-941a5729f7cf"
      unitRef="usd">7179000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i521bf812b8ca4f2f8127d65ed79ea126_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE1LTgtMS0xLTE5NjM1_7608056a-7691-4ba2-afbe-d6b4eceb1104"
      unitRef="usd">7179000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ieb94485c24fb48c8b7669be4b0fc8159_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE1LTktMS0xLTE5NjM1_fa6bab22-9058-4028-b15d-6b11aa87f8fd"
      unitRef="usd">13000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE1LTEwLTEtMS0xOTYzNQ_74b5fa81-2547-4fac-a687-4658fa0a47de"
      unitRef="usd">7192000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0b3e30b3db154240b2043b0ca843e316_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE2LTctMS0xLTE5NjM1_ac4ec36d-37d3-44ad-9d04-afa78313c66d"
      unitRef="usd">395000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i521bf812b8ca4f2f8127d65ed79ea126_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE2LTgtMS0xLTE5NjM1_f404f976-c603-4e16-b051-0aa55c31f593"
      unitRef="usd">395000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE2LTEwLTEtMS0xOTYzNQ_652d6cf0-cf10-4a95-8935-a10c732379fc"
      unitRef="usd">395000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3850625417ca4ca39a069dd8c4de7097_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE4LTEtMS0xLTE5NjM1_dcbd26d8-8889-4733-8703-2dce84bd5c51"
      unitRef="shares">6000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id7cf273211e3434f968bd606d4a81280_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE4LTQtMS0xLTE5NjM1_894b75b1-c20f-4e61-b105-8dbd70b2299b"
      unitRef="usd">541000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i521bf812b8ca4f2f8127d65ed79ea126_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE4LTgtMS0xLTE5NjM1_ef3d6562-7668-44bd-869a-4585a0eba71c"
      unitRef="usd">541000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE4LTEwLTEtMS0xOTYzNQ_32c877c4-6c7d-41ac-90af-86d3aa06242f"
      unitRef="usd">541000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod
      contextRef="i41a840db4ee84036b3bbb93303320613_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE5LTItMS0xLTE5NjM1_d4eb5856-eaa6-4799-9256-144e4a9519d9"
      unitRef="shares">2000000</cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i41a840db4ee84036b3bbb93303320613_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE5LTUtMS0xLTE5NjM1_b10aa279-9966-4bd0-bcf8-71cf5a78c8cc"
      unitRef="usd">57000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i521bf812b8ca4f2f8127d65ed79ea126_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE5LTgtMS0xLTE5NjM1_e2eabb19-efb9-4767-8dff-35773f72ead4"
      unitRef="usd">57000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE5LTEwLTEtMS0xOTYzNQ_de2adec5-83f2-4741-9cc9-e44819a647f0"
      unitRef="usd">57000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStock
      contextRef="ia9b253e4431e4506b41e93b4e3ffbff3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIwLTYtMS0xLTE5NjM1_208861ca-730f-45be-963b-9a061651a275"
      unitRef="usd">2644000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i521bf812b8ca4f2f8127d65ed79ea126_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIwLTgtMS0xLTE5NjM1_91dc6697-9e08-4567-9836-dd9fb9c5c796"
      unitRef="usd">2644000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIwLTEwLTEtMS0xOTYzNQ_e14e59e1-da97-4956-9f82-c690848774c7"
      unitRef="usd">2644000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="ieb94485c24fb48c8b7669be4b0fc8159_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIyLTktMS0xLTE5NjM1_f4f94624-d2f3-43e6-96ee-1d3e1a0ec25d"
      unitRef="usd">-7000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIyLTEwLTEtMS0xOTYzNQ_e55d63dd-594a-4a9d-b207-74a1c114f5e2"
      unitRef="usd">-7000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="ibd578f81db5a45f1bc8d5b32e6e26a16_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTEtMS0xLTE5NjM1_50c55617-ad70-485d-be3b-cab34ce8f246"
      unitRef="shares">1733000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i6be5d7176aa0457288fec9de68e4d419_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTItMS0xLTE5NjM1_64feac16-0132-4d16-bed6-5f25ece31268"
      unitRef="shares">-423000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i929ccc146bfa424592ecfc18373af370_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTQtMS0xLTE5NjM1_bbdfedd3-ce88-4726-99fa-8969a6b266a6"
      unitRef="usd">46513000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6be5d7176aa0457288fec9de68e4d419_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTUtMS0xLTE5NjM1_6e5e1472-d133-4873-995b-e0e350248ee0"
      unitRef="usd">-28178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb577f06e3b04c518c1c4543d6ddf983_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTYtMS0xLTE5NjM1_3bf21ebb-c3b6-4f8f-a4a1-5269d4923fac"
      unitRef="usd">49640000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i79a394a32aeb4c939df5cb7fd7e0d46f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTctMS0xLTE5NjM1_e999f2a7-4913-4dfc-8771-54a5c0676c86"
      unitRef="usd">1414000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if386c5ae7c994951b21ec945131fa3c6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTgtMS0xLTE5NjM1_4e1e7631-0ccc-4b3d-aeb6-ff40d09aa775"
      unitRef="usd">69389000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0e4d5f3f2aa745b6b9ea7a35265f341e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTktMS0xLTE5NjM1_995710dd-a536-45a4-aa0f-e9b0fb6f064c"
      unitRef="usd">312000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTEwLTEtMS0xOTYzNQ_86233165-c748-4f1b-9d5d-a5745f848460"
      unitRef="usd">69701000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i85992156090b4f72a932455b1978952b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI1LTYtMS0xLTE5NjM1_8891224b-4445-405f-82f8-e47681c86998"
      unitRef="usd">7910000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7770de66bbf94051817d87cf6240655a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI1LTgtMS0xLTE5NjM1_12e91338-a119-474b-8b86-7cd6d401309e"
      unitRef="usd">7910000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3a4a4ed30a054247bfaad062f649f9ee_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI1LTktMS0xLTE5NjM1_cc32bf8a-d92b-4a46-abb6-8ad3371253a0"
      unitRef="usd">-12000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI1LTEwLTEtMS0xOTYzNQ_3ebcfa62-21ca-468f-8755-a1b4dbd67024"
      unitRef="usd">7898000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id62e90e3302f484ca4017d1a85b7a1ff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI2LTctMS0xLTE5NjM1_cd5abcec-58e2-4c11-b6b4-61752bd647cb"
      unitRef="usd">-449000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7770de66bbf94051817d87cf6240655a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI2LTgtMS0xLTE5NjM1_c9e1a140-6be8-41b1-b6dd-f17db8739e25"
      unitRef="usd">-449000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI2LTEwLTEtMS0xOTYzNQ_a0348da8-14a1-40db-8087-ae8679b86e07"
      unitRef="usd">-449000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4eb317bccff647f6823df9e9b149c181_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI3LTEtMS0xLTE5NjM1_d2ebba53-346a-4a0d-8493-d5299f05ac9a"
      unitRef="shares">11000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i45641c304daa44c9bd1f3c9070317105_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI3LTQtMS0xLTE5NjM1_2ac0022b-9661-459b-8995-856a8677ed8a"
      unitRef="usd">864000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7770de66bbf94051817d87cf6240655a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI3LTgtMS0xLTE5NjM1_11b13436-b3e2-4326-8ac7-0e9222dc46ba"
      unitRef="usd">864000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI3LTEwLTEtMS0xOTYzNQ_7e1e23ea-4e69-4acc-87ed-dd2a9e4cef49"
      unitRef="usd">864000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod
      contextRef="ic1c4532731df4ec9acf2bba885ccbc0b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI4LTItMS0xLTE5NjM1_c99be6d6-9e00-435a-b19e-b4a88922d547"
      unitRef="shares">1000000</cvs:ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="ic1c4532731df4ec9acf2bba885ccbc0b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI4LTUtMS0xLTE5NjM1_f55a21f2-2a69-40c6-a897-99c2f68660c1"
      unitRef="usd">5000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i7770de66bbf94051817d87cf6240655a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI4LTgtMS0xLTE5NjM1_2bf73e51-b429-45e1-8768-59548fb2da7b"
      unitRef="usd">5000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI4LTEwLTEtMS0xOTYzNQ_04ce3220-b53b-44e5-b604-44ed6fb669ed"
      unitRef="usd">5000000</cvs:ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStock
      contextRef="i85992156090b4f72a932455b1978952b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI5LTYtMS0xLTE5NjM1_5d145465-f479-437b-8075-93fafac50de5"
      unitRef="usd">2644000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i7770de66bbf94051817d87cf6240655a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI5LTgtMS0xLTE5NjM1_84585cc3-8a43-4f0e-acd1-ccc86132d720"
      unitRef="usd">2644000000</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI5LTEwLTEtMS0xOTYzNQ_2af4ca73-7402-42e0-a5bf-06a85a7686fd"
      unitRef="usd">2644000000</us-gaap:DividendsCommonStock>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i3a4a4ed30a054247bfaad062f649f9ee_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMwLTktMS0xLTE5NjM1_fe161968-610a-4ca7-9697-138c4e12f8fe"
      unitRef="usd">6000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMwLTEwLTEtMS0xOTYzNQ_03302628-ee4e-43cf-9f1b-5cec40f314aa"
      unitRef="usd">6000000</cvs:NoncontrollinginterestOtherPeriodIncreaseDecrease>
    <us-gaap:SharesOutstanding
      contextRef="ie84ce40f593a4f1b8e95de37fcec950f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTEtMS0xLTE5NjM1_e52f52b5-9ef3-4f6f-9997-7ac02f8b1909"
      unitRef="shares">1744000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i71a1c12ec5c146a387fb13e1ae8a699c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTItMS0xLTE5NjM1_1c356d2b-3495-4a7b-9749-f110807b49c6"
      unitRef="shares">-422000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i66a5573b2fbd4cec83bc9c6bed71ef29_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTQtMS0xLTE5NjM1_97c21c66-2d45-4ea3-968e-8464fda4be09"
      unitRef="usd">47377000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i71a1c12ec5c146a387fb13e1ae8a699c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTUtMS0xLTE5NjM1_b17f1bab-ba67-4dd0-965f-3feec675cba8"
      unitRef="usd">-28173000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic88e5b2354294af7a046754ddfa0a46d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTYtMS0xLTE5NjM1_86eb78f2-04af-48e9-838e-ffc92feeab4c"
      unitRef="usd">54906000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i61119d4aa25b44fb9ab0ce32bfac9893_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTctMS0xLTE5NjM1_e5842af6-afd4-4a4e-b3a5-c55accd9e1b0"
      unitRef="usd">965000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if9bf280de01e423da0805c5548da8598_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTgtMS0xLTE5NjM1_6de59978-0501-41ba-9246-81623245d535"
      unitRef="usd">75075000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4f46c0fc299d40469a5d7302133c63f1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTktMS0xLTE5NjM1_7c03f277-0226-49a3-b87b-9d6fe7f91e8d"
      unitRef="usd">306000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTEwLTEtMS0xOTYzNQ_fd4e15cb-8af8-4d51-8a22-b14d9654a28f"
      unitRef="usd">75381000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyNg_2742f4c1-ccab-4fa2-bafe-ea5d173eb180"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyNg_6419c046-b48f-4618-a968-99bc4d3645ed"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyNg_e3309405-dac6-4007-ad93-3e3b3eae9f42"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzIzNg_27d37e70-1658-4c4c-9586-0927176f1e3b"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzIzNg_2be11832-e74f-41f4-80f8-2c6c8574e523"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <cvs:TreasuryStockValueSharesHeldInTrust
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzIzNg_dda28916-8460-4dbb-9c04-c367d9f849ae"
      unitRef="usd">29000000</cvs:TreasuryStockValueSharesHeldInTrust>
    <us-gaap:CommonStockValue
      contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzQ0NA_56345325-2c2c-460c-a3dc-9492ee914d3b"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzQ0NA_85768385-ff6b-4e82-9d2d-cb40ec9ab58f"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzQ0NA_f6c55ca3-0a33-461c-a79c-c71fc19c1f56"
      unitRef="usd">17000000</us-gaap:CommonStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i922cc6127555413782578a7efd08aea4_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEwOTk1MTE2Mjk5MDk_1e2731a0-00e0-482d-b011-76cfe76e7e7c"
      unitRef="usd">178000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia694d76108a14467a887dab2055e6ad0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NDY_9af37667-cc3f-4e43-8268-dda837632fca"
      unitRef="usd">-3000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDIy_bca58685-3d1b-427f-8507-2cee9fde4a0b">Significant Accounting Policies &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Business&#160; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVS Health Corporation, together with its subsidiaries (collectively, &#x201c;CVS Health&#x201d; or the &#x201c;Company&#x201d;), has more than 9,900 retail locations, nearly 1,200 walk-in medical clinics, a leading pharmacy benefits manager with approximately 110 million plan members with expanding specialty pharmacy solutions and a dedicated senior pharmacy care business serving more than one million patients per year. The Company also serves an estimated 35 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan (&#x201c;PDP&#x201d;). The Company believes its innovative health care model increases access to quality care, delivers better health outcomes and lowers overall health care costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The coronavirus disease 2019 (&#x201c;COVID-19&#x201d;) and its emerging new variants continue to impact the economies of the U.S. and other countries around the world. The impact of COVID-19 on the Company&#x2019;s businesses, operating results, cash flows and financial condition in the years ended December 31, 2021 and 2020, as well as information regarding certain expected impacts of COVID-19 on the Company, is discussed throughout this Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Care Benefits segment operates as one of the nation&#x2019;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#x2019; compensation administrative services through its Coventry Health Care Workers&#x2019; Compensation business (&#x201c;Workers&#x2019; Compensation business&#x201d;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#x2019;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#x201c;providers&#x201d;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#x201c;Insured&#x201d; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#x201c;ASC.&#x201d; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#x201c;Public Exchanges&#x201d;) in eight states through which it sells Insured plans directly to individual consumers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment provides a full range of pharmacy benefit management (&#x201c;PBM&#x201d;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services and mail order pharmacy. In addition, through the Pharmacy Services segment, the Company provides specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#x201c;Covered Entities&#x201d;). The Pharmacy Services segment&#x2019;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#x201c;LTC&#x201d;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of December&#160;31, 2021, the Retail/LTC segment operated more than 9,900 retail locations, nearly 1,200 MinuteClinic locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corporate/Other Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management and administrative expenses to support the Company&#x2019;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#x2019;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform with the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when purchased. The Company invests in short-term money market funds, commercial paper and time deposits, as well as other debt securities that are classified as cash equivalents within the accompanying consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash (included in other current assets) represents funds held on behalf of members, including health savings account (&#x201c;HSA&#x201d;) funds associated with high deductible health plans. Beginning in 2021, the Company began presenting these funds held on behalf of members in restricted cash and, for statement of cash flow purposes, retrospectively adjusted the 2020 and 2019 balances by the amounts shown in the table below in the line item &#x201c;restricted cash (included in other current assets)&#x201d; to conform with the current year presentation. Restricted cash (included in other assets) represents amounts held in a trust in one of the Company&#x2019;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of cash and cash equivalents on the consolidated balance sheets to total cash, cash equivalents and restricted cash on the consolidated statements of cash flows as of December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other current assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Securities &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities consist primarily of U.S. Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next twelve months, in which case it is classified as current on the consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. See Note 4 &#x2018;&#x2018;Fair Value&#x2019;&#x2019; for additional information on how the Company estimates the fair value of these investments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principal payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. Interest is not accrued on debt securities when management believes the collection of interest is unlikely.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#x2019;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities with readily available fair values are measured at fair value with changes in fair value recognized in net income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mortgage Loans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mortgage loan investments on the consolidated balance sheets are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other investments consist primarily of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Private equity and hedge fund limited partnerships, which are accounted for using the equity method of accounting. Under this method, the carrying value of the investment is based on the value of the Company&#x2019;s equity ownership of the underlying investment funds provided by the general partner or manager of the investments, the financial statements of which generally are audited. As a result of the timing of the receipt of the valuation information provided by the fund managers, these investments are generally reported on up to a three month lag. The Company reviews investments for impairment at least quarterly and monitors their performance throughout the year through discussions with the administrators, managers and/or general partners. If the Company becomes aware of an impairment of a limited partnership&#x2019;s investments through its review or prior to receiving the limited partnership&#x2019;s financial statements at the financial statement date, an impairment will be recognized by recording a reduction in the carrying value of the limited partnership with a corresponding charge to net investment income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Investment real estate, which is carried on the consolidated balance sheets at depreciated cost, including capital additions, net of write-downs for other-than-temporary declines in fair value. Depreciation is calculated using the straight-line method based on the estimated useful life of each asset. If any real estate investment is considered held-for-sale, it is carried at the lower of its carrying value or fair value less estimated selling costs. The Company generally estimates fair value using net operating income and applying a capitalization rate in conjunction with comparable sales information. At the time of the sale, the difference between the sales price and the carrying value is recorded as a realized capital gain or loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Privately-placed equity securities, which are carried on the consolidated balance sheets at cost less impairments, plus or minus subsequent adjustments for observable price changes. Additionally, as a member of the Federal Home Loan Bank of Boston (&#x201c;FHLBB&#x201d;), a subsidiary of the Company is required to purchase and hold shares of the FHLBB. These shares are restricted and carried at cost. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Investment Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net investment income on the Company&#x2019;s investments is recorded when earned and is reflected in the Company&#x2019;s net income (other than net investment income on assets supporting experience-rated products). Experience-rated products are products in the large case pensions business where the contract holder, not the Company, assumes investment and other risks, subject to, among other things, minimum guarantees provided by the Company. The effect of investment performance on experience-rated products is allocated to contract holders&#x2019; accounts daily, based on the underlying investment experience and, therefore, does not impact the Company&#x2019;s net income (as long as the contract&#x2019;s minimum guarantees are not triggered). Net investment income on assets supporting large case pensions&#x2019; experience-rated products is included in net investment income in the consolidated statements of operations and is credited to contract holders&#x2019; accounts through a charge to benefit costs. The contract holders&#x2019; accounts are reflected in policyholders&#x2019; funds on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized capital gains and losses on investments (other than realized capital gains and losses on investments supporting experience-rated products) are included as a component of net investment income in the consolidated statements of operations. Realized capital gains and losses are determined on a specific identification basis. Purchases and sales of debt and equity securities and alternative investments are reflected on the trade date. Purchases and sales of mortgage loans and investment real estate are reflected on the closing date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized capital gains and losses on investments supporting large case pensions&#x2019; experience-rated products are not included in realized capital gains and losses in the consolidated statements of operations and instead are credited directly to contract holders&#x2019; accounts. The contract holders&#x2019; accounts are reflected in policyholders&#x2019; funds on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized capital gains and losses on investments (other than unrealized capital gains and losses on investments supporting experience-rated products) are reflected in shareholders&#x2019; equity, net of tax, as a component of accumulated other comprehensive income. Unrealized capital gains and losses on investments supporting large case pensions&#x2019; experience-rated products are credited directly to contract holders&#x2019; accounts. The contract holders&#x2019; accounts are reflected in policyholders&#x2019; funds on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#x2019;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations. Accounts receivable, net is composed of the following at December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor and manufacturer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s allowance for credit losses was $339&#160;million and $358&#160;million as of December&#160;31, 2021 and 2020, respectively. When developing an estimate of the Company&#x2019;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#x2019;s accounts receivable are short duration in nature and typically settle in less than 30 days. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventories &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories are valued at the lower of cost or net realizable value using the weighted average cost method. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. During the interim period between physical inventory counts, the Company accrues for anticipated physical inventory losses on a location-by-location basis based on historical results and current physical inventory trends. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reinsurance Recoverables &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#x2019;s primary liability as the direct insurer of the risks reinsured. Failure of reinsurers to indemnify the Company could result in losses; however, the Company does not expect charges for unrecoverable reinsurance to have a material effect on its consolidated operating results or financial condition. The Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities or economic characteristics of its reinsurers. At December&#160;31, 2021, the Company&#x2019;s reinsurance recoverables consisted primarily of amounts due from third parties that are rated consistent with companies that are considered to have the ability to meet their obligations. Reinsurance recoverables are recorded as other current assets or other assets on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Contract Acquisition Costs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Insurance products included in the Health Care Benefits segment are cancellable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. Acquisition costs for certain long-duration insurance contracts are deferred and are recorded as other current assets or other assets on the consolidated balance sheets and are amortized over the estimated life of the contracts. The amortization of deferred acquisition costs is recorded in operating expenses in the consolidated statements of operations. At December&#160;31, 2021 and 2020, the balance of deferred acquisition costs was $895 million and $546 million, respectively, comprised primarily of commissions paid on Medicare Supplement products within the Health Care Benefits segment. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment is reported at historical cost, net of accumulated depreciation. Property, equipment and improvements to leased premises are depreciated using the straight-line method over the estimated useful lives of the assets, or when applicable, the term of the lease, whichever is shorter. Estimated useful lives generally range from 1 to 40 years for buildings, building improvements and leasehold improvements and 3 to 10 years for fixtures, equipment and internally developed software. Repair and maintenance costs are charged directly to expense as incurred. Major renewals or replacements that &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;substantially extend the useful life of an asset are capitalized and depreciated. Application development stage costs for significant internally developed software projects are capitalized and depreciated. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consists of the following at December&#160;31, 2021 and 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixtures and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense (which includes the amortization of property and equipment under finance or capital leases) totaled $2.3 billion, $2.1 billion and $1.9 billion for the years ended December&#160;31, 2021, 2020 and 2019, respectively. During the year ended December&#160;31, 2021, the Company recorded an impairment on property and equipment of $261&#160;million in connection with the planned closure of certain retail stores. See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for additional information about this impairment charge as well as the Company&#x2019;s finance leases. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Right-of-Use Assets and Lease Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#x2019;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s real estate leases typically contain options that permit renewals for additional periods of up to five years each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For real estate leases, the Company accounts for lease components and nonlease components as a single lease component.  Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for additional information about right-of-use assets and lease liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently if necessary, as further described in &#x201c;Long-Lived Asset Impairment&#x201d; below. See Note 5 &#x2018;&#x2018;Goodwill and Other Intangibles&#x2019;&#x2019; for additional information about goodwill. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#x201c;VOBA&#x201d;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Other than VOBA, definite-lived intangible assets are amortized using the straight-line method. VOBA is amortized over the expected life of the acquired contracts in proportion to estimated premiums. Indefinite-lived intangible assets are not amortized but are tested for impairment annually, or more frequently if necessary, as further described in &#x201c;Long-Lived Asset Impairment&#x201d; below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 5 &#x2018;&#x2018;Goodwill and Other Intangibles&#x2019;&#x2019; for additional information about intangible assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Asset Impairment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#x2019;s estimated future cash flows (discounted). If required, an impairment loss is recorded for the portion of the asset group&#x2019;s carrying value that exceeds the asset group&#x2019;s estimated future cash flows (discounted). During the year ended December&#160;31, 2021, the Company recorded a store impairment charge of approximately $1.4 billion primarily related to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. There were no material impairment charges recognized on long-lived assets in the year ended 2020. During the year ended December&#160;31, 2019 the Company recorded a store impairment charge of $231 million primarily related to operating lease right-of-use assets. See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for additional information about the right-of-use asset impairment charges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When evaluating goodwill for potential impairment, the Company compares the fair value of its reporting units to their respective carrying amounts. The Company estimates the fair value of its reporting units using a combination of a discounted cash flow method and a market multiple method. If the carrying amount of a reporting unit exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill, the results of which indicated an impairment of the goodwill associated with the LTC reporting unit. Accordingly, during the third quarter of 2021, the Company recorded a $431&#160;million goodwill impairment charge. The results of the impairment tests indicated that there was no impairment of goodwill of the remaining reporting units as of the testing date or during the year ended December&#160;31, 2021. During the third quarter of both 2020 and 2019, the Company performed its required annual goodwill impairment tests and concluded there were no goodwill impairments as of the testing dates or during the years ended December&#160;31, 2020 and 2019. See Note 5 &#x2018;&#x2018;Goodwill and Other Intangibles&#x2019;&#x2019; for additional information about the goodwill impairment charge recorded during the year ended December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite-lived intangible assets are tested for impairment by comparing the estimated fair value of the asset to its carrying value. The Company estimates the fair value of its indefinite-lived trademarks using the relief from royalty method under the income approach. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value. There were no impairment losses recognized on indefinite-lived intangible assets in any of the years ended December&#160;31, 2021, 2020 or 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Separate Accounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#x2019;s other businesses. Deposits, withdrawals and net &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Costs Payable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Health care costs payable consist principally of unpaid fee-for-service medical, dental and pharmacy claims, capitation costs, other amounts due to providers pursuant to risk-sharing arrangements related to the Health Care Benefits segment&#x2019;s Insured Commercial, Medicare and Medicaid products and accruals for state assessments. Unpaid health care claims include an estimate of payments the Company will make for (i) services rendered to the Company&#x2019;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid, each as of the financial statement date (collectively, &#x201c;IBNR&#x201d;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. Such estimates are developed using actuarial principles and assumptions which consider, among other things, historical and projected claim submission and processing patterns, assumed and historical medical cost trends, historical utilization of medical services, claim inventory levels, changes in Insured membership and product mix, seasonality and other relevant factors. The Company reflects changes in these estimates in benefit costs in the Company&#x2019;s consolidated operating results in the period they are determined. Capitation costs represent contractual monthly fees paid to participating physicians and other medical providers for providing medical care, regardless of the volume of medical services provided to the Insured member. Amounts due under risk-sharing arrangements are based on the terms of the underlying contracts with the providers and consider claims experience under the contracts through the financial statement date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. Of those factors, the Company considers the analysis of historical and projected claim payment patterns (including claims submission and processing patterns) and the assumed health care cost trend rate (the year-over-year change in per member per month health care costs) to be the most critical assumptions. In developing its IBNR estimate, the Company consistently applies these actuarial principles and assumptions each period, with consideration to the variability of related factors. There have been no significant changes to the methodologies or assumptions used to develop the Company&#x2019;s estimate of IBNR in 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company analyzes historical claim payment patterns by comparing claim incurred dates (i.e., the date services were provided) to claim payment dates to estimate &#x201c;completion factors.&#x201d; The Company uses completion factors predominantly to estimate the ultimate cost of claims incurred more than three months before the financial statement date. The Company estimates completion factors by aggregating claim data based on the month of service and month of claim payment and estimating the percentage of claims incurred for a given month that are complete by each month thereafter. For any given month, substantially all claims are paid within six months of the date of service, but it can take up to 48 months or longer after the date of service before all of the claims are completely resolved and paid. These historically-derived completion factors are then applied to claims paid through the financial statement date to estimate the ultimate claim cost for a given month&#x2019;s incurred claim activity. The difference between the estimated ultimate claim cost and the claims paid through the financial statement date represents the Company&#x2019;s estimate of claims remaining to be paid as of the financial statement date and is included in the Company&#x2019;s health care costs payable. The completion factors the Company uses reflect judgments and possible adjustments based on data such as claim inventory levels, claim submission and processing patterns and, to a lesser extent, other factors such as changes in health care cost trend rates, changes in Insured membership and changes in product mix. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claims may be more (less) complete than originally estimated using the Company&#x2019;s completion factors, which may result in reserves that are higher (lower) than the ultimate cost of claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because claims incurred within three months before the financial statement date are less mature, the Company uses a combination of historically-derived completion factors and the assumed health care cost trend rate to estimate the ultimate cost of claims incurred for these months. The Company applies its actuarial judgment and places a greater emphasis on the assumed health care cost trend rate for the most recent claim incurred dates as these months may be influenced by seasonal patterns and changes in membership and product mix.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s health care cost trend rate is affected by changes in per member utilization of medical services as well as changes in the unit cost of such services. Many factors influence the health care cost trend rate, including the Company&#x2019;s ability to manage benefit costs through product design, negotiation of favorable provider contracts and medical management programs, as well as the mix of the Company&#x2019;s business. The health status of the Company&#x2019;s Insured members, aging of the population and other demographic characteristics, advances in medical technology and other factors continue to contribute to rising per member utilization and unit costs. Changes in health care practices, inflation, new technologies, increases in the cost of &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;prescription drugs (including specialty pharmacy drugs), direct-to-consumer marketing by pharmaceutical companies, clusters of high-cost cases, claim intensity, changes in the regulatory environment, health care provider or member fraud and numerous other factors also contribute to the cost of health care and the Company&#x2019;s health care cost trend rate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each reporting period, the Company uses an extensive degree of judgment in the process of estimating its health care costs payable. As a result, considerable variability and uncertainty is inherent in such estimates, particularly with respect to claims with claim incurred dates of three months or less before the financial statement date; and the adequacy of such estimates is highly sensitive to changes in assumed completion factors and the assumed health care cost trend rates. For each reporting period the Company recognizes the actuarial best estimate of health care costs payable considering the potential volatility in assumed completion factors and health care cost trend rates, as well as other factors. The Company believes its estimate of health care costs payable is reasonable and adequate to cover its obligations at December&#160;31, 2021; however, actual claim payments may differ from the Company&#x2019;s estimates. A worsening (or improvement) of the Company&#x2019;s health care cost trend rates or changes in completion factors from those that the Company assumed in estimating health care costs payable at December&#160;31, 2021 would cause these estimates to change in the near term, and such a change could be material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each quarter, the Company re-examines previously established health care costs payable estimates based on actual claim payments for prior periods and other changes in facts and circumstances. Given the extensive degree of judgment in this estimate, it is possible that the Company&#x2019;s estimates of health care costs payable could develop either favorably (that is, its actual benefit costs for the period were less than estimated) or unfavorably. The changes in the Company&#x2019;s estimate of health care costs payable may relate to a prior quarter, prior year or earlier periods. For a roll forward of the Company&#x2019;s health care costs payable, see Note 7 &#x2018;&#x2018;Health Care Costs Payable.&#x2019;&#x2019; The Company&#x2019;s reserving practice is to consistently recognize the actuarial best estimate of its ultimate liability for health care costs payable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Insurance Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unpaid Claims&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unpaid claims consist primarily of reserves associated with certain short-duration group disability and term life insurance contracts, including an estimate for IBNR as of the financial statement date. Reserves associated with certain short-duration group disability and term life insurance contracts are based upon the Company&#x2019;s estimate of the present value of future benefits, which is based on assumed investment yields and assumptions regarding mortality, morbidity and recoveries from the U.S. Social Security Administration. The Company develops its estimate of IBNR using actuarial principles and assumptions which consider, among other things, contractual requirements, claim incidence rates, claim recovery rates, seasonality and other relevant factors. The Company discounts certain claim liabilities related to group long-term disability and life insurance waiver of premium contracts. The discount rates generally reflect the Company&#x2019;s expected investment returns for the investments supporting all incurral years of these liabilities. The discount rates for retrospectively-rated contracts are set at contractually specified levels. The Company&#x2019;s estimates of unpaid claims are subject to change due to changes in the underlying experience of the insurance contracts, changes in investment yields or other factors, and these changes are recorded in current and future benefits in the consolidated statements of operations in the period they are determined. The Company estimates its reserve for claims IBNR for life products largely based on completion factors. The completion factors used are based on the Company&#x2019;s historical experience and reflect judgments and possible adjustments based on data such as claim inventory levels, claim payment patterns, changes in business volume and other factors. If claims are submitted or processed on a faster (slower) pace than historical periods, the actual claims may be more (less) complete than originally estimated using completion factors, which may result in reserves that are higher (lower) than required to cover future life benefit payments. There have been no significant changes to the methodologies or assumptions used to develop the Company&#x2019;s estimate of unpaid claims IBNR in 2021. As of December&#160;31, 2021, unpaid claims balances of $324 million and $1.3 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2020, unpaid claims balances of $532 million and $1.5 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all life and disability insurance liabilities have been fully ceded to unrelated third parties through indemnity reinsurance agreements; however, the Company remains directly obligated to the policyholders.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Future Policy Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future policy benefits consist primarily of reserves for limited payment pension and annuity contracts and long-term care insurance contracts. Reserves for limited payment pension and annuity contracts are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality, retirement, expense and interest rate experience. Such assumptions generally vary by plan, year of issue and policy duration. Assumed interest rates on such contracts ranged from 3.0% to 11.3% in the year ended December&#160;31, 2021 and from 3.3% to 11.3% in the year ended December&#160;31, 2020. The Company periodically reviews mortality assumptions against both industry standards and its experience. Reserves for long-&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;duration long-term care contracts represent the Company&#x2019;s estimate of the present value of future benefits and essential maintenance expenses to be paid to or on behalf of policyholders less the present value of future gross premiums. The assumed interest rate on such contracts was 5.1% in both the years ended December 31, 2021 and 2020. The Company&#x2019;s estimate of the present value of future benefits under such contracts is based upon mortality, morbidity and interest rate assumptions. As of December&#160;31, 2021, future policy benefits balances of $416 million and $5.1 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2020, future policy benefits balances of $462 million and $5.5 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Premium Deficiency Reserves&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates its insurance contracts to determine if it is probable that a loss will be incurred. A premium deficiency loss is recognized when it is probable that expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), will exceed existing reserves plus anticipated future premiums and reinsurance recoveries. Anticipated investment income is not considered in the calculation of premium deficiency losses for short-duration contracts. For purposes of determining premium deficiency losses, contracts are grouped consistent with the Company&#x2019;s method of acquiring, servicing and measuring the profitability of such contracts. As of December&#160;31, 2021 and 2020, the Company established a premium deficiency reserve of $16 million and $11 million, respectively, related to Medicaid products in the Health Care Benefits segment. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Policyholders&#x2019; Funds&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Policyholders&#x2019; funds consist primarily of reserves for pension and annuity investment contracts and customer funds associated with certain health contracts. Reserves for such contracts are equal to cumulative deposits less withdrawals and charges plus  interest credited thereon, net of experience-rated adjustments. In 2021, interest rates for pension and annuity investment contracts ranged from 3.5% to 4.8%. In 2020, interest rates for pension and annuity investment contracts ranged from 4.1% to 5.1%. Reserves for contracts subject to experience rating reflect the Company&#x2019;s rights as well as the rights of policyholders and plan participants. The Company also holds funds for HSAs on behalf of members associated with high deductible health plans. These amounts are held to pay for qualified health care expenses incurred by these members. The HSA balances were approximately $2.9 billion and $2.7 billion at December&#160;31, 2021 and 2020, respectively, and are reflected in other current assets with a corresponding liability in policyholders&#x2019; funds. These assets are considered restricted cash for cash flow statement purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Policyholders&#x2019; funds liabilities that are expected to be paid within twelve months from the balance sheet date are classified as current on the consolidated balance sheets. Policyholders&#x2019; funds liabilities that are expected to be paid greater than twelve months from the balance sheet date are included in other long-term liabilities on the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Self-Insurance Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is self-insured for certain losses related to general liability, workers&#x2019; compensation and auto liability. The Company obtains third party insurance coverage to limit exposure from these claims. The Company is also self-insured for certain losses related to health and medical liabilities. The Company&#x2019;s self-insurance accruals, which include reported claims and claims incurred but not reported, are calculated using standard insurance industry actuarial assumptions and the Company&#x2019;s historical claims experience. At December&#160;31, 2021 and 2020, self-insurance liabilities totaled $1.1 billion and $927 million, respectively, and were recorded as accrued expenses on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Translation and Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For non-U.S. dollar functional currency locations, (i) assets and liabilities are translated at end-of-period exchange rates, (ii) revenues and expenses are translated at average exchange rates in effect during the period and (iii) equity is translated at historical exchange rates. The resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For U.S. dollar functional currency locations, foreign currency assets and liabilities are remeasured into U.S. dollars at end-of-period exchange rates, except for nonmonetary balance sheet accounts which are remeasured at historical exchange rates. Revenues and expenses are remeasured at average exchange rates in effect during each period, except for those expenses related to the nonmonetary balance sheet amounts which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in net income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains and losses from foreign currency transactions and the effects of foreign currency remeasurements were not material in the years ended December&#160;31, 2021 or 2020. On July 1, 2019, the Company sold its Brazilian subsidiary, Drogaria Onofre Ltda. (&#x201c;Onofre&#x201d;) for an immaterial amount. The Company recorded a loss on the divestiture, which included the elimination of the subsidiary&#x2019;s $154 million cumulative translation adjustment from accumulated other comprehensive income during the year ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which, in the Company&#x2019;s Commercial business, reflect contracted rates per member and the number of covered members recorded in the Company&#x2019;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. Revenue related to the Company&#x2019;s Government business is collected monthly from the U.S. federal government and various government agencies based on fixed payment rates and member eligibility. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Premium Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the minimum medical loss ratio (&#x201c;MLR&#x201d;) rebate requirements of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (as amended, collectively, the &#x201c;ACA&#x201d;) is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Services Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#x2019;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#x2019;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#x2019;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounting for Medicare Part D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues include insurance premiums earned by the Company&#x2019;s PDPs, which are determined based on the PDP&#x2019;s annual bid and related contractual arrangements with the U.S. Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;). The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment sells prescription drugs directly through its mail service dispensing pharmacies and indirectly through the Company&#x2019;s retail pharmacy network. The Company&#x2019;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the dispensing of prescription drugs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions dispensed indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#x201c;Drug Discounts&#x201d; and &#x201c;Guarantees&#x201d; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#x201c;retail co-payments&#x201d;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Pharmacy Services segment:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Revenues generated from prescription drugs sold by mail service dispensing pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Revenues generated from prescription drugs sold by third party pharmacies in the Company&#x2019;s retail pharmacy network and associated administrative fees are recognized at the Company&#x2019;s point-of-sale, which is when the claim is adjudicated by the Company&#x2019;s online claims processing system and the Company has transferred control of the prescription drug and completed all of its performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Drug Discounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records revenue net of manufacturers&#x2019; rebates earned by its clients based on their plan members&#x2019; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#x2019; rebates earned by its clients. The estimates are based on the best available data at period-end and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#x2019; rebate amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Retail Pharmacy&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer returns are not material to the Company&#x2019;s operating results or financial condition. Sales taxes are not included in revenues.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Loyalty and Other Programs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s customer loyalty program, ExtraCare&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, consists of two components, ExtraSavings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also offers a subscription-based membership program, CarePass&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long-term Care&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of long-term care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#x2019;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Walk-In Medical Clinics&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For services provided by the Company&#x2019;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates the Company&#x2019;s revenue by major source in each segment for the years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;152,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;76,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43,765)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;184,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;76,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;76,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;82,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;153,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;100,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;292,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;60,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;153,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;70,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(40,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;171,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;75,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(40,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;85,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;56,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;140,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;66,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(41,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;165,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;86,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(41,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;256,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;88,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;52,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#x2019;s retail pharmacies under the Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;program. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily represent the Company&#x2019;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2021 and 2020, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rewards earnings and gift card issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption and breakage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Products Sold&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for cost of products sold as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of products sold includes: (i) the cost of prescription drugs sold during the reporting period directly through the Company&#x2019;s mail service dispensing pharmacies and indirectly through the Company&#x2019;s retail pharmacy network, (ii) shipping and handling costs, and (iii) the operating costs of the Company&#x2019;s mail service dispensing pharmacies and client service operations and related information technology support costs including depreciation and amortization. The cost of prescription drugs sold component of cost of products sold includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients&#x2019; benefit plans from the Company&#x2019;s mail service dispensing pharmacies, net of any volume-related or other discounts (see &#x201c;Vendor Allowances and Purchase Discounts&#x201d; below) and (ii) the cost of prescription drugs sold (including retail co-payments) through the Company&#x2019;s retail pharmacy network under contracts where the Company is the principal, net of any volume-related or other discounts. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of products sold includes: the cost of merchandise sold during the reporting period, including prescription drug costs, and the related purchasing costs, warehousing and delivery costs (including depreciation and amortization) and actual and estimated inventory losses. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Vendor Allowances and Purchase Discounts &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for vendor allowances and purchase discounts as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Pharmacy Services segment to receive &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, (ii) a discount for the prompt payment of invoices or (iii) when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#x2019;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Pharmacy Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Pharmacy Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vendor allowances received by the Retail/LTC segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any amounts received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon sales volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract. The total amortization of these upfront payments was not material to the Company&#x2019;s consolidated financial statements in any of the periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Reform&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Insurer Fee&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since January 1, 2014, the ACA has imposed an annual premium-based health insurer fee (&#x201c;HIF&#x201d;) for each calendar year, payable in September, which was not deductible for tax purposes. The Company has been required to estimate a liability for the HIF at the beginning of the calendar year in which the fee was payable with a corresponding deferred asset that was amortized ratably to operating expenses over the calendar year. The Company recorded the liability for the HIF in accrued expenses and recorded the deferred asset in other current assets. In December 2019, the HIF was repealed for calendar years after 2020, therefore there was no expense related to the HIF in the year ended December&#160;31, 2021. In the year ended December 31, 2020, operating expenses included $1.0&#160;billion related to the Company&#x2019;s share of the HIF. There was no expense related to the HIF in 2019, since there was a one-year suspension of the HIF for 2019. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Adjustment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA established a permanent risk adjustment program to transfer funds from qualified individual and small group insurance plans with below average risk scores to plans with above average risk scores. Based on the risk of the Company&#x2019;s qualified plan members relative to the average risk of members of other qualified plans in comparable markets, as defined by the ACA, the Company estimates its ultimate risk adjustment receivable (recorded in accounts receivable) or payable (recorded in accrued expenses) for the current calendar year and reflects the pro-rata year-to-date impact as an adjustment to premium revenue. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Corridor&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#x201c;HHS&#x201d;) based on their ratio of allowable costs to target costs (as defined by the ACA). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company filed a lawsuit in August 2019 to recover the $313&#160;million it was owed under the ACA&#x2019;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#x2019;s temporary risk corridor program. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the Company received the $313&#160;million it was owed under the ACA&#x2019;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the year ended December 31, 2020. After considering &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;offsetting items such as the ACA&#x2019;s minimum MLR rebate requirements and premium taxes, the Company recorded pre-tax income of $307 million and after-tax income of $223&#160;million during the year ended December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Costs &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs, which are reduced by the portion funded by vendors, are expensed when the related advertising takes place. Net advertising costs, which are included in operating expenses, were $523 million, $461 million and $396 million in 2021, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcyMzEz_ea62d84c-7b65-4b23-9d75-3a8341c56a52"&gt;three&lt;/span&gt; to five years) using the straight-line method. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year or years in which the differences are expected to reverse. The effect of a change in the tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date of such change.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and the Company&#x2019;s recent operating results. The Company establishes a valuation allowance when it does not consider it more likely than not that a deferred tax asset will be recovered.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records uncertain tax positions on the basis of a two-step process whereby (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors defined benefit pension plans (&#x201c;pension plans&#x201d;) and other postretirement employee benefit plans (&#x201c;OPEB plans&#x201d;) for its employees and retirees. The Company recognizes the funded status of its pension and OPEB plans on the consolidated balance sheets based on the year-end measurements of plan assets and benefit obligations. When the fair value of plan assets are in excess of the plan benefit obligations, the amounts are reported in other current assets and other assets. When the fair value of plan benefit obligations are in excess of plan assets, the amounts are reported in accrued expenses and other long-term liabilities based on the amount by which the actuarial present value of benefits payable in the next twelve months included in the benefit obligation exceeds the fair value of plan assets. The net periodic benefit cost (income) for the Company&#x2019;s pension and OPEB plans do not contain a service cost component as these plans have been frozen for an extended period of time.&#160;Non-service cost components of pension and postretirement net periodic benefit cost (income) are included in other income in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share is computed using the two-class method. The Company calculates basic earnings per share based on the weighted average number of common shares outstanding for the period. See Note 14 &#x2018;&#x2018;Earnings Per Share&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shares Held in Trust&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains grantor trusts, which held approximately one million shares of its common stock at both December&#160;31, 2021 and 2020. These shares are designated for use under various employee compensation plans. Since the Company holds these shares, they are excluded from the computation of basic and diluted shares outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has investments in (i) a generic pharmaceutical sourcing entity, (ii) certain hedge fund and private equity investments and (iii) certain real estate partnerships that are considered VIEs. The Company does not have a future obligation to fund losses or debts on behalf of these investments; however, it may voluntarily contribute funds. In evaluating whether the Company is the primary beneficiary of a VIE, the Company considers several factors, including whether the Company has (a) the power to direct the activities that most significantly impact the VIE&#x2019;s economic performance and (b) the obligation to absorb losses and the right to receive benefits that could potentially be significant to the VIE. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Interest Entities - Primary Beneficiary&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2014, the Company and Cardinal Health, Inc. (&#x201c;Cardinal&#x201d;) established Red Oak Sourcing, LLC (&#x201c;Red Oak&#x201d;), a generic pharmaceutical sourcing entity in which the Company and Cardinal each own 50%. The Red Oak arrangement had an initial term of ten years. In 2021, the Red Oak arrangement was amended to extend the initial term an additional five years, for a total term of 15 years. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak; however, Red Oak does not own or hold inventory on behalf of either company. No physical assets (e.g., property and equipment) were contributed to Red Oak by either company, and minimal funding was provided to capitalize Red Oak. The Company has determined that it is the primary beneficiary of this VIE because it has the ability to direct the activities of Red Oak. Consequently, the Company consolidates Red Oak in its consolidated financial statements within the Retail/LTC segment. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cardinal is required to pay the Company quarterly payments, which began in October 2014 and will extend through June 2029. As milestones are met, the quarterly payments increase. The Company received $183 million from Cardinal during each of the years ended December&#160;31, 2021, 2020 and 2019. The payments reduce the Company&#x2019;s carrying value of inventory and are recognized in cost of products sold when the related inventory is sold. Amounts reimbursed by Cardinal for the years ended December&#160;31, 2021, 2020 and 2019, and amounts due to or due from Cardinal at December&#160;31, 2021 and 2020 were immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Interest Entities - Other Variable Interest Holder&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has invested in certain VIEs for which it has determined that it is not the primary beneficiary, consisting of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Hedge fund and private equity investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company invests in hedge fund and private equity investments in order to generate investment returns for its investment portfolio supporting its insurance businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Real estate partnerships&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company invests in various real estate partnerships, including those that construct, own and manage low-income housing developments. For the low income housing development investments, substantially all of the projected benefits to the Company are from tax credits and other tax benefits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is not the primary beneficiary of these VIEs because the nature of the Company&#x2019;s involvement with the activities of these VIEs does not give the Company the power to direct the activities that most significantly impact their economic performance. The Company records the amount of its investment in these VIEs as long-term investments on the consolidated balance sheets and recognizes its share of each VIE&#x2019;s income or losses in net income (loss).&#160;The Company&#x2019;s maximum exposure to loss from these VIEs is limited to its investment balances as disclosed below and the risk of recapture of previously recognized tax credits related to the real estate partnerships, which the Company does not consider significant.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total amount of other variable interest holder VIE assets included in long-term investments on the consolidated balance sheets at December&#160;31, 2021 and 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedge fund investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in SureScripts, LLC (&#x201c;SureScripts&#x201d;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $52 million, $56 million and $32 million in the years ended December&#160;31, 2021, 2020 and 2019, respectively. The Company&#x2019;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in Heartland Healthcare Services, LLC (&#x201c;Heartland&#x201d;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $79 million, $77 million and $96 million for pharmaceutical inventory purchases during the years ended December&#160;31, 2021, 2020 and 2019, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#x2019;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2021, 2020 and 2019, the Company made charitable contributions of&#160;$50&#160;million, $50 million and $30&#160;million, respectively,&#160;to the CVS Health Foundation, a non-profit entity that focuses on health, education and community involvement programs. The charitable contributions were recorded as operating expenses in the consolidated statements of operations within the Corporate/Other segment for the years ended December&#160;31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Discontinued Operations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with certain business dispositions completed between 1995 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens &#x2018;n Things and Bob&#x2019;s Stores, each of which subsequently filed for bankruptcy. The Company&#x2019;s loss from discontinued operations includes lease-related costs that the Company believes it will likely be required to satisfy pursuant to these lease guarantees. See &#x201c;Lease Guarantees&#x201d; in Note 16 &#x2018;&#x2018;Commitments and Contingencies&#x2019;&#x2019; for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the results of discontinued operations for the year ended December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Results from discontinued operations were immaterial for the years ended December 31, 2021 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Recently Adopted &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated operating results, cash flows, financial condition or related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Insurance Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#x2019;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#x2019;s &lt;/span&gt;&lt;/div&gt;liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#x2019;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#x2019;s expected investment yield under the existing guidance.</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfStores
      contextRef="i7310250aa7db49e5bb0700f9d3b0c92b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzE4Mg_70a0cc07-ad41-4499-a7b3-c923041a2ba4"
      unitRef="store">9900</us-gaap:NumberOfStores>
    <cvs:NumberofWalkInMedicalClinics
      contextRef="i7310250aa7db49e5bb0700f9d3b0c92b_I20211231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIxNw_a65730ac-5bd4-4e33-bd78-d2a948100c4d"
      unitRef="member">1200</cvs:NumberofWalkInMedicalClinics>
    <cvs:NumberOfPlanMembers
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMwMA_3ea1504a-5527-4a2f-a0f9-d1b3a21fd218"
      unitRef="people">110000000</cvs:NumberOfPlanMembers>
    <cvs:NumberofPatientsServedperYear
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzM3Nw_31ec9d15-40f8-4717-9583-660e8af2b6f4"
      unitRef="patient">1000000</cvs:NumberofPatientsServedperYear>
    <cvs:NumberOfPeopleServed
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ3OA_5b92280b-68f8-4f95-8bfb-a8567ee9a731"
      unitRef="people">35000000</cvs:NumberOfPeopleServed>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDAy_69497644-3d0d-45d5-ae72-3d14f6a41f4e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has four reportable segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other, which are described below. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Health Care Benefits segment operates as one of the nation&#x2019;s leading diversified health care benefits providers. The Health Care Benefits segment has the information and resources to help members, in consultation with their health care professionals, make more informed decisions about their health care. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs, Medicaid health care management services and health information technology products and services. The Health Care Benefits segment also provided workers&#x2019; compensation administrative services through its Coventry Health Care Workers&#x2019; Compensation business (&#x201c;Workers&#x2019; Compensation business&#x201d;) prior to the sale of this business on July 31, 2020. The Health Care Benefits segment&#x2019;s customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers (&#x201c;providers&#x201d;), governmental units, government-sponsored plans, labor groups and expatriates. The Company refers to insurance products (where it assumes all or a majority of the risk for medical and dental care costs) as &#x201c;Insured&#x201d; and administrative services contract products (where the plan sponsor assumes all or a majority of the risk for medical and dental care costs) as &#x201c;ASC.&#x201d; In addition, effective January 2022, the Company entered the individual public health insurance exchanges (&#x201c;Public Exchanges&#x201d;) in eight states through which it sells Insured plans directly to individual consumers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment provides a full range of pharmacy benefit management (&#x201c;PBM&#x201d;) solutions, including plan design offerings and administration, formulary management, retail pharmacy network management services and mail order pharmacy. In addition, through the Pharmacy Services segment, the Company provides specialty pharmacy and infusion services, clinical services, disease management services, medical spend management and pharmacy and/or other administrative services for providers and federal 340B drug pricing program covered entities (&#x201c;Covered Entities&#x201d;). The Pharmacy Services segment&#x2019;s clients are primarily employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, plans offered on Public Exchanges and private health insurance exchanges, other sponsors of health benefit plans throughout the United States and Covered Entities. The Pharmacy Services segment operates retail specialty pharmacy stores, specialty mail order pharmacies, mail order dispensing pharmacies, compounding pharmacies and branches for infusion and enteral nutrition services. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, provides health care services through its MinuteClinic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;walk-in medical clinics, provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19 and shingles and conducts long-term care pharmacy (&#x201c;LTC&#x201d;) operations, which distribute prescription drugs and provide related pharmacy consulting and other ancillary services to long-term care facilities and other care settings. As of December&#160;31, 2021, the Retail/LTC segment operated more than 9,900 retail locations, nearly 1,200 MinuteClinic locations as well as online retail pharmacy websites, LTC pharmacies and on-site pharmacies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Corporate/Other Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company presents the remainder of its financial results in the Corporate/Other segment, which primarily consists of:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Management and administrative expenses to support the Company&#x2019;s overall operations, which include certain aspects of executive management and the corporate relations, legal, compliance, human resources, information technology and finance departments, expenses associated with the Company&#x2019;s investments in its transformation and enterprise modernization programs and acquisition-related transaction and integration costs; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Products for which the Company no longer solicits or accepts new customers such as its large case pensions and long-term care insurance products.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzE4Nzg_b07a84ab-91f6-49c5-84e5-b7d1dd84638e"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <cvs:IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates
      contextRef="idf62411f04644ec5a62a251e4c8f705a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzEwOTk1MTE3NDE2MTQ_4fa57cca-000e-4968-89b3-00c3a130252a"
      unitRef="state">8</cvs:IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates>
    <us-gaap:NumberOfStores
      contextRef="i7310250aa7db49e5bb0700f9d3b0c92b_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzM1ODA_98772ac3-184b-436a-abc8-e47603e7e8cc"
      unitRef="store">9900</us-gaap:NumberOfStores>
    <cvs:NumberofWalkInMedicalClinics
      contextRef="i7310250aa7db49e5bb0700f9d3b0c92b_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzM2MTU_ae986bd4-cc63-4d95-867a-5c34a8cbef09"
      unitRef="clinic">1200</cvs:NumberofWalkInMedicalClinics>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NTM2_07b6c8ba-a753-4ecc-a2e6-adaae48ff289">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements of CVS Health and its subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries and variable interest entities (&#x201c;VIEs&#x201d;) for which the Company is the primary beneficiary. All material intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NTA0_839b7957-50eb-4f78-8585-00729c89120b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform with the current year presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDIz_ffb93942-02aa-4bca-a57c-a7b9005fe80b">Use of EstimatesThe preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDM1_dff7f813-ceab-4fa9-985a-bae807fdac81">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of cash and temporary investments with maturities of three months or less when purchased. The Company invests in short-term money market funds, commercial paper and time deposits, as well as other debt securities that are classified as cash equivalents within the accompanying consolidated balance sheets, as these funds are highly liquid and readily convertible to known amounts of cash. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash (included in other current assets) represents funds held on behalf of members, including health savings account (&#x201c;HSA&#x201d;) funds associated with high deductible health plans. Beginning in 2021, the Company began presenting these funds held on behalf of members in restricted cash and, for statement of cash flow purposes, retrospectively adjusted the 2020 and 2019 balances by the amounts shown in the table below in the line item &#x201c;restricted cash (included in other current assets)&#x201d; to conform with the current year presentation. Restricted cash (included in other assets) represents amounts held in a trust in one of the Company&#x2019;s captive insurance companies to satisfy collateral requirements associated with the assignment of certain insurance policies. All restricted cash is invested in time deposits, money market funds or commercial paper.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDgz_57c314b7-aff9-462c-9b7a-9e02ebfe3589">&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of cash and cash equivalents on the consolidated balance sheets to total cash, cash equivalents and restricted cash on the consolidated statements of cash flows as of December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other current assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash (included in other assets)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzEtMS0xLTEtMTk2MzU_f5cc04aa-c641-4c96-9046-12137ac56422"
      unitRef="usd">9408000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzEtMy0xLTEtMTk2MzU_c6dae105-688e-42f8-af5e-b8f75a2bf934"
      unitRef="usd">7854000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzEtNS0xLTEtMTk2MzU_4e612a02-07eb-437a-9e24-917513ab4745"
      unitRef="usd">5683000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzItMS0xLTEtNjQyOTQ_6264c47b-6a64-44ca-a242-fbb133a86d44"
      unitRef="usd">3065000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzItMy0xLTEtNjQyOTQ_14856876-cc2d-4546-a297-fe25a0c3f6a4"
      unitRef="usd">2913000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzItNS0xLTEtNjQyOTQ_c7be8a26-26c0-4955-8d63-db8d56fec7b7"
      unitRef="usd">2454000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzMtMS0xLTEtMTk2MzU_bbd330e8-3987-437e-9cf5-76b3adab4213"
      unitRef="usd">218000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzMtMy0xLTEtMTk2MzU_6bf5e6a0-7be6-4994-9635-bf6d733cf93e"
      unitRef="usd">276000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzMtNS0xLTEtMTk2MzU_c1808d78-6bad-4095-8298-2559fa40bd47"
      unitRef="usd">271000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzQtMS0xLTEtMTk2MzU_90ffd139-0d59-4cbb-bc97-4dbe106f4110"
      unitRef="usd">12691000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzQtMy0xLTEtMTk2MzU_d6a874e4-f062-40eb-9be7-d5ef2cb3b139"
      unitRef="usd">11043000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkODllZTg5MWFkMDg0M2QxYTllZTIyMjU5MTIzYjg1MC90YWJsZXJhbmdlOmQ4OWVlODkxYWQwODQzZDFhOWVlMjIyNTkxMjNiODUwXzQtNS0xLTEtMTk2MzU_7ca78e29-f74f-40a8-a220-67dd631124e4"
      unitRef="usd">8408000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDg0_bc3e775d-b4f2-480e-adb8-4d10d9fa8ed3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Securities &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities consist primarily of U.S. Treasury and agency securities, mortgage-backed securities, corporate and foreign bonds and other debt securities. Debt securities are classified as either current or long-term investments based on their contractual maturities unless the Company intends to sell an investment within the next twelve months, in which case it is classified as current on the consolidated balance sheets. Debt securities are classified as available for sale and are carried at fair value. See Note 4 &#x2018;&#x2018;Fair Value&#x2019;&#x2019; for additional information on how the Company estimates the fair value of these investments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a debt security is in an unrealized loss position and the Company has the intent to sell the security, or it is more likely than not that the Company will have to sell the security before recovery of its amortized cost basis, the amortized cost basis of the security is written down to its fair value and the difference is recognized in net income. If a debt security is in an unrealized loss position and the Company does not have the intent to sell and it is more likely than not that the Company will not have to sell such security before recovery of its amortized cost basis, the Company bifurcates the impairment into credit-related and non-credit related components. In evaluating whether a credit related loss exists, the Company considers a variety of factors including: the extent to which the fair value is less than the amortized cost basis; adverse conditions specifically related to the issuer of a security, an industry or geographic area; the payment structure of the security; the failure of the issuer of the security to make scheduled interest or principal payments; and any changes to the rating of the security by a rating agency. The amount of the credit-related component is recorded as an allowance for credit losses and recognized in net income, and the amount of the non-credit related component is included in other comprehensive income. Interest is not accrued on debt securities when management believes the collection of interest is unlikely.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The credit-related component is determined by comparing the present value of cash flows expected to be collected from the security, considering all reasonably available information relevant to the collectability of the security, with the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis of the security, the Company records an allowance for credit losses, which is limited by the amount that the fair value is less than amortized cost basis. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For mortgage-backed and other asset-backed securities, the Company recognizes income using an effective yield based on anticipated prepayments and the estimated economic life of the securities. When estimates of prepayments change, the effective yield is recalculated to reflect actual payments to date and anticipated future payments. The Company&#x2019;s investment in the security is adjusted to the amount that would have existed had the new effective yield been applied since the acquisition of the security, with adjustments recognized in net income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equity securities with readily available fair values are measured at fair value with changes in fair value recognized in net income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mortgage Loans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Mortgage loan investments on the consolidated balance sheets are valued at the unpaid principal balance, net of an allowance for credit losses. Mortgage loans with a maturity date or a committed prepayment date within twelve months are classified as current on the consolidated balance sheets. The Company assesses whether its loans share similar risk characteristics and, if so, groups such loans in a risk pool when measuring expected credit losses. The Company considers the following characteristics when evaluating whether its loans share similar risk characteristics:&#160;loan-to-value ratios, property type (e.g., office, retail, apartment, industrial), geographic location, vacancy rates and property condition. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit loss reserves are determined using a loss rate method that multiplies the unpaid principal balance of each loan within a risk pool group by an estimated loss rate percentage. The loss rate percentage considers both the expected loan loss severity and the probability of loan default. For periods where the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions (e.g., gross domestic product, employment), the Company adjusts its expected loss rates to reflect these forecasted economic conditions. For periods beyond which the Company is able to make or obtain reasonable and supportable forecasts of expected economic conditions, the Company reverts to historical loss rates in determining expected credit losses. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income on a potential problem loan (i.e., high probability of default) or restructured loan is accrued to the extent it is deemed to be collectible and the loan continues to perform under its original or restructured terms. Interest income on problem loans (i.e., more than 60 days delinquent, in bankruptcy or in process of foreclosure) is recognized on a cash basis. Cash payments on loans in the process of foreclosure are treated as a return of principal.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Investments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other investments consist primarily of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Private equity and hedge fund limited partnerships, which are accounted for using the equity method of accounting. Under this method, the carrying value of the investment is based on the value of the Company&#x2019;s equity ownership of the underlying investment funds provided by the general partner or manager of the investments, the financial statements of which generally are audited. As a result of the timing of the receipt of the valuation information provided by the fund managers, these investments are generally reported on up to a three month lag. The Company reviews investments for impairment at least quarterly and monitors their performance throughout the year through discussions with the administrators, managers and/or general partners. If the Company becomes aware of an impairment of a limited partnership&#x2019;s investments through its review or prior to receiving the limited partnership&#x2019;s financial statements at the financial statement date, an impairment will be recognized by recording a reduction in the carrying value of the limited partnership with a corresponding charge to net investment income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Investment real estate, which is carried on the consolidated balance sheets at depreciated cost, including capital additions, net of write-downs for other-than-temporary declines in fair value. Depreciation is calculated using the straight-line method based on the estimated useful life of each asset. If any real estate investment is considered held-for-sale, it is carried at the lower of its carrying value or fair value less estimated selling costs. The Company generally estimates fair value using net operating income and applying a capitalization rate in conjunction with comparable sales information. At the time of the sale, the difference between the sales price and the carrying value is recorded as a realized capital gain or loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Privately-placed equity securities, which are carried on the consolidated balance sheets at cost less impairments, plus or minus subsequent adjustments for observable price changes. Additionally, as a member of the Federal Home Loan Bank of Boston (&#x201c;FHLBB&#x201d;), a subsidiary of the Company is required to purchase and hold shares of the FHLBB. These shares are restricted and carried at cost. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Investment Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net investment income on the Company&#x2019;s investments is recorded when earned and is reflected in the Company&#x2019;s net income (other than net investment income on assets supporting experience-rated products). Experience-rated products are products in the large case pensions business where the contract holder, not the Company, assumes investment and other risks, subject to, among other things, minimum guarantees provided by the Company. The effect of investment performance on experience-rated products is allocated to contract holders&#x2019; accounts daily, based on the underlying investment experience and, therefore, does not impact the Company&#x2019;s net income (as long as the contract&#x2019;s minimum guarantees are not triggered). Net investment income on assets supporting large case pensions&#x2019; experience-rated products is included in net investment income in the consolidated statements of operations and is credited to contract holders&#x2019; accounts through a charge to benefit costs. The contract holders&#x2019; accounts are reflected in policyholders&#x2019; funds on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized capital gains and losses on investments (other than realized capital gains and losses on investments supporting experience-rated products) are included as a component of net investment income in the consolidated statements of operations. Realized capital gains and losses are determined on a specific identification basis. Purchases and sales of debt and equity securities and alternative investments are reflected on the trade date. Purchases and sales of mortgage loans and investment real estate are reflected on the closing date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized capital gains and losses on investments supporting large case pensions&#x2019; experience-rated products are not included in realized capital gains and losses in the consolidated statements of operations and instead are credited directly to contract holders&#x2019; accounts. The contract holders&#x2019; accounts are reflected in policyholders&#x2019; funds on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unrealized capital gains and losses on investments (other than unrealized capital gains and losses on investments supporting experience-rated products) are reflected in shareholders&#x2019; equity, net of tax, as a component of accumulated other comprehensive income. Unrealized capital gains and losses on investments supporting large case pensions&#x2019; experience-rated products are credited directly to contract holders&#x2019; accounts. The contract holders&#x2019; accounts are reflected in policyholders&#x2019; funds on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NTA2_6dd78741-02ef-4243-b004-931169250bf7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses derivative financial instruments in order to manage interest rate and foreign exchange risk and credit exposure. The Company&#x2019;s use of these derivatives is generally limited to hedging risk and has principally consisted of using interest rate swaps, treasury rate locks, forward contracts, futures contracts, warrants, put options and credit default swaps.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDEz_f0f1fcd8-0245-431c-87df-3d4692a30524">Accounts ReceivableAccounts receivable are stated net of allowances for credit losses, customer credit allowances, contractual allowances and estimated terminations.When developing an estimate of the Company&#x2019;s expected credit losses, the Company considers all available relevant information regarding the collectability of cash flows, including historical information, current conditions and reasonable and supportable forecasts of future economic conditions over the contractual life of the receivable. The Company&#x2019;s accounts receivable are short duration in nature and typically settle in less than 30 days.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3Mzkx_c93a3843-cb8f-4eb7-a199-4a5e7950df32">Accounts receivable, net is composed of the following at December&#160;31, 2021 and 2020:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor and manufacturer receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Total accounts receivable, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzEtMS0xLTEtMTk2MzU_bb28417b-43ee-4bbc-b77c-a2aad7c11130"
      unitRef="usd">7932000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzEtMy0xLTEtMTk2MzU_2e5d788f-bf36-4ff1-b0bf-b252ef9a6f2b"
      unitRef="usd">7101000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <cvs:VendorandManufacturerReceivables
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzItMS0xLTEtMTk2MzU_152dd4eb-37a9-4d43-9d23-b2363acfbf7a"
      unitRef="usd">10573000000</cvs:VendorandManufacturerReceivables>
    <cvs:VendorandManufacturerReceivables
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzItMy0xLTEtMTk2MzU_3f0f8d51-655d-46b8-988b-a3eef4a4d9bc"
      unitRef="usd">9815000000</cvs:VendorandManufacturerReceivables>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzMtMS0xLTEtMTk2MzU_de478219-38e8-4a1f-a496-d478765eeeef"
      unitRef="usd">2537000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:PremiumsReceivableAtCarryingValue
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzMtMy0xLTEtMTk2MzU_c7cb5c1c-2bb4-4bda-a5ba-c42d236dadd9"
      unitRef="usd">2628000000</us-gaap:PremiumsReceivableAtCarryingValue>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzQtMS0xLTEtMTk2MzU_3fc64a66-d74e-4297-8cbd-c7f3407d8f0a"
      unitRef="usd">3389000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzQtMy0xLTEtMTk2MzU_b2946550-ef66-496d-bc84-710cfe0414a9"
      unitRef="usd">2198000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzUtMS0xLTEtMTk2MzU_d110776d-5772-4c4f-996b-7eb67644a4c9"
      unitRef="usd">24431000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpjZTAxMjI4NTFiZWQ0ZmZmYjYxNWIxY2UwYmVjODNlOC90YWJsZXJhbmdlOmNlMDEyMjg1MWJlZDRmZmZiNjE1YjFjZTBiZWM4M2U4XzUtMy0xLTEtMTk2MzU_a4219712-5840-4327-8201-704060ced36b"
      unitRef="usd">21742000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzEwOTk1MTE3MjAxNDQ_09c63d05-9504-40bb-a6a6-f27be387100c"
      unitRef="usd">339000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzE5MDI5_592e6fdf-ea72-4028-820d-17b511ed8991"
      unitRef="usd">358000000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDU0_3efb3cab-d66a-4008-b23d-36e8432f18f9">Inventories Inventories are valued at the lower of cost or net realizable value using the weighted average cost method. Physical inventory counts are taken on a regular basis in each retail store and LTC pharmacy, and a continuous cycle count process is the primary procedure used to validate the inventory balances on hand in each distribution center and mail facility to ensure that the amounts reflected in the consolidated financial statements are properly stated. During the interim period between physical inventory counts, the Company accrues for anticipated physical inventory losses on a location-by-location basis based on historical results and current physical inventory trends.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ReinsuranceAccountingPolicy
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3Mzky_959029d9-d82f-46d0-a56a-f16958f9197e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reinsurance Recoverables &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#x2019;s primary liability as the direct insurer of the risks reinsured. Failure of reinsurers to indemnify the Company could result in losses; however, the Company does not expect charges for unrecoverable reinsurance to have a material effect on its consolidated operating results or financial condition. The Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities or economic characteristics of its reinsurers. At December&#160;31, 2021, the Company&#x2019;s reinsurance recoverables consisted primarily of amounts due from third parties that are rated consistent with companies that are considered to have the ability to meet their obligations. Reinsurance recoverables are recorded as other current assets or other assets on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReinsuranceAccountingPolicy>
    <us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDU1_accffcfc-7426-4b78-b9d3-4cdcafc58d89">Health Care Contract Acquisition CostsInsurance products included in the Health Care Benefits segment are cancellable by either the customer or the member monthly upon written notice. Acquisition costs related to prepaid health care and health indemnity contracts are generally expensed as incurred. Acquisition costs for certain long-duration insurance contracts are deferred and are recorded as other current assets or other assets on the consolidated balance sheets and are amortized over the estimated life of the contracts. The amortization of deferred acquisition costs is recorded in operating expenses in the consolidated statements of operations.</us-gaap:CapitalizationOfDeferredPolicyAcquisitionCostsPolicy>
    <us-gaap:DeferredPolicyAcquisitionCosts
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIyMTQ1_2fb2da89-8834-4020-915a-0fbfbf65e3ba"
      unitRef="usd">895000000</us-gaap:DeferredPolicyAcquisitionCosts>
    <us-gaap:DeferredPolicyAcquisitionCosts
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIyMTUy_9d335161-0a79-484a-bf5a-bd09293301d3"
      unitRef="usd">546000000</us-gaap:DeferredPolicyAcquisitionCosts>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDY2_e059627e-e05f-4963-b8ad-e5e029f315e0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment is reported at historical cost, net of accumulated depreciation. Property, equipment and improvements to leased premises are depreciated using the straight-line method over the estimated useful lives of the assets, or when applicable, the term of the lease, whichever is shorter. Estimated useful lives generally range from 1 to 40 years for buildings, building improvements and leasehold improvements and 3 to 10 years for fixtures, equipment and internally developed software. Repair and maintenance costs are charged directly to expense as incurred. Major renewals or replacements that &lt;/span&gt;&lt;/div&gt;substantially extend the useful life of an asset are capitalized and depreciated. Application development stage costs for significant internally developed software projects are capitalized and depreciated.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iaa2dfaae047842b6941420922ac5d9c3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIyNjU2_e02e900e-89bb-4398-9d64-e8c46aedfc8a">P1Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9d5000b271614c1d855c110b625f929b_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIyNjYy_040c87af-eacc-4395-b6c4-f25e639d38cb">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ib812c723ed9c436d8f87f4410c352090_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIyNzM5_3b30d882-c3fb-4583-b015-3d4067a39741">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i485bcdbe665a4e4cbd15d510c347723d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIyNzQ1_2da148ac-acca-4d60-a5d1-f8838c2535ad">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDAw_39fe2768-e442-420f-a888-a000b3bd0f1d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consists of the following at December&#160;31, 2021 and 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixtures and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,700)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i11f43eb2bc384595bbbc2dc60fb0e429_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzEtMS0xLTEtMTk2MzU_f02c77c3-af22-44fd-9a00-83600f210d07"
      unitRef="usd">2038000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iab960c5fc78c435185612e456997735f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzEtMy0xLTEtMTk2MzU_f76cf44b-4cc4-4770-8caa-a52547824d3c"
      unitRef="usd">2134000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ibb17dc7419794c27a906e798d28163ce_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzItMS0xLTEtMTk2MzU_d86775da-5e48-4b4c-8cc6-2be73a0186f6"
      unitRef="usd">4225000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3d5a1e36661d4e01b93add403e998d55_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzItMy0xLTEtMTk2MzU_1b9bddf3-0b7a-43d7-97b5-e7fff2464cd2"
      unitRef="usd">3950000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie95f04d20e7d4540beba10c465fb945c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzMtMS0xLTEtMTk2MzU_c76b78b4-8251-49a4-b7b4-46215e3eee0a"
      unitRef="usd">13619000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i220afc16aa4243638833bb1917d74494_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzMtMy0xLTEtMTk2MzU_24232579-d343-4ee4-ac70-09bc183ffaf2"
      unitRef="usd">13125000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i06c0e02c68194f43b7f9e96b2667ef52_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzQtMS0xLTEtMTk2MzU_c48fde66-b130-4963-be76-867ad818e5b0"
      unitRef="usd">6242000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i334820a07cbd4de3a8b8dc2ef2625448_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzQtMy0xLTEtMTk2MzU_7654bc1f-7bf4-4556-953c-d880676ac079"
      unitRef="usd">6077000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i01b95bc53d324e16ab4248f13d4f4b5d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzUtMS0xLTEtMTk2MzU_347a140c-4239-4ed8-97be-249cb2c6b068"
      unitRef="usd">7426000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7b10e7dd209b41c8afef5d331b8732be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzUtMy0xLTEtMTk2MzU_6766b410-3434-4283-b6c4-d564e27ce67e"
      unitRef="usd">6020000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzYtMS0xLTEtMTk2MzU_b01d17ac-fde2-4ca2-b848-cef2631efde0"
      unitRef="usd">33550000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzYtMy0xLTEtMTk2MzU_42ca96fb-b6ce-4edd-aa5e-fef4367fd821"
      unitRef="usd">31306000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzctMS0xLTEtMTk2MzU_3fd9b6e4-ab2d-4225-a257-41f3b0171b7d"
      unitRef="usd">20654000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzctMy0xLTEtMTk2MzU_203c6677-a832-45cc-a725-189d28d656b5"
      unitRef="usd">18700000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzgtMS0xLTEtMTk2MzU_a0335999-6488-4fa4-8095-5e857271a3c6"
      unitRef="usd">12896000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpiMTQzOGMwMTM1MjE0ZDcwOGRjZjJkNWI0MjYwNTNiOS90YWJsZXJhbmdlOmIxNDM4YzAxMzUyMTRkNzA4ZGNmMmQ1YjQyNjA1M2I5XzgtMy0xLTEtMTk2MzU_a0829871-dd4a-45fd-911f-49599343d7cc"
      unitRef="usd">12606000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIzMzIw_9ad8ac32-2b0e-44e4-8014-87099347455b"
      unitRef="usd">2300000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIzMzI0_fac1e01c-169a-4ed2-959b-0d54243d2f78"
      unitRef="usd">2100000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzIzMzMx_c6307603-475e-4a10-8431-7747e09ef388"
      unitRef="usd">1900000000</us-gaap:Depreciation>
    <cvs:StoreImpairmentCharges
      contextRef="i73df28e0580843f0af8aec248d34934d_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzM4NDgyOTA4MzkzOTk_d99fc181-eba5-4789-af84-a684f768a25f"
      unitRef="usd">261000000</cvs:StoreImpairmentCharges>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDA1_3c31acbe-07a6-4969-bdda-c98a49e668c0">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Right-of-Use Assets and Lease Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement contains a lease at the inception of a contract. Right-of-use assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. As the interest rate implicit in the Company&#x2019;s leases is not readily determinable, the Company utilizes its incremental borrowing rate, determined by class of underlying asset, to discount the lease payments. The operating lease right-of-use assets also include lease payments made before commencement and are reduced by lease incentives. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s real estate leases typically contain options that permit renewals for additional periods of up to five years each. For real estate leases, the options to extend are not considered reasonably certain at lease commencement because the Company reevaluates each lease on a regular basis to consider the economic and strategic incentives of exercising the renewal options and regularly opens or closes stores to align with its operating strategy. Generally, the renewal option periods are not included within the lease term and the associated payments are not included in the measurement of the right-of-use asset and lease liability. Similarly, renewal options are not included in the lease term for non-real estate leases because they are not considered reasonably certain of being exercised at lease commencement. Leases with an initial term of 12 months or less are not recorded on the balance sheets, and lease expense is recognized on a straight-line basis over the term of the short-term lease.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For real estate leases, the Company accounts for lease components and nonlease components as a single lease component.  Certain real estate leases require additional payments based on sales volume, as well as reimbursement for real estate taxes, common area maintenance and insurance, which are expensed as incurred as variable lease costs. Other real estate leases contain one fixed lease payment that includes real estate taxes, common area maintenance and insurance. These fixed payments are considered part of the lease payment and included in the right-of-use assets and lease liabilities.&lt;/span&gt;&lt;/div&gt;See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for additional information about right-of-use assets and lease liabilities.</us-gaap:LesseeLeasesPolicyTextBlock>
    <cvs:LesseeOperatingAndFinanceLeasesRenewalTerm
      contextRef="i2f08d731825c4986934a5374bd021d17_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzI0NDY5_2d866c1d-af3e-4e32-8063-97b506c29a2e">P5Y</cvs:LesseeOperatingAndFinanceLeasesRenewalTerm>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDQw_936818a0-7491-469b-850b-9fd7424bf9fe">Goodwill The Company accounts for business combinations using the acquisition method of accounting, which requires the excess cost of an acquisition over the fair value of net assets acquired and identifiable intangible assets to be recorded as goodwill. Goodwill is not amortized, but is subject to impairment reviews annually, or more frequently if necessary, as further described in &#x201c;Long-Lived Asset Impairment&#x201d; below.</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDQx_9fda69f5-47cc-4c80-aa63-39d30576889a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s identifiable intangible assets consist primarily of trademarks, trade names, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired (&#x201c;VOBA&#x201d;). These intangible assets arise primarily from the determination of their respective fair market values at the date of acquisition. Amounts assigned to identifiable intangible assets, and their related useful lives, are derived from established valuation techniques and management estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s definite-lived intangible assets are amortized over their estimated useful lives based upon the pattern of future cash flows attributable to the asset. Other than VOBA, definite-lived intangible assets are amortized using the straight-line method. VOBA is amortized over the expected life of the acquired contracts in proportion to estimated premiums. Indefinite-lived intangible assets are not amortized but are tested for impairment annually, or more frequently if necessary, as further described in &#x201c;Long-Lived Asset Impairment&#x201d; below.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDY0_7f59e140-b252-4f29-9c5d-f53adc39c674">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Asset Impairment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates the recoverability of long-lived assets, excluding goodwill and indefinite-lived intangible assets, which are tested for impairment using separate tests described below, whenever events or changes in circumstances indicate that the carrying value of such asset may not be recoverable. The Company groups and evaluates these long-lived assets for impairment at the lowest level at which individual cash flows can be identified. If indicators of impairment are present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated future cash flows used in this analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to the asset group&#x2019;s estimated future cash flows (discounted). If required, an impairment loss is recorded for the portion of the asset group&#x2019;s carrying value that exceeds the asset group&#x2019;s estimated future cash flows (discounted). During the year ended December&#160;31, 2021, the Company recorded a store impairment charge of approximately $1.4 billion primarily related to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. There were no material impairment charges recognized on long-lived assets in the year ended 2020. During the year ended December&#160;31, 2019 the Company recorded a store impairment charge of $231 million primarily related to operating lease right-of-use assets. See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for additional information about the right-of-use asset impairment charges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When evaluating goodwill for potential impairment, the Company compares the fair value of its reporting units to their respective carrying amounts. The Company estimates the fair value of its reporting units using a combination of a discounted cash flow method and a market multiple method. If the carrying amount of a reporting unit exceeds its estimated fair value, an impairment loss is recognized in an amount equal to that excess. During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill, the results of which indicated an impairment of the goodwill associated with the LTC reporting unit. Accordingly, during the third quarter of 2021, the Company recorded a $431&#160;million goodwill impairment charge. The results of the impairment tests indicated that there was no impairment of goodwill of the remaining reporting units as of the testing date or during the year ended December&#160;31, 2021. During the third quarter of both 2020 and 2019, the Company performed its required annual goodwill impairment tests and concluded there were no goodwill impairments as of the testing dates or during the years ended December&#160;31, 2020 and 2019. See Note 5 &#x2018;&#x2018;Goodwill and Other Intangibles&#x2019;&#x2019; for additional information about the goodwill impairment charge recorded during the year ended December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;Indefinite-lived intangible assets are tested for impairment by comparing the estimated fair value of the asset to its carrying value. The Company estimates the fair value of its indefinite-lived trademarks using the relief from royalty method under the income approach. If the carrying value of the asset exceeds its estimated fair value, an impairment loss is recognized, and the asset is written down to its estimated fair value.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <cvs:StoreImpairmentCharges
      contextRef="i0b5082eb85c041ac945f01d6bc51973d_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzEwOTk1MTE3NDc1NTQ_86ad6253-a937-489a-98d3-272c929c5407"
      unitRef="usd">1400000000</cvs:StoreImpairmentCharges>
    <cvs:NumberOfStoresPlannedClosure
      contextRef="i0b5082eb85c041ac945f01d6bc51973d_D20210101-20211231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMyOTg1MzUwMzA1Mjg_faf16a90-e7e8-448b-b01d-9455286893a3"
      unitRef="store">900</cvs:NumberOfStoresPlannedClosure>
    <cvs:StoreImpairmentCharges
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzEwOTk1MTE3NDgyOTk_790d8935-3f83-44c3-8ea2-ae35cd9802d1"
      unitRef="usd">0</cvs:StoreImpairmentCharges>
    <cvs:StoreImpairmentCharges
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzI5MDQy_9b4539d8-ff1d-41b9-b8ca-aef4a7ad6ca1"
      unitRef="usd">231000000</cvs:StoreImpairmentCharges>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i66d7d53744704d0d935a2fefbe9f6853_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzOTgwNDY2MzcyNDE_b6a3f7a7-b9d0-4db1-9ee1-d123799f81cc"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i2350df645dc04e808a96e20dad3a3fba_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzI5OTUx_22f8906a-c9c3-446d-b283-1a3b007c91d1"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7f4611487c414f69acafa1f966054637_D20190701-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzI5OTUx_291e250c-a71f-4226-95a9-89bd84bdad76"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMwNTk3_21d2f110-c6c8-47f4-8332-dcc02788c8e4"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMwNTk3_23d3f0e4-c465-45e5-a264-415ebaebfa2a"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMwNTk3_6c9cbe79-1b3d-4a25-bd91-766f6be850d3"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:PolicyholderAccountsPolicy
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDcy_b91c3987-7fbb-4beb-ac3c-03792b5875a6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Separate Accounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets and liabilities related to large case pensions products represent funds maintained to meet specific objectives of contract holders who bear the investment risk. These assets and liabilities are carried at fair value. Net investment income (including net realized capital gains and losses) accrue directly to such contract holders. The assets of each account are legally segregated and are not subject to claims arising from the Company&#x2019;s other businesses. Deposits, withdrawals and net &lt;/span&gt;&lt;/div&gt;investment income (including net realized and net unrealized capital gains and losses) on Separate Accounts assets are not reflected in the consolidated statements of operations or cash flows. Management fees charged to contract holders are included in services revenue and recognized over the period earned.</us-gaap:PolicyholderAccountsPolicy>
    <us-gaap:HealthCareCostsPolicyPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDQ4_a80e0dbb-74b7-43be-becf-dcd365ee4f2b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Costs Payable&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Health care costs payable consist principally of unpaid fee-for-service medical, dental and pharmacy claims, capitation costs, other amounts due to providers pursuant to risk-sharing arrangements related to the Health Care Benefits segment&#x2019;s Insured Commercial, Medicare and Medicaid products and accruals for state assessments. Unpaid health care claims include an estimate of payments the Company will make for (i) services rendered to the Company&#x2019;s Insured members but not yet reported to the Company and (ii) claims which have been reported to the Company but not yet paid, each as of the financial statement date (collectively, &#x201c;IBNR&#x201d;). Health care costs payable also include an estimate of the cost of services that will continue to be rendered after the financial statement date if the Company is obligated to pay for such services in accordance with contractual or regulatory requirements. Such estimates are developed using actuarial principles and assumptions which consider, among other things, historical and projected claim submission and processing patterns, assumed and historical medical cost trends, historical utilization of medical services, claim inventory levels, changes in Insured membership and product mix, seasonality and other relevant factors. The Company reflects changes in these estimates in benefit costs in the Company&#x2019;s consolidated operating results in the period they are determined. Capitation costs represent contractual monthly fees paid to participating physicians and other medical providers for providing medical care, regardless of the volume of medical services provided to the Insured member. Amounts due under risk-sharing arrangements are based on the terms of the underlying contracts with the providers and consider claims experience under the contracts through the financial statement date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company develops its estimate of IBNR using actuarial principles and assumptions that consider numerous factors. Of those factors, the Company considers the analysis of historical and projected claim payment patterns (including claims submission and processing patterns) and the assumed health care cost trend rate (the year-over-year change in per member per month health care costs) to be the most critical assumptions. In developing its IBNR estimate, the Company consistently applies these actuarial principles and assumptions each period, with consideration to the variability of related factors. There have been no significant changes to the methodologies or assumptions used to develop the Company&#x2019;s estimate of IBNR in 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company analyzes historical claim payment patterns by comparing claim incurred dates (i.e., the date services were provided) to claim payment dates to estimate &#x201c;completion factors.&#x201d; The Company uses completion factors predominantly to estimate the ultimate cost of claims incurred more than three months before the financial statement date. The Company estimates completion factors by aggregating claim data based on the month of service and month of claim payment and estimating the percentage of claims incurred for a given month that are complete by each month thereafter. For any given month, substantially all claims are paid within six months of the date of service, but it can take up to 48 months or longer after the date of service before all of the claims are completely resolved and paid. These historically-derived completion factors are then applied to claims paid through the financial statement date to estimate the ultimate claim cost for a given month&#x2019;s incurred claim activity. The difference between the estimated ultimate claim cost and the claims paid through the financial statement date represents the Company&#x2019;s estimate of claims remaining to be paid as of the financial statement date and is included in the Company&#x2019;s health care costs payable. The completion factors the Company uses reflect judgments and possible adjustments based on data such as claim inventory levels, claim submission and processing patterns and, to a lesser extent, other factors such as changes in health care cost trend rates, changes in Insured membership and changes in product mix. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claims may be more (less) complete than originally estimated using the Company&#x2019;s completion factors, which may result in reserves that are higher (lower) than the ultimate cost of claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because claims incurred within three months before the financial statement date are less mature, the Company uses a combination of historically-derived completion factors and the assumed health care cost trend rate to estimate the ultimate cost of claims incurred for these months. The Company applies its actuarial judgment and places a greater emphasis on the assumed health care cost trend rate for the most recent claim incurred dates as these months may be influenced by seasonal patterns and changes in membership and product mix.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s health care cost trend rate is affected by changes in per member utilization of medical services as well as changes in the unit cost of such services. Many factors influence the health care cost trend rate, including the Company&#x2019;s ability to manage benefit costs through product design, negotiation of favorable provider contracts and medical management programs, as well as the mix of the Company&#x2019;s business. The health status of the Company&#x2019;s Insured members, aging of the population and other demographic characteristics, advances in medical technology and other factors continue to contribute to rising per member utilization and unit costs. Changes in health care practices, inflation, new technologies, increases in the cost of &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;prescription drugs (including specialty pharmacy drugs), direct-to-consumer marketing by pharmaceutical companies, clusters of high-cost cases, claim intensity, changes in the regulatory environment, health care provider or member fraud and numerous other factors also contribute to the cost of health care and the Company&#x2019;s health care cost trend rate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each reporting period, the Company uses an extensive degree of judgment in the process of estimating its health care costs payable. As a result, considerable variability and uncertainty is inherent in such estimates, particularly with respect to claims with claim incurred dates of three months or less before the financial statement date; and the adequacy of such estimates is highly sensitive to changes in assumed completion factors and the assumed health care cost trend rates. For each reporting period the Company recognizes the actuarial best estimate of health care costs payable considering the potential volatility in assumed completion factors and health care cost trend rates, as well as other factors. The Company believes its estimate of health care costs payable is reasonable and adequate to cover its obligations at December&#160;31, 2021; however, actual claim payments may differ from the Company&#x2019;s estimates. A worsening (or improvement) of the Company&#x2019;s health care cost trend rates or changes in completion factors from those that the Company assumed in estimating health care costs payable at December&#160;31, 2021 would cause these estimates to change in the near term, and such a change could be material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each quarter, the Company re-examines previously established health care costs payable estimates based on actual claim payments for prior periods and other changes in facts and circumstances. Given the extensive degree of judgment in this estimate, it is possible that the Company&#x2019;s estimates of health care costs payable could develop either favorably (that is, its actual benefit costs for the period were less than estimated) or unfavorably. The changes in the Company&#x2019;s estimate of health care costs payable may relate to a prior quarter, prior year or earlier periods. For a roll forward of the Company&#x2019;s health care costs payable, see Note 7 &#x2018;&#x2018;Health Care Costs Payable.&#x2019;&#x2019; The Company&#x2019;s reserving practice is to consistently recognize the actuarial best estimate of its ultimate liability for health care costs payable.&lt;/span&gt;&lt;/div&gt;</us-gaap:HealthCareCostsPolicyPolicyTextBlock>
    <cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid
      contextRef="ic8b00a5656814734a6bb268b8e3ca5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzM0Nzk1_c5bd2584-1589-4595-9200-ae57af096ce3">P6M</cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid>
    <cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid
      contextRef="i2f08d731825c4986934a5374bd021d17_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzM0ODQ0_62f87a9f-0b6c-4e57-8211-0d01f395b15d">P48M</cvs:HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid>
    <us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NTI1_c6bf175e-bd20-4a2f-bd59-a98b9bff0698">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Insurance Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Unpaid Claims&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unpaid claims consist primarily of reserves associated with certain short-duration group disability and term life insurance contracts, including an estimate for IBNR as of the financial statement date. Reserves associated with certain short-duration group disability and term life insurance contracts are based upon the Company&#x2019;s estimate of the present value of future benefits, which is based on assumed investment yields and assumptions regarding mortality, morbidity and recoveries from the U.S. Social Security Administration. The Company develops its estimate of IBNR using actuarial principles and assumptions which consider, among other things, contractual requirements, claim incidence rates, claim recovery rates, seasonality and other relevant factors. The Company discounts certain claim liabilities related to group long-term disability and life insurance waiver of premium contracts. The discount rates generally reflect the Company&#x2019;s expected investment returns for the investments supporting all incurral years of these liabilities. The discount rates for retrospectively-rated contracts are set at contractually specified levels. The Company&#x2019;s estimates of unpaid claims are subject to change due to changes in the underlying experience of the insurance contracts, changes in investment yields or other factors, and these changes are recorded in current and future benefits in the consolidated statements of operations in the period they are determined. The Company estimates its reserve for claims IBNR for life products largely based on completion factors. The completion factors used are based on the Company&#x2019;s historical experience and reflect judgments and possible adjustments based on data such as claim inventory levels, claim payment patterns, changes in business volume and other factors. If claims are submitted or processed on a faster (slower) pace than historical periods, the actual claims may be more (less) complete than originally estimated using completion factors, which may result in reserves that are higher (lower) than required to cover future life benefit payments. There have been no significant changes to the methodologies or assumptions used to develop the Company&#x2019;s estimate of unpaid claims IBNR in 2021. As of December&#160;31, 2021, unpaid claims balances of $324 million and $1.3 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively. As of December&#160;31, 2020, unpaid claims balances of $532 million and $1.5 billion were recorded in other insurance liabilities and other long-term insurance liabilities, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all life and disability insurance liabilities have been fully ceded to unrelated third parties through indemnity reinsurance agreements; however, the Company remains directly obligated to the policyholders.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Future Policy Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future policy benefits consist primarily of reserves for limited payment pension and annuity contracts and long-term care insurance contracts. Reserves for limited payment pension and annuity contracts are computed using actuarial principles that consider, among other things, assumptions reflecting anticipated mortality, retirement, expense and interest rate experience. Such assumptions generally vary by plan, year of issue and policy duration. Assumed interest rates on such contracts ranged from 3.0% to 11.3% in the year ended December&#160;31, 2021 and from 3.3% to 11.3% in the year ended December&#160;31, 2020. The Company periodically reviews mortality assumptions against both industry standards and its experience. Reserves for long-&lt;/span&gt;&lt;/div&gt;duration long-term care contracts represent the Company&#x2019;s estimate of the present value of future benefits and essential maintenance expenses to be paid to or on behalf of policyholders less the present value of future gross premiums. The assumed interest rate on such contracts was 5.1% in both the years ended December 31, 2021 and 2020. The Company&#x2019;s estimate of the present value of future benefits under such contracts is based upon mortality, morbidity and interest rate assumptions.</us-gaap:UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy>
    <cvs:LiabilityforUnpaidClaims
      contextRef="ia549907bd80b4d05927cab95ed27791d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQxOTc4_3c73685a-c06c-4592-b15d-3c604da34c24"
      unitRef="usd">324000000</cvs:LiabilityforUnpaidClaims>
    <cvs:LiabilityforUnpaidClaims
      contextRef="if864780575b94e94ab5aaeb609bdc2fc_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQxOTg1_ff104f70-01e9-4e29-8fb8-9420bcf55153"
      unitRef="usd">1300000000</cvs:LiabilityforUnpaidClaims>
    <cvs:LiabilityforUnpaidClaims
      contextRef="i7923496932ec4872a3aac9f738db85f9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQyMTI2_e05b7b19-da05-4df6-bb52-3b66b4bb5d51"
      unitRef="usd">532000000</cvs:LiabilityforUnpaidClaims>
    <cvs:LiabilityforUnpaidClaims
      contextRef="i6b4429ac745c44638a7414f5ff8d6894_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQyMTMz_2238f18a-3709-4ab4-9d5b-81f34ef7f86b"
      unitRef="usd">1500000000</cvs:LiabilityforUnpaidClaims>
    <cvs:LimitedPaymentsContracts
      contextRef="ic8b00a5656814734a6bb268b8e3ca5ce_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQyOTg2_3c8ce723-962f-459d-a522-3cd82093eddb"
      unitRef="number">0.030</cvs:LimitedPaymentsContracts>
    <cvs:LimitedPaymentsContracts
      contextRef="i2f08d731825c4986934a5374bd021d17_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQyOTky_23a3e361-0a9b-405f-8d14-955a57f3e5f6"
      unitRef="number">0.113</cvs:LimitedPaymentsContracts>
    <cvs:LimitedPaymentsContracts
      contextRef="if6a4e820cff84a708a34d9940c913923_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzMDM4_dd8e1ba8-0ecf-4ee3-bc37-45dd76951265"
      unitRef="number">0.033</cvs:LimitedPaymentsContracts>
    <cvs:LimitedPaymentsContracts
      contextRef="i45c5b8fb4d364022b20880618cc963ec_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzMDQ0_a2d09667-3c67-4ed2-859e-17440149d9f5"
      unitRef="number">0.113</cvs:LimitedPaymentsContracts>
    <cvs:AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzNDU1_58a797ac-8f44-417d-b90a-57bcaabaae6f"
      unitRef="number">0.051</cvs:AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts>
    <cvs:AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzNDU1_d1b5f252-4427-4ded-84c1-261333705446"
      unitRef="number">0.051</cvs:AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="ia549907bd80b4d05927cab95ed27791d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzNzAz_c1c1f288-72f1-4532-a1ea-e3c0b05e582b"
      unitRef="usd">416000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="if864780575b94e94ab5aaeb609bdc2fc_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzNzEw_af57df69-63fa-409d-992a-542d5bd50e0e"
      unitRef="usd">5100000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i7923496932ec4872a3aac9f738db85f9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzODYw_af90dfd5-a99f-4bf8-a43a-5b1714e19d96"
      unitRef="usd">462000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefits
      contextRef="i6b4429ac745c44638a7414f5ff8d6894_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQzODY3_c4da48d4-a080-4bc2-b089-c21efc0ec6fe"
      unitRef="usd">5500000000</us-gaap:LiabilityForFuturePolicyBenefits>
    <cvs:InsurancePremiumDeficiencyReservePolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDkw_6f7b838b-5204-4b11-8d67-f5d7b9390648">Premium Deficiency ReservesThe Company evaluates its insurance contracts to determine if it is probable that a loss will be incurred. A premium deficiency loss is recognized when it is probable that expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), will exceed existing reserves plus anticipated future premiums and reinsurance recoveries. Anticipated investment income is not considered in the calculation of premium deficiency losses for short-duration contracts. For purposes of determining premium deficiency losses, contracts are grouped consistent with the Company&#x2019;s method of acquiring, servicing and measuring the profitability of such contracts.</cvs:InsurancePremiumDeficiencyReservePolicyTextBlock>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ0NzYy_a0918f1b-b36d-4143-90d0-ee5479de8fba"
      unitRef="usd">16000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i7e7c0dce760d47df841954664e69c360_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ0NzY5_c0e64093-26e8-4fb7-b52c-4eebe190937f"
      unitRef="usd">11000000</cvs:PremiumDeficiencyReserveLiability>
    <us-gaap:AllocationsToPolicyholdersPolicies
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDg2_5d0b0780-01f1-488c-b53e-8c4261d956d2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Policyholders&#x2019; Funds&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Policyholders&#x2019; funds consist primarily of reserves for pension and annuity investment contracts and customer funds associated with certain health contracts. Reserves for such contracts are equal to cumulative deposits less withdrawals and charges plus  interest credited thereon, net of experience-rated adjustments. In 2021, interest rates for pension and annuity investment contracts ranged from 3.5% to 4.8%. In 2020, interest rates for pension and annuity investment contracts ranged from 4.1% to 5.1%. Reserves for contracts subject to experience rating reflect the Company&#x2019;s rights as well as the rights of policyholders and plan participants. The Company also holds funds for HSAs on behalf of members associated with high deductible health plans. These amounts are held to pay for qualified health care expenses incurred by these members. The HSA balances were approximately $2.9 billion and $2.7 billion at December&#160;31, 2021 and 2020, respectively, and are reflected in other current assets with a corresponding liability in policyholders&#x2019; funds. These assets are considered restricted cash for cash flow statement purposes.&lt;/span&gt;&lt;/div&gt;Policyholders&#x2019; funds liabilities that are expected to be paid within twelve months from the balance sheet date are classified as current on the consolidated balance sheets. Policyholders&#x2019; funds liabilities that are expected to be paid greater than twelve months from the balance sheet date are included in other long-term liabilities on the consolidated balance sheets.</us-gaap:AllocationsToPolicyholdersPolicies>
    <cvs:PensionAndAnnuityInvestmentContractsInterest
      contextRef="ic8b00a5656814734a6bb268b8e3ca5ce_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ1Mjcz_d3b511fe-c1b5-4eba-856d-fa98a4d681ba"
      unitRef="number">0.035</cvs:PensionAndAnnuityInvestmentContractsInterest>
    <cvs:PensionAndAnnuityInvestmentContractsInterest
      contextRef="i2f08d731825c4986934a5374bd021d17_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ1Mjc5_ff73afce-8538-43c3-8081-1d3011830820"
      unitRef="number">0.048</cvs:PensionAndAnnuityInvestmentContractsInterest>
    <cvs:PensionAndAnnuityInvestmentContractsInterest
      contextRef="if6a4e820cff84a708a34d9940c913923_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ1MzY0_ff663d7d-53a6-4497-9832-a2d139e5a315"
      unitRef="number">0.041</cvs:PensionAndAnnuityInvestmentContractsInterest>
    <cvs:PensionAndAnnuityInvestmentContractsInterest
      contextRef="i45c5b8fb4d364022b20880618cc963ec_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ1Mzcw_fb6d40f3-3a1c-40a6-a5bc-eaab594d4ea5"
      unitRef="number">0.051</cvs:PensionAndAnnuityInvestmentContractsInterest>
    <cvs:HeathSavingsAccountBalance
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ1Nzc4_4bc67c31-a9b3-41cd-bebf-4ac3d48587eb"
      unitRef="usd">2900000000</cvs:HeathSavingsAccountBalance>
    <cvs:HeathSavingsAccountBalance
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ1Nzg1_91f9ccb1-de78-40d1-82f6-9f2bab9d1b4f"
      unitRef="usd">2700000000</cvs:HeathSavingsAccountBalance>
    <us-gaap:SelfInsuranceReservePolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3Mzk0_d453d2c3-f7d9-4afc-b7f6-da0415e08320">Self-Insurance LiabilitiesThe Company is self-insured for certain losses related to general liability, workers&#x2019; compensation and auto liability. The Company obtains third party insurance coverage to limit exposure from these claims. The Company is also self-insured for certain losses related to health and medical liabilities. The Company&#x2019;s self-insurance accruals, which include reported claims and claims incurred but not reported, are calculated using standard insurance industry actuarial assumptions and the Company&#x2019;s historical claims experience.</us-gaap:SelfInsuranceReservePolicyTextBlock>
    <us-gaap:SelfInsuranceReserve
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ2ODkz_f96163ed-6eb8-41d0-b6b3-811b0f20a8b5"
      unitRef="usd">1100000000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ2OTAw_da560efc-d03c-49d1-a426-357a471607a9"
      unitRef="usd">927000000</us-gaap:SelfInsuranceReserve>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDMw_be736bae-1229-4f8b-af71-28017e30af85">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency Translation and Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For non-U.S. dollar functional currency locations, (i) assets and liabilities are translated at end-of-period exchange rates, (ii) revenues and expenses are translated at average exchange rates in effect during the period and (iii) equity is translated at historical exchange rates. The resulting cumulative translation adjustments are included as a component of accumulated other comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For U.S. dollar functional currency locations, foreign currency assets and liabilities are remeasured into U.S. dollars at end-of-period exchange rates, except for nonmonetary balance sheet accounts which are remeasured at historical exchange rates. Revenues and expenses are remeasured at average exchange rates in effect during each period, except for those expenses related to the nonmonetary balance sheet amounts which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in net income.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i92c848c1cac74063a225275fcd16ac3e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzQ4Mzc4_642a042b-9e6f-4e20-8a96-b7a25b6721c5"
      unitRef="usd">154000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDc2_4cc14bb5-2d28-4047-9860-509a99459a3b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Benefits Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Health Care Benefits revenue is principally derived from insurance premiums and fees billed to customers. Revenue is recognized based on customer billings, which, in the Company&#x2019;s Commercial business, reflect contracted rates per member and the number of covered members recorded in the Company&#x2019;s records at the time the billings are prepared. Billings are generally sent monthly for coverage during the following month. Revenue related to the Company&#x2019;s Government business is collected monthly from the U.S. federal government and various government agencies based on fixed payment rates and member eligibility. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s billings may be subsequently adjusted to reflect enrollment changes due to member terminations or other factors. These adjustments are known as retroactivity adjustments. In each period, the Company estimates the amount of future retroactivity and adjusts the recorded revenue accordingly. As information regarding actual retroactivity amounts becomes known, the Company refines its estimates and records any required adjustments to revenues in the period in which they arise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Premium Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premiums are recognized as revenue in the month in which the enrollee is entitled to receive health care services. Premiums are reported net of an allowance for estimated terminations and uncollectible amounts. Additionally, premium revenue subject to the minimum medical loss ratio (&#x201c;MLR&#x201d;) rebate requirements of the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (as amended, collectively, the &#x201c;ACA&#x201d;) is recorded net of the estimated minimum MLR rebates for the current calendar year. Premiums related to unexpired contractual coverage periods (unearned premiums) are reported as other insurance liabilities on the consolidated balance sheets and recognized as revenue when earned.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s contracts allow for premiums to be adjusted to reflect actual experience or the relative health status of Insured members. Such adjustments are reasonably estimable at the outset of the contract, and adjustments to those estimates are made based on actual experience of the customer emerging under the contract and the terms of the underlying contract.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Services Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Services revenue relates to contracts that can include various combinations of services or series of services which generally are capable of being distinct and accounted for as separate performance obligations. The Health Care Benefits segment&#x2019;s services revenue primarily consists of ASC fees received in exchange for performing certain claim processing and member services for ASC members. ASC fee revenue is recognized over the period the service is provided. Some of the Company&#x2019;s administrative services contracts include guarantees with respect to certain functions, such as customer service response time, claim processing accuracy and claim processing turnaround time, as well as certain guarantees that a plan sponsor&#x2019;s benefit claim experience will fall within a certain range. With any of these guarantees, the Company is financially at risk if the conditions of the arrangements are not met, although the maximum amount at risk typically is limited to a percentage of the fees otherwise payable to the Company by the customer involved. Each period the Company estimates its obligations under the terms of these guarantees and records its estimate as an offset to services revenues.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounting for Medicare Part D&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues include insurance premiums earned by the Company&#x2019;s PDPs, which are determined based on the PDP&#x2019;s annual bid and related contractual arrangements with the U.S. Centers for Medicare &amp;amp; Medicaid Services (&#x201c;CMS&#x201d;). The insurance premiums include a beneficiary premium, which is the responsibility of the PDP member, and can be subsidized by CMS in the case of low-income members, and a direct premium paid by CMS. Premiums collected in advance are initially recorded within other insurance liabilities and are then recognized ratably as revenue over the period in which members are entitled to receive benefits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues also include a risk-sharing feature of the Medicare Part D program design referred to as the risk corridor. The Company estimates variable consideration in the form of amounts payable to, or receivable from, CMS under the risk corridor, and adjusts revenue based on calculations of additional subsidies to be received from or owed to CMS at the end of the reporting year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to Medicare Part D premiums, the Company receives additional payments each month from CMS related to catastrophic reinsurance, low-income cost-sharing subsidies and coverage gap benefits. If the subsidies received differ from the amounts earned from actual prescriptions transferred, the difference is recorded in either accounts receivable, net or accrued expenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment sells prescription drugs directly through its mail service dispensing pharmacies and indirectly through the Company&#x2019;s retail pharmacy network. The Company&#x2019;s pharmacy benefit arrangements are accounted for in a manner consistent with a master supply arrangement as there are no contractual minimum volumes and each prescription is considered a separate purchasing decision and distinct performance obligation transferred at a point in time. PBM services performed in connection with each prescription claim are considered part of a single performance obligation which culminates in the dispensing of prescription drugs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue using the gross method at the contract price negotiated with its clients when the Company has concluded it controls the prescription drug before it is transferred to the client plan members. The Company controls prescriptions dispensed indirectly through its retail pharmacy network because it has separate contractual arrangements with those pharmacies, has discretion in setting the price for the transaction and assumes primary responsibility for fulfilling the promise to provide prescription drugs to its client plan members while also performing the related PBM services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues include (i) the portion of the price the client pays directly to the Company, net of any discounts earned on brand name drugs or other discounts and refunds paid back to the client (see &#x201c;Drug Discounts&#x201d; and &#x201c;Guarantees&#x201d; below), (ii) the price paid to the Company by client plan members for mail order prescriptions and the price paid to retail network pharmacies by client plan members for retail prescriptions (&#x201c;retail co-payments&#x201d;), and (iii) claims based administrative fees for retail pharmacy network contracts. Sales taxes are not included in revenues. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue when control of the prescription drugs is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those prescription drugs. The Company has established the following revenue recognition policies for the Pharmacy Services segment:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Revenues generated from prescription drugs sold by mail service dispensing pharmacies are recognized when the prescription drug is delivered to the client plan member. At the time of delivery, the Company has performed substantially all of its performance obligations under its client contracts and does not experience a significant level of returns or reshipments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Revenues generated from prescription drugs sold by third party pharmacies in the Company&#x2019;s retail pharmacy network and associated administrative fees are recognized at the Company&#x2019;s point-of-sale, which is when the claim is adjudicated by the Company&#x2019;s online claims processing system and the Company has transferred control of the prescription drug and completed all of its performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For contracts under which the Company acts as an agent or does not control the prescription drugs prior to transfer to the client plan member, revenue is recognized using the net method.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Drug Discounts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records revenue net of manufacturers&#x2019; rebates earned by its clients based on their plan members&#x2019; utilization of brand-name formulary drugs. The Company estimates these rebates at period-end based on actual and estimated claims data and its estimates of the manufacturers&#x2019; rebates earned by its clients. The estimates are based on the best available data at period-end and recent history for the various factors that can affect the amount of rebates due to the client. The Company adjusts its rebates payable to clients to the actual amounts paid when these rebates are paid or as significant events occur. Any cumulative effect of these adjustments is recorded against revenues at the time it is identified. Adjustments generally result from contract changes with clients or manufacturers that have retroactive rebate adjustments, differences between the estimated and actual product mix subject to rebates, or whether the brand name drug was included in the applicable formulary. The effect of adjustments between estimated and actual manufacturers&#x2019; rebate amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also adjusts revenues for refunds owed to clients resulting from pricing guarantees and performance against defined service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Retail Pharmacy&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s retail drugstores recognize revenue at the time the customer takes possession of the merchandise. For pharmacy sales, each prescription claim is its own arrangement with the customer and is a performance obligation, separate and distinct from other prescription claims under other retail network arrangements. Revenues are adjusted for refunds owed to third party payers resulting from pricing guarantees and performance against defined value-based service and performance metrics. The inputs to these estimates are not subject to a high degree of subjectivity or volatility. The effect of adjustments between estimated and actual pricing and performance refund amounts has not been material to the Company&#x2019;s operating results or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from Company gift cards purchased by customers is deferred as a contract liability until goods or services are transferred. Any amounts not expected to be redeemed by customers (i.e., breakage) are recognized based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer returns are not material to the Company&#x2019;s operating results or financial condition. Sales taxes are not included in revenues.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Loyalty and Other Programs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s customer loyalty program, ExtraCare&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, consists of two components, ExtraSavings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Rewards. ExtraSavings are coupons that are recorded as a reduction of revenue when redeemed as the Company concluded that they do not represent a promise to the customer to deliver additional goods or services at the time of issuance because they are not tied to a specific transaction or spending level. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ExtraBucks Rewards are accumulated by customers based on their historical spending levels. Thus, the Company has determined that there is an additional performance obligation to those customers at the time of the initial transaction. The Company allocates the transaction price to the initial transaction and the ExtraBucks Rewards transaction based upon the relative standalone selling price, which considers historical redemption patterns for the rewards. Revenue allocated to ExtraBucks Rewards is recognized as those rewards are redeemed. At the end of each period, unredeemed ExtraBucks Rewards are reflected as a contract liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also offers a subscription-based membership program, CarePass&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, under which members are entitled to a suite of benefits delivered over the course of the subscription period, as well as a promotional reward that can be redeemed for future goods and services. Subscriptions are paid for on a monthly or annual basis at the time of or in advance of the Company delivering the goods and services. Revenue from these arrangements is recognized as the performance obligations are satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long-term Care&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when control of the promised goods or services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services. Each prescription claim represents a separate performance obligation of the Company, separate and distinct from other prescription claims under customer arrangements. A significant portion of long-term care revenue from sales of pharmaceutical and medical products is reimbursed by the federal Medicare Part D program and, to a lesser extent, state Medicaid programs. The Company monitors its revenues and receivables from these reimbursement sources, as well as long-term care facilities and other third party insurance payors, and reduces revenue at the revenue recognition date to properly account for the variable consideration due to anticipated differences between billed and reimbursed amounts. Accordingly, the total revenues and receivables reported in the Company&#x2019;s consolidated financial statements are recorded at the amount expected to be ultimately received from these payors. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient co-payments associated with Medicare Part D, certain state Medicaid programs, Medicare Part B and certain third party payors typically are not collected at the time products are delivered or services are rendered, but are billed to the individuals as part of normal billing procedures and subject to normal accounts receivable collections procedures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Walk-In Medical Clinics&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For services provided by the Company&#x2019;s walk-in medical clinics, revenue recognition occurs for completed services provided to patients, with adjustments taken for third party payor contractual obligations and patient direct bill historical collection rates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates the Company&#x2019;s revenue by major source in each segment for the years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;152,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;76,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43,765)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;184,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;76,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;76,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;82,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;153,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;100,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;292,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;60,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;153,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;70,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(40,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;171,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;75,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(40,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;85,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;56,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;140,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;66,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(41,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;165,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;86,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(41,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;256,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;88,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;52,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#x2019;s retail pharmacies under the Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;program. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily represent the Company&#x2019;s obligation to transfer additional goods or services to a customer for which the Company has received consideration, and include ExtraBucks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Rewards and unredeemed Company gift cards. The consideration received remains a contract liability until goods or services have been provided to the customer. In addition, the Company recognizes breakage on Company gift cards based on historical redemption patterns.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2021 and 2020, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDc0_363406e4-ec87-4478-96ff-1a3a2ddff602">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table disaggregates the Company&#x2019;s revenue by major source in each segment for the years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.944%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.390%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.462%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;br/&gt;Eliminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;152,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;76,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43,765)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;184,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;21,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;76,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;76,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;2,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;8,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;82,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;153,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;100,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(43,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;292,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;60,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;153,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;70,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(40,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;171,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;75,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(40,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;85,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;56,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Major goods/services lines:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;140,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;66,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(41,413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;165,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Front Store&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;19,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;5,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;7,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;69,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;86,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(41,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;256,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy Services distribution channel:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Pharmacy network&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;88,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Mail choice &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.17pt;font-weight:400;line-height:100%;position:relative;top:-3.32pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;52,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;141,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company&#x2019;s retail pharmacies and LTC pharmacies, but excluding Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; activity, which is included within the mail choice category. Maintenance Choice permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS Pharmacy retail store for the same price as mail order.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Pharmacy Services mail choice is defined as claims filled at a Pharmacy Services mail order facility, which includes specialty mail claims inclusive of Specialty Connect&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; claims picked up at a retail pharmacy, as well as prescriptions filled at the Company&#x2019;s retail pharmacies under the Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; &lt;/span&gt;program.</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4498de5248d54d40afb291f1fc098731_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMtMS0xLTEtMjU2NDE_c6668d41-a73b-410c-9710-4ccc9b3383e4"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic1002f99fed94f288ca5f74eedbdeab1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMtMS0xLTEtMTk2MzU_958dcec6-c468-4b26-9861-543e1efc9f21"
      unitRef="usd">152262000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iebcc3ed38ad2471582d090e796d7ce3b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMtMy0xLTEtMTk2MzU_ea1c5b63-ff58-4a4e-927f-160e60c08523"
      unitRef="usd">76121000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fef8cff035c4c69a8c38c9106be1c8d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMtNy0xLTEtMTk2MzU_e62686b6-cef8-4f43-8386-654dc1968d43"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c932f46423b4eb0b5ffe12d1cb5e4f7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMtOS0xLTEtMTk2MzU_59517358-0d86-42e9-9251-5d0850fd7a10"
      unitRef="usd">-43765000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58bb9dd9de57438c8823cb7f0f5b7456_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMtMTEtMS0xLTE5NjM1_1c69da4f-0999-4289-b900-1f4738160cb7"
      unitRef="usd">184618000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ddd2583249240ab9fd8716ea50815be_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQtMS0xLTEtMjU2NDE_e0e87fbe-8fc8-4446-8ab7-4b48ebc2fe48"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i62292b173722422f93bc0d15e20388ff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQtMS0xLTEtMTk2MzU_2e35b7da-ad79-4531-a54e-0ddaf71a87f0"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if247a044060a414a9731ef3f633443ec_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQtMy0xLTEtMTk2MzU_f083234e-ca61-4587-ad30-a9f9e73201c2"
      unitRef="usd">21315000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ed9316414794c62b549ee70109c3a1c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQtNy0xLTEtMTk2MzU_e317f2b6-8d31-4204-998e-534286252f6f"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia48e9a22e1fd4d718486619d4e3719f1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQtOS0xLTEtMTk2MzU_655456d5-62e9-48b6-b0bc-5fb5dfcc6ffc"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie803710aa3d14d08b76f31d1d981933a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQtMTEtMS0xLTE5NjM1_1a771d79-e8eb-4aec-be01-893bed2b8261"
      unitRef="usd">21315000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d061d240a9e43d88eb56b03b4b1c305_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzUtMS0xLTEtMjU2NDE_aff90937-9685-4e90-8e64-75ae44822bba"
      unitRef="usd">76064000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5762aa2abba7409a8044131daa10dbbe_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzUtMS0xLTEtMTk2MzU_dc8f25fd-c436-4171-87af-e2b644e1b8f1"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f9354e553ba4e88889df599c49592a9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzUtMy0xLTEtMTk2MzU_78939051-f88a-47a7-93d5-f7465d771eb9"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42258aba1f3844c79f036592fd2314f6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzUtNy0xLTEtMTk2MzU_a8b6935d-c6c5-420f-b0c5-b748c5e1f8e6"
      unitRef="usd">68000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief81cfdad9484af6b31eff5e1128145b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzUtOS0xLTEtMTk2MzU_5046e6c2-ea4b-41cb-8b28-1860d68bb967"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e052765fbe5467a80a1782764372f99_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzUtMTEtMS0xLTE5NjM1_44e410d6-4d4e-4bf7-8817-0f649567ef3a"
      unitRef="usd">76132000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i9d8f78677d6943988b31d555638bbaf9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzYtMS0xLTEtMjU2NDE_87203dc5-275f-4c9c-af26-9d298658f2cf"
      unitRef="usd">586000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzYtMS0xLTEtMTk2MzU_4f0b9e61-a8bc-4ba3-87ea-5484b815ff7b"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i2301583729e7424597c39ac7978d0401_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzYtMy0xLTEtMTk2MzU_75c5b9b9-5e70-4f4f-8f3a-13e1ff733cf9"
      unitRef="usd">17000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i7f0540b87ed34aee812a4602f32b0fb6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzYtNy0xLTEtMTk2MzU_ca0e21d1-eb80-4330-9646-12bc22b6f83c"
      unitRef="usd">596000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i4344db6c31344de2b14b66847d6c28a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzYtOS0xLTEtMTk2MzU_1056160d-b4a9-4190-a225-acafe4b9ba25"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzYtMTEtMS0xLTE5NjM1_df8d0650-4ac8-497f-bd9a-b2cb8fac22df"
      unitRef="usd">1199000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77576c1c65984cc3b50354c3450129d5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzctMS0xLTEtMjU2NDE_8cf7d1f5-2e64-4321-aa3d-5101952f75b2"
      unitRef="usd">5536000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc537d99f46e4ee089fc01dc7844328e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzctMS0xLTEtMTk2MzU_66d62d76-848f-40b2-9676-303c4148ed4d"
      unitRef="usd">760000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i071a8d3987fb4484affa36468d188f51_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzctMy0xLTEtMTk2MzU_eb1b9846-0c04-4ba5-9a3b-95340f84f989"
      unitRef="usd">2652000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f2f0ce0e931416b9534dcfd36624ed0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzctNy0xLTEtMTk2MzU_a92d8ac1-835e-4763-8684-0d916e3a780d"
      unitRef="usd">57000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b8deab908c04d898d7365d0a57ffc0b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzctOS0xLTEtMTk2MzU_b7ff53ac-3f6f-4001-9d51-d5776c023880"
      unitRef="usd">-158000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45a45ada9f7246c3b344e458342767f2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzctMTEtMS0xLTE5NjM1_cd02065f-012f-4b24-b90f-4f5515b78442"
      unitRef="usd">8847000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i9d8f78677d6943988b31d555638bbaf9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzgtMS0xLTEtMjU2NDE_0002a2f1-e946-4539-970a-ede506440c3a"
      unitRef="usd">82186000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzgtMS0xLTEtMTk2MzU_3a7f4585-06a0-4959-b23b-4d41406372b0"
      unitRef="usd">153022000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2301583729e7424597c39ac7978d0401_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzgtMy0xLTEtMTk2MzU_4fa2e3b3-8a6c-4d1a-874a-b9fbd0fad65e"
      unitRef="usd">100105000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7f0540b87ed34aee812a4602f32b0fb6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzgtNy0xLTEtMTk2MzU_8c9433c4-80b4-456d-806f-0500e4e4dc56"
      unitRef="usd">721000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4344db6c31344de2b14b66847d6c28a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzgtOS0xLTEtMTk2MzU_8834d9b7-6a4e-4b8d-9b9b-475e25fbff52"
      unitRef="usd">-43923000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzgtMTEtMS0xLTE5NjM1_1e46d657-98ef-4088-ba5d-a11688b20e7d"
      unitRef="usd">292111000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i61039a6c4f3941c78fea069998c3b394_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzExLTEtMS0xLTE5NjM1_eef48ca0-91b2-4a7e-83ac-526d70921b00"
      unitRef="usd">91715000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1ffa587016394b5784b3a8591967b741_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzEyLTEtMS0xLTE5NjM1_5e21e99f-f357-4317-ac89-83471c3140f2"
      unitRef="usd">60547000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7055234871404d9bafa8741c06125a63_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzEzLTEtMS0xLTE5NjM1_95da85c6-7a3f-46a1-ab53-5f7bc31a3501"
      unitRef="usd">760000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE0LTEtMS0xLTE5NjM1_25c5df10-98c7-4b1f-97fc-95134a35ac41"
      unitRef="usd">153022000000</us-gaap:Revenues>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1cdd84a2122f4e48bd7e94aa5a543fc7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE4LTEtMS0xLTI1NjQ0_3d5b2c2a-9a43-4b93-9feb-ecb31e2ee5da"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i248dfcc1ff5a4287a22a16423cabbfd0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE4LTEtMS0xLTE5NjM1_d11a0f36-4810-4f32-803b-00dc28fb2602"
      unitRef="usd">141116000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21ddaf2aa6974aadb1b64f7b7a5257ea_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE4LTMtMS0xLTE5NjM1_14a2104c-2831-4bae-ae51-1c85e9e448d1"
      unitRef="usd">70176000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab97b765af4e49ffad5046609f678a8f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE4LTctMS0xLTE5NjM1_f08442f0-2ae6-4d86-854e-4cc0ed0d9280"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4fe7b82658e94a3fb768194bb39484ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE4LTktMS0xLTE5NjM1_ed91e107-281e-44d2-8949-642c94f768b1"
      unitRef="usd">-40003000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic786c87383ae4399b318ad961ecca522_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE4LTExLTEtMS0xOTYzNQ_9c74a3a1-49c3-4481-811b-d017829b1e95"
      unitRef="usd">171289000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide7ebc79d9a54efb884b6972df58c788_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE5LTEtMS0xLTI1NjQ0_7f7cf61b-ad04-4fe5-8dd9-273f23911741"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7dffb1a91abc47afa1350fc6dd222a18_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE5LTEtMS0xLTE5NjM1_1529eaa4-8a78-44cb-bde8-fa3c2334e829"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a337ef5a1564ee49dd9f743f426f9c9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE5LTMtMS0xLTE5NjM1_1b5554f9-6cae-4c50-af86-a41ef5336f0b"
      unitRef="usd">19655000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic10b456383584d7aaf8f683720fcb914_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE5LTctMS0xLTE5NjM1_1019c2e8-54fb-47d9-801f-8af69c207354"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id140f9f8dcd14083b50ec69d7cbc65da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE5LTktMS0xLTE5NjM1_cd18ba18-56a9-4b81-85e7-7fe564025182"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c6cb5365a9c4dfe9062cee2d3a679f4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzE5LTExLTEtMS0xOTYzNQ_9eb444f2-8d57-4d48-9d5a-ae82d80b2656"
      unitRef="usd">19655000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia41f6d7659764a9394360d2e7ea49f1d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIwLTEtMS0xLTI1NjQ0_a871bbe2-d45a-43fb-9f1e-c47c6d7bec87"
      unitRef="usd">69301000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib84692036a6a43eea3efda3fce3a9e9d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIwLTEtMS0xLTE5NjM1_22e2add3-9aff-407f-bffc-0a2f97058502"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id67aa7e2958543c5b2a212d2e9f5ce6f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIwLTMtMS0xLTE5NjM1_bd539977-136c-499f-bf58-4fb09d788fad"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f1ba091cd86434eb258ca50211e3939_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIwLTctMS0xLTE5NjM1_02d104f3-b34a-438f-a358-005365328166"
      unitRef="usd">63000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic31dfa14042e414482c4216963d92547_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIwLTktMS0xLTE5NjM1_92a3a80c-fe62-4b8c-a302-5183cb514fba"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i76be16bc9f6249b9b235ac3756529601_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIwLTExLTEtMS0xOTYzNQ_13303828-0239-48cf-a780-00f1a4bbb56f"
      unitRef="usd">69364000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i53db5e5b0b444479a8a8759dbf521388_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIxLTEtMS0xLTI1NjQ0_7b942c53-3aad-4f5a-8c38-e5ecefe7049e"
      unitRef="usd">483000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIxLTEtMS0xLTE5NjM1_8b2dec84-88a2-4ed1-bb22-e68e12520e19"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ia854c1c4120946f68b69cb19bc260e4b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIxLTMtMS0xLTE5NjM1_0827eba8-38ea-4ace-a87d-2309f6ab7049"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i7e61340f47284992812b376b1458946d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIxLTctMS0xLTE5NjM1_b6cb1e51-ae88-45a1-90f0-774778836e86"
      unitRef="usd">315000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iccc3d52c70ae4beeabf495e0d535c807_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIxLTktMS0xLTE5NjM1_5b126704-8639-4736-b25f-3d62547b8ef0"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIxLTExLTEtMS0xOTYzNQ_11c3f093-98d8-4ae1-839e-48bdc2d1b70b"
      unitRef="usd">798000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie27ebf5be86d42d08d5b00b28a499bb0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIyLTEtMS0xLTI1NjQ0_0984b82d-c7e9-4ee8-92c8-0e0afb123d89"
      unitRef="usd">5683000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i52561c6040014302a3dbd0c238d7e542_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIyLTEtMS0xLTE5NjM1_781caed2-8ada-4339-9ce0-065e8f5f9d38"
      unitRef="usd">822000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia1e0f32f6d3d4988bc853318d22b23fd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIyLTMtMS0xLTE5NjM1_5e88c8b3-7b75-4485-8a1b-15aad5a0434b"
      unitRef="usd">1367000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic465100ccba348a3afd34c383000632c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIyLTctMS0xLTE5NjM1_ff9cdef4-74e1-4608-9be1-36c2974f5191"
      unitRef="usd">48000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0249f41894f841a6b7dafe5cbba83478_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIyLTktMS0xLTE5NjM1_dc32c2d5-a39b-4b39-ac4c-42b7351bebcd"
      unitRef="usd">-320000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i14fe0625f7df490f81964160bf26ed60_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIyLTExLTEtMS0xOTYzNQ_df364998-dbfe-4f74-b066-12b509f6eda8"
      unitRef="usd">7600000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i53db5e5b0b444479a8a8759dbf521388_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIzLTEtMS0xLTI1NjQ0_9eb1b82b-2c57-4542-a21d-67735f48bb86"
      unitRef="usd">75467000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIzLTEtMS0xLTE5NjM1_7d86cce2-2c7e-4173-8b11-f829ac76aaab"
      unitRef="usd">141938000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia854c1c4120946f68b69cb19bc260e4b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIzLTMtMS0xLTE5NjM1_f79b069f-4b6a-4dfe-ab83-a8078865a3bc"
      unitRef="usd">91198000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7e61340f47284992812b376b1458946d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIzLTctMS0xLTE5NjM1_07015ac0-4d46-49b0-92ec-d36585cc9c24"
      unitRef="usd">426000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iccc3d52c70ae4beeabf495e0d535c807_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIzLTktMS0xLTE5NjM1_7e4edfdf-7918-4ec5-b1fa-35d89bb72683"
      unitRef="usd">-40323000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzIzLTExLTEtMS0xOTYzNQ_353346d5-c79c-4c99-881e-b2ec3e07e83f"
      unitRef="usd">268706000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icaaa14ca219c45319101f3294251d63b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzI2LTEtMS0xLTE5NjM1_8a2108d5-62b2-4f38-87c8-ff6f219f9d49"
      unitRef="usd">85045000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i447cc1b65f104221ab26818c3ed22faf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzI3LTEtMS0xLTE5NjM1_23e4ce6f-e789-4f28-bc46-51c410a985ec"
      unitRef="usd">56071000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic21b7b1b632e49739aa4555420878cbf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzI4LTEtMS0xLTE5NjM1_d82b1e25-2a73-4329-b34e-aa90c26721ca"
      unitRef="usd">822000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzI5LTEtMS0xLTE5NjM1_34ef07a2-d8c0-46a8-ace2-797c7653cac7"
      unitRef="usd">141938000000</us-gaap:Revenues>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8af99e3f8f9947f49861abe488bdd637_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMzLTEtMS0xLTI1NjQ3_e7f212f9-c1d0-4e06-ba6e-adb378952e61"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i012def96350649cfbe7d7eb9602d64e1_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMzLTEtMS0xLTE5NjM1_8d5ea816-edc7-416b-9984-7b6f84d6cb07"
      unitRef="usd">140896000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9001e42259074da8941f556efd30f660_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMzLTMtMS0xLTE5NjM1_cb6e3b3e-fa50-4f4e-a3d1-fdf0aeecce99"
      unitRef="usd">66442000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i966eb89f8da54934ba00320af7713451_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMzLTctMS0xLTE5NjM1_bcecaf08-3a7a-4200-8e37-ec458b5eb9e2"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i157fcde113c546639a94d73e35c8837f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMzLTktMS0xLTE5NjM1_5efc8185-29cc-4631-8292-9dc271d3fb4d"
      unitRef="usd">-41413000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib92544612b6649778126fe8e9ab6e9b6_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzMzLTExLTEtMS0xOTYzNQ_74731546-cba2-4ac1-922a-d94a6df2cc34"
      unitRef="usd">165925000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa6bf06bf5cd4d70ac02de5a1d25d970_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM0LTEtMS0xLTI1NjQ3_7c65cb37-5b81-45ba-aecd-fe5c458a3a27"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9fa3db576bc34c4b81beaf1e716f51d7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM0LTEtMS0xLTE5NjM1_702d3642-8244-49cc-89ea-0adbe2de556d"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib11ea18304ed4f7cab2400be338b0bf5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM0LTMtMS0xLTE5NjM1_4d2c1607-9bc3-44ef-b332-c1c78c2bb4a3"
      unitRef="usd">19422000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75513592809349c7a84c02e527ec7282_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM0LTctMS0xLTE5NjM1_821c4ad1-4c6a-49f4-be18-0a41a3f8195f"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56591423c17340e982228082d680b5f2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM0LTktMS0xLTE5NjM1_e2e1dbb9-d415-4eb4-8706-0c35f15195ac"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2fb12e17ce2a48c9b260a608e997c399_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM0LTExLTEtMS0xOTYzNQ_4a78fbb3-1ab5-4aca-bd9e-e90a908d7007"
      unitRef="usd">19422000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib775f94073ab4897a08bc1477642f227_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM1LTEtMS0xLTI1NjQ3_099f928f-acee-43f2-92fb-2d678f4dae74"
      unitRef="usd">63031000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87a4d0a1226941d4b0d276cb76e9483e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM1LTEtMS0xLTE5NjM1_434a7561-0286-4263-aef0-78b76abc8a11"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe2fbb48419543c3b63c3ed144b5a10f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM1LTMtMS0xLTE5NjM1_2aee2116-ffa2-4c50-8628-3b25a5e70ea5"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26af9cce866f4682bb01349800a2150e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM1LTctMS0xLTE5NjM1_8410c6f2-1b9a-4ea9-8729-8e9a81124cad"
      unitRef="usd">91000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifba04a8e07ae4647988ad6d2b6bf1364_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM1LTktMS0xLTE5NjM1_da114265-a1ac-48bf-bd64-f11eed9ea830"
      unitRef="usd">0</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icfe3ddb6c3a34749a2820654200c6a8c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM1LTExLTEtMS0xOTYzNQ_20f65f25-9fb6-4986-bed4-4a5449bdae99"
      unitRef="usd">63122000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i7683c6a5bd9a46859b7c36e87aefa23f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM2LTEtMS0xLTI1NjQ3_b5c2faf5-1723-4fb0-8341-d961ddefc548"
      unitRef="usd">599000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM2LTEtMS0xLTE5NjM1_3422700f-c34e-42f7-9432-7f9b867805a2"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i0059ff87fc364aec80f3c7eef6a97f6a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM2LTMtMS0xLTE5NjM1_39544555-7a52-4339-89ff-4f4ced2f9a1a"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iaa96e65bf6294c0ca787cbef203ccb23_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM2LTctMS0xLTE5NjM1_3788f6ed-90ef-4a4a-8968-6c5e2d52da9e"
      unitRef="usd">412000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic17eebf2b4964519a5671bddafa2ecae_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM2LTktMS0xLTE5NjM1_4a29f702-b4ab-4e92-8a14-9776484b9182"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM2LTExLTEtMS0xOTYzNQ_9e85dbd2-25ef-44cd-a83c-84a273256515"
      unitRef="usd">1011000000</us-gaap:NetInvestmentIncome>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie4d27cdb62c44a25a61a4be0d895fc4c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM3LTEtMS0xLTI1NjQ3_4ceb7f96-279f-4593-841b-89ee1ee68663"
      unitRef="usd">5974000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3037e334694c4257a0adcaa55fac67f7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM3LTEtMS0xLTE5NjM1_0130747e-bfc2-41a3-a1b3-2618476f284a"
      unitRef="usd">595000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie27c33f5643f48a6ab725eac74707192_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM3LTMtMS0xLTE5NjM1_6d5052e8-86d4-463b-a34e-78df0c7c353f"
      unitRef="usd">744000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a078bd350664f23bfb042a07d7c28aa_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM3LTctMS0xLTE5NjM1_d897c2f7-362f-47c1-8148-c2593d505aa8"
      unitRef="usd">9000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id33fc8f7a4874100ab8c405e4632eb30_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM3LTktMS0xLTE5NjM1_aa8c3199-1cad-4c73-89d3-3a388563e86e"
      unitRef="usd">-26000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i054efc215dfa4b1fa92da514a6fad49b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM3LTExLTEtMS0xOTYzNQ_8267c123-92ef-45b3-af15-6a330c65b986"
      unitRef="usd">7296000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i7683c6a5bd9a46859b7c36e87aefa23f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM4LTEtMS0xLTI1NjQ3_ac3810ad-7a40-4bbe-b041-748b4905223a"
      unitRef="usd">69604000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM4LTEtMS0xLTE5NjM1_8d0a3c76-046b-47b2-91fa-8996b55743a9"
      unitRef="usd">141491000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0059ff87fc364aec80f3c7eef6a97f6a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM4LTMtMS0xLTE5NjM1_1fbdbb59-e903-4a00-9d7a-e9d032d19dfa"
      unitRef="usd">86608000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaa96e65bf6294c0ca787cbef203ccb23_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM4LTctMS0xLTE5NjM1_83a6c50f-2a63-41ee-b002-456544fac06c"
      unitRef="usd">512000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic17eebf2b4964519a5671bddafa2ecae_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM4LTktMS0xLTE5NjM1_033f757a-e7d4-45f1-a00c-58cd996bb014"
      unitRef="usd">-41439000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzM4LTExLTEtMS0xOTYzNQ_5f249e96-2546-4a6c-b469-d251b5637267"
      unitRef="usd">256776000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i55c01612bdda4f1bb914815afe3bbf95_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQxLTEtMS0xLTE5NjM1_c3912754-b7f6-431b-a377-d07c242987f8"
      unitRef="usd">88755000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i72491a4fae084225942f973da304ba25_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQyLTEtMS0xLTE5NjM1_e3c5eeb3-2f01-47d0-8b17-07af8325aa46"
      unitRef="usd">52141000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i76238069608f4813b8d2ac5bfe67dae8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQzLTEtMS0xLTE5NjM1_dc2a4afa-a32e-4473-8a94-b58d23015101"
      unitRef="usd">595000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmI0YWQ1ZDU1Nzg0ZGE5OThiNTUyYWZhOWU2OWYzMS90YWJsZXJhbmdlOmRiYjRhZDVkNTU3ODRkYTk5OGI1NTJhZmE5ZTY5ZjMxXzQ0LTEtMS0xLTE5NjM1_e561c2f9-9c5e-463c-a91f-2e9eb3aea6d4"
      unitRef="usd">141491000000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDAx_e6c5c13d-7ced-4b5e-bfcc-2283c43deda9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides information about receivables and contract liabilities from contracts with customers as of December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables (included in accounts receivable, net)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (included in accrued expenses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2021 and 2020, the contract liabilities balance includes increases related to customers&#x2019; earnings in ExtraBucks Rewards or issuances of Company gift cards and decreases for revenues recognized during the period as a result of the redemption of ExtraBucks Rewards or Company gift cards and breakage of Company gift cards. Below is a summary of such changes:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rewards earnings and gift card issuances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redemption and breakage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTo5ZGZlNzA5ODQyMDA0ZTRiYjhmNjZlYWQ1ZWY3NmU4NS90YWJsZXJhbmdlOjlkZmU3MDk4NDIwMDRlNGJiOGY2NmVhZDVlZjc2ZTg1XzEtMS0xLTEtMTk2MzU_bb28417b-43ee-4bbc-b77c-a2aad7c11130"
      unitRef="usd">7932000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTo5ZGZlNzA5ODQyMDA0ZTRiYjhmNjZlYWQ1ZWY3NmU4NS90YWJsZXJhbmdlOjlkZmU3MDk4NDIwMDRlNGJiOGY2NmVhZDVlZjc2ZTg1XzEtMy0xLTEtMTk2MzU_2e5d788f-bf36-4ff1-b0bf-b252ef9a6f2b"
      unitRef="usd">7101000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTo5ZGZlNzA5ODQyMDA0ZTRiYjhmNjZlYWQ1ZWY3NmU4NS90YWJsZXJhbmdlOjlkZmU3MDk4NDIwMDRlNGJiOGY2NmVhZDVlZjc2ZTg1XzItMS0xLTEtMTk2MzU_491655a3-e1e4-4837-bae2-0354cafd40d0"
      unitRef="usd">87000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTo5ZGZlNzA5ODQyMDA0ZTRiYjhmNjZlYWQ1ZWY3NmU4NS90YWJsZXJhbmdlOjlkZmU3MDk4NDIwMDRlNGJiOGY2NmVhZDVlZjc2ZTg1XzItMy0xLTEtMTk2MzU_8996082b-281d-4a99-b34e-3b3bd2502f37"
      unitRef="usd">71000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTphNTk1NjEwOTE2MjA0MzE2OGFmZDhlMmY1OGUwYmNiZi90YWJsZXJhbmdlOmE1OTU2MTA5MTYyMDQzMTY4YWZkOGUyZjU4ZTBiY2JmXzEtMS0xLTEtMTk2MzU_4be091b9-7ec2-4445-aa7f-1a073fc65be4"
      unitRef="usd">71000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTphNTk1NjEwOTE2MjA0MzE2OGFmZDhlMmY1OGUwYmNiZi90YWJsZXJhbmdlOmE1OTU2MTA5MTYyMDQzMTY4YWZkOGUyZjU4ZTBiY2JmXzEtMy0xLTEtMTk2MzU_cad4c496-8ff8-4f05-a0b8-c4c512c84aff"
      unitRef="usd">73000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTphNTk1NjEwOTE2MjA0MzE2OGFmZDhlMmY1OGUwYmNiZi90YWJsZXJhbmdlOmE1OTU2MTA5MTYyMDQzMTY4YWZkOGUyZjU4ZTBiY2JmXzMtMS0xLTEtMTk2MzU_9a0725fd-fb17-414d-ba0c-ac66338e7db3"
      unitRef="usd">387000000</cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance>
    <cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTphNTk1NjEwOTE2MjA0MzE2OGFmZDhlMmY1OGUwYmNiZi90YWJsZXJhbmdlOmE1OTU2MTA5MTYyMDQzMTY4YWZkOGUyZjU4ZTBiY2JmXzMtMy0xLTEtMTk2MzU_71b3fd07-4d05-46bd-b7bf-bc50a3155cdb"
      unitRef="usd">357000000</cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance>
    <cvs:ContractWithCustomerLiabilityRedemptionAndBreakage
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTphNTk1NjEwOTE2MjA0MzE2OGFmZDhlMmY1OGUwYmNiZi90YWJsZXJhbmdlOmE1OTU2MTA5MTYyMDQzMTY4YWZkOGUyZjU4ZTBiY2JmXzQtMS0xLTEtMTk2MzU_e7edb254-e9b0-49f2-93a4-2332c1e549f0"
      unitRef="usd">371000000</cvs:ContractWithCustomerLiabilityRedemptionAndBreakage>
    <cvs:ContractWithCustomerLiabilityRedemptionAndBreakage
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTphNTk1NjEwOTE2MjA0MzE2OGFmZDhlMmY1OGUwYmNiZi90YWJsZXJhbmdlOmE1OTU2MTA5MTYyMDQzMTY4YWZkOGUyZjU4ZTBiY2JmXzQtMy0xLTEtMTk2MzU_9a55f171-469a-42ff-b939-e20974a7dfde"
      unitRef="usd">359000000</cvs:ContractWithCustomerLiabilityRedemptionAndBreakage>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTphNTk1NjEwOTE2MjA0MzE2OGFmZDhlMmY1OGUwYmNiZi90YWJsZXJhbmdlOmE1OTU2MTA5MTYyMDQzMTY4YWZkOGUyZjU4ZTBiY2JmXzUtMS0xLTEtMTk2MzU_870dbdac-f2cf-47cd-9cc7-49db8b03d133"
      unitRef="usd">87000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTphNTk1NjEwOTE2MjA0MzE2OGFmZDhlMmY1OGUwYmNiZi90YWJsZXJhbmdlOmE1OTU2MTA5MTYyMDQzMTY4YWZkOGUyZjU4ZTBiY2JmXzUtMy0xLTEtMTk2MzU_c492300a-fdf1-4941-9b92-7ed349961511"
      unitRef="usd">71000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDY4_f1800253-0b55-4edb-9e81-0b94a5aaa68b">&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Products Sold&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for cost of products sold as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of products sold includes: (i) the cost of prescription drugs sold during the reporting period directly through the Company&#x2019;s mail service dispensing pharmacies and indirectly through the Company&#x2019;s retail pharmacy network, (ii) shipping and handling costs, and (iii) the operating costs of the Company&#x2019;s mail service dispensing pharmacies and client service operations and related information technology support costs including depreciation and amortization. The cost of prescription drugs sold component of cost of products sold includes: (i) the cost of the prescription drugs purchased from manufacturers or distributors and shipped to members in clients&#x2019; benefit plans from the Company&#x2019;s mail service dispensing pharmacies, net of any volume-related or other discounts (see &#x201c;Vendor Allowances and Purchase Discounts&#x201d; below) and (ii) the cost of prescription drugs sold (including retail co-payments) through the Company&#x2019;s retail pharmacy network under contracts where the Company is the principal, net of any volume-related or other discounts. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment&lt;/span&gt;&lt;/div&gt;Cost of products sold includes: the cost of merchandise sold during the reporting period, including prescription drug costs, and the related purchasing costs, warehousing and delivery costs (including depreciation and amortization) and actual and estimated inventory losses.</us-gaap:CostOfSalesPolicyTextBlock>
    <cvs:VendorAllowancesAndPurchaseDiscountsPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDg3_af328b2e-3edc-4c3a-8e54-9279b618c390">&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Vendor Allowances and Purchase Discounts &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for vendor allowances and purchase discounts as follows: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pharmacy Services Segment&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pharmacy Services segment receives purchase discounts on products purchased. Contractual arrangements with vendors, including manufacturers, wholesalers and retail pharmacies, normally provide for the Pharmacy Services segment to receive &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;purchase discounts from established list prices in one, or a combination, of the following forms: (i) a direct discount at the time of purchase, (ii) a discount for the prompt payment of invoices or (iii) when products are purchased indirectly from a manufacturer (e.g., through a wholesaler or retail pharmacy), a discount (or rebate) paid subsequent to dispensing. These rebates are recognized when prescriptions are dispensed and are generally calculated and billed to manufacturers within 30 days of the end of each completed quarter. Historically, the effect of adjustments resulting from the reconciliation of rebates recognized to the amounts billed and collected has not been material to the Company&#x2019;s operating results or financial condition. The Company accounts for the effect of any such differences as a change in accounting estimate in the period the reconciliation is completed. The Pharmacy Services segment also receives additional discounts under its wholesaler contracts if it exceeds contractually defined purchase volumes. In addition, the Pharmacy Services segment receives fees from pharmaceutical manufacturers for administrative services. Purchase discounts and administrative service fees are recorded as a reduction of cost of products sold. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Retail/LTC Segment&lt;/span&gt;&lt;/div&gt;Vendor allowances received by the Retail/LTC segment reduce the carrying cost of inventory and are recognized in cost of products sold when the related inventory is sold, unless they are specifically identified as a reimbursement of incremental costs for promotional programs and/or other services provided. Amounts that are directly linked to advertising commitments are recognized as a reduction of advertising expense (included in operating expenses) when the related advertising commitment is satisfied. Any amounts received in excess of the actual cost incurred also reduce the carrying cost of inventory. The total value of any upfront payments received from vendors that are linked to purchase commitments is initially deferred. The deferred amounts are then amortized to reduce cost of products sold over the life of the contract based upon sales volume. The total value of any upfront payments received from vendors that are not linked to purchase commitments is also initially deferred. The deferred amounts are then amortized to reduce cost of products sold on a straight-line basis over the life of the related contract. The total amortization of these upfront payments was not material to the Company&#x2019;s consolidated financial statements in any of the periods presented.</cvs:VendorAllowancesAndPurchaseDiscountsPolicyTextBlock>
    <cvs:PharmacyRebatePeriod
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzY2OTMz_0e4b163c-fe6e-4b65-9150-c8f9ee166988">P30D</cvs:PharmacyRebatePeriod>
    <us-gaap:HealthCareEntitiesPolicyPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NTIz_0771b3cb-4da9-4bf7-9175-c31f8a2fde6c">&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Reform&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Insurer Fee&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since January 1, 2014, the ACA has imposed an annual premium-based health insurer fee (&#x201c;HIF&#x201d;) for each calendar year, payable in September, which was not deductible for tax purposes. The Company has been required to estimate a liability for the HIF at the beginning of the calendar year in which the fee was payable with a corresponding deferred asset that was amortized ratably to operating expenses over the calendar year. The Company recorded the liability for the HIF in accrued expenses and recorded the deferred asset in other current assets. In December 2019, the HIF was repealed for calendar years after 2020, therefore there was no expense related to the HIF in the year ended December&#160;31, 2021. In the year ended December 31, 2020, operating expenses included $1.0&#160;billion related to the Company&#x2019;s share of the HIF. There was no expense related to the HIF in 2019, since there was a one-year suspension of the HIF for 2019. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Adjustment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA established a permanent risk adjustment program to transfer funds from qualified individual and small group insurance plans with below average risk scores to plans with above average risk scores. Based on the risk of the Company&#x2019;s qualified plan members relative to the average risk of members of other qualified plans in comparable markets, as defined by the ACA, the Company estimates its ultimate risk adjustment receivable (recorded in accounts receivable) or payable (recorded in accrued expenses) for the current calendar year and reflects the pro-rata year-to-date impact as an adjustment to premium revenue. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk Corridor&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ACA established a temporary risk corridor program, which expired at the end of 2016, for qualified individual and small group health insurance plans. Under this program, health insurance companies were to make payments to, or receive payments from, the U.S. Department of Health and Human Services (&#x201c;HHS&#x201d;) based on their ratio of allowable costs to target costs (as defined by the ACA). &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company filed a lawsuit in August 2019 to recover the $313&#160;million it was owed under the ACA&#x2019;s risk corridor program, which had been stayed pending the Supreme Court decision. In April 2020, the U.S. Supreme Court ruled that health insurance companies may sue the federal government for amounts owed as calculated under the ACA&#x2019;s temporary risk corridor program. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the Company received the $313&#160;million it was owed under the ACA&#x2019;s risk corridor program. The Company recorded the risk corridor payment as an increase to premium revenue in the year ended December 31, 2020. After considering &lt;/span&gt;&lt;/div&gt;offsetting items such as the ACA&#x2019;s minimum MLR rebate requirements and premium taxes, the Company recorded pre-tax income of $307 million and after-tax income of $223&#160;million during the year ended December&#160;31, 2020.</us-gaap:HealthCareEntitiesPolicyPolicyTextBlock>
    <cvs:HealthInsurerFee
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzYwNDczMTQwNzA1MjY_3c823ba7-b625-4296-8723-ae3f56bce692"
      unitRef="usd">0</cvs:HealthInsurerFee>
    <cvs:HealthInsurerFee
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzEwOTk1MTE3MTk2MTY_14d0909a-d923-4b8f-b365-b23d6b6d78da"
      unitRef="usd">1000000000</cvs:HealthInsurerFee>
    <cvs:HealthInsurerFee
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzY5NzQ0_97359291-bacc-4f86-be71-89c060a69148"
      unitRef="usd">0</cvs:HealthInsurerFee>
    <us-gaap:GainContingencyUnrecordedAmount
      contextRef="i5d8804cf6abb4698a6a8f6b7fc6e7b28_I20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcxMDIy_017a8888-4980-41c4-8848-914dab223551"
      unitRef="usd">313000000</us-gaap:GainContingencyUnrecordedAmount>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="i78a023c8e08447dd9462aefe43f9ffb4_D20201022-20201022"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcxMzY1_5ae05736-2dda-4dda-9ce0-207d05f0b4fc"
      unitRef="usd">313000000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax
      contextRef="i55877e993992468ea1377ad4577db051_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcxNjY1_a2e59d72-d9a0-4cc6-8743-3d59b837e681"
      unitRef="usd">307000000</cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax>
    <cvs:FormerGainContingencyRecognizedInCurrentPeriodNetOfTax
      contextRef="i55877e993992468ea1377ad4577db051_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcxNjky_e787c239-8536-4e38-9624-20bd97d0d921"
      unitRef="usd">223000000</cvs:FormerGainContingencyRecognizedInCurrentPeriodNetOfTax>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDc1_fe1f5231-0826-486c-90be-98a01edfbe89">Advertising Costs Advertising costs, which are reduced by the portion funded by vendors, are expensed when the related advertising takes place. Net advertising costs, which are included in operating expenses, were $523 million, $461 million and $396 million in 2021, 2020 and 2019, respectively.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcyMDU0_2c68f05b-d8d4-40aa-9b5b-d880e75b358d"
      unitRef="usd">523000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcyMDU4_3b5015f9-393f-408b-9b16-01a23ba567e1"
      unitRef="usd">461000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcyMDY1_35e019d0-6bf7-4c67-8b3e-0e6bac06fe47"
      unitRef="usd">396000000</us-gaap:AdvertisingExpense>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NTAy_afb3cc99-b625-4874-adb9-49efad49a6e1">Stock-Based CompensationStock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzcyMzEz_ea62d84c-7b65-4b23-9d75-3a8341c56a52"&gt;three&lt;/span&gt; to five years) using the straight-line method.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i2f08d731825c4986934a5374bd021d17_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMyOTg1MzUwMjc2NDA_4666c407-4d00-4ae1-9777-71426957336f">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDQ0_9baa14f3-7478-46ba-8438-62ee7b132eaa">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the consolidated financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year or years in which the differences are expected to reverse. The effect of a change in the tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date of such change.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and the Company&#x2019;s recent operating results. The Company establishes a valuation allowance when it does not consider it more likely than not that a deferred tax asset will be recovered.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records uncertain tax positions on the basis of a two-step process whereby (1) the Company determines whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that is more than 50% likely to be realized upon ultimate settlement with the related tax authority. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest and/or penalties related to uncertain tax positions are recognized in the income tax provision.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:PensionAndOtherPostretirementPlansPolicy
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDAz_8c6f8126-4aa3-4761-bbe3-dc647f2d495f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors defined benefit pension plans (&#x201c;pension plans&#x201d;) and other postretirement employee benefit plans (&#x201c;OPEB plans&#x201d;) for its employees and retirees. The Company recognizes the funded status of its pension and OPEB plans on the consolidated balance sheets based on the year-end measurements of plan assets and benefit obligations. When the fair value of plan assets are in excess of the plan benefit obligations, the amounts are reported in other current assets and other assets. When the fair value of plan benefit obligations are in excess of plan assets, the amounts are reported in accrued expenses and other long-term liabilities based on the amount by which the actuarial present value of benefits payable in the next twelve months included in the benefit obligation exceeds the fair value of plan assets. The net periodic benefit cost (income) for the Company&#x2019;s pension and OPEB plans do not contain a service cost component as these plans have been frozen for an extended period of time.&#160;Non-service cost components of pension and postretirement net periodic benefit cost (income) are included in other income in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementPlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDc3_4cd9f64f-1c66-47a2-83ee-ac9ae91b91cd">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share is computed using the two-class method. The Company calculates basic earnings per share based on the weighted average number of common shares outstanding for the period. See Note 14 &#x2018;&#x2018;Earnings Per Share&#x2019;&#x2019; for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <cvs:SharesHeldInTrustPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDM0_648b2174-889f-4129-a697-cef74cae9982">Shares Held in TrustThe Company maintains grantor trusts, which held approximately one million shares of its common stock at both December&#160;31, 2021 and 2020. These shares are designated for use under various employee compensation plans. Since the Company holds these shares, they are excluded from the computation of basic and diluted shares outstanding.</cvs:SharesHeldInTrustPolicyTextBlock>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMyOTg1MzUwMjc2MjQ_075b8416-9926-4969-b17a-000d0d88693c"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <cvs:TreasuryStockSharesHeldinTrust
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMyOTg1MzUwMjc2MjQ_ba365d0d-aeae-4693-af71-a08519b594c9"
      unitRef="shares">1000000</cvs:TreasuryStockSharesHeldinTrust>
    <us-gaap:ConsolidationVariableInterestEntityPolicy
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDcw_a757b7c8-4c01-4f15-b4f6-c43e29c863b2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable Interest Entities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has investments in (i) a generic pharmaceutical sourcing entity, (ii) certain hedge fund and private equity investments and (iii) certain real estate partnerships that are considered VIEs. The Company does not have a future obligation to fund losses or debts on behalf of these investments; however, it may voluntarily contribute funds. In evaluating whether the Company is the primary beneficiary of a VIE, the Company considers several factors, including whether the Company has (a) the power to direct the activities that most significantly impact the VIE&#x2019;s economic performance and (b) the obligation to absorb losses and the right to receive benefits that could potentially be significant to the VIE. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Interest Entities - Primary Beneficiary&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2014, the Company and Cardinal Health, Inc. (&#x201c;Cardinal&#x201d;) established Red Oak Sourcing, LLC (&#x201c;Red Oak&#x201d;), a generic pharmaceutical sourcing entity in which the Company and Cardinal each own 50%. The Red Oak arrangement had an initial term of ten years. In 2021, the Red Oak arrangement was amended to extend the initial term an additional five years, for a total term of 15 years. Under this arrangement, the Company and Cardinal contributed their sourcing and supply chain expertise to Red Oak and agreed to source and negotiate generic pharmaceutical supply contracts for both companies through Red Oak; however, Red Oak does not own or hold inventory on behalf of either company. No physical assets (e.g., property and equipment) were contributed to Red Oak by either company, and minimal funding was provided to capitalize Red Oak. The Company has determined that it is the primary beneficiary of this VIE because it has the ability to direct the activities of Red Oak. Consequently, the Company consolidates Red Oak in its consolidated financial statements within the Retail/LTC segment. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cardinal is required to pay the Company quarterly payments, which began in October 2014 and will extend through June 2029. As milestones are met, the quarterly payments increase. The Company received $183 million from Cardinal during each of the years ended December&#160;31, 2021, 2020 and 2019. The payments reduce the Company&#x2019;s carrying value of inventory and are recognized in cost of products sold when the related inventory is sold. Amounts reimbursed by Cardinal for the years ended December&#160;31, 2021, 2020 and 2019, and amounts due to or due from Cardinal at December&#160;31, 2021 and 2020 were immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Interest Entities - Other Variable Interest Holder&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has invested in certain VIEs for which it has determined that it is not the primary beneficiary, consisting of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Hedge fund and private equity investments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company invests in hedge fund and private equity investments in order to generate investment returns for its investment portfolio supporting its insurance businesses.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Real estate partnerships&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Company invests in various real estate partnerships, including those that construct, own and manage low-income housing developments. For the low income housing development investments, substantially all of the projected benefits to the Company are from tax credits and other tax benefits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is not the primary beneficiary of these VIEs because the nature of the Company&#x2019;s involvement with the activities of these VIEs does not give the Company the power to direct the activities that most significantly impact their economic performance. The Company records the amount of its investment in these VIEs as long-term investments on the consolidated balance sheets and recognizes its share of each VIE&#x2019;s income or losses in net income (loss).&#160;The Company&#x2019;s maximum exposure to loss from these VIEs is limited to its investment balances as disclosed below and the risk of recapture of previously recognized tax credits related to the real estate partnerships, which the Company does not consider significant.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="ifed7853cc1c344298bd8003d3174178b_D20140101-20141231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzc3OTA2_9d811b47-00dc-43ab-b99b-c8fbdc68f861"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <cvs:Initialcontractualterm
      contextRef="ifed7853cc1c344298bd8003d3174178b_D20140101-20141231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzc3OTU3_927ba7f6-b68d-454d-98c5-49d716be06ab">P10Y</cvs:Initialcontractualterm>
    <cvs:VariableInterestEntityAmendedContractExtensionTerm
      contextRef="i5565b4e7fc4f4e8aa341da7b6e4e4d86_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzM4NDgyOTA4Mzk5NTk_7c8e0ef9-cb17-4a51-8136-0d27ff243193">P5Y</cvs:VariableInterestEntityAmendedContractExtensionTerm>
    <cvs:VariableInterestEntityAmendedContractTerm
      contextRef="i5565b4e7fc4f4e8aa341da7b6e4e4d86_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMyOTg1MzUwMDc3NDY_6d2bd8e8-43e0-4325-8f33-9e5d7d867039">P15Y</cvs:VariableInterestEntityAmendedContractTerm>
    <cvs:ProceedsFromVariableInterestEntity
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzk4OTU2MDQ3OTQyNjE_06b41edc-0213-430a-9247-29526ddeac4d"
      unitRef="usd">183000000</cvs:ProceedsFromVariableInterestEntity>
    <cvs:ProceedsFromVariableInterestEntity
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzk4OTU2MDQ3OTQyNjE_20065b4c-c358-4f1d-be7b-21fe53a37ab5"
      unitRef="usd">183000000</cvs:ProceedsFromVariableInterestEntity>
    <cvs:ProceedsFromVariableInterestEntity
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzk4OTU2MDQ3OTQyNjE_28c94540-7318-4017-aaa9-f01b382ed73e"
      unitRef="usd">183000000</cvs:ProceedsFromVariableInterestEntity>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NTA5_1221fb11-be38-4d18-a07b-813668cc564c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total amount of other variable interest holder VIE assets included in long-term investments on the consolidated balance sheets at December&#160;31, 2021 and 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.990%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedge fund investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:LongTermInvestments
      contextRef="i50b4460d87d840bbaafccbc86903992c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmQxM2ZkMmYzMmE0NmUzOWYxYzRjYmY5OTk3OWFkMi90YWJsZXJhbmdlOmRiZDEzZmQyZjMyYTQ2ZTM5ZjFjNGNiZjk5OTc5YWQyXzEtMS0xLTEtMTk2MzU_f907d989-a977-4ad1-8a2e-0be1925ccef9"
      unitRef="usd">463000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i1711347a62744966b4e74fee52b0bae9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmQxM2ZkMmYzMmE0NmUzOWYxYzRjYmY5OTk3OWFkMi90YWJsZXJhbmdlOmRiZDEzZmQyZjMyYTQ2ZTM5ZjFjNGNiZjk5OTc5YWQyXzEtMy0xLTEtMTk2MzU_d2e01e3a-b3ea-4f5c-9923-e506f8d3a9eb"
      unitRef="usd">342000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i064ed72a7c7d4834b6d490201f178cc6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmQxM2ZkMmYzMmE0NmUzOWYxYzRjYmY5OTk3OWFkMi90YWJsZXJhbmdlOmRiZDEzZmQyZjMyYTQ2ZTM5ZjFjNGNiZjk5OTc5YWQyXzItMS0xLTEtMTk2MzU_7fa34b33-ccb4-4c6f-81fa-458fef554cf2"
      unitRef="usd">601000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i440e6a46ec8f4ce48ae8a4a7e478b725_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmQxM2ZkMmYzMmE0NmUzOWYxYzRjYmY5OTk3OWFkMi90YWJsZXJhbmdlOmRiZDEzZmQyZjMyYTQ2ZTM5ZjFjNGNiZjk5OTc5YWQyXzItMy0xLTEtMTk2MzU_757bde2f-5f7f-4428-a04c-c31b49bd28bf"
      unitRef="usd">547000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i2d327db9f7284c37b77bcfaebbe9509a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmQxM2ZkMmYzMmE0NmUzOWYxYzRjYmY5OTk3OWFkMi90YWJsZXJhbmdlOmRiZDEzZmQyZjMyYTQ2ZTM5ZjFjNGNiZjk5OTc5YWQyXzMtMS0xLTEtMTk2MzU_e4ee08df-f21e-4b40-ae88-7d0291f572bc"
      unitRef="usd">225000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i4f571724a5864c5596b142666580c1a9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmQxM2ZkMmYzMmE0NmUzOWYxYzRjYmY5OTk3OWFkMi90YWJsZXJhbmdlOmRiZDEzZmQyZjMyYTQ2ZTM5ZjFjNGNiZjk5OTc5YWQyXzMtMy0xLTEtMTk2MzU_d0c0b72b-0081-4ecd-9a48-65880c5076ea"
      unitRef="usd">200000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ibbf81618e0074484b1b2cd8ceee6f5d3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmQxM2ZkMmYzMmE0NmUzOWYxYzRjYmY5OTk3OWFkMi90YWJsZXJhbmdlOmRiZDEzZmQyZjMyYTQ2ZTM5ZjFjNGNiZjk5OTc5YWQyXzQtMS0xLTEtMTk2MzU_72df66ae-e590-4122-9e51-9721f23279af"
      unitRef="usd">1289000000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ia2865e7a41644a8186918f7b00a1a60d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZTpkYmQxM2ZkMmYzMmE0NmUzOWYxYzRjYmY5OTk3OWFkMi90YWJsZXJhbmdlOmRiZDEzZmQyZjMyYTQ2ZTM5ZjFjNGNiZjk5OTc5YWQyXzQtMy0xLTEtMTk2MzU_a147e5b5-9b71-4d03-a926-91e3e69f25e3"
      unitRef="usd">1089000000</us-gaap:LongTermInvestments>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDc4_4a319ba8-52fc-4011-930c-4e61f85739cd">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Related Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in SureScripts, LLC (&#x201c;SureScripts&#x201d;), which operates a clinical health information network. The Company utilizes this clinical health information network in providing services to its client plan members and retail customers. The Company expensed fees for the use of this network of $52 million, $56 million and $32 million in the years ended December&#160;31, 2021, 2020 and 2019, respectively. The Company&#x2019;s investment in and equity in the earnings of SureScripts for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has an equity method investment in Heartland Healthcare Services, LLC (&#x201c;Heartland&#x201d;). Heartland operates several LTC pharmacies in four states. Heartland paid the Company $79 million, $77 million and $96 million for pharmaceutical inventory purchases during the years ended December&#160;31, 2021, 2020 and 2019, respectively. Additionally, the Company performs certain collection functions for Heartland and then transfers those customer cash collections to Heartland. The Company&#x2019;s investment in and equity in the earnings of Heartland for all periods presented is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2021, 2020 and 2019, the Company made charitable contributions of&#160;$50&#160;million, $50 million and $30&#160;million, respectively,&#160;to the CVS Health Foundation, a non-profit entity that focuses on health, education and community involvement programs. The charitable contributions were recorded as operating expenses in the consolidated statements of operations within the Corporate/Other segment for the years ended December&#160;31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzgxMTk4_1ec7e2cf-2787-4bf1-803e-954e54f8a891"
      unitRef="usd">52000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzgxMjAy_2f4a7648-1557-43c3-81b3-79f1e8a2e49e"
      unitRef="usd">56000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzgxMjA5_9bf5aeb0-4ed0-456b-b5ff-dc8fd154024e"
      unitRef="usd">32000000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="i9bc52b3acf264acbbaa97645df36b813_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzgxNTE0_e1ca778f-2263-4862-8ebf-348630d0a583"
      unitRef="state">4</us-gaap:NumberOfStatesInWhichEntityOperates>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzgxNTUy_0aa0a6bb-1a12-4568-a641-fbcb861e9603"
      unitRef="usd">79000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzgxNTU2_a6edfddf-67e1-4ae2-a636-a853571319b5"
      unitRef="usd">77000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzgxNTYz_854c6d15-0c06-4dee-bbad-e381e1d5407d"
      unitRef="usd">96000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzgxOTg5_6f60aaf7-7b0e-4de9-a465-ca852cc3f652"
      unitRef="usd">50000000</cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity>
    <cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzE2NDkyNjc1NTkyNTE_6b37f4b5-dd30-40f5-bb9c-b4fdb4225f2d"
      unitRef="usd">50000000</cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity>
    <cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzE2NDkyNjc1NTkyODM_4e593b77-b387-4403-abc5-78d2a01d6fcc"
      unitRef="usd">30000000</cvs:RelatedPartyTransactionCharitableContributionToNonProfitEntity>
    <us-gaap:DiscontinuedOperationsPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NDgw_722405c9-37f2-4824-85a7-887a9e5f4004">Discontinued OperationsIn connection with certain business dispositions completed between 1995 and 1997, the Company retained guarantees on store lease obligations for a number of former subsidiaries, including Linens &#x2018;n Things and Bob&#x2019;s Stores, each of which subsequently filed for bankruptcy. The Company&#x2019;s loss from discontinued operations includes lease-related costs that the Company believes it will likely be required to satisfy pursuant to these lease guarantees.</us-gaap:DiscontinuedOperationsPolicyTextBlock>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5XzMyOTg1MzUwMzA1MzI_2c57979d-998e-423d-910e-eeab8da73ab7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the results of discontinued operations for the year ended December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZToxZDc0N2U4YzA5ZDI0ODQ3YWQyM2ExMmI1YjAyYTY1ZS90YWJsZXJhbmdlOjFkNzQ3ZThjMDlkMjQ4NDdhZDIzYTEyYjViMDJhNjVlXzEtMS0xLTEtMTk2MzU_78643e69-8f05-4546-81fa-f4fa01239e3a"
      unitRef="usd">-12000000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZToxZDc0N2U4YzA5ZDI0ODQ3YWQyM2ExMmI1YjAyYTY1ZS90YWJsZXJhbmdlOjFkNzQ3ZThjMDlkMjQ4NDdhZDIzYTEyYjViMDJhNjVlXzItMS0xLTEtMTk2MzU_f68246aa-87a4-46b7-bb03-555cffa7629a"
      unitRef="usd">-3000000</us-gaap:DiscontinuedOperationTaxEffectOfDiscontinuedOperation>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90YWJsZToxZDc0N2U4YzA5ZDI0ODQ3YWQyM2ExMmI1YjAyYTY1ZS90YWJsZXJhbmdlOjFkNzQ3ZThjMDlkMjQ4NDdhZDIzYTEyYjViMDJhNjVlXzMtMS0xLTEtMTk2MzU_630ef0f1-2d73-4b5f-bd83-e9d8201a021b"
      unitRef="usd">-9000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzAvZnJhZzoxNDIzNTEzMTYwZjM0MTdlYTIxYWEzMWM4M2FiY2IyOS90ZXh0cmVnaW9uOjE0MjM1MTMxNjBmMzQxN2VhMjFhYTMxYzgzYWJjYjI5Xzg3NTAw_bec131f0-f357-4a85-a0a8-6c9408fa5afd">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Recently Adopted &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Topic 740). This standard simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Accounting Standards Codification 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The Company adopted this new accounting standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company&#x2019;s consolidated operating results, cash flows, financial condition or related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Insurance Contracts&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Targeted Improvements to the Accounting for Long-Duration Contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (Topic 944). This standard requires the Company to review cash flow assumptions for its long-duration insurance contracts at least annually and recognize the effect of changes in future cash flow assumptions in net income. This standard also requires the Company to update discount rate assumptions quarterly and recognize the effect of changes in these assumptions in other comprehensive income. The rate used to discount the Company&#x2019;s liability for future policy benefits will be based on an estimate of the yield for an upper-medium grade fixed-income instrument with a duration profile matching that of the Company&#x2019;s &lt;/span&gt;&lt;/div&gt;liabilities. In addition, this standard changes the amortization method for deferred acquisition costs and requires additional disclosures regarding the long duration insurance contract liabilities in the Company&#x2019;s interim and annual financial statements. The standard is effective for public companies for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company will adopt the new standard on January 1, 2023, using the modified retrospective transition method as of the earliest period presented for changes to the liability for future policy benefits and deferred acquisition costs. While the Company is still evaluating the impact of the new standard on its financial statements, the Company anticipates an increase to its liability for future policy benefits with a corresponding change in accumulated other comprehensive income as a result of updating the rate used to discount the liabilities to reflect the yield for an upper-medium grade fixed-income instrument compared to the Company&#x2019;s expected investment yield under the existing guidance.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzMvZnJhZzpjM2Y0NTYzMWI3Y2Y0ODRlOGQ5NWQ4NDlkMDRlMjVkZS90ZXh0cmVnaW9uOmMzZjQ1NjMxYjdjZjQ4NGU4ZDk1ZDg0OWQwNGUyNWRlXzU5Nzg_73e62459-44ee-4e40-8dc8-18ad12f8d116">Divestitures&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestiture of Workers&#x2019; Compensation Business&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 31, 2020, the Company sold its Workers&#x2019; Compensation business for approximately $850&#160;million. The results of this business were reported within the Health Care Benefits segment. The Company recorded a pre-tax gain on the divestiture of $269 million in the year ended December&#160;31, 2020, which is reflected as a reduction in operating expenses in the Company&#x2019;s consolidated statement of operations within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestiture of Brazilian Subsidiary&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 1, 2019, the Company sold its Brazilian subsidiary, Onofre, for an immaterial amount. Onofre operated 50 retail pharmacy stores, the results of which historically had been reported within the Retail/LTC segment. The Company recorded a pre-tax loss on the divestiture of $205 million in the year ended December 31, 2019, which primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in operating expenses in the Company&#x2019;s consolidated statement of operations within the Retail/LTC segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="ic3bfdde04dbf4f498310d896a5a94507_D20200731-20200731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzMvZnJhZzpjM2Y0NTYzMWI3Y2Y0ODRlOGQ5NWQ4NDlkMDRlMjVkZS90ZXh0cmVnaW9uOmMzZjQ1NjMxYjdjZjQ4NGU4ZDk1ZDg0OWQwNGUyNWRlXzQ1Nzc_12c6b2b3-4334-4049-8382-d2e29c70f483"
      unitRef="usd">850000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i707e6377bc8f46819c6e330be95da61e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzMvZnJhZzpjM2Y0NTYzMWI3Y2Y0ODRlOGQ5NWQ4NDlkMDRlMjVkZS90ZXh0cmVnaW9uOmMzZjQ1NjMxYjdjZjQ4NGU4ZDk1ZDg0OWQwNGUyNWRlXzEwOTk1MTE2MzM3NzQ_5e1dc08e-85f1-4e1a-9c4a-f0ba4c0c9bd9"
      unitRef="usd">269000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:NumberOfStores
      contextRef="ic78da50417e849b5a59cd5089920fa13_I20190701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzMvZnJhZzpjM2Y0NTYzMWI3Y2Y0ODRlOGQ5NWQ4NDlkMDRlMjVkZS90ZXh0cmVnaW9uOmMzZjQ1NjMxYjdjZjQ4NGU4ZDk1ZDg0OWQwNGUyNWRlXzUwNjY_179c3886-34a0-4d6d-9146-67f7a938f5e8"
      unitRef="store">50</us-gaap:NumberOfStores>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i7fd8613bfc0d4364b6e49aa6a8b2d288_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzMvZnJhZzpjM2Y0NTYzMWI3Y2Y0ODRlOGQ5NWQ4NDlkMDRlMjVkZS90ZXh0cmVnaW9uOmMzZjQ1NjMxYjdjZjQ4NGU4ZDk1ZDg0OWQwNGUyNWRlXzUyMzQ_dfeacd8c-f173-42c3-b4bc-f6ce38383ffc"
      unitRef="usd">-205000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzczNzg_5cdcccba-1559-4c5a-b7bf-bc5bff6ee94b">Investments&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total investments at December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021 and 2020, the Company held investments of $450 million and $524 million, respectively, related to the 2012 conversion of an existing group annuity contract from a participating to a non-participating contract. These investments are included in the total investments of large case pensions supporting non-experience-rated products. Although these investments are not accounted for as Separate Accounts assets, they are legally segregated and are not subject to claims that arise out of the Company&#x2019;s business and only support future policy benefits obligations under that group annuity contract. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities available for sale at December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;There was no allowance for expected credit losses recorded on available-for-sale debt securities at December&#160;31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Investment risks associated with the Company&#x2019;s experience-rated products generally do not impact the Company&#x2019;s consolidated operating results.&#160;At December&#160;31, 2021, debt securities with a fair value of $864 million, gross unrealized capital gains of $94 million and gross unrealized capital losses of $2 million and at December&#160;31, 2020, debt securities with a fair value of $919 million, gross unrealized capital gains of $135 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and fair value of debt securities at December&#160;31, 2021 are shown below by contractual maturity.&#160;&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mortgage-Backed and Other Asset-Backed Securities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s residential mortgage-backed securities at December&#160;31, 2021 were issued by the Government National Mortgage Association, the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation and carry agency guarantees and explicit or implicit guarantees by the U.S. Government.&#160;At December&#160;31, 2021, the Company&#x2019;s residential mortgage-backed securities had an average credit quality rating of AAA and a weighted average duration of 4.7 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s commercial mortgage-backed securities have underlying loans that are dispersed throughout the United States. Significant market observable inputs used to value these securities include loss severity and probability of default.&#160;At December&#160;31, 2021, these securities had an average credit quality rating of AAA and a weighted average duration of 6.1 years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s other asset-backed securities have a variety of underlying collateral (e.g., automobile loans, credit card receivables, home equity loans and commercial loans). Significant market observable inputs used to value these securities include the unemployment rate, loss severity and probability of default.&#160;At December&#160;31, 2021, these securities had an average credit quality rating of AA and a weighted average duration of 1.0 year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the debt securities the Company held at December&#160;31, 2021 and 2020 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except number of securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;&#160;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;&#160;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;&#160;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviewed the securities in the table above and concluded that they are performing assets generating investment income to support the needs of the Company&#x2019;s business.&#160;In performing this review, the Company considered factors such as the quality of the investment security based on research performed by the Company&#x2019;s internal credit analysts and&#160;external rating agencies and the prospects of realizing the carrying value of the security based on the investment&#x2019;s current prospects for recovery. Unrealized capital losses at December&#160;31, 2021 were generally caused by interest rate increases and not by unfavorable changes in the credit quality associated with these securities. As of December&#160;31, 2021, the Company did not intend to sell these securities, and did not believe it was more likely than not that it would be required to sell these securities prior to the anticipated recovery of their amortized cost basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity dates for debt securities in an unrealized capital loss position at December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting experience-&lt;br/&gt;rated products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting remaining&lt;br/&gt;products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Mortgage Loans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s mortgage loans are collateralized by commercial real estate.&#160;During the years ended December 31, 2021 and 2020, the Company had the following activity in its mortgage loan portfolio:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans fully repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans foreclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses mortgage loans on a regular basis for credit impairments, and assigns a credit quality indicator to each loan.&#160;The Company&#x2019;s credit quality indicator is internally developed and categorizes each loan in its portfolio on a scale from 1 to 7.&#160;These indicators are based upon several factors, including current loan-to-value ratios, current and future property cash flow, property condition, market trends, creditworthiness of the borrower and deal structure. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Category 1 - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Represents loans of superior quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Categories 2 to 4 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- Represent loans where credit risk is minimal to acceptable; however, these loans may display some susceptibility to economic changes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Categories 5 and 6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Represent loans where credit risk is not substantial, but these loans warrant management&#x2019;s close attention.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Category 7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Represents loans where collections are potentially at risk; if necessary, an impairment is recorded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based upon the Company&#x2019;s assessments at December&#160;31, 2021 and 2020, the amortized cost basis of the Company&#x2019;s mortgage loans within each credit quality indicator by year of origination was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.950%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost Basis by Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except credit quality indicator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021 scheduled mortgage loan principal repayments were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Investment Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net investment income for the years ended December 31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (excluding net realized capital gains or losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital gains &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net realized capital gains are net of yield-related impairment losses on debt securities of $42 million and $49 million for the years ended December&#160;31, 2021 and 2020, respectively. There were no credit-related losses on debt securities in the years ended December&#160;31, 2021 and 2020. Net realized capital gains are net of other-than-temporary impairment (&#x201c;OTTI&#x201d;) losses on debt securities of $24 million for the year ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net investment income includes $38 million, $42 million and $44 million for the years ended December 31, 2021, 2020 and 2019, respectively, related to investments supporting experience-rated products. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capital gains and losses recognized during the year ended December 31, 2021 related to investments in equity securities held as of December 31, 2021 were not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses in the years ended December 31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <cvs:TotalInvestmentsTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzczNzQ_82b3e5d6-8859-468e-a437-846f98c7edd1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total investments at December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.309%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.016%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities available for sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:TotalInvestmentsTableTextBlock>
    <us-gaap:ShortTermInvestments
      contextRef="if05932426083419b815e008b577a2a15_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzItMS0xLTEtMTk2MzU_7ad5e762-d95c-48ae-b8bd-d643a7793ece"
      unitRef="usd">3009000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="if05932426083419b815e008b577a2a15_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzItMy0xLTEtMTk2MzU_913ddb1e-aff3-4227-8b47-99e468cd6364"
      unitRef="usd">20231000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="if05932426083419b815e008b577a2a15_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzItNS0xLTEtMTk2MzU_0b699cb7-4848-4351-9412-1e84c5500c23"
      unitRef="usd">23240000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="idce08b4519f44779aca159357248a636_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzItNy0xLTEtMTk2MzU_5e50620b-69b9-4ffa-9d0a-65d4961607ba"
      unitRef="usd">2774000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="idce08b4519f44779aca159357248a636_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzItOS0xLTEtMTk2MzU_460b8bc1-8018-401a-bd04-0e821a2418c1"
      unitRef="usd">18414000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="idce08b4519f44779aca159357248a636_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzItMTEtMS0xLTE5NjM1_f04bac4e-750c-41fb-b72a-408ef8a157b8"
      unitRef="usd">21188000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i05f36709bd8949388b2c0bffca648d32_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzMtMS0xLTEtMTk2MzU_b7dd802c-79b8-4f6e-b694-a3b4c7c1c737"
      unitRef="usd">58000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i05f36709bd8949388b2c0bffca648d32_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzMtMy0xLTEtMTk2MzU_57197ce8-a3d3-4faa-8c90-db1b81cca651"
      unitRef="usd">844000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i05f36709bd8949388b2c0bffca648d32_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzMtNS0xLTEtMTk2MzU_674443f5-c452-4137-9313-6001fe17c2b1"
      unitRef="usd">902000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="ifa3a2978a5aa4a7f8e4552df2eb04ad5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzMtNy0xLTEtMTk2MzU_5bb2911e-8329-46e4-a48f-3c6285f803e9"
      unitRef="usd">226000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ifa3a2978a5aa4a7f8e4552df2eb04ad5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzMtOS0xLTEtMTk2MzU_0424cc44-5c87-49a5-9aae-cd269660dfc3"
      unitRef="usd">821000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="ifa3a2978a5aa4a7f8e4552df2eb04ad5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzMtMTEtMS0xLTE5NjM1_ef6c4de3-3cc8-45bc-9111-f1121cba8ac0"
      unitRef="usd">1047000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i22a8dacd69894d99a9e39bcc2ceaa8c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzQtMS0xLTEtMTk2MzU_fca6c35f-fe2b-480d-a599-9b607e91ba9b"
      unitRef="usd">50000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i22a8dacd69894d99a9e39bcc2ceaa8c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzQtMy0xLTEtMTk2MzU_3652fbbf-8f61-45f6-82d7-66a6d79ed658"
      unitRef="usd">1950000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i22a8dacd69894d99a9e39bcc2ceaa8c3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzQtNS0xLTEtMTk2MzU_ebbc31aa-6e70-48c8-b491-778290f4d910"
      unitRef="usd">2000000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i43542666d6064074a52d8421444a3563_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzQtNy0xLTEtMTk2MzU_fc4697f4-e8b2-4ec0-9e16-86a2eeb1314c"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i43542666d6064074a52d8421444a3563_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzQtOS0xLTEtMTk2MzU_d5a9ef4a-1bd5-4af9-b6af-c1c4bdaa6fc5"
      unitRef="usd">1577000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i43542666d6064074a52d8421444a3563_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzQtMTEtMS0xLTE5NjM1_80f5752e-b0f9-4fb0-a9d3-c13fd7a2b0e0"
      unitRef="usd">1577000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzUtMS0xLTEtMTk2MzU_5656d119-6e8d-4a81-a1e0-f424d02f775d"
      unitRef="usd">3117000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzUtMy0xLTEtMTk2MzU_0bdf8d13-1309-40bb-8926-84b5da1151cf"
      unitRef="usd">23025000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzUtNS0xLTEtMTk2MzU_483a21ea-7410-4217-b6de-03e96fb96414"
      unitRef="usd">26142000000</us-gaap:Investments>
    <us-gaap:ShortTermInvestments
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzUtNy0xLTEtMTk2MzU_5d61fc62-7b2c-426c-ad77-36adc7eb49a5"
      unitRef="usd">3000000000</us-gaap:ShortTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzUtOS0xLTEtMTk2MzU_6a98e062-9b27-4a1f-a493-2cb69ff3eef1"
      unitRef="usd">20812000000</us-gaap:LongTermInvestments>
    <us-gaap:Investments
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTozNTZkZTdlZWUwZDg0ZWZkOWRiZDU3M2MyMzcyNGIxNy90YWJsZXJhbmdlOjM1NmRlN2VlZTBkODRlZmQ5ZGJkNTczYzIzNzI0YjE3XzUtMTEtMS0xLTE5NjM1_9d97edae-a1fc-4ab0-bba4-f950581426a2"
      unitRef="usd">23812000000</us-gaap:Investments>
    <us-gaap:RestrictedInvestmentsAtFairValue
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzEzNA_f78a7108-d9dd-433b-869a-a36aba6083b6"
      unitRef="usd">450000000</us-gaap:RestrictedInvestmentsAtFairValue>
    <us-gaap:RestrictedInvestmentsAtFairValue
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzE0MQ_fc30eda0-e123-41b2-816b-5e5802086277"
      unitRef="usd">524000000</us-gaap:RestrictedInvestmentsAtFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzczOTc_a93d9f36-0aeb-43a5-9b03-fa594973d984">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities available for sale at December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.014%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cost &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;There was no allowance for expected credit losses recorded on available-for-sale debt securities at December&#160;31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Investment risks associated with the Company&#x2019;s experience-rated products generally do not impact the Company&#x2019;s consolidated operating results.&#160;At December&#160;31, 2021, debt securities with a fair value of $864 million, gross unrealized capital gains of $94 million and gross unrealized capital losses of $2 million and at December&#160;31, 2020, debt securities with a fair value of $919 million, gross unrealized capital gains of $135 million and no gross unrealized capital losses were included in total debt securities, but support experience-rated products. Changes in net unrealized capital gains (losses) on these securities are not reflected in accumulated other comprehensive income.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzMtNS0xLTEtMTk2MzU_4dbd2232-e718-4b32-987d-718361766f79"
      unitRef="usd">2349000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzMtNy0xLTEtMTk2MzU_60c5e3dc-f501-4d0a-bfa1-bd552d11c374"
      unitRef="usd">70000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzMtOS0xLTEtMTk2MzU_34425626-3500-4630-a631-4b1d4b6a73bb"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzMtMTEtMS0xLTE5NjM1_11e701d1-37da-4abb-9376-d4fbf32521a1"
      unitRef="usd">2416000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzQtNS0xLTEtMTk2MzU_82b8addd-059a-416f-bbe3-309eafed1c9a"
      unitRef="usd">2947000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzQtNy0xLTEtMTk2MzU_da8f5f54-7d88-40b8-83f5-4f3f90a415a7"
      unitRef="usd">148000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzQtOS0xLTEtMTk2MzU_c6e018a3-f64f-4f0d-a455-ab2e57228a7a"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzQtMTEtMS0xLTE5NjM1_646b1d2f-3e80-4379-990b-9da972797e7a"
      unitRef="usd">3091000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzUtNS0xLTEtMTk2MzU_3cb344e9-e395-41d3-99dc-7479468d2798"
      unitRef="usd">9093000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzUtNy0xLTEtMTk2MzU_6e5f82c4-1997-43c7-9802-78a469860021"
      unitRef="usd">682000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzUtOS0xLTEtMTk2MzU_beb35a03-8caf-423e-81ac-c95d6380846c"
      unitRef="usd">40000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzUtMTEtMS0xLTE5NjM1_42a4ceb8-7e4e-430d-922f-b99a9ebb66ae"
      unitRef="usd">9735000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i73c392053811482a985a060e47a06d01_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzYtNS0xLTEtMTk2MzU_740cce5f-1d5b-4161-9e16-3d9925027548"
      unitRef="usd">2821000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i73c392053811482a985a060e47a06d01_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzYtNy0xLTEtMTk2MzU_d5d80475-34e7-4e56-9690-4e6e84213201"
      unitRef="usd">196000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i73c392053811482a985a060e47a06d01_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzYtOS0xLTEtMTk2MzU_8fb29c3a-8733-45a6-8c02-4c5558bdb047"
      unitRef="usd">24000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i73c392053811482a985a060e47a06d01_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzYtMTEtMS0xLTE5NjM1_e31e4db8-e820-4372-a9ee-53d5985c5d80"
      unitRef="usd">2993000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzctNS0xLTEtMTk2MzU_97a21407-b09c-4213-b5b5-b9f585d75138"
      unitRef="usd">870000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzctNy0xLTEtMTk2MzU_9652d178-67e4-4d1d-bb16-7622c54e3982"
      unitRef="usd">15000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzctOS0xLTEtMTk2MzU_615e316d-1233-4a97-82cf-7530c720ab51"
      unitRef="usd">10000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzctMTEtMS0xLTE5NjM1_8bca9613-d0b6-4f07-9f1f-ff3c6c157949"
      unitRef="usd">875000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzgtNS0xLTEtMTk2MzU_8fd009b3-edbd-44b5-b488-5e165351d785"
      unitRef="usd">1278000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzgtNy0xLTEtMTk2MzU_24e46491-90c3-4305-bd64-1d9df1ce16ae"
      unitRef="usd">44000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzgtOS0xLTEtMTk2MzU_a7b44de5-3cd4-461a-8d17-e24d3adb24e1"
      unitRef="usd">12000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzgtMTEtMS0xLTE5NjM1_44cd7055-e434-422d-a86c-7d567e0490c2"
      unitRef="usd">1310000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i914670b585864902b9f69fc74ba23aec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzktNS0xLTEtMTk2MzU_6551a2cb-9896-468f-90fb-212a1598ef2b"
      unitRef="usd">2791000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i914670b585864902b9f69fc74ba23aec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzktNy0xLTEtMTk2MzU_e4b6ae8d-b793-4892-b726-3475585aea97"
      unitRef="usd">14000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i914670b585864902b9f69fc74ba23aec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzktOS0xLTEtMTk2MzU_7975359a-64d9-40f9-b1a3-6432d9ab5ef6"
      unitRef="usd">13000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i914670b585864902b9f69fc74ba23aec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzktMTEtMS0xLTE5NjM1_1a95d8a4-eaed-4e99-b898-df530894eb7b"
      unitRef="usd">2792000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ia121561a4c96461ebf10b737edd09fd8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzEwLTUtMS0xLTE5NjM1_324d57b9-f790-48b9-883b-b880bb66f6e9"
      unitRef="usd">25000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia121561a4c96461ebf10b737edd09fd8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzEwLTctMS0xLTE5NjM1_9f581f9d-9796-4725-ae98-136a20b782f9"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia121561a4c96461ebf10b737edd09fd8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzEwLTktMS0xLTE5NjM1_9325bb11-f068-4a48-b12a-99ae762c5bd0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia121561a4c96461ebf10b737edd09fd8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzEwLTExLTEtMS0xOTYzNQ_1773e46a-0051-4463-b07b-3d97bc41f3e8"
      unitRef="usd">28000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzExLTUtMS0xLTE5NjM1_18abacbb-5cd6-43eb-a0df-fbcf102102cc"
      unitRef="usd">22174000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzExLTctMS0xLTE5NjM1_4b608a7c-7546-47ca-b3a0-4c8daa3b5704"
      unitRef="usd">1172000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzExLTktMS0xLTE5NjM1_5a3b3bee-67f0-42e9-9272-f6400994da70"
      unitRef="usd">106000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzExLTExLTEtMS0xOTYzNQ_d57bcb83-bac6-4e9c-9054-51608d5d7935"
      unitRef="usd">23240000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE1LTUtMS0xLTE5NjM1_a3c6445f-88bd-4780-b16b-324193c5b8e5"
      unitRef="usd">2341000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE1LTctMS0xLTE5NjM1_3d9fc609-1946-4e46-9811-e0061f88939a"
      unitRef="usd">128000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE1LTktMS0xLTE5NjM1_238e7520-6419-49ff-bcf0-d65d03fe4f93"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE1LTExLTEtMS0xOTYzNQ_8be5ba68-bd6c-4995-a895-08719713fa3f"
      unitRef="usd">2469000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE2LTUtMS0xLTE5NjM1_f37c2fa1-5154-4f16-b989-20312e48609f"
      unitRef="usd">2556000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE2LTctMS0xLTE5NjM1_4625e90c-5ccb-4e19-95ce-86d5f314921c"
      unitRef="usd">172000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE2LTktMS0xLTE5NjM1_89ae21ee-074f-4376-9264-1017f0f5aceb"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE2LTExLTEtMS0xOTYzNQ_fc4ecbf5-1541-4c40-9746-c22a6545f8e4"
      unitRef="usd">2728000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE3LTUtMS0xLTE5NjM1_bfe03327-8545-4567-9b6a-df0d3f90bfb7"
      unitRef="usd">7879000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE3LTctMS0xLTE5NjM1_c3ddc394-72d2-4240-a176-b6f614494bfd"
      unitRef="usd">1023000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE3LTktMS0xLTE5NjM1_6c69c120-1829-4b8e-8828-20ecfdaf4919"
      unitRef="usd">8000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE3LTExLTEtMS0xOTYzNQ_e91d47a7-deb9-4630-b2e1-f494f9341b17"
      unitRef="usd">8894000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE4LTUtMS0xLTE5NjM1_4e93e990-363e-4985-b10d-7804a0c0c1f1"
      unitRef="usd">2595000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE4LTctMS0xLTE5NjM1_29257d45-e6ba-4cec-8805-6c1a642df0c8"
      unitRef="usd">324000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE4LTktMS0xLTE5NjM1_fe942981-d255-4437-85bc-25d47de4290b"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE4LTExLTEtMS0xOTYzNQ_dc84fa1f-8b55-4dbd-acc2-056af490280c"
      unitRef="usd">2918000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE5LTUtMS0xLTE5NjM1_92434672-d338-44f6-baf9-8979565b0d00"
      unitRef="usd">673000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE5LTctMS0xLTE5NjM1_871d552a-068c-4679-87d5-af068be425ef"
      unitRef="usd">32000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE5LTktMS0xLTE5NjM1_966b1c6f-a5eb-4977-a104-1e739a1c8245"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzE5LTExLTEtMS0xOTYzNQ_26c8c714-2726-436e-9c00-e330c3f3e1ab"
      unitRef="usd">705000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIwLTUtMS0xLTE5NjM1_1d9fc348-6281-4ce4-a923-aafb1c2b3bb7"
      unitRef="usd">962000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIwLTctMS0xLTE5NjM1_9fea54c7-7894-42ac-b0b1-99de8849bf28"
      unitRef="usd">84000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIwLTktMS0xLTE5NjM1_8b6e18e1-d92a-4f0c-8bce-c55b636c3f5d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIwLTExLTEtMS0xOTYzNQ_796f8998-7f50-4ee2-a478-62643252ce01"
      unitRef="usd">1046000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIxLTUtMS0xLTE5NjM1_6183bff6-c7f8-43f4-b7ea-639728d4c969"
      unitRef="usd">2369000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIxLTctMS0xLTE5NjM1_7e61bfe8-05da-4c94-9855-fb308f200d4e"
      unitRef="usd">36000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIxLTktMS0xLTE5NjM1_2e572e0f-ee45-47a6-acd6-cc2b484983c0"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIxLTExLTEtMS0xOTYzNQ_74a5be17-5443-446f-9285-d19c44576f29"
      unitRef="usd">2403000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i77885636f2644bf19423ab2c4b27960a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIyLTUtMS0xLTE5NjM1_45d10d64-84d2-4db0-a38a-21b256f16792"
      unitRef="usd">21000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i77885636f2644bf19423ab2c4b27960a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIyLTctMS0xLTE5NjM1_53825b3c-ddc6-456d-ad11-6098d2a289db"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i77885636f2644bf19423ab2c4b27960a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIyLTktMS0xLTE5NjM1_21fe3187-5129-469c-b624-d81804aeb5bc"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i77885636f2644bf19423ab2c4b27960a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIyLTExLTEtMS0xOTYzNQ_413ae11a-ba2f-41c1-aeb1-7e97689b5ade"
      unitRef="usd">25000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIzLTUtMS0xLTE5NjM1_fe4c37f3-2749-4189-bab2-f32dcb425658"
      unitRef="usd">19396000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIzLTctMS0xLTE5NjM1_503a00ab-61c8-4bac-b46d-20bf56f2c9b7"
      unitRef="usd">1803000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIzLTktMS0xLTE5NjM1_0c2291e2-60ab-4db4-afd7-23ab371ae636"
      unitRef="usd">11000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTowNjM4ODQyZTdiY2Q0ZGZiYmE3NTA1OGI0NTJhYTM4My90YWJsZXJhbmdlOjA2Mzg4NDJlN2JjZDRkZmJiYTc1MDU4YjQ1MmFhMzgzXzIzLTExLTEtMS0xOTYzNQ_d1354d3f-d889-4b83-ae0b-a62cecf80345"
      unitRef="usd">21188000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzM4NDgyOTA3MDY5NTM_0e764b78-4fa5-481c-8480-0a5db3d2caac"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzM4NDgyOTA3MDY5NTM_878a8a9f-8072-4467-8825-231fc3a18d87"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzE3MzI_4c7fda01-3d6b-4ad9-8b65-a997202b47bb"
      unitRef="usd">864000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzE3NzA_f18a9437-57c0-4513-ad88-4843518e2ed3"
      unitRef="usd">94000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzE3Nzc_ed565204-493c-4035-9d81-7269d624d2a4"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4a167c8b5fbe46be92df6070dc1ae32b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzE4NjA_369fd297-6001-46ce-bcc0-ea45b89a4f70"
      unitRef="usd">919000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4a167c8b5fbe46be92df6070dc1ae32b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzE4OTg_15ff4fd9-ef0f-45ae-b1f5-0247deb4a2e0"
      unitRef="usd">135000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4a167c8b5fbe46be92df6070dc1ae32b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzE5MDU_13194ecb-271e-4b2b-8202-948bc44ec435"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzczNzU_064af826-27a8-4bf0-8556-483e5296a6e2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortized cost and fair value of debt securities at December&#160;31, 2021 are shown below by contractual maturity.&#160;&#160;Actual maturities may differ from contractual maturities because securities may be restructured, called or prepaid, or the Company intends to sell a security prior to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzItMS0xLTEtMTk2MzU_572a8185-f63b-449a-8706-5a7ecdae15f5"
      unitRef="usd">1205000000</cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzItMy0xLTEtMTk2MzU_d757b36c-b658-49b2-a696-f0c5ab9dd517"
      unitRef="usd">1218000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzMtMS0xLTEtMTk2MzU_d54ff84e-493b-4908-8818-64674e34077a"
      unitRef="usd">6965000000</cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzMtMy0xLTEtMTk2MzU_f310d1bb-56f7-40e7-8bc6-d0dbd9ee2478"
      unitRef="usd">7142000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzQtMS0xLTEtMTk2MzU_cda72a1d-a821-4a67-b579-adb65e1e3b3f"
      unitRef="usd">4733000000</cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzQtMy0xLTEtMTk2MzU_ac9aa7f5-1dc5-4846-bc35-7378df2223a7"
      unitRef="usd">4910000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <cvs:DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzUtMS0xLTEtMTk2MzU_101e60aa-d565-4952-aaee-d0a6420f0900"
      unitRef="usd">4332000000</cvs:DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzUtMy0xLTEtMTk2MzU_ac03ca26-7bd9-4b2e-ae06-69cbc9dd4b69"
      unitRef="usd">4993000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet
      contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzYtMS0xLTEtMTk2MzU_b0f5a7ae-d194-4188-811f-760225a79fe1"
      unitRef="usd">870000000</cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzYtMy0xLTEtMTk2MzU_205eeff8-290a-4291-966b-959275a1a11a"
      unitRef="usd">875000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet
      contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzctMS0xLTEtMTk2MzU_b8ea90af-03f8-4f38-a5fe-ccd114542326"
      unitRef="usd">1278000000</cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzctMy0xLTEtMTk2MzU_6a6ed9e5-b530-4963-903b-418722fa0460"
      unitRef="usd">1310000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet
      contextRef="i914670b585864902b9f69fc74ba23aec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzgtMS0xLTEtMTk2MzU_9b3b21d5-90f1-4f84-b933-9d51308dc4b6"
      unitRef="usd">2791000000</cvs:DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i914670b585864902b9f69fc74ba23aec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzgtMy0xLTEtMTk2MzU_77920ef6-f7e3-4fc3-807e-2da72db1a89b"
      unitRef="usd">2792000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzktMS0xLTEtMTk2MzU_5ba374dc-6507-4386-9e22-a892017eaad8"
      unitRef="usd">22174000000</cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo5MTdlNzM2ZTcwYzU0ZTk0YTE3MjM1ZmQzNWJlY2QyMC90YWJsZXJhbmdlOjkxN2U3MzZlNzBjNTRlOTRhMTcyMzVmZDM1YmVjZDIwXzktMy0xLTEtMTk2MzU_014da023-74d1-482b-8e03-2565f383b672"
      unitRef="usd">23240000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities
      contextRef="i353376cd927a4bd89775bb7b09c7be82_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzI5MjM_330afaf3-61be-4c3d-9b78-7f68285c9645">P4Y8M12D</cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities>
    <cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities
      contextRef="i6d5babc8be6a447486746fada4d351b2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzMyNzE_8f6e6341-e8a8-47b1-ad3f-ef2d5bbf4ea0">P6Y1M6D</cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities>
    <cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities
      contextRef="i13b5f509cde24908a226440920b1a447_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzM2OTQ_9cb6e6ca-8f85-4085-ad62-56e046548203">P1Y</cvs:DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities>
    <us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzczODg_615f5c6f-a40f-4bb5-a0a9-9b3f54ffdbff">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the debt securities the Company held at December&#160;31, 2021 and 2020 that were in an unrealized capital loss position, aggregated by the length of time the investments have been in that position:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Greater than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except number of securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;&#160;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;&#160;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&lt;br/&gt;of&lt;br/&gt;&#160;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity dates for debt securities in an unrealized capital loss position at December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting experience-&lt;br/&gt;rated products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Supporting remaining&lt;br/&gt;products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due to mature:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtMS0xLTEtMTk2MzU_909747fb-c166-4593-bbf6-58a93deb0806"
      unitRef="security">43</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtMy0xLTEtMTk2MzU_5aac47a8-9450-42bc-a840-fb05c25ab014"
      unitRef="usd">242000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtNS0xLTEtMTk2MzU_c047f086-d5c5-4781-929d-f418414a59d5"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtNy0xLTEtMTk2MzU_01338be3-a43a-436a-8735-a9c84b2a8ec1"
      unitRef="security">10</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtOS0xLTEtMTk2MzU_0c8c434f-f072-4ec0-9a77-b3ff6ceb52c1"
      unitRef="usd">40000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtMTEtMS0xLTE5NjM1_d3536376-5836-41c5-8c97-b8fbf01745b5"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtMTMtMS0xLTE5NjM1_4dd27c03-19f4-43f2-b728-457e3c24052f"
      unitRef="security">53</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtMTUtMS0xLTE5NjM1_27a912c0-6d47-442d-83b1-8c5de96bef25"
      unitRef="usd">282000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="id321828fa20f46e2b90c44c7dba1e761_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzQtMTctMS0xLTE5NjM1_ae012a04-2666-4e93-8cea-28fa39c6a6f7"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtMS0xLTEtMTk2MzU_97de3a8f-4d32-4ff6-ab36-d0cdd30166c4"
      unitRef="security">233</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtMy0xLTEtMTk2MzU_a1a1d9ec-4507-4b34-a68e-f2674a6f2667"
      unitRef="usd">428000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtNS0xLTEtMTk2MzU_a4e9d598-83eb-4aec-b75d-ec866dc77c67"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtNy0xLTEtMTk2MzU_87aad035-1805-4505-8e66-5bce47e032ba"
      unitRef="security">13</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtOS0xLTEtMTk2MzU_00ce669b-595e-4d20-813e-c27625f40bfc"
      unitRef="usd">33000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtMTEtMS0xLTE5NjM1_919117f4-9b5d-4de1-898b-1768cb580be3"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtMTMtMS0xLTE5NjM1_b40d6dd4-c1f4-4096-b5c8-db80cba98d31"
      unitRef="security">246</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtMTUtMS0xLTE5NjM1_db14c7d0-67ab-434c-82a7-49ede4e6fb27"
      unitRef="usd">461000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ibee6f0b8ca6a48f28900b5036af4c5da_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzUtMTctMS0xLTE5NjM1_8dee5533-5075-4723-baa6-c61fca34ba4b"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtMS0xLTEtMTk2MzU_d0bcf906-8d8c-4b05-9dbd-84fc8f6cac57"
      unitRef="security">1610</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtMy0xLTEtMTk2MzU_7c961f12-1646-4c22-a8c5-5dc63dfc22a2"
      unitRef="usd">2296000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtNS0xLTEtMTk2MzU_0c7235ac-2929-44c1-83cf-fccf0382e65f"
      unitRef="usd">31000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtNy0xLTEtMTk2MzU_9aa9134b-0a67-460e-8209-78f293527ccf"
      unitRef="security">165</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtOS0xLTEtMTk2MzU_c76f6b76-7156-453c-bce8-60aa186154e1"
      unitRef="usd">238000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtMTEtMS0xLTE5NjM1_4e83a0e9-cecb-4c4d-8556-d33d92eeaa8f"
      unitRef="usd">9000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtMTMtMS0xLTE5NjM1_d077acb4-ad94-4dbc-9e5a-8f669dfd52b8"
      unitRef="security">1775</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtMTUtMS0xLTE5NjM1_73e0676b-4c41-4b78-9e26-2517787d5647"
      unitRef="usd">2534000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ic84b4f2bceac40b7ba79ff355caa4e3c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzYtMTctMS0xLTE5NjM1_b5dd81bd-0bd9-4cc4-9352-c19aea17c1ae"
      unitRef="usd">40000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i73c392053811482a985a060e47a06d01_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctMS0xLTEtMTk2MzU_72867dfb-4cc7-4a12-8abd-36d9bf44d275"
      unitRef="security">449</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i73c392053811482a985a060e47a06d01_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctMy0xLTEtMTk2MzU_a45f42f0-fb86-4fdd-9dc0-6133bb90f2d0"
      unitRef="usd">747000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i73c392053811482a985a060e47a06d01_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctNS0xLTEtMTk2MzU_7d9950d8-ea55-4299-b582-a1601d79e31d"
      unitRef="usd">20000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i73c392053811482a985a060e47a06d01_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctNy0xLTEtMTk2MzU_bfe182a2-1b61-4182-b095-70445d1256d8"
      unitRef="security">57</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i73c392053811482a985a060e47a06d01_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctOS0xLTEtMTk2MzU_a56259e1-e3b4-4052-85b7-6617047ced44"
      unitRef="usd">91000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i73c392053811482a985a060e47a06d01_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctMTEtMS0xLTE5NjM1_3e09e342-54fa-47ac-a29d-835d971dca36"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i73c392053811482a985a060e47a06d01_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctMTMtMS0xLTE5NjM1_640e62fc-d879-4af8-91ff-82c20b5041c2"
      unitRef="security">506</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i73c392053811482a985a060e47a06d01_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctMTUtMS0xLTE5NjM1_534e49cc-e883-456c-b5f0-24aa84a03896"
      unitRef="usd">838000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i73c392053811482a985a060e47a06d01_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzctMTctMS0xLTE5NjM1_ca370e16-ae80-4271-85f9-53495d8c0d11"
      unitRef="usd">24000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtMS0xLTEtMTk2MzU_4be77c42-c79c-4aaf-9838-44045f12e60e"
      unitRef="security">165</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtMy0xLTEtMTk2MzU_c263f3c5-314c-4229-b005-f5b8176e727c"
      unitRef="usd">593000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtNS0xLTEtMTk2MzU_14ed8039-1747-4e78-8d49-c84adeb707a7"
      unitRef="usd">9000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtNy0xLTEtMTk2MzU_9e910cea-99d2-4463-9736-500fc799dcd8"
      unitRef="security">10</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtOS0xLTEtMTk2MzU_dfb8cdde-bd38-4231-8361-a8b5655fb858"
      unitRef="usd">36000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtMTEtMS0xLTE5NjM1_38680f4d-865e-4217-b74d-898f6ee3b385"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtMTMtMS0xLTE5NjM1_10697314-f298-477b-a04f-1d3cb3a7eae1"
      unitRef="security">175</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtMTUtMS0xLTE5NjM1_11d8a23c-57be-4c8b-ade1-0257648e88e9"
      unitRef="usd">629000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzgtMTctMS0xLTE5NjM1_685ac922-f082-47d2-866d-6fb9cd9caaa3"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktMS0xLTEtMTk2MzU_e62dcee0-cbbb-494e-946a-0937f8d6b75b"
      unitRef="security">188</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktMy0xLTEtMTk2MzU_b0f3ee66-f5f4-4594-9dac-e5b5fa92a220"
      unitRef="usd">462000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktNS0xLTEtMTk2MzU_dc9e4195-b026-4e86-8a55-d6258e6f9589"
      unitRef="usd">7000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktNy0xLTEtMTk2MzU_aac69b25-2c89-4fdc-97e0-f64724acefe5"
      unitRef="security">35</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktOS0xLTEtMTk2MzU_35306e69-6d69-4daf-8917-5c5c094ce782"
      unitRef="usd">112000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktMTEtMS0xLTE5NjM1_4ddafb69-74bb-450d-963a-95967b7b1ed2"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktMTMtMS0xLTE5NjM1_2c82817b-d590-4a75-aad2-85241741d878"
      unitRef="security">223</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktMTUtMS0xLTE5NjM1_685a2c99-bb6e-4fc9-8092-6c68064b4f5a"
      unitRef="usd">574000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzktMTctMS0xLTE5NjM1_1e33bfc7-60db-4904-b714-4753a6a49a98"
      unitRef="usd">12000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i914670b585864902b9f69fc74ba23aec_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTEtMS0xLTE5NjM1_1987e043-fabb-431a-92f3-f83def640644"
      unitRef="security">1011</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i914670b585864902b9f69fc74ba23aec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTMtMS0xLTE5NjM1_9c9e4d49-0ffc-48e3-bf0d-05cd05318483"
      unitRef="usd">2030000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i914670b585864902b9f69fc74ba23aec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTUtMS0xLTE5NjM1_7bd0deef-7d31-4031-904c-ed9b203406ed"
      unitRef="usd">12000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i914670b585864902b9f69fc74ba23aec_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTctMS0xLTE5NjM1_3b1c2f65-4b6b-47a4-bec9-001af4ac41e4"
      unitRef="security">26</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i914670b585864902b9f69fc74ba23aec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTktMS0xLTE5NjM1_173fb7fd-c2aa-4587-b80d-8a05843c820a"
      unitRef="usd">31000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i914670b585864902b9f69fc74ba23aec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTExLTEtMS0xOTYzNQ_801ca60f-bca3-4e54-9f4e-5701e0aa2349"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i914670b585864902b9f69fc74ba23aec_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTEzLTEtMS0xOTYzNQ_ec10e9db-06ab-487f-801c-58e597b7f7b1"
      unitRef="security">1037</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i914670b585864902b9f69fc74ba23aec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTE1LTEtMS0xOTYzNQ_f882bd5a-b503-4799-a7fc-e4c38c1508a3"
      unitRef="usd">2061000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i914670b585864902b9f69fc74ba23aec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzEwLTE3LTEtMS0xOTYzNQ_bbef891f-1f63-4656-8f80-5504448d87e2"
      unitRef="usd">13000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTEtMS0xLTYzNTEy_00e4f358-f90a-4806-a2fd-3f9cf08430e2"
      unitRef="security">1</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTMtMS0xLTYzNTEy_f123ff6b-062b-4063-9518-875ac351e956"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTUtMS0xLTYzNTEy_9ecbb866-174d-495e-a847-257cd7fdc90e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTctMS0xLTYzNTEy_f39eff5b-2e5b-4aee-a3ae-8e78bf5232f8"
      unitRef="security">1</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTktMS0xLTYzNTEy_0a021167-aae8-49e0-b11d-67cb4f39a6cf"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTExLTEtMS02MzUxMg_81ac6e64-7dae-425f-89f8-5586ef3bd439"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTEzLTEtMS02MzUxMg_a0f04f9e-34e8-493e-9415-81c6a00c720c"
      unitRef="security">2</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTE1LTEtMS02MzUxMg_dcf33b63-8307-4520-a5bf-9b0b02cd628b"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="id9b4c5764cb743b6955c25b489dc04b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTE3LTEtMS02MzUxMg_96e83855-ced9-43bb-8ce3-5138a2f6c3f6"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTEtMS0xLTE5NjM1_eea68539-b5ff-4997-8d78-c9cba1643c71"
      unitRef="security">3700</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTMtMS0xLTE5NjM1_85b25866-8872-4a25-95c1-13e3c9932ed7"
      unitRef="usd">6800000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTUtMS0xLTE5NjM1_dcdb78bd-9fda-47a5-99ec-d789a64c41f0"
      unitRef="usd">84000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTctMS0xLTE5NjM1_65a2421e-a0c5-4b57-a99b-cd4f417a0c16"
      unitRef="security">317</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTktMS0xLTE5NjM1_80da21dd-2635-46d3-91c7-5b76a650b4cb"
      unitRef="usd">584000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTExLTEtMS0xOTYzNQ_527ae343-367e-45c7-b77d-81a3fca3fd72"
      unitRef="usd">22000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTEzLTEtMS0xOTYzNQ_30ef4b48-53fa-4762-90c4-95e5196b2c45"
      unitRef="security">4017</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTE1LTEtMS0xOTYzNQ_20f53a83-e859-4bd9-b406-1b2efe96656c"
      unitRef="usd">7384000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzExLTE3LTEtMS0xOTYzNQ_db7ef677-233a-4ee9-8372-85abfc8af7da"
      unitRef="usd">106000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTEtMS0xLTE5NjM1_5324c51d-04c0-4f7a-b59b-1d7df337769a"
      unitRef="security">32</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTMtMS0xLTE5NjM1_882375f9-7248-4481-bad7-9bb39ccd3fa6"
      unitRef="usd">205000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTUtMS0xLTE5NjM1_a13c8509-7822-408a-9c8e-d737c7302a8e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTctMS0xLTE5NjM1_12fb62a6-9e75-4fbb-b050-305e4c1df52f"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTktMS0xLTE5NjM1_10f2864b-33d1-4df3-95ac-98bc4c3872c5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTExLTEtMS0xOTYzNQ_48f7e33f-deee-4847-9370-8aa0a2226575"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTEzLTEtMS0xOTYzNQ_46fd63aa-40ff-46cc-9186-878e540db68f"
      unitRef="security">32</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTE1LTEtMS0xOTYzNQ_f4602399-19fc-41ec-9b59-60bfcb44745b"
      unitRef="usd">205000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="iea2a9101cbed443999a6811800e4ec0b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE1LTE3LTEtMS0xOTYzNQ_d2d1c5b8-7e75-4043-a92a-839e499c0c0e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTEtMS0xLTE5NjM1_1e04a0ff-5972-4915-b593-d4dc4ec1754f"
      unitRef="security">49</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTMtMS0xLTE5NjM1_4b993329-fe74-4845-97c0-0cfc7cc63b65"
      unitRef="usd">83000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTUtMS0xLTE5NjM1_e6a59517-34f4-498b-bbd1-7262e75a3b2c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTctMS0xLTE5NjM1_7b186206-d33d-4472-9ceb-0cabe612c1f1"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTktMS0xLTE5NjM1_ebffe669-0886-4e02-846e-6d0b0464206c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTExLTEtMS0xOTYzNQ_3985e684-1f30-4dc4-91d2-d67c9d3962c9"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTEzLTEtMS0xOTYzNQ_b1e62d6d-66c2-477b-a75e-fb251d14b49b"
      unitRef="security">49</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTE1LTEtMS0xOTYzNQ_c64030e9-6d73-455c-935f-f346605553a8"
      unitRef="usd">83000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ic4ba03b036ca4e15a75d3097ecd4dff7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE2LTE3LTEtMS0xOTYzNQ_4267382f-8bd6-42b5-af0c-0c93c6dcdfa8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTEtMS0xLTE5NjM1_f5bb909a-7bd7-45e3-8bfa-8119d6731b6a"
      unitRef="security">145</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTMtMS0xLTE5NjM1_8f942d19-1b93-439d-8a9c-76e3f4b91e6f"
      unitRef="usd">155000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTUtMS0xLTE5NjM1_edeb8e47-d410-4095-8b1f-1fccb2a8b14e"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTctMS0xLTE5NjM1_76d22ee8-68a8-49c5-bdd9-ece303ca50ad"
      unitRef="security">2</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTktMS0xLTE5NjM1_99ff63c2-2a80-49a6-9527-35d45a0d0f6f"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTExLTEtMS0xOTYzNQ_23055e83-20fc-480f-9305-f5901f5e2e91"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTEzLTEtMS0xOTYzNQ_33e54939-ca6f-4ac4-a4dd-4a931e474975"
      unitRef="security">147</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTE1LTEtMS0xOTYzNQ_860e20f4-451e-4a40-bc88-bac407c7f7c6"
      unitRef="usd">155000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i747eaf1c298249988bd0ca02e9600501_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE3LTE3LTEtMS0xOTYzNQ_80c21284-51f5-4610-a3ed-e0fa3e1ad6f0"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTEtMS0xLTE5NjM1_cbd00b73-b7a3-43ec-858d-91b4828eeff2"
      unitRef="security">41</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTMtMS0xLTE5NjM1_4e98c8ef-4a25-45e9-bca8-9ee2867703b3"
      unitRef="usd">69000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTUtMS0xLTE5NjM1_62cb4bee-6b1d-42c9-bd80-dd381d4b718b"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTctMS0xLTE5NjM1_b9c5637d-4c36-4705-ac05-e98af2d550dd"
      unitRef="security">5</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTktMS0xLTE5NjM1_327519a9-2ef5-49d9-a119-4141e5288b5f"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTExLTEtMS0xOTYzNQ_50adc07a-e33b-4f4b-a598-7a68c32de5d0"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTEzLTEtMS0xOTYzNQ_739685a1-9d1d-4841-86cd-e0a5a247a142"
      unitRef="security">46</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTE1LTEtMS0xOTYzNQ_c39c5aaa-e0ad-4806-82e4-6289b70c22a1"
      unitRef="usd">74000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ice38ed4258344c1a88da2935b0835f1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE4LTE3LTEtMS0xOTYzNQ_df506dd4-0c4d-41de-83e0-d970204bad7e"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTEtMS0xLTE5NjM1_f102ae38-01a1-4c92-b2f2-08bcd5aaccef"
      unitRef="security">23</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTMtMS0xLTE5NjM1_e3945631-8318-4101-ae0a-099da3829560"
      unitRef="usd">26000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTUtMS0xLTE5NjM1_5715feeb-27c6-4326-bf83-1d816d59895e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTctMS0xLTE5NjM1_b7645a3b-bad4-434a-8275-39d109f8106b"
      unitRef="security">3</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTktMS0xLTE5NjM1_691e18e4-4bbc-4309-9fe5-b3dfe1631571"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTExLTEtMS0xOTYzNQ_13660649-bc1a-4ae5-bf7f-4e7bfe266cb1"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTEzLTEtMS0xOTYzNQ_2e41295f-e5db-4328-b880-478073bba5d7"
      unitRef="security">26</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTE1LTEtMS0xOTYzNQ_16170205-25d4-49b1-8a9d-6eb5b9d8fdd7"
      unitRef="usd">26000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i51538ba2863d4a39bc671cc6ee1872c4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzE5LTE3LTEtMS0xOTYzNQ_d4ae9363-e213-4aa3-b63b-414170351855"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTEtMS0xLTE5NjM1_c3153f9a-f52f-454c-9e0b-e268d8bc5710"
      unitRef="security">22</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTMtMS0xLTE5NjM1_93ced934-8add-4888-83d9-0abe1838b45f"
      unitRef="usd">75000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTUtMS0xLTE5NjM1_317a46c2-bf84-4379-bb7f-869f5da8a27b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTctMS0xLTE5NjM1_42a31a8e-d61e-4619-aab5-02d4391961d6"
      unitRef="security">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTktMS0xLTE5NjM1_1e471acb-8f09-4b4b-8648-0db3368da4fb"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTExLTEtMS0xOTYzNQ_1911db05-a343-4010-9683-46bd7bd60d77"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTEzLTEtMS0xOTYzNQ_e6febbd1-cb20-4060-9063-c69a5e834a71"
      unitRef="security">22</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTE1LTEtMS0xOTYzNQ_94e82adc-f35e-4e1b-8d12-92570f73c6d4"
      unitRef="usd">75000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i46e1d222a5ef406c92305c7baf40a7d4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIwLTE3LTEtMS0xOTYzNQ_844b7de1-7354-4061-97c3-dcb34cdac8bc"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTEtMS0xLTE5NjM1_b0ee50e9-8c18-4863-a5bd-cb29d404d5a5"
      unitRef="security">156</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTMtMS0xLTE5NjM1_87e7b1ff-7a0e-49c8-b125-4799b8ed8562"
      unitRef="usd">256000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTUtMS0xLTE5NjM1_b5ebd76f-1163-4da2-a6dd-d566635fbc54"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTctMS0xLTE5NjM1_7805375e-9e51-4ffb-a300-9db5eb2c47f6"
      unitRef="security">49</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTktMS0xLTE5NjM1_e8847200-a9f0-4769-9951-cc4eb1b63e22"
      unitRef="usd">41000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTExLTEtMS0xOTYzNQ_160a23a2-b516-4e79-b6eb-1bbbb60d7656"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTEzLTEtMS0xOTYzNQ_cae74488-3076-4189-b0e2-aa44715a2cad"
      unitRef="security">205</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTE1LTEtMS0xOTYzNQ_1cbeddcf-018b-412b-9dba-447e0e9cd00e"
      unitRef="usd">297000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i3554a3796746414fb74d5c4eff0aa6b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIxLTE3LTEtMS0xOTYzNQ_341f602a-5f1c-4a87-8b97-c1e3f7c2e254"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTEtMS0xLTE5NjM1_ed75f261-782e-4351-aeeb-9b0b9aaee98f"
      unitRef="security">468</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTMtMS0xLTE5NjM1_17ba183a-4bd4-4f03-9262-a13eb0c13687"
      unitRef="usd">869000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTUtMS0xLTE5NjM1_4b1668e5-cc87-4bbd-a602-360977fa2536"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTctMS0xLTE5NjM1_b6592e90-1a76-4fb2-9591-98cea5f920fd"
      unitRef="security">59</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTktMS0xLTE5NjM1_f0715e06-2ce8-48c4-9d94-21be63be6360"
      unitRef="usd">46000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTExLTEtMS0xOTYzNQ_aa33ce36-c64f-4fdc-b415-32a54f435a78"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTEzLTEtMS0xOTYzNQ_cd7e15b2-a4e9-4222-ad6a-12dca9ce2c80"
      unitRef="security">527</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTE1LTEtMS0xOTYzNQ_75934444-3618-4b24-908c-d3274d6dacd7"
      unitRef="usd">915000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpiMGZhMWE1YTZjOTI0OTYwYThjZTg2OTVmNmUzYjRjNC90YWJsZXJhbmdlOmIwZmExYTVhNmM5MjQ5NjBhOGNlODY5NWY2ZTNiNGM0XzIzLTE3LTEtMS0xOTYzNQ_1a901b12-44eb-4d30-bd93-39dac870b052"
      unitRef="usd">11000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzMtMS0xLTEtMTk2MzU_ad765219-a5b0-4bec-8709-4076f59088e0"
      unitRef="usd">2000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzMtMy0xLTEtMTk2MzU_104dc908-e0eb-4b64-87ae-fbc464dd1221"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzMtNS0xLTEtMTk2MzU_f654a26c-76b7-4b27-b335-02d279430a9b"
      unitRef="usd">49000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzMtNy0xLTEtMTk2MzU_47e5bcc0-5900-4fde-8430-a78b459674fe"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzMtOS0xLTEtMTk2MzU_e3aa7230-b264-44ff-98b3-ae6426a64dbd"
      unitRef="usd">51000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzMtMTEtMS0xLTE5NjM1_b45bc3d4-6e6f-4c3e-a4a5-179f7a2a278b"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzQtMS0xLTEtMTk2MzU_7d4ad260-e7a2-4acb-94d9-c85256daee5c"
      unitRef="usd">13000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzQtMy0xLTEtMTk2MzU_fdfd1054-da65-468a-9c02-d85f2a723199"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzQtNS0xLTEtMTk2MzU_5c6b57dd-19cd-4733-bd8d-0ad84edc0331"
      unitRef="usd">2229000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzQtNy0xLTEtMTk2MzU_e8811b2f-0c8c-41a1-9fad-a5691c75b077"
      unitRef="usd">32000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzQtOS0xLTEtMTk2MzU_54504037-89d4-459b-8196-c5f51d0a175c"
      unitRef="usd">2242000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzQtMTEtMS0xLTE5NjM1_08a52a3e-d6b0-4241-8f6d-3fe1a41df47e"
      unitRef="usd">33000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzUtMS0xLTEtMTk2MzU_5a5083b2-d20b-49e7-9c98-7d0827f9c7a7"
      unitRef="usd">33000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzUtMy0xLTEtMTk2MzU_4e70df7f-22c7-4142-8ca4-b5c6e284160e"
      unitRef="usd">1000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzUtNS0xLTEtMTk2MzU_021738df-7f7c-4ff6-93d0-d4936959446f"
      unitRef="usd">1332000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzUtNy0xLTEtMTk2MzU_7b1c024b-49eb-4ff1-a628-fdd24c46b95d"
      unitRef="usd">26000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzUtOS0xLTEtMTk2MzU_f6ce1cbc-2170-4fd9-8361-4dc101aa4c7d"
      unitRef="usd">1365000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzUtMTEtMS0xLTE5NjM1_a4eee589-1c20-4b0c-b47a-98c9ca6fb74c"
      unitRef="usd">27000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzYtMS0xLTEtMTk2MzU_c4266e55-89a2-455a-b4e1-599b5cfe23ed"
      unitRef="usd">17000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzYtMy0xLTEtMTk2MzU_816ffb61-5254-4aa0-9bb9-e2e6b7a910ab"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzYtNS0xLTEtMTk2MzU_feaa73df-8344-448f-b1d4-9aba0cc32f64"
      unitRef="usd">445000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzYtNy0xLTEtMTk2MzU_493e0b84-37d9-4aad-82b5-b213ecf4b1ad"
      unitRef="usd">10000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzYtOS0xLTEtMTk2MzU_2f9f6a6f-1c97-41ca-b0b5-d3f685cf1a30"
      unitRef="usd">462000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears>
    <cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzYtMTEtMS0xLTE5NjM1_eb7747ac-9b2d-4a3a-86fa-910d65dbdffb"
      unitRef="usd">10000000</cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="ib7cf85e44bf749c6855a45cc29a5d06c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzctMS0xLTEtMTk2MzU_27e57e0f-19ba-4021-b15d-d63e3fd56852"
      unitRef="usd">4000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="ib7cf85e44bf749c6855a45cc29a5d06c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzctMy0xLTEtMTk2MzU_8757c92f-1af4-470f-920f-791bf8b7c12d"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="ib4529e06963a470caeb617df5697e606_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzctNS0xLTEtMTk2MzU_a1a09706-2d5f-4cd1-bc49-ef00ca56a0d4"
      unitRef="usd">625000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="ib4529e06963a470caeb617df5697e606_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzctNy0xLTEtMTk2MzU_1748da3d-29a5-4240-a11b-5fc71ad2e524"
      unitRef="usd">10000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzctOS0xLTEtMTk2MzU_d60c14d0-bd14-456d-8b48-bac7d08418da"
      unitRef="usd">629000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="iaf0593d9cf6f4d2d998803704f53be46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzctMTEtMS0xLTE5NjM1_3199f0f1-c64f-469b-b836-7805be242d44"
      unitRef="usd">10000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i33ae4ceb49244377b0e406cc7280c9f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzgtMS0xLTEtMTk2MzU_218eb37d-ee40-4b78-946a-c93da820d142"
      unitRef="usd">6000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i33ae4ceb49244377b0e406cc7280c9f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzgtMy0xLTEtMTk2MzU_79324475-c34b-4e33-b3a9-b26de9b14138"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="ib6aa7bf1b9da4fc39d8638e04992a04e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzgtNS0xLTEtMTk2MzU_4e71e6b8-e97c-412c-be11-0100f36a4b89"
      unitRef="usd">568000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="ib6aa7bf1b9da4fc39d8638e04992a04e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzgtNy0xLTEtMTk2MzU_b26cc690-4245-44f3-ba17-a9d2a5c157e0"
      unitRef="usd">12000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzgtOS0xLTEtMTk2MzU_aea531fd-3a21-4c44-be03-1e194e4b10a2"
      unitRef="usd">574000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="ib6d4dcde819446d8a73300389b73166e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzgtMTEtMS0xLTE5NjM1_fb04bbd3-36ee-4fae-b64f-33000253eae6"
      unitRef="usd">12000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i5690dfe9c84946ccbe72c9f299796db2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzktMS0xLTEtMTk2MzU_df411115-91b3-4a57-ae2c-12c62f0b48ec"
      unitRef="usd">4000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i5690dfe9c84946ccbe72c9f299796db2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzktMy0xLTEtMTk2MzU_b8da32f2-c921-4bd6-a77b-8b1a03012f6b"
      unitRef="usd">0</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i094255554a304e7eb4a00d380e2496bd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzktNS0xLTEtMTk2MzU_6b8f5c4e-08f7-41c9-ae49-56586529be24"
      unitRef="usd">2057000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i094255554a304e7eb4a00d380e2496bd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzktNy0xLTEtMTk2MzU_d6b66de2-f778-4692-b067-0515a4cc9ccc"
      unitRef="usd">13000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue
      contextRef="i914670b585864902b9f69fc74ba23aec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzktOS0xLTEtMTk2MzU_18a92837-c4a5-4dce-ab53-a072a65b99cc"
      unitRef="usd">2061000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue>
    <cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost
      contextRef="i914670b585864902b9f69fc74ba23aec_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzktMTEtMS0xLTE5NjM1_ef28a158-392b-4f26-814e-3370b1249d20"
      unitRef="usd">13000000</cvs:DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzEwLTEtMS0xLTE5NjM1_5f21ae59-1ed7-4b73-961d-05d5e56a2fae"
      unitRef="usd">79000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i4de919088b4a4df583b8260319c32ee6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzEwLTMtMS0xLTE5NjM1_3a1f961c-afec-4900-b7ea-985201953dac"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzEwLTUtMS0xLTE5NjM1_1f34b9ef-d1be-4480-bdc5-69e89d3ce35d"
      unitRef="usd">7305000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i1ba594078fe94f1fb02a07e79c808914_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzEwLTctMS0xLTE5NjM1_d5b30692-b8b2-4622-b4d8-d9f3629b0c22"
      unitRef="usd">104000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzEwLTktMS0xLTE5NjM1_f7a52476-49af-440f-a5c0-fbbbf7662222"
      unitRef="usd">7384000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToxZTE1YmY5MTlmZjc0Y2JhYjQyZWM5Y2YwMjE4ZjBjMy90YWJsZXJhbmdlOjFlMTViZjkxOWZmNzRjYmFiNDJlYzljZjAyMThmMGMzXzEwLTExLTEtMS0xOTYzNQ_219a5b6a-b00f-4434-8b4d-403efcf01af1"
      unitRef="usd">106000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <cvs:ActivityInMortgageLoanPortfolioTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzczOTA_a978b356-5665-4f30-a988-7b4bcea04aa7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s mortgage loans are collateralized by commercial real estate.&#160;During the years ended December 31, 2021 and 2020, the Company had the following activity in its mortgage loan portfolio:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;New mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans fully repaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans foreclosed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021 scheduled mortgage loan principal repayments were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ActivityInMortgageLoanPortfolioTableTextBlock>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="i81f297d193504b64a77dc2ee3da88ccb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyN2M4ZWJlY2VkNGE0NWQ0OTI2YzY4MmI1MGM1MTU5My90YWJsZXJhbmdlOjI3YzhlYmVjZWQ0YTQ1ZDQ5MjZjNjgyYjUwYzUxNTkzXzEtMS0xLTEtMTk2MzU_e40f7733-2b60-4c4d-bb37-4fa457fd7109"
      unitRef="usd">262000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <us-gaap:MortgageLoansOnRealEstateNewMortgageLoans
      contextRef="i62d2db3895b440f7a78f511f11dee508_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyN2M4ZWJlY2VkNGE0NWQ0OTI2YzY4MmI1MGM1MTU5My90YWJsZXJhbmdlOjI3YzhlYmVjZWQ0YTQ1ZDQ5MjZjNjgyYjUwYzUxNTkzXzEtMy0xLTEtMTk2MzU_0446ec3b-9bdf-4c26-871d-033bd17c2dc1"
      unitRef="usd">63000000</us-gaap:MortgageLoansOnRealEstateNewMortgageLoans>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="i81f297d193504b64a77dc2ee3da88ccb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyN2M4ZWJlY2VkNGE0NWQ0OTI2YzY4MmI1MGM1MTU5My90YWJsZXJhbmdlOjI3YzhlYmVjZWQ0YTQ1ZDQ5MjZjNjgyYjUwYzUxNTkzXzItMS0xLTEtMTk2MzU_5c7beebd-193c-4d5a-b684-918bfec6969d"
      unitRef="usd">373000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <cvs:MortgageLoansOnRealEstateLoansFullyRepaid
      contextRef="i62d2db3895b440f7a78f511f11dee508_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyN2M4ZWJlY2VkNGE0NWQ0OTI2YzY4MmI1MGM1MTU5My90YWJsZXJhbmdlOjI3YzhlYmVjZWQ0YTQ1ZDQ5MjZjNjgyYjUwYzUxNTkzXzItMy0xLTEtMTk2MzU_6928f44c-c409-4596-a51d-edae8282f0b8"
      unitRef="usd">187000000</cvs:MortgageLoansOnRealEstateLoansFullyRepaid>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="i81f297d193504b64a77dc2ee3da88ccb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyN2M4ZWJlY2VkNGE0NWQ0OTI2YzY4MmI1MGM1MTU5My90YWJsZXJhbmdlOjI3YzhlYmVjZWQ0YTQ1ZDQ5MjZjNjgyYjUwYzUxNTkzXzMtMS0xLTEtMTk2MzU_7cc7c293-bede-445e-9558-0743e603fc7e"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <us-gaap:MortgageLoansOnRealEstateForeclosures
      contextRef="i62d2db3895b440f7a78f511f11dee508_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyN2M4ZWJlY2VkNGE0NWQ0OTI2YzY4MmI1MGM1MTU5My90YWJsZXJhbmdlOjI3YzhlYmVjZWQ0YTQ1ZDQ5MjZjNjgyYjUwYzUxNTkzXzMtMy0xLTEtMTk2MzU_d86fd2b5-cacb-4d6e-832e-14a3cb2889f6"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstateForeclosures>
    <cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzc0MDA_32f62cde-104f-4c2f-ad23-df69df733046">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based upon the Company&#x2019;s assessments at December&#160;31, 2021 and 2020, the amortized cost basis of the Company&#x2019;s mortgage loans within each credit quality indicator by year of origination was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.382%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.950%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost Basis by Year of Origination&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except credit quality indicator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prior&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2 to 4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 and 6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i236369a8589648caae4e40a4994ea5c7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzMtMS0xLTEtMTk2MzU_93b6c834-d6ce-4b2e-b5f9-b0b367cd6c15"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="if75d546f79f443b2b493051643070b9d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzMtMy0xLTEtMTk2MzU_6a68f1be-5006-4b4c-bafc-d02747d10335"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i7d3bdf971c2e453aaac23e35b5bfcece_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzMtNS0xLTEtMTk2MzU_46fcd4c9-91be-4cf5-b5e3-1b89a753de3e"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i3f9e513cbe72495ebcf4e63dba757063_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzMtNy0xLTEtMTk2MzU_284b38dc-9df4-4908-8fc6-8975ccac40a5"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="if9e730fea2f548c28423a0d3c0b5d6d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzMtOS0xLTEtMTk2MzU_eb8d0ccc-c945-470a-b21b-c19d29171801"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2b3b6d3e1f854783ab31e0f74ac19914_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzMtMTEtMS0xLTE5NjM1_788f115f-691f-4c2b-bb45-3b7670abbb28"
      unitRef="usd">28000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i16a55dfb514944cebf081afcdb79c176_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzMtMTMtMS0xLTE5NjM1_1a7d96f1-5e64-4ae6-96d2-64cf631c3d68"
      unitRef="usd">28000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i43d06180041f4758a6cd666c4e52ac41_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzQtMS0xLTEtMTk2MzU_62b2e678-06a9-43c0-a8b7-368d6af49eed"
      unitRef="usd">255000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="idd01e0aad9534804950ee3b5c49b699a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzQtMy0xLTEtMTk2MzU_dcd520a6-dca4-4ddd-8b4c-bc6b545b3676"
      unitRef="usd">48000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ide4fcc1c4d10426e82ac1562b152a03f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzQtNS0xLTEtMTk2MzU_db94cd70-4c42-4578-91dc-422e2253c62a"
      unitRef="usd">40000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i1a11e2f0c8864c3a835f65250185e431_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzQtNy0xLTEtMTk2MzU_37ee8427-caf6-4ca3-a064-2fb22dea5455"
      unitRef="usd">72000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i86f7b3a22ee74b3b99c1724212e5f620_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzQtOS0xLTEtMTk2MzU_278446a0-ceed-4cde-93df-566e2d8ace89"
      unitRef="usd">97000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i4f64507e6bfd4e3c94c4e571436f0709_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzQtMTEtMS0xLTE5NjM1_8f02c82a-3410-4521-bd99-3730ba4f0e49"
      unitRef="usd">349000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="if4d761a33dad484ab0489a71620aac4c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzQtMTMtMS0xLTE5NjM1_2c6ab70d-4aa5-43a1-90be-03a4412d9b01"
      unitRef="usd">861000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iec0a30bbded74a4a87b264a68da01b48_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzUtMS0xLTEtMTk2MzU_e07e0d0e-f32b-4cd5-b155-7add03d26e0c"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i4bf8902ea23448c6aa2a6cdd04056a11_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzUtMy0xLTEtMTk2MzU_10528dd1-7a2a-4a4d-bfc7-1505e9e56d19"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia5bd4e5698b542e1afdf687466e73faf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzUtNS0xLTEtMTk2MzU_7bcfccd2-09c3-412d-b93a-71cec349337e"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i656346f8e3fc48149bc198665aa2ba23_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzUtNy0xLTEtMTk2MzU_5f774121-0854-4666-986a-352774fcc955"
      unitRef="usd">3000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i214cd12a886b42369217bf01fba03479_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzUtOS0xLTEtMTk2MzU_76b3fd3b-108f-4c9d-81f6-8946f8283d5c"
      unitRef="usd">4000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i8250607938c048e5bfa38afa06687ac7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzUtMTEtMS0xLTE5NjM1_86bc41dc-aaf5-4265-95b7-6abe45055354"
      unitRef="usd">6000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i53a9e1cc311f4d7389a00b2614f65e4a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzUtMTMtMS0xLTE5NjM1_79805612-5d38-446f-ab84-8ed7d8cec2a3"
      unitRef="usd">13000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="id5eb557f297b45a983e00f3a6ebabbc0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzYtMS0xLTEtMTk2MzU_c02d8baf-5e57-48cd-8d7b-36e39b842526"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="id98e3f5681054b74aee1fe95b47cec5d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzYtMy0xLTEtMTk2MzU_a0cf105c-c659-4105-b399-5f22787e8c63"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iac455272570c46e5ba3c2c051f9dd18b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzYtNS0xLTEtMTk2MzU_59073d05-51e9-4b53-b3de-f33929be7d77"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i4798911f466146f6a09993eaa2849e0e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzYtNy0xLTEtMTk2MzU_24ff6119-ea28-4589-9026-732549101279"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i5cac87f1a93a493b810d93704fdee5ab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzYtOS0xLTEtMTk2MzU_1219e669-4b04-41c1-8555-0bc3acf13f11"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i954fdd1992694dc7a1ffada1f90479f7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzYtMTEtMS0xLTE5NjM1_4750e1cd-8f74-4312-bafa-543f6c9c97bb"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ifb149f2594e24e5e9608148da07fdd9e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzYtMTMtMS0xLTE5NjM1_8ad24737-0f89-494d-b360-34cb81a72ec7"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i9366cbf54d89424ea99dd1bf935c263f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzctMS0xLTEtMTk2MzU_4ad8a11e-0796-4dbd-851c-7ef9c627b7a3"
      unitRef="usd">255000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iee791b6d216a4e52ba8577e512aefe77_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzctMy0xLTEtMTk2MzU_254aa705-f304-423d-b860-7cf6036ca58b"
      unitRef="usd">48000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ie04adbbb84d840c68db8746ae5c2ec4e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzctNS0xLTEtMTk2MzU_4f656ee1-7368-47f1-b28f-219247b5c3e7"
      unitRef="usd">40000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ib4c1fa1e1f5b4cfab3344b2360bda448_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzctNy0xLTEtMTk2MzU_4b2cebf7-eaf4-4f40-8451-c42550e30019"
      unitRef="usd">75000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic220147cd8734098b32bf1e587f1066f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzctOS0xLTEtMTk2MzU_5563d6a1-39eb-4078-b446-057bea565063"
      unitRef="usd">101000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i2b1552ff84a14d329639fbcf910ccda7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzctMTEtMS0xLTE5NjM1_3d1a5ae5-0a3e-4346-bf70-130d7e73a7f5"
      unitRef="usd">383000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="if07ab5ed5fe44735bee0f7db6106013d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzctMTMtMS0xLTE5NjM1_756fdbb5-8ca5-4050-80b1-78255a66ab02"
      unitRef="usd">902000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i7cfce5629c994ec789d3036601d70793_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEwLTMtMS0xLTE5NjM1_5df10d21-2e0c-4139-9304-e3f895513093"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i72e8544f389d4c46a1811d3a41ccd343_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEwLTUtMS0xLTE5NjM1_34aab280-7452-4cdc-80bf-984885f31812"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i8c04a5353793424ea6dd4c537d171bfd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEwLTctMS0xLTE5NjM1_1766a6e1-b12e-4f29-8577-3944b079811d"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i9debbd88735e4e51b8568db394038442_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEwLTktMS0xLTE5NjM1_90966b81-508c-47cd-b732-09691e681d98"
      unitRef="usd">22000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i5bb90e71f4ce4742b80486f33e02cf5e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEwLTExLTEtMS0xOTYzNQ_9478242f-19ba-456d-982f-7e120be2067c"
      unitRef="usd">37000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i366b9b5ee8aa4b6f97820e04b932038c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEwLTEzLTEtMS0xOTYzNQ_9c6548ac-fddf-4e5f-8927-df45770f77b3"
      unitRef="usd">59000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="iccf3cac287074066895d1a02163e6ea5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzExLTMtMS0xLTE5NjM1_cb1e42f8-5edc-4e7e-ac0b-09190f65d493"
      unitRef="usd">46000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i96d87ac36ba5416ebb4aef216fdd2adb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzExLTUtMS0xLTE5NjM1_8cf4969a-6a68-4d7e-b905-cb8784a6def4"
      unitRef="usd">96000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i97c3ee33af8444709579e3a43a1b8ab6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzExLTctMS0xLTE5NjM1_b5ddc38a-ffcf-41a5-953c-764d7ac68b7d"
      unitRef="usd">91000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0377da301945465092de5eaea76ac47d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzExLTktMS0xLTE5NjM1_e976d7ca-08ea-49b8-8f68-ef68fbf83aeb"
      unitRef="usd">124000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i62b02d0505564979b7eca3037be36f23_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzExLTExLTEtMS0xOTYzNQ_1a3f628c-a3cc-451e-8ca1-ad578c60f720"
      unitRef="usd">595000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i7997178cc177444ea3249f37548ee4e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzExLTEzLTEtMS0xOTYzNQ_4bb68260-8e8d-4e98-a069-a04fec098417"
      unitRef="usd">952000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i70079745684b497bb807ab287dd604b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEyLTMtMS0xLTE5NjM1_914b822f-9aa4-4a55-ba4c-7e00383e7274"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i8e1919b277f44b2fb842c59d94d1425f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEyLTUtMS0xLTE5NjM1_6f68da66-0eae-4df3-8bbd-9d5ec86845e2"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i6701a00e113f4e5498744bb48caecc5f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEyLTctMS0xLTE5NjM1_d9f21653-3c63-489c-831d-62a0498838eb"
      unitRef="usd">3000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i7fad7dcab3954d96965b1614328749b8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEyLTktMS0xLTE5NjM1_76224a9b-2d37-49d0-859d-d113bb23c31f"
      unitRef="usd">4000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic031473f406049eeab488d7910cbe99c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEyLTExLTEtMS0xOTYzNQ_7f4394d1-6bc0-4459-ba5f-98590bdfdd78"
      unitRef="usd">29000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0a49286ac2764f6c960b95c3ff551ef9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEyLTEzLTEtMS0xOTYzNQ_773a86d9-c8a9-4a6c-a17d-da246afde386"
      unitRef="usd">36000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i92c71ec3b83541a1aff2732364f1942b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEzLTMtMS0xLTE5NjM1_ddd4f59a-4298-40b5-a62f-2a715c737922"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ief0401c6d4364a2d91dc94d588b6675b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEzLTUtMS0xLTE5NjM1_de592ec5-3d8e-491f-b801-79bb3e871eec"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i8d7e2c257e7e410baa65d8db69f23863_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEzLTctMS0xLTE5NjM1_3cfb4ea8-306c-413f-b38b-06c421ceaa07"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia6c586309d7344cca6910ecd0006b772_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEzLTktMS0xLTE5NjM1_71f96318-24f7-49a7-b2e6-526a360d4e63"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i19b89cce7eda4f3faf261107006bca5d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEzLTExLTEtMS0xOTYzNQ_328fa938-243a-4251-8c9a-52b87ed26925"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i60dd9ff415cf4307be34d85ab7b5fd40_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzEzLTEzLTEtMS0xOTYzNQ_ec7b8b27-c1d9-40a9-9a9c-574e940f6555"
      unitRef="usd">0</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ic8aa576e20ec407ba27840a430d3d8d0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzE0LTMtMS0xLTE5NjM1_e387e5e4-753f-413e-9934-96ab4d9ffd7c"
      unitRef="usd">46000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="ia63d6c6f272f4145a25f9f7581ceda3e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzE0LTUtMS0xLTE5NjM1_6a4d7471-c7bf-402d-aa4c-9a601b85a9a6"
      unitRef="usd">96000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i1e137b6416194b0c80702e6ccaf7cd12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzE0LTctMS0xLTE5NjM1_5b3c8288-f76c-4cfe-bbb3-a70a0c8aec09"
      unitRef="usd">94000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i450ae32012bd4a4da4f68d20e1c51dc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzE0LTktMS0xLTE5NjM1_36b139da-5125-49dc-b5df-05c55791e332"
      unitRef="usd">150000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i028a59a7a3bf4c1285313639042fd9a5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzE0LTExLTEtMS0xOTYzNQ_978b8a8e-ffae-40d7-a3d6-18fc87b7ae16"
      unitRef="usd">661000000</us-gaap:MortgageLoansOnRealEstate>
    <us-gaap:MortgageLoansOnRealEstate
      contextRef="i0f32471feded4c178b2f2c05cebf159d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZToyNjhhM2EwMjA5NmE0MjQ3ODZmZmEyYjA1YTdjNmVmZS90YWJsZXJhbmdlOjI2OGEzYTAyMDk2YTQyNDc4NmZmYTJiMDVhN2M2ZWZlXzE0LTEzLTEtMS0xOTYzNQ_a5f76123-4860-4265-9bbd-75235b81245f"
      unitRef="usd">1047000000</us-gaap:MortgageLoansOnRealEstate>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths
      contextRef="if07ab5ed5fe44735bee0f7db6106013d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYWM2ZDU4M2E1MmE0MjBjYTQ2ZjIyNmExM2VjOTM5Mi90YWJsZXJhbmdlOmRhYzZkNTgzYTUyYTQyMGNhNDZmMjI2YTEzZWM5MzkyXzEtMS0xLTEtMTk2MzU_a2a33053-e781-49de-8b05-c21bcdd352f0"
      unitRef="usd">58000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo
      contextRef="if07ab5ed5fe44735bee0f7db6106013d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYWM2ZDU4M2E1MmE0MjBjYTQ2ZjIyNmExM2VjOTM5Mi90YWJsZXJhbmdlOmRhYzZkNTgzYTUyYTQyMGNhNDZmMjI2YTEzZWM5MzkyXzItMS0xLTEtMTk2MzU_a1604387-3de6-4b1f-a03c-42c6987d627c"
      unitRef="usd">100000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree
      contextRef="if07ab5ed5fe44735bee0f7db6106013d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYWM2ZDU4M2E1MmE0MjBjYTQ2ZjIyNmExM2VjOTM5Mi90YWJsZXJhbmdlOmRhYzZkNTgzYTUyYTQyMGNhNDZmMjI2YTEzZWM5MzkyXzMtMS0xLTEtMTk2MzU_83f817a5-8754-428b-ae38-a1e0f196d1f4"
      unitRef="usd">210000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour
      contextRef="if07ab5ed5fe44735bee0f7db6106013d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYWM2ZDU4M2E1MmE0MjBjYTQ2ZjIyNmExM2VjOTM5Mi90YWJsZXJhbmdlOmRhYzZkNTgzYTUyYTQyMGNhNDZmMjI2YTEzZWM5MzkyXzQtMS0xLTEtMTk2MzU_8e35eaf3-7c57-4d98-b4b7-f1133d7da945"
      unitRef="usd">76000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive
      contextRef="if07ab5ed5fe44735bee0f7db6106013d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYWM2ZDU4M2E1MmE0MjBjYTQ2ZjIyNmExM2VjOTM5Mi90YWJsZXJhbmdlOmRhYzZkNTgzYTUyYTQyMGNhNDZmMjI2YTEzZWM5MzkyXzUtMS0xLTEtMTk2MzU_44d67ce2-5a11-4494-a9fd-9b7aba93c31e"
      unitRef="usd">177000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive>
    <cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive
      contextRef="if07ab5ed5fe44735bee0f7db6106013d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYWM2ZDU4M2E1MmE0MjBjYTQ2ZjIyNmExM2VjOTM5Mi90YWJsZXJhbmdlOmRhYzZkNTgzYTUyYTQyMGNhNDZmMjI2YTEzZWM5MzkyXzYtMS0xLTEtMTk2MzU_a3861b97-c905-4e87-8c9f-b333868f4fb6"
      unitRef="usd">281000000</cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet
      contextRef="if07ab5ed5fe44735bee0f7db6106013d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYWM2ZDU4M2E1MmE0MjBjYTQ2ZjIyNmExM2VjOTM5Mi90YWJsZXJhbmdlOmRhYzZkNTgzYTUyYTQyMGNhNDZmMjI2YTEzZWM5MzkyXzctMS0xLTEtMTk2MzU_2de30d9a-0976-4009-a42f-5f5d1e8dc17b"
      unitRef="usd">902000000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <us-gaap:InvestmentIncomeTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzczODA_4d03d083-f8a1-44f4-8b0b-243ae89cce12">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sources of net investment income for the years ended December 31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income (excluding net realized capital gains or losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized capital gains &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Net realized capital gains are net of yield-related impairment losses on debt securities of $42 million and $49 million for the years ended December&#160;31, 2021 and 2020, respectively. There were no credit-related losses on debt securities in the years ended December&#160;31, 2021 and 2020. Net realized capital gains are net of other-than-temporary impairment (&#x201c;OTTI&#x201d;) losses on debt securities of $24 million for the year ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;(2)Net investment income includes $38 million, $42 million and $44 million for the years ended December 31, 2021, 2020 and 2019, respectively, related to investments supporting experience-rated products.</us-gaap:InvestmentIncomeTextBlock>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i05fb3cf4bea94dcd9507a7f609bba804_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzEtMS0xLTEtMTk2MzU_66c0e673-46d1-43c0-b1a9-8fa5178bfcf0"
      unitRef="usd">634000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ib8da629000164e189d42edeb512f786e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzEtMy0xLTEtMTk2MzU_206cae12-8071-4a63-8cd5-0c6cb71abb74"
      unitRef="usd">598000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ibce5743406e44d979a44db538128707d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzEtNS0xLTEtMTk2MzU_2401840f-5c10-4939-9d23-3899e5f996d6"
      unitRef="usd">589000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i41b25c02378c46c99b73c18360004c60_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzItMS0xLTEtMTk2MzU_fcbe29ec-e162-4f55-b4ff-608c445c78db"
      unitRef="usd">55000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i8c71ab108d124b2fb04b4be93eea1a95_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzItMy0xLTEtMTk2MzU_fa36c9b8-4d44-48fe-8beb-2498bc81d982"
      unitRef="usd">60000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i9edfca3af9614ff38ae3dda45b1fe0d3_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzItNS0xLTEtMTk2MzU_8f531f03-ffd8-4997-b6b6-42c807de326e"
      unitRef="usd">71000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i24d0c995b652444da95a99ac0befe361_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzMtMS0xLTEtMTk2MzU_404d04d2-56fb-4629-9dc9-fe89f83d3119"
      unitRef="usd">381000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ieebeaa16b5e7407db27c743c37fe3062_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzMtMy0xLTEtMTk2MzU_c43f0c8c-72b4-4fd9-af99-6784823b1efd"
      unitRef="usd">123000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ia48569365a5049b89c3839c388ba8841_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzMtNS0xLTEtMTk2MzU_59090781-2392-4276-8cf7-387ed2ba3a63"
      unitRef="usd">194000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzQtMS0xLTEtMTk2MzU_3b295aba-b594-450a-b8c4-1bc482cf93c0"
      unitRef="usd">1070000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzQtMy0xLTEtMTk2MzU_2e2783bd-8160-4e47-96cb-a9cb5b94a04b"
      unitRef="usd">781000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzQtNS0xLTEtMTk2MzU_f521926b-3c2a-4e64-99db-41ad76d2cf38"
      unitRef="usd">854000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzUtMS0xLTEtMTk2MzU_c68e8356-4b9a-448b-a2b6-2ae6239a8dda"
      unitRef="usd">47000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzUtMy0xLTEtMTk2MzU_59ce104b-f44f-475a-b077-28b6e5fdc3d3"
      unitRef="usd">35000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <us-gaap:InvestmentIncomeInvestmentExpense
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzUtNS0xLTEtMTk2MzU_6b837156-e030-457c-afee-9dc934022db5"
      unitRef="usd">42000000</us-gaap:InvestmentIncomeInvestmentExpense>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzYtMS0xLTEtMTk2MzU_ea584060-1d8a-4b52-b695-4ffcc0093262"
      unitRef="usd">1023000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzYtMy0xLTEtMTk2MzU_00c42c76-1085-43ee-85b0-07612d991fcc"
      unitRef="usd">746000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <cvs:InvestmentIncomeExcludingCapitalGainsorLosses
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzYtNS0xLTEtMTk2MzU_8322900a-08ae-473a-8983-88424be07afc"
      unitRef="usd">812000000</cvs:InvestmentIncomeExcludingCapitalGainsorLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzctMS0xLTEtMTk2MzU_617ef422-9e1a-4fda-8fcd-656d42d073ec"
      unitRef="usd">176000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzctMy0xLTEtMTk2MzU_acdba65c-f5a8-418e-b203-dd6a3e3ca9a7"
      unitRef="usd">52000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzctNS0xLTEtMTk2MzU_ba3b2b7f-0144-4b48-ae80-c243635b72c3"
      unitRef="usd">199000000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:InvestmentIncomeNet
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzgtMS0xLTEtMTk2MzU_d3ba924f-538f-4ac8-af20-ad20203c1a4c"
      unitRef="usd">1199000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzgtMy0xLTEtMTk2MzU_526d7a09-73a2-4d4e-a490-240e73f29806"
      unitRef="usd">798000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTo1ZmRlYWVkOTc1MmI0ODI1ODU2NjM1ZDkzN2VkOGQyZC90YWJsZXJhbmdlOjVmZGVhZWQ5NzUyYjQ4MjU4NTY2MzVkOTM3ZWQ4ZDJkXzgtNS0xLTEtMTk2MzU_3f17974d-ebb6-4c52-9795-5b49f1b77288"
      unitRef="usd">1011000000</us-gaap:InvestmentIncomeNet>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzY0MTE_e665b9d1-35d2-4438-a719-28cf3d9dd8fe"
      unitRef="usd">-42000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzEwOTk1MTE2MzY5NDI_7e34111c-e32d-4e70-a3da-5fcee792ee13"
      unitRef="usd">-49000000</cvs:YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzY0NDg_408c5854-cd6e-483c-b8b0-6bdb632c5e15"
      unitRef="usd">0</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzY0NDg_a4b0dd46-0f1b-4277-87a1-6c2eee6fd16f"
      unitRef="usd">0</cvs:CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzEwOTk1MTE2MzY3MjE_dca84a66-fb5a-4fba-9218-ce9fa48fd5f1"
      unitRef="usd">-24000000</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:InvestmentIncomeNet
      contextRef="ieed51d61b0d54c6086fdef46e9dc9295_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzY3ODM_749e4b6e-1dbd-4b68-b7cb-5aff5f30c7cf"
      unitRef="usd">38000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="id1746900c4bb4eee8150b6ee721d8c44_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzY3ODc_b006f672-52b8-4b80-953b-12a564f6a157"
      unitRef="usd">42000000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i0c8f49c4abf245e0ac15d06a1fd72813_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzY3OTQ_67cca0fc-d718-4dc4-bdc0-34556c9e9ebd"
      unitRef="usd">44000000</us-gaap:InvestmentIncomeNet>
    <cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90ZXh0cmVnaW9uOjA5ZmRhMmYzNGZjMDQxMjk5OWNlYTkxZTIwMGJiMGRhXzczODE_d7c33fd2-ffb0-4715-b689-3221641e9a7a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding amounts related to experience-rated products, proceeds from the sale of available-for-sale debt securities and the related gross realized capital gains and losses in the years ended December 31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross realized capital losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzEtMS0xLTEtMTk2MzU_5eda9453-f58b-47e4-84cf-1db9d3beade4"
      unitRef="usd">3572000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzEtMy0xLTEtMTk2MzU_6d4c71a8-73d3-4042-86e2-ae6f0976a1d3"
      unitRef="usd">3913000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzEtNS0xLTEtMTk2MzU_3cb3f641-4aa5-4307-95bc-464086e01565"
      unitRef="usd">4773000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzItMS0xLTEtMTk2MzU_cb4fdd63-e380-49f0-9536-a4fb2e386833"
      unitRef="usd">72000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzItMy0xLTEtMTk2MzU_d843ade3-3e35-4e59-b79a-52fecbea267c"
      unitRef="usd">80000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzItNS0xLTEtMTk2MzU_51f10caf-8571-4c7f-bce2-86d681b02d44"
      unitRef="usd">146000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzMtMS0xLTEtMTk2MzU_9abe0ec6-ebcc-4285-97ab-4d9caa4a55f0"
      unitRef="usd">-14000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzMtMy0xLTEtMTk2MzU_c9de41df-5ed3-43dc-8f14-d7f75c3d6679"
      unitRef="usd">-62000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzYvZnJhZzowOWZkYTJmMzRmYzA0MTI5OTljZWE5MWUyMDBiYjBkYS90YWJsZTpkYTk0MmMzOTBjMTU0MTU5ODQ0N2M4NjgwMWQ3MmViMS90YWJsZXJhbmdlOmRhOTQyYzM5MGMxNTQxNTk4NDQ3Yzg2ODAxZDcyZWIxXzMtNS0xLTEtMTk2MzU_db98fa8c-6608-4979-8665-950682686667"
      unitRef="usd">-17000000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzEwNTM3_dae7fc92-21a0-40cb-8e02-177ec2b38277">Fair Value&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the Company&#x2019;s consolidated financial statements in accordance with GAAP requires certain assets and liabilities to be reflected at their fair value and others to be reflected on another basis, such as an adjusted historical cost basis.&#160;In this note, the Company provides details on the fair value of financial assets and liabilities and how it determines those fair values.&#160;The Company presents this information for those financial instruments that are measured at fair value for which the change in fair value impacts net income attributable to CVS Health or other comprehensive income separately from other financial assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments Measured at Fair Value on the Consolidated Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s financial instruments are measured at fair value on the consolidated balance sheets.&#160;The fair values of these instruments are based on valuations that include inputs that can be classified within one of three levels of a hierarchy established by GAAP.&#160;&#160;The following are the levels of the hierarchy and a brief description of the type of valuation information (&#x201c;valuation inputs&#x201d;) that qualifies a financial asset or liability for each level:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &#x2013; Unadjusted quoted prices for identical assets or liabilities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &#x2013; Valuation inputs other than Level 1 that are based on observable market data.&#160;These include: quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets, valuation inputs that are observable that are not prices (such as interest rates and credit risks) and valuation inputs that are derived from or corroborated by observable markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &#x2013; Developed from unobservable data, reflecting the Company&#x2019;s assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities are classified based upon the lowest level of input that is significant to the valuation.&#160;When quoted prices in active markets for identical assets and liabilities are available, the Company uses these quoted market prices to determine the fair value of financial assets and liabilities and classifies these assets and liabilities in Level 1.&#160;In other cases where a quoted market price for identical assets and liabilities in an active market is either not available or not observable, the Company estimates fair value using valuation methodologies based on available and observable market information or by using a matrix pricing model.&#160;These financial assets and liabilities are classified in Level 2.&#160;If quoted market prices are not available, the Company determines fair value using broker quotes or an internal analysis of each investment&#x2019;s financial performance and cash flow projections.&#160;Thus, financial assets and liabilities may be classified in Level 3 even though there may be some significant inputs that may be observable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a description of the valuation methodologies used for the Company&#x2019;s financial assets and liabilities that are measured at fair value, including the general classification of such assets and liabilities pursuant to the valuation hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash and Cash Equivalents &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of cash and cash equivalents approximates fair value as maturities are less than three months. When quoted prices are available in an active market, cash equivalents are classified in Level 1 of the fair value hierarchy. Fair values of cash equivalent instruments that do not trade on a regular basis in active markets are classified as Level 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Where quoted prices are available in an active market, debt securities are classified in Level 1 of the fair value hierarchy.&#160;The Company&#x2019;s&#160;Level 1 debt securities consist primarily of U.S. Treasury securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s Level 2 debt securities are obtained using models, such as matrix pricing, which use quoted market prices of debt securities with similar characteristics or discounted cash flows to estimate fair value. The &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company reviews these prices to ensure they are based on observable market inputs that include quoted prices for similar assets in active markets, quoted prices for identical assets in inactive markets and inputs that are observable that are not prices (such as interest rates and credit risks). The Company also reviews the methodologies and the assumptions used to calculate prices from these observable inputs. On a quarterly basis, the Company selects a sample of its Level 2 debt securities&#x2019; prices and compares them to prices provided by a secondary source. Variances over a specified threshold are identified and reviewed to confirm the price provided by the primary source represents an appropriate estimate of fair value. In addition, the Company&#x2019;s internal investment team consistently compares the prices obtained for select Level 2 debt securities to the team&#x2019;s own independent estimates of fair value for those securities.&#160;The Company obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December&#160;31, 2021 or 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also values certain debt securities using Level 3 inputs.&#160;For Level 3 debt securities, fair values are determined by outside brokers or, in the case of certain private placement securities, are priced internally.&#160;Outside brokers determine the value of these debt securities through a combination of their knowledge of the current pricing environment and market flows.&#160;The Company did not have any broker quoted debt securities for the years ended December&#160;31, 2021 and 2020. For some private placement securities, the Company&#x2019;s internal staff determines the value of these debt securities by analyzing spreads of corporate and sector indices as well as interest spreads of comparable public bonds.&#160;Examples of these private placement Level 3 debt securities include certain U.S. and foreign securities and certain tax-exempt municipal securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company currently has two classifications of equity securities:&#160;those that are publicly traded and those that are privately placed.&#160;Publicly-traded equity securities are classified in Level 1 because quoted prices are available for these securities in an active market.&#160;For privately placed equity securities, there is no active market; therefore, these securities are classified in Level 3 because the Company prices these securities through an internal analysis of each investment&#x2019;s financial statements and cash flow projections. Significant unobservable inputs consist of earnings and revenue multiples, discount for lack of marketability and comparability adjustments. An increase or decrease in any of these unobservable inputs would have resulted in a change in the fair value measurement. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no financial liabilities measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2021 or 2020. Financial assets measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;States, &lt;br/&gt;municipalities&lt;br/&gt;&#160;and political &lt;br/&gt;subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;br/&gt;corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other asset-&lt;br/&gt;backed&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;preferred&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized and unrealized capital gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in earnings&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers into Level 3, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in unrealized capital losses included in other comprehensive income associated with Level 3 financial assets which were held as of December&#160;31, 2021 was $4 million during the year ended December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;States, &lt;br/&gt;municipalities&lt;br/&gt;&#160;and political &lt;br/&gt;subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;br/&gt;corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;preferred&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized and unrealized capital gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in earnings&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers into Level 3, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in unrealized capital losses included in other comprehensive income associated with Level 3 financial assets which were held as of December&#160;31, 2020 was $4&#160;million during the year ended December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total gross transfers into (out of) Level 3 during the years ended December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross transfers into Level 3&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net transfers into Level 3&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instruments Not Measured at Fair Value on the Consolidated Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the consolidated balance sheets at adjusted cost or contract value at December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information regarding the valuation of cost method investments. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Separate Accounts Measured at Fair Value on the Consolidated Balance Sheets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets relate to the Company&#x2019;s large case pensions products which represent funds maintained to meet specific objectives of contract holders.&#160;Since contract holders bear the investment risk of these assets, a corresponding Separate Accounts liability has been established equal to the assets.&#160;These assets and liabilities are carried at fair value.&#160;Net investment income and capital gains and losses on Separate Accounts assets accrue directly to such contract holders.&#160;The assets of each account are legally segregated and are not subject to claims arising from the Company&#x2019;s other businesses.&#160;Deposits, withdrawals, net investment income and realized and unrealized capital gains and losses on Separate Accounts assets are not reflected in the consolidated statements of operations, shareholders&#x2019; equity or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts assets include debt and equity securities.&#160;The valuation methodologies used for these assets are similar to the methodologies described above in this Note 4 &#x2018;&#x2018;Fair Value.&#x2019;&#x2019;&#160;Separate Accounts assets also include investments in common/collective trusts that are carried at fair value. Common/collective trusts invest in other investment funds otherwise known as the underlying funds. The Separate Accounts&#x2019; interests in the common/collective trust funds are based on the fair values of the investments of the underlying funds and therefore are classified in Level 2. The assets in the underlying funds primarily consist of equity securities. Investments in common/collective trust funds are valued at their respective net asset value (&#x201c;NAV&#x201d;) per share/unit on the valuation date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts financial assets at December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $70 million and $29&#160;million of other receivables at December&#160;31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December 31, 2021 and 2020, the Company had no gross transfers of Separate Accounts financial assets into or out of Level 3.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i11640c062e35437a84e8bdd5240da928_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzMyOTg1MzQ4OTQ5Nzc_3c16b411-d347-4500-9147-cd4bf404e6c8"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i91e5f841bc1148249e50546c6b0c4b62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzMyOTg1MzQ4OTQ5Nzc_4850a2fe-c335-411c-8af3-a5de271a1d8b"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzEwNTQy_87d4faa8-f647-405a-a317-ef19ecbb1f5b">Financial assets measured at fair value on a recurring basis on the consolidated balance sheets at December&#160;31, 2021 and 2020 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id661ddecbffb4d32b875d7dde00d256b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzItMS0xLTEtMTk2MzU_db62e9ac-8bd1-432d-a6d4-0b13de837aa9"
      unitRef="usd">4954000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id38966f39d564693bc52e2003aea2649_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzItMy0xLTEtMTk2MzU_d0d5f3de-7a93-4bad-8af0-b6f521fff828"
      unitRef="usd">4454000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i324d950c15024b0bb7034483bcf91fcc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzItNS0xLTEtMTk2MzU_02324820-ed68-4f71-a59a-854d620825a7"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i91e5f841bc1148249e50546c6b0c4b62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzItNy0xLTEtMTk2MzU_1ead85df-300a-431d-9d6d-e460370e54e0"
      unitRef="usd">9408000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i451babf334c54e97bb6b9b0f190306a4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzQtMS0xLTEtMTk2MzU_9e48daa6-d215-4330-a1c0-43e93a82cd84"
      unitRef="usd">2372000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia7dc90b07e3e44409f77d5cb120f1791_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzQtMy0xLTEtMTk2MzU_f80f41d0-ec34-46a7-a097-7d91688ff446"
      unitRef="usd">44000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3de66b1934ef4735bf9ab13a87c166e6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzQtNS0xLTEtMTk2MzU_c1dc05e1-1d5f-40cb-9ae2-4ae41ad45a12"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i866ae3e88ea547cf994e2b7dc57084e0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzQtNy0xLTEtMTk2MzU_8bcebada-6bd4-494c-85ac-c670853df2bd"
      unitRef="usd">2416000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i36ebd6ac03f94f7b9b09d2e42eb22df2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzUtMS0xLTEtMTk2MzU_3e4b1634-2b14-43d1-abe3-85b7df675711"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6ef2601295cf468496155923c2d3720c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzUtMy0xLTEtMTk2MzU_3a227fb5-4c15-4fba-928c-0f37234bbbc0"
      unitRef="usd">3086000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieb049bcdaf39409381032754ef26a6e4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzUtNS0xLTEtMTk2MzU_ffabe6d4-2978-4b4f-8233-0c3cab2a3dca"
      unitRef="usd">5000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id3543b9dfd21451eb0a643264ccb77b8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzUtNy0xLTEtMTk2MzU_5582b093-074c-4a39-b578-5749187a4b60"
      unitRef="usd">3091000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i683159f0075e4dc4bd3680b9a30ee79b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzYtMS0xLTEtMTk2MzU_1eb2b1a2-7d2c-4ef8-beb6-bc69dff5fc07"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idc3513b74a1349019be42383809506e3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzYtMy0xLTEtMTk2MzU_9229edee-d1dd-4add-9626-aab93ca78a67"
      unitRef="usd">9697000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib52cf4a485134e87be898eb27b20e43c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzYtNS0xLTEtMTk2MzU_b9304929-5b7b-4f71-a478-3a61e6f43f39"
      unitRef="usd">38000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if5285fd9babe408da40e34a5f27ecdbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzYtNy0xLTEtMTk2MzU_e5853983-c6c3-4da4-bd71-57e1a29d53a6"
      unitRef="usd">9735000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1e189ef58904439b8c798dfe80e60a25_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzctMS0xLTEtMTk2MzU_71b4ecaf-d6d8-41f7-bece-58a3f3c20fc2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i20f2f71ab9e345a3960755605a1726ab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzctMy0xLTEtMTk2MzU_47760a92-1a63-4adf-97b5-dce73989673a"
      unitRef="usd">2983000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i71543114cab743abbb973d2eb97c593b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzctNS0xLTEtMTk2MzU_8908cf00-8299-4140-af68-b5d1a9a6a855"
      unitRef="usd">10000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3a2c8eac231a44ccb5e9b62290d31c14_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzctNy0xLTEtMTk2MzU_3fb0a85e-eaad-45d2-947f-fb240ded9ee2"
      unitRef="usd">2993000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icdfdcb99b98d46498997a64233fe6284_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzgtMS0xLTEtMTk2MzU_96a43783-9bb5-420b-86af-233452ed797f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0776297f1b3c4b35a1681eb98f0e6ddc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzgtMy0xLTEtMTk2MzU_e18b8c8e-b82d-40b3-a899-79b5fe1b6ad9"
      unitRef="usd">875000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iecac0db5b3bc4f71a118bac63aeab3eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzgtNS0xLTEtMTk2MzU_94ac00ca-6181-422f-acea-ff5021bd1e0a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if6693eb63ed74a828d0366b9db5e4445_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzgtNy0xLTEtMTk2MzU_87d83000-bd66-41a5-926d-8a36d18729cf"
      unitRef="usd">875000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ied406e9d2fff4ac3ac935e90506bb4cf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzktMS0xLTEtMTk2MzU_fa06ad9a-cd8a-429a-b8f0-1189b30906e6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i767a0ee4a63e4ed4aa122d6036cf7f2e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzktMy0xLTEtMTk2MzU_09210249-2a58-4b9c-a9a1-1d7802f06cf1"
      unitRef="usd">1310000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3c7677c6fdc940cca39670933eff94b7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzktNS0xLTEtMTk2MzU_e40ea364-b1bc-4fec-a327-86b4a8518e55"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0c74cc1d42334984a93d5efc6aa1eb3a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzktNy0xLTEtMTk2MzU_4a4dd173-15bb-47dc-a2f4-42a48f87ddf8"
      unitRef="usd">1310000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3c0b5fa5eb4a425db34364e49d4cbdfc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEwLTEtMS0xLTE5NjM1_1aafa62d-a277-4cea-af7b-d8ee2823a546"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i655ea2abe74d44e981581e84041b0fdb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEwLTMtMS0xLTE5NjM1_85f2abfe-09c4-47cb-9799-4fdf6641fe1a"
      unitRef="usd">2789000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i94ed5a8a301045ac95dc4f35d8a94a70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEwLTUtMS0xLTE5NjM1_ea65eb08-58ca-43d2-8062-87f985df7852"
      unitRef="usd">3000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id5a62cd495034feaa642a45f38861a84_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEwLTctMS0xLTE5NjM1_7e440a99-a361-4b2f-80b7-feb3e160c198"
      unitRef="usd">2792000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i02d753bb590a4315b54f9533067bd31c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzExLTEtMS0xLTE5NjM1_d22fb185-d2e2-437d-8e6f-731d5b4689ca"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8fca60115c0f4442898a26ce68ec0a7e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzExLTMtMS0xLTE5NjM1_294d52f1-5d51-42f0-8f32-a6b23f10ad4a"
      unitRef="usd">28000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia57d02a5ebe347a2b9e0de4938be4404_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzExLTUtMS0xLTE5NjM1_a4eb8f36-eb71-4ff0-8ea6-2473b5041e9d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i94d0b79c49904cfb8e3bb6884eba4148_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzExLTctMS0xLTE5NjM1_02328b43-7c81-430d-98b7-de0daac7ab71"
      unitRef="usd">28000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id661ddecbffb4d32b875d7dde00d256b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEyLTEtMS0xLTE5NjM1_8a2daec4-767a-450a-a68b-572468373214"
      unitRef="usd">2372000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id38966f39d564693bc52e2003aea2649_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEyLTMtMS0xLTE5NjM1_acdcf2eb-484d-4bd8-9d15-a8781811cc54"
      unitRef="usd">20812000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i324d950c15024b0bb7034483bcf91fcc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEyLTUtMS0xLTE5NjM1_0996909e-5138-4d7f-8ebe-1f436c011722"
      unitRef="usd">56000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i91e5f841bc1148249e50546c6b0c4b62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEyLTctMS0xLTE5NjM1_3187dd14-e58e-4621-bda0-feecf2fd94b2"
      unitRef="usd">23240000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id661ddecbffb4d32b875d7dde00d256b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEzLTEtMS0xLTE5NjM1_455cf5e6-1d2a-491d-9982-b15a533e1b51"
      unitRef="usd">114000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="id38966f39d564693bc52e2003aea2649_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEzLTMtMS0xLTE5NjM1_d56a73c5-dde3-4776-b252-56ad94ae954f"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i324d950c15024b0bb7034483bcf91fcc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEzLTUtMS0xLTE5NjM1_d17038f9-34aa-4fd4-842a-a63e33a25d82"
      unitRef="usd">55000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i91e5f841bc1148249e50546c6b0c4b62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzEzLTctMS0xLTE5NjM1_76584318-bc25-4737-af1f-033b90b29ab1"
      unitRef="usd">169000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id661ddecbffb4d32b875d7dde00d256b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE0LTEtMS0xLTE5NjM1_88732148-344d-4cf3-95f3-f91f3f3eccdd"
      unitRef="usd">7440000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id38966f39d564693bc52e2003aea2649_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE0LTMtMS0xLTE5NjM1_2a9cefa1-9056-40b2-b2fe-2cccb6179e65"
      unitRef="usd">25266000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i324d950c15024b0bb7034483bcf91fcc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE0LTUtMS0xLTE5NjM1_fe563017-34d1-469b-b37d-3acc7d1f5e43"
      unitRef="usd">111000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i91e5f841bc1148249e50546c6b0c4b62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE0LTctMS0xLTE5NjM1_c209bf84-c72e-4d23-8ab0-31b740237aa4"
      unitRef="usd">32817000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i6cc1a0e274864af480f200c3ae61c8a9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE3LTEtMS0xLTE5NjM1_a01272fa-2bae-4454-866b-b476c8b8f29c"
      unitRef="usd">3985000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i5c68ea82b6954ea6b55c0177a55e7799_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE3LTMtMS0xLTE5NjM1_7cd1f333-8c00-4b71-9346-3a6e1fa2befa"
      unitRef="usd">3869000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia658e0719f064994a3725fa8e7cd5a8f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE3LTUtMS0xLTE5NjM1_717586c6-f7bf-4466-8148-864693f1e0c7"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i11640c062e35437a84e8bdd5240da928_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE3LTctMS0xLTE5NjM1_ba5b1571-3c0a-47eb-be3b-4b1998a80421"
      unitRef="usd">7854000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i46044f2e055c425fa8412971d2e99d30_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE5LTEtMS0xLTE5NjM1_2cd8387f-86c7-48b0-8496-9e95546dabad"
      unitRef="usd">2370000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i300ca3e38be14ff1a4fd2b2fd45caf61_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE5LTMtMS0xLTE5NjM1_c06e6087-87b7-4a02-99ab-430444f0b527"
      unitRef="usd">99000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i75a98c27eb9942459eccbefdfca783c9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE5LTUtMS0xLTE5NjM1_1cb0e2c6-9d18-4120-b719-c18100456f0a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8819a5b1bd5746e9a7bbc6f8ba9cad82_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzE5LTctMS0xLTE5NjM1_849fb874-caca-4efe-ae05-95f3662bbf3e"
      unitRef="usd">2469000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9de95e7ef9124c3eab5c6cc2fef4f3f0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIwLTEtMS0xLTE5NjM1_72244562-f7fd-4343-88be-fc2cca1c2d81"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i86b4035143a84effa56728c42ea05b4f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIwLTMtMS0xLTE5NjM1_1776cb3f-aa51-4c3e-9af4-261347c263fe"
      unitRef="usd">2727000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib6476b9e6b9444e0970ef1e348c4b56b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIwLTUtMS0xLTE5NjM1_5143aee6-7819-48e7-a31f-f0fb51b8c3bb"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i002609847daf4257836b24066c83c6cc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIwLTctMS0xLTE5NjM1_3b15ddca-03e8-4275-8c72-39cb010d6e5d"
      unitRef="usd">2728000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id8de359f7ead4526b1face6a322f74ad_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIxLTEtMS0xLTE5NjM1_c3e9a53e-6cca-4e29-afd1-c3f6fc909785"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if02a53ac99ee4a1ea26c7d5e3f59cdc6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIxLTMtMS0xLTE5NjM1_eb6264aa-f556-4ebd-8b61-dcf56cb3aaea"
      unitRef="usd">8842000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idb0ed2c7f70d4aa5b6f870dab5201af9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIxLTUtMS0xLTE5NjM1_0d9e4f40-c0c8-42fc-9f79-0c34892abe8a"
      unitRef="usd">52000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i831eb2d9681540c1865ef9261f998f72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIxLTctMS0xLTE5NjM1_ef8212ff-081c-449d-add5-aff3ebc69d80"
      unitRef="usd">8894000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i802ceb0372954e3b98eecca23defdd06_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIyLTEtMS0xLTE5NjM1_f9290e9c-f76e-4317-a3e7-bf2e9ade8ba0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i87d19268d0744fb497410eaae66e13b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIyLTMtMS0xLTE5NjM1_bdd10e32-aba2-4b7c-9e83-f8190a6528d0"
      unitRef="usd">2918000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia5c0b1f4b23f45dfacb98c427e6d4b31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIyLTUtMS0xLTE5NjM1_66d4e55d-7dd2-449a-b2ea-eb715d3254fd"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4e84fb13164240338a6262a473ae3ecc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIyLTctMS0xLTE5NjM1_a74d7b0f-6567-41af-a268-0e83d0624abd"
      unitRef="usd">2918000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i306cad7c3b5a47c1a8e32bae3a96c55e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIzLTEtMS0xLTE5NjM1_089362e4-163f-4adc-ba9f-b6394c45bcdc"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic52bb1dcf3f9437ebd76d07e0d8d07ca_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIzLTMtMS0xLTE5NjM1_e8504914-0e1a-4526-86d7-8ed0efb8d9a2"
      unitRef="usd">705000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if97e7b2c34d34d7e990cfbbf44d5d6ed_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIzLTUtMS0xLTE5NjM1_64a15a37-5c1e-407c-92ca-d3c1353a892c"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ife5fc6b885a64f58ad6f866ffc705455_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzIzLTctMS0xLTE5NjM1_505d7564-398e-4757-ab15-8b97851b6ba2"
      unitRef="usd">705000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ieaf20faa368b44408a78e930b5996ccf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI0LTEtMS0xLTE5NjM1_fe1aec9c-32d3-42d0-ac45-6ee8400446e5"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i994073ade33544f0933c360c139ab39f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI0LTMtMS0xLTE5NjM1_f6787c3b-5eb2-4e58-b69b-0de7785fb02e"
      unitRef="usd">1046000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i28d3d92a5cf94a3f868e18fd184f97f3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI0LTUtMS0xLTE5NjM1_195145ca-8c73-4615-b64f-5e1d22d334c7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iae8be572405d45c991240d652b7efbee_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI0LTctMS0xLTE5NjM1_631c1321-8e30-4662-8af7-00f737fd34ca"
      unitRef="usd">1046000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4297a85b816143cebb737cc1343a70fe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI1LTEtMS0xLTE5NjM1_949d7017-be06-455d-aa43-891deb91a529"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i49f8a85ce40f4cdfb469db46fc0a3149_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI1LTMtMS0xLTE5NjM1_545d7275-cae6-4567-93c6-665c6e9b5a28"
      unitRef="usd">2403000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if3e2dfc3a14448e4949b0e6ca2e96253_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI1LTUtMS0xLTE5NjM1_dfc0d49f-b425-4718-9898-b9ea7363af94"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id5019bc214954769b41323ef11d4d630_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI1LTctMS0xLTE5NjM1_d1eb0cbb-9b5f-45be-83ac-ae2933c620cf"
      unitRef="usd">2403000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if0f58cb3118b4270929fe6a3d48f0daf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI2LTEtMS0xLTE5NjM1_21d954fb-582e-47b1-8f82-6a6621f96a62"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i956d74f44abd4029b6c77cb197d9452d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI2LTMtMS0xLTE5NjM1_2920a0a5-70e4-42b6-bfa0-17c173abcb79"
      unitRef="usd">24000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3363136ad6a64578bfae7d6bb46bc920_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI2LTUtMS0xLTE5NjM1_89424af6-03b9-4992-82ae-97c2f81e17ee"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0ebbb82192964b068ed1295f2d2d0aff_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI2LTctMS0xLTE5NjM1_48e97154-b12a-4ef3-9af6-576723f36ba3"
      unitRef="usd">25000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6cc1a0e274864af480f200c3ae61c8a9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI3LTEtMS0xLTE5NjM1_08a6d599-e9fd-4119-b14f-de50b9c3eeca"
      unitRef="usd">2370000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5c68ea82b6954ea6b55c0177a55e7799_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI3LTMtMS0xLTE5NjM1_0ecdae13-e763-4850-b02d-6d7136b9f737"
      unitRef="usd">18764000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia658e0719f064994a3725fa8e7cd5a8f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI3LTUtMS0xLTE5NjM1_625a5da5-8b01-4052-8ab9-82c17d67cb74"
      unitRef="usd">54000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i11640c062e35437a84e8bdd5240da928_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI3LTctMS0xLTE5NjM1_9cf64201-9188-4e34-a294-9ccbb7cfe200"
      unitRef="usd">21188000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6cc1a0e274864af480f200c3ae61c8a9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI4LTEtMS0xLTE5NjM1_6e911efc-2093-40ac-a6c9-f9031c3bca3c"
      unitRef="usd">17000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i5c68ea82b6954ea6b55c0177a55e7799_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI4LTMtMS0xLTE5NjM1_2df8b09f-482a-4abd-9b28-18896ecb1e96"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia658e0719f064994a3725fa8e7cd5a8f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI4LTUtMS0xLTE5NjM1_98c3e500-ff30-4c97-9a66-94dc356c1da7"
      unitRef="usd">30000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i11640c062e35437a84e8bdd5240da928_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI4LTctMS0xLTE5NjM1_05f83af2-b8fb-46e4-90ff-f6e606e02eaf"
      unitRef="usd">47000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6cc1a0e274864af480f200c3ae61c8a9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI5LTEtMS0xLTE5NjM1_10d37f15-cf68-41dc-8244-1c2f7ebfe52c"
      unitRef="usd">6372000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5c68ea82b6954ea6b55c0177a55e7799_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI5LTMtMS0xLTE5NjM1_b32befd9-0d01-4a0a-b1cd-950bed7dc526"
      unitRef="usd">22633000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia658e0719f064994a3725fa8e7cd5a8f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI5LTUtMS0xLTE5NjM1_00ab9972-781a-44c3-9149-90eaaa43874b"
      unitRef="usd">84000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i11640c062e35437a84e8bdd5240da928_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MWM2YWNiMzAyYWU0MWM5YTUwOTM5MTY3YmM2M2QyYi90YWJsZXJhbmdlOjgxYzZhY2IzMDJhZTQxYzlhNTA5MzkxNjdiYzYzZDJiXzI5LTctMS0xLTE5NjM1_04d28fe6-80d6-41a4-9c37-33fec6d6612f"
      unitRef="usd">29089000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzEwNTM4_c0fc7a2c-13ab-4d98-836b-c9f548f8ce28">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;States, &lt;br/&gt;municipalities&lt;br/&gt;&#160;and political &lt;br/&gt;subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;br/&gt;corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other asset-&lt;br/&gt;backed&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;preferred&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized and unrealized capital gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in earnings&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers into Level 3, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 financial assets during the year ended December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.859%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;States, &lt;br/&gt;municipalities&lt;br/&gt;&#160;and political &lt;br/&gt;subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S.&lt;br/&gt;corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Redeemable&lt;br/&gt;preferred&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net realized and unrealized capital gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in earnings&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Included in other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers into Level 3, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in unrealized capital losses included in other comprehensive income associated with Level 3 financial assets which were held as of December&#160;31, 2020 was $4&#160;million during the year ended December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total gross transfers into (out of) Level 3 during the years ended December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross transfers into Level 3&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net transfers into Level 3&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i002609847daf4257836b24066c83c6cc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzEtMS0xLTEtMTk2MzU_e2568add-0f00-4e15-99f5-6e950c562086"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i831eb2d9681540c1865ef9261f998f72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzEtMy0xLTEtMTk2MzU_7716959b-cb17-440d-a6bb-4d530a3ffb2f"
      unitRef="usd">52000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i51e8f4940ba94ec990e364c713cce559_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzEtNS0xLTEtNjEyMDI_3ff94bc1-3bfc-4853-b8c9-27942b3dcfa7"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="id5019bc214954769b41323ef11d4d630_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzEtMTEtMS0xLTYxMTYw_35272a5a-401f-4645-ba3e-7767408ded16"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i0ebbb82192964b068ed1295f2d2d0aff_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzEtMTMtMS0xLTYxMjE3_24fe1a34-5cfa-4e41-a270-5016577fc38c"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ia8fe6509813f4691be74589fc2c7309c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzEtMTQtMS0xLTYxMjM4_73245753-e2a1-4473-a211-3bfd5cd2c96f"
      unitRef="usd">30000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i11640c062e35437a84e8bdd5240da928_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzEtOS0xLTEtMTk2MzU_93d278cf-2153-4934-911d-5dc90cda3415"
      unitRef="usd">84000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i0665950998f344f1870f81fb5b6506c5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzMtMS0xLTEtMTk2MzU_c7aa3401-b655-4d4c-bd47-e995574e5359"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="if31d2cf121644c3fa2ca449a00878b1c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzMtMy0xLTEtMTk2MzU_fbb5ada7-af3f-40e6-ae5e-34ea7fa7de8c"
      unitRef="usd">-10000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="if094b6a90e654e42969ee969a10fb465_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzMtNS0xLTEtNjEyMDI_1c3923b2-abf4-4dc3-a98d-4a0f83c294ae"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i79c72a2ed64a45778e58402ff15ba10d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzMtMTEtMS0xLTYxMTY5_7ff02735-c413-4d26-a6b3-60b39fa4759b"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i0e8169d5bee54b719cf109e92dfaf014_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzMtMTMtMS0xLTYxMjE3_ed2d207e-1e72-419e-99a3-1c04df097a05"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i946cf0e9eaeb44bd9b10d99d0d2271ff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzMtMTQtMS0xLTYxMjM4_a531a252-8c43-49d6-8925-4c5b9b72a5ae"
      unitRef="usd">13000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i4f78308e3c32426bb0c2ca2138e491d2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzMtOS0xLTEtMTk2MzU_0d684171-acb6-49b5-813d-3d6bf662d961"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i0665950998f344f1870f81fb5b6506c5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzQtMS0xLTEtMTk2MzU_0f0722a3-505a-492f-84fb-da6ee284a5fb"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="if31d2cf121644c3fa2ca449a00878b1c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzQtMy0xLTEtMTk2MzU_eecc2652-c973-4b32-8995-20cbffadbeba"
      unitRef="usd">-3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="if094b6a90e654e42969ee969a10fb465_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzQtNS0xLTEtNjEyMDI_397df3e1-06c2-482d-9ade-409a3c850131"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i79c72a2ed64a45778e58402ff15ba10d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzQtMTEtMS0xLTYxMTY5_c6c54bfc-4a4f-455e-ba52-a6ab20bc41aa"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i0e8169d5bee54b719cf109e92dfaf014_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzQtMTMtMS0xLTYxMjE3_e75f95bc-ef37-4d28-8119-44be84848de6"
      unitRef="usd">-1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i946cf0e9eaeb44bd9b10d99d0d2271ff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzQtMTQtMS0xLTYxMjM4_b610d731-c7bb-4daa-998e-39c9ccae0333"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i4f78308e3c32426bb0c2ca2138e491d2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzQtOS0xLTEtMTk2MzU_cc149a5f-9eb2-4814-b0c8-2240d1504e8b"
      unitRef="usd">-4000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i0665950998f344f1870f81fb5b6506c5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzUtMS0xLTEtMTk2MzU_36f11c46-9886-4538-a132-5b05cee91694"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="if31d2cf121644c3fa2ca449a00878b1c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzUtMy0xLTEtMTk2MzU_7a6db92a-1658-48e1-90cc-0f1dd8ab44ff"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="if094b6a90e654e42969ee969a10fb465_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzUtNS0xLTEtNjEyMDI_a3d2ae7e-07ff-4118-9f55-41912a146271"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i79c72a2ed64a45778e58402ff15ba10d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzUtMTEtMS0xLTYxMTc2_8e000e27-2ada-44e6-a6c9-ac11f76ef5f6"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i0e8169d5bee54b719cf109e92dfaf014_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzUtMTMtMS0xLTYxMjE3_81b09c93-7a35-45bc-987c-0b703f0179ae"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i946cf0e9eaeb44bd9b10d99d0d2271ff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzUtMTQtMS0xLTYxMjM4_5c3ffb6a-c756-46ee-83cd-d5f233c81602"
      unitRef="usd">13000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i4f78308e3c32426bb0c2ca2138e491d2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzUtOS0xLTEtMTk2MzU_3ebf5617-9c26-422f-a334-f860573adca4"
      unitRef="usd">17000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i0665950998f344f1870f81fb5b6506c5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzYtMS0xLTEtMTk2MzU_33d772e1-e631-42d1-b40c-03ee212cc54f"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="if31d2cf121644c3fa2ca449a00878b1c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzYtMy0xLTEtMTk2MzU_7f7e8229-0f9f-4724-b9d1-9c1bfa39120a"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="if094b6a90e654e42969ee969a10fb465_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzYtNS0xLTEtNjEyMDI_1bfc8383-e6e1-4674-8f4c-502b500895ad"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i79c72a2ed64a45778e58402ff15ba10d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzYtMTEtMS0xLTYxMTc2_05efbdfb-be6f-4fe5-8009-13cd77197df8"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i0e8169d5bee54b719cf109e92dfaf014_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzYtMTMtMS0xLTYxMjE3_4fcba971-b04b-4853-a386-2424327b1160"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i946cf0e9eaeb44bd9b10d99d0d2271ff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzYtMTQtMS0xLTYxMjM4_c3992b1e-3ad0-4b52-b5b7-a5b7c533ea3c"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i4f78308e3c32426bb0c2ca2138e491d2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzYtOS0xLTEtMTk2MzU_93fa06ec-91ff-44a2-85fa-82cec241da92"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i0665950998f344f1870f81fb5b6506c5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzctMS0xLTEtMTk2MzU_1286444a-85b0-46ef-ad04-08b3ce418f6e"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="if31d2cf121644c3fa2ca449a00878b1c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzctMy0xLTEtMTk2MzU_3e1783f5-6a4e-4344-bba1-cd78613c3c52"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="if094b6a90e654e42969ee969a10fb465_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzctNS0xLTEtNjEyMDI_06bfabb3-3c7d-4f6e-ba55-0e993e635beb"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i79c72a2ed64a45778e58402ff15ba10d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzctMTEtMS0xLTYxMTc2_c9523e19-82d9-4c47-8982-ac1c45006d7a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i0e8169d5bee54b719cf109e92dfaf014_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzctMTMtMS0xLTYxMjE3_aca98ba6-a12b-468d-83aa-6c2a4ab4f719"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i946cf0e9eaeb44bd9b10d99d0d2271ff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzctMTQtMS0xLTYxMjM4_3dfdef08-7548-4737-b9e8-5e48a49b0746"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i4f78308e3c32426bb0c2ca2138e491d2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzctOS0xLTEtMTk2MzU_c192cc18-82c3-444f-93d4-ca0901b082c7"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i0665950998f344f1870f81fb5b6506c5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzgtMS0xLTEtMTk2MzU_6653efec-4345-488a-b4c1-0e25f8856fdc"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="if31d2cf121644c3fa2ca449a00878b1c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzgtMy0xLTEtMTk2MzU_51611d54-e7c0-43db-bbba-01b5c245d731"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="if094b6a90e654e42969ee969a10fb465_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzgtNS0xLTEtNjEyMDI_103f50f3-8bbc-40ca-b87f-2b0a544c040a"
      unitRef="usd">10000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i79c72a2ed64a45778e58402ff15ba10d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzgtMTEtMS0xLTYxMTc2_d70b1767-54ca-4afa-96cf-b2a2abea84f3"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i0e8169d5bee54b719cf109e92dfaf014_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzgtMTMtMS0xLTYxMjE3_c9c96225-45fc-4377-9ff8-5a15dc3ffaf5"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i946cf0e9eaeb44bd9b10d99d0d2271ff_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzgtMTQtMS0xLTYxMjM4_1ae8a352-444f-4408-a0f4-1f9f1762a93f"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i4f78308e3c32426bb0c2ca2138e491d2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzgtOS0xLTEtMTk2MzU_ebeb2aa8-d9f7-4a51-aa58-1b371726ccd6"
      unitRef="usd">15000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="id3543b9dfd21451eb0a643264ccb77b8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzktMS0xLTEtMTk2MzU_102fdb19-d937-487c-b4e7-ddf238112298"
      unitRef="usd">5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="if5285fd9babe408da40e34a5f27ecdbe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzktMy0xLTEtMTk2MzU_c1d971ef-c063-4079-bbc0-a2e0791fb8e6"
      unitRef="usd">38000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i1462db60599849f7840faeff7ff4b4f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzktNS0xLTEtNjEyMDI_49baf63f-6c5d-4328-a2da-8536c2b19121"
      unitRef="usd">10000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="id5a62cd495034feaa642a45f38861a84_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzktMTEtMS0xLTYxMTc2_7ab991eb-c37c-45a1-8541-107293326658"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i94d0b79c49904cfb8e3bb6884eba4148_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzktMTMtMS0xLTYxMjE3_df764627-91a4-4530-92f9-f28cf65351b9"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i561ca763e6b04428a37bd3c7b792dcce_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzktMTQtMS0xLTYxMjM4_7b80bb46-1e43-4600-8210-cdbb0ce1c550"
      unitRef="usd">55000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i91e5f841bc1148249e50546c6b0c4b62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTozMGM2OWQ5NzQ3NzY0ZTEwOTdjMDJhZjRmY2E4ZDFjMi90YWJsZXJhbmdlOjMwYzY5ZDk3NDc3NjRlMTA5N2MwMmFmNGZjYThkMWMyXzktOS0xLTEtMTk2MzU_c116bbf7-7150-416a-8ccc-9f0d703e3fa6"
      unitRef="usd">111000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzcyMzA_d2f52fd8-30c5-4e63-a779-dfc8240792db"
      unitRef="usd">-4000000</us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="id9f150f106cf4152b9dec763e74aa596_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzEtMS0xLTEtMTk2MzU_952fece9-3f4f-4c61-b352-fc01ca6838b8"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i565ff383eb0845fbb762f16160ecd982_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzEtMy0xLTEtMTk2MzU_db38f959-dd86-4f2c-9c31-f296b6be7aaf"
      unitRef="usd">37000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ie843e7d6706242f988cc00f4c975f5ba_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzEtNy0xLTEtMTk2MzU_97a70c9e-b11b-4942-abf9-43c32aec2c39"
      unitRef="usd">12000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i9109f42655d2473a86af8d939c6306d2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzEtOS0xLTEtNjEyNTk_b6dc766b-f6bf-4510-a89d-77825f3b8571"
      unitRef="usd">39000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ica9f4747830d4246a5c48c387611d7ed_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzEtOS0xLTEtMTk2MzU_e767aa5e-d330-4025-a5d2-3ff743716efc"
      unitRef="usd">88000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i96db7954709446f6a42325acd7ec241d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzMtMS0xLTEtMTk2MzU_e3e985fe-4c28-4783-9328-6c96146f89e0"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i8da99b3fc771435a97faa9c280e0aebf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzMtMy0xLTEtMTk2MzU_cb608e0d-c5bc-4f98-8501-6dde44844fe8"
      unitRef="usd">-11000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i444b6c2c628f473895e24001c99313a1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzMtNy0xLTEtMTk2MzU_dbd44ff8-21a1-4f3d-a40c-3ecc9b5b1169"
      unitRef="usd">18000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="ifb26232bc7ae41f5a142a468a1d38e94_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzMtOS0xLTEtNjEyNTk_c0bbffe7-db9b-45a4-a89a-13c8a072d5ee"
      unitRef="usd">-3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="ie1e88e7393e140ac8689b32b97e80fb3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzMtOS0xLTEtMTk2MzU_fec554f9-7cbf-4ede-aff9-76f5dc5804e8"
      unitRef="usd">4000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i96db7954709446f6a42325acd7ec241d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzQtMS0xLTEtMTk2MzU_efdc1e15-404d-4126-9405-fc606c27e36b"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i8da99b3fc771435a97faa9c280e0aebf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzQtMy0xLTEtMTk2MzU_dd057fd9-409c-4c9f-ab9f-89c41652a256"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i444b6c2c628f473895e24001c99313a1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzQtNy0xLTEtMTk2MzU_23dbda95-3f8f-4f24-9a38-61c43fb6f982"
      unitRef="usd">-5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="ifb26232bc7ae41f5a142a468a1d38e94_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzQtOS0xLTEtNjEyNTk_ca8f400e-fce2-4bc2-80c7-57a245e9adc8"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="ie1e88e7393e140ac8689b32b97e80fb3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzQtOS0xLTEtMTk2MzU_67ed2ef5-b822-4799-b12d-8cf74620782f"
      unitRef="usd">-5000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i96db7954709446f6a42325acd7ec241d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzUtMS0xLTEtMTk2MzU_95e9c909-06be-461f-854d-417e360f21fd"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i8da99b3fc771435a97faa9c280e0aebf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzUtMy0xLTEtMTk2MzU_8cc0a8a0-a0f8-4590-826e-36eb82ace6ed"
      unitRef="usd">27000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="i444b6c2c628f473895e24001c99313a1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzUtNy0xLTEtMTk2MzU_06115f6f-e664-457a-9125-192b2bd596b3"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="ifb26232bc7ae41f5a142a468a1d38e94_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzUtOS0xLTEtNjEyNTk_9ab268dc-00a7-4a59-9106-0c5d24f71a61"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="ie1e88e7393e140ac8689b32b97e80fb3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzUtOS0xLTEtMTk2MzU_b3371598-d8b6-4517-bdd5-e3e129caa923"
      unitRef="usd">30000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i96db7954709446f6a42325acd7ec241d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzYtMS0xLTEtMTk2MzU_ac3b23ff-6ee9-4359-b24f-b5297e988d6a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i8da99b3fc771435a97faa9c280e0aebf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzYtMy0xLTEtMTk2MzU_1ad12012-7ef2-4d27-b64f-6283b00a2f36"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="i444b6c2c628f473895e24001c99313a1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzYtNy0xLTEtMTk2MzU_55893f83-f5d6-41dd-858d-3c4498dc23f4"
      unitRef="usd">24000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="ifb26232bc7ae41f5a142a468a1d38e94_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzYtOS0xLTEtNjEyNTk_2de83249-3997-4c77-8417-50837e73f91e"
      unitRef="usd">9000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="ie1e88e7393e140ac8689b32b97e80fb3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzYtOS0xLTEtMTk2MzU_654fd91e-f439-4b6c-b1a2-e0e08af2e1c5"
      unitRef="usd">33000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i96db7954709446f6a42325acd7ec241d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzctMS0xLTEtMTk2MzU_c85282b2-a508-4cd7-b42e-33ca99fef6cd"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i8da99b3fc771435a97faa9c280e0aebf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzctMy0xLTEtMTk2MzU_58aad34e-8dcc-4a05-abe9-4f91ecda3ac7"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="i444b6c2c628f473895e24001c99313a1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzctNy0xLTEtMTk2MzU_e70a8435-4027-4a10-9b1d-a21b5c3877ec"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="ifb26232bc7ae41f5a142a468a1d38e94_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzctOS0xLTEtNjEyNTk_2e5537d8-8f5f-4d44-b6fe-85e4ea95bc06"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="ie1e88e7393e140ac8689b32b97e80fb3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzctOS0xLTEtMTk2MzU_c70a46c2-ff33-4d21-a6dc-f6a009fabe9a"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i96db7954709446f6a42325acd7ec241d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzgtMS0xLTEtMTk2MzU_b4d0a3d8-adf1-4f06-b318-ffa883e42b1b"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i8da99b3fc771435a97faa9c280e0aebf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzgtMy0xLTEtMTk2MzU_656348ce-3a57-4ee2-872f-f1cb78a32bc6"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i444b6c2c628f473895e24001c99313a1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzgtNy0xLTEtMTk2MzU_8e717dd6-5bb3-4aad-91f1-a36e56e270f3"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="ifb26232bc7ae41f5a142a468a1d38e94_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzgtOS0xLTEtNjEyNTk_9b22a7ef-41d0-4ccd-850d-c17826e42850"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="ie1e88e7393e140ac8689b32b97e80fb3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzgtOS0xLTEtMTk2MzU_324cf59c-37e6-4272-8eff-45de7b1e6d3a"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i002609847daf4257836b24066c83c6cc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzktMS0xLTEtMTk2MzU_d6099dd4-396b-4b17-8ad4-8ac3fb5ab243"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i831eb2d9681540c1865ef9261f998f72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzktMy0xLTEtMTk2MzU_1a073e41-0e09-4e5b-b802-dff1bacf1938"
      unitRef="usd">52000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i0ebbb82192964b068ed1295f2d2d0aff_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzktNy0xLTEtMTk2MzU_06da7cea-522b-450a-8433-506ecd447d81"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ia8fe6509813f4691be74589fc2c7309c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzktOS0xLTEtNjEyNTk_d4441c70-6926-479a-978b-13c0752b8ee4"
      unitRef="usd">30000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i11640c062e35437a84e8bdd5240da928_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkYTBkOWEwMjk1YTc0MzhhODY5YTdkNGNjZTVmZjg1YS90YWJsZXJhbmdlOmRhMGQ5YTAyOTVhNzQzOGE4NjlhN2Q0Y2NlNWZmODVhXzktOS0xLTEtMTk2MzU_bc9f046d-118b-4ea6-9d59-80b41f60eab6"
      unitRef="usd">84000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzEwOTk1MTE2Mzg3NTM_d8807777-5dc0-4400-b8de-f7cc9883a238"
      unitRef="usd">-4000000</us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="i870c8f372f074816aa15ac75a237b726_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkM2I1ZDA0NjNjNjE0MTc4YWJiOGQ5MTk4NTIyZjQ4ZS90YWJsZXJhbmdlOmQzYjVkMDQ2M2M2MTQxNzhhYmI4ZDkxOTg1MjJmNDhlXzEtMS0xLTEtMTk2MzU_4fa08dbd-f859-46f7-8aac-58e10696bea4"
      unitRef="usd">15000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="i3f1063eb8760432499ef1d5ac46274bb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkM2I1ZDA0NjNjNjE0MTc4YWJiOGQ5MTk4NTIyZjQ4ZS90YWJsZXJhbmdlOmQzYjVkMDQ2M2M2MTQxNzhhYmI4ZDkxOTg1MjJmNDhlXzEtMy0xLTEtMTk2MzU_4ddaa93c-ff60-456c-891b-b9b7049d68e1"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i870c8f372f074816aa15ac75a237b726_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkM2I1ZDA0NjNjNjE0MTc4YWJiOGQ5MTk4NTIyZjQ4ZS90YWJsZXJhbmdlOmQzYjVkMDQ2M2M2MTQxNzhhYmI4ZDkxOTg1MjJmNDhlXzItMS0xLTEtMTk2MzU_4cf1bdf9-f08e-4600-847c-fc190b939f7a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i3f1063eb8760432499ef1d5ac46274bb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkM2I1ZDA0NjNjNjE0MTc4YWJiOGQ5MTk4NTIyZjQ4ZS90YWJsZXJhbmdlOmQzYjVkMDQ2M2M2MTQxNzhhYmI4ZDkxOTg1MjJmNDhlXzItMy0xLTEtMTk2MzU_6d9ab05e-1b07-4d6a-979f-224aa22e9165"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i870c8f372f074816aa15ac75a237b726_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkM2I1ZDA0NjNjNjE0MTc4YWJiOGQ5MTk4NTIyZjQ4ZS90YWJsZXJhbmdlOmQzYjVkMDQ2M2M2MTQxNzhhYmI4ZDkxOTg1MjJmNDhlXzMtMS0xLTEtMTk2MzU_812c1e3f-b6c5-41a5-bdd2-88204e3c7a0a"
      unitRef="usd">15000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i3f1063eb8760432499ef1d5ac46274bb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTpkM2I1ZDA0NjNjNjE0MTc4YWJiOGQ5MTk4NTIyZjQ4ZS90YWJsZXJhbmdlOmQzYjVkMDQ2M2M2MTQxNzhhYmI4ZDkxOTg1MjJmNDhlXzMtMy0xLTEtMTk2MzU_ea552476-1b04-482b-85d1-d31e74fa793a"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzEwNTI5_ca4652bb-56de-4730-8e02-7f1858a29323">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value and estimated fair value classified by level of fair value hierarchy for financial instruments carried on the consolidated balance sheets at adjusted cost or contract value at December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment contract liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;With a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Without a fixed maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;(1)It was not practical to estimate the fair value of these cost-method investments as it represents shares of unlisted companies. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information regarding the valuation of cost method investments.</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="ie5ff79f6ea7640da8266c10697cb62dc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzQtMS0xLTEtMTk2MzU_6784e2ad-f15e-44b7-acdb-de35059ada91"
      unitRef="usd">902000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i62b52466f3974cad83656f04e7bc004c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzQtMy0xLTEtMTk2MzU_8ad41c73-10d1-4bba-b8d6-b27dce0e1524"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i63642ca94ea246beba927f59e1a13b04_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzQtNS0xLTEtMTk2MzU_d96f972a-f06b-4289-bba3-4c85be9783ae"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="ib09205453efc4716a5382309d32f4410_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzQtNy0xLTEtMTk2MzU_b8e7fd9a-d417-4529-9cde-5599b748c15b"
      unitRef="usd">907000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i6cd5d43d704d45d99a5b19bab4753e1e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzQtOS0xLTEtMTk2MzU_7a41b9f8-ea31-40c7-a962-cc24d648d92b"
      unitRef="usd">907000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="ie5ff79f6ea7640da8266c10697cb62dc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzUtMS0xLTEtMTk2MzU_db613405-dbd6-4422-985f-b82db4c7b423"
      unitRef="usd">126000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="ie5ff79f6ea7640da8266c10697cb62dc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzgtMS0xLTEtMTk2MzU_774b12ad-23be-498f-9e27-a53415fd7761"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i62b52466f3974cad83656f04e7bc004c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzgtMy0xLTEtMTk2MzU_e49a44a6-26a9-4fa4-a8f8-927c33bad12c"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i63642ca94ea246beba927f59e1a13b04_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzgtNS0xLTEtMTk2MzU_52f6087e-eb3b-4b45-9542-8fa6d0c46db8"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="ib09205453efc4716a5382309d32f4410_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzgtNy0xLTEtMTk2MzU_6b789418-4d79-4f7c-9b3c-c760f9ea1426"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i6cd5d43d704d45d99a5b19bab4753e1e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzgtOS0xLTEtMTk2MzU_e61fca18-3380-4ffe-beba-ae9d1dd9a78a"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="ie5ff79f6ea7640da8266c10697cb62dc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzktMS0xLTEtMTk2MzU_0d1cc272-609f-41f1-b65e-874a7bb02527"
      unitRef="usd">336000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i62b52466f3974cad83656f04e7bc004c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzktMy0xLTEtMTk2MzU_e45b7da9-065a-4674-9096-d79da2d2e69f"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i63642ca94ea246beba927f59e1a13b04_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzktNS0xLTEtMTk2MzU_9e5e8aa3-aae9-4f93-8a79-1763d98532e1"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="ib09205453efc4716a5382309d32f4410_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzktNy0xLTEtMTk2MzU_49363323-a45b-49c0-8c6c-1b11e04500d5"
      unitRef="usd">373000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i6cd5d43d704d45d99a5b19bab4753e1e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzktOS0xLTEtMTk2MzU_a2bed119-ed2f-429f-a3dc-261049990a09"
      unitRef="usd">373000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie5ff79f6ea7640da8266c10697cb62dc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzEwLTEtMS0xLTE5NjM1_97835fb6-6430-4310-8c98-35096598481f"
      unitRef="usd">56176000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i62b52466f3974cad83656f04e7bc004c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzEwLTMtMS0xLTE5NjM1_a31aa1cf-ec7e-4eb1-ac24-93c68f79ca8f"
      unitRef="usd">64157000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i63642ca94ea246beba927f59e1a13b04_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzEwLTUtMS0xLTE5NjM1_160d635d-ee11-4364-83b7-d878f65b2ce8"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib09205453efc4716a5382309d32f4410_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzEwLTctMS0xLTE5NjM1_0aa00725-f842-4846-9ecb-153b7e22f3d4"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6cd5d43d704d45d99a5b19bab4753e1e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzEwLTktMS0xLTE5NjM1_6c5ab8c0-6fde-4d9a-9ccf-5a77544538aa"
      unitRef="usd">64157000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i39d069b7167947778afa7bcbccb0af02_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE0LTEtMS0xLTE5NjM1_22493822-f29a-4b1a-bb69-16056088495e"
      unitRef="usd">1047000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="icc64edc684564c32a2cb0d0d05d56c6b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE0LTMtMS0xLTE5NjM1_166dfa25-77c6-4c44-be6a-83de892aeb4b"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="ia8f3733991824a44905aef5259a7f9df_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE0LTUtMS0xLTE5NjM1_f095241e-e89a-4237-a9b6-a9c467ebfa03"
      unitRef="usd">0</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="i9da88bdaea8642ffbc4835811efe1f4a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE0LTctMS0xLTE5NjM1_8f136d5c-f154-42d6-bdba-64d1641815cd"
      unitRef="usd">1070000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:MortgagesHeldForSaleFairValueDisclosure
      contextRef="idb08a50cbb6149819b84374b7f1bb9fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE0LTktMS0xLTE5NjM1_7dba34c7-99b0-4a83-995c-e4827f111ea6"
      unitRef="usd">1070000000</us-gaap:MortgagesHeldForSaleFairValueDisclosure>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i39d069b7167947778afa7bcbccb0af02_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE1LTEtMS0xLTE5NjM1_87eebda8-64f6-4b40-a2ac-9073f3fd88d6"
      unitRef="usd">145000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i39d069b7167947778afa7bcbccb0af02_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE4LTEtMS0xLTE5NjM1_8b9b18fe-b8bf-4c32-8fc3-bc0fccb4b232"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="icc64edc684564c32a2cb0d0d05d56c6b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE4LTMtMS0xLTE5NjM1_5bba2df2-33f3-48c4-9882-f2e0fb14c5cf"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="ia8f3733991824a44905aef5259a7f9df_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE4LTUtMS0xLTE5NjM1_a417f633-5916-49b9-bbf2-e4ce1de6a390"
      unitRef="usd">0</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="i9da88bdaea8642ffbc4835811efe1f4a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE4LTctMS0xLTE5NjM1_87878509-5498-47c4-ab5b-25e7d50a8c48"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure
      contextRef="idb08a50cbb6149819b84374b7f1bb9fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE4LTktMS0xLTE5NjM1_c58e59b5-a975-42a6-8fa6-7446d971fd2a"
      unitRef="usd">5000000</cvs:InvestmentContractsWithFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i39d069b7167947778afa7bcbccb0af02_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE5LTEtMS0xLTE5NjM1_cc0fb63e-8a66-4d2c-b41e-ccbbbe933ed3"
      unitRef="usd">322000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="icc64edc684564c32a2cb0d0d05d56c6b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE5LTMtMS0xLTE5NjM1_84fd0a33-b157-4454-a9aa-c5f88e13546b"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="ia8f3733991824a44905aef5259a7f9df_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE5LTUtMS0xLTE5NjM1_c1ab4ea4-28fa-4408-b8f2-b60bc8dd0f53"
      unitRef="usd">0</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="i9da88bdaea8642ffbc4835811efe1f4a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE5LTctMS0xLTE5NjM1_3c0b9704-71eb-4b2d-b5d3-14c8a4b54acc"
      unitRef="usd">371000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure
      contextRef="idb08a50cbb6149819b84374b7f1bb9fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzE5LTktMS0xLTE5NjM1_c378de15-1322-4914-9969-ef7e6e849abe"
      unitRef="usd">371000000</cvs:InvestmentContractsWithoutFixedMaturityFairValueDisclosure>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i39d069b7167947778afa7bcbccb0af02_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzIwLTEtMS0xLTE5NjM1_2164657c-7222-4534-b534-a59871fe266b"
      unitRef="usd">64647000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="icc64edc684564c32a2cb0d0d05d56c6b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzIwLTMtMS0xLTE5NjM1_8ba60e71-ccd8-43b7-947f-f1020e727baa"
      unitRef="usd">75940000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia8f3733991824a44905aef5259a7f9df_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzIwLTUtMS0xLTE5NjM1_214dc609-574c-4dad-9c71-2615bb1904d8"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i9da88bdaea8642ffbc4835811efe1f4a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzIwLTctMS0xLTE5NjM1_a3e9e815-4dbd-401c-840d-d15f9689b523"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="idb08a50cbb6149819b84374b7f1bb9fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTo4MGYzZDU1OWNhZjU0ZmIyYThlNzBkZGNmOTFhZmRlMi90YWJsZXJhbmdlOjgwZjNkNTU5Y2FmNTRmYjJhOGU3MGRkY2Y5MWFmZGUyXzIwLTktMS0xLTE5NjM1_e1507715-2bb5-4c22-b870-374c159b9347"
      unitRef="usd">75940000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzEwNTM0_dfb9fc95-3ad8-4b95-8a65-a68f7ef10b11">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Separate Accounts financial assets at December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.953%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common/collective trusts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $70 million and $29&#160;million of other receivables at December&#160;31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock>
    <us-gaap:SeparateAccountAssets
      contextRef="i1f215dc5a0264a64b253b72d4f6fcd37_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzItMS0xLTEtMTk2MzU_a14278f4-1023-446d-aa81-07ddc625241a"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i95b551d0a20b448ab0a332b566d52832_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzItMy0xLTEtMTk2MzU_acc25ff8-c2cf-4b17-8b63-a925f8e9e1e8"
      unitRef="usd">186000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ifd1e6f617ae2403f8ab8866007e71088_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzItNS0xLTEtMTk2MzU_c1417beb-638c-4378-8fe5-826c6c3336d0"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic0eb0df1025b44c38bf26427309bbed0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzItNy0xLTEtMTk2MzU_b24bb46a-1951-4efb-b36d-51ba5a8b38af"
      unitRef="usd">188000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ifd10d01df7834214b6c5d531c819e017_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzItOS0xLTEtMTk2MzU_9886422c-aa16-45e4-a87b-126cb80e1216"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="if9f3a4b21109462a92ecc4a3617a03a4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzItMTEtMS0xLTE5NjM1_9c12eae2-2d8d-41bf-9dd6-c3d79c585b1b"
      unitRef="usd">186000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i23df6084b54047e19d2389b69af21997_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzItMTMtMS0xLTE5NjM1_06746873-ebe5-4b6b-8152-189fe3c6baf9"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic7c3cc36bebc406d91f45d441bd00dda_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzItMTUtMS0xLTE5NjM1_80f67f33-4258-4143-bccb-0ee04ee1633c"
      unitRef="usd">188000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iae825b6c46034c2f9017cf824110744e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzMtMS0xLTEtMTk2MzU_d0f93502-c029-407d-957a-80dd35aa3566"
      unitRef="usd">1233000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i77d5d134cdca428089c8e81e51a6eb39_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzMtMy0xLTEtMTk2MzU_24ed5866-cca8-44e4-839c-2ae4fe5f241f"
      unitRef="usd">3048000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i25759438875e48d88a44ca557ed1c835_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzMtNS0xLTEtMTk2MzU_8414c3c3-8ae4-43ef-869a-51a4e0c3c0eb"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="if536320d76ef47fb99ae9bca2ae44681_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzMtNy0xLTEtMTk2MzU_0439efb1-95a4-40a7-ba67-6594b7341ab3"
      unitRef="usd">4281000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i1e2ef37787f44952bf1c36f39df42b89_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzMtOS0xLTEtMTk2MzU_8d8c67fb-a034-416c-95a7-b0a5ecd1f02d"
      unitRef="usd">1465000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i1671fc71896b4cbfb0aa01fae5b55103_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzMtMTEtMS0xLTE5NjM1_21be7a37-03fd-47ad-a97f-922b3cbf5e0f"
      unitRef="usd">2634000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="iadfb5cadc1144fe58f4ba77d2fde510b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzMtMTMtMS0xLTE5NjM1_10f4500a-30a2-4bf8-a651-a8c54dd41351"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="icb6c57c636ec4b3284104f81a13fd09a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzMtMTUtMS0xLTE5NjM1_a7431921-5c46-4e55-91e5-f779e7ea6773"
      unitRef="usd">4099000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="icb1458668b5e49a588377fbba57db275_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzQtMS0xLTEtMTk2MzU_8f1f0691-207d-4588-8fed-b8b97366ef79"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib5a2a1f6fc504570bf00460f0dd185f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzQtMy0xLTEtMTk2MzU_46c4c659-bb73-47a0-a40a-66f89bd2fd86"
      unitRef="usd">1000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia00a40ff338a463a87188f3855a06aa6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzQtNS0xLTEtMTk2MzU_b351541f-0ce4-4695-abfa-9b0cdc7e230d"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ib12b30c60e774f8aafb2ac1b598f1c70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzQtNy0xLTEtMTk2MzU_ab9968f2-3813-471c-9bd7-f795b3dd5fda"
      unitRef="usd">1000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i96dabaf8b16941228a15177e351ad141_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzQtOS0xLTEtMTk2MzU_6603786c-3999-495a-9dc0-1ebfbd367473"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ie6e912b4083b44c5a957335b177c7c50_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzQtMTEtMS0xLTE5NjM1_03dc8f74-67e6-4bb3-bbc8-d520d16f318e"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i99fe407ef24f415ea6a7582d16faf5db_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzQtMTMtMS0xLTE5NjM1_195647b3-897d-447d-ab89-52e7a33f049c"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i61412be3a3f547039aecad27f0ec3dad_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzQtMTUtMS0xLTE5NjM1_e04375f6-44ff-4e67-8fef-83598a28d38d"
      unitRef="usd">2000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="if0cf3ff73fbc48efb1b7df6e63ad2a1c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzUtMS0xLTEtMTk2MzU_715c7049-98b3-4979-a484-e4bed968ab57"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i5d3c804bcc694053a4a943ffedb0ed74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzUtMy0xLTEtMTk2MzU_dbdd7ab6-89da-4286-9588-c1102b72bfd8"
      unitRef="usd">547000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i25f0d513b0894261bdb02c2d00130e8e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzUtNS0xLTEtMTk2MzU_17438ad3-24cf-48da-ad27-6bc7dab58fda"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i82e9727495714f18b22c4dbf7b2c2ab3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzUtNy0xLTEtMTk2MzU_6cff5218-96fb-4b75-a55f-cede6bdc34e1"
      unitRef="usd">547000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i0b2dcf414fa5408591f2c20e94023b4f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzUtOS0xLTEtMTk2MzU_1e704cb3-9885-4d27-a252-8e25fc47a627"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i8e2f30ce8c9747828f395554d282e011_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzUtMTEtMS0xLTE5NjM1_feab2031-cf91-4087-b605-9bf3db75e0f8"
      unitRef="usd">563000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i94dd966fcddd49c79185fb0a8b2d0815_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzUtMTMtMS0xLTE5NjM1_d4e42d1a-16e0-4fbb-887c-ca40e4a8d462"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia4f6242a6485437e8da177a1f5b0f951_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzUtMTUtMS0xLTE5NjM1_c8b5ffb8-9db0-4b4f-9ca0-31e93a9a3d19"
      unitRef="usd">563000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="id661ddecbffb4d32b875d7dde00d256b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzYtMS0xLTEtMTk2MzU_b6da7363-3e80-4641-8c4b-5a9294800ed6"
      unitRef="usd">1235000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="id38966f39d564693bc52e2003aea2649_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzYtMy0xLTEtMTk2MzU_06f4d325-c9e8-42d2-9581-eb25fefa87ff"
      unitRef="usd">3782000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i324d950c15024b0bb7034483bcf91fcc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzYtNS0xLTEtMTk2MzU_ea00d81b-0eb3-4ba0-81e1-fb956007fba0"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i91e5f841bc1148249e50546c6b0c4b62_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzYtNy0xLTEtMTk2MzU_c6403eef-44e4-4674-bf13-1cdb92e8e5aa"
      unitRef="usd">5017000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i6cc1a0e274864af480f200c3ae61c8a9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzYtOS0xLTEtMTk2MzU_59d5bdae-a6e1-452c-9976-7f38c22205e6"
      unitRef="usd">1467000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i5c68ea82b6954ea6b55c0177a55e7799_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzYtMTEtMS0xLTE5NjM1_79514d9f-ea86-4ec4-9065-de6f15788b73"
      unitRef="usd">3385000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ia658e0719f064994a3725fa8e7cd5a8f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzYtMTMtMS0xLTE5NjM1_cb4ea781-9aed-4add-ab6a-5b9acd531d6f"
      unitRef="usd">0</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i11640c062e35437a84e8bdd5240da928_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90YWJsZTplZDc3MDdlOTg4NjQ0OTkzOWVhYTk1MzI4MzVmOWU2NS90YWJsZXJhbmdlOmVkNzcwN2U5ODg2NDQ5OTM5ZWFhOTUzMjgzNWY5ZTY1XzYtMTUtMS0xLTE5NjM1_c0fd025d-e949-4699-94dd-2fe76b7649e4"
      unitRef="usd">4852000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="ic0519e37b33f47f38604624a1c7d2928_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzE2NDkyNjc0NTIzODM_bbd4bd0b-9708-43a9-a655-c673d321719f"
      unitRef="usd">70000000</us-gaap:SeparateAccountAssets>
    <us-gaap:SeparateAccountAssets
      contextRef="i6fead32c72504f0d91f1a4db5eaceb10_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzYwNDczMTM5NjM1MDQ_49b1e105-cc6f-4e29-baea-af9f1167107c"
      unitRef="usd">29000000</us-gaap:SeparateAccountAssets>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="i6e9ffd0e0d5f4defad6c6e47302cd444_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzk5NzA_e286aa51-bce0-45dd-ae13-2a215ac711a3"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
      contextRef="icfcc06f892d44fcead268e6e21698a4a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMzkvZnJhZzo3YzljNzg0MmVjZTI0YzIyODg0OTY2M2I4Nzk0NTU4YS90ZXh0cmVnaW9uOjdjOWM3ODQyZWNlMjRjMjI4ODQ5NjYzYjg3OTQ1NThhXzk5NzA_fd4e3214-d755-4d39-ad09-9923aa9a1c27"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzQxMDA_57c7d9c4-2ca7-47d6-b38f-76adac0e9750">Goodwill and Other Intangibles&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the changes in the carrying amount of goodwill by segment for the&#160;years ended December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture of Workers&#x2019; Compensation business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2021, the decrease in the carrying amount of goodwill was primarily driven by a goodwill impairment charge related to the LTC reporting unit within the Retail/LTC segment. During the year ended December&#160;31, 2020, the decrease in the carrying amount of goodwill was primarily driven by the divestiture of the Workers&#x2019; Compensation business, partially offset by goodwill associated with immaterial acquisitions. See Note 2 &#x2018;&#x2018;Divestitures&#x2019;&#x2019; for further discussion regarding the Workers&#x2019; Compensation business divestiture.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2021, the Company performed its required annual impairment tests of goodwill. The results of the impairment tests indicated an impairment of the goodwill associated with the LTC reporting unit, as the reporting unit&#x2019;s carrying value exceeded its fair value as of the testing date. The results of the impairment tests of the remaining reporting units indicated that there was no impairment of goodwill as of the testing date. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2021, the LTC reporting unit has continued to face challenges that have impacted the Company&#x2019;s ability to grow the LTC reporting unit&#x2019;s business at the rate estimated when its 2020 goodwill impairment test was performed. These challenges include lower net facility admissions, net long-term care facility customer losses and the prolonged adverse impact of the COVID-19 pandemic and the emerging new variants, which resulted in more significant declines in occupancy rates experienced by the Company&#x2019;s long-term care facility customers than previously anticipated. During the third quarter of 2021, LTC management updated their 2021 annual forecast and submitted their long-term plan which showed deterioration in the financial results for the remainder of 2021 and beyond. The Company utilized these updated projections in performing its annual impairment test, which indicated that the fair value of the LTC reporting unit was lower than its carrying value, resulting in a $431&#160;million goodwill impairment charge in the third quarter of 2021. The fair value of the LTC reporting unit was determined using a combination of a discounted cash flow method and a market multiple method. As of December&#160;31, 2021, there was no remaining goodwill balance in the LTC reporting unit. During the third quarter of 2021, the Company also performed an impairment test of the intangible assets of the LTC reporting unit and concluded these assets were not impaired. As of December&#160;31, 2021, there was $2.7 billion of intangible assets related to customer lists in the LTC reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the third quarter of 2020, the Company performed its required annual impairment tests of goodwill. The results of the impairment tests indicated that there was no impairment of goodwill. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021 and 2020, cumulative goodwill impairments were $6.6 billion and $6.1 billion, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s intangible assets as of December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions, except weighted average life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks (indefinite-lived)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts/relationships and covenants not to compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of Business Acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks (indefinite-lived)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts/relationships and covenants not to compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of Business Acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(260)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,481)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense for intangible assets totaled $2.3 billion, $2.3 billion and $2.4 billion for the years ended December 31, 2021, 2020 and 2019, respectively. The projected annual amortization expense for the Company&#x2019;s intangible assets for the next five&#160;years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzQxMDI_63d7eb18-0013-45fd-8643-eebbb4273d8d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Below is a summary of the changes in the carrying amount of goodwill by segment for the&#160;years ended December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&lt;br/&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture of Workers&#x2019; Compensation business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(505)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i594e36f005d3463fa1392c6b6973335e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzEtMS0xLTEtMjU2NjI_c49fb271-d8af-4c34-b9e7-cc98312b5767"
      unitRef="usd">45361000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i54659b176aca43799d4dfafb1ae013bf_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzEtMS0xLTEtMTk2MzU_e410d2e5-8b81-4c29-a08d-14e1436ed5db"
      unitRef="usd">23581000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id4560a747fb0428cbb2dfab79c812259_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzEtMy0xLTEtMTk2MzU_d66c50fc-2da9-40be-ba59-262b25d93cd6"
      unitRef="usd">10807000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzEtNy0xLTEtMTk2MzU_6cf093e3-14d1-4d28-ae0d-981120c5a54a"
      unitRef="usd">79749000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ibbcca6fad4064d56beecf38dab7c745c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzItMS0xLTEtMjU2NjI_e53043f5-70d2-4d79-bd90-8e260615c8a8"
      unitRef="usd">274000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="idcf5b0d060a34d59946618c193cd6961_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzItMS0xLTEtMTk2MzU_4c23c45f-64c6-4dc6-97ce-db534f167b1a"
      unitRef="usd">34000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia42958bc5a30456892df849915469aa3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzItMy0xLTEtMTk2MzU_d7577df6-716d-47ae-afde-181d587cc111"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzItNy0xLTEtMTk2MzU_b1417023-300f-4838-925c-99aa080092a2"
      unitRef="usd">308000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ibbcca6fad4064d56beecf38dab7c745c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzMtMS0xLTEtMjU2NjI_e1492e09-6c21-4caf-bfd3-9b322961d065"
      unitRef="usd">505000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="idcf5b0d060a34d59946618c193cd6961_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzMtMS0xLTEtMTk2MzU_7ee11f96-abdf-46fc-8c7c-ee2aef19d3fb"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ia42958bc5a30456892df849915469aa3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzMtMy0xLTEtMTk2MzU_c85e75bc-0642-4ca7-8ce6-eaeb5a39adca"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzMtNy0xLTEtMTk2MzU_dee0fe1e-24d3-4b0e-9350-0409116bc15c"
      unitRef="usd">505000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:Goodwill
      contextRef="i974da252533f4b86b21d77a4afd36380_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzYtMS0xLTEtMjU2NjI_63a403ab-75fc-4eda-a65f-595c85eeb04d"
      unitRef="usd">45130000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i225edcbeb1284c59bae6307ce64ff3e7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzYtMS0xLTEtMTk2MzU_5bbc7abc-e883-473f-9f67-ec8cb44ab036"
      unitRef="usd">23615000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i99c9da9fc50c410b8c73ff24aedfb629_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzYtMy0xLTEtMTk2MzU_edae0a91-0849-4c56-b7b2-fdeb69390d0a"
      unitRef="usd">10807000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzYtNy0xLTEtMTk2MzU_ed164b88-26a3-4684-b1e8-cfc3a00d587c"
      unitRef="usd">79552000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="idf62411f04644ec5a62a251e4c8f705a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzgtMS0xLTEtMjU2NjI_e3ff06ed-a5cd-4a0e-b429-f58fc0bab1b6"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i0701631a0de043b89fd026737221cc81_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzgtMS0xLTEtMTk2MzU_024ff943-f55e-424d-8712-766169c7c946"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i0b5082eb85c041ac945f01d6bc51973d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzgtMy0xLTEtMTk2MzU_fa736855-69e1-4a34-bb04-3ed94cbac49e"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzgtNy0xLTEtMTk2MzU_3e3bb22a-25b1-493f-82e7-9252a1634b6f"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i6355e336e53c4e8f9fad360d96598544_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzEwLTEtMS0xLTI1NjYy_443e0eb4-0fda-4221-9ab7-0e5f0e5196f1"
      unitRef="usd">45130000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i361a96861ee14db9bb7f3e35b6cfabd4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzEwLTEtMS0xLTE5NjM1_90fbf0e5-f974-46eb-9963-51859729bf51"
      unitRef="usd">23615000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7310250aa7db49e5bb0700f9d3b0c92b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzEwLTMtMS0xLTE5NjM1_0f65fb02-28f6-4805-8c26-ad3e5332c718"
      unitRef="usd">10376000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxYzZhODZjM2RjYmM0Yzk4YTZiMWNmMzRmYTBmYWI1MS90YWJsZXJhbmdlOjFjNmE4NmMzZGNiYzRjOThhNmIxY2YzNGZhMGZhYjUxXzEwLTctMS0xLTE5NjM1_6ab851d3-3370-41cb-bb3d-148194fc9eb6"
      unitRef="usd">79121000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i66d7d53744704d0d935a2fefbe9f6853_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzE2NDkyNjc0NTExNzI_b6a3f7a7-b9d0-4db1-9ee1-d123799f81cc"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="iaeb126eb30f245fabd59c464ac7e4e32_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzE2NDkyNjc0NTExNTc_c8d60bcf-4668-4c90-af09-1d9b1c58015a"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i887e2e3179ff4e359cd08c7e8f1fe438_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3Xzk4OTU2MDQ2NjQwNjU_4ba82a07-c3f3-49f3-a59b-2f5ec64c3883"
      unitRef="usd">2700000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3Xzk4OTU2MDQ2NjM4MDA_d0515d83-1b3e-4b73-bc3a-b7954ac2131b"
      unitRef="usd">6600000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3Xzk4OTU2MDQ2NjM4MDg_58c32051-c5a0-46e8-90d7-96569b6e2049"
      unitRef="usd">6100000000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <cvs:FinitelivedandindefinitelivedintangibleassetsTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzQwOTc_d55fcf32-8a02-4918-9c5b-3713ad2e5637">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s intangible assets as of December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions, except weighted average life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks (indefinite-lived)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts/relationships and covenants not to compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of Business Acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks (indefinite-lived)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts/relationships and covenants not to compete&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider networks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Value of Business Acquired &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(260)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,481)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:FinitelivedandindefinitelivedintangibleassetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzItMS0xLTEtMTk2MzU_415a4881-3546-4095-abce-365d9ac68564"
      unitRef="usd">10498000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzItNS0xLTEtMTk2MzU_957b7872-2929-4d9f-9d53-b05b33b49ab2"
      unitRef="usd">10498000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i37da7fe8ff6e4ca79c5d414c9bdf0e79_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzMtMS0xLTEtMTk2MzU_22c024c5-6126-44b1-9f2c-cd3cae199849"
      unitRef="usd">25084000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i37da7fe8ff6e4ca79c5d414c9bdf0e79_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzMtMy0xLTEtMTk2MzU_6b92ce60-0975-47cc-970a-7ec1d3780f93"
      unitRef="usd">10564000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i37da7fe8ff6e4ca79c5d414c9bdf0e79_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzMtNS0xLTEtMTk2MzU_8c8d501b-7214-47b5-9d49-19320e954677"
      unitRef="usd">14520000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i73c432f6e33b44139455c132f65ef574_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzMtNy0xLTEtMTk2MzU_413860c6-79cd-4fce-8069-4366c1620929">P15Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8fdc1e0fae4b4a2698619c6886a71a11_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzQtMS0xLTEtMTk2MzU_433e73ef-7a4e-40f1-a48d-0e8589253b30"
      unitRef="usd">1060000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8fdc1e0fae4b4a2698619c6886a71a11_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzQtMy0xLTEtMTk2MzU_fa664650-147b-4672-8ff1-6cbab2c48b53"
      unitRef="usd">1060000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8fdc1e0fae4b4a2698619c6886a71a11_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzQtNS0xLTEtMTk2MzU_9de25386-e686-47c3-8765-bc38330cc2e2"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="ib4bb0f2698a942c58b64c02bb8890e28_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzQtNy0xLTEtMTk2MzU_4c6749fd-4721-4c69-8309-04fa59bed357">P3Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i103983e6616d4a4990a7c5de9eaf95be_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzUtMS0xLTEtMTk2MzU_b2f9ba98-e203-47f4-a286-bc61a00684e4"
      unitRef="usd">4203000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i103983e6616d4a4990a7c5de9eaf95be_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzUtMy0xLTEtMTk2MzU_9f43637d-1f8d-4845-b207-43a8978cc72c"
      unitRef="usd">651000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i103983e6616d4a4990a7c5de9eaf95be_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzUtNS0xLTEtMTk2MzU_f2e5440f-f0e8-4758-9aad-38dc4e31146e"
      unitRef="usd">3552000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i00d050761ad14c2da89fffbb93d65282_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzUtNy0xLTEtMTk2MzU_848d4b6b-d7f0-4f24-9a97-6f8e3e956a00">P20Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6d83e40a2262423baedabda99555727d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzYtMS0xLTEtMTk2MzU_c6d0bce6-e091-4baa-97ea-b7341b542591"
      unitRef="usd">590000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6d83e40a2262423baedabda99555727d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzYtMy0xLTEtMTk2MzU_bf621161-7698-49db-a5f0-26a9d6bb0035"
      unitRef="usd">173000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6d83e40a2262423baedabda99555727d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzYtNS0xLTEtMTk2MzU_204b3bac-188f-4feb-95ab-9de9401f8b16"
      unitRef="usd">417000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i79e27bc569ff49dbade03b69248d8b84_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzYtNy0xLTEtMTk2MzU_92fc8009-5eb4-4d82-ac61-32bcd819e63b">P20Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibb54e269a38e408f8d2a458b20a0a2f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzctMS0xLTEtMTk2MzU_3e7597cd-6ba0-4d16-b4a5-f823e1f22cec"
      unitRef="usd">318000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibb54e269a38e408f8d2a458b20a0a2f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzctMy0xLTEtMTk2MzU_546578e4-235f-44af-acbf-22940006dba2"
      unitRef="usd">279000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibb54e269a38e408f8d2a458b20a0a2f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzctNS0xLTEtMTk2MzU_f39accb8-aae1-4688-badf-98e377342419"
      unitRef="usd">39000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i3a4de046b34c4136a97065ee6419a19d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzctNy0xLTEtMTk2MzU_df15fa61-b66a-47c2-bf78-6ed59d434eb2">P8Y4M24D</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzgtMS0xLTEtMTk2MzU_11c48f62-6611-4fc2-bb04-9ad9d692a116"
      unitRef="usd">41753000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzgtMy0xLTEtMTk2MzU_e02d53f7-0921-4168-a89f-12433223b4a1"
      unitRef="usd">12727000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzgtNS0xLTEtMTk2MzU_07b783d0-257c-444d-aded-dbc6d35d63c1"
      unitRef="usd">29026000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzgtNy0xLTEtMTk2MzU_aaeb80a7-a309-421c-b05d-708f9014e759">P15Y3M18D</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzExLTEtMS0xLTE5NjM1_99b76b4c-e7dc-497a-ac5e-9d119d997c1c"
      unitRef="usd">10498000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzExLTUtMS0xLTE5NjM1_f7fa3d4d-ab64-4593-bbfc-4bb71ba096a1"
      unitRef="usd">10498000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if06fa0eea15746e6a253c5997edbd86d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzEyLTEtMS0xLTE5NjM1_718ed45a-efec-4850-8e5f-c73215a9a76e"
      unitRef="usd">24952000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if06fa0eea15746e6a253c5997edbd86d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzEyLTMtMS0xLTE5NjM1_9f45ab58-62e9-4a7e-8ae1-0278db85794e"
      unitRef="usd">8923000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="if06fa0eea15746e6a253c5997edbd86d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzEyLTUtMS0xLTE5NjM1_43ab3be2-7d4a-45ab-8e2c-ecad94581486"
      unitRef="usd">16029000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i77da570f38b34e80824f67bbd3e96001_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzEyLTctMS0xLTE5NjM1_15a339da-121c-4ef8-89e1-fdebf46d8494">P14Y10M24D</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idbce2e04d85b437ab5c70fe68d26c55a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzEzLTEtMS0xLTE5NjM1_36a3f064-444f-4d7b-9416-b710262d4c43"
      unitRef="usd">1060000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idbce2e04d85b437ab5c70fe68d26c55a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzEzLTMtMS0xLTE5NjM1_5808fd68-c3f3-412e-ada7-6723da00c20d"
      unitRef="usd">739000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idbce2e04d85b437ab5c70fe68d26c55a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzEzLTUtMS0xLTE5NjM1_7a27276f-3588-4dd6-a07c-74e62fb9b1ba"
      unitRef="usd">321000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="id3fcb171d2594f08acb2adf5555f935c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzEzLTctMS0xLTE5NjM1_609de0f2-c3be-45e3-a4b6-abc831f72861">P3Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia3dd11c0ec7649d2b02e6e800b19ee58_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE0LTEtMS0xLTE5NjM1_152f01ad-5bff-4628-8c91-19be4b7fc3ff"
      unitRef="usd">4203000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia3dd11c0ec7649d2b02e6e800b19ee58_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE0LTMtMS0xLTE5NjM1_8c567514-2bac-484c-8b36-4c309693359e"
      unitRef="usd">440000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia3dd11c0ec7649d2b02e6e800b19ee58_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE0LTUtMS0xLTE5NjM1_d03d2a3d-82e8-4ab1-b1e0-bdec6e4fed30"
      unitRef="usd">3763000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i5e56982d83d84bda83b00a3ffffe885e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE0LTctMS0xLTE5NjM1_0fb85706-298c-47a8-b2de-09759991689e">P20Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iefcbd5f8eaa54f5f81cbe1bbdb76713e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE1LTEtMS0xLTE5NjM1_dc7e20ec-2eba-4671-b18e-2922813edaee"
      unitRef="usd">590000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iefcbd5f8eaa54f5f81cbe1bbdb76713e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE1LTMtMS0xLTE5NjM1_785aa2f5-73cb-4003-b0c9-bf561d942077"
      unitRef="usd">119000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iefcbd5f8eaa54f5f81cbe1bbdb76713e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE1LTUtMS0xLTE5NjM1_3c6a668f-b787-4643-af73-736704121bb1"
      unitRef="usd">471000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i20ffed25fb4d4e59851adea90169ac61_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE1LTctMS0xLTE5NjM1_93e033c5-c53e-4212-83cc-c05f5bbf84fd">P20Y</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9b7b56c81acb43f6a6abd4fa631a8739_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE2LTEtMS0xLTE5NjM1_bcc0f1c3-1f80-4b37-bab7-5478f86b54b7"
      unitRef="usd">320000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9b7b56c81acb43f6a6abd4fa631a8739_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE2LTMtMS0xLTE5NjM1_bfc91a95-ebad-417d-b2c5-16bff5f39383"
      unitRef="usd">260000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9b7b56c81acb43f6a6abd4fa631a8739_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE2LTUtMS0xLTE5NjM1_1f741fba-aea7-4955-8141-098bea2447d5"
      unitRef="usd">60000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i2a39a03b1bea4d85859fc29eb70c86d2_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE2LTctMS0xLTE5NjM1_51d460e4-6012-4d16-aca8-c19e9d1e8b03">P7Y8M12D</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE3LTEtMS0xLTE5NjM1_0068ead0-0a6e-4c5c-b8e6-05cb331077f5"
      unitRef="usd">41623000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE3LTMtMS0xLTE5NjM1_1561110d-9803-41d2-abff-5ec8d4dbaeb9"
      unitRef="usd">10481000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE3LTUtMS0xLTE5NjM1_77752c56-4adb-4151-b6b1-3dd11e70a3f4"
      unitRef="usd">31142000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZToxMDE5NDRiZGU1MWI0OTJkYmM1NjY4NjZlYTFhZTE4MS90YWJsZXJhbmdlOjEwMTk0NGJkZTUxYjQ5MmRiYzU2Njg2NmVhMWFlMTgxXzE3LTctMS0xLTE5NjM1_3d1e7791-3635-4ceb-aba8-85361520b459">P15Y2M12D</us-gaap:FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzM4OTY_2322f286-38d8-494a-8e5b-76d575fa7232"
      unitRef="usd">2300000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzM5MDA_b0be262d-b34e-407f-acea-b46e595b4d45"
      unitRef="usd">2300000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzM5MDc_0212d21f-7cc6-4384-a5f2-d7a7e8492540"
      unitRef="usd">2400000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90ZXh0cmVnaW9uOmIyYTVhMWRkZDhhMTQ3NzVhYjhjOWRiNGE5NmQ3OGI3XzQwOTM_6fae97e7-01d0-4f36-bf91-affd994058a9">The projected annual amortization expense for the Company&#x2019;s intangible assets for the next five&#160;years is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZTpjNzYzYTBiMGJlNmY0MmVjOGIzMWQ0OGMwMTEyNmU5NS90YWJsZXJhbmdlOmM3NjNhMGIwYmU2ZjQyZWM4YjMxZDQ4YzAxMTI2ZTk1XzEtMS0xLTEtMTk2MzU_f3e112ed-93f6-4595-b30f-e35864c00789"
      unitRef="usd">1858000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZTpjNzYzYTBiMGJlNmY0MmVjOGIzMWQ0OGMwMTEyNmU5NS90YWJsZXJhbmdlOmM3NjNhMGIwYmU2ZjQyZWM4YjMxZDQ4YzAxMTI2ZTk1XzItMS0xLTEtMTk2MzU_cd32200c-9d7e-42d5-b134-3ecc1f7f41ae"
      unitRef="usd">1826000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZTpjNzYzYTBiMGJlNmY0MmVjOGIzMWQ0OGMwMTEyNmU5NS90YWJsZXJhbmdlOmM3NjNhMGIwYmU2ZjQyZWM4YjMxZDQ4YzAxMTI2ZTk1XzMtMS0xLTEtMTk2MzU_36eae7c2-cd73-4f2a-b6a0-6bd2e1f6213f"
      unitRef="usd">1785000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZTpjNzYzYTBiMGJlNmY0MmVjOGIzMWQ0OGMwMTEyNmU5NS90YWJsZXJhbmdlOmM3NjNhMGIwYmU2ZjQyZWM4YjMxZDQ4YzAxMTI2ZTk1XzQtMS0xLTEtMTk2MzU_1ce399e8-ba41-46e9-954b-7c5b1e9f49d0"
      unitRef="usd">1734000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDIvZnJhZzpiMmE1YTFkZGQ4YTE0Nzc1YWI4YzlkYjRhOTZkNzhiNy90YWJsZTpjNzYzYTBiMGJlNmY0MmVjOGIzMWQ0OGMwMTEyNmU5NS90YWJsZXJhbmdlOmM3NjNhMGIwYmU2ZjQyZWM4YjMxZDQ4YzAxMTI2ZTk1XzUtMS0xLTEtMTk2MzU_28f2b847-a5a6-4073-b86b-2f2ec4e68eae"
      unitRef="usd">1494000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzU0NjA_0ee4fecf-f4c9-416a-9b54-7d6f5401fb8a">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases most of its retail stores and mail order facilities and certain distribution centers and corporate offices under operating or finance leases, typically with initial terms of 15 to 25 years. The Company also leases certain equipment and other assets under operating or finance leases, typically with initial terms of 3 to 10 years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company leases pharmacy space at the stores of another retail chain for which the noncancelable contractual term of the pharmacy lease arrangement exceeds the remaining estimated economic life of the buildings. For these pharmacy lease arrangements, the Company concluded that for accounting purposes the lease term was the remaining estimated economic life of the buildings. Consequently, most of these individual pharmacy leases are finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases for the years ended December&#160;31, 2021, 2020 and 2019 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for interest portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows paid for principal portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases as of December&#160;31, 2021 and 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except remaining lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,729&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,638&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,177&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,757&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,823&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,395&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance leases:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,375&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,001&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining lease term &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating&lt;br/&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Future operating lease payments have not been reduced by minimum sublease rentals of $311 million due in the future under noncancelable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.4 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sale-Leaseback Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company finances a portion of its store development program through sale-leaseback transactions. The properties are generally sold at net book value, which generally approximates fair value, and the resulting leases generally qualify and are accounted for as operating leases. The operating leases that resulted from these transactions are included in the tables above. The Company does not have any retained or contingent interests in the stores and does not provide any guarantees, other than a &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;guarantee of lease payments, in connection with the sale-leaseback transactions. There were no sale-leaseback transactions in 2021. Proceeds from sale-leaseback transactions totaled $101 million and $5 million in the years ended December 31, 2020 and 2019, respectively. Gains from sale-leaseback transactions totaled $3 million in the year ended December 31, 2020. There were no material gains from sale-leaseback transactions in the year ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Store Impairment Charges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates its retail store right-of-use and property and equipment assets for impairment at the retail store level, which is the lowest level at which cash flows can be identified. For retail stores where there is an indicator of impairment present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated undiscounted future cash flows used in the analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to its estimated fair value which is the greater of the asset group&#x2019;s estimated future cash flows (discounted), or the consideration of what a market participant would pay to lease the assets, net of leasing costs. The Company&#x2019;s estimate of fair value considers historical results, current operating trends, consolidated sales, profitability and cash flow results and forecasts. For assets which the Company has determined it will be able to sublease, the estimated future cash flows include the estimated sublease income, net of estimated leasing costs. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the carrying value of an asset group exceeds its estimated fair value, an impairment loss is recorded to reduce the value of the asset group to its estimated fair value. As the impaired assets are measured at fair value on a nonrecurring basis primarily using unobservable inputs as of the measurement date, the assets are classified in Level 3 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2021, the Company completed a strategic review of its retail business and announced the creation of new formats for its stores to continue to drive higher engagement with customers. As part of this review, the Company evaluated changes in population, consumer buying patterns and future health needs to ensure it has the right kinds of stores in the right locations for consumers and for the business. In connection with this initiative, on November 17, 2021, the Board of Directors of CVS Health Corporation (the &#x201c;Board&#x201d;) authorized the closing of approximately 900 retail stores over the next three years. The Company expects to close approximately 300 stores each year between 2022 and 2024. As a result, management determined that there were indicators of impairment with respect to the impacted stores&#x2019; asset groups, including the associated operating lease right-of-use assets and property and equipment. A long-lived asset impairment test was performed during the fourth quarter of 2021 and the results of the impairment test indicated that the fair value of certain retail store asset groups was lower than their respective carrying values. Accordingly, in the three months ended December 31, 2021, the Company recorded a store impairment charge of approximately $1.4&#160;billion, consisting of a write down of approximately $1.1&#160;billion related to operating lease right-of-use assets and $261&#160;million related to property and equipment, within the Retail/LTC segment. Subsequent to the impairment loss, the fair value of the associated operating lease right-of use assets and property and equipment were $356&#160;million and $185&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2019, the Company performed reviews of its retail stores and determined it would close 68 underperforming retail pharmacy stores. As a result, management determined that there were indicators of impairment with respect to the impacted stores, including the associated operating lease right-of-use assets. Long-lived asset impairment tests were performed and the results indicated that the fair value of those underperforming retail stores were lower than their respective carrying values. Accordingly, the Company recorded store impairment charges of $231 million during the year ended December 31, 2019, primarily related to these operating lease right-of-use asset impairment charges, within the Retail/LTC segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzU0NjU_b4e5dfb9-b8a8-4854-b03c-5608a7fc0bbe">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases most of its retail stores and mail order facilities and certain distribution centers and corporate offices under operating or finance leases, typically with initial terms of 15 to 25 years. The Company also leases certain equipment and other assets under operating or finance leases, typically with initial terms of 3 to 10 years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company leases pharmacy space at the stores of another retail chain for which the noncancelable contractual term of the pharmacy lease arrangement exceeds the remaining estimated economic life of the buildings. For these pharmacy lease arrangements, the Company concluded that for accounting purposes the lease term was the remaining estimated economic life of the buildings. Consequently, most of these individual pharmacy leases are finance leases.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases for the years ended December&#160;31, 2021, 2020 and 2019 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for interest portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows paid for principal portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases as of December&#160;31, 2021 and 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except remaining lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,729&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,638&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,177&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,757&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,823&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,395&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance leases:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,375&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,001&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining lease term &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating&lt;br/&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Future operating lease payments have not been reduced by minimum sublease rentals of $311 million due in the future under noncancelable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.4 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sale-Leaseback Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company finances a portion of its store development program through sale-leaseback transactions. The properties are generally sold at net book value, which generally approximates fair value, and the resulting leases generally qualify and are accounted for as operating leases. The operating leases that resulted from these transactions are included in the tables above. The Company does not have any retained or contingent interests in the stores and does not provide any guarantees, other than a &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;guarantee of lease payments, in connection with the sale-leaseback transactions. There were no sale-leaseback transactions in 2021. Proceeds from sale-leaseback transactions totaled $101 million and $5 million in the years ended December 31, 2020 and 2019, respectively. Gains from sale-leaseback transactions totaled $3 million in the year ended December 31, 2020. There were no material gains from sale-leaseback transactions in the year ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Store Impairment Charges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates its retail store right-of-use and property and equipment assets for impairment at the retail store level, which is the lowest level at which cash flows can be identified. For retail stores where there is an indicator of impairment present, the Company first compares the carrying amount of the asset group to the estimated future cash flows associated with the asset group (undiscounted). If the estimated undiscounted future cash flows used in the analysis are less than the carrying amount of the asset group, an impairment loss calculation is prepared. The impairment loss calculation compares the carrying amount of the asset group to its estimated fair value which is the greater of the asset group&#x2019;s estimated future cash flows (discounted), or the consideration of what a market participant would pay to lease the assets, net of leasing costs. The Company&#x2019;s estimate of fair value considers historical results, current operating trends, consolidated sales, profitability and cash flow results and forecasts. For assets which the Company has determined it will be able to sublease, the estimated future cash flows include the estimated sublease income, net of estimated leasing costs. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the carrying value of an asset group exceeds its estimated fair value, an impairment loss is recorded to reduce the value of the asset group to its estimated fair value. As the impaired assets are measured at fair value on a nonrecurring basis primarily using unobservable inputs as of the measurement date, the assets are classified in Level 3 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2021, the Company completed a strategic review of its retail business and announced the creation of new formats for its stores to continue to drive higher engagement with customers. As part of this review, the Company evaluated changes in population, consumer buying patterns and future health needs to ensure it has the right kinds of stores in the right locations for consumers and for the business. In connection with this initiative, on November 17, 2021, the Board of Directors of CVS Health Corporation (the &#x201c;Board&#x201d;) authorized the closing of approximately 900 retail stores over the next three years. The Company expects to close approximately 300 stores each year between 2022 and 2024. As a result, management determined that there were indicators of impairment with respect to the impacted stores&#x2019; asset groups, including the associated operating lease right-of-use assets and property and equipment. A long-lived asset impairment test was performed during the fourth quarter of 2021 and the results of the impairment test indicated that the fair value of certain retail store asset groups was lower than their respective carrying values. Accordingly, in the three months ended December 31, 2021, the Company recorded a store impairment charge of approximately $1.4&#160;billion, consisting of a write down of approximately $1.1&#160;billion related to operating lease right-of-use assets and $261&#160;million related to property and equipment, within the Retail/LTC segment. Subsequent to the impairment loss, the fair value of the associated operating lease right-of use assets and property and equipment were $356&#160;million and $185&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2019, the Company performed reviews of its retail stores and determined it would close 68 underperforming retail pharmacy stores. As a result, management determined that there were indicators of impairment with respect to the impacted stores, including the associated operating lease right-of-use assets. Long-lived asset impairment tests were performed and the results indicated that the fair value of those underperforming retail stores were lower than their respective carrying values. Accordingly, the Company recorded store impairment charges of $231 million during the year ended December 31, 2019, primarily related to these operating lease right-of-use asset impairment charges, within the Retail/LTC segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeaseTermOfContract1
      contextRef="i447bb7cdaf5843b5906448ab4622616a_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzEwOTk1MTE2MzYwNzk_95d502f9-db4f-4f75-848b-1383495064f5">P15Y</us-gaap:LesseeFinanceLeaseTermOfContract1>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i447bb7cdaf5843b5906448ab4622616a_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzEwOTk1MTE2MzYwNzk_979bd2b7-56f8-407f-b348-6c20a0444ee1">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i254473f0a9d24243b38c3ad981a7cf96_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzMyOTg1MzQ5MTUyNzk_3b95cd4a-57c3-4474-887f-acbab295749c">P25Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeFinanceLeaseTermOfContract1
      contextRef="i254473f0a9d24243b38c3ad981a7cf96_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzMyOTg1MzQ5MTUyNzk_ce1fb6ea-8a36-42a4-9462-203141b420e7">P25Y</us-gaap:LesseeFinanceLeaseTermOfContract1>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="icd712a6b3d0143dca70cd166d1917ef8_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzEwOTk1MTE2MzYwOTM_9132547a-a369-4220-b0c5-5e74c97f4dbe">P3Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeFinanceLeaseTermOfContract1
      contextRef="icd712a6b3d0143dca70cd166d1917ef8_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzMyOTg1MzQ5MTUyODI_d2b8aeb8-7bcc-47ca-afda-689c9e99be08">P3Y</us-gaap:LesseeFinanceLeaseTermOfContract1>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i88e46bad2a4a460281a974cda1807f05_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzMyOTg1MzQ5MTUyODA_864aa545-cb93-4f0c-bf3f-258d9aa95cb0">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeFinanceLeaseTermOfContract1
      contextRef="i88e46bad2a4a460281a974cda1807f05_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzMyOTg1MzQ5MTUyODA_e7b024f9-e60f-4c4e-a332-b5233e0fdeab">P10Y</us-gaap:LesseeFinanceLeaseTermOfContract1>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzU0NzA_fb6dc1a6-79c2-4a90-a726-33caa31acabe">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the components of net lease cost for the years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases for the years ended December&#160;31, 2021, 2020 and 2019 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash flows paid for interest portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash flows paid for principal portion of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzEtMS0xLTEtMTk2MzU_474fba18-50ad-4308-9071-92e158ea35b2"
      unitRef="usd">2633000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzEtMy0xLTEtMTk2MzU_374407af-73cd-424d-9902-edd399456563"
      unitRef="usd">2670000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzEtNS0xLTEtNDQxMjY_70b51ecf-e899-4529-906c-a4f7f30f1ce5"
      unitRef="usd">2720000000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzMtMS0xLTEtMTk2MzU_99a78375-d9c3-4340-994a-46dc10be7234"
      unitRef="usd">62000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzMtMy0xLTEtMTk2MzU_bb80bdea-de4d-4810-8350-d350853b5690"
      unitRef="usd">56000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzMtNS0xLTEtNDQxMzU_b01aafdf-b089-4030-a57f-b5037cd87a20"
      unitRef="usd">38000000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzQtMS0xLTEtMTk2MzU_0aa0a16e-8139-4e87-9cf4-43ff2d1fafd0"
      unitRef="usd">62000000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzQtMy0xLTEtMTk2MzU_3959d376-2868-415a-a635-a41345e53354"
      unitRef="usd">58000000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzQtNS0xLTEtNDQxMzg_e463bc39-0107-4c34-88bc-986773f370c0"
      unitRef="usd">44000000</us-gaap:FinanceLeaseInterestExpense>
    <cvs:FinanceLeaseCost
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzUtMS0xLTEtMTk2MzU_4c2c8f23-2b75-4a4d-90af-bf9d3052b588"
      unitRef="usd">124000000</cvs:FinanceLeaseCost>
    <cvs:FinanceLeaseCost
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzUtMy0xLTEtMTk2MzU_4fc31568-94c6-4b23-81c8-1af2ec2b682a"
      unitRef="usd">114000000</cvs:FinanceLeaseCost>
    <cvs:FinanceLeaseCost
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzUtNS0xLTEtNDQxNDE_f491e808-be4a-4b83-893d-1afaf84fe00c"
      unitRef="usd">82000000</cvs:FinanceLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzYtMS0xLTEtMTk2MzU_625c46d1-769b-4d36-a533-bbf1e86d8e61"
      unitRef="usd">25000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzYtMy0xLTEtMTk2MzU_9335dd3a-b391-4249-b35f-253f335ed544"
      unitRef="usd">22000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzYtNS0xLTEtNDQxNDQ_5180e24d-42e9-4e16-9122-22ccab9ea210"
      unitRef="usd">24000000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzctMS0xLTEtMTk2MzU_aca01ef2-423b-4c44-b7e3-3cc38676d819"
      unitRef="usd">604000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzctMy0xLTEtMTk2MzU_ba07f03d-47d0-419d-ba22-ab31d3f4d247"
      unitRef="usd">599000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzctNS0xLTEtNDQxNDc_37d516c8-a176-466e-a45c-9911a0c11dcf"
      unitRef="usd">581000000</us-gaap:VariableLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzgtMS0xLTEtMTk2MzU_d9443d9b-e79e-429e-b8d8-7abcafe59c87"
      unitRef="usd">59000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzgtMy0xLTEtMTk2MzU_10bc744f-d44f-4ca6-9605-c6d280c080f2"
      unitRef="usd">55000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzgtNS0xLTEtNDQxNTA_e46a4280-407d-452f-9b7a-5646ed574804"
      unitRef="usd">50000000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzktMS0xLTEtMTk2MzU_3d94eb94-8f88-4618-8dfc-44b19efbcb07"
      unitRef="usd">3327000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzktMy0xLTEtMTk2MzU_2d9de24d-1701-4186-838c-7fdb0933d218"
      unitRef="usd">3350000000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZToxMTUzNWUzNDdhZDE0ZDQ2OGQwODA0ODcwNjIwMDRiZi90YWJsZXJhbmdlOjExNTM1ZTM0N2FkMTRkNDY4ZDA4MDQ4NzA2MjAwNGJmXzktNS0xLTEtNDQxNTM_02713661-8159-4a25-b9f5-64184ae6ae3c"
      unitRef="usd">3357000000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzItMS0xLTEtMTk2MzU_6bb1b6e7-9585-4c40-9ed4-2ba2b81ec052"
      unitRef="usd">2714000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzItMy0xLTEtMTk2MzU_82c4b54a-d5e7-41f1-93b1-62c99ca9a459"
      unitRef="usd">2724000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzItNS0xLTEtNDQxNjQ_eec5c524-c8db-4f83-baaf-1ac740fce685"
      unitRef="usd">2701000000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzMtMS0xLTEtMTk2MzU_1b4e739c-67ab-48cb-bede-a1c44759582f"
      unitRef="usd">62000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzMtMy0xLTEtMTk2MzU_701268a2-7b8f-4ffa-845d-d077b35c0e49"
      unitRef="usd">58000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzMtNS0xLTEtNDQxNjQ_2d9d0cbf-ab6e-4bbb-ac30-788ddca20f7f"
      unitRef="usd">44000000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzQtMS0xLTEtMTk2MzU_176981bf-ecba-4554-a44c-cb85e6accb47"
      unitRef="usd">50000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzQtMy0xLTEtMTk2MzU_13691bad-7503-4978-9b05-64cd3dbba3de"
      unitRef="usd">34000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzQtNS0xLTEtNDQxNjQ_61239d26-4890-40e6-8018-4c631bb4a3da"
      unitRef="usd">26000000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzYtMS0xLTEtMTk2MzU_6d01827b-1e61-4c5e-bc8f-b1ff066881cc"
      unitRef="usd">1254000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzYtMy0xLTEtMTk2MzU_ea0b4ee0-3022-4e54-8844-a28e5b6d02c1"
      unitRef="usd">1679000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzYtNS0xLTEtNDQxNjc_a8f2a7d7-9af0-4a5f-86a1-cfe5c6849495"
      unitRef="usd">1824000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzctMS0xLTEtMTk2MzU_67d68bfe-348d-4e4c-9267-80c7780a1284"
      unitRef="usd">278000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzctMy0xLTEtMTk2MzU_27e173d2-c3a3-42df-adb1-8a4bdf5ea7d2"
      unitRef="usd">313000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplMTAyZmNjMGNkMjY0MWU0OTE2ODZjYjNlNTlhZTkxMi90YWJsZXJhbmdlOmUxMDJmY2MwY2QyNjQxZTQ5MTY4NmNiM2U1OWFlOTEyXzctNS0xLTEtNDQxNjc_c26aff2a-eaa3-45a2-a630-95f900313675"
      unitRef="usd">283000000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <cvs:LesseeLeaseTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzU0NjM_2b8236eb-76e5-4220-8693-0b9a6deaf3d7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases as of December&#160;31, 2021 and 2020 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions, except remaining lease term and discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,122&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,729&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt 0 7pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,638&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,177&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,757&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,823&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,395&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance leases:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,375&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,001&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,083&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining lease term &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cvs:LesseeLeaseTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzItMS0xLTEtMTk2MzU_699bac86-5aa1-4edf-ade5-77d85b2c42bf"
      unitRef="usd">19122000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzItMy0xLTEtMTk2MzU_0d824f40-7e24-42b1-b0bc-551d87d40d05"
      unitRef="usd">20729000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzQtMS0xLTEtMTk2MzU_82131072-2aa5-4443-a82a-87bb46cccdd6"
      unitRef="usd">1646000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzQtMy0xLTEtMTk2MzU_89fbdd0d-388e-4309-b6ef-9df6d3da0853"
      unitRef="usd">1638000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzUtMS0xLTEtMTk2MzU_a95e0048-5f3f-4750-8392-b36a207612b5"
      unitRef="usd">18177000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzUtMy0xLTEtMTk2MzU_24f8173f-eb08-42f2-8cd5-443c1a1becd0"
      unitRef="usd">18757000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzYtMS0xLTEtMTk2MzU_c8384606-8e0e-4370-91f0-a9328663328a"
      unitRef="usd">19823000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzYtMy0xLTEtMTk2MzU_f487ab0c-f0ba-4dcd-b52a-700b824c9d7a"
      unitRef="usd">20395000000</us-gaap:OperatingLeaseLiability>
    <cvs:FinanceLeaseRightOfUseAssetGross
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzktMS0xLTEtMTk2MzU_9df79f05-dbc6-4fe3-b4f9-cf2a641991d9"
      unitRef="usd">1375000000</cvs:FinanceLeaseRightOfUseAssetGross>
    <cvs:FinanceLeaseRightOfUseAssetGross
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzktMy0xLTEtMTk2MzU_de8aa7ce-a5e3-43f5-8d7c-7ae790b06a99"
      unitRef="usd">1107000000</cvs:FinanceLeaseRightOfUseAssetGross>
    <cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzEwLTEtMS0xLTE5NjM1_3b290fa9-7eec-4ac6-ba03-623d335ffae1"
      unitRef="usd">188000000</cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation>
    <cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzEwLTMtMS0xLTE5NjM1_ba25c300-3f2b-42c0-8c3d-009ed7f50003"
      unitRef="usd">106000000</cvs:FinanceLeaseRightOfUseAssetAccumulatedDepreciation>
    <cvs:FinanceLeaseRightOfUseAssetNet
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzExLTEtMS0xLTE5NjM1_2c301296-4c09-4215-9511-32bcd5109318"
      unitRef="usd">1187000000</cvs:FinanceLeaseRightOfUseAssetNet>
    <cvs:FinanceLeaseRightOfUseAssetNet
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzExLTMtMS0xLTE5NjM1_d6581ed2-c556-4d2d-a5cf-92b286950bc9"
      unitRef="usd">1001000000</cvs:FinanceLeaseRightOfUseAssetNet>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzEzLTEtMS0xLTE5NjM1_85635bb8-6639-4e9b-a2b5-b47894034308"
      unitRef="usd">50000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzEzLTMtMS0xLTE5NjM1_55629b72-4d74-4c56-864b-3b7e3f0e344a"
      unitRef="usd">33000000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzE0LTEtMS0xLTE5NjM1_32c73653-e4c6-4a50-b907-d7253a194a52"
      unitRef="usd">1250000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzE0LTMtMS0xLTE5NjM1_8557d32e-70a5-40a5-86f3-6931e2b46c3a"
      unitRef="usd">1050000000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzE1LTEtMS0xLTE5NjM1_936b9c0a-cd53-4811-b0d7-2c387d51c358"
      unitRef="usd">1300000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzE1LTMtMS0xLTE5NjM1_aab0d997-cc3f-4ff0-a552-ea14f48286f3"
      unitRef="usd">1083000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzE4LTEtMS0xLTE5NjM1_7f3c88f0-5968-4936-aa4c-6b4e6ce2b77a">P12Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzE4LTMtMS0xLTE5NjM1_99b0406b-155e-4ebf-a9c7-cd3fc730a0cc">P13Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzE5LTEtMS0xLTE5NjM1_7c1d4f5d-68e4-4931-b56b-9db2002a76ed">P20Y</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzE5LTMtMS0xLTE5NjM1_112c8660-51d2-4ba9-bc4c-844237c87720">P20Y3M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzIyLTEtMS0xLTE5NjM1_149c3b0a-8efb-4870-b7a2-807ca2ca941e"
      unitRef="number">0.044</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzIyLTMtMS0xLTE5NjM1_461ac1eb-0686-47e1-a0ae-b9bc1c6a076a"
      unitRef="number">0.045</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzIzLTEtMS0xLTE5NjM1_bddbd346-c032-49f2-b374-fd1c91b56d34"
      unitRef="number">0.050</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTo0ZDBiNjZmZDk0ZWM0ZmM3ODYyMmZhNDgyMTMzMWQ4ZS90YWJsZXJhbmdlOjRkMGI2NmZkOTRlYzRmYzc4NjIyZmE0ODIxMzMxZDhlXzIzLTMtMS0xLTE5NjM1_f8edce3a-7c34-4c3a-a057-1230732fcc9d"
      unitRef="number">0.056</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzU0NjQ_55128836-f272-4a75-b72f-5cabf8aa8675">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating&lt;br/&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Future operating lease payments have not been reduced by minimum sublease rentals of $311 million due in the future under noncancelable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.4 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzU0Njc_05144a34-42e1-4fcf-9709-14fd3ca3816b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the maturity of lease liabilities under finance and operating leases as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating&lt;br/&gt;Leases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease payments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,015)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Future operating lease payments have not been reduced by minimum sublease rentals of $311 million due in the future under noncancelable subleases.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.4 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzEtMS0xLTEtMTk2MzU_0efbebb4-246e-47eb-ae26-6169b87af65d"
      unitRef="usd">122000000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzEtMy0xLTEtMTk2MzU_43d5919e-4074-4340-a918-004e1d0e6546"
      unitRef="usd">2685000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <cvs:LesseeLiabilityPaymentsYearOne
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzEtNS0xLTEtMTk2MzU_95e8c041-9477-4011-9f15-64be9eb4a1e6"
      unitRef="usd">2807000000</cvs:LesseeLiabilityPaymentsYearOne>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzItMS0xLTEtMTk2MzU_85fb9f8b-c291-4ccc-a2f5-c27f747b3d81"
      unitRef="usd">121000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzItMy0xLTEtMTk2MzU_374bf0aa-bf99-46d6-acc0-1929f0a66919"
      unitRef="usd">2613000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <cvs:LesseeLiabilityPaymentsDueYearTwo
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzItNS0xLTEtMTk2MzU_df5d2265-9242-41a8-af19-d227d0b9c054"
      unitRef="usd">2734000000</cvs:LesseeLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzMtMS0xLTEtMTk2MzU_3121c2db-6fb2-4af5-bc80-eaeb5cc750b1"
      unitRef="usd">111000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzMtMy0xLTEtMTk2MzU_1dee61a1-7fb2-40a9-867d-a43b4e413ef4"
      unitRef="usd">2398000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <cvs:LesseeLiabilityPaymentsDueYearThree
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzMtNS0xLTEtMTk2MzU_57ca02fe-034d-4d88-9d0b-11caea8e6bc2"
      unitRef="usd">2509000000</cvs:LesseeLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzQtMS0xLTEtMTk2MzU_f5c01d6d-e2a0-4981-8c2a-12b84bcc91af"
      unitRef="usd">110000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzQtMy0xLTEtMTk2MzU_2f3d2039-d8d9-4e20-b203-6cdacb6bfb3e"
      unitRef="usd">2217000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <cvs:LesseeLiabilityPaymentsDueYearFour
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzQtNS0xLTEtMTk2MzU_6cb3d0fc-be22-4624-abdd-a75fa3aab764"
      unitRef="usd">2327000000</cvs:LesseeLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzUtMS0xLTEtMTk2MzU_97f03861-15f6-48e8-97d8-efe8a6f1293e"
      unitRef="usd">109000000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzUtMy0xLTEtMTk2MzU_23af2f05-0d7b-4fb5-9c74-5c65d47a683a"
      unitRef="usd">2054000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <cvs:LesseeLiabilityPaymentsDueYearFive
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzUtNS0xLTEtMTk2MzU_18bbbcd4-5105-4edb-aefe-997716250fa6"
      unitRef="usd">2163000000</cvs:LesseeLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzYtMS0xLTEtMTk2MzU_aec96d25-ba77-4231-8250-c3c278abdaa1"
      unitRef="usd">1495000000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzYtMy0xLTEtMTk2MzU_f67448fe-1158-4a04-96fe-19fc439fcf38"
      unitRef="usd">14103000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <cvs:LesseeLiabilityPaymentsDueAfterYearFive
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzYtNS0xLTEtMTk2MzU_e02cb550-6a9e-4634-82ab-4bc0a88f56d7"
      unitRef="usd">15598000000</cvs:LesseeLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzctMS0xLTEtMTk2MzU_0116ce97-38d5-43c5-9d69-cb23a9bbc06b"
      unitRef="usd">2068000000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzctMy0xLTEtMTk2MzU_aab3122a-0a32-4e3a-8091-18a8314aee93"
      unitRef="usd">26070000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <cvs:LesseeLiabilityPaymentsDue
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzctNS0xLTEtMTk2MzU_c6edd9b0-1bae-41e5-9523-66bea50a7fec"
      unitRef="usd">28138000000</cvs:LesseeLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzgtMS0xLTEtMTk2MzU_d0c8967b-66b2-4ed2-bc63-41d74e8bca63"
      unitRef="usd">768000000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzgtMy0xLTEtMTk2MzU_fd806136-d7c2-44e7-ac1d-0f9186b8dbbc"
      unitRef="usd">6247000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <cvs:LesseeLiabilityUndiscountedExcessAmount
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzgtNS0xLTEtMTk2MzU_6bbf95a0-eb60-4b7b-b241-5ce834d85a58"
      unitRef="usd">7015000000</cvs:LesseeLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzktMS0xLTEtMTk2MzU_c481cedb-ef63-45fe-87d1-f4b177fa3794"
      unitRef="usd">1300000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzktMy0xLTEtMTk2MzU_f96c1c1d-b482-4591-91c6-8f848c78b772"
      unitRef="usd">19823000000</us-gaap:OperatingLeaseLiability>
    <cvs:LeaseLiability
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90YWJsZTplZjAxYjQyNTg4OTk0YjljOTBkZjE2MDliODA0ZjJmNi90YWJsZXJhbmdlOmVmMDFiNDI1ODg5OTRiOWM5MGRmMTYwOWI4MDRmMmY2XzktNS0xLTEtMTk2MzU_6da34e48-df1b-4769-b3a5-88087f1208a8"
      unitRef="usd">21123000000</cvs:LeaseLiability>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzE5MDE_749f7d30-5f85-4edb-80bb-470315434372"
      unitRef="usd">311000000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <cvs:OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzIyMTA_8fa393cc-be95-4c2d-a7a8-dcb9c728b028"
      unitRef="usd">2400000000</cvs:OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife>
    <us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzEwOTk1MTE2MzQzMjI_5d07c110-bd6b-42ab-bc1a-4d1df836b9d2"
      unitRef="usd">101000000</us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity>
    <us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzE2NDkyNjc0NDg2NjQ_f38c4076-04ef-414e-8094-704d4105ddea"
      unitRef="usd">5000000</us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzEwOTk1MTE2MzQzMzQ_00d40f3c-cc23-482d-9360-0988806a994a"
      unitRef="usd">3000000</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <us-gaap:SaleAndLeasebackTransactionGainLossNet
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzE2NDkyNjc0NDg3OTI_eeba95b8-9ef4-4f5c-a8f0-52d8b763ebf7"
      unitRef="usd">0</us-gaap:SaleAndLeasebackTransactionGainLossNet>
    <cvs:NumberOfStoresPlannedClosure
      contextRef="i5f21266668244130a2a3ae68e0af51a2_D20211001-20211231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3MjQ2NjA_e66c9210-df27-4321-98e2-e77e051ca067"
      unitRef="store">900</cvs:NumberOfStoresPlannedClosure>
    <cvs:NumberOfStoresPlannedClosurePeriod
      contextRef="i5f21266668244130a2a3ae68e0af51a2_D20211001-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzMyOTg1MzQ5MTM2ODk_0dce3385-efaf-46d1-96ca-319587e449d5">P3Y</cvs:NumberOfStoresPlannedClosurePeriod>
    <cvs:NumberOfStoresAnnualPlannedClosuresForClosurePeriod
      contextRef="i5f21266668244130a2a3ae68e0af51a2_D20211001-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3MjQ2NjU_2cf24495-e6c1-4ff4-8ea3-df3f243fac78"
      unitRef="store">300</cvs:NumberOfStoresAnnualPlannedClosuresForClosurePeriod>
    <cvs:StoreImpairmentCharges
      contextRef="i5f21266668244130a2a3ae68e0af51a2_D20211001-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3MzkwMTE_faf1f322-030b-46b5-bd4e-f252a5586314"
      unitRef="usd">1400000000</cvs:StoreImpairmentCharges>
    <cvs:StoreImpairmentCharges
      contextRef="id393d68c87a14ecfa59ccd66f88d6986_D20211001-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3MjQ2ODY_23f86224-e59a-4512-9314-ff4e9bc572b1"
      unitRef="usd">1100000000</cvs:StoreImpairmentCharges>
    <cvs:StoreImpairmentCharges
      contextRef="i73df28e0580843f0af8aec248d34934d_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3MjQ3MDA_d99fc181-eba5-4789-af84-a684f768a25f"
      unitRef="usd">261000000</cvs:StoreImpairmentCharges>
    <cvs:OperatingLeaseRightOfUseAssetFairValueDisclosure
      contextRef="if36ce4c23dc24bb698d0b377df751c48_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3MjgzNjc_44ee4395-6917-4abd-ae32-34decc28e121"
      unitRef="usd">356000000</cvs:OperatingLeaseRightOfUseAssetFairValueDisclosure>
    <us-gaap:PropertyPlantAndEquipmentFairValueDisclosure
      contextRef="i2ec38326eb9b46b19c242875eaaa6067_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3MjgzODE_4c091dad-102d-429b-9b95-8c191d903c95"
      unitRef="usd">185000000</us-gaap:PropertyPlantAndEquipmentFairValueDisclosure>
    <cvs:NumberOfStoresPlannedClosure
      contextRef="i662bccf7d999425aaee1852c1b46776a_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3Mjg3NjA_76bf9c92-c385-4e68-8e5a-d121f67896eb"
      unitRef="store">68</cvs:NumberOfStoresPlannedClosure>
    <cvs:StoreImpairmentCharges
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDUvZnJhZzo4YjJhNzMyN2NhOTI0OWQ5YWU4ZWU2ODIwY2VhMzk5ZC90ZXh0cmVnaW9uOjhiMmE3MzI3Y2E5MjQ5ZDlhZThlZTY4MjBjZWEzOTlkXzM4NDgyOTA3Mjg5NTA_9b4539d8-ff1d-41b9-b8ca-aef4a7ad6ca1"
      unitRef="usd">231000000</cvs:StoreImpairmentCharges>
    <us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzM4MTM_c17e1be7-c740-4a4b-93a1-08e738617759">Health Care Costs Payable&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is information about incurred and cumulative paid health care claims development as of December&#160;31, 2021, net of reinsurance, and the total IBNR liabilities plus expected development on reported claims included within the net incurred claims amounts. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for information on how the Company estimates IBNR reserves and health care costs payable as well as changes to those methodologies, if any. The Company&#x2019;s estimate of IBNR liabilities is primarily based on trend and completion factors. Claim frequency is not used in the calculation of the Company&#x2019;s liability. In addition, it is impracticable to disclose claim frequency information for health care claims due to the Company&#x2019;s inability to gather consistent claim frequency information across its multiple claims processing systems. Any claim frequency count disclosure would not be comparable across the Company&#x2019;s different claim processing systems and would not be consistent from period to period based on the volume of claims processed through each system. As a result, health care claim count frequency is not included in the disclosures below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The information about incurred and paid health care claims development for the year ended December&#160;31, 2020 is presented as required unaudited supplemental information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Incurred Health Care Claims,&lt;br/&gt;Net of Reinsurance&lt;br/&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Date of Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cumulative Paid Health Care Claims,&lt;br/&gt;Net of Reinsurance&lt;br/&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Date of Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All outstanding liabilities for health care costs payable prior to 2020, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total outstanding liabilities for health care costs payable, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021, the Company&#x2019;s liabilities for IBNR plus expected development on reported claims totaled approximately $6.6 billion. Substantially all of the Company&#x2019;s liabilities for IBNR plus expected development on reported claims at December&#160;31, 2021 related to the current calendar year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of the December&#160;31, 2021 health care net incurred and paid claims development tables to the health care costs payable liability on the consolidated balance sheet is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-duration health care costs payable, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance lines other than short duration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total health care costs payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in health care costs payable during the years ended December 31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of period &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Components of incurred health care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(788)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred health care costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total incurred health care costs for the years ended December&#160;31, 2021, 2020 and 2019 in the table above exclude (i) $16 million, $11 million and $4 million, respectively, for a premium deficiency reserve related to the Company&#x2019;s Medicaid products, (ii) $59 million, $41 million and $41 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the consolidated balance sheets and (iii) $212 million, $221 million and $285 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s estimates of prior years&#x2019; health care costs payable decreased by $788 million, $429 million and $524 million in 2021, 2020 and 2019, respectively, because claims were settled for amounts less than originally estimated (i.e., the amount of claims incurred was lower than originally estimated), primarily due to lower health care cost trends as well as the actual claim submission time being faster than originally assumed (i.e., the Company&#x2019;s completion factors were higher than originally assumed) in estimating health care costs payable at the end of the prior year. This development does not directly correspond to an increase in the Company&#x2019;s operating results as these reductions were offset by estimated current period health care costs when the Company established the estimate of the current year health care costs payable.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock>
    <us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzM4MTQ_1d0450c6-4f8b-4e88-b6de-fea80d52c529">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The information about incurred and paid health care claims development for the year ended December&#160;31, 2020 is presented as required unaudited supplemental information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Incurred Health Care Claims,&lt;br/&gt;Net of Reinsurance&lt;br/&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Date of Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cumulative Paid Health Care Claims,&lt;br/&gt;Net of Reinsurance&lt;br/&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Date of Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Unaudited)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All outstanding liabilities for health care costs payable prior to 2020, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total outstanding liabilities for health care costs payable, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="id4963e68529a4b8092a5dbb197266a3c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzMtMS0xLTEtMTk2MzU_1c57de17-04cb-4f2b-994c-1613daa5e0ae"
      unitRef="usd">54529000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i72c01c7edc6746428feb2cca829e603b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzMtMy0xLTEtMTk2MzU_7d3c346a-5b6c-4904-bc56-9fd9d55980db"
      unitRef="usd">53804000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="if19bfb96ace84f7ba6e1dda34847936f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzQtMy0xLTEtMTk2MzU_73e37307-e50a-4a81-9c95-d3dd1868cec5"
      unitRef="usd">62830000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzUtMy0xLTEtMTk2MzU_bab644ac-2523-44a7-80f9-92bae16cbe79"
      unitRef="usd">116634000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="id4963e68529a4b8092a5dbb197266a3c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzEwLTEtMS0xLTE5NjM1_60dbb0be-78b4-469f-9dbe-e1212e1e5f5a"
      unitRef="usd">47567000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i72c01c7edc6746428feb2cca829e603b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzEwLTMtMS0xLTE5NjM1_5f9b7ca9-df03-45fc-a5c2-70cc4d7d8fbf"
      unitRef="usd">53590000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="if19bfb96ace84f7ba6e1dda34847936f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzExLTMtMS0xLTE5NjM1_78c90f5b-a65e-468e-975a-04ae150cd5d5"
      unitRef="usd">54600000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzEyLTMtMS0xLTE5NjM1_e18e95b6-3f8f-4afd-8e2b-ea0c3604a47c"
      unitRef="usd">108190000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented
      contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzEzLTMtMS0xLTE5NjM1_f545a6b5-1a4d-4a7e-9eba-540b84fd5d94"
      unitRef="usd">130000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZToxYzM2NTYwNzNhNDA0MmY1ODc5ZDIwZmZkYjFmNTJlNi90YWJsZXJhbmdlOjFjMzY1NjA3M2E0MDQyZjU4NzlkMjBmZmRiMWY1MmU2XzE0LTMtMS0xLTE5NjM1_54fa32cf-800c-4399-be0c-b123eb6c74a2"
      unitRef="usd">8574000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet
      contextRef="i6355e336e53c4e8f9fad360d96598544_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzE0MjQ_e90537ee-ed96-4dad-9524-f75063a6671e"
      unitRef="usd">6600000000</us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzM4MTU_1d30dd13-4658-4441-8810-bae9be604669">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation of the December&#160;31, 2021 health care net incurred and paid claims development tables to the health care costs payable liability on the consolidated balance sheet is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:83.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-duration health care costs payable, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance lines other than short duration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total health care costs payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTozNjA1YzA3YzNiZmM0NWJlYWZhYWM5OTQ3OWFhYWVmYS90YWJsZXJhbmdlOjM2MDVjMDdjM2JmYzQ1YmVhZmFhYzk5NDc5YWFhZWZhXzEtMS0xLTEtMTk2MzU_54fa32cf-800c-4399-be0c-b123eb6c74a2"
      unitRef="usd">8574000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTozNjA1YzA3YzNiZmM0NWJlYWZhYWM5OTQ3OWFhYWVmYS90YWJsZXJhbmdlOjM2MDVjMDdjM2JmYzQ1YmVhZmFhYzk5NDc5YWFhZWZhXzItMS0xLTEtMTk2MzU_f66f534e-644e-47c0-be85-09370d32bc25"
      unitRef="usd">8000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTozNjA1YzA3YzNiZmM0NWJlYWZhYWM5OTQ3OWFhYWVmYS90YWJsZXJhbmdlOjM2MDVjMDdjM2JmYzQ1YmVhZmFhYzk5NDc5YWFhZWZhXzMtMS0xLTEtMTk2MzU_37bc4395-e4a5-4a23-acf5-b5e8c2d80836"
      unitRef="usd">16000000</cvs:PremiumDeficiencyReserveLiability>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem
      contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTozNjA1YzA3YzNiZmM0NWJlYWZhYWM5OTQ3OWFhYWVmYS90YWJsZXJhbmdlOjM2MDVjMDdjM2JmYzQ1YmVhZmFhYzk5NDc5YWFhZWZhXzQtMS0xLTEtMTk2MzU_15c58acd-af85-49bc-b4fa-95f60e183074"
      unitRef="usd">210000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTozNjA1YzA3YzNiZmM0NWJlYWZhYWM5OTQ3OWFhYWVmYS90YWJsZXJhbmdlOjM2MDVjMDdjM2JmYzQ1YmVhZmFhYzk5NDc5YWFhZWZhXzUtMS0xLTEtMTk2MzU_e47fc71e-f3b5-4587-ac09-3df9434b8569"
      unitRef="usd">8808000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzM4MTg_a6366dd5-bcf2-44b8-b6cf-7bcd76703403">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of the change in health care costs payable during the years ended December 31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.160%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of period &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, beginning of period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Components of incurred health care costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(788)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred health care costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total claims paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Premium deficiency reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of period, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care costs payable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Total incurred health care costs for the years ended December&#160;31, 2021, 2020 and 2019 in the table above exclude (i) $16 million, $11 million and $4 million, respectively, for a premium deficiency reserve related to the Company&#x2019;s Medicaid products, (ii) $59 million, $41 million and $41 million, respectively, of benefit costs recorded in the Health Care Benefits segment that are included in other insurance liabilities on the consolidated balance sheets and (iii) $212 million, $221 million and $285 million, respectively, of benefit costs recorded in the Corporate/Other segment that are included in other insurance liabilities on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i7e7c0dce760d47df841954664e69c360_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEtMS0xLTEtMTk2MzU_f633aba6-79e0-4026-8150-3cc7a44d7104"
      unitRef="usd">7936000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEtMy0xLTEtMTk2MzU_28ed5aef-cca8-4f39-a3e7-b3266d7e54e2"
      unitRef="usd">6879000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i2fa3d998066f4ae1b676b83334f1c904_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEtNS0xLTEtMTk2MzU_4c29b99b-1457-493e-ad40-6a986301392f"
      unitRef="usd">6147000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i7e7c0dce760d47df841954664e69c360_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzItMS0xLTEtMTk2MzU_c7a7ab4d-ed36-4346-9e3c-0e0c8a80ccdc"
      unitRef="usd">10000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzItMy0xLTEtMTk2MzU_008ad40d-8522-4c04-abb4-1abe70aab888"
      unitRef="usd">5000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i2fa3d998066f4ae1b676b83334f1c904_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzItNS0xLTEtMTk2MzU_a97273e2-bab8-4a62-bbf4-c0ef42fe49b8"
      unitRef="usd">4000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i7e7c0dce760d47df841954664e69c360_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzMtMS0xLTEtMTk2MzU_22ceaebc-e941-408c-a31e-b9d08851cfdd"
      unitRef="usd">7926000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzMtMy0xLTEtMTk2MzU_fae10964-8f3a-4846-9671-2818e808641e"
      unitRef="usd">6874000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i2fa3d998066f4ae1b676b83334f1c904_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzMtNS0xLTEtMTk2MzU_c914bba4-42aa-4008-a206-1acf5a66e84c"
      unitRef="usd">6143000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzQtMS0xLTEtMTk2MzU_4d470c83-0975-40e9-8f96-cfe7881bb3a7"
      unitRef="usd">0</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i76012d8261584b91889a99647c4b75ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzQtMy0xLTEtMTk2MzU_0cd5dc36-1e8a-4fb0-8e77-adf2f66c3253"
      unitRef="usd">414000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzQtNS0xLTEtMTk2MzU_37f52d98-fde4-4a46-ac9e-d1e6723651ee"
      unitRef="usd">0</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzctMS0xLTEtMTk2MzU_1c66d126-229d-4457-aba3-291eac190e4d"
      unitRef="usd">64761000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i76012d8261584b91889a99647c4b75ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzctMy0xLTEtMTk2MzU_5608ce8c-5cdf-47a8-8d41-33ca75bfb023"
      unitRef="usd">55835000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzctNS0xLTEtMTk2MzU_c43c8828-ae99-4bd1-9e71-4913cd26152e"
      unitRef="usd">52723000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzgtMS0xLTEtMTk2MzU_e9bc5fc5-6339-4902-9d6f-cf6fbfcd9ccf"
      unitRef="usd">-788000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i76012d8261584b91889a99647c4b75ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzgtMy0xLTEtMTk2MzU_c88168d3-f2bb-4a2b-9948-2703f83e3fc8"
      unitRef="usd">-429000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzgtNS0xLTEtMTk2MzU_7ecb3779-d4fd-4141-a4ee-29f5a1f6200d"
      unitRef="usd">-524000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzktMS0xLTEtMTk2MzU_136f707f-b6d6-4b20-b3ac-027b10ccbc99"
      unitRef="usd">63973000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i76012d8261584b91889a99647c4b75ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzktMy0xLTEtMTk2MzU_3e0ec571-9a89-42cc-92b0-f469a4dde290"
      unitRef="usd">55406000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzktNS0xLTEtMTk2MzU_dafafddd-84ee-49e1-b055-df46a5794411"
      unitRef="usd">52199000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzExLTEtMS0xLTE5NjM1_8bed8f72-acb4-4a5d-81c1-d788881069f7"
      unitRef="usd">56323000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i76012d8261584b91889a99647c4b75ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzExLTMtMS0xLTE5NjM1_38a3a44c-68a8-4e3d-b46e-16764049715e"
      unitRef="usd">48770000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzExLTUtMS0xLTE5NjM1_ad7ff34f-0c70-46da-a8d9-2455ac816227"
      unitRef="usd">46158000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEyLTEtMS0xLTE5NjM1_fde5dc0e-45b0-4dbc-9705-46f4cbe29ddb"
      unitRef="usd">6792000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i76012d8261584b91889a99647c4b75ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEyLTMtMS0xLTE5NjM1_14a3aeb3-0efe-45ab-a6b8-0fd121bfe007"
      unitRef="usd">6009000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEyLTUtMS0xLTE5NjM1_96228bcd-78d5-4d5e-ab81-0bf03fe46724"
      unitRef="usd">5314000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEzLTEtMS0xLTE5NjM1_8b448c83-dea1-40ac-b688-741932c903d1"
      unitRef="usd">63115000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i76012d8261584b91889a99647c4b75ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEzLTMtMS0xLTE5NjM1_397a7b34-add4-4059-972e-f9e3f81c4a78"
      unitRef="usd">54779000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzEzLTUtMS0xLTE5NjM1_b6a7ca41-9404-4f47-b0bc-cac0187841df"
      unitRef="usd">51472000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE0LTEtMS0xLTE5NjM1_a0918f1b-b36d-4143-90d0-ee5479de8fba"
      unitRef="usd">16000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i7e7c0dce760d47df841954664e69c360_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE0LTMtMS0xLTE5NjM1_c0e64093-26e8-4fb7-b52c-4eebe190937f"
      unitRef="usd">11000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE0LTUtMS0xLTE5NjM1_b0792ca7-ca45-4b2c-9f34-a79c4c822bd3"
      unitRef="usd">4000000</cvs:PremiumDeficiencyReserveLiability>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE1LTEtMS0xLTE5NjM1_8c2909f6-c06b-42a8-a1b3-b9fd6defd246"
      unitRef="usd">8800000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i7e7c0dce760d47df841954664e69c360_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE1LTMtMS0xLTE5NjM1_6aebc9fa-29e4-4aa1-b5eb-09893dcccf3a"
      unitRef="usd">7926000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE1LTUtMS0xLTE5NjM1_48aa1849-4de4-4bed-b6f0-2753ed314d2e"
      unitRef="usd">6874000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE2LTEtMS0xLTE5NjM1_5e0826de-cfd7-4684-bb41-75e2ae6e44d6"
      unitRef="usd">8000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i7e7c0dce760d47df841954664e69c360_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE2LTMtMS0xLTE5NjM1_2924a524-3445-4d31-a78d-f6b6903ba7de"
      unitRef="usd">10000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE2LTUtMS0xLTE5NjM1_9ef49f65-aa23-4db9-a1cc-2c590d4cff19"
      unitRef="usd">5000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE3LTEtMS0xLTE5NjM1_70a776a9-006d-43e0-9072-c6bb906d769a"
      unitRef="usd">8808000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i7e7c0dce760d47df841954664e69c360_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE3LTMtMS0xLTE5NjM1_7a20f91d-9c81-465d-a375-8c244504ef49"
      unitRef="usd">7936000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90YWJsZTo2YTQyMGFjYzA3ZDM0ZDA3OTA2ZTk4M2U0NDZhNmY2YS90YWJsZXJhbmdlOjZhNDIwYWNjMDdkMzRkMDc5MDZlOTgzZTQ0NmE2ZjZhXzE3LTUtMS0xLTE5NjM1_6d7e7158-67e5-4876-afab-880af2fb1e90"
      unitRef="usd">6879000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI1NDQ_a0918f1b-b36d-4143-90d0-ee5479de8fba"
      unitRef="usd">16000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="i7e7c0dce760d47df841954664e69c360_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI1NDg_c0e64093-26e8-4fb7-b52c-4eebe190937f"
      unitRef="usd">11000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:PremiumDeficiencyReserveLiability
      contextRef="ia48f5cb5606d454f8bd8a7c72cd64787_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI1NTU_b0792ca7-ca45-4b2c-9f34-a79c4c822bd3"
      unitRef="usd">4000000</cvs:PremiumDeficiencyReserveLiability>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="idf62411f04644ec5a62a251e4c8f705a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI2NTU_b11f2e5e-4b4e-408b-b3dc-01d36c739c14"
      unitRef="usd">59000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="ibbcca6fad4064d56beecf38dab7c745c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI2NTk_dd924c04-a816-4e41-97a2-00ac4b0eb6c5"
      unitRef="usd">41000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i96bd81c6654246d5be1e598d6b692530_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI2NjY_464216aa-3118-43dd-9c12-dc2725e0435f"
      unitRef="usd">41000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="iadbcbd4d470f4615bf38443ed006d736_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI4NDA_cbf363f2-f842-4c5b-8394-81c35cdf1f71"
      unitRef="usd">212000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i158b727557ce414a986ec4f36279d415_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI4NDQ_3f66eb40-9b8f-4319-96a0-2f5685eea198"
      unitRef="usd">221000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts
      contextRef="i59f215ec163143bab8341e2e7c77c7f5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzI4NTE_64b04354-37c3-4837-a08b-fc4d86967fdd"
      unitRef="usd">285000000</cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i7bbd6e94ed2e498baa2afcaefc11b0c5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzMwOTE_e9bc5fc5-6339-4902-9d6f-cf6fbfcd9ccf"
      unitRef="usd">-788000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i76012d8261584b91889a99647c4b75ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzMwOTg_c88168d3-f2bb-4a2b-9948-2703f83e3fc8"
      unitRef="usd">-429000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="i8526bdf5169a4a518976a971913ad0de_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNDgvZnJhZzo2ODdlOGRiMjQxZWM0OTQyYmUxZWZhYjgyZTc1NzlkMS90ZXh0cmVnaW9uOjY4N2U4ZGIyNDFlYzQ5NDJiZTFlZmFiODJlNzU3OWQxXzEwOTk1MTE2MzIxOTE_7ecb3779-d4fd-4141-a4ee-29f5a1f6200d"
      unitRef="usd">-524000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzgwMzM_d14d1173-46ca-45b3-9900-2ddaf5bc273b">Borrowings and Credit Agreements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s borrowings as of December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.452%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.35% senior notes due March 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Floating rate notes due March 2021 (0.950% at December 31, 2020)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due May 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.45% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due July 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due November 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.7% senior notes due March 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4% senior notes due December 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.375% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.625% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due November 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5% senior notes due December 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.1% senior notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.875% senior notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3% senior notes due August 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.625% senior notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.25% senior notes due June 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.3% senior notes due August 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.3% senior notes due March 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.75% senior notes due April 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.75% senior notes due August 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.875% senior notes due February 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due September 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.875% senior notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.625% senior notes due June 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.75% senior notes due December 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.78% senior notes due March 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.125% senior notes due September 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due April 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.7% senior notes due August 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.75% senior notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.5% senior notes due May 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due November 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.3% senior notes due December 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due March 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.125% senior notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due August 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.05% senior notes due March 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.25% senior notes due April 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTAtMS0xLTE5NjM1_55ac48cb-f36e-4b9d-8b69-3e86d1c383ef"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTAtMS0xLTE5NjM1_fc260d98-5cca-40f0-8e2a-2fb2b3ac6249"&gt;Finance lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;65,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Debt premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Debt discounts and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(786)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s required repayments of debt principal due during each of the next five&#160;years and thereafter, as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for a summary of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;maturities of the Company&#x2019;s finance lease liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper and Back-up Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not have any commercial paper outstanding as of December 31, 2021 or 2020. In connection with its commercial paper program, the Company maintains a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 17, 2023, a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 16, 2024, and a $2.0 billion, five-year unsecured back-up revolving credit facility, which expires on May 11, 2026. The credit facilities allow for borrowings at various rates that are dependent, in part, on the Company&#x2019;s public debt ratings and require the Company to pay a weighted average quarterly facility fee of approximately 0.03%, regardless of usage. As of December&#160;31, 2021 and 2020, there were no borrowings outstanding under any of the Company&#x2019;s back-up credit facilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Federal Home Loan Bank of Boston (&#x201c;FHLBB&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A subsidiary of the Company is a member of the FHLBB. As a member, the subsidiary has the ability to obtain cash advances, subject to certain minimum collateral requirements. The maximum borrowing capacity available from the FHLBB as of December&#160;31, 2021 was approximately $995 million. At both December&#160;31, 2021 and 2020, there were no outstanding advances from the FHLBB.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2021 Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 18, 2021, the Company issued $1.0&#160;billion aggregate principal amount of 2.125% unsecured senior notes due September 15, 2031 for total proceeds of $987&#160;million, net of discounts, underwriting fees and offering expenses. The net proceeds of this offering were used for the purchase of senior notes in connection with the Company&#x2019;s cash tender offer in August 2021 as described below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2020 Notes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 16, 2020, the Company issued $750&#160;million aggregate principal amount of 1.3% unsecured senior notes due August 21, 2027 and $1.25&#160;billion aggregate principal amount of 1.875% unsecured senior notes due February 28, 2031 for total proceeds of approximately $1.99&#160;billion, net of discounts and underwriting fees. The $750&#160;million aggregate principal amount of 1.3% unsecured senior notes represent a further issuance of the Company&#x2019;s 1.3% unsecured senior notes due August 21, 2027 initially issued in an aggregate principal amount of $1.5&#160;billion on August 21, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 21, 2020, the Company issued $1.5&#160;billion aggregate principal amount of 1.3% unsecured senior notes due August 21, 2027, $1.25&#160;billion aggregate principal amount of 1.75% unsecured senior notes due August 21, 2030 and $1.25&#160;billion aggregate principal amount of 2.7% unsecured senior notes due August 21, 2040 (collectively, the &#x201c;August 2020 Notes&#x201d;) for total proceeds of approximately $3.97&#160;billion, net of discounts and underwriting fees.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 31, 2020, the Company issued $750&#160;million aggregate principal amount of 3.625% unsecured senior notes due April 1, 2027, $1.5&#160;billion aggregate principal amount of 3.75% unsecured senior notes due April 1, 2030, $1.0&#160;billion aggregate principal amount of 4.125% unsecured senior notes due April 1, 2040 and $750&#160;million aggregate principal amount of 4.25% &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;unsecured senior notes due April 1, 2050 (collectively, the &#x201c;March 2020 Notes&#x201d;) for total proceeds of approximately $3.95&#160;billion, net of discounts and underwriting fees.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net proceeds of these offerings were used for general corporate purposes, which may include working capital, capital expenditures, as well as the repurchase and/or repayment of indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During March 2020, the Company entered into several interest rate swap transactions to manage interest rate risk. These agreements were designated as cash flow hedges and were used to hedge the exposure to variability in future cash flows resulting from changes in interest rates related to the anticipated issuance of the March 2020 Notes. In connection with the issuance of the March 2020 Notes, the Company terminated all outstanding cash flow hedges. The Company paid a net amount of $7&#160;million to the hedge counterparties upon termination, which was recorded as a loss, net of tax, of $5&#160;million in accumulated other comprehensive income and will be reclassified as interest expense over the life of the March 2020 Notes. See Note 13 &#x2018;&#x2018;Other Comprehensive Income&#x2019;&#x2019; for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Early Extinguishments of Debt&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company redeemed for cash the remaining $2.3&#160;billion of its outstanding 3.7% senior notes due 2023. In connection with the early redemption of such senior notes, the Company paid a make-whole premium of $80 million in excess of the aggregate principal amount of the senior notes that were redeemed, wrote-off $8 million of unamortized deferred financing costs and incurred $1 million in fees, for a total loss on early extinguishment of debt of $89&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2021, the Company purchased approximately $2.0&#160;billion of its outstanding 4.3% senior notes due 2028 through a cash tender offer. In connection with the purchase of such senior notes, the Company paid a premium of $332 million&#160;in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $26&#160;million of unamortized deferred financing costs and incurred $5&#160;million in fees, for a total loss on early extinguishment of debt of $363&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, the Company purchased $4.5&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $113&#160;million of its 4.0% senior notes due 2023, $1.4&#160;billion of its 3.7% senior notes due 2023, $1.0&#160;billion of its 4.1% senior notes due 2025 and $2.0&#160;billion of its 4.3% senior notes due 2028. In connection with the purchase of such senior notes, the Company paid a premium of $619&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $45&#160;million of unamortized deferred financing costs and incurred $10&#160;million in fees, for a total loss on early extinguishment of debt of $674&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Company purchased $6.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $723&#160;million of its 4.0% senior notes due 2023, $2.3&#160;billion of its 3.7% senior notes due 2023 and $3.0&#160;billion of its 4.1% senior notes due 2025. In connection with the purchase of such senior notes, the Company paid a premium of $706&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, wrote-off $47&#160;million of unamortized deferred financing costs and incurred $13&#160;million in fees, for a total loss on early extinguishment of debt of $766&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2019, the Company purchased $4.0&#160;billion of its outstanding senior notes through cash tender offers. The senior notes purchased included the following: $1.3&#160;billion of its 3.125% senior notes due 2020, $723&#160;million of its floating rate notes due 2020, $328&#160;million of its 4.125% senior notes due 2021, $297&#160;million of 4.125% senior notes due 2021 issued by Aetna Inc. (&#x201c;Aetna&#x201d;), $413&#160;million of 5.45% senior notes due 2021 issued by Coventry Health Care, Inc., a wholly-owned subsidiary of Aetna, and $962&#160;million of its 3.35% senior notes due 2021. In connection with the purchase of such senior notes, the Company paid a premium of $76&#160;million in excess of the aggregate principal amount of the senior notes that were purchased, incurred $8&#160;million in fees and recognized a net gain of $5&#160;million on the write-off of net unamortized deferred financing premiums, for a net loss on early extinguishment of debt of $79&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Covenants&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s back-up revolving credit facilities, unsecured senior notes and unsecured floating rate notes contain customary restrictive financial and operating covenants. These covenants do not include an acceleration of the Company&#x2019;s debt maturities in the event of a downgrade in the Company&#x2019;s credit ratings. The Company does not believe the restrictions contained in these covenants materially affect its financial or operating flexibility. As of December&#160;31, 2021, the Company was in compliance with all of its debt covenants.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzc5NDQ_23154819-34d5-4e47-bfba-79cd011fea90">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s borrowings as of December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.452%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.35% senior notes due March 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Floating rate notes due March 2021 (0.950% at December 31, 2020)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due May 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.45% senior notes due June 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due July 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due November 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due December 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.7% senior notes due March 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.8% senior notes due June 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4% senior notes due December 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.375% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.625% senior notes due August 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5% senior notes due November 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5% senior notes due December 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.1% senior notes due March 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due July 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.875% senior notes due June 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3% senior notes due August 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.625% senior notes due April 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.25% senior notes due June 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.3% senior notes due August 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.3% senior notes due March 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.25% senior notes due August 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.75% senior notes due April 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.75% senior notes due August 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.875% senior notes due February 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.125% senior notes due September 2031&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.875% senior notes due July 2035&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.625% senior notes due June 2036&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.75% senior notes due December 2037&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.78% senior notes due March 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6.125% senior notes due September 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due April 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.7% senior notes due August 2040&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.75% senior notes due May 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.5% senior notes due May 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.125% senior notes due November 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.3% senior notes due December 2043&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.75% senior notes due March 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.125% senior notes due July 2045&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.875% senior notes due August 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.05% senior notes due March 2048&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.25% senior notes due April 2050&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTAtMS0xLTE5NjM1_55ac48cb-f36e-4b9d-8b69-3e86d1c383ef"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTAtMS0xLTE5NjM1_fc260d98-5cca-40f0-8e2a-2fb2b3ac6249"&gt;Finance lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;65,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Debt premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Debt discounts and deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(786)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;56,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5,440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;51,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;59,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i91523901360c46a3b3e64cd533486ad3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246N2I4YTU4ZTMwMmMxNGM0NDliZWVlMGIyMGJjMjZkOTFfNA_1698ffe3-14f0-47a4-9701-af754fc624a5"
      unitRef="number">0.0335</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i91523901360c46a3b3e64cd533486ad3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEwLTEtMS0xLTE5NjM1_0ef3c07f-c980-4d77-98b8-e336c3cf936e"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2efd3deebdcf481d98efcf7a26363660_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEwLTMtMS0xLTE5NjM1_abf1b70f-c58e-496e-b2b6-9cc0143b9b9c"
      unitRef="usd">2038000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id4c47a098f1b415db3606ac2bcdcf33b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzExLTAtMS0xLTE5NjM1L3RleHRyZWdpb246NGIwNjk1MWVkNTk2NDQwNTlkNTQ0ODQ0OGJhYWFiZDJfNDA_451e3526-7a0f-41fa-a987-b57715383705"
      unitRef="number">0.00950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id230e348ab594d0499b52ae6f1d6b47d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzExLTEtMS0xLTE5NjM1_a7cff589-01a5-44ff-9506-602fe42f4372"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id4c47a098f1b415db3606ac2bcdcf33b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzExLTMtMS0xLTE5NjM1_3ce76cba-9006-4172-876f-b6f77d69ceee"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3e3b186508ca40dd93af39cb786b7ba9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEyLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MDNmZjNjNmZjYmJhNGNhODhlZTg0Y2M1YTg5OGU5NzJfNA_940844c2-9192-488e-8560-c67170fa4ad5"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3e3b186508ca40dd93af39cb786b7ba9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEyLTEtMS0xLTE5NjM1_3c3eeb7d-8900-4e06-ae73-e02141c67476"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i529804562b5e4b20964ec542de3a4305_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEyLTMtMS0xLTE5NjM1_b8ad611e-3ed6-4762-80e2-bb5bc153c6de"
      unitRef="usd">222000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if03bd9fe13614b36a4342b0424978822_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEzLTAtMS0xLTE5NjM1L3RleHRyZWdpb246YTM5YzY2YmQ4MTQ1NGY1MzkzMDI4N2QwMjBmNzllNWRfNA_ec450893-8bc8-420e-b308-7f14c337d036"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if03bd9fe13614b36a4342b0424978822_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEzLTEtMS0xLTE5NjM1_30d99a92-3c76-47c8-8f1b-cb4d733b1b93"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8f67a675f3fa45c69b8fee2598feedaf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzEzLTMtMS0xLTE5NjM1_f52bac95-c503-4a84-9c6c-ff5313133ac9"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8d3ecc7d88d84421b8594f43a72e7bb9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE0LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZWQyMmRjMmMyZDU2NDk1YjhlOTk2YTg1NTY4NmM3MzlfNA_6c23d856-5aab-472a-ab10-881d726364e8"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8d3ecc7d88d84421b8594f43a72e7bb9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE0LTEtMS0xLTE5NjM1_67f0b305-7adf-49ec-a6f0-7de4a9804a66"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie046158c6aa149abae5894fdb3e124c7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE0LTMtMS0xLTE5NjM1_8bfdf6fc-0504-4621-a9de-b5785c4007a6"
      unitRef="usd">203000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifa15869b2ddd4074bd9606c1b61a3b53_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE1LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YmQwOWU5N2M5MWFiNDgwN2JkMmI3NjNiODlmYTAxY2VfNA_5a4a7364-b983-4a4c-b11b-69b7e67a0b7c"
      unitRef="number">0.0545</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifa15869b2ddd4074bd9606c1b61a3b53_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE1LTEtMS0xLTE5NjM1_1cbd2773-67de-4265-a18d-98618789a436"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4892cc30de7a4f45a88addf5dc0f50f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE1LTMtMS0xLTE5NjM1_37264f05-374e-4a7f-aa8f-4cba30a881a9"
      unitRef="usd">187000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1545ac7575274fbab03041015d476d86_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE3LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MmM4NTM3YzE1ZjA1NDBiMmE5OTc4YzYxYThhOTZhNzFfNA_fba90f29-3e68-4c02-9fb6-aba202b38fca"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1545ac7575274fbab03041015d476d86_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE3LTEtMS0xLTE5NjM1_2f157950-fc14-45a8-84c7-4a0ee0c07bcd"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i566f70fe4fc44db799a8e103eafc538a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE3LTMtMS0xLTE5NjM1_c511be90-73e5-44a0-9d06-dd4fab69e7c2"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia06ed28b864c45d09aa4e68d0dcd0b8e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE4LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ODUyYzI3OWQzZTc4NGU0M2IwYzhmM2IyNjAxMDRlYzFfNA_b5e6152f-caf3-4f03-be71-375c0902434e"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia06ed28b864c45d09aa4e68d0dcd0b8e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE4LTEtMS0xLTE5NjM1_74076771-499d-4a9d-90f1-96bd79dcdfa6"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i83c484e09e5c48ef8e40ce7a9666c2e3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE4LTMtMS0xLTE5NjM1_c1aeaf23-fadf-4ebc-8caf-e65a5af385eb"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i38871ce4eafc42498a31f0b4aa3e0fd6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZmQ3NjRhZWRkYTNlNDhkY2IzOGNiNmEzODQxNjA5OTBfNA_e103bed6-1f6a-4bd0-8409-18e0fedc3224"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i38871ce4eafc42498a31f0b4aa3e0fd6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE5LTEtMS0xLTE5NjM1_1a5333b7-9a24-4675-b35b-84392cca9648"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4b47680e6fa347cebcc6cb6ba06e1468_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzE5LTMtMS0xLTE5NjM1_526bf786-0ee7-4354-bf55-eea3dcfb1981"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i528008a52e3c42f88ac57efdeb1d1e22_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246Y2M3MjMzYzA3MWNhNDJjNDlkYWQ4NGEwZjQ3ZDQwZTJfNA_2101d99b-5df6-4d35-a6fc-01e4e7b8bd10"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i528008a52e3c42f88ac57efdeb1d1e22_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIwLTEtMS0xLTE5NjM1_d9d74cb1-2bab-47b2-b021-d941f6becb74"
      unitRef="usd">399000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i78c173076a904738ac9a7ceaa5fad016_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIwLTMtMS0xLTE5NjM1_a48f16ff-841e-4fc5-bb54-3b9930da141f"
      unitRef="usd">399000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia90eaa0d021a4defb944082e8dfa339c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIxLTAtMS0xLTE5NjM1L3RleHRyZWdpb246M2EwMmNmMmIxZjFmNDdjOWFjOTk5MzEzMjg2MjgyNWNfNA_167a2201-002c-4271-9950-fd8493951b46"
      unitRef="number">0.037</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia90eaa0d021a4defb944082e8dfa339c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIxLTEtMS0xLTE5NjM1_e213909b-9534-493c-9414-3d6c35d7edd6"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4acc5bb45f824af59b9b441ae8323056_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIxLTMtMS0xLTE5NjM1_12c9d0e8-1f45-4dc8-b056-bbf10673b11d"
      unitRef="usd">2336000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia75e4b48aa6d46ac8cebd9bd97a2168b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIyLTAtMS0xLTE5NjM1L3RleHRyZWdpb246YjljNjAwZjdiNTE3NGM2ZThmNTc2YjI5MzQyOTk1MDRfNA_1245a264-87fb-48e1-bed1-6d1103ccf548"
      unitRef="number">0.028</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia75e4b48aa6d46ac8cebd9bd97a2168b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIyLTEtMS0xLTE5NjM1_4d0d0d7c-b7f2-4aca-8053-371b1caf86b9"
      unitRef="usd">1300000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id6391c2fe51344c3b0267bc8490521b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIyLTMtMS0xLTE5NjM1_55318ba1-9885-4f8a-9e63-b59900c25521"
      unitRef="usd">1300000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3f81ece57db84513aa5335f4b3d6ac08_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIzLTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZmM5Y2UzZGVkYTYxNGEzMmI3NmUzMWJhMTk1MzhiNzZfNA_cbf73771-81e3-4cf0-8779-2e2ea9dc6547"
      unitRef="number">0.04</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3f81ece57db84513aa5335f4b3d6ac08_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIzLTEtMS0xLTE5NjM1_4bdff1d0-f531-43e0-b0dd-ad2dfe6dedb4"
      unitRef="usd">414000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="icea1808ecadc40d6ae18942dd91a82b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzIzLTMtMS0xLTE5NjM1_c546d0e4-7c42-4710-9d54-4feb3f8e5652"
      unitRef="usd">414000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i90b9d6ed5b7745dba7e056a1af581ada_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI0LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YWM1OWNlYTIwYjAyNGY1MjlhMjQxMDllYTU4ODQxY2FfNA_f5de9bf9-f35d-4352-9e86-06d667cbc1be"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i90b9d6ed5b7745dba7e056a1af581ada_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI0LTEtMS0xLTE5NjM1_37fb7488-2508-4382-8d93-e29a148382d7"
      unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifc98b0c5fe2c4b849511375a8a2ddc06_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI0LTMtMS0xLTE5NjM1_5c9d912f-e8eb-4198-99c1-918d76236c23"
      unitRef="usd">650000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iaeff74e546b24362a8ad306bbfe3bac2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI1LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjZmOWQ1OTVlY2ZkNDY0YTliN2FmMWQ1MzI0NTgyYzVfNA_7777defe-1678-4824-8a93-3847aad4264f"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iaeff74e546b24362a8ad306bbfe3bac2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI1LTEtMS0xLTE5NjM1_2fa6da57-be16-4d95-b00b-5217754cd61a"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia937c17cc45547f2b5ebc4e8a8bc29ad_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI1LTMtMS0xLTE5NjM1_9e4a42a0-0ffb-476b-850e-b1026356f140"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3df15a807dfe4bc393599d84bb5ae0b8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI2LTAtMS0xLTE5NjM1L3RleHRyZWdpb246N2Q1Nzc0ZjVkMWE0NGNhN2I4NzU0OTY3ZTIxYmE1YmNfNA_f39fdf6c-9ef9-4c71-910e-02b280b5ee84"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3df15a807dfe4bc393599d84bb5ae0b8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI2LTEtMS0xLTE5NjM1_7455ca00-a3f7-4c9c-9593-c114768b3017"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ideb967d8ef3440d2aad2a3470fb2b109_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI2LTMtMS0xLTE5NjM1_a5245e5b-1848-48a9-abd3-c5ba4c5d625c"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic5a6bf862703486796be7735801625f7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI3LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YTJkNjc4OTI1MjJjNGVjMGIzYjE1MzU3YmZjY2QzZjNfNA_3ac8b6c8-d1af-47ac-9c09-edf3c94e4ce2"
      unitRef="number">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic5a6bf862703486796be7735801625f7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI3LTEtMS0xLTE5NjM1_b6c262e1-1fd8-419c-b334-d529622acb2b"
      unitRef="usd">299000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i02180112f1f84663b7aaefed8c65784d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI3LTMtMS0xLTE5NjM1_9bfcb7f3-255c-4eca-970b-3751c5f387b0"
      unitRef="usd">299000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ida41dacc05104cc79603a44d10527e6f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI4LTAtMS0xLTE5NjM1L3RleHRyZWdpb246NmU2ZGMyMjFiOGI4NDk4OGFiN2UwMjcyMTlhMTUwMDFfNA_e98cdaff-40f5-4c16-a0a4-edff8cc31f65"
      unitRef="number">0.041</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ida41dacc05104cc79603a44d10527e6f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI4LTEtMS0xLTE5NjM1_5914551e-06da-43ac-8a37-e346a081c2ab"
      unitRef="usd">950000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iad98b34b91f2400e8d921831383f78ff_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI4LTMtMS0xLTE5NjM1_dcbf0aca-2e30-4cc4-8a32-2a2cd60104dd"
      unitRef="usd">950000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic5f70911c7434c7c9d30f3e9f6370e8f_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZWU4ODJjNDhjMGZhNGJkZjhhNGU4Y2U1MTEzZGI3NTNfNA_091ffb00-f31a-4e11-84af-61d8316c17ae"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic5f70911c7434c7c9d30f3e9f6370e8f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI5LTEtMS0xLTE5NjM1_1523b6e9-194e-40b0-b17f-652cfe75bcf0"
      unitRef="usd">2828000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib58d5abd3f97466997c356cc6d003abb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzI5LTMtMS0xLTE5NjM1_03636a60-9489-47bb-b92b-74577b942069"
      unitRef="usd">2828000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i59b67f5f8f844ccc9ef30578495be520_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246N2Y1ZjdhZGNiYjFmNGQ0ZTgzZDkxYjM1OTFhMGYxMzJfNA_36bf964c-e647-412f-89b4-4acfa4c50a06"
      unitRef="number">0.02875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i59b67f5f8f844ccc9ef30578495be520_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMwLTEtMS0xLTE5NjM1_2581b30e-61df-45a5-82b0-9b886284ecd8"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib1b1585ec2b24b72b0323f62ac998309_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMwLTMtMS0xLTE5NjM1_258e5a04-9e86-40b3-865e-66f3e6264dcc"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3bd90d57c71c40889aa14f074e72525d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMxLTAtMS0xLTE5NjM1L3RleHRyZWdpb246NTU1NDE0NzdkMzc2NDgzNTg0OTY3M2MzZDFlNTY0YTVfNA_c7f11fd6-766d-4289-ac34-db14b25df22d"
      unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3bd90d57c71c40889aa14f074e72525d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMxLTEtMS0xLTE5NjM1_e242ce25-1542-4237-80e2-b7fdde66df91"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i196c3c3a85b54d0c823aea5345bb1b47_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMxLTMtMS0xLTE5NjM1_034a9993-fd0c-4167-b35c-0825f22391fd"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia31f8a1af0f74612b2137086a863b2f5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMyLTAtMS0xLTE5NjM1L3RleHRyZWdpb246YTg1NTkwMTM0Mjk2NGNhODk2ZjMzZGM3YjRhOGVmNWRfNA_6360918f-27ce-4108-8bba-96bce1728b94"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia31f8a1af0f74612b2137086a863b2f5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMyLTEtMS0xLTE5NjM1_eaeef7db-50e4-45c8-8204-d00d45c9c8a0"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5e16f05ccac849f6b7239ceda71c5435_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMyLTMtMS0xLTE5NjM1_1a2ec139-bca9-407f-bba3-7c26cb73a0ae"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib01ceb33ad054c6a90191f9d95d44d72_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMzLTAtMS0xLTE5NjM1L3RleHRyZWdpb246M2FlOGYzNTQ4MTUyNDk0ZDkwYmFmY2QwNGM4ODhkMmFfNA_2184ec94-acb9-498f-a553-04cc9ec92696"
      unitRef="number">0.0625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib01ceb33ad054c6a90191f9d95d44d72_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMzLTEtMS0xLTE5NjM1_5babb4fe-aa4c-4b0b-9931-019b45d6f301"
      unitRef="usd">372000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6e79f25e44ce4192aef42fac92e6ebba_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzMzLTMtMS0xLTE5NjM1_2415e6dd-1e0d-4dbf-bbf4-418f50faad28"
      unitRef="usd">372000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7dfa4017c31e4a769e1726240bec574a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM0LTAtMS0xLTE5NjM1L3RleHRyZWdpb246NTEwOTdjZmI2Yjg5NGFiYmExMmQzMDdmYjBmYWIyMDlfNA_d77e4b6c-0c04-47e4-9274-6c6e82ac0592"
      unitRef="number">0.013</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7dfa4017c31e4a769e1726240bec574a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM0LTEtMS0xLTE5NjM1_8d1a6b03-47bc-48f9-b97c-48557f79e232"
      unitRef="usd">2250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i46f1a5a00e9349149a87d2a1ca48676d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM0LTMtMS0xLTE5NjM1_16668e27-cc86-41bd-a5b4-4c3272ec688e"
      unitRef="usd">2250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9e941767d34940eb84521c5bead4b66d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM1LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YTNhMzY2N2YxYjM1NDllMmE5ZTcxOGYzZjNmYjIyOTRfNA_1ba3fc35-62fa-45f9-a9e6-d0f44528ac9f"
      unitRef="number">0.043</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9e941767d34940eb84521c5bead4b66d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM1LTEtMS0xLTE5NjM1_4e0f8ad4-e16c-4ba6-b47c-5f699411dc72"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifeff226b8f72491b84a7b76931939c6c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM1LTMtMS0xLTE5NjM1_96d88726-d64e-4f75-a8ea-b2d5493ec9b1"
      unitRef="usd">7050000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i829935f435f8417e9ebe4db76abf40d6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM2LTAtMS0xLTE5NjM1L3RleHRyZWdpb246OWU5NThlNDllZTQ2NDcxMjg0MjRjZTQ1NzNlOTZlN2JfNA_9b1a9289-8916-40c5-b63c-58b8af166ac1"
      unitRef="number">0.0325</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i829935f435f8417e9ebe4db76abf40d6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM2LTEtMS0xLTE5NjM1_d5c63735-488b-433d-ab1d-23e7394435bd"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic9a0fde9614c415093ac05b5ccf09851_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM2LTMtMS0xLTE5NjM1_352a5526-6bb1-48a8-8114-5b8604bf66a9"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2383f6f259884a2ca2d37bfea6f7f9b1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM3LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YzQyMDBjMjBlNTI1NGUzYjkyZWFmZDcyZjA0ODg3NTZfNA_af8a0964-978f-404b-95ea-92d6cbf09c06"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2383f6f259884a2ca2d37bfea6f7f9b1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM3LTEtMS0xLTE5NjM1_8ebf3807-942e-4ea2-910f-26b9384158f5"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i963597ecd59945d0b5207daf0eb2b186_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM3LTMtMS0xLTE5NjM1_ee5332ac-b5a6-4076-b9c3-5e9eb744a073"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib90e1ba9c1fb44d496c2f63b444e51ab_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM4LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YmMyZGFmYzhhMDJlNDM0Njk0OTUxNTc5ODllNzYxOTFfNA_6c8ceca7-b7de-4b1b-bd6b-505c9dce38a1"
      unitRef="number">0.0175</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib90e1ba9c1fb44d496c2f63b444e51ab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM4LTEtMS0xLTE5NjM1_218789ce-3882-487e-8e29-852ed74b156b"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i17a365c216d54612a53d69c5c0e80a5f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM4LTMtMS0xLTE5NjM1_ef334dd4-3284-4472-b683-32dd56b7e917"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8c47829d25484ecdabdc89287f759465_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YjU3Zjc5MmIxYjBkNGUzZDhjZTFhYmI5NzU1YTU0OTZfNA_dd587e93-e607-46f0-8044-27df90434d7f"
      unitRef="number">0.01875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8c47829d25484ecdabdc89287f759465_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM5LTEtMS0xLTE5NjM1_5cf56346-9cfc-4420-b04d-6053f2424156"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8fc01427e2da4fb88ab22fdc0b7e32fc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzM5LTMtMS0xLTE5NjM1_8ece5eb7-679f-469b-9f13-5f891b4a791f"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie6286228091e44d0a7a084cebf96e83d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQwLTAtMS0xLTIwNzM3L3RleHRyZWdpb246OTY4ZWNjM2FlYmYzNDQ2M2EyNmZhNjFkNjRkN2NjNGVfMTA5OTUxMTYyNzgyNg_35f6416d-2261-4508-8962-61fb6484e24a"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie6286228091e44d0a7a084cebf96e83d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQwLTEtMS0xLTIwODAx_9d095400-4218-4a50-8013-521e846254af"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id7974392fedf4d69b48cf73026d43053_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQwLTMtMS0xLTIwODI4_c6e99cfd-a2c6-46a2-89bf-cf0ab2407955"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i66d6bb918a1841c7b29b4e54eaff9002_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246YTlmYTk2ZDk0ZGYxNGYxN2FlY2FmYmI5OWM3OWY2ZjNfNA_d4a49f4d-d1bd-43f0-bf5d-cdb51513e247"
      unitRef="number">0.04875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i66d6bb918a1841c7b29b4e54eaff9002_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQwLTEtMS0xLTE5NjM1_3b1fe4db-4242-4112-ba37-11214bccaad8"
      unitRef="usd">652000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i22855f4f70944d80a431f1009d80d2d6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQwLTMtMS0xLTE5NjM1_df0e546b-293b-40b5-ba6c-7e996895e932"
      unitRef="usd">652000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6deef011e2dd4c96bd53333619f01231_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQxLTAtMS0xLTE5NjM1L3RleHRyZWdpb246MWRjMzBkMTA0YTBmNDljOGE1ODNkMzA3Y2ZiZTI1YjFfNA_a2df4f2f-2ada-4a00-bcbd-55e0504448ae"
      unitRef="number">0.06625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6deef011e2dd4c96bd53333619f01231_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQxLTEtMS0xLTE5NjM1_3051ec61-ef62-4b61-aa7f-ef54d4a46e87"
      unitRef="usd">771000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie75ef397faf445d3a901e0af5e125899_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQxLTMtMS0xLTE5NjM1_a7856a97-b600-404d-94eb-138eb57c05a8"
      unitRef="usd">771000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6d9e820cbb5640bcaab284f7fdabd210_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQyLTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZDU3NmMzZjMzODIxNDJmNjkzYWEzNGRmM2I4MWQzN2ZfNA_14460d2e-c386-4c86-9ab7-25612f58b725"
      unitRef="number">0.0675</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6d9e820cbb5640bcaab284f7fdabd210_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQyLTEtMS0xLTE5NjM1_2140a8d6-a126-4142-a103-01e06dcf7ea5"
      unitRef="usd">533000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic356af28bfd045ffa9174ee4741a3d1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQyLTMtMS0xLTE5NjM1_a816bb15-de65-40a3-9de8-07bbec900086"
      unitRef="usd">533000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if36b1314b05240d98146140634ecdbbc_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQzLTAtMS0xLTE5NjM1L3RleHRyZWdpb246NWUyOWExM2FlNmMyNDMzODgyNzExYmM0OTI4OTUwODZfNA_022eb6e5-6b4f-4089-a684-2c9920f1481b"
      unitRef="number">0.0478</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if36b1314b05240d98146140634ecdbbc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQzLTEtMS0xLTE5NjM1_a6e9db67-7851-4dd6-95cb-11dedb161aab"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ica522c18f13c411eae44d16f4d18ce20_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQzLTMtMS0xLTE5NjM1_d973db6b-8bee-4935-a238-da8f75282cde"
      unitRef="usd">5000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibedc3ae92ee24ab597438f089a05003c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ0LTAtMS0xLTE5NjM1L3RleHRyZWdpb246M2JhNzcyNjYxOWQ1NDNmM2I3MzU5ZmQ3YmRhZjRkMjNfNA_ba59d202-b2d7-4ae0-86b1-538fe03f3ae4"
      unitRef="number">0.06125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibedc3ae92ee24ab597438f089a05003c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ0LTEtMS0xLTE5NjM1_4c55c3a7-dcd6-4e53-a5b8-8b5bd3dab63a"
      unitRef="usd">447000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if7ccf63bdf184cf98f51d95c1720b750_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ0LTMtMS0xLTE5NjM1_30cc8302-ad06-43dd-9384-e013c4e832d9"
      unitRef="usd">447000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i66980e2699e94ff68df99ccb53d43a5d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ1LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YzYxZjc5YzhjZDU5NDg2NzkzY2UyODRlZTM4YzhmZTNfNA_5e024777-14d6-4231-9abc-15fef3c274b2"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i66980e2699e94ff68df99ccb53d43a5d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ1LTEtMS0xLTE5NjM1_a53876fa-eb8b-475b-b9f5-b466917d3bff"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i59a1bba78be542ef8a8f0f0622414168_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ1LTMtMS0xLTE5NjM1_e837bcab-b0a3-424c-af48-c6be21c80794"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6b5f82fd2e9948249d51305151c10a0a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ2LTAtMS0xLTE5NjM1L3RleHRyZWdpb246Zjg4YjBlNTA0YTZkNDFkNWIwZjljMjAzYjg4ZmQwMThfNA_544fcdca-0db6-4af9-84b9-66b50357af6e"
      unitRef="number">0.027</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i6b5f82fd2e9948249d51305151c10a0a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ2LTEtMS0xLTE5NjM1_81510492-b238-48da-8996-57e99c8ef01f"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i0a3a26ae8b3f4d658d7d84e925e6932c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ2LTMtMS0xLTE5NjM1_be8e5d35-e1e3-4de7-8aa3-44bccfffa04e"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iba9e24130d424bf7933c036abe3fcacf_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ3LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZWFkYTY0ZjYwMmQyNDc4OGIxNzRjMWE1NTBjYWEzNGFfNA_e94d5fac-5c49-444f-b96e-c21c2f80667f"
      unitRef="number">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="iba9e24130d424bf7933c036abe3fcacf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ3LTEtMS0xLTE5NjM1_134f19b9-d8f7-4574-b7f3-d53d90fbd265"
      unitRef="usd">133000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i731815b798d2445687a0b94d8984740b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ3LTMtMS0xLTE5NjM1_52de2486-b8db-49e2-b247-1ed3ee44f0b1"
      unitRef="usd">133000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id78a04082f9f4d9abbc5e0508e3f4590_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ4LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZTQwN2Q0NmIyN2MwNDZmNWExMmQ3OTM1YWRkNTQxODFfNA_4375a82c-b40f-4bb5-8c71-b834c92fd429"
      unitRef="number">0.045</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id78a04082f9f4d9abbc5e0508e3f4590_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ4LTEtMS0xLTE5NjM1_a75b66ca-0511-443a-8294-2c544236d2ea"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifcbe63373aad4f449cf221d8fb8bed34_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ4LTMtMS0xLTE5NjM1_8d82d0ac-9ec7-46a9-a1d0-3d5cc0d68f22"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i08f395fb692848039e5b5e89cf899bd7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YTQwMWZkNDkwMzgzNDkxNTkzY2Q1NzllMjYzZjBjMjBfNA_a33226d6-8325-4c39-86ee-f9cf6e7a42f4"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i08f395fb692848039e5b5e89cf899bd7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ5LTEtMS0xLTE5NjM1_fa2cf9e3-c5ca-4d7d-8d43-9bbd998ed765"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i5872f67f264f4286ab44e43e24612b0d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzQ5LTMtMS0xLTE5NjM1_10a227c9-4c26-4456-b507-3451fd3e9643"
      unitRef="usd">500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie72908e23c3040c0a69888583cbcc793_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246NTgxMzMzNDYxYmFhNDM0NmIwYjI2MTRhYjU2MDllM2NfNA_85a7313b-ce74-41d6-8ea5-a6c6445a3838"
      unitRef="number">0.053</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ie72908e23c3040c0a69888583cbcc793_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUwLTEtMS0xLTE5NjM1_e292dfda-7190-48d0-8ce2-f258f710e948"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifed64cc823de43c7bf2f78098c4438cb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUwLTMtMS0xLTE5NjM1_8e69bfcf-534e-41c1-bbd5-9d38c99b77db"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2ba90e1b15f247189f65ef311ff3a5d8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUxLTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZjQzNzhiZDFjZmM1NDFjNWE2NmY2NWY4YWNmY2RjZGRfNA_49493277-4ad0-4a5a-ba99-22b72fa3f94d"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2ba90e1b15f247189f65ef311ff3a5d8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUxLTEtMS0xLTE5NjM1_4ed75ca3-b348-40f1-a278-ba125f4b56e9"
      unitRef="usd">375000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i369332f01d914260ad39bb9f3745585c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUxLTMtMS0xLTE5NjM1_8aa58304-7cca-46d4-88cd-e20367548fcd"
      unitRef="usd">375000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i189a6cf6ec97415ea1727e01c3f51404_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUyLTAtMS0xLTE5NjM1L3RleHRyZWdpb246Yjk2MzdmMTQ5NTBhNDU5ZmJiMTIxNmZjMTUwNzYwNDBfNA_d39ea20a-d565-432d-bd3b-f6e5d9614f13"
      unitRef="number">0.05125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i189a6cf6ec97415ea1727e01c3f51404_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUyLTEtMS0xLTE5NjM1_57374eba-bfd7-4198-89ab-d8ed610afbf5"
      unitRef="usd">3500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ia4a2069eda0d49ae856f3a624d3da473_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUyLTMtMS0xLTE5NjM1_f0e13dd2-234b-45a5-a662-51c610ee8bc8"
      unitRef="usd">3500000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2e79648650b54806a91c3d411f2ea35c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUzLTAtMS0xLTE5NjM1L3RleHRyZWdpb246YjdkZTI4MTA3MWIyNGVlZjgzNDY1MWQ2NTYwMGUxMGZfNA_a45c63f8-e62b-4ad9-834a-d3789e01e547"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2e79648650b54806a91c3d411f2ea35c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUzLTEtMS0xLTE5NjM1_a0e9acc5-9eca-4d62-903b-6784fc1f452b"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9e6ba14d8ad442b0b834bdfbf7a454bf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzUzLTMtMS0xLTE5NjM1_e0a58aed-35c2-4430-92be-2a0af76af304"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8c6e0f8b2d6a4e219ead75b3e364997a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU0LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MjY1YTExZGUzYTcwNDllM2JiMzY5ZWFmMTNiYjdkOTlfNA_6d39105d-186f-45a1-939b-ca387f8c2bb2"
      unitRef="number">0.0505</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8c6e0f8b2d6a4e219ead75b3e364997a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU0LTEtMS0xLTE5NjM1_cd3e04fc-5b49-40ff-a76b-65307e3e2d29"
      unitRef="usd">8000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i67abdddccc3d4638bf07489a3670086b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU0LTMtMS0xLTE5NjM1_8240c4a8-02de-4789-bc9e-3fa530448f22"
      unitRef="usd">8000000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i301c0abd44f8465691076dc9cc3fae50_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU1LTAtMS0xLTE5NjM1L3RleHRyZWdpb246YzQ5OGIyM2ZlZmQyNDA3Njg2MWE4MTc4ZDEyYWVjMWVfNA_0e3942fd-867e-4957-834a-f42975f08bac"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i301c0abd44f8465691076dc9cc3fae50_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU1LTEtMS0xLTE5NjM1_f5bab5d7-ae48-4af4-a37f-42f70b984884"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i73fa3cf6a6e94e878b2a4e89d3fa5283_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU1LTMtMS0xLTE5NjM1_71ebd14e-325e-41df-a1d0-56f9ace57a94"
      unitRef="usd">750000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTEtMS0xLTE5NjM1_eaa71fe3-07b4-4caf-ac18-da82465a2248"
      unitRef="usd">1300000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU2LTMtMS0xLTE5NjM1_915f2e11-66eb-4d4a-a54f-372f0f52b93d"
      unitRef="usd">1083000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i014942cdefe642299553301bde433b97_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU3LTEtMS0xLTE5NjM1_15ad3ad6-5bfc-4277-bbff-d3c02e74bd5e"
      unitRef="usd">320000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i46529d5778ae40bb990d932509dbac03_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU3LTMtMS0xLTE5NjM1_8497a552-3805-42fd-83fc-a5ade171ef7f"
      unitRef="usd">326000000</us-gaap:DebtInstrumentCarryingAmount>
    <cvs:LongtermDebtGrossAndLeaseObligation
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU4LTEtMS0xLTE5NjM1_6e096837-3e0c-4d0c-9ae9-e3bc07368c16"
      unitRef="usd">56743000000</cvs:LongtermDebtGrossAndLeaseObligation>
    <cvs:LongtermDebtGrossAndLeaseObligation
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU4LTMtMS0xLTE5NjM1_4ca00125-0075-4946-b496-4a3d58c622df"
      unitRef="usd">65318000000</cvs:LongtermDebtGrossAndLeaseObligation>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU5LTEtMS0xLTE5NjM1_9740e1f0-337a-4b50-974a-7ae084dd56e2"
      unitRef="usd">219000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzU5LTMtMS0xLTE5NjM1_9b9e63d4-e356-4aee-9b93-9e682f248b30"
      unitRef="usd">238000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzYwLTEtMS0xLTE5NjM1_236eb5e5-f6b3-4663-af96-0f516769cadd"
      unitRef="usd">786000000</cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet>
    <cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzYwLTMtMS0xLTE5NjM1_840e7aad-736d-4a88-9631-88ddc201987c"
      unitRef="usd">909000000</cvs:DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzYxLTEtMS0xLTE5NjM1_bc3800e2-2322-409a-b57f-f322c100a67e"
      unitRef="usd">56176000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzYxLTMtMS0xLTE5NjM1_cac595ea-3a8d-4a8d-a1a5-9d924fa43c75"
      unitRef="usd">64647000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzY0LTEtMS0xLTE5NjM1_6bf808ad-6e9e-4f47-b520-5d516c4e1165"
      unitRef="usd">4205000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzY0LTMtMS0xLTE5NjM1_0971eb8c-fa05-43ec-92a4-8f86c8a8860d"
      unitRef="usd">5440000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzY1LTEtMS0xLTE5NjM1_ca4e1c17-8921-44b9-9412-80e8ff5d92ed"
      unitRef="usd">51971000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo4MGRmOWZjYmM2NmU0ZjMwODYxOWQzNDhkMmMyZWZlMi90YWJsZXJhbmdlOjgwZGY5ZmNiYzY2ZTRmMzA4NjE5ZDM0OGQyYzJlZmUyXzY1LTMtMS0xLTE5NjM1_9eaf23e6-0277-40fb-b0f9-ee587333aacd"
      unitRef="usd">59207000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzgwMTc_8dbe4983-9f76-4d19-9405-7b62838b5e25">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the Company&#x2019;s required repayments of debt principal due during each of the next five&#160;years and thereafter, as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt principal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;See Note 6 &#x2018;&#x2018;Leases&#x2019;&#x2019; for a summary of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;maturities of the Company&#x2019;s finance lease liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzEtMS0xLTEtMTk2MzU_d4f9958a-8e72-4bed-a56c-37a66d10f840"
      unitRef="usd">4154000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzItMS0xLTEtMTk2MzU_bcb58a17-e61a-4b6d-949f-badf0cc06101"
      unitRef="usd">1719000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzMtMS0xLTEtMTk2MzU_54b86650-0c95-4a58-b083-7eeab7be56ee"
      unitRef="usd">2706000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzQtMS0xLTEtMTk2MzU_4b6e7951-ca2b-4639-87d7-d39ad26d6430"
      unitRef="usd">3785000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzUtMS0xLTEtMTk2MzU_9128ae42-d234-4ec3-824d-70f1e70c03a0"
      unitRef="usd">2507000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzYtMS0xLTEtMTk2MzU_4a504396-ec0e-4ed7-befd-5308d0b870ea"
      unitRef="usd">40572000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzctMS0xLTEtMTk2MzU_f70eae16-c586-4c4f-b122-aa06b5fa8374"
      unitRef="usd">55443000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzgtMS0xLTEtMTk2MzU_eaa71fe3-07b4-4caf-ac18-da82465a2248"
      unitRef="usd">1300000000</us-gaap:FinanceLeaseLiability>
    <cvs:LongtermDebtGrossAndLeaseObligation
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90YWJsZTo0Yjc2OGJhYWY2OTA0NmNjYjk1ZTRmMDBjMjAwY2VkNC90YWJsZXJhbmdlOjRiNzY4YmFhZjY5MDQ2Y2NiOTVlNGYwMGMyMDBjZWQ0XzktMS0xLTEtMTk2MzU_9713317c-7ff2-43da-b3a4-fbe7dd421547"
      unitRef="usd">56743000000</cvs:LongtermDebtGrossAndLeaseObligation>
    <us-gaap:ShortTermBorrowings
      contextRef="i96887b3ac58640beb52a82bd21eb813a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzQ4Mg_f8481535-772b-418a-8c0f-2ec2c8821cca"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ie9cad6a94a214f4bbea75d3fac5eaaa9_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzgwOA_b3b8c069-e154-4350-8740-e046f6b854d8"
      unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i0889c6d0f22449efaf79e5043bc52d47_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzgwMjg_58aee847-e40c-4027-b9d1-884aba8994d9">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i006c485c30a0471dac8a843ae0803178_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzkwMQ_5cdf4c45-bf3c-4a2d-b15d-c37b0e012be9"
      unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i54d42741e9a84f52af2882db08c58b47_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzc5ODk_a6ea6a7d-5e24-490c-b165-51f6b5629239">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ib44b6fdea84a4c50aac9b470b1ca8124_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2MzgzMjU_9dab7c39-56ad-4f3b-9c10-35290dd7e13c"
      unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i6d78ef11f57e4edfa8419e4be3cfac0b_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzMyOTg1MzQ5MDM5ODQ_ea307430-b01b-4808-84d6-5928f71c38c1">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i4daa4bf26a7e4ba985ffd4fefd569f08_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEyMDU_7fb68130-b4eb-4f0b-b65c-1b73c12fbfb9"
      unitRef="number">0.0003</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:ShortTermBorrowings
      contextRef="i5b91388b635e423cafe7fb2c8c8f40f5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEyNTg_8ba6fddb-b7dc-4782-8bfc-fcaec8904f85"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i6c07b91fc15c48388a8d68005ad93a4b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEyNTg_98167d72-b9b9-4762-9e4c-ed2a0594bac4"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE2NzQ_19044dfe-add9-469a-be5c-e0520a67050b"
      unitRef="usd">995000000</us-gaap:FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable>
    <us-gaap:ShortTermBorrowings
      contextRef="i3d1e81300be74367a642cc8e00fcf76c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE3MDg_b7ba726c-5288-4c87-93ec-167869f494be"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i03fc12d9dcc14bec980f92dcfea940fd_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE3MDg_c958c82b-091b-4c7e-99ac-f0ab013a1f89"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib06d0888e42f4a7f9d3dd17b79f3d08d_I20210818"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDIyNTg_3d732491-594c-4398-9eb7-7b932a315047"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib06d0888e42f4a7f9d3dd17b79f3d08d_I20210818"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDIyNzM_9b82a038-21e2-4d9e-92ce-a9d25f2cbda5"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i2a2c1f6bdf614434afbf804874bfc4c5_D20210818-20210818"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDIyODI_006a7ece-f39b-4ede-98d5-f26d509b41c4"
      unitRef="usd">987000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if4ec5d2a13b34d5b970af83c0b03a435_I20201216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE4MjM_07ef0088-d57d-420f-9635-0987522d53ed"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if4ec5d2a13b34d5b970af83c0b03a435_I20201216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE4NTY_b556cdd0-4497-4d3e-ad5f-7c7c7310d225"
      unitRef="number">0.013</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i94cc0d983ab94bde8b7090b07fa45718_I20201216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE5MDY_81a52418-e2e8-4645-bbd3-3bac0f23879e"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i94cc0d983ab94bde8b7090b07fa45718_I20201216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE5Mzk_11415f82-74e5-40da-8a1d-70918b4c35d3"
      unitRef="number">0.01875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="ibd90a04249054ea4ad16eada8a0b09f2_D20201216-20201216"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzIwMjM_00476b1b-5f18-48ce-9b4d-0ab7838efc2a"
      unitRef="usd">1990000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if4ec5d2a13b34d5b970af83c0b03a435_I20201216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzIwNzE_6e9ee254-ee2e-40c9-b3cc-c21f55e4af98"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if4ec5d2a13b34d5b970af83c0b03a435_I20201216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzIxMDQ_b556cdd0-4497-4d3e-ad5f-7c7c7310d225"
      unitRef="number">0.013</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if4ec5d2a13b34d5b970af83c0b03a435_I20201216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzM4NDgyOTA3MTc4OTM_56176a31-18df-42b3-ab5c-7ec80151ebc7"
      unitRef="number">0.013</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id52f5d9f143f42e29ddaadb1b8837a16_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzIyNzU_183d7b18-e5d6-4543-af9f-b019e54cd666"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id52f5d9f143f42e29ddaadb1b8837a16_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzIzMzg_183d7b18-e5d6-4543-af9f-b019e54cd666"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id52f5d9f143f42e29ddaadb1b8837a16_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzIzNzE_2f3ec7be-45ca-40e3-9987-1fb24c019415"
      unitRef="number">0.013</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="idce8059065244c0699beb758c0989a41_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI0MTg_1fbbba77-12a2-48ef-bca2-902c7a7201df"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idce8059065244c0699beb758c0989a41_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI0NTE_88ec4589-6038-4d15-b63a-c003f950a280"
      unitRef="number">0.0175</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i529043993c644dd8aac8807ee5d2c7c0_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI1MDE_8b288d33-e67a-4efa-8555-4506e3482740"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i529043993c644dd8aac8807ee5d2c7c0_I20200821"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI1MzQ_9a0f3d12-d456-492d-b447-a2ebbc178c9e"
      unitRef="number">0.027</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i8afcc1e6458e4e11b0ded455489215ee_D20200821-20200821"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI2NTY_7ed1fe2e-3046-4ea2-ad37-719ecbe888fc"
      unitRef="usd">3970000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if63aa33153fe4482bfd5fceb634e5359_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI3Mzk_bb6b234d-77cc-48c2-bb14-4aa09e869158"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if63aa33153fe4482bfd5fceb634e5359_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI3NzI_a0b13ac9-88e7-486c-bfb5-3d254bbf4169"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i86d4fa4ab95046118e795a12d33f7b88_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI4MTc_a92c8442-7e0a-46cd-af50-77187f8d9126"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i86d4fa4ab95046118e795a12d33f7b88_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI4NTA_91fc7dc3-4ebf-417d-bc5b-310381858a14"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie826ee2c5ef840c18914ca3433d41756_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI4OTU_3875a13d-a3cb-4c81-866e-27d7dfe06f32"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie826ee2c5ef840c18914ca3433d41756_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI5Mjg_fb74747c-9aff-40b4-87f3-a0e58e7dc0b8"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib4fae0970ac644b7a0ad3a6efb7c6d19_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzI5NzY_bd2a18d5-1c37-453f-a13a-060217b05d3c"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib4fae0970ac644b7a0ad3a6efb7c6d19_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzMwMDk_98263f88-301a-4426-9265-26277284913e"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="iacc2ab2c48914d7f9b06a37e300d7eb8_D20200101-20200331"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzMxMjg_a37c1e51-324c-429d-a914-93fdd2d2f38d"
      unitRef="usd">3950000000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="i18bedffd3ee14bd4b98e02cbf1196a0c_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzM4NTY_a8724d46-5e91-4ed0-b425-59dd1bce7388"
      unitRef="usd">7000000</us-gaap:PaymentsForProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i18bedffd3ee14bd4b98e02cbf1196a0c_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzM5NTA_14a53352-e71c-4ebb-986d-c9b06689f5e8"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i149ae25cc3b64a2f92739b6ff6dac510_D20211201-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE2NDkyNjc0NjAxNDA_6945710b-6751-4693-b09c-14f72a798284"
      unitRef="usd">2300000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icd0ee6924ea342c4a56038c2e5e18a64_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE2NDkyNjc0NjAxNTU_03a15c60-d9c8-41f8-8068-543dec6519d8"
      unitRef="number">0.037</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="i5f0b12ab5b464e1496ae54d1e5e61e87_D20211201-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE2NDkyNjc0NjAxNjM_1946ec4b-d16a-46c0-91ce-79c5f7df0284"
      unitRef="usd">-80000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i5f0b12ab5b464e1496ae54d1e5e61e87_D20211201-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE2NDkyNjc0NjAxNjU_fb98f9d3-36a0-47ad-82b2-14247cf09713"
      unitRef="usd">8000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <cvs:DebtExtinguishmentFees
      contextRef="i5f0b12ab5b464e1496ae54d1e5e61e87_D20211201-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE2NDkyNjc0NjAxNjc_a0e09f65-4af4-446e-bc9a-3292ffaa7f6b"
      unitRef="usd">1000000</cvs:DebtExtinguishmentFees>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i5f0b12ab5b464e1496ae54d1e5e61e87_D20211201-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzE2NDkyNjc0NjAxNjk_f35e99f5-ee0a-4055-9e98-fcf2dc047952"
      unitRef="usd">-89000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i53460cbad4244ab5955cd283bcde34d7_D20210801-20210831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDIxOTk_69caecda-b76c-4a44-b421-ed5a931ffb22"
      unitRef="usd">2000000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i276b01d57f2045d0a76f58a233e35d9f_I20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDIyMTQ_fce7349e-bb5f-440f-a2d1-291ec2f9285c"
      unitRef="number">0.043</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="i39b25004923a449c988737a1efdfe4c5_D20210801-20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDIyMjE_fba7d30e-4b09-4590-94dd-de710d534571"
      unitRef="usd">-332000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="i39b25004923a449c988737a1efdfe4c5_D20210801-20210831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDIyMjg_d14f983d-ee27-49c3-9533-3869c40fb82e"
      unitRef="usd">26000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <cvs:DebtExtinguishmentFees
      contextRef="i39b25004923a449c988737a1efdfe4c5_D20210801-20210831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYwNDczMTM5NjcyOTE_11641377-ef9f-4f2f-b321-2d947e598a2d"
      unitRef="usd">5000000</cvs:DebtExtinguishmentFees>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i39b25004923a449c988737a1efdfe4c5_D20210801-20210831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDIyNDM_c7659ea5-cec2-4111-b7d2-18c0d5077d8a"
      unitRef="usd">-363000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i82ee6a03a2f04ee8b61b452feff3664b_D20201201-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU0NDI_ab8b5208-773f-4e78-b95d-79aee0342b5e"
      unitRef="usd">4500000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i2a7bb6963c09454281cf0360dcec5944_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU1NTY_6fa42455-d316-4cc9-8a7b-1bb31a2dab3e"
      unitRef="usd">113000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icea1808ecadc40d6ae18942dd91a82b4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU1NjY_70f034c9-9ca1-4c82-aaf7-ea3e96319273"
      unitRef="number">0.040</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ie4644ff08f014f1b9eb1fa8df30f2d1d_D20201201-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU1OTI_b7323a00-2ed4-4ed1-b7df-e75234c5e0ab"
      unitRef="usd">1400000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4acc5bb45f824af59b9b441ae8323056_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU2MDI_4c88a56c-1d61-4889-8c6d-703b0ed3067f"
      unitRef="number">0.037</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i72ca6906eceb40d5b6a9866cb6f06416_D20201201-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU2Mjg_54f15ca4-e1d0-4b07-b4e1-86d201a2e6f3"
      unitRef="usd">1000000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iad98b34b91f2400e8d921831383f78ff_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU2Mzg_864b32ee-8915-41fb-8c0e-efc0ad1ceab4"
      unitRef="number">0.041</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i7ac0d8f26f1643619504cfda7d91bffd_D20201201-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU2Njc_fd52d78e-0f98-4015-9f63-a6ca34868670"
      unitRef="usd">2000000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4b86af123f0342d4a6104d4be9148913_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU2Nzc_cffebc7d-1f24-49d2-94cb-fa5da1a31e47"
      unitRef="number">0.043</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="ia73567778f2f4e638670d5dc29eefd86_D20201201-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU3ODc_c716fec7-5949-45aa-a459-f1c1cc5afea2"
      unitRef="usd">-619000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="ia73567778f2f4e638670d5dc29eefd86_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU4ODU_b1949adb-f4f0-46b6-80da-885755e2aaaf"
      unitRef="usd">45000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <cvs:DebtExtinguishmentFees
      contextRef="ia73567778f2f4e638670d5dc29eefd86_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzU5NDE_638694bd-a40a-4bc1-a7fd-f2757124d28f"
      unitRef="usd">10000000</cvs:DebtExtinguishmentFees>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia73567778f2f4e638670d5dc29eefd86_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYwMDU_f41cebca-e001-4d6c-bc28-8c5a23344c15"
      unitRef="usd">-674000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i2b3cb303f4194f528bfb52cc092455a7_D20200801-20200831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYwNDg_f8dab376-660a-4e14-8fd8-c32ea7da1a3e"
      unitRef="usd">6000000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i67806e913a8940939ff3cb535bf4e3a6_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYxNjI_04bd086b-5cbc-48bf-a612-87c3af211b56"
      unitRef="usd">723000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2e64a0aea79e4b548c70ee282eaf1af6_I20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYxNzI_d6ab33ac-7ac7-4400-8208-cf24a2ff86b9"
      unitRef="number">0.040</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ie519cc2420df4c91a4824dffc41155eb_D20200801-20200831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYxOTg_32d52c2e-f4d6-49dc-8125-601ebbc7636d"
      unitRef="usd">2300000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifb5f940a259047c798edf06df3e9a282_I20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYyMDg_7d52b654-039c-4bdd-82c0-86bc9d0df1d2"
      unitRef="number">0.037</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i0c074aa9c6834d2497da9aa3b1bf52d1_D20200801-20200831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYyMzc_a1890b72-83e0-4003-b39b-ba8fed92db68"
      unitRef="usd">3000000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib61285362251444c8c2bfd25138ec3a5_I20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYyNDc_b7ca28e9-0a11-4f39-9fe1-71c9e2df9671"
      unitRef="number">0.041</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="id4d09fbb1bb54cb382bf1b47e6f77cce_D20200801-20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzYzNTc_0191a5fb-5a75-4fcf-8124-c8dc3b88d1a3"
      unitRef="usd">-706000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="id4d09fbb1bb54cb382bf1b47e6f77cce_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzY0NTU_25686a15-fae2-47ce-9cdc-e33e1db5775e"
      unitRef="usd">47000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <cvs:DebtExtinguishmentFees
      contextRef="id4d09fbb1bb54cb382bf1b47e6f77cce_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzY1MTE_5ea9b2dd-c9fb-491d-bd63-c85e35f0829a"
      unitRef="usd">13000000</cvs:DebtExtinguishmentFees>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="id4d09fbb1bb54cb382bf1b47e6f77cce_D20200801-20200831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzY1NzU_3c8bc8b7-683e-4003-ac13-f3b4779caf2f"
      unitRef="usd">-766000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i362f2c27267d4320a08ef6b47fda9bc1_D20190801-20190831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQxOTY_2b2bda18-0d58-4c9d-b1bc-f1c5f0af78b3"
      unitRef="usd">4000000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="if5d47a67418245f7b61330d02abc51c3_D20190801-20190831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQyMTE_7aa8f484-f403-4a94-8ca9-f660e95232a2"
      unitRef="usd">1300000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4b1b35e1f5e04251b8abbf5474581c4c_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQyMjY_28a4c85a-efa5-4bae-b981-da35b0df0405"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ia9179b36d9334dc682bda5ab696933e3_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzMyOTg1MzQ5MDIwMTE_cb84381b-6ae1-4e52-86bf-94338bf65c79"
      unitRef="usd">723000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i32d5285ef7b24b989560ef483b6354fe_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQyMzc_c5c9907c-1450-4939-9c8a-569731493711"
      unitRef="usd">328000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i08a8d0eb8ca548e48203788144525a13_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQyNTI_9934796f-6f20-4d65-ba73-efde477107df"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="icc7d49779e63442cafbb5b988ec993dd_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQyNjE_4cf09c10-918e-4920-8f34-ed82b8f9ddd8"
      unitRef="usd">297000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib08d4d156b344abfbbdb0a987bffa850_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQyNzY_2249407d-d0e8-410e-9381-b45f524eb243"
      unitRef="number">0.04125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ia80bef5306614fe7bc79d4a80fdd7a83_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQyODY_44f6be25-ad94-46e1-813e-70cf49891d90"
      unitRef="usd">413000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie617a7b5c5cd46409dcd4dd2149324f8_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQzMDE_f905f65d-c064-432b-b368-e6760d6a3fbd"
      unitRef="number">0.0545</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="iad60f7a1628244d2a8b435b05fc44593_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQzMDk_d9e532b5-ef3d-4b4a-91c3-854dc8efb7bf"
      unitRef="usd">962000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if1e7d725090f4e1cbead4dffeddf31c7_I20190831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQzMjQ_9962cc29-2720-4b66-89a4-0eaa379120b8"
      unitRef="number">0.0335</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="i03679feac9004c3babd99a1e76970bde_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQzMzI_e2bc098e-5882-47d6-9b0c-bcb965b0ecf2"
      unitRef="usd">-76000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <cvs:DebtExtinguishmentFees
      contextRef="i03679feac9004c3babd99a1e76970bde_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzMyOTg1MzQ5MDE5OTg_bd682bb1-44bd-42bb-97fc-4e3add32d6c2"
      unitRef="usd">8000000</cvs:DebtExtinguishmentFees>
    <cvs:NetGainFromWriteOffOfDeferredDebtIssuanceCosts
      contextRef="i03679feac9004c3babd99a1e76970bde_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQzNTA_1e234789-40c2-4ab3-96cc-ad9472dabce8"
      unitRef="usd">5000000</cvs:NetGainFromWriteOffOfDeferredDebtIssuanceCosts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i03679feac9004c3babd99a1e76970bde_D20190801-20190831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTEvZnJhZzo2ZjlhMmQyYmUzZGQ0NWZiOTlmMWQ5NWFhOGM2NWZlYy90ZXh0cmVnaW9uOjZmOWEyZDJiZTNkZDQ1ZmI5OWYxZDk1YWE4YzY1ZmVjXzEwOTk1MTE2NDQzNjM_10d2d067-81e6-4331-a8fa-deebf966d4d1"
      unitRef="usd">-79000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODU3_2dc42c37-ae54-4d5c-a330-ed230c114f59">Pension Plans and Other Postretirement Benefits&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Contribution Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company sponsors several active 401(k) savings plans that cover all employees who meet plan eligibility requirements. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company makes matching contributions consistent with the provisions of the respective plans. At the participant&#x2019;s option, account balances, including the Company&#x2019;s matching contribution, can be invested among various investment options under each plan. The CVS Health Future Fund 401(k) Plan offers CVS Health Corporation&#x2019;s common stock fund as an investment option. The Company also maintains nonqualified, unfunded deferred compensation plans for certain key employees. The plans provide participants the opportunity to defer portions of their eligible compensation and for certain nonqualified plans, participants receive matching contributions equivalent to what they could have received under the CVS Health Future Fund 401(k) Plan absent certain restrictions and limitations under the Internal Revenue Code. The Company&#x2019;s contributions under its defined contribution plans were $552 million, $520 million and $550 million in the years ended December&#160;31, 2021, 2020 and 2019, respectively. The Company&#x2019;s contributions for the year ended December 31, 2019 include contributions to the Aetna 401(k) Plan, which was merged into the CVS Health Future Fund 401(k) Plan on January 1, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Benefit Pension Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sponsors a tax-qualified defined benefit pension plan that was frozen in 2010 and a nonqualified supplemental pension plan that was frozen in 2007. The Company also sponsors several other defined benefit pension plans that are unfunded nonqualified supplemental retirement plans.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pension Benefit Obligation and Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables outline the change in pension benefit obligation and plan assets over the specified periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the pension benefit obligation during the years ended December&#160;31, 2021 and 2020 was primarily driven by the change in the discount rate during each respective period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assets (liabilities) recognized on the consolidated balance sheets at December&#160;31, 2021 and 2020 for the defined benefit pension plans consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets reflected in other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities reflected in accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities reflected in other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Periodic Benefit Cost (Income)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of net periodic benefit cost (income) for the years ended December&#160;31, 2021, 2020 and 2019 are shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Components of net periodic benefit cost (income):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pension Plan Assumptions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a series of actuarial assumptions to determine its benefit obligation and net periodic benefit cost (income), the most significant of which include discount rates and expected return on plan assets assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Discount Rates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The discount rate is determined using a yield curve as of the annual measurement date. The yield curve consists of a series of individual discount rates, with each discount rate corresponding to a single point in time, based on high-quality bonds. Projected benefit payments are discounted to the measurement date using the corresponding rate from the yield curve that is consistent with the maturity profile of the expected liability cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Return on Plan Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The expected long-term rate of return on plan assets is determined by using the plan&#x2019;s target allocation and return expectations based on many factors including forecasted long-term capital market real returns and the inflationary outlook on a plan by plan basis. See &#x201c;Pension Plan Assets&#x201d; below for additional details regarding the pension plan assets as of December 31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also considers other assumptions including mortality, interest crediting rate, termination and retirement rates and cost of living adjustments. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined its benefit obligation based on the following weighted average assumptions as of December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined its net periodic benefit cost (income) based on the following weighted average assumptions for the years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pension Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s pension plan assets primarily include debt and equity securities held in separate accounts, common/collective trusts and real estate investments. The valuation methodologies used to value these debt and equity securities and common/collective trusts are similar to the methodologies described in Note 4 &#x201c;Fair Value.&#x201d; Pension plan assets also include investments in other assets that are carried at fair value. The following is a description of the valuation methodologies used to value real estate investments and these additional investments, including the general classification pursuant to the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Real Estate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Real estate investments are valued by independent third party appraisers. The appraisals comply with the Uniform Standards of Professional Appraisal Practice, which include, among other things, the income, cost, and sales comparison approaches to estimating property value. Therefore, these investments are classified in Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Private equity and hedge fund limited partnerships&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Private equity and hedge fund limited partnerships are carried at fair value which is estimated using the NAV per unit as reported by the administrator of the underlying investment fund as a practical expedient to fair value. Therefore, these investments have been excluded from the fair value table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2021 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Domestic real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Common/collective trusts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total pension investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The assets in the underlying funds of common/collective trusts consist of $261 million of equity securities and $149 million of debt securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $76 million of other receivables as well as $583 million of private equity limited partnership investments and $237 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2020 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Domestic real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Common/collective trusts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total pension investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The assets in the underlying funds of common/collective trusts consist of $84 million of equity securities and $182 million of debt securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $142 million of other receivables as well as $624 million of private equity limited partnership investments and $214 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S. corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s pension plan invests in a diversified mix of assets designed to generate returns that will enable the plan to meet its future benefit obligations. The risk of unexpected investment and actuarial outcomes is regularly evaluated. This evaluation is performed through forecasting and assessing ranges of investment outcomes over short- and long-term horizons and by assessing the pension plan&#x2019;s liability characteristics. Complementary investment styles and strategies are utilized by professional investment management firms to further improve portfolio and operational risk characteristics. Public and private equity investments are used primarily to increase overall plan returns. Real estate investments are viewed favorably for their diversification benefits and above-average dividend generation. Fixed income investments provide diversification benefits and liability hedging attributes that are desirable, especially in falling interest rate environments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021, target investment allocations for the Company&#x2019;s pension plan were: 12% in equity securities, 77% in fixed income and debt securities, 5% in real estate, 3% in private equity limited partnerships and 3% in hedge funds. Actual asset allocations may differ from target allocations due to tactical decisions to overweight or underweight certain assets or as a result of normal fluctuations in asset values. Asset allocations are consistent with stated investment policies and, as a general rule, periodically rebalanced back to target asset allocations. Asset allocations and investment performance are formally reviewed periodically throughout the year by the pension plan&#x2019;s Investment Subcommittee. Forecasting of asset and liability growth is performed at least annually.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Flows&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally contributes to its tax-qualified pension plan based on minimum funding requirements determined under applicable federal laws and regulations. Employer contributions related to the nonqualified supplemental pension plans generally represent payments to retirees for current benefits. The Company contributed $78 million, $25 million and $25 million to its pension plans during 2021, 2020 and 2019, respectively. No contributions are required for the tax-qualified pension plan in 2022. The Company expects to make an immaterial amount of contributions for all other pension plans in 2022. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the pension benefit obligation as of December&#160;31, 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027-2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Multiemployer Pension Plans&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also contributes to a number of multiemployer pension plans under the terms of collective-bargaining agreements that cover its union-represented employees. The risks of participating in these multiemployer plans are different from single-employer pension plans in the following respects: (i) assets contributed to the multiemployer plan by one employer may be used to provide benefits to employees of other participating employers, (ii) if a participating employer stops contributing to the plan, the unfunded obligations of the plan may be borne by the remaining participating employers, and (iii) if the Company chooses to stop participating in some of its multiemployer plans, the Company may be required to pay those plans an amount based on the underfunded status of the applicable plan, which is referred to as a withdrawal liability. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;None of the multiemployer pension plans in which the Company participates are individually significant to the Company. The Company&#x2019;s contributions to multiemployer pension plans were $19 million, $19 million and $18 million in 2021, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Postretirement Benefits&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides postretirement health care and life insurance benefits to certain retirees who meet eligibility requirements. The Company&#x2019;s funding policy is generally to pay covered expenses as they are incurred. For retiree medical plan accounting, the Company reviews external data and its own historical trends for health care costs to determine the health care cost trend rates. As of December&#160;31, 2021 and 2020, the Company&#x2019;s other postretirement benefits had an accumulated postretirement benefit obligation of $207 million and $226 million, respectively. Net periodic benefit costs related to these other postretirement benefits were $4 million, $12 million and $7 million in 2021, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the accumulated other postretirement benefit obligation as of December&#160;31, 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027-2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Pursuant to various collective bargaining agreements, the Company also contributes to multiemployer health and welfare plans that cover certain union-represented employees. The plans provide postretirement health care and life insurance benefits to certain employees who meet eligibility requirements. The Company&#x2019;s contributions to multiemployer health and welfare plans totaled $60 million, $54 million and $57 million in 2021, 2020 and 2019, respectively.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwOTQ_9031425c-af99-4273-89ce-905e0b80ea10"
      unitRef="usd">552000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwOTg_7562583a-d3d3-4fc4-af1c-2e97e2036be7"
      unitRef="usd">520000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExMDU_972384aa-7026-4317-b14f-1e08e7875569"
      unitRef="usd">550000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODYz_e1cde68d-737b-4853-b882-d03f29d10855">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables outline the change in pension benefit obligation and plan assets over the specified periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODY0_a3ff7557-1892-4e3f-8d34-fd0fd431e31a">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables outline the change in pension benefit obligation and plan assets over the specified periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial (gain) loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets, end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzItMS0xLTEtMTk2MzU_f546d37a-77b5-4cfe-881b-bd42136996f5"
      unitRef="usd">6462000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i7f04ec02cc3f4ecd8284b436de929707_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzItMy0xLTEtMTk2MzU_516fcb95-b1ec-4584-aabd-763037da88e9"
      unitRef="usd">6239000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzQtMS0xLTEtMTk2MzU_54b45615-59b8-4708-887f-d892033efb34"
      unitRef="usd">110000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzQtMy0xLTEtMTk2MzU_e2f76b95-f0aa-4dbf-a540-c63cd7df3f5c"
      unitRef="usd">168000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzUtMS0xLTEtMTk2MzU_cef6e18e-dea1-4942-8026-bf3eeac6053e"
      unitRef="usd">102000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzUtMy0xLTEtMTk2MzU_7612b68b-980d-4a53-a721-b039279ce272"
      unitRef="usd">-413000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzYtMS0xLTEtMTk2MzU_e4eed65e-6eb0-4e74-aa04-1c6460a7b142"
      unitRef="usd">408000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzYtMy0xLTEtMTk2MzU_57de96f1-6450-4a00-8739-07179c07ec5a"
      unitRef="usd">358000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement
      contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzctMS0xLTEtNjgyODk_b848b85a-650e-48ed-801f-40207159c709"
      unitRef="usd">53000000</us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement>
    <us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement
      contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzctMy0xLTEtNzA0MTE_30c9f2eb-9857-41f2-aed0-9650b2e88c04"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzctMS0xLTEtMTk2MzU_215d2502-5f2a-48e6-88e3-d81f1590864d"
      unitRef="usd">6009000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzctMy0xLTEtMTk2MzU_f43a0b4a-5552-4d40-a9a2-33dafb465df2"
      unitRef="usd">6462000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzEwLTEtMS0xLTE5NjM1_e904f2d7-6fce-40fd-b847-bcdb44e3b544"
      unitRef="usd">6845000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7f04ec02cc3f4ecd8284b436de929707_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzEwLTMtMS0xLTE5NjM1_fb1ee381-3934-46e0-a9ca-0bcf25337af4"
      unitRef="usd">6395000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzEyLTEtMS0xLTE5NjM1_1805ec5e-42d4-441d-9d71-9407f00e6681"
      unitRef="usd">215000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzEyLTMtMS0xLTE5NjM1_d150bed0-269d-4041-9431-0fd1f2734b53"
      unitRef="usd">783000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzEzLTEtMS0xLTE5NjM1_223ecddc-4afe-4057-97f0-47870bc46730"
      unitRef="usd">78000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzEzLTMtMS0xLTE5NjM1_4a519dc0-7ad9-496f-aca1-078b7bcd5b3f"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzE0LTEtMS0xLTE5NjM1_f66fc7aa-5284-41c9-879d-b7853c23086d"
      unitRef="usd">408000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzE0LTMtMS0xLTE5NjM1_d2a0b73a-2d59-489c-975a-35af7deba7bc"
      unitRef="usd">358000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzE2LTEtMS0xLTY4MzAw_95f15130-3c11-4645-8edb-976ce53af01e"
      unitRef="usd">53000000</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanSettlementsPlanAssets
      contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzE2LTMtMS0xLTcwNDE1_668fa81b-134e-41c6-80cb-10fd6c23dccc"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanSettlementsPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzE1LTEtMS0xLTE5NjM1_dc07a06d-413e-4efd-a10c-94a446c73027"
      unitRef="usd">6677000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzE1LTMtMS0xLTE5NjM1_5a114c62-fc40-4724-ad06-9313f1c69527"
      unitRef="usd">6845000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzE3LTEtMS0xLTE5NjM1_15bd0465-8489-4e3c-b35c-c6928276479f"
      unitRef="usd">668000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTowYzFiNzMyNzMyYmM0Zjc1ODQwYzM3OGQ2YWM2OGYyNy90YWJsZXJhbmdlOjBjMWI3MzI3MzJiYzRmNzU4NDBjMzc4ZDZhYzY4ZjI3XzE3LTMtMS0xLTE5NjM1_b7a7bd04-9f55-499b-8196-4a857f7792ee"
      unitRef="usd">383000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODY1_5d443bc0-726e-4787-83c0-03d45e0feef3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assets (liabilities) recognized on the consolidated balance sheets at December&#160;31, 2021 and 2020 for the defined benefit pension plans consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets reflected in other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities reflected in accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities reflected in other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZToxMzJkNDQ5Y2JkNmU0ZmY1ODZmNzkyMzMyMGY3YjlmZS90YWJsZXJhbmdlOjEzMmQ0NDljYmQ2ZTRmZjU4NmY3OTIzMzIwZjdiOWZlXzEtMS0xLTEtMTk2MzU_933df598-666b-4d40-9be1-b5597b3d31c9"
      unitRef="usd">946000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZToxMzJkNDQ5Y2JkNmU0ZmY1ODZmNzkyMzMyMGY3YjlmZS90YWJsZXJhbmdlOjEzMmQ0NDljYmQ2ZTRmZjU4NmY3OTIzMzIwZjdiOWZlXzEtMy0xLTEtMTk2MzU_8f6f1fe9-63d7-4b23-906f-3bb6f0285aaf"
      unitRef="usd">744000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZToxMzJkNDQ5Y2JkNmU0ZmY1ODZmNzkyMzMyMGY3YjlmZS90YWJsZXJhbmdlOjEzMmQ0NDljYmQ2ZTRmZjU4NmY3OTIzMzIwZjdiOWZlXzItMS0xLTEtMTk2MzU_37b191c9-c08b-45ce-9892-75a7966e4a8d"
      unitRef="usd">28000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZToxMzJkNDQ5Y2JkNmU0ZmY1ODZmNzkyMzMyMGY3YjlmZS90YWJsZXJhbmdlOjEzMmQ0NDljYmQ2ZTRmZjU4NmY3OTIzMzIwZjdiOWZlXzItMy0xLTEtMTk2MzU_75742209-7bc6-4e30-874e-8a02070c3b76"
      unitRef="usd">76000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZToxMzJkNDQ5Y2JkNmU0ZmY1ODZmNzkyMzMyMGY3YjlmZS90YWJsZXJhbmdlOjEzMmQ0NDljYmQ2ZTRmZjU4NmY3OTIzMzIwZjdiOWZlXzMtMS0xLTEtMTk2MzU_c4d8272c-9c55-42b7-adea-38076ce0a4e6"
      unitRef="usd">250000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZToxMzJkNDQ5Y2JkNmU0ZmY1ODZmNzkyMzMyMGY3YjlmZS90YWJsZXJhbmdlOjEzMmQ0NDljYmQ2ZTRmZjU4NmY3OTIzMzIwZjdiOWZlXzMtMy0xLTEtMTk2MzU_7724ab46-fa83-4695-95dd-87f54605e3c6"
      unitRef="usd">285000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZToxMzJkNDQ5Y2JkNmU0ZmY1ODZmNzkyMzMyMGY3YjlmZS90YWJsZXJhbmdlOjEzMmQ0NDljYmQ2ZTRmZjU4NmY3OTIzMzIwZjdiOWZlXzQtMS0xLTEtMTk2MzU_d02fb97c-8c35-486c-a41a-c9d3abd5f1c7"
      unitRef="usd">668000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i4d6e9082a5464b3c81907ef022a3e221_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZToxMzJkNDQ5Y2JkNmU0ZmY1ODZmNzkyMzMyMGY3YjlmZS90YWJsZXJhbmdlOjEzMmQ0NDljYmQ2ZTRmZjU4NmY3OTIzMzIwZjdiOWZlXzQtMy0xLTEtMTk2MzU_56e8e9f1-4d9c-453a-ae36-5389b5ca8984"
      unitRef="usd">383000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODUx_c593a6bd-da6d-4aed-9012-8a1577876252">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of net periodic benefit cost (income) for the years ended December&#160;31, 2021, 2020 and 2019 are shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Components of net periodic benefit cost (income):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzItMS0xLTEtMTk2MzU_05931d8a-b941-40ba-9172-d83260b4bf02"
      unitRef="usd">110000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzItMy0xLTEtMTk2MzU_9cc17b29-6030-499e-9aaa-2b6313cfbc9e"
      unitRef="usd">168000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="iaf1063688e1c402b918f2251c5ebcda8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzItNS0xLTEtMTk2MzU_9485760e-9351-4532-86bc-4a0f22b32938"
      unitRef="usd">225000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzMtMS0xLTEtMTk2MzU_56ed9d4b-15ce-48c3-9790-b1ffed2470b5"
      unitRef="usd">317000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzMtMy0xLTEtMTk2MzU_7f537545-d465-4074-b927-0ce23ee07395"
      unitRef="usd">388000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="iaf1063688e1c402b918f2251c5ebcda8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzMtNS0xLTEtMTk2MzU_ed168074-113a-4429-8b71-c50a03a042e4"
      unitRef="usd">357000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzQtMS0xLTEtMTk2MzU_8bc1a84b-b6ed-4e4f-87c5-e9a9808aa601"
      unitRef="usd">-5000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzQtMy0xLTEtMTk2MzU_42e37742-d1cc-4d55-950f-e2dcb8a073eb"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="iaf1063688e1c402b918f2251c5ebcda8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzQtNS0xLTEtMTk2MzU_58d235d8-f400-4113-917c-db834e4b248c"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzUtMS0xLTEtNjgzMzQ_a4405cc8-ca4a-4027-bb1f-19278fd5c8a6"
      unitRef="usd">-16000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzUtMy0xLTEtNzA0MTg_89508622-6f4e-4339-981a-f92eac2c4fd5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
      contextRef="iaf1063688e1c402b918f2251c5ebcda8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzUtNS0xLTEtNzA0MTg_e89b15f6-7572-455d-bb7f-7c2d9eabfa59"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzUtMS0xLTEtMTk2MzU_c7dbe635-d310-400b-8a12-1f865c3f5c9e"
      unitRef="usd">-186000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzUtMy0xLTEtMTk2MzU_3df0b8fd-3be4-4d86-8166-c644a8198806"
      unitRef="usd">-218000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="iaf1063688e1c402b918f2251c5ebcda8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiYzg5MGNlYTRiZDQ0NjI1Yjk0NmU4NDQ4NzM4M2JlMC90YWJsZXJhbmdlOmJjODkwY2VhNGJkNDQ2MjViOTQ2ZTg0NDg3MzgzYmUwXzUtNS0xLTEtMTk2MzU_a578cb62-b4e7-4e9a-8ce9-3aac682a7223"
      unitRef="usd">-131000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODU5_7ddebfb0-e483-4d09-8e88-74f14617026c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined its benefit obligation based on the following weighted average assumptions as of December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined its net periodic benefit cost (income) based on the following weighted average assumptions for the years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected long-term rate of return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo2ODRmZWJmM2Q3YmI0N2JjYWZiYzc4MDg3NDRlZjlkZC90YWJsZXJhbmdlOjY4NGZlYmYzZDdiYjQ3YmNhZmJjNzgwODc0NGVmOWRkXzEtMS0xLTEtMTk2MzU_dfe75005-8501-4a5d-8213-f090fba85d96"
      unitRef="number">0.028</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo2ODRmZWJmM2Q3YmI0N2JjYWZiYzc4MDg3NDRlZjlkZC90YWJsZXJhbmdlOjY4NGZlYmYzZDdiYjQ3YmNhZmJjNzgwODc0NGVmOWRkXzEtMy0xLTEtMTk2MzU_be79df72-27ea-44a1-95f2-c4d1d4b4c7b7"
      unitRef="number">0.025</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpjYWQ2MjEwNWZjNjk0ODdiYThjZmJkMDAzMjJkODE3MS90YWJsZXJhbmdlOmNhZDYyMTA1ZmM2OTQ4N2JhOGNmYmQwMDMyMmQ4MTcxXzEtMS0xLTEtMTk2MzU_6eda6782-6c67-4a76-b4aa-dfac5f6fabf9"
      unitRef="number">0.018</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpjYWQ2MjEwNWZjNjk0ODdiYThjZmJkMDAzMjJkODE3MS90YWJsZXJhbmdlOmNhZDYyMTA1ZmM2OTQ4N2JhOGNmYmQwMDMyMmQ4MTcxXzEtMy0xLTEtMTk2MzU_dc2d1abc-7a28-4911-81ea-a3bc46f13cd4"
      unitRef="number">0.029</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpjYWQ2MjEwNWZjNjk0ODdiYThjZmJkMDAzMjJkODE3MS90YWJsZXJhbmdlOmNhZDYyMTA1ZmM2OTQ4N2JhOGNmYmQwMDMyMmQ4MTcxXzEtNS0xLTEtMTk2MzU_4fee6ec7-3bce-47b1-9386-8ce5c7d53451"
      unitRef="number">0.040</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpjYWQ2MjEwNWZjNjk0ODdiYThjZmJkMDAzMjJkODE3MS90YWJsZXJhbmdlOmNhZDYyMTA1ZmM2OTQ4N2JhOGNmYmQwMDMyMmQ4MTcxXzItMS0xLTEtMTk2MzU_3c201a26-c0b4-44dd-8ce8-7f6ff598bf15"
      unitRef="number">0.048</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpjYWQ2MjEwNWZjNjk0ODdiYThjZmJkMDAzMjJkODE3MS90YWJsZXJhbmdlOmNhZDYyMTA1ZmM2OTQ4N2JhOGNmYmQwMDMyMmQ4MTcxXzItMy0xLTEtMTk2MzU_15c83b70-0bfd-4131-a96e-1f93d80b72a6"
      unitRef="number">0.063</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpjYWQ2MjEwNWZjNjk0ODdiYThjZmJkMDAzMjJkODE3MS90YWJsZXJhbmdlOmNhZDYyMTA1ZmM2OTQ4N2JhOGNmYmQwMDMyMmQ4MTcxXzItNS0xLTEtMTk2MzU_0fa58b55-9631-4afb-995b-75e5804472ec"
      unitRef="number">0.065</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODcw_60e380c6-6c76-44b1-bec9-13b816f078f2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2021 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Domestic real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Common/collective trusts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total pension investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The assets in the underlying funds of common/collective trusts consist of $261 million of equity securities and $149 million of debt securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Excludes $76 million of other receivables as well as $583 million of private equity limited partnership investments and $237 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pension plan assets with changes in fair value measured on a recurring basis at December&#160;31, 2020 were as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;States, municipalities and political subdivisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. corporate securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Foreign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Residential mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Commercial mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Redeemable preferred securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;U.S. domestic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Domestic real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Common/collective trusts &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total pension investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The assets in the underlying funds of common/collective trusts consist of $84 million of equity securities and $182 million of debt securities. &lt;/span&gt;&lt;/div&gt;(2)Excludes $142 million of other receivables as well as $624 million of private equity limited partnership investments and $214 million of hedge fund limited partnership investments as these amounts are measured at NAV per share or an equivalent and are not subject to leveling within the fair value hierarchy.</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3134e38a37b94c8182ff22d5897d2115_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEtMS0xLTEtMTk2MzU_7080cb57-971b-4317-9a4a-56417cd579a2"
      unitRef="usd">60000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie905fb72796946948258390b761711b2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEtMy0xLTEtMTk2MzU_020b885f-9811-492e-b1f0-7e05aefe1b35"
      unitRef="usd">97000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia00abbc1dfc2420285ca81d07349c1ce_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEtNS0xLTEtMTk2MzU_9f6c1f1e-ad18-4159-a240-82b4af54abc3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i875e79c2473a452583e29e73a01bfa80_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEtNy0xLTEtMTk2MzU_9f57220c-e3f1-4a0d-994b-4ff15c4e3787"
      unitRef="usd">157000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1b5c96f524674979ae3cadfd2532827d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzMtMS0xLTEtMTk2MzU_dd02092d-e9f5-4c18-b519-980216e9a779"
      unitRef="usd">1223000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i59c39c821a3d4218a3cb728d2a385e90_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzMtMy0xLTEtMTk2MzU_0b3cbea1-6c97-41d3-8728-ed5d9d7437ac"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if5e7e03431254181936fa5c2d257ec24_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzMtNS0xLTEtMTk2MzU_f4392c6d-a3d6-4dc5-b065-18722b9926f1"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2bc62d9f7c66433aa13e9e6998d9d964_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzMtNy0xLTEtMTk2MzU_90467741-2ee9-4e8e-acbe-ba046fbc2e9a"
      unitRef="usd">1224000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i56a20a0bce804c38b73ff7f520b87651_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzQtMS0xLTEtMTk2MzU_0051f958-6635-4d8f-b343-0fb1ec3325bb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia01c644b76e14ee0b5670b383fc44619_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzQtMy0xLTEtMTk2MzU_4ed44182-aeb3-4879-a6c3-1f245c049c49"
      unitRef="usd">150000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i720c85d38c4b4a209ace565912f63128_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzQtNS0xLTEtMTk2MzU_26d90b77-3731-4654-b0f7-f00280c9d8f4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i299dbb93baaa4adf91b29303de9f256c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzQtNy0xLTEtMTk2MzU_833d6eda-1cec-4bba-84ce-0879a429681d"
      unitRef="usd">150000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iba101ed2ac8446029ae5d685f8acc341_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzUtMS0xLTEtMTk2MzU_4359b308-5d83-4755-9d30-d60992791886"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6e7a8e35e6064852930a027b3b59f8bf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzUtMy0xLTEtMTk2MzU_07a4a457-f9a2-43f0-a4a0-198e3f7122a4"
      unitRef="usd">2458000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibbde729393d64e52859d704b20cee518_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzUtNS0xLTEtMTk2MzU_29ecbd6c-0a7c-4e14-a539-b007ea49405f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i412f89f8ca8d4dbfb8137a440ded6b98_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzUtNy0xLTEtMTk2MzU_9d7ce209-652d-45aa-a7f6-2cd98a03ffd3"
      unitRef="usd">2458000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iae01dbcfa8ad41769f633687cc03a2f7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzYtMS0xLTEtMTk2MzU_6404837a-981f-47a2-aa89-3175fa9e0708"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if8e7a22df5454c2ea08ecd37884fc4ca_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzYtMy0xLTEtMTk2MzU_e52456fe-e3bd-4b50-acd3-bec69d23757f"
      unitRef="usd">202000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1fe528bb55e54ddf9c9174d483315925_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzYtNS0xLTEtMTk2MzU_7e3570f1-4d78-453e-8781-c3a33a30e111"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i03065bcf27f649d5aea3ecbbae57c360_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzYtNy0xLTEtMTk2MzU_11575abc-b332-425a-b66a-adf5f0cf7e09"
      unitRef="usd">202000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i03983d809b5d48ac822709e714733860_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzctMS0xLTEtMTk2MzU_085a55e4-8566-4699-9a03-a10d5579b6bf"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7896784f71444553a77160a44c511d51_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzctMy0xLTEtMTk2MzU_73f477b2-6fc7-489b-8767-fbedbd20f311"
      unitRef="usd">277000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2f997b24060b4e2e831b7dd663bd1b51_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzctNS0xLTEtMTk2MzU_973a625c-18df-48bc-ac29-2b120c07643d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ica9d19a21f7b4daa8e6810612ddacae0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzctNy0xLTEtMTk2MzU_8b470dc7-1ea9-45cb-9540-809922597c89"
      unitRef="usd">277000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5b76b6127e2345bdbe4b25521e947671_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzgtMS0xLTEtMTk2MzU_b84162f3-637b-4881-b2ce-2b7b7e26d265"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id17472de8a564798bb9bbabef75337c9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzgtMy0xLTEtMTk2MzU_eedf27e5-f31b-41fd-a10b-f15936ce2d51"
      unitRef="usd">76000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i76f91d5a4d3f4fde8c530ad87b420488_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzgtNS0xLTEtMTk2MzU_660040d4-f60e-4394-8dc7-c001175ff315"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie018639f7a93495f8a043153b2b66e54_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzgtNy0xLTEtMTk2MzU_3b7b5862-ad5f-4404-a763-a3ca34cb642c"
      unitRef="usd">76000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i790751c0557c4bcd879d0876e81497d8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzktMS0xLTEtMTk2MzU_13e836ce-fb88-4900-b1ec-c5681133d70b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1878272b63d84cb3ad191576cc40347f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzktMy0xLTEtMTk2MzU_a9cffd52-b48a-4700-b00b-b92e98204a5a"
      unitRef="usd">162000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i236be83c9a654e4bb93dd0760efff694_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzktNS0xLTEtMTk2MzU_0c9c85c8-55e8-402e-9cc8-915af4795b2a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0da2d0c3648145a5b8e2644ab1e5983d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzktNy0xLTEtMTk2MzU_a09fec6c-656e-4e96-b4b2-908f4ee92b97"
      unitRef="usd">162000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2a93d02e74b1445c87a77245502f00bd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEwLTEtMS0xLTE5NjM1_e07340a7-8c25-4291-b05d-94404fd5333d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i46e716287be2403d9f9833d066720161_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEwLTMtMS0xLTE5NjM1_2047a40f-ca29-4ae4-9df9-51dad694f631"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if0685d6246774c2192e1c757f435ee9f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEwLTUtMS0xLTE5NjM1_520a60ed-dd16-4a27-bc1e-776505f81e7b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6907babce69b467f895e80b4a8a98771_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEwLTctMS0xLTE5NjM1_2483a545-19f2-4e16-b3f3-44b35f4fdacc"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i752af8c51ae54195805ebd256b2b704b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzExLTEtMS0xLTE5NjM1_778ccdff-e6b3-48d6-ac57-e1d07f18e2f7"
      unitRef="usd">1223000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4f35241461c340e69d4ae399ca59d584_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzExLTMtMS0xLTE5NjM1_ac4feb09-b78f-4164-881e-b7d290b3d898"
      unitRef="usd">3330000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i59783636e8a14fa99c118f4ba1fe28ce_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzExLTUtMS0xLTE5NjM1_9045c6ab-ad01-46aa-ba7b-43875338006c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie59012b0b1f342f68b2de7d2cf4ab087_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzExLTctMS0xLTE5NjM1_955b56b4-e3e6-4821-be95-dde68a983230"
      unitRef="usd">4553000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib5cc0c0211dd4cb0b9436d1dcc14e45f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEzLTEtMS0xLTE5NjM1_04ea240f-f464-4c2e-b2fe-f80ae17e8902"
      unitRef="usd">201000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia291c95e9323450a8b9d5c75e58e6dde_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEzLTMtMS0xLTE5NjM1_a8ef7d91-6623-4a4a-b5a2-63759aee8f2c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i13f56229e6a44220ac924ebb86adafa3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEzLTUtMS0xLTE5NjM1_812eafee-0054-4a4e-a2e9-98e45edd5edb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i22bbe4588fd541d6a564c67c1022e726_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzEzLTctMS0xLTE5NjM1_e80c579b-234c-4f42-aae6-64b79921022e"
      unitRef="usd">201000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if240d2be64a04252b3b1f214f2c30cce_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE0LTEtMS0xLTE5NjM1_f46c00ce-9e8e-46bd-8876-fe0396754148"
      unitRef="usd">81000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4e572606f72547578135489453dbfd32_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE0LTMtMS0xLTE5NjM1_bdb4abaf-2a6e-4e5a-9d11-22d5c7964bb3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9c636fbb95ec447f84da5fad0bd31870_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE0LTUtMS0xLTE5NjM1_7ebaf61d-a642-4e95-b1dd-f952d90beb12"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0ca55a5008304969aa971098edc7db65_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE0LTctMS0xLTE5NjM1_fff7bfe9-117f-48f6-afd9-31c7b608d562"
      unitRef="usd">81000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5750f985ec4049d5a4ce86e6955f062c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE1LTEtMS0xLTE5NjM1_f27f486b-46c7-44d9-8c69-3aaf76cfd4a5"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8275b2c1a4584bab8295523437070a66_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE1LTMtMS0xLTE5NjM1_8d14157b-99d2-4aaf-8fee-f5715c1852d6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i353fe81c894e473d8489f94900073b72_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE1LTUtMS0xLTE5NjM1_24ca399e-e184-4304-a4d3-58db8798945d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0142cf66eb9e474ba86ff2ef25aa7bb2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE1LTctMS0xLTE5NjM1_a5bf7545-6e0f-4886-a0e9-4eab04c1b673"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i09446e526f7f40f1b8b3303c458d33ce_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE2LTEtMS0xLTE5NjM1_5cce19d0-b858-4f3d-8c6a-636740a8a474"
      unitRef="usd">283000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id83eb75fcc284b5f8068a783a9650faf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE2LTMtMS0xLTE5NjM1_a6cfba02-7e34-4536-9b52-b5f914f5ff33"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i347ffec6d213490c86926a3020149905_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE2LTUtMS0xLTE5NjM1_80fcc0f4-763d-4315-a634-245953931857"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i68728028bd74499a908379ef355b4da0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE2LTctMS0xLTE5NjM1_57ddbb63-5fbd-4ddc-b7b2-1b5c9835f5d5"
      unitRef="usd">283000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i16f188fd81734863b4051130ab9f098b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE4LTEtMS0xLTE5NjM1_c03ec167-3535-41a7-9718-96f2e43db121"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i97f4fe722e6e43d6bf5d820d11cc2e2c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE4LTMtMS0xLTE5NjM1_5aa565d5-28d7-4a2a-9f87-66446b33b03c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3aab0ea7df2549f09b6ae42102668e65_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE4LTUtMS0xLTE5NjM1_358dc9ef-2dd5-414f-b39d-138e1ccf012f"
      unitRef="usd">378000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i22a8679306fb4d1ba271a7b5a547276e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE4LTctMS0xLTE5NjM1_6e4a29cf-c080-41e8-a5c7-3c106ce97b42"
      unitRef="usd">378000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1e5acd236a544fff8d2d17bd87ad5a43_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE5LTEtMS0xLTE5NjM1_2a075803-703c-4b7b-8117-07ff0c6b7871"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i87a55c8247be45b09ee66e3eeef70a7c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE5LTMtMS0xLTE5NjM1_7a68e742-b720-492a-9918-4fad92f503fc"
      unitRef="usd">410000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idb6a1ac4f81447019bc03b2d0cdb655e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE5LTUtMS0xLTE5NjM1_3d855267-8f51-42d2-9e4d-dd8f7e43f2de"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7c06aac8a3d747f9985177c9ed3a77fd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzE5LTctMS0xLTE5NjM1_1abb2e38-a70f-4026-86ee-80ffd643e007"
      unitRef="usd">410000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7ee6597ca53e484eada5596583046f3e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzIxLTEtMS0xLTE5NjM1_e91a7315-406b-461a-8f87-36557823a41e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i37d7609b746045a585af149f288da888_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzIxLTMtMS0xLTE5NjM1_f99be0fa-8a67-4f19-98ed-42a998a70d31"
      unitRef="usd">410000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib44b71f83a2d49289abcbf4aac524e75_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzIxLTUtMS0xLTE5NjM1_25fd7a0e-d659-4a48-942b-c7a8e2275d18"
      unitRef="usd">378000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i248a5597803e4cdf9daeedf87c82dc5e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzIxLTctMS0xLTE5NjM1_9454341d-a18d-4b36-aa33-41000ee3d767"
      unitRef="usd">788000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1308d93a146c4c8488b59a3c5a030c08_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzIyLTEtMS0xLTE5NjM1_be04e760-2f80-4736-bde0-8434e5771b99"
      unitRef="usd">1566000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i63f7417ba6374a9bb024726d61971b6c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzIyLTMtMS0xLTE5NjM1_46209144-0df5-46cf-86ac-713933dbaaba"
      unitRef="usd">3837000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0fc62e7b55b64c639f28ec82a4ab6bd1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzIyLTUtMS0xLTE5NjM1_9611715f-f99f-44bb-a5e8-9c08127789ae"
      unitRef="usd">378000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifbd48617b54d4e418e1d710b3ae6d615_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTphOGNhOTBlOWFhY2I0ZDFiYmZlZDJmOTRjYzIzNWUyZC90YWJsZXJhbmdlOmE4Y2E5MGU5YWFjYjRkMWJiZmVkMmY5NGNjMjM1ZTJkXzIyLTctMS0xLTE5NjM1_daf7c794-4585-49f8-a99c-cbc3a86bc730"
      unitRef="usd">5781000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount
      contextRef="i20fea02b40f94c0ba48b95b826283484_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzU3NTM_579875e5-92b3-4c63-90bc-bae1593fd6d3"
      unitRef="usd">261000000</us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount>
    <us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount
      contextRef="if275586315f94ce8aa9f0a9ac4422fce_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzU3ODE_f21385ea-c62d-43ad-a84b-f6f4f77ca284"
      unitRef="usd">149000000</us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icdfdfa352a47493f87219a5298ddedc0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzM4NDgyOTA3MTA5MTI_100873c8-9565-447f-bf0d-6478ef70c7b7"
      unitRef="usd">76000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib3a9437b6cce406685b52a5c81de0dc3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzU4NTA_5cce71b5-5ece-4b04-bcf4-4d8940a73073"
      unitRef="usd">583000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i31173b20feb34137842581c3c8ce276b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzU5MDc_09cf3937-588f-4700-86a0-2dbadb5806f5"
      unitRef="usd">237000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifd69bf1ffd684edcb0e0780c09b5e3ff_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEtMS0xLTEtMTk2MzU_69d35d7c-d05e-47fe-bf3b-34d64b69c9d9"
      unitRef="usd">118000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5e1d94487b2b4e17bcc6022785274fa4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEtMy0xLTEtMTk2MzU_efca0dd8-04cc-4d84-b939-5b99dd686c0f"
      unitRef="usd">81000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5790b806681342228c412540032c2845_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEtNS0xLTEtMTk2MzU_a4cdaa08-a681-4c97-aaf3-a87e1e3ef172"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic2bca73c906b44578c01f6b232e46777_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEtNy0xLTEtMTk2MzU_6df0df2f-0548-4292-9906-3e019b6295f9"
      unitRef="usd">199000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7b1bf3752dcf4f309d29e28b80c56ffe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzMtMS0xLTEtMTk2MzU_11d92d77-0e00-4fdd-8521-e4cf55752fbf"
      unitRef="usd">575000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6a371f76601c443b8b6c9bcd816f3a93_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzMtMy0xLTEtMTk2MzU_eec61db6-73cd-4d2f-87b2-30ada18dc49b"
      unitRef="usd">36000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5b9cd1a5ea464c6daf3d809cfa440c90_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzMtNS0xLTEtMTk2MzU_73f15893-1fd8-458b-aa11-2cfa3897707a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9ab5d14a774c4e00912a293ffe6f87bb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzMtNy0xLTEtMTk2MzU_a3e37c9f-f9da-45e4-9d34-b43b9fa3f6b2"
      unitRef="usd">611000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib65d80ddf5114b28a867a900c7850eac_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzQtMS0xLTEtMTk2MzU_16b5191b-d792-4436-a42c-c37cfbd943d7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id189ff74332342fa9efe4364610c858b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzQtMy0xLTEtMTk2MzU_35eb92bc-776d-4e75-9eaf-6ce93e8ca294"
      unitRef="usd">170000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id6b00b26ffba4cad87f82b5285574b87_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzQtNS0xLTEtMTk2MzU_9bb63697-7b52-4fd0-a7d2-a5f44474d342"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9149c44a31594b36a308ac1f8c72e95b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzQtNy0xLTEtMTk2MzU_296eefdb-46d4-4446-b99f-91bb404d6de9"
      unitRef="usd">170000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i03315b2d0c214dc9ae1f36aa4a7b1182_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzUtMS0xLTEtMTk2MzU_1b43c22f-57fd-402e-83cd-8f4f78bb2d24"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ieabcbb36fc544fe1a63bec192e6a5369_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzUtMy0xLTEtMTk2MzU_2c1ea008-5260-4cd0-9790-791dc581385a"
      unitRef="usd">2006000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icbab6554354142219fbf65a19f9f7258_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzUtNS0xLTEtMTk2MzU_3b8b741a-2f3d-466f-a3d1-01df22f858e6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2d537c7cac0d4b2bb971a7f1b19afd54_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzUtNy0xLTEtMTk2MzU_ca1ae84e-d852-4da4-9db4-e4d31ef163bc"
      unitRef="usd">2006000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iee91350be21e4df98a159fbf2f617178_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzYtMS0xLTEtMTk2MzU_7b1c1dec-7fae-4306-a08a-50b2996636e8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5b09818a0a4a496a9fa00fed53ac3bc0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzYtMy0xLTEtMTk2MzU_5fcea0b0-cc00-4a51-8937-7a28b9a3beda"
      unitRef="usd">167000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie7c8684e46134d5d94ecbacac811adbf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzYtNS0xLTEtMTk2MzU_a732a0c8-3971-45f5-9c8c-9da9c83d13ec"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if725d6e275a94ba883eb02d3137c3b23_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzYtNy0xLTEtMTk2MzU_f1317ada-95f2-490c-b356-fdb38d68a75a"
      unitRef="usd">167000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0dacb79ba9f7420094ee7ba16c6f78c7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzctMS0xLTEtMTk2MzU_6606e61a-c3b2-4603-ac9c-b78955df0d4d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4e824e97dad749fa8146593c0a7fa864_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzctMy0xLTEtMTk2MzU_69385c02-ac30-415c-a504-ad4fa66db8e4"
      unitRef="usd">287000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2f2924405ec24521a9aa09e98be58eec_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzctNS0xLTEtMTk2MzU_481ba285-b528-4991-95c5-89e07a5a9f8a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i36dd5abbbdcc4f9a9f25788b549f76f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzctNy0xLTEtMTk2MzU_8b2bf15f-82f9-4e9c-a057-315b0b35ddc8"
      unitRef="usd">287000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibd4080c110824cc891e5f7c1bfadc274_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzgtMS0xLTEtMTk2MzU_6570148f-463d-493c-a275-d11f18996ab7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i45c05f5dd5d3432185804a21006dd535_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzgtMy0xLTEtMTk2MzU_090e9a3e-8713-4a7b-885a-ad77b9bce950"
      unitRef="usd">83000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifdc0d801d333478e818a374400b463a0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzgtNS0xLTEtMTk2MzU_497d9ddd-a6d2-43c0-a85f-3c620fbb6e55"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i69656313398948a58d187e87db585202_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzgtNy0xLTEtMTk2MzU_9f49b518-291d-4252-b29e-0737dcf3093c"
      unitRef="usd">83000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5dd797aa72de45759796b65f361f095d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzktMS0xLTEtMTk2MzU_d58ee0e4-e1b8-4df9-97d9-6511bad36e30"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3f11128fcfa749d782d3026befe4c0b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzktMy0xLTEtMTk2MzU_dac6177b-1eac-4d3e-8e49-117cce931aa4"
      unitRef="usd">133000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6d2c9c46d28343c39add06320df583f6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzktNS0xLTEtMTk2MzU_ff6d9db7-646b-4e23-abeb-69a4d9fbab04"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i504c90860189474a9e7671e231444fcb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzktNy0xLTEtMTk2MzU_c5e7aca8-f158-4bfa-b622-20f7341219d9"
      unitRef="usd">133000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i98e2d75cd63240afb79819d5aa10ec90_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEwLTEtMS0xLTE5NjM1_8b091776-f14b-4275-9d72-985bb938ff70"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie1f96d3ab2794a19976e875f2624ea6e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEwLTMtMS0xLTE5NjM1_5b208c28-b0b4-45bd-96e2-abd0b2f0fa8d"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i41b1ed139bba42e9bb825bb820df17c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEwLTUtMS0xLTE5NjM1_5436ea5c-2ff3-4dc0-bb37-a229bba9feba"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iabdd8d0f4b884bafb6a33a56b77ba2d2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEwLTctMS0xLTE5NjM1_39ee6108-8742-4c79-8d7b-0a1b0856031a"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9978503911fa41aa862248d7a8b2f088_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzExLTEtMS0xLTE5NjM1_777ec4fd-ccea-436a-b423-8249b44166e7"
      unitRef="usd">575000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9890742ae5e746e59b2065d06764be7a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzExLTMtMS0xLTE5NjM1_7debb720-2547-4858-b9d3-dfa7d85019ba"
      unitRef="usd">2887000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i18e230719b394883bd34f909e74c7ec7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzExLTUtMS0xLTE5NjM1_24cc1999-9d35-4540-b181-11b8de372c31"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icbb9853b8df849048580a1fd16e6682d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzExLTctMS0xLTE5NjM1_091ecd19-126b-4ec7-b888-a8eb5e041627"
      unitRef="usd">3462000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5917c3c349de4954858ab57a50dd8cb9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEzLTEtMS0xLTE5NjM1_9fe14bcf-1dd7-4757-8981-2f3da5c92f8e"
      unitRef="usd">1046000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7cabad59a0dc44a6ac1fd35c4b99265b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEzLTMtMS0xLTE5NjM1_970e926e-2e22-4dfb-b78e-25634598d0c0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6aedf877fb364df6a2c31ee163a6cfe2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEzLTUtMS0xLTE5NjM1_09c5a25c-2ad0-4147-9894-b029296c1eb8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i28dff85338264876bb38fd87ca595a93_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzEzLTctMS0xLTE5NjM1_351e0952-6d83-41b2-86c0-f6b4802804ad"
      unitRef="usd">1046000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3ae7533aef2d4ae58181147c89948033_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE0LTEtMS0xLTE5NjM1_feeaf988-9146-4a57-a1d7-29a43debb799"
      unitRef="usd">537000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i980a0570d54d438e9ca44fce0d36118f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE0LTMtMS0xLTE5NjM1_cd1411a0-33b1-4174-92e8-c0fc541c0ffd"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7f5b472d5fd248fc9d8e4d0ca5faba33_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE0LTUtMS0xLTE5NjM1_2552ec11-31c2-4415-b1b6-16d3268e0f88"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5541dbb601c340fc980f125354496618_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE0LTctMS0xLTE5NjM1_d039f8eb-8bea-447a-bf08-52cf8941ecf3"
      unitRef="usd">537000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9db72d0c676148af9dada1f290d09a49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE1LTEtMS0xLTE5NjM1_b98f1b3f-219c-4579-8461-4cfa9a5f6a6d"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8c114d81513142deb782de5f4fb900d7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE1LTMtMS0xLTE5NjM1_6fc51609-f000-4be0-8047-d7d9d6a4aaee"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia89b4748c514428786ab4dbcbb1f9083_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE1LTUtMS0xLTE5NjM1_2e5ae276-44e1-4591-b23a-1866adf115a6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7fbed6015e9f445a8b1b5c27ee92141a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE1LTctMS0xLTE5NjM1_a3256ffa-bbd3-4a19-8291-35c1ecfbe0a4"
      unitRef="usd">15000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibadbdf8585c74e21a8128d74084c1630_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE2LTEtMS0xLTE5NjM1_0e18b0fd-5db6-444d-ab50-4a3c59543495"
      unitRef="usd">1598000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7afb56947f304bfc81fc6a4e5e0609a2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE2LTMtMS0xLTE5NjM1_3d25291e-ca4c-47de-817e-45be53957cb1"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i40b0233400e741c69f64993477c55a4b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE2LTUtMS0xLTE5NjM1_37586b95-73da-4902-acde-a365acad3bce"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0ac32e06a1214b17a9a0b84d07f40f6a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE2LTctMS0xLTE5NjM1_80d1c1d3-6c54-4b49-93c6-b649d2f37385"
      unitRef="usd">1598000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id1503d3a6c2e498cb8692a32b8d66212_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE4LTEtMS0xLTE5NjM1_9c74936e-74cf-4d5a-a89e-51aebaeb26c7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i92012f7aded14a9d87023bc2cc81aca5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE4LTMtMS0xLTE5NjM1_e05d2e02-1420-4346-a3f1-be25bfae1521"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib9cf82de093b4218a4e15181bf7ad103_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE4LTUtMS0xLTE5NjM1_096c9ad0-64a5-4c91-86b8-25166a81e0ed"
      unitRef="usd">343000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i73089e6a3a2241938de74ace9cba6d4d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE4LTctMS0xLTE5NjM1_f25d8b56-8f20-4203-950c-5533116bf25c"
      unitRef="usd">343000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6e982f6ad3ab46928953aac66f4ed7cd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE5LTEtMS0xLTE5NjM1_a07d2ea0-7f63-45a6-aa4f-573eb0d245c7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibd833f359c8e4d79b0a869ad0038a7ea_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE5LTMtMS0xLTE5NjM1_6aec7a59-79cb-4b41-bbda-d3784875c0cf"
      unitRef="usd">266000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id11c855da6024638a23cf8dee7acc5da_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE5LTUtMS0xLTE5NjM1_ca2d3f8c-bb7d-4914-8e7b-6c959292391c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5dc8d2b37fd24bc5ba0361ec6cb6d65b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzE5LTctMS0xLTE5NjM1_13d48e2c-6398-49e9-b6fa-23163e367027"
      unitRef="usd">266000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4bb5df4dc2c74cb6a22410f86a771e30_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIwLTEtMS0xLTE5NjM1_b8e20ec5-cc47-4218-a0f9-a37ea7efc1ca"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8d85bdcd4cfc46a8af15a02b4c576aef_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIwLTMtMS0xLTE5NjM1_34f9b3d3-79e8-4326-8d75-5ccf4f34fd03"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i50b42474671845488782a3036f501d1b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIwLTUtMS0xLTE5NjM1_72d7f060-7475-4eb4-8514-8d679414a5d5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i28df8a8c64394346a9c15d1cc0276d57_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIwLTctMS0xLTE5NjM1_43877f6b-458d-470e-86bd-6911c76f9701"
      unitRef="usd">-3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibafcbe43a8324a158a723bf16031e45e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIxLTEtMS0xLTE5NjM1_823915e2-76c7-462b-8558-b38bf39a034b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i94adba46e20a49038784a49900c2c598_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIxLTMtMS0xLTE5NjM1_d0452839-0016-4473-94d4-93272077241a"
      unitRef="usd">263000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i73a6d94969d34f66be2e45328cb8f039_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIxLTUtMS0xLTE5NjM1_90d61417-57a0-4d56-9024-f087fd738f60"
      unitRef="usd">343000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i25eb35fe769e4798b61a524290097389_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIxLTctMS0xLTE5NjM1_d0cd67bc-973a-4b4e-a259-bc4923287e6a"
      unitRef="usd">606000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i263c92882506448d9de97c225b5380ac_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIyLTEtMS0xLTE5NjM1_981a7952-6706-4353-bbc9-4df59bb8c340"
      unitRef="usd">2291000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic142f878870649039fd16edd170bbf6d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIyLTMtMS0xLTE5NjM1_f66629a3-2240-4781-92d4-19576505c283"
      unitRef="usd">3231000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i615e9d3a8c03432b9318ebab3d589854_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIyLTUtMS0xLTE5NjM1_0bb72a49-9e60-4f39-93b2-fca2311a8222"
      unitRef="usd">343000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ica25f49a766947a2adc2da48b7b82874_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1NWYxZmFiNTg4ZTA0NTRiODZlMTdiYzRmNTIzMDE5Yi90YWJsZXJhbmdlOjU1ZjFmYWI1ODhlMDQ1NGI4NmUxN2JjNGY1MjMwMTliXzIyLTctMS0xLTE5NjM1_5e1a313f-ec41-4087-9e74-afd0f1e5a599"
      unitRef="usd">5865000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount
      contextRef="i629a1b7b7b2446cc8b1de566b5f3c0de_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwOTk1MTE2NDAzNDE_eba42899-f85b-4bfa-a5a2-bfa7ba62103f"
      unitRef="usd">84000000</us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount>
    <us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount
      contextRef="i05c170e5b7b94386b7fcd1a8079be955_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwOTk1MTE2NDAzNDc_1598093b-b481-4402-a837-7f9082fdc280"
      unitRef="usd">182000000</us-gaap:DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i60dddc7de4d647b3b43c5f0623bcf0f0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwOTk1MTE2NDAzNTM_b7baf838-d2c3-4fcb-81fa-6547c3985e20"
      unitRef="usd">142000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9a78c5e8b0784b46b5d4bb5a8fc3a21d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwOTk1MTE2NDAzNTk_92f5355b-33ad-477f-8c2d-b95cd5896a4c"
      unitRef="usd">624000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i243c32908d3d4416bc7ff18ee7ffd240_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwOTk1MTE2NDAzNjU_94dadf15-9d5c-4ddb-b6e0-561ebe43ddcb"
      unitRef="usd">214000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsCategoryTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODQ5_4d970e31-a30c-4488-9f96-4d89c358a9f3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.759%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in the balances of Level 3 pension plan assets during the year ended December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Real estate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;U.S. corporate&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases, sales and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DefinedBenefitPlanPlanAssetsCategoryTableTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib9cf82de093b4218a4e15181bf7ad103_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzItMS0xLTEtMTk2MzU_af6193bb-b50a-4d4c-bf44-1f51e0d1c406"
      unitRef="usd">343000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i615e9d3a8c03432b9318ebab3d589854_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzItNS0xLTEtMTk2MzU_f5b267ac-1e77-4828-9b83-695617d57b64"
      unitRef="usd">343000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld
      contextRef="iab646cf33e884b1698a49fc5490b1a94_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzMtMS0xLTEtMTk2MzU_daea7945-721f-4c9e-b34b-4447e5ca9eb5"
      unitRef="usd">43000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld
      contextRef="i7de4764ce7104e8cb8330af8da0f29b3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzMtNS0xLTEtMTk2MzU_03cee1ee-1543-4f2a-91bb-1e474009ac0f"
      unitRef="usd">43000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements
      contextRef="iab646cf33e884b1698a49fc5490b1a94_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzQtMS0xLTEtMTk2MzU_b34f1c92-17cc-4d63-95c0-c6f8f10dac64"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements
      contextRef="i7de4764ce7104e8cb8330af8da0f29b3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzQtNS0xLTEtMTk2MzU_1d63aff9-c0de-46f2-8634-10a3a61d36e8"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels
      contextRef="iab646cf33e884b1698a49fc5490b1a94_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzUtMS0xLTEtMTk2MzU_e5ad0722-d0dd-43f9-b97d-1a6fab1ea47c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels>
    <us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels
      contextRef="i7de4764ce7104e8cb8330af8da0f29b3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzUtNS0xLTEtMTk2MzU_0a71b6da-b480-43b6-94cb-d7a11965a664"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3aab0ea7df2549f09b6ae42102668e65_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzYtMS0xLTEtMTk2MzU_d448a432-6d30-4643-b02b-0b7b854d3684"
      unitRef="usd">378000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0fc62e7b55b64c639f28ec82a4ab6bd1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTpiN2QyNWEyZDI1ZjE0NTc5OGMxN2Q0YzJiMTIyYTA5ZC90YWJsZXJhbmdlOmI3ZDI1YTJkMjVmMTQ1Nzk4YzE3ZDRjMmIxMjJhMDlkXzYtNS0xLTEtMTk2MzU_1c61f1f7-4a3b-4fc5-89ba-4d00e0a34233"
      unitRef="usd">378000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib96bf7bb8a4e46c2bb1e0d91aacf9454_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzItMS0xLTEtMTk2MzU_317b3964-682e-4abb-ac73-1bac6943a6eb"
      unitRef="usd">353000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2fe8d48e437a42c8ac2e33f34b85a197_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzItMy0xLTEtMTk2MzU_4613433a-c739-436d-9dea-7adbb23980ba"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie319f6a95cc24bbdb8d73ca1db401d8f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzItNS0xLTEtMTk2MzU_56c33031-9a18-46cf-9a02-d66d12cb7d13"
      unitRef="usd">354000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld
      contextRef="i68c26fea49fd41b19bc33b4ee7857fdf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzMtMS0xLTEtMTk2MzU_4ec189e6-5c3d-4aa6-8f17-4db72923b61b"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld
      contextRef="i8a9138b4f181419d87234459e11ed427_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzMtMy0xLTEtMTk2MzU_8bf6892a-a5e3-4375-8f76-7f3ef8394f2a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld
      contextRef="icf6ce37a6c304453aa21c72054c6c418_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzMtNS0xLTEtMTk2MzU_5f1b8708-1b34-4b86-bed8-ad85c3f6fd05"
      unitRef="usd">-2000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements
      contextRef="i68c26fea49fd41b19bc33b4ee7857fdf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzQtMS0xLTEtMTk2MzU_f6fa2f4d-ef79-43a2-9465-115570b4eed5"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements
      contextRef="i8a9138b4f181419d87234459e11ed427_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzQtMy0xLTEtMTk2MzU_6fa4e0fc-ca31-4a06-927e-ff2ee24df40e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements
      contextRef="icf6ce37a6c304453aa21c72054c6c418_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzQtNS0xLTEtMTk2MzU_591e38d8-6264-4a55-86a9-abb844ff6e7c"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanPurchasesSalesAndSettlements>
    <us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels
      contextRef="i68c26fea49fd41b19bc33b4ee7857fdf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzUtMS0xLTEtMTk2MzU_60139571-67b3-45e8-b0c5-76fe386c1cd3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels>
    <us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels
      contextRef="i8a9138b4f181419d87234459e11ed427_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzUtMy0xLTEtMTk2MzU_38faf527-786f-4af1-ae5a-15aae815cae7"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels>
    <us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels
      contextRef="icf6ce37a6c304453aa21c72054c6c418_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzUtNS0xLTEtMTk2MzU_133fb37b-ff7c-47a5-8d20-b304fc852e6c"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanTransfersBetweenMeasurementLevels>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib9cf82de093b4218a4e15181bf7ad103_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzYtMS0xLTEtMTk2MzU_835521e6-56eb-4f33-9d48-d5a53f99115e"
      unitRef="usd">343000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="icbab6554354142219fbf65a19f9f7258_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzYtMy0xLTEtMTk2MzU_a0845ad9-29de-49bc-b5d4-e87f4284a966"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i615e9d3a8c03432b9318ebab3d589854_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo1YWU0ZmNmMzdiNTc0ODZjYmE5MzM1YWUzZDI3ZmU0Mi90YWJsZXJhbmdlOjVhZTRmY2YzN2I1NzQ4NmNiYTkzMzVhZTNkMjdmZTQyXzYtNS0xLTEtMTk2MzU_7a1bb3bf-f82f-486d-b0fc-cc69257437a2"
      unitRef="usd">343000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i025b8e46060344f99b00103d8305d8f2_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5Xzc4Mzg_61a8e1bb-15f7-4662-9f0b-478043a72dc6"
      unitRef="number">0.12</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i9e4ad64d899d4ef984f319b18bd41d23_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5Xzc4NjM_e42ca180-cc20-4c62-88b2-9b985447e18b"
      unitRef="number">0.77</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i76b12c0d6c6040539968eac6791ef12d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5Xzc5MDM_2e3bbfb5-4a26-4e3e-adda-9f09c707e920"
      unitRef="number">0.05</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="id5b88ad8263249b9a5226487582fc404_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5Xzc5MjI_216c1e30-5fe3-4484-9b82-6a815f82bc2f"
      unitRef="number">0.03</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i7fe3ea32ebf64cf49fb9d49975086ee9_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5Xzc5Njg_49a640d5-fb4e-4a50-af33-0183dc6d5699"
      unitRef="number">0.03</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5Xzg4ODE_5dc6f303-8fbc-482d-92d2-8db7de7db745"
      unitRef="usd">78000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5Xzg4ODU_6aa6229e-14e7-48d4-868c-88cbe1a07da5"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="iaf1063688e1c402b918f2251c5ebcda8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5Xzg4OTI_1a9ece45-4468-4c40-8161-fed349a01250"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODcz_054b1266-7148-412e-a6f7-85fe1d281daf">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the pension benefit obligation as of December&#160;31, 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027-2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the following future benefit payments, which are calculated using the same actuarial assumptions used to measure the accumulated other postretirement benefit obligation as of December&#160;31, 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.105%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027-2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo0YWM1NDc5M2E0NTA0MGU2OGU3NWI2MWQ1YjY1ZjZlMS90YWJsZXJhbmdlOjRhYzU0NzkzYTQ1MDQwZTY4ZTc1YjYxZDViNjVmNmUxXzEtMS0xLTEtMTk2MzU_e9614773-bb05-4532-ba58-70ed4b83aad2"
      unitRef="usd">371000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo0YWM1NDc5M2E0NTA0MGU2OGU3NWI2MWQ1YjY1ZjZlMS90YWJsZXJhbmdlOjRhYzU0NzkzYTQ1MDQwZTY4ZTc1YjYxZDViNjVmNmUxXzItMS0xLTEtMTk2MzU_cd00236d-cdd9-4cf3-88a5-feedaca3b0be"
      unitRef="usd">371000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo0YWM1NDc5M2E0NTA0MGU2OGU3NWI2MWQ1YjY1ZjZlMS90YWJsZXJhbmdlOjRhYzU0NzkzYTQ1MDQwZTY4ZTc1YjYxZDViNjVmNmUxXzMtMS0xLTEtMTk2MzU_ab898eb8-8c57-4304-a1b2-da49f30a958f"
      unitRef="usd">371000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo0YWM1NDc5M2E0NTA0MGU2OGU3NWI2MWQ1YjY1ZjZlMS90YWJsZXJhbmdlOjRhYzU0NzkzYTQ1MDQwZTY4ZTc1YjYxZDViNjVmNmUxXzQtMS0xLTEtMTk2MzU_05fb1b13-9514-403e-a306-04b5bc251557"
      unitRef="usd">371000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo0YWM1NDc5M2E0NTA0MGU2OGU3NWI2MWQ1YjY1ZjZlMS90YWJsZXJhbmdlOjRhYzU0NzkzYTQ1MDQwZTY4ZTc1YjYxZDViNjVmNmUxXzUtMS0xLTEtMTk2MzU_dbd9d005-c349-47eb-a20d-9ae3429042db"
      unitRef="usd">368000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i42e14e6ecf0d4519bad91c300172ce00_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo0YWM1NDc5M2E0NTA0MGU2OGU3NWI2MWQ1YjY1ZjZlMS90YWJsZXJhbmdlOjRhYzU0NzkzYTQ1MDQwZTY4ZTc1YjYxZDViNjVmNmUxXzYtMS0xLTEtMTk2MzU_fec0ef43-41e5-4df0-bbc2-fcbeb4195923"
      unitRef="usd">1776000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwMzc2_c18594d6-6b8c-4d6d-b97c-9b57b76a6343"
      unitRef="usd">19000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="i155bec7d75a941458fedd191eb885b03_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwMzgw_33decb15-5611-49b6-882c-f1d7158293fa"
      unitRef="usd">19000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="iaf1063688e1c402b918f2251c5ebcda8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzEwMzg3_bbff391b-2918-4b5f-a9bb-88d9a8b147a2"
      unitRef="usd">18000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i85cd553b0d4e4d00807d021b0529afcb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExMDU5_e093eb3a-ad7b-4851-a80a-05ec7253a284"
      unitRef="usd">207000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i70428484fd564ff2a11599326e08e7f3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExMDY2_5eb1dc3f-50c6-48c5-9a40-fbf84043b8fe"
      unitRef="usd">226000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i2809337bb72a4fa6997eeb7883adae59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExMTYz_a6359bee-660e-4930-ac1a-657beeb52f13"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i94a38e87618941bb9c641ca41807e1e2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExMTY3_0c1a19ae-4f76-470d-a2e6-84eb026eff5b"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ife890af6894342c6ab78227d1ee5350c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExMTc0_fcc5a02d-9ad7-469e-aeb9-4c22d7591bf9"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i85cd553b0d4e4d00807d021b0529afcb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo3M2Q0OTZmMzU5Zjk0MDFmODA1MTk3NzE1OTg2MmFjNC90YWJsZXJhbmdlOjczZDQ5NmYzNTlmOTQwMWY4MDUxOTc3MTU5ODYyYWM0XzEtMS0xLTEtMTk2MzU_f6651ff3-2162-4155-8d39-5c0b9f3b5b8e"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i85cd553b0d4e4d00807d021b0529afcb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo3M2Q0OTZmMzU5Zjk0MDFmODA1MTk3NzE1OTg2MmFjNC90YWJsZXJhbmdlOjczZDQ5NmYzNTlmOTQwMWY4MDUxOTc3MTU5ODYyYWM0XzItMS0xLTEtMTk2MzU_d18b5ff9-f4f9-48c4-8905-369d4650ff2e"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i85cd553b0d4e4d00807d021b0529afcb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo3M2Q0OTZmMzU5Zjk0MDFmODA1MTk3NzE1OTg2MmFjNC90YWJsZXJhbmdlOjczZDQ5NmYzNTlmOTQwMWY4MDUxOTc3MTU5ODYyYWM0XzMtMS0xLTEtMTk2MzU_efd45581-e013-4f81-99ef-84e4dd7b46ae"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i85cd553b0d4e4d00807d021b0529afcb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo3M2Q0OTZmMzU5Zjk0MDFmODA1MTk3NzE1OTg2MmFjNC90YWJsZXJhbmdlOjczZDQ5NmYzNTlmOTQwMWY4MDUxOTc3MTU5ODYyYWM0XzQtMS0xLTEtMTk2MzU_4b689038-d53d-4bcb-ac92-2eb907daca7a"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i85cd553b0d4e4d00807d021b0529afcb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo3M2Q0OTZmMzU5Zjk0MDFmODA1MTk3NzE1OTg2MmFjNC90YWJsZXJhbmdlOjczZDQ5NmYzNTlmOTQwMWY4MDUxOTc3MTU5ODYyYWM0XzUtMS0xLTEtMTk2MzU_5bdc423d-2460-4e2e-aa96-a053865f2c2f"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i85cd553b0d4e4d00807d021b0529afcb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90YWJsZTo3M2Q0OTZmMzU5Zjk0MDFmODA1MTk3NzE1OTg2MmFjNC90YWJsZXJhbmdlOjczZDQ5NmYzNTlmOTQwMWY4MDUxOTc3MTU5ODYyYWM0XzYtMS0xLTEtMTk2MzU_ee85f9d0-fc0e-4aa7-84c0-7b6ca3c1d1bc"
      unitRef="usd">60000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="i2809337bb72a4fa6997eeb7883adae59_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODAx_79c6573f-2994-4c0d-8249-e2af2bbca7be"
      unitRef="usd">60000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="i94a38e87618941bb9c641ca41807e1e2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODA1_cd204597-344c-4c0b-b2e5-c6fad1888577"
      unitRef="usd">54000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:MultiemployerPlanPensionInsignificantPlanContribution
      contextRef="ife890af6894342c6ab78227d1ee5350c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNTQvZnJhZzplNmIyNTgwNjgxMmY0MjAzODhmOGRmZjVhMzE0OTVmOS90ZXh0cmVnaW9uOmU2YjI1ODA2ODEyZjQyMDM4OGY4ZGZmNWEzMTQ5NWY5XzExODEy_545d9bbd-f1d2-4a81-9f2e-5b7b81f4d316"
      unitRef="usd">57000000</us-gaap:MultiemployerPlanPensionInsignificantPlanContribution>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzQyODY_b8282ef2-874e-4055-bdb2-891481b541cd">Income Taxes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision for continuing operations consisted of the following for the&#160;years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(535)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(428)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(564)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of the statutory income tax rate to the Company&#x2019;s effective income tax rate for continuing operations for the&#160;years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health insurer fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basis difference upon disposition of subsidiary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year refund claim &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the components of the Company&#x2019;s deferred income tax assets and liabilities as of December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and rents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debts and other allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss and capital loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll tax deferral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(454)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and rents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,568)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,794)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company had net operating and capital loss carryovers of $416 million, which expire between 2022 and 2041. The Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies and the Company&#x2019;s recent operating results. The Company established a valuation allowance of $325 million as of December&#160;31, 2021 because it does not consider it more likely than not that these deferred tax assets will be recovered.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balance of unrecognized tax benefits in 2021, 2020 and 2019 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expiration of statutes of limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVS Health Corporation and most of its subsidiaries are subject to U.S. federal income tax as well as income tax of numerous state and local jurisdictions. CVS Health Corporation participated in the Compliance Assurance Process through 2019, which is a program made available by the U.S. Internal Revenue Service (&#x201c;IRS&#x201d;) to certain qualifying large taxpayers, under which participants work collaboratively with the IRS to identify and resolve potential tax issues through open, cooperative and transparent interaction prior to the annual filing of their federal income tax returns. The IRS has completed its examinations of the Company&#x2019;s consolidated U.S. federal income tax returns for tax years through and including 2013 and 2018. The IRS has substantially completed its examinations of the Company&#x2019;s consolidated U.S. federal income tax returns for tax years 2014 through 2017 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CVS Health Corporation and its subsidiaries are also currently under income tax examinations by a number of state and local tax authorities. As of December&#160;31, 2021, no examination has resulted in any proposed adjustments that would result in a material change to the Company&#x2019;s operating results, financial condition or liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all material state and local income tax matters have been concluded for fiscal years through 2014. Certain state exams are likely to be concluded and certain state statutes of limitations will lapse in 2022, but the change in the balance of the Company&#x2019;s uncertain tax positions is projected to be immaterial. In addition, it is reasonably possible that the Company&#x2019;s unrecognized tax benefits could change within the next twelve months due to the anticipated conclusion of various examinations with the IRS for various years. An estimate of the range of the possible change cannot be made at this time.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records interest expense related to unrecognized tax benefits and penalties in the income tax provision. The Company accrued interest expense of approximately $40 million, $34 million and $49 million in 2021, 2020 and 2019, respectively. The Company had approximately $151 million and $121 million accrued for interest and penalties as of December&#160;31, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the total amount of unrecognized tax benefits that, if recognized, would affect the Company&#x2019;s effective income tax rate is approximately $669 million, after considering the federal benefit of state income taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzQyODg_ffbf19fd-dbf7-4592-8010-1c54721ad091">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The income tax provision for continuing operations consisted of the following for the&#160;years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(306)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(450)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(535)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(428)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(564)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(649)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzItMS0xLTEtMTk2MzU_7ef96f07-d71c-4b84-b5f1-6e1abbfbcc4a"
      unitRef="usd">2285000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzItMy0xLTEtMTk2MzU_a8b790fe-f7bc-4f6b-8303-7fc4897c0480"
      unitRef="usd">2615000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzItNS0xLTEtMTk2MzU_cc0c784d-06d3-4af2-b41a-d69f803c1220"
      unitRef="usd">2450000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzMtMS0xLTEtMTk2MzU_793bed85-4249-4132-a9f1-7ef4d7dc78a7"
      unitRef="usd">665000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzMtMy0xLTEtMTk2MzU_58b23dd4-de79-4a3b-b5bf-72e17a695946"
      unitRef="usd">518000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzMtNS0xLTEtMTk2MzU_66ea4942-bdf6-4c91-a63d-2ea335156cb3"
      unitRef="usd">565000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzQtMS0xLTEtMTk2MzU_42897588-7534-42cf-8df1-a3aa97c3b65a"
      unitRef="usd">2950000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzQtMy0xLTEtMTk2MzU_bf096000-4ba4-4f71-af53-57789ae14f63"
      unitRef="usd">3133000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzQtNS0xLTEtMTk2MzU_806fb6c4-3794-411e-ac7b-1a63670d341a"
      unitRef="usd">3015000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzYtMS0xLTEtMTk2MzU_54486388-d9c9-4af7-ba2e-a6d505e8196d"
      unitRef="usd">-306000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzYtMy0xLTEtMTk2MzU_752ec94f-0a4d-42cd-9d3f-a5b50ae4f36a"
      unitRef="usd">-450000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzYtNS0xLTEtMTk2MzU_1ccb064d-8016-49be-864b-a098bcd3eab9"
      unitRef="usd">-535000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzctMS0xLTEtMTk2MzU_89276498-f747-4845-8e6e-08f1bc67f154"
      unitRef="usd">-122000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzctMy0xLTEtMTk2MzU_4f395ad3-b0ba-4b2c-88f3-3e93a3ae6068"
      unitRef="usd">-114000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzctNS0xLTEtMTk2MzU_e1c6ffab-5943-4e5b-8ce1-10076450dbea"
      unitRef="usd">-114000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzgtMS0xLTEtMTk2MzU_ad7e4e3b-a0a6-4969-8364-a9d28ba32000"
      unitRef="usd">-428000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzgtMy0xLTEtMTk2MzU_01be94ba-70e5-4bf4-a8af-cda3eaf90d9b"
      unitRef="usd">-564000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzgtNS0xLTEtMTk2MzU_ded3090b-8fe9-4e72-bd2c-dbda8b9f6cf3"
      unitRef="usd">-649000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzktMS0xLTEtMTk2MzU_6076048e-065c-4ad9-b18f-debc6e6bcc9e"
      unitRef="usd">2522000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzktMy0xLTEtMTk2MzU_cf627594-97c2-4057-a3b6-838625db083a"
      unitRef="usd">2569000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo4NDU1ZjA5MzRjZDg0YzQyOTdmZjRkZmRiODFjZDQ4Zi90YWJsZXJhbmdlOjg0NTVmMDkzNGNkODRjNDI5N2ZmNGRmZGI4MWNkNDhmXzktNS0xLTEtMTk2MzU_65ec79e7-01e4-4aa5-aeef-765e37840151"
      unitRef="usd">2366000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzQyODk_85963f0a-cfd3-4eff-973e-75d0a83efce6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a reconciliation of the statutory income tax rate to the Company&#x2019;s effective income tax rate for continuing operations for the&#160;years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health insurer fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basis difference upon disposition of subsidiary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year refund claim &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzEtMS0xLTEtMTk2MzU_690b91b1-04a9-4b6f-b91c-59635c2e62b4"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzEtMy0xLTEtMTk2MzU_764188b8-71b3-4f94-b281-4012963eec6c"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzEtNS0xLTEtMTk2MzU_f7966e61-da66-4b99-84b5-e77397206774"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzItMS0xLTEtMTk2MzU_2e72dc8f-d942-4190-bf50-3556bc8b0a1a"
      unitRef="number">0.041</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzItMy0xLTEtMTk2MzU_384451f6-3b77-444b-8036-dbc0ee247d4d"
      unitRef="number">0.032</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzItNS0xLTEtMTk2MzU_716bec7e-c481-4dc5-92a6-bc1cf2ed8241"
      unitRef="number">0.040</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <cvs:HealthInsurerFeeTaxEffectPercent
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzQtMS0xLTEtMTk2MzU_9f908fc5-4c53-402c-bca4-8116bf597d0c"
      unitRef="number">0</cvs:HealthInsurerFeeTaxEffectPercent>
    <cvs:HealthInsurerFeeTaxEffectPercent
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzQtMy0xLTEtMTk2MzU_b049a64d-ef88-4895-8746-60d652765f64"
      unitRef="number">0.022</cvs:HealthInsurerFeeTaxEffectPercent>
    <cvs:HealthInsurerFeeTaxEffectPercent
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzQtNS0xLTEtMTk2MzU_621e0fc3-4eef-480c-97d3-155811e84d94"
      unitRef="number">0</cvs:HealthInsurerFeeTaxEffectPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzYtMS0xLTEtMTk2MzU_60d38d37-9f18-414d-a1ed-487b3398c16e"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzYtMy0xLTEtMTk2MzU_651f8635-017f-48af-ba73-4ced03e17415"
      unitRef="number">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzYtNS0xLTEtMTk2MzU_e4966db4-b182-45c3-9f5f-f11bfe6bb543"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationDispositionOfBusiness>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzUtMS0xLTEtNjc1NTk_3e564ec3-1ff7-4817-9f25-0703beab4df5"
      unitRef="number">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzUtMy0xLTEtNjc1NTk_3252c4a5-99ae-4bea-a123-9ee4894bc183"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzUtNS0xLTEtNjc1NTk_fc392397-5c14-4118-95cb-9ca1292b9a26"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzctMS0xLTEtMTk2MzU_10a8819f-3745-459d-a0cf-81c5923fc07d"
      unitRef="number">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzctMy0xLTEtMTk2MzU_00ede423-e95d-41f9-a0b7-f15e96699534"
      unitRef="number">0.011</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzctNS0xLTEtMTk2MzU_0b61f719-8d00-4c96-b187-6d0e4efc3982"
      unitRef="number">0.013</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzgtMS0xLTEtMTk2MzU_62910e5c-d1f0-4315-8dec-558d378d378e"
      unitRef="number">0.242</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzgtMy0xLTEtMTk2MzU_d2c4a1f1-565f-418d-9de5-f2cd4443caba"
      unitRef="number">0.263</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo5MzczYjU3MzVkODM0NzUxODg0NTI4OWU3N2FhMTZmNy90YWJsZXJhbmdlOjkzNzNiNTczNWQ4MzQ3NTE4ODQ1Mjg5ZTc3YWExNmY3XzgtNS0xLTEtMTk2MzU_4c46f1be-6e02-486c-97ee-62d4d7c5975c"
      unitRef="number">0.263</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzQyNzY_9deb747b-c8a2-4e76-9416-1a220a1d672b">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the components of the Company&#x2019;s deferred income tax assets and liabilities as of December&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and rents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debts and other allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss and capital loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll tax deferral&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(325)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(454)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and rents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,368)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,568)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,794)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzItMS0xLTEtMTk2MzU_a8933681-62d5-4c74-8f80-3d2bbe19eab7"
      unitRef="usd">5563000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzItMy0xLTEtMTk2MzU_26df5aa1-f651-4334-bed6-373dda65d727"
      unitRef="usd">5742000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzMtMS0xLTEtMTk2MzU_c6bb36b4-5178-41a0-a09f-51df0baf5817"
      unitRef="usd">99000000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzMtMy0xLTEtMTk2MzU_0430780d-7586-494c-861f-616ce4fc170b"
      unitRef="usd">80000000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzQtMS0xLTEtMTk2MzU_ef56f27e-9c18-4de0-bba1-61ff1181226f"
      unitRef="usd">193000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzQtMy0xLTEtMTk2MzU_84a026d7-0d66-42e3-867c-308231fe2714"
      unitRef="usd">238000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzUtMS0xLTEtMTk2MzU_e7a770e4-f3f4-47c2-a421-c6ffb10bee73"
      unitRef="usd">489000000</cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances>
    <cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzUtMy0xLTEtMTk2MzU_43958928-b56b-4296-bcff-172248aeae01"
      unitRef="usd">395000000</cvs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzctMS0xLTEtMTk2MzU_f8128262-f0a9-4e25-8c8d-411b0a3e5f8a"
      unitRef="usd">416000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzctMy0xLTEtMTk2MzU_963ddbce-60e1-4491-98bd-fe65f320db03"
      unitRef="usd">568000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzgtMS0xLTEtMTk2MzU_e0314f80-d986-4f0f-87fd-6952726323fb"
      unitRef="usd">78000000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzgtMy0xLTEtMTk2MzU_133213e3-4dee-4420-a785-0cc1a98243f2"
      unitRef="usd">43000000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzktMS0xLTEtMTk2MzU_fdc59ee5-45ba-4f03-bd84-9c8672cf1f30"
      unitRef="usd">501000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzktMy0xLTEtMTk2MzU_125a4d23-26d3-4b59-baba-894600a22a29"
      unitRef="usd">489000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <cvs:DeferredTaxAssetsPayrollTaxDeferral
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzEwLTEtMS0xLTE5NjM1_3d1f54a3-660c-4ef3-992c-176dc2b88cb9"
      unitRef="usd">87000000</cvs:DeferredTaxAssetsPayrollTaxDeferral>
    <cvs:DeferredTaxAssetsPayrollTaxDeferral
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzEwLTMtMS0xLTE5NjM1_79e3be5c-58ba-429d-ab86-0f99e915043b"
      unitRef="usd">173000000</cvs:DeferredTaxAssetsPayrollTaxDeferral>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzExLTEtMS0xLTE5NjM1_12128ac1-600a-47c3-8b1d-b32c2426fb2a"
      unitRef="usd">396000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzExLTMtMS0xLTE5NjM1_e946ed14-74fa-40a3-88c2-67410addd203"
      unitRef="usd">500000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzEyLTEtMS0xLTE5NjM1_868810f9-2a73-4dae-b2e8-13dee4ef487d"
      unitRef="usd">325000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzEyLTMtMS0xLTE5NjM1_3ca1baa2-8524-4399-99d2-43f86cac974d"
      unitRef="usd">454000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzEzLTEtMS0xLTE5NjM1_5c0a4a99-ac24-4282-9323-0aee17fa9b58"
      unitRef="usd">7497000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzEzLTMtMS0xLTE5NjM1_89af1c84-3dbd-44c5-ab76-f3119949c1f5"
      unitRef="usd">7774000000</us-gaap:DeferredTaxAssetsNet>
    <cvs:DeferredTaxLiabilitiesRetirementBenefits
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE1LTEtMS0xLTE5NjM1_fc23fb4b-435d-4fa4-8624-c2211a6a9604"
      unitRef="usd">105000000</cvs:DeferredTaxLiabilitiesRetirementBenefits>
    <cvs:DeferredTaxLiabilitiesRetirementBenefits
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE1LTMtMS0xLTE5NjM1_d2e9e3ce-8a7a-4b19-b45b-8eac6ce7614a"
      unitRef="usd">29000000</cvs:DeferredTaxLiabilitiesRetirementBenefits>
    <us-gaap:DeferredTaxLiabilitiesInvestments
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE2LTEtMS0xLTE5NjM1_ad6c31f8-2353-4749-ba24-fb90284e0ea3"
      unitRef="usd">334000000</us-gaap:DeferredTaxLiabilitiesInvestments>
    <us-gaap:DeferredTaxLiabilitiesInvestments
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE2LTMtMS0xLTE5NjM1_62fa2e9e-18e0-4c45-95fc-61b35e79a808"
      unitRef="usd">421000000</us-gaap:DeferredTaxLiabilitiesInvestments>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE3LTEtMS0xLTE5NjM1_1d5493a2-1b79-4941-a446-ba5525e1fa77"
      unitRef="usd">4947000000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE3LTMtMS0xLTE5NjM1_bf65d831-706e-4f8a-88f2-00e957fb670e"
      unitRef="usd">5368000000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <cvs:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE4LTEtMS0xLTE5NjM1_cca5a37c-6bbd-4b29-8153-2b5f61c6adce"
      unitRef="usd">8381000000</cvs:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <cvs:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE4LTMtMS0xLTE5NjM1_38fb2ef4-6b3b-4dc4-a492-24e9e4ccbbd1"
      unitRef="usd">8750000000</cvs:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE5LTEtMS0xLTE5NjM1_8ef6f913-55c1-4bea-b1c5-d530a042f456"
      unitRef="usd">13767000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzE5LTMtMS0xLTE5NjM1_21ecc55e-045f-42ef-b043-9b179728607f"
      unitRef="usd">14568000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzIwLTEtMS0xLTE5NjM1_5ae6499a-542b-415a-9108-5a074178d044"
      unitRef="usd">6270000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZTo0MjY0Nzk5YWVjMjY0NjIxYTExNzRjNzE0ZjYwYjc1ZS90YWJsZXJhbmdlOjQyNjQ3OTlhZWMyNjQ2MjFhMTE3NGM3MTRmNjBiNzVlXzIwLTMtMS0xLTE5NjM1_eebcb7a7-2f80-4f5f-9c72-843b15ddba08"
      unitRef="usd">6794000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzEzMDI_f8128262-f0a9-4e25-8c8d-411b0a3e5f8a"
      unitRef="usd">416000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzE2MzA_868810f9-2a73-4dae-b2e8-13dee4ef487d"
      unitRef="usd">325000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzQyNzc_83ff644f-80aa-408a-a486-de257d7360f9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balance of unrecognized tax benefits in 2021, 2020 and 2019 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expiration of statutes of limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzEtMS0xLTEtMTk2MzU_14fb7866-659b-42ac-bfee-c29816ff8302"
      unitRef="usd">768000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzEtMy0xLTEtMTk2MzU_2e326ba8-4ea8-4150-ad14-f7fb2751c5b5"
      unitRef="usd">655000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i23e34e947aac44fc9f5cf5448f94f452_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzEtNS0xLTEtMTk2MzU_881a6e9e-7a55-4677-95b1-aa13deddbd1d"
      unitRef="usd">661000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzItMS0xLTEtMTk2MzU_328ff217-08d0-4956-b214-16fe4aae7101"
      unitRef="usd">3000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzItMy0xLTEtMTk2MzU_ccbbaf28-1784-4795-8ebf-b9f5980653d0"
      unitRef="usd">3000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzItNS0xLTEtMTk2MzU_51fe54a0-d59c-45ef-a387-f4111ee72639"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzMtMS0xLTEtMTk2MzU_777f1d36-51b5-43d4-9414-5060381fe99b"
      unitRef="usd">52000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzMtMy0xLTEtMTk2MzU_3a604df1-f216-406b-8550-901006300793"
      unitRef="usd">182000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzMtNS0xLTEtMTk2MzU_babd2a68-9344-4e17-9934-fe5f45a551f1"
      unitRef="usd">115000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzQtMS0xLTEtMTk2MzU_d6f82796-bd84-4ab8-9f38-5cf7b1bb7bde"
      unitRef="usd">33000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzQtMy0xLTEtMTk2MzU_9220d01a-c5db-406b-9a9c-4bbcf7c9c0a4"
      unitRef="usd">56000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzQtNS0xLTEtMTk2MzU_0c3896fe-7e6e-400f-b42c-6688a60f4825"
      unitRef="usd">111000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzUtMS0xLTEtMTk2MzU_21ec9212-5f36-4494-831a-d5445947599b"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzUtMy0xLTEtMTk2MzU_2c161acc-6f3f-4efa-813a-66de9461d3eb"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzUtNS0xLTEtMTk2MzU_3608831d-f7db-4678-ac1b-6edc8742e11b"
      unitRef="usd">7000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzYtMS0xLTEtMTk2MzU_723110cb-c316-4178-8de8-2859be48c23d"
      unitRef="usd">7000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzYtMy0xLTEtMTk2MzU_8fadc74f-4192-436a-bf7f-08819c06f586"
      unitRef="usd">14000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzYtNS0xLTEtMTk2MzU_c62e69e5-fd26-46bd-8971-e968cbaae626"
      unitRef="usd">7000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzctMS0xLTEtMTk2MzU_bfb2a475-d3f6-46e7-8f13-e00a48120016"
      unitRef="usd">782000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzctMy0xLTEtMTk2MzU_d46f984f-2199-47db-ac7a-3f09296ba59e"
      unitRef="usd">768000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90YWJsZToxNzg3NWRlZWE2MDg0NTRmODYzMmExMGFjYTRhOTIyOC90YWJsZXJhbmdlOjE3ODc1ZGVlYTYwODQ1NGY4NjMyYTEwYWNhNGE5MjI4XzctNS0xLTEtMTk2MzU_2b84a8a1-fbe5-4246-9d6a-cf5e8b27367c"
      unitRef="usd">655000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzM5MTA_8fda36d5-f051-4e0e-952a-7efff3395dc2"
      unitRef="usd">40000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzM5MTQ_cbadba4f-4665-4133-9e73-1f69679854f9"
      unitRef="usd">34000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzM5MjE_9734ed2a-6c12-4c29-b4bd-0ba36708d80a"
      unitRef="usd">49000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzM5ODY_b06fb92a-63b6-4044-8210-72ec672c234b"
      unitRef="usd">151000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzM5OTM_53257055-119a-47c7-aff5-8e1b84f64df6"
      unitRef="usd">121000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjAvZnJhZzpjNmY2M2RlNzMwMGM0ODc2YjZmODlmZjhkOTRiZDIxZC90ZXh0cmVnaW9uOmM2ZjYzZGU3MzAwYzQ4NzZiNmY4OWZmOGQ5NGJkMjFkXzQyMTE_d6b6135f-fb69-4197-80f4-fbc0dbd326cb"
      unitRef="usd">669000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NTU_b690a805-f63d-4ecc-bf73-fffc67da84ec">Stock Incentive Plans&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The terms of the CVS Health 2017 Incentive Compensation Plan (&#x201c;ICP&#x201d;) provide for grants of annual incentive and long-term performance awards to executive officers and other officers and employees of the Company or any subsidiary of the Company, as well as equity compensation to outside directors of CVS Health Corporation. Payment of such annual incentive and long-term performance awards will be in cash, stock, other awards or other property, at the discretion of the Management Planning and Development Committee (the &#x201c;MP&amp;amp;D Committee&#x201d;) of the Board. The ICP allows for a maximum of 58 million shares of CVS Health Corporation common stock to be reserved and available for grants. As of December&#160;31, 2021, there were approximately 30 million shares of CVS Health Corporation common stock available for future grants under the ICP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the acquisition of Aetna (the &#x201c;Aetna Acquisition&#x201d;) on November 28, 2018, approximately 22 million shares of Aetna common stock subject to awards outstanding under the Amended Aetna Inc. 2010 Stock Incentive Plan (&#x201c;SIP&#x201d;) were assumed by CVS Health Corporation. In addition, in accordance with the merger agreement, shares which were available for future issuance under the SIP were converted into approximately 32 million shares of CVS Health Corporation common stock reserved and available for issuance pursuant to future awards. Subsequent to the expiration of the SIP on May 21, 2020, the ICP is the only compensation plan under which the Company grants stock options, restricted stock and other stock-based awards to its employees.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense over the requisite service period of the stock award (generally &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzE3MDk_ea62d84c-7b65-4b23-9d75-3a8341c56a52"&gt;three&lt;/span&gt; to five years) using the straight-line method. The following table is a summary of stock-based compensation for the&#160;years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and stock appreciation rights (&#x201c;SARs&#x201d;) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ESPP&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;) provides for the purchase of up to 60 million shares of CVS Health Corporation common stock. Under the ESPP, eligible employees may purchase common stock at the end of each six&#160;month offering period at a purchase price equal to 90% of the lower of the fair market value on the first day or the last day of the offering period. During 2021, approximately 3 million shares of common stock were purchased under the provisions of the ESPP at an average price of $60.51 per share. As of December&#160;31, 2021, approximately 31 million shares of common stock were available for issuance under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of stock-based compensation associated with the ESPP is estimated on the date of grant (the first day of the six&#160;month offering period) using the Black-Scholes option pricing model.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the assumptions used to value the ESPP awards for the&#160;years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The dividend yield is calculated based on semi-annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#x2019;s daily stock price over the previous six&#160;month period.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The risk-free interest rate is selected based on the Treasury constant maturity interest rate whose term is consistent with the expected term of ESPP purchases (i.e., six&#160;months).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected life is based on the semi-annual purchase period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units and Performance Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s restricted stock units and performance stock units are considered nonvested share awards and require no payment from the employee. The fair value of the restricted stock units is based on the market price of CVS Health Corporation common stock on the grant date and is recognized on a straight-line basis over the vesting period. For each restricted stock unit granted, employees receive one share of common stock, net of taxes, at the end of the vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s performance stock units contain performance vesting conditions in addition to a service vesting condition. Vesting of the Company&#x2019;s performance stock units is dependent upon the degree to which the Company achieves its performance goals, which are generally set for a three-year performance period and are approved at the time of grant by the MP&amp;amp;D Committee. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of performance stock units granted with service and performance vesting conditions is based on the market price of CVS Health Corporation common stock on the grant date and is recognized over the vesting period. Certain of the performance stock units also contain a market vesting condition based on the performance of CVS Health Corporation common stock relative to a comparator group. The fair value of these performance stock units is determined using a Monte Carlo simulation as of the grant date and is recognized over the vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, there was $529 million of total unrecognized compensation cost related to the Company&#x2019;s restricted stock units and performance stock units that are expected to vest. These costs are expected to be recognized over a weighted-average period of 2.1 years. The total fair value of restricted stock units vested during 2021, 2020 and 2019 was $406 million, $229 million and $265 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the restricted stock unit and performance stock unit activity for the&#160;year ended December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In thousands, except weighted average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year, nonvested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year, nonvested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options and SARs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All stock option grants are awarded at fair value on the date of grant. The fair value of stock options is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;service period. Stock options granted generally become exercisable over a four-year period from the grant date. Stock options granted through 2018 generally expire seven years after the grant date. Stock options granted subsequent to 2018 generally expire ten years after the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All unvested Aetna SARs outstanding upon the acquisition of Aetna were converted into replacement CVS Health Corporation SARs. The replacement SARs granted are settled in CVS Health Corporation common stock, net of taxes, based on the appreciation of the stock price on the exercise date over the market price on the date of grant. The fair value of SARs is estimated using the Black-Scholes option pricing model, and stock-based compensation is recognized on a straight-line basis over the requisite service period. SARs generally become exercisable over a three-year period from the grant date. SARs generally expire ten years after the grant date. No SARs have been granted subsequent to the Aetna Acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of stock option and SAR activity that occurred for the years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received from stock options exercised (including ESPP)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for taxes for net share settlement of equity awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intrinsic value of stock options and SARs exercised &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of stock options and SARs vested &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each stock option is estimated using the Black-Scholes option pricing model based on the following assumptions at the time of grant:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The dividend yield is based on annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#x2019;s daily stock price over a period equal to the expected life of each option grant after adjustments for infrequent events such as stock splits.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The risk-free interest rate is selected based on yields from U.S. Treasury zero-coupon issues with a remaining term equal to the expected term of the options being valued.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected life represents the number of&#160;years the options are expected to be outstanding from grant date based on historical option or SAR holder exercise experience.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, unrecognized compensation expense related to unvested stock options totaled $38 million, which the Company expects to be recognized over a weighted-average period of 2.0 years. After considering anticipated forfeitures, the Company expects approximately 9 million of the unvested stock options to vest over the requisite service period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s stock option and SAR activity for the&#160;year ended December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;thousands, except weighted average exercise price and remaining contractual term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,366)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(694)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.61&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at end of year and expected to vest in the future&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i1e00ca9657da47ec87effc5e2a1aeac7_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzYzOQ_d693c3e1-3eec-4378-a99c-aca530e4c2ce"
      unitRef="shares">58000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i1e00ca9657da47ec87effc5e2a1aeac7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzc1Mg_1e61ff49-7303-43b7-b3fe-fa9445bbad45"
      unitRef="shares">30000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="iac75a9034e7c40fb82a43cf2c75280b0_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg4MQ_d48f7141-f2bc-4efd-aa01-1a6c4dc1b212"
      unitRef="shares">22000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="iac75a9034e7c40fb82a43cf2c75280b0_I20181128"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzExODQ_a76d3f0c-4bf4-4a9c-bb21-ebde2eed5bf7"
      unitRef="shares">32000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i2f08d731825c4986934a5374bd021d17_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzMyOTg1MzQ4OTM5NzY_b5633e98-197b-4cd4-88cd-ffd41e6077cb">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NTY_a6dd0f24-32b9-4cca-b42b-61ec98152950">The following table is a summary of stock-based compensation for the&#160;years ended December&#160;31, 2021, 2020 and 2019:&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and stock appreciation rights (&#x201c;SARs&#x201d;) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units and performance stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Includes the ESPP.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzEtMS0xLTEtMTk2MzU_faee2223-30c5-4de6-b2cb-674e3f7ced70"
      unitRef="usd">80000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i85d379918d1544988d301637f8418348_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzEtMy0xLTEtMTk2MzU_bb60bf11-99fe-4595-b85c-bf3b71c881fa"
      unitRef="usd">71000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie67cd2601892401dbc7e134d3a278afc_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzEtNS0xLTEtMTk2MzU_e4ae17ee-3637-4646-87ce-5d86c8fe2d81"
      unitRef="usd">76000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzItMS0xLTEtMTk2MzU_72add207-0944-40a2-b2b0-5d5f243c9f23"
      unitRef="usd">404000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i43347484543148728067fc355f1bc0cb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzItMy0xLTEtMTk2MzU_ba2ebc70-30e0-49bd-975f-ef3a55f86ce6"
      unitRef="usd">329000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4ee318d09ac047368832cb3dc191916e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzItNS0xLTEtMTk2MzU_912042cb-9cdb-4d3b-a926-5bc3677dd6d9"
      unitRef="usd">377000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzMtMS0xLTEtMTk2MzU_044e5f0f-7ba6-495f-acd4-ce140640f497"
      unitRef="usd">484000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzMtMy0xLTEtMTk2MzU_bf8cc9be-2df4-45df-9f36-9fca66c5c984"
      unitRef="usd">400000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTplYWM4NjZkMGFiZjA0MzQ2YTFhNTY1OTUyN2VjYWE4Yi90YWJsZXJhbmdlOmVhYzg2NmQwYWJmMDQzNDZhMWE1NjU5NTI3ZWNhYThiXzMtNS0xLTEtMTk2MzU_af20f758-5ee2-4db5-ba8e-41a15c5036be"
      unitRef="usd">453000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i93c58d30105d4b0c9c482412ced85d79_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzIyNzQ_b55debeb-c595-45c5-9a8f-571a4798e1d6"
      unitRef="shares">60000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="ie549abdb9cf943f6acd4a4f0dc937118_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzI0NDY_ccc59db3-810e-4c53-9148-823fa34ea065"
      unitRef="number">0.90</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzI1Njk_22341548-c6ea-4f02-b7ae-745ca21957a3"
      unitRef="shares">3000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <cvs:StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzI2NjY_2234520c-0d3a-469f-b6c2-2b242f8ae605"
      unitRef="usdPerShare">60.51</cvs:StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i93c58d30105d4b0c9c482412ced85d79_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzI3MDQ_895a2bfc-cfc4-4286-89a2-8edaaf9b8d97"
      unitRef="shares">31000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NjM_bed2892f-de1f-4b4b-b26f-0b233c350352">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the assumptions used to value the ESPP awards for the&#160;years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 13pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The dividend yield is calculated based on semi-annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#x2019;s daily stock price over the previous six&#160;month period.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The risk-free interest rate is selected based on the Treasury constant maturity interest rate whose term is consistent with the expected term of ESPP purchases (i.e., six&#160;months).&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected life is based on the semi-annual purchase period.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ie549abdb9cf943f6acd4a4f0dc937118_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzEtMS0xLTEtMTk2MzU_81317cb9-8a1c-4bac-b551-fe6de7e427f7"
      unitRef="number">0.0134</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ie333142c626e457f8b7400acc37b2e0e_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzEtMy0xLTEtMTk2MzU_60674811-85ef-41b5-80f4-2a9ae77cfc91"
      unitRef="number">0.0146</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i2a27cad79fee4e3fb41f31a513d985a2_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzEtNS0xLTEtMTk2MzU_24c13af7-180a-42e6-ae75-f65aac367d93"
      unitRef="number">0.0170</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ie549abdb9cf943f6acd4a4f0dc937118_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzItMS0xLTEtMTk2MzU_d0e67670-9dda-4534-b163-0484977b2873"
      unitRef="number">0.2527</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ie333142c626e457f8b7400acc37b2e0e_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzItMy0xLTEtMTk2MzU_131f94fe-fafd-480d-9480-3ac2f22acbf8"
      unitRef="number">0.3721</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i2a27cad79fee4e3fb41f31a513d985a2_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzItNS0xLTEtMTk2MzU_ae3a0959-293d-4cdd-9bde-827db7e3cbd3"
      unitRef="number">0.2796</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ie549abdb9cf943f6acd4a4f0dc937118_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzMtMS0xLTEtMTk2MzU_9d8b1789-83e8-499b-b59a-fa5e50ff865f"
      unitRef="number">0.0008</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ie333142c626e457f8b7400acc37b2e0e_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzMtMy0xLTEtMTk2MzU_c023f15b-bb0f-4783-87e7-7819623247ed"
      unitRef="number">0.0081</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i2a27cad79fee4e3fb41f31a513d985a2_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzMtNS0xLTEtMTk2MzU_2c66aa63-18ec-4101-afb7-476052d4e455"
      unitRef="number">0.0227</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ie549abdb9cf943f6acd4a4f0dc937118_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzQtMS0xLTEtMTk2MzU_22fa1c0c-3ee8-4716-9c09-b596566c363f">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ie333142c626e457f8b7400acc37b2e0e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzQtMy0xLTEtMTk2MzU_c9356cca-7d64-43c6-96f6-72056a09942a">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i2a27cad79fee4e3fb41f31a513d985a2_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzQtNS0xLTEtMTk2MzU_f33cb9e1-72df-45a1-ae40-4ed4dd1157d5">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie549abdb9cf943f6acd4a4f0dc937118_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzUtMS0xLTEtMTk2MzU_6ad54796-93e7-4277-a08f-e3aec84a8320"
      unitRef="usdPerShare">12.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie333142c626e457f8b7400acc37b2e0e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzUtMy0xLTEtMTk2MzU_ab3746cb-8cb5-4631-aed0-f21c9f93026f"
      unitRef="usdPerShare">13.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2a27cad79fee4e3fb41f31a513d985a2_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo5MTJkYjIyMjBhYjE0YTViYWMzMmMxZTlmYWIwYTJjMi90YWJsZXJhbmdlOjkxMmRiMjIyMGFiMTRhNWJhYzMyYzFlOWZhYjBhMmMyXzUtNS0xLTEtMTk2MzU_4aa65ea9-8d04-425f-9035-a2ac0ad83417"
      unitRef="usdPerShare">10.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i39274e5a60794450836f17e832f652ef_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzUzNTk_33d36230-e001-4ca3-9940-6564ef0add4b"
      unitRef="usd">529000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzU1ODE_e384cdd2-1e3d-4fea-bdc9-329a03019e03">P2Y1M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzU2NjQ_220ef69e-9fa3-45c7-bfaf-1e2dc8d0dbf6"
      unitRef="usd">406000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i43347484543148728067fc355f1bc0cb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzU2Njg_5aa87985-ee75-4920-81ed-71f6b8490938"
      unitRef="usd">229000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i4ee318d09ac047368832cb3dc191916e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzU2NzU_87db9e91-09f4-4e5d-b255-2f06a9a93908"
      unitRef="usd">265000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NDk_2513ed8f-a007-4b9b-ae49-c0578cc62f7d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the restricted stock unit and performance stock unit activity for the&#160;year ended December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.422%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In thousands, except weighted average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year, nonvested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year, nonvested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="if7c3db8973f246b592a6bdc7ae66c5d4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzEtMS0xLTEtMTk2MzU_535188c2-a77c-43d6-8fc7-07a99eba88fd"
      unitRef="shares">14824000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="if7c3db8973f246b592a6bdc7ae66c5d4_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzEtMy0xLTEtMTk2MzU_135d162f-cda7-40b4-92de-e39f3e61046f"
      unitRef="usdPerShare">58.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzItMS0xLTEtMTk2MzU_96ff9d53-04fd-4fa8-92c7-e9e87c61989f"
      unitRef="shares">6190000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzItMy0xLTEtMTk2MzU_be28c381-88e4-495f-bf27-1ca70b9904ac"
      unitRef="usdPerShare">74.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzMtMS0xLTEtMTk2MzU_b51d9f52-3bf2-4645-86c9-573282951089"
      unitRef="shares">5448000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzMtMy0xLTEtMTk2MzU_26008efb-f0eb-4172-95c2-471689e18795"
      unitRef="usdPerShare">74.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzQtMS0xLTEtMTk2MzU_8b424cf6-eef0-4cc2-9e15-868fbbc2dbe9"
      unitRef="shares">1236000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i02c8540613844c24bb3232a954d598c7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzQtMy0xLTEtMTk2MzU_4e5802f8-5f88-4da3-9eab-e56bb4fef751"
      unitRef="usdPerShare">63.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i39274e5a60794450836f17e832f652ef_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzUtMS0xLTEtMTk2MzU_c41c8af2-e633-415d-ab13-3172276cc87b"
      unitRef="shares">14330000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i39274e5a60794450836f17e832f652ef_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpjMjBlNzFkODc0OTk0ODdlYWVmMmJhZjczZjM3ZmM4Mi90YWJsZXJhbmdlOmMyMGU3MWQ4NzQ5OTQ4N2VhZWYyYmFmNzNmMzdmYzgyXzUtMy0xLTEtMTk2MzU_6f3acca2-1ea4-48a0-b1c9-f509117adb14"
      unitRef="usdPerShare">63.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ied331db8439f40e395a4f8943266cba6_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NTI_0a28066e-868e-4721-9d9a-98028250aad9">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i69a67aadd34647f781446b1f63119ac5_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzYyNTU_36f0f9bb-9dca-4d5b-ba09-3e9e0c8566f1">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="if24ed4bf2c534b4b938b4ca3b222bbd1_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzYzMzg_ceef3672-cac8-452b-bab5-636125253a93">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="id0b126cbb01d4598a07ab0c18962d7ac_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NDI_e1e5de9e-dcc4-4ff0-8182-c14d96ffa296">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="id0b126cbb01d4598a07ab0c18962d7ac_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzcwMzA_f831be10-82e0-4494-8c72-75848ff54195">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NjA_4e8cf7ce-61c1-495f-8401-5efa3a89d732">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of stock option and SAR activity that occurred for the years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash received from stock options exercised (including ESPP)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments for taxes for net share settlement of equity awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intrinsic value of stock options and SARs exercised &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of stock options and SARs vested &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzEtMS0xLTEtMTk2MzU_79d5f3a8-64df-41d5-945a-d4c69a89de69"
      unitRef="usd">549000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i85d379918d1544988d301637f8418348_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzEtMy0xLTEtMTk2MzU_38fbe0fa-c7e1-4d5f-b3e2-18df83b3f2b1"
      unitRef="usd">264000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ie67cd2601892401dbc7e134d3a278afc_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzEtNS0xLTEtMTk2MzU_302941cd-2913-446f-9cc9-cb66237a6cb8"
      unitRef="usd">210000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzItMS0xLTEtMTk2MzU_3a217fff-04b4-4164-a753-24d76975f7bd"
      unitRef="usd">168000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i85d379918d1544988d301637f8418348_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzItMy0xLTEtMTk2MzU_86fd83b7-0fed-4430-9666-39cc8df5d742"
      unitRef="usd">88000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ie67cd2601892401dbc7e134d3a278afc_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzItNS0xLTEtMTk2MzU_bc6515c5-1d78-4fcd-9c89-e6f057fb392b"
      unitRef="usd">112000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzMtMS0xLTEtMTk2MzU_06cb35ca-6a95-42d1-9291-731cf65a911d"
      unitRef="usd">105000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i85d379918d1544988d301637f8418348_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzMtMy0xLTEtMTk2MzU_792ec368-c1f9-4a15-9979-d7307d31a9d9"
      unitRef="usd">24000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ie67cd2601892401dbc7e134d3a278afc_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzMtNS0xLTEtMTk2MzU_e5e928b3-ec96-45ee-9fc9-50faeee40234"
      unitRef="usd">30000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue
      contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzQtMS0xLTEtMTk2MzU_396209e9-f3cb-41b8-8132-9f4b60d86f80"
      unitRef="usd">224000000</cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue>
    <cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue
      contextRef="i85d379918d1544988d301637f8418348_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzQtMy0xLTEtMTk2MzU_14e1a4e9-7840-4fd4-9ee7-0aeb9854842b"
      unitRef="usd">252000000</cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue>
    <cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue
      contextRef="ie67cd2601892401dbc7e134d3a278afc_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo4MTY3OWVjYWNmYzU0OTY4YTk0MGU5NDdhZDdhY2QwMC90YWJsZXJhbmdlOjgxNjc5ZWNhY2ZjNTQ5NjhhOTQwZTk0N2FkN2FjZDAwXzQtNS0xLTEtMTk2MzU_349f55c7-49f1-45ce-b0b4-90cf2d3da26e"
      unitRef="usd">467000000</cvs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NjE_ae33d7bc-3797-4f4b-8561-828ce7904f11">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each stock option is estimated using the Black-Scholes option pricing model based on the following assumptions at the time of grant:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average grant date fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The dividend yield is based on annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected volatility is estimated based on the historical volatility of CVS Health Corporation&#x2019;s daily stock price over a period equal to the expected life of each option grant after adjustments for infrequent events such as stock splits.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The risk-free interest rate is selected based on yields from U.S. Treasury zero-coupon issues with a remaining term equal to the expected term of the options being valued.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;The expected life represents the number of&#160;years the options are expected to be outstanding from grant date based on historical option or SAR holder exercise experience.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ied331db8439f40e395a4f8943266cba6_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzEtMS0xLTEtMTk2MzU_630f4c6c-120a-4ecc-9740-cda06f3ba46b"
      unitRef="number">0.0268</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ie4ebc26cbc0c4a72b41fad331a976a13_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzEtMy0xLTEtMTk2MzU_47500623-6a43-4d20-a7b3-008ff79c26cf"
      unitRef="number">0.0342</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i047eb0ccbb624e599edde0bdc4b342b3_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzEtNS0xLTEtMTk2MzU_730831b7-3329-42d3-ab5f-3f4848462b94"
      unitRef="number">0.0368</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ied331db8439f40e395a4f8943266cba6_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzItMS0xLTEtMTk2MzU_c4e09ef0-aeeb-47b7-9784-3892726cd865"
      unitRef="number">0.2710</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ie4ebc26cbc0c4a72b41fad331a976a13_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzItMy0xLTEtMTk2MzU_927b0ab9-39dc-464f-abca-6975a6a69c13"
      unitRef="number">0.2522</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i047eb0ccbb624e599edde0bdc4b342b3_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzItNS0xLTEtMTk2MzU_53ff54f5-d6ab-4e81-8a9e-78f667191d1c"
      unitRef="number">0.2176</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ied331db8439f40e395a4f8943266cba6_D20210101-20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzMtMS0xLTEtMTk2MzU_912f3cf1-64ba-4178-91ba-40737077fe26"
      unitRef="number">0.0113</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ie4ebc26cbc0c4a72b41fad331a976a13_D20200101-20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzMtMy0xLTEtMTk2MzU_f9935a48-7884-4ef6-845f-c1141dca0509"
      unitRef="number">0.0061</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i047eb0ccbb624e599edde0bdc4b342b3_D20190101-20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzMtNS0xLTEtMTk2MzU_489e1292-9ba4-479d-8006-c4ef3a1ca92e"
      unitRef="number">0.0056</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ied331db8439f40e395a4f8943266cba6_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzQtMS0xLTEtMTk2MzU_b04bedb8-b97f-4ca4-b4f8-4c2d29e1f9fa">P6Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ie4ebc26cbc0c4a72b41fad331a976a13_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzQtMy0xLTEtMTk2MzU_9145058b-a42d-4ae8-972e-37b656c83eda">P6Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i047eb0ccbb624e599edde0bdc4b342b3_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzQtNS0xLTEtMTk2MzU_2faf8602-4831-41e7-ae25-b84cdb40eead">P6Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ied331db8439f40e395a4f8943266cba6_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzUtMS0xLTEtMTk2MzU_99eda277-ef61-4f62-9867-0f8513b5f6eb"
      unitRef="usdPerShare">14.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie4ebc26cbc0c4a72b41fad331a976a13_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzUtMy0xLTEtMTk2MzU_b6eaea6c-0e46-456e-baba-258455807663"
      unitRef="usdPerShare">8.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i047eb0ccbb624e599edde0bdc4b342b3_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTpkOGYxOWFjNTkwMjY0ZDI2YTJkZWI0NTJhOTFlZmE2Ni90YWJsZXJhbmdlOmQ4ZjE5YWM1OTAyNjRkMjZhMmRlYjQ1MmE5MWVmYTY2XzUtNS0xLTEtMTk2MzU_6bcd6e86-0242-49e0-b913-f78ad226a9a7"
      unitRef="usdPerShare">6.27</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5XzgzODk_ec8fa21c-9c61-4ce4-8ef8-d3be1990bf3d"
      unitRef="usd">38000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg0NzA_0f4e6e96-7ab7-4692-bcf7-91621b36a2f4">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <cvs:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber
      contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg1NTE_e12d8f03-f884-4a66-bf7b-fd378931982c"
      unitRef="shares">9000000</cvs:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90ZXh0cmVnaW9uOjNhMjVmNTE2ZWM5MzQ2YjFhYTYxZmE0YTg2ZTYzNmQ5Xzg3NTQ_06988345-18a0-4a8d-8025-63dffdcf026c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of the Company&#x2019;s stock option and SAR activity for the&#160;year ended December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.747%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;thousands, except weighted average exercise price and remaining contractual term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,366)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(694)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.61&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at end of year and expected to vest in the future&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if345988696b749e88cd89e722c59ebd7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzEtMS0xLTEtMTk2MzU_744ebb94-125e-4594-9ffa-c988e1503ca8"
      unitRef="shares">23955000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="if345988696b749e88cd89e722c59ebd7_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzEtMy0xLTEtMTk2MzU_ceb8c6e8-e96c-4bfb-8e30-0e5eb6804f6a"
      unitRef="usdPerShare">69.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzItMS0xLTEtMTk2MzU_48f8f30b-ce46-48b6-86c1-0abd3e9e000d"
      unitRef="shares">3322000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzItMy0xLTEtMTk2MzU_a406db26-5200-43db-9c04-b222109901c4"
      unitRef="usdPerShare">74.66</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzMtMS0xLTEtMTk2MzU_0ddcb770-a146-484b-ab70-ffc8068b79da"
      unitRef="shares">6366000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzMtMy0xLTEtMTk2MzU_d6195562-942d-4341-8f00-24191c72df95"
      unitRef="usdPerShare">63.41</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzQtMS0xLTEtMTk2MzU_96196d90-3a00-4394-856b-82476d146361"
      unitRef="shares">694000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzQtMy0xLTEtMTk2MzU_de84493e-934f-42fa-bf12-6917afe8a359"
      unitRef="usdPerShare">62.66</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzUtMS0xLTEtMTk2MzU_23aa87fa-3cd6-4840-8131-8d15abd639fa"
      unitRef="shares">1156000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzUtMy0xLTEtMTk2MzU_64844068-f4f8-4b3d-9652-23b1519eee4e"
      unitRef="usdPerShare">87.42</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzYtMS0xLTEtMTk2MzU_1e8fe726-c831-41fb-8954-dcacbf844c27"
      unitRef="shares">19061000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzYtMy0xLTEtMTk2MzU_258a5423-a78f-4595-aa2c-a50ddc61a069"
      unitRef="usdPerShare">71.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzYtNS0xLTEtMTk2MzU_7c46d0a6-5124-42b0-8d3d-2362ebd7a613">P4Y9M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzYtNy0xLTEtMTk2MzU_d32dbdbb-95ae-42d7-b95d-48ecbd6d4f4c"
      unitRef="usd">603137000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzctMS0xLTEtMTk2MzU_45f968a1-b9bd-4325-b981-a1f4a2a1efc9"
      unitRef="shares">9704000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzctMy0xLTEtMTk2MzU_b092dd8d-3cc6-40ed-a12d-490646d1b3a7"
      unitRef="usdPerShare">79.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzctNS0xLTEtMTk2MzU_7eae689b-f871-43e3-8264-623bdd88b239">P2Y7M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzctNy0xLTEtMTk2MzU_ad970ed0-9487-4101-860d-83b1ba5b25ef"
      unitRef="usd">229034000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzgtMS0xLTEtMTk2MzU_7b362d2d-8ff2-4b7b-ba43-c79e583e75e4"
      unitRef="shares">18709000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzgtMy0xLTEtMTk2MzU_2d5261d9-fc0b-46c3-adb4-f162872b7399"
      unitRef="usdPerShare">71.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i20f43916c6d4405d89c83ccd06525a2d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzgtNS0xLTEtMTk2MzU_732decf9-8bab-42e2-95fb-661784493a40">P4Y8M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i5ab7d5420e7b4704b9a8208ddfe0c148_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjMvZnJhZzozYTI1ZjUxNmVjOTM0NmIxYWE2MWZhNGE4NmU2MzZkOS90YWJsZTo1ZDFhZDBmMWU0YzM0MzZmOWUyMTdhNzUzMjgzZmZhMC90YWJsZXJhbmdlOjVkMWFkMGYxZTRjMzQzNmY5ZTIxN2E3NTMyODNmZmEwXzgtNy0xLTEtMTk2MzU_a2ad0d28-c18b-4fae-9caf-38cd9060c065"
      unitRef="usd">590514000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzI4NTI_a37e823a-3fae-42d2-8f50-5ba1ab42cc2d">Shareholders&#x2019; Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following share repurchase programs have been authorized by the Board:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In billions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Authorization&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Remaining as of&lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 9, 2021 (&#x201c;2021 Repurchase Program&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2, 2016 (&#x201c;2016 Repurchase Program&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each of the share Repurchase Programs was effective immediately. The 2016 Repurchase program was terminated effective December 9, 2021. The 2021 Repurchase Program permits the Company to effect repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase (&#x201c;ASR&#x201d;) transactions, and/or other derivative transactions. The 2021 Repurchase Program can be modified or terminated by the Board at any time.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2021, 2020 and 2019, the Company did not repurchase any shares of common stock pursuant to the 2016 or 2021 Repurchase Programs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the authorization under the 2021 Repurchase Program, the Company entered into a $1.5&#160;billion fixed dollar ASR with Barclays Bank PLC (&#x201c;Barclays&#x201d;). Upon payment of the $1.5&#160;billion purchase price on January 4, 2022, the Company received a number of shares of CVS Health Corporation&#x2019;s common stock equal to 80% of the $1.5 billion notional amount of the ASR or approximately 11.6&#160;million shares at a price of $103.34 per share, which were placed into treasury stock in January 2022. At the conclusion of the ASR, the Company may receive additional shares equal to the remaining 20% of the $1.5&#160;billion notional amount. The ultimate number of shares the Company may receive will depend on the daily volume-weighted average price of the Company&#x2019;s stock over an averaging period, less a discount. It is also possible, depending on such weighted average price, that the Company will have an obligation to Barclays which, at the Company&#x2019;s option, could be settled in additional cash or by issuing shares. Under the terms of the ASR, the maximum number of shares that could be delivered to the Company is 29.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The quarterly cash dividend declared by the Board was $0.50 per share in 2021 and 2020. In December 2021, the Board authorized a 10% increase in the quarterly cash dividend to $0.55 per share effective in 2022. CVS Health Corporation has paid cash dividends every quarter since becoming a public company. Future dividend payments will depend on the Company&#x2019;s earnings, capital requirements, financial condition and other factors considered relevant by the Board.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Regulatory Requirements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s insurance business operations are conducted through subsidiaries that principally consist of health maintenance organizations (&#x201c;HMOs&#x201d;) and insurance companies. The Company&#x2019;s HMO and insurance subsidiaries report their financial &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;statements in accordance with accounting practices prescribed by state regulatory authorities which may differ from GAAP. The combined statutory net income for the years ended and estimated combined statutory and capital surplus at December&#160;31, 2021, 2020 and 2019 for the Company&#x2019;s insurance and HMO subsidiaries were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory net income &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated statutory capital and surplus&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s insurance and HMO subsidiaries paid $1.6 billion of gross dividends to the Company for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to general state law restrictions on payments of dividends and other distributions to stockholders applicable to all corporations, HMOs and insurance companies are subject to further regulations that, among other things, may require those companies to maintain certain levels of equity and restrict the amount of dividends and other distributions that may be paid to their equity holders. In addition, in connection with the Aetna Acquisition, the Company made certain undertakings that require prior regulatory approval of dividends by certain of its HMOs and insurance companies. At December&#160;31, 2021, these amounts were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated minimum statutory surplus required by regulators&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments on deposit with regulatory bodies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated maximum dividend distributions permitted in 2022 without prior regulatory approval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021 and 2020, noncontrolling interests were $306 million and $312 million, respectively, primarily related to third party interests in the Company&#x2019;s operating entities.&#160;The noncontrolling entities&#x2019; share is included in total shareholders&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; equity on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzI4NDU_ef0f2302-d0bf-4045-9a92-2a89e171d596">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following share repurchase programs have been authorized by the Board:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In billions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Authorization&#160;Date&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Remaining as of&lt;br/&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 9, 2021 (&#x201c;2021 Repurchase Program&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2, 2016 (&#x201c;2016 Repurchase Program&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i432b0c5043074ae0812170d09abfa592_I20211209"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZToyMzg0MzVhMWFlZWQ0NDRmYjQyM2FiYWNhMDhjNzFlNi90YWJsZXJhbmdlOjIzODQzNWExYWVlZDQ0NGZiNDIzYWJhY2EwOGM3MWU2XzEtMS0xLTEtNTQ1MzI_26645ded-3513-4f08-8fa6-a4964509cca9"
      unitRef="usd">10000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i03653ea4eb4a467299768217a91a7509_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZToyMzg0MzVhMWFlZWQ0NDRmYjQyM2FiYWNhMDhjNzFlNi90YWJsZXJhbmdlOjIzODQzNWExYWVlZDQ0NGZiNDIzYWJhY2EwOGM3MWU2XzEtMy0xLTEtNTQ1Mzk_21109f0a-654a-4309-84ba-377088ccb034"
      unitRef="usd">10000000000.0</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i5d02c104c6dc4d8080674b3a902331b0_I20161102"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZToyMzg0MzVhMWFlZWQ0NDRmYjQyM2FiYWNhMDhjNzFlNi90YWJsZXJhbmdlOjIzODQzNWExYWVlZDQ0NGZiNDIzYWJhY2EwOGM3MWU2XzEtMS0xLTEtMTk2MzU_28a81533-9ea3-4610-a48b-7ca868c32437"
      unitRef="usd">15000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i9f4bc0f557304063afaa3e85428dd4f9_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZToyMzg0MzVhMWFlZWQ0NDRmYjQyM2FiYWNhMDhjNzFlNi90YWJsZXJhbmdlOjIzODQzNWExYWVlZDQ0NGZiNDIzYWJhY2EwOGM3MWU2XzEtMy0xLTEtMTk2MzU_3e4a6cbc-c9ef-4b60-8103-25b04a38e750"
      unitRef="usd">0</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="i910e0cab88ca49569118b221e7416e1d_I20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzEwOTk1MTE2MzMzMzc_630c9d78-e4ba-43d5-a8ac-baa9fffb207b"
      unitRef="usd">1500000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <cvs:PaymentsForAcceleratedShareRepurchasesAmount
      contextRef="i25393db4ea824bb8a945d34240542336_D20220104-20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzEwOTk1MTE2MzMzNTU_a8877e9d-ed48-4689-b625-2ac77f59dd6a"
      unitRef="usd">1500000000</cvs:PaymentsForAcceleratedShareRepurchasesAmount>
    <cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares
      contextRef="i910e0cab88ca49569118b221e7416e1d_I20220104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzMyOTg1MzQ4OTIyNjA_b38940f0-9b2c-4941-9b97-3b489397ef07"
      unitRef="number">0.80</cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="i910e0cab88ca49569118b221e7416e1d_I20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzEwOTk1MTE2MzMzNzI_c1c5e7f0-f3e9-41d8-a12a-c2d4862d78aa"
      unitRef="usd">1500000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i910e0cab88ca49569118b221e7416e1d_I20220104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzEwOTk1MTE2MzMzNzk_9f97580a-f803-42bd-a9de-31a6430cdc5d"
      unitRef="shares">11600000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:SharePrice
      contextRef="i910e0cab88ca49569118b221e7416e1d_I20220104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzEwOTk1MTE2MzM0NzQ_8b0d73dd-fdf0-448f-bb53-49bbdf7b5239"
      unitRef="usdPerShare">103.34</us-gaap:SharePrice>
    <cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram
      contextRef="i910e0cab88ca49569118b221e7416e1d_I20220104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzMyOTg1MzQ4OTIyNjY_fcafce7a-be35-4b06-88c5-2d807576a71c"
      unitRef="number">0.20</cvs:AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram>
    <cvs:AcceleratedShareRepurchasesAgreementAmount
      contextRef="i910e0cab88ca49569118b221e7416e1d_I20220104"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzEwOTk1MTE2MzMzOTg_60b28f48-81f0-42d0-b710-572d1edf282a"
      unitRef="usd">1500000000</cvs:AcceleratedShareRepurchasesAgreementAmount>
    <cvs:AcceleratedShareRepurchaseProgramMaximumNumberOfShares
      contextRef="i910e0cab88ca49569118b221e7416e1d_I20220104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzEwOTk1MTE2MzM0Mjc_eb1c2f09-ec9a-4ea9-8de0-2ae4117c1cc6"
      unitRef="shares">29000000</cvs:AcceleratedShareRepurchaseProgramMaximumNumberOfShares>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="ia7be16ef324b484ba18d3c2c816b7220_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzY2OA_8b31424c-8820-44e9-8183-9e7966c9eea7"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i341bdbaf02b943349d5742511da4e641_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzY2OA_9337e0db-dfae-4b64-bc0d-c995016e97ac"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzY2OA_b4917a0e-2e5b-4edf-bb26-e1b6bd3b2278"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="ib8220880f08f4b52bfb75c957326a67e_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzY2OA_ccab11ff-1256-4117-ac23-ee97aed62a7e"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i7fc99c6f6f5e4521b483fbb38f266a09_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzY2OA_d41d0c33-6ab4-466a-9d6d-97f3f5881a99"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="ib746ed191a50496e8dcb173944e10da4_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzY2OA_d682fb99-6820-4ed2-ac53-cc0c052d180e"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="ie5e000b7c7ed4445a36ad3eb67d14356_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzY2OA_f74b980b-88c4-4e8c-a7d1-874cb8e3e8b4"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzY2OA_fb854b76-19db-48a2-befd-81d4f62047d2"
      unitRef="usdPerShare">0.50</us-gaap:DividendsPayableAmountPerShare>
    <cvs:DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzk4OTU2MDQ2NTYzMjM_1c677507-6846-4227-ba69-f149d95893dc"
      unitRef="number">0.10</cvs:DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="if41fb896ff264b3ead6f51a18d2a3f8e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzk4OTU2MDQ2NTY0NTM_2177a185-7eb6-4e52-a588-160e73bebb72"
      unitRef="usdPerShare">0.55</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:ScheduleOfRegulatoryAssetsTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzYwNDczMTM5NTU5NjA_f5f1e7ce-ed03-4ad2-bb01-240971ee34fa">The combined statutory net income for the years ended and estimated combined statutory and capital surplus at December&#160;31, 2021, 2020 and 2019 for the Company&#x2019;s insurance and HMO subsidiaries were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Statutory net income &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated statutory capital and surplus&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRegulatoryAssetsTextBlock>
    <us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount
      contextRef="ia2d7b1824eba4f87a7eafd51d7fd5787_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTpmYzA3ODM2MDM1NTM0ZDA4OTI1YTgzNzU5ODI1YzQwNi90YWJsZXJhbmdlOmZjMDc4MzYwMzU1MzRkMDg5MjVhODM3NTk4MjVjNDA2XzEtMS0xLTEtMTk2MzU_04b5da87-5575-4957-947b-36a63dc541c9"
      unitRef="usd">3302000000</us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount>
    <us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount
      contextRef="i067da125651c46ffad3ae31756f6ebce_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTpmYzA3ODM2MDM1NTM0ZDA4OTI1YTgzNzU5ODI1YzQwNi90YWJsZXJhbmdlOmZjMDc4MzYwMzU1MzRkMDg5MjVhODM3NTk4MjVjNDA2XzEtMy0xLTEtMTk2MzU_c8753965-bdeb-4b23-bd60-610024a2e2b0"
      unitRef="usd">3667000000</us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount>
    <us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount
      contextRef="iaf290335ae9a4ad68f960df21ff9fc4e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTpmYzA3ODM2MDM1NTM0ZDA4OTI1YTgzNzU5ODI1YzQwNi90YWJsZXJhbmdlOmZjMDc4MzYwMzU1MzRkMDg5MjVhODM3NTk4MjVjNDA2XzEtNS0xLTEtMjQyNDU_48c6417a-25a8-4f6c-9f9c-63943ea09076"
      unitRef="usd">2842000000</us-gaap:StatutoryAccountingPracticesStatutoryNetIncomeAmount>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="i3f97c5d3b527409f84299ce04961b6b5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTpmYzA3ODM2MDM1NTM0ZDA4OTI1YTgzNzU5ODI1YzQwNi90YWJsZXJhbmdlOmZjMDc4MzYwMzU1MzRkMDg5MjVhODM3NTk4MjVjNDA2XzItMS0xLTEtMTk2MzU_9de88895-fec0-47cb-9827-e0f9927b26bf"
      unitRef="usd">14879000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="iba1b0c6fc0e8431cb642d84f64a10a03_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTpmYzA3ODM2MDM1NTM0ZDA4OTI1YTgzNzU5ODI1YzQwNi90YWJsZXJhbmdlOmZjMDc4MzYwMzU1MzRkMDg5MjVhODM3NTk4MjVjNDA2XzItMy0xLTEtMTk2MzU_4eb73acb-bf17-4d37-94cf-7f2a34ce561e"
      unitRef="usd">13238000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="i75b1f170bf184fb4b59ba89128a6bf98_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTpmYzA3ODM2MDM1NTM0ZDA4OTI1YTgzNzU5ODI1YzQwNi90YWJsZXJhbmdlOmZjMDc4MzYwMzU1MzRkMDg5MjVhODM3NTk4MjVjNDA2XzItNS0xLTEtMTk2MzU_44e21580-cf5a-4f38-8c45-b49e99190dce"
      unitRef="usd">10975000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries
      contextRef="ia2d7b1824eba4f87a7eafd51d7fd5787_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzE4NjE_c79ea909-ad3b-4c69-9f1a-4fad340c3c88"
      unitRef="usd">1600000000</us-gaap:CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries>
    <us-gaap:StatutoryAccountingPracticesDisclosureTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzI4NTE_3fd3b7da-76dc-4cba-a03b-6ac204837e1f">At December&#160;31, 2021, these amounts were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated minimum statutory surplus required by regulators&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments on deposit with regulatory bodies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated maximum dividend distributions permitted in 2022 without prior regulatory approval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:StatutoryAccountingPracticesDisclosureTextBlock>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTo3NTk5MDcwMmI2NjY0OThkOGE4ZjU2YTY0ZTVhZDAzZS90YWJsZXJhbmdlOjc1OTkwNzAyYjY2NjQ5OGQ4YThmNTZhNjRlNWFkMDNlXzEtMS0xLTEtMTk2MzU_9f8fc2f4-f1b6-4732-8cf3-cb4327ddb316"
      unitRef="usd">7261000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired>
    <us-gaap:AssetsHeldByInsuranceRegulators
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTo3NTk5MDcwMmI2NjY0OThkOGE4ZjU2YTY0ZTVhZDAzZS90YWJsZXJhbmdlOjc1OTkwNzAyYjY2NjQ5OGQ4YThmNTZhNjRlNWFkMDNlXzItMS0xLTEtMTk2MzU_d6bc5c94-9512-40bd-b665-e3c9360e930e"
      unitRef="usd">794000000</us-gaap:AssetsHeldByInsuranceRegulators>
    <us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90YWJsZTo3NTk5MDcwMmI2NjY0OThkOGE4ZjU2YTY0ZTVhZDAzZS90YWJsZXJhbmdlOjc1OTkwNzAyYjY2NjQ5OGQ4YThmNTZhNjRlNWFkMDNlXzMtMS0xLTEtMTk2MzU_f3ee22f3-e05e-49cc-b997-465d839c7607"
      unitRef="usd">2939000000</us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval>
    <us-gaap:MinorityInterest
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzI2Mjg_37a31958-e90e-4fb1-9466-e0d1bcadaa66"
      unitRef="usd">306000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjYvZnJhZzplYmZjNDlkMjIzNWM0YmQ0YWNkMDY1NGE2OGQyYWMxZi90ZXh0cmVnaW9uOmViZmM0OWQyMjM1YzRiZDRhY2QwNjU0YTY4ZDJhYzFmXzI2MzU_81a668fa-01f8-477b-a3a8-2520723fcd8a"
      unitRef="usd">312000000</us-gaap:MinorityInterest>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90ZXh0cmVnaW9uOjVmNjIzZDYyYWY0NDQxNmRiNDRhMmMzZDQ0YmM4NmU0XzE1MDA_86b6e1f9-38c6-45f1-b11a-cb6c44b80b55">Other Comprehensive Income&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shareholders&#x2019; equity included the following activity in accumulated other comprehensive income in 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized investment gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(489), $497 and $927 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(32), $31 and $(105) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $(7) and $(25) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(34), $(35) and $(20) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($20, $(30) and $162 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($6, $7 and $(12) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total beginning of year accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total end of year accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income (loss) represent the elimination of the cumulative translation adjustment associated with the sale of Onofre, which was sold on July 1, 2019. The loss on the divestiture of Onofre is reflected in operating expenses in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included within interest expense in the consolidated statements of operations. The Company expects to reclassify approximately $11 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90ZXh0cmVnaW9uOjVmNjIzZDYyYWY0NDQxNmRiNDRhMmMzZDQ0YmM4NmU0XzE1MDE_5dd94f07-155b-4502-9c77-b1354d542a43">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shareholders&#x2019; equity included the following activity in accumulated other comprehensive income in 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.529%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;At December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net unrealized investment gains (losses):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(489), $497 and $927 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(410)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(32), $31 and $(105) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign currency translation adjustments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income (loss) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($0, $(7) and $(25) pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive income &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($(34), $(35) and $(20) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension and other postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($20, $(30) and $162 pretax)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified from accumulated other comprehensive loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;($6, $7 and $(12) pretax)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of year balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total beginning of year accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total end of year accumulated other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified debt securities are included in net investment income in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income (loss) represent the elimination of the cumulative translation adjustment associated with the sale of Onofre, which was sold on July 1, 2019. The loss on the divestiture of Onofre is reflected in operating expenses in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive income for specifically identified cash flow hedges are included within interest expense in the consolidated statements of operations. The Company expects to reclassify approximately $11 million, net of tax, in net gains associated with its cash flow hedges into net income within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Amounts reclassified from accumulated other comprehensive loss for specifically identified pension and other postretirement benefits are included in other income in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i11c81300ece14b5cb35d720e3d27f084_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMtMS0xLTEtMTk2MzU_54792f24-1103-4c8e-97fa-c9ddd131a142"
      unitRef="usd">1214000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3fc98fb6952142bebe0c28e8a1b5c4a8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMtMy0xLTEtMTk2MzU_e2449b41-8d96-4cd5-bf44-d1f979703680"
      unitRef="usd">774000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i84a0c7a5f87a43ea863b4f7e44c6d8c2_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMtNS0xLTEtMTk2MzU_5b5eb474-d515-4413-935d-bf1f71be7837"
      unitRef="usd">97000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="id4cc032a34c645ef8cc2877c8cab5ad0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzQtMC0xLTEtMTk2MzUvdGV4dHJlZ2lvbjphNDQxMmE3ZjEyN2E0ZmE1OGNiYjkwNGZiMTc0N2RhNl81Nw_477b0ba3-83a5-4309-8096-a7f891d3bf4e"
      unitRef="usd">-489000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i930652f9892c44cc8ed5915dcd507083_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzQtMC0xLTEtMTk2MzUvdGV4dHJlZ2lvbjphNDQxMmE3ZjEyN2E0ZmE1OGNiYjkwNGZiMTc0N2RhNl82MQ_04a00d59-4102-4162-b5c6-512c0fbc81a3"
      unitRef="usd">497000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="icbaffe77aefc4d6d9017917c96a5f507_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzQtMC0xLTEtMTk2MzUvdGV4dHJlZ2lvbjphNDQxMmE3ZjEyN2E0ZmE1OGNiYjkwNGZiMTc0N2RhNl82OA_c5e28289-12f2-4d3d-9408-97ec940bb524"
      unitRef="usd">927000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id4cc032a34c645ef8cc2877c8cab5ad0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzQtMS0xLTEtMTk2MzU_220a346e-c720-4ddd-a5ca-8ff938d6b6af"
      unitRef="usd">-410000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i930652f9892c44cc8ed5915dcd507083_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzQtMy0xLTEtMTk2MzU_dbb9d825-1a41-4a7a-8b94-2ca21f85e14f"
      unitRef="usd">415000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="icbaffe77aefc4d6d9017917c96a5f507_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzQtNS0xLTEtMTk2MzU_7f8a39b9-75ce-4930-8d2e-b47303a25b3c"
      unitRef="usd">763000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="id4cc032a34c645ef8cc2877c8cab5ad0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzUtMC0xLTEtMTk2MzUvdGV4dHJlZ2lvbjpiNDlmN2IyMDM5ZWM0MGI1OWY5NTRlZGMzMjgwMmRiMV83MA_c652741c-5012-45df-a92e-cea8c30f5f02"
      unitRef="usd">-32000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i930652f9892c44cc8ed5915dcd507083_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzUtMC0xLTEtMTk2MzUvdGV4dHJlZ2lvbjpiNDlmN2IyMDM5ZWM0MGI1OWY5NTRlZGMzMjgwMmRiMV83NA_b0d4932c-434d-433d-8da1-bb7a73ee146a"
      unitRef="usd">31000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="icbaffe77aefc4d6d9017917c96a5f507_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzUtMC0xLTEtMTk2MzUvdGV4dHJlZ2lvbjpiNDlmN2IyMDM5ZWM0MGI1OWY5NTRlZGMzMjgwMmRiMV84MQ_245164a8-364f-4fe9-91ec-15a92fb7df75"
      unitRef="usd">-105000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id4cc032a34c645ef8cc2877c8cab5ad0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzUtMS0xLTEtMTk2MzU_851f2ae0-d334-4f10-bfa2-68c659161afe"
      unitRef="usd">26000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i930652f9892c44cc8ed5915dcd507083_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzUtMy0xLTEtMTk2MzU_1fd3a042-12a4-43a7-b2d2-54f8c5177370"
      unitRef="usd">-25000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="icbaffe77aefc4d6d9017917c96a5f507_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzUtNS0xLTEtMTk2MzU_20ff54b2-135e-4b97-a24d-079d5ee43bd0"
      unitRef="usd">86000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id4cc032a34c645ef8cc2877c8cab5ad0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzYtMS0xLTEtMTk2MzU_38331e2d-1c9c-43f5-84d8-56e053f3debf"
      unitRef="usd">-436000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i930652f9892c44cc8ed5915dcd507083_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzYtMy0xLTEtMTk2MzU_d3138014-d0c0-493a-bb0c-49b011f09b83"
      unitRef="usd">440000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icbaffe77aefc4d6d9017917c96a5f507_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzYtNS0xLTEtMTk2MzU_44d32e24-a7d0-4eaf-9aed-5d37a9815bf4"
      unitRef="usd">677000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64c2bd153480429785df4f0aa2b99af8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzctMS0xLTEtMTk2MzU_90527a60-e672-487c-a594-2a8eeb68cdfc"
      unitRef="usd">778000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i11c81300ece14b5cb35d720e3d27f084_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzctMy0xLTEtMTk2MzU_3a7daf08-037b-4c3d-bccf-854846bcaaa8"
      unitRef="usd">1214000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3fc98fb6952142bebe0c28e8a1b5c4a8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzctNS0xLTEtMTk2MzU_23ad0e63-9470-4d57-9999-1bc58bdfc853"
      unitRef="usd">774000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ife5fc67699f945fa837f90b613f6c602_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEwLTEtMS0xLTE5NjM1_72d76b10-c551-4378-93ff-1241cb25c12e"
      unitRef="usd">7000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5c93d0cc21864237a54084f2b97bd15f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEwLTMtMS0xLTE5NjM1_fea9a5ab-996b-477e-9af9-c9cbedb57cf3"
      unitRef="usd">4000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i91b3a6b550364049b4a377a44fda6b09_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEwLTUtMS0xLTE5NjM1_1df7acdf-6949-4225-83a4-7bb54b64057e"
      unitRef="usd">-158000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ied0d6e0ce99e4b72a1d89046d51bad0d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzExLTEtMS0xLTE5NjM1_b3aa1326-c656-42c5-841a-2e7bc75a75ef"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i20b34efac8084fcf97e669d6e307466a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzExLTMtMS0xLTE5NjM1_d5ba679c-7c51-4c91-b634-27e557785024"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i303cec39156742cabcd569434ed22a00_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzExLTUtMS0xLTE5NjM1_6ad40516-15f9-4080-805e-2513339a6250"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ied0d6e0ce99e4b72a1d89046d51bad0d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEyLTEtMS0xLTE5NjM1_bf77ce45-03c5-41bb-b59e-1aee4add2b80"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i20b34efac8084fcf97e669d6e307466a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEyLTMtMS0xLTE5NjM1_70bae644-8da8-4b3b-923c-0be720b68284"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i303cec39156742cabcd569434ed22a00_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEyLTUtMS0xLTE5NjM1_51ee5aa3-9b4c-4e41-b196-b67958168f16"
      unitRef="usd">-154000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ied0d6e0ce99e4b72a1d89046d51bad0d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEzLTEtMS0xLTE5NjM1_c256a8f2-7f94-4c73-ae31-35ef3c65a2a5"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i20b34efac8084fcf97e669d6e307466a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEzLTMtMS0xLTE5NjM1_c7b7fcbc-5b37-4a26-9359-a35933ae211e"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i303cec39156742cabcd569434ed22a00_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzEzLTUtMS0xLTE5NjM1_5626f11e-1442-4008-ac4e-7497eec1f090"
      unitRef="usd">162000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1adb1295de224123a78020e0f95fb49f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE0LTEtMS0xLTE5NjM1_5920311a-c59d-41d7-9673-05f9a649cd52"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ife5fc67699f945fa837f90b613f6c602_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE0LTMtMS0xLTE5NjM1_c04dadef-72a4-4778-900a-ab4713361f9a"
      unitRef="usd">7000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5c93d0cc21864237a54084f2b97bd15f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE0LTUtMS0xLTE5NjM1_a28a8a2d-d358-4d01-8515-789f9fc0973d"
      unitRef="usd">4000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c37ca64bf504cc4beccb76f7eae0e86_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE3LTEtMS0xLTE5NjM1_315531fc-a94c-411e-8e3c-dc8588da2c1f"
      unitRef="usd">248000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib8b8354161494117b37c8c706d4ff661_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE3LTMtMS0xLTE5NjM1_c70d238f-2880-4a28-88c6-9081cc811c19"
      unitRef="usd">279000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec37d7e54e8e4663af7b1e9dd4764b6d_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE3LTUtMS0xLTE5NjM1_9684fba3-195b-407b-a572-a883e6817e1f"
      unitRef="usd">312000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i17206db04de740ee9100c779b2d2d0c6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MzRmNDQzMDE1MDk2NDAyYzljYmYzYmU4NmUxZjc4OTZfNjQ_eb488d12-283c-4a19-af07-2d6562e93527"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="iccee865f86ef46af8613bee2f36c8b98_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MzRmNDQzMDE1MDk2NDAyYzljYmYzYmU4NmUxZjc4OTZfNjg_2563fc9f-5b45-4552-8d07-ad32a048c007"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i94e5299b9a1643d5a0693be093306c61_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE5LTAtMS0xLTE5NjM1L3RleHRyZWdpb246MzRmNDQzMDE1MDk2NDAyYzljYmYzYmU4NmUxZjc4OTZfNzU_0b1aa829-3449-4c5d-ab6b-ada04baf4852"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i17206db04de740ee9100c779b2d2d0c6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE5LTEtMS0xLTE5NjM1_d610cde5-ae1f-431c-b8b4-ca068bdab632"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iccee865f86ef46af8613bee2f36c8b98_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE5LTMtMS0xLTE5NjM1_ebadf186-1b32-49e6-b2eb-e528d09fe766"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i94e5299b9a1643d5a0693be093306c61_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzE5LTUtMS0xLTE5NjM1_7695b353-d10d-4624-9eb8-67837fa21bba"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i17206db04de740ee9100c779b2d2d0c6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZDkzMDVjNDJjZTU5NGNkMzhkMWIxNDFjZDhlOTIxNDdfNzc_6f0de9a0-2a59-4424-a50e-bdd3c750dbb7"
      unitRef="usd">-34000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="iccee865f86ef46af8613bee2f36c8b98_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZDkzMDVjNDJjZTU5NGNkMzhkMWIxNDFjZDhlOTIxNDdfODE_6cc767b9-e794-4473-9a97-ad084d96b109"
      unitRef="usd">-35000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i94e5299b9a1643d5a0693be093306c61_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIwLTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZDkzMDVjNDJjZTU5NGNkMzhkMWIxNDFjZDhlOTIxNDdfODg_cad1abcc-3228-4143-a4a4-1c305271a3ab"
      unitRef="usd">-20000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i17206db04de740ee9100c779b2d2d0c6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIwLTEtMS0xLTE5NjM1_fe3f266d-f185-43cc-8c48-d4cad93e2fa0"
      unitRef="usd">26000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iccee865f86ef46af8613bee2f36c8b98_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIwLTMtMS0xLTE5NjM1_980025b5-a6bd-4748-8360-cbc09e4889e1"
      unitRef="usd">26000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i94e5299b9a1643d5a0693be093306c61_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIwLTUtMS0xLTE5NjM1_4e82fae8-d865-43d3-ab00-c3065d683392"
      unitRef="usd">15000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i17206db04de740ee9100c779b2d2d0c6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIxLTEtMS0xLTE5NjM1_db1e6669-27ea-4ea5-9bb0-dc38d0ba891f"
      unitRef="usd">-26000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iccee865f86ef46af8613bee2f36c8b98_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIxLTMtMS0xLTE5NjM1_da71aca6-ad82-4925-9530-19aebbeb3f37"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i94e5299b9a1643d5a0693be093306c61_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIxLTUtMS0xLTE5NjM1_aa6c871c-e7f9-4f75-a967-bdc3ed9da69e"
      unitRef="usd">-33000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i348fed93b022492e8b3985b2e2ba1a8f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIyLTEtMS0xLTE5NjM1_5545cd55-aa3e-45cf-89ba-47943f589024"
      unitRef="usd">222000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c37ca64bf504cc4beccb76f7eae0e86_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIyLTMtMS0xLTE5NjM1_424f23a1-6124-4473-92c1-e32eb6709e82"
      unitRef="usd">248000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib8b8354161494117b37c8c706d4ff661_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzIyLTUtMS0xLTE5NjM1_5e50b812-e639-48b7-8ae7-0bc4e9598ed8"
      unitRef="usd">279000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iac8f4cd98d954c89b07ab4b4c2f7eefc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI1LTEtMS0xLTE5NjM1_eec9e83f-9a8f-4784-915d-9795ed323707"
      unitRef="usd">-55000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9fb139f86fed450cbb2024fcc197f70c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI1LTMtMS0xLTE5NjM1_b583e681-d897-4d54-ad06-c97d0dd9de72"
      unitRef="usd">-38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5ac9beb213414c5a99e0c44cdb3d790d_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI1LTUtMS0xLTE5NjM1_0861a15a-4472-4394-859c-f258d51e1830"
      unitRef="usd">-149000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i5e511f7eb0324f2f878592c7974ed086_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI3LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZDYxMzE1NTBjZDU0NGY4NDgxN2JlNzllZTlkY2Q3YjBfNjQ_47f4d7b2-3cb4-4ff1-b8b4-a0328ad8e6a6"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="if460e957577f480e84fb0142bcff8589_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI3LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZDYxMzE1NTBjZDU0NGY4NDgxN2JlNzllZTlkY2Q3YjBfNjg_c1322a33-a63c-4679-b593-7209d9ddd41c"
      unitRef="usd">-30000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i725fef702fc24e31915c10eeb3b3c3cc_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI3LTAtMS0xLTE5NjM1L3RleHRyZWdpb246ZDYxMzE1NTBjZDU0NGY4NDgxN2JlNzllZTlkY2Q3YjBfNzU_aa7b0d1d-6a9a-4a02-8b97-5bddaaf4d6c9"
      unitRef="usd">162000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i5e511f7eb0324f2f878592c7974ed086_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI3LTEtMS0xLTE5NjM1_41b0f714-5b0a-4000-a59b-644eb57f010d"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="if460e957577f480e84fb0142bcff8589_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI3LTMtMS0xLTE5NjM1_a12b80a0-93f8-4801-b3cc-bd1333b30f5f"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i725fef702fc24e31915c10eeb3b3c3cc_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI3LTUtMS0xLTE5NjM1_1e710af0-9fd1-4f02-b001-298911e9ba32"
      unitRef="usd">120000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i5e511f7eb0324f2f878592c7974ed086_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI4LTAtMS0xLTE5NjM1L3RleHRyZWdpb246Njk0YmU4ZDRmYmY0NGY0NGEyZTI0NjUyYTFhNmNhNzJfNjg_3bb7f437-d265-4601-9309-0730afa5c32e"
      unitRef="usd">6000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="if460e957577f480e84fb0142bcff8589_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI4LTAtMS0xLTE5NjM1L3RleHRyZWdpb246Njk0YmU4ZDRmYmY0NGY0NGEyZTI0NjUyYTFhNmNhNzJfNzI_22a6016e-16d7-4eb2-8576-6c7604acdf56"
      unitRef="usd">7000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i725fef702fc24e31915c10eeb3b3c3cc_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI4LTAtMS0xLTE5NjM1L3RleHRyZWdpb246Njk0YmU4ZDRmYmY0NGY0NGEyZTI0NjUyYTFhNmNhNzJfNzk_1edbe4ce-3ed5-4201-a93d-49b7a3e268be"
      unitRef="usd">-12000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i5e511f7eb0324f2f878592c7974ed086_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI4LTEtMS0xLTE5NjM1_2ccb7395-fdd4-4e2f-bec0-d0caf5b702e7"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if460e957577f480e84fb0142bcff8589_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI4LTMtMS0xLTE5NjM1_073e956d-333b-4fad-bfb7-e715eed995ff"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i725fef702fc24e31915c10eeb3b3c3cc_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI4LTUtMS0xLTE5NjM1_fee1df0f-0228-499d-9338-3cb1e4d347d5"
      unitRef="usd">9000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5e511f7eb0324f2f878592c7974ed086_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI5LTEtMS0xLTE5NjM1_52a00d76-883a-4fd1-9501-5703c457dea7"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if460e957577f480e84fb0142bcff8589_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI5LTMtMS0xLTE5NjM1_6c3e9227-4607-470b-a8f0-3cb6eecaea9e"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i725fef702fc24e31915c10eeb3b3c3cc_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzI5LTUtMS0xLTE5NjM1_e50dd45a-9b36-4ed1-b997-d0caddfd552a"
      unitRef="usd">111000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i314a931ba51c4432ab932591b600df30_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMwLTEtMS0xLTE5NjM1_df182b08-e9eb-4126-bc1d-1a4f99e9fcd9"
      unitRef="usd">-35000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iac8f4cd98d954c89b07ab4b4c2f7eefc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMwLTMtMS0xLTE5NjM1_11734762-6aa1-4353-a800-92b5db2ee712"
      unitRef="usd">-55000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9fb139f86fed450cbb2024fcc197f70c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMwLTUtMS0xLTE5NjM1_89a125e5-b586-41e6-8e3b-732fab06a83f"
      unitRef="usd">-38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8be428b3931542c4965732a9b0d77591_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMyLTEtMS0xLTE5NjM1_2fbace21-15dd-4fa6-8b67-1ac145fd6e0b"
      unitRef="usd">1414000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0df7f1ff461e44849cb29208fac61c4d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMyLTMtMS0xLTE5NjM1_dc8cf481-f3ac-4adc-a96d-a235959af47e"
      unitRef="usd">1019000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id530b2ec12d240fe97ae812c8d6c1fed_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzMyLTUtMS0xLTE5NjM1_61332c54-5ed1-4257-8f3f-167b24fd55a0"
      unitRef="usd">102000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzM0LTEtMS0xLTE5NjM1_eef6559a-abe3-4299-bea8-9f97e5554331"
      unitRef="usd">-449000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzM0LTMtMS0xLTE5NjM1_a1b78711-2601-4d16-a3dc-5deea61fda9f"
      unitRef="usd">395000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzM0LTUtMS0xLTE5NjM1_4216b621-dbd2-43dd-8d74-b1317fe37c3b"
      unitRef="usd">917000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6049578cfc4647f693b348ad92ec2d2b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzM1LTEtMS0xLTE5NjM1_42ba789d-5a43-4a7c-95ac-f11c13509c3b"
      unitRef="usd">965000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8be428b3931542c4965732a9b0d77591_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzM1LTMtMS0xLTE5NjM1_50d98a2f-9c0d-4dde-954c-720335185838"
      unitRef="usd">1414000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0df7f1ff461e44849cb29208fac61c4d_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90YWJsZTo5ODNjNmRiOGM4NjE0Y2M1OTE1YTE5ZDA4ZTk5ZDY0YS90YWJsZXJhbmdlOjk4M2M2ZGI4Yzg2MTRjYzU5MTVhMTlkMDhlOTlkNjRhXzM1LTUtMS0xLTE5NjM1_23beb49c-01a7-43bd-8b08-0662037f2b06"
      unitRef="usd">1019000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
      contextRef="i348fed93b022492e8b3985b2e2ba1a8f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNjkvZnJhZzo1ZjYyM2Q2MmFmNDQ0MTZkYjQ0YTJjM2Q0NGJjODZlNC90ZXh0cmVnaW9uOjVmNjIzZDYyYWY0NDQxNmRiNDRhMmMzZDQ0YmM4NmU0XzEwOTk1MTE2Mjk3Njg_eb2c2da2-02dc-4bee-9959-2824ee5ba872"
      unitRef="usd">11000000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90ZXh0cmVnaW9uOmU2MjIxNDE3YmVlMDQ0MGNiNzllMDlhZmQ0NWNiOWM1XzEzMDY_11e1eedc-168a-47aa-9e9c-b78d9540608d">Earnings Per Share&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share is computed using the two-class method. SARs and options to purchase 7 million, 15&#160;million, and 17&#160;million shares of common stock were outstanding, but were excluded from the calculation of diluted earnings per share for the years ended December&#160;31, 2021, 2020 and 2019, respectively, because their exercise prices were greater than the average market price of the common shares and, therefore, the effect would be antidilutive. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic and diluted earnings per share from continuing operations for the years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (income) loss attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share from continuing operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia08c0a1adcca414ca646fb74221de9ab_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90ZXh0cmVnaW9uOmU2MjIxNDE3YmVlMDQ0MGNiNzllMDlhZmQ0NWNiOWM1XzM3Mw_e4d14f81-8fcf-44c8-9311-90e123b8a283"
      unitRef="shares">7000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if2efea1496c248cdb677d680fb00e679_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90ZXh0cmVnaW9uOmU2MjIxNDE3YmVlMDQ0MGNiNzllMDlhZmQ0NWNiOWM1XzM4MA_d9598794-786c-4e44-8b7c-1fae7e93325c"
      unitRef="shares">15000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7992428725ee4b7598c31808d507c883_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90ZXh0cmVnaW9uOmU2MjIxNDE3YmVlMDQ0MGNiNzllMDlhZmQ0NWNiOWM1XzE2NDkyNjc0NDMwNDA_488be5fa-7582-440d-a5d7-2c1e51fa1cf0"
      unitRef="shares">17000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90ZXh0cmVnaW9uOmU2MjIxNDE3YmVlMDQ0MGNiNzllMDlhZmQ0NWNiOWM1XzEzMDk_cd3ecc0c-7d7a-4def-829f-1e973e2935e1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of basic and diluted earnings per share from continuing operations for the years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions,&#160;except&#160;per&#160;share&#160;amounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (income) loss attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to CVS Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator for earnings per share calculation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares, diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings per share from continuing operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzItMS0xLTEtMTk2MzU_979db47b-6805-46e0-991c-091818447fa6"
      unitRef="usd">7898000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzItMy0xLTEtMTk2MzU_49192a1b-5222-4d12-897f-3d379539d6cf"
      unitRef="usd">7201000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzItNS0xLTEtMTk2MzU_8f99dab8-2d30-4c98-ba49-6f62b13cffb2"
      unitRef="usd">6631000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzMtMS0xLTEtMTk2MzU_dd5586ca-ea10-4b17-ad73-e8920ec76790"
      unitRef="usd">0</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzMtMy0xLTEtMTk2MzU_1a0204d6-0f0b-4c0e-9b2b-b644b41ac61e"
      unitRef="usd">0</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzMtNS0xLTEtMTk2MzU_2c2156f8-3f24-4ff2-9198-7b7acf27e8b9"
      unitRef="usd">5000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzQtMS0xLTEtMTk2MzU_91b5c468-d298-45f0-9caa-04997601865f"
      unitRef="usd">-12000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzQtMy0xLTEtMTk2MzU_82ab9e40-9569-491d-a2d3-012f0373553b"
      unitRef="usd">13000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzQtNS0xLTEtMTk2MzU_4e7d05c6-e010-4bcd-a70a-3eb6e633b024"
      unitRef="usd">-3000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzUtMS0xLTEtMTk2MzU_a7ef9ad9-a049-4f7b-aa75-d7d6ce7f80f9"
      unitRef="usd">7910000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzUtMy0xLTEtMTk2MzU_fe30c3ba-da01-4668-8070-abe2c39a3331"
      unitRef="usd">7188000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzUtNS0xLTEtMTk2MzU_9e7e1b4e-0a44-4b93-8b66-5484c85528bb"
      unitRef="usd">6629000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzgtMS0xLTEtMTk2MzU_9d73d772-18c8-44c6-a51b-4c367ff0db9a"
      unitRef="shares">1319000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzgtMy0xLTEtMTk2MzU_e7e99a03-5c36-418d-bb90-3c1efb830e93"
      unitRef="shares">1309000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzgtNS0xLTEtMTk2MzU_31bc37c9-bb3d-4361-885b-2058b465c90c"
      unitRef="shares">1301000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzktMS0xLTEtMTk2MzU_77d40692-96f7-4e22-9779-48c5604da026"
      unitRef="shares">10000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzktMy0xLTEtMTk2MzU_db9423e0-09d7-4d6f-90be-f39de783c8c7"
      unitRef="shares">5000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzktNS0xLTEtMTk2MzU_86dada29-760d-4e2a-8875-7592c1df8663"
      unitRef="shares">4000000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzEwLTEtMS0xLTE5NjM1_66a56f2b-73ac-4a85-9138-95370707e2bd"
      unitRef="shares">1329000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzEwLTMtMS0xLTE5NjM1_d5d38fc0-1664-46e4-ba3d-1aaebf55d20b"
      unitRef="shares">1314000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzEwLTUtMS0xLTE5NjM1_163ba47e-a7e7-44ba-bbb9-32a35d2d5dc3"
      unitRef="shares">1305000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzEzLTEtMS0xLTE5NjM1_7d590c1d-937a-4216-886e-9e867dea1dcd"
      unitRef="usdPerShare">6.00</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzEzLTMtMS0xLTE5NjM1_dfcd2dc0-2917-43e4-b23a-1c9d63953925"
      unitRef="usdPerShare">5.49</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzEzLTUtMS0xLTE5NjM1_ad3d93ec-2f3c-41bb-bade-bf2d6c170e3c"
      unitRef="usdPerShare">5.10</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzE0LTEtMS0xLTE5NjM1_f5b8a036-3154-4150-97f1-1f24dfe1d4dd"
      unitRef="usdPerShare">5.95</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzE0LTMtMS0xLTE5NjM1_86a5bce7-344a-4b70-b4fd-7c51ee0d9d77"
      unitRef="usdPerShare">5.47</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzIvZnJhZzplNjIyMTQxN2JlZTA0NDBjYjc5ZTA5YWZkNDVjYjljNS90YWJsZTpmYjk2Y2FjYzFkOTE0OTgzODA3NDdkM2U1YTk3MDFmMC90YWJsZXJhbmdlOmZiOTZjYWNjMWQ5MTQ5ODM4MDc0N2QzZTVhOTcwMWYwXzE0LTUtMS0xLTE5NjM1_b1dd4782-e759-435c-8d9e-5d1c31f9c3f0"
      unitRef="usdPerShare">5.08</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:ReinsuranceTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90ZXh0cmVnaW9uOmNiMzdlNWRmMjk2YTQ5ZDE5YWUyNDFjOTA5ZWRiYWE0XzIxMDc_2ec6393c-2e7c-4363-91e3-6eeb931dc7ee">Reinsurance&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company utilizes reinsurance agreements primarily to: (a) reduce required capital and (b) facilitate the acquisition or disposition of certain insurance contracts. Ceded reinsurance agreements permit the Company to recover a portion of its losses from reinsurers, although they do not discharge the Company&#x2019;s primary liability as the direct insurer of the risks reinsured.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 30, 2018, the Company completed the sale of Aetna&#x2019;s standalone Medicare Part D prescription drug plans to a subsidiary of WellCare Health Plans, Inc. (&#x201c;WellCare&#x201d;), effective December 31, 2018. In connection with that sale, subsidiaries of WellCare and Aetna entered into reinsurance agreements under which WellCare ceded to Aetna 100% of the insurance risk related to the divested standalone Medicare Part D prescription drug plans for the 2019 PDP plan year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2022, the Company entered into two four-year reinsurance agreements with an unrelated reinsurer that allow it to reduce required capital and provide collateralized excess of loss reinsurance coverage on a portion of the Health Care Benefits segment&#x2019;s group Commercial Insured business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reinsurance recoverables (recorded as other current assets or other assets on the consolidated balance sheets) at December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reinsurer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hartford Life and Accident Insurance Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lincoln Life &amp;amp; Annuity Company of New York&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VOYA Retirement Insurance and Annuity Company &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Direct, assumed and ceded premiums earned for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(825)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net premiums&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact of reinsurance on benefit costs for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net benefit costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There is not a material difference between premiums on a written basis versus an earned basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has various agreements with unrelated reinsurers that do not qualify for reinsurance accounting under GAAP, and consequently are accounted for using deposit accounting. The Company entered into these contracts to reduce the risk of catastrophic loss which in turn reduces the Company&#x2019;s capital and surplus requirements. Total deposit assets and liabilities related to reinsurance agreements that do not qualify for reinsurance accounting under GAAP were not material as of December&#160;31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReinsuranceTextBlock>
    <cvs:NumberofReinsuranceContractsEnteredInto
      contextRef="i9b7aa9f9810b45008c9d9fed20ef83c3_D20220101-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90ZXh0cmVnaW9uOmNiMzdlNWRmMjk2YTQ5ZDE5YWUyNDFjOTA5ZWRiYWE0XzkxMw_8a1a21fd-d603-4619-b920-b0da4db8e028"
      unitRef="reinsurance_agreement">2</cvs:NumberofReinsuranceContractsEnteredInto>
    <cvs:FourYearsReinsuranceAgreementWithUnrelatedInsurer
      contextRef="i9b7aa9f9810b45008c9d9fed20ef83c3_D20220101-20220131"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90ZXh0cmVnaW9uOmNiMzdlNWRmMjk2YTQ5ZDE5YWUyNDFjOTA5ZWRiYWE0XzIxMDg_37fe2f59-7376-4210-9e64-68627dd04171">P4Y</cvs:FourYearsReinsuranceAgreementWithUnrelatedInsurer>
    <us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90ZXh0cmVnaW9uOmNiMzdlNWRmMjk2YTQ5ZDE5YWUyNDFjOTA5ZWRiYWE0XzIxMDM_eac10661-fa3a-498a-9e0a-2e1e3dd7e698">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reinsurance recoverables (recorded as other current assets or other assets on the consolidated balance sheets) at December&#160;31, 2021 and 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reinsurer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hartford Life and Accident Insurance Company&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lincoln Life &amp;amp; Annuity Company of New York&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VOYA Retirement Insurance and Annuity Company &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i9301095d345049e394b9ba1daee2e4e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzItMS0xLTEtMTk2MzU_41c77f71-d644-4c84-80c4-430b2dca5350"
      unitRef="usd">1887000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i301adeecaf97464ca03a693c09b0877a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzItMy0xLTEtMTk2MzU_244dd01e-77ab-4e05-975f-b3ca1c4b4f51"
      unitRef="usd">2364000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="ib2d969162ec640c4bc7ab0e676c9f6e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzMtMS0xLTEtMTk2MzU_800d15f2-abf7-4183-9584-f9a43b0c9c11"
      unitRef="usd">395000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i46f805b90593415b99804a3433aa2813_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzMtMy0xLTEtMTk2MzU_288baeb6-c6a6-4f50-b36f-1c246c55f1ff"
      unitRef="usd">406000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i5c99d471482b411db975233daa1b1c2d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzUtMS0xLTEtMTk2MzU_d343b795-5cb4-4fe4-900e-336bad22851e"
      unitRef="usd">167000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i60a27aec77334f2c9335b816c8cba90b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzUtMy0xLTEtMTk2MzU_5ecc870b-62aa-42c0-8f73-d05690cdc4af"
      unitRef="usd">170000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i3af40793c6c847eea71843a3d54a8e74_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzYtMS0xLTEtMTk2MzU_2fe55a10-cf65-4213-b7f5-ad369012373e"
      unitRef="usd">100000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="id7a078c31fd54364814330592da72814_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzYtMy0xLTEtMTk2MzU_244de8dd-39d7-4473-abe7-4ee3d59332b6"
      unitRef="usd">115000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzctMS0xLTEtMTk2MzU_4cbe883f-abd9-4d9a-a6ce-a86476a4f5a7"
      unitRef="usd">2549000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1ZDhjZjY1ZjQ1YmY0NDU2YjhjNjNlYmQ4ZTdhMGNmOC90YWJsZXJhbmdlOjVkOGNmNjVmNDViZjQ0NTZiOGM2M2ViZDhlN2EwY2Y4XzctMy0xLTEtMTk2MzU_0c9f07fa-2321-4ec9-8222-785315eb61fd"
      unitRef="usd">3055000000</us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses>
    <srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90ZXh0cmVnaW9uOmNiMzdlNWRmMjk2YTQ5ZDE5YWUyNDFjOTA5ZWRiYWE0XzIxMTE_3d4ccefd-2476-4093-8c95-1246e2e0bda1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Direct, assumed and ceded premiums earned for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(825)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,954)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net premiums&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock>
    <us-gaap:DirectPremiumsEarned
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzEtMS0xLTEtMTk2MzU_d35e981f-c0ce-45a2-8bb3-f6f5445c5133"
      unitRef="usd">76320000000</us-gaap:DirectPremiumsEarned>
    <us-gaap:DirectPremiumsEarned
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzEtMy0xLTEtMTk2MzU_4cf99bc0-371f-4a83-9ecd-c32d82b8a4df"
      unitRef="usd">69711000000</us-gaap:DirectPremiumsEarned>
    <us-gaap:DirectPremiumsEarned
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzEtNS0xLTEtMTk2MzU_b08498ff-eb8f-428a-aa7b-1b3689e5c366"
      unitRef="usd">62968000000</us-gaap:DirectPremiumsEarned>
    <us-gaap:AssumedPremiumsEarned
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzItMS0xLTEtMTk2MzU_25648372-4ced-4990-8841-1bfca736e836"
      unitRef="usd">492000000</us-gaap:AssumedPremiumsEarned>
    <us-gaap:AssumedPremiumsEarned
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzItMy0xLTEtMTk2MzU_75afd8b8-794b-4cd8-a61d-1a6acbc6c4da"
      unitRef="usd">478000000</us-gaap:AssumedPremiumsEarned>
    <us-gaap:AssumedPremiumsEarned
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzItNS0xLTEtMTk2MzU_5d3b8ca2-4334-4859-967e-9d8744ec0cea"
      unitRef="usd">2108000000</us-gaap:AssumedPremiumsEarned>
    <us-gaap:CededPremiumsEarned
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzMtMS0xLTEtMTk2MzU_a9df8b9b-2e36-49db-9a6b-1335faf6e181"
      unitRef="usd">680000000</us-gaap:CededPremiumsEarned>
    <us-gaap:CededPremiumsEarned
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzMtMy0xLTEtMTk2MzU_302d65a1-7908-4c8a-ad5d-522f20c81f44"
      unitRef="usd">825000000</us-gaap:CededPremiumsEarned>
    <us-gaap:CededPremiumsEarned
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzMtNS0xLTEtMTk2MzU_b8f9fee7-ea01-4f75-907e-3e01c0f0d973"
      unitRef="usd">1954000000</us-gaap:CededPremiumsEarned>
    <us-gaap:PremiumsEarnedNet
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzQtMS0xLTEtMTk2MzU_1ccc9180-af15-4a6b-8946-47094df8e317"
      unitRef="usd">76132000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzQtMy0xLTEtMTk2MzU_546d1500-cc3b-46c5-acb2-b9258b4f7408"
      unitRef="usd">69364000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTowYzVkMDdiMGU5Nzg0YjRkYjE1OGE4NWIxNWE1ZDZkMC90YWJsZXJhbmdlOjBjNWQwN2IwZTk3ODRiNGRiMTU4YTg1YjE1YTVkNmQwXzQtNS0xLTEtMTk2MzU_66bb51bf-fbe8-4eb1-9cc2-67cdd9703584"
      unitRef="usd">63122000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:EffectsOfReinsuranceTableTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90ZXh0cmVnaW9uOmNiMzdlNWRmMjk2YTQ5ZDE5YWUyNDFjOTA5ZWRiYWE0XzIxMTM_0aaf2029-cc42-4780-9580-d6984f6589a5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact of reinsurance on benefit costs for the years ended December&#160;31, 2021, 2020 and 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ceded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net benefit costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EffectsOfReinsuranceTableTextBlock>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredGross
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzEtMS0xLTEtMTk2MzU_a40021bd-8bbd-460e-9e28-6d73c3cfa51e"
      unitRef="usd">64414000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredGross>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredGross
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzEtMy0xLTEtMTk2MzU_a5ee0e35-5996-4a45-bd66-a0d723f1a912"
      unitRef="usd">56077000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredGross>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredGross
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzEtNS0xLTEtMTk2MzU_b8cf1574-bda4-4859-becd-c4d6cc55a3cb"
      unitRef="usd">52592000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredGross>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzItMS0xLTEtMTk2MzU_6fb63cef-17eb-4243-bcb0-d8f26f4dd202"
      unitRef="usd">398000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzItMy0xLTEtMTk2MzU_d7bf5f48-6d8f-4040-8915-e4a2b0a56cd9"
      unitRef="usd">329000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzItNS0xLTEtMTk2MzU_5e4ee7d4-081d-41fb-923c-5a13555c91f5"
      unitRef="usd">1562000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzMtMS0xLTEtMTk2MzU_c0976ff2-50af-4f14-83a5-7d572efa98cb"
      unitRef="usd">552000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzMtMy0xLTEtMTk2MzU_9d241656-a058-4b87-85f6-913bc901af3a"
      unitRef="usd">727000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzMtNS0xLTEtMTk2MzU_8a561673-f4d8-4388-9cea-c8bfe1f1ecbc"
      unitRef="usd">1625000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzQtMS0xLTEtMTk2MzU_14e7a61d-5de0-4167-99d8-9b52fb593e31"
      unitRef="usd">64260000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzQtMy0xLTEtMTk2MzU_17d5f655-01ea-4f59-aa9c-6843e0ad50dc"
      unitRef="usd">55679000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredNet
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzUvZnJhZzpjYjM3ZTVkZjI5NmE0OWQxOWFlMjQxYzkwOWVkYmFhNC90YWJsZTo1MjQ1YWU2MTRmNzM0MDMwYTE2ZDNkZjExY2JjMzM2NS90YWJsZXJhbmdlOjUyNDVhZTYxNGY3MzQwMzBhMTZkM2RmMTFjYmMzMzY1XzQtNS0xLTEtMTk2MzU_86526826-eb60-40f9-a3c9-87b36354734a"
      unitRef="usd">52529000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredNet>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzgvZnJhZzo2MTM1NGM4M2Q3YTU0YjdlYTIwOTlkOWIzZWQyNWY1OC90ZXh0cmVnaW9uOjYxMzU0YzgzZDdhNTRiN2VhMjA5OWQ5YjNlZDI1ZjU4XzI5ODA1_6a7ced0b-a87c-4f2f-9a58-3f7049fa626f">Commitments and Contingencies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;COVID-19&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The COVID-19 pandemic continues to evolve. The Company believes COVID-19&#x2019;s impact on its businesses, operating results, cash flows and/or financial condition primarily will be driven by the geographies impacted and the severity and duration of the pandemic; the pandemic&#x2019;s impact on the U.S. and global economies and consumer behavior and health care utilization patterns; and the timing, scope and impact of stimulus legislation as well as other federal, state and local governmental responses to the pandemic. Those primary drivers are beyond the Company&#x2019;s knowledge and control. As a result, the impact COVID-19 will have on the Company&#x2019;s businesses, operating results, cash flows and/or financial condition is uncertain, but the impact could be adverse and material. COVID-19 also may result in legal and regulatory proceedings, investigations and claims against the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has the following significant guarantee arrangements at December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;ASC Claim Funding Accounts - The Company has arrangements with certain banks for the processing of claim payments for its ASC customers. The banks maintain accounts to fund claims of the Company&#x2019;s ASC customers. The customer is responsible for funding the amount paid by the bank each day. In these arrangements, the Company guarantees that the banks will not sustain losses if the responsible ASC customer does not properly fund its account. The aggregate maximum exposure under these arrangements is generally limited to $250 million. The Company can limit its exposure to these guarantees by suspending the payment of claims for ASC customers that have not adequately funded the amount paid by the bank. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Separate Accounts Assets - Certain Separate Accounts assets associated with the large case pensions business in the Corporate/Other segment represent funds maintained as a contractual requirement to fund specific pension annuities that the Company has guaranteed. Minimum contractual obligations underlying the guaranteed benefits in these Separate Accounts were approximately $1.3&#160;billion and $1.4 billion at December&#160;31, 2021 and 2020, respectively. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information on Separate Accounts. Contract holders assume all investment and mortality risk and are required to maintain Separate Accounts balances at or above a specified level. The level of required funds is a function of the risk underlying the Separate Account&#x2019;s investment strategy. If contract holders do not maintain the required level of Separate Accounts assets to meet the annuity guarantees, the Company would &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;establish an additional liability. Contract holders&#x2019; balances in the Separate Accounts at December&#160;31, 2021 exceeded the value of the guaranteed benefit obligation. As a result, the Company was not required to maintain any additional liability for its related guarantees at December&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lease Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Between 1995 and 1997, the Company sold or spun off a number of subsidiaries, including Bob&#x2019;s Stores and Linens &#x2018;n Things, each of which subsequently filed for bankruptcy, and Marshalls. In many cases, when a former subsidiary leased a store, the Company provided a guarantee of the former subsidiary&#x2019;s lease obligations for the initial lease term and any extension thereof pursuant to a renewal option provided for in the lease prior to the time of the disposition. When the subsidiaries were disposed of and accounted for as discontinued operations, the Company&#x2019;s guarantees remained in place, although each initial purchaser agreed to indemnify the Company for any lease obligations the Company was required to satisfy. If any of the purchasers or any of the former subsidiaries fail to make the required payments under a store lease, the Company could be required to satisfy those obligations, and any significant adverse impact of COVID-19 on such purchasers and/or former subsidiaries increases the risk that the Company will be required to satisfy those obligations. As of December&#160;31, 2021, the Company guaranteed 72 such store leases (excluding the lease guarantees related to Linens &#x2018;n Things, which have been recorded as a liability on the consolidated balance sheets), with the maximum remaining lease term extending through 2030.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guaranty Fund Assessments, Market Stabilization and Other Non-Voluntary Risk Sharing Pools&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under guaranty fund laws existing in all states, insurers doing business in those states can be assessed (in most states up to prescribed limits) for certain obligations of insolvent insurance companies to policyholders and claimants. The life and health insurance guaranty associations in which the Company participates that operate under these laws respond to insolvencies of long-term care insurers and life insurers as well as health insurers. The Company&#x2019;s assessments generally are based on a formula relating to the Company&#x2019;s health care premiums in the state compared to the premiums of other insurers. Certain states allow assessments to be recovered over time as offsets to premium taxes. Some states have similar laws relating to HMOs and/or other payors such as not-for-profit consumer-governed health plans established under the ACA.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, &#x201c;Penn Treaty&#x201d;) in rehabilitation, an intermediate action before insolvency, and subsequently petitioned a state court to convert the rehabilitation into a liquidation. Penn Treaty was placed in liquidation in March 2017. The Company has recorded a liability for its estimated share of future assessments by applicable life and health insurance guaranty associations. It is reasonably possible that in the future the Company may record a liability and expense relating to other insolvencies which could have a material adverse effect on the Company&#x2019;s operating results, financial condition and cash flows, and the risk is heightened by any significant adverse impact of the COVID-19 pandemic on the solvency of other insurers, including long-term care and life insurers. While historically the Company has ultimately recovered more than half of guaranty fund assessments through statutorily permitted premium tax offsets, significant increases in assessments could lead to legislative and/or regulatory actions that limit future offsets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;HMOs in certain states in which the Company does business are subject to assessments, including market stabilization and other risk-sharing pools, for which the Company is assessed charges based on incurred claims, demographic membership mix and other factors. The Company establishes liabilities for these assessments based on applicable laws and regulations. In certain states, the ultimate assessments the Company pays are dependent upon the Company&#x2019;s experience relative to other entities subject to the assessment, and the ultimate liability is not known at the financial statement date. While the ultimate amount of the assessment is dependent upon the experience of all pool participants, the Company believes it has adequate reserves to cover such assessments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s total guaranty fund assessments liability was immaterial at both December&#160;31, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation and Regulatory Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been involved or is currently involved in numerous legal proceedings, including litigation, arbitration, government investigations, audits, reviews and claims. These include routine, regular and special investigations, audits and reviews by&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; CMS, state insurance and health and welfare departments, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the U.S. Department of Justice (the &#x201c;DOJ&#x201d;), &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;state attorneys general, the U.S. Drug Enforcement Administration (the &#x201c;DEA&#x201d;) and other governmental authorities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legal proceedings, in general, and securities, class action and multi-district litigation, in particular, and governmental special investigations, audits and reviews can be expensive and disruptive. Some of the litigation matters may purport or be determined &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to be class actions and/or involve parties seeking large and/or indeterminate amounts, including punitive or exemplary damages, and may remain unresolved for several years. The Company also may be named from time to time in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; actions initiated by private third parties that could also be separately pursued by a governmental body. The results of legal proceedings, including government investigations, are often uncertain and difficult to predict, and the costs incurred in these matters can be substantial, regardless of the outcome.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and reasonably estimable, the Company does not establish an accrued liability. None of the Company&#x2019;s accruals for outstanding legal matters are material individually or in the aggregate to the Company&#x2019;s financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Except as otherwise noted, the Company cannot predict with certainty the timing or outcome of the legal matters described below, and the Company is unable to reasonably estimate a possible loss or range of possible loss in excess of amounts already accrued for these matters. The Company believes that its defenses and assertions in pending legal proceedings have merit and does not believe that any of these pending matters, after consideration of applicable reserves and rights to indemnification, will have a material adverse effect on the Company&#x2019;s financial position. Substantial unanticipated verdicts, fines and rulings, however, do sometimes occur, which could result in judgments against the Company, entry into settlements or a revision to its expectations regarding the outcome of certain matters, and such developments could have a material adverse effect on its results of operations.  In addition, as a result of governmental investigations or proceedings, the Company may be subject to damages, civil or criminal fines or penalties, or other sanctions including possible suspension or loss of licensure and/or exclusion from participating in government programs. The outcome of such governmental investigations of proceedings could be material to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Usual and Customary Pricing Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and certain current and former directors and officers are named as a defendant in a number of lawsuits that allege that the Company&#x2019;s retail pharmacies overcharged for prescription drugs by not submitting the correct usual and customary price during the claims adjudication process. These actions are brought by a number of different types of plaintiffs, including plan members, private payors, government payors, and shareholders based on different legal theories. Some of these cases are brought as putative class actions, and in some instances, classes have been certified. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;PBM Litigation and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its PBM practices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is facing multiple lawsuits, including by a State Attorney General, governmental subdivisions and several putative class actions, regarding drug pricing and its rebate arrangements with drug manufacturers.  These complaints, brought by a number of different types of plaintiffs under a variety of legal theories, generally allege that rebate agreements between the drug manufacturers and PBMs caused inflated prices for certain drug products. The Company is defending itself against these claims.  The Company has also received subpoenas, civil investigative demands (&#x201c;CIDs&#x201d;) and other requests for documents and information from, and is being investigated by, Attorneys General of multiple states and the District of Columbia regarding its PBM practices, including pricing and rebates. The Company has been providing documents and information in response to these subpoenas, CIDs and requests for information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Behnke v. CVS Caremark Corporation, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. (U.S. District Court for the Eastern District of Pennsylvania). In April 2018, the Court unsealed a complaint filed in February 2014. The government has declined to intervene in this case. The relator alleges that the Company submitted, or caused to be submitted, to Part D of the Medicare program Prescription Drug Event data and/or Direct and Indirect Remuneration reports that misrepresented true prices paid by the Company&#x2019;s PBM to pharmacies for drugs dispensed to Part D beneficiaries with prescription benefits administered by the Company&#x2019;s PBM. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Controlled Substances Litigation, Audits and Subpoenas&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2017, the U.S. Judicial Panel on Multidistrict Litigation consolidated numerous cases filed against various defendants by plaintiffs such as counties, cities, hospitals, Indian tribes and third-party payors, alleging claims generally concerning the impacts of widespread prescription opioid abuse. The consolidated multidistrict litigation captioned In re National Prescription Opiate Litigation (MDL No. 2804) is pending in the U.S. District Court for the Northern District of Ohio. This multidistrict litigation presumptively includes hundreds of relevant federal court cases that name the Company as a defendant. A significant number of similar cases that name the Company as a defendant in some capacity are pending in state courts. In addition, the Company has been named as a defendant in similar cases brought by certain state Attorneys General. The Company is defending itself against all such claims. Additionally, the Company has received subpoenas, CIDs and/or other requests for information regarding opioids from state Attorneys General and insurance and other regulators of several U.S. jurisdictions. The Company has been cooperating with the government with respect to these subpoenas, CIDs and other requests for information. In November 2021, the Company was among the chain pharmacies found liable by a jury in a trial in federal court in Ohio; the remedy pursuant to that verdict has not been determined and the Company plans to appeal.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the DOJ served the Company with a DEA administrative subpoena. The subpoena seeks documents relating to practices with respect to prescription opioids and other controlled substances at CVS Pharmacy locations concerning potential violations of the federal Controlled Substances Act and the federal False Claims Act. In January 2022, the DOJ served the Company with a CID regarding similar subjects. The Company is providing documents and information in response to these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Prescription Processing Litigation and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in a number of lawsuits and is subject to a number of investigations concerning its prescription processing practices, including the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ex rel.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Bassan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; v. Omnicare, Inc. and CVS Health Corp. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(U.S. District Court for the Southern District of New York). In December 2019, the U.S. Attorney&#x2019;s Office for the Southern District of New York (the &#x201c;SDNY&#x201d;) filed a complaint-in-intervention in this previously sealed &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; case. The complaint alleges that for certain non-skilled nursing facilities, Omnicare improperly filled prescriptions beyond one year where a valid prescription did not exist and that these dispensing events violated the federal False Claims Act. The Company is defending itself against these claims.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2017, the Company also received a subpoena from the California Department of Insurance requesting documents concerning the Company&#x2019;s Omnicare pharmacies&#x2019; cycle fill process for assisted living facilities. The Company has been cooperating with the California Department of Insurance and providing documents and information in response to this subpoena.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2016, the Company received a CID from the U.S. Attorney&#x2019;s Office for the Northern District of New York requesting documents and information in connection with a federal False Claims Act investigation concerning whether the Company&#x2019;s retail pharmacies improperly submitted certain insulin claims to Part D of the Medicare program rather than Part B of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to this CID.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Provider Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is named as a defendant in purported class actions and individual lawsuits arising out of its practices related to the payment of claims for services rendered to its members by providers with whom the Company has a contract and with whom the Company does not have a contract (&#x201c;out-of-network providers&#x201d;).&#160;Among other things, these lawsuits allege that the Company paid too little to its health plan members and/or providers for out-of-network services and/or otherwise allege that the Company failed to timely or appropriately pay or administer out-of-network claims and benefits (including the Company&#x2019;s post payment audit and collection practices and reductions in payments to providers due to sequestration). Other major health insurers are the subject of similar litigation or have settled similar litigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has received subpoenas and/or requests for documents and other information from, and been investigated by, state Attorneys General and other state and/or federal regulators, legislators and agencies relating to, and the Company is involved in other litigation regarding, its out-of-network benefit payment and administration practices. It is reasonably possible that others could initiate additional litigation or additional regulatory action against the Company with respect to its out-of-network benefit payment and/or administration practices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;CMS Actions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CMS regularly audits the Company&#x2019;s performance to determine its compliance with CMS&#x2019;s regulations and its contracts with CMS and to assess the quality of services it provides to Medicare beneficiaries. CMS uses various payment mechanisms to allocate and adjust premium payments to the Company&#x2019;s and other companies&#x2019; Medicare plans by considering the applicable health status of Medicare members as supported by information prepared, maintained and provided by providers. The Company collects claim and encounter data from providers and generally relies on providers to appropriately code their submissions to the Company and document their medical records, including the diagnosis data submitted to the Company with claims. CMS pays increased premiums to Medicare Advantage plans and Medicare PDP plans for members who have certain medical conditions identified with specific diagnosis codes. Federal regulators review and audit the providers&#x2019; medical records to determine whether those records support the related diagnosis codes that determine the members&#x2019; health status and the resulting risk-adjusted premium payments to the Company. In that regard, CMS has instituted risk adjustment data validation (&#x201c;RADV&#x201d;) audits of various Medicare Advantage plans, including certain of the Company&#x2019;s plans, to validate coding practices and supporting medical record documentation maintained by providers and the resulting risk adjusted premium payments to the plans. CMS may require the Company to refund premium payments if the Company&#x2019;s risk adjusted premiums are not properly supported by medical record data. The Office of the Inspector General of the HHS (the &#x201c;OIG&#x201d;) also is auditing the Company&#x2019;s risk adjustment-related data and that of other companies. The Company expects CMS and the OIG to continue these types of audits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2012, CMS revised its audit methodology for RADV audits to determine refunds payable by Medicare Advantage plans for contract year 2011 and forward. Under the revised methodology, among other things, CMS will extrapolate the error rate identified in the audit sample of approximately 200 members to all risk adjusted premium payments made under the contract being audited. For contract years prior to 2011, CMS did not extrapolate sample error rates to the entire contract. As a result, the revised methodology may increase the Company&#x2019;s exposure to premium refunds to CMS based on incomplete medical records maintained by providers. Since 2013, CMS has selected certain of the Company&#x2019;s Medicare Advantage contracts for various contract years for RADV audit, and the number of RADV audits continues to increase. The Company is currently unable to predict which of its Medicare Advantage contracts will be selected for future audit, the amounts of any retroactive refunds of, or prospective adjustments to, Medicare Advantage premium payments made to the Company, the effect of any such refunds or adjustments on the actuarial soundness of the Company&#x2019;s Medicare Advantage bids, or whether any RADV audit findings would require the Company to change its method of estimating future premium revenue in future bid submissions to CMS or compromise premium assumptions made in the Company&#x2019;s bids for prior contract years, the current contract year or future contract years. Any premium or fee refunds or adjustments resulting from regulatory audits, whether as a result of RADV, Public Exchange related or other audits by CMS, the OIG or otherwise, including audits of the Company&#x2019;s MLR rebates, methodology and/or reports, could be material and could adversely affect the Company&#x2019;s operating results, cash flows and/or financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Medicare and Medicaid CIDs&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has received CIDs from the Civil Division of the DOJ in connection with a current investigation of the Company&#x2019;s patient chart review processes in connection with risk adjustment data submissions under Parts C and D of the Medicare program. The Company has been cooperating with the government and providing documents and information in response to these CIDs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, the Company received a CID from the SDNY requesting documents and information concerning possible false claims submitted to Medicare in connection with reimbursements for prescription drugs under the Medicare Part D program. The Company has been cooperating with the government and providing documents and information in response to this CID.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Stockholder Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in February 2019, multiple class action complaints, as well as a derivative complaint, were filed by putative plaintiffs against the Company and certain current and former officers and directors. The plaintiffs in these cases assert a variety of causes of action under federal securities laws that are premised on allegations that the defendants made certain omissions and misrepresentations relating to the performance of the Company&#x2019;s LTC business unit. The Company and its current and former officers and directors are defending themselves against these claims. Since filing, several of the cases have been consolidated, and the first-filed federal case, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;City of Miami Fire Fighters&#x2019; and Police Officers&#x2019; Retirement Trust, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Anarkat&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;), was dismissed with prejudice in February 2021. Plaintiffs have appealed that decision to the First Circuit after their motion for reconsideration was denied. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re CVS Health Corp. Securities Act Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Waterford&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;re CVS Health Corp. Securities Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (formerly known as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;City of Warren&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Freundlich&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) have been stayed pending the outcome of the First Circuit appeal. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August and September 2020, two class actions under the Employee Retirement Income Security Act of 1974 (&#x201c;ERISA&#x201d;) were filed in the U.S. District Court for the District of Connecticut against CVS Health, Aetna, and several current and former executives, directors and/or members of Aetna&#x2019;s Compensation and Talent Management Committee: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Radcliffe v. Aetna Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Flaim v. Aetna Inc., &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;et al. The plaintiffs in these cases assert a variety of causes of action premised on allegations that the defendants breached fiduciary duties and engaged in prohibited transactions relating to participants in the Aetna 401(k) Plan&#x2019;s investment in company stock between December 3, 2017 and February 20, 2019, claiming losses related to the performance of the Company&#x2019;s LTC business unit. The district court consolidated the actions and the Company is defending itself against these claims. In October 2021, the consolidated case was dismissed without prejudice. Plaintiffs may seek leave to file an amended complaint. The Company also received a related document request pursuant to ERISA &#xa7; 104(b), to which the Company has responded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company received a demand for inspection of books and records pursuant to Delaware Corporation Law Section 220 (the &#x201c;Demand&#x201d;). The Demand purports to be related to potential breaches of fiduciary duties by the Board in relation to certain matters concerning opioids.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Other Legal and Regulatory Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also a party to other legal proceedings and is subject to government investigations, inquiries and audits and has received and is cooperating with the government in response to CIDs, subpoenas or similar process from various governmental agencies requesting information. These other legal proceedings and government actions include claims of or relating to bad faith, medical or professional malpractice, breach of fiduciary duty, claims processing, dispensing of medications, non-compliance with state and federal regulatory regimes, marketing misconduct, denial of or failure to timely or appropriately pay or administer claims and benefits, provider network structure (including the use of performance-based networks and termination of provider contracts), rescission of insurance coverage, improper disclosure or use of personal information, anticompetitive practices, general contractual matters, product liability, intellectual property litigation and employment litigation. Some of these other legal proceedings are or are purported to be class actions or derivative claims. The Company is defending itself against the claims brought in these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Awards to the Company and others of certain government contracts, particularly Medicaid contracts and other contracts with government customers in the Company&#x2019;s Health Care Benefits segment, frequently are subject to protests by unsuccessful bidders. These protests may result in awards to the Company being reversed, delayed or modified. The loss or delay in implementation of any government contract could adversely affect the Company&#x2019;s operating results. The Company will continue to defend contract awards it receives.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There also continues to be a heightened level of review and/or audit by regulatory authorities and legislators of, and increased litigation regarding, the Company&#x2019;s and the rest of the health care and related benefits industry&#x2019;s business and reporting practices, including premium rate increases, utilization management, development and application of medical policies, complaint, grievance and appeal processing, information privacy, provider network structure (including provider network adequacy, the use of performance-based networks and termination of provider contracts), provider directory accuracy, calculation of minimum medical loss ratios and/or payment of related rebates, delegated arrangements, rescission of insurance coverage, limited benefit health products, student health products, pharmacy benefit management practices (including manufacturers&#x2019; rebates, pricing, the use of narrow networks and the placement of drugs in formulary tiers), sales practices, customer service practices, vendor oversight and claim payment practices (including payments to out-of-network providers).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a leading national health solutions company, the Company regularly is the subject of government actions of the types described above. These government actions may prevent or delay the Company from implementing planned premium rate increases and may result, and have resulted, in restrictions on the Company&#x2019;s businesses, changes to or clarifications of the Company&#x2019;s business practices, retroactive adjustments to premiums, refunds or other payments to members, beneficiaries, states or the federal government, withholding of premium payments to the Company by government agencies,&#160;assessments of damages, civil or criminal fines or penalties, or other sanctions, including the possible suspension or loss of licensure and/or suspension or exclusion from participation in government programs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company can give no assurance that its businesses, financial condition, operating results and/or cash flows will not be materially adversely affected, or that the Company will not be required to materially change its business practices, based on: (i)&#160;future enactment of new health care or other laws or regulations; (ii)&#160;the interpretation or application of existing laws or &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;regulations as they may relate to one or more of the Company&#x2019;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iii)&#160;pending or future federal or state government investigations of one or more of the Company&#x2019;s businesses, one or more of the industries in which the Company competes and/or the health care industry generally; (iv)&#160;pending or future government audits, investigations or enforcement actions against the Company; (v)&#160;adverse developments in any pending &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit against the Company, whether sealed or unsealed, or in any future &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; lawsuit that may be filed against the Company; or (vi)&#160;adverse developments in pending or future legal proceedings against the Company or affecting one or more of the industries in which the Company competes and/or the health care industry generally.&lt;/span&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:GuaranteeObligationsMaximumExposure
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzgvZnJhZzo2MTM1NGM4M2Q3YTU0YjdlYTIwOTlkOWIzZWQyNWY1OC90ZXh0cmVnaW9uOjYxMzU0YzgzZDdhNTRiN2VhMjA5OWQ5YjNlZDI1ZjU4XzE0OTg_dd63254a-b781-4396-b23e-b1c6edf1f100"
      unitRef="usd">250000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzgvZnJhZzo2MTM1NGM4M2Q3YTU0YjdlYTIwOTlkOWIzZWQyNWY1OC90ZXh0cmVnaW9uOjYxMzU0YzgzZDdhNTRiN2VhMjA5OWQ5YjNlZDI1ZjU4XzEzNzQzODk1NDI3MDgx_ce781649-8c37-444f-a5f2-bfaa3d58f423"
      unitRef="usd">1300000000</cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts>
    <cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts
      contextRef="ic9bbc3798d714a95928e301134f0a8b4_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzgvZnJhZzo2MTM1NGM4M2Q3YTU0YjdlYTIwOTlkOWIzZWQyNWY1OC90ZXh0cmVnaW9uOjYxMzU0YzgzZDdhNTRiN2VhMjA5OWQ5YjNlZDI1ZjU4XzIwNTE_fd3e7de7-c4b2-4f2b-952c-720382ecc8ab"
      unitRef="usd">1400000000</cvs:ContractualObligationsToMaintainLevelsOfSeparateAccounts>
    <cvs:GuarantorObligationsNumberofLeases
      contextRef="i48425c9c7d6d41fe9f23b091c65a31d4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzgvZnJhZzo2MTM1NGM4M2Q3YTU0YjdlYTIwOTlkOWIzZWQyNWY1OC90ZXh0cmVnaW9uOjYxMzU0YzgzZDdhNTRiN2VhMjA5OWQ5YjNlZDI1ZjU4XzM5MDY_9b861239-698a-4b2f-876c-5e29c4a66260"
      unitRef="lease">72</cvs:GuarantorObligationsNumberofLeases>
    <cvs:LossContingencyAuditMethodologySampleSize
      contextRef="i63b662edcef14a498dbf400ce0e7d2f8_D20120101-20121231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzgvZnJhZzo2MTM1NGM4M2Q3YTU0YjdlYTIwOTlkOWIzZWQyNWY1OC90ZXh0cmVnaW9uOjYxMzU0YzgzZDdhNTRiN2VhMjA5OWQ5YjNlZDI1ZjU4XzEwOTk1MTE3MDQyMzU_174a2e50-225f-4471-b762-630459d21b1d"
      unitRef="member">200</cvs:LossContingencyAuditMethodologySampleSize>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ia4e995a2f68a477fbac8891b9ff45d93_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xNzgvZnJhZzo2MTM1NGM4M2Q3YTU0YjdlYTIwOTlkOWIzZWQyNWY1OC90ZXh0cmVnaW9uOjYxMzU0YzgzZDdhNTRiN2VhMjA5OWQ5YjNlZDI1ZjU4XzM4NDgyOTA3ODEyMjc_d6f90f92-5393-4a72-a34a-57f25548100f"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzc2MzE_74e27502-f3b5-487b-ba07-7f0ab6445a58">Segment Reporting&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has three operating segments, Health Care Benefits, Pharmacy Services and Retail/LTC, as well as a Corporate/Other segment. The Company&#x2019;s segments maintain separate financial information, and the Company&#x2019;s chief operating decision maker (the &#x201c;CODM&#x201d;) evaluates the segments&#x2019; operating results on a regular basis in deciding how to allocate resources among the segments and in assessing segment performance. The CODM evaluates the performance of the Company&#x2019;s segments based on adjusted operating income, which is defined as operating income (GAAP measure) excluding the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company&#x2019;s business nor reflect the Company&#x2019;s underlying business performance. See the reconciliation of consolidated operating income (GAAP measure) to consolidated adjusted operating income below for further context regarding the items excluded from operating income in determining adjusted operating income. The Company uses adjusted operating income as its principal measure of segment performance as it enhances the Company&#x2019;s ability to compare past financial performance with current performance and analyze underlying business performance and trends. Non-GAAP financial measures the Company discloses, such as consolidated adjusted operating income, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2021, 2020 and 2019, revenues from the federal government accounted for 17%, 16% and 16%, respectively, of the Company&#x2019;s consolidated total revenues, primarily related to contracts with CMS for coverage of Medicare-eligible individuals within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of financial measures of the Company&#x2019;s segments to the consolidated totals:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.003%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&#160;&lt;br/&gt;Services &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(708)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;Total revenues of the Pharmacy Services segment include approximately $11.6 billion, $10.9 billion and $11.5 billion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;of retail co-payments for 2021, 2020 and 2019, respectively. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information about retail co-payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#x201c;PSS members&#x201d;) enrolled in Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; elect to pick up maintenance prescriptions at one of the Company&#x2019;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of consolidated operating income to adjusted operating income for the years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (GAAP measure)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Store impairments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition purchase price adjustment outside of measurement period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Gain) loss on divestiture of subsidiary &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receipt of fully reserved ACA risk corridor receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;The Company&#x2019;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#x2019;s GAAP consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#x2019;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#x2019;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#x2019;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2021, 2020 and 2019, acquisition-related integration costs relate to the Aetna Acquisition. The acquisition-related integration costs are reflected in the Company&#x2019;s GAAP consolidated statements of operations in operating expenses within the Corporate/Other segment.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;During the year ended December 31, 2021, the store impairment charge relates to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. During the year ended December 31, 2019, the store impairment charges related to the write down of operating lease right-of-use assets in connection with the planned closure of 68 underperforming retail pharmacy stores in 2019 and 2020. The store impairment charges are reflected in the Company&#x2019;s GAAP consolidated statements of operations within the Retail/LTC segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;During the year ended December 31, 2021, the goodwill impairment charge relates to the LTC reporting unit within the Retail/LTC segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In June 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#x2019;s GAAP consolidated statement of operations for the year ended December 31, 2021 as a reduction of operating expenses within the Health Care Benefits segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#x2019; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction of operating expenses in the Company&#x2019;s GAAP consolidated statement of operations within the Health Care Benefits segment. In 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in the Company&#x2019;s GAAP consolidated statement of operations in operating expenses within the Retail/LTC segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2020, the Company received $313&#160;million owed to it under the ACA&#x2019;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#x2019;s minimum MLR rebate requirements and premium taxes, the Company recognized pre-tax income of $307&#160;million in the Company&#x2019;s GAAP consolidated statement of operations within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzQx_dc76b93e-26a9-440b-806e-4846b1e4521f"
      unitRef="segment">3</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i7c55eec168db4721bd5fa5e6c7afd8f1_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzE1MDk_cff551ef-4838-42c4-85fb-d0c3c3b0c20f"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8549b1a793e64b2bb212ac0ced243d88_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzE1MTY_6a04b784-4151-4f9d-b5c9-910ddb74afff"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4020d7e493d642d5966e8ca82cc66798_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzEwOTk1MTE2Mzk0MTU_1f79d34e-32a3-49cd-af3d-c3ccdd66d06d"
      unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzc2Mjg_47e74491-3db2-45a0-a2e7-12e7780d944c">&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.556%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.827%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.383%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.003%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Health Care&lt;br/&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Pharmacy&#160;&lt;br/&gt;Services &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Retail/&lt;br/&gt;LTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Corporate/&lt;br/&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Intersegment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Eliminations &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;br/&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;290,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,923)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(708)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues from external customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Adjusted operating income (loss) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(697)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;Total revenues of the Pharmacy Services segment include approximately $11.6 billion, $10.9 billion and $11.5 billion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;of retail co-payments for 2021, 2020 and 2019, respectively. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information about retail co-payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Pharmacy Services segment, and/or the Retail/LTC segment. Intersegment adjusted operating income eliminations occur when members of Pharmacy Services Segment clients (&#x201c;PSS members&#x201d;) enrolled in Maintenance Choice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; elect to pick up maintenance prescriptions at one of the Company&#x2019;s retail pharmacies instead of receiving them through the mail. When this occurs, both the Pharmacy Services and Retail/LTC segments record the adjusted operating income on a stand-alone basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d8f78677d6943988b31d555638bbaf9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzItMS0xLTEtMjU2ODI_f922d649-1bf1-4a83-a26d-33679e96f1ca"
      unitRef="usd">81515000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzItMS0xLTEtMTk2MzU_91fc60f2-0375-47df-a937-1696da49fdbf"
      unitRef="usd">143194000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2301583729e7424597c39ac7978d0401_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzItMy0xLTEtMTk2MzU_a4e188d4-ca60-4187-8f8d-68849b7f0e9e"
      unitRef="usd">66078000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f0540b87ed34aee812a4602f32b0fb6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzItNy0xLTEtMTk2MzU_8d1b99b3-f1a7-4ebc-9b5d-3ecd8d3fbcbc"
      unitRef="usd">125000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzItMTEtMS0xLTE5NjM1_855fc45f-8ba5-40db-b13e-68fe63fa5f6e"
      unitRef="usd">290912000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i528bf90615b04a4388c9e042e7d52e2d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzMtMS0xLTEtMjU2ODI_894cbd53-4c1d-4883-98fd-2654fadd7788"
      unitRef="usd">85000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b5addf84c5d4652a8c88278ee498b80_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzMtMS0xLTEtMTk2MzU_39271600-3e8a-4f20-b960-c4f5d0efeea8"
      unitRef="usd">9828000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8ae9e7058b940a287f7a508f1290213_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzMtMy0xLTEtMTk2MzU_c8300a79-0ed1-453f-b9c2-f47a921f7419"
      unitRef="usd">34010000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4344db6c31344de2b14b66847d6c28a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzMtOS0xLTEtMTk2MzU_b6909b73-3c35-4c03-877c-4477f2690975"
      unitRef="usd">-43923000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i9d8f78677d6943988b31d555638bbaf9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzQtMS0xLTEtMjU2ODI_87203dc5-275f-4c9c-af26-9d298658f2cf"
      unitRef="usd">586000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzQtMS0xLTEtMTk2MzU_4f0b9e61-a8bc-4ba3-87ea-5484b815ff7b"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i2301583729e7424597c39ac7978d0401_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzQtMy0xLTEtMTk2MzU_75c5b9b9-5e70-4f4f-8f3a-13e1ff733cf9"
      unitRef="usd">17000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i7f0540b87ed34aee812a4602f32b0fb6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzQtNy0xLTEtMTk2MzU_ca0e21d1-eb80-4330-9646-12bc22b6f83c"
      unitRef="usd">596000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i4344db6c31344de2b14b66847d6c28a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzQtOS0xLTEtMTk2MzU_1056160d-b4a9-4190-a225-acafe4b9ba25"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzQtMTEtMS0xLTE5NjM1_e0facd50-fc02-40c5-a6fe-1669168efe3b"
      unitRef="usd">1199000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i9d8f78677d6943988b31d555638bbaf9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzUtMS0xLTEtMjU2ODI_5b0f0779-3a95-4a5c-aa7f-18465cb8dc33"
      unitRef="usd">82186000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzUtMS0xLTEtMTk2MzU_87d774f8-5f03-441f-a34a-8f98a7c6e65b"
      unitRef="usd">153022000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2301583729e7424597c39ac7978d0401_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzUtMy0xLTEtMTk2MzU_fa37708b-0fde-4536-8271-b0693872355e"
      unitRef="usd">100105000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7f0540b87ed34aee812a4602f32b0fb6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzUtNy0xLTEtMTk2MzU_55058538-8582-4b5e-9bba-dc76ea4483fe"
      unitRef="usd">721000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4344db6c31344de2b14b66847d6c28a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzUtOS0xLTEtMTk2MzU_6a1b84d2-521c-48e3-9c51-28a1ed13c4fc"
      unitRef="usd">-43923000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzUtMTEtMS0xLTE5NjM1_0ed770e6-258e-4be6-bba0-8ee5df73f1ee"
      unitRef="usd">292111000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i9d8f78677d6943988b31d555638bbaf9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzYtMS0xLTEtMjU2ODI_27822a4f-f934-4e43-b7f8-cadb15565b59"
      unitRef="usd">5012000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzYtMS0xLTEtMTk2MzU_e349eddb-f385-4880-9f22-5a7f36e6b60a"
      unitRef="usd">6859000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i2301583729e7424597c39ac7978d0401_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzYtMy0xLTEtMTk2MzU_42d3ec3a-3ffa-451d-aa04-ab9342d66191"
      unitRef="usd">7623000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i7f0540b87ed34aee812a4602f32b0fb6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzYtNy0xLTEtMTk2MzU_62958ad2-8063-4eb4-bf72-b8b827ad5252"
      unitRef="usd">-1471000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i4344db6c31344de2b14b66847d6c28a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzYtOS0xLTEtMTk2MzU_aa15573f-4d99-4435-a01f-3f87a86805c0"
      unitRef="usd">-711000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzYtMTEtMS0xLTE5NjM1_4bd521cf-737b-4d7e-aaa8-dc79672ce2b8"
      unitRef="usd">17312000000</cvs:AdjustedOperatingIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9d8f78677d6943988b31d555638bbaf9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzctMS0xLTEtMjU2ODI_fa42cbf7-e13d-4a17-a15c-525057a5542f"
      unitRef="usd">1837000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzctMS0xLTEtMTk2MzU_d56c11d3-0a21-44b4-af77-652b2343061d"
      unitRef="usd">576000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2301583729e7424597c39ac7978d0401_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzctMy0xLTEtMTk2MzU_916de669-6c8c-4027-8e59-518a673b17b8"
      unitRef="usd">1884000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7f0540b87ed34aee812a4602f32b0fb6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzctNy0xLTEtMTk2MzU_aac5ac6c-f117-4b7a-aa06-e2e713f7d00a"
      unitRef="usd">215000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4344db6c31344de2b14b66847d6c28a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzctOS0xLTEtMTk2MzU_4cd11d06-af4c-4010-99f1-caec8ad01087"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzctMTEtMS0xLTE5NjM1_b64bfcbe-7153-4703-ac81-053e19ff2847"
      unitRef="usd">4512000000</us-gaap:DepreciationDepletionAndAmortization>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i53db5e5b0b444479a8a8759dbf521388_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzktMS0xLTEtMjU2ODI_c156ee7e-e4bb-47d3-8ad7-21f677338804"
      unitRef="usd">74926000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzktMS0xLTEtMTk2MzU_11fd5dea-5944-48bb-97bd-ed68d25511a7"
      unitRef="usd">132663000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia854c1c4120946f68b69cb19bc260e4b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzktMy0xLTEtMTk2MzU_7b767408-39da-4590-be3c-7d77b17d2f27"
      unitRef="usd">60208000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e61340f47284992812b376b1458946d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzktNy0xLTEtMTk2MzU_3f2b3dc5-4245-481b-bfa0-eb8774af8dc3"
      unitRef="usd">111000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzktMTEtMS0xLTE5NjM1_56e040ce-44a8-4ad0-93af-6430253422eb"
      unitRef="usd">267908000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5eab19a267b14681b658f1fd1f748401_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEwLTEtMS0xLTI1Njgy_5a963705-3bba-46f9-b0b8-010874f9f88a"
      unitRef="usd">58000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03972e1ca7ae40f3b269cf247834e557_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEwLTEtMS0xLTE5NjM1_4fde681e-d252-402c-8459-3600a8e71bb7"
      unitRef="usd">9275000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i326e08f13dd84d729af0ed31957c20b2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEwLTMtMS0xLTE5NjM1_94b493d9-015a-4c0f-b9f4-d257dd638843"
      unitRef="usd">30990000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iccc3d52c70ae4beeabf495e0d535c807_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEwLTktMS0xLTE5NjM1_c03c34d6-9ad8-4140-a24b-c7d7c6ea2cd1"
      unitRef="usd">-40323000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i53db5e5b0b444479a8a8759dbf521388_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzExLTEtMS0xLTI1Njgy_c54d4114-4d67-4e41-99cf-be3ff7805eef"
      unitRef="usd">483000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzExLTEtMS0xLTE5NjM1_d7648abe-98a0-4bee-941c-c0aae62c7f29"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ia854c1c4120946f68b69cb19bc260e4b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzExLTMtMS0xLTE5NjM1_18ac0791-adbf-4112-9d5b-14d15fee55c9"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i7e61340f47284992812b376b1458946d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzExLTctMS0xLTE5NjM1_a25aa740-51da-4271-8e0d-4af42f2b0348"
      unitRef="usd">315000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iccc3d52c70ae4beeabf495e0d535c807_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzExLTktMS0xLTE5NjM1_c16d4e37-b78a-499c-ad94-bfe77bb9c2a2"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzExLTExLTEtMS0xOTYzNQ_5c4d47e5-2781-4b50-81f4-cc59d2cbe833"
      unitRef="usd">798000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i53db5e5b0b444479a8a8759dbf521388_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEyLTEtMS0xLTI1Njgy_dd00c25c-f239-4e06-bd4d-c04ba93dbbf5"
      unitRef="usd">75467000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEyLTEtMS0xLTE5NjM1_1c3be91e-718b-4adb-a921-0e01e610afda"
      unitRef="usd">141938000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia854c1c4120946f68b69cb19bc260e4b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEyLTMtMS0xLTE5NjM1_cd45eb3c-2e1c-48ad-942c-2eaba156a8db"
      unitRef="usd">91198000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7e61340f47284992812b376b1458946d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEyLTctMS0xLTE5NjM1_d4610d07-8bcc-4d9e-8930-a8bf3d6d8155"
      unitRef="usd">426000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iccc3d52c70ae4beeabf495e0d535c807_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEyLTktMS0xLTE5NjM1_c14fdba1-9910-4c6b-bc9c-2f29da2fdb80"
      unitRef="usd">-40323000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEyLTExLTEtMS0xOTYzNQ_3ee84e57-1aa6-4a5e-91fa-93a3c200b5a9"
      unitRef="usd">268706000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i53db5e5b0b444479a8a8759dbf521388_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEzLTEtMS0xLTI1Njgy_7d31b04d-35fd-449c-a6b4-90659364eeb4"
      unitRef="usd">6188000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEzLTEtMS0xLTE5NjM1_4b35f394-7d77-4034-b2cf-c7d4d113ffe9"
      unitRef="usd">5688000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ia854c1c4120946f68b69cb19bc260e4b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEzLTMtMS0xLTE5NjM1_59acbeaf-dd9f-4f7b-b2fd-f0a4c21f3fc9"
      unitRef="usd">6146000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i7e61340f47284992812b376b1458946d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEzLTctMS0xLTE5NjM1_f4e67923-0212-49e9-870c-1f160473ed19"
      unitRef="usd">-1306000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iccc3d52c70ae4beeabf495e0d535c807_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEzLTktMS0xLTE5NjM1_711846b8-23ce-4fc3-a3ca-f46bbe7a33ba"
      unitRef="usd">-708000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzEzLTExLTEtMS0xOTYzNQ_739c5c76-ab06-4017-87bd-bd269d8aedab"
      unitRef="usd">16008000000</cvs:AdjustedOperatingIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i53db5e5b0b444479a8a8759dbf521388_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE0LTEtMS0xLTI1Njgy_94f6adb5-b22d-4ea2-8bd9-24d533c068e5"
      unitRef="usd">1832000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE0LTEtMS0xLTE5NjM1_a01c222c-660a-4291-a2c1-df6f98f0178a"
      unitRef="usd">612000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia854c1c4120946f68b69cb19bc260e4b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE0LTMtMS0xLTE5NjM1_61365730-fbbb-42d1-b23a-e24e62a79755"
      unitRef="usd">1801000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7e61340f47284992812b376b1458946d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE0LTctMS0xLTE5NjM1_7c86ee01-acaa-49eb-83b5-73aaba9ef456"
      unitRef="usd">196000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iccc3d52c70ae4beeabf495e0d535c807_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE0LTktMS0xLTE5NjM1_6e8b2bc4-81c2-44fe-9f9c-bdfdf924fcde"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE0LTExLTEtMS0xOTYzNQ_8b77882b-b357-46a3-8d1c-4a8b59880704"
      unitRef="usd">4441000000</us-gaap:DepreciationDepletionAndAmortization>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7683c6a5bd9a46859b7c36e87aefa23f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE2LTEtMS0xLTI1Njgy_dcb46a5f-e066-4863-8ba3-393f4ec2fa1b"
      unitRef="usd">68979000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE2LTEtMS0xLTE5NjM1_1f043516-e066-4fbe-9bac-e49e06d383eb"
      unitRef="usd">130428000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0059ff87fc364aec80f3c7eef6a97f6a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE2LTMtMS0xLTE5NjM1_0b658d39-b927-4420-95d3-1472de6df251"
      unitRef="usd">56258000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa96e65bf6294c0ca787cbef203ccb23_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE2LTctMS0xLTE5NjM1_78750d91-3054-4e31-baa6-b526f3abb462"
      unitRef="usd">100000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE2LTExLTEtMS0xOTYzNQ_26ef95e2-2d55-4db8-8abc-cfc84e254cef"
      unitRef="usd">255765000000</cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48f87e61e37e492f9c3f8051c3c9e4f5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE3LTEtMS0xLTI1Njgy_12464791-d241-439b-ac32-d04899615908"
      unitRef="usd">26000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icae6f1ee606a4353bd0cf7e6f048d3cc_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE3LTEtMS0xLTE5NjM1_14a6257a-e976-415f-9289-87da86451aea"
      unitRef="usd">11063000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i53edb1dedd7242ae84fe83beefc1c6ca_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE3LTMtMS0xLTE5NjM1_fe76b8ae-83b3-4e26-a830-2e61c525db2c"
      unitRef="usd">30350000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic17eebf2b4964519a5671bddafa2ecae_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE3LTktMS0xLTE5NjM1_46e37e39-931d-43aa-a89a-75a20113bc4e"
      unitRef="usd">-41439000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:NetInvestmentIncome
      contextRef="i7683c6a5bd9a46859b7c36e87aefa23f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE4LTEtMS0xLTI1Njgy_916b1714-8bd9-4c2e-b262-76aa5dd58cd4"
      unitRef="usd">599000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE4LTEtMS0xLTE5NjM1_197a7ddc-4171-426a-bda0-39823db00557"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="i0059ff87fc364aec80f3c7eef6a97f6a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE4LTMtMS0xLTE5NjM1_f5636e0f-1d7a-4ffa-a1bd-f38386d06e35"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="iaa96e65bf6294c0ca787cbef203ccb23_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE4LTctMS0xLTE5NjM1_1691061e-97bf-4bd6-9d69-a47454c2dd6f"
      unitRef="usd">412000000</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="ic17eebf2b4964519a5671bddafa2ecae_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE4LTktMS0xLTE5NjM1_ed65de10-a8fb-44ce-b1aa-87c416fdbabf"
      unitRef="usd">0</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE4LTExLTEtMS0xOTYzNQ_7862a8b1-67a0-4ad3-8928-63ead322c698"
      unitRef="usd">1011000000</us-gaap:NetInvestmentIncome>
    <us-gaap:Revenues
      contextRef="i7683c6a5bd9a46859b7c36e87aefa23f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE5LTEtMS0xLTI1Njgy_bcc889b7-3a2c-474b-ab7a-f9785a5c8cf8"
      unitRef="usd">69604000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE5LTEtMS0xLTE5NjM1_d6fc221a-79b3-48df-8e2a-780d65e0e2f7"
      unitRef="usd">141491000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0059ff87fc364aec80f3c7eef6a97f6a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE5LTMtMS0xLTE5NjM1_ebcc83a7-f33c-48ce-93bb-56547cf84b7e"
      unitRef="usd">86608000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaa96e65bf6294c0ca787cbef203ccb23_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE5LTctMS0xLTE5NjM1_3f12e3a8-3736-4bda-9c3b-0f5c50b3927f"
      unitRef="usd">512000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic17eebf2b4964519a5671bddafa2ecae_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE5LTktMS0xLTE5NjM1_f1ca6677-0126-475a-91ce-6f2c8c581dd1"
      unitRef="usd">-41439000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzE5LTExLTEtMS0xOTYzNQ_722ff73d-1d89-46cf-a891-b4572c7b9c00"
      unitRef="usd">256776000000</us-gaap:Revenues>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i7683c6a5bd9a46859b7c36e87aefa23f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIwLTEtMS0xLTI1Njgy_a225af20-f680-420a-9170-3dc104a63bc7"
      unitRef="usd">5202000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIwLTEtMS0xLTE5NjM1_eed9e406-cf5d-44dd-9d21-ebcec4371c6d"
      unitRef="usd">5129000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i0059ff87fc364aec80f3c7eef6a97f6a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIwLTMtMS0xLTE5NjM1_17e0e39d-a01a-42dc-b093-74c738006e67"
      unitRef="usd">6705000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="iaa96e65bf6294c0ca787cbef203ccb23_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIwLTctMS0xLTE5NjM1_b37c5497-f889-453b-b813-245fb1ccb494"
      unitRef="usd">-1000000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="ic17eebf2b4964519a5671bddafa2ecae_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIwLTktMS0xLTE5NjM1_cb795cb0-36b1-48a6-a4ab-03cc7f923043"
      unitRef="usd">-697000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIwLTExLTEtMS0xOTYzNQ_91fc1491-ea3c-4502-b851-01b6a706171e"
      unitRef="usd">15339000000</cvs:AdjustedOperatingIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7683c6a5bd9a46859b7c36e87aefa23f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIxLTEtMS0xLTI1Njgy_5a45b603-7a81-4ee2-9c52-00cf9e63b29f"
      unitRef="usd">1721000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIxLTEtMS0xLTE5NjM1_a6bf0f00-f31e-4b98-b6d8-8c4a0d433ef3"
      unitRef="usd">766000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i0059ff87fc364aec80f3c7eef6a97f6a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIxLTMtMS0xLTE5NjM1_01fb6e36-b03f-49d7-81b6-5951b1738847"
      unitRef="usd">1723000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iaa96e65bf6294c0ca787cbef203ccb23_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIxLTctMS0xLTE5NjM1_2ee0a1ab-8e1e-457e-b0e8-d429b38cc6a3"
      unitRef="usd">161000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic17eebf2b4964519a5671bddafa2ecae_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIxLTktMS0xLTE5NjM1_61fae447-1b4d-4c9d-ad7c-a4a41bf43284"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTo1MWE0ZWNkN2ZmMjQ0NmI1YWVkZGI5YjE4NDJkZTExZS90YWJsZXJhbmdlOjUxYTRlY2Q3ZmYyNDQ2YjVhZWRkYjliMTg0MmRlMTFlXzIxLTExLTEtMS0xOTYzNQ_61a26b9b-4b15-4296-a75d-ac12a19a3883"
      unitRef="usd">4371000000</us-gaap:DepreciationDepletionAndAmortization>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="i4a0c1652a0344342af1130f11f7cfc1c_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzI0NTg_69d68eac-8733-41a7-a926-bf84aedf6574"
      unitRef="usd">11600000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="id61e0a206f8b454396a80561bba41d8f_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzI0NjI_2c349245-b8e0-4b25-a0bc-6756c23694cf"
      unitRef="usd">10900000000</cvs:NetRevenuesRetailCoPayments>
    <cvs:NetRevenuesRetailCoPayments
      contextRef="id7a9899058b146b98d338385726b8c33_D20190101-20191231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzI0Njk_fde9a5f6-105e-449c-9279-b618c3b5b280"
      unitRef="usd">11500000000</cvs:NetRevenuesRetailCoPayments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzc2Mjk_e87ae3c3-2838-421d-815e-0ac88aa9db0e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of consolidated operating income to adjusted operating income for the years ended December&#160;31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;In&#160;millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income (GAAP measure)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition-related integration costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Store impairments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill impairment &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition purchase price adjustment outside of measurement period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Gain) loss on divestiture of subsidiary &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receipt of fully reserved ACA risk corridor receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(7)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;_____________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;The Company&#x2019;s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in the Company&#x2019;s GAAP consolidated statements of operations in operating expenses within each segment. Although intangible assets contribute to the Company&#x2019;s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company&#x2019;s insurance products, the services performed for the Company&#x2019;s customers or the sale of the Company&#x2019;s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company&#x2019;s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company&#x2019;s and investors&#x2019; ability to compare the Company&#x2019;s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company&#x2019;s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2021, 2020 and 2019, acquisition-related integration costs relate to the Aetna Acquisition. The acquisition-related integration costs are reflected in the Company&#x2019;s GAAP consolidated statements of operations in operating expenses within the Corporate/Other segment.  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;During the year ended December 31, 2021, the store impairment charge relates to the write down of operating lease right-of-use assets and property and equipment in connection with the planned closure of approximately 900 retail stores between 2022 and 2024. During the year ended December 31, 2019, the store impairment charges related to the write down of operating lease right-of-use assets in connection with the planned closure of 68 underperforming retail pharmacy stores in 2019 and 2020. The store impairment charges are reflected in the Company&#x2019;s GAAP consolidated statements of operations within the Retail/LTC segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;During the year ended December 31, 2021, the goodwill impairment charge relates to the LTC reporting unit within the Retail/LTC segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In June 2021, the Company received $61&#160;million related to a purchase price working capital adjustment for an acquisition completed during the first quarter of 2020. The resolution of this matter occurred subsequent to the acquisition accounting measurement period and is reflected in the Company&#x2019;s GAAP consolidated statement of operations for the year ended December 31, 2021 as a reduction of operating expenses within the Health Care Benefits segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(6)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2020, the gain on divestiture of subsidiary represents the pre-tax gain on the sale of the Workers&#x2019; Compensation business, which the Company sold on July 31, 2020 for approximately $850&#160;million. The gain on divestiture is reflected as a reduction of operating expenses in the Company&#x2019;s GAAP consolidated statement of operations within the Health Care Benefits segment. In 2019, the loss on divestiture of subsidiary represents the pre-tax loss on the sale of Onofre, which occurred on July 1, 2019. The loss on divestiture primarily relates to the elimination of the cumulative translation adjustment from accumulated other comprehensive income and is reflected in the Company&#x2019;s GAAP consolidated statement of operations in operating expenses within the Retail/LTC segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:13.5pt;text-indent:-11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(7)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt"&gt;In 2020, the Company received $313&#160;million owed to it under the ACA&#x2019;s risk corridor program that was previously fully reserved for as payment was uncertain. After considering offsetting items such as the ACA&#x2019;s minimum MLR rebate requirements and premium taxes, the Company recognized pre-tax income of $307&#160;million in the Company&#x2019;s GAAP consolidated statement of operations within the Health Care Benefits segment.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzEtMS0xLTEtMTk2MzU_91e0a4cd-4a0c-476c-8fe7-d24684e548fc"
      unitRef="usd">13193000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzEtMy0xLTEtMTk2MzU_d4d2ae5d-7345-4393-88f4-e660572caa9d"
      unitRef="usd">13911000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzEtNS0xLTEtMTk2MzU_1cec23cf-0dcd-44a6-862c-259b9ef0f3b0"
      unitRef="usd">11987000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzItMS0xLTEtMTk2MzU_0cdc7da2-0199-41bd-bf7a-bdcad10e4140"
      unitRef="usd">2259000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzItMy0xLTEtMTk2MzU_fcc74278-d4c0-49e0-a000-78d55e30b5d4"
      unitRef="usd">2341000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzItNS0xLTEtMTk2MzU_7bd76e82-2b63-49e4-bd24-20c4dd72b561"
      unitRef="usd">2436000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzMtMS0xLTEtMTk2MzU_ff000350-b9c0-4432-9226-e8b6f9afcb94"
      unitRef="usd">132000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzMtMy0xLTEtMTk2MzU_85089311-2125-402a-9405-84be4411dfcc"
      unitRef="usd">332000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzMtNS0xLTEtMTk2MzU_5cda08f6-f0f8-49d4-b991-a065210d1312"
      unitRef="usd">480000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <cvs:StoreImpairmentCharges
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtMS0xLTEtNDM0Njk_8bff20cc-6cd6-4b10-b128-40a616ad4ae2"
      unitRef="usd">1358000000</cvs:StoreImpairmentCharges>
    <cvs:StoreImpairmentCharges
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtMy0xLTEtNDM0Njk_70115544-d440-4ea9-8313-f97bd5a5a432"
      unitRef="usd">0</cvs:StoreImpairmentCharges>
    <cvs:StoreImpairmentCharges
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtNS0xLTEtNDM0Njk_011b5419-8d51-4394-b864-064aa740ff77"
      unitRef="usd">231000000</cvs:StoreImpairmentCharges>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtMS0xLTEtMzAxNTA_42406a52-dc1a-4408-b15c-b9be2db21719"
      unitRef="usd">431000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtMy0xLTEtMzAxNTM_b6e65f0f-3b2d-48b7-b7d8-056e7b9067b0"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtNS0xLTEtMzAxNTY_efbbbf8b-3ec4-4dc9-87bb-d577672f3e2e"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzUtMS0xLTEtMzE2MTE_40c00cce-eafa-4dda-9377-4a55e77e712a"
      unitRef="usd">-61000000</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzUtMy0xLTEtMzE2Mzk_244b30d8-19e8-46a8-9885-7583f93e51b4"
      unitRef="usd">0</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzUtNS0xLTEtMzE2NTc_c07d1af3-d3c2-4c37-96f7-91601d80a19e"
      unitRef="usd">0</cvs:BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtMS0xLTEtMTk2MzU_84a5d76c-daeb-4994-9c8b-390fec963b1f"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtMy0xLTEtMTk2MzU_516ee691-0304-40a1-a5f7-b4b3f39515e3"
      unitRef="usd">269000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzQtNS0xLTEtMTk2MzU_da76e5a4-735b-4c24-8378-9173e6004e76"
      unitRef="usd">-205000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzUtMS0xLTEtMTk2MzU_ad2f8415-2590-460f-a5bf-1d68b9c7e1c7"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzUtMy0xLTEtMTk2MzU_3e065e01-1c41-4fc8-8340-700a357af023"
      unitRef="usd">307000000</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzUtNS0xLTEtMTk2MzU_65d335d2-19ac-49da-8aec-e2684695750d"
      unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzEwLTEtMS0xLTE5NjM1_d760a1bd-890f-4ebd-9c20-d833251e6118"
      unitRef="usd">17312000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="i7c0970400e154d55993f70f521cd55da_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzEwLTMtMS0xLTE5NjM1_739c5c76-ab06-4017-87bd-bd269d8aedab"
      unitRef="usd">16008000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:AdjustedOperatingIncomeLoss
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90YWJsZTpjY2Y4MTkwNTBhYjA0MzAwYTlkZTFjMmYxM2RiZjBkZi90YWJsZXJhbmdlOmNjZjgxOTA1MGFiMDQzMDBhOWRlMWMyZjEzZGJmMGRmXzEwLTUtMS0xLTE5NjM1_91fc1491-ea3c-4502-b851-01b6a706171e"
      unitRef="usd">15339000000</cvs:AdjustedOperatingIncomeLoss>
    <cvs:NumberOfStoresPlannedClosure
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzE2NDkyNjc0NjgyMjE_e365fcb5-15b2-49f6-89b5-ca9c36ebf6b3"
      unitRef="store">900</cvs:NumberOfStoresPlannedClosure>
    <cvs:NumberOfStoresPlannedClosure
      contextRef="if8acfbff9a8442c8a91bb4891476e3e9_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzE2NDkyNjc0NjgyMjc_05bb6628-18cf-47ba-8e9c-2fbfc8639069"
      unitRef="store">68</cvs:NumberOfStoresPlannedClosure>
    <cvs:ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod
      contextRef="i869e87b37b534c77b68def0dd025f28b_D20210601-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzEwOTk1MTE2NTQzNTE_398b6915-efff-4d7a-9073-cbb0346b0b80"
      unitRef="usd">61000000</cvs:ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i707e6377bc8f46819c6e330be95da61e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzEwOTk1MTE2NTQzNjY_477cdf0a-10c5-4a66-9325-bdc551ce9049"
      unitRef="usd">850000000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:GainContingencyUnrecordedAmount
      contextRef="i55877e993992468ea1377ad4577db051_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzEwOTk1MTE2NTQzODI_fd128ea6-178a-4e5a-8a0c-830a9fcdcd82"
      unitRef="usd">313000000</us-gaap:GainContingencyUnrecordedAmount>
    <cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax
      contextRef="i55877e993992468ea1377ad4577db051_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODEvZnJhZzpkZDQyNzBkYWQ2ZTM0NDZhODVlZjI3NzgxNmMwODFjZS90ZXh0cmVnaW9uOmRkNDI3MGRhZDZlMzQ0NmE4NWVmMjc3ODE2YzA4MWNlXzEwOTk1MTE2NTQzOTc_4258e0ce-c133-4615-b3db-bd26f58e6102"
      unitRef="usd">307000000</cvs:FormerGainContingencyRecognizedInCurrentPeriodBeforeTax>
    <dei:AuditorName
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODQvZnJhZzo2ZDRmNDUxOTQ3NTc0ZmViYTVhMTlhNzU4YTAwOTIyNy90ZXh0cmVnaW9uOjZkNGY0NTE5NDc1NzRmZWJhNWExOWE3NThhMDA5MjI3XzMyOTg1MzQ4ODcyMDc_ec8b0da6-7ee7-4cf1-ab65-3934ee7e9166">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xODQvZnJhZzo2ZDRmNDUxOTQ3NTc0ZmViYTVhMTlhNzU4YTAwOTIyNy90ZXh0cmVnaW9uOjZkNGY0NTE5NDc1NzRmZWJhNWExOWE3NThhMDA5MjI3XzMyOTg1MzQ4ODcyMDk_933f6590-458b-4891-afe4-32f90de8dbf2">Boston, Massachusetts</dei:AuditorLocation>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtNC0xLTEtMTk2MzU_056fb5fc-124d-4929-b5de-d982249e8938"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtNC0xLTEtMTk2MzU_056fb5fc-124d-4929-b5de-d982249e8938"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTQtMS0xLTE5NjM1_c22f687b-bcc8-4d02-b351-d409fc63a5da"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTQtMS0xLTE5NjM1_c22f687b-bcc8-4d02-b351-d409fc63a5da"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE4LTQtMS0xLTE5NjM1_894b75b1-c20f-4e61-b105-8dbd70b2299b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE4LTQtMS0xLTE5NjM1_894b75b1-c20f-4e61-b105-8dbd70b2299b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTQtMS0xLTE5NjM1_97c21c66-2d45-4ea3-968e-8464fda4be09"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTQtMS0xLTE5NjM1_97c21c66-2d45-4ea3-968e-8464fda4be09"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI3LTQtMS0xLTE5NjM1_2ac0022b-9661-459b-8995-856a8677ed8a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI3LTQtMS0xLTE5NjM1_2ac0022b-9661-459b-8995-856a8677ed8a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTQtMS0xLTE5NjM1_bbdfedd3-ce88-4726-99fa-8969a6b266a6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTQtMS0xLTE5NjM1_bbdfedd3-ce88-4726-99fa-8969a6b266a6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtNC0xLTEtMTk2MzU_03d25cee-62ac-4b19-83d5-83527c502af5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtNC0xLTEtMTk2MzU_03d25cee-62ac-4b19-83d5-83527c502af5"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjQ_cc82e256-da53-42d6-8a53-0ccced714fe0" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjQ_cc82e256-da53-42d6-8a53-0ccced714fe0" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Common stock and capital surplus includes the par value of common stock of $17 million as of December 31, 2021, 2020 and 2019.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtNC0xLTEtMTk2MzU_056fb5fc-124d-4929-b5de-d982249e8938"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjQ_cc82e256-da53-42d6-8a53-0ccced714fe0"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTQtMS0xLTE5NjM1_c22f687b-bcc8-4d02-b351-d409fc63a5da"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjQ_cc82e256-da53-42d6-8a53-0ccced714fe0"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE4LTQtMS0xLTE5NjM1_894b75b1-c20f-4e61-b105-8dbd70b2299b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjQ_cc82e256-da53-42d6-8a53-0ccced714fe0"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTQtMS0xLTE5NjM1_97c21c66-2d45-4ea3-968e-8464fda4be09"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjQ_cc82e256-da53-42d6-8a53-0ccced714fe0"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI3LTQtMS0xLTE5NjM1_2ac0022b-9661-459b-8995-856a8677ed8a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjQ_cc82e256-da53-42d6-8a53-0ccced714fe0"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTQtMS0xLTE5NjM1_bbdfedd3-ce88-4726-99fa-8969a6b266a6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjQ_cc82e256-da53-42d6-8a53-0ccced714fe0"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtNC0xLTEtMTk2MzU_03d25cee-62ac-4b19-83d5-83527c502af5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjQ_cc82e256-da53-42d6-8a53-0ccced714fe0"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTEwLTEtMS0xOTYzNQ_012f1e61-d950-4e7d-9219-63301f2cfd55"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTEwLTEtMS0xOTYzNQ_012f1e61-d950-4e7d-9219-63301f2cfd55"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTgtMS0xLTE5NjM1_3e80ea5b-0225-4195-b65a-cd326b24be66"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTgtMS0xLTE5NjM1_3e80ea5b-0225-4195-b65a-cd326b24be66"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTYtMS0xLTE5NjM1_0d72284e-6ae8-4fab-975d-68db230b7230"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTYtMS0xLTE5NjM1_0d72284e-6ae8-4fab-975d-68db230b7230"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NDM_62e832f8-7207-4461-9589-4a17539d4b88" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NDM_62e832f8-7207-4461-9589-4a17539d4b88" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of <xhtml:span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NjQ_6d63f6c0-91a9-453b-838f-78265109358a">ASU 2016-13</xhtml:span>, </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Topic 326), which resulted in a reduction to retained earnings of $3&#160;million during the year ended December 31, 2020.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTEwLTEtMS0xOTYzNQ_012f1e61-d950-4e7d-9219-63301f2cfd55"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NDM_62e832f8-7207-4461-9589-4a17539d4b88"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTgtMS0xLTE5NjM1_3e80ea5b-0225-4195-b65a-cd326b24be66"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NDM_62e832f8-7207-4461-9589-4a17539d4b88"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE0LTYtMS0xLTE5NjM1_0d72284e-6ae8-4fab-975d-68db230b7230"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NDM_62e832f8-7207-4461-9589-4a17539d4b88"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTItMS0xLTE5NjM1_97bbe756-c530-44c3-bf07-3dcd93863f56"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTItMS0xLTE5NjM1_97bbe756-c530-44c3-bf07-3dcd93863f56"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTItMS0xLTE5NjM1_64feac16-0132-4d16-bed6-5f25ece31268"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTItMS0xLTE5NjM1_64feac16-0132-4d16-bed6-5f25ece31268"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTItMS0xLTE5NjM1_1c356d2b-3495-4a7b-9749-f110807b49c6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTItMS0xLTE5NjM1_1c356d2b-3495-4a7b-9749-f110807b49c6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE5LTUtMS0xLTE5NjM1_b10aa279-9966-4bd0-bcf8-71cf5a78c8cc"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE5LTUtMS0xLTE5NjM1_b10aa279-9966-4bd0-bcf8-71cf5a78c8cc"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtNS0xLTEtMTk2MzU_f8dcefcc-b66e-42ce-a3d6-883dd1c703f9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtNS0xLTEtMTk2MzU_f8dcefcc-b66e-42ce-a3d6-883dd1c703f9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTUtMS0xLTE5NjM1_6e5e1472-d133-4873-995b-e0e350248ee0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTUtMS0xLTE5NjM1_6e5e1472-d133-4873-995b-e0e350248ee0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzktNS0xLTEtMTk2MzU_726be931-cfc8-48b9-9d92-a974cab2539e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzktNS0xLTEtMTk2MzU_726be931-cfc8-48b9-9d92-a974cab2539e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtMi0xLTEtMTk2MzU_5a2af167-1a8c-4cd3-92d3-86f595f11839"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtMi0xLTEtMTk2MzU_5a2af167-1a8c-4cd3-92d3-86f595f11839"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzktMi0xLTEtMTk2MzU_8d9b2c4a-a066-410c-b98f-35ad52f2251c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzktMi0xLTEtMTk2MzU_8d9b2c4a-a066-410c-b98f-35ad52f2251c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTUtMS0xLTE5NjM1_b17f1bab-ba67-4dd0-965f-3feec675cba8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTUtMS0xLTE5NjM1_b17f1bab-ba67-4dd0-965f-3feec675cba8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE5LTItMS0xLTE5NjM1_d4eb5856-eaa6-4799-9256-144e4a9519d9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE5LTItMS0xLTE5NjM1_d4eb5856-eaa6-4799-9256-144e4a9519d9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTUtMS0xLTE5NjM1_513ca101-da7d-4884-9350-f18e2e7d65ed"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTUtMS0xLTE5NjM1_513ca101-da7d-4884-9350-f18e2e7d65ed"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI4LTItMS0xLTE5NjM1_c99be6d6-9e00-435a-b19e-b4a88922d547"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI4LTItMS0xLTE5NjM1_c99be6d6-9e00-435a-b19e-b4a88922d547"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI4LTUtMS0xLTE5NjM1_f55a21f2-2a69-40c6-a897-99c2f68660c1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI4LTUtMS0xLTE5NjM1_f55a21f2-2a69-40c6-a897-99c2f68660c1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtMi0xLTEtMTk2MzU_38a4f088-ebc0-42d5-9452-dcc4dc666000"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtMi0xLTEtMTk2MzU_38a4f088-ebc0-42d5-9452-dcc4dc666000"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Treasury shares include 1 million shares held in trust for each of the years ended December 31, 2021, 2020 and 2019. Treasury stock includes $29 million related to shares held in trust for each of the years ended December 31, 2021, 2020 and 2019. See Note 1 &#x2018;&#x2018;Significant Accounting Policies&#x2019;&#x2019; for additional information.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTItMS0xLTE5NjM1_97bbe756-c530-44c3-bf07-3dcd93863f56"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTItMS0xLTE5NjM1_64feac16-0132-4d16-bed6-5f25ece31268"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTItMS0xLTE5NjM1_1c356d2b-3495-4a7b-9749-f110807b49c6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE5LTUtMS0xLTE5NjM1_b10aa279-9966-4bd0-bcf8-71cf5a78c8cc"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtNS0xLTEtMTk2MzU_f8dcefcc-b66e-42ce-a3d6-883dd1c703f9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzIzLTUtMS0xLTE5NjM1_6e5e1472-d133-4873-995b-e0e350248ee0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzktNS0xLTEtMTk2MzU_726be931-cfc8-48b9-9d92-a974cab2539e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMtMi0xLTEtMTk2MzU_5a2af167-1a8c-4cd3-92d3-86f595f11839"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzktMi0xLTEtMTk2MzU_8d9b2c4a-a066-410c-b98f-35ad52f2251c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzMxLTUtMS0xLTE5NjM1_b17f1bab-ba67-4dd0-965f-3feec675cba8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzE5LTItMS0xLTE5NjM1_d4eb5856-eaa6-4799-9256-144e4a9519d9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzEzLTUtMS0xLTE5NjM1_513ca101-da7d-4884-9350-f18e2e7d65ed"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI4LTItMS0xLTE5NjM1_c99be6d6-9e00-435a-b19e-b4a88922d547"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzI4LTUtMS0xLTE5NjM1_f55a21f2-2a69-40c6-a897-99c2f68660c1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzgtMi0xLTEtMTk2MzU_38a4f088-ebc0-42d5-9452-dcc4dc666000"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEyMjI_e187c13a-c75a-41c7-aeeb-7a13a153bdc7"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEwOTk1MTE2Mjk5MDk_1e2731a0-00e0-482d-b011-76cfe76e7e7c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEwOTk1MTE2Mjk5MDk_1e2731a0-00e0-482d-b011-76cfe76e7e7c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtNi0xLTEtMTk2MzU_1e2731a0-00e0-482d-b011-76cfe76e7e7c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtNi0xLTEtMTk2MzU_1e2731a0-00e0-482d-b011-76cfe76e7e7c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtMTAtMS0xLTE5NjM1_4cea8a88-2053-457a-81cf-9f156ab4de60"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtMTAtMS0xLTE5NjM1_4cea8a88-2053-457a-81cf-9f156ab4de60"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtOC0xLTEtMTk2MzU_27e8ee4a-bc07-4563-9ed8-b0e3e9b0302d"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtOC0xLTEtMTk2MzU_27e8ee4a-bc07-4563-9ed8-b0e3e9b0302d"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU0Njg_97cc772a-a9cc-45ab-acfe-b04e7678cb48" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU0Njg_97cc772a-a9cc-45ab-acfe-b04e7678cb48" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:1.93pt">Reflects the adoption of <xhtml:span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU3NjM_bdbd7ade-1f47-46a7-92fa-bfb084c43320">Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-02</xhtml:span>, </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Leases</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Topic 842), which resulted in an increase to retained earnings of $178 million during the year ended December 31, 2019.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzEwOTk1MTE2Mjk5MDk_1e2731a0-00e0-482d-b011-76cfe76e7e7c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU0Njg_97cc772a-a9cc-45ab-acfe-b04e7678cb48"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtNi0xLTEtMTk2MzU_1e2731a0-00e0-482d-b011-76cfe76e7e7c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU0Njg_97cc772a-a9cc-45ab-acfe-b04e7678cb48"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtMTAtMS0xLTE5NjM1_4cea8a88-2053-457a-81cf-9f156ab4de60"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU0Njg_97cc772a-a9cc-45ab-acfe-b04e7678cb48"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90YWJsZTpmZDU3ZmEyY2NiM2M0ODU5YTcwNzZkNzUwNjFiNzJlMC90YWJsZXJhbmdlOmZkNTdmYTJjY2IzYzQ4NTlhNzA3NmQ3NTA2MWI3MmUwXzQtOC0xLTEtMTk2MzU_27e8ee4a-bc07-4563-9ed8-b0e3e9b0302d"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmJhYjlmYjcxZDY3NjQ4ZjBiNzU4ODY5ZjE2MGI3ZjRiL3NlYzpiYWI5ZmI3MWQ2NzY0OGYwYjc1ODg2OWYxNjBiN2Y0Yl8xMjEvZnJhZzo4NDgzZjdiZTIwZjM0ODEwYTkwYTE4YTc3M2Y1ZTNkMS90ZXh0cmVnaW9uOjg0ODNmN2JlMjBmMzQ4MTBhOTBhMThhNzczZjVlM2QxXzMyOTg1MzQ4ODU0Njg_97cc772a-a9cc-45ab-acfe-b04e7678cb48"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>138
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( *PT250'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "L-$E4M9)'P.X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M2L0P$(=?17)OIVE!,71S43PI""XHWD(RNQML_I",M/OVIG6WB^@#"+EDYI=O
MOH'T.@H=$CZG$#&1Q7PUN<%GH>.&'8BB ,CZ@$[ENB1\:>Y"<HK*->TA*OVA
M]@AMTUR#0U)&D8(96,65R&1OM- )%85TPAN]XN-G&A:8T8 #.O24@=<<F)PG
MQN,T]' !S##"Y/)W <U*7*I_8I<.L%-RRG9-C>-8C]V2*SMP>'MZ?%G6K:S/
MI+S&\BI;0<>(&W:>_-K=W6\?F&R;MJV:<FZWG(ON1C3\?7;]X7<1=L'8G?W'
MQF=!V<.O?R&_ %!+ P04    " "L-$E4F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M *PT250%[$&?RP8  'P:   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MI5EM;^(X$/Y\]RLL;G5JI5(2!RC=;2NQT-YRVVT1=+OJG>Z#24RQFL2<[93R
M[V]L F&K,(ET_5#RXGG\>,9^QIY<K*1ZT0O.#7E+XE1?-A;&+#^V6CI<\(3I
M4[GD*;R92Y4P [?JN:67BK/(&25QBWI>MY4PD3:N+MRSL;JZD)F)1<K'BN@L
M29A:?^:Q7%TV_,;VP40\+XQ]T+JZ6+)G/N7F^W*LX*ZU0XE$PE,M9$H4GU\V
M^O['87!F#5R+1\%7>N^:V*',I'RQ-Z/HLN%91CSFH;$0#'Y>^8#'L44"'O_F
MH(U=G]9P_WJ+?N,&#X.9,<T',OXA(K.X;/0:).)SEL5F(E=?>#Z@CL4+9:S=
M?[+:M&VW&R3,M)%);@P,$I%N?ME;[H@]@YYWP(#F!O2=@7^HAR W"-X;G!TP
M:.<&;>>9S5"<'X;,L*L+)5=$V=: 9B^<,YTU#%^D-NY3H^"M #MS-9"O7)$Q
MA)@TR??ID!Q].+YH&4"V[UMACO)Y@T(/H/B4?).I66ARG48\^AF@!91VO.B6
MUV>*(@YY>$H"_X10C_HEA :X^0V?G1*/.G-:8C[$S?_,4NC=*^O]I]$$.R\'
M#B] O?QW?Z:-@IG^#P+9WD&V'63[D(-DF,'Z,^1AO>1E$</-?:_Y%6'1V;'H
MU&/13].,Q63"EU*9,CHXCE$91^AT=W2Z]>B,N1(RLK.1P+(H]4\%4C[_?OWE
MEXHY<+;C=H8B#C*E++4;H4/PU!-G"N6'HS6;/FT&&*_>CE>OYD12#.3<J?'A
M,.)8<Q9K+([G.T[G*,YU:H19@ZMB3NZR9,95&1<<P_/\IN=[/N8CWRMDTJO#
M:,*?A5W#X*X[EI3&K0)H\#@E7Z[[MP]?R.!^,KZ?]!]&]W<8QSTI]^MP'*6A
M5! _9D-Y0J8&)AB1B@QDEAJUAM^HG#B./KS&2-*")*U#\H&]D5$$TT[,1>B8
M(H&N@/0Z3:]]WO;:'L:PT&H_J,.P'T6*:WVRO2"WT([<I^6^PR'!BMC #Q5L
M<DXPEH7\^[B OV<YL'<0Y0>Y2DL9XG _I$RU#%^X0>D5><''!?T]O=TL'"OY
M*M*PW(LXYF2$42MRA(]+^WMJ8ZD-"/)?8GEX:>"('NV==S!N18[P*Y*$8P8;
M^,-4<("CMN<?8U2*M.#C6GXK;9H:+V2*:7 %R%FWT_0['KHPBZ3@XXK^( SD
M SDG/CV:'9,I#S,%_BJEA2,-9)* XDP-S/@3LH1,_,KBC),/WJGGDR7LU?2"
M*2R3T2)S4%SP(:U&(GTFTW4RDW$9V0H $ Z,2)$>*"[@6W^1Z[=PP5+8\1]*
M815 =T]3+!?0(A?06KG@!YSZFB\I"!?$E&F8<!$9:9V5S[@*S">N,6Y%%J"U
MLL"CC"%KPHG8;4:4+F6$(]U)C% A^+26X&^WD9LMFIM8(*U9.3$<L<)5A=;3
M6EH_2@U7FW.\W=2R+=529CAB!;-"ZFDMJ7>A(P/(0,]2E>I%!<XM4[!<^F'(
M 0A@H@TDQK&0?(HK=LYQFK X)I\S#:]U>31QG*J]-RV4G^*BG3.Z3KAZMA/L
M#T P"\A(R9*EY>[[?\<"6J0 B@OW:' S(?TL$@:V$GUC.*1NMWF\B=ES*3,<
MK^+<&10J']0Z'TP7H&68IRI@JCP5%&H?U#H,C+-9+$)PCV1E"W&8HW0<BBT2
MOE[YWGFWXP=!F_9@4_-:QJ)0^*"6PO^<;Z<VMVIRGQF(7FJ38UF!)T?N[C,+
M?-KQO3;M'N"U5X_!-7E[Z-5[IR58U3-[PIMS4*WR#6H%ZL."D[F,8[FRRR8!
M2"4@H 2&2\2[?M2V'WAC)#$+H8FM9!);F?D(M#8U73NW0PD92-BL*%)HR&U=
M4Z3"">U2R;<UL:N NT/\W![T[!&3L]BMV=U)\/??>M0_^Z1=26Q;K_G&N<LA
ML*ERP5G(.((L=T* T@P& RH7D94 )-MOOH,0$#R(6[&/L.$5VI6";5M@Z5./
M1&P-[>;@!&?,P0*ZL9?S30ED;4L@W!8,R9"'W&XQ=R4_<F0;6L[4^S1V@YQN
M!^F>^I^.3PCX#/,K&3-E0SP:.;ZC1^(\#5S>C'56Q'6HQ P,X:'B(CW%EEZ1
MJ8-ZF1JZ4##,$8SPC7SEY7J 0WGVK]ON>0'&K,C40<URW7X1Z@8>EB:<"K"J
MVFB1I8.:5;N<55Z\.\P+A[MYPE@5>3G \VD?*$4;6@=R2P7 02UO[97K;8YU
MGSTT+'/8:6XJ][NGNT\K??=!H54TWWR7^<9LBM8DYG,P]4[/(&1J\ZEC<V/D
MTA7_9](8F;C+!6>PQFT#>#^7TFQO; >[#TY7_P%02P,$%     @ K#1)5%=%
MUZHB @  <@4  !@   !X;"]W;W)K<VAE971S+W-H965T,BYX;6R-5$UOVS ,
M_2N"#SL5<:)\;.@< TG38@&2(6BQ#<.P@V(SME!+\B1Z;O_])-GQ/"#Q>K%$
MB>_QD3(9U4H_FQP R8LHI%D&.6)Y&X8FR4$P,U(E2'MS4EHPM*;.0E-J8*D'
MB2*DX_$B%(S+(([\V4''D:JPX!(.FIA*"*9?UU"H>AE,@O/!(\]R= =A')4L
M@R? +^5!6ROL6%(N0!JN)-%P6@:KR>UZX?R]PU<.M>GMB<ODJ-2S,[;I,A@[
M05! @HZ!V>4WW$%1."(KXU?+&70A';"_/[,_^-QM+D=FX$X5WWB*^3+X$) 4
M3JPJ\%'5GZ#-9^[X$E48_R5UXSNU$9/*H!(MV-J"RV9E+VT=>@!*KP!H"Z!>
M=Q/(J]PP9'&D54VT\[9L;N-3]6@KCDOW*$^H[2VW.(Q75<J1;&7SO+9.48B6
MUEV&24NQ;BCH%8H))7LE,3?D7J:0_DL06CV=*'H6M::#C!M(1F0ZN2%T3"<#
M?-,NR:GGFPXEJ70_3?)C=32H[4_Q<R# K LP\P%F_PGPF0FX5,!A]+V6!LD[
M)LJ/Y+NJ9$9VN\. JGFG:OXF53N57'W:88:ULC^@O"%[9@Q+\LH HAE0MNB4
M+=ZD[(%K0;:;2\*&"6;TDHJPUP<"=.:[W9#$UA2;ENA.NX&R:OKHKWLSC?9,
M9UP:4L#)0L>C][90NNGPQD!5^JXZ*K0]ZK>Y'8J@G8.]/RF%9\,%Z,9L_ =0
M2P,$%     @ K#1)5($_8[9-!P  [2,  !@   !X;"]W;W)K<VAE971S+W-H
M965T,RYX;6R]6M]SFS@0_E<TGGMH9YH82?S,))EI3.^:F?8NDUS;AYM[($:.
MF0+R@>RD__U)0)!!B^RTG>8A-OC;1=^NM/L).'_DU==ZS9A 3T5>UA>SM1";
ML_F\7JY9D=2G?,-*^<N*5T4BY&'U,*\W%4O2QJC(Y\1Q_'F19.7L\KPY=U-=
MGO.MR+.2W52HWA9%4GV[8CE_O)CAV?.)V^QA+=2)^>7Y)GE@=TQ\VMQ4\FC>
M>TFS@I5UQDM4L=7%["T^BUVB#!K$YXP]UGO?D:)RS_E7=7"=7LP<-2*6LZ50
M+A+YL6,+EN?*DQS'?YW367]-9;C__=G[[PUY2>8^J=F"YU^R5*PO9N$,I6R5
M;'-QRQ_?LXZ0I_PM>5XW_]%CAW5F:+FM!2\Z8SF"(BO;S^2I"\2> 0XF#$AG
M0(XUH)T!/=; [0S<)C(ME28.<2*2R_.*/Z)*H:4W]:4)9F,MZ6>ERON=J.2O
MF;03EPM>UCS/TD2P%-T)^2&3*FK$5^BO#:L2E9P:G:!/=S%Z]=MK5*^3BM4H
M*]''+,_5C^=S(<>AO,V7W36OVFN2B6MB@C[R4JQK]*Y,63IT,)<$>A;DF<45
ML7J,V?(44?P&$8=@8$"+X\T=P#P^VAQ'%C:TSPEM_-$)?[=LQ\HMJ\\LOMS>
ME]OX<B=\W52LR+8%F*76TFLL57W8708^IK)BJ+_S^6X_@";6CZCO0M@8P%),
MQGX'=+R>CF>E\Z>LA%FY8[50TU1^7?*"0=Q:-_[>&#".(I":"0VB$"0&.'4P
MMO'R>UZ^E=??7"2YK*-MXB%"OG%M$A%L7+VE!(#],'!\D!4 ]OP@&(,'O(*>
M5V"=RET-*1_0DM?".J/#WF5H#=5".E+E:5/Q=+N4I4K6KQ2*6&AF*_!"AX(1
M \ ^C4(PO#$ ]L( CZ?7@%[4TXNL]*Y8R5:9:.,%T8J,B_LNZ9(U9F5B/9E:
M<!G$ )9XQ,H).[K+.%96=X)7#&7%)LFJIL& 7<,QXTH]<"DN .R8$  AU+I:
M\5[7Q%8^?W">/LH&N$<)9(2-(;C&$#I")M0@9(,,B1!-A%B)Z 7*GJ26K.'B
MTSG9OS*5Y02L)PL([,E$@K,. M/G$$VQTXT4TR/**A\6(9 @->=*$$9X8O(!
M:,\-H@F* -IUI7<K1]W@L;W#ZPQ.=\/.Q7!EX0@NA2 X@CM-#(%Q)'N-C9ON
M]MC>[J]+P:3<%,^3$^1F=F7B351Y"!LYX\%VS$PL=8Q9/"2FVSVV]_L/O)8:
MNT0LJ?)ODIW*WS:KUXVJD<TM9?=P03&;M>O!B@V 8M<%^T0,8(TN,62J!0 .
M[--3K%EEFYJ!<>D3'$Y0 K!D0M6 ?LE8L Y):0F"[1KDNJ&#[MFJ:6OMD4B>
ME"C996I/#%(%=(/C$KAU ^ H"";29V+#*+*O0:U'L%V07!_+SA004C],)!+"
M^K N@;#4:#W#;:/6)<2N2SIRJXH7LCF4<AEN527E_=878DI,82&K.=PJ(*S<
M)H), :SOVQ4+T8J%V!5+4W$:GFE6=U3EEE\S?8-*UM0>F6F0]4&!L@ @)W!2
MK<Z&#+64(78IT^X-I^H,,87&=-( +([ J1P#V(-)T_J%V/6+HO2JY?0:Y2J#
MB1!5=K\5R7TNUR1')2]5,BN>YZT$:!LF/&]-(8+A]0D@3S#84F, .@8.R6MA
M0^S"1N?38+WX?(?>LR07:Y G<&,C,B1EQQ3 XHD=$H"5J;:V%**E#O&L.^6K
MI,Z62@^4,H\UDLNRO==FVS(3K3>(76\<K'.6$*L9B%(YP9)J;UROP<C[9H3&
M 6\AP?X^\]2-QJ&&4'@BQEJ+$+L6.5@#?U(43.EA3+L6$NXO,.?4P>,PV#P-
M@Z"U"[%KEZ.6U4O8AH=S'D(Y#\=D(=14SK5\(7;Y\J6Y\R^SG.QDEA^8>DH@
M%UIW'YMO12V2,E6+05%N3\,\31VB]E!CJA#*,:8WB)K@2K6:H8ZUAL19OE54
M7U9%J-80U*XA?E$5Z48QG B1-XHTB'*#4:1!E!-.1%IK#6K7&K^HDE!37(PK
M20<Y5$FLGH9!V'M,<5B=_,Q*TEWN4-XAE.N/^4*HR;QK34+MFL2H)FFWY%Y>
M3RATFX6,ZPF(PNZ8+81RO FV6I-0^^V7.-ME*2O3&J5L*1,H>?89?$E>/:-#
MD#'-@Y#8"AD2U+*(VF61>I;P!MVT3Q*0S!NZ8]4N6S+TS[LGH9YNJ_G\(:O%
MOR QN_?.+Z3%%]]O&G^7Z3! 6C%1NV(ZQIE6'C3\X>>:5#=V:F_LMY:'99WI
M8*XX-*#P=@] X\CQ0_@A((0./4*M=R1<W</= T]*V@EHB[BK&[:+?SCBKFYZ
MKKWIV2+>F0ZBHF]NC1\FF^ @].#[>!#6-6[9MHSF>^]!%*QZ:-XGJ:54V9:B
M?9F@/]N_L_*V>5-C=/X*G\7MFR?:3?LBS,>D>LAD>\_92KIT3@,YL*I]MZ0]
M$'S3O&UQSX7@1?-US9*450H@?U]Q+IX/U 7Z-WPN_P=02P,$%     @ K#1)
M5/91R+#6 P  Z P  !@   !X;"]W;W)K<VAE971S+W-H965T-"YX;6R55]]S
MFS@0_E<T3!^2F28@P&!G',\D]MVT#^EEZFGOX>8>9%@;KB#Y)-E.[Z^_E7"(
M \))7VPDOOWQ[6I7R_0@Y ]5 &CR5%=<W7J%UML;WU=9 353UV(+'-^LA:R9
MQJ7<^&HK@>56J*[\, @2OV8E]V93N_<H9U.QTU7)X5$2M:MK)G_>0R4.MQ[U
MGC>^EIM"FPU_-MVR#2Q!?]L^2ESYK9:\K(&K4G B87WKW=&;!8V,@$5\+^&@
M3IZ)H;(2XH=9?,YOO<!X!!5DVJA@^+>'.525T81^_'M4ZK4VC>#I\[/VWRUY
M)+-B"N:B^K/,=7'KC3V2PYKM*OU5'#[!D=#(Z,M$I>PO.338-/1(ME-:U$=A
M]* N>?//GHZ!.!&@R8! >!0(NP+Q@$!T%(C>*Q ?!6(;F8:*C<.":3:;2G$@
MTJ!1FWFPP;322+_D)N]++?%MB7)Z-A=<B:K,F8:<+#7^85*U(F)-YJ+&HU28
M'.^!?.:9J(%<D6_+!;GX<$D^D)*3A[*J,'UJZFMTQJCTLZ/A^\9P.&"8AN1!
M<%TH\AO/(7^MP$<6+97PF<I]>%;C K)K$M&/) Q"ZG!H_G[QP"&^>+<XG9QA
M$[6)B:R^:$!?FXO!5/QUMU):8N'\?<9<W)J+K;EXP-P7;#&EU>M*92,[LK*F
MD^QGZ7@RGOK[T_ Z0'02O@8M^J DB6@+>N7[J/5]=#94?^@"),E>Q:CA0BXJ
MH=3E1\+!QE&SIYLSP4I:@\F;P=IQ;+-5^1^63<GWH+3-U08[K6JL@KITA;+1
MG)P$X"J.DDXH^Z X#CJ1[&.2-'4',FUYI6=Y82?%/LFQ[T@)//M)\'AQ5;&F
M0^?_[!J6SFI/^[S2#JL^).IPZB-H$KHYC5M.XS=SE3%5D#5><:2 ? -._\=]
M_\-N6AR8D[/;4'!A(C>%24MA<I;"X_&:93PGPI[UK<#*!UW*ID.L@,.Z=.=E
MTO,G[)RD>1]R13NY6_0QE Z4+0U>[I[@++$W"]=YK02."HHG'4X.5#09=4@Y
M0!,Z4$/TY$:E9UG-'7R<1&C/>NH@XD"-QMWT.%'Q>(!*^$(E_ 4J%PV72V)R
M0YC6LESM-%M50+0@7.!;KJ7 B8!OD+<&B6W1/1J$_>,4=HGW,5>TVS <H(%B
MHR\7+XU^.7\]MO/O2_()+P!=./E%_;LP3FB7H0,U2N,N11=JU*T]_V0$K$%N
M["BML+9V7#<C5+O;CNMW=DCM[-^;,=Z.EB]JFF^ !R8WYG:K8(TJ@^L479+-
M6-TLM-C:07,E-(ZM]K' 3Q&0!H#OUT+HYX4QT'[<S/X'4$L#!!0    ( *PT
M253+N-&Y@0<  )$@   8    >&PO=V]R:W-H965T<R]S:&5E=#4N>&ULK9IM
M;]LV$,>_"N$5Q08D,9_TE"8!V@3;"G1;T&S=:T:F8Z&2Z%%TTNS3[RC+EB,^
M. 7VIK'L(_D_\G2_(]F+)Z6_=BLI#?K6U&UW.5L9LSZ?S[MR)1O1G:FU;.&7
MI=*-,/"H'^;=6DNQZ!LU]9QBG,X;4;6SJXO^NUM]=:$VIJY:>:M1MVD:H9\_
MR%H]7<[(;/?%Y^IA9>P7\ZN+M7B0=]+\M;[5\#3?][*H&MEVE6J1ELO+V7MR
M?LVY;=!;?*GD4W?P&5E7[I7Z:A\^+BYGV"J2M2R-[4+ GT=Y+>O:]@0Z_ADZ
MG>W'M T//^]Z_[EW'IRY%YV\5O7?U<*L+F?Y#"WD4FQJ\UD]_2H'AQ+;7ZGJ
MKO\7/0VV>(;*36=4,S0&!4W5;O^*;\-$'#0@/-" #@WH:QNPH0'K'=TJZ]VZ
M$49<76CUA+2UAM[LAWYN^M;@3=7:9;PS&GZMH)VYNE9MI^IJ(8Q<H ^B%FTI
MT9WMKD.GZ*^[&_3CFY_0&U2UZ+>JKF'FNXNY@8%M\WDY#/)A.P@-#'(CRS/$
MR FBF!)/\^O7-\<OF\_!W;W/=.\S[?MC@?[>=QVX=Q[IB>U[8GU//#1[HELA
MT2Y0:3_(?S;5HZAE:[QSM.TJZ;NR;]?C5<%Q?C%_/)P)URC+$[XW>J&2[U7R
MJ,J/[:/L3!/2M6V<'@S)",DFNCQ&&&._KF2O*XGJ>E^6:@.B(!V4$F;NOI8G
MJ)7&)S)QQJ><,S)1Z;$B&:=^F>E>9GIT^EJC="6]TY<Z8Y(L2_%$F<<JYT7J
M5Y;ME65197^8E=20);0&@4CT8>V3F#F#)[2@$X4^HRSS"\SW O.HP#^5$?4K
M!.;.V"E$U_3=<*V2E*6%7V*QEUA$)7Y2[<.ID;J!%!=]30HWMABFR42CQPKG
M)!"!!(]9&D=5WFH MS;/?;*Q>69M=0;?EJ&W%^%&\X-P&]*NSRS%@:@D!TPA
M\;@$K<)4[0.J)2 6:<O24[4\W<!#. J&7E_(*0B=!JK'C.*,!N* C%0@-*KZ
M%Z463\ XKS3JC)F!M&G^\9HE26CY1\R0.&<^MD:T#Q4DR&'ZPBO/W,DI,'56
MWC6#I!_*E&0D#8FCYDZN!2P]R-SE]LARNTQ)<#X%C\>*YSD)"!W10^+LV:;.
MB#@7)3PC?"K.8Y72 *[)"!P2)\XV;4;$N32AC!9%,97GL\,920("1^Z0+%I!
M?:K$?557!I 8*Z/(R D2!\6^%%B+9UL'>+UV\S^A"7?6Q&-&",L#/H^<('%0
MW*X$;!O*9U36HFJZ/A,OJNX5NETFD(RQ:87@,TL@>_AUTQ$=-(Z.7Z6HS0HJ
M5"U1J;JX5NH2(<\=$'NLLH(%L$%';- X-FYA(U(^KU2]D+I[^T,.M=L[M-RT
M"^]+0%T,<(:G&=EG1;- X4H/=A!Q5D"\Z@WLF.0WV$]W_L*0NC @69I-U]UG
MQBEG 8DC,VB<&=L,5[7=1O>;NGI\9[UJ72(0AME4K,<J20)5(AVQ0>/8N!XJ
MQ+72_>9>+9&:U!#'Y+N8("F?8L]K%4H-=(0)C</$([_>EY4+>>\E-?6P@^)I
M/>FQ@I07BM^1,/0UA-D5YL?FUL5(FN5X2FJ?&<4D%!PC;&A\ES-6Z-\;$^Z6
MAN0D<W3[S+)@4(],HW&F?3H> IX=#2DR)X=YS J*0P)'HM$XT6[D4D( +"!)
ME*J1R(AO@8ETT912-Y%YK+(B4 RQD5\LSB^WI#RR[,REDZ>N]%B%ZTHV,HP=
MV?KT6;<^V%2^,O\R%U0IQ].]C\<JPZ%(8"/.6!QG4]7'M'J05>!I(>:QHBP)
MS?#!D5N<:]O4=4RACU-92ISC-H]=2C )1>U(-':$:*IIJNUAPO: 4+4V<<FV
M!,7HQ]\5!#1)?_)JC_9LS_7/N[4HY>5LK64G]:.<72'?J>K_T-%+[T<@LB2Z
M/[B#6EE."CE[:F&>HZ>N([Y8'%^W>I>Z.J/*KR=0TFKT*.J-1&_P&2;G")\1
MU%D5,/T;LU*Z^E<NWJ%6M1)576=K-Z61VI@.=M8+6!GO2KA$FR:]J,E+[T;@
ML3CP;.Q %1%RC9U0C'W.D9.,\]T/@Y,V]L@)HW3W_8'+2!AT(TO9W$O]]@>2
MXG>[,_JA&>Q2_-T1_#W=X>&(?%W9-Q?RX;K>^-]:E\0\8PZP?69I0@(5,QN!
MS8Z<5FJH*C;Z>3?SX(_=,)TC#M-G7>!T/Q_QJ7,O*@8'79*?4BA)IF5VR"Y0
MJ;(1^2R._,_2"/@*-BY"M[!F_F5P09[P D^+:8\9+])0;<I'X/,X\&%OM6DV
M=7\CI;8GW*J!#+6REX>/<JA6O#<9+M.+=%I1>XP(#R5\/H*?Q\&_Q=+UESLT
M;+B[8 [T2O> /<&9(]Y3)10L#YQ]\K$ X/$"X'?56D)I5=?V3:Y:* -D%[@O
M<KG.G.#P&86.P?G(?OX:]G_GS+J(SQ*63XMLCUE:9#A0KO"#N[=X(>"4*WV"
M^$X7N',KZ#WO\]IYSOOF!_?%]K+^-Z$?H%"%7=42&N*S#'K0V_OO[8-1Z_X*
M^5X9HYK^XTH*$&\-X/>E@GIF>+"WTOO_A7#U'U!+ P04    " "L-$E4J*FA
MH^T"  !\"@  &    'AL+W=O<FMS:&5E=',O<VAE970V+GAM;*666V_:,!3'
MOXH5[:&5.G(#0BM :JFJ[6$2*KL\3'LPB2%6'3NS'6CWZ7?LA(Q N'5Y -LY
ME]_?/DG.<"WDBTH)T>@U8UR-G%3K_,YU59R2#*N.R F'.PLA,ZQA*I>NRB7!
MB77*F!MX7M_-,.7.>&C7IG(\%(5FE).I1*K(,BS?'@@3ZY'C.YN%9[I,M5EP
MQ\,<+\F,Z&_Y5,+,K:,D-"-<4<&1)(N1<^_?37SK8"V^4[)66V-DI,R%>#&3
MS\G(\0P18236)@2&OQ69$,9,).#X705UZIS&<7N\B?YDQ8.8.59D(M@/FNAT
MY P<E) %+IA^%NM/I!+4,_%BP93]1>O2MA<Y*"Z4%EGE# 09Y>4_?JTV8LO!
M[QYP""J'X%R'L'((K="2S,IZQ!J/AU*LD336$,T,[-Y8;U!#N3G&F99PEX*?
M'D\$5X+1!&N2H ?,,(\)FIEP"EU-L21<IT33&+-K]!%]0"Y2*:RJH:LANXGA
MQE6FAS)3<"#3(XD[*/1O4. %?HO[Y'QWK^GN@N9:>% +#VR\\$"\F0;)4(\:
MB05ZHAR$4\S05"AJZ^OG_5QI"57VZTBRL$X6VF3= \FF4)M$2MAB.-#XY0;E
M6*(59@5!5Y2C1#"&I4(YD>7V7K=M;YDBLBG,T[D:>QT/=G*UO8DGC!KTW9J^
M>QE]60((%SH5DOZ!&T9%N=J*7L;O;U'YGKEVX$^:-?![-7[O7?A4J>(T>F^/
M:9?ZF$4#N%\#]]\%#&]AI3%/*%^>HNZ?I#YFT:".:NKH*/5$9!D\-_]1X-$Y
M!7["J($^J-$'%Z!?7-V#O:T, Z^Z=NC/,FUHN*TUW%ZNX;P2O]U_[*)NMY6_
MS30,C_'[WK\OD7>Y@@MJO@K?@ N#H%5'JZU_]"#\K4^J?U3(5^BG5"'?=J2<
MPO?WD+J'Z-M,VT_!W6H-3%_V!<LEY0HQL@!?KQ/!VTN6K4XYT2*WW<)<:.@]
M[#"%]I!(8P#W%T+HS<0T('7#.?X+4$L#!!0    ( *PT252+B$@:NPD  $$O
M   8    >&PO=V]R:W-H965T<R]S:&5E=#<N>&ULM5K;;N,X$OT5P=B''J#3
M-B^Z-9( :7MGIH&=V:"#V7VF)3KFMBQZ2#KI[-<O*<FF;99H9X#MAXXM'UY.
ML5AU6.+MJU3?]9ISD_S8-*V^FZR-V7Z>3G6UYANF/\DM;^TO*ZDVS-BOZGFJ
MMXJSNFNT::9X-LNF&R;:R?UM]^Q1W=_*G6E$RQ]5HG>;#5-O7W@C7^\F:+)_
M\$T\KXU[,+V_W;)G_L3-']M'9;]-#[W48L-;+62;*+ZZFSR@SXL4NP8=XE^"
MO^JCSXFCLI3RN_ORM;Z;S-R,>,,KX[I@]L\+G_.F<3W9>?PY=#HYC.D:'G_>
M]_YS1]Z263+-Y[+YMZC-^FY23)*:K]BN,=_DZZ]\()2Z_BK9Z.[_Y'7 SB9)
MM=-&;H;&=@8;T?9_V8_!$$<-4#[2  \-\+4-R-" 7-N #@UH9YF>2F>'!3/L
M_E;)UT0YM.W-?>B,V;6V]$7KUOW)*/NKL.W,_5RV6C:B9H;7R9.Q?^RB&IW(
M53)G>IW\;!U#)S?)'T^+Y,/??KJ=&CNH:SJMA@&^] /@D0$03GZ3K5GKY.]M
MS>O3#J9VMH<IX_V4O^!HCPM>?4H(^IC@&4; A.;7-Y\!S1=7-T=EA TY+ #I
M^B-C"^"LO.JLO%)RD]@=K9@1[7._)8017'^.C$,/X]!N'!H;1_&*BZT9ANK=
MBRL-K6K?6]KUYH+'RSTN*$;EK/MW.WTYMC@ SBC!.01> &!:D)*<@4]8I@>6
MZ6666R;JQ(;$1+0OUIFE>DM86R<V+NI*6?HVWNBD%MK&3FV]?OEF[6*8:)*6
M&Q>EDNV:V9!26<M#ENEGD!W-_P9E:5Z<$^A- Z'3(B,9:!L(3<LL36/&R0[&
MR:+&^=KJG6)MQ9,E;_E*6#]PIH(X9N$\,I*6!4@1 *<IPA1D"($QICA&,#\0
MS*]<?2,3:=;<);CMMA'6QSL7X)MM(]\XO*YY.#-B%_9\9CUG (S+/ -]8 &!
MBY)$.1<'SL6%137<.K;I^#F'U\9%</NQLGN[W_$OYW&W)UP$T\HI[,0ALBCA
MY0V19=QYRP//\CJ>8RY; D:F&1RO(&PY@QF!V/0<>\()S7SVG5U@U:V283_X
M^&8<^CCSS/+<K#TU"(Q+#-IA 8)S=!ZW3\D=20L4)?>[E:U5MR65?!%U'VJA
M_ :21L'44(&S$=( V 99$+R P#:WG<>V4]+8D\;ORN?]EKP^GR,O'!")FO=1
MR8KS>AA'LX;W0<Z*X9WJQG$JSH<$V,PD# )VV\!6#K$9S> D#_4[H^=>>,K<
M2QD4US*/.U6MK=B_BB -7;PLX4 ]!\$9&=D\ #A/23PR>"&#XDKFA*/=0';;
MF%['\#]W8NOX@G0!!8'W.2R@"X$I&5E1$)S&8X67)BBN34)GOFFXI;]DU??$
M6-6B67=0A-<X%!4!U1""9@@F&D*C&0QY>8+B^N2ALDNG12] /UBUZ=:VBY#,
M_:)X#1^P /V QO8H@"TR6&Q"6$KC_NME"8KKDG!!'5F]6VI1"Z;>0**A>@CX
M 5*$@MZ]B/9VRLJ+$!17(?]THA*<>B@3$(:E(P -IAY"X@H9>\6!XXKCD)1W
M[NPC6C!!00PQH!52G(%[: Z"P]@X'+@A?4."J'M*V*L0C-Z5D%>BM6>@ZQ,R
M]JD?XXNF57S+W@XE%+V6RMQ8X;I):KX$ _;09\SG+T,6 .0F#Z+^*2\O-/![
MA(;0>M<=(BV_1K;/%^B%.J LP 0SAZ!E"AXY%P"6Y,&9^I2OEQ<X+B^^G:SA
M%1P!(8!F.#@C##0A=)H1.!E!Z()<8.I%!HZ+C 57XH6YRFNBN3$-'Y51.,S^
M 3% (,!2 D+B:([%7DC@N)!8"'?4:.OQXQ0&2A X"\8?2,'@D4 &@F?1RA;V
MZ@''U</I-N0_N*J$[K.JD58ER>VH0,)AID\#,3X0#J$X&Z$+0%$\YGCY@"_(
MA_T.='6\_GBL>--5J8UTA3H;6YDZ=EMG"">-G4I^9:J&#1%J@AN4P64M"%N,
MA".H6Q3/V%YSX+^H.3"@.8)BR\ %$!1!_6G@ O1:1N,-\>*#O%-\0,D8HDH
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M9"HD[GN$\N.OA'+>[)C3JN,:M(P]M(S<B+>,E.\PZJ;_90XKF, YX<E+?!V
MS?THIM:?.SB0!6WU<VHVUIEE<24][U$E0\E/'Z5Y4^F4XT&T]NY96O>*[6)9
MVRX*=\G+,$[38\QKJS&-,;453/;0F>EU:O[8>W]LK3\%[2AVA.*D":@X(6G!
M1B0HTIR4Q+G?![47*[5V8WZ*!]=-#67=W>BGJR^RH[W3H^=S&DOHJ.&&R15'
MG!XZ,[U.S;?QWK>QUK?[;;)<P6E?[A_9CIL6.3LA$2Q.:+]:W-^3($VW<F-)
M.[)ZH1\/+]?78TVB:W[1876<&3ZS9^@Q9=BL"2I*2QU3HW/3,5D\+#/]Z/7
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M3Z[G+]^>X?/TP"_.WC71[PFN9%E57_"/#_DW3TX0(%O8K,41#/RXM>]L4>!
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M_+K: 1&KB"9241;*"-NDJD%0$AT%2:FO6"_5^X)YH*H9@;D(:GZ$&8F($.[
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M],WVE:N;5GKW] 0N147_H#!&!1^=H0<+>!Z=$$?3A]KZ(9[AYU@::59_[IN
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MQ[]+#'6-F7625.QH>5T4,(D9ULN1*ZN:\F.]SRA/8VF5.=&E8>1,/ #1Y4N
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MOE]2M''W(AP?,M$90\ '#6>+. X#*LL%,$% Q , '$#6!?4<AF(.5VP0&/!
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;,U;Z6[<R!%^E89B!#)
M2T-R3E^ +-N)@3V,E=?[(PB"'K)GIF.2/<M#TN3I4U5]L'G,2/)B@^Q"'A[=
M5=557QU]\/6=*K]5.R%J=I]G1?7F;%?7^Y>7EU6R$SFO+M1>%/!FH\J<UW!;
M;B^K?2EX2IWR[#*:3.:7.9?%V=O7].QS^?:U:NI,%N)SR:HFSWEY>"<R=??F
M+#RS#WZ1VUV-#R[?OM[SK;@1]:_[SR7<73HJJ<Q%44E5L%)LWIQ=A2_?3;$]
M-?@JQ5WE73,<R5JI;WCS*7US-D&!1":2&BEP^+D5UR++D!"(\;NA>>988D?_
MVE+_2&.'L:QY):Y5]IM,Z]V;L^492\6&-UG]B[K[NS#CF2&]1&45_<ON=-MX
M>L:2IJI5;CJ#!+DL]"^_-WKP.BPG1SI$ID-$<FM&).5[7O.WKTMUQTIL#=3P
M@H9*O4$X6:!1;NH2WDKH5[_]R&7)OO*L$:\O:Z"'3R\3T_>=[AL=Z1M&[$=5
MU+N*?2A2D78)7((@3IK(2O,N.DGQO4@N6!P&+)I$X0EZL1M=3/3B!T?'WLLJ
MR535E*)B_[A:5W4)@/CG"1Y3QV-*/*;?I<'']F5?=H*!6^UYR0FN:L-J>'2M
M\CTO#G_]RS(*%Z\JEJBB4IE,>2U2MI$%+Q+),U;5\ !\I:Z81*@GJDSAE0 T
MU3OVMZNKS^!!OS<21Y^(LN;8JJH$M.=%RC+)US*3M837M6)K@?Z&C@-,>(V"
M@)P;%/:6A,4^"IZ6P^;H:06]0V^150#^GNR &3QF//TW0!I:[20@NY0)B)ZH
MJM9-+]BG GC)B@$!$?CC!]6H6YF">*D X;,*^>![3RC06*N0(X/#^QW85]9(
M2)3@43CDG:I\4B#)EPYO49%J2399Z%"(1H(KV]EQE@5@J\E-!] >+P7+!4?H
MD38]D;'_W4Z"?G LR8X76X$&])I(D"$!4@4$:%DD*@?MUW4IUTW-UYE _5]_
MO6%_%SP#2P,]K7MH"&+O,'K>"MNQTO 2V8%M2I6;I@\I[8)]="T^>8/[T1N3
M!V1CF&L?J.]X1FB\P3A5L6N#P",8']?E"34:EAW?6!N6%!J-03T+&]Z5&/#
M&$\PQH9D9F-'4&+6I-AAWUC;)@!J@'^2@>KD1D)'=#@<6B$TBU((EHE;D1%+
M#L@7)2^3W8&)"BTH04"0]D!.:L14&>1*66Q)'AQ92P#O6A)H*<[6I10;P'.5
ME'+O!X_ZL"<IW$@ZX#U'A4>35_Y;'!D]#E\]UR/\O>$9C@R4TT<*HLWBY$!8
M%AR@3,*^9$1F_HK]@+<LI/LP?,5^+5P4^+U1^+.'0 #TD0"X>%%36#!8]%B@
M#-+F<<B!Y3<R;)=/Y/A\[0W+H!T&53B9G'\ZHZMU)<I;\BS-@0&<.-F%L$(0
M>#DB>25SF?'2RCT0-'C,:"4*V^_7MT\KM2>L>P:AT[(XMY%7%A#J &X,G5_[
M=P)>!$&PE-6WZCD].<XF%24(E)J8@;&E+-5:E=K/#D.=#:P2.ZN\QWLH*0VU
MIO ZHZ8#FTH0_F/! 335Y(3R3F Z%N_+CG-J,S=[$S# RU K!%CT$QJX<?8*
M++HMH!NX>(U1%CLX'5VPWR"V]DPZL/FXD<=DY+>0U% )W:S75)2=$'J&E0&E
MX0ABN33VO>G0J<=R.M)6.K>A/&W2#$<)[^ 2^HW)^#@5H.9ZRD,+"$E,$-).
M00A ?-#BIJLR,*C,">:>+IH*X=0B/!>0M5.5J2UR=\[?,J$"9Q *_.@)8JP/
MAC"'!I"2[VG(^"!7J<ALT'C8"EV0.D5'H.C-N.&MIQ_!C5?;#+2P+M4W4"J1
MI?C*"QT@"I00_CE *8;HH6 NBUO0*&;'D?2\%R4I!/,L08E7.[8!K\)R[=]Z
MWD6IMX$P]J :<G[HY5*GB9C!#_JL:K94*V$MH)M75-AXKNI'+].FM60_P4I,
M:R.9\QA4&D2*KOI.U2W'2NO3Y6!@\HL-?5M10*+/G$82-S,P@7V4R;XIJV8L
M9K5UPP6[1DMA3[KX #,#:$8ED W4J*>$E^7!>@Y%E,3VHPOA]>-[L/G]T/4X
M&K9NRA;JF:@JG89U=933''(THG9"XUB4"$8$.>)-H;6M)YRGD8_=VK!'=EC5
MIXH<$*:1*16@'!+7ML$*@.8R(\F@)Q@HQKGY>[&NV8U(K)JL$7XCI#]9)RF2
MJUIRWZF2+R,8MQW[++#VACD="@E22)AA .E?+VZ 2DE@/WBMCU7C1[A%HP-2
M:YQ#8#JO7,CU9IO=B!R8:59S+).JS8 )39UM60=S,UPP@$H(\DM"<3.55:*:
M FFYP$<IV:8@;X3="64I;G%UR>3;-I?#;*W1%?_AH:K4CW)V8O*_*THI!/Q9
MU6A75SRKE*^P7D#&WOC4*PMUD 9UPA@2\,C:J9A*3JUT3U@]C@OV<T$E#"]!
M/,"O6;WPTZI>3,244?%\GU%$E/51F!H8.\?%@2*E4I=:.<IHWIGE#2JG.9)0
M1<K19U13)H">K^!3F&8!>+>0O*')7B3:FS&(5CN5I:1P;3T=8("?5IQ1ARHV
MLB0%F-K,YVJ>YBU7Z.Q6/C#&8("'%JA/AW L,CV0?\(E'K DF"$8=6A7:+1U
M!:L%SVW\@'M0O:\EYZ#6W0G79(BCX<%D/B3L.*L[A'$J]J) %7EU8F<,WI).
M/UY9%#A)<([?%KE4+IT&!)DDE:DNW6@6S(CBQK"T2*DA(R0B7X.I[6HH1ASX
MG8QXAXFA=EVOSU3'1UM(6;1_!'KV6:]'T G->@9HZDD]WP," !M326(LQ,I%
M+\'P2M<)1A88T"TY8,836I_LL$'2-.34 2.#O/-SCWYWBN-J$>W( ]OO2BH2
M.:)H#8'+*^M@4-\*=9>)=&LI,.A8HERV=!?%K2Q50;*BN4R\I>#>U;TUY([?
M"C*C7UFG \%LU7@0',:$*$Q'K(PLM9G10%3<GM;A22^K:K[9=%<Z'U0@1B"<
M!?P'M6%V>LBDJMS3G)]DA XU)HLBU8B%="FRK!/>.WW1H2G:[IMU)A.VA@ '
M^OQP3X'46XX;CO8(2EW:LUBC:@-E TT+F!#T'<^VJ_G]"W$O(%NPO"G ZGO4
ME.?L6 [7A[%ZS#>_ 0Z$JQV,NKY3O3I=SZ$TJ9;Z2^/I+D-J?0 5JB13D]"Z
M3;1*H TI);U@GTVG%Z;3@,V)DF\M$NZ50:-5I<%J)PB.E9H:I7WYAN($9LY&
M2_M=$J_T*[19,.1Y;!BQ&T9WDT!74GTJ+B9\]TS7VU\Y,=&]\::AG94M4RK9
M(IE8E@4X6&6SM"C )_,FJR6Z0^"*2S(%:/4;=M(:LPNN;3WAGE!*(3$OV!4.
M-L'BF]9,4F&NR8R'UN'&!+U3#=03%-C E4$JK7ON;5'TI@UF1HN\*4J"W>X$
M%8">%CNS_:-+^3B30N>BQ0J:2SV\OO] RARL$_XON-M0KA7!*[/L "$ RB2H
MRS,*$M8M;<E@\?U%U2#ND.KUT1GX,S8-5K,I_4[IEX <O8*K53"=+/4TTX]%
M%#*W6%(6O<3"HB!>1&PZ=42B8!K.V0TZ N#31<XVONX5WN#$H6K6J;R5%0W0
M]H^#R7+.9OB["C7G-J54O5@+[5?!?+5@\1(N%O$, TT_J+>2K98Q"R=XL8K9
M+Z+253!(DJNRWO*M>+$&%Q+I6._E8M:YAF"2BS)Y9.\PB(%Q]^YG6K4DI)WH
M&06+Y0H,#;^K"(1.A<AUAH1H*,KR2*^E?ZE!TD^,VG31)%B&$9O-610'T71B
MTYK7, Q;\\YF+)RO#,5G;!%,H<LS%LV":#Z'BS ,X=\X J*+ 2PG)V$9@WUF
M]+L$#CXL%\$2@/I46$[8:N7#$HA^/RQ!_=$"_ ]_EX^ Y3)83D&K$5ZLI@_
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M<(A7V #>;Q3D(G.##-SWRV__"U!+ P04    " "L-$E4DVUR75<(   /%P
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MKK*L!6NT5X(.??H)0$B!1I+W->VYB_[(1.?K&I:)!ZE:@Y(&H3*3#;GDF,)
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MG0R8]D?1_H=5E3O^72AK5>%N 383FA;@_5(IV_X@!=W_#[C[#U!+ P04
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M$5T O4&6+^L-1%(<&[$92(97X,X&S=@=VU7?L&VZZHX8P@.OA]06L0!4AA>
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M;?U5];I"9=3S5E69]*4_@"8UG.X)#I&J8H4A8>[Y2W4'SO]-9C52'V'9NVQ
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M%@4M9W&[;)8_E[UEM*:LQ%"W<9E4]6*I'1"\ U-(U ,\KT&_U+J"3U&](4K
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MP4C/- C2=$!M?Q-Z2V?CO_E@SI^Y]<# 5C[LL7IO">"V,YD)2_0B+\"*#2#
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M,UZA^-$9&/4L (^:SA*Q@Y#1< DXB,/1CZRF$Y7'68B@45DH*_;GB-.^H?S
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MQ>)ZWZM&^K7)MK"=Y@PJX6]IUKQN$#0Q]/JF:F1J=N7O39^:C-.EQ1LX)L>
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M6EK=YB"J"X;7LJ"8D7V.Z38/82!F\JKB77 \E%5L=:YK/!\^_:-K.NQR;U9
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M9T7> QT.G>'!JJ4_Z,V4I6.COZWIG([:#:#O<Z7L]L$%V)W\K_X%4$L#!!0
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M[5S+9LA,K=';WQW$;^&M00CV==H5XV!7-NE@A+S@FW3?E&Z[BMQ?-M3A8;#
M:$+CMU'W)0BL+""FXX [>:T7O1V9"[H*].#U,/%!F S'LS" P,W.AE_.)MWF
M>1B2*;W6H>.#-P\%N DON^^#J-'N^>NE_<_#9?=F?C_>_7E\%F8CD3G%:Z@F
MP_-)1*9[S;N%TTUX05?:X3T.TQ(_0&S\ >ROM7;[A3?0_U(M_P)02P,$%
M  @ K#1)5"-0/<E5!@  YPX  !D   !X;"]W;W)K<VAE971S+W-H965T,C0N
M>&ULO5=;;]LV%/XK!UXW)(!F2_*]30(XR;9V6->@[5H4PQYHB;:)2J1*4G&S
M7[_O4)?87=,5?=A++#+G^ITKS_;&OG<[*3U]+ OMS@<[[ZO'HY'+=K(4;F@J
MJ?&?C;&E\#C:[<A55HH\,)7%*(WCV:@42@\NSL+=C;TX,[4OE)8WEEQ=EL+>
M7<K"[,\'R:"[>*FV.\\7HXNS2FSE*^G_J&XL3J->2JY*J9TRFJS<G ]6R>/+
M"=,'@C=*[MW!-[$G:V/>\^%9?CZ(V2!9R,RS!(&?6WDEBX(%P8P/K<Q!KY(9
M#[\[Z3\'W^'+6CAY98JW*O>[\\%B0+G<B+KP+\W^J6S]F;*\S!0N_*5]0SN>
M#BBKG3=ERPP+2J6;7_&QQ>& 81$_P)"V#&FPNU$4K+P67ER<6;,GR]20QA_!
MU< -XY3FH+SR%O]5X/,7+Z72KK9"9_)LY"&0KT=9RWS9,*</,"<I/3?:[QS]
MI'.9'PL8P9+>G+0SYS+]HL1KF0UIG$24QFGR!7GCWKUQD#?^;_?H6KFL,#A)
M1W^NULY;I,1?7U RZ95,@I+)MV'XU<ST>B?IRI25T'=4>U6HOV&J/2 06RLE
M2L([JJQ"%:GBCKQY3"?B%(1Y#1HK/]0*WY2)2GE1D- YG:Q/:2,RB/3"2_)0
M)#+0.15JPUC*E:M,=]Q0)JU'2=.][@R19L3<D*XDHOV@8=*6R@<5G2_>@#@S
MM]*2H,K83HD".2+BX.7&FK*3**V+2!1^9^KMC@7=46Y(&\]&9CMAM_)0_ _?
M+=)D_J2#Y(X*)=;LZ1T)%PASX)%Y:H6S9KZURKWOX97YD%YH^AU&EFO0C&/.
MP601'3F2X;>0'L[SK1.%9&$KZ;7HK7 >@(O":$G/9:XR827=".OI&@9*EUE5
M!?]S6V^I*H1VC(] 6UP[E2MV #+?HD]=,>M3R4C0#1-&]$RC/DY85QH_Z6C"
M,7ER&I'<;&1H<X1":AU)&D>&X.48ZK8=[I5G;(4/;D3WZA6B<6@ IT_PD!!>
MR8FE= CH9Z-?HQ%8VN]4MKL7D85\ 5,C)XGC[[L@W OA<$!J(7Q#VP3N5CH^
M?P.H&%A!!IQ?TLWU3;BF.REL@.)7H6O&&HTF/0[RD9M^;R"IMC\RXT-.!RPA
MO-:=_7TF-Q"+ L./N"K,%\NTLN96Y5QK!<NQ@EM 3O)C)EV("E?+D16AJC ]
MB2?<86VQ1VWNA!A<2BTW7'!.;MGJ/E^WUM05.U]*FRD8\JRI!UK7#KW*H=X/
M>U1;R&)=($].^&0YN*@T Y46,\M:B,>%D]"&(#3WW5D'RY"(SA0J#V"M11%$
MARGF3@F ?9*^:1+@P4=,>\E)R?%E4-UC#F:IB@)^NX8TD+WL(_ 4>8)DR.DW
MM6G3.<N ,HQ\UKO5!?\1)=%B,<=O&HUG$_!H!$,WO#^(LGI"*ZUK;BX="\#^
M'=O'.VP?-%Y.:1+/Z,V+=RN8X!'A\EA1T/^)A&0VIV0>TZHHZ$5 "R5"23*E
MUX93@XV93I;X'4?Q=(I)QOTL8DSKDL&'S*;&4 REJDM'R%:-<U<$G+VXY"G]
M;VRC!K$&813+5R(<:!M38-E\%HUQ^8AFRVB>)/R11LO9@E:MD9-E2I/Y JXD
M\:(=(2>S17Q*)XMTBK])M)Q.3H&EOW<CR$W&:2.7 X*/<92D:1B6"OA!.R)P
M6!/(L763[<@SY]W_B,)L$DT2-G(ZB^(YI]$4H8/G'0KCY8+&Z1)9-IVE'0K3
M:0K_Y^D\H#!C-!B%8R>"\'3&$$^GT6R^;(5#&*" K<J%&2FP'J)U<"7G"O,
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M2>*7:)*W$1H>'H8'?QBUAM1KYC3>QN-R_S]#WDP6DL-]L^"?-\<?4/Q&;$A
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M-&H#PO AQ_B(;ZZO)$K0>U'#;:@ !VLD9+0QC"]>UM\*HL5$$MST>GK "]I
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MDN!T0FPL!A"B.S-.Q\$H3$]CD0+7,1!)\1?7@Y2P2,*4L C'P +F"=%/8P%
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MMFCJ#@XWO_Y00NO01ME&PX%1K(H.>51>P5?K_%.1K9M6NX+!+XM%B;_#O&^
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M&28[)[YR<O%6_O,]OO0KOB2'4SV!V+*:VDDT#PHP_"]PL=C'8D(9/@T]"P/
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M:P.C0@:3OV5=/M^S>1]N>V"O;=$GZK<Z@\K]&/J+Z%\U.PP=7.ZJ8AG,#>0
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M%"1FCW:WCHW5G/&0DG/3/: 9@% =J(\GD\=O/:W*(?R1?9S,GGY\ZVY;Y!+
MH^?8YPD_=A#_#QW77^HGGSE_8'=/__SP(QO-DV2@WC29_DWQV>:?9XGC#6NW
M6XL.,^5Z_X*E^#V(\_\A:IF(CCPY#JA#QY,ACM\6I#3@RG]O&O_[&JV?HT&3
MO[')2*/;X3XNPQ?![%"Z+TC;(7->(Z:7$$0QB([4;&3VC9!<SA9KV'FR@:9=
MP;O.!=>%$9&$$?1.M5(03,WR%FG-NL'X.;.AAN3!@DR3K)O&H^X><C1T;C5
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M(0/N%,G/KJ-M_JFH6?H%.D.,$8F+0B06- XJG )B)]""N^3M_4Q !\2QUNR
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MSED=65%?T>AE]I*PKRG]P^=X.7<$K=K_:&[H;(E]$@M;Q#B4WNPJX3@'K*!
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M3!,Q*=JEII>4%R=H;4SQ N&EZ>,L!:M:X0X*2/AB$V98,3;<3:^X@7M0O]7
M>C 3HT=+I$@C1Z8*6A?<L4N7OD3K6?YC9W40#*0CX$HF*6)9K/#"+XXJZB*U
M?"FK&XQWQ*S"UQQ9.$EGRK=H;G".=0=L ;^1CU,30LT>H_<0>;AQFV=/'>BT
M<6A.C5*4<L*@:+FPSIYHQ!>,GYS5J$XK%.UM1<AFM>.,RH,&'K$[XG;DNF9P
MN7XNV/]=;"[ U)U,0\U-])9D>).MI2V9$UU,>+;,:>*RNZ$=WB\]J'!)2MR)
M7E@B;#RVOUX62V\HTVK'T+?\4M<OB#8CZR09'8M[-C.W'JMB4;8+(+@M1Q-@
MC9@%NW/57C)(2!-H;URE=;XG"KR)'$B]O"17E,BO'HI0_=5*9"]JU >EV-P7
M%3Y3*/A0SR:PAD6.2)S&/M&>^'ZE\Y*R&[Z'ULPSL?R_*MMN*SE.BE2D2Q$#
M*O%2,,2 )F#;@4[PKC2>I#7Q#&MG=)+4^]R2):>:I%@1$EJ1,8'RL$=E"*<6
MH_P\/H%^!B.EO&MFG23:*2@Y;_/4RU^X>NY1"!V;F/ZS_GIIO$)R-MY-H]9,
M%T P-H#>.:#S@?)OL>Q^AT&[8!E*N"VP%N4C+F@G#$L,DINJQ#2@I+&!R^8S
MC0/8_-<G\_,,^%7%^<HJV_2PVB@QD_$!@U-JVDKG,4!Z?A_*':P+ESI(:PXZ
M/\HZFGP_&*HKN"&&( T<PK);@GY[>DYDV&*H%UV'#N"]OQI]&\*0_8CBY[:
MR\H=M#TG;[Y@=[X^/3O)UE/[<<#J.\C-BQ[D)MMH#H?;M/*/*=O5<$45QRH
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M;N&"$$6#_;MDJ"%%(,M<EYU5*96D'2JYQN;I3C$VF-6ZYJRZ)^X)9XU$W7'
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MH=L^HU%<\+_OEK<A!V73P-U)"HY#1K0C3 =:ZTF/2L4'RNL"_=90#@4HL*V
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M&%ZCJ#+D'A%OIG3IR[,.?) F6_<NC4\UHKP1B/BV;33?::"$1NS,V\5C?*T
M;276H%ZKM:JW 4"SY<)_O,UY@'(BKT:ZV*LY_J.VA4'>%,BE.IY8WX:_XM(J
M6^\YU@@(-G$:&D&DB/,^R T1>UCA7\R3Q=5:(L*\6AR5?#\8TVCCHB2.^_AD
M1=^H;'Q!O 2#1+>5$@;6@HTS"$+*0:]+D7>UR%(=JOS284P7^=5 8@&M(.>J
M@JQ=&AQ215C,/&&=C5/Q.2N :YN8'(]F3S+,&2CS3S\:!@:T<L,9<"&R0[WQ
M'^"C@HM,;052$ =YN5HAV 2.D)C[Y2)DWGFFC\^^ WV=20KOC1I+6/(_\2."
M"3LYSIZA$+4F$_LLBU$[L$T9].65 4E'P)):YSW*#M1%@)G*#$/XA=4>SJL"
MU0FR\+M-=/QO5X/T$$$*DT=8N:E&4C[;830HPB7IC?4\)@6+"DX[V XLKI8F
M9K)A<_<81;0>+0GMC&U(CQ(1*I/F+,84+Y1)^V"-5CB*",J#]))>*HDZA7KL
MT!7$X(V3P%QLN]EMN["O.O*9XVK&*T3*BT!,N%A-+R!V&&YBD@'0?7O+\&]]
M5 8C[<= (!#_3!*7E!5=!T0=?[5J1*2A/N2<-:P:L]Z)4?T CS6#YE..(?-/
MF8L%*8!5Z TMJU4:69)O0:8E0KRF5G<!WU@0Z(@"HT*6/]\="'[4]><>K,]B
MCZ;17UY?L60G')9#N%6J9MLH#866.HH"<VX4)PQ8O_@MMFY$*%UY&=2#E"JT
MN,M"T*SL,N"+3!^QW 7MW3MD 0](SGM\NX.%AJ4ONF$6B,Q2%4(,GE/_D1*L
MCHP-?QU+BK/$PH RVF*NAUE=_*\8EI:W0 )+^=YGW,DHW$#%YT9V7NJV:8.(
MI2'6U(<[:@Q0B@$'DD2:6]-DS)YG?^.B-OL0[1;ZC(4*V <+.$4"ER*UI7$)
M*P(OX,)]5!>T,:VQ8I:O3PS<XC-=%B)1:;.A&!7TJ_YZCM>.8 I(F,;U(1;_
M4'*I$X^7;^D?^YCME/4]9?%+=D B_R4.&?,Y'H%3><84+5XD;D6AHCEE3C6K
M%3)9!,'K'=9NKMB"A%D')\EPRSY@79=O@PZO!)W0VN1.O-DGS\J';S]$N.N^
MVIF/58/WPOEB!,R;<BESJZ(81_PMVG/S$I(*<E746P4=LOG\1[[>O U(;,:R
M55:Z^NDZJE^1FJCAA,DQ /JD O/TLPLIYEN3CDX9_(TR26%4?,<)M#HJ*N62
MU=E]!D,)WMFN8!#\AR/QY(:\3>3LZG]689%BD[@-)^H$I0T/)B=LBCVBE% A
MD[/D^#X6G63 $HZW CND:]Y)+7UV:U*X^7_0.Y.0P#6,QYN1(JRV&-AI55#F
MN:YSGXPEMU;2=5'FX9*S>,S5XP6L %TLY;)IQ^(YK4Y3#+DCFX77%VD"HC8%
M[C!C=#:<&3U!E7E&^QR.=S2 6:37Z6(&4T=PVA-'<#BJ0DJ%*^]3!)L+JK /
M/&_L7:0P3,XRK%P-4V9I^7UMC>-'PW5E"AM  !>$')JJO>5@6VA(. XGBH,:
MD</%VDC9<5=&RYT!#*>PK0\S9B@N$=IO\XTC(@&,#N_:NO1SX73WA*O1<^$Y
M/C-8+,],1X(R%+!,>H6+)7W)C*F!%,1GW0ID:;"3PNG5_&+C56IR0^(<_JKE
ML#NXV;M4%G. 0]6X/4H'+"T5'Z5&<E$3L!NUK\N*Z,N]K]-V+0*7M]1H*2.4
M-M?86RI4#.[Q6' EH6*-$/?M($0$?Z# 7PRT)Z$X%'GE$]X6(AI$UX@JD!QZ
M+*9JNJ3]^I6=]YKF3G[>M0O$>T")N\"BC*([F_B=%K ][60L;#6E9-65Z#3X
M\.XGAWD78**'N/_#P0K,3NSIU3)M5DIO9&"2*;*KR& 1+#..,I(I\GVT0TOG
M5=X5<$]N6[14*,R[EI 5+0RTAT5A: H:%$#AG%7)=_U=$=E4L[N<=D<-ZV*Z
M;:K.,H&BH6H2-8>#^8W0!'?JB,7?*#C (;AQ^S$_D"4JDH>%C>+)PV$5)6%$
M=UXY>TS<07TX'-,9?8SY(FVAMQ*(?0%SBU96C2/;X#4,V4*4F(K:V[XOOE 1
MZUVU8@.KQE-A+7 'LIOB.5AVRS8O6E,D-05@=;J?61Q@'?TIF ]%4?1<<I1P
M5&J$)^IW,M]W$1:THYY0(SW*0Q+FCQ$K+4$DY'#K\(S,"AS>E@0*BG9A 2Q?
M?.J1TS/,Q!19\ULDPV_U<X60PU;DA3^;;!_5?GHN+M8P2P7E[&D?J>7&+21F
MC[=2VZ-=-7[$K0K!*IVZ*V&B#Z7RJ'V5LN7'17.D\H *W3/GW;78>DIJB75M
MTL!\/_W3Y +1KJFZ)]6\3!9]#5K0(\R+>(X<>Y]BV"/V(3\Q[Q4YH4(1"5*Q
M#1-6C8(.Q-&+GQ2CJO)<2E;NFU*$-3S"I)%=^.3SV%D43%G!#TAA1J4SL8X*
M(=\P)5^\#:>6#59;%:D2R]<U%>DNAX@DL<W?[H0AMR^Q?!=6I)GD\* '.T\<
MQ:_2-_O9X*H)M_$05%!RF4>L:B+L.WX8!UPNFX*C='UN5I3#P^6Z**J34PWI
M'""4D[B5?L.J^^@DM]*C#LSTZ9.[1$/Z4H>W[Z])QR620(31"UBBU^G6MM62
M<-:1EJ2E049L$ VYN0TO,%C&NCT(C:$VM=]G?Y(?._JB>7":V/( 4N"PD+#]
M3!G!/V7!E N.S43.<4N!)VT@$QW5"#=B> $D>9G)./G/1HRE06C#6U*+[\37
MUX!WHA5*FY/+%>:_0Z<I:.@AAD[]-<%\Y,4\;QLJV^B:T09ZN&)T4Q_138U+
MCM@[^Q3?B]RK6/U)QL&%Y\MF>83Z<-^KX%!,0XP;94!:#H=/G&5[XU-GS0.-
M?1R1D8R@$_)[.'ID1^#^HW&++1 WF.-7]L:MU=\0H"3%(<$0;CUOLPY4'.*!
M<'KAOF*C8 &7/W%F4=U.K4,GBVD6DC(P;[\5BLHJ[@K' K7B(AJ\,>EA[T.Y
M)%[(;*3>A>15<DW+";%JCONS8N"K'5ZZ9GQZ..5S$E\U_47#" 3;B2=/DI>C
M!5YY2K<+#G>=O1_TS-D40JVVV 7*#AZQ3QB4G_<6RZJ2$0H6>WLG%J>>:$O%
ME/J I82!N&"CE1XJH5);ZR@Y6,:8'-_$@3"2N,L[J7^)0+("JS,6HS($OT<]
MQ; JS%,PSX)$/0Q6[YG95+QD>5[-9;J7(810+E3.-^E9XSW;5V*CXJ0H-CC(
M9/\>L%=HK%/K\V9GQV;@]^S5GLDU:EYA>N0WCN* R00 K"_>.YUH?]2\3O_J
M[?M(XL8++%6F1C!^%$30E(5)I!2Z!+C>8<"DL?B87@B6>6T0W)D!C0K&OU6V
M7J#-!RN*2G2G"4$HJG2S49-,*=X=# YRYBES7EC/ AZ<CT@/LV BB&Q-;.&E
MXSWL764,Q>.(-#MO7? &]]:%"J0.120SYGN.?/NMYX,P6X[XVOO_9^5+S@H3
M-EO7A='=EBN\ZU$V$YLE"Q^FH+*BI"9)CG:6.RVDFJ"CD O3:7""(+AJ=#=_
MS_>R3E,UFH58^,DIL<34\-X(!+#_IBWR3R#M/N]K"B8)N<!<;(F3  Q;8IY=
MZ4%2-<E\PK_;(A]N6OBQV1-<*!(# T1]$*#7),LR)E#)=^*ZFF7??88EIF",
M__BWDU?G;[-9%&$!)SD$J'?R^G5^3P&1/__$85KX[-UN\:G3-CX6""P&PXQ>
M9^,QHBTYC(H@/3%@)J5H,5N,["2VN7F,5NXK%C+3!?&\T7P0 6S*O5TQ9L>-
M*N7>K92@Q5B1Q[3SG.'E#?%O;UNV+=77;X7OO&44V]T4DG"%NO?<+Z&LG7HJ
M+!L@(NJ>'N-(-VZ9>-FN&]H;G+_<%;XL62=T_K411X,&3H41]19H>V=N8#_W
M?E(?I2A(2*I?(K&V-F/MF&Z=6#C_6@_@RX+..!>H JHFQQ;G$U,=AAC4JGN$
M*Y@6U"K%*Y_4N1$A)$89J\1$U$UG[<C18)(W,Y)X5*,07T31D),Q0D0A%7"$
M 2<R+1O4#_!MM$;IE2^WIT/Z-BZ"#.1#WG6!B7C;PYA7'ILOMQ)?)I%@P:QF
M3G[@&6UG5.5'9*O@0H_XK#="P+R>02GUUP2['\C!SP>>H#C-,W#M.G+*(WY%
MF$ :J4Z503BRA##:>R=!7(P2'A&'?NELS8F5&$9T\8H"ZMTV"4(:C<!CG"/X
MNV,5]$<#'J$;()T*D393$SM=)CCEA+GZO]Y:/1B>!DL-Y6A7Q2-_+)2QMXV_
M270.\GDD+E]&]@GGC.J!Q;2>/$A5(%=J# KN,S,-&(QVN5S?X.$R&Z<F6HR%
MNN1C53FXU*2O24G22,Q;X,B4C*SO%6,U+G'L0N<IW0;(,0C "!8]O.3><JSR
MQ1#M*)TB"ZJ%0;Z1W.%<,W*&4^X*K5T#,]Q@%*]5=O4&L40XCUB\/!!'R@PC
M.4J"R:&[$X+Y?0EM8C/-EMC<R%I:$/DA5?\2>)P]_+L\LN?UY&\%6ZTL5F?I
M]Y+7>VZ) <Y=-\C7[Y'?+.!^ILELUOOB'=O.Y:.>0DE62@O/5*$M1+-Y!AYJ
MJU*0H=U-/35%RW1R'2<RL%JN&8LP2U %EU28%;T]$C=1(VNI-,.(70C+72O[
MZ/1+>3$1ZF,I#U*361J89W_+JT]'[VM9F"J[@BY N27;PK#PX8B+XP$;<248
M%MS(+'DRR'JJ$!+JM4C66-PP"4AQXC@F/_^$4&%-.]RU*'0ANM50(Q:JDLA%
M7-(H3]M629,MORT[JTG&G%6OOY\CE^66;>+A[2)=YLG"Z=#5^'=<9.)6=#'E
M5&.$+4S*)J;JHO>KHW^#$7." ==%$?1FJ!);%@RKA1,/HWR!5=+ATI5NK_Q!
M)PB)GVB4=$.^L%U"CU;W36CV:P9X/GT+?YV\/)V=7IS"7Z\N9B?0@O_QV?G9
M[-7%R^?XWNOSV<7)Z^S[%O8KNT83F;VH_X4IGIV\''ML(:;0T?'%^>"UB]?V
M)P[E['2DQO?+UQ?VXLFK[.4;]\_9R9LWHCJ_G+T\NX"6CK/3V<7+T^SEJ^S9
MR<O7S[/7L]?GK[*?B<5^G;T^G9U @[@09[/C4UR(D^/CV<GQ2UP26@]<A3>G
M9[@*IV_@]9.3A#<;Y0.J?D&RP!V&GE5NR=5\]NP$FWES,GL%*_(3!3C<-:@6
M/3M]GET<SU["T'C\.'(=I(Z-Z.?I6WP.ZW*"<WP%$WMUT=OBX]GQ,4WNY-7)
M[/3UF\DM/GD#BSG<8GEL6WSQ9G9V?#+<XK/P)[P!1)#>XO/79X-O/66]>O/:
M=OD"WGT-:P-$=O$*:^L].SL]?IZ]FET<AP5\]7)V#K_R6KPY>\U[</(&_S@_
MO9!U.)--OG@]>W5\\5LW^?7+V?'Y<)-? O6_.I'AX\!MDV5HR!N^9)./9Z_?
MX$PN+F;GYZ>]33Z9G9_P)E^\!&)^^=@FG\/ 1AZ'30:B/!MN\IL3M]_ 4D;/
M,1S5_K?G)Z?N,!^?G-@VOWEU#E^\S%Z=GV=O8"$O<(M/8<*Z?$!0%\?GLH[G
M;_#@OKZ 1[C%+T].=17.WM 6PRZ\>O7;MQ@(Y65BBX%)G-O08=!^BW%H_^LI
M_T-]#0<ZB*=@JRQ9?Q17#I-C6/+<JAV?9! K3!3'9FBQHXFB5X,/J$%TMO@V
M4%X"Q4W:^<GAXEWQ*HE%0=.'7="&64:MP%S!43ZROFA^N6W0LYAH=H/F+_2O
M4_IWE0S01%$%5T6L;!ZTKQ>T+?&8+A).0WW(/( 6R*M?K\/6R-J0^\@D@BY?
M:ZQ<WKFVYD0IPVWU<WUD1_.QSWFPHC7M>^@[G=M^[LR0=ZH=P9& U'1MKUQQ
M$+'NF,;%E(M/9(/C<?1"?")=+E[4,/K#J"LD/:2VFQ6%.0Z2S5_O%)#KJF\0
M*RUBM2151JW(2=M^;!35F)A)6S*ISP$'KTF%Z-SE+ID@4B1G$CG/T:HIFQ^E
M@IN5:^BK4;AOKYU:7PJ?^R1/3<#X[5=2UVE&.1^#O Z-C%0G#1K8$CZF@UTU
M*0E>1A9#%>0WS6X;*<P<<Y6@B"@B0T,Q@OD[C4=M.&VQ!$\_D83V<YLOBV@
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MP*!B)*'+W2UL+SO)6<^S.^?KLY,S*ZI8\L5%Z4?!B22(L5+.9F)O[_(E7\M
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M?N1RR1;YIMR2T41;&L9&]3'-I!;'.!<D"H"#W:^505Q+O "CO(P (V0D5VK
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M1/JN.N +W?VJJ+SS 0_(HJA\23SN520L&[L*;-5%X2V)"Z+6_ B)ANC:[D&
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M;\(J\PV=N5'E1G^W-B^5*G-]N9;Q0E;4 .^79:FV-S1 ]R7CV_\#4$L#!!0
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MR1G*EA-FR+RW(W  <*)LK92H%@ADH?&A67*2R4K+0N3,P+(9*X @)Q92&JF
M+7@YXZJUAQ4%.B[9<,6!,9G+ KQ;WY"?*@!I48"_:?*1O_"">$U+F]8G7Z6!
M[1Y2?6)Z:4EGV.&_KP5LG5>PB0L2.&D8V#:P[9__E%"/_@5ZJ1.X"5";&:)1
M/*O<&_++]?,U6<@7KBH((?UWA#I^3$D0M$2H$W@1>38@OW9(N:Y$)E:L-I/=
MT$KB((-=Z_4L%R]"6P&WZWW'32(28IMZ->=,JI540+#/>#L_=:(T)GX"G=@/
M"407B!W5T$SJI(E//!<[J4^^<"URD ;-74IE%A V?YBQ[!O8;6!U$H<[_2=9
MEEQE)Z[V'!\8[X[^!G!1-=)&5E(G3E(P-+0IA4WG'!()A!8"L)USI8ZL2OK=
M&B3YKED;TU'722#DA!&AOD,#E[P'K)C7_D3/Z\P;AL2+TH;B!8F= )9<$!HZ
M-(J@XWD>?/L4B,8'L'1'8>F#?4+;)L"A#\O820"HY\+2)6G:AR40_>]A">JG
M,?@?MLD)L$R<) "M4NRDP1NP])*]T9G8C-UPIW\N-MT@VAN=BLW ]?=&)R,T
M0&V&(]ATB9<X<100L#WU'"])AK 9=Y'#)4'<(C.RZ 9D4B?R?>@D&.IH"N$E
M)2,)*FP35#B:H)Z6K%K !D1%BB86[V>IH:PT2G0X*WW%K-)QPR33Y!6-N?'C
M$>XD7]OLA/-?.5.$8SDQD"I&\\[68RSBMRCNHZ-O\,8\M0D>^4)459T?ZRP(
MT0$^(=WQ[:YG X=;6^IGJ*"A+"[$OS'Y@GNNJW:8L95 !@NHDC6YA/)#0Z&%
MV\Z*-8H(2@)YD74'MTO/O6H'+0:)YT.JZ2^45K1,EJ#_)9;++QP>PYAWI/Q#
M2I=>]^PRN"*?UPI,IOM>UN&T>^8C?I\A FI+H4^EI4;KYY?A%8&JWA2\M/%R
MB/.Q%N=\5:S2X(Z((2.WJ'%(!9KNHD<O2>VW7H@%Z:X];;A.T'9H-W_'G&'8
MI(,_%K]OU$T[^#T'JIT@?HR"(&I]3$L0AOX =(*%(.XCM()S\=@2":]V^H<8
MI+U@B:Y6(^\0<0#@RQ0^OG\ZYM["F'<<6(>X:N-$/R9T.$+%#*B\UC6JYQ3U
M <HDP W+](TPR^,XW"Q%MJQ1MN1%CE #V [@$%Y<!%OHG0K?:RN7L3A<*)"
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M$TY1,L8R_@Z5;(R^0W=\'@JRUI^Q[9.#C-6'"JL"Q&?UF8AJSO)[ VV0_O%
MJP]E$$!2K#/VSEBZ/#0L3,AVP^.-J?2@_(B+Q!QZ%ZIV'T53UCK@.S@B@Y*P
MJMS,\*&_1/4?0!T<>#K&_<WIC5LWO+KAUXT JJL(&^$[QX*4;T]"*,W_AS1!
MX[A(*R(EQN7=;QG^H(ILI]10>?>JNU_=@^I>:2>P>MU[VOI@ PJVM?DL!?$+
M-@SEMQM-;_/IRTWYP<=N>/G=S/=40C)0@"<KF&I=A/Z(R/)3E/)!B]Q\_K$0
M6HO4-#>, JKB 'B_$D+7#[A \T'0]>]02P,$%     @ K#1)5+#^XT72!0
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MG-$%R;2OL';A]-*_?&;:T3O*3Q?T<$7#!/3_7&NW7K""_BE\^B]02P,$%
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M?4C#Q.V*]855+7ULO576JII.5X+#)L8%\'RAE%U?H('AZ_OI7U!+ P04
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M+>F&1>,7T/]":W>8>('NSE[]!E!+ P04    " "L-$E4*H+\^=(#  ","0
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M$FJW@+[/E;([PP7H?\ F_P%02P,$%     @ K#1)5-TZ1Z!-#   JB,  !D
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M<Q#8V4B+6N9V8S5NL8_A.*ER=A53-0NNCX1??8^=>LVH$E)0YY+*LS28;CN
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M$]L4\6.-WGVW8END7:L"S2Z3H&U*^Y#SPT:,R#,MG?&UI$.[7F-F#[/*/9I
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M#48'#:Q16^&&F\H-^[[#VA9;J79KDTVY+:7>;=6P-@6W#BO>GLNFY)92\];
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M_U#F*_%%\5E>EGDJ/L)XCPGC!O!\GN?EY@?^W?/M7\JX_!]02P,$%     @
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MO2$/32RJ09W:#K1T<0?J5'>@5Y1WH/&0P01,',984^^4=:"9A#Q-G6#4J?M
M2Q=^H$[E!WI%Z0<:Y^0)F#B,L:;>J?I 85X.N62T#*=;R(87#B/@7I7;_$#"
M2]MNL>H;S&W1Z(51XGC%!R-V7L"Z4]M],,6VK9$OH[92^U@%?;YZ+L1_WU:?
M6]>OF@+]MF8<NCE6]W],BFU:>VUO[NLNT=LFZE<<Z^6/7ZK\H:T@_YQ757YH
M/^Y,<F>*!E#_?I_GU<N79H#S?UMP^7]02P,$%     @ K#1)5$7_7J=> @
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M/(\'5,_G_5*VF,2-R1OB7D/<.TF\0)>[ 63:$1I@,H6,KRTDM [<F*V_BVW
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MYZU^BR0PY<O4WJKU5R@7U'%\L4I-_I>LR]BP1>*EL2HKP:@@$[+XY$_E1FP
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MH%T OI\J95\>7(+J'PO#_P%02P,$%     @ K#1)5-2J+9N/ @  U 8  !D
M  !X;"]W;W)K<VAE971S+W-H965T-3$N>&ULI57?;YLP$/Y73J@/K=26'TG8
M6A&DI&Q:I56+&G5[F/;@P$&L&IO93M/]][,-86E+HDI[ ?M\WW??W>$CV0KY
MJ-:(&IYKQM746VO=7/N^RM=8$W4I&N3FI!2R)MIL9>6K1B(I'*AF?A0$L5\3
MRKTT<;:%3!.QT8QR7$A0F[HF\L\<F=A.O=#;&>YIM=;6X*=)0RI<HGYH%M+L
M_)ZEH#5R104'B>74FX7766S]G<-WBENUMP:;R4J(1[NY+:9>8 4APUQ;!F)>
M3WB#C%DB(^-WQ^GU(2UP?[UC_^QR-[FLB,(;P7[00J^GWD</"BS)ANE[L?V"
M73X3RY<+IMP3MIUOX$&^45K4'=@HJ"EOW^2YJ\,>((P/ *(.$+T&C \ 1AU@
M]%[ N .,767:5%P=,J))FDBQ!6F]#9M=N&(ZM$F?<MOVI9;FE!J<3I>TXK2D
M.>$:9GDN-EQ37L%",)I35' !&56YL-8-%O"M04ELPQ2<9J@)9>K,^#PL,S@]
M.8,3H!SN*&/6(_&U$6C#^'DG9MZ*B0Z("2.X,Z'6"C[Q HN7!+[)K$\OVJ4W
MCXXR9IA?PB@\ARB(P@%!-^^'!P/P[-WP\.I(-J.^62/'-SK -]2@G[.5TM)<
MGU]' HS[ &,78'P@P%>A%)12U%#L=UWT71\J84LY<91VRCRE%V&4^$\#.B:]
MCLE1';<\%S6")L^P0HXEU4.!6XYX+_!H.&S<AXW_+_USX&82B](J&_J\XS>E
M"'I%K>:W'A=7+UVR8R1M6O[>?:]15FYN*G ?1WLW>FL_FF=N(KVRS\W(;B?L
M/YIVWM\165%SRQF6AC*X_&#TR':&MALM&C=55D*;&>66:_/;06D=S'DIA-YM
M;(#^1Y;^!5!+ P04    " "L-$E4^W/?(X\#  !F#0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970U,BYX;6RU5]MNVS@0_15"Z$,*M)$H6W)<V 9J*]FV2-L@
M;K</BWV@I9%-E!)=DHJ;13Y^A[(B7Z5U%_6+S<N<,YPKJ<%*JN]Z 6#(STSD
M>N@LC%F^<5T=+R!C^E(N(<>=5*J,&9RJN:N7"EA2@C+A^IX7NAGCN3,:E&MW
M:C20A1$\ASM%=)%E3#V.0<C5T*'.\\(]GR^,77!'@R6;PQ3,U^6=PIE;LR0\
M@UQSF1,%Z=!Y2]_<T)X%E!)_<ECIK3&QILRD_&XG[Y.AX]D3@8#86 J&?P\P
M 2$L$Y[C1T7JU#HM<'O\S'Y3&H_&S)B&B13?>&(60^?*(0FDK!#F7J[>0650
M8/EB*73Y2U:5K.>0N-!&9A483Y#Q?/W/?E:.V +XM '@5P!_'Q V #H5H'.J
MAFX%Z)X*""I L >@_09 6 '"TO=K9Y6>CIAAHX&2*Z*L-++901FN$HT.YKG-
MK*E1N,L19T81QE4;;@H%FKPFGYA2S,::7$1@&!?Z)7E!>$X^<B$P$_3 -:C5
M8MVXTC!>:_ ;-'PHQ"7IT%?$]WSOZS0B%R]>'F&9M+-$$-<LM&)!YR@X0A6=
M3M5RH.N366B_F>7F!.=X%<L1>UP,9QU3OXZI7Y)V&DC'A<85K<G;^$?!-2]+
M^*];7"/O#63Z[Q8=G5I'I]31;=!QIV0,D&B2*ID1S000F6)_FFF><&Q1QR*\
M9@Q*1MOQ'D;>P'W8#MRAQ%5W3^:ZC67'E&YM2K?5E#^P_Y(+(37F.CKJP!8.
MQ[)^TOU/:]82X9:$'_;WK#F4>>U[P7&#@MJ@H-6@^[)R77+[9=(2Z;!F"\^6
M3;U:1Z_UQ)^*; :J]+JM 4V>2%-Q3WH''NOWO884N*KU7[7JC[B.96YX7D!"
M/B_!]D!L=J\(;BREQD4\VNR13&UN/)&)?(#<J$?R#I@P"S)A"L@WO$%!:=S,
M\-K7)0.IG?>T(SN&'%)N=(OK^O71^V<+#_4VMX3WN\M]7%'N5'.P7R.54-@@
MM'O<K4N-GJ&DHXHU:*C8W<-LNC'U?V=RC17[APLRK7V+:Z=5--TT;]HY7])L
M^BIM;ZR_4-4W]+ 1-J;!I@_2]D;XBYZ/E)QC;C!,&9EBE=Z:A%V>[OU-0Z7G
MZZATTU)I>T_]?S5P7;$&[3>2N_7BM%\@'YF:\UP3 2G"O,L>XM7Z4;^>&+DL
M'Z$S:?!)6PX7^"$$R@K@?BJE>9[8=VW]:37Z%U!+ P04    " "L-$E4BM4F
M%D\#   :#0  &0   'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6RU5UUOVC 4
M_2M6M(=-VAI?)R&A J05-*W2JE7K/AZF/1@P$-6)F6U@^_>S0YJ$Q$$355\@
M3LZY]_CZ^L09'81\5!O&-/J3\5R-O8W6VVO?5XL-RZBZ$EN6FR<K(3.JS5"N
M?;65C"X+4L9]@O' SVB:>Y-1<>]>3D9BIWF:LWN)U"[+J/Q[P[@XC#WPGFY\
M2=<;;6_XD]&6KMD#T]^V]]*,_"K*,LU8KE*1(\E68^\]7$\)MH0"\3UE!]6X
M1G8J<R$>[>!V.?:P5<0X6V@;@IJ_/9LRSFTDH^-W&=2K<EIB\_HI^H=B\F8R
M<ZK85/ ?Z5)OQE[BH25;T1W77\3A(RLG%-EX"\%5\8L.1VQLP(N=TB(KR49!
MEN;'?_JG+$2# &$/@90$\K^$H"0$Q42/RHIIS:BFDY$4!R0MVD2S%T5M"K:9
M39K;97S0TCQ-#4]/;O,]4]JLBU;H'7HP7;+<<8;$"GT5FG+4?/YZQC1-N7IC
MD-\>9NCUJS?H%4IS=)=R;M9$C7QM)-G _J),?W-,3WK2S]CB"@7P%A%,P$&?
M_C\=G])]4XBJ&J2J!BGB!3WQNG/^^<E T*UFF?IU)D%0)0B*!&%/@NE.2A/7
M5:@C,2J(=O/M)P% //+WS7(X0!CC"G2B*:PTA6<U?1+Y^IUF,G.I.E('C80D
MP"1JR7*@< +$K2NJ=$5G=16+X=(4=;,-("0M30Y4T*MI4&D:G-4T8W.-%%OL
M9*I3IA#=FPU!YV;'&$=%BG)VIDGB*DG\,EV85 F22[LPZ53---BP5=HNB,1Q
MZ*[LL-(TO+P+AX[^(@&T9'51D(30HPMP[9#XLCXL>:<M1D+<DN6" 21)CZZ&
M<\-977="ZK5YU2(N:-M[3T/6]@<OY']0&R!<[( ELUFH*&D7LXLA9-!3RMH!
MX1D6"%UW2\*PK<L!(M"CJW9 N- "H>MN0]QV0 <(<!CWB*HM$,Y[X&>]8=*\
M]JLF.=<7M>?!"YD>U*X'%]L>="TMZNSC+J;GS0NUZ<$S7 \<AC;LRG*@HKAG
ME4GM>N1"URMYT8D9X[8J!\JARF\<7.U7PQV5ZS17B+.5H>&KV/#E\2!^'&BQ
M+<ZR<Z'-R;BXW)B/%R8MP#Q?":&?!O9X7'T.3?X!4$L#!!0    ( *PT251P
MGMR4]P(  +T)   9    >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;+U6;4_;
M,!#^*U:T#R!1\M*F%-16@G;3D,:&J!@?IGUPDVMCX<2=?6WAW^_LI&G9:&"3
MX$OCE[OG[IZG/KN_5OK>9 #('G)9F(&7(2[.?-\D&>3<'*L%%+0S4SKG2%,]
M]\U" T^=4R[]* BZ?LY%X0W[;NU:#_MJB5(4<*V96>8YUX\7(-5ZX(7>9N%&
MS#.T"_ZPO^!SF #>+JXUS?P:)14Y%$:H@FF8#;SS\&P4MJV#L_@N8&UVQLR6
M,E7JWDXNTX$7V(Q 0H(6@M-G!2.0TB)1'K\J4*^.:1UWQQOT3ZYX*F;*#8R4
MO!,I9@.OY[$49GPI\4:M/T-54&SQ$B6-^V7KTC8FXV1I4.65,V60BZ+\\H>*
MB!V'*-[C$%4.T1\.86>/0[MR<,SY96:NK#%'/NQKM6;:6A.:'3ANG#=5(PHK
MXP0U[0KRP^%EL0*#I L:UF)?N=;<\LH.QH!<2'-(J[>3,3OX<,@^,%&P*R$E
M\6_Z/E)X"^(G5:B+,E2T)U08L2M58&;8QR*%]"F 3WG7R4>;Y"^B1L0Q),>L
M'1ZQ*(C"9Q(:O=X]:$BG77/9=GCMO7A39!-(EEJ@ '/$SE=$(9]*:-%Y:QDN
M@?WX0D[L$B$W/QM"=NJ0'1>R\PKY-$B.D#)45!"1G1#9FHZ)':Q VX/WG&AE
M@-@%L(=^->S$Q,9JE\>_;>*H4]L\R3RN,X\;,[\!(U+*6W#)<J5Q3DVC->7)
M/55@:@X;*.K6@;KOI<I)'?*DL;8[USRH$$Z\4UTL7=IC15U+S?865ZK1#-QA
MC\"U83VBS)TDDCGECTTT]>J<>XW0(Y7GH)/_EN.TCG/Z7G*$P;;)!6\ER O(
MW4J1L%2$=5_2(]SIS&$C]#?,0#-N#. _*1%&VPC1NVFQ;9)A^\VT:$8.G1;/
M)>GO7)#T+Y^[=X.AQK@LL+PKZ]7Z;7+N;F1_:UX^;*ZXGHO", DS<@V.3ZC-
MZ?*M4$Y0+=QU.U5(E[<;9O2^ FT-:'^F%&XF-D#]8AO^!E!+ P04    " "L
M-$E4<\^5MVP&  "$)   &0   'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6R]
MFEN/VC@8AO^*A7K12F6(3SE4#%([HW8KM=IJT'0O5GL1@@>BYL ZANGNKU\G
MT!A\&E@0-S,$7MN?';^/OWPP?J[YCV;)F  _RZ)J;@=+(5;O1J,F6[(R;6[J
M%:OD)T\U+U,A+_EBU*PX2^==H[(8H2 (1V6:5X/)N'OO&Y^,Z[4H\HI]XZ!9
MEV7*__G BOKY=@ 'O]YXR!=+T;XQFHQ7Z8)-F7A<?>/R:M3W,L]+5C5Y70'.
MGFX'[^&[NS!H&W2*[SE[;O9>@W8JL[K^T5Y\GM\.@C8B5K!,M%VD\M^&W;&B
M:'N2<?R]ZW30C]DVW'_]J_>/W>3E9&9IP^[JXH]\+I:W@W@ YNPI71?BH7[^
MC>TF1-O^LKIHNK_@>:L-R0!DZT;4Y:ZQC*#,J^W_].=N(?8:0%<#M&N CFV
M=PUP-]%M9-VT[E.13L:\?@:\5<O>VA?=VG2MY6SRJKV-4\'EI[EL)R:?JPUK
MA+POH@%#<,]F DQ9MN:YR%D#7M\SD>9%\T9^]CB]!Z]?O0&O0%Z!KWE1R+O0
MC$="!M%V-<IV W[8#H@< ]ZS[ 9@^!:@ $%+\[OCFP>'S4=RZOW\43]_U/6'
MG?T=S/@M>+^1$TYG!1M*CPR;M&#@SR^R$?@L6-G\Y1D2]T/B;DCB&/)]67.1
M_\OFX*YNA&T%M^UIU[[UX6:"$(S(>+397RA3!1.<A+WJ(#C2!T>\P7WB==.
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M<LG2.>.M0'[^5-?BUT7[0Y3^AT>3_P!02P,$%     @ K#1)5)1=@ Y,!
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M!O18 ICB8^T"<C>7\TT%4(V/D,KQP5#C #6.0VW0.D#^(P?OBW!@'!\AKQ/
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M=:3,1+E0D]3'%X":PK.R??@2 ;6B(R5G@W*3"#V_?6PR(#'"D?@[?SRT:(L
MD=$(A[<1T"YZEL/;J.?P5D:>60 >1G@"MY<[ N:B(]6MP]RQAX^>-2H"/$:'
MX?&I]5H$5(Q&H&+4^33O6:@8N52D@?!LTT> Q6@\+,X B[/GQ&*CO'O>YIS<
M3#M?55>?M'^.B]LD*TFJE[93\*9:ZXO=5^*[&Y-OZ@^M;W)C\G5]N=+Q0A=5
M _O[,L_-SYOJV^WV6_WS_P%02P,$%     @ K#1)5 ;AO^J' @  > 8  !D
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MA^+8Z43%JB4*H* !C \%E%!?ZT-=[^.(BH4,$P/H4!PZG:A8O42!)32 2:)
M&^IKDZAK@AQ1W9 DF?'F ":&@ZE1=:E@8D 3%L L,> -\S5+S#5"SN-](H;.
MK7D F]B"68IL$3%LEKWUDP!VB0%OF*]=8JX54F)<VT\$:3[W=04ZL07#U,JZ
M7#HQP H+X)P8@(?Y.B?FFJ+9I24&!&(X@?K"8144!W+P .:( UJXKSGBKN]Q
MEIJF8F861CA@B.,8ZFF+%E(<Z,$#V"0.A.&^-HF[%LA9=)J(F5MTXKU57YQ&
M?6VQ>HH#0G@ K\2!+]S7*W'7*\GQPOQ$C)ZQ]!Q8Q'$6];7%RBH.E.$!7)4
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ME3YY.TH#=31.';E<0FD@A0[@ES1 1/OZ);V\'86&#!,#W&@<-W*Y>-) "!W
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M02NJ8,O%"_KK-XV&;A4D\N^!6,95+.,\EG%/++\(+J4N=Q4%RZ.P%;T FN1
M1G&>EMCU=3J?FH7H&ODS?&P3=&UFDW%E<T1C4M&8#-)HI!&>M6Q*L+ZW!<BT
M,?/YV&\QL-AXDQ8#&PZQ,YA6#*:##,SJ[)0!G<!S&.\CEFY1J@VT^,?L7_UJ
MA#1CBL9HJ\5?(BY0K,L(\M1&>MH)%KO$:['N&OGC:8MUUV:&>UC[%6O_AZSM
MI&Q,_"X3OQ7DJFLS(2T>%ICYW,YC5O&8O;]Z-@JS[MS-R0L.72-_/FN1L "Y
M&-M9S"L6\T$6?S*(HW,!,37RPY*,,I'S,6^7C<U\<!T49&PV/=G&;MW8W,%(
M5P(BIMX3:@G8C*.M78,FQX$V.C >#/3SER^WY>(\:[PA^L:(?+&_"ODVS1>
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M "*+UM6R@[PW>;9>#4NSQ_BHA+[+=)Z:?25,@)\DWE-P!>9$B"-+-^4%DJY
M[?X\)E*R-:,KL#B"._I$8_#QEBK"8OE)9__-4T&7>R&R"E?@Q^,M^/CA$_@
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MO#K:JQXDVY1'44LF)<O*VX3@F/!"0+U?,29?'@H#S0'K^#]02P,$%     @
MK#1)5.& 4O-3 P  (0P  !D   !X;"]W;W)K<VAE971S+W-H965T-S$N>&UL
MK5=;3]LP%/XK5K0'D :)DR:AJ*U$6^B08$,PMH=I#Z9Q4PO'SFR7,FD_?K83
MTEN:1H@^M+Z<[SM7VZ>])1?/<HZQ J\99;+OS)7*SUU73N<X0_*4YYCIG1D7
M&5)Z*E)7Y@*CQ((RZOJ>%[D9(LP9].S:G1CT^$)1PO"= '*194C\'6+*EWT'
M.F\+]R2=*[/@#GHY2O$#5H_YG= SMV))2(:9))P!@6=]YP*>3V!@ %;B!\%+
MN38&QI4GSI_-Y#KI.YZQ"%,\588"Z9\7/,*4&B9MQY^2U*ET&N#Z^(W]RCJO
MG7E"$H\X_4D2->\[9PY(\ PMJ+KGRR^X="@T?%-.I?T&RT(V"APP74C%LQ*L
M+<@(*W[1:QF(-8#FJ0?X)<#?!G3V ((2$+0%=$I 9QL0[0&$)2!LZT-4 J*V
M&N(2$-MD%=&UJ1DCA08]P9= &&G-9@8VOQ:M,T*8*<4')?0NT3@UF'">+ FE
M +$$?%-S+, U4XBEY(EB"4[ 5R0$,N4"CL98(4+EL5Y]?!B#HT_'/5=I&PR3
M.RWU#0M]_AY] ;CE3,TEN&0)3FKPE\UXZ#<0N-KY*@+^6P2&?B/C \Y/0>!]
M!K[GPQJ#1NWA7@U\W!H.NW7A:(:/\53#X5[CK]K#ZXR?M(9O&[^1BJ JQL#R
M!8>*\=>-W@'7"F?R=P-OI^+M6-[.(5Z2Y8@(?9.JND07)*$E,5?XRT#'Y&4]
MEP<E+G<E.@'T[&=3\NH@UZ1)8B,.816'L%4<ZNJL0$9KRN(N].M-KY,-0[].
M=A+N.!%WXTYW2W;#G:AR)VIT9[3(%K2XF]+=#,LZ+Z,=RZ/(\VJ=C'8,C^".
MZ(;=<65WW&CW#6?IR7<L,C!" H-[G'.A"$O!(R.JH=S/*OZS#SU&W8JW^P''
M:-AM<00V]$-O]5AY[R[@$AH=/BYP[7&$[\\4^ =&]H'6;^8-D=L%MZG27ZGT
M/S1Y<'6YPJ#1F=6[#I"46$G=2NKC@Q.@>-EJ:$_HKB=E?(.=O/KQG@/AKC4D
MFC2UO:8$4[Y@JG@.JM6JG[VP7=S6^A">CV'-^J7I?VT#M*(OFN=;)%+")*!X
MIE5YI[$V6!3]:#%1/+?MT!-7VF,[G.L>'@LCH/=GG*NWB5%0_2L8_ =02P,$
M%     @ K#1)5,=YU+29!0  <1T  !D   !X;"]W;W)K<VAE971S+W-H965T
M-S(N>&ULO5G;;MLX$/T5PNA#"[252.IB%8Z!)-[N!FBP0:\/BWU@)-H6*HDN
M2<?-?OU2LB+J0M%.X_0EUF5F.(>3,T<D9SO&OXLUI1+\S+-"G$W64F[>.8Z(
MUS0GXBW;T$*]63*>$ZEN^<H1&TY)4CGEF8-<-W!RDA:3^:QZ=L/G,[:565K0
M&P[$-L\)O[^@&=N=3>#DX<''=+66Y0-G/MN0%?U$Y9?-#5=W3A,E27-:B)05
M@-/EV>0<OEO@J'2H++ZF="=:UZ"$<LO8]_+F*CF;N&5&-*.Q+$,0]7-'+VF6
ME9%4'C_JH)-FS-*Q??T0_7T%7H&Y)8)>LNQ;FLCUV60Z 0E=DFTF/[+=7[0&
MY)?Q8I:)ZB_8U;;N!,1;(5E>.ZL,\K38_Y*?]42T'% PXH!J!]1W"$<<<.V
M>P[0&W'P:@>OFID]E&H>%D22^8RS'>"EM8I67E2367DK^&E1UOV3Y.IMJOSD
M_$_&DEV:98 4"?A;KBD'5X4DQ2J]S:@ ;UIWX%P(*@5XN:"2I)EXI=Y^^;0
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ML['1J[J2U .26_=ZEY),+7#=C2F^J.P&L[Z2DEX'MB"TY3SY"U!+ P04
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M4TMO)ORLR]]&=T=BOC^[,FA3?:._,5X(%O+64VQ0UR.0OTF<=GEG5OP2*&R
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M6G2;$5_7YW>]L&KC#ZB5LG3<^4L:0H': >CY6BE[6+@SK_T3-?L?4$L#!!0
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M$[!@0@JPPH_XMB#@+;@A&:LR6E!<AXBMP3CZ]9)(3 OQ1LE]^;P$KU^] :\
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M1)G$F[O;YD6R;7V;><ND9&7]J/IF3K@&J-_7C,FG%[U =X,^_PY02P,$%
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M1$4!:H$)$%4$D[$B,'!%IIHPL466FD#"ZD87#?%EM]E+?7S0110%DM!E("-
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MG,?J1+DRT27*N+9%J(%HRB@KC+!@2'L'!GS#<F@ZB#(^=X2\_GJ=1DL5"\&
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MUIPR]"2_TTM6;17VM(FILL2@"_B#O&/E _#[&N]8J4M,;D128CT5@QZ*30]
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M"6XMPZA+"@=X#Y[&*8>/WNCH7W3W<\W4,Y(0KP73*U Z=B,FU@DYQ?;']C#
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M+X8Z'E%>2)4#Q5?%%<V,*\6SXG4)- %A!/3W.>=J.S .ZFO!R7]02P,$%
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M \%;(BW /-\)H<\#.T'U@6;^'U!+ P04    " "L-$E4*G^+A"(#   K"0
M&0   'AL+W=O<FMS:&5E=',O<VAE970X.2YX;6R-5M%NVC 4_14KZD.1VH8$
M"%D%2 4ZK0_=4*MN#],>3'(#5AT[LTWI]O6[=D(&(:"^0.R<<W/.O;:O1UNI
M7O4:P)#WG L]]M;&%+>^KY,UY%3?R ($OLFDRJG!H5KYNE! 4T?*N1]VNY&?
M4R:\R<C-+=1D)#>&,P$+1?0FSZGZ,P4NMV,O\'833VRU-G;"GXP*NH)G,"_%
M0N'(KZ.D+ >AF11$03;V[H+;>6SQ#O"=P5;O/1/K9"GEJQT\I&.O:P4!A\38
M"!3_WF &G-M *.-W%=.K/VF)^\^[Z)^==_2RI!IFDO]@J5F/O=@C*61TP\V3
MW'Z!RL_ QDLDU^Z7;"MLUR/)1AN95V14D#-1_M/W*@][A" Z00@K0M@D]$\0
M>A6A]U%"OR+T769**RX/<VKH9*3DEBB+QFCVP273L=$^$[;LST;A6X8\,UE4
M%5QP*C2A(B7?S!H464AM%!BF &MLR!0$9,QH<DV^XEI<@&(R9<ENGLP0KLGE
M' QE7'<0MA\8AR_/<W)YT2$7A GRR#C'=WKD&[1@A?A))7=:R@U/R U"\BB%
M66MR+U)(#P/XZ+U.0+A+P#0\&W$.R0WI!5<D[(9!BZ#9Q^G=%OK\P_3@TQDW
MO;J</1>O=S)>AC-I71>;_:O3)2.7,P4I,QWR\VZ)!<==^.N,BGZMHN]4]$^H
M>! &%&#X!+_15N22/G!T>S"]38( L_>VG_<63!0?8N;'F# <U)@#[8-:^^"L
M]OOW H\D3"&N_HT2!)=P89<PU1I,ZXHMXT5[(JY[P;#AI@T4-^VT@0;#=C]1
M[2<ZZ^<NE\JPO]2=LC(C M<"EGE#%:.<<*E;/45'2@8-0\>(L.'F&!&T6QG6
M5H9GK6 /,KP\CZQN:%4^//YJU)!^#&FLO?DYQ('TN)8>GY5N=V"QVX'+:@<F
M;@<RD<@<.FU>XJ/E?1W$33<MH#!HKJRV2+UF.?R]-I*#6KEVK%'F1ICR0*UG
MZXY_YQI=8WZ*-X&R<?\/4UXC'JE:,6PT'#(,V;T9HB15MN9R8&3AFM52&FQ]
M[G&-MQE0%H#O,RG-;F _4-^/)O\ 4$L#!!0    ( *PT253^8?><M0(  % (
M   9    >&PO=V]R:W-H965T<R]S:&5E=#DP+GAM;*56;6_:,!#^*U:D29NT
MY1UH*T""TFG[4 VUZOK9) >QZMB9[93NW^_LA(PBDE;J%^*WY[F[YTYW3/=2
M/>D"P)"7D@L]\PICJJL@T%D!)=6^K$#@S5:JDAK<JEV@*P4T=Z"2!W$8CH.2
M,N'-I^YLK>9361O.!*P5T7594O5W"5SN9U[D'0[NV*XP]B"83RNZ@WLP#]5:
MX2[H6')6@M!,"J)@._,6T=5J8M^[![\9[/71FMA(-E(^V<W/?.:%UB'@D!G+
M0/'S#-? N25"-_ZTG%YGT@*/UP?V[RYVC&5#-5Q+_LAR4\R\"X_DL*4U-W=R
M_P/:>$:6+Y-<NU^R;]^&'LEJ;639@M&#DHGF2U]:'8X T;@'$+> ^!20]@"2
M%I"\%Y"V@-0ITX3B=%A10^=3)?=$V=?(9A=.3(?&\)FP:;\W"F\9XLQ\W69P
MS:G0A(J<_#(%*+*6VB@P3 'FV) E"-@RH\DW\NBDA)PLGD%A99"%QIJI;!8U
M>=!X\7D%AC*NOTP#@RY:0T'6NK-LW(E[W(EB<BN%*32Y$3GDKPD"C*T+,#X$
MN(P'&5>0^22)OI(XC*,S#EV_'QZ>@:_>#8\N!Z))NG0ECB_IX3O6NK9:&XE5
M;D!A:0#9-%DB<L/9CKI7 S;3SF;J;*9],3"=R1J+0%$#YU(Z#(_]B_#3.>'?
M@HU.8:^\'W7>CSZ@F,#&>E MPY(?TFO<61Q_3*]A>-2GUS L]B_/PE;#L-0/
M!V6>=$%/!GEN7BKLY"@OEV+WS<KKPB=RB\/!U$H0;#(5-AE"M893G1M=ABVD
M?;H,P\9^<EZ7MV ]Y1<<]=H2U,[-+$U<QINNU)UV8W'AIL')^1+'93/=_M,T
ML_:6JAW#<N6P1<K0GV"%JV9^-1LC*]?1-]+@?'#+ D<^*/L [[=2FL/&&NC^
M1,S_ 5!+ P04    " "L-$E4,LBI#+0.  "IA0  &0   'AL+W=O<FMS:&5E
M=',O<VAE970Y,2YX;6R]G6]OW#82QK^*8/1%"R2QAJ3^%8Z!)KZB 9H[([[V
M7ASNA;Q+VT)V5ZZDM5O@/OQ)\JXY*Y)#*>#Q36)[1USNC/6,?A8?\>*Y;KZV
M#U)VT9_;S:Y]?_;0=8\_GI^WJP>Y+=MW]:/<]:_<U<VV[/IOF_OS]K&1Y7H\
M:+LY9W&<GF_+:G=V>3'^[+JYO*CWW:;:R>LF:O?;;=G\]4%NZN?W9W!V_,&7
MZOZA&WYP?GGQ6-[+&]G]]GC=]-^=OXZRKK9RUU;U+FKDW?NSG^#'*Y:PX8@Q
MY/=*/K?HZVCX++=U_77XYM/Z_5D\3$ENY*H;QBC[_Y[D1[G9#$/U$_GC,.K9
MZYL.!^*OCZ/_/'[Z_M/<EJW\6&_^5:V[A_=G^5FTEG?E?M-]J9]_D8=/E SC
MK>I-._X;/1]BX[-HM6^[>GLXN)_!MMJ]_%_^><@$.@"$Y0!V.(#-/8 ?#N!S
M#Q"' \28F9>/,N;AJNS*RXNF?HZ:(;H?;?AB3.9X=/_QJ]U0^)NNZ5^M^N.Z
MR^M##:\WY:Z-RMTZ^D?W()OHNFZ[1G95(_LJ=]$'N9-W5==&;Z.?RZJ)?B\W
M>QG5=Q$^/OJI;64?\_V5[,IJT_[01Y^\_C;Z[>8J^OZ['Z+OHFH7?:XVF_ZU
M]N*\ZS_),)_SU6'6'UYFS2RSOI*K=Q&'-Q&+&1@._SC_\-AP^-7LPZ$X/?R\
M3_]K#=AK#=@X'K>.=]?_9'U,\DNNKJIVM:G;?2.C?__:OQQ]ZN2V_0_Q=OSU
M[?CX=L+R=F,!GXX%?!S>K!P+9ZK#RU#).-0@(D^7:9IE%^=/.-N&H%PDIT%7
MAB!>J*"3CR)>/XH@/\JO\DEN(B"2DKR.E(2H0?KZ=JF_&KP,E:+,09*FDQKH
M08P58$YO]CK+;$9Z&?%Y\]>1\A#I+5[?KO"7WD++',_Y]%?<$,2X);T0*_&-
M9R28$Y\8D)!#B!2#4BU@_I)\&.LD@5D^2;(I2/")CIB"$F&IA-)$H$7QGW57
M;E!O>Q-]VCWNN_9-=-"87NW']D@62^D6B"#%4O(&B<=B)5J*DRR':;4,47EJ
M4710R@BT-'XLVX<QTZOA"_G'ONJGW5^#M-%_([?>@](VR(*40$D@Y!Y+D&O)
M3>-I ?08@-R2?R6=0&NG._]40V!*^U@<(O],"20#?_D_C(5S6TQ[@B$FM[0$
MAJX%:55UIY]2(*8$C_$@Z5>2Q^AKM67I%UIJI[_]9,CI')5*,EHEJ>1[Z1!,
MR2!+@]1'Z2&C+_:6U2<S7)-JYX<AJ"@L-5(RRF@9O9*W7=3*U;ZINDK.ZPI,
MJ1\K@K"8DD%.7P(NH[%8SRAC?(IC>E226?HR5_+):?FTY9WJ!ES)'@_#P B"
M?5(PUZ\Y.9\JDB&*Y7EF2;P23DX+IRWQE,YP)7D\"/AR)6S<(_IR'6NUK%,A
MIW-46LAI+=13[D7]N1(Y'H27N=(][I&8N4[#(DDT&3(PLTB9Y2\^2C %+9B_
MO;MY%]W73[+9C7^:7-@*A!(\$02HA=) X1&HA8[!AE9@B+*V J&T4]#:.:,$
M5%<0Z,][03!9*#44'C%9Z  \961#"$\MZ5<**F@%G9%^2H6$DD$1!)&%DCWA
M$9&%CK_3WD"&G,Y1*:6@E9+,OI<VD2@M3((P=*(T,?'(T(G.Q[U$B4F-#%$I
M6# Z45J:T%IZTY6=[-.^W>^J5?58;EXJ-*3^L1Z^6?5U:O>WZ^JI&FY0S6L>
MB9+() A>)THJ$X]XG;CQF@PYG2.ZQT*KZ[<7A6HGB1+.) A3)TI $X],G9B8
M6BN+(2BS%4;I;D+K[K<7AM0QI:E)$.I.E7"F'JD[U7EZ6A8RY'2.2FM36FN_
MI2A>^D^J5#8-0NVIDM74([6G.H_K)Y0IR'9"I4J-4UJ-QXN$5=T\UDU?Q*6,
MDBI%3</<MD;WK7W>N';3.QER.D>ENBFMNN[D4^TD5:J9!H'T5,EDZA'24QV_
MF4BFMUQ-47%L091,Z6LV ]+)$E "E"F-S((P>J84+_/(Z)E.W]/??W?(E2'$
MMJY#Z6@V@^ M]?'20S(EE5D0QL^49F8>&3_3 =YP%IFB[&>1$MO,(;9U(ZO[
MW=+VD:'U/4$ /U.2F7D$_,P-^&3(Z1R5RF8.E;5GG5P*I<0Q#T+MN5+)W".U
MYSJ/LYA-\FX(@M1RIR-7XIH[Q-6>>4IK<B5[>1 JSY6XY1ZI/'=3.1ER.D>E
MA[E##TU9]]($<J5T>1 RSY7RY1[)/->AVW!*&,C<>DJ@=9.T8'Z1;;66NZ[J
MJ[&MF^Z^O)=O;\O5USY9"]M"KA0P#X+CA5+$PB..%VX<)T-.YZA$M*!%=&$E
MJ%91*$4L@@!VH12R\ C8A>&&M[8XW!1DNRE>*&$M:&%=6 U*I0JEE$40VBZ4
M+!8>:;MPTS89<CI'I:0%K:2S*^&EI11*.8LP2\[1FG.?B\X-W*V?.H8@VZD#
M,5YU3LOMQWJ[E<W*0T^!&*U/C\,L4(_1"O78YQ+UV(WK=,QDGFCQ>4RK[K*"
M4*T%8K0&/0ZS"#U&J]!CG\O08QVKLZGOQ124<UM)T"KTV+$,?5%)2%= C-:D
MQV$6I<=H57KL<UEZ[&9R.F8R3[0L/7:L2Y]9$#].#NSA@2 X#R=6'X] ?QR,
M/HT,0=;3"'N$'":A%S?I.+EO;3'8Q -!^!ZPD0<\$OYQ,/+T(6,F\T3*ZS
MS2L$V5JPAP>"\#Q@.P]X)/KC8*>T/D5Z8Q2WGA5(<QU6H'G%H 4**2<$P7E
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MC%[0H3?=<@Z%O#TA%=92H9$*.Z3N(05.J&V.2F)DB'J#>!_[?C\:NN_-NEE
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MUFRSQ2[0:8L==N%K7]J.X.ALO0-C;AIC;JP\<TX81Z^ N;[\2YJ@.,>D:#/
M3M0=R<P.['(N.AMV8,!M8\"ME>>KS("WA6N'>;VP/=]VF-]Q;D3'8/^I'03K
M>[LJP;,R[:ZF$RZ'(UQ!OV-3SXX!!QWN1>\ 5D:X>Y53 7QE*E"!8GV]5F5(
M,]I4N1-3V[T9G^KJUU1D.YJJ='[$?*6.3I1#JBB]WK4ZM'E5C58=R=:F/ELR
MJ:H]T\Q4!0]<3U#O4\;DMJ,%FO\$XW]02P,$%     @ K#1)5**;W5H/!
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M>'-&:VXD.];'G"V3ZM!47Q[4N19S;:">[QB3+S?ZY-2=E-?_ 5!+ P04
M" "L-$E4ABS9Z7$#  #O"@  &0   'AL+W=O<FMS:&5E=',O<VAE970Y."YX
M;6RM5DUOVS@0_2N$T$,+M-&';=DI; -QE,7V$"!PMNUAL0=&&MM$*5)+4K';
M7[]#2E%MF59RV(LMDN\-W^/P8^9[J7[H'8 AAY(+O0AVQE2?PU#G.RBIOI(5
M"!S92%52@TVU#76E@!:.5/(PB:(T+"D3P7+N^A[4<BYKPYF !T5T7994_5P!
ME_M%$ <O'6NVW1G;$2[G%=W"(YBOU8/"5MA%*5@)0C,IB(+-(KB)/V=Q9 D.
M\8W!7A]]$VOE2<H?MO&E6 21500<<F-#4/Q[AEO@W$9"'?^V08-N3DL\_GZ)
M_H<SCV:>J(9;R;^SPNP6P2P@!6QHS<U:[O^$UM#$QLLEU^Z7[%ML%)"\UD:6
M+1D5E$PT__30+L01(4XO$)*6D/0)XPN$44L8O94P;@ECMS*-%;<.&35T.5=R
M3Y1%8S3[X1;3L=$^$S;OCT;A*$.>67X1N2R!_$4/H,DG\E4HR.56L%]0V$ZR
M @$;9C1YGX&AC.L/%O68D??O/I!WA ERSSC'#.IY:%"/C1KF[=RK9N[DPMQQ
M0NZE,#M-[D0!Q6F $(UT;I(7-ZMD,&(&^149Q1])$B6Q1]#MV^F1AYZ]F1Y?
M#[@9=;D9N7BC"_'6F J1,\ZH.R)R<SD]'\G=(>=UP<26W)2R%IBQ!U"8,6&[
MC,1QBMNGI:W!U$IH\O=:<D[P .VI*OX9D#SN)(^=Y/$%R2O8,N&F?**<BAQ\
MNZ(),7$A[+WTO)RFLWGX?)RH<TPZF9QB,@\FC3O,B?Y)IW\RJ/^F*)A=;.TN
MDX+@LAM<KTKJMEL!IP8'<$7-#O"$*@7"D)] E<]J,UMZ)''4,_HJ(CM'C/TF
MT\YD^K^9K!23RMGS'O#T3-LDZ1D\A\2S'B;S8.*)W^2T,SD=-+F&HLX;._@Z
M]@SB47K%V/1,T:=1/W4>S"3M.?-@XOC")IUUUF:#UNX.%5/=G: --;4!9XJS
MDADWXO,T\VCI6?) ^KGR0*9^/]>=G^M!/UA<& Y83!AO*JZ')FQD>R#QN*=[
M,,R)[CCZ_7A&PYD0Q2MW71O@Y++K;_];'ZA_(V8>T/&5V#@(CRJ!$M36552:
MY/9%:)[1KK>KVFY<K=+K7]EJSE48O\,TI> ]57C':\)A@R&CJRDJ4DUUU32,
MK%R]\20-5B_N<X<5*2@+P/&-E.:E82?H:MSE?U!+ P04    " "L-$E4;2R9
M+@4&   &'0  &0   'AL+W=O<FMS:&5E=',O<VAE970Y.2YX;6S-65UOVS84
M_2N$T0$ID$8B)7\5C@$G]M "2V?$:/<P[(&Q:%NH)'H4;2?[];ND9%&V:<KK
M^N  2?3!>WG(>^\Y%#G8<?$]7S$FT6N:9/E]:R7E^J/GY?,52VE^Q]<L@S<+
M+E(JX58LO7PM&(VT49IXQ/<[7DKCK#4<Z&=3,1SPC4SBC$T%RC=I2L7; TOX
M[KZ%6_L'S_%R)=4#;SA8TR6;,?EU/15PYU5>HCAE61[S# FVN&^-\,=)&"H#
MW>);S'9Y[1JIH;QP_EW=?([N6[Y"Q!(VE\H%A7];]LB21'D"''^73EM5G\JP
M?KWW_JL>/ SFA>;LD2=_Q)%<W;=Z+12Q!=TD\IGO/K%R0&WE;\Z37/]%N[*M
MWT+S32YY6AH#@C3.BO_TM9R(F@$)SAB0TH <&>#PC$%0&@27&H2E07BI0;LT
MT$/WBK'KB1M328<#P7=(J-;@35WHV=?6,%]QIA)E)@6\C<%.#F>2S[^CS]F<
M92IB:)K0+$<?D'[^X0%"$*%'GD)>YE1'=O*JKAFB680FL^D4W8R9I'&2OP>K
MK[,QNGGW'KU#'LI75+ <Q1GZFL4ROX6'</T4)PFXR0>>!/0*@S<OD3X42,D9
MI)B@)Y[)58XF6<2B0P<>#+L:.]F/_8$X/8[9_ X%^!81GV +H,?+S7V+^?AB
M<]RWF$_<YE_X]@Z1GC;O.28CJ!(AT/Z"<XF@PO7A10=\2M^ "R0:"4&S)5/7
MM_O 1SKRCW0=2YK$_[#H%HU2OH'6?_X&+M%GR=+\+P>@L (4:D"A*S-+0/-Z
M!K("B"V#"H]M[5%1Y'88]L*!MZT'U=+&]P_;C"UMVD'5YF X[6HX;?=PRG+(
M\PT,B*7KA+\QAG)=?^N-F*]@I&@-Y8=NH$Z*ZGEO&V313Z<&+O#UCQU@IP+8
M<0(<;9D ::AA$?&<(;[85_+^1:0!1CQ)J("G3!0-K%B++KLUK!W_KHWM2+L5
MTJX3Z60_>05Y_;Y6:9'KO"R>C-8@FO.X2!>M?;DC(7M5M[WKJ)!^!:C_TRND
M?Y+9O:/D?^R?Y%<7']6'I4G''E/L&R'RG:,Y4)F,2_0&RR0((U]FQ21"IL4\
M0K XVC]63:U"XNZ)@&M(74<$<$T^\?]#S8OLM,+$)\$(>F>FD1A Q%T<$/NY
MA(R0'&U9+IO8I'17CV7?12?8" H.G$B>H7>@$(6E*$N]#M#%,65"KW%AV8%T
M617O7!$QLH'#ZRA3;*@?-W#_#Q1JZ?)0IXZU#%NT@/2/BM76J-L]$UVC%M@M
M%\V)+U<@#7(%@N:J@<[),-NU$1R",P*!W0KQ,[G$W5/))0BC5"U.40=%],V9
MR$9N<,_I^AO4#R0,E&^!]A8M:"S0EB8;>\;T+!G3.<Z8TT;D-&,LC3KM,T$Q
M:H4OD"N;-J.;V>CYF)T.5_1&18A_'=5/C$00MT2,=E1$FHOC;%G&TA:_!C=!
MHVH1(Q*D421B483 @<?M _O-@(Q6$+=66)=T+L]&#LB5R $Q<D#<<G!Q0KC=
MA,WS;]B<N-G\</Y=+@T'D^Z53+QA5.)FU"^;] 4TR7S2T(U<<:$ZM<Y_[T0X
M.[YK;40,%Q(W%YXBV=(XH2\)TYJTA&F25DBG*^\ NR %ACD#]ZIX>O+=!TL5
M$+7])RH3:H_(!JK!<=^_\_U?7%L4ADH#-P<^Q5F<;E*7+\.! ;F._ QJ6S!N
M%KR4&!K<-"M%8.@S<._"/-'7IADWO!>TKV3&#>\%#9L>E\ZXVTV[><8-;P8-
M:]=O,_2)T006D\3'W=K>[,&J5FW4NOHSI!A<R;9&8-@Q^*_LZ.3IX)04VST7
M*8:&%$,W=_TH3Y=N+9MTYR 9#@P;EI-,9E1EA4H/']DV\%V[KX8?PROAQ]#P
M8^@FMA^,QJ1T>_B9[(Q&;9/:S8_EN/> X)>)+2N^+!<;N1%,;_GJG0[W3LRD
M[*F.DMA1>K7SGI2)I3YHRT&O8=:+XX_J:768-])'6$?/'_#'<7$D9]P4)X1/
M5"SC+$<)6X!+_ZX+U"Z*0[?B1O*U/E5ZX5+R5%^N&(V84 W@_8)SN;]1'51'
MG\-_ 5!+ P04    " "L-$E4VJ-X%0D$  ""$   &@   'AL+W=O<FMS:&5E
M=',O<VAE970Q,# N>&ULS5A=;^(X%/TK%MJ19J1M$B>0P B0:)G55MK1HE8[
M\S#:!Y=<P*H3L[:!\N_7=M+P,<9A9ONP?2AQ\#GV.3>YUY?ACHMGN0)0Z*5@
MI1QU5DJM/X:AG*^@(#+@:RCU-PLN"J+T4"Q#N19 <@LJ6!A'41H6A):=\=#>
MFXGQD&\4HR7,!)*;HB!B?PN,[T8=W'F]\4"7*V5NA./AFBSA$=1?ZYG0H[!A
MR6D!I:2\1 (6H\X$?YSBU #LC"\4=O+H&ADI3YP_F\%]/NI$9D? 8*X,!=$?
M6[@#Q@R3WL<_-6FG6=, CZ]?V7^SXK68)R+ACK.O-%>K4:??03DLR(:I![[[
M'6I!/<,WYTS:_VA7S<T&'33?2,6+&JQW4-"R^B0OM1%'@+AW 1#7@/A:0%(#
MDFL!W1K0M<Y44JP/4Z+(>"CX#@DS6[.9"VNF16OYM#1Q?U1"?TLU3HT?%9\_
MH_MR#J4) )HQ4DIT@[X0MB%59,H<3:1^+M9F*-'[*2A"F?R@9_V"0B171( <
MADKOQG"&\WKEVVKE^,+*.$:?>:E6$GTJ<\A/"4(MH]$2OVJYC;V,4Y@'*,&_
MHCB*L6-#=]?#(P=\>C4<#SQJDB8RB>7K7N#[5*P9WP,@&R(/8;<A[%K"Y%*H
M3:!NS$N2HSM>Z,PAJPA/A"#E$O3;K-#3'AW/FY&]O3W9$9&C;W]H2G2OH)!_
M>S;4:S;4\RJ<TBW-03]>>PHL=SU!?CP.DNX[5YS;8-W4!9NVP;+HG4=UVJA.
M_7%]6>N<I[W=<J;]9U3M7=+])'$OB#.G=C\NR8(8.\6WK)<%@W/33M1GC?K,
M2_1 Y?/-0NC'FI8*=.)02! %+@?\1%$0]9T&M,'Z;OU^6/R]W2?R^XW\_G7!
M9W0!Z#TMT1Z(D!]<^OU,*2IL]G19\-/(Z<\@3XP8-$8,O%1?;4&&_(9L0>@#
M!EKJ'*10KI\%M"!4H*TN0)5#.6=,>X36(*IBXW2K6BZSRYG#SE87F*#7&X;;
M8V<<LY*@?S9KZI@5!3W<S#I1C*-#J8V\FJM:^V=51ST>XJ/BC?\?*1W'ARW%
M_S&IMQ#$0>I^L5MP2="-G6]V*^Z[]4ZE'PHV;JG8UV7V%A:=:O%YH:D-: 'J
MFG#!@1:@+FW>Y(X/1PS<?:OTWL*$ YRX7?#CHB!U)_A67,_OP>%4@_T'A1_)
M\2U4:05%29UX$>[K%+EW)OVWHYJ^"=6I>X?3$?:?--Z\,-3KG63S;M#+SBJ#
M8UH_R++!\=]9F7! 4GU.."L3X5%S5H!8VB97HCG?E*KJ;9J[32,]L>WCV?U;
MTV#;IN] 4W7GGXE84MV:,5AHRBC(=/Q$U?!6 \77M@5\XDHWE/9R!20'82;H
M[Q><J]>!6:#YV6'\+U!+ P04    " "L-$E4IZENM"T#  "#"@  &@   'AL
M+W=O<FMS:&5E=',O<VAE970Q,#$N>&ULI999;^(P$,>_RBC:AU;:DI.C%2#U
MV*,/E5"[;9]-,A"KB<W:!K;2?OCU$0*[)(BR+XGM>/[^>3(SFN&:BS>9(RKX
M519,CKQ<J<65[\LTQY+(#E\@TU]F7)1$Z:F8^W(AD&36J"S\* AZ?DDH\\9#
MNS81XR%?JH(RG B0R[(DXOT&"[X>>:&W67BD\UR9!7\\7) Y/J%Z7DR$GOFU
M2D9+9))R!@)G(^\ZO+H)$V-@=[Q07,N=,9BK3#E_,Y/[;.0%A@@+3)61(/JU
MPELL"J.D.7Y6HEY]IC'<'6_4O]K+Z\M,B<1;7KS23.4C;^!!AC.R+-0C7W_'
MZD)=HY?R0MHGK*N]@0?I4BI>5L::H*3,O<FORA$[!G&;05091);;'60I[X@B
MXZ'@:Q!FMU8S WM5:ZWA*#-_Y4D)_95J.S5^4CQ]@WN6(C/N@4E!F(0+>$2I
M!$T59N"V7!OW4?4.9W>H""WD>=.N9T:5!,(RF*"P,:.5X2DG JMOTHPE4 8_
M<KZ4>JL<^DK?Q/#X:45]XZBC%NHP@@?.5"[A"\LP^UO URZH_1!M_' 3'52\
MP[0#<?@9HB */X%?<;KG ?VX]G-L]>,6?7OY SI)K9-8G:159Z5]KOU-%$QQ
M3AFC; Y\!@L4E&=PIAWKH,_A-S3A.V^X4WKV%).YJW&8#*)DZ*\:X+HU7/<@
MW#=!F&$[%J*[!]$++X-FAE[-T#O(\.+<<RQ";P_AHILD@V:&?LW0/\B@Z\4,
MZ4<P^OL8813WFC$&-<;@Z%A!G9(?CY)!0Y3$<<L?NJRQ+@^FPJNME 9KA4)7
M?IB;L(&,*(09H0)6I%BB9<QX41 A#;:C/#^00F&PK7G!:4GTCD2T'*S]M"T+
MC17+G=G?<59WT FC9F>%.P4Z/#JI3L%RZH,=K'[2B2];L*(M5G1LGIU"%351
M)?T6JFV5#>,/9-XI8/$>6"_NM-3%<%NUP^/+=I6*_Q5KR5ZL:<K@WUCS=_J"
M$L7<=C\24KYDRK4(]6K=85V[OF*[W;5G#T3H/)%0X$R;!IV^KMW"=3QNHOC"
M=AE3KG3/8H>Y[A)1F WZ^XQSM9F8 ^J^<_P'4$L#!!0    ( *PT250N9CN-
MT 8  /,A   :    >&PO=V]R:W-H965T<R]S:&5E=#$P,BYX;6S-6EUOFSH8
M_BM6U(M6:A-L$PA36REM.IU*FT[4GIU=3.?"!2=! YS93C_^_;&!8!+ I.O.
M3G>Q@O/:?M[/QR]P_L3X=[&B5(+G-,G$Q6 EY?K#:"3"%4V)&+(US=0O"\93
M(M4M7X[$FE,2Y9/29(0<QQNE),X&E^?YV)Q?GK.-3.*,SCD0FS0E_.6*)NSI
M8@ 'VX&[>+F2>F!T>;XF2WI/Y9?UG*N[4;5*%*<T$S'+ *>+B\$4?IBY8STA
ME_@[ID^B=@VT*@^,?=<WM]'%P-&(:$)#J9<@ZL\CO:9)HE=2.'Z4BPZJ/?7$
M^O5V]8^Y\DJ9!R+H-4N^QI%<70PF Q#1!=DD\HX]_4%+A7* (4M$_C]X*F6=
M 0@W0K*TG*P0I'%6_"7/I2%J$Y#;,0&5$]#>!-@U 9<3\*$3W'*"FUNF4"6W
MPXQ(<GG.V1/@6EJMIB]R8^:SE?IQIOU^+[GZ-5;SY.6]9.%W<)N%--,. /.$
M9 *<@6+\SW7AG"P"]],[,-5.BN4+.)Y12>)$G"C)+_<S<'QT H[ "(@5X52
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M]P<F)4OSRQ4E$>5:0/V^8$QN;_0&U7<>E_\"4$L#!!0    ( *PT252#3_J
M>0(  ','   :    >&PO=V]R:W-H965T<R]S:&5E=#$P,RYX;6R]E5MOVC 4
MQ[^*%4U:*W7DPJ50A4@MV;1*W81@W1ZF/9CD0*S:<6H[4/;I9SNIQ5:@[32-
M!^)C^_<_-SB)-US<R0) H0=&2SGV"J6J"]^760$,RPZOH-0G2RX85MH4*U]6
M G!N(4;]* @&/L.D])+8[DU%$O-:45+"5"!9,X;%]@HHWXR]T'O<F)%5H<R&
MG\057L$<U&TU%=KRG4I.&)22\!()6(Z]R_ B'9G[]L)7 ANYLT8FDP7G=\:X
MSL=>8 (""IDR"E@_UC !2HV0#N.^U?2<2P/NKA_5/]C<=2X++&'"Z3>2JV+L
M#3V4PQ+75,WXYB.T^?2-7L:IM-]HT]P=:(]9+15G+:QM1LKFB1_:.NP X?
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MO81L((3D>.\LM#47)(K<8,>,1SLUOPC9!+;K1FK_%I=DW*ET/"J6M3!0HZK
MV _LZ]-6TBO[Q'Z@+E&30>4(&W:K"0Q8LNQT#B2DLF<.]+"<L].3,W;"I&9W
MTD%1VYR3L^7%>3E8N.DMI$<LS*&<L"SYR-(X30[09^^GQW_3N0MC3"0=$TF#
M7G9$;\C@]_7*DG%3]N<_FMFHF07-\R.:_\0I=W$>"JM7N@A*_AM\+K+X,N?/
M^XD<P"3IB.DM\KVA\!_DG3 ;J2U3L':L>/+9T4T_Y'U!V(8Y62&YJ0O+VOT7
MP'B .U\CTJ[PHS?^:8HW4$L#!!0    ( *PT250<)HO!SP8  (\F   :
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M=351BS.>G% 3)W:\F8IH0T;F)!_T$@&0/@[&\!P370 0?P%P6CDDMF+W3:X
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M?=S 4$ZE <#WE1!Z_V(V*,?\Z;]02P,$%     @ K#1)5(4![.E% @  -@4
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MTTC/NE;+0A%,R)SID5C>0%%0EF HF,I^T3*W;7H6"N=*B[@0FPQBRO,G>2]
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M?HW))UHDV4U@++2Y5V3#F;GZ@4P-S/>)$'HU22\7Y66R]Q]02P,$%     @
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M2@LPZY40^GE@'?1=]/(74$L#!!0    ( *PT250=\ITE-@,  ",)   :
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M@T-;5*KNR/7$R*7O40MI;,?SP]*^8E"Y#?9[+J5YF3@'[;MH\A=02P,$%
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M2.D-1GB79#.KFXT6M9U>*Z'QMMAE@<\;2.. YVLA]'YC G0/9O('4$L#!!0
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M/I>UOM'5JCNI]+G21DVZRX7*9JIN >;W>57I^YNV@LWIN-/_ 5!+ P04
M" "L-$E4!M6+OF(&  !)'   &@   'AL+W=O<FMS:&5E=',O<VAE970Q,38N
M>&ULO5E=;]LV%/TKA+&'%DABD?)GD01P[-5VT&U!O*X/Q1YHF;:Y2*)&4G%3
M[,>/E&3),FE:W=+VH9&L>P_O(7G/O92N=XP_B2TA$GR)PEC<M+92)N_:;1%L
M283%%4M(K)ZL&8^P5+=\TQ8))WB5.45A&WE>KQUA&K=NK[/?'OCM-4ME2&/R
MP(%(HPCSESL2LMU-"[;V/SS2S5;J']JWUPG>D 61'Y,'KN[:)<J*1B06E,6
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M<&V@GJ\9D_L;_=&C_'IX^R]02P,$%     @ K#1)5'Y%LS<= P  "A(   T
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M%BX.C>#JT(C92WW5SSUSW*,(KA>-F+5$"Z!Q5=((;R3 O9- "$J/%BXLN0Y
M\>X"S%H*0;L8M)U$[EX(0*&6N#<=@&LD@TJO$=Z*@'LO@L>%\,&=&H!"+7%O
M1] 'ZN].UZ*EED'?A#<JX-ZI ((&4\DCO&%!MV/!27MY_?K52JUUI5:?W3^I
MW?E"EL7<"O^C?:_Q-/:KX]>'LCQWY[Y4'XU<W6YR=;M!U^O_ %!+ P04
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M\]\O/][LO^_O7 ]?9TPW?P%02P,$%     @ K#1)5+QM*B., @  8T$  !,
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ K#1)5+621\#N    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
MK#1)5)E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    " "L-$E4!>Q!G\L&  !\&@  &
M    @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
MK#1)5%=%UZHB @  <@4  !@              ("!#@\  'AL+W=O<FMS:&5E
M=',O<VAE970R+GAM;%!+ 0(4 Q0    ( *PT252!/V.V30<  .TC   8
M          " @681  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M    " "L-$E4]E'(L-8#  #H#   &               @('I&   >&PO=V]R
M:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ K#1)5,NXT;F!!P  D2
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M965T.2YX;6Q02P$"% ,4    " "L-$E4A,;%R!0H   XAP  &0
M    @(&(0@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    (
M *PT252$S2N^F0,  ,8(   9              " @=-J  !X;"]W;W)K<VAE
M971S+W-H965T,3$N>&UL4$L! A0#%     @ K#1)5!?6IV0&$0  W#0  !D
M             ("!HVX  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"
M% ,4    " "L-$E4^Y";X(@1  #+/   &0              @('@?P  >&PO
M=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( *PT2523;7)=5P@
M  \7   9              " @9^1  !X;"]W;W)K<VAE971S+W-H965T,30N
M>&UL4$L! A0#%     @ K#1)5.N@?I&H#0  LDD  !D              ("!
M+9H  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " "L-$E4
M8>:(R%X(   ;&   &0              @($,J   >&PO=V]R:W-H965T<R]S
M:&5E=#$V+GAM;%!+ 0(4 Q0    ( *PT250Z_3>D70T  *,P   9
M      " @:&P  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%
M  @ K#1)5 P8$!D%%   %4$  !D              ("!-;X  'AL+W=O<FMS
M:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " "L-$E4/XY_7IP)  #C&
M&0              @(%QT@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+
M 0(4 Q0    ( *PT252\5[EEEPT  "\L   9              " @43<  !X
M;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ K#1)5+&AZ*[?
M"   LQ8  !D              ("!$NH  'AL+W=O<FMS:&5E=',O<VAE970R
M,2YX;6Q02P$"% ,4    " "L-$E4&19E]E8%   %$   &0
M@($H\P  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( *PT
M251WQI:)  0  %X)   9              " @;7X  !X;"]W;W)K<VAE971S
M+W-H965T,C,N>&UL4$L! A0#%     @ K#1)5"-0/<E5!@  YPX  !D
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M=#(X+GAM;%!+ 0(4 Q0    ( *PT251N(!*-30P  -4H   9
M  " @<F> 0!X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @
MK#1)5!)-:D7"!P  WQD  !D              ("!3:L! 'AL+W=O<FMS:&5E
M=',O<VAE970S,"YX;6Q02P$"% ,4    " "L-$E4&!Q6G 4%   :#   &0
M            @(%&LP$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4
M Q0    ( *PT250"&IH4J@8   D6   9              " @8*X 0!X;"]W
M;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ K#1)5!X,QD*\!0
M:!   !D              ("!8[\! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX
M;6Q02P$"% ,4    " "L-$E4O7QQ8[$%  #M$   &0              @(%6
MQ0$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( *PT252^
MT)HLG@D  !PD   9              " @3[+ 0!X;"]W;W)K<VAE971S+W-H
M965T,S4N>&UL4$L! A0#%     @ K#1)5+#^XT72!0  %@\  !D
M     ("!$]4! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *PT250J@OSYT@,  (P)   9              "
M@7OP 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ K#1)
M5-TZ1Z!-#   JB,  !D              ("!A/0! 'AL+W=O<FMS:&5E=',O
M<VAE970T,BYX;6Q02P$"% ,4    " "L-$E4-3W4!*<,   U0P  &0
M        @($( 0( >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0
M   ( *PT251G@2^OV0(  '\(   9              " @>8- @!X;"]W;W)K
M<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ K#1)5+?N=>BY @  PP<
M !D              ("!]A " 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q0
M2P$"% ,4    " "L-$E4?P^*HV,#   X#0  &0              @('F$P(
M>&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( *PT250YL*QQ
M3 D  ,)    9              " @8 7 @!X;"]W;W)K<VAE971S+W-H965T
M-#<N>&UL4$L! A0#%     @ K#1)5$7_7J=> @  X@4  !D
M ("! R$" 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " "L
M-$E4"(9\KL\"  !9!P  &0              @(&8(P( >&PO=V]R:W-H965T
M<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( *PT2506_6"D  0  &00   9
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M970U-"YX;6Q02P$"% ,4    " "L-$E4<\^5MVP&  "$)   &0
M    @($5. ( >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    (
M *PT252478 .3 0  . 3   9              " @;@^ @!X;"]W;W)K<VAE
M971S+W-H965T-38N>&UL4$L! A0#%     @ K#1)5 O[2!+,"0  \T4  !D
M             ("!.T," 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"
M% ,4    " "L-$E4_7WG =P&  "W+P  &0              @($^30( >&PO
M=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( *PT250&X;_JAP(
M '@&   9              " @5%4 @!X;"]W;W)K<VAE971S+W-H965T-3DN
M>&UL4$L! A0#%     @ K#1)5#D1RPB<!@  BS$  !D              ("!
M#U<" 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    " "L-$E4
M<Y*V'',"  "0!@  &0              @('B70( >&PO=V]R:W-H965T<R]S
M:&5E=#8Q+GAM;%!+ 0(4 Q0    ( *PT250:;[_<900  -P1   9
M      " @8Q@ @!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%
M  @ K#1)5/@\A9J6 @  , <  !D              ("!*&4" 'AL+W=O<FMS
M:&5E=',O<VAE970V,RYX;6Q02P$"% ,4    " "L-$E4>SU 21 *  "75P
M&0              @('U9P( >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+
M 0(4 Q0    ( *PT251D'>I4Z0<  +HQ   9              " @3QR @!X
M;"]W;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ K#1)5$IOW)W#
M @  1P@  !D              ("!7'H" 'AL+W=O<FMS:&5E=',O<VAE970V
M-BYX;6Q02P$"% ,4    " "L-$E4(9:_!%8$  !7%@  &0
M@(%6?0( >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( *PT
M252/=2Q 204  (LD   9              " @>.! @!X;"]W;W)K<VAE971S
M+W-H965T-C@N>&UL4$L! A0#%     @ K#1)5!6I%(O% @  F@@  !D
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M=#<S+GAM;%!+ 0(4 Q0    ( *PT251B4EKS% 4  &4:   9
M  " @0^; @!X;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @
MK#1)5&L-9=UT P  @0L  !D              ("!6J " 'AL+W=O<FMS:&5E
M=',O<VAE970W-2YX;6Q02P$"% ,4    " "L-$E4J=,'VC<#  #3"0  &0
M            @($%I ( >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4
M Q0    ( *PT2539G$+XY ,  !4/   9              " @7.G @!X;"]W
M;W)K<VAE971S+W-H965T-S<N>&UL4$L! A0#%     @ K#1)5(-C&F0P!
M?A(  !D              ("!CJL" 'AL+W=O<FMS:&5E=',O<VAE970W."YX
M;6Q02P$"% ,4    " "L-$E4MF2Q01H#  #J"@  &0              @('U
MKP( >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( *PT251M
M+9=%1P(  )L$   9              " @4:S @!X;"]W;W)K<VAE971S+W-H
M965T.# N>&UL4$L! A0#%     @ K#1)5(<IH8<E P  4 D  !D
M     ("!Q+4" 'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *PT2530Y>9_;@L  '!2   9              "
M@9K3 @!X;"]W;W)K<VAE971S+W-H965T.#8N>&UL4$L! A0#%     @ K#1)
M5/@L=L5@!   (A0  !D              ("!/]\" 'AL+W=O<FMS:&5E=',O
M<VAE970X-RYX;6Q02P$"% ,4    " "L-$E4% N.F*($  "L$0  &0
M        @('6XP( >&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0
M   ( *PT250J?XN$(@,  "L)   9              " @:_H @!X;"]W;W)K
M<VAE971S+W-H965T.#DN>&UL4$L! A0#%     @ K#1)5/YA]YRU @  4 @
M !D              ("!".P" 'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6Q0
M2P$"% ,4    " "L-$E4,LBI#+0.  "IA0  &0              @('T[@(
M>&PO=V]R:W-H965T<R]S:&5E=#DQ+GAM;%!+ 0(4 Q0    ( *PT252!CZFL
M!00  # 1   9              " @=_] @!X;"]W;W)K<VAE971S+W-H965T
M.3(N>&UL4$L! A0#%     @ K#1)5%$#DS3% @  X0D  !D
M ("!&P(# 'AL+W=O<FMS:&5E=',O<VAE970Y,RYX;6Q02P$"% ,4    " "L
M-$E4"1ICJ0L#  !/"@  &0              @($7!0, >&PO=V]R:W-H965T
M<R]S:&5E=#DT+GAM;%!+ 0(4 Q0    ( *PT250.FNU1!0,  &<(   9
M          " @5D( P!X;"]W;W)K<VAE971S+W-H965T.34N>&UL4$L! A0#
M%     @ K#1)5."2[=XY P  'PP  !D              ("!E0L# 'AL+W=O
M<FMS:&5E=',O<VAE970Y-BYX;6Q02P$"% ,4    " "L-$E4HIO=6@\$   U
M#P  &0              @($%#P, >&PO=V]R:W-H965T<R]S:&5E=#DW+GAM
M;%!+ 0(4 Q0    ( *PT252&+-GI<0,  .\*   9              " @4L3
M P!X;"]W;W)K<VAE971S+W-H965T.3@N>&UL4$L! A0#%     @ K#1)5&TL
MF2X%!@  !AT  !D              ("!\Q8# 'AL+W=O<FMS:&5E=',O<VAE
M970Y.2YX;6Q02P$"% ,4    " "L-$E4VJ-X%0D$  ""$   &@
M    @($O'0, >&PO=V]R:W-H965T<R]S:&5E=#$P,"YX;6Q02P$"% ,4
M" "L-$E4IZENM"T#  "#"@  &@              @(%P(0, >&PO=V]R:W-H
M965T<R]S:&5E=#$P,2YX;6Q02P$"% ,4    " "L-$E4+F8[C= &  #S(0
M&@              @('5) , >&PO=V]R:W-H965T<R]S:&5E=#$P,BYX;6Q0
M2P$"% ,4    " "L-$E4@T_Z@'D"  !S!P  &@              @('=*P,
M>&PO=V]R:W-H965T<R]S:&5E=#$P,RYX;6Q02P$"% ,4    " "L-$E4G&XZ
M$Q\#   K"   &@              @(&.+@, >&PO=V]R:W-H965T<R]S:&5E
M=#$P-"YX;6Q02P$"% ,4    " "L-$E42$D?\<0"  !#"@  &@
M    @('E,0, >&PO=V]R:W-H965T<R]S:&5E=#$P-2YX;6Q02P$"% ,4
M" "L-$E4O9O-/6T#  #E"0  &@              @('A- , >&PO=V]R:W-H
M965T<R]S:&5E=#$P-BYX;6Q02P$"% ,4    " "L-$E4[NC2*00"  !U!
M&@              @(&&. , >&PO=V]R:W-H965T<R]S:&5E=#$P-RYX;6Q0
M2P$"% ,4    " "L-$E4'":+P<\&  "/)@  &@              @('".@,
M>&PO=V]R:W-H965T<R]S:&5E=#$P."YX;6Q02P$"% ,4    " "L-$E4\K1!
MA6 $  #R#P  &@              @(')00, >&PO=V]R:W-H965T<R]S:&5E
M=#$P.2YX;6Q02P$"% ,4    " "L-$E4A0'LZ44"   V!0  &@
M    @(%A1@, >&PO=V]R:W-H965T<R]S:&5E=#$Q,"YX;6Q02P$"% ,4
M" "L-$E4Z9SR8_H"  !8"@  &@              @('>2 , >&PO=V]R:W-H
M965T<R]S:&5E=#$Q,2YX;6Q02P$"% ,4    " "L-$E4TCGWP&4#  !1"P
M&@              @($03 , >&PO=V]R:W-H965T<R]S:&5E=#$Q,BYX;6Q0
M2P$"% ,4    " "L-$E4'?*=)38#   C"0  &@              @(&M3P,
M>&PO=V]R:W-H965T<R]S:&5E=#$Q,RYX;6Q02P$"% ,4    " "L-$E4\U@V
MC)D"   \!P  &@              @($;4P, >&PO=V]R:W-H965T<R]S:&5E
M=#$Q-"YX;6Q02P$"% ,4    " "L-$E4_+HWNB@'   I)P  &@
M    @('L50, >&PO=V]R:W-H965T<R]S:&5E=#$Q-2YX;6Q02P$"% ,4
M" "L-$E4!M6+OF(&  !)'   &@              @(%,70, >&PO=V]R:W-H
M965T<R]S:&5E=#$Q-BYX;6Q02P$"% ,4    " "L-$E4?D6S-QT#   *$@
M#0              @ 'F8P, >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( *PT
M2527BKL<P    !,"   +              "  2YG P!?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( *PT252-HI#9! @  "1,   /              "  1=H P!X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "L-$E4R3 A4S@#   71   &@
M            @ %(< , >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " "L-$E4O&TJ(XP"  !C00  $P              @ &X<P, 6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     ? !\ "PB  !U=@,    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>965</ContextCount>
  <ElementCount>789</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>235</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>15</UnitCount>
  <MyReports>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000010001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>000020002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100010003 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100020004 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100030005 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100040006 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100050007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100060008 - Statement - Consolidated Statements of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity</Role>
      <ShortName>Consolidated Statements of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100070009 - Statement - Consolidated Statements of Shareholders' Equity (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals</Role>
      <ShortName>Consolidated Statements of Shareholders' Equity (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>210011001 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>210131002 - Disclosure - Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Divestitures</Role>
      <ShortName>Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>210151003 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>210281004 - Disclosure - Fair Value</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValue</Role>
      <ShortName>Fair Value</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>210361005 - Disclosure - Goodwill and Other Intangibles</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangibles</Role>
      <ShortName>Goodwill and Other Intangibles</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>210421006 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>210491007 - Disclosure - Health Care Costs Payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayable</Role>
      <ShortName>Health Care Costs Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>210551008 - Disclosure - Borrowings and Credit Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditArrangements</Role>
      <ShortName>Borrowings and Credit Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>210611009 - Disclosure - Pension Plans and Other Postretirement Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>210701010 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>210771011 - Disclosure - Stock Incentive Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlans</Role>
      <ShortName>Stock Incentive Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>210831012 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>210901013 - Disclosure - Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncome</Role>
      <ShortName>Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>210931014 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>210961015 - Disclosure - Reinsurance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/Reinsurance</Role>
      <ShortName>Reinsurance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>211011016 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>211031017 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>220022001 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>230033001 - Disclosure - Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>230163002 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Investments</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>230293003 - Disclosure - Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueTables</Role>
      <ShortName>Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/FairValue</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>230373004 - Disclosure - Goodwill and Other Intangibles (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables</Role>
      <ShortName>Goodwill and Other Intangibles (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/GoodwillandOtherIntangibles</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>230433005 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Leases</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>230503006 - Disclosure - Health Care Costs Payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableTables</Role>
      <ShortName>Health Care Costs Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/HealthCareCostsPayable</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>230563007 - Disclosure - Borrowings and Credit Arrangements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables</Role>
      <ShortName>Borrowings and Credit Arrangements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/BorrowingsandCreditArrangements</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>230623008 - Disclosure - Pension Plans and Other Postretirement Benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>230713009 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/IncomeTaxes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>230783010 - Disclosure - Stock Incentive Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlansTables</Role>
      <ShortName>Stock Incentive Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/StockIncentivePlans</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>230843011 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/ShareholdersEquity</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>230913012 - Disclosure - Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeTables</Role>
      <ShortName>Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherComprehensiveIncome</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>230943013 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/EarningsPerShare</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>230973014 - Disclosure - Reinsurance (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ReinsuranceTables</Role>
      <ShortName>Reinsurance (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/Reinsurance</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>231043015 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/SegmentReporting</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>240044001 - Disclosure - Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>240054002 - Disclosure - Significant Accounting Policies - Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails</Role>
      <ShortName>Significant Accounting Policies - Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>240064003 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails</Role>
      <ShortName>Significant Accounting Policies - Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>240074004 - Disclosure - Significant Accounting Policies - Property Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails</Role>
      <ShortName>Significant Accounting Policies - Property Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>240084005 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails</Role>
      <ShortName>Significant Accounting Policies - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>240094006 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails</Role>
      <ShortName>Significant Accounting Policies - Receivables and Contracted Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>240104007 - Disclosure - Significant Accounting Policies - Contract Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails</Role>
      <ShortName>Significant Accounting Policies - Contract Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>240114008 - Disclosure - Significant Accounting Policies - Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails</Role>
      <ShortName>Significant Accounting Policies - Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>240124009 - Disclosure - Significant Accounting Policies - Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails</Role>
      <ShortName>Significant Accounting Policies - Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>240144010 - Disclosure - Divestitures - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/DivestituresNarrativeDetails</Role>
      <ShortName>Divestitures - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>240174011 - Disclosure - Investments - Schedule of Total Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails</Role>
      <ShortName>Investments - Schedule of Total Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>240184012 - Disclosure - Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>240194013 - Disclosure - Investments - Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails</Role>
      <ShortName>Investments - Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>240204014 - Disclosure - Investments - Debt Securities by Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails</Role>
      <ShortName>Investments - Debt Securities by Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>240214015 - Disclosure - Investments - Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails</Role>
      <ShortName>Investments - Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>240224016 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails</Role>
      <ShortName>Investments - Unrealized Loss Position Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>240234017 - Disclosure - Investments - Mortgage Loans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails</Role>
      <ShortName>Investments - Mortgage Loans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>240244018 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails</Role>
      <ShortName>Investments - Mortgage Loans Credit Ratings Indicator (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>240254019 - Disclosure - Investments - Schedule of Mortgage Loan Principal Repayments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails</Role>
      <ShortName>Investments - Schedule of Mortgage Loan Principal Repayments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>240264020 - Disclosure - Investments - Net Investment Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails</Role>
      <ShortName>Investments - Net Investment Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>240274021 - Disclosure - Investments - Realized Gains (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails</Role>
      <ShortName>Investments - Realized Gains (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>240304022 - Disclosure - Fair Value - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails</Role>
      <ShortName>Fair Value - Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>240314023 - Disclosure - Fair Value - Changes in Level 3 Financial Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails</Role>
      <ShortName>Fair Value - Changes in Level 3 Financial Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>240324024 - Disclosure - Fair Value - Gross Transfers Into (Out Of) Level 3 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details</Role>
      <ShortName>Fair Value - Gross Transfers Into (Out Of) Level 3 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>240334025 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails</Role>
      <ShortName>Fair Value - Carrying Value and Fair Value Classified by Level (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>240344026 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails</Role>
      <ShortName>Fair Value - Separate Accounts Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>240354027 - Disclosure - Fair Value - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/FairValueNarrativeDetails</Role>
      <ShortName>Fair Value - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>240384028 - Disclosure - Goodwill and Other Intangibles - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails</Role>
      <ShortName>Goodwill and Other Intangibles - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>240394029 - Disclosure - Goodwill and Other Intangibles - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails</Role>
      <ShortName>Goodwill and Other Intangibles - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>240404030 - Disclosure - Goodwill and Other Intangibles - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangibles - Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>240414031 - Disclosure - Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>240444032 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>240454033 - Disclosure - Leases - Summary of the Components of Net Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails</Role>
      <ShortName>Leases - Summary of the Components of Net Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>240464034 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails</Role>
      <ShortName>Leases - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>240474035 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>240484036 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Operating and Finance Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>240514037 - Disclosure - Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails</Role>
      <ShortName>Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>240524038 - Disclosure - Health Care Costs Payable - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails</Role>
      <ShortName>Health Care Costs Payable - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>240534039 - Disclosure - Health Care Costs Payable - Reconciliation of Health Care Net Incurred and Paid Claims Development to Health Care Costs Payable Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails</Role>
      <ShortName>Health Care Costs Payable - Reconciliation of Health Care Net Incurred and Paid Claims Development to Health Care Costs Payable Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>240544040 - Disclosure - Health Care Costs Payable - Reconciliation of Health Care Costs Payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails</Role>
      <ShortName>Health Care Costs Payable - Reconciliation of Health Care Costs Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>240574041 - Disclosure - Borrowings and Credit Arrangements - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>240584042 - Disclosure - Borrowings and Credit Arrangements - Debt Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Debt Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>240594043 - Disclosure - Borrowings and Credit Arrangements - Short-term Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Short-term Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>240604044 - Disclosure - Borrowings and Credit Arrangements - Long-Term Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Long-Term Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>240634045 - Disclosure - Pension Plans and Other Postretirement Benefits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>240644046 - Disclosure - Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>240654047 - Disclosure - Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>240664048 - Disclosure - Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>240674049 - Disclosure - Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>240684050 - Disclosure - Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>240694051 - Disclosure - Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails</Role>
      <ShortName>Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>240724052 - Disclosure - Income Taxes - Income Tax Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails</Role>
      <ShortName>Income Taxes - Income Tax Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>240734053 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>240744054 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes - Effective Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>240754055 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>240764056 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>240794057 - Disclosure - Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails</Role>
      <ShortName>Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>240804058 - Disclosure - Stock Incentive Plans - Valuation and Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails</Role>
      <ShortName>Stock Incentive Plans - Valuation and Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>240814059 - Disclosure - Stock Incentive Plans - Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails</Role>
      <ShortName>Stock Incentive Plans - Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>240824060 - Disclosure - Stock Incentive Plans - Stock Option and SAR Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails</Role>
      <ShortName>Stock Incentive Plans - Stock Option and SAR Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>240854061 - Disclosure - Shareholders' Equity - Share Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails</Role>
      <ShortName>Shareholders' Equity - Share Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>240864062 - Disclosure - Shareholders' Equity - Accelerated Share Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails</Role>
      <ShortName>Shareholders' Equity - Accelerated Share Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>240874063 - Disclosure - Shareholders' Equity - Dividends (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails</Role>
      <ShortName>Shareholders' Equity - Dividends (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>240884064 - Disclosure - Shareholders' Equity - Regulatory Requirements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails</Role>
      <ShortName>Shareholders' Equity - Regulatory Requirements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>240894065 - Disclosure - Shareholders' Equity - Noncontrolling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails</Role>
      <ShortName>Shareholders' Equity - Noncontrolling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>240924066 - Disclosure - Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails</Role>
      <ShortName>Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/OtherComprehensiveIncomeTables</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>240954067 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/EarningsPerShareTables</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>240984068 - Disclosure - Reinsurance - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ReinsuranceNarrativeDetails</Role>
      <ShortName>Reinsurance - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>240994069 - Disclosure - Reinsurance - Reinsurance Recoverables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails</Role>
      <ShortName>Reinsurance - Reinsurance Recoverables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>241004070 - Disclosure - Reinsurance - Effects of Reinsurance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails</Role>
      <ShortName>Reinsurance - Effects of Reinsurance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>241024071 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cvshealth.com/role/CommitmentsandContingencies</ParentRole>
      <Position>113</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>241054072 - Disclosure - Segment Reporting - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>Segment Reporting - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>241064073 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails</Role>
      <ShortName>Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>115</Position>
    </Report>
    <Report instance="cvs-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>241074074 - Disclosure - Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails</Role>
      <ShortName>Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="cvs-20211231.htm">cvs-20211231.htm</File>
    <File>cvs-20211231.xsd</File>
    <File>cvs-20211231_cal.xml</File>
    <File>cvs-20211231_def.xml</File>
    <File>cvs-20211231_lab.xml</File>
    <File>cvs-20211231_pre.xml</File>
    <File>exhibit1010-2021.htm</File>
    <File>exhibit1025-2021.htm</File>
    <File>exhibit1055-2021.htm</File>
    <File>exhibit211-2021.htm</File>
    <File>exhibit231-2021.htm</File>
    <File>exhibit311-2021.htm</File>
    <File>exhibit312-2021.htm</File>
    <File>exhibit321-2021.htm</File>
    <File>exhibit322-2021.htm</File>
    <File>exhibit423-2021.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>cvs-20211231_g1.jpg</File>
    <File>cvs-20211231_g2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="2530">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>144
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cvs-20211231.htm": {
   "axisCustom": 2,
   "axisStandard": 44,
   "contextCount": 965,
   "dts": {
    "calculationLink": {
     "local": [
      "cvs-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cvs-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cvs-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cvs-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 1179,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 9,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 13
   },
   "keyCustom": 124,
   "keyStandard": 665,
   "memberCustom": 122,
   "memberStandard": 96,
   "nsprefix": "cvs",
   "nsuri": "http://www.cvshealth.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000010001 - Document - Cover Page",
     "role": "http://www.cvshealth.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210011001 - Disclosure - Significant Accounting Policies",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "ie549abdb9cf943f6acd4a4f0dc937118_D20210101-20211231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240804058 - Disclosure - Stock Incentive Plans - Valuation and Assumptions (Details)",
     "role": "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails",
     "shortName": "Stock Incentive Plans - Valuation and Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "ie549abdb9cf943f6acd4a4f0dc937118_D20210101-20211231",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "if7c3db8973f246b592a6bdc7ae66c5d4_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240814059 - Disclosure - Stock Incentive Plans - Restricted Stock Activity (Details)",
     "role": "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
     "shortName": "Stock Incentive Plans - Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "if7c3db8973f246b592a6bdc7ae66c5d4_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromStockOptionsExercised",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240824060 - Disclosure - Stock Incentive Plans - Stock Option and SAR Activity (Details)",
     "role": "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails",
     "shortName": "Stock Incentive Plans - Stock Option and SAR Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i69a67aadd34647f781446b1f63119ac5_D20210101-20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i432b0c5043074ae0812170d09abfa592_I20211209",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240854061 - Disclosure - Shareholders' Equity - Share Repurchases (Details)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails",
     "shortName": "Shareholders' Equity - Share Repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i432b0c5043074ae0812170d09abfa592_I20211209",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i910e0cab88ca49569118b221e7416e1d_I20220104",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "cvs:AcceleratedShareRepurchasesAgreementAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240864062 - Disclosure - Shareholders' Equity - Accelerated Share Repurchases (Details)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
     "shortName": "Shareholders' Equity - Accelerated Share Repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i910e0cab88ca49569118b221e7416e1d_I20220104",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "cvs:AcceleratedShareRepurchasesAgreementAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsPayableAmountPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240874063 - Disclosure - Shareholders' Equity - Dividends (Details)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails",
     "shortName": "Shareholders' Equity - Dividends (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "us-gaap:DividendsPayableAmountPerShare",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsPayableAmountPerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240884064 - Disclosure - Shareholders' Equity - Regulatory Requirements (Details)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails",
     "shortName": "Shareholders' Equity - Regulatory Requirements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240894065 - Disclosure - Shareholders' Equity - Noncontrolling Interests (Details)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails",
     "shortName": "Shareholders' Equity - Noncontrolling Interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240924066 - Disclosure - Other Comprehensive Income (Details)",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails",
     "shortName": "Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i84a0c7a5f87a43ea863b4f7e44c6d8c2_I20181231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240954067 - Disclosure - Earnings Per Share (Details)",
     "role": "http://www.cvshealth.com/role/EarningsPerShareDetails",
     "shortName": "Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210131002 - Disclosure - Divestitures",
     "role": "http://www.cvshealth.com/role/Divestitures",
     "shortName": "Divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i9b7aa9f9810b45008c9d9fed20ef83c3_D20220101-20220131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cvs:NumberofReinsuranceContractsEnteredInto",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reinsurance_agreement",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240984068 - Disclosure - Reinsurance - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails",
     "shortName": "Reinsurance - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i9b7aa9f9810b45008c9d9fed20ef83c3_D20220101-20220131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cvs:NumberofReinsuranceContractsEnteredInto",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reinsurance_agreement",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240994069 - Disclosure - Reinsurance - Reinsurance Recoverables (Details)",
     "role": "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails",
     "shortName": "Reinsurance - Reinsurance Recoverables (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceRecoverablesOnPaidAndUnpaidLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DirectPremiumsEarned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241004070 - Disclosure - Reinsurance - Effects of Reinsurance (Details)",
     "role": "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails",
     "shortName": "Reinsurance - Effects of Reinsurance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DirectPremiumsEarned",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241024071 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241054072 - Disclosure - Segment Reporting - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails",
     "shortName": "Segment Reporting - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241064073 - Disclosure - Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
     "shortName": "Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i9d8f78677d6943988b31d555638bbaf9_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:AdjustedOperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R116": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "241074074 - Disclosure - Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)",
     "role": "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
     "shortName": "Segment Reporting - Reconciliation from Operating Income to Adjusted Operating Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationIntegrationRelatedCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210151003 - Disclosure - Investments",
     "role": "http://www.cvshealth.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210281004 - Disclosure - Fair Value",
     "role": "http://www.cvshealth.com/role/FairValue",
     "shortName": "Fair Value",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210361005 - Disclosure - Goodwill and Other Intangibles",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangibles",
     "shortName": "Goodwill and Other Intangibles",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210421006 - Disclosure - Leases",
     "role": "http://www.cvshealth.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210491007 - Disclosure - Health Care Costs Payable",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayable",
     "shortName": "Health Care Costs Payable",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortDurationInsuranceAndDepositContractsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210551008 - Disclosure - Borrowings and Credit Arrangements",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditArrangements",
     "shortName": "Borrowings and Credit Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210611009 - Disclosure - Pension Plans and Other Postretirement Benefits",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits",
     "shortName": "Pension Plans and Other Postretirement Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210701010 - Disclosure - Income Taxes",
     "role": "http://www.cvshealth.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "000020002 - Document - Audit Information",
     "role": "http://www.cvshealth.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210771011 - Disclosure - Stock Incentive Plans",
     "role": "http://www.cvshealth.com/role/StockIncentivePlans",
     "shortName": "Stock Incentive Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210831012 - Disclosure - Shareholders' Equity",
     "role": "http://www.cvshealth.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210901013 - Disclosure - Other Comprehensive Income",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncome",
     "shortName": "Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210931014 - Disclosure - Earnings Per Share",
     "role": "http://www.cvshealth.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "210961015 - Disclosure - Reinsurance",
     "role": "http://www.cvshealth.com/role/Reinsurance",
     "shortName": "Reinsurance",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211011016 - Disclosure - Commitments and Contingencies",
     "role": "http://www.cvshealth.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "211031017 - Disclosure - Segment Reporting",
     "role": "http://www.cvshealth.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "220022001 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230033001 - Disclosure - Significant Accounting Policies (Tables)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:TotalInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230163002 - Disclosure - Investments (Tables)",
     "role": "http://www.cvshealth.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "cvs:TotalInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010003 - Statement - Consolidated Statements of Operations",
     "role": "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230293003 - Disclosure - Fair Value (Tables)",
     "role": "http://www.cvshealth.com/role/FairValueTables",
     "shortName": "Fair Value (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230373004 - Disclosure - Goodwill and Other Intangibles (Tables)",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables",
     "shortName": "Goodwill and Other Intangibles (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230433005 - Disclosure - Leases (Tables)",
     "role": "http://www.cvshealth.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230503006 - Disclosure - Health Care Costs Payable (Tables)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableTables",
     "shortName": "Health Care Costs Payable (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230563007 - Disclosure - Borrowings and Credit Arrangements (Tables)",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables",
     "shortName": "Borrowings and Credit Arrangements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230623008 - Disclosure - Pension Plans and Other Postretirement Benefits (Tables)",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables",
     "shortName": "Pension Plans and Other Postretirement Benefits (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230713009 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.cvshealth.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230783010 - Disclosure - Stock Incentive Plans (Tables)",
     "role": "http://www.cvshealth.com/role/StockIncentivePlansTables",
     "shortName": "Stock Incentive Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230843011 - Disclosure - Shareholders' Equity (Tables)",
     "role": "http://www.cvshealth.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230913012 - Disclosure - Other Comprehensive Income (Tables)",
     "role": "http://www.cvshealth.com/role/OtherComprehensiveIncomeTables",
     "shortName": "Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100020004 - Statement - Consolidated Statements of Comprehensive Income",
     "role": "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230943013 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.cvshealth.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "230973014 - Disclosure - Reinsurance (Tables)",
     "role": "http://www.cvshealth.com/role/ReinsuranceTables",
     "shortName": "Reinsurance (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCededCreditRiskByReinsurerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "231043015 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.cvshealth.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:NumberOfPlanMembers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "people",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240044001 - Disclosure - Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:NumberOfPlanMembers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "people",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240054002 - Disclosure - Significant Accounting Policies - Restricted Cash (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails",
     "shortName": "Significant Accounting Policies - Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240064003 - Disclosure - Significant Accounting Policies - Accounts Receivable (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
     "shortName": "Significant Accounting Policies - Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:VendorandManufacturerReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240074004 - Disclosure - Significant Accounting Policies - Property Plant and Equipment (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails",
     "shortName": "Significant Accounting Policies - Property Plant and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240084005 - Disclosure - Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
     "shortName": "Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i58bb9dd9de57438c8823cb7f0f5b7456_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240094006 - Disclosure - Significant Accounting Policies - Receivables and Contracted Balances (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails",
     "shortName": "Significant Accounting Policies - Receivables and Contracted Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "ic9bbc3798d714a95928e301134f0a8b4_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240104007 - Disclosure - Significant Accounting Policies - Contract Balances (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails",
     "shortName": "Significant Accounting Policies - Contract Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030005 - Statement - Consolidated Balance Sheets",
     "role": "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:InventoryNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:TotalInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240114008 - Disclosure - Significant Accounting Policies - Variable Interest Entities (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails",
     "shortName": "Significant Accounting Policies - Variable Interest Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "cvs:ProceedsFromVariableInterestEntity",
       "span",
       "div",
       "us-gaap:ConsolidationVariableInterestEntityPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:ProceedsFromVariableInterestEntity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i7c0970400e154d55993f70f521cd55da_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240124009 - Disclosure - Significant Accounting Policies - Discontinued Operations (Details)",
     "role": "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails",
     "shortName": "Significant Accounting Policies - Discontinued Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i7c0970400e154d55993f70f521cd55da_D20200101-20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240144010 - Disclosure - Divestitures - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/DivestituresNarrativeDetails",
     "shortName": "Divestitures - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i7fd8613bfc0d4364b6e49aa6a8b2d288_D20190101-20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GainLossOnSaleOfBusiness",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:TotalInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240174011 - Disclosure - Investments - Schedule of Total Investments (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails",
     "shortName": "Investments - Schedule of Total Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:TotalInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedInvestmentsAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240184012 - Disclosure - Investments - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
     "shortName": "Investments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedInvestmentsAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleAmortizedCostNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240194013 - Disclosure - Investments - Debt Securities (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
     "shortName": "Investments - Debt Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240204014 - Disclosure - Investments - Debt Securities by Maturity (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
     "shortName": "Investments - Debt Securities by Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240214015 - Disclosure - Investments - Unrealized Loss Position (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
     "shortName": "Investments - Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240224016 - Disclosure - Investments - Unrealized Loss Position Maturities (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
     "shortName": "Investments - Unrealized Loss Position Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ActivityInMortgageLoanPortfolioTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i81f297d193504b64a77dc2ee3da88ccb_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240234017 - Disclosure - Investments - Mortgage Loans (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
     "shortName": "Investments - Mortgage Loans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ActivityInMortgageLoanPortfolioTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i81f297d193504b64a77dc2ee3da88ccb_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstateNewMortgageLoans",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040006 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "if07ab5ed5fe44735bee0f7db6106013d_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240244018 - Disclosure - Investments - Mortgage Loans Credit Ratings Indicator (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
     "shortName": "Investments - Mortgage Loans Credit Ratings Indicator (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "if07ab5ed5fe44735bee0f7db6106013d_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgageLoansOnRealEstate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "if07ab5ed5fe44735bee0f7db6106013d_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240254019 - Disclosure - Investments - Schedule of Mortgage Loan Principal Repayments (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails",
     "shortName": "Investments - Schedule of Mortgage Loan Principal Repayments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "if07ab5ed5fe44735bee0f7db6106013d_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240264020 - Disclosure - Investments - Net Investment Income (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
     "shortName": "Investments - Net Investment Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentIncomeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240274021 - Disclosure - Investments - Realized Gains (Details)",
     "role": "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails",
     "shortName": "Investments - Realized Gains (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240304022 - Disclosure - Fair Value - Fair Value Measurements (Details)",
     "role": "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
     "shortName": "Fair Value - Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FinancialLiabilitiesFairValueDisclosure",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i91e5f841bc1148249e50546c6b0c4b62_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240314023 - Disclosure - Fair Value - Changes in Level 3 Financial Assets (Details)",
     "role": "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
     "shortName": "Fair Value - Changes in Level 3 Financial Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4f78308e3c32426bb0c2ca2138e491d2_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240324024 - Disclosure - Fair Value - Gross Transfers Into (Out Of) Level 3 (Details)",
     "role": "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
     "shortName": "Fair Value - Gross Transfers Into (Out Of) Level 3 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i870c8f372f074816aa15ac75a237b726_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "ie5ff79f6ea7640da8266c10697cb62dc_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgagesHeldForSaleFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240334025 - Disclosure - Fair Value - Carrying Value and Fair Value Classified by Level (Details)",
     "role": "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
     "shortName": "Fair Value - Carrying Value and Fair Value Classified by Level (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "ie5ff79f6ea7640da8266c10697cb62dc_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MortgagesHeldForSaleFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240344026 - Disclosure - Fair Value - Separate Accounts Fair Value (Details)",
     "role": "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
     "shortName": "Fair Value - Separate Accounts Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i91e5f841bc1148249e50546c6b0c4b62_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SeparateAccountAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4f78308e3c32426bb0c2ca2138e491d2_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240354027 - Disclosure - Fair Value - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/FairValueNarrativeDetails",
     "shortName": "Fair Value - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "icfcc06f892d44fcead268e6e21698a4a_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050007 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "ic9bbc3798d714a95928e301134f0a8b4_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240384028 - Disclosure - Goodwill and Other Intangibles - Goodwill (Details)",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
     "shortName": "Goodwill and Other Intangibles - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i7c0970400e154d55993f70f521cd55da_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i2350df645dc04e808a96e20dad3a3fba_D20200701-20200930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240394029 - Disclosure - Goodwill and Other Intangibles - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
     "shortName": "Goodwill and Other Intangibles - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairedAccumulatedImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:FinitelivedandindefinitelivedintangibleassetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240404030 - Disclosure - Goodwill and Other Intangibles - Intangible Assets (Details)",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangibles - Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:FinitelivedandindefinitelivedintangibleassetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240414031 - Disclosure - Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)",
     "role": "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails",
     "shortName": "Goodwill and Other Acquired Intangibles - Future Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240444032 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i7c0970400e154d55993f70f521cd55da_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SaleAndLeasebackTransactionGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240454033 - Disclosure - Leases - Summary of the Components of Net Lease Cost (Details)",
     "role": "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails",
     "shortName": "Leases - Summary of the Components of Net Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240464034 - Disclosure - Leases - Supplemental Cash Flow Information (Details)",
     "role": "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails",
     "shortName": "Leases - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:LesseeLeaseTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240474035 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
     "role": "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cvs:LesseeLeaseTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:FinanceLeaseRightOfUseAssetGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240484036 - Disclosure - Leases - Maturities of Operating and Finance Lease Liabilities (Details)",
     "role": "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturities of Operating and Finance Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240514037 - Disclosure - Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails",
     "shortName": "Health Care Costs Payable - Incurred and Paid Health Care Claims Development (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i13739c11655d4b66b619ac881014f765_I20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060008 - Statement - Consolidated Statements of Shareholders' Equity",
     "role": "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
     "shortName": "Consolidated Statements of Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i13739c11655d4b66b619ac881014f765_I20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i6355e336e53c4e8f9fad360d96598544_I20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240524038 - Disclosure - Health Care Costs Payable - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
     "shortName": "Health Care Costs Payable - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i6355e336e53c4e8f9fad360d96598544_I20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240534039 - Disclosure - Health Care Costs Payable - Reconciliation of Health Care Net Incurred and Paid Claims Development to Health Care Costs Payable Liability (Details)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails",
     "shortName": "Health Care Costs Payable - Reconciliation of Health Care Net Incurred and Paid Claims Development to Health Care Costs Payable Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i2d081ebfc3b747a899e5a8ee7f9179b0_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "ic9bbc3798d714a95928e301134f0a8b4_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240544040 - Disclosure - Health Care Costs Payable - Reconciliation of Health Care Costs Payable (Details)",
     "role": "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
     "shortName": "Health Care Costs Payable - Reconciliation of Health Care Costs Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "idf62411f04644ec5a62a251e4c8f705a_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240574041 - Disclosure - Borrowings and Credit Arrangements - Schedule of Debt (Details)",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails",
     "shortName": "Borrowings and Credit Arrangements - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedPremium",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240584042 - Disclosure - Borrowings and Credit Arrangements - Debt Maturities (Details)",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails",
     "shortName": "Borrowings and Credit Arrangements - Debt Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240594043 - Disclosure - Borrowings and Credit Arrangements - Short-term Borrowings (Details)",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails",
     "shortName": "Borrowings and Credit Arrangements - Short-term Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i2a2c1f6bdf614434afbf804874bfc4c5_D20210818-20210818",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDebtNetOfIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240604044 - Disclosure - Borrowings and Credit Arrangements - Long-Term Borrowings (Details)",
     "role": "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
     "shortName": "Borrowings and Credit Arrangements - Long-Term Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i2a2c1f6bdf614434afbf804874bfc4c5_D20210818-20210818",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDebtNetOfIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240634045 - Disclosure - Pension Plans and Other Postretirement Benefits - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4d6e9082a5464b3c81907ef022a3e221_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240644046 - Disclosure - Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details)",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Benefit Obligations and Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActuarialGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanInterestCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240654047 - Disclosure - Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Costs (Details)",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Net Periodic Benefit Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i91e3b1a50898436e96566b8b401ba50a_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "cvs:TreasuryStockSharesHeldinTrust",
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "cvs:TreasuryStockSharesHeldinTrust",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070009 - Statement - Consolidated Statements of Shareholders' Equity (Parentheticals)",
     "role": "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
     "shortName": "Consolidated Statements of Shareholders' Equity (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "cvs:TreasuryStockValueSharesHeldInTrust",
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "ifcbe414ba05c4538bc76281ff3ac3fa4_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "cvs:TreasuryStockValueSharesHeldInTrust",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240664048 - Disclosure - Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Weighted Average Assumptions Used (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i42e14e6ecf0d4519bad91c300172ce00_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240674049 - Disclosure - Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details)",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Fair Value of Pension Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i1308d93a146c4c8488b59a3c5a030c08_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4d6e9082a5464b3c81907ef022a3e221_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240684050 - Disclosure - Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details)",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Changes in Level 3 Pension Plan Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DefinedBenefitPlanPlanAssetsCategoryTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i7de4764ce7104e8cb8330af8da0f29b3_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i42e14e6ecf0d4519bad91c300172ce00_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240694051 - Disclosure - Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)",
     "role": "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
     "shortName": "Pension Plans and Other Postretirement Benefits - Defined Benefit Plans Expected Benefit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i42e14e6ecf0d4519bad91c300172ce00_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240724052 - Disclosure - Income Taxes - Income Tax Provision (Details)",
     "role": "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails",
     "shortName": "Income Taxes - Income Tax Provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240734053 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240744054 - Disclosure - Income Taxes - Effective Tax Rate Reconciliation (Details)",
     "role": "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails",
     "shortName": "Income Taxes - Effective Tax Rate Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240754055 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "role": "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes - Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i48425c9c7d6d41fe9f23b091c65a31d4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "ic9bbc3798d714a95928e301134f0a8b4_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240764056 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details)",
     "role": "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i23e34e947aac44fc9f5cf5448f94f452_I20181231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "240794057 - Disclosure - Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details)",
     "role": "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
     "shortName": "Stock Incentive Plans - Stock-Based Compensation Expense and ESPP (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvs-20211231.htm",
      "contextRef": "i4fa4f86ecd2d49489934d0916692e4b7_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 235,
   "tag": {
    "cvs_A2016RepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2016 Repurchase Program [Member]",
        "label": "2016 Repurchase Program [Member]",
        "terseLabel": "2016 Repurchase Program"
       }
      }
     },
     "localname": "A2016RepurchaseProgramMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_A2021AcceleratedRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Accelerated Repurchase Program",
        "label": "2021 Accelerated Repurchase Program [Member]",
        "terseLabel": "2021 ASR"
       }
      }
     },
     "localname": "A2021AcceleratedRepurchaseProgramMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_A2021RepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Repurchase Program",
        "label": "2021 Repurchase Program [Member]",
        "terseLabel": "2021 Repurchase Program"
       }
      }
     },
     "localname": "A2021RepurchaseProgramMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_AcceleratedShareRepurchaseProgramMaximumNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase Program, Maximum Number of Shares",
        "label": "Accelerated Share Repurchase Program, Maximum Number of Shares",
        "terseLabel": "ASR, maximum amount of shares received or delivered"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseProgramMaximumNumberOfShares",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_AcceleratedShareRepurchasesAgreementAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases Agreement, Amount",
        "label": "Accelerated Share Repurchases Agreement, Amount",
        "terseLabel": "ASR agreement, amount"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesAgreementAmount",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Percent of Notional Amount in Shares to be Received at End of Program",
        "label": "Accelerated Share Repurchases, Percent of Notional Amount in Shares to be Received at End of Program",
        "terseLabel": "ASR, shares to be received at the end of program as a percent of notional amount"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesPercentOfNotionalAmountInSharesToBeReceivedAtEndOfProgram",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Percent of Notional Amount Received in Shares",
        "label": "Accelerated Share Repurchases, Percent of Notional Amount Received in Shares",
        "terseLabel": "ASR percent of notional amount received in shares"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesPercentOfNotionalAmountReceivedInShares",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_ActivityInMortgageLoanPortfolioTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table representing activities in mortgage loan portfolio during the period.",
        "label": "Activity in mortgage loan portfolio [Table Text Block]",
        "verboseLabel": "Activity in mortgage loan portfolio"
       }
      }
     },
     "localname": "ActivityInMortgageLoanPortfolioTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_AdjustedOperatingIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted Operating Income (Loss)",
        "label": "Adjusted Operating Income (Loss)",
        "terseLabel": "Adjusted operating income",
        "verboseLabel": "Adjusted operating income (loss)"
       }
      }
     },
     "localname": "AdjustedOperatingIncomeLoss",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_AetnaInc2010StockIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aetna Inc 2010 Stock Incentive Plan [Member]",
        "label": "Aetna Inc 2010 Stock Incentive Plan [Member]",
        "terseLabel": "Aetna Inc 2010 Stock Incentive Plan"
       }
      }
     },
     "localname": "AetnaInc2010StockIncentivePlanMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_AllOtherReinsurersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All Other Reinsurers [Member]",
        "label": "All Other Reinsurers [Member]",
        "terseLabel": "All Other"
       }
      }
     },
     "localname": "AllOtherReinsurersMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assumed Interest Rates On Long Duration Group Life And Long Term Care Contracts",
        "label": "Assumed Interest Rates On Long Duration Group Life And Long Term Care Contracts",
        "terseLabel": "Assumed interest rates on long-duration group life and long-term care contracts"
       }
      }
     },
     "localname": "AssumedInterestRatesOnLongDurationGroupLifeAndLongTermCareContracts",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_AuditorInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditor Information [Abstract]",
        "label": "Auditor Information [Abstract]"
       }
      }
     },
     "localname": "AuditorInformationAbstract",
     "nsuri": "http://www.cvshealth.com/20211231",
     "xbrltype": "stringItemType"
    },
    "cvs_BackUpCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Back-Up Credit Facilities [Member]",
        "label": "Back-Up Credit Facilities [Member]",
        "terseLabel": "Back-Up Credit Facilities"
       }
      }
     },
     "localname": "BackUpCreditFacilitiesMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_BarclaysBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Barclays Bank",
        "label": "Barclays Bank [Member]",
        "terseLabel": "Barclays Bank"
       }
      }
     },
     "localname": "BarclaysBankMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_BrazilSubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Brazil Subsidiary [Member]",
        "label": "Brazil Subsidiary [Member]",
        "terseLabel": "Brazil Subsidiary"
       }
      }
     },
     "localname": "BrazilSubsidiaryMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Purchase Price Adjustment, Outside of Measurement Period",
        "label": "Business Combination, Purchase Price Adjustment, Outside of Measurement Period",
        "terseLabel": "Acquisition purchase price adjustments outside of measurement period"
       }
      }
     },
     "localname": "BusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_CVSHealth2017IncentiveCompensationPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CVS Health 2017 Incentive Compensation Plan [Member]",
        "label": "CVS Health 2017 Incentive Compensation Plan [Member]",
        "terseLabel": "CVS Health 2017 Incentive Compensation Plan"
       }
      }
     },
     "localname": "CVSHealth2017IncentiveCompensationPlanMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_CashFlowLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow, Lessee [Abstract]",
        "label": "Cash Flow, Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashFlowLesseeAbstract",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_Categories5and6Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage loan credit quality indicator - Categories 5 and 6",
        "label": "Categories 5 and 6 [Member]",
        "terseLabel": "5 and 6"
       }
      }
     },
     "localname": "Categories5and6Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan Credit Quality Indicator - Category 1 [Member].",
        "label": "Category 1 [Member]",
        "terseLabel": "1"
       }
      }
     },
     "localname": "Category1Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category2To4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loan Credit Quality Indicator - Category 2 to 4 [Member].",
        "label": "Category 2 to 4 [Member]",
        "terseLabel": "2 to 4"
       }
      }
     },
     "localname": "Category2To4Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_Category7Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage loan credit quality indicator - Category 7",
        "label": "Category 7 [Member]",
        "terseLabel": "7"
       }
      }
     },
     "localname": "Category7Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ChangeInContractWithCustomerLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in Contract with Customer, Liability",
        "label": "Change in Contract with Customer, Liability [Roll Forward]",
        "terseLabel": "Change in Contract with Customer, Liability [Roll Forward]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityRollForward",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_CommonAndCollectiveTrustsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of Common/Collective Trusts held by the company, primarily related to investment funds otherwise known as underlying funds.",
        "label": "Common and Collective Trusts [Member]",
        "terseLabel": "Common/collective trusts"
       }
      }
     },
     "localname": "CommonAndCollectiveTrustsMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in contract liability recognized for loyalty program earnings and gift card issuance.",
        "label": "Contract With Customer Liability Loyalty Program Earnings And Gift Card Issuance",
        "terseLabel": "Rewards earnings and gift card issuances"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityLoyaltyProgramEarningsAndGiftCardIssuance",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ContractWithCustomerLiabilityRedemptionAndBreakage": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer Liability Redemption And Breakage",
        "label": "Contract With Customer Liability Redemption And Breakage",
        "negatedTerseLabel": "Redemption and breakage"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRedemptionAndBreakage",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ContractualObligationsToMaintainLevelsOfSeparateAccounts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the contractual obligation to maintain the required level of funding in Separate Accounts necessary to fund specific guaranteed pensions annuities.",
        "label": "Contractual Obligations To Maintain Levels Of Separate Accounts",
        "terseLabel": "Contractual obligations underlying the guaranteed benefits"
       }
      }
     },
     "localname": "ContractualObligationsToMaintainLevelsOfSeparateAccounts",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_CoventryHealthCareWorkersCompensationBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coventry Health Care Workers Compensation Business",
        "label": "Coventry Health Care Workers Compensation Business [Member]",
        "terseLabel": "Coventry Health Care Workers Compensation Business"
       }
      }
     },
     "localname": "CoventryHealthCareWorkersCompensationBusinessMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings",
        "label": "Credit Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings",
        "terseLabel": "Credit-related impairment loss"
       }
      }
     },
     "localname": "CreditRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtAndEquitySecuritiesAvailableForSaleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt and equity securities which are categorized neither as trading securities nor held-to-maturity securities. Such securities are reported at fair value; unrealized gains and losses related to Available-for-sale securities are excluded from earnings and reported in a separate component of shareholders' equity (other comprehensive income)",
        "label": "Debt And Equity Securities Available For Sale [Member]",
        "terseLabel": "Debt securities available for sale"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesAvailableForSaleMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_DebtExtinguishmentFees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Extinguishment Fees",
        "label": "Debt Extinguishment Fees",
        "terseLabel": "Debt extinguishment fees"
       }
      }
     },
     "localname": "DebtExtinguishmentFees",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net",
        "label": "Debt Instrument, Unamortized Discount and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Debt discounts and deferred financing costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountandDebtIssuanceCostsNet",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 4.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Allocated And Single Maturity Date, Maturity, After 10 Years, Amortized Cost, Net",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllocatedAndSingleMaturityDateMaturityAfter10YearsAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available For Sale, Amortized Cost, Net",
        "label": "Debt Securities, Available For Sale, Amortized Cost, Net",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYears",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Five Through Ten Years, Accumulated Loss",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterFiveThroughTenYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYears",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After One Through Five Years, Accumulated Loss",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYears",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, After Ten Years, Accumulated Loss",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateAfterTenYearsAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYear",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss",
        "label": "Debt Securities, Available-For-Sale, Continuous Unrealized Loss Position, Allocated And Single Maturity Date, Within One Year, Accumulated Loss",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAllocatedAndSingleMaturityDateWithinOneYearAccumulatedLoss",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 2.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, After One Through Five Years, Amortized Cost, Net",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateAfterOneThroughFiveYearsAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 1.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, Within One Year, Amortized Cost, Net",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateWithinOneYearAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 3.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-Sale, Maturity, Allocated And Single Maturity Date, after Five Through Ten Years, Amortized Cost, Net",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleMaturityAllocatedAndSingleMaturityDateafterFiveThroughTenYearsAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]",
        "label": "Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueAbstract",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Weighted Average Duration Of Securities",
        "label": "Debt Securities, Available-For-Sale, Weighted Average Duration Of Securities",
        "terseLabel": "Weighted average duration of securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleWeightedAverageDurationOfSecurities",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 5.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net",
        "label": "Debt Securities, Available-For-sale, Maturity, Without Single Maturity Date, Amortized Cost, Net",
        "terseLabel": "Debt securities, maturity, without single maturity date"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForsaleMaturityWithoutSingleMaturityDateAmortizedCostNet",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Amortized Cost",
        "terseLabel": "Debt securities, maturity, without single maturity date, unrealized losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateAmortizedCost",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, without Single Maturity Date, Fair Value",
        "terseLabel": "Debt securities, maturity, without single maturity date, fair value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleContinuousUnrealizedLossPositionwithoutSingleMaturityDateFairValue",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DeferredTaxAssetsPayrollTaxDeferral": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Payroll Tax Deferral",
        "label": "Deferred Tax Assets, Payroll Tax Deferral",
        "terseLabel": "Payroll tax deferral"
       }
      }
     },
     "localname": "DeferredTaxAssetsPayrollTaxDeferral",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Bad Debts And Other Allowances",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves And Accruals, Bad Debts And Other Allowances",
        "terseLabel": "Bad debts and other allowances"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsBadDebtsAndOtherAllowances",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DeferredTaxLiabilitiesDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Depreciation and Amortization - Amount of deferred tax liability attributable to taxable temporary differences from depreciation and amortization",
        "label": "Deferred Tax Liabilities, Depreciation and Amortization",
        "negatedTerseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDepreciationAndAmortization",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DeferredTaxLiabilitiesRetirementBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Retirement Benefits",
        "label": "Deferred Tax Liabilities, Retirement Benefits",
        "negatedTerseLabel": "Retirement benefits"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesRetirementBenefits",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Common Collective Trust, Debt Securities [Member]",
        "label": "Defined Benefit Plan, Common Collective Trust, Debt Securities [Member]",
        "terseLabel": "Common/collective trusts, Debt Securities"
       }
      }
     },
     "localname": "DefinedBenefitPlanCommonCollectiveTrustDebtSecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Common Collective Trust, Equity Securities [Member]",
        "label": "Defined Benefit Plan, Common Collective Trust, Equity Securities [Member]",
        "terseLabel": "Common/collective trusts, Equity Securities"
       }
      }
     },
     "localname": "DefinedBenefitPlanCommonCollectiveTrustEquitySecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_DenominatorForEarningsPerShareCalculationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Denominator For Earnings Per Share Calculation [Abstract]",
        "label": "Denominator For Earnings Per Share Calculation [Abstract]",
        "terseLabel": "Denominator for earnings per share calculation:"
       }
      }
     },
     "localname": "DenominatorForEarningsPerShareCalculationAbstract",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends Payable, Quarterly Dividends Declared, Increase Amount, Percent",
        "label": "Dividends Payable, Quarterly Dividends Declared, Increase Amount, Percent",
        "terseLabel": "Quarterly dividends declared, percent increase"
       }
      }
     },
     "localname": "DividendsPayableQuarterlyDividendsDeclaredIncreaseAmountPercent",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_DrogariaOnofreLtdaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Drogaria onofre Ltda.",
        "label": "Drogaria onofre Ltda. [Member]",
        "terseLabel": "Drogaria onofre Ltda."
       }
      }
     },
     "localname": "DrogariaOnofreLtdaMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method",
        "label": "ESPP Issuance, Net of Treasury Stock, Shares, Acquired, Cost Method",
        "terseLabel": "ESPP issuances, net of purchase of treasury shares (in shares)"
       }
      }
     },
     "localname": "ESPPIssuanceNetOfTreasuryStockSharesAcquiredCostMethod",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method",
        "label": "ESPP Issuance, Net of Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "ESPP issuances, net of purchase of treasury shares"
       }
      }
     },
     "localname": "ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_EmployeeStockOptionsandStockAppreciationRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Options and Stock Appreciation Rights [Member]",
        "label": "Employee Stock Options and Stock Appreciation Rights [Member]",
        "terseLabel": "Employee Stock Options and Stock Appreciation Rights"
       }
      }
     },
     "localname": "EmployeeStockOptionsandStockAppreciationRightsMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_EquitySecuritiesDomesticRealEstateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about ownership interests or the right to acquire ownership interests in domestic real estate whose ownership interest is represented by shares of common or preferred stock (which is neither mandatorily redeemable no redeemable at the option of the holder), convertible securities, stock rights, or stock warrants categorized by other type.",
        "label": "Equity Securities Domestic Real Estate [Member]",
        "terseLabel": "Domestic real estate"
       }
      }
     },
     "localname": "EquitySecuritiesDomesticRealEstateMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Assets Measured On Recurring Basis, Unobservable Unput Reconciliation, Net Realized And Unrealized Capital Gaines (Losses) [Abstract]",
        "label": "Fair Value, Assets Measured On Recurring Basis, Unobservable Unput Reconciliation, Net Realized And Unrealized Capital Gaines (Losses) [Abstract]",
        "terseLabel": "Net realized and unrealized capital gains (losses):"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableUnputReconciliationNetRealizedAndUnrealizedCapitalGainesLossesAbstract",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Assets And Liabilities, Lessee [Abstract]",
        "label": "Finance Lease, Assets And Liabilities, Lessee [Abstract]",
        "terseLabel": "Finance leases:"
       }
      }
     },
     "localname": "FinanceLeaseAssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Cost",
        "label": "Finance Lease Cost",
        "totalLabel": "Total finance lease costs"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FinanceLeaseRightOfUseAssetAccumulatedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "cvs_FinanceLeaseRightOfUseAssetNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Right-Of-Use Asset, Accumulated Depreciation",
        "label": "Finance Lease, Right-Of-Use Asset, Accumulated Depreciation",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAccumulatedDepreciation",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FinanceLeaseRightOfUseAssetGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "cvs_FinanceLeaseRightOfUseAssetNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Right-Of-Use Asset, Gross",
        "label": "Finance Lease, Right-Of-Use Asset, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetGross",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FinanceLeaseRightOfUseAssetNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Right-Of-Use Asset, Net",
        "label": "Finance Lease, Right-Of-Use Asset, Net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetNet",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FinitelivedandindefinitelivedintangibleassetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the cost, accumulated amortization and net balance of intangibles assets and amortization period, in total and by major class. Finite-lived intangible assets have a stated useful life over which their gross carrying value is amortized. Indefinite intangible assets have a projected indefinite period of benefit (hence are not amortized).",
        "label": "Finite lived and indefinite lived intangible assets [Table Text Block]",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "FinitelivedandindefinitelivedintangibleassetsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_FixturesEquipmentAndInternallyDevelopedSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixtures, Equipment And Internally Developed Software [Member]",
        "label": "Fixtures, Equipment And Internally Developed Software [Member]",
        "terseLabel": "Fixtures, equipment and internally developed software"
       }
      }
     },
     "localname": "FixturesEquipmentAndInternallyDevelopedSoftwareMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FloatingRateNotesDueMarch2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating Rate Notes Due March 2020 [Member]",
        "label": "Floating Rate Notes Due March 2020 [Member]",
        "terseLabel": "Floating rate notes due March 2020"
       }
      }
     },
     "localname": "FloatingRateNotesDueMarch2020Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FloatingRateNotesDueMarch2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating Rate Notes Due March 2021 [Member]",
        "label": "Floating Rate Notes Due March 2021 [Member]",
        "terseLabel": "Floating rate notes due March 2021"
       }
      }
     },
     "localname": "FloatingRateNotesDueMarch2021Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FloatingRateNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Floating Rate Notes",
        "label": "Floating Rate Notes [Member]",
        "terseLabel": "Floating Rate Notes"
       }
      }
     },
     "localname": "FloatingRateNotesMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_FormerGainContingencyRecognizedInCurrentPeriodBeforeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Gain Contingency, Recognized in Current Period, Before Tax",
        "label": "Former Gain Contingency, Recognized in Current Period, Before Tax",
        "terseLabel": "Former gain contingency, recognized in current period, before tax"
       }
      }
     },
     "localname": "FormerGainContingencyRecognizedInCurrentPeriodBeforeTax",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FormerGainContingencyRecognizedInCurrentPeriodNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Gain Contingency, Recognized in Current Period, Net of Tax",
        "label": "Former Gain Contingency, Recognized in Current Period, Net of Tax",
        "terseLabel": "Former gain contingency, recognized in current period, net of tax"
       }
      }
     },
     "localname": "FormerGainContingencyRecognizedInCurrentPeriodNetOfTax",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_FourYearsReinsuranceAgreementWithUnrelatedInsurer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This line item represents the four years of a reinsurance agreement with an unrelated insurer.",
        "label": "Four Years Reinsurance Agreement With Unrelated Insurer",
        "terseLabel": "Four years reinsurance agreement with unrelated insurer"
       }
      }
     },
     "localname": "FourYearsReinsuranceAgreementWithUnrelatedInsurer",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_FrontStoreRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Front Store Revenue [Member]",
        "label": "Front Store Revenue [Member]",
        "terseLabel": "Front Store"
       }
      }
     },
     "localname": "FrontStoreRevenueMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_GuarantorObligationsNumberofLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantor Obligations, Number of Leases",
        "label": "Guarantor Obligations, Number of Leases",
        "terseLabel": "Number of leases guaranteed"
       }
      }
     },
     "localname": "GuarantorObligationsNumberofLeases",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_HartfordLifeAndAccidentInsuranceCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hartford Life And Accident Insurance Company [Member]",
        "label": "Hartford Life And Accident Insurance Company [Member]",
        "terseLabel": "Hartford Life and Accident Insurance Company"
       }
      }
     },
     "localname": "HartfordLifeAndAccidentInsuranceCompanyMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_HealthCareBenefitsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Benefits Segment [Member]",
        "label": "Health Care Benefits Segment [Member]",
        "terseLabel": "Health Care Benefits"
       }
      }
     },
     "localname": "HealthCareBenefitsSegmentMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Costs Payable, Period After Date Of Services Claims Are Paid",
        "label": "Health Care Costs Payable, Period After Date Of Services Claims Are Paid",
        "terseLabel": "Period after date of service a claim is paid"
       }
      }
     },
     "localname": "HealthCareCostsPayablePeriodAfterDateOfServicesClaimsArePaid",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_HealthInsurerFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the estimated amount of the health insurer fee accrued during the reporting period, as required by Health Care Reform.",
        "label": "Health Insurer Fee",
        "terseLabel": "Health insurer fee"
       }
      }
     },
     "localname": "HealthInsurerFee",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_HealthInsurerFeeTaxEffectPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the tax effect of the health care reform's non-tax deductible health insurer fee.",
        "label": "Health Insurer Fee Tax Effect, Percent",
        "terseLabel": "Health insurer fee"
       }
      }
     },
     "localname": "HealthInsurerFeeTaxEffectPercent",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_HeartlandHealthcareServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Heartland Healthcare Services [Member]",
        "label": "Heartland Healthcare Services [Member]",
        "terseLabel": "Heartland Healthcare Services"
       }
      }
     },
     "localname": "HeartlandHealthcareServicesMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_HeathSavingsAccountBalance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Heath Savings Account Balance",
        "label": "Heath Savings Account Balance",
        "terseLabel": "HSA balances"
       }
      }
     },
     "localname": "HeathSavingsAccountBalance",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States",
        "label": "Individual Public Health Insurance Exchanges, Submitted Regulatory Filings, Number of States",
        "terseLabel": "Number of states the Company has submitted regulatory filings for a January 2022 entrance into the individual public health insurance exchange"
       }
      }
     },
     "localname": "IndividualPublicHealthInsuranceExchangesSubmittedRegulatoryFilingsNumberOfStates",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_Initialcontractualterm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entity, Initial Contractual Term",
        "label": "Initial contractual term",
        "terseLabel": "Initial contractual term (in years)"
       }
      }
     },
     "localname": "Initialcontractualterm",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_InsuranceAndHmoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance and HMO subsidiaries [Member].",
        "label": "Insurance and HMO [Member]",
        "terseLabel": "Insurance and HMO"
       }
      }
     },
     "localname": "InsuranceAndHmoMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_InsurancePremiumDeficiencyReservePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance Premium Deficiency Reserve [Policy Text Block]",
        "label": "Insurance Premium Deficiency Reserve [Policy Text Block]",
        "terseLabel": "Premium Deficiency Reserves"
       }
      }
     },
     "localname": "InsurancePremiumDeficiencyReservePolicyTextBlock",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_InvestmentContractsWithFixedMaturityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Contracts With Fixed Maturity, Fair Value Disclosure.",
        "label": "Investment Contracts With Fixed Maturity, Fair Value Disclosure",
        "terseLabel": "Investment contracts with a fixed maturity"
       }
      }
     },
     "localname": "InvestmentContractsWithFixedMaturityFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_InvestmentContractsWithoutFixedMaturityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Contracts Without A Fixed Maturity, Fair Value Disclosure.",
        "label": "Investment Contracts Without A Fixed Maturity, Fair Value Disclosure",
        "terseLabel": "Investment contracts without a fixed maturity"
       }
      }
     },
     "localname": "InvestmentContractsWithoutFixedMaturityFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_InvestmentIncomeExcludingCapitalGainsorLosses": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Income, Excluding Capital Gains or Losses",
        "label": "Investment Income, Excluding Capital Gains or Losses",
        "totalLabel": "Net investment income (excluding net realized capital gains or losses)"
       }
      }
     },
     "localname": "InvestmentIncomeExcludingCapitalGainsorLosses",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability",
        "label": "Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "LeaseLiability",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LeasesWeightedAverageDiscountRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases, Weighted Average Discount Rate [Abstract]",
        "label": "Leases, Weighted Average Discount Rate [Abstract]",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "LeasesWeightedAverageDiscountRateAbstract",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_LesseeLeaseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Lease [Table Text Block]",
        "label": "Lessee, Lease [Table Text Block]",
        "terseLabel": "Supplemental balance sheet information"
       }
      }
     },
     "localname": "LesseeLeaseTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_LesseeLeasesLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Leases Liabilities Payments Due [Abstract]",
        "label": "Lessee, Leases Liabilities Payments Due [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "LesseeLeasesLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_LesseeLiabilityPaymentsDue": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due",
        "label": "Lessee, Liability, Payments, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDue",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due After Year Five",
        "label": "Lessee, Liability, Payments, Due After Year Five",
        "totalLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsDueYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due Year Five",
        "label": "Lessee, Liability, Payments, Due Year Five",
        "totalLabel": "2026"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDueYearFive",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsDueYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due Year Four",
        "label": "Lessee, Liability, Payments, Due Year Four",
        "totalLabel": "2025"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDueYearFour",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsDueYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due Year Three",
        "label": "Lessee, Liability, Payments, Due Year Three",
        "totalLabel": "2024"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDueYearThree",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsDueYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Due Year Two",
        "label": "Lessee, Liability, Payments, Due Year Two",
        "totalLabel": "2023"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsDueYearTwo",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityPaymentsYearOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Payments, Year One",
        "label": "Lessee, Liability, Payments, Year One",
        "totalLabel": "2022"
       }
      }
     },
     "localname": "LesseeLiabilityPaymentsYearOne",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Liability, Undiscounted Excess Amount",
        "label": "Lessee, Liability, Undiscounted Excess Amount",
        "negatedTotalLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeLiabilityUndiscountedExcessAmount",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LesseeOperatingAndFinanceLeasesRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating And Finance Leases, Renewal Term",
        "label": "Lessee, Operating And Finance Leases, Renewal Term",
        "terseLabel": "Lease renewal term"
       }
      }
     },
     "localname": "LesseeOperatingAndFinanceLeasesRenewalTerm",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs",
        "label": "Liability For Unpaid Claims And Claims Adjustment Expense, Claims Paid, Excluded From Total Incurred Health Care Costs",
        "terseLabel": "Benefit costs recorded in other insurance liabilities"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidExcludedFromTotalIncurredHealthCareCosts",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LiabilityforUnpaidClaims": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total liability on the balance sheet for unpaid claims for both short-duration and long-duration insurance contracts after reinsurance.",
        "label": "Liability for Unpaid Claims",
        "terseLabel": "Liability for unpaid claims"
       }
      }
     },
     "localname": "LiabilityforUnpaidClaims",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LimitedPaymentsContracts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum assumed interest rates on limited payment contracts on large case pensions business.",
        "label": "Limited Payments Contracts",
        "terseLabel": "Assumed interest rates on limited payment pension contracts on large case pension business (in hundredths)"
       }
      }
     },
     "localname": "LimitedPaymentsContracts",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_LincolnLifeAnnuityCompanyOfNewYorkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lincoln Life &amp; Annuity Company Of New York [Member]",
        "label": "Lincoln Life &amp; Annuity Company Of New York [Member]",
        "terseLabel": "Lincoln Life &amp; Annuity Company of New York"
       }
      }
     },
     "localname": "LincolnLifeAnnuityCompanyOfNewYorkMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_LongTermCareReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term Care Reporting Unit [Member]",
        "label": "Long-Term Care Reporting Unit [Member]",
        "terseLabel": "Long-Term Care Reporting Unit"
       }
      }
     },
     "localname": "LongTermCareReportingUnitMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_LongtermDebtGrossAndLeaseObligation": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt, Gross And Lease Obligation",
        "label": "Long-term Debt, Gross And Lease Obligation",
        "terseLabel": "Total debt principal",
        "totalLabel": "Total debt principal"
       }
      }
     },
     "localname": "LongtermDebtGrossAndLeaseObligation",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_LossContingencyAuditMethodologySampleSize": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Audit Methodology Sample Size",
        "label": "Loss Contingency, Audit Methodology Sample Size",
        "terseLabel": "Audit methodology sample size"
       }
      }
     },
     "localname": "LossContingencyAuditMethodologySampleSize",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_MortgageLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents mortgage loans for the reporting period measured at carrying value. We carry the value of our mortgage loan investments on our balance sheet at the unpaid principal balance, net of impairment reserves.",
        "label": "Mortgage Loans [Member]",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal After Year Five",
        "label": "Mortgage Loans On Real Estate Collections Of Principal After Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalAfterYearFive",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal In Next Twelve Months",
        "label": "Mortgage Loans On Real Estate Collections Of Principal In Next Twelve Months",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal In Year Five",
        "label": "Mortgage Loans On Real Estate Collections Of Principal In Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFive",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal In Year Four",
        "label": "Mortgage Loans On Real Estate Collections Of Principal In Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalInYearFour",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal In Year Three",
        "label": "Mortgage Loans On Real Estate Collections Of Principal In Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalInYearThree",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Collections Of Principal In Year Two",
        "label": "Mortgage Loans On Real Estate Collections Of Principal In Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCollectionsOfPrincipalInYearTwo",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateLoansFullyRepaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pertains to amount of mortgage loans fully repaid.",
        "label": "Mortgage Loans on Real Estate, Loans Fully Repaid",
        "terseLabel": "Mortgage loans fully repaid"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateLoansFullyRepaid",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_MortgageLoansOnRealEstateYearOfOriginationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Year Of Origination",
        "label": "Mortgage Loans On Real Estate Year Of Origination [Axis]",
        "terseLabel": "Mortgage Loans On Real Estate Year Of Origination [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateYearOfOriginationAxis",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_MortgageLoansOnRealEstateYearOfOriginationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mortgage Loans On Real Estate Year Of Origination",
        "label": "Mortgage Loans On Real Estate Year Of Origination [Domain]",
        "terseLabel": "Mortgage Loans On Real Estate Year Of Origination [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateYearOfOriginationDomain",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_NetGainFromWriteOffOfDeferredDebtIssuanceCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Gain from Write Off of Deferred Debt Issuance Costs",
        "label": "Net Gain from Write Off of Deferred Debt Issuance Costs",
        "terseLabel": "Net gain on write-off of net unamortized deferred financing premiums on early extinguishment of debt"
       }
      }
     },
     "localname": "NetGainFromWriteOffOfDeferredDebtIssuanceCosts",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NetRevenuesRetailCoPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Revenues, Retail CoPayments",
        "label": "Net Revenues, Retail CoPayments",
        "terseLabel": "Co-payments"
       }
      }
     },
     "localname": "NetRevenuesRetailCoPayments",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NoncontrollinginterestOtherPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling interest, Other Period Increase (Decrease)",
        "label": "Noncontrolling interest, Other Period Increase (Decrease)",
        "terseLabel": "Other increases (decreases) in noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollinginterestOtherPeriodIncreaseDecrease",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_NumberOfPeopleServed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of People Served",
        "label": "Number Of People Served",
        "terseLabel": "Number of people served"
       }
      }
     },
     "localname": "NumberOfPeopleServed",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberOfPlanMembers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Plan Members",
        "label": "Number Of Plan Members",
        "terseLabel": "Number of plan members"
       }
      }
     },
     "localname": "NumberOfPlanMembers",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberOfStoresAnnualPlannedClosuresForClosurePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Stores, Annual Planned Closures For Closure Period",
        "label": "Number of Stores, Annual Planned Closures For Closure Period",
        "terseLabel": "Number of stores, annual planned closures for closure period"
       }
      }
     },
     "localname": "NumberOfStoresAnnualPlannedClosuresForClosurePeriod",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberOfStoresPlannedClosure": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Stores, Planned Closure",
        "label": "Number of Stores, Planned Closure",
        "terseLabel": "Number of stores, planned closure"
       }
      }
     },
     "localname": "NumberOfStoresPlannedClosure",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberOfStoresPlannedClosurePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Stores, Planned Closure Period",
        "label": "Number of Stores, Planned Closure Period",
        "terseLabel": "Number of stores, planned closure period (in years)"
       }
      }
     },
     "localname": "NumberOfStoresPlannedClosurePeriod",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_NumberofPatientsServedperYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Patients Served per Year",
        "label": "Number of Patients Served per Year",
        "terseLabel": "Number of patients served per year (more than)"
       }
      }
     },
     "localname": "NumberofPatientsServedperYear",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofReinsuranceContractsEnteredInto": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reinsurance contracts entered into with an unrelated insurer.",
        "label": "Number of Reinsurance Contracts Entered Into",
        "terseLabel": "Number of reinsurance contracts entered into"
       }
      }
     },
     "localname": "NumberofReinsuranceContractsEnteredInto",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumberofWalkInMedicalClinics": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Walk In Medical Clinics",
        "label": "Number of Walk In Medical Clinics",
        "terseLabel": "Number of walk-in medical clinics"
       }
      }
     },
     "localname": "NumberofWalkInMedicalClinics",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvs_NumeratorForEarningsPerShareCalculationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Numerator For Earnings Per Share Calculation [Abstract]",
        "label": "Numerator For Earnings Per Share Calculation [Abstract]",
        "terseLabel": "Numerator for earnings per share calculation:"
       }
      }
     },
     "localname": "NumeratorForEarningsPerShareCalculationAbstract",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating And Capital Leases, Amount Due In Excess Of Remaining Estimated Economic Life",
        "label": "Operating And Capital Leases, Amount Due In Excess Of Remaining Estimated Economic Life",
        "terseLabel": "Leases, amount due in excess of remaining estimated economic life"
       }
      }
     },
     "localname": "OperatingAndCapitalLeasesAmountDueInExcessOfRemainingEstimatedEconomicLife",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Expenses, Excluding Store Impairments and Goodwill Impairments",
        "label": "Operating Expenses, Excluding Store Impairments and Goodwill Impairments",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesExcludingStoreImpairmentsAndGoodwillImpairments",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Assets And Liabilities, Lessee [Abstract]",
        "label": "Operating Lease, Assets And Liabilities, Lessee [Abstract]",
        "terseLabel": "Operating leases:"
       }
      }
     },
     "localname": "OperatingLeaseAssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_OperatingLeaseRightOfUseAssetFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease, Right-of-Use Asset, Fair Value Disclosure",
        "label": "Operating lease, Right-of-Use Asset, Fair Value Disclosure",
        "terseLabel": "Operating lease, right-of-use asset, fair value"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetFairValueDisclosure",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherAcquiredIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Other Acquired Intangible Assets [Line Items]",
        "terseLabel": "Other Intangible Assets[Line Items]"
       }
      }
     },
     "localname": "OtherAcquiredIntangibleAssetsLineItems",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_OtherAcquiredIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Other Acquired Intangible Assets [Table]",
        "terseLabel": "Other Intangible Assets [Table]"
       }
      }
     },
     "localname": "OtherAcquiredIntangibleAssetsTable",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_OtherAssetBackedSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by a variety of assets such as automobile loans, credit card receivables, home equity loans, etc.",
        "label": "Other Asset-Backed Securities [Member]",
        "terseLabel": "Other asset-backed securities"
       }
      }
     },
     "localname": "OtherAssetBackedSecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OtherInsuranceLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities, Current",
        "label": "Other Insurance Liabilities, Current",
        "terseLabel": "Other insurance liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesCurrent",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherInsuranceLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities [Member]",
        "label": "Other Insurance Liabilities [Member]",
        "terseLabel": "Other Insurance Liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OtherInsuranceLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Insurance Liabilities, Noncurrent",
        "label": "Other Insurance Liabilities, Noncurrent",
        "terseLabel": "Other long-term insurance liabilities"
       }
      }
     },
     "localname": "OtherInsuranceLiabilitiesNoncurrent",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_OtherLongTermInsuranceLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Long-Term Insurance Liabilities [Member]",
        "label": "Other Long-Term Insurance Liabilities [Member]",
        "terseLabel": "Other Long-Term Insurance Liabilities"
       }
      }
     },
     "localname": "OtherLongTermInsuranceLiabilitiesMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_OutstandingSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding Senior Notes [Member]",
        "label": "Outstanding Senior Notes [Member]",
        "terseLabel": "Outstanding Senior Notes"
       }
      }
     },
     "localname": "OutstandingSeniorNotesMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PaymentsForAcceleratedShareRepurchasesAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Accelerated Share Repurchases, Amount",
        "label": "Payments for Accelerated Share Repurchases, Amount",
        "terseLabel": "Payments for ASR, amount"
       }
      }
     },
     "localname": "PaymentsForAcceleratedShareRepurchasesAmount",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PaymentsforInsuranceBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Insurance Benefits",
        "label": "Payments for Insurance Benefits",
        "negatedTerseLabel": "Insurance benefits paid"
       }
      }
     },
     "localname": "PaymentsforInsuranceBenefits",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies",
        "label": "Payments for Inventory and Prescriptions Dispensed by Retail Network Pharmacies",
        "negatedTerseLabel": "Cash paid for inventory and prescriptions dispensed by retail network pharmacies"
       }
      }
     },
     "localname": "PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PensionAndAnnuityInvestmentContractsInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension And Annuity Investment Contracts Interest",
        "label": "Pension And Annuity Investment Contracts Interest",
        "terseLabel": "Interest rate for pension and annuity investment contracts"
       }
      }
     },
     "localname": "PensionAndAnnuityInvestmentContractsInterest",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvs_PharmacyClaimsandDiscountsPayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Claims and Discounts Payable, Current",
        "label": "Pharmacy Claims and Discounts Payable, Current",
        "terseLabel": "Pharmacy claims and discounts payable"
       }
      }
     },
     "localname": "PharmacyClaimsandDiscountsPayableCurrent",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PharmacyRebatePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Rebate Period",
        "label": "Pharmacy Rebate Period",
        "terseLabel": "Pharmacy rebate period"
       }
      }
     },
     "localname": "PharmacyRebatePeriod",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_PharmacyRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Revenue [Member]",
        "label": "Pharmacy Revenue [Member]",
        "terseLabel": "Pharmacy"
       }
      }
     },
     "localname": "PharmacyRevenueMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PharmacyServicesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy Services Segment [Member]",
        "label": "Pharmacy Services Segment [Member]",
        "terseLabel": "Pharmacy Services"
       }
      }
     },
     "localname": "PharmacyServicesSegmentMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_PremiumDeficiencyReserveLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of reserves related to expected future claims, including maintenance costs (for example, direct costs such as claim processing costs), in excess of existing reserves plus anticipated future premiums and reinsurance recoveries.",
        "label": "Premium Deficiency Reserve Liability",
        "terseLabel": "Add: Premium deficiency reserve",
        "verboseLabel": "Premium deficiency reserve"
       }
      }
     },
     "localname": "PremiumDeficiencyReserveLiability",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax",
        "label": "Premiums Earned, Net And Revenue From Contract With Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues from external customers",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "PremiumsEarnedNetAndRevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_PremiumsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Premiums [Member]",
        "label": "Premiums [Member]",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PremiumsMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item includes proceeds from the sale of debt securities and the related gross realized capital gains and losses, excluding amounts related to experience-rated and discontinued products.",
        "label": "Proceeds And Related Gross Realized Capital Gains Losses From Sale Of Debt Securities [Table Text Block]",
        "verboseLabel": "Proceeds and related gross realized capital gains and losses from the sale of debt securities"
       }
      }
     },
     "localname": "ProceedsAndRelatedGrossRealizedCapitalGainsLossesFromSaleOfDebtSecuritiesTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_ProceedsFromVariableInterestEntity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Variable Interest Entity",
        "label": "Proceeds From Variable Interest Entity",
        "terseLabel": "Proceeds from VIE"
       }
      }
     },
     "localname": "ProceedsFromVariableInterestEntity",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ProviderNetworksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired in a business combination or other transaction. This item represents the value ascribed to the relationships with the acquiree's physicians, hospitals and other health care providers network.",
        "label": "Provider networks [Member]",
        "terseLabel": "Provider networks"
       }
      }
     },
     "localname": "ProviderNetworksMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RadcliffAndFlaimVAetnaIncEtAlMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Radcliff and Flaim v Aetna Inc., et al",
        "label": "Radcliff and Flaim v Aetna Inc., et al [Member]",
        "terseLabel": "Radcliff and Flaim v Aetna Inc., et al"
       }
      }
     },
     "localname": "RadcliffAndFlaimVAetnaIncEtAlMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receipt from Business Combination, Purchase Price Adjustment, Outside of Measurement Period",
        "label": "Receipt from Business Combination, Purchase Price Adjustment, Outside of Measurement Period",
        "terseLabel": "Receipt related purchase price adjustment from acquisition"
       }
      }
     },
     "localname": "ReceiptFromBusinessCombinationPurchasePriceAdjustmentOutsideOfMeasurementPeriod",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_RedOakMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Red Oak",
        "label": "Red Oak [Member]",
        "terseLabel": "Red Oak"
       }
      }
     },
     "localname": "RedOakMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RedeemablePreferredSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Preferred Securities [Member]",
        "label": "Redeemable Preferred Securities [Member]",
        "terseLabel": "Redeemable preferred securities"
       }
      }
     },
     "localname": "RedeemablePreferredSecuritiesMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RelatedPartyTransactionCharitableContributionToNonProfitEntity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Transaction, Charitable Contribution To Non-Profit Entity",
        "label": "Related Party Transaction, Charitable Contribution To Non-Profit Entity",
        "terseLabel": "Charitable contribution to CVS Health Foundation"
       }
      }
     },
     "localname": "RelatedPartyTransactionCharitableContributionToNonProfitEntity",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_RestrictedStockUnitsandPerformanceShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Units and Performance Share Units [Member]",
        "label": "Restricted Stock Units and Performance Share Units [Member]",
        "terseLabel": "Restricted Stock Units and Performance Share Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsandPerformanceShareUnitsMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RetailLongTermCareSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retail Long-Term Care Segment [Member]",
        "label": "Retail Long-Term Care Segment [Member]",
        "terseLabel": "Retail/ LTC"
       }
      }
     },
     "localname": "RetailLongTermCareSegmentMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RevolvingCreditFacilityExpiringMay112026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility, Expiring May 11, 2026",
        "label": "Revolving Credit Facility, Expiring May 11, 2026 [Member]",
        "terseLabel": "Revolving Credit Facility, Expiring May 11, 2026"
       }
      }
     },
     "localname": "RevolvingCreditFacilityExpiringMay112026Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RevolvingCreditFacilityExpiringMay162024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility, Expiring May 16, 2024 [Member]",
        "label": "Revolving Credit Facility, Expiring May 16, 2024 [Member]",
        "terseLabel": "Revolving Credit Facility, Expiring May 16, 2024"
       }
      }
     },
     "localname": "RevolvingCreditFacilityExpiringMay162024Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RevolvingCreditFacilityExpiringMay172023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility, Expiring May 17, 2023 [Member]",
        "label": "Revolving Credit Facility, Expiring May 17, 2023 [Member]",
        "terseLabel": "Revolving Credit Facility, Expiring May 17, 2023"
       }
      }
     },
     "localname": "RevolvingCreditFacilityExpiringMay172023Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "label": "Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "terseLabel": "Right-of-use assets obtained in exchange for lease obligations:"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_SalesChannelOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Channel, Other [Member]",
        "label": "Sales Channel, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "SalesChannelOtherMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing credit quality information related to financing receivables by credit quality indicator and by class of financing receivable.",
        "label": "Schedule Of Mortgage Loan Internal Credit Ratings [Table Text Block]",
        "verboseLabel": "Mortgage loan internal credit rating"
       }
      }
     },
     "localname": "ScheduleOfMortgageLoanInternalCreditRatingsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_SeniorNotes13DueAugust2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1.3%, Due August 2027",
        "label": "Senior Notes, 1.3%, Due August 2027 [Member]",
        "terseLabel": "1.3% senior notes due August 2027"
       }
      }
     },
     "localname": "SeniorNotes13DueAugust2027Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes175DueAugust2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1.75%, Due August 2030",
        "label": "Senior Notes, 1.75%, Due August 2030 [Member]",
        "terseLabel": "1.75% senior notes due August 2030"
       }
      }
     },
     "localname": "SeniorNotes175DueAugust2030Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes1875DueFebruary2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1.875%, Due February 2031",
        "label": "Senior Notes, 1.875%, Due February 2031 [Member]",
        "terseLabel": "1.875%, senior notes due February 2031"
       }
      }
     },
     "localname": "SeniorNotes1875DueFebruary2031Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes1Point3PercentAugust2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1 Point 3 Percent, August 2027",
        "label": "Senior Notes, 1 Point 3 Percent, August 2027 [Member]",
        "terseLabel": "1.3% senior notes due August 2027"
       }
      }
     },
     "localname": "SeniorNotes1Point3PercentAugust2027Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes1Point75PercentAugust2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1 Point 75 Percent, August 2030",
        "label": "Senior Notes, 1 Point 75 Percent, August 2030 [Member]",
        "terseLabel": "1.75% senior notes due August 2030"
       }
      }
     },
     "localname": "SeniorNotes1Point75PercentAugust2030Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes1Point875PercentFebruary2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 1 Point 875 Percent, February 2031",
        "label": "Senior Notes, 1 Point 875 Percent, February 2031 [Member]",
        "terseLabel": "1.875% senior notes due February 2031"
       }
      }
     },
     "localname": "SeniorNotes1Point875PercentFebruary2031Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.125June2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.125%, June 2021 [Member]",
        "label": "Senior Notes, 2.125%, June 2021 [Member]",
        "terseLabel": "2.125% senior notes due June 2021"
       }
      }
     },
     "localname": "SeniorNotes2.125June2021Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.625DueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.625%, Due August 2024 [Member]",
        "label": "Senior Notes, 2.625%, Due August 2024 [Member]",
        "terseLabel": "2.625% senior notes due August 2024"
       }
      }
     },
     "localname": "SeniorNotes2.625DueAugust2024Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.75DueDecember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.75%, Due December 2022 [Member]",
        "label": "Senior Notes, 2.75%, Due December 2022 [Member]",
        "terseLabel": "2.75% senior notes due December 2022"
       }
      }
     },
     "localname": "SeniorNotes2.75DueDecember2022Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.75DueNovember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.75%, Due November 2022 [Member]",
        "label": "Senior Notes, 2.75%, Due November 2022 [Member]",
        "terseLabel": "2.75% senior notes due November 2022"
       }
      }
     },
     "localname": "SeniorNotes2.75DueNovember2022Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.875DueJune2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.875%, Due June 2026 [Member]",
        "label": "Senior Notes, 2.875%, Due June 2026 [Member]",
        "terseLabel": "2.875% senior notes due June 2026"
       }
      }
     },
     "localname": "SeniorNotes2.875DueJune2026Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2.8DueJune2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.8%, Due June 2023 [Member]",
        "label": "Senior Notes, 2.8%, Due June 2023 [Member]",
        "terseLabel": "2.8% senior notes due June 2023"
       }
      }
     },
     "localname": "SeniorNotes2.8DueJune2023Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes27DueAugust2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2.7%, Due August 2040",
        "label": "Senior Notes, 2.7%, Due August 2040 [Member]",
        "terseLabel": "2.7% senior notes due August 2040"
       }
      }
     },
     "localname": "SeniorNotes27DueAugust2040Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2Point125PercentDueSeptember2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2 Point 125 Percent, Due September 2031",
        "label": "Senior Notes, 2 Point 125 Percent, Due September 2031 [Member]",
        "terseLabel": "2.125% senior notes due September 2031"
       }
      }
     },
     "localname": "SeniorNotes2Point125PercentDueSeptember2031Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes2Point7PercentAugust2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 2 Point 7 Percent, August 2040",
        "label": "Senior Notes, 2 Point 7 Percent, August 2040 [Member]",
        "terseLabel": "2.7% senior notes due August 2040"
       }
      }
     },
     "localname": "SeniorNotes2Point7PercentAugust2040Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.125DueMarch2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.125%, Due March 2020 [Member]",
        "label": "Senior Notes, 3.125%, Due March 2020 [Member]",
        "terseLabel": "3.125% senior notes due March 2020"
       }
      }
     },
     "localname": "SeniorNotes3.125DueMarch2020Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.25DueAugust2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.25%, Due August 2029 [Member]",
        "label": "Senior Notes, 3.25%, Due August 2029 [Member]",
        "terseLabel": "3.25% senior notes due August 2029"
       }
      }
     },
     "localname": "SeniorNotes3.25DueAugust2029Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.35DueMarch2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.35%, Due March 2021 [Member]",
        "label": "Senior Notes, 3.35%, Due March 2021 [Member]",
        "terseLabel": "3.35% senior notes due March 2021"
       }
      }
     },
     "localname": "SeniorNotes3.35DueMarch2021Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.375DueAugust2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.375%, Due August 2024 [Member]",
        "label": "Senior Notes, 3.375%, Due August 2024 [Member]",
        "terseLabel": "3.375% senior notes due August 2024"
       }
      }
     },
     "localname": "SeniorNotes3.375DueAugust2024Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.5DueJuly2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.5%, Due July 2022 [Member]",
        "label": "Senior Notes, 3.5%, Due July 2022 [Member]",
        "terseLabel": "3.5% senior notes due July 2022"
       }
      }
     },
     "localname": "SeniorNotes3.5DueJuly2022Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.5DueNovember2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.5%, Due November 2024 [Member]",
        "label": "Senior Notes, 3.5%, Due November 2024 [Member]",
        "terseLabel": "3.5% senior notes due November 2024"
       }
      }
     },
     "localname": "SeniorNotes3.5DueNovember2024Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.7DueMarch2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.7%, Due March 2023 [Member]",
        "label": "Senior Notes, 3.7%, Due March 2023 [Member]",
        "terseLabel": "3.7% senior notes due March 2023"
       }
      }
     },
     "localname": "SeniorNotes3.7DueMarch2023Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.875DueAugust2047Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.875%, Due August 2047 [Member]",
        "label": "Senior Notes, 3.875%, Due August 2047 [Member]",
        "terseLabel": "3.875% senior notes due August 2047"
       }
      }
     },
     "localname": "SeniorNotes3.875DueAugust2047Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3.875DueJuly2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.875%, Due July 2025 [Member]",
        "label": "Senior Notes, 3.875%, Due July 2025 [Member]",
        "terseLabel": "3.875% senior notes due July 2025"
       }
      }
     },
     "localname": "SeniorNotes3.875DueJuly2025Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3625DueApril2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.625%, Due April 2027",
        "label": "Senior Notes, 3.625%, Due April 2027 [Member]",
        "terseLabel": "3.625% senior notes due April 2027"
       }
      }
     },
     "localname": "SeniorNotes3625DueApril2027Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes375DueApril2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3.75%, Due April 2030",
        "label": "Senior Notes, 3.75%, Due April 2030 [Member]",
        "terseLabel": "3.75% senior notes due April 2030"
       }
      }
     },
     "localname": "SeniorNotes375DueApril2030Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3DueAugust2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3%, Due August 2026 [Member]",
        "label": "Senior Notes, 3%, Due August 2026 [Member]",
        "terseLabel": "3% senior notes due August 2026"
       }
      }
     },
     "localname": "SeniorNotes3DueAugust2026Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3Point625PercentApril2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3 Point 625 Percent, April 2027",
        "label": "Senior Notes, 3 Point 625 Percent, April 2027 [Member]",
        "terseLabel": "3.625% senior notes due April 2027"
       }
      }
     },
     "localname": "SeniorNotes3Point625PercentApril2027Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3Point70PercentDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3 Point 70 Percent, Due 2023",
        "label": "Senior Notes, 3 Point 70 Percent, Due 2023 [Member]",
        "terseLabel": "Senior Notes, 3 Point 70 Percent, Due 2023"
       }
      }
     },
     "localname": "SeniorNotes3Point70PercentDue2023Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes3Point75PercentApril2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 3 Point 75 Percent, April 2030",
        "label": "Senior Notes, 3 Point 75 Percent, April 2030 [Member]",
        "terseLabel": "3.75% senior notes due April 2030"
       }
      }
     },
     "localname": "SeniorNotes3Point75PercentApril2030Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueJune2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.125%, Due June 2021 [Member]",
        "label": "Senior Notes, 4.125%, Due June 2021 [Member]",
        "terseLabel": "4.125% senior notes due June 2021"
       }
      }
     },
     "localname": "SeniorNotes4.125DueJune2021Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueMay2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.125%, Due May 2021 [Member]",
        "label": "Senior Notes, 4.125%, Due May 2021 [Member]",
        "terseLabel": "4.125% senior notes due May 2021"
       }
      }
     },
     "localname": "SeniorNotes4.125DueMay2021Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.125DueNovember2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents senior notes due 2042 with a coupon rate of 4.125%.",
        "label": "Senior Notes, 4.125%, Due November 2042 [Member]",
        "terseLabel": "4.125% senior notes due November 2042"
       }
      }
     },
     "localname": "SeniorNotes4.125DueNovember2042Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.1DueMarch2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.1%, Due March 2025 [Member]",
        "label": "Senior Notes, 4.1%, Due March 2025 [Member]",
        "terseLabel": "4.1% senior notes due March 2025"
       }
      }
     },
     "localname": "SeniorNotes4.1DueMarch2025Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.3DueMarch2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.3%, Due March 2028 [Member]",
        "label": "Senior Notes, 4.3%, Due March 2028 [Member]",
        "terseLabel": "4.3% senior notes due March 2028"
       }
      }
     },
     "localname": "SeniorNotes4.3DueMarch2028Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.5DueMay2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.5%, Due May 2042 [Member]",
        "label": "Senior Notes, 4.5%, Due May 2042 [Member]",
        "terseLabel": "4.5% senior notes due May 2042"
       }
      }
     },
     "localname": "SeniorNotes4.5DueMay2042Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.75DueDecember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.75%, Due December 2022 [Member]",
        "label": "Senior Notes, 4.75%, Due December 2022 [Member]",
        "terseLabel": "4.75% senior notes due December 2022"
       }
      }
     },
     "localname": "SeniorNotes4.75DueDecember2022Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.75DueMarch2044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.75%, Due March 2044 [Member]",
        "label": "Senior Notes, 4.75%, Due March 2044 [Member]",
        "terseLabel": "4.75% senior notes due March 2044"
       }
      }
     },
     "localname": "SeniorNotes4.75DueMarch2044Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.78DueMarch2038Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.78%, Due March 2038 [Member]",
        "label": "Senior Notes, 4.78%, Due March 2038 [Member]",
        "terseLabel": "4.78% senior notes due March 2038"
       }
      }
     },
     "localname": "SeniorNotes4.78DueMarch2038Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4.875DueJuly2035Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.875%, Due July 2035 [Member]",
        "label": "Senior Notes, 4.875%, Due July 2035 [Member]",
        "terseLabel": "4.875% senior notes due July 2035"
       }
      }
     },
     "localname": "SeniorNotes4.875DueJuly2035Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4125DueApril2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.125%, Due April 2040",
        "label": "Senior Notes, 4.125%, Due April 2040 [Member]",
        "terseLabel": "4.125% senior notes due April 2040"
       }
      }
     },
     "localname": "SeniorNotes4125DueApril2040Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes425DueApril2050Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.25%, Due April 2050",
        "label": "Senior Notes, 4.25%, Due April 2050 [Member]",
        "terseLabel": "4.25% senior notes due April 2050"
       }
      }
     },
     "localname": "SeniorNotes425DueApril2050Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes43Due2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4.3%, Due 2028",
        "label": "Senior Notes, 4.3%, Due 2028 [Member]",
        "terseLabel": "4.3% senior notes due 2028"
       }
      }
     },
     "localname": "SeniorNotes43Due2028Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4DueDecember2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4%, Due December 2023 [Member]",
        "label": "Senior Notes, 4%, Due December 2023 [Member]",
        "terseLabel": "4% senior notes due December 2023"
       }
      }
     },
     "localname": "SeniorNotes4DueDecember2023Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4Point125PercentApril2040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4 Point 125 Percent, April 2040",
        "label": "Senior Notes, 4 Point 125 Percent, April 2040 [Member]",
        "terseLabel": "4.125% senior notes due April 2040"
       }
      }
     },
     "localname": "SeniorNotes4Point125PercentApril2040Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4Point25PercentApril2050Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4 Point 25 Percent, April 2050",
        "label": "Senior Notes, 4 Point 25 Percent, April 2050 [Member]",
        "terseLabel": "4.25% senior notes due April 2050"
       }
      }
     },
     "localname": "SeniorNotes4Point25PercentApril2050Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes4PointThreePercentDue2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 4 Point Three Percent, Due 2028",
        "label": "Senior Notes, 4 Point Three Percent, Due 2028 [Member]",
        "terseLabel": "Senior Notes, 4.3%, Due 2028"
       }
      }
     },
     "localname": "SeniorNotes4PointThreePercentDue2028Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.05DueMarch2048Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.05%, Due March 2048 [Member]",
        "label": "Senior Notes, 5.05%, Due March 2048 [Member]",
        "terseLabel": "5.05% senior notes due March 2048"
       }
      }
     },
     "localname": "SeniorNotes5.05DueMarch2048Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.125DueJuly2045Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.125%, Due July 2045 [Member]",
        "label": "Senior Notes, 5.125%, Due July 2045 [Member]",
        "terseLabel": "5.125% senior notes due July 2045"
       }
      }
     },
     "localname": "SeniorNotes5.125DueJuly2045Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.3DueDecember2043Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.3%, Due December 2043 [Member]",
        "label": "Senior Notes, 5.3%, Due December 2043 [Member]",
        "terseLabel": "5.3% senior notes due December 2043"
       }
      }
     },
     "localname": "SeniorNotes5.3DueDecember2043Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.45DueJune2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents senior notes due 2021 with a coupon rate of 5.45%.",
        "label": "Senior Notes, 5.45%, Due June 2021 [Member]",
        "terseLabel": "5.45% senior notes due June 2021"
       }
      }
     },
     "localname": "SeniorNotes5.45DueJune2021Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5.75DueMay2041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5.75%, Due May 2041 [Member]",
        "label": "Senior Notes, 5.75%, Due May 2041 [Member]",
        "terseLabel": "5.75% senior notes due May 2041"
       }
      }
     },
     "localname": "SeniorNotes5.75DueMay2041Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes5DueDecember2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 5%, Due December 2024 [Member]",
        "label": "Senior Notes, 5%, Due December 2024 [Member]",
        "terseLabel": "5% senior notes due December 2024"
       }
      }
     },
     "localname": "SeniorNotes5DueDecember2024Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.125DueSeptember2039Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.125%, Due September 2039 [Member]",
        "label": "Senior Notes, 6.125%, Due September 2039 [Member]",
        "terseLabel": "6.125% senior notes due September 2039"
       }
      }
     },
     "localname": "SeniorNotes6.125DueSeptember2039Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.25DueJune2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.25%, Due June 2027 [Member]",
        "label": "Senior Notes, 6.25%, Due June 2027 [Member]",
        "terseLabel": "6.25% senior notes due June 2027"
       }
      }
     },
     "localname": "SeniorNotes6.25DueJune2027Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.625DueJune2036Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.625%, Due June 2036 [Member]",
        "label": "Senior Notes, 6.625%, Due June 2036 [Member]",
        "terseLabel": "6.625% senior notes due June 2036"
       }
      }
     },
     "localname": "SeniorNotes6.625DueJune2036Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeniorNotes6.75DueDecember2037Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes, 6.75%, Due December 2037 [Member]",
        "label": "Senior Notes, 6.75%, Due December 2037 [Member]",
        "terseLabel": "6.75% senior notes due December 2037"
       }
      }
     },
     "localname": "SeniorNotes6.75DueDecember2037Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SeparateAccountFinancialAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separate Account, Financial Assets",
        "label": "Separate Account, Financial Assets [Member]",
        "terseLabel": "Separate Accounts, financial assets"
       }
      }
     },
     "localname": "SeparateAccountFinancialAssetsMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueNarrativeDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Equity Instruments Other Than Options, Vested In Period, Fair Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Equity Instruments Other Than Options, Vested In Period, Fair Value",
        "terseLabel": "Fair value of stock options and SARs vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsVestedInPeriodFairValue",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Payment Arrangement, Option, Granted Prior Through 2018",
        "label": "Share-Based Payment Arrangement, Option, Granted Prior Through 2018 [Member]",
        "terseLabel": "Stock options granted through 2018"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementOptionGrantedPriorThrough2018Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Payment Arrangement, Option, Granted Subsequent to 2018",
        "label": "Share-Based Payment Arrangement, Option, Granted Subsequent to 2018 [Member]",
        "terseLabel": "Stock options granted subsequent to 2018"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementOptionGrantedSubsequentTo2018Member",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Number",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Number",
        "terseLabel": "Expected to vest (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingNumber",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_SharesHeldInTrustPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares Held In Trust [Policy Text Block]",
        "label": "Shares Held In Trust [Policy Text Block]",
        "terseLabel": "Shares Held in Trust"
       }
      }
     },
     "localname": "SharesHeldInTrustPolicyTextBlock",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Employee Stock Purchase Plan, Average Purchase Price of Shares Purchased",
        "label": "Stock Issued During Period, Employee Stock Purchase Plan, Average Purchase Price of Shares Purchased",
        "terseLabel": "Average purchase price of shares purchased (in dollars per share)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodEmployeeStockPurchasePlanAveragePurchasePriceofSharesPurchased",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cvs_StoreImpairmentCharges": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Store Impairment Charges",
        "label": "Store Impairment Charges",
        "terseLabel": "Store impairments",
        "verboseLabel": "Store impairment charges"
       }
      }
     },
     "localname": "StoreImpairmentCharges",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_SupportingExperienceRatedProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supporting discontinued and experience-rated products.",
        "label": "Supporting Experience Rated Products [Member]",
        "terseLabel": "Supporting experience- rated products"
       }
      }
     },
     "localname": "SupportingExperienceRatedProductsMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_SupportingRemainingProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities in an unrealized capital loss position supporting remaining products.",
        "label": "Supporting Remaining Products [Member]",
        "terseLabel": "Supporting remaining products"
       }
      }
     },
     "localname": "SupportingRemainingProductsMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_TotalInvestmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Axis]",
        "terseLabel": "Total Investments [Axis]"
       }
      }
     },
     "localname": "TotalInvestmentsAxis",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Domain]",
        "terseLabel": "Total Investments [Domain]"
       }
      }
     },
     "localname": "TotalInvestmentsDomain",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_TotalInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Line Items]",
        "terseLabel": "Total Investments [Line Items]"
       }
      }
     },
     "localname": "TotalInvestmentsLineItems",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Investments [Table]",
        "terseLabel": "Total Investments [Table]"
       }
      }
     },
     "localname": "TotalInvestmentsTable",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_TotalInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item includes total investments, both current and long-term.",
        "label": "Total Investments [Table Text Block]",
        "verboseLabel": "Total investments"
       }
      }
     },
     "localname": "TotalInvestmentsTableTextBlock",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance",
        "label": "Treasury Stock, Shares, Acquired, Cost Method, Net Of ESPP Issuance",
        "terseLabel": "Purchase of treasury shares, net of ESPP issuances (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquiredCostMethodNetOfESPPIssuance",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_TreasuryStockSharesHeldinTrust": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Shares, Held in Trust",
        "label": "Treasury Stock, Shares, Held in Trust",
        "terseLabel": "Treasury shares held in trust (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesHeldinTrust",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvs_TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance",
        "label": "Treasury Stock, Value, Acquired, Cost Method, Net Of ESPP Issuance",
        "negatedTerseLabel": "Purchase of treasury shares, net of ESPP issuances"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_TreasuryStockValueSharesHeldInTrust": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Value, Shares Held In Trust",
        "label": "Treasury Stock, Value, Shares Held In Trust",
        "terseLabel": "Treasury shares held in trust"
       }
      }
     },
     "localname": "TreasuryStockValueSharesHeldInTrust",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Department of Health and Human Services, ACA Risk Corridor Receivables",
        "label": "U.S. Department of Health and Human Services, ACA Risk Corridor Receivables [Member]",
        "terseLabel": "U.S. Department of Health and Human Services, ACA Risk Corridor Receivables"
       }
      }
     },
     "localname": "USDepartmentOfHealthAndHumanServicesACARiskCorridorReceivablesMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_USFederalGovernmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Federal Government",
        "label": "US Federal Government [Member]",
        "terseLabel": "US Federal Government"
       }
      }
     },
     "localname": "USFederalGovernmentMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_VOYARetirementInsuranceAndAnnuityCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "VOYA Retirement Insurance And Annuity Company [Member]",
        "label": "VOYA Retirement Insurance And Annuity Company [Member]",
        "terseLabel": "VOYA Retirement Insurance and Annuity Company"
       }
      }
     },
     "localname": "VOYARetirementInsuranceAndAnnuityCompanyMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_ValueOfBusinessAcquiredMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value Of Business Acquired [Member]",
        "label": "Value Of Business Acquired [Member]",
        "terseLabel": "Value of Business Acquired"
       }
      }
     },
     "localname": "ValueOfBusinessAcquiredMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_VariableInterestEntityAmendedContractExtensionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entity, Amended Contract Extension Term",
        "label": "Variable Interest Entity, Amended Contract Extension Term",
        "terseLabel": "Amended contract extension term"
       }
      }
     },
     "localname": "VariableInterestEntityAmendedContractExtensionTerm",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_VariableInterestEntityAmendedContractTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entity, Amended Contract Term",
        "label": "Variable Interest Entity, Amended Contract Term",
        "terseLabel": "Amended contract term (in years)"
       }
      }
     },
     "localname": "VariableInterestEntityAmendedContractTerm",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvs_VendorAllowancesAndPurchaseDiscountsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor Allowances And Purchase Discounts",
        "label": "Vendor Allowances And Purchase Discounts [Policy Text Block]",
        "terseLabel": "Vendor Allowances And Purchase Discounts"
       }
      }
     },
     "localname": "VendorAllowancesAndPurchaseDiscountsPolicyTextBlock",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cvs_VendorandManufacturerReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor and Manufacturer Receivables",
        "label": "Vendor and Manufacturer Receivables",
        "terseLabel": "Vendor and manufacturer receivables"
       }
      }
     },
     "localname": "VendorandManufacturerReceivables",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvs_WeightedAverageRemainingLeaseTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Lease Term [Abstract]",
        "label": "Weighted Average Remaining Lease Term [Abstract]",
        "terseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingLeaseTermAbstract",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cvs_YearOfOriginationPeriodFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Period Five",
        "label": "Year Of Origination Period Five [Member]",
        "terseLabel": "2017"
       }
      }
     },
     "localname": "YearOfOriginationPeriodFiveMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Period Four",
        "label": "Year Of Origination Period Four [Member]",
        "terseLabel": "2018"
       }
      }
     },
     "localname": "YearOfOriginationPeriodFourMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Period One",
        "label": "Year Of Origination Period One [Member]",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "YearOfOriginationPeriodOneMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Period Three",
        "label": "Year Of Origination Period Three [Member]",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "YearOfOriginationPeriodThreeMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Period Two",
        "label": "Year Of Origination Period Two [Member]",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "YearOfOriginationPeriodTwoMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YearOfOriginationPriorToPeriodFiveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Year Of Origination Prior To Period Five",
        "label": "Year Of Origination Prior To Period Five [Member]",
        "terseLabel": "Prior"
       }
      }
     },
     "localname": "YearOfOriginationPriorToPeriodFiveMember",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvs_YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Yield Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings",
        "label": "Yield Related Impairment Loss Debt Securities Available For Sale Recognized In Earnings",
        "terseLabel": "Yield-related impairment loss"
       }
      }
     },
     "localname": "YieldRelatedImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://www.cvshealth.com/20211231",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r1076",
      "r1077",
      "r1078"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r1076",
      "r1077",
      "r1078"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r1076",
      "r1077",
      "r1078"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r1076",
      "r1077",
      "r1078"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r1079"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1074"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1073"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1073"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r1073"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r1088"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1073"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r1073"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r1073"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1073"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r1115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r1076",
      "r1077",
      "r1078"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1072"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1075"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cvshealth.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r176",
      "r400",
      "r405",
      "r413",
      "r704",
      "r705",
      "r713",
      "r714",
      "r825",
      "r1066",
      "r1091",
      "r1103",
      "r1112",
      "r1113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by consolidated entity or group of entities.",
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r176",
      "r400",
      "r405",
      "r413",
      "r704",
      "r705",
      "r713",
      "r714",
      "r825",
      "r1066",
      "r1091",
      "r1103",
      "r1112",
      "r1113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity or group of entities consolidated into reporting entity.",
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r176",
      "r230",
      "r249",
      "r250",
      "r251",
      "r252",
      "r254",
      "r256",
      "r260",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r407",
      "r408",
      "r410",
      "r412",
      "r413",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r176",
      "r230",
      "r249",
      "r250",
      "r251",
      "r252",
      "r254",
      "r256",
      "r260",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r407",
      "r408",
      "r410",
      "r412",
      "r413",
      "r1103",
      "r1104",
      "r1105",
      "r1106",
      "r1107",
      "r1108",
      "r1109",
      "r1110",
      "r1111",
      "r1112",
      "r1113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r86",
      "r88",
      "r173",
      "r174",
      "r419",
      "r455",
      "r1114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r182",
      "r190",
      "r196",
      "r313",
      "r639",
      "r640",
      "r641",
      "r679",
      "r680",
      "r739",
      "r742",
      "r744",
      "r745",
      "r1118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r182",
      "r190",
      "r196",
      "r313",
      "r639",
      "r640",
      "r641",
      "r679",
      "r680",
      "r739",
      "r742",
      "r744",
      "r745",
      "r1118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r182",
      "r190",
      "r196",
      "r313",
      "r639",
      "r640",
      "r641",
      "r679",
      "r680",
      "r739",
      "r742",
      "r744",
      "r745",
      "r1118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.",
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim.",
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information.",
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r266",
      "r492",
      "r496",
      "r980"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name or description of a single external customer or a group of external customers.",
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r418",
      "r454",
      "r592",
      "r599",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r861",
      "r978",
      "r982",
      "r1067",
      "r1068"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r418",
      "r454",
      "r592",
      "r599",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r861",
      "r978",
      "r982",
      "r1067",
      "r1068"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": {
     "auth_ref": [
      "r1045",
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1090",
      "r1092"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of real estate property.",
        "label": "Real Estate, Type of Property [Axis]",
        "terseLabel": "Real Estate, Type of Property [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]",
        "terseLabel": "Mortgage Loans on Real Estate [Line Items]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": {
     "auth_ref": [
      "r1057",
      "r1058",
      "r1059",
      "r1060",
      "r1061",
      "r1062",
      "r1063",
      "r1064",
      "r1065",
      "r1090",
      "r1093",
      "r1094",
      "r1095",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Land and any structures permanently fixed to it.",
        "label": "Real Estate [Domain]",
        "terseLabel": "Real Estate [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateScheduleTable": {
     "auth_ref": [
      "r1047",
      "r1102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]",
        "terseLabel": "Mortgage Loans on Real Estate [Table]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateScheduleTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r266",
      "r492",
      "r496",
      "r980"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Single external customer or group of external customers.",
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r263",
      "r492",
      "r494",
      "r863",
      "r975",
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r263",
      "r492",
      "r494",
      "r863",
      "r975",
      "r979"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r418",
      "r454",
      "r531",
      "r592",
      "r599",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r861",
      "r978",
      "r982",
      "r1067",
      "r1068"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r418",
      "r454",
      "r531",
      "r592",
      "r599",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r861",
      "r978",
      "r982",
      "r1067",
      "r1068"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r87",
      "r88",
      "r173",
      "r174",
      "r419",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.",
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r191",
      "r593",
      "r1089"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact.",
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r191",
      "r196",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated.",
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r191",
      "r196",
      "r383",
      "r593",
      "r830"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.",
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock": {
     "auth_ref": [
      "r955",
      "r1101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the supplemental schedule of reinsurance information. Reinsurance schedule includes, but is not limited to, the type of insurance, gross amount of premiums, premiums ceded to other entities, premiums assumed from other entities, net amount of premium revenue, and the percentage of the premiums assumed to net premium revenue.",
        "label": "SEC Schedule, 12-17, Insurance Companies, Reinsurance [Text Block]",
        "terseLabel": "Schedule of direct, assumed and ceded premiums earned"
       }
      }
     },
     "localname": "SupplementalScheduleOfReinsurancePremiumsForInsuranceCompaniesTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "ASU 2016-02"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "ASU 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r183",
      "r184",
      "r185",
      "r186",
      "r277",
      "r278",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r399",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r679",
      "r680",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r823",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r35",
      "r66"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r1051"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r31",
      "r53",
      "r268",
      "r269"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net",
        "totalLabel": "Total accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r95",
      "r100",
      "r108",
      "r109",
      "r110",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Pension and OPEB plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r64",
      "r372"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r90",
      "r100",
      "r108",
      "r109",
      "r110",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": {
     "auth_ref": [
      "r100",
      "r108",
      "r109",
      "r110",
      "r709"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.",
        "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net cash flow hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r92",
      "r93",
      "r94",
      "r100",
      "r108",
      "r109",
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]",
        "terseLabel": "Net unrealized investment gains (losses)"
       }
      }
     },
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r56",
      "r98",
      "r99",
      "r100",
      "r923",
      "r991",
      "r995"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r97",
      "r100",
      "r108",
      "r109",
      "r110",
      "r179",
      "r180",
      "r181",
      "r710",
      "r986",
      "r987",
      "r1120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r183",
      "r184",
      "r185",
      "r186",
      "r196",
      "r277",
      "r278",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r399",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r677",
      "r678",
      "r679",
      "r680",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r823",
      "r865",
      "r866",
      "r867",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments required to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Costs"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r647"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r602",
      "r631",
      "r644"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocationsToPolicyholdersPolicies": {
     "auth_ref": [
      "r996"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining amounts of income and expenses allocated to policyholders and contract holders, excluding the method for determining dividends payable to policyholders and accounting policies pertaining to separate accounts for variable annuity contracts.",
        "label": "Allocations to Policyholders, Policies [Policy Text Block]",
        "terseLabel": "Policyholders' Funds"
       }
      }
     },
     "localname": "AllocationsToPolicyholdersPolicies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r272",
      "r316",
      "r318",
      "r320"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": {
     "auth_ref": [
      "r319"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Recovery",
        "negatedTerseLabel": "Receipt of fully reserved ACA risk corridor receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r156",
      "r356",
      "r363"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Antidilutive securities excluded from computation of EPS (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r97",
      "r100",
      "r108",
      "r109",
      "r110",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r293",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-backed Securities [Member]",
        "terseLabel": "Other asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r168",
      "r238",
      "r251",
      "r258",
      "r308",
      "r400",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r409",
      "r411",
      "r413",
      "r414",
      "r704",
      "r713",
      "r772",
      "r826",
      "r828",
      "r874",
      "r920"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r32",
      "r33",
      "r85",
      "r168",
      "r308",
      "r400",
      "r401",
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r409",
      "r411",
      "r413",
      "r414",
      "r704",
      "r713",
      "r772",
      "r826",
      "r828"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r748"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsHeldByInsuranceRegulators": {
     "auth_ref": [
      "r1022"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of cash and investment securities on deposit with state regulatory authorities in connection with capital requirements.",
        "label": "Assets Held by Insurance Regulators",
        "terseLabel": "Investments on deposit with regulatory bodies"
       }
      }
     },
     "localname": "AssetsHeldByInsuranceRegulators",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssumedPremiumsEarned": {
     "auth_ref": [
      "r936",
      "r953",
      "r1007",
      "r1010"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PremiumsEarnedNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earned premiums assumed from other entities.",
        "label": "Assumed Premiums Earned",
        "terseLabel": "Assumed"
       }
      }
     },
     "localname": "AssumedPremiumsEarned",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r285"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r286"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss [Abstract]",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r287",
      "r290",
      "r900"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "After five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r287",
      "r289",
      "r899"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "One year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r287",
      "r291",
      "r901"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Greater than ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r287",
      "r288",
      "r898"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Less than one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "auth_ref": [
      "r292",
      "r902"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-sale, Maturity, without Single Maturity Date, Fair Value",
        "terseLabel": "Debt securities, maturity, without single maturity date"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r279",
      "r283",
      "r328",
      "r882"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "cvs_DebtSecuritiesAvailableForSaleAmortizedCostNet",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Debt securities",
        "totalLabel": "Total",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Number of Positions [Abstract]",
        "terseLabel": "Number of Securities"
       }
      }
     },
     "localname": "AvailableForsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r603",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r730",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building, building improvements and leasehold improvements",
        "verboseLabel": "Building and improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Distribution centers and Corporate offices"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "verboseLabel": "Acquisition-related integration costs"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizationOfDeferredPolicyAcquisitionCostsPolicy": {
     "auth_ref": [
      "r956"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferred policy acquisition costs, including the nature, type, and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs.",
        "label": "Deferred Policy Acquisition Costs, Policy [Policy Text Block]",
        "terseLabel": "Health Care Contract Acquisition Costs"
       }
      }
     },
     "localname": "CapitalizationOfDeferredPolicyAcquisitionCostsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r767",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r29",
      "r60",
      "r158"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r38",
      "r159",
      "r871"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r148",
      "r158",
      "r162"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at the end of the period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the period",
        "totalLabel": "Total cash, cash equivalents and restricted cash in the consolidated statements of cash flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r148",
      "r781"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries": {
     "auth_ref": [
      "r177"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents disclosure of the aggregate cash dividends paid to the entity by consolidated subsidiaries.",
        "label": "SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries",
        "terseLabel": "Dividends paid"
       }
      }
     },
     "localname": "CashDividendsPaidToParentCompanyByConsolidatedSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock": {
     "auth_ref": [
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash received from exercise of stock options and similar instruments granted under share-based payment arrangements and tax benefit from exercise of stock options.",
        "label": "Cash Proceeds Received and Tax Benefit from Share-based Payment Awards [Table Text Block]",
        "terseLabel": "Cash proceeds received and tax benefit from share-based payment awards"
       }
      }
     },
     "localname": "CashProceedsReceivedAndTaxBenefitFromShareBasedPaymentAwardsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CededCreditRiskAxis": {
     "auth_ref": [
      "r1024"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reinsurer or group of reinsurers of concentrated credit risk arising from a reinsurance arrangement.",
        "label": "Ceded Credit Risk, Reinsurer [Axis]",
        "terseLabel": "Ceded Credit Risk, Reinsurer [Axis]"
       }
      }
     },
     "localname": "CededCreditRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CededCreditRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Ceded Credit Risk [Line Items]",
        "terseLabel": "Ceded Credit Risk [Line Items]"
       }
      }
     },
     "localname": "CededCreditRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CededCreditRiskReinsurerDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reinsurer or group of reinsurers for whom the entity has a concentration of credit risk.",
        "label": "Ceded Credit Risk, Reinsurer [Domain]",
        "terseLabel": "Ceded Credit Risk, Reinsurer [Domain]"
       }
      }
     },
     "localname": "CededCreditRiskReinsurerDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CededCreditRiskTable": {
     "auth_ref": [
      "r1024"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about reinsurer or group of reinsurers for whom the entity has a concentration of credit risk.",
        "label": "Ceded Credit Risk [Table]",
        "terseLabel": "Ceded Credit Risk [Table]"
       }
      }
     },
     "localname": "CededCreditRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CededPremiumsEarned": {
     "auth_ref": [
      "r936",
      "r952",
      "r1004",
      "r1005",
      "r1008",
      "r1010"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PremiumsEarnedNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earned premiums ceded to other entities.",
        "label": "Ceded Premiums Earned",
        "negatedTerseLabel": "Ceded"
       }
      }
     },
     "localname": "CededPremiumsEarned",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Change in Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClaimsDevelopmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Claims Development [Line Items]",
        "terseLabel": "Claims Development [Line Items]"
       }
      }
     },
     "localname": "ClaimsDevelopmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r474",
      "r475",
      "r476",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r292",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by commercial real estate mortgage loans.",
        "label": "Commercial Mortgage Backed Securities [Member]",
        "terseLabel": "Commercial mortgage-backed securities"
       }
      }
     },
     "localname": "CommercialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialRealEstateMember": {
     "auth_ref": [
      "r325",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property that is solely used for business purposes.",
        "label": "Commercial Real Estate [Member]",
        "terseLabel": "Commercial Real Estate"
       }
      }
     },
     "localname": "CommercialRealEstateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails",
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r76",
      "r382",
      "r884",
      "r930"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 16)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r379",
      "r380",
      "r381",
      "r391",
      "r1053"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Capital shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock held by shareholders with par value plus amounts in excess of par value or issuance value (in cases of no-par value stock).",
        "label": "Common Stock Including Additional Paid in Capital [Member]",
        "terseLabel": "Common Stock and Capital Surplus"
       }
      }
     },
     "localname": "CommonStockIncludingAdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r179",
      "r180",
      "r744"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r52",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r52",
      "r828"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStocksIncludingAdditionalPaidInCapital": {
     "auth_ref": [
      "r52",
      "r54",
      "r473"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of par value plus amounts in excess of par value or issuance value for common stock issued.",
        "label": "Common Stocks, Including Additional Paid in Capital",
        "terseLabel": "Common stock, par value $0.01: 3,200 shares authorized; 1,744 shares issued and 1,322 shares outstanding at December\u00a031, 2021 and 1,733 shares issued and 1,310 shares outstanding at December\u00a031, 2020 and capital surplus"
       }
      }
     },
     "localname": "CommonStocksIncludingAdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred income tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets and Liabilities [Abstract]",
        "terseLabel": "Components of Deferred Tax Assets and Liabilities [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred income tax liabilities:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r103",
      "r105",
      "r106",
      "r120",
      "r892",
      "r943"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to CVS Health"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r103",
      "r105",
      "r119",
      "r702",
      "r725",
      "r891",
      "r942"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r118",
      "r128",
      "r890",
      "r940"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Other Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r219",
      "r220",
      "r266",
      "r769",
      "r770",
      "r1051"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r219",
      "r220",
      "r266",
      "r769",
      "r770",
      "r1024",
      "r1051"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r219",
      "r220",
      "r266",
      "r769",
      "r770",
      "r1024",
      "r1051"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r219",
      "r220",
      "r266",
      "r769",
      "r770"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percent"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r217",
      "r219",
      "r220",
      "r221",
      "r769",
      "r771",
      "r1051"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r219",
      "r220",
      "r266",
      "r769",
      "r770",
      "r1051"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "auth_ref": [
      "r712",
      "r716",
      "r718"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Schedule of contract with customer assets and liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "auth_ref": [
      "r479",
      "r481",
      "r493"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "verboseLabel": "Trade receivables"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r479",
      "r480",
      "r493"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "periodEndLabel": "Contract liabilities, end of period",
        "periodStartLabel": "Contract liabilities, beginning of period",
        "terseLabel": "Contract liabilities (included in accrued expenses)"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesContractBalancesDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesReceivablesandContractedBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r492",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r492",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateAndOtherMember": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that provides financial and operational oversight and administrative support for other segments and other segments not separately reported due to size or nature of business activities. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate and Other [Member]",
        "terseLabel": "Corporate/ Other"
       }
      }
     },
     "localname": "CorporateAndOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r249",
      "r250",
      "r251",
      "r252",
      "r254",
      "r260",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate/ Other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r124",
      "r863"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Products Sold"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r169",
      "r673",
      "r683"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r169",
      "r673",
      "r683",
      "r685"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current taxes"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r169",
      "r673",
      "r683"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r218",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerListsMember": {
     "auth_ref": [
      "r697"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information.",
        "label": "Customer Lists [Member]",
        "terseLabel": "Customer Lists"
       }
      }
     },
     "localname": "CustomerListsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer-related asset, including, but not limited to, customer lists, and noncontractual customer relationships.",
        "label": "Customer-Related Intangible Assets [Member]",
        "terseLabel": "Customer contracts/relationships and covenants not to compete"
       }
      }
     },
     "localname": "CustomerRelatedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r165",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r432",
      "r439",
      "r440",
      "r442",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Borrowings and Credit Arrangements"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r44",
      "r46",
      "r47",
      "r167",
      "r176",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r422",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r444",
      "r445",
      "r446",
      "r447",
      "r795",
      "r875",
      "r877",
      "r915"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r47",
      "r443",
      "r877",
      "r915"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "cvs_LongtermDebtGrossAndLeaseObligation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Long-term debt",
        "totalLabel": "Subtotal",
        "verboseLabel": "Amount outstanding"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r415",
      "r444",
      "r445",
      "r793",
      "r795",
      "r796"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r430",
      "r444",
      "r445",
      "r766"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r73",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r74",
      "r167",
      "r176",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r422",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r444",
      "r445",
      "r446",
      "r447",
      "r795"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r74",
      "r167",
      "r176",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r422",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r441",
      "r444",
      "r445",
      "r446",
      "r447",
      "r469",
      "r470",
      "r471",
      "r472",
      "r792",
      "r793",
      "r795",
      "r796",
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r428",
      "r792",
      "r796"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt premiums"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r284",
      "r328",
      "r336",
      "r337"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Allowance for Credit Loss",
        "negatedTerseLabel": "Allowance for credit loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r300",
      "r334",
      "r339"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Fair Value, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r300",
      "r334"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "terseLabel": "Unrealized Losses, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions": {
     "auth_ref": [
      "r332"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions",
        "terseLabel": "Number of Securities, Greater than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r300",
      "r334",
      "r339"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "verboseLabel": "Fair Value, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r300",
      "r334"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "verboseLabel": "Unrealized Losses, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions": {
     "auth_ref": [
      "r332"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without an allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions",
        "terseLabel": "Number of Securities, Less than 12 months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Realized Gain",
        "terseLabel": "Gross realized capital gains"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Realized Loss",
        "negatedTerseLabel": "Gross realized capital losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Debt securities available for sale"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r296",
      "r330",
      "r339"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position",
        "totalLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r297",
      "r331"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss",
        "totalLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r298",
      "r332"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "totalLabel": "Number of Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesMember": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporations, governments and governmental agencies, municipalities, and other institutions.",
        "label": "Debt Securities [Member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r169",
      "r674",
      "r683"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r156",
      "r169",
      "r674",
      "r683",
      "r684",
      "r685"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r49",
      "r50",
      "r666",
      "r876",
      "r914"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r651",
      "r652"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredPolicyAcquisitionCosts": {
     "auth_ref": [
      "r928",
      "r957",
      "r958",
      "r959",
      "r989",
      "r1021"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred policy acquisition cost capitalized on contract remaining in force.",
        "label": "Deferred Policy Acquisition Cost",
        "terseLabel": "Deferred acquisition costs"
       }
      }
     },
     "localname": "DeferredPolicyAcquisitionCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r169",
      "r674",
      "r683"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r671",
      "r672"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Tax Assets, Deferred Income",
        "terseLabel": "Deferred income"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r671",
      "r672"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r668"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r671",
      "r672"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss and capital loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r671",
      "r672"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": {
     "auth_ref": [
      "r671",
      "r672"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation",
        "terseLabel": "Employee benefits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent": {
     "auth_ref": [
      "r671",
      "r672"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred rent.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Rent",
        "terseLabel": "Lease and rents"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves": {
     "auth_ref": [
      "r671",
      "r672"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves",
        "terseLabel": "Insurance reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r667"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Valuation allowance",
        "verboseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r652",
      "r668"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).",
        "label": "Deferred Tax Liabilities, Investments",
        "negatedLabel": "Investments"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r671",
      "r672"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Lease and rents"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r521",
      "r578"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld": {
     "auth_ref": [
      "r536",
      "r578"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan from actual return (loss) on assets still held.",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Actual Return (Loss) on Plan Assets Still Held",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssetsStillHeld",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r514"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedTerseLabel": "Actuarial (gain) loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r507",
      "r547",
      "r572",
      "r578",
      "r579"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedTerseLabel": "Amortization of net actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": {
     "auth_ref": [
      "r505",
      "r529"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position",
        "totalLabel": "Net assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract]",
        "terseLabel": "Assets (liabilities) recognized on the consolidated balance sheet"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r42",
      "r505",
      "r506",
      "r529",
      "r578",
      "r873",
      "r918"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Noncurrent assets reflected in other assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r555",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Expected long-term rate of return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r509"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Benefit obligation, end of year",
        "periodStartLabel": "Benefit obligation, beginning of year",
        "terseLabel": "Benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r516",
      "r584"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Benefit payments"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationPaymentForSettlement": {
     "auth_ref": [
      "r511"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases benefit obligation of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract. Excludes decreases to benefit obligation for remeasurement due to settlement.",
        "label": "Defined Benefit Plan, Benefit Obligation, Payment for Settlement",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationPaymentForSettlement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r531",
      "r532",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r558",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change in benefit obligation:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change in plan assets:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanCommonCollectiveTrustMember": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated trust, responsible for collective investment and reinvestment of asset from employee benefit plan maintained by more than one employer, in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Common Collective Trust [Member]",
        "verboseLabel": "Common/collective trusts"
       }
      }
     },
     "localname": "DefinedBenefitPlanCommonCollectiveTrustMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r523",
      "r532",
      "r534",
      "r576",
      "r578",
      "r579"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer contributions",
        "verboseLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDerivativeMember": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or other contract with one or more underlyings, notional amount or payment provision or both; can be settled net by means outside contract or delivery of asset; and with minimal or no initial net investment, in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Derivative [Member]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DefinedBenefitPlanDerivativeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember": {
     "auth_ref": [
      "r532",
      "r534",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity, not domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities, Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesNonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember": {
     "auth_ref": [
      "r532",
      "r534",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity, domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities, US [Member]",
        "terseLabel": "U.S. domestic"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r541"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "2027-2031"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r541"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r541"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r541"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r541"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r541"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r507",
      "r546",
      "r571",
      "r578",
      "r579"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r520",
      "r532",
      "r534",
      "r535",
      "r578"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r505",
      "r529",
      "r578"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded status"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r507",
      "r512",
      "r545",
      "r570",
      "r578",
      "r579"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r543",
      "r568",
      "r578",
      "r579"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "terseLabel": "Net periodic benefit cost",
        "totalLabel": "Net periodic benefit cost (income)"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r525",
      "r584"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedTerseLabel": "Benefit payments"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsCategoryTableTextBlock": {
     "auth_ref": [
      "r532",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of defined benefit plan asset investment. Includes, but is not limited to, fair value of category of plan asset and its level within fair value hierarchy.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Table Text Block]",
        "terseLabel": "Schedule of change in level 3 plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsCategoryTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount": {
     "auth_ref": [
      "r532"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment within defined benefit plan asset category.",
        "label": "Defined Benefit Plan, Plan Assets, Investment within Plan Asset Category, Amount",
        "terseLabel": "Plan assets, investment within plan asset category, amount"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsInvestmentWithinPlanAssetCategoryAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r531",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Target investment allocations"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanPurchasesSalesAndSettlements": {
     "auth_ref": [
      "r537",
      "r578"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, measured using unobservable input, of increase (decrease) in plan asset of defined benefit plan from purchase, sale and settlement of trade associated with underlying investment.",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement",
        "verboseLabel": "Purchases, sales and settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanPurchasesSalesAndSettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRealEstateMember": {
     "auth_ref": [
      "r532",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property composed of building, land and land improvement; in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Real Estate [Member]",
        "terseLabel": "Real estate"
       }
      }
     },
     "localname": "DefinedBenefitPlanRealEstateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": {
     "auth_ref": [
      "r508",
      "r550",
      "r575"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement",
        "negatedTerseLabel": "Settlement losses"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanSettlementsPlanAssets": {
     "auth_ref": [
      "r528"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment, which decreases plan assets of defined benefit plan, for irrevocable action relieving primary responsibility for benefit obligation and eliminating risk for obligation and assets used to effect settlement. Transaction constituting settlement includes, but is not limited to, making lump-sum cash payment to participant in exchange for their rights to receive specified benefits and purchasing nonparticipating annuity contract.",
        "label": "Defined Benefit Plan, Plan Assets, Payment for Settlement",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanSettlementsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanTransfersBetweenMeasurementLevels": {
     "auth_ref": [
      "r538",
      "r578"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, measured using unobservable inputs, of increase (decrease) in plan assets of defined benefit plan, for assets transferred into (out of) Level 3 of fair value hierarchy. Includes, but is not limited to, transfer due to change in observability of significant inputs.",
        "label": "Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Assets Transferred into (out of) Level 3",
        "terseLabel": "Transfers out of Level 3"
       }
      }
     },
     "localname": "DefinedBenefitPlanTransfersBetweenMeasurementLevels",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]",
        "terseLabel": "Assumptions used to determine benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingBenefitObligationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]",
        "terseLabel": "Assumptions used to determine net benefit costs"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssumptionsUsedInCalculatingNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsWeightedAverageAssumptionsUsedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r564",
      "r565",
      "r566",
      "r567",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Defined contribution plan, employer contributions"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r156",
      "r370"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r156",
      "r233"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r175",
      "r726",
      "r727",
      "r728",
      "r729",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DirectPremiumsEarned": {
     "auth_ref": [
      "r936",
      "r951",
      "r1006",
      "r1009"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PremiumsEarnedNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Direct Premiums Earned",
        "terseLabel": "Direct"
       }
      }
     },
     "localname": "DirectPremiumsEarned",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r492",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of disaggregation of revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock Incentive Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r20",
      "r116",
      "r938"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax",
        "terseLabel": "Loss from discontinued operations"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share",
        "terseLabel": "Loss from discontinued operations attributable to CVS Health (in dollars per share)"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share",
        "terseLabel": "Loss from discontinued operations attributable to CVS Health (in dollars per share)"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": {
     "auth_ref": [
      "r9",
      "r10",
      "r11",
      "r12",
      "r20",
      "r23",
      "r653",
      "r682",
      "r689"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.",
        "label": "Discontinued Operation, Tax Effect of Discontinued Operation",
        "negatedTerseLabel": "Income tax benefit"
       }
      }
     },
     "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.",
        "label": "Discontinued Operations, Disposed of by Sale [Member]",
        "terseLabel": "Discontinued Operations, Disposed of by Sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsDisposedOfBySaleMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DiscontinuedOperationsPolicyTextBlock": {
     "auth_ref": [
      "r14",
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for discontinued operations. Includes, but is not limited to, method of interest allocation to a discontinued operation.",
        "label": "Discontinued Operations, Policy [Policy Text Block]",
        "terseLabel": "Discontinued Operations"
       }
      }
     },
     "localname": "DiscontinuedOperationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r587",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r473",
      "r905"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "negatedTerseLabel": "Common stock dividends"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.",
        "label": "Dividends Payable, Amount Per Share",
        "terseLabel": "Cash dividend declared (USD per share)"
       }
      }
     },
     "localname": "DividendsPayableAmountPerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DividendsPayableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Dividends Payable [Line Items]",
        "terseLabel": "Dividends Payable [Line Items]"
       }
      }
     },
     "localname": "DividendsPayableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsPayableTable": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table that contains information regarding dividends that have been declared but not paid as of the financial reporting date. This information may contain the amount, amount per share, declared date, and date to be paid.",
        "label": "Dividends Payable [Table]",
        "terseLabel": "Dividends Payable [Table]"
       }
      }
     },
     "localname": "DividendsPayableTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityDividendsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r282",
      "r532",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by corporation domiciled in United States of America (US).",
        "label": "Debt Security, Corporate, US [Member]",
        "terseLabel": "U.S. corporate securities",
        "verboseLabel": "U.S. corporate securities"
       }
      }
     },
     "localname": "DomesticCorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r121",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r197",
      "r199",
      "r202",
      "r203",
      "r204",
      "r208",
      "r209",
      "r745",
      "r746",
      "r893",
      "r944"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Net income attributable to CVS Health (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "verboseLabel": "Basic earnings per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings per share from continuing operations:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r121",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r199",
      "r202",
      "r203",
      "r204",
      "r208",
      "r209",
      "r745",
      "r746",
      "r893",
      "r944"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Net income attributable to CVS Health (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted earnings per share:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r205",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings per Common Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r205",
      "r206",
      "r207",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r654"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r170",
      "r654",
      "r686"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Statutory income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationDispositionOfBusiness": {
     "auth_ref": [
      "r654",
      "r686"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to disposition of a business not qualifying as a discontinued operation.",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Business, Percent",
        "terseLabel": "Basis difference upon disposition of subsidiary"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDispositionOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r654",
      "r686"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r654",
      "r686"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic": {
     "auth_ref": [
      "r654",
      "r686"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to domestic income tax settlement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Settlement, Domestic, Percent",
        "terseLabel": "Prior year refund claim"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectsOfReinsuranceTableTextBlock": {
     "auth_ref": [
      "r1012"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effects of reinsurance, for example, but not limited to, disclosure of direct, assumed, and ceded insurance.",
        "label": "Effects of Reinsurance [Table Text Block]",
        "terseLabel": "Schedule of impact of reinsurance on benefit costs"
       }
      }
     },
     "localname": "EffectsOfReinsuranceTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Compensation not yet recognized, period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r632"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Compensation not yet recognized, other than options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r632"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Compensation not yet recognized, options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Option",
        "verboseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r108",
      "r109",
      "r110",
      "r179",
      "r180",
      "r181",
      "r184",
      "r193",
      "r195",
      "r212",
      "r313",
      "r468",
      "r473",
      "r639",
      "r640",
      "r641",
      "r679",
      "r680",
      "r744",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r788",
      "r986",
      "r987",
      "r988",
      "r1120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r61",
      "r147",
      "r307",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r764"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r39",
      "r45",
      "r302",
      "r916",
      "r1040",
      "r1041",
      "r1042"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r303"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r430",
      "r444",
      "r445",
      "r766"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "verboseLabel": "Aggregate principal of debt extinguished"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci": {
     "auth_ref": [
      "r758"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3) and still held.",
        "label": "Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), OCI",
        "terseLabel": "Change in unrealized capital losses included in OCI associated with Level 3 financial assets"
       }
      }
     },
     "localname": "FairValueAssetRecurringBasisStillHeldUnrealizedGainLossOci",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r748",
      "r749",
      "r750",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r753",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Changes in level 3 financial assets"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r748",
      "r767",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r748",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Carrying value and estimated fair value of certain financial instruments"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r430",
      "r444",
      "r445",
      "r532",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r578",
      "r749",
      "r834",
      "r835",
      "r836"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r430",
      "r444",
      "r445",
      "r748",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r748",
      "r749",
      "r751",
      "r752",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r430",
      "r444",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel12And3Member": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3).",
        "label": "Fair Value, Inputs, Level 1, 2 and 3 [Member]",
        "terseLabel": "Total Fair Value, Inputs, Level 1, 2 and 3"
       }
      }
     },
     "localname": "FairValueInputsLevel12And3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r430",
      "r532",
      "r534",
      "r539",
      "r578",
      "r749",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r430",
      "r444",
      "r445",
      "r532",
      "r534",
      "r539",
      "r578",
      "r749",
      "r835"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r430",
      "r444",
      "r445",
      "r532",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r578",
      "r749",
      "r836"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": {
     "auth_ref": [
      "r534",
      "r747",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Measured at Net Asset Value Per Share [Member]",
        "terseLabel": "Fair Value Measured at Net Asset Value Per Share"
       }
      }
     },
     "localname": "FairValueMeasuredAtNetAssetValuePerShareMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "auth_ref": [
      "r754"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "terseLabel": "Included in earnings"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r755"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Included in other comprehensive income"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": {
     "auth_ref": [
      "r756"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases",
        "terseLabel": "Purchases"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": {
     "auth_ref": [
      "r756"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales",
        "negatedTerseLabel": "Sales"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": {
     "auth_ref": [
      "r756"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": {
     "auth_ref": [
      "r757"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details": {
       "order": 1.0,
       "parentTag": "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3",
        "terseLabel": "Gross transfers into Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net",
        "terseLabel": "Transfers into Level 3, net",
        "totalLabel": "Net transfers into Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "auth_ref": [
      "r757"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details": {
       "order": 2.0,
       "parentTag": "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "negatedTerseLabel": "Gross transfers out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r753"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r430",
      "r444",
      "r445",
      "r532",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r578",
      "r834",
      "r835",
      "r836"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r748",
      "r749",
      "r751",
      "r752",
      "r759",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r760",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/FairValueGrossTransfersIntoOutOfLevel3Details",
      "http://www.cvshealth.com/role/FairValueNarrativeDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable": {
     "auth_ref": [
      "r72",
      "r883",
      "r906"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of maximum advances or credit lines available from the Federal Home Loan Bank (FHLB).",
        "label": "Federal Home Loan Bank, Advances, General Debt Obligations, Maximum Amount Available",
        "terseLabel": "Federal home loan bank advances maximum amount available"
       }
      }
     },
     "localname": "FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FederalHomeLoanBankAdvancesMember": {
     "auth_ref": [
      "r883"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowings from the Federal Home Loan Bank, which are primarily used to cover shortages in the required reserve balance and also in times of liquidity shortages. The member institution executes a promissory note, which is generally collateralized by government securities to the Federal Reserve or loans.",
        "label": "Federal Home Loan Bank Advances [Member]",
        "terseLabel": "Federal Home Loan Bank Advances"
       }
      }
     },
     "localname": "FederalHomeLoanBankAdvancesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r801",
      "r807",
      "r819"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "cvs_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r803",
      "r813"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows paid for interest portion of finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r799",
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "cvs_LongtermDebtGrossAndLeaseObligation",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_LeaseLiability",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total finance lease liabilities",
        "totalLabel": "Total finance lease liabilities",
        "verboseLabel": "Finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails",
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails",
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r799"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Maturities of financing lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r799"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsYearOne",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease liability.",
        "label": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_LesseeLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r802",
      "r813"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows paid for principal portion of finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r801",
      "r807",
      "r819"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "cvs_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r816",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r815",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r293",
      "r294",
      "r303",
      "r304",
      "r305",
      "r317",
      "r321",
      "r322",
      "r323",
      "r324",
      "r333",
      "r335",
      "r338",
      "r339",
      "r441",
      "r466",
      "r735",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "terseLabel": "Financial liabilities fair value on a recurring basis"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average period before the next renewal or extension (both explicit and implicit) for intangible assets that have been renewed or extended, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Weighted Average Period before Next Renewal or Extension",
        "terseLabel": "Weighted Average Life (years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r362"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Finite-lived intangible assets, accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r357",
      "r358",
      "r362",
      "r366",
      "r864",
      "r868"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherAcquiredIntangiblesFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r362",
      "r868"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Finite-lived intangible assets, gross carrying amount",
        "verboseLabel": "Intangible assets related to customer lists"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r357",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r362",
      "r864"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Finite-lived intangible assets, net carrying amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r282",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by corporation not domiciled in United States of America (US).",
        "label": "Debt Security, Corporate, Non-US [Member]",
        "terseLabel": "Foreign securities"
       }
      }
     },
     "localname": "ForeignCorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r790"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Translation and Transactions"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignGovernmentShorttermDebtSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term debt securities issued by a national, local, or municipal government not within the country of domicile of the reporting entity.",
        "label": "Foreign Government Short-term Debt Securities [Member]",
        "terseLabel": "Foreign securities"
       }
      }
     },
     "localname": "ForeignGovernmentShorttermDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Fixtures and equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainContingencyUnrecordedAmount": {
     "auth_ref": [
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount or range of possible amounts of gain that could be realized upon the resolution of a contingency.",
        "label": "Gain Contingency, Unrecorded Amount",
        "terseLabel": "Gain contingency, unrecorded amount"
       }
      }
     },
     "localname": "GainContingencyUnrecordedAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r156",
      "r711"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "(Gain) loss on sale of subsidiaries",
        "terseLabel": "Gain (loss) on sale of subsidiaries"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/DivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r156",
      "r448",
      "r449"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on early extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r448",
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.",
        "label": "Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost",
        "negatedTerseLabel": "Premium paid in excess of debt principal"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r343",
      "r345",
      "r828",
      "r872"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Balance, end of the period",
        "periodStartLabel": "Balance, beginning of the period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r347"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Goodwill and Other Intangibles"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangibles"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.",
        "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r346",
      "r350"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "terseLabel": "Cumulative goodwill impairments"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r156",
      "r344",
      "r349",
      "r353"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Impairment",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r348"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedTerseLabel": "Divestiture of Workers\u2019 Compensation business"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsMaximumExposure": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.",
        "label": "Guarantor Obligations, Maximum Exposure, Undiscounted",
        "terseLabel": "Guarantor obligations, maximum exposure"
       }
      }
     },
     "localname": "GuaranteeObligationsMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthCareCostsPolicyPolicyTextBlock": {
     "auth_ref": [
      "r1052",
      "r1054"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for  accruing health care costs for a prepaid health care service provider.",
        "label": "Health Care Costs, Policy [Policy Text Block]",
        "terseLabel": "Health Care Costs Payable"
       }
      }
     },
     "localname": "HealthCareCostsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HealthCareEntitiesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for all health care policies.",
        "label": "Health Care Entities, Policy [Policy Text Block]",
        "terseLabel": "Health Care Reform"
       }
      }
     },
     "localname": "HealthCareEntitiesPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HealthInsuranceProductLineMember": {
     "auth_ref": [
      "r983"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product line consisting of insurance against loss by illness or injury.",
        "label": "Health Insurance Product Line [Member]",
        "terseLabel": "Health Insurance Product Line"
       }
      }
     },
     "localname": "HealthInsuranceProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgeFundsMember": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in registered hedge funds.",
        "label": "Hedge Funds [Member]",
        "terseLabel": "Hedge Funds",
        "verboseLabel": "Hedge fund investments"
       }
      }
     },
     "localname": "HedgeFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r156",
      "r368"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Impairment of intangible assets, indefinite-lived"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-Lived Asset Impairment"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r123",
      "r157",
      "r188",
      "r189",
      "r190",
      "r191",
      "r200",
      "r204",
      "r701"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Income from continuing operations attributable to CVS Health"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r115",
      "r238",
      "r250",
      "r254",
      "r257",
      "r260",
      "r869",
      "r887",
      "r896",
      "r946"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income tax provision"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r168",
      "r183",
      "r238",
      "r250",
      "r254",
      "r257",
      "r260",
      "r308",
      "r400",
      "r401",
      "r402",
      "r405",
      "r406",
      "r407",
      "r409",
      "r411",
      "r413",
      "r414",
      "r702",
      "r746",
      "r772"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Income from continuing operations",
        "verboseLabel": "Income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r112",
      "r121",
      "r183",
      "r188",
      "r189",
      "r190",
      "r191",
      "r199",
      "r202",
      "r203",
      "r746",
      "r885",
      "r888",
      "r893",
      "r937"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Income from continuing operations attributable to CVS Health (in dollars per share)",
        "verboseLabel": "Earnings (loss) per share from continuing operations, basic (USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r112",
      "r121",
      "r183",
      "r188",
      "r189",
      "r190",
      "r191",
      "r199",
      "r202",
      "r203",
      "r204",
      "r746",
      "r893",
      "r937",
      "r940",
      "r944"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Income from continuing operations attributable to CVS Health (in dollars per share)",
        "verboseLabel": "Earnings (loss) per share from continuing operations, diluted (USD per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r23",
      "r26",
      "r690",
      "r938"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Loss from discontinued operations, net of tax",
        "totalLabel": "Loss from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r587",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r170",
      "r655",
      "r664",
      "r670",
      "r681",
      "r687",
      "r691",
      "r692",
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r171",
      "r194",
      "r195",
      "r236",
      "r653",
      "r682",
      "r688",
      "r947"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "totalLabel": "Total",
        "verboseLabel": "Income tax provision"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/IncomeTaxesIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Amount [Abstract]",
        "terseLabel": "Effective Income Tax Rate Reconciliation, Amount [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesEffectiveTaxRateReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r107",
      "r649",
      "r650",
      "r664",
      "r665",
      "r669",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "negatedTerseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable and pharmacy claims and discounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInsuranceLiabilities": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in insurance liability balances during the period.",
        "label": "Increase (Decrease) in Insurance Liabilities",
        "terseLabel": "Health care costs payable and other insurance liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInInsuranceLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities, net of effects from acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r365"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived intangible assets, Trademarks"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InsuranceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance [Abstract]",
        "terseLabel": "Insurance [Abstract]"
       }
      }
     },
     "localname": "InsuranceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Intangible assets, gross"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r355",
      "r360"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r113",
      "r232",
      "r791",
      "r794",
      "r894"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "verboseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r145",
      "r152",
      "r160"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "negatedTerseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "auth_ref": [
      "r734"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "terseLabel": "Amount expected to be reclassified"
       }
      }
     },
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalCreditAssessmentAxis": {
     "auth_ref": [
      "r271",
      "r324",
      "r326",
      "r327",
      "r394",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by entity-defined rating.",
        "label": "Internal Credit Assessment [Axis]",
        "terseLabel": "Internal Credit Assessment [Axis]"
       }
      }
     },
     "localname": "InternalCreditAssessmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InternalCreditAssessmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity defined credit risk rating.",
        "label": "Internal Credit Assessment [Domain]",
        "terseLabel": "Internal Credit Assessment [Domain]"
       }
      }
     },
     "localname": "InternalCreditAssessmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r230",
      "r249",
      "r250",
      "r251",
      "r252",
      "r254",
      "r256",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r30",
      "r82",
      "r828"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r36",
      "r83",
      "r163",
      "r211",
      "r340",
      "r341",
      "r342",
      "r862"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "auth_ref": [
      "r125"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "cvs_InvestmentIncomeExcludingCapitalGainsorLosses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Interest and Dividend",
        "terseLabel": "Gross investment income"
       }
      }
     },
     "localname": "InvestmentIncomeInterestAndDividend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInvestmentExpense": {
     "auth_ref": [
      "r127",
      "r948"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "cvs_InvestmentIncomeExcludingCapitalGainsorLosses",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses related to the generation of investment income.",
        "label": "Investment Income, Investment Expense",
        "negatedLabel": "Investment expenses"
       }
      }
     },
     "localname": "InvestmentIncomeInvestmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r125",
      "r126"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "totalLabel": "Net investment income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeTextBlock": {
     "auth_ref": [
      "r125",
      "r126",
      "r127",
      "r948"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table Text Block]",
        "verboseLabel": "Net investment income"
       }
      }
     },
     "localname": "InvestmentIncomeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r307",
      "r945"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r1027",
      "r1028",
      "r1029",
      "r1030",
      "r1031",
      "r1032",
      "r1033",
      "r1034",
      "r1035",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r933"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments [Abstract]",
        "terseLabel": "Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "verboseLabel": "Fair value of debt securities by contractual maturity"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r302",
      "r870",
      "r903",
      "r1043",
      "r1087"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r817",
      "r819"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Lease, Cost, Total"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Finance lease cost:"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease costs and supplemental cash flow information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseTermOfContract1": {
     "auth_ref": [
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Finance Lease, Term of Contract",
        "terseLabel": "Finance lease term (in years)"
       }
      }
     },
     "localname": "LesseeFinanceLeaseTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Right-of-Use Assets and Lease Liabilities"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of operating lease liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueAfterYearFive",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsYearOne",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueYearFive",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueYearFour",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueYearThree",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityPaymentsDueYearTwo",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r818"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "cvs_LesseeLiabilityUndiscountedExcessAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease term (in years)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r820"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceived": {
     "auth_ref": [
      "r821"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease payments to be received by lessor for operating lease.",
        "label": "Lessor, Operating Lease, Payments to be Received",
        "terseLabel": "Future noncancelable subleases, future minimum payments"
       }
      }
     },
     "localname": "LessorOperatingLeasePaymentsToBeReceived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r69",
      "r168",
      "r252",
      "r308",
      "r400",
      "r401",
      "r402",
      "r405",
      "r406",
      "r407",
      "r409",
      "r411",
      "r413",
      "r414",
      "r705",
      "r713",
      "r714",
      "r772",
      "r826",
      "r827"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r59",
      "r168",
      "r308",
      "r772",
      "r828",
      "r879",
      "r927"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r71",
      "r168",
      "r308",
      "r400",
      "r401",
      "r402",
      "r405",
      "r406",
      "r407",
      "r409",
      "r411",
      "r413",
      "r414",
      "r705",
      "r713",
      "r714",
      "r772",
      "r826",
      "r827",
      "r828"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r963",
      "r966"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Health care costs payable, end of period",
        "periodStartLabel": "Health care costs payable, beginning of period",
        "totalLabel": "Total health care costs payable"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Liability for Claims and Claims Adjustment Expense [Line Items]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Line Items]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the liability for claims and claims adjustment expense.",
        "label": "Liability for Claims and Claims Adjustment Expense [Table]",
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Table]"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForFuturePolicyBenefits": {
     "auth_ref": [
      "r912",
      "r976",
      "r977",
      "r981",
      "r989"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.",
        "label": "Liability for Future Policy Benefit, before Reinsurance",
        "terseLabel": "Future policy benefits"
       }
      }
     },
     "localname": "LiabilityForFuturePolicyBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions",
        "verboseLabel": "Acquisitions, net"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]",
        "terseLabel": "Less: Claims paid"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r965"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r965"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r964"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "totalLabel": "Total incurred health care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]",
        "terseLabel": "Add: Components of incurred health care costs"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": {
     "auth_ref": [
      "r913",
      "r963",
      "r966"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net",
        "periodEndLabel": "Health care costs payable, end of period, net",
        "periodStartLabel": "Health care costs payable, beginning of period, net",
        "terseLabel": "Health care costs payable"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r67"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded from other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded from Other Party",
        "terseLabel": "Amount awarded from other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedFromOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails",
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "negatedTerseLabel": "Current portion of long-term debt",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails",
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-term Debt and Lease Obligation, Including Current Maturities",
        "terseLabel": "Long-term debt and lease obligations"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term Debt, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Long-term Debt, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "LongTermDebtByMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r176",
      "r397",
      "r434"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r176",
      "r397",
      "r434"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r176",
      "r397",
      "r434"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r176",
      "r397",
      "r434"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r176",
      "r397",
      "r434"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r176",
      "r397",
      "r434"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsDebtMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-term Investments",
        "terseLabel": "Long-term",
        "verboseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r74",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r382",
      "r383",
      "r384",
      "r386",
      "r387",
      "r388",
      "r389",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Number of claims"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r28",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "verboseLabel": "Divestitures"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/Divestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r81",
      "r168",
      "r308",
      "r400",
      "r405",
      "r406",
      "r407",
      "r413",
      "r414",
      "r772",
      "r878",
      "r926"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/ShareholdersEquityNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstate": {
     "auth_ref": [
      "r1044"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansCreditRatingsIndicatorDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet": {
     "auth_ref": [
      "r932"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio.",
        "label": "Mortgage Loans on Real Estate, Commercial and Consumer, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateCommercialAndConsumerNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsScheduleofMortgageLoanPrincipalRepaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateForeclosures": {
     "auth_ref": [
      "r1046"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from foreclosure.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Foreclosure",
        "terseLabel": "Mortgage loans foreclosed"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateForeclosures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageLoansOnRealEstateNewMortgageLoans": {
     "auth_ref": [
      "r1046"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate, from new investment.",
        "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, New Mortgage Loan",
        "terseLabel": "New mortgage loans"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNewMortgageLoans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsMortgageLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgagesHeldForSaleFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of mortgage loans held-for-sale.",
        "label": "Mortgages Held-for-sale, Fair Value Disclosure",
        "terseLabel": "Mortgage loans"
       }
      }
     },
     "localname": "MortgagesHeldForSaleFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MultiemployerPlanPensionInsignificantPlanContribution": {
     "auth_ref": [
      "r597"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by multiemployer pension plan from all employers participating in multiemployer pension plan determined to be individually insignificant.",
        "label": "Multiemployer Plan, Pension, Insignificant, Plan Contribution",
        "terseLabel": "Multiemployer plans, plan contributions"
       }
      }
     },
     "localname": "MultiemployerPlanPensionInsignificantPlanContribution",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r148"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r148"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r148",
      "r154",
      "r157"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Reconciliation of net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r26",
      "r101",
      "r104",
      "r110",
      "r117",
      "r157",
      "r168",
      "r183",
      "r188",
      "r189",
      "r190",
      "r191",
      "r194",
      "r195",
      "r200",
      "r238",
      "r250",
      "r254",
      "r257",
      "r260",
      "r308",
      "r400",
      "r401",
      "r402",
      "r405",
      "r406",
      "r407",
      "r409",
      "r411",
      "r413",
      "r414",
      "r746",
      "r772",
      "r889",
      "r939"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to CVS Health"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r101",
      "r104",
      "r110",
      "r194",
      "r195",
      "r707",
      "r724"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net (income) loss attributable to noncontrolling interests",
        "negatedTerseLabel": "Comprehensive (income) loss attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentIncome": {
     "auth_ref": [
      "r941"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.",
        "label": "Net Investment Income",
        "terseLabel": "Net investment income"
       }
      }
     },
     "localname": "NetInvestmentIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "verboseLabel": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r190",
      "r196",
      "r208",
      "r277",
      "r278",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r399",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r677",
      "r678",
      "r679",
      "r680",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r823",
      "r865",
      "r866",
      "r867",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "verboseLabel": "Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements Recently Adopted and Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r473",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableToBanksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a bank.",
        "label": "Notes Payable to Banks [Member]",
        "terseLabel": "Notes Payable"
       }
      }
     },
     "localname": "NotesPayableToBanksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of states the entity operates in as of the balance sheet date.",
        "label": "Number of States in which Entity Operates",
        "terseLabel": "Number of states in which entity operates"
       }
      }
     },
     "localname": "NumberOfStatesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfStores": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the number of stores.",
        "label": "Number of Stores",
        "terseLabel": "Number of retail locations (more than)",
        "verboseLabel": "Number of stores"
       }
      }
     },
     "localname": "NumberOfStores",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OffsettingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offsetting [Abstract]",
        "terseLabel": "Offsetting [Abstract]"
       }
      }
     },
     "localname": "OffsettingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating costs:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r238",
      "r250",
      "r254",
      "r257",
      "r260"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "netLabel": "Operating income (GAAP measure)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r808",
      "r819"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r799"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total operating lease liabilities",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails",
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r799"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities",
        "verboseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r799"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities",
        "verboseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r804",
      "r813"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows paid for operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r798"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r816",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r815",
      "r819"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r249",
      "r250",
      "r251",
      "r252",
      "r254",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r84",
      "r828"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r702",
      "r703",
      "r709"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Net unrealized investment gains (losses)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r100",
      "r108",
      "r109",
      "r782",
      "r784",
      "r788"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "OCI before Reclass, pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r100",
      "r108",
      "r109",
      "r111",
      "r782",
      "r784",
      "r788"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "negatedTerseLabel": "Loss on net cash flow hedges",
        "verboseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r91",
      "r98"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Net cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r102",
      "r105",
      "r108",
      "r109",
      "r111",
      "r118",
      "r468",
      "r782",
      "r787",
      "r788",
      "r890",
      "r940"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive income (loss)",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r96",
      "r98"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Pension and other postretirement benefits"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r295",
      "r329",
      "r532",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other Debt Obligations"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other investments.",
        "label": "Other Investments [Member]",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "OtherInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails",
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other noncash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPolicyholderFunds": {
     "auth_ref": [
      "r934"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due to policyholders for funds held that are returnable under the terms of insurance contracts, classified as other.",
        "label": "Other Policyholder Funds",
        "terseLabel": "Policyholders\u2019 funds"
       }
      }
     },
     "localname": "OtherPolicyholderFunds",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r504",
      "r505",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r531",
      "r532",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r554",
      "r555",
      "r556",
      "r558",
      "r561",
      "r565",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Other Postretirement Benefits"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings.",
        "label": "Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings",
        "terseLabel": "OTTI losses, investments, portion recognized in earnings, net"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total CVS Health Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted": {
     "auth_ref": [
      "r201"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted",
        "negatedTerseLabel": "Income allocated to participating securities"
       }
      }
     },
     "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r153",
      "r965"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "totalLabel": "Total claims paid"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromDerivativeInstrumentFinancingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash outflow or inflow from derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.",
        "label": "Payments for (Proceeds from) Derivative Instrument, Financing Activities",
        "negatedTerseLabel": "Derivative settlements",
        "terseLabel": "Proceeds from derivative instruments"
       }
      }
     },
     "localname": "PaymentsForProceedsFromDerivativeInstrumentFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r132",
      "r135"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r139"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Payments for taxes related to net share settlement of equity awards",
        "terseLabel": "Payments for taxes for net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions (net of cash acquired)"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToSuppliersAndEmployees": {
     "auth_ref": [
      "r143",
      "r144",
      "r151"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to suppliers for goods and services provided and to employees for services provided.",
        "label": "Payments to Suppliers and Employees",
        "negatedTerseLabel": "Cash paid to other suppliers and employees"
       }
      }
     },
     "localname": "PaymentsToSuppliersAndEmployees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r531",
      "r533",
      "r539",
      "r557",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r578",
      "r580",
      "r583",
      "r585",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "verboseLabel": "Pension Plans and Other Postretirement Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r46",
      "r505",
      "r506",
      "r529",
      "r578"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "negatedTerseLabel": "Current liabilities reflected in accrued expenses"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r48",
      "r505",
      "r506",
      "r529",
      "r578"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "negatedTerseLabel": "Noncurrent liabilities reflected in other long-term liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementPlansPolicy": {
     "auth_ref": [
      "r564",
      "r581",
      "r582",
      "r585",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.",
        "label": "Pension and Other Postretirement Plans, Policy [Policy Text Block]",
        "terseLabel": "Measurement of Defined Benefit Pension and Other Postretirement Employee Benefit (OPEB) Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r503",
      "r505",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r531",
      "r532",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r554",
      "r555",
      "r556",
      "r558",
      "r561",
      "r565",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r585",
      "r586",
      "r594",
      "r595",
      "r596",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r531",
      "r532",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r558",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r603",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderAccountsPolicy": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for contracts reported in separate accounts, including the extent and terms of minimum guarantees, basis of presentation for separate account assets and liabilities and related separate account activity, the liability valuation method and assumptions used in valuing each type of policyholder and contract holder account maintained by the entity.",
        "label": "Policyholder Accounts, Policy [Policy Text Block]",
        "terseLabel": "Separate Accounts"
       }
      }
     },
     "localname": "PolicyholderAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredGross": {
     "auth_ref": [
      "r950"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred.",
        "label": "Policyholder Benefits and Claims Incurred, Direct",
        "terseLabel": "Direct"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": {
     "auth_ref": [
      "r950"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.",
        "label": "Policyholder Benefits and Claims Incurred, Net, Health",
        "terseLabel": "Benefit costs"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet": {
     "auth_ref": [
      "r908",
      "r950"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred.",
        "label": "Policyholder Benefits and Claims Incurred, Net",
        "totalLabel": "Net benefit costs"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Policyholder Benefits and Claims Incurred, Net [Abstract]",
        "terseLabel": "Policyholder Benefits and Claims Incurred, Net [Abstract]"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r765"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueCarryingValueandFairValueClassifiedbyLevelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r51",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r51",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r51"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r51",
      "r828"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsEarnedNet": {
     "auth_ref": [
      "r886",
      "r936",
      "r954",
      "r1011"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Premiums Earned, Net",
        "terseLabel": "Premiums",
        "totalLabel": "Net premiums"
       }
      }
     },
     "localname": "PremiumsEarnedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsReceivableAtCarryingValue": {
     "auth_ref": [
      "r931"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount as of the balance sheet date due the entity from (a) agents and insureds, (b) uncollected premiums and (c) others, net of the allowance for doubtful accounts.",
        "label": "Premiums Receivable, Net",
        "terseLabel": "Premium receivables"
       }
      }
     },
     "localname": "PremiumsReceivableAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PrivateEquityFundsMember": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments held in private equity funds.",
        "label": "Private Equity Funds [Member]",
        "verboseLabel": "Private equity investments"
       }
      }
     },
     "localname": "PrivateEquityFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromCustomers": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash receipts from customers during the current period which are usually for sales of goods and services.",
        "label": "Proceeds from Customers",
        "terseLabel": "Cash receipts from customers"
       }
      }
     },
     "localname": "ProceedsFromCustomers",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r137"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from debt"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from sale of subsidiary"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/DivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromInterestAndDividendsReceived": {
     "auth_ref": [
      "r142",
      "r150"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows_1": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for dividends and interest on the entity's equity and debt investments during the current period.",
        "label": "Proceeds from Interest and Dividends Received",
        "terseLabel": "Interest and investment income received"
       }
      }
     },
     "localname": "ProceedsFromInterestAndDividendsReceived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r137"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity": {
     "auth_ref": [
      "r895"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from principal payment received from sales-type and direct financing leases classified as investing activity.",
        "label": "Proceeds from Lease Payment, Sales-Type and Direct Financing Leases, Investing Activity",
        "terseLabel": "Proceeds from sale-leaseback transactions"
       }
      }
     },
     "localname": "ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r138",
      "r141"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-term Debt",
        "terseLabel": "Net repayments of short-term debt"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sales and maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r129",
      "r130",
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from sales"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsRealizedGainsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r136",
      "r634"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options",
        "verboseLabel": "Cash received from stock options exercised (including ESPP)"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r26",
      "r101",
      "r104",
      "r110",
      "r146",
      "r168",
      "r183",
      "r194",
      "r195",
      "r238",
      "r250",
      "r254",
      "r257",
      "r260",
      "r308",
      "r400",
      "r401",
      "r402",
      "r405",
      "r406",
      "r407",
      "r409",
      "r411",
      "r413",
      "r414",
      "r702",
      "r706",
      "r708",
      "r724",
      "r725",
      "r746",
      "r772",
      "r896"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r64",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentFairValueDisclosure": {
     "auth_ref": [
      "r748"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant, and Equipment, Fair Value Disclosure",
        "terseLabel": "Property and equipment, fair value"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r63",
      "r371"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "verboseLabel": "Total property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment [Member]",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r40",
      "r41",
      "r373",
      "r828",
      "r904",
      "r929"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r62",
      "r373",
      "r1055",
      "r1056"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r40",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r40",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Useful life of property plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PropertySubjectToOperatingLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property subject to an operating lease.",
        "label": "Property Subject to Operating Lease [Member]",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "PropertySubjectToOperatingLeaseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RealEstateFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in funds that invest in commercial or residential real estate.",
        "label": "Real Estate Funds [Member]",
        "verboseLabel": "Real estate partnerships"
       }
      }
     },
     "localname": "RealEstateFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RealEstateInvestmentMember": {
     "auth_ref": [
      "r1039",
      "r1040",
      "r1041",
      "r1042"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents direct equity investments in real estate projects (Land, buildings and improvements owned for income production and capital accretion potential) and certain loans accounted for as real estate investments. For loans accounted for as real estate investments, the entity (lender) has virtually the same risks and rewards as those of owners or joint venture participants. Such arrangements are treated as if the entity actually has an ownership interest in the property. In such arrangements, the entity (lender) participates in expected residual profits, which may be in the form of an equity kicker or a higher than usual effective interest rate. At the outset and during the construction and development of the property, the borrower generally has little or no equity in the property and the entity's (lender's) only source of repayment is the property. The entity (lender) generally (a) agrees to provide substantially all funds to acquire, develop, and construct the property, (b) funds the commitment or origination fees or both, and (c) funds interest during the development and construction of the property.",
        "label": "Real Estate Investment [Member]",
        "terseLabel": "Real Estate Investment"
       }
      }
     },
     "localname": "RealEstateInvestmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r949"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InvestmentIncomeNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized Investment Gains (Losses)",
        "terseLabel": "Net realized capital gains"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r270",
      "r274",
      "r275",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r100",
      "r108",
      "r109",
      "r782",
      "r786",
      "r788"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "terseLabel": "Amounts reclassified, pre-tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r100",
      "r108",
      "r109",
      "r111",
      "r782",
      "r786",
      "r788"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive loss, net of tax",
        "verboseLabel": "Cumulative translation adjustment from AOCI eliminated upon divestiture"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "Changes in Accumulated Other Comprehensive Income (Loss) by Component"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r250",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of operating earnings to net income"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemablePreferredStockMember": {
     "auth_ref": [
      "r37",
      "r168",
      "r308",
      "r400",
      "r405",
      "r406",
      "r407",
      "r413",
      "r414",
      "r451",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable preferred stock. For instance, cumulative preferred stock, noncumulative preferred stock, convertible or series.",
        "label": "Redeemable Preferred Stock [Member]",
        "terseLabel": "Redeemable preferred securities"
       }
      }
     },
     "localname": "RedeemablePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReinsuranceAccountingPolicy": {
     "auth_ref": [
      "r908",
      "r909",
      "r1013",
      "r1014"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of reinsurance accounting policy, for example, but not limited to, description of the methodologies and assumptions underlying determination of reinsurance recoverables, reinsurance payables and retention policy.",
        "label": "Reinsurance Accounting Policy [Policy Text Block]",
        "terseLabel": "Reinsurance Recoverables"
       }
      }
     },
     "localname": "ReinsuranceAccountingPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReinsuranceDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reinsurance Disclosures [Abstract]",
        "terseLabel": "Reinsurance Disclosures [Abstract]"
       }
      }
     },
     "localname": "ReinsuranceDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed": {
     "auth_ref": [
      "r908"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of policy benefits and costs incurred for policies assumed.",
        "label": "Policyholder Benefits and Claims Incurred, Assumed",
        "terseLabel": "Assumed"
       }
      }
     },
     "localname": "ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountAssumed",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded": {
     "auth_ref": [
      "r908"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PolicyholderBenefitsAndClaimsIncurredNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reduction of provision for policy benefits and costs incurred for policies ceded.",
        "label": "Policyholder Benefits and Claims Incurred, Ceded",
        "negatedTerseLabel": "Ceded"
       }
      }
     },
     "localname": "ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Premiums Earned, Net [Abstract]",
        "terseLabel": "Premiums Earned, Net [Abstract]"
       }
      }
     },
     "localname": "ReinsurancePremiumsForInsuranceCompaniesByProductSegmentNetAmountAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceEffectsofReinsuranceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": {
     "auth_ref": [
      "r910",
      "r961",
      "r963",
      "r966"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.",
        "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments",
        "periodEndLabel": "Add: Reinsurance recoverables",
        "periodStartLabel": "Less: Reinsurance recoverables",
        "terseLabel": "Reinsurance recoverables"
       }
      }
     },
     "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceRecoverablesOnPaidAndUnpaidLosses": {
     "auth_ref": [
      "r910",
      "r960",
      "r961",
      "r1023"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, policy benefits and policy reserves. Excludes premiums paid under reinsurance contracts.",
        "label": "Reinsurance Recoverable for Paid and Unpaid Claims and Claims Adjustments",
        "terseLabel": "Total reinsurance recoverables"
       }
      }
     },
     "localname": "ReinsuranceRecoverablesOnPaidAndUnpaidLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceReinsuranceRecoverablesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceTextBlock": {
     "auth_ref": [
      "r1025"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure pertaining to the existence, magnitude and information about insurance that has been ceded to or assumed from another insurance company, including the methodologies and assumptions used in determining recorded amounts.",
        "label": "Reinsurance [Text Block]",
        "terseLabel": "Reinsurance"
       }
      }
     },
     "localname": "ReinsuranceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/Reinsurance"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r824"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Expenses from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.",
        "label": "Related Party Transaction, Other Revenues from Transactions with Related Party",
        "terseLabel": "Other revenues from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r140"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResidentialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r282",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by residential real estate mortgage loans.",
        "label": "Residential Mortgage Backed Securities [Member]",
        "terseLabel": "Residential mortgage-backed securities"
       }
      }
     },
     "localname": "ResidentialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r29",
      "r38",
      "r162"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash (included in other current assets)"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r34",
      "r42",
      "r162",
      "r1049"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash (included in other assets)"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedInvestmentsAtFairValue": {
     "auth_ref": [
      "r1026",
      "r1036",
      "r1048",
      "r1050"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate value of all restricted investments.",
        "label": "Restricted Investments, at Fair Value",
        "terseLabel": "Investments related to 2012 contract conversion"
       }
      }
     },
     "localname": "RestrictedInvestmentsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r55",
      "r473",
      "r642",
      "r828",
      "r924",
      "r990",
      "r995"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r179",
      "r180",
      "r181",
      "r184",
      "r193",
      "r195",
      "r313",
      "r639",
      "r640",
      "r641",
      "r679",
      "r680",
      "r744",
      "r986",
      "r988"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r503",
      "r504",
      "r505",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r531",
      "r532",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r554",
      "r555",
      "r556",
      "r558",
      "r561",
      "r565",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r594",
      "r595",
      "r596",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r503",
      "r504",
      "r505",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r531",
      "r532",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r554",
      "r555",
      "r556",
      "r558",
      "r561",
      "r565",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r594",
      "r595",
      "r596",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsChangesinLevel3PensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r229",
      "r230",
      "r249",
      "r255",
      "r256",
      "r263",
      "r264",
      "r266",
      "r491",
      "r492",
      "r863"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r164",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r114",
      "r168",
      "r229",
      "r230",
      "r249",
      "r255",
      "r256",
      "r263",
      "r264",
      "r266",
      "r308",
      "r400",
      "r401",
      "r402",
      "r405",
      "r406",
      "r407",
      "r409",
      "r411",
      "r413",
      "r414",
      "r772",
      "r896"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r814",
      "r819"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r814",
      "r819"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleAndLeasebackTransactionGainLossNet": {
     "auth_ref": [
      "r812",
      "r819",
      "r822"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale and leaseback transaction from transfer of asset accounted for as sale.",
        "label": "Sale and Leaseback Transaction, Gain (Loss), Net",
        "terseLabel": "Gains from sale-leaseback transactions"
       }
      }
     },
     "localname": "SaleAndLeasebackTransactionGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred directly to consumer.",
        "label": "Sales Channel, Directly to Consumer [Member]",
        "terseLabel": "Mail choice"
       }
      }
     },
     "localname": "SalesChannelDirectlyToConsumerMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred through intermediary.",
        "label": "Sales Channel, Through Intermediary [Member]",
        "terseLabel": "Pharmacy network"
       }
      }
     },
     "localname": "SalesChannelThroughIntermediaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r219",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of accounts receivable, net"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r100",
      "r787",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of changes in fair value of plan assets"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.",
        "label": "Schedule of Amounts Recognized in Balance Sheet [Table Text Block]",
        "terseLabel": "Schedule of assets (liabilities) recognized in Balance Sheet"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Weighted average assumptions used in determining benefit obligations and net benefit costs"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r694",
      "r695"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of cash and cash equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCededCreditRiskByReinsurerTextBlock": {
     "auth_ref": [
      "r1024"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of reinsurer or group of reinsurers for whom the entity has a concentration of credit risk.",
        "label": "Ceded Credit Risk [Table Text Block]",
        "terseLabel": "Schedule of reinsurance recoverables"
       }
      }
     },
     "localname": "ScheduleOfCededCreditRiskByReinsurerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.",
        "label": "Schedule of Changes in Fair Value of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of changes in plan assets"
       }
      }
     },
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.",
        "label": "Schedule of Changes in Projected Benefit Obligations [Table Text Block]",
        "terseLabel": "Schedule of changes in benefit obligations"
       }
      }
     },
     "localname": "ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of components of income tax expense (benefit)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r74",
      "r176",
      "r444",
      "r446",
      "r469",
      "r470",
      "r471",
      "r472",
      "r792",
      "r793",
      "r796",
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Carrying value of long-term debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of deferred tax assets and liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r564",
      "r565",
      "r566",
      "r567",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsBenefitObligationsandPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsDefinedBenefitPlansExpectedBenefitDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNarrativeDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsNetPeriodicBenefitCostsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r6",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r21",
      "r24",
      "r25",
      "r26",
      "r375",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Schedule of discontinued operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Reconciliation of basic and diluted earnings (loss) per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of effective income tax rate reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r602",
      "r630",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r602",
      "r630",
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of expected future benefits payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r748",
      "r749"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "verboseLabel": "Fair value of financial assets and liabilities"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Separate Account Investment [Line Items]",
        "terseLabel": "Fair Value, Separate Account Investment [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable": {
     "auth_ref": [
      "r911",
      "r1016",
      "r1019"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about fair value of asset supporting separate account.",
        "label": "Fair Value, Separate Account Investment [Table]",
        "terseLabel": "Fair Value, Separate Account Investment [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock": {
     "auth_ref": [
      "r911",
      "r1016",
      "r1019"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of asset supporting separate account.",
        "label": "Fair Value, Separate Account Investment [Table Text Block]",
        "verboseLabel": "Separate account financial assets"
       }
      }
     },
     "localname": "ScheduleOfFairValueOfSeparateAccountsByMajorCategoryOfInvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r351",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r351",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Change in goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Net Investment Income [Line Items]",
        "terseLabel": "Schedule of Investment Income, Reported Amounts, by Category [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable": {
     "auth_ref": [
      "r125",
      "r126",
      "r948"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment income, including, but not limited to, interest and dividend income and amortization of discount (premium) derived from debt and equity securities. Excludes realized and unrealized gain (loss) on investments.",
        "label": "Investment Income [Table]",
        "terseLabel": "Schedule of Investment Income, Reported Amounts, by Category [Table]"
       }
      }
     },
     "localname": "ScheduleOfInvestmentIncomeReportedAmountsByCategoryTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsNetInvestmentIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r967"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Schedule of liability for unpaid claims and claims adjustment expense"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of maturities of long-term debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of net periodic benefit cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares.",
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "terseLabel": "RSU and performance share unit activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r64",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRegulatoryAssetsTextBlock": {
     "auth_ref": [
      "r1069",
      "r1070",
      "r1071"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets that are created when regulatory agencies permit public utilities to defer certain costs included in rate-setting to the balance sheet.",
        "label": "Schedule of Regulatory Assets [Table Text Block]",
        "terseLabel": "Schedule of regulatory Requirements"
       }
      }
     },
     "localname": "ScheduleOfRegulatoryAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r238",
      "r241",
      "r253",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r238",
      "r241",
      "r253",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summarized financial information of segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r603",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.",
        "label": "Share-based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block]",
        "terseLabel": "Schedule of stock options and stock appreciation rights award activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule ESPP valuation assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r624"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of valuation assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r474",
      "r475",
      "r476",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Share repurchase programs"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).",
        "label": "Schedule of Unrealized Loss on Investments [Table Text Block]",
        "verboseLabel": "Debt securities in an unrealized capital loss position"
       }
      }
     },
     "localname": "ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r663",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of unrecognized tax benefits roll forward"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r704",
      "r705",
      "r713",
      "r714",
      "r715",
      "r717",
      "r720",
      "r721",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "auth_ref": [
      "r715",
      "r717",
      "r720",
      "r721",
      "r722"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "terseLabel": "Schedule of variable interest entities"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "verboseLabel": "Estimated annual pretax amortization for other acquired intangible assets over the next five years"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r225",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r249",
      "r250",
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r260",
      "r266",
      "r377",
      "r378",
      "r975"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r225",
      "r227",
      "r228",
      "r238",
      "r242",
      "r254",
      "r258",
      "r259",
      "r260",
      "r261",
      "r263",
      "r265",
      "r266",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Policy"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SelfInsuranceReserve": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.",
        "label": "Self Insurance Reserve",
        "terseLabel": "Self insurance liabilities"
       }
      }
     },
     "localname": "SelfInsuranceReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SelfInsuranceReservePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR).",
        "label": "Self Insurance Reserve [Policy Text Block]",
        "terseLabel": "Self-Insurance Liabilities"
       }
      }
     },
     "localname": "SelfInsuranceReservePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails",
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountAssetCategoryAxis": {
     "auth_ref": [
      "r1016",
      "r1019"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by separate account asset investment.",
        "label": "Separate Account Asset Category [Axis]",
        "terseLabel": "Separate Account Asset Category [Axis]"
       }
      }
     },
     "localname": "SeparateAccountAssetCategoryAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueNarrativeDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeparateAccountAssetCategoryDomain": {
     "auth_ref": [
      "r1016",
      "r1019"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separate account asset investment.",
        "label": "Separate Account Asset Category [Domain]",
        "terseLabel": "Separate Account Asset Category [Domain]"
       }
      }
     },
     "localname": "SeparateAccountAssetCategoryDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueNarrativeDetails",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeparateAccountAssets": {
     "auth_ref": [
      "r919",
      "r1015",
      "r1016",
      "r1019"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset at fair value held for benefit of separate account policyholder.",
        "label": "Separate Account Asset",
        "terseLabel": "Separate accounts assets"
       }
      }
     },
     "localname": "SeparateAccountAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/FairValueSeparateAccountsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeparateAccountsLiability": {
     "auth_ref": [
      "r922",
      "r1015",
      "r1017",
      "r1018",
      "r1020"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability for variable contract in which all or portion of contract holder's funds is allocated to specific separate account and supported by assets held in separate account.",
        "label": "Separate Account, Liability",
        "terseLabel": "Separate accounts liabilities"
       }
      }
     },
     "localname": "SeparateAccountsLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)",
        "verboseLabel": "Weighted-average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Unvested at end of period (in shares)",
        "periodStartLabel": "Unvested at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Unvested at end of year (in dollars per share)",
        "periodStartLabel": "Unvested at beginning of year (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r621"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Vested in period, fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "verboseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "verboseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "verboseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for grant"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Shares exercisable at end of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price exercisable at end of year ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r621"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of stock options and SARs exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedTerseLabel": "Shares expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Shares forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Shares granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic value outstanding at end of year"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r611",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Shares, Outstanding at end of year (in shares)",
        "periodStartLabel": "Shares, Outstanding at beginning of year (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted average exercise price, outstanding at end of year ($ per share)",
        "periodStartLabel": "Weighted average exercise price, outstanding at beginning of year ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r622"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value vested at end of year and expected to vest in the future"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Shares vested at end of year and expected to vest in the future (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price vested at end of year and expected to vest in the future ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r601",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansRestrictedStockActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, exercised ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, expired ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, forfeited ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, granted ($ per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r603",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r625",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansValuationandAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value exercisable at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term exercisable at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average contractual term, outstanding at end of year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term vested at end of year and expected to vest in the future"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock percent"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortDurationInsuranceAndDepositContractsTextBlock": {
     "auth_ref": [
      "r1025"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for insurance products considered to be short-duration contracts because the contract provides insurance protection for a fixed period of short duration and enables the insurer to cancel the contract or to adjust the provisions of the contract at the end of any contract period, such as adjusting the amount of premiums charged or coverage provided, and on contracts on which amounts are paid but insurance risk is not transferred.",
        "label": "Short-Duration Insurance and Deposit Contracts [Text Block]",
        "terseLabel": "Health Care Costs Payable"
       }
      }
     },
     "localname": "ShortDurationInsuranceAndDepositContractsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortDurationInsuranceContractAccidentYear2019Member": {
     "auth_ref": [
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2019 in which covered event occurs under terms of short-duration insurance contract.",
        "label": "Short-Duration Insurance Contract, Accident Year 2019 [Member]",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractAccidentYear2019Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortDurationInsuranceContractAccidentYear2020Member": {
     "auth_ref": [
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2020 in which covered event occurs under terms of short-duration insurance contract.",
        "label": "Short-Duration Insurance Contract, Accident Year 2020 [Member]",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractAccidentYear2020Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r43",
      "r828",
      "r875",
      "r921"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Short-term debt"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r45",
      "r880",
      "r881",
      "r917"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Investments",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/InvestmentsScheduleofTotalInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r809",
      "r819"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short-term lease costs"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearAxis": {
     "auth_ref": [
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-duration Insurance Contracts, Accident Year [Axis]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year [Axis]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearDomain": {
     "auth_ref": [
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-duration Insurance Contracts, Accident Year [Domain]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year [Domain]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable": {
     "auth_ref": [
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about undiscounted information about claims development by accident year for short-duration insurance contracts.",
        "label": "Short-duration Insurance Contracts, Claims Development [Table]",
        "terseLabel": "Short-duration Insurance Contracts, Claims Development [Table]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsClaimsDevelopmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock": {
     "auth_ref": [
      "r971"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted information about claims development by accident year for short-duration insurance contracts.",
        "label": "Short-duration Insurance Contracts, Claims Development [Table Text Block]",
        "terseLabel": "Information about incurred and paid health care claims development"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r970"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net",
        "terseLabel": "Cumulative Paid Health Care Claims, Net of Reinsurance"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet": {
     "auth_ref": [
      "r973",
      "r974"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of incurred-but-not-reported (IBNR) liabilities plus expected development on reported claims, for claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) Claims Liability, Net",
        "verboseLabel": "Short-duration Insurance Contracts, Incurred but Not Reported (IBNR) claims liability, net"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsIncurredButNotReportedIbnrClaimsLiabilityNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r969"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of incurred claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net",
        "terseLabel": "Incurred Health Care Claims, Net of Reinsurance"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r971",
      "r972"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net",
        "terseLabel": "Short-duration health care costs payable, net of reinsurance",
        "totalLabel": "Total outstanding liabilities for health care costs payable, net of reinsurance"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented": {
     "auth_ref": [
      "r971"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts for accident years not separately presented in claim development information. Excludes unallocated claim adjustment expense.",
        "label": "Short-duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net, Not Separately Presented",
        "terseLabel": "All outstanding liabilities for health care costs payable prior to 2020, net of reinsurance"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNetNotSeparatelyPresented",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableIncurredandPaidHealthCareClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem": {
     "auth_ref": [
      "r972"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reconciling item for the reconciliation of the liability in the disclosure of claims development (in excess of) less than the liability for unpaid claims and claims adjustment expense for short-duration insurance contracts, classified as other.",
        "label": "Short-duration Insurance Contracts, Liability for Unpaid Claims and Claim Adjustment Expense, Other Reconciling Item",
        "terseLabel": "Insurance lines other than short duration"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndClaimAdjustmentExpenseOtherReconcilingItem",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]",
        "terseLabel": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Line Items]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable": {
     "auth_ref": [
      "r972"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the reconciliation of claims development to the liability for unpaid claims and claim adjustment expense for short-duration insurance contracts.",
        "label": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]",
        "terseLabel": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareNetIncurredandPaidClaimsDevelopmenttoHealthCareCostsPayableLiabilityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock": {
     "auth_ref": [
      "r972"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for the reconciliation of claims development to the liability for unpaid claims and claim adjustment expense for short-duration insurance contracts.",
        "label": "Short-duration Insurance Contracts, Reconciliation of Claims Development to Liability [Table Text Block]",
        "terseLabel": "Components of change in health care costs payable"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsReconciliationOfClaimsDevelopmentToLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r13",
      "r225",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r249",
      "r250",
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r260",
      "r266",
      "r351",
      "r374",
      "r377",
      "r378",
      "r975"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/DivestituresNarrativeDetails",
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesGoodwillDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails",
      "http://www.cvshealth.com/role/LeasesNarrativeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationfromOperatingIncometoAdjustedOperatingIncomeDetails",
      "http://www.cvshealth.com/role/SegmentReportingReconciliationofFinancialMeasuresofSegmentstoConsolidatedTotalsDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r79",
      "r108",
      "r109",
      "r110",
      "r179",
      "r180",
      "r181",
      "r184",
      "r193",
      "r195",
      "r212",
      "r313",
      "r468",
      "r473",
      "r639",
      "r640",
      "r641",
      "r679",
      "r680",
      "r744",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r788",
      "r986",
      "r987",
      "r988",
      "r1120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r212",
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatutoryAccountingPracticesDisclosureTextBlock": {
     "auth_ref": [
      "r935",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of how the entity's reporting under GAAP as of the balance sheet date differs from the results based on prescribed and permitted accounting practices of the state or country of domicile in which a relevant statutory filing is made, or differences in results based on the National Association of Insurance Commissioners (NAIC) prescribed practices, or a combination thereof. Describes the accounting practices used and the related monetary effect on statutory surplus, net income, and risk-based capital. If an insurance enterprise's risk-based capital would have triggered a regulatory event had it not used a permitted practice, that fact is disclosed in the financial statements. Permitted statutory accounting practices include practices not prescribed but allowed by the domiciliary state insurance department regulatory authority.",
        "label": "Statutory Accounting Practices Disclosure [Table Text Block]",
        "terseLabel": "Statutory accounting practices disclosure"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatutoryAccountingPracticesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statutory Accounting Practices [Line Items]",
        "terseLabel": "Statutory Accounting Practices [Line Items]"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of dividends that can be declared or paid without approval of regulatory agency.",
        "label": "Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval",
        "terseLabel": "Estimated maximum dividend distributions permitted in 2022 without prior regulatory approval"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance": {
     "auth_ref": [
      "r925",
      "r997"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.",
        "label": "Statutory Accounting Practices, Statutory Capital and Surplus, Balance",
        "terseLabel": "Combined statutory capital and surplus"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired": {
     "auth_ref": [
      "r998"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.",
        "label": "Statutory Accounting Practices, Statutory Capital and Surplus Required",
        "terseLabel": "Estimated minimum statutory surplus required by regulators"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryNetIncomeAmount": {
     "auth_ref": [
      "r925"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net income for the period determined using accounting principles prescribed or permitted by insurance regulators.",
        "label": "Statutory Accounting Practices, Statutory Net Income Amount",
        "terseLabel": "Combined statutory net income"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryNetIncomeAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesTable": {
     "auth_ref": [
      "r935",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail by state, country, or other jurisdiction of domicile in which financial statements are filed reflecting statutory capital and surplus, net income and the differences between financial reports which are in conformity with generally accepted accounting principles and the statutory financial statements which also use state permitted or prescribed accounting practices.",
        "label": "Statutory Accounting Practices [Table]",
        "terseLabel": "Statutory Accounting Practices [Table]"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityRegulatoryRequirementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r51",
      "r52",
      "r468",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Shares issued employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/StockIncentivePlansStockBasedCompensationExpenseandESPPDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r51",
      "r52",
      "r468",
      "r473",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Shares exercised (in shares)",
        "verboseLabel": "Stock option activity, stock awards and other (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/StockIncentivePlansStockOptionandSARActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r79",
      "r468",
      "r473"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock option activity, stock awards and other"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining as of December 31, 2021"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r52",
      "r57",
      "r58",
      "r168",
      "r273",
      "r308",
      "r772",
      "r828"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total CVS Health shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r109",
      "r168",
      "r179",
      "r180",
      "r181",
      "r184",
      "r193",
      "r308",
      "r313",
      "r473",
      "r639",
      "r640",
      "r641",
      "r679",
      "r680",
      "r699",
      "r700",
      "r723",
      "r744",
      "r772",
      "r782",
      "r783",
      "r788",
      "r987",
      "r988",
      "r1120"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "End of year balance",
        "periodStartLabel": "Beginning of year balance",
        "terseLabel": "Cumulative adjustment to retained earnings as a result of new accounting standard adoption",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity",
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals",
      "http://www.cvshealth.com/role/OtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r166",
      "r453",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r467",
      "r473",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r811",
      "r819"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "terseLabel": "Less: sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r789",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r789",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r789",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r789",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ReinsuranceNarrativeDetails",
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r964"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r964"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "verboseLabel": "Decrease in prior years' healthcare costs payable"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/HealthCareCostsPayableNarrativeDetails",
      "http://www.cvshealth.com/role/HealthCareCostsPayableReconciliationofHealthCareCostsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/GoodwillandOtherIntangiblesIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r293",
      "r294",
      "r303",
      "r304",
      "r305",
      "r441",
      "r466",
      "r735",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesbyMaturityDetails",
      "http://www.cvshealth.com/role/InvestmentsNarrativeDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionMaturitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Shares repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ShareholdersEquityAcceleratedShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r78",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Shares"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r78",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r78",
      "r474",
      "r477"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost: 422 and 423 shares at December\u00a031, 2021 and 2020"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r183",
      "r184",
      "r185",
      "r186",
      "r196",
      "r277",
      "r278",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r399",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r677",
      "r678",
      "r679",
      "r680",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r823",
      "r865",
      "r866",
      "r867",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r1116",
      "r1117",
      "r1118",
      "r1119",
      "r1120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofShareholdersEquityParentheticals"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfCostGoodOrServiceExtensibleList": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates type of cost from product sold and service rendered.",
        "label": "Cost, Product and Service [Extensible Enumeration]",
        "terseLabel": "Cost, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "TypeOfCostGoodOrServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r172",
      "r532",
      "r897"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. government securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USStatesAndPoliticalSubdivisionsMember": {
     "auth_ref": [
      "r532",
      "r1016"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bonds or similar securities issued by state, city, or local US governments or the agencies operated by state, city, or local governments. Debt securities issued by state governments may include bond issuances of US state authorities including, for example, but not limited to, housing authorities, dormitory authorities, and general obligations while debt securities issued by political subdivisions of US states would include, for example, debt issuances by county, borough, city, or municipal governments.",
        "label": "US States and Political Subdivisions Debt Securities [Member]",
        "terseLabel": "States, municipalities and political subdivisions",
        "verboseLabel": "States, municipalities and political subdivisions"
       }
      }
     },
     "localname": "USStatesAndPoliticalSubdivisionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/FairValueChangesinLevel3FinancialAssetsDetails",
      "http://www.cvshealth.com/role/FairValueFairValueMeasurementsDetails",
      "http://www.cvshealth.com/role/InvestmentsDebtSecuritiesDetails",
      "http://www.cvshealth.com/role/InvestmentsUnrealizedLossPositionDetails",
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r532",
      "r897",
      "r1016"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "U.S. government securities"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/PensionPlansandOtherPostretirementBenefitsFairValueofPensionPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy": {
     "auth_ref": [
      "r962",
      "r968"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Unpaid Policy Claims and Claims Adjustment Expense, Policy [Policy Text Block]",
        "terseLabel": "Other Insurance Liabilities"
       }
      }
     },
     "localname": "UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r648",
      "r657"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r658"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Reductions for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r660"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r656"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Income tax penalties and interest accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r656"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Income tax penalties and interest expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r659"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions based on tax positions related to the current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r658"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions based on tax positions related to prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r661"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Expiration of statutes of limitation"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r662"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r213",
      "r214",
      "r215",
      "r216",
      "r222",
      "r223",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "auth_ref": [
      "r719"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "terseLabel": "VIE, ownership percentage"
       }
      }
     },
     "localname": "VariableInterestEntityOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesNarrativeDetails",
      "http://www.cvshealth.com/role/SignificantAccountingPoliciesVariableInterestEntitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r810",
      "r819"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease costs"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/LeasesSummaryoftheComponentsofNetLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r204"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Effect of dilutive securities (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r198",
      "r204"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average diluted shares outstanding (in shares)",
        "totalLabel": "Weighted average shares, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r197",
      "r204"
     ],
     "calculation": {
      "http://www.cvshealth.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average basic shares outstanding (in shares)",
        "verboseLabel": "Weighted average shares, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/ConsolidatedStatementsofOperations",
      "http://www.cvshealth.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Write off of deferred debt issuance cost"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cvshealth.com/role/BorrowingsandCreditArrangementsLongTermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 15
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r1000": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486098&loc=d3e24746-158529"
  },
  "r1001": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486098&loc=d3e24790-158529"
  },
  "r1002": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=82848697&loc=d3e24938-158530"
  },
  "r1003": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=82848697&loc=d3e24959-158530"
  },
  "r1004": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=84167274&loc=d3e27175-158546"
  },
  "r1005": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(a)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r1006": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(b)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r1007": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(b)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r1008": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(b)(3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r1009": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r1010": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r1011": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(3)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r1012": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547"
  },
  "r1013": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99379264&loc=d3e27758-158548"
  },
  "r1014": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99379264&loc=d3e27830-158548"
  },
  "r1015": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6484091&loc=d3e19268-158472"
  },
  "r1016": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r1017": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473"
  },
  "r1018": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=SL117422267-158473"
  },
  "r1019": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124505678&loc=SL117422397-158474"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r1020": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124505678&loc=SL117422401-158474"
  },
  "r1021": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506110&loc=d3e32546-158582"
  },
  "r1022": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600598&loc=SL75763979-209797"
  },
  "r1023": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r1024": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r1025": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "944",
   "URI": "http://asc.fasb.org/topic&trid=2303980"
  },
  "r1026": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12.6(c))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010"
  },
  "r1027": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r1028": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r1029": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r1030": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r1031": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r1032": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r1033": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r1034": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r1035": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r1036": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Footnote 11(c)))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r1037": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r1038": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r1039": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r1040": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r1041": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r1042": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r1043": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r1044": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Column G))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r1045": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r1046": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 6))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r1047": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29)",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r1048": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r1049": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r1050": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581"
  },
  "r1051": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r1052": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491204&loc=d3e4879-115612"
  },
  "r1053": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r1054": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "720",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=49178521&loc=d3e9162-115647"
  },
  "r1055": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r1056": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r1057": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1058": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1059": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r1060": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1061": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1062": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1063": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1064": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1065": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1066": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r1067": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r1068": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r1069": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "980",
   "URI": "http://asc.fasb.org/extlink&oid=6499975&loc=d3e44250-110382"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r1070": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "980",
   "URI": "http://asc.fasb.org/extlink&oid=6499975&loc=d3e44264-110382"
  },
  "r1071": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "715",
   "Topic": "980",
   "URI": "http://asc.fasb.org/extlink&oid=6501251&loc=d3e52485-110419"
  },
  "r1072": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1073": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1074": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r1075": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r1076": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r1077": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r1078": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r1079": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r1080": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r1081": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r1082": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r1083": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r1084": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r1085": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r1086": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r1087": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r1088": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r1089": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "11",
   "Subsection": "03"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r1090": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1091": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1092": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r1093": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1094": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1095": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1096": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1097": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1098": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1099": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r1100": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r1101": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "17"
  },
  "r1102": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r1103": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r1104": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02"
  },
  "r1105": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01"
  },
  "r1106": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01"
  },
  "r1107": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01"
  },
  "r1108": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02"
  },
  "r1109": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r1110": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02"
  },
  "r1111": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02"
  },
  "r1112": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r1113": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r1114": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(m)",
   "Publisher": "SEC",
   "Section": "4",
   "Subparagraph": "(1)(iii)",
   "Subsection": "08"
  },
  "r1115": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r1116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r1117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r1118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r1119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868656-224227"
  },
  "r1120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3337-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=SL94080555-108585"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(b))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=26872618&loc=d3e7436-122677"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953659-111524"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=SL6284422-111562"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL6283291-111563"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL82887624-210437"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921842-210448"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "79",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82922352-210448"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6412939&loc=d3e15145-114933"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=d3e29149-114947"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450678-114947"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613673-111683"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2AA",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759068-111685"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22 (b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=122636397&loc=SL7495116-110257"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL77916155-209984"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r821": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=124258985&loc=SL77919396-209981"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123417830&loc=SL77919786-209982"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13(3)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123398031&loc=SL120154370-112784"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6479118&loc=d3e64650-112822"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6816-158387"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504833&loc=d3e7104-158389"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(7))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),5)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.14)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.23(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=35755530&loc=d3e11264-158415"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504731&loc=d3e11522-158419"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99404803&loc=d3e21409-158489"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14754-158437"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884095&loc=d3e14784-158437"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438"
  },
  "r972": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671315-158438"
  },
  "r973": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671317-158438"
  },
  "r974": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671321-158438"
  },
  "r975": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r976": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439"
  },
  "r977": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=d3e14931-158439"
  },
  "r978": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r979": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r980": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r981": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819541-158441"
  },
  "r982": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r983": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=122147696&loc=SL65671395-207642"
  },
  "r984": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r985": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r986": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r987": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r988": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r989": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r990": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r991": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r992": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r993": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r994": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r995": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r996": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6483535&loc=d3e16392-158451"
  },
  "r997": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529"
  },
  "r998": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529"
  },
  "r999": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>145
<FILENAME>0000064803-22-000008-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000064803-22-000008-xbrl.zip
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MF4\^N,9O_N)[VF_^M?O#X_)<#FEG<C0_IJ/R[AN?S'>>$;UZ]\I&<UZ\[OQ
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M)JG/@RJ>,N=:G#37JUI!WK!&=?-0+;%5J:!0:QY\]0Y$XR!K',S-^JIMC,,
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M(45'Y(B94M_*(*N(MQI\B*RI/"9-KI4QH]G\:Y&VH0\@(7CN,X_U/ZPM(!;
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M2,U)J1&U751$0O'(I;@B1+FL<5KSC[%XM]*C+REY[^A F@?XL!CAJU%OEDE
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M9-!AZZN<*N1F*@TAD[2&FF\LL7V#N= 0:X(&0%S!..184BIL,56$X+9DD'.
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M;GF'X6E6I@!+ LT:LC(1JCRL<&A/1LW+I:[,<^X.G65M(G;5;BZC$H)6G@9
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M1<U&=V;&4D4B,M5B>0+4>WML#ICYS0;4T=KIP\)(YO?><GJW#]3'J!;D!E.
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M'<1D0;K.X &99Z[1=C"J^]I9.&$OV<*\;EG-_]-T$,&AL=J"-=&Q+MY<A%^
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M"4NE-TW9:Q^KRYHGZ6U4D@(0L [ ?JQ/.A#:*$+O%B:=IO:3M=24D O(&J'
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M)VC0@B3CD,ELSC10)8\H= PBN6SML&MTHW+*19/F 5A&(RT>W8L-%$VT@XX
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MI!^:^4HU\X<LL*TP[5,N9S$<E!%[RJR60%<#VE716:]$=1R"XY*8[I::B)&
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M@FP]]G!+Y)#!5XJNJ3)54/)!R E7,9ODX;E%:U1V<+1\:-]KYK?RVF<P0/9
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ML+ ')W^,C^"?@Y,Q+' ,SWV?'UA_?P%ZO3KX]/<_()TL;KF>GC#7UATK\?0
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MTKHYP@^^Q^$PD9-%Y;31RFFE[;5U%D>RSF)SIM=COSWGYC.]R0[X6=D!F_2
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MR/&!]IC;H;0LZ;7?Y3&9M:*IG&V.$/;8W-)VIZ23X8=!;%TH4A$_PY$#_Z%
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MR/$'#=AHD^GD*U>!\I$VR1(:DT@+JB>HWBDK:6 ?"2V6)PM,C[G@2MU*(##
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MG\-VI)*;XS-%7CJ&X 7!R<8%7#M4(<$= E-HN+ ?>J=2NHR4\#S<^7N[RR+
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MC7H/%'MO@*,AV;VIRJ977[0M:^F!3Y!5OQTW[='N6_OXW5Y;<_$6*]EC*H3
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MH+G>^OK;UKJ[$5Z25:UMUCEEI)E'N;S4J0335EKSA^0WHA:O]P(*0V*8^4'
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M5J W*U>#]@@]PTV$^EIHZ[8&]8\<E+B=JI0Y,_3Q&*R*/.E#.LLZ9UR$NJ_
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MI ZOV1Q7C+N49O9-B4/*#@LEVV2!E'H5-Y0'3UE^\F :43[27)YI]'& =G'
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M1&[MOYY2^H,Y6\)F_N838CH&<_,5(5#^\,>7$?C A(<Q9W)9Q'2DHSB8J@T
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ML9GI,*9[3R]]YQK#,Q!EKE&#$30JL6R2$=GU38@>BQ]F<RJ$PY3UH"]I %)
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M%4YW$/X#^5*)/AV.=DCEAA5JYR^W,.$F.,5=@!6_AJ$65*-@.GB:=JQ:L5H
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M7=E--PRV/9<""-B!2]!N!\YI_&(B;%/M4[36$J/)<R2!2[D%X3@.$8&1*N$
MX1+FJ59V))@P6\-#)+P)1/=824+:$/GBQO,WV*2B(<I=([/3!=&AA<^H'O<Q
MEM+Z4^8#2TV0 ,$5)B:[&'AKD^DKJ^TA4\8WH@D!%#K3:H'?B2IRAP_"<Q-"
M;1L\I_+@=&QN<8N>%-5B3> L\HV*3^T9O4A*Z2=)U$COAX,$"3668-;&F8@_
M8YM,+)RY/6)2W3^>/;_Q9PP!X(/8\%:^;&ZJJO$&_!LRFXDHV5?')PHC:+@
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MMH!$=<;Z)"3'69+>$KQ"\7Y1["+F0ZL"KM$MB]3Y5!UTTPFT@>$C&R<O[KD
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MA1T9?B6/2^<J,TL$5\)<7,M;SJ^E?UF:T,.U= YXX,9SG R).^4QWL&D(I1
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MY%MWKQ@:6AU\4"SWR1C>$7&F!G:1YWE>#%TTRA)D[/0<V,*<+A*Z0]$.U .
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M$_+TU,E]:LX<TQ2.;M?RV[H]SR5;0)\2E!<>(%-1*1,WX=9XJ&MQ?3<#K[,
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M/X&"CCO+K^@#"^:F+>7K)R\-3SER[32;+Z7_/HFI6=C.\[:,*5DF@1CN_2K
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MIVA+3M2?1UOILMR4%Y)=<NECKJBF,NHMCPAW(#RL_FOJ,368O,'B_?BB.82
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M5!;NO"+G<J_3A6]<HD!I&B36FS#^39Z(/D[P?2ND(0VP0XV%&4.7/_>,H)?
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M>V3PD?S*)5@Z>O!!,R:_P;A1,HV=ZVLI[:JH 1@<QYY%&Q/5K#V.8^I]0/
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M:8$S1W=("$49G&;M;+,C@VQ=BG'.Y9Q:V15#C)X7>- X/KE-D-1EE20LXT:
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M@+*[G*VBI7G<IZ<N(8>0&C9U3^;WE=97W7BN&W.^UT-/T[8GWU [?-L6AEQ
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MV$ F(+7V<MB#]BW*..D7$QF>ZZAF,A8RI4L+:T;-_T/Y[Z&9R#"-OA>I7 !
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MTV;>K+7*'6]ZJE7MOS+8-R/#B@Y:OQMZ5RE5J8?FU(:^#O.N@EW8W;>M.NB
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M(2'1C.$';:V5(+# )L5VI03GD*<E6C.PV<4["<6/I$&U>03<)AF!U3 J2'0
MNDWE?)-4K"-'.;+1WO\R>$^D-U_]\./YW>???$U+A@D7.7G+S35D*F-8:>4I
M\=8Z9 WH*^JX0CM>X-A&TF/YM;2VC/$MVE K#1+ASR];:GAI2YQ;1?6XZNY3
MGBHMK0.\1BGU9RQ(MR,[RB-$N88#:4GA(A7L/LO-).LU_Y5UBWV.Q 96<(K+
MY;B:[FLUN7ES"XI+^DJ,,/F=(H_Z!0"ME \;RE>H!"_EP+5<2,CL@PU(6''-
MC(F\F#F)LV&!@157U473<FD7VKV2N]-R%8?'= ,^3KU/;1^!'@UT4RXP]')J
M%WT9X\E="/PH+"U,I90Y_=>.R(=T+QW7ZF^S5@^N3?O\)APS?C,^M1DOKU(@
MJW =<IWAKYJA= @737=!NT< YZ-CMN]2P:,!Y)MX%R2+%Q>KW24C:[E.3?_Z
MA1MTM(X+ZN$L*//[<ABGU"/$\+6*)M,6!S-NX:(1<\+,G! 0"->)E$U\+E=X
MU6X.41PXKI+[=_-OGGCG\.<]7RGQ2D"YK./+1P6.S'@PSR'Q&=^F]:L8H?'&
M +MTO?E^JI&_.$A4>J@%X*MF0+&LOP(=5,YH:$5"?:YB%LK%96)DO1XKZJ:R
MR&0B? 0634A1@8D&!8D&@XB&+PX0/6[;^S7N#N$SO1R3^4_+?;0\;\=4VQF3
M^$!J3.DTXU[9;'>9U)4BS1D^-3-OTK4_,O9<X#?@8KZNQU17KK9D^66!'!_#
MI_M>9-<!>!M#;2M!;<L@X!@8+V>.M9: ?]RQJ?90(HRFM6X.$GHTM%:2>21,
MLTO<3/%CD1/+\8OP4F#5#-6R\@[UA$5>AE5)8!5:BXCAW-T9ZV,\R(7A+[3P
MR7\H<B*O@Y=9$"#/729KGZ8_%L06%O]S3<PVJJNY;HC3*GG:.Y^LN 4VXK@#
M?H,=L!H2Z_G@>^J<O8VA3?1\N6X315KB,X$'FG8+G&-K!EBZC)?G0IF@,7);
MZ,#^(98D.3O #T/ER^QG1*F??A9]G(H>S[R<Q3#)=ERW#VG=8AI)"6S>5<NJ
M;*O@LYF5)>IEO;!BW%[^MF;'U:\:Z;>CZ-YR2LO,"=DY%G-F>_0TK^D.@Z5U
M7":_Y3*98A7"DMDQ^+43@+\3]6GB-2%/RK& T25P,+,*[D?2V9Y8^B\95F6K
MAR JRGF=]0WA0.PXBT51C5MZ!'CKP$9&%'MR>Q@KM%GOX5 8S2E"O/+&NN%Q
M!?WB)%/A6PA2+X7C5&72&.+# RT&RQP!_:*QL/:>A/E EM!^(PRT@B([?+@4
M_A!4D8&AYR:NZ-T\T(-5I$E(- SJ).QU8J,]"JA/!G(])$HB:9?D^@#(,T49
M-.IPNEVKRN=SE1-4#,X],GDL\J'4+P*A#1U@86VJ>6J-[ FX^>S<E#?CU]YN
MZBI>?/:R7UY$?_X]HE0T@/+ZAXK;$R$N[&:TBY^].'_[\OT9_??S%T\=>0<"
MASA4(,-6F:5</,QW>-"B(XJ/-0Y6):X!9\H#64EW!/-]*WDRSE5)U4(8?UG8
MC-Z?5;!,&YN:M4!'20UI.LFN1>?% %,NG,RRXH0+M^([F#]MA;ARKWB&AS*J
M-^[/J3$L)K=*,4;XN#,:S56=%;QU6(M!<:GX%:;G=/8!78HKW@*_$'YW] 7_
MX9/\K)LYJ=^Q:<Z83=U.D17@G4)_'1(L0K-;0,\,K<:<1\<+H'#BF@G%. M?
M*DN^:YJDIE>6DV#'@L@]M->WZBSX9-J>7C C 4>_DH=K,X'Q9<N7B'_"K=]C
M^/%E:T_:1=.%\%$08*[K,=J:B[:Y9JXP:;"%IA!:?6.(4*'MAAIJLD^D*SJN
MRK#LJ.W6*[<9Q5L=)\](M$"TQ/2 &P2PX#.CWNV""S1"$$5>*4,HXA.Y9O<C
M;EB7XN^>/5;<\!<:L&&ASAW&JF<WKY9&LN=[ZIKV\+F<G< _536E (B%K(D#
M7FNO$)=9EJXO,5YG#JX)UZD8?[8TN!/U$H)#>,X%_&5;7M><421UT-0XA$H!
M=0I=0#GD:&GOT=*>JZ1E:EV]5=VO#8Z'$*F74HG X&/6S$R76'=2Q,?$!4(2
M1>V/JW7X5,T-';!IV",41AIAE!RLWM/9VT2"]S'L#0373+CJ>#R7CP]BYM<,
M1C":R2EF*J2T.@NF$&6R;A;3[;5,O,>AG_H>JJE>DMLB'&GDOB3/"?)*U2Z(
M)FU\=@TY;TO.X&JY[B<IE%'2VM6$;*'/G]"#B8=#?9?%0$C+2U$8\7KA;RH=
MBXG933/*RO<YUNZ9?K $<1@,%]NS:#W6+")EU0IOSCABQW3XOFPE?YK =WN
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MZ<4[!7F!GB>=CDD>@+J!4B%S%]@+FH=1#Z@14IU].'=M-M]54%]B9I]BI!C
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M7M_17=!!,N[AS8\'<P!9+P7=MI-;85+%-7XANGCQ;NV>/8K'D2U"07- IN/
MXDS)85XS8DL+G-?-'H-9Q)]31UD[QJJH!^P.]OC5K@?^-6L*61']5[WS4X9R
MBG9YU'CP&6$W.4'E"B:^)JW!(O"I .TUJO:E<SB<HMGKE!<0D+$ADYLV0REY
ML*7N2 ?*,*REKK6:EX5(ZTI!0]4A &QGB8$%:G()!Q\WZ48!"UI<Q6_CWSTO
M$<C\EEI]UI(09[)$;]R4:;11ST&/F(Z$H-KR^I1-\G0)<_:E6LU;6,SD!]9S
ML-[0Z#I!EI+QO-*CN<>\[?;C'PZ$+\,G6LO(C4&*<_"8CV)/_B1]"GXWI-$:
MK>)!C9.*7%?Q-U0<(EQJQRNX/+2_#%"-.);WFGY)X-*P$N4ZR%#:_>W.DB3I
MQ.F+*SCN9R$/=#;2RJT:I*?J(WV7-)Z7?+S%F4=_=NUO! ^EI,1HNE0T/UL^
M)>54R )__ECA9IKC:\MK*Y#Q$*R0'KK,N'H'EBO#*<5O[71Y \>W!GRCYQ>+
M)H[>)TYH6L_R3^[A51;(W675+GEO*:B84YX\<*F0&PT+&(,(RP'@'? ME28.
MN9.F&,5, NT_B0LA>$)(+;02V*VKX@(N]8[*5&F:QX:,Z[BSUR\@G_)U%#)W
MF@ZZ[^GL#!BB9(D=T6FTZ"WUAB"7"[31>BT9L4[7ER][UA/E3O?(B:KK5KCI
M*>6RV9F=,>N]6.:DZK*3C6*'Z?C,.8R_L!\F5JKK.EER&ME*#6:Z@O0'*]FQ
M*B+)MW/'B!&(;E6CKV(7.,>](F)-)8VGA==QB3G=&F D%;!4WLY$P"5GLS9
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M3!I>3"AW&213>E6V%4OZ8G')8V?,$-;4OPQ<?%RX[RD-0YU*DT1M*ZU3\J+
MD(B$B#WY >F=5 [SS%VCREB2GG6[8>>H#1=-VTH=U'AVE&!7'#E>I/(&4EUY
M*$ONQM/DC#/TOH3FVY)DT*F'L-D!2A)?37IJ^FX60P8 ^%9*/4D:4=P3\U]]
M#!&I<T,*7PD9U&)-@_];=+"8F:8UMDAC]. T'AXMY#R$/-SQ/&%)=V$Z<4 H
MH6573=)LM>@3QB5"'YA#389'WSAQ(\DGM#M2:Z4]%X_$O-_1".W!6E16RP3E
M(&BDWIQ/A UB+2_:HV_"K.CXSIL?WB,R2$]+C8GG;SY83O7MNS?VWWS%=)TX
MJ@3V*:1U M!A]P=D=+G,]_>:ZH ?=DS_(D&\:]I*3Q0?P(F# >LI*5':T!TG
MN,4!D2S H]@!;X=KX_!"R^QFZ2JS<O;G<A&@UXZ#E\28+HV&@M>4(X J: &1
MW+4\BPPCE<BD:_)CZ+3Y,)EF-<CLT& ?T:.R+69S1MK9;*6)9(7TR9/MM$4T
MX,Y)@Q(O $^1&$,I>\",9!X@H/K&O%?(3HA>%H/@J#7382X=_6'T5IC&(EK2
MFMI[';.6OT52YW8?._:4[/.)A/PM:7@\;G@8U163+^U%G=W?V9;Q=^(R+2]4
ML$?[=%,_]SC G'LZVZR88[;D\$)5&0G%02W)/O*Q2 >QB;P/W_? Z8QE0F;;
M42A)B?1$)3!&QZ_XU -9^PPU4M*.>Q4-%&VE;YX729T[_L>S8JC;?),+@4O]
M]^=_B$MAO=:E]]^?/]=_%P1N4:1+X=M#E70D@T)]CHH#'"'7<=<',H1/X,,S
MYAU_?#IE27B1"-=6DZUN-@@2(:5=PEWY9$JT$ HNL0W/@)J*02_QP&@=&.)K
M<HX8\,*0/><)-HZX".-0@Y8&7>&%9CZ OS+^Q8&;]2CL_FMN+45_=B'@*'5S
ME+3.<6+++MQL=_0/%1<7\!GA32?, ?-BVD4R+T"]CKC]L)&6F0MAWH48U*8=
M?93\$6:!#S4Y'B-L[!T]V?%"8A<B.5*R[[-][;D,!^QJ>HCESK&R2?(JU#;?
M:!<6H9WK$-$IQ_P2M7GN%BD>BO1459W@"*Q<X&39RT4?K[[D>)XA(*#/IB<E
M0]8Q">4OHJ-3OL:)E4"^0P!1]Q%%92BJWQU15/\3WGE<Y,XY9+U-:7MR2&\B
ME61JR>B1^22(>4[F=1BU(DE-@ ',6>ZT-73C;4JZ6&*%B=Z^<\,<;Z GD4U4
M@$EMQO<347;5M8D(T9_LDF0R4GL7G85^ZQW>40_ED+EC1N?M-/X8C2$#1193
M1V%;2-#OO:-=T 7".4MI67*M20]E@#[/B)2:VJ;&@7A$]/6YK4@ZNSRD_-;#
MXAU>1$E-#(@55S\5R*6B =W;N6S68);$'[:H^!3#EC/JSQUVG2%+%L-K4U<J
MXC^L3X#Z:^)=UR$]6ZBOJK;AL'SAG+<R89<D(^LVT*@+PI_O@XTV6T:O/&38
M2- 'I=/-Y43TW=UW4\,1DI1Y/PHW-#V2 LLJ[X$S#B;;M=*4))GK^#%$]2CA
M3]1)5=-*5I(R)_N!,A>1"76+&,WTP&];501VDEO[M,=&;X(&B[PMSXG_Z&7C
M=<3-*V;"&;V,OL/>@@J269)$45RFDKD:5@*:P=OKI?ON,PU_!UMG;B1T&T)@
M9SFM4"/TP>QH3^2G'+-DN:?NR0$SV;Q?7H2=1(L\RK85K6S4<?:YZ^E/V920
MZB$5K(CPG&$5AZ@X78@MZS^-(TT&&X!4!NO%M3>M1V,;3Y*3U.S2/Y+-(U%5
M:E5*[5E=9E31,-=)M7&U!@F[]DMX$TNB8FMMGW.7<EZ(EQVG19B6WKAK-DD.
MV-ZB9-X"S$>\E:"R->XP#(N>NJ:$V),,&G=HT?-PGO2SEPF? L4?*$J>K&&3
M(=S!J!R-R*8O9<DBEM@R/B;0S''. &1RS;IJT ;'D=(@'>8/TF+R%*4VJ(F)
MNPWTW9_BF7UT<5ET6P<_MMS!. 0<2M-)AHHJTERU)PJX)6]B#)1LRZ2SY#Z
MCFCTF#N6,^0&\9-$?D?><_S$-B=4BMB+]NE(8^87R##ZBF @HUL:#1&38,(N
MTXH)'PMS7%/W L>]), 82IK2C6B0$O'C)'%X^O5(Q@N^A=7;A3=[J*+\8'SE
MVP,;#K)EN]"&JQ#DC"Q(I4(3D^)%,0&=<P'%,]2_)S(S:-LEF4NW;;RAM[ _
M2VBR_1Z+4+N2_C*3H*891$+/GFP!!Z'4 &\0OU6#]^,-LS,A72F) R]OG73:
MGCNU37\AN3#5XCXW(<"$&.\HLSPFDL5Y[MD#ZD^4\^X4-EZ$=&CVTG3,KR+K
M/3G*ZO-/&*UX! F@)(F''5@1QFEWFQF(YC5Y&*8^.'3&DE &T6,S=@,OH9"(
MSXUE6AV<Q)^G1OO=?DNK<;[W@C4JAZC%[)NU6#4=-[5NW"R5@Y,D)P5[<(*<
M=^]<$@^NZ=@?GNYAZH"(J+DRIKRU'8%X'LJ+?[8[.*=19U%'/NC8W;CH2ZC\
M0"X$U$7E=9> B8A(UFM1BN(H8+Y6:EM.8?,([3(V67!B5CD;[;JI+T[@SJB&
M)X_BTV+VW9NW<<<BZQ0/X6;K#]TD/+N-[LUB#PQ,HB8IJPTX@P=U)3TFJS;Z
MF I%B$_Z];/G?XRW";L:.W@!X-F2K2?CGY>6HU\Z_@L^D+F^]/4W5E#"4;LK
M/UE<E'[:7=*!L;)SVHWWBH"A4^,P>Q?J>O8CSOI]G'ONACK; '95,K*'1E;9
M1IE]AVY3,<U'5RVKDL^SO_KY[*3KF.F9>&=S5)7-EY1L->@3&HT;!EV'.5R)
MK,>.LPWT-C2G;DKSU#E-JI'DI@6$8[/SP3((@?%ZR9]TBT]S_>DE^ZXG@\]?
M%R/F1E]9J'7I:1 AW^1AB8MI/&\F'W70 _XG[>_\]M,.)!(\RXF>:'>)A2I@
MA.P+([5$K=B,HP3O7SD[,0]QI)%&48WHIU(]?B C>#.M;K]84[Y]7D$!CQSX
MI/*TV\6 CT?1=)_(B,;W73,4Q 'FN%;7738-#%A7I2@YNBK\\SS=<5VV-$&A
M;6.4TVWL/M=5%UXH:W=9GQ '0;1[9;<#[>8L'OX]QML^*DRM];)O88)JPFA$
M9X'>" $P MRXLAO@'J*IQ=_CB^\NH\']2%_N>G!%8$GL%]'FT6?[;7R;FAQD
M73C7<2%)>*41IRG%EC\WK7P7F+'E[)IR!W;_)=$C*9M/T];ELCD\/(NU0+Z$
M^3(;G+"-X1RH+=#?5/-_YDA?M\Q9P(#W_RA+G7$CY[3)N%[?,=9YQ<X=);T\
M\S$C=/+;C7;=U)>&A%N^1G3'K:8%6L(>71NOR" W?P.G=NK]I1P=Q'K_+WMO
MWMPVEFR)?Q5&3[^)<@2DMNSR5OY-1ZCLVKK;;8?M?AV_OR8@$I10)@$] )3,
M_O1S\^1R\P(@M907JHH3\:;+(HGE+GES.7F.$-D)W;0\4$X*KT8%EWI7DW?7
M&8E]0=4*JH_V!=6_CFT,QXXC!%>1B$D(L:Q20Q\,B;%:QQ614F_U<M;P!%E5
MR2!>=6L9.Z%%GS"^8CQQ 4@NY8[(V@;WJ\LK2Q%H\NBDAVMP08R@>?#FNH6\
M??C-67H$F5GJ_3D_8%HVT]4R>%*LQTQ7'V'K0I&KC,P0_F7*N82PS,DOO1+Q
M/6CP(+5DE1(TK"0#[:0\=\5MN 6O*L]T](?SZ5E9"*VJ*PC202,2':!#@%F&
M7W]:A[6_:0"^_CMN*FI\I1AYQL1-A>BV-^<HY>G0ZE$F82'C*=#!D[L_@0RE
M)T[+"W(1_,)34%(XMD]<A60(-,2R$F':Y4*S*8P@U?6F?HE*<VON!6?2F+./
M;00,$!A0>S!+RZ_5(&%LA6*6=]8/[WY2Y?7@NQSSBI02([[ ORI;GW(0S EY
M/YJ]8V;%(3V6(^SB<8.D!H]4V=%U@ZECH1<%1=(^46HSW2+\BOPL7BY\PSS4
M33H-2UH=FM=C6KT2[J=PI(;8KVX&<+/^^XDS+P!O!1@J_U97?[>I0N0"2M"5
MJ=2]G"G>#O KN@ZV2%X403<1R\?(.FD?HHKQO,F71!S>I^L1L$4KK0I5<<FT
MI<&Q/?4M<,;6^9SIT$JL/A8!])@) D/.U,&GYH3317TBRS:$X4K+YE1)N_QC
MP17!YK0P!E(EZ'"4VCYC)S[^@>)[,3S/PZ%Z4C?V1X]@XON[JV&I:#^VZ):<
MA5T_*"J21%?;8_<&08]RAT9RJKK1$9Y:WJROS3VJ;OT<"0?78T?;@A+484@:
M84*LM#PE.C0,#666Q1 /G2,G)6RBMB$N<5JB58-YN$+L.*.AI+5%:;_P,K:3
M<:56[9"*'C';/'M%.=?D;")AC'B"*=,6K-):X<Q.W4<#+0)3]W6@XMK>X+>,
M2M5Y9R8S3XPJ:SGK;5K./-WQ< ;#CKYC=?8([Q$(*WF4I.*%]76]$V<JG2-M
M_SC3GE900$+=B<=S"04NJR#[T)(K*E:5-LE@M/()QKJ7WK-YMFK*HL;A%)\>
MN2)*OI&*,+F)D'>:-BLF9F*Y]_AU?@  N5(+3WNRXG_TU'_$TW)*>:H'G8DO
M:F)]PZ^FK800(%V;/JT],B((4=X0@75'O9DI?ZX'1E^OY#Y*F9L6X2-)[FZM
M[G&O\"T.TQ_)6KR(Q5A1FGZ#A#3>[S7,WC_"1+"]>1L1(;C$CKSK[<I2SGF*
MC-J^\TFL'X8CXYI-#YSK<XFH%R\53HITE=^W[;KMBJ5F?:ZASGDX^8&HKA?:
MU(2./[D+&BKHN*3>!\L(7ZU^NR$0K5UPOJN-W5?3 %(@C]2I!W*.Z7<JKL$<
MR6 [.R:2R]NZ0E4Y]8 3_<%TT&[=%DTI/B=A8GKQ*F^2++]8(.9LJ"+U<,32
M.P'3[ODJKI#K3" 5QAN9>:RMK B12?5H\7B7N!=HX;-0J&V)[_KBG^X-_1SU
MQ;=YDTG12$KW8WK666S<]3\1,_;#1TE"N_WZW#\1-G1DHL.$\JB!07 P2K&E
M$F/UO/]V8P;"79 &1Y*XV>3-RS>&>Y7+OD('8Q3H#H]VFE<"'[8O(SFO+BZ<
M4S?15*;K=7(;7]C@S7-5#MOX]J/,9-)2?</K)0/9HI$*=E?X1RAT.EG'2P O
M@9_!\<=>H?%+[EHN0P@I/+;8)65$@TL1--E")4F+,"^0;GCRNN-.IYHL#7YG
MU0UX\<#;K*5[76Y/BO)L??D[.5;Q<OA%<E30(?:-;UUFR0FTT')"#<?%FV!
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M\W$8=F<(EYI)%4Y*6F_^05OI4&7LT:PDHJ;%VIH-;77A0NA\E4U_7D^Y.=H
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M0$<9.8X#E-YTK#@['!COR[A1 !*5_;;Q1YH1;1+5TWR^A$A<B >&?N"7'5F
M? ;BHWE2E<.2!.<#\9Z12<CM&?\6IH>^\&#+CX_Z/PZ3Y&_\X$YL^0V98BH>
M+*73DK:LC#!"XDVEMX2LU$N6;(ZWR\;/8=9+B$W2_)?U%!;63[7FY>GSPV,
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M3[J;"\.6]'HG20CJ*,: 1*/E]G"X\?0#+%U[3H+(J'!I_&1KY4[LD=%YD@2
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MHV1^*H]-F,J1ZTHF23_5EB>.S\2SODZ$8SVH@1R: WX<H6_(!,V</%-X9N1
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MD%"7YH)Y!BAXNXBR)B=K_UMZC&0FMSQ U#SLKK^>HKX*L1>)5CD-7:'B6.
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M@_UY8MZ"MU0+D[[E8FJ*_2(IB>[)V5?RXV>V_DF0A.DG09A^F$0Y?;NB'SB
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MZ1UII5C^*-+A6>@?XTOI=3)>3+X>]E<Q(3H#(10\1VG%?UY"8F==67)O^AG
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M?C![],[M_]ME]&Q&31IA]<CQY)C,R$1T/:V<B@>KJ=WSM43,,. =D=)R<VR
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MG6J:KS/X4@@!OBLRV,>,P=+0'_ 9MZOU-;OZ"U"G.W%M= 0>;!OK65!8? I
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MA\<;QGDC"YFF_#V7$I\SWDQSE9$LY$ASB[\%X9PG&%5EPAQ "MB 0GK@IKP
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M?!N>QII,A*@$$!3$'JHSH'(@-C!W$L\*D0;< )6@QS6)O\F?L(\ U;V0^\B
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MX7&3TB=$'[M"*)I!]-'X2#^MT?SL";]_? FV>'#^G40Q<Y1@W<9JWG7NF\*
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M)+#S\W^/P[<_;_GR!-S.5[QS8V ,>P6;@U):X@ZB'UOA4KE5C(ZA@V ' (0
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M=1LKY9>C[LK4^GMLZWX11&[L!B!'F >;>F+WV#?UMLM_O0Y#*V*X +IJN2?
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MW_)7])?!V]>BSG17U,B^3Q!9FIAD$N5>^BY9[8NUCX03T#ZKLON11@;,(Z5
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M"]U0)"7XA5$:P/0A+<J\HG/MR*DVKGVI\(8B>ZB9.51L#X780I6YG7%=O&-
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M^WEP_-*;LKIJKSBJ%;9Z:K<:*++\.+L<MSKL=VR574?HE??6+-":!?M:7AF
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M<^S</)\7#S9(=8M.Y(]Q\.&X=WQVO*/#9.^IY_X!EY\)+O?&YZ<'5#Z@\A-
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MPY9_ 7FH&2 .S7 [?X%5\R]MP&I9:1_N$F.\&K.,]A0QWCAM%5\I?F23";N
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M[=8U(,A6WU/YU,=PB<QX1XZS.J)8\HVL[5%Y=LI:XMG92T]+I+%-4M$SY18
M!27Y+MD_E;MT((B!KGKB-+IO_*OXM9V@@)D[.JNR3>>V#F=R2-6ZIZ-&W'B6
M=HXCH;!Q5CPO1%$FSRQUTNYZSEV;\I9?Z2GK?':I\_GP[F^?=)E/7Q<%M4'#
M[:D5VDZ3UE'-\#"PX(F!:+.X;BZ2^0(DTC1KCDG33I?][+%']L@@I0V<E$,
MXT6_NHR%EC>WS [V9M/G;M:3GW?V1SUJUHT>L9L?2 .4J1<+CA+0<X$X]PNS
MH+C'#3^)BA6%MG56N7BWK6=Z4>5%%<JL,AQ7B8E(%""XRI5N-DS>TVE>Z>97
MW S#3J:LU5E%6+J>+7P5AE1;0  =Q$( Y>P?UGTD^46.,YONU72D2C$Q"KLZ
MBR#H!Y^5XN#^H!;<_^Q8CY>V9>5'[$@;;QO=K_?[<B5(UM[?CKN6XBLYS@9L
MZFH?_#+&L[%BR&TVH8ZLG!VDW=]QJHLW$2I:4FMCE_E%IK,JE6EWR ,]=5%,
M/[@D,M4WKG41X4;$6>+4WQO37*3YIAY-Q0L+FVJ6I/&[.?A.K^\ZHFS7-)NA
MK;2UAV^<W4XQE=V>2&.B1193,(PJ39NC+/VT *-(-2+1IE<NE0$=G]7:*Y^:
MO]<A5G\E?-_->>@4M;';]M)\LI?\%I/MCS_EY$7*?;3A*$XX;$#LMB41M^UW
MN@&$RUT*PUY6-OL-_IK=8H.07NO<$+Y<&]#5?9R=SEA^2^<VTG=B-1M@"=JG
M-]B&'B.$245&+IP>_C 8^?AB.HVV# @F',TY&9EE-K?2E1AJ]_4VG%S^'EX,
MSL<&CQ98<OEU+YC8)2H0T>:<C!.O&E"BDFG1A$BR$WX87A!99<VI%=4-SJ3O
MYTJ5HUZJVD;X(.6<T5P]T62V9Y&MF]?9.W?GD$VH6<9WVC]F;?@$_T#GK#,?
M:NN-B?*U'6S.![UY7R].SP<U1GAQ\C"<T.&"^T 2OUFW1FO7C_K!N31 ,M[*
M[$J1&FDJXKZDV6VB(JYIQOE$6*%UH\P@-^1KPGUT48-T#A$N3QHBM19T.;C^
M[:K=V(D0/$>*$WH)'8N5W-_'8-NU@_++A(FN!(.FECDGRT^Y5YQ#^\!.!_WS
ME\RK5R[%3R>6D)KVD/?[QHBAVTP<!]8Z,TFC$YUD)\XND;S4X2(U*8OUK$E;
M0SDM_=FO%>C2H/%*_,4.^L6,0BI0"JX43OM;7,=N>B1%7)Q]\-+&!C$;N VI
MS.#=PTODE5?2+8I'_=.75OY^H[RM2=B3T^,=E;!;3XNB!)<_L"1K1TZP<1Z?
MUUK3K2US1D(Y+5MULU:31/FS'@.($S+<MHRU?N_NL&\R*K&.4,VQ*4J^]$8A
MZ+8C5G4@7R4L;Z.9DU!G25.W()H_1S8+]8Q1,GF01@O5QYZI5-++<4&3U#PM
M;9%NJD<QFVF8[1O%-+(<.]]_IEYYSA \;S"P/Y7Y$#(U(=.S'0R9?F\@F/)2
M%TL!,Y/P5NB&T17UM:LPCQ)IE:!1D]L9,[X"GG30H^VW3X-S4H4EY(#./8XS
MV#)9,^_/5IN7U,66JTEE;)S-/LB<<52133LU0V]Q$R8@X\TD O%E E"[THK8
M=9V9N%?LI*W$32.=W(D%V;5U!EJ?-<.?&D\OCNC<@'E2:,[TYJ%F/2&/",O9
M Z+3=746.@5O<P!#Z-0\>G-N;NEWGI\=-Y!5)2=J.K'!?G!IO'^ZIWA=R6#6
M# B2-J/>581]*DB[(',J@A> 3C(UI;G8T)Q.SZVOZ,CB^T2U0M*T8V>6I\MH
MC2N#^3);1O [4B<$%R791XAJ[?0L['_L>5=:)@CA1U[@<X))0G:$EA=H8\T,
M5E,UA'%:;&XP1JBL10QKMN",JL[=:S3&B#-5*+$2K-3+VCZK=QG'MRLJV_H9
M;Y85\<EIB([NJ87?:A'::+..G0EFHGY3IH9,\R)+'4T%HW][RW .,=)#@>]@
M;%%?0].%0<P1>(C" I8">CYVE6IZG4J*=>Z$MO6;9"RTRVO]5B(;W:0SK4HO
M[ QUEK;^D;^SA%HFE0:P4L:'!197V(I0NS-.T0F"0(NOLRRRS?59H"@]ZEJ5
M9>*T'JPQ3P.A)2:Q2*V\%*4O0$XF,M[(^"G:K[<Q?\@T?="\V](HSB383B9T
MO+/I+G858B_"U+5KUL?Q<LT^B!<1.]2=EO5*W)&>9E21]B"&)VD9N,PLU&:L
MEU>T*]2\I0&&"[NQKCSCIIB$USMRI-6:QW>,YDG)A\DAQ3HE;[:="SSTD<.K
M]&!(-SGDT(%H,S/GO-O,P>W&T9]^B"?AY&(V.1M$X[/QR?GL>')V>GX^OI@-
MQO#'V<GDGQ=G/SRL;=0"EMGL49+@_V^X,WL)KD$A^M,/_V?]_<#U_$%$@FU?
M,YR*@8PG7#=\:(&Q]?3JB#H3OAGWSTZ_P_RA#B<6\HNSRWX0_ \F15 VQ0VK
MN_!!HO_^<UQ@B2;U&;J<@*X9_,;)99_BXLNNB(^M!Z.I,$?I+1V#C')D<NKT
M")9,BOC\5CT\D78*V@"H0/\F8"WE0\F\LQ8V?ZPM'W;Z3_6O:;A*I)^FS4@9
M'65?Y#L$XBTE])\M!"C/6\#WB9)IX)CO&7C_(\!#9-J1@V[L265SLFC!#2KJ
M4.J+Y+'2V!R:8P=6(7:J!NL,E&[M]T09&U6Y-5\[' /D G*ZF?4YY-.VI1;4
M[-H3YF;8J'WM.:KGY)T R%5>T. -6 <C^DP?U'2,V^3&-*=D4N+WE9CVZ,"=
M@?*2R6Y;VFYS5QH< 6UT7-JP8ZYGY&# %DVU.5$8_*X**FO-XQOF6):<X[0H
M\XKUFEOR73GD27X/&?%54I]SL9?=L9H]S";#'L7LW<( '&R!YI705?E35SQ,
M*()7S@BNS.E \;IG[KO''@&>@B11%C0TT.%.6^52 +X6N0Z@!)PB6C3OW["W
MJM )A(5R0$,N.3OI.(GGL5A.8)20F6#8$%HLDJVFAT5BOV;.Q!/+Q,/[XC;$
M/MUE3G8C]P_!ENQ?"N)^M]@O7:<+XD<5MZYS/A+K!5N]5:4W4U'.'ZE9B,XA
M>I4]/:5DF8ON!5A+04C* W30BV4\5 [NP*DQ!$8%80H3 +E7N7LH<Q< "1EY
MI:\".3/OP*39$'U2P@ZJW0+16K-\W96]OFNG2QL5;B1[POR[JF4T->]*_4X;
MD3@\QW IP)2%SONE7!'TCXN5))'@LB/D;E(MWJP;%5MFBS>L]Y6D0AJ;!\L;
MCC"=&/!;O=%_>!O%Q2()EV_BE Y&#[WUQUBBG@]X0R4,8@21ELM?6Q.@?\QF
M0)G#_R/]9OFZ3U_]6$;-[\[.^F?'@\ZOC_O=WZU:]KQ_<7YVIU57?S<Z/[GW
MO5[T3X;G&ZWZ(T&7(0R7B,CPIQ]&/]1L@#?#Q==@ /?F&*Z)FC7ND:_POHV$
MB^WUNN/59AQ(=@GN6Z(72&T'!+;>OS,85AR:^RIN<:9C/-$/3^KXQ][QUR#X
M))Q^P7Z]:70D.YQ.E0*+?B<P?[W$H$/_V23B'.6Z:1=+@#HFK#NU\'7D^G#H
M@)SR@3Z "Y+C8!\ \^+ASN^>FSPD.W7PB],SEO@/!@#\=DM K. Q:\FPSJ<.
MB/P\$'G0.Q[M*BIO+5IF],]>B99/IF&@EBF=RL5PNY.W$M[N(>#PM#<X/]T2
M ]LO^D'Y9>V5G7K=$[VE8>_L[!%OZ9ZT3'KW&45:=IHK_)&5Y+)LNDZVX\WB
M$1C!R:.L0O^"WOM!?M\;@':<<L>]P<GPFR3\/0!I/[39 [D<R&74.Q_L+;F0
MF/R1G,*/'B?8,"I L8VB,51#=;I<;,PJRB@!4ZJ/VK*3;1]:R:V5]A.MKW3$
MK7;]4Z%>8R?8CUB/9TI3"0K)[F(G-Q)[DBO]<V<@0=S>/$&/"58_\E@&&2W*
M52Y2?"59HSI2%EQG2:1G_%#=FM>7/WAET[';HY<ZVQ 3&.?5/+BJ0LH:5,5K
M"6EQZ[75 -&'EX1C)P>\ME$,8%)T%4.)DND9Y>%MF.Q,]N$&P]3\J';';;9&
ME+@)^.H0.T8>+S&T!*1]O2Z^)+6)8:T?6VUF[KA_IGL2<W7PN#\R'_ =7EY>
M;A#.JK6 M$%G__5U$-G2:'[91&&??@="5WD8*9R-C0GX@);7X8UT_&^%$#__
M[MV[HQ_?A>'HM;1>=@Y%IQST+^P'6YXM>$6%-I@:/WRYZ6TX$<-.(GF]%XA^
MN0&X7$9SK1(L.C\^K56A#YTQO8V^4/,J)4:0K$ 8PY"$]V'36>(@F!UAALDB
M4@Q>4II#W7+:].Z\' )G*QN3[,8T:_/;S>%T3[B[O'=S5N%? .X"4_C\C33S
MB*),<4VT3"KP>]0"@\<@56[2NUS0RT'UG2WU>[ #R"L5DR2*XAQE!=5/\9_W
M@T)<$%F59)J I,;$J&;V$Q9&F"(AZB85)JHG!5IYSFBOYGB=+C=M*>#0K>F+
M:P6B6<OI3;& J@BI,(,IIKY/(CMZ>622>Q:5;G"@"VL[.[)(JLXK;%!ZE>54
M9 %'_Q73I(*17JNE?YB7AFY:8UG0PO=JX50G_3VEA*7/I6ZB<(D%,M-0*RXF
MK?ZDEE9/W2#_@0>\]WY8MNM5+#6 7[!*TX'+)I,@'!+J![]TO]2I=G$>Z6%J
M'Y]\5#NYDXNSW='WCB*Y^UQ.(^&YGVZ+VH;)AE8W\R[E]IH;?X1ZM@W^WNU\
M2AJ(:<K''8NR1AM>S)S#,5I8YZF3'FEND;,9:KG'(Y^KU-1$4>M64TU6FX%)
MZW+94BGM60N<T((?Z56IM? F96NFZRI6K!&/;UM.]_61;L+4Q9,:B/!\6FP1
M9@#!JD';-[IXS3UZ6XM>=P"BF<2BB^^;T[)I!#Q5<%&GX6^'KR_S6B!-TV2W
M!:Y=4%:1GHIWA;!I0QG/JGS*'6NNO4%6L.M,5(<CS2W85$R/=/:B?(Q-NK+4
M-C64\>.Z]:2_AOFQO@MJ=H 2SBTC/]0!F3J@BT.[@Y]F-GO9F7381<E.,V\/
M$U>A+E.ZE63LZZ#&H>H:W3 WRO")/WQ*:5&$8J^M']JB,;>%=C45K,5;.AJ'
M+W#?ZT=:RO>"(V?(A[1O@@U\-AN0EK%:W_GMY_\*YXNWETU9?;:IFK(K8OR;
MZD>DY.@?YC.L%]F+0L]V!47QZ12WC:6D>RK&YIS_(SO]S$T1GRREF)S2RA^]
M+D$*L3MJ$[SR9RK3:#L]D;JM:$FEV8EK3[I]56U%R!$]Q2W'K4>I KKEH82O
M;"F5*G1]"K<OL;]Z;=B-<=/:0A,MBHVRN!_>RM^QRD@Z"P*H6S0'K1QKM8&'
MRWH]\'ER+;%K49E;/9L=#8$]NS558<Z8UE)EUVLZZ\4VEKF>8E_JWBNB5J.>
M@0WTQ(_=UB#-07Z[ RG^89S ]U!91^$T%Z"B%?WL*VT0V,X;1*1NYQY=[;*,
M51*YM3I"![8SCG1!?6T=6+:_GFEU0IS E%6).;TTS?AT)7;382,-!J3WFWNU
M]?E%SGB #C;C]GM 3*C-/9BYUZ.GM)I#,:UB^S#XH:C(TDRH5B\$RAGVB-&J
M9]U>)I=$6$@)1O&&)X'@Z$%J8)[:CL"@!OGM8ULX'GMU/05:=X Q6\<F%O,L
M4EPT9(9SZHV^IFNP8X1)=8AAVZH^&KGGCL]DZO%.[H#=<5FFD7]$M^GQX/0E
MGHKQE?:QJ"8@2-'^0#=Z9/OL")>^6[!B+UC<I68)WX 1S!+A_V!],<]S;'Z?
M8(JU%-,=9X@+%X7OUD#!+_09H?DD1>288O!F<*[S#K"Y?EJ^.<)/'LGF(?5U
M;(+HWW\+-=B<]*G.JAFMVH2,92:-1HQ&_^@7)_VQB36]>G':/S=_X^Z6K_O!
M>[\7X<I-W"&TC>*E1:YVSVD[H,X=4,=E$[8%<^N5;L+I;:EQ-INAI-1MH;[]
M-5ZY>*V?6DC"O-VUV1(^/K>]6E^].!_7.[>^=CW1,HF$AF"#J=X9!^T'G[Q1
MU:O<X%YX0@^'LNW*V.]4=^YA*T^2?R2"75IV@C2Z*GJ#4$UMUH?V$++WRV]Y
M6N[;9#$9SU:?1>TQG"VT#(H&.XT 6BT&4NK(Z6YX*J@V/79D;(FP+P8G+&TM
MF@[._4\T&]Z'ZS MH77]MS$#6MN/D+[H5:=S1Y%6%5>[I@O/,.HPA^0>$,^=
M+H(R(OS;;#L*ECBFW8KI%3MR9=_DM?I%FKZ\UTU?J/&):?FR+SU/MLT+B>+(
MSQTPYFVC"X[ZROC(>)WE3D,<IZ&'JVNC%92$THS!(#@/VK7TLN9%1$!QX>'X
MD\"XWYWF07OI(B5/X2Q$-J3=._6&2.0P0$<>9W3JV6G\M]KXGD;C?]-=IO C
MZ3; ;F.I=O;B=(ECY>2+?C/&M:- 91\4=2@3.%" 6+<)+L,OBJ*O<V#85V1#
M8](G/=23AK1$P[83+[6?9+<(MZ N2&)5L*BTB8?EQ.U*'VO'*G9=USVK$P^V
MU#M4A+Z9>4>S@Y3)'*7I"$S</!M3:UWHD DGJ*RA1QM;'_6Q85E>+8R.B;O
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M#@%#"H4:C4G1$>)FD*L%/Q:2C8-)#DB/1DD#VJFV#?,_8R$YZ!:2T<:-KN&
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M77AMOI.\BMQC+53N@N"!:9-XS<E<3IU$RP0/BL5</J5!]I5B/VV@&Z0 >=5
MGM%-#")6<Q5S#G\24!@78!R.@%0()@$<":QR$\7B UD?##>B+''!\O*Q/*-L
M1.>ERL5]5* .F/06#$W?*6$\MUQ+'_'6=I/:C#TLG\><$O'TKW>M_P33'1TM
M3<N[EK(:MT;_N[SY;PQ5U^[Z^8ZABQVH1FJ>;UB/B=,8,0M)2K; $*%@G4E?
M"+581<25,=D$G/YH7>Q -9F "],5IENI7EF8KEZFFW5VH70K$<. YAQ$IF,
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M/4C'<0C(:R]EY:V5A9\*/ZT9/]U+3F[AIX7X:<9H8K'W3"H"07(-C'('RNL
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MO%8RV;E$4M5?O?YNV_X]WK77W;0"Q;*R(*6Y.04EL8T71%,@Q'A@)+%9OKQ
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M]&9.2$I<8[@S#H3'N4.]X:"=R$1D(^>$!FURCY4VKJUNT)JF:&PV@.N2*@J
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M#*ND\P>,A=_:UM?$)Y5TC%7K!MGO4-P*JU,!I@O_.JW[7EB;7@_K0$0?Y]0
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M/"M#YP07!!(/Q+E,D_-."*EV]O2N4INDU9]"[FIQOR7A4U_U6.[H;XYO^[G
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M %&7F>54\PK#C83A3(FGL" SM98D']#%Y5$1)Q4G,0090^GZ1.G.WGP[Y\V
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M4LVSEBZ[E.X OUL*#*_BL$)M0:C-I!Y"$-QG"R0ZCA8%2$W >TTL1"$,XTH
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MG*+YP_X=&S(T'_YF-!P,H5MD5L/<2R2RSW-M-9/B67&OB$NYI/,TTIA#0\)
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MKBG4*[[2[)4U1WR+,SV1P"JN\\6[E\^F%[G?O3A+O]M*2'!-*J[U3T#?!9&
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MCA<?G"V-2((@S$I/I-! P =+DC2:BF22#6&)=9=CX"YWV6O9Y7=N '2[?_\
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M/5D*(9.\+%0>,5ZF95SH)(RBA%4A+X3A>^&![^TCW]OT^9[,%-=1F 994>B
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MTY<Q#EXNYM+QI@/[N0/[.=D*6 FADB3419"418X.#!V4LDJ#/!,)5URP.$J
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MA,+)X">TA_H#XG/U)T1"P&"!$UR$7M%J*N"8BV73-JS\@7X%C,]N;0L3T2$
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M]1J@6R DTF\19W/I7F(@B8D15<O%A1N1P*OX#"0/-OV&@383M:"6O(@'93N
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MX4D@"JX"G>HP!J4H@C^WFE@G15944DLN<SB4O$B%X"R.LXKE8"LF^^SH<O1
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MO,G?*K=]'@>^ XD[$*,6SG)A\3$[PG PA/WY!?Q\;5BU%RM;+'1$/,+<7]?
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M'"JNP%RIA+,/[&4+[^>R'6P$TKY>O?GSPVD<5T499ECH*]$PR%0@$.<EXHF
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M_D' D9; GD=\ 7NC7/T+CF9U_@P6^@R;GAS*$GSQ)SOE1:A#!1I6#GL9L$0
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MH__8:M(*NUS(C5=8.J'BAFX")=8BW>.NXKQ:VG?Z[.=IZHWQ!(^>\E:_"<K
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M&WQ!EL/4B0L;%,,Q[:2/GQW[2=<=@6FWF4[/[ZS;!%BI76$+9^FRS="4Q,P
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M+W.E:PBJNJHP^N!B0HZW6;7$YB*0TH!0&W)9VRH=2EXP7'9J,VEP)#)'ZGY
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MD+T%S<Y82B-)@0=%--=2$A-X9(J8M 7A?!W9?S?9+WM8I!!<R""0S,X5K@$
M''8>B>1$2-[+E'Q']H^![*/&0-_86A8(#U@[)1,C@02CB6',WC_9=X+^+07]
M%;^$58ID!3_JZ!"WT2,7X7RU82X&ZC259 LE_4>7&583TW?Y)*[K,-YM\-(!
M2Q*R.\)$SH*&^RRDP\QQ1SS#H@.OW0:O/U8<$S8E@PU3R$@M$(\&(QTE1TK8
MR+FFU#E;PG:QY%OD4MUTSGU'^D)):BVU<-Z*8V,UYIR X&(MP<%U[LB'0?6U
MNA*\3E0DN.*<2<2) F%%V80B=9+SF*M_D@<<YMJ1_8SC)\,$CT(P9WG4\#\3
MDC#&<R,,M:8C^UTF^R7CI *-Q&!!4-+:(JXLL'T6!$J*2Q% B8G.=&3_&,B>
M4RJT=98DICGWRB3,)!!\"D#@/-U3]&1'WC<B[V7?@]5. IK#599>9-]#0@[#
M3TYQ[44D"23[O4.Y3:&1'65OW/Z8-/$IV&"XYC9)E^,,$IP^H9IPL069MQU#
M_VZ*7TGLP%Q&Z2F*EN=B*-XA[:A&1$L<9(Z0EZICZ(^![&7$@BHIDHN"2P7J
MNR5*PU\X4[FHR/V3?6>YNZ4PO^QV $6=$R!SQ ./B+NDD-9$(9PD*&]2Q<0J
MTQUAVU0\Y+%E0P#Y]/K#S['J= 4_>J"7+B_B0B0S02>EI5)!&LZ,UB#!!"&$
M9,#/;+H^DC7=@>  7K;[_[)L?P<^-P*?]RMN ZTH9@%T"ZI$0MP;CVS*Y8L"
M-5H*G:A/>X="RRWR=W:Q#ANW(ECLB134XAS$S*E-A# ,_R3ED[]!9..EI-KI
M#ILEX5IWX D[$R5!5CL/XH-E2*MHD0"]T6DB4E*N"UEZ#&1,&29"@YY@HN*4
M"Z,\,]8KHW3 '%\_4K'CN!LDUV7;O?#"&6>0B KGRC0):1#P$6&1 *DRYI/9
M.R2JH]0'3*DJ8<&Q YP.C-L8-:&62TP3HPXG=WVS?4>IFZ/493.\MSA2$@B*
M3@.E,H:1D5PB0IVGU,FDF0?9V'2R\4,F59"'>7#2,Y)_B-01[J34'-1:3[5E
MG6R\122\;%<G6$@@Q8 <MP9Q8C"RE IDO4V1 QNV5'2R\:,@X^_I3GTK,N[L
MY+<4G)?MY"'EL&8!K-CFVAM&)>2"L<A1G[M< T\."23G?6+,%I'R8XO.O[S9
M8N?@4THHZ8F7PFCN/7,",\$]XP(3:D(7FK_CP.57;>P^J4"20#0'Y'-&"<I9
M94C &1M!DQ*.@AZQ+]BM-8G.M;_%E.^\8"H8D[B,/$:L3?*8!*\TATNA[RDR
MOR/N[R/N)F%8!DF#DDASG1#'CB(CX5>&F>>$ZQAXR,Y[W)'V R9MG&M !69R
M;3A>XO6299)+'8C626Q!C8".J=^2[I?K@SCB0("3"'O,L]=-(&.90T8PCI/F
MR6BS=TCWI=BFF)V.\C<>KY=HPC[B:!CA1+I\_L&GP*2D/ ;<,?4=(.Z5 'Q#
M@[:>(,U$1%Q)AK34'.%@B(S,*HV!J8M;^^@ZRM[F1@O,Z=ROSV -$!^TT4$Q
M*0*V0B60W*\3@7^7C18Z&K\1C2^[!AP<HF#6(Y9D%MSA%$T0! 6AE/28,JUQ
M[MFWFF6SRXT4'CI]W\0C("S\7[ F*<JE9X[E0&RA&:=*JD0[F7W727[%@^ #
MIEB*A#"A*??IY+GQ /R4A"#"94,,W3O4^YIO$VO?9* ]H0=TZUT([T93.[BI
MK\:-QB&.T71T^C0O=C(:]$.OF>R#[@]SXPUX.!B^\1R#&K,G'1!O#HB/5CPB
M<(&HI8F@:+C,Y=0-,@I;%$,46'*.?<YXTG2?;"SQX-K4<<\A&QW,=3!W]_D9
M'<S=*<S5*B:S*H%"(1"6%J-<B <YRES.\R0<2Z:H*RHFV\?TUE;B#N<ZG-MU
MG-MX DN'<W>"<^?+&6B61N88TE9Z0#=BD5;<@FZ=7,#)!BDBX!S&^P1OJG!N
MAW,=SFW7RN\S_6>&<QV4W0C*ECU_VAO.F.=(8\=1;@4 /\F$L, X\LB#%W+O
M4%'2P5@'8P\2QF[B(=U ;M22A[03W.X2[99]H%HS'HQ32-I2>4@'9)P!!56)
M2$5R*0E:^LD;RF[A!NVPKL.ZK<2Z^\P?ZQ#N3E33E9XND4O0/Q4R.N8P#ZV1
MLR(@2XC4VE$<5=@[I(;N$[(S0EWM$6XFTMSI"L8V'2ERC3'F%LQ@26%TY@9Q
M9<6W>4,WRVZ6W2RG2P"P^"IRPRSOK1=,?CNVP!G]>>]M''_N>Q@Y]"?3<=^=
M%6[MC^UP& =/+TPVW43F?#?&PQIC0^G8UR:<T/_<C%T/@?+S3V5)Y;YWRAK&
MZ9?1^%-#0AN=C#P@ZAJS^?ET-.EG@GXZC@,[[7^./V<H1.R T=/5C;63F$?8
M.^P](3,5%+;Y_@#\QHKD=0-LMP^2KZ\KKEOCPU$')<',6.EY8H83KW2*%DMC
MC,Z!Q(9WZN 6J(,O*F/7O#H(=Y)K;S$RQ%'$K8I(YR0 0650V%#B,-X[-&1?
MW;[%YQ9'_W=C/*PQ-A0BON-2S2O;'X!6, )5H;>+$LT3>AN!YD=*WUT],9*2
M%5IA(H';.Z$T=\QJ88B1RBG>A2IMA0!POB( B$A)-":AQ(1"G!&%K-<&I "N
MB&>$XT3W#B7>%[?/ 5H/LEM1$+ ;XV&-T569VQ91K$NR78ATPT)0QK4"8,VA
M!C99#=S18TFHL/+FU7.[2+?OXX3?5CBA$0$$%B^1LBPA+BU!U@F&1%(.&*%E
M I.'7KFJ&^-AC=&E2F^-1-(%4G6!5%TNXZZ*"WA%7*#"BY (1D9[4)P=2<BH
MY)$1A'$0%JSGY+$F,W9C/- QMBW0;EO&V(W JFZ,'1KC1[NP[EA.4FOE))!H
M\+9*Z]T8W1B[8*/>%@J_R ?]<33N'8U&8?*721.VFA^;?%^<ZBY =S=&-\:/
MLLKM@G.JB:Z]C:/XH9J\'JA5B_@0-+>44)IXY-H%%0VW5EC!6?)5>B!NK%KX
M'HK)=ETEO]<6QF>V,/C\X^_X PO"44\M,I8SQ)UAR*3H4/2.D4AC%,$^X+:2
M'8X]6!RC7(?D/4E)6$ZULI1:(CEEWCJ7ZG86]XICG6%_4V#6M-4DQ.+$).*:
MY(;TC"*-F4,8!T]U<E1BNG=(.-DGY &VNN[ [.&"&0G!)FJM- IDL>"(DSPI
MIZR@0D7;@=GN@]FKI7(/60;'W".J&<EMN2*R41!$O!;11 [L+0<UX7VB.BSK
ML&QWL,PZ \ EA<WJI4G)!H&YE-@DJ;35Z?ZQK%,P;P%C?A'&$LZM2!)&U$80
MS(*62(M<HLM[' ,.AN;F1)V"V>'85BSN1C4#4U1.4RET-I"Q!*"FB>$N9TUK
M;MTU@.PNNZIUTMDF8>W34O9U,"02K$ Z(P!F/("J:;A!DE-O0#*7VH%TQO$^
MQANH-]@!6@=H=R^8>:6EUXII9B-GQCA&M U&DN@]Z)GT_@6S#L9N;3%K"TF\
M>??^V^O?/QBO@'=9T#"-9P!DFB!-B$,!$Z6I<20:L7=(%-FGVFR1?/;8T@2!
M:(;3WMOI:!POC+[HDO1"5-%Y98*QH&0DIS5WTB@:DM  ;_K^(:S3+;\7O<2*
M\U+E1 L)8&5#[ER?HD Z!(.H8HDR0XC*@?P;TBVW./>OHWL54G+$&F*=Y\HF
M2YC R<L0:';[=73_,.B^,8T+:J*U'&FK-,@LWB$7HH9KR#QEC$<07#JZ?Q1T
M;QE3,0E+A.0Q<@/PGQ1GB5.9C#?W3_>=RG);XE_VBSDA!$\&26^S&5E@9).6
MR'("%X$QF; #A<7L2_&0Z]YUM.\)=CSW1V9"\Z LW((D<\L]8/S.$'[_M-_Q
M_%N0_9(?"8[1> I,'F@_MW4!,5]CDD $2!(^P(H)WO'\QT#W(5<V,TD'GW_2
MS D<O31!>>>E"%L0"]/1_2WH?LG1 H>L'6AP2$AK<F,G@K2("BG0]B7'5!!-
M.[I_#'2/O?1.,"FL\3RD:+"DL' :F)7*I"W@]YVL?VM%?\4]$1WG/%&D0RYR
M&;A&)@B++.CX06-'9>YBN772_J/+$ZO)Z;M<$]?U'.\V?(%^FF104A@EN37,
M<"9QH%%%RTTBH8.OW8:OEU]6_!-6*^)<I"AP@"S.0'&!DX[(<^7A*KCHM=H[
ME&:?X4TU;-NB2)&.]EO:=YI+0S&35EK.8K0LIF!9\I%9$\T6T'ZGLFR [)OZ
M8C12N,\,&9MRHT:5D$O)(VQI,@H++?#F5):.[K>8[H-4UJI(#9PY9UXXFO.J
M@>F;)'R47:C[;M/]DF?"!<&,40H1)CWBN32_2T(CGAPV06F=;.CH_C'0/4_$
M66R(#UIRQJ.C0GLK<A'0R$#TOQ^Z[^C[AO2]Y(+ -!#,$T..\2S.ZX0L _K&
M.%NE&-5$2A#G5^.].])^.*3M&0G)YAX -'+"N::>4R*-9,%0P;OR*+M-\DO>
M!T,MLQI[E**DV?O@@>0Q18)HYIT@P-H?<GF4CNYGD4;212*=-TE2;IQQ-!>*
M9DI(08W$Y/[IOC/?W5J/7_8^$,8PTQ18/&4&<>V!XRN-@>,G8KES3LA4&? D
MWR+J?VRY$4! O?[P<YQ,3^(P_^B!8KHLB0NQ3+#@1!0.9]\:5\9JJY4P ;15
M2M@-LB2:Q@5P "_;_7]9MK^#GYO!S]?5[ 9G./6"(69M0#P)B[1G&D41?4Q1
M86[BWB'7M]8WNJB'+:;5($G$EF*9M..",R-!'A62.&<Y"3>HEG$IK7;ZPX9I
MN-8?M*-P%IHCK2WH#S$0Y!RE*$H="1441])E*CP*.K9:<$\\)Q0;+I/43AKO
MB'&>2ASY=8I%='3\X^AXR;2/-57168V8CA9QZR,"D2D@RG+9(NLR,^[H^#'0
ML8J2,(X35U1S8Z@FU#$E'>%" V%?WY7?R<Z;I-<E4[V3@*VY6IZ-6B,N+$$&
M)XR4XDIIS634<N^0D6V*&>QH=>.V>N]9$-0K;('#QFA=XD9$' 037N/KV^H[
MGOLC:'C)]BX<H1(8*](R&]\4D\A1D1 +,CM:G(YI<Y7C.CK>8CI6'ANX"!BT
M)<&#$,:PI' V5GGX[089/QW/W:BNNV(N)YXEG%L(Z !<UT:"-#,1Y282G@8"
M8K+;.U1&;Q&U/K9(_3?3XSCNPO0OQ)J8%;TD' B(@=. =1 .8T>U!6G?N:YM
MP*X#U_F*H1T;S9VF<-%5!$$C1HT,]1KAB&T"(80%#<J]V)>W-[5W+OXM)GU!
MA21>9D&#<(:I9<$%["G3047![ZG^84?=WTG=M1JA-/$VYOJL-N2H/= EC(\8
M82FB3B*9P/3>H=Y8I^^.MK>1MBV).#&:9&"!&ZV=UX(QH@.ECK*T!1DX'5N_
M+>$OV>R!O+77CB'EE,B5305  '&("&N#L)@SG@L%[3.I.M)_P*3ON13P)>^=
M95Q;9E-@W#/-8(J24=^Q]9V@[N6^$LGX$!-'BD>"N,0@M#OXB4E/C>))$),+
ML-_:U-"1]C:W8,"4F\2)-CQI3JQT*M@4A7?.:L;5=2+9[K(%0T?D-R3R)1=
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M7;\_"NIJOW SD>965T"VZ8B1:XPQMV &2PJC,S>(*RN^S1NZ67:S[&8Y70*
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M'M"GWG]-MFT-)@TFS22FSEAC</T GC1ULS*V=J[ U@L&>W>YV3AU ^J2U S
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MZJ6CCB'.&$?@0!BDF:8HT$B-5SCQS*BF?T85T?C\Y_4ZE6MQMFN:>NIC<"K
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M=?/\.-!O5>_H4:=J'ET_:/G:;70NZK&\;_*U;G]2W>*Z:J]%%Z<:N%&3/&<
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M1<PLQM8A2;Q&W.7R+RX#HM@E ?XG[ 65,\?URHY:5R=Q!7M;A3 %>U="?_S
MX%LRTVZ'KW,A7>PI-212)#/(\N XLBDHE.-Y3!$;)9. K[?A/RZX6G#U>>)J
M"V"UY C>#ZPN$E$3)GA@"06MJ^9X#-F(';*2^N@3V*N9AXV2=:)OS43=&H2M
M O;_&N?]-XT KSZF?HT(-OWE"/;^3?[G8JP;_IF^8S.7*&/U"Z*G -[M9]+K
M%RC_9=60I*\Q)V#ID7_>R:G"=9[^VX59T1NRFH6]PSB,G>]VU+E)@;CF5'CC
M59"!DQ1-HLQA0[P4EI&F0)S\'"U_$F'M]0;?;=_GWU\.8^B.L_'YT_0"_$A!
M\_-_#[$_^JMO_S83 $!XWOO#;?C6SIO/7[9?O?NQ_>6KV/T;QK/W]<?GO;??
MM]_\V=U^\_[POZ?; )0')[M[6VP;QK^SM[V/HY+<*?#8DQ6(:^*1YAHC;$5P
M+%!OK7\0_5A6_(Y67"MMM34)::QHSHE7N1FL $>"),\LT4&KM<W^8$'7+?RA
M8Z>KD.>]$W\<1P]^8,=7"]+IP8H (@VCS]HL=&#?V.DR(O@"&L&:+)REVG'G
M5?3QR,5AK5P96>]DD.C (_+6V7B$8$[;!N9O^]_B:'P$\](9=D=?1YE,8."[
MV8WO?.^.#SOCP]AY.3B"T9Y4:4+JMU&UP,-NA/5&P^J3Q\-!F/CQJ',0^W$(
MN^$$#)E.?S#N=.&;?KST+H 6E3U3W6$ =P2=WS^ ;3*:],:CC7K1MR[;!>L+
M&Z8:KNTDVQUVOMG>)'8&J?,_-]%1(1IBL 9PLCPDH9G35&)&C&<T1GE='54L
M^MM!U6NV??IVGWN5@L4$L2 =XC88I)T4R!JC8!T<5\ZM;6JYF*;: ='IP0_K
MG8,<B8(EGX:B.MX>=W/BQH'M]D=MV1_E%&.EFV?G=&L_$=!LN3.84!XC+@CX
M<N#6@5W#F2 ZTAC8VN:2MLC3O=.Q_7#Y]FDTVB/;/U?DW);],[M__'X,0@J*
M.>*&><0Q$\@$39"BT@1)>:"6+RO_O;!]+K-@\%WH+DND\MJ)Y"*7+AH:DL0*
M!T]L9-25:-0];1^^\V5KGTF3 C4*20P*C$LPE)P'((J6"Z>-Y4EA@!^RR/)R
M9[KKCO9'T5TKW3R[>P?[1*3$$Y@[,>$$NLO"YB%)($QS>TO0'33"YB%L,>_W
M OH\HLUQLV*0Y^>[P[U>?=PG8"CPZ!VBBD3$'75(P[H@P[7S'*Z :;/47_^I
M'?,]!_2Z?=^;9/>\V^^,EV4WKW?<!'Z?'!\/AN/+?<"-SLM#VS^ V\*-^G%\
M.83]HW[\/W-  !S$4;S@_L.0L@,YC*E71Q/@=O9\"W4&%?>=!Z=R& ]C?]3]
M5KW#X"C.!0::Z=B9',& ??U[WO[=_L36\8RSB/?F_^N&_]I<B"M<>7'JQ#>N
M-L_!ZL5(]O=N&!].#YEFOM6$_O'Y5ZP#KW@ROOPK,P%^#WY['-[_65D5S"#4
MS$WTS+^'P_-@3&ZW %O@*[()1OO"]K[;D]':ORZ\U%&WCV9G</[E+U^"^M^Y
M-:T1@O+$5!(^4">YX4H'2JPDW@E.M0RJAD'X3@Q;&6] 8PMEN8E&! X6NO54
M$,&]4 PL/F//XI_-7II#T01Z7<L(CPOP-&T,? L;(J6AD3NU_RJ;]QC^%YW;
M^1<!]#P:,WK9LZ-1-W5C^/WD)3PF"_/$]K;M.$O(R2N0@;T,M7OP_-][ __U
MV:&B/X6Q[V/);0(W"E#1YG2SA)$60H*GQZ*@1EH9Z5HG@NXXSK(SG,0'*ANI
M9&;O,';L- T<ML]H7.GJBW;_]2.A&21'AX/O_8Z+O<'WCCNIMF2S5SI'S69I
M8FE-1.W"M7S_(WO2"=V4 $[3<'"T[!;Y8RYZ.[D(TOF;+N:0'4PL?&$8PSJ
M?*^7\7F823R.;1?^!#_/1  !IL>Q'T:@9N!FO1XX/LT]3^ KW?SAP?G8+P7<
M(SL\ -3(9X2B"NA6IYCGP%J=G,+"]NSQ*+Z8_O#;M(ZDVZ^6I_K2;\V]&C1>
M<MY8@6Y]^1R;-G"-3TW!4_/DYO)&=6GN)+B^IOB&H>S2RWB#7'KMJML2O"&,
M^*7;7GV-:7XW@]77NNU/BLI^M79LI?)OIN)?W?!%MG*Z_@(@J&5%6]580SX8
MJ=36BTD?-FU]KOVV/S7GKT-\<\4DU$;"/4_#%2^]UB1+G)7#5$H]U\3<X#TO
MK?1]I%/R1]8 U43\E=7 A9FX[Z+*ATB\>@6J;XKZ\<4U-L+/<FJN3IFYQO;Y
M=?J\50WR,:S;DKRG5;*6J0W5=M*R?T?PK<?@\H(;&SLGT0YO4WC]U!)(E[WB
MDTD!O6U2T\]+1J?N7DYS\3GLL=4/'V BSZ]D1_#O[OBPV]_MQT^P^YYEE:G8
MW@N]G=-M^GG/?_]T^A%_WON*/^V]9MM?MLGGHW>G.W__V?M$WYULOYS/&_WZ
M8X=^9-NGG^'[OW_9V7O?V]T#%W3/GVR?_G7T^=4V^73TUY?/K]Y^_^_IVVDJ
M_GA[[RO=!O=3*&HUT0(ER1SBW%BD%99(6!5]L)&()'*U$[U]!]#VT:L48"O
M=HO3Q.VSV,(% ,NF<&4$%^1:*7*=7$2NH(1R3&9"**$1-XXB*XU$"7MAG0E!
MD*I.DY);9[NWCV#FL1B7NXU)"08FO-7!82?E8X[\E\N# L^>O;LM9ME6/NZ
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MR 07D.;)ZR2]]0(,%K(NGV)1_'-%A$63Y=? X.YS>:XC^L6TN:;HSQT&*F_
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MN2&F$+16 2HY;$N]!H++ D2NV>5L=;)F:]OW>NX=VUV>MR$4,)#GD8TF&.E
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MY)V!K%NB"&IY]G4,K79BH9 D2NW[ 8E[P 3)QNA2E2F4B#7K4+S5G@2&H*)
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M_/-T-([F=+CIJ11OB)EV5KP*ES.'-D%#HM(.-AB"8(P'X5"3%;IF1[UJTSW
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M/ZJJ2089DG*NM@R>M54>SR:4@$6B,K5C>#P8'JRP6X[]2[06!$4"+%6#3ZE
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M9!QJ%)802W A\G^2T5XJ[X0KC=]D..4W&3J_W0:_/1UNV*"0'D4%DZ4 ##I
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MM:JTHJ9&?1^:ZJE1 D-V.A>F. ]DZXG,?#:9(1BN+$<-R#>V_"9P-R"26J^
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M@*$%0ZTSLSG+:D0$%B4&AM$*G9744'(3U \ TH".Y+-0PH $KI0+1AH9P*J
MM6U7$]3#QG7/.1 L9!MY848;RT"$P@*I88R3M"9+2D*(>7B"^J'E"/R"LW'&
MP^-QV!\=3*;'K\-K9/4I,;>$@1N=/S8I9)M4U,14201'NFDDP@K>)*VQZ2'#
MY*N/2PX#[KPR$H$)HPJ#D!/AP!<6C?*00,>44TL8> "03EK&*'(JJGA0%F.V
M)G.+/%<?0@HMM/C=H=O/"7":@Q= NH4(K.9M,6>R90XSQQ)=]D%N;%F^AN67
M&VS/\GR\11ME4I#I?Q:]YZG$6 "RS@9;ZMYPX=SW"$ 0.BC+=!+(@%<7GTR!
M996$TBHX^JM)XH< :=0EF>B<#@:*=B&;XHPI)1&7@]9-$G]WZ/:,?LUUMMH
M4]X1=*VV+$2AF8LUWU9$$X<GB1]:/L!/DX,#G*8[L/@?A)L20Y&\A*",BP#
M7; .O>)1>S+YTQV?*FYZQI>2%5].$2!K 9-/3,FL&,C,62!#GQE$1]L$P.#J
MC@BTR,-P(>T]*9DJ9%1*UQ)T7JFD#"=MTX>H?"L4,'!<]]P!Q5A7/;),8Y0,
M4#L6:R-QGM&2%E(BE[BQ)38YF(;J]46U=%EE+X-.I?8%(<O!H7 E"P?%VZ*:
MH!XLH/M%!KT6M9YK/61,@MJ001')("1\BRQ)=BM886>0!NGA0CJ@BZBM!#(S
M:4/X6JN+9Z-EM%@BWG&TK0GJK\5USUM@E" =2PKF4''"M9',A6(9Y\4J6S+A
M.@Q/4#^T%('GQWLX'879#(];9L MTIFDM\'IZ(01H!+&2'LZT7X'%2PO+3-@
MH#0EEOP$'GRV7%@6D1L&-5<QA%I5T(N,T8N@I6_QB(< :5\<03HA\ (IEPC&
M9_I1$@]*P!V7+6_JQ]?BNN<GT*"SK;6+4L"*:V.95\DP8W0RZ*,.TG4UCKEJ
MJ%Y?5!>%,I>D@@  AT!T'SF:%"1Z(W7S$PP7T#T_ :TBSU!S]D!J!E8XYIUW
M+'H,5AD5BH<FJ!\ I+/FPL<D229KL,9'(#-381$B0S:MU]?0<=WS$V2!D:<8
M&<GD0H(Z(G,J)!90UE"-D3R5X0GJAY97\ MFQ(.*EM'1% M.IRVCX(85RHIV
M*2HA' DNR[WTI=8<S. *SZ%E% R4J.1R4T*12>"4R+23-?TI"N:*D\P$8Z0H
MGOZ5+5#Q "#MM<D6"M1#;L"ECR99FZ+P-GO0\@Z2D1MT;PG=GC- >LD##YI9
MCL! 1L-B"9P)FX15(:9H/>D87UW(J*%VN*A59",*94(FG@9M'6T M-G$""8F
MVA\-M=\=M3V+W]7VD:$8QE7T#+R7S,F S-LDBQ,H+&)K+;#6H.488R2%BK1F
M Y$;AUE(KXO,,O-0[D![;J"])6A[YCPX]%9H8%'(KK>@JHU\#-/66*F*,C$H
M$K5??49@>#'_0=OONY/CL$\0B<<KBN_'R33CE!U/CA[7>9]-]L=YM'B.]28E
MDY(('*4%9T@^@>-%<IY40".2"RU2.&3&4E?4!@@F:^\9^MI24 A/W 6%)ECS
MZ)-"K(E*<E-9OB('Y(VQ<X]B#@^8#W0BO20XLBIK7=%@HM:)"VN#UFBM;WPP
M<#[H.0LXIAQ0*(;6* 9.<Q:YS,QD2_9C]#5]D<P.MVG-JBH?-T)8*T((1COD
M5OC"#9FM$)25N@2'-F4=7+-:OC_F^U4)I XZAWJ6F0L&7-=DY>B9DTG8;&R*
M%C:V=,-[P_L5>!?" $_<2%0:E*T-B5W,6=?S"\%+UQ2 89-!SX7A4S% Z\6\
M<(X!*F!!>F ^I1AM*DC6'AD$8I/>OB^$L*)\A4'[.)[^]V1\_*%E)7Q#%\9\
MRL^9Z>=W.^-&0+<C(%CR2!CT0F!)3')/%@BOV5 F>58\5R*IF()*9(&T3NAK
MC-!5.16N1FC+$5H1<ON)!KF0!>$+ U>C'R%FYJ-TC#0%;S!%@=ZT'*$' -]5
MN0":@%T)3'OFOG=)H>:<E5+/)B=OF0_&, \Y*6V2R,%N;*FO]O<WA X7H:LR
MVAM"5X+0G@W.=7$J%,FB*Y&!03*_>2FL&#3<()<8RL86#$D%?C!I!%_HW)@/
M_+&BZ<V3DWJ28#'>KW,=#FZ2_N<[3M#:T//*DBQJ:8O9SV$\_3WLG^"3\2SM
M3V8G4VQ.U!42N%[R80B>E2U"LU2,8R!R8DX",)%DL1@+ZEKGV6R27KQ:'^H*
M4/2=HRZ-3QN?#M:?U/CT&_%IOS6FDA%+]HSG&J$./+ H4F9>\XC9YJ2EV=B2
M<M.H59V3;83:"+41ZITG^5Q/J(TS;\F9/3<?YR%Z;R6SKK8.@J28%^"9KRVB
M RAG(6YLN15G]32^;'S9^/+NDJ2: OIMR+3OD84L74'#',^FMGRM"5'*,J4*
M)I.-$;+6:?&;W/FU(=3.I_OWXYJ3M]4]5-W2X\.3T#W5__E['K^[ZO7NY?FS
MQNG?M\Z>NWN=?BR>_!1+4*N_'$UFX_KMQU/<I\N\PQ_>C_/QW@)H%[YU.A_\
M_"LATJ.?'%__E0M/G9! .?WV?"'KF(0RER?CXL^]Z6(X1UW;FBF&MRP4&NWC
ML/\^?)AM_/W20QV,#]G%&>P__/5+,/_96[8Y+P@IK(H@7-18BQ'%[(E"(FIC
MN)>8YJQ&W\'\XW'7Q@HX2J5,")%H33I%Q":3+26C=<&?<>3.R0'-6>H5G2P!
MBC.8LLS@P7FO(',OC*%[0;2OGA I"D[_9?67.3M>YL,S)IP3XS:&2H;Y^>$O
M-20U)03\(\S&L]\.)Y$6[5W=RL\.CTYH #22--X?=P^_2T/ZQ_XDO;VG]/CG
M?_9X.OC],/SA3YZ_R6^>_[&MGC]Y\>'//W;VM]_\\F;[S3,:WPNB,B*Y-Z_5
M\]T78F=W;^\_'Y^^W]G=AE>)EV2#3$RH$!ED[YA3)K+DBP977$+I^FL/6M"G
ML]?)!T =G?8Z:Y]R@!PDAHT1DM0YJOB;GN#%3?FM<;>[AZ.T%PY?TR7'AZ-C
M^C.&_7"8Z.])&?T+W^'^2(W*^)!>J\VCNHK0LU$^J1NH^_P'#-,1'F;,HR>8
M\"#B=,[J2FR.ZN8<O<<ITA=)#._O3][/'E]+>P=A^IJP6VE;=XIG1[#G]-:1
M.DW-?CB:X>/%+S_D\>QH/WQX/#[L'K#[T@^GUSKEQ$H#/4+OJ&_^]CE#/.)S
MEC@-UYW>^?3M1]U;/2$U?T_R1\:I:]_FC\2U[WWJLH(_ O!?=-E/OT=DM/+!
M^D<@31MK&VL;ZUV,5=WLJI_)-AA$4H%?R*;N@H_'QW2S=$E:V2NLROE82>F:
M3#O5Y#$9!CBMG]K8>G8XH@'LTZO7)_??:!+F6O WGH9///3&UJ_'X1AGFZ-.
M73T@0SJ-CVA4W3F&^M)<V(;#/#J:U)=IU///SDXBR=;Q[):3<FUFV#V=O]\>
M_?JHFP_:-T=UZ^!\=CY_&F3]Y^;GR93^/&P3<E7;DVY6YKU/V@0MUWOMYN2L
MYFN;H<NGS=I\7)\:^! 2(O^!9'T>5AOYU)Z^LY.?ZQTJ>4B1$,ZEX=Z!S:&
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M<92Z.*=-R6D%C7Y;:M5PL3[D>.5EK#=K934<T MD:F&$R!H8VL2)"')D,<;
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M[C8 $$V2R4A7P"KG-4JZJ$C>*Z&"&*QFT&!_*]CW8U,Y9H)V<4R*( CV*K,
M/#&%*?FHHQ"FQJ96Y95HV!^B\"]1&C($8K(!010=1"TC9UP063GTT(3_FK%
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MZ9H]LA+>>KGD@ Q)1:E*80:QEE4D!2628L*BEB2@O'/9A!98?0 4,&0'9*.
ME5) SR4A0A9U09G%(AED2:J+(0HPTJE(=HLLJJ5FWEL*^,:IF7?- 0WKM\)Z
MW_VHM?.J.,6*SF2FB)R9TRXSE0"\RXE4 =C8DLL'UUJFY5H@?,A>QX;P+T%X
MW^,H,SHEP3/EO65 ZAQS("S3W"F+5A4O<&-KN5IP _A: 'S(WL8&\*\!^%FR
MHX:2"<2L@"*+G10V%D60#,E0<Z%(%$EO;*FOJ3C1LAV_S,GX_[/WK4UM'-O:
M?T5%G0_[5+E)7U;?[%-4.;&3UZ<VL.W@./875U^-L) XDC#!O_Y=/9*X2&"#
M$7@D.JD0T(QF^O8\Z]*KUTKC<:\!2(UW7$U7X_D$5F_#4N@K+#@<@Y'<<,^)
M0XT$]9.HB0>>B!#!69M35J%&/*XL$3QPWLR'88**^-LA?M[G8)R+ A(Q,00"
MCDKB?-EL**9(B$ZXH#>V:G;,%8+YNO@4J[Q?.OKG/8Y)4V>0WDO9CA(!Q2BQ
MGD7B./.R%&=!O:_*^T= !*UV/58B6#H1+#@FDY1"1T-,EIE !"!>9=0*9(+D
MK/2!+F^;L1)!BQ7_5OLHJ^)_9\2?F?HH^@%U/Y*S$"6P@!&G8B!9.4IM+D:
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M^(PZAZ[;'^-_.$SXT$,<H,[H"/4'7+"=@3](H7#V:++&ICE"]@>]F(:CS8F
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M>W,&5'P_*+[G*SP8F;3T@:#2Q8O8UHCOI$ARR>-46Q>#J_A>57S?1O^^-_=
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MBQ J21$@F6RSBT+1:)6T1@+<M$IMW2^XAUQ9)XTH;*S-5VSGX/WI1P"1:/)
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M\X>]M_^\/W@MMP_?=-]_+7D6/_&=P^+V^;VWO?=I4FQ^+GT;,.G &$:$!$6
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M%-H5-POBS^HEG*N(G2F_SG@,S^3G]T7QE$?(66>24R1();E.V"FAM30))NM
MW71')#O;9_U-PXFA#''OJ!JA0*,=8KO_#N5/5D[P,ZZ+(DY(;HVF^O1O_WEB
M68C9NO+%K="3_'L$:(D .K;MX^_1]F)O?3S#7X= T0$B_<_)[F7]8I?N BA\
MPGO?/HN#;U_YX;>O=&\'")K^=5*__"X.?YWR#)^>9)!A]<M/[(!^$/73S^)P
MIWERN'_2/-P_X/737TX/OWVXW-MO?@>BQ[NG[X]PS,7<?4*)>X,XD189)S@"
M9$^"8Y*<MC.>8:>XT4%3"M\T,FA%E--:>\DY""9RVC/\)+NZ=Q:S"ZY]7.WK
M[NG7(\>C",D9@&VK$=>PI0XSCX3$VJKDL7-Q>E]%,BH0F["ACG.-'=?2)RJM
MA6,!_T[O:[G2LX[W>QSQMV/MS9[X>T_;Y"RX3TX*DXM)1,ZT=3&X8&EPG.JH
M#;W-XW__["??XYST0!^8668XH]A9.*?*AA04B\F2C6>, -V_CJZH-8M=JK4Z
MO7ZN:=[H]VK=V+>-)@RJTX4K.:RGE?\N0AAJR?I&L]%O#*]X8+BVT:Z%1J_?
M;;A!L6 >6%?L#K_0Z9YE[W>NF)X:'FXK?."USH@@X;FU5&+N<#";M?[%6>;B
MS8O:>:-_4LMB8,,V:_#05B^/\D[(X,HYY8--0G/FA,%P$F"?N:14PEZ-"Y_W
MX?\^O' O_0J/S](+6=]0[*=&D0_G>R :@G@)XN#!^>[E]R,C@L T&024E!!/
M2B#-M4.$:<:-@$W(6<:KW+A)B)_<NFKG[M@Y95R@N6B=3+H,$W6,:R0]Q18#
MBL9(<CS\?4A>ZW?N)$PJ8(=9PM8$RBGL,-.>V6 TL<HG(ZO]7<;^UB_V]H])
M_?*SJ.]_O<C[RYP1/G"+A/(,P1YPI'41"PPZ"S4"^*>_IQC/(W>N@M0';9R/
M(%_+:)&VN3\:M1P9 $.0=!GA! 06'-7&-KV?,(N R*W:.-NWS5YGQ/M'/#S^
M[Z!QU@+>73#N3J[1.HJT7#'/]D$1:J5C 1/.@K<*^P!"?B"&J)AT!0W+A_X<
M^&L( ]I6%L$! _6.4IP[!0@DH@)]3R4>W#T*VF-WKH*&A:$!GGL$_%K;Z#12
MSN=V31ZV, 6+I#;>1&-<Q'ICFSV696L=N70V /18+C$%P ?-"40THD%,P**B
MRU5L[_LC+7GNW2"0=R9[D+%'+K&$J-#!6 O\W.&[Z?*Q.U?1Y8,V+BJ'*0<M
M*$H,6I#G$:"54>0$92SB%*)UN0#(O"Q[ >O(LUD3/K5KV5C;+Y(%^[.FA;,3
M"\?%7]1@<" OV'[QI:%U 00#VRY%C:'9P9]D622G=IR?-/Q)F>#1:?M\')M%
M3H4?GL3!4+S(#\G?NGI1\>*:[79M^S@6 DW\X6,,O>)KW=B"-V0I)O;ZC58N
MD5.+\,Q."XBHV4AQ]#PW:#2S$1KVX6.9:=*[ZR6]R=G#$W.5"'AX_P3FG"=D
MO>\,VH4 =3;HGG7RZN1;RD<54SFW#Q\D4&@/9#@82O-B\\JB4PZ[T8;ST0AY
MR29GT(,IQ"EA;FOR9-W@*EG82?+PBZ/C/#QS/*?#P-(5Y^U=%XY$SC.[SH+Y
MOQL3=PUS:/#U+=;U.LU!__9;QIQ*I2'KZ1VN!5V1W )Y8A_&?IYTKQU(QQ&Y
M;K3?002 T;ZSS7-[T=OX:3*MJ=%&XRLX/?G;M^ .V^N]MM0IFVBB*1@?!*'&
M<!I 4F&*&:JL)@3#I[?97N^UI4[;>%, #=5K4&X9#P%&F//;G*06,VIS\-7*
M?0Y 1K\" :Y9>N$S.!LNWQ_!(0F>6(F4\11Q:S"RBDK$F+>6$>MM=C9,.86>
MU3A>9@UF]"VS^'(N8:TW:+5L]V($O!YPOM/.N)\_:<?^$,9]QMV[\F9+!_@M
MR;/OYD],?#$)AI*M),&0P(U"/>BQ=U]CFE>#E;=?GGKL#3%>HT,'$!L7_^9+
MB$1=13YH[0&IH#<L0BFT//$RW#'I(EJ./#2]]75,'[_IZ>=.H_=.?Z68\2J"
M3J^L:6.2Q@/KVKWU2IEOJ1#F8PMRS83E3EIULYKS4J)M'Z;_7%6LV_]ZN?L-
M_G\GG!SN?,"'.Y_IWF^?S_=VWN.]'7^^>_KIO)XKVC5F*M;]V-VOD\/].MZE
M'[_7][]\W]TYX(<[[WE]YS,''8G63]^?[_[VG]9-R=)<\>0LT4C@W***88T,
M5@3!]A&AHV7"Y2)>FY(MN7[[VA>W?/ \WC34O5*<>VSMN0KGGAKG+J;R)A7G
M6-F4^]8#SE$>D#&8HA@",X8+*20K<$X]NLO70B12@5P%<NL"<H\ML%B!W!.#
MW.Y0F-O=^?RC?GIPI+ 3)&=41!#$$1?4@# G/0(97266FPG'7)1S4SV^9_ S
M@MSK-P#.2=H?QQVKA<;^;C6FH)?PU;4P\;R4;G\39;H[J5;0(NHD-.B-"F!6
M&<A/9O,8CX?ZDL>TE[[VRESD->W'_1+8XVSM%&.LTDP)%$P.5F<<@P[ +>+9
MA8Q=5)3QC6VYK#8?:R3F5\2[,D6^(MX5$>^4 N^<QBY$"\H"Z.Y<$XPT$Q@%
M^*$%<T(:O+$M%JRX5A'O2R+>I2NH%?&NAG@G%--,O)A8FT)"#FM03#'#R(J<
M"R@P4SYH92D0+UNG>JS/KWN^%&7B4PX*B#D@N#U419L-ZX:)W%6IM%5J"Z.E
M'U8IJG!J(9R:K7V&K<66R(@T88!342MD?.*@*Z1$ TF 87AQ#6%U<+2 R/"Z
MJ6RE8GU%98^DLFE?G!$F,"41U5+GEIL6V=PNSW+"N(B",0%Z^*+5V2LJ>]GR
M=T5ECZ.R29G[^"ARR9P'-@;[H1#W+)=F<!X9+95BB2GL@9?Q9RCBN<8&_+46
MM/=SQ\S)=+K"Z_,H6_WC@C9?-)PM333W__0FH*ST=%?XM0!^S=8!Y1XX3*(,
M4:<$XC9'[&";<O>XP+"@3FB]L4WHLJJ OI2XQ*40]RNG[*6I Q5E+X.RI^1_
MGCPC D1_PW/O4 <TKHG7B-A<XI<ZJ:D%RB8KI^R*K%\662]-_ZC(>@ED/:YP
M[.Y\.$K<D*BQ1BYFI[K30-:&A4S6-FF>(L9^8ULOR[U>A9X](]'^>=+I]E%1
M560Q/>1U ]32C?W%.N<:215,/0RF#F;T"DF%YS(0I*1QB <FD16,(><2P)<,
M.DHR7OGPN>TBE?5Q53;^BK@>3UQ3HKUA3(3 +'+,D)QF8^ WD8O+L0278A"<
M W%5#K1U(ZZEF_8KXGHT<4T*V)^/!-$XYLPU3F/V3A.)8",HHM1[ZTS,E:N
MN"J+_HL1H_^RW491:6E)QOS7C5%+EZY'RU]!U,,@RL\(U]9;3&*B %',Y1JE
M'#D5&6+>,RT52-?$;&Q+O$ZMNZHPW747U"LZ?32=3D?3VURIF8$HH0)&G)B
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M6#UL3/AP3C\?Q>B%%Y0CKX-#(#TRY*Q-B%BO.$X^2EVVTL0+IEZMM<OE[71
MO%OO:XQ:FISE)D!EC\2)NLM5E8;G;7@R!,&]]N]#:]5%A7@+(=YL=T3B>%3,
M>"25!<33WB$70T26>,Z5 *V+IJH[XNNFW2=IHU+1[N-I=TK) 2F$2FTI4DXG
MD%:219J+@ )6RC'A<>1F\8XJ%>V^)-I]DN8L%>T^FG:G-8T<8XN]2\@Z&1%W
MSB'K&49*ZQ"\I3BIM'B?EJK"PUK0;TE#MZD99]T&7#RSS4?I&:\;UE:J3OPQ
MVH!KHTJ%9@N@V6P'1:*DT030+'IG$1>"(\NY1]YI$:7UWA6%I=8FU;;*87\*
MT;^BLT?3V72M""9!OK,!*8$9XD9I9!S.,>8^L."<90%8*UM[G\:;H[.5BND5
MG3V6SJ:E<PD;8 *5"+8HUX^($FE,-.)>LKQQ0&=V8YO*=:&SM7 "K+5(_B7_
MCCH)#7JQ9GN]V._5.JYOX8M%8&3\X4]L^S@6$GH9$MEQ,.PB"OMQ(9'K$E#X
M I]1*9=W^; J77$UNF*!%7OI:R^^ST"Q-X2)3^T/0Y#XV.E.>N?'[&*5>WY9
M;/F&)CX!F#!5#I$H"3!C$9'S.B%'4L)2:DV\W]@FFU14$O"Z4>G2-<V*2M>%
M2J>4U&BQXS%BQ#"EB$>16Y!SCBS543B@8>I)IE*IJF*AZT:E2]=3*RI=$RJ=
M5'']D=6)6A44,C:!BFM%0EI:@GR*PDL-@I01F4KU^D3(KH66^U+4A(]5X-KZ
M:@_CUKO*I_XP2)MM0R15D-JEB!C7 00/[I&A4B&-O5(:6T)U;D.HJH"85TS/
MSZ)G5/2\%'J>KD.G(E$L4.2998C3D) -CB!MN0M)1!!?Z,8V(ZRBY]=+S\^B
MD53TO QZGE8Y/)4V@=:!HLWT+"Q%5C*,C$@&8Z!CJ7)VC5Y_>EYZG;/AA'<'
M+2 H7_Z=R:#1'A0>J)L^F:\VVBT71^,;DB7/ZLQ9I]<HB@X5Q<L:_\3KREZ9
M9L?N&M8%P]>W6-?K- ?]VV^9J4#S]-!3U&XCG$PNQOC/D^ZU%GL<D>M&^QW9
M!*-]9YOG]J*W\=-DR;5&&XVOX/3D;]^"\N?4GI:PDF@*!H050HT!IN=-9(H9
MJJPF!,.G)4#"/3&\S\81*SV.3LJH;>0A6.VLH %TEIA(\E9OW/(>G@+3WFMJ
M!*@\01AEHU%.4HL9M2Q-OP<HEW .3PV)<>:"-8P(2930+ 7IU16L#T_Q$O2L
M$KG]/[UWN6E6+ %Y/Q/./CSXEV;'?W^A6'SX]PGVK;_:]IL9[)V>-.JM#ZQ^
M^8D=T ^B?OI9'.YD##YI'@*VUD]_.3W\]N%R;[_Y_>_+KQB0^X@Z39F,#@$7
M%" ;48RT- QA9ZP,T286U$8M L<ZR\37'<2-=2F8Z&RSL$ST3F+LWU,TT?9R
M<.S-91*'!1(I?OT%$I78TGCN>GMS/_;%U1P49J['OOGZ@)LYGB6"R-.-+9!N
MKX(%:L#)6@7=P*'VN3Q8#9YS>_/!%UM0KBHG.#[]UQ7@-3-I>E-8S!NN8G?S
MTQ<^!*GX;TT/P5RQ4;7N;-3?W$KD#=-_H757YC(FW3!=M;C.O.;&)*XY%=YX
M%63@)$63*'.@A'@I+".!'WUZ2"6X*8O26_!;=_#A#CSK]+!UN/,='WZKX\-6
MG<&X+NJMPY/=G>.+^G[]$L;!#_^<+K/_Y3N,F^ZV#K_O[7^!<7]I'5QZOGOZ
MZ>*P]0'#^W[ G3#GD^:-!>&,@<.K)1+6$L1C810&%4BIH(6CGE.70,LWFX3.
M%BUX$$^8HHRY&W]4 /+Z ,0;YSQ31@=%N#7"4!T9)H3QA*UV)8 L7!.N I!5
M LB45PD'37GB&*E(.0*X(,AAYY$0)&@5. XX6Z'QIJ*S\6DWB=53IE0RM"T\
MJT!X0_NY-11;IUN63#P>P%*]+>GUUT&WFXMRCZ6%3Y4B'B_370FR;Y@/K4:0
MO7)U#D]BQ8B6QXAFD^8U)8Q@11&U5B#..4-64XNT<HY+[WT(LHB3YK-YAI4@
M6P'(&@JR%8"L%$"FBQR;Y$+  3&M(^(,&^1D3,B$) ,+%FO!"@!ALQ&/K]@^
M?#-M_-YI'Z/"_;& 3/70Q1CAQ6L*Q%JQR+';:?L*-)8-&E]GI [ ^H@QUT@D
MEA!7 B/-#$6.24NQDH2ZG/>A-XF:[5.Y+FGPKY7&5LR5*QI;$8U-!R[SI(D"
M\HH.:\1IHDC[D&5\YHDE+OJ "QI3-_2"?1QGOMGL\5*2EO8[.4!HB4:/N1RY
M;T2AF7LM7I^VLV+9I4+3Y:'I;-4'KYGF$DND(\YJCL+(D(21-8QJ*1G\M(7'
M3]/9R/'G,)3,V;'^#2/.*X>;%8MQ%=PL%6ZFA+?$M;(.>Y1PKF4:?$!.4(L4
MQDY3[DU0MO /,B,J_^#S^0>?RS/X!$'T-T<X3F;T7\4W+G4H<DO,,98;,H7R
M=B&V=4,@O(/1E@'*M:D4F"6RY+5XQELPH_[1S=I9_Z(((H__.VB<Y:R.S1I,
MK#>_=C9OYNK:3?]AXM =UJO7(_0\5L?*65[C>;=305&_Y0-623[+DWR^SRA:
M)B1E$A8H."\13Y$AQY-!/E$K.3&&!)/]24S=(_@L26JHX.,-P<=C=:8*/IX<
M/J84IQ"UM<I'9 4@!V=)(-A,CY2-RF"'I34%?!#\-$;OM4:"]]X/6H,RW37$
MLRZ<P2*A;QGVJA?E'?O7^H@88WNR,[8E%3 L! P?S@M0*&4+L7M:)T?,48.3
M-4C%Z!&W(%TXBQF2E 7&1$HVYHJ@>C9,Y=^KL-]6-/5T?+>BJ6715'V2IIP%
M*&08(Y:H0YQZC+1G 6%L8E!)P G+P5]X-G;TWZN(_7HI'N;;[!?MV%_4>E'Y
MEA^P%J]/<5FQ4+);Y8,M%4E_S$@G%&"44",1]]@ DA*!C" $,>IR%29L&-&%
MWJ*?)B#N\7G_;QUT7CGBK%ADJQ!GZ8@S);L%*32)N;"I$  [@09DA4_(4$>U
M- ([7UA*,"9/X&%>HK:T0@_SDXSR[?KU;L@];5YE3(3H%I:.WQ@O>MT<9UGQ
MDS?6U;W*%:O8RB)LY7)&D-5",N&<1E(R$&2C<<A2)Y#C2AN.&6=8W]B%N7+>
M5?BP%@&/%3XL%1^FQ$X0-JEQBH+$J7ANGR>1EMPAYE1D"4?&N=W89O<$4;\%
M[]SO=XH^K]Y_L"Z2096OMA)DP+,..NH5DX*AR'/DCQ48.8,5"HH*9HF!3VC9
M6'-)PL-;]]"M"V^M*&Q5%%:?ELV%"HQ&I' N]I)_:)D8DH:12'.]%V8+D\]]
M%/;&_'5E1F@:#WU_4#YHY;.K?'9/)+542+I$)"4SLHIATAF/+?(!!!:N2:[?
M&!2BGFD5!/%,%.XZAM?#T%&YZRIWW>H$N ILE@LV4V*;M8 MQBCD?:Z6DW+:
MN1 414MXXIIF&:X0VVYH6E9YZEZ]I^XY<D$+^/E6_!%#S<+0['&\N='+2E)$
MKT=8/''>SC4;V_]JM&L7T79[_WY$'N@*BDDM_1EOP4(ZW6YE63;2EV*YN;G'
MW0)JQ5V5'D;4_;XD[B\CVB[;WP%EDPFV#U/Q[\*@FXFK8O3S,'H^HU6HQ+S6
MP-Z%D1IQ4#*0M=PCZ7B4/E*G<M4'0K?T;*_.];%_OFCJ641.KJCG>:EG2DPV
MQF&.I4-$B(AX= E9@$%0T5GRBF&+O0?J85OL3NIY"X%6DU4\EE5P]D43_L/9
MYKA*7)']BLE>S#)-#[N31$!21YZ9)D%.  J8X"C&U"H90RZ5M(67PC175$CV
M1=/.PYEF13M/2SM3+!/PS&LI0> D@2+NK$'.@\"I.:=,>:T4Q07MS,4RU\:N
MM-;/>%WRQ9R6H44[_58VE^??VD?:7!;L;G*C[VEMV>"LRZ4]R,WAE^+B90NI
MECM#TOH"E/5'[/KQ*%5$*\XX3W^^BQFIDG#C8:LLTC$YQ+7"R"E+D<;*6^JM
MX21N;/,M/N-Q^>__0R3^^3&-T<C+\#[^WY4:G2KX>*C3MH*/9X"/*<&:2V(]
MB0YAJ27B*A)DL8W(&><!_2U6TF;XF*UA]T;AXW5)Q8^RNBV8R/,JD6])@M,=
MYH4*]QZ/>[/9?RX$%QB7R&-&$8=M0XXICE(@WA G)%S<V!9;LU%Q"^+>'0'%
M+PKWEJVZ5N"Q-+&I H]5@\>4T)1T##XRBY1G.340?K-8* 0[A16CR7L3,GC,
M5A-[H^!1"$T_]:UKQJLXIBDS[55PV/;_N.Y/VY-!3W>YPY+E2<OH PW<<&T,
MXP$8L)2&1N[4T4YFP!C^#\WC%[L*%:W;_J +_^[G0>_#ZWYI=OSW%THQAW^?
M8-_ZJVV_F<'>Z4FCWOK ZI>?V '](.JGG\7A3O/D</^D>;A_P.NGOYP>?OMP
MN;??_/[WY5<,<S@2@E"MF42)YH18JP1RBB8DO'5)6ZNE$ANU",!R!NO:[P[B
M/3[,QV_:[['7B_&6GB_5YEUMGC_"@G!N,U!1T.YXRJ5S%#:(\!28MTP3Z68V
M[PEB-6> H^C;L7\2:ZG3;';.L^FV@(Q:;]!JV2X\I%?KP^76<'>+LBO3.4[
M<D/L7N5 Y<*%4QWR>C7;R[?N1!\S4RXQF9'-6CYK[R:1!WZ,5@"&<-QH%^&U
M0X=1.;@A>)?!M[!,37O6B^]&O_P<&KVSIKUXUV@7DRUN^GGXK!*BW]W0!Z0
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M(99(VE/Z $TL4,P,"CKD]L84(P=_(^F#]4ZZY%C,,@0ECPX_J(C[]1+W_?I
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ML"O3MHHGOLODT/!S .F?<+A103A9J*[MP]KTROWK/=V8[TYL&@/6(0P"Y-4
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MW_^UUHO'I3#PY\#UX-L%B^Y,,^UL2=N\@4W/*9#4YA)(2OEIH0@0)GWDGK(
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M[,6-*4G+A;%?!KU<X*$WOG.3N)8:/V) E[';J2!M(4B;K1+ 0;'%7C.$C1(
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M@'36^+B)!#DL! J %U8HPSDAA7N+F$?7F5V(M"K'UP+E%DM2J67J>DPPZEQ
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MCA=0L,BF/U'&3;7IMVSZ_M<'9]-<4WDW]LZBSQR_>;%9L ];.[LUQ;Q6B ?
M4_J=@EO\VFD!8[SX[_^C*5$_]VKU&$!0 "'IK-L) ]_O;0+S6)![A"0I)R1A
M+CF/7EA)+14DPGR2PL+.7;$JGZ_'E.'[4+*_\+';:16,=]0#K'3@_ I<]]?,
M=*LC>LL1I<41A:VD440XG1Q^8)UY4O (D\"D5\QXDDOLS0KT#^-$SGEO9;*!
M8\F#D"Y&GY@.U@$R<>'G+FI4G9[G/SW?CT(PE'L,B*:)!%Z6BY<H2Q'&UG.'
MHY-> , MD:L9"6R,>"D%IUP& <PS"J-#CGRA@N&YJ]]4!^C9#]#IP1$P$4JD
MM8@1 F(1"]EF2R@*GBHJ(N9,I#L/T#2+[*2:BVW@C/VARI5#>[M9SQIJ4$/W
M?MZ?VB_E-WNU7CS.FPQ?L/U:O@(Z7+&[^:X.W-:M70<+-X>GI@&Z9*=\*!S1
MPOI0,%]GF\7W>B<QPK/S"0<NNR";M<%Y%SB(ZSAQ280#E.2<Q9"]AHK)BLV^
ME'/.=W?>'WG8/\D21:![4<2]<$@SPW-C+B9\2"0ILK%-R6QAIX?Q62*T4U0)
MH3R ,K=&R^@YC(&">LF)J/CL"SH^GX]8DC(ZCI%Q.@%,$H.,M!C1)*06,5IB
M-!P?ND1&*TRB1$1/)".<.>LTXR32"'(:_"^)BM&^G!.T_^%(@C@&S)0CICQ#
M7#.%;!;VD^=!2R-5"@%.D)Z--GPPI_VUTSWK=($E_K17<- 5,MFM2>OU< J[
M@U;L-OR8W7[[?USWI^T94_>3.],*^_7^#1IZ[/7AN/;SI!-HZ5=M@89?N,&D
M/ Q.S*37C;:7E^9B,>/@XTM0]QK';?AMVG7WY^#LK!GSGF>B+:D3!@,8\$>W
M<Q:[_8M?;6\ $[KX--KWK^T0N^?=1C]V>U=U]M^VV^_AE%\_WP/*C\9YD;Q
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MS<&C[O9ZX',LQUSYC'/@R\,K *UDD$]=X.2V/!M9%%%\CN-S1Y)?>Y#%R>F
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M[;7E[;V-P18?RIX8#K;TVLH[W;_\H\;</7 'D"3SPDL&CIQ;IPUGR5A![FZ
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M' (!K@A3"OF7 AF4I&L7,6 J>J]X#H( NVA(;5'8J?,,/"?@\4PZ.$#&$CT
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MBDD(=1R8N%M*[G_PPPE647LHYWT*T:#[X:^9RGF"\?4G,*XMOSK?])E[38+
M0 K'(.CJ,593*04Z,.3-A,Y4SJ#JK(5U%Q;(V7H+RLN"N4 FO@0N%:NX-!D4
M>3^SY[QEYQPSN\2CPX;AJ3'<^P+#J["9#'IR63,+,AFBNT'6B9B%I<+)=P%N
MO=;/"*U."OF/!4)QB^E.2WB-R29&+UP0#D2R41)440.&4CSGK9_M8N#SMH8*
MM$:#7;E1^]BNT#W6/Y7\RC?[-::[]KZGZ-[I'OM=3!<">-+*+-<^*: *9[%H
MPD2.6FBAB.#:VE#ASO-N][IXKF[QW.^WR;P7U%J;S!]$7S_6HD11:B$@T=<Z
M$HSV@\6@+*,' F)*(=21MD8O4IO,%K"=<?*\=%H7*)9[<D(=#Z!$H4_Q]#C+
M/*.<VX;4>Y+4C^6?A9/V-)%)KV*=6:L)J28Q2]S5.*_1U^9]BX74%I&=FJ!F
M6@ N!,J<(7D3LU;T/R-\Z1#8".K\L7GKQ-K>^[>CWN7ON[W!*SX<_+[?7]X;
MK:V\IGON[]+G*OJ&G8W!JAB.NJ3:(#-I7UF8##DP")P(:B*JJC5RS0' U5$J
MYJXCP:XF+JB'S*Q]"C&;^T&MF;U'AM8D0>5:8#*"83%$4",]"L$6^J>&ZMD9
M=.2]62L6*"[3HJLS/B:Q&HORMH3: C&K.AP%>2@:A=3.^T90YX+4"8(:K-,F
M>,NBJ<<A-?'' T8FE,.H;>(ZN$5#:HN@3D]0/3K)4XS:D!.20HC2D>]8:L*>
M%+P1U/EC\]:9M1O+[U2?/J'.J%U;7CWO+_^QWQ_M7@[?O[[LTS7VY"KTZC7)
M+BM6 !B>);*D:KOIVG/:AVB9U$;(HEVT4E>">K< ZC*F3PD";2K8;1SU/FAK
MEN^1T76MM MX<-FP(&1MQPZ2'G'%*DLQ.16+@?!!WL4"A69:$'7&?;D4D9\B
M72R9@RXE>&$!$2R(H++ QE'G@M1)CNI$;;JE64:CB:,&Q7Q&Q[B-$9,G87)F
MT9#:@JC3<M2B3!1*0.1: L_>"3"DHHVJ=24QIL91YX_-6Z?6]M^_NUA[__J\
MIK425[WH+U>NNG71OWQ]3M?&UP:KL#9X1]?6<50N)4:#FID(M?&6\RP8!TPF
M[R4O IR(]93?NFGF)JB'S$UX"J&9^T&M9;#.$W<3[#48]#D:RZS3@D$F'NMU
MBDR(C#D*(\CIF-'<A!9C75@@IZ"E3,(5H1((@:$FI M3Z(=+*'FKVEH\($]F
M"'BK",B1N8C(P"O-@E2.Y>"*U=+)E''Q@-Q"L%,WWL*<5$ OL=;F1%U3SUTA
MQA.XYEPU>KL Z+QUZ&U/_K'=OTP7_5'WW:*_W*]A5]6[?$??L:Z&^V^W:8UV
M>^,DUABTS[2M=0B*91"0,T?,BVG:>>2JD#Q #<'>ITKK(;,3GD)HYWYX:Z&=
M1\;7Y/BOI#5MDV4Y$8,%U*K.Q'1D#'7,*H=H5" '$.P"A79:$';&WJA-J;;%
MRT4X2,6[HD4F9T98R:/5,R*Q#:E3(G5R_@%/R2FR92%S0JK*F=4.SPQY]3W0
M*9G]HB&U!6&G+[7RCJ,TOH[6+,6X7+Q/*6J5007=>@LL #9OGUU[.3RO[;.&
ME]NCC>5WND_WVK_<I4]^=[&V_'9O8] #>FY_8]"Q5(U<@K66":@VF/:V)@HD
M)G3!HI*T$&4-PMZ1I7X<?P"M/>QMM5;WP5H+WLP3>)-16/+DK"F!8:S3O:R.
M+/JB603:7&&SBJ7U$?CE@:Q]$#$&ZR)JD%A<($>S<",E"!#&M2CLX@%YLCVL
M4S:F0/"MV04@(;%0P+%D(DJ1'+<>%@_(+0H[-;^-NCA9LD3OP4GP68M:K*!%
M$CSPT/CM_-%YZ_3:C=$6#+O)7K52:V.WO_QFM_]^]8SN:=0;O;H<TO,;^^MG
MO<%VQV\!2LHI,)XC\=M0/',0/3,D#%QI&XK!VBOKNN?ZO>D'#Z*W3R&L<S^H
M-:LX3]Q-3O>BS>+@Z_F%<@Q<#LQY;YBNY<O)U4*\!>PHV>*SLP4R,:(@34 7
M56V3I5VVV0%ZJ=%X)5MKV 4$\@2]C>A09Z49"B1ZF]$R%RK1K=U"2( #!UP\
M(+?P[=1)!L$C.9V*9W)A8K%>J<25"1%522&51F_GC\Y;A]=NO'^S.QP,Z?N'
M9_4>^LL)UE96S_N7;T>]]Z]%?_#[:%SSU34B0 ]9EY"83N )T5!8] 99(K]5
M%L>-J=,/]!WKO'JA]LF"U@/VENR">P&MG5D^,K F^*M04(0G5R^[8AEH"RS:
MHEC6*GM>8I:F3J=]>.%("\XN+%*M$N3&1.M=E@#:.!MX))7IO ,+/+;L@KD@
M=8*@:IE)GSK#HJMM[4BYDL\)E@G,"I%L&H]BT9#:HJ_3TM-L'7D:W,E26WOZ
M$&/JNB4YLIJ@?6M#L #8O'7X[,9@_:POZ9KW5R_ZLG?67Z9/KB5?^^MJ;= 3
MP_=O=_N#]?.UY8Z>@K(Z.)E8!%X8Q*B92U80T!4D+PL1J)HW]&(:=BI;Z/66
MQN;WP5FS>8^,J\GD :NC,?5<0@M!CIL*S$E?BQ\U@%0F2PSDN"W4P/466YUQ
M[FN*:)2R*H0,!<"G(J4@=R6Z2-0'&CN="U(G)VME)S,/B7E,=<!D\"R(S)G*
M.B6>C:--6S2DMN#IM.R4NZ*\+M%XZ<!QY5%'C8X@Z;R/V39V.G]LWCXZEMAI
M[WW-"=@]ZUUNT7?OTKW5W-=UT;_<V^N-AI>T;J/>Z/>NBZM24IILF%-2,TC*
M,V<06:%=-V@#R )3Y+[V#__Z6*#U()+Z% (S]X-;,WV/#*\)DEJ"3,6C8DD3
M4X5L,W,9%/,Q9N\=9EM#J#,P?2V$NK!(U<[*8FR1ABBJ="9$ (0Z@L4(&7EN
M)'4N2)T@J8('*6WR9,5J/SO0AD7-+5.@1<D*O0&U:$AM(=2IA[]:Z;E#J9+B
MP!,/QCOGM%,IIF2]:B1U[MA\=^LLK/Y@Z[QWV:/O')X/]]]L]^DS^ONK=-^K
MLC=X2VOX3O:6B:S*KD#+Z6"54)$EM,! 5+J*0;-@DB&<!^64JR?\UP]'OM_(
M%52+H][2POP^8&N&[Y'!-4%147J92P[,"L]KEBIGM?D1*U*[8@5'#[6%^4*E
MMK4XZHSCJ)@-I.2DRL1,DXU%%NNX=PE N=1.^>>#U,DX*AH?2RI,*T R9$DP
M<B,U\YGVB)Q^:W-<-*2V..JT%%7&X#F**'218(7SQ=1)($*44LN:7:.H\\?F
MK=.P-D;T?9?;.QO+;T8;^SW1I[_[[U_3-0WIFH<P?%\?O1UMK+SM3OD]>"5M
M;7)%YA>"#HRDP#,IHY4EJ.(A=XU<[WC,/V[D"M!BJ-\? GDOJ#6S]\C0FFQR
MA=GJ%!2+"AP#7@0+TCI"B)"Z0-0&_;.7ZAO8:#'47P6IRGBE9.$B>P'2\)"5
MC]$794%KIV=41-60.B52)PEJ".3=<V VU=,.DX$YES+#.IG1:G EY45#:HNA
M3DM0R4X&4\]WD[<@- 9AI44NDBI: (=&4.>/S5NG80U'N[)WF?=[ [K6P>_;
M_>7:@O6/G=Y@];R_3U<U>'=&:W'67^X.^DG=8I \L*SK#!$E,XM91492H+,W
M HJHIR-W/>C_XW2ORT35+8+Z7;-W/ZBUVN%YXFZ"O6I+' 4C.72E-C$6WC':
MU,BRPVP$#R4633;Q^6*EO[4 ZVR!'("TI_&8 \_@ SIMR,4T$FJ77K"J-0%8
M/"!/D-O"4:B<)9,*(@/=G2 :R;1(A&-$%Y-;/""W^.O4\5>TWH SFD?R6+@)
MGLQM!B&*Q*!TFS2P .B\=9#6<)1W-P:KT!N\HOM>O>BO_+FW,:KYK$/1K<-@
M>-9;>7?>6^D&:070R:CB&!H9:Q#6,Z> V*ZRSA/?0@V6L/W"W2T ^[G+U4-F
MO3Z%N,[]P-;LXCR1-UF'Q=&'E'2M[J@IKF02/2?7T%@')8D"6L;%Z_W8 K2S
M!;)'$X. [$(&D)'7^M28R;FQI%LAED9P%P_(DTU<>= N8&:D=V4MJ.3,RXA,
M!O)2K0E%\=;$]1<@N"X9Y,5%F4T E,)CR%9'A<J ][8U<5T =-X^2FLT%,/!
MZ_.-E7>7PT$ZZW?YKG_L]"[I.]Z_V>\-Z'N(!-/]5()KLO*"Z\R$,Z4ZKX)Y
MY2-+03E;7)*Q#BG0+_AT"08/F13[%,(^]X-:LXKSQ-T$O4U9(2<BRW2L_>%X
M*2Q80_16*VY1H<RU 8>;A55L\=N%!;*Q(>:<4ZK>J5$N%F[!^:",Y=R9&27(
M-B#/$LB3R0D2>(+@&)<9&5CG64P>F2J!H PP[D*P:$!N\=MIZ:WB(G%"*T!Q
M8+0AWF--3IZ@6P+JUB5K =!YAQE<ZWIM9?6B)S?H/;6)ZRM:JRW9>_\:>H,$
M&\NO+X;O_QSUWO]9Z2U'Y4&6S)RQ=0JTMN/X;0'IK2[<$4YJ_NQT([AT&\%U
M2U;>O:#6LO(>&5J3/0AT#%%GRP+6_-E0@ 5ER0N4Q?+H'3@',RD;:>'9A46J
M)4"J5$PPZ &=)9>4'%+G<V4_TLTH_Z A=4JD3E!4*S!F <1)I:X%7KF,&V5I
M4WQ(J&WP"X?4&<5?N^^V'<F\,U>=!^2^_$[ZC,1VSMGV3LYX\%N3]^_+^[7!
M5)M:AP0N15:4(7F/G@A<-)XI=":+I)S"TM9\MFM>DC0\>\=TEZ//"V<.96"R
M1!E52$:"?_;RS<Y!.$BXM(?AF'[NA+BSMW.R@\>?5,S7?[5XT=?V%AQ(3438
M9I-!%/1%JLB]2$8')?*=$W>O]N%?=1O^=;4+%RU0-%N$3#9$",'2EBG&;00&
M*9 53L*Q'!QYICI(61LBB.=JH0)%+>([6P0G'V-2=>Z!%1"\]M(A^;MU)@8/
M+MZYM6Q#\ ] \ 2/]K6@%X5@QF!DD"&PH*$P967A1<OH5>XR&=R#!R(L7JCW
M)V'2:R?;>'0O_O 4_'4NP(-,&0L:D-)[K15IGUC;LZCH6W?/.>B9;PQ(TB&K
MD W3L20&M8%#C*6PK!*7:"%FC<]>*KE(_GJ+K,V8Z1LM?=;6NH# 8_2>O"LE
M-?>9%H2WR-I\D#IY^ O>!JTE4XYK-CXJ4H390 A&8066.N5/2;- 2)UE9$W(
M%W+!"<'@\"3L$43BR=*'HYV#M/,A[#TDOA /CS(>L9/##[_553@^W-O)2Q_O
MXM=620\,/J2_CG_[U^'!U@D>[5>UM')T>'S\ZB!W/LQ:I*4(]1*:$S-#E75]
MOHU![HU3EBGD1"XR_? !/4,5$[?*N"3,LY?:/+<P*R_FSI#YB8(43U<-/#2"
MT=3 7-3 !'.!%#AMDF:<6V(N'@R+X V#H+)VR4B9B;D8_5P)][.H@1^=U#8'
MG"Z/>0SN[YSN'[<PQR,?DWSM/+VC)P]I.2XQ_WN\ TT-3:>&K@\R\18XBL*9
M4C8PB)HS^E5@-B!WD+,V*)^]E,(OD /50AV+12@:6A\-K9,'(-&C41G(6="5
M*B R^I5B]%LGBP07%2>TJ@<SAL4+=RP\*<@[QZD&]8Z7PD%>JA'^HR/,2Z4[
M)Z0;H9L_/KD?9?AISV7_]H.C&S=JH.6KS:&MZ5YS?'Q:3V__6;>DCRT0.YUF
M&EZ?-B&5P:A1LV*B8F",8J&0.\.+%L8:GTAVG[VT[GH@]K];5L4O@-Y9!"4:
M>G\8>J\=HW"T(61FE<G$*YQCWBC!G,LYT;9Y9].SEYY?]P+F@MZ'QAD>X@D\
MW;CCK)SZ&GL<7,4>7QWD?X8/.R=A;R+Z>+QZD/9.ZV+^\Y1XU,%)+YR<'G6I
MJBTP.4-=<+TM/ZEQQSG6?HA2,N ^L*AM887^F4AH@K'8G4\(.ZM3U84YGVAZ
M8H'""4U/+):>F. ,*23M-0:F@NLX0V9!A#JURDLHH8X;T\]>&GAN:K?$GT-/
M/(%8Q;_P^/BW&Z,0L_"%YOD9MVQ@WCG^L!<NJBCB][_V1[WR:24'7^GHI0_5
ML2,K<EB6]DC+LWH4W:4(/:T3M1\9'IO.JEYM5#.A,S2AUWM0F5@<=^1V&_3(
MH( EJBTYTUD+DP"%,&1"X;G\1ONVNSO>[>1M<5']8[ER0_6CH'J"&'-?Z_U=
M(N&J.<D*$_,R '/%F>2"<X9G<J"? URO'Y@+JI\"Z_TNR[ACXM3X!GY3M,SY
M\#3NX2??XV'._J(MUO^9X_HLM&9?6+K6-/H,-?KU3DLI$!=+PC+GI6  T3,/
M0C+'T96BLY=8-;IX3II_MKF:,X#4G(](FVYMNO6G#C WW3I;W3J9TH:!3",:
MQKLYZ;Q$%GGQ#%$[JY0*H<Z6U9Z<X >'D1=&MW:,^^\G@;[T4Q/*\:WU3_<)
M/FG\[RKU.P>GG1Q^U<+U"CE0PWT?#H]WZ@M^.\(]>N5?^(^SG7RR_1%67[SK
MZH;YY[>$2/=V>G+S6[ZXK=H3%8]FK1P$OTT[R'I- LQ$S\XO?FX??6YMNX4L
M'F'89:'0U?X6]L["Q?&SOW]U4_L[!^S+%9R\^?$MOOS_XM'?7W[K6R=V9@Q\
MFX(GI41^7\P00HA9JE1'6%OMO=5VK,/H/9A?55TBI(<(Z(--'G@6 972 H/#
MK L6_TDC7DG$!+TL <B=Q)1E!@_.>P69Z*4QQ$4@VLWE2B\Y_<<^\\ROM=]_
MTC;FTSU<*Y^/S-;*ESIQ4.5S0-_Y^]YAVOU)%=S&_V[SM/_G07CO3]=&&Z3D
M7E]L+/^QLS'H[VXLKPOZ?EV_:V-Y5PS?OP928O2[/T?_>[EUUAND39<C@G>*
M^6(-@RPJ]R._WD8CG7)1H]3/EI#,P(>*EZ-3_%*(?C1.!MM(YFIO[_"L9ISN
M'"^%I>/3_?UP=%%C[2?T[#\/]^FZ+O[?_\=)8?]QO'2$__=TIR:J'N&'<%$3
MKX[K2[^NU^W:YV82$OI0#&G[XX<=D' L%=(Y8T5\@>%HG/Y:FX!@!\'G2Z'[
MP&5,6+LZCU^IQ/.E*IB_?8VO+T$:CK8(IU4'CQM4=]KRLRKK-#0MZU[X<(R_
M?7SPCX]G+#L'W>)T;_K'U6==Z;\*^0GMW*FY\=.?M<$+/M8(5Y&1JV^^>OI%
M]]2$Q1D_Y]P+K]V-3_,7XL;GOONQ+\BEO-.GWA+/68BPC?\HSMT'_E:)UT[Z
M2L#M-VCB^%J)>QT>=:KW-S+N>%1?]>SEZL%8M.@J]BION\,9YWV.$!>[B.UV
M-=')-$%//B32.&=7ZXYW>7=?ZUNW."=OZ8[W-N=0U&?*\/:3V5@K__YH+U8/
M^O3U@S/<^PM[="W;3\.+XO2Y<FV%KO']4*X-7O'^?G\T'.V*SBM:_GW4&[TZ
M&\H_=_O_G/2BWM(]#&&X_V:;?##=6UZ70]FG[_MSK[]21YKV+NK[-]ZO\_^]
M_!2=.ND-=F7O\MUFAN+)Y@3FT$H&$3,+VB2F;# F"UX<\'J0*#2TRJ ?K6G5
MKU+S\XNHIB&QU,'98=-(L]-(J]<T4DR1])&P#(VH=<4FD]OD"XLA%YX2-^2:
MUE:-]N&5Q0M46/"3:"3X5=*L?B6-M'V$V'32['12[YI.TA"=,9HSGKQF$+1C
MD3O%+&*(-J(VM ,OY7/+?\%V<8NNDW1C20NGD]X<GAXUE30[E;1^3241,4+K
MM6 IR,C *,^<S99EY4.6)ANH#1W4<^NN9X VFO3(*LDTFK1X*FGGK\:29JB2
MWEU325[(VO)8LBP5,,"DF).0F>5%H.6)JU![S#S7#S^/;RQI*GP./AVJ-:ZT
M0(KI5=V1IIMFKYN&U^E2T!R4-PP31])-Q)0BELRTXB[SZ"S'\.PE\.?:RE^/
M+\V]R.^.</W/:3RI3;\?0I]^FO+YQ55A3WXF_0]24^F:FBI5#Z$P+&EG&"0H
M+ HI60C<1%V"4Q:>O=2U!.C!+;Y_U=+X>:10=4B]<43BTL<]F>E5F1?Z#I?U
MC2S/NM5,O?A&-E.D"Q_GQ/Q-_/=$ F,CC&VBX\^I9K>NJ=F?<Z#C$R.#=QG_
M<D?C]O/7"#U6XMK/7R2T>(J]C<GXX2I^]WHPT@JEA$W,EB(9J!Q85 %8B6AS
M!BDTV%D-RYDYEF98'31[-GP'WBGOS3LWI_G?C24 5VO)JG[^3;B/2GOG(),_
M^QNKO_GAM8I=E<47M/J'?_L_OEH5]\)TJ_ ?Q*7^X0DNF:6NLL/\X^JO3EL=
M7U5[7/U5-=97A2&/<C-WK%AY'*_J;ONX_RFP>U-U3+G)&7PQX5=-5.]]MXKL
M,5W;NY=3="OPG^W#HY-Q8XS?#X^.NK*AXQNN=F%NY=N;25M'BY]VB&W^.WS
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M@,<2BO58S]YBTC+#7>J+OSY^J/KEJQTEC9E^RZ='9\2FC_'@"6YC;[2UJ5U
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MGWS,I7"R]%<XVCD\/5XZ"B?TJI-M^E4X0M(+'[ +\CU?VCD@A^:('M W?2M
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M.5?2LY?JA;\I[VG:HX.?Q%/OA:.T_;'%U0RR<LC@!Z6$5@6!='LL69>$Q ,
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M%>F3X$[K^;C<PV_@[\/!)[)'.4U%[4S2VFVD^^:[J$HA2F"9<%[6%)G"7%+
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M:4]+<Y>+-URCN&TIVH(4>D8GXM>MC3=BUQA7L'9 %PIR=04,<SS2K[PD0ZY
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M;MIS^W+WUJ?4A=N:E\JU7;CM(CM;/[\.P&W_YU5K@+QQWH^\2][^W<8C+5\
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M9.L.+*LRSSGX(07 @(5);(J.-3*?A&!2UH"-)VX15%L\L (:[:-1IH3@=8X
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MXQ_LVG&;1BH_U"?BIC'=]B:7^B97(1QX_<R?NZ7ZK$3BH3!%U+)")ZP"9U0
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M]I\R1;4,;BGMP-O+<YZS%VAKOC?PIO^+0.)RSC)%/-PZJ1#$XAA<F_G]'+%
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MK9XG(%%DY-PQ+0UG$,ES\-9S9KU(4;O:1Q/7UN4+SMM4@&>LTS%@,%J#TB!
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M_$B%S29Y8GR)S0?MB,_4$,E#-A98"EFT3;->YPB K>GA?V>87*^#O[IQJH$
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MS:?M@Y??MC_][_[V5N_SOT]>S@Z5Q]N[G_GVR=L/+BN&2X7&HJ0.M6X(Q&<
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M4+WQ[+2;S&L+M$?"UHM5>8R0DK,2^:52J0$A!+$1#(G229&M94RF6^CI<U/
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M5F3W0YFX_Y#W*A:K%@OQP?N<A66><%P> EYFXJSW*!O1.N,9-*7"V.4),=/
M\)^%N;=D$[]ZI&6SK;]J5,8_!Z/Q)&>L27><6N.7V1RMTDO.&B13!7G4.3S_
M//O)]<;[G5 TCTF>9BXJR.AHV.2.GM6G9]FTIQET7_>G!:02JKO=:7KGV:3
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MTY?!*U1M1&FV+B(!'SQQP7+"D[>EHF]PVE55IV8O5])Y?-G+=T0ZB]G+TL<
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M5"+49.:#TAE5MU*Y=+%TZ65<4V,K'A2.;U])KSB^#1S/J>JHBUOIHB">>D?
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MA?5S4VVDM"2XGD,55VRK+!B^-,F]/5VMRE=+\=7;15U$.ZUI I)%!@(Z<.*
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M:YU9%(I(YB4!$8%80'5>4D6%*8&JUF]L2KXB3T2+_*85V>TP#2JR5X3L.<-
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MH3O(DU3:5WG0,"5PA[@6BC'> #,O3"_T2T,)9B$W#(V=?ARGS5J\?%F$X>,
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MJT6L]#QXXBBA&]MTMFQKCJ:5TC2A6&-YG4-+":RW@2T+2&]4:P=@,V=GE+<
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M;T=90_[V[[^F&5B6IWU\+F7=>3#K4+I].(?M=5@]6?%S_'79\Z>@(Y/T''F
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M7P$[0L',<I@$+@QXZ,HZ[(DVD@9E?6U\/2WUS]YQ)%$$V!U1\)XCGE)F%-.
M>82'7"9CJ9$ <B/VZ>6LKTD9NL66N"J!J;?$%4N+_]Z\WCE.FA$7"<@(C1AQ
M;CC*WB120H,WF00G.=5MR2VQL=\M)>74?@. BK&SP,+*UY7[R\[-IO-\J,;^
ML/W3OWI=,!M"_T/)Y1]V.N'0_O,[J$!J#=Z!CLS'JGY-0W:V<\RC]DGYB"3Q
MI"R!T1PF7,1DF=4F*$;7BX9L(L18Q4=O:,8*-N2N]Y>]W#BC(ATK->>'A&-3
M_+,OD7],JBV#Q<HYO?26YG?E&'ML_K%U>];;K=:KI4JK>#*780E;"^JO#$BO
MF/DL(_&K'CXQ3\K?-KO;#<^?MK!8?1>W6R8V9%-PV,^I\HTFSP6' 870^*75
M\>W+(J:2N]K].G445',TU1Q-\XFY*4Z<@8/B9> <BZ"-U\S[@*6@PM*P=!>!
MH>]2N"E96JN#_;=#65U[FNRJVS-O'AZQ@\^?SHX^[Y\?77_$!X='_.CP*V[^
M^5'L[X;3+_#_(_K^>_./Z6[/)_#=7GSYO _O?SG;/WPO]L].3P\.WW__ M?O
MTW=?X?]G7W9WOL\CH5,FB 2>#)(\),1)$,AP85'@7IKLX$29BV/YDA7^-0-=
MC6XO#=VT"$P90W0@@G.C=6"82*82.$6:<;UT.XL:W5:.;E/I>$PG%W&RR*M(
M\N%K0HY%BF -DV:.)>I(;B)0\VO6Z/;*T2U*Y0.5F&A#.2;!995A/#!+E;;)
M+]U4I4:W5:/;_I3MQC UG/B J"$,<2X3,MX;Y)V4E"DKO<LM4LB*2S*>C/QR
M]L%2\=\+\]2K4YA^&7[/&0+%;SEEH.S!7"8;%(D(W=2(1?I_U=1ZOJM^J\*X
M.7.Y[J5MC^&A5HOUH6Q,>=@]M/]\;@U.3[OM/(WONKWYV0(U^"T%?K.$F; O
M$04"BS!W'!Q7R9%5@B'*@Y)&B:1<9D^7LYQ.2X+??(QY4.MMZBL71FA?O3JO
MWB6KU?F1U'G*4],R!?#(%,(I!K!E&$9&2HD86#3@K(F@.-W8UK4VOV!M7KT+
M4FOSXVCSM&?BO!1$>(%(4!KQ!#X*&%H&19FP4,DQ0W.]^/UI^5>HSO4Q85;7
MO<Z@U^KT6WY1^>"PI'+LO/ >3L?Z<M,^I=-QYP3DJ1!,?Z(Q[6CI)TO!:PR\
M#0;.TLYBZ1T3WB)IC4"<!H(,-00I1GR2PAI"LH."9QO8/ETA^(K"R[7J/YB#
M4JO^<U3]J^E#=1H]DQIYD@SBE@ADC#(H*(958,2:7#ZZLJYNM>8_0\U?N3-3
M:_XSU/QIQR>*:*AV#$5O).(B1F12YIK'R<88.::,;VROC"2K/G19&4OS#QA3
M1BY/57]:'[(\DK_CO_7O#7L[G67IZ6?9L&HTO T:SE(Z,R,I-M&@Q'RFH7<:
M:<(H0")W$@<MD\9@!]W?$*JCNL\7#5;F M5HL&9H,-VME4=B.:"!TAPCG@)'
M)D:%L(W.:,$UST%A*IY34+A&@^?J%M5HL%YH,).\QDT2PBL$_Q+PE'Q$KFC@
MC'VB@05+9=S8YO+>#6I6?41T#Y[,ARWV_]N?QG#9C@=IOM"/)V%F&2Z5I=^_
M/"]?JPO^S]X>V\A84,XCL%E -L%015I(@C35/BJ#>2+DF17\3WBNT?K3R1K_
M._/Z3-(2W? *V!N1R82D^4VX_0W#4%W\_V(+ZM?I65=:_/_RBJ3K$OG7//RZ
M1'[.M.RVOK5";C5SU8KMFS#O2A]%;HE;/,L<;NN\:2*V-6>CR]MTR>GQ"UE0
MJW^'SC@OO_%-IVH<<W]NYAO_E*_LU&[D:8Y9Z&__N8@>S+BAH'X FV[DB"*Z
MIB9[U;/A*]S[GX//[\"3_/J]>7:$O^SNT:/#?W_]\GD/[Q_^&SS+=VTPV^G^
M3,^&/(ZWXNASDQP<[ESMGWWXVCS[<MH\_] ^.GM/FN=O1?/SIW,P^^F\$GC)
M<.)>>@0VM44\>H^,XACY8+%,S%DN<UQJZ_ZE!(]01_44&O:O6VRE#YI)\,HA
MBT?G,T.EQYY;11TGR688LT9)2]A/ NPU9*T!9$WW)U0"8TD9DI8SQ /%R"K'
M$,8Z)66R-*2-;;;%5]5EIH:L&K)6"%F8J^BP]\Y)RJ,P)H80L0N>.\:I8S\Y
M!:@AZ_E#UG2\7S&<F7H58HR:G [-D'4BH=ST!?XGJ3,Y,ZJVLFX'60]$6OD\
M'?.A1C:^=;,WW,[U[FOHG=/;>^<O?@=8"S_[TTC<ZCU@^3U@MF;?\XA-3&"L
MQN@05[ ;&*4Y8MI0!39KT%* IZVVEJ4L67LXOV/\^34!QCIXN35@W!,PIOQ<
M@ 6'K3.(F> 1ESR!T9A+ZHP25EII/&$Y96R++NGHUH#QX@%C+7S,&C#N!QC3
M7J9@N>5+$BA("Q9&U 1I:R)2.DFI8)4#\9D2;4O)5P88]1%OGI,/K?Y7E'HQ
MY@9PL1?[@T;/CK4@7B-ODJW@K/?%;P+/VLW,PO@.9'&O$L5Z"UA^"YCE78"=
M/#&?")+<6<2)TLB0_!M63&&E4J1R8YML$?8\BC"??FNH:[]?F;M: \]*@&?*
M64W&,-A>-!B;FH/MF2327"3D">$D>(L%-AO;>$N2&GAJX'F5;F\-/*L GFFG
MEVL3"344&6<!>)0)2&,LD0<,8I9X:VC,P".6]'E?+O"\SM/3=BO%W-RK[.?Y
MZX/XO#?/5-QQ7J?"^4^YCBXX_YD+?BN1>G[*\J-"Q3MYU"MJA_VC2.IA[)W/
M[Z:>I;W>66ZQL\P2>#C,783%1LZHA+B'[<7!:L-O-%#8=)))=F-;;K&9.MC'
M*JY9,^6YBU=8*\^:*,_TX27A @OMD.4T(&ZC1D;1B)AR4DBO60RU\BRA/'?R
M;&KE60_EF?9I:+))2TP1UXP@3J)"-E*!P/#PP8'A$6WXN?(\]J'74ZC,Y^*/
M&)"%I[(GL2S";X1\K'7##7 ?%^^%-GE[(7W<_HIE%X/5GGS1E<6!?LJP\V>6
MUQ$KZ5"<=TII+M[<!5F>9=[!-;3> EH_SAZ0P<9IJ5(H)@G0FB1%1LO<>44+
MPIQ(,N;F#'Q+W)M[Y_D1%->X]])Q[WX';S7NO1S<F_+'G(PV6ND1CCQS,\N(
MG'464:&Y$!HK*=G&MMY2JZI JF&OAKW'@KU['OO5L/=B8&_:DY;.!QFU1)AR
M<*=-Q,CE?L%):1LHE=98E3UI^IRLO3E,BZLGV;O%X1"]\^'0\3+_+63,J^82
M9?A]0_00DUN= *KU!N575HU1^E;,@V-40X_^[;]-S(K>DL4L9"[$,,G@U.K?
M<!C:3N?2MD>?Z#<N;"L4U/Z#(8GBN>U]C8,;+L4_/OW=^-]HVX/3QA_=WD6W
M5V!@Q:Y8,1_>!%NVUG 1Z7-<Q#BGVG>"Q'*"E_*T!>O1RRHX_OF%J_??_Y^F
M1/W6AR6# 55KF6DO8<5!EQNV<5'L2[FM-MQRT"V^)$X<H0]I-BO2S%($;!KD
MR\/997]PT[Z[U4D]N%-NU1V_%:_V+^%*VZ^^N7\!C]M?1]%ASU%T>@O2^T%\
M )?+)1Q)3X$1L$R][GGCX];?6XW#7K3]R]Y5XSKVNK"I75X4]*G]2WCN[RV0
M(]OHQ7/;ZA0<JK%WOD!(BK= 2/*+PQXB+N:+"F@)Z[C<_#DN]Z1:]N(%K'BA
M9'GFR^PX6(?2BBER7B:6!*S7L37KPA(UNI>#_@#VA+Q6A5R,Q=)'<C.&.!4"
M@*+_O?.AD=O*PC<.&V,6-^^U8L=/[PU+D48_&;GP3C\+\6[T,4]D.8N,;#9R
MN'@3?))>]-V3#MPPNZ@W/D(Q[$X_KT?1=3=/[66G:ITSV5AGD#M0P:O_M02!
MO+!.!<$ICLIQA;DS5E.L0T@1>\+U\=[M>FB^/;]H=Z]B_#OVO@'ZS_=W]KO5
M@Q>N3;_HF#7^_A_=_F"_.SB*\'##R1BGV9XX%7P#$HE"=X"JQUI["OE[<&U?
M'^Q^/8Y>)TN)1\;G0+2/'.F8- K,16(,=HF%C6TV&XYI@+2WX9?-QO?3%FRG
M6:OSLMC.5:71_4JAQV2TVMZ_3Q^75?L]B/J/#I_OU-/HD22N:DW0[54OY<^]
MN /I>P@;WK_>.8;UBS(:B10 ".+24.1\4@C6E!+'I*6)9Y9'/(W.9;;D5F.G
M,/! */K@0/0*(O0.N'ZMBP+D8+)3; TN80?:G"N/]N*BU_VGL&#![EP(>/TL
M%?T58]ZH5\:/4A_<@M2'@\ELAT$W=\0XN-DH]ZLL]!KIY@H?@<\=1T*#3IBA
M5)2&6"F12\JA%)C2AA&CJ=_8-@N!;FA-+MQ'B]9T)<3ESV6?H]5O@=72+\&F
M0KDY=D@6M%:G; 9Q6TMDP9M# Z6R(GB.C\P&3T9<_/^:S)@>IDK?7&)=O]N^
M'"R^9(9D^_'CM86E1(2>FMBQGZ>]&^O^)"('3L975'B+;VS[N[WJ;_S/9.9X
MJX/&9W!Z\(N78-1D9'Q-*X6S+EILHE4VY:86&FNIO<K(E[C.R/<$S4G&@6C<
M:MKIE$;4#D F $CQ_H<\(?T"D'9 -[Z!DU_W*SE\?XRET9IQ ;ZAQ8 L.M=^
M4($D"RD%GS"5_IGU*QDU$BF[?X!O;AO]R_-SV[L:XERU>8Z"-1,-3:IVG U;
MR4$1:(&K;OR\1@2'.2QP75YB>Q+!MA1]B#8:'-,U:OFQ+NU)"+S)[G;;)WA8
MO*6X6F4SE2<]7AYUR%A8GS2O9T;YK&#.5F'D-Y> ,+WRI&>O4P+,X+1["5\9
MP &(__AX,1CYFHVAKSD*#941YXQD-Q'%O.5FPZ\(*<;>^1)IX&O1=:38^/NO
MN.W*\*R[,-VJ ^_B]V%K]N*/4IC^R@)2S]7L7'T8ZDOQUQ\W.E/\?;B<WKRT
M6=LY.>G%$SLHIVH/YJ;5Z;=\\=>GF33PUY =/Q:HR$>V+H)55J M6)K95%PH
M+#6'^T^"4@F\#O ]I)%.<1.U]D&;J"CUPD075!&4FFWGS%:6:51YBW<,1;$U
M=1BKOJWDR^Z[TR^[OY\W/W_$1]=-#.^?'WS^>-4\#*?PC-?-LQ-XY<OI;-_6
M3U^;G]]];?X)3N7AAS-P,L&AA/$<[OVS3]^"4]F\.MC=/P>'\_N\;CF*\^B<
MX8A0$1&( $<F)8L\R$(D C-O]<8V99M&B#5@<G_,),O[X<6S@]:E,S!O/_XU
MQ<G%Z9EW \O5967.8N54XN70!"WLSA>2<_F((#F5:NZCTUY&C:*1'G&7'-*1
M882CB$YJS)/,I;]F2ZY#@YX'X6JZQ3UN-:;[?,'3/.1R49)BL=26$L]\-R@R
MM\%?^[D]_>(MXSOE"CRDB3R9<O]GK]N_969*;23?!O]G&UUPG71BV"%?E!II
M)Y&6GB!L76#11)#6G-FRR1Z9M_X.(9';*NVS Z1%YNG+-C3OB3W+6YS]I;"G
MMCI7B3I35J?E6 9')1(48\19<,AXS)&C%);<&$P\W]A6?$L^+OG]:@.QC_#1
M%05&U\5T&VKA;8RWET2L^LM3FW4YJV$OUQ>$W<N<45AB9'E.-IX0,UJ@VFI;
M'7[.,L?C$+Q3"B-+"JN-.V0=_)F2UUAJITQ!V+7)YN#GKT]1)5D7A]?%X6MI
M% X!K;8+'P37INS"((D1(M/\%$2$C!.D$UB(E!-#O*(A&0&XQK;X,V&F?ZI8
MWK.^Q\L,&[XKZR9>:N#PR4W,>T8.W]V4M0RANC8SEX+C65)E W L@\&(V<)-
M-QQI(1W2E"L9P/1DDN3#(7YK([.."M91P?4R .?@2FT"KA)SIDW J#DW+"+#
M>$*<)HM<(A1)0Y1-45LF#& .K4.#=6APJG=(JU<'!M?,:BM6K;AFS&JK(X>K
M@M=92EW*K-4*0)7Y4$0.,=*$@9L=B+ N2%;TR2";9$X+ICIR^)Q4OXX</F_#
M<0ZTU8;C*I%MRG"4 &8<2XU2T??'L8 ,K#VBS!%!3(R1QXUMK;;XJC(9GQ&\
MO9A[K$-AYMT*>C+9XQ*E/*^Z8N>.-#)UQ<XZ0?C1C'%*HDY148E\V4HG)Z,;
MP5'PUKL$\.ZI N/4;.*E.Q,_3=)Y'91<(R1:;%O>#8[JFIAU@:$I2Y(*;6&U
M&;)*IUPX*)"UU",K<MZ-)!9+L[&MR)::/?A8GQ#D.ID-#T5T>.<N>S_5R%'Q
M_UC=?R[YIR^-[?"QE76Z:8#R7 9L)1*$<L2IPT@'\/THDS37*UI)V,8VWU)B
MA<TKZ_W[R2'A 1EX']*-&#%=5"U#:G=BA= P?93(:'#!.62$C0 -02%G1$!<
M1^\"[!J)^XUMB=DF84NV%%E9YY 73FI2&:8%.]WR,9!;5+(RF/S0O<SWKZ,C
MCPQK8XM;1T=6#6=^ME13)".U)0!B+B?'YA[#1A-D2>*66A*3![?$;()$K+Y4
M_R=Z5I_NU:=[KR ",X9X=01FE5 WW0 3&QJ"#@C\>8DXSDT02*X(,%B"NT<<
MRYW@E-DRLTSDK_(L;YVLG.<:S%FLW(N".2^N=<5CZ_U,,"?:*+5Q*&E%P,2)
M#&DJ.9*4.< #[2@SN?7%S?'/$L&<NROBR\P=?*I RFI4=#*00FK78Z5Z.<W7
M$(R"31@CP[5"/*.PEC@@S1QQ5C@J8@*]I&83LU4Y'X\08EFG2,JGLIW*9!"E
MX.4>[PQ7-%=IE?TFTV6N6GB9U6KK&3 IUW"G$X8MB@[OTZ*H!K/;@-G)+"^L
M8Y(&\"9T2A1QIQQREC/DE8E"LZA$Y!O;1&\JO*1W42>2U =1ZQ#&^#D.U=&-
M50+0='Y)$%228%#RV"$N/4,V.(X2D50KZA0S97Z)?O:<>W5^R8.&))96U#I2
M\4 Z/!.I8!0 .AFDG04=II$B(Y)#4A)5%+!:CG/:B30K3#MYX;;[\TW@^+D>
MCOJ9U D>#ZB$TV$):@,.5"-/-"AALA$9;Q-BV@>#)?8 U1O;PN!-09X@5;.(
M/OQ/T65O>T$_]>7[FI:2 J!CDE,D2"6Y3M@ID3G[P8* 7Q-WQT3*C>W9QH$3
M#>JI&D)%JQ- XM^@_,J#H\),0Z"R,RD=M7Q]_*__;6)>"-\JNRH^<*/1S)MX
MVFV'V.N__<]E:W"UWQW$W5;?M[O]R]XS:AAZ5*'#1?OH_,O9_F[[:_-L[WK_
M<Q,?G;\'C=[_VMP](H .].#/]U='GYO_?&E--0P]_]3Z<M[$!Y_?7S7/FN3H
M^D/KR^Z'TR/Z_OO^&:#&X1'_L@OCN'YW_G_7>WS_<._8,A4U91:Q5*9O4?#8
M!4;"66(=I][3:K\ [0%TSB KN1/)4DJH,IP:  *10B I61T)2V*ZP6B!^M4:
M5#T\&^5:+-RV?]Y@>&Y?VY\_V>1(.-94&F&<"X23D(,65J<HB22:49XV'K8Y
M:G''6_4<I*..>8T/\>*RYT]A$^TO-UV/TL[WL!<MZ-55H7>_7_W1MOW^J]:Q
MW8_',>%$&:8H8)<0QUP@8PU%U&H3">POPLCGVI2W"/4V>B.9:USTNB<]>]YO
MG-IOL>%B[#3LY>"TVX.O" UW543%?^^"6?<2.^M*MD7I[;J?+M5456YQSM:E
M VQ^6/F4'6!7KQL/T0:VX5KM=G9L%L#TZA_^CH^Z4^EO\49IL._FII&3W>1?
M2D_,$5B]XL:@HPA6P_8;W538"\/VZ(UA9_0G;0[Z%-M?,36C:3#E+#1^R28K
MQ;\5?]P87XV_RHVP>)?\]NM\;5DB^7>R9/HU9-/><O O)M#&&778"\P95MQ&
MK FX0AA,;>N2%88. VW8C ?:]O;?S75J;T2QDL0;9-LYA]D>D%'HRZRIX5V%
MOJZ:UR>X>?WIM/GY7?O+Y_=X?_<#/"L8X/0=/,?^:7/W]&S_^EU[OS4=^MJ[
M/MA]#]_S]I^CSY_:7W;AVC^_M/9W]Z[A<V"TO_U^\&<3QO"1CC<WW3]\3YK7
M>\=42BY"#(@)PA!/6(-S;"6RW, ;V'AOS<8V 6ORH=OV/:?4V1K3:DP;81IF
M4K!H>73<<JFH,4KF"(\UQ"I0D06'!_IVD#:R4VZP[>8S-<K=$>6NQE'NZS$L
M#S8)6R0%MP@V)X,T=Q8QI;#6WCO,^!JAW-*6:BK^6ZN*S_WNM])(I=E()7+,
M2(4_;F&D+I-\/6=^7N A:,#4$\R]#)X'C366BCMF#::,$8<SCA$)FD)KV^Q)
M;;-1?H^VF@C&D(D6;#-),)AEVB'EK9;:,\I9IK$2]T>M^?CPH!;8U%?>J6;B
M5:BM2=QYG(10#',LF4W6LJ@%ISH$GA[%_!A//DBM?\!=N(Z];JW@=S1+A@K.
M(K?2.X^\B0EQ)S.),F:("H>Y93J">;FQ79PGTM^>D8[_Q/X8'F+ P\8?P\)C
M??(6&10_RY=XFI.JM]:?YB*-?.+4GSH;'5H^_<9WVV^ U1E!+K[%1NO\/(:6
M'<3VU58C'W5-6TS5^59QV2#VSEL=F\L^;NXP'2 <WF9N=+!QD6\QZ!?/F-.B
M;.<JEY"4MQL[5^LW4J][WAC _.3WRW]/049/3AL65O+<Y0?): @#[E[$3N/<
M]K[&B5MLPL.WOA5C:W3B27?0*AY]T(,Y+M4"/F+!"&_'7O'.S.'>T(S<^?O#
MT&2<OKP3_J?;:W1A/#U U.+[\JR,?^K',^)!4%QLG'=#*[7@(>!N8_,\?H"8
MZW"*^8+)V%KBK/O)!+)LVUD,(&=]]G,5$8QI*#$E)@W#Z\5/7!07@0R",(V+
M2 "/J-,=7]UB)LK"FRP"(!'GW3Q V+<:\)G^I>T,"LD9RC3,ZX(EZ*_%9/XU
M-2@[?DK5*(ZOJL'.'>3D?!8G,+ 4K0[<S3;^:QD3@^"(O77@"EMNA#2$: >J
M$14G,I)0F!@PXYC/-S'\M_Z;G1NE*Y(XQG(X=DYZL<B.+.V)V^4RKJM-<?=,
M"K 5#K^2YB$\]W7^GS^6#'L3E$8Q!RLX"P)9;3URUAK8RQW%RH$#L"46V ;5
MZ6RC,-D:(2<9]!H ?(WOK<%IXW?;\[!1]N&7SM?&7__OCQ$V#M\9 N16X^,%
MW.:B3&@=[D?+2!@5S+#@>+2:<N>T-5P$QBG'F2"3R2(!IY P]'-1JQ)K<TNE
M'TE=+6RW%K;]PX_'5FNEH@DH!J[!V]0&.4D%HM8KE80)0=K;"-N8F='RL0&O
M_-MV+FWOJL&+_8!.PE8/=@[876$G;'2*HL4L7C>;P!^?_F[\;[1MD-<_NKV+
MZFB_2K'K3^X1\3^7MIVQ=*%@=JJRR!6@'[TE^/T5>_EP_"#M=_.SV'8IEQ^J
M8>]U_JXJ32M11/35R6+SZN#PA#2OW_.#P[VK_;.=8\>TX3AA9!SUB!M.X#>C
M$'-<&V943%AM;.O9N,>_[@).]?;W'*1@"I&N]XX]\2(JD(+$HD&<!)W9>RSR
M%!!*4M@8[0)$&N8E90.S4+J&+>9^*!UY#P3CT5Z *_0/S'OA3RQ7"WY'H1'3
M89F);-(_"C@;(L)MY$2^>CGY>FR244)CBY+&+%/W!F1-B(@1*SF84,&+ ')"
MMA9U^CNOI*7:=K)/-MR]TH^19$%][MV$8UZH/=_\N57+/NF*X_WK]\?:X:!8
M""@%@ ?.=4+."5C[G.:>E!,%OP_!;&L.C4@.6)1+O=GX?MKRIXWOX#@U+MK6
M#]VG0:64E6'1NK%A\KIM-78&!8S FOOV9;\*653 ,FG>G-N1B=/(D;<*CBI)
M&UDL^9+>*&-M#>R7H=URV/T]#FV9G<';3CA(E7=:6S0W%LW1<?(V^:@L<I$)
MQ!V6"-8+K.N@L1)*6D7\QC:M+9H7) 63.Q5(Q+'$CNH$[I4F&;=HP,@I@I%0
M-) 8$M7T5C[6E%E31B,OVX/"E)GUHQ8!TG>X':S_1<$$5)+]!-L"4^A;MWUY
M'JO@5?;-RJKPFTUQ[(XC7ZS$RBY\M&$[U249S2Z*GG6;C7;LP][:"*V^+Q]Z
M;]!HP2OM?K=QT>WW6ZX-B%P^3KXN;\B7!3K/>XH,LW8P,;1B.$7-!GQ_U[5;
M)V4@#?!U%.LH '^S,7GE: C=HDQW$Y3ILAUR"+<?!X-VL2N,H[>W_=-L/[HK
M&$#_<E1$TM]J?!P%[7+$MS^S+YQ;L#<OS^>M$3S3Z'M#;,,"]4HRIO$QPH0]
MKIWZ8RBHL+Y9CJID'3I(M0%[>W.F>>:/HR.>)FQ0],8B'JU!.D2,J(V<$ 5^
MD)>P.9B%!_V5 ?M<@MY+%OWMMKZU BC],L5^3UH[!E9;#]0;@+) @E ]?]:?
MMNU-'_'D8[:[.!%6N0@JFACECN=T-:(#\]1K(IT"E2TT%V/#\$^<B-'\_F6O
M\A%HN6O??.NK=2R.Z,$.^!*,<,H]V&,T^Q(1E(_HG'2CC)3>Q)@Y@N^P?HP3
M%YQ-F#K#&>,F",6I("18'B4GU?JQR<2->OV67#_#F(HX.!2*\FXG.7(>!^2-
M$1CTQRCK[[1^'IQ)SY3101%NC3!41X8)83QAJQTOUV\Z\:9>OR77SW%#E,41
MT2@<;'XA^_)4HDB<=(&!K:+TG=;/Y;,LK7'"8'([05UR2G@C%*/22A4K_9,U
M?MYK_3P8EX2DA @5$F5[!5E/&8I9\V*0U*IXI_53"538RR23B%Q0 IL@2\XQ
MG:B4=IAW7^]_]UR_P$G GC$DK>.(P]0B$V1 1B66A-;$9A:YN^B?XC(&8H@5
MF!L9=?".*&9@BR48]L!J_>K][Y[K)S5-SA@D"_LE!@KZ)QCR'GLL:" :WTW_
MHHA@2COE50R<<V&9M(%%)U4@G E9K5^-G_=;OZ2X,QJ[' \$_8O:(PLSC+3B
MWH'%$<'4N-/Z@<] 8;_S*K<H(RF:1)G#AG@)2TD"GY\X7*_?LNOGM.!.240,
M&*%<6XI<3 &<B,"3I)BK0#>V\9:8==Z?Z(6; Y <URJ2R\H4/8JW&GN=F_3/
M,H=O+%GQA@7%+GE(<6]AS'&H:4%\/_3#1V_L5A[X7L?G(YP;4<UG&*_Y1.(K
M/SC\2)N[\&R'1]?P^6.8>J4$5K!O<+#;P,Q&SDJ#$@%/U0AM6/#Y#&W.B42K
MFMTA0_RB>,B@>Z? 1\H=V[61"0P][EBT 4Q DL,?U+*D2\.=UL"U(FG ^X?-
M8TJ4@AD62,$&#[N0 "L"C#]$)(Z*N>B<*E%L3K+%#9R,):%WJJ/2^0E<C5/;
M;US85IB4F'XC?HN]JZ% -?H@:9F!R7?/"R:/QL6E:Q?D7D4T?*OQKNA-<"-Q
M58IB?][1QG2P/]I>/FWM;\(S7.1@9:,7_W/9ZA4G6_!J:G5LQ[=RO+_;*6/_
M!4Z6B>$)1M_MY0RT3A^^.T?]>K$=O^5TWO'PWYK&9#_$D\NVA1%>-3Z,S<IR
M@YDBPZH(K-@C<$,NCMU.2T&KT[_LV4+,+D'<\AE5]R*64MIO9*'.JW]9-L:H
MJA7ZEP[6O&5[K>'!S44/)+5U8=L9 [-$](M<H]-2\/.Y_B!VBF_I]DYLITKQ
M[H\R;O^W>3#*MBV$[.:Q2EEOQ:KF8/KYX<JI"R:>KA=!Y8K#KE9O3**GJ%SF
ML8<.%Z>:09YYQRZZ_4(/WH"H%T41-W1C_]J8N*I::WQSB77];OMRL/B2&3JA
M)Y(2(LS4](S]/.W=L"&=1.1@'_R*;(*G?6/;W^U5?^-_)D4?Y'Y\!J<'OUA_
M?L !>3M.Q^>F??V!'90H4ARG>M_MA4)@BVST_/=E'N@)*%/>63Q\\T4O]GVO
MY<HCE>(&(-$C9*KLT4$6]#*3)Y]NAQ;L0KVRV.C/G9V_MAJ/1@UY@YH[_7X<
MO&):R*/O^[O^NGG8%/N''T7.Z4TBD:A\1#'D+#T;P$]R>58Y-HK$R& EILE+
MF71<6"*BI)9S)ZT,(8@@+4W"8XNG*24/BZ2L7$B62[] 7"X+.>G$W,P(WLBT
MC[V9XJ6B^5&_3)X(\Z[/'QC:"("R%^W+(DGP5D5/HV]<O/'DCV88GP#N(B<-
MC*22I[+_YA8\LG.QXJ=3N$[4E&K+8+%RMD>]I?E=V2<?FYERW9[U=JNU#OW5
M'H0_\WR:/_.%L"_.D"N^+O+)O .\ZN$3\]34FO.M7]AZQ%,8P,6T_#W/(%DQ
MJ>9KYZ![N31TEH*C1S3ET66/15D5;0H"W#_XJ?1\1V4LHU/.$L)4XK@S<KW^
M&GI>H_?VXV"O$-1E4KW7-:>SY(.Y.#^ZWF$'NTW:W&V2_<,F_K*[DQ/YR='A
MR34\HSC8A=^OP>V9YH.![VKN>MX$]Z=Y_9$TKS_ ]YR(YMFG4[@?VS_\RN%W
M>)Z=N81/F#L1K%9(""40-T(APY5#X-Y+%KS@Q)N-;;;)\)(-W>ZO1^M*R%GC
MX4O%0RQ5L#GG2!#/94HV,!L944(F&9V/!1[B(1[.Y.G5>/@,\7"*'\MK)9B1
M KD0'>*.,OA-8B1!6"BW-%*',QY*J6H\K/'P=>.A3=1@QH2-QG(;I$Y&XI H
M2<DDSPL\)*;"0V)J/'S^>#AJ%GKV_BIW6>+:2TZ41518C7B2'IED/)+,<!8M
M-ECE.J%-S=?&/GQL*N/G&1EX.SI]N#ET&!XXY-.!ZM#A)^UJ7CU5*DM&>1&8
M$U1Q;!+H@3$^YNSC7$P@%E"EW@WY_BC79Z<3_BY7YW?;SL<Y-02N#@+W9EQD
M$Z+6V@B4HL>(*^^0T52AB),Q5#DJ7=K8)GQ3*_.,&%-K5N05J[JSQ&$OD\=1
M<T:\DYP&#5LBMP1;S.879]6J_IQ5?<K[X]$I9D'!72(*\<!R-,PGI!*UC/LH
M)(F@ZFR3,EVK^LM5=24< 0G ( :@X(X[89S5X,!H"V!OBN;M*_-G:E5_#%7?
MG]K5.8^4"(V13\*"8\,TTIX+Y+B)QH#7&GQ6=;QIU")JE"?C01_1BL\D43YW
M&H,E,Y**=.UE6(A6?F+UA^V?CN7TM\)A]R_;BYU!-9+?K_[H=@H?M: J&7OX
MFJ)H 1<)WS][>^R5B=9@@RSX3HA[:9!))"LBO,"Q9U[K3$LTRY\W(EKLI@:H
M6;\_ELH_Q5PSGGGW0];PYY(Q_T/]V;LA!,H#/8F=V,O9@46*:MM^;_1B?]!K
ME6SQC1ORY((1Z&:.;NH)0BM_WEV6%\ M"SJEJJ5\9JIL PSE/+W,[MW.-0FC
M8HK^9E;6_J*\\2*)'33Y+-/QP]7ILE=\8Y5(6W[?J1UL9C:IS+M4O#LX+6LC
M2KZHH@( 7NOVQV\,-RM2V^'_#0] F?]MQV^Q78PR7S0HDR>'DU&RG(^H.&\Q
M#SFY/C^"BR7^E$+5Z@WO7DU04;<V7)#-G%\,2-2))405^<4%"U,<=&QCQ\.E
M_>J3D]18(8[&4>1I#>S7/ OE8PQGX:+7ZO8FTI SC>@W6/V)(;FKT;W@]=P@
MX4>+]/!)RC^P?G9;?=_NPC/%UYNPO,?W#]\>LP0(J()%2@8/2.@L F?2(6D]
MQ5PS%4F:3E)V"1MF([?)._!/J.8DV4@D$2EH(>UTDO+.XLQAD,;^4$'ND (\
M%=F\:3X_-S/XI\_]V)G!QFPIK.Z2&*SU%C&WZ]>^S&W-EL2W2XNM$UCOF.WX
MV)F!3QO=/V]U"O:_FRC_L)R@VER*.I?1UC(SJ\O,R@L]V7V9A[=W*X]?58RC
MJO ,KR'(T<W!"-'<]=^;YWL4[H4/#D^_'OSY%I[Q(P6; '\Y_'3Z97?G^LO?
MT]W>X'D.OW[?O]ZY.CH[@FO?"[@_/SH\/=\__'*Z?_:AO?_Y'7SW?GM>=I])
M.GF:.$HDEU@K1I'VB2'8?1E5(3A&Y,:VVJ22K.CT=AT/:)]"4?<ZW\!!J=RS
M3BX;ST6KI=\P9N>[;@!+O6XP^] @5M9._F]LA]^O]H:NTJBTLE\#T5) -'N&
M&J3SL$X<&4$HXM@%Y*04*#)OF,31L,P8I<PL=?ZS;3GYTNS$BB7ZAEEV(BI2
M=EP<E+S4F6:C@*KNY6!Q;.).J'5;J[)&K=N:7F66W,XWVVIG+_E=MS>,9P^;
MFGTN5W*LDKQ:P=HX6QTF-F<P,;$8*05K+&(1$3?>(V>,0ER*H!E(A\P=I^BF
M8?=.*UFU<?9L#Z"6I)S9[W;RX_>Z[79F@=@K^EGVE^6<>9KC@(4QO1&SVF:C
M,SF^UG!\99QOF8.U54%6L]7)]!E7PZE^V1!SC]@P;9Z='#,%DVN$1M%@@(CD
M"#)<2D",0)RWP5H)_AO#<T[)A@VFLC LL]!WHZ"N%_H>"PU[@2:PDCI9A$G2
MX*@KARRS&E%!L:(L^: M+#293;(>+O1F/O&Z**G0VE=%T^ISV\N=50KBI&%;
MCU8O,Y;U!E=C8-":3U96<5(!;H"14##>;)5 DP_RIY!E^(GJXB'58[ZW;U^&
MTFP<= ?#/E35&=H02L?Q<Z%-_UC 6HUAWK,]UB,,CQHK&CD_EF+0<&5V$,QC
M!)=UZN1Z+JW6K0C37A_GEL13<S?V,S]O>6)EG4E.D2"5Y#IAIX36TB2XVJG$
MW3&1F:KZ:9BZQFY5F78H>YAOJ!HZ2ZT.&/J#-RB_\N#S/-_&(FSK<51IWM?_
M-C$OA&^-#B<?\-P[ RE 7.ST077*4J7][N 9'71_K?:X+OER=G35I.]I\_S=
M^?[N>]P\_/+UZ SVN<-_G\'K>/_/?Y\=['YI[_\QM<>=?3K?AWT1G@_VP",,
MU_ZS?_ZAM0_[7/.\":_#/<Z;?/_\(_Z_Z[>DN;MSK*63D22#F/82<9$(<H18
MY)WTG#N-G1#3!]TX!<>D O=%<\X2<Y$HP^ "*XFTSD\?=!\4"1T3"] H5^ 6
M9%:+E&WN4?9/G^RAI>R& @Z\_\OSRV*3+\8_1_[^7[??/\P^V^L6PK?'(@0#
MEJQ"1.36'P)3!$Z- DED@@?!J>5L6JB>SL?[>\Q6&II6E6DP,JRR@5"F:Q1\
MM=D +-_/_(9#N:@RG?R$8E1T,!4A]Q2)W)O;IWJL#9F;(EM:L)7G;*@M0>]&
M$??X!&GK]JQFE;DP"PL>B%A/UJNQ&%"#D<UE"+">Q2G%4^<'+5-K_+PEX9;L
M=[<:\"VXX5[4Q-V&-Z^>N&?'N/?(WF0QZ/TX:%QVP*]O%RU)6J,LCL:);65R
M]388VK'_ZYO;B-2]&!!N(VO+4KS4#_DJ<H]^CV!S=XI^UZFLC:EBBO?)LGAI
MN9_SAOAB$A (\9HPC,%V)-P)[Y@(BN+( E4)ZUL?\OP]5C#TMO!+]PJW-"<B
M='OY*78&91))$7OH3IZWKMO1T-TB%E6:@3C8W3_+T8F#/YNY @X?T28Y.'Q+
MC@[?BEST^N7P*_P+WS639O"5-VF3?OESCQ]=G]#FX8>SH^N/HGGXZ;1YV/[:
MW#UM'\"_^V<?3N>E&0BN#$V4(T(R";[7,?=9M,B;$ )AQ!).-[;))B7/*?EJ
M127M-8*]4 1CR1N=G#0"Y):ZZ"+V5$=M"< 9MTM4Z*\&P6J06@ZDIH@W(N7<
M.$Z0#D8"2 6!7.(<!9*,,@HSJ?'&ME(U1-40M2X0I;G%7EF1:0@R5YZ6S/&D
M(N=>!NUI 5&ZAJAG"E'3A"'"B>BX DP21"#."4,&S.9,%904<5%IIC:VS;UI
M8=<X@WU1/H+<4D]'='BP^.2KB-;\VG 1_(_<Y<NW;;_?2C"T,NG]@?,6%@:]
MYP_DE__Z90GT"=Q[S K:*LE%3-J#?:24U]XZ80.^!1-*'Q87?IO&HQ^=,?]>
M3.6'Z9DL7SZT_]0HM!0*O1\T_YA H6_AST\\_.^_VU]H^YL[NSC-9][-\[<P
M#V^O]NE;_.7\+3GX<[]U=/;U^_Z?7UK-0X_WZ8?3_;8F^]^/<V8A=I8AS2R
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MM"#"@I5:I#0E>0%H[TTB<V[75YKW,+J3K+&1P<]K_-$.<NW=23;:(%[=G>3
M33I&C4\[OC>\Z)PZ>^)NV8EDC8UD'OTSGD)L>+V=2)Y&P8'AN0&C6OLT$<8(
M[8S1>>9SIUSBBJPUE#99-^)+OA-.TY13;XB2F+:"SN+"<4.L*=*BL(H9ZK>>
M,[%)10=M%=&:F5H7NN"IH!D5$D@@UQQ/FLF3S KOLXRV!L^&,_52K#>QC!>>
ML*)(,-9;D*(P&9%)08TI*#54 E/GLF7JQ\O4#B2US5TJ7.%$EG'E<TV=M%;D
M(+XS>W4SDI:I-X*I%[P8,BN$UXH3*E--1))KHM*<$544W&4%S1U*:D[7%<Q]
MB/':C2P/7)6!BIFG5W8E^3F%@+/1AB<^ZTY@\<QUDD+_ZR8QUYR!VJ 385TN
M$N<D/,/DN<2S6&UBLAN7N]VB(#E^W6:0W!ATTC^/=N= YT_^IN?^_>;RPWM[
MKIG(]K^^P3%_W=][2??WSMC!WN[E\=?>I^/^\=?C_CMQT'_WY<,G(PZ//GA8
MPX]."S B* -%!&P*H:@DRB<Y839+,^8D3UF^]7SY5*SMSG_=Z-A70(TB2WV1
M.2\R!?^E7#O'/,],H65Q^R.>6^I[L-1W\I&E&7::]R35(B4B31DI+%"?LIRI
M1!0F2?*5&<X=-; WHT I7,JDU%+13'";JB230(*)Y#S)#%A0MZ[R:2GPH5+@
MUW<?$TV5*I@D7&#?.)-:HG0&BIL%^M/*BP(S4U8<2OYK!_9[HKZTY?4/0-]H
MJVG7SH8+7DJ;T<18EQ(%1@X1G!JB"RV( 9PMM 6>XFO/\'J@>1L/D-T?K*K7
M9JK?FL$7/)9.*^MID1&J.2-"NHQHYC0!K0I4-NE=GF5;SU?(R9:K'P-7;Y3Z
MW'+UK;EZP6699S+5/.7$TL02D3%!I-,%R7+,KU6,:JVVGM/'U37Y83LK?[B7
MV:;Y+F\"0VLP)GYBKX[6K+\=,+V^^)Y9_V'O#$SZ?SX=[/WGTX>C=^G!'P=G
M^U]/S_;?O_YRL/?JTX?P//QLP:PW'S.?6"=50IA*P:P7> 9XFCBBK>4F3Q.K
M=;[UG"]GE/ZZ,8[-EB ?"T$>[KW\F!F39[F6Q.78RT'DG$@ET=.9%,)*/&I(
M D&N\C-MD*NSI<G'0Y,G'XVR5&EC"&>L(((*3I10@E##\:AQJKC26\_9<O!G
MR?=Y'WK00VS&RG_$6_QP<V+N6,-KF[!M$&2]7#R$BWN6999X6J1$<$"?PHB"
M6 %H)#DH3BH!S,G:XRT>)WNO05]NV7N#V'O!2RR+)&&I3HG*M"4B!\XN>)80
MHTTBG2@*Z6C+WH^7O==@>K3LO4'LO> N%JX  >U 7 .&@_2V8#'H!-@;=C>U
M6<&Y9-A"=3/8^W&57MXL=;5M2'1OYD?;,_7.$&KY]#RKJ<NR3.(16XH(IU(B
MM4Z(-;RPB5:%#-5R/Z* M"U%'B7GWT_>2LOYM^;\Q;/V5$Z541E1ML $%0:<
MG_*$4*F<UDYSSS'D0UO.;SE_$W);6LZ_-><O=@]2@- Y-<3E>"B?SU.B9)83
M#4+?66E5)K%Q\G+GY,WC_*?0TV-=[5/;IL]<%!X(G.N$,1!XKM!<%JEFCFE%
M57'G[5-;(+L)D"T?29>F(C4V!?A2W!'X[$DA-9@QN13<IX4,QP4S]F"Z0;<]
MX-O./RT<7!L.%BP:P81G7%&245;E##%#B>/,Z2Q/I"O8.CO_M'#PJ."@[1GT
MP.%@\:P(ER:ZH(RXC(.94^B<%,KE)-%&.)G*PMEBG3V#'D:;U#5V6?QY'4C;
M0:Z]3>I&&[ZKVZ3^A2X@P&Q,Z(WU&>?#\63D)MV1Z[O!I*/=P/GNY):]4]?8
MYO;1/^,IA(;7VSOU:90Y*E-X8:PLK$R% >,[R9466A@&5I3SYFH3Z@H/<*L\
MW8?R1)=<*\X9,)>X)U(5GHB\$$32U!*9R]19SGB.G6;2MG[YD3*V])IRZ8O,
M.RO2Q&@-C"R\,53F/D_,U<90R]B;Q=@+3A*=QN:*Q!8R)\*F FNJ,F)D;A-K
MI74YVWK.-Z2"N67L=3-VJHS43C/*!14F55*ZQ B0X9K;7";?:*+:,O9F,?:"
MNR,I,JIHJM#QR8C@4I BE89XEA8VI8X6'(_&%,ONCK8WP28U4BV[#OR"6:F_
M/LJ.JJE+*07[0"<</?:^R(%0F<EE+IP%,FX[JFXP\/#O5]4>?]G_^I(>'/W^
MZ</>.QCKL3C8._ERP/[3._C:ZWV 9QVSO_GQI]]#1U61>V%SS0@W6A#A/8V=
MT!101Z%LX3*5K:RJO6'G 2^RQ,DT3W-X89$X[#V=4,&T\;Y("]FV5'V"Y'?R
MT5#.F.*<J P;^F:Y)#J5G.0LD: -6RNH 7UX55%W:#1P PK,6>H=&$_,&R8<
M!_,I-31Q3G/-#3=FK6>.MX2WR83W]=U'I7*=6&I)IB0H;2IAI-!@DJ7:6J4
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M"%0W\;Z!6BKP\&5CF152%%)R81-)LTPR)W3>GKR^2<B4K.BP[[,4% NBM..
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MM1R,<2$=ET)+K:A5SH%!XN3'U]=KO-+08=\T5-C#P5^J:W<']MW@'#[\&?S
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M>X[U\V'\,,7S'JS5"";1'<75@L$-\?=ZV..QFXS#Y;VNTMU>=])U>$M<S##
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MK#'\.$7QWW,GW7$O/@(D[87K18D+#X"E<R"750\>,0%I'/6 (2C3G9,A+,$
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MF1F%2D3CN7%/0:,,0J-.Q?SL*F1NI )&[BT%;4Q%**FM?.>#0-H@=F 5S+P
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M@XRAII^H8T\1><1_TV)1?A='&GHD[*+)T/7HN^+J]'*R+A@\C#P!@F1;ATC
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M;IOLAF'T2W>]^C,>\T>]UACNFFS-6N- ;LE:&=N58EN(@"&W+W?;9TX>>)D
M8@<UTO^WPW>FXCW/@_,?+38IRC"'.BUYO-!9M\&47%L&,9/LI5>WJ;[M^4(#
M6$5W8O)<OEVK[807ZG>\%U>\^<Y>S2UQ)EWAFJSPGA3?<N=7M^1*XKA+8WNY
M_2JR69XJW):5>:U;*5<(=^-PB97-\730J"!\E\W1^YC0\?3]A#V=LN)O^\ W
MCP?R7*0[S#^.7MT9Z6_>3E3)5[<9+@/;2(+Y>_46'YU[;PMC$1NRUC?=3M&%
MMJ5B*FC$U*M:9,"QYY&+#DSPYS5&6JKTZ?$ !P61?-%:6YME+S;">KN^,L_M
M T8NGB\AE1:^;.Y$(^'!N[;<IK:*=:] /=?NYDWNT2RR6>3V+W)E>92Y_Z;E
M40O_EJZ&8$-$TTQL.+<DZQ4%L% [Z#G@R!QB8EIJK;(-M+59PGG^#OSK1J]8
M?S57.+)1[[8PDSP>FJDT<F+B3,:1E"9*!$_B..7,A&$8\3A-599<4_E!HOIT
MTO=Y!^\;->A9<VA'^SV34]IO0&>O\BSEI\[HY%5.:6^*RKI]5QQHS9'Z,5$)
MBU6PQ/1=V ,?6N:BHRV-Y'_^])_AEZ,^._CTAG[Y='AZ&'PY._B&$?RW[/.G
MOT^__/XV_/SMC3A\_9_3+T=O?I37_/.?D_3,=-]]^^O'YZ,/W<_!G_S+V>?+
MP]=_!I^__7WRY=.'4WC?SL'1,3TX^] ]./JM^\_/MZ.#C_3''T=O1@??_@K>
MO7[[-4N"P$0B(2S-&!$JYD0%D2&<1S*Q290QK7;V8M8.63B3PLZC"3=@G4)(
MKL!"*VF J4=.:Y%&D#U00284U2P* T6Y$%P$*F.,4_@CDSK33#>"[,$(LJ/3
M *<Z)RS3$<T"0KD,B9 F(RKADK HB8P22692++<2O,T2T4BR1I)MB20+.&5A
MS&606"D"$292\T1IF<C84$&O*\9M)-GF2[++24FFA&5Q; 31*J)$L%B2.(L-
MB>)8)*G,J$WLSEX4M:F,&T'6"+(M$61 N*&@:2RMX4)9&[- B8@&&0]2FJ71
M_0BR1E:M)*L.IV15;%B:)"DG&5.2")MJDJ0AN(]6F]CP+-6I!JLK:'S'1E#=
MZ[NYPM7@14-U#=5MIGJ\(;9 8^=OO.X\0+WIHQ;AX;<#]C4.PTR+,"-QJD(B
MJ$E)RK@%0S^S$<]4F$5@Z <);2<LV" %NJ9L_;9DQ^H5,V7KU<)$?K#:/LR5
MT5LMR,(@3K.$1BQ,J5""Q[%.+!6!E28,;&"6%F1%:T=CU]^V;#J820O%B="I
M"3D1FADBXIB3),X,":(0%)4Q4L;QSEY\8[/^"LEP6P;6LH4%CYZ1>1K"^V6Q
MT*$1F$N)=1P',K96)'$:T[MAY,8"N04NS[UWG@02V)6"NQXK(K* DC2)*-$B
M"PVUF;4*N#QIQ\&- XT-HV\NHZM8V<1*&L9I(J@*8IE)%=(X8V![!HPWC+YU
MC#X5IM,QIU3)A%!K&!$ASX#1=4 R(542L$P*ENSL<=&&0VXX?<LX_=="6\TQ
MW?$Q/5DE&,2%,&FD.<-_V"!E(HVB6$@3Z2!6RTCD(;PP_*L1S1LFFM]-V6!I
ME- DE9QPS4-PMR@GL92:""%E%N"',MS9$[R=!'Q&-#]MV'U3V?W>I?(CJV$_
MM,7\A'R4@@-N_*4PW;*IE,TCNOLH]2ZAC.WH;;G_;]WV-\IA)>7PYVP83@:4
M&QV20(89*(=$$P5*@20F2.(HC+- 9SM[83R++K;UB<Z&4]=>RWPEI]9MO*SS
MPQKRTP[Z#0?_*@?GYIW(:)K8B!$5IV#4I0K-.ZM(*&*1QBS,,IF6QD+#Q0^7
MB]=6Q]OHVS5RZU2<3(8Z3),T(:&5E(A,9"3.N"*,6P:<RKG.DKE8O VC/AA&
M75N=:L.HZV/4Z;I3K:@-F&'$IC$P*N>4))&(" M2'01IE,5<@V&<-(;Q ^;4
M-41)&\/XKCAX.N[):!@!)QJ2"ASCPQ*$( U"HK3*K  EK(*P,8P? Q>OJ_!U
M:2YN4A@WM)JG"UDMS90V(269I@$15 ,;1YDE>(8LBFUF.3BYK,V29(,X>9UE
MK"S8#38]0GXT,3O@)@6L2P'J/$QIM?:P>8&]TXBH]8FHOV8"Z2&X;E3*A'"5
MA$2H4!.E9$98+*)0I['1G._LQ4&;W3R6OBJ3;%$>]A$S_MJC\ WCWRKC%PVJ
MTD@)]B4),\J)$"PCB@M%XBR)E=21C4(T34+>IL&->VP:SG^(G+_VR'W#^;?"
M^5,APDQQ*6F<$IH9BS6O$8D#R4A*HX3',N!A:('S*6TSNJX^EH;S'Q3GKST5
M4'%^P]PK,?=T_#\,:1B'/"9Q& =$I*$E"?A?!(>#6R5$S#-@;AFPAK$?#6-O
M5(%UH]S7RO_3V8-(L306)B!AP#01L>4DT2$<5JR8-8QKD>GU54TWW+_YW'^?
M&8>&YV_%H)].,U +OCRU$0G"&"SZ%/X%.I^2V-K09))GS#J\C*#-V-8H_C65
MZ6]TYL%OO?]SWWP;#W%(:/_<XMPR'$;J:_6?=/O#X=.F9/]NT-F+<WA7'(//
ME/X!9]"(L?6)L<\SJ8A Q@&XD1G)0.T0804GJ<QBHI5)&1QFF(;)SE[8IAN%
M^=.4/6QJ/J%AYOM@YMP/L5PDUIB49#P.$2>'DB0+P"U1,N.1C=*(JIV]J!V'
MFU3YT##SIJ8(&F:^2V:>"BJ*P'"KN2(\RQ01(3-$*2J(2D%3!R:*6,)V]F0[
MFA-3:)AYLYEYE>#@&L+^4\'!AJWOD*VG<P51D(2Q,@&):<01HUJ0-),!2>,T
M#J0R81 &6)THY&S08/E08</1&\S1ZP_W7\O1#=.NQ+33 7ZEP!>6/"/") D!
M#RDDBK(,5',L51S%--04=/&<.%_#LAO+LO<%A]VHWKNRJ*=#]B(UF*'+B.0R
M!5Z6%DQJ%6.>/HEDH$$4Q]A0V^8;%>UZ9 C7K^WY "C>#5IOJ9YIJ;,^K.ZG
M^T6#='UGO0#U<X!_=RW^8[]G]FO'T0BL]0DL/3L.58E @W= +..&",4D 4-$
M$_ 1:"A5&(H IPBV8WYC#( &D6US.7OMQ?[+<7;#O+_&O+G/8,)(,V8XH2I@
MX#. HZ\R*0D<9!IPP6G$S,Y>*-?5X=.P[@:R[MJK]1NE?.=\?3D]VC<R%AP_
M$NE8$T$#26(;)B1DL8HD3YET3D0[CF\\V+?A[,WE[+57XS=*^1:8=SKZKI0.
ME8XT >M)$I%*A4FUB-C 2L8S:2AFR /6C))YP*R[=J2>U95R ]WSRRP]'9L7
MVH"9#3RL,H'ZF%&2)!DC6ED=*P,_QW)MT#T-6V\P6Z^[D+ZQM>_<UIZ.V*>1
M2#.=6B(9CG^3E!.E8T9HR"U+LBP J;VS)]KAS0/VFP=VOR%1>CF7,8&%Z/.%
MT?AU9!V;>S3WV-1[/+*47-%2ULH&_;,6+-0.>JK;TOF<GF;^[.+YL]RDH0U3
MF@KX3R8J5K$,$Y-F8<!X'#NCA!9&"6T&:6^9S7(ZD[33+(RLE9: S9F"R6(X
M 3=$DH!ED90<SIR*G3TIVDG0A/X?,.>;B%FJ AIE<2I"P9-(Q8@RFZ9*,!-G
M#><_&,XO0(199D*#XS02(8B(@?T3F1IB312;( P94^"L,!ZTH^C&-?L-ZV\N
MZZLX%)IIP0*:B"B+XC1*=,J25 <1!;70L/[6L_[TJ(Y41E+0F/#$8+-.0DEJ
MN2:(]Y<R:8(L -:/:#N@S?#J!\SYTD:,"YH)&<0B28*8!2F74<I$&(,H,/?#
M^0USK\3<TTE#GL$AXMP[K.  O<Y2DF:*XK0/*87*$*\7]/K:4#X:SKX[*)!F
M6/46'-,J EC31%*XC66A,&&8)#R3%(,M&GXRJC&]METZS^2(PLC"@6M+A% Q
M$<I0DG"5D4AP&H1<!(%-=_:"2+:3C3*^'ME(Y+? I8.A/78#D6\T]^%1M)R%
M5H''J(!LP7B,P.;  ;LL,RR3(BXJ1Y<19%.P<(WE>&NRZ<W%'Z5L>LL.OQU?
M?@U5$G%)0\(1#U9$64)2FL;$5:6(+,GB6.'(Y WJ-FN:1]?,R90G,K!,*ZDL
MN(8\#:)$9X&0,1<V#.7=<')C@MP&FQ>-I9FQ(*,M,4&((Z<"36(1)H1'E*K8
M2I:F<F<O:0?RQH6E#:=O+J?S $Q1T-+<F%@8&20JH]9PEH12!S0-&D[?/DX_
MF.3T1*0BX28!#1Z"0M<T(VF2"61\:4S$XUCPG3U.VTE"&U;?,E;_M7!0<TP;
MC+6CM>8F#+2D8'RE%IRJ3"2AI2;DH8[I,L;7U=#ZC6R^/]E\.BF;->6:"Q.1
M1)F8""9PB*](B98&9VNI0!NVLR=HF]\(AK_A]\<FEA]9M>>A';4ZY<SB'!"]
M*?&\]1+/*T=&-\IA%>7P8R82IT-A!&."@(*0"'3.2)+H#,LTLDS&- 1*!>40
M-X59#YA5UU:3N?1T]Z;1<PTLG-MW1D8B5JDE2:PH3ER!?PFFB:9*V0AL_"Q(
MFD[/1\#&:ZNO;-CX+MAX*H3&8J6I3!A18"*!F\8"DI@P)4P8%F;6AJ%NV/@Q
ML/':BB4;PWF=[*HGV54%H5)24!(R+&W&H<6QI0A'F(D@"U+*1;RSQQO(E(?,
MJFL(HS8:]^Y8>#HPRB(C+)<DE3&P,/B]H'L3'#Q@I4S31 <J:#3N(V#CM57'
M-AIWK7YNZ>N^._K\\_#/KZ$61D@;DD#&# >*4Q*S3!"MP\0$.K4QYSM[,GFH
MY:PLV TV/4I^U!^I;EG(>J-!H8]X^O':@^?-].-;D%&7,^%T8RC50:A)%O"$
M"$LCDAH!A$U%JA(X5#A D%!A6T0WQB9?E4NV*!O[B#E_[;'XAO-OE_.+\)WF
MJ4T80K+%*;;;I$0E 2/44F8C1E5FU,X>$ZR=\'75M3>L_Z!8?^WQ^X;U;X?U
MIR+WVHC0IEP3;&<@(E:&)"+ 'U6J6 @"W*0[>PEKLYM[)@WG/T3.7WO(O^+\
MAKE79.ZI.+\1H+P-E21.M<9!AY;$":=$Q6G&361B%H)%+VX.6M9P]M9P]D95
M6C?:?<T"8"9+(#(#>IPD":-$Z"@EJ4Y NV=!8E0 G\5T?>73#?MO/OO?9V:A
M8?I;\N:G<PW<VEC84!*F5 3^?&A)PC*%&!I<PY&EH4H0/B-N2[HUNG]-%?L;
MG8#P6^__+&8*M_K%4.&\;+_UI-L?#I_^6GKB4>1$UXK0W,QVOAM!]G,F(2$-
M9RD5AO P,T0(K'&(4D$2&H4)CX2UJ=C9B]HLWJ2D:5/AL*E9A8:;[X6;RTGM
MP,8\$0Y E0C*!4D#G6$KIS",\2RS8)2$[:CAYH?,S6L%4FZX^<ZX>2IO$"9*
MIU9EQ)@D(R*3*7 S:.F,*J$#EO$,*_Y!-XMF(L*V<?,J(<(U1/^G0H0-7]\I
M7T^E##)A(YD$G-" !40D-B&QI)JP#'A62&X-2W 4,I\3.%@^8-BP] :S]/JC
M_M>R=,.U*W+M5)Q?,A:+*(U)P!$T-].<**X5R>"7J96*\U3M[,DY6+D-SVXL
MS]X71':C?._.19Z.W$N>Z%#+B*B41CCY6(+Z30U)31 E)E;6J!34;]2F#>[U
M_7%F?8IP2_5,2]7&!S?XUW?6&-!,<[YCD45G8O2)R"(%QPK>?V"(L"H@<6H2
M$H :XES3*+8A^@LQO_$TYP:D;7-9>^V5_\NQ=L.]O\B]!1  93H( DVBB"(0
M ")X!)H1DT59$F=@?B"6?73S2>P-[VXN[ZZ]=+]1RW?/V%/A^8CQ*)2<DBS%
MB<6!8:"@N2(V$#8*E$QDZ-4RO?&$LX:U-Y>UUUZ;WZCE6^'>J2"\U'%D+1R*
MT@K!/6Q*8@XVMN1*I2JQF0@CX-YD7;5[#>]N(.^N'9]G=;7< /;<@*>G0O21
MC=,@U8+$8'(3(3)+DBS1)#69R9) 9-K8M0'V-'R]N7R]]K+ZQMR^!S]Z.G ?
MIU+&<9"2E(>2B$AQ$AOLJ%5Q&B8QR&LJ=O9$6XA-,K@?5DV]G,N:P$+)\X5!
M^76D'YM[-/?8U'L\LLQ<T6+6R@;]LQ8LU YZJMO2^02?9CCM8K,DBKF.5)B:
M1(DH#I-4:@Y&JU0V4P%W$7R6Y&8)2YHIV]MFM02S@%\Z!4,ES(BE441$'('-
MDH+APL$B%58'F6+ISEX4MQ.9;)#1TG@DZT[>297$24+#.&4B2I/8<![S.)1!
ME,::\X;U'P[K%XA?&14\9%'.^AE.X #J)U8D\!L#QV^QSHC3M@B:2=8/F/<I
M#9,LBV4&REXHJV.:<2W!GHQ4(N&/AO>WG_>G<H,TC4(0\0E)DT 2(0)*DM!P
MPH0,C(U,%H1L9R^,VD$SQ/XAL[Y2262C,,VB(!&::B5CJ5.;!91KG0;WI/8;
M[EZ1NZ=SA[$,J4D8X3041%C.2(HH(&D81!E7*9C\ 6AVVHRRWC;6OO>9J<TQ
MK5D"9['269IEB8I!#>M8)0SX,TY $T>6VZ0QOK9?/,]DBH+(9DEH Q*8,"3"
MI#&)5:J)SG0L;! *C5-+@S!LR^C& Y@V+U>T+9'DM\"G@Z$]=O.2BY$0#>32
M(E$F8G B;<0LEU8D099HGL4T9)KKQ(HL7%J438'%-<;C[4DG/A,19H&(!,YQ
M-(%@1/ D)4KS@!@*6BF)6)C0&('C-JCUK.DE77?=F;)1QJR-:*0$#WEJJ,Z
MM3.@ 0.>X=UP<F.$W :;%]%?H:(@E(K81$9$L# C21 CTH-1<21"IBS.>V!M
M&C6STQ\PJX?<FI09:XP,1*!L+#(;\Q3>7#,=Z>6#OPVK;PRK3P5[,RNC-%86
M"\@Y ?\B(BKFE 1@J^DP"$T:Z)T]3ML\O'%$J&'UK8@(-<>TR> [3%J;9D$J
M$E3$B0HCR5)C5*8""Z;9$B+Y:LC]1C;?GVR>:@D0$7K+/"$)9P:\+:5 -B>*
MR%#!V3*>:F%W]@1K@R/6 /=L#[_?NUA^9$6?AW;4ZI0CBW.4]*;2\]8K/9N)
MT6M3#F(66(5%*9-,>#@5H0-+TB *B(R4"HT)8VW$SEZ8-)69#YA5UU:9>26K
M-BV?:V;A(LR62"6-T40 (Q,11(JD1E'"DSC@)J4T#&73\OD(V'AM198-&]\%
M&T^'T,((S".:$0;BF(@L S<-7'*2H2B.# 4O+FS8^!&P\=H*)AO#>9WL.E4
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MA810'"4VEBF7:<B%EC*-8F,S:@P-PBR(T]PHB7*CA$:<+DX(Y;U)OX%KNGZ
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MK_;?O7SJ?3&7G9@PF^?5PTX50COYB73B3ZJ5:TZ;#L9J<.F/*7&G%+0QUC3
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MECK9&YQAT8ZH1CYG?)[GUEP:W[A:A>E7=<M.K:N"4SALN->=:ZBI,9SLH!Y
MJ-GX?G-KD;&)O<1/G_!K]K-BEG/73NBW:( -MGC$<.JVK$(9]XK5N(TH2_K:
MV S8QJMJ)SVUG*HMUA^\VRS8RJ[)_>M*(WJ%5NBK>6>U/9IAODQ\F7=YHK)V
ME(<>-IQGMU(1[16$0-%DGY^@.PAW;BTTO:M=:^UWAWV',/#-ZHG>T,+.\,<V
M:5$ %V5C7V[C4JN>XX;C]%O-U:A,FWRU0[<JWT8*KP(D_E_LYRX;7.$QWD,H
M^F%\N_BP[3M-<S0!8X\'/J3FRE0[DU9U*>WZ$]8*/AC?'Q:+@FK;B>79\%G1
M")0G-]?0K.;SZL9VGN^C6=8?',(O[CT)_F>>!.\'7UY_.#M\_=>/=T=_\L,C
M3;^<_=WY?/3WR<%1]P2?]_EH_^+=T=O+P\NI)/BW+Z>'OW^FAXB_\UJSPY\?
MSKY\^L_)X:<W/]Y]>@/W.CDY>+T?'GQ[R__Y>7#Y[NB8'?S\$]:O+P]>ZZ]6
MQRDU*B+26DF$SAA1:102#IL*O[&XK3M[;P:]X:CU?ZNS\Q>MSZ .CEM__/%^
M-@.]U61W^R3W1U\[D?/HR>[T:\)Y%KGY$6&<$FS:(RJS@O @2ZBQL4FS -1&
M?SA";7L .E3IDS$6 0V7)+N[)I^YP>;%]8J/L,PA6$^9@UQ+F4/@BA=F=NWQ
MY-"W/8K59-%7R*+CILRO(UG3RV]&/GTFE3*11TQ5UYG3PQ.;>^)+)9.O2OF6
M/<KM"9R:I1J-VW,+[=NPO(JBBTX=C)+GR!!:#4]:6;=_D8=F$,4K]SQ')^@[
M8-M7V2V1-YE-=H%-IZTK:*$"K@<["Y[ *7:]6^3C'7:09V+RPEM<7$!?7)NK
M==]C+^8D\[V[?%VJ-^^NR",O5V7T)]WG:<>\S!6/KC_-:DL0<V]8.*ZUHDW7
M$(&H5.L_#^\?N@@U'+KS_ESJ:OD(V_;S]?T7(OQZ+O3VJG%NI8F$!<6AN#L^
MQQ[:CE[BF&YG<N.R]G91.-3L2?GPVZ[0NILJFP=C@#W  ISA_/ATJ\!UG*HW
M60!7647TUU*E,G=%LP4IPZ8BY1%4I,S-:VU"2<JBW(XCJRR/^I=&;3V1T2[O
M8<8.R1 L<:P<&*!L'AO/0^7+YR4=M1J'>EZTG]=#E$F,X<+'%OLT'X_TRB7-
ME%E,IV8]Q^>88OUAOI3=UD<LQZA]N7P=^T.=N0J5-O*T<D4COHH"5 UF^V83
MX1YWM<S(YC!CI2D^-\]6WTIG@E8+F*Q,F6MX8UK0(WI@YA[4G5:PC06$Z- G
M/D$[5_*O[4M-P)V!OZ<>X<"CX9/<_YEH[IZ_^(55*,,R)_KPJU!>H0S4L#,N
MZMXZ<%@MLY&.37VIQ;6ONG@Q+WP\" W"<Y^=C7L.E=S@\?<OG$0I/E; 64Z_
M%:"\-1AEAS_C;G8%616"<& G'^6&N$\HPXF/"R <=WM=FJ)%W<!S5YU1@;/F
M_#3,D^HEL_KJ,?\^7D3E-YXO2K$"('B*,-3][O=<+3B-W'%^,VC$;M?VCIT<
MR3.ZG>\^E>]Q@7ZTOHW-<<Y/1R?UE\K9;\$QE$CFJHOMRZB$0.^C15WCK<*"
MN3;H 2ZH.K4]CXQQ<=+O6B]2+[P! \]IHR"I+2X7&@M6Y^BBP-IW=6^^/L06
M*RNA*A;< &5$KR[Y9D^J7R''%/@4BXW[J3C\(TF!\,4ID(U)9E2"SHTTJ?;=
MS5#!H* Z']KGQ3]>8 E,5UT^[_3<&[N+7IRI 3!9,9)ESO 1]T#_<;7N7>K7
MGL]_S9^<?[SK/IJ:"5-<NALFX<*/Z2[[I<_8KJ2+'WKUE8NOB\-=3I=;[#7#
M<*^=;WVCKV[(U*V%\9<9[2\%5E_V>F,07O/P(IW)6'FD9W;@A&X!#S6%&CDQ
MA&C)@UARRT;]\WO8K_D#NE[;(4C\\[IMZ2VFZ2%,=TI4?H<VT1#;'RV"*)V.
M2I0D.(6??#WIN4Z$?P71;MA*"QRM_:%3MF,740/CXK /NIL5]US"GJ@X(C=3
MBODX8$B EPJV 'ISG6&]T,TYOHZ?:FR$J"[VPIE,9WWONGKH0_\!%O)EQ;@<
ME["J5\I7 W1P?D)U4]\+L/6M%<[E\!6*A8?W_PR+/5PHDWZ-0 I[%??X!-8
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M7(_*/'BE1EM>HRVO=T%KN%:YX9R/ERL!AY:7G'BZG0)VL@8*AF"I*(9C?VY
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MKM/MCD$.QQ4#][-ED ?N<[750"F_XE'?_YW:35^Y%])^M2BI-WV]A1+9%LH
MQ5D@I&S\4G.=[+>V4,R;OFK86[_@W'BXE6Q]N!N'2ZQF3K9LU#]_3O@NFV,?
M8,[<)U.P >!)\'33M_J)FEKBK<,C^;>]&[S/Y?;@D_O!&F?)*YP;=IS+HD(R
MN4_.!^#^E#(*?U,7!.[G^=SF;CM)TNYW3])J[^\58W7SR'+25/!_5PIYTYEJ
M8,]\YU3>E_A==;KH7_@?P0?;]!?P@/Y^N6A-8*HDMR?0C]OTY7M?TB^X[E!N
M^KJ=O^N7_<3^R,.BF[[H:3LY[TXK#-#.QN]ZUAD4I9WPQ/%9+Z\OVE*K8].W
M^XF>9W%<XR_/UHUJ;6V6O;B!RKOS$)U[_3>+XUP.-="7N]7+<V_'_(UVI^EP
MWGH7T^'59,BOLRJ#ZX\V#]WA\^!D6ZYBME6\<?W<:6O.Z3L[ZZY1Y:\\^2!I
M4QE.RI:I.-+-]P(_=7NR_%Y<85!>RW;31NGMGNE]# JX\DC_=6OGN,+YW<>+
M2[%+DX=-RH]<5(7QIHJJE4V%O,7D 9D*;@3A S(7Q-/6#>R%.>>[)7P6MFDD
M5F2S^=1\JY)RZI&_)"FW]Y $WXUX<TB;?4BNCB!X<7_'M"8'UCU;>OS33;9\
MC_HCU5T8O5[>9,I++3B\N>F/L7"C6/M#LZFX:#-^,YMY#9NU'?[A;5'%QK'1
MKSJ0Z]B@S687&>Q&\2/GED:>WJZ/>H\4,G\,P]T[;<$O.VU?5_GOVFIKUW#'
M_"/=3G8<=L9SPMAN< OEZ/%2];2U=,J=/_W%Y-;L)AQWP55:Y^@Z_3'<W"Q1
MRKZAFQMLVN:^0D34H4.K?-YZTGG:8K(=RK U])ON8,%JA=&U04&U2I"J#OI)
M!VX1AV+1]2ZSCE)G?CEU[9;^^QCQP:E!'AS!ET85(T(_[G\HBNN?>KS'#CZ=
MA6W)Z+4+R!__O8)'JS\=+AT-.KHLC/<3B-N(RFQ=&W#MMQYVR(-+.6R0B2O<
M&"!?FCXXMJ,<R;C^]7*DDM^$!7?RJ&P]5R3B@)@+KL@;&!V:!$+<.IC4_L3;
MX$YAM^-HWAT6]T?.EL1?5)B5#B8CKXT_47X>F'N.^Z X53,%2]CM#W/T4.WF
M _E%++L&;%&:'2BK"OSBZCF'GS^^*6"_+N#S?S'*=UE4GPJ]98*#;[#@\,T-
MU?D%E$GLQ43<D^FV.&QGVUKI+3;]$/;// C!OAWU%![!+AX&]?U(M2/!4V@]
MP2N*MEMW@?\:?C@YT'?Z4\3V=2@U<* 'ZK(5>%ZD#N=E8$%\6?\OU_34Z[>J
M@IE661GF,-1\U56K*+BJ R&<SZ64#>U FMDAE#I=-9S,6;AO57AD*/J*# 8(
MU\E/'1--ME(7V\W<Q"$F)X Z6]:7(*'LQZZQ3F_LX!F/L2"SI2X<1%75'#>S
M8(0+KJ,X^B\40/D3V/BU=JMJN.!5J,<56G)YYP6$=>$F'U0(_[!W9_T%PP8<
M?I =CHKAOWVO/]URZ\DA]VD?2&W@@$B<49]/(2]N@-IP^I)J-Q"5TYD\^2XB
MN#G& D'M /7ZN0"UJ]LMBXA(3L_A._D1QYUSUQ^&@)G:XW\4N)B(^NS37M6"
M)E&G:L"&;D3C1//M.:H^-!'P:"H$OM+ FMZVFGUQQ2%@NLV-T1[E-#7O5K-[
M-E\N[+;^6DAXL%MP( Z4?V*C=#& P1%P:7'UBW'@_<6J_!$"/\G;&>?70#@]
M#@BG^61U/A[H$_1*5O(4VLX-:#L0?5*X5R <GOF)GX7L*3_JE%9)SN&#VJ\J
M!\N-??5?(=ZG\-+XEE #&-L*U ".PZGR=F_7^H_"\:1S/IP  SBJS91HY]/-
M<G"+MR5HZT- !KH90$!]+\#1]+. <VQG-%9+M( Y< #%5K\'50B<4-OQUGN$
MZ+[< "0,)JZGZ>!6_*N5:%H 35=0"M70O=9O-@<V_V@'WSMZ^?EK$R^UJ02[
M-+V6Y(J[%3QO?7 0R+K$8MGWJ,K%J(FW-5CF#Q4L<PY36X.G_:TS.'-TCF&5
M$JIFN'9J?;Q66KP.>$XPO1MXS@=DV\V-?6T/#N/?MZ.K CI/5\%2-8'7'X!J
M?>Y17BY?;)P""QV&VDDG=0F :K!D)=,_ZA-K<*KCP]!@54"HF%/CQR5DG:Z?
M6X:>_02PXCP0FR5TQB2/1#/1X?C>YN16(QWN_NE3L6&ZZTAE#MT-=\%TLG5S
M]P<&4E[5L?GG75;AUDW#YSO4RY7;[[;VE(-M..6:=&GM=[OSIBVTAL57')_V
M\S!?:K4:#UVT]3(/W8]JTW[:[N<2HKXR3#L5(NK0(</[7U;(6U-(JSYL?-U
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MPX8C5^#(J.'(AB-SCHR6Y<AP-8Z,&HY<@2-EPY$-1^8<*9?ER'@UCI0-1Z[
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M#Y:&PF(YO91S6*8/\-VP-'5;LZL RXIM&GEV8J=-V_7R!)CD_)&IL&0.D;F
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M0I"_:*%NT0,-?19]8PF-CSZ,+E(82R[O[R%83W*,M$CM "U*\$IY 8I+(OI
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M\&.(0@W_C0:>'SY&,,=W=H6*;-V*/)-N7I#&)([O\8/Q=V2!OU2NWA G+;_
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M':ORM6!#I#ISG/*IH]^BOIO6 @&X>R;1C+@+L9-)0@\#:1")'+E,DW8BK<_
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M;,*?BIL 6]ZT ,!><ZYT4;("1SN'<,<E\>N^=/Y?]L;Y<\!VRJ*%0J$U7K-
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MQ :U[?%>BF&&@B@[CI<8/($Q["0B&@].&D+E2>DX,(5[%\R4M/5>4G\T/7O
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MLD:+0+Z"Q\JV*F."9 4/,$>5<RE!1'.XWW8PSBE$NY,A]9'%/IC(ZUO+],E
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MC/Z>3__ DS]?/O[0&PGVCGB.@W9@E'2"Z>X46=U>E3<+X.J+^\2?)5N-KM&
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M.*%:#V8#QDK!"DY[L#5IDM9F'-3#>AMTA^\PW'_' W',M/#(D54$DBKQ+,@
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M9#JN ?,4E+ZOC-N^YY>^RHN<%Z(-HW=A2![PJ_!Y. ^C)6#.64@I1O"*N2H
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M,WQ;S-*8+917QVG,!I:,*2W1@;"UV3Z]2A!""I!%81PQ&)/;1/KNQ_5<&-=
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M5Q^+!R8<:FV]-#P!JX"4"QD<UAYEBLD<:Z1#=NEO<&HC(H]W)/8H[S54V#L
M_E]A.JQ9C:M[NU]H_?-O;_\<XW3V:?B9&)M(2.$C#B0WCJ=(AAZ/B4@K.0D@
M*\A2RB(Y4S*V*=+J#/&YT*JM[M:P;*^X].NJA#!*RQOB\S":+PI*O,XZ9")^
M<@P4<[1FJQ5(XXK,3 CINVPTZS_]N3"A)_FN4?E>T>GUQ'QQMFB6MTH56 ZR
MFXP7]47,!RU4B2"%$P17!@A,.?IK2&BET*53%ZWMG_R<J-)8+VMHM%<V<R>X
M"Y16*6FUD<!UK*FWAM<NG"2:6&+R0KJ24U_L^4Z:/K2PABM[Q[G?X^+*=A'\
M_)T,\QD!(Z4LG<A9C8Y>^_;LG\/YI^O_9(#"T<8HZX"L6A(?O*QF.1+AF>2"
M91]DF\JO/8$_%S8>0\]K>+IWNO3-!C&OQ__\-$R?EL;;HA:WEF>;@%J28RBX
ME>07B%I%(FN'82$$28[;V\GXO?<<W0CNN?&M;WVMX=3>_30VO!.+VZ#W^ 7'
MYQU>#(/*>E$TR"@5**M)/AP%H!$Q,BQ.LX-N@%NA?VZL/+C&U]!VK]3N#0NH
M#2J&BQ9O"^.B3DROQF@=F$XR+L.E 3+((K)@LX%8?(T),P]19824A;-H#3>E
M2VK3?BB>"^D.K*\U_1U[:."\:B5=VR*-R78=36JJST!9%HM"!DQK77-04VW0
M%D&8Z%/F(<3 .Q#IOF<\)YKT)NLU)-@[+7Q7L5P,H^+>9"?(&>8Q.U!990@\
M>!#92.(#8RJ>5D?\!>P>R1=&HU.CW.$UNZZQ^ ]59'G^UT0\Q_RW'^?3<[SZ
M)NV+^'7^RT7&SM]^G%VT+MUGXC$M,)^G^=OILOG 8JY10!>8#AG(Y"S+OA:2
M(3A7TU2M5Y9WR@?L--5X'8)CS8P[H.XG/>J@YRG82SRS%^.\:DFQ&M[< =0V
M8^2V(<A=.(>=']>/INZJO2<Q'XP#)NIL,M*VZFL+49$<1"$D>!>=#D7[Q#L%
M%$Y1]QNFPQU0]=M(M\$$N%M-BI<XZ\&ZG"25BG,Y&@E%!G8Q=2P*DR&YH"PB
M"SFU"2<]A.RPP^Y[4N"DH?1;SK1_>3XC4+/9JG?ZXF4H44M54@26:F<_[@LX
M*^D,5"G3#R)FT^9>_UY8S\>4Z%]+/0Y$N2K>7&!9OBQ=P#0=2WL#SI%'WN^O
MKCN%LOO*NL$)<Q.49HF\,Y>!>5-J\]@"T28&+BKFO31)-!H-=P#%=QUMWUCO
MVXBXYU%7BR'KH^NMAI;0EL>9<II;71""3S62E\E-3]$ 0_3>1]KE1)<V&P\\
MYO QLST4,&DCO9[GV%TU-%SU^[D)C4>6E?4:F#8U9P@C>#2F-K'S*=0H[>UN
MN@_TEUS[F,>JV#ZEUV"'OJA+O]J>+AIQ?/B$6$< O,AY(>0P^GDX2Q?1V-G+
M;_27SY-9&"UZC,WH(RY:I=;?611PG&->MH>>C)<[G"JT,I9J2Q<.2AH/86'L
ML.1Y(4LYWXZ6]]4>]R#K>WYVYPGRIL=1;JM5;@7XMW"&*_.K ^RFINZ.P(]C
M%)\BEVZ/O3@@$1KL\KO"1V6X%)F!*;0O*,TEA,P%(!>:5L6R3>GI\_<!V_X)
MTW<;_??L3KR<AO\>CCZ<Q]DP#\/TV])<0FY\U$G6QLAUMF>ILWRCKT.=G5=<
M%H.Y@[&Y_M,/;V,>1#&37J7:(-1X0PJO;C166E!?\R!"- ZR%Y7P09+SHQF@
M<M%$<H&L;5-6^P"PYV?V]:FI!N-8[X&W<N,Z #R<9;8.XG%LL%X5VYTT>VBE
MM9FT%JAP0G"6.20AZ"26H0XTTN2\AU*KX60NRCTEVCQ@^AR7-=LHHPU;UAS2
M%[#I.^7EMP]AM+K,PYQXT5&!%[7_B4<Z7 W)) ;/O2U>1M6F?'\;E$>V?_97
M\ET*M=%0CS90O6!^7T_LQ0OC<V'.\@Q&AP"U, H<6@$<DY,QF:!XIR9:G?(M
M+A_[?.R8W:7=XQ#P2Q!+YG6!T7NBU34 AT^MVE$%MY6XA_QZSJ"Z#D=R99(2
ML=X/9/+6LR9'71"<4G21U7/K%NL^#37>DR75KQ:W$5O/VOL'2>KL_&P))" K
MVI*5HFG?KT ">)0(TJEL%>E E/[T=^/1ATUKVEGXDSXDU_,1^H_P]1J0(NAM
MKX:F+T*#PB+ F>PA*<Z243++;BGWW51X_=&/4(4[2ZZ!3;UQ!OG+;[_31RPV
M&SKN@TFUI4#!.HBQ]H&O>9A:UI&RQKFHV@2E.X![/I94*XW=)=7>%?X;(5:
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M_/5\G%=% 5PK5V*F0\](#BK'"#'G""RYY"Q&XUV;B[3;2 X?,^M;6Y,>1=W
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MC"?*:I$3:K"U5YZRKL[)S0&R5](+'@,?-*9O=P2O7'%&D]#88]\)=74W3YQ
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M#FG3;\/R<ZTZI__YQ_]<S+Z%TWHT; ,:N94\1 E)L]K2"05$EP04PNQ"%G0
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M<RM,E,E#"5K2,<Y3+4CQX$2(FM-E(LP>NC4 P0_UZL)5ARNW-@BY$=DUP)/
M.2N)69!,U0$VSH+/%1;/(C.FE8M]P@,/ 'I-&M62FYY32G[^OFWOEX^+G!0Y
M22'!.L?JXZ(!SR*"2(K<&Y,]W^SCTO[U]D%TD^=B'L2R:DW32\JL+)IQDEV
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MM=LA5H#KL1\#(';-UQT \C YNLT)'JI >[)S($4RD2F,IN;6D&.OO%80;=#
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M2](]:C,V,%T//WD:5=>DI>VX#I.]M#]O3RC"'D*?3B5RU,Y9+T&&6NO,68"
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M W*Z:<B@2$GZ0KSR;(>44 U9Z[@H;R/2AAEX]^X<>\OCEVO[D0DC48::*I!
M^8A !X^"E(-/,K,@QG[A6]<Y+JKW%^66X,E>T;([1X^[L1_7V)3$2/LMP&S-
M0.9*0I2U8;M#%[V3Q7LQ]B"_O\QQL;RW(+>0W"Q$=O>D6:,+=5"80@<Z:%7[
M\DMPSF3@.7/T);*@AP1$GUSHN(AN(,PM5+<*D\F?Y.IB>7/QZ6)Y3OC46A6]
MC]8E"U:ZNGWM("BOP=5(+4.!EH^\J1]:ZKCH;B+0+82W"IN)GXS8B@^3*>AR
M &>1+AC'#7BA/3 768HYH5<CG[8>6NJX"&\BT"V$MXJ>748#;KF':WQ185;9
MBMIURH&*49,)23ZB3M8:[D1FC(_]PK<O=5R$-Q'H%L);Q=$V_(0U.EN2\D(R
M**(&@*21X*64H"-WY!YZ@C@R,+Y]H>,BNX$PMU#=*IRF?N*W7 5]!<Y(;T*I
M@P==3;7-IJ;:DC)R,B"3S5*@&VF.;UWGN(C>7Y1;>&X50Y,_.7LKIKM&EUWF
MDE2.;ICD:DZU@EB]AZ S.0I6:RW2V!-\VT+'Q70#86ZANE7L3%RC6WF&9FT]
MHB"7@-5V A[)F& >HF(($AG+-?\V#4I&>7*AXZ*Z@3"W4-TL9G;;:EQC8]F6
MDKD"X<E65++.W$S"@,XZ!$4GD-OLQ__D-[UEF>.B>6]!;DE#:14PD^_G)#%R
M$:Y:'[[YNIB=$DQ[';X59%Z@A.)=/79J^+:05D;CBR6D!<W8!\['5SPRZAN*
M=XL6M(JHF9]NIU?8:X>!*:S6A;9UA*;&")$Y"5EH45*)6:J1*0Q;USDNQO<7
MY1:>6X73^$H=Y5H9UV?2&J40*(P5";Q1&A3G&EP@F](ZH^A0$H9',X[PQQ<\
M+N8;"G>+"K3+2Y.W' FW/H?HPF%!&6#&U(?9' E<D(#<:6^M9\R//.:WKG-<
MA.\ORBT\MXNKW0W[^776A;1,Q.A ZCJ0DGP*B$'H.LQ:&!%#27JT4[9UI>/B
MNH4XM[#=+#EM=?;8#3-#LG6L-YJLI?=@4K% N\[@;=*0Z12*9':B"T/:/@Y>
M\,BX;R?<+2K0*MC&-U!>:>H-3"ZMSI9P,5G;E=;PK\B&!,&%#LDGC&&7R_W!
M%8]+"5J*=XL6M K%7<)TUSA_Q;BX"(OOA'2=3FNDH@T+"=+5SO;986UIK$%F
M--PY':7?R<I[;-%CU(5F0MZB#LW"=2ND_-K_I"OL(WX]OWHON$8K@DVA2')#
M6:R5[N2+>B\X^)*5(,]4^['FW["%CTLM.@A[BVJT"N^I.W%FN8XSZ\@Q:RW
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MN?TG/UXM+ZJ5R-=?2Y #DWR%Y%)E6TE(+6VN877N^]I$I/O6.*+<HZVD,.W
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M]"00, S#!TZN?G,ZQ>;J:+DK-\%9LU8V^01.M7QOE3UOE*^Y)(QEO<<47"W
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MIW*>0<A_06LO68_SFM_/NI,V\YAO>[874_9@T 2(B53K[JG0:"F+/1+U\;D
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MO!F^7_^52R?+J];[Y,_S=B^\K<O?SE^=+SY/9XW($R13LW(>DL "!LD",K#
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M^_.^5\S@%F67ALPFM/6/8-U!W6$B44-)<B. ["&&L:%BT5@,Q!=K:JD)6FE
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M;B&V7LTU$2I;J*C4Z5)83] 34RH&X'J/60JWR;J*V&] 6%]UXB[2#J1+#"'
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MB.A8D^TVC)0Z*+@K-%TEZ&Q 5-?VSVO).E#KY^'$-^W%^]& @3X(74(!J7,
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MB>LH?$%5S;[N9W%EQY_%[Y,0=L(#V\=HJ7.83SU$A2::.>A,?3->0W/3D41
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M)A%Z2E]#AUOWW4W?!9_K"] ,B5=#,@.9LMZ%$.SI<R4^QS\[Z=9-<%2=(>R
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M-"6[=["T6ERS1*/JZZXF7C..K0U+9#'M*KKMO"D7LP=;A>G 3QW!=>2D)(1
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M)!A##68\,E8F5IP8:%.0#)#NE.OJ;X$SQ79O2WV\/TAI:M?QQ(!Q^"'KGY8
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M"Q#3(R]]!;_;Q6'*AQ-1RB\FQ4$;!KZ9HOW-/?F NY,]ECMV<:&'/,BPY*N
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M"108T:<U3[P2W$\;J7<I\%TCB?L,7AXHZY41.]==5_K:.3%.WJI5G/;]V"V
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M=7FC450$!&2>"0J*BA@1$4$@.  B(B(B,D9%9@&140@)BLQ"5!2.H$1Q $1
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M$EJ_SCO4LOI*&)N]B+BU,F=3UW>(<E\Z-2#97,GZY*PIB9^>@!I.9\8R]GS
M-MYEF3O8BNRU&VUB&AD33QXI,5_/R3OA.V1#FMA(F!T_/*!G2E&+DYI.OCK
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MH$URO>JV]"=?IH?WXYJ]@\UQ9VL=TWVN1;<RI9^@'F/"G^M-+/G3(*CT"#.
M_(2;;V'YH94* 3[610!AP]!^\/$0J0IG:B'GR=Q\][7#F351VS&C/=U6R\(Z
M^.E-("#H)$!?!@7[(!1SG'T0P)&)"4Z"G$>*^F&-:6-E!:_&B&PCAL1\T&#*
MTL=/GZ]7]JG$F^?'!U4=>7'M_O&",O=7PB> .=9!MBPG,Q A!"13)./"A0AD
M@<I\M"KE)8]M9:^6XZXIW)<7)X.]=I\K[% 4/1NG\7GSHO%(12T=S@P"3K*.
M J>F&U"\:%5.NG>V9_)L6LM8Y_Q@:E79:XUM7J,=U3%W%Q;@ E6VCB^BK+])
M&-*R_Y\KNHU2@RP(W=H"<%U,2IMN\ 4LX:.H(8(K%Q:7RMX#=UVNF;L* 44;
MILTH3MMW7&<T0_->RPR*?M71BV*9VB2+F*\3>8];*Q>FGBZ2 )>QKS$OS6'A
MO;^]-J:7QV%)1;*#$8LVIP<(+H65RHJ7VZE61=8\<D\Y"2NS:OF_W@N3/N#I
M/4B%H\C[1'HFLA!;5M?+A8DA@',&O1/KQXJZP(+YG&J#*\0:C6H]ZA:>N:I_
M51DUX6:"6)U\R!%G+PH1[CYRJT'[KM3(4\NSQIJ-Q9NQFSKOKL4B?>##RR:*
M3JD4.9HKJ?V3W8R=P[LAELPI9<P.=YY!]P)IB ^G +64L"8/^BCS*D.>46/_
MJH:QI<G"ZO&CV[.6,3T7PCV5?5G!(3T]QY(OTGT?\/X1_%&CM*4>=;O1?92^
M.T*_J%C/A(K:!N@>36\95^\]^C:98S]KPZB7^^D8[=7*-J6+V95%4QV -=8-
M+[^9WEUB!Z4>SQP;?[OS6[<(K00C,:FH!$"T=\LE8.<K]'E.(2B2MUHM&3@
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MW+0([$6RQ7#D"VV /VL;6K%[$K<P9LL^WGO%?S6U?9P8IS5?)1S-/D%VU _
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M*%R!ODC&-W4]R)"*;$#MT!-[]U/6_!/G&_[ML(H(SUCL16V-A3:5#%.M2J.
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MH'JKFB: ]Z(]_D 7(I@N65^Q3;6(2#;\;8C:67.H:1QJZ"E?PP%!^0G,88!
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MUC4_3!_#SA$;;S=Q89GU^=A+D/@N@JUVV;OGF.'TJFDP/*I/'Y+IP2D[G>)
MI@>!%0HA2._K\V@#/)O0<AHD7\*#4_=6FC6;_'>FC;L\EENH.JP$[GZ)VONK
M&-HM3OR#]]/F@+DB'EHY*66*>_O?*#&5PK/O)=7J?D>2'A-X((HSX<0H3PQX
M&$Z<)\I["I3WRKWU>4&=]6#=ZO<UAA_ K;Z/9)V(R**[:@T"GSZA-BX<0#U>
M?2FQ=!NZ5OMP'&BT.'J"FI2,J^2\9.PE!W&TE8.H,Y=4V6)95*>7K3&0U50
M^B("P.^,(V.8,*H,=74*]W%* (T<V[,QA"P\;HS=YNW+N)@-F1#-V1&UR0!.
M'-);0<_Y-#1^&M"@CRS1TW()Y,)>;Z*!YF>1+K]BJ#$O--]C&\QI^9<#8BX"
MI]_#V>'V2(ZSR:"?%_HH> $/\;Q(CMUG-[K;52PK5+IT_?I;@MCL.;7)+L *
M3[\BJ WJ$6[A8M)2=+'N $_[&!&_CS'3YHDDRT G;?4@,"89FB3%=TGX$=TK
MN4*8NHN+G*T(&G]"J(34%\12LO"JF0""/%5ABQWM=^;"WG7'K2I(+/7.P>E7
M.=J@08T<7<ZJ#35/L["*"?;1ZZ<.9O2+L6V@H<L\:AS =J+PZL'@7G9 H5LY
MNQ35-F/"?*E5JYL _DAF0T.K22'(U,._V%Z:)<1.)\5F/ZA-;N.\(Y"R=?U:
M<Z!I)44'<&$95=@6<VA6!1^X,=[#1T\S?_2N#W)AI)=.QQX*$89'\A*)X'VJ
M'J;&DI/[8/9]K4<?ZL5ISNDN8H.>'J$IH=&,;IUN4)199P91.XLVP1.@L?"0
M'/5A"(LX7,>;M+@T>KP+7B".IR_CB["?6UB'T?[=C#5"29W8N>IP_S+7F;8I
MZ.1>+APWW\N#4Y'@+BY,"ADIV G*]*:"R<?"O9PT6/;@B,$63DI ]BV?@]\*
M*&; PS1,G/CHL?=^T^>!$V)*]QH.GH1=$]5K Q5KZ<=Z06-EJJ,R',LR(Y=N
MT/0;1A*)N#PTDD&@)!4RWE#**AEJ=M5W\59UP9$A;:FP]1L/A1J<^35H<TZ2
MV.:GG_XX\\G_THN7U4OYS$7()[W>$(Y1%'&UK0N:Q),_7&KJM2E)QI4$]QQP
M++_C%SSL$59PF8%EBQ.8N0SC8L5<9XJWYMDDON &CZR?WZMVS0SX*2OJS_76
MP2!C9JMGZ_5Q]">RY%"45W#6.3+<L<?[J]7H-# 1*UJ$R#9\N^.1-,FF];)-
M@R5EQU2BKWNNZ;IVX)J^ 77#!$[&;7:F(P0.;CVN9GM.Q#)M><JNK&8!?[EK
M&*& #@,0] XR&R5AH(2VZ [ "SL8%MO-EI?_?.R@=FARJ?+K1Y-=%R7UHT($
MP!%"23#-D/86;$#!WH(M3VE<6%068_?^@T=?U>IUV-^ZNW9:00ZV^7![/*,
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M(I X_YOU&4"7S+!W?"$<U5Z'QNFS"[N5]J?;V+DB)TCIH^BKP!EW_O"-[Q9
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M@'R@2<UBT<A3I2+.;7>[G9Z$-OQ<#4J0^/!M%7'-I58&=.S]^F0T[0LS$QT
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M0@5GBZ MWL.'^NMG+P2)+41@BS?=<.8C]TIRZMHT9R>^#=QJTJ6HW*^1J9H
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MN1D).;P#B@Z R +"O5"*Z5!4LU@,P[O8SV%*++Y*/:1%2@KXGF?S;%G,T\Q
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MVPI1W_5*=D":1YM,,:UH7V@J@0\"0FK:2"%AHO.XJ?B$WV@!V!FB<6"\W9>
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MH8;'LF>%DQ]:"XFMC0_$$-GT+X20 A,@D%XO<,("H;.-%(EZTO;T8#]4L%G
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ML 4F'\\=_QYS%&^Z?MD=94PTO/&U\^[-VC4A/8,;6C%^"H)/<[8JE\WR=U*
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MH\0GL>0AN&S([7LAJ?DBJF\"6[JRO5HMLO7/&1,*ZI]7?G'9_V;/\"2V+&U
M;(:0,-PH/EH"(%%-X<-PA/"\!FV="@?N-!F]*;G]+$<_ZO";@LV,_<ESJG-)
MRNR!M[ ]WLZ*Q9-+/QP,@Z*5Z9=V(3UM4YKH$)*=<"2&*_@.O,_T]HB,@KWP
M8];[ Q62KT(?Y"OJQ;M.C7[DJ17<V^QIB@FP3\8V*[73@U#&/;+RB12WM%#'
M(3A5?*K/^_8JLO:!2C:/)N)M;&#6/JV^GRUE1RX+Q'J+0=P^%DTQ1'1I^KN0
M)$(-F^$X5*)&R=%I#+L;"*K+2@\\]0XNY=CD=\6'Q[_4/EI%JA=H#-AKG [4
M<"\-6>U0V9\-Z@."9$RWG=2Z-7CS^5Q%1R8E#NXVJ9]1:^\XL<S7[-_QMBO/
M*Z/ A</YO4+89?$;SWBITQC20UC]%3,%:OPK,HX;+.[ML.I3_Z?=%4?"\8%_
M7<8C!87FK/<-Z8^4A-UX(*J6T'#?V6-*7>T=#]>JD<K^/DRP-JALM1%'#T";
M =L]R!DN<MQ6.1G#<V7V"BJBMT,YXT^8R(<!KTC5\-5#3Z+"GZ39N+_GNDJ^
M"5?"$(>-M/(#V+:^285UXW@&7Z\;C;RJ^2%\_8[D3'ASF"-+/<YS,FCA;Y9F
M'UG>$I&;X9?98CVZ*B#&0<*PXZ#O]K3.#GN^"4<8ZM4A>(-ZX'7S8*\?!283
M+#6)?5:05?8KE-+^Y-/%5)_C1>:_SK]8=#/WN#2X>81^,'YX@2W)^[3Y&8'4
M74CR'SO#P5*!;/<NS<4%;E3RMM5D).C_+N^;MZ=UE@;_D5_\G8O&LTM#(G%Y
MZ9!?@BELA;/=G9,L"Z$J]RX<^'%G^&G\R:Z048GU]Y0YZY [_>/R96U8%\E]
M?RJXTZ3J'H=FN>K-)*@,,W,)5W'3<)H$Z!(!&-.N@;&89Z#9FH<B1F!-5O.+
M?NRICTF9SU7^2#_IDQNJC\JY?LOFJETL>[34$3;GYN3?B\9!6&Z&$R"O/5UI
MTW6<\GXFI(3W[X!4<S_^\:;1%8GQ/-M*J9 C?F<]9X<0^_TD[ O>2E/^,D16
M:%+@$M#8#3_(.L801WPV.[SF=QE0#XI7F(BDSZFM8'6<WS:W92_-.]I>&%4X
M<F7[UF@R[IG*,\&#8 [[R</,3#8I<P&X!@B2:(-)MSX,[Z8 KK>X5IIRL+WR
M'/GK11N^X[7-)1N7S\NJ+%KM@\VK)="3KJ-CF0F$P-$9*&4YB7X.575F,M(^
MM52Z[J']F$DL"2?J<[VCP;W]^,;WTK'SAA+?\]"O$I\7'#=7?+BI=YDK'Q5-
M4V>6F*@";GUP2)<I6>;"^!EJ4O_P:,:;L"Z75U:OUZ,-(1I_#3V+KO!-5^:>
M+;\P+JE2IMMTX*C!7OV4(N;]W[AI>?A7*WL00;'&BPRW^P.>#$<J-'>I:5CW
MK"+KTR]7B=PG'^7Z K(O%.T8[1TUP,>0!@0WF$"O)7@:Z!AU: '^IM3(-WS>
M^&-ZYY=CWLR,'L_1L['3 4]R75R<=9]"(&_^GXO[_W[A1J"@9@ZC0/ @YFNS
M-NN1?GP.6U;?C73;?B'&\<^+/2AV8'_8G<+JK]YF5L%?.__7K&E4U2 &5![<
M:*9;H>'US&?XXRAC5WN952E%3]>D1>@AL-'A\Q]3M9G3B,* M_V95)O#B/:'
MJ/<>![_<^'#29XH=SP>)R*_J- RH2O5%YDQ^!@O[X\T*+QA=,=,'[U)FYR(N
M-]1IOJW5]-FR\CKU!!_H+@$[\9.>*KZ\"Y$DD-(7ZB0'!&<<=R&TMC8 FL90
M7YP+UX6F11%2,$)1R$/XEOLJUR+UZ*FM!;R&#9N(M?YL@3BX!01=2S^'(8K!
M2$\P35,]6 &&')A!UUJ5:)$5S%\"\"_(LT]^S]E>*K Q>>_O]4XF,+_BH8YU
M .*7HI+E$./+I#N&>!+C)V!(<RRF*=>!R.I9]&E\.EF_%FI/':A'F#6$0[R2
M\9VMG=D4X,,S]7]CI]3V^5WG-:6Q71@^[4>S!(7I$FBM)E"5?AH5Z_:Y2[W*
M4F%<S\ZJ?Z>R5B S=HYVAED6<3HIVGHE6)Q+0>%NS@4V&_PWM>C&$"'0C,%M
M^@7<9@P%*PAV6H'W=\Y[NI93M/<S;"89IEHO J#?[BW2#;8$3YHOUJLGV/ ^
MBT7TVB=#!>,%0+4A\FC/ M?7ZYY*I36:>IM&D-QJX\)HT[FYZ9*Y-,3M0%^/
M-..)RUR)8">+YQ4=BEKH*Z(UX] F$X>**:-"2IV+@@=G0.SEQ-X95N4+P9GM
MR)<K$H4ZNE;2-GB=1KWK8S69SW(N@[V &]E^D!U*.EJ)]IEXSG'&.;+WK4]>
MP7<T&1[I[KT''0T>O/OQX4WV?2,C=577RU9L8A>#((Y^G24AB=I0;[0GP,*^
M"3'3ZO@\;KT+N=\X$*]&F-)7T9N(6P\0Z/\]UB4DR3&MH*9X0]9N:[_;J\__
M;^\<^_^O___Z__KE V6+YD-,O!DOAJA/"!1PHU6!VYI]198E+SV^S@9-*DI7
MTXO3"O33Q6$Q^2;OK5G?M6(O<[4Y>+!$J?!D1C396W=0]M!D[1]-!8]Q,GZL
M6=IF?W]4F Z/?/[AN"7_@*NQ]]3/_@^;XSZ:&<5/LWGRRL84109&7)#"ZZX:
M&;2_GC&=+WDFJ+-RN71:.N1;;6U'U_S95@&MX724AOHY4O2F&UT_?AP6SJ9.
M,> F&2XMH#,RN>)H=GBR[*W$S6\FJX)%OGY+C?JU/1NA)TZ>..:;8+RCG@F2
MZ><8PLQB$TWD(BR;(*J'XU_]VTK]&C3Z<C1->^O[R% (ZM$1+:50$?DTCW>.
MYMWZRD18#O;@+N3Z]D'#/NC=78C0[VWAU9-P.[^HF]?DYH*BA?=Y!2U>5;SG
MKQB>;N'FW7O,_S(7W"*F:I./[L\:@C8$--?N0C9UJ2N]\9S-^  OXU&Q8/4@
MSH^S0(;&X[.#?B7M(V)/?1OP/&P:>09V+6?F7+\J"9ZPT+S=FR.Q/M83F'+F
M$\,/8?H[-\$F-VS27O\!Y!*IPN\M)/: F-M3UF=,\]^-5KK<CQED*B88FL,2
M!00*ZF_1=EQ&TYO;0B>WG+U'<I\<1JI5B&8_.;*FLO_SRS?J).5-&4":]@)0
M9F@*3@]1YA,7X8?B6FQ/UH(1#K;5?B;7; <4SYX)^-:^OS*$KQO3,K613SU'
MT<#PFD'C/YD=^?)G/6WK67UCP\3^XXS):;JS0<,NY'5'WE&HOASB>DL+T'8*
M\D=-_3'83BTGP[KMN0QS6+KH,V-=AN6U$ZZOXJJ]:VSU^VI;U%'$?R^*+/\Y
M*O)OH2[;BT.)NY!L.#<>A@K&2**/4EDE%#YIVW\:R/D!^+R']V".S@Q%:9]M
M3.&M O9<<]Q5X+S,Y6;ABSX/YI(P]^>%.ZDK?1@1KU4I_7O(MQ/A/^7O0MY'
M'Y-Y#5&L)W$\])%[@2%>(9 >[VRFT-ZDT2/1^EW-[Z%!S503':O<J65'*S&.
MWR[B@PP!YC,S;M8X7/ 9B*.;,EP^=2'(U<5I5UNGT,8O7WRIR1N8]3\C+\+C
M2LH>Z/RO6=)O!&DYS)<PQ/:T(#EJ>P [XT7!YY)V(?Q?K]J_#AX7.I)CO6AQ
M8#EB1$0_\-0I\3$&C+J09*:*$CP/%I/LW#9GH*F_,\*<+/$_%3,V)0J%->K>
M-UBXV;U;N]V0?(0(H9I+_78VRBZO6I5"[[34Q@G4UM9HZ@\/]Y4II.MS-C8>
M/7"90[$4(KX$.T! PK[^HJ51GS-,V<3"',3T&75-.LZOTEJ<ZJ1*:BY*>!4K
M1SGCDXX\TFO9E%<->']$C&/]D8-SEQ4%)HB"]?[%:U!OOPUX$>094%'HF5WU
M<DY1@E9G^:+40_&6A)X+9X$O!))W?=^F^"_:0S94[&6,1:YSCUO1X:#.I%)#
MWM9 G)N#@4/P#<O.4EOE-F>O/_N?SC[1G=7_+?"_0XP;=9 VRWRT"PG<3O/A
M PVIU8N!#\O 1HI2>T@%RK W^WCI7\>.ML?GN-VO6?EG51BCI_@.'UM*/@0Q
M=?R/K$!U]0&\ =#:B^.?0PT-=/3=B2_TO;NU?=Q5723OX&*3R$'K]YL3[#EK
M<ALQ,F1([&?Q^%&X?=9M][+;&/(AJ._NRUV%@ZX.9T3K.5R68O;)*6;ZI^_L
M[_51!A:R3& (RB@7*GG0E0U>46WC?TQU-I5;.]*27:V_GW69R#ZW[\PSOHG_
M&(E+<Q;<#F#E1N%"#-.0"+_0OY+1(G%?GUMH?(Q+X&2)<02F4[4%_N-MKR]4
M//Y= ;:UH)A^_L<#AB(^F[QI$O!JT/21SC]16\Y4^;8L)1V>8_EH@G;,5VO.
M"$\S/68G)@":@JW_!FM=R61I6EP#LA=[6Z0VS+0>6G<%A/!-)H4%T'5ZPB,4
M[+EYEI 'NM5.=W.]85OR-$5&LG]>MHX-R'\X.\?W/NML:%%&ILMR]Y=G_KI7
M([CH=OV_<GZJ@!^+]QQ=*$A6<8*A#MT4+%^+]I09]PH90]WFRW)<L'D2_SLZ
M6N+FD'@UCJKQYD4L)<$4G[Z(%V1]PN[#7+<SVO8 A:DIO?&Z]76HO*U=2,_.
M1T,:M2DW31C]U>-!7J8TY+=\I]3_\#ZS'9X)EV:)L$9+>=K 7&KCX$QT,AH6
M]#"F9FT\QG5R3:P^2%$A-!BBV"C$50N)<G;;#W#1*IDEA."<0[:+T.G>18FD
M16]9296=UA3D@>%75_LOI#E]]^5]8*YX[W1_],3>YG3$?4P887J/>S:QZNE'
M4-*+@;DUZ(L [:Y!\QO0RT[DTD[<4S>AV7?C%U.O94UZI3[H&3D^)-K(VP>Y
M4_)_>ISD*-H>Q)*U[\>+8 =D3Q!^/LM82A8CYE'.FKDO^FS<_+U?D;0OQ)B$
M'=CF1M\"GH,9O8[_G/KO3^A-7SD2YF^:\[KT=ATIYRPW1";_O]W739 Z2WL$
M"M!U4+?&^^&R>+4?+,G&"63!T 6I_!&E":W'(IJ;95?>1ZA"L%K' [N5#W-^
MXKII$6//ALK98IHYR*2@NOB :%H:@']+.8+>9$DU33P*OLVZ4/U^91JOW#KS
M)N7ORRZCQ6W^OW"1>"6T,6A(LK.GI/1CCZZ:20'+&<'A47'15PC9DV,CQ\P7
M%!N$7NJ8?_]IO?^AN?0CMZ<,+F;M7N&9F> 5EW$\%\-M_,_0G,"U./A%]Z76
MKJ;LJP-'_%M+1%S2S7%+0ZU^&V$U-V[BV/Z\3<1.#Q(;&.?!32K4%GB3>#!^
MO&9=]Y]!'4>V_P-&?;:5AOER@M&.>C=+ANT?SC!2T2Y$ GW.CPQ+P;1B>N*<
MG+XH":W>0<L:UXO"+UPR:1.N.(@8E792GGG[DTT;\L%QZB!I>V,16*93_@X2
MTCJ4$QG:E7JV+T-8<A-^S<VM0?[NY0**]R$><\Z'EA+>^-%N,%L(_O#9?78^
MVM,AM"P@)6<DH4X&R1*V"U;_[*NTL!13J7,;^;-BMK136D8 <B=+? FOL=<&
MMX]AATG$:^W5GKM&44'6UN TE"<@7NJ=3^.*9I8=Z-5!R]_PSHX-)L53OBUD
M[!DJ,J-+E03E#Y8UH$ZE-3$E+<?"%#N^Z(=Y4C4W:T@6_U$-1^._5,/A?V@N
MI>=6RA!C5F,0\!DM&MT6U*2&V$PA(V>OAR.;0,7K6[XMQ69VHP_5:I)Y#%H+
M3SA);^Y-\USPS(ODE!=7UCTK6"ZU)9VC$5ICLPH6&H,0D1L<)/Y/!]+5!_$B
M&*(YQA>7 Q?68HF@)9B5: 4*5G1UK.E.06+96G5$E/]:O[N=5$"9W*-7"YG"
MV4U8MAQ^1JB'$>W3"@@'X[7BQ^.%@84,Y))[TR[D4(C4<V(L:F-6[)SHM<HA
M=/G5TR:'KN__^O)EY-S94;?QVC_>9DB=^36Q AZ#W/;#^ZJX./V%)ROW$/O#
M;]PLDN8TM0L)MB'X$@09H6-1@ND2'4=W^K?O-U$U?GEZ]"K>?/?+.M4W*?%#
MXE"TV^E3CAS=7*\=7/YXN]E^BNPLB;@R4;M14U,['SLTU%YPZEF:6..[K;X#
M+I=M_J-LR @A4'M6@1;(;(R$":.P-#C8>FU1QK"G5*FX=V:KO/+,B7LREBJ^
M1=:.-L*N5T50.4^$(__52<LE0'[/J+S$X6J:AE2;-2_\5(\-015Y9:1]Y\Z5
MSVS4E16#\"@"D&<\UW'<XP12%:Q."6>">\&:8(FWC9>UG;"EN+_Q;G)^<-*Q
MRHF/II$LC9F*6JR],]6;DPX]A#^!NH*:)2.R(A>$KF_&10465>;>;NS^-7O%
M!FFD_DHNW4XL]<;-1WH<G?^M[I;;E^8P[3-C6U'#$8ZM#0V-=U>ZNCJ?^*5S
MY]KJ=M9S.$-L%/?(C#2"'7S/,!/^<'LY-S"K&,9:F0UB2 GEIY%"Y\).?T$3
MZCE*=5=\$TS7TGO ,"J,O#"@S=V[N)WDHS]N8E'VS=O;RVMMQW1F-$RO94K$
MZ](K>1%<PW7_LV<45&)J9_X'O.[:IMUCUF("L=-65JU4Z*8JM;&7Q34>_E11
MJC -.3DY_?0IYR\X]V$2V>;]X+X$4Y'T998HXRH80!TGNA*$64+@V%"?D<!:
M<L.7WU/:R%LO7+XLHJ]-5*ORMW/*"D0^@CC8%5T/*XO-2"LXM>@X9KVQ[_7=
M/!O3 S$I&U1Z,&L(UHQ-,PD@VT\3%LT*%_D(*3M//:,SO"P]?/C4GXA/*X@^
M$KYX4_I[WXAD. ^7&,>:WO]".>1$Y4J-%.3Y,26K0+W4CJ@,HN7^*XS>2?IP
MCE^5N1(MYQS[\ J"H9^RT;@+L5(']G:'\*E#6<9>&$F\$$,/_ >,>X"GJ3G$
MEG@Y@) :.ES9_'R-]Z+AC3P>*\@]2_/M&;S_+B2%$T.4QJS*+@CN0H!#2-9I
M<Z@YIM<]?@CV^Q9A[[>&^EW(8M/__%/SKUT(XY0"BWMV%V)- _=VSD1@J!]@
M9"(4L%S8L6KM9?^_OYA-JB]S?8("D]"&4>91W-Z/&C48<!-CP+[1[16&&-V"
M^086HBE-.P-J+H9X>W7#><IT@]UF7"C#(:_ >Y03 5&1Q_V]4!?,*^*F9;]'
MX\:QH#IL@V,7PGF!3:E"XHFE1LQ7?^Q!Y87>&/TX8WNZ8&+D>H:--6%RBR-[
M3!./^/CZ7X'YZ9]E#VBXI4M!GC&>"%Z^>E_A?9E8\U/[O]XTAXY+,J3BV"LZ
M&(RF*M"4.IE9A.L+&7>T,BCV]YT4S:3:J;*- CA:2LI*X EYO8^=,S/FP .S
M#;M0]3\(EE0OS6,74IZ_-P-)^3F[$!D<Q8FF"KX"HDFX31<29F_S#ZPGS'#0
M;%_=5!G\" KNW/++[^VXOYGWP"=NLV %O=P'5ML*%ZD/,+6$/27&3R"E^1@#
M;YXLYG#%]T %_KN:M8WQ4:\.>F C]K+'_HG'$7=94CIDY]Q_TH7R_ZQ;V%W(
M_VP<!S:P<K/GD6V.,5,\6W^3CBXP;B6897R"7=^%3"_VWQDFI)AH4E>(=PK*
MHI4+@ZY5@95C0968K>>*28_I'-XOT.^!%!;W,-L>;2 75=L2' 0B:"H /*7+
M@;Q.C'J^[AE74ZU?T2TDPW.+@VC:.34>R?&/C]I*FZ+B&,*V+#XNZL-%MDQM
M!^SADWCN^$\$( >7Q-+Y(17K ^67YM-6H.M$.N2G6H^UIUG?DAP^_ZCS==P"
M70+E1CO'YG!P"M=>[05#*GN<C#-EC.N??G/K=V[S&NFY>687[!2LOZ+];-44
M9PA;9U?+%U_K"E=J>VO(XE6F*S LP45J(TV*V:2_"^'^X=>+5_=6OS@>+]][
MH.4AI40I3.?#>JBCC^_\S_,%07G6' B7\[YMIW&Y,%(AH3$GA8 @@&J&FV<H
M"^#Q SW!NY#&;P1>!8E) Z/B*^ M>.I9YSQU:;Z\)2V1PP4WY;*^FH<SGCMS
MND ZV2MMF5G'4*"+8HCVNQ!_P9E.GR^;:*=RAE$;50:7B1;P>SG+;+U@YS-B
M;.MMD1<D8GQC99A';UA*--0\-%Q]LP,V("B+(1ITA=RD8A;A&TP*4A;\2R."
M0X)?3=2!Y'7[CGK@S\<[YPUH!IJ:F\.XTH5KX_.Q&:2,0]\?M?0Y(\ ,%D\C
M_1Q[K1G @C#@<<G^G*][F4G4>S!^= 1U,+.Y"AP,HZS;N/4;E79,9>[$;;YH
MSQR.-NVHK;DY>[[F'6T86B .3&)(A6POOOR+OH_A!BQLL*UX8'H*;4_R#B%C
M[EXJH1N#Q?TL\?;L'KI%NV] 1_ZB2!N!KN/I^0:HG#\<T!KWT$;G'<?O*H;,
MPXBH:G9O1)K?.KE]JAC?JJ!&IP06]"Q;?\\;LVR3+@_,>L*G1:DH%S<A/8CP
M@>]"N#31%J RW1EM"HH#ZS1QZGS:8LY, %X]Z"^6'P&&O2;&50<5V(H-Q!:6
M3C^>]>3!?USZ]CH\$S:7?K:#W>=(S.89H)Q2R! ^<66P)DO4B=J:WA3"1E"4
M7Y]&RYUF6FEK7I,;QO=!VJ*-7,8(QV=O\7OO7I(?Q5<RY*GV1&1:_)%$"HYH
MA^R],UE<>[9!BT!N?U9J7&<>^J3L7<2[4\H*>AQCJT$O+2IG!ZOMC[;:[N-[
M(G]%_7U3N)KQOHB[\'PHX&+G1&L ;]+]P41:.?,YV_.R9869+]B$5YL7#!RW
M^]2_.5GR>LU'NL5[2JJT^M"3B*,+7066%K<4=B%.5<0.ZS,/L%_6_CVT8WOO
MP)XIFZ%II?K@\2BZ_:H4)@O-19$N$?4"?' !42'5W^9[^J74^53E1=<"4HW-
MWCU$DMZ<.0+Y9\7B=:-'LD;V*L*1OL%$6&-0X** K@60D\@(J?#ZP3K4 B2G
M',J5S9XI>*[Y1UR"]J$Z[-9=G$OZK<: 7MG#OZ& QT*B)V:#+0DXN9O:0"-1
M\RD"8E;PP#I<4-]6C'O'M;QJP7TV[=,N).YY =E]%R+Y=+:Q;>416/X?&6<9
M5%T6MR[U(<T!0-Z%][+4J O9S0NIK / T1?"32>5FIDOJGZD</G:TDX];PT8
MZ2M"'.G9,H"1*F!-/EGL]:;#'KT5RH]FR"R.FK5S6A0<C ;FT^)(+U\(O$*Y
MVL:NVY8$ACE.Q-,^J&LW#(N-JKUT\W<HB.3G4$XA7"]QHJVPV^^@]P&EK>&2
M/0N"F(! \$75]6R;)/VYJQ:AX;RE,L];.M(4 M^?'1,_5O]FT 5,><4:Q0(1
MR25 9\_#QY'0G(7&>W"P^N*YU)7)W\6=_:V$8U&YH22#?UM5I8E'%B0(B#DH
MBV?/-^Z#TO2@*]\T4WJ\HTDA:"FJ?1KNRG%<"D[36TNO??OX*7?YCA/]P0T&
M0A?2:YS?M<^ -@ --FO/XIM[S5J0A;Q-<0;A@!>I*7[_IRZ7:\<*!KVHQ[_,
M#??/S%QJM[W?TMIV/=!?4;'?R3B_&\(4B+01*W\9<.T>]SMY@AB&- <%594W
MTNCB&*+$\4XV],G:F?WJC9>GRE;=?$%\/O_QYX#B?"I.3*L8>_@H8']*G*Y*
M%:7 >PGWS80[V>C:#Y<)DI7^M*&@'5N]7I1YN^63"N=21>Z];(YM>"$&"-+.
M8@FAS^V9@RW$L]NHX2FOUCZC6OOV]\F*&]VWCY9Y^K-J6+,M;%VTXK6A<-/V
M0(0Y%(':7AS<V$M(^,<L'AR4AN_SGF&W_DPM>;0C>!=M5*\_V4XI0;YWWPC]
M\O%F&N*QWIN/+F=^O? ]:'$5M<WBM5^TG\ZA)8)(P(VVQ"SYO0O9%P25U'=X
M#DH/XB6HO2$=GB&A'!D7)TQFI4]K+!>>RLH/3!NQ!,0_@%6,HUS 0PHBD76(
M-0IO=B/B]@?'']O;;3%.'3*GIF2@-2O._I44*/,4:OAF^;0K6?PRS_?7%WZ*
MWO=C+V+ #2:!%F,/%L=0!SGH>JP!J&2D('3=1Q&<(V^+O]V^'W5JVSX%#4/(
M#,V'2%KJV#V7OR#OH#484^G^2/(=!.H)SM(FIZ)P,\@^:/W"!@[ V5%'LTW$
MR;.FB,&'ZRRU.$DK@!'=.9Q5,^7@Z7-Q*IKG:%Z%3;CS^:2Y<97:++H\AGC)
M3)3UF0871^M3C7L-87R,:$!MQQ:3,2](U2H3JWY^MM[D_4N+R,>VQ4?DLK[;
MT,K4[C>HJ'DM8:8[!PM@P"4LJ(79-"039E;Z"DH/ ZV;JF'/0"S9+0=M$=G2
M$5AF4!*F(6GD-E,AK]>>><7@JT>B6"L_U[80]!1838>B+S$[X_4PQ'.$8/BT
MIU,<>9O-= [^WH8PC+YL'-\W-3!34HGE@^M7M/.9J-%6KS;>\XW.,W]S]N0S
MP;/LB:MAL2TM30BR!^5S^G$YI1#F@UZT'+4UX8UE$BY85N=GE_E,Z,:KD!K\
M@U#&BZ9;CE?-IE=J#C4</O-!>PY:Q\5X'$V$T17CI7<AX]YOXSW!5A9O!OTX
M^OI>5;HN%[JA+55JU@)L)VLG8(!D%)9LQ^RJ7V\QRBY&R#S="FWY]WSAKUE0
M,;)0Q$#1/^ J["*&]'C>%)CJ0X+*542X$,IQ+::V'/1^-O-N?-J.0]2BRJLB
M(\W%9H;\Z 'WAP>"!Q-,?K'X6C)>8XA*\0:@P2CE>&%*%%P(-(@S/F,8W<.C
M'S(@-VZ;(/JDJM,Y-C+MUDC ;.)#N!JK&]8DBZ/?CO\(Y2"0RHLPO:=^CW*P
MWA,$_^AA^*\;E3Q<]U&@'C42I 7\Z;KYQ%'&;$#Z=I%[7HRK5Z+B@3R5SU*>
M6#9-"QWE9(U @5O/%S!$ZS]?@-9> 6/2VFS\R/QQJEK#==<[%;N0@+BSOX:O
M+9V+7-DL&#86<M7+.GQ7'K%$R&2I 5,;"G07Q@603->T6Q04VRLN&F^V/FE+
M'?4 $,G+Q9<^;P<66+[-N/@XWR.TZO+5HN5O>F?YIC4=&. S-0XZ@BX2/RG*
MFEG@T(//J V1H)F,_<]1!0-L:QSR!$GN@S&8 !5-F7?ID\L859G;#6F\C>K5
M'(E%5"2H#6-K*RO6. :PTS[,,&$61.I-F3@@7@=YCH.6E]SZ"FX;UE\9K1)_
M]XLS0W9;'?;V9.J@EOK$+L3/GBTU:,[,MDV</S,+;:N=WG6<O"X=V4&U2$Z[
MB:@\<^/?S]]@5M_-PB<*WMM2JD+5YZ%!N1;*##%)&A[^-9'$2J0..GS:;I8Y
MBC;_W(03\5J]<Z6U5;7*>_3[J,F-/BFK$]4Q?<<T7)4@1RD)9@:@#1NS]]*"
M(S'$:!C"-(+& W96]@($"G.XK 6>#!6JN2]99/8V5)=S)_;=2RU9GD\GLM"=
M6:EK5+6'V#/LADWQ4X06*'&O8I,G> "P(F]EW20C4^&B@[07$RRU6-O:\-A3
M4E'C[MPR8;6MAY>"[!^/Z047BY^3!.Q!;<Q>1L<C;"MB(R>"2B 5]F$X486T
M%!T/*P#A#'K4$B,H)0B77XM"7V,,PA%MEPW#150-OB(.ZE29&C+$M?M8:LS2
MKKW\SV5PD>Z'*C(6)F%3)6@+XEU^9IXC0R[%%NFG PJ<#[CX4$Z_"W_L>(<7
MLK,XB&FMZJN&SA3W8NNJ>K:G5RY.QFL&PWBQ@RS%^JDNI%9QV?6BX+G:]$%F
MN00VXOC'T<A^<<>O JG>Z4!5)AC-GK+4SR91]/T,=V;3X$8G9>"+&1>JL$]6
M%BPA"6B[U17%:>U"+%/MT.^C3.JL;H;GZL >9RP_Z-/0L%0?9.LN4!61$+4-
MJAU*H:O&CV$E_V,[V %]>.(D2QD(&'YDN&.QW1?F2/DA/R/=YH"4SS[UJ^'#
M?K%&F[XDHKO7,N%K"$6YUQ8*'A]DB"N3)),C:VUM)C:Z8J@Y5Q)["XL$OC2N
MWKG8H7C94X/E?]7KW8"J^-4':?:YJKSG0\VYQC$B&!)).PW+3PC<AK"^S;0R
M1/Y2V-[!P; J^S&%UP)SD93J8SMBA9_[/LJ-/SDPO-3E>$&.?B4C3.P-H?.X
MCV$,C-2$/PGD](T>P1!A>"64M%NBT^?F[9D5XDYRQFNOGX6NT4+O-1S+%(R]
M>4_0^F.6")OZ=!CZ\EXV6-=)@*\;KS]FXK9($&>-%+DEH T!^H6N[+C OWUY
MJP^F>T,+S/_-CH5>NO1-P^%)@X+T.A^+UZ(25*"I@^P%QSG +(S71KL S%("
ML+#HU@MVG:.]]55A5(?PR05%H*/K5(,;]^%#KD$&[ \FP*S,-.+9R[ >G(9M
M$.F&#.UQ-)*ZWQ[H\I&;VFQ>$#/(JOA1(#JD88 -Z4J?W'(I6K;6XG2P0LJI
M(]7;L\Y* M@4*' %>J^#L+% ':)L#R"3BEKOH:_1C5!ID8+I4,$77ZYVAL3^
M>V,V[!^&LRH4FYS21:<9IR;,;'QX75:\1)B%45HW.ND\&.)UA@W=$D.T9!WX
M8:8.<M'/,$Y_.@:D]#'A1 =4HCVPC*L<5,0$PMKSG]L\SWVA=,R6*ZGN0X->
M_!)%,&<!N( [S.J!2K#T0"^:-= 3_[%CHE1V[W!DIQ>HXUVF@NF^'5\</VQM
MJ8S-2Z?51NY"FOLUHM6>-57?J'O@=\C<["D@N"E'MWJ_M[&49#5 F,XY]VG#
MQ(XL8']E'!U UDYU#'%5/?YTTJ%8U37,Z/,8PHLH_^ (;]^L1^I5_ K\$;;.
M_FZ\(ENL X[PY(4&Q(8='3G/B&8^B9<'=;V^-$/YUHI^2VT0^)\UW?7Y0%'_
MP2,\<^6;=0%0]A7W!.^&8A!W<A;MCZ+4R83D-UU!5-$!*9_$\J_/0N:\/"<4
MFEM:'<T/+.7G"_G??7\TUQR:R28@9Y"S<!J$68PA%4,/Q\O$3T&E&#R!K0LR
M:->':.,OR-JM9M/@L>N;\EXHO6>>L415URP'^:O?A;\N_A@%V4Y%"V=6[NT/
M!I5IG>6L3_$\4UUR%6 &Q?5%+7O1P=(-:UDI9<-']YU:2K<O74!7J_^[R#%T
MA/MC)7[O2Y9:_#"TH8HA#F/Q\%"K:#I41%^M/%3D&P--E4SM4H@)B#OR!0V+
M_C[]-KF>T^L^WH?B7->=RU^_Q?DT+I>]4)OW4NL7&!<_18V"2J,,,1A%HI"$
MF4DA]Q,!?".R>NWD;&NF^(/CI;BJ([Q\5:4&61^L?ND*'W.Q<5;A*F,$L9M7
MH:T!S,8L!3/[D!2]D2^9@^<%S4)6]>V%!:%OL-5KGE&9VP);596KFP@--X/Z
M)B<=O2G74;7S(ZD.Y0@J8;:1Q1M 71^ BL+\^$:_#O5T6-8"O8NM6:'-[OI>
M!)&W2;0V^19#A]6\@6,W$2*-EC_;=4[FR<GV\_:S/-F/]V9](0 7"%^'2#?V
M4AK9 =0-%@#E KT65WI*7+?/EVHB2#C:\%267,@KV9'E#^X:E7E+WVT4LO8?
M_;#/2,+M7QR=Q5M&6>!%<U%S&*)TVGWP"3 P2%9.8&A3"SRB-@V,%9.'>H3F
M/4ZVM+9+K"^9D_8ISM+KY6V;\J53N:9\3)AOXX\'+30K)Q.NL8-1X\"3&K37
M%S,)F\5MX:\A>(/"2Y^:[$Z&3[Y3IF5ZQGTLU#7]K/*ZH'?)<<,M(23^ Q1P
M.@P+QD[[4;0'X_;3D%0-'S708=$[A,@R!,.JUB9UYZQJ@Y)U(P2:O_05 /82
M[_UN*AQ^+YUPMEL=O4ZW9@_8%KW_#89HSX#1U>+'8))1VTD$SC\YB74H+'&J
MY?)"D"1!.,HKHUYJNG@/J-/DOSF.L(':^J;<U2&^F&V&T.SB0C<T"<9+"+=/
M\1QY/7\HY3RS$AU-X0DUL:BTK[)X?GW<(@")H%6U6=BZW;;,DLLO<#UIDV0L
M#9%=Q,5/E@HPW\)(WW(R8,U6=UF"YTC>DOV8QEU(G](X6EG\8X0F6Z/LU#YG
M?.Z7"A@F%)U]QNNO7C"PF$1:F+6U9MZ%L151(K2I*@,3.&Q/N9WXG,$%/)YL
MLK4=.APV=CJTYIEENZ%]6Y]_OMB_RR.]IU7$1$SX6#Q_J(VDK2=LHAN'*K>=
MB%<%[\QO#9)R^NPD:&-AON(% I9K8<B-ENRD5HWQF%2_S*P1F0OWN,MI3> B
M@'!@@[QIDRV?8/J\3"D%>4_VT*=K+2D>=U_$.?+HE9D^,)_6';SG<\SP&.<#
MR# DKIT>LG=2!(F9'H;G]%F'-BRDHRTJ&6'4["3R5_TXZ<NM(7%*BP[''M^W
MP6]MD>5%K'./=U1T[N-Q*>8@\,%(+V'". )R6))V:,_5?=]&D-EL(+M+.^X-
M0WM*&QUPK5K@EC2L:'E^6=WT?<"-W$2Y,QI#=__^<XS?J\[0$C^&:?S"5F.[
M$%#9ISF VML3X:F]J0_0??*684)>33=7;U-MC_ZM(0)UEBM^[VZ\[+YWADL&
MNSE.-V?PM+"'>I_@ZZ$,#I,#;*'<J._P#U'TN(*%\#&NKUT#"_=_4>FU?3'W
ML]K?O>.:6*&!5'@_;$:4'0_(=#FT\#@ZHIIQN+$>+KV 2AQ G&\*N_13LE1
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MHWHXQF&K74B_JW8._C3Z)!A%SL"*A?AH-!2<DOQ[>[+01G&<X&_!E8>1FWC
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M*G+,F.>) 7*3ANK9#>LLBG>*5R**W]OX:,[EL3GRD'R^@ &Q:7-]AKUK'I3
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MGMWHJX+$#7)DW!=EJMBZ/"H57#@36NUP=54=QZ^ 3DBC["6P;<Y.<M(^)=R
M3:HX6[<^:3]CVY5J^$<7\7 +0C!Z0-L CFYRI&U8CD P^P1ZW(Y9GH05!\;@
M&="]IJ[T!FN3=1,[!]<[/S/=7R27*(=''X]O"J5^JK-W#U#_B72;:&L0M.^8
MBIP_O_#V[=OY_QRJ-,U9LW!U%2A2@?"IW88IPV@/H'B=M6'V<5RO#T@5'F<R
M-Y:@J:8'U C,$Z1!!]YLC\.MJ,.9+GIK(PL4_S/Q<['C6Y PT&/C6"AN#8[V
M@LJ =^7>QLER3);X*H!4,K];O-2O /;1. WK5*SQU<%#B$W'0%RO.#$0=YNG
M#-I #VB^%@;KPDOJ*=HU3$1_Z:XP82NQ#GZCU@.=*WGG6;=A?^S):X^SXFXO
M=+!)6N _2+Q1'(1C!J+Z>VX"ZM=(%D^V+4P(2!S ,0KC*WSN[,IE=<6=1/5\
M=%BDOLL_X4HEJ#I"L D83VYM-[P:@\+-X%@1@'\->G9Q7TWR>+_G_/..Q:C1
MME)9>%'0P?;@KM?KH<N70E53PJ6=9E_;$@K_(C]V . D'* MV.MCR;H%@*PF
M>JF\SR>NUU>3^\!07M-<DV.&[\J\6"8_9.SYLO"MT-B*<*JUQ[)_YDZY%V?Y
M1H9P[5\&$#.I+#E0_A$P(K8-<J0=:->2%S=FMB!+FR2S/2-]Q+V1B)T#BZ(P
M4BSY+U6G4%RDAG6!E;*]YT&'],.7Y9TMH3682.Y+GB1G'_B4 $X,MPM&RT.T
M;*?436UFT'/M(-O-BB"F0F>,>@Z_""8G_&&BL","A*A8C$NZP+L>ES>L9*B*
MLRYDTT>?MR>(:?(*%"2W%WJ['"^[UHJD"R,HXO"7.,@J3Y'Y(QAQ]65[6\YZ
M?>01U?%UT;:4H]*[DK]+]+A'\<7^3=U/!MU T!ZM'9$F&S;=\E/*N$E)I9@?
MELY978917%@YW QM8LC(M FK%/!A6P(UBRD/9?L=G4P#F+<N)3H3O;JZLO4,
M4D:-!EAQ,>_J?X^'($\+'Q?=(^-#M0"FE@9[RX$,Y*O)8IBT@49<"C<_U,"M
MO7/"+\?VEUWDMVN.9A/WI3MULWFG^^_WSKY^)$;8YKK^V#FB$H[V%(>7)2$R
MB(+=,+%4V@%$'Q;J:$X:U!Y%WQQHP M7EA@:/4)XPUD)?^=]6I_.2UA5P*,#
M.'O56?>!WVS3(")!!<04V)I7 \9GHHTXBUR4J7TZ?7K1RV</F3*L0/WDU56(
M,U_N)LR$B=R4D)97.*3B&U"![:,J]<A@1W ,;_'95+H.&2IU0+S?UWB*(UL'
M.)SK;"V.JJFQJK#7UD%>KL*.0&Z,O;.U_:CK9_07"**]8K@@Q QED 0E8(E/
M.1&,)!DMM@_Z1[_?RE*_VQOYT>\*,P<_ZKWG:\_CG2W^KB_!IW+' AK/Z]N"
MX#=)U%DJRYX!6X]A$,YWMXQB4)6*+T(,1:N#3U44V6IKS36*(,N.(N=.HAX<
M"*;# 6WW 804]@.44+S6".)@3-OD]S53>69T?WXP& WH+2\"$9ZCFAYO.Y'&
M$F?UA>,:CT=KR#X6Q&]!$MTY*-KV[DVO)$\2'7":>;X\KC90"DB@>H^OATG9
M_?Q]E;FKQB!(;X?GX5%CXQ3^8Z]R1*_@>F]M0:[!LGLDN)6X "*@05U;9HQ?
M9+97L&'H! _>0;3)Z=O#3U>4%%Y<^3(<+/?9[I!-QT[K\]K\2R$H"VA%+#R1
MH_X(<*:^BE5/,6";B8WUAJ B@KU4<B8571TS=_0_.DR60 GM^G"2K+$L+HLN
MH)5S)*$LMQ9&-*D\E5#ROGA)/&L+,DT5[A9]\F361J9V4?2,'7W\7<U-+\]!
M@V+!=Y0S9Y\]RYIU[4(D;Y^K@0)JJ63QU':<E.E>-@IC'.<U/76M.&XQ+@[E
M=BK7(6!\V;_3*ZOTR5[H_7<6KBI9 (ZSKYBW1XM9S@KDWL<J<ER;&+Q:QGA?
MN82YP3?? \R W(TV7-N*KRBC?HWL>&E=-7UR;,4JZ_YDX*?CFFDJ6><Q]R"_
MB$E4QH5RQ148P0U4M<#?W,?$@(<(831KEIX/;)+<L5+,!U,&+Z/MV%=:(RY]
MUUR[FK <H(@A9 ;Q/7S'O[/;??MS_SPG#O0TG4Q?06[I]J=[HB0F8!&62)6D
M,T8R3&'0K(BN&#H!B?\^TYLO4Q"U7L2P,_^4_2G?UCTHC _,=KI8, :4L]^.
M\6-1O ^NL$II3.I&L#5]OGG"LB-=ZJZG#GA6!%>[E2C./E9>Z&]2\Z1[S/;?
M?;&0OA?U"P8<*A^$)_ ,N9VP4)PHVG*1D(HWX;JP[A2XC*UK&J;YQZWJAOJ=
MD-B)_')6Z83SMT*!FS'2?+]L<H@H6!9/?0)[\!NN.6!MJ&:[]F&RS].>PL7:
M7^5*6Y#+@]%UJMW1>X-B@[PTB'CO@?W-@GK<,DF5)[JZ_O=L/FR7?(&%B2<B
M&,[P&3B)B,]]]76CH:TT['W"#[L))[?5<R^3W]VBO)4NU*S7D]NOIW><O.:^
M/-*[!<DM9\!Q@+KL^A#;%CL$+K['%@3$X[[8R*DLK-XJ48*WC^/"+"9)3Z)^
MK<M>O']>2X:.NG;70*N<Q=_=G)]U!_$+SCHT8:X %-!"?/4!+;;Y)8P1XQJA
M=B2.;B9%)=E5.,1</J,9F\1RV']M_KN1O-.!LV4.9ZX*+>=!MINK)K1R'#]N
M5T@$- ;7P)D%+D]$'EWG*0(9?;@TJ&P$H'JD1[FUU6NF_F<MBX;OLJM^\WGP
M+UBIX@VD"Z)BX103"F) (D)$.Q(F-Q!4"<!MQY-.Z%I5MU(HEYZA*'[I<IK'
M$@67*<].O=KW&WS^SA)NL;D91H';@^4'U88B7LM-,2;F5 -6(F50H(Y&%?>2
M_Z51+C+,*LQ?&>-[MR$=O?GXKO^=0"]%IQGL2P9(099XNZE,85H]4<$@;%:?
MWH)&K?E\?QZ)D*',O F,*OTP=_K&-ZWN5YP&D8P6_EYOIH72/D8!:Y";AO,3
M!]1M^G4R0;K)=@-(C%GZ0D,C.OTG(M5=IHD2>,-[#E[K/5N_J6<CD2)88KE,
M^FR?]T;.PT-DRHYM#$KK87X(@QR+$,]&2.&N4*4XH,758?8BH%1.P"0&'JQ=
M7M/B.1A^Z]IDKPR-?*=2<DZOPENHNS]UZ/(OQHDUR6#U-3 7VI6"N=@$? GD
M[>E@BB=APF0RPQ:?YI2K56G-Z3<\Z6M-UC>8YDY[;_ OO]=8R42DG@#=4APP
MTK$&9-E:Z!''*5.K6NRPPJZ\8+'"6ANU2"\M[3>?QS[YAUCIFZK-Y[VF7/W=
M=.J1^#E@NUD9 JABU+$\QG"T1SP-;CJ>GZ'NW-[Z\3L^&":OV7-LW,"D^O2N
MAO GW+MG#FFHW&P+IYJ.#AZ\9N%F=9ZPY [JV@* ,V=9L4#<8\R)=B8B$1=T
MP'*M1Y#Y.7WQ2KNJ4=Z\YM^S9B_>P:6?.>6[J03<.,_W.\Z12R0&Y.8B&&&\
M9H8/QQ),UX3]OM"LID@.(XG.QY54MR!)+X(<JY[_U7EE"V*W,&7B$PZ5A!ZG
M:4A^@>$;^WQL>+L)#/"G^#EO]$]S,V.S5T?ATC?<7LPYU^JV4>W0-ORYH<.[
M9G><:R&KL+N0@EG;P6@5Q[B@!>\K9S@[ZO-V3RW"[[08?DDS5UP 1DB\HV,<
MZP+5X:KNS_QAJMU-_7ZEI7 EI#6?"S%?MM_T!*BI!F"=6>$"D&@Z,TC>;G^F
M('G!$( MI7-@#6B_'^18M_N9^R53\F,:A1U"6_2_VS8T4%;LSNAC,A,PQ=[<
M)MX.CA?H"+GF@IQS0/AB7 .RCS*X]J4^2$$PO3XB,UT3GYGZL?+R9,[3<XQE
M^_C'-OG>>JFJ7@I4ANT(!<G" C;L,-Y"F3#0RBP@864^PNA/PO"!2TRU5M&,
MX6M-:_F!"U&N><ACIL.5OZ\L:=U>O2L.!D_: P3#B9@,9;@09QJP,(XAXWTM
M?6C=Q//%!\X5&C>"+^[1]4FZR&0+#4(*R>OLV>5*=I73TTG ]8XY@:D(XPPQ
M>^WK;AO&FS,V\S!&09"E,D,%:QC&$W)@6/HR>AZPK7@3!0!VU9;Q9;"1HHQ@
M1I/8BD-NA/PEBZ ,RLHN=;XGLBIOCM5"[K\+U=OOK@\R,C?,>> 6O1PX/#6
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M<8?B=-=K&5VKB4FHW$29CL.-[AEF6WZ^PR5_A2O.I#4K3%GU0%Z5I7B*N'Q
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M*BVEQ\D;WOQWDRRF$IWQ[%&=;00HC5$DJZ-@0B#RQ3]QY#'(N$^C..2<)L$
M5QV=OF?JI=,)"LJ-I L9<V*:'54#?#U#WAJ64V4[;<0$WW<"_["3UJH"6Z%M
M9C35A\ARYE*-CB?.4*H/Q6$F4H-[K7@R5YNL",O$C0.*9)$3YB&(0L%)JD!!
M'#I.ZH?4%71T@0/SMJ>YV? ;7UO<O2*KK3O41<[*.^AJGF';P&SL?<@]U^3%
MQA/P=,J%2[V1#X$8TPEYI[>7]#T^5/J,R_&1&P9L)+0NR]Z7 K7[74F:Q#A(
M*$34B6384PPQ]R*8Q!0C1Q@IF&F=KQYO?FYTX,EH5V2PX#L$3&/]?1$,8R^B
MNRB#!HKS^X(ZF!BL9"_"9J+EZ+,S%= N3INCX2>QO&298C@ P2DP+57C. U6
MW^KQ\*;IEH G!7ZVCCM]E3FE?>9Y5I0?BII7P8_^F[6TKU2;GH/\+M^2&\01
M#EU(HH@+ZR>*8<*%"422T(\9\]U0-*;)<1K]S8WTA)S_#"HE-\BEX(#) ,96
M;B %UW_[=? ^3Y&641S=*E+8*7$70,*Y &_V(1S I#I8ZE.K94PGXEI+V!KQ
MJ@%2/42KT\IDS&N@TBX5F]QFSLTGC\-?%ZL5IRKX_R9M<ROCU77^7QR77P3D
M?$FQ+_!./8B=*(7(BPDD7'RER&-)[%,_2;2<PR\38VY,+IY! ^/U OC/,_@T
MH(Y,['O.,S?YGL_-1A-PDX*-+O*$06H#E#J3C(?^+##-N+R$(6Y[?(RFC,MA
M[9E)+FA\L@GF<@!VYQT+K0W-NU\\\+)^DAEIZJN<O?USG3VH4Z1- 0T?X\CC
MO@\)B0.($H(@\<,$X@@Y.'#3-,1&>Z7GNYS;---)O%!YI6H55;V1^H+B)AK@
MZVVEVH5TY$G& IH#TO+K F0Y2__9;B=.VJ\+PV$.?^T[S8B(\6S9.)[_QE>K
M_SLOON:?.:Z*G#-5FZ%<>@XEV(\CZ.!$\ ]-,$Q<+X2A1]W0$7:QB[$._YSM
M:6ZTTP@+I+3P#RDNZ.1MRE:4>FQS'N%^DK&*V\C<,APR;4K1AN,(DU2<_GA;
M//XDVE D\B>2'V'S43''^=8G(0QM)3N>T+]AF)TB_?U+?L?S*GODUSDM[F7&
M^IOT"_XFOJW6LM+-1V%$"4/IJJ[+C*QK5;NR^" 4E<4MA1TE+NE"799A'#&6
M>AB&B%.(@HA '+HNY$RLKP,2A#A-EG51XY6>46-9/B,JVD@YXBG)KGH@4_J9
MV3JV!U#/,'K!81G[W.K9B#2J@>^E[]</"Y7'M$AEYAH9'M/J"5I%P:ZF\ISF
MN:Z;($![UM=(HV#55+,MXZ1VW4@ [QN!8W4SL)YPELM"H2K1U69E_!$_-8FI
M,$NIZW@.3",QV,@C8OV*A.G(9;K]-$D1QT9%GGI[FYOEV @K7V:*JSN0KHJO
M%5!U@F3)H(?-QM!#RPB"*])&/["2"II6&NX="3VFMH;OR+S;RJF2@/'%SB9;
M)ZO%TL(ZD-@M*]S;X[0EA764/R@GK'63^<'-E<3K$W\0#]&=:KJX+?%]5\ #
MHSB*6 R]*,0018Q#L2CE8GV*DI2[" =ZV;W.=30WDI&B@JVLH!56?_^_%]7S
M)RZVL!J9,$[ -.!XO!<O_1,16[A-=.9A^I@9'6/H8-%S4-%[^V1'$3I*[!XV
M:%T_S"9[>_^P*IXX_\S+QXQRE1_GE>B#2=-1V(WJ6;E:J4%1R72VH2A-AGN9
MV+[:;G]CS$GBIC&,4LX@2D(.XSB)89R&#G:#B ;(*$&$9?GF1LE*'TBD0IT]
MLINE=-%5@F1-H4C\D-5X)95;@*M[E7IY^&&&[:'7,QM?<$!'GC<F&DMCJW0D
MQ*W:L;9EG-3R'0G@?5MYK&X&ANJL'QY6ZL&6I]N;Q%+OBK([>7J-JS5>U4_7
M>;4NI97_:RZ:_UIFDEB%L5^4\DS\7)G3I5CY4YZ$" :1F%:0X[HP"0B5<?\Q
MIBDGF#&S)"%3B6["3=/D'>E"MV3(W8-4 SP)/:K_$]QQH>X=E<D75=$L\("?
M>H/P7O:9T)MJYCC.HQ_5RT%5OD,Z!:8MAD1-C+7="*NIA)\V8&OB(3F(_YJZ
M_X$KH+WLH&)*S>@R20*>^'X*$S?&8M8),8Q='D$W#5@<$>XA,>L8'#<>[65N
MAX;R%*HY*@1X[\CI]=\_@_]4DP3X7DP>K%BMQ,0ADWB"2NKS@^':XRCHFBN(
M2Z$<VZ7A(*'Q B@9+9KT?1#8-<R/]C2M>=VG[(&1W'OQ4%.7K)J =_EJ+#WJ
MT]AW8\B9ET*48@Q)X*0P2L,0!0ES@]"LEM:SYN>V0_&>5]7?0-7*.,B38 \_
M7>-M*"IC+_,[**[[H1A@0AW3V+*A\ZR+B<V18^H=&@U'K[(8NB--BIOTILQN
MLUP9)&V=-C?!D4MH F,_3B *75_&6+H0.U[*L.\Z8:*U<SFD\[F]]/UA"VIY
M<9."'34,R^<-&J#S!TQCPCXRJ\P2<0M!.Q:0GT6HSI$1&#DNYPQR0Z)Q3C7Y
M\C$X9Y35BKPYU\9 X^_X-NMV7__5T_:2=MO_ZBLNE<.]6MJVU5ZKF_J.EU_N
M<'[35(W^4*@\V)Q]6*L#84YXBMV8PCA&$43<19!@%$ 6)31AA/C$BY8/:B?W
M<XW+6M.ZG$I^DU=Z7XOQWNI?6QG%@A80+IX,N3J0[E.-"&HQJQ:PE>$*=KKG
MPH\"%$11"'U,7(B2-(+B0P!#0DD:>"ST/=(^%V]S]I=_*CH=IGDF>,[^6D^#
MYNIICN,[X?GKKM:[A[" /(&CY[12]P5HM-^IF"[L *D_J 4 H$5@ 388B(\*
M!8N+P*D'SN[Z<C+IIUVZ3CTH!ZOBR06P7XG^ZEM6+0FA3N@G'D1$VCA1RF&2
MQ@3&GH,\E],P<;FM.O2RP[DMK,]63I="6ZQ!KT#7G#(L0CDVTU^&HM7J\[O0
M3%9[7G4ZF\KSNQ"8U)U_=M\PPGE?Y+=?>'DOTV?_@NLV??8GT6GC0OXL!<,'
M_JW^\I6O'ODO15[?5<O(HS%RB0-)+/-'ACZ&L2-XB2,W]1B-?8<;%7"]2)JY
M495X+#TS(KIL,/18:C*(1Z8PJ0>4BJC:  O0ZO*T:'>:<HL'"U8PL\IMETDT
M*?%9 6^?%>TT.HPR]VL+;*L./)?F<Y;?KGCW7+Z1''XOH\_^ARM'0GFP6ET1
M85AB6B_]R$L)1PET:!A"Y#,&$]</8.I[;DAH@,,D,6'2,82<&\%N) 525#.J
M'640]1CXI8=F9&+>*]6RV-9J@6E1P@K+@@];MF[];5NG[D;GS<] :JV\NW<&
M6EBGK=86+=0Q!\4J\X\BZ*03PIA0[\\3H_8UM)*CBD'.;W_-L[H])R2<.CYV
M8NC$@;"C78HAIGX,,7,PQ\0)_,@HZ.=('W,C[XV(0,IH>!C;AZ4>"5^(T,@<
M:@K.@,J-)]6W7+?QL)^)JS:>5/2P9N/I2\W=9[X4RFNW*]1;M4\G=>/4C9P
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M09[KA02&-(K%BCYQY-YA"#U?+.Q1[/B18Y18UJCWN;'&M4SEGZNAP"MC(\X
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M$TC<&!$'.Q0[6O;:N8[FQCUMCN =8:6S).[21YDF4#Z!;C^OV,1L9#H9"M>
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M9YAD*[DD)U4MZZ\M7<08IS+CI.\SB-*0P"1Q74A9&B,'X3 A3)?\AXLQM^E
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M_=B^,9WPSP5+XBB.N( ZD=J,UR2"1.4IC(G42D<Q0XE7^:'+S<UM&ONA1UQ
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M-&-"2D6Y4]7F\TW,\LNOXE-MJ"J[WSS6Y7VMVJKZU.R= O?U3F];_&!E0X#
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MT\==8.UV ^P" _C)?-:E-; \[TY,WL'=T^49==O(4ER9 2L[P*&MX,!8P)_
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M*9*E&659'F<T<]WH'(1D;FI20S=O08L=;"UX>[:]'C^_>N:H'MY7W3N<D_7
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M)1&*FT.EFHA(*(&A3/,,XIRDD"$MC).$2"I3K?+(*36G:X-STZ+X%X/TWZY
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M2,QYFDC(B=3&5TT8Y#PS7FM$<*ZS6$J_4(=S#<W-[ZQ]D?WA>M]EOW-\.JX
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MQE BN]*K[.JOXL)XKYS%G(E8<J\L0+V1S$T3]V>J/%>#>W>%XW+Q% 2/'A;
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M%/E"_UV0XE-W3:;!%R ?BN^ERT(ZHS9__C?#E5I$&.%,Q1(BFC&(&1.0TUQ
M)@UW-%5**#S<*]VU-S?WU*\JF0NA0_S27C2]LH-:UV*H4(<E,H33VHO0F7BO
M+L0&<F2/:.KET>Z?,@/7]L@D-Q_W^+9^RY6N%=P_JA_;;W^IU7?U^V:]O2L7
M>9;A.&((9D(9KUAJ HG.$"2"RPQC*3+$?18P^P*9F_MLWL/$;\&R=Q>X+6%.
M0>Q$TKXSHE[=?"9)VPW@R@C34E[5@O1I'4".0I$8=+FS-YA)%T"'4O9R273P
M\_H)Y-ME^; IV:HZ/%V^7S>1N]51@;4!\JAD@VFS+C^:E[C=\#5^*L<HA1GC
MMDR9II#CE$/"B39"J9*4>*5FZ(EC;O+8FE$G$0 6:,]=X;X=XZ::$] ]LFCV
M8MI;& ?R%%07^V*95!8'$O92%8<^KI\H/IO^?UI_46SU:VEK<]QL[N]58<MR
M7*_EC6G23%"*:K_;REZ2V\JUF!LYM/$O$4VA8I(1C1/-2.0R?>^-8&X3^FJ_
MR4_Q_%EWT[I1N9QVA=;&W!KXH,9OS]6T%E2;XJT-@;>^>Q,85/[\44PJ?+U)
M>BEY_1_43^Q.ED%[^K!<J_=;=5\NB!0TL@%]F>T73-,$DC1B,,^EC#.-=9)X
MS80[VIN;1W>FUM\3^--"!A5F3]>NBW$W60O(X\@B-HQ";[ER)":H.'6U.:D4
M.1+P4GA<;^LYT53:/$F^46OSP]8F%GQ3I1>LTD#>&'F[W11+55[_6)8+GF,E
M4REAEEEOBL4"TBPC$(E4,VS^2JE710*/MN<F/PUTT&"O,I+6>4GK!)JE<0)J
M VS]96. [S33HUL<IY;CD#WV=#(<S_Z33'_&PDXL/=J?=C+I3\S1!++'(_H)
MW"[.NORDWS;9A+ZQ'_7;LRLYRBA/\S1ED,O4EE@4&601Q3#3A*L,)WF>>>6J
M<&IUAJ)6)UM:KL7F7H$M^P%8A?C?_=3+C7,WW0K.Y,B*M<=KHSQVE!K(C6*-
M4NG5BZ6@*N76\J3ZY$7&2V7RN]E/D\IBN_BPW"YOZTP$K%35 "YIRB.[E2F0
M$-"(C9&A.,U@IG3"D"(ZSYRF<J<?/S>5V2,$%J*7>W2&P,M*,IR6L3<:_1AQ
M%H?+AE]2 7/G@0*8?[W\^L\\>I+/_+)9[??<<95_N-CG8B.4DN4[ ^3TG&R1
MBD31V'R^5"*[W!PED,4V,7HL:13GN<+"Z4-V:VYN'W:+N#Y9]??WO[H'/#EP
M>_D;#\_8R-_\CJQW%5EGEF*",N@>,1:6R8D"Q@8RZA4KYD[0A5 QAX=,%BGF
M;M!AH)C'7<-JD]D2T(8_TL:RZSA&QD*8$!4;G;4;?%1R*(S&)HD@.:9.Q7 N
M-S,W?<6_H!/%R"S>?@6T7I#:+;!AJ!I96%^6R&IKM%NP RN.O7P+>Y4:ZT_<
M*]48.R0P?$VQTW0X%A-[<?.K5!$[;<"Y\F%GKO97QW>K3160]H5M5?7H?56R
M)&Y>4)3B%&%N]P2YD<DX2R$W,TW#J999G.:YR)UK7SBT-S>];"&#PF ^4;XQ
MB=UEP(7N;@$-3.+(2KKCS\*M]>!9K<$D[J&G+D2Z"VM@0B=2V!#$>@FN!TT7
ME-?E*9-)L(=)AUKL<UN__88OQO<MEF*KY TK[SX:2QZ+PKQ3BYQ)$AE!AJGD
MR%9-2R#%D<UR$,DHC7)&E5? QKF&YB;#>YQ &*#@IV45+EAM,S29JNM-AI_]
M-AG.$NVVKQ""OI$%^( YB[%*Z=R@#+=ST,5#T,V"LXU-NC_09?+++8'.Z_W=
MMRH.\_W^+/&'7911+E2&%3&3V2RV<5U&(:AQ&2&+4BIR+$62I*Y.V]E6YJ81
M=1J4 Z0]PK@NT]KMG 4A:V1%Z,F3E[/0R<,%%^'\O9,Y!IWP#]V![HM[5G1N
M#@9]VS2UIP[:6."(XH3& A(L(H@%RB#-&8$YC14S\S(9"]X6@G)S!2XUY_3V
M/J_U-/8^05-JL-H@/\BGX%FS^1+%;B[ 8-HFVBIH8-K#A@W00PD(6*+9@8^P
MM9DO-3AM468'TX^J,;O<X^\:5,4'WJ_+Q\+F"VG/&BY5F\@%Z92B..80<Z$@
MUHA R@DV_H+2-%$120AU=1 ZVIJ;FU#!!3N\X "PNX_0Q6^WIQ"0M9&EXP)A
M/=9NNIAS7[<)R.!$:S:#F/3ROQRYN>"%=3UA,E_,T91#C\SUEIYI<N\VQ?:;
M*NYMH;5OYAE5^%!*-:(QM36BTQ1BJ33D/-50*9:BA(I(*N:5%?=4*W/3T@HD
M-"W=5P4$KX %VBM6_32I;B[88*K&WDWLPY)_$MM++(3-67NRI6E3U%XR]B@C
M[<6+>R:?V8O*+A8Y42KCL4ZAQ-(NSN($$II%MNR2D)P9_XHX111<:&-N G
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M\9?I80.&5UHX.M"D?-"GZDLBZ+W6?6?P2W%?; 5O Z2U :.+=U7+@.:"Q6$
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M<!.RGW :)3D/8,)U]V'-.X2H"> IBW":)@DG5C66!XP]-Q+2\H):X %9$:[
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M/JGE,]_"2753]X37ZOB0P=4IR9H59-6>3!>BVB="ZW.,U49G0B\3[=-*S&#
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MYQ(23"@D/,YD0-,L0M9UL@?*,#?R/J@!6*M'FT$JM2[@OE'&GGB&3L]Y6I\
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M5<%,^8DEC5B>()3#+-4QMS&6D.H#URC-91"J'Y'$+K3I5;JYD:G6H+%=.SJ
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MH77A=U'>+],@)0D+$Y@A&>KV5P+B%.<029%FDH<ASIV\T]=#S(UFM(2=?JM
MC7GO:B"]@M'6#+H$G-&-';I]UOCT>Q\P XR94[I[-EE>#3.Q87)*S=?FQ\DK
MAW_=WP3;E6;CZ^J1%"M-]I\VY3>R$H;XEWE,,HZR$-(\0Q Q3"!-F(2IR(3(
M$4E%[.@:G1USEM__0>8%V$L-Y::$E9*[628=CRMM\+?G"8^H3D$<%P(ZB$XL
M(?+.+^?&G9QP+($XQD"VM[H'OGTJ?NC6'M7>BJF+-(ER35:KIP\Z'%B9._S;
M1F[_(J5H M=I(G@0\P3FE.GJ*S&&-$MT.WG.!<]0AH1U5Z%!$LR-KEHE%@<W
MR-CTQ5X1P%M-0-6H8A\I-FR6^FEL$NQ')K4#[ ?GZ:HN)-?"OE<"M%H,2"8;
MAK]]#-_H\S!1=-](\^$4_'<1ECUA@<.>.UG X$5J=T,)+WO0,*/X=Z&,[$=1
M;?5X]>;>4L0\Q)F,81Q''** 9C /<0PS%H8L8KDRC9V*BQX98VZKB Z.+?8R
M-B>N;N;M,23MS-D+\1F9Z34T!_&:K7U_AFJ/\EX-TV/C3&J(]BCZTO#LN]3S
M!KL::AG$(8XB(6!$6 I1&"&8I\K$Y"P.6!A)Y?3ZV5I7@\WMP[\YNI%NHBP\
M[:9KA 7FJ2!Q#C'#%"(2<DBH@IDHW+-(RDSHPXOS-1.](SQ!Q<1I$+[PI,(1
MM[<\HS!=Y2<XE>A ,LUYA!YP'B<1'=6MSR"Z]PSCZ*L-*SZW;4=O-J6)\-UN
MRX+NMGJOX?OF=Z779KU5.JK'W!K34"T2;6$80B@+,P0C3!*(TB""A"4YC$G$
M$IGK$U,G%K],G+GQ_-7U^\]@KPYH] %=A70[V.<J@58G-Z*Z<"+MJ&RZZ1F9
M["Z;F1%J&OA!UBMG7BC2I*SJ![Z7O.OIJ<.8^3<UWBVY%=5_B!5OMG_WY1L^
M%!5;;2KEN"\Q";#$,84BQ@@B*@7$RFF&81#2*(UEK.P]%PJV''=N7-N*#58;
MLK;,RG6%VHXD1P!P9#;<2PRTR/L#HD6G2 XX".Z/]!R1\LINMF-/2F..@+SD
M*]?;W<^/^D^GWBLJ+-:[S:[Z8UT*LBK^*?B7357=;*K"<.?*O!."*QOVF^++
ME?B-;/6SGG0'@2NI>.)Z+;[?E9O=[=VGXM%4O*Z6G&<8A1&&D>X\;L)A\D#W
M(,_2.,L3$L>I]?'36R@P-ZI4(H(G7;M]6PL*I$XST+]QJ&;P)F_"^2.NN<_O
MR$S><^RO((#?#*L?4  '&(#& ;1 J!M;*,R)3@T&:-$PK534-1H0H%^G!A*@
M,3%] >;^)MD?ULW]C9KHK.]?X,UR.C=\RVGM.79\$[$F.[5\2]"[AYYO*L?
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M)2$0Q3F#A"GW(X@5I4<LRD2 EP_F4%[I7&XM.7P:Z5T8Y:4.XY%+*S$@M<A
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M3H"\#@%QN]W]#/&F%/?%[GY_5BXC+.((PR -1)T-C1.90YD&,<81(SA!MB>
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M '+)]:F2[OK("(4RDRCC+!4TM2JO>VJ N:V271F!%A+\J<6T=-]/PMB_C/D
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MP$>5:#_0XW\<9DI\*M:Z"H>I^;</W]F'HEW+^N\%6;7.75._27F+7]0L+H7
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MGCEHW&,FGLY6P:5.:UGI1/^Z,U\?'.:= W;CQJ5.,&-^%YB.P]V=I0K&^U<
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M,VT6-9K6'[6ZA,HYU44&-+QUU\F_N&'P\]UVAK1/7#@:3Y\WO$_-%WXY<&&
M/ZAG]2M_5OOKRX<F<7O_N'_("AX*.4?!&4UE6,P#F',EHA#2F,9!1'F06ZT&
MF+0Z-<YNC6X/+5A.](U@-IS=NP;/]Y2^Q6UK\#CG/JQ@<CMS-VIYW.FZ#1@'
M<W2KB^UXB/%R_G&Y+M=:O;V2+>C!1J5I\/=*OJ1Z>;]B?!XE01IRG,& \02B
M(@X@27@&LX+F45;@(@^8"0,9MC<U[FE,!J]LGNFR"5R-\JWE0)EN1DRFN)^G
M) ]H>B8C%T :4Y$E/$=(J.;TEX?5C_\C[Z3YYY](_0F;/S7IF+8Q"MU8.MP1
MC>UE]A-/7<_G<UUO./NPJ12'\:I<L>[0I_[ZKBM/)A^8MF;M]J.JI'PE]*9W
MW7W(YCQ,TH*0"*9IH(YH2'HB##&8XPRS+..8%M1TWNK%PJG16%=9NU=S3)JM
M5O=U>E&]_8*!G^2TAJT6"UPUPN3Z!S^;3P3]]/CE6?:;]Z/O:$Y7-VL<!(V'
MH'%QMCM#W?RH,[\]D])U_N[CKO,;;[=?&);(]-?+YJL%;][;(RTVO&FO6RT$
M>.V1,^L(?MH=;1G"*VS]50R_#0V(#/2=_L87[//R6[6IU_N3\B2(\C@,$A@(
MCB&*L@ 6L9QYT#@)\B 4.,F,Y*U-&IO:>-V^HLI@M<RH3;8@YTO0&HRF#@'S
M/3#VL/K<8F6UPF&/G\4XY1#'L8:<:_&T&S8, 3HW ERZQ7AD;NC,*UXVO6:@
M))W:"6AV%+](!S:5DE.>8T'D](E&4$V5($I"(KE55<D+$8K#O A)8B7.>[25
MJ9%J(X@S2/OL*(AFJ\970^.9/AM4NJW^G8D.!<[.(>!6V.QH2^,*FIUS]D#(
M[.R/[6.J&TKY0JEF<*9IY:#T^^_XK_)I\_1EHW:P;MMH;DZRB,N7GL \R$.(
M8A'!@B8(IHP)RG# D#".M(:9,#6JN+G_.@-/C:7JK/FF$3=K%TNV![96%6!<
MG5>O;.;. WOI<M#F'WO/7-1SH)FE@IT+H/5A!EHO0./&;D;KO0?,PS[_/3%:
MLH.7'K$*$:\#\TS@./#&HX63USG>#S*OO),KG25UN()*&[[R]:9:WB[U.H,>
M_N99+ <AE!&894S&H;$<B&0,RB!/LBBDC.0DBCIQ%+.8U*9YHS?OM2**[XW'
MUE8YV"ACE0;YL_S!H/#5JB/,HEKGX+ZE:-,6Z\;VKA2-A%Q]W\;&/L6<+F/G
M6=KIC %O+/1T&9K+LD\&]QB8Q*4V2M4HW%4(;#,VZIN_RGH>9H&(4!+!B*CD
M+2'[HBC2')(XQB*-61Q0*SV$LZU-+8+N; -_*.LL#[*>Q]6,H9RAY7OYTA H
M^SPL$P#<YE^=;7'<O"L3YP_RK8PN&JJSHM-S6R6E6]'E^S>K?;UBO+J.:*M3
M3<,DYUE(828"I90DXZ$\S0/(B@S37&!:!(6=HHJ]$5,CEJ9DGE)X505<ENL*
MTS7HF7ZAJJZ[SC&C(=^0^P^8FO- [?K_ =#CY)1>@Z)C]9(!AHRL4S(<JD-%
MDBON9;]\J45/GK7,R9&2RZ]VHG<']F\WZ[IDZASK3E6LV=J>"Y8$1)TGC:-0
M%=RA <0Q([# ,@S+6%P$9@62/=@V-59MW0-=)?B]1#&\4\?0TD9XU_7FJVZN
MN_?R@N@;=IIG7N[Z2_?&\8KS>XD_.P=GH'51G_7O:?$U7KY=AYJOK[YAQXZT
M\/H6'6RU*NNI"\XLU[IN<;1U7$]0]1=X?34Q<%UD*U*F2BSR9:VMN*DJ)5NI
M)U@OQW7,M@7(;^IZ\_2LCS]VJS<?2G4*;\F^R@%J3D@>A#AE,$:%@"AD<F:4
M1!S2(L2(L2R67]O5TO-NLPW)C%./K[,.O)1\8<C[XW6QX3+/E+K-]U)13U"R
M[RWHN0O(RVGAR1E07@/M-NCYW5L"WSX3RG>'BU%C=9/;!2WO5H^[*#96)QPL
MK(W6\,#%N;Y52[5/T-;4^E#6=+%28^,-J?52TYP7*&!%F$ 6Q"E$11Y#7% &
M"R5]S% 8Y=RJJJA%V].;-&[KRK6[+6H5NS76<LG?I@L,5][\ .M]8C<(4_L5
M-7MTW"ZD6;0_[OJ9/3 'RV8#;C%$5HVL[SEMM=MN?N!RH13;/JVJ>[S@;=T&
MQ;CU^HNJ/LWR,"%Y!A$F"*(DIGHC$F8H"&,:49JH,Y.K-5Y<7@RS:]J*MK8&
M>,QIZNP[7Z3I6L O+T_Y@]'[K@!9@YWEZK!9:SN0Q@-E_0R\AGD&OIPIFGPM
MUC:R;+XP'TVAS3'VEH)M0^ [J]UF=<,19=R&./I:T6W0'>P'@M_EG1[P _]M
MA9?U[?(KQXN/=7.$?['@6GRJOA5W5;FDY3->?%[^)\?5)_E SC."XD1P#B,<
MR3&!%G+6&$41+&*4Q3EF15X8Z[\-MF)J4:U\1!-SHAH._N7Q811(/0\5G0]
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M+YGG+$W#(LJ@R(7D><)E7(8X@2%F24%HC*/<:O?J2GNF-@9T=C=I5SWU[E:
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M. 5SG^7=WMRE2%?=D\I0U917F_6A2L:!I$Z2*16N6, @2SE$,0HAYG+*P$A
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M_>!_HM^!?J_.X^"*U>#[LRJ5I(FR<47MN?>[I_/&_9:*$UR=TN=U%HW*J4[
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M^"/WMQD_3[<7/1.[]@H2Y1;HNPYZOFM-O=[O6O^!!F &&@A #P/0' 982Q1
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MV:X3U+A?RXBMV3RZH?_<E)5:O*_7OW,YL65:K.?C_=W=Y[K>J.G3/$91@H.
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M!2499'D817G&,H&YS5!VI(VIC6"=B:9U(XRQ-&.%*Q'R3 :VX%C3P1GWG;+
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M/(9QE%*(L"I=S](4THC&N<BXH,PJA\"TX:D1_/=?[G\!#UO3)=5W]MI%HL;
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MDQ/&FLJWJVTOO/K.:"G7V]_Q5=G?(.M>-E<+S-MB#$Q0QPL+[TD_DHUEA==
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MWHZ]!@%T8/)Z)O,,G(#6M&"M) ??F_\.<OGC#*#G@ ';V4<.(7 $Y3"HP'6
M2^^[VY*X;0.KM@?U\PM4KF(LI6GO($UAF]BT?(A"#*,H2*A,)2/2*M6TY_Q3
M8[5]5[=L:PJKS7I3R/8ZNP2/C2I]K[3M5L;U:ML[W@.3WC[4V_+-V_ON1OJ1
MKKF=L!OHNMM.AE>Z]G8"Z/3UM]LP%WO\.-\\;!;F3'>SOI>%J0)0R'NY+/,?
MFGOYZD$:V_'%>X=CF6:A5# 4IL9R&"C-B%C_$6013RF+LI3W] 3VD6?*#+FG
M$*@T L]4 K5.S;U1;P=@KU5T=@P.O38CLJG3LHSE2+P$WZ$<C+UD>BW'XR4
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M$<ER[173ZS7:U#1F^F.)_PU4#K9MH6BL,KE5H(8-+&Y_97"9ZLL*-"J!0Y\
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MZNN]4IN?UZOMH]FK?6@[B.V&?<OJ,K7[IQBQ4BB6&W60HP(BG4C(RQQ!CKG
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MY%#QY>B,4^7B+49SK/@*TW6N>%\38V?Q;EXUAI22>R6_RXPEDN:4EQE,:5Y
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M]6'Z\MEQ9/X&UI@[ZIHTSR:*IH;LRHT94Q%\BT^D_W%S9$)'.GV.06S0D70
M36=.J'WN,MJ!=8!(W?/KD,MZ'F??FZE6'Y=M&WB;'_76W';UH-9MW=RG-[QR
M?[S%!..22P29X$8[9S2!1)04TDQKQ(NB3%G0F5/0Z%/3U35XJYU;^'4:9"O
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MORBS5*1% ?/,UO=.40Z9HAQFNJ!E3E$A6!:RCL3D?HR%H\8+%ZYI^_SE-,S
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MS?(=9]=/O,ZYJ.JMI*Y0YJ?Z?/+N@?/M1<XN&,OD97BS)[2JEU..!.<P%\&
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ML)RXM;B6*!_<:]P$KM/-QXV>-C)TLBCE R^VW1;>.^6YFX _/_!X''D()CA
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M(+Y;=5\ T[8 2\%8N_770N1=D &QT,2@R8[MP0/JVFE; ="^Q4'SQ>OZ&ZQ
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M,0F@\,,8) [SA4N&$?>CV*&15@B _I!+(ZY6:J#$!JHU$-Z 6O(FT%US16F
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MTEK29D,<1?PGF5@V 3Q[<"#J"*F *V*F]9-J)0$.%'8#>.F[Q\%ZL\/[+-D
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MK]+,,*J=@X2AJ7"E+0L0KQW'6"2ZC"N/NUBGP_DC"6WD8.] 7/RPE'$\)36
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M29E28#$$J-.KZ@F+^>H[/>- <@*5-@#D>T.%UZ7Z;-TAJ^\Z9,L9ECSD,J&
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M7G<7+B^/S&24/C 1" VA<*0E\=*@&^JY4BXX956E/GH_I&T8WI[;:<?(.FD
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M<!C.GMMY0Q7]-("[BV%7)[#JK?6=HSK+4FD%2FC.#",?+HB7Z#%0\-EP!<E
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M^4"[6R8\F]IE+SB34$57[HZ(:SWK<JS(Q/OT"?/%&;XM#[[JPV:]::TT(_L
MF->E9A/0!N]3(H*+D5D'&X5N(H*A%$X;HQ@70_>*8EMHJ0/+[D%N7G[[0(]X
M\>_Y>N;1>VX-@@ZUF8P)"9R0&DJTT:M:KJ3:&'@#B)L6<VU0,72<[)XJZAEU
ME:&?EI_#?#&SUO.H';E("@6H$FM!96T.B")D1P*[-Q2T->INB.MTI]L7$$,!
MMZ=V.@#<FQHZQ)I5-S/.:]KU$WB>JV6L,D29,C#II<>4BLEM,H!N:.@4/ONJ
M]VZOLOUDW0%*7E[,:\N!.M'T^N.OG[^LEE\OLSZOF H%F?/.UF:VNI;N9G")
M2<A%V^1=LMZV<4D'D3=MZ+\UML;7T*1W1M=L_7RQ6LSKG<9FENZ_ZZ=K7K0O
MG-/R 1_KY7XI" X- V&E%$9('U(;X^MAFJ:] &@-L9%TT<%VMAG'_&EYEK<L
M$8TZ>Y$%,%$3YE)&B,8*0&5$+L%EG]I4]SU"U+27 ,V/Q9&TT0&PWB_+^9]A
MLT*N/_Z$7_%L^>5R;,OZAK$@E; :24*&S%"AR.])-:'.6J=E%$:[U 1F@TF<
M]J*@->C::*H#"#XHN#??JV^,BT5X98 ^,%"!A.=,*,!34)B\B4:T2>=YFK9I
MC;1IHQ;[*:AGR/VRJA/H46"1%B.)B)QM)9.'&(V#@B()'PLFTV8JXN-T=>IK
M[HF"H2#;725=^ &WYJW\A$1&FF\T19_/\/QJ2MKGY>I\_I_-SQ]D?V:X=H47
M!CQX16>&=1"YB^!]9 8Y>>(N- 'C6!QTZL:. ]M)U+P[P/TEP!?XL5+ZH?U&
M^AN>SY23V9/X:@8]63NI)/"I%$"3I#(YH!'NN-LH4=6IQ]MX$]U5':=96_#3
M?!T^?ESAY7B%9;EJ.-'HBO^)MQWA@G\7?MN7&@B5DF*$V11KVTS:MB#*K$!;
M0QZ'\X;'9@=5HU*#'P7\]EK ER9U9*B9Y0C&6P/*)P8A>@0K0[:!9U]*&X?X
M,:JZ+2[8!1UWM[71U#"AZ[%>G=<BB37))6_8V.SVFPL^*32Y7Y%L6ZY)-(Z<
M]J!)2*5P9]%+X\*@ZCUZQ2T0T7=W ?0P#=/"9CS]+D<5=G=PN0HC.9>RD-&!
M$6$C$@.!:0M:8M%&RY#8(,-J3\!,>7$^EF8?!<H>8NX@J''9,8[VWO?X\8<K
M-%L+9W+MQ" E[;P)P0LDKD)MM1Z#C*S-M=,#!/4$G'TT?;<T8 2Q=X">5\O5
MEV7M./A;'4RVX>2*D2A+8M%JL *)&U$41'(7(-(Z"S$)C,..ISUJ*1\@:9J(
M0C,$C2/Z#C"T:2"\ON3@]=G\\WRQD=,5,Y;+I&(AF6A6^Z33JHC),/ J29=M
M'>;>)EOG4;*FB0<TP])X*N@ 3YNVJ)MLN(OU?('K]?46NSGOA2\)+:T&D9T#
M)3UY% (+:%0R!'(S##:ZD'R,K&FCG:-;TN.KH@=<7=)^M=RX(C)CJM56JM!!
M[30$R11PF7T*BAOOVS3J^8&,B;.?QU/O7>#L+>LN)H2_JM.Q<(%E?K[^\6S.
MRJ"L<SX<I[V9A,+!82T#=3IH591(=YMJ/S(P_,'73 R+_95W;Q3X.)*<&!37
M8^_?X^KK/.$=1DJT)FOE(*=, B+3#9SW'IB+:+6E'1;= $@\^I*)\PU& <1X
M4IR\^W.-M+]9+C[6\1@5X3^R8IA*+I(E%Z.*9&]Q7^=E,' :HY<R*Z>' .*)
MUTQ[I34.),:4Y,1AN]]7RWR1SM^NKN"].4(5HHO9"<B*U^&)#B%@*%"L]=D@
M;74XR,@8%++;1L&T(&D2X3U8T'T 95TS^JYVPJM5I*TJ@9P],$;64"8BN?R*
M()^*SUEGY<='RWTRI@O4':[9^S Y4,R=&!Y7"^?ZJ&2\&"4,H*U94:*Z\L)P
M*%DHGEP0M.WN8'#\\/#)M7^HPK88'/M+;^HY]JOEXGS30_Y'%JS7BF>4()&1
MZ9Q\ 5\D!S2ZN.!2Y7   !YX_'1QUO$A,(8$I]X#KAI;75$N-;>6T;&92FV/
M'+2$J",QHE5*.?@Z^&_(XO_AJ=.%0QNL^OWEU4&0ZDH>-^+8]*"ZWKJ$2+;4
M*A.L@_B83Q")"R#'R7$CN4#5IG#Q,:JF*?H9'SNC:Z #-&WKS_D^G.&Z3C]9
MX-G&P@HJ.%HB$8H3",JF#-[$0"O$:T<F>E2R3<+F$.JF+2EK%E@?73$G +:K
MM>F3BG6<-L1<6[=8]. 2??)<EH@*(S$]"=QZB,B/CXL=@;>'DCJ WFT./GQ:
M+2\^?MI<B7[&/ ^K;]^+-%-A*B*9^I4I%VC!YD!RLYQ9%85%U::>;!!Y?0-O
M'US<O1,:74F=(>^G^0K3^=FW#\MZR7_Q^;O5P%6Q,?$"4G &JN@,$7, C4CG
M1V(B89M^K4.HF_9JX<BX&T5%$SN$M_FY;9L*%T76)A,. GDZ6A4(@EM(9.P6
M$21&<P=E6SW#!QX_;22Y(4S&$FD'F]$#YNJ;FWF&&)QP+H#1G.3CZU3A%!0X
M&SD/,@:NVB0]/$79M$7\S<S\417221SJ=5@M,/^&YYN1-AM^ZFC?;2OT];_3
MV<6FV\]ZC?1?_A#^/=,YF\#H@,\HR(5V6H"+9+V&I"W] @.R70)8!Y+390G$
MGOC8$@0[IK*Z*, F5G]=?,7U>;U%_G61B+.91/*+ A.0C#>UFU2H_I*#@-D5
MFZR6ODVKG"W$=)DH>!C>QA)]!P?H]:SR60DLL:0]>(R^-HHBW$LL8(7'$EW0
M:-NTZKVFH,N+^W%PLI>03[,T^=;LB+#(U[LNYI?AK+9G7S<;C3SLM4<9EKR'
M!-I7+<N4O&1& 4_HZ%QC9-ASED ['TKF,NO2)A0T[8 T9@S*XA.45*\]O<KD
M&CD':'QD*B2C.#9A^Y0'I.V"E7T&I.VBE"YLK&U,O9F'.#^;GW^[YDHE;U-B
M&0KS=:!O00C:DN@T1]KNHS+-ZL>>IJ[;\6IC8^T@M9SFS(]K,30^8Q]ZS1'.
MU$$<MC]# WH9I"';GHM(^Y8-X+)R8"RW)B<7C3^USA\U!/@1?UT\NI1NQE$D
M*6C/5D!.<JU@D+1Q(YG#(46!L42?L<V$OYW([/9<W04_]_:Z9HJ:.,HVB+%W
MR[.SGY>K/\,JSTA,9$"0]1!0,%"V2/"1!TB1E>2R1"6&)(/N^MZ);RO;J7]Y
M)%UT$.T89# $IK)#(\$F8DR13PZ16?+9M5%DG5I.B[AO.VYT%+;'QCZ6W2Z*
MVAM\7W U7^;WYV%U?OA6]QA7;Y;?R"+Z]OMJ^7$5/M<P-ATA-=/OEWFI<UWS
MK^OU1;5^9E$KI2)'(,/6D$7K&3A; F!0L13CBDZ#-L!1J)G&L3@:("=2V]1G
M\J,BQ8R?OUPU_7RYPO!'^(CD9ED1+ DWE50GE9%P'2,Q&R50A*(92GLH*+>^
M>9JX<3\ /%P=_;19';;M"UY$Y.30JU";RW,+08D /F?NL"1_+^NCM_-Y].S=
M3L_G'11UX/G\>I&GBK[\,ZSF-=J_R>S#]?EK^NWYO%D4YJG7'2$:LQ/'[:,R
M.B<EN="@E?2@DL[D53O:[Y36V1?#1*,DUW91F9MQ!P_)^C)31R7.K38&7&T
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M4<B?U@+H'^#[ZWIW@/M+@"_P8R6D"<1O9[K?%L L\N0#4YOBF%J#&FJQM-3
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M>$\UCA9!;%B7_6,+C]^7ZWE]^BA5V8\_>O2:[!TX:5B1'223QDH-0J$ %3%
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M30"SJ> 2T8!C](7KY *3Q*@9-#W\F,5)HQ]U4V:+[:>*#BZT'^1HID)"PY0
MEZTC&?$$P04/R*,4BGR$C&WNLA\DJ<,\G#WU/C2%?R<EG$+:_O4R7);;/-,F
MO4CS+S7SZ$OX=CE==8SD_9W?-GH*_V'\CI_(7UOZO%CDU_]S,3__=JNWSW4N
M=RHZ^WIG'I 3WH387)MYB-9@#C%)+72313^<QB.D_3/D*7"TD%V=#!!EG;JK
M+"UHQI2,F5;@H([USS'M?TP$[5$-L(MJ>K7;'D\9%F288-WCH_ U@:4V[C=6
M@A4,8P@EJ/3?:H Q47)X-< N*NL5E ]E%.? F1<6<--*5R('7UP=-1T4HI(J
MFD%%G?^M!M@5)X=4 ^R@M Y\D,<RSXTS!2.2P<LV$JO9?,0)X\'E[$U2?% !
MWE^S&F 7&.Q0#;"#3GK=[6[\-L%X],([X+RVZ;<R0.2&0XFNF"2\U/X(&]QN
MH9,I*P%&/UKW4T6O:3:OEF=GF*J^UG7SO_+S?EW\1K[<AS_Q["O^?;DX_[2>
ME4@"$]&#0#H!E"P<0BYT%N@DLO=1,LX.R;L92DB'V]F>B!B2?--$/:>&Q1HD
M__#G<A8B"W4Q@_6<@6*)5K'P&5)F-BM4)0?1 H)7[^]PJYL >?LHXR0!5_,'
M9LIJD1-JL*HN*^OJ>*H<('LEO>"13I:#L@V?I*##E-:I0+>S0DX1=C7W8.8$
M&A>-!AX"K:T2!/AJ#8NB,16;O&%#,NKW)J##^[")0+>S.DX2<_.O. N88U2T
MG,@)\V0GLPR!20G"H_<E&TN6<S/,$0'3)(UTB;E=U7%:F-M,Z?G.IXN>64T;
M>)$UP4H'13Y_"F ,^6TH1!&F@4WW PW3I)GTA;S]E=)!/.X17J^#0B\6^15Q
M?$'?_H;G,^19LUP2:,](JHY9"#)),#(Y886V/K09\+ SJ8/ :4\(G,=1VBF,
M9B&>;K[[=4%_@J-D$3SRW-'S!8;RT+#%7^8.DZL]BHP.H&36$#/!$2TKBGN=
M%6--UO*(+?[NCTR_*]5W^(46#.87GY<7],*7WZY+22^CG$8949CSM0)5@/+"
M@#?<@'#&EI2ME'%00MW.0MB7XF[R _;"T=W-["AZZ^"DO>&N7MML[@BKS"+3
M!DH1M2&*K>VE70!MG)7.&;)B6V?@7-,R+::.@X%[+64.4DAWD+INCO"?C=JN
M+_"T%UR2+V0*,W3PHX>@R1-WL10R &2=['D$B&VCK9=M;#_M/PJF@U71 ;A^
MG AXS8-"ED,)D"SR.NA<@\^D_R1<\6@%FM3FK-Q&34\ .ESCCPYDW$/\/44V
MKLC7F4D=I0%$1^0;JR":H"$9GB3G1HDPI(AJRZ.G;GG4! ICB+&#C>3M^2=<
MW6YU?E58ZI1 KC1@+<U1B)J$D3)X:9/W/)#.V_@>V^F9NE]2T\UD!!5,G-WS
M^VJ9+]+YV]5[7'V=I\L#6V&I380D>&\U*&X+!$ZK(>>H(]+W#L=+G]U&P;3;
MSE&MYE&4T >(UB\6^8J#]57ZG/.*61],O2-P=8*5@V"] 6YLULPDR<R@S6@7
M)-TG8[K\G,,U>Q\F!XIY8OOE_<67NH;FBX^O__T%5W-<)'Q'JRA?<W>UAP:I
M'5E?$ABF!"K0.4S;9P9AN4ZTDEAF0WKX#7S=Y @Y5*G+MA+NP-S98U>^N160
M3!=E;0+)2B%9I@)1N Q,*EF<-.24MG'7#Z%Z6M-IDMC1T93< :#O<KCI[T@_
MH9W@I_G7><9%GKDH/&<D/&1T2JC R241Q4 NG$5N49;<)G=_ '$G%]K<$RD/
M1J3&45N72+S^OIX@BS7.9)1"9R[(-8JUN6A)-;/20;3D+_.8DVI>T_H :2?G
M*K1"X2$JVQV#_A*#"_Q8+8N#K<*[[+S^=SJ[R&3"O I?YN?A[!<RB-;+U9ME
M[7H[PQ)S\5B@Q-J@.C@.SJA477:A+)=2ER%Y83N]].0.X\-PUE8IHZ5"[+_G
MU>2.^7\PWS"Y8>>*&9VB2(&V(Q&5 :5]S38J&DJ)C,OB12QM@FB/DC5M_^G)
M]KKQ5-7A65NSB()4Q<MB(147ZV!1VJ4]BY#)Q:.MFC-C6Z>+?"=FFIS7R3%V
MJ%HFW-$V/;OF>);?X5D]C'_]_"7,5Y65ND)^O.]Z\37,SZJ7]O-R]3[4++&T
M_+BX7%ROPVI1!Z/.E&8^U6[_7N4 *OD SH<"W"<>@DZ.ZSS@>!V3IFGR82<]
M?2=3Z=2C'"Z']([$.%I5HB?;%Z-4H(PA3\Q9.B)B]NA$*#X-P?*H1$V3/SLI
MF*=3:@='_N:6\,.GL/B GTG"8?7M8 G(Q'-(V@&KC6"5<<2\CYR<NX!9*N=<
M:'C).RHO@U:#>S:KH1-0G$*CNVN[?V/MCY*&OO6)HR>@/TUWP]1S31NCM"J"
M#37T:#.#P+R%'++C,?FD6?/N<V.EGO^^6B;$O/Z9EFU%_=MR=QW<K)"Z7F;,
M.,3H'0AO'*A8AZP6^I1YPF"DL=&VZ;>Y*Z6]I-CMAYN[>UE3/75P@#^U%]\L
M]UGQ$;GT FI_93H2:D]D%.0S1I2*P..P#&I[>& BYV,T]I+3-P[V&NGF9%!7
M;8699T(A>@G6>S*(<]%TZ->;?2M#EJ@\-FKQ-9S&7O( CXFZG75SZ#W,A\;&
MV<]DH/XSG%W@'F;8S;\=Q^!Z@):13*OO3_]IODYGR_7%ZG9_5F:C-BX"UZ8.
M_HD:?+"6^,W>>VTS]Z')<GN,JD.WFVW/_D#2?$E_],?,(V/1%0'"* U*6@'!
MY0@B\^QET#DX/!K+W\F:UHP:#2-W=Y?Q5+'W,?855W%YG+UDDS6TCV-W]PDC
M[RO;Z#K&[J+0>BE2 &GJ1:K-!J(IM99=2X%&%&7:>' M=Y>;.,OWM]0)MIN\
MQS?S$.=G5_4XH;XVU^)[.EU7\\7'EV$]7V]T<;,$F/-U%D  +1C62(>&$,BF
M"R+7>?>RL+L) *.G\XW 1L>[URX8?#B'[]BJ'G&W&V%M7S+]$)O_6"SC&E=?
M*[>_+KY<G->0WB*1<#8(N!% DM;;X S4OK"D .+=D0%)KHMS.5F?N&X3ZAV9
MD6G=SF9HGU+='3BIW]E_^>UE. N+A.\_(9[_LEI>?"'>;ZWC[)@P9 5EIQFH
M:@I%)L@R,B1C$11CV,9%'4KAM YJ>WR.J: .@+?EE'E;WB-)FQSA%RE=7=K\
M/?R?Y>KZYN;V)<\-X^C)WZ_-MPUW%E2,";RI(S=J(STO;2S#VO./84SLQ\*T
M>6''-"2.H.)3<)F^?[@Z;@X<]S3LN2.[5\-Y.(;3)8)4P1,P;4)11]37ENQ9
M0A3"\)"\P5).SNG:U?ZF/_AMN5C=-\=G3F-F)BM:,74,@G !G) (0FC+I-,E
M'<<(W9^%CIVM7;#WA/EY)!5W</[?LFMN;2 _K_!_+G"1+F?%8,PI<A]KW60U
M:6(!7ZP"5;/@LB=^^: Z]D-LSH>(ZP2/QX7-P[;I*#KL"9;;&+J>*6.B5=J3
MC%PB2XBH@.B0 [>HLS.<2]ZFV<\ XCJ!Y5B > AP(VFG4\"MOZ_;JU+O8J.(
M)1<H=<P,_<]!3"F#M(E9A2KY?#S$W:6N$\B-!8D!D#M(/SU@;KX(B]H-]]<%
MF3 7E:7-TI1&)Q$% ^YKWQN-%B+R!$ZB4YP9*5O%>+83U$G(<=HS=@1==0"Y
M#ZNP6-.;;_IDD(C>EBW<K6NGI_7V7UVO9UK,V94(261;)T);"#H50%NL%-ZC
M-6V2M,;D8N)M<PQ8+3O1<0?X_L?[7Y9?<;78"/(CG3U7J9+W6A5&HEOQF&M]
MHP>%QD.@GP$FKA+YD9R5-C[-4 JGQ>5T&%H>0:%= /5][8A?Y?O[LIYE*9R]
MOXAY_G6^K@,<KKABGJ.(?'-D";+2LP>7,0$72+8.F>K1M0FJ#Z-O6LN@(Y".
MKLP.($J"P37Q\FJYJI4U=:+PEG6GDLNVU/LNP^FDXI*,>N846)FX(;Z2;]2>
M?A!YT]Y&=@/0\579 3Y_7JYP_G'Q.$^)AZ0,&?F6:4V&E"Q /Q"0.<\*0^:H
M1!M?:@!UTUXX=H/.T179 3C?X;KVL#HG85WW2'X9TA^8[S%&+JF2CCFP#A49
M+D5 M,D"'0BL8.2EI#8IP8-)G+:713<P;:/2#K!Z,Y;I";Y84KGDPH"8D'1
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MYI$QFN@[N.6N>7G_%>MX@L7G36Y*R-9XR8!ED>EDM1Z"+I',SERXH-N;^Y9
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M?+5NQ:\BW8S*J="HA.01'=,^CHY\F.POX0[P<0]LJ8G1D#/(7#./BC#UX;9
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MIHO<]0"X/574+^9F*;#(HXX@:OV5<K1K'"\,>%'"T#=5T,>H/!GF7#:)X_6
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M)X#<7W$G@,J9<:DHX2-8'4WML6OK%/@(G"G+L<@HS#1W\[0=;#O!WB#U])J
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MM=KZUW_(_W5U<5E9_OFOK[BXP%GARA0KB-=0(BA=.T4R'D%'72*YFE&P-M4
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MS?[H%E =&"M#7FQGPIKDH]<@DG.U362!:+0 E3++ON9'BS;=H(90.>U@I.Y
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M0Z_WQY_ZB63W(WW[7S.F+)DDW( V%?.FUHICKC/31$R23&\9VT1,GR%HV@>
M$;"P>1F/(?B.A]6]LF/7=9L-SIN;SSW*J;.-A[9GCX]96Y]O.\TXLLZ"B0R2
MTL9YYQ+YRR=T]GQ,7S!?G>'[4C__EP5]ZM6U9.]V@R [DZ[_4CL?6]IAS(%G
MM!N25(KS),@L:-0QYE7:NCR1AB#D29;5N.KH(*)XS]%OX?)J-;^<X\7[\NMR
M\?D3KLXKE^L]?,\?9ILU>@^9Y0*J,AE"8'0">UDLE\R5-EW\AU(ZK7G?%'P-
M5'6J]OBM4);K';E_@]N]ECG*';H#AVVOU%+/,T.>)H_5W/(<(0CE 'VT+ 4M
MC6F3/MS.G+\_N:^[8Y 9RJ4)!HRW"$K6\<=<*JC'M6'1R]RH]\@68KJ\-(=@
M8)L9?XC .[@EZR%[>7O(TK^Y&7&8?43)P9F8H4XR 2<,0L88$WVGE$:C@;=1
M,SUJ#E+Q9ACV4'EWB)F;_E Y:N>LER!#39'@+$! 1?ZQYX)++PT3QT%-#\WX
M#M?S*\#90^@=0.<C+N;+U>_+2[RXZ0#&?<"B-2DU$=E*VP(N&@XHD?'(/-.\
MD9.W24I?@-E'OT_:-AXB[ [0LB;]9L+!I^6/8?&O6T8*L9$9MT!NA0&50H)8
MB@3!@\ HG(BY3>'*LR1-_.8R/GK&$7X'*%KW&ZR"^8CIQKF\881<QA!52F!2
M;1BGA $BW8$HUA91O$F-:MB?)6GB3,GQ432.\#M T6-#\+J5?%8A6'(8?#&,
M3M,L(7A3YUMD9EE )K'=,\EC6J8/"8UI)!\HZ^[0\GLXO]U+J="&2772=_'$
M!RH&(>D(J&*(D@='5N 1,'-/44_NU7!-OPB</<4^<<_J!U:;_$'JGZ[P-Z+E
M2U7K[<FIB^>QT"ELZLMC,1Y"T);<""F#3]&JO)$LN#43Y=6%>H+&OKI<MA+L
MQ"AY=[8D32P^?PB7N&9I"SO*!9M*=N!SR%5:"H(T=,TZQ[ET/F&1.^!DAZ5Z
MNGY&0,K8PNWG1%$_<'&-_.\/>(DQ*>95!LDPTI$K.=")*T JERSW*-#L4JGQ
MVCK3&K<MSY/#Q=H/1$3EY?^[6N!#3D(IIC /SCL/RIH",=H +A<T/IL271D&
MD"VK3-N*KB4\#A5I/^"X!?H&,XD'KVTB$S\5=5U;&8PW(!-B$"RA&8J/[0M-
MV[/M&"?( 8+M!R7Z![6%%RMJ3KD6$*SGY/#GVE^GOMPS[1P*;HWPPT"R=9UI
M>V2TQ,CA8NT'(O*':U;.ZH4I;E@A-6?%48-GL=K?ED$T'L&ADCH7$<)F/.YU
MQ^;I,M/6B[9U:PX4:C_X$#_8RLOORV]K+A[PX[U3H:@Z%"_40>V)TYWI(CEI
MVD7.Z&0<:JP^N]:T!9MM+9(QQ-L=7'["M,F/X$SDE".8J.I =.[(12.)F20-
MUXY8]6PON#Q=:]J2R"/ Y4#Q]@,7]2P_6EHLN4[QQ$AF>4!.MRD97"E)7P@3
M/-O7$NYV76OB4L2VUNP8\NT'+_('^R $)&^-<R:,1!EJ_D8"Y2,"G9 *4@X^
MR<R"&'JT;%UG-YR<:!SV4+GV@Q'Q@[LWSF]941(CB:< L[;.MU,2HJQ=.!RZ
MZ)TL?K-@[/7;Y^DRNR'D=.*O8TJU'X"HQR?B+3.A=ME4Z$ 'K6JC%@G.F0P\
M9XZ^1!;T+E'Z5Q?:#22G&7X]7++]P$3^(->7YYNKSU<7E\2.ND6]]]&Z9,%*
M5Z6E'03E-;CZW,!0H.4#39/GEMH-*B<9BAU%NOV 1?Q@Q%9V,)F"+@=P%ND.
M==R %[58U4668D[HU< WXN>6V@TL)QF4'46Z_8#E.CSTP.>_92<JS"I;46?O
M.E QUK)C<OQULM9P)_*3V5R[Q=V>+K4;6$XR.CN*=/L!RX;_=LN,+4EY(1D4
M4:.)TDCP4DK0D3OR^3UQ-/"E9_M"NP'E)*.T(TBV'YBH'_@##T[?\&*D-Z'4
M3L.NYIEG4_/,"?><;/-DLQ3H!KH]6]?9#20G&: ]7*[]8$3^X.R#AXE;9K++
M7.HZ_+(^<"IM%<3JU 6=R7^S6FN1AMXZVQ;:#24G&9<=0;+]P$3<,;-V]LVM
M88Z"/#7&@,"/9&LQ#U$Q!(F,Y9I\GG;*8GMUH=URV$XR'#N"9/N!B7QHD-^R
MPK(M)7,%PI,9KF1M[IV$ 9UU"(H.2O+L!IXE6Y;9#2*G&8D]5*H= >2/Y7QQ
M29[;'[A*-:O\ZVI^1ES9NR<(0=872BC>U=.Q/D$4V@#1^&*)L8)F:);!RRON
M!IN3#,^.*>M^$&1^>)B+9>_\.*:P&E_:UNZ;&B-$YB1DH45))6:I!N8O;5UG
M-[2<9)SV<+GV@Q&^1KZ\Q?WMT7G+E! HC!4)O%$:%.<:7"!SW3JCZ.P4AD<S
M#"PO+[@;:DXR9#NBI/N!C_I!/O#OW.UQ27<J"\H ,Z9F4^1(O 0)R)WVUGK&
M_,"K:>LZNX'E)$.VA\NU'XS('QY'G_UMBI:T3,3H0.K:LH9</8A!Z#HE1!@1
M0TEZL..\=:7=<'*BT=K#9=L14M9'I-VPPB2[?:Z()FOI/9A4+)"0,GB;-&0Z
M+"-9].B"WL?B?6[!W7!SDL';$27=#WSX!E,WF^*>*RZMSI;88)*#LO4%0V1#
M<N-"A^03QK"/,?/LBKL!Z"0#NV/*NC<$N3NVWF%<7875=V*,W\6N%<E'2)#.
MUQGFCKQ :33(C(8[IZ/T>UG$+RVZ&XY.,O0[LL3[@9)8,\;O0@IT2W_$KY<W
MSV5WS(E@4RA20F&QM@]Q#KP7''S)2GCBS@\UE7=;>+<BUM,,$X\O^7Y@I1X]
ME<C;IQ(=.6:M!9BBZDQ45ML_(LE.<Y9,B3F%H=EW6Q?:#38G&3H>0;+]P,3<
MI/Q<QZCD;23<Y5CHN%1 5[ #%;@%AR*0 UER\EHR+09>7ML7V@TF)QDJ'D&R
M/<%DH\!!WH:C3#3(E9:@F$AUR+(&Y\F5I,NXMG?41>J!"3+/KK4;6$XT4CR&
M?/O!B_K!NONXE+R-2^68K":DUS.2)&6EH>-1:Z@AJ9116K<YX6"':J,M"^V&
ME).,#H\@V7Y@8FZZ #PTNVXC4S*@RC4MV6;KJMGEP2>F(7EFE:"#$M7@*^C9
MU78#S$E&B,>2<3^H41MV^TU02MV&%*S)P@7O(<DZS2\ILL2T1RC55/=9!LX'
MYH*_LN)NZ#G)N/&8LNX'0=>>G]V(2=TQ):)4W%L)J?#:0B#R:L77X9,Z">?0
MA3CPY?OE!7?#STG&CT>4=#_PT=?6VKK[E;KK2U*0P$XV&D^U2,\D!BYP!G3&
M,LRV5OL.?*7:MLQN4#G)2/'!4NT'(.J'>TYN*\$E=\D5+VO_7UDY*>",C^NF
MTM:+:%$/MGV?K+(;/$XR 'RH3'M"Q[5%=E\[<\>0%DE:G13P4KL(:QYKOT4#
M!/2HDM-,^*&FR[.+[=9_[B0CNR-)N!_(Z'6:QWUX0-W6_$H=4XF"#*Y,II?*
M]7QDRH%.)"67LLAI8.7)<TOM!I>3C.B.(MU^P*)N+])UB$#=%EPQALAYXE!8
MJFWMB2-G,]GK"9G.TB4^/-EJVT*[ >4D8[HC2+8?F.B[%HSU'4/=OF,P+72R
M==H%1L)\G3KH+-VIP1,[QEIAAV9R;E]H-YB<9#1W!,GV Y/;FJL[W^TV,DU4
M!>FR!31Z[?H3.Z%62P1KE8G.!C?02WYNJ=V@<I+AW%&DVP]8] _LX0%Y&YUV
M4F!0JD#VM3-T+(F,+N_ "Q9T-MJIS<&3KY\IVQ;:#2@G&<8=0;+]P.0ZJK@9
M5-2W42&Z,4MP@6Y141^^.*OBPFJR8TD\QFS2T*9T+RZX&VQ..'X[BJ2[&S/S
MZWR!OUSB^<6L</+HE,H0LR,#K/;;<PXE"&-"$"X4:S<2-IM,F;DCJ*?._V./
M)]I/ZMV!YY<%?3)>7-:9%Q])-YAOMDCXC+-2HJ)354#!FDGH4@1G. .AT#*-
MSBG69E#:[C3V-*QF3TB\"+/1]-,=\MZ&U>K[?/'YS?GR:G$Y8RK)+!,"J[D=
MRA8#T3))K@$K64GCC!1'P-ICJGH:<-,"70?HH ,\O9LOPB+AKQCH ^<ASL_F
ME]]G-DLGD"DP1M9@N+/@&<N0N-&:# 8K<IO1YUO)Z>D*' =!ATM];^A\PU5<
MCF""/QQX^8_5\N+BS2*O^7D?S^:?U]J92<VX1I'J.YNHEF<-4+A24^ECT85'
MKW8QOG=8JJ<!.(=!I(5L]S]GEI?AK,&]]<]%.%^N+N?_0U?Q"L_G5^<S9H47
M'#UHRVOQ#J=S,S('5DN4446#S!SA[GI*64^#<UK<7P?J8N)(P+.\_#2_2/5"
M#HN\_IF+BZMZY+Y=7EQ>_(Z7,Y\T$U$HR"HX4$P9$J 6P%/03BOIO-JEL'/?
M]7L:M7/X@744+0Q'FK]&V@(_5Z/_TVA&4SV?/]V<SW0TOPU?Y_6<?'Q"7_RR
M2&=7F2S#MU>KJI3?PN7-&.>9$$%GJQ ,I@1*U5A)T;6;%!WK*>F<K6URV!U*
M>4\#@,8Y#(^JRPX,_MWXO6%S%J)FC"D+J=#YKWC.$!+'FN) @BWHE)H2J#=D
M]C1LZ)BHW$=+IW:*S@06'9PQ('U-VRO"@S-,0XA)94'W1 E^0@CV-+GHF-@;
MI)<.SKVM+O<Z&E@E][Y<?W\>SOY87LPKAS__=8F+BWD\HQ^_N)Q)8M,:5FH+
M'-ICGA?P4180 4U&F^FOV_@G!Q+>U:BDAM&31JH<#;G_Z]^>*("D\:_UM];?
MJ?_J Y;_I_[^SP^_//I\LK&_8#B[_/)#6IY??_Z/R]5J^2=9)!=D6[\EJN:7
M;U:KL/B\%L)%E?N]D?(37H;YV<5CIB[FYU_/7HN_[+7,O]USM<GOS6I/,-:$
M0ZQZSYC_W\-C%]61.5M>7*WP320TAW0Y$PI+Y,:"ST:!TG4R5Y&!K+^:YX<H
M4,HF)\)V>L:\CG_\?B/9[W?<1HF:-D:=.69IPT81P*N (%620KDLM"S-K^&G
M=$W_=G4@,EZZ?0]40P>W[D-N[C?K!_P:OJ\W\?ORQVI.9_77</;+XG?:KY_^
MQ+-O^-MR<?GE8A9U"CYK!]K4 O<<(P1D"62R.C(O,6XVWVJ N<%D3PO),?'S
M C3;*O/4D/N?&%:?_ER2=%V07&?RP7R=5\)IXVN;P.6$.=K"96IC).Y#[;0/
ML[W@=!_5G20\"6](3AOG204++->!.E9S\$$Y<(E));C1^0BW^.[T3OORVQ5$
M!ZOO%$'Z;GFUFF7+C!.605#$GTHA@;<N@H@^R1@5"S+V@=%*[K0OSSU!=+#R
M3A*A\V\X,V3;IRP=H"N,3!E5P#EB4@;C+,M>E=#)*5K)G?8!NRN$#E7>:2'T
M3:%E[_A,(NH<<P)136U%NQ"B9P%TR58J9U I/C5('U$\[9-X'SC=7X4=0/7E
MO,AD:7^9&F4U"52H\V%3S""X<CI)J:1HDU)X<&YJL^?LAI ;314=I(YM3Y8,
M)1?GDZ$=X12HVJ_,<]H@@66I##,JI#:QH?U35)LF.8\<ACQ<Z">1H9H32YB$
M@&1)V4HB@M/5_W=:6JZSMGR7'K9C9:@V36(>"2$M1'NJKVP?ORQ7EU40]S_7
M[*GMA;6.\MZV*Z]M']UXXH'^GP"QCOJU*M9W8TUGD9!1!RX<:W/LMWET^YB^
M8+XZP_=E+=Y;:^"ZT"Z2<R*R8)!HCQ*'5D,=B TL!IMXEEHT2KYZB:HN']R&
MH&+SIAM-!1U8X(\YH'_TYJ_YQ4Q'&8TH$;ABY$;4X1B>;$M GEVQRBN/;4H0
MMY(S+8#&T_8FC X6?8_XN:D>SR*SK.K<;*SC;HMA$'4MEY2U0A*1E=CH)-I.
MT,08.ES5KX%G#[EW )^WR_-S7*TSK\)77-VU'XFL5M."S&1ITA;3$.H3,!=>
MFA"LEKY-M'0K.9U!9Q]%+\>6>@?0(5N5SN1KJ_.&@\!MR"HS\"K5$<JH($;Z
M4U!>T#=8T *;X.8I+=.Z]RU <Z"\.T#,.R2IA[-_7Y[CK\NP^#$L_O4F?ZM!
MBXO;>0>8N9,Q0,Z&&!+DXOJ(M:&T)%LQ,*E9F\SQ5TF;-AC0 D_C:J,#>#V.
MH*YO>(?"8=98=X2NT1(!/O  &B-S7L3@71LKZ"DM$Q](K8SH X7>'6P>-&#2
M0:)#9B!CJ=VG;09?C(3 7&1!EB#ON\XU!,\]1=,[\H=H^D7@["GVB4N9?PSI
M7__\>GTEOPNI1MSG=Z>G947S0!NJMO(#%6V!:&(A/X-QR74J#G=I>_?2&CT!
M8E\-+AN(<V)8?,!OR[-OM?3T(2O??_[KZWQ%?_M;^,XMZ?FVS[#F)ILB+80Z
MI5M%<D-C, A"6L:$4,5OOK-N!<JP5:>!SKA:7AY%Y/V#R1!GM]V(E8C%T$E<
M\9% <9/ I51H*S+,C#,IXBXMP8>M.HUM,R68]A5Y_V#BQ,7MN$+C2LJ9;G6R
M U4=\(W@)2=&@Q/>V\BEWV44]K!5I_&TI@33OB+OP'A^Y$W\>E<K:I&(]<X
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M[!/?FHQ=MI/4_<3J!6WS1B8=DG+&Y]=?-+5+E,3E;;Y-34Y.>6Q9%AO  S2
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MQ>7ZBHC1^<S6KY HB)6&K@A.5X0-B;GL4I2ZU>2KK0\Y+@J/Y[.UDEL'D-Q
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M6;,@F.K3C7M RHFFD0;$9SN5V0,LI]\JOK%U]G\6\R59,D6HCL$#JE"3W6C
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MZ)O2F(=+H%LL7:Y6UT'IX)!!7=%(][Z0$+BF7V)*G%L>E2E'1-/%J3IH?AM
M\EL!:@\QC+S0[U45Z ,Z_H;K8A;OHU61&2BA1%"IV+KF,P O,:*3(C'%GW%^
MGON,'L&QCQ3G#5@Z/C2X>8R.;'0J]24)9:ZZPPH$[1&"<SQ@B"*Y;98Q/O49
M'73S-8#&,"SMX"*Z</0V7=>_73?H!QVS0E_ *4XD<;JW8S#$ME081BNY;12\
M;W&X<>'5QLT96B8=P&Q]^H?W]_GJZWPQ_5_,K[[5) 6G0,/E*+2 0I85E%("
M8K(6E#9.6E&D:K6&;+L#]A"5#0B,3>]N TNI6_!=5QC=T'?S/5>48@H^,AF!
MF^! ,:' D3D'2W]1K'"EE$:-''N?N8>T^;$A.K@L3RC%^2HE/,-%7?#2,MNY
MQ<>T2GSN2F&;'*@AGU^@ST"^O03E";"Q" _,ZN)]G1/+VCS''BL'FE&CR%E!
MYC)5M>3DM$8-$JU!X3)%UFW2#J>1 ]U%_MOG0'=A>@]7Z>-Y&%1&%\441&GK
MN#GIR:J3H4W)!AFBR=XVK!X_J1SH3D+?/@>ZBP2ZQ=)E;*Z<=%8B0EV[2=HF
M,[&HB%KG):,S0NC4<&+FJ>5 =Y+\+CG07<0P?J)+\%NNPF,)FL(BBA@B,%25
M5ZB!HAE/OP0,F@?+<<N<US8?UR-D]I'M_<SHP(SNP1R=QR7^^YRX^N8'_?*9
M_ME:MW0QPCOA(-1Z"(5:@Z^C1TK$(#2YF2(VLD2;#]1KQNN@2VT WO<)H4M=
M2R8&;E"!]M(0<RI)S#BB1LB<K16\5?W38T<:V3 -(?#G0;0']_N#T:4Y#3XY
MGAB=7R@$I5+-FM@ KL02A%58?*-2S4W'Z0X^^XCZ:0#MP?<1P;-<K":O:Z(+
M%\3#U<_?P[<+E2HB*4%^(9 GJ(@CKC9B1 LLJAQL"BAUV 8W] &W,$-_NH^7
MQTXP;DWEL!?6(%P>&26W,J-?%KAN_[M/TJ4R^6PS<:@N<J\%[YP'B%%;P,R"
M=,&;O%W+TU;0V?I8XYB>820_;RV&D8.P7^B3S\+/Y2]A]J^K!W$>4HDQ0V*:
M3J\,!V^#!RQ")JZ*HW!CBWCKX4\>#P>-1#<?C(\=.#';/ 3Q&$72=3DB5I)2
M$O5)R$,M;\\8$9-J\]H[5&%!LSF?;<*LH64R=L;G\7>A:[V\>/R;,*POTS*
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M)]4Q6U4GV.W"&<E4<DKQOG-X6PE*'/J[92@MMQC_:6F(J?/F4=]N74P7XUB
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MUYC<U8A>)I3A)>)QO/A]//_GFY^;+TZS.Z@3%IW4A@#Z; ZAGC,8)P48F73
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MRZR;ST>,E]0GGBX?_6K9$1[BLJ<[<AEB*I7_E0HO]J=QV""C+E:. >;ABFL
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M$/(]CY^KMIB+7C+W1*>P20>AV//#P'?'D B13O6V\E5-[T >ID;I'.NGX-D
M/&_N)$1C?A)+O5UTBHW:!SA"!KJ^.]9^"W?JW0G!K OW_S-5W<*SGLL1.(S&
M4^UTIR/LDK-<^3;B..'UN8-O#3?_@@*:8HB0/*P :J2C\C\I<@5W_T[I^9*?
MFOA11;W4SS_M'7T4,'"QBCZ=":Z*\O-I.@ZCO#V3?N+'- B$1TF(,?FYRK/"
MT^1AO>CFHH#JU55DXW;IJ"IV*:"A4S^+A*^%E6TN5^CFE8WRY>UM5L+Z^]T]
M)'8\QB(_L%+( AS4['RKN(.R;ZG",=R0HJ7G'ML,0/V9K'V;I>>&J"J2"OP)
MM1+.V](286X-^T>'^QV#K*K+?X$A30B1R^BSKD V Z>P?Z?EQ60KC8Y#+":
MR*-9?[QMUAP+QT7YA/ (KAW\@9'(Q.MR9_,)KXY3V[P*;!@<:*B CE[73Q.6
MA2&Y%>:2GPG@B^"]^:%]"* K7_:D]$V7;-WD[EL:VD^/ P6CL:%BMR&C$:CZ
M73?-C71A\WD_V*+;6_W!]I:[K?-8 $%C?R>0@[A+7$?@:_AWN*<5/"O,EH\"
M+H.&QHX7T^\X?8\ _<D?E?!0J&/ \ 38-9$9@<58/)?R[:0+JK,7QCC@10-@
MX8+3(&R_@I*KNUU[:[)A7&:1-6EP=L.<!13=U= =*T [+(EO 1U+M&+#:%!;
M*S#+6CM5^))RJH%,(6\;".8)=SV]8(Y?I 21TFXO/:O;>72G[%=&8%%&KYJ3
MS^YO&.5G"K=92U0_$1\%P;=OC,U1M*4]W0)P43*2_]R*Y(DGF&QG:0ASI5 B
MXAR$3L:A*6SM+K</[MO(:#EX:MKH\PW#,/H2190!Z71WB0C48PK)QMKV]N"+
M+9??\P$8")YZXWGHBA!ZYJX=PH?/+QL#M?0]B^0MRP8ACJ0.K"^ GHRM2CUL
MK[M??X7>,/XPI]"F(-9/JX7BR;(:<58H+&I$A!_B:85'!@!&1^6?;+JVM*Y8
M'&?@%&-HU!+T7^;1MD.7,;(Y?ZZ$-ZZ[:Y"%MFB6%LW2HEE:- NB679:-,O;
M\ HVC%M-O8(_;\@Q=T3Y)'XCUPPPREB@11\Q9553_X#<A7R7E:6-/CE5[1).
MO[-Q MMBMBX7V4-$DP7A_Z=X"6./)FI/%HSC>$K&=&$T98S[^W<A$V=J9(7!
M.V-@5?"!+8+KP_-)!%44)6.E"(Z!Q@N*E1W.'GIAOW>@9*B+&)-QX/O2D] $
MM?S*.WZQZ]\'WCV<B-2E'7VMKJAO3.)]PY SK:,J[%?K3$Y:CV,&/VDIW4CJ
M#/?K+XD;!AGE)+&-"CTY*@16'7-QGF?(.I:0V2#$VDOSH"J IF)Z&=7%O'ZR
MK3"J3+[A$["Z!C($Y!AP)MC>B?L><<R%7O1Z0OF>\ZETL#H3M02,>+02:+<#
M2!$:.DBY!FVC@@=HT +0XQ$C,719<3I268J+B]#!BM(F5)1 7:$$O907$OW\
MT^[!QZ"LP#JPTW,9Q/"6E=+ *D#N."6^8CI0& /^)[>=81!XBD^(D-7X44Q_
M^@*%7J85DDH7!F*ST&P&FT;)W1/X,Z(%V-[S@%]X"QYJ^K[BM<YOSZZV@;J9
MSYJ6%XISJ\V7]@@QF"1,X$Q\R,<@.OTXL+JJ;-:5!J\ ^8U93_YV?)F3F*^A
MB**O[C"CZ.4*A=.V9?CXE&):]N@IR-XBV6XXRS8NT^^\.$07PR6Z?EB^A=TK
M@5\P9DX"Q(& D1YY+E_\!6I1__V@*K#!$S>B(W[@BE_];+,)8&OZ=@:B=0GU
M%-B']V@?TJL;XJ14!<AW8AK0DW645*S=+W&0-\(OHDS1DIC=1Z(Q-YJ)IZ%I
MR#"!X0QN6.=R$S7)4Z0OG]F^36N> ]J4>88J$83C%HB]&/I+XN:D#@T2= N(
M6-@*YWQZ J?^:E,5Q%JFR56M=";3O:K^0E45P)<P  ;95<TB<OGW*_ 1C)ZV
M]9>\JJ"Q\E'_>DG>T$_?C.^N <%CIWSG!?VG,;0@TS+\<Q44WNE".]7ZBV=5
ML$6G,NE4-Z'$/L*SP'_OT0<R23Q/<(]&$#H"[BK9&MC,N2VD&S5I3_D[!"&3
MW8O##IE/:3BC8^[GPG5?7#^)V3$?E#OF(DZY7(-DB\Y9@# '@!'SG]FWO<4+
MM7BA%B_4XH7(;L'\M'BA"N[T5<$+R0[W==KF(02E'!B 0+FAR#F<^7SS9^!3
M)B'$/8?C6%1;'^Q:U=:U]S*K@H.I\=E'B1_W[2)FY2>W#!B[HD="Q#J6*<[H
M=W>6S+!K%?_M;F^;3(,DA)Y7W\@#8]^V"0.J58QL B$I<R+R__H'>QW^)DBR
MJ@LT!-<ZN+>0V8+_9AW*!ARHJ@*T,8,LM1)V,+: .?V#42^>FL$D13S<B/32
M3E4P, L;B-5/]%:"=[UTL9]9+52<W2HKQ5.9)BSCDQ5W%$W_"1LS;*&^(ZKM
MP"51EKPD*-:$:KN=JF )%C?<:Q5KJ6)!1:RM7#^"VM)L^8#E'\,#D  %$\8&
MDK@CJF;MYP(4RH!LKG:KW8XY1GY7?MO,?2583)5<B&9'SWG.4H/0U-K;G:J
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MX\'E'_#KH3P$_,DY?417!WU(?D[5#\@R=ZL'X1083SJ43RHA(,\^,_><Q:.
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MJ84R1GT!%?E;[QP*OV)9/[0Y2V1P]6B1'JK-W680G"C'!1*['DTB)F195K#
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ML%@R B.><, ?P3?>2(!WS$-%F>J7]\XB-VE'13EL73^O_']\QVQ3H.R!3+D
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MKA?Y3I_!A_((,F,LEJ<*?OSQQT"AJ2<^7QW?29D\Y>TB^WYS</WX"TT8]X&
M:( ?HF(D%H!S']!S8HX_IM]9OH6\B7K. K@(O:>NARJ:^%BP@O8%)2@=.K]9
MD(1\/ 5C-Q*[[/N48FE^5U'NYJ4#KBXE="\YZ#[5]"26Z0$R^9 5+01,!IK;
MR(YD4=/D+LC/]%^._:NRA[T-=[G4A[V33![K=[YNSH2B3CO%Q.6PIO;/,I:B
M5H?%'R*HSV4*%YC>%69^X:P7M8RVS<0R^YR65J>L?'S,BL%X!TNJ=P57*[3-
MY)/ 55Z%E"@W3(Y )PBP1.8Z"742^)4Q?VCLQ@F&UF90; T69!8XD(T4<6$D
M12QI;X_>COBU<'<TOF,(E#84JD4@!L[BX$>$T1 ]X)QA84O_UY[NV]-]>[JW
M3O='#3G=FX;R>99Q]>T?I^7#^_YAT;,L[ZU_^&+.VV"9&X5S-[R^/3L^/^7[
M.W*1]P<?B?%G>/+E[.+LYO9Z>'MV>5%O-_:@N^&4A<8,K#]/O)D01<J/(-\5
M'4%Y]B\F>(/K(L&3%\<,/*?Y/ #(GIE@$]^!4U460"B-D(@TWIS[<R[X'8)Z
MCY$[YC.,(\R!S1^+."#LD=[ Y+-3:3^X>$S#\!&AO$D.+RDC#0N1A0[SN%L:
M8_(6S]L1&?/-A&*S##BZ:V=W1GUN1_7Q78]4_T \(@TA((K"Z(,VX>_#AQ:$
MD=&% )\N7TZM$?BV#C\ ,&3[5($C<%RY7+I.@F4L=K&]1&;HN[F1D9RJ^?'X
MH+OAT[&V*[]+*;X*'D"0@/[0DN!Z6IDB-=>X)/:=JT,$J".M]@*$"RH@B\#,
ML"9$VFC"#XRA1.JJ!FMP,ZUSG:PVEEL*V2L$!C47RV*%])B ;KC "@:W]\1#
MP:J@28E$D-48N@M,^T;+'VA*ACPS4#Z&X 3%POG $!VK <^V]1+=/P6XVI$!
M=J!CY6.*P!-T(ZOT;X(&ZYM 4SV:I!K\U6152-H+0[RY CI/Z#@&0E0+"1+)
M [FZHVI2RH_7,4P3#5V@Y\1S,=YXI;<V<&@J%,ZXB*I5GV"[%<")Q%'F CSC
MAXD0&[@VLI?1^C&@C1V 4$=B'Z&SD7N7Z,5A?Z=_A_N"6?7'8%"A48RB@.UH
M.VS<EY^@N;#"1.AU<P$"C;=$68%;8&06(^\"$"_GREX L?$X;%P0-;&5)I#E
MP>*^D%!Z1,JZ2.G"_V++3G5S,3L*1XZQ4]A'0RB=@ZW36$6]ZT+@U>/KYOJ.
M0N3QF5'**:_B"A!)DFFAO+'L8X0[/KH 'GU8LL6C[A?J6X % WA4E%NN5#\"
M"FCI':0_3*7FMQ1;(@*88'-+RS6%-+JZ\#/#JJN0325SGS%8_"E"%Y;I;RK@
M<'TJ"[@?@VL14BRX4NJ#Q;MB7B%MD @O "4O2ENF8A\/(]['_Y7BJE"BE>V0
MLH(KMM#%8=]9.(:A:*L4X:A&4G1$2&QYOND"$BJJ/]+*'J1!^XM#Q1Z8GDN5
M]X>F1YJRF!LKOSPWI7(CZ(WA2-+2#ED+Z=^#^D;\Q;AEX))WQVV/X%P.L11S
MDG#5X.\4^$[R@K1=576,=BKB&!T'4=P$?VBLWC,]<.GN.=:!;!2$/LM %G7J
MSS?;,YL9-@G@CM"QA\H]O@.[HB )?HI54JZR?J(*U#:A.#Y1*9SR"XA!(U$2
M] A,6ZM!"R <-M;YP+#\P%<->[@YB_AHL3*,.V@4ZR(]L<.+TFQ]:;W@@#?I
MG.GE'$_YH"'K>4>A)#.[<+G*DC3_.X*,KRO*/$/T0455&/?6T#KRGYB[@<SZ
MFX_'BK/O8R9IZ##S!'F64/>9C_A.Z5%P;060GN%"IN?*.5ILN4G9CC0@]/F[
MBT,H..13-W24@V+:9KM3A"%7--3M*SU5R.<HQRMD&)"LO1W>K8@=/N-3,/-U
MTJQ6>GEK6%*A&:Y\VT?1-,1QN?U$<%4PX3/ T.UFTNM*TX7B#M(S&4Z C@2<
M5119O(_M!!GA,-]9-:AFX$P$/F:L[X) "Q&3TA&LCC8LYD$-4?/<(?0"L,0=
MXM 9/Q)'4-@)C[:.J9#FA"TGK3.>,/D#@=<06]$L=2_!1<,S6W:T"AFCNCA$
M+(X]EO9JX;=QI9]_#R<.=392' 7PI6Q\$?*3J>M!)2DDA8%14]:D/@!S!UHS
MRJT)/P;]BS]_+$R( 6,2Y'[9IB3B&:MY@!V!QN+'OL33[2CAN"S<^*GN>"/J
MI!XPV1W>6YLZMB%^Y&>7.1UC9$,80H7,L@5K32K7IIS;E'.;<FY3SIAR'O0:
MF')^BV[B7D7<1,1/P8;%G0"^==;*3<S2""!V6'> 3KGARK%DZ<8OV5H<X8ID
MZ5?  9"T&%8[Z.P==13:2%T*OZ^8-(40@>^6L&Z1_^/[=H3H\F<]V21WB8V
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MU_7'"19R4<,%,/'[8Y;2&-OU?'MF,\(I=:#1%0GF\R",$Q_Z<_ K9O0;P[Y
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MT[O<'2,'O9]_ZA\>?>SP34#V>;#WAJFUD>(< R5"VMS!,##$[M78@>]#-F;
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MC6(HS7&028H2;7\V60E+%#N*?]KA.JKK@0@R#?.Z_;8OE^*W/2-R?%5>VNW
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MCV=*DOBP#ND!OMW7C_GW/U!+ P04    " "M-$E4,Y>S(_Y$   86 , %
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MVY#=DNE.;$]>!_3;I2P@,FTD..[;?;*QSJ;XLH07M-*"<S*ZX"]T[P N%%K
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M([L@23//*FGN(\1$&SP$1%$F7D^T"Z">>2&@^-#E;E5,:?8=7\Q^<:Q[AS\
M8E\LKID(*)%* <K%[K'!R;GNI>-K$+ZZ9+D%60&9_)R$;F(*4,I;F9@5-(LH
MC81T9^'6!HRYU/.2"+&+'O:[ &=;:!EN>??U69I<FK7'4M;>.9\'",0VQ\AC
M<\D/FQHW;@^W2#C)!&<2O(C>W]<IL%RE2X]'TY%CBO- T"G'WPY98JN6K"/E
M6M#S:/5>W8392R<O<>&C>I[D3:5G6OH3D',CB211S[T'7#"8%[= _%PQ'>\D
MJ*9I'BOC$^WHD_8TV[=M]_,H<_C-^>8NU\OB[M:GVIQ\%YU$&%5^=I0JK 19
M:RE3N:)IYR<O\^6A4!8R+O^8>L<A!?H\,>:+N:SW'"WP0!I62_$P+F:=;4:Z
MK_69I;S%[YP29Y/RC22W[EP_0Z=8^#IS0MZ\-%U6"@I-#7;>WZ*4Z5HQ):EQ
M5A7-CPB"B:@E]NOPTPT[A(JT,!S/$0L5OZW68;1V>"U $C2T@91G]N6Y'CI4
M*<>9IWN:B4S&<:0Z3.<<QM0#5J*O>^"RAXMY@.9TMZ\2C3-A[:<L)),8RNL.
M0?;VZ__%8_:2 1$2%JY<@LALL9&:]PWG%H;7ITP.[DXO0SH"*$!M4N*^CY2X
MH4F)>]8I<?6=FZMIY2>F;^4UJI;JE-@".VA0W18GNUE+V2FK]M(#CR(2X#E)
M;ETZGTXS_#<J\?R4^2Q":"5YX0FN*!G2LF%T;!!3BQ"<, %[-TM-5I=E1$GM
M')]$(2<MR"8>JH9'+XA-.UL*S_HT>CD"#@#6F"%CRQ(K7VL$Z8IQOLDBT@O@
M+.1$U MKRON8);YRA*ASK/1#%.:6A=8QK,[GZVX*KYM9"F ^[COLYGF8CZ_!
MOE .BK2*H_2.S]K(O0J*GDK*FO?(*"&G(?ID4 "S.EQE ^\V87!38:VHE\KI
MCZ("*I[S(%2>-HB1^WU]=$(M18EU2?T5*)LYP]Z'NZ>$]0[6^+Y18K_O!)5G
M+_97)!"O13V!3'80>0\5-- HTP%N)"?08UM$AQS &[7!A %?1Z43X3()9:HY
M8\JQ6IRB#9?&]$U>?TG !>/:W$DP=</I>LFSH7B&?$LFPR=7_NH']X 6',"&
MV7Z?F\%5^>06+0W?H8Z0;%:,>M.-[QTBD.S-4ZS2],_?;VS?IW7,+FB9':TC
M+ \GC3=?Q^NPH!&G*"PH \> X#R6IJ7KWS'0.[>@3[D+K6PO*/\6%HJP5+27
M2[XK^S"T%/929X L2(^2PH&BU.!,&80DFD"*KQU*\BMN+[K#X<%GKPL&X82D
M'AAH [3V/$/4L5-@XF!"IE;&492N%#(992EKHF4.J2V'U- <4@6'U+OERN$]
M*]^P"350KCC(L5,-/O+0)$Y,5#6N':0^2>#:N?=&P;<S;>3.2^<2A P-9Z$&
MM7CI;(U.C6 ^CUC<4M4)+;U;IU .>V15RS488Q,$^M((=-',(RDF5>3O<A&^
MRDWI?$SOBI)TQV2@JNC6Z(2Q.W57'"J)!IXBYJD"^Q3$I[X&(K0?K;"G+U89
MHN=K/8G<&3G.LOE%&APH&*>9Q%KTB%DJW4?UH&TEN01R%;L?V?W#351KE(B/
MC(@7B/@5=J"I0JY!LJC[#;(PS1KC(PE*+8<D R>*@^E7*UAQP>:_@<Q,%R18
M5*Z';V%_9AR'0+),K!FEFED7'?,*+B>M8%4/9_@9+ACSWHL[]=O64O/HQK,
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MNIVNO2N;]]NC? ]7^[*H$E*]O4>]X#[.L,OV.#_L5+Y;%&V-"?BK.'0()+\
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M5[01O9IMQ"42?;1O_=MA;9M3/GBWPR.'^ *LU\-?>_AK'_FOC_S71Z+T@2C
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M[OP]?4Y)Z4F^XDS@)%S'Y5])B\]0E[N:G1R@6>TB=6L_3=\^91_)RV9W=WR
M07D(I6_C?_O0=K03:<&^784NBYWPX:"ROMO=LZ> _CH)9@_POT6\]'[Z7U!+
M P04    " "M-$E4@B2$"W$6  #KGP  %    &5X:&EB:70Q,#4U+3(P,C$N
M:'1M[5U9=]LXLGZ_OP*3W,[8Y\BR)"_QDLXYBJTD/I-8;EGI3#_= Y&0A Y%
M:+A8UOSZ6U4 N(FTY<2Q9,=Z\"*26 JU?E4 W_SCM'O2_^NBP\;1Q&,77]Y]
M.CMA+[:VM[_NG&QOG_9/V<?^YT]LM]YHLG[ _5!&4OG<V][NG+]@+\91-#W:
MWI[-9O793ET%H^U^;QN;VMWVE I%W8W<%V_?X#?P4W#W[?^\^<?6%CM53CP1
M?L2<0/!(N"P.I3]B7UT1?F-;6^:N$S6=!W(TCEBKT6JQKRKX)J^XOA[)R!-O
M;3MOMO7_;[:IDS<#Y<[?OG'E%9/N[R^D:+@NWV^Z>\[AP6YCMW7PVFWN'(K#
MUMY^0QSN#?^O"8/<AMOU,V$T]\3O+R;2WQH+[/]H[Z"^TYI&QS/I1N.C9J/Q
MVXO\K3P8P=V1FAXUZHU]N'/*71>FM.6)872TL]^ KR)Q'6UQ3X[\(YH5-#%4
M?@2C#:!W_>?B('Z@9=N&HSP5'+ULT.<8KVP-^41Z\Z-_G@#QXF#./JAH+)U_
MUD)8XJU0!'*H[POE?P7,%_J@?V>:'*^A&4_ZPI)'$Z1S/98#&;%FH[ZWEY_0
M3=.".<%XY63$N!?!8*]"6$,O&GMJI)KUOZ>C%RP,G(H+NC4SC)W=Z?6Q:7F@
MHDA-CO9@Y%<BB*3#/4,A(I:^;-:SU6I.K\LX($-7!P@E@J66['Z?NK=%;-ZV
MB"U<Q),_+]G'3OM3_R,[Z?8NNKUV_ZQ[ONZC/N^>__&E_>GL_5GGE%WVNR?_
M8MT+'#AK?^AU.I\[YWVVC(CMYX5IE5/ZT&O#H$_;_<ZKEWL'QXR]>GG8//[<
MZ7V *<(\/YW"%SO'/SJKI9GR[SB,Y'#^X*J%B-&LVR'^U,YW2SM'TC?W&\>+
M/Q]D4&44T<OI"D<%' WR4>R[(L"[+.-TW[/VUW;O=(5TJS/&+N(@C#ETS7V7
MA?'@;^%$+%(L&@LV#=25#&'T(5-#^N:G#'8Y<;M9NE;!=4 34L9D\\ 7"J9F
ML=D&TNK5RX-6:X4L^.+MA<?]%1*("- \WJPQ( E2Q 5/DH4B8D,5 ,7X0%V)
M=:'5AP"%X!1&N!84NY6QFJLDUHF:3+D_?\B!E!-LDXUYR$:X=A"CH H;BT ,
MYDQ<25?XC@B)\?3B6JTF@A!(Z?,)/#(0GIJM"P]></2#)9 V6@LF+)@#\$DF
M(1'94;Y+<6:8$6<5,.D[AEF!M!*%7H;L7/G_B<%%&4KX\C)2SC?6G1(WMT>!
M$!1E;JR>^,E@UH+T2&^*%&M$<$4$J^%*3./  :87;!BH"=UGI)'^YB.8Q@CU
MK!]/!B) (Q6.>2#(A,.=$Z"[7H2-_T7,8,H#=L6]6&Q:&V^;6X,UN:21K\&"
M9-B<- :L2J25B5V-:2 = 3SO0B ;K9MBT?*V!G1$G>*,K?P#-P\$$]<B<&2(
M^CLD]2U]/@1=H]U/5[C@IO:!C.C-,!E:#3_A+K [\F]$7P'WHJ1D="@( XAT
M:+H9*'#!&3S(/:_"N\4>H+,3/I41**S_PI"TSO-5Q( *(IC!.)DKAC!!UXP5
MQ0M:''/P9;"1B> ^0F4\#"$JPR:4GC0VM1%N:KV8=(8S,^2 N7'H*J,MM=@C
M76R?V8?O'A3^$)*UOU/?S7Y)ZBGYMBQ\C?C $[;U@0H@ MH"AO/X-!1']H]C
M5X93C\^/I$]\0P]]%TC4W*DW&H1513#+R+4]&TRPKJ]M1V[)Q=:N?;;\^HT/
MWW3Q8&_YAK=IW$$!-&ONZ3FAV?5"8.S?7^PDP)I9C*/6])HU\\M@EGZ!<&JZ
M&O0Q(YD$F"1\:.BRKK.[-3QMW!Z>_@++VYE,/347@IV=/B_OTUM>[8H]K^S3
M6UGC?5R@ _L+K^\V.1[WYTVM"S+?JC\J<+S?Z7U&;%QGAU88,X%OOL* J6_P
M%AV:0&1@I%0'&Q#.0#"*T0^TKERZ2?ALH]G89'/!@S %!U)<<P'/@1L]"7$6
M]@,Q%[5O(J&NP1MX%N#)Q!X4:EF )T%.@&3GBDWAYH6FTH&;<(]" QWG1;FY
MVB?N/;Q9%X'<>5P"V?EWIW=R=ME9$Z%<:9J1;?#-JL7K9\3FUCP:RE!M028$
MX1/P\$1&$6$(+!#_B45(+=F;;*L9$+[Y^A@$E5 ]"QFX(-(RC& ]55!#4>4.
MK*[+?4>PF01I+FO"B8, X=BDJZGR(&03&O6%:3C"C<$-A*%/A0,2A(/$A@S8
M"!^8H'85#>QB 3*WQF:P F-[ZX3/"5:!6SP1(DP/6D7Y@HV!]P*@!"@ST&:F
MK8W8-W=E@4US,>D"$112)BKB0%?NZ=E2M_J2GU4_FZ"OVGXZ6:!]%CU"0 F6
M!_0L84Q5BE@,A[#4B/., Q6/R@EK($"'AV.:A^W3X&(9TL*8NA9I2E#&2$X$
M#L ^5LL-5 \%#("+RC3'' Q[Q"G0;^ E><4]7&$T'WF\V#".QC$-FQH"9SO#
M?(OPS(PS:#3V@1[?D/#/D#JX+ >>"SBSFOF:\;/=D'F+@#4X,'\HK]G&_B:#
M)J)QJ-F7LR&7R$;!-S!0A&"G#PB$T"PI[FN*-48FUU&30<%:PF#%2($LU*MK
M6$H\9/I*PJKY6"8V7:[<;%VLV$IM6+E^WAA4*F<(;A3)AHQ0^*;2Y%-5WOM!
M+2>N'3&-T/-)$5^+1!O(MY9U;&:2] "PA6!7H*HU2%NF;?$J*LS0&8.L>V(Q
MJ2 X:"K*DF/#I+?L0\H!Y8P \>JS"7^:(:U'LEPGR%"1&.KGUR7G;Q:4S-1R
M!7G#&:X8$I^03QHJYBF"\Q=TQ(1+/^($RSLP6NG'*@;N(AR,LII%.ZL5"-CW
M4+J2 QD*FK#$:<]9E<12(8OHHK-*/9&#[IN-@P7@?F>_/&[/:J6MI=52KKO7
MK>_KK=6J[TU_>FULA?*0E<JCM?=;:3"#_&9+6YHA5E#Y\DH$869ETX6L#F>>
M .E^C'8MDM]?EG8_1KR=X%<FWM4/T6X7_<AUH=U=]>N]J>[OA%/2C1<'E!56
M>N?)42 \L*)7HG(KALGI-M)'^"!47AQ5/[)$J?3#YIIAB/6&'F9%KOFWJHSO
MX4']L%%]N5%O)M=^(._00%A>$[%R,1>Q[R5EN!U([E6([N%MDDMS;RY9%5_-
MB=F?XR"=_DAL#0+!OVT1MGC$O1F?AR_N8=O03]HS],/-/C5X=/=QP:/]]K\[
ME[]LFN++%*-FMH!K%4QO-LC19AA#H['RW#3F(0A,N E$6M$4-H&@J$2,,.+7
MB)B=Y>Z0809/I1A>@XLVDBH;;GYP22V7WML( :+I,1<"(C3$3=7E1,4&,81&
M[-P(',41,CF9"(CX(N'-:RQ&FOG*0&4XXF(E9PWB5L24\G1);ZLB38"U:1ZZ
M,QJYRHRVSM[' =)B NW6<@N"2"S!7?B(*]P8_M(%:S1VZI6"5R*EGJH!4V'^
M9';S?2'^87%'^-.B@$%54[85JF%%I!.O"I,;4D6::P)$&%_#6JD9[DTEY)-/
MIQY0%%OR^.Q.4-RC4I![CTM!GG?/M_J]]OGE^TZO_>[LTUG_KU]67?:+T8C)
M@$2X<7LH@C*0*J/!!G.-:C$4IH%6/<#JI#)=$3K";.-R,?$C![')X>(W<8#:
M*%>"9U(3GAP*DKJ2;)3RO;GM*#LFTQQ^;9 O0CIA&&4]W(2(6>P.'H4/HFX)
M/"91M3]5(=Y?Y7[)1Z4_WG=[[SMG_2^]3 ::?;F 'U@J<G9.VY_Q4N?SQ:?N
M7[B3>+5;*K_H5&5)]F"H#6)21&'_S=904,V%L>OY3,#WB%91H))L!^9PLX4>
M><,:^[FB?.N1I9WELB:N+B[)5*8,A:0\2.KVX$0I]P+:(A 1N#@)54"UP:SE
ML*AE[F.2]("*(W;"XU#<-&63/,#V,K-?S-%K3R5*G16=1<HX;#XP120%#'3C
ML/$S6'$?4:-;>;$$D<%X<VNG7H)P#'@HM+A%XY5NYW/!&<VRS5"ACV>-3883
MB@R(*[?(QGI5;V/.)UMJ]/IQN8H%A7[1[O7/3LXNVN=]HPLN,TJ>?3WK?^Q^
MZ;.3]I?+SFK]NC.MU,45<2;HL_O18S*CRMR\*EO8ZQ0(1X",8[T>R#:Y8QB=
MIO)SRXBF]AP $"'.9H&,L**0IV8)/DDNN@17-WY@(6'IN_;FS+!TS>)"76'2
MES$-V!-:3(I%<[/";5,ERKNV.*J"WLXI[HP3NS XVG-YHV*/QEI9Y164A]4G
M^'7%K,FZVWRRK]A(P76?)AV(4>QQO:D6^@UB#\NNH.LKJ3R]I7"N:6%)[:8+
M$F1*MJBC5R_W#H\3&UMC8PB4H:N:YDZ) (1A5XHH,H0KILS%7!G>5($< 2]Z
MQ)14.S6O*/;$L,8:U,1]N(TV94IZ^:=A/#=*(= 7Q-VGLK3;4O3^/)NDOZ%*
MH'R)%VNS*,33YVC!C,#509</&L7([FZ#*50,C+F;88>LZ"U0%T4)A!R\ F$"
M1JU;D'_ ]H_D0'HRFM-]"QRV:"$?DQD\>%QFL-?IG_7TD4AY*[A:W&1M#.SW
M8@S58I0)& 8(+_-0RS=G?R1[<7L"(Q=M"[,2OL$W%TR@TFEF8]BJ8JP%#1DD
M79B8:K'*?PPVDFWL)&7^-YKW0GM$B(W!ID9\DVKBRA$F9C5K-9&Z9E[W-*P:
M&X!7 Q\-AI&YP>9SYJ:X,0&&, "^0IP9S>3#&-4%OR-90[@W'S1'1?\G3Z)4
M*=^)4&7^36(LBQ:PK,7"5H^,U-A-YT3,<KY?W%_OA8I1 AZ,FD^.8VIV4G>N
M*)!Z'GIGO:VJOA0.#>K 3 S!?)U) 2I@L7F"_=OET;6:Y8F0M,[^9E51#"+K
M; W**\M(O_HR2[,N>+K!#5RD?6:=NN$1%D?JKT&5CH!5Y3":;PTEGOJTM[=I
M"KEMT79A!Q,\DZFJA,%?2<?48*<-VY9#>0VNR\9^H]BHZ>R61G-8%!56:O>
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M252(YAW>>2(  *'] @ 3    97AH:6)I=#(Q,2TR,#(Q+FAT;>V=67?CN)6
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MI\U&"OJ"G106H-H%>)N$OCY]\%D6R9QKJVOPB.GJU)8D<;@D^2O -QZK377
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M1IJ'-\WIX&5!RA!Q6!UQF*V@'.MCYJ0G3UD3M.K'H%"BGES[L4)A729*$'*
MG0GVMLZ*;W$2'NIGIO$%;6,<RC*'>@Z/YS16VZ_ERI+^3G7X;FTWT.'_:$.H
MH5H3Y193)=52'7_DG-$+D(]B(KVMV4X7 NMQYZYZ*:-36@6(&R7.7G !VF""
M+S7!E;J02IV4<]P!R2XDV5_41V#0)-7QCCS?0+PJXK?JC;!71'T#\$+ ]:?=
MDE=J,6!>%?,V\U-!>^!>%??9SM* W#ARC1AH5T7[B0J+>8)Z@-P0\B#=:JJ9
MYG@F6P*.0B;;.EY[MDX 0GI8L4>X<.AH=F(Q+$-%O4S#9H(0\#3A;9DJD]4^
MK5#N(]C1(PA[EA?V_,RQ9S]3]0$S*2LY68-<YY+KN-]7P?9?H+6+]T1.9^6C
M)UT2E"-9'UJ89!2*$VAA G=M&7?M&*D-"K7]T<B=/7*$_J0+/,A1"PQK4&@-
MHE[RM]1^41H3HE]5L.=L1+@<HW#DT% ! ^X5=)-O,D_XKL2>C"..TWYKH%XF
M]8<[* JNG/H#(\)RB#<I/$NY4\/ZD-BA"L>_4HY_K;E=<4&;FYN2,"(65<>@
M;SK9=>$D2LNA?0PE4&6"?\2N3]*3^B!,4 'TV1YWD&1<P?P$(1W\3)+\>46]
M0/P1NF=F@-UQ."'H$^,#@1HCIHZBRE:)Q7MUG?:J1N^P!AG6X.O=]7:@T&=2
M88/T-:S>(S5MZPH/1\*A\U1.[OZR^T<;M3@;&<69TV,_=_??_:,BW7^/]M=;
MG:8NT"5<P_EU:\@\)D;J*/B?;_G7XV6IGQZ<J%O&T_-&@]JVJ PEG(F9<6V
M\@K*C1MT087DM.M')801YH:+NSCS#'3@O(JSVPWMRHD4YQJM"'Q7\;UOIH^I
M$>6<!ORZO?)_",IZ#!3C.#@N?6ABE_88SQZ!!T%>@3BP%)O,L]2O[)-B!U&
MO )R9(DW1B.76H$HQ[ZM!X?9!%V+'(6N0#L;[>G)/S/N+27Q'K$DM7P)V$O%
MWM;),EK"0948I/RH?2E<?=BZ06< GA/X)]^ST>=6,=K':X;?2J2]4;ZKI;0+
M!9A!KE>03C*VH\-+OD1BX+N2KR3<"XR]H)WC^QP1?XAQ:LWFM8XYJ.N\+=2N
M_?)SO7YPAAX4<65@*^KM&KKQ7\FPJV2NGS7>HUO0;A+YC=+7R:0&[,MQNF]]
M,3'?--H;&3QHX>'(5=H$M;$2\</=,W5R).B<N.0;1C>=BP;Z<,[Q-^J""B]'
MA7^AMD?&Z9%&H+T-:.]ITF_"E@"^(O -^UD/]K91AUB.I[Y9GP+^"N5>-Z6^
MH-@="UHP"6MW?_TNC]^SW7):.XW1;[>OFDOPLQYJ^$(W%(.%>.^%N-%M9[V^
MLG/@MGC_U6@YU,4V<4<.+3C/!Y8CWW(\$ ^[DS,6>'E-F/J)&STH860<W.G&
M0%L.$5+_QJOI_)0ER8C NA!K8BL=??EJ.5AMGR#/1AA'Q2FIOM7YRE6 \ K"
M]UPG1S#T:5'JX,I)=] ,(J,,G$(S"+@]<]Z>K<:"V[+ 5%6 O0IV7")Y_TRX
M(%B@>\^-2SJ <3F,'U S4,)Q@09D]98'N.43+AEZH!9#T\4P$[617 ' 2Y!H
M);A#S <HQ15@5P@;127N<ER*L(/Z7J&^']JHP>DWEDYMBOX (KX^X@AEH+S;
MDO%T^0M@+E62]^M')^@S=;LD\$8"9".0CP\.48LP3D%?F&(<R; 2Z.-Z4<BP
M[ZW:]UY3!8GAP25GT2?(\1+$Y[X01.]ZJ83I:'(>X%T?[V?&[#'!?)HPZ.'2
M +<=TNM1XMJH\4P\'T39'.F@"^43[F+A &53E#N.>E>ACM2,>/05U(8AS$]*
MB-6?)//0#1YVISE#:Y0R#;AV<T$@I5!;6\"]"K?$4NV">$1ENCXKZ) %C,MA
MW+E;(-*327= NB327+VE3EO#TZ"AJ+-4S(^$KY.( K"SPKZH-6I/M;@!,!8"
M6XXOB)19C6>@NXQN%-%>$(*%',$240>:PI(Z=;[)7'_8I7@1]CF7PA*LOP27
M.IECQ*D@J*6VQR#'&_>('*-[WL<>_1;OF="0R0#\6J=V7HL]TAWRBD&#EX#U
M,^:A-^^<J)UQ^E@.3?)*)4T8[R_4V=&S +H,T(JMARY85^C.^,4=>D!Y&64>
MC&F3-;47^NXTYENJ3^79A[0!Z"6@K]2SVHC0HZ ':\4! /,RS,Q51^[Q-& X
MB)?(EPVVV_Z(/+S" =$$X&L;.XMRH8/G '()D-G+(@M./P6(UT?\1;T;%@L@
MAT\"YA(P1T-T%H%>.6,'4&=%?<-TNX4+[O>C3&>4G*SAM&V*N9Z-AKU%VGKR
M/,!>'_8MYN/@B#*?=?PTH"X!-7&?J>L2]$""4J#)X#_(U#41ISTGKCMDNJ==
MD.P(<W",R#3U?$G",0LP \<T8=V$JZ]^GE3_U-WIPGE910=H ?:"V/D@.,I$
MT<+X(?0>6;OWR-XN-!^!N[2LNS0N  [GA^<+:P#U8M2;^DMAF\43EL)' -TH
M]"C4 :)>*?4H[ _4*Z5^I0X6E"8F;_@8H!N%'@>KWV<"PH]*/?;C%_;L _AB
MX"<.YN(^9T!?#'U0>E6L$@N0%T4>NOC!D*D8>ZJ@98TB%^!?C/\=Z7(L!C@=
M%PC_ N -@T^U>5^O^SLL0?$EN"6O4VT@D[\!?*/P[QW*(GVO_PFTS=(>N%BW
M"8F)1P^!NEGJG/0GY73A R!NE'BZTSI8\I6B3Y>+ OI*T4^WQ5FS70XL0K%%
M" IZ0? K9?Y58B<1=_T(@!L%_DAYGR9[:_P0J!NEGK2> UNR0NI46,P3--76
M:/(G0%\R^G!X3WH%DA;.$&TU2;[EC 6U*/90BV-+D2<3:R9?EQ) GA5YA[C$
MT=4/#DCY^R%/Q+PA!%-W@$XMAL8\)?(70O_?:$07E54E5P#P<H#KW[>$MGX:
M4)> 6KUF<6EF]"R 7A]T'(U>0#IGL!I0+T7]@O[4LS075=0G%P#N$G SGG+.
M+D(^=1%@7Q^[#C;/'=F6(PH-@)<!CF++"R0Z9^@94"]#';@!%X'.XR,$S$LP
MIX/*BT;UPH3O<I%SIB?()E.^+R@GE@1M;1IT0AC:/Y=+^H'8Z!X/=+">6^JY
M8AX_0+P,<4ID%RAJD&H3(]Y6G&)@;%/I,]_BJ4$+B,-4H1)AZ[R2!9QSI)P
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M:0Q;ITO'];SGVGG/T^FZ+,;!L/VBU'>#%V6O6NVXK2CZ]F8C-PY>5GULUK-
M5& @W"5RYT,C:BP5:B[TPN*.!,\,B$\AK]#^\:5H)_5#+"/;F.\)66?_ML0,
M[W^JO(YAK&94+4C7#BGA=TQOJZ/V\PUV=R?>OS_1;QK _D;^K[^+[[<D7XVH
MZ_]G'Z^.+NS,\^5B>/+DQ?0-Q>T;BC0VXM,&6^LF;IH^[C53,TO)$JE7>%F1
M;$N%M_:69PMO=:A<*;NM0/O_0F^C$7P=5,\^W1]-$]NIO/7A?I.)Y\EW)'Q!
MM&-;3P&G)NVU+TL/56.G&/]!A8ZQ=&9Z7>4_/D;5_]6G,?N1[N!?4$L#!!0
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ML/0R2&+:2SBN(:D;# *8F')L:'C\[0O$/'4WN+@R.>4Y47\8FR604$P-;38
MB(;;^O\BH(]TCNY1$?"/X4"-CK,=*"F'"FR6Q6!M:0UA$@D^"*DG)&9M(18S
M2#F(\Q)_N\658PA 56H15$R$.<GE$AO8-"R6]W%!L)([HD"*@"9W#;^X2A+"
M@][IL,5Q(9@/0WKCO%/+=V%M7^YC$)^9&EU&&<+K .Q\ &;!P:I3,$?T1.G]
MSH5V=UHFJ MO3P(Q3.XYG2EWMX*$GI*0\%-GR%K8,V?V8*  27WG,07I\<#R
M!ST":!=#)(P7QV+8'%M< LRVXXF)7=V%\CS>:VP$!>HPL!$8&S85)T?&?)30
M(?3S[4(5 N3HZ]Q!+4R$_ TYX#'"L/T$[X-U,Y-;@E+"K9"P8A")12>&!,<[
M?UJ5&VRJ:=>PSF:ZH*9M=NGJX=&3K\.3G/%#$V.>_K;GR>(>(7.#4%83MB8
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M@D%ZU>&K_P902P$"% ,4    " "L-$E41(*W)L+]!P#7<5@ $
M    @ $     8W9S+3(P,C$Q,C,Q+FAT;5!+ 0(4 Q0    ( *TT2520<5_\
ML"@  '/F 0 0              "  ?#]!P!C=G,M,C R,3$R,S$N>'-D4$L!
M A0#%     @ K31)5'JJ=&1930  <$4# !0              ( !SB8( &-V
M<RTR,#(Q,3(S,5]C86PN>&UL4$L! A0#%     @ K31)5&8$C,K!^   MEP+
M !0              ( !670( &-V<RTR,#(Q,3(S,5]D968N>&UL4$L! A0#
M%     @ K31)5$?_\BG$#@  ?@\  !,              ( !3&T) &-V<RTR
M,#(Q,3(S,5]G,2YJ<&=02P$"% ,4    " "M-$E48M^OM3QI 0#'\0$ $P
M            @ %!? D 8W9S+3(P,C$Q,C,Q7V<R+FIP9U!+ 0(4 Q0    (
M *TT252*_1MWWE$" /DS&  4              "  :[E"@!C=G,M,C R,3$R
M,S%?;&%B+GAM;%!+ 0(4 Q0    ( *TT251W@\_EUV4! /#/$  4
M      "  ;XW#0!C=G,M,C R,3$R,S%?<')E+GAM;%!+ 0(4 Q0    ( *TT
M252!=/1 37<  -:G!0 4              "  <>=#@!E>&AI8FET,3 Q,"TR
M,#(Q+FAT;5!+ 0(4 Q0    ( *TT250SE[,C_D0  !A8 P 4
M  "  485#P!E>&AI8FET,3 R-2TR,#(Q+FAT;5!+ 0(4 Q0    ( *TT252"
M)(0+<18  .N?   4              "  79:#P!E>&AI8FET,3 U-2TR,#(Q
M+FAT;5!+ 0(4 Q0    ( *TT252(YAW>>2(  *'] @ 3              "
M 1EQ#P!E>&AI8FET,C$Q+3(P,C$N:'1M4$L! A0#%     @ K31)5%^4<<_%
M P  W@T  !,              ( !PY,/ &5X:&EB:70R,S$M,C R,2YH=&U0
M2P$"% ,4    " "M-$E4O4DT?!,(  #3)0  $P              @ &YEP\
M97AH:6)I=#,Q,2TR,#(Q+FAT;5!+ 0(4 Q0    ( *TT250=2MF>)@@  -LE
M   3              "  ?V?#P!E>&AI8FET,S$R+3(P,C$N:'1M4$L! A0#
M%     @ K31)5"0FS7;E!   _Q,  !,              ( !5*@/ &5X:&EB
M:70S,C$M,C R,2YH=&U02P$"% ,4    " "M-$E4I,#H#N\$   Z$P  $P
M            @ %JK0\ 97AH:6)I=#,R,BTR,#(Q+FAT;5!+ 0(4 Q0    (
M *TT251)4]P,X!,  $51   3              "  8JR#P!E>&AI8FET-#(S
?+3(P,C$N:'1M4$L%!@     2 !( DP0  )O&#P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
